data_2l29_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2l29 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 27.3 m-20 . . . . . 0 N--CA 1.471 0.588 0 N-CA-C 110.857 -0.053 . . . . 2.9 110.857 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A 1516 ' ' CYS . . . . . 0.421 ' SG ' ' HB2' ' A' 1579 ' ' LYS . 77.8 m 54.11 35.84 23.3 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 113.876 1.065 . . . . 1.41 113.876 -176.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -143.6 129.33 19.3 Favored 'General case' 0 N--CA 1.434 -1.267 0 C-N-CA 120.07 -0.652 . . . . 2.18 109.662 176.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1518 ' ' VAL . . . . . 0.447 HG22 HD22 ' A' 1581 ' ' LEU . 2.5 m -138.57 137.89 42.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 CA-C-N 115.379 -0.828 . . . . 1.52 111.366 -175.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1519 ' ' THR . . . . . . . . . . . . . 6.3 m -98.15 136.85 37.78 Favored 'General case' 0 C--N 1.277 -2.579 0 CA-C-N 115.465 -0.789 . . . . 1.36 109.476 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -77.35 117.71 67.2 Favored Pre-proline 0 N--CA 1.428 -1.537 0 N-CA-C 108.808 -0.812 . . . . 2.02 108.808 176.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -69.47 -13.49 35.49 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 122.491 2.127 . . . . 1.82 113.795 -177.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 15.0 m -82.41 -36.74 26.4 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 112.498 0.555 . . . . 1.89 112.498 -177.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1523 ' ' THR . . . . . . . . . . . . . 12.4 t -137.1 3.48 2.65 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 119.599 -0.84 . . . . 1.99 112.215 -176.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 72.39 28.72 67.31 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.755 -0.736 . . . . 1.19 112.599 177.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 62.3 t-80 -85.18 119.81 25.98 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.797 -0.816 . . . . 1.82 108.797 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 2.6 tm? -87.15 112.47 21.98 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 109.032 -0.729 . . . . 1.3 109.032 -178.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -91.4 114.28 26.77 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 109.82 -0.437 . . . . 0.8 109.82 175.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 17.5 t70 -110.07 116.41 31.52 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.813 -0.81 . . . . 1.17 108.813 175.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1529 ' ' LEU . . . . . 0.476 ' HG ' HD12 ' A' 1581 ' ' LEU . 3.3 mm? -97.49 0.6 47.85 Favored 'General case' 0 N--CA 1.423 -1.817 0 CA-C-O 121.083 0.468 . . . . 1.29 110.301 -177.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1530 ' ' SER . . . . . 0.55 ' HA ' ' OG ' ' A' 1533 ' ' SER . 2.2 m -70.19 -19.31 63.18 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 122.193 0.997 . . . . 0.91 109.419 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 21.2 m -68.68 -18.4 64.26 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 114.931 -1.031 . . . . 1.98 110.238 175.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 82.6 mt -102.93 -6.73 22.13 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 122.322 -0.236 . . . . 1.34 110.979 178.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1533 ' ' SER . . . . . 0.649 ' HA ' ' HB ' ' A' 1552 ' ' ILE . 30.2 m -60.97 162.5 6.93 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-O 120.947 0.403 . . . . 1.93 111.286 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . 170.72 151.61 7.64 Favored Glycine 0 N--CA 1.426 -1.991 0 C-N-CA 120.513 -0.851 . . . . 1.1 111.107 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 33.8 ttt85 -87.21 -30.75 20.74 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 122.946 0.498 . . . . 5.21 111.377 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -78.37 -35.82 46.81 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.727 -0.842 . . . . 1.94 108.727 177.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 80.7 -140.16 21.48 Favored Glycine 0 N--CA 1.409 -3.109 0 CA-C-N 114.535 -1.211 . . . . 1.08 112.324 173.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -142.21 143.14 32.77 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 106.454 -1.684 . . . . 1.07 106.454 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 1.2 m -108.59 130.19 55.31 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 108.793 -0.817 . . . . 1.46 108.793 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1540 ' ' ALA . . . . . 0.409 ' HB3' ' HG2' ' A' 1624 ' ' PRO . . . -124.71 147.33 48.67 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.999 -0.741 . . . . 1.19 108.999 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -91.17 128.18 36.89 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 120.794 0.331 . . . . 1.37 110.225 -177.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1542 ' ' TYR . . . . . 0.584 ' CE2' ' HG ' ' A' 1626 ' ' LEU . 2.3 t80 -113.02 -99.32 0.43 Allowed 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.015 -1.105 . . . . 1.38 108.015 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1543 ' ' SER . . . . . 0.432 ' H ' ' HB3' ' A' 1542 ' ' TYR . 4.5 m -69.81 159.19 34.07 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 108.372 -0.973 . . . . 1.98 108.372 178.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 97.4 mttt -50.6 -42.69 56.19 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.269 0.841 . . . . 3.96 113.269 -177.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 19.9 m -106.53 28.5 7.77 Favored 'General case' 0 N--CA 1.416 -2.137 0 C-N-CA 122.189 0.196 . . . . 2.81 111.487 -177.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . -144.04 149.18 21.2 Favored Glycine 0 C--O 1.245 0.819 0 C-N-CA 119.425 -1.369 . . . . 1.68 113.868 -177.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 19.8 m -130.87 152.06 36.95 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.979 0 N-CA-C 108.564 -0.902 . . . . 1.38 108.564 177.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 10.3 p -108.68 134.63 50.0 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 N-CA-C 109.35 -0.611 . . . . 1.24 109.35 178.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -93.62 133.89 36.48 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 107.148 -1.427 . . . . 1.29 107.148 176.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 25.3 ptm -148.23 127.84 13.28 Favored 'General case' 0 C--N 1.282 -2.33 0 O-C-N 123.771 0.669 . . . . 1.47 109.836 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 5.0 p -119.0 134.42 55.2 Favored 'General case' 0 C--N 1.27 -2.856 0 CA-C-N 115.318 -0.855 . . . . 1.4 109.222 177.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1552 ' ' ILE . . . . . 0.649 ' HB ' ' HA ' ' A' 1533 ' ' SER . 46.3 mm -82.64 116.45 26.88 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 N-CA-C 109.527 -0.546 . . . . 1.11 109.527 -177.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 62.3 m 63.61 11.42 5.7 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.552 1.141 . . . . 1.4 113.701 173.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . -146.36 176.41 25.3 Favored Glycine 0 N--CA 1.42 -2.392 0 N-CA-C 108.972 -1.651 . . . . 0.4 108.972 -177.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -99.34 145.34 27.45 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 117.214 0.507 . . . . 1.62 110.853 -178.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -91.12 131.43 36.69 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 108.092 -1.077 . . . . 1.12 108.092 -176.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -81.7 -2.87 52.06 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 113.709 1.003 . . . . 2.49 113.709 -175.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -84.59 -6.44 59.37 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.381 -0.528 . . . . 1.38 110.781 -178.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1559 ' ' CYS . . . . . 0.643 ' SG ' ' HD2' ' A' 1560 ' ' PRO . 29.5 t -136.02 153.92 77.23 Favored Pre-proline 0 C--N 1.299 -1.612 0 N-CA-C 107.352 -1.351 . . . . 1.21 107.352 -178.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1560 ' ' PRO . . . . . 0.643 ' HD2' ' SG ' ' A' 1559 ' ' CYS . 7.7 Cg_exo -28.61 134.18 0.03 OUTLIER 'Trans proline' 0 CA--C 1.562 1.899 1 C-N-CA 125.471 4.114 . . . . 0.98 115.585 175.718 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -46.95 126.45 11.17 Favored 'Trans proline' 0 C--O 1.249 1.036 0 C-N-CA 124.818 3.679 . . . . 1.15 114.196 -178.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 105.62 -11.96 46.53 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 115.583 -0.735 . . . . 0.55 112.802 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1563 ' ' VAL . . . . . 0.592 HG12 ' HB2' ' A' 1566 ' ' CYS . 3.6 t -80.28 125.19 38.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 N-CA-C 112.904 0.705 . . . . 1.53 112.904 -178.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -96.73 -34.81 5.6 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.226 -0.897 . . . . 0.29 111.306 176.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -133.77 133.91 42.29 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 109.393 -0.595 . . . . 1.08 109.393 178.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1566 ' ' CYS . . . . . 0.592 ' HB2' HG12 ' A' 1563 ' ' VAL . 52.8 t -159.51 136.67 9.62 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 119.652 -0.213 . . . . 0.43 110.489 -174.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -84.54 137.91 33.06 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.142 -1.058 . . . . 1.3 108.142 173.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -89.33 11.79 68.65 Favored Glycine 0 N--CA 1.435 -1.37 0 N-CA-C 117.15 1.62 . . . . 1.43 117.15 -168.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1569 ' ' GLN . . . . . 0.446 ' HG2' HE21 ' B' ' 18' ' ' GLN . 0.8 OUTLIER -75.27 -70.59 0.41 Allowed 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 119.035 1.418 . . . . 3.09 110.049 176.661 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 58.7 p -100.4 -4.68 28.51 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 119.809 -0.757 . . . . 2.52 112.873 176.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1571 ' ' ARG . . . . . . . . . . . . 0.269 5.0 mpt_? 74.32 59.08 0.08 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.978 1.311 . . . . 3.19 112.595 -178.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 21.4 mt -90.6 131.2 38.41 Favored 'Isoleucine or valine' 0 C--O 1.243 0.742 0 CA-C-N 114.34 -1.3 . . . . 1.51 107.676 176.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 31.2 t -86.22 130.3 34.57 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.158 0.504 . . . . 0.96 110.642 -175.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1574 ' ' VAL . . . . . 0.489 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 25.4 m -117.8 16.12 7.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-O 121.532 0.682 . . . . 1.6 111.063 179.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 166.34 129.75 1.09 Allowed Glycine 0 N--CA 1.431 -1.684 0 CA-C-N 115.274 -0.876 . . . . 0.34 111.8 176.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 29.6 ttpp -78.74 145.36 34.48 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 107.5 -1.296 . . . . 2.68 107.5 176.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -66.88 80.0 0.11 Allowed 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 124.006 0.922 . . . . 1.08 112.783 -175.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1578 ' ' ASN . . . . . 0.42 ' O ' ' HE1' ' A' 1592 ' ' TYR . 89.6 m-20 -96.06 -172.63 2.61 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 107.636 -1.246 . . . . 1.95 107.636 177.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1579 ' ' LYS . . . . . 0.421 ' HB2' ' SG ' ' A' 1516 ' ' CYS . 15.5 ptpt -149.9 46.71 0.93 Allowed 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 121.882 0.848 . . . . 3.11 110.416 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 57.0 ttp180 -95.13 84.77 4.15 Favored 'General case' 0 N--CA 1.418 -2.066 0 CA-C-N 115.224 -0.898 . . . . 4.04 109.117 -175.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1581 ' ' LEU . . . . . 0.476 HD12 ' HG ' ' A' 1529 ' ' LEU . 2.4 tt -91.56 130.82 37.32 Favored 'General case' 0 C--N 1.294 -1.848 0 CA-C-N 114.135 -1.393 . . . . 1.32 109.618 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 46.6 mtm180 -125.67 141.09 52.19 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 116.074 -0.512 . . . . 3.4 110.235 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1583 ' ' TYR . . . . . . . . . . . . . 46.0 t80 -103.85 105.05 15.13 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.872 -0.788 . . . . 1.26 108.872 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1584 ' ' VAL . . . . . 0.505 ' O ' ' HB ' ' A' 1587 ' ' VAL . 15.5 m -123.51 91.04 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 CA-C-N 115.571 -0.74 . . . . 1.71 112.349 -175.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1585 ' ' ASP . . . . . 0.404 ' O ' ' HG2' ' A' 1586 ' ' GLN . 37.5 t70 57.62 66.79 1.06 Allowed 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.693 0.797 . . . . 1.17 111.357 175.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1586 ' ' GLN . . . . . 0.404 ' HG2' ' O ' ' A' 1585 ' ' ASP . 14.4 pt20 70.63 -3.56 1.89 Allowed 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 128.178 2.591 . . . . 2.43 111.525 178.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1587 ' ' VAL . . . . . 0.505 ' HB ' ' O ' ' A' 1584 ' ' VAL . 24.7 t -97.76 120.9 47.69 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.521 0 CA-C-N 115.158 -0.928 . . . . 1.16 110.787 -177.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1588 ' ' LEU . . . . . 0.992 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 2.9 mm? -91.64 107.22 19.06 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 107.074 -1.454 . . . . 1.11 107.074 175.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1589 ' ' GLN . . . . . 0.467 ' O ' ' HA ' ' A' 1581 ' ' LEU . 33.8 tt0 -98.74 126.63 44.41 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 109.558 -0.534 . . . . 1.74 109.558 -176.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1590 ' ' LEU . . . . . 0.644 ' HB3' ' HB ' ' A' 1610 ' ' ILE . 1.4 tt -121.4 100.05 6.82 Favored 'General case' 0 C--N 1.275 -2.652 0 N-CA-C 104.79 -2.3 . . . . 1.4 104.79 175.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 5.1 p -97.99 131.98 43.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 C-N-CA 120.232 -0.587 . . . . 1.7 111.809 -174.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1592 ' ' TYR . . . . . 0.569 ' O ' ' HG3' ' A' 1607 ' ' LYS . 21.2 m-85 -116.43 142.56 46.71 Favored 'General case' 0 CA--C 1.504 -0.814 0 N-CA-C 107.824 -1.176 . . . . 1.08 107.824 176.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 10.4 ptmm? -147.61 -179.0 6.56 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 106.336 -1.728 . . . . 2.21 106.336 -175.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 16.5 m-20 61.61 47.27 6.57 Favored 'General case' 0 CA--C 1.508 -0.646 0 O-C-N 124.323 1.014 . . . . 1.11 110.478 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -83.43 -140.68 4.18 Favored Glycine 0 N--CA 1.432 -1.578 0 N-CA-C 109.954 -1.258 . . . . 0.78 109.954 178.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1596 ' ' SER . . . . . . . . . . . . . 59.8 p -102.99 156.2 35.62 Favored Pre-proline 0 C--N 1.281 -2.393 0 N-CA-C 107.627 -1.249 . . . . 1.36 107.627 176.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1597 ' ' PRO . . . . . 0.497 ' HA ' ' O ' ' A' 1604 ' ' LEU . 54.0 Cg_exo -54.58 123.81 14.58 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 122.386 2.058 . . . . 1.4 111.322 178.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 31.9 t -74.63 120.47 81.67 Favored Pre-proline 0 C--N 1.303 -1.436 0 N-CA-C 108.62 -0.882 . . . . 0.75 108.62 -178.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -62.71 -19.32 67.94 Favored 'Trans proline' 0 N--CA 1.484 0.915 0 C-N-CA 123.585 2.857 . . . . 1.7 112.966 -176.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1600 ' ' SER . . . . . 0.552 ' HA ' ' HB2' ' B' ' 53' ' ' LEU . 6.4 m -58.66 -37.67 76.5 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 124.938 1.295 . . . . 2.8 111.95 178.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1601 ' ' LYS . . . . . 0.446 ' HE2' ' N ' ' A' 1602 ' ' SER . 0.0 OUTLIER -148.5 108.4 4.04 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 104.47 -2.418 . . . . 3.45 104.47 -179.503 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A 1602 ' ' SER . . . . . 0.446 ' N ' ' HE2' ' A' 1601 ' ' LYS . 8.4 t -57.42 117.35 4.03 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 123.02 0.528 . . . . 2.44 110.927 -174.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 106.18 -7.11 40.33 Favored Glycine 0 N--CA 1.437 -1.24 0 C-N-CA 120.828 -0.701 . . . . 1.2 112.481 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1604 ' ' LEU . . . . . 0.56 HD21 ' SG ' ' A' 1634 ' ' CYS . 10.7 tp -84.77 163.09 19.34 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.169 -1.419 . . . . 2.38 107.169 178.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 19.0 t -127.27 153.86 45.61 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.426 -0.953 . . . . 1.96 108.426 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1606 ' ' TYR . . . . . 0.489 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 57.5 m-85 -80.95 166.38 20.89 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.786 -0.45 . . . . 1.06 109.786 176.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1607 ' ' LYS . . . . . 0.569 ' HG3' ' O ' ' A' 1592 ' ' TYR . 36.5 ttpt -160.74 131.74 5.51 Favored 'General case' 0 CA--C 1.503 -0.83 0 N-CA-C 109.922 -0.399 . . . . 2.0 109.922 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1608 ' ' SER . . . . . . . . . . . . . 22.2 m -113.05 123.35 50.1 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 108.81 -0.811 . . . . 1.61 108.81 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 41.5 t -107.91 110.21 31.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 108.909 -0.775 . . . . 1.09 108.909 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1610 ' ' ILE . . . . . 0.644 ' HB ' ' HB3' ' A' 1590 ' ' LEU . 20.3 mm -89.63 128.45 41.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 106.23 -1.767 . . . . 1.2 106.23 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 23.1 t -127.1 101.11 6.39 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-O 121.386 0.612 . . . . 1.89 109.576 -177.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1612 ' ' PHE . . . . . 0.992 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 60.4 m-85 -86.18 130.18 34.61 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.468 -0.787 . . . . 0.28 111.07 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 54.4 t -127.09 139.32 52.24 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.003 0 C-N-CA 123.132 0.573 . . . . 1.23 110.709 -177.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1614 ' ' CYS . . . . . 0.533 ' SG ' ' HD3' ' A' 1616 ' ' PRO . 2.0 t -60.73 111.47 1.64 Allowed 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 125.234 1.414 . . . . 0.77 112.402 177.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1615 ' ' ARG . . . . . 0.619 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 22.2 tpt180 -128.3 86.86 56.82 Favored Pre-proline 0 C--N 1.316 -0.861 0 N-CA-C 108.292 -1.003 . . . . 2.92 108.292 172.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1616 ' ' PRO . . . . . 0.563 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 43.3 Cg_endo -67.72 -23.62 41.98 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 122.272 1.981 . . . . 1.22 113.389 -174.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -86.3 -4.97 59.27 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 121.03 -0.268 . . . . 3.05 111.078 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . 58.34 -162.69 0.22 Allowed 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 123.351 0.661 . . . . 1.55 109.704 -176.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . 139.75 -161.8 26.24 Favored Glycine 0 N--CA 1.411 -3.003 0 C-N-CA 120.279 -0.962 . . . . 1.16 111.522 178.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -83.26 15.45 2.1 Favored 'Trans proline' 0 C--N 1.321 -0.878 0 C-N-CA 123.277 2.651 . . . . 1.06 112.762 -178.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1621 ' ' THR . . . . . . . . . . . . . 20.6 p -106.11 1.39 26.26 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 115.564 -0.743 . . . . 1.58 110.454 -178.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -86.74 65.84 9.19 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 107.158 -1.423 . . . . 0.88 107.158 176.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1623 ' ' ARG . . . . . 0.475 ' O ' ' HG3' ' A' 1625 ' ' MET . 14.2 ptm180 -170.17 140.93 1.65 Allowed Pre-proline 0 C--N 1.291 -1.951 0 N-CA-C 106.566 -1.642 . . . . 3.82 106.566 -175.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1624 ' ' PRO . . . . . 0.409 ' HG2' ' HB3' ' A' 1540 ' ' ALA . 15.4 Cg_endo -55.71 106.51 0.2 Allowed 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 122.78 2.32 . . . . 0.77 111.627 -178.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1625 ' ' MET . . . . . 0.683 ' HB2' ' HB3' ' A' 1639 ' ' SER . 93.2 mtp -98.64 109.36 22.13 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.732 -0.84 . . . . 1.43 108.732 -177.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1626 ' ' LEU . . . . . 0.584 ' HG ' ' CE2' ' A' 1542 ' ' TYR . 0.3 OUTLIER -71.84 115.39 10.99 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 106.685 -1.598 . . . . 1.43 106.685 -179.68 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A 1627 ' ' ILE . . . . . 0.845 HD12 ' HB2' ' A' 1639 ' ' SER . 44.4 mm -70.82 -53.56 21.42 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.119 0 N-CA-C 108.767 -0.827 . . . . 1.23 108.767 -178.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 19.7 t -179.41 162.42 1.15 Allowed 'General case' 0 N--CA 1.422 -1.862 0 N-CA-C 107.435 -1.32 . . . . 1.88 107.435 -176.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1629 ' ' LEU . . . . . . . . . . . . . 43.2 tp -112.75 115.5 28.62 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 107.423 -1.325 . . . . 1.92 107.423 176.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 12.0 t70 -68.6 107.52 2.99 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 107.503 -1.295 . . . . 1.09 107.503 174.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1631 ' ' LYS . . . . . 0.492 ' HD2' HD23 ' B' ' 53' ' ' LEU . 4.0 tppp? -56.6 -37.63 70.91 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.168 -1.378 . . . . 3.98 114.38 -169.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -89.22 -29.11 19.5 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 119.684 -0.807 . . . . 2.6 112.449 -174.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 60.2 p -100.6 -2.57 32.5 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 113.471 0.915 . . . . 1.35 113.471 -174.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1634 ' ' CYS . . . . . 0.56 ' SG ' HD21 ' A' 1604 ' ' LEU . 71.0 m 58.31 37.56 25.98 Favored 'General case' 0 C--N 1.367 1.355 0 CA-C-O 121.849 0.833 . . . . 0.53 111.541 178.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1635 ' ' THR . . . . . . . . . . . . . 88.5 m -105.45 124.12 49.01 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 114.964 -1.017 . . . . 1.11 109.905 -178.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1636 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -104.39 133.07 49.89 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 107.527 -1.286 . . . . 1.56 107.527 -177.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1637 ' ' PHE . . . . . 0.406 ' HB2' ' HB ' ' A' 1627 ' ' ILE . 85.8 m-85 -108.35 137.07 46.94 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.844 -0.428 . . . . 0.54 109.844 178.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -129.58 130.53 45.81 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 109.859 -0.422 . . . . 0.64 109.859 -175.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1639 ' ' SER . . . . . 0.845 ' HB2' HD12 ' A' 1627 ' ' ILE . 11.3 t -106.59 154.67 20.57 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.102 -1.444 . . . . 1.34 107.102 176.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 1.8 t90 -156.44 114.94 3.36 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 106.113 -1.81 . . . . 0.8 106.113 178.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1641 ' ' HIS . . . . . 0.619 ' HB3' ' HB2' ' A' 1615 ' ' ARG . 38.4 m-70 -105.13 112.31 25.39 Favored 'General case' 0 C--N 1.288 -2.105 0 C-N-CA 119.861 -0.736 . . . . 1.14 110.201 -177.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1642 ' ' THR . . . . . . . . . . . . . 4.4 t -142.69 148.94 48.44 Favored Pre-proline 0 C--N 1.307 -1.258 0 CA-C-N 115.731 -0.668 . . . . 1.11 110.375 -175.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1643 ' ' PRO . . . . . 0.563 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 73.5 Cg_endo -79.45 -5.33 14.14 Favored 'Trans proline' 0 C--N 1.367 1.544 0 C-N-CA 122.51 2.14 . . . . 0.78 112.54 176.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 7.6 tt -75.41 -23.21 57.0 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.829 0.823 . . . . 1.66 109.614 177.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -103.0 28.41 6.26 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.006 -0.997 . . . . 1.29 111.395 -174.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 28.6 t -120.56 149.87 41.76 Favored 'General case' 0 C--N 1.287 -2.147 0 C-N-CA 119.971 -0.692 . . . . 1.48 110.57 -175.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.419 -2.016 0 N-CA-C 107.655 -1.239 . . . . 3.14 107.655 172.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . 0.444 ' O ' HG13 ' B' ' 14' ' ' VAL . . . . . . . . 0 N--CA 1.417 -2.578 0 N-CA-C 109.742 -1.343 . . . . 2.28 109.742 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -47.38 -70.53 0.69 Allowed Glycine 0 C--O 1.224 -0.495 0 N-CA-C 115.205 0.842 . . . . 1.94 115.205 -177.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -65.79 -35.4 80.59 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-N 117.814 0.807 . . . . 2.55 110.621 -177.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' LEU . . . . . 0.537 HD21 ' HB2' ' B' ' 46' ' ' CYS . 5.7 mt -58.73 -60.75 3.34 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 113.306 0.854 . . . . 2.82 113.306 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . 0.444 HG13 ' O ' ' B' ' 10' ' ' GLY . 7.7 p -74.99 -30.37 23.47 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 C-N-CA 120.017 -0.673 . . . . 2.5 111.773 -176.031 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' ASP . . . . . 0.417 ' OD2' ' HB2' ' A' 1569 ' ' GLN . 18.2 t0 -67.5 -42.27 83.16 Favored 'General case' 0 C--O 1.207 -1.137 0 C-N-CA 119.483 -0.887 . . . . 2.04 111.426 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 23.8 p -61.51 -40.77 95.8 Favored 'General case' 0 C--O 1.25 1.104 0 CA-C-N 118.292 0.496 . . . . 2.31 110.718 177.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.534 ' O ' ' HB2' ' B' ' 21' ' ' CYS . 4.3 mm? -58.5 -51.21 70.81 Favored 'General case' 0 C--O 1.21 -1.022 0 CA-C-N 115.86 -0.609 . . . . 2.27 111.309 174.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' GLN . . . . . 0.446 HE21 ' HG2' ' A' 1569 ' ' GLN . 29.5 tt0 -69.07 -29.12 67.17 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 116.349 -0.387 . . . . 2.39 111.268 -177.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -61.22 -61.09 2.8 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.949 -0.568 . . . . 1.0 112.248 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 14.2 p -97.9 -13.39 8.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 C-N-CA 118.604 -1.238 . . . . 1.83 111.686 -176.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' CYS . . . . . 0.534 ' HB2' ' O ' ' B' ' 17' ' ' LEU . 73.3 m -106.38 14.43 27.35 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.341 -0.849 . . . . 1.66 112.652 178.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -52.14 -45.39 57.26 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 121.252 -0.499 . . . . 1.53 112.899 176.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -79.19 -42.89 25.02 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.398 0.518 . . . . 2.72 112.398 177.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 6.3 tpm_? -71.25 -33.86 70.21 Favored 'General case' 0 C--O 1.244 0.799 0 N-CA-C 112.864 0.69 . . . . 5.02 112.864 -174.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.92 139.43 8.05 Favored Glycine 0 N--CA 1.424 -2.153 0 N-CA-C 108.551 -1.82 . . . . 1.63 108.551 -175.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . 0.47 ' HB2' ' HB3' ' B' ' 17' ' ' LEU . 50.9 p90 -128.4 122.78 32.21 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 117.523 0.662 . . . . 1.71 110.484 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -163.04 96.14 0.89 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.28 0.562 . . . . 3.67 111.553 178.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' PHE . . . . . 0.419 ' HA ' ' HE1' ' B' ' 59' ' ' TYR . 42.5 p90 . . . . . 0 N--CA 1.44 -0.948 0 CA-C-O 121.358 0.599 . . . . 2.44 110.398 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.419 -2.434 0 N-CA-C 111.583 -0.607 . . . . 2.62 111.583 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 14.4 pt 61.61 -24.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 C-N-CA 128.245 2.618 . . . . 2.28 116.488 174.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 2.8 p -51.34 -51.35 24.3 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 N-CA-C 114.612 1.338 . . . . 2.6 114.612 -178.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -92.65 -29.64 16.0 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.074 -1.084 . . . . 3.36 108.074 -176.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . 0.713 ' O ' ' HG2' ' B' ' 49' ' ' ARG . 40.6 mt-10 -59.96 -66.67 0.48 Allowed 'General case' 0 N--CA 1.432 -1.371 0 CA-C-N 114.968 -1.015 . . . . 3.08 109.385 177.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' CYS . . . . . 0.537 ' HB2' HD21 ' B' ' 13' ' ' LEU . 72.1 m -76.72 1.24 17.72 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 112.787 0.662 . . . . 2.23 112.787 -175.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 41.1 t -82.47 -50.41 8.88 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 119.496 -0.882 . . . . 2.48 109.105 171.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -102.75 -20.87 14.19 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 114.38 1.252 . . . . 2.97 114.38 -173.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . 0.713 ' HG2' ' O ' ' B' ' 45' ' ' GLU . 17.2 ptp180 -113.05 165.75 12.07 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 108.142 -1.058 . . . . 4.65 108.142 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 28.1 t -86.19 139.72 30.81 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 108.242 -1.021 . . . . 2.86 108.242 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 95.6 m -124.25 159.9 29.17 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-O 121.599 0.714 . . . . 2.11 111.88 -175.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -106.4 149.05 27.39 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 107.167 -1.42 . . . . 2.67 107.167 175.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . 0.552 ' HB2' ' HA ' ' A' 1600 ' ' SER . 55.0 tp -56.34 -27.99 57.62 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 124.905 1.282 . . . . 2.36 112.047 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . 0.616 ' O ' HG23 ' B' ' 58' ' ' THR . . . -58.17 -47.83 82.17 Favored 'General case' 0 CA--C 1.516 -0.352 0 O-C-N 123.2 0.312 . . . . 1.92 110.841 -178.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . 0.423 ' O ' ' HB2' ' B' ' 59' ' ' TYR . 58.7 tp -54.24 -50.97 65.95 Favored 'General case' 0 CA--C 1.509 -0.604 0 C-N-CA 123.847 0.859 . . . . 2.35 111.308 -178.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 3.4 pp -74.15 -36.07 64.1 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-N 116.07 -0.514 . . . . 2.01 111.555 -174.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -68.63 -48.76 63.25 Favored 'General case' 0 N--CA 1.439 -0.976 0 O-C-N 123.495 0.497 . . . . 2.27 111.357 -178.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 58' ' ' THR . . . . . 0.616 HG23 ' O ' ' B' ' 54' ' ' ALA . 9.2 t -74.08 -15.27 61.06 Favored 'General case' 0 C--O 1.246 0.909 0 C-N-CA 120.186 -0.606 . . . . 2.67 111.73 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 59' ' ' TYR . . . . . 0.423 ' HB2' ' O ' ' B' ' 55' ' ' LEU . 8.6 t80 -80.34 -76.32 0.23 Allowed 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 105.807 -1.923 . . . . 3.2 105.807 174.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 60' ' ' CYS . . . . . 0.417 ' H ' ' HB3' ' B' ' 59' ' ' TYR . 47.2 t . . . . . 0 CA--C 1.557 1.235 0 C-N-CA 125.096 1.359 . . . . 2.3 112.604 176.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1515 ' ' ASP . . . . . 0.4 ' HB3' ' H ' ' A' 1516 ' ' CYS . 5.5 m-20 . . . . . 0 CA--C 1.516 -0.357 0 CA-C-O 121.334 0.588 . . . . 2.9 111.626 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1516 ' ' CYS . . . . . 0.412 ' HA ' ' HB2' ' A' 1581 ' ' LEU . 6.4 p -76.05 66.32 2.21 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 124.034 0.933 . . . . 1.41 111.976 -177.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1517 ' ' GLN . . . . . 0.402 ' HA ' ' O ' ' A' 1527 ' ' PHE . 3.9 pt20 -154.93 130.95 10.18 Favored 'General case' 0 N--CA 1.421 -1.89 0 CA-C-N 115.355 -0.838 . . . . 2.18 109.638 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1518 ' ' VAL . . . . . 0.408 HG22 ' HB2' ' A' 1583 ' ' TYR . 9.6 m -135.0 144.39 34.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 C-N-CA 123.183 0.593 . . . . 1.52 111.188 -177.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1519 ' ' THR . . . . . . . . . . . . . 24.6 m -111.26 133.61 53.46 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 109.384 -0.599 . . . . 1.36 109.384 178.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -94.63 123.83 56.9 Favored Pre-proline 0 C--N 1.309 -1.152 0 N-CA-C 109.838 -0.43 . . . . 2.02 109.838 175.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -65.33 -16.17 53.27 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.288 2.658 . . . . 1.82 114.638 -176.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 50.2 m -83.04 -49.64 9.34 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 111.985 0.365 . . . . 1.89 111.985 -177.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1523 ' ' THR . . . . . . . . . . . . . 4.4 t -101.75 -9.1 21.13 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.686 0.755 . . . . 1.99 111.337 -177.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 64.85 35.03 91.43 Favored Glycine 0 CA--C 1.488 -1.64 0 CA-C-N 115.291 -0.868 . . . . 1.19 111.772 178.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 22.3 t-80 -99.45 123.1 43.43 Favored 'General case' 0 N--CA 1.422 -1.83 0 C-N-CA 119.979 -0.688 . . . . 1.82 110.218 -177.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 1.7 tm? -88.34 106.99 18.6 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 114.423 -1.262 . . . . 1.3 108.011 177.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1527 ' ' PHE . . . . . 0.402 ' O ' ' HA ' ' A' 1517 ' ' GLN . 85.8 m-85 -89.07 112.83 23.88 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.052 -0.721 . . . . 0.8 109.052 175.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 22.0 t70 -110.9 114.52 27.92 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.886 -0.783 . . . . 1.17 108.886 177.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 3.5 mm? -90.69 -4.06 57.03 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.288 0.566 . . . . 1.29 110.205 -174.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 7.2 m -61.66 -20.32 63.29 Favored 'General case' 0 C--O 1.219 -0.544 0 CA-C-N 114.976 -1.011 . . . . 0.91 110.685 178.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 19.5 m -65.99 -19.52 65.89 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 120.754 0.311 . . . . 1.98 111.606 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 73.4 mt -98.51 11.37 38.48 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.675 0.274 . . . . 1.34 111.513 -178.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1533 ' ' SER . . . . . . . . . . . . . 25.4 p -66.13 155.97 35.35 Favored 'General case' 0 C--O 1.252 1.229 0 CA-C-O 121.385 0.612 . . . . 1.93 112.426 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -175.86 142.53 6.12 Favored Glycine 0 N--CA 1.428 -1.864 0 N-CA-C 109.727 -1.349 . . . . 1.1 109.727 178.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 44.0 ttm180 -89.26 -37.9 14.61 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 123.688 0.287 . . . . 5.21 110.841 -177.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -71.36 -33.92 69.99 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-O 122.017 0.913 . . . . 1.94 109.274 178.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 96.89 -171.44 27.29 Favored Glycine 0 N--CA 1.417 -2.626 0 CA-C-N 114.865 -1.061 . . . . 1.08 113.05 172.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -124.86 143.97 50.55 Favored 'General case' 0 C--N 1.279 -2.487 0 N-CA-C 107.845 -1.168 . . . . 1.07 107.845 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 19.7 p -106.2 130.76 54.01 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 123.852 0.72 . . . . 1.46 110.319 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1540 ' ' ALA . . . . . 0.449 ' HB3' ' CG1' ' A' 1548 ' ' VAL . . . -118.97 140.92 49.2 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 107.944 -1.132 . . . . 1.19 107.944 177.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -79.24 139.63 37.86 Favored 'General case' 0 C--N 1.316 -0.875 0 O-C-N 123.726 0.641 . . . . 1.37 109.872 -178.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1542 ' ' TYR . . . . . 0.474 ' CE2' ' HG ' ' A' 1626 ' ' LEU . 0.5 OUTLIER -149.89 -102.72 0.07 Allowed 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.953 -0.758 . . . . 1.38 108.953 -178.603 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A 1543 ' ' SER . . . . . 0.401 ' H ' ' HB3' ' A' 1542 ' ' TYR . 16.2 m -67.91 152.8 44.98 Favored 'General case' 0 N--CA 1.432 -1.342 0 C-N-CA 124.008 0.923 . . . . 1.98 109.364 -179.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1544 ' ' LYS . . . . . 0.48 ' HB2' ' HZ1' ' A' 1544 ' ' LYS . 0.1 OUTLIER -63.49 -27.24 69.14 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.453 -0.794 . . . . 3.96 112.326 -171.47 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 20.3 m -123.25 33.09 5.47 Favored 'General case' 0 N--CA 1.397 -3.087 0 N-CA-C 109.588 -0.523 . . . . 2.81 109.588 176.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . -162.73 130.75 2.32 Favored Glycine 0 N--CA 1.438 -1.203 0 C-N-CA 118.528 -1.796 . . . . 1.68 115.172 -177.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 27.8 m -112.44 160.9 11.65 Favored 'Isoleucine or valine' 0 C--O 1.252 1.184 0 N-CA-C 108.44 -0.948 . . . . 1.38 108.44 177.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1548 ' ' VAL . . . . . 0.449 ' CG1' ' HB3' ' A' 1540 ' ' ALA . 14.8 p -106.85 134.84 47.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 C-N-CA 120.477 -0.489 . . . . 1.24 110.258 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -93.07 130.98 38.5 Favored 'General case' 0 CA--C 1.484 -1.562 0 N-CA-C 108.637 -0.875 . . . . 1.29 108.637 175.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1550 ' ' MET . . . . . 0.43 ' HA ' ' O ' ' A' 1564 ' ' GLY . 15.2 ptp -137.44 137.03 38.33 Favored 'General case' 0 C--N 1.284 -2.27 0 CA-C-N 115.63 -0.714 . . . . 1.47 111.315 175.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 11.6 p -117.63 113.8 22.45 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 115.261 -0.881 . . . . 1.4 108.965 176.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1552 ' ' ILE . . . . . . . . . . . . . 48.9 mm -77.71 119.39 26.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 N-CA-C 110.016 -0.364 . . . . 1.11 110.016 -177.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 77.4 m 64.42 44.36 4.2 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 124.041 0.838 . . . . 1.4 110.932 177.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 174.81 -179.49 46.08 Favored Glycine 0 N--CA 1.432 -1.575 0 C-N-CA 120.42 -0.895 . . . . 0.4 111.279 -179.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -104.64 158.63 16.37 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 120.617 0.246 . . . . 1.62 110.656 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -119.06 111.17 17.96 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.25 -1.019 . . . . 1.12 108.25 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -69.77 2.9 2.9 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 114.169 1.174 . . . . 2.49 114.169 -173.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -76.34 -15.73 59.9 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 120.154 -0.618 . . . . 1.38 110.029 178.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1559 ' ' CYS . . . . . 0.713 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 71.1 m -132.5 174.57 4.56 Favored Pre-proline 0 C--N 1.302 -1.482 0 CA-C-O 117.717 -1.135 . . . . 1.21 110.238 -178.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1560 ' ' PRO . . . . . 0.713 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 22.9 Cg_exo -28.75 128.7 0.04 OUTLIER 'Trans proline' 0 C--N 1.396 3.072 1 C-N-CA 125.506 4.137 . . . . 0.98 114.733 178.629 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -43.64 119.87 2.02 Favored 'Trans proline' 0 C--O 1.247 0.942 0 C-N-CA 124.547 3.498 . . . . 1.15 114.21 -177.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 87.43 23.62 39.41 Favored Glycine 0 N--CA 1.437 -1.29 0 CA-C-N 115.515 -0.766 . . . . 0.55 113.368 177.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1563 ' ' VAL . . . . . 0.426 HG12 ' HB2' ' A' 1559 ' ' CYS . 5.5 p -100.98 144.11 13.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 117.94 0.87 . . . . 1.53 109.852 -178.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1564 ' ' GLY . . . . . 0.43 ' O ' ' HA ' ' A' 1550 ' ' MET . . . -106.07 -30.35 4.52 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 121.235 -0.507 . . . . 0.29 113.252 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -128.26 130.14 47.45 Favored 'General case' 0 C--O 1.247 0.964 0 CA-C-N 117.307 0.553 . . . . 1.08 109.867 178.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1566 ' ' CYS . . . . . 0.436 ' SG ' ' HA ' ' A' 1571 ' ' ARG . 9.9 t -157.72 141.05 15.38 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 116.372 -0.376 . . . . 0.43 111.32 -176.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1567 ' ' PHE . . . . . 0.497 ' CE2' HG11 ' A' 1574 ' ' VAL . 74.3 m-85 -88.08 138.38 31.5 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 108.646 -0.872 . . . . 1.3 108.646 175.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -72.77 -9.08 74.31 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 117.854 1.902 . . . . 1.43 117.854 -168.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -80.16 -70.61 0.51 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 119.997 1.899 . . . . 3.09 112.412 -176.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1570 ' ' THR . . . . . 0.406 HG23 ' HA ' ' B' ' 12' ' ' GLU . 19.1 p -91.96 -3.69 55.57 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 119.862 -0.735 . . . . 2.52 112.782 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1571 ' ' ARG . . . . . 0.436 ' HA ' ' SG ' ' A' 1566 ' ' CYS . 10.8 mmt85 65.49 44.11 3.17 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.59 1.156 . . . . 3.19 111.051 177.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 40.7 mt -74.66 137.23 23.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-N 115.914 -0.585 . . . . 1.51 109.461 178.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 26.7 t -83.3 120.45 25.86 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 109.377 -0.601 . . . . 0.96 109.377 -179.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1574 ' ' VAL . . . . . 0.543 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 32.6 m -118.3 10.18 6.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 C-N-CA 119.368 -0.933 . . . . 1.6 111.377 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 173.99 113.71 0.33 Allowed Glycine 0 N--CA 1.419 -2.482 0 N-CA-C 110.122 -1.191 . . . . 0.34 110.122 178.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1576 ' ' LYS . . . . . 0.501 ' HE2' ' O ' ' A' 1594 ' ' ASP . 24.9 ttmm -73.93 155.47 38.65 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.681 -1.229 . . . . 2.68 107.681 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -67.13 77.55 0.14 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.77 0.795 . . . . 1.08 111.865 -177.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1578 ' ' ASN . . . . . 0.46 ' HB3' ' HD1' ' A' 1592 ' ' TYR . 14.5 t-20 -91.2 -175.73 4.37 Favored 'General case' 0 C--N 1.29 -2.01 0 C-N-CA 125.583 1.553 . . . . 1.95 107.41 -178.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 22.2 pttp -158.58 52.48 0.41 Allowed 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.839 0.828 . . . . 3.11 110.008 176.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1580 ' ' ARG . . . . . 0.518 ' HB3' HG13 ' A' 1591 ' ' VAL . 0.1 OUTLIER -97.48 87.31 4.07 Favored 'General case' 0 N--CA 1.413 -2.314 0 N-CA-C 108.287 -1.005 . . . . 4.04 108.287 -176.509 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A 1581 ' ' LEU . . . . . 0.517 ' HA ' ' O ' ' A' 1589 ' ' GLN . 0.4 OUTLIER -86.37 126.16 34.16 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.999 -1.001 . . . . 1.32 109.05 -177.341 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -124.51 140.94 52.48 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 109.159 -0.682 . . . . 3.4 109.159 175.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1583 ' ' TYR . . . . . 0.687 ' CE1' ' HA ' ' A' 1586 ' ' GLN . 67.9 t80 -105.81 97.38 7.21 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 107.004 -1.48 . . . . 1.26 107.004 176.158 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1584 ' ' VAL . . . . . 0.533 ' O ' ' HB ' ' A' 1587 ' ' VAL . 15.7 m -111.81 89.69 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.234 0 CA-C-N 115.338 -0.846 . . . . 1.71 112.373 -173.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 29.3 t70 56.88 64.45 1.65 Allowed 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 115.246 -0.888 . . . . 1.17 109.961 179.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1586 ' ' GLN . . . . . 0.687 ' HA ' ' CE1' ' A' 1583 ' ' TYR 0.26 4.2 pt20 63.09 15.22 8.31 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 126.926 2.09 . . . . 2.43 112.897 177.596 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A 1587 ' ' VAL . . . . . 0.533 ' HB ' ' O ' ' A' 1584 ' ' VAL . 29.1 t -108.89 129.39 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.024 0 CA-C-N 114.418 -1.265 . . . . 1.16 109.128 176.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1588 ' ' LEU . . . . . 0.937 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 2.9 mm? -97.57 108.22 20.89 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.644 -0.873 . . . . 1.11 108.644 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1589 ' ' GLN . . . . . 0.517 ' O ' ' HA ' ' A' 1581 ' ' LEU . 35.1 tt0 -100.97 118.32 36.75 Favored 'General case' 0 C--N 1.281 -2.375 0 CA-C-N 116.136 -0.484 . . . . 1.74 111.416 -177.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 1.6 mt -108.51 97.68 7.31 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 106.603 -1.628 . . . . 1.4 106.603 170.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1591 ' ' VAL . . . . . 0.518 HG13 ' HB3' ' A' 1580 ' ' ARG . 8.9 p -94.59 133.44 35.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 CA-C-N 116.275 -0.421 . . . . 1.7 110.084 -177.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1592 ' ' TYR . . . . . 0.46 ' HD1' ' HB3' ' A' 1578 ' ' ASN . 14.7 m-30 -118.52 114.22 22.49 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.277 -1.009 . . . . 1.08 108.277 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 21.3 pttp -115.53 178.92 4.12 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 110.303 -0.258 . . . . 2.21 110.303 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1594 ' ' ASP . . . . . 0.501 ' O ' ' HE2' ' A' 1576 ' ' LYS . 8.7 m-20 68.35 36.6 3.0 Favored 'General case' 0 CA--C 1.506 -0.728 0 C-N-CA 124.028 0.931 . . . . 1.11 112.134 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -72.82 -158.32 4.34 Favored Glycine 0 N--CA 1.443 -0.861 0 N-CA-C 109.675 -1.37 . . . . 0.78 109.675 173.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1596 ' ' SER . . . . . . . . . . . . . 41.0 p -87.92 148.64 43.85 Favored Pre-proline 0 C--N 1.28 -2.455 0 C-N-CA 118.292 -1.363 . . . . 1.36 109.304 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -48.01 131.47 21.42 Favored 'Trans proline' 0 C--O 1.241 0.647 0 C-N-CA 123.423 2.748 . . . . 1.4 111.726 176.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1598 ' ' CYS . . . . . 0.499 ' HA ' ' CE2' ' A' 1606 ' ' TYR . 49.4 t -76.67 127.1 85.02 Favored Pre-proline 0 C--N 1.294 -1.805 0 CA-C-N 114.834 -1.075 . . . . 0.75 110.191 -175.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1599 ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' 1598 ' ' CYS . 20.1 Cg_exo -69.4 -34.03 16.64 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.021 2.481 . . . . 1.7 111.24 176.2 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1600 ' ' SER . . . . . 0.45 ' HB2' ' SG ' ' A' 1598 ' ' CYS . 9.6 m -57.69 -43.15 84.9 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 123.665 0.786 . . . . 2.8 111.294 178.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1601 ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -145.54 123.54 12.07 Favored 'General case' 0 N--CA 1.423 -1.788 0 N-CA-C 109.006 -0.738 . . . . 3.45 109.006 178.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 10.0 m -78.85 148.59 32.77 Favored 'General case' 0 N--CA 1.407 -2.623 0 C-N-CA 123.229 0.612 . . . . 2.44 110.186 -175.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 105.96 -14.61 44.82 Favored Glycine 0 C--N 1.306 -1.136 0 CA-C-N 116.082 -0.508 . . . . 1.2 113.304 176.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1604 ' ' LEU . . . . . 0.454 HD23 ' HB2' ' A' 1634 ' ' CYS . 0.0 OUTLIER -135.74 147.36 48.4 Favored 'General case' 0 N--CA 1.406 -2.629 0 CA-C-O 121.423 0.63 . . . . 2.38 112.202 -179.68 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 10.3 p -96.17 153.37 17.83 Favored 'General case' 0 C--N 1.308 -1.239 0 C-N-CA 124.297 1.039 . . . . 1.96 110.06 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1606 ' ' TYR . . . . . 0.554 ' HD1' HD11 ' A' 1636 ' ' LEU . 51.7 m-85 -60.46 154.12 21.45 Favored 'General case' 0 C--O 1.25 1.102 0 O-C-N 123.287 0.367 . . . . 1.06 111.07 176.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -151.86 126.77 9.67 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 108.795 -0.817 . . . . 2.0 108.795 -176.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1608 ' ' SER . . . . . . . . . . . . . 40.1 m -105.72 130.29 53.76 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 116.269 -0.423 . . . . 1.61 110.202 -177.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 28.2 t -109.15 108.26 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.999 0 N-CA-C 107.845 -1.169 . . . . 1.09 107.845 177.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 64.5 mt -97.77 103.92 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.797 0 N-CA-C 107.598 -1.26 . . . . 1.2 107.598 179.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 23.2 t -99.93 107.82 19.9 Favored 'General case' 0 C--N 1.282 -2.341 0 CA-C-N 114.231 -1.35 . . . . 1.89 110.154 -174.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1612 ' ' PHE . . . . . 0.937 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 68.0 m-85 -90.61 118.2 29.87 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.439 -0.801 . . . . 0.28 109.752 178.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 43.1 t -122.65 139.22 50.17 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 108.531 -0.915 . . . . 1.23 108.531 -177.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 9.0 t -66.88 117.59 9.19 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 124.054 0.942 . . . . 0.77 112.564 -177.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1615 ' ' ARG . . . . . 0.735 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 13.5 tpt180 -137.75 91.16 13.86 Favored Pre-proline 0 N--CA 1.442 -0.835 0 N-CA-C 107.951 -1.129 . . . . 2.92 107.951 172.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1616 ' ' PRO . . . . . 0.742 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 45.7 Cg_endo -67.24 -15.68 46.65 Favored 'Trans proline' 0 N--CA 1.486 1.056 0 C-N-CA 122.754 2.303 . . . . 1.22 113.503 -174.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -58.18 -38.98 77.74 Favored 'General case' 0 C--O 1.242 0.697 0 C-N-CA 124.75 1.22 . . . . 3.05 111.056 178.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . 51.19 96.59 0.01 OUTLIER 'General case' 0 C--O 1.248 0.989 0 C-N-CA 124.363 1.065 . . . . 1.55 113.057 178.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1619 ' ' GLY . . . . . 0.401 ' HA3' ' HD2' ' A' 1620 ' ' PRO . . . -151.1 -143.7 3.77 Favored Glycine 0 C--N 1.29 -1.998 0 N-CA-C 110.679 -0.969 . . . . 1.16 110.679 -179.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1620 ' ' PRO . . . . . 0.401 ' HD2' ' HA3' ' A' 1619 ' ' GLY . 38.9 Cg_endo -67.01 2.77 1.92 Allowed 'Trans proline' 0 N--CA 1.488 1.172 0 C-N-CA 123.039 2.492 . . . . 1.06 114.832 -178.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1621 ' ' THR . . . . . . . . . . . . . 8.0 m -102.72 -3.4 26.56 Favored 'General case' 0 N--CA 1.42 -1.959 0 CA-C-O 122.057 0.932 . . . . 1.58 108.953 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 43.8 t30 -87.22 61.9 6.97 Favored 'General case' 0 C--O 1.246 0.872 0 CA-C-O 122.488 1.137 . . . . 0.88 108.666 178.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -165.87 138.7 3.39 Favored Pre-proline 0 C--N 1.303 -1.446 0 CA-C-N 113.733 -1.576 . . . . 3.82 106.984 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -65.11 111.69 1.84 Allowed 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 122.393 2.062 . . . . 0.77 111.19 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 72.5 mtm -115.29 143.9 44.56 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 116.531 -0.304 . . . . 1.43 110.59 -178.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1626 ' ' LEU . . . . . 0.474 ' HG ' ' CE2' ' A' 1542 ' ' TYR . 1.6 tm? -80.95 117.38 21.53 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.152 -1.055 . . . . 1.43 108.152 -178.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 50.7 mm -77.87 -58.1 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 CA-C-O 121.296 0.569 . . . . 1.23 109.727 178.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 66.8 m -163.92 149.8 11.13 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.007 -1.108 . . . . 1.88 108.007 -178.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1629 ' ' LEU . . . . . 0.758 HD12 ' HG ' ' A' 1636 ' ' LEU . 30.0 tp -111.87 110.47 20.83 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 107.557 -1.275 . . . . 1.92 107.557 175.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 17.5 t70 -70.54 117.46 12.1 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 107.347 -1.353 . . . . 1.09 107.347 175.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 95.3 mttt -82.15 -11.13 58.9 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.875 -0.602 . . . . 3.98 111.904 -169.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -95.86 -43.56 7.79 Favored 'General case' 0 N--CA 1.418 -2.065 0 C-N-CA 120.373 -0.531 . . . . 2.6 110.928 -175.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 45.5 p -96.42 -0.38 49.29 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 116.253 -0.43 . . . . 1.35 110.929 178.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1634 ' ' CYS . . . . . 0.454 ' HB2' HD23 ' A' 1604 ' ' LEU . 60.9 m 51.24 39.39 23.7 Favored 'General case' 0 C--N 1.374 1.636 0 C-N-CA 124.921 1.288 . . . . 0.53 112.195 176.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1635 ' ' THR . . . . . . . . . . . . . 90.7 m -100.9 128.08 47.09 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 114.09 -1.414 . . . . 1.11 108.288 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1636 ' ' LEU . . . . . 0.758 ' HG ' HD12 ' A' 1629 ' ' LEU . 0.6 OUTLIER -105.23 122.16 45.35 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.365 -0.606 . . . . 1.56 109.365 -174.497 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -99.91 116.91 33.08 Favored 'General case' 0 C--O 1.244 0.812 0 CA-C-O 121.293 0.568 . . . . 0.54 111.848 -178.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -117.26 134.81 54.36 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 115.105 -0.952 . . . . 0.64 109.361 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1639 ' ' SER . . . . . . . . . . . . . 71.6 m -119.73 138.94 53.0 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 116.219 -0.446 . . . . 1.34 109.902 176.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1640 ' ' TRP . . . . . 0.476 ' CE3' ' HE1' ' A' 1612 ' ' PHE . 3.7 t90 -138.36 103.72 4.98 Favored 'General case' 0 N--CA 1.424 -1.753 0 N-CA-C 103.942 -2.614 . . . . 0.8 103.942 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1641 ' ' HIS . . . . . 0.735 ' HB3' ' HB2' ' A' 1615 ' ' ARG . 28.3 m-70 -95.56 98.77 10.76 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.863 0.84 . . . . 1.14 109.757 -176.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1642 ' ' THR . . . . . . . . . . . . . 3.1 t -124.26 150.83 64.95 Favored Pre-proline 0 C--N 1.299 -1.594 0 CA-C-N 113.732 -1.576 . . . . 1.11 110.388 -170.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1643 ' ' PRO . . . . . 0.742 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 59.8 Cg_endo -77.21 -5.54 15.81 Favored 'Trans proline' 0 C--N 1.364 1.36 0 C-N-CA 122.487 2.125 . . . . 0.78 112.729 175.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 9.0 tt -69.48 -27.45 65.23 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.307 -0.627 . . . . 1.66 109.307 177.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -90.35 14.97 11.43 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.47 -0.786 . . . . 1.29 110.713 -177.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1646 ' ' CYS . . . . . 0.587 ' SG ' ' HA ' ' A' 1643 ' ' PRO . 78.3 m -99.69 156.33 17.14 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 109.614 -0.513 . . . . 1.48 109.614 178.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.289 -2.034 0 N-CA-C 107.294 -1.373 . . . . 3.14 107.294 175.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.14 0 CA-C-O 120.48 -0.067 . . . . 2.28 113.252 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -51.26 -52.32 32.56 Favored Glycine 0 C--O 1.214 -1.128 0 C-N-CA 123.697 0.665 . . . . 1.94 114.469 -176.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . 0.406 ' HA ' HG23 ' A' 1570 ' ' THR . 1.6 mp0 -57.41 -42.74 82.9 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 122.816 0.446 . . . . 2.55 110.917 -178.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' LEU . . . . . 0.424 ' HG ' ' SG ' ' B' ' 46' ' ' CYS . 1.1 tt -61.39 -52.61 63.88 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 115.371 -0.831 . . . . 2.82 109.853 -178.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 22.2 m -72.72 -30.37 33.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.37 0 C-N-CA 119.531 -0.867 . . . . 2.5 111.869 -176.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -69.34 -42.82 74.79 Favored 'General case' 0 C--O 1.203 -1.375 0 C-N-CA 120.728 -0.389 . . . . 2.04 111.94 177.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 25.3 p -62.85 -38.8 92.24 Favored 'General case' 0 C--O 1.258 1.523 0 CA-C-O 121.446 0.641 . . . . 2.31 110.054 176.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.56 ' HB3' ' HB3' ' B' ' 26' ' ' PHE . 3.6 mm? -56.75 -49.73 74.37 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-N 115.317 -0.856 . . . . 2.27 111.012 171.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -66.64 -32.37 73.65 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 124.384 1.074 . . . . 2.39 109.809 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -52.84 -57.67 9.43 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 116.023 -0.535 . . . . 1.0 111.939 178.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 13.0 p -98.87 -26.24 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 C-N-CA 118.204 -1.398 . . . . 1.83 112.854 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 85.1 m -106.92 1.08 24.3 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 113.597 0.962 . . . . 1.66 113.597 -177.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -55.86 -24.17 40.57 Favored Glycine 0 N--CA 1.479 1.558 0 N-CA-C 116.969 1.548 . . . . 1.53 116.969 -173.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -58.77 -40.73 84.77 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 118.136 0.968 . . . . 2.72 109.699 175.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 25.2 tpp180 -90.45 -48.57 7.02 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 108.07 -1.085 . . . . 5.02 108.07 177.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 130.33 -152.05 19.65 Favored Glycine 0 N--CA 1.424 -2.144 0 N-CA-C 109.84 -1.304 . . . . 1.63 109.84 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . 0.56 ' HB3' ' HB3' ' B' ' 17' ' ' LEU . 23.2 p90 -137.83 139.28 39.86 Favored 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 108.956 -0.757 . . . . 1.71 108.956 176.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -125.74 -67.78 0.86 Allowed 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 112.827 0.677 . . . . 3.67 112.827 -176.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' PHE . . . . . . . . . . . . . 50.4 p90 . . . . . 0 N--CA 1.509 2.511 0 N-CA-C 117.319 2.34 . . . . 2.44 117.319 171.195 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.416 -2.686 0 N-CA-C 111.583 -0.607 . . . . 2.62 111.583 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . 0.263 10.6 pt 64.44 -33.92 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.213 -0.835 0 C-N-CA 128.651 2.78 . . . . 2.28 114.9 177.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . 0.409 ' O ' ' HB2' ' B' ' 47' ' ' CYS . 2.4 p -48.03 -44.49 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 C-N-CA 123.833 0.853 . . . . 2.6 112.896 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -97.14 -38.35 9.76 Favored 'General case' 0 N--CA 1.415 -2.211 0 CA-C-N 115.606 -0.725 . . . . 3.36 109.506 -172.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -61.54 -47.46 85.46 Favored 'General case' 0 C--O 1.197 -1.702 0 CA-C-N 116.002 -0.544 . . . . 3.08 110.725 178.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' CYS . . . . . 0.424 ' SG ' ' HG ' ' B' ' 13' ' ' LEU . 42.6 t -78.01 -16.27 58.24 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 121.222 0.534 . . . . 2.23 109.823 -178.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' CYS . . . . . 0.409 ' HB2' ' O ' ' B' ' 43' ' ' VAL . 44.3 t -79.66 -48.01 14.44 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 116.216 -0.447 . . . . 2.48 110.857 177.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -98.42 -25.8 14.68 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 113.678 0.992 . . . . 2.97 113.678 -176.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -110.26 -179.8 3.88 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.333 -0.988 . . . . 4.65 108.333 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 8.2 t -93.05 132.5 37.11 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 106.771 -1.566 . . . . 2.86 106.771 176.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 1.6 p -111.38 137.44 49.15 Favored 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 123.205 0.602 . . . . 2.11 110.887 -175.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -112.0 177.72 4.55 Favored 'General case' 0 C--O 1.244 0.764 0 N-CA-C 112.489 0.551 . . . . 2.67 112.489 -178.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . 0.42 HD12 ' HB3' ' A' 1600 ' ' SER . 52.6 tp -51.24 -53.89 31.01 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 125.125 1.37 . . . . 2.36 113.601 -178.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.72 -41.05 73.31 Favored 'General case' 0 C--O 1.244 0.793 0 C-N-CA 124.023 0.929 . . . . 1.92 112.456 -170.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 61.3 tp -63.47 -46.22 87.23 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 114.921 -1.036 . . . . 2.35 111.957 -178.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' B' ' 53' ' ' LEU . 3.3 pp -79.66 -24.64 41.67 Favored 'General case' 0 N--CA 1.41 -2.459 0 C-N-CA 119.765 -0.774 . . . . 2.01 111.143 -176.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -70.6 -43.68 68.85 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 116.082 -0.508 . . . . 2.27 110.616 178.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 24.2 p -63.58 -43.12 97.9 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-N 116.25 -0.432 . . . . 2.67 111.848 179.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -73.31 -59.61 2.63 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 116.739 -0.21 . . . . 3.2 110.505 178.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 41.8 t . . . . . 0 CA--C 1.555 1.141 0 C-N-CA 125.029 1.332 . . . . 2.3 113.984 179.115 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A 1515 ' ' ASP . . . . . 0.4 ' HA ' ' HB3' ' A' 1579 ' ' LYS . 7.0 t70 . . . . . 0 N--CA 1.442 -0.857 0 N-CA-C 104.138 -2.541 . . . . 2.9 104.138 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1516 ' ' CYS . . . . . 0.903 ' HB3' ' HB2' ' A' 1529 ' ' LEU . 72.6 m -79.89 60.41 3.48 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 123.35 0.66 . . . . 1.41 112.247 -174.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1517 ' ' GLN . . . . . 0.451 ' HA ' ' O ' ' A' 1527 ' ' PHE . 16.5 pt20 -164.41 129.33 2.73 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-O 121.392 0.615 . . . . 2.18 110.905 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 2.9 m -148.56 143.59 18.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-N 114.726 -1.125 . . . . 1.52 109.725 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1519 ' ' THR . . . . . 0.412 ' HG1' HD22 ' A' 1526 ' ' LEU . 91.6 m -114.04 121.49 44.0 Favored 'General case' 0 N--CA 1.423 -1.787 0 N-CA-C 108.173 -1.047 . . . . 1.36 108.173 174.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1520 ' ' ASN . . . . . 0.451 ' HA ' ' HD3' ' A' 1521 ' ' PRO . 26.3 t-20 -80.26 121.93 82.25 Favored Pre-proline 0 C--N 1.294 -1.82 0 N-CA-C 109.33 -0.619 . . . . 2.02 109.33 177.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1521 ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' 1520 ' ' ASN . 12.6 Cg_exo -69.75 -19.61 35.96 Favored 'Trans proline' 0 CA--C 1.529 0.227 0 C-N-CA 123.051 2.5 . . . . 1.82 113.509 -175.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1522 ' ' SER . . . . . 0.447 ' HB2' ' OD1' ' A' 1520 ' ' ASN . 22.5 m -72.33 -32.21 66.32 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 120.836 0.35 . . . . 1.89 111.094 -179.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1523 ' ' THR . . . . . 0.675 HG23 ' HG3' ' A' 1647 ' ' GLU . 8.8 t -124.87 -9.46 7.23 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 119.433 -0.907 . . . . 1.99 112.14 -177.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 68.73 34.34 77.79 Favored Glycine 0 CA--C 1.501 -0.795 0 CA-C-N 115.828 -0.623 . . . . 1.19 113.399 176.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 9.7 t-160 -107.03 121.16 43.93 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 119.163 -1.015 . . . . 1.82 111.415 178.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1526 ' ' LEU . . . . . 0.412 HD22 ' HG1' ' A' 1519 ' ' THR . 2.3 tm? -82.47 115.99 21.72 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 114.494 -1.23 . . . . 1.3 108.688 176.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1527 ' ' PHE . . . . . 0.451 ' O ' ' HA ' ' A' 1517 ' ' GLN . 96.8 m-85 -96.32 121.69 38.39 Favored 'General case' 0 C--N 1.31 -1.149 0 O-C-N 122.158 -0.339 . . . . 0.8 110.494 174.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 10.3 t70 -105.49 109.83 21.94 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 106.923 -1.51 . . . . 1.17 106.923 175.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1529 ' ' LEU . . . . . 0.903 ' HB2' ' HB3' ' A' 1516 ' ' CYS . 3.7 mm? -90.69 -3.5 57.43 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 121.282 0.563 . . . . 1.29 110.22 -177.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 16.0 m -72.84 -15.56 61.62 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.624 -0.716 . . . . 0.91 109.632 178.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 14.8 m -66.38 -22.39 66.25 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-O 121.287 0.565 . . . . 1.98 109.709 173.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 80.4 mt -101.5 3.96 40.7 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.18 -0.464 . . . . 1.34 111.315 177.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1533 ' ' SER . . . . . . . . . . . . . 46.2 t -60.07 158.68 10.68 Favored 'General case' 0 C--O 1.245 0.825 0 CA-C-O 121.959 0.885 . . . . 1.93 111.682 -177.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -178.53 116.09 0.52 Allowed Glycine 0 C--N 1.278 -2.667 0 CA-C-N 114.237 -1.347 . . . . 1.1 110.132 -175.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -92.79 -36.75 12.7 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 112.373 0.509 . . . . 5.21 112.373 -176.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -59.52 -54.42 46.73 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-O 121.262 0.553 . . . . 1.94 110.372 -176.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 136.09 152.99 6.47 Favored Glycine 0 N--CA 1.413 -2.886 0 C-N-CA 120.535 -0.84 . . . . 1.08 113.382 173.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -114.51 139.56 49.46 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 106.151 -1.796 . . . . 1.07 106.151 174.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 5.1 p -106.58 128.71 54.35 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.21 0.528 . . . . 1.46 111.858 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -123.95 141.03 52.4 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 107.991 -1.115 . . . . 1.19 107.991 176.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -82.95 128.98 34.96 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 120.773 0.321 . . . . 1.37 110.72 -177.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1542 ' ' TYR . . . . . 0.591 ' CE2' ' HG ' ' A' 1626 ' ' LEU . 2.0 t80 -121.1 -100.6 0.43 Allowed 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 107.626 -1.25 . . . . 1.38 107.626 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1543 ' ' SER . . . . . . . . . . . . . 8.0 m -66.35 164.06 16.89 Favored 'General case' 0 N--CA 1.437 -1.123 0 C-N-CA 122.815 0.446 . . . . 1.98 110.808 -178.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 23.4 tptm -56.83 -41.54 78.05 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 118.103 0.41 . . . . 3.96 111.132 -176.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 49.9 m -110.88 34.41 4.02 Favored 'General case' 0 N--CA 1.412 -2.352 0 N-CA-C 109.621 -0.511 . . . . 2.81 109.621 178.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . -144.63 134.48 5.67 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 118.808 -1.663 . . . . 1.68 115.335 -176.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 28.1 m -121.68 148.4 25.16 Favored 'Isoleucine or valine' 0 C--O 1.247 0.944 0 N-CA-C 108.561 -0.903 . . . . 1.38 108.561 174.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 11.9 p -104.05 137.11 34.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 N-CA-C 109.747 -0.464 . . . . 1.24 109.747 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -98.01 125.07 42.78 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.834 -0.802 . . . . 1.29 108.834 175.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 23.3 ptm -136.17 133.67 37.41 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 115.539 -0.755 . . . . 1.47 110.342 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 12.7 p -117.69 137.53 52.61 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.549 -0.75 . . . . 1.4 109.627 176.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1552 ' ' ILE . . . . . . . . . . . . . 42.4 mm -96.83 118.53 43.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 110.37 -0.233 . . . . 1.11 110.37 -177.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 75.4 m 65.84 24.76 11.31 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-O 122.199 1.0 . . . . 1.4 112.047 175.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . -164.51 -177.73 37.38 Favored Glycine 0 N--CA 1.406 -3.337 0 CA-C-N 114.261 -1.336 . . . . 0.4 110.004 -178.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -109.39 145.35 36.25 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-O 121.043 0.449 . . . . 1.62 110.933 -176.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -81.41 145.25 30.89 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.345 -0.843 . . . . 1.12 111.809 -172.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -84.96 10.07 12.78 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 123.819 0.848 . . . . 2.49 113.176 -171.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -119.41 -10.73 9.63 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 119.586 -0.846 . . . . 1.38 112.562 -176.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1559 ' ' CYS . . . . . 0.535 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 83.4 m -132.26 164.26 44.54 Favored Pre-proline 0 C--N 1.296 -1.755 0 CA-C-O 117.877 -1.058 . . . . 1.21 110.04 -177.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1560 ' ' PRO . . . . . 0.535 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 12.0 Cg_exo -31.11 131.59 0.06 OUTLIER 'Trans proline' 0 C--N 1.376 2.001 1 C-N-CA 125.536 4.157 . . . . 0.98 115.489 -179.418 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -49.34 128.34 20.03 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 123.77 2.98 . . . . 1.15 111.731 179.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 102.3 -3.86 51.18 Favored Glycine 0 N--CA 1.43 -1.73 0 CA-C-N 116.018 -0.537 . . . . 0.55 113.765 -178.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1563 ' ' VAL . . . . . . . . . . . . . 5.2 p -98.52 138.21 23.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 118.362 1.081 . . . . 1.53 111.291 -178.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -102.11 -31.16 5.44 Favored Glycine 0 CA--C 1.522 0.491 0 CA-C-N 115.693 -0.685 . . . . 0.29 113.172 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -129.28 130.81 46.66 Favored 'General case' 0 N--CA 1.445 -0.723 0 O-C-N 122.528 -0.395 . . . . 1.08 109.967 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 44.0 t -157.02 138.61 14.05 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 110.018 -0.364 . . . . 0.43 110.018 -176.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -85.28 137.67 32.82 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 108.87 -0.789 . . . . 1.3 108.87 174.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -72.33 -18.61 78.3 Favored Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 116.983 1.553 . . . . 1.43 116.983 -167.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -73.23 -70.24 0.38 Allowed 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 118.362 1.081 . . . . 3.09 111.246 -175.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.16 -2.47 58.07 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.198 -0.91 . . . . 2.52 112.755 -176.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 9.9 mmt85 60.04 36.76 21.38 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 114.923 -1.035 . . . . 3.19 110.519 178.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 30.6 mt -74.97 125.24 34.25 Favored 'Isoleucine or valine' 0 C--O 1.245 0.867 0 CA-C-N 115.909 -0.587 . . . . 1.51 109.761 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 21.9 t -74.48 125.09 27.81 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 114.995 -1.002 . . . . 0.96 109.812 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1574 ' ' VAL . . . . . 0.644 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 33.6 m -122.19 16.51 5.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 C-N-CA 120.009 -0.676 . . . . 1.6 112.026 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 167.82 122.72 0.63 Allowed Glycine 0 N--CA 1.432 -1.594 0 C-N-CA 119.977 -1.106 . . . . 0.34 112.618 175.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 4.1 ttmp? -71.64 142.1 49.93 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.23 -1.026 . . . . 2.68 108.23 177.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -72.83 88.23 1.32 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.29 0.567 . . . . 1.08 110.965 -177.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1578 ' ' ASN . . . . . 0.41 ' O ' ' HE1' ' A' 1592 ' ' TYR . 74.2 m-20 -109.56 150.79 27.66 Favored 'General case' 0 C--N 1.29 -1.978 0 N-CA-C 107.283 -1.377 . . . . 1.95 107.283 179.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1579 ' ' LYS . . . . . 0.4 ' HB3' ' HA ' ' A' 1515 ' ' ASP . 48.6 mtmt -105.15 45.71 0.95 Allowed 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 106.275 -1.75 . . . . 3.11 106.275 -177.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 56.3 ttt180 -84.97 76.59 10.25 Favored 'General case' 0 N--CA 1.411 -2.376 0 CA-C-N 113.638 -1.619 . . . . 4.04 108.775 -173.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1581 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.42 127.58 32.94 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 113.596 -1.638 . . . . 1.32 108.875 -178.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -127.08 140.96 51.9 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-N 116.098 -0.501 . . . . 3.4 110.215 172.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1583 ' ' TYR . . . . . 0.568 ' CZ ' ' HA ' ' A' 1586 ' ' GLN . 39.6 t80 -99.88 105.56 17.31 Favored 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 106.903 -1.517 . . . . 1.26 106.903 175.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1584 ' ' VAL . . . . . 0.631 ' O ' ' HB ' ' A' 1587 ' ' VAL . 7.5 p -129.51 97.39 3.46 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.333 0 CA-C-O 121.614 0.721 . . . . 1.71 111.061 -175.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 36.3 t70 64.01 49.36 2.78 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-O 122.456 1.122 . . . . 1.17 110.771 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1586 ' ' GLN . . . . . 0.568 ' HA ' ' CZ ' ' A' 1583 ' ' TYR . 1.8 pt20 65.39 9.26 5.59 Favored 'General case' 0 N--CA 1.5 2.059 0 C-N-CA 127.026 2.131 . . . . 2.43 111.09 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1587 ' ' VAL . . . . . 0.631 ' HB ' ' O ' ' A' 1584 ' ' VAL . 38.1 t -96.81 122.76 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.75 0 CA-C-N 114.303 -1.317 . . . . 1.16 108.331 178.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1588 ' ' LEU . . . . . 0.462 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 3.0 mm? -93.15 107.76 19.5 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 106.562 -1.644 . . . . 1.11 106.562 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -120.63 125.1 46.87 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 113.296 0.851 . . . . 1.74 113.296 -172.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1590 ' ' LEU . . . . . 0.468 HD22 ' SG ' ' A' 1516 ' ' CYS . 16.6 mt -101.69 126.27 48.51 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 113.84 -1.527 . . . . 1.4 107.282 176.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 47.2 t -112.0 120.36 62.17 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.997 0 C-N-CA 119.438 -0.905 . . . . 1.7 111.026 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1592 ' ' TYR . . . . . 0.413 ' HB2' ' HB2' ' A' 1608 ' ' SER . 13.5 m-30 -105.32 95.83 6.1 Favored 'General case' 0 CA--C 1.486 -1.485 0 N-CA-C 107.866 -1.161 . . . . 1.08 107.866 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 12.3 ptmm? -107.5 170.22 8.11 Favored 'General case' 0 C--N 1.283 -2.312 0 CA-C-N 115.02 -0.991 . . . . 2.21 111.597 -175.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 24.0 m-20 57.24 56.06 5.44 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 125.454 1.502 . . . . 1.11 112.448 177.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -74.88 -115.62 0.09 OUTLIER Glycine 0 CA--C 1.528 0.893 0 C-N-CA 120.33 -0.938 . . . . 0.78 111.143 173.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1596 ' ' SER . . . . . . . . . . . . . 78.2 p -115.32 169.76 6.4 Favored Pre-proline 0 C--N 1.296 -1.744 0 O-C-N 121.857 -0.79 . . . . 1.36 109.164 176.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -70.03 122.62 9.22 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 122.932 2.421 . . . . 1.4 112.354 177.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1598 ' ' CYS . . . . . 0.421 ' HA ' ' HD3' ' A' 1599 ' ' PRO . 34.3 t -76.44 141.16 69.34 Favored Pre-proline 0 C--N 1.292 -1.916 0 CA-C-N 114.671 -1.15 . . . . 0.75 109.202 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1599 ' ' PRO . . . . . 0.54 ' HD3' ' OH ' ' A' 1606 ' ' TYR . 8.1 Cg_exo -72.04 -7.84 21.8 Favored 'Trans proline' 0 C--N 1.371 1.731 0 C-N-CA 123.608 2.872 . . . . 1.7 113.25 -175.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1600 ' ' SER . . . . . 0.676 ' HA ' ' HB3' ' B' ' 53' ' ' LEU . 22.8 p -61.17 -51.22 69.97 Favored 'General case' 0 C--O 1.258 1.535 0 CA-C-O 121.76 0.79 . . . . 2.8 109.733 174.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1601 ' ' LYS . . . . . 0.477 ' HB3' ' HG ' ' A' 1604 ' ' LEU . 49.9 tptt -155.14 117.96 4.33 Favored 'General case' 0 N--CA 1.387 -3.614 0 N-CA-C 106.533 -1.654 . . . . 3.45 106.533 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 4.7 p -60.09 131.27 50.3 Favored 'General case' 0 N--CA 1.409 -2.478 0 N-CA-C 109.139 -0.689 . . . . 2.44 109.139 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 106.83 -20.99 32.92 Favored Glycine 0 C--N 1.296 -1.687 0 C-N-CA 121.065 -0.588 . . . . 1.2 111.837 -174.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1604 ' ' LEU . . . . . 0.477 ' HG ' ' HB3' ' A' 1601 ' ' LYS . 69.5 mt -81.55 124.46 29.52 Favored 'General case' 0 CA--C 1.503 -0.837 0 N-CA-C 107.728 -1.212 . . . . 2.38 107.728 172.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 4.9 p -101.26 143.46 31.3 Favored 'General case' 0 C--N 1.28 -2.415 0 CA-C-O 120.643 0.259 . . . . 1.96 110.61 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1606 ' ' TYR . . . . . 0.644 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 96.2 m-85 -68.39 153.28 44.06 Favored 'General case' 0 C--O 1.255 1.356 0 N-CA-C 109.598 -0.519 . . . . 1.06 109.598 177.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -151.5 127.48 10.38 Favored 'General case' 0 N--CA 1.437 -1.104 0 O-C-N 123.673 0.608 . . . . 2.0 109.952 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1608 ' ' SER . . . . . 0.467 ' HB3' ' HE2' ' A' 1638 ' ' PHE . 38.6 m -104.64 122.04 44.8 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 108.522 -0.918 . . . . 1.61 108.522 -179.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 41.0 t -104.68 108.06 23.94 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 109.304 -0.628 . . . . 1.09 109.304 -177.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 69.5 mt -97.27 110.18 24.66 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 115.588 -0.733 . . . . 1.2 109.323 -178.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 7.0 t -113.56 108.01 16.58 Favored 'General case' 0 C--N 1.282 -2.345 0 CA-C-N 115.143 -0.935 . . . . 1.89 110.114 -174.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1612 ' ' PHE . . . . . 0.462 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 64.1 m-85 -84.9 118.9 24.8 Favored 'General case' 0 C--O 1.254 1.332 0 CA-C-N 115.99 -0.55 . . . . 0.28 109.557 177.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1613 ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' A' 1641 ' ' HIS . 21.5 t -110.69 124.91 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.577 0 CA-C-N 115.595 -0.73 . . . . 1.23 110.366 -175.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 22.2 t -58.88 110.64 1.06 Allowed 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 114.571 -1.195 . . . . 0.77 111.895 177.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1615 ' ' ARG . . . . . . . . . . . . . 22.4 ttt180 -137.59 98.59 9.82 Favored Pre-proline 0 C--N 1.316 -0.884 0 N-CA-C 110.25 -0.278 . . . . 2.92 110.25 171.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1616 ' ' PRO . . . . . 0.811 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 34.6 Cg_exo -61.22 -30.55 88.58 Favored 'Trans proline' 0 CA--C 1.55 1.282 0 C-N-CA 122.139 1.892 . . . . 1.22 111.989 176.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -77.05 44.17 0.39 Allowed 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.116 1.367 . . . . 3.05 113.61 178.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -32.69 130.31 0.19 Allowed 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 126.781 2.032 . . . . 1.55 113.476 176.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . -163.86 -142.16 3.33 Favored Glycine 0 N--CA 1.425 -2.089 0 N-CA-C 109.958 -1.257 . . . . 1.16 109.958 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -80.34 15.06 1.81 Allowed 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 122.95 2.433 . . . . 1.06 112.655 -178.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1621 ' ' THR . . . . . . . . . . . . . 17.1 p -102.48 -6.71 22.61 Favored 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 124.791 1.237 . . . . 1.58 108.625 179.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 48.9 t30 -94.66 61.89 2.7 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.392 -1.277 . . . . 0.88 108.659 -176.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -162.28 138.74 5.96 Favored Pre-proline 0 N--CA 1.428 -1.535 0 CA-C-N 113.795 -1.548 . . . . 3.82 107.427 -179.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.92 108.2 1.25 Allowed 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 122.556 2.171 . . . . 0.77 112.17 -177.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 63.8 mtm -116.11 147.42 41.35 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.455 -0.339 . . . . 1.43 110.543 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1626 ' ' LEU . . . . . 0.591 ' HG ' ' CE2' ' A' 1542 ' ' TYR . 0.4 OUTLIER -85.41 114.95 22.85 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.452 -1.314 . . . . 1.43 107.452 -178.354 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A 1627 ' ' ILE . . . . . 0.41 HD12 ' HB2' ' A' 1639 ' ' SER . 44.3 mm -72.53 -54.51 16.01 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.217 0 N-CA-C 109.191 -0.67 . . . . 1.23 109.191 -178.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 28.0 p -173.44 154.04 2.5 Favored 'General case' 0 N--CA 1.423 -1.808 0 CA-C-N 114.752 -1.113 . . . . 1.88 109.281 -173.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1629 ' ' LEU . . . . . 0.433 HD12 ' HG ' ' A' 1636 ' ' LEU . 54.2 tp -106.29 117.57 34.38 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 108.434 -0.95 . . . . 1.92 108.434 174.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1630 ' ' ASP . . . . . 0.428 ' HB3' ' HB ' ' A' 1635 ' ' THR . 8.6 t70 -73.75 99.09 3.06 Favored 'General case' 0 CA--C 1.496 -1.108 0 N-CA-C 103.317 -2.846 . . . . 1.09 103.317 167.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -80.76 -10.31 59.74 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 114.192 -1.367 . . . . 3.98 110.395 -166.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -86.11 -45.95 10.9 Favored 'General case' 0 N--CA 1.426 -1.66 0 CA-C-N 115.584 -0.735 . . . . 2.6 110.874 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 70.5 p -95.91 -3.79 44.67 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-O 120.812 0.339 . . . . 1.35 111.571 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 60.9 m 63.7 51.17 2.51 Favored 'General case' 0 C--N 1.355 0.823 0 C-N-CA 124.743 1.217 . . . . 0.53 111.744 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1635 ' ' THR . . . . . 0.428 ' HB ' ' HB3' ' A' 1630 ' ' ASP . 32.4 m -113.42 123.14 49.35 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 114.101 -1.409 . . . . 1.11 109.026 -176.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1636 ' ' LEU . . . . . 0.433 ' HG ' HD12 ' A' 1629 ' ' LEU . 1.0 OUTLIER -105.44 129.78 53.67 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 108.557 -0.905 . . . . 1.56 108.557 -175.383 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -105.72 135.45 47.12 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 120.83 -0.348 . . . . 0.54 111.259 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1638 ' ' PHE . . . . . 0.467 ' HE2' ' HB3' ' A' 1608 ' ' SER . 96.9 m-85 -128.46 137.18 51.69 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 124.09 0.956 . . . . 0.64 108.719 -178.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1639 ' ' SER . . . . . 0.41 ' HB2' HD12 ' A' 1627 ' ' ILE . 17.9 t -124.56 155.1 39.61 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 108.327 -0.99 . . . . 1.34 108.327 177.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1640 ' ' TRP . . . . . 0.439 ' CE3' ' HE1' ' A' 1612 ' ' PHE . 3.6 t90 -155.54 104.35 2.36 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 104.689 -2.337 . . . . 0.8 104.689 -178.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1641 ' ' HIS . . . . . 0.42 ' HA ' ' O ' ' A' 1613 ' ' VAL . 38.8 m-70 -93.63 100.59 12.81 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 121.201 0.524 . . . . 1.14 109.834 -176.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1642 ' ' THR . . . . . . . . . . . . . 3.6 t -134.06 147.33 63.52 Favored Pre-proline 0 C--N 1.292 -1.905 0 CA-C-N 115.002 -0.999 . . . . 1.11 109.377 -173.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1643 ' ' PRO . . . . . 0.811 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 50.1 Cg_endo -76.93 -2.65 12.9 Favored 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 122.069 1.846 . . . . 0.78 112.416 176.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 9.3 tt -69.42 -28.82 66.47 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 108.876 -0.787 . . . . 1.66 108.876 177.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -88.26 21.27 2.89 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.591 -0.731 . . . . 1.29 110.732 -178.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1646 ' ' CYS . . . . . 0.457 ' SG ' ' HA ' ' A' 1643 ' ' PRO . 75.1 m -113.03 152.13 29.86 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 116.139 -0.482 . . . . 1.48 110.279 -179.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1647 ' ' GLU . . . . . 0.675 ' HG3' HG23 ' A' 1523 ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.421 -1.922 0 N-CA-C 107.592 -1.262 . . . . 3.14 107.592 174.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.39 0 CA-C-O 120.554 -0.026 . . . . 2.28 113.037 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . 0.475 ' HA2' HG12 ' B' ' 14' ' ' VAL . . . -60.28 -27.99 66.26 Favored Glycine 0 N--CA 1.461 0.319 0 N-CA-C 112.127 -0.389 . . . . 1.94 112.127 178.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -65.53 -29.9 70.59 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.302 0.572 . . . . 2.55 110.003 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' LEU . . . . . 0.514 HD22 ' HB3' ' B' ' 46' ' ' CYS . 0.2 OUTLIER -72.79 -50.93 21.21 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.619 0.723 . . . . 2.82 109.433 179.944 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . 0.475 HG12 ' HA2' ' B' ' 11' ' ' GLY . 9.1 p -68.08 -37.73 78.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-N 115.665 -0.698 . . . . 2.5 112.254 -176.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -76.24 -22.27 55.37 Favored 'General case' 0 C--O 1.212 -0.907 0 N-CA-C 113.608 0.966 . . . . 2.04 113.608 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 9.7 p -71.55 -39.35 70.73 Favored 'General case' 0 C--O 1.262 1.753 0 O-C-N 120.959 -1.088 . . . . 2.31 109.268 174.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.468 ' HB3' ' HB2' ' B' ' 26' ' ' PHE . 4.3 mm? -52.71 -47.31 67.4 Favored 'General case' 0 C--O 1.216 -0.666 0 CA-C-N 114.938 -1.028 . . . . 2.27 109.535 169.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -63.44 -42.89 98.67 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.485 1.114 . . . . 2.39 110.084 178.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -48.76 -54.96 12.9 Favored 'General case' 0 C--O 1.245 0.823 0 N-CA-C 112.943 0.72 . . . . 1.0 112.943 -177.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 14.8 p -98.74 -26.15 3.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 C-N-CA 117.713 -1.595 . . . . 1.83 112.361 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' CYS . . . . . 0.443 ' HB2' ' O ' ' B' ' 17' ' ' LEU . 74.7 m -102.28 18.91 19.79 Favored 'General case' 0 C--N 1.308 -1.227 0 O-C-N 121.403 -0.81 . . . . 1.66 112.683 -175.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -57.35 -46.17 92.09 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 121.056 -0.593 . . . . 1.53 113.656 178.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -72.99 -39.16 66.3 Favored 'General case' 0 C--N 1.32 -0.708 0 O-C-N 122.669 -0.312 . . . . 2.72 111.507 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . 0.41 ' HD2' ' SG ' ' B' ' 60' ' ' CYS . 40.7 ttm180 -76.44 -38.48 55.44 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.334 0.588 . . . . 5.02 111.597 -177.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.35 151.72 9.69 Favored Glycine 0 N--CA 1.423 -2.2 0 N-CA-C 107.95 -2.06 . . . . 1.63 107.95 -174.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . 0.468 ' HB2' ' HB3' ' B' ' 17' ' ' LEU . 45.6 p90 -138.09 146.82 43.37 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 117.549 0.675 . . . . 1.71 110.229 -179.089 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -170.63 136.75 1.27 Allowed 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 110.205 -0.294 . . . . 3.67 110.205 174.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' PHE . . . . . . . . . . . . . 22.5 p90 . . . . . 0 C--N 1.308 -1.21 0 N-CA-C 112.347 0.499 . . . . 2.44 112.347 173.583 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . 0.422 ' C ' ' H ' ' B' ' 43' ' ' VAL . . . . . . . . 0 N--CA 1.433 -1.559 0 CA-C-O 118.765 -1.02 . . . . 2.62 115.311 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . 0.416 HD13 HD21 ' B' ' 17' ' ' LEU . 42.9 pt 52.89 -18.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.527 3.405 0 N-CA-C 118.289 2.7 . . . . 2.28 118.289 170.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . 0.422 ' H ' ' C ' ' B' ' 41' ' ' GLY . 4.4 p -49.06 -40.58 13.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 C-N-CA 125.551 1.54 . . . . 2.6 114.673 -175.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -91.01 -34.11 15.27 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 109.497 -0.557 . . . . 3.36 109.497 -173.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . 0.436 ' O ' ' HB2' ' B' ' 49' ' ' ARG . 11.1 mp0 -64.7 -50.89 65.2 Favored 'General case' 0 C--O 1.192 -1.925 0 CA-C-N 115.758 -0.655 . . . . 3.08 110.118 178.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' CYS . . . . . 0.514 ' HB3' HD22 ' B' ' 13' ' ' LEU . 31.8 t -73.59 -22.77 59.94 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 119.821 -0.752 . . . . 2.23 110.7 -176.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 54.1 t -77.88 -39.34 43.52 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.364 -0.38 . . . . 2.48 111.994 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -119.05 6.03 11.31 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.904 1.076 . . . . 2.97 113.904 -176.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . 0.436 ' HB2' ' O ' ' B' ' 45' ' ' GLU . 98.7 mtt180 -130.51 169.55 15.41 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 106.754 -1.573 . . . . 4.65 106.754 176.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 45.9 m -87.35 99.94 12.36 Favored 'General case' 0 N--CA 1.415 -2.183 0 N-CA-C 108.86 -0.792 . . . . 2.86 108.86 177.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 2.6 p -84.67 142.65 29.74 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.835 -1.172 . . . . 2.11 107.835 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -106.29 171.51 7.31 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 119.763 -0.775 . . . . 2.67 110.672 176.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . 0.676 ' HB3' ' HA ' ' A' 1600 ' ' SER . 1.9 pt? -62.32 -37.1 84.29 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 113.886 1.069 . . . . 2.36 113.886 -176.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . 0.409 ' O ' HG21 ' B' ' 58' ' ' THR . . . -58.31 -36.37 73.25 Favored 'General case' 0 CA--C 1.504 -0.792 0 C-N-CA 122.615 0.366 . . . . 1.92 111.857 -173.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . 0.493 ' O ' ' HB2' ' B' ' 59' ' ' TYR . 60.2 tp -60.67 -56.58 19.57 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.59 -0.732 . . . . 2.35 111.101 -177.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 3.2 pp -72.64 -26.76 61.77 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-O 120.831 0.348 . . . . 2.01 110.879 -177.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -69.08 -55.4 10.87 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 115.306 -0.861 . . . . 2.27 111.444 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 58' ' ' THR . . . . . 0.409 HG21 ' O ' ' B' ' 54' ' ' ALA . 13.0 t -78.05 -17.39 57.09 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 119.877 -0.729 . . . . 2.67 111.801 -178.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 59' ' ' TYR . . . . . 0.493 ' HB2' ' O ' ' B' ' 55' ' ' LEU . 6.3 t80 -77.08 -74.16 0.26 Allowed 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 106.219 -1.771 . . . . 3.2 106.219 176.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 60' ' ' CYS . . . . . 0.41 ' SG ' ' HD2' ' B' ' 24' ' ' ARG . 36.6 t . . . . . 0 CA--C 1.557 1.218 0 C-N-CA 125.529 1.532 . . . . 2.3 114.536 175.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1515 ' ' ASP . . . . . 0.439 ' HA ' ' HD3' ' A' 1579 ' ' LYS . 4.5 m-20 . . . . . 0 N--CA 1.505 2.308 0 N-CA-C 113.663 0.986 . . . . 2.9 113.663 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1516 ' ' CYS . . . . . 0.458 ' HB3' ' HB2' ' A' 1529 ' ' LEU . 71.2 m -144.55 78.61 1.58 Allowed 'General case' 0 C--O 1.251 1.165 0 CA-C-O 120.894 0.378 . . . . 1.41 111.278 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -157.32 130.22 7.63 Favored 'General case' 0 N--CA 1.422 -1.874 0 N-CA-C 108.982 -0.748 . . . . 2.18 108.982 175.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1518 ' ' VAL . . . . . 0.446 ' CG2' HD12 ' A' 1581 ' ' LEU . 5.9 m -131.79 135.63 58.45 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.16 0 CA-C-O 121.143 0.497 . . . . 1.52 110.936 -178.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1519 ' ' THR . . . . . 0.429 ' OG1' HD22 ' A' 1526 ' ' LEU . 23.5 m -106.46 129.63 54.4 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 107.202 -1.407 . . . . 1.36 107.202 176.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1520 ' ' ASN . . . . . 0.465 ' OD1' ' HB2' ' A' 1522 ' ' SER . 23.9 t-20 -89.02 112.47 51.17 Favored Pre-proline 0 C--N 1.287 -2.152 0 N-CA-C 108.247 -1.019 . . . . 2.02 108.247 176.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.69 -9.99 25.82 Favored 'Trans proline' 0 C--N 1.333 -0.237 0 C-N-CA 122.813 2.342 . . . . 1.82 113.257 -175.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1522 ' ' SER . . . . . 0.465 ' HB2' ' OD1' ' A' 1520 ' ' ASN . 24.6 m -74.13 -39.06 63.57 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 116.426 -0.352 . . . . 1.89 110.437 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1523 ' ' THR . . . . . 0.453 HG21 ' OD1' ' A' 1520 ' ' ASN . 9.7 t -122.58 -10.03 8.4 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 120.314 -0.554 . . . . 1.99 112.268 -179.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 81.06 22.6 60.77 Favored Glycine 0 C--N 1.32 -0.361 0 O-C-N 122.334 -0.229 . . . . 1.19 113.593 176.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1525 ' ' HIS . . . . . 0.558 ' CE1' ' HB3' ' A' 1647 ' ' GLU . 11.8 t-160 -93.65 125.26 38.17 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 120.535 -0.466 . . . . 1.82 110.69 -178.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1526 ' ' LEU . . . . . 0.429 HD22 ' OG1' ' A' 1519 ' ' THR . 2.5 tm? -94.28 116.52 28.92 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 114.866 -1.061 . . . . 1.3 109.764 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -92.71 119.09 31.75 Favored 'General case' 0 C--N 1.317 -0.808 0 O-C-N 122.296 -0.252 . . . . 0.8 110.438 173.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 14.2 t70 -103.92 110.67 22.9 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 109.123 -0.695 . . . . 1.17 109.123 178.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1529 ' ' LEU . . . . . 0.458 ' HB2' ' HB3' ' A' 1516 ' ' CYS . 3.6 mm? -99.01 3.16 46.85 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 121.326 0.584 . . . . 1.29 109.973 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 1.1 m -64.55 -29.66 70.69 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.049 -0.978 . . . . 0.91 109.344 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 23.1 t -62.26 -32.27 72.95 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.244 -0.889 . . . . 1.98 110.482 178.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 81.3 mt -96.28 1.37 51.98 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.255 -0.43 . . . . 1.34 110.944 -176.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1533 ' ' SER . . . . . . . . . . . . . 16.7 m -75.0 161.46 29.45 Favored 'General case' 0 C--O 1.256 1.42 0 CA-C-O 121.294 0.569 . . . . 1.93 111.982 -177.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -178.59 139.8 4.22 Favored Glycine 0 N--CA 1.429 -1.82 0 CA-C-N 115.623 -0.717 . . . . 1.1 111.532 178.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1535 ' ' ARG . . . . . 0.478 ' HD3' ' O ' ' A' 1535 ' ' ARG . 0.8 OUTLIER -92.92 -30.37 15.43 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 123.514 0.726 . . . . 5.21 109.252 -179.588 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -73.2 -34.11 65.78 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 121.582 0.706 . . . . 1.94 109.697 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 106.26 -177.47 22.3 Favored Glycine 0 N--CA 1.417 -2.574 0 CA-C-N 115.322 -0.854 . . . . 1.08 113.497 172.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -138.28 145.7 41.58 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 106.92 -1.511 . . . . 1.07 106.92 178.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 20.2 p -102.58 124.18 47.66 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 123.513 0.508 . . . . 1.46 110.526 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1540 ' ' ALA . . . . . 0.707 ' HB1' HG22 ' A' 1548 ' ' VAL . . . -117.37 134.89 54.3 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 109.087 -0.709 . . . . 1.19 109.087 178.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -88.13 124.47 33.82 Favored 'General case' 0 N--CA 1.439 -0.976 0 O-C-N 123.663 0.602 . . . . 1.37 110.71 -178.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1542 ' ' TYR . . . . . 0.521 ' HD2' ' CZ ' ' A' 1567 ' ' PHE . 2.2 t80 -123.5 -101.34 0.4 Allowed 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.235 -0.893 . . . . 1.38 109.675 -179.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1543 ' ' SER . . . . . . . . . . . . . 14.6 m -62.98 159.77 16.34 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 118.735 -0.65 . . . . 1.98 109.601 177.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 63.2 tttp -50.49 -40.87 52.32 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 112.902 0.705 . . . . 3.96 112.902 -175.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 27.3 t -116.98 34.43 5.11 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 108.47 -0.937 . . . . 2.81 108.47 177.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . -128.34 118.84 2.91 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.078 -1.058 . . . . 1.68 114.312 -175.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 28.1 m -124.66 137.61 56.82 Favored 'Isoleucine or valine' 0 C--O 1.254 1.325 0 CA-C-O 121.027 0.441 . . . . 1.38 109.939 176.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1548 ' ' VAL . . . . . 0.707 HG22 ' HB1' ' A' 1540 ' ' ALA . 0.0 OUTLIER -95.88 132.69 39.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-N 115.818 -0.628 . . . . 1.24 110.862 175.68 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A 1549 ' ' TYR . . . . . 0.413 ' HB3' ' ND2' ' A' 1556 ' ' ASN . 51.8 m-85 -96.33 99.8 11.46 Favored 'General case' 0 N--CA 1.423 -1.776 0 N-CA-C 106.756 -1.572 . . . . 1.29 106.756 171.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 6.4 ptp -110.75 142.15 43.09 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 115.392 -0.822 . . . . 1.47 111.589 -178.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1551 ' ' SER . . . . . 0.428 ' HB3' ' HB2' ' A' 1556 ' ' ASN . 12.3 p -118.34 110.64 17.73 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-N 115.719 -0.673 . . . . 1.4 109.428 176.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1552 ' ' ILE . . . . . . . . . . . . . 41.6 mm -75.49 119.6 23.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 109.465 -0.569 . . . . 1.11 109.465 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 56.8 m 64.41 41.68 5.61 Favored 'General case' 0 C--O 1.25 1.101 0 CA-C-O 121.97 0.891 . . . . 1.4 111.994 174.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 174.84 -178.02 46.73 Favored Glycine 0 N--CA 1.421 -2.36 0 N-CA-C 109.452 -1.459 . . . . 0.4 109.452 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -109.54 146.08 35.24 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-O 120.882 0.372 . . . . 1.62 110.224 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1556 ' ' ASN . . . . . 0.428 ' HB2' ' HB3' ' A' 1551 ' ' SER . 45.2 t-20 -94.92 139.49 31.25 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 115.672 -0.695 . . . . 1.12 109.166 -175.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1557 ' ' GLU . . . . . 0.403 ' HB3' ' CZ ' ' A' 1535 ' ' ARG . 12.9 pt-20 -77.92 -13.45 59.88 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 122.932 0.493 . . . . 2.49 112.304 -176.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -73.87 -8.25 55.37 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.38 0.511 . . . . 1.38 112.38 -177.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1559 ' ' CYS . . . . . 0.756 ' SG ' ' HD2' ' A' 1560 ' ' PRO . 1.6 t -137.72 169.41 13.07 Favored Pre-proline 0 C--N 1.288 -2.106 0 N-CA-C 106.747 -1.575 . . . . 1.21 106.747 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1560 ' ' PRO . . . . . 0.756 ' HD2' ' SG ' ' A' 1559 ' ' CYS . 14.2 Cg_exo -38.58 149.51 0.08 OUTLIER 'Trans proline' 0 CA--C 1.557 1.644 0 C-N-CA 124.003 3.135 . . . . 0.98 114.699 174.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -58.05 125.59 19.02 Favored 'Trans proline' 0 C--O 1.242 0.72 0 C-N-CA 123.151 2.567 . . . . 1.15 110.85 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 106.91 -7.28 38.13 Favored Glycine 0 N--CA 1.433 -1.517 0 CA-C-N 115.926 -0.579 . . . . 0.55 112.828 -178.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1563 ' ' VAL . . . . . 0.613 HG13 ' HB3' ' A' 1559 ' ' CYS . 9.8 t -79.37 121.8 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.836 0 N-CA-C 112.712 0.634 . . . . 1.53 112.712 -179.054 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -97.3 -34.75 5.49 Favored Glycine 0 C--N 1.306 -1.086 0 CA-C-N 114.918 -1.037 . . . . 0.29 111.023 176.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -131.4 125.17 31.91 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 109.653 -0.499 . . . . 1.08 109.653 178.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1566 ' ' CYS . . . . . 0.603 ' HB2' HG13 ' A' 1563 ' ' VAL . 49.4 t -150.78 138.46 19.77 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 110.115 -0.328 . . . . 0.43 110.115 -179.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1567 ' ' PHE . . . . . 0.928 ' HB3' ' HG2' ' A' 1569 ' ' GLN . 23.8 m-85 -85.74 139.62 31.19 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.812 -0.81 . . . . 1.3 108.812 172.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -87.57 23.32 13.04 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.211 -0.995 . . . . 1.43 111.245 -178.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1569 ' ' GLN . . . . . 0.928 ' HG2' ' HB3' ' A' 1567 ' ' PHE . 9.9 mm100 -67.71 -70.81 0.24 Allowed 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 122.912 0.485 . . . . 3.09 110.361 -177.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 14.3 t -131.85 34.74 3.83 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-O 122.539 1.161 . . . . 2.52 108.19 173.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 22.9 mmt180 63.56 61.02 1.05 Allowed 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 113.747 -1.569 . . . . 3.19 109.803 -178.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 34.8 mt -104.26 115.4 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-N 116.242 -0.436 . . . . 1.51 110.529 -177.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1573 ' ' SER . . . . . 0.544 ' HB3' ' HB2' ' A' 1596 ' ' SER . 28.6 t -80.13 142.02 35.19 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 120.957 0.408 . . . . 0.96 110.71 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1574 ' ' VAL . . . . . 0.448 HG13 ' CG ' ' A' 1606 ' ' TYR . 27.0 m -133.04 17.12 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 O-C-N 122.031 -0.418 . . . . 1.6 111.673 178.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 172.97 131.57 1.4 Allowed Glycine 0 N--CA 1.428 -1.843 0 C-N-CA 119.193 -1.48 . . . . 0.34 111.981 178.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -85.37 143.84 28.39 Favored 'General case' 0 N--CA 1.427 -1.578 0 N-CA-C 108.142 -1.058 . . . . 2.68 108.142 178.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -68.43 92.23 0.43 Allowed 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 115.456 -0.793 . . . . 1.08 111.8 -177.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -100.94 173.9 6.27 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 107.205 -1.406 . . . . 1.95 107.205 172.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1579 ' ' LYS . . . . . 0.439 ' HD3' ' HA ' ' A' 1515 ' ' ASP . 16.7 ptpt -142.8 54.5 1.39 Allowed 'General case' 0 C--N 1.294 -1.815 0 CA-C-O 122.395 1.093 . . . . 3.11 109.502 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1580 ' ' ARG . . . . . 0.426 ' NH1' HH21 ' A' 1582 ' ' ARG . 69.5 ttt180 -105.99 77.11 1.22 Allowed 'General case' 0 N--CA 1.419 -2.015 0 CA-C-N 114.953 -1.021 . . . . 4.04 109.7 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1581 ' ' LEU . . . . . 0.446 HD12 ' CG2' ' A' 1518 ' ' VAL . 0.5 OUTLIER -63.28 126.08 26.24 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.047 -0.979 . . . . 1.32 109.304 177.436 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A 1582 ' ' ARG . . . . . 0.536 ' HB2' ' HB3' ' A' 1589 ' ' GLN . 91.3 mtt180 -121.73 144.69 48.65 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 116.032 -0.531 . . . . 3.4 110.137 177.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1583 ' ' TYR . . . . . 0.618 ' CE1' ' HA ' ' A' 1586 ' ' GLN . 61.9 t80 -115.09 108.76 17.07 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.896 -0.409 . . . . 1.26 109.896 178.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1584 ' ' VAL . . . . . 0.528 ' O ' ' HB ' ' A' 1587 ' ' VAL . 13.1 m -124.81 89.56 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.61 0.719 . . . . 1.71 112.275 -178.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 21.0 t70 55.75 58.66 4.31 Favored 'General case' 0 N--CA 1.505 2.299 0 C-N-CA 124.739 1.215 . . . . 1.17 110.874 178.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1586 ' ' GLN . . . . . 0.618 ' HA ' ' CE1' ' A' 1583 ' ' TYR 0.352 3.9 pt20 63.92 17.66 10.69 Favored 'General case' 0 CA--C 1.503 -0.863 0 C-N-CA 127.513 2.325 . . . . 2.43 112.805 179.463 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A 1587 ' ' VAL . . . . . 0.528 ' HB ' ' O ' ' A' 1584 ' ' VAL . 39.5 t -102.0 120.48 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.235 0 N-CA-C 106.723 -1.584 . . . . 1.16 106.723 170.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1588 ' ' LEU . . . . . 0.932 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 2.5 mm? -96.6 108.03 20.56 Favored 'General case' 0 C--N 1.283 -2.283 0 N-CA-C 107.38 -1.341 . . . . 1.11 107.38 -179.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1589 ' ' GLN . . . . . 0.536 ' HB3' ' HB2' ' A' 1582 ' ' ARG . 34.4 tt0 -100.07 131.16 46.19 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 116.022 -0.535 . . . . 1.74 112.075 -173.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 12.1 mt -125.71 102.15 7.2 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 106.711 -1.589 . . . . 1.4 106.711 170.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 7.8 p -95.96 126.02 48.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 CA-C-O 121.39 0.614 . . . . 1.7 110.184 -177.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1592 ' ' TYR . . . . . . . . . . . . . 13.0 m-30 -117.25 110.69 18.43 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 107.966 -1.124 . . . . 1.08 107.966 -178.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 47.4 pttt -130.56 -179.13 5.1 Favored 'General case' 0 C--N 1.281 -2.381 0 CA-C-N 115.625 -0.716 . . . . 2.21 109.375 -177.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 19.9 m-20 61.66 43.33 9.97 Favored 'General case' 0 CA--C 1.507 -0.701 0 O-C-N 124.383 1.052 . . . . 1.11 110.264 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -90.81 -134.43 5.92 Favored Glycine 0 N--CA 1.432 -1.623 0 CA-C-N 114.594 -1.184 . . . . 0.78 110.942 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1596 ' ' SER . . . . . 0.544 ' HB2' ' HB3' ' A' 1573 ' ' SER . 33.1 t -86.31 148.24 46.68 Favored Pre-proline 0 C--N 1.303 -1.424 0 N-CA-C 108.583 -0.895 . . . . 1.36 108.583 -178.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -63.11 140.12 76.53 Favored 'Trans proline' 0 N--CA 1.443 -1.496 0 C-N-CA 122.499 2.133 . . . . 1.4 109.711 174.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1598 ' ' CYS . . . . . 0.552 ' HA ' ' CE2' ' A' 1606 ' ' TYR . 49.4 t -79.58 110.18 14.52 Favored Pre-proline 0 C--N 1.294 -1.817 0 N-CA-C 107.721 -1.215 . . . . 0.75 107.721 -178.1 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -58.59 -34.11 98.62 Favored 'Trans proline' 0 C--N 1.358 1.044 0 C-N-CA 123.191 2.594 . . . . 1.7 112.007 -176.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1600 ' ' SER . . . . . 0.713 ' HB3' ' HB2' ' B' ' 53' ' ' LEU . 4.8 m -60.62 -22.44 63.79 Favored 'General case' 0 CA--C 1.56 1.334 0 C-N-CA 125.271 1.428 . . . . 2.8 113.171 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1601 ' ' LYS . . . . . 0.483 ' HE2' ' OD2' ' B' ' 52' ' ' ASP . 4.9 tppp? -157.4 120.62 4.04 Favored 'General case' 0 C--O 1.241 0.622 0 O-C-N 121.952 -0.468 . . . . 3.45 110.339 178.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 19.8 m -70.18 133.93 47.58 Favored 'General case' 0 N--CA 1.414 -2.273 0 N-CA-C 109.686 -0.487 . . . . 2.44 109.686 -177.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 105.51 -16.89 44.01 Favored Glycine 0 C--N 1.301 -1.377 0 CA-C-N 116.072 -0.513 . . . . 1.2 112.343 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1604 ' ' LEU . . . . . 0.476 HD12 ' HB3' ' A' 1601 ' ' LYS . 56.9 mt -102.95 138.76 39.4 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 122.164 -0.61 . . . . 2.38 110.451 -179.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 20.5 m -115.92 147.04 41.54 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 107.698 -1.223 . . . . 1.96 107.698 175.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1606 ' ' TYR . . . . . 0.552 ' CE2' ' HA ' ' A' 1598 ' ' CYS . 54.4 m-85 -70.14 150.21 46.75 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 116.687 -0.233 . . . . 1.06 111.543 -178.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1607 ' ' LYS . . . . . 0.522 ' HZ1' ' HB3' ' A' 1607 ' ' LYS . 6.6 ttpm? -148.07 135.51 20.6 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.771 -0.826 . . . . 2.0 108.771 177.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1608 ' ' SER . . . . . . . . . . . . . 2.6 p -119.1 126.42 51.6 Favored 'General case' 0 C--N 1.281 -2.387 0 CA-C-N 115.384 -0.826 . . . . 1.61 109.83 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 39.1 t -107.51 105.16 18.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 109.52 -0.548 . . . . 1.09 109.52 -178.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 92.9 mt -89.97 119.38 36.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 107.972 -1.121 . . . . 1.2 107.972 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 20.0 m -124.55 116.0 21.76 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-N 115.85 -0.614 . . . . 1.89 110.494 -177.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1612 ' ' PHE . . . . . 0.932 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 75.5 m-85 -85.62 122.82 30.28 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.606 -0.887 . . . . 0.28 108.606 176.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 58.8 t -111.62 135.58 50.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 CA-C-N 115.382 -0.826 . . . . 1.23 109.576 -174.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 39.5 t -68.3 107.54 2.86 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.246 -0.888 . . . . 0.77 110.587 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1615 ' ' ARG . . . . . 0.425 ' CB ' ' HB3' ' A' 1641 ' ' HIS . 32.7 tpt180 -132.35 94.28 23.48 Favored Pre-proline 0 N--CA 1.437 -1.107 0 N-CA-C 108.746 -0.835 . . . . 2.92 108.746 176.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1616 ' ' PRO . . . . . 0.77 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 18.6 Cg_exo -66.89 -26.17 44.58 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 122.034 1.823 . . . . 1.22 112.397 -177.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -77.87 43.31 0.42 Allowed 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 125.067 1.347 . . . . 3.05 112.977 178.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -31.99 126.24 0.26 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.726 1.611 . . . . 1.55 113.171 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . -167.19 -141.17 3.08 Favored Glycine 0 N--CA 1.412 -2.906 0 N-CA-C 109.175 -1.57 . . . . 1.16 109.175 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -75.49 8.77 2.45 Favored 'Trans proline' 0 CA--C 1.533 0.437 0 C-N-CA 122.525 2.15 . . . . 1.06 113.337 -176.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1621 ' ' THR . . . . . 0.694 ' HB ' ' HB2' ' A' 1641 ' ' HIS . 14.4 p -96.18 -10.48 28.02 Favored 'General case' 0 C--N 1.292 -1.905 0 C-N-CA 124.102 0.961 . . . . 1.58 109.971 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 52.9 t30 -85.86 65.34 9.08 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 114.945 -1.025 . . . . 0.88 109.38 -178.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1623 ' ' ARG . . . . . 0.516 ' O ' ' HG3' ' A' 1625 ' ' MET . 10.8 ptp180 -165.34 141.84 4.61 Favored Pre-proline 0 C--N 1.31 -1.126 0 N-CA-C 107.78 -1.193 . . . . 3.82 107.78 -175.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1624 ' ' PRO . . . . . 0.436 ' HG3' ' CZ3' ' A' 1640 ' ' TRP . 23.5 Cg_exo -56.11 107.37 0.25 Allowed 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.551 2.167 . . . . 0.77 111.005 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1625 ' ' MET . . . . . 0.516 ' HG3' ' O ' ' A' 1623 ' ' ARG . 89.8 mtp -107.05 132.46 52.94 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.345 -0.613 . . . . 1.43 109.345 -177.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1626 ' ' LEU . . . . . 0.405 HD23 ' CE1' ' A' 1638 ' ' PHE . 0.5 OUTLIER -85.4 114.06 22.17 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 106.406 -1.702 . . . . 1.43 106.406 179.793 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A 1627 ' ' ILE . . . . . 0.701 HD11 ' HB2' ' A' 1639 ' ' SER . 45.2 mm -69.4 -55.1 16.42 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.139 0 N-CA-C 109.027 -0.731 . . . . 1.23 109.027 -179.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 11.8 t -176.44 152.88 1.12 Allowed 'General case' 0 N--CA 1.425 -1.704 0 N-CA-C 108.616 -0.883 . . . . 1.88 108.616 -176.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1629 ' ' LEU . . . . . 0.602 HD13 HD23 ' A' 1636 ' ' LEU . 19.0 tp -99.89 109.51 21.89 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.304 -0.862 . . . . 1.92 109.408 175.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 20.6 t70 -73.03 98.79 2.6 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 106.372 -1.714 . . . . 1.09 106.372 170.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1631 ' ' LYS . . . . . 0.612 ' HD3' ' H ' ' A' 1631 ' ' LYS . 0.2 OUTLIER -73.31 -16.21 61.38 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 113.73 1.011 . . . . 3.98 113.73 -172.989 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 16.7 mm100 -73.56 -36.63 65.63 Favored 'General case' 0 CA--C 1.498 -1.052 0 C-N-CA 120.41 -0.516 . . . . 2.6 111.193 178.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 58.9 p -108.01 -6.15 16.72 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 115.886 -0.597 . . . . 1.35 112.432 -176.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 82.5 m 63.73 47.08 3.77 Favored 'General case' 0 C--N 1.36 1.03 0 C-N-CA 124.368 1.067 . . . . 0.53 109.754 -178.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1635 ' ' THR . . . . . . . . . . . . . 56.1 m -115.36 133.17 56.29 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.92 -1.036 . . . . 1.11 110.808 -175.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1636 ' ' LEU . . . . . 0.602 HD23 HD13 ' A' 1629 ' ' LEU . 15.7 mt -110.14 135.75 50.44 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.996 -0.742 . . . . 1.56 108.996 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -109.55 133.15 53.43 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 109.421 -0.585 . . . . 0.54 109.421 176.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1638 ' ' PHE . . . . . 0.405 ' CE1' HD23 ' A' 1626 ' ' LEU . 97.3 m-85 -123.34 135.39 54.16 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 116.137 -0.483 . . . . 0.64 110.021 -178.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1639 ' ' SER . . . . . 0.701 ' HB2' HD11 ' A' 1627 ' ' ILE . 23.3 t -115.62 156.17 26.32 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 107.221 -1.399 . . . . 1.34 107.221 175.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1640 ' ' TRP . . . . . 0.436 ' CZ3' ' HG3' ' A' 1624 ' ' PRO . 3.1 t90 -151.5 106.21 3.25 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 103.973 -2.603 . . . . 0.8 103.973 177.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1641 ' ' HIS . . . . . 0.694 ' HB2' ' HB ' ' A' 1621 ' ' THR . 12.3 m-70 -93.39 103.45 15.67 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.694 -0.854 . . . . 1.14 108.694 -173.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1642 ' ' THR . . . . . . . . . . . . . 15.3 t -142.21 145.33 35.06 Favored Pre-proline 0 CA--C 1.558 1.277 0 C-N-CA 120.776 -0.369 . . . . 1.11 110.341 -172.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1643 ' ' PRO . . . . . 0.77 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 72.6 Cg_endo -78.42 -5.5 14.96 Favored 'Trans proline' 0 C--N 1.372 1.793 0 C-N-CA 122.303 2.002 . . . . 0.78 112.233 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 9.2 tt -66.49 -24.44 66.41 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.104 -0.702 . . . . 1.66 109.104 177.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -92.7 16.2 12.78 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.251 -0.886 . . . . 1.29 110.566 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 58.6 m -121.79 145.87 47.62 Favored 'General case' 0 N--CA 1.424 -1.748 0 O-C-N 122.28 -0.262 . . . . 1.48 110.998 -178.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1647 ' ' GLU . . . . . 0.558 ' HB3' ' CE1' ' A' 1525 ' ' HIS . 0.4 OUTLIER . . . . . 0 C--N 1.296 -1.729 0 N-CA-C 108.509 -0.923 . . . . 3.14 108.509 167.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . 0.461 ' O ' HG13 ' B' ' 14' ' ' VAL . . . . . . . . 0 N--CA 1.412 -2.962 0 N-CA-C 110.07 -1.212 . . . . 2.28 110.07 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . 0.543 ' O ' ' HB2' ' B' ' 15' ' ' ASP . . . -56.32 -62.38 6.4 Favored Glycine 0 N--CA 1.44 -1.05 0 O-C-N 124.687 0.875 . . . . 1.94 113.325 -176.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -74.12 -30.04 62.12 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.981 0.391 . . . . 2.55 111.222 -176.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' LEU . . . . . 0.428 ' O ' HD21 ' B' ' 17' ' ' LEU . 67.1 mt -56.67 -64.86 0.73 Allowed 'General case' 0 N--CA 1.468 0.446 0 O-C-N 123.374 0.421 . . . . 2.82 111.09 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . 0.461 HG13 ' O ' ' B' ' 10' ' ' GLY . 14.0 p -65.38 -29.85 48.45 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 CA-C-O 121.355 0.598 . . . . 2.5 110.269 -178.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' ASP . . . . . 0.543 ' HB2' ' O ' ' B' ' 11' ' ' GLY . 4.0 t70 -66.69 -48.38 69.44 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-N 115.422 -0.808 . . . . 2.04 112.251 -177.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 13.4 t -65.91 -31.87 73.05 Favored 'General case' 0 C--O 1.256 1.414 0 CA-C-N 118.099 0.409 . . . . 2.31 110.82 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.619 ' HB3' ' HB3' ' B' ' 26' ' ' PHE . 4.1 mm? -58.6 -48.79 79.78 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.423 0.63 . . . . 2.27 110.374 174.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -80.22 -15.1 57.76 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.549 0.69 . . . . 2.39 110.902 -178.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -65.07 -52.76 53.85 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.786 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 30.7 m -98.43 -24.95 4.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 C-N-CA 118.666 -1.214 . . . . 1.83 112.141 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' CYS . . . . . 0.42 ' HB2' ' O ' ' B' ' 17' ' ' LEU . 95.9 m -105.03 19.84 19.9 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 120.681 -0.407 . . . . 1.66 111.841 -177.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -49.22 -40.89 30.21 Favored Glycine 0 N--CA 1.474 1.168 0 N-CA-C 115.093 0.797 . . . . 1.53 115.093 -178.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -71.4 -32.35 68.32 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 112.476 0.547 . . . . 2.72 112.476 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 21.0 ttm180 -93.12 -41.12 10.11 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 120.738 -0.385 . . . . 5.02 111.852 -175.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 120.25 -176.15 16.12 Favored Glycine 0 N--CA 1.436 -1.355 0 N-CA-C 110.191 -1.164 . . . . 1.63 110.191 -177.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . 0.619 ' HB3' ' HB3' ' B' ' 17' ' ' LEU . 12.9 p90 -132.4 127.78 36.15 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 116.914 0.357 . . . . 1.71 110.277 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -131.09 84.04 2.15 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.089 0.471 . . . . 3.67 112.103 -175.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' PHE . . . . . . . . . . . . . 33.4 p90 . . . . . 0 C--N 1.302 -1.491 0 CA-C-O 122.367 1.08 . . . . 2.44 108.806 177.232 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.206 0 CA-C-O 119.094 -0.837 . . . . 2.62 113.253 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . 0.65 ' HA ' ' HG2' ' B' ' 45' ' ' GLU . 27.5 pt 52.75 26.94 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.38 1.899 0 C-N-CA 126.549 1.94 . . . . 2.28 112.739 179.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 1.4 p -103.05 -44.42 9.75 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.921 0 CA-C-N 113.771 -1.559 . . . . 2.6 112.638 -173.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -83.72 -22.06 32.11 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.758 -1.201 . . . . 3.36 107.758 -178.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . 0.65 ' HG2' ' HA ' ' B' ' 42' ' ' ILE . 1.5 pm0 -77.53 -28.36 51.95 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 114.241 -1.345 . . . . 3.08 112.22 173.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' CYS . . . . . . . . . . . . . 12.1 t -112.77 -3.25 14.24 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 118.729 -1.188 . . . . 2.23 112.793 -177.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 43.3 t -86.77 -53.34 4.98 Favored 'General case' 0 C--N 1.314 -0.975 0 O-C-N 121.201 -0.937 . . . . 2.48 110.958 175.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -91.71 -5.73 53.19 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.31 0.576 . . . . 2.97 111.902 -176.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -139.5 152.16 46.73 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 106.348 -1.723 . . . . 4.65 106.348 179.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 32.3 t -80.3 139.59 36.56 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 106.209 -1.774 . . . . 2.86 106.209 175.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . 0.594 ' HB2' HD21 ' B' ' 55' ' ' LEU . 25.7 p -105.46 138.18 42.08 Favored 'General case' 0 N--CA 1.422 -1.855 0 N-CA-C 108.6 -0.889 . . . . 2.11 108.6 -175.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . 0.483 ' OD2' ' HE2' ' A' 1601 ' ' LYS . 3.5 m-20 -66.33 139.44 58.04 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.944 -0.761 . . . . 2.67 108.944 177.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . 0.713 ' HB2' ' HB3' ' A' 1600 ' ' SER . 36.0 tp -55.18 -30.86 60.77 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.246 -1.343 . . . . 2.36 110.555 177.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.48 -45.44 84.84 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 123.688 0.795 . . . . 1.92 110.431 177.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . 0.594 HD21 ' HB2' ' B' ' 51' ' ' CYS . 44.9 tp -58.77 -50.57 73.43 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 123.936 0.895 . . . . 2.35 110.52 -179.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 3.1 pp -74.11 -33.08 63.47 Favored 'General case' 0 N--CA 1.424 -1.74 0 C-N-CA 120.716 -0.394 . . . . 2.01 111.842 -175.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -66.75 -49.45 65.92 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.117 0.484 . . . . 2.27 110.812 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 7.2 t -73.75 -24.46 59.88 Favored 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 120.294 -0.562 . . . . 2.67 111.039 -177.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -76.7 -67.48 0.7 Allowed 'General case' 0 C--O 1.241 0.611 0 N-CA-C 107.576 -1.268 . . . . 3.2 107.576 176.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 42.9 t . . . . . 0 CA--C 1.549 0.926 0 C-N-CA 125.311 1.444 . . . . 2.3 113.881 175.732 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A 1515 ' ' ASP . . . . . 0.411 ' CG ' ' H ' ' A' 1516 ' ' CYS . 14.6 t70 . . . . . 0 N--CA 1.442 -0.843 0 N-CA-C 106.006 -1.85 . . . . 2.9 106.006 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1516 ' ' CYS . . . . . 0.411 ' H ' ' CG ' ' A' 1515 ' ' ASP . 21.7 t -90.31 73.32 7.07 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 107.154 -1.424 . . . . 1.41 107.154 178.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -166.7 172.34 10.66 Favored 'General case' 0 N--CA 1.423 -1.822 0 N-CA-C 104.949 -2.241 . . . . 2.18 104.949 -174.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 10.6 p -168.27 137.07 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 CA-C-O 121.414 0.626 . . . . 1.52 110.531 177.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1519 ' ' THR . . . . . . . . . . . . . 35.4 m -92.92 135.85 33.78 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 115.809 -0.632 . . . . 1.36 109.973 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -86.23 124.94 69.45 Favored Pre-proline 0 N--CA 1.414 -2.231 0 CA-C-N 116.226 -0.443 . . . . 2.02 110.106 176.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.76 -13.62 24.4 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.991 2.461 . . . . 1.82 113.602 -175.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 14.1 m -80.38 -41.62 24.31 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 116.657 -0.247 . . . . 1.89 111.442 -177.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1523 ' ' THR . . . . . . . . . . . . . 6.6 t -125.43 2.8 7.7 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 119.502 -0.879 . . . . 1.99 112.662 -175.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 65.35 28.12 73.22 Favored Glycine 0 CA--C 1.503 -0.697 0 C-N-CA 121.129 -0.558 . . . . 1.19 112.423 178.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 18.9 t-80 -98.2 127.65 44.26 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 121.268 0.556 . . . . 1.82 109.593 -179.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 2.8 tm? -86.03 118.5 25.54 Favored 'General case' 0 C--N 1.288 -2.078 0 CA-C-N 114.171 -1.377 . . . . 1.3 109.825 -177.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1527 ' ' PHE . . . . . 0.568 ' HE2' ' HE2' ' A' 1583 ' ' TYR . 30.6 m-85 -90.39 128.07 36.38 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 109.333 -0.617 . . . . 0.8 109.333 170.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 23.0 t70 -115.16 123.67 49.5 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 123.709 0.631 . . . . 1.17 109.768 178.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 3.0 mm? -100.34 -5.94 26.57 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-O 121.565 0.698 . . . . 1.29 109.798 -178.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1530 ' ' SER . . . . . 0.441 ' HA ' ' OG ' ' A' 1533 ' ' SER . 1.1 m -70.67 -18.17 62.84 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.381 -0.827 . . . . 0.91 109.704 -177.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 40.5 m -62.81 -19.21 63.84 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 115.369 -0.832 . . . . 1.98 110.228 176.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1532 ' ' LEU . . . . . 0.443 ' HB2' HG21 ' A' 1552 ' ' ILE . 75.9 mt -105.87 3.86 29.06 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 120.672 0.272 . . . . 1.34 111.147 177.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1533 ' ' SER . . . . . 0.441 ' OG ' ' HA ' ' A' 1530 ' ' SER . 50.2 m -68.11 155.46 39.54 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 121.472 0.653 . . . . 1.93 111.792 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . 173.68 149.57 7.04 Favored Glycine 0 N--CA 1.422 -2.248 0 N-CA-C 109.373 -1.491 . . . . 1.1 109.373 -177.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 41.7 ttp180 -89.52 -21.29 22.99 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.189 0.519 . . . . 5.21 109.922 -177.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -81.02 -40.91 23.52 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 109.172 -0.677 . . . . 1.94 109.172 176.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 91.94 -151.16 20.64 Favored Glycine 0 N--CA 1.42 -2.424 0 CA-C-N 115.651 -0.704 . . . . 1.08 113.976 171.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -135.04 145.07 47.66 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 107.78 -1.192 . . . . 1.07 107.78 -177.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 15.5 p -111.45 127.69 55.76 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 123.903 0.752 . . . . 1.46 110.526 179.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1540 ' ' ALA . . . . . 0.692 ' HB3' ' HG2' ' A' 1624 ' ' PRO . . . -120.14 142.95 48.47 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 108.367 -0.975 . . . . 1.19 108.367 175.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -80.93 136.97 36.12 Favored 'General case' 0 C--N 1.314 -0.937 0 O-C-N 123.817 0.698 . . . . 1.37 110.354 -176.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1542 ' ' TYR . . . . . 0.82 ' HE2' ' HG ' ' A' 1626 ' ' LEU . 3.1 t80 -149.21 -99.08 0.07 Allowed 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 115.984 -0.553 . . . . 1.38 109.743 -174.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1543 ' ' SER . . . . . 0.406 ' H ' ' HB3' ' A' 1542 ' ' TYR . 30.0 t -72.31 151.48 42.73 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 109.04 -0.726 . . . . 1.98 109.04 -177.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1544 ' ' LYS . . . . . 0.568 ' HD2' ' HA ' ' B' ' 23' ' ' ASP . 62.7 tttp -57.95 -22.35 48.56 Favored 'General case' 0 C--N 1.346 0.416 0 C-N-CA 125.326 1.45 . . . . 3.96 112.318 -174.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 34.5 t -132.21 19.93 4.44 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 116.271 -0.422 . . . . 2.81 109.985 -178.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1546 ' ' GLY . . . . . 0.49 ' HA3' ' OE1' ' A' 1569 ' ' GLN . . . -159.14 127.93 1.93 Allowed Glycine 0 N--CA 1.439 -1.115 0 C-N-CA 118.816 -1.659 . . . . 1.68 113.988 -176.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 26.9 m -100.91 164.64 2.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 108.154 -1.054 . . . . 1.38 108.154 176.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1548 ' ' VAL . . . . . 0.482 ' CG1' ' HB2' ' A' 1540 ' ' ALA . 10.2 p -102.15 130.85 51.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 109.614 -0.513 . . . . 1.24 109.614 178.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -101.96 118.5 37.05 Favored 'General case' 0 CA--C 1.497 -1.068 0 C-N-CA 123.462 0.705 . . . . 1.29 109.287 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1550 ' ' MET . . . . . 0.522 ' SD ' ' HZ3' ' A' 1640 ' ' TRP . 8.9 ptp -127.81 144.93 51.07 Favored 'General case' 0 C--N 1.29 -2.011 0 C-N-CA 120.182 -0.607 . . . . 1.47 111.46 175.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 8.3 p -119.34 123.36 43.99 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 115.59 -0.732 . . . . 1.4 109.177 175.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1552 ' ' ILE . . . . . 0.458 HG23 ' SG ' ' A' 1553 ' ' CYS . 46.6 mm -81.24 114.09 21.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 C-N-CA 121.152 -0.219 . . . . 1.11 110.671 -177.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1553 ' ' CYS . . . . . 0.458 ' SG ' HG23 ' A' 1552 ' ' ILE . 31.1 m 66.91 38.38 3.67 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.62 0.768 . . . . 1.4 110.563 173.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . -177.41 -173.25 42.75 Favored Glycine 0 N--CA 1.417 -2.582 0 N-CA-C 109.343 -1.503 . . . . 0.4 109.343 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -110.38 148.62 31.63 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-O 121.095 0.474 . . . . 1.62 110.469 -178.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -99.09 131.1 45.38 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.656 -0.868 . . . . 1.12 108.656 -176.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -81.71 1.59 33.67 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 113.355 0.872 . . . . 2.49 113.355 -174.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 51.9 m-80 -83.39 -7.48 59.56 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 120.429 -0.508 . . . . 1.38 111.391 -179.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1559 ' ' CYS . . . . . 0.695 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 98.0 m -136.72 175.13 3.74 Favored Pre-proline 0 C--N 1.31 -1.127 0 CA-C-O 117.931 -1.033 . . . . 1.21 110.041 179.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1560 ' ' PRO . . . . . 0.695 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 4.3 Cg_exo -40.27 137.72 1.39 Allowed 'Trans proline' 0 C--N 1.387 2.559 0 C-N-CA 123.917 3.078 . . . . 0.98 113.516 177.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -53.99 127.16 24.52 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 123.624 2.882 . . . . 1.15 112.845 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 102.29 6.7 47.6 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-N 115.85 -0.613 . . . . 0.55 113.028 -178.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1563 ' ' VAL . . . . . 0.545 HG13 ' HB2' ' A' 1566 ' ' CYS . 2.8 t -96.08 124.64 48.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 C-N-CA 123.171 0.588 . . . . 1.53 111.648 -177.099 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -97.26 -33.56 5.92 Favored Glycine 0 N--CA 1.44 -1.048 0 CA-C-N 115.34 -0.846 . . . . 0.29 111.747 178.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -129.9 125.54 35.79 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 109.62 -0.511 . . . . 1.08 109.62 178.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1566 ' ' CYS . . . . . 0.545 ' HB2' HG13 ' A' 1563 ' ' VAL . 43.7 t -151.24 139.73 20.52 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 120.664 0.269 . . . . 0.43 110.878 -179.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1567 ' ' PHE . . . . . 0.436 ' HB3' ' HG2' ' A' 1569 ' ' GLN . 10.9 m-85 -91.4 143.0 27.07 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 122.427 -0.17 . . . . 1.3 110.682 173.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -90.36 41.16 2.96 Favored Glycine 0 N--CA 1.431 -1.651 0 C-N-CA 120.54 -0.838 . . . . 1.43 111.821 -176.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1569 ' ' GLN . . . . . 0.49 ' OE1' ' HA3' ' A' 1546 ' ' GLY . 8.4 mm100 -80.33 -72.19 0.42 Allowed 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 108.838 -0.801 . . . . 3.09 108.838 177.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1570 ' ' THR . . . . . 0.411 ' H ' ' HB2' ' A' 1569 ' ' GLN . 19.0 p -133.37 35.14 3.46 Favored 'General case' 0 N--CA 1.433 -1.31 0 C-N-CA 123.869 0.868 . . . . 2.52 110.198 176.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 11.6 mmt180 67.61 63.02 0.42 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.743 1.217 . . . . 3.19 108.791 -174.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 31.1 mt -105.89 111.53 35.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 CA-C-N 115.946 -0.57 . . . . 1.51 110.814 -176.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 31.2 t -81.98 139.15 34.73 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.597 -0.729 . . . . 0.96 111.052 -177.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1574 ' ' VAL . . . . . 0.562 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 34.6 m -132.13 12.98 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-O 121.163 0.506 . . . . 1.6 111.329 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 178.98 122.62 0.77 Allowed Glycine 0 N--CA 1.423 -2.186 0 C-N-CA 120.158 -1.02 . . . . 0.34 111.761 177.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 29.5 ttpp -81.0 146.47 30.66 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 107.558 -1.275 . . . . 2.68 107.558 178.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -68.28 90.29 0.35 Allowed 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.232 0.539 . . . . 1.08 112.295 -175.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -107.37 179.69 4.18 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.414 -1.328 . . . . 1.95 107.414 176.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 60.0 mttp -138.47 48.13 1.95 Allowed 'General case' 0 CA--C 1.49 -1.341 0 N-CA-C 109.181 -0.674 . . . . 3.11 109.181 178.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1580 ' ' ARG . . . . . 0.517 ' HB3' HG12 ' A' 1591 ' ' VAL . 31.1 ttm180 -87.21 76.97 9.12 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.839 -0.745 . . . . 4.04 109.286 -177.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1581 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.13 124.98 31.01 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 114.478 -1.237 . . . . 1.32 108.65 -179.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -127.89 138.46 52.68 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 116.342 -0.39 . . . . 3.4 110.125 172.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1583 ' ' TYR . . . . . 0.568 ' HE2' ' HE2' ' A' 1527 ' ' PHE . 32.6 t80 -95.97 115.56 27.62 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 107.084 -1.45 . . . . 1.26 107.084 176.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1584 ' ' VAL . . . . . 0.704 ' O ' ' HB ' ' A' 1587 ' ' VAL . 6.3 p -138.76 102.0 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.044 0 C-N-CA 120.529 -0.468 . . . . 1.71 111.646 -176.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 19.4 t70 58.58 56.45 4.26 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 122.381 1.086 . . . . 1.17 110.658 179.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1586 ' ' GLN . . . . . 0.441 ' HA ' ' CZ ' ' A' 1583 ' ' TYR . 11.1 pt20 58.84 10.79 1.62 Allowed 'General case' 0 N--CA 1.499 1.993 0 C-N-CA 127.472 2.309 . . . . 2.43 112.32 -178.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1587 ' ' VAL . . . . . 0.704 ' HB ' ' O ' ' A' 1584 ' ' VAL . 2.8 t -97.02 124.61 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.245 0 CA-C-N 114.573 -1.194 . . . . 1.16 109.846 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1588 ' ' LEU . . . . . 0.899 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 4.1 mm? -90.41 108.92 20.08 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 107.239 -1.393 . . . . 1.11 107.239 175.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -109.52 122.0 46.45 Favored 'General case' 0 C--N 1.287 -2.114 0 C-N-CA 119.47 -0.892 . . . . 1.74 111.443 -176.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1590 ' ' LEU . . . . . 0.676 ' HB3' ' HB ' ' A' 1610 ' ' ILE . 44.8 tp -113.44 109.93 19.48 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 106.18 -1.785 . . . . 1.4 106.18 177.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1591 ' ' VAL . . . . . 0.517 HG12 ' HB3' ' A' 1580 ' ' ARG . 4.6 p -102.52 129.04 54.68 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 119.619 -0.832 . . . . 1.7 110.599 -177.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1592 ' ' TYR . . . . . 0.428 ' O ' ' HG3' ' A' 1607 ' ' LYS . 13.2 m-30 -117.37 126.91 53.46 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.437 -1.32 . . . . 1.08 107.437 177.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 12.9 ptmm? -140.6 176.69 8.58 Favored 'General case' 0 C--N 1.278 -2.515 0 N-CA-C 108.619 -0.882 . . . . 2.21 108.619 -174.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 9.3 m-20 58.58 41.8 21.76 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 124.599 1.187 . . . . 1.11 111.81 178.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -76.14 -98.8 0.14 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.15 -1.024 . . . . 0.78 110.954 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1596 ' ' SER . . . . . . . . . . . . . 12.4 t -120.97 152.44 56.43 Favored Pre-proline 0 C--N 1.285 -2.208 0 N-CA-C 105.61 -1.996 . . . . 1.36 105.61 174.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -61.84 139.12 78.27 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 122.376 2.05 . . . . 1.4 110.767 175.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 39.2 t -81.79 102.95 1.73 Allowed Pre-proline 0 C--N 1.302 -1.494 0 N-CA-C 106.658 -1.608 . . . . 0.75 106.658 178.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -62.11 -39.47 49.05 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 123.106 2.538 . . . . 1.7 113.184 -170.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1600 ' ' SER . . . . . 0.414 ' HB3' ' HA ' ' B' ' 53' ' ' LEU . 8.7 m -69.12 -15.09 63.34 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.47 -0.786 . . . . 2.8 112.817 -177.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1601 ' ' LYS . . . . . . . . . . . . . 13.7 tppt? -135.31 87.91 2.37 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 107.318 -1.364 . . . . 3.45 107.318 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 14.9 m -44.66 114.47 0.71 Allowed 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 125.896 1.678 . . . . 2.44 114.456 -174.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 100.64 10.53 43.57 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 114.415 0.526 . . . . 1.2 114.415 175.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 9.2 mp -110.57 156.25 21.19 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 117.28 0.54 . . . . 2.38 111.197 178.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 16.5 m -121.34 147.8 45.2 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.514 -1.291 . . . . 1.96 107.514 173.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1606 ' ' TYR . . . . . 0.562 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 85.8 m-85 -71.91 149.99 44.61 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 110.377 -0.231 . . . . 1.06 110.377 177.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1607 ' ' LYS . . . . . 0.538 ' HZ1' ' HB3' ' A' 1607 ' ' LYS . 6.1 ttpm? -146.94 135.86 22.32 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 123.856 0.723 . . . . 2.0 109.455 178.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1608 ' ' SER . . . . . . . . . . . . . 19.2 m -114.36 125.58 54.03 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 108.645 -0.872 . . . . 1.61 108.645 -178.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 39.1 t -105.59 108.26 24.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 108.808 -0.812 . . . . 1.09 108.808 178.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1610 ' ' ILE . . . . . 0.676 ' HB ' ' HB3' ' A' 1590 ' ' LEU . 79.1 mt -95.08 118.87 42.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 108.583 -0.895 . . . . 1.2 108.583 -178.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1611 ' ' SER . . . . . 0.434 ' HG ' HG12 ' A' 1587 ' ' VAL . 26.6 t -117.24 110.52 18.22 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 108.972 -0.751 . . . . 1.89 108.972 -178.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1612 ' ' PHE . . . . . 0.899 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 70.8 m-85 -86.7 122.95 31.32 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.654 -0.869 . . . . 0.28 108.654 177.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 44.8 t -116.53 135.37 57.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.457 0 CA-C-N 115.433 -0.803 . . . . 1.23 110.144 -174.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1614 ' ' CYS . . . . . 0.438 ' HB2' ' HA ' ' A' 1646 ' ' CYS . 4.9 t -54.53 111.11 0.73 Allowed 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 124.573 1.149 . . . . 0.77 113.095 177.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1615 ' ' ARG . . . . . 0.679 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 18.6 tpt180 -137.29 91.04 14.78 Favored Pre-proline 0 N--CA 1.441 -0.911 0 N-CA-C 108.815 -0.809 . . . . 2.92 108.815 169.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1616 ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -66.68 -23.49 48.95 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.251 1.967 . . . . 1.22 112.996 -175.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -71.5 -22.83 61.74 Favored 'General case' 0 N--CA 1.432 -1.35 0 C-N-CA 122.923 0.489 . . . . 3.05 111.822 178.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . 63.61 -156.52 0.32 Allowed 'General case' 0 C--N 1.359 1.006 0 N-CA-C 108.155 -1.054 . . . . 1.55 108.155 -174.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . 116.43 -157.3 15.12 Favored Glycine 0 N--CA 1.414 -2.773 0 C-N-CA 120.202 -0.999 . . . . 1.16 112.484 176.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -78.45 13.94 1.73 Allowed 'Trans proline' 0 C--N 1.325 -0.67 0 C-N-CA 123.683 2.922 . . . . 1.06 113.053 -175.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1621 ' ' THR . . . . . 0.729 ' HB ' ' HB2' ' A' 1641 ' ' HIS . 16.5 p -105.39 -7.84 18.54 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 115.002 -0.999 . . . . 1.58 109.598 178.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 56.6 t30 -87.79 65.68 8.49 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.444 -0.947 . . . . 0.88 108.444 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -166.72 141.53 3.47 Favored Pre-proline 0 C--N 1.307 -1.255 0 N-CA-C 107.743 -1.206 . . . . 3.82 107.743 -175.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1624 ' ' PRO . . . . . 0.692 ' HG2' ' HB3' ' A' 1540 ' ' ALA . 21.3 Cg_endo -60.87 104.58 0.28 Allowed 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.532 2.154 . . . . 0.77 111.408 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 85.3 mtp -101.98 135.46 43.5 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.824 -0.806 . . . . 1.43 108.824 -178.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1626 ' ' LEU . . . . . 0.82 ' HG ' ' HE2' ' A' 1542 ' ' TYR . 0.3 OUTLIER -87.63 118.68 27.28 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 107.9 -1.148 . . . . 1.43 107.9 -176.357 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A 1627 ' ' ILE . . . . . 0.745 HD11 ' HB2' ' A' 1639 ' ' SER . 39.9 mm -79.41 -50.28 18.41 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.879 0 N-CA-C 108.925 -0.768 . . . . 1.23 108.925 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 17.1 t -172.41 161.18 5.09 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 108.827 -0.805 . . . . 1.88 108.827 -176.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1629 ' ' LEU . . . . . 0.812 HD13 HD22 ' A' 1636 ' ' LEU . 13.6 tp -117.51 106.49 13.22 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.0 -1.111 . . . . 1.92 108.0 176.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 18.0 t70 -72.2 107.42 4.84 Favored 'General case' 0 CA--C 1.487 -1.478 0 N-CA-C 105.849 -1.908 . . . . 1.09 105.849 174.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1631 ' ' LYS . . . . . 0.513 ' HB3' HD23 ' B' ' 53' ' ' LEU . 54.4 mtmt -72.5 -35.42 68.15 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 115.173 -0.921 . . . . 3.98 111.138 -171.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -70.77 -38.99 73.48 Favored 'General case' 0 N--CA 1.417 -2.091 0 C-N-CA 120.412 -0.515 . . . . 2.6 112.089 -173.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 47.4 p -97.38 -0.87 45.6 Favored 'General case' 0 CA--C 1.566 1.562 0 N-CA-C 112.593 0.59 . . . . 1.35 112.593 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 84.5 m 59.61 52.77 5.41 Favored 'General case' 0 C--N 1.374 1.64 0 C-N-CA 124.709 1.204 . . . . 0.53 111.153 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1635 ' ' THR . . . . . . . . . . . . . 92.5 m -125.21 133.5 52.72 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.727 -0.67 . . . . 1.11 111.994 -175.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1636 ' ' LEU . . . . . 0.812 HD22 HD13 ' A' 1629 ' ' LEU . 9.7 mt -104.7 136.03 44.99 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.37 -0.974 . . . . 1.56 108.37 -179.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -108.59 129.72 55.31 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 109.113 -0.699 . . . . 0.54 109.113 177.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -120.11 142.56 48.8 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 116.225 -0.443 . . . . 0.64 110.935 -178.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1639 ' ' SER . . . . . 0.745 ' HB2' HD11 ' A' 1627 ' ' ILE . 31.8 t -117.44 153.45 33.07 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 107.068 -1.456 . . . . 1.34 107.068 173.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1640 ' ' TRP . . . . . 0.522 ' HZ3' ' SD ' ' A' 1550 ' ' MET . 2.1 t90 -154.1 105.79 2.75 Favored 'General case' 0 N--CA 1.42 -1.973 0 N-CA-C 105.163 -2.162 . . . . 0.8 105.163 179.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1641 ' ' HIS . . . . . 0.729 ' HB2' ' HB ' ' A' 1621 ' ' THR . 38.1 m-70 -95.19 105.03 16.93 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 108.868 -0.79 . . . . 1.14 108.868 -175.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1642 ' ' THR . . . . . . . . . . . . . 14.3 t -141.97 152.41 61.88 Favored Pre-proline 0 CA--C 1.559 1.298 0 N-CA-C 108.846 -0.798 . . . . 1.11 108.846 -171.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1643 ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.1 -24.31 12.79 Favored 'Trans proline' 0 C--N 1.367 1.522 0 C-N-CA 122.715 2.277 . . . . 0.78 114.139 -178.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 3.3 pp -75.73 -4.93 43.16 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 119.935 -0.706 . . . . 1.66 111.672 -177.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -116.15 23.87 11.85 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-O 122.318 1.056 . . . . 1.29 109.005 -178.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1646 ' ' CYS . . . . . 0.438 ' HA ' ' HB2' ' A' 1614 ' ' CYS . 52.9 t -115.67 140.46 49.17 Favored 'General case' 0 N--CA 1.401 -2.884 0 CA-C-N 115.0 -1.0 . . . . 1.48 110.511 -177.052 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 27.3 tt0 . . . . . 0 N--CA 1.427 -1.601 0 N-CA-C 106.309 -1.737 . . . . 3.14 106.309 172.653 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.427 -1.925 0 CA-C-O 120.792 0.107 . . . . 2.28 113.173 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -56.04 -42.77 87.83 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 115.236 0.854 . . . . 1.94 115.236 -173.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -63.2 -49.12 75.5 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.434 0.635 . . . . 2.55 110.39 -176.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 13.6 tp -66.99 -49.45 65.33 Favored 'General case' 0 C--O 1.252 1.203 0 CA-C-N 115.015 -0.993 . . . . 2.82 111.196 -175.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 14.3 p -64.68 -37.66 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 C-N-CA 120.399 -0.52 . . . . 2.5 110.944 -178.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -77.17 -17.56 58.47 Favored 'General case' 0 C--O 1.196 -1.734 0 C-N-CA 118.08 -1.448 . . . . 2.04 111.358 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 92.0 m -62.5 -41.31 98.74 Favored 'General case' 0 C--O 1.272 2.267 0 O-C-N 121.302 -0.874 . . . . 2.31 108.983 173.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.873 HD23 HD11 ' B' ' 42' ' ' ILE . 10.7 mp -63.4 -42.67 98.78 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 115.568 -0.742 . . . . 2.27 110.99 176.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -75.55 -11.85 60.1 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.02 -0.991 . . . . 2.39 111.267 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -67.95 -55.24 13.47 Favored 'General case' 0 C--N 1.314 -0.967 0 O-C-N 121.892 -0.505 . . . . 1.0 109.686 176.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 12.6 p -98.52 -17.5 6.68 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 C-N-CA 118.112 -1.435 . . . . 1.83 112.487 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 83.8 m -116.81 30.62 7.22 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.457 -0.777 . . . . 1.66 111.586 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -55.0 -57.11 19.78 Favored Glycine 0 C--N 1.342 0.894 0 N-CA-C 114.082 0.393 . . . . 1.53 114.082 -179.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . 0.568 ' HA ' ' HD2' ' A' 1544 ' ' LYS . 17.6 t70 -65.93 -32.85 74.59 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-O 121.063 0.459 . . . . 2.72 111.182 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 21.3 tpp180 -69.53 -47.99 61.93 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.79 -0.641 . . . . 5.02 111.186 -178.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 111.43 170.49 18.95 Favored Glycine 0 N--CA 1.427 -1.961 0 N-CA-C 108.797 -1.721 . . . . 1.63 108.797 -175.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -135.6 140.63 44.75 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 117.399 0.6 . . . . 1.71 111.598 178.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -136.51 141.99 43.46 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.77 -0.455 . . . . 3.67 109.77 178.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' PHE . . . . . 0.448 ' CD2' ' HB ' ' B' ' 43' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.243 0.712 0 N-CA-C 112.321 0.489 . . . . 2.44 112.321 178.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.401 -3.694 0 N-CA-C 110.142 -1.183 . . . . 2.62 110.142 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . 0.873 HD11 HD23 ' B' ' 17' ' ' LEU . 28.3 pt -84.96 -22.53 7.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 113.152 0.797 . . . . 2.28 113.152 -170.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . 0.448 ' HB ' ' CD2' ' B' ' 28' ' ' PHE . 2.9 p -58.69 -42.64 85.68 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.418 0 N-CA-C 112.399 0.518 . . . . 2.6 112.399 -177.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -83.14 -27.23 30.26 Favored 'General case' 0 N--CA 1.425 -1.681 0 N-CA-C 109.193 -0.669 . . . . 3.36 109.193 -174.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -70.01 -29.62 66.73 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 115.293 -0.867 . . . . 3.08 111.932 177.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' CYS . . . . . . . . . . . . . 36.3 t -98.07 -16.27 19.66 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 121.252 0.548 . . . . 2.23 111.058 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 42.8 t -77.3 -36.32 54.22 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.111 0.481 . . . . 2.48 110.654 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -109.81 -9.92 14.79 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 113.218 0.821 . . . . 2.97 113.218 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -135.64 151.09 49.88 Favored 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 106.037 -1.838 . . . . 4.65 106.037 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 14.7 m -76.04 117.73 18.06 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 108.981 -0.748 . . . . 2.86 108.981 -178.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 28.1 p -92.71 135.33 34.2 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 108.67 -0.863 . . . . 2.11 108.67 -176.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -87.54 139.66 30.31 Favored 'General case' 0 N--CA 1.416 -2.155 0 N-CA-C 109.03 -0.73 . . . . 2.67 109.03 177.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . 0.513 HD23 ' HB3' ' A' 1631 ' ' LYS . 61.0 tp -36.07 -39.86 0.19 Allowed 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 127.469 2.308 . . . . 2.36 113.952 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.42 -40.82 83.51 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 123.868 0.73 . . . . 1.92 111.796 -176.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 50.8 tp -58.56 -47.53 83.91 Favored 'General case' 0 C--O 1.22 -0.47 0 O-C-N 123.802 0.689 . . . . 2.35 111.03 -177.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 3.9 pp -80.45 -35.29 35.17 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 116.145 -0.479 . . . . 2.01 111.513 -174.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -67.33 -44.25 79.57 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 116.031 -0.532 . . . . 2.27 111.456 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 6.3 t -76.1 -31.29 58.62 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 119.598 -0.841 . . . . 2.67 111.251 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -69.12 -60.42 2.37 Favored 'General case' 0 C--O 1.244 0.775 0 N-CA-C 107.772 -1.196 . . . . 3.2 107.772 178.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 37.0 t . . . . . 0 CA--C 1.537 0.465 0 C-N-CA 125.303 1.441 . . . . 2.3 112.473 175.967 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A 1515 ' ' ASP . . . . . 0.525 ' O ' ' HB3' ' A' 1579 ' ' LYS . 14.3 t70 . . . . . 0 N--CA 1.437 -1.081 0 N-CA-C 106.649 -1.612 . . . . 2.9 106.649 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1516 ' ' CYS . . . . . 0.471 ' SG ' HD23 ' A' 1581 ' ' LEU . 46.9 t -148.92 79.18 1.41 Allowed 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.787 -1.19 . . . . 1.41 107.787 176.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -168.07 151.04 5.68 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 105.938 -1.875 . . . . 2.18 105.938 -173.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1518 ' ' VAL . . . . . 0.461 ' CG2' HD12 ' A' 1581 ' ' LEU . 2.9 m -144.89 142.58 22.95 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-O 120.885 0.374 . . . . 1.52 111.442 -176.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1519 ' ' THR . . . . . . . . . . . . . 33.8 m -95.79 139.29 32.23 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 109.497 -0.557 . . . . 1.36 109.497 177.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -76.95 116.13 54.51 Favored Pre-proline 0 C--O 1.244 0.787 0 N-CA-C 108.501 -0.926 . . . . 2.02 108.501 176.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -60.81 -24.85 80.01 Favored 'Trans proline' 0 C--O 1.243 0.728 0 C-N-CA 123.43 2.753 . . . . 1.82 113.807 -177.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 33.7 m -74.33 -31.17 62.34 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 113.348 0.87 . . . . 1.89 113.348 -175.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1523 ' ' THR . . . . . . . . . . . . . 8.9 t -137.65 -10.74 1.6 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 118.617 -1.233 . . . . 1.99 113.455 -176.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 82.45 31.07 31.54 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 119.897 -1.144 . . . . 1.19 112.173 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 25.1 t-80 -97.74 131.2 44.49 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.641 -0.874 . . . . 1.82 108.641 178.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 2.8 tm? -89.67 121.71 32.1 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.718 -0.674 . . . . 1.3 111.515 -175.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -91.81 127.84 37.41 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 108.544 -0.91 . . . . 0.8 108.544 168.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 15.2 t70 -120.64 113.89 20.9 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 109.055 -0.72 . . . . 1.17 109.055 177.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 3.7 mm? -97.13 -0.25 47.32 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 121.578 0.704 . . . . 1.29 109.931 -178.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 1.5 m -65.87 -25.74 67.32 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.841 -1.072 . . . . 0.91 109.945 -178.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 40.5 t -61.09 -24.06 65.95 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 123.224 0.61 . . . . 1.98 110.816 178.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1532 ' ' LEU . . . . . 0.527 ' HB2' HG21 ' A' 1552 ' ' ILE . 73.0 mt -97.49 8.61 44.29 Favored 'General case' 0 C--N 1.32 -0.674 0 O-C-N 122.106 -0.371 . . . . 1.34 111.729 -177.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1533 ' ' SER . . . . . . . . . . . . . 77.2 p -68.66 174.19 4.48 Favored 'General case' 0 C--O 1.251 1.174 0 CA-C-O 121.454 0.645 . . . . 1.93 111.818 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . 171.81 150.9 7.43 Favored Glycine 0 N--CA 1.419 -2.493 0 N-CA-C 109.956 -1.258 . . . . 1.1 109.956 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 22.9 ttt180 -87.42 -30.0 21.04 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.08 0.467 . . . . 5.21 110.802 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -90.16 -35.82 15.17 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.579 0.704 . . . . 1.94 109.439 178.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 92.89 -150.99 20.24 Favored Glycine 0 N--CA 1.409 -3.123 0 CA-C-N 115.403 -0.817 . . . . 1.08 112.329 173.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -128.82 153.33 47.54 Favored 'General case' 0 C--N 1.281 -2.396 0 N-CA-C 106.435 -1.691 . . . . 1.07 106.435 -178.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 4.1 m -128.46 134.79 48.83 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 109.399 -0.593 . . . . 1.46 109.399 -175.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1540 ' ' ALA . . . . . 0.589 ' HB1' HG11 ' A' 1548 ' ' VAL . . . -129.93 143.61 50.89 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 115.758 -0.656 . . . . 1.19 109.488 -177.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -88.99 121.4 31.31 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.346 0.593 . . . . 1.37 110.517 -177.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1542 ' ' TYR . . . . . 0.597 ' CE2' ' HG ' ' A' 1626 ' ' LEU . 0.9 OUTLIER -111.49 -101.86 0.4 Allowed 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.464 -1.31 . . . . 1.38 107.464 -179.326 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A 1543 ' ' SER . . . . . 0.466 ' H ' ' HB3' ' A' 1542 ' ' TYR . 7.7 m -73.34 162.5 29.26 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 118.984 -0.532 . . . . 1.98 109.941 178.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -50.17 -42.93 51.95 Favored 'General case' 0 C--O 1.25 1.091 0 N-CA-C 113.388 0.884 . . . . 3.96 113.388 -178.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 23.3 t -100.67 15.1 29.33 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 110.516 -0.179 . . . . 2.81 110.516 -178.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . -132.7 131.29 6.12 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 118.81 -1.662 . . . . 1.68 116.726 -170.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 15.1 m -121.39 149.83 24.49 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 108.794 -0.817 . . . . 1.38 108.794 171.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1548 ' ' VAL . . . . . 0.589 HG11 ' HB1' ' A' 1540 ' ' ALA . 7.8 p -104.87 137.74 32.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 109.319 -0.622 . . . . 1.24 109.319 177.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -103.86 126.95 51.35 Favored 'General case' 0 N--CA 1.424 -1.755 0 CA-C-N 115.642 -0.708 . . . . 1.29 109.15 175.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1550 ' ' MET . . . . . 0.414 ' HB2' ' HE2' ' A' 1550 ' ' MET . 5.5 ppp? -144.24 138.5 28.04 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 115.082 -0.963 . . . . 1.47 110.27 -175.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 7.1 p -125.48 134.41 52.06 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 115.926 -0.579 . . . . 1.4 109.855 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1552 ' ' ILE . . . . . 0.527 HG21 ' HB2' ' A' 1532 ' ' LEU . 49.5 mm -82.24 114.94 23.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-N 116.625 -0.261 . . . . 1.11 111.36 -177.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 74.8 m 71.33 16.51 6.09 Favored 'General case' 0 CA--C 1.509 -0.6 0 C-N-CA 124.036 0.934 . . . . 1.4 113.057 171.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . -163.17 -175.26 33.99 Favored Glycine 0 N--CA 1.403 -3.5 0 C-N-CA 120.127 -1.035 . . . . 0.4 110.98 -176.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -91.36 148.57 22.23 Favored 'General case' 0 C--N 1.282 -2.351 0 C-N-CA 124.102 0.961 . . . . 1.62 111.755 -176.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 46.2 t-20 -114.46 129.85 56.68 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.729 -1.212 . . . . 1.12 107.729 178.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -79.93 2.18 24.48 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.025 0.75 . . . . 2.49 113.025 -173.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -74.24 -16.68 60.95 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 112.37 0.507 . . . . 1.38 112.37 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1559 ' ' CYS . . . . . 0.711 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 88.9 m -137.75 173.49 5.34 Favored Pre-proline 0 C--N 1.306 -1.289 0 CA-C-O 117.811 -1.09 . . . . 1.21 111.003 179.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1560 ' ' PRO . . . . . 0.711 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 7.3 Cg_exo -31.83 131.59 0.08 OUTLIER 'Trans proline' 0 C--N 1.393 2.917 0 C-N-CA 124.801 3.668 . . . . 0.98 114.735 177.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -48.56 125.75 13.04 Favored 'Trans proline' 0 C--O 1.25 1.08 0 C-N-CA 124.553 3.502 . . . . 1.15 114.452 -174.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 93.88 23.94 21.61 Favored Glycine 0 N--CA 1.432 -1.575 0 CA-C-N 115.284 -0.871 . . . . 0.55 112.451 178.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1563 ' ' VAL . . . . . 0.486 HG13 ' HB2' ' A' 1559 ' ' CYS . 4.0 p -109.6 139.85 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 C-N-CA 119.773 -0.771 . . . . 1.53 110.543 -177.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -104.41 -27.29 6.18 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 121.156 -0.545 . . . . 0.29 113.279 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -135.46 129.95 33.99 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 117.144 0.472 . . . . 1.08 110.188 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 31.7 t -160.3 137.61 9.42 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 122.465 0.306 . . . . 0.43 110.48 -178.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1567 ' ' PHE . . . . . 0.402 ' HA ' ' HA ' ' A' 1548 ' ' VAL . 76.2 m-85 -85.62 138.88 31.85 Favored 'General case' 0 C--O 1.247 0.963 0 N-CA-C 108.142 -1.058 . . . . 1.3 108.142 173.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -82.36 38.19 2.6 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.937 -0.649 . . . . 1.43 112.92 -176.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1569 ' ' GLN . . . . . 0.506 ' HB3' ' OD1' ' B' ' 15' ' ' ASP . 16.4 mm100 -83.48 -72.3 0.46 Allowed 'General case' 0 N--CA 1.443 -0.804 0 CA-C-O 121.045 0.45 . . . . 3.09 110.341 176.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 5.5 t -132.44 34.24 3.74 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-O 122.194 0.997 . . . . 2.52 109.217 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 61.32 55.86 2.8 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 124.902 1.281 . . . . 3.19 110.029 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 19.6 mt -97.17 114.37 34.01 Favored 'Isoleucine or valine' 0 C--O 1.244 0.805 0 N-CA-C 109.211 -0.662 . . . . 1.51 109.211 -177.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1573 ' ' SER . . . . . 0.72 ' HB3' ' HB2' ' A' 1596 ' ' SER . 19.5 t -74.39 130.73 40.2 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.552 0.692 . . . . 0.96 110.918 -178.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1574 ' ' VAL . . . . . 0.55 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 34.8 m -123.41 10.93 5.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 CA-C-O 121.33 0.586 . . . . 1.6 110.607 177.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 177.4 118.95 0.57 Allowed Glycine 0 N--CA 1.428 -1.852 0 C-N-CA 120.589 -0.815 . . . . 0.34 111.652 177.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -74.62 148.32 40.81 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.978 -1.119 . . . . 2.68 107.978 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -75.74 83.98 2.72 Favored 'General case' 0 CA--C 1.499 -0.998 0 CA-C-O 121.456 0.646 . . . . 1.08 111.756 -175.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1578 ' ' ASN . . . . . 0.429 ' O ' ' HE1' ' A' 1592 ' ' TYR . 86.5 m-20 -99.06 166.04 11.45 Favored 'General case' 0 C--N 1.281 -2.39 0 N-CA-C 108.213 -1.032 . . . . 1.95 108.213 178.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1579 ' ' LYS . . . . . 0.525 ' HB3' ' O ' ' A' 1515 ' ' ASP . 67.3 mttm -120.32 42.09 3.06 Favored 'General case' 0 C--N 1.286 -2.158 0 CA-C-O 122.601 1.191 . . . . 3.11 107.869 -176.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 43.5 ttt180 -93.65 75.84 4.34 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 114.188 -1.369 . . . . 4.04 108.41 -173.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1581 ' ' LEU . . . . . 0.471 HD23 ' SG ' ' A' 1516 ' ' CYS . 0.6 OUTLIER -84.3 125.07 31.92 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 113.549 -1.66 . . . . 1.32 108.196 -178.566 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 60.8 mtm180 -125.73 138.51 53.87 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 116.457 -0.338 . . . . 3.4 111.289 178.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1583 ' ' TYR . . . . . 0.433 ' HE1' ' HA ' ' A' 1586 ' ' GLN . 48.5 t80 -112.86 110.41 20.49 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 122.31 0.244 . . . . 1.26 110.48 -178.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1584 ' ' VAL . . . . . 0.559 ' O ' ' HB ' ' A' 1587 ' ' VAL . 15.4 m -129.69 93.23 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.265 0.555 . . . . 1.71 112.431 -178.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 26.9 t70 59.75 65.94 1.06 Allowed 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 123.805 0.842 . . . . 1.17 111.137 174.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1586 ' ' GLN . . . . . 0.433 ' HA ' ' HE1' ' A' 1583 ' ' TYR 0.254 8.7 pt20 66.1 5.43 3.56 Favored 'General case' 0 N--CA 1.503 2.197 0 C-N-CA 127.163 2.185 . . . . 2.43 112.11 178.482 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A 1587 ' ' VAL . . . . . 0.559 ' HB ' ' O ' ' A' 1584 ' ' VAL . 36.0 t -104.0 120.14 53.75 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.749 0 CA-C-N 114.789 -1.096 . . . . 1.16 109.378 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1588 ' ' LEU . . . . . 0.807 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 2.6 mm? -96.16 107.58 19.93 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 106.135 -1.802 . . . . 1.11 106.135 176.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1589 ' ' GLN . . . . . 0.481 ' HA ' ' O ' ' A' 1610 ' ' ILE . 27.8 tt0 -107.96 116.45 31.99 Favored 'General case' 0 N--CA 1.409 -2.49 0 CA-C-O 121.955 0.883 . . . . 1.74 110.368 -176.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1590 ' ' LEU . . . . . 0.436 ' HB3' ' HB ' ' A' 1610 ' ' ILE . 1.1 tt -107.64 107.42 18.22 Favored 'General case' 0 C--N 1.28 -2.418 0 N-CA-C 105.009 -2.219 . . . . 1.4 105.009 -178.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 4.2 p -101.72 129.63 52.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 C-N-CA 119.572 -0.851 . . . . 1.7 111.403 -174.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1592 ' ' TYR . . . . . 0.429 ' HE1' ' O ' ' A' 1578 ' ' ASN . 15.1 m-85 -119.4 105.74 11.58 Favored 'General case' 0 CA--C 1.496 -1.118 0 N-CA-C 108.502 -0.925 . . . . 1.08 108.502 177.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1593 ' ' LYS . . . . . 0.633 ' HB3' ' HD3' ' A' 1607 ' ' LYS . 18.4 pttp -126.43 174.76 8.38 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 109.428 -0.582 . . . . 2.21 109.428 -179.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 9.8 m-20 58.98 36.79 24.59 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 124.677 1.235 . . . . 1.11 110.996 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -73.52 -88.08 0.19 Allowed Glycine 0 N--CA 1.44 -1.082 0 N-CA-C 110.412 -1.075 . . . . 0.78 110.412 178.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1596 ' ' SER . . . . . 0.72 ' HB2' ' HB3' ' A' 1573 ' ' SER . 47.0 t -132.25 144.73 54.31 Favored Pre-proline 0 N--CA 1.416 -2.139 0 N-CA-C 107.788 -1.19 . . . . 1.36 107.788 175.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1597 ' ' PRO . . . . . 0.548 ' HA ' ' HA ' ' A' 1605 ' ' SER . 18.0 Cg_endo -58.89 130.78 38.33 Favored 'Trans proline' 0 C--O 1.24 0.578 0 C-N-CA 123.829 3.019 . . . . 1.4 112.462 179.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1598 ' ' CYS . . . . . 0.437 ' SG ' ' HB2' ' A' 1600 ' ' SER . 47.4 t -72.65 120.53 81.18 Favored Pre-proline 0 C--N 1.289 -2.041 0 CA-C-N 114.516 -1.22 . . . . 0.75 109.309 -174.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -65.13 -32.32 52.86 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.684 2.256 . . . . 1.7 110.635 178.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1600 ' ' SER . . . . . 0.789 ' HB3' HD13 ' B' ' 53' ' ' LEU . 7.1 m -64.47 -45.97 85.07 Favored 'General case' 0 N--CA 1.419 -1.983 0 CA-C-N 115.297 -0.865 . . . . 2.8 110.713 176.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1601 ' ' LYS . . . . . 0.562 ' HG2' HD21 ' A' 1604 ' ' LEU . 0.0 OUTLIER -121.9 93.54 4.03 Favored 'General case' 0 N--CA 1.429 -1.513 0 O-C-N 121.374 -0.828 . . . . 3.45 108.919 -178.942 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 7.0 m -55.8 125.04 19.6 Favored 'General case' 0 N--CA 1.426 -1.646 0 C-N-CA 124.316 1.046 . . . . 2.44 111.28 -177.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 106.03 -8.5 42.25 Favored Glycine 0 C--N 1.313 -0.702 0 C-N-CA 121.126 -0.559 . . . . 1.2 114.403 174.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1604 ' ' LEU . . . . . 0.562 HD21 ' HG2' ' A' 1601 ' ' LYS . 4.2 pp -128.35 155.7 44.27 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-N 118.218 1.009 . . . . 2.38 110.237 176.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1605 ' ' SER . . . . . 0.548 ' HA ' ' HA ' ' A' 1597 ' ' PRO . 7.7 p -103.19 152.83 21.0 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 123.042 0.537 . . . . 1.96 111.357 -176.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1606 ' ' TYR . . . . . 0.55 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 58.5 m-85 -63.34 161.3 14.28 Favored 'General case' 0 C--O 1.25 1.083 0 CA-C-N 116.4 -0.364 . . . . 1.06 110.906 175.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1607 ' ' LYS . . . . . 0.633 ' HD3' ' HB3' ' A' 1593 ' ' LYS . 24.5 ttpp -155.89 125.4 6.31 Favored 'General case' 0 CA--C 1.5 -0.968 0 CA-C-N 116.291 -0.413 . . . . 2.0 110.333 -178.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1608 ' ' SER . . . . . . . . . . . . . 22.3 m -105.4 127.04 52.77 Favored 'General case' 0 C--N 1.286 -2.185 0 N-CA-C 108.444 -0.947 . . . . 1.61 108.444 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 39.6 t -111.0 108.72 26.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 109.183 -0.673 . . . . 1.09 109.183 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1610 ' ' ILE . . . . . 0.481 ' O ' ' HA ' ' A' 1589 ' ' GLN . 25.7 mm -89.67 123.41 41.86 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 106.776 -1.564 . . . . 1.2 106.776 -178.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 21.5 p -122.09 105.42 10.26 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 120.517 -0.473 . . . . 1.89 111.031 177.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1612 ' ' PHE . . . . . 0.807 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 68.1 m-85 -86.16 119.69 26.72 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.71 -0.848 . . . . 0.28 108.71 177.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 45.9 t -114.2 134.53 56.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 108.514 -0.921 . . . . 1.23 108.514 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 12.2 t -59.64 114.74 2.89 Favored 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 123.964 0.906 . . . . 0.77 112.403 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1615 ' ' ARG . . . . . 0.73 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 0.0 OUTLIER -132.2 89.52 37.23 Favored Pre-proline 0 N--CA 1.446 -0.66 0 N-CA-C 106.967 -1.494 . . . . 2.92 106.967 172.783 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A 1616 ' ' PRO . . . . . 0.538 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 34.4 Cg_exo -59.46 -32.84 97.04 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 123.077 2.518 . . . . 1.22 114.629 -173.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -77.23 -5.49 49.49 Favored 'General case' 0 C--O 1.252 1.228 0 N-CA-C 111.931 0.345 . . . . 3.05 111.931 -178.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . 58.49 -143.11 0.64 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.23 0.612 . . . . 1.55 109.98 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . 110.47 -157.64 14.89 Favored Glycine 0 N--CA 1.416 -2.681 0 CA-C-N 119.532 1.06 . . . . 1.16 111.821 178.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -80.55 13.63 2.22 Favored 'Trans proline' 0 C--N 1.323 -0.799 0 C-N-CA 123.455 2.77 . . . . 1.06 113.249 -177.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1621 ' ' THR . . . . . 0.883 ' HB ' ' HB2' ' A' 1641 ' ' HIS . 36.2 p -96.16 -14.46 22.77 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 115.48 -0.782 . . . . 1.58 110.049 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1622 ' ' ASN . . . . . 0.417 ' OD1' ' HB ' ' A' 1642 ' ' THR . 55.1 t30 -88.73 62.66 6.55 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 122.057 0.932 . . . . 0.88 110.148 -175.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 6.7 ptp180 -168.53 139.73 2.15 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-N 114.155 -1.384 . . . . 3.82 108.169 -178.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -63.35 119.1 6.03 Favored 'Trans proline' 0 C--O 1.25 1.111 0 C-N-CA 122.762 2.308 . . . . 0.77 113.353 -174.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 76.8 mtm -116.68 138.44 51.45 Favored 'General case' 0 C--O 1.245 0.865 0 N-CA-C 108.79 -0.819 . . . . 1.43 108.79 175.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1626 ' ' LEU . . . . . 0.597 ' HG ' ' CE2' ' A' 1542 ' ' TYR . 0.4 OUTLIER -88.16 118.71 27.93 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 107.661 -1.237 . . . . 1.43 107.661 -176.455 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A 1627 ' ' ILE . . . . . 0.635 HD12 ' HB2' ' A' 1639 ' ' SER . 33.3 mm -78.3 -53.18 14.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.392 -0.596 . . . . 1.23 109.392 -178.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 8.4 t -167.85 152.08 6.42 Favored 'General case' 0 N--CA 1.416 -2.136 0 N-CA-C 108.652 -0.87 . . . . 1.88 108.652 -174.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1629 ' ' LEU . . . . . 0.78 HD22 ' HG ' ' A' 1636 ' ' LEU . 1.8 tm? -121.64 102.17 8.06 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 105.741 -1.948 . . . . 1.92 105.741 176.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 31.9 t70 -70.63 124.18 23.64 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 120.118 -0.633 . . . . 1.09 109.784 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1631 ' ' LYS . . . . . 0.471 ' HZ3' ' CD ' ' B' ' 57' ' ' GLU . 16.6 ptpt -79.38 -10.89 59.9 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 112.654 0.612 . . . . 3.98 112.654 -171.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -100.62 -34.71 9.77 Favored 'General case' 0 N--CA 1.421 -1.878 0 C-N-CA 120.221 -0.592 . . . . 2.6 111.515 -175.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 40.8 p -103.3 -6.86 21.58 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.05 0.452 . . . . 1.35 111.795 177.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 78.7 m 56.37 35.97 26.75 Favored 'General case' 0 C--N 1.361 1.085 0 C-N-CA 124.396 1.078 . . . . 0.53 111.982 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1635 ' ' THR . . . . . . . . . . . . . 59.5 m -99.54 132.08 45.11 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-N 114.218 -1.355 . . . . 1.11 109.996 178.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1636 ' ' LEU . . . . . 0.78 ' HG ' HD22 ' A' 1629 ' ' LEU . 0.8 OUTLIER -108.53 132.51 53.76 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.861 -1.533 . . . . 1.56 106.861 -178.39 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -107.04 135.56 48.38 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 110.153 -0.314 . . . . 0.54 110.153 179.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -128.59 129.17 45.55 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.069 -0.514 . . . . 0.64 110.09 -175.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1639 ' ' SER . . . . . 0.635 ' HB2' HD12 ' A' 1627 ' ' ILE . 22.7 t -108.48 149.38 28.87 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.445 -0.946 . . . . 1.34 108.445 178.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 2.1 t90 -156.46 115.74 3.47 Favored 'General case' 0 N--CA 1.425 -1.714 0 N-CA-C 105.032 -2.21 . . . . 0.8 105.032 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1641 ' ' HIS . . . . . 0.883 ' HB2' ' HB ' ' A' 1621 ' ' THR . 18.9 m-70 -112.86 107.91 16.68 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 120.528 -0.469 . . . . 1.14 110.257 -177.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1642 ' ' THR . . . . . 0.417 ' HB ' ' OD1' ' A' 1622 ' ' ASN . 7.3 t -138.19 152.01 70.84 Favored Pre-proline 0 C--N 1.296 -1.727 0 CA-C-N 114.744 -1.116 . . . . 1.11 109.63 -171.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1643 ' ' PRO . . . . . 0.538 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 74.1 Cg_endo -79.49 -7.98 14.87 Favored 'Trans proline' 0 C--N 1.372 1.767 0 C-N-CA 122.496 2.131 . . . . 0.78 112.167 177.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 8.7 tt -68.11 -23.1 64.88 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-O 121.491 0.662 . . . . 1.66 109.549 177.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -93.51 5.65 50.87 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.706 -0.679 . . . . 1.29 110.948 -177.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1646 ' ' CYS . . . . . 0.441 ' SG ' ' HA ' ' A' 1643 ' ' PRO . 72.2 m -93.82 142.77 26.99 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 120.804 0.335 . . . . 1.48 111.501 -177.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 . . . . . 0 C--N 1.297 -1.687 0 C-N-CA 123.691 0.796 . . . . 3.14 108.887 178.339 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.426 -2.003 0 N-CA-C 111.278 -0.729 . . . . 2.28 111.278 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -101.03 -64.18 0.78 Allowed Glycine 0 C--N 1.306 -1.134 0 N-CA-C 115.03 0.772 . . . . 1.94 115.03 -177.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -71.07 -45.08 64.42 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.894 0.702 . . . . 2.55 112.894 -170.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 12.5 tp -45.52 -57.88 3.8 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 123.729 0.643 . . . . 2.82 112.562 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 13.2 p -70.89 -31.35 45.2 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 CA-C-N 115.726 -0.67 . . . . 2.5 111.386 -177.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' ASP . . . . . 0.506 ' OD1' ' HB3' ' A' 1569 ' ' GLN . 3.3 t0 -72.95 -40.53 65.3 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 119.271 -0.972 . . . . 2.04 111.766 -176.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 12.4 t -65.0 -32.09 73.65 Favored 'General case' 0 C--O 1.254 1.293 0 O-C-N 121.302 -0.874 . . . . 2.31 109.773 176.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.522 ' O ' ' HB2' ' B' ' 21' ' ' CYS . 9.5 mt -67.05 -23.03 65.84 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-N 115.663 -0.699 . . . . 2.27 112.58 172.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -91.47 -17.7 25.32 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 121.643 0.735 . . . . 2.39 109.552 176.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -68.64 -60.23 2.56 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.819 -0.628 . . . . 1.0 111.699 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 12.5 p -94.43 -20.28 6.21 Favored 'Isoleucine or valine' 0 C--O 1.242 0.671 0 C-N-CA 118.128 -1.429 . . . . 1.83 111.841 -178.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' CYS . . . . . 0.522 ' HB2' ' O ' ' B' ' 17' ' ' LEU . 7.7 m -107.07 18.3 21.92 Favored 'General case' 0 C--O 1.201 -1.453 0 C-N-CA 120.022 -0.671 . . . . 1.66 109.822 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.53 -44.65 97.5 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 115.702 1.041 . . . . 1.53 115.702 -178.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -76.46 -48.5 19.41 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 117.483 0.642 . . . . 2.72 111.62 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 35.9 ttp180 -73.84 -25.35 60.03 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.316 0.579 . . . . 5.02 111.746 -175.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.16 144.15 10.09 Favored Glycine 0 N--CA 1.425 -2.062 0 N-CA-C 110.9 -0.88 . . . . 1.63 110.9 177.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -88.1 124.09 33.44 Favored 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 120.035 -0.666 . . . . 1.71 109.354 175.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -128.55 76.61 1.72 Allowed 'General case' 0 CA--C 1.497 -1.081 0 CA-C-O 121.618 0.723 . . . . 3.67 110.418 -173.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' PHE . . . . . . . . . . . . . 12.9 p90 . . . . . 0 C--N 1.289 -2.03 0 CA-C-N 115.455 -0.793 . . . . 2.44 110.808 -179.767 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.387 -4.6 0 N-CA-C 107.653 -2.179 . . . . 2.62 107.653 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . 0.438 ' HA ' ' CB ' ' B' ' 45' ' ' GLU . 33.4 pt -69.93 -4.61 4.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 111.943 0.349 . . . . 2.28 111.943 -175.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 2.5 p -52.81 -40.63 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 CA-C-N 115.661 -0.699 . . . . 2.6 110.08 169.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -92.51 -19.28 22.14 Favored 'General case' 0 N--CA 1.419 -2.003 0 O-C-N 121.294 -0.879 . . . . 3.36 108.941 -175.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . 0.438 ' CB ' ' HA ' ' B' ' 42' ' ' ILE . 6.4 tp10 -81.28 -2.47 49.06 Favored 'General case' 0 CA--C 1.555 1.161 0 CA-C-N 114.46 -1.245 . . . . 3.08 109.517 -178.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' CYS . . . . . . . . . . . . . 88.8 m -133.84 -20.3 1.99 Allowed 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.249 0.833 . . . . 2.23 113.249 178.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 98.4 m -80.94 -9.84 59.79 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 119.576 -0.85 . . . . 2.48 113.178 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -133.7 20.5 3.88 Favored 'General case' 0 C--N 1.319 -0.727 0 O-C-N 121.498 -0.751 . . . . 2.97 111.773 178.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -169.68 174.7 5.66 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 106.772 -1.566 . . . . 4.65 106.772 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 22.8 t -101.0 143.69 30.84 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-O 121.444 0.64 . . . . 2.86 110.763 -174.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 26.4 p -145.0 151.09 38.03 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-N 115.44 -0.8 . . . . 2.11 108.908 178.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' 1600 ' ' SER . 4.4 p-10 -127.55 -173.99 3.06 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.6 -0.727 . . . . 2.67 109.232 174.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . 0.789 HD13 ' HB3' ' A' 1600 ' ' SER . 46.3 tp -35.58 -39.88 0.15 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 128.088 2.555 . . . . 2.36 115.503 -174.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -49.32 -59.39 3.74 Favored 'General case' 0 CA--C 1.502 -0.888 0 C-N-CA 123.865 0.866 . . . . 1.92 112.129 -172.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 67.6 tp -59.78 -41.78 91.86 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 125.132 1.373 . . . . 2.35 112.803 -176.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 2.6 pp -83.54 -22.48 32.38 Favored 'General case' 0 N--CA 1.422 -1.827 0 C-N-CA 118.654 -1.219 . . . . 2.01 112.257 -173.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . 0.471 ' CD ' ' HZ3' ' A' 1631 ' ' LYS . 36.5 tt0 -86.48 -33.7 20.27 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 119.397 -0.921 . . . . 2.27 111.186 173.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 18.0 p -60.56 -44.01 96.65 Favored 'General case' 0 C--N 1.357 0.916 0 CA-C-N 118.02 0.373 . . . . 2.67 110.08 176.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -82.16 -81.55 0.15 Allowed 'General case' 0 N--CA 1.428 -1.528 0 C-N-CA 119.507 -0.877 . . . . 3.2 109.505 173.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 41.3 t . . . . . 0 N--CA 1.474 0.732 0 C-N-CA 123.69 0.796 . . . . 2.3 111.652 -178.333 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 12.7 t70 . . . . . 0 CA--C 1.515 -0.376 0 N-CA-C 106.857 -1.535 . . . . 2.9 106.857 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 12.9 m -139.84 81.77 1.84 Allowed 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.546 -0.752 . . . . 1.41 110.204 173.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -162.65 130.34 3.8 Favored 'General case' 0 N--CA 1.417 -2.106 0 N-CA-C 108.19 -1.041 . . . . 2.18 108.19 -179.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1518 ' ' VAL . . . . . 0.59 ' CG2' HD13 ' A' 1581 ' ' LEU . 4.3 m -129.72 136.97 57.9 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.125 0 CA-C-O 121.276 0.56 . . . . 1.52 110.789 -176.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1519 ' ' THR . . . . . 0.455 ' OG1' HD22 ' A' 1526 ' ' LEU . 23.8 m -112.33 132.42 54.99 Favored 'General case' 0 C--N 1.286 -2.164 0 CA-C-N 115.584 -0.734 . . . . 1.36 109.398 -178.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1520 ' ' ASN . . . . . 0.424 ' OD1' ' HB2' ' A' 1522 ' ' SER . 27.0 t-20 -86.8 110.19 30.45 Favored Pre-proline 0 N--CA 1.423 -1.804 0 N-CA-C 107.845 -1.168 . . . . 2.02 107.845 174.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -68.54 -16.29 42.58 Favored 'Trans proline' 0 N--CA 1.466 -0.136 0 C-N-CA 122.852 2.368 . . . . 1.82 112.775 -174.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1522 ' ' SER . . . . . 0.424 ' HB2' ' OD1' ' A' 1520 ' ' ASN . 15.2 m -71.76 -31.63 66.85 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 116.042 -0.526 . . . . 1.89 111.458 -178.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1523 ' ' THR . . . . . 0.413 HG22 ' OD1' ' A' 1520 ' ' ASN . 7.5 t -132.99 -4.06 3.14 Favored 'General case' 0 CA--C 1.56 1.345 0 C-N-CA 119.377 -0.929 . . . . 1.99 112.675 179.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 77.39 20.79 74.22 Favored Glycine 0 CA--C 1.497 -1.037 0 O-C-N 121.898 -0.501 . . . . 1.19 113.089 177.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -87.75 118.2 27.1 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 109.006 -0.739 . . . . 1.82 109.006 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1526 ' ' LEU . . . . . 0.455 HD22 ' OG1' ' A' 1519 ' ' THR . 1.0 OUTLIER -100.12 114.81 28.44 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-N 114.22 -1.355 . . . . 1.3 110.458 -175.153 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -93.75 113.61 25.71 Favored 'General case' 0 CA--C 1.508 -0.665 0 N-CA-C 109.375 -0.602 . . . . 0.8 109.375 176.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 19.9 t70 -104.4 119.17 38.37 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 120.073 -0.651 . . . . 1.17 110.487 175.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1529 ' ' LEU . . . . . 0.712 ' HG ' HD21 ' A' 1581 ' ' LEU . 3.0 mm? -104.23 1.96 31.11 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.751 -0.659 . . . . 1.29 109.645 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 3.1 m -67.07 -24.42 65.97 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 108.641 -0.874 . . . . 0.91 108.641 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 22.8 t -61.18 -27.11 68.18 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 115.093 -0.958 . . . . 1.98 110.295 175.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 81.9 mt -95.28 0.67 54.05 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 122.094 -0.379 . . . . 1.34 111.691 -177.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1533 ' ' SER . . . . . 0.524 ' HA ' ' O ' ' A' 1552 ' ' ILE . 34.3 t -70.94 171.04 11.46 Favored 'General case' 0 C--O 1.26 1.646 0 CA-C-O 121.577 0.703 . . . . 1.93 111.405 -178.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . 170.56 152.03 7.86 Favored Glycine 0 N--CA 1.43 -1.739 0 CA-C-N 115.278 -0.874 . . . . 1.1 111.423 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 23.2 ttt180 -89.37 -32.75 17.15 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 123.682 0.793 . . . . 5.21 110.524 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -83.59 -34.27 25.18 Favored 'General case' 0 C--O 1.245 0.816 0 CA-C-O 121.606 0.717 . . . . 1.94 109.41 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 92.24 -150.04 19.96 Favored Glycine 0 N--CA 1.415 -2.707 0 CA-C-N 115.057 -0.974 . . . . 1.08 111.905 174.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -138.06 152.22 48.61 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 107.338 -1.356 . . . . 1.07 107.338 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 2.6 p -108.19 128.47 54.74 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 123.628 0.58 . . . . 1.46 110.673 179.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1540 ' ' ALA . . . . . 0.475 ' HB2' ' CG1' ' A' 1548 ' ' VAL . . . -117.31 140.93 48.93 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.31 -0.996 . . . . 1.19 108.31 175.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -79.92 127.55 32.39 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 116.09 -0.505 . . . . 1.37 109.986 -177.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1542 ' ' TYR . . . . . . . . . . . . . 4.6 t80 -111.44 -99.5 0.41 Allowed 'General case' 0 N--CA 1.417 -2.112 0 N-CA-C 105.832 -1.914 . . . . 1.38 105.832 178.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1543 ' ' SER . . . . . . . . . . . . . 4.9 m -70.71 173.91 6.62 Favored 'General case' 0 N--CA 1.414 -2.25 0 N-CA-C 108.611 -0.885 . . . . 1.98 108.611 172.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -68.8 -37.9 79.56 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.093 -1.004 . . . . 3.96 109.512 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 38.9 m -107.26 35.53 3.02 Favored 'General case' 0 N--CA 1.408 -2.549 0 CA-C-N 115.25 -0.886 . . . . 2.81 110.079 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . -155.66 121.94 1.15 Allowed Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.055 -1.069 . . . . 1.68 114.044 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 34.7 m -112.85 149.89 15.18 Favored 'Isoleucine or valine' 0 C--O 1.253 1.28 0 CA-C-O 121.502 0.668 . . . . 1.38 110.672 176.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1548 ' ' VAL . . . . . 0.475 ' CG1' ' HB2' ' A' 1540 ' ' ALA . 10.3 p -102.18 139.23 23.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 109.078 -0.712 . . . . 1.24 109.078 177.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1549 ' ' TYR . . . . . 0.526 ' HB3' ' ND2' ' A' 1556 ' ' ASN . 58.0 m-85 -97.46 129.74 44.62 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 123.173 0.589 . . . . 1.29 109.8 178.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 24.9 ptm -144.35 127.41 16.53 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-N 115.538 -0.756 . . . . 1.47 110.228 -178.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 7.4 p -112.68 117.0 31.05 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 115.514 -0.766 . . . . 1.4 109.177 178.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1552 ' ' ILE . . . . . 0.524 ' O ' ' HA ' ' A' 1533 ' ' SER . 41.3 mm -74.83 113.66 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.374 0 N-CA-C 109.845 -0.428 . . . . 1.11 109.845 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 75.6 m 66.13 45.56 2.32 Favored 'General case' 0 CA--C 1.493 -1.231 0 O-C-N 124.229 0.956 . . . . 1.4 111.745 174.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . -179.72 177.05 47.98 Favored Glycine 0 N--CA 1.406 -3.318 0 C-N-CA 119.306 -1.426 . . . . 0.4 111.184 177.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -95.75 141.05 29.68 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 109.469 -0.567 . . . . 1.62 109.469 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1556 ' ' ASN . . . . . 0.526 ' ND2' ' HB3' ' A' 1549 ' ' TYR . 44.4 t-20 -92.75 124.68 36.93 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 109.03 -0.729 . . . . 1.12 109.03 -177.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -67.41 -5.89 16.72 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.188 0.81 . . . . 2.49 113.188 -176.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -98.62 0.18 44.3 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 112.09 0.404 . . . . 1.38 112.09 -174.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1559 ' ' CYS . . . . . 0.492 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 20.4 m -137.82 170.39 10.62 Favored Pre-proline 0 C--N 1.307 -1.277 0 CA-C-O 117.966 -1.016 . . . . 1.21 111.068 177.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1560 ' ' PRO . . . . . 0.492 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 64.4 Cg_exo -29.6 134.96 0.04 OUTLIER 'Trans proline' 0 C--N 1.392 2.855 0 C-N-CA 125.006 3.804 . . . . 0.98 114.063 174.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1561 ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' 1560 ' ' PRO . 52.3 Cg_exo -53.82 126.72 22.85 Favored 'Trans proline' 0 C--O 1.242 0.701 0 C-N-CA 123.616 2.877 . . . . 1.15 113.799 -175.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 89.56 18.56 51.77 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 115.677 -0.692 . . . . 0.55 113.664 175.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1563 ' ' VAL . . . . . . . . . . . . . 4.1 p -109.44 140.34 28.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 117.74 0.77 . . . . 1.53 110.151 -177.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -101.27 -30.03 6.13 Favored Glycine 0 C--N 1.315 -0.635 0 CA-C-N 116.035 -0.529 . . . . 0.29 112.9 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -128.17 126.99 42.14 Favored 'General case' 0 C--N 1.313 -0.997 0 O-C-N 122.414 -0.463 . . . . 1.08 109.906 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 9.4 t -160.44 141.7 12.19 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 122.894 0.478 . . . . 0.43 110.154 -176.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1567 ' ' PHE . . . . . 0.42 ' HE1' HG21 ' A' 1574 ' ' VAL . 85.9 m-85 -85.78 132.93 34.03 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.744 -0.836 . . . . 1.3 108.744 176.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -81.56 14.14 31.44 Favored Glycine 0 C--N 1.342 0.878 0 C-N-CA 120.494 -0.86 . . . . 1.43 113.45 -173.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -84.64 -70.17 0.6 Allowed 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.188 0.518 . . . . 3.09 110.993 177.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 1.1 p -108.56 10.76 27.07 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 113.019 0.748 . . . . 2.52 113.019 -174.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 11.8 mmt180 59.52 36.54 22.92 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.451 -0.795 . . . . 3.19 110.383 178.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 45.0 mt -83.2 125.73 40.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 109.584 -0.524 . . . . 1.51 109.584 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 37.2 t -78.11 129.02 34.69 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.47 -0.786 . . . . 0.96 110.444 -176.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1574 ' ' VAL . . . . . 0.42 HG21 ' HE1' ' A' 1567 ' ' PHE . 1.4 t -112.85 -19.13 7.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 N-CA-C 112.857 0.688 . . . . 1.6 112.857 -177.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . -179.9 127.62 1.14 Allowed Glycine 0 C--N 1.305 -1.174 0 C-N-CA 119.172 -1.49 . . . . 0.34 112.576 -179.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -63.99 149.32 47.62 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 123.869 0.868 . . . . 2.68 109.99 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -64.93 83.42 0.04 OUTLIER 'General case' 0 C--O 1.244 0.769 0 C-N-CA 123.494 0.718 . . . . 1.08 111.352 177.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 45.5 t30 -89.18 150.39 22.7 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 106.966 -1.494 . . . . 1.95 106.966 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -137.5 51.09 1.94 Allowed 'General case' 0 C--N 1.287 -2.149 0 CA-C-O 122.911 1.339 . . . . 3.11 109.132 -172.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -123.66 81.31 1.89 Allowed 'General case' 0 N--CA 1.412 -2.342 0 CA-C-N 113.754 -1.566 . . . . 4.04 108.83 -176.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1581 ' ' LEU . . . . . 0.712 HD21 ' HG ' ' A' 1529 ' ' LEU . 0.5 OUTLIER -63.65 125.04 22.97 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 113.154 -1.839 . . . . 1.32 110.266 -177.834 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A 1582 ' ' ARG . . . . . 0.609 ' HB2' ' HB3' ' A' 1589 ' ' GLN . 92.5 mtt180 -112.45 140.34 47.27 Favored 'General case' 0 C--N 1.293 -1.874 0 O-C-N 121.657 -0.652 . . . . 3.4 111.274 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1583 ' ' TYR . . . . . 0.662 ' HE1' ' HA ' ' A' 1586 ' ' GLN . 32.7 t80 -113.28 104.17 12.06 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 109.287 -0.634 . . . . 1.26 109.287 177.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1584 ' ' VAL . . . . . 0.509 ' O ' ' HB ' ' A' 1587 ' ' VAL . 16.8 m -125.18 89.43 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-N 115.519 -0.764 . . . . 1.71 112.572 -175.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 37.2 t70 61.0 51.17 4.64 Favored 'General case' 0 N--CA 1.502 2.155 0 CA-C-O 122.205 1.002 . . . . 1.17 110.498 177.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1586 ' ' GLN . . . . . 0.662 ' HA ' ' HE1' ' A' 1583 ' ' TYR 0.288 28.4 pt20 65.2 20.65 11.98 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 126.929 2.091 . . . . 2.43 111.703 179.157 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A 1587 ' ' VAL . . . . . 0.509 ' HB ' ' O ' ' A' 1584 ' ' VAL . 45.4 t -108.96 121.62 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.406 0 CA-C-N 113.775 -1.557 . . . . 1.16 106.881 172.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1588 ' ' LEU . . . . . 0.746 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 2.4 mm? -95.36 113.22 24.86 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 107.576 -1.268 . . . . 1.11 107.576 -177.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1589 ' ' GLN . . . . . 0.609 ' HB3' ' HB2' ' A' 1582 ' ' ARG . 35.9 tt0 -107.97 140.08 41.65 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.559 0.695 . . . . 1.74 112.484 -172.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 29.6 mt -133.12 93.16 3.13 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 114.065 -1.425 . . . . 1.4 107.807 173.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 5.4 p -89.39 122.33 40.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.867 -0.79 . . . . 1.7 108.867 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1592 ' ' TYR . . . . . 0.419 ' HB2' ' HB3' ' A' 1608 ' ' SER . 12.9 m-30 -111.84 102.96 11.19 Favored 'General case' 0 C--N 1.29 -2.017 0 O-C-N 121.672 -0.643 . . . . 1.08 110.096 -177.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -104.21 178.99 4.4 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 109.852 -0.425 . . . . 2.21 109.852 177.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 17.1 m-20 68.9 55.22 0.45 Allowed 'General case' 0 C--O 1.246 0.883 0 C-N-CA 123.763 0.825 . . . . 1.11 112.497 178.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -88.54 -122.41 1.94 Allowed Glycine 0 N--CA 1.43 -1.765 0 N-CA-C 109.781 -1.328 . . . . 0.78 109.781 174.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1596 ' ' SER . . . . . . . . . . . . . 43.9 p -108.35 153.91 41.72 Favored Pre-proline 0 C--N 1.294 -1.843 0 N-CA-C 108.734 -0.839 . . . . 1.36 108.734 176.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.23 120.51 8.45 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 122.448 2.099 . . . . 1.4 110.509 176.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 43.3 t -78.94 129.2 74.06 Favored Pre-proline 0 C--N 1.289 -2.034 0 CA-C-N 115.173 -0.921 . . . . 0.75 109.949 -174.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -71.37 -14.16 30.92 Favored 'Trans proline' 0 C--O 1.247 0.968 0 C-N-CA 122.852 2.368 . . . . 1.7 113.316 -178.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1600 ' ' SER . . . . . . . . . . . . . 4.7 m -75.62 -52.85 9.63 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 116.45 -0.341 . . . . 2.8 110.627 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1601 ' ' LYS . . . . . 0.76 ' HE3' ' HA ' ' A' 1601 ' ' LYS . 1.1 tpmt? -116.09 101.95 9.19 Favored 'General case' 0 N--CA 1.401 -2.894 0 N-CA-C 106.359 -1.719 . . . . 3.45 106.359 178.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 16.9 m -58.38 119.85 7.7 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 123.213 0.605 . . . . 2.44 110.245 -178.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 102.16 -1.61 50.93 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 111.524 -0.631 . . . . 1.2 111.524 -178.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1604 ' ' LEU . . . . . 0.413 HD21 ' HB3' ' A' 1601 ' ' LYS . 8.8 tp -102.97 164.19 11.76 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 107.985 -1.117 . . . . 2.38 107.985 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 31.1 t -131.03 150.58 52.08 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 107.724 -1.213 . . . . 1.96 107.724 -178.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1606 ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -67.62 155.5 39.02 Favored 'General case' 0 C--O 1.245 0.854 0 N-CA-C 109.578 -0.527 . . . . 1.06 109.578 177.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 26.2 pttm -154.67 137.58 15.41 Favored 'General case' 0 N--CA 1.44 -0.928 0 C-N-CA 120.061 -0.656 . . . . 2.0 110.691 178.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1608 ' ' SER . . . . . 0.419 ' HB3' ' HB2' ' A' 1592 ' ' TYR . 41.4 t -107.61 122.84 47.51 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 114.949 -1.023 . . . . 1.61 110.244 -176.021 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 22.5 t -104.79 98.51 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 108.618 -0.882 . . . . 1.09 108.618 176.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 80.2 mt -90.95 116.72 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.653 0 N-CA-C 107.693 -1.225 . . . . 1.2 107.693 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 10.8 p -121.45 114.84 21.83 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 115.616 -0.72 . . . . 1.89 111.547 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1612 ' ' PHE . . . . . 0.746 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 65.9 m-85 -87.4 123.69 32.61 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 108.213 -1.032 . . . . 0.28 108.213 175.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 46.9 t -114.24 134.15 58.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 116.182 -0.463 . . . . 1.23 109.987 -175.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1614 ' ' CYS . . . . . 0.489 ' HA ' ' HB2' ' A' 1646 ' ' CYS . 0.9 OUTLIER -50.94 111.24 0.52 Allowed 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.347 1.059 . . . . 0.77 112.479 175.724 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A 1615 ' ' ARG . . . . . 0.576 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 30.1 tpt180 -134.44 91.31 22.45 Favored Pre-proline 0 N--CA 1.446 -0.668 0 C-N-CA 120.283 -0.567 . . . . 2.92 109.933 173.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1616 ' ' PRO . . . . . 0.482 ' HD2' ' OE1' ' A' 1617 ' ' GLU . 17.2 Cg_exo -66.76 -28.38 43.64 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.393 2.062 . . . . 1.22 112.442 -179.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1617 ' ' GLU . . . . . 0.482 ' OE1' ' HD2' ' A' 1616 ' ' PRO . 17.9 mp0 -59.73 -39.81 85.96 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 123.928 0.891 . . . . 3.05 110.638 178.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . 49.04 86.54 0.03 OUTLIER 'General case' 0 C--O 1.246 0.874 0 C-N-CA 124.44 1.096 . . . . 1.55 113.581 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . -118.23 -151.31 9.11 Favored Glycine 0 C--N 1.281 -2.499 0 N-CA-C 110.221 -1.152 . . . . 1.16 110.221 178.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.97 10.25 0.91 Allowed 'Trans proline' 0 N--CA 1.486 1.054 0 C-N-CA 122.964 2.443 . . . . 1.06 114.166 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1621 ' ' THR . . . . . . . . . . . . . 14.5 p -100.68 6.93 44.14 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 122.012 0.91 . . . . 1.58 110.435 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -85.06 65.28 9.15 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 106.67 -1.604 . . . . 0.88 106.67 175.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -169.96 139.56 1.59 Allowed Pre-proline 0 N--CA 1.435 -1.195 0 C-N-CA 124.849 1.26 . . . . 3.82 107.647 -177.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1624 ' ' PRO . . . . . 0.461 ' HA ' ' O ' ' A' 1639 ' ' SER . 50.6 Cg_endo -67.93 106.91 1.4 Allowed 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.885 2.39 . . . . 0.77 112.327 -176.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 72.1 mtm -105.63 147.36 28.55 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 120.779 -0.368 . . . . 1.43 110.885 178.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 1.9 tm? -82.55 118.16 23.07 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 106.727 -1.582 . . . . 1.43 106.727 -178.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 42.9 mm -80.46 -54.08 11.38 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.783 0 N-CA-C 108.61 -0.885 . . . . 1.23 108.61 178.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 34.4 t -164.9 159.14 17.94 Favored 'General case' 0 N--CA 1.411 -2.384 0 N-CA-C 107.287 -1.375 . . . . 1.88 107.287 -177.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1629 ' ' LEU . . . . . 0.969 ' HG ' ' HG ' ' A' 1636 ' ' LEU . 1.6 tt -135.77 102.77 5.18 Favored 'General case' 0 N--CA 1.414 -2.252 0 N-CA-C 105.082 -2.192 . . . . 1.92 105.082 177.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 25.3 t70 -78.35 107.33 10.9 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.041 -1.466 . . . . 1.09 107.041 175.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1631 ' ' LYS . . . . . 0.412 ' HG2' HD22 ' A' 1629 ' ' LEU . 37.2 mtmm -78.62 -5.35 52.66 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 113.213 0.82 . . . . 3.98 113.213 -173.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 10.8 mm100 -89.67 -40.74 12.36 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 119.132 -1.027 . . . . 2.6 108.503 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 74.4 p -89.77 -5.14 57.25 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 115.034 -0.985 . . . . 1.35 109.438 177.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1634 ' ' CYS . . . . . 0.412 ' SG ' HD23 ' A' 1604 ' ' LEU . 27.9 m 58.0 41.03 24.92 Favored 'General case' 0 C--N 1.362 1.138 0 C-N-CA 125.073 1.349 . . . . 0.53 110.906 174.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1635 ' ' THR . . . . . . . . . . . . . 74.9 m -112.4 127.65 56.08 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 114.743 -1.117 . . . . 1.11 110.523 -174.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1636 ' ' LEU . . . . . 0.969 ' HG ' ' HG ' ' A' 1629 ' ' LEU . 0.3 OUTLIER -113.77 131.97 56.02 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.485 -0.932 . . . . 1.56 108.485 -176.634 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -111.62 129.27 56.13 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 116.692 -0.231 . . . . 0.54 110.458 -178.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -126.77 132.39 51.08 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 116.054 -0.521 . . . . 0.64 109.733 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1639 ' ' SER . . . . . 0.461 ' O ' ' HA ' ' A' 1624 ' ' PRO . 22.8 t -115.43 152.95 31.96 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.326 -0.99 . . . . 1.34 108.326 178.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 3.1 t90 -151.2 111.12 4.07 Favored 'General case' 0 N--CA 1.414 -2.256 0 N-CA-C 104.205 -2.517 . . . . 0.8 104.205 -177.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1641 ' ' HIS . . . . . 0.576 ' HB3' ' HB2' ' A' 1615 ' ' ARG . 42.7 m-70 -97.9 110.27 22.87 Favored 'General case' 0 C--N 1.293 -1.873 0 C-N-CA 120.097 -0.641 . . . . 1.14 109.365 -177.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1642 ' ' THR . . . . . 0.553 HG21 ' HB3' ' A' 1645 ' ' ALA . 4.6 t -142.63 146.94 40.46 Favored Pre-proline 0 C--N 1.296 -1.719 0 CA-C-N 115.158 -0.928 . . . . 1.11 110.123 -172.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1643 ' ' PRO . . . . . 0.468 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 37.6 Cg_endo -79.68 -11.11 14.22 Favored 'Trans proline' 0 C--N 1.368 1.565 0 C-N-CA 121.991 1.794 . . . . 0.78 112.874 177.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 7.1 tt -68.37 -29.93 68.75 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 122.295 1.045 . . . . 1.66 108.199 178.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1645 ' ' ALA . . . . . 0.553 ' HB3' HG21 ' A' 1642 ' ' THR . . . -97.06 20.87 10.59 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 114.167 -1.379 . . . . 1.29 109.405 -177.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1646 ' ' CYS . . . . . 0.489 ' HB2' ' HA ' ' A' 1614 ' ' CYS . 49.6 t -122.1 158.32 29.53 Favored 'General case' 0 N--CA 1.42 -1.957 0 CA-C-N 115.967 -0.561 . . . . 1.48 109.601 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 . . . . . 0 C--N 1.299 -1.624 0 N-CA-C 105.753 -1.943 . . . . 3.14 105.753 175.545 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.455 0 N-CA-C 111.499 -0.641 . . . . 2.28 111.499 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.34 -68.28 1.72 Allowed Glycine 0 N--CA 1.445 -0.716 0 O-C-N 123.923 0.425 . . . . 1.94 113.204 -178.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -61.24 -32.75 72.55 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.176 -0.676 . . . . 2.55 109.176 -178.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' LEU . . . . . 0.401 ' O ' HD22 ' B' ' 17' ' ' LEU . 0.1 OUTLIER -53.34 -66.53 0.37 Allowed 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 114.761 -1.109 . . . . 2.82 109.245 -179.559 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 18.9 m -75.21 -16.7 15.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 C-N-CA 119.384 -0.927 . . . . 2.5 110.701 -177.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -73.27 -49.72 26.16 Favored 'General case' 0 C--O 1.184 -2.368 0 C-N-CA 118.844 -1.142 . . . . 2.04 112.497 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 21.9 p -56.15 -44.83 79.64 Favored 'General case' 0 C--O 1.263 1.778 0 CA-C-N 118.693 0.679 . . . . 2.31 109.628 176.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.552 ' HB3' ' CB ' ' B' ' 26' ' ' PHE . 4.1 mm? -50.37 -55.1 17.12 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 114.344 -1.298 . . . . 2.27 112.346 172.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -77.46 -21.91 52.17 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.23 0.538 . . . . 2.39 111.996 -178.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -55.55 -52.67 62.95 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 124.034 0.934 . . . . 1.0 110.777 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 12.9 p -98.56 -24.07 4.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 C-N-CA 118.272 -1.371 . . . . 1.83 112.365 -178.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 34.5 m -104.56 19.64 20.01 Favored 'General case' 0 C--N 1.309 -1.166 0 O-C-N 121.871 -0.518 . . . . 1.66 111.935 -174.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -49.17 -34.19 16.71 Favored Glycine 0 N--CA 1.469 0.875 0 N-CA-C 116.852 1.501 . . . . 1.53 116.852 -175.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -74.99 -34.47 61.97 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 117.773 0.787 . . . . 2.72 112.641 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 20.6 tpp180 -93.1 -39.47 11.04 Favored 'General case' 0 C--N 1.314 -0.949 0 O-C-N 122.064 -0.398 . . . . 5.02 111.195 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.94 -168.17 13.26 Favored Glycine 0 N--CA 1.433 -1.534 0 N-CA-C 109.078 -1.609 . . . . 1.63 109.078 -177.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . 0.552 ' CB ' ' HB3' ' B' ' 17' ' ' LEU . 18.0 p90 -129.73 128.6 42.81 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 117.69 0.745 . . . . 1.71 111.098 179.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -142.02 129.33 21.12 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 109.491 -0.559 . . . . 3.67 109.491 -176.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' PHE . . . . . 0.657 ' HD2' ' H ' ' B' ' 41' ' ' GLY . 6.7 p90 . . . . . 0 C--N 1.306 -1.304 0 N-CA-C 107.283 -1.377 . . . . 2.44 107.283 -177.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . 0.657 ' H ' ' HD2' ' B' ' 28' ' ' PHE . . . . . . . . 0 N--CA 1.424 -2.131 0 N-CA-C 108.288 -1.925 . . . . 2.62 108.288 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . 0.508 ' HB ' HD23 ' B' ' 55' ' ' LEU . 15.0 pt 55.05 8.26 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.42 0 C-N-CA 126.906 2.082 . . . . 2.28 112.578 -177.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . 0.465 ' O ' ' HB2' ' B' ' 47' ' ' CYS . 9.0 p -80.25 -35.48 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.312 0 CA-C-N 114.796 -1.093 . . . . 2.6 111.95 -173.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -84.63 -38.37 19.94 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 106.593 -1.632 . . . . 3.36 106.593 177.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -64.97 -19.38 65.95 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 113.886 -1.506 . . . . 3.08 111.798 -177.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' CYS . . . . . . . . . . . . . 41.9 t -118.06 -0.21 11.68 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 119.779 -0.769 . . . . 2.23 110.888 175.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' CYS . . . . . 0.465 ' HB2' ' O ' ' B' ' 43' ' ' VAL . 51.9 t -83.91 -60.05 2.23 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 121.941 -0.474 . . . . 2.48 111.998 177.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -96.48 4.24 52.23 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-O 121.228 0.537 . . . . 2.97 110.222 -175.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 8.2 mmt180 -130.29 161.78 30.47 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 105.294 -2.113 . . . . 4.65 105.294 -176.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 9.3 t -97.32 115.48 27.75 Favored 'General case' 0 C--N 1.278 -2.505 0 N-CA-C 105.086 -2.19 . . . . 2.86 105.086 174.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 31.9 p -88.89 137.48 32.28 Favored 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 109.294 -0.632 . . . . 2.11 109.294 -172.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -85.09 146.87 26.93 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 107.855 -1.165 . . . . 2.67 107.855 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -62.23 -22.52 66.02 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.058 -0.974 . . . . 2.36 112.508 -174.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.75 -38.19 69.5 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.19 0.519 . . . . 1.92 109.969 178.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . 0.508 HD23 ' HB ' ' B' ' 42' ' ' ILE . 34.6 tp -54.66 -63.4 1.16 Allowed 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 114.371 -1.286 . . . . 2.35 111.576 179.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . 0.463 HD11 ' N ' ' B' ' 57' ' ' GLU . 0.0 OUTLIER -75.09 -27.37 59.87 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 120.267 -0.573 . . . . 2.01 111.656 -176.341 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . 0.463 ' N ' HD11 ' B' ' 56' ' ' LEU . 11.6 tp10 -59.93 -44.91 94.06 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 109.912 -0.403 . . . . 2.27 109.912 177.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 11.7 t -80.48 -10.81 59.73 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 120.419 -0.512 . . . . 2.67 110.752 177.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 59' ' ' TYR . . . . . 0.519 ' HE1' ' HA ' ' B' ' 28' ' ' PHE . 1.1 t80 -94.72 -70.77 0.69 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 119.504 -0.878 . . . . 3.2 108.865 -178.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 54.0 t . . . . . 0 C--N 1.308 -1.209 0 C-N-CA 125.809 1.644 . . . . 2.3 114.955 177.319 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 17.0 t70 . . . . . 0 N--CA 1.45 -0.471 0 CA-C-O 121.09 0.471 . . . . 2.9 110.134 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A 1516 ' ' CYS . . . . . 0.713 ' HA ' ' HB2' ' A' 1581 ' ' LEU . 91.6 m 64.21 46.93 3.39 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 115.057 1.503 . . . . 1.41 115.057 175.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -150.1 129.88 13.28 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 107.122 -1.436 . . . . 2.18 107.122 172.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1518 ' ' VAL . . . . . 0.656 HG21 ' HB2' ' A' 1583 ' ' TYR . 5.3 m -131.12 140.52 48.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 CA-C-O 121.249 0.547 . . . . 1.52 111.542 -174.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1519 ' ' THR . . . . . 0.561 ' HG1' HD21 ' A' 1526 ' ' LEU . 20.5 m -108.44 140.58 41.54 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 115.452 -0.795 . . . . 1.36 109.064 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1520 ' ' ASN . . . . . 0.618 HD21 ' HE2' ' A' 1583 ' ' TYR . 25.9 t-20 -93.62 114.59 63.38 Favored Pre-proline 0 C--N 1.305 -1.347 0 N-CA-C 107.876 -1.157 . . . . 2.02 107.876 172.054 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -63.94 -21.3 68.74 Favored 'Trans proline' 0 N--CA 1.477 0.536 0 C-N-CA 123.208 2.605 . . . . 1.82 114.032 -174.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 14.2 m -75.56 -41.54 54.53 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-O 120.646 0.26 . . . . 1.89 111.498 -177.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1523 ' ' THR . . . . . 0.53 HG21 ' OD1' ' A' 1520 ' ' ASN . 2.7 t -107.94 -20.57 13.14 Favored 'General case' 0 CA--C 1.561 1.391 0 CA-C-O 121.345 0.593 . . . . 1.99 111.96 -178.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 83.1 22.51 57.2 Favored Glycine 0 CA--C 1.505 -0.533 0 O-C-N 122.092 -0.38 . . . . 1.19 113.482 175.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 55.1 t-80 -95.36 132.82 39.98 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 120.981 0.42 . . . . 1.82 110.114 -178.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1526 ' ' LEU . . . . . 0.561 HD21 ' HG1' ' A' 1519 ' ' THR . 2.7 tm? -101.47 116.38 32.65 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 114.902 -1.045 . . . . 1.3 109.51 -177.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -87.35 118.12 26.58 Favored 'General case' 0 C--N 1.318 -0.804 0 O-C-N 122.068 -0.395 . . . . 0.8 111.108 173.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 8.7 t70 -98.01 113.67 25.59 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 108.27 -1.011 . . . . 1.17 108.27 176.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1529 ' ' LEU . . . . . 0.646 ' HG ' HD23 ' A' 1581 ' ' LEU . 3.5 mm? -101.87 -6.7 23.23 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 121.111 0.481 . . . . 1.29 110.051 177.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 6.1 m -62.63 -22.15 66.21 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.498 -0.774 . . . . 0.91 112.45 -177.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 16.2 t -66.12 -32.53 74.03 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 121.317 0.58 . . . . 1.98 110.036 177.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 7.9 mt -89.03 -7.62 55.57 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.253 -0.647 . . . . 1.34 109.253 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1533 ' ' SER . . . . . 0.43 ' HA ' ' HB ' ' A' 1552 ' ' ILE . 24.5 t -76.99 176.28 8.79 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.379 -0.6 . . . . 1.93 109.379 179.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . 152.71 174.77 23.51 Favored Glycine 0 N--CA 1.422 -2.24 0 N-CA-C 110.193 -1.163 . . . . 1.1 110.193 -177.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 33.2 ttm180 -92.31 -29.73 16.21 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 121.161 0.505 . . . . 5.21 110.095 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -76.55 -53.08 8.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.206 0.527 . . . . 1.94 110.96 -178.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 93.83 -150.16 19.73 Favored Glycine 0 N--CA 1.425 -2.067 0 C-N-CA 120.624 -0.798 . . . . 1.08 111.883 177.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -136.8 151.49 49.23 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.377 -0.971 . . . . 1.07 108.377 -177.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 17.7 p -112.81 139.55 48.34 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 116.266 -0.424 . . . . 1.46 109.952 177.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1540 ' ' ALA . . . . . 0.45 ' HB1' ' CG1' ' A' 1548 ' ' VAL . . . -125.25 143.41 50.96 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 107.943 -1.132 . . . . 1.19 107.943 172.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -84.67 151.94 24.12 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 108.552 -0.907 . . . . 1.37 108.552 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1542 ' ' TYR . . . . . 0.637 ' HE2' ' HG ' ' A' 1626 ' ' LEU . 1.8 t80 -162.95 -100.74 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 121.62 0.724 . . . . 1.38 109.914 -174.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1543 ' ' SER . . . . . 0.407 ' H ' ' HB3' ' A' 1542 ' ' TYR . 31.2 t -73.93 159.41 32.81 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 124.568 1.147 . . . . 1.98 110.404 -173.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 13.2 tppt? -74.98 -3.71 33.9 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 109.329 -0.619 . . . . 3.96 109.329 178.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1545 ' ' SER . . . . . 0.464 ' HB2' ' HG2' ' B' ' 18' ' ' GLN . 15.3 t -77.62 -43.3 31.97 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 108.884 -0.784 . . . . 2.81 108.884 176.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 165.72 -148.84 14.45 Favored Glycine 0 N--CA 1.41 -3.066 0 N-CA-C 110.872 -0.891 . . . . 1.68 110.872 -175.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 34.6 m -109.11 179.41 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.281 2.761 0 CA-C-O 122.118 0.961 . . . . 1.38 111.975 -172.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1548 ' ' VAL . . . . . 0.865 ' HB ' ' CE1' ' A' 1567 ' ' PHE . 7.8 p -112.01 130.85 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.941 0 CA-C-N 113.193 -1.821 . . . . 1.24 108.362 173.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -95.06 134.81 37.35 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.938 -1.134 . . . . 1.29 107.938 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 24.1 ptm -150.93 118.73 6.17 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 121.767 0.794 . . . . 1.47 111.337 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 5.4 p -112.4 118.31 34.85 Favored 'General case' 0 C--N 1.28 -2.428 0 CA-C-N 114.507 -1.224 . . . . 1.4 109.973 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1552 ' ' ILE . . . . . 0.43 ' HB ' ' HA ' ' A' 1533 ' ' SER . 46.0 mm -71.95 114.63 10.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.503 -0.317 . . . . 1.11 110.585 -178.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 72.0 m 60.9 29.43 19.01 Favored 'General case' 0 CA--C 1.511 -0.533 0 C-N-CA 124.532 1.133 . . . . 1.4 113.401 175.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . -161.04 177.75 37.28 Favored Glycine 0 N--CA 1.417 -2.601 0 N-CA-C 109.412 -1.475 . . . . 0.4 109.412 -179.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -107.97 140.73 40.68 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-O 121.127 0.489 . . . . 1.62 111.684 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -87.21 140.5 29.48 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 107.426 -1.324 . . . . 1.12 107.426 178.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -94.41 3.45 55.16 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 113.587 0.958 . . . . 2.49 113.587 -173.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -88.62 -4.65 58.52 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 121.552 0.692 . . . . 1.38 110.575 -178.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1559 ' ' CYS . . . . . 0.628 ' SG ' ' HD2' ' A' 1560 ' ' PRO . 20.2 t -136.31 157.48 75.39 Favored Pre-proline 0 C--N 1.298 -1.633 0 N-CA-C 106.229 -1.767 . . . . 1.21 106.229 -178.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1560 ' ' PRO . . . . . 0.628 ' HD2' ' SG ' ' A' 1559 ' ' CYS . 31.6 Cg_exo -29.05 134.77 0.04 OUTLIER 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 125.104 3.869 . . . . 0.98 115.428 177.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -49.13 124.44 11.62 Favored 'Trans proline' 0 C--O 1.247 0.948 0 C-N-CA 124.176 3.251 . . . . 1.15 112.792 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 101.76 7.32 48.1 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 116.004 -0.544 . . . . 0.55 113.302 -177.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1563 ' ' VAL . . . . . 0.534 HG12 ' HB2' ' A' 1566 ' ' CYS . 2.3 t -85.93 124.56 40.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 112.185 0.439 . . . . 1.53 112.185 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -97.71 -37.61 4.42 Favored Glycine 0 C--N 1.31 -0.916 0 N-CA-C 110.702 -0.959 . . . . 0.29 110.702 174.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -130.25 137.3 49.94 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.021 -0.733 . . . . 1.08 109.021 177.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1566 ' ' CYS . . . . . 0.534 ' HB2' HG12 ' A' 1563 ' ' VAL . 42.4 t -156.96 135.29 11.3 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 121.243 -0.183 . . . . 0.43 111.201 -177.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1567 ' ' PHE . . . . . 0.865 ' CE1' ' HB ' ' A' 1548 ' ' VAL . 9.5 m-85 -112.9 163.76 14.25 Favored 'General case' 0 C--O 1.245 0.857 0 C-N-CA 123.308 0.643 . . . . 1.3 110.491 173.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . 94.31 169.53 37.61 Favored Glycine 0 N--CA 1.399 -3.831 0 C-N-CA 118.831 -1.652 . . . . 1.43 114.324 164.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -89.6 -30.14 18.37 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 114.242 -0.979 . . . . 3.09 108.985 177.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 66.3 p -85.09 2.65 42.49 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.555 -0.748 . . . . 2.52 112.74 -177.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1571 ' ' ARG . . . . . 0.588 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 2.2 mpt_? 67.6 69.07 0.36 Allowed 'General case' 0 C--N 1.348 0.518 0 CA-C-N 114.704 -1.134 . . . . 3.19 110.831 175.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 32.0 mt -96.59 106.02 17.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-N 115.582 -0.735 . . . . 1.51 109.727 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 30.9 t -66.81 130.07 41.97 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-N 114.732 -1.122 . . . . 0.96 110.379 -177.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1574 ' ' VAL . . . . . 0.554 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 34.4 m -123.55 20.92 4.56 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.336 0 CA-C-O 121.535 0.683 . . . . 1.6 110.607 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 169.43 124.17 0.72 Allowed Glycine 0 N--CA 1.418 -2.546 0 CA-C-N 114.915 -1.039 . . . . 0.34 111.329 176.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -75.53 141.94 42.9 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.079 -0.711 . . . . 2.68 109.079 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -69.9 84.19 0.49 Allowed 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 123.404 0.681 . . . . 1.08 112.708 -177.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -93.68 168.18 11.18 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 115.569 -0.741 . . . . 1.95 109.346 176.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 55.1 mttm -129.31 41.92 3.38 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.519 -0.919 . . . . 3.11 108.519 -176.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 46.4 ttm-85 -105.98 77.65 1.26 Allowed 'General case' 0 N--CA 1.403 -2.786 0 CA-C-N 115.314 -0.857 . . . . 4.04 109.841 -175.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1581 ' ' LEU . . . . . 0.713 ' HB2' ' HA ' ' A' 1516 ' ' CYS . 1.2 tm? -65.47 124.97 23.69 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 113.798 -1.546 . . . . 1.32 107.49 175.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 63.9 mtp180 -118.54 141.0 49.01 Favored 'General case' 0 C--N 1.289 -2.048 0 C-N-CA 120.853 -0.339 . . . . 3.4 110.706 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1583 ' ' TYR . . . . . 0.656 ' HB2' HG21 ' A' 1518 ' ' VAL . 64.0 t80 -120.01 109.01 14.99 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 109.249 -0.648 . . . . 1.26 109.249 -179.217 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1584 ' ' VAL . . . . . 0.495 ' O ' ' HB ' ' A' 1587 ' ' VAL . 9.4 m -128.7 94.9 2.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-N 115.8 -0.636 . . . . 1.71 111.752 -179.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 12.3 t70 56.53 60.91 2.88 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 123.851 0.86 . . . . 1.17 110.714 176.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1586 ' ' GLN . . . . . 0.417 ' HA ' ' HE1' ' A' 1583 ' ' TYR 0.313 10.0 pt20 65.24 12.08 7.75 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 126.828 2.051 . . . . 2.43 113.147 178.972 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A 1587 ' ' VAL . . . . . 0.495 ' HB ' ' O ' ' A' 1584 ' ' VAL . 39.6 t -101.78 120.07 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.95 0 N-CA-C 107.588 -1.264 . . . . 1.16 107.588 174.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1588 ' ' LEU . . . . . 0.709 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 2.9 mm? -96.82 110.35 22.85 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 106.009 -1.848 . . . . 1.11 106.009 177.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1589 ' ' GLN . . . . . 0.403 ' HA ' ' O ' ' A' 1610 ' ' ILE . 28.5 tt0 -125.48 132.16 52.71 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-O 121.672 0.748 . . . . 1.74 112.767 -171.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 11.7 mt -115.1 128.31 56.14 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 107.27 -1.381 . . . . 1.4 107.27 175.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 59.3 t -119.03 118.9 59.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 C-N-CA 119.66 -0.816 . . . . 1.7 110.511 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1592 ' ' TYR . . . . . 0.453 ' O ' ' HA ' ' A' 1607 ' ' LYS . 16.8 m-30 -106.18 95.2 5.61 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 115.65 -0.705 . . . . 1.08 109.104 -179.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1593 ' ' LYS . . . . . 0.524 ' HB3' ' HD3' ' A' 1607 ' ' LYS . 0.0 OUTLIER -109.28 163.07 13.71 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 116.685 -0.234 . . . . 2.21 111.332 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 6.4 m-20 66.12 55.84 0.87 Allowed 'General case' 0 C--N 1.318 -0.787 0 O-C-N 124.472 1.108 . . . . 1.11 112.003 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -83.55 -107.27 0.53 Allowed Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 110.029 -1.228 . . . . 0.78 110.029 174.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1596 ' ' SER . . . . . . . . . . . . . 85.8 p -102.41 148.82 36.0 Favored Pre-proline 0 C--O 1.261 1.7 0 N-CA-C 108.847 -0.797 . . . . 1.36 108.847 175.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -63.66 122.8 11.02 Favored 'Trans proline' 0 N--CA 1.446 -1.269 0 C-N-CA 122.751 2.3 . . . . 1.4 108.998 174.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 17.0 t -78.83 110.46 14.42 Favored Pre-proline 0 C--N 1.301 -1.534 0 N-CA-C 108.621 -0.881 . . . . 0.75 108.621 -172.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.07 -12.22 35.23 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 122.843 2.362 . . . . 1.7 112.839 -173.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1600 ' ' SER . . . . . 0.796 ' HB3' ' HB2' ' B' ' 53' ' ' LEU . 18.0 m -61.56 -31.06 71.08 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.929 0.891 . . . . 2.8 111.907 178.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1601 ' ' LYS . . . . . 0.567 ' HB3' HD22 ' A' 1604 ' ' LEU . 41.0 ttmt -161.06 122.0 2.85 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 107.445 -1.317 . . . . 3.45 107.445 176.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 15.1 m -59.05 131.26 50.51 Favored 'General case' 0 N--CA 1.424 -1.73 0 C-N-CA 123.028 0.531 . . . . 2.44 111.39 -176.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 105.37 -3.96 40.4 Favored Glycine 0 C--N 1.309 -0.951 0 CA-C-N 116.258 -0.428 . . . . 1.2 112.768 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1604 ' ' LEU . . . . . 0.567 HD22 ' HB3' ' A' 1601 ' ' LYS . 10.3 mp -100.45 157.77 16.4 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 122.462 -0.434 . . . . 2.38 111.551 -178.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 33.8 m -146.88 143.93 28.91 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 108.312 -0.996 . . . . 1.96 108.312 175.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1606 ' ' TYR . . . . . 0.554 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 76.1 m-85 -69.53 151.63 45.77 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 116.334 -0.394 . . . . 1.06 110.928 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1607 ' ' LYS . . . . . 0.524 ' HD3' ' HB3' ' A' 1593 ' ' LYS . 36.6 ttpt -150.95 130.33 12.87 Favored 'General case' 0 N--CA 1.441 -0.878 0 O-C-N 124.007 0.817 . . . . 2.0 109.824 -175.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1608 ' ' SER . . . . . 0.453 ' HB3' ' HB2' ' A' 1592 ' ' TYR . 37.3 t -105.38 120.11 40.76 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 108.939 -0.763 . . . . 1.61 108.939 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 22.8 t -105.32 107.3 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 N-CA-C 107.831 -1.174 . . . . 1.09 107.831 177.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1610 ' ' ILE . . . . . 0.403 ' O ' ' HA ' ' A' 1589 ' ' GLN . 64.3 mt -101.91 111.73 32.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 CA-C-N 115.676 -0.693 . . . . 1.2 110.046 -176.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 21.4 p -111.64 117.84 34.03 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.928 -0.578 . . . . 1.89 112.153 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1612 ' ' PHE . . . . . 0.709 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 78.0 m-85 -93.08 124.34 36.99 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.19 -1.041 . . . . 0.28 108.19 177.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 49.1 t -118.74 137.23 53.39 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 116.544 -0.298 . . . . 1.23 110.984 -175.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 3.5 t -59.69 103.0 0.17 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.668 1.187 . . . . 0.77 112.633 177.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1615 ' ' ARG . . . . . 0.556 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 20.8 mmt180 -138.49 112.58 8.53 Favored Pre-proline 0 C--N 1.32 -0.693 0 O-C-N 122.369 -0.207 . . . . 2.92 111.224 171.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1616 ' ' PRO . . . . . 0.584 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 37.3 Cg_endo -74.06 -1.71 11.27 Favored 'Trans proline' 0 N--CA 1.489 1.213 0 C-N-CA 122.902 2.401 . . . . 1.22 113.213 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -89.5 41.7 1.05 Allowed 'General case' 0 C--N 1.291 -1.959 0 C-N-CA 124.936 1.294 . . . . 3.05 110.83 -177.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -41.54 123.79 2.28 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.86 1.664 . . . . 1.55 112.647 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1619 ' ' GLY . . . . . 0.435 ' HA3' ' HD2' ' A' 1620 ' ' PRO . . . 171.03 -135.8 3.65 Favored Glycine 0 CA--C 1.48 -2.151 0 N-CA-C 110.13 -1.188 . . . . 1.16 110.13 -177.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1620 ' ' PRO . . . . . 0.435 ' HD2' ' HA3' ' A' 1619 ' ' GLY . 35.1 Cg_endo -64.12 -2.46 4.76 Favored 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 123.342 2.695 . . . . 1.06 115.231 -177.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1621 ' ' THR . . . . . 0.661 ' HB ' ' HB2' ' A' 1641 ' ' HIS . 13.0 p -98.82 -11.4 21.82 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 121.728 0.775 . . . . 1.58 109.677 178.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 48.0 t30 -93.48 64.9 3.7 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 122.457 1.122 . . . . 0.88 108.333 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -166.97 140.47 3.05 Favored Pre-proline 0 C--N 1.3 -1.55 0 N-CA-C 106.422 -1.695 . . . . 3.82 106.422 -178.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -59.45 110.26 0.69 Allowed 'Trans proline' 0 C--O 1.243 0.766 0 C-N-CA 122.56 2.174 . . . . 0.77 111.527 -178.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 74.9 mtm -110.14 141.77 42.57 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 116.078 -0.51 . . . . 1.43 110.066 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1626 ' ' LEU . . . . . 0.637 ' HG ' ' HE2' ' A' 1542 ' ' TYR . 1.4 tm? -86.2 119.06 26.08 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 108.141 -1.059 . . . . 1.43 108.141 -176.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1627 ' ' ILE . . . . . 0.6 HD12 ' HB2' ' A' 1639 ' ' SER . 44.5 mm -79.69 -55.42 9.2 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 CA-C-O 121.513 0.673 . . . . 1.23 109.434 178.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 22.6 t -163.72 148.41 10.62 Favored 'General case' 0 N--CA 1.419 -2.01 0 N-CA-C 107.969 -1.123 . . . . 1.88 107.969 -176.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1629 ' ' LEU . . . . . 0.736 HD13 ' HG ' ' A' 1636 ' ' LEU . 50.3 tp -116.91 105.43 12.33 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.662 -0.866 . . . . 1.92 108.662 176.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 12.5 t70 -84.32 106.24 15.78 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.015 -1.476 . . . . 1.09 107.015 176.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1631 ' ' LYS . . . . . 0.423 ' HD2' ' HA ' ' A' 1631 ' ' LYS . 14.4 mmmt -85.74 -3.43 58.89 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 112.86 0.689 . . . . 3.98 112.86 -175.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -87.69 -33.63 18.69 Favored 'General case' 0 N--CA 1.421 -1.888 0 O-C-N 123.43 0.456 . . . . 2.6 109.804 -177.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 40.3 p -102.37 -16.34 16.25 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.096 0.474 . . . . 1.35 110.29 173.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1634 ' ' CYS . . . . . 0.451 ' O ' ' HA ' ' A' 1606 ' ' TYR . 60.2 m 72.56 37.57 0.87 Allowed 'General case' 0 C--N 1.355 0.845 0 C-N-CA 125.203 1.401 . . . . 0.53 111.307 179.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1635 ' ' THR . . . . . . . . . . . . . 94.7 m -103.23 134.03 47.32 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 115.253 -0.885 . . . . 1.11 109.697 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1636 ' ' LEU . . . . . 0.736 ' HG ' HD13 ' A' 1629 ' ' LEU . 0.5 OUTLIER -114.97 124.39 51.55 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.548 -0.908 . . . . 1.56 108.548 -177.826 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -104.37 130.73 52.22 Favored 'General case' 0 C--O 1.25 1.101 0 N-CA-C 110.37 -0.233 . . . . 0.54 110.37 -178.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -127.81 137.99 52.57 Favored 'General case' 0 C--O 1.251 1.135 0 CA-C-O 121.065 0.46 . . . . 0.64 110.48 -178.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1639 ' ' SER . . . . . 0.6 ' HB2' HD12 ' A' 1627 ' ' ILE . 21.4 t -116.08 157.95 23.93 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.148 -1.056 . . . . 1.34 108.148 177.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 2.3 t90 -156.34 113.21 3.14 Favored 'General case' 0 N--CA 1.409 -2.497 0 N-CA-C 105.349 -2.093 . . . . 0.8 105.349 -177.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1641 ' ' HIS . . . . . 0.661 ' HB2' ' HB ' ' A' 1621 ' ' THR . 13.0 m170 -104.01 105.29 15.42 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 109.485 -0.561 . . . . 1.14 109.485 -176.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1642 ' ' THR . . . . . . . . . . . . . 11.3 t -142.95 145.13 31.99 Favored Pre-proline 0 C--N 1.306 -1.3 0 CA-C-N 116.111 -0.495 . . . . 1.11 109.881 -173.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1643 ' ' PRO . . . . . 0.584 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 73.4 Cg_endo -76.49 -10.37 18.82 Favored 'Trans proline' 0 C--N 1.366 1.5 0 C-N-CA 122.595 2.197 . . . . 0.78 112.136 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 7.7 tt -69.0 -24.31 64.21 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.396 0.617 . . . . 1.66 109.896 177.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -100.1 17.44 21.13 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 122.123 0.963 . . . . 1.29 109.21 -176.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 20.1 t -121.46 155.04 35.75 Favored 'General case' 0 N--CA 1.41 -2.451 0 N-CA-C 107.761 -1.2 . . . . 1.48 107.761 -178.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 31.7 tt0 . . . . . 0 C--N 1.298 -1.633 0 N-CA-C 108.57 -0.9 . . . . 3.14 108.57 179.182 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.859 0 N-CA-C 111.92 -0.472 . . . . 2.28 111.92 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -75.57 -17.69 80.05 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 121.418 -0.42 . . . . 1.94 113.627 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -66.96 -27.29 67.34 Favored 'General case' 0 C--O 1.215 -0.722 0 N-CA-C 109.387 -0.597 . . . . 2.55 109.387 -176.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' LEU . . . . . 0.423 ' CD1' HG23 ' B' ' 43' ' ' VAL . 32.1 mt -66.85 -61.42 1.96 Allowed 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 115.059 -0.973 . . . . 2.82 108.907 -179.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 9.9 p -64.39 -40.76 90.17 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.525 0 CA-C-N 114.853 -1.067 . . . . 2.5 112.097 -176.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -74.47 -26.5 60.07 Favored 'General case' 0 CA--C 1.557 1.246 0 N-CA-C 113.961 1.097 . . . . 2.04 113.961 -176.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 20.4 p -75.0 -43.25 54.98 Favored 'General case' 0 C--O 1.248 0.974 0 O-C-N 121.066 -1.022 . . . . 2.31 109.144 175.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.565 ' O ' ' HB2' ' B' ' 21' ' ' CYS . 0.9 OUTLIER -56.06 -40.91 74.26 Favored 'General case' 0 N--CA 1.42 -1.951 0 CA-C-N 114.863 -1.062 . . . . 2.27 111.513 169.471 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' GLN . . . . . 0.464 ' HG2' ' HB2' ' A' 1545 ' ' SER . 8.8 tt0 -71.86 -24.85 61.75 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 121.127 0.489 . . . . 2.39 109.718 179.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -64.07 -62.68 1.47 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.036 -0.529 . . . . 1.0 112.109 178.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 12.6 p -94.65 -20.32 6.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 C-N-CA 118.53 -1.268 . . . . 1.83 111.909 -177.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' CYS . . . . . 0.565 ' HB2' ' O ' ' B' ' 17' ' ' LEU . 96.1 m -102.94 18.46 21.56 Favored 'General case' 0 C--N 1.312 -1.027 0 O-C-N 121.834 -0.541 . . . . 1.66 111.448 178.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -54.02 -50.25 55.87 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 121.355 -0.45 . . . . 1.53 113.219 178.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -75.86 -11.13 59.92 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 122.548 0.339 . . . . 2.72 111.591 178.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . 0.536 ' HG2' ' SG ' ' B' ' 60' ' ' CYS . 21.1 tpp180 -91.53 -50.13 5.94 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.715 0.769 . . . . 5.02 110.434 -178.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 115.79 157.6 11.32 Favored Glycine 0 N--CA 1.417 -2.593 0 N-CA-C 107.949 -2.06 . . . . 1.63 107.949 -173.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -119.23 137.58 53.56 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 117.943 0.871 . . . . 1.71 111.453 177.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -128.89 -54.25 1.22 Allowed 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 107.684 -1.228 . . . . 3.67 107.684 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' PHE . . . . . . . . . . . . . 43.4 p90 . . . . . 0 N--CA 1.498 1.958 0 C-N-CA 128.06 2.544 . . . . 2.44 117.776 172.55 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.492 -1.375 0 N-CA-C 112.722 -0.151 . . . . 2.62 112.722 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 41.4 pt -85.73 -17.55 9.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 O-C-N 122.701 -0.293 . . . . 2.28 111.349 -177.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . 0.423 HG23 ' CD1' ' B' ' 13' ' ' LEU . 14.9 p -53.05 -41.39 41.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 N-CA-C 114.456 1.28 . . . . 2.6 114.456 -172.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -74.01 -31.92 63.15 Favored 'General case' 0 C--O 1.244 0.793 0 C-N-CA 118.933 -1.107 . . . . 3.36 108.876 -175.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -85.22 -14.27 47.33 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 114.869 -1.06 . . . . 3.08 112.296 -176.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' CYS . . . . . . . . . . . . . 81.2 m -104.4 -22.76 13.27 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 112.669 0.618 . . . . 2.23 112.669 175.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 95.9 m -79.39 -49.0 13.03 Favored 'General case' 0 C--O 1.239 0.544 0 O-C-N 121.759 -0.588 . . . . 2.48 112.27 178.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -97.38 -7.91 30.75 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.115 0.483 . . . . 2.97 111.471 -177.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 52.9 mtp180 -139.65 177.64 7.8 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 115.946 -0.57 . . . . 4.65 109.483 -176.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 50.9 m -106.46 135.92 47.12 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 115.475 -0.784 . . . . 2.86 109.372 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . 0.502 ' HB2' HD21 ' B' ' 55' ' ' LEU . 11.7 p -120.63 138.98 53.63 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 109.647 -0.501 . . . . 2.11 109.647 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -82.49 142.77 31.61 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.062 0.458 . . . . 2.67 109.768 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . 0.796 ' HB2' ' HB3' ' A' 1600 ' ' SER . 66.2 tp -37.69 -42.0 0.53 Allowed 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 127.186 2.194 . . . . 2.36 113.808 -177.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . 0.594 ' O ' HG23 ' B' ' 58' ' ' THR . . . -53.27 -38.97 63.54 Favored 'General case' 0 C--N 1.318 -0.789 0 O-C-N 124.423 1.077 . . . . 1.92 111.635 -177.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . 0.502 HD21 ' HB2' ' B' ' 51' ' ' CYS . 53.6 tp -59.67 -56.32 23.34 Favored 'General case' 0 C--O 1.213 -0.827 0 O-C-N 124.146 0.903 . . . . 2.35 110.599 -178.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 3.3 pp -69.8 -31.04 68.73 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 116.309 -0.405 . . . . 2.01 110.967 -174.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -66.84 -51.65 53.07 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.891 -0.595 . . . . 2.27 111.575 178.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 58' ' ' THR . . . . . 0.594 HG23 ' O ' ' B' ' 54' ' ' ALA . 12.0 t -83.63 -13.24 54.72 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 112.901 0.704 . . . . 2.67 112.901 -177.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -85.61 -72.33 0.49 Allowed 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 105.929 -1.878 . . . . 3.2 105.929 175.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 60' ' ' CYS . . . . . 0.536 ' SG ' ' HG2' ' B' ' 24' ' ' ARG . 43.7 t . . . . . 0 CA--C 1.568 1.669 0 N-CA-C 114.554 1.316 . . . . 2.3 114.554 172.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1515 ' ' ASP . . . . . 0.452 ' HB3' ' HG2' ' A' 1517 ' ' GLN . 23.0 t70 . . . . . 0 N--CA 1.416 -2.164 0 N-CA-C 106.014 -1.847 . . . . 2.9 106.014 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 34.9 t -91.09 69.25 6.19 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 107.953 -1.129 . . . . 1.41 107.953 -175.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1517 ' ' GLN . . . . . 0.452 ' HG2' ' HB3' ' A' 1515 ' ' ASP . 9.8 pt20 -165.23 148.18 8.13 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-N 114.591 -1.186 . . . . 2.18 108.953 -174.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 3.7 m -145.74 143.06 21.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 C-N-CA 123.344 0.657 . . . . 1.52 110.051 177.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1519 ' ' THR . . . . . . . . . . . . . 42.6 m -93.83 139.82 30.41 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 116.017 -0.538 . . . . 1.36 109.762 177.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1520 ' ' ASN . . . . . 0.544 ' OD1' HG23 ' A' 1523 ' ' THR . 16.4 t-20 -75.29 117.89 66.57 Favored Pre-proline 0 N--CA 1.428 -1.575 0 N-CA-C 107.712 -1.218 . . . . 2.02 107.712 174.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.39 -17.71 49.39 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 122.782 2.321 . . . . 1.82 113.529 -176.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 10.7 m -80.98 -42.97 20.36 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 112.216 0.451 . . . . 1.89 112.216 -176.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1523 ' ' THR . . . . . 0.544 HG23 ' OD1' ' A' 1520 ' ' ASN . 6.2 t -120.99 -8.47 9.35 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.674 0.62 . . . . 1.99 112.674 -175.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 80.39 24.29 59.25 Favored Glycine 0 C--O 1.239 0.446 0 C-N-CA 120.339 -0.934 . . . . 1.19 112.826 177.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -89.93 123.17 33.62 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 109.369 -0.604 . . . . 1.82 109.369 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 2.2 tm? -87.58 113.12 22.98 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 123.623 0.769 . . . . 1.3 109.237 -177.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -88.87 114.01 25.03 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 109.705 -0.48 . . . . 0.8 109.705 176.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 14.6 t70 -101.62 110.37 22.35 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.342 -0.984 . . . . 1.17 108.342 177.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 3.3 mm? -92.11 -2.42 56.62 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.986 0.898 . . . . 1.29 109.309 -177.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 2.9 m -73.98 -10.27 59.47 Favored 'General case' 0 C--O 1.215 -0.737 0 CA-C-N 114.48 -1.236 . . . . 0.91 109.615 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1531 ' ' SER . . . . . 0.56 ' HB2' HD11 ' A' 1644 ' ' LEU . 19.0 m -72.3 -16.97 61.9 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 109.027 -0.731 . . . . 1.98 109.027 176.038 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1532 ' ' LEU . . . . . 0.417 ' O ' ' HB ' ' A' 1552 ' ' ILE . 67.9 mt -107.05 5.59 28.18 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.253 -0.885 . . . . 1.34 110.891 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1533 ' ' SER . . . . . 0.431 ' HA ' ' O ' ' A' 1552 ' ' ILE . 69.3 p -67.5 164.34 19.09 Favored 'General case' 0 C--O 1.249 1.062 0 CA-C-O 121.367 0.604 . . . . 1.93 111.614 -178.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -170.81 142.0 6.84 Favored Glycine 0 N--CA 1.418 -2.561 0 C-N-CA 120.343 -0.932 . . . . 1.1 111.151 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 23.1 ttt180 -92.86 -36.41 12.84 Favored 'General case' 0 C--N 1.292 -1.911 0 C-N-CA 122.688 0.395 . . . . 5.21 111.156 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -82.93 -36.72 25.0 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.721 0.772 . . . . 1.94 109.421 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 97.36 179.19 34.02 Favored Glycine 0 N--CA 1.418 -2.555 0 CA-C-N 114.918 -1.037 . . . . 1.08 112.476 173.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -119.84 147.23 44.93 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 107.675 -1.231 . . . . 1.07 107.675 178.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 5.5 p -103.37 117.68 35.04 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.334 0.587 . . . . 1.46 111.963 -177.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1540 ' ' ALA . . . . . 0.437 ' HB3' ' CG1' ' A' 1548 ' ' VAL . . . -108.16 121.78 45.55 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 107.927 -1.138 . . . . 1.19 107.927 176.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -70.92 134.07 46.94 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 116.144 -0.48 . . . . 1.37 110.761 -178.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1542 ' ' TYR . . . . . 0.469 ' HB3' ' H ' ' A' 1543 ' ' SER . 1.2 t80 -126.94 -99.94 0.37 Allowed 'General case' 0 N--CA 1.418 -2.054 0 N-CA-C 106.564 -1.643 . . . . 1.38 106.564 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1543 ' ' SER . . . . . 0.469 ' H ' ' HB3' ' A' 1542 ' ' TYR . 3.3 m -66.06 159.22 26.46 Favored 'General case' 0 N--CA 1.416 -2.126 0 C-N-CA 123.223 0.609 . . . . 1.98 110.236 178.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -51.23 -44.3 61.66 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.373 0.533 . . . . 3.96 112.094 -178.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 7.5 t -117.41 37.64 3.83 Favored 'General case' 0 N--CA 1.424 -1.759 0 N-CA-C 108.999 -0.741 . . . . 2.81 108.999 178.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . -147.44 109.36 0.47 Allowed Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 120.083 -1.056 . . . . 1.68 113.934 -177.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 36.0 m -98.89 160.63 3.21 Favored 'Isoleucine or valine' 0 C--O 1.252 1.187 0 N-CA-C 108.876 -0.786 . . . . 1.38 108.876 175.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1548 ' ' VAL . . . . . 0.498 ' HB ' ' CE1' ' A' 1567 ' ' PHE . 10.9 p -109.33 131.76 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.675 0 N-CA-C 107.647 -1.242 . . . . 1.24 107.647 174.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -93.27 125.54 37.92 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.988 -1.115 . . . . 1.29 107.988 178.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 24.0 ptm -136.39 134.29 37.64 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 120.033 -0.667 . . . . 1.47 112.169 -177.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 11.9 p -123.41 125.04 44.24 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-N 115.073 -0.967 . . . . 1.4 109.73 177.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1552 ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' A' 1533 ' ' SER . 47.9 mm -84.18 124.46 39.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 N-CA-C 109.86 -0.422 . . . . 1.11 109.86 -179.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1553 ' ' CYS . . . . . 0.416 ' SG ' HG23 ' A' 1552 ' ' ILE . 56.6 m 64.43 26.07 13.44 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.896 0.878 . . . . 1.4 112.231 174.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . -172.07 -179.23 42.86 Favored Glycine 0 N--CA 1.431 -1.643 0 N-CA-C 110.308 -1.117 . . . . 0.4 110.308 -178.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -101.34 145.56 28.74 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 121.283 0.563 . . . . 1.62 111.825 -177.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -92.57 137.45 32.35 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.014 -0.994 . . . . 1.12 108.845 -177.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -80.43 -8.83 59.69 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.354 0.872 . . . . 2.49 113.354 -172.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -83.62 -9.06 59.15 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 120.946 0.403 . . . . 1.38 112.026 -175.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1559 ' ' CYS . . . . . 0.799 ' HB3' HG13 ' A' 1563 ' ' VAL . 9.3 t -136.87 153.71 75.72 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 108.164 -1.05 . . . . 1.21 108.164 -177.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1560 ' ' PRO . . . . . 0.593 ' HD2' ' SG ' ' A' 1559 ' ' CYS . 23.7 Cg_exo -28.84 135.51 0.03 OUTLIER 'Trans proline' 0 C--N 1.379 2.183 1 C-N-CA 125.988 4.459 . . . . 0.98 115.133 178.293 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -45.93 120.95 3.85 Favored 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 125.104 3.87 . . . . 1.15 114.125 -177.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 101.73 21.75 10.94 Favored Glycine 0 CA--C 1.531 1.081 0 CA-C-N 115.826 -0.625 . . . . 0.55 113.045 -176.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1563 ' ' VAL . . . . . 0.799 HG13 ' HB3' ' A' 1559 ' ' CYS . 2.3 t -102.02 124.29 55.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 O-C-N 122.162 -0.61 . . . . 1.53 110.931 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -97.3 -35.76 5.14 Favored Glycine 0 C--N 1.3 -1.447 0 N-CA-C 110.495 -1.042 . . . . 0.29 110.495 175.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -138.58 132.89 31.79 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.202 -0.666 . . . . 1.08 109.202 177.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 53.0 t -156.42 139.3 15.28 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.459 -0.571 . . . . 0.43 109.459 -177.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1567 ' ' PHE . . . . . 0.498 ' CE1' ' HB ' ' A' 1548 ' ' VAL . 67.3 m-85 -87.3 147.94 25.29 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.294 -0.562 . . . . 1.3 110.0 177.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -89.34 40.34 3.06 Favored Glycine 0 N--CA 1.437 -1.265 0 C-N-CA 120.393 -0.908 . . . . 1.43 113.363 -175.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1569 ' ' GLN . . . . . 0.401 ' HB2' ' OD2' ' B' ' 15' ' ' ASP . 28.3 mm-40 -95.16 -71.61 0.66 Allowed 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 119.874 -0.731 . . . . 3.09 110.449 175.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 81.6 p -130.69 40.65 3.47 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 118.638 0.653 . . . . 2.52 112.354 175.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 13.0 mmt85 63.6 49.76 2.96 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 123.923 0.889 . . . . 3.19 111.114 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 26.0 mm -98.53 113.72 34.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 N-CA-C 109.149 -0.686 . . . . 1.51 109.149 -178.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1573 ' ' SER . . . . . 0.495 ' HB3' ' OG ' ' A' 1596 ' ' SER . 31.6 t -86.11 142.16 28.88 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 121.713 0.768 . . . . 0.96 110.402 -176.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1574 ' ' VAL . . . . . 0.612 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 30.5 m -124.17 15.09 4.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 CA-C-N 115.495 -0.775 . . . . 1.6 110.237 179.139 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . -179.44 123.48 0.85 Allowed Glycine 0 N--CA 1.417 -2.58 0 C-N-CA 118.825 -1.655 . . . . 0.34 112.21 177.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1576 ' ' LYS . . . . . 0.43 ' HB2' ' O ' ' A' 1594 ' ' ASP . 57.7 tttp -77.26 134.29 38.61 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 108.013 -1.106 . . . . 2.68 108.013 176.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -70.72 117.47 12.28 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.889 -0.596 . . . . 1.08 110.74 -177.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -133.56 174.88 9.94 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 106.913 -1.514 . . . . 1.95 106.913 177.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -123.93 45.83 2.39 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 106.184 -1.784 . . . . 3.11 106.184 178.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.86 88.01 3.9 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 113.527 -1.669 . . . . 4.04 107.579 -172.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1581 ' ' LEU . . . . . 0.46 HD23 ' HG ' ' A' 1590 ' ' LEU . 0.2 OUTLIER -89.73 133.51 34.65 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.228 -1.027 . . . . 1.32 108.228 -177.684 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -122.93 138.57 54.63 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 109.992 -0.373 . . . . 3.4 109.992 174.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1583 ' ' TYR . . . . . . . . . . . . . 50.0 t80 -109.43 111.9 23.71 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 107.624 -1.25 . . . . 1.26 107.624 177.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1584 ' ' VAL . . . . . 0.613 ' O ' ' HB ' ' A' 1587 ' ' VAL . 14.7 m -131.96 99.02 3.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 112.602 0.594 . . . . 1.71 112.602 -177.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 37.4 t70 52.5 66.23 1.28 Allowed 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 124.297 1.039 . . . . 1.17 111.605 175.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1586 ' ' GLN . . . . . . . . . . . . 0.255 30.1 pt20 65.14 12.4 7.95 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 127.515 2.326 . . . . 2.43 112.426 177.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1587 ' ' VAL . . . . . 0.613 ' HB ' ' O ' ' A' 1584 ' ' VAL . 13.9 t -110.51 128.28 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 CA-C-N 114.751 -1.113 . . . . 1.16 110.681 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1588 ' ' LEU . . . . . 0.805 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 3.2 mm? -95.28 107.98 20.12 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 106.613 -1.625 . . . . 1.11 106.613 176.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -115.48 116.77 28.76 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-O 121.672 0.748 . . . . 1.74 112.692 -174.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1590 ' ' LEU . . . . . 0.46 ' HG ' HD23 ' A' 1581 ' ' LEU . 5.7 mt -100.18 108.06 20.08 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 114.197 -1.365 . . . . 1.4 107.38 172.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 10.0 p -99.09 126.82 52.24 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.15 0 CA-C-O 121.531 0.681 . . . . 1.7 110.089 -179.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1592 ' ' TYR . . . . . . . . . . . . . 12.4 m-30 -113.28 99.21 7.63 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 109.317 -0.623 . . . . 1.08 109.317 177.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 60.1 pttt -111.41 179.39 4.04 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.585 -0.895 . . . . 2.21 108.585 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1594 ' ' ASP . . . . . 0.43 ' O ' ' HB2' ' A' 1576 ' ' LYS . 32.3 m-20 57.82 45.9 17.83 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.108 0.963 . . . . 1.11 110.955 178.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -79.59 -95.3 0.33 Allowed Glycine 0 CA--C 1.498 -0.979 0 N-CA-C 109.791 -1.324 . . . . 0.78 109.791 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1596 ' ' SER . . . . . 0.495 ' OG ' ' HB3' ' A' 1573 ' ' SER . 72.2 m -124.94 149.35 62.83 Favored Pre-proline 0 C--N 1.273 -2.736 0 N-CA-C 107.216 -1.402 . . . . 1.36 107.216 173.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -61.92 138.4 73.44 Favored 'Trans proline' 0 N--CA 1.445 -1.367 0 C-N-CA 122.273 1.982 . . . . 1.4 109.229 174.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1598 ' ' CYS . . . . . 0.511 ' HA ' ' CE2' ' A' 1606 ' ' TYR . 5.0 t -70.02 113.47 17.91 Favored Pre-proline 0 C--N 1.296 -1.718 0 N-CA-C 106.954 -1.499 . . . . 0.75 106.954 -178.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1599 ' ' PRO . . . . . 0.43 ' HD3' ' HE2' ' A' 1606 ' ' TYR . 24.2 Cg_exo -62.89 -33.78 74.08 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.984 2.456 . . . . 1.7 113.008 -173.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1600 ' ' SER . . . . . 0.65 ' HB2' ' HG ' ' B' ' 53' ' ' LEU . 5.2 m -86.18 7.6 24.39 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 116.307 -0.406 . . . . 2.8 112.061 178.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1601 ' ' LYS . . . . . 0.506 ' HG2' HD23 ' A' 1604 ' ' LEU . 3.0 tppp? -161.5 96.4 1.05 Allowed 'General case' 0 C--O 1.251 1.141 0 O-C-N 121.743 -0.598 . . . . 3.45 110.316 175.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 13.0 t -66.76 126.05 27.79 Favored 'General case' 0 N--CA 1.401 -2.886 0 N-CA-C 108.649 -0.871 . . . . 2.44 108.649 -176.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 106.2 -6.5 39.69 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 116.443 -0.344 . . . . 1.2 112.334 -177.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1604 ' ' LEU . . . . . 0.506 HD23 ' HG2' ' A' 1601 ' ' LYS . 7.5 mp -106.34 155.97 18.98 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 122.94 0.496 . . . . 2.38 109.981 176.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 44.8 t -135.24 151.06 50.25 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 107.99 -1.115 . . . . 1.96 107.99 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1606 ' ' TYR . . . . . 0.612 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 90.8 m-85 -80.45 150.86 29.58 Favored 'General case' 0 N--CA 1.419 -2.012 0 N-CA-C 108.903 -0.777 . . . . 1.06 108.903 176.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -150.82 127.46 10.85 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 123.623 0.577 . . . . 2.0 109.716 -175.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1608 ' ' SER . . . . . . . . . . . . . 20.7 m -105.35 115.96 31.15 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 109.437 -0.579 . . . . 1.61 109.437 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 38.4 t -98.41 107.07 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 108.103 -1.073 . . . . 1.09 108.103 176.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 70.5 mt -100.25 101.37 12.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 CA-C-N 115.765 -0.652 . . . . 1.2 109.304 -179.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 5.9 p -100.2 119.02 37.71 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.619 0.723 . . . . 1.89 112.694 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1612 ' ' PHE . . . . . 0.805 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 72.0 m-85 -94.51 122.27 36.91 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.131 -0.94 . . . . 0.28 109.744 177.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 42.0 t -119.99 138.67 49.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-N 115.397 -0.819 . . . . 1.23 109.475 -175.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 13.2 t -58.75 113.54 2.09 Favored 'General case' 0 C--O 1.243 0.732 0 C-N-CA 124.352 1.061 . . . . 0.77 111.856 178.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1615 ' ' ARG . . . . . 0.676 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 23.7 tpt180 -136.64 97.46 11.43 Favored Pre-proline 0 N--CA 1.431 -1.386 0 N-CA-C 109.272 -0.64 . . . . 2.92 109.272 175.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1616 ' ' PRO . . . . . 0.452 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 60.5 Cg_endo -73.62 -14.9 24.62 Favored 'Trans proline' 0 N--CA 1.487 1.138 0 C-N-CA 122.551 2.167 . . . . 1.22 112.846 -177.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -91.82 42.68 1.11 Allowed 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 124.704 1.201 . . . . 3.05 110.333 -176.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -30.72 127.96 0.14 Allowed 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 126.648 1.979 . . . . 1.55 113.591 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . 178.63 -145.14 6.66 Favored Glycine 0 N--CA 1.428 -1.843 0 N-CA-C 109.846 -1.302 . . . . 1.16 109.846 -178.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -61.44 -4.07 3.91 Favored 'Trans proline' 0 CA--C 1.556 1.581 0 C-N-CA 123.568 2.846 . . . . 1.06 115.756 -177.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1621 ' ' THR . . . . . . . . . . . . . 23.3 p -91.96 -10.06 40.75 Favored 'General case' 0 C--O 1.247 0.939 0 O-C-N 121.563 -0.711 . . . . 1.58 110.662 176.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 47.1 t30 -90.43 58.66 4.07 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 122.338 1.066 . . . . 0.88 109.378 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -163.69 139.43 5.13 Favored Pre-proline 0 C--N 1.309 -1.192 0 CA-C-N 114.455 -1.248 . . . . 3.82 107.916 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -65.11 102.04 0.43 Allowed 'Trans proline' 0 C--O 1.239 0.528 0 C-N-CA 123.314 2.676 . . . . 0.77 112.837 -175.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 75.3 mtm -107.34 146.59 31.39 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.897 -0.592 . . . . 1.43 111.049 -178.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 1.6 tm? -86.76 115.34 24.13 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 107.438 -1.319 . . . . 1.43 107.438 -176.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 49.2 mm -79.16 -56.49 7.02 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-O 121.26 0.552 . . . . 1.23 109.792 179.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 66.5 m -161.36 147.22 14.12 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.513 -0.767 . . . . 1.88 109.704 -177.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1629 ' ' LEU . . . . . 0.798 HD12 ' HG ' ' A' 1636 ' ' LEU . 42.7 tp -113.92 112.85 24.01 Favored 'General case' 0 N--CA 1.424 -1.737 0 N-CA-C 107.428 -1.323 . . . . 1.92 107.428 172.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 30.6 t70 -85.93 110.75 19.66 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.68 -1.23 . . . . 1.09 107.68 174.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1631 ' ' LYS . . . . . 0.601 ' HB3' HD23 ' B' ' 53' ' ' LEU . 0.1 OUTLIER -73.72 -31.6 63.47 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.761 -0.654 . . . . 3.98 110.086 -174.037 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -70.16 -36.82 74.99 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-N 115.481 -0.781 . . . . 2.6 112.863 -173.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 54.8 p -101.32 -6.52 24.01 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.032 0.444 . . . . 1.35 110.7 175.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1634 ' ' CYS . . . . . 0.48 ' O ' ' HA ' ' A' 1606 ' ' TYR . 32.7 m 63.27 40.85 8.33 Favored 'General case' 0 C--N 1.364 1.209 0 C-N-CA 124.546 1.138 . . . . 0.53 109.961 -178.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1635 ' ' THR . . . . . . . . . . . . . 55.9 m -106.24 133.71 50.51 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.924 -1.034 . . . . 1.11 110.356 -176.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1636 ' ' LEU . . . . . 0.798 ' HG ' HD12 ' A' 1629 ' ' LEU . 0.7 OUTLIER -116.85 131.69 56.89 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.443 -0.577 . . . . 1.56 109.443 -177.709 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -111.23 128.09 55.81 Favored 'General case' 0 C--O 1.252 1.199 0 CA-C-O 120.821 0.343 . . . . 0.54 111.012 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -125.61 131.82 52.62 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.92 -0.77 . . . . 0.64 108.92 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1639 ' ' SER . . . . . . . . . . . . . 64.6 m -115.46 140.7 48.9 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 122.892 0.477 . . . . 1.34 109.857 178.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 3.1 t90 -142.35 114.29 8.12 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 104.327 -2.471 . . . . 0.8 104.327 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1641 ' ' HIS . . . . . 0.676 ' HB3' ' HB2' ' A' 1615 ' ' ARG . 31.5 m-70 -106.26 112.44 25.46 Favored 'General case' 0 C--N 1.293 -1.886 0 C-N-CA 119.916 -0.714 . . . . 1.14 110.005 -177.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1642 ' ' THR . . . . . . . . . . . . . 3.9 t -142.46 150.42 54.56 Favored Pre-proline 0 C--N 1.302 -1.491 0 CA-C-N 115.615 -0.72 . . . . 1.11 109.512 -172.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1643 ' ' PRO . . . . . 0.452 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 71.9 Cg_endo -77.07 -10.75 17.93 Favored 'Trans proline' 0 C--N 1.362 1.251 0 C-N-CA 122.411 2.074 . . . . 0.78 111.464 176.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1644 ' ' LEU . . . . . 0.56 HD11 ' HB2' ' A' 1531 ' ' SER . 7.3 tt -68.36 -24.33 64.79 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.712 0.805 . . . . 1.66 110.493 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -95.04 6.96 47.61 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 122.187 0.994 . . . . 1.29 109.619 -177.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 15.6 t -123.9 159.11 30.4 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-N 114.404 -1.271 . . . . 1.48 108.579 -175.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 31.7 tt0 . . . . . 0 C--N 1.308 -1.208 0 N-CA-C 108.455 -0.943 . . . . 3.14 108.455 169.573 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.549 0 N-CA-C 112.071 -0.411 . . . . 2.28 112.071 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.98 -21.95 73.77 Favored Glycine 0 C--N 1.311 -0.847 0 C-N-CA 121.72 -0.276 . . . . 1.94 113.353 179.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -71.46 -20.83 62.04 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.728 0.775 . . . . 2.55 109.265 -176.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' LEU . . . . . 0.416 ' O ' HD22 ' B' ' 17' ' ' LEU . 62.1 mt -68.14 -49.59 60.09 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 115.059 -0.973 . . . . 2.82 108.419 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 8.5 p -77.66 -18.12 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 CA-C-N 115.111 -0.95 . . . . 2.5 110.488 -176.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' ASP . . . . . 0.401 ' OD2' ' HB2' ' A' 1569 ' ' GLN . 12.5 t70 -62.83 -67.53 0.41 Allowed 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 109.535 -0.543 . . . . 2.04 109.535 176.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 15.2 t -61.13 -36.6 80.18 Favored 'General case' 0 C--O 1.25 1.125 0 O-C-N 123.635 0.584 . . . . 2.31 111.226 -176.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.588 HD21 HD13 ' B' ' 42' ' ' ILE . 4.0 mm? -57.37 -49.6 75.64 Favored 'General case' 0 C--O 1.215 -0.757 0 N-CA-C 113.109 0.781 . . . . 2.27 113.109 175.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -84.75 -14.97 46.66 Favored 'General case' 0 C--N 1.317 -0.809 0 O-C-N 121.583 -0.698 . . . . 2.39 111.034 -178.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -63.86 -54.66 31.34 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 116.314 -0.403 . . . . 1.0 111.017 176.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 16.0 m -98.18 -14.52 7.73 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.691 0 C-N-CA 118.911 -1.116 . . . . 1.83 112.319 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' CYS . . . . . 0.509 ' HB2' ' O ' ' B' ' 17' ' ' LEU . 68.7 m -114.49 23.03 13.12 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 120.358 -0.537 . . . . 1.66 111.666 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -52.22 -40.49 52.5 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 114.557 0.583 . . . . 1.53 114.557 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -86.12 -31.93 21.59 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 113.753 1.019 . . . . 2.72 113.753 -178.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -90.52 -25.03 20.46 Favored 'General case' 0 C--O 1.248 0.991 0 CA-C-O 121.353 0.597 . . . . 5.02 111.44 -176.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 109.29 163.06 19.97 Favored Glycine 0 N--CA 1.439 -1.132 0 N-CA-C 110.183 -1.167 . . . . 1.63 110.183 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -123.62 131.11 53.54 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 117.52 0.66 . . . . 1.71 110.96 179.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' TYR . . . . . 0.416 ' O ' ' HE2' ' B' ' 59' ' ' TYR . 26.9 m-85 -136.71 80.84 1.84 Allowed 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 111.754 0.279 . . . . 3.67 111.754 -177.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' PHE . . . . . 0.546 ' HA ' ' HE2' ' B' ' 59' ' ' TYR . 34.3 p90 . . . . . 0 C--N 1.304 -1.378 0 CA-C-O 121.7 0.762 . . . . 2.44 109.674 173.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.409 -3.146 0 N-CA-C 110.248 -1.141 . . . . 2.62 110.248 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . 0.588 HD13 HD21 ' B' ' 17' ' ' LEU . 10.2 pt 59.65 -28.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 C-N-CA 127.737 2.415 . . . . 2.28 116.491 176.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . . . . . . . . 0.26 2.7 p -51.41 -49.53 31.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 114.958 1.466 . . . . 2.6 114.958 -175.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -96.12 -26.0 15.65 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.357 -0.979 . . . . 3.36 108.357 -176.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . 0.51 ' O ' ' HB2' ' B' ' 49' ' ' ARG . 9.5 tp10 -60.9 -43.72 98.12 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 114.933 -1.03 . . . . 3.08 109.428 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' CYS . . . . . . . . . . . . . 10.1 t -94.48 -14.62 24.97 Favored 'General case' 0 C--N 1.314 -0.956 0 O-C-N 121.988 -0.445 . . . . 2.23 111.736 -177.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 52.2 t -66.75 -47.74 71.29 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.141 -0.623 . . . . 2.48 110.181 179.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -105.71 -12.77 15.78 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 113.152 0.797 . . . . 2.97 113.152 -177.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . 0.51 ' HB2' ' O ' ' B' ' 45' ' ' GLU . 64.7 mtt180 -125.6 158.68 34.05 Favored 'General case' 0 CA--C 1.498 -1.036 0 N-CA-C 108.35 -0.981 . . . . 4.65 108.35 178.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 23.0 t -84.61 123.55 30.45 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 109.562 -0.533 . . . . 2.86 109.562 -177.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . 0.478 ' HB2' HD23 ' B' ' 55' ' ' LEU . 29.4 p -105.81 133.52 50.41 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 108.316 -0.994 . . . . 2.11 108.316 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -80.27 147.37 31.21 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.685 -1.228 . . . . 2.67 107.685 177.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . 0.718 HD11 ' H ' ' B' ' 53' ' ' LEU . 3.0 mp -52.49 -29.04 22.92 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 125.789 1.635 . . . . 2.36 112.185 -175.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . 0.412 ' O ' HG22 ' B' ' 58' ' ' THR . . . -61.96 -37.81 86.15 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 123.581 0.551 . . . . 1.92 110.772 -178.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . 0.478 HD23 ' HB2' ' B' ' 51' ' ' CYS . 50.5 tp -59.93 -50.59 73.17 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-N 115.787 -0.642 . . . . 2.35 110.617 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 3.9 pp -75.54 -32.76 60.57 Favored 'General case' 0 N--CA 1.422 -1.85 0 CA-C-N 116.202 -0.453 . . . . 2.01 111.99 -174.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -71.24 -42.44 68.84 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 112.195 0.442 . . . . 2.27 112.195 -176.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 58' ' ' THR . . . . . 0.412 HG22 ' O ' ' B' ' 54' ' ' ALA . 12.2 t -78.09 -25.4 47.58 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 118.83 -1.148 . . . . 2.67 111.742 176.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 59' ' ' TYR . . . . . 0.546 ' HE2' ' HA ' ' B' ' 28' ' ' PHE . 30.2 t80 -67.5 -68.55 0.37 Allowed 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 106.576 -1.639 . . . . 3.2 106.576 176.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 42.0 t . . . . . 0 CA--C 1.559 1.311 0 C-N-CA 125.391 1.476 . . . . 2.3 114.213 173.274 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 14.0 t70 . . . . . 0 N--CA 1.435 -1.195 0 N-CA-C 105.395 -2.076 . . . . 2.9 105.395 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A 1516 ' ' CYS . . . . . 0.552 ' HA ' ' HB2' ' A' 1581 ' ' LEU . 91.1 m -88.5 66.5 8.26 Favored 'General case' 0 C--N 1.283 -2.293 0 CA-C-O 121.68 0.752 . . . . 1.41 110.926 -177.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -152.22 130.86 12.3 Favored 'General case' 0 N--CA 1.415 -2.206 0 CA-C-N 114.666 -1.152 . . . . 2.18 109.301 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1518 ' ' VAL . . . . . 0.571 HG23 ' HB2' ' A' 1583 ' ' TYR . 2.9 m -145.12 142.9 22.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 C-N-CA 123.926 0.89 . . . . 1.52 110.153 -179.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1519 ' ' THR . . . . . . . . . . . . . 18.9 m -101.81 145.34 29.31 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 116.301 -0.409 . . . . 1.36 111.026 -177.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1520 ' ' ASN . . . . . 0.41 ' OD1' HG22 ' A' 1523 ' ' THR . 24.5 t-20 -76.2 111.88 17.72 Favored Pre-proline 0 N--CA 1.433 -1.289 0 N-CA-C 106.389 -1.708 . . . . 2.02 106.389 170.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -74.21 0.46 8.44 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.491 2.127 . . . . 1.82 113.736 -174.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 19.6 m -91.15 -43.22 10.01 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 116.256 -0.429 . . . . 1.89 111.603 177.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1523 ' ' THR . . . . . 0.41 HG22 ' OD1' ' A' 1520 ' ' ASN . 4.9 t -119.24 -8.86 10.05 Favored 'General case' 0 C--O 1.244 0.79 0 C-N-CA 119.943 -0.703 . . . . 1.99 112.43 -177.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 85.95 20.37 55.73 Favored Glycine 0 C--N 1.317 -0.494 0 C-N-CA 120.423 -0.894 . . . . 1.19 113.095 177.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 24.3 t-80 -84.35 123.63 30.4 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.057 0.455 . . . . 1.82 110.574 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 2.9 tm? -94.71 119.32 33.14 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 115.336 -0.847 . . . . 1.3 110.943 -175.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -91.64 130.83 37.38 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 109.604 -0.517 . . . . 0.8 109.604 169.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 16.3 t70 -125.64 122.56 36.75 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.452 -1.314 . . . . 1.17 107.452 173.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 3.7 mm? -93.86 5.87 50.26 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 113.683 0.994 . . . . 1.29 113.683 -170.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1530 ' ' SER . . . . . 0.556 ' HA ' ' OG ' ' A' 1533 ' ' SER . 3.6 m -66.16 -7.94 21.03 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 113.804 1.039 . . . . 0.91 113.804 -174.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 8.5 t -69.22 -31.88 70.76 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 109.391 -0.596 . . . . 1.98 109.391 179.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 81.1 mt -95.38 -7.03 39.63 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.069 0.461 . . . . 1.34 110.795 -178.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1533 ' ' SER . . . . . 0.556 ' OG ' ' HA ' ' A' 1530 ' ' SER . 24.5 m -66.97 161.3 24.55 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.85 -0.614 . . . . 1.93 111.433 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . 155.86 159.82 9.61 Favored Glycine 0 N--CA 1.423 -2.174 0 N-CA-C 109.811 -1.316 . . . . 1.1 109.811 -176.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1535 ' ' ARG . . . . . 0.404 ' O ' ' HA ' ' A' 1556 ' ' ASN . 42.2 ttp180 -92.26 -31.16 15.52 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 109.972 -0.381 . . . . 5.21 109.972 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -66.67 -34.01 76.91 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 121.126 0.488 . . . . 1.94 110.878 -177.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 73.75 -157.29 51.48 Favored Glycine 0 N--CA 1.428 -1.85 0 CA-C-N 115.042 -0.981 . . . . 1.08 113.676 172.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -137.26 152.05 49.38 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.84 -1.17 . . . . 1.07 107.84 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 27.0 p -112.73 139.75 48.09 Favored 'General case' 0 C--N 1.308 -1.215 0 O-C-N 123.489 0.493 . . . . 1.46 111.177 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1540 ' ' ALA . . . . . 0.465 ' HB1' HG13 ' A' 1548 ' ' VAL . . . -131.35 135.14 46.99 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 108.409 -0.96 . . . . 1.19 108.409 174.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -73.58 141.7 46.62 Favored 'General case' 0 C--O 1.243 0.719 0 C-N-CA 122.601 0.36 . . . . 1.37 110.866 -178.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1542 ' ' TYR . . . . . 0.489 ' HB3' ' H ' ' A' 1543 ' ' SER . 1.3 t80 -149.43 -101.14 0.07 Allowed 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 109.285 -0.635 . . . . 1.38 109.285 -176.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1543 ' ' SER . . . . . 0.489 ' H ' ' HB3' ' A' 1542 ' ' TYR . 4.3 m -63.95 160.24 18.17 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.468 1.107 . . . . 1.98 111.225 -178.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 52.3 tptt -50.76 -41.38 56.67 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 113.611 0.967 . . . . 3.96 113.611 -173.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 11.9 t -128.75 37.93 4.03 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 108.785 -0.82 . . . . 2.81 108.785 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1546 ' ' GLY . . . . . 0.57 ' HA3' ' HG2' ' A' 1569 ' ' GLN . . . -147.96 120.34 1.21 Allowed Glycine 0 N--CA 1.428 -1.859 0 C-N-CA 119.555 -1.307 . . . . 1.68 113.573 -177.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 29.3 m -99.89 152.58 4.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 107.001 -1.481 . . . . 1.38 107.001 174.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1548 ' ' VAL . . . . . 0.465 HG13 ' HB1' ' A' 1540 ' ' ALA . 12.3 p -92.76 134.42 30.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.865 0 C-N-CA 119.922 -0.711 . . . . 1.24 109.202 178.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -99.87 129.13 45.93 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 115.355 -0.839 . . . . 1.29 108.763 177.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 25.8 ptm -144.14 126.27 15.55 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 115.453 -0.794 . . . . 1.47 110.972 -176.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 5.3 p -118.55 132.89 56.2 Favored 'General case' 0 C--N 1.282 -2.355 0 CA-C-N 115.002 -0.999 . . . . 1.4 109.795 179.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1552 ' ' ILE . . . . . . . . . . . . . 46.8 mm -83.28 112.15 20.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 120.477 0.18 . . . . 1.11 111.159 -176.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 57.9 m 64.99 29.6 12.17 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.622 1.169 . . . . 1.4 112.093 174.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . -167.01 -174.8 36.55 Favored Glycine 0 N--CA 1.409 -3.113 0 N-CA-C 108.961 -1.656 . . . . 0.4 108.961 -178.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -109.78 152.86 25.16 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-N 116.845 0.323 . . . . 1.62 111.724 -175.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1556 ' ' ASN . . . . . 0.404 ' HA ' ' O ' ' A' 1535 ' ' ARG . 26.7 t-20 -103.29 138.63 39.81 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.008 -1.108 . . . . 1.12 108.008 178.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -85.97 2.33 46.66 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 114.06 1.133 . . . . 2.49 114.06 -171.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -91.03 -1.81 57.75 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 120.491 -0.484 . . . . 1.38 111.027 -178.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1559 ' ' CYS . . . . . 0.625 ' SG ' ' HD2' ' A' 1560 ' ' PRO . 16.0 t -137.43 151.74 71.81 Favored Pre-proline 0 C--N 1.304 -1.373 0 N-CA-C 106.648 -1.612 . . . . 1.21 106.648 178.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1560 ' ' PRO . . . . . 0.625 ' HD2' ' SG ' ' A' 1559 ' ' CYS . 13.3 Cg_exo -30.6 132.13 0.05 OUTLIER 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 125.226 3.95 . . . . 0.98 114.655 178.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -45.02 129.25 9.86 Favored 'Trans proline' 0 C--N 1.364 1.385 0 C-N-CA 124.768 3.645 . . . . 1.15 113.332 -177.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 96.6 18.98 28.67 Favored Glycine 0 C--N 1.313 -0.727 0 CA-C-N 116.204 -0.453 . . . . 0.55 113.14 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1563 ' ' VAL . . . . . 0.524 HG13 ' HB2' ' A' 1566 ' ' CYS . 2.3 t -106.61 124.51 62.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 C-N-CA 123.02 0.528 . . . . 1.53 111.661 -178.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -97.27 -33.97 5.77 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 115.242 -0.89 . . . . 0.29 111.814 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -133.94 129.59 36.51 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 109.018 -0.734 . . . . 1.08 109.018 177.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1566 ' ' CYS . . . . . 0.524 ' HB2' HG13 ' A' 1563 ' ' VAL . 48.5 t -158.32 138.11 12.09 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 110.52 -0.178 . . . . 0.43 110.52 -176.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -84.72 135.45 34.14 Favored 'General case' 0 C--O 1.245 0.859 0 N-CA-C 108.428 -0.953 . . . . 1.3 108.428 173.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -91.79 27.71 9.55 Favored Glycine 0 N--CA 1.422 -2.286 0 N-CA-C 115.88 1.112 . . . . 1.43 115.88 -170.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1569 ' ' GLN . . . . . 0.594 ' HB2' ' OD2' ' B' ' 15' ' ' ASP . 20.8 mt-30 -77.49 -69.04 0.56 Allowed 'General case' 0 C--O 1.241 0.617 0 C-N-CA 117.349 -1.74 . . . . 3.09 109.579 171.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 71.0 p -114.33 15.7 17.98 Favored 'General case' 0 CA--C 1.553 1.058 0 N-CA-C 112.809 0.67 . . . . 2.52 112.809 177.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? 66.43 68.78 0.43 Allowed 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.923 1.289 . . . . 3.19 112.703 -179.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 18.8 mt -106.3 122.61 60.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 114.727 -1.124 . . . . 1.51 108.793 177.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 35.7 t -83.2 138.53 33.59 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.669 0.747 . . . . 0.96 111.244 -174.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1574 ' ' VAL . . . . . 0.533 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 27.1 m -123.39 18.05 5.03 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 CA-C-N 115.661 -0.699 . . . . 1.6 110.392 178.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 167.52 126.44 0.84 Allowed Glycine 0 N--CA 1.422 -2.253 0 CA-C-N 115.113 -0.949 . . . . 0.34 112.383 175.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 53.9 tttm -68.64 146.03 53.38 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.525 -0.917 . . . . 2.68 108.525 177.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -73.48 79.45 1.43 Allowed 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.208 0.528 . . . . 1.08 111.566 -178.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -96.35 -177.6 4.02 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 109.263 -0.643 . . . . 1.95 109.263 178.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 66.7 mttm -132.38 47.56 2.5 Favored 'General case' 0 CA--C 1.485 -1.548 0 N-CA-C 105.28 -2.119 . . . . 3.11 105.28 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.49 76.62 5.83 Favored 'General case' 0 N--CA 1.415 -2.197 0 CA-C-N 113.773 -1.558 . . . . 4.04 108.593 -171.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1581 ' ' LEU . . . . . 0.552 ' HB2' ' HA ' ' A' 1516 ' ' CYS . 0.3 OUTLIER -86.14 129.58 34.8 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.608 -1.178 . . . . 1.32 108.691 -179.309 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A 1582 ' ' ARG . . . . . 0.536 ' HB2' ' HB3' ' A' 1589 ' ' GLN . 70.3 mtp180 -124.15 137.26 54.57 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 116.522 -0.308 . . . . 3.4 110.273 173.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1583 ' ' TYR . . . . . 0.571 ' HB2' HG23 ' A' 1518 ' ' VAL . 66.9 t80 -105.62 104.37 14.07 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 107.853 -1.165 . . . . 1.26 107.853 177.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1584 ' ' VAL . . . . . 0.519 ' O ' ' HB ' ' A' 1587 ' ' VAL . 16.7 m -121.2 89.51 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 112.81 0.67 . . . . 1.71 112.81 -175.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 17.4 t70 56.91 57.9 4.38 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.119 0.968 . . . . 1.17 110.134 177.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1586 ' ' GLN . . . . . 0.55 ' HA ' ' CE1' ' A' 1583 ' ' TYR 0.296 9.1 pt20 68.87 4.67 4.58 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 128.196 2.598 . . . . 2.43 112.637 179.116 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A 1587 ' ' VAL . . . . . 0.519 ' HB ' ' O ' ' A' 1584 ' ' VAL . 23.1 t -93.71 124.03 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.012 0 N-CA-C 108.491 -0.929 . . . . 1.16 108.491 174.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1588 ' ' LEU . . . . . 0.824 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 3.4 mm? -92.73 107.77 19.47 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.157 -1.053 . . . . 1.11 108.157 178.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1589 ' ' GLN . . . . . 0.536 ' HB3' ' HB2' ' A' 1582 ' ' ARG . 35.5 tt0 -99.05 123.65 43.5 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 116.025 -0.534 . . . . 1.74 110.23 -178.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1590 ' ' LEU . . . . . 0.456 ' HB3' ' HB ' ' A' 1610 ' ' ILE . 0.7 OUTLIER -117.83 96.02 5.18 Favored 'General case' 0 C--N 1.284 -2.27 0 N-CA-C 105.065 -2.198 . . . . 1.4 105.065 174.885 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 8.4 p -96.31 132.16 41.29 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 CA-C-O 121.317 0.579 . . . . 1.7 111.665 -175.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1592 ' ' TYR . . . . . . . . . . . . . 14.2 m-30 -121.51 122.18 39.15 Favored 'General case' 0 CA--C 1.496 -1.12 0 N-CA-C 108.306 -0.998 . . . . 1.08 108.306 176.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 58.4 pttt -131.09 179.04 6.24 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 108.98 -0.748 . . . . 2.21 108.98 177.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 19.9 m-20 62.17 53.2 2.97 Favored 'General case' 0 C--O 1.249 1.049 0 O-C-N 124.286 0.992 . . . . 1.11 110.864 178.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -85.67 -105.23 0.71 Allowed Glycine 0 N--CA 1.429 -1.796 0 N-CA-C 109.558 -1.417 . . . . 0.78 109.558 177.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1596 ' ' SER . . . . . . . . . . . . . 36.3 p -129.11 153.63 80.37 Favored Pre-proline 0 C--N 1.282 -2.331 0 N-CA-C 107.753 -1.202 . . . . 1.36 107.753 174.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 90.7 Cg_exo -50.67 133.76 39.21 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.287 2.658 . . . . 1.4 113.509 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1598 ' ' CYS . . . . . 0.527 ' HA ' ' CE2' ' A' 1606 ' ' TYR . 44.4 t -81.83 119.27 74.89 Favored Pre-proline 0 C--N 1.283 -2.285 0 CA-C-N 113.875 -1.512 . . . . 0.75 109.018 -178.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1599 ' ' PRO . . . . . 0.465 ' HD2' ' OH ' ' A' 1606 ' ' TYR . 40.2 Cg_exo -60.43 -23.92 76.34 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 123.097 2.532 . . . . 1.7 112.965 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1600 ' ' SER . . . . . 0.731 ' HA ' ' HB2' ' B' ' 53' ' ' LEU . 19.5 m -54.37 -44.81 72.54 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 123.364 0.665 . . . . 2.8 111.782 178.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1601 ' ' LYS . . . . . 0.538 ' HB3' HD12 ' A' 1604 ' ' LEU . 4.5 tppp? -148.24 127.88 13.31 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.97 -0.752 . . . . 3.45 108.97 179.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 20.4 m -65.48 129.48 39.9 Favored 'General case' 0 N--CA 1.412 -2.345 0 N-CA-C 108.796 -0.816 . . . . 2.44 108.796 -178.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 105.25 -10.87 47.53 Favored Glycine 0 N--CA 1.436 -1.359 0 C-N-CA 120.496 -0.859 . . . . 1.2 112.499 178.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1604 ' ' LEU . . . . . 0.538 HD12 ' HB3' ' A' 1601 ' ' LYS . 67.6 mt -99.33 150.19 22.38 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.667 -0.494 . . . . 2.38 109.667 178.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 22.4 t -123.4 153.15 40.79 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.555 -1.276 . . . . 1.96 107.555 177.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1606 ' ' TYR . . . . . 0.533 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 49.6 m-85 -73.77 158.48 34.52 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 116.171 -0.468 . . . . 1.06 111.903 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1607 ' ' LYS . . . . . 0.458 ' HZ3' HG22 ' A' 1635 ' ' THR . 20.0 ttpp -156.26 125.87 6.31 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.808 -0.633 . . . . 2.0 110.502 -178.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1608 ' ' SER . . . . . . . . . . . . . 20.0 m -106.45 129.86 54.35 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 109.015 -0.735 . . . . 1.61 109.015 -179.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 26.2 t -114.21 102.41 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.598 0 N-CA-C 108.508 -0.923 . . . . 1.09 108.508 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1610 ' ' ILE . . . . . 0.456 ' HB ' ' HB3' ' A' 1590 ' ' LEU . 85.4 mt -90.11 113.8 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.662 0 N-CA-C 108.709 -0.848 . . . . 1.2 108.709 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 34.5 m -109.64 106.76 16.56 Favored 'General case' 0 C--N 1.283 -2.288 0 CA-C-N 114.855 -1.066 . . . . 1.89 110.249 -178.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1612 ' ' PHE . . . . . 0.824 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 45.7 m-85 -80.27 119.24 22.76 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.88 -0.6 . . . . 0.28 109.79 176.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1613 ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' 1641 ' ' HIS . 54.1 t -109.64 128.83 65.39 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-N 115.004 -0.998 . . . . 1.23 110.927 -174.149 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 5.8 t -55.19 109.44 0.53 Allowed 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 125.012 1.325 . . . . 0.77 112.97 176.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1615 ' ' ARG . . . . . 0.777 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 4.3 tpt180 -129.08 94.36 34.07 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 106.963 -1.495 . . . . 2.92 106.963 169.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1616 ' ' PRO . . . . . 0.527 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 37.6 Cg_endo -63.47 -32.41 70.9 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 122.789 2.326 . . . . 1.22 115.999 -169.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -85.94 -18.16 33.44 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.211 -0.595 . . . . 3.05 111.646 -176.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . 68.65 113.15 0.04 OUTLIER 'General case' 0 C--N 1.358 0.949 0 C-N-CA 125.23 1.412 . . . . 1.55 110.937 -174.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . -131.25 -155.87 8.3 Favored Glycine 0 N--CA 1.422 -2.292 0 C-N-CA 119.976 -1.107 . . . . 1.16 111.208 -177.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -82.43 20.88 1.05 Allowed 'Trans proline' 0 C--O 1.235 0.375 0 C-N-CA 123.253 2.635 . . . . 1.06 113.588 -174.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1621 ' ' THR . . . . . . . . . . . . . 22.4 p -116.71 14.4 15.33 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-O 121.901 0.858 . . . . 1.58 109.717 178.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 42.6 t30 -90.68 58.9 4.04 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 122.802 1.287 . . . . 0.88 108.325 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1623 ' ' ARG . . . . . 0.42 ' HE ' ' HB2' ' A' 1623 ' ' ARG . 3.5 ptm180 -168.05 140.55 2.51 Favored Pre-proline 0 N--CA 1.428 -1.551 0 CA-C-N 113.486 -1.688 . . . . 3.82 107.003 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1624 ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' A' 1639 ' ' SER . 35.7 Cg_endo -61.98 103.99 0.31 Allowed 'Trans proline' 0 C--O 1.243 0.733 0 C-N-CA 123.133 2.555 . . . . 0.77 113.012 -176.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 69.9 mtm -99.66 144.92 28.18 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.988 -0.551 . . . . 1.43 109.869 176.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 1.5 tm? -86.89 115.33 24.23 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 106.883 -1.525 . . . . 1.43 106.883 -176.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1627 ' ' ILE . . . . . 0.697 HD13 ' HB2' ' A' 1639 ' ' SER . 38.6 mm -75.94 -58.35 4.67 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.605 0 CA-C-O 121.589 0.709 . . . . 1.23 109.186 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 40.3 m -164.18 151.3 11.78 Favored 'General case' 0 N--CA 1.427 -1.575 0 N-CA-C 107.639 -1.245 . . . . 1.88 107.639 -174.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1629 ' ' LEU . . . . . 0.665 HD13 ' HG ' ' A' 1636 ' ' LEU . 33.0 tp -116.05 104.7 11.83 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 107.102 -1.444 . . . . 1.92 107.102 172.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 14.3 t70 -75.35 100.99 4.58 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.082 -1.047 . . . . 1.09 108.63 178.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1631 ' ' LYS . . . . . 0.689 ' HD3' ' H ' ' A' 1631 ' ' LYS . 0.0 OUTLIER -65.31 -8.48 18.35 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 114.336 1.236 . . . . 3.98 114.336 -175.677 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A 1632 ' ' GLN . . . . . 0.787 HE21 ' HA ' ' A' 1632 ' ' GLN . 0.0 OUTLIER -96.06 -37.89 10.43 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 119.409 -0.916 . . . . 2.6 110.909 -179.292 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 66.9 p -94.74 -16.4 23.07 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 116.026 -0.534 . . . . 1.35 110.798 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 74.5 m 68.59 35.76 3.08 Favored 'General case' 0 C--N 1.353 0.73 0 C-N-CA 124.572 1.149 . . . . 0.53 110.698 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1635 ' ' THR . . . . . 0.458 HG22 ' HZ3' ' A' 1607 ' ' LYS . 41.3 m -99.19 131.79 44.97 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 114.455 -1.248 . . . . 1.11 109.693 -179.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1636 ' ' LEU . . . . . 0.665 ' HG ' HD13 ' A' 1629 ' ' LEU . 0.5 OUTLIER -110.24 121.62 45.72 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.638 -1.245 . . . . 1.56 107.638 -179.018 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -101.93 129.46 48.2 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 120.898 0.38 . . . . 0.54 110.836 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -125.83 137.37 53.76 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.312 -0.858 . . . . 0.64 109.82 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1639 ' ' SER . . . . . 0.697 ' HB2' HD13 ' A' 1627 ' ' ILE . 16.5 t -117.81 150.8 38.55 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.288 -1.004 . . . . 1.34 108.288 178.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 2.8 t90 -152.55 113.63 4.2 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 104.868 -2.271 . . . . 0.8 104.868 -179.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1641 ' ' HIS . . . . . 0.777 ' HB3' ' HB2' ' A' 1615 ' ' ARG . 10.6 m-70 -101.2 111.13 23.26 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-O 121.357 0.599 . . . . 1.14 109.79 -176.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1642 ' ' THR . . . . . . . . . . . . . 3.2 t -142.57 148.14 45.56 Favored Pre-proline 0 C--N 1.297 -1.71 0 CA-C-N 115.148 -0.933 . . . . 1.11 109.278 -174.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1643 ' ' PRO . . . . . 0.527 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 58.9 Cg_endo -79.42 -14.41 13.06 Favored 'Trans proline' 0 C--N 1.363 1.318 0 C-N-CA 122.28 1.987 . . . . 0.78 112.847 178.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 8.2 tt -70.76 -26.93 63.58 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.796 -0.816 . . . . 1.66 108.796 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -99.09 28.42 4.44 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 114.718 -1.128 . . . . 1.29 110.44 -177.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 47.7 t -121.57 140.95 51.58 Favored 'General case' 0 N--CA 1.419 -1.997 0 N-CA-C 108.794 -0.817 . . . . 1.48 108.794 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 16.8 tp10 . . . . . 0 N--CA 1.421 -1.921 0 N-CA-C 107.629 -1.249 . . . . 3.14 107.629 177.208 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.806 0 N-CA-C 110.911 -0.875 . . . . 2.28 110.911 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -57.16 -64.66 4.2 Favored Glycine 0 C--N 1.33 0.24 0 N-CA-C 113.919 0.328 . . . . 1.94 113.919 -177.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -63.96 -32.32 73.81 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 109.349 -0.611 . . . . 2.55 109.349 -178.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' LEU . . . . . 0.46 ' O ' HD22 ' B' ' 17' ' ' LEU . 0.1 OUTLIER -60.29 -59.56 5.22 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 114.441 -1.254 . . . . 2.82 109.214 -178.926 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 14.2 p -69.21 -33.31 57.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 112.259 0.466 . . . . 2.5 112.259 -176.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' ASP . . . . . 0.594 ' OD2' ' HB2' ' A' 1569 ' ' GLN . 11.9 t0 -59.86 -53.34 59.09 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 120.164 -0.614 . . . . 2.04 109.444 179.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 34.5 m -57.29 -51.14 70.56 Favored 'General case' 0 CA--C 1.566 1.571 0 C-N-CA 123.983 0.913 . . . . 2.31 111.322 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.538 ' HG ' ' HD2' ' B' ' 28' ' ' PHE . 4.2 mm? -53.72 -46.98 70.99 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.628 -0.715 . . . . 2.27 112.214 176.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -83.15 -10.67 58.51 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-O 121.554 0.692 . . . . 2.39 111.558 -177.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -68.5 -56.78 7.22 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.719 -0.673 . . . . 1.0 110.283 177.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 15.0 p -95.32 -22.83 5.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 C-N-CA 118.571 -1.252 . . . . 1.83 112.063 -176.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 60.3 m -108.81 27.01 9.89 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 120.197 -0.601 . . . . 1.66 110.13 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -54.16 -54.82 29.53 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 121.171 -0.538 . . . . 1.53 113.125 178.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -71.97 -43.11 65.69 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 112.168 0.433 . . . . 2.72 112.168 178.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 39.1 ttm180 -67.73 -49.36 62.96 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 112.452 0.538 . . . . 5.02 112.452 -175.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 125.84 140.86 5.43 Favored Glycine 0 N--CA 1.437 -1.244 0 N-CA-C 110.002 -1.239 . . . . 1.63 110.002 -175.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . 0.469 ' HB2' ' HB3' ' B' ' 17' ' ' LEU . 30.6 p90 -113.69 130.22 56.45 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 117.121 0.46 . . . . 1.71 109.99 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -133.45 73.64 1.52 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.679 0.622 . . . . 3.67 112.679 -177.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' PHE . . . . . 0.538 ' HD2' ' HG ' ' B' ' 17' ' ' LEU . 34.3 p90 . . . . . 0 C--N 1.306 -1.295 0 C-N-CA 119.223 -0.991 . . . . 2.44 109.013 173.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . 0.428 ' C ' ' H ' ' B' ' 43' ' ' VAL . . . . . . . . 0 N--CA 1.407 -3.259 0 N-CA-C 109.773 -1.331 . . . . 2.62 109.773 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . 0.521 HD11 HD21 ' B' ' 17' ' ' LEU . 20.0 pt 61.51 -30.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 C-N-CA 127.953 2.501 . . . . 2.28 114.821 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . 0.608 ' O ' ' HB2' ' B' ' 47' ' ' CYS . 2.6 p -49.88 -43.01 19.27 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 114.236 1.199 . . . . 2.6 114.236 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -96.28 -35.04 11.39 Favored 'General case' 0 N--CA 1.429 -1.523 0 C-N-CA 120.207 -0.597 . . . . 3.36 109.566 -175.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . 0.405 ' HG3' ' HD2' ' B' ' 49' ' ' ARG . 33.7 tt0 -63.87 -45.4 89.59 Favored 'General case' 0 C--O 1.202 -1.431 0 CA-C-N 115.905 -0.589 . . . . 3.08 109.769 179.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' CYS . . . . . . . . . . . . . 29.3 m -85.16 -4.16 59.06 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.216 0.531 . . . . 2.23 110.88 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' CYS . . . . . 0.608 ' HB2' ' O ' ' B' ' 43' ' ' VAL . 42.2 t -77.62 -45.36 25.35 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.523 0.677 . . . . 2.48 109.195 175.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -105.23 -10.25 17.19 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 113.236 0.828 . . . . 2.97 113.236 -176.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . 0.405 ' HD2' ' HG3' ' B' ' 45' ' ' GLU . 93.0 mtt180 -129.47 171.31 12.69 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 106.956 -1.498 . . . . 4.65 106.956 177.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 22.7 t -99.71 148.11 24.72 Favored 'General case' 0 N--CA 1.426 -1.66 0 N-CA-C 107.609 -1.256 . . . . 2.86 107.609 173.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 76.9 m -125.98 142.01 51.71 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 109.553 -0.536 . . . . 2.11 109.553 -175.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -81.77 161.79 23.15 Favored 'General case' 0 C--O 1.243 0.725 0 O-C-N 123.15 0.281 . . . . 2.67 110.88 176.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . 0.731 ' HB2' ' HA ' ' A' 1600 ' ' SER . 62.7 tp -55.33 -36.23 66.04 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 122.508 0.323 . . . . 2.36 111.405 178.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.9 -26.51 65.96 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 123.648 0.779 . . . . 1.92 112.556 -174.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 52.6 tp -74.44 -54.56 7.32 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 109.551 -0.537 . . . . 2.35 109.551 177.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' B' ' 60' ' ' CYS . 2.8 pp -70.92 -33.32 70.41 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-N 115.923 -0.58 . . . . 2.01 111.392 -174.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -54.47 -51.39 65.2 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 123.663 0.602 . . . . 2.27 111.318 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 8.9 t -82.7 -28.29 30.65 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 112.492 0.553 . . . . 2.67 112.492 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -78.38 -36.27 46.13 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 121.807 -0.558 . . . . 3.2 110.695 -175.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 60' ' ' CYS . . . . . 0.468 ' HB2' ' O ' ' B' ' 56' ' ' LEU . 12.0 t . . . . . 0 N--CA 1.493 1.69 0 C-N-CA 126.011 1.724 . . . . 2.3 111.84 -178.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 26.5 p-10 . . . . . 0 N--CA 1.414 -2.234 0 N-CA-C 107.068 -1.456 . . . . 2.9 107.068 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 11.8 m -87.06 51.07 2.14 Favored 'General case' 0 C--N 1.276 -2.628 0 CA-C-N 115.703 -0.68 . . . . 1.41 110.271 -174.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -162.98 132.05 4.09 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-O 121.23 0.538 . . . . 2.18 111.381 -174.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 6.6 m -135.46 144.79 33.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 CA-C-N 116.083 -0.508 . . . . 1.52 110.038 179.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1519 ' ' THR . . . . . 0.412 ' HG1' HD22 ' A' 1526 ' ' LEU . 28.9 m -114.65 134.52 55.0 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.386 -0.598 . . . . 1.36 109.386 177.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1520 ' ' ASN . . . . . 0.535 ' OD1' HG23 ' A' 1523 ' ' THR . 13.9 t-20 -89.98 115.23 63.46 Favored Pre-proline 0 N--CA 1.43 -1.429 0 N-CA-C 108.322 -0.992 . . . . 2.02 108.322 175.291 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -66.54 -16.51 51.09 Favored 'Trans proline' 0 CA--C 1.533 0.439 0 C-N-CA 122.898 2.399 . . . . 1.82 113.514 -175.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1522 ' ' SER . . . . . 0.469 ' HB2' ' OD1' ' A' 1520 ' ' ASN . 15.9 m -71.8 -50.05 33.26 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 116.439 -0.346 . . . . 1.89 111.393 -179.067 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1523 ' ' THR . . . . . 0.535 HG23 ' OD1' ' A' 1520 ' ' ASN . 9.9 t -111.62 -1.86 15.61 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 120.479 -0.488 . . . . 1.99 111.524 -176.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 66.58 33.26 84.0 Favored Glycine 0 CA--C 1.501 -0.817 0 CA-C-N 115.737 -0.665 . . . . 1.19 112.41 177.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 55.5 t-80 -94.85 123.73 38.48 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 119.971 -0.692 . . . . 1.82 109.408 -178.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1526 ' ' LEU . . . . . 0.412 HD22 ' HG1' ' A' 1519 ' ' THR . 2.0 tm? -93.71 111.52 23.22 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.101 -1.074 . . . . 1.3 108.101 179.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -94.0 115.32 27.65 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.92 -0.488 . . . . 0.8 110.217 176.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 20.5 t70 -104.78 113.3 26.8 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 109.188 -0.671 . . . . 1.17 109.188 176.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1529 ' ' LEU . . . . . 0.419 ' HG ' HD22 ' A' 1581 ' ' LEU . 3.0 mm? -102.31 2.33 36.76 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 108.727 -0.842 . . . . 1.29 108.727 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 2.1 m -66.98 -27.97 67.88 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.659 -0.7 . . . . 0.91 109.886 -177.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 27.7 t -69.85 -18.41 63.43 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.866 -0.606 . . . . 1.98 110.637 178.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1532 ' ' LEU . . . . . 0.482 ' O ' ' HB ' ' A' 1552 ' ' ILE . 74.8 mt -94.76 0.83 55.27 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.323 0.583 . . . . 1.34 110.192 -178.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1533 ' ' SER . . . . . . . . . . . . . 41.5 m -77.72 164.72 25.01 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 109.351 -0.611 . . . . 1.93 109.351 175.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -179.62 155.01 14.62 Favored Glycine 0 N--CA 1.421 -2.362 0 N-CA-C 108.386 -1.886 . . . . 1.1 108.386 178.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 58.0 ttp180 -86.49 -29.27 22.89 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 121.092 0.472 . . . . 5.21 110.852 -177.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -88.01 -29.42 20.73 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.445 0.641 . . . . 1.94 110.021 177.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 94.06 -155.77 22.06 Favored Glycine 0 N--CA 1.418 -2.514 0 CA-C-N 115.299 -0.864 . . . . 1.08 111.645 175.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -130.49 148.39 52.29 Favored 'General case' 0 C--N 1.278 -2.535 0 N-CA-C 107.546 -1.279 . . . . 1.07 107.546 177.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 7.3 p -109.15 132.73 53.84 Favored 'General case' 0 C--N 1.292 -1.913 0 O-C-N 123.677 0.611 . . . . 1.46 111.001 -176.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1540 ' ' ALA . . . . . 0.433 ' HB2' ' CG1' ' A' 1548 ' ' VAL . . . -125.65 144.34 50.64 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.9 -1.148 . . . . 1.19 107.9 175.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -77.35 132.04 38.38 Favored 'General case' 0 C--N 1.313 -1.008 0 O-C-N 123.556 0.535 . . . . 1.37 110.312 -177.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1542 ' ' TYR . . . . . 0.714 ' HE2' ' HG ' ' A' 1626 ' ' LEU . 9.3 t80 -136.76 -99.79 0.21 Allowed 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.326 -0.99 . . . . 1.38 108.326 -178.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1543 ' ' SER . . . . . 0.404 ' H ' ' HB3' ' A' 1542 ' ' TYR . 47.7 t -86.84 160.82 18.62 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-O 121.602 0.715 . . . . 1.98 109.726 -175.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -72.39 -18.52 61.72 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.637 -0.71 . . . . 3.96 110.724 -178.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 13.2 t -87.63 -41.07 13.67 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.156 0.503 . . . . 2.81 110.22 -178.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . -153.27 159.05 28.34 Favored Glycine 0 N--CA 1.431 -1.69 0 C-N-CA 120.708 -0.758 . . . . 1.68 112.021 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 33.7 m -94.59 -179.41 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 107.929 -1.137 . . . . 1.38 107.929 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1548 ' ' VAL . . . . . 0.433 ' CG1' ' HB2' ' A' 1540 ' ' ALA . 14.2 p -104.37 135.94 39.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 C-N-CA 119.716 -0.794 . . . . 1.24 109.561 177.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1549 ' ' TYR . . . . . 0.416 ' HB3' ' ND2' ' A' 1556 ' ' ASN . 86.1 m-85 -102.05 129.28 48.33 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 108.81 -0.811 . . . . 1.29 108.81 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 26.1 ptm -148.43 132.96 17.7 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 116.045 -0.525 . . . . 1.47 111.484 -178.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 6.8 p -118.89 126.47 51.87 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 115.775 -0.648 . . . . 1.4 110.041 178.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1552 ' ' ILE . . . . . 0.482 ' HB ' ' O ' ' A' 1532 ' ' LEU . 36.0 mm -77.6 112.46 15.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 112.362 0.505 . . . . 1.11 112.362 -177.174 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1553 ' ' CYS . . . . . 0.532 ' H ' ' HH ' ' A' 1592 ' ' TYR . 46.3 t 62.12 32.12 17.54 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.398 1.079 . . . . 1.4 110.977 174.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . -163.96 174.28 40.08 Favored Glycine 0 N--CA 1.422 -2.281 0 N-CA-C 108.947 -1.661 . . . . 0.4 108.947 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -100.54 155.0 18.09 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 117.48 0.64 . . . . 1.62 110.761 -178.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1556 ' ' ASN . . . . . 0.416 ' ND2' ' HB3' ' A' 1549 ' ' TYR . 49.8 t-20 -108.4 132.74 53.45 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 115.05 -0.977 . . . . 1.12 109.236 -176.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -82.72 1.83 36.77 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.599 0.592 . . . . 2.49 112.599 -176.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -78.89 -19.95 50.63 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.326 0.584 . . . . 1.38 110.273 176.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1559 ' ' CYS . . . . . 0.623 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 76.1 m -132.71 172.42 7.41 Favored Pre-proline 0 C--N 1.299 -1.612 0 CA-C-O 117.795 -1.098 . . . . 1.21 109.871 -178.038 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1560 ' ' PRO . . . . . 0.623 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 18.1 Cg_exo -36.84 148.22 0.06 OUTLIER 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 124.296 3.33 . . . . 0.98 115.747 178.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -58.73 127.72 25.49 Favored 'Trans proline' 0 C--O 1.254 1.292 0 C-N-CA 123.626 2.884 . . . . 1.15 112.113 178.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 92.45 9.12 61.95 Favored Glycine 0 N--CA 1.438 -1.213 0 CA-C-N 115.942 -0.572 . . . . 0.55 112.124 -179.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1563 ' ' VAL . . . . . 0.585 ' HB ' ' O ' ' A' 1560 ' ' PRO . 2.8 t -96.09 124.55 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.339 0 CA-C-O 121.021 0.438 . . . . 1.53 111.231 179.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -101.73 -31.95 5.27 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 115.147 -0.933 . . . . 0.29 112.069 178.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -128.62 129.8 46.39 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 109.669 -0.493 . . . . 1.08 109.669 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 11.4 t -159.52 136.48 9.48 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 116.409 -0.36 . . . . 0.43 110.395 -176.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -89.71 149.89 22.56 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 121.991 -0.443 . . . . 1.3 110.763 177.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -89.05 20.81 30.9 Favored Glycine 0 N--CA 1.438 -1.227 0 CA-C-N 116.69 -0.232 . . . . 1.43 113.492 -177.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1569 ' ' GLN . . . . . 0.529 ' HG3' ' HD1' ' B' ' 19' ' ' PHE . 15.8 mm100 -68.22 -69.94 0.29 Allowed 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.579 -0.897 . . . . 3.09 108.579 173.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 6.0 p -130.09 28.49 5.02 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.28 0.562 . . . . 2.52 111.056 175.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 12.6 mmt85 60.56 48.1 7.81 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 115.157 -0.929 . . . . 3.19 110.808 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 40.2 mt -93.38 129.12 44.28 Favored 'Isoleucine or valine' 0 C--O 1.247 0.964 0 CA-C-N 115.392 -0.822 . . . . 1.51 110.039 179.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 29.0 t -80.74 148.95 29.88 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 123.605 0.762 . . . . 0.96 111.416 -178.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1574 ' ' VAL . . . . . . . . . . . . . 29.8 m -134.78 12.6 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 115.859 -0.609 . . . . 1.6 110.522 176.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 175.52 131.64 1.48 Allowed Glycine 0 N--CA 1.423 -2.214 0 C-N-CA 119.46 -1.352 . . . . 0.34 112.627 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1576 ' ' LYS . . . . . 0.415 ' HE3' ' HB2' ' A' 1576 ' ' LYS . 39.0 ttmt -74.79 147.69 41.01 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.759 -0.83 . . . . 2.68 108.759 177.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -73.93 79.26 1.65 Allowed 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 115.813 -0.63 . . . . 1.08 111.136 -178.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -89.77 146.65 24.32 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 115.657 -0.701 . . . . 1.95 110.393 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -111.15 45.96 1.13 Allowed 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.527 -1.286 . . . . 3.11 107.527 -176.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -101.42 76.78 1.72 Allowed 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 114.007 -1.451 . . . . 4.04 107.401 -176.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1581 ' ' LEU . . . . . 0.419 HD22 ' HG ' ' A' 1529 ' ' LEU . 0.4 OUTLIER -74.11 124.06 25.59 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.309 -1.367 . . . . 1.32 107.309 178.531 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -126.22 140.93 52.16 Favored 'General case' 0 C--N 1.288 -2.099 0 C-N-CA 119.92 -0.712 . . . . 3.4 111.617 177.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1583 ' ' TYR . . . . . 0.476 ' CE1' ' HA ' ' A' 1586 ' ' GLN . 72.4 t80 -108.43 123.24 48.56 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.044 -1.095 . . . . 1.26 108.044 178.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1584 ' ' VAL . . . . . 0.546 ' O ' ' HB ' ' A' 1587 ' ' VAL . 12.5 p -149.25 110.91 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-O 121.433 0.635 . . . . 1.71 111.044 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 30.7 t70 56.99 55.23 6.26 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 125.247 1.419 . . . . 1.17 111.257 -178.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1586 ' ' GLN . . . . . 0.476 ' HA ' ' CE1' ' A' 1583 ' ' TYR . 13.7 pt20 60.72 9.51 2.22 Favored 'General case' 0 N--CA 1.499 2.015 0 C-N-CA 126.864 2.066 . . . . 2.43 112.498 177.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1587 ' ' VAL . . . . . 0.546 ' HB ' ' O ' ' A' 1584 ' ' VAL . 20.5 t -102.08 127.88 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.327 0 CA-C-N 113.877 -1.51 . . . . 1.16 109.326 178.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1588 ' ' LEU . . . . . 0.942 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 2.4 mm? -92.34 117.48 29.95 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 106.605 -1.628 . . . . 1.11 106.605 178.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -119.88 133.32 55.62 Favored 'General case' 0 C--N 1.283 -2.302 0 CA-C-O 121.806 0.813 . . . . 1.74 111.86 -176.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 11.2 mt -121.25 112.21 18.34 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 106.807 -1.553 . . . . 1.4 106.807 173.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 6.1 p -101.39 125.36 55.42 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.33 0 C-N-CA 119.92 -0.712 . . . . 1.7 109.683 -178.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1592 ' ' TYR . . . . . 0.638 ' HB2' ' HB2' ' A' 1608 ' ' SER . 14.1 m-30 -107.23 136.45 47.04 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 108.345 -0.983 . . . . 1.08 108.345 178.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 13.2 ptmm? -150.47 177.41 10.03 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 108.192 -1.04 . . . . 2.21 108.192 -172.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 28.4 m-20 59.56 63.93 1.43 Allowed 'General case' 0 C--N 1.317 -0.835 0 O-C-N 124.591 1.182 . . . . 1.11 111.163 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -112.81 -126.13 4.52 Favored Glycine 0 N--CA 1.424 -2.103 0 N-CA-C 109.877 -1.289 . . . . 0.78 109.877 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1596 ' ' SER . . . . . 0.406 ' HA ' ' HD3' ' A' 1597 ' ' PRO . 49.7 m -87.4 140.51 32.07 Favored Pre-proline 0 C--N 1.295 -1.765 0 N-CA-C 109.311 -0.626 . . . . 1.36 109.311 177.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1597 ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' 1596 ' ' SER . 38.2 Cg_exo -62.51 119.95 7.27 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 122.293 1.995 . . . . 1.4 108.275 173.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1598 ' ' CYS . . . . . 0.469 ' HA ' ' HD3' ' A' 1599 ' ' PRO . 37.8 t -77.33 128.2 81.06 Favored Pre-proline 0 C--N 1.294 -1.825 0 CA-C-N 115.728 -0.669 . . . . 0.75 109.612 -173.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1599 ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' 1598 ' ' CYS . 16.9 Cg_exo -68.35 -28.46 33.05 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.46 2.773 . . . . 1.7 112.639 -176.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1600 ' ' SER . . . . . . . . . . . . . 2.0 m -59.94 -42.55 94.27 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 123.748 0.819 . . . . 2.8 111.935 -178.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1601 ' ' LYS . . . . . 0.569 ' HB3' HD22 ' A' 1604 ' ' LEU . 3.8 tppp? -131.54 105.21 7.41 Favored 'General case' 0 N--CA 1.407 -2.613 0 N-CA-C 107.207 -1.405 . . . . 3.45 107.207 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 36.8 p -51.76 121.75 7.07 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 123.531 0.52 . . . . 2.44 111.972 179.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 92.44 11.41 59.58 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.93 -0.652 . . . . 1.2 112.369 178.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1604 ' ' LEU . . . . . 0.569 HD22 ' HB3' ' A' 1601 ' ' LYS . 9.4 tp -109.56 160.25 16.41 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.913 -1.143 . . . . 2.38 107.913 179.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 29.5 t -123.51 157.48 33.48 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 109.073 -0.714 . . . . 1.96 109.073 177.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1606 ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -71.97 153.5 41.77 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 108.118 -1.067 . . . . 1.06 108.118 172.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1607 ' ' LYS . . . . . 0.554 ' HZ2' ' HB2' ' A' 1607 ' ' LYS . 0.0 OUTLIER -154.42 126.4 7.72 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.216 0.531 . . . . 2.0 110.533 -175.237 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A 1608 ' ' SER . . . . . 0.638 ' HB2' ' HB2' ' A' 1592 ' ' TYR . 16.4 m -105.07 128.58 53.41 Favored 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 115.323 -0.853 . . . . 1.61 109.129 -175.236 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 34.4 t -111.22 101.74 12.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 CA-C-O 121.268 0.556 . . . . 1.09 109.795 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1610 ' ' ILE . . . . . 0.426 ' HA ' ' HB2' ' A' 1638 ' ' PHE . 96.8 mt -91.62 117.57 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.608 0 N-CA-C 108.84 -0.8 . . . . 1.2 108.84 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 32.7 m -120.38 116.72 26.04 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.69 -0.686 . . . . 1.89 110.902 -178.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1612 ' ' PHE . . . . . 0.942 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 70.7 m-85 -90.41 122.69 33.5 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.787 -0.642 . . . . 0.28 109.386 177.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 43.7 t -113.39 140.89 31.25 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 CA-C-N 115.306 -0.861 . . . . 1.23 109.308 -176.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 35.3 t -71.91 111.23 6.98 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.162 -0.472 . . . . 0.77 111.308 -178.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1615 ' ' ARG . . . . . 0.718 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 19.8 tpt180 -124.92 87.39 55.32 Favored Pre-proline 0 CA--C 1.54 0.585 0 N-CA-C 109.331 -0.618 . . . . 2.92 109.331 174.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1616 ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -62.8 -35.06 70.41 Favored 'Trans proline' 0 N--CA 1.483 0.855 0 C-N-CA 123.128 2.552 . . . . 1.22 114.365 -173.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -79.09 -13.24 59.87 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 112.491 0.552 . . . . 3.05 112.491 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . 66.57 -168.12 0.21 Allowed 'General case' 0 C--N 1.318 -0.775 0 O-C-N 124.507 1.13 . . . . 1.55 109.266 -174.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1619 ' ' GLY . . . . . 0.418 ' C ' ' H ' ' A' 1621 ' ' THR . . . 148.42 -163.39 28.96 Favored Glycine 0 N--CA 1.413 -2.835 0 N-CA-C 110.394 -1.082 . . . . 1.16 110.394 179.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -82.65 21.42 1.0 Allowed 'Trans proline' 0 C--N 1.327 -0.574 0 C-N-CA 123.755 2.97 . . . . 1.06 111.971 -176.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1621 ' ' THR . . . . . 0.651 ' HB ' ' HB2' ' A' 1641 ' ' HIS . 18.6 p -108.08 -0.5 21.13 Favored 'General case' 0 C--N 1.282 -2.353 0 CA-C-N 113.933 -1.485 . . . . 1.58 109.899 -178.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -88.46 56.85 3.96 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 122.332 1.063 . . . . 0.88 109.258 -177.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1623 ' ' ARG . . . . . 0.546 ' O ' ' HG3' ' A' 1625 ' ' MET . 27.4 ptt180 -165.96 141.09 3.93 Favored Pre-proline 0 C--N 1.29 -1.996 0 N-CA-C 106.449 -1.685 . . . . 3.82 106.449 -178.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -53.81 104.55 0.11 Allowed 'Trans proline' 0 CA--C 1.534 0.49 0 C-N-CA 123.187 2.591 . . . . 0.77 111.901 -178.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1625 ' ' MET . . . . . 0.546 ' HG3' ' O ' ' A' 1623 ' ' ARG . 92.1 mtp -98.3 110.2 22.83 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.335 -0.987 . . . . 1.43 108.335 -176.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1626 ' ' LEU . . . . . 0.714 ' HG ' ' HE2' ' A' 1542 ' ' TYR . 0.7 OUTLIER -72.92 112.87 9.35 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 106.756 -1.572 . . . . 1.43 106.756 179.615 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A 1627 ' ' ILE . . . . . 0.537 HD12 ' HB2' ' A' 1639 ' ' SER . 31.0 mm -73.14 -57.54 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 N-CA-C 108.993 -0.743 . . . . 1.23 108.993 -178.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 49.9 m -163.99 152.39 13.19 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.598 -0.728 . . . . 1.88 109.416 -174.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1629 ' ' LEU . . . . . 0.907 HD11 ' HG ' ' A' 1636 ' ' LEU . 23.0 tp -117.35 100.71 7.86 Favored 'General case' 0 N--CA 1.426 -1.659 0 N-CA-C 107.345 -1.354 . . . . 1.92 107.345 171.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 20.6 t70 -74.23 114.23 12.34 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.47 -0.937 . . . . 1.09 108.47 178.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1631 ' ' LYS . . . . . 0.565 ' HB3' HD22 ' B' ' 53' ' ' LEU . 65.2 mttp -66.66 -20.78 66.06 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 113.759 1.022 . . . . 3.98 113.759 -175.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -88.66 -42.18 12.15 Favored 'General case' 0 CA--C 1.495 -1.143 0 CA-C-O 121.506 0.67 . . . . 2.6 111.311 -175.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 73.3 p -93.12 -8.2 43.32 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-N 115.34 -0.846 . . . . 1.35 110.792 -177.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1634 ' ' CYS . . . . . 0.479 ' SG ' HD21 ' A' 1604 ' ' LEU . 39.4 m 57.94 33.07 22.79 Favored 'General case' 0 C--N 1.361 1.084 0 C-N-CA 124.753 1.221 . . . . 0.53 110.908 175.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1635 ' ' THR . . . . . . . . . . . . . 64.3 m -104.89 130.76 52.98 Favored 'General case' 0 N--CA 1.425 -1.703 0 CA-C-N 114.219 -1.355 . . . . 1.11 109.313 -177.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1636 ' ' LEU . . . . . 0.907 ' HG ' HD11 ' A' 1629 ' ' LEU . 0.6 OUTLIER -111.43 126.47 54.98 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 106.522 -1.659 . . . . 1.56 106.522 -178.736 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A 1637 ' ' PHE . . . . . 0.438 ' HB2' ' HB ' ' A' 1627 ' ' ILE . 87.8 m-85 -102.09 138.83 38.52 Favored 'General case' 0 C--N 1.293 -1.879 0 C-N-CA 120.915 -0.314 . . . . 0.54 110.315 -178.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1638 ' ' PHE . . . . . 0.477 ' HE1' ' HB3' ' A' 1608 ' ' SER . 96.0 m-85 -131.57 134.49 46.12 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 108.671 -0.862 . . . . 0.64 108.671 -177.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1639 ' ' SER . . . . . 0.537 ' HB2' HD12 ' A' 1627 ' ' ILE . 22.6 t -116.85 152.36 34.61 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 107.542 -1.281 . . . . 1.34 107.542 175.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 2.9 t90 -153.35 109.79 3.37 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 104.535 -2.394 . . . . 0.8 104.535 178.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1641 ' ' HIS . . . . . 0.718 ' HB3' ' HB2' ' A' 1615 ' ' ARG . 33.3 m-70 -102.04 109.27 20.94 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 109.006 -0.738 . . . . 1.14 109.006 -176.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1642 ' ' THR . . . . . . . . . . . . . 3.9 t -138.05 148.93 62.14 Favored Pre-proline 0 C--N 1.302 -1.482 0 CA-C-N 115.948 -0.569 . . . . 1.11 109.768 -174.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1643 ' ' PRO . . . . . 0.453 ' HA ' ' SG ' ' A' 1646 ' ' CYS . 53.3 Cg_endo -78.97 -3.21 13.04 Favored 'Trans proline' 0 C--N 1.368 1.564 0 C-N-CA 122.034 1.823 . . . . 0.78 111.956 175.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 5.8 tp -63.96 -30.84 71.89 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.919 0.866 . . . . 1.66 108.756 176.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -89.78 13.09 15.25 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.307 -1.315 . . . . 1.29 110.455 -179.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1646 ' ' CYS . . . . . 0.453 ' SG ' ' HA ' ' A' 1643 ' ' PRO . 62.7 m -121.43 154.72 36.17 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 109.724 -0.472 . . . . 1.48 109.724 -179.006 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 42.5 tt0 . . . . . 0 C--N 1.297 -1.711 0 N-CA-C 105.031 -2.211 . . . . 3.14 105.031 168.563 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.423 -2.182 0 N-CA-C 110.407 -1.077 . . . . 2.28 110.407 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . 0.441 ' O ' ' HB2' ' B' ' 15' ' ' ASP . . . -57.01 -56.82 23.0 Favored Glycine 0 CA--C 1.511 -0.217 0 CA-C-N 115.415 -0.393 . . . . 1.94 113.863 -176.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . 0.512 ' HA ' ' CB ' ' B' ' 15' ' ' ASP . 39.3 mt-10 -84.2 -14.94 48.73 Favored 'General case' 0 CA--C 1.489 -1.378 0 CA-C-N 117.259 0.53 . . . . 2.55 110.475 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.57 -53.22 45.02 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 107.139 -1.43 . . . . 2.82 107.139 179.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 22.2 m -74.55 -22.88 17.76 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 C-N-CA 119.672 -0.811 . . . . 2.5 110.098 178.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 15' ' ' ASP . . . . . 0.512 ' CB ' ' HA ' ' B' ' 12' ' ' GLU . 15.7 t70 -64.41 -51.22 64.31 Favored 'General case' 0 C--O 1.217 -0.653 0 CA-C-N 116.008 -0.542 . . . . 2.04 110.939 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 22.6 p -65.82 -46.46 78.53 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.392 0.677 . . . . 2.31 111.004 178.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.497 HD23 HD12 ' B' ' 42' ' ' ILE . 3.6 mm? -48.99 -49.82 38.89 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.904 0.882 . . . . 2.27 111.887 171.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -79.58 -15.64 57.3 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.279 -0.873 . . . . 2.39 110.992 -179.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 19' ' ' PHE . . . . . 0.529 ' HD1' ' HG3' ' A' 1569 ' ' GLN . 88.0 t80 -64.42 -55.96 17.43 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.65 178.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.473 HG23 ' HZ1' ' A' 1631 ' ' LYS . 8.4 p -95.58 -26.56 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.357 0 C-N-CA 119.024 -1.071 . . . . 1.83 111.547 -177.275 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 89.2 m -116.36 18.72 15.11 Favored 'General case' 0 C--O 1.212 -0.869 0 N-CA-C 113.229 0.826 . . . . 1.66 113.229 -177.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -54.87 -37.59 62.6 Favored Glycine 0 N--CA 1.472 1.05 0 N-CA-C 114.813 0.685 . . . . 1.53 114.813 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -69.0 -27.2 65.48 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 123.08 0.552 . . . . 2.72 111.176 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 16.3 tpp180 -91.68 -44.72 8.85 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.038 0.447 . . . . 5.02 110.328 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 129.38 177.1 14.7 Favored Glycine 0 N--CA 1.436 -1.352 0 N-CA-C 109.359 -1.496 . . . . 1.63 109.359 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -137.92 122.36 18.36 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 117.91 0.855 . . . . 1.71 110.394 175.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -133.32 80.88 1.9 Allowed 'General case' 0 C--O 1.21 -1.003 0 N-CA-C 113.359 0.874 . . . . 3.67 113.359 -175.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 28' ' ' PHE . . . . . . . . . . . . . 32.8 p90 . . . . . 0 C--N 1.307 -1.277 0 C-N-CA 119.931 -0.707 . . . . 2.44 109.733 169.007 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . 0.453 ' C ' ' H ' ' B' ' 43' ' ' VAL . . . . . . . . 0 N--CA 1.429 -1.777 0 N-CA-C 109.423 -1.471 . . . . 2.62 109.423 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . 0.497 HD12 HD23 ' B' ' 17' ' ' LEU 0.258 13.3 pt 61.61 -21.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 C-N-CA 127.663 2.385 . . . . 2.28 115.295 178.471 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . 0.612 ' O ' ' HB2' ' B' ' 47' ' ' CYS . 2.3 p -49.78 -47.12 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.775 0 N-CA-C 113.23 0.826 . . . . 2.6 113.23 178.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -86.9 -30.95 21.0 Favored 'General case' 0 N--CA 1.427 -1.624 0 N-CA-C 109.228 -0.656 . . . . 3.36 109.228 -177.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -66.16 -23.03 66.4 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.499 -0.773 . . . . 3.08 112.027 -179.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 46' ' ' CYS . . . . . . . . . . . . . 63.7 m -114.34 2.07 14.63 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.967 0.413 . . . . 2.23 111.05 175.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 47' ' ' CYS . . . . . 0.612 ' HB2' ' O ' ' B' ' 43' ' ' VAL . 36.4 t -82.07 -50.45 9.07 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.561 0.696 . . . . 2.48 110.377 -179.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -116.16 15.75 15.98 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.408 0.623 . . . . 2.97 110.322 -176.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 22.2 mmm180 -146.64 152.74 39.37 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.065 -1.087 . . . . 4.65 108.065 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 7.3 p -94.37 131.06 40.42 Favored 'General case' 0 C--N 1.282 -2.355 0 N-CA-C 108.661 -0.866 . . . . 2.86 108.661 174.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 13.4 p -118.62 140.05 50.52 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 109.07 -0.715 . . . . 2.11 109.07 -173.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -61.71 147.03 47.41 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 107.858 -1.164 . . . . 2.67 107.858 177.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . 0.565 HD22 ' HB3' ' A' 1631 ' ' LYS . 14.8 tp -71.08 -16.79 62.6 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.103 -1.073 . . . . 2.36 108.103 -178.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . 0.405 ' O ' ' HB3' ' B' ' 57' ' ' GLU . . . -60.11 -27.19 66.82 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 114.522 -1.217 . . . . 1.92 110.702 174.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 10.5 tp -60.49 -60.75 3.31 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 115.827 -0.624 . . . . 2.35 110.392 177.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . 0.456 HD12 ' N ' ' B' ' 57' ' ' GLU . 0.8 OUTLIER -72.12 -17.43 61.98 Favored 'General case' 0 C--O 1.214 -0.806 0 CA-C-N 115.827 -0.624 . . . . 2.01 111.683 -175.932 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . 0.456 ' N ' HD12 ' B' ' 56' ' ' LEU . 9.1 tp10 -60.49 -56.72 17.97 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 109.026 -0.731 . . . . 2.27 109.026 172.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 9.0 t -80.5 -14.69 58.04 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 115.993 -0.548 . . . . 2.67 112.268 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -82.73 -60.19 2.26 Favored 'General case' 0 N--CA 1.427 -1.61 0 N-CA-C 107.824 -1.176 . . . . 3.2 107.824 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 33.6 t . . . . . 0 C--N 1.32 -0.681 0 C-N-CA 126.908 2.083 . . . . 2.3 113.482 176.095 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A 1515 ' ' ASP . . . . . 0.448 ' HA ' ' HD2' ' A' 1579 ' ' LYS . 9.8 t70 . . . . . 0 N--CA 1.442 -0.868 0 N-CA-C 106.801 -1.555 . . . . 2.9 106.801 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1516 ' ' CYS . . . . . 0.565 ' O ' ' HB2' ' A' 1529 ' ' LEU . 16.7 m 63.16 33.9 14.0 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 115.128 -0.942 . . . . 1.41 110.387 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -166.66 162.76 16.58 Favored 'General case' 0 CA--C 1.479 -1.76 0 N-CA-C 107.813 -1.181 . . . . 2.18 107.813 -177.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 9.8 p -162.0 147.23 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.945 0 O-C-N 123.68 0.613 . . . . 1.52 109.535 -174.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1519 ' ' THR . . . . . 0.41 ' HG1' HD23 ' A' 1526 ' ' LEU . 25.0 m -115.86 124.96 51.98 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 109.295 -0.632 . . . . 1.36 109.295 177.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1520 ' ' ASN . . . . . 0.425 ' OD1' HG21 ' A' 1523 ' ' THR . 24.2 t-20 -86.95 122.41 71.27 Favored Pre-proline 0 N--CA 1.439 -0.979 0 O-C-N 123.427 0.454 . . . . 2.02 109.922 177.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.72 -19.9 53.09 Favored 'Trans proline' 0 CA--C 1.533 0.466 0 C-N-CA 123.218 2.612 . . . . 1.82 114.541 -175.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 50.7 m -76.7 -39.94 50.4 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 112.157 0.429 . . . . 1.89 112.157 -177.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1523 ' ' THR . . . . . 0.682 HG22 ' HG3' ' A' 1647 ' ' GLU . 5.0 t -114.31 -6.48 12.96 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.813 0.816 . . . . 1.99 111.43 -178.076 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 64.54 30.49 78.03 Favored Glycine 0 CA--C 1.499 -0.913 0 CA-C-N 115.368 -0.833 . . . . 1.19 112.28 177.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 35.7 t-80 -98.26 125.28 43.28 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 109.644 -0.502 . . . . 1.82 109.644 -175.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1526 ' ' LEU . . . . . 0.41 HD23 ' HG1' ' A' 1519 ' ' THR . 1.7 tm? -90.88 109.15 20.36 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 108.323 -0.992 . . . . 1.3 108.323 177.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -85.69 114.53 22.74 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 110.067 -0.345 . . . . 0.8 110.067 176.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 25.5 t70 -99.46 107.74 20.02 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 109.23 -0.656 . . . . 1.17 109.23 177.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1529 ' ' LEU . . . . . 0.565 ' HB2' ' O ' ' A' 1516 ' ' CYS . 3.4 mm? -90.11 -0.13 57.45 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.718 0.771 . . . . 1.29 109.363 -178.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.24 -26.54 63.89 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.077 -0.965 . . . . 0.91 108.771 178.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 40.5 t -60.38 -26.82 66.94 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.927 0.891 . . . . 1.98 109.848 174.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 51.3 mt -98.38 0.51 45.54 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.557 -0.747 . . . . 1.34 110.984 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1533 ' ' SER . . . . . . . . . . . . . 33.6 t -72.31 174.75 6.87 Favored 'General case' 0 C--O 1.245 0.825 0 CA-C-O 121.635 0.731 . . . . 1.93 111.329 -177.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . 179.81 145.17 6.26 Favored Glycine 0 N--CA 1.425 -2.046 0 N-CA-C 109.218 -1.553 . . . . 1.1 109.218 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 -74.3 -43.36 57.09 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 120.695 0.284 . . . . 5.21 111.585 -177.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -84.14 -38.84 20.2 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.465 0.65 . . . . 1.94 109.288 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 105.19 -138.77 14.39 Favored Glycine 0 N--CA 1.409 -3.143 0 CA-C-N 115.134 -0.939 . . . . 1.08 111.476 177.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -140.33 154.14 46.66 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 107.619 -1.252 . . . . 1.07 107.619 -177.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1539 ' ' THR . . . . . 0.457 HG21 ' HB ' ' A' 1547 ' ' VAL . 1.3 m -121.31 124.99 45.92 Favored 'General case' 0 N--CA 1.426 -1.646 0 N-CA-C 108.68 -0.859 . . . . 1.46 108.68 -178.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -119.75 140.18 51.12 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 115.815 -0.629 . . . . 1.19 109.559 -177.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -82.57 113.42 20.27 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.605 -0.725 . . . . 1.37 110.509 -179.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1542 ' ' TYR . . . . . 0.537 ' CE2' ' HG ' ' A' 1626 ' ' LEU . 0.3 OUTLIER -104.36 -101.07 0.31 Allowed 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 106.019 -1.845 . . . . 1.38 106.019 177.613 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A 1543 ' ' SER . . . . . 0.439 ' H ' ' HB3' ' A' 1542 ' ' TYR . 2.1 m -68.57 168.69 12.44 Favored 'General case' 0 N--CA 1.425 -1.721 0 C-N-CA 124.137 0.975 . . . . 1.98 110.744 178.036 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 59.6 tttp -60.12 -41.49 92.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 118.694 0.679 . . . . 3.96 112.261 -176.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 33.5 t -116.78 20.68 13.83 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 109.567 -0.531 . . . . 2.81 109.567 -177.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . -131.73 104.22 0.56 Allowed Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 120.646 -0.788 . . . . 1.68 113.231 -175.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1547 ' ' VAL . . . . . 0.457 ' HB ' HG21 ' A' 1539 ' ' THR . 28.0 m -96.84 151.1 4.2 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-O 121.176 0.512 . . . . 1.38 110.109 175.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 14.2 p -105.2 138.49 29.91 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 CA-C-N 115.913 -0.585 . . . . 1.24 109.528 178.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -105.71 128.34 53.62 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 123.492 0.717 . . . . 1.29 109.678 176.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 23.5 ptm -141.8 119.46 11.75 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 115.331 -0.85 . . . . 1.47 110.695 -177.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 11.4 p -103.67 119.58 39.2 Favored 'General case' 0 C--N 1.276 -2.609 0 CA-C-N 114.883 -1.053 . . . . 1.4 110.184 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1552 ' ' ILE . . . . . 0.741 HG13 ' HZ3' ' A' 1640 ' ' TRP . 39.4 mm -83.22 119.44 32.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 108.999 -0.741 . . . . 1.11 108.999 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 28.2 t 62.02 46.39 6.55 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-O 122.053 0.93 . . . . 1.4 110.544 177.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 175.93 178.01 45.4 Favored Glycine 0 N--CA 1.407 -3.238 0 N-CA-C 109.431 -1.467 . . . . 0.4 109.431 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -106.11 154.9 20.01 Favored 'General case' 0 C--N 1.285 -2.236 0 CA-C-O 121.046 0.451 . . . . 1.62 110.415 -178.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -93.21 138.11 31.92 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 108.283 -1.006 . . . . 1.12 108.283 178.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -99.98 0.57 41.32 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 114.889 1.44 . . . . 2.49 114.889 -169.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 9.6 p30 -105.01 5.26 32.46 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 122.273 1.035 . . . . 1.38 110.134 178.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1559 ' ' CYS . . . . . 0.615 ' SG ' ' HD2' ' A' 1560 ' ' PRO . 34.5 t -132.15 152.99 81.15 Favored Pre-proline 0 C--N 1.288 -2.068 0 N-CA-C 106.211 -1.774 . . . . 1.21 106.211 178.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1560 ' ' PRO . . . . . 0.615 ' HD2' ' SG ' ' A' 1559 ' ' CYS . 49.6 Cg_exo -28.34 121.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.379 2.176 1 C-N-CA 125.575 4.184 . . . . 0.98 115.211 179.154 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A 1561 ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' 1560 ' ' PRO . 6.0 Cg_endo -44.72 130.2 9.63 Favored 'Trans proline' 0 C--N 1.357 1.01 0 C-N-CA 125.075 3.85 . . . . 1.15 114.126 -176.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 98.64 -2.15 58.64 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.974 -0.557 . . . . 0.55 113.753 178.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1563 ' ' VAL . . . . . 0.411 HG21 ' HA ' ' A' 1573 ' ' SER . 8.7 p -93.8 140.38 16.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 O-C-N 121.93 -0.747 . . . . 1.53 110.637 -177.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -102.34 -30.56 5.59 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 121.213 -0.518 . . . . 0.29 112.869 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -124.32 127.89 48.3 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 109.403 -0.591 . . . . 1.08 109.403 178.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1566 ' ' CYS . . . . . 0.471 ' SG ' ' HA ' ' A' 1571 ' ' ARG . 43.5 t -155.04 142.75 19.85 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 110.254 -0.276 . . . . 0.43 110.254 -178.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1567 ' ' PHE . . . . . 0.509 ' CE2' HG12 ' A' 1574 ' ' VAL . 54.9 m-85 -85.6 130.53 34.55 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 107.796 -1.187 . . . . 1.3 107.796 172.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -61.14 -31.16 75.82 Favored Glycine 0 C--N 1.35 1.314 0 N-CA-C 114.545 0.578 . . . . 1.43 114.545 -171.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1569 ' ' GLN . . . . . 0.459 ' HB3' ' OD2' ' B' ' 15' ' ' ASP . 11.3 mm100 -69.54 -54.56 13.54 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.594 0.711 . . . . 3.09 111.986 177.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1570 ' ' THR . . . . . 0.657 ' HB ' HG13 ' A' 1572 ' ' ILE . 58.3 p -81.47 -29.11 33.85 Favored 'General case' 0 N--CA 1.421 -1.878 0 N-CA-C 114.382 1.253 . . . . 2.52 114.382 -167.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1571 ' ' ARG . . . . . 0.471 ' HA ' ' SG ' ' A' 1566 ' ' CYS . 3.1 mpt_? 59.35 28.94 18.42 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.189 0.519 . . . . 3.19 110.691 -172.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1572 ' ' ILE . . . . . 0.657 HG13 ' HB ' ' A' 1570 ' ' THR . 19.2 mt -94.58 129.15 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.832 0 N-CA-C 107.89 -1.152 . . . . 1.51 107.89 177.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1573 ' ' SER . . . . . 0.411 ' HA ' HG21 ' A' 1563 ' ' VAL . 15.1 t -69.27 113.8 6.94 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.327 -0.851 . . . . 0.96 109.68 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1574 ' ' VAL . . . . . 0.802 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 19.7 m -110.38 17.92 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 CA-C-O 121.893 0.854 . . . . 1.6 110.8 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 161.46 115.64 0.37 Allowed Glycine 0 N--CA 1.427 -1.957 0 CA-C-N 114.779 -1.1 . . . . 0.34 111.042 177.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -73.66 146.39 44.57 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.881 -0.785 . . . . 2.68 108.881 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -71.36 90.52 0.95 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.028 0.442 . . . . 1.08 111.585 -178.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -103.37 170.24 8.07 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.08 -1.081 . . . . 1.95 108.08 175.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1579 ' ' LYS . . . . . 0.448 ' HD2' ' HA ' ' A' 1515 ' ' ASP . 15.4 pttm -130.11 40.46 3.54 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.755 0.788 . . . . 3.11 110.698 -178.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 75.0 ttt180 -89.82 100.49 13.29 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 113.561 -1.654 . . . . 4.04 107.933 -174.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1581 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.76 126.55 48.64 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.713 -0.676 . . . . 1.32 109.425 -174.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -125.2 138.95 54.12 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 120.532 -0.467 . . . . 3.4 110.914 176.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1583 ' ' TYR . . . . . 0.467 ' CE1' ' HA ' ' A' 1586 ' ' GLN . 88.3 t80 -106.25 108.41 19.91 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.724 -0.843 . . . . 1.26 108.724 178.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1584 ' ' VAL . . . . . 0.614 ' O ' ' HB ' ' A' 1587 ' ' VAL . 14.2 m -126.98 93.49 2.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 CA-C-O 121.48 0.657 . . . . 1.71 112.108 -178.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 36.6 t70 57.89 64.37 1.55 Allowed 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.853 0.861 . . . . 1.17 110.691 179.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1586 ' ' GLN . . . . . 0.467 ' HA ' ' CE1' ' A' 1583 ' ' TYR 0.272 4.5 pt20 58.72 20.55 7.95 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 126.45 1.9 . . . . 2.43 112.384 178.527 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A 1587 ' ' VAL . . . . . 0.614 ' HB ' ' O ' ' A' 1584 ' ' VAL . 22.5 t -107.24 120.26 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.493 0 CA-C-N 114.038 -1.437 . . . . 1.16 107.751 174.11 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1588 ' ' LEU . . . . . 0.833 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 3.3 mm? -95.62 109.03 21.34 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 105.824 -1.917 . . . . 1.11 105.824 176.014 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -111.02 116.81 31.81 Favored 'General case' 0 C--N 1.266 -3.056 0 C-N-CA 119.962 -0.695 . . . . 1.74 110.961 -175.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.87 99.48 9.69 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 104.888 -2.264 . . . . 1.4 104.888 176.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 8.9 p -89.41 127.01 42.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 C-N-CA 119.64 -0.824 . . . . 1.7 112.308 -174.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1592 ' ' TYR . . . . . 0.64 ' HB2' ' HB3' ' A' 1608 ' ' SER . 12.8 m-30 -106.95 142.75 36.07 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.443 -1.317 . . . . 1.08 107.443 173.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 10.6 ptmm? -158.08 -172.24 3.83 Favored 'General case' 0 C--N 1.283 -2.308 0 N-CA-C 106.043 -1.836 . . . . 2.21 106.043 -175.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 36.4 m-20 66.46 45.56 2.1 Favored 'General case' 0 C--O 1.239 0.503 0 O-C-N 124.006 0.816 . . . . 1.11 109.116 177.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -86.76 -175.06 49.39 Favored Glycine 0 N--CA 1.435 -1.379 0 CA-C-N 114.892 -1.049 . . . . 0.78 111.582 -178.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1596 ' ' SER . . . . . 0.736 ' HB2' ' HD2' ' A' 1597 ' ' PRO . 62.9 p -95.31 173.86 4.02 Favored Pre-proline 0 C--N 1.291 -1.968 0 CA-C-O 118.672 -0.68 . . . . 1.36 109.457 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1597 ' ' PRO . . . . . 0.736 ' HD2' ' HB2' ' A' 1596 ' ' SER . 10.3 Cg_endo -50.85 127.11 20.29 Favored 'Trans proline' 0 C--N 1.361 1.197 0 C-N-CA 122.785 2.323 . . . . 1.4 113.676 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1598 ' ' CYS . . . . . 0.596 ' HA ' ' CE1' ' A' 1606 ' ' TYR . 49.5 t -81.16 118.74 73.6 Favored Pre-proline 0 C--N 1.284 -2.269 0 CA-C-N 113.718 -1.583 . . . . 0.75 107.888 178.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1599 ' ' PRO . . . . . 0.635 ' HD2' ' HE1' ' A' 1606 ' ' TYR . 6.9 Cg_endo -52.12 -21.16 12.13 Favored 'Trans proline' 0 C--N 1.366 1.483 0 C-N-CA 124.357 3.371 . . . . 1.7 114.362 -178.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1600 ' ' SER . . . . . . . . . . . . . 7.8 m -55.72 -45.63 77.91 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 123.815 0.846 . . . . 2.8 110.438 177.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1601 ' ' LYS . . . . . 0.465 ' HE2' HD13 ' A' 1604 ' ' LEU . 36.5 ttpt -162.84 127.43 3.08 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 108.395 -0.965 . . . . 3.45 108.395 178.242 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 14.2 p -58.36 132.02 52.4 Favored 'General case' 0 N--CA 1.415 -2.191 0 N-CA-C 109.26 -0.644 . . . . 2.44 109.26 177.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 106.54 -17.38 39.74 Favored Glycine 0 C--N 1.303 -1.265 0 C-N-CA 121.329 -0.463 . . . . 1.2 112.354 -176.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1604 ' ' LEU . . . . . 0.481 ' HB2' ' HB3' ' A' 1598 ' ' CYS . 60.2 mt -91.83 152.06 20.29 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 107.254 -1.387 . . . . 2.38 107.254 173.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 37.9 m -135.87 142.93 44.81 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 108.628 -0.878 . . . . 1.96 108.628 179.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1606 ' ' TYR . . . . . 0.802 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 71.5 m-85 -73.22 158.95 34.22 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 112.141 0.423 . . . . 1.06 112.141 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -147.89 152.72 38.07 Favored 'General case' 0 N--CA 1.421 -1.914 0 N-CA-C 106.38 -1.711 . . . . 2.0 106.38 172.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1608 ' ' SER . . . . . 0.64 ' HB3' ' HB2' ' A' 1592 ' ' TYR . 28.0 t -122.5 123.08 40.45 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 109.038 -0.727 . . . . 1.61 109.038 -174.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 30.8 t -105.09 98.1 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.748 0 N-CA-C 108.846 -0.798 . . . . 1.09 108.846 179.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 84.1 mt -89.63 106.11 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.787 0 N-CA-C 108.1 -1.074 . . . . 1.2 108.1 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 17.0 m -104.54 114.48 28.73 Favored 'General case' 0 N--CA 1.421 -1.917 0 CA-C-N 115.007 -0.997 . . . . 1.89 111.01 -175.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1612 ' ' PHE . . . . . 0.833 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 69.3 m-85 -91.33 108.41 19.87 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.054 -0.721 . . . . 0.28 109.054 176.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1613 ' ' VAL . . . . . 0.857 ' HB ' ' HB3' ' A' 1641 ' ' HIS . 33.5 t -103.96 144.16 14.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 CA-C-N 114.774 -1.103 . . . . 1.23 109.233 -176.103 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 39.1 t -69.88 108.31 3.93 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 123.809 0.844 . . . . 0.77 110.982 179.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1615 ' ' ARG . . . . . 0.553 ' HB2' ' HB2' ' A' 1641 ' ' HIS . 25.3 tpt180 -135.69 91.69 17.8 Favored Pre-proline 0 N--CA 1.435 -1.214 0 C-N-CA 119.584 -0.846 . . . . 2.92 109.671 173.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1616 ' ' PRO . . . . . 0.893 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 19.2 Cg_exo -65.7 -22.21 57.72 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.392 2.061 . . . . 1.22 113.535 -176.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -57.96 -38.48 76.1 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 123.94 0.896 . . . . 3.05 112.221 179.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . 64.93 -172.63 0.18 Allowed 'General case' 0 C--N 1.358 0.946 0 O-C-N 123.916 0.76 . . . . 1.55 109.61 -176.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . 119.09 -159.5 14.5 Favored Glycine 0 N--CA 1.426 -2.018 0 C-N-CA 120.222 -0.989 . . . . 1.16 112.632 177.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 94.9 Cg_exo -56.38 -11.73 6.84 Favored 'Trans proline' 0 N--CA 1.5 1.911 0 C-N-CA 124.893 3.728 . . . . 1.06 114.211 178.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1621 ' ' THR . . . . . . . . . . . . . 19.0 p -87.6 -9.37 54.52 Favored 'General case' 0 C--N 1.282 -2.364 0 C-N-CA 124.396 1.079 . . . . 1.58 110.869 -179.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 49.2 t30 -88.02 58.36 4.77 Favored 'General case' 0 C--O 1.253 1.266 0 CA-C-O 122.729 1.252 . . . . 0.88 110.16 -178.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1623 ' ' ARG . . . . . 0.43 ' HA ' ' HD3' ' A' 1624 ' ' PRO . 34.7 ptt180 -159.82 138.81 7.97 Favored Pre-proline 0 C--N 1.303 -1.415 0 CA-C-N 113.839 -1.528 . . . . 3.82 107.183 178.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1624 ' ' PRO . . . . . 0.432 ' HG3' ' CE3' ' A' 1640 ' ' TRP . 7.1 Cg_exo -69.43 111.23 2.69 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.333 2.022 . . . . 0.77 111.172 -178.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 74.7 mtm -114.0 147.83 37.96 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 116.415 -0.357 . . . . 1.43 110.337 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1626 ' ' LEU . . . . . 0.537 ' HG ' ' CE2' ' A' 1542 ' ' TYR . 0.3 OUTLIER -85.89 113.95 22.43 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 107.954 -1.128 . . . . 1.43 107.954 -176.56 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 42.0 mm -76.36 -54.85 12.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 N-CA-C 109.262 -0.644 . . . . 1.23 109.262 -177.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 70.5 m -163.83 152.27 13.4 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.468 -0.938 . . . . 1.88 108.468 -173.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1629 ' ' LEU . . . . . 0.573 ' HG ' ' CD2' ' A' 1636 ' ' LEU . 2.5 tt -114.25 110.91 20.67 Favored 'General case' 0 N--CA 1.416 -2.172 0 N-CA-C 106.531 -1.655 . . . . 1.92 106.531 179.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 14.8 t70 -77.81 95.35 4.68 Favored 'General case' 0 CA--C 1.494 -1.198 0 N-CA-C 106.919 -1.512 . . . . 1.09 106.919 173.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1631 ' ' LYS . . . . . 0.608 ' HD3' ' H ' ' A' 1631 ' ' LYS . 0.0 OUTLIER -75.96 2.86 11.48 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 114.419 1.266 . . . . 3.98 114.419 -172.768 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -88.36 -41.93 12.52 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.709 -0.848 . . . . 2.6 108.709 175.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 67.6 p -100.48 -15.62 17.82 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-N 115.118 -0.946 . . . . 1.35 111.065 -177.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 83.3 m 70.25 35.05 2.18 Favored 'General case' 0 C--N 1.351 0.662 0 C-N-CA 125.053 1.341 . . . . 0.53 110.891 -179.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1635 ' ' THR . . . . . . . . . . . . . 90.0 m -90.96 121.87 33.16 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 113.727 -1.579 . . . . 1.11 109.088 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1636 ' ' LEU . . . . . 0.573 ' CD2' ' HG ' ' A' 1629 ' ' LEU . 26.2 mt -98.58 130.7 45.13 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 109.483 -0.562 . . . . 1.56 109.483 178.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -101.77 116.48 32.82 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 116.076 -0.511 . . . . 0.54 111.137 177.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -114.19 140.73 48.3 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 109.529 -0.545 . . . . 0.64 109.529 176.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1639 ' ' SER . . . . . . . . . . . . . 48.0 t -119.86 129.16 54.26 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 108.512 -0.921 . . . . 1.34 108.512 173.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1640 ' ' TRP . . . . . 0.741 ' HZ3' HG13 ' A' 1552 ' ' ILE . 6.3 t90 -133.74 93.5 3.13 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 104.217 -2.512 . . . . 0.8 104.217 173.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1641 ' ' HIS . . . . . 0.857 ' HB3' ' HB ' ' A' 1613 ' ' VAL 0.317 0.1 OUTLIER -101.64 95.17 6.27 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-O 122.474 1.13 . . . . 1.14 113.085 -175.612 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A 1642 ' ' THR . . . . . . . . . . . . . 3.1 t -114.77 153.02 46.91 Favored Pre-proline 0 C--N 1.299 -1.609 0 CA-C-N 112.542 -2.117 . . . . 1.11 108.583 -177.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1643 ' ' PRO . . . . . 0.893 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 49.7 Cg_endo -68.94 -4.89 14.37 Favored 'Trans proline' 0 C--N 1.369 1.65 0 C-N-CA 123.269 2.646 . . . . 0.78 113.366 -178.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 8.2 tt -65.35 -30.29 71.11 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.969 -0.382 . . . . 1.66 109.969 176.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -84.2 21.7 1.35 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.377 0.608 . . . . 1.29 111.513 -175.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 33.3 m -121.22 136.52 54.96 Favored 'General case' 0 N--CA 1.415 -2.193 0 N-CA-C 107.629 -1.248 . . . . 1.48 107.629 178.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1647 ' ' GLU . . . . . 0.682 ' HG3' HG22 ' A' 1523 ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.301 -1.531 0 N-CA-C 109.529 -0.545 . . . . 3.14 109.529 177.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.225 0 N-CA-C 112.856 -0.098 . . . . 2.28 112.856 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.94 -36.88 92.88 Favored Glycine 0 C--O 1.22 -0.765 0 CA-C-N 115.557 -0.322 . . . . 1.94 112.924 -177.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -68.18 -28.34 67.18 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 111.915 0.339 . . . . 2.55 111.915 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.65 -53.54 13.27 Favored 'General case' 0 N--CA 1.42 -1.959 0 N-CA-C 109.486 -0.561 . . . . 2.82 109.486 -177.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 3.8 p -63.58 -35.42 72.64 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-N 115.561 -0.745 . . . . 2.5 111.133 177.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 15' ' ' ASP . . . . . 0.459 ' OD2' ' HB3' ' A' 1569 ' ' GLN . 14.8 t0 -72.32 -37.07 69.01 Favored 'General case' 0 CA--C 1.557 1.248 0 N-CA-C 112.209 0.448 . . . . 2.04 112.209 -179.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 14.9 t -68.78 -37.7 79.49 Favored 'General case' 0 C--O 1.254 1.316 0 CA-C-N 119.079 0.854 . . . . 2.31 110.117 175.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.598 HD21 HD13 ' B' ' 42' ' ' ILE . 3.2 mm? -49.37 -52.66 26.82 Favored 'General case' 0 C--N 1.355 0.823 0 CA-C-O 121.358 0.599 . . . . 2.27 110.197 168.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 18' ' ' GLN . . . . . 0.401 ' HB2' ' CD2' ' B' ' 26' ' ' PHE . 28.5 tt0 -66.97 -23.8 65.98 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 123.659 0.784 . . . . 2.39 112.385 -177.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -62.9 -62.85 1.44 Allowed 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 116.467 -0.333 . . . . 1.0 110.938 175.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 14.4 p -91.32 -15.92 8.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 C-N-CA 117.609 -1.636 . . . . 1.83 112.791 -175.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 59.1 m -99.8 10.17 41.77 Favored 'General case' 0 C--O 1.206 -1.227 0 O-C-N 121.099 -1.0 . . . . 1.66 111.318 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -53.42 -28.36 35.85 Favored Glycine 0 CA--C 1.54 1.617 0 N-CA-C 116.632 1.413 . . . . 1.53 116.632 -178.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -72.56 -49.0 35.53 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 118.305 1.053 . . . . 2.72 111.891 -179.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.15 -38.58 15.23 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.37 0.605 . . . . 5.02 109.803 -179.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 124.23 164.52 11.98 Favored Glycine 0 N--CA 1.428 -1.892 0 N-CA-C 107.62 -2.192 . . . . 1.63 107.62 -174.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . 0.415 ' CB ' ' HB3' ' B' ' 17' ' ' LEU . 17.4 p90 -95.69 129.79 42.78 Favored 'General case' 0 C--N 1.286 -2.177 0 CA-C-N 118.779 1.29 . . . . 1.71 110.067 179.012 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -129.98 59.31 1.63 Allowed 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 112.939 0.718 . . . . 3.67 112.939 -174.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 28' ' ' PHE . . . . . 0.634 ' HA ' ' HE2' ' B' ' 59' ' ' TYR . 32.6 p90 . . . . . 0 C--N 1.313 -0.996 0 C-N-CA 119.048 -1.061 . . . . 2.44 108.485 173.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . 0.455 ' C ' ' H ' ' B' ' 43' ' ' VAL . . . . . . . . 0 CA--C 1.476 -2.401 0 N-CA-C 109.723 -1.351 . . . . 2.62 109.723 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . 0.598 HD13 HD21 ' B' ' 17' ' ' LEU . 16.1 pt 58.1 -26.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 C-N-CA 127.346 2.258 . . . . 2.28 115.74 179.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . 0.455 ' H ' ' C ' ' B' ' 41' ' ' GLY . 2.7 p -48.12 -46.95 13.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 114.71 1.374 . . . . 2.6 114.71 -177.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -87.79 -29.75 20.76 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.913 -1.143 . . . . 3.36 107.913 -174.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . 0.545 ' O ' ' HB2' ' B' ' 49' ' ' ARG . 30.2 mt-10 -75.82 -10.06 59.12 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 113.963 -1.471 . . . . 3.08 112.179 -177.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 46' ' ' CYS . . . . . . . . . . . . . 21.5 t -119.42 -21.92 7.25 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-O 121.056 0.455 . . . . 2.23 110.285 176.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 49.7 t -74.28 -47.62 33.73 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.333 -0.547 . . . . 2.48 111.433 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -119.09 7.61 11.4 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 120.1 -0.64 . . . . 2.97 110.987 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . 0.545 ' HB2' ' O ' ' B' ' 45' ' ' GLU . 36.0 mmt180 -128.0 156.68 42.33 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.301 -1.37 . . . . 4.65 107.301 -177.123 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 14.0 p -78.3 110.75 13.61 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 109.855 -0.424 . . . . 2.86 109.855 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 3.0 p -100.87 126.75 47.5 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 115.59 -0.732 . . . . 2.11 110.365 -177.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -101.8 135.62 43.04 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.772 -1.195 . . . . 2.67 107.772 178.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . 0.425 HD21 ' HG3' ' A' 1631 ' ' LYS . 56.9 tp -36.47 -37.91 0.14 Allowed 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 126.613 1.965 . . . . 2.36 114.834 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.95 -29.97 63.64 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 123.483 0.49 . . . . 1.92 111.374 -177.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 53.1 tp -68.58 -57.0 6.39 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-N 115.863 -0.608 . . . . 2.35 110.048 177.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 1.9 pp -71.28 -27.18 63.24 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 116.496 -0.32 . . . . 2.01 111.559 -174.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -71.95 -46.11 58.68 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 111.835 0.309 . . . . 2.27 111.835 178.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 11.2 t -77.66 -30.09 51.93 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 118.619 -1.233 . . . . 2.67 111.601 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 59' ' ' TYR . . . . . 0.634 ' HE2' ' HA ' ' B' ' 28' ' ' PHE . 11.1 t80 -70.66 -64.51 0.88 Allowed 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 106.278 -1.749 . . . . 3.2 106.278 177.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 54.1 t . . . . . 0 N--CA 1.477 0.886 0 C-N-CA 127.208 2.203 . . . . 2.3 115.762 173.725 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 16.4 t70 . . . . . 0 CA--C 1.531 0.225 0 CA-C-O 120.546 0.213 . . . . 2.9 111.331 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A 1516 ' ' CYS . . . . . 0.616 ' SG ' ' HB2' ' A' 1529 ' ' LEU . 30.8 t -138.83 55.59 1.72 Allowed 'General case' 0 C--O 1.25 1.113 0 N-CA-C 108.312 -0.995 . . . . 1.41 108.312 -179.06 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -169.06 149.04 4.18 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 115.565 -0.743 . . . . 2.18 109.06 -174.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1518 ' ' VAL . . . . . 0.422 ' CG2' HD12 ' A' 1581 ' ' LEU . 4.8 m -149.43 142.37 17.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 C-N-CA 124.227 1.011 . . . . 1.52 110.585 178.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1519 ' ' THR . . . . . . . . . . . . . 31.9 m -106.16 137.35 44.25 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.915 -0.402 . . . . 1.36 109.915 177.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 52.6 t-20 -82.68 110.33 21.72 Favored Pre-proline 0 C--O 1.245 0.829 0 N-CA-C 107.009 -1.478 . . . . 2.02 107.009 174.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.23 -14.69 43.94 Favored 'Trans proline' 0 N--CA 1.474 0.376 0 C-N-CA 123.173 2.582 . . . . 1.82 113.148 -174.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 28.3 m -75.04 -33.87 61.81 Favored 'General case' 0 N--CA 1.425 -1.702 0 CA-C-N 116.307 -0.406 . . . . 1.89 111.844 -179.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1523 ' ' THR . . . . . . . . . . . . . 12.5 t -136.19 -5.3 2.1 Favored 'General case' 0 CA--C 1.564 1.484 0 C-N-CA 118.132 -1.427 . . . . 1.99 113.418 -175.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 85.75 8.31 80.03 Favored Glycine 0 CA--C 1.494 -1.252 0 C-N-CA 120.632 -0.794 . . . . 1.19 114.048 176.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 51.9 t-80 -76.27 123.27 25.64 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.706 -0.85 . . . . 1.82 108.706 177.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -103.2 116.91 33.37 Favored 'General case' 0 C--N 1.268 -2.965 0 CA-C-N 114.796 -1.093 . . . . 1.3 109.008 -176.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -88.86 118.38 28.53 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 109.989 -0.375 . . . . 0.8 109.989 175.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 7.7 t70 -110.72 126.25 54.37 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.111 -1.44 . . . . 1.17 107.111 174.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1529 ' ' LEU . . . . . 0.616 ' HB2' ' SG ' ' A' 1516 ' ' CYS . 2.9 mm? -103.21 20.47 17.65 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 111.88 0.326 . . . . 1.29 111.88 -174.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 6.9 m -66.74 -23.84 66.15 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 113.369 0.878 . . . . 0.91 113.369 -175.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 33.6 t -72.29 -30.1 64.49 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-O 121.534 0.683 . . . . 1.98 109.196 178.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1532 ' ' LEU . . . . . 0.484 HD13 HD13 ' A' 1529 ' ' LEU . 59.9 mt -88.9 -18.31 27.82 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.387 -0.824 . . . . 1.34 109.792 -179.294 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1533 ' ' SER . . . . . 0.531 ' HA ' ' HB ' ' A' 1552 ' ' ILE . 34.8 t -75.46 171.57 14.02 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.61 -0.723 . . . . 1.93 110.288 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . 159.94 150.37 5.83 Favored Glycine 0 N--CA 1.424 -2.159 0 N-CA-C 110.106 -1.197 . . . . 1.1 110.106 -178.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 35.6 ttp180 -92.02 -13.69 30.56 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 121.475 0.655 . . . . 5.21 109.843 -179.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -79.66 -39.03 32.33 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 121.364 0.602 . . . . 1.94 109.977 178.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 90.62 -171.89 36.82 Favored Glycine 0 N--CA 1.424 -2.118 0 CA-C-N 115.054 -0.975 . . . . 1.08 111.136 176.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -132.84 146.57 51.93 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 108.281 -1.007 . . . . 1.07 108.281 178.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 31.1 p -102.43 123.46 46.25 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 123.491 0.494 . . . . 1.46 111.77 -178.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1540 ' ' ALA . . . . . 0.402 ' HB2' ' CG1' ' A' 1548 ' ' VAL . . . -115.29 135.15 54.46 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.255 -0.646 . . . . 1.19 109.255 177.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -70.59 134.58 47.75 Favored 'General case' 0 C--O 1.249 1.032 0 CA-C-N 115.567 -0.742 . . . . 1.37 110.901 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1542 ' ' TYR . . . . . 0.609 ' CE2' ' HG ' ' A' 1626 ' ' LEU . 7.1 t80 -133.24 -100.84 0.26 Allowed 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.787 -0.82 . . . . 1.38 108.787 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1543 ' ' SER . . . . . . . . . . . . . 13.6 t -92.63 179.95 5.35 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 109.763 -0.458 . . . . 1.98 109.763 -176.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 20.2 pttp -75.21 -23.65 57.66 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 120.976 0.417 . . . . 3.96 111.416 -177.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1545 ' ' SER . . . . . 0.627 ' HB2' ' HG2' ' A' 1569 ' ' GLN . 5.2 p -65.49 -36.94 85.36 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 124.325 1.05 . . . . 2.81 112.751 -176.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 178.73 -167.1 37.27 Favored Glycine 0 N--CA 1.425 -2.098 0 C-N-CA 120.874 -0.679 . . . . 1.68 112.216 -178.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 27.2 m -113.58 166.46 7.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 109.82 -0.437 . . . . 1.38 109.82 -176.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1548 ' ' VAL . . . . . 0.402 ' CG1' ' HB2' ' A' 1540 ' ' ALA . 13.1 p -102.26 131.0 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 N-CA-C 108.911 -0.774 . . . . 1.24 108.911 177.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -92.16 134.84 34.48 Favored 'General case' 0 CA--C 1.481 -1.673 0 CA-C-N 115.504 -0.771 . . . . 1.29 109.223 178.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 24.0 ptm -146.64 116.06 7.08 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 115.478 -0.783 . . . . 1.47 111.057 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 8.5 p -106.39 124.13 49.12 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-N 115.145 -0.934 . . . . 1.4 110.214 178.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1552 ' ' ILE . . . . . 0.531 ' HB ' ' HA ' ' A' 1533 ' ' SER . 43.5 mm -81.92 119.1 30.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 109.99 -0.374 . . . . 1.11 109.99 -179.009 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 57.8 m 60.9 41.94 13.69 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 123.937 0.773 . . . . 1.4 111.366 176.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . -178.0 174.23 46.63 Favored Glycine 0 N--CA 1.422 -2.274 0 N-CA-C 109.961 -1.256 . . . . 0.4 109.961 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -100.16 150.8 22.14 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 120.856 0.36 . . . . 1.62 110.405 -179.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -98.81 139.28 34.72 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.0 -0.741 . . . . 1.12 109.0 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -85.12 -3.63 58.87 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 113.108 0.781 . . . . 2.49 113.108 -172.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -93.67 1.73 56.52 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 120.547 -0.461 . . . . 1.38 110.816 -176.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1559 ' ' CYS . . . . . 0.74 ' SG ' ' HD2' ' A' 1560 ' ' PRO . 13.3 t -137.59 166.34 27.27 Favored Pre-proline 0 C--N 1.3 -1.562 0 N-CA-C 106.542 -1.651 . . . . 1.21 106.542 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1560 ' ' PRO . . . . . 0.74 ' HD2' ' SG ' ' A' 1559 ' ' CYS . 16.3 Cg_exo -33.83 145.3 0.04 OUTLIER 'Trans proline' 0 C--N 1.379 2.173 0 C-N-CA 124.542 3.494 . . . . 0.98 114.627 173.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1561 ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' 1560 ' ' PRO . 43.0 Cg_exo -58.94 127.44 24.31 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 123.223 2.615 . . . . 1.15 112.841 -177.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 94.5 13.21 54.56 Favored Glycine 0 C--N 1.311 -0.812 0 N-CA-C 115.166 0.826 . . . . 0.55 115.166 176.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1563 ' ' VAL . . . . . 0.92 HG22 ' HB2' ' A' 1573 ' ' SER . 9.9 p -109.08 140.19 28.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-N 118.242 1.021 . . . . 1.53 110.95 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -100.7 -32.98 5.21 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 120.984 -0.627 . . . . 0.29 113.272 -177.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -123.35 128.76 50.36 Favored 'General case' 0 C--O 1.244 0.806 0 N-CA-C 109.569 -0.53 . . . . 1.08 109.569 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 50.6 t -163.48 144.82 9.33 Favored 'General case' 0 C--O 1.206 -1.194 0 C-N-CA 121.249 -0.18 . . . . 0.43 110.889 -175.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -85.72 143.61 28.26 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 118.05 0.386 . . . . 1.3 110.178 174.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -88.89 8.16 80.35 Favored Glycine 0 N--CA 1.443 -0.861 0 N-CA-C 116.239 1.256 . . . . 1.43 116.239 -170.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1569 ' ' GLN . . . . . 0.627 ' HG2' ' HB2' ' A' 1545 ' ' SER . 0.4 OUTLIER -78.48 -67.39 0.74 Allowed 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 118.328 1.064 . . . . 3.09 110.319 177.612 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 15.2 p -111.99 7.45 19.86 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.817 -1.083 . . . . 2.52 113.568 -175.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1571 ' ' ARG . . . . . 0.459 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 0.0 OUTLIER 64.68 44.34 3.87 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 122.964 0.506 . . . . 3.19 111.757 -178.91 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 42.6 mt -83.06 112.39 20.67 Favored 'Isoleucine or valine' 0 C--O 1.246 0.902 0 N-CA-C 107.973 -1.121 . . . . 1.51 107.973 174.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1573 ' ' SER . . . . . 0.92 ' HB2' HG22 ' A' 1563 ' ' VAL . 91.0 p -80.14 134.57 36.17 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.557 -0.747 . . . . 0.96 111.416 -174.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1574 ' ' VAL . . . . . 0.493 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 33.2 m -118.11 9.11 6.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 O-C-N 121.32 -0.862 . . . . 1.6 112.42 -178.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 175.33 123.88 0.78 Allowed Glycine 0 N--CA 1.433 -1.515 0 C-N-CA 120.331 -0.938 . . . . 0.34 111.403 176.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -69.24 153.34 43.82 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.043 -0.725 . . . . 2.68 109.043 -178.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -74.46 88.61 2.11 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-O 121.115 0.483 . . . . 1.08 110.258 -177.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -97.07 160.05 14.56 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 115.106 -0.952 . . . . 1.95 110.464 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 24.2 pttm -120.51 45.29 2.25 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 122.878 1.323 . . . . 3.11 108.363 -178.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 24.0 ttm180 -103.6 76.36 1.39 Allowed 'General case' 0 N--CA 1.412 -2.331 0 CA-C-N 113.956 -1.475 . . . . 4.04 108.54 -173.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1581 ' ' LEU . . . . . 0.44 HD22 ' HG ' ' A' 1590 ' ' LEU . 0.2 OUTLIER -82.35 124.7 30.23 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 114.146 -1.388 . . . . 1.32 107.534 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A 1582 ' ' ARG . . . . . 0.473 ' HB2' ' HB3' ' A' 1589 ' ' GLN . 64.3 mtp180 -122.56 143.4 49.76 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 116.768 -0.196 . . . . 3.4 110.599 176.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1583 ' ' TYR . . . . . 0.441 ' HE1' ' HA ' ' A' 1586 ' ' GLN . 74.9 t80 -113.35 107.57 16.04 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 109.323 -0.621 . . . . 1.26 109.323 177.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1584 ' ' VAL . . . . . 0.618 ' O ' ' HB ' ' A' 1587 ' ' VAL . 9.7 m -121.63 90.01 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 CA-C-N 115.722 -0.672 . . . . 1.71 111.153 -177.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 31.1 t70 53.51 72.63 0.42 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.053 0.941 . . . . 1.17 111.761 178.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1586 ' ' GLN . . . . . 0.441 ' HA ' ' HE1' ' A' 1583 ' ' TYR . 4.2 pt20 57.21 26.39 12.17 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 125.818 1.647 . . . . 2.43 111.296 176.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1587 ' ' VAL . . . . . 0.618 ' HB ' ' O ' ' A' 1584 ' ' VAL . 24.6 t -124.23 120.88 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.32 0 CA-C-N 113.769 -1.56 . . . . 1.16 108.117 175.341 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1588 ' ' LEU . . . . . 0.807 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 2.9 mm? -95.05 117.36 30.04 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.09 -1.448 . . . . 1.11 107.09 178.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1589 ' ' GLN . . . . . 0.473 ' HB3' ' HB2' ' A' 1582 ' ' ARG . 35.3 tt0 -106.56 127.42 53.31 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 116.02 -0.536 . . . . 1.74 111.454 -175.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1590 ' ' LEU . . . . . 0.44 ' HG ' HD22 ' A' 1581 ' ' LEU . 11.2 mt -121.49 101.6 7.72 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 107.463 -1.31 . . . . 1.4 107.463 170.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 6.4 p -96.92 124.68 49.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 CA-C-O 121.494 0.664 . . . . 1.7 109.966 -178.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1592 ' ' TYR . . . . . 0.453 ' HB2' ' HB3' ' A' 1608 ' ' SER . 14.4 m-30 -115.55 105.05 12.35 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.269 -1.012 . . . . 1.08 108.269 -179.053 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 20.7 pttp -115.27 -178.94 3.49 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 109.759 -0.46 . . . . 2.21 109.759 -179.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 36.2 m-20 65.16 42.42 4.06 Favored 'General case' 0 C--O 1.247 0.962 0 O-C-N 124.28 0.987 . . . . 1.11 110.405 177.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -75.88 -145.64 1.57 Allowed Glycine 0 N--CA 1.438 -1.217 0 CA-C-N 114.798 -1.092 . . . . 0.78 111.007 174.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1596 ' ' SER . . . . . . . . . . . . . 72.0 p -88.94 146.47 36.7 Favored Pre-proline 0 C--N 1.284 -2.278 0 N-CA-C 108.444 -0.947 . . . . 1.36 108.444 179.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.49 120.74 8.85 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.646 2.23 . . . . 1.4 109.308 174.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 42.4 t -73.25 132.21 82.29 Favored Pre-proline 0 C--N 1.288 -2.084 0 CA-C-N 114.663 -1.153 . . . . 0.75 112.425 -169.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1599 ' ' PRO . . . . . 0.457 ' HD2' ' OH ' ' A' 1606 ' ' TYR . 14.7 Cg_exo -72.44 80.2 1.7 Allowed 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 123.122 2.548 . . . . 1.7 109.338 171.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1600 ' ' SER . . . . . 0.812 ' HA ' ' HB2' ' B' ' 53' ' ' LEU . 50.6 m -160.62 -67.29 0.07 Allowed 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 126.613 1.965 . . . . 2.8 110.004 -178.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1601 ' ' LYS . . . . . 0.46 ' O ' ' HG ' ' A' 1604 ' ' LEU . 81.4 tttt -140.11 112.04 7.53 Favored 'General case' 0 N--CA 1.398 -3.05 0 N-CA-C 106.398 -1.704 . . . . 3.45 106.398 178.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 15.4 m -49.52 133.05 20.95 Favored 'General case' 0 N--CA 1.425 -1.72 0 C-N-CA 124.599 1.16 . . . . 2.44 112.549 -177.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 106.5 -21.49 32.6 Favored Glycine 0 C--N 1.304 -1.215 0 CA-C-N 115.91 -0.586 . . . . 1.2 113.945 177.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1604 ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' 1601 ' ' LYS . 4.3 pp -103.21 145.98 29.12 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 118.387 1.094 . . . . 2.38 111.238 178.124 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 22.8 p -111.77 155.89 22.81 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.624 -0.716 . . . . 1.96 110.797 -175.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1606 ' ' TYR . . . . . 0.493 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 63.9 m-85 -64.25 161.7 16.07 Favored 'General case' 0 C--O 1.249 1.046 0 CA-C-N 116.075 -0.511 . . . . 1.06 110.493 173.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -161.38 130.17 4.5 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-O 120.882 0.372 . . . . 2.0 111.145 -178.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1608 ' ' SER . . . . . 0.453 ' HB3' ' HB2' ' A' 1592 ' ' TYR . 38.0 t -105.23 123.03 47.15 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 115.376 -0.829 . . . . 1.61 109.723 -177.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 24.1 t -107.55 100.75 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 107.946 -1.131 . . . . 1.09 107.946 175.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 89.7 mt -89.77 112.19 24.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 108.317 -0.994 . . . . 1.2 108.317 -179.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 40.1 m -112.86 110.68 20.93 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 115.043 -0.98 . . . . 1.89 111.355 -177.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1612 ' ' PHE . . . . . 0.807 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 62.8 m-85 -83.42 115.85 22.23 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.793 -0.817 . . . . 0.28 108.793 175.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 84.1 t -110.31 135.75 48.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 O-C-N 123.651 0.594 . . . . 1.23 110.572 -174.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 41.4 t -72.13 98.24 2.08 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 124.069 0.948 . . . . 0.77 111.686 -178.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1615 ' ' ARG . . . . . 0.763 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 9.5 mmt180 -138.11 99.31 9.07 Favored Pre-proline 0 N--CA 1.431 -1.404 0 CA-C-N 116.058 -0.519 . . . . 2.92 109.812 175.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1616 ' ' PRO . . . . . 0.49 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 16.4 Cg_exo -75.26 39.57 0.62 Allowed 'Trans proline' 0 N--CA 1.488 1.188 0 C-N-CA 123.37 2.713 . . . . 1.22 112.412 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1617 ' ' GLU . . . . . 0.512 ' OE1' ' HD2' ' A' 1615 ' ' ARG . 42.9 mt-10 -110.57 40.46 1.98 Allowed 'General case' 0 C--N 1.272 -2.772 0 N-CA-C 108.076 -1.083 . . . . 3.05 108.076 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -41.48 115.45 0.63 Allowed 'General case' 0 C--O 1.244 0.765 0 C-N-CA 126.288 1.835 . . . . 1.55 113.867 -175.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . 173.42 -127.16 1.31 Allowed Glycine 0 N--CA 1.412 -2.929 0 N-CA-C 108.149 -1.981 . . . . 1.16 108.149 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -77.2 7.03 3.9 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 122.545 2.163 . . . . 1.06 112.657 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1621 ' ' THR . . . . . 0.533 ' HB ' ' HB2' ' A' 1641 ' ' HIS . 3.8 p -91.11 -27.17 18.73 Favored 'General case' 0 C--N 1.288 -2.081 0 C-N-CA 124.924 1.29 . . . . 1.58 108.203 176.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 51.2 t30 -87.01 56.78 4.16 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.387 -1.278 . . . . 0.88 108.566 -176.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -157.99 139.54 9.84 Favored Pre-proline 0 C--N 1.302 -1.493 0 CA-C-N 114.632 -1.167 . . . . 3.82 108.443 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -68.28 110.91 2.35 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.898 2.399 . . . . 0.77 112.01 -177.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 75.8 mtm -111.98 142.95 43.76 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 120.69 -0.404 . . . . 1.43 110.187 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1626 ' ' LEU . . . . . 0.609 ' HG ' ' CE2' ' A' 1542 ' ' TYR . 0.8 OUTLIER -81.78 112.88 19.34 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 108.34 -0.985 . . . . 1.43 108.34 -175.412 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 44.2 mm -81.12 -52.25 14.32 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 CA-C-O 121.31 0.576 . . . . 1.23 109.852 -178.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 50.9 m -159.56 145.42 15.99 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.541 -0.754 . . . . 1.88 109.772 -176.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1629 ' ' LEU . . . . . 1.001 HD12 ' HG ' ' A' 1636 ' ' LEU . 23.0 tp -129.7 95.13 3.9 Favored 'General case' 0 N--CA 1.421 -1.879 0 N-CA-C 107.785 -1.191 . . . . 1.92 107.785 171.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 27.5 t70 -68.0 122.11 17.52 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 107.121 -1.437 . . . . 1.09 107.121 175.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 26.0 tptp -89.36 -0.17 57.28 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 119.882 -0.727 . . . . 3.98 110.709 -171.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -96.17 -41.08 8.88 Favored 'General case' 0 N--CA 1.426 -1.643 0 C-N-CA 119.884 -0.726 . . . . 2.6 109.933 179.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 22.9 p -89.39 -22.05 22.76 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.4 0.619 . . . . 1.35 110.596 175.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 68.3 m 63.64 36.63 10.73 Favored 'General case' 0 C--N 1.354 0.771 0 C-N-CA 124.965 1.306 . . . . 0.53 111.824 178.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1635 ' ' THR . . . . . . . . . . . . . 38.6 m -100.35 130.5 46.46 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 108.028 -1.101 . . . . 1.11 108.028 178.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1636 ' ' LEU . . . . . 1.001 ' HG ' HD12 ' A' 1629 ' ' LEU . 0.6 OUTLIER -109.38 129.96 55.51 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 108.712 -0.847 . . . . 1.56 108.712 -176.373 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -106.86 121.59 44.72 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 120.901 0.382 . . . . 0.54 110.811 -179.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -119.09 127.78 53.7 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.293 -0.867 . . . . 0.64 108.794 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1639 ' ' SER . . . . . . . . . . . . . 59.1 m -114.23 144.09 43.78 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.293 -1.003 . . . . 1.34 108.293 177.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 2.8 t90 -141.39 107.95 5.33 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 103.792 -2.67 . . . . 0.8 103.792 -177.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1641 ' ' HIS . . . . . 0.763 ' HB3' ' HB2' ' A' 1615 ' ' ARG . 16.4 m170 -93.61 103.25 15.43 Favored 'General case' 0 C--N 1.287 -2.129 0 C-N-CA 120.706 -0.397 . . . . 1.14 110.487 -174.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1642 ' ' THR . . . . . . . . . . . . . 15.0 t -142.62 145.77 35.62 Favored Pre-proline 0 CA--C 1.565 1.529 0 N-CA-C 109.304 -0.628 . . . . 1.11 109.304 -174.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1643 ' ' PRO . . . . . 0.49 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 56.3 Cg_endo -72.57 -13.74 27.43 Favored 'Trans proline' 0 C--N 1.37 1.681 0 C-N-CA 122.635 2.224 . . . . 0.78 112.885 -179.027 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 9.1 tt -65.23 -19.24 65.88 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.37 0.605 . . . . 1.66 110.399 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -78.24 -7.2 56.86 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.58 -0.737 . . . . 1.29 112.241 -179.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 1.2 m -108.93 156.46 19.67 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 121.474 0.654 . . . . 1.48 111.869 178.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.292 -1.919 0 N-CA-C 107.531 -1.285 . . . . 3.14 107.531 169.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.972 0 CA-C-O 120.339 -0.145 . . . . 2.28 113.307 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -59.31 -39.16 94.33 Favored Glycine 0 N--CA 1.461 0.343 0 O-C-N 123.654 0.267 . . . . 1.94 113.202 -176.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 18.0 mp0 -65.61 -40.44 92.62 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 124.213 1.005 . . . . 2.55 110.067 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 13' ' ' LEU . . . . . 0.424 HD21 ' HB3' ' B' ' 46' ' ' CYS . 0.1 OUTLIER -65.15 -51.62 60.06 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.206 -0.906 . . . . 2.82 108.571 -178.884 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 7.6 p -63.42 -37.61 80.01 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 CA-C-N 116.405 -0.361 . . . . 2.5 111.655 179.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -68.1 -32.81 73.37 Favored 'General case' 0 C--O 1.193 -1.907 0 C-N-CA 120.088 -0.645 . . . . 2.04 111.859 177.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 96.5 m -59.16 -49.73 76.73 Favored 'General case' 0 C--O 1.279 2.613 0 CA-C-O 121.551 0.691 . . . . 2.31 109.62 174.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.787 HD21 HD12 ' B' ' 42' ' ' ILE . 4.6 mm? -51.52 -48.46 62.96 Favored 'General case' 0 C--O 1.222 -0.365 0 CA-C-N 114.472 -1.24 . . . . 2.27 110.416 174.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 18' ' ' GLN . . . . . 0.482 ' CD ' ' HB3' ' A' 1545 ' ' SER . 9.7 tt0 -78.11 -15.2 59.08 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.584 -0.734 . . . . 2.39 112.264 -176.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -66.75 -48.46 69.04 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.727 -0.471 . . . . 1.0 109.727 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 23.8 m -92.77 -29.11 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 117.49 -1.684 . . . . 1.83 111.995 176.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 63.0 m -96.94 25.19 5.52 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 112.203 0.445 . . . . 1.66 112.203 -178.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -54.3 -58.43 13.01 Favored Glycine 0 N--CA 1.472 1.085 0 C-N-CA 120.997 -0.62 . . . . 1.53 112.735 179.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -80.77 -3.63 51.63 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 121.027 0.441 . . . . 2.72 111.27 178.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -99.08 -55.25 2.75 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 112.157 0.429 . . . . 5.02 112.157 -173.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 122.09 143.67 6.59 Favored Glycine 0 C--N 1.301 -1.37 0 N-CA-C 108.64 -1.784 . . . . 1.63 108.64 -173.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . 0.421 ' HB2' ' HB3' ' B' ' 17' ' ' LEU . 41.6 p90 -132.33 146.36 51.92 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 117.52 0.66 . . . . 1.71 110.785 -177.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 15.4 p90 -160.97 91.36 0.88 Allowed 'General case' 0 CA--C 1.547 0.865 0 CA-C-O 121.245 0.545 . . . . 3.67 111.923 178.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 28' ' ' PHE . . . . . . . . . . . . . 36.1 p90 . . . . . 0 C--O 1.238 0.482 0 O-C-N 121.187 -0.946 . . . . 2.44 110.932 -179.973 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . 0.474 ' C ' ' H ' ' B' ' 43' ' ' VAL . . . . . . . . 0 N--CA 1.415 -2.73 0 N-CA-C 109.336 -1.506 . . . . 2.62 109.336 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . 0.787 HD12 HD21 ' B' ' 17' ' ' LEU . 11.1 pt 64.6 -24.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 C-N-CA 128.581 2.752 . . . . 2.28 113.866 179.016 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . 0.564 ' O ' ' HB2' ' B' ' 47' ' ' CYS . 2.0 p -50.56 -45.01 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 C-N-CA 124.628 1.171 . . . . 2.6 113.362 177.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -93.89 -39.98 10.4 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.418 -0.956 . . . . 3.36 108.418 -174.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . 0.488 ' O ' ' HB2' ' B' ' 49' ' ' ARG . 3.1 mp0 -55.25 -44.66 75.74 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 113.968 -1.469 . . . . 3.08 111.261 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 46' ' ' CYS . . . . . 0.424 ' HB3' HD21 ' B' ' 13' ' ' LEU . 13.1 t -94.8 -2.16 51.45 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.356 0.598 . . . . 2.23 110.717 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 47' ' ' CYS . . . . . 0.564 ' HB2' ' O ' ' B' ' 43' ' ' VAL . 45.4 t -78.54 -56.88 4.09 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.374 -0.602 . . . . 2.48 109.374 177.227 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -90.97 -12.07 37.07 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.406 0.521 . . . . 2.97 112.406 -175.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . 0.488 ' HB2' ' O ' ' B' ' 45' ' ' GLU . 72.4 mtp180 -129.95 -171.07 2.43 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 107.904 -1.147 . . . . 4.65 107.904 -178.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 8.3 t -110.81 129.79 55.76 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 106.278 -1.749 . . . . 2.86 106.278 178.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . 0.411 ' HB3' ' HB2' ' B' ' 46' ' ' CYS . 14.7 p -96.44 131.73 42.71 Favored 'General case' 0 N--CA 1.428 -1.57 0 CA-C-O 120.949 0.404 . . . . 2.11 110.148 -174.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -74.68 154.42 38.46 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-N 115.806 -0.634 . . . . 2.67 110.763 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . 0.812 ' HB2' ' HA ' ' A' 1600 ' ' SER . 34.1 tp -55.45 -43.65 75.63 Favored 'General case' 0 C--N 1.309 -1.194 0 O-C-N 123.585 0.553 . . . . 2.36 110.605 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -52.64 -36.75 57.23 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 124.958 1.303 . . . . 1.92 112.043 -176.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 64.2 tp -70.27 -57.88 4.38 Favored 'General case' 0 N--CA 1.427 -1.621 0 CA-C-N 115.451 -0.795 . . . . 2.35 110.676 -179.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . 0.409 ' O ' ' HB2' ' B' ' 60' ' ' CYS . 3.0 pp -68.78 -33.87 74.59 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 111.867 0.321 . . . . 2.01 111.867 -174.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -54.43 -60.64 3.07 Favored 'General case' 0 C--N 1.318 -0.771 0 O-C-N 123.947 0.779 . . . . 2.27 111.679 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 12.4 t -80.74 -25.55 37.96 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 119.974 -0.69 . . . . 2.67 111.995 -175.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -71.7 -40.53 69.45 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 109.096 -0.705 . . . . 3.2 109.096 -179.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 60' ' ' CYS . . . . . 0.409 ' HB2' ' O ' ' B' ' 56' ' ' LEU . 30.4 t . . . . . 0 N--CA 1.485 1.297 0 O-C-N 124.72 1.262 . . . . 2.3 111.335 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1515 ' ' ASP . . . . . 0.411 ' HB3' ' HE2' ' A' 1579 ' ' LYS . 29.5 m-20 . . . . . 0 CA--C 1.505 -0.776 0 N-CA-C 109.047 -0.723 . . . . 2.9 109.047 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1516 ' ' CYS . . . . . 0.482 ' HA ' ' HB2' ' A' 1581 ' ' LEU . 83.7 m -138.64 41.75 2.17 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 116.214 -0.448 . . . . 1.41 111.024 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -149.13 137.16 20.66 Favored 'General case' 0 N--CA 1.428 -1.564 0 C-N-CA 120.351 -0.539 . . . . 2.18 109.9 178.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1518 ' ' VAL . . . . . 0.479 HG21 ' HB2' ' A' 1583 ' ' TYR . 10.4 m -140.67 141.06 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 123.16 0.584 . . . . 1.52 110.204 178.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1519 ' ' THR . . . . . . . . . . . . . 9.6 m -101.04 131.2 47.05 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 115.77 -0.65 . . . . 1.36 109.343 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1520 ' ' ASN . . . . . 0.445 ' OD1' HG23 ' A' 1523 ' ' THR . 26.5 t-20 -83.49 118.27 71.04 Favored Pre-proline 0 N--CA 1.426 -1.661 0 N-CA-C 109.332 -0.618 . . . . 2.02 109.332 176.315 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.14 -16.82 49.88 Favored 'Trans proline' 0 C--O 1.239 0.572 0 C-N-CA 123.224 2.616 . . . . 1.82 113.906 -177.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 74.2 m -77.2 -46.34 23.62 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 112.28 0.474 . . . . 1.89 112.28 -179.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1523 ' ' THR . . . . . 0.445 HG23 ' OD1' ' A' 1520 ' ' ASN . 5.7 t -109.68 -14.43 14.34 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 119.547 -0.861 . . . . 1.99 111.626 -178.065 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 79.55 31.68 40.25 Favored Glycine 0 N--CA 1.44 -1.044 0 N-CA-C 111.352 -0.699 . . . . 1.19 111.352 178.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1525 ' ' HIS . . . . . 0.402 ' HB2' ' OE2' ' A' 1647 ' ' GLU . 5.2 t-80 -98.22 120.9 39.43 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.623 -0.88 . . . . 1.82 108.623 -178.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 1.9 tm? -86.31 112.66 21.62 Favored 'General case' 0 C--N 1.285 -2.212 0 N-CA-C 107.022 -1.473 . . . . 1.3 107.022 176.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -99.79 120.01 39.06 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 109.194 -0.669 . . . . 0.8 109.194 177.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 23.1 t70 -112.64 118.09 34.09 Favored 'General case' 0 CA--C 1.482 -1.657 0 N-CA-C 108.652 -0.87 . . . . 1.17 108.652 177.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 6.0 mp -107.38 5.8 27.73 Favored 'General case' 0 N--CA 1.412 -2.353 0 CA-C-O 121.571 0.7 . . . . 1.29 110.769 -177.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 1.5 m -72.72 -11.08 60.48 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.838 -1.074 . . . . 0.91 109.089 178.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 24.7 m -75.49 -23.63 56.81 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 115.3 -0.864 . . . . 1.98 109.712 176.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 97.9 mt -87.1 -5.16 59.12 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.258 0.552 . . . . 1.34 110.312 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1533 ' ' SER . . . . . 0.491 ' HA ' ' HB ' ' A' 1552 ' ' ILE . 21.0 m -70.53 166.76 19.86 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.842 -0.617 . . . . 1.93 111.862 -178.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . 173.47 164.15 28.24 Favored Glycine 0 N--CA 1.436 -1.301 0 N-CA-C 110.069 -1.212 . . . . 1.1 110.069 -179.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 44.6 ttp180 -92.57 -33.66 14.34 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 121.028 0.442 . . . . 5.21 110.197 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -82.06 -30.83 31.14 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 116.088 -0.505 . . . . 1.94 110.597 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 84.51 -145.65 22.11 Favored Glycine 0 N--CA 1.422 -2.255 0 CA-C-N 115.5 -0.773 . . . . 1.08 113.634 170.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -137.3 153.18 50.34 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 124.98 1.312 . . . . 1.07 107.548 -178.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 8.6 p -115.28 136.93 52.58 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 123.632 0.582 . . . . 1.46 110.508 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1540 ' ' ALA . . . . . 0.444 ' HB3' HG11 ' A' 1548 ' ' VAL . . . -132.61 136.36 46.47 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.969 -1.123 . . . . 1.19 107.969 175.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -84.73 129.31 34.84 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.275 0.559 . . . . 1.37 110.589 -176.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1542 ' ' TYR . . . . . 0.631 ' CE2' ' HG ' ' A' 1626 ' ' LEU . 1.6 t80 -120.04 -100.58 0.43 Allowed 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.588 -1.264 . . . . 1.38 107.588 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1543 ' ' SER . . . . . 0.496 ' H ' ' HB3' ' A' 1542 ' ' TYR . 5.2 m -71.94 161.52 30.81 Favored 'General case' 0 N--CA 1.421 -1.91 0 C-N-CA 124.373 1.069 . . . . 1.98 108.838 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1544 ' ' LYS . . . . . 0.784 ' HG3' ' HB3' ' B' ' 23' ' ' ASP . 39.0 mmtm -72.57 -1.11 14.78 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.398 0.888 . . . . 3.96 113.398 -177.299 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 22.6 t -139.82 37.98 1.99 Allowed 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 108.937 -0.764 . . . . 2.81 108.937 176.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . -172.29 126.58 1.29 Allowed Glycine 0 N--CA 1.434 -1.494 0 C-N-CA 119.555 -1.307 . . . . 1.68 114.166 -178.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 26.8 m -109.1 150.53 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.568 0 N-CA-C 107.184 -1.413 . . . . 1.38 107.184 174.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1548 ' ' VAL . . . . . 0.444 HG11 ' HB3' ' A' 1540 ' ' ALA . 10.0 p -97.46 130.4 46.18 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 C-N-CA 120.171 -0.612 . . . . 1.24 109.403 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -94.22 131.53 39.71 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 108.358 -0.978 . . . . 1.29 108.358 176.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 26.2 ptm -145.59 127.03 14.99 Favored 'General case' 0 C--N 1.286 -2.183 0 CA-C-N 115.471 -0.786 . . . . 1.47 110.983 -177.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 69.1 m -118.15 128.48 54.77 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 115.769 -0.65 . . . . 1.4 109.968 177.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1552 ' ' ILE . . . . . 0.491 ' HB ' ' HA ' ' A' 1533 ' ' SER . 50.7 mm -77.35 125.34 37.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 109.16 -0.682 . . . . 1.11 109.16 -179.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 75.8 m 59.08 39.42 23.26 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.589 0.755 . . . . 1.4 112.045 175.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . -179.99 178.51 48.56 Favored Glycine 0 N--CA 1.42 -2.376 0 C-N-CA 120.096 -1.049 . . . . 0.4 110.919 -177.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -96.85 160.78 14.17 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 109.337 -0.616 . . . . 1.62 109.337 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -103.48 130.29 50.81 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 109.891 -0.411 . . . . 1.12 109.891 -178.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -73.3 2.1 8.15 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.676 0.991 . . . . 2.49 113.676 -175.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -101.71 1.31 37.33 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.91 -0.494 . . . . 1.38 110.427 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1559 ' ' CYS . . . . . 0.605 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 16.1 m -137.03 175.26 3.62 Favored Pre-proline 0 C--N 1.303 -1.421 0 CA-C-O 118.647 -0.692 . . . . 1.21 112.07 -177.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1560 ' ' PRO . . . . . 0.605 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 21.9 Cg_exo -38.76 142.93 0.27 Allowed 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 124.063 3.175 . . . . 0.98 114.562 175.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1561 ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' 1560 ' ' PRO . 31.6 Cg_exo -61.51 126.69 19.77 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.533 2.155 . . . . 1.15 111.018 176.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 100.33 -9.0 59.09 Favored Glycine 0 C--N 1.31 -0.87 0 N-CA-C 114.345 0.498 . . . . 0.55 114.345 178.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1563 ' ' VAL . . . . . 0.595 HG12 ' O ' ' A' 1560 ' ' PRO . 9.8 p -99.9 134.92 37.7 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 O-C-N 121.6 -0.941 . . . . 1.53 111.294 -177.418 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -95.35 -31.39 7.57 Favored Glycine 0 N--CA 1.453 -0.191 0 CA-C-N 115.725 -0.67 . . . . 0.29 112.854 -177.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -124.14 125.62 44.77 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 109.71 -0.478 . . . . 1.08 109.71 178.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 4.5 t -159.36 141.42 13.52 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 116.492 -0.322 . . . . 0.43 110.361 -177.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1567 ' ' PHE . . . . . 0.509 ' HE1' HG21 ' A' 1574 ' ' VAL . 84.0 m-85 -86.24 139.91 30.6 Favored 'General case' 0 C--O 1.245 0.828 0 N-CA-C 109.61 -0.515 . . . . 1.3 109.61 175.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -86.3 29.85 4.64 Favored Glycine 0 CA--C 1.508 -0.361 0 C-N-CA 120.856 -0.687 . . . . 1.43 112.454 -175.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1569 ' ' GLN . . . . . 0.585 ' HB3' ' OD1' ' B' ' 15' ' ' ASP . 27.7 mt-30 -83.3 -70.58 0.55 Allowed 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 110.281 -0.266 . . . . 3.09 110.281 177.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 8.3 t -130.96 32.31 4.34 Favored 'General case' 0 CA--C 1.557 1.228 0 CA-C-O 121.563 0.697 . . . . 2.52 111.107 176.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 15.2 mmt85 64.64 48.86 2.45 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 124.213 1.005 . . . . 3.19 110.895 178.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 27.8 mt -89.36 120.22 37.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 109.552 -0.536 . . . . 1.51 109.552 -178.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1573 ' ' SER . . . . . 0.405 ' HB3' ' HB3' ' A' 1596 ' ' SER . 29.5 t -76.13 128.72 35.54 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.392 -0.822 . . . . 0.96 111.009 -177.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1574 ' ' VAL . . . . . 0.509 HG21 ' HE1' ' A' 1567 ' ' PHE . 0.9 OUTLIER -112.15 -16.57 9.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 115.884 -0.598 . . . . 1.6 112.084 -179.918 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 179.11 124.5 0.88 Allowed Glycine 0 N--CA 1.435 -1.403 0 C-N-CA 119.34 -1.409 . . . . 0.34 112.4 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 22.2 ttmm -61.65 145.99 50.46 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 123.683 0.793 . . . . 2.68 109.399 178.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -59.63 119.92 8.49 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 108.834 -0.802 . . . . 1.08 108.834 175.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 60.2 t30 -132.49 147.12 52.36 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.474 -1.306 . . . . 1.95 107.474 -174.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1579 ' ' LYS . . . . . 0.411 ' HE2' ' HB3' ' A' 1515 ' ' ASP . 56.4 mtpt -132.27 57.66 1.78 Allowed 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 122.298 1.047 . . . . 3.11 108.772 -175.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 31.2 ttm180 -117.69 76.56 1.07 Allowed 'General case' 0 N--CA 1.413 -2.311 0 CA-C-N 114.775 -1.102 . . . . 4.04 108.051 -176.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1581 ' ' LEU . . . . . 0.482 ' HB2' ' HA ' ' A' 1516 ' ' CYS . 0.6 OUTLIER -64.23 125.72 25.45 Favored 'General case' 0 C--O 1.252 1.196 0 CA-C-N 114.266 -1.334 . . . . 1.32 109.975 -178.103 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A 1582 ' ' ARG . . . . . 0.401 ' HD2' ' OE1' ' A' 1589 ' ' GLN . 91.6 mtt180 -124.48 138.23 54.36 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.865 -0.607 . . . . 3.4 110.391 177.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1583 ' ' TYR . . . . . 0.479 ' HB2' HG21 ' A' 1518 ' ' VAL . 46.0 t80 -110.8 107.26 16.71 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 107.303 -1.369 . . . . 1.26 107.303 174.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1584 ' ' VAL . . . . . 0.476 ' O ' ' HB ' ' A' 1587 ' ' VAL . 16.5 m -120.97 90.1 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 CA-C-N 115.9 -0.591 . . . . 1.71 112.065 -176.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 29.6 t70 58.02 57.66 3.97 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.892 0.853 . . . . 1.17 110.555 178.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1586 ' ' GLN . . . . . 0.458 ' HA ' ' CZ ' ' A' 1583 ' ' TYR . 2.1 pt20 73.99 -7.64 1.58 Allowed 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 128.243 2.617 . . . . 2.43 111.476 178.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1587 ' ' VAL . . . . . 0.476 ' HB ' ' O ' ' A' 1584 ' ' VAL . 30.5 t -88.07 124.9 41.46 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.444 0 CA-C-N 115.719 -0.673 . . . . 1.16 109.337 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1588 ' ' LEU . . . . . 0.679 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 3.3 mm? -93.93 120.85 34.74 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 107.581 -1.266 . . . . 1.11 107.581 179.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1589 ' ' GLN . . . . . 0.401 ' OE1' ' HD2' ' A' 1582 ' ' ARG . 35.8 tt0 -116.78 135.65 53.59 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 112.63 0.604 . . . . 1.74 112.63 -173.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 18.3 mt -129.96 99.25 5.03 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 125.373 1.469 . . . . 1.4 107.224 172.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 7.5 p -95.81 125.87 48.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 109.527 -0.546 . . . . 1.7 109.527 -178.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1592 ' ' TYR . . . . . 0.582 ' HB2' ' HB3' ' A' 1608 ' ' SER . 15.8 m-30 -110.76 107.1 16.51 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 108.592 -0.892 . . . . 1.08 108.592 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 19.5 pttp -109.68 168.77 9.17 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 115.557 -0.747 . . . . 2.21 110.057 -177.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 15.3 m-20 66.29 78.89 0.25 Allowed 'General case' 0 CA--C 1.507 -0.681 0 C-N-CA 124.488 1.115 . . . . 1.11 110.69 -178.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -98.99 -122.07 4.65 Favored Glycine 0 C--N 1.287 -2.143 0 N-CA-C 109.703 -1.359 . . . . 0.78 109.703 175.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1596 ' ' SER . . . . . 0.405 ' HB3' ' HB3' ' A' 1573 ' ' SER . 50.7 p -120.29 164.68 21.3 Favored Pre-proline 0 C--N 1.297 -1.683 0 N-CA-C 107.927 -1.138 . . . . 1.36 107.927 175.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.16 119.94 7.53 Favored 'Trans proline' 0 C--N 1.361 1.214 0 C-N-CA 122.317 2.012 . . . . 1.4 112.306 -178.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1598 ' ' CYS . . . . . 0.413 ' HA ' ' HD3' ' A' 1599 ' ' PRO . 44.5 t -81.08 125.21 80.18 Favored Pre-proline 0 C--N 1.292 -1.901 0 CA-C-N 115.129 -0.941 . . . . 0.75 109.182 -179.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1599 ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' 1598 ' ' CYS . 14.9 Cg_exo -71.1 -15.15 32.16 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 123.429 2.753 . . . . 1.7 112.995 -178.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1600 ' ' SER . . . . . 0.853 ' HA ' ' HB3' ' B' ' 53' ' ' LEU . 10.6 m -59.0 -40.89 86.28 Favored 'General case' 0 N--CA 1.434 -1.257 0 C-N-CA 123.296 0.638 . . . . 2.8 111.635 177.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1601 ' ' LYS . . . . . . . . . . . . . 18.5 ttmm -145.9 127.18 14.84 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 106.832 -1.544 . . . . 3.45 106.832 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 19.2 m -61.94 117.18 5.59 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 112.176 0.435 . . . . 2.44 112.176 -174.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 95.16 14.68 47.62 Favored Glycine 0 C--O 1.241 0.539 0 C-N-CA 121.404 -0.427 . . . . 1.2 112.846 178.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1604 ' ' LEU . . . . . 0.598 HD21 ' SG ' ' A' 1634 ' ' CYS . 12.5 tp -108.16 157.11 18.59 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.861 -1.163 . . . . 2.38 107.861 -178.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 33.4 t -120.53 154.32 35.5 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.965 -0.754 . . . . 1.96 108.965 -178.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1606 ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -76.35 158.26 31.63 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.901 -0.777 . . . . 1.06 108.901 174.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 56.7 pttt -158.4 140.81 14.28 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 120.397 -0.521 . . . . 2.0 110.976 175.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1608 ' ' SER . . . . . 0.582 ' HB3' ' HB2' ' A' 1592 ' ' TYR . 45.4 t -105.68 127.88 53.33 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 115.168 -0.924 . . . . 1.61 109.894 -175.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 40.8 t -113.72 101.75 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 N-CA-C 108.905 -0.776 . . . . 1.09 108.905 176.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 80.4 mt -91.87 114.53 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.611 0 N-CA-C 107.85 -1.167 . . . . 1.2 107.85 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 8.1 t -116.9 111.59 19.86 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 115.401 -0.818 . . . . 1.89 109.703 -176.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1612 ' ' PHE . . . . . 0.679 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 71.2 m-85 -90.86 118.36 30.21 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.733 -0.667 . . . . 0.28 110.036 179.066 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 47.6 t -120.69 138.0 52.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.721 -0.672 . . . . 1.23 110.575 -174.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1614 ' ' CYS . . . . . 0.457 ' HA ' ' HB2' ' A' 1646 ' ' CYS . 15.3 t -51.49 114.87 1.36 Allowed 'General case' 0 C--O 1.247 0.929 0 C-N-CA 125.409 1.484 . . . . 0.77 113.088 176.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1615 ' ' ARG . . . . . 0.806 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 18.8 tpt180 -128.22 96.6 30.77 Favored Pre-proline 0 N--CA 1.436 -1.139 0 N-CA-C 109.243 -0.651 . . . . 2.92 109.243 173.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1616 ' ' PRO . . . . . 0.462 ' HD2' ' OE1' ' A' 1617 ' ' GLU . 31.7 Cg_exo -62.43 -37.42 59.98 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 121.909 1.739 . . . . 1.22 111.311 175.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1617 ' ' GLU . . . . . 0.462 ' OE1' ' HD2' ' A' 1616 ' ' PRO . 2.6 mp0 -77.82 44.39 0.46 Allowed 'General case' 0 C--O 1.24 0.571 0 C-N-CA 124.89 1.276 . . . . 3.05 112.059 178.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -37.15 132.63 0.72 Allowed 'General case' 0 C--O 1.244 0.792 0 C-N-CA 125.296 1.438 . . . . 1.55 112.613 178.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1619 ' ' GLY . . . . . 0.448 ' HA3' ' HD2' ' A' 1620 ' ' PRO . . . 172.46 -137.33 4.18 Favored Glycine 0 N--CA 1.423 -2.221 0 N-CA-C 110.195 -1.162 . . . . 1.16 110.195 -177.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1620 ' ' PRO . . . . . 0.448 ' HD2' ' HA3' ' A' 1619 ' ' GLY . 36.3 Cg_endo -63.68 -1.46 3.33 Favored 'Trans proline' 0 CA--C 1.551 1.335 0 C-N-CA 123.269 2.646 . . . . 1.06 114.852 -178.254 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1621 ' ' THR . . . . . 0.643 ' HB ' ' HB2' ' A' 1641 ' ' HIS . 5.2 p -89.96 -11.82 40.55 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 121.807 0.813 . . . . 1.58 109.785 177.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 48.5 t30 -92.66 55.34 2.43 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 122.679 1.228 . . . . 0.88 109.599 -178.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -156.59 139.19 10.55 Favored Pre-proline 0 C--N 1.3 -1.55 0 N-CA-C 106.514 -1.661 . . . . 3.82 106.514 178.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -61.72 113.9 2.03 Favored 'Trans proline' 0 C--O 1.245 0.863 0 C-N-CA 122.881 2.387 . . . . 0.77 112.123 -176.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 75.3 mtm -117.17 140.13 49.91 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 116.508 -0.314 . . . . 1.43 110.603 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1626 ' ' LEU . . . . . 0.631 ' HG ' ' CE2' ' A' 1542 ' ' TYR . 0.3 OUTLIER -87.99 115.18 25.28 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 107.681 -1.229 . . . . 1.43 107.681 -175.463 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 48.8 mm -80.12 -49.46 18.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 CA-C-N 116.249 -0.432 . . . . 1.23 109.839 -178.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 33.1 t -167.78 149.53 5.51 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.545 -0.752 . . . . 1.88 110.134 -175.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1629 ' ' LEU . . . . . 0.583 HD12 ' HG ' ' A' 1636 ' ' LEU . 48.0 tp -112.63 105.59 13.8 Favored 'General case' 0 N--CA 1.418 -2.053 0 N-CA-C 107.116 -1.439 . . . . 1.92 107.116 173.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 30.4 t70 -76.92 114.38 15.63 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.462 -0.895 . . . . 1.09 108.994 178.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1631 ' ' LYS . . . . . 0.409 ' HB3' HD11 ' B' ' 53' ' ' LEU . 98.7 mttt -66.91 -21.1 66.0 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 113.445 0.905 . . . . 3.98 113.445 -174.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -86.32 -35.26 19.98 Favored 'General case' 0 CA--C 1.497 -1.071 0 CA-C-O 121.343 0.592 . . . . 2.6 111.348 -177.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 53.5 p -104.9 -7.03 19.62 Favored 'General case' 0 C--N 1.285 -2.198 0 CA-C-N 115.741 -0.663 . . . . 1.35 112.391 -175.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1634 ' ' CYS . . . . . 0.598 ' SG ' HD21 ' A' 1604 ' ' LEU . 75.0 m 56.38 34.61 24.48 Favored 'General case' 0 C--N 1.363 1.156 0 C-N-CA 124.284 1.033 . . . . 0.53 110.934 -177.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1635 ' ' THR . . . . . . . . . . . . . 88.2 m -99.03 129.26 45.3 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-N 114.193 -1.367 . . . . 1.11 109.979 -177.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1636 ' ' LEU . . . . . 0.583 ' HG ' HD12 ' A' 1629 ' ' LEU . 1.5 mp -108.02 121.33 44.58 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 107.542 -1.281 . . . . 1.56 107.542 -179.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -95.02 131.22 41.22 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 120.685 0.279 . . . . 0.54 110.542 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -126.26 119.34 27.17 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.716 -0.675 . . . . 0.64 109.343 -176.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1639 ' ' SER . . . . . . . . . . . . . 59.7 m -103.15 138.15 40.36 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 115.781 -0.645 . . . . 1.34 109.567 175.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 2.8 t90 -141.85 113.19 7.61 Favored 'General case' 0 N--CA 1.422 -1.84 0 N-CA-C 103.95 -2.611 . . . . 0.8 103.95 178.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1641 ' ' HIS . . . . . 0.806 ' HB3' ' HB2' ' A' 1615 ' ' ARG . 18.1 m-70 -107.08 111.04 23.31 Favored 'General case' 0 C--N 1.286 -2.182 0 C-N-CA 120.067 -0.653 . . . . 1.14 110.402 -174.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1642 ' ' THR . . . . . . . . . . . . . 4.9 t -142.75 150.07 52.36 Favored Pre-proline 0 C--N 1.306 -1.29 0 CA-C-N 115.479 -0.782 . . . . 1.11 109.683 -174.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1643 ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -76.64 -6.39 16.9 Favored 'Trans proline' 0 C--N 1.366 1.483 0 C-N-CA 122.281 1.987 . . . . 0.78 112.316 175.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 8.6 tt -64.45 -30.27 71.31 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.435 0.636 . . . . 1.66 109.445 177.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -94.51 8.03 43.58 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.051 -0.977 . . . . 1.29 109.828 -177.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1646 ' ' CYS . . . . . 0.457 ' HB2' ' HA ' ' A' 1614 ' ' CYS . 33.7 t -122.09 158.54 29.03 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 115.532 -0.758 . . . . 1.48 109.496 -173.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1647 ' ' GLU . . . . . 0.402 ' OE2' ' HB2' ' A' 1525 ' ' HIS . 8.6 tp10 . . . . . 0 N--CA 1.417 -2.094 0 N-CA-C 106.728 -1.582 . . . . 3.14 106.728 171.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.421 -2.343 0 N-CA-C 110.576 -1.01 . . . . 2.28 110.576 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.22 -62.67 4.48 Favored Glycine 0 N--CA 1.444 -0.806 0 O-C-N 123.98 0.459 . . . . 1.94 112.972 -179.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 77.7 mt-10 -69.53 -27.06 64.84 Favored 'General case' 0 CA--C 1.496 -1.108 0 C-N-CA 120.186 -0.606 . . . . 2.55 109.416 177.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 13' ' ' LEU . . . . . 0.47 ' O ' HD21 ' B' ' 17' ' ' LEU . 0.1 OUTLIER -57.32 -57.89 10.64 Favored 'General case' 0 C--O 1.212 -0.898 0 CA-C-N 115.651 -0.704 . . . . 2.82 109.726 176.319 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . 0.445 ' HB ' ' HZ ' ' B' ' 28' ' ' PHE . 13.7 p -66.07 -34.09 67.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.981 -0.288 . . . . 2.5 111.148 -178.191 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 15' ' ' ASP . . . . . 0.585 ' OD1' ' HB3' ' A' 1569 ' ' GLN . 29.3 t70 -71.22 -40.84 70.85 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 113.658 0.984 . . . . 2.04 113.658 -177.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 21.6 p -66.8 -40.92 88.28 Favored 'General case' 0 C--O 1.262 1.739 0 CA-C-O 121.644 0.735 . . . . 2.31 109.917 176.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.48 ' HG ' ' CD2' ' B' ' 28' ' ' PHE . 4.1 mm? -52.95 -50.12 64.69 Favored 'General case' 0 C--O 1.213 -0.824 0 CA-C-N 114.896 -1.047 . . . . 2.27 110.598 170.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -67.09 -25.68 66.34 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 123.841 0.857 . . . . 2.39 111.777 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -58.59 -55.27 37.25 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.982 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 14.7 p -99.08 -22.19 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.07 0 C-N-CA 118.105 -1.438 . . . . 1.83 112.819 178.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 21' ' ' CYS . . . . . 0.473 ' HB2' ' HB3' ' B' ' 26' ' ' PHE . 57.9 m -103.36 24.89 10.29 Favored 'General case' 0 C--N 1.315 -0.914 0 O-C-N 121.555 -0.716 . . . . 1.66 110.881 -178.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.69 -67.79 2.01 Favored Glycine 0 N--CA 1.461 0.345 0 C-N-CA 121.424 -0.417 . . . . 1.53 113.414 -177.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . 0.784 ' HB3' ' HG3' ' A' 1544 ' ' LYS . 8.8 p-10 -76.88 -4.16 42.3 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 122.826 0.45 . . . . 2.72 111.646 179.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 21.1 tpp180 -97.48 -42.71 7.58 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 116.02 -0.536 . . . . 5.02 111.745 -175.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 112.73 121.76 3.9 Favored Glycine 0 N--CA 1.426 -2.028 0 N-CA-C 108.998 -1.641 . . . . 1.63 108.998 -174.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . 0.572 ' HA ' ' SG ' ' B' ' 60' ' ' CYS . 13.4 p90 -98.12 144.94 27.07 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 117.422 0.611 . . . . 1.71 111.318 -179.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -125.64 105.05 8.72 Favored 'General case' 0 C--O 1.218 -0.581 0 N-CA-C 113.003 0.742 . . . . 3.67 113.003 -175.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 28' ' ' PHE . . . . . 0.48 ' CD2' ' HG ' ' B' ' 17' ' ' LEU . 53.8 p90 . . . . . 0 C--N 1.311 -1.08 0 CA-C-O 121.471 0.653 . . . . 2.44 109.84 162.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . 0.428 ' O ' ' HB2' ' B' ' 28' ' ' PHE . . . . . . . . 0 N--CA 1.413 -2.882 0 N-CA-C 109.685 -1.366 . . . . 2.62 109.685 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . 0.262 23.0 pt 59.8 -27.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 C-N-CA 127.849 2.46 . . . . 2.28 115.583 178.136 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . 0.474 ' O ' ' HB2' ' B' ' 47' ' ' CYS . 2.5 p -53.98 -41.29 48.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 C-N-CA 124.566 1.146 . . . . 2.6 112.738 177.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -95.47 -25.84 16.07 Favored 'General case' 0 N--CA 1.419 -1.997 0 N-CA-C 109.048 -0.723 . . . . 3.36 109.048 -173.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 22.0 tp10 -61.11 -56.66 18.34 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 114.651 -1.159 . . . . 3.08 108.441 176.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 46' ' ' CYS . . . . . . . . . . . . . 56.5 m -84.83 2.59 41.73 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.069 -0.514 . . . . 2.23 111.945 -177.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 47' ' ' CYS . . . . . 0.474 ' HB2' ' O ' ' B' ' 43' ' ' VAL . 49.7 t -78.89 -48.0 15.45 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 120.257 -0.577 . . . . 2.48 109.537 176.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -101.66 -2.27 30.75 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.053 -0.521 . . . . 2.97 111.81 -176.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 21.0 mmt180 -132.56 162.89 30.12 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.896 -1.15 . . . . 4.65 107.896 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 1.9 p -102.4 127.66 49.33 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 108.371 -0.974 . . . . 2.86 108.371 176.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 85.2 m -106.81 171.35 7.41 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.568 0.699 . . . . 2.11 112.257 -172.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -126.35 158.33 36.15 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 105.839 -1.911 . . . . 2.67 105.839 173.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . 0.853 ' HB3' ' HA ' ' A' 1600 ' ' SER . 2.6 pt? -60.71 -21.19 62.64 Favored 'General case' 0 CA--C 1.501 -0.936 0 N-CA-C 114.693 1.368 . . . . 2.36 114.693 -167.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.31 -29.46 65.91 Favored 'General case' 0 CA--C 1.514 -0.415 0 O-C-N 123.509 0.505 . . . . 1.92 111.282 -176.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 64.9 tp -65.06 -54.82 24.18 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 115.636 -0.711 . . . . 2.35 110.16 178.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 1.3 pp -76.04 -32.69 59.46 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 116.588 -0.278 . . . . 2.01 111.483 -175.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -55.51 -49.01 73.73 Favored 'General case' 0 C--N 1.318 -0.803 0 O-C-N 123.83 0.706 . . . . 2.27 110.553 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 10.9 t -86.78 -17.41 33.58 Favored 'General case' 0 CA--C 1.567 1.607 0 N-CA-C 112.405 0.52 . . . . 2.67 112.405 -177.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -86.67 -37.52 17.92 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.52 -0.737 . . . . 3.2 109.961 -178.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 60' ' ' CYS . . . . . 0.572 ' SG ' ' HA ' ' B' ' 26' ' ' PHE . 6.6 t . . . . . 0 C--N 1.312 -1.057 0 CA-C-N 115.466 -0.788 . . . . 2.3 111.461 -178.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 34.3 t70 . . . . . 0 C--O 1.218 -0.596 0 N-CA-C 108.893 -0.78 . . . . 2.9 108.893 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 12.6 t -150.89 61.38 0.92 Allowed 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 106.431 -1.692 . . . . 1.41 106.431 172.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 26.1 pt20 -165.13 162.92 20.43 Favored 'General case' 0 N--CA 1.419 -1.998 0 N-CA-C 106.485 -1.672 . . . . 2.18 106.485 -175.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1518 ' ' VAL . . . . . 0.559 HG22 ' HB2' ' A' 1583 ' ' TYR . 0.0 OUTLIER -154.59 146.05 13.61 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 O-C-N 123.896 0.747 . . . . 1.52 110.449 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A 1519 ' ' THR . . . . . . . . . . . . . 49.9 m -98.09 137.69 36.51 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 115.965 -0.561 . . . . 1.36 109.561 176.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1520 ' ' ASN . . . . . 0.498 ' ND2' ' OH ' ' A' 1583 ' ' TYR . 21.2 t-20 -79.31 117.27 66.09 Favored Pre-proline 0 N--CA 1.43 -1.46 0 N-CA-C 108.6 -0.889 . . . . 2.02 108.6 174.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -69.56 -10.79 29.62 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 122.687 2.258 . . . . 1.82 113.586 -176.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 19.7 m -82.47 -44.22 16.27 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 120.77 0.319 . . . . 1.89 111.809 -178.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1523 ' ' THR . . . . . . . . . . . . . 9.0 t -122.16 -3.23 9.03 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 119.459 -0.896 . . . . 1.99 112.24 -177.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 80.46 16.34 76.15 Favored Glycine 0 C--O 1.238 0.344 0 C-N-CA 120.691 -0.766 . . . . 1.19 112.708 175.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 81.1 t60 -80.69 125.3 29.87 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 120.832 0.348 . . . . 1.82 110.546 -178.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 1.2 tm? -90.38 108.39 19.75 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 114.921 -1.036 . . . . 1.3 108.981 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -87.9 111.32 21.31 Favored 'General case' 0 CA--C 1.499 -0.981 0 N-CA-C 107.981 -1.118 . . . . 0.8 107.981 177.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -101.71 134.72 44.42 Favored 'General case' 0 N--CA 1.404 -2.737 0 N-CA-C 107.123 -1.436 . . . . 1.17 107.123 174.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 3.4 mm? -100.94 5.15 43.12 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-O 122.017 0.913 . . . . 1.29 108.687 177.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 4.0 m -64.82 -32.91 74.82 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.102 -1.408 . . . . 0.91 109.75 178.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1531 ' ' SER . . . . . 0.578 ' HB2' HD13 ' A' 1644 ' ' LEU . 46.0 m -66.28 -25.74 67.01 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.952 -0.567 . . . . 1.98 111.238 177.162 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 90.1 mt -97.11 -1.11 45.9 Favored 'General case' 0 C--O 1.215 -0.72 0 CA-C-O 121.194 0.521 . . . . 1.34 110.463 176.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1533 ' ' SER . . . . . . . . . . . . . 46.8 t -85.25 175.03 9.18 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.329 0.585 . . . . 1.93 110.145 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . 170.33 169.15 33.12 Favored Glycine 0 C--N 1.299 -1.512 0 N-CA-C 109.019 -1.633 . . . . 1.1 109.019 -179.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -92.5 -35.38 13.65 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 117.239 0.519 . . . . 5.21 110.518 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1536 ' ' ALA . . . . . 0.636 ' HA ' ' HG2' ' A' 1557 ' ' GLU . . . -77.35 -35.43 54.65 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 121.376 0.608 . . . . 1.94 109.919 -179.018 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 91.59 -149.98 20.1 Favored Glycine 0 N--CA 1.42 -2.399 0 CA-C-N 115.274 -0.876 . . . . 1.08 111.78 176.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -137.41 149.32 46.84 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.654 -0.869 . . . . 1.07 108.654 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1539 ' ' THR . . . . . 0.45 ' HA ' ' O ' ' A' 1548 ' ' VAL . 4.0 m -125.08 122.11 36.26 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 109.326 -0.62 . . . . 1.46 109.326 -177.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1540 ' ' ALA . . . . . 0.499 ' HB2' ' CG1' ' A' 1548 ' ' VAL . . . -115.38 150.18 36.77 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 108.113 -1.069 . . . . 1.19 108.113 -178.428 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -93.35 138.78 31.36 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 121.108 0.48 . . . . 1.37 111.179 -176.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1542 ' ' TYR . . . . . 0.838 ' HE1' ' HG ' ' A' 1626 ' ' LEU . 1.5 t80 -121.77 -101.33 0.41 Allowed 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 107.625 -1.25 . . . . 1.38 107.625 -179.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1543 ' ' SER . . . . . 0.469 ' H ' ' HB3' ' A' 1542 ' ' TYR . 32.8 t -66.8 159.75 27.39 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 107.304 -1.369 . . . . 1.98 107.304 172.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1544 ' ' LYS . . . . . 0.421 ' HZ2' ' CG ' ' B' ' 23' ' ' ASP . 62.7 mttp -59.38 -37.05 76.93 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-N 119.921 1.237 . . . . 3.96 113.619 -175.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 14.7 t -100.83 15.19 29.25 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 110.104 -0.332 . . . . 2.81 110.104 178.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1546 ' ' GLY . . . . . 0.432 ' HA2' ' OE1' ' A' 1569 ' ' GLN . . . -130.42 147.95 18.44 Favored Glycine 0 CA--C 1.54 1.633 0 C-N-CA 120.03 -1.081 . . . . 1.68 114.092 -174.074 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 22.6 m -136.67 176.94 6.85 Favored 'Isoleucine or valine' 0 C--O 1.252 1.235 0 CA-C-N 117.488 0.644 . . . . 1.38 110.573 -178.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1548 ' ' VAL . . . . . 0.846 ' HB ' ' CE1' ' A' 1567 ' ' PHE . 7.3 p -127.1 136.63 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 CA-C-N 115.034 -0.985 . . . . 1.24 109.913 175.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1549 ' ' TYR . . . . . 0.581 ' HB2' ' HB3' ' A' 1566 ' ' CYS . 62.0 m-85 -101.63 116.04 31.87 Favored 'General case' 0 C--N 1.293 -1.854 0 C-N-CA 124.812 1.245 . . . . 1.29 108.186 177.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 8.6 ptp -125.43 146.39 49.64 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 120.189 -0.604 . . . . 1.47 110.455 175.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 8.2 p -129.46 119.79 24.36 Favored 'General case' 0 C--N 1.281 -2.398 0 CA-C-N 115.763 -0.653 . . . . 1.4 109.579 174.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1552 ' ' ILE . . . . . . . . . . . . . 38.7 mm -81.5 116.97 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.668 0 C-N-CA 120.84 -0.344 . . . . 1.11 110.238 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 64.3 m 69.84 26.94 4.66 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.108 0.963 . . . . 1.4 111.649 175.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . -172.3 -167.67 32.67 Favored Glycine 0 CA--C 1.482 -2.004 0 C-N-CA 120.098 -1.048 . . . . 0.4 111.233 -177.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -107.94 135.79 48.73 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-O 121.165 0.507 . . . . 1.62 111.374 -178.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -78.93 129.2 34.24 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.632 -0.713 . . . . 1.12 109.37 -174.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1557 ' ' GLU . . . . . 0.636 ' HG2' ' HA ' ' A' 1536 ' ' ALA . 5.3 pt-20 -73.33 -12.73 60.93 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.633 0.975 . . . . 2.49 113.633 -174.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 9.7 m120 -89.19 -2.74 58.63 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 120.48 -0.488 . . . . 1.38 110.373 -173.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1559 ' ' CYS . . . . . 0.604 ' SG ' ' HD2' ' A' 1560 ' ' PRO . 34.2 t -135.81 155.82 77.73 Favored Pre-proline 0 C--N 1.308 -1.196 0 N-CA-C 108.255 -1.017 . . . . 1.21 108.255 -175.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1560 ' ' PRO . . . . . 0.604 ' HD2' ' SG ' ' A' 1559 ' ' CYS . 69.1 Cg_exo -29.06 132.83 0.04 OUTLIER 'Trans proline' 0 C--N 1.379 2.134 1 C-N-CA 125.7 4.267 . . . . 0.98 114.73 176.175 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A 1561 ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' 1560 ' ' PRO . 9.6 Cg_endo -48.77 127.62 17.0 Favored 'Trans proline' 0 CA--C 1.547 1.147 0 C-N-CA 124.443 3.428 . . . . 1.15 114.306 -178.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 101.05 1.05 54.79 Favored Glycine 0 CA--C 1.525 0.672 0 CA-C-N 115.589 -0.732 . . . . 0.55 114.78 176.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1563 ' ' VAL . . . . . 0.466 HG11 ' SG ' ' A' 1559 ' ' CYS . 7.7 p -102.26 137.73 29.13 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 C-N-CA 119.626 -0.83 . . . . 1.53 111.18 -175.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -100.05 -31.86 5.79 Favored Glycine 0 CA--C 1.521 0.417 0 CA-C-N 115.526 -0.761 . . . . 0.29 112.681 -178.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -127.53 128.61 45.93 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 108.473 -0.936 . . . . 1.08 108.473 178.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1566 ' ' CYS . . . . . 0.581 ' HB3' ' HB2' ' A' 1549 ' ' TYR . 45.2 t -145.76 124.88 12.86 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 110.376 -0.231 . . . . 0.43 110.376 -176.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1567 ' ' PHE . . . . . 0.846 ' CE1' ' HB ' ' A' 1548 ' ' VAL . 9.7 m-85 -110.51 160.36 16.69 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 122.597 0.359 . . . . 1.3 110.296 175.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . 100.19 156.01 27.92 Favored Glycine 1 N--CA 1.394 -4.159 0 C-N-CA 119.353 -1.403 . . . . 1.43 112.026 171.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1569 ' ' GLN . . . . . 0.432 ' OE1' ' HA2' ' A' 1546 ' ' GLY . 2.3 mp0 -84.92 -23.5 28.83 Favored 'General case' 0 C--N 1.284 -2.272 0 N-CA-C 107.571 -1.27 . . . . 3.09 107.571 179.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 24.3 p -82.65 -11.7 58.18 Favored 'General case' 0 N--CA 1.423 -1.781 0 CA-C-N 115.353 -0.839 . . . . 2.52 111.68 176.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1571 ' ' ARG . . . . . 0.445 ' HB3' ' SG ' ' A' 1559 ' ' CYS . 4.8 mpt_? 73.76 75.21 0.13 Allowed 'General case' 0 CA--C 1.506 -0.726 0 C-N-CA 124.311 1.044 . . . . 3.19 111.251 178.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 61.5 mt -98.46 121.65 49.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 CA-C-N 114.074 -1.421 . . . . 1.51 109.505 -177.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1573 ' ' SER . . . . . 0.445 ' HB3' ' HB3' ' A' 1596 ' ' SER . 17.7 t -65.55 124.79 23.27 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.532 -0.758 . . . . 0.96 110.866 -178.468 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1574 ' ' VAL . . . . . 0.548 HG21 ' HD2' ' A' 1567 ' ' PHE . 32.8 m -126.48 20.21 3.51 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-O 121.866 0.841 . . . . 1.6 110.746 178.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 164.23 113.54 0.29 Allowed Glycine 0 N--CA 1.425 -2.034 0 CA-C-N 114.607 -1.179 . . . . 0.34 111.779 177.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 56.7 tttp -72.27 136.12 46.21 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 107.721 -1.214 . . . . 2.68 107.721 178.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -69.04 141.42 54.83 Favored 'General case' 0 C--N 1.314 -0.975 0 O-C-N 123.486 0.491 . . . . 1.08 111.59 -175.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 9.4 p30 -161.32 175.74 11.93 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 105.138 -2.171 . . . . 1.95 105.138 176.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 7.2 ptpp? -132.54 42.88 3.05 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 119.001 0.818 . . . . 3.11 110.951 -173.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 47.2 ttt180 -85.34 76.77 10.08 Favored 'General case' 0 N--CA 1.427 -1.6 0 N-CA-C 108.495 -0.928 . . . . 4.04 108.495 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1581 ' ' LEU . . . . . 0.557 HD13 ' CG2' ' A' 1518 ' ' VAL . 0.4 OUTLIER -70.15 121.36 17.38 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 114.846 -1.07 . . . . 1.32 108.541 179.446 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 58.2 mtp180 -116.03 120.68 39.89 Favored 'General case' 0 C--N 1.287 -2.13 0 C-N-CA 120.611 -0.436 . . . . 3.4 111.31 177.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1583 ' ' TYR . . . . . 0.559 ' HB2' HG22 ' A' 1518 ' ' VAL . 62.1 t80 -94.0 109.43 21.17 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 109.412 -0.588 . . . . 1.26 109.412 175.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1584 ' ' VAL . . . . . 0.528 ' O ' ' HB ' ' A' 1587 ' ' VAL . 11.9 m -128.22 89.57 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-O 121.518 0.675 . . . . 1.71 111.968 -179.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 34.6 t70 53.1 71.54 0.48 Allowed 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 124.359 1.063 . . . . 1.17 112.942 174.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 9.2 pt20 67.74 12.81 9.02 Favored 'General case' 0 N--CA 1.508 2.465 0 C-N-CA 127.46 2.304 . . . . 2.43 111.319 178.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1587 ' ' VAL . . . . . 0.528 ' HB ' ' O ' ' A' 1584 ' ' VAL . 39.5 t -116.86 120.66 65.71 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.152 0 CA-C-N 114.55 -1.204 . . . . 1.16 109.51 177.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1588 ' ' LEU . . . . . 0.863 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 1.8 mm? -100.46 107.81 19.63 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 105.122 -2.177 . . . . 1.11 105.122 176.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -112.89 134.74 54.27 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 112.875 0.694 . . . . 1.74 112.875 -172.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 18.6 mt -124.75 112.49 16.79 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 114.103 -1.408 . . . . 1.4 108.193 175.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 7.0 p -101.58 127.39 54.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-O 121.268 0.556 . . . . 1.7 109.61 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1592 ' ' TYR . . . . . . . . . . . . . 13.4 m-30 -114.46 101.37 9.08 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 109.467 -0.568 . . . . 1.08 109.467 -177.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 15.4 pttp -109.29 -178.16 3.49 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 114.661 -1.154 . . . . 2.21 108.138 -175.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 8.2 m-20 63.82 44.78 4.72 Favored 'General case' 0 C--N 1.319 -0.752 0 O-C-N 124.128 0.892 . . . . 1.11 110.765 179.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -79.44 -166.34 32.05 Favored Glycine 0 N--CA 1.437 -1.236 0 CA-C-N 115.0 -1.0 . . . . 0.78 110.917 176.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1596 ' ' SER . . . . . 0.647 ' HB2' ' HD2' ' A' 1597 ' ' PRO . 79.1 p -86.68 167.53 22.15 Favored Pre-proline 0 C--N 1.297 -1.679 0 C-N-CA 120.209 -0.596 . . . . 1.36 109.842 -177.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1597 ' ' PRO . . . . . 0.647 ' HD2' ' HB2' ' A' 1596 ' ' SER . 12.2 Cg_endo -56.05 120.4 8.21 Favored 'Trans proline' 0 C--N 1.364 1.349 0 C-N-CA 122.592 2.195 . . . . 1.4 111.048 178.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1598 ' ' CYS . . . . . 0.46 ' HA ' ' HD3' ' A' 1599 ' ' PRO . 44.1 t -83.98 123.97 75.09 Favored Pre-proline 0 C--N 1.286 -2.195 0 CA-C-N 114.369 -1.287 . . . . 0.75 110.12 -177.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1599 ' ' PRO . . . . . 0.487 ' HD2' ' OH ' ' A' 1606 ' ' TYR . 3.1 Cg_exo -80.01 2.7 8.22 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 123.551 2.834 . . . . 1.7 112.679 178.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1600 ' ' SER . . . . . 0.422 ' HB2' ' SG ' ' A' 1634 ' ' CYS . 14.8 m -77.54 -55.98 4.91 Favored 'General case' 0 N--CA 1.42 -1.971 0 N-CA-C 108.465 -0.939 . . . . 2.8 108.465 173.155 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1601 ' ' LYS . . . . . 0.565 ' HE3' HD11 ' A' 1604 ' ' LEU . 16.9 ttpp -119.58 117.18 27.67 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 105.836 -1.913 . . . . 3.45 105.836 173.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 12.9 p -63.14 116.35 5.32 Favored 'General case' 0 N--CA 1.422 -1.868 0 N-CA-C 113.189 0.811 . . . . 2.44 113.189 -170.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 105.47 -6.24 41.73 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 121.313 -0.47 . . . . 1.2 112.229 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1604 ' ' LEU . . . . . 0.587 HD23 ' SG ' ' A' 1634 ' ' CYS . 10.9 tp -91.52 170.45 9.93 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.399 -0.963 . . . . 2.38 108.399 -178.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 15.1 m -126.45 149.75 49.1 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 108.446 -0.946 . . . . 1.96 108.446 -179.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1606 ' ' TYR . . . . . 0.534 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 63.8 m-85 -71.0 158.1 37.09 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 122.679 0.391 . . . . 1.06 111.682 177.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -156.49 125.45 5.98 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 109.346 -0.613 . . . . 2.0 109.346 178.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1608 ' ' SER . . . . . . . . . . . . . 30.4 m -107.93 132.68 53.22 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-N 115.995 -0.548 . . . . 1.61 109.808 -178.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 31.6 t -111.6 108.17 24.8 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 109.261 -0.644 . . . . 1.09 109.261 178.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 75.6 mt -96.31 113.86 31.72 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 N-CA-C 108.917 -0.771 . . . . 1.2 108.917 -178.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 48.9 m -116.02 119.88 37.3 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 115.942 -0.572 . . . . 1.89 111.749 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1612 ' ' PHE . . . . . 0.863 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 74.6 m-85 -98.26 122.16 41.08 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.961 -1.126 . . . . 0.28 107.961 175.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 45.5 t -117.95 137.42 51.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 109.588 -0.523 . . . . 1.23 109.588 -176.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 3.5 t -52.99 112.4 0.85 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.131 0.894 . . . . 0.77 112.275 176.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1615 ' ' ARG . . . . . 0.709 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 27.9 tpt180 -133.13 93.4 22.74 Favored Pre-proline 0 C--N 1.325 -0.468 0 N-CA-C 110.224 -0.287 . . . . 2.92 110.224 174.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1616 ' ' PRO . . . . . 0.569 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 13.1 Cg_exo -70.53 -24.16 26.47 Favored 'Trans proline' 0 CA--C 1.545 1.052 0 C-N-CA 122.063 1.842 . . . . 1.22 112.428 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -85.25 43.49 1.02 Allowed 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 125.151 1.38 . . . . 3.05 110.954 179.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -33.34 117.48 0.29 Allowed 'General case' 0 C--O 1.241 0.638 0 C-N-CA 126.293 1.837 . . . . 1.55 113.2 178.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . -155.79 -135.21 1.96 Allowed Glycine 0 N--CA 1.433 -1.558 0 N-CA-C 109.078 -1.609 . . . . 1.16 109.078 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -81.86 21.09 0.98 Allowed 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.285 1.99 . . . . 1.06 112.523 -179.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1621 ' ' THR . . . . . 0.752 ' HB ' ' HB2' ' A' 1641 ' ' HIS . 46.7 p -99.17 -15.99 18.74 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 114.917 -1.038 . . . . 1.58 109.528 178.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 52.1 t30 -89.89 56.34 3.45 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 122.389 1.09 . . . . 0.88 109.369 -173.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 18.6 ptp180 -157.25 139.54 10.4 Favored Pre-proline 0 N--CA 1.427 -1.595 0 CA-C-N 114.665 -1.152 . . . . 3.82 108.248 -177.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.71 97.16 0.26 Allowed 'Trans proline' 0 C--O 1.238 0.506 0 C-N-CA 122.873 2.382 . . . . 0.77 111.687 -178.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 76.8 mtm -97.44 136.88 37.25 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 116.105 -0.498 . . . . 1.43 110.274 -178.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1626 ' ' LEU . . . . . 0.838 ' HG ' ' HE1' ' A' 1542 ' ' TYR . 0.4 OUTLIER -88.16 112.63 22.94 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 107.397 -1.335 . . . . 1.43 107.397 -179.44 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A 1627 ' ' ILE . . . . . 0.813 HD13 ' HB2' ' A' 1639 ' ' SER . 3.3 mm -72.82 -57.45 7.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 C-N-CA 123.651 0.78 . . . . 1.23 109.908 -177.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 30.6 t -163.42 151.38 13.3 Favored 'General case' 0 N--CA 1.415 -2.18 0 CA-C-N 114.657 -1.156 . . . . 1.88 107.936 -172.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1629 ' ' LEU . . . . . 0.839 HD12 ' HG ' ' A' 1636 ' ' LEU . 35.2 tp -122.44 95.62 4.71 Favored 'General case' 0 N--CA 1.419 -2.022 0 N-CA-C 107.225 -1.398 . . . . 1.92 107.225 178.017 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 15.8 t70 -75.54 97.44 3.73 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.461 -1.311 . . . . 1.09 107.461 177.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 62.0 mttp -66.83 -22.09 66.01 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 112.857 0.688 . . . . 3.98 112.857 -176.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -72.61 -36.11 68.0 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.556 0.694 . . . . 2.6 109.699 -178.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 69.6 p -102.72 -4.77 24.55 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.682 -0.69 . . . . 1.35 110.821 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1634 ' ' CYS . . . . . 0.587 ' SG ' HD23 ' A' 1604 ' ' LEU . 74.9 m 55.34 37.16 28.49 Favored 'General case' 0 C--N 1.356 0.853 0 C-N-CA 125.231 1.413 . . . . 0.53 111.811 -178.45 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1635 ' ' THR . . . . . . . . . . . . . 40.0 m -106.43 129.28 54.44 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 115.151 -0.931 . . . . 1.11 109.555 -178.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1636 ' ' LEU . . . . . 0.839 ' HG ' HD12 ' A' 1629 ' ' LEU . 0.3 OUTLIER -111.39 135.88 51.32 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 107.287 -1.375 . . . . 1.56 107.287 -177.663 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -112.19 131.31 55.55 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 120.798 -0.361 . . . . 0.54 111.2 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1638 ' ' PHE . . . . . 0.488 ' CE1' HD21 ' A' 1626 ' ' LEU . 98.4 m-85 -123.23 130.89 53.36 Favored 'General case' 0 C--O 1.243 0.726 0 N-CA-C 108.241 -1.022 . . . . 0.64 108.241 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1639 ' ' SER . . . . . 0.813 ' HB2' HD13 ' A' 1627 ' ' ILE . 11.7 t -115.9 148.47 39.97 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 107.645 -1.243 . . . . 1.34 107.645 178.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 3.2 t90 -152.36 107.82 3.3 Favored 'General case' 0 N--CA 1.414 -2.251 0 N-CA-C 104.984 -2.228 . . . . 0.8 104.984 -179.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1641 ' ' HIS . . . . . 0.752 ' HB2' ' HB ' ' A' 1621 ' ' THR . 17.4 m-70 -102.87 107.93 18.95 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 109.358 -0.608 . . . . 1.14 109.358 -177.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1642 ' ' THR . . . . . . . . . . . . . 7.9 t -140.74 148.06 51.24 Favored Pre-proline 0 C--N 1.301 -1.521 0 CA-C-N 115.049 -0.978 . . . . 1.11 109.731 -171.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1643 ' ' PRO . . . . . 0.569 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 56.9 Cg_endo -80.4 -11.17 13.23 Favored 'Trans proline' 0 C--N 1.365 1.423 0 C-N-CA 122.314 2.009 . . . . 0.78 112.365 178.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1644 ' ' LEU . . . . . 0.578 HD13 ' HB2' ' A' 1531 ' ' SER . 7.4 tt -67.08 -25.82 66.42 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 108.407 -0.96 . . . . 1.66 108.407 176.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -103.09 23.36 12.46 Favored 'General case' 0 N--CA 1.424 -1.746 0 CA-C-N 114.833 -1.076 . . . . 1.29 109.735 -175.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 37.9 t -122.08 146.8 46.85 Favored 'General case' 0 N--CA 1.423 -1.797 0 CA-C-N 115.203 -0.908 . . . . 1.48 109.588 -179.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1647 ' ' GLU . . . . . 0.476 ' OE2' ' OH ' ' A' 1583 ' ' TYR . 0.1 OUTLIER . . . . . 0 C--N 1.295 -1.8 0 N-CA-C 108.25 -1.019 . . . . 3.14 108.25 176.198 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.424 -2.154 0 N-CA-C 110.023 -1.231 . . . . 2.28 110.023 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . 0.446 ' HA2' HG12 ' B' ' 14' ' ' VAL . . . -60.32 -45.17 96.64 Favored Glycine 0 C--O 1.201 -1.934 0 O-C-N 124.06 0.506 . . . . 1.94 113.01 -177.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 44.4 mp0 -61.38 -39.17 89.67 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.781 0.8 . . . . 2.55 111.154 -179.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 13' ' ' LEU . . . . . 0.413 HD21 ' HB3' ' B' ' 46' ' ' CYS . 0.1 OUTLIER -71.26 -40.9 70.7 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.03 -0.986 . . . . 2.82 110.141 -178.818 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . 0.446 HG12 ' HA2' ' B' ' 11' ' ' GLY . 5.1 p -76.83 -32.05 19.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 C-N-CA 120.019 -0.672 . . . . 2.5 110.485 -178.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -68.6 -36.08 78.2 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 116.175 -0.466 . . . . 2.04 111.832 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 11.7 p -69.99 -40.29 75.42 Favored 'General case' 0 C--O 1.262 1.75 0 O-C-N 121.899 -0.501 . . . . 2.31 110.149 177.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.481 ' HB3' ' HB3' ' B' ' 26' ' ' PHE . 3.7 mm? -54.66 -49.88 69.55 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 115.546 -0.752 . . . . 2.27 111.052 172.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -65.97 -33.35 75.63 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.828 -0.624 . . . . 2.39 111.265 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 19' ' ' PHE . . . . . 0.464 ' HE1' ' CD1' ' A' 1567 ' ' PHE . 74.1 t80 -50.63 -57.47 8.16 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 123.038 0.535 . . . . 1.0 111.751 178.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 15.0 p -99.54 -22.4 4.78 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.984 0 C-N-CA 118.389 -1.324 . . . . 1.83 113.298 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 21' ' ' CYS . . . . . 0.438 ' HB2' ' O ' ' B' ' 17' ' ' LEU . 86.2 m -104.85 27.26 8.25 Favored 'General case' 0 C--N 1.316 -0.886 0 O-C-N 121.518 -0.739 . . . . 1.66 112.665 -178.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -53.17 -52.43 40.31 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 121.509 -0.377 . . . . 1.53 114.037 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . 0.421 ' CG ' ' HZ2' ' A' 1544 ' ' LYS . 2.6 m-20 -74.7 -23.59 58.63 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 113.614 0.968 . . . . 2.72 113.614 -179.051 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . 0.538 ' HD2' ' SG ' ' B' ' 60' ' ' CYS . 41.5 ttm180 -87.87 -35.45 17.74 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.68 -0.808 . . . . 5.02 110.507 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.83 168.46 23.38 Favored Glycine 0 N--CA 1.423 -2.214 0 N-CA-C 110.279 -1.128 . . . . 1.63 110.279 -178.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . 0.481 ' HB3' ' HB3' ' B' ' 17' ' ' LEU . 3.2 p90 -122.22 138.94 54.31 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 116.954 0.377 . . . . 1.71 110.197 175.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -122.0 -91.15 0.56 Allowed 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 118.876 -0.583 . . . . 3.67 110.133 -177.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 28' ' ' PHE . . . . . . . . . . . . . 51.7 p90 . . . . . 0 N--CA 1.507 2.397 0 N-CA-C 115.752 1.76 . . . . 2.44 115.752 179.592 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.489 -1.594 0 N-CA-C 109.384 -1.486 . . . . 2.62 109.384 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 22.5 pt 62.01 -37.62 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 C-N-CA 127.48 2.312 . . . . 2.28 116.182 175.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . 0.405 ' O ' ' HB2' ' B' ' 47' ' ' CYS . 2.5 p -50.03 -50.31 19.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 114.751 1.389 . . . . 2.6 114.751 -176.043 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -93.74 -27.66 16.37 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.98 -0.748 . . . . 3.36 108.98 -174.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . 0.462 ' O ' ' HB2' ' B' ' 49' ' ' ARG . 41.7 mt-10 -61.2 -56.62 18.62 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.863 -1.062 . . . . 3.08 110.127 178.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 46' ' ' CYS . . . . . 0.481 ' HB2' ' HB3' ' B' ' 51' ' ' CYS . 48.3 t -83.67 -3.91 58.15 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 116.117 -0.492 . . . . 2.23 111.276 -176.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 47' ' ' CYS . . . . . 0.405 ' HB2' ' O ' ' B' ' 43' ' ' VAL . 34.3 t -80.42 -38.87 29.36 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 118.905 -1.118 . . . . 2.48 110.29 176.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -111.55 9.29 21.19 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 112.609 0.596 . . . . 2.97 112.609 -175.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . 0.462 ' HB2' ' O ' ' B' ' 45' ' ' GLU . 63.1 mtp180 -146.88 -177.89 5.9 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 105.874 -1.899 . . . . 4.65 105.874 177.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 11.2 t -106.05 145.32 31.55 Favored 'General case' 0 C--N 1.278 -2.524 0 N-CA-C 106.157 -1.794 . . . . 2.86 106.157 177.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . 0.481 ' HB3' ' HB2' ' B' ' 46' ' ' CYS . 23.4 p -118.17 143.11 46.77 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 110.45 -0.204 . . . . 2.11 110.45 -175.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -94.59 163.15 13.5 Favored 'General case' 0 C--O 1.253 1.248 0 N-CA-C 107.414 -1.328 . . . . 2.67 107.414 173.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -66.75 -9.26 34.85 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 120.756 0.313 . . . . 2.36 110.938 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.63 -15.96 44.2 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.167 0.987 . . . . 1.92 110.541 176.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . 0.656 ' O ' ' HB2' ' B' ' 59' ' ' TYR . 49.1 mt -98.56 -55.78 2.64 Favored 'General case' 0 C--O 1.2 -1.545 0 CA-C-O 120.971 0.415 . . . . 2.35 111.404 174.046 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 1.7 pp -74.73 -33.28 62.34 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 114.537 1.31 . . . . 2.01 114.537 -170.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -76.85 -32.5 57.57 Favored 'General case' 0 CA--C 1.559 1.293 0 C-N-CA 120.31 -0.556 . . . . 2.27 110.768 178.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 73.9 p -75.37 -50.99 14.22 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 120.844 0.354 . . . . 2.67 111.165 177.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 59' ' ' TYR . . . . . 0.656 ' HB2' ' O ' ' B' ' 55' ' ' LEU . 0.3 OUTLIER -65.17 -64.67 0.81 Allowed 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 108.76 -0.83 . . . . 3.2 108.76 -178.725 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 60' ' ' CYS . . . . . 0.538 ' SG ' ' HD2' ' B' ' 24' ' ' ARG . 43.6 t . . . . . 0 N--CA 1.482 1.174 0 C-N-CA 125.32 1.448 . . . . 2.3 113.441 176.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 50.3 m-20 . . . . . 0 C--O 1.237 0.4 0 N-CA-C 111.799 0.296 . . . . 2.9 111.799 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A 1516 ' ' CYS . . . . . 0.511 ' HA ' ' HB2' ' A' 1581 ' ' LEU . 95.6 m 52.53 50.49 18.11 Favored 'General case' 0 CA--C 1.497 -1.083 0 CA-C-O 121.717 0.77 . . . . 1.41 112.029 -178.141 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -150.91 130.35 12.93 Favored 'General case' 0 N--CA 1.407 -2.591 0 CA-C-N 115.049 -0.978 . . . . 2.18 109.76 -176.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1518 ' ' VAL . . . . . 0.455 HG22 ' HB2' ' A' 1583 ' ' TYR . 3.0 m -137.54 142.32 37.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-N 115.274 -0.876 . . . . 1.52 110.18 -178.011 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1519 ' ' THR . . . . . . . . . . . . . 44.3 m -107.17 141.97 37.61 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 116.312 -0.404 . . . . 1.36 111.511 -178.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1520 ' ' ASN . . . . . 0.518 ' OD1' HG22 ' A' 1523 ' ' THR . 6.4 t-20 -89.52 120.78 69.61 Favored Pre-proline 0 N--CA 1.441 -0.915 0 N-CA-C 108.58 -0.896 . . . . 2.02 108.58 173.179 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -62.66 -27.69 76.23 Favored 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 123.22 2.614 . . . . 1.82 113.927 -176.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 15.0 m -68.14 -47.66 67.49 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 112.939 0.718 . . . . 1.89 112.939 -175.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1523 ' ' THR . . . . . 0.518 HG22 ' OD1' ' A' 1520 ' ' ASN . 11.8 t -118.8 2.64 11.63 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 119.785 -0.766 . . . . 1.99 111.833 -173.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 63.42 34.0 88.77 Favored Glycine 0 CA--C 1.504 -0.632 0 CA-C-N 115.749 -0.66 . . . . 1.19 112.007 178.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1525 ' ' HIS . . . . . 0.451 ' HB2' HG21 ' A' 1523 ' ' THR . 32.7 t-80 -94.22 127.27 39.96 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 120.095 -0.642 . . . . 1.82 109.46 -177.453 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 3.1 tm? -90.88 117.37 29.44 Favored 'General case' 0 C--N 1.289 -2.065 0 CA-C-N 115.019 -0.991 . . . . 1.3 108.956 -177.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -95.51 126.07 40.55 Favored 'General case' 0 N--CA 1.432 -1.33 0 C-N-CA 119.749 -0.78 . . . . 0.8 110.577 173.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 10.5 t70 -115.92 126.98 54.61 Favored 'General case' 0 C--N 1.309 -1.16 0 O-C-N 123.738 0.649 . . . . 1.17 109.727 175.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1529 ' ' LEU . . . . . 0.494 ' HG ' HD23 ' A' 1581 ' ' LEU . 3.4 mm? -106.9 2.35 25.27 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 120.982 0.42 . . . . 1.29 111.149 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 3.8 m -71.78 -14.28 61.94 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.145 0.497 . . . . 0.91 111.796 -176.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 6.1 p -70.0 -31.62 69.38 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.634 0.73 . . . . 1.98 110.831 179.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 77.5 mt -84.97 7.06 22.53 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.025 -0.989 . . . . 1.34 110.713 -179.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1533 ' ' SER . . . . . 0.43 ' HA ' ' HB ' ' A' 1552 ' ' ILE . 19.7 t -74.97 172.47 12.24 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.683 0.754 . . . . 1.93 111.118 -179.423 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -176.94 141.24 5.31 Favored Glycine 0 N--CA 1.422 -2.24 0 N-CA-C 108.141 -1.984 . . . . 1.1 108.141 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 11.5 tpp180 -92.2 -31.66 15.37 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 120.954 0.407 . . . . 5.21 111.454 -176.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -80.61 -37.36 31.27 Favored 'General case' 0 CA--C 1.502 -0.904 0 N-CA-C 108.164 -1.051 . . . . 1.94 108.164 177.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1537 ' ' GLY . . . . . 0.411 ' HA3' ' ND2' ' A' 1556 ' ' ASN . . . 110.04 -177.37 19.73 Favored Glycine 0 N--CA 1.406 -3.304 0 CA-C-N 114.792 -1.094 . . . . 1.08 111.938 174.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -121.68 142.56 50.03 Favored 'General case' 0 C--N 1.277 -2.571 0 N-CA-C 106.954 -1.499 . . . . 1.07 106.954 178.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 3.3 p -105.33 129.78 53.59 Favored 'General case' 0 C--N 1.292 -1.903 0 O-C-N 123.652 0.595 . . . . 1.46 110.764 179.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1540 ' ' ALA . . . . . 0.455 ' HB1' ' CG1' ' A' 1548 ' ' VAL . . . -121.83 144.56 48.75 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.615 -1.254 . . . . 1.19 107.615 176.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -80.84 126.57 31.5 Favored 'General case' 0 N--CA 1.431 -1.377 0 O-C-N 123.643 0.589 . . . . 1.37 109.545 -176.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1542 ' ' TYR . . . . . 0.545 ' CE1' ' HG ' ' A' 1626 ' ' LEU . 10.6 t80 -131.73 -102.09 0.28 Allowed 'General case' 0 N--CA 1.419 -2.0 0 CA-C-N 115.484 -0.78 . . . . 1.38 109.733 -175.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1543 ' ' SER . . . . . . . . . . . . . 43.1 t -77.57 155.32 31.6 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.651 -0.87 . . . . 1.98 108.651 178.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -55.76 -42.16 75.06 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 119.175 0.898 . . . . 3.96 111.002 178.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 41.8 m -106.24 30.72 5.69 Favored 'General case' 0 N--CA 1.407 -2.609 0 CA-C-O 121.078 0.466 . . . . 2.81 110.795 -176.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . -170.71 113.53 0.5 Allowed Glycine 0 N--CA 1.433 -1.514 0 C-N-CA 119.643 -1.265 . . . . 1.68 113.336 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 30.9 m -94.02 167.52 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 N-CA-C 107.794 -1.187 . . . . 1.38 107.794 175.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1548 ' ' VAL . . . . . 0.467 HG22 ' CD1' ' A' 1567 ' ' PHE . 10.9 p -107.7 131.05 58.98 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.178 0 C-N-CA 119.448 -0.901 . . . . 1.24 109.476 178.105 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -97.74 127.19 43.52 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.129 -1.063 . . . . 1.29 108.129 178.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 25.6 ptm -143.82 137.52 28.04 Favored 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 120.377 -0.529 . . . . 1.47 112.005 -178.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 11.2 p -127.7 125.78 40.67 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 115.397 -0.82 . . . . 1.4 109.76 176.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1552 ' ' ILE . . . . . 0.43 ' HB ' ' HA ' ' A' 1533 ' ' SER . 42.4 mm -80.98 116.68 25.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 N-CA-C 109.817 -0.438 . . . . 1.11 109.817 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1553 ' ' CYS . . . . . 0.48 ' SG ' HD12 ' A' 1590 ' ' LEU . 85.6 m 62.59 31.81 16.69 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 112.813 0.672 . . . . 1.4 112.813 173.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . -166.55 175.2 41.98 Favored Glycine 0 N--CA 1.417 -2.591 0 N-CA-C 108.201 -1.96 . . . . 0.4 108.201 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -98.18 148.76 23.26 Favored 'General case' 0 C--N 1.289 -2.049 0 C-N-CA 119.91 -0.716 . . . . 1.62 110.925 -179.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1556 ' ' ASN . . . . . 0.411 ' ND2' ' HA3' ' A' 1537 ' ' GLY . 25.7 t-20 -92.44 125.21 36.99 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 108.384 -0.969 . . . . 1.12 108.384 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -81.07 4.88 18.33 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 114.4 1.259 . . . . 2.49 114.4 -175.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -95.95 -4.21 43.77 Favored 'General case' 0 C--N 1.317 -0.838 0 O-C-N 121.638 -0.664 . . . . 1.38 111.234 -179.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1559 ' ' CYS . . . . . 0.777 ' SG ' ' HD2' ' A' 1560 ' ' PRO . 17.6 t -136.87 162.93 53.06 Favored Pre-proline 0 C--N 1.302 -1.489 0 N-CA-C 106.84 -1.541 . . . . 1.21 106.84 -177.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1560 ' ' PRO . . . . . 0.777 ' HD2' ' SG ' ' A' 1559 ' ' CYS . 45.5 Cg_exo -28.46 128.53 0.04 OUTLIER 'Trans proline' 0 C--N 1.384 2.444 0 C-N-CA 124.982 3.788 . . . . 0.98 115.25 176.215 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -48.96 122.68 8.66 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 124.067 3.178 . . . . 1.15 113.826 -178.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 98.94 14.68 35.88 Favored Glycine 0 C--N 1.311 -0.814 0 CA-C-N 115.63 -0.714 . . . . 0.55 114.328 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1563 ' ' VAL . . . . . 0.601 HG22 ' HB2' ' A' 1573 ' ' SER . 9.9 p -104.66 144.43 14.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.885 -0.773 . . . . 1.53 110.662 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -102.39 -33.3 4.57 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 121.213 -0.518 . . . . 0.29 113.033 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -130.15 139.6 50.86 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.79 -0.448 . . . . 1.08 109.79 178.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 45.7 t -159.16 133.23 7.6 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 119.529 -0.272 . . . . 0.43 110.724 -177.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1567 ' ' PHE . . . . . 0.467 ' CD1' HG22 ' A' 1548 ' ' VAL . 28.5 m-85 -84.89 139.64 31.72 Favored 'General case' 0 C--O 1.249 1.047 0 N-CA-C 108.458 -0.942 . . . . 1.3 108.458 171.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -82.47 39.43 2.66 Favored Glycine 0 N--CA 1.442 -0.933 0 C-N-CA 121.703 -0.284 . . . . 1.43 113.783 -175.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -76.51 -71.42 0.39 Allowed 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 108.661 -0.866 . . . . 3.09 108.661 174.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 2.9 p -132.52 33.31 3.81 Favored 'General case' 0 C--N 1.308 -1.209 0 C-N-CA 122.935 0.494 . . . . 2.52 110.278 174.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1571 ' ' ARG . . . . . 0.497 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 3.1 mpt_? 61.9 60.08 1.61 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.9 0.857 . . . . 3.19 109.442 -173.072 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 39.9 mt -96.26 101.72 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 107.748 -1.204 . . . . 1.51 107.748 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1573 ' ' SER . . . . . 0.601 ' HB2' HG22 ' A' 1563 ' ' VAL . 94.1 p -63.31 129.39 40.05 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 114.321 -1.309 . . . . 0.96 111.288 -176.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1574 ' ' VAL . . . . . 0.457 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 35.1 m -120.14 16.77 6.47 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-O 121.511 0.672 . . . . 1.6 112.054 -176.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 173.27 118.24 0.49 Allowed Glycine 0 N--CA 1.428 -1.9 0 CA-C-N 115.414 -0.812 . . . . 0.34 111.135 176.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 55.3 tttp -70.42 139.27 51.78 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 107.805 -1.183 . . . . 2.68 107.805 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -68.5 98.79 0.89 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.207 0.447 . . . . 1.08 112.207 -175.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1578 ' ' ASN . . . . . 0.553 ' O ' ' HE1' ' A' 1592 ' ' TYR . 84.5 m-20 -115.67 157.61 23.97 Favored 'General case' 0 C--O 1.206 -1.223 0 N-CA-C 106.926 -1.509 . . . . 1.95 106.926 175.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1579 ' ' LYS . . . . . 0.434 ' HB3' ' SG ' ' A' 1516 ' ' CYS . 28.2 mtmm -122.97 42.07 3.29 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 122.167 0.984 . . . . 3.11 108.512 -178.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 25.9 ttm180 -90.4 76.9 6.64 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 122.257 1.027 . . . . 4.04 109.313 -173.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1581 ' ' LEU . . . . . 0.511 ' HB2' ' HA ' ' A' 1516 ' ' CYS . 0.3 OUTLIER -65.87 133.02 50.06 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 113.184 -1.825 . . . . 1.32 109.517 -178.518 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A 1582 ' ' ARG . . . . . 0.721 ' HB2' ' HB3' ' A' 1589 ' ' GLN . 94.5 mtt180 -120.52 141.17 50.48 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 109.765 -0.458 . . . . 3.4 109.765 175.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1583 ' ' TYR . . . . . 0.536 ' OH ' ' OE1' ' A' 1647 ' ' GLU . 16.2 t80 -114.94 102.37 9.9 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 109.512 -0.551 . . . . 1.26 109.512 177.155 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1584 ' ' VAL . . . . . 0.549 ' O ' ' HB ' ' A' 1587 ' ' VAL . 27.8 m -123.68 91.15 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.763 -0.653 . . . . 1.71 111.868 -177.358 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1585 ' ' ASP . . . . . 0.404 ' O ' ' HG2' ' A' 1586 ' ' GLN . 24.0 t70 56.5 62.62 2.24 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.896 0.878 . . . . 1.17 111.576 176.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1586 ' ' GLN . . . . . 0.404 ' HG2' ' O ' ' A' 1585 ' ' ASP . 9.0 pt20 68.89 2.22 3.45 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 127.628 2.371 . . . . 2.43 111.547 178.033 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1587 ' ' VAL . . . . . 0.549 ' HB ' ' O ' ' A' 1584 ' ' VAL . 25.0 t -92.11 123.49 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.116 0 CA-C-N 115.329 -0.85 . . . . 1.16 109.406 175.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1588 ' ' LEU . . . . . 0.648 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 3.6 mm? -99.51 108.25 20.64 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.089 -1.078 . . . . 1.11 108.089 179.17 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1589 ' ' GLN . . . . . 0.721 ' HB3' ' HB2' ' A' 1582 ' ' ARG . 4.0 tp-100 -100.41 133.46 44.8 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 115.233 -0.894 . . . . 1.74 111.376 -174.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1590 ' ' LEU . . . . . 0.48 HD12 ' SG ' ' A' 1553 ' ' CYS . 0.4 OUTLIER -130.94 92.48 3.23 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 105.843 -1.91 . . . . 1.4 105.843 175.066 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 8.3 p -93.77 125.94 46.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 CA-C-O 121.835 0.826 . . . . 1.7 112.906 -174.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1592 ' ' TYR . . . . . 0.553 ' HE1' ' O ' ' A' 1578 ' ' ASN . 17.5 m-30 -112.49 138.26 49.51 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 107.76 -1.2 . . . . 1.08 107.76 176.116 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 22.7 pttm -148.54 -178.53 6.38 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.082 -1.081 . . . . 2.21 108.082 178.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 11.0 m-20 60.74 50.45 5.48 Favored 'General case' 0 C--O 1.242 0.701 0 O-C-N 124.223 0.952 . . . . 1.11 110.978 176.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -78.35 -112.48 0.19 Allowed Glycine 0 N--CA 1.433 -1.561 0 N-CA-C 110.272 -1.131 . . . . 0.78 110.272 178.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1596 ' ' SER . . . . . . . . . . . . . 56.2 p -124.98 159.69 57.81 Favored Pre-proline 0 C--N 1.274 -2.675 0 N-CA-C 107.691 -1.226 . . . . 1.36 107.691 174.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -54.73 124.75 16.98 Favored 'Trans proline' 0 C--N 1.358 1.028 0 C-N-CA 122.386 2.057 . . . . 1.4 110.339 177.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1598 ' ' CYS . . . . . 0.615 ' HA ' ' CE2' ' A' 1606 ' ' TYR . 21.7 t -58.47 115.96 13.4 Favored Pre-proline 0 C--N 1.308 -1.239 0 N-CA-C 108.775 -0.824 . . . . 0.75 108.775 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1599 ' ' PRO . . . . . 0.65 ' HB2' ' HB ' ' B' ' 16' ' ' THR . 31.8 Cg_exo -60.87 -23.96 78.11 Favored 'Trans proline' 0 C--N 1.361 1.21 0 C-N-CA 123.016 2.477 . . . . 1.7 112.676 -176.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1600 ' ' SER . . . . . 0.606 ' HB3' ' HB3' ' B' ' 53' ' ' LEU . 44.3 m -80.52 -14.66 58.06 Favored 'General case' 0 CA--C 1.566 1.571 0 N-CA-C 113.033 0.753 . . . . 2.8 113.033 177.452 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1601 ' ' LYS . . . . . 0.419 ' HG3' HD12 ' A' 1604 ' ' LEU . 3.2 tppp? -160.76 116.07 2.21 Favored 'General case' 0 C--O 1.24 0.588 0 O-C-N 121.698 -0.626 . . . . 3.45 110.797 -176.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 38.3 t -69.74 141.95 53.36 Favored 'General case' 0 N--CA 1.416 -2.15 0 N-CA-C 108.457 -0.942 . . . . 2.44 108.457 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 99.26 -17.6 57.68 Favored Glycine 0 C--N 1.3 -1.439 0 C-N-CA 121.222 -0.513 . . . . 1.2 112.72 179.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1604 ' ' LEU . . . . . 0.419 HD12 ' HG3' ' A' 1601 ' ' LYS . 8.9 mp -102.57 145.9 28.93 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 123.212 0.605 . . . . 2.38 110.561 178.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 31.5 t -121.59 153.6 37.85 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 106.757 -1.571 . . . . 1.96 106.757 175.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1606 ' ' TYR . . . . . 0.615 ' CE2' ' HA ' ' A' 1598 ' ' CYS . 49.1 m-85 -78.56 155.07 29.88 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 116.522 -0.308 . . . . 1.06 111.558 178.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? -150.16 145.1 26.09 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 106.943 -1.502 . . . . 2.0 106.943 175.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1608 ' ' SER . . . . . . . . . . . . . 17.2 m -120.0 120.91 37.69 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 107.789 -1.189 . . . . 1.61 107.789 -178.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 21.3 t -99.99 103.87 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 CA-C-O 121.118 0.485 . . . . 1.09 109.701 178.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 83.1 mt -96.69 106.27 18.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 C-N-CA 123.845 0.858 . . . . 1.2 109.171 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 14.4 t -106.98 113.94 27.72 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 108.392 -0.966 . . . . 1.89 108.392 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1612 ' ' PHE . . . . . 0.648 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 60.0 m-85 -81.8 121.51 26.52 Favored 'General case' 0 C--O 1.258 1.551 0 N-CA-C 109.477 -0.564 . . . . 0.28 109.477 176.08 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 46.4 t -111.54 129.86 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-N 114.798 -1.092 . . . . 1.23 109.862 -174.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 22.1 t -61.14 110.86 1.5 Allowed 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.112 -0.949 . . . . 0.77 111.884 178.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1615 ' ' ARG . . . . . 0.611 ' HG3' ' HB3' ' A' 1617 ' ' GLU . 32.5 tpt180 -137.48 95.76 11.27 Favored Pre-proline 0 N--CA 1.438 -1.033 0 N-CA-C 109.246 -0.65 . . . . 2.92 109.246 173.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1616 ' ' PRO . . . . . 0.778 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 39.5 Cg_exo -61.45 -21.26 71.43 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 122.86 2.373 . . . . 1.22 113.387 -178.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1617 ' ' GLU . . . . . 0.611 ' HB3' ' HG3' ' A' 1615 ' ' ARG . 38.9 tt0 -49.44 -41.12 39.07 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 125.586 1.554 . . . . 3.05 112.451 176.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . 43.58 81.03 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.527 0.731 . . . . 1.55 112.564 -177.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1619 ' ' GLY . . . . . 0.41 ' HA3' ' HD2' ' A' 1620 ' ' PRO . . . -153.45 -134.33 1.98 Allowed Glycine 0 C--N 1.274 -2.907 0 C-N-CA 120.581 -0.819 . . . . 1.16 111.569 -177.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1620 ' ' PRO . . . . . 0.41 ' HD2' ' HA3' ' A' 1619 ' ' GLY . 42.3 Cg_endo -66.88 1.09 3.01 Favored 'Trans proline' 0 CA--C 1.55 1.298 0 C-N-CA 122.656 2.237 . . . . 1.06 114.465 -179.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1621 ' ' THR . . . . . 0.778 ' HB ' ' HB2' ' A' 1641 ' ' HIS . 2.7 p -98.67 -13.66 20.19 Favored 'General case' 0 N--CA 1.419 -1.979 0 C-N-CA 124.13 0.972 . . . . 1.58 109.727 178.061 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 53.0 t30 -86.03 69.2 10.5 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.956 -1.02 . . . . 0.88 108.566 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1623 ' ' ARG . . . . . 0.462 ' O ' ' HG3' ' A' 1625 ' ' MET . 11.5 ptp180 -166.23 140.63 3.62 Favored Pre-proline 0 C--N 1.296 -1.744 0 N-CA-C 107.537 -1.283 . . . . 3.82 107.537 -178.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -58.07 104.71 0.18 Allowed 'Trans proline' 0 C--O 1.238 0.515 0 C-N-CA 122.92 2.413 . . . . 0.77 110.885 178.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1625 ' ' MET . . . . . 0.462 ' HG3' ' O ' ' A' 1623 ' ' ARG . 94.2 mtp -98.75 131.27 45.02 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.476 -0.935 . . . . 1.43 108.476 -176.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1626 ' ' LEU . . . . . 0.545 ' HG ' ' CE1' ' A' 1542 ' ' TYR . 1.0 OUTLIER -86.82 111.86 21.17 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 106.938 -1.505 . . . . 1.43 106.938 -178.031 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A 1627 ' ' ILE . . . . . 0.516 HD12 ' HB2' ' A' 1639 ' ' SER . 37.8 mm -73.07 -56.89 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.883 0 N-CA-C 108.902 -0.777 . . . . 1.23 108.902 -178.472 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 23.8 t -171.88 162.21 6.01 Favored 'General case' 0 N--CA 1.417 -2.124 0 N-CA-C 107.839 -1.171 . . . . 1.88 107.839 -175.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1629 ' ' LEU . . . . . 0.5 HD12 ' CD1' ' A' 1636 ' ' LEU . 5.7 tp -112.11 109.2 18.78 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 107.731 -1.211 . . . . 1.92 107.731 175.112 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1630 ' ' ASP . . . . . 0.509 ' HB3' ' HB ' ' A' 1635 ' ' THR . 13.4 t70 -75.02 85.91 2.31 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 106.16 -1.793 . . . . 1.09 106.16 173.205 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1631 ' ' LYS . . . . . 0.568 ' HG3' HD12 ' B' ' 53' ' ' LEU . 21.6 tptm -64.65 -19.8 65.92 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 114.229 -1.351 . . . . 3.98 112.702 -173.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1632 ' ' GLN . . . . . 0.4 HE21 ' HB3' ' A' 1632 ' ' GLN . 3.2 mt-30 -76.19 -31.67 58.6 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 119.599 -0.841 . . . . 2.6 110.376 -176.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 59.6 p -107.26 -10.46 15.81 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 116.116 -0.493 . . . . 1.35 111.631 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 65.9 m 67.23 49.26 1.09 Allowed 'General case' 0 C--N 1.36 1.054 0 CA-C-O 122.76 1.267 . . . . 0.53 109.975 -178.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1635 ' ' THR . . . . . 0.509 ' HB ' ' HB3' ' A' 1630 ' ' ASP . 93.3 m -109.87 130.0 55.58 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 113.854 -1.521 . . . . 1.11 109.088 -177.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1636 ' ' LEU . . . . . 0.5 ' CD1' HD12 ' A' 1629 ' ' LEU . 0.2 OUTLIER -105.68 135.82 46.39 Favored 'General case' 0 CA--C 1.504 -0.802 0 N-CA-C 108.009 -1.108 . . . . 1.56 108.009 177.68 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -109.37 125.59 52.53 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 109.556 -0.535 . . . . 0.54 109.556 177.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -125.11 136.89 54.07 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.307 -0.627 . . . . 0.64 109.307 -178.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1639 ' ' SER . . . . . 0.516 ' HB2' HD12 ' A' 1627 ' ' ILE . 33.1 t -116.8 154.87 29.94 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 107.285 -1.376 . . . . 1.34 107.285 175.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 2.7 t90 -150.38 108.21 3.7 Favored 'General case' 0 N--CA 1.417 -2.087 0 N-CA-C 104.882 -2.266 . . . . 0.8 104.882 178.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1641 ' ' HIS . . . . . 0.778 ' HB2' ' HB ' ' A' 1621 ' ' THR . 51.2 m-70 -95.06 104.63 16.51 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 121.281 0.562 . . . . 1.14 109.941 -175.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1642 ' ' THR . . . . . . . . . . . . . 8.6 t -142.38 148.99 49.72 Favored Pre-proline 0 C--N 1.3 -1.584 0 CA-C-N 115.67 -0.696 . . . . 1.11 109.674 -173.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1643 ' ' PRO . . . . . 0.778 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 77.7 Cg_endo -78.87 -6.41 15.12 Favored 'Trans proline' 0 C--N 1.369 1.626 0 C-N-CA 122.483 2.122 . . . . 0.78 112.586 179.412 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 8.2 tt -70.21 -25.35 63.36 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.1 -0.704 . . . . 1.66 109.1 178.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -95.29 17.12 14.98 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.962 -1.017 . . . . 1.29 110.342 -178.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1646 ' ' CYS . . . . . 0.511 ' SG ' ' HA ' ' A' 1643 ' ' PRO . 95.7 m -96.28 145.59 25.45 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 109.716 -0.476 . . . . 1.48 109.716 177.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1647 ' ' GLU . . . . . 0.536 ' OE1' ' OH ' ' A' 1583 ' ' TYR . 35.4 tt0 . . . . . 0 C--N 1.297 -1.684 0 N-CA-C 108.654 -0.869 . . . . 3.14 108.654 -177.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . 0.481 ' O ' HG13 ' B' ' 14' ' ' VAL . . . . . . . . 0 N--CA 1.417 -2.593 0 CA-C-O 119.087 -0.841 . . . . 2.28 112.708 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -44.79 -74.67 0.2 Allowed Glycine 0 N--CA 1.473 1.153 0 N-CA-C 115.626 1.011 . . . . 1.94 115.626 -170.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -75.0 -17.14 60.57 Favored 'General case' 0 C--N 1.314 -0.966 0 O-C-N 122.317 -0.519 . . . . 2.55 111.578 -179.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 13' ' ' LEU . . . . . 0.477 ' O ' HD22 ' B' ' 17' ' ' LEU . 36.7 tp -71.98 -53.73 12.1 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-O 120.884 0.373 . . . . 2.82 110.284 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . 0.481 HG13 ' O ' ' B' ' 10' ' ' GLY . 13.7 p -70.64 -23.54 24.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-O 121.5 0.667 . . . . 2.5 109.796 -179.465 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -72.49 -42.43 64.87 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.815 -0.629 . . . . 2.04 111.233 175.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 16' ' ' THR . . . . . 0.65 ' HB ' ' HB2' ' A' 1599 ' ' PRO . 15.1 t -67.43 -30.14 69.81 Favored 'General case' 0 C--O 1.248 1.005 0 CA-C-N 118.674 0.67 . . . . 2.31 110.727 176.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.477 HD22 ' O ' ' B' ' 13' ' ' LEU . 3.3 mm? -51.97 -51.69 55.48 Favored 'General case' 0 C--O 1.212 -0.918 0 O-C-N 123.637 0.586 . . . . 2.27 109.89 168.077 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.69 -33.69 69.01 Favored 'General case' 0 C--O 1.214 -0.793 0 CA-C-N 116.014 -0.539 . . . . 2.39 110.213 -178.417 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -47.97 -64.09 0.89 Allowed 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 113.084 0.772 . . . . 1.0 113.084 177.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 10.1 p -91.93 -14.52 8.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 C-N-CA 118.588 -1.245 . . . . 1.83 111.62 -176.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 21' ' ' CYS . . . . . 0.555 ' HB2' ' HB3' ' B' ' 26' ' ' PHE . 61.9 m -106.95 17.51 23.0 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 119.806 -0.758 . . . . 1.66 112.659 -178.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -53.01 -44.14 62.03 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 121.226 -0.512 . . . . 1.53 112.43 174.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -82.22 -52.5 6.9 Favored 'General case' 0 C--N 1.314 -0.937 0 O-C-N 122.627 -0.337 . . . . 2.72 111.718 178.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 44.9 ttp180 -69.09 -29.04 67.06 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.38 0.882 . . . . 5.02 113.38 -175.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.09 133.03 7.14 Favored Glycine 0 N--CA 1.435 -1.37 0 N-CA-C 109.826 -1.309 . . . . 1.63 109.826 -177.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . 0.555 ' HB3' ' HB2' ' B' ' 21' ' ' CYS . 22.9 p90 -107.68 112.98 25.94 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 117.448 0.624 . . . . 1.71 110.235 -179.028 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -135.74 133.77 38.35 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.149 -1.056 . . . . 3.67 108.149 -177.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 28' ' ' PHE . . . . . 0.446 ' HA ' ' HE1' ' B' ' 59' ' ' TYR . 18.0 p90 . . . . . 0 C--N 1.315 -0.895 0 O-C-N 123.293 0.371 . . . . 2.44 111.501 -178.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.414 -2.789 0 N-CA-C 110.685 -0.966 . . . . 2.62 110.685 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . 0.291 17.5 pt 65.55 -36.22 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 128.318 2.647 . . . . 2.28 115.12 175.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 2.5 p -52.27 -41.02 32.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 123.532 0.733 . . . . 2.6 112.926 178.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -87.81 -47.43 8.61 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 109.368 -0.604 . . . . 3.36 109.368 -176.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -54.49 -44.5 72.73 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 114.985 -1.007 . . . . 3.08 111.676 -179.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 46' ' ' CYS . . . . . . . . . . . . . 22.9 t -86.22 -15.68 40.1 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.029 0.442 . . . . 2.23 111.246 -176.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 49.5 t -75.17 -37.97 61.06 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.235 0.54 . . . . 2.48 110.991 178.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -105.75 -12.79 15.76 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 113.766 1.024 . . . . 2.97 113.766 -177.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 56.6 mtm180 -138.61 158.24 44.62 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.703 -0.851 . . . . 4.65 108.703 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 16.0 t -80.27 114.91 19.51 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.782 -0.822 . . . . 2.86 108.782 -177.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 32.0 p -89.42 143.61 26.69 Favored 'General case' 0 N--CA 1.421 -1.904 0 N-CA-C 108.247 -1.02 . . . . 2.11 108.247 -176.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -92.81 150.03 20.89 Favored 'General case' 0 N--CA 1.421 -1.884 0 N-CA-C 107.322 -1.362 . . . . 2.67 107.322 174.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . 0.606 ' HB3' ' HB3' ' A' 1600 ' ' SER . 3.9 pp -70.35 -9.16 55.4 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 113.199 0.814 . . . . 2.36 113.199 -171.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.24 -33.67 65.44 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.313 -0.995 . . . . 1.92 108.313 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 54.0 tp -60.67 -49.34 77.93 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-N 114.851 -1.068 . . . . 2.35 109.293 177.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 3.3 pp -73.83 -29.27 62.04 Favored 'General case' 0 N--CA 1.412 -2.353 0 C-N-CA 120.295 -0.562 . . . . 2.01 111.584 -176.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -63.98 -52.77 58.09 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.059 0.457 . . . . 2.27 110.929 -179.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 13.6 t -77.61 -23.07 49.94 Favored 'General case' 0 CA--C 1.557 1.214 0 CA-C-N 116.039 -0.528 . . . . 2.67 111.958 -177.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 59' ' ' TYR . . . . . 0.446 ' HE1' ' HA ' ' B' ' 28' ' ' PHE . 10.2 t80 -81.67 -34.4 30.73 Favored 'General case' 0 C--O 1.243 0.732 0 N-CA-C 108.817 -0.808 . . . . 3.2 108.817 179.227 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 9.6 t . . . . . 0 C--O 1.248 1.018 0 CA-C-N 115.269 -0.878 . . . . 2.3 111.733 -178.234 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 25.3 t70 . . . . . 0 CA--C 1.544 0.727 0 CA-C-O 121.96 0.886 . . . . 2.9 109.759 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A 1516 ' ' CYS . . . . . 0.647 ' HA ' ' HB2' ' A' 1581 ' ' LEU . 69.2 m 59.05 49.57 9.28 Favored 'General case' 0 C--O 1.246 0.884 0 N-CA-C 114.393 1.257 . . . . 1.41 114.393 -179.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -156.45 134.66 11.32 Favored 'General case' 0 N--CA 1.427 -1.599 0 CA-C-N 115.22 -0.9 . . . . 2.18 110.819 175.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1518 ' ' VAL . . . . . 0.547 HG22 ' HB2' ' A' 1583 ' ' TYR . 5.6 m -141.21 145.25 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 C-N-CA 124.411 1.085 . . . . 1.52 109.892 -178.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1519 ' ' THR . . . . . 0.449 ' OG1' HD21 ' A' 1526 ' ' LEU . 25.8 m -114.89 137.1 52.37 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 109.239 -0.652 . . . . 1.36 109.239 177.253 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1520 ' ' ASN . . . . . 0.518 ' OD1' HG21 ' A' 1523 ' ' THR . 26.8 t-20 -91.36 110.75 44.92 Favored Pre-proline 0 C--N 1.3 -1.556 0 N-CA-C 108.088 -1.078 . . . . 2.02 108.088 173.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -65.32 -19.08 61.86 Favored 'Trans proline' 0 N--CA 1.478 0.601 0 C-N-CA 123.464 2.776 . . . . 1.82 113.246 -173.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1522 ' ' SER . . . . . 0.486 ' HB2' ' OD1' ' A' 1520 ' ' ASN . 18.0 m -70.08 -44.58 68.79 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-N 115.849 -0.614 . . . . 1.89 111.259 -178.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1523 ' ' THR . . . . . 0.518 HG21 ' OD1' ' A' 1520 ' ' ASN . 9.6 t -119.01 6.86 11.33 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.54 0.686 . . . . 1.99 111.067 -175.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 57.83 36.02 77.88 Favored Glycine 0 CA--C 1.511 -0.199 0 CA-C-N 115.104 -0.953 . . . . 1.19 113.798 177.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 13.0 t-160 -100.72 122.14 42.86 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 120.537 -0.465 . . . . 1.82 110.578 -179.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1526 ' ' LEU . . . . . 0.449 HD21 ' OG1' ' A' 1519 ' ' THR . 2.2 tm? -96.92 114.61 26.25 Favored 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 124.76 1.224 . . . . 1.3 109.522 -179.149 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -91.24 115.28 27.9 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 116.777 -0.192 . . . . 0.8 111.167 176.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 6.3 t70 -101.74 115.02 29.62 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 108.094 -1.076 . . . . 1.17 108.094 174.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1529 ' ' LEU . . . . . 0.405 ' HB2' ' HB3' ' A' 1516 ' ' CYS . 3.6 mm? -101.07 4.17 42.0 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.346 0.593 . . . . 1.29 110.129 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1530 ' ' SER . . . . . 0.424 ' HA ' ' OG ' ' A' 1533 ' ' SER . 1.2 m -67.01 -30.19 70.22 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.16 -0.927 . . . . 0.91 109.011 179.174 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 30.9 m -61.38 -27.76 68.75 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 114.962 -1.017 . . . . 1.98 111.008 178.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 83.1 mt -99.09 -1.08 40.43 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 120.696 0.284 . . . . 1.34 110.819 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1533 ' ' SER . . . . . 0.424 ' OG ' ' HA ' ' A' 1530 ' ' SER . 19.6 m -75.0 158.92 32.44 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 120.736 0.303 . . . . 1.93 110.877 -177.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . 176.71 146.48 6.09 Favored Glycine 0 N--CA 1.443 -0.833 0 N-CA-C 110.867 -0.893 . . . . 1.1 110.867 -179.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -92.62 -29.07 16.32 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 123.205 0.602 . . . . 5.21 111.036 -177.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -75.83 -38.89 57.64 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.864 0.84 . . . . 1.94 108.986 177.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 94.87 -165.52 25.66 Favored Glycine 0 N--CA 1.422 -2.283 0 CA-C-N 114.939 -1.028 . . . . 1.08 114.081 172.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -128.34 153.69 46.75 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 107.267 -1.383 . . . . 1.07 107.267 -178.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 3.0 p -112.56 136.11 52.48 Favored 'General case' 0 C--N 1.31 -1.149 0 O-C-N 123.539 0.525 . . . . 1.46 111.388 -177.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1540 ' ' ALA . . . . . 0.401 ' HB1' ' CG1' ' A' 1548 ' ' VAL . . . -128.22 148.62 50.63 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.517 -0.92 . . . . 1.19 108.517 175.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -82.4 135.86 35.08 Favored 'General case' 0 C--N 1.315 -0.9 0 O-C-N 123.556 0.535 . . . . 1.37 111.494 -176.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1542 ' ' TYR . . . . . 0.416 ' CE2' ' HG ' ' A' 1626 ' ' LEU . 2.4 t80 -134.11 -101.32 0.24 Allowed 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 115.628 -0.714 . . . . 1.38 109.434 179.33 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1543 ' ' SER . . . . . 0.41 ' H ' ' HB3' ' A' 1542 ' ' TYR . 39.8 t -72.32 160.42 32.4 Favored 'General case' 0 C--O 1.246 0.92 0 CA-C-N 115.907 -0.588 . . . . 1.98 110.569 -178.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1544 ' ' LYS . . . . . 0.418 ' HE2' ' HA ' ' B' ' 23' ' ' ASP . 24.3 ttmm -53.61 -40.3 65.64 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.958 0.409 . . . . 3.96 111.634 -178.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 45.6 m -104.32 12.02 34.07 Favored 'General case' 0 N--CA 1.413 -2.294 0 N-CA-C 112.42 0.526 . . . . 2.81 112.42 -174.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . -155.42 147.69 16.92 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 117.822 -2.132 . . . . 1.68 115.683 -173.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 35.1 m -113.0 172.94 2.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 108.557 -0.905 . . . . 1.38 108.557 178.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1548 ' ' VAL . . . . . 0.44 ' HA ' ' HA ' ' A' 1567 ' ' PHE . 14.9 p -115.69 141.39 33.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 109.125 -0.694 . . . . 1.24 109.125 176.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -103.74 129.5 51.12 Favored 'General case' 0 CA--C 1.491 -1.327 0 N-CA-C 109.32 -0.622 . . . . 1.29 109.32 176.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 23.1 ptm -139.66 128.62 23.54 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 115.435 -0.802 . . . . 1.47 110.494 -179.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1551 ' ' SER . . . . . 0.427 ' HB3' HD21 ' A' 1556 ' ' ASN . 15.4 p -112.12 131.46 55.44 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 115.773 -0.649 . . . . 1.4 109.721 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1552 ' ' ILE . . . . . . . . . . . . . 46.9 mm -91.0 121.11 41.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 N-CA-C 109.529 -0.545 . . . . 1.11 109.529 -178.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1553 ' ' CYS . . . . . 0.461 ' O ' ' HE2' ' A' 1579 ' ' LYS . 72.7 m 60.33 42.84 14.32 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 121.73 0.776 . . . . 1.4 112.058 175.077 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 177.64 171.88 41.56 Favored Glycine 0 N--CA 1.417 -2.62 0 N-CA-C 110.312 -1.115 . . . . 0.4 110.312 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -87.33 153.45 21.45 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 109.441 -0.577 . . . . 1.62 109.441 179.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1556 ' ' ASN . . . . . 0.427 HD21 ' HB3' ' A' 1551 ' ' SER . 18.4 t-20 -102.06 120.98 41.3 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 108.815 -0.809 . . . . 1.12 108.815 -177.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -78.87 13.85 1.57 Allowed 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 113.549 0.944 . . . . 2.49 113.549 -174.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 54.6 m-80 -96.08 -12.54 24.69 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 120.214 -0.595 . . . . 1.38 110.368 177.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1559 ' ' CYS . . . . . 0.751 ' SG ' ' HD2' ' A' 1560 ' ' PRO . 3.8 t -136.77 164.09 44.95 Favored Pre-proline 0 C--N 1.307 -1.253 0 CA-C-O 117.154 -1.403 . . . . 1.21 107.555 -175.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1560 ' ' PRO . . . . . 0.751 ' HD2' ' SG ' ' A' 1559 ' ' CYS . 37.9 Cg_exo -28.5 140.96 0.02 OUTLIER 'Trans proline' 0 C--N 1.381 2.249 1 C-N-CA 125.549 4.166 . . . . 0.98 116.341 177.657 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -53.04 127.4 24.86 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 124.017 3.144 . . . . 1.15 114.194 -177.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 93.58 7.05 62.01 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-N 115.755 -0.657 . . . . 0.55 114.345 177.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1563 ' ' VAL . . . . . 0.607 HG13 ' HB3' ' A' 1559 ' ' CYS . 5.5 p -99.3 141.98 15.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 O-C-N 121.929 -0.748 . . . . 1.53 110.401 -179.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -104.68 -28.71 5.58 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-N 116.339 -0.391 . . . . 0.29 112.99 178.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -130.56 131.78 45.21 Favored 'General case' 0 C--O 1.245 0.827 0 O-C-N 122.294 -0.533 . . . . 1.08 110.794 179.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 44.3 t -159.81 141.32 12.81 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.785 -0.82 . . . . 0.43 108.785 -178.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1567 ' ' PHE . . . . . 0.517 ' HB2' ' OG1' ' A' 1570 ' ' THR . 93.9 m-85 -86.91 146.51 26.15 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.776 -0.824 . . . . 1.3 108.776 178.211 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -68.71 -20.67 74.34 Favored Glycine 0 C--O 1.222 -0.625 0 N-CA-C 115.269 0.868 . . . . 1.43 115.269 -172.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 35.7 mm-40 -96.8 -30.68 13.03 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 117.535 0.667 . . . . 3.09 112.048 176.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1570 ' ' THR . . . . . 0.569 ' HA ' ' OD2' ' B' ' 15' ' ' ASP . 46.8 p -81.92 -32.0 31.07 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 115.236 1.569 . . . . 2.52 115.236 -163.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 69.78 -2.63 1.93 Allowed 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.984 0.914 . . . . 3.19 109.993 -172.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 28.5 mt -86.32 132.73 31.47 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 CA-C-O 121.473 0.654 . . . . 1.51 110.834 -171.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 17.6 t -78.65 116.53 19.07 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 114.446 -1.252 . . . . 0.96 109.589 179.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1574 ' ' VAL . . . . . 0.512 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 23.2 m -114.22 8.36 7.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-O 121.316 0.579 . . . . 1.6 111.437 -178.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . -174.45 112.63 0.42 Allowed Glycine 0 N--CA 1.428 -1.898 0 C-N-CA 120.35 -0.929 . . . . 0.34 111.527 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1576 ' ' LYS . . . . . 0.433 ' HB3' ' O ' ' A' 1593 ' ' LYS . 87.0 tttt -71.07 134.67 47.24 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.406 -0.961 . . . . 2.68 108.406 177.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -68.11 131.35 45.26 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-O 120.942 0.401 . . . . 1.08 110.465 -178.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -150.16 165.26 33.41 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 104.394 -2.447 . . . . 1.95 104.394 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1579 ' ' LYS . . . . . 0.461 ' HE2' ' O ' ' A' 1553 ' ' CYS . 97.4 mttt -130.83 40.1 3.52 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 108.675 -0.861 . . . . 3.11 108.675 -178.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -92.99 76.63 4.72 Favored 'General case' 0 N--CA 1.418 -2.073 0 CA-C-O 122.181 0.991 . . . . 4.04 109.893 -171.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1581 ' ' LEU . . . . . 0.647 ' HB2' ' HA ' ' A' 1516 ' ' CYS . 1.0 OUTLIER -63.71 125.93 25.92 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 113.18 -1.827 . . . . 1.32 109.173 178.856 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 78.3 mtp180 -125.28 139.99 53.22 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 115.919 -0.582 . . . . 3.4 109.719 175.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1583 ' ' TYR . . . . . 0.621 ' CE1' ' HA ' ' A' 1586 ' ' GLN . 64.6 t80 -112.52 110.73 21.08 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 108.757 -0.831 . . . . 1.26 108.757 -178.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1584 ' ' VAL . . . . . 0.517 ' O ' ' HB ' ' A' 1587 ' ' VAL . 10.9 m -122.52 88.99 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-O 121.36 0.6 . . . . 1.71 112.142 -178.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 38.6 t70 55.13 65.09 1.59 Allowed 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 115.09 -0.959 . . . . 1.17 111.083 178.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1586 ' ' GLN . . . . . 0.621 ' HA ' ' CE1' ' A' 1583 ' ' TYR 0.291 11.6 pt20 64.69 15.37 9.7 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 126.826 2.05 . . . . 2.43 112.631 177.562 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A 1587 ' ' VAL . . . . . 0.517 ' HB ' ' O ' ' A' 1584 ' ' VAL . 41.9 t -110.63 121.28 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.338 0 CA-C-N 114.219 -1.355 . . . . 1.16 108.265 175.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1588 ' ' LEU . . . . . 0.819 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 2.6 mm? -95.83 114.65 26.4 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 106.688 -1.597 . . . . 1.11 106.688 179.054 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -126.77 125.19 41.33 Favored 'General case' 0 C--N 1.289 -2.031 0 C-N-CA 119.177 -1.009 . . . . 1.74 112.674 -175.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 19.1 mt -107.88 126.76 53.05 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 113.993 -1.458 . . . . 1.4 107.178 175.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 48.5 t -115.47 122.04 68.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 C-N-CA 119.879 -0.728 . . . . 1.7 109.893 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1592 ' ' TYR . . . . . . . . . . . . . 15.7 m-30 -105.49 94.74 5.37 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.932 -1.136 . . . . 1.08 107.932 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1593 ' ' LYS . . . . . 0.433 ' O ' ' HB3' ' A' 1576 ' ' LYS . 49.6 pttt -105.07 172.46 6.78 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 115.997 -0.547 . . . . 2.21 109.672 -176.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 70.1 m-20 57.11 52.79 8.6 Favored 'General case' 0 CA--C 1.51 -0.568 0 O-C-N 124.502 1.126 . . . . 1.11 111.554 178.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -71.88 -113.18 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 110.364 -1.095 . . . . 0.78 110.364 176.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1596 ' ' SER . . . . . 0.649 ' HB3' ' HD2' ' A' 1597 ' ' PRO . 72.2 m -133.43 168.68 16.72 Favored Pre-proline 0 C--N 1.284 -2.262 0 O-C-N 121.317 -1.108 . . . . 1.36 111.155 172.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1597 ' ' PRO . . . . . 0.649 ' HD2' ' HB3' ' A' 1596 ' ' SER . 2.5 Cg_endo -40.28 127.1 2.14 Favored 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 124.118 3.212 . . . . 1.4 114.058 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1598 ' ' CYS . . . . . 0.518 ' SG ' ' HB2' ' A' 1600 ' ' SER . 48.3 t -92.14 123.15 63.5 Favored Pre-proline 0 C--N 1.287 -2.124 0 CA-C-N 114.526 -1.215 . . . . 0.75 109.825 -179.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1599 ' ' PRO . . . . . 0.447 ' O ' ' HA ' ' B' ' 52' ' ' ASP . 17.2 Cg_exo -71.48 -27.99 18.33 Favored 'Trans proline' 0 C--O 1.211 -0.87 0 C-N-CA 122.206 1.937 . . . . 1.7 111.158 174.271 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1600 ' ' SER . . . . . 0.853 ' HA ' ' HB2' ' B' ' 53' ' ' LEU . 7.4 m -61.07 -47.16 87.64 Favored 'General case' 0 CA--C 1.555 1.145 0 CA-C-N 116.358 -0.383 . . . . 2.8 110.667 178.096 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1601 ' ' LYS . . . . . . . . . . . . . 5.4 tppp? -126.31 111.14 14.18 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 107.407 -1.331 . . . . 3.45 107.407 174.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 35.2 t -71.27 122.13 19.7 Favored 'General case' 0 N--CA 1.419 -2.001 0 C-N-CA 122.469 0.308 . . . . 2.44 110.223 -171.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 104.76 -10.15 48.57 Favored Glycine 0 N--CA 1.441 -1.032 0 N-CA-C 111.472 -0.651 . . . . 1.2 111.472 179.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1604 ' ' LEU . . . . . 0.486 HD23 ' SG ' ' A' 1634 ' ' CYS . 9.2 tp -101.09 168.63 9.47 Favored 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 107.832 -1.173 . . . . 2.38 107.832 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 20.2 m -129.64 146.93 51.39 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 109.117 -0.697 . . . . 1.96 109.117 178.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1606 ' ' TYR . . . . . 0.586 ' HD1' HD13 ' A' 1636 ' ' LEU . 67.0 m-85 -64.64 162.69 15.2 Favored 'General case' 0 C--O 1.251 1.182 0 N-CA-C 113.213 0.82 . . . . 1.06 113.213 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1607 ' ' LYS . . . . . 0.523 ' HE3' HG22 ' A' 1635 ' ' THR . 33.3 ttpt -158.54 130.78 6.86 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.067 -0.969 . . . . 2.0 109.194 -177.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1608 ' ' SER . . . . . . . . . . . . . 19.9 m -107.34 130.18 54.82 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 109.48 -0.563 . . . . 1.61 109.48 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 39.0 t -110.63 109.19 27.55 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 N-CA-C 108.687 -0.857 . . . . 1.09 108.687 178.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 62.1 mt -101.18 110.16 27.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 115.762 -0.654 . . . . 1.2 109.632 -177.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 27.9 t -111.59 115.09 28.58 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 115.61 -0.723 . . . . 1.89 110.361 -178.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1612 ' ' PHE . . . . . 0.819 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 71.9 m-85 -89.53 122.74 32.98 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 107.96 -1.126 . . . . 0.28 107.96 175.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 43.9 t -116.19 138.72 45.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 109.333 -0.617 . . . . 1.23 109.333 -176.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 40.5 t -66.77 119.02 11.13 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 123.998 0.919 . . . . 0.77 111.252 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1615 ' ' ARG . . . . . 0.814 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 20.2 tpt180 -122.16 96.72 46.21 Favored Pre-proline 0 N--CA 1.446 -0.663 0 N-CA-C 109.856 -0.424 . . . . 2.92 109.856 176.422 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1616 ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -66.6 -40.48 13.44 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.251 1.967 . . . . 1.22 110.607 176.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -80.6 43.28 0.65 Allowed 'General case' 0 C--O 1.241 0.647 0 C-N-CA 124.3 1.04 . . . . 3.05 111.272 176.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1618 ' ' ALA . . . . . 0.586 ' HB2' ' HG3' ' A' 1643 ' ' PRO . . . -39.51 124.68 1.65 Allowed 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 125.617 1.567 . . . . 1.55 113.166 -178.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1619 ' ' GLY . . . . . 0.482 ' C ' ' H ' ' A' 1621 ' ' THR . . . -154.63 -140.37 3.01 Favored Glycine 0 N--CA 1.43 -1.734 0 N-CA-C 108.431 -1.868 . . . . 1.16 108.431 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.36 20.14 0.36 Allowed 'Trans proline' 0 N--CA 1.486 1.062 0 C-N-CA 122.904 2.402 . . . . 1.06 112.827 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1621 ' ' THR . . . . . 0.836 ' HB ' ' HB2' ' A' 1641 ' ' HIS . 56.9 p -91.18 -14.21 31.49 Favored 'General case' 0 C--N 1.292 -1.922 0 C-N-CA 124.86 1.264 . . . . 1.58 108.975 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -87.93 68.26 9.22 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.963 -1.017 . . . . 0.88 109.002 -174.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 3.5 ptp180 -167.38 139.33 2.64 Favored Pre-proline 0 C--N 1.317 -0.821 0 C-N-CA 124.435 1.094 . . . . 3.82 108.561 179.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.99 109.62 1.54 Allowed 'Trans proline' 0 C--O 1.238 0.522 0 C-N-CA 122.757 2.305 . . . . 0.77 111.584 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 72.3 mtm -113.74 140.87 47.91 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 116.467 -0.333 . . . . 1.43 111.255 -178.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1626 ' ' LEU . . . . . 0.416 ' HG ' ' CE2' ' A' 1542 ' ' TYR . 1.8 tm? -78.48 119.78 22.27 Favored 'General case' 0 C--O 1.244 0.787 0 N-CA-C 107.358 -1.349 . . . . 1.43 107.358 179.149 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1627 ' ' ILE . . . . . 0.654 HD13 ' HB2' ' A' 1639 ' ' SER . 42.3 mm -80.16 -55.28 9.17 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 N-CA-C 108.833 -0.803 . . . . 1.23 108.833 178.448 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 22.7 t -173.82 158.4 3.23 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 106.933 -1.506 . . . . 1.88 106.933 -177.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1629 ' ' LEU . . . . . 0.798 ' HG ' ' HG ' ' A' 1636 ' ' LEU . 3.4 tt -115.58 113.02 23.04 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 104.312 -2.477 . . . . 1.92 104.312 175.165 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 16.4 t70 -69.48 103.95 2.19 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 108.602 -0.888 . . . . 1.09 108.602 176.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -61.94 -23.96 66.69 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 125.239 1.415 . . . . 3.98 113.319 -172.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 18.0 mm100 -86.13 -38.65 17.52 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 120.85 -0.34 . . . . 2.6 111.533 -177.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 67.0 p -103.88 2.27 32.39 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 112.657 0.614 . . . . 1.35 112.657 -174.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1634 ' ' CYS . . . . . 0.486 ' SG ' HD23 ' A' 1604 ' ' LEU . 81.4 m 57.47 35.67 26.13 Favored 'General case' 0 C--N 1.369 1.425 0 C-N-CA 123.96 0.904 . . . . 0.53 111.443 177.245 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1635 ' ' THR . . . . . 0.523 HG22 ' HE3' ' A' 1607 ' ' LYS . 90.8 m -107.85 126.86 53.17 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 115.155 -0.93 . . . . 1.11 109.97 -176.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1636 ' ' LEU . . . . . 0.798 ' HG ' ' HG ' ' A' 1629 ' ' LEU . 0.8 OUTLIER -107.07 122.15 45.9 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 108.588 -0.893 . . . . 1.56 108.588 -175.66 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -101.87 133.25 46.93 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 120.81 0.338 . . . . 0.54 111.465 -178.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -129.25 145.07 51.42 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.67 -0.696 . . . . 0.64 109.895 -178.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1639 ' ' SER . . . . . 0.654 ' HB2' HD13 ' A' 1627 ' ' ILE . 8.4 t -125.9 157.34 37.95 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 109.567 -0.531 . . . . 1.34 109.567 177.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 3.2 t90 -156.58 108.41 2.48 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 104.923 -2.251 . . . . 0.8 104.923 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1641 ' ' HIS . . . . . 0.836 ' HB2' ' HB ' ' A' 1621 ' ' THR . 18.1 m-70 -101.5 104.53 15.45 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 109.283 -0.636 . . . . 1.14 109.283 -178.254 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1642 ' ' THR . . . . . . . . . . . . . 3.2 t -133.64 150.11 73.93 Favored Pre-proline 0 C--N 1.3 -1.554 0 CA-C-N 115.186 -0.916 . . . . 1.11 110.608 -171.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1643 ' ' PRO . . . . . 0.586 ' HG3' ' HB2' ' A' 1618 ' ' ALA . 7.6 Cg_exo -73.63 -7.36 20.1 Favored 'Trans proline' 0 C--N 1.385 2.463 0 C-N-CA 122.44 2.094 . . . . 0.78 112.327 173.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 10.5 tt -66.95 -26.68 66.95 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.439 0.637 . . . . 1.66 109.814 179.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -92.39 9.87 32.36 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.193 -0.912 . . . . 1.29 109.82 179.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1646 ' ' CYS . . . . . 0.432 ' SG ' ' HA ' ' A' 1643 ' ' PRO . 72.9 m -111.86 146.92 36.85 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-N 115.958 -0.565 . . . . 1.48 110.416 -178.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 31.2 tt0 . . . . . 0 N--CA 1.424 -1.739 0 N-CA-C 106.57 -1.641 . . . . 3.14 106.57 173.432 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . 0.413 ' O ' HG12 ' B' ' 14' ' ' VAL . . . . . . . . 0 N--CA 1.431 -1.642 0 N-CA-C 111.301 -0.719 . . . . 2.28 111.301 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -59.96 -67.09 2.32 Favored Glycine 0 CA--C 1.5 -0.871 0 CA-C-O 119.504 -0.609 . . . . 1.94 113.069 -175.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -62.59 -29.14 70.38 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 117.371 0.585 . . . . 2.55 110.886 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 13' ' ' LEU . . . . . 0.427 ' HA ' HD11 ' B' ' 13' ' ' LEU . 1.2 mm? -59.38 -62.36 1.93 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.857 -0.61 . . . . 2.82 111.879 177.191 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . 0.413 HG12 ' O ' ' B' ' 10' ' ' GLY . 10.9 p -69.45 -28.74 39.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 115.834 -0.621 . . . . 2.5 110.494 -176.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 15' ' ' ASP . . . . . 0.569 ' OD2' ' HA ' ' A' 1570 ' ' THR . 31.7 t70 -70.71 -45.98 63.93 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 113.85 1.055 . . . . 2.04 113.85 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 20.3 p -63.95 -39.85 95.09 Favored 'General case' 0 C--O 1.275 2.422 0 CA-C-O 121.859 0.838 . . . . 2.31 109.935 178.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.444 ' HB3' ' HB3' ' B' ' 26' ' ' PHE . 11.2 mp -59.52 -48.34 82.03 Favored 'General case' 0 N--CA 1.416 -2.15 0 CA-C-N 114.947 -1.024 . . . . 2.27 110.689 172.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -56.74 -29.47 62.56 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.499 0.72 . . . . 2.39 111.942 174.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -58.1 -56.63 19.57 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-O 119.335 -0.365 . . . . 1.0 111.374 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 10.3 p -99.71 -17.62 6.64 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.309 0 C-N-CA 117.557 -1.657 . . . . 1.83 112.706 177.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 21' ' ' CYS . . . . . 0.593 ' HA ' ' HB3' ' B' ' 24' ' ' ARG . 58.9 m -112.22 30.77 6.78 Favored 'General case' 0 C--N 1.293 -1.849 0 O-C-N 121.717 -0.614 . . . . 1.66 112.0 -176.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.19 -64.47 4.24 Favored Glycine 0 C--O 1.241 0.571 0 C-N-CA 120.347 -0.93 . . . . 1.53 111.762 177.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . 0.418 ' HA ' ' HE2' ' A' 1544 ' ' LYS . 31.6 t70 -69.73 -34.8 74.35 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 122.674 0.39 . . . . 2.72 111.086 175.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . 0.593 ' HB3' ' HA ' ' B' ' 21' ' ' CYS . 8.6 tpm_? -64.57 -35.74 81.96 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 124.24 1.016 . . . . 5.02 112.399 -177.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.81 149.59 23.42 Favored Glycine 0 N--CA 1.423 -2.204 0 N-CA-C 110.853 -0.899 . . . . 1.63 110.853 -179.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . 0.444 ' HB3' ' HB3' ' B' ' 17' ' ' LEU . 0.3 OUTLIER -131.41 136.18 47.8 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 111.917 0.34 . . . . 1.71 111.917 178.769 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -139.84 78.65 1.67 Allowed 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.785 -0.45 . . . . 3.67 109.785 176.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 28' ' ' PHE . . . . . 0.572 ' O ' ' HA3' ' B' ' 41' ' ' GLY . 11.1 p90 . . . . . 0 C--N 1.311 -1.108 0 CA-C-O 121.794 0.807 . . . . 2.44 109.102 178.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . 0.572 ' HA3' ' O ' ' B' ' 28' ' ' PHE . . . . . . . . 0 N--CA 1.398 -3.882 0 N-CA-C 106.337 -2.705 . . . . 2.62 106.337 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . 0.453 ' HA ' ' HG2' ' B' ' 45' ' ' GLU . 31.2 pt 60.24 -8.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 C-N-CA 127.786 2.434 . . . . 2.28 114.904 -179.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . 0.472 ' H ' ' C ' ' B' ' 41' ' ' GLY . 9.8 p -62.48 -34.1 62.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 C-N-CA 123.301 0.64 . . . . 2.6 112.42 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -84.07 -24.69 30.28 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 118.089 -1.444 . . . . 3.36 108.803 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . 0.453 ' HG2' ' HA ' ' B' ' 42' ' ' ILE . 32.2 mm-40 -67.66 -62.39 1.44 Allowed 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.377 -0.829 . . . . 3.08 109.154 -179.115 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 46' ' ' CYS . . . . . . . . . . . . . 21.1 m -76.39 -22.74 54.4 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 113.996 1.11 . . . . 2.23 113.996 -171.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 85.0 m -76.67 -1.66 28.9 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 121.201 -0.937 . . . . 2.48 112.594 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -133.94 -47.57 0.79 Allowed 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 112.467 0.543 . . . . 2.97 112.467 177.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 56.7 mtt-85 -104.53 168.9 8.78 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 120.889 0.375 . . . . 4.65 110.029 178.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 37.1 t -90.95 109.98 21.22 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 107.629 -1.249 . . . . 2.86 107.629 176.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . 0.544 ' HB2' HD22 ' B' ' 55' ' ' LEU . 21.8 p -90.93 135.48 33.71 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.851 -0.796 . . . . 2.11 108.851 -177.249 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . 0.447 ' HA ' ' O ' ' A' 1599 ' ' PRO . 3.7 p30 -98.66 172.05 7.73 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 113.376 0.88 . . . . 2.67 113.376 -176.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . 0.853 ' HB2' ' HA ' ' A' 1600 ' ' SER . 41.9 tp -51.12 -40.48 58.57 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 113.298 0.851 . . . . 2.36 113.298 -174.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . 0.4 ' O ' HG21 ' B' ' 58' ' ' THR . . . -54.94 -46.39 74.95 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 123.623 0.577 . . . . 1.92 111.575 -172.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . 0.544 HD22 ' HB2' ' B' ' 51' ' ' CYS . 48.0 tp -62.49 -58.0 9.16 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 114.925 -1.034 . . . . 2.35 110.516 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 3.9 pp -69.11 -34.1 74.54 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 112.692 0.627 . . . . 2.01 112.692 -172.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -76.24 -40.37 52.18 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 112.204 0.446 . . . . 2.27 112.204 -179.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 58' ' ' THR . . . . . 0.4 HG21 ' O ' ' B' ' 54' ' ' ALA . 7.0 t -77.71 -11.52 59.88 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 118.653 -1.219 . . . . 2.67 110.635 176.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 59' ' ' TYR . . . . . 0.442 ' OH ' ' HA2' ' B' ' 41' ' ' GLY . 17.6 t80 -85.59 -72.03 0.51 Allowed 'General case' 0 N--CA 1.426 -1.673 0 N-CA-C 106.477 -1.675 . . . . 3.2 106.477 175.21 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 41.3 t . . . . . 0 C--O 1.253 1.245 0 C-N-CA 126.071 1.748 . . . . 2.3 114.559 174.782 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 15.4 m-20 . . . . . 0 CA--C 1.509 -0.625 0 N-CA-C 111.687 0.254 . . . . 2.9 111.687 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A 1516 ' ' CYS . . . . . 0.594 ' HA ' ' HB2' ' A' 1581 ' ' LEU . 59.8 m 56.34 41.49 28.98 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-O 121.267 0.556 . . . . 1.41 110.951 -177.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -150.77 130.11 12.86 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 108.884 -0.784 . . . . 2.18 108.884 -179.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1518 ' ' VAL . . . . . 0.43 HG23 ' HB2' ' A' 1583 ' ' TYR . 3.3 m -136.03 138.22 47.66 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 O-C-N 124.13 0.894 . . . . 1.52 110.47 -177.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1519 ' ' THR . . . . . . . . . . . . . 44.2 m -104.8 136.13 44.89 Favored 'General case' 0 C--N 1.281 -2.397 0 N-CA-C 107.612 -1.255 . . . . 1.36 107.612 175.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1520 ' ' ASN . . . . . 0.502 ' OD1' ' HB2' ' A' 1522 ' ' SER . 21.3 t-20 -91.23 115.76 65.06 Favored Pre-proline 0 C--N 1.287 -2.126 0 N-CA-C 108.816 -0.809 . . . . 2.02 108.816 174.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -66.34 -15.52 48.37 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.998 2.465 . . . . 1.82 113.713 -176.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1522 ' ' SER . . . . . 0.502 ' HB2' ' OD1' ' A' 1520 ' ' ASN . 30.2 m -75.98 -44.76 38.2 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 111.772 0.286 . . . . 1.89 111.772 -179.142 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1523 ' ' THR . . . . . 0.459 HG21 ' OD1' ' A' 1520 ' ' ASN . 11.1 t -118.44 -1.26 11.27 Favored 'General case' 0 CA--C 1.556 1.178 0 CA-C-O 121.506 0.669 . . . . 1.99 112.092 -175.131 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 67.3 33.66 83.1 Favored Glycine 0 CA--C 1.503 -0.718 0 CA-C-N 115.829 -0.623 . . . . 1.19 112.937 176.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -98.68 121.9 41.22 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 109.626 -0.509 . . . . 1.82 109.626 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 1.9 tm? -94.12 111.84 23.6 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.208 -0.905 . . . . 1.3 108.804 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -83.48 114.57 21.57 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 120.676 0.274 . . . . 0.8 111.445 174.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 22.4 t70 -102.91 101.13 11.14 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.112 -1.07 . . . . 1.17 108.112 176.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1529 ' ' LEU . . . . . 0.468 ' HB2' ' O ' ' A' 1516 ' ' CYS . 4.2 mm? -83.88 -7.91 59.32 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 116.294 -0.412 . . . . 1.29 110.823 -177.017 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1530 ' ' SER . . . . . 0.602 ' HA ' ' OG ' ' A' 1533 ' ' SER . 17.1 m -66.48 -16.79 64.39 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.913 -0.585 . . . . 0.91 111.369 178.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 41.2 t -67.32 -29.06 68.53 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 109.327 -0.62 . . . . 1.98 109.327 173.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 81.3 mt -96.93 -10.33 26.58 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 116.451 -0.341 . . . . 1.34 111.061 -176.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1533 ' ' SER . . . . . 0.602 ' OG ' ' HA ' ' A' 1530 ' ' SER . 19.0 m -61.74 154.89 24.3 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.33 0.586 . . . . 1.93 110.718 178.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -171.13 131.2 2.14 Favored Glycine 0 C--N 1.286 -2.223 0 N-CA-C 109.443 -1.463 . . . . 1.1 109.443 -177.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 24.3 ttt180 -92.47 -34.49 14.08 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 112.337 0.495 . . . . 5.21 112.337 -172.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -59.7 -57.1 14.41 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.524 0.678 . . . . 1.94 110.571 -178.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 130.53 164.13 11.21 Favored Glycine 0 N--CA 1.409 -3.122 0 CA-C-N 115.433 -0.803 . . . . 1.08 111.999 173.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -120.51 138.91 53.58 Favored 'General case' 0 C--N 1.276 -2.617 0 N-CA-C 106.804 -1.554 . . . . 1.07 106.804 178.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 28.1 p -108.79 123.69 49.43 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 123.499 0.499 . . . . 1.46 110.783 -179.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1540 ' ' ALA . . . . . 0.436 ' HB1' ' CG1' ' A' 1548 ' ' VAL . . . -114.73 138.98 50.07 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 108.423 -0.955 . . . . 1.19 108.423 177.216 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -75.11 140.16 43.24 Favored 'General case' 0 CA--C 1.502 -0.872 0 O-C-N 123.93 0.769 . . . . 1.37 110.188 -177.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1542 ' ' TYR . . . . . 0.609 ' HE2' HD11 ' A' 1626 ' ' LEU . 1.7 t80 -152.53 -100.87 0.05 Allowed 'General case' 0 N--CA 1.424 -1.769 0 CA-C-N 115.954 -0.566 . . . . 1.38 110.25 -176.049 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1543 ' ' SER . . . . . 0.415 ' H ' ' HB3' ' A' 1542 ' ' TYR . 12.6 m -70.44 156.24 39.62 Favored 'General case' 0 N--CA 1.428 -1.544 0 C-N-CA 123.731 0.812 . . . . 1.98 109.735 -176.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 27.5 tptp -62.65 -22.07 66.16 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 125.502 1.521 . . . . 3.96 111.34 -173.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 34.3 t -137.94 37.65 2.37 Favored 'General case' 0 N--CA 1.427 -1.589 0 CA-C-N 115.746 -0.661 . . . . 2.81 109.6 -178.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1546 ' ' GLY . . . . . 0.489 ' HA3' ' HG2' ' A' 1569 ' ' GLN . . . -176.42 129.56 1.52 Allowed Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 119.025 -1.56 . . . . 1.68 113.974 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 35.9 m -102.75 162.68 3.76 Favored 'Isoleucine or valine' 0 C--O 1.251 1.175 0 N-CA-C 108.806 -0.812 . . . . 1.38 108.806 175.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1548 ' ' VAL . . . . . 0.451 ' HA ' ' HA ' ' A' 1567 ' ' PHE . 13.6 p -101.4 132.3 47.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 109.618 -0.512 . . . . 1.24 109.618 178.297 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -97.8 126.03 42.95 Favored 'General case' 0 CA--C 1.494 -1.202 0 C-N-CA 123.695 0.798 . . . . 1.29 109.435 177.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 24.0 ptm -139.2 135.48 34.02 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.311 -0.858 . . . . 1.47 111.42 -178.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 74.8 m -124.15 134.72 53.25 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.379 -0.828 . . . . 1.4 109.42 175.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1552 ' ' ILE . . . . . . . . . . . . . 46.4 mm -88.19 121.82 39.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 116.281 -0.418 . . . . 1.11 111.385 -175.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 34.0 t 66.04 25.35 10.92 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.615 1.166 . . . . 1.4 111.632 173.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . -167.51 174.99 42.63 Favored Glycine 0 N--CA 1.418 -2.552 0 N-CA-C 109.323 -1.511 . . . . 0.4 109.323 -179.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -95.63 155.94 16.53 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.081 0.467 . . . . 1.62 110.558 -178.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -104.25 134.84 46.8 Favored 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 107.258 -1.386 . . . . 1.12 107.258 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -95.93 7.96 44.94 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 112.943 0.719 . . . . 2.49 112.943 -172.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -83.04 -13.91 54.92 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.786 0.803 . . . . 1.38 109.533 177.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1559 ' ' CYS . . . . . 0.743 ' SG ' ' HD2' ' A' 1560 ' ' PRO . 9.3 t -131.89 162.16 58.2 Favored Pre-proline 0 C--N 1.293 -1.864 0 N-CA-C 106.039 -1.838 . . . . 1.21 106.039 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1560 ' ' PRO . . . . . 0.743 ' HD2' ' SG ' ' A' 1559 ' ' CYS . 41.8 Cg_exo -28.9 145.81 0.02 OUTLIER 'Trans proline' 0 CA--C 1.565 2.064 1 C-N-CA 125.301 4.001 . . . . 0.98 116.563 175.602 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.28 128.07 27.2 Favored 'Trans proline' 0 C--O 1.245 0.849 0 C-N-CA 123.56 2.84 . . . . 1.15 112.283 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 102.61 -9.73 55.74 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 116.139 -0.482 . . . . 0.55 112.354 -179.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1563 ' ' VAL . . . . . 0.508 HG12 ' HB3' ' A' 1559 ' ' CYS . 3.0 t -79.46 125.38 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 N-CA-C 112.665 0.617 . . . . 1.53 112.665 -178.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -98.6 -36.18 4.66 Favored Glycine 0 C--N 1.315 -0.616 0 CA-C-N 115.338 -0.847 . . . . 0.29 111.518 176.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -132.18 128.18 37.47 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 109.332 -0.618 . . . . 1.08 109.332 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1566 ' ' CYS . . . . . 0.453 ' HB2' HG12 ' A' 1563 ' ' VAL . 42.2 t -157.27 139.34 14.41 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 110.197 -0.297 . . . . 0.43 110.197 -177.032 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1567 ' ' PHE . . . . . 0.451 ' HA ' ' HA ' ' A' 1548 ' ' VAL . 37.8 m-85 -84.96 143.83 28.71 Favored 'General case' 0 C--O 1.245 0.846 0 N-CA-C 109.577 -0.527 . . . . 1.3 109.577 174.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -87.38 17.34 44.03 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.865 -0.683 . . . . 1.43 112.75 -175.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1569 ' ' GLN . . . . . 0.586 ' HB3' ' OD1' ' B' ' 15' ' ' ASP . 27.3 mt-30 -70.22 -69.97 0.32 Allowed 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 122.257 0.223 . . . . 3.09 110.507 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 13.8 t -130.41 29.74 4.81 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-O 121.604 0.716 . . . . 2.52 110.82 173.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 7.7 mmt180 65.29 55.17 1.1 Allowed 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 114.83 -1.077 . . . . 3.19 109.83 178.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 29.6 mt -95.97 115.74 35.95 Favored 'Isoleucine or valine' 0 C--O 1.246 0.907 0 CA-C-N 114.413 -1.267 . . . . 1.51 108.83 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 29.6 t -85.17 140.71 30.71 Favored 'General case' 0 C--O 1.245 0.855 0 CA-C-O 121.575 0.702 . . . . 0.96 110.845 -176.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1574 ' ' VAL . . . . . 0.594 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 35.7 m -126.2 15.49 3.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 CA-C-N 115.523 -0.762 . . . . 1.6 110.954 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 170.1 129.27 1.09 Allowed Glycine 0 N--CA 1.424 -2.154 0 C-N-CA 119.14 -1.505 . . . . 0.34 112.812 177.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 86.8 tttt -77.9 142.95 38.1 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 108.277 -1.009 . . . . 2.68 108.277 176.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -73.78 91.49 1.94 Allowed 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 123.036 0.534 . . . . 1.08 110.883 -178.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -109.85 171.63 7.33 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 108.273 -1.01 . . . . 1.95 108.273 178.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 62.3 mttp -124.05 44.61 2.69 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.688 -0.856 . . . . 3.11 108.688 -177.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 43.6 ttp180 -86.92 77.88 9.14 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 114.904 -1.044 . . . . 4.04 109.622 -177.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1581 ' ' LEU . . . . . 0.594 ' HB2' ' HA ' ' A' 1516 ' ' CYS . 0.5 OUTLIER -84.33 123.06 29.76 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.602 -1.181 . . . . 1.32 108.976 -179.053 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -126.35 140.37 52.56 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 110.108 -0.33 . . . . 3.4 110.108 173.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1583 ' ' TYR . . . . . 0.451 ' CE1' ' HA ' ' A' 1586 ' ' GLN . 51.0 t80 -106.35 111.63 24.3 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 108.975 -0.75 . . . . 1.26 108.975 177.089 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1584 ' ' VAL . . . . . 0.607 ' O ' ' HB ' ' A' 1587 ' ' VAL . 6.8 m -130.01 95.72 2.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 112.289 0.477 . . . . 1.71 112.289 -178.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 37.0 t70 57.99 65.81 1.23 Allowed 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 121.774 0.797 . . . . 1.17 111.929 174.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1586 ' ' GLN . . . . . 0.451 ' HA ' ' CE1' ' A' 1583 ' ' TYR 0.254 30.2 pt20 60.67 20.72 10.68 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 127.021 2.128 . . . . 2.43 111.847 177.993 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A 1587 ' ' VAL . . . . . 0.607 ' HB ' ' O ' ' A' 1584 ' ' VAL . 18.3 t -117.32 121.0 66.64 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.606 0 CA-C-N 113.593 -1.64 . . . . 1.16 109.922 176.497 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1588 ' ' LEU . . . . . 0.821 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 2.7 mm? -95.59 115.58 27.63 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 106.061 -1.829 . . . . 1.11 106.061 175.282 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -118.01 126.44 52.31 Favored 'General case' 0 C--N 1.277 -2.558 0 C-N-CA 119.844 -0.743 . . . . 1.74 112.445 -174.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 11.9 mt -114.0 117.41 31.25 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 125.414 1.486 . . . . 1.4 107.043 175.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 26.9 t -104.88 128.89 58.26 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 C-N-CA 119.734 -0.786 . . . . 1.7 109.62 -178.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1592 ' ' TYR . . . . . 0.534 ' HB2' ' HB3' ' A' 1608 ' ' SER . 14.4 m-30 -117.58 96.13 5.26 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.901 -0.777 . . . . 1.08 108.901 178.166 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 38.8 pttt -111.4 175.62 5.35 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.823 -0.751 . . . . 2.21 109.876 177.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 33.3 m-20 67.48 60.23 0.48 Allowed 'General case' 0 CA--C 1.502 -0.889 0 C-N-CA 124.318 1.047 . . . . 1.11 110.904 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -91.11 -104.74 1.34 Allowed Glycine 0 N--CA 1.424 -2.153 0 N-CA-C 109.469 -1.452 . . . . 0.78 109.469 177.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1596 ' ' SER . . . . . . . . . . . . . 48.4 m -120.69 156.16 56.35 Favored Pre-proline 0 C--N 1.286 -2.172 0 N-CA-C 107.697 -1.223 . . . . 1.36 107.697 175.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -53.94 120.92 8.7 Favored 'Trans proline' 0 C--N 1.357 0.991 0 C-N-CA 122.927 2.418 . . . . 1.4 110.276 173.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1598 ' ' CYS . . . . . 0.444 ' HA ' ' HD3' ' A' 1599 ' ' PRO . 48.9 t -79.8 126.42 80.25 Favored Pre-proline 0 C--N 1.28 -2.453 0 CA-C-N 114.385 -1.279 . . . . 0.75 110.578 -175.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1599 ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' 1598 ' ' CYS . 12.2 Cg_exo -73.52 -15.72 24.55 Favored 'Trans proline' 0 C--O 1.212 -0.784 0 C-N-CA 122.942 2.428 . . . . 1.7 112.051 177.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1600 ' ' SER . . . . . 0.657 ' HA ' ' HB2' ' B' ' 53' ' ' LEU . 15.4 m -65.77 -31.85 73.06 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-O 120.67 0.271 . . . . 2.8 111.416 177.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1601 ' ' LYS . . . . . 0.443 ' HA ' ' HB2' ' B' ' 52' ' ' ASP . 22.9 ttmm -150.62 120.74 7.22 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 108.084 -1.08 . . . . 3.45 108.084 175.374 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 8.0 m -59.02 123.54 16.93 Favored 'General case' 0 N--CA 1.428 -1.548 0 C-N-CA 124.241 1.017 . . . . 2.44 112.707 -171.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 84.06 23.18 53.02 Favored Glycine 0 CA--C 1.499 -0.961 0 CA-C-N 116.167 -0.47 . . . . 1.2 112.482 175.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1604 ' ' LEU . . . . . 0.464 HD23 ' SG ' ' A' 1634 ' ' CYS . 11.5 tp -119.67 165.93 13.86 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 106.854 -1.535 . . . . 2.38 106.854 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 22.9 t -124.82 154.37 41.1 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.628 -0.878 . . . . 1.96 108.628 -177.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1606 ' ' TYR . . . . . 0.594 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 58.1 m-85 -74.86 163.58 27.5 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 116.011 -0.541 . . . . 1.06 109.892 176.273 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -160.33 128.26 4.61 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-N 116.338 -0.392 . . . . 2.0 109.944 -176.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1608 ' ' SER . . . . . 0.534 ' HB3' ' HB2' ' A' 1592 ' ' TYR . 34.5 t -104.95 126.3 51.87 Favored 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 108.447 -0.946 . . . . 1.61 108.447 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 25.8 t -110.61 99.21 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.66 0 N-CA-C 107.864 -1.161 . . . . 1.09 107.864 177.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 77.1 mt -90.29 120.64 39.47 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 CA-C-N 115.014 -0.994 . . . . 1.2 108.917 -177.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 43.9 m -124.67 123.97 41.18 Favored 'General case' 0 C--N 1.287 -2.11 0 CA-C-N 115.863 -0.608 . . . . 1.89 112.025 -178.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1612 ' ' PHE . . . . . 0.821 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 75.5 m-85 -97.97 123.14 41.83 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.42 -0.956 . . . . 0.28 108.42 176.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 44.7 t -113.51 134.96 54.6 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 O-C-N 123.589 0.556 . . . . 1.23 110.621 -174.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -54.07 112.56 0.99 Allowed 'General case' 0 C--O 1.241 0.623 0 C-N-CA 124.265 1.026 . . . . 0.77 111.679 175.054 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1615 ' ' ARG . . . . . 0.537 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 23.0 tpt180 -126.0 88.95 53.35 Favored Pre-proline 0 N--CA 1.443 -0.798 0 N-CA-C 107.881 -1.155 . . . . 2.92 107.881 174.11 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1616 ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -72.57 -19.59 24.45 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 122.341 2.027 . . . . 1.22 113.325 -174.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -87.29 -10.8 51.39 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.612 -0.267 . . . . 3.05 111.552 179.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . 63.05 -172.53 0.16 Allowed 'General case' 0 CA--C 1.546 0.794 0 O-C-N 123.904 0.753 . . . . 1.55 109.087 -172.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . 147.64 -165.27 28.78 Favored Glycine 0 N--CA 1.424 -2.107 0 C-N-CA 120.292 -0.956 . . . . 1.16 112.565 175.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -87.23 19.14 1.43 Allowed 'Trans proline' 0 C--O 1.237 0.45 0 C-N-CA 123.614 2.876 . . . . 1.06 113.726 -174.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1621 ' ' THR . . . . . . . . . . . . . 24.1 p -114.62 12.46 17.22 Favored 'General case' 0 C--N 1.285 -2.212 0 CA-C-O 122.173 0.987 . . . . 1.58 109.744 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -89.55 66.71 7.38 Favored 'General case' 0 C--O 1.246 0.92 0 N-CA-C 106.682 -1.599 . . . . 0.88 106.682 178.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -170.5 140.79 1.52 Allowed Pre-proline 0 N--CA 1.428 -1.531 0 N-CA-C 106.849 -1.538 . . . . 3.82 106.849 -173.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -57.63 107.56 0.31 Allowed 'Trans proline' 0 CA--C 1.545 1.058 0 C-N-CA 122.511 2.141 . . . . 0.77 111.571 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 81.4 mtp -114.18 148.08 37.85 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.576 -0.898 . . . . 1.43 108.576 -178.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1626 ' ' LEU . . . . . 0.609 HD11 ' HE2' ' A' 1542 ' ' TYR . 7.2 tt -101.9 138.31 39.04 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.132 -0.692 . . . . 1.43 109.132 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1627 ' ' ILE . . . . . 0.759 HD12 ' HB2' ' A' 1639 ' ' SER . 38.4 mm -85.09 -63.09 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.214 -0.812 0 CA-C-N 115.375 -0.829 . . . . 1.23 109.701 -178.069 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 52.2 m -161.88 152.11 17.08 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 106.897 -1.52 . . . . 1.88 106.897 -176.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1629 ' ' LEU . . . . . 0.615 HD12 ' HG ' ' A' 1636 ' ' LEU . 44.4 tp -105.42 110.3 22.59 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 107.885 -1.154 . . . . 1.92 107.885 175.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 18.6 t70 -82.75 95.41 7.86 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 118.388 -1.325 . . . . 1.09 107.651 175.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 21.8 pttm -76.14 7.24 4.35 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 114.739 -1.119 . . . . 3.98 113.467 -174.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -95.68 -45.0 7.2 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 108.794 -0.817 . . . . 2.6 108.794 173.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 73.5 p -96.92 -1.68 45.31 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-N 115.368 -0.833 . . . . 1.35 111.342 -177.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1634 ' ' CYS . . . . . 0.574 ' SG ' ' HB2' ' A' 1600 ' ' SER . 74.7 m 60.73 35.04 19.78 Favored 'General case' 0 C--N 1.364 1.196 0 C-N-CA 124.043 0.937 . . . . 0.53 110.746 178.146 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1635 ' ' THR . . . . . . . . . . . . . 57.2 m -105.96 128.56 53.89 Favored 'General case' 0 N--CA 1.418 -2.029 0 CA-C-N 114.973 -1.012 . . . . 1.11 109.987 -176.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1636 ' ' LEU . . . . . 0.615 ' HG ' HD12 ' A' 1629 ' ' LEU . 0.9 OUTLIER -110.11 119.57 39.7 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 108.223 -1.028 . . . . 1.56 108.223 -177.376 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -99.52 129.18 45.67 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 116.293 -0.412 . . . . 0.54 110.257 -177.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -126.26 143.41 51.16 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.838 -0.619 . . . . 0.64 109.833 -178.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1639 ' ' SER . . . . . 0.759 ' HB2' HD12 ' A' 1627 ' ' ILE . 23.0 t -124.39 159.97 29.22 Favored 'General case' 0 C--N 1.31 -1.13 0 C-N-CA 124.284 1.033 . . . . 1.34 108.524 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 2.9 t90 -156.71 111.75 2.84 Favored 'General case' 0 N--CA 1.418 -2.073 0 N-CA-C 104.26 -2.496 . . . . 0.8 104.26 179.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1641 ' ' HIS . . . . . 0.537 ' HB3' ' HB2' ' A' 1615 ' ' ARG . 62.2 m-70 -97.63 110.01 22.65 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 108.926 -0.768 . . . . 1.14 108.926 -177.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1642 ' ' THR . . . . . . . . . . . . . 4.6 t -139.11 148.69 58.41 Favored Pre-proline 0 C--N 1.292 -1.931 0 CA-C-N 115.302 -0.863 . . . . 1.11 110.869 -171.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1643 ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -78.36 -6.17 15.4 Favored 'Trans proline' 0 C--N 1.364 1.39 0 C-N-CA 122.467 2.111 . . . . 0.78 112.168 176.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 7.3 tt -68.41 -31.04 70.09 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 108.915 -0.772 . . . . 1.66 108.915 176.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -86.08 4.08 39.69 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.195 -0.911 . . . . 1.29 111.284 -174.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 1.3 t -123.69 144.09 49.86 Favored 'General case' 0 N--CA 1.424 -1.77 0 C-N-CA 119.263 -0.975 . . . . 1.48 110.403 -178.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.302 -1.468 0 C-N-CA 122.554 0.342 . . . . 3.14 110.182 174.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . 0.477 ' O ' HG11 ' B' ' 14' ' ' VAL . . . . . . . . 0 N--CA 1.424 -2.11 0 N-CA-C 111.005 -0.838 . . . . 2.28 111.005 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -52.07 -55.11 22.94 Favored Glycine 0 N--CA 1.464 0.518 0 N-CA-C 115.344 0.898 . . . . 1.94 115.344 -174.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -78.36 -30.65 48.13 Favored 'General case' 0 CA--C 1.499 -0.998 0 CA-C-N 117.013 0.407 . . . . 2.55 110.3 -177.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 13' ' ' LEU . . . . . 0.545 ' O ' HD22 ' B' ' 17' ' ' LEU . 0.8 OUTLIER -58.16 -62.05 2.11 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-N 115.489 -0.778 . . . . 2.82 111.288 178.669 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . 0.477 HG11 ' O ' ' B' ' 10' ' ' GLY . 14.2 p -64.72 -29.18 46.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-N 116.107 -0.497 . . . . 2.5 111.244 -177.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 15' ' ' ASP . . . . . 0.586 ' OD1' ' HB3' ' A' 1569 ' ' GLN . 33.6 t70 -73.83 -37.95 64.69 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 113.11 0.782 . . . . 2.04 113.11 178.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 14.8 t -69.85 -32.17 70.41 Favored 'General case' 0 C--O 1.254 1.306 0 CA-C-N 119.432 1.014 . . . . 2.31 109.485 175.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.614 HD21 HD12 ' B' ' 42' ' ' ILE . 3.8 mm? -56.12 -44.28 78.98 Favored 'General case' 0 C--O 1.208 -1.118 0 CA-C-N 115.431 -0.804 . . . . 2.27 108.995 169.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -77.18 -21.72 53.53 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.27 -0.877 . . . . 2.39 112.006 -178.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -64.35 -56.67 12.85 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 116.349 -0.387 . . . . 1.0 110.239 178.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 15.0 p -98.66 -20.93 5.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 118.519 -1.273 . . . . 1.83 112.555 -177.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 21' ' ' CYS . . . . . 0.577 ' HB2' ' HB3' ' B' ' 26' ' ' PHE . 64.0 m -105.2 19.24 20.94 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 119.445 -0.902 . . . . 1.66 110.758 179.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.67 -56.58 24.49 Favored Glycine 0 C--N 1.31 -0.888 0 C-N-CA 120.382 -0.913 . . . . 1.53 112.254 178.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -70.34 -38.08 74.79 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.783 0.325 . . . . 2.72 111.307 177.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 43.2 ttp180 -72.68 -39.02 67.39 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 113.888 1.069 . . . . 5.02 113.888 -176.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 112.09 112.87 3.26 Favored Glycine 0 N--CA 1.429 -1.77 0 N-CA-C 109.157 -1.577 . . . . 1.63 109.157 -175.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . 0.577 ' HB3' ' HB2' ' B' ' 21' ' ' CYS . 39.8 p90 -92.2 134.73 34.6 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 120.696 -0.402 . . . . 1.71 110.895 -178.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -148.35 116.72 6.54 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.984 -0.747 . . . . 3.67 108.984 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 28' ' ' PHE . . . . . . . . . . . . . 43.3 p90 . . . . . 0 CA--C 1.547 0.836 0 C-N-CA 120.521 -0.472 . . . . 2.44 111.909 175.528 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.426 -1.987 0 N-CA-C 110.236 -1.146 . . . . 2.62 110.236 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . 0.614 HD12 HD21 ' B' ' 17' ' ' LEU . 15.0 pt 59.87 -33.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 C-N-CA 128.097 2.559 . . . . 2.28 116.731 176.198 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . 0.472 ' O ' ' HB2' ' B' ' 47' ' ' CYS . 2.7 p -52.57 -41.38 36.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 113.55 0.944 . . . . 2.6 113.55 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -94.72 -31.0 13.99 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 108.574 -0.899 . . . . 3.36 108.574 -174.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -56.92 -50.97 70.96 Favored 'General case' 0 C--O 1.206 -1.194 0 CA-C-N 115.35 -0.841 . . . . 3.08 109.638 174.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 46' ' ' CYS . . . . . 0.522 ' HB3' HD23 ' B' ' 13' ' ' LEU . 9.1 t -89.96 2.46 55.08 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.524 0.678 . . . . 2.23 111.17 -175.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 47' ' ' CYS . . . . . 0.472 ' HB2' ' O ' ' B' ' 43' ' ' VAL . 45.6 t -85.61 -52.41 5.83 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 116.331 -0.395 . . . . 2.48 110.459 177.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -104.59 13.02 32.37 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.289 0.566 . . . . 2.97 111.571 -175.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 28.7 mtp85 -155.86 -170.11 3.3 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 125.64 1.576 . . . . 4.65 107.477 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 21.3 t -121.9 129.13 52.31 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 109.188 -0.671 . . . . 2.86 109.188 -176.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . 0.447 ' HB3' ' HB2' ' B' ' 46' ' ' CYS . 26.7 p -99.71 149.89 22.86 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.943 -0.762 . . . . 2.11 108.943 -177.101 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . 0.443 ' HB2' ' HA ' ' A' 1601 ' ' LYS . 3.0 p-10 -116.57 174.62 5.97 Favored 'General case' 0 C--O 1.251 1.164 0 C-N-CA 120.348 -0.541 . . . . 2.67 110.829 170.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . 0.657 ' HB2' ' HA ' ' A' 1600 ' ' SER . 34.3 tp -54.61 -43.13 71.93 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 113.342 0.867 . . . . 2.36 113.342 -173.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . 0.404 ' O ' HG21 ' B' ' 58' ' ' THR . . . -55.39 -31.82 62.13 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.225 0.61 . . . . 1.92 112.341 -171.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 61.9 tp -72.41 -58.08 3.67 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 115.491 -0.777 . . . . 2.35 110.244 179.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 2.0 pp -70.2 -32.18 69.98 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 111.827 0.306 . . . . 2.01 111.827 -175.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -60.61 -48.54 81.33 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 116.291 -0.413 . . . . 2.27 111.262 179.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 58' ' ' THR . . . . . 0.404 HG21 ' O ' ' B' ' 54' ' ' ALA . 6.4 t -88.37 -8.7 54.63 Favored 'General case' 0 CA--C 1.569 1.697 0 CA-C-O 120.867 0.365 . . . . 2.67 111.895 -177.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 16.7 t80 -95.05 -33.4 12.72 Favored 'General case' 0 N--CA 1.441 -0.878 0 O-C-N 121.291 -0.88 . . . . 3.2 109.839 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 60' ' ' CYS . . . . . 0.512 ' SG ' ' HA ' ' B' ' 26' ' ' PHE . 38.8 t . . . . . 0 C--O 1.255 1.391 0 CA-C-N 115.783 -0.644 . . . . 2.3 110.963 -176.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1515 ' ' ASP . . . . . 0.423 ' O ' ' HB2' ' A' 1581 ' ' LEU . 17.5 m-20 . . . . . 0 CA--C 1.497 -1.064 0 N-CA-C 108.88 -0.785 . . . . 2.9 108.88 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1516 ' ' CYS . . . . . 0.769 ' HB3' ' HB2' ' A' 1529 ' ' LEU . 83.0 m -126.46 46.58 2.43 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 107.048 -1.464 . . . . 1.41 107.048 176.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1517 ' ' GLN . . . . . 0.462 ' HA ' ' O ' ' A' 1527 ' ' PHE . 14.0 pt20 -151.72 133.92 15.18 Favored 'General case' 0 N--CA 1.425 -1.712 0 CA-C-N 114.836 -1.074 . . . . 2.18 109.483 -175.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1518 ' ' VAL . . . . . 0.473 HG23 ' HB2' ' A' 1583 ' ' TYR . 2.3 m -150.26 136.96 12.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 C-N-CA 124.361 1.064 . . . . 1.52 109.497 175.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1519 ' ' THR . . . . . . . . . . . . . 43.4 m -111.81 134.51 53.33 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 108.797 -0.816 . . . . 1.36 108.797 178.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -90.38 124.13 63.69 Favored Pre-proline 0 C--N 1.298 -1.647 0 N-CA-C 109.184 -0.673 . . . . 2.02 109.184 176.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -68.8 -15.69 40.89 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 123.072 2.515 . . . . 1.82 113.725 -174.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 22.5 m -80.62 -50.45 9.95 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-O 120.593 0.235 . . . . 1.89 111.478 -177.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1523 ' ' THR . . . . . . . . . . . . . 5.6 t -103.96 -11.75 17.25 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 119.878 -0.729 . . . . 1.99 111.867 -176.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 75.09 25.92 67.74 Favored Glycine 0 CA--C 1.506 -0.529 0 CA-C-N 116.275 -0.42 . . . . 1.19 112.639 177.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 84.8 t60 -92.81 127.4 38.3 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 120.487 -0.485 . . . . 1.82 110.424 -177.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 2.0 tm? -92.71 110.93 22.37 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 114.444 -1.253 . . . . 1.3 108.354 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1527 ' ' PHE . . . . . 0.462 ' O ' ' HA ' ' A' 1517 ' ' GLN . 93.3 m-85 -85.07 119.55 25.59 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 120.463 -0.495 . . . . 0.8 109.723 173.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 24.1 t70 -115.39 114.21 24.8 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.44 -0.8 . . . . 1.17 109.417 178.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1529 ' ' LEU . . . . . 0.769 ' HB2' ' HB3' ' A' 1516 ' ' CYS . 2.8 mm? -102.41 -0.83 31.91 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 108.849 -0.797 . . . . 1.29 108.849 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -68.59 -32.35 72.19 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.627 0.727 . . . . 0.91 109.16 -178.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 31.5 t -64.81 -12.7 50.84 Favored 'General case' 0 CA--C 1.554 1.123 0 CA-C-N 114.881 -1.054 . . . . 1.98 110.858 177.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 90.5 mt -92.77 -3.13 55.27 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 122.02 -0.425 . . . . 1.34 110.703 177.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1533 ' ' SER . . . . . 0.968 ' HA ' ' HB1' ' A' 1536 ' ' ALA . 14.4 t -95.2 -179.62 4.86 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 109.526 -0.546 . . . . 1.93 109.526 179.149 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . 83.92 -65.73 4.05 Favored Glycine 0 C--N 1.312 -0.761 0 N-CA-C 109.609 -1.396 . . . . 1.1 109.609 -174.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 42.4 ttp180 -83.89 -2.24 56.06 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 124.424 1.09 . . . . 5.21 109.192 174.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1536 ' ' ALA . . . . . 0.968 ' HB1' ' HA ' ' A' 1533 ' ' SER . . . -46.84 -22.28 0.29 Allowed 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 127.551 2.34 . . . . 1.94 116.66 -175.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . -72.61 103.53 1.36 Allowed Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.361 -0.923 . . . . 1.08 111.208 178.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -119.93 149.34 42.27 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 120.93 0.395 . . . . 1.07 110.777 -178.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 9.9 p -112.94 117.48 32.2 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 115.458 -0.792 . . . . 1.46 110.38 179.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1540 ' ' ALA . . . . . 0.44 ' HB3' ' CG1' ' A' 1548 ' ' VAL . . . -112.54 146.68 38.1 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.953 -0.758 . . . . 1.19 108.953 177.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -86.28 151.68 23.39 Favored 'General case' 0 C--N 1.311 -1.081 0 O-C-N 123.22 0.325 . . . . 1.37 111.022 -175.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1542 ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -159.15 -101.93 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 109.511 -0.551 . . . . 1.38 109.511 -178.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1543 ' ' SER . . . . . . . . . . . . . 2.2 p -68.59 172.22 6.53 Favored 'General case' 0 CA--C 1.562 1.409 0 C-N-CA 124.641 1.176 . . . . 1.98 110.302 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -94.55 4.59 53.66 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 113.561 0.948 . . . . 3.96 113.561 -165.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 7.3 t -129.8 21.33 5.46 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.43 -0.908 . . . . 2.81 110.208 -178.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 169.25 179.73 41.37 Favored Glycine 0 N--CA 1.424 -2.127 0 C-N-CA 119.801 -1.19 . . . . 1.68 112.153 179.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 28.0 m -122.07 176.1 4.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 109.148 -0.686 . . . . 1.38 109.148 -177.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1548 ' ' VAL . . . . . 0.44 ' CG1' ' HB3' ' A' 1540 ' ' ALA . 14.9 p -103.62 128.12 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 N-CA-C 108.538 -0.912 . . . . 1.24 108.538 175.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -92.32 131.07 37.81 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.656 -0.868 . . . . 1.29 108.656 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 23.5 ptm -144.98 140.65 28.34 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 116.051 -0.522 . . . . 1.47 110.587 -178.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 12.3 p -131.95 125.96 32.89 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 115.824 -0.626 . . . . 1.4 111.551 177.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1552 ' ' ILE . . . . . 0.66 ' H ' ' HB2' ' A' 1536 ' ' ALA . 49.5 mm -82.63 124.5 39.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.556 -0.535 . . . . 1.11 109.556 177.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1553 ' ' CYS . . . . . 0.547 ' HB2' ' HB2' ' A' 1533 ' ' SER . 60.2 m 59.35 49.7 8.56 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.598 0.713 . . . . 1.4 110.696 177.118 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 168.92 172.14 35.4 Favored Glycine 0 N--CA 1.42 -2.401 0 N-CA-C 109.76 -1.336 . . . . 0.4 109.76 178.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -100.01 150.15 22.73 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 109.562 -0.532 . . . . 1.62 109.562 178.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -91.81 130.97 37.49 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.696 -0.684 . . . . 1.12 109.984 -174.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -67.34 -7.29 23.57 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 113.969 1.1 . . . . 2.49 113.969 -174.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -93.12 -4.72 51.75 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 120.302 -0.559 . . . . 1.38 112.065 -175.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1559 ' ' CYS . . . . . 0.729 ' SG ' ' HD2' ' A' 1560 ' ' PRO . 3.1 t -137.37 162.52 54.64 Favored Pre-proline 0 C--N 1.293 -1.871 0 N-CA-C 108.08 -1.082 . . . . 1.21 108.08 -178.479 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1560 ' ' PRO . . . . . 0.729 ' HD2' ' SG ' ' A' 1559 ' ' CYS . 16.6 Cg_exo -32.91 145.82 0.03 OUTLIER 'Trans proline' 0 CA--C 1.563 1.964 0 C-N-CA 125.175 3.916 . . . . 0.98 115.536 175.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.03 124.06 14.85 Favored 'Trans proline' 0 C--O 1.25 1.106 0 C-N-CA 123.236 2.624 . . . . 1.15 111.803 178.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 107.08 -5.66 36.41 Favored Glycine 0 N--CA 1.44 -1.072 0 CA-C-N 115.615 -0.72 . . . . 0.55 111.878 -177.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1563 ' ' VAL . . . . . 0.7 HG13 ' HB3' ' A' 1559 ' ' CYS . 10.6 t -84.36 120.64 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.227 0 CA-C-O 121.217 0.532 . . . . 1.53 112.33 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -96.8 -31.3 7.09 Favored Glycine 0 C--N 1.303 -1.298 0 CA-C-N 115.146 -0.934 . . . . 0.29 111.535 177.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -136.18 135.26 39.01 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 109.474 -0.565 . . . . 1.08 109.474 177.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1566 ' ' CYS . . . . . 0.482 ' HB2' HG13 ' A' 1563 ' ' VAL . 53.9 t -157.84 140.2 14.48 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 110.149 -0.315 . . . . 0.43 110.149 -176.443 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1567 ' ' PHE . . . . . 0.485 ' CE2' HG13 ' A' 1574 ' ' VAL . 64.1 m-85 -85.34 133.5 34.14 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 107.954 -1.128 . . . . 1.3 107.954 174.531 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -75.03 -9.73 83.96 Favored Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 115.561 0.984 . . . . 1.43 115.561 -171.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1569 ' ' GLN . . . . . 0.543 ' NE2' HE22 ' B' ' 18' ' ' GLN . 16.3 mt-30 -70.52 -69.4 0.36 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 117.258 0.529 . . . . 3.09 110.908 -177.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -97.85 2.08 48.91 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 113.394 0.887 . . . . 2.52 113.394 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 10.4 mmt85 58.63 41.9 21.4 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.0 -1.0 . . . . 3.19 110.444 178.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 32.3 mt -88.51 129.58 39.42 Favored 'Isoleucine or valine' 0 C--O 1.247 0.945 0 N-CA-C 108.085 -1.08 . . . . 1.51 108.085 177.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 30.0 t -81.09 131.65 35.31 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.391 0.615 . . . . 0.96 110.852 -177.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1574 ' ' VAL . . . . . 0.658 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 33.9 m -118.95 15.12 6.96 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 CA-C-N 115.981 -0.554 . . . . 1.6 111.346 -179.253 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 176.95 126.23 0.95 Allowed Glycine 0 N--CA 1.423 -2.223 0 C-N-CA 119.58 -1.295 . . . . 0.34 111.814 176.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 49.8 tttp -81.99 135.35 35.37 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 107.271 -1.381 . . . . 2.68 107.271 177.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -70.28 96.99 1.17 Allowed 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 122.956 0.502 . . . . 1.08 110.785 -176.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -110.49 173.65 6.23 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 108.72 -0.845 . . . . 1.95 108.72 177.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1579 ' ' LYS . . . . . 0.585 ' HB2' ' HZ2' ' A' 1579 ' ' LYS . 9.8 mtmp? -136.53 53.74 1.91 Allowed 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 107.662 -1.236 . . . . 3.11 107.662 -177.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 49.1 ttp180 -107.0 76.19 1.08 Allowed 'General case' 0 N--CA 1.419 -1.984 0 CA-C-N 114.497 -1.228 . . . . 4.04 108.027 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1581 ' ' LEU . . . . . 0.562 HD23 ' HA ' ' A' 1516 ' ' CYS . 0.3 OUTLIER -69.18 126.27 29.27 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.632 -1.167 . . . . 1.32 108.923 179.915 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 60.8 mtp180 -124.72 131.12 53.48 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 120.315 -0.554 . . . . 3.4 110.649 173.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1583 ' ' TYR . . . . . 0.5 ' CE1' ' HA ' ' A' 1586 ' ' GLN . 45.1 t80 -100.93 108.31 20.02 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 108.803 -0.814 . . . . 1.26 108.803 178.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1584 ' ' VAL . . . . . 0.594 ' O ' ' HB ' ' A' 1587 ' ' VAL . 15.5 m -127.4 91.82 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 CA-C-N 115.918 -0.583 . . . . 1.71 111.993 -178.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 32.8 t70 59.18 66.91 0.97 Allowed 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 124.039 0.936 . . . . 1.17 111.221 175.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1586 ' ' GLN . . . . . 0.5 ' HA ' ' CE1' ' A' 1583 ' ' TYR 0.267 28.5 pt20 61.41 14.75 6.02 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 127.074 2.15 . . . . 2.43 112.605 178.895 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A 1587 ' ' VAL . . . . . 0.594 ' HB ' ' O ' ' A' 1584 ' ' VAL . 15.7 t -110.44 120.82 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.325 0 CA-C-N 114.222 -1.354 . . . . 1.16 109.436 177.263 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1588 ' ' LEU . . . . . 0.966 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 2.2 mm? -97.79 107.76 20.33 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 106.556 -1.646 . . . . 1.11 106.556 177.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -105.22 120.72 42.24 Favored 'General case' 0 C--N 1.282 -2.36 0 CA-C-O 121.204 0.526 . . . . 1.74 111.544 -176.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 2.3 mt -107.78 108.5 19.73 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 106.196 -1.779 . . . . 1.4 106.196 172.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 7.8 p -97.39 131.14 44.92 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 CA-C-O 121.192 0.52 . . . . 1.7 110.62 -175.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1592 ' ' TYR . . . . . . . . . . . . . 13.1 m-30 -122.57 95.87 4.81 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 107.947 -1.131 . . . . 1.08 107.947 177.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1593 ' ' LYS . . . . . 0.517 ' HB3' ' HG3' ' A' 1607 ' ' LYS . 48.0 pttt -117.68 175.95 5.41 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.816 -0.754 . . . . 2.21 110.007 -176.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 7.4 m-20 57.11 42.32 25.93 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 124.697 1.248 . . . . 1.11 111.885 177.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -68.42 -95.97 0.04 OUTLIER Glycine 0 C--N 1.332 0.323 0 N-CA-C 110.627 -0.989 . . . . 0.78 110.627 178.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1596 ' ' SER . . . . . . . . . . . . . 79.1 p -122.06 158.48 55.04 Favored Pre-proline 0 C--N 1.288 -2.083 0 N-CA-C 107.691 -1.226 . . . . 1.36 107.691 172.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -57.67 137.63 82.14 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.323 2.016 . . . . 1.4 111.257 178.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1598 ' ' CYS . . . . . 0.493 ' HA ' ' CE2' ' A' 1606 ' ' TYR . 12.0 t -75.0 107.5 4.0 Favored Pre-proline 0 C--N 1.304 -1.399 0 N-CA-C 104.865 -2.272 . . . . 0.75 104.865 177.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 92.1 Cg_exo -44.22 -59.18 1.17 Allowed 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 123.973 3.115 . . . . 1.7 114.814 -169.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1600 ' ' SER . . . . . . . . . . . . . 8.1 m -87.77 12.92 11.66 Favored 'General case' 0 N--CA 1.402 -2.866 0 N-CA-C 112.827 0.676 . . . . 2.8 112.827 -174.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1601 ' ' LYS . . . . . 0.733 ' HE3' ' HB3' ' B' ' 53' ' ' LEU . 96.0 mttt -142.43 69.62 1.32 Allowed 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 122.506 1.146 . . . . 3.45 109.063 174.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 7.2 m -46.71 123.68 5.32 Favored 'General case' 0 N--CA 1.413 -2.315 0 C-N-CA 127.669 2.388 . . . . 2.44 112.326 -177.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 103.96 -21.95 36.62 Favored Glycine 0 N--CA 1.436 -1.348 0 N-CA-C 111.7 -0.56 . . . . 1.2 111.7 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1604 ' ' LEU . . . . . 0.514 HD13 ' HB3' ' A' 1601 ' ' LYS . 46.9 mt -94.11 152.46 18.74 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.019 -1.104 . . . . 2.38 108.019 179.195 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 26.6 m -131.75 145.24 51.5 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 108.078 -1.082 . . . . 1.96 108.078 178.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1606 ' ' TYR . . . . . 0.658 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 91.4 m-85 -64.37 155.99 30.64 Favored 'General case' 0 C--O 1.254 1.327 0 CA-C-N 116.231 -0.44 . . . . 1.06 111.656 -177.364 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1607 ' ' LYS . . . . . 0.517 ' HG3' ' HB3' ' A' 1593 ' ' LYS . 13.0 ttmm -151.89 127.79 10.31 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.502 -0.772 . . . . 2.0 109.553 -173.149 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1608 ' ' SER . . . . . . . . . . . . . 35.1 m -108.79 119.25 39.0 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 108.773 -0.825 . . . . 1.61 108.773 177.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 45.3 t -101.39 104.82 16.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 107.729 -1.211 . . . . 1.09 107.729 178.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 73.9 mt -94.54 111.05 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 N-CA-C 108.621 -0.881 . . . . 1.2 108.621 -178.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 34.3 t -109.12 110.33 21.55 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 115.398 -0.819 . . . . 1.89 110.927 -176.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1612 ' ' PHE . . . . . 0.966 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 63.0 m-85 -86.35 119.69 26.89 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.702 -0.851 . . . . 0.28 108.702 175.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 44.6 t -117.8 137.92 50.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-N 115.954 -0.566 . . . . 1.23 109.72 -176.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 24.4 t -67.93 111.22 4.24 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 123.758 0.823 . . . . 0.77 112.596 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1615 ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -138.43 105.46 7.76 Favored Pre-proline 0 N--CA 1.434 -1.225 0 N-CA-C 109.464 -0.569 . . . . 2.92 109.464 169.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1616 ' ' PRO . . . . . 0.737 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 35.9 Cg_exo -64.3 -10.62 24.42 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 123.224 2.616 . . . . 1.22 113.716 179.505 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -87.14 42.58 1.04 Allowed 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 125.09 1.356 . . . . 3.05 110.9 -177.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -36.58 119.12 0.61 Allowed 'General case' 0 C--O 1.241 0.607 0 C-N-CA 125.531 1.532 . . . . 1.55 112.738 -178.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . -178.83 -138.4 3.18 Favored Glycine 0 N--CA 1.425 -2.054 0 N-CA-C 110.505 -1.038 . . . . 1.16 110.505 -175.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -66.77 3.31 1.55 Allowed 'Trans proline' 0 N--CA 1.487 1.106 0 C-N-CA 123.516 2.81 . . . . 1.06 115.463 -175.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1621 ' ' THR . . . . . 0.517 ' HB ' ' HB2' ' A' 1641 ' ' HIS . 23.0 p -105.62 -4.52 21.01 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.657 0.741 . . . . 1.58 110.053 176.392 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 47.0 t30 -92.81 51.72 1.75 Allowed 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 123.215 1.483 . . . . 0.88 108.219 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1623 ' ' ARG . . . . . 0.484 ' O ' ' HG3' ' A' 1625 ' ' MET . 4.7 ptp180 -150.81 141.56 14.75 Favored Pre-proline 0 C--N 1.294 -1.819 0 N-CA-C 105.777 -1.934 . . . . 3.82 105.777 -176.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -57.0 106.77 0.24 Allowed 'Trans proline' 0 C--O 1.245 0.83 0 C-N-CA 122.374 2.049 . . . . 0.77 111.121 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1625 ' ' MET . . . . . 0.484 ' HG3' ' O ' ' A' 1623 ' ' ARG . 93.5 mtp -100.13 128.56 46.19 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 109.051 -0.722 . . . . 1.43 109.051 -176.319 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 1.8 tm? -87.1 112.51 21.98 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 106.741 -1.577 . . . . 1.43 106.741 -178.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1627 ' ' ILE . . . . . 0.729 HD13 ' HB2' ' A' 1639 ' ' SER . 39.3 mm -72.13 -55.24 14.01 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.613 0 N-CA-C 108.351 -0.981 . . . . 1.23 108.351 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 22.4 t -179.18 173.99 1.09 Allowed 'General case' 0 N--CA 1.422 -1.833 0 N-CA-C 106.286 -1.746 . . . . 1.88 106.286 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1629 ' ' LEU . . . . . 0.76 ' HG ' ' HG ' ' A' 1636 ' ' LEU . 3.8 tt -122.07 110.72 16.13 Favored 'General case' 0 N--CA 1.409 -2.51 0 N-CA-C 104.582 -2.377 . . . . 1.92 104.582 177.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 13.1 t70 -69.21 87.14 0.41 Allowed 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 107.728 -1.212 . . . . 1.09 107.728 176.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1631 ' ' LYS . . . . . 0.509 ' H ' ' HD2' ' A' 1631 ' ' LYS . 0.0 OUTLIER -54.96 -20.71 9.66 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.32 1.048 . . . . 3.98 113.116 -179.278 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A 1632 ' ' GLN . . . . . 0.411 ' HA ' ' NZ ' ' A' 1601 ' ' LYS . 0.3 OUTLIER -71.5 -45.68 61.81 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.441 -0.577 . . . . 2.6 109.441 -177.954 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 44.5 p -102.01 -5.21 24.87 Favored 'General case' 0 CA--C 1.557 1.212 0 N-CA-C 112.928 0.714 . . . . 1.35 112.928 -177.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 58.1 m 65.88 35.67 6.47 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.126 0.97 . . . . 0.53 109.767 -176.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1635 ' ' THR . . . . . 0.489 HG21 ' HD2' ' A' 1607 ' ' LYS . 86.1 m -100.96 129.04 46.75 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.662 -1.154 . . . . 1.11 110.211 -177.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1636 ' ' LEU . . . . . 0.76 ' HG ' ' HG ' ' A' 1629 ' ' LEU . 1.1 mp -107.97 122.36 46.67 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.837 -0.801 . . . . 1.56 108.837 -179.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -100.91 130.01 46.85 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 116.353 -0.385 . . . . 0.54 111.267 -178.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -127.97 130.63 48.7 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.789 -0.641 . . . . 0.64 109.478 -179.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1639 ' ' SER . . . . . 0.729 ' HB2' HD13 ' A' 1627 ' ' ILE . 10.1 t -106.61 156.67 18.35 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.821 -1.178 . . . . 1.34 107.821 178.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 2.0 t90 -156.14 108.62 2.6 Favored 'General case' 0 N--CA 1.423 -1.816 0 N-CA-C 105.689 -1.967 . . . . 0.8 105.689 178.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1641 ' ' HIS . . . . . 0.517 ' HB2' ' HB ' ' A' 1621 ' ' THR . 59.1 m-70 -101.75 102.74 13.42 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 110.018 -0.364 . . . . 1.14 110.018 -175.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1642 ' ' THR . . . . . . . . . . . . . 3.6 t -132.69 149.78 73.94 Favored Pre-proline 0 C--N 1.299 -1.627 0 CA-C-N 115.357 -0.838 . . . . 1.11 109.834 -173.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1643 ' ' PRO . . . . . 0.737 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 71.6 Cg_endo -79.72 -0.12 10.45 Favored 'Trans proline' 0 C--N 1.365 1.4 0 C-N-CA 122.461 2.108 . . . . 0.78 112.139 176.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 11.5 tp -67.12 -28.75 68.4 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.916 0.865 . . . . 1.66 109.038 175.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -89.61 15.61 9.21 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 114.892 -1.049 . . . . 1.29 110.502 -178.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1646 ' ' CYS . . . . . 0.51 ' SG ' ' HA ' ' A' 1643 ' ' PRO . 39.9 m -118.67 146.32 44.79 Favored 'General case' 0 N--CA 1.419 -1.985 0 N-CA-C 106.991 -1.485 . . . . 1.48 106.991 178.252 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.305 -1.343 0 C-N-CA 119.884 -0.727 . . . . 3.14 109.813 177.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.893 0 N-CA-C 112.861 -0.095 . . . . 2.28 112.861 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.12 -23.92 64.55 Favored Glycine 0 C--O 1.223 -0.562 0 N-CA-C 114.143 0.417 . . . . 1.94 114.143 -175.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -67.0 -37.84 84.94 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.428 0.633 . . . . 2.55 109.725 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.2 -49.77 58.64 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 115.227 -0.897 . . . . 2.82 109.613 -177.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 8.2 p -67.41 -32.46 57.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 C-N-CA 119.961 -0.695 . . . . 2.5 111.273 179.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -70.9 -40.05 72.41 Favored 'General case' 0 C--O 1.212 -0.896 0 C-N-CA 119.219 -0.992 . . . . 2.04 112.785 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 16.5 p -63.82 -40.75 97.36 Favored 'General case' 0 C--O 1.265 1.917 0 CA-C-N 118.444 0.566 . . . . 2.31 110.052 177.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.518 HD22 HD13 ' B' ' 42' ' ' ILE . 3.9 mm? -53.34 -53.86 44.83 Favored 'General case' 0 C--O 1.211 -0.929 0 CA-C-N 115.26 -0.882 . . . . 2.27 110.574 171.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 18' ' ' GLN . . . . . 0.543 HE22 ' NE2' ' A' 1569 ' ' GLN . 0.8 OUTLIER -68.89 -20.97 64.26 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 113.001 0.741 . . . . 2.39 113.001 -179.137 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -59.86 -62.67 1.7 Allowed 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 120.927 0.394 . . . . 1.0 110.665 178.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 14.1 p -92.56 -26.09 4.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 C-N-CA 119.119 -1.032 . . . . 1.83 111.33 -177.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 21' ' ' CYS . . . . . 0.449 ' HB2' ' O ' ' B' ' 17' ' ' LEU . 62.6 m -95.98 12.1 31.64 Favored 'General case' 0 N--CA 1.437 -1.111 0 C-N-CA 120.326 -0.55 . . . . 1.66 111.594 -177.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -56.7 -47.47 84.95 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 111.715 -0.554 . . . . 1.53 111.715 173.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -72.24 -14.4 61.77 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 122.816 0.447 . . . . 2.72 111.624 175.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 12.3 tpp180 -100.21 -60.04 1.6 Allowed 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.831 0.824 . . . . 5.02 112.649 -171.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 131.5 152.4 7.21 Favored Glycine 0 N--CA 1.423 -2.232 0 N-CA-C 105.856 -2.897 . . . . 1.63 105.856 -171.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -142.57 141.1 31.95 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 118.832 1.316 . . . . 1.71 111.59 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -161.87 134.61 5.99 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 108.12 -1.067 . . . . 3.67 108.12 175.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 28' ' ' PHE . . . . . 0.428 ' CD1' ' HG ' ' B' ' 17' ' ' LEU . 24.2 p90 . . . . . 0 C--N 1.311 -1.07 0 CA-C-O 122.105 0.955 . . . . 2.44 110.503 -177.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.418 -2.565 0 N-CA-C 110.279 -1.128 . . . . 2.62 110.279 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . 0.518 HD13 HD22 ' B' ' 17' ' ' LEU 0.255 11.8 pt 60.52 -33.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 128.421 2.689 . . . . 2.28 115.346 179.155 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . 0.634 ' O ' ' HB2' ' B' ' 47' ' ' CYS . 6.8 p -56.03 -44.2 77.75 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.452 0 N-CA-C 113.2 0.815 . . . . 2.6 113.2 -178.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -94.73 -31.21 13.89 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.321 -0.992 . . . . 3.36 108.321 -173.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . 0.511 ' O ' ' HB2' ' B' ' 49' ' ' ARG . 28.7 tt0 -67.57 -13.4 62.03 Favored 'General case' 0 CA--C 1.555 1.14 0 CA-C-N 114.728 -1.124 . . . . 3.08 109.924 177.329 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 46' ' ' CYS . . . . . . . . . . . . . 45.5 t -117.86 -14.19 10.08 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-O 121.397 0.618 . . . . 2.23 110.165 174.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 47' ' ' CYS . . . . . 0.634 ' HB2' ' O ' ' B' ' 43' ' ' VAL . 27.3 t -70.04 -44.55 68.99 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.967 -0.383 . . . . 2.48 109.967 -177.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -119.65 23.3 11.23 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.422 -0.354 . . . . 2.97 110.712 -178.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . 0.511 ' HB2' ' O ' ' B' ' 45' ' ' GLU . 68.4 mtt180 -145.36 162.38 37.4 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 108.393 -0.965 . . . . 4.65 108.393 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 22.4 t -85.18 109.16 18.1 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 106.523 -1.658 . . . . 2.86 106.523 173.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 15.8 p -101.67 144.89 29.83 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 108.001 -1.111 . . . . 2.11 108.001 -176.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -93.13 144.61 25.1 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.419 0.628 . . . . 2.67 109.434 177.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . 0.733 ' HB3' ' HE3' ' A' 1601 ' ' LYS . 48.8 tp -58.46 -27.88 64.8 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.098 1.359 . . . . 2.36 111.363 -179.027 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.32 -39.23 75.4 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.425 -0.807 . . . . 1.92 111.122 178.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 31.3 tp -56.38 -54.63 43.29 Favored 'General case' 0 CA--C 1.516 -0.331 0 O-C-N 124.272 0.983 . . . . 2.35 111.323 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 2.4 pp -73.85 -28.53 61.64 Favored 'General case' 0 N--CA 1.427 -1.61 0 C-N-CA 121.099 -0.24 . . . . 2.01 111.427 -176.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -63.5 -50.47 69.5 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 123.512 0.507 . . . . 2.27 110.711 177.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 14.6 t -80.11 -7.91 59.13 Favored 'General case' 0 CA--C 1.557 1.224 0 CA-C-O 121.092 0.473 . . . . 2.67 111.076 -179.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 59' ' ' TYR . . . . . 0.433 ' HB3' ' H ' ' B' ' 60' ' ' CYS . 15.3 t80 -89.07 -80.13 0.3 Allowed 'General case' 0 N--CA 1.42 -1.973 0 N-CA-C 106.891 -1.522 . . . . 3.2 106.891 176.076 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 60' ' ' CYS . . . . . 0.433 ' H ' ' HB3' ' B' ' 59' ' ' TYR . 43.5 t . . . . . 0 CA--C 1.554 1.12 0 C-N-CA 126.067 1.747 . . . . 2.3 113.869 -178.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 13.3 t70 . . . . . 0 C--O 1.225 -0.203 0 CA-C-O 121.4 0.619 . . . . 2.9 109.448 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A 1516 ' ' CYS . . . . . 0.661 ' HA ' HD21 ' A' 1581 ' ' LEU . 96.0 m 62.35 20.86 12.13 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.756 0.822 . . . . 1.41 112.952 -176.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -155.8 130.83 9.31 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 108.404 -0.961 . . . . 2.18 108.404 177.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1518 ' ' VAL . . . . . 0.446 HG22 HD13 ' A' 1581 ' ' LEU . 0.5 OUTLIER -144.14 145.58 21.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 C-N-CA 123.575 0.75 . . . . 1.52 110.066 -178.706 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A 1519 ' ' THR . . . . . . . . . . . . . 27.1 m -114.48 142.49 46.32 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 109.86 -0.422 . . . . 1.36 109.86 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1520 ' ' ASN . . . . . 0.497 ' OD1' HG23 ' A' 1523 ' ' THR . 18.1 t-20 -87.68 113.36 54.06 Favored Pre-proline 0 C--N 1.307 -1.257 0 N-CA-C 107.632 -1.248 . . . . 2.02 107.632 171.577 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -69.44 -7.49 21.09 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.949 2.433 . . . . 1.82 113.351 -174.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1522 ' ' SER . . . . . 0.484 ' HB2' ' OD1' ' A' 1520 ' ' ASN . 42.9 m -79.26 -45.98 18.7 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 121.116 -0.234 . . . . 1.89 110.95 178.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1523 ' ' THR . . . . . 0.497 HG23 ' OD1' ' A' 1520 ' ' ASN . 7.7 t -111.0 -15.37 13.76 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 120.358 -0.537 . . . . 1.99 112.3 -176.19 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 83.52 25.82 45.4 Favored Glycine 0 C--O 1.225 -0.457 0 C-N-CA 121.041 -0.6 . . . . 1.19 113.195 176.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -92.81 125.14 37.27 Favored 'General case' 0 C--N 1.309 -1.158 0 C-N-CA 120.589 -0.445 . . . . 1.82 110.074 -178.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 2.7 tm? -94.91 116.62 28.94 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 124.071 0.948 . . . . 1.3 109.447 -178.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -92.54 131.39 37.7 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 120.22 -0.592 . . . . 0.8 109.976 173.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 17.3 t70 -120.13 121.06 37.98 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.589 -0.893 . . . . 1.17 108.589 174.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1529 ' ' LEU . . . . . 0.546 ' HG ' HD23 ' A' 1581 ' ' LEU . 3.1 mm? -100.98 5.82 43.29 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 121.332 0.587 . . . . 1.29 110.509 -176.19 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 2.4 m -73.45 -24.75 60.27 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.715 -0.675 . . . . 0.91 110.235 -178.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 23.0 t -66.7 -28.75 68.69 Favored 'General case' 0 CA--C 1.555 1.149 0 CA-C-O 121.366 0.603 . . . . 1.98 110.38 178.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1532 ' ' LEU . . . . . 0.472 ' HG ' HD21 ' A' 1644 ' ' LEU . 95.5 mt -90.92 3.19 55.26 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.071 0.462 . . . . 1.34 110.925 178.177 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1533 ' ' SER . . . . . . . . . . . . . 13.1 t -80.91 176.49 9.77 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.496 0.665 . . . . 1.93 109.622 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . 150.79 153.77 6.26 Favored Glycine 0 N--CA 1.423 -2.195 0 N-CA-C 110.998 -0.841 . . . . 1.1 110.998 -176.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -78.71 -31.97 46.68 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 121.016 0.436 . . . . 5.21 110.604 -178.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -78.11 -29.5 48.97 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.211 0.529 . . . . 1.94 110.723 -179.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 74.34 -141.52 28.98 Favored Glycine 0 N--CA 1.426 -2.028 0 C-N-CA 120.871 -0.681 . . . . 1.08 112.232 177.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -145.18 144.99 31.16 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.82 -1.178 . . . . 1.07 107.82 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 2.6 m -106.62 133.37 51.4 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.317 0.58 . . . . 1.46 110.193 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1540 ' ' ALA . . . . . 0.675 ' HB3' ' HG2' ' A' 1624 ' ' PRO . . . -127.13 140.84 51.98 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.606 -0.887 . . . . 1.19 108.606 178.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -84.08 142.79 30.16 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 123.518 0.511 . . . . 1.37 110.631 -179.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1542 ' ' TYR . . . . . 0.463 ' HD2' ' HE1' ' A' 1567 ' ' PHE . 0.3 OUTLIER -129.53 -101.8 0.32 Allowed 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 107.899 -1.149 . . . . 1.38 107.899 177.713 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A 1543 ' ' SER . . . . . 0.419 ' H ' ' HB3' ' A' 1542 ' ' TYR . 12.5 t -75.2 178.25 5.89 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 109.869 -0.419 . . . . 1.98 109.869 178.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 60.7 tttp -52.61 -44.13 65.8 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.804 0.841 . . . . 3.96 113.235 -173.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 11.1 t -123.01 32.33 5.73 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 107.329 -1.36 . . . . 2.81 107.329 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . -126.6 111.23 1.36 Allowed Glycine 0 N--CA 1.43 -1.707 0 CA-C-N 115.114 -0.948 . . . . 1.68 113.133 -174.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 20.4 m -110.31 157.45 10.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 N-CA-C 108.331 -0.988 . . . . 1.38 108.331 175.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1548 ' ' VAL . . . . . 0.492 ' HA ' ' HA ' ' A' 1567 ' ' PHE . 10.2 p -114.68 132.28 64.3 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 N-CA-C 109.369 -0.604 . . . . 1.24 109.369 177.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -101.1 117.51 35.16 Favored 'General case' 0 CA--C 1.488 -1.405 0 N-CA-C 108.714 -0.847 . . . . 1.29 108.714 178.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 13.0 ptp -129.53 139.41 51.54 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-N 115.824 -0.626 . . . . 1.47 110.402 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 7.1 p -117.48 120.61 38.63 Favored 'General case' 0 C--N 1.274 -2.678 0 CA-C-N 115.016 -0.993 . . . . 1.4 108.459 176.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1552 ' ' ILE . . . . . 0.414 ' HB ' ' O ' ' A' 1532 ' ' LEU . 38.6 mm -77.5 120.85 28.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 C-N-CA 120.672 -0.411 . . . . 1.11 110.571 -177.264 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 38.1 t 67.61 39.43 2.78 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 122.282 1.039 . . . . 1.4 109.314 174.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 176.86 -169.86 42.4 Favored Glycine 0 N--CA 1.422 -2.288 0 C-N-CA 120.436 -0.888 . . . . 0.4 111.258 -178.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -113.53 151.5 31.48 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 120.967 0.413 . . . . 1.62 111.53 -176.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -99.23 146.38 26.25 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 114.676 -1.147 . . . . 1.12 109.107 -176.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -92.45 4.94 52.47 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 112.374 0.509 . . . . 2.49 112.374 -170.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -93.63 -7.77 42.97 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 121.594 -0.691 . . . . 1.38 111.655 -179.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1559 ' ' CYS . . . . . 0.465 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 78.7 m -136.6 165.96 31.29 Favored Pre-proline 0 C--N 1.297 -1.682 0 CA-C-O 118.398 -0.811 . . . . 1.21 109.849 -178.166 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1560 ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 7.7 Cg_exo -36.5 118.57 0.2 Allowed 'Trans proline' 0 C--N 1.367 1.518 0 C-N-CA 124.561 3.508 . . . . 0.98 113.951 176.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -44.74 130.66 9.89 Favored 'Trans proline' 0 C--N 1.362 1.255 0 C-N-CA 124.59 3.527 . . . . 1.15 112.18 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 111.79 -6.69 27.7 Favored Glycine 0 N--CA 1.435 -1.408 0 CA-C-N 115.906 -0.588 . . . . 0.55 112.404 -177.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1563 ' ' VAL . . . . . . . . . . . . . 7.5 p -105.27 137.19 35.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 O-C-N 122.109 -0.642 . . . . 1.53 111.496 -178.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -99.54 -32.68 5.63 Favored Glycine 0 C--N 1.322 -0.241 0 CA-C-N 115.615 -0.72 . . . . 0.29 112.771 -178.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -122.88 126.21 46.88 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 109.479 -0.563 . . . . 1.08 109.479 178.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 46.5 t -153.73 148.38 26.32 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.842 -0.799 . . . . 0.43 108.842 -179.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1567 ' ' PHE . . . . . 0.721 ' HB2' ' HG1' ' A' 1570 ' ' THR . 96.7 m-85 -92.11 158.78 16.01 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 119.732 -0.787 . . . . 1.3 109.548 176.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -62.6 -75.92 0.29 Allowed Glycine 0 C--O 1.245 0.81 0 N-CA-C 115.183 0.833 . . . . 1.43 115.183 -173.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -67.18 -34.48 77.62 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 113.159 0.799 . . . . 3.09 113.159 -173.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1570 ' ' THR . . . . . 0.783 ' HB ' HG13 ' A' 1572 ' ' ILE . 45.9 p -67.81 -35.17 78.15 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 112.429 0.529 . . . . 2.52 112.429 -177.019 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 18.1 mmt180 64.55 8.88 4.66 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.672 1.189 . . . . 3.19 110.746 -174.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1572 ' ' ILE . . . . . 0.783 HG13 ' HB ' ' A' 1570 ' ' THR . 18.1 mt -74.61 127.29 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-O 121.301 0.572 . . . . 1.51 111.438 -175.404 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 13.0 t -74.79 118.21 17.5 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 114.922 -1.035 . . . . 0.96 108.656 177.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1574 ' ' VAL . . . . . 0.549 ' HA ' ' CB ' ' A' 1606 ' ' TYR . 24.8 m -114.58 20.29 6.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 C-N-CA 119.738 -0.785 . . . . 1.6 111.933 -179.168 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 161.44 119.75 0.52 Allowed Glycine 0 N--CA 1.432 -1.602 0 C-N-CA 120.327 -0.94 . . . . 0.34 112.451 176.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 57.7 tttm -64.66 139.89 58.81 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.843 -0.429 . . . . 2.68 109.843 178.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -71.73 144.34 49.31 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 115.477 -0.783 . . . . 1.08 110.057 -179.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 22.2 p30 -161.31 179.01 8.66 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 107.853 -1.166 . . . . 1.95 107.853 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 17.7 pttm -134.04 46.53 2.51 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-O 122.941 1.353 . . . . 3.11 108.784 177.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 64.7 ttt180 -101.48 99.88 10.26 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-N 113.383 -1.735 . . . . 4.04 107.75 -175.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1581 ' ' LEU . . . . . 0.661 HD21 ' HA ' ' A' 1516 ' ' CYS . 0.3 OUTLIER -93.53 137.58 32.68 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.855 -0.795 . . . . 1.32 108.855 -175.58 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 75.6 mtp180 -123.91 124.77 43.35 Favored 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 120.652 -0.419 . . . . 3.4 111.045 171.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1583 ' ' TYR . . . . . . . . . . . . . 71.1 t80 -96.31 112.78 24.4 Favored 'General case' 0 CA--C 1.49 -1.364 0 N-CA-C 107.239 -1.393 . . . . 1.26 107.239 173.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1584 ' ' VAL . . . . . 0.536 ' O ' ' HB ' ' A' 1587 ' ' VAL . 20.3 t -128.39 92.33 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 N-CA-C 109.501 -0.555 . . . . 1.71 109.501 -178.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 32.6 t70 50.83 69.2 0.67 Allowed 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 124.905 1.282 . . . . 1.17 112.041 175.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 3.0 pt20 71.37 -8.04 1.09 Allowed 'General case' 0 N--CA 1.504 2.271 0 C-N-CA 128.498 2.719 . . . . 2.43 112.197 178.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1587 ' ' VAL . . . . . 0.536 ' HB ' ' O ' ' A' 1584 ' ' VAL . 13.8 t -91.68 120.31 40.54 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.23 0 CA-C-N 115.263 -0.881 . . . . 1.16 110.106 178.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1588 ' ' LEU . . . . . 0.791 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 3.2 mm? -91.06 107.66 19.35 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 105.923 -1.88 . . . . 1.11 105.923 174.49 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -111.08 131.07 55.38 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-O 121.694 0.759 . . . . 1.74 112.515 -173.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 15.0 mt -123.86 104.76 9.14 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 114.0 -1.455 . . . . 1.4 107.699 173.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1591 ' ' VAL . . . . . 0.478 HG21 HG22 ' A' 1609 ' ' VAL . 6.3 p -97.53 128.57 48.72 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 N-CA-C 108.799 -0.815 . . . . 1.7 108.799 179.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1592 ' ' TYR . . . . . 0.479 ' O ' ' HA ' ' A' 1607 ' ' LYS . 15.9 m-30 -115.19 102.65 10.09 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.673 -0.862 . . . . 1.08 108.673 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 57.8 pttt -109.9 176.43 5.07 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.244 -0.65 . . . . 2.21 109.244 -178.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 21.8 m-20 61.0 51.11 4.67 Favored 'General case' 0 C--N 1.312 -1.037 0 O-C-N 124.095 0.872 . . . . 1.11 112.158 177.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -83.09 -134.51 2.28 Favored Glycine 0 N--CA 1.425 -2.098 0 N-CA-C 109.629 -1.389 . . . . 0.78 109.629 172.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1596 ' ' SER . . . . . . . . . . . . . 29.9 p -100.33 157.96 32.85 Favored Pre-proline 0 C--N 1.29 -1.994 0 O-C-N 122.036 -0.685 . . . . 1.36 109.648 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1597 ' ' PRO . . . . . 0.464 ' HA ' ' O ' ' A' 1604 ' ' LEU . 73.4 Cg_exo -52.01 123.6 12.86 Favored 'Trans proline' 0 C--N 1.36 1.167 0 C-N-CA 123.059 2.506 . . . . 1.4 112.234 177.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1598 ' ' CYS . . . . . 0.624 ' HA ' ' CE1' ' A' 1606 ' ' TYR . 43.7 t -77.94 117.84 68.42 Favored Pre-proline 0 C--N 1.299 -1.627 0 CA-C-N 114.959 -1.018 . . . . 0.75 109.659 -178.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -63.93 -30.31 67.23 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.914 2.409 . . . . 1.7 111.855 178.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1600 ' ' SER . . . . . 0.599 ' HA ' ' HB2' ' B' ' 53' ' ' LEU . 14.4 m -61.65 -49.27 77.23 Favored 'General case' 0 C--O 1.25 1.083 0 CA-C-N 116.009 -0.542 . . . . 2.8 110.852 178.264 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1601 ' ' LYS . . . . . 0.66 ' HG2' HD21 ' A' 1604 ' ' LEU . 0.6 OUTLIER -120.81 98.49 6.03 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 107.114 -1.439 . . . . 3.45 107.114 -178.958 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 19.3 m -57.96 119.32 6.55 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 113.822 1.045 . . . . 2.44 113.822 -171.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 98.96 -8.45 61.19 Favored Glycine 0 CA--C 1.499 -0.964 0 N-CA-C 111.595 -0.602 . . . . 1.2 111.595 177.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1604 ' ' LEU . . . . . 0.66 HD21 ' HG2' ' A' 1601 ' ' LYS . 8.8 tp -90.97 170.98 9.6 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.735 -1.209 . . . . 2.38 107.735 -179.222 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 32.5 t -130.48 150.93 51.47 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 108.644 -0.873 . . . . 1.96 108.644 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1606 ' ' TYR . . . . . 0.624 ' CE1' ' HA ' ' A' 1598 ' ' CYS . 57.8 m-85 -71.48 157.76 37.46 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.744 -0.662 . . . . 1.06 110.856 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1607 ' ' LYS . . . . . 0.479 ' HA ' ' O ' ' A' 1592 ' ' TYR . 75.7 tttt -157.39 125.44 5.47 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 109.21 -0.663 . . . . 2.0 109.21 -173.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1608 ' ' SER . . . . . . . . . . . . . 28.5 m -112.48 132.05 55.26 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-N 116.278 -0.419 . . . . 1.61 109.933 -178.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1609 ' ' VAL . . . . . 0.478 HG22 HG21 ' A' 1591 ' ' VAL . 39.8 t -109.35 108.59 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.507 0 N-CA-C 108.448 -0.945 . . . . 1.09 108.448 177.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 68.7 mt -95.24 126.66 47.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 N-CA-C 108.06 -1.089 . . . . 1.2 108.06 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 23.4 m -127.26 118.47 24.3 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 116.138 -0.483 . . . . 1.89 110.911 -178.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1612 ' ' PHE . . . . . 0.791 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 70.0 m-85 -95.55 128.02 42.07 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.912 -0.585 . . . . 0.28 109.596 177.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1613 ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' 1641 ' ' HIS . 66.2 t -122.7 138.84 51.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 CA-C-N 115.402 -0.817 . . . . 1.23 109.443 -177.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1614 ' ' CYS . . . . . 0.694 ' HB2' ' HA ' ' A' 1646 ' ' CYS . 4.0 t -52.07 119.82 4.75 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 124.352 1.061 . . . . 0.77 113.169 176.394 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1615 ' ' ARG . . . . . 0.756 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 22.2 tpt180 -135.29 89.66 22.63 Favored Pre-proline 0 N--CA 1.439 -0.993 0 N-CA-C 107.739 -1.208 . . . . 2.92 107.739 170.09 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1616 ' ' PRO . . . . . 0.567 ' HD3' ' SG ' ' A' 1614 ' ' CYS . 51.3 Cg_endo -68.94 -23.06 35.06 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.195 1.93 . . . . 1.22 113.425 -172.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -94.86 -3.56 48.61 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.527 -0.306 . . . . 3.05 111.051 -179.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . 59.51 -165.85 0.19 Allowed 'General case' 0 CA--C 1.554 1.108 0 N-CA-C 109.455 -0.572 . . . . 1.55 109.455 -173.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . 135.3 -163.54 24.88 Favored Glycine 0 N--CA 1.415 -2.739 0 C-N-CA 120.961 -0.637 . . . . 1.16 112.403 174.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -61.3 -8.24 10.02 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 124.243 3.295 . . . . 1.06 115.069 -177.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1621 ' ' THR . . . . . . . . . . . . . 19.0 p -96.43 -0.65 48.9 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-O 121.199 0.523 . . . . 1.58 111.369 -177.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 41.4 t30 -87.25 63.43 7.79 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 122.243 1.02 . . . . 0.88 109.059 178.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 -172.76 140.07 0.95 Allowed Pre-proline 0 C--N 1.304 -1.387 0 N-CA-C 107.443 -1.318 . . . . 3.82 107.443 -177.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1624 ' ' PRO . . . . . 0.675 ' HG2' ' HB3' ' A' 1540 ' ' ALA . 35.1 Cg_endo -64.08 99.72 0.29 Allowed 'Trans proline' 0 C--O 1.246 0.917 0 C-N-CA 122.859 2.372 . . . . 0.77 112.355 -176.243 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 70.7 mtm -98.07 133.49 42.45 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.99 -0.55 . . . . 1.43 110.703 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 1.4 tm? -74.58 116.62 15.48 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 108.15 -1.056 . . . . 1.43 108.15 -178.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1627 ' ' ILE . . . . . 0.448 HD11 ' HB2' ' A' 1639 ' ' SER . 43.1 mm -79.56 -55.63 8.83 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 N-CA-C 108.378 -0.971 . . . . 1.23 108.378 177.41 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 77.9 p -164.72 150.27 10.03 Favored 'General case' 0 N--CA 1.419 -1.982 0 CA-C-N 114.833 -1.076 . . . . 1.88 109.537 -179.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1629 ' ' LEU . . . . . 0.846 HD11 ' HG ' ' A' 1636 ' ' LEU . 27.8 tp -119.14 112.31 19.36 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 106.885 -1.524 . . . . 1.92 106.885 172.188 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 33.1 t70 -78.4 128.86 34.24 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 117.549 -1.661 . . . . 1.09 111.628 177.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1631 ' ' LYS . . . . . 0.491 ' HD3' ' N ' ' A' 1631 ' ' LYS . 0.1 OUTLIER -66.05 -28.96 69.24 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 112.726 -2.034 . . . . 3.98 113.108 -175.564 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 11.1 mm100 -103.0 -35.44 8.55 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 119.918 -0.713 . . . . 2.6 112.134 -174.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 73.9 p -91.99 -6.59 50.92 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-O 120.8 0.333 . . . . 1.35 111.605 -178.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 64.1 m 54.06 33.51 17.83 Favored 'General case' 0 C--N 1.362 1.147 0 C-N-CA 124.669 1.187 . . . . 0.53 111.898 176.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1635 ' ' THR . . . . . . . . . . . . . 29.2 m -100.53 132.1 46.09 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 115.624 -0.716 . . . . 1.11 109.37 -178.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1636 ' ' LEU . . . . . 0.846 ' HG ' HD11 ' A' 1629 ' ' LEU . 0.6 OUTLIER -111.08 124.11 51.54 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 107.919 -1.141 . . . . 1.56 107.919 -177.604 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -106.5 129.38 54.47 Favored 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 120.997 -0.281 . . . . 0.54 110.494 -179.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -125.36 134.9 52.01 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.197 -0.456 . . . . 0.64 110.269 -178.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1639 ' ' SER . . . . . 0.448 ' HB2' HD11 ' A' 1627 ' ' ILE . 31.0 t -110.29 148.81 31.18 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 107.663 -1.236 . . . . 1.34 107.663 176.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 2.6 t90 -152.69 114.27 4.29 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 105.951 -1.87 . . . . 0.8 105.951 -178.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1641 ' ' HIS . . . . . 0.756 ' HB3' ' HB2' ' A' 1615 ' ' ARG . 8.9 m-70 -105.04 115.56 30.48 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 108.889 -0.782 . . . . 1.14 108.889 -178.197 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1642 ' ' THR . . . . . . . . . . . . . 3.0 t -137.24 150.59 69.51 Favored Pre-proline 0 C--N 1.3 -1.547 0 C-N-CA 123.065 0.546 . . . . 1.11 110.445 -172.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1643 ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.49 -18.38 17.74 Favored 'Trans proline' 0 C--N 1.367 1.524 0 C-N-CA 122.622 2.215 . . . . 0.78 113.328 178.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1644 ' ' LEU . . . . . 0.472 HD21 ' HG ' ' A' 1532 ' ' LEU . 3.8 pp -84.45 -1.47 55.72 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 119.806 -0.757 . . . . 1.66 111.729 -178.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -120.06 28.66 7.95 Favored 'General case' 0 CA--C 1.498 -1.048 0 CA-C-O 122.103 0.954 . . . . 1.29 109.531 -178.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1646 ' ' CYS . . . . . 0.694 ' HA ' ' HB2' ' A' 1614 ' ' CYS . 45.9 t -105.7 140.87 38.1 Favored 'General case' 0 N--CA 1.41 -2.471 0 CA-C-N 114.842 -1.072 . . . . 1.48 109.835 -177.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 35.8 tt0 . . . . . 0 N--CA 1.419 -2.018 0 N-CA-C 104.928 -2.249 . . . . 3.14 104.928 175.971 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . 0.421 ' O ' HG12 ' B' ' 14' ' ' VAL . . . . . . . . 0 N--CA 1.425 -2.071 0 N-CA-C 111.433 -0.667 . . . . 2.28 111.433 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -55.72 -55.07 30.72 Favored Glycine 0 C--O 1.24 0.502 0 N-CA-C 114.388 0.515 . . . . 1.94 114.388 -174.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -74.25 -32.49 62.98 Favored 'General case' 0 CA--C 1.505 -0.775 0 C-N-CA 120.69 -0.404 . . . . 2.55 111.282 -177.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 13' ' ' LEU . . . . . 0.452 HD11 ' HA ' ' B' ' 13' ' ' LEU . 1.1 mm? -58.1 -59.0 5.96 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.175 0.512 . . . . 2.82 111.411 178.006 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . 0.421 HG12 ' O ' ' B' ' 10' ' ' GLY . 13.0 p -68.89 -35.33 68.84 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 CA-C-N 115.857 -0.61 . . . . 2.5 111.882 -176.131 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -78.34 -26.69 46.85 Favored 'General case' 0 C--O 1.213 -0.866 0 N-CA-C 114.105 1.15 . . . . 2.04 114.105 -179.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 19.6 p -67.09 -36.6 82.33 Favored 'General case' 0 C--O 1.256 1.437 0 CA-C-N 119.692 1.133 . . . . 2.31 108.819 174.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.711 ' HB3' ' HB3' ' B' ' 26' ' ' PHE . 10.4 mp -60.77 -47.85 84.43 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-N 114.978 -1.01 . . . . 2.27 111.335 171.312 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -63.09 -33.3 75.15 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.036 0.446 . . . . 2.39 110.07 179.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -55.52 -59.25 5.09 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 112.905 0.706 . . . . 1.0 112.905 -179.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 9.8 p -98.51 -20.21 5.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 C-N-CA 117.314 -1.755 . . . . 1.83 112.068 -179.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 21' ' ' CYS . . . . . 0.469 ' HB2' ' O ' ' B' ' 17' ' ' LEU . 69.4 m -99.66 1.25 43.33 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 113.473 0.916 . . . . 1.66 113.473 -175.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -49.29 -36.59 22.94 Favored Glycine 0 N--CA 1.483 1.806 0 N-CA-C 114.789 0.676 . . . . 1.53 114.789 -178.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -52.05 -46.91 65.28 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.873 0.869 . . . . 2.72 111.891 176.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -97.56 -43.47 7.22 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.277 0.56 . . . . 5.02 111.348 178.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 128.19 165.54 11.84 Favored Glycine 0 N--CA 1.425 -2.082 0 N-CA-C 110.19 -1.164 . . . . 1.63 110.19 -179.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . 0.711 ' HB3' ' HB3' ' B' ' 17' ' ' LEU . 3.4 p90 -98.25 128.01 44.48 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 117.163 0.481 . . . . 1.71 109.83 175.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -132.78 72.92 1.5 Allowed 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 121.577 0.703 . . . . 3.67 110.482 -176.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 28' ' ' PHE . . . . . . . . . . . . . 8.4 p90 . . . . . 0 C--N 1.321 -0.66 0 CA-C-N 115.123 -0.944 . . . . 2.44 109.282 -179.667 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.2 0 N-CA-C 110.139 -1.184 . . . . 2.62 110.139 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . 0.27 18.4 pt 60.84 -30.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 C-N-CA 127.185 2.194 . . . . 2.28 116.314 178.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 2.7 p -48.97 -46.23 16.61 Favored 'Isoleucine or valine' 0 C--O 1.245 0.837 0 N-CA-C 114.047 1.128 . . . . 2.6 114.047 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -96.69 -30.61 13.13 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 108.579 -0.897 . . . . 3.36 108.579 -172.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -64.72 -42.4 95.26 Favored 'General case' 0 C--O 1.214 -0.798 0 CA-C-N 114.869 -1.059 . . . . 3.08 111.179 177.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 46' ' ' CYS . . . . . 0.428 ' HA ' ' O ' ' B' ' 49' ' ' ARG . 35.7 t -89.33 -3.12 58.6 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.447 0.642 . . . . 2.23 110.703 -179.468 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 41.9 t -83.41 -50.42 8.33 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.638 0.732 . . . . 2.48 109.491 175.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -88.67 -20.04 25.4 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.866 0.691 . . . . 2.97 112.866 -177.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . 0.428 ' O ' ' HA ' ' B' ' 46' ' ' CYS . 36.1 mmt180 -130.68 150.31 51.93 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 106.68 -1.6 . . . . 4.65 106.68 177.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 22.1 t -79.96 127.5 32.34 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 106.827 -1.545 . . . . 2.86 106.827 178.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 24.3 p -90.52 139.21 30.91 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 109.36 -0.607 . . . . 2.11 109.36 -173.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -85.87 165.0 17.16 Favored 'General case' 0 C--O 1.249 1.07 0 C-N-CA 120.566 -0.454 . . . . 2.67 110.305 177.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . 0.599 ' HB2' ' HA ' ' A' 1600 ' ' SER . 63.5 tp -53.2 -45.02 68.43 Favored 'General case' 0 C--N 1.321 -0.663 0 O-C-N 123.479 0.487 . . . . 2.36 111.649 178.141 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.89 -32.41 63.69 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.368 -0.833 . . . . 1.92 113.184 -171.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 65.9 tp -70.42 -57.65 4.58 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 121.012 0.434 . . . . 2.35 110.295 179.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 2.9 pp -71.97 -25.25 61.79 Favored 'General case' 0 C--O 1.213 -0.867 0 CA-C-N 116.043 -0.526 . . . . 2.01 111.195 -174.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -64.82 -55.6 18.62 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 122.638 0.375 . . . . 2.27 110.162 178.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 13.2 t -78.89 -27.42 43.91 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 119.331 -0.947 . . . . 2.67 112.06 -177.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -71.66 -57.19 4.6 Favored 'General case' 0 C--O 1.219 -0.527 0 N-CA-C 107.02 -1.474 . . . . 3.2 107.02 178.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 9.9 t . . . . . 0 N--CA 1.488 1.464 0 N-CA-C 117.121 2.267 . . . . 2.3 117.121 174.492 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 86.6 mtp . . . . . 0 CA--C 1.502 -0.893 0 N-CA-C 108.685 -0.857 . . . . 9.74 108.685 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -76.71 111.76 12.57 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-N 115.619 -0.719 . . . . 9.32 112.023 -174.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 36.0 m 71.68 130.76 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 124.895 1.278 . . . . 5.97 113.399 175.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1511 ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -78.48 -11.94 59.98 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 109.299 -0.63 . . . . 3.48 109.299 176.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1512 ' ' GLU . . . . . 0.505 ' HA ' HG13 ' A' 1518 ' ' VAL . 29.5 mt-10 -92.64 147.77 22.6 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 114.914 -1.039 . . . . 5.95 108.287 176.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 50.1 m80 -155.71 141.97 18.43 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 105.394 -2.076 . . . . 6.14 105.394 -173.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 21.1 t70 -88.11 46.48 1.39 Allowed 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 107.795 -1.187 . . . . 5.06 107.795 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -132.43 24.4 4.44 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 114.972 -1.013 . . . . 2.9 110.857 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1516 ' ' CYS . . . . . 0.421 ' SG ' ' HB2' ' A' 1579 ' ' LYS . 77.8 m 54.11 35.84 23.3 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 113.876 1.065 . . . . 1.41 113.876 -176.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -143.6 129.33 19.3 Favored 'General case' 0 N--CA 1.434 -1.267 0 C-N-CA 120.07 -0.652 . . . . 2.18 109.662 176.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1518 ' ' VAL . . . . . 0.505 HG13 ' HA ' ' A' 1512 ' ' GLU . 2.5 m -138.57 137.89 42.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 CA-C-N 115.379 -0.828 . . . . 1.52 111.366 -175.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1519 ' ' THR . . . . . . . . . . . . . 6.3 m -98.15 136.85 37.78 Favored 'General case' 0 C--N 1.277 -2.579 0 CA-C-N 115.465 -0.789 . . . . 1.36 109.476 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -77.35 117.71 67.2 Favored Pre-proline 0 N--CA 1.428 -1.537 0 N-CA-C 108.808 -0.812 . . . . 2.02 108.808 176.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -69.47 -13.49 35.49 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 122.491 2.127 . . . . 1.82 113.795 -177.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 15.0 m -82.41 -36.74 26.4 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 112.498 0.555 . . . . 1.89 112.498 -177.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1523 ' ' THR . . . . . . . . . . . . . 12.4 t -137.1 3.48 2.65 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 119.599 -0.84 . . . . 1.99 112.215 -176.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 72.39 28.72 67.31 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.755 -0.736 . . . . 1.19 112.599 177.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 62.3 t-80 -85.18 119.81 25.98 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.797 -0.816 . . . . 1.82 108.797 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 2.6 tm? -87.15 112.47 21.98 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 109.032 -0.729 . . . . 1.3 109.032 -178.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -91.4 114.28 26.77 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 109.82 -0.437 . . . . 0.8 109.82 175.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 17.5 t70 -110.07 116.41 31.52 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.813 -0.81 . . . . 1.17 108.813 175.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1529 ' ' LEU . . . . . 0.476 ' HG ' HD12 ' A' 1581 ' ' LEU . 3.3 mm? -97.49 0.6 47.85 Favored 'General case' 0 N--CA 1.423 -1.817 0 CA-C-O 121.083 0.468 . . . . 1.29 110.301 -177.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1530 ' ' SER . . . . . 0.55 ' HA ' ' OG ' ' A' 1533 ' ' SER . 2.2 m -70.19 -19.31 63.18 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 122.193 0.997 . . . . 0.91 109.419 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 21.2 m -68.68 -18.4 64.26 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 114.931 -1.031 . . . . 1.98 110.238 175.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 82.6 mt -102.93 -6.73 22.13 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 122.322 -0.236 . . . . 1.34 110.979 178.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1533 ' ' SER . . . . . 0.649 ' HA ' ' HB ' ' A' 1552 ' ' ILE . 30.2 m -60.97 162.5 6.93 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-O 120.947 0.403 . . . . 1.93 111.286 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . 170.72 151.61 7.64 Favored Glycine 0 N--CA 1.426 -1.991 0 C-N-CA 120.513 -0.851 . . . . 1.1 111.107 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 33.8 ttt85 -87.21 -30.75 20.74 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 122.946 0.498 . . . . 5.21 111.377 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -78.37 -35.82 46.81 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.727 -0.842 . . . . 1.94 108.727 177.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 80.7 -140.16 21.48 Favored Glycine 0 N--CA 1.409 -3.109 0 CA-C-N 114.535 -1.211 . . . . 1.08 112.324 173.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -142.21 143.14 32.77 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 106.454 -1.684 . . . . 1.07 106.454 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 1.2 m -108.59 130.19 55.31 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 108.793 -0.817 . . . . 1.46 108.793 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1540 ' ' ALA . . . . . 0.409 ' HB3' ' HG2' ' A' 1624 ' ' PRO . . . -124.71 147.33 48.67 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.999 -0.741 . . . . 1.19 108.999 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -91.17 128.18 36.89 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 120.794 0.331 . . . . 1.37 110.225 -177.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1542 ' ' TYR . . . . . 0.584 ' CE2' ' HG ' ' A' 1626 ' ' LEU . 2.3 t80 -113.02 -99.32 0.43 Allowed 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.015 -1.105 . . . . 1.38 108.015 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1543 ' ' SER . . . . . 0.432 ' H ' ' HB3' ' A' 1542 ' ' TYR . 4.5 m -69.81 159.19 34.07 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 108.372 -0.973 . . . . 1.98 108.372 178.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 97.4 mttt -50.6 -42.69 56.19 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.269 0.841 . . . . 3.96 113.269 -177.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 19.9 m -106.53 28.5 7.77 Favored 'General case' 0 N--CA 1.416 -2.137 0 C-N-CA 122.189 0.196 . . . . 2.81 111.487 -177.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . -144.04 149.18 21.2 Favored Glycine 0 C--O 1.245 0.819 0 C-N-CA 119.425 -1.369 . . . . 1.68 113.868 -177.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 19.8 m -130.87 152.06 36.95 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.979 0 N-CA-C 108.564 -0.902 . . . . 1.38 108.564 177.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 10.3 p -108.68 134.63 50.0 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 N-CA-C 109.35 -0.611 . . . . 1.24 109.35 178.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -93.62 133.89 36.48 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 107.148 -1.427 . . . . 1.29 107.148 176.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 25.3 ptm -148.23 127.84 13.28 Favored 'General case' 0 C--N 1.282 -2.33 0 O-C-N 123.771 0.669 . . . . 1.47 109.836 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 5.0 p -119.0 134.42 55.2 Favored 'General case' 0 C--N 1.27 -2.856 0 CA-C-N 115.318 -0.855 . . . . 1.4 109.222 177.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1552 ' ' ILE . . . . . 0.649 ' HB ' ' HA ' ' A' 1533 ' ' SER . 46.3 mm -82.64 116.45 26.88 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 N-CA-C 109.527 -0.546 . . . . 1.11 109.527 -177.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 62.3 m 63.61 11.42 5.7 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.552 1.141 . . . . 1.4 113.701 173.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . -146.36 176.41 25.3 Favored Glycine 0 N--CA 1.42 -2.392 0 N-CA-C 108.972 -1.651 . . . . 0.4 108.972 -177.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -99.34 145.34 27.45 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 117.214 0.507 . . . . 1.62 110.853 -178.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -91.12 131.43 36.69 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 108.092 -1.077 . . . . 1.12 108.092 -176.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -81.7 -2.87 52.06 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 113.709 1.003 . . . . 2.49 113.709 -175.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -84.59 -6.44 59.37 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.381 -0.528 . . . . 1.38 110.781 -178.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1559 ' ' CYS . . . . . 0.643 ' SG ' ' HD2' ' A' 1560 ' ' PRO . 29.5 t -136.02 153.92 77.23 Favored Pre-proline 0 C--N 1.299 -1.612 0 N-CA-C 107.352 -1.351 . . . . 1.21 107.352 -178.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1560 ' ' PRO . . . . . 0.643 ' HD2' ' SG ' ' A' 1559 ' ' CYS . 7.7 Cg_exo -28.61 134.18 0.03 OUTLIER 'Trans proline' 0 CA--C 1.562 1.899 1 C-N-CA 125.471 4.114 . . . . 0.98 115.585 175.718 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -46.95 126.45 11.17 Favored 'Trans proline' 0 C--O 1.249 1.036 0 C-N-CA 124.818 3.679 . . . . 1.15 114.196 -178.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 105.62 -11.96 46.53 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 115.583 -0.735 . . . . 0.55 112.802 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1563 ' ' VAL . . . . . 0.592 HG12 ' HB2' ' A' 1566 ' ' CYS . 3.6 t -80.28 125.19 38.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 N-CA-C 112.904 0.705 . . . . 1.53 112.904 -178.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -96.73 -34.81 5.6 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.226 -0.897 . . . . 0.29 111.306 176.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -133.77 133.91 42.29 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 109.393 -0.595 . . . . 1.08 109.393 178.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1566 ' ' CYS . . . . . 0.592 ' HB2' HG12 ' A' 1563 ' ' VAL . 52.8 t -159.51 136.67 9.62 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 119.652 -0.213 . . . . 0.43 110.489 -174.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -84.54 137.91 33.06 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.142 -1.058 . . . . 1.3 108.142 173.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -89.33 11.79 68.65 Favored Glycine 0 N--CA 1.435 -1.37 0 N-CA-C 117.15 1.62 . . . . 1.43 117.15 -168.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1569 ' ' GLN . . . . . 0.446 ' HG2' HE21 ' B' ' 18' ' ' GLN . 0.8 OUTLIER -75.27 -70.59 0.41 Allowed 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 119.035 1.418 . . . . 3.09 110.049 176.661 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 58.7 p -100.4 -4.68 28.51 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 119.809 -0.757 . . . . 2.52 112.873 176.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1571 ' ' ARG . . . . . . . . . . . . 0.269 5.0 mpt_? 74.32 59.08 0.08 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.978 1.311 . . . . 3.19 112.595 -178.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 21.4 mt -90.6 131.2 38.41 Favored 'Isoleucine or valine' 0 C--O 1.243 0.742 0 CA-C-N 114.34 -1.3 . . . . 1.51 107.676 176.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 31.2 t -86.22 130.3 34.57 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.158 0.504 . . . . 0.96 110.642 -175.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1574 ' ' VAL . . . . . 0.489 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 25.4 m -117.8 16.12 7.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-O 121.532 0.682 . . . . 1.6 111.063 179.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 166.34 129.75 1.09 Allowed Glycine 0 N--CA 1.431 -1.684 0 CA-C-N 115.274 -0.876 . . . . 0.34 111.8 176.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 29.6 ttpp -78.74 145.36 34.48 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 107.5 -1.296 . . . . 2.68 107.5 176.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -66.88 80.0 0.11 Allowed 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 124.006 0.922 . . . . 1.08 112.783 -175.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1578 ' ' ASN . . . . . 0.42 ' O ' ' HE1' ' A' 1592 ' ' TYR . 89.6 m-20 -96.06 -172.63 2.61 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 107.636 -1.246 . . . . 1.95 107.636 177.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1579 ' ' LYS . . . . . 0.421 ' HB2' ' SG ' ' A' 1516 ' ' CYS . 15.5 ptpt -149.9 46.71 0.93 Allowed 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 121.882 0.848 . . . . 3.11 110.416 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 57.0 ttp180 -95.13 84.77 4.15 Favored 'General case' 0 N--CA 1.418 -2.066 0 CA-C-N 115.224 -0.898 . . . . 4.04 109.117 -175.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1581 ' ' LEU . . . . . 0.476 HD12 ' HG ' ' A' 1529 ' ' LEU . 2.4 tt -91.56 130.82 37.32 Favored 'General case' 0 C--N 1.294 -1.848 0 CA-C-N 114.135 -1.393 . . . . 1.32 109.618 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 46.6 mtm180 -125.67 141.09 52.19 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 116.074 -0.512 . . . . 3.4 110.235 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1583 ' ' TYR . . . . . . . . . . . . . 46.0 t80 -103.85 105.05 15.13 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.872 -0.788 . . . . 1.26 108.872 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1584 ' ' VAL . . . . . 0.505 ' O ' ' HB ' ' A' 1587 ' ' VAL . 15.5 m -123.51 91.04 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 CA-C-N 115.571 -0.74 . . . . 1.71 112.349 -175.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1585 ' ' ASP . . . . . 0.404 ' O ' ' HG2' ' A' 1586 ' ' GLN . 37.5 t70 57.62 66.79 1.06 Allowed 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.693 0.797 . . . . 1.17 111.357 175.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1586 ' ' GLN . . . . . 0.404 ' HG2' ' O ' ' A' 1585 ' ' ASP . 14.4 pt20 70.63 -3.56 1.89 Allowed 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 128.178 2.591 . . . . 2.43 111.525 178.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1587 ' ' VAL . . . . . 0.505 ' HB ' ' O ' ' A' 1584 ' ' VAL . 24.7 t -97.76 120.9 47.69 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.521 0 CA-C-N 115.158 -0.928 . . . . 1.16 110.787 -177.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1588 ' ' LEU . . . . . 0.992 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 2.9 mm? -91.64 107.22 19.06 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 107.074 -1.454 . . . . 1.11 107.074 175.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1589 ' ' GLN . . . . . 0.467 ' O ' ' HA ' ' A' 1581 ' ' LEU . 33.8 tt0 -98.74 126.63 44.41 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 109.558 -0.534 . . . . 1.74 109.558 -176.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1590 ' ' LEU . . . . . 0.644 ' HB3' ' HB ' ' A' 1610 ' ' ILE . 1.4 tt -121.4 100.05 6.82 Favored 'General case' 0 C--N 1.275 -2.652 0 N-CA-C 104.79 -2.3 . . . . 1.4 104.79 175.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 5.1 p -97.99 131.98 43.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 C-N-CA 120.232 -0.587 . . . . 1.7 111.809 -174.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1592 ' ' TYR . . . . . 0.569 ' O ' ' HG3' ' A' 1607 ' ' LYS . 21.2 m-85 -116.43 142.56 46.71 Favored 'General case' 0 CA--C 1.504 -0.814 0 N-CA-C 107.824 -1.176 . . . . 1.08 107.824 176.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 10.4 ptmm? -147.61 -179.0 6.56 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 106.336 -1.728 . . . . 2.21 106.336 -175.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 16.5 m-20 61.61 47.27 6.57 Favored 'General case' 0 CA--C 1.508 -0.646 0 O-C-N 124.323 1.014 . . . . 1.11 110.478 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -83.43 -140.68 4.18 Favored Glycine 0 N--CA 1.432 -1.578 0 N-CA-C 109.954 -1.258 . . . . 0.78 109.954 178.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1596 ' ' SER . . . . . . . . . . . . . 59.8 p -102.99 156.2 35.62 Favored Pre-proline 0 C--N 1.281 -2.393 0 N-CA-C 107.627 -1.249 . . . . 1.36 107.627 176.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1597 ' ' PRO . . . . . 0.497 ' HA ' ' O ' ' A' 1604 ' ' LEU . 54.0 Cg_exo -54.58 123.81 14.58 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 122.386 2.058 . . . . 1.4 111.322 178.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 31.9 t -74.63 120.47 81.67 Favored Pre-proline 0 C--N 1.303 -1.436 0 N-CA-C 108.62 -0.882 . . . . 0.75 108.62 -178.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -62.71 -19.32 67.94 Favored 'Trans proline' 0 N--CA 1.484 0.915 0 C-N-CA 123.585 2.857 . . . . 1.7 112.966 -176.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1600 ' ' SER . . . . . 0.552 ' HA ' ' HB2' ' B' ' 53' ' ' LEU . 6.4 m -58.66 -37.67 76.5 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 124.938 1.295 . . . . 2.8 111.95 178.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1601 ' ' LYS . . . . . 0.446 ' HE2' ' N ' ' A' 1602 ' ' SER . 0.0 OUTLIER -148.5 108.4 4.04 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 104.47 -2.418 . . . . 3.45 104.47 -179.503 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A 1602 ' ' SER . . . . . 0.446 ' N ' ' HE2' ' A' 1601 ' ' LYS . 8.4 t -57.42 117.35 4.03 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 123.02 0.528 . . . . 2.44 110.927 -174.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 106.18 -7.11 40.33 Favored Glycine 0 N--CA 1.437 -1.24 0 C-N-CA 120.828 -0.701 . . . . 1.2 112.481 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1604 ' ' LEU . . . . . 0.56 HD21 ' SG ' ' A' 1634 ' ' CYS . 10.7 tp -84.77 163.09 19.34 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.169 -1.419 . . . . 2.38 107.169 178.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 19.0 t -127.27 153.86 45.61 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.426 -0.953 . . . . 1.96 108.426 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1606 ' ' TYR . . . . . 0.489 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 57.5 m-85 -80.95 166.38 20.89 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.786 -0.45 . . . . 1.06 109.786 176.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1607 ' ' LYS . . . . . 0.569 ' HG3' ' O ' ' A' 1592 ' ' TYR . 36.5 ttpt -160.74 131.74 5.51 Favored 'General case' 0 CA--C 1.503 -0.83 0 N-CA-C 109.922 -0.399 . . . . 2.0 109.922 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1608 ' ' SER . . . . . . . . . . . . . 22.2 m -113.05 123.35 50.1 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 108.81 -0.811 . . . . 1.61 108.81 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 41.5 t -107.91 110.21 31.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 108.909 -0.775 . . . . 1.09 108.909 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1610 ' ' ILE . . . . . 0.644 ' HB ' ' HB3' ' A' 1590 ' ' LEU . 20.3 mm -89.63 128.45 41.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 106.23 -1.767 . . . . 1.2 106.23 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 23.1 t -127.1 101.11 6.39 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-O 121.386 0.612 . . . . 1.89 109.576 -177.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1612 ' ' PHE . . . . . 0.992 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 60.4 m-85 -86.18 130.18 34.61 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.468 -0.787 . . . . 0.28 111.07 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 54.4 t -127.09 139.32 52.24 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.003 0 C-N-CA 123.132 0.573 . . . . 1.23 110.709 -177.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1614 ' ' CYS . . . . . 0.533 ' SG ' ' HD3' ' A' 1616 ' ' PRO . 2.0 t -60.73 111.47 1.64 Allowed 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 125.234 1.414 . . . . 0.77 112.402 177.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1615 ' ' ARG . . . . . 0.619 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 22.2 tpt180 -128.3 86.86 56.82 Favored Pre-proline 0 C--N 1.316 -0.861 0 N-CA-C 108.292 -1.003 . . . . 2.92 108.292 172.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1616 ' ' PRO . . . . . 0.563 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 43.3 Cg_endo -67.72 -23.62 41.98 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 122.272 1.981 . . . . 1.22 113.389 -174.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -86.3 -4.97 59.27 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 121.03 -0.268 . . . . 3.05 111.078 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . 58.34 -162.69 0.22 Allowed 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 123.351 0.661 . . . . 1.55 109.704 -176.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . 139.75 -161.8 26.24 Favored Glycine 0 N--CA 1.411 -3.003 0 C-N-CA 120.279 -0.962 . . . . 1.16 111.522 178.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -83.26 15.45 2.1 Favored 'Trans proline' 0 C--N 1.321 -0.878 0 C-N-CA 123.277 2.651 . . . . 1.06 112.762 -178.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1621 ' ' THR . . . . . . . . . . . . . 20.6 p -106.11 1.39 26.26 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 115.564 -0.743 . . . . 1.58 110.454 -178.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -86.74 65.84 9.19 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 107.158 -1.423 . . . . 0.88 107.158 176.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1623 ' ' ARG . . . . . 0.475 ' O ' ' HG3' ' A' 1625 ' ' MET . 14.2 ptm180 -170.17 140.93 1.65 Allowed Pre-proline 0 C--N 1.291 -1.951 0 N-CA-C 106.566 -1.642 . . . . 3.82 106.566 -175.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1624 ' ' PRO . . . . . 0.409 ' HG2' ' HB3' ' A' 1540 ' ' ALA . 15.4 Cg_endo -55.71 106.51 0.2 Allowed 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 122.78 2.32 . . . . 0.77 111.627 -178.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1625 ' ' MET . . . . . 0.683 ' HB2' ' HB3' ' A' 1639 ' ' SER . 93.2 mtp -98.64 109.36 22.13 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.732 -0.84 . . . . 1.43 108.732 -177.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1626 ' ' LEU . . . . . 0.584 ' HG ' ' CE2' ' A' 1542 ' ' TYR . 0.3 OUTLIER -71.84 115.39 10.99 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 106.685 -1.598 . . . . 1.43 106.685 -179.68 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A 1627 ' ' ILE . . . . . 0.845 HD12 ' HB2' ' A' 1639 ' ' SER . 44.4 mm -70.82 -53.56 21.42 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.119 0 N-CA-C 108.767 -0.827 . . . . 1.23 108.767 -178.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 19.7 t -179.41 162.42 1.15 Allowed 'General case' 0 N--CA 1.422 -1.862 0 N-CA-C 107.435 -1.32 . . . . 1.88 107.435 -176.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1629 ' ' LEU . . . . . . . . . . . . . 43.2 tp -112.75 115.5 28.62 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 107.423 -1.325 . . . . 1.92 107.423 176.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 12.0 t70 -68.6 107.52 2.99 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 107.503 -1.295 . . . . 1.09 107.503 174.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1631 ' ' LYS . . . . . 0.492 ' HD2' HD23 ' B' ' 53' ' ' LEU . 4.0 tppp? -56.6 -37.63 70.91 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.168 -1.378 . . . . 3.98 114.38 -169.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -89.22 -29.11 19.5 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 119.684 -0.807 . . . . 2.6 112.449 -174.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 60.2 p -100.6 -2.57 32.5 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 113.471 0.915 . . . . 1.35 113.471 -174.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1634 ' ' CYS . . . . . 0.56 ' SG ' HD21 ' A' 1604 ' ' LEU . 71.0 m 58.31 37.56 25.98 Favored 'General case' 0 C--N 1.367 1.355 0 CA-C-O 121.849 0.833 . . . . 0.53 111.541 178.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1635 ' ' THR . . . . . . . . . . . . . 88.5 m -105.45 124.12 49.01 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 114.964 -1.017 . . . . 1.11 109.905 -178.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1636 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -104.39 133.07 49.89 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 107.527 -1.286 . . . . 1.56 107.527 -177.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1637 ' ' PHE . . . . . 0.406 ' HB2' ' HB ' ' A' 1627 ' ' ILE . 85.8 m-85 -108.35 137.07 46.94 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.844 -0.428 . . . . 0.54 109.844 178.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -129.58 130.53 45.81 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 109.859 -0.422 . . . . 0.64 109.859 -175.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1639 ' ' SER . . . . . 0.845 ' HB2' HD12 ' A' 1627 ' ' ILE . 11.3 t -106.59 154.67 20.57 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.102 -1.444 . . . . 1.34 107.102 176.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 1.8 t90 -156.44 114.94 3.36 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 106.113 -1.81 . . . . 0.8 106.113 178.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1641 ' ' HIS . . . . . 0.619 ' HB3' ' HB2' ' A' 1615 ' ' ARG . 38.4 m-70 -105.13 112.31 25.39 Favored 'General case' 0 C--N 1.288 -2.105 0 C-N-CA 119.861 -0.736 . . . . 1.14 110.201 -177.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1642 ' ' THR . . . . . . . . . . . . . 4.4 t -142.69 148.94 48.44 Favored Pre-proline 0 C--N 1.307 -1.258 0 CA-C-N 115.731 -0.668 . . . . 1.11 110.375 -175.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1643 ' ' PRO . . . . . 0.563 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 73.5 Cg_endo -79.45 -5.33 14.14 Favored 'Trans proline' 0 C--N 1.367 1.544 0 C-N-CA 122.51 2.14 . . . . 0.78 112.54 176.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 7.6 tt -75.41 -23.21 57.0 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.829 0.823 . . . . 1.66 109.614 177.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -103.0 28.41 6.26 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.006 -0.997 . . . . 1.29 111.395 -174.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 28.6 t -120.56 149.87 41.76 Favored 'General case' 0 C--N 1.287 -2.147 0 C-N-CA 119.971 -0.692 . . . . 1.48 110.57 -175.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.42 119.47 36.13 Favored Pre-proline 0 N--CA 1.419 -2.016 0 N-CA-C 107.655 -1.239 . . . . 3.14 107.655 172.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1648 ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.76 108.81 2.16 Favored 'Trans proline' 0 C--O 1.243 0.761 0 C-N-CA 122.803 2.336 . . . . 2.92 114.972 -171.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 . . . . . 0 C--N 1.307 -1.272 0 N-CA-C 107.412 -1.329 . . . . 4.72 107.412 172.889 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.337 0 N-CA-C 109.209 -0.663 . . . . 10.26 109.209 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -128.21 135.3 49.52 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.899 -0.778 . . . . 7.94 108.899 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 39.3 ptt180 -124.09 144.02 44.13 Favored Pre-proline 0 C--N 1.29 -2.01 0 N-CA-C 108.399 -0.963 . . . . 6.56 108.399 -179.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -67.24 -14.25 42.37 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 123.186 2.591 . . . . 5.51 114.808 -178.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 50.7 m -135.94 118.2 15.59 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 122.016 0.126 . . . . 4.91 111.117 -178.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -78.77 -21.44 47.88 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-O 121.319 0.58 . . . . 4.23 109.738 173.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 6.9 p -122.7 98.37 5.88 Favored 'General case' 0 N--CA 1.415 -2.193 0 N-CA-C 107.915 -1.143 . . . . 3.48 107.915 172.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . 0.617 ' HB3' ' HG3' ' B' ' 12' ' ' GLU . 29.1 tp -74.2 94.89 2.52 Favored 'General case' 0 C--O 1.25 1.125 0 N-CA-C 109.523 -0.547 . . . . 4.35 109.523 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 46.7 m -54.49 119.55 5.4 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 109.008 -0.738 . . . . 2.84 109.008 176.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . 0.444 ' O ' HG13 ' B' ' 14' ' ' VAL . . . 102.22 -82.69 0.44 Allowed Glycine 0 N--CA 1.417 -2.578 0 N-CA-C 109.742 -1.343 . . . . 2.28 109.742 -175.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . 0.43 ' HA3' HD23 ' B' ' 8' ' ' LEU . . . -47.38 -70.53 0.69 Allowed Glycine 0 C--O 1.224 -0.495 0 N-CA-C 115.205 0.842 . . . . 1.94 115.205 -177.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . 0.617 ' HG3' ' HB3' ' B' ' 8' ' ' LEU . 44.5 mt-10 -65.79 -35.4 80.59 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-N 117.814 0.807 . . . . 2.55 110.621 -177.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . 0.537 HD21 ' HB2' ' B' ' 46' ' ' CYS . 5.7 mt -58.73 -60.75 3.34 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 113.306 0.854 . . . . 2.82 113.306 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . 0.444 HG13 ' O ' ' B' ' 10' ' ' GLY . 7.7 p -74.99 -30.37 23.47 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 C-N-CA 120.017 -0.673 . . . . 2.5 111.773 -176.031 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' ASP . . . . . 0.417 ' OD2' ' HB2' ' A' 1569 ' ' GLN . 18.2 t0 -67.5 -42.27 83.16 Favored 'General case' 0 C--O 1.207 -1.137 0 C-N-CA 119.483 -0.887 . . . . 2.04 111.426 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 23.8 p -61.51 -40.77 95.8 Favored 'General case' 0 C--O 1.25 1.104 0 CA-C-N 118.292 0.496 . . . . 2.31 110.718 177.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.534 ' O ' ' HB2' ' B' ' 21' ' ' CYS . 4.3 mm? -58.5 -51.21 70.81 Favored 'General case' 0 C--O 1.21 -1.022 0 CA-C-N 115.86 -0.609 . . . . 2.27 111.309 174.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . 0.446 HE21 ' HG2' ' A' 1569 ' ' GLN . 29.5 tt0 -69.07 -29.12 67.17 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 116.349 -0.387 . . . . 2.39 111.268 -177.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -61.22 -61.09 2.8 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.949 -0.568 . . . . 1.0 112.248 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 14.2 p -97.9 -13.39 8.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 C-N-CA 118.604 -1.238 . . . . 1.83 111.686 -176.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' CYS . . . . . 0.534 ' HB2' ' O ' ' B' ' 17' ' ' LEU . 73.3 m -106.38 14.43 27.35 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.341 -0.849 . . . . 1.66 112.652 178.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -52.14 -45.39 57.26 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 121.252 -0.499 . . . . 1.53 112.899 176.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -79.19 -42.89 25.02 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.398 0.518 . . . . 2.72 112.398 177.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 6.3 tpm_? -71.25 -33.86 70.21 Favored 'General case' 0 C--O 1.244 0.799 0 N-CA-C 112.864 0.69 . . . . 5.02 112.864 -174.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.92 139.43 8.05 Favored Glycine 0 N--CA 1.424 -2.153 0 N-CA-C 108.551 -1.82 . . . . 1.63 108.551 -175.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . 0.47 ' HB2' ' HB3' ' B' ' 17' ' ' LEU . 50.9 p90 -128.4 122.78 32.21 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 117.523 0.662 . . . . 1.71 110.484 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -163.04 96.14 0.89 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.28 0.562 . . . . 3.67 111.553 178.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' PHE . . . . . 0.419 ' HA ' ' HE1' ' B' ' 59' ' ' TYR . 42.5 p90 -94.13 -10.52 32.98 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-O 121.358 0.599 . . . . 2.44 110.398 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 46.9 t -109.28 108.06 18.51 Favored 'General case' 0 N--CA 1.424 -1.733 0 N-CA-C 107.686 -1.227 . . . . 3.85 107.686 177.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 78.3 mtm-85 -123.02 108.57 32.37 Favored Pre-proline 0 N--CA 1.442 -0.835 0 C-N-CA 120.851 -0.34 . . . . 4.27 110.333 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -65.85 -49.06 2.41 Favored 'Trans proline' 0 C--O 1.237 0.462 0 C-N-CA 123.427 2.752 . . . . 4.2 112.598 178.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' ALA . . . . . 0.817 ' HA ' ' HB3' ' B' ' 38' ' ' ARG . . . -159.41 -178.83 7.43 Favored 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 110.193 -0.299 . . . . 5.12 110.193 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 29.6 t 169.99 150.61 0.04 OUTLIER 'General case' 0 N--CA 1.42 -1.954 0 C-N-CA 126.936 2.094 . . . . 6.93 105.485 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 16.4 ttm180 -81.11 -1.86 46.03 Favored 'General case' 0 C--N 1.283 -2.286 0 CA-C-O 122.275 1.036 . . . . 12.14 108.699 -177.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 51.9 t -91.39 -3.8 10.67 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 CA-C-N 114.447 -1.251 . . . . 9.9 108.823 176.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 23.1 t 62.32 31.3 17.44 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 114.805 -1.089 . . . . 6.82 109.463 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 39.3 ptt180 -92.27 11.45 25.76 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 115.064 -0.971 . . . . 10.71 111.41 -175.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . 0.817 ' HB3' ' HA ' ' B' ' 32' ' ' ALA . 10.2 ptt180 -66.01 80.13 0.08 Allowed 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 114.361 -1.29 . . . . 8.6 112.236 178.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 50.8 m -141.69 115.38 9.08 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 107.656 -1.238 . . . . 5.79 107.656 174.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -81.57 148.39 29.15 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.757 -0.831 . . . . 6.57 108.757 175.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . -147.22 167.22 28.46 Favored Glycine 0 N--CA 1.419 -2.434 0 C-N-CA 119.668 -1.253 . . . . 2.62 111.583 178.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 14.4 pt 61.61 -24.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 C-N-CA 128.245 2.618 . . . . 2.28 116.488 174.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 2.8 p -51.34 -51.35 24.3 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 N-CA-C 114.612 1.338 . . . . 2.6 114.612 -178.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -92.65 -29.64 16.0 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.074 -1.084 . . . . 3.36 108.074 -176.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . 0.713 ' O ' ' HG2' ' B' ' 49' ' ' ARG . 40.6 mt-10 -59.96 -66.67 0.48 Allowed 'General case' 0 N--CA 1.432 -1.371 0 CA-C-N 114.968 -1.015 . . . . 3.08 109.385 177.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' CYS . . . . . 0.537 ' HB2' HD21 ' B' ' 13' ' ' LEU . 72.1 m -76.72 1.24 17.72 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 112.787 0.662 . . . . 2.23 112.787 -175.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 41.1 t -82.47 -50.41 8.88 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 119.496 -0.882 . . . . 2.48 109.105 171.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -102.75 -20.87 14.19 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 114.38 1.252 . . . . 2.97 114.38 -173.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . 0.713 ' HG2' ' O ' ' B' ' 45' ' ' GLU . 17.2 ptp180 -113.05 165.75 12.07 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 108.142 -1.058 . . . . 4.65 108.142 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 28.1 t -86.19 139.72 30.81 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 108.242 -1.021 . . . . 2.86 108.242 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 95.6 m -124.25 159.9 29.17 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-O 121.599 0.714 . . . . 2.11 111.88 -175.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -106.4 149.05 27.39 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 107.167 -1.42 . . . . 2.67 107.167 175.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . 0.552 ' HB2' ' HA ' ' A' 1600 ' ' SER . 55.0 tp -56.34 -27.99 57.62 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 124.905 1.282 . . . . 2.36 112.047 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . 0.616 ' O ' HG23 ' B' ' 58' ' ' THR . . . -58.17 -47.83 82.17 Favored 'General case' 0 CA--C 1.516 -0.352 0 O-C-N 123.2 0.312 . . . . 1.92 110.841 -178.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . 0.423 ' O ' ' HB2' ' B' ' 59' ' ' TYR . 58.7 tp -54.24 -50.97 65.95 Favored 'General case' 0 CA--C 1.509 -0.604 0 C-N-CA 123.847 0.859 . . . . 2.35 111.308 -178.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 3.4 pp -74.15 -36.07 64.1 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-N 116.07 -0.514 . . . . 2.01 111.555 -174.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -68.63 -48.76 63.25 Favored 'General case' 0 N--CA 1.439 -0.976 0 O-C-N 123.495 0.497 . . . . 2.27 111.357 -178.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' THR . . . . . 0.616 HG23 ' O ' ' B' ' 54' ' ' ALA . 9.2 t -74.08 -15.27 61.06 Favored 'General case' 0 C--O 1.246 0.909 0 C-N-CA 120.186 -0.606 . . . . 2.67 111.73 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' TYR . . . . . 0.423 ' HB2' ' O ' ' B' ' 55' ' ' LEU . 8.6 t80 -80.34 -76.32 0.23 Allowed 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 105.807 -1.923 . . . . 3.2 105.807 174.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' CYS . . . . . 0.417 ' H ' ' HB3' ' B' ' 59' ' ' TYR . 47.2 t 58.56 -78.04 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 125.096 1.359 . . . . 2.3 112.604 176.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -139.52 -75.73 0.35 Allowed 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 107.459 -1.311 . . . . 3.19 107.459 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -136.37 131.78 18.65 Favored Pre-proline 0 C--N 1.307 -1.277 0 N-CA-C 109.434 -0.58 . . . . 4.14 109.434 175.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -64.67 -24.54 62.31 Favored 'Trans proline' 0 C--O 1.237 0.453 0 C-N-CA 123.598 2.865 . . . . 5.59 117.041 -167.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -124.7 25.39 7.5 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 112.416 0.524 . . . . 5.51 112.416 -177.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . 0.402 ' HD3' ' HA ' ' B' ' 65' ' ' LYS . 24.0 mmtp -94.29 4.5 53.79 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 114.633 1.345 . . . . 8.8 114.633 -178.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 43.7 m -101.91 7.48 41.49 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 121.958 0.885 . . . . 8.12 108.707 174.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 56.7 mm-40 . . . . . 0 N--CA 1.428 -1.529 0 CA-C-N 114.477 -1.238 . . . . 10.21 109.186 -177.914 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.515 -0.37 0 N-CA-C 109.712 -0.477 . . . . 9.74 109.712 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1509 ' ' LYS . . . . . 0.463 ' HB3' ' HZ2' ' A' 1509 ' ' LYS . 6.7 ttpm? -96.98 -11.13 24.96 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 122.241 1.02 . . . . 9.32 110.356 -175.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 34.0 t -140.35 -170.3 2.95 Favored 'General case' 0 C--N 1.268 -2.964 0 N-CA-C 107.583 -1.265 . . . . 5.97 107.583 177.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1511 ' ' ASN . . . . . . . . . . . . . 30.7 p-10 -77.72 -28.17 50.79 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.361 0.601 . . . . 3.48 110.186 178.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1512 ' ' GLU . . . . . 0.762 ' HA ' HG13 ' A' 1518 ' ' VAL . 10.9 pt-20 -87.16 159.44 18.87 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.687 -0.688 . . . . 5.95 111.54 -177.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1513 ' ' HIS . . . . . 0.595 ' HB2' ' HG3' ' A' 1517 ' ' GLN . 21.5 m-70 -120.13 -175.72 3.05 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 107.112 -1.44 . . . . 6.14 107.112 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 29.0 t70 -68.99 -33.3 73.44 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 119.562 1.074 . . . . 5.06 112.62 -175.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1515 ' ' ASP . . . . . 0.4 ' HB3' ' H ' ' A' 1516 ' ' CYS . 5.5 m-20 -106.38 -164.18 0.98 Allowed 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.334 0.588 . . . . 2.9 111.626 177.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1516 ' ' CYS . . . . . 0.412 ' HA ' ' HB2' ' A' 1581 ' ' LEU . 6.4 p -76.05 66.32 2.21 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 124.034 0.933 . . . . 1.41 111.976 -177.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1517 ' ' GLN . . . . . 0.595 ' HG3' ' HB2' ' A' 1513 ' ' HIS . 3.9 pt20 -154.93 130.95 10.18 Favored 'General case' 0 N--CA 1.421 -1.89 0 CA-C-N 115.355 -0.838 . . . . 2.18 109.638 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1518 ' ' VAL . . . . . 0.762 HG13 ' HA ' ' A' 1512 ' ' GLU . 9.6 m -135.0 144.39 34.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 C-N-CA 123.183 0.593 . . . . 1.52 111.188 -177.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1519 ' ' THR . . . . . . . . . . . . . 24.6 m -111.26 133.61 53.46 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 109.384 -0.599 . . . . 1.36 109.384 178.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -94.63 123.83 56.9 Favored Pre-proline 0 C--N 1.309 -1.152 0 N-CA-C 109.838 -0.43 . . . . 2.02 109.838 175.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -65.33 -16.17 53.27 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.288 2.658 . . . . 1.82 114.638 -176.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 50.2 m -83.04 -49.64 9.34 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 111.985 0.365 . . . . 1.89 111.985 -177.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1523 ' ' THR . . . . . . . . . . . . . 4.4 t -101.75 -9.1 21.13 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.686 0.755 . . . . 1.99 111.337 -177.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 64.85 35.03 91.43 Favored Glycine 0 CA--C 1.488 -1.64 0 CA-C-N 115.291 -0.868 . . . . 1.19 111.772 178.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 22.3 t-80 -99.45 123.1 43.43 Favored 'General case' 0 N--CA 1.422 -1.83 0 C-N-CA 119.979 -0.688 . . . . 1.82 110.218 -177.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 1.7 tm? -88.34 106.99 18.6 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 114.423 -1.262 . . . . 1.3 108.011 177.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1527 ' ' PHE . . . . . 0.402 ' O ' ' HA ' ' A' 1517 ' ' GLN . 85.8 m-85 -89.07 112.83 23.88 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.052 -0.721 . . . . 0.8 109.052 175.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 22.0 t70 -110.9 114.52 27.92 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.886 -0.783 . . . . 1.17 108.886 177.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 3.5 mm? -90.69 -4.06 57.03 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.288 0.566 . . . . 1.29 110.205 -174.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 7.2 m -61.66 -20.32 63.29 Favored 'General case' 0 C--O 1.219 -0.544 0 CA-C-N 114.976 -1.011 . . . . 0.91 110.685 178.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 19.5 m -65.99 -19.52 65.89 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 120.754 0.311 . . . . 1.98 111.606 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 73.4 mt -98.51 11.37 38.48 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.675 0.274 . . . . 1.34 111.513 -178.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1533 ' ' SER . . . . . . . . . . . . . 25.4 p -66.13 155.97 35.35 Favored 'General case' 0 C--O 1.252 1.229 0 CA-C-O 121.385 0.612 . . . . 1.93 112.426 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -175.86 142.53 6.12 Favored Glycine 0 N--CA 1.428 -1.864 0 N-CA-C 109.727 -1.349 . . . . 1.1 109.727 178.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 44.0 ttm180 -89.26 -37.9 14.61 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 123.688 0.287 . . . . 5.21 110.841 -177.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -71.36 -33.92 69.99 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-O 122.017 0.913 . . . . 1.94 109.274 178.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 96.89 -171.44 27.29 Favored Glycine 0 N--CA 1.417 -2.626 0 CA-C-N 114.865 -1.061 . . . . 1.08 113.05 172.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -124.86 143.97 50.55 Favored 'General case' 0 C--N 1.279 -2.487 0 N-CA-C 107.845 -1.168 . . . . 1.07 107.845 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 19.7 p -106.2 130.76 54.01 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 123.852 0.72 . . . . 1.46 110.319 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1540 ' ' ALA . . . . . 0.449 ' HB3' ' CG1' ' A' 1548 ' ' VAL . . . -118.97 140.92 49.2 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 107.944 -1.132 . . . . 1.19 107.944 177.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -79.24 139.63 37.86 Favored 'General case' 0 C--N 1.316 -0.875 0 O-C-N 123.726 0.641 . . . . 1.37 109.872 -178.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1542 ' ' TYR . . . . . 0.474 ' CE2' ' HG ' ' A' 1626 ' ' LEU . 0.5 OUTLIER -149.89 -102.72 0.07 Allowed 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.953 -0.758 . . . . 1.38 108.953 -178.603 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A 1543 ' ' SER . . . . . 0.401 ' H ' ' HB3' ' A' 1542 ' ' TYR . 16.2 m -67.91 152.8 44.98 Favored 'General case' 0 N--CA 1.432 -1.342 0 C-N-CA 124.008 0.923 . . . . 1.98 109.364 -179.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1544 ' ' LYS . . . . . 0.48 ' HB2' ' HZ1' ' A' 1544 ' ' LYS . 0.1 OUTLIER -63.49 -27.24 69.14 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.453 -0.794 . . . . 3.96 112.326 -171.47 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 20.3 m -123.25 33.09 5.47 Favored 'General case' 0 N--CA 1.397 -3.087 0 N-CA-C 109.588 -0.523 . . . . 2.81 109.588 176.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . -162.73 130.75 2.32 Favored Glycine 0 N--CA 1.438 -1.203 0 C-N-CA 118.528 -1.796 . . . . 1.68 115.172 -177.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 27.8 m -112.44 160.9 11.65 Favored 'Isoleucine or valine' 0 C--O 1.252 1.184 0 N-CA-C 108.44 -0.948 . . . . 1.38 108.44 177.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1548 ' ' VAL . . . . . 0.449 ' CG1' ' HB3' ' A' 1540 ' ' ALA . 14.8 p -106.85 134.84 47.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 C-N-CA 120.477 -0.489 . . . . 1.24 110.258 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -93.07 130.98 38.5 Favored 'General case' 0 CA--C 1.484 -1.562 0 N-CA-C 108.637 -0.875 . . . . 1.29 108.637 175.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1550 ' ' MET . . . . . 0.43 ' HA ' ' O ' ' A' 1564 ' ' GLY . 15.2 ptp -137.44 137.03 38.33 Favored 'General case' 0 C--N 1.284 -2.27 0 CA-C-N 115.63 -0.714 . . . . 1.47 111.315 175.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 11.6 p -117.63 113.8 22.45 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 115.261 -0.881 . . . . 1.4 108.965 176.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1552 ' ' ILE . . . . . . . . . . . . . 48.9 mm -77.71 119.39 26.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 N-CA-C 110.016 -0.364 . . . . 1.11 110.016 -177.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 77.4 m 64.42 44.36 4.2 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 124.041 0.838 . . . . 1.4 110.932 177.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 174.81 -179.49 46.08 Favored Glycine 0 N--CA 1.432 -1.575 0 C-N-CA 120.42 -0.895 . . . . 0.4 111.279 -179.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -104.64 158.63 16.37 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 120.617 0.246 . . . . 1.62 110.656 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -119.06 111.17 17.96 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.25 -1.019 . . . . 1.12 108.25 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -69.77 2.9 2.9 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 114.169 1.174 . . . . 2.49 114.169 -173.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -76.34 -15.73 59.9 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 120.154 -0.618 . . . . 1.38 110.029 178.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1559 ' ' CYS . . . . . 0.713 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 71.1 m -132.5 174.57 4.56 Favored Pre-proline 0 C--N 1.302 -1.482 0 CA-C-O 117.717 -1.135 . . . . 1.21 110.238 -178.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1560 ' ' PRO . . . . . 0.713 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 22.9 Cg_exo -28.75 128.7 0.04 OUTLIER 'Trans proline' 0 C--N 1.396 3.072 1 C-N-CA 125.506 4.137 . . . . 0.98 114.733 178.629 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -43.64 119.87 2.02 Favored 'Trans proline' 0 C--O 1.247 0.942 0 C-N-CA 124.547 3.498 . . . . 1.15 114.21 -177.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 87.43 23.62 39.41 Favored Glycine 0 N--CA 1.437 -1.29 0 CA-C-N 115.515 -0.766 . . . . 0.55 113.368 177.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1563 ' ' VAL . . . . . 0.426 HG12 ' HB2' ' A' 1559 ' ' CYS . 5.5 p -100.98 144.11 13.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 117.94 0.87 . . . . 1.53 109.852 -178.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1564 ' ' GLY . . . . . 0.43 ' O ' ' HA ' ' A' 1550 ' ' MET . . . -106.07 -30.35 4.52 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 121.235 -0.507 . . . . 0.29 113.252 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -128.26 130.14 47.45 Favored 'General case' 0 C--O 1.247 0.964 0 CA-C-N 117.307 0.553 . . . . 1.08 109.867 178.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1566 ' ' CYS . . . . . 0.436 ' SG ' ' HA ' ' A' 1571 ' ' ARG . 9.9 t -157.72 141.05 15.38 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 116.372 -0.376 . . . . 0.43 111.32 -176.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1567 ' ' PHE . . . . . 0.497 ' CE2' HG11 ' A' 1574 ' ' VAL . 74.3 m-85 -88.08 138.38 31.5 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 108.646 -0.872 . . . . 1.3 108.646 175.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -72.77 -9.08 74.31 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 117.854 1.902 . . . . 1.43 117.854 -168.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -80.16 -70.61 0.51 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 119.997 1.899 . . . . 3.09 112.412 -176.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1570 ' ' THR . . . . . 0.406 HG23 ' HA ' ' B' ' 12' ' ' GLU . 19.1 p -91.96 -3.69 55.57 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 119.862 -0.735 . . . . 2.52 112.782 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1571 ' ' ARG . . . . . 0.436 ' HA ' ' SG ' ' A' 1566 ' ' CYS . 10.8 mmt85 65.49 44.11 3.17 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.59 1.156 . . . . 3.19 111.051 177.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 40.7 mt -74.66 137.23 23.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-N 115.914 -0.585 . . . . 1.51 109.461 178.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 26.7 t -83.3 120.45 25.86 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 109.377 -0.601 . . . . 0.96 109.377 -179.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1574 ' ' VAL . . . . . 0.543 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 32.6 m -118.3 10.18 6.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 C-N-CA 119.368 -0.933 . . . . 1.6 111.377 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 173.99 113.71 0.33 Allowed Glycine 0 N--CA 1.419 -2.482 0 N-CA-C 110.122 -1.191 . . . . 0.34 110.122 178.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1576 ' ' LYS . . . . . 0.501 ' HE2' ' O ' ' A' 1594 ' ' ASP . 24.9 ttmm -73.93 155.47 38.65 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.681 -1.229 . . . . 2.68 107.681 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -67.13 77.55 0.14 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.77 0.795 . . . . 1.08 111.865 -177.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1578 ' ' ASN . . . . . 0.46 ' HB3' ' HD1' ' A' 1592 ' ' TYR . 14.5 t-20 -91.2 -175.73 4.37 Favored 'General case' 0 C--N 1.29 -2.01 0 C-N-CA 125.583 1.553 . . . . 1.95 107.41 -178.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 22.2 pttp -158.58 52.48 0.41 Allowed 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.839 0.828 . . . . 3.11 110.008 176.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1580 ' ' ARG . . . . . 0.518 ' HB3' HG13 ' A' 1591 ' ' VAL . 0.1 OUTLIER -97.48 87.31 4.07 Favored 'General case' 0 N--CA 1.413 -2.314 0 N-CA-C 108.287 -1.005 . . . . 4.04 108.287 -176.509 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A 1581 ' ' LEU . . . . . 0.517 ' HA ' ' O ' ' A' 1589 ' ' GLN . 0.4 OUTLIER -86.37 126.16 34.16 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.999 -1.001 . . . . 1.32 109.05 -177.341 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -124.51 140.94 52.48 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 109.159 -0.682 . . . . 3.4 109.159 175.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1583 ' ' TYR . . . . . 0.687 ' CE1' ' HA ' ' A' 1586 ' ' GLN . 67.9 t80 -105.81 97.38 7.21 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 107.004 -1.48 . . . . 1.26 107.004 176.158 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1584 ' ' VAL . . . . . 0.533 ' O ' ' HB ' ' A' 1587 ' ' VAL . 15.7 m -111.81 89.69 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.234 0 CA-C-N 115.338 -0.846 . . . . 1.71 112.373 -173.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 29.3 t70 56.88 64.45 1.65 Allowed 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 115.246 -0.888 . . . . 1.17 109.961 179.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1586 ' ' GLN . . . . . 0.687 ' HA ' ' CE1' ' A' 1583 ' ' TYR 0.26 4.2 pt20 63.09 15.22 8.31 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 126.926 2.09 . . . . 2.43 112.897 177.596 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A 1587 ' ' VAL . . . . . 0.533 ' HB ' ' O ' ' A' 1584 ' ' VAL . 29.1 t -108.89 129.39 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.024 0 CA-C-N 114.418 -1.265 . . . . 1.16 109.128 176.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1588 ' ' LEU . . . . . 0.937 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 2.9 mm? -97.57 108.22 20.89 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.644 -0.873 . . . . 1.11 108.644 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1589 ' ' GLN . . . . . 0.517 ' O ' ' HA ' ' A' 1581 ' ' LEU . 35.1 tt0 -100.97 118.32 36.75 Favored 'General case' 0 C--N 1.281 -2.375 0 CA-C-N 116.136 -0.484 . . . . 1.74 111.416 -177.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 1.6 mt -108.51 97.68 7.31 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 106.603 -1.628 . . . . 1.4 106.603 170.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1591 ' ' VAL . . . . . 0.518 HG13 ' HB3' ' A' 1580 ' ' ARG . 8.9 p -94.59 133.44 35.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 CA-C-N 116.275 -0.421 . . . . 1.7 110.084 -177.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1592 ' ' TYR . . . . . 0.46 ' HD1' ' HB3' ' A' 1578 ' ' ASN . 14.7 m-30 -118.52 114.22 22.49 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.277 -1.009 . . . . 1.08 108.277 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 21.3 pttp -115.53 178.92 4.12 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 110.303 -0.258 . . . . 2.21 110.303 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1594 ' ' ASP . . . . . 0.501 ' O ' ' HE2' ' A' 1576 ' ' LYS . 8.7 m-20 68.35 36.6 3.0 Favored 'General case' 0 CA--C 1.506 -0.728 0 C-N-CA 124.028 0.931 . . . . 1.11 112.134 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -72.82 -158.32 4.34 Favored Glycine 0 N--CA 1.443 -0.861 0 N-CA-C 109.675 -1.37 . . . . 0.78 109.675 173.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1596 ' ' SER . . . . . . . . . . . . . 41.0 p -87.92 148.64 43.85 Favored Pre-proline 0 C--N 1.28 -2.455 0 C-N-CA 118.292 -1.363 . . . . 1.36 109.304 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1597 ' ' PRO . . . . . 0.503 ' HG2' ' HB2' ' B' ' 4' ' ' PRO . 64.4 Cg_exo -48.01 131.47 21.42 Favored 'Trans proline' 0 C--O 1.241 0.647 0 C-N-CA 123.423 2.748 . . . . 1.4 111.726 176.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1598 ' ' CYS . . . . . 0.499 ' HA ' ' CE2' ' A' 1606 ' ' TYR . 49.4 t -76.67 127.1 85.02 Favored Pre-proline 0 C--N 1.294 -1.805 0 CA-C-N 114.834 -1.075 . . . . 0.75 110.191 -175.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1599 ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' 1598 ' ' CYS . 20.1 Cg_exo -69.4 -34.03 16.64 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.021 2.481 . . . . 1.7 111.24 176.2 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1600 ' ' SER . . . . . 0.45 ' HB2' ' SG ' ' A' 1598 ' ' CYS . 9.6 m -57.69 -43.15 84.9 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 123.665 0.786 . . . . 2.8 111.294 178.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1601 ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -145.54 123.54 12.07 Favored 'General case' 0 N--CA 1.423 -1.788 0 N-CA-C 109.006 -0.738 . . . . 3.45 109.006 178.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 10.0 m -78.85 148.59 32.77 Favored 'General case' 0 N--CA 1.407 -2.623 0 C-N-CA 123.229 0.612 . . . . 2.44 110.186 -175.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 105.96 -14.61 44.82 Favored Glycine 0 C--N 1.306 -1.136 0 CA-C-N 116.082 -0.508 . . . . 1.2 113.304 176.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1604 ' ' LEU . . . . . 0.454 HD23 ' HB2' ' A' 1634 ' ' CYS . 0.0 OUTLIER -135.74 147.36 48.4 Favored 'General case' 0 N--CA 1.406 -2.629 0 CA-C-O 121.423 0.63 . . . . 2.38 112.202 -179.68 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 10.3 p -96.17 153.37 17.83 Favored 'General case' 0 C--N 1.308 -1.239 0 C-N-CA 124.297 1.039 . . . . 1.96 110.06 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1606 ' ' TYR . . . . . 0.554 ' HD1' HD11 ' A' 1636 ' ' LEU . 51.7 m-85 -60.46 154.12 21.45 Favored 'General case' 0 C--O 1.25 1.102 0 O-C-N 123.287 0.367 . . . . 1.06 111.07 176.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -151.86 126.77 9.67 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 108.795 -0.817 . . . . 2.0 108.795 -176.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1608 ' ' SER . . . . . . . . . . . . . 40.1 m -105.72 130.29 53.76 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 116.269 -0.423 . . . . 1.61 110.202 -177.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 28.2 t -109.15 108.26 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.999 0 N-CA-C 107.845 -1.169 . . . . 1.09 107.845 177.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 64.5 mt -97.77 103.92 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.797 0 N-CA-C 107.598 -1.26 . . . . 1.2 107.598 179.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 23.2 t -99.93 107.82 19.9 Favored 'General case' 0 C--N 1.282 -2.341 0 CA-C-N 114.231 -1.35 . . . . 1.89 110.154 -174.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1612 ' ' PHE . . . . . 0.937 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 68.0 m-85 -90.61 118.2 29.87 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.439 -0.801 . . . . 0.28 109.752 178.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 43.1 t -122.65 139.22 50.17 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 108.531 -0.915 . . . . 1.23 108.531 -177.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 9.0 t -66.88 117.59 9.19 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 124.054 0.942 . . . . 0.77 112.564 -177.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1615 ' ' ARG . . . . . 0.735 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 13.5 tpt180 -137.75 91.16 13.86 Favored Pre-proline 0 N--CA 1.442 -0.835 0 N-CA-C 107.951 -1.129 . . . . 2.92 107.951 172.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1616 ' ' PRO . . . . . 0.742 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 45.7 Cg_endo -67.24 -15.68 46.65 Favored 'Trans proline' 0 N--CA 1.486 1.056 0 C-N-CA 122.754 2.303 . . . . 1.22 113.503 -174.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -58.18 -38.98 77.74 Favored 'General case' 0 C--O 1.242 0.697 0 C-N-CA 124.75 1.22 . . . . 3.05 111.056 178.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . 51.19 96.59 0.01 OUTLIER 'General case' 0 C--O 1.248 0.989 0 C-N-CA 124.363 1.065 . . . . 1.55 113.057 178.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1619 ' ' GLY . . . . . 0.401 ' HA3' ' HD2' ' A' 1620 ' ' PRO . . . -151.1 -143.7 3.77 Favored Glycine 0 C--N 1.29 -1.998 0 N-CA-C 110.679 -0.969 . . . . 1.16 110.679 -179.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1620 ' ' PRO . . . . . 0.401 ' HD2' ' HA3' ' A' 1619 ' ' GLY . 38.9 Cg_endo -67.01 2.77 1.92 Allowed 'Trans proline' 0 N--CA 1.488 1.172 0 C-N-CA 123.039 2.492 . . . . 1.06 114.832 -178.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1621 ' ' THR . . . . . . . . . . . . . 8.0 m -102.72 -3.4 26.56 Favored 'General case' 0 N--CA 1.42 -1.959 0 CA-C-O 122.057 0.932 . . . . 1.58 108.953 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 43.8 t30 -87.22 61.9 6.97 Favored 'General case' 0 C--O 1.246 0.872 0 CA-C-O 122.488 1.137 . . . . 0.88 108.666 178.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -165.87 138.7 3.39 Favored Pre-proline 0 C--N 1.303 -1.446 0 CA-C-N 113.733 -1.576 . . . . 3.82 106.984 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -65.11 111.69 1.84 Allowed 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 122.393 2.062 . . . . 0.77 111.19 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 72.5 mtm -115.29 143.9 44.56 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 116.531 -0.304 . . . . 1.43 110.59 -178.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1626 ' ' LEU . . . . . 0.474 ' HG ' ' CE2' ' A' 1542 ' ' TYR . 1.6 tm? -80.95 117.38 21.53 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.152 -1.055 . . . . 1.43 108.152 -178.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 50.7 mm -77.87 -58.1 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 CA-C-O 121.296 0.569 . . . . 1.23 109.727 178.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 66.8 m -163.92 149.8 11.13 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.007 -1.108 . . . . 1.88 108.007 -178.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1629 ' ' LEU . . . . . 0.758 HD12 ' HG ' ' A' 1636 ' ' LEU . 30.0 tp -111.87 110.47 20.83 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 107.557 -1.275 . . . . 1.92 107.557 175.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 17.5 t70 -70.54 117.46 12.1 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 107.347 -1.353 . . . . 1.09 107.347 175.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 95.3 mttt -82.15 -11.13 58.9 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.875 -0.602 . . . . 3.98 111.904 -169.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -95.86 -43.56 7.79 Favored 'General case' 0 N--CA 1.418 -2.065 0 C-N-CA 120.373 -0.531 . . . . 2.6 110.928 -175.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 45.5 p -96.42 -0.38 49.29 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 116.253 -0.43 . . . . 1.35 110.929 178.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1634 ' ' CYS . . . . . 0.454 ' HB2' HD23 ' A' 1604 ' ' LEU . 60.9 m 51.24 39.39 23.7 Favored 'General case' 0 C--N 1.374 1.636 0 C-N-CA 124.921 1.288 . . . . 0.53 112.195 176.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1635 ' ' THR . . . . . . . . . . . . . 90.7 m -100.9 128.08 47.09 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 114.09 -1.414 . . . . 1.11 108.288 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1636 ' ' LEU . . . . . 0.758 ' HG ' HD12 ' A' 1629 ' ' LEU . 0.6 OUTLIER -105.23 122.16 45.35 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.365 -0.606 . . . . 1.56 109.365 -174.497 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -99.91 116.91 33.08 Favored 'General case' 0 C--O 1.244 0.812 0 CA-C-O 121.293 0.568 . . . . 0.54 111.848 -178.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -117.26 134.81 54.36 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 115.105 -0.952 . . . . 0.64 109.361 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1639 ' ' SER . . . . . . . . . . . . . 71.6 m -119.73 138.94 53.0 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 116.219 -0.446 . . . . 1.34 109.902 176.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1640 ' ' TRP . . . . . 0.476 ' CE3' ' HE1' ' A' 1612 ' ' PHE . 3.7 t90 -138.36 103.72 4.98 Favored 'General case' 0 N--CA 1.424 -1.753 0 N-CA-C 103.942 -2.614 . . . . 0.8 103.942 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1641 ' ' HIS . . . . . 0.735 ' HB3' ' HB2' ' A' 1615 ' ' ARG . 28.3 m-70 -95.56 98.77 10.76 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.863 0.84 . . . . 1.14 109.757 -176.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1642 ' ' THR . . . . . . . . . . . . . 3.1 t -124.26 150.83 64.95 Favored Pre-proline 0 C--N 1.299 -1.594 0 CA-C-N 113.732 -1.576 . . . . 1.11 110.388 -170.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1643 ' ' PRO . . . . . 0.742 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 59.8 Cg_endo -77.21 -5.54 15.81 Favored 'Trans proline' 0 C--N 1.364 1.36 0 C-N-CA 122.487 2.125 . . . . 0.78 112.729 175.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 9.0 tt -69.48 -27.45 65.23 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.307 -0.627 . . . . 1.66 109.307 177.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -90.35 14.97 11.43 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.47 -0.786 . . . . 1.29 110.713 -177.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1646 ' ' CYS . . . . . 0.587 ' SG ' ' HA ' ' A' 1643 ' ' PRO . 78.3 m -99.69 156.33 17.14 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 109.614 -0.513 . . . . 1.48 109.614 178.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -106.03 146.9 33.84 Favored Pre-proline 0 C--N 1.289 -2.034 0 N-CA-C 107.294 -1.373 . . . . 3.14 107.294 175.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1648 ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -74.52 95.07 0.93 Allowed 'Trans proline' 0 N--CA 1.442 -1.521 0 C-N-CA 121.23 1.287 . . . . 2.92 110.511 177.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 . . . . . 0 C--N 1.309 -1.195 0 CA-C-N 115.199 -0.909 . . . . 4.72 108.674 179.004 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.51 -0.566 0 N-CA-C 109.904 -0.406 . . . . 10.26 109.904 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -84.14 107.89 16.73 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.25 -1.019 . . . . 7.94 108.25 177.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 4.5 ptp180 -108.13 128.41 25.78 Favored Pre-proline 0 C--N 1.3 -1.558 0 CA-C-N 115.451 -0.795 . . . . 6.56 109.944 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . 0.503 ' HB2' ' HG2' ' A' 1597 ' ' PRO . 88.6 Cg_endo -78.16 47.05 2.26 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 123.259 2.64 . . . . 5.51 114.159 -177.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 19.9 m 45.95 55.72 6.75 Favored 'General case' 0 C--N 1.312 -1.035 0 C-N-CA 125.703 1.601 . . . . 4.91 113.31 176.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -90.39 -46.26 8.48 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.79 -0.818 . . . . 4.23 108.79 178.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 62.1 p -134.9 138.09 43.79 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 107.002 -1.481 . . . . 3.48 107.002 175.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . 0.611 ' HB2' ' SG ' ' B' ' 46' ' ' CYS . 6.9 mp -116.43 93.48 4.24 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 109.329 -0.619 . . . . 4.35 109.329 -178.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' CYS . . . . . 0.644 ' HB2' ' HA ' ' B' ' 47' ' ' CYS . 49.2 t -116.16 109.92 18.11 Favored 'General case' 0 N--CA 1.422 -1.841 0 O-C-N 121.359 -0.838 . . . . 2.84 110.44 -178.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.13 -121.39 6.69 Favored Glycine 0 C--N 1.304 -1.196 0 CA-C-N 115.144 -0.934 . . . . 2.28 113.252 178.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -51.26 -52.32 32.56 Favored Glycine 0 C--O 1.214 -1.128 0 C-N-CA 123.697 0.665 . . . . 1.94 114.469 -176.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . 0.406 ' HA ' HG23 ' A' 1570 ' ' THR . 1.6 mp0 -57.41 -42.74 82.9 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 122.816 0.446 . . . . 2.55 110.917 -178.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . 0.424 ' HG ' ' SG ' ' B' ' 46' ' ' CYS . 1.1 tt -61.39 -52.61 63.88 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 115.371 -0.831 . . . . 2.82 109.853 -178.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 22.2 m -72.72 -30.37 33.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.37 0 C-N-CA 119.531 -0.867 . . . . 2.5 111.869 -176.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -69.34 -42.82 74.79 Favored 'General case' 0 C--O 1.203 -1.375 0 C-N-CA 120.728 -0.389 . . . . 2.04 111.94 177.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 25.3 p -62.85 -38.8 92.24 Favored 'General case' 0 C--O 1.258 1.523 0 CA-C-O 121.446 0.641 . . . . 2.31 110.054 176.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.56 ' HB3' ' HB3' ' B' ' 26' ' ' PHE . 3.6 mm? -56.75 -49.73 74.37 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-N 115.317 -0.856 . . . . 2.27 111.012 171.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -66.64 -32.37 73.65 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 124.384 1.074 . . . . 2.39 109.809 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -52.84 -57.67 9.43 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 116.023 -0.535 . . . . 1.0 111.939 178.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 13.0 p -98.87 -26.24 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 C-N-CA 118.204 -1.398 . . . . 1.83 112.854 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 85.1 m -106.92 1.08 24.3 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 113.597 0.962 . . . . 1.66 113.597 -177.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -55.86 -24.17 40.57 Favored Glycine 0 N--CA 1.479 1.558 0 N-CA-C 116.969 1.548 . . . . 1.53 116.969 -173.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -58.77 -40.73 84.77 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 118.136 0.968 . . . . 2.72 109.699 175.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 25.2 tpp180 -90.45 -48.57 7.02 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 108.07 -1.085 . . . . 5.02 108.07 177.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 130.33 -152.05 19.65 Favored Glycine 0 N--CA 1.424 -2.144 0 N-CA-C 109.84 -1.304 . . . . 1.63 109.84 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . 0.56 ' HB3' ' HB3' ' B' ' 17' ' ' LEU . 23.2 p90 -137.83 139.28 39.86 Favored 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 108.956 -0.757 . . . . 1.71 108.956 176.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -125.74 -67.78 0.86 Allowed 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 112.827 0.677 . . . . 3.67 112.827 -176.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' PHE . . . . . . . . . . . . . 50.4 p90 43.82 17.74 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.511 0 N-CA-C 117.319 2.34 . . . . 2.44 117.319 171.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' SER . . . . . 0.63 ' HA ' ' HA ' ' B' ' 40' ' ' ARG . 37.7 t -157.53 133.65 9.51 Favored 'General case' 0 N--CA 1.42 -1.951 0 N-CA-C 109.101 -0.703 . . . . 3.85 109.101 -177.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . 0.62 ' HB2' ' H ' ' B' ' 39' ' ' SER . 1.1 mmp_? -123.68 108.03 31.18 Favored Pre-proline 0 C--N 1.303 -1.437 0 N-CA-C 106.148 -1.797 . . . . 4.27 106.148 177.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -68.2 -39.3 10.54 Favored 'Trans proline' 0 C--O 1.245 0.868 0 C-N-CA 122.638 2.226 . . . . 4.2 113.119 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -163.26 177.05 9.33 Favored 'General case' 0 N--CA 1.423 -1.822 0 N-CA-C 108.777 -0.823 . . . . 5.12 108.777 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' SER . . . . . 0.461 ' CB ' ' HG2' ' B' ' 37' ' ' ARG . 15.8 t 171.45 153.69 0.07 Allowed 'General case' 0 N--CA 1.412 -2.367 0 C-N-CA 126.566 1.946 . . . . 6.93 106.565 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 9.6 ttm180 -83.43 3.23 32.85 Favored 'General case' 0 C--N 1.282 -2.354 0 CA-C-O 122.474 1.131 . . . . 12.14 108.866 -178.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . 0.504 HG21 ' HG2' ' B' ' 67' ' ' GLU . 61.3 t -100.01 -3.64 9.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-N 114.484 -1.235 . . . . 9.9 108.538 175.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 47.0 t 61.98 30.79 18.1 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 114.57 -1.195 . . . . 6.82 109.272 -178.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . 0.564 ' NH1' ' HB2' ' B' ' 67' ' ' GLU . 38.7 ptt180 -85.69 11.19 11.44 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.925 -1.034 . . . . 10.71 112.608 -173.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -46.14 111.18 0.33 Allowed 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.218 0.607 . . . . 8.6 109.92 178.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' SER . . . . . 0.62 ' H ' ' HB2' ' B' ' 30' ' ' ARG . 70.4 m -155.16 98.18 1.98 Allowed 'General case' 0 N--CA 1.425 -1.71 0 CA-C-O 121.142 0.496 . . . . 5.79 109.752 -179.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . 0.63 ' HA ' ' HA ' ' B' ' 29' ' ' SER . 0.0 OUTLIER -85.69 145.24 27.38 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 107.369 -1.345 . . . . 6.57 107.369 171.664 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . -152.46 163.4 30.29 Favored Glycine 0 N--CA 1.416 -2.686 0 C-N-CA 119.598 -1.287 . . . . 2.62 111.583 -178.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . 0.263 10.6 pt 64.44 -33.92 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.213 -0.835 0 C-N-CA 128.651 2.78 . . . . 2.28 114.9 177.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . 0.409 ' O ' ' HB2' ' B' ' 47' ' ' CYS . 2.4 p -48.03 -44.49 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 C-N-CA 123.833 0.853 . . . . 2.6 112.896 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -97.14 -38.35 9.76 Favored 'General case' 0 N--CA 1.415 -2.211 0 CA-C-N 115.606 -0.725 . . . . 3.36 109.506 -172.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -61.54 -47.46 85.46 Favored 'General case' 0 C--O 1.197 -1.702 0 CA-C-N 116.002 -0.544 . . . . 3.08 110.725 178.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' CYS . . . . . 0.611 ' SG ' ' HB2' ' B' ' 8' ' ' LEU . 42.6 t -78.01 -16.27 58.24 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 121.222 0.534 . . . . 2.23 109.823 -178.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' CYS . . . . . 0.644 ' HA ' ' HB2' ' B' ' 9' ' ' CYS . 44.3 t -79.66 -48.01 14.44 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 116.216 -0.447 . . . . 2.48 110.857 177.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -98.42 -25.8 14.68 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 113.678 0.992 . . . . 2.97 113.678 -176.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -110.26 -179.8 3.88 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.333 -0.988 . . . . 4.65 108.333 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 8.2 t -93.05 132.5 37.11 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 106.771 -1.566 . . . . 2.86 106.771 176.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 1.6 p -111.38 137.44 49.15 Favored 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 123.205 0.602 . . . . 2.11 110.887 -175.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -112.0 177.72 4.55 Favored 'General case' 0 C--O 1.244 0.764 0 N-CA-C 112.489 0.551 . . . . 2.67 112.489 -178.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . 0.42 HD12 ' HB3' ' A' 1600 ' ' SER . 52.6 tp -51.24 -53.89 31.01 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 125.125 1.37 . . . . 2.36 113.601 -178.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.72 -41.05 73.31 Favored 'General case' 0 C--O 1.244 0.793 0 C-N-CA 124.023 0.929 . . . . 1.92 112.456 -170.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 61.3 tp -63.47 -46.22 87.23 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 114.921 -1.036 . . . . 2.35 111.957 -178.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' B' ' 53' ' ' LEU . 3.3 pp -79.66 -24.64 41.67 Favored 'General case' 0 N--CA 1.41 -2.459 0 C-N-CA 119.765 -0.774 . . . . 2.01 111.143 -176.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -70.6 -43.68 68.85 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 116.082 -0.508 . . . . 2.27 110.616 178.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 24.2 p -63.58 -43.12 97.9 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-N 116.25 -0.432 . . . . 2.67 111.848 179.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -73.31 -59.61 2.63 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 116.739 -0.21 . . . . 3.2 110.505 178.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 41.8 t 46.44 -98.21 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 125.029 1.332 . . . . 2.3 113.984 179.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -154.39 178.5 9.97 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 107.688 -1.227 . . . . 3.19 107.688 -176.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 10.2 p -145.04 155.72 55.12 Favored Pre-proline 0 C--N 1.293 -1.87 0 N-CA-C 107.738 -1.208 . . . . 4.14 107.738 177.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . 0.568 ' HG2' ' HB2' ' B' ' 66' ' ' SER . 37.6 Cg_endo -73.42 0.09 8.52 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 123.13 2.553 . . . . 5.59 111.771 177.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 72.25 5.04 5.2 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.165 1.786 . . . . 5.51 113.796 173.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -144.52 39.55 1.28 Allowed 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 123.218 1.485 . . . . 8.8 107.941 178.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 66' ' ' SER . . . . . 0.568 ' HB2' ' HG2' ' B' ' 63' ' ' PRO . 25.6 t -106.01 98.55 8.22 Favored 'General case' 0 C--N 1.275 -2.643 0 CA-C-N 113.785 -1.552 . . . . 8.12 109.088 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . 0.564 ' HB2' ' NH1' ' B' ' 37' ' ' ARG . 14.7 tp10 . . . . . 0 C--O 1.247 0.953 0 N-CA-C 107.993 -1.114 . . . . 10.21 107.993 176.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 88.4 mtp . . . . . 0 CA--C 1.503 -0.85 0 N-CA-C 108.847 -0.798 . . . . 9.74 108.847 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A 1509 ' ' LYS . . . . . 0.545 ' HG3' ' OE1' ' A' 1512 ' ' GLU . 23.3 ttmm -134.81 34.4 3.15 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 122.897 1.332 . . . . 9.32 108.904 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1510 ' ' SER . . . . . 0.424 ' HB3' ' CB ' ' A' 1519 ' ' THR . 39.5 m -85.5 -34.43 21.58 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 107.991 -1.114 . . . . 5.97 107.991 176.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1511 ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -119.91 103.16 9.09 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 114.686 -1.143 . . . . 3.48 108.751 174.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1512 ' ' GLU . . . . . 0.545 ' OE1' ' HG3' ' A' 1509 ' ' LYS . 12.4 mm-40 -78.19 -28.8 48.22 Favored 'General case' 0 CA--C 1.494 -1.193 0 N-CA-C 108.537 -0.912 . . . . 5.95 108.537 172.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 53.9 t-80 73.8 -51.37 0.69 Allowed 'General case' 0 C--O 1.215 -0.757 0 CA-C-N 113.811 -1.54 . . . . 6.14 111.366 176.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -103.02 32.63 3.62 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-O 121.871 0.843 . . . . 5.06 110.654 -177.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1515 ' ' ASP . . . . . 0.4 ' HA ' ' HB3' ' A' 1579 ' ' LYS . 7.0 t70 -149.12 164.45 34.65 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 104.138 -2.541 . . . . 2.9 104.138 175.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1516 ' ' CYS . . . . . 0.903 ' HB3' ' HB2' ' A' 1529 ' ' LEU . 72.6 m -79.89 60.41 3.48 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 123.35 0.66 . . . . 1.41 112.247 -174.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1517 ' ' GLN . . . . . 0.451 ' HA ' ' O ' ' A' 1527 ' ' PHE . 16.5 pt20 -164.41 129.33 2.73 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-O 121.392 0.615 . . . . 2.18 110.905 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 2.9 m -148.56 143.59 18.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-N 114.726 -1.125 . . . . 1.52 109.725 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1519 ' ' THR . . . . . 0.424 ' CB ' ' HB3' ' A' 1510 ' ' SER . 91.6 m -114.04 121.49 44.0 Favored 'General case' 0 N--CA 1.423 -1.787 0 N-CA-C 108.173 -1.047 . . . . 1.36 108.173 174.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1520 ' ' ASN . . . . . 0.451 ' HA ' ' HD3' ' A' 1521 ' ' PRO . 26.3 t-20 -80.26 121.93 82.25 Favored Pre-proline 0 C--N 1.294 -1.82 0 N-CA-C 109.33 -0.619 . . . . 2.02 109.33 177.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1521 ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' 1520 ' ' ASN . 12.6 Cg_exo -69.75 -19.61 35.96 Favored 'Trans proline' 0 CA--C 1.529 0.227 0 C-N-CA 123.051 2.5 . . . . 1.82 113.509 -175.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1522 ' ' SER . . . . . 0.447 ' HB2' ' OD1' ' A' 1520 ' ' ASN . 22.5 m -72.33 -32.21 66.32 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 120.836 0.35 . . . . 1.89 111.094 -179.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1523 ' ' THR . . . . . 0.675 HG23 ' HG3' ' A' 1647 ' ' GLU . 8.8 t -124.87 -9.46 7.23 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 119.433 -0.907 . . . . 1.99 112.14 -177.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 68.73 34.34 77.79 Favored Glycine 0 CA--C 1.501 -0.795 0 CA-C-N 115.828 -0.623 . . . . 1.19 113.399 176.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 9.7 t-160 -107.03 121.16 43.93 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 119.163 -1.015 . . . . 1.82 111.415 178.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1526 ' ' LEU . . . . . 0.412 HD22 ' HG1' ' A' 1519 ' ' THR . 2.3 tm? -82.47 115.99 21.72 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 114.494 -1.23 . . . . 1.3 108.688 176.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1527 ' ' PHE . . . . . 0.451 ' O ' ' HA ' ' A' 1517 ' ' GLN . 96.8 m-85 -96.32 121.69 38.39 Favored 'General case' 0 C--N 1.31 -1.149 0 O-C-N 122.158 -0.339 . . . . 0.8 110.494 174.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 10.3 t70 -105.49 109.83 21.94 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 106.923 -1.51 . . . . 1.17 106.923 175.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1529 ' ' LEU . . . . . 0.903 ' HB2' ' HB3' ' A' 1516 ' ' CYS . 3.7 mm? -90.69 -3.5 57.43 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 121.282 0.563 . . . . 1.29 110.22 -177.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 16.0 m -72.84 -15.56 61.62 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.624 -0.716 . . . . 0.91 109.632 178.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 14.8 m -66.38 -22.39 66.25 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-O 121.287 0.565 . . . . 1.98 109.709 173.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 80.4 mt -101.5 3.96 40.7 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.18 -0.464 . . . . 1.34 111.315 177.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1533 ' ' SER . . . . . . . . . . . . . 46.2 t -60.07 158.68 10.68 Favored 'General case' 0 C--O 1.245 0.825 0 CA-C-O 121.959 0.885 . . . . 1.93 111.682 -177.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -178.53 116.09 0.52 Allowed Glycine 0 C--N 1.278 -2.667 0 CA-C-N 114.237 -1.347 . . . . 1.1 110.132 -175.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -92.79 -36.75 12.7 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 112.373 0.509 . . . . 5.21 112.373 -176.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -59.52 -54.42 46.73 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-O 121.262 0.553 . . . . 1.94 110.372 -176.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 136.09 152.99 6.47 Favored Glycine 0 N--CA 1.413 -2.886 0 C-N-CA 120.535 -0.84 . . . . 1.08 113.382 173.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -114.51 139.56 49.46 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 106.151 -1.796 . . . . 1.07 106.151 174.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 5.1 p -106.58 128.71 54.35 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.21 0.528 . . . . 1.46 111.858 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -123.95 141.03 52.4 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 107.991 -1.115 . . . . 1.19 107.991 176.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -82.95 128.98 34.96 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 120.773 0.321 . . . . 1.37 110.72 -177.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1542 ' ' TYR . . . . . 0.591 ' CE2' ' HG ' ' A' 1626 ' ' LEU . 2.0 t80 -121.1 -100.6 0.43 Allowed 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 107.626 -1.25 . . . . 1.38 107.626 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1543 ' ' SER . . . . . . . . . . . . . 8.0 m -66.35 164.06 16.89 Favored 'General case' 0 N--CA 1.437 -1.123 0 C-N-CA 122.815 0.446 . . . . 1.98 110.808 -178.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 23.4 tptm -56.83 -41.54 78.05 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 118.103 0.41 . . . . 3.96 111.132 -176.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 49.9 m -110.88 34.41 4.02 Favored 'General case' 0 N--CA 1.412 -2.352 0 N-CA-C 109.621 -0.511 . . . . 2.81 109.621 178.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . -144.63 134.48 5.67 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 118.808 -1.663 . . . . 1.68 115.335 -176.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 28.1 m -121.68 148.4 25.16 Favored 'Isoleucine or valine' 0 C--O 1.247 0.944 0 N-CA-C 108.561 -0.903 . . . . 1.38 108.561 174.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 11.9 p -104.05 137.11 34.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 N-CA-C 109.747 -0.464 . . . . 1.24 109.747 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -98.01 125.07 42.78 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.834 -0.802 . . . . 1.29 108.834 175.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 23.3 ptm -136.17 133.67 37.41 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 115.539 -0.755 . . . . 1.47 110.342 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 12.7 p -117.69 137.53 52.61 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.549 -0.75 . . . . 1.4 109.627 176.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1552 ' ' ILE . . . . . . . . . . . . . 42.4 mm -96.83 118.53 43.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 110.37 -0.233 . . . . 1.11 110.37 -177.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 75.4 m 65.84 24.76 11.31 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-O 122.199 1.0 . . . . 1.4 112.047 175.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . -164.51 -177.73 37.38 Favored Glycine 0 N--CA 1.406 -3.337 0 CA-C-N 114.261 -1.336 . . . . 0.4 110.004 -178.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -109.39 145.35 36.25 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-O 121.043 0.449 . . . . 1.62 110.933 -176.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -81.41 145.25 30.89 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.345 -0.843 . . . . 1.12 111.809 -172.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -84.96 10.07 12.78 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 123.819 0.848 . . . . 2.49 113.176 -171.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -119.41 -10.73 9.63 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 119.586 -0.846 . . . . 1.38 112.562 -176.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1559 ' ' CYS . . . . . 0.535 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 83.4 m -132.26 164.26 44.54 Favored Pre-proline 0 C--N 1.296 -1.755 0 CA-C-O 117.877 -1.058 . . . . 1.21 110.04 -177.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1560 ' ' PRO . . . . . 0.535 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 12.0 Cg_exo -31.11 131.59 0.06 OUTLIER 'Trans proline' 0 C--N 1.376 2.001 1 C-N-CA 125.536 4.157 . . . . 0.98 115.489 -179.418 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -49.34 128.34 20.03 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 123.77 2.98 . . . . 1.15 111.731 179.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 102.3 -3.86 51.18 Favored Glycine 0 N--CA 1.43 -1.73 0 CA-C-N 116.018 -0.537 . . . . 0.55 113.765 -178.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1563 ' ' VAL . . . . . . . . . . . . . 5.2 p -98.52 138.21 23.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 118.362 1.081 . . . . 1.53 111.291 -178.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -102.11 -31.16 5.44 Favored Glycine 0 CA--C 1.522 0.491 0 CA-C-N 115.693 -0.685 . . . . 0.29 113.172 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -129.28 130.81 46.66 Favored 'General case' 0 N--CA 1.445 -0.723 0 O-C-N 122.528 -0.395 . . . . 1.08 109.967 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 44.0 t -157.02 138.61 14.05 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 110.018 -0.364 . . . . 0.43 110.018 -176.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -85.28 137.67 32.82 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 108.87 -0.789 . . . . 1.3 108.87 174.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -72.33 -18.61 78.3 Favored Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 116.983 1.553 . . . . 1.43 116.983 -167.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -73.23 -70.24 0.38 Allowed 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 118.362 1.081 . . . . 3.09 111.246 -175.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.16 -2.47 58.07 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.198 -0.91 . . . . 2.52 112.755 -176.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 9.9 mmt85 60.04 36.76 21.38 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 114.923 -1.035 . . . . 3.19 110.519 178.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 30.6 mt -74.97 125.24 34.25 Favored 'Isoleucine or valine' 0 C--O 1.245 0.867 0 CA-C-N 115.909 -0.587 . . . . 1.51 109.761 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 21.9 t -74.48 125.09 27.81 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 114.995 -1.002 . . . . 0.96 109.812 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1574 ' ' VAL . . . . . 0.644 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 33.6 m -122.19 16.51 5.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 C-N-CA 120.009 -0.676 . . . . 1.6 112.026 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 167.82 122.72 0.63 Allowed Glycine 0 N--CA 1.432 -1.594 0 C-N-CA 119.977 -1.106 . . . . 0.34 112.618 175.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 4.1 ttmp? -71.64 142.1 49.93 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.23 -1.026 . . . . 2.68 108.23 177.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -72.83 88.23 1.32 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.29 0.567 . . . . 1.08 110.965 -177.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1578 ' ' ASN . . . . . 0.41 ' O ' ' HE1' ' A' 1592 ' ' TYR . 74.2 m-20 -109.56 150.79 27.66 Favored 'General case' 0 C--N 1.29 -1.978 0 N-CA-C 107.283 -1.377 . . . . 1.95 107.283 179.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1579 ' ' LYS . . . . . 0.4 ' HB3' ' HA ' ' A' 1515 ' ' ASP . 48.6 mtmt -105.15 45.71 0.95 Allowed 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 106.275 -1.75 . . . . 3.11 106.275 -177.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 56.3 ttt180 -84.97 76.59 10.25 Favored 'General case' 0 N--CA 1.411 -2.376 0 CA-C-N 113.638 -1.619 . . . . 4.04 108.775 -173.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1581 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.42 127.58 32.94 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 113.596 -1.638 . . . . 1.32 108.875 -178.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -127.08 140.96 51.9 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-N 116.098 -0.501 . . . . 3.4 110.215 172.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1583 ' ' TYR . . . . . 0.568 ' CZ ' ' HA ' ' A' 1586 ' ' GLN . 39.6 t80 -99.88 105.56 17.31 Favored 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 106.903 -1.517 . . . . 1.26 106.903 175.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1584 ' ' VAL . . . . . 0.631 ' O ' ' HB ' ' A' 1587 ' ' VAL . 7.5 p -129.51 97.39 3.46 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.333 0 CA-C-O 121.614 0.721 . . . . 1.71 111.061 -175.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 36.3 t70 64.01 49.36 2.78 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-O 122.456 1.122 . . . . 1.17 110.771 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1586 ' ' GLN . . . . . 0.568 ' HA ' ' CZ ' ' A' 1583 ' ' TYR . 1.8 pt20 65.39 9.26 5.59 Favored 'General case' 0 N--CA 1.5 2.059 0 C-N-CA 127.026 2.131 . . . . 2.43 111.09 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1587 ' ' VAL . . . . . 0.631 ' HB ' ' O ' ' A' 1584 ' ' VAL . 38.1 t -96.81 122.76 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.75 0 CA-C-N 114.303 -1.317 . . . . 1.16 108.331 178.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1588 ' ' LEU . . . . . 0.462 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 3.0 mm? -93.15 107.76 19.5 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 106.562 -1.644 . . . . 1.11 106.562 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -120.63 125.1 46.87 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 113.296 0.851 . . . . 1.74 113.296 -172.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1590 ' ' LEU . . . . . 0.468 HD22 ' SG ' ' A' 1516 ' ' CYS . 16.6 mt -101.69 126.27 48.51 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 113.84 -1.527 . . . . 1.4 107.282 176.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 47.2 t -112.0 120.36 62.17 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.997 0 C-N-CA 119.438 -0.905 . . . . 1.7 111.026 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1592 ' ' TYR . . . . . 0.413 ' HB2' ' HB2' ' A' 1608 ' ' SER . 13.5 m-30 -105.32 95.83 6.1 Favored 'General case' 0 CA--C 1.486 -1.485 0 N-CA-C 107.866 -1.161 . . . . 1.08 107.866 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 12.3 ptmm? -107.5 170.22 8.11 Favored 'General case' 0 C--N 1.283 -2.312 0 CA-C-N 115.02 -0.991 . . . . 2.21 111.597 -175.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 24.0 m-20 57.24 56.06 5.44 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 125.454 1.502 . . . . 1.11 112.448 177.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -74.88 -115.62 0.09 OUTLIER Glycine 0 CA--C 1.528 0.893 0 C-N-CA 120.33 -0.938 . . . . 0.78 111.143 173.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1596 ' ' SER . . . . . . . . . . . . . 78.2 p -115.32 169.76 6.4 Favored Pre-proline 0 C--N 1.296 -1.744 0 O-C-N 121.857 -0.79 . . . . 1.36 109.164 176.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -70.03 122.62 9.22 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 122.932 2.421 . . . . 1.4 112.354 177.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1598 ' ' CYS . . . . . 0.421 ' HA ' ' HD3' ' A' 1599 ' ' PRO . 34.3 t -76.44 141.16 69.34 Favored Pre-proline 0 C--N 1.292 -1.916 0 CA-C-N 114.671 -1.15 . . . . 0.75 109.202 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1599 ' ' PRO . . . . . 0.54 ' HD3' ' OH ' ' A' 1606 ' ' TYR . 8.1 Cg_exo -72.04 -7.84 21.8 Favored 'Trans proline' 0 C--N 1.371 1.731 0 C-N-CA 123.608 2.872 . . . . 1.7 113.25 -175.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1600 ' ' SER . . . . . 0.676 ' HA ' ' HB3' ' B' ' 53' ' ' LEU . 22.8 p -61.17 -51.22 69.97 Favored 'General case' 0 C--O 1.258 1.535 0 CA-C-O 121.76 0.79 . . . . 2.8 109.733 174.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1601 ' ' LYS . . . . . 0.477 ' HB3' ' HG ' ' A' 1604 ' ' LEU . 49.9 tptt -155.14 117.96 4.33 Favored 'General case' 0 N--CA 1.387 -3.614 0 N-CA-C 106.533 -1.654 . . . . 3.45 106.533 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 4.7 p -60.09 131.27 50.3 Favored 'General case' 0 N--CA 1.409 -2.478 0 N-CA-C 109.139 -0.689 . . . . 2.44 109.139 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 106.83 -20.99 32.92 Favored Glycine 0 C--N 1.296 -1.687 0 C-N-CA 121.065 -0.588 . . . . 1.2 111.837 -174.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1604 ' ' LEU . . . . . 0.477 ' HG ' ' HB3' ' A' 1601 ' ' LYS . 69.5 mt -81.55 124.46 29.52 Favored 'General case' 0 CA--C 1.503 -0.837 0 N-CA-C 107.728 -1.212 . . . . 2.38 107.728 172.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 4.9 p -101.26 143.46 31.3 Favored 'General case' 0 C--N 1.28 -2.415 0 CA-C-O 120.643 0.259 . . . . 1.96 110.61 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1606 ' ' TYR . . . . . 0.644 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 96.2 m-85 -68.39 153.28 44.06 Favored 'General case' 0 C--O 1.255 1.356 0 N-CA-C 109.598 -0.519 . . . . 1.06 109.598 177.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -151.5 127.48 10.38 Favored 'General case' 0 N--CA 1.437 -1.104 0 O-C-N 123.673 0.608 . . . . 2.0 109.952 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1608 ' ' SER . . . . . 0.467 ' HB3' ' HE2' ' A' 1638 ' ' PHE . 38.6 m -104.64 122.04 44.8 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 108.522 -0.918 . . . . 1.61 108.522 -179.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 41.0 t -104.68 108.06 23.94 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 109.304 -0.628 . . . . 1.09 109.304 -177.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 69.5 mt -97.27 110.18 24.66 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 115.588 -0.733 . . . . 1.2 109.323 -178.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 7.0 t -113.56 108.01 16.58 Favored 'General case' 0 C--N 1.282 -2.345 0 CA-C-N 115.143 -0.935 . . . . 1.89 110.114 -174.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1612 ' ' PHE . . . . . 0.462 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 64.1 m-85 -84.9 118.9 24.8 Favored 'General case' 0 C--O 1.254 1.332 0 CA-C-N 115.99 -0.55 . . . . 0.28 109.557 177.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1613 ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' A' 1641 ' ' HIS . 21.5 t -110.69 124.91 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.577 0 CA-C-N 115.595 -0.73 . . . . 1.23 110.366 -175.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 22.2 t -58.88 110.64 1.06 Allowed 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 114.571 -1.195 . . . . 0.77 111.895 177.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1615 ' ' ARG . . . . . . . . . . . . . 22.4 ttt180 -137.59 98.59 9.82 Favored Pre-proline 0 C--N 1.316 -0.884 0 N-CA-C 110.25 -0.278 . . . . 2.92 110.25 171.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1616 ' ' PRO . . . . . 0.811 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 34.6 Cg_exo -61.22 -30.55 88.58 Favored 'Trans proline' 0 CA--C 1.55 1.282 0 C-N-CA 122.139 1.892 . . . . 1.22 111.989 176.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -77.05 44.17 0.39 Allowed 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.116 1.367 . . . . 3.05 113.61 178.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -32.69 130.31 0.19 Allowed 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 126.781 2.032 . . . . 1.55 113.476 176.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . -163.86 -142.16 3.33 Favored Glycine 0 N--CA 1.425 -2.089 0 N-CA-C 109.958 -1.257 . . . . 1.16 109.958 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -80.34 15.06 1.81 Allowed 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 122.95 2.433 . . . . 1.06 112.655 -178.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1621 ' ' THR . . . . . . . . . . . . . 17.1 p -102.48 -6.71 22.61 Favored 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 124.791 1.237 . . . . 1.58 108.625 179.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 48.9 t30 -94.66 61.89 2.7 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.392 -1.277 . . . . 0.88 108.659 -176.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -162.28 138.74 5.96 Favored Pre-proline 0 N--CA 1.428 -1.535 0 CA-C-N 113.795 -1.548 . . . . 3.82 107.427 -179.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.92 108.2 1.25 Allowed 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 122.556 2.171 . . . . 0.77 112.17 -177.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 63.8 mtm -116.11 147.42 41.35 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.455 -0.339 . . . . 1.43 110.543 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1626 ' ' LEU . . . . . 0.591 ' HG ' ' CE2' ' A' 1542 ' ' TYR . 0.4 OUTLIER -85.41 114.95 22.85 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.452 -1.314 . . . . 1.43 107.452 -178.354 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A 1627 ' ' ILE . . . . . 0.41 HD12 ' HB2' ' A' 1639 ' ' SER . 44.3 mm -72.53 -54.51 16.01 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.217 0 N-CA-C 109.191 -0.67 . . . . 1.23 109.191 -178.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 28.0 p -173.44 154.04 2.5 Favored 'General case' 0 N--CA 1.423 -1.808 0 CA-C-N 114.752 -1.113 . . . . 1.88 109.281 -173.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1629 ' ' LEU . . . . . 0.433 HD12 ' HG ' ' A' 1636 ' ' LEU . 54.2 tp -106.29 117.57 34.38 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 108.434 -0.95 . . . . 1.92 108.434 174.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1630 ' ' ASP . . . . . 0.428 ' HB3' ' HB ' ' A' 1635 ' ' THR . 8.6 t70 -73.75 99.09 3.06 Favored 'General case' 0 CA--C 1.496 -1.108 0 N-CA-C 103.317 -2.846 . . . . 1.09 103.317 167.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -80.76 -10.31 59.74 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 114.192 -1.367 . . . . 3.98 110.395 -166.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -86.11 -45.95 10.9 Favored 'General case' 0 N--CA 1.426 -1.66 0 CA-C-N 115.584 -0.735 . . . . 2.6 110.874 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 70.5 p -95.91 -3.79 44.67 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-O 120.812 0.339 . . . . 1.35 111.571 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 60.9 m 63.7 51.17 2.51 Favored 'General case' 0 C--N 1.355 0.823 0 C-N-CA 124.743 1.217 . . . . 0.53 111.744 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1635 ' ' THR . . . . . 0.428 ' HB ' ' HB3' ' A' 1630 ' ' ASP . 32.4 m -113.42 123.14 49.35 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 114.101 -1.409 . . . . 1.11 109.026 -176.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1636 ' ' LEU . . . . . 0.433 ' HG ' HD12 ' A' 1629 ' ' LEU . 1.0 OUTLIER -105.44 129.78 53.67 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 108.557 -0.905 . . . . 1.56 108.557 -175.383 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -105.72 135.45 47.12 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 120.83 -0.348 . . . . 0.54 111.259 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1638 ' ' PHE . . . . . 0.467 ' HE2' ' HB3' ' A' 1608 ' ' SER . 96.9 m-85 -128.46 137.18 51.69 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 124.09 0.956 . . . . 0.64 108.719 -178.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1639 ' ' SER . . . . . 0.41 ' HB2' HD12 ' A' 1627 ' ' ILE . 17.9 t -124.56 155.1 39.61 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 108.327 -0.99 . . . . 1.34 108.327 177.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1640 ' ' TRP . . . . . 0.439 ' CE3' ' HE1' ' A' 1612 ' ' PHE . 3.6 t90 -155.54 104.35 2.36 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 104.689 -2.337 . . . . 0.8 104.689 -178.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1641 ' ' HIS . . . . . 0.42 ' HA ' ' O ' ' A' 1613 ' ' VAL . 38.8 m-70 -93.63 100.59 12.81 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 121.201 0.524 . . . . 1.14 109.834 -176.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1642 ' ' THR . . . . . . . . . . . . . 3.6 t -134.06 147.33 63.52 Favored Pre-proline 0 C--N 1.292 -1.905 0 CA-C-N 115.002 -0.999 . . . . 1.11 109.377 -173.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1643 ' ' PRO . . . . . 0.811 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 50.1 Cg_endo -76.93 -2.65 12.9 Favored 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 122.069 1.846 . . . . 0.78 112.416 176.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 9.3 tt -69.42 -28.82 66.47 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 108.876 -0.787 . . . . 1.66 108.876 177.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -88.26 21.27 2.89 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.591 -0.731 . . . . 1.29 110.732 -178.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1646 ' ' CYS . . . . . 0.457 ' SG ' ' HA ' ' A' 1643 ' ' PRO . 75.1 m -113.03 152.13 29.86 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 116.139 -0.482 . . . . 1.48 110.279 -179.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1647 ' ' GLU . . . . . 0.675 ' HG3' HG23 ' A' 1523 ' ' THR . 0.0 OUTLIER -108.97 127.23 27.67 Favored Pre-proline 0 N--CA 1.421 -1.922 0 N-CA-C 107.592 -1.262 . . . . 3.14 107.592 174.082 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A 1648 ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -68.21 100.06 0.62 Allowed 'Trans proline' 0 CA--C 1.532 0.399 0 C-N-CA 122.585 2.19 . . . . 2.92 113.274 -175.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 13.5 tp10 . . . . . 0 N--CA 1.431 -1.394 0 N-CA-C 106.625 -1.62 . . . . 4.72 106.625 178.171 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.619 0 N-CA-C 109.239 -0.652 . . . . 10.26 109.239 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -114.88 131.79 56.74 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.82 -1.178 . . . . 7.94 107.82 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 -111.88 130.07 23.58 Favored Pre-proline 0 C--N 1.283 -2.291 0 N-CA-C 109.489 -0.559 . . . . 6.56 109.489 177.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -57.6 -25.54 67.87 Favored 'Trans proline' 0 C--N 1.37 1.702 0 C-N-CA 123.834 3.023 . . . . 5.51 113.367 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 23.3 m -87.17 100.07 12.4 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 105.777 -1.934 . . . . 4.91 105.777 170.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -77.37 -21.04 53.86 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 112.421 0.526 . . . . 4.23 112.421 -169.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' THR . . . . . 0.498 HG23 ' HA ' ' B' ' 50' ' ' SER . 16.9 p -98.05 146.28 25.69 Favored 'General case' 0 C--N 1.287 -2.137 0 C-N-CA 120.551 -0.46 . . . . 3.48 110.278 177.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . 0.519 ' HB2' ' CB ' ' B' ' 12' ' ' GLU . 1.4 pp -75.9 163.81 26.83 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 113.164 0.801 . . . . 4.35 113.164 -176.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 48.6 t -151.27 156.08 40.1 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 120.861 -0.336 . . . . 2.84 111.261 -174.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.91 -123.94 7.63 Favored Glycine 0 CA--C 1.508 -0.39 0 CA-C-N 116.377 -0.374 . . . . 2.28 113.037 175.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . 0.475 ' HA2' HG12 ' B' ' 14' ' ' VAL . . . -60.28 -27.99 66.26 Favored Glycine 0 N--CA 1.461 0.319 0 N-CA-C 112.127 -0.389 . . . . 1.94 112.127 178.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . 0.519 ' CB ' ' HB2' ' B' ' 8' ' ' LEU . 46.1 mt-10 -65.53 -29.9 70.59 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.302 0.572 . . . . 2.55 110.003 179.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . 0.514 HD22 ' HB3' ' B' ' 46' ' ' CYS . 0.2 OUTLIER -72.79 -50.93 21.21 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.619 0.723 . . . . 2.82 109.433 179.944 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . 0.475 HG12 ' HA2' ' B' ' 11' ' ' GLY . 9.1 p -68.08 -37.73 78.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-N 115.665 -0.698 . . . . 2.5 112.254 -176.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -76.24 -22.27 55.37 Favored 'General case' 0 C--O 1.212 -0.907 0 N-CA-C 113.608 0.966 . . . . 2.04 113.608 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 9.7 p -71.55 -39.35 70.73 Favored 'General case' 0 C--O 1.262 1.753 0 O-C-N 120.959 -1.088 . . . . 2.31 109.268 174.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.468 ' HB3' ' HB2' ' B' ' 26' ' ' PHE . 4.3 mm? -52.71 -47.31 67.4 Favored 'General case' 0 C--O 1.216 -0.666 0 CA-C-N 114.938 -1.028 . . . . 2.27 109.535 169.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -63.44 -42.89 98.67 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.485 1.114 . . . . 2.39 110.084 178.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -48.76 -54.96 12.9 Favored 'General case' 0 C--O 1.245 0.823 0 N-CA-C 112.943 0.72 . . . . 1.0 112.943 -177.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 14.8 p -98.74 -26.15 3.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 C-N-CA 117.713 -1.595 . . . . 1.83 112.361 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' CYS . . . . . 0.443 ' HB2' ' O ' ' B' ' 17' ' ' LEU . 74.7 m -102.28 18.91 19.79 Favored 'General case' 0 C--N 1.308 -1.227 0 O-C-N 121.403 -0.81 . . . . 1.66 112.683 -175.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -57.35 -46.17 92.09 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 121.056 -0.593 . . . . 1.53 113.656 178.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -72.99 -39.16 66.3 Favored 'General case' 0 C--N 1.32 -0.708 0 O-C-N 122.669 -0.312 . . . . 2.72 111.507 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . 0.41 ' HD2' ' SG ' ' B' ' 60' ' ' CYS . 40.7 ttm180 -76.44 -38.48 55.44 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.334 0.588 . . . . 5.02 111.597 -177.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.35 151.72 9.69 Favored Glycine 0 N--CA 1.423 -2.2 0 N-CA-C 107.95 -2.06 . . . . 1.63 107.95 -174.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . 0.468 ' HB2' ' HB3' ' B' ' 17' ' ' LEU . 45.6 p90 -138.09 146.82 43.37 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 117.549 0.675 . . . . 1.71 110.229 -179.089 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -170.63 136.75 1.27 Allowed 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 110.205 -0.294 . . . . 3.67 110.205 174.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -118.96 -25.44 6.26 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 112.347 0.499 . . . . 2.44 112.347 173.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 67.9 m -80.06 138.11 36.92 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 108.785 -0.82 . . . . 3.85 108.785 176.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . 0.438 ' H ' ' HB3' ' B' ' 39' ' ' SER . 29.0 mmm180 -121.72 168.81 10.46 Favored Pre-proline 0 C--N 1.298 -1.643 0 N-CA-C 109.139 -0.689 . . . . 4.27 109.139 -174.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -80.24 14.27 2.0 Allowed 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 123.505 2.803 . . . . 4.2 114.841 -175.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' ALA . . . . . 0.471 ' HB2' ' OG ' ' B' ' 39' ' ' SER . . . -68.03 -51.26 48.91 Favored 'General case' 0 CA--C 1.5 -0.971 0 CA-C-O 121.443 0.639 . . . . 5.12 109.738 175.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 28.8 t -167.56 150.5 6.05 Favored 'General case' 0 N--CA 1.392 -3.344 0 N-CA-C 106.636 -1.616 . . . . 6.93 106.636 177.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 43.0 ttp180 -91.47 3.48 54.86 Favored 'General case' 0 C--N 1.264 -3.111 0 N-CA-C 108.009 -1.108 . . . . 12.14 108.009 -177.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 47.9 t -90.17 -6.52 10.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 107.697 -1.223 . . . . 9.9 107.697 175.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 21.8 m 66.69 30.71 8.05 Favored 'General case' 0 N--CA 1.418 -2.052 0 CA-C-N 114.176 -1.375 . . . . 6.82 112.293 175.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 21.3 mmm180 -64.26 -71.34 0.18 Allowed 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 115.599 -0.728 . . . . 10.71 111.112 175.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 51.8 mtm180 -83.24 -21.48 33.37 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-O 121.873 0.844 . . . . 8.6 110.172 175.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' SER . . . . . 0.471 ' OG ' ' HB2' ' B' ' 32' ' ' ALA . 19.7 m -95.16 61.07 2.4 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 114.75 -1.114 . . . . 5.79 109.377 179.004 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 5.5 tpp180 -57.05 -48.31 78.85 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 114.375 -1.284 . . . . 6.57 111.134 -178.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . 0.422 ' C ' ' H ' ' B' ' 43' ' ' VAL . . . 51.01 54.14 24.02 Favored Glycine 0 C--N 1.287 -2.186 0 CA-C-O 118.765 -1.02 . . . . 2.62 115.311 172.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . 0.416 HD13 HD21 ' B' ' 17' ' ' LEU . 42.9 pt 52.89 -18.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.527 3.405 0 N-CA-C 118.289 2.7 . . . . 2.28 118.289 170.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . 0.422 ' H ' ' C ' ' B' ' 41' ' ' GLY . 4.4 p -49.06 -40.58 13.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 C-N-CA 125.551 1.54 . . . . 2.6 114.673 -175.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -91.01 -34.11 15.27 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 109.497 -0.557 . . . . 3.36 109.497 -173.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . 0.436 ' O ' ' HB2' ' B' ' 49' ' ' ARG . 11.1 mp0 -64.7 -50.89 65.2 Favored 'General case' 0 C--O 1.192 -1.925 0 CA-C-N 115.758 -0.655 . . . . 3.08 110.118 178.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' CYS . . . . . 0.514 ' HB3' HD22 ' B' ' 13' ' ' LEU . 31.8 t -73.59 -22.77 59.94 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 119.821 -0.752 . . . . 2.23 110.7 -176.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 54.1 t -77.88 -39.34 43.52 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.364 -0.38 . . . . 2.48 111.994 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -119.05 6.03 11.31 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.904 1.076 . . . . 2.97 113.904 -176.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . 0.436 ' HB2' ' O ' ' B' ' 45' ' ' GLU . 98.7 mtt180 -130.51 169.55 15.41 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 106.754 -1.573 . . . . 4.65 106.754 176.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' SER . . . . . 0.498 ' HA ' HG23 ' B' ' 7' ' ' THR . 45.9 m -87.35 99.94 12.36 Favored 'General case' 0 N--CA 1.415 -2.183 0 N-CA-C 108.86 -0.792 . . . . 2.86 108.86 177.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 2.6 p -84.67 142.65 29.74 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.835 -1.172 . . . . 2.11 107.835 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -106.29 171.51 7.31 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 119.763 -0.775 . . . . 2.67 110.672 176.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . 0.676 ' HB3' ' HA ' ' A' 1600 ' ' SER . 1.9 pt? -62.32 -37.1 84.29 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 113.886 1.069 . . . . 2.36 113.886 -176.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . 0.409 ' O ' HG21 ' B' ' 58' ' ' THR . . . -58.31 -36.37 73.25 Favored 'General case' 0 CA--C 1.504 -0.792 0 C-N-CA 122.615 0.366 . . . . 1.92 111.857 -173.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . 0.493 ' O ' ' HB2' ' B' ' 59' ' ' TYR . 60.2 tp -60.67 -56.58 19.57 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.59 -0.732 . . . . 2.35 111.101 -177.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 3.2 pp -72.64 -26.76 61.77 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-O 120.831 0.348 . . . . 2.01 110.879 -177.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -69.08 -55.4 10.87 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 115.306 -0.861 . . . . 2.27 111.444 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 58' ' ' THR . . . . . 0.409 HG21 ' O ' ' B' ' 54' ' ' ALA . 13.0 t -78.05 -17.39 57.09 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 119.877 -0.729 . . . . 2.67 111.801 -178.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 59' ' ' TYR . . . . . 0.493 ' HB2' ' O ' ' B' ' 55' ' ' LEU . 6.3 t80 -77.08 -74.16 0.26 Allowed 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 106.219 -1.771 . . . . 3.2 106.219 176.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 60' ' ' CYS . . . . . 0.41 ' SG ' ' HD2' ' B' ' 24' ' ' ARG . 36.6 t 51.31 -77.09 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 125.529 1.532 . . . . 2.3 114.536 175.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -161.22 -50.43 0.04 OUTLIER 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 104.789 -2.3 . . . . 3.19 104.789 -177.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 62' ' ' THR . . . . . 0.581 HG21 ' HA ' ' B' ' 66' ' ' SER . 2.7 p -146.64 150.15 39.05 Favored Pre-proline 0 N--CA 1.411 -2.376 0 CA-C-N 112.428 -2.169 . . . . 4.14 106.961 178.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -77.26 -16.92 15.22 Favored 'Trans proline' 0 C--N 1.326 -0.622 0 C-N-CA 122.725 2.283 . . . . 5.59 113.527 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -143.7 51.1 1.34 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 120.855 0.36 . . . . 5.51 111.549 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 65.5 tttm 68.18 143.08 0.04 OUTLIER 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 125.264 1.426 . . . . 8.8 112.548 178.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 66' ' ' SER . . . . . 0.581 ' HA ' HG21 ' B' ' 62' ' ' THR . 15.7 m -84.15 35.29 0.53 Allowed 'General case' 0 C--O 1.243 0.714 0 O-C-N 121.894 -0.504 . . . . 8.12 112.159 -173.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 . . . . . 0 N--CA 1.42 -1.933 0 N-CA-C 106.447 -1.686 . . . . 10.21 106.447 179.933 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 CA--C 1.501 -0.907 0 N-CA-C 108.359 -0.978 . . . . 9.74 108.359 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 27.7 mtpp 64.3 65.04 0.68 Allowed 'General case' 0 C--O 1.226 -0.172 0 O-C-N 123.843 0.715 . . . . 9.32 111.264 177.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 50.0 m 55.14 85.84 0.06 Allowed 'General case' 0 C--O 1.244 0.771 0 O-C-N 124.077 0.861 . . . . 5.97 112.07 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1511 ' ' ASN . . . . . 0.5 HD21 ' N ' ' A' 1512 ' ' GLU . 0.2 OUTLIER -74.14 -18.86 60.73 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.432 -0.349 . . . . 3.48 111.318 -177.794 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A 1512 ' ' GLU . . . . . 0.5 ' N ' HD21 ' A' 1511 ' ' ASN . 0.5 OUTLIER -93.62 145.42 24.56 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 121.717 0.77 . . . . 5.95 113.077 -174.641 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A 1513 ' ' HIS . . . . . 0.404 ' O ' ' HB2' ' A' 1514 ' ' ASP . 50.7 t-80 -170.1 145.5 2.85 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 103.063 -2.94 . . . . 6.14 103.063 176.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1514 ' ' ASP . . . . . 0.404 ' HB2' ' O ' ' A' 1513 ' ' HIS . 20.0 m-20 67.46 151.98 0.08 Allowed 'General case' 0 CA--C 1.567 1.607 0 C-N-CA 124.114 0.966 . . . . 5.06 110.044 -176.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1515 ' ' ASP . . . . . 0.439 ' HA ' ' HD3' ' A' 1579 ' ' LYS . 4.5 m-20 -30.26 -74.37 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.308 0 N-CA-C 113.663 0.986 . . . . 2.9 113.663 175.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1516 ' ' CYS . . . . . 0.458 ' HB3' ' HB2' ' A' 1529 ' ' LEU . 71.2 m -144.55 78.61 1.58 Allowed 'General case' 0 C--O 1.251 1.165 0 CA-C-O 120.894 0.378 . . . . 1.41 111.278 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -157.32 130.22 7.63 Favored 'General case' 0 N--CA 1.422 -1.874 0 N-CA-C 108.982 -0.748 . . . . 2.18 108.982 175.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1518 ' ' VAL . . . . . 0.446 ' CG2' HD12 ' A' 1581 ' ' LEU . 5.9 m -131.79 135.63 58.45 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.16 0 CA-C-O 121.143 0.497 . . . . 1.52 110.936 -178.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1519 ' ' THR . . . . . 0.429 ' OG1' HD22 ' A' 1526 ' ' LEU . 23.5 m -106.46 129.63 54.4 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 107.202 -1.407 . . . . 1.36 107.202 176.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1520 ' ' ASN . . . . . 0.465 ' OD1' ' HB2' ' A' 1522 ' ' SER . 23.9 t-20 -89.02 112.47 51.17 Favored Pre-proline 0 C--N 1.287 -2.152 0 N-CA-C 108.247 -1.019 . . . . 2.02 108.247 176.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.69 -9.99 25.82 Favored 'Trans proline' 0 C--N 1.333 -0.237 0 C-N-CA 122.813 2.342 . . . . 1.82 113.257 -175.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1522 ' ' SER . . . . . 0.465 ' HB2' ' OD1' ' A' 1520 ' ' ASN . 24.6 m -74.13 -39.06 63.57 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 116.426 -0.352 . . . . 1.89 110.437 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1523 ' ' THR . . . . . 0.453 HG21 ' OD1' ' A' 1520 ' ' ASN . 9.7 t -122.58 -10.03 8.4 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 120.314 -0.554 . . . . 1.99 112.268 -179.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 81.06 22.6 60.77 Favored Glycine 0 C--N 1.32 -0.361 0 O-C-N 122.334 -0.229 . . . . 1.19 113.593 176.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1525 ' ' HIS . . . . . 0.558 ' CE1' ' HB3' ' A' 1647 ' ' GLU . 11.8 t-160 -93.65 125.26 38.17 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 120.535 -0.466 . . . . 1.82 110.69 -178.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1526 ' ' LEU . . . . . 0.429 HD22 ' OG1' ' A' 1519 ' ' THR . 2.5 tm? -94.28 116.52 28.92 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 114.866 -1.061 . . . . 1.3 109.764 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -92.71 119.09 31.75 Favored 'General case' 0 C--N 1.317 -0.808 0 O-C-N 122.296 -0.252 . . . . 0.8 110.438 173.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 14.2 t70 -103.92 110.67 22.9 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 109.123 -0.695 . . . . 1.17 109.123 178.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1529 ' ' LEU . . . . . 0.458 ' HB2' ' HB3' ' A' 1516 ' ' CYS . 3.6 mm? -99.01 3.16 46.85 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 121.326 0.584 . . . . 1.29 109.973 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 1.1 m -64.55 -29.66 70.69 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.049 -0.978 . . . . 0.91 109.344 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 23.1 t -62.26 -32.27 72.95 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.244 -0.889 . . . . 1.98 110.482 178.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 81.3 mt -96.28 1.37 51.98 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.255 -0.43 . . . . 1.34 110.944 -176.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1533 ' ' SER . . . . . . . . . . . . . 16.7 m -75.0 161.46 29.45 Favored 'General case' 0 C--O 1.256 1.42 0 CA-C-O 121.294 0.569 . . . . 1.93 111.982 -177.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -178.59 139.8 4.22 Favored Glycine 0 N--CA 1.429 -1.82 0 CA-C-N 115.623 -0.717 . . . . 1.1 111.532 178.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1535 ' ' ARG . . . . . 0.478 ' HD3' ' O ' ' A' 1535 ' ' ARG . 0.8 OUTLIER -92.92 -30.37 15.43 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 123.514 0.726 . . . . 5.21 109.252 -179.588 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -73.2 -34.11 65.78 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 121.582 0.706 . . . . 1.94 109.697 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 106.26 -177.47 22.3 Favored Glycine 0 N--CA 1.417 -2.574 0 CA-C-N 115.322 -0.854 . . . . 1.08 113.497 172.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -138.28 145.7 41.58 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 106.92 -1.511 . . . . 1.07 106.92 178.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 20.2 p -102.58 124.18 47.66 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 123.513 0.508 . . . . 1.46 110.526 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1540 ' ' ALA . . . . . 0.707 ' HB1' HG22 ' A' 1548 ' ' VAL . . . -117.37 134.89 54.3 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 109.087 -0.709 . . . . 1.19 109.087 178.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -88.13 124.47 33.82 Favored 'General case' 0 N--CA 1.439 -0.976 0 O-C-N 123.663 0.602 . . . . 1.37 110.71 -178.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1542 ' ' TYR . . . . . 0.521 ' HD2' ' CZ ' ' A' 1567 ' ' PHE . 2.2 t80 -123.5 -101.34 0.4 Allowed 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.235 -0.893 . . . . 1.38 109.675 -179.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1543 ' ' SER . . . . . . . . . . . . . 14.6 m -62.98 159.77 16.34 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 118.735 -0.65 . . . . 1.98 109.601 177.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 63.2 tttp -50.49 -40.87 52.32 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 112.902 0.705 . . . . 3.96 112.902 -175.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 27.3 t -116.98 34.43 5.11 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 108.47 -0.937 . . . . 2.81 108.47 177.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . -128.34 118.84 2.91 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.078 -1.058 . . . . 1.68 114.312 -175.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 28.1 m -124.66 137.61 56.82 Favored 'Isoleucine or valine' 0 C--O 1.254 1.325 0 CA-C-O 121.027 0.441 . . . . 1.38 109.939 176.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1548 ' ' VAL . . . . . 0.707 HG22 ' HB1' ' A' 1540 ' ' ALA . 0.0 OUTLIER -95.88 132.69 39.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-N 115.818 -0.628 . . . . 1.24 110.862 175.68 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A 1549 ' ' TYR . . . . . 0.413 ' HB3' ' ND2' ' A' 1556 ' ' ASN . 51.8 m-85 -96.33 99.8 11.46 Favored 'General case' 0 N--CA 1.423 -1.776 0 N-CA-C 106.756 -1.572 . . . . 1.29 106.756 171.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 6.4 ptp -110.75 142.15 43.09 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 115.392 -0.822 . . . . 1.47 111.589 -178.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1551 ' ' SER . . . . . 0.428 ' HB3' ' HB2' ' A' 1556 ' ' ASN . 12.3 p -118.34 110.64 17.73 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-N 115.719 -0.673 . . . . 1.4 109.428 176.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1552 ' ' ILE . . . . . . . . . . . . . 41.6 mm -75.49 119.6 23.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 109.465 -0.569 . . . . 1.11 109.465 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 56.8 m 64.41 41.68 5.61 Favored 'General case' 0 C--O 1.25 1.101 0 CA-C-O 121.97 0.891 . . . . 1.4 111.994 174.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 174.84 -178.02 46.73 Favored Glycine 0 N--CA 1.421 -2.36 0 N-CA-C 109.452 -1.459 . . . . 0.4 109.452 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -109.54 146.08 35.24 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-O 120.882 0.372 . . . . 1.62 110.224 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1556 ' ' ASN . . . . . 0.428 ' HB2' ' HB3' ' A' 1551 ' ' SER . 45.2 t-20 -94.92 139.49 31.25 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 115.672 -0.695 . . . . 1.12 109.166 -175.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1557 ' ' GLU . . . . . 0.403 ' HB3' ' CZ ' ' A' 1535 ' ' ARG . 12.9 pt-20 -77.92 -13.45 59.88 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 122.932 0.493 . . . . 2.49 112.304 -176.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -73.87 -8.25 55.37 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.38 0.511 . . . . 1.38 112.38 -177.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1559 ' ' CYS . . . . . 0.756 ' SG ' ' HD2' ' A' 1560 ' ' PRO . 1.6 t -137.72 169.41 13.07 Favored Pre-proline 0 C--N 1.288 -2.106 0 N-CA-C 106.747 -1.575 . . . . 1.21 106.747 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1560 ' ' PRO . . . . . 0.756 ' HD2' ' SG ' ' A' 1559 ' ' CYS . 14.2 Cg_exo -38.58 149.51 0.08 OUTLIER 'Trans proline' 0 CA--C 1.557 1.644 0 C-N-CA 124.003 3.135 . . . . 0.98 114.699 174.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -58.05 125.59 19.02 Favored 'Trans proline' 0 C--O 1.242 0.72 0 C-N-CA 123.151 2.567 . . . . 1.15 110.85 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 106.91 -7.28 38.13 Favored Glycine 0 N--CA 1.433 -1.517 0 CA-C-N 115.926 -0.579 . . . . 0.55 112.828 -178.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1563 ' ' VAL . . . . . 0.613 HG13 ' HB3' ' A' 1559 ' ' CYS . 9.8 t -79.37 121.8 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.836 0 N-CA-C 112.712 0.634 . . . . 1.53 112.712 -179.054 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -97.3 -34.75 5.49 Favored Glycine 0 C--N 1.306 -1.086 0 CA-C-N 114.918 -1.037 . . . . 0.29 111.023 176.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -131.4 125.17 31.91 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 109.653 -0.499 . . . . 1.08 109.653 178.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1566 ' ' CYS . . . . . 0.603 ' HB2' HG13 ' A' 1563 ' ' VAL . 49.4 t -150.78 138.46 19.77 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 110.115 -0.328 . . . . 0.43 110.115 -179.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1567 ' ' PHE . . . . . 0.928 ' HB3' ' HG2' ' A' 1569 ' ' GLN . 23.8 m-85 -85.74 139.62 31.19 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.812 -0.81 . . . . 1.3 108.812 172.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -87.57 23.32 13.04 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.211 -0.995 . . . . 1.43 111.245 -178.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1569 ' ' GLN . . . . . 0.928 ' HG2' ' HB3' ' A' 1567 ' ' PHE . 9.9 mm100 -67.71 -70.81 0.24 Allowed 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 122.912 0.485 . . . . 3.09 110.361 -177.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 14.3 t -131.85 34.74 3.83 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-O 122.539 1.161 . . . . 2.52 108.19 173.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 22.9 mmt180 63.56 61.02 1.05 Allowed 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 113.747 -1.569 . . . . 3.19 109.803 -178.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 34.8 mt -104.26 115.4 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-N 116.242 -0.436 . . . . 1.51 110.529 -177.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1573 ' ' SER . . . . . 0.544 ' HB3' ' HB2' ' A' 1596 ' ' SER . 28.6 t -80.13 142.02 35.19 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 120.957 0.408 . . . . 0.96 110.71 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1574 ' ' VAL . . . . . 0.448 HG13 ' CG ' ' A' 1606 ' ' TYR . 27.0 m -133.04 17.12 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 O-C-N 122.031 -0.418 . . . . 1.6 111.673 178.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 172.97 131.57 1.4 Allowed Glycine 0 N--CA 1.428 -1.843 0 C-N-CA 119.193 -1.48 . . . . 0.34 111.981 178.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -85.37 143.84 28.39 Favored 'General case' 0 N--CA 1.427 -1.578 0 N-CA-C 108.142 -1.058 . . . . 2.68 108.142 178.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -68.43 92.23 0.43 Allowed 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 115.456 -0.793 . . . . 1.08 111.8 -177.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -100.94 173.9 6.27 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 107.205 -1.406 . . . . 1.95 107.205 172.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1579 ' ' LYS . . . . . 0.439 ' HD3' ' HA ' ' A' 1515 ' ' ASP . 16.7 ptpt -142.8 54.5 1.39 Allowed 'General case' 0 C--N 1.294 -1.815 0 CA-C-O 122.395 1.093 . . . . 3.11 109.502 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1580 ' ' ARG . . . . . 0.426 ' NH1' HH21 ' A' 1582 ' ' ARG . 69.5 ttt180 -105.99 77.11 1.22 Allowed 'General case' 0 N--CA 1.419 -2.015 0 CA-C-N 114.953 -1.021 . . . . 4.04 109.7 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1581 ' ' LEU . . . . . 0.446 HD12 ' CG2' ' A' 1518 ' ' VAL . 0.5 OUTLIER -63.28 126.08 26.24 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.047 -0.979 . . . . 1.32 109.304 177.436 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A 1582 ' ' ARG . . . . . 0.536 ' HB2' ' HB3' ' A' 1589 ' ' GLN . 91.3 mtt180 -121.73 144.69 48.65 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 116.032 -0.531 . . . . 3.4 110.137 177.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1583 ' ' TYR . . . . . 0.618 ' CE1' ' HA ' ' A' 1586 ' ' GLN . 61.9 t80 -115.09 108.76 17.07 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.896 -0.409 . . . . 1.26 109.896 178.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1584 ' ' VAL . . . . . 0.528 ' O ' ' HB ' ' A' 1587 ' ' VAL . 13.1 m -124.81 89.56 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.61 0.719 . . . . 1.71 112.275 -178.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 21.0 t70 55.75 58.66 4.31 Favored 'General case' 0 N--CA 1.505 2.299 0 C-N-CA 124.739 1.215 . . . . 1.17 110.874 178.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1586 ' ' GLN . . . . . 0.618 ' HA ' ' CE1' ' A' 1583 ' ' TYR 0.352 3.9 pt20 63.92 17.66 10.69 Favored 'General case' 0 CA--C 1.503 -0.863 0 C-N-CA 127.513 2.325 . . . . 2.43 112.805 179.463 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A 1587 ' ' VAL . . . . . 0.528 ' HB ' ' O ' ' A' 1584 ' ' VAL . 39.5 t -102.0 120.48 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.235 0 N-CA-C 106.723 -1.584 . . . . 1.16 106.723 170.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1588 ' ' LEU . . . . . 0.932 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 2.5 mm? -96.6 108.03 20.56 Favored 'General case' 0 C--N 1.283 -2.283 0 N-CA-C 107.38 -1.341 . . . . 1.11 107.38 -179.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1589 ' ' GLN . . . . . 0.536 ' HB3' ' HB2' ' A' 1582 ' ' ARG . 34.4 tt0 -100.07 131.16 46.19 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 116.022 -0.535 . . . . 1.74 112.075 -173.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 12.1 mt -125.71 102.15 7.2 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 106.711 -1.589 . . . . 1.4 106.711 170.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 7.8 p -95.96 126.02 48.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 CA-C-O 121.39 0.614 . . . . 1.7 110.184 -177.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1592 ' ' TYR . . . . . . . . . . . . . 13.0 m-30 -117.25 110.69 18.43 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 107.966 -1.124 . . . . 1.08 107.966 -178.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 47.4 pttt -130.56 -179.13 5.1 Favored 'General case' 0 C--N 1.281 -2.381 0 CA-C-N 115.625 -0.716 . . . . 2.21 109.375 -177.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 19.9 m-20 61.66 43.33 9.97 Favored 'General case' 0 CA--C 1.507 -0.701 0 O-C-N 124.383 1.052 . . . . 1.11 110.264 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -90.81 -134.43 5.92 Favored Glycine 0 N--CA 1.432 -1.623 0 CA-C-N 114.594 -1.184 . . . . 0.78 110.942 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1596 ' ' SER . . . . . 0.544 ' HB2' ' HB3' ' A' 1573 ' ' SER . 33.1 t -86.31 148.24 46.68 Favored Pre-proline 0 C--N 1.303 -1.424 0 N-CA-C 108.583 -0.895 . . . . 1.36 108.583 -178.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -63.11 140.12 76.53 Favored 'Trans proline' 0 N--CA 1.443 -1.496 0 C-N-CA 122.499 2.133 . . . . 1.4 109.711 174.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1598 ' ' CYS . . . . . 0.552 ' HA ' ' CE2' ' A' 1606 ' ' TYR . 49.4 t -79.58 110.18 14.52 Favored Pre-proline 0 C--N 1.294 -1.817 0 N-CA-C 107.721 -1.215 . . . . 0.75 107.721 -178.1 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -58.59 -34.11 98.62 Favored 'Trans proline' 0 C--N 1.358 1.044 0 C-N-CA 123.191 2.594 . . . . 1.7 112.007 -176.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1600 ' ' SER . . . . . 0.713 ' HB3' ' HB2' ' B' ' 53' ' ' LEU . 4.8 m -60.62 -22.44 63.79 Favored 'General case' 0 CA--C 1.56 1.334 0 C-N-CA 125.271 1.428 . . . . 2.8 113.171 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1601 ' ' LYS . . . . . 0.483 ' HE2' ' OD2' ' B' ' 52' ' ' ASP . 4.9 tppp? -157.4 120.62 4.04 Favored 'General case' 0 C--O 1.241 0.622 0 O-C-N 121.952 -0.468 . . . . 3.45 110.339 178.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 19.8 m -70.18 133.93 47.58 Favored 'General case' 0 N--CA 1.414 -2.273 0 N-CA-C 109.686 -0.487 . . . . 2.44 109.686 -177.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 105.51 -16.89 44.01 Favored Glycine 0 C--N 1.301 -1.377 0 CA-C-N 116.072 -0.513 . . . . 1.2 112.343 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1604 ' ' LEU . . . . . 0.476 HD12 ' HB3' ' A' 1601 ' ' LYS . 56.9 mt -102.95 138.76 39.4 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 122.164 -0.61 . . . . 2.38 110.451 -179.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 20.5 m -115.92 147.04 41.54 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 107.698 -1.223 . . . . 1.96 107.698 175.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1606 ' ' TYR . . . . . 0.552 ' CE2' ' HA ' ' A' 1598 ' ' CYS . 54.4 m-85 -70.14 150.21 46.75 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 116.687 -0.233 . . . . 1.06 111.543 -178.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1607 ' ' LYS . . . . . 0.522 ' HZ1' ' HB3' ' A' 1607 ' ' LYS . 6.6 ttpm? -148.07 135.51 20.6 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.771 -0.826 . . . . 2.0 108.771 177.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1608 ' ' SER . . . . . . . . . . . . . 2.6 p -119.1 126.42 51.6 Favored 'General case' 0 C--N 1.281 -2.387 0 CA-C-N 115.384 -0.826 . . . . 1.61 109.83 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 39.1 t -107.51 105.16 18.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 109.52 -0.548 . . . . 1.09 109.52 -178.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 92.9 mt -89.97 119.38 36.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 107.972 -1.121 . . . . 1.2 107.972 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 20.0 m -124.55 116.0 21.76 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-N 115.85 -0.614 . . . . 1.89 110.494 -177.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1612 ' ' PHE . . . . . 0.932 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 75.5 m-85 -85.62 122.82 30.28 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.606 -0.887 . . . . 0.28 108.606 176.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 58.8 t -111.62 135.58 50.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 CA-C-N 115.382 -0.826 . . . . 1.23 109.576 -174.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 39.5 t -68.3 107.54 2.86 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.246 -0.888 . . . . 0.77 110.587 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1615 ' ' ARG . . . . . 0.425 ' CB ' ' HB3' ' A' 1641 ' ' HIS . 32.7 tpt180 -132.35 94.28 23.48 Favored Pre-proline 0 N--CA 1.437 -1.107 0 N-CA-C 108.746 -0.835 . . . . 2.92 108.746 176.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1616 ' ' PRO . . . . . 0.77 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 18.6 Cg_exo -66.89 -26.17 44.58 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 122.034 1.823 . . . . 1.22 112.397 -177.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -77.87 43.31 0.42 Allowed 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 125.067 1.347 . . . . 3.05 112.977 178.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -31.99 126.24 0.26 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.726 1.611 . . . . 1.55 113.171 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . -167.19 -141.17 3.08 Favored Glycine 0 N--CA 1.412 -2.906 0 N-CA-C 109.175 -1.57 . . . . 1.16 109.175 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -75.49 8.77 2.45 Favored 'Trans proline' 0 CA--C 1.533 0.437 0 C-N-CA 122.525 2.15 . . . . 1.06 113.337 -176.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1621 ' ' THR . . . . . 0.694 ' HB ' ' HB2' ' A' 1641 ' ' HIS . 14.4 p -96.18 -10.48 28.02 Favored 'General case' 0 C--N 1.292 -1.905 0 C-N-CA 124.102 0.961 . . . . 1.58 109.971 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 52.9 t30 -85.86 65.34 9.08 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 114.945 -1.025 . . . . 0.88 109.38 -178.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1623 ' ' ARG . . . . . 0.516 ' O ' ' HG3' ' A' 1625 ' ' MET . 10.8 ptp180 -165.34 141.84 4.61 Favored Pre-proline 0 C--N 1.31 -1.126 0 N-CA-C 107.78 -1.193 . . . . 3.82 107.78 -175.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1624 ' ' PRO . . . . . 0.436 ' HG3' ' CZ3' ' A' 1640 ' ' TRP . 23.5 Cg_exo -56.11 107.37 0.25 Allowed 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.551 2.167 . . . . 0.77 111.005 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1625 ' ' MET . . . . . 0.516 ' HG3' ' O ' ' A' 1623 ' ' ARG . 89.8 mtp -107.05 132.46 52.94 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.345 -0.613 . . . . 1.43 109.345 -177.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1626 ' ' LEU . . . . . 0.405 HD23 ' CE1' ' A' 1638 ' ' PHE . 0.5 OUTLIER -85.4 114.06 22.17 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 106.406 -1.702 . . . . 1.43 106.406 179.793 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A 1627 ' ' ILE . . . . . 0.701 HD11 ' HB2' ' A' 1639 ' ' SER . 45.2 mm -69.4 -55.1 16.42 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.139 0 N-CA-C 109.027 -0.731 . . . . 1.23 109.027 -179.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 11.8 t -176.44 152.88 1.12 Allowed 'General case' 0 N--CA 1.425 -1.704 0 N-CA-C 108.616 -0.883 . . . . 1.88 108.616 -176.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1629 ' ' LEU . . . . . 0.602 HD13 HD23 ' A' 1636 ' ' LEU . 19.0 tp -99.89 109.51 21.89 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.304 -0.862 . . . . 1.92 109.408 175.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 20.6 t70 -73.03 98.79 2.6 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 106.372 -1.714 . . . . 1.09 106.372 170.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1631 ' ' LYS . . . . . 0.612 ' HD3' ' H ' ' A' 1631 ' ' LYS . 0.2 OUTLIER -73.31 -16.21 61.38 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 113.73 1.011 . . . . 3.98 113.73 -172.989 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 16.7 mm100 -73.56 -36.63 65.63 Favored 'General case' 0 CA--C 1.498 -1.052 0 C-N-CA 120.41 -0.516 . . . . 2.6 111.193 178.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 58.9 p -108.01 -6.15 16.72 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 115.886 -0.597 . . . . 1.35 112.432 -176.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 82.5 m 63.73 47.08 3.77 Favored 'General case' 0 C--N 1.36 1.03 0 C-N-CA 124.368 1.067 . . . . 0.53 109.754 -178.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1635 ' ' THR . . . . . . . . . . . . . 56.1 m -115.36 133.17 56.29 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.92 -1.036 . . . . 1.11 110.808 -175.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1636 ' ' LEU . . . . . 0.602 HD23 HD13 ' A' 1629 ' ' LEU . 15.7 mt -110.14 135.75 50.44 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.996 -0.742 . . . . 1.56 108.996 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -109.55 133.15 53.43 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 109.421 -0.585 . . . . 0.54 109.421 176.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1638 ' ' PHE . . . . . 0.405 ' CE1' HD23 ' A' 1626 ' ' LEU . 97.3 m-85 -123.34 135.39 54.16 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 116.137 -0.483 . . . . 0.64 110.021 -178.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1639 ' ' SER . . . . . 0.701 ' HB2' HD11 ' A' 1627 ' ' ILE . 23.3 t -115.62 156.17 26.32 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 107.221 -1.399 . . . . 1.34 107.221 175.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1640 ' ' TRP . . . . . 0.436 ' CZ3' ' HG3' ' A' 1624 ' ' PRO . 3.1 t90 -151.5 106.21 3.25 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 103.973 -2.603 . . . . 0.8 103.973 177.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1641 ' ' HIS . . . . . 0.694 ' HB2' ' HB ' ' A' 1621 ' ' THR . 12.3 m-70 -93.39 103.45 15.67 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.694 -0.854 . . . . 1.14 108.694 -173.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1642 ' ' THR . . . . . . . . . . . . . 15.3 t -142.21 145.33 35.06 Favored Pre-proline 0 CA--C 1.558 1.277 0 C-N-CA 120.776 -0.369 . . . . 1.11 110.341 -172.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1643 ' ' PRO . . . . . 0.77 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 72.6 Cg_endo -78.42 -5.5 14.96 Favored 'Trans proline' 0 C--N 1.372 1.793 0 C-N-CA 122.303 2.002 . . . . 0.78 112.233 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 9.2 tt -66.49 -24.44 66.41 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.104 -0.702 . . . . 1.66 109.104 177.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -92.7 16.2 12.78 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.251 -0.886 . . . . 1.29 110.566 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 58.6 m -121.79 145.87 47.62 Favored 'General case' 0 N--CA 1.424 -1.748 0 O-C-N 122.28 -0.262 . . . . 1.48 110.998 -178.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1647 ' ' GLU . . . . . 0.558 ' HB3' ' CE1' ' A' 1525 ' ' HIS . 0.4 OUTLIER -116.41 126.97 27.11 Favored Pre-proline 0 C--N 1.296 -1.729 0 N-CA-C 108.509 -0.923 . . . . 3.14 108.509 167.14 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A 1648 ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -70.27 124.17 10.62 Favored 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 122.012 1.808 . . . . 2.92 110.679 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 . . . . . 0 C--N 1.299 -1.624 0 N-CA-C 108.951 -0.759 . . . . 4.72 108.951 -178.877 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.721 0 N-CA-C 109.087 -0.708 . . . . 10.26 109.087 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -74.11 129.31 37.59 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 107.077 -1.453 . . . . 7.94 107.077 177.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 22.5 ptt180 -97.38 128.84 33.47 Favored Pre-proline 0 C--N 1.297 -1.684 0 C-N-CA 120.21 -0.596 . . . . 6.56 111.281 -176.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -71.86 -1.43 9.93 Favored 'Trans proline' 0 N--CA 1.49 1.298 0 C-N-CA 123.993 3.128 . . . . 5.51 113.726 -178.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 32.8 m -144.0 141.15 29.98 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 106.032 -1.84 . . . . 4.91 106.032 179.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . 0.46 ' HB2' ' HB2' ' B' ' 50' ' ' SER . 72.9 mm-40 -78.65 -16.23 57.58 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 120.927 0.394 . . . . 4.23 110.874 -178.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 3.5 p -130.67 113.78 14.6 Favored 'General case' 0 N--CA 1.426 -1.635 0 CA-C-N 114.785 -1.098 . . . . 3.48 109.024 176.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . 0.608 ' HB2' ' HG3' ' B' ' 12' ' ' GLU . 9.4 mp -70.17 136.78 50.42 Favored 'General case' 0 C--O 1.248 0.986 0 O-C-N 122.136 -0.353 . . . . 4.35 111.856 178.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' CYS . . . . . 0.426 ' HA ' ' CD1' ' B' ' 13' ' ' LEU . 43.7 m -83.37 85.06 7.29 Favored 'General case' 0 N--CA 1.436 -1.159 0 C-N-CA 123.74 0.816 . . . . 2.84 111.04 -172.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . 0.461 ' O ' HG13 ' B' ' 14' ' ' VAL . . . 140.86 -77.59 0.3 Allowed Glycine 0 N--CA 1.412 -2.962 0 N-CA-C 110.07 -1.212 . . . . 2.28 110.07 177.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . 0.543 ' O ' ' HB2' ' B' ' 15' ' ' ASP . . . -56.32 -62.38 6.4 Favored Glycine 0 N--CA 1.44 -1.05 0 O-C-N 124.687 0.875 . . . . 1.94 113.325 -176.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . 0.608 ' HG3' ' HB2' ' B' ' 8' ' ' LEU . 44.1 mt-10 -74.12 -30.04 62.12 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.981 0.391 . . . . 2.55 111.222 -176.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . 0.563 ' HG ' ' O ' ' B' ' 8' ' ' LEU . 67.1 mt -56.67 -64.86 0.73 Allowed 'General case' 0 N--CA 1.468 0.446 0 O-C-N 123.374 0.421 . . . . 2.82 111.09 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . 0.461 HG13 ' O ' ' B' ' 10' ' ' GLY . 14.0 p -65.38 -29.85 48.45 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 CA-C-O 121.355 0.598 . . . . 2.5 110.269 -178.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' ASP . . . . . 0.543 ' HB2' ' O ' ' B' ' 11' ' ' GLY . 4.0 t70 -66.69 -48.38 69.44 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-N 115.422 -0.808 . . . . 2.04 112.251 -177.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 13.4 t -65.91 -31.87 73.05 Favored 'General case' 0 C--O 1.256 1.414 0 CA-C-N 118.099 0.409 . . . . 2.31 110.82 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.619 ' HB3' ' HB3' ' B' ' 26' ' ' PHE . 4.1 mm? -58.6 -48.79 79.78 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.423 0.63 . . . . 2.27 110.374 174.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -80.22 -15.1 57.76 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.549 0.69 . . . . 2.39 110.902 -178.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -65.07 -52.76 53.85 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.786 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 30.7 m -98.43 -24.95 4.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 C-N-CA 118.666 -1.214 . . . . 1.83 112.141 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' CYS . . . . . 0.42 ' HB2' ' O ' ' B' ' 17' ' ' LEU . 95.9 m -105.03 19.84 19.9 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 120.681 -0.407 . . . . 1.66 111.841 -177.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -49.22 -40.89 30.21 Favored Glycine 0 N--CA 1.474 1.168 0 N-CA-C 115.093 0.797 . . . . 1.53 115.093 -178.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -71.4 -32.35 68.32 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 112.476 0.547 . . . . 2.72 112.476 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 21.0 ttm180 -93.12 -41.12 10.11 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 120.738 -0.385 . . . . 5.02 111.852 -175.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 120.25 -176.15 16.12 Favored Glycine 0 N--CA 1.436 -1.355 0 N-CA-C 110.191 -1.164 . . . . 1.63 110.191 -177.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . 0.619 ' HB3' ' HB3' ' B' ' 17' ' ' LEU . 12.9 p90 -132.4 127.78 36.15 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 116.914 0.357 . . . . 1.71 110.277 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -131.09 84.04 2.15 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.089 0.471 . . . . 3.67 112.103 -175.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -120.19 22.49 11.37 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 122.367 1.08 . . . . 2.44 108.806 177.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 3.3 p -80.69 41.34 0.56 Allowed 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 113.992 -1.458 . . . . 3.85 111.928 -178.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . 0.403 ' HA ' ' HD3' ' B' ' 31' ' ' PRO . 29.4 mmm180 -105.28 131.66 21.57 Favored Pre-proline 0 C--N 1.306 -1.302 0 N-CA-C 107.758 -1.201 . . . . 4.27 107.758 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' B' ' 30' ' ' ARG . 2.6 Cg_endo -86.26 13.54 2.7 Favored 'Trans proline' 0 C--O 1.248 0.991 0 C-N-CA 123.163 2.576 . . . . 4.2 113.792 -173.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' ALA . . . . . 0.644 ' HA ' ' HB3' ' B' ' 36' ' ' SER . . . 72.9 91.9 0.09 Allowed 'General case' 0 CA--C 1.514 -0.419 0 C-N-CA 125.082 1.353 . . . . 5.12 111.298 178.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 92.4 p -111.07 -147.5 0.42 Allowed 'General case' 1 N--CA 1.365 -4.684 0 N-CA-C 104.419 -2.437 . . . . 6.93 104.419 -177.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 50.5 mtp180 -80.64 -21.0 41.84 Favored 'General case' 0 C--N 1.275 -2.649 0 CA-C-N 118.859 0.754 . . . . 12.14 109.364 175.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 24.0 t -89.83 -2.12 9.61 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 CA-C-O 122.935 1.35 . . . . 9.9 107.965 -178.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' SER . . . . . 0.644 ' HB3' ' HA ' ' B' ' 32' ' ' ALA . 10.4 t -143.78 44.38 1.48 Allowed 'General case' 0 N--CA 1.411 -2.406 0 CA-C-N 114.559 -1.201 . . . . 6.82 107.802 -176.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -91.42 -7.03 51.82 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 122.18 0.991 . . . . 10.71 108.683 174.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -141.44 134.45 29.08 Favored 'General case' 0 N--CA 1.417 -2.117 1 N-CA-C 99.979 -4.082 . . . . 8.6 99.979 176.41 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 15.8 m 60.58 56.78 2.95 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 107.199 -1.408 . . . . 5.79 107.199 -171.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . 0.608 ' HA ' ' OG ' ' B' ' 36' ' ' SER . 0.0 OUTLIER -81.25 76.5 8.19 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 114.39 -1.277 . . . . 6.57 110.132 -177.271 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.22 7.12 56.56 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-N 115.043 -0.98 . . . . 2.62 113.253 -172.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . 0.65 ' HA ' ' HG2' ' B' ' 45' ' ' GLU . 27.5 pt 52.75 26.94 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.38 1.899 0 C-N-CA 126.549 1.94 . . . . 2.28 112.739 179.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 1.4 p -103.05 -44.42 9.75 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.921 0 CA-C-N 113.771 -1.559 . . . . 2.6 112.638 -173.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -83.72 -22.06 32.11 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.758 -1.201 . . . . 3.36 107.758 -178.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . 0.65 ' HG2' ' HA ' ' B' ' 42' ' ' ILE . 1.5 pm0 -77.53 -28.36 51.95 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 114.241 -1.345 . . . . 3.08 112.22 173.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' CYS . . . . . . . . . . . . . 12.1 t -112.77 -3.25 14.24 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 118.729 -1.188 . . . . 2.23 112.793 -177.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 43.3 t -86.77 -53.34 4.98 Favored 'General case' 0 C--N 1.314 -0.975 0 O-C-N 121.201 -0.937 . . . . 2.48 110.958 175.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -91.71 -5.73 53.19 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.31 0.576 . . . . 2.97 111.902 -176.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -139.5 152.16 46.73 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 106.348 -1.723 . . . . 4.65 106.348 179.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' SER . . . . . 0.46 ' HB2' ' HB2' ' B' ' 6' ' ' GLU . 32.3 t -80.3 139.59 36.56 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 106.209 -1.774 . . . . 2.86 106.209 175.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . 0.594 ' HB2' HD21 ' B' ' 55' ' ' LEU . 25.7 p -105.46 138.18 42.08 Favored 'General case' 0 N--CA 1.422 -1.855 0 N-CA-C 108.6 -0.889 . . . . 2.11 108.6 -175.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . 0.483 ' OD2' ' HE2' ' A' 1601 ' ' LYS . 3.5 m-20 -66.33 139.44 58.04 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.944 -0.761 . . . . 2.67 108.944 177.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . 0.713 ' HB2' ' HB3' ' A' 1600 ' ' SER . 36.0 tp -55.18 -30.86 60.77 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.246 -1.343 . . . . 2.36 110.555 177.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.48 -45.44 84.84 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 123.688 0.795 . . . . 1.92 110.431 177.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . 0.594 HD21 ' HB2' ' B' ' 51' ' ' CYS . 44.9 tp -58.77 -50.57 73.43 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 123.936 0.895 . . . . 2.35 110.52 -179.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 3.1 pp -74.11 -33.08 63.47 Favored 'General case' 0 N--CA 1.424 -1.74 0 C-N-CA 120.716 -0.394 . . . . 2.01 111.842 -175.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -66.75 -49.45 65.92 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.117 0.484 . . . . 2.27 110.812 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 7.2 t -73.75 -24.46 59.88 Favored 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 120.294 -0.562 . . . . 2.67 111.039 -177.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -76.7 -67.48 0.7 Allowed 'General case' 0 C--O 1.241 0.611 0 N-CA-C 107.576 -1.268 . . . . 3.2 107.576 176.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 42.9 t 59.61 -85.27 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.311 1.444 . . . . 2.3 113.881 175.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -140.87 -88.81 0.17 Allowed 'General case' 0 N--CA 1.426 -1.627 0 N-CA-C 108.982 -0.747 . . . . 3.19 108.982 -174.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 4.1 p -146.58 138.93 13.85 Favored Pre-proline 0 N--CA 1.415 -2.207 0 N-CA-C 107.61 -1.255 . . . . 4.14 107.61 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -83.88 -2.11 10.17 Favored 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.73 2.287 . . . . 5.59 112.702 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . 0.416 ' HA ' ' HB2' ' B' ' 67' ' ' GLU . . . -129.94 50.59 2.17 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 115.425 -0.807 . . . . 5.51 110.295 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 47.1 tttm -92.93 -26.66 17.49 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 122.11 0.957 . . . . 8.8 108.906 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 66.0 m -137.33 56.92 1.76 Allowed 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 114.089 -1.414 . . . . 8.12 107.407 175.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . 0.416 ' HB2' ' HA ' ' B' ' 64' ' ' ALA . 6.3 tp10 . . . . . 0 N--CA 1.439 -1.024 0 CA-C-N 114.4 -1.273 . . . . 10.21 108.664 -175.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 25.2 mmt . . . . . 0 CA--C 1.496 -1.12 0 N-CA-C 108.129 -1.063 . . . . 9.74 108.129 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 97.8 mttt -125.06 39.0 4.08 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 121.332 0.587 . . . . 9.32 111.482 -176.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 16.3 m -77.54 -21.29 52.85 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 122.576 1.179 . . . . 5.97 108.094 174.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1511 ' ' ASN . . . . . 0.412 ' ND2' ' HD3' ' A' 1521 ' ' PRO . 19.2 p-10 -134.85 128.34 32.51 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 105.683 -1.969 . . . . 3.48 105.683 174.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1512 ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -123.24 167.59 13.55 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 120.315 -0.554 . . . . 5.95 111.436 -178.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 39.4 p-80 -75.18 -43.75 50.46 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 112.811 0.671 . . . . 6.14 112.811 -176.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 21.2 t70 64.92 -68.46 0.11 Allowed 'General case' 0 C--O 1.223 -0.321 0 C-N-CA 125.677 1.591 . . . . 5.06 110.828 -171.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1515 ' ' ASP . . . . . 0.411 ' CG ' ' H ' ' A' 1516 ' ' CYS . 14.6 t70 -111.01 -158.53 0.65 Allowed 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 106.006 -1.85 . . . . 2.9 106.006 178.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1516 ' ' CYS . . . . . 0.411 ' H ' ' CG ' ' A' 1515 ' ' ASP . 21.7 t -90.31 73.32 7.07 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 107.154 -1.424 . . . . 1.41 107.154 178.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -166.7 172.34 10.66 Favored 'General case' 0 N--CA 1.423 -1.822 0 N-CA-C 104.949 -2.241 . . . . 2.18 104.949 -174.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 10.6 p -168.27 137.07 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 CA-C-O 121.414 0.626 . . . . 1.52 110.531 177.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1519 ' ' THR . . . . . . . . . . . . . 35.4 m -92.92 135.85 33.78 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 115.809 -0.632 . . . . 1.36 109.973 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -86.23 124.94 69.45 Favored Pre-proline 0 N--CA 1.414 -2.231 0 CA-C-N 116.226 -0.443 . . . . 2.02 110.106 176.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1521 ' ' PRO . . . . . 0.412 ' HD3' ' ND2' ' A' 1511 ' ' ASN . 60.3 Cg_endo -73.76 -13.62 24.4 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.991 2.461 . . . . 1.82 113.602 -175.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 14.1 m -80.38 -41.62 24.31 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 116.657 -0.247 . . . . 1.89 111.442 -177.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1523 ' ' THR . . . . . . . . . . . . . 6.6 t -125.43 2.8 7.7 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 119.502 -0.879 . . . . 1.99 112.662 -175.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 65.35 28.12 73.22 Favored Glycine 0 CA--C 1.503 -0.697 0 C-N-CA 121.129 -0.558 . . . . 1.19 112.423 178.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 18.9 t-80 -98.2 127.65 44.26 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 121.268 0.556 . . . . 1.82 109.593 -179.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 2.8 tm? -86.03 118.5 25.54 Favored 'General case' 0 C--N 1.288 -2.078 0 CA-C-N 114.171 -1.377 . . . . 1.3 109.825 -177.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1527 ' ' PHE . . . . . 0.568 ' HE2' ' HE2' ' A' 1583 ' ' TYR . 30.6 m-85 -90.39 128.07 36.38 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 109.333 -0.617 . . . . 0.8 109.333 170.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 23.0 t70 -115.16 123.67 49.5 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 123.709 0.631 . . . . 1.17 109.768 178.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 3.0 mm? -100.34 -5.94 26.57 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-O 121.565 0.698 . . . . 1.29 109.798 -178.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1530 ' ' SER . . . . . 0.441 ' HA ' ' OG ' ' A' 1533 ' ' SER . 1.1 m -70.67 -18.17 62.84 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.381 -0.827 . . . . 0.91 109.704 -177.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 40.5 m -62.81 -19.21 63.84 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 115.369 -0.832 . . . . 1.98 110.228 176.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1532 ' ' LEU . . . . . 0.443 ' HB2' HG21 ' A' 1552 ' ' ILE . 75.9 mt -105.87 3.86 29.06 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 120.672 0.272 . . . . 1.34 111.147 177.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1533 ' ' SER . . . . . 0.441 ' OG ' ' HA ' ' A' 1530 ' ' SER . 50.2 m -68.11 155.46 39.54 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 121.472 0.653 . . . . 1.93 111.792 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . 173.68 149.57 7.04 Favored Glycine 0 N--CA 1.422 -2.248 0 N-CA-C 109.373 -1.491 . . . . 1.1 109.373 -177.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 41.7 ttp180 -89.52 -21.29 22.99 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.189 0.519 . . . . 5.21 109.922 -177.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -81.02 -40.91 23.52 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 109.172 -0.677 . . . . 1.94 109.172 176.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 91.94 -151.16 20.64 Favored Glycine 0 N--CA 1.42 -2.424 0 CA-C-N 115.651 -0.704 . . . . 1.08 113.976 171.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -135.04 145.07 47.66 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 107.78 -1.192 . . . . 1.07 107.78 -177.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 15.5 p -111.45 127.69 55.76 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 123.903 0.752 . . . . 1.46 110.526 179.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1540 ' ' ALA . . . . . 0.692 ' HB3' ' HG2' ' A' 1624 ' ' PRO . . . -120.14 142.95 48.47 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 108.367 -0.975 . . . . 1.19 108.367 175.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -80.93 136.97 36.12 Favored 'General case' 0 C--N 1.314 -0.937 0 O-C-N 123.817 0.698 . . . . 1.37 110.354 -176.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1542 ' ' TYR . . . . . 0.82 ' HE2' ' HG ' ' A' 1626 ' ' LEU . 3.1 t80 -149.21 -99.08 0.07 Allowed 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 115.984 -0.553 . . . . 1.38 109.743 -174.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1543 ' ' SER . . . . . 0.406 ' H ' ' HB3' ' A' 1542 ' ' TYR . 30.0 t -72.31 151.48 42.73 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 109.04 -0.726 . . . . 1.98 109.04 -177.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1544 ' ' LYS . . . . . 0.568 ' HD2' ' HA ' ' B' ' 23' ' ' ASP . 62.7 tttp -57.95 -22.35 48.56 Favored 'General case' 0 C--N 1.346 0.416 0 C-N-CA 125.326 1.45 . . . . 3.96 112.318 -174.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 34.5 t -132.21 19.93 4.44 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 116.271 -0.422 . . . . 2.81 109.985 -178.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1546 ' ' GLY . . . . . 0.49 ' HA3' ' OE1' ' A' 1569 ' ' GLN . . . -159.14 127.93 1.93 Allowed Glycine 0 N--CA 1.439 -1.115 0 C-N-CA 118.816 -1.659 . . . . 1.68 113.988 -176.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 26.9 m -100.91 164.64 2.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 108.154 -1.054 . . . . 1.38 108.154 176.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1548 ' ' VAL . . . . . 0.482 ' CG1' ' HB2' ' A' 1540 ' ' ALA . 10.2 p -102.15 130.85 51.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 109.614 -0.513 . . . . 1.24 109.614 178.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -101.96 118.5 37.05 Favored 'General case' 0 CA--C 1.497 -1.068 0 C-N-CA 123.462 0.705 . . . . 1.29 109.287 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1550 ' ' MET . . . . . 0.522 ' SD ' ' HZ3' ' A' 1640 ' ' TRP . 8.9 ptp -127.81 144.93 51.07 Favored 'General case' 0 C--N 1.29 -2.011 0 C-N-CA 120.182 -0.607 . . . . 1.47 111.46 175.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 8.3 p -119.34 123.36 43.99 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 115.59 -0.732 . . . . 1.4 109.177 175.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1552 ' ' ILE . . . . . 0.458 HG23 ' SG ' ' A' 1553 ' ' CYS . 46.6 mm -81.24 114.09 21.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 C-N-CA 121.152 -0.219 . . . . 1.11 110.671 -177.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1553 ' ' CYS . . . . . 0.458 ' SG ' HG23 ' A' 1552 ' ' ILE . 31.1 m 66.91 38.38 3.67 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.62 0.768 . . . . 1.4 110.563 173.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . -177.41 -173.25 42.75 Favored Glycine 0 N--CA 1.417 -2.582 0 N-CA-C 109.343 -1.503 . . . . 0.4 109.343 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -110.38 148.62 31.63 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-O 121.095 0.474 . . . . 1.62 110.469 -178.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -99.09 131.1 45.38 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.656 -0.868 . . . . 1.12 108.656 -176.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -81.71 1.59 33.67 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 113.355 0.872 . . . . 2.49 113.355 -174.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 51.9 m-80 -83.39 -7.48 59.56 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 120.429 -0.508 . . . . 1.38 111.391 -179.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1559 ' ' CYS . . . . . 0.695 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 98.0 m -136.72 175.13 3.74 Favored Pre-proline 0 C--N 1.31 -1.127 0 CA-C-O 117.931 -1.033 . . . . 1.21 110.041 179.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1560 ' ' PRO . . . . . 0.695 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 4.3 Cg_exo -40.27 137.72 1.39 Allowed 'Trans proline' 0 C--N 1.387 2.559 0 C-N-CA 123.917 3.078 . . . . 0.98 113.516 177.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -53.99 127.16 24.52 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 123.624 2.882 . . . . 1.15 112.845 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 102.29 6.7 47.6 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-N 115.85 -0.613 . . . . 0.55 113.028 -178.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1563 ' ' VAL . . . . . 0.545 HG13 ' HB2' ' A' 1566 ' ' CYS . 2.8 t -96.08 124.64 48.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 C-N-CA 123.171 0.588 . . . . 1.53 111.648 -177.099 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -97.26 -33.56 5.92 Favored Glycine 0 N--CA 1.44 -1.048 0 CA-C-N 115.34 -0.846 . . . . 0.29 111.747 178.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -129.9 125.54 35.79 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 109.62 -0.511 . . . . 1.08 109.62 178.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1566 ' ' CYS . . . . . 0.545 ' HB2' HG13 ' A' 1563 ' ' VAL . 43.7 t -151.24 139.73 20.52 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 120.664 0.269 . . . . 0.43 110.878 -179.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1567 ' ' PHE . . . . . 0.436 ' HB3' ' HG2' ' A' 1569 ' ' GLN . 10.9 m-85 -91.4 143.0 27.07 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 122.427 -0.17 . . . . 1.3 110.682 173.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -90.36 41.16 2.96 Favored Glycine 0 N--CA 1.431 -1.651 0 C-N-CA 120.54 -0.838 . . . . 1.43 111.821 -176.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1569 ' ' GLN . . . . . 0.49 ' OE1' ' HA3' ' A' 1546 ' ' GLY . 8.4 mm100 -80.33 -72.19 0.42 Allowed 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 108.838 -0.801 . . . . 3.09 108.838 177.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1570 ' ' THR . . . . . 0.411 ' H ' ' HB2' ' A' 1569 ' ' GLN . 19.0 p -133.37 35.14 3.46 Favored 'General case' 0 N--CA 1.433 -1.31 0 C-N-CA 123.869 0.868 . . . . 2.52 110.198 176.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 11.6 mmt180 67.61 63.02 0.42 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.743 1.217 . . . . 3.19 108.791 -174.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 31.1 mt -105.89 111.53 35.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 CA-C-N 115.946 -0.57 . . . . 1.51 110.814 -176.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 31.2 t -81.98 139.15 34.73 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.597 -0.729 . . . . 0.96 111.052 -177.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1574 ' ' VAL . . . . . 0.562 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 34.6 m -132.13 12.98 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-O 121.163 0.506 . . . . 1.6 111.329 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 178.98 122.62 0.77 Allowed Glycine 0 N--CA 1.423 -2.186 0 C-N-CA 120.158 -1.02 . . . . 0.34 111.761 177.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 29.5 ttpp -81.0 146.47 30.66 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 107.558 -1.275 . . . . 2.68 107.558 178.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -68.28 90.29 0.35 Allowed 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.232 0.539 . . . . 1.08 112.295 -175.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -107.37 179.69 4.18 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.414 -1.328 . . . . 1.95 107.414 176.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 60.0 mttp -138.47 48.13 1.95 Allowed 'General case' 0 CA--C 1.49 -1.341 0 N-CA-C 109.181 -0.674 . . . . 3.11 109.181 178.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1580 ' ' ARG . . . . . 0.517 ' HB3' HG12 ' A' 1591 ' ' VAL . 31.1 ttm180 -87.21 76.97 9.12 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.839 -0.745 . . . . 4.04 109.286 -177.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1581 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.13 124.98 31.01 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 114.478 -1.237 . . . . 1.32 108.65 -179.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -127.89 138.46 52.68 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 116.342 -0.39 . . . . 3.4 110.125 172.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1583 ' ' TYR . . . . . 0.568 ' HE2' ' HE2' ' A' 1527 ' ' PHE . 32.6 t80 -95.97 115.56 27.62 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 107.084 -1.45 . . . . 1.26 107.084 176.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1584 ' ' VAL . . . . . 0.704 ' O ' ' HB ' ' A' 1587 ' ' VAL . 6.3 p -138.76 102.0 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.044 0 C-N-CA 120.529 -0.468 . . . . 1.71 111.646 -176.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 19.4 t70 58.58 56.45 4.26 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 122.381 1.086 . . . . 1.17 110.658 179.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1586 ' ' GLN . . . . . 0.441 ' HA ' ' CZ ' ' A' 1583 ' ' TYR . 11.1 pt20 58.84 10.79 1.62 Allowed 'General case' 0 N--CA 1.499 1.993 0 C-N-CA 127.472 2.309 . . . . 2.43 112.32 -178.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1587 ' ' VAL . . . . . 0.704 ' HB ' ' O ' ' A' 1584 ' ' VAL . 2.8 t -97.02 124.61 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.245 0 CA-C-N 114.573 -1.194 . . . . 1.16 109.846 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1588 ' ' LEU . . . . . 0.899 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 4.1 mm? -90.41 108.92 20.08 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 107.239 -1.393 . . . . 1.11 107.239 175.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -109.52 122.0 46.45 Favored 'General case' 0 C--N 1.287 -2.114 0 C-N-CA 119.47 -0.892 . . . . 1.74 111.443 -176.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1590 ' ' LEU . . . . . 0.676 ' HB3' ' HB ' ' A' 1610 ' ' ILE . 44.8 tp -113.44 109.93 19.48 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 106.18 -1.785 . . . . 1.4 106.18 177.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1591 ' ' VAL . . . . . 0.517 HG12 ' HB3' ' A' 1580 ' ' ARG . 4.6 p -102.52 129.04 54.68 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 119.619 -0.832 . . . . 1.7 110.599 -177.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1592 ' ' TYR . . . . . 0.428 ' O ' ' HG3' ' A' 1607 ' ' LYS . 13.2 m-30 -117.37 126.91 53.46 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.437 -1.32 . . . . 1.08 107.437 177.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 12.9 ptmm? -140.6 176.69 8.58 Favored 'General case' 0 C--N 1.278 -2.515 0 N-CA-C 108.619 -0.882 . . . . 2.21 108.619 -174.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 9.3 m-20 58.58 41.8 21.76 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 124.599 1.187 . . . . 1.11 111.81 178.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -76.14 -98.8 0.14 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.15 -1.024 . . . . 0.78 110.954 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1596 ' ' SER . . . . . . . . . . . . . 12.4 t -120.97 152.44 56.43 Favored Pre-proline 0 C--N 1.285 -2.208 0 N-CA-C 105.61 -1.996 . . . . 1.36 105.61 174.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -61.84 139.12 78.27 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 122.376 2.05 . . . . 1.4 110.767 175.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 39.2 t -81.79 102.95 1.73 Allowed Pre-proline 0 C--N 1.302 -1.494 0 N-CA-C 106.658 -1.608 . . . . 0.75 106.658 178.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -62.11 -39.47 49.05 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 123.106 2.538 . . . . 1.7 113.184 -170.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1600 ' ' SER . . . . . 0.414 ' HB3' ' HA ' ' B' ' 53' ' ' LEU . 8.7 m -69.12 -15.09 63.34 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.47 -0.786 . . . . 2.8 112.817 -177.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1601 ' ' LYS . . . . . . . . . . . . . 13.7 tppt? -135.31 87.91 2.37 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 107.318 -1.364 . . . . 3.45 107.318 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 14.9 m -44.66 114.47 0.71 Allowed 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 125.896 1.678 . . . . 2.44 114.456 -174.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 100.64 10.53 43.57 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 114.415 0.526 . . . . 1.2 114.415 175.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 9.2 mp -110.57 156.25 21.19 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 117.28 0.54 . . . . 2.38 111.197 178.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 16.5 m -121.34 147.8 45.2 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.514 -1.291 . . . . 1.96 107.514 173.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1606 ' ' TYR . . . . . 0.562 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 85.8 m-85 -71.91 149.99 44.61 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 110.377 -0.231 . . . . 1.06 110.377 177.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1607 ' ' LYS . . . . . 0.538 ' HZ1' ' HB3' ' A' 1607 ' ' LYS . 6.1 ttpm? -146.94 135.86 22.32 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 123.856 0.723 . . . . 2.0 109.455 178.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1608 ' ' SER . . . . . . . . . . . . . 19.2 m -114.36 125.58 54.03 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 108.645 -0.872 . . . . 1.61 108.645 -178.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 39.1 t -105.59 108.26 24.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 108.808 -0.812 . . . . 1.09 108.808 178.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1610 ' ' ILE . . . . . 0.676 ' HB ' ' HB3' ' A' 1590 ' ' LEU . 79.1 mt -95.08 118.87 42.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 108.583 -0.895 . . . . 1.2 108.583 -178.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1611 ' ' SER . . . . . 0.434 ' HG ' HG12 ' A' 1587 ' ' VAL . 26.6 t -117.24 110.52 18.22 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 108.972 -0.751 . . . . 1.89 108.972 -178.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1612 ' ' PHE . . . . . 0.899 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 70.8 m-85 -86.7 122.95 31.32 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.654 -0.869 . . . . 0.28 108.654 177.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 44.8 t -116.53 135.37 57.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.457 0 CA-C-N 115.433 -0.803 . . . . 1.23 110.144 -174.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1614 ' ' CYS . . . . . 0.438 ' HB2' ' HA ' ' A' 1646 ' ' CYS . 4.9 t -54.53 111.11 0.73 Allowed 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 124.573 1.149 . . . . 0.77 113.095 177.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1615 ' ' ARG . . . . . 0.679 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 18.6 tpt180 -137.29 91.04 14.78 Favored Pre-proline 0 N--CA 1.441 -0.911 0 N-CA-C 108.815 -0.809 . . . . 2.92 108.815 169.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1616 ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -66.68 -23.49 48.95 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.251 1.967 . . . . 1.22 112.996 -175.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -71.5 -22.83 61.74 Favored 'General case' 0 N--CA 1.432 -1.35 0 C-N-CA 122.923 0.489 . . . . 3.05 111.822 178.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . 63.61 -156.52 0.32 Allowed 'General case' 0 C--N 1.359 1.006 0 N-CA-C 108.155 -1.054 . . . . 1.55 108.155 -174.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . 116.43 -157.3 15.12 Favored Glycine 0 N--CA 1.414 -2.773 0 C-N-CA 120.202 -0.999 . . . . 1.16 112.484 176.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -78.45 13.94 1.73 Allowed 'Trans proline' 0 C--N 1.325 -0.67 0 C-N-CA 123.683 2.922 . . . . 1.06 113.053 -175.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1621 ' ' THR . . . . . 0.729 ' HB ' ' HB2' ' A' 1641 ' ' HIS . 16.5 p -105.39 -7.84 18.54 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 115.002 -0.999 . . . . 1.58 109.598 178.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 56.6 t30 -87.79 65.68 8.49 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.444 -0.947 . . . . 0.88 108.444 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -166.72 141.53 3.47 Favored Pre-proline 0 C--N 1.307 -1.255 0 N-CA-C 107.743 -1.206 . . . . 3.82 107.743 -175.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1624 ' ' PRO . . . . . 0.692 ' HG2' ' HB3' ' A' 1540 ' ' ALA . 21.3 Cg_endo -60.87 104.58 0.28 Allowed 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.532 2.154 . . . . 0.77 111.408 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 85.3 mtp -101.98 135.46 43.5 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.824 -0.806 . . . . 1.43 108.824 -178.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1626 ' ' LEU . . . . . 0.82 ' HG ' ' HE2' ' A' 1542 ' ' TYR . 0.3 OUTLIER -87.63 118.68 27.28 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 107.9 -1.148 . . . . 1.43 107.9 -176.357 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A 1627 ' ' ILE . . . . . 0.745 HD11 ' HB2' ' A' 1639 ' ' SER . 39.9 mm -79.41 -50.28 18.41 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.879 0 N-CA-C 108.925 -0.768 . . . . 1.23 108.925 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 17.1 t -172.41 161.18 5.09 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 108.827 -0.805 . . . . 1.88 108.827 -176.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1629 ' ' LEU . . . . . 0.812 HD13 HD22 ' A' 1636 ' ' LEU . 13.6 tp -117.51 106.49 13.22 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.0 -1.111 . . . . 1.92 108.0 176.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 18.0 t70 -72.2 107.42 4.84 Favored 'General case' 0 CA--C 1.487 -1.478 0 N-CA-C 105.849 -1.908 . . . . 1.09 105.849 174.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1631 ' ' LYS . . . . . 0.513 ' HB3' HD23 ' B' ' 53' ' ' LEU . 54.4 mtmt -72.5 -35.42 68.15 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 115.173 -0.921 . . . . 3.98 111.138 -171.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -70.77 -38.99 73.48 Favored 'General case' 0 N--CA 1.417 -2.091 0 C-N-CA 120.412 -0.515 . . . . 2.6 112.089 -173.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 47.4 p -97.38 -0.87 45.6 Favored 'General case' 0 CA--C 1.566 1.562 0 N-CA-C 112.593 0.59 . . . . 1.35 112.593 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 84.5 m 59.61 52.77 5.41 Favored 'General case' 0 C--N 1.374 1.64 0 C-N-CA 124.709 1.204 . . . . 0.53 111.153 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1635 ' ' THR . . . . . . . . . . . . . 92.5 m -125.21 133.5 52.72 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.727 -0.67 . . . . 1.11 111.994 -175.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1636 ' ' LEU . . . . . 0.812 HD22 HD13 ' A' 1629 ' ' LEU . 9.7 mt -104.7 136.03 44.99 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.37 -0.974 . . . . 1.56 108.37 -179.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -108.59 129.72 55.31 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 109.113 -0.699 . . . . 0.54 109.113 177.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -120.11 142.56 48.8 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 116.225 -0.443 . . . . 0.64 110.935 -178.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1639 ' ' SER . . . . . 0.745 ' HB2' HD11 ' A' 1627 ' ' ILE . 31.8 t -117.44 153.45 33.07 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 107.068 -1.456 . . . . 1.34 107.068 173.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1640 ' ' TRP . . . . . 0.522 ' HZ3' ' SD ' ' A' 1550 ' ' MET . 2.1 t90 -154.1 105.79 2.75 Favored 'General case' 0 N--CA 1.42 -1.973 0 N-CA-C 105.163 -2.162 . . . . 0.8 105.163 179.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1641 ' ' HIS . . . . . 0.729 ' HB2' ' HB ' ' A' 1621 ' ' THR . 38.1 m-70 -95.19 105.03 16.93 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 108.868 -0.79 . . . . 1.14 108.868 -175.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1642 ' ' THR . . . . . . . . . . . . . 14.3 t -141.97 152.41 61.88 Favored Pre-proline 0 CA--C 1.559 1.298 0 N-CA-C 108.846 -0.798 . . . . 1.11 108.846 -171.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1643 ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.1 -24.31 12.79 Favored 'Trans proline' 0 C--N 1.367 1.522 0 C-N-CA 122.715 2.277 . . . . 0.78 114.139 -178.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 3.3 pp -75.73 -4.93 43.16 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 119.935 -0.706 . . . . 1.66 111.672 -177.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -116.15 23.87 11.85 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-O 122.318 1.056 . . . . 1.29 109.005 -178.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1646 ' ' CYS . . . . . 0.529 ' O ' ' HD3' ' A' 1648 ' ' PRO . 52.9 t -115.67 140.46 49.17 Favored 'General case' 0 N--CA 1.401 -2.884 0 CA-C-N 115.0 -1.0 . . . . 1.48 110.511 -177.052 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -102.69 94.98 5.65 Favored Pre-proline 0 N--CA 1.427 -1.601 0 N-CA-C 106.309 -1.737 . . . . 3.14 106.309 172.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1648 ' ' PRO . . . . . 0.529 ' HD3' ' O ' ' A' 1646 ' ' CYS . 7.5 Cg_exo -76.86 151.04 31.02 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 122.438 2.092 . . . . 2.92 111.517 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 . . . . . 0 C--N 1.289 -2.023 0 N-CA-C 106.815 -1.55 . . . . 4.72 106.815 177.657 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.605 0 N-CA-C 109.275 -0.639 . . . . 10.26 109.275 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -99.01 123.33 43.23 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.773 -0.825 . . . . 7.94 108.773 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -92.04 147.53 34.97 Favored Pre-proline 0 C--N 1.305 -1.345 0 N-CA-C 108.805 -0.813 . . . . 6.56 108.805 178.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -75.95 48.64 2.29 Favored 'Trans proline' 0 C--O 1.238 0.515 0 C-N-CA 123.487 2.792 . . . . 5.51 113.063 -177.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 19.2 t 66.4 -63.52 0.25 Allowed 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 126.696 1.998 . . . . 4.91 114.391 175.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -84.91 -44.03 13.54 Favored 'General case' 0 C--N 1.265 -3.075 0 N-CA-C 113.956 1.095 . . . . 4.23 113.956 -171.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 18.0 p -94.52 153.75 17.74 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 120.711 -0.395 . . . . 3.48 110.585 -179.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . 0.644 HD22 ' HG3' ' B' ' 12' ' ' GLU . 4.7 mp -123.56 156.4 35.79 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.695 -0.854 . . . . 4.35 108.695 -177.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 38.7 m -101.12 150.66 22.7 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.75 -0.833 . . . . 2.84 108.75 178.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.57 -137.2 13.12 Favored Glycine 0 N--CA 1.427 -1.925 0 C-N-CA 120.535 -0.841 . . . . 2.28 113.173 177.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -56.04 -42.77 87.83 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 115.236 0.854 . . . . 1.94 115.236 -173.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . 0.644 ' HG3' HD22 ' B' ' 8' ' ' LEU . 9.0 mm-40 -63.2 -49.12 75.5 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.434 0.635 . . . . 2.55 110.39 -176.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 13.6 tp -66.99 -49.45 65.33 Favored 'General case' 0 C--O 1.252 1.203 0 CA-C-N 115.015 -0.993 . . . . 2.82 111.196 -175.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 14.3 p -64.68 -37.66 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 C-N-CA 120.399 -0.52 . . . . 2.5 110.944 -178.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -77.17 -17.56 58.47 Favored 'General case' 0 C--O 1.196 -1.734 0 C-N-CA 118.08 -1.448 . . . . 2.04 111.358 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 92.0 m -62.5 -41.31 98.74 Favored 'General case' 0 C--O 1.272 2.267 0 O-C-N 121.302 -0.874 . . . . 2.31 108.983 173.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.873 HD23 HD11 ' B' ' 42' ' ' ILE . 10.7 mp -63.4 -42.67 98.78 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 115.568 -0.742 . . . . 2.27 110.99 176.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -75.55 -11.85 60.1 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.02 -0.991 . . . . 2.39 111.267 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -67.95 -55.24 13.47 Favored 'General case' 0 C--N 1.314 -0.967 0 O-C-N 121.892 -0.505 . . . . 1.0 109.686 176.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 12.6 p -98.52 -17.5 6.68 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 C-N-CA 118.112 -1.435 . . . . 1.83 112.487 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 83.8 m -116.81 30.62 7.22 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.457 -0.777 . . . . 1.66 111.586 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -55.0 -57.11 19.78 Favored Glycine 0 C--N 1.342 0.894 0 N-CA-C 114.082 0.393 . . . . 1.53 114.082 -179.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . 0.568 ' HA ' ' HD2' ' A' 1544 ' ' LYS . 17.6 t70 -65.93 -32.85 74.59 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-O 121.063 0.459 . . . . 2.72 111.182 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 21.3 tpp180 -69.53 -47.99 61.93 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.79 -0.641 . . . . 5.02 111.186 -178.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 111.43 170.49 18.95 Favored Glycine 0 N--CA 1.427 -1.961 0 N-CA-C 108.797 -1.721 . . . . 1.63 108.797 -175.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -135.6 140.63 44.75 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 117.399 0.6 . . . . 1.71 111.598 178.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -136.51 141.99 43.46 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.77 -0.455 . . . . 3.67 109.77 178.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' PHE . . . . . 0.448 ' CD2' ' HB ' ' B' ' 43' ' ' VAL . 0.0 OUTLIER -154.52 23.45 0.47 Allowed 'General case' 0 C--O 1.243 0.712 0 N-CA-C 112.321 0.489 . . . . 2.44 112.321 178.238 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 17.9 m -118.35 84.15 2.13 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.416 0.627 . . . . 3.85 111.925 -172.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . 0.507 HH22 ' HB ' ' B' ' 35' ' ' VAL . 74.2 mtm180 -123.13 119.65 27.61 Favored Pre-proline 0 C--N 1.303 -1.455 0 N-CA-C 108.031 -1.1 . . . . 4.27 108.031 177.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . 0.663 ' HA ' ' HA ' ' B' ' 39' ' ' SER . 31.8 Cg_exo -61.98 -27.96 80.18 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.609 2.872 . . . . 4.2 113.451 -178.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -166.27 157.63 13.32 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 108.712 -0.847 . . . . 5.12 108.712 177.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 36.9 t 175.47 178.64 0.16 Allowed 'General case' 0 N--CA 1.4 -2.932 0 N-CA-C 102.881 -3.007 . . . . 6.93 102.881 -177.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 46.6 ttp180 -93.2 -8.09 43.38 Favored 'General case' 0 C--N 1.266 -3.041 0 N-CA-C 108.562 -0.903 . . . . 12.14 108.562 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . 0.507 ' HB ' HH22 ' B' ' 30' ' ' ARG . 13.3 t -118.11 3.28 7.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-O 122.763 1.268 . . . . 9.9 108.001 179.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 51.1 m -155.59 71.45 0.76 Allowed 'General case' 0 N--CA 1.422 -1.84 0 N-CA-C 107.143 -1.429 . . . . 6.82 107.143 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 9.7 ptp85 -80.76 6.94 11.5 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-O 122.406 1.098 . . . . 10.71 110.659 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . 0.5 ' C ' ' H ' ' B' ' 40' ' ' ARG . 32.8 tpt180 -110.68 159.4 17.63 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 104.565 -2.383 . . . . 8.6 104.565 176.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' SER . . . . . 0.663 ' HA ' ' HA ' ' B' ' 31' ' ' PRO . 24.9 m -76.37 26.92 0.12 Allowed 'General case' 0 CA--C 1.549 0.915 0 CA-C-O 122.04 0.924 . . . . 5.79 111.694 178.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . 0.5 ' H ' ' C ' ' B' ' 38' ' ' ARG . 27.8 mmt180 -149.94 155.0 39.22 Favored 'General case' 0 N--CA 1.423 -1.814 0 N-CA-C 105.184 -2.154 . . . . 6.57 105.184 -179.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . -101.66 -104.6 2.77 Favored Glycine 0 N--CA 1.401 -3.694 0 N-CA-C 110.142 -1.183 . . . . 2.62 110.142 175.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . 0.873 HD11 HD23 ' B' ' 17' ' ' LEU . 28.3 pt -84.96 -22.53 7.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 113.152 0.797 . . . . 2.28 113.152 -170.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . 0.448 ' HB ' ' CD2' ' B' ' 28' ' ' PHE . 2.9 p -58.69 -42.64 85.68 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.418 0 N-CA-C 112.399 0.518 . . . . 2.6 112.399 -177.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -83.14 -27.23 30.26 Favored 'General case' 0 N--CA 1.425 -1.681 0 N-CA-C 109.193 -0.669 . . . . 3.36 109.193 -174.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -70.01 -29.62 66.73 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 115.293 -0.867 . . . . 3.08 111.932 177.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' CYS . . . . . . . . . . . . . 36.3 t -98.07 -16.27 19.66 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 121.252 0.548 . . . . 2.23 111.058 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 42.8 t -77.3 -36.32 54.22 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.111 0.481 . . . . 2.48 110.654 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -109.81 -9.92 14.79 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 113.218 0.821 . . . . 2.97 113.218 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -135.64 151.09 49.88 Favored 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 106.037 -1.838 . . . . 4.65 106.037 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 14.7 m -76.04 117.73 18.06 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 108.981 -0.748 . . . . 2.86 108.981 -178.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 28.1 p -92.71 135.33 34.2 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 108.67 -0.863 . . . . 2.11 108.67 -176.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -87.54 139.66 30.31 Favored 'General case' 0 N--CA 1.416 -2.155 0 N-CA-C 109.03 -0.73 . . . . 2.67 109.03 177.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . 0.513 HD23 ' HB3' ' A' 1631 ' ' LYS . 61.0 tp -36.07 -39.86 0.19 Allowed 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 127.469 2.308 . . . . 2.36 113.952 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.42 -40.82 83.51 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 123.868 0.73 . . . . 1.92 111.796 -176.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 50.8 tp -58.56 -47.53 83.91 Favored 'General case' 0 C--O 1.22 -0.47 0 O-C-N 123.802 0.689 . . . . 2.35 111.03 -177.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 3.9 pp -80.45 -35.29 35.17 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 116.145 -0.479 . . . . 2.01 111.513 -174.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -67.33 -44.25 79.57 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 116.031 -0.532 . . . . 2.27 111.456 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 6.3 t -76.1 -31.29 58.62 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 119.598 -0.841 . . . . 2.67 111.251 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 59' ' ' TYR . . . . . 0.455 ' CZ ' ' HA ' ' B' ' 63' ' ' PRO . 14.8 t80 -69.12 -60.42 2.37 Favored 'General case' 0 C--O 1.244 0.775 0 N-CA-C 107.772 -1.196 . . . . 3.2 107.772 178.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 37.0 t 68.14 -64.05 0.31 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.303 1.441 . . . . 2.3 112.473 175.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -157.35 -45.88 0.07 Allowed 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 107.492 -1.299 . . . . 3.19 107.492 -176.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -62.84 132.67 94.9 Favored Pre-proline 0 N--CA 1.445 -0.699 0 CA-C-N 114.753 -1.112 . . . . 4.14 111.827 175.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . 0.455 ' HA ' ' CZ ' ' B' ' 59' ' ' TYR . 72.0 Cg_endo -82.06 -8.1 12.04 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.997 2.465 . . . . 5.59 114.833 -175.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -141.59 73.63 1.42 Allowed 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 109.194 -0.669 . . . . 5.51 109.194 178.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 3.4 tmtp? -136.96 70.17 1.41 Allowed 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 107.941 -1.133 . . . . 8.8 107.941 -178.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 11.9 p -89.65 -5.87 56.7 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 115.022 -0.99 . . . . 8.12 110.521 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 . . . . . 0 C--N 1.309 -1.167 0 CA-C-N 114.868 -1.06 . . . . 10.21 109.691 -178.201 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 50.9 tpp . . . . . 0 N--CA 1.453 -0.288 0 CA-C-O 121.407 0.622 . . . . 9.74 110.789 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 28.6 tptp -108.68 145.6 34.77 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 104.288 -2.486 . . . . 9.32 104.288 173.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1510 ' ' SER . . . . . 0.418 ' CB ' ' HB3' ' A' 1521 ' ' PRO . 35.5 m -138.39 172.76 12.42 Favored 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 119.578 -0.849 . . . . 5.97 111.138 -174.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1511 ' ' ASN . . . . . . . . . . . . . 15.4 m120 72.17 26.82 2.7 Favored 'General case' 0 C--N 1.34 0.172 0 C-N-CA 124.517 1.127 . . . . 3.48 111.977 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1512 ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -74.83 161.87 29.18 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 108.259 -1.015 . . . . 5.95 108.259 174.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 23.2 p-80 -129.96 112.68 13.75 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-O 121.446 0.641 . . . . 6.14 111.426 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 19.3 t70 -62.38 -54.23 43.44 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 114.783 -1.099 . . . . 5.06 108.187 174.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1515 ' ' ASP . . . . . 0.525 ' O ' ' HB3' ' A' 1579 ' ' LYS . 14.3 t70 -130.32 -75.29 0.54 Allowed 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 106.649 -1.612 . . . . 2.9 106.649 173.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1516 ' ' CYS . . . . . 0.471 ' SG ' HD23 ' A' 1581 ' ' LEU . 46.9 t -148.92 79.18 1.41 Allowed 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.787 -1.19 . . . . 1.41 107.787 176.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -168.07 151.04 5.68 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 105.938 -1.875 . . . . 2.18 105.938 -173.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1518 ' ' VAL . . . . . 0.461 ' CG2' HD12 ' A' 1581 ' ' LEU . 2.9 m -144.89 142.58 22.95 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-O 120.885 0.374 . . . . 1.52 111.442 -176.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1519 ' ' THR . . . . . . . . . . . . . 33.8 m -95.79 139.29 32.23 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 109.497 -0.557 . . . . 1.36 109.497 177.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -76.95 116.13 54.51 Favored Pre-proline 0 C--O 1.244 0.787 0 N-CA-C 108.501 -0.926 . . . . 2.02 108.501 176.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1521 ' ' PRO . . . . . 0.418 ' HB3' ' CB ' ' A' 1510 ' ' SER . 16.1 Cg_endo -60.81 -24.85 80.01 Favored 'Trans proline' 0 C--O 1.243 0.728 0 C-N-CA 123.43 2.753 . . . . 1.82 113.807 -177.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 33.7 m -74.33 -31.17 62.34 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 113.348 0.87 . . . . 1.89 113.348 -175.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1523 ' ' THR . . . . . . . . . . . . . 8.9 t -137.65 -10.74 1.6 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 118.617 -1.233 . . . . 1.99 113.455 -176.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 82.45 31.07 31.54 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 119.897 -1.144 . . . . 1.19 112.173 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 25.1 t-80 -97.74 131.2 44.49 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.641 -0.874 . . . . 1.82 108.641 178.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 2.8 tm? -89.67 121.71 32.1 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.718 -0.674 . . . . 1.3 111.515 -175.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -91.81 127.84 37.41 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 108.544 -0.91 . . . . 0.8 108.544 168.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 15.2 t70 -120.64 113.89 20.9 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 109.055 -0.72 . . . . 1.17 109.055 177.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 3.7 mm? -97.13 -0.25 47.32 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 121.578 0.704 . . . . 1.29 109.931 -178.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 1.5 m -65.87 -25.74 67.32 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.841 -1.072 . . . . 0.91 109.945 -178.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 40.5 t -61.09 -24.06 65.95 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 123.224 0.61 . . . . 1.98 110.816 178.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1532 ' ' LEU . . . . . 0.527 ' HB2' HG21 ' A' 1552 ' ' ILE . 73.0 mt -97.49 8.61 44.29 Favored 'General case' 0 C--N 1.32 -0.674 0 O-C-N 122.106 -0.371 . . . . 1.34 111.729 -177.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1533 ' ' SER . . . . . . . . . . . . . 77.2 p -68.66 174.19 4.48 Favored 'General case' 0 C--O 1.251 1.174 0 CA-C-O 121.454 0.645 . . . . 1.93 111.818 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . 171.81 150.9 7.43 Favored Glycine 0 N--CA 1.419 -2.493 0 N-CA-C 109.956 -1.258 . . . . 1.1 109.956 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 22.9 ttt180 -87.42 -30.0 21.04 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.08 0.467 . . . . 5.21 110.802 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -90.16 -35.82 15.17 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.579 0.704 . . . . 1.94 109.439 178.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 92.89 -150.99 20.24 Favored Glycine 0 N--CA 1.409 -3.123 0 CA-C-N 115.403 -0.817 . . . . 1.08 112.329 173.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -128.82 153.33 47.54 Favored 'General case' 0 C--N 1.281 -2.396 0 N-CA-C 106.435 -1.691 . . . . 1.07 106.435 -178.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 4.1 m -128.46 134.79 48.83 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 109.399 -0.593 . . . . 1.46 109.399 -175.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1540 ' ' ALA . . . . . 0.589 ' HB1' HG11 ' A' 1548 ' ' VAL . . . -129.93 143.61 50.89 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 115.758 -0.656 . . . . 1.19 109.488 -177.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -88.99 121.4 31.31 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.346 0.593 . . . . 1.37 110.517 -177.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1542 ' ' TYR . . . . . 0.597 ' CE2' ' HG ' ' A' 1626 ' ' LEU . 0.9 OUTLIER -111.49 -101.86 0.4 Allowed 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.464 -1.31 . . . . 1.38 107.464 -179.326 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A 1543 ' ' SER . . . . . 0.466 ' H ' ' HB3' ' A' 1542 ' ' TYR . 7.7 m -73.34 162.5 29.26 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 118.984 -0.532 . . . . 1.98 109.941 178.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -50.17 -42.93 51.95 Favored 'General case' 0 C--O 1.25 1.091 0 N-CA-C 113.388 0.884 . . . . 3.96 113.388 -178.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 23.3 t -100.67 15.1 29.33 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 110.516 -0.179 . . . . 2.81 110.516 -178.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . -132.7 131.29 6.12 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 118.81 -1.662 . . . . 1.68 116.726 -170.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 15.1 m -121.39 149.83 24.49 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 108.794 -0.817 . . . . 1.38 108.794 171.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1548 ' ' VAL . . . . . 0.589 HG11 ' HB1' ' A' 1540 ' ' ALA . 7.8 p -104.87 137.74 32.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 109.319 -0.622 . . . . 1.24 109.319 177.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -103.86 126.95 51.35 Favored 'General case' 0 N--CA 1.424 -1.755 0 CA-C-N 115.642 -0.708 . . . . 1.29 109.15 175.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1550 ' ' MET . . . . . 0.414 ' HB2' ' HE2' ' A' 1550 ' ' MET . 5.5 ppp? -144.24 138.5 28.04 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 115.082 -0.963 . . . . 1.47 110.27 -175.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 7.1 p -125.48 134.41 52.06 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 115.926 -0.579 . . . . 1.4 109.855 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1552 ' ' ILE . . . . . 0.527 HG21 ' HB2' ' A' 1532 ' ' LEU . 49.5 mm -82.24 114.94 23.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-N 116.625 -0.261 . . . . 1.11 111.36 -177.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 74.8 m 71.33 16.51 6.09 Favored 'General case' 0 CA--C 1.509 -0.6 0 C-N-CA 124.036 0.934 . . . . 1.4 113.057 171.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . -163.17 -175.26 33.99 Favored Glycine 0 N--CA 1.403 -3.5 0 C-N-CA 120.127 -1.035 . . . . 0.4 110.98 -176.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -91.36 148.57 22.23 Favored 'General case' 0 C--N 1.282 -2.351 0 C-N-CA 124.102 0.961 . . . . 1.62 111.755 -176.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 46.2 t-20 -114.46 129.85 56.68 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.729 -1.212 . . . . 1.12 107.729 178.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -79.93 2.18 24.48 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.025 0.75 . . . . 2.49 113.025 -173.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -74.24 -16.68 60.95 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 112.37 0.507 . . . . 1.38 112.37 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1559 ' ' CYS . . . . . 0.711 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 88.9 m -137.75 173.49 5.34 Favored Pre-proline 0 C--N 1.306 -1.289 0 CA-C-O 117.811 -1.09 . . . . 1.21 111.003 179.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1560 ' ' PRO . . . . . 0.711 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 7.3 Cg_exo -31.83 131.59 0.08 OUTLIER 'Trans proline' 0 C--N 1.393 2.917 0 C-N-CA 124.801 3.668 . . . . 0.98 114.735 177.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -48.56 125.75 13.04 Favored 'Trans proline' 0 C--O 1.25 1.08 0 C-N-CA 124.553 3.502 . . . . 1.15 114.452 -174.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 93.88 23.94 21.61 Favored Glycine 0 N--CA 1.432 -1.575 0 CA-C-N 115.284 -0.871 . . . . 0.55 112.451 178.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1563 ' ' VAL . . . . . 0.486 HG13 ' HB2' ' A' 1559 ' ' CYS . 4.0 p -109.6 139.85 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 C-N-CA 119.773 -0.771 . . . . 1.53 110.543 -177.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -104.41 -27.29 6.18 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 121.156 -0.545 . . . . 0.29 113.279 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -135.46 129.95 33.99 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 117.144 0.472 . . . . 1.08 110.188 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 31.7 t -160.3 137.61 9.42 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 122.465 0.306 . . . . 0.43 110.48 -178.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1567 ' ' PHE . . . . . 0.402 ' HA ' ' HA ' ' A' 1548 ' ' VAL . 76.2 m-85 -85.62 138.88 31.85 Favored 'General case' 0 C--O 1.247 0.963 0 N-CA-C 108.142 -1.058 . . . . 1.3 108.142 173.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -82.36 38.19 2.6 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.937 -0.649 . . . . 1.43 112.92 -176.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1569 ' ' GLN . . . . . 0.506 ' HB3' ' OD1' ' B' ' 15' ' ' ASP . 16.4 mm100 -83.48 -72.3 0.46 Allowed 'General case' 0 N--CA 1.443 -0.804 0 CA-C-O 121.045 0.45 . . . . 3.09 110.341 176.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 5.5 t -132.44 34.24 3.74 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-O 122.194 0.997 . . . . 2.52 109.217 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 61.32 55.86 2.8 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 124.902 1.281 . . . . 3.19 110.029 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 19.6 mt -97.17 114.37 34.01 Favored 'Isoleucine or valine' 0 C--O 1.244 0.805 0 N-CA-C 109.211 -0.662 . . . . 1.51 109.211 -177.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1573 ' ' SER . . . . . 0.72 ' HB3' ' HB2' ' A' 1596 ' ' SER . 19.5 t -74.39 130.73 40.2 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.552 0.692 . . . . 0.96 110.918 -178.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1574 ' ' VAL . . . . . 0.55 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 34.8 m -123.41 10.93 5.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 CA-C-O 121.33 0.586 . . . . 1.6 110.607 177.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 177.4 118.95 0.57 Allowed Glycine 0 N--CA 1.428 -1.852 0 C-N-CA 120.589 -0.815 . . . . 0.34 111.652 177.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -74.62 148.32 40.81 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.978 -1.119 . . . . 2.68 107.978 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -75.74 83.98 2.72 Favored 'General case' 0 CA--C 1.499 -0.998 0 CA-C-O 121.456 0.646 . . . . 1.08 111.756 -175.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1578 ' ' ASN . . . . . 0.429 ' O ' ' HE1' ' A' 1592 ' ' TYR . 86.5 m-20 -99.06 166.04 11.45 Favored 'General case' 0 C--N 1.281 -2.39 0 N-CA-C 108.213 -1.032 . . . . 1.95 108.213 178.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1579 ' ' LYS . . . . . 0.525 ' HB3' ' O ' ' A' 1515 ' ' ASP . 67.3 mttm -120.32 42.09 3.06 Favored 'General case' 0 C--N 1.286 -2.158 0 CA-C-O 122.601 1.191 . . . . 3.11 107.869 -176.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 43.5 ttt180 -93.65 75.84 4.34 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 114.188 -1.369 . . . . 4.04 108.41 -173.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1581 ' ' LEU . . . . . 0.471 HD23 ' SG ' ' A' 1516 ' ' CYS . 0.6 OUTLIER -84.3 125.07 31.92 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 113.549 -1.66 . . . . 1.32 108.196 -178.566 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 60.8 mtm180 -125.73 138.51 53.87 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 116.457 -0.338 . . . . 3.4 111.289 178.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1583 ' ' TYR . . . . . 0.433 ' HE1' ' HA ' ' A' 1586 ' ' GLN . 48.5 t80 -112.86 110.41 20.49 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 122.31 0.244 . . . . 1.26 110.48 -178.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1584 ' ' VAL . . . . . 0.559 ' O ' ' HB ' ' A' 1587 ' ' VAL . 15.4 m -129.69 93.23 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.265 0.555 . . . . 1.71 112.431 -178.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 26.9 t70 59.75 65.94 1.06 Allowed 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 123.805 0.842 . . . . 1.17 111.137 174.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1586 ' ' GLN . . . . . 0.433 ' HA ' ' HE1' ' A' 1583 ' ' TYR 0.254 8.7 pt20 66.1 5.43 3.56 Favored 'General case' 0 N--CA 1.503 2.197 0 C-N-CA 127.163 2.185 . . . . 2.43 112.11 178.482 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A 1587 ' ' VAL . . . . . 0.559 ' HB ' ' O ' ' A' 1584 ' ' VAL . 36.0 t -104.0 120.14 53.75 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.749 0 CA-C-N 114.789 -1.096 . . . . 1.16 109.378 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1588 ' ' LEU . . . . . 0.807 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 2.6 mm? -96.16 107.58 19.93 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 106.135 -1.802 . . . . 1.11 106.135 176.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1589 ' ' GLN . . . . . 0.481 ' HA ' ' O ' ' A' 1610 ' ' ILE . 27.8 tt0 -107.96 116.45 31.99 Favored 'General case' 0 N--CA 1.409 -2.49 0 CA-C-O 121.955 0.883 . . . . 1.74 110.368 -176.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1590 ' ' LEU . . . . . 0.436 ' HB3' ' HB ' ' A' 1610 ' ' ILE . 1.1 tt -107.64 107.42 18.22 Favored 'General case' 0 C--N 1.28 -2.418 0 N-CA-C 105.009 -2.219 . . . . 1.4 105.009 -178.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 4.2 p -101.72 129.63 52.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 C-N-CA 119.572 -0.851 . . . . 1.7 111.403 -174.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1592 ' ' TYR . . . . . 0.429 ' HE1' ' O ' ' A' 1578 ' ' ASN . 15.1 m-85 -119.4 105.74 11.58 Favored 'General case' 0 CA--C 1.496 -1.118 0 N-CA-C 108.502 -0.925 . . . . 1.08 108.502 177.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1593 ' ' LYS . . . . . 0.633 ' HB3' ' HD3' ' A' 1607 ' ' LYS . 18.4 pttp -126.43 174.76 8.38 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 109.428 -0.582 . . . . 2.21 109.428 -179.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 9.8 m-20 58.98 36.79 24.59 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 124.677 1.235 . . . . 1.11 110.996 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -73.52 -88.08 0.19 Allowed Glycine 0 N--CA 1.44 -1.082 0 N-CA-C 110.412 -1.075 . . . . 0.78 110.412 178.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1596 ' ' SER . . . . . 0.72 ' HB2' ' HB3' ' A' 1573 ' ' SER . 47.0 t -132.25 144.73 54.31 Favored Pre-proline 0 N--CA 1.416 -2.139 0 N-CA-C 107.788 -1.19 . . . . 1.36 107.788 175.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1597 ' ' PRO . . . . . 0.548 ' HA ' ' HA ' ' A' 1605 ' ' SER . 18.0 Cg_endo -58.89 130.78 38.33 Favored 'Trans proline' 0 C--O 1.24 0.578 0 C-N-CA 123.829 3.019 . . . . 1.4 112.462 179.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1598 ' ' CYS . . . . . 0.437 ' SG ' ' HB2' ' A' 1600 ' ' SER . 47.4 t -72.65 120.53 81.18 Favored Pre-proline 0 C--N 1.289 -2.041 0 CA-C-N 114.516 -1.22 . . . . 0.75 109.309 -174.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -65.13 -32.32 52.86 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.684 2.256 . . . . 1.7 110.635 178.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1600 ' ' SER . . . . . 0.789 ' HB3' HD13 ' B' ' 53' ' ' LEU . 7.1 m -64.47 -45.97 85.07 Favored 'General case' 0 N--CA 1.419 -1.983 0 CA-C-N 115.297 -0.865 . . . . 2.8 110.713 176.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1601 ' ' LYS . . . . . 0.562 ' HG2' HD21 ' A' 1604 ' ' LEU . 0.0 OUTLIER -121.9 93.54 4.03 Favored 'General case' 0 N--CA 1.429 -1.513 0 O-C-N 121.374 -0.828 . . . . 3.45 108.919 -178.942 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 7.0 m -55.8 125.04 19.6 Favored 'General case' 0 N--CA 1.426 -1.646 0 C-N-CA 124.316 1.046 . . . . 2.44 111.28 -177.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 106.03 -8.5 42.25 Favored Glycine 0 C--N 1.313 -0.702 0 C-N-CA 121.126 -0.559 . . . . 1.2 114.403 174.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1604 ' ' LEU . . . . . 0.562 HD21 ' HG2' ' A' 1601 ' ' LYS . 4.2 pp -128.35 155.7 44.27 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-N 118.218 1.009 . . . . 2.38 110.237 176.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1605 ' ' SER . . . . . 0.548 ' HA ' ' HA ' ' A' 1597 ' ' PRO . 7.7 p -103.19 152.83 21.0 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 123.042 0.537 . . . . 1.96 111.357 -176.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1606 ' ' TYR . . . . . 0.55 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 58.5 m-85 -63.34 161.3 14.28 Favored 'General case' 0 C--O 1.25 1.083 0 CA-C-N 116.4 -0.364 . . . . 1.06 110.906 175.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1607 ' ' LYS . . . . . 0.633 ' HD3' ' HB3' ' A' 1593 ' ' LYS . 24.5 ttpp -155.89 125.4 6.31 Favored 'General case' 0 CA--C 1.5 -0.968 0 CA-C-N 116.291 -0.413 . . . . 2.0 110.333 -178.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1608 ' ' SER . . . . . . . . . . . . . 22.3 m -105.4 127.04 52.77 Favored 'General case' 0 C--N 1.286 -2.185 0 N-CA-C 108.444 -0.947 . . . . 1.61 108.444 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 39.6 t -111.0 108.72 26.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 109.183 -0.673 . . . . 1.09 109.183 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1610 ' ' ILE . . . . . 0.481 ' O ' ' HA ' ' A' 1589 ' ' GLN . 25.7 mm -89.67 123.41 41.86 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 106.776 -1.564 . . . . 1.2 106.776 -178.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 21.5 p -122.09 105.42 10.26 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 120.517 -0.473 . . . . 1.89 111.031 177.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1612 ' ' PHE . . . . . 0.807 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 68.1 m-85 -86.16 119.69 26.72 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.71 -0.848 . . . . 0.28 108.71 177.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 45.9 t -114.2 134.53 56.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 108.514 -0.921 . . . . 1.23 108.514 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 12.2 t -59.64 114.74 2.89 Favored 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 123.964 0.906 . . . . 0.77 112.403 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1615 ' ' ARG . . . . . 0.73 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 0.0 OUTLIER -132.2 89.52 37.23 Favored Pre-proline 0 N--CA 1.446 -0.66 0 N-CA-C 106.967 -1.494 . . . . 2.92 106.967 172.783 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A 1616 ' ' PRO . . . . . 0.538 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 34.4 Cg_exo -59.46 -32.84 97.04 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 123.077 2.518 . . . . 1.22 114.629 -173.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -77.23 -5.49 49.49 Favored 'General case' 0 C--O 1.252 1.228 0 N-CA-C 111.931 0.345 . . . . 3.05 111.931 -178.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . 58.49 -143.11 0.64 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.23 0.612 . . . . 1.55 109.98 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . 110.47 -157.64 14.89 Favored Glycine 0 N--CA 1.416 -2.681 0 CA-C-N 119.532 1.06 . . . . 1.16 111.821 178.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -80.55 13.63 2.22 Favored 'Trans proline' 0 C--N 1.323 -0.799 0 C-N-CA 123.455 2.77 . . . . 1.06 113.249 -177.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1621 ' ' THR . . . . . 0.883 ' HB ' ' HB2' ' A' 1641 ' ' HIS . 36.2 p -96.16 -14.46 22.77 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 115.48 -0.782 . . . . 1.58 110.049 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1622 ' ' ASN . . . . . 0.417 ' OD1' ' HB ' ' A' 1642 ' ' THR . 55.1 t30 -88.73 62.66 6.55 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 122.057 0.932 . . . . 0.88 110.148 -175.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 6.7 ptp180 -168.53 139.73 2.15 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-N 114.155 -1.384 . . . . 3.82 108.169 -178.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -63.35 119.1 6.03 Favored 'Trans proline' 0 C--O 1.25 1.111 0 C-N-CA 122.762 2.308 . . . . 0.77 113.353 -174.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 76.8 mtm -116.68 138.44 51.45 Favored 'General case' 0 C--O 1.245 0.865 0 N-CA-C 108.79 -0.819 . . . . 1.43 108.79 175.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1626 ' ' LEU . . . . . 0.597 ' HG ' ' CE2' ' A' 1542 ' ' TYR . 0.4 OUTLIER -88.16 118.71 27.93 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 107.661 -1.237 . . . . 1.43 107.661 -176.455 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A 1627 ' ' ILE . . . . . 0.635 HD12 ' HB2' ' A' 1639 ' ' SER . 33.3 mm -78.3 -53.18 14.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.392 -0.596 . . . . 1.23 109.392 -178.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 8.4 t -167.85 152.08 6.42 Favored 'General case' 0 N--CA 1.416 -2.136 0 N-CA-C 108.652 -0.87 . . . . 1.88 108.652 -174.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1629 ' ' LEU . . . . . 0.78 HD22 ' HG ' ' A' 1636 ' ' LEU . 1.8 tm? -121.64 102.17 8.06 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 105.741 -1.948 . . . . 1.92 105.741 176.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 31.9 t70 -70.63 124.18 23.64 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 120.118 -0.633 . . . . 1.09 109.784 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1631 ' ' LYS . . . . . 0.471 ' HZ3' ' CD ' ' B' ' 57' ' ' GLU . 16.6 ptpt -79.38 -10.89 59.9 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 112.654 0.612 . . . . 3.98 112.654 -171.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -100.62 -34.71 9.77 Favored 'General case' 0 N--CA 1.421 -1.878 0 C-N-CA 120.221 -0.592 . . . . 2.6 111.515 -175.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 40.8 p -103.3 -6.86 21.58 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.05 0.452 . . . . 1.35 111.795 177.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 78.7 m 56.37 35.97 26.75 Favored 'General case' 0 C--N 1.361 1.085 0 C-N-CA 124.396 1.078 . . . . 0.53 111.982 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1635 ' ' THR . . . . . . . . . . . . . 59.5 m -99.54 132.08 45.11 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-N 114.218 -1.355 . . . . 1.11 109.996 178.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1636 ' ' LEU . . . . . 0.78 ' HG ' HD22 ' A' 1629 ' ' LEU . 0.8 OUTLIER -108.53 132.51 53.76 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.861 -1.533 . . . . 1.56 106.861 -178.39 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -107.04 135.56 48.38 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 110.153 -0.314 . . . . 0.54 110.153 179.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -128.59 129.17 45.55 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.069 -0.514 . . . . 0.64 110.09 -175.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1639 ' ' SER . . . . . 0.635 ' HB2' HD12 ' A' 1627 ' ' ILE . 22.7 t -108.48 149.38 28.87 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.445 -0.946 . . . . 1.34 108.445 178.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 2.1 t90 -156.46 115.74 3.47 Favored 'General case' 0 N--CA 1.425 -1.714 0 N-CA-C 105.032 -2.21 . . . . 0.8 105.032 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1641 ' ' HIS . . . . . 0.883 ' HB2' ' HB ' ' A' 1621 ' ' THR . 18.9 m-70 -112.86 107.91 16.68 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 120.528 -0.469 . . . . 1.14 110.257 -177.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1642 ' ' THR . . . . . 0.417 ' HB ' ' OD1' ' A' 1622 ' ' ASN . 7.3 t -138.19 152.01 70.84 Favored Pre-proline 0 C--N 1.296 -1.727 0 CA-C-N 114.744 -1.116 . . . . 1.11 109.63 -171.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1643 ' ' PRO . . . . . 0.538 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 74.1 Cg_endo -79.49 -7.98 14.87 Favored 'Trans proline' 0 C--N 1.372 1.767 0 C-N-CA 122.496 2.131 . . . . 0.78 112.167 177.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 8.7 tt -68.11 -23.1 64.88 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-O 121.491 0.662 . . . . 1.66 109.549 177.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -93.51 5.65 50.87 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.706 -0.679 . . . . 1.29 110.948 -177.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1646 ' ' CYS . . . . . 0.441 ' SG ' ' HA ' ' A' 1643 ' ' PRO . 72.2 m -93.82 142.77 26.99 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 120.804 0.335 . . . . 1.48 111.501 -177.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -93.2 149.23 37.09 Favored Pre-proline 0 C--N 1.297 -1.687 0 C-N-CA 123.691 0.796 . . . . 3.14 108.887 178.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1648 ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -59.31 112.44 1.24 Allowed 'Trans proline' 0 C--O 1.238 0.521 0 C-N-CA 123.063 2.508 . . . . 2.92 111.803 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 34.8 tt0 . . . . . 0 C--O 1.254 1.316 0 O-C-N 124.631 1.207 . . . . 4.72 109.608 179.608 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.301 0 CA-C-O 121.335 0.588 . . . . 10.26 109.814 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -110.27 130.1 55.61 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.059 0.457 . . . . 7.94 110.268 -177.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' ARG . . . . . 0.532 ' HD3' HD21 ' B' ' 8' ' ' LEU . 14.7 ptp180 -112.72 147.24 36.71 Favored Pre-proline 0 C--N 1.302 -1.47 0 N-CA-C 107.944 -1.132 . . . . 6.56 107.944 177.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -80.09 15.11 1.76 Allowed 'Trans proline' 0 C--O 1.244 0.802 0 C-N-CA 123.136 2.557 . . . . 5.51 113.933 -174.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 50.7 m -140.4 117.43 11.16 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 115.461 -0.79 . . . . 4.91 109.973 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -86.09 -35.96 19.92 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.757 -0.831 . . . . 4.23 108.757 174.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 17.3 p -110.05 99.33 8.44 Favored 'General case' 0 N--CA 1.424 -1.739 0 N-CA-C 106.073 -1.825 . . . . 3.48 106.073 168.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . 0.532 HD21 ' HD3' ' B' ' 3' ' ' ARG . 5.4 mp -79.37 103.68 9.47 Favored 'General case' 0 C--O 1.247 0.942 0 N-CA-C 113.025 0.75 . . . . 4.35 113.025 -170.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 83.3 m -84.98 146.76 27.05 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-O 120.839 0.352 . . . . 2.84 110.454 177.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.77 -62.64 0.3 Allowed Glycine 0 N--CA 1.426 -2.003 0 N-CA-C 111.278 -0.729 . . . . 2.28 111.278 178.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -101.03 -64.18 0.78 Allowed Glycine 0 C--N 1.306 -1.134 0 N-CA-C 115.03 0.772 . . . . 1.94 115.03 -177.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . 0.503 ' HG3' HD23 ' B' ' 8' ' ' LEU . 25.8 mm-40 -71.07 -45.08 64.42 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.894 0.702 . . . . 2.55 112.894 -170.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 12.5 tp -45.52 -57.88 3.8 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 123.729 0.643 . . . . 2.82 112.562 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 13.2 p -70.89 -31.35 45.2 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 CA-C-N 115.726 -0.67 . . . . 2.5 111.386 -177.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' ASP . . . . . 0.506 ' OD1' ' HB3' ' A' 1569 ' ' GLN . 3.3 t0 -72.95 -40.53 65.3 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 119.271 -0.972 . . . . 2.04 111.766 -176.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 12.4 t -65.0 -32.09 73.65 Favored 'General case' 0 C--O 1.254 1.293 0 O-C-N 121.302 -0.874 . . . . 2.31 109.773 176.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.522 ' O ' ' HB2' ' B' ' 21' ' ' CYS . 9.5 mt -67.05 -23.03 65.84 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-N 115.663 -0.699 . . . . 2.27 112.58 172.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -91.47 -17.7 25.32 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 121.643 0.735 . . . . 2.39 109.552 176.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -68.64 -60.23 2.56 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.819 -0.628 . . . . 1.0 111.699 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 12.5 p -94.43 -20.28 6.21 Favored 'Isoleucine or valine' 0 C--O 1.242 0.671 0 C-N-CA 118.128 -1.429 . . . . 1.83 111.841 -178.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' CYS . . . . . 0.522 ' HB2' ' O ' ' B' ' 17' ' ' LEU . 7.7 m -107.07 18.3 21.92 Favored 'General case' 0 C--O 1.201 -1.453 0 C-N-CA 120.022 -0.671 . . . . 1.66 109.822 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.53 -44.65 97.5 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 115.702 1.041 . . . . 1.53 115.702 -178.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -76.46 -48.5 19.41 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 117.483 0.642 . . . . 2.72 111.62 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . 0.624 ' HE ' ' HB3' ' B' ' 61' ' ' ALA . 35.9 ttp180 -73.84 -25.35 60.03 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.316 0.579 . . . . 5.02 111.746 -175.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . 0.516 ' O ' ' HB1' ' B' ' 61' ' ' ALA . . . 110.16 144.15 10.09 Favored Glycine 0 N--CA 1.425 -2.062 0 N-CA-C 110.9 -0.88 . . . . 1.63 110.9 177.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -88.1 124.09 33.44 Favored 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 120.035 -0.666 . . . . 1.71 109.354 175.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' TYR . . . . . 0.629 ' HB2' ' HA ' ' B' ' 61' ' ' ALA . 27.7 m-85 -128.55 76.61 1.72 Allowed 'General case' 0 CA--C 1.497 -1.081 0 CA-C-O 121.618 0.723 . . . . 3.67 110.418 -173.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -114.12 8.65 17.03 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 115.455 -0.793 . . . . 2.44 110.808 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 7.4 p -107.05 46.26 0.94 Allowed 'General case' 0 N--CA 1.423 -1.786 0 CA-C-N 115.061 -0.972 . . . . 3.85 109.289 177.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 22.6 mmm180 -122.39 107.11 34.85 Favored Pre-proline 0 C--O 1.214 -0.772 0 N-CA-C 107.302 -1.37 . . . . 4.27 107.302 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . 0.608 ' HA ' ' O ' ' B' ' 39' ' ' SER . 2.6 Cg_endo -98.7 12.38 0.74 Allowed 'Trans proline' 0 C--O 1.249 1.069 0 C-N-CA 122.919 2.413 . . . . 4.2 113.208 178.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' ALA . . . . . 0.591 ' HB2' ' HB3' ' B' ' 38' ' ' ARG . . . 68.19 -0.54 2.1 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.917 1.687 . . . . 5.12 114.508 177.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 44.6 t 173.55 -177.98 0.08 Allowed 'General case' 0 N--CA 1.416 -2.172 0 N-CA-C 103.973 -2.602 . . . . 6.93 103.973 -178.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 61.3 ttt180 -102.34 10.09 39.38 Favored 'General case' 0 C--N 1.28 -2.439 0 CA-C-O 122.18 0.99 . . . . 12.14 109.095 -177.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . 0.438 ' C ' ' HG ' ' B' ' 36' ' ' SER . 22.5 t -91.87 -10.67 9.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 122.424 1.106 . . . . 9.9 108.105 173.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' SER . . . . . 0.456 ' HA ' ' HB2' ' B' ' 31' ' ' PRO . 87.4 p 59.01 33.21 22.89 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 125.903 1.681 . . . . 6.82 113.963 172.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 18.2 mmt180 -73.13 -53.56 10.71 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.648 -0.705 . . . . 10.71 112.611 177.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . 0.591 ' HB3' ' HB2' ' B' ' 32' ' ' ALA . 60.4 ttt180 -89.52 86.66 6.81 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 120.939 -0.304 . . . . 8.6 110.573 -175.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' SER . . . . . 0.608 ' O ' ' HA ' ' B' ' 31' ' ' PRO . 16.6 m 67.15 87.17 0.12 Allowed 'General case' 0 C--O 1.204 -1.323 0 CA-C-N 114.947 -1.024 . . . . 5.79 111.992 177.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . 0.48 ' HD2' ' HB3' ' B' ' 44' ' ' GLU . 0.1 OUTLIER -64.18 -2.97 2.35 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 113.046 0.758 . . . . 6.57 113.046 179.543 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 126.97 119.66 2.28 Favored Glycine 1 N--CA 1.387 -4.6 0 N-CA-C 107.653 -2.179 . . . . 2.62 107.653 -174.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . 0.438 ' HA ' ' CB ' ' B' ' 45' ' ' GLU . 33.4 pt -69.93 -4.61 4.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 111.943 0.349 . . . . 2.28 111.943 -175.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 2.5 p -52.81 -40.63 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 CA-C-N 115.661 -0.699 . . . . 2.6 110.08 169.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' GLU . . . . . 0.48 ' HB3' ' HD2' ' B' ' 40' ' ' ARG . 28.1 tt0 -92.51 -19.28 22.14 Favored 'General case' 0 N--CA 1.419 -2.003 0 O-C-N 121.294 -0.879 . . . . 3.36 108.941 -175.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . 0.438 ' CB ' ' HA ' ' B' ' 42' ' ' ILE . 6.4 tp10 -81.28 -2.47 49.06 Favored 'General case' 0 CA--C 1.555 1.161 0 CA-C-N 114.46 -1.245 . . . . 3.08 109.517 -178.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' CYS . . . . . . . . . . . . . 88.8 m -133.84 -20.3 1.99 Allowed 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.249 0.833 . . . . 2.23 113.249 178.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 98.4 m -80.94 -9.84 59.79 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 119.576 -0.85 . . . . 2.48 113.178 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -133.7 20.5 3.88 Favored 'General case' 0 C--N 1.319 -0.727 0 O-C-N 121.498 -0.751 . . . . 2.97 111.773 178.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -169.68 174.7 5.66 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 106.772 -1.566 . . . . 4.65 106.772 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 22.8 t -101.0 143.69 30.84 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-O 121.444 0.64 . . . . 2.86 110.763 -174.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 26.4 p -145.0 151.09 38.03 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-N 115.44 -0.8 . . . . 2.11 108.908 178.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' 1600 ' ' SER . 4.4 p-10 -127.55 -173.99 3.06 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.6 -0.727 . . . . 2.67 109.232 174.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . 0.789 HD13 ' HB3' ' A' 1600 ' ' SER . 46.3 tp -35.58 -39.88 0.15 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 128.088 2.555 . . . . 2.36 115.503 -174.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -49.32 -59.39 3.74 Favored 'General case' 0 CA--C 1.502 -0.888 0 C-N-CA 123.865 0.866 . . . . 1.92 112.129 -172.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 67.6 tp -59.78 -41.78 91.86 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 125.132 1.373 . . . . 2.35 112.803 -176.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 2.6 pp -83.54 -22.48 32.38 Favored 'General case' 0 N--CA 1.422 -1.827 0 C-N-CA 118.654 -1.219 . . . . 2.01 112.257 -173.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . 0.471 ' CD ' ' HZ3' ' A' 1631 ' ' LYS . 36.5 tt0 -86.48 -33.7 20.27 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 119.397 -0.921 . . . . 2.27 111.186 173.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 18.0 p -60.56 -44.01 96.65 Favored 'General case' 0 C--N 1.357 0.916 0 CA-C-N 118.02 0.373 . . . . 2.67 110.08 176.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -82.16 -81.55 0.15 Allowed 'General case' 0 N--CA 1.428 -1.528 0 C-N-CA 119.507 -0.877 . . . . 3.2 109.505 173.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 41.3 t 58.47 -77.37 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.69 0.796 . . . . 2.3 111.652 -178.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 61' ' ' ALA . . . . . 0.629 ' HA ' ' HB2' ' B' ' 27' ' ' TYR . . . -162.3 168.96 21.44 Favored 'General case' 0 N--CA 1.42 -1.97 0 N-CA-C 106.568 -1.641 . . . . 3.19 106.568 -178.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 14.6 p -99.66 137.45 20.24 Favored Pre-proline 0 C--N 1.275 -2.657 0 CA-C-O 120.852 0.358 . . . . 4.14 110.037 178.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -75.99 -12.45 19.62 Favored 'Trans proline' 0 CA--C 1.53 0.283 0 C-N-CA 122.851 2.367 . . . . 5.59 111.497 178.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -137.72 97.25 3.39 Favored 'General case' 0 N--CA 1.419 -1.981 0 N-CA-C 105.498 -2.038 . . . . 5.51 105.498 175.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -63.33 149.31 46.06 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.766 -1.107 . . . . 8.8 110.012 -175.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 6.8 t -105.94 150.44 25.67 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 106.774 -1.565 . . . . 8.12 106.774 178.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.299 -1.612 0 N-CA-C 109.98 -0.378 . . . . 10.21 109.98 177.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 24.7 ptm . . . . . 0 C--O 1.236 0.39 0 N-CA-C 109.854 -0.424 . . . . 9.74 109.854 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 63.7 mttp -82.58 65.71 7.84 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.555 0.693 . . . . 9.32 111.944 -178.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 27.3 m -98.42 -26.86 14.33 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.299 -1.0 . . . . 5.97 108.299 174.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1511 ' ' ASN . . . . . . . . . . . . . 14.4 m120 -87.51 -16.26 35.21 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.785 -1.098 . . . . 3.48 110.191 178.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1512 ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -117.04 140.49 49.42 Favored 'General case' 0 N--CA 1.41 -2.474 0 N-CA-C 107.166 -1.42 . . . . 5.95 107.166 179.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 21.8 t60 -155.25 -25.06 0.11 Allowed 'General case' 0 C--N 1.283 -2.301 0 CA-C-N 116.273 -0.421 . . . . 6.14 109.988 -173.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 30.8 t70 -163.79 -68.5 0.04 OUTLIER 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 109.536 -0.542 . . . . 5.06 109.536 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 12.7 t70 -144.88 -74.49 0.24 Allowed 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 106.857 -1.535 . . . . 2.9 106.857 177.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 12.9 m -139.84 81.77 1.84 Allowed 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.546 -0.752 . . . . 1.41 110.204 173.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -162.65 130.34 3.8 Favored 'General case' 0 N--CA 1.417 -2.106 0 N-CA-C 108.19 -1.041 . . . . 2.18 108.19 -179.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1518 ' ' VAL . . . . . 0.59 ' CG2' HD13 ' A' 1581 ' ' LEU . 4.3 m -129.72 136.97 57.9 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.125 0 CA-C-O 121.276 0.56 . . . . 1.52 110.789 -176.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1519 ' ' THR . . . . . 0.455 ' OG1' HD22 ' A' 1526 ' ' LEU . 23.8 m -112.33 132.42 54.99 Favored 'General case' 0 C--N 1.286 -2.164 0 CA-C-N 115.584 -0.734 . . . . 1.36 109.398 -178.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1520 ' ' ASN . . . . . 0.424 ' OD1' ' HB2' ' A' 1522 ' ' SER . 27.0 t-20 -86.8 110.19 30.45 Favored Pre-proline 0 N--CA 1.423 -1.804 0 N-CA-C 107.845 -1.168 . . . . 2.02 107.845 174.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -68.54 -16.29 42.58 Favored 'Trans proline' 0 N--CA 1.466 -0.136 0 C-N-CA 122.852 2.368 . . . . 1.82 112.775 -174.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1522 ' ' SER . . . . . 0.424 ' HB2' ' OD1' ' A' 1520 ' ' ASN . 15.2 m -71.76 -31.63 66.85 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 116.042 -0.526 . . . . 1.89 111.458 -178.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1523 ' ' THR . . . . . 0.413 HG22 ' OD1' ' A' 1520 ' ' ASN . 7.5 t -132.99 -4.06 3.14 Favored 'General case' 0 CA--C 1.56 1.345 0 C-N-CA 119.377 -0.929 . . . . 1.99 112.675 179.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 77.39 20.79 74.22 Favored Glycine 0 CA--C 1.497 -1.037 0 O-C-N 121.898 -0.501 . . . . 1.19 113.089 177.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -87.75 118.2 27.1 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 109.006 -0.739 . . . . 1.82 109.006 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1526 ' ' LEU . . . . . 0.455 HD22 ' OG1' ' A' 1519 ' ' THR . 1.0 OUTLIER -100.12 114.81 28.44 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-N 114.22 -1.355 . . . . 1.3 110.458 -175.153 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -93.75 113.61 25.71 Favored 'General case' 0 CA--C 1.508 -0.665 0 N-CA-C 109.375 -0.602 . . . . 0.8 109.375 176.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 19.9 t70 -104.4 119.17 38.37 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 120.073 -0.651 . . . . 1.17 110.487 175.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1529 ' ' LEU . . . . . 0.712 ' HG ' HD21 ' A' 1581 ' ' LEU . 3.0 mm? -104.23 1.96 31.11 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.751 -0.659 . . . . 1.29 109.645 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 3.1 m -67.07 -24.42 65.97 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 108.641 -0.874 . . . . 0.91 108.641 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 22.8 t -61.18 -27.11 68.18 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 115.093 -0.958 . . . . 1.98 110.295 175.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 81.9 mt -95.28 0.67 54.05 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 122.094 -0.379 . . . . 1.34 111.691 -177.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1533 ' ' SER . . . . . 0.524 ' HA ' ' O ' ' A' 1552 ' ' ILE . 34.3 t -70.94 171.04 11.46 Favored 'General case' 0 C--O 1.26 1.646 0 CA-C-O 121.577 0.703 . . . . 1.93 111.405 -178.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . 170.56 152.03 7.86 Favored Glycine 0 N--CA 1.43 -1.739 0 CA-C-N 115.278 -0.874 . . . . 1.1 111.423 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 23.2 ttt180 -89.37 -32.75 17.15 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 123.682 0.793 . . . . 5.21 110.524 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -83.59 -34.27 25.18 Favored 'General case' 0 C--O 1.245 0.816 0 CA-C-O 121.606 0.717 . . . . 1.94 109.41 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 92.24 -150.04 19.96 Favored Glycine 0 N--CA 1.415 -2.707 0 CA-C-N 115.057 -0.974 . . . . 1.08 111.905 174.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -138.06 152.22 48.61 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 107.338 -1.356 . . . . 1.07 107.338 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 2.6 p -108.19 128.47 54.74 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 123.628 0.58 . . . . 1.46 110.673 179.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1540 ' ' ALA . . . . . 0.475 ' HB2' ' CG1' ' A' 1548 ' ' VAL . . . -117.31 140.93 48.93 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.31 -0.996 . . . . 1.19 108.31 175.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -79.92 127.55 32.39 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 116.09 -0.505 . . . . 1.37 109.986 -177.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1542 ' ' TYR . . . . . . . . . . . . . 4.6 t80 -111.44 -99.5 0.41 Allowed 'General case' 0 N--CA 1.417 -2.112 0 N-CA-C 105.832 -1.914 . . . . 1.38 105.832 178.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1543 ' ' SER . . . . . . . . . . . . . 4.9 m -70.71 173.91 6.62 Favored 'General case' 0 N--CA 1.414 -2.25 0 N-CA-C 108.611 -0.885 . . . . 1.98 108.611 172.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -68.8 -37.9 79.56 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.093 -1.004 . . . . 3.96 109.512 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 38.9 m -107.26 35.53 3.02 Favored 'General case' 0 N--CA 1.408 -2.549 0 CA-C-N 115.25 -0.886 . . . . 2.81 110.079 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . -155.66 121.94 1.15 Allowed Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.055 -1.069 . . . . 1.68 114.044 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 34.7 m -112.85 149.89 15.18 Favored 'Isoleucine or valine' 0 C--O 1.253 1.28 0 CA-C-O 121.502 0.668 . . . . 1.38 110.672 176.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1548 ' ' VAL . . . . . 0.475 ' CG1' ' HB2' ' A' 1540 ' ' ALA . 10.3 p -102.18 139.23 23.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 109.078 -0.712 . . . . 1.24 109.078 177.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1549 ' ' TYR . . . . . 0.526 ' HB3' ' ND2' ' A' 1556 ' ' ASN . 58.0 m-85 -97.46 129.74 44.62 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 123.173 0.589 . . . . 1.29 109.8 178.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 24.9 ptm -144.35 127.41 16.53 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-N 115.538 -0.756 . . . . 1.47 110.228 -178.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 7.4 p -112.68 117.0 31.05 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 115.514 -0.766 . . . . 1.4 109.177 178.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1552 ' ' ILE . . . . . 0.524 ' O ' ' HA ' ' A' 1533 ' ' SER . 41.3 mm -74.83 113.66 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.374 0 N-CA-C 109.845 -0.428 . . . . 1.11 109.845 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 75.6 m 66.13 45.56 2.32 Favored 'General case' 0 CA--C 1.493 -1.231 0 O-C-N 124.229 0.956 . . . . 1.4 111.745 174.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . -179.72 177.05 47.98 Favored Glycine 0 N--CA 1.406 -3.318 0 C-N-CA 119.306 -1.426 . . . . 0.4 111.184 177.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -95.75 141.05 29.68 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 109.469 -0.567 . . . . 1.62 109.469 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1556 ' ' ASN . . . . . 0.526 ' ND2' ' HB3' ' A' 1549 ' ' TYR . 44.4 t-20 -92.75 124.68 36.93 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 109.03 -0.729 . . . . 1.12 109.03 -177.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -67.41 -5.89 16.72 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.188 0.81 . . . . 2.49 113.188 -176.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -98.62 0.18 44.3 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 112.09 0.404 . . . . 1.38 112.09 -174.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1559 ' ' CYS . . . . . 0.492 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 20.4 m -137.82 170.39 10.62 Favored Pre-proline 0 C--N 1.307 -1.277 0 CA-C-O 117.966 -1.016 . . . . 1.21 111.068 177.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1560 ' ' PRO . . . . . 0.492 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 64.4 Cg_exo -29.6 134.96 0.04 OUTLIER 'Trans proline' 0 C--N 1.392 2.855 0 C-N-CA 125.006 3.804 . . . . 0.98 114.063 174.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1561 ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' 1560 ' ' PRO . 52.3 Cg_exo -53.82 126.72 22.85 Favored 'Trans proline' 0 C--O 1.242 0.701 0 C-N-CA 123.616 2.877 . . . . 1.15 113.799 -175.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 89.56 18.56 51.77 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 115.677 -0.692 . . . . 0.55 113.664 175.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1563 ' ' VAL . . . . . . . . . . . . . 4.1 p -109.44 140.34 28.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 117.74 0.77 . . . . 1.53 110.151 -177.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -101.27 -30.03 6.13 Favored Glycine 0 C--N 1.315 -0.635 0 CA-C-N 116.035 -0.529 . . . . 0.29 112.9 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -128.17 126.99 42.14 Favored 'General case' 0 C--N 1.313 -0.997 0 O-C-N 122.414 -0.463 . . . . 1.08 109.906 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 9.4 t -160.44 141.7 12.19 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 122.894 0.478 . . . . 0.43 110.154 -176.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1567 ' ' PHE . . . . . 0.42 ' HE1' HG21 ' A' 1574 ' ' VAL . 85.9 m-85 -85.78 132.93 34.03 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.744 -0.836 . . . . 1.3 108.744 176.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -81.56 14.14 31.44 Favored Glycine 0 C--N 1.342 0.878 0 C-N-CA 120.494 -0.86 . . . . 1.43 113.45 -173.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -84.64 -70.17 0.6 Allowed 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.188 0.518 . . . . 3.09 110.993 177.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 1.1 p -108.56 10.76 27.07 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 113.019 0.748 . . . . 2.52 113.019 -174.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 11.8 mmt180 59.52 36.54 22.92 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.451 -0.795 . . . . 3.19 110.383 178.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 45.0 mt -83.2 125.73 40.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 109.584 -0.524 . . . . 1.51 109.584 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 37.2 t -78.11 129.02 34.69 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.47 -0.786 . . . . 0.96 110.444 -176.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1574 ' ' VAL . . . . . 0.42 HG21 ' HE1' ' A' 1567 ' ' PHE . 1.4 t -112.85 -19.13 7.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 N-CA-C 112.857 0.688 . . . . 1.6 112.857 -177.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . -179.9 127.62 1.14 Allowed Glycine 0 C--N 1.305 -1.174 0 C-N-CA 119.172 -1.49 . . . . 0.34 112.576 -179.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -63.99 149.32 47.62 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 123.869 0.868 . . . . 2.68 109.99 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -64.93 83.42 0.04 OUTLIER 'General case' 0 C--O 1.244 0.769 0 C-N-CA 123.494 0.718 . . . . 1.08 111.352 177.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 45.5 t30 -89.18 150.39 22.7 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 106.966 -1.494 . . . . 1.95 106.966 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -137.5 51.09 1.94 Allowed 'General case' 0 C--N 1.287 -2.149 0 CA-C-O 122.911 1.339 . . . . 3.11 109.132 -172.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -123.66 81.31 1.89 Allowed 'General case' 0 N--CA 1.412 -2.342 0 CA-C-N 113.754 -1.566 . . . . 4.04 108.83 -176.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1581 ' ' LEU . . . . . 0.712 HD21 ' HG ' ' A' 1529 ' ' LEU . 0.5 OUTLIER -63.65 125.04 22.97 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 113.154 -1.839 . . . . 1.32 110.266 -177.834 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A 1582 ' ' ARG . . . . . 0.609 ' HB2' ' HB3' ' A' 1589 ' ' GLN . 92.5 mtt180 -112.45 140.34 47.27 Favored 'General case' 0 C--N 1.293 -1.874 0 O-C-N 121.657 -0.652 . . . . 3.4 111.274 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1583 ' ' TYR . . . . . 0.662 ' HE1' ' HA ' ' A' 1586 ' ' GLN . 32.7 t80 -113.28 104.17 12.06 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 109.287 -0.634 . . . . 1.26 109.287 177.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1584 ' ' VAL . . . . . 0.509 ' O ' ' HB ' ' A' 1587 ' ' VAL . 16.8 m -125.18 89.43 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-N 115.519 -0.764 . . . . 1.71 112.572 -175.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 37.2 t70 61.0 51.17 4.64 Favored 'General case' 0 N--CA 1.502 2.155 0 CA-C-O 122.205 1.002 . . . . 1.17 110.498 177.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1586 ' ' GLN . . . . . 0.662 ' HA ' ' HE1' ' A' 1583 ' ' TYR 0.288 28.4 pt20 65.2 20.65 11.98 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 126.929 2.091 . . . . 2.43 111.703 179.157 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A 1587 ' ' VAL . . . . . 0.509 ' HB ' ' O ' ' A' 1584 ' ' VAL . 45.4 t -108.96 121.62 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.406 0 CA-C-N 113.775 -1.557 . . . . 1.16 106.881 172.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1588 ' ' LEU . . . . . 0.746 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 2.4 mm? -95.36 113.22 24.86 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 107.576 -1.268 . . . . 1.11 107.576 -177.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1589 ' ' GLN . . . . . 0.609 ' HB3' ' HB2' ' A' 1582 ' ' ARG . 35.9 tt0 -107.97 140.08 41.65 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.559 0.695 . . . . 1.74 112.484 -172.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 29.6 mt -133.12 93.16 3.13 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 114.065 -1.425 . . . . 1.4 107.807 173.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 5.4 p -89.39 122.33 40.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.867 -0.79 . . . . 1.7 108.867 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1592 ' ' TYR . . . . . 0.419 ' HB2' ' HB3' ' A' 1608 ' ' SER . 12.9 m-30 -111.84 102.96 11.19 Favored 'General case' 0 C--N 1.29 -2.017 0 O-C-N 121.672 -0.643 . . . . 1.08 110.096 -177.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -104.21 178.99 4.4 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 109.852 -0.425 . . . . 2.21 109.852 177.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 17.1 m-20 68.9 55.22 0.45 Allowed 'General case' 0 C--O 1.246 0.883 0 C-N-CA 123.763 0.825 . . . . 1.11 112.497 178.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -88.54 -122.41 1.94 Allowed Glycine 0 N--CA 1.43 -1.765 0 N-CA-C 109.781 -1.328 . . . . 0.78 109.781 174.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1596 ' ' SER . . . . . . . . . . . . . 43.9 p -108.35 153.91 41.72 Favored Pre-proline 0 C--N 1.294 -1.843 0 N-CA-C 108.734 -0.839 . . . . 1.36 108.734 176.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.23 120.51 8.45 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 122.448 2.099 . . . . 1.4 110.509 176.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 43.3 t -78.94 129.2 74.06 Favored Pre-proline 0 C--N 1.289 -2.034 0 CA-C-N 115.173 -0.921 . . . . 0.75 109.949 -174.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -71.37 -14.16 30.92 Favored 'Trans proline' 0 C--O 1.247 0.968 0 C-N-CA 122.852 2.368 . . . . 1.7 113.316 -178.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1600 ' ' SER . . . . . . . . . . . . . 4.7 m -75.62 -52.85 9.63 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 116.45 -0.341 . . . . 2.8 110.627 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1601 ' ' LYS . . . . . 0.76 ' HE3' ' HA ' ' A' 1601 ' ' LYS . 1.1 tpmt? -116.09 101.95 9.19 Favored 'General case' 0 N--CA 1.401 -2.894 0 N-CA-C 106.359 -1.719 . . . . 3.45 106.359 178.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 16.9 m -58.38 119.85 7.7 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 123.213 0.605 . . . . 2.44 110.245 -178.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 102.16 -1.61 50.93 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 111.524 -0.631 . . . . 1.2 111.524 -178.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1604 ' ' LEU . . . . . 0.413 HD21 ' HB3' ' A' 1601 ' ' LYS . 8.8 tp -102.97 164.19 11.76 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 107.985 -1.117 . . . . 2.38 107.985 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 31.1 t -131.03 150.58 52.08 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 107.724 -1.213 . . . . 1.96 107.724 -178.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1606 ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -67.62 155.5 39.02 Favored 'General case' 0 C--O 1.245 0.854 0 N-CA-C 109.578 -0.527 . . . . 1.06 109.578 177.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 26.2 pttm -154.67 137.58 15.41 Favored 'General case' 0 N--CA 1.44 -0.928 0 C-N-CA 120.061 -0.656 . . . . 2.0 110.691 178.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1608 ' ' SER . . . . . 0.419 ' HB3' ' HB2' ' A' 1592 ' ' TYR . 41.4 t -107.61 122.84 47.51 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 114.949 -1.023 . . . . 1.61 110.244 -176.021 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 22.5 t -104.79 98.51 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 108.618 -0.882 . . . . 1.09 108.618 176.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 80.2 mt -90.95 116.72 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.653 0 N-CA-C 107.693 -1.225 . . . . 1.2 107.693 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 10.8 p -121.45 114.84 21.83 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 115.616 -0.72 . . . . 1.89 111.547 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1612 ' ' PHE . . . . . 0.746 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 65.9 m-85 -87.4 123.69 32.61 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 108.213 -1.032 . . . . 0.28 108.213 175.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 46.9 t -114.24 134.15 58.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 116.182 -0.463 . . . . 1.23 109.987 -175.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1614 ' ' CYS . . . . . 0.489 ' HA ' ' HB2' ' A' 1646 ' ' CYS . 0.9 OUTLIER -50.94 111.24 0.52 Allowed 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.347 1.059 . . . . 0.77 112.479 175.724 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A 1615 ' ' ARG . . . . . 0.576 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 30.1 tpt180 -134.44 91.31 22.45 Favored Pre-proline 0 N--CA 1.446 -0.668 0 C-N-CA 120.283 -0.567 . . . . 2.92 109.933 173.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1616 ' ' PRO . . . . . 0.482 ' HD2' ' OE1' ' A' 1617 ' ' GLU . 17.2 Cg_exo -66.76 -28.38 43.64 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.393 2.062 . . . . 1.22 112.442 -179.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1617 ' ' GLU . . . . . 0.482 ' OE1' ' HD2' ' A' 1616 ' ' PRO . 17.9 mp0 -59.73 -39.81 85.96 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 123.928 0.891 . . . . 3.05 110.638 178.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . 49.04 86.54 0.03 OUTLIER 'General case' 0 C--O 1.246 0.874 0 C-N-CA 124.44 1.096 . . . . 1.55 113.581 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . -118.23 -151.31 9.11 Favored Glycine 0 C--N 1.281 -2.499 0 N-CA-C 110.221 -1.152 . . . . 1.16 110.221 178.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.97 10.25 0.91 Allowed 'Trans proline' 0 N--CA 1.486 1.054 0 C-N-CA 122.964 2.443 . . . . 1.06 114.166 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1621 ' ' THR . . . . . . . . . . . . . 14.5 p -100.68 6.93 44.14 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 122.012 0.91 . . . . 1.58 110.435 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -85.06 65.28 9.15 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 106.67 -1.604 . . . . 0.88 106.67 175.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -169.96 139.56 1.59 Allowed Pre-proline 0 N--CA 1.435 -1.195 0 C-N-CA 124.849 1.26 . . . . 3.82 107.647 -177.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1624 ' ' PRO . . . . . 0.461 ' HA ' ' O ' ' A' 1639 ' ' SER . 50.6 Cg_endo -67.93 106.91 1.4 Allowed 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.885 2.39 . . . . 0.77 112.327 -176.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 72.1 mtm -105.63 147.36 28.55 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 120.779 -0.368 . . . . 1.43 110.885 178.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 1.9 tm? -82.55 118.16 23.07 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 106.727 -1.582 . . . . 1.43 106.727 -178.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 42.9 mm -80.46 -54.08 11.38 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.783 0 N-CA-C 108.61 -0.885 . . . . 1.23 108.61 178.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 34.4 t -164.9 159.14 17.94 Favored 'General case' 0 N--CA 1.411 -2.384 0 N-CA-C 107.287 -1.375 . . . . 1.88 107.287 -177.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1629 ' ' LEU . . . . . 0.969 ' HG ' ' HG ' ' A' 1636 ' ' LEU . 1.6 tt -135.77 102.77 5.18 Favored 'General case' 0 N--CA 1.414 -2.252 0 N-CA-C 105.082 -2.192 . . . . 1.92 105.082 177.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 25.3 t70 -78.35 107.33 10.9 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.041 -1.466 . . . . 1.09 107.041 175.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1631 ' ' LYS . . . . . 0.412 ' HG2' HD22 ' A' 1629 ' ' LEU . 37.2 mtmm -78.62 -5.35 52.66 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 113.213 0.82 . . . . 3.98 113.213 -173.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 10.8 mm100 -89.67 -40.74 12.36 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 119.132 -1.027 . . . . 2.6 108.503 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 74.4 p -89.77 -5.14 57.25 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 115.034 -0.985 . . . . 1.35 109.438 177.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1634 ' ' CYS . . . . . 0.412 ' SG ' HD23 ' A' 1604 ' ' LEU . 27.9 m 58.0 41.03 24.92 Favored 'General case' 0 C--N 1.362 1.138 0 C-N-CA 125.073 1.349 . . . . 0.53 110.906 174.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1635 ' ' THR . . . . . . . . . . . . . 74.9 m -112.4 127.65 56.08 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 114.743 -1.117 . . . . 1.11 110.523 -174.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1636 ' ' LEU . . . . . 0.969 ' HG ' ' HG ' ' A' 1629 ' ' LEU . 0.3 OUTLIER -113.77 131.97 56.02 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.485 -0.932 . . . . 1.56 108.485 -176.634 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -111.62 129.27 56.13 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 116.692 -0.231 . . . . 0.54 110.458 -178.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -126.77 132.39 51.08 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 116.054 -0.521 . . . . 0.64 109.733 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1639 ' ' SER . . . . . 0.461 ' O ' ' HA ' ' A' 1624 ' ' PRO . 22.8 t -115.43 152.95 31.96 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.326 -0.99 . . . . 1.34 108.326 178.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 3.1 t90 -151.2 111.12 4.07 Favored 'General case' 0 N--CA 1.414 -2.256 0 N-CA-C 104.205 -2.517 . . . . 0.8 104.205 -177.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1641 ' ' HIS . . . . . 0.576 ' HB3' ' HB2' ' A' 1615 ' ' ARG . 42.7 m-70 -97.9 110.27 22.87 Favored 'General case' 0 C--N 1.293 -1.873 0 C-N-CA 120.097 -0.641 . . . . 1.14 109.365 -177.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1642 ' ' THR . . . . . 0.553 HG21 ' HB3' ' A' 1645 ' ' ALA . 4.6 t -142.63 146.94 40.46 Favored Pre-proline 0 C--N 1.296 -1.719 0 CA-C-N 115.158 -0.928 . . . . 1.11 110.123 -172.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1643 ' ' PRO . . . . . 0.468 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 37.6 Cg_endo -79.68 -11.11 14.22 Favored 'Trans proline' 0 C--N 1.368 1.565 0 C-N-CA 121.991 1.794 . . . . 0.78 112.874 177.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 7.1 tt -68.37 -29.93 68.75 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 122.295 1.045 . . . . 1.66 108.199 178.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1645 ' ' ALA . . . . . 0.553 ' HB3' HG21 ' A' 1642 ' ' THR . . . -97.06 20.87 10.59 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 114.167 -1.379 . . . . 1.29 109.405 -177.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1646 ' ' CYS . . . . . 0.489 ' HB2' ' HA ' ' A' 1614 ' ' CYS . 49.6 t -122.1 158.32 29.53 Favored 'General case' 0 N--CA 1.42 -1.957 0 CA-C-N 115.967 -0.561 . . . . 1.48 109.601 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -115.21 117.88 40.67 Favored Pre-proline 0 C--N 1.299 -1.624 0 N-CA-C 105.753 -1.943 . . . . 3.14 105.753 175.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1648 ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.28 96.82 0.65 Allowed 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.394 2.063 . . . . 2.92 112.784 -175.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 43.6 tt0 . . . . . 0 C--O 1.257 1.458 0 N-CA-C 108.316 -0.994 . . . . 4.72 108.316 177.207 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.621 0 N-CA-C 109.668 -0.493 . . . . 10.26 109.668 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -96.89 128.02 43.44 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 109.016 -0.735 . . . . 7.94 109.016 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' ARG . . . . . 0.513 ' HD2' HD21 ' B' ' 8' ' ' LEU . 38.2 ptt180 -98.51 142.33 24.4 Favored Pre-proline 0 C--N 1.296 -1.753 0 N-CA-C 108.864 -0.791 . . . . 6.56 108.864 -178.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -51.15 -27.03 21.07 Favored 'Trans proline' 0 C--N 1.365 1.395 0 C-N-CA 124.763 3.642 . . . . 5.51 115.386 -174.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 62.5 m -126.96 115.43 19.24 Favored 'General case' 0 N--CA 1.426 -1.662 0 N-CA-C 108.47 -0.937 . . . . 4.91 108.47 174.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -63.33 -32.34 73.74 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 107.991 -1.114 . . . . 4.23 107.991 176.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 13.7 p -111.31 99.46 8.26 Favored 'General case' 0 N--CA 1.41 -2.446 0 CA-C-N 114.505 -1.225 . . . . 3.48 108.712 176.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . 0.513 HD21 ' HD2' ' B' ' 3' ' ' ARG . 86.6 mt -60.72 141.34 56.98 Favored 'General case' 0 C--O 1.246 0.917 0 N-CA-C 110.229 -0.286 . . . . 4.35 110.229 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 5.4 m -76.41 22.36 0.17 Allowed 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.434 0.901 . . . . 2.84 113.434 -169.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -156.7 -60.99 0.01 OUTLIER Glycine 0 N--CA 1.434 -1.455 0 C-N-CA 120.771 -0.728 . . . . 2.28 111.499 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.34 -68.28 1.72 Allowed Glycine 0 N--CA 1.445 -0.716 0 O-C-N 123.923 0.425 . . . . 1.94 113.204 -178.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . 0.455 ' HG2' ' HB2' ' B' ' 8' ' ' LEU . 4.7 mm-40 -61.24 -32.75 72.55 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.176 -0.676 . . . . 2.55 109.176 -178.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . 0.401 ' O ' HD22 ' B' ' 17' ' ' LEU . 0.1 OUTLIER -53.34 -66.53 0.37 Allowed 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 114.761 -1.109 . . . . 2.82 109.245 -179.559 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 18.9 m -75.21 -16.7 15.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 C-N-CA 119.384 -0.927 . . . . 2.5 110.701 -177.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -73.27 -49.72 26.16 Favored 'General case' 0 C--O 1.184 -2.368 0 C-N-CA 118.844 -1.142 . . . . 2.04 112.497 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 21.9 p -56.15 -44.83 79.64 Favored 'General case' 0 C--O 1.263 1.778 0 CA-C-N 118.693 0.679 . . . . 2.31 109.628 176.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.552 ' HB3' ' CB ' ' B' ' 26' ' ' PHE . 4.1 mm? -50.37 -55.1 17.12 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 114.344 -1.298 . . . . 2.27 112.346 172.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -77.46 -21.91 52.17 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.23 0.538 . . . . 2.39 111.996 -178.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -55.55 -52.67 62.95 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 124.034 0.934 . . . . 1.0 110.777 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 12.9 p -98.56 -24.07 4.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 C-N-CA 118.272 -1.371 . . . . 1.83 112.365 -178.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 34.5 m -104.56 19.64 20.01 Favored 'General case' 0 C--N 1.309 -1.166 0 O-C-N 121.871 -0.518 . . . . 1.66 111.935 -174.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -49.17 -34.19 16.71 Favored Glycine 0 N--CA 1.469 0.875 0 N-CA-C 116.852 1.501 . . . . 1.53 116.852 -175.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -74.99 -34.47 61.97 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 117.773 0.787 . . . . 2.72 112.641 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 20.6 tpp180 -93.1 -39.47 11.04 Favored 'General case' 0 C--N 1.314 -0.949 0 O-C-N 122.064 -0.398 . . . . 5.02 111.195 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.94 -168.17 13.26 Favored Glycine 0 N--CA 1.433 -1.534 0 N-CA-C 109.078 -1.609 . . . . 1.63 109.078 -177.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . 0.552 ' CB ' ' HB3' ' B' ' 17' ' ' LEU . 18.0 p90 -129.73 128.6 42.81 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 117.69 0.745 . . . . 1.71 111.098 179.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -142.02 129.33 21.12 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 109.491 -0.559 . . . . 3.67 109.491 -176.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' PHE . . . . . 0.657 ' HD2' ' H ' ' B' ' 41' ' ' GLY . 6.7 p90 -140.06 42.92 1.94 Allowed 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.283 -1.377 . . . . 2.44 107.283 -177.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 6.0 m -67.72 106.86 2.37 Favored 'General case' 0 N--CA 1.42 -1.959 0 CA-C-N 113.104 -1.862 . . . . 3.85 113.02 -172.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . 0.707 ' O ' ' HA ' ' B' ' 39' ' ' SER . 3.1 mmp_? -113.19 114.36 48.45 Favored Pre-proline 0 C--N 1.308 -1.232 0 N-CA-C 105.449 -2.056 . . . . 4.27 105.449 170.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' B' ' 30' ' ' ARG . 32.0 Cg_exo -54.97 -33.28 82.23 Favored 'Trans proline' 0 C--O 1.243 0.764 0 C-N-CA 123.762 2.974 . . . . 4.2 113.909 -171.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . 69.13 -78.52 0.04 OUTLIER 'General case' 0 N--CA 1.433 -1.283 0 C-N-CA 125.427 1.491 . . . . 5.12 112.092 176.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' SER . . . . . 0.457 ' HB3' ' OG ' ' B' ' 36' ' ' SER . 31.0 t -177.16 166.34 2.36 Favored 'General case' 0 N--CA 1.398 -3.033 0 N-CA-C 104.816 -2.29 . . . . 6.93 104.816 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 39.5 ttt180 -99.35 7.08 45.88 Favored 'General case' 0 C--N 1.284 -2.268 0 CA-C-O 122.361 1.076 . . . . 12.14 108.307 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 39.1 t -106.61 -13.56 9.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 107.09 -1.448 . . . . 9.9 107.09 175.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' SER . . . . . 0.457 ' OG ' ' HB3' ' B' ' 33' ' ' SER . 5.3 p -144.76 67.4 1.25 Allowed 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 113.777 -1.556 . . . . 6.82 107.228 178.024 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -49.44 11.72 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 129.513 3.125 . . . . 10.71 117.834 -172.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 28.1 mtm180 -76.78 85.21 3.38 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-N 119.109 0.868 . . . . 8.6 110.967 -170.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' SER . . . . . 0.707 ' HA ' ' O ' ' B' ' 30' ' ' ARG . 33.9 p -77.15 61.66 2.1 Favored 'General case' 0 C--O 1.249 1.054 0 CA-C-O 122.803 1.287 . . . . 5.79 111.751 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . 0.444 ' HB2' ' HE2' ' B' ' 28' ' ' PHE . 36.0 ptt180 -148.23 162.34 39.67 Favored 'General case' 0 C--N 1.285 -2.226 0 CA-C-N 113.85 -1.523 . . . . 6.57 109.27 -175.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . 0.657 ' H ' ' HD2' ' B' ' 28' ' ' PHE . . . -161.53 178.01 37.6 Favored Glycine 0 N--CA 1.424 -2.131 0 N-CA-C 108.288 -1.925 . . . . 2.62 108.288 -175.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . 0.508 ' HB ' HD23 ' B' ' 55' ' ' LEU . 15.0 pt 55.05 8.26 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.42 0 C-N-CA 126.906 2.082 . . . . 2.28 112.578 -177.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . 0.465 ' O ' ' HB2' ' B' ' 47' ' ' CYS . 9.0 p -80.25 -35.48 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.312 0 CA-C-N 114.796 -1.093 . . . . 2.6 111.95 -173.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -84.63 -38.37 19.94 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 106.593 -1.632 . . . . 3.36 106.593 177.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -64.97 -19.38 65.95 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 113.886 -1.506 . . . . 3.08 111.798 -177.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' CYS . . . . . . . . . . . . . 41.9 t -118.06 -0.21 11.68 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 119.779 -0.769 . . . . 2.23 110.888 175.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' CYS . . . . . 0.465 ' HB2' ' O ' ' B' ' 43' ' ' VAL . 51.9 t -83.91 -60.05 2.23 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 121.941 -0.474 . . . . 2.48 111.998 177.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -96.48 4.24 52.23 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-O 121.228 0.537 . . . . 2.97 110.222 -175.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 8.2 mmt180 -130.29 161.78 30.47 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 105.294 -2.113 . . . . 4.65 105.294 -176.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 9.3 t -97.32 115.48 27.75 Favored 'General case' 0 C--N 1.278 -2.505 0 N-CA-C 105.086 -2.19 . . . . 2.86 105.086 174.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 31.9 p -88.89 137.48 32.28 Favored 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 109.294 -0.632 . . . . 2.11 109.294 -172.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -85.09 146.87 26.93 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 107.855 -1.165 . . . . 2.67 107.855 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -62.23 -22.52 66.02 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.058 -0.974 . . . . 2.36 112.508 -174.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.75 -38.19 69.5 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.19 0.519 . . . . 1.92 109.969 178.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . 0.508 HD23 ' HB ' ' B' ' 42' ' ' ILE . 34.6 tp -54.66 -63.4 1.16 Allowed 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 114.371 -1.286 . . . . 2.35 111.576 179.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . 0.463 HD11 ' N ' ' B' ' 57' ' ' GLU . 0.0 OUTLIER -75.09 -27.37 59.87 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 120.267 -0.573 . . . . 2.01 111.656 -176.341 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . 0.463 ' N ' HD11 ' B' ' 56' ' ' LEU . 11.6 tp10 -59.93 -44.91 94.06 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 109.912 -0.403 . . . . 2.27 109.912 177.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 11.7 t -80.48 -10.81 59.73 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 120.419 -0.512 . . . . 2.67 110.752 177.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 59' ' ' TYR . . . . . 0.519 ' HE1' ' HA ' ' B' ' 28' ' ' PHE . 1.1 t80 -94.72 -70.77 0.69 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 119.504 -0.878 . . . . 3.2 108.865 -178.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 54.0 t 56.11 -94.04 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.209 0 C-N-CA 125.809 1.644 . . . . 2.3 114.955 177.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -165.4 163.61 19.74 Favored 'General case' 0 N--CA 1.423 -1.792 0 N-CA-C 107.973 -1.121 . . . . 3.19 107.973 -173.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 8.5 p -142.34 138.64 16.72 Favored Pre-proline 0 C--N 1.29 -1.988 0 N-CA-C 107.609 -1.256 . . . . 4.14 107.609 177.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -74.77 -18.67 19.15 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.814 2.343 . . . . 5.59 113.638 -177.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -126.5 62.77 1.28 Allowed 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 116.405 -0.361 . . . . 5.51 111.333 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 61.4 tttp 67.38 148.77 0.05 Allowed 'General case' 0 CA--C 1.559 1.309 0 C-N-CA 124.974 1.31 . . . . 8.8 112.501 176.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 13.4 m -103.55 103.12 13.03 Favored 'General case' 0 C--N 1.313 -0.986 0 O-C-N 121.183 -0.948 . . . . 8.12 111.698 -177.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 . . . . . 0 C--N 1.307 -1.252 0 N-CA-C 107.852 -1.166 . . . . 10.21 107.852 173.32 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 49.8 ttm . . . . . 0 C--O 1.237 0.4 0 N-CA-C 109.075 -0.713 . . . . 9.74 109.075 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 86.6 tttt -157.8 88.2 0.97 Allowed 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 108.082 -1.081 . . . . 9.32 108.082 179.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 49.5 m -160.27 -35.86 0.05 Allowed 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 121.39 0.614 . . . . 5.97 111.516 -178.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1511 ' ' ASN . . . . . 0.496 ' HB3' ' HA ' ' A' 1582 ' ' ARG . 15.6 m120 -127.9 60.25 1.46 Allowed 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 121.263 0.554 . . . . 3.48 110.233 -172.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1512 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.75 142.02 20.53 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.729 -0.669 . . . . 5.95 109.955 178.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 20.0 t-80 -179.28 -49.4 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.229 0 O-C-N 124.402 1.064 . . . . 6.14 109.415 -176.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 7.5 t70 -141.4 177.52 8.06 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 107.939 -1.134 . . . . 5.06 107.939 -176.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 17.0 t70 -79.82 87.2 5.3 Favored 'General case' 0 C--N 1.289 -2.037 0 C-N-CA 125.341 1.457 . . . . 2.9 110.134 -175.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1516 ' ' CYS . . . . . 0.713 ' HA ' ' HB2' ' A' 1581 ' ' LEU . 91.6 m 64.21 46.93 3.39 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 115.057 1.503 . . . . 1.41 115.057 175.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -150.1 129.88 13.28 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 107.122 -1.436 . . . . 2.18 107.122 172.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1518 ' ' VAL . . . . . 0.656 HG21 ' HB2' ' A' 1583 ' ' TYR . 5.3 m -131.12 140.52 48.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 CA-C-O 121.249 0.547 . . . . 1.52 111.542 -174.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1519 ' ' THR . . . . . 0.561 ' HG1' HD21 ' A' 1526 ' ' LEU . 20.5 m -108.44 140.58 41.54 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 115.452 -0.795 . . . . 1.36 109.064 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1520 ' ' ASN . . . . . 0.618 HD21 ' HE2' ' A' 1583 ' ' TYR . 25.9 t-20 -93.62 114.59 63.38 Favored Pre-proline 0 C--N 1.305 -1.347 0 N-CA-C 107.876 -1.157 . . . . 2.02 107.876 172.054 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -63.94 -21.3 68.74 Favored 'Trans proline' 0 N--CA 1.477 0.536 0 C-N-CA 123.208 2.605 . . . . 1.82 114.032 -174.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 14.2 m -75.56 -41.54 54.53 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-O 120.646 0.26 . . . . 1.89 111.498 -177.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1523 ' ' THR . . . . . 0.53 HG21 ' OD1' ' A' 1520 ' ' ASN . 2.7 t -107.94 -20.57 13.14 Favored 'General case' 0 CA--C 1.561 1.391 0 CA-C-O 121.345 0.593 . . . . 1.99 111.96 -178.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 83.1 22.51 57.2 Favored Glycine 0 CA--C 1.505 -0.533 0 O-C-N 122.092 -0.38 . . . . 1.19 113.482 175.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 55.1 t-80 -95.36 132.82 39.98 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 120.981 0.42 . . . . 1.82 110.114 -178.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1526 ' ' LEU . . . . . 0.561 HD21 ' HG1' ' A' 1519 ' ' THR . 2.7 tm? -101.47 116.38 32.65 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 114.902 -1.045 . . . . 1.3 109.51 -177.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -87.35 118.12 26.58 Favored 'General case' 0 C--N 1.318 -0.804 0 O-C-N 122.068 -0.395 . . . . 0.8 111.108 173.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 8.7 t70 -98.01 113.67 25.59 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 108.27 -1.011 . . . . 1.17 108.27 176.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1529 ' ' LEU . . . . . 0.646 ' HG ' HD23 ' A' 1581 ' ' LEU . 3.5 mm? -101.87 -6.7 23.23 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 121.111 0.481 . . . . 1.29 110.051 177.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 6.1 m -62.63 -22.15 66.21 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.498 -0.774 . . . . 0.91 112.45 -177.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 16.2 t -66.12 -32.53 74.03 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 121.317 0.58 . . . . 1.98 110.036 177.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 7.9 mt -89.03 -7.62 55.57 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.253 -0.647 . . . . 1.34 109.253 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1533 ' ' SER . . . . . 0.43 ' HA ' ' HB ' ' A' 1552 ' ' ILE . 24.5 t -76.99 176.28 8.79 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.379 -0.6 . . . . 1.93 109.379 179.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . 152.71 174.77 23.51 Favored Glycine 0 N--CA 1.422 -2.24 0 N-CA-C 110.193 -1.163 . . . . 1.1 110.193 -177.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 33.2 ttm180 -92.31 -29.73 16.21 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 121.161 0.505 . . . . 5.21 110.095 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -76.55 -53.08 8.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.206 0.527 . . . . 1.94 110.96 -178.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 93.83 -150.16 19.73 Favored Glycine 0 N--CA 1.425 -2.067 0 C-N-CA 120.624 -0.798 . . . . 1.08 111.883 177.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -136.8 151.49 49.23 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.377 -0.971 . . . . 1.07 108.377 -177.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 17.7 p -112.81 139.55 48.34 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 116.266 -0.424 . . . . 1.46 109.952 177.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1540 ' ' ALA . . . . . 0.45 ' HB1' ' CG1' ' A' 1548 ' ' VAL . . . -125.25 143.41 50.96 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 107.943 -1.132 . . . . 1.19 107.943 172.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -84.67 151.94 24.12 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 108.552 -0.907 . . . . 1.37 108.552 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1542 ' ' TYR . . . . . 0.637 ' HE2' ' HG ' ' A' 1626 ' ' LEU . 1.8 t80 -162.95 -100.74 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 121.62 0.724 . . . . 1.38 109.914 -174.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1543 ' ' SER . . . . . 0.407 ' H ' ' HB3' ' A' 1542 ' ' TYR . 31.2 t -73.93 159.41 32.81 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 124.568 1.147 . . . . 1.98 110.404 -173.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 13.2 tppt? -74.98 -3.71 33.9 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 109.329 -0.619 . . . . 3.96 109.329 178.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1545 ' ' SER . . . . . 0.464 ' HB2' ' HG2' ' B' ' 18' ' ' GLN . 15.3 t -77.62 -43.3 31.97 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 108.884 -0.784 . . . . 2.81 108.884 176.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 165.72 -148.84 14.45 Favored Glycine 0 N--CA 1.41 -3.066 0 N-CA-C 110.872 -0.891 . . . . 1.68 110.872 -175.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 34.6 m -109.11 179.41 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.281 2.761 0 CA-C-O 122.118 0.961 . . . . 1.38 111.975 -172.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1548 ' ' VAL . . . . . 0.865 ' HB ' ' CE1' ' A' 1567 ' ' PHE . 7.8 p -112.01 130.85 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.941 0 CA-C-N 113.193 -1.821 . . . . 1.24 108.362 173.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -95.06 134.81 37.35 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.938 -1.134 . . . . 1.29 107.938 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 24.1 ptm -150.93 118.73 6.17 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 121.767 0.794 . . . . 1.47 111.337 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 5.4 p -112.4 118.31 34.85 Favored 'General case' 0 C--N 1.28 -2.428 0 CA-C-N 114.507 -1.224 . . . . 1.4 109.973 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1552 ' ' ILE . . . . . 0.43 ' HB ' ' HA ' ' A' 1533 ' ' SER . 46.0 mm -71.95 114.63 10.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.503 -0.317 . . . . 1.11 110.585 -178.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 72.0 m 60.9 29.43 19.01 Favored 'General case' 0 CA--C 1.511 -0.533 0 C-N-CA 124.532 1.133 . . . . 1.4 113.401 175.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . -161.04 177.75 37.28 Favored Glycine 0 N--CA 1.417 -2.601 0 N-CA-C 109.412 -1.475 . . . . 0.4 109.412 -179.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -107.97 140.73 40.68 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-O 121.127 0.489 . . . . 1.62 111.684 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -87.21 140.5 29.48 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 107.426 -1.324 . . . . 1.12 107.426 178.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -94.41 3.45 55.16 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 113.587 0.958 . . . . 2.49 113.587 -173.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -88.62 -4.65 58.52 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 121.552 0.692 . . . . 1.38 110.575 -178.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1559 ' ' CYS . . . . . 0.628 ' SG ' ' HD2' ' A' 1560 ' ' PRO . 20.2 t -136.31 157.48 75.39 Favored Pre-proline 0 C--N 1.298 -1.633 0 N-CA-C 106.229 -1.767 . . . . 1.21 106.229 -178.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1560 ' ' PRO . . . . . 0.628 ' HD2' ' SG ' ' A' 1559 ' ' CYS . 31.6 Cg_exo -29.05 134.77 0.04 OUTLIER 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 125.104 3.869 . . . . 0.98 115.428 177.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -49.13 124.44 11.62 Favored 'Trans proline' 0 C--O 1.247 0.948 0 C-N-CA 124.176 3.251 . . . . 1.15 112.792 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 101.76 7.32 48.1 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 116.004 -0.544 . . . . 0.55 113.302 -177.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1563 ' ' VAL . . . . . 0.534 HG12 ' HB2' ' A' 1566 ' ' CYS . 2.3 t -85.93 124.56 40.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 112.185 0.439 . . . . 1.53 112.185 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -97.71 -37.61 4.42 Favored Glycine 0 C--N 1.31 -0.916 0 N-CA-C 110.702 -0.959 . . . . 0.29 110.702 174.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -130.25 137.3 49.94 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.021 -0.733 . . . . 1.08 109.021 177.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1566 ' ' CYS . . . . . 0.534 ' HB2' HG12 ' A' 1563 ' ' VAL . 42.4 t -156.96 135.29 11.3 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 121.243 -0.183 . . . . 0.43 111.201 -177.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1567 ' ' PHE . . . . . 0.865 ' CE1' ' HB ' ' A' 1548 ' ' VAL . 9.5 m-85 -112.9 163.76 14.25 Favored 'General case' 0 C--O 1.245 0.857 0 C-N-CA 123.308 0.643 . . . . 1.3 110.491 173.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . 94.31 169.53 37.61 Favored Glycine 0 N--CA 1.399 -3.831 0 C-N-CA 118.831 -1.652 . . . . 1.43 114.324 164.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -89.6 -30.14 18.37 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 114.242 -0.979 . . . . 3.09 108.985 177.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 66.3 p -85.09 2.65 42.49 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.555 -0.748 . . . . 2.52 112.74 -177.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1571 ' ' ARG . . . . . 0.588 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 2.2 mpt_? 67.6 69.07 0.36 Allowed 'General case' 0 C--N 1.348 0.518 0 CA-C-N 114.704 -1.134 . . . . 3.19 110.831 175.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 32.0 mt -96.59 106.02 17.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-N 115.582 -0.735 . . . . 1.51 109.727 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 30.9 t -66.81 130.07 41.97 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-N 114.732 -1.122 . . . . 0.96 110.379 -177.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1574 ' ' VAL . . . . . 0.554 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 34.4 m -123.55 20.92 4.56 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.336 0 CA-C-O 121.535 0.683 . . . . 1.6 110.607 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 169.43 124.17 0.72 Allowed Glycine 0 N--CA 1.418 -2.546 0 CA-C-N 114.915 -1.039 . . . . 0.34 111.329 176.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -75.53 141.94 42.9 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.079 -0.711 . . . . 2.68 109.079 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -69.9 84.19 0.49 Allowed 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 123.404 0.681 . . . . 1.08 112.708 -177.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -93.68 168.18 11.18 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 115.569 -0.741 . . . . 1.95 109.346 176.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 55.1 mttm -129.31 41.92 3.38 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.519 -0.919 . . . . 3.11 108.519 -176.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 46.4 ttm-85 -105.98 77.65 1.26 Allowed 'General case' 0 N--CA 1.403 -2.786 0 CA-C-N 115.314 -0.857 . . . . 4.04 109.841 -175.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1581 ' ' LEU . . . . . 0.713 ' HB2' ' HA ' ' A' 1516 ' ' CYS . 1.2 tm? -65.47 124.97 23.69 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 113.798 -1.546 . . . . 1.32 107.49 175.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1582 ' ' ARG . . . . . 0.496 ' HA ' ' HB3' ' A' 1511 ' ' ASN . 63.9 mtp180 -118.54 141.0 49.01 Favored 'General case' 0 C--N 1.289 -2.048 0 C-N-CA 120.853 -0.339 . . . . 3.4 110.706 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1583 ' ' TYR . . . . . 0.656 ' HB2' HG21 ' A' 1518 ' ' VAL . 64.0 t80 -120.01 109.01 14.99 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 109.249 -0.648 . . . . 1.26 109.249 -179.217 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1584 ' ' VAL . . . . . 0.495 ' O ' ' HB ' ' A' 1587 ' ' VAL . 9.4 m -128.7 94.9 2.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-N 115.8 -0.636 . . . . 1.71 111.752 -179.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 12.3 t70 56.53 60.91 2.88 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 123.851 0.86 . . . . 1.17 110.714 176.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1586 ' ' GLN . . . . . 0.417 ' HA ' ' HE1' ' A' 1583 ' ' TYR 0.313 10.0 pt20 65.24 12.08 7.75 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 126.828 2.051 . . . . 2.43 113.147 178.972 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A 1587 ' ' VAL . . . . . 0.495 ' HB ' ' O ' ' A' 1584 ' ' VAL . 39.6 t -101.78 120.07 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.95 0 N-CA-C 107.588 -1.264 . . . . 1.16 107.588 174.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1588 ' ' LEU . . . . . 0.709 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 2.9 mm? -96.82 110.35 22.85 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 106.009 -1.848 . . . . 1.11 106.009 177.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1589 ' ' GLN . . . . . 0.403 ' HA ' ' O ' ' A' 1610 ' ' ILE . 28.5 tt0 -125.48 132.16 52.71 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-O 121.672 0.748 . . . . 1.74 112.767 -171.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 11.7 mt -115.1 128.31 56.14 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 107.27 -1.381 . . . . 1.4 107.27 175.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 59.3 t -119.03 118.9 59.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 C-N-CA 119.66 -0.816 . . . . 1.7 110.511 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1592 ' ' TYR . . . . . 0.453 ' O ' ' HA ' ' A' 1607 ' ' LYS . 16.8 m-30 -106.18 95.2 5.61 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 115.65 -0.705 . . . . 1.08 109.104 -179.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1593 ' ' LYS . . . . . 0.524 ' HB3' ' HD3' ' A' 1607 ' ' LYS . 0.0 OUTLIER -109.28 163.07 13.71 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 116.685 -0.234 . . . . 2.21 111.332 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 6.4 m-20 66.12 55.84 0.87 Allowed 'General case' 0 C--N 1.318 -0.787 0 O-C-N 124.472 1.108 . . . . 1.11 112.003 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -83.55 -107.27 0.53 Allowed Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 110.029 -1.228 . . . . 0.78 110.029 174.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1596 ' ' SER . . . . . . . . . . . . . 85.8 p -102.41 148.82 36.0 Favored Pre-proline 0 C--O 1.261 1.7 0 N-CA-C 108.847 -0.797 . . . . 1.36 108.847 175.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1597 ' ' PRO . . . . . 0.495 ' HB2' ' HG2' ' B' ' 6' ' ' GLU . 31.6 Cg_exo -63.66 122.8 11.02 Favored 'Trans proline' 0 N--CA 1.446 -1.269 0 C-N-CA 122.751 2.3 . . . . 1.4 108.998 174.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 17.0 t -78.83 110.46 14.42 Favored Pre-proline 0 C--N 1.301 -1.534 0 N-CA-C 108.621 -0.881 . . . . 0.75 108.621 -172.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1599 ' ' PRO . . . . . 0.541 ' HB2' HD22 ' B' ' 8' ' ' LEU . 37.1 Cg_endo -67.07 -12.22 35.23 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 122.843 2.362 . . . . 1.7 112.839 -173.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1600 ' ' SER . . . . . 0.796 ' HB3' ' HB2' ' B' ' 53' ' ' LEU . 18.0 m -61.56 -31.06 71.08 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.929 0.891 . . . . 2.8 111.907 178.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1601 ' ' LYS . . . . . 0.567 ' HB3' HD22 ' A' 1604 ' ' LEU . 41.0 ttmt -161.06 122.0 2.85 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 107.445 -1.317 . . . . 3.45 107.445 176.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 15.1 m -59.05 131.26 50.51 Favored 'General case' 0 N--CA 1.424 -1.73 0 C-N-CA 123.028 0.531 . . . . 2.44 111.39 -176.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 105.37 -3.96 40.4 Favored Glycine 0 C--N 1.309 -0.951 0 CA-C-N 116.258 -0.428 . . . . 1.2 112.768 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1604 ' ' LEU . . . . . 0.567 HD22 ' HB3' ' A' 1601 ' ' LYS . 10.3 mp -100.45 157.77 16.4 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 122.462 -0.434 . . . . 2.38 111.551 -178.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 33.8 m -146.88 143.93 28.91 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 108.312 -0.996 . . . . 1.96 108.312 175.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1606 ' ' TYR . . . . . 0.554 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 76.1 m-85 -69.53 151.63 45.77 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 116.334 -0.394 . . . . 1.06 110.928 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1607 ' ' LYS . . . . . 0.524 ' HD3' ' HB3' ' A' 1593 ' ' LYS . 36.6 ttpt -150.95 130.33 12.87 Favored 'General case' 0 N--CA 1.441 -0.878 0 O-C-N 124.007 0.817 . . . . 2.0 109.824 -175.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1608 ' ' SER . . . . . 0.453 ' HB3' ' HB2' ' A' 1592 ' ' TYR . 37.3 t -105.38 120.11 40.76 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 108.939 -0.763 . . . . 1.61 108.939 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 22.8 t -105.32 107.3 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 N-CA-C 107.831 -1.174 . . . . 1.09 107.831 177.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1610 ' ' ILE . . . . . 0.403 ' O ' ' HA ' ' A' 1589 ' ' GLN . 64.3 mt -101.91 111.73 32.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 CA-C-N 115.676 -0.693 . . . . 1.2 110.046 -176.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 21.4 p -111.64 117.84 34.03 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.928 -0.578 . . . . 1.89 112.153 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1612 ' ' PHE . . . . . 0.709 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 78.0 m-85 -93.08 124.34 36.99 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.19 -1.041 . . . . 0.28 108.19 177.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 49.1 t -118.74 137.23 53.39 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 116.544 -0.298 . . . . 1.23 110.984 -175.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 3.5 t -59.69 103.0 0.17 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.668 1.187 . . . . 0.77 112.633 177.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1615 ' ' ARG . . . . . 0.556 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 20.8 mmt180 -138.49 112.58 8.53 Favored Pre-proline 0 C--N 1.32 -0.693 0 O-C-N 122.369 -0.207 . . . . 2.92 111.224 171.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1616 ' ' PRO . . . . . 0.584 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 37.3 Cg_endo -74.06 -1.71 11.27 Favored 'Trans proline' 0 N--CA 1.489 1.213 0 C-N-CA 122.902 2.401 . . . . 1.22 113.213 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -89.5 41.7 1.05 Allowed 'General case' 0 C--N 1.291 -1.959 0 C-N-CA 124.936 1.294 . . . . 3.05 110.83 -177.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -41.54 123.79 2.28 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.86 1.664 . . . . 1.55 112.647 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1619 ' ' GLY . . . . . 0.435 ' HA3' ' HD2' ' A' 1620 ' ' PRO . . . 171.03 -135.8 3.65 Favored Glycine 0 CA--C 1.48 -2.151 0 N-CA-C 110.13 -1.188 . . . . 1.16 110.13 -177.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1620 ' ' PRO . . . . . 0.435 ' HD2' ' HA3' ' A' 1619 ' ' GLY . 35.1 Cg_endo -64.12 -2.46 4.76 Favored 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 123.342 2.695 . . . . 1.06 115.231 -177.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1621 ' ' THR . . . . . 0.661 ' HB ' ' HB2' ' A' 1641 ' ' HIS . 13.0 p -98.82 -11.4 21.82 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 121.728 0.775 . . . . 1.58 109.677 178.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 48.0 t30 -93.48 64.9 3.7 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 122.457 1.122 . . . . 0.88 108.333 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -166.97 140.47 3.05 Favored Pre-proline 0 C--N 1.3 -1.55 0 N-CA-C 106.422 -1.695 . . . . 3.82 106.422 -178.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -59.45 110.26 0.69 Allowed 'Trans proline' 0 C--O 1.243 0.766 0 C-N-CA 122.56 2.174 . . . . 0.77 111.527 -178.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 74.9 mtm -110.14 141.77 42.57 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 116.078 -0.51 . . . . 1.43 110.066 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1626 ' ' LEU . . . . . 0.637 ' HG ' ' HE2' ' A' 1542 ' ' TYR . 1.4 tm? -86.2 119.06 26.08 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 108.141 -1.059 . . . . 1.43 108.141 -176.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1627 ' ' ILE . . . . . 0.6 HD12 ' HB2' ' A' 1639 ' ' SER . 44.5 mm -79.69 -55.42 9.2 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 CA-C-O 121.513 0.673 . . . . 1.23 109.434 178.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 22.6 t -163.72 148.41 10.62 Favored 'General case' 0 N--CA 1.419 -2.01 0 N-CA-C 107.969 -1.123 . . . . 1.88 107.969 -176.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1629 ' ' LEU . . . . . 0.736 HD13 ' HG ' ' A' 1636 ' ' LEU . 50.3 tp -116.91 105.43 12.33 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.662 -0.866 . . . . 1.92 108.662 176.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 12.5 t70 -84.32 106.24 15.78 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.015 -1.476 . . . . 1.09 107.015 176.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1631 ' ' LYS . . . . . 0.423 ' HD2' ' HA ' ' A' 1631 ' ' LYS . 14.4 mmmt -85.74 -3.43 58.89 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 112.86 0.689 . . . . 3.98 112.86 -175.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -87.69 -33.63 18.69 Favored 'General case' 0 N--CA 1.421 -1.888 0 O-C-N 123.43 0.456 . . . . 2.6 109.804 -177.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 40.3 p -102.37 -16.34 16.25 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.096 0.474 . . . . 1.35 110.29 173.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1634 ' ' CYS . . . . . 0.451 ' O ' ' HA ' ' A' 1606 ' ' TYR . 60.2 m 72.56 37.57 0.87 Allowed 'General case' 0 C--N 1.355 0.845 0 C-N-CA 125.203 1.401 . . . . 0.53 111.307 179.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1635 ' ' THR . . . . . . . . . . . . . 94.7 m -103.23 134.03 47.32 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 115.253 -0.885 . . . . 1.11 109.697 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1636 ' ' LEU . . . . . 0.736 ' HG ' HD13 ' A' 1629 ' ' LEU . 0.5 OUTLIER -114.97 124.39 51.55 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.548 -0.908 . . . . 1.56 108.548 -177.826 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -104.37 130.73 52.22 Favored 'General case' 0 C--O 1.25 1.101 0 N-CA-C 110.37 -0.233 . . . . 0.54 110.37 -178.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -127.81 137.99 52.57 Favored 'General case' 0 C--O 1.251 1.135 0 CA-C-O 121.065 0.46 . . . . 0.64 110.48 -178.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1639 ' ' SER . . . . . 0.6 ' HB2' HD12 ' A' 1627 ' ' ILE . 21.4 t -116.08 157.95 23.93 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.148 -1.056 . . . . 1.34 108.148 177.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 2.3 t90 -156.34 113.21 3.14 Favored 'General case' 0 N--CA 1.409 -2.497 0 N-CA-C 105.349 -2.093 . . . . 0.8 105.349 -177.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1641 ' ' HIS . . . . . 0.661 ' HB2' ' HB ' ' A' 1621 ' ' THR . 13.0 m170 -104.01 105.29 15.42 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 109.485 -0.561 . . . . 1.14 109.485 -176.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1642 ' ' THR . . . . . . . . . . . . . 11.3 t -142.95 145.13 31.99 Favored Pre-proline 0 C--N 1.306 -1.3 0 CA-C-N 116.111 -0.495 . . . . 1.11 109.881 -173.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1643 ' ' PRO . . . . . 0.584 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 73.4 Cg_endo -76.49 -10.37 18.82 Favored 'Trans proline' 0 C--N 1.366 1.5 0 C-N-CA 122.595 2.197 . . . . 0.78 112.136 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 7.7 tt -69.0 -24.31 64.21 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.396 0.617 . . . . 1.66 109.896 177.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -100.1 17.44 21.13 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 122.123 0.963 . . . . 1.29 109.21 -176.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 20.1 t -121.46 155.04 35.75 Favored 'General case' 0 N--CA 1.41 -2.451 0 N-CA-C 107.761 -1.2 . . . . 1.48 107.761 -178.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -95.82 119.0 65.62 Favored Pre-proline 0 C--N 1.298 -1.633 0 N-CA-C 108.57 -0.9 . . . . 3.14 108.57 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1648 ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -50.02 113.09 0.86 Allowed 'Trans proline' 0 C--N 1.364 1.392 0 C-N-CA 123.345 2.697 . . . . 2.92 112.306 177.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 . . . . . 0 C--N 1.299 -1.611 0 N-CA-C 105.987 -1.857 . . . . 4.72 105.987 -177.924 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.512 -0.511 0 N-CA-C 109.392 -0.596 . . . . 10.26 109.392 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' TYR . . . . . 0.729 ' HH ' HG21 ' B' ' 7' ' ' THR . 29.1 t80 -122.73 129.77 52.16 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 106.831 -1.544 . . . . 7.94 106.831 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' ARG . . . . . 0.486 ' HG3' ' HG3' ' B' ' 6' ' ' GLU . 29.8 ptt180 -126.66 126.2 24.48 Favored Pre-proline 0 C--N 1.298 -1.663 0 CA-C-O 120.944 0.402 . . . . 6.56 110.303 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -63.28 -11.09 23.7 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 123.483 2.789 . . . . 5.51 113.741 -175.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 5.9 m -66.05 -19.21 65.78 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.511 0.672 . . . . 4.91 111.239 177.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . 0.495 ' HG2' ' HB2' ' A' 1597 ' ' PRO . 37.1 mt-10 -98.87 1.83 46.11 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 115.445 -0.798 . . . . 4.23 110.74 -178.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' THR . . . . . 0.729 HG21 ' HH ' ' B' ' 2' ' ' TYR . 64.9 p -110.94 98.15 7.35 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 106.121 -1.807 . . . . 3.48 106.121 175.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . 0.673 HD21 ' H ' ' B' ' 8' ' ' LEU . 1.9 pt? -72.1 137.68 47.24 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 122.632 0.373 . . . . 4.35 111.64 -173.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 6.5 t -150.73 167.51 27.17 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 109.011 -0.737 . . . . 2.84 109.011 177.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.95 -123.98 16.24 Favored Glycine 0 C--O 1.246 0.859 0 C-N-CA 121.263 -0.494 . . . . 2.28 111.92 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -75.57 -17.69 80.05 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 121.418 -0.42 . . . . 1.94 113.627 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -66.96 -27.29 67.34 Favored 'General case' 0 C--O 1.215 -0.722 0 N-CA-C 109.387 -0.597 . . . . 2.55 109.387 -176.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . 0.423 ' CD1' HG23 ' B' ' 43' ' ' VAL . 32.1 mt -66.85 -61.42 1.96 Allowed 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 115.059 -0.973 . . . . 2.82 108.907 -179.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 9.9 p -64.39 -40.76 90.17 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.525 0 CA-C-N 114.853 -1.067 . . . . 2.5 112.097 -176.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -74.47 -26.5 60.07 Favored 'General case' 0 CA--C 1.557 1.246 0 N-CA-C 113.961 1.097 . . . . 2.04 113.961 -176.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 20.4 p -75.0 -43.25 54.98 Favored 'General case' 0 C--O 1.248 0.974 0 O-C-N 121.066 -1.022 . . . . 2.31 109.144 175.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.565 ' O ' ' HB2' ' B' ' 21' ' ' CYS . 0.9 OUTLIER -56.06 -40.91 74.26 Favored 'General case' 0 N--CA 1.42 -1.951 0 CA-C-N 114.863 -1.062 . . . . 2.27 111.513 169.471 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . 0.464 ' HG2' ' HB2' ' A' 1545 ' ' SER . 8.8 tt0 -71.86 -24.85 61.75 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 121.127 0.489 . . . . 2.39 109.718 179.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -64.07 -62.68 1.47 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.036 -0.529 . . . . 1.0 112.109 178.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 12.6 p -94.65 -20.32 6.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 C-N-CA 118.53 -1.268 . . . . 1.83 111.909 -177.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' CYS . . . . . 0.565 ' HB2' ' O ' ' B' ' 17' ' ' LEU . 96.1 m -102.94 18.46 21.56 Favored 'General case' 0 C--N 1.312 -1.027 0 O-C-N 121.834 -0.541 . . . . 1.66 111.448 178.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -54.02 -50.25 55.87 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 121.355 -0.45 . . . . 1.53 113.219 178.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -75.86 -11.13 59.92 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 122.548 0.339 . . . . 2.72 111.591 178.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . 0.536 ' HG2' ' SG ' ' B' ' 60' ' ' CYS . 21.1 tpp180 -91.53 -50.13 5.94 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.715 0.769 . . . . 5.02 110.434 -178.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 115.79 157.6 11.32 Favored Glycine 0 N--CA 1.417 -2.593 0 N-CA-C 107.949 -2.06 . . . . 1.63 107.949 -173.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -119.23 137.58 53.56 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 117.943 0.871 . . . . 1.71 111.453 177.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' TYR . . . . . 0.78 ' HB2' ' HA ' ' B' ' 61' ' ' ALA . 3.5 m-85 -128.89 -54.25 1.22 Allowed 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 107.684 -1.228 . . . . 3.67 107.684 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' PHE . . . . . . . . . . . . . 43.4 p90 43.93 12.71 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 128.06 2.544 . . . . 2.44 117.776 172.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 16.6 m -153.1 150.98 29.68 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 106.85 -1.537 . . . . 3.85 106.85 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 9.4 mmm180 -122.83 124.81 26.53 Favored Pre-proline 0 C--N 1.302 -1.473 0 N-CA-C 105.634 -1.987 . . . . 4.27 105.634 174.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . 0.537 ' HA ' ' HB3' ' B' ' 39' ' ' SER . 76.0 Cg_exo -53.21 -34.05 67.64 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 123.899 3.066 . . . . 4.2 112.668 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -154.94 151.24 28.29 Favored 'General case' 0 N--CA 1.42 -1.943 0 N-CA-C 109.489 -0.56 . . . . 5.12 109.489 176.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 9.0 t 177.85 167.79 0.71 Allowed 'General case' 0 N--CA 1.402 -2.833 0 N-CA-C 103.868 -2.641 . . . . 6.93 103.868 -178.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 25.1 ttt180 -96.31 2.22 52.64 Favored 'General case' 0 C--N 1.279 -2.459 0 CA-C-O 122.271 1.034 . . . . 12.14 108.583 177.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 42.9 t -110.23 -21.94 5.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 114.39 -1.277 . . . . 9.9 107.653 175.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 42.5 p -147.57 73.32 1.27 Allowed 'General case' 0 N--CA 1.408 -2.533 0 CA-C-N 114.376 -1.283 . . . . 6.82 109.691 178.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -74.2 -4.29 35.04 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-O 121.976 0.894 . . . . 10.71 109.605 172.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . 0.528 ' HG3' ' HG3' ' B' ' 40' ' ' ARG . 24.2 tpp180 -95.12 137.58 33.98 Favored 'General case' 0 N--CA 1.424 -1.766 0 N-CA-C 104.281 -2.489 . . . . 8.6 104.281 174.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' SER . . . . . 0.537 ' HB3' ' HA ' ' B' ' 31' ' ' PRO . 4.6 p -83.92 56.27 3.62 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 123.26 1.505 . . . . 5.79 111.587 -178.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . 0.528 ' HG3' ' HG3' ' B' ' 38' ' ' ARG . 58.9 mtp180 -144.83 164.38 31.23 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 103.709 -2.7 . . . . 6.57 103.709 -178.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . -135.32 -87.62 0.25 Allowed Glycine 0 C--N 1.295 -1.743 0 C-N-CA 119.054 -1.546 . . . . 2.62 112.722 -177.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 41.4 pt -85.73 -17.55 9.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 O-C-N 122.701 -0.293 . . . . 2.28 111.349 -177.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . 0.477 ' CG1' ' HB3' ' B' ' 40' ' ' ARG . 14.9 p -53.05 -41.39 41.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 N-CA-C 114.456 1.28 . . . . 2.6 114.456 -172.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -74.01 -31.92 63.15 Favored 'General case' 0 C--O 1.244 0.793 0 C-N-CA 118.933 -1.107 . . . . 3.36 108.876 -175.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -85.22 -14.27 47.33 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 114.869 -1.06 . . . . 3.08 112.296 -176.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' CYS . . . . . . . . . . . . . 81.2 m -104.4 -22.76 13.27 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 112.669 0.618 . . . . 2.23 112.669 175.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 95.9 m -79.39 -49.0 13.03 Favored 'General case' 0 C--O 1.239 0.544 0 O-C-N 121.759 -0.588 . . . . 2.48 112.27 178.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -97.38 -7.91 30.75 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.115 0.483 . . . . 2.97 111.471 -177.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 52.9 mtp180 -139.65 177.64 7.8 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 115.946 -0.57 . . . . 4.65 109.483 -176.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 50.9 m -106.46 135.92 47.12 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 115.475 -0.784 . . . . 2.86 109.372 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . 0.502 ' HB2' HD21 ' B' ' 55' ' ' LEU . 11.7 p -120.63 138.98 53.63 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 109.647 -0.501 . . . . 2.11 109.647 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -82.49 142.77 31.61 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.062 0.458 . . . . 2.67 109.768 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . 0.796 ' HB2' ' HB3' ' A' 1600 ' ' SER . 66.2 tp -37.69 -42.0 0.53 Allowed 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 127.186 2.194 . . . . 2.36 113.808 -177.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . 0.594 ' O ' HG23 ' B' ' 58' ' ' THR . . . -53.27 -38.97 63.54 Favored 'General case' 0 C--N 1.318 -0.789 0 O-C-N 124.423 1.077 . . . . 1.92 111.635 -177.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . 0.502 HD21 ' HB2' ' B' ' 51' ' ' CYS . 53.6 tp -59.67 -56.32 23.34 Favored 'General case' 0 C--O 1.213 -0.827 0 O-C-N 124.146 0.903 . . . . 2.35 110.599 -178.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 3.3 pp -69.8 -31.04 68.73 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 116.309 -0.405 . . . . 2.01 110.967 -174.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -66.84 -51.65 53.07 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.891 -0.595 . . . . 2.27 111.575 178.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 58' ' ' THR . . . . . 0.594 HG23 ' O ' ' B' ' 54' ' ' ALA . 12.0 t -83.63 -13.24 54.72 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 112.901 0.704 . . . . 2.67 112.901 -177.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -85.61 -72.33 0.49 Allowed 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 105.929 -1.878 . . . . 3.2 105.929 175.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 60' ' ' CYS . . . . . 0.536 ' SG ' ' HG2' ' B' ' 24' ' ' ARG . 43.7 t 51.36 -86.88 0.01 OUTLIER 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 114.554 1.316 . . . . 2.3 114.554 172.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 61' ' ' ALA . . . . . 0.78 ' HA ' ' HB2' ' B' ' 27' ' ' TYR . . . -130.42 -63.74 0.87 Allowed 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 107.407 -1.331 . . . . 3.19 107.407 -177.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 1.5 p -119.64 141.87 31.83 Favored Pre-proline 0 N--CA 1.407 -2.589 0 CA-C-N 114.441 -1.254 . . . . 4.14 107.711 175.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . 0.425 ' HA ' ' O ' ' B' ' 58' ' ' THR . 36.3 Cg_endo -70.12 -7.69 21.79 Favored 'Trans proline' 0 C--O 1.25 1.109 0 C-N-CA 122.985 2.456 . . . . 5.59 113.24 -175.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . 0.638 ' HA ' ' OE1' ' B' ' 67' ' ' GLU . . . 70.19 22.07 5.68 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 125.567 1.547 . . . . 5.51 112.544 175.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -135.71 6.95 3.23 Favored 'General case' 0 N--CA 1.416 -2.125 0 CA-C-N 115.558 -0.747 . . . . 8.8 111.105 -177.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 33.9 p -138.44 22.98 2.74 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.143 0.497 . . . . 8.12 111.286 -175.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . 0.638 ' OE1' ' HA ' ' B' ' 64' ' ' ALA . 2.8 mp0 . . . . . 0 N--CA 1.432 -1.364 0 N-CA-C 108.031 -1.1 . . . . 10.21 108.031 -177.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 64.3 mtt . . . . . 0 CA--C 1.505 -0.754 0 N-CA-C 109.097 -0.705 . . . . 9.74 109.097 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A 1509 ' ' LYS . . . . . 0.654 ' O ' ' HB ' ' A' 1519 ' ' THR . 51.5 mtpt -89.51 15.69 8.93 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 120.728 0.299 . . . . 9.32 110.978 177.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1510 ' ' SER . . . . . 0.603 ' HA ' ' O ' ' A' 1519 ' ' THR . 8.1 p -90.67 -72.89 0.55 Allowed 'General case' 0 N--CA 1.433 -1.316 0 CA-C-O 121.066 0.46 . . . . 5.97 111.685 -179.05 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1511 ' ' ASN . . . . . . . . . . . . . 14.1 m120 -78.39 75.37 4.91 Favored 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 123.541 0.736 . . . . 3.48 110.198 178.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1512 ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -88.29 -28.36 21.12 Favored 'General case' 0 C--N 1.305 -1.37 0 CA-C-N 115.627 -0.715 . . . . 5.95 110.405 -178.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -128.67 141.83 51.22 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 108.459 -0.941 . . . . 6.14 108.459 -176.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -73.48 46.43 0.2 Allowed 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 125.995 1.718 . . . . 5.06 110.496 176.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1515 ' ' ASP . . . . . 0.452 ' HB3' ' HG2' ' A' 1517 ' ' GLN . 23.0 t70 -130.98 177.7 7.24 Favored 'General case' 0 C--N 1.28 -2.436 0 N-CA-C 106.014 -1.847 . . . . 2.9 106.014 -174.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 34.9 t -91.09 69.25 6.19 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 107.953 -1.129 . . . . 1.41 107.953 -175.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1517 ' ' GLN . . . . . 0.452 ' HG2' ' HB3' ' A' 1515 ' ' ASP . 9.8 pt20 -165.23 148.18 8.13 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-N 114.591 -1.186 . . . . 2.18 108.953 -174.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 3.7 m -145.74 143.06 21.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 C-N-CA 123.344 0.657 . . . . 1.52 110.051 177.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1519 ' ' THR . . . . . 0.654 ' HB ' ' O ' ' A' 1509 ' ' LYS . 42.6 m -93.83 139.82 30.41 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 116.017 -0.538 . . . . 1.36 109.762 177.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1520 ' ' ASN . . . . . 0.544 ' OD1' HG23 ' A' 1523 ' ' THR . 16.4 t-20 -75.29 117.89 66.57 Favored Pre-proline 0 N--CA 1.428 -1.575 0 N-CA-C 107.712 -1.218 . . . . 2.02 107.712 174.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.39 -17.71 49.39 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 122.782 2.321 . . . . 1.82 113.529 -176.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 10.7 m -80.98 -42.97 20.36 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 112.216 0.451 . . . . 1.89 112.216 -176.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1523 ' ' THR . . . . . 0.544 HG23 ' OD1' ' A' 1520 ' ' ASN . 6.2 t -120.99 -8.47 9.35 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.674 0.62 . . . . 1.99 112.674 -175.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 80.39 24.29 59.25 Favored Glycine 0 C--O 1.239 0.446 0 C-N-CA 120.339 -0.934 . . . . 1.19 112.826 177.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -89.93 123.17 33.62 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 109.369 -0.604 . . . . 1.82 109.369 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 2.2 tm? -87.58 113.12 22.98 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 123.623 0.769 . . . . 1.3 109.237 -177.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -88.87 114.01 25.03 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 109.705 -0.48 . . . . 0.8 109.705 176.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 14.6 t70 -101.62 110.37 22.35 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.342 -0.984 . . . . 1.17 108.342 177.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 3.3 mm? -92.11 -2.42 56.62 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.986 0.898 . . . . 1.29 109.309 -177.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 2.9 m -73.98 -10.27 59.47 Favored 'General case' 0 C--O 1.215 -0.737 0 CA-C-N 114.48 -1.236 . . . . 0.91 109.615 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1531 ' ' SER . . . . . 0.56 ' HB2' HD11 ' A' 1644 ' ' LEU . 19.0 m -72.3 -16.97 61.9 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 109.027 -0.731 . . . . 1.98 109.027 176.038 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1532 ' ' LEU . . . . . 0.417 ' O ' ' HB ' ' A' 1552 ' ' ILE . 67.9 mt -107.05 5.59 28.18 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.253 -0.885 . . . . 1.34 110.891 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1533 ' ' SER . . . . . 0.431 ' HA ' ' O ' ' A' 1552 ' ' ILE . 69.3 p -67.5 164.34 19.09 Favored 'General case' 0 C--O 1.249 1.062 0 CA-C-O 121.367 0.604 . . . . 1.93 111.614 -178.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -170.81 142.0 6.84 Favored Glycine 0 N--CA 1.418 -2.561 0 C-N-CA 120.343 -0.932 . . . . 1.1 111.151 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 23.1 ttt180 -92.86 -36.41 12.84 Favored 'General case' 0 C--N 1.292 -1.911 0 C-N-CA 122.688 0.395 . . . . 5.21 111.156 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -82.93 -36.72 25.0 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.721 0.772 . . . . 1.94 109.421 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 97.36 179.19 34.02 Favored Glycine 0 N--CA 1.418 -2.555 0 CA-C-N 114.918 -1.037 . . . . 1.08 112.476 173.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -119.84 147.23 44.93 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 107.675 -1.231 . . . . 1.07 107.675 178.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 5.5 p -103.37 117.68 35.04 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.334 0.587 . . . . 1.46 111.963 -177.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1540 ' ' ALA . . . . . 0.437 ' HB3' ' CG1' ' A' 1548 ' ' VAL . . . -108.16 121.78 45.55 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 107.927 -1.138 . . . . 1.19 107.927 176.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -70.92 134.07 46.94 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 116.144 -0.48 . . . . 1.37 110.761 -178.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1542 ' ' TYR . . . . . 0.469 ' HB3' ' H ' ' A' 1543 ' ' SER . 1.2 t80 -126.94 -99.94 0.37 Allowed 'General case' 0 N--CA 1.418 -2.054 0 N-CA-C 106.564 -1.643 . . . . 1.38 106.564 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1543 ' ' SER . . . . . 0.469 ' H ' ' HB3' ' A' 1542 ' ' TYR . 3.3 m -66.06 159.22 26.46 Favored 'General case' 0 N--CA 1.416 -2.126 0 C-N-CA 123.223 0.609 . . . . 1.98 110.236 178.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -51.23 -44.3 61.66 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.373 0.533 . . . . 3.96 112.094 -178.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 7.5 t -117.41 37.64 3.83 Favored 'General case' 0 N--CA 1.424 -1.759 0 N-CA-C 108.999 -0.741 . . . . 2.81 108.999 178.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . -147.44 109.36 0.47 Allowed Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 120.083 -1.056 . . . . 1.68 113.934 -177.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 36.0 m -98.89 160.63 3.21 Favored 'Isoleucine or valine' 0 C--O 1.252 1.187 0 N-CA-C 108.876 -0.786 . . . . 1.38 108.876 175.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1548 ' ' VAL . . . . . 0.498 ' HB ' ' CE1' ' A' 1567 ' ' PHE . 10.9 p -109.33 131.76 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.675 0 N-CA-C 107.647 -1.242 . . . . 1.24 107.647 174.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -93.27 125.54 37.92 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.988 -1.115 . . . . 1.29 107.988 178.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 24.0 ptm -136.39 134.29 37.64 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 120.033 -0.667 . . . . 1.47 112.169 -177.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 11.9 p -123.41 125.04 44.24 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-N 115.073 -0.967 . . . . 1.4 109.73 177.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1552 ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' A' 1533 ' ' SER . 47.9 mm -84.18 124.46 39.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 N-CA-C 109.86 -0.422 . . . . 1.11 109.86 -179.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1553 ' ' CYS . . . . . 0.416 ' SG ' HG23 ' A' 1552 ' ' ILE . 56.6 m 64.43 26.07 13.44 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.896 0.878 . . . . 1.4 112.231 174.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . -172.07 -179.23 42.86 Favored Glycine 0 N--CA 1.431 -1.643 0 N-CA-C 110.308 -1.117 . . . . 0.4 110.308 -178.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -101.34 145.56 28.74 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 121.283 0.563 . . . . 1.62 111.825 -177.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -92.57 137.45 32.35 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.014 -0.994 . . . . 1.12 108.845 -177.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -80.43 -8.83 59.69 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.354 0.872 . . . . 2.49 113.354 -172.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -83.62 -9.06 59.15 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 120.946 0.403 . . . . 1.38 112.026 -175.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1559 ' ' CYS . . . . . 0.799 ' HB3' HG13 ' A' 1563 ' ' VAL . 9.3 t -136.87 153.71 75.72 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 108.164 -1.05 . . . . 1.21 108.164 -177.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1560 ' ' PRO . . . . . 0.593 ' HD2' ' SG ' ' A' 1559 ' ' CYS . 23.7 Cg_exo -28.84 135.51 0.03 OUTLIER 'Trans proline' 0 C--N 1.379 2.183 1 C-N-CA 125.988 4.459 . . . . 0.98 115.133 178.293 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -45.93 120.95 3.85 Favored 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 125.104 3.87 . . . . 1.15 114.125 -177.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 101.73 21.75 10.94 Favored Glycine 0 CA--C 1.531 1.081 0 CA-C-N 115.826 -0.625 . . . . 0.55 113.045 -176.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1563 ' ' VAL . . . . . 0.799 HG13 ' HB3' ' A' 1559 ' ' CYS . 2.3 t -102.02 124.29 55.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 O-C-N 122.162 -0.61 . . . . 1.53 110.931 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -97.3 -35.76 5.14 Favored Glycine 0 C--N 1.3 -1.447 0 N-CA-C 110.495 -1.042 . . . . 0.29 110.495 175.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -138.58 132.89 31.79 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.202 -0.666 . . . . 1.08 109.202 177.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 53.0 t -156.42 139.3 15.28 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.459 -0.571 . . . . 0.43 109.459 -177.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1567 ' ' PHE . . . . . 0.498 ' CE1' ' HB ' ' A' 1548 ' ' VAL . 67.3 m-85 -87.3 147.94 25.29 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.294 -0.562 . . . . 1.3 110.0 177.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -89.34 40.34 3.06 Favored Glycine 0 N--CA 1.437 -1.265 0 C-N-CA 120.393 -0.908 . . . . 1.43 113.363 -175.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1569 ' ' GLN . . . . . 0.401 ' HB2' ' OD2' ' B' ' 15' ' ' ASP . 28.3 mm-40 -95.16 -71.61 0.66 Allowed 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 119.874 -0.731 . . . . 3.09 110.449 175.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 81.6 p -130.69 40.65 3.47 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 118.638 0.653 . . . . 2.52 112.354 175.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 13.0 mmt85 63.6 49.76 2.96 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 123.923 0.889 . . . . 3.19 111.114 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 26.0 mm -98.53 113.72 34.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 N-CA-C 109.149 -0.686 . . . . 1.51 109.149 -178.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1573 ' ' SER . . . . . 0.495 ' HB3' ' OG ' ' A' 1596 ' ' SER . 31.6 t -86.11 142.16 28.88 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 121.713 0.768 . . . . 0.96 110.402 -176.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1574 ' ' VAL . . . . . 0.612 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 30.5 m -124.17 15.09 4.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 CA-C-N 115.495 -0.775 . . . . 1.6 110.237 179.139 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . -179.44 123.48 0.85 Allowed Glycine 0 N--CA 1.417 -2.58 0 C-N-CA 118.825 -1.655 . . . . 0.34 112.21 177.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1576 ' ' LYS . . . . . 0.43 ' HB2' ' O ' ' A' 1594 ' ' ASP . 57.7 tttp -77.26 134.29 38.61 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 108.013 -1.106 . . . . 2.68 108.013 176.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -70.72 117.47 12.28 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.889 -0.596 . . . . 1.08 110.74 -177.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -133.56 174.88 9.94 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 106.913 -1.514 . . . . 1.95 106.913 177.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -123.93 45.83 2.39 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 106.184 -1.784 . . . . 3.11 106.184 178.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.86 88.01 3.9 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 113.527 -1.669 . . . . 4.04 107.579 -172.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1581 ' ' LEU . . . . . 0.46 HD23 ' HG ' ' A' 1590 ' ' LEU . 0.2 OUTLIER -89.73 133.51 34.65 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.228 -1.027 . . . . 1.32 108.228 -177.684 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -122.93 138.57 54.63 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 109.992 -0.373 . . . . 3.4 109.992 174.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1583 ' ' TYR . . . . . . . . . . . . . 50.0 t80 -109.43 111.9 23.71 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 107.624 -1.25 . . . . 1.26 107.624 177.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1584 ' ' VAL . . . . . 0.613 ' O ' ' HB ' ' A' 1587 ' ' VAL . 14.7 m -131.96 99.02 3.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 112.602 0.594 . . . . 1.71 112.602 -177.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 37.4 t70 52.5 66.23 1.28 Allowed 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 124.297 1.039 . . . . 1.17 111.605 175.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1586 ' ' GLN . . . . . . . . . . . . 0.255 30.1 pt20 65.14 12.4 7.95 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 127.515 2.326 . . . . 2.43 112.426 177.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1587 ' ' VAL . . . . . 0.613 ' HB ' ' O ' ' A' 1584 ' ' VAL . 13.9 t -110.51 128.28 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 CA-C-N 114.751 -1.113 . . . . 1.16 110.681 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1588 ' ' LEU . . . . . 0.805 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 3.2 mm? -95.28 107.98 20.12 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 106.613 -1.625 . . . . 1.11 106.613 176.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -115.48 116.77 28.76 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-O 121.672 0.748 . . . . 1.74 112.692 -174.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1590 ' ' LEU . . . . . 0.46 ' HG ' HD23 ' A' 1581 ' ' LEU . 5.7 mt -100.18 108.06 20.08 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 114.197 -1.365 . . . . 1.4 107.38 172.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 10.0 p -99.09 126.82 52.24 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.15 0 CA-C-O 121.531 0.681 . . . . 1.7 110.089 -179.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1592 ' ' TYR . . . . . . . . . . . . . 12.4 m-30 -113.28 99.21 7.63 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 109.317 -0.623 . . . . 1.08 109.317 177.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 60.1 pttt -111.41 179.39 4.04 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.585 -0.895 . . . . 2.21 108.585 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1594 ' ' ASP . . . . . 0.43 ' O ' ' HB2' ' A' 1576 ' ' LYS . 32.3 m-20 57.82 45.9 17.83 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.108 0.963 . . . . 1.11 110.955 178.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -79.59 -95.3 0.33 Allowed Glycine 0 CA--C 1.498 -0.979 0 N-CA-C 109.791 -1.324 . . . . 0.78 109.791 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1596 ' ' SER . . . . . 0.495 ' OG ' ' HB3' ' A' 1573 ' ' SER . 72.2 m -124.94 149.35 62.83 Favored Pre-proline 0 C--N 1.273 -2.736 0 N-CA-C 107.216 -1.402 . . . . 1.36 107.216 173.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -61.92 138.4 73.44 Favored 'Trans proline' 0 N--CA 1.445 -1.367 0 C-N-CA 122.273 1.982 . . . . 1.4 109.229 174.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1598 ' ' CYS . . . . . 0.511 ' HA ' ' CE2' ' A' 1606 ' ' TYR . 5.0 t -70.02 113.47 17.91 Favored Pre-proline 0 C--N 1.296 -1.718 0 N-CA-C 106.954 -1.499 . . . . 0.75 106.954 -178.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1599 ' ' PRO . . . . . 0.643 ' HB2' HD22 ' B' ' 8' ' ' LEU . 24.2 Cg_exo -62.89 -33.78 74.08 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.984 2.456 . . . . 1.7 113.008 -173.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1600 ' ' SER . . . . . 0.65 ' HB2' ' HG ' ' B' ' 53' ' ' LEU . 5.2 m -86.18 7.6 24.39 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 116.307 -0.406 . . . . 2.8 112.061 178.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1601 ' ' LYS . . . . . 0.506 ' HG2' HD23 ' A' 1604 ' ' LEU . 3.0 tppp? -161.5 96.4 1.05 Allowed 'General case' 0 C--O 1.251 1.141 0 O-C-N 121.743 -0.598 . . . . 3.45 110.316 175.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 13.0 t -66.76 126.05 27.79 Favored 'General case' 0 N--CA 1.401 -2.886 0 N-CA-C 108.649 -0.871 . . . . 2.44 108.649 -176.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 106.2 -6.5 39.69 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 116.443 -0.344 . . . . 1.2 112.334 -177.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1604 ' ' LEU . . . . . 0.506 HD23 ' HG2' ' A' 1601 ' ' LYS . 7.5 mp -106.34 155.97 18.98 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 122.94 0.496 . . . . 2.38 109.981 176.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 44.8 t -135.24 151.06 50.25 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 107.99 -1.115 . . . . 1.96 107.99 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1606 ' ' TYR . . . . . 0.612 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 90.8 m-85 -80.45 150.86 29.58 Favored 'General case' 0 N--CA 1.419 -2.012 0 N-CA-C 108.903 -0.777 . . . . 1.06 108.903 176.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -150.82 127.46 10.85 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 123.623 0.577 . . . . 2.0 109.716 -175.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1608 ' ' SER . . . . . . . . . . . . . 20.7 m -105.35 115.96 31.15 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 109.437 -0.579 . . . . 1.61 109.437 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 38.4 t -98.41 107.07 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 108.103 -1.073 . . . . 1.09 108.103 176.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 70.5 mt -100.25 101.37 12.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 CA-C-N 115.765 -0.652 . . . . 1.2 109.304 -179.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 5.9 p -100.2 119.02 37.71 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.619 0.723 . . . . 1.89 112.694 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1612 ' ' PHE . . . . . 0.805 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 72.0 m-85 -94.51 122.27 36.91 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.131 -0.94 . . . . 0.28 109.744 177.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 42.0 t -119.99 138.67 49.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-N 115.397 -0.819 . . . . 1.23 109.475 -175.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 13.2 t -58.75 113.54 2.09 Favored 'General case' 0 C--O 1.243 0.732 0 C-N-CA 124.352 1.061 . . . . 0.77 111.856 178.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1615 ' ' ARG . . . . . 0.676 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 23.7 tpt180 -136.64 97.46 11.43 Favored Pre-proline 0 N--CA 1.431 -1.386 0 N-CA-C 109.272 -0.64 . . . . 2.92 109.272 175.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1616 ' ' PRO . . . . . 0.452 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 60.5 Cg_endo -73.62 -14.9 24.62 Favored 'Trans proline' 0 N--CA 1.487 1.138 0 C-N-CA 122.551 2.167 . . . . 1.22 112.846 -177.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -91.82 42.68 1.11 Allowed 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 124.704 1.201 . . . . 3.05 110.333 -176.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -30.72 127.96 0.14 Allowed 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 126.648 1.979 . . . . 1.55 113.591 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . 178.63 -145.14 6.66 Favored Glycine 0 N--CA 1.428 -1.843 0 N-CA-C 109.846 -1.302 . . . . 1.16 109.846 -178.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -61.44 -4.07 3.91 Favored 'Trans proline' 0 CA--C 1.556 1.581 0 C-N-CA 123.568 2.846 . . . . 1.06 115.756 -177.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1621 ' ' THR . . . . . . . . . . . . . 23.3 p -91.96 -10.06 40.75 Favored 'General case' 0 C--O 1.247 0.939 0 O-C-N 121.563 -0.711 . . . . 1.58 110.662 176.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 47.1 t30 -90.43 58.66 4.07 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 122.338 1.066 . . . . 0.88 109.378 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -163.69 139.43 5.13 Favored Pre-proline 0 C--N 1.309 -1.192 0 CA-C-N 114.455 -1.248 . . . . 3.82 107.916 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -65.11 102.04 0.43 Allowed 'Trans proline' 0 C--O 1.239 0.528 0 C-N-CA 123.314 2.676 . . . . 0.77 112.837 -175.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 75.3 mtm -107.34 146.59 31.39 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.897 -0.592 . . . . 1.43 111.049 -178.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 1.6 tm? -86.76 115.34 24.13 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 107.438 -1.319 . . . . 1.43 107.438 -176.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 49.2 mm -79.16 -56.49 7.02 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-O 121.26 0.552 . . . . 1.23 109.792 179.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 66.5 m -161.36 147.22 14.12 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.513 -0.767 . . . . 1.88 109.704 -177.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1629 ' ' LEU . . . . . 0.798 HD12 ' HG ' ' A' 1636 ' ' LEU . 42.7 tp -113.92 112.85 24.01 Favored 'General case' 0 N--CA 1.424 -1.737 0 N-CA-C 107.428 -1.323 . . . . 1.92 107.428 172.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 30.6 t70 -85.93 110.75 19.66 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.68 -1.23 . . . . 1.09 107.68 174.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1631 ' ' LYS . . . . . 0.601 ' HB3' HD23 ' B' ' 53' ' ' LEU . 0.1 OUTLIER -73.72 -31.6 63.47 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.761 -0.654 . . . . 3.98 110.086 -174.037 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -70.16 -36.82 74.99 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-N 115.481 -0.781 . . . . 2.6 112.863 -173.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 54.8 p -101.32 -6.52 24.01 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.032 0.444 . . . . 1.35 110.7 175.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1634 ' ' CYS . . . . . 0.48 ' O ' ' HA ' ' A' 1606 ' ' TYR . 32.7 m 63.27 40.85 8.33 Favored 'General case' 0 C--N 1.364 1.209 0 C-N-CA 124.546 1.138 . . . . 0.53 109.961 -178.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1635 ' ' THR . . . . . . . . . . . . . 55.9 m -106.24 133.71 50.51 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.924 -1.034 . . . . 1.11 110.356 -176.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1636 ' ' LEU . . . . . 0.798 ' HG ' HD12 ' A' 1629 ' ' LEU . 0.7 OUTLIER -116.85 131.69 56.89 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.443 -0.577 . . . . 1.56 109.443 -177.709 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -111.23 128.09 55.81 Favored 'General case' 0 C--O 1.252 1.199 0 CA-C-O 120.821 0.343 . . . . 0.54 111.012 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -125.61 131.82 52.62 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.92 -0.77 . . . . 0.64 108.92 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1639 ' ' SER . . . . . . . . . . . . . 64.6 m -115.46 140.7 48.9 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 122.892 0.477 . . . . 1.34 109.857 178.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 3.1 t90 -142.35 114.29 8.12 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 104.327 -2.471 . . . . 0.8 104.327 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1641 ' ' HIS . . . . . 0.676 ' HB3' ' HB2' ' A' 1615 ' ' ARG . 31.5 m-70 -106.26 112.44 25.46 Favored 'General case' 0 C--N 1.293 -1.886 0 C-N-CA 119.916 -0.714 . . . . 1.14 110.005 -177.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1642 ' ' THR . . . . . . . . . . . . . 3.9 t -142.46 150.42 54.56 Favored Pre-proline 0 C--N 1.302 -1.491 0 CA-C-N 115.615 -0.72 . . . . 1.11 109.512 -172.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1643 ' ' PRO . . . . . 0.452 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 71.9 Cg_endo -77.07 -10.75 17.93 Favored 'Trans proline' 0 C--N 1.362 1.251 0 C-N-CA 122.411 2.074 . . . . 0.78 111.464 176.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1644 ' ' LEU . . . . . 0.56 HD11 ' HB2' ' A' 1531 ' ' SER . 7.3 tt -68.36 -24.33 64.79 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.712 0.805 . . . . 1.66 110.493 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -95.04 6.96 47.61 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 122.187 0.994 . . . . 1.29 109.619 -177.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 15.6 t -123.9 159.11 30.4 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-N 114.404 -1.271 . . . . 1.48 108.579 -175.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -98.58 103.28 17.83 Favored Pre-proline 0 C--N 1.308 -1.208 0 N-CA-C 108.455 -0.943 . . . . 3.14 108.455 169.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1648 ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -87.44 94.57 0.46 Allowed 'Trans proline' 0 N--CA 1.444 -1.409 0 C-N-CA 121.845 1.697 . . . . 2.92 111.498 178.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 10.0 tp10 . . . . . 0 C--N 1.311 -1.071 0 N-CA-C 105.73 -1.952 . . . . 4.72 105.73 179.223 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.845 0 N-CA-C 109.528 -0.545 . . . . 10.26 109.528 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -106.22 134.9 48.62 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.23 -1.396 . . . . 7.94 107.23 177.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 47.1 ptt85 -120.36 151.15 53.17 Favored Pre-proline 0 C--N 1.294 -1.831 0 N-CA-C 108.119 -1.067 . . . . 6.56 108.119 -179.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.65 1.68 4.15 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.371 2.714 . . . . 5.51 115.008 -175.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 19.4 m 59.0 39.67 23.22 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.229 1.412 . . . . 4.91 111.897 176.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -67.69 -37.41 82.26 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 121.613 0.72 . . . . 4.23 110.847 -176.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 60.3 p -122.8 169.97 10.56 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 104.834 -2.284 . . . . 3.48 104.834 175.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . 0.643 HD22 ' HB2' ' A' 1599 ' ' PRO . 4.5 pp -99.49 133.25 44.08 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 120.007 1.276 . . . . 4.35 112.949 -175.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 36.5 t -153.47 160.19 42.49 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 108.081 -1.081 . . . . 2.84 108.081 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.59 -125.85 10.58 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 112.071 -0.411 . . . . 2.28 112.071 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.98 -21.95 73.77 Favored Glycine 0 C--N 1.311 -0.847 0 C-N-CA 121.72 -0.276 . . . . 1.94 113.353 179.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -71.46 -20.83 62.04 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.728 0.775 . . . . 2.55 109.265 -176.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . 0.535 HD22 HD12 ' B' ' 8' ' ' LEU . 62.1 mt -68.14 -49.59 60.09 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 115.059 -0.973 . . . . 2.82 108.419 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 8.5 p -77.66 -18.12 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 CA-C-N 115.111 -0.95 . . . . 2.5 110.488 -176.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' ASP . . . . . 0.401 ' OD2' ' HB2' ' A' 1569 ' ' GLN . 12.5 t70 -62.83 -67.53 0.41 Allowed 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 109.535 -0.543 . . . . 2.04 109.535 176.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 15.2 t -61.13 -36.6 80.18 Favored 'General case' 0 C--O 1.25 1.125 0 O-C-N 123.635 0.584 . . . . 2.31 111.226 -176.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.588 HD21 HD13 ' B' ' 42' ' ' ILE . 4.0 mm? -57.37 -49.6 75.64 Favored 'General case' 0 C--O 1.215 -0.757 0 N-CA-C 113.109 0.781 . . . . 2.27 113.109 175.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -84.75 -14.97 46.66 Favored 'General case' 0 C--N 1.317 -0.809 0 O-C-N 121.583 -0.698 . . . . 2.39 111.034 -178.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -63.86 -54.66 31.34 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 116.314 -0.403 . . . . 1.0 111.017 176.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 16.0 m -98.18 -14.52 7.73 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.691 0 C-N-CA 118.911 -1.116 . . . . 1.83 112.319 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' CYS . . . . . 0.509 ' HB2' ' O ' ' B' ' 17' ' ' LEU . 68.7 m -114.49 23.03 13.12 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 120.358 -0.537 . . . . 1.66 111.666 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -52.22 -40.49 52.5 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 114.557 0.583 . . . . 1.53 114.557 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -86.12 -31.93 21.59 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 113.753 1.019 . . . . 2.72 113.753 -178.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . 0.404 ' HD3' ' OG1' ' B' ' 62' ' ' THR . 43.6 ttm180 -90.52 -25.03 20.46 Favored 'General case' 0 C--O 1.248 0.991 0 CA-C-O 121.353 0.597 . . . . 5.02 111.44 -176.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 109.29 163.06 19.97 Favored Glycine 0 N--CA 1.439 -1.132 0 N-CA-C 110.183 -1.167 . . . . 1.63 110.183 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -123.62 131.11 53.54 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 117.52 0.66 . . . . 1.71 110.96 179.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' TYR . . . . . 0.416 ' O ' ' HE2' ' B' ' 59' ' ' TYR . 26.9 m-85 -136.71 80.84 1.84 Allowed 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 111.754 0.279 . . . . 3.67 111.754 -177.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' PHE . . . . . 0.546 ' HA ' ' HE2' ' B' ' 59' ' ' TYR . 34.3 p90 -90.74 -17.62 26.39 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.7 0.762 . . . . 2.44 109.674 173.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 8.1 m -100.67 129.13 46.54 Favored 'General case' 0 N--CA 1.428 -1.543 0 N-CA-C 107.303 -1.369 . . . . 3.85 107.303 176.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . 0.459 ' HE ' ' HH ' ' B' ' 59' ' ' TYR . 20.9 mmt180 -105.78 158.31 32.68 Favored Pre-proline 0 C--N 1.305 -1.35 0 N-CA-C 107.537 -1.283 . . . . 4.27 107.537 -178.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -59.4 -50.49 8.24 Favored 'Trans proline' 0 C--O 1.25 1.076 0 C-N-CA 121.232 1.288 . . . . 4.2 113.319 -174.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' ALA . . . . . 0.781 ' HB3' ' HA ' ' B' ' 37' ' ' ARG . . . 69.62 -76.34 0.06 Allowed 'General case' 0 CA--C 1.507 -0.695 0 C-N-CA 125.281 1.433 . . . . 5.12 111.811 177.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 29.6 t 173.02 164.37 0.13 Allowed 'General case' 0 N--CA 1.396 -3.169 0 N-CA-C 103.548 -2.76 . . . . 6.93 103.548 178.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -93.21 -3.01 54.58 Favored 'General case' 0 C--N 1.27 -2.852 0 N-CA-C 108.364 -0.976 . . . . 12.14 108.364 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 41.0 t -110.14 -17.61 8.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 122.196 0.998 . . . . 9.9 108.721 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 13.0 p -148.69 63.53 1.07 Allowed 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 114.593 -1.185 . . . . 6.82 109.17 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . 0.781 ' HA ' ' HB3' ' B' ' 32' ' ' ALA . 27.1 ptt180 -73.06 12.07 0.6 Allowed 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 115.06 1.504 . . . . 10.71 115.06 -176.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -82.41 66.65 8.1 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.584 0.707 . . . . 8.6 112.826 -174.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' SER . . . . . 0.441 ' HB2' ' HB1' ' B' ' 32' ' ' ALA . 39.5 m -150.55 89.0 1.52 Allowed 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 108.351 -0.981 . . . . 5.79 108.351 173.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 66.3 mtm180 -132.11 149.13 52.48 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 106.236 -1.764 . . . . 6.57 106.236 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . -116.34 155.99 15.9 Favored Glycine 0 N--CA 1.409 -3.146 0 C-N-CA 119.468 -1.349 . . . . 2.62 110.248 -177.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . 0.588 HD13 HD21 ' B' ' 17' ' ' LEU . 10.2 pt 59.65 -28.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 C-N-CA 127.737 2.415 . . . . 2.28 116.491 176.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . . . . . . . . 0.26 2.7 p -51.41 -49.53 31.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 114.958 1.466 . . . . 2.6 114.958 -175.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -96.12 -26.0 15.65 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.357 -0.979 . . . . 3.36 108.357 -176.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . 0.51 ' O ' ' HB2' ' B' ' 49' ' ' ARG . 9.5 tp10 -60.9 -43.72 98.12 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 114.933 -1.03 . . . . 3.08 109.428 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' CYS . . . . . . . . . . . . . 10.1 t -94.48 -14.62 24.97 Favored 'General case' 0 C--N 1.314 -0.956 0 O-C-N 121.988 -0.445 . . . . 2.23 111.736 -177.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 52.2 t -66.75 -47.74 71.29 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.141 -0.623 . . . . 2.48 110.181 179.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -105.71 -12.77 15.78 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 113.152 0.797 . . . . 2.97 113.152 -177.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . 0.51 ' HB2' ' O ' ' B' ' 45' ' ' GLU . 64.7 mtt180 -125.6 158.68 34.05 Favored 'General case' 0 CA--C 1.498 -1.036 0 N-CA-C 108.35 -0.981 . . . . 4.65 108.35 178.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 23.0 t -84.61 123.55 30.45 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 109.562 -0.533 . . . . 2.86 109.562 -177.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . 0.478 ' HB2' HD23 ' B' ' 55' ' ' LEU . 29.4 p -105.81 133.52 50.41 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 108.316 -0.994 . . . . 2.11 108.316 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -80.27 147.37 31.21 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.685 -1.228 . . . . 2.67 107.685 177.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . 0.718 HD11 ' H ' ' B' ' 53' ' ' LEU . 3.0 mp -52.49 -29.04 22.92 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 125.789 1.635 . . . . 2.36 112.185 -175.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . 0.412 ' O ' HG22 ' B' ' 58' ' ' THR . . . -61.96 -37.81 86.15 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 123.581 0.551 . . . . 1.92 110.772 -178.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . 0.478 HD23 ' HB2' ' B' ' 51' ' ' CYS . 50.5 tp -59.93 -50.59 73.17 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-N 115.787 -0.642 . . . . 2.35 110.617 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 3.9 pp -75.54 -32.76 60.57 Favored 'General case' 0 N--CA 1.422 -1.85 0 CA-C-N 116.202 -0.453 . . . . 2.01 111.99 -174.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -71.24 -42.44 68.84 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 112.195 0.442 . . . . 2.27 112.195 -176.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 58' ' ' THR . . . . . 0.412 HG22 ' O ' ' B' ' 54' ' ' ALA . 12.2 t -78.09 -25.4 47.58 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 118.83 -1.148 . . . . 2.67 111.742 176.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 59' ' ' TYR . . . . . 0.546 ' HE2' ' HA ' ' B' ' 28' ' ' PHE . 30.2 t80 -67.5 -68.55 0.37 Allowed 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 106.576 -1.639 . . . . 3.2 106.576 176.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 42.0 t 52.2 -85.17 0.01 OUTLIER 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 125.391 1.476 . . . . 2.3 114.213 173.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -143.9 -84.27 0.15 Allowed 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 105.548 -2.019 . . . . 3.19 105.548 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 62' ' ' THR . . . . . 0.404 ' OG1' ' HD3' ' B' ' 24' ' ' ARG . 3.3 p -81.27 138.32 48.71 Favored Pre-proline 0 N--CA 1.405 -2.687 0 N-CA-C 107.396 -1.335 . . . . 4.14 107.396 168.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -79.68 3.92 7.13 Favored 'Trans proline' 0 C--O 1.245 0.837 0 C-N-CA 122.93 2.42 . . . . 5.59 112.519 -176.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 64.23 46.42 3.57 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-N 113.517 -1.674 . . . . 5.51 109.815 177.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -116.55 131.99 56.8 Favored 'General case' 0 N--CA 1.423 -1.822 0 CA-C-N 114.463 -1.244 . . . . 8.8 109.472 -177.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 9.3 p -87.77 62.15 6.82 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 121.505 0.669 . . . . 8.12 110.381 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 . . . . . 0 N--CA 1.433 -1.312 0 N-CA-C 107.34 -1.356 . . . . 10.21 107.34 179.724 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 87.7 mtp . . . . . 0 C--O 1.237 0.427 0 N-CA-C 108.134 -1.061 . . . . 9.74 108.134 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A 1509 ' ' LYS . . . . . 0.578 ' HA ' ' HB3' ' A' 1512 ' ' GLU . 55.7 pttt -135.51 24.73 3.45 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 114.345 1.239 . . . . 9.32 114.345 -170.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1510 ' ' SER . . . . . 0.592 ' HB3' ' HB ' ' A' 1519 ' ' THR . 50.0 m -99.99 -28.91 12.84 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.891 0.853 . . . . 5.97 109.136 175.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1511 ' ' ASN . . . . . . . . . . . . . 17.7 m120 -123.46 31.43 5.94 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.046 -0.979 . . . . 3.48 108.826 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1512 ' ' GLU . . . . . 0.578 ' HB3' ' HA ' ' A' 1509 ' ' LYS . 16.4 pt-20 -71.0 169.79 14.16 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-N 114.979 -1.01 . . . . 5.95 109.444 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 27.3 m170 -120.03 92.39 3.77 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 109.507 -0.553 . . . . 6.14 109.507 -177.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 19.3 t70 -134.44 -53.75 0.83 Allowed 'General case' 0 C--N 1.286 -2.193 0 C-N-CA 120.289 -0.564 . . . . 5.06 111.431 179.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 14.0 t70 -127.48 -175.9 3.59 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 105.395 -2.076 . . . . 2.9 105.395 177.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1516 ' ' CYS . . . . . 0.552 ' HA ' ' HB2' ' A' 1581 ' ' LEU . 91.1 m -88.5 66.5 8.26 Favored 'General case' 0 C--N 1.283 -2.293 0 CA-C-O 121.68 0.752 . . . . 1.41 110.926 -177.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -152.22 130.86 12.3 Favored 'General case' 0 N--CA 1.415 -2.206 0 CA-C-N 114.666 -1.152 . . . . 2.18 109.301 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1518 ' ' VAL . . . . . 0.571 HG23 ' HB2' ' A' 1583 ' ' TYR . 2.9 m -145.12 142.9 22.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 C-N-CA 123.926 0.89 . . . . 1.52 110.153 -179.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1519 ' ' THR . . . . . 0.592 ' HB ' ' HB3' ' A' 1510 ' ' SER . 18.9 m -101.81 145.34 29.31 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 116.301 -0.409 . . . . 1.36 111.026 -177.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1520 ' ' ASN . . . . . 0.41 ' OD1' HG22 ' A' 1523 ' ' THR . 24.5 t-20 -76.2 111.88 17.72 Favored Pre-proline 0 N--CA 1.433 -1.289 0 N-CA-C 106.389 -1.708 . . . . 2.02 106.389 170.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -74.21 0.46 8.44 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.491 2.127 . . . . 1.82 113.736 -174.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 19.6 m -91.15 -43.22 10.01 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 116.256 -0.429 . . . . 1.89 111.603 177.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1523 ' ' THR . . . . . 0.41 HG22 ' OD1' ' A' 1520 ' ' ASN . 4.9 t -119.24 -8.86 10.05 Favored 'General case' 0 C--O 1.244 0.79 0 C-N-CA 119.943 -0.703 . . . . 1.99 112.43 -177.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 85.95 20.37 55.73 Favored Glycine 0 C--N 1.317 -0.494 0 C-N-CA 120.423 -0.894 . . . . 1.19 113.095 177.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 24.3 t-80 -84.35 123.63 30.4 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.057 0.455 . . . . 1.82 110.574 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 2.9 tm? -94.71 119.32 33.14 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 115.336 -0.847 . . . . 1.3 110.943 -175.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -91.64 130.83 37.38 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 109.604 -0.517 . . . . 0.8 109.604 169.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 16.3 t70 -125.64 122.56 36.75 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.452 -1.314 . . . . 1.17 107.452 173.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 3.7 mm? -93.86 5.87 50.26 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 113.683 0.994 . . . . 1.29 113.683 -170.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1530 ' ' SER . . . . . 0.556 ' HA ' ' OG ' ' A' 1533 ' ' SER . 3.6 m -66.16 -7.94 21.03 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 113.804 1.039 . . . . 0.91 113.804 -174.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 8.5 t -69.22 -31.88 70.76 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 109.391 -0.596 . . . . 1.98 109.391 179.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 81.1 mt -95.38 -7.03 39.63 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.069 0.461 . . . . 1.34 110.795 -178.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1533 ' ' SER . . . . . 0.556 ' OG ' ' HA ' ' A' 1530 ' ' SER . 24.5 m -66.97 161.3 24.55 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.85 -0.614 . . . . 1.93 111.433 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . 155.86 159.82 9.61 Favored Glycine 0 N--CA 1.423 -2.174 0 N-CA-C 109.811 -1.316 . . . . 1.1 109.811 -176.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1535 ' ' ARG . . . . . 0.404 ' O ' ' HA ' ' A' 1556 ' ' ASN . 42.2 ttp180 -92.26 -31.16 15.52 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 109.972 -0.381 . . . . 5.21 109.972 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -66.67 -34.01 76.91 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 121.126 0.488 . . . . 1.94 110.878 -177.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 73.75 -157.29 51.48 Favored Glycine 0 N--CA 1.428 -1.85 0 CA-C-N 115.042 -0.981 . . . . 1.08 113.676 172.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -137.26 152.05 49.38 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.84 -1.17 . . . . 1.07 107.84 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 27.0 p -112.73 139.75 48.09 Favored 'General case' 0 C--N 1.308 -1.215 0 O-C-N 123.489 0.493 . . . . 1.46 111.177 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1540 ' ' ALA . . . . . 0.465 ' HB1' HG13 ' A' 1548 ' ' VAL . . . -131.35 135.14 46.99 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 108.409 -0.96 . . . . 1.19 108.409 174.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -73.58 141.7 46.62 Favored 'General case' 0 C--O 1.243 0.719 0 C-N-CA 122.601 0.36 . . . . 1.37 110.866 -178.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1542 ' ' TYR . . . . . 0.489 ' HB3' ' H ' ' A' 1543 ' ' SER . 1.3 t80 -149.43 -101.14 0.07 Allowed 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 109.285 -0.635 . . . . 1.38 109.285 -176.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1543 ' ' SER . . . . . 0.489 ' H ' ' HB3' ' A' 1542 ' ' TYR . 4.3 m -63.95 160.24 18.17 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.468 1.107 . . . . 1.98 111.225 -178.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 52.3 tptt -50.76 -41.38 56.67 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 113.611 0.967 . . . . 3.96 113.611 -173.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 11.9 t -128.75 37.93 4.03 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 108.785 -0.82 . . . . 2.81 108.785 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1546 ' ' GLY . . . . . 0.57 ' HA3' ' HG2' ' A' 1569 ' ' GLN . . . -147.96 120.34 1.21 Allowed Glycine 0 N--CA 1.428 -1.859 0 C-N-CA 119.555 -1.307 . . . . 1.68 113.573 -177.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 29.3 m -99.89 152.58 4.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 107.001 -1.481 . . . . 1.38 107.001 174.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1548 ' ' VAL . . . . . 0.465 HG13 ' HB1' ' A' 1540 ' ' ALA . 12.3 p -92.76 134.42 30.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.865 0 C-N-CA 119.922 -0.711 . . . . 1.24 109.202 178.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -99.87 129.13 45.93 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 115.355 -0.839 . . . . 1.29 108.763 177.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 25.8 ptm -144.14 126.27 15.55 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 115.453 -0.794 . . . . 1.47 110.972 -176.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 5.3 p -118.55 132.89 56.2 Favored 'General case' 0 C--N 1.282 -2.355 0 CA-C-N 115.002 -0.999 . . . . 1.4 109.795 179.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1552 ' ' ILE . . . . . . . . . . . . . 46.8 mm -83.28 112.15 20.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 120.477 0.18 . . . . 1.11 111.159 -176.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 57.9 m 64.99 29.6 12.17 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.622 1.169 . . . . 1.4 112.093 174.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . -167.01 -174.8 36.55 Favored Glycine 0 N--CA 1.409 -3.113 0 N-CA-C 108.961 -1.656 . . . . 0.4 108.961 -178.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -109.78 152.86 25.16 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-N 116.845 0.323 . . . . 1.62 111.724 -175.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1556 ' ' ASN . . . . . 0.404 ' HA ' ' O ' ' A' 1535 ' ' ARG . 26.7 t-20 -103.29 138.63 39.81 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.008 -1.108 . . . . 1.12 108.008 178.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -85.97 2.33 46.66 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 114.06 1.133 . . . . 2.49 114.06 -171.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -91.03 -1.81 57.75 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 120.491 -0.484 . . . . 1.38 111.027 -178.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1559 ' ' CYS . . . . . 0.625 ' SG ' ' HD2' ' A' 1560 ' ' PRO . 16.0 t -137.43 151.74 71.81 Favored Pre-proline 0 C--N 1.304 -1.373 0 N-CA-C 106.648 -1.612 . . . . 1.21 106.648 178.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1560 ' ' PRO . . . . . 0.625 ' HD2' ' SG ' ' A' 1559 ' ' CYS . 13.3 Cg_exo -30.6 132.13 0.05 OUTLIER 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 125.226 3.95 . . . . 0.98 114.655 178.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -45.02 129.25 9.86 Favored 'Trans proline' 0 C--N 1.364 1.385 0 C-N-CA 124.768 3.645 . . . . 1.15 113.332 -177.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 96.6 18.98 28.67 Favored Glycine 0 C--N 1.313 -0.727 0 CA-C-N 116.204 -0.453 . . . . 0.55 113.14 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1563 ' ' VAL . . . . . 0.524 HG13 ' HB2' ' A' 1566 ' ' CYS . 2.3 t -106.61 124.51 62.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 C-N-CA 123.02 0.528 . . . . 1.53 111.661 -178.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -97.27 -33.97 5.77 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 115.242 -0.89 . . . . 0.29 111.814 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -133.94 129.59 36.51 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 109.018 -0.734 . . . . 1.08 109.018 177.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1566 ' ' CYS . . . . . 0.524 ' HB2' HG13 ' A' 1563 ' ' VAL . 48.5 t -158.32 138.11 12.09 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 110.52 -0.178 . . . . 0.43 110.52 -176.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -84.72 135.45 34.14 Favored 'General case' 0 C--O 1.245 0.859 0 N-CA-C 108.428 -0.953 . . . . 1.3 108.428 173.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -91.79 27.71 9.55 Favored Glycine 0 N--CA 1.422 -2.286 0 N-CA-C 115.88 1.112 . . . . 1.43 115.88 -170.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1569 ' ' GLN . . . . . 0.594 ' HB2' ' OD2' ' B' ' 15' ' ' ASP . 20.8 mt-30 -77.49 -69.04 0.56 Allowed 'General case' 0 C--O 1.241 0.617 0 C-N-CA 117.349 -1.74 . . . . 3.09 109.579 171.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 71.0 p -114.33 15.7 17.98 Favored 'General case' 0 CA--C 1.553 1.058 0 N-CA-C 112.809 0.67 . . . . 2.52 112.809 177.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? 66.43 68.78 0.43 Allowed 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.923 1.289 . . . . 3.19 112.703 -179.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 18.8 mt -106.3 122.61 60.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 114.727 -1.124 . . . . 1.51 108.793 177.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 35.7 t -83.2 138.53 33.59 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.669 0.747 . . . . 0.96 111.244 -174.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1574 ' ' VAL . . . . . 0.533 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 27.1 m -123.39 18.05 5.03 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 CA-C-N 115.661 -0.699 . . . . 1.6 110.392 178.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 167.52 126.44 0.84 Allowed Glycine 0 N--CA 1.422 -2.253 0 CA-C-N 115.113 -0.949 . . . . 0.34 112.383 175.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 53.9 tttm -68.64 146.03 53.38 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.525 -0.917 . . . . 2.68 108.525 177.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -73.48 79.45 1.43 Allowed 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.208 0.528 . . . . 1.08 111.566 -178.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -96.35 -177.6 4.02 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 109.263 -0.643 . . . . 1.95 109.263 178.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 66.7 mttm -132.38 47.56 2.5 Favored 'General case' 0 CA--C 1.485 -1.548 0 N-CA-C 105.28 -2.119 . . . . 3.11 105.28 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.49 76.62 5.83 Favored 'General case' 0 N--CA 1.415 -2.197 0 CA-C-N 113.773 -1.558 . . . . 4.04 108.593 -171.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1581 ' ' LEU . . . . . 0.552 ' HB2' ' HA ' ' A' 1516 ' ' CYS . 0.3 OUTLIER -86.14 129.58 34.8 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.608 -1.178 . . . . 1.32 108.691 -179.309 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A 1582 ' ' ARG . . . . . 0.536 ' HB2' ' HB3' ' A' 1589 ' ' GLN . 70.3 mtp180 -124.15 137.26 54.57 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 116.522 -0.308 . . . . 3.4 110.273 173.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1583 ' ' TYR . . . . . 0.571 ' HB2' HG23 ' A' 1518 ' ' VAL . 66.9 t80 -105.62 104.37 14.07 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 107.853 -1.165 . . . . 1.26 107.853 177.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1584 ' ' VAL . . . . . 0.519 ' O ' ' HB ' ' A' 1587 ' ' VAL . 16.7 m -121.2 89.51 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 112.81 0.67 . . . . 1.71 112.81 -175.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 17.4 t70 56.91 57.9 4.38 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.119 0.968 . . . . 1.17 110.134 177.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1586 ' ' GLN . . . . . 0.55 ' HA ' ' CE1' ' A' 1583 ' ' TYR 0.296 9.1 pt20 68.87 4.67 4.58 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 128.196 2.598 . . . . 2.43 112.637 179.116 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A 1587 ' ' VAL . . . . . 0.519 ' HB ' ' O ' ' A' 1584 ' ' VAL . 23.1 t -93.71 124.03 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.012 0 N-CA-C 108.491 -0.929 . . . . 1.16 108.491 174.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1588 ' ' LEU . . . . . 0.824 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 3.4 mm? -92.73 107.77 19.47 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.157 -1.053 . . . . 1.11 108.157 178.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1589 ' ' GLN . . . . . 0.536 ' HB3' ' HB2' ' A' 1582 ' ' ARG . 35.5 tt0 -99.05 123.65 43.5 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 116.025 -0.534 . . . . 1.74 110.23 -178.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1590 ' ' LEU . . . . . 0.456 ' HB3' ' HB ' ' A' 1610 ' ' ILE . 0.7 OUTLIER -117.83 96.02 5.18 Favored 'General case' 0 C--N 1.284 -2.27 0 N-CA-C 105.065 -2.198 . . . . 1.4 105.065 174.885 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 8.4 p -96.31 132.16 41.29 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 CA-C-O 121.317 0.579 . . . . 1.7 111.665 -175.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1592 ' ' TYR . . . . . . . . . . . . . 14.2 m-30 -121.51 122.18 39.15 Favored 'General case' 0 CA--C 1.496 -1.12 0 N-CA-C 108.306 -0.998 . . . . 1.08 108.306 176.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 58.4 pttt -131.09 179.04 6.24 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 108.98 -0.748 . . . . 2.21 108.98 177.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 19.9 m-20 62.17 53.2 2.97 Favored 'General case' 0 C--O 1.249 1.049 0 O-C-N 124.286 0.992 . . . . 1.11 110.864 178.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -85.67 -105.23 0.71 Allowed Glycine 0 N--CA 1.429 -1.796 0 N-CA-C 109.558 -1.417 . . . . 0.78 109.558 177.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1596 ' ' SER . . . . . . . . . . . . . 36.3 p -129.11 153.63 80.37 Favored Pre-proline 0 C--N 1.282 -2.331 0 N-CA-C 107.753 -1.202 . . . . 1.36 107.753 174.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 90.7 Cg_exo -50.67 133.76 39.21 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.287 2.658 . . . . 1.4 113.509 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1598 ' ' CYS . . . . . 0.527 ' HA ' ' CE2' ' A' 1606 ' ' TYR . 44.4 t -81.83 119.27 74.89 Favored Pre-proline 0 C--N 1.283 -2.285 0 CA-C-N 113.875 -1.512 . . . . 0.75 109.018 -178.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1599 ' ' PRO . . . . . 0.465 ' HD2' ' OH ' ' A' 1606 ' ' TYR . 40.2 Cg_exo -60.43 -23.92 76.34 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 123.097 2.532 . . . . 1.7 112.965 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1600 ' ' SER . . . . . 0.731 ' HA ' ' HB2' ' B' ' 53' ' ' LEU . 19.5 m -54.37 -44.81 72.54 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 123.364 0.665 . . . . 2.8 111.782 178.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1601 ' ' LYS . . . . . 0.538 ' HB3' HD12 ' A' 1604 ' ' LEU . 4.5 tppp? -148.24 127.88 13.31 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.97 -0.752 . . . . 3.45 108.97 179.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 20.4 m -65.48 129.48 39.9 Favored 'General case' 0 N--CA 1.412 -2.345 0 N-CA-C 108.796 -0.816 . . . . 2.44 108.796 -178.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 105.25 -10.87 47.53 Favored Glycine 0 N--CA 1.436 -1.359 0 C-N-CA 120.496 -0.859 . . . . 1.2 112.499 178.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1604 ' ' LEU . . . . . 0.538 HD12 ' HB3' ' A' 1601 ' ' LYS . 67.6 mt -99.33 150.19 22.38 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.667 -0.494 . . . . 2.38 109.667 178.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 22.4 t -123.4 153.15 40.79 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.555 -1.276 . . . . 1.96 107.555 177.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1606 ' ' TYR . . . . . 0.533 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 49.6 m-85 -73.77 158.48 34.52 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 116.171 -0.468 . . . . 1.06 111.903 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1607 ' ' LYS . . . . . 0.458 ' HZ3' HG22 ' A' 1635 ' ' THR . 20.0 ttpp -156.26 125.87 6.31 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.808 -0.633 . . . . 2.0 110.502 -178.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1608 ' ' SER . . . . . . . . . . . . . 20.0 m -106.45 129.86 54.35 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 109.015 -0.735 . . . . 1.61 109.015 -179.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 26.2 t -114.21 102.41 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.598 0 N-CA-C 108.508 -0.923 . . . . 1.09 108.508 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1610 ' ' ILE . . . . . 0.456 ' HB ' ' HB3' ' A' 1590 ' ' LEU . 85.4 mt -90.11 113.8 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.662 0 N-CA-C 108.709 -0.848 . . . . 1.2 108.709 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 34.5 m -109.64 106.76 16.56 Favored 'General case' 0 C--N 1.283 -2.288 0 CA-C-N 114.855 -1.066 . . . . 1.89 110.249 -178.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1612 ' ' PHE . . . . . 0.824 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 45.7 m-85 -80.27 119.24 22.76 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.88 -0.6 . . . . 0.28 109.79 176.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1613 ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' 1641 ' ' HIS . 54.1 t -109.64 128.83 65.39 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-N 115.004 -0.998 . . . . 1.23 110.927 -174.149 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 5.8 t -55.19 109.44 0.53 Allowed 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 125.012 1.325 . . . . 0.77 112.97 176.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1615 ' ' ARG . . . . . 0.777 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 4.3 tpt180 -129.08 94.36 34.07 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 106.963 -1.495 . . . . 2.92 106.963 169.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1616 ' ' PRO . . . . . 0.527 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 37.6 Cg_endo -63.47 -32.41 70.9 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 122.789 2.326 . . . . 1.22 115.999 -169.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -85.94 -18.16 33.44 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.211 -0.595 . . . . 3.05 111.646 -176.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . 68.65 113.15 0.04 OUTLIER 'General case' 0 C--N 1.358 0.949 0 C-N-CA 125.23 1.412 . . . . 1.55 110.937 -174.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . -131.25 -155.87 8.3 Favored Glycine 0 N--CA 1.422 -2.292 0 C-N-CA 119.976 -1.107 . . . . 1.16 111.208 -177.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -82.43 20.88 1.05 Allowed 'Trans proline' 0 C--O 1.235 0.375 0 C-N-CA 123.253 2.635 . . . . 1.06 113.588 -174.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1621 ' ' THR . . . . . . . . . . . . . 22.4 p -116.71 14.4 15.33 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-O 121.901 0.858 . . . . 1.58 109.717 178.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 42.6 t30 -90.68 58.9 4.04 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 122.802 1.287 . . . . 0.88 108.325 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1623 ' ' ARG . . . . . 0.42 ' HE ' ' HB2' ' A' 1623 ' ' ARG . 3.5 ptm180 -168.05 140.55 2.51 Favored Pre-proline 0 N--CA 1.428 -1.551 0 CA-C-N 113.486 -1.688 . . . . 3.82 107.003 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1624 ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' A' 1639 ' ' SER . 35.7 Cg_endo -61.98 103.99 0.31 Allowed 'Trans proline' 0 C--O 1.243 0.733 0 C-N-CA 123.133 2.555 . . . . 0.77 113.012 -176.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 69.9 mtm -99.66 144.92 28.18 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.988 -0.551 . . . . 1.43 109.869 176.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 1.5 tm? -86.89 115.33 24.23 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 106.883 -1.525 . . . . 1.43 106.883 -176.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1627 ' ' ILE . . . . . 0.697 HD13 ' HB2' ' A' 1639 ' ' SER . 38.6 mm -75.94 -58.35 4.67 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.605 0 CA-C-O 121.589 0.709 . . . . 1.23 109.186 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 40.3 m -164.18 151.3 11.78 Favored 'General case' 0 N--CA 1.427 -1.575 0 N-CA-C 107.639 -1.245 . . . . 1.88 107.639 -174.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1629 ' ' LEU . . . . . 0.665 HD13 ' HG ' ' A' 1636 ' ' LEU . 33.0 tp -116.05 104.7 11.83 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 107.102 -1.444 . . . . 1.92 107.102 172.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 14.3 t70 -75.35 100.99 4.58 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.082 -1.047 . . . . 1.09 108.63 178.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1631 ' ' LYS . . . . . 0.689 ' HD3' ' H ' ' A' 1631 ' ' LYS . 0.0 OUTLIER -65.31 -8.48 18.35 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 114.336 1.236 . . . . 3.98 114.336 -175.677 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A 1632 ' ' GLN . . . . . 0.787 HE21 ' HA ' ' A' 1632 ' ' GLN . 0.0 OUTLIER -96.06 -37.89 10.43 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 119.409 -0.916 . . . . 2.6 110.909 -179.292 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 66.9 p -94.74 -16.4 23.07 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 116.026 -0.534 . . . . 1.35 110.798 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 74.5 m 68.59 35.76 3.08 Favored 'General case' 0 C--N 1.353 0.73 0 C-N-CA 124.572 1.149 . . . . 0.53 110.698 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1635 ' ' THR . . . . . 0.458 HG22 ' HZ3' ' A' 1607 ' ' LYS . 41.3 m -99.19 131.79 44.97 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 114.455 -1.248 . . . . 1.11 109.693 -179.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1636 ' ' LEU . . . . . 0.665 ' HG ' HD13 ' A' 1629 ' ' LEU . 0.5 OUTLIER -110.24 121.62 45.72 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.638 -1.245 . . . . 1.56 107.638 -179.018 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -101.93 129.46 48.2 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 120.898 0.38 . . . . 0.54 110.836 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -125.83 137.37 53.76 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.312 -0.858 . . . . 0.64 109.82 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1639 ' ' SER . . . . . 0.697 ' HB2' HD13 ' A' 1627 ' ' ILE . 16.5 t -117.81 150.8 38.55 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.288 -1.004 . . . . 1.34 108.288 178.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 2.8 t90 -152.55 113.63 4.2 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 104.868 -2.271 . . . . 0.8 104.868 -179.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1641 ' ' HIS . . . . . 0.777 ' HB3' ' HB2' ' A' 1615 ' ' ARG . 10.6 m-70 -101.2 111.13 23.26 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-O 121.357 0.599 . . . . 1.14 109.79 -176.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1642 ' ' THR . . . . . . . . . . . . . 3.2 t -142.57 148.14 45.56 Favored Pre-proline 0 C--N 1.297 -1.71 0 CA-C-N 115.148 -0.933 . . . . 1.11 109.278 -174.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1643 ' ' PRO . . . . . 0.527 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 58.9 Cg_endo -79.42 -14.41 13.06 Favored 'Trans proline' 0 C--N 1.363 1.318 0 C-N-CA 122.28 1.987 . . . . 0.78 112.847 178.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 8.2 tt -70.76 -26.93 63.58 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.796 -0.816 . . . . 1.66 108.796 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -99.09 28.42 4.44 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 114.718 -1.128 . . . . 1.29 110.44 -177.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 47.7 t -121.57 140.95 51.58 Favored 'General case' 0 N--CA 1.419 -1.997 0 N-CA-C 108.794 -0.817 . . . . 1.48 108.794 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -89.56 108.55 25.78 Favored Pre-proline 0 N--CA 1.421 -1.921 0 N-CA-C 107.629 -1.249 . . . . 3.14 107.629 177.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1648 ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -69.51 106.22 1.58 Allowed 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 122.667 2.245 . . . . 2.92 112.337 -173.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 9.6 tp10 . . . . . 0 C--N 1.297 -1.676 0 N-CA-C 107.787 -1.19 . . . . 4.72 107.787 179.295 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.467 0 CA-C-O 121.039 0.447 . . . . 10.26 110.423 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -134.2 137.89 44.73 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.31 -0.996 . . . . 7.94 108.31 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -107.65 137.07 19.61 Favored Pre-proline 0 C--N 1.302 -1.494 0 N-CA-C 109.068 -0.716 . . . . 6.56 109.068 -178.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -77.52 7.63 3.73 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.836 2.358 . . . . 5.51 112.389 177.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' SER . . . . . 0.431 ' HB2' HD22 ' B' ' 8' ' ' LEU . 31.8 p -123.06 57.73 1.12 Allowed 'General case' 0 N--CA 1.425 -1.682 0 C-N-CA 124.019 0.927 . . . . 4.91 109.78 -176.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -68.93 -38.68 79.66 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.827 -0.624 . . . . 4.23 111.101 -177.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 19.4 p -127.07 99.61 5.77 Favored 'General case' 0 N--CA 1.421 -1.906 0 CA-C-N 115.513 -0.767 . . . . 3.48 110.375 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . 0.507 ' H ' ' HG3' ' B' ' 12' ' ' GLU . 91.0 mt -76.91 145.18 38.39 Favored 'General case' 0 C--O 1.249 1.062 0 N-CA-C 109.487 -0.56 . . . . 4.35 109.487 178.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 8.2 m -87.05 62.84 7.59 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 122.006 0.908 . . . . 2.84 109.469 -173.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.32 -69.13 0.29 Allowed Glycine 0 C--N 1.293 -1.845 0 CA-C-N 114.753 -1.112 . . . . 2.28 110.911 -178.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -57.16 -64.66 4.2 Favored Glycine 0 C--N 1.33 0.24 0 N-CA-C 113.919 0.328 . . . . 1.94 113.919 -177.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . 0.507 ' HG3' ' H ' ' B' ' 8' ' ' LEU . 19.3 mm-40 -63.96 -32.32 73.81 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 109.349 -0.611 . . . . 2.55 109.349 -178.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . 0.46 ' O ' HD22 ' B' ' 17' ' ' LEU . 0.1 OUTLIER -60.29 -59.56 5.22 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 114.441 -1.254 . . . . 2.82 109.214 -178.926 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 14.2 p -69.21 -33.31 57.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 112.259 0.466 . . . . 2.5 112.259 -176.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' ASP . . . . . 0.594 ' OD2' ' HB2' ' A' 1569 ' ' GLN . 11.9 t0 -59.86 -53.34 59.09 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 120.164 -0.614 . . . . 2.04 109.444 179.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 34.5 m -57.29 -51.14 70.56 Favored 'General case' 0 CA--C 1.566 1.571 0 C-N-CA 123.983 0.913 . . . . 2.31 111.322 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.538 ' HG ' ' HD2' ' B' ' 28' ' ' PHE . 4.2 mm? -53.72 -46.98 70.99 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.628 -0.715 . . . . 2.27 112.214 176.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -83.15 -10.67 58.51 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-O 121.554 0.692 . . . . 2.39 111.558 -177.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -68.5 -56.78 7.22 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.719 -0.673 . . . . 1.0 110.283 177.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 15.0 p -95.32 -22.83 5.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 C-N-CA 118.571 -1.252 . . . . 1.83 112.063 -176.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 60.3 m -108.81 27.01 9.89 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 120.197 -0.601 . . . . 1.66 110.13 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -54.16 -54.82 29.53 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 121.171 -0.538 . . . . 1.53 113.125 178.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -71.97 -43.11 65.69 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 112.168 0.433 . . . . 2.72 112.168 178.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . 0.457 ' HD2' ' HB1' ' B' ' 61' ' ' ALA . 39.1 ttm180 -67.73 -49.36 62.96 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 112.452 0.538 . . . . 5.02 112.452 -175.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 125.84 140.86 5.43 Favored Glycine 0 N--CA 1.437 -1.244 0 N-CA-C 110.002 -1.239 . . . . 1.63 110.002 -175.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . 0.469 ' HB2' ' HB3' ' B' ' 17' ' ' LEU . 30.6 p90 -113.69 130.22 56.45 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 117.121 0.46 . . . . 1.71 109.99 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -133.45 73.64 1.52 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.679 0.622 . . . . 3.67 112.679 -177.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' PHE . . . . . 0.538 ' HD2' ' HG ' ' B' ' 17' ' ' LEU . 34.3 p90 -93.7 -22.9 18.45 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.223 -0.991 . . . . 2.44 109.013 173.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 13.4 t -104.09 92.63 4.46 Favored 'General case' 0 N--CA 1.424 -1.725 0 CA-C-N 115.402 -0.817 . . . . 3.85 108.946 -175.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 27.0 mtm180 -123.38 162.72 38.43 Favored Pre-proline 0 C--N 1.31 -1.136 0 CA-C-N 115.958 -0.565 . . . . 4.27 109.584 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -76.71 -7.85 17.8 Favored 'Trans proline' 0 C--N 1.355 0.906 0 C-N-CA 123.339 2.692 . . . . 4.2 113.216 177.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' ALA . . . . . 0.603 ' HA ' ' HA ' ' B' ' 39' ' ' SER . . . -169.51 168.33 9.4 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 105.5 -2.037 . . . . 5.12 105.5 178.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' SER . . . . . 0.65 ' HG ' ' HH ' ' B' ' 59' ' ' TYR . 22.9 t -144.06 -157.55 0.79 Allowed 'General case' 1 N--CA 1.369 -4.502 0 N-CA-C 106.519 -1.66 . . . . 6.93 106.519 -179.862 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 62.0 mtp180 -63.95 -24.46 67.74 Favored 'General case' 0 C--N 1.255 -3.505 0 C-N-CA 123.977 0.911 . . . . 12.14 113.096 -177.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . 0.422 ' O ' HG21 ' B' ' 35' ' ' VAL . 7.3 p -119.45 8.17 6.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-O 122.82 1.295 . . . . 9.9 112.398 -173.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 48.4 t 67.66 -57.56 0.45 Allowed 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 113.495 -1.684 . . . . 6.82 113.087 179.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 14.9 tpp180 -44.54 -51.25 9.08 Favored 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 127.289 2.236 . . . . 10.71 111.449 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 23.2 mmm180 -91.04 108.27 19.75 Favored 'General case' 0 N--CA 1.391 -3.419 0 N-CA-C 105.677 -1.972 . . . . 8.6 105.677 175.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' SER . . . . . 0.603 ' HA ' ' HA ' ' B' ' 32' ' ' ALA . 19.2 m -74.61 -43.24 56.43 Favored 'General case' 0 N--CA 1.427 -1.62 0 N-CA-C 108.513 -0.921 . . . . 5.79 108.513 177.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 67.6 mtt180 -107.67 149.87 27.59 Favored 'General case' 0 N--CA 1.412 -2.344 0 N-CA-C 106.257 -1.757 . . . . 6.57 106.257 177.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . 0.428 ' C ' ' H ' ' B' ' 43' ' ' VAL . . . -121.15 160.63 15.43 Favored Glycine 0 N--CA 1.407 -3.259 0 N-CA-C 109.773 -1.331 . . . . 2.62 109.773 -176.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . 0.521 HD11 HD21 ' B' ' 17' ' ' LEU . 20.0 pt 61.51 -30.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 C-N-CA 127.953 2.501 . . . . 2.28 114.821 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . 0.608 ' O ' ' HB2' ' B' ' 47' ' ' CYS . 2.6 p -49.88 -43.01 19.27 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 114.236 1.199 . . . . 2.6 114.236 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -96.28 -35.04 11.39 Favored 'General case' 0 N--CA 1.429 -1.523 0 C-N-CA 120.207 -0.597 . . . . 3.36 109.566 -175.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . 0.405 ' HG3' ' HD2' ' B' ' 49' ' ' ARG . 33.7 tt0 -63.87 -45.4 89.59 Favored 'General case' 0 C--O 1.202 -1.431 0 CA-C-N 115.905 -0.589 . . . . 3.08 109.769 179.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' CYS . . . . . . . . . . . . . 29.3 m -85.16 -4.16 59.06 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.216 0.531 . . . . 2.23 110.88 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' CYS . . . . . 0.608 ' HB2' ' O ' ' B' ' 43' ' ' VAL . 42.2 t -77.62 -45.36 25.35 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.523 0.677 . . . . 2.48 109.195 175.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -105.23 -10.25 17.19 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 113.236 0.828 . . . . 2.97 113.236 -176.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . 0.405 ' HD2' ' HG3' ' B' ' 45' ' ' GLU . 93.0 mtt180 -129.47 171.31 12.69 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 106.956 -1.498 . . . . 4.65 106.956 177.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 22.7 t -99.71 148.11 24.72 Favored 'General case' 0 N--CA 1.426 -1.66 0 N-CA-C 107.609 -1.256 . . . . 2.86 107.609 173.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 76.9 m -125.98 142.01 51.71 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 109.553 -0.536 . . . . 2.11 109.553 -175.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -81.77 161.79 23.15 Favored 'General case' 0 C--O 1.243 0.725 0 O-C-N 123.15 0.281 . . . . 2.67 110.88 176.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . 0.731 ' HB2' ' HA ' ' A' 1600 ' ' SER . 62.7 tp -55.33 -36.23 66.04 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 122.508 0.323 . . . . 2.36 111.405 178.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.9 -26.51 65.96 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 123.648 0.779 . . . . 1.92 112.556 -174.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 52.6 tp -74.44 -54.56 7.32 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 109.551 -0.537 . . . . 2.35 109.551 177.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' B' ' 60' ' ' CYS . 2.8 pp -70.92 -33.32 70.41 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-N 115.923 -0.58 . . . . 2.01 111.392 -174.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -54.47 -51.39 65.2 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 123.663 0.602 . . . . 2.27 111.318 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 8.9 t -82.7 -28.29 30.65 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 112.492 0.553 . . . . 2.67 112.492 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 59' ' ' TYR . . . . . 0.65 ' HH ' ' HG ' ' B' ' 33' ' ' SER . 8.1 t80 -78.38 -36.27 46.13 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 121.807 -0.558 . . . . 3.2 110.695 -175.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 60' ' ' CYS . . . . . 0.468 ' HB2' ' O ' ' B' ' 56' ' ' LEU . 12.0 t -39.87 -62.41 0.72 Allowed 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 126.011 1.724 . . . . 2.3 111.84 -178.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 61' ' ' ALA . . . . . 0.457 ' HB1' ' HD2' ' B' ' 24' ' ' ARG . . . -176.44 172.67 2.19 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 105.437 -2.061 . . . . 3.19 105.437 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 19.6 p -135.09 152.21 76.7 Favored Pre-proline 0 C--N 1.29 -1.993 0 N-CA-C 109.015 -0.735 . . . . 4.14 109.015 -173.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -59.92 -8.89 8.59 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 123.481 2.787 . . . . 5.59 112.933 176.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 73.47 28.11 1.77 Allowed 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 126.282 1.833 . . . . 5.51 112.535 173.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -98.38 -7.81 28.1 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 107.341 -1.355 . . . . 8.8 107.341 176.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 43.5 p -118.23 -174.77 2.72 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 114.263 -1.335 . . . . 8.12 108.33 176.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 . . . . . 0 C--N 1.311 -1.076 0 N-CA-C 108.275 -1.009 . . . . 10.21 108.275 177.779 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 23.6 ptp . . . . . 0 N--CA 1.473 0.712 0 CA-C-O 119.351 -0.357 . . . . 9.74 111.136 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 64.8 tttp 56.36 73.97 0.42 Allowed 'General case' 0 C--O 1.245 0.862 0 CA-C-O 122.427 1.108 . . . . 9.32 110.478 -178.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 28.9 m -145.83 149.65 34.71 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 107.815 -1.179 . . . . 5.97 107.815 -177.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1511 ' ' ASN . . . . . . . . . . . . . 2.8 m-20 59.86 57.36 3.14 Favored 'General case' 0 C--O 1.246 0.887 0 CA-C-O 121.829 0.823 . . . . 3.48 109.596 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1512 ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -76.86 -28.42 55.43 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 114.531 -1.213 . . . . 5.95 110.843 -175.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 27.6 t-80 81.35 142.7 0.07 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.891 1.676 . . . . 6.14 111.102 -178.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 18.5 t70 78.02 8.41 2.42 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.182 1.393 . . . . 5.06 109.698 178.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 26.5 p-10 -121.98 138.8 54.29 Favored 'General case' 0 N--CA 1.414 -2.234 0 N-CA-C 107.068 -1.456 . . . . 2.9 107.068 176.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 11.8 m -87.06 51.07 2.14 Favored 'General case' 0 C--N 1.276 -2.628 0 CA-C-N 115.703 -0.68 . . . . 1.41 110.271 -174.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -162.98 132.05 4.09 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-O 121.23 0.538 . . . . 2.18 111.381 -174.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 6.6 m -135.46 144.79 33.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 CA-C-N 116.083 -0.508 . . . . 1.52 110.038 179.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1519 ' ' THR . . . . . 0.412 ' HG1' HD22 ' A' 1526 ' ' LEU . 28.9 m -114.65 134.52 55.0 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.386 -0.598 . . . . 1.36 109.386 177.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1520 ' ' ASN . . . . . 0.535 ' OD1' HG23 ' A' 1523 ' ' THR . 13.9 t-20 -89.98 115.23 63.46 Favored Pre-proline 0 N--CA 1.43 -1.429 0 N-CA-C 108.322 -0.992 . . . . 2.02 108.322 175.291 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -66.54 -16.51 51.09 Favored 'Trans proline' 0 CA--C 1.533 0.439 0 C-N-CA 122.898 2.399 . . . . 1.82 113.514 -175.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1522 ' ' SER . . . . . 0.469 ' HB2' ' OD1' ' A' 1520 ' ' ASN . 15.9 m -71.8 -50.05 33.26 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 116.439 -0.346 . . . . 1.89 111.393 -179.067 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1523 ' ' THR . . . . . 0.535 HG23 ' OD1' ' A' 1520 ' ' ASN . 9.9 t -111.62 -1.86 15.61 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 120.479 -0.488 . . . . 1.99 111.524 -176.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 66.58 33.26 84.0 Favored Glycine 0 CA--C 1.501 -0.817 0 CA-C-N 115.737 -0.665 . . . . 1.19 112.41 177.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 55.5 t-80 -94.85 123.73 38.48 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 119.971 -0.692 . . . . 1.82 109.408 -178.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1526 ' ' LEU . . . . . 0.412 HD22 ' HG1' ' A' 1519 ' ' THR . 2.0 tm? -93.71 111.52 23.22 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.101 -1.074 . . . . 1.3 108.101 179.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -94.0 115.32 27.65 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.92 -0.488 . . . . 0.8 110.217 176.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 20.5 t70 -104.78 113.3 26.8 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 109.188 -0.671 . . . . 1.17 109.188 176.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1529 ' ' LEU . . . . . 0.419 ' HG ' HD22 ' A' 1581 ' ' LEU . 3.0 mm? -102.31 2.33 36.76 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 108.727 -0.842 . . . . 1.29 108.727 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 2.1 m -66.98 -27.97 67.88 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.659 -0.7 . . . . 0.91 109.886 -177.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 27.7 t -69.85 -18.41 63.43 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.866 -0.606 . . . . 1.98 110.637 178.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1532 ' ' LEU . . . . . 0.482 ' O ' ' HB ' ' A' 1552 ' ' ILE . 74.8 mt -94.76 0.83 55.27 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.323 0.583 . . . . 1.34 110.192 -178.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1533 ' ' SER . . . . . . . . . . . . . 41.5 m -77.72 164.72 25.01 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 109.351 -0.611 . . . . 1.93 109.351 175.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -179.62 155.01 14.62 Favored Glycine 0 N--CA 1.421 -2.362 0 N-CA-C 108.386 -1.886 . . . . 1.1 108.386 178.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 58.0 ttp180 -86.49 -29.27 22.89 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 121.092 0.472 . . . . 5.21 110.852 -177.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -88.01 -29.42 20.73 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.445 0.641 . . . . 1.94 110.021 177.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 94.06 -155.77 22.06 Favored Glycine 0 N--CA 1.418 -2.514 0 CA-C-N 115.299 -0.864 . . . . 1.08 111.645 175.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -130.49 148.39 52.29 Favored 'General case' 0 C--N 1.278 -2.535 0 N-CA-C 107.546 -1.279 . . . . 1.07 107.546 177.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 7.3 p -109.15 132.73 53.84 Favored 'General case' 0 C--N 1.292 -1.913 0 O-C-N 123.677 0.611 . . . . 1.46 111.001 -176.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1540 ' ' ALA . . . . . 0.433 ' HB2' ' CG1' ' A' 1548 ' ' VAL . . . -125.65 144.34 50.64 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.9 -1.148 . . . . 1.19 107.9 175.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -77.35 132.04 38.38 Favored 'General case' 0 C--N 1.313 -1.008 0 O-C-N 123.556 0.535 . . . . 1.37 110.312 -177.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1542 ' ' TYR . . . . . 0.714 ' HE2' ' HG ' ' A' 1626 ' ' LEU . 9.3 t80 -136.76 -99.79 0.21 Allowed 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.326 -0.99 . . . . 1.38 108.326 -178.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1543 ' ' SER . . . . . 0.404 ' H ' ' HB3' ' A' 1542 ' ' TYR . 47.7 t -86.84 160.82 18.62 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-O 121.602 0.715 . . . . 1.98 109.726 -175.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -72.39 -18.52 61.72 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.637 -0.71 . . . . 3.96 110.724 -178.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 13.2 t -87.63 -41.07 13.67 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.156 0.503 . . . . 2.81 110.22 -178.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . -153.27 159.05 28.34 Favored Glycine 0 N--CA 1.431 -1.69 0 C-N-CA 120.708 -0.758 . . . . 1.68 112.021 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 33.7 m -94.59 -179.41 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 107.929 -1.137 . . . . 1.38 107.929 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1548 ' ' VAL . . . . . 0.433 ' CG1' ' HB2' ' A' 1540 ' ' ALA . 14.2 p -104.37 135.94 39.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 C-N-CA 119.716 -0.794 . . . . 1.24 109.561 177.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1549 ' ' TYR . . . . . 0.416 ' HB3' ' ND2' ' A' 1556 ' ' ASN . 86.1 m-85 -102.05 129.28 48.33 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 108.81 -0.811 . . . . 1.29 108.81 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 26.1 ptm -148.43 132.96 17.7 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 116.045 -0.525 . . . . 1.47 111.484 -178.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 6.8 p -118.89 126.47 51.87 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 115.775 -0.648 . . . . 1.4 110.041 178.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1552 ' ' ILE . . . . . 0.482 ' HB ' ' O ' ' A' 1532 ' ' LEU . 36.0 mm -77.6 112.46 15.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 112.362 0.505 . . . . 1.11 112.362 -177.174 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1553 ' ' CYS . . . . . 0.532 ' H ' ' HH ' ' A' 1592 ' ' TYR . 46.3 t 62.12 32.12 17.54 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.398 1.079 . . . . 1.4 110.977 174.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . -163.96 174.28 40.08 Favored Glycine 0 N--CA 1.422 -2.281 0 N-CA-C 108.947 -1.661 . . . . 0.4 108.947 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -100.54 155.0 18.09 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 117.48 0.64 . . . . 1.62 110.761 -178.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1556 ' ' ASN . . . . . 0.416 ' ND2' ' HB3' ' A' 1549 ' ' TYR . 49.8 t-20 -108.4 132.74 53.45 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 115.05 -0.977 . . . . 1.12 109.236 -176.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -82.72 1.83 36.77 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.599 0.592 . . . . 2.49 112.599 -176.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -78.89 -19.95 50.63 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.326 0.584 . . . . 1.38 110.273 176.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1559 ' ' CYS . . . . . 0.623 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 76.1 m -132.71 172.42 7.41 Favored Pre-proline 0 C--N 1.299 -1.612 0 CA-C-O 117.795 -1.098 . . . . 1.21 109.871 -178.038 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1560 ' ' PRO . . . . . 0.623 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 18.1 Cg_exo -36.84 148.22 0.06 OUTLIER 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 124.296 3.33 . . . . 0.98 115.747 178.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -58.73 127.72 25.49 Favored 'Trans proline' 0 C--O 1.254 1.292 0 C-N-CA 123.626 2.884 . . . . 1.15 112.113 178.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 92.45 9.12 61.95 Favored Glycine 0 N--CA 1.438 -1.213 0 CA-C-N 115.942 -0.572 . . . . 0.55 112.124 -179.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1563 ' ' VAL . . . . . 0.585 ' HB ' ' O ' ' A' 1560 ' ' PRO . 2.8 t -96.09 124.55 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.339 0 CA-C-O 121.021 0.438 . . . . 1.53 111.231 179.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -101.73 -31.95 5.27 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 115.147 -0.933 . . . . 0.29 112.069 178.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -128.62 129.8 46.39 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 109.669 -0.493 . . . . 1.08 109.669 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 11.4 t -159.52 136.48 9.48 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 116.409 -0.36 . . . . 0.43 110.395 -176.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -89.71 149.89 22.56 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 121.991 -0.443 . . . . 1.3 110.763 177.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -89.05 20.81 30.9 Favored Glycine 0 N--CA 1.438 -1.227 0 CA-C-N 116.69 -0.232 . . . . 1.43 113.492 -177.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1569 ' ' GLN . . . . . 0.529 ' HG3' ' HD1' ' B' ' 19' ' ' PHE . 15.8 mm100 -68.22 -69.94 0.29 Allowed 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.579 -0.897 . . . . 3.09 108.579 173.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 6.0 p -130.09 28.49 5.02 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.28 0.562 . . . . 2.52 111.056 175.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 12.6 mmt85 60.56 48.1 7.81 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 115.157 -0.929 . . . . 3.19 110.808 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 40.2 mt -93.38 129.12 44.28 Favored 'Isoleucine or valine' 0 C--O 1.247 0.964 0 CA-C-N 115.392 -0.822 . . . . 1.51 110.039 179.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 29.0 t -80.74 148.95 29.88 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 123.605 0.762 . . . . 0.96 111.416 -178.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1574 ' ' VAL . . . . . . . . . . . . . 29.8 m -134.78 12.6 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 115.859 -0.609 . . . . 1.6 110.522 176.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 175.52 131.64 1.48 Allowed Glycine 0 N--CA 1.423 -2.214 0 C-N-CA 119.46 -1.352 . . . . 0.34 112.627 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1576 ' ' LYS . . . . . 0.415 ' HE3' ' HB2' ' A' 1576 ' ' LYS . 39.0 ttmt -74.79 147.69 41.01 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.759 -0.83 . . . . 2.68 108.759 177.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -73.93 79.26 1.65 Allowed 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 115.813 -0.63 . . . . 1.08 111.136 -178.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -89.77 146.65 24.32 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 115.657 -0.701 . . . . 1.95 110.393 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -111.15 45.96 1.13 Allowed 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.527 -1.286 . . . . 3.11 107.527 -176.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -101.42 76.78 1.72 Allowed 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 114.007 -1.451 . . . . 4.04 107.401 -176.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1581 ' ' LEU . . . . . 0.419 HD22 ' HG ' ' A' 1529 ' ' LEU . 0.4 OUTLIER -74.11 124.06 25.59 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.309 -1.367 . . . . 1.32 107.309 178.531 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -126.22 140.93 52.16 Favored 'General case' 0 C--N 1.288 -2.099 0 C-N-CA 119.92 -0.712 . . . . 3.4 111.617 177.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1583 ' ' TYR . . . . . 0.476 ' CE1' ' HA ' ' A' 1586 ' ' GLN . 72.4 t80 -108.43 123.24 48.56 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.044 -1.095 . . . . 1.26 108.044 178.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1584 ' ' VAL . . . . . 0.546 ' O ' ' HB ' ' A' 1587 ' ' VAL . 12.5 p -149.25 110.91 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-O 121.433 0.635 . . . . 1.71 111.044 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 30.7 t70 56.99 55.23 6.26 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 125.247 1.419 . . . . 1.17 111.257 -178.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1586 ' ' GLN . . . . . 0.476 ' HA ' ' CE1' ' A' 1583 ' ' TYR . 13.7 pt20 60.72 9.51 2.22 Favored 'General case' 0 N--CA 1.499 2.015 0 C-N-CA 126.864 2.066 . . . . 2.43 112.498 177.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1587 ' ' VAL . . . . . 0.546 ' HB ' ' O ' ' A' 1584 ' ' VAL . 20.5 t -102.08 127.88 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.327 0 CA-C-N 113.877 -1.51 . . . . 1.16 109.326 178.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1588 ' ' LEU . . . . . 0.942 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 2.4 mm? -92.34 117.48 29.95 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 106.605 -1.628 . . . . 1.11 106.605 178.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -119.88 133.32 55.62 Favored 'General case' 0 C--N 1.283 -2.302 0 CA-C-O 121.806 0.813 . . . . 1.74 111.86 -176.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 11.2 mt -121.25 112.21 18.34 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 106.807 -1.553 . . . . 1.4 106.807 173.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 6.1 p -101.39 125.36 55.42 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.33 0 C-N-CA 119.92 -0.712 . . . . 1.7 109.683 -178.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1592 ' ' TYR . . . . . 0.638 ' HB2' ' HB2' ' A' 1608 ' ' SER . 14.1 m-30 -107.23 136.45 47.04 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 108.345 -0.983 . . . . 1.08 108.345 178.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 13.2 ptmm? -150.47 177.41 10.03 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 108.192 -1.04 . . . . 2.21 108.192 -172.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 28.4 m-20 59.56 63.93 1.43 Allowed 'General case' 0 C--N 1.317 -0.835 0 O-C-N 124.591 1.182 . . . . 1.11 111.163 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -112.81 -126.13 4.52 Favored Glycine 0 N--CA 1.424 -2.103 0 N-CA-C 109.877 -1.289 . . . . 0.78 109.877 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1596 ' ' SER . . . . . 0.406 ' HA ' ' HD3' ' A' 1597 ' ' PRO . 49.7 m -87.4 140.51 32.07 Favored Pre-proline 0 C--N 1.295 -1.765 0 N-CA-C 109.311 -0.626 . . . . 1.36 109.311 177.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1597 ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' 1596 ' ' SER . 38.2 Cg_exo -62.51 119.95 7.27 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 122.293 1.995 . . . . 1.4 108.275 173.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1598 ' ' CYS . . . . . 0.469 ' HA ' ' HD3' ' A' 1599 ' ' PRO . 37.8 t -77.33 128.2 81.06 Favored Pre-proline 0 C--N 1.294 -1.825 0 CA-C-N 115.728 -0.669 . . . . 0.75 109.612 -173.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1599 ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' 1598 ' ' CYS . 16.9 Cg_exo -68.35 -28.46 33.05 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.46 2.773 . . . . 1.7 112.639 -176.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1600 ' ' SER . . . . . . . . . . . . . 2.0 m -59.94 -42.55 94.27 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 123.748 0.819 . . . . 2.8 111.935 -178.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1601 ' ' LYS . . . . . 0.569 ' HB3' HD22 ' A' 1604 ' ' LEU . 3.8 tppp? -131.54 105.21 7.41 Favored 'General case' 0 N--CA 1.407 -2.613 0 N-CA-C 107.207 -1.405 . . . . 3.45 107.207 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 36.8 p -51.76 121.75 7.07 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 123.531 0.52 . . . . 2.44 111.972 179.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 92.44 11.41 59.58 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.93 -0.652 . . . . 1.2 112.369 178.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1604 ' ' LEU . . . . . 0.569 HD22 ' HB3' ' A' 1601 ' ' LYS . 9.4 tp -109.56 160.25 16.41 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.913 -1.143 . . . . 2.38 107.913 179.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 29.5 t -123.51 157.48 33.48 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 109.073 -0.714 . . . . 1.96 109.073 177.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1606 ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -71.97 153.5 41.77 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 108.118 -1.067 . . . . 1.06 108.118 172.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1607 ' ' LYS . . . . . 0.554 ' HZ2' ' HB2' ' A' 1607 ' ' LYS . 0.0 OUTLIER -154.42 126.4 7.72 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.216 0.531 . . . . 2.0 110.533 -175.237 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A 1608 ' ' SER . . . . . 0.638 ' HB2' ' HB2' ' A' 1592 ' ' TYR . 16.4 m -105.07 128.58 53.41 Favored 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 115.323 -0.853 . . . . 1.61 109.129 -175.236 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 34.4 t -111.22 101.74 12.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 CA-C-O 121.268 0.556 . . . . 1.09 109.795 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1610 ' ' ILE . . . . . 0.426 ' HA ' ' HB2' ' A' 1638 ' ' PHE . 96.8 mt -91.62 117.57 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.608 0 N-CA-C 108.84 -0.8 . . . . 1.2 108.84 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 32.7 m -120.38 116.72 26.04 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.69 -0.686 . . . . 1.89 110.902 -178.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1612 ' ' PHE . . . . . 0.942 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 70.7 m-85 -90.41 122.69 33.5 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.787 -0.642 . . . . 0.28 109.386 177.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 43.7 t -113.39 140.89 31.25 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 CA-C-N 115.306 -0.861 . . . . 1.23 109.308 -176.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 35.3 t -71.91 111.23 6.98 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.162 -0.472 . . . . 0.77 111.308 -178.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1615 ' ' ARG . . . . . 0.718 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 19.8 tpt180 -124.92 87.39 55.32 Favored Pre-proline 0 CA--C 1.54 0.585 0 N-CA-C 109.331 -0.618 . . . . 2.92 109.331 174.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1616 ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -62.8 -35.06 70.41 Favored 'Trans proline' 0 N--CA 1.483 0.855 0 C-N-CA 123.128 2.552 . . . . 1.22 114.365 -173.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -79.09 -13.24 59.87 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 112.491 0.552 . . . . 3.05 112.491 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . 66.57 -168.12 0.21 Allowed 'General case' 0 C--N 1.318 -0.775 0 O-C-N 124.507 1.13 . . . . 1.55 109.266 -174.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1619 ' ' GLY . . . . . 0.418 ' C ' ' H ' ' A' 1621 ' ' THR . . . 148.42 -163.39 28.96 Favored Glycine 0 N--CA 1.413 -2.835 0 N-CA-C 110.394 -1.082 . . . . 1.16 110.394 179.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -82.65 21.42 1.0 Allowed 'Trans proline' 0 C--N 1.327 -0.574 0 C-N-CA 123.755 2.97 . . . . 1.06 111.971 -176.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1621 ' ' THR . . . . . 0.651 ' HB ' ' HB2' ' A' 1641 ' ' HIS . 18.6 p -108.08 -0.5 21.13 Favored 'General case' 0 C--N 1.282 -2.353 0 CA-C-N 113.933 -1.485 . . . . 1.58 109.899 -178.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -88.46 56.85 3.96 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 122.332 1.063 . . . . 0.88 109.258 -177.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1623 ' ' ARG . . . . . 0.546 ' O ' ' HG3' ' A' 1625 ' ' MET . 27.4 ptt180 -165.96 141.09 3.93 Favored Pre-proline 0 C--N 1.29 -1.996 0 N-CA-C 106.449 -1.685 . . . . 3.82 106.449 -178.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -53.81 104.55 0.11 Allowed 'Trans proline' 0 CA--C 1.534 0.49 0 C-N-CA 123.187 2.591 . . . . 0.77 111.901 -178.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1625 ' ' MET . . . . . 0.546 ' HG3' ' O ' ' A' 1623 ' ' ARG . 92.1 mtp -98.3 110.2 22.83 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.335 -0.987 . . . . 1.43 108.335 -176.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1626 ' ' LEU . . . . . 0.714 ' HG ' ' HE2' ' A' 1542 ' ' TYR . 0.7 OUTLIER -72.92 112.87 9.35 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 106.756 -1.572 . . . . 1.43 106.756 179.615 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A 1627 ' ' ILE . . . . . 0.537 HD12 ' HB2' ' A' 1639 ' ' SER . 31.0 mm -73.14 -57.54 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 N-CA-C 108.993 -0.743 . . . . 1.23 108.993 -178.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 49.9 m -163.99 152.39 13.19 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.598 -0.728 . . . . 1.88 109.416 -174.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1629 ' ' LEU . . . . . 0.907 HD11 ' HG ' ' A' 1636 ' ' LEU . 23.0 tp -117.35 100.71 7.86 Favored 'General case' 0 N--CA 1.426 -1.659 0 N-CA-C 107.345 -1.354 . . . . 1.92 107.345 171.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 20.6 t70 -74.23 114.23 12.34 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.47 -0.937 . . . . 1.09 108.47 178.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1631 ' ' LYS . . . . . 0.565 ' HB3' HD22 ' B' ' 53' ' ' LEU . 65.2 mttp -66.66 -20.78 66.06 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 113.759 1.022 . . . . 3.98 113.759 -175.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -88.66 -42.18 12.15 Favored 'General case' 0 CA--C 1.495 -1.143 0 CA-C-O 121.506 0.67 . . . . 2.6 111.311 -175.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 73.3 p -93.12 -8.2 43.32 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-N 115.34 -0.846 . . . . 1.35 110.792 -177.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1634 ' ' CYS . . . . . 0.479 ' SG ' HD21 ' A' 1604 ' ' LEU . 39.4 m 57.94 33.07 22.79 Favored 'General case' 0 C--N 1.361 1.084 0 C-N-CA 124.753 1.221 . . . . 0.53 110.908 175.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1635 ' ' THR . . . . . . . . . . . . . 64.3 m -104.89 130.76 52.98 Favored 'General case' 0 N--CA 1.425 -1.703 0 CA-C-N 114.219 -1.355 . . . . 1.11 109.313 -177.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1636 ' ' LEU . . . . . 0.907 ' HG ' HD11 ' A' 1629 ' ' LEU . 0.6 OUTLIER -111.43 126.47 54.98 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 106.522 -1.659 . . . . 1.56 106.522 -178.736 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A 1637 ' ' PHE . . . . . 0.438 ' HB2' ' HB ' ' A' 1627 ' ' ILE . 87.8 m-85 -102.09 138.83 38.52 Favored 'General case' 0 C--N 1.293 -1.879 0 C-N-CA 120.915 -0.314 . . . . 0.54 110.315 -178.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1638 ' ' PHE . . . . . 0.477 ' HE1' ' HB3' ' A' 1608 ' ' SER . 96.0 m-85 -131.57 134.49 46.12 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 108.671 -0.862 . . . . 0.64 108.671 -177.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1639 ' ' SER . . . . . 0.537 ' HB2' HD12 ' A' 1627 ' ' ILE . 22.6 t -116.85 152.36 34.61 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 107.542 -1.281 . . . . 1.34 107.542 175.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 2.9 t90 -153.35 109.79 3.37 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 104.535 -2.394 . . . . 0.8 104.535 178.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1641 ' ' HIS . . . . . 0.718 ' HB3' ' HB2' ' A' 1615 ' ' ARG . 33.3 m-70 -102.04 109.27 20.94 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 109.006 -0.738 . . . . 1.14 109.006 -176.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1642 ' ' THR . . . . . . . . . . . . . 3.9 t -138.05 148.93 62.14 Favored Pre-proline 0 C--N 1.302 -1.482 0 CA-C-N 115.948 -0.569 . . . . 1.11 109.768 -174.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1643 ' ' PRO . . . . . 0.453 ' HA ' ' SG ' ' A' 1646 ' ' CYS . 53.3 Cg_endo -78.97 -3.21 13.04 Favored 'Trans proline' 0 C--N 1.368 1.564 0 C-N-CA 122.034 1.823 . . . . 0.78 111.956 175.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 5.8 tp -63.96 -30.84 71.89 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.919 0.866 . . . . 1.66 108.756 176.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -89.78 13.09 15.25 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.307 -1.315 . . . . 1.29 110.455 -179.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1646 ' ' CYS . . . . . 0.453 ' SG ' ' HA ' ' A' 1643 ' ' PRO . 62.7 m -121.43 154.72 36.17 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 109.724 -0.472 . . . . 1.48 109.724 -179.006 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -91.53 123.1 64.7 Favored Pre-proline 0 C--N 1.297 -1.711 0 N-CA-C 105.031 -2.211 . . . . 3.14 105.031 168.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1648 ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -62.4 117.3 4.16 Favored 'Trans proline' 0 C--O 1.238 0.512 0 C-N-CA 122.783 2.322 . . . . 2.92 112.893 -174.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 . . . . . 0 C--N 1.316 -0.877 0 N-CA-C 108.692 -0.855 . . . . 4.72 108.692 -179.522 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.987 0 CA-C-O 121.642 0.734 . . . . 10.26 109.958 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -94.32 138.62 32.08 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 107.876 -1.157 . . . . 7.94 107.876 179.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 15.5 ptt180 -111.27 121.82 39.38 Favored Pre-proline 0 C--N 1.291 -1.975 0 N-CA-C 109.424 -0.584 . . . . 6.56 109.424 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -62.63 -27.01 75.86 Favored 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 122.868 2.378 . . . . 5.51 113.642 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 29.3 m -105.9 106.36 16.83 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 107.779 -1.193 . . . . 4.91 107.779 175.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -102.17 23.25 11.91 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.721 0.772 . . . . 4.23 109.666 -177.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 20.8 p -122.59 98.74 6.05 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-N 114.441 -1.254 . . . . 3.48 109.891 174.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . 0.549 ' HG ' ' OE1' ' B' ' 12' ' ' GLU . 84.4 mt -69.0 132.64 46.98 Favored 'General case' 0 C--O 1.251 1.168 0 N-CA-C 109.09 -0.707 . . . . 4.35 109.09 174.374 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 11.8 m -80.54 71.9 7.41 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 121.714 0.768 . . . . 2.84 109.95 -176.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.19 -74.24 0.26 Allowed Glycine 0 N--CA 1.423 -2.182 0 CA-C-N 114.448 -1.251 . . . . 2.28 110.407 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . 0.441 ' O ' ' HB2' ' B' ' 15' ' ' ASP . . . -57.01 -56.82 23.0 Favored Glycine 0 CA--C 1.511 -0.217 0 CA-C-N 115.415 -0.393 . . . . 1.94 113.863 -176.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . 0.549 ' OE1' ' HG ' ' B' ' 8' ' ' LEU . 39.3 mt-10 -84.2 -14.94 48.73 Favored 'General case' 0 CA--C 1.489 -1.378 0 CA-C-N 117.259 0.53 . . . . 2.55 110.475 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.57 -53.22 45.02 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 107.139 -1.43 . . . . 2.82 107.139 179.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 22.2 m -74.55 -22.88 17.76 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 C-N-CA 119.672 -0.811 . . . . 2.5 110.098 178.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 15' ' ' ASP . . . . . 0.512 ' CB ' ' HA ' ' B' ' 12' ' ' GLU . 15.7 t70 -64.41 -51.22 64.31 Favored 'General case' 0 C--O 1.217 -0.653 0 CA-C-N 116.008 -0.542 . . . . 2.04 110.939 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 22.6 p -65.82 -46.46 78.53 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.392 0.677 . . . . 2.31 111.004 178.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.497 HD23 HD12 ' B' ' 42' ' ' ILE . 3.6 mm? -48.99 -49.82 38.89 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.904 0.882 . . . . 2.27 111.887 171.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -79.58 -15.64 57.3 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.279 -0.873 . . . . 2.39 110.992 -179.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 19' ' ' PHE . . . . . 0.529 ' HD1' ' HG3' ' A' 1569 ' ' GLN . 88.0 t80 -64.42 -55.96 17.43 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.65 178.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.473 HG23 ' HZ1' ' A' 1631 ' ' LYS . 8.4 p -95.58 -26.56 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.357 0 C-N-CA 119.024 -1.071 . . . . 1.83 111.547 -177.275 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 89.2 m -116.36 18.72 15.11 Favored 'General case' 0 C--O 1.212 -0.869 0 N-CA-C 113.229 0.826 . . . . 1.66 113.229 -177.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -54.87 -37.59 62.6 Favored Glycine 0 N--CA 1.472 1.05 0 N-CA-C 114.813 0.685 . . . . 1.53 114.813 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -69.0 -27.2 65.48 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 123.08 0.552 . . . . 2.72 111.176 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 16.3 tpp180 -91.68 -44.72 8.85 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.038 0.447 . . . . 5.02 110.328 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . 0.49 ' O ' ' HB2' ' B' ' 61' ' ' ALA . . . 129.38 177.1 14.7 Favored Glycine 0 N--CA 1.436 -1.352 0 N-CA-C 109.359 -1.496 . . . . 1.63 109.359 -179.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -137.92 122.36 18.36 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 117.91 0.855 . . . . 1.71 110.394 175.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -133.32 80.88 1.9 Allowed 'General case' 0 C--O 1.21 -1.003 0 N-CA-C 113.359 0.874 . . . . 3.67 113.359 -175.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 28' ' ' PHE . . . . . 0.515 ' O ' ' HA ' ' B' ' 40' ' ' ARG . 32.8 p90 -101.49 -4.66 26.38 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.931 -0.707 . . . . 2.44 109.733 169.007 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 5.4 m -92.03 89.11 6.82 Favored 'General case' 0 N--CA 1.422 -1.829 0 N-CA-C 106.662 -1.607 . . . . 3.85 106.662 175.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . 0.766 ' HE ' ' HH ' ' B' ' 59' ' ' TYR . 78.6 mtt-85 -118.57 162.14 32.1 Favored Pre-proline 0 C--N 1.297 -1.707 0 N-CA-C 109.375 -0.602 . . . . 4.27 109.375 -174.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_exo -61.17 -51.65 4.26 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 N-CA-C 109.012 -1.188 . . . . 4.2 109.012 173.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -157.2 169.58 24.44 Favored 'General case' 0 N--CA 1.415 -2.189 0 N-CA-C 108.065 -1.087 . . . . 5.12 108.065 176.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 33' ' ' SER . . . . . 0.711 ' HB3' ' HB2' ' B' ' 36' ' ' SER . 13.7 t 179.66 161.05 0.84 Allowed 'General case' 0 N--CA 1.397 -3.114 0 N-CA-C 104.243 -2.503 . . . . 6.93 104.243 -179.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 34.5 ttm180 -90.78 -0.73 57.8 Favored 'General case' 0 C--N 1.271 -2.819 0 N-CA-C 107.819 -1.178 . . . . 12.14 107.819 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 24.5 t -113.8 -9.97 12.18 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 107.568 -1.271 . . . . 9.9 107.568 175.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 36' ' ' SER . . . . . 0.711 ' HB2' ' HB3' ' B' ' 33' ' ' SER . 21.5 m -145.42 62.1 1.28 Allowed 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 122.25 1.024 . . . . 6.82 109.306 -177.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -79.2 -5.72 54.91 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.705 -1.134 . . . . 10.71 112.653 -178.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 32.5 tpt180 -111.25 32.03 5.64 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 107.075 -1.454 . . . . 8.6 107.075 176.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 22.6 t 71.27 -50.3 0.69 Allowed 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.774 1.63 . . . . 5.79 110.747 -176.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . 0.515 ' HA ' ' O ' ' B' ' 28' ' ' PHE . 70.9 mtm180 -99.49 140.81 33.13 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 108.767 -0.827 . . . . 6.57 108.767 178.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . 0.453 ' C ' ' H ' ' B' ' 43' ' ' VAL . . . -118.52 163.24 13.1 Favored Glycine 0 N--CA 1.429 -1.777 0 N-CA-C 109.423 -1.471 . . . . 2.62 109.423 177.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . 0.497 HD12 HD23 ' B' ' 17' ' ' LEU 0.258 13.3 pt 61.61 -21.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 C-N-CA 127.663 2.385 . . . . 2.28 115.295 178.471 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . 0.612 ' O ' ' HB2' ' B' ' 47' ' ' CYS . 2.3 p -49.78 -47.12 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.775 0 N-CA-C 113.23 0.826 . . . . 2.6 113.23 178.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -86.9 -30.95 21.0 Favored 'General case' 0 N--CA 1.427 -1.624 0 N-CA-C 109.228 -0.656 . . . . 3.36 109.228 -177.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -66.16 -23.03 66.4 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.499 -0.773 . . . . 3.08 112.027 -179.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 46' ' ' CYS . . . . . . . . . . . . . 63.7 m -114.34 2.07 14.63 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.967 0.413 . . . . 2.23 111.05 175.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 47' ' ' CYS . . . . . 0.612 ' HB2' ' O ' ' B' ' 43' ' ' VAL . 36.4 t -82.07 -50.45 9.07 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.561 0.696 . . . . 2.48 110.377 -179.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -116.16 15.75 15.98 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.408 0.623 . . . . 2.97 110.322 -176.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 22.2 mmm180 -146.64 152.74 39.37 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.065 -1.087 . . . . 4.65 108.065 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 7.3 p -94.37 131.06 40.42 Favored 'General case' 0 C--N 1.282 -2.355 0 N-CA-C 108.661 -0.866 . . . . 2.86 108.661 174.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 13.4 p -118.62 140.05 50.52 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 109.07 -0.715 . . . . 2.11 109.07 -173.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -61.71 147.03 47.41 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 107.858 -1.164 . . . . 2.67 107.858 177.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . 0.565 HD22 ' HB3' ' A' 1631 ' ' LYS . 14.8 tp -71.08 -16.79 62.6 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.103 -1.073 . . . . 2.36 108.103 -178.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . 0.405 ' O ' ' HB3' ' B' ' 57' ' ' GLU . . . -60.11 -27.19 66.82 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 114.522 -1.217 . . . . 1.92 110.702 174.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 10.5 tp -60.49 -60.75 3.31 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 115.827 -0.624 . . . . 2.35 110.392 177.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . 0.456 HD12 ' N ' ' B' ' 57' ' ' GLU . 0.8 OUTLIER -72.12 -17.43 61.98 Favored 'General case' 0 C--O 1.214 -0.806 0 CA-C-N 115.827 -0.624 . . . . 2.01 111.683 -175.932 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . 0.456 ' N ' HD12 ' B' ' 56' ' ' LEU . 9.1 tp10 -60.49 -56.72 17.97 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 109.026 -0.731 . . . . 2.27 109.026 172.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 9.0 t -80.5 -14.69 58.04 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 115.993 -0.548 . . . . 2.67 112.268 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 59' ' ' TYR . . . . . 0.766 ' HH ' ' HE ' ' B' ' 30' ' ' ARG . 12.5 t80 -82.73 -60.19 2.26 Favored 'General case' 0 N--CA 1.427 -1.61 0 N-CA-C 107.824 -1.176 . . . . 3.2 107.824 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 33.6 t 56.67 -77.78 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 126.908 2.083 . . . . 2.3 113.482 176.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 61' ' ' ALA . . . . . 0.49 ' HB2' ' O ' ' B' ' 25' ' ' GLY . . . -165.86 -56.42 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 104.519 -2.4 . . . . 3.19 104.519 -174.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 4.3 p -113.68 148.98 40.96 Favored Pre-proline 0 N--CA 1.395 -3.205 0 CA-C-N 112.412 -2.176 . . . . 4.14 106.338 173.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -82.51 12.7 2.79 Favored 'Trans proline' 0 N--CA 1.484 0.914 0 C-N-CA 123.502 2.801 . . . . 5.59 112.63 -174.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 69.3 54.51 0.42 Allowed 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 113.625 -1.625 . . . . 5.51 108.54 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 51.9 tttp 72.24 134.82 0.04 OUTLIER 'General case' 0 N--CA 1.434 -1.237 0 C-N-CA 126.961 2.104 . . . . 8.8 110.805 -177.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 17.9 t -126.26 57.16 1.41 Allowed 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.193 -1.41 . . . . 8.12 107.193 -179.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 . . . . . 0 C--O 1.247 0.969 0 CA-C-N 114.491 -1.231 . . . . 10.21 111.018 -176.837 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 60.9 mtm . . . . . 0 CA--C 1.517 -0.304 0 N-CA-C 108.962 -0.755 . . . . 9.74 108.962 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A 1509 ' ' LYS . . . . . 0.724 ' HD2' ' HB3' ' A' 1512 ' ' GLU . 33.1 ttmt -128.85 148.57 50.9 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 108.834 -0.802 . . . . 9.32 108.834 -177.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 15.4 m -95.71 126.81 41.24 Favored 'General case' 0 N--CA 1.423 -1.782 0 N-CA-C 110.336 -0.246 . . . . 5.97 110.336 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1511 ' ' ASN . . . . . . . . . . . . . 4.6 m-20 49.52 69.27 0.61 Allowed 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 115.121 1.526 . . . . 3.48 115.121 174.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1512 ' ' GLU . . . . . 0.724 ' HB3' ' HD2' ' A' 1509 ' ' LYS . 4.0 pt-20 -108.97 167.92 9.74 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 119.554 -0.858 . . . . 5.95 110.863 176.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 10.4 t-80 53.67 53.69 11.08 Favored 'General case' 0 CA--C 1.51 -0.595 0 C-N-CA 125.745 1.618 . . . . 6.14 110.242 176.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 36.2 t70 -63.98 70.09 0.02 OUTLIER 'General case' 0 C--N 1.291 -1.955 0 CA-C-N 113.063 -1.88 . . . . 5.06 110.787 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1515 ' ' ASP . . . . . 0.448 ' HA ' ' HD2' ' A' 1579 ' ' LYS . 9.8 t70 -134.47 70.52 1.45 Allowed 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 106.801 -1.555 . . . . 2.9 106.801 179.066 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1516 ' ' CYS . . . . . 0.565 ' O ' ' HB2' ' A' 1529 ' ' LEU . 16.7 m 63.16 33.9 14.0 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 115.128 -0.942 . . . . 1.41 110.387 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -166.66 162.76 16.58 Favored 'General case' 0 CA--C 1.479 -1.76 0 N-CA-C 107.813 -1.181 . . . . 2.18 107.813 -177.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 9.8 p -162.0 147.23 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.945 0 O-C-N 123.68 0.613 . . . . 1.52 109.535 -174.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1519 ' ' THR . . . . . 0.41 ' HG1' HD23 ' A' 1526 ' ' LEU . 25.0 m -115.86 124.96 51.98 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 109.295 -0.632 . . . . 1.36 109.295 177.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1520 ' ' ASN . . . . . 0.425 ' OD1' HG21 ' A' 1523 ' ' THR . 24.2 t-20 -86.95 122.41 71.27 Favored Pre-proline 0 N--CA 1.439 -0.979 0 O-C-N 123.427 0.454 . . . . 2.02 109.922 177.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.72 -19.9 53.09 Favored 'Trans proline' 0 CA--C 1.533 0.466 0 C-N-CA 123.218 2.612 . . . . 1.82 114.541 -175.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 50.7 m -76.7 -39.94 50.4 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 112.157 0.429 . . . . 1.89 112.157 -177.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1523 ' ' THR . . . . . 0.682 HG22 ' HG3' ' A' 1647 ' ' GLU . 5.0 t -114.31 -6.48 12.96 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.813 0.816 . . . . 1.99 111.43 -178.076 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 64.54 30.49 78.03 Favored Glycine 0 CA--C 1.499 -0.913 0 CA-C-N 115.368 -0.833 . . . . 1.19 112.28 177.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 35.7 t-80 -98.26 125.28 43.28 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 109.644 -0.502 . . . . 1.82 109.644 -175.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1526 ' ' LEU . . . . . 0.41 HD23 ' HG1' ' A' 1519 ' ' THR . 1.7 tm? -90.88 109.15 20.36 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 108.323 -0.992 . . . . 1.3 108.323 177.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -85.69 114.53 22.74 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 110.067 -0.345 . . . . 0.8 110.067 176.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 25.5 t70 -99.46 107.74 20.02 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 109.23 -0.656 . . . . 1.17 109.23 177.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1529 ' ' LEU . . . . . 0.565 ' HB2' ' O ' ' A' 1516 ' ' CYS . 3.4 mm? -90.11 -0.13 57.45 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.718 0.771 . . . . 1.29 109.363 -178.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.24 -26.54 63.89 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.077 -0.965 . . . . 0.91 108.771 178.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 40.5 t -60.38 -26.82 66.94 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.927 0.891 . . . . 1.98 109.848 174.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 51.3 mt -98.38 0.51 45.54 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.557 -0.747 . . . . 1.34 110.984 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1533 ' ' SER . . . . . . . . . . . . . 33.6 t -72.31 174.75 6.87 Favored 'General case' 0 C--O 1.245 0.825 0 CA-C-O 121.635 0.731 . . . . 1.93 111.329 -177.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . 179.81 145.17 6.26 Favored Glycine 0 N--CA 1.425 -2.046 0 N-CA-C 109.218 -1.553 . . . . 1.1 109.218 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 -74.3 -43.36 57.09 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 120.695 0.284 . . . . 5.21 111.585 -177.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -84.14 -38.84 20.2 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.465 0.65 . . . . 1.94 109.288 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 105.19 -138.77 14.39 Favored Glycine 0 N--CA 1.409 -3.143 0 CA-C-N 115.134 -0.939 . . . . 1.08 111.476 177.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -140.33 154.14 46.66 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 107.619 -1.252 . . . . 1.07 107.619 -177.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1539 ' ' THR . . . . . 0.457 HG21 ' HB ' ' A' 1547 ' ' VAL . 1.3 m -121.31 124.99 45.92 Favored 'General case' 0 N--CA 1.426 -1.646 0 N-CA-C 108.68 -0.859 . . . . 1.46 108.68 -178.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -119.75 140.18 51.12 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 115.815 -0.629 . . . . 1.19 109.559 -177.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -82.57 113.42 20.27 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.605 -0.725 . . . . 1.37 110.509 -179.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1542 ' ' TYR . . . . . 0.537 ' CE2' ' HG ' ' A' 1626 ' ' LEU . 0.3 OUTLIER -104.36 -101.07 0.31 Allowed 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 106.019 -1.845 . . . . 1.38 106.019 177.613 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A 1543 ' ' SER . . . . . 0.439 ' H ' ' HB3' ' A' 1542 ' ' TYR . 2.1 m -68.57 168.69 12.44 Favored 'General case' 0 N--CA 1.425 -1.721 0 C-N-CA 124.137 0.975 . . . . 1.98 110.744 178.036 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 59.6 tttp -60.12 -41.49 92.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 118.694 0.679 . . . . 3.96 112.261 -176.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 33.5 t -116.78 20.68 13.83 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 109.567 -0.531 . . . . 2.81 109.567 -177.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . -131.73 104.22 0.56 Allowed Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 120.646 -0.788 . . . . 1.68 113.231 -175.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1547 ' ' VAL . . . . . 0.457 ' HB ' HG21 ' A' 1539 ' ' THR . 28.0 m -96.84 151.1 4.2 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-O 121.176 0.512 . . . . 1.38 110.109 175.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 14.2 p -105.2 138.49 29.91 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 CA-C-N 115.913 -0.585 . . . . 1.24 109.528 178.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -105.71 128.34 53.62 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 123.492 0.717 . . . . 1.29 109.678 176.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 23.5 ptm -141.8 119.46 11.75 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 115.331 -0.85 . . . . 1.47 110.695 -177.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 11.4 p -103.67 119.58 39.2 Favored 'General case' 0 C--N 1.276 -2.609 0 CA-C-N 114.883 -1.053 . . . . 1.4 110.184 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1552 ' ' ILE . . . . . 0.741 HG13 ' HZ3' ' A' 1640 ' ' TRP . 39.4 mm -83.22 119.44 32.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 108.999 -0.741 . . . . 1.11 108.999 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 28.2 t 62.02 46.39 6.55 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-O 122.053 0.93 . . . . 1.4 110.544 177.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 175.93 178.01 45.4 Favored Glycine 0 N--CA 1.407 -3.238 0 N-CA-C 109.431 -1.467 . . . . 0.4 109.431 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -106.11 154.9 20.01 Favored 'General case' 0 C--N 1.285 -2.236 0 CA-C-O 121.046 0.451 . . . . 1.62 110.415 -178.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -93.21 138.11 31.92 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 108.283 -1.006 . . . . 1.12 108.283 178.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -99.98 0.57 41.32 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 114.889 1.44 . . . . 2.49 114.889 -169.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 9.6 p30 -105.01 5.26 32.46 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 122.273 1.035 . . . . 1.38 110.134 178.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1559 ' ' CYS . . . . . 0.615 ' SG ' ' HD2' ' A' 1560 ' ' PRO . 34.5 t -132.15 152.99 81.15 Favored Pre-proline 0 C--N 1.288 -2.068 0 N-CA-C 106.211 -1.774 . . . . 1.21 106.211 178.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1560 ' ' PRO . . . . . 0.615 ' HD2' ' SG ' ' A' 1559 ' ' CYS . 49.6 Cg_exo -28.34 121.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.379 2.176 1 C-N-CA 125.575 4.184 . . . . 0.98 115.211 179.154 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A 1561 ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' 1560 ' ' PRO . 6.0 Cg_endo -44.72 130.2 9.63 Favored 'Trans proline' 0 C--N 1.357 1.01 0 C-N-CA 125.075 3.85 . . . . 1.15 114.126 -176.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 98.64 -2.15 58.64 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.974 -0.557 . . . . 0.55 113.753 178.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1563 ' ' VAL . . . . . 0.411 HG21 ' HA ' ' A' 1573 ' ' SER . 8.7 p -93.8 140.38 16.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 O-C-N 121.93 -0.747 . . . . 1.53 110.637 -177.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -102.34 -30.56 5.59 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 121.213 -0.518 . . . . 0.29 112.869 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -124.32 127.89 48.3 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 109.403 -0.591 . . . . 1.08 109.403 178.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1566 ' ' CYS . . . . . 0.471 ' SG ' ' HA ' ' A' 1571 ' ' ARG . 43.5 t -155.04 142.75 19.85 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 110.254 -0.276 . . . . 0.43 110.254 -178.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1567 ' ' PHE . . . . . 0.509 ' CE2' HG12 ' A' 1574 ' ' VAL . 54.9 m-85 -85.6 130.53 34.55 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 107.796 -1.187 . . . . 1.3 107.796 172.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -61.14 -31.16 75.82 Favored Glycine 0 C--N 1.35 1.314 0 N-CA-C 114.545 0.578 . . . . 1.43 114.545 -171.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1569 ' ' GLN . . . . . 0.459 ' HB3' ' OD2' ' B' ' 15' ' ' ASP . 11.3 mm100 -69.54 -54.56 13.54 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.594 0.711 . . . . 3.09 111.986 177.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1570 ' ' THR . . . . . 0.657 ' HB ' HG13 ' A' 1572 ' ' ILE . 58.3 p -81.47 -29.11 33.85 Favored 'General case' 0 N--CA 1.421 -1.878 0 N-CA-C 114.382 1.253 . . . . 2.52 114.382 -167.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1571 ' ' ARG . . . . . 0.471 ' HA ' ' SG ' ' A' 1566 ' ' CYS . 3.1 mpt_? 59.35 28.94 18.42 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.189 0.519 . . . . 3.19 110.691 -172.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1572 ' ' ILE . . . . . 0.657 HG13 ' HB ' ' A' 1570 ' ' THR . 19.2 mt -94.58 129.15 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.832 0 N-CA-C 107.89 -1.152 . . . . 1.51 107.89 177.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1573 ' ' SER . . . . . 0.411 ' HA ' HG21 ' A' 1563 ' ' VAL . 15.1 t -69.27 113.8 6.94 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.327 -0.851 . . . . 0.96 109.68 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1574 ' ' VAL . . . . . 0.802 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 19.7 m -110.38 17.92 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 CA-C-O 121.893 0.854 . . . . 1.6 110.8 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 161.46 115.64 0.37 Allowed Glycine 0 N--CA 1.427 -1.957 0 CA-C-N 114.779 -1.1 . . . . 0.34 111.042 177.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -73.66 146.39 44.57 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.881 -0.785 . . . . 2.68 108.881 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -71.36 90.52 0.95 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.028 0.442 . . . . 1.08 111.585 -178.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -103.37 170.24 8.07 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.08 -1.081 . . . . 1.95 108.08 175.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1579 ' ' LYS . . . . . 0.448 ' HD2' ' HA ' ' A' 1515 ' ' ASP . 15.4 pttm -130.11 40.46 3.54 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.755 0.788 . . . . 3.11 110.698 -178.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 75.0 ttt180 -89.82 100.49 13.29 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 113.561 -1.654 . . . . 4.04 107.933 -174.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1581 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.76 126.55 48.64 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.713 -0.676 . . . . 1.32 109.425 -174.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -125.2 138.95 54.12 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 120.532 -0.467 . . . . 3.4 110.914 176.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1583 ' ' TYR . . . . . 0.467 ' CE1' ' HA ' ' A' 1586 ' ' GLN . 88.3 t80 -106.25 108.41 19.91 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.724 -0.843 . . . . 1.26 108.724 178.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1584 ' ' VAL . . . . . 0.614 ' O ' ' HB ' ' A' 1587 ' ' VAL . 14.2 m -126.98 93.49 2.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 CA-C-O 121.48 0.657 . . . . 1.71 112.108 -178.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 36.6 t70 57.89 64.37 1.55 Allowed 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.853 0.861 . . . . 1.17 110.691 179.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1586 ' ' GLN . . . . . 0.467 ' HA ' ' CE1' ' A' 1583 ' ' TYR 0.272 4.5 pt20 58.72 20.55 7.95 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 126.45 1.9 . . . . 2.43 112.384 178.527 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A 1587 ' ' VAL . . . . . 0.614 ' HB ' ' O ' ' A' 1584 ' ' VAL . 22.5 t -107.24 120.26 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.493 0 CA-C-N 114.038 -1.437 . . . . 1.16 107.751 174.11 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1588 ' ' LEU . . . . . 0.833 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 3.3 mm? -95.62 109.03 21.34 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 105.824 -1.917 . . . . 1.11 105.824 176.014 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -111.02 116.81 31.81 Favored 'General case' 0 C--N 1.266 -3.056 0 C-N-CA 119.962 -0.695 . . . . 1.74 110.961 -175.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.87 99.48 9.69 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 104.888 -2.264 . . . . 1.4 104.888 176.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 8.9 p -89.41 127.01 42.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 C-N-CA 119.64 -0.824 . . . . 1.7 112.308 -174.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1592 ' ' TYR . . . . . 0.64 ' HB2' ' HB3' ' A' 1608 ' ' SER . 12.8 m-30 -106.95 142.75 36.07 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.443 -1.317 . . . . 1.08 107.443 173.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 10.6 ptmm? -158.08 -172.24 3.83 Favored 'General case' 0 C--N 1.283 -2.308 0 N-CA-C 106.043 -1.836 . . . . 2.21 106.043 -175.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 36.4 m-20 66.46 45.56 2.1 Favored 'General case' 0 C--O 1.239 0.503 0 O-C-N 124.006 0.816 . . . . 1.11 109.116 177.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -86.76 -175.06 49.39 Favored Glycine 0 N--CA 1.435 -1.379 0 CA-C-N 114.892 -1.049 . . . . 0.78 111.582 -178.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1596 ' ' SER . . . . . 0.736 ' HB2' ' HD2' ' A' 1597 ' ' PRO . 62.9 p -95.31 173.86 4.02 Favored Pre-proline 0 C--N 1.291 -1.968 0 CA-C-O 118.672 -0.68 . . . . 1.36 109.457 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1597 ' ' PRO . . . . . 0.736 ' HD2' ' HB2' ' A' 1596 ' ' SER . 10.3 Cg_endo -50.85 127.11 20.29 Favored 'Trans proline' 0 C--N 1.361 1.197 0 C-N-CA 122.785 2.323 . . . . 1.4 113.676 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1598 ' ' CYS . . . . . 0.596 ' HA ' ' CE1' ' A' 1606 ' ' TYR . 49.5 t -81.16 118.74 73.6 Favored Pre-proline 0 C--N 1.284 -2.269 0 CA-C-N 113.718 -1.583 . . . . 0.75 107.888 178.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1599 ' ' PRO . . . . . 0.635 ' HD2' ' HE1' ' A' 1606 ' ' TYR . 6.9 Cg_endo -52.12 -21.16 12.13 Favored 'Trans proline' 0 C--N 1.366 1.483 0 C-N-CA 124.357 3.371 . . . . 1.7 114.362 -178.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1600 ' ' SER . . . . . . . . . . . . . 7.8 m -55.72 -45.63 77.91 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 123.815 0.846 . . . . 2.8 110.438 177.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1601 ' ' LYS . . . . . 0.465 ' HE2' HD13 ' A' 1604 ' ' LEU . 36.5 ttpt -162.84 127.43 3.08 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 108.395 -0.965 . . . . 3.45 108.395 178.242 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 14.2 p -58.36 132.02 52.4 Favored 'General case' 0 N--CA 1.415 -2.191 0 N-CA-C 109.26 -0.644 . . . . 2.44 109.26 177.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 106.54 -17.38 39.74 Favored Glycine 0 C--N 1.303 -1.265 0 C-N-CA 121.329 -0.463 . . . . 1.2 112.354 -176.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1604 ' ' LEU . . . . . 0.481 ' HB2' ' HB3' ' A' 1598 ' ' CYS . 60.2 mt -91.83 152.06 20.29 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 107.254 -1.387 . . . . 2.38 107.254 173.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 37.9 m -135.87 142.93 44.81 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 108.628 -0.878 . . . . 1.96 108.628 179.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1606 ' ' TYR . . . . . 0.802 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 71.5 m-85 -73.22 158.95 34.22 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 112.141 0.423 . . . . 1.06 112.141 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -147.89 152.72 38.07 Favored 'General case' 0 N--CA 1.421 -1.914 0 N-CA-C 106.38 -1.711 . . . . 2.0 106.38 172.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1608 ' ' SER . . . . . 0.64 ' HB3' ' HB2' ' A' 1592 ' ' TYR . 28.0 t -122.5 123.08 40.45 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 109.038 -0.727 . . . . 1.61 109.038 -174.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 30.8 t -105.09 98.1 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.748 0 N-CA-C 108.846 -0.798 . . . . 1.09 108.846 179.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 84.1 mt -89.63 106.11 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.787 0 N-CA-C 108.1 -1.074 . . . . 1.2 108.1 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 17.0 m -104.54 114.48 28.73 Favored 'General case' 0 N--CA 1.421 -1.917 0 CA-C-N 115.007 -0.997 . . . . 1.89 111.01 -175.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1612 ' ' PHE . . . . . 0.833 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 69.3 m-85 -91.33 108.41 19.87 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.054 -0.721 . . . . 0.28 109.054 176.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1613 ' ' VAL . . . . . 0.857 ' HB ' ' HB3' ' A' 1641 ' ' HIS . 33.5 t -103.96 144.16 14.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 CA-C-N 114.774 -1.103 . . . . 1.23 109.233 -176.103 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 39.1 t -69.88 108.31 3.93 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 123.809 0.844 . . . . 0.77 110.982 179.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1615 ' ' ARG . . . . . 0.553 ' HB2' ' HB2' ' A' 1641 ' ' HIS . 25.3 tpt180 -135.69 91.69 17.8 Favored Pre-proline 0 N--CA 1.435 -1.214 0 C-N-CA 119.584 -0.846 . . . . 2.92 109.671 173.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1616 ' ' PRO . . . . . 0.893 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 19.2 Cg_exo -65.7 -22.21 57.72 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.392 2.061 . . . . 1.22 113.535 -176.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -57.96 -38.48 76.1 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 123.94 0.896 . . . . 3.05 112.221 179.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . 64.93 -172.63 0.18 Allowed 'General case' 0 C--N 1.358 0.946 0 O-C-N 123.916 0.76 . . . . 1.55 109.61 -176.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . 119.09 -159.5 14.5 Favored Glycine 0 N--CA 1.426 -2.018 0 C-N-CA 120.222 -0.989 . . . . 1.16 112.632 177.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 94.9 Cg_exo -56.38 -11.73 6.84 Favored 'Trans proline' 0 N--CA 1.5 1.911 0 C-N-CA 124.893 3.728 . . . . 1.06 114.211 178.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1621 ' ' THR . . . . . . . . . . . . . 19.0 p -87.6 -9.37 54.52 Favored 'General case' 0 C--N 1.282 -2.364 0 C-N-CA 124.396 1.079 . . . . 1.58 110.869 -179.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 49.2 t30 -88.02 58.36 4.77 Favored 'General case' 0 C--O 1.253 1.266 0 CA-C-O 122.729 1.252 . . . . 0.88 110.16 -178.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1623 ' ' ARG . . . . . 0.43 ' HA ' ' HD3' ' A' 1624 ' ' PRO . 34.7 ptt180 -159.82 138.81 7.97 Favored Pre-proline 0 C--N 1.303 -1.415 0 CA-C-N 113.839 -1.528 . . . . 3.82 107.183 178.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1624 ' ' PRO . . . . . 0.432 ' HG3' ' CE3' ' A' 1640 ' ' TRP . 7.1 Cg_exo -69.43 111.23 2.69 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.333 2.022 . . . . 0.77 111.172 -178.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 74.7 mtm -114.0 147.83 37.96 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 116.415 -0.357 . . . . 1.43 110.337 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1626 ' ' LEU . . . . . 0.537 ' HG ' ' CE2' ' A' 1542 ' ' TYR . 0.3 OUTLIER -85.89 113.95 22.43 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 107.954 -1.128 . . . . 1.43 107.954 -176.56 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 42.0 mm -76.36 -54.85 12.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 N-CA-C 109.262 -0.644 . . . . 1.23 109.262 -177.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 70.5 m -163.83 152.27 13.4 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.468 -0.938 . . . . 1.88 108.468 -173.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1629 ' ' LEU . . . . . 0.573 ' HG ' ' CD2' ' A' 1636 ' ' LEU . 2.5 tt -114.25 110.91 20.67 Favored 'General case' 0 N--CA 1.416 -2.172 0 N-CA-C 106.531 -1.655 . . . . 1.92 106.531 179.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 14.8 t70 -77.81 95.35 4.68 Favored 'General case' 0 CA--C 1.494 -1.198 0 N-CA-C 106.919 -1.512 . . . . 1.09 106.919 173.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1631 ' ' LYS . . . . . 0.608 ' HD3' ' H ' ' A' 1631 ' ' LYS . 0.0 OUTLIER -75.96 2.86 11.48 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 114.419 1.266 . . . . 3.98 114.419 -172.768 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -88.36 -41.93 12.52 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.709 -0.848 . . . . 2.6 108.709 175.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 67.6 p -100.48 -15.62 17.82 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-N 115.118 -0.946 . . . . 1.35 111.065 -177.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 83.3 m 70.25 35.05 2.18 Favored 'General case' 0 C--N 1.351 0.662 0 C-N-CA 125.053 1.341 . . . . 0.53 110.891 -179.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1635 ' ' THR . . . . . . . . . . . . . 90.0 m -90.96 121.87 33.16 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 113.727 -1.579 . . . . 1.11 109.088 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1636 ' ' LEU . . . . . 0.573 ' CD2' ' HG ' ' A' 1629 ' ' LEU . 26.2 mt -98.58 130.7 45.13 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 109.483 -0.562 . . . . 1.56 109.483 178.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -101.77 116.48 32.82 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 116.076 -0.511 . . . . 0.54 111.137 177.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -114.19 140.73 48.3 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 109.529 -0.545 . . . . 0.64 109.529 176.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1639 ' ' SER . . . . . . . . . . . . . 48.0 t -119.86 129.16 54.26 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 108.512 -0.921 . . . . 1.34 108.512 173.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1640 ' ' TRP . . . . . 0.741 ' HZ3' HG13 ' A' 1552 ' ' ILE . 6.3 t90 -133.74 93.5 3.13 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 104.217 -2.512 . . . . 0.8 104.217 173.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1641 ' ' HIS . . . . . 0.857 ' HB3' ' HB ' ' A' 1613 ' ' VAL 0.317 0.1 OUTLIER -101.64 95.17 6.27 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-O 122.474 1.13 . . . . 1.14 113.085 -175.612 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A 1642 ' ' THR . . . . . . . . . . . . . 3.1 t -114.77 153.02 46.91 Favored Pre-proline 0 C--N 1.299 -1.609 0 CA-C-N 112.542 -2.117 . . . . 1.11 108.583 -177.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1643 ' ' PRO . . . . . 0.893 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 49.7 Cg_endo -68.94 -4.89 14.37 Favored 'Trans proline' 0 C--N 1.369 1.65 0 C-N-CA 123.269 2.646 . . . . 0.78 113.366 -178.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 8.2 tt -65.35 -30.29 71.11 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.969 -0.382 . . . . 1.66 109.969 176.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -84.2 21.7 1.35 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.377 0.608 . . . . 1.29 111.513 -175.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 33.3 m -121.22 136.52 54.96 Favored 'General case' 0 N--CA 1.415 -2.193 0 N-CA-C 107.629 -1.248 . . . . 1.48 107.629 178.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1647 ' ' GLU . . . . . 0.682 ' HG3' HG22 ' A' 1523 ' ' THR . 0.1 OUTLIER -107.94 142.26 24.88 Favored Pre-proline 0 C--N 1.301 -1.531 0 N-CA-C 109.529 -0.545 . . . . 3.14 109.529 177.399 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A 1648 ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -62.73 109.28 0.86 Allowed 'Trans proline' 0 C--O 1.244 0.811 0 C-N-CA 122.82 2.346 . . . . 2.92 113.102 -178.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 8.9 tp10 . . . . . 0 C--N 1.304 -1.401 0 N-CA-C 107.152 -1.425 . . . . 4.72 107.152 177.766 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.731 0 N-CA-C 108.895 -0.78 . . . . 10.26 108.895 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -141.53 147.07 37.17 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.775 -0.824 . . . . 7.94 108.775 -177.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 -139.64 149.26 59.06 Favored Pre-proline 0 C--N 1.302 -1.495 0 N-CA-C 107.899 -1.149 . . . . 6.56 107.899 176.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -44.16 -47.79 10.19 Favored 'Trans proline' 0 C--O 1.243 0.762 0 C-N-CA 123.853 3.036 . . . . 5.51 113.009 -177.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 15.9 t -118.95 102.13 8.54 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 106.678 -1.601 . . . . 4.91 106.678 178.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -72.33 -25.84 61.7 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.137 0.494 . . . . 4.23 110.64 -176.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 20.8 p -105.79 166.36 10.53 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.473 -0.936 . . . . 3.48 108.473 174.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . 0.467 HD12 ' HB3' ' B' ' 12' ' ' GLU . 79.5 mt -85.39 136.07 33.61 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 110.19 -0.3 . . . . 4.35 110.19 -177.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 9' ' ' CYS . . . . . 0.487 ' HA ' HD11 ' B' ' 13' ' ' LEU . 49.1 t -139.03 152.06 47.29 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 109.206 -0.664 . . . . 2.84 109.206 -179.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.14 -124.26 6.87 Favored Glycine 0 N--CA 1.438 -1.225 0 C-N-CA 120.907 -0.663 . . . . 2.28 112.856 177.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.94 -36.88 92.88 Favored Glycine 0 C--O 1.22 -0.765 0 CA-C-N 115.557 -0.322 . . . . 1.94 112.924 -177.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . 0.467 ' HB3' HD12 ' B' ' 8' ' ' LEU . 6.3 mp0 -68.18 -28.34 67.18 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 111.915 0.339 . . . . 2.55 111.915 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . 0.487 HD11 ' HA ' ' B' ' 9' ' ' CYS . 0.7 OUTLIER -71.65 -53.54 13.27 Favored 'General case' 0 N--CA 1.42 -1.959 0 N-CA-C 109.486 -0.561 . . . . 2.82 109.486 -177.664 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 3.8 p -63.58 -35.42 72.64 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-N 115.561 -0.745 . . . . 2.5 111.133 177.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 15' ' ' ASP . . . . . 0.459 ' OD2' ' HB3' ' A' 1569 ' ' GLN . 14.8 t0 -72.32 -37.07 69.01 Favored 'General case' 0 CA--C 1.557 1.248 0 N-CA-C 112.209 0.448 . . . . 2.04 112.209 -179.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 14.9 t -68.78 -37.7 79.49 Favored 'General case' 0 C--O 1.254 1.316 0 CA-C-N 119.079 0.854 . . . . 2.31 110.117 175.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.598 HD21 HD13 ' B' ' 42' ' ' ILE . 3.2 mm? -49.37 -52.66 26.82 Favored 'General case' 0 C--N 1.355 0.823 0 CA-C-O 121.358 0.599 . . . . 2.27 110.197 168.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . 0.401 ' HB2' ' CD2' ' B' ' 26' ' ' PHE . 28.5 tt0 -66.97 -23.8 65.98 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 123.659 0.784 . . . . 2.39 112.385 -177.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -62.9 -62.85 1.44 Allowed 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 116.467 -0.333 . . . . 1.0 110.938 175.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 14.4 p -91.32 -15.92 8.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 C-N-CA 117.609 -1.636 . . . . 1.83 112.791 -175.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 59.1 m -99.8 10.17 41.77 Favored 'General case' 0 C--O 1.206 -1.227 0 O-C-N 121.099 -1.0 . . . . 1.66 111.318 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -53.42 -28.36 35.85 Favored Glycine 0 CA--C 1.54 1.617 0 N-CA-C 116.632 1.413 . . . . 1.53 116.632 -178.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -72.56 -49.0 35.53 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 118.305 1.053 . . . . 2.72 111.891 -179.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.15 -38.58 15.23 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.37 0.605 . . . . 5.02 109.803 -179.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . 0.429 ' O ' ' HB3' ' B' ' 61' ' ' ALA . . . 124.23 164.52 11.98 Favored Glycine 0 N--CA 1.428 -1.892 0 N-CA-C 107.62 -2.192 . . . . 1.63 107.62 -174.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . 0.415 ' CB ' ' HB3' ' B' ' 17' ' ' LEU . 17.4 p90 -95.69 129.79 42.78 Favored 'General case' 0 C--N 1.286 -2.177 0 CA-C-N 118.779 1.29 . . . . 1.71 110.067 179.012 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 27' ' ' TYR . . . . . 0.724 ' HB2' ' HA ' ' B' ' 61' ' ' ALA . 24.9 m-85 -129.98 59.31 1.63 Allowed 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 112.939 0.718 . . . . 3.67 112.939 -174.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 28' ' ' PHE . . . . . 0.634 ' HA ' ' HE2' ' B' ' 59' ' ' TYR . 32.6 p90 -92.05 -9.09 44.01 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 119.048 -1.061 . . . . 2.44 108.485 173.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 29' ' ' SER . . . . . 0.597 ' HA ' ' HG2' ' B' ' 40' ' ' ARG . 22.7 p -85.33 50.62 1.99 Allowed 'General case' 0 N--CA 1.428 -1.566 0 CA-C-N 115.298 -0.864 . . . . 3.85 110.215 179.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -89.96 116.41 66.29 Favored Pre-proline 0 N--CA 1.434 -1.236 0 N-CA-C 107.857 -1.164 . . . . 4.27 107.857 178.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . 0.603 ' HA ' ' HA ' ' B' ' 39' ' ' SER . 50.0 Cg_exo -54.06 -31.83 66.32 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.945 3.097 . . . . 4.2 114.799 -172.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -162.01 151.71 16.35 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-O 121.388 0.613 . . . . 5.12 110.925 177.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 88.3 p -168.17 -170.63 1.34 Allowed 'General case' 0 N--CA 1.411 -2.376 0 N-CA-C 101.773 -3.417 . . . . 6.93 101.773 177.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -104.18 -1.31 27.38 Favored 'General case' 0 C--N 1.267 -3.004 0 CA-C-O 121.783 0.802 . . . . 12.14 109.434 178.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 38.9 t -105.79 -19.71 6.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 107.724 -1.213 . . . . 9.9 107.724 177.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 33.3 m -144.71 85.25 1.76 Allowed 'General case' 0 N--CA 1.398 -3.025 0 CA-C-N 114.58 -1.191 . . . . 6.82 108.307 177.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -71.05 -3.58 20.46 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 115.317 -0.856 . . . . 10.71 111.425 173.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -90.87 152.25 20.82 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 106.822 -1.547 . . . . 8.6 106.822 173.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 39' ' ' SER . . . . . 0.603 ' HA ' ' HA ' ' B' ' 31' ' ' PRO . 33.3 t -67.31 -3.44 8.05 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.887 0.699 . . . . 5.79 112.887 -175.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . 0.597 ' HG2' ' HA ' ' B' ' 29' ' ' SER . 79.2 mtt180 -144.04 130.34 19.79 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 107.577 -1.268 . . . . 6.57 107.577 172.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . 0.455 ' C ' ' H ' ' B' ' 43' ' ' VAL . . . -103.58 177.19 24.59 Favored Glycine 0 CA--C 1.476 -2.401 0 N-CA-C 109.723 -1.351 . . . . 2.62 109.723 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . 0.598 HD13 HD21 ' B' ' 17' ' ' LEU . 16.1 pt 58.1 -26.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 C-N-CA 127.346 2.258 . . . . 2.28 115.74 179.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . 0.455 ' H ' ' C ' ' B' ' 41' ' ' GLY . 2.7 p -48.12 -46.95 13.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 114.71 1.374 . . . . 2.6 114.71 -177.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -87.79 -29.75 20.76 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.913 -1.143 . . . . 3.36 107.913 -174.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . 0.545 ' O ' ' HB2' ' B' ' 49' ' ' ARG . 30.2 mt-10 -75.82 -10.06 59.12 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 113.963 -1.471 . . . . 3.08 112.179 -177.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 46' ' ' CYS . . . . . . . . . . . . . 21.5 t -119.42 -21.92 7.25 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-O 121.056 0.455 . . . . 2.23 110.285 176.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 49.7 t -74.28 -47.62 33.73 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.333 -0.547 . . . . 2.48 111.433 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -119.09 7.61 11.4 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 120.1 -0.64 . . . . 2.97 110.987 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . 0.545 ' HB2' ' O ' ' B' ' 45' ' ' GLU . 36.0 mmt180 -128.0 156.68 42.33 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.301 -1.37 . . . . 4.65 107.301 -177.123 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 14.0 p -78.3 110.75 13.61 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 109.855 -0.424 . . . . 2.86 109.855 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 3.0 p -100.87 126.75 47.5 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 115.59 -0.732 . . . . 2.11 110.365 -177.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -101.8 135.62 43.04 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.772 -1.195 . . . . 2.67 107.772 178.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . 0.425 HD21 ' HG3' ' A' 1631 ' ' LYS . 56.9 tp -36.47 -37.91 0.14 Allowed 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 126.613 1.965 . . . . 2.36 114.834 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.95 -29.97 63.64 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 123.483 0.49 . . . . 1.92 111.374 -177.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 53.1 tp -68.58 -57.0 6.39 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-N 115.863 -0.608 . . . . 2.35 110.048 177.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 1.9 pp -71.28 -27.18 63.24 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 116.496 -0.32 . . . . 2.01 111.559 -174.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -71.95 -46.11 58.68 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 111.835 0.309 . . . . 2.27 111.835 178.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 11.2 t -77.66 -30.09 51.93 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 118.619 -1.233 . . . . 2.67 111.601 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 59' ' ' TYR . . . . . 0.634 ' HE2' ' HA ' ' B' ' 28' ' ' PHE . 11.1 t80 -70.66 -64.51 0.88 Allowed 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 106.278 -1.749 . . . . 3.2 106.278 177.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 54.1 t 33.42 -87.02 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 127.208 2.203 . . . . 2.3 115.762 173.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 61' ' ' ALA . . . . . 0.724 ' HA ' ' HB2' ' B' ' 27' ' ' TYR . . . -144.49 151.92 39.86 Favored 'General case' 0 N--CA 1.42 -1.945 0 N-CA-C 108.212 -1.033 . . . . 3.19 108.212 -176.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 6.7 p -85.21 131.38 48.54 Favored Pre-proline 0 N--CA 1.416 -2.157 0 N-CA-C 109.042 -0.725 . . . . 4.14 109.042 -178.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -73.24 -32.93 7.79 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 123.002 2.468 . . . . 5.59 115.308 -172.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -149.32 55.43 0.98 Allowed 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.432 0.634 . . . . 5.51 109.932 -178.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 45.6 tttp -162.97 130.5 3.64 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 115.795 -0.639 . . . . 8.8 109.426 -177.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 15.0 m -134.85 11.99 3.66 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.692 0.758 . . . . 8.12 109.692 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 . . . . . 0 C--O 1.253 1.279 0 CA-C-N 114.909 -1.042 . . . . 10.21 109.121 -179.396 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 77.0 mtp . . . . . 0 C--O 1.24 0.599 0 CA-C-O 120.59 0.234 . . . . 9.74 110.414 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A 1509 ' ' LYS . . . . . 0.401 ' HB2' ' HE3' ' A' 1509 ' ' LYS . 38.8 ttmt -110.12 89.29 2.98 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 108.564 -0.902 . . . . 9.32 108.564 178.038 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1510 ' ' SER . . . . . 0.62 ' HA ' ' HG3' ' A' 1521 ' ' PRO . 51.3 m 70.76 156.25 0.15 Allowed 'General case' 0 C--O 1.242 0.665 0 C-N-CA 124.568 1.147 . . . . 5.97 111.785 -177.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1511 ' ' ASN . . . . . 0.625 ' OD1' ' HB3' ' A' 1583 ' ' TYR . 82.6 m-20 68.05 96.52 0.06 Allowed 'General case' 0 C--O 1.248 0.993 0 N-CA-C 115.051 1.5 . . . . 3.48 115.051 169.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1512 ' ' GLU . . . . . 0.528 ' O ' HG13 ' A' 1518 ' ' VAL . 29.9 mm-40 -78.5 169.62 17.95 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.549 -0.751 . . . . 5.95 109.364 169.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 13.9 p-80 -144.43 103.49 3.97 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-O 121.5 0.667 . . . . 6.14 112.06 -179.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 22.2 t70 -96.07 -69.1 0.77 Allowed 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 115.538 -0.756 . . . . 5.06 109.214 176.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 16.4 t70 -150.84 -63.38 0.19 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.998 -0.546 . . . . 2.9 111.331 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1516 ' ' CYS . . . . . 0.616 ' SG ' ' HB2' ' A' 1529 ' ' LEU . 30.8 t -138.83 55.59 1.72 Allowed 'General case' 0 C--O 1.25 1.113 0 N-CA-C 108.312 -0.995 . . . . 1.41 108.312 -179.06 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -169.06 149.04 4.18 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 115.565 -0.743 . . . . 2.18 109.06 -174.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1518 ' ' VAL . . . . . 0.528 HG13 ' O ' ' A' 1512 ' ' GLU . 4.8 m -149.43 142.37 17.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 C-N-CA 124.227 1.011 . . . . 1.52 110.585 178.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1519 ' ' THR . . . . . . . . . . . . . 31.9 m -106.16 137.35 44.25 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.915 -0.402 . . . . 1.36 109.915 177.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 52.6 t-20 -82.68 110.33 21.72 Favored Pre-proline 0 C--O 1.245 0.829 0 N-CA-C 107.009 -1.478 . . . . 2.02 107.009 174.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1521 ' ' PRO . . . . . 0.62 ' HG3' ' HA ' ' A' 1510 ' ' SER . 42.5 Cg_endo -67.23 -14.69 43.94 Favored 'Trans proline' 0 N--CA 1.474 0.376 0 C-N-CA 123.173 2.582 . . . . 1.82 113.148 -174.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 28.3 m -75.04 -33.87 61.81 Favored 'General case' 0 N--CA 1.425 -1.702 0 CA-C-N 116.307 -0.406 . . . . 1.89 111.844 -179.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1523 ' ' THR . . . . . . . . . . . . . 12.5 t -136.19 -5.3 2.1 Favored 'General case' 0 CA--C 1.564 1.484 0 C-N-CA 118.132 -1.427 . . . . 1.99 113.418 -175.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 85.75 8.31 80.03 Favored Glycine 0 CA--C 1.494 -1.252 0 C-N-CA 120.632 -0.794 . . . . 1.19 114.048 176.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 51.9 t-80 -76.27 123.27 25.64 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.706 -0.85 . . . . 1.82 108.706 177.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -103.2 116.91 33.37 Favored 'General case' 0 C--N 1.268 -2.965 0 CA-C-N 114.796 -1.093 . . . . 1.3 109.008 -176.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -88.86 118.38 28.53 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 109.989 -0.375 . . . . 0.8 109.989 175.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 7.7 t70 -110.72 126.25 54.37 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.111 -1.44 . . . . 1.17 107.111 174.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1529 ' ' LEU . . . . . 0.616 ' HB2' ' SG ' ' A' 1516 ' ' CYS . 2.9 mm? -103.21 20.47 17.65 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 111.88 0.326 . . . . 1.29 111.88 -174.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 6.9 m -66.74 -23.84 66.15 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 113.369 0.878 . . . . 0.91 113.369 -175.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 33.6 t -72.29 -30.1 64.49 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-O 121.534 0.683 . . . . 1.98 109.196 178.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1532 ' ' LEU . . . . . 0.484 HD13 HD13 ' A' 1529 ' ' LEU . 59.9 mt -88.9 -18.31 27.82 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.387 -0.824 . . . . 1.34 109.792 -179.294 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1533 ' ' SER . . . . . 0.531 ' HA ' ' HB ' ' A' 1552 ' ' ILE . 34.8 t -75.46 171.57 14.02 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.61 -0.723 . . . . 1.93 110.288 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . 159.94 150.37 5.83 Favored Glycine 0 N--CA 1.424 -2.159 0 N-CA-C 110.106 -1.197 . . . . 1.1 110.106 -178.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 35.6 ttp180 -92.02 -13.69 30.56 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 121.475 0.655 . . . . 5.21 109.843 -179.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -79.66 -39.03 32.33 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 121.364 0.602 . . . . 1.94 109.977 178.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 90.62 -171.89 36.82 Favored Glycine 0 N--CA 1.424 -2.118 0 CA-C-N 115.054 -0.975 . . . . 1.08 111.136 176.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -132.84 146.57 51.93 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 108.281 -1.007 . . . . 1.07 108.281 178.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 31.1 p -102.43 123.46 46.25 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 123.491 0.494 . . . . 1.46 111.77 -178.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1540 ' ' ALA . . . . . 0.402 ' HB2' ' CG1' ' A' 1548 ' ' VAL . . . -115.29 135.15 54.46 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.255 -0.646 . . . . 1.19 109.255 177.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -70.59 134.58 47.75 Favored 'General case' 0 C--O 1.249 1.032 0 CA-C-N 115.567 -0.742 . . . . 1.37 110.901 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1542 ' ' TYR . . . . . 0.609 ' CE2' ' HG ' ' A' 1626 ' ' LEU . 7.1 t80 -133.24 -100.84 0.26 Allowed 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.787 -0.82 . . . . 1.38 108.787 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1543 ' ' SER . . . . . . . . . . . . . 13.6 t -92.63 179.95 5.35 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 109.763 -0.458 . . . . 1.98 109.763 -176.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 20.2 pttp -75.21 -23.65 57.66 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 120.976 0.417 . . . . 3.96 111.416 -177.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1545 ' ' SER . . . . . 0.627 ' HB2' ' HG2' ' A' 1569 ' ' GLN . 5.2 p -65.49 -36.94 85.36 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 124.325 1.05 . . . . 2.81 112.751 -176.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 178.73 -167.1 37.27 Favored Glycine 0 N--CA 1.425 -2.098 0 C-N-CA 120.874 -0.679 . . . . 1.68 112.216 -178.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 27.2 m -113.58 166.46 7.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 109.82 -0.437 . . . . 1.38 109.82 -176.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1548 ' ' VAL . . . . . 0.402 ' CG1' ' HB2' ' A' 1540 ' ' ALA . 13.1 p -102.26 131.0 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 N-CA-C 108.911 -0.774 . . . . 1.24 108.911 177.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -92.16 134.84 34.48 Favored 'General case' 0 CA--C 1.481 -1.673 0 CA-C-N 115.504 -0.771 . . . . 1.29 109.223 178.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 24.0 ptm -146.64 116.06 7.08 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 115.478 -0.783 . . . . 1.47 111.057 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 8.5 p -106.39 124.13 49.12 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-N 115.145 -0.934 . . . . 1.4 110.214 178.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1552 ' ' ILE . . . . . 0.531 ' HB ' ' HA ' ' A' 1533 ' ' SER . 43.5 mm -81.92 119.1 30.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 109.99 -0.374 . . . . 1.11 109.99 -179.009 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 57.8 m 60.9 41.94 13.69 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 123.937 0.773 . . . . 1.4 111.366 176.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . -178.0 174.23 46.63 Favored Glycine 0 N--CA 1.422 -2.274 0 N-CA-C 109.961 -1.256 . . . . 0.4 109.961 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -100.16 150.8 22.14 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 120.856 0.36 . . . . 1.62 110.405 -179.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -98.81 139.28 34.72 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.0 -0.741 . . . . 1.12 109.0 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -85.12 -3.63 58.87 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 113.108 0.781 . . . . 2.49 113.108 -172.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -93.67 1.73 56.52 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 120.547 -0.461 . . . . 1.38 110.816 -176.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1559 ' ' CYS . . . . . 0.74 ' SG ' ' HD2' ' A' 1560 ' ' PRO . 13.3 t -137.59 166.34 27.27 Favored Pre-proline 0 C--N 1.3 -1.562 0 N-CA-C 106.542 -1.651 . . . . 1.21 106.542 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1560 ' ' PRO . . . . . 0.74 ' HD2' ' SG ' ' A' 1559 ' ' CYS . 16.3 Cg_exo -33.83 145.3 0.04 OUTLIER 'Trans proline' 0 C--N 1.379 2.173 0 C-N-CA 124.542 3.494 . . . . 0.98 114.627 173.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1561 ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' 1560 ' ' PRO . 43.0 Cg_exo -58.94 127.44 24.31 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 123.223 2.615 . . . . 1.15 112.841 -177.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 94.5 13.21 54.56 Favored Glycine 0 C--N 1.311 -0.812 0 N-CA-C 115.166 0.826 . . . . 0.55 115.166 176.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1563 ' ' VAL . . . . . 0.92 HG22 ' HB2' ' A' 1573 ' ' SER . 9.9 p -109.08 140.19 28.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-N 118.242 1.021 . . . . 1.53 110.95 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -100.7 -32.98 5.21 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 120.984 -0.627 . . . . 0.29 113.272 -177.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -123.35 128.76 50.36 Favored 'General case' 0 C--O 1.244 0.806 0 N-CA-C 109.569 -0.53 . . . . 1.08 109.569 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 50.6 t -163.48 144.82 9.33 Favored 'General case' 0 C--O 1.206 -1.194 0 C-N-CA 121.249 -0.18 . . . . 0.43 110.889 -175.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -85.72 143.61 28.26 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 118.05 0.386 . . . . 1.3 110.178 174.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -88.89 8.16 80.35 Favored Glycine 0 N--CA 1.443 -0.861 0 N-CA-C 116.239 1.256 . . . . 1.43 116.239 -170.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1569 ' ' GLN . . . . . 0.627 ' HG2' ' HB2' ' A' 1545 ' ' SER . 0.4 OUTLIER -78.48 -67.39 0.74 Allowed 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 118.328 1.064 . . . . 3.09 110.319 177.612 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 15.2 p -111.99 7.45 19.86 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.817 -1.083 . . . . 2.52 113.568 -175.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1571 ' ' ARG . . . . . 0.459 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 0.0 OUTLIER 64.68 44.34 3.87 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 122.964 0.506 . . . . 3.19 111.757 -178.91 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 42.6 mt -83.06 112.39 20.67 Favored 'Isoleucine or valine' 0 C--O 1.246 0.902 0 N-CA-C 107.973 -1.121 . . . . 1.51 107.973 174.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1573 ' ' SER . . . . . 0.92 ' HB2' HG22 ' A' 1563 ' ' VAL . 91.0 p -80.14 134.57 36.17 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.557 -0.747 . . . . 0.96 111.416 -174.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1574 ' ' VAL . . . . . 0.493 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 33.2 m -118.11 9.11 6.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 O-C-N 121.32 -0.862 . . . . 1.6 112.42 -178.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 175.33 123.88 0.78 Allowed Glycine 0 N--CA 1.433 -1.515 0 C-N-CA 120.331 -0.938 . . . . 0.34 111.403 176.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -69.24 153.34 43.82 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.043 -0.725 . . . . 2.68 109.043 -178.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -74.46 88.61 2.11 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-O 121.115 0.483 . . . . 1.08 110.258 -177.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -97.07 160.05 14.56 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 115.106 -0.952 . . . . 1.95 110.464 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 24.2 pttm -120.51 45.29 2.25 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 122.878 1.323 . . . . 3.11 108.363 -178.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 24.0 ttm180 -103.6 76.36 1.39 Allowed 'General case' 0 N--CA 1.412 -2.331 0 CA-C-N 113.956 -1.475 . . . . 4.04 108.54 -173.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1581 ' ' LEU . . . . . 0.44 HD22 ' HG ' ' A' 1590 ' ' LEU . 0.2 OUTLIER -82.35 124.7 30.23 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 114.146 -1.388 . . . . 1.32 107.534 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A 1582 ' ' ARG . . . . . 0.473 ' HB2' ' HB3' ' A' 1589 ' ' GLN . 64.3 mtp180 -122.56 143.4 49.76 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 116.768 -0.196 . . . . 3.4 110.599 176.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1583 ' ' TYR . . . . . 0.625 ' HB3' ' OD1' ' A' 1511 ' ' ASN . 74.9 t80 -113.35 107.57 16.04 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 109.323 -0.621 . . . . 1.26 109.323 177.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1584 ' ' VAL . . . . . 0.618 ' O ' ' HB ' ' A' 1587 ' ' VAL . 9.7 m -121.63 90.01 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 CA-C-N 115.722 -0.672 . . . . 1.71 111.153 -177.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 31.1 t70 53.51 72.63 0.42 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.053 0.941 . . . . 1.17 111.761 178.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1586 ' ' GLN . . . . . 0.441 ' HA ' ' HE1' ' A' 1583 ' ' TYR . 4.2 pt20 57.21 26.39 12.17 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 125.818 1.647 . . . . 2.43 111.296 176.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1587 ' ' VAL . . . . . 0.618 ' HB ' ' O ' ' A' 1584 ' ' VAL . 24.6 t -124.23 120.88 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.32 0 CA-C-N 113.769 -1.56 . . . . 1.16 108.117 175.341 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1588 ' ' LEU . . . . . 0.807 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 2.9 mm? -95.05 117.36 30.04 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.09 -1.448 . . . . 1.11 107.09 178.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1589 ' ' GLN . . . . . 0.473 ' HB3' ' HB2' ' A' 1582 ' ' ARG . 35.3 tt0 -106.56 127.42 53.31 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 116.02 -0.536 . . . . 1.74 111.454 -175.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1590 ' ' LEU . . . . . 0.44 ' HG ' HD22 ' A' 1581 ' ' LEU . 11.2 mt -121.49 101.6 7.72 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 107.463 -1.31 . . . . 1.4 107.463 170.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 6.4 p -96.92 124.68 49.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 CA-C-O 121.494 0.664 . . . . 1.7 109.966 -178.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1592 ' ' TYR . . . . . 0.453 ' HB2' ' HB3' ' A' 1608 ' ' SER . 14.4 m-30 -115.55 105.05 12.35 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.269 -1.012 . . . . 1.08 108.269 -179.053 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 20.7 pttp -115.27 -178.94 3.49 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 109.759 -0.46 . . . . 2.21 109.759 -179.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 36.2 m-20 65.16 42.42 4.06 Favored 'General case' 0 C--O 1.247 0.962 0 O-C-N 124.28 0.987 . . . . 1.11 110.405 177.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -75.88 -145.64 1.57 Allowed Glycine 0 N--CA 1.438 -1.217 0 CA-C-N 114.798 -1.092 . . . . 0.78 111.007 174.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1596 ' ' SER . . . . . . . . . . . . . 72.0 p -88.94 146.47 36.7 Favored Pre-proline 0 C--N 1.284 -2.278 0 N-CA-C 108.444 -0.947 . . . . 1.36 108.444 179.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.49 120.74 8.85 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.646 2.23 . . . . 1.4 109.308 174.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 42.4 t -73.25 132.21 82.29 Favored Pre-proline 0 C--N 1.288 -2.084 0 CA-C-N 114.663 -1.153 . . . . 0.75 112.425 -169.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1599 ' ' PRO . . . . . 0.457 ' HD2' ' OH ' ' A' 1606 ' ' TYR . 14.7 Cg_exo -72.44 80.2 1.7 Allowed 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 123.122 2.548 . . . . 1.7 109.338 171.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1600 ' ' SER . . . . . 0.812 ' HA ' ' HB2' ' B' ' 53' ' ' LEU . 50.6 m -160.62 -67.29 0.07 Allowed 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 126.613 1.965 . . . . 2.8 110.004 -178.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1601 ' ' LYS . . . . . 0.46 ' O ' ' HG ' ' A' 1604 ' ' LEU . 81.4 tttt -140.11 112.04 7.53 Favored 'General case' 0 N--CA 1.398 -3.05 0 N-CA-C 106.398 -1.704 . . . . 3.45 106.398 178.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 15.4 m -49.52 133.05 20.95 Favored 'General case' 0 N--CA 1.425 -1.72 0 C-N-CA 124.599 1.16 . . . . 2.44 112.549 -177.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 106.5 -21.49 32.6 Favored Glycine 0 C--N 1.304 -1.215 0 CA-C-N 115.91 -0.586 . . . . 1.2 113.945 177.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1604 ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' 1601 ' ' LYS . 4.3 pp -103.21 145.98 29.12 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 118.387 1.094 . . . . 2.38 111.238 178.124 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 22.8 p -111.77 155.89 22.81 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.624 -0.716 . . . . 1.96 110.797 -175.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1606 ' ' TYR . . . . . 0.493 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 63.9 m-85 -64.25 161.7 16.07 Favored 'General case' 0 C--O 1.249 1.046 0 CA-C-N 116.075 -0.511 . . . . 1.06 110.493 173.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -161.38 130.17 4.5 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-O 120.882 0.372 . . . . 2.0 111.145 -178.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1608 ' ' SER . . . . . 0.453 ' HB3' ' HB2' ' A' 1592 ' ' TYR . 38.0 t -105.23 123.03 47.15 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 115.376 -0.829 . . . . 1.61 109.723 -177.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 24.1 t -107.55 100.75 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 107.946 -1.131 . . . . 1.09 107.946 175.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 89.7 mt -89.77 112.19 24.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 108.317 -0.994 . . . . 1.2 108.317 -179.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 40.1 m -112.86 110.68 20.93 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 115.043 -0.98 . . . . 1.89 111.355 -177.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1612 ' ' PHE . . . . . 0.807 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 62.8 m-85 -83.42 115.85 22.23 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.793 -0.817 . . . . 0.28 108.793 175.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 84.1 t -110.31 135.75 48.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 O-C-N 123.651 0.594 . . . . 1.23 110.572 -174.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 41.4 t -72.13 98.24 2.08 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 124.069 0.948 . . . . 0.77 111.686 -178.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1615 ' ' ARG . . . . . 0.763 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 9.5 mmt180 -138.11 99.31 9.07 Favored Pre-proline 0 N--CA 1.431 -1.404 0 CA-C-N 116.058 -0.519 . . . . 2.92 109.812 175.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1616 ' ' PRO . . . . . 0.49 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 16.4 Cg_exo -75.26 39.57 0.62 Allowed 'Trans proline' 0 N--CA 1.488 1.188 0 C-N-CA 123.37 2.713 . . . . 1.22 112.412 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1617 ' ' GLU . . . . . 0.512 ' OE1' ' HD2' ' A' 1615 ' ' ARG . 42.9 mt-10 -110.57 40.46 1.98 Allowed 'General case' 0 C--N 1.272 -2.772 0 N-CA-C 108.076 -1.083 . . . . 3.05 108.076 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -41.48 115.45 0.63 Allowed 'General case' 0 C--O 1.244 0.765 0 C-N-CA 126.288 1.835 . . . . 1.55 113.867 -175.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . 173.42 -127.16 1.31 Allowed Glycine 0 N--CA 1.412 -2.929 0 N-CA-C 108.149 -1.981 . . . . 1.16 108.149 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -77.2 7.03 3.9 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 122.545 2.163 . . . . 1.06 112.657 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1621 ' ' THR . . . . . 0.533 ' HB ' ' HB2' ' A' 1641 ' ' HIS . 3.8 p -91.11 -27.17 18.73 Favored 'General case' 0 C--N 1.288 -2.081 0 C-N-CA 124.924 1.29 . . . . 1.58 108.203 176.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 51.2 t30 -87.01 56.78 4.16 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.387 -1.278 . . . . 0.88 108.566 -176.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -157.99 139.54 9.84 Favored Pre-proline 0 C--N 1.302 -1.493 0 CA-C-N 114.632 -1.167 . . . . 3.82 108.443 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -68.28 110.91 2.35 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.898 2.399 . . . . 0.77 112.01 -177.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 75.8 mtm -111.98 142.95 43.76 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 120.69 -0.404 . . . . 1.43 110.187 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1626 ' ' LEU . . . . . 0.609 ' HG ' ' CE2' ' A' 1542 ' ' TYR . 0.8 OUTLIER -81.78 112.88 19.34 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 108.34 -0.985 . . . . 1.43 108.34 -175.412 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 44.2 mm -81.12 -52.25 14.32 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 CA-C-O 121.31 0.576 . . . . 1.23 109.852 -178.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 50.9 m -159.56 145.42 15.99 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.541 -0.754 . . . . 1.88 109.772 -176.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1629 ' ' LEU . . . . . 1.001 HD12 ' HG ' ' A' 1636 ' ' LEU . 23.0 tp -129.7 95.13 3.9 Favored 'General case' 0 N--CA 1.421 -1.879 0 N-CA-C 107.785 -1.191 . . . . 1.92 107.785 171.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 27.5 t70 -68.0 122.11 17.52 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 107.121 -1.437 . . . . 1.09 107.121 175.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 26.0 tptp -89.36 -0.17 57.28 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 119.882 -0.727 . . . . 3.98 110.709 -171.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -96.17 -41.08 8.88 Favored 'General case' 0 N--CA 1.426 -1.643 0 C-N-CA 119.884 -0.726 . . . . 2.6 109.933 179.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 22.9 p -89.39 -22.05 22.76 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.4 0.619 . . . . 1.35 110.596 175.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 68.3 m 63.64 36.63 10.73 Favored 'General case' 0 C--N 1.354 0.771 0 C-N-CA 124.965 1.306 . . . . 0.53 111.824 178.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1635 ' ' THR . . . . . . . . . . . . . 38.6 m -100.35 130.5 46.46 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 108.028 -1.101 . . . . 1.11 108.028 178.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1636 ' ' LEU . . . . . 1.001 ' HG ' HD12 ' A' 1629 ' ' LEU . 0.6 OUTLIER -109.38 129.96 55.51 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 108.712 -0.847 . . . . 1.56 108.712 -176.373 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -106.86 121.59 44.72 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 120.901 0.382 . . . . 0.54 110.811 -179.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -119.09 127.78 53.7 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.293 -0.867 . . . . 0.64 108.794 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1639 ' ' SER . . . . . . . . . . . . . 59.1 m -114.23 144.09 43.78 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.293 -1.003 . . . . 1.34 108.293 177.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 2.8 t90 -141.39 107.95 5.33 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 103.792 -2.67 . . . . 0.8 103.792 -177.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1641 ' ' HIS . . . . . 0.763 ' HB3' ' HB2' ' A' 1615 ' ' ARG . 16.4 m170 -93.61 103.25 15.43 Favored 'General case' 0 C--N 1.287 -2.129 0 C-N-CA 120.706 -0.397 . . . . 1.14 110.487 -174.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1642 ' ' THR . . . . . . . . . . . . . 15.0 t -142.62 145.77 35.62 Favored Pre-proline 0 CA--C 1.565 1.529 0 N-CA-C 109.304 -0.628 . . . . 1.11 109.304 -174.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1643 ' ' PRO . . . . . 0.49 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 56.3 Cg_endo -72.57 -13.74 27.43 Favored 'Trans proline' 0 C--N 1.37 1.681 0 C-N-CA 122.635 2.224 . . . . 0.78 112.885 -179.027 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 9.1 tt -65.23 -19.24 65.88 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.37 0.605 . . . . 1.66 110.399 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -78.24 -7.2 56.86 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.58 -0.737 . . . . 1.29 112.241 -179.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 1.2 m -108.93 156.46 19.67 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 121.474 0.654 . . . . 1.48 111.869 178.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -108.96 142.96 26.64 Favored Pre-proline 0 C--N 1.292 -1.919 0 N-CA-C 107.531 -1.285 . . . . 3.14 107.531 169.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1648 ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -60.27 112.86 1.44 Allowed 'Trans proline' 0 N--CA 1.464 -0.214 0 C-N-CA 122.62 2.213 . . . . 2.92 111.924 -178.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 7.5 tp10 . . . . . 0 C--N 1.302 -1.487 0 N-CA-C 107.558 -1.275 . . . . 4.72 107.558 179.999 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 -0.293 0 N-CA-C 109.362 -0.607 . . . . 10.26 109.362 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -98.85 134.27 41.96 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.612 -0.884 . . . . 7.94 108.612 -178.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -107.19 126.83 29.17 Favored Pre-proline 0 C--N 1.302 -1.481 0 N-CA-C 109.92 -0.4 . . . . 6.56 109.92 178.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . 0.661 ' HB2' ' HG2' ' B' ' 6' ' ' GLU . 31.4 Cg_endo -65.76 -15.0 47.38 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 122.149 1.899 . . . . 5.51 112.968 176.258 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 32.8 m 58.38 30.03 19.03 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 125.02 1.328 . . . . 4.91 112.015 178.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . 0.661 ' HG2' ' HB2' ' B' ' 4' ' ' PRO . 42.8 mm-40 -75.86 -37.17 59.21 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 121.725 0.774 . . . . 4.23 108.918 -178.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 19.7 p -118.75 121.61 40.49 Favored 'General case' 0 N--CA 1.416 -2.166 0 N-CA-C 106.701 -1.592 . . . . 3.48 106.701 175.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . 0.593 HD11 ' HG2' ' B' ' 12' ' ' GLU . 6.2 mp -94.83 145.17 25.08 Favored 'General case' 0 N--CA 1.428 -1.562 0 C-N-CA 119.154 -1.019 . . . . 4.35 109.736 -178.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 8.7 m -91.89 56.39 2.91 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 121.27 0.557 . . . . 2.84 111.203 -168.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -171.87 -107.76 0.2 Allowed Glycine 0 C--N 1.298 -1.571 0 C-N-CA 120.224 -0.989 . . . . 2.28 113.307 -179.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -59.31 -39.16 94.33 Favored Glycine 0 N--CA 1.461 0.343 0 O-C-N 123.654 0.267 . . . . 1.94 113.202 -176.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . 0.593 ' HG2' HD11 ' B' ' 8' ' ' LEU . 18.0 mp0 -65.61 -40.44 92.62 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 124.213 1.005 . . . . 2.55 110.067 179.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . 0.424 HD21 ' HB3' ' B' ' 46' ' ' CYS . 0.1 OUTLIER -65.15 -51.62 60.06 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.206 -0.906 . . . . 2.82 108.571 -178.884 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 7.6 p -63.42 -37.61 80.01 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 CA-C-N 116.405 -0.361 . . . . 2.5 111.655 179.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -68.1 -32.81 73.37 Favored 'General case' 0 C--O 1.193 -1.907 0 C-N-CA 120.088 -0.645 . . . . 2.04 111.859 177.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 96.5 m -59.16 -49.73 76.73 Favored 'General case' 0 C--O 1.279 2.613 0 CA-C-O 121.551 0.691 . . . . 2.31 109.62 174.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.787 HD21 HD12 ' B' ' 42' ' ' ILE . 4.6 mm? -51.52 -48.46 62.96 Favored 'General case' 0 C--O 1.222 -0.365 0 CA-C-N 114.472 -1.24 . . . . 2.27 110.416 174.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . 0.482 ' CD ' ' HB3' ' A' 1545 ' ' SER . 9.7 tt0 -78.11 -15.2 59.08 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.584 -0.734 . . . . 2.39 112.264 -176.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -66.75 -48.46 69.04 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.727 -0.471 . . . . 1.0 109.727 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 23.8 m -92.77 -29.11 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 117.49 -1.684 . . . . 1.83 111.995 176.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 63.0 m -96.94 25.19 5.52 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 112.203 0.445 . . . . 1.66 112.203 -178.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -54.3 -58.43 13.01 Favored Glycine 0 N--CA 1.472 1.085 0 C-N-CA 120.997 -0.62 . . . . 1.53 112.735 179.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -80.77 -3.63 51.63 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 121.027 0.441 . . . . 2.72 111.27 178.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -99.08 -55.25 2.75 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 112.157 0.429 . . . . 5.02 112.157 -173.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 122.09 143.67 6.59 Favored Glycine 0 C--N 1.301 -1.37 0 N-CA-C 108.64 -1.784 . . . . 1.63 108.64 -173.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . 0.421 ' HB2' ' HB3' ' B' ' 17' ' ' LEU . 41.6 p90 -132.33 146.36 51.92 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 117.52 0.66 . . . . 1.71 110.785 -177.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 27' ' ' TYR . . . . . 0.657 ' HE2' ' HE2' ' B' ' 65' ' ' LYS . 15.4 p90 -160.97 91.36 0.88 Allowed 'General case' 0 CA--C 1.547 0.865 0 CA-C-O 121.245 0.545 . . . . 3.67 111.923 178.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 28' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -103.31 2.5 34.21 Favored 'General case' 0 C--O 1.238 0.482 0 O-C-N 121.187 -0.946 . . . . 2.44 110.932 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 67.5 m -150.43 88.0 1.48 Allowed 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 109.223 -0.658 . . . . 3.85 109.223 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . 0.813 ' HB2' ' HB3' ' B' ' 39' ' ' SER . 47.9 mtp180 -100.49 153.52 37.7 Favored Pre-proline 0 C--N 1.304 -1.38 0 N-CA-C 106.309 -1.738 . . . . 4.27 106.309 -177.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -58.44 -51.55 7.19 Favored 'Trans proline' 0 C--O 1.243 0.755 0 C-N-CA 121.427 1.418 . . . . 4.2 112.52 -175.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -176.55 167.3 2.71 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 106.725 -1.583 . . . . 5.12 106.725 -178.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 25.6 m -152.05 157.61 41.89 Favored 'General case' 0 N--CA 1.394 -3.246 0 N-CA-C 101.988 -3.338 . . . . 6.93 101.988 178.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 33.5 ttm180 -92.5 -3.5 55.05 Favored 'General case' 0 C--N 1.284 -2.256 0 CA-C-O 121.749 0.785 . . . . 12.14 112.639 -169.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 63.6 t -115.87 -29.22 2.15 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.234 0 N-CA-C 108.117 -1.068 . . . . 9.9 108.117 177.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 22.1 t -134.66 75.62 1.59 Allowed 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 107.466 -1.309 . . . . 6.82 107.466 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 28.8 ptt180 -64.73 -15.85 62.1 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 113.617 0.969 . . . . 10.71 113.617 -178.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 31.8 tpt180 -98.1 69.96 2.06 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 106.563 -1.643 . . . . 8.6 106.563 176.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 39' ' ' SER . . . . . 0.813 ' HB3' ' HB2' ' B' ' 30' ' ' ARG . 20.3 m -81.44 26.69 0.45 Allowed 'General case' 0 C--N 1.283 -2.315 0 CA-C-N 113.519 -1.673 . . . . 5.79 113.141 -174.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 -140.02 141.84 36.29 Favored 'General case' 0 N--CA 1.431 -1.393 0 O-C-N 121.875 -0.516 . . . . 6.57 110.245 176.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . 0.474 ' C ' ' H ' ' B' ' 43' ' ' VAL . . . -166.59 -175.81 37.14 Favored Glycine 0 N--CA 1.415 -2.73 0 N-CA-C 109.336 -1.506 . . . . 2.62 109.336 -178.277 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . 0.787 HD12 HD21 ' B' ' 17' ' ' LEU . 11.1 pt 64.6 -24.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 C-N-CA 128.581 2.752 . . . . 2.28 113.866 179.016 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . 0.564 ' O ' ' HB2' ' B' ' 47' ' ' CYS . 2.0 p -50.56 -45.01 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 C-N-CA 124.628 1.171 . . . . 2.6 113.362 177.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -93.89 -39.98 10.4 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.418 -0.956 . . . . 3.36 108.418 -174.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . 0.488 ' O ' ' HB2' ' B' ' 49' ' ' ARG . 3.1 mp0 -55.25 -44.66 75.74 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 113.968 -1.469 . . . . 3.08 111.261 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 46' ' ' CYS . . . . . 0.424 ' HB3' HD21 ' B' ' 13' ' ' LEU . 13.1 t -94.8 -2.16 51.45 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.356 0.598 . . . . 2.23 110.717 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 47' ' ' CYS . . . . . 0.564 ' HB2' ' O ' ' B' ' 43' ' ' VAL . 45.4 t -78.54 -56.88 4.09 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.374 -0.602 . . . . 2.48 109.374 177.227 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -90.97 -12.07 37.07 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.406 0.521 . . . . 2.97 112.406 -175.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . 0.488 ' HB2' ' O ' ' B' ' 45' ' ' GLU . 72.4 mtp180 -129.95 -171.07 2.43 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 107.904 -1.147 . . . . 4.65 107.904 -178.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 8.3 t -110.81 129.79 55.76 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 106.278 -1.749 . . . . 2.86 106.278 178.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . 0.411 ' HB3' ' HB2' ' B' ' 46' ' ' CYS . 14.7 p -96.44 131.73 42.71 Favored 'General case' 0 N--CA 1.428 -1.57 0 CA-C-O 120.949 0.404 . . . . 2.11 110.148 -174.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -74.68 154.42 38.46 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-N 115.806 -0.634 . . . . 2.67 110.763 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . 0.812 ' HB2' ' HA ' ' A' 1600 ' ' SER . 34.1 tp -55.45 -43.65 75.63 Favored 'General case' 0 C--N 1.309 -1.194 0 O-C-N 123.585 0.553 . . . . 2.36 110.605 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -52.64 -36.75 57.23 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 124.958 1.303 . . . . 1.92 112.043 -176.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 64.2 tp -70.27 -57.88 4.38 Favored 'General case' 0 N--CA 1.427 -1.621 0 CA-C-N 115.451 -0.795 . . . . 2.35 110.676 -179.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . 0.409 ' O ' ' HB2' ' B' ' 60' ' ' CYS . 3.0 pp -68.78 -33.87 74.59 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 111.867 0.321 . . . . 2.01 111.867 -174.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -54.43 -60.64 3.07 Favored 'General case' 0 C--N 1.318 -0.771 0 O-C-N 123.947 0.779 . . . . 2.27 111.679 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 12.4 t -80.74 -25.55 37.96 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 119.974 -0.69 . . . . 2.67 111.995 -175.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -71.7 -40.53 69.45 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 109.096 -0.705 . . . . 3.2 109.096 -179.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 60' ' ' CYS . . . . . 0.409 ' HB2' ' O ' ' B' ' 56' ' ' LEU . 30.4 t -47.12 -68.71 0.17 Allowed 'General case' 0 N--CA 1.485 1.297 0 O-C-N 124.72 1.262 . . . . 2.3 111.335 179.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . 175.59 172.76 0.31 Allowed 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 105.548 -2.019 . . . . 3.19 105.548 -177.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 18.4 p -108.34 154.88 41.16 Favored Pre-proline 0 C--N 1.279 -2.497 0 N-CA-C 109.136 -0.69 . . . . 4.14 109.136 -178.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_exo -54.34 -31.21 66.44 Favored 'Trans proline' 0 C--O 1.243 0.768 0 C-N-CA 123.108 2.539 . . . . 5.59 110.98 176.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -106.55 67.29 0.72 Allowed 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.128 -1.064 . . . . 5.51 108.128 174.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . 0.657 ' HE2' ' HE2' ' B' ' 27' ' ' TYR . 64.6 tttm -51.23 -34.88 34.24 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 125.338 1.455 . . . . 8.8 112.55 -178.005 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 20.0 m -119.65 -71.18 0.75 Allowed 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 108.232 -1.025 . . . . 8.12 108.232 176.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 . . . . . 0 CA--C 1.493 -1.231 0 N-CA-C 106.179 -1.786 . . . . 10.21 106.179 -179.924 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 27.1 ttt . . . . . 0 N--CA 1.466 0.339 0 N-CA-C 108.578 -0.897 . . . . 9.74 108.578 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 25.3 ttmm -159.5 73.28 0.56 Allowed 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 108.801 -0.814 . . . . 9.32 108.801 -174.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 47.4 t 71.36 145.34 0.07 Allowed 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.675 1.19 . . . . 5.97 113.395 176.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1511 ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -93.79 3.77 54.93 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.918 -0.583 . . . . 3.48 110.143 174.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1512 ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 59.69 161.53 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 126.873 2.069 . . . . 5.95 115.732 178.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 55.7 p-80 -149.63 84.76 1.42 Allowed 'General case' 0 N--CA 1.431 -1.378 0 CA-C-O 122.587 1.184 . . . . 6.14 110.68 176.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1514 ' ' ASP . . . . . 0.43 ' CG ' ' H ' ' A' 1515 ' ' ASP . 21.0 t70 -105.2 -152.98 0.48 Allowed 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 105.378 -2.082 . . . . 5.06 105.378 177.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1515 ' ' ASP . . . . . 0.43 ' H ' ' CG ' ' A' 1514 ' ' ASP . 29.5 m-20 -76.56 -70.81 0.43 Allowed 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 118.98 0.809 . . . . 2.9 109.047 179.115 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1516 ' ' CYS . . . . . 0.482 ' HA ' ' HB2' ' A' 1581 ' ' LEU . 83.7 m -138.64 41.75 2.17 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 116.214 -0.448 . . . . 1.41 111.024 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -149.13 137.16 20.66 Favored 'General case' 0 N--CA 1.428 -1.564 0 C-N-CA 120.351 -0.539 . . . . 2.18 109.9 178.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1518 ' ' VAL . . . . . 0.479 HG21 ' HB2' ' A' 1583 ' ' TYR . 10.4 m -140.67 141.06 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 123.16 0.584 . . . . 1.52 110.204 178.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1519 ' ' THR . . . . . . . . . . . . . 9.6 m -101.04 131.2 47.05 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 115.77 -0.65 . . . . 1.36 109.343 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1520 ' ' ASN . . . . . 0.445 ' OD1' HG23 ' A' 1523 ' ' THR . 26.5 t-20 -83.49 118.27 71.04 Favored Pre-proline 0 N--CA 1.426 -1.661 0 N-CA-C 109.332 -0.618 . . . . 2.02 109.332 176.315 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.14 -16.82 49.88 Favored 'Trans proline' 0 C--O 1.239 0.572 0 C-N-CA 123.224 2.616 . . . . 1.82 113.906 -177.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 74.2 m -77.2 -46.34 23.62 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 112.28 0.474 . . . . 1.89 112.28 -179.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1523 ' ' THR . . . . . 0.445 HG23 ' OD1' ' A' 1520 ' ' ASN . 5.7 t -109.68 -14.43 14.34 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 119.547 -0.861 . . . . 1.99 111.626 -178.065 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 79.55 31.68 40.25 Favored Glycine 0 N--CA 1.44 -1.044 0 N-CA-C 111.352 -0.699 . . . . 1.19 111.352 178.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1525 ' ' HIS . . . . . 0.402 ' HB2' ' OE2' ' A' 1647 ' ' GLU . 5.2 t-80 -98.22 120.9 39.43 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.623 -0.88 . . . . 1.82 108.623 -178.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 1.9 tm? -86.31 112.66 21.62 Favored 'General case' 0 C--N 1.285 -2.212 0 N-CA-C 107.022 -1.473 . . . . 1.3 107.022 176.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -99.79 120.01 39.06 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 109.194 -0.669 . . . . 0.8 109.194 177.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 23.1 t70 -112.64 118.09 34.09 Favored 'General case' 0 CA--C 1.482 -1.657 0 N-CA-C 108.652 -0.87 . . . . 1.17 108.652 177.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 6.0 mp -107.38 5.8 27.73 Favored 'General case' 0 N--CA 1.412 -2.353 0 CA-C-O 121.571 0.7 . . . . 1.29 110.769 -177.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 1.5 m -72.72 -11.08 60.48 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.838 -1.074 . . . . 0.91 109.089 178.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 24.7 m -75.49 -23.63 56.81 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 115.3 -0.864 . . . . 1.98 109.712 176.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 97.9 mt -87.1 -5.16 59.12 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.258 0.552 . . . . 1.34 110.312 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1533 ' ' SER . . . . . 0.491 ' HA ' ' HB ' ' A' 1552 ' ' ILE . 21.0 m -70.53 166.76 19.86 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.842 -0.617 . . . . 1.93 111.862 -178.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . 173.47 164.15 28.24 Favored Glycine 0 N--CA 1.436 -1.301 0 N-CA-C 110.069 -1.212 . . . . 1.1 110.069 -179.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 44.6 ttp180 -92.57 -33.66 14.34 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 121.028 0.442 . . . . 5.21 110.197 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -82.06 -30.83 31.14 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 116.088 -0.505 . . . . 1.94 110.597 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 84.51 -145.65 22.11 Favored Glycine 0 N--CA 1.422 -2.255 0 CA-C-N 115.5 -0.773 . . . . 1.08 113.634 170.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -137.3 153.18 50.34 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 124.98 1.312 . . . . 1.07 107.548 -178.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 8.6 p -115.28 136.93 52.58 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 123.632 0.582 . . . . 1.46 110.508 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1540 ' ' ALA . . . . . 0.444 ' HB3' HG11 ' A' 1548 ' ' VAL . . . -132.61 136.36 46.47 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.969 -1.123 . . . . 1.19 107.969 175.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -84.73 129.31 34.84 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.275 0.559 . . . . 1.37 110.589 -176.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1542 ' ' TYR . . . . . 0.631 ' CE2' ' HG ' ' A' 1626 ' ' LEU . 1.6 t80 -120.04 -100.58 0.43 Allowed 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.588 -1.264 . . . . 1.38 107.588 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1543 ' ' SER . . . . . 0.496 ' H ' ' HB3' ' A' 1542 ' ' TYR . 5.2 m -71.94 161.52 30.81 Favored 'General case' 0 N--CA 1.421 -1.91 0 C-N-CA 124.373 1.069 . . . . 1.98 108.838 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1544 ' ' LYS . . . . . 0.784 ' HG3' ' HB3' ' B' ' 23' ' ' ASP . 39.0 mmtm -72.57 -1.11 14.78 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.398 0.888 . . . . 3.96 113.398 -177.299 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 22.6 t -139.82 37.98 1.99 Allowed 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 108.937 -0.764 . . . . 2.81 108.937 176.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . -172.29 126.58 1.29 Allowed Glycine 0 N--CA 1.434 -1.494 0 C-N-CA 119.555 -1.307 . . . . 1.68 114.166 -178.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 26.8 m -109.1 150.53 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.568 0 N-CA-C 107.184 -1.413 . . . . 1.38 107.184 174.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1548 ' ' VAL . . . . . 0.444 HG11 ' HB3' ' A' 1540 ' ' ALA . 10.0 p -97.46 130.4 46.18 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 C-N-CA 120.171 -0.612 . . . . 1.24 109.403 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -94.22 131.53 39.71 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 108.358 -0.978 . . . . 1.29 108.358 176.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 26.2 ptm -145.59 127.03 14.99 Favored 'General case' 0 C--N 1.286 -2.183 0 CA-C-N 115.471 -0.786 . . . . 1.47 110.983 -177.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 69.1 m -118.15 128.48 54.77 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 115.769 -0.65 . . . . 1.4 109.968 177.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1552 ' ' ILE . . . . . 0.491 ' HB ' ' HA ' ' A' 1533 ' ' SER . 50.7 mm -77.35 125.34 37.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 109.16 -0.682 . . . . 1.11 109.16 -179.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 75.8 m 59.08 39.42 23.26 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.589 0.755 . . . . 1.4 112.045 175.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . -179.99 178.51 48.56 Favored Glycine 0 N--CA 1.42 -2.376 0 C-N-CA 120.096 -1.049 . . . . 0.4 110.919 -177.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -96.85 160.78 14.17 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 109.337 -0.616 . . . . 1.62 109.337 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -103.48 130.29 50.81 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 109.891 -0.411 . . . . 1.12 109.891 -178.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -73.3 2.1 8.15 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.676 0.991 . . . . 2.49 113.676 -175.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -101.71 1.31 37.33 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.91 -0.494 . . . . 1.38 110.427 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1559 ' ' CYS . . . . . 0.605 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 16.1 m -137.03 175.26 3.62 Favored Pre-proline 0 C--N 1.303 -1.421 0 CA-C-O 118.647 -0.692 . . . . 1.21 112.07 -177.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1560 ' ' PRO . . . . . 0.605 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 21.9 Cg_exo -38.76 142.93 0.27 Allowed 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 124.063 3.175 . . . . 0.98 114.562 175.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1561 ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' 1560 ' ' PRO . 31.6 Cg_exo -61.51 126.69 19.77 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.533 2.155 . . . . 1.15 111.018 176.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 100.33 -9.0 59.09 Favored Glycine 0 C--N 1.31 -0.87 0 N-CA-C 114.345 0.498 . . . . 0.55 114.345 178.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1563 ' ' VAL . . . . . 0.595 HG12 ' O ' ' A' 1560 ' ' PRO . 9.8 p -99.9 134.92 37.7 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 O-C-N 121.6 -0.941 . . . . 1.53 111.294 -177.418 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -95.35 -31.39 7.57 Favored Glycine 0 N--CA 1.453 -0.191 0 CA-C-N 115.725 -0.67 . . . . 0.29 112.854 -177.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -124.14 125.62 44.77 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 109.71 -0.478 . . . . 1.08 109.71 178.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 4.5 t -159.36 141.42 13.52 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 116.492 -0.322 . . . . 0.43 110.361 -177.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1567 ' ' PHE . . . . . 0.509 ' HE1' HG21 ' A' 1574 ' ' VAL . 84.0 m-85 -86.24 139.91 30.6 Favored 'General case' 0 C--O 1.245 0.828 0 N-CA-C 109.61 -0.515 . . . . 1.3 109.61 175.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -86.3 29.85 4.64 Favored Glycine 0 CA--C 1.508 -0.361 0 C-N-CA 120.856 -0.687 . . . . 1.43 112.454 -175.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1569 ' ' GLN . . . . . 0.585 ' HB3' ' OD1' ' B' ' 15' ' ' ASP . 27.7 mt-30 -83.3 -70.58 0.55 Allowed 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 110.281 -0.266 . . . . 3.09 110.281 177.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 8.3 t -130.96 32.31 4.34 Favored 'General case' 0 CA--C 1.557 1.228 0 CA-C-O 121.563 0.697 . . . . 2.52 111.107 176.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 15.2 mmt85 64.64 48.86 2.45 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 124.213 1.005 . . . . 3.19 110.895 178.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 27.8 mt -89.36 120.22 37.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 109.552 -0.536 . . . . 1.51 109.552 -178.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1573 ' ' SER . . . . . 0.405 ' HB3' ' HB3' ' A' 1596 ' ' SER . 29.5 t -76.13 128.72 35.54 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.392 -0.822 . . . . 0.96 111.009 -177.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1574 ' ' VAL . . . . . 0.509 HG21 ' HE1' ' A' 1567 ' ' PHE . 0.9 OUTLIER -112.15 -16.57 9.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 115.884 -0.598 . . . . 1.6 112.084 -179.918 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 179.11 124.5 0.88 Allowed Glycine 0 N--CA 1.435 -1.403 0 C-N-CA 119.34 -1.409 . . . . 0.34 112.4 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 22.2 ttmm -61.65 145.99 50.46 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 123.683 0.793 . . . . 2.68 109.399 178.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -59.63 119.92 8.49 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 108.834 -0.802 . . . . 1.08 108.834 175.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 60.2 t30 -132.49 147.12 52.36 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.474 -1.306 . . . . 1.95 107.474 -174.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1579 ' ' LYS . . . . . 0.411 ' HE2' ' HB3' ' A' 1515 ' ' ASP . 56.4 mtpt -132.27 57.66 1.78 Allowed 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 122.298 1.047 . . . . 3.11 108.772 -175.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 31.2 ttm180 -117.69 76.56 1.07 Allowed 'General case' 0 N--CA 1.413 -2.311 0 CA-C-N 114.775 -1.102 . . . . 4.04 108.051 -176.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1581 ' ' LEU . . . . . 0.482 ' HB2' ' HA ' ' A' 1516 ' ' CYS . 0.6 OUTLIER -64.23 125.72 25.45 Favored 'General case' 0 C--O 1.252 1.196 0 CA-C-N 114.266 -1.334 . . . . 1.32 109.975 -178.103 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A 1582 ' ' ARG . . . . . 0.401 ' HD2' ' OE1' ' A' 1589 ' ' GLN . 91.6 mtt180 -124.48 138.23 54.36 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.865 -0.607 . . . . 3.4 110.391 177.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1583 ' ' TYR . . . . . 0.479 ' HB2' HG21 ' A' 1518 ' ' VAL . 46.0 t80 -110.8 107.26 16.71 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 107.303 -1.369 . . . . 1.26 107.303 174.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1584 ' ' VAL . . . . . 0.476 ' O ' ' HB ' ' A' 1587 ' ' VAL . 16.5 m -120.97 90.1 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 CA-C-N 115.9 -0.591 . . . . 1.71 112.065 -176.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 29.6 t70 58.02 57.66 3.97 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.892 0.853 . . . . 1.17 110.555 178.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1586 ' ' GLN . . . . . 0.458 ' HA ' ' CZ ' ' A' 1583 ' ' TYR . 2.1 pt20 73.99 -7.64 1.58 Allowed 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 128.243 2.617 . . . . 2.43 111.476 178.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1587 ' ' VAL . . . . . 0.476 ' HB ' ' O ' ' A' 1584 ' ' VAL . 30.5 t -88.07 124.9 41.46 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.444 0 CA-C-N 115.719 -0.673 . . . . 1.16 109.337 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1588 ' ' LEU . . . . . 0.679 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 3.3 mm? -93.93 120.85 34.74 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 107.581 -1.266 . . . . 1.11 107.581 179.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1589 ' ' GLN . . . . . 0.401 ' OE1' ' HD2' ' A' 1582 ' ' ARG . 35.8 tt0 -116.78 135.65 53.59 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 112.63 0.604 . . . . 1.74 112.63 -173.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 18.3 mt -129.96 99.25 5.03 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 125.373 1.469 . . . . 1.4 107.224 172.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 7.5 p -95.81 125.87 48.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 109.527 -0.546 . . . . 1.7 109.527 -178.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1592 ' ' TYR . . . . . 0.582 ' HB2' ' HB3' ' A' 1608 ' ' SER . 15.8 m-30 -110.76 107.1 16.51 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 108.592 -0.892 . . . . 1.08 108.592 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 19.5 pttp -109.68 168.77 9.17 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 115.557 -0.747 . . . . 2.21 110.057 -177.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 15.3 m-20 66.29 78.89 0.25 Allowed 'General case' 0 CA--C 1.507 -0.681 0 C-N-CA 124.488 1.115 . . . . 1.11 110.69 -178.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -98.99 -122.07 4.65 Favored Glycine 0 C--N 1.287 -2.143 0 N-CA-C 109.703 -1.359 . . . . 0.78 109.703 175.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1596 ' ' SER . . . . . 0.405 ' HB3' ' HB3' ' A' 1573 ' ' SER . 50.7 p -120.29 164.68 21.3 Favored Pre-proline 0 C--N 1.297 -1.683 0 N-CA-C 107.927 -1.138 . . . . 1.36 107.927 175.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.16 119.94 7.53 Favored 'Trans proline' 0 C--N 1.361 1.214 0 C-N-CA 122.317 2.012 . . . . 1.4 112.306 -178.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1598 ' ' CYS . . . . . 0.413 ' HA ' ' HD3' ' A' 1599 ' ' PRO . 44.5 t -81.08 125.21 80.18 Favored Pre-proline 0 C--N 1.292 -1.901 0 CA-C-N 115.129 -0.941 . . . . 0.75 109.182 -179.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1599 ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' 1598 ' ' CYS . 14.9 Cg_exo -71.1 -15.15 32.16 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 123.429 2.753 . . . . 1.7 112.995 -178.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1600 ' ' SER . . . . . 0.853 ' HA ' ' HB3' ' B' ' 53' ' ' LEU . 10.6 m -59.0 -40.89 86.28 Favored 'General case' 0 N--CA 1.434 -1.257 0 C-N-CA 123.296 0.638 . . . . 2.8 111.635 177.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1601 ' ' LYS . . . . . . . . . . . . . 18.5 ttmm -145.9 127.18 14.84 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 106.832 -1.544 . . . . 3.45 106.832 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 19.2 m -61.94 117.18 5.59 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 112.176 0.435 . . . . 2.44 112.176 -174.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 95.16 14.68 47.62 Favored Glycine 0 C--O 1.241 0.539 0 C-N-CA 121.404 -0.427 . . . . 1.2 112.846 178.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1604 ' ' LEU . . . . . 0.598 HD21 ' SG ' ' A' 1634 ' ' CYS . 12.5 tp -108.16 157.11 18.59 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.861 -1.163 . . . . 2.38 107.861 -178.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 33.4 t -120.53 154.32 35.5 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.965 -0.754 . . . . 1.96 108.965 -178.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1606 ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -76.35 158.26 31.63 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.901 -0.777 . . . . 1.06 108.901 174.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 56.7 pttt -158.4 140.81 14.28 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 120.397 -0.521 . . . . 2.0 110.976 175.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1608 ' ' SER . . . . . 0.582 ' HB3' ' HB2' ' A' 1592 ' ' TYR . 45.4 t -105.68 127.88 53.33 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 115.168 -0.924 . . . . 1.61 109.894 -175.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 40.8 t -113.72 101.75 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 N-CA-C 108.905 -0.776 . . . . 1.09 108.905 176.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 80.4 mt -91.87 114.53 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.611 0 N-CA-C 107.85 -1.167 . . . . 1.2 107.85 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 8.1 t -116.9 111.59 19.86 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 115.401 -0.818 . . . . 1.89 109.703 -176.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1612 ' ' PHE . . . . . 0.679 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 71.2 m-85 -90.86 118.36 30.21 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.733 -0.667 . . . . 0.28 110.036 179.066 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 47.6 t -120.69 138.0 52.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.721 -0.672 . . . . 1.23 110.575 -174.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1614 ' ' CYS . . . . . 0.457 ' HA ' ' HB2' ' A' 1646 ' ' CYS . 15.3 t -51.49 114.87 1.36 Allowed 'General case' 0 C--O 1.247 0.929 0 C-N-CA 125.409 1.484 . . . . 0.77 113.088 176.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1615 ' ' ARG . . . . . 0.806 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 18.8 tpt180 -128.22 96.6 30.77 Favored Pre-proline 0 N--CA 1.436 -1.139 0 N-CA-C 109.243 -0.651 . . . . 2.92 109.243 173.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1616 ' ' PRO . . . . . 0.462 ' HD2' ' OE1' ' A' 1617 ' ' GLU . 31.7 Cg_exo -62.43 -37.42 59.98 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 121.909 1.739 . . . . 1.22 111.311 175.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1617 ' ' GLU . . . . . 0.462 ' OE1' ' HD2' ' A' 1616 ' ' PRO . 2.6 mp0 -77.82 44.39 0.46 Allowed 'General case' 0 C--O 1.24 0.571 0 C-N-CA 124.89 1.276 . . . . 3.05 112.059 178.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -37.15 132.63 0.72 Allowed 'General case' 0 C--O 1.244 0.792 0 C-N-CA 125.296 1.438 . . . . 1.55 112.613 178.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1619 ' ' GLY . . . . . 0.448 ' HA3' ' HD2' ' A' 1620 ' ' PRO . . . 172.46 -137.33 4.18 Favored Glycine 0 N--CA 1.423 -2.221 0 N-CA-C 110.195 -1.162 . . . . 1.16 110.195 -177.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1620 ' ' PRO . . . . . 0.448 ' HD2' ' HA3' ' A' 1619 ' ' GLY . 36.3 Cg_endo -63.68 -1.46 3.33 Favored 'Trans proline' 0 CA--C 1.551 1.335 0 C-N-CA 123.269 2.646 . . . . 1.06 114.852 -178.254 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1621 ' ' THR . . . . . 0.643 ' HB ' ' HB2' ' A' 1641 ' ' HIS . 5.2 p -89.96 -11.82 40.55 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 121.807 0.813 . . . . 1.58 109.785 177.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 48.5 t30 -92.66 55.34 2.43 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 122.679 1.228 . . . . 0.88 109.599 -178.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -156.59 139.19 10.55 Favored Pre-proline 0 C--N 1.3 -1.55 0 N-CA-C 106.514 -1.661 . . . . 3.82 106.514 178.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -61.72 113.9 2.03 Favored 'Trans proline' 0 C--O 1.245 0.863 0 C-N-CA 122.881 2.387 . . . . 0.77 112.123 -176.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 75.3 mtm -117.17 140.13 49.91 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 116.508 -0.314 . . . . 1.43 110.603 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1626 ' ' LEU . . . . . 0.631 ' HG ' ' CE2' ' A' 1542 ' ' TYR . 0.3 OUTLIER -87.99 115.18 25.28 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 107.681 -1.229 . . . . 1.43 107.681 -175.463 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 48.8 mm -80.12 -49.46 18.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 CA-C-N 116.249 -0.432 . . . . 1.23 109.839 -178.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 33.1 t -167.78 149.53 5.51 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.545 -0.752 . . . . 1.88 110.134 -175.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1629 ' ' LEU . . . . . 0.583 HD12 ' HG ' ' A' 1636 ' ' LEU . 48.0 tp -112.63 105.59 13.8 Favored 'General case' 0 N--CA 1.418 -2.053 0 N-CA-C 107.116 -1.439 . . . . 1.92 107.116 173.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 30.4 t70 -76.92 114.38 15.63 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.462 -0.895 . . . . 1.09 108.994 178.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1631 ' ' LYS . . . . . 0.409 ' HB3' HD11 ' B' ' 53' ' ' LEU . 98.7 mttt -66.91 -21.1 66.0 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 113.445 0.905 . . . . 3.98 113.445 -174.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -86.32 -35.26 19.98 Favored 'General case' 0 CA--C 1.497 -1.071 0 CA-C-O 121.343 0.592 . . . . 2.6 111.348 -177.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 53.5 p -104.9 -7.03 19.62 Favored 'General case' 0 C--N 1.285 -2.198 0 CA-C-N 115.741 -0.663 . . . . 1.35 112.391 -175.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1634 ' ' CYS . . . . . 0.598 ' SG ' HD21 ' A' 1604 ' ' LEU . 75.0 m 56.38 34.61 24.48 Favored 'General case' 0 C--N 1.363 1.156 0 C-N-CA 124.284 1.033 . . . . 0.53 110.934 -177.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1635 ' ' THR . . . . . . . . . . . . . 88.2 m -99.03 129.26 45.3 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-N 114.193 -1.367 . . . . 1.11 109.979 -177.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1636 ' ' LEU . . . . . 0.583 ' HG ' HD12 ' A' 1629 ' ' LEU . 1.5 mp -108.02 121.33 44.58 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 107.542 -1.281 . . . . 1.56 107.542 -179.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -95.02 131.22 41.22 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 120.685 0.279 . . . . 0.54 110.542 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -126.26 119.34 27.17 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.716 -0.675 . . . . 0.64 109.343 -176.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1639 ' ' SER . . . . . . . . . . . . . 59.7 m -103.15 138.15 40.36 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 115.781 -0.645 . . . . 1.34 109.567 175.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 2.8 t90 -141.85 113.19 7.61 Favored 'General case' 0 N--CA 1.422 -1.84 0 N-CA-C 103.95 -2.611 . . . . 0.8 103.95 178.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1641 ' ' HIS . . . . . 0.806 ' HB3' ' HB2' ' A' 1615 ' ' ARG . 18.1 m-70 -107.08 111.04 23.31 Favored 'General case' 0 C--N 1.286 -2.182 0 C-N-CA 120.067 -0.653 . . . . 1.14 110.402 -174.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1642 ' ' THR . . . . . . . . . . . . . 4.9 t -142.75 150.07 52.36 Favored Pre-proline 0 C--N 1.306 -1.29 0 CA-C-N 115.479 -0.782 . . . . 1.11 109.683 -174.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1643 ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -76.64 -6.39 16.9 Favored 'Trans proline' 0 C--N 1.366 1.483 0 C-N-CA 122.281 1.987 . . . . 0.78 112.316 175.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 8.6 tt -64.45 -30.27 71.31 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.435 0.636 . . . . 1.66 109.445 177.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -94.51 8.03 43.58 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.051 -0.977 . . . . 1.29 109.828 -177.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1646 ' ' CYS . . . . . 0.549 ' O ' ' HD3' ' A' 1648 ' ' PRO . 33.7 t -122.09 158.54 29.03 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 115.532 -0.758 . . . . 1.48 109.496 -173.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1647 ' ' GLU . . . . . 0.402 ' OE2' ' HB2' ' A' 1525 ' ' HIS . 8.6 tp10 -99.85 96.09 4.45 Favored Pre-proline 0 N--CA 1.417 -2.094 0 N-CA-C 106.728 -1.582 . . . . 3.14 106.728 171.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1648 ' ' PRO . . . . . 0.549 ' HD3' ' O ' ' A' 1646 ' ' CYS . 23.2 Cg_exo -67.29 118.02 5.26 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 122.56 2.173 . . . . 2.92 111.804 -179.031 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 32.8 tt0 . . . . . 0 C--N 1.292 -1.893 0 N-CA-C 106.003 -1.851 . . . . 4.72 106.003 176.135 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.142 0 CA-C-O 121.816 0.817 . . . . 10.26 109.992 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -142.38 136.25 29.41 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 107.275 -1.38 . . . . 7.94 107.275 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 20.4 ptp180 -89.01 110.03 35.03 Favored Pre-proline 0 C--N 1.307 -1.254 0 O-C-N 123.126 0.266 . . . . 6.56 110.416 -179.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -66.88 -17.08 51.48 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 121.675 1.584 . . . . 5.51 113.167 178.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 66.9 m 51.69 23.74 2.1 Favored 'General case' 0 C--O 1.25 1.083 0 C-N-CA 125.576 1.55 . . . . 4.91 113.613 177.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 57.78 30.08 18.43 Favored 'General case' 0 C--N 1.349 0.558 0 CA-C-N 114.105 -1.407 . . . . 4.23 110.492 178.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 20.3 p -133.33 131.55 40.26 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 114.821 -1.081 . . . . 3.48 111.313 -179.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . 0.78 ' HB2' ' HG3' ' B' ' 12' ' ' GLU . 4.2 mm? -90.46 115.4 27.59 Favored 'General case' 0 C--O 1.251 1.151 0 N-CA-C 109.31 -0.626 . . . . 4.35 109.31 173.028 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 57.4 m -74.72 85.12 2.14 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.761 0.791 . . . . 2.84 110.998 -176.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.7 -50.66 0.87 Allowed Glycine 0 N--CA 1.421 -2.343 0 N-CA-C 110.576 -1.01 . . . . 2.28 110.576 178.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.22 -62.67 4.48 Favored Glycine 0 N--CA 1.444 -0.806 0 O-C-N 123.98 0.459 . . . . 1.94 112.972 -179.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . 0.78 ' HG3' ' HB2' ' B' ' 8' ' ' LEU . 77.7 mt-10 -69.53 -27.06 64.84 Favored 'General case' 0 CA--C 1.496 -1.108 0 C-N-CA 120.186 -0.606 . . . . 2.55 109.416 177.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . 0.47 ' O ' HD21 ' B' ' 17' ' ' LEU . 0.1 OUTLIER -57.32 -57.89 10.64 Favored 'General case' 0 C--O 1.212 -0.898 0 CA-C-N 115.651 -0.704 . . . . 2.82 109.726 176.319 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . 0.445 ' HB ' ' HZ ' ' B' ' 28' ' ' PHE . 13.7 p -66.07 -34.09 67.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.981 -0.288 . . . . 2.5 111.148 -178.191 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 15' ' ' ASP . . . . . 0.585 ' OD1' ' HB3' ' A' 1569 ' ' GLN . 29.3 t70 -71.22 -40.84 70.85 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 113.658 0.984 . . . . 2.04 113.658 -177.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 21.6 p -66.8 -40.92 88.28 Favored 'General case' 0 C--O 1.262 1.739 0 CA-C-O 121.644 0.735 . . . . 2.31 109.917 176.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.48 ' HG ' ' CD2' ' B' ' 28' ' ' PHE . 4.1 mm? -52.95 -50.12 64.69 Favored 'General case' 0 C--O 1.213 -0.824 0 CA-C-N 114.896 -1.047 . . . . 2.27 110.598 170.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -67.09 -25.68 66.34 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 123.841 0.857 . . . . 2.39 111.777 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -58.59 -55.27 37.25 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.982 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 14.7 p -99.08 -22.19 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.07 0 C-N-CA 118.105 -1.438 . . . . 1.83 112.819 178.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 21' ' ' CYS . . . . . 0.473 ' HB2' ' HB3' ' B' ' 26' ' ' PHE . 57.9 m -103.36 24.89 10.29 Favored 'General case' 0 C--N 1.315 -0.914 0 O-C-N 121.555 -0.716 . . . . 1.66 110.881 -178.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.69 -67.79 2.01 Favored Glycine 0 N--CA 1.461 0.345 0 C-N-CA 121.424 -0.417 . . . . 1.53 113.414 -177.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . 0.784 ' HB3' ' HG3' ' A' 1544 ' ' LYS . 8.8 p-10 -76.88 -4.16 42.3 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 122.826 0.45 . . . . 2.72 111.646 179.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . 0.491 ' HG2' ' O ' ' B' ' 61' ' ' ALA . 21.1 tpp180 -97.48 -42.71 7.58 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 116.02 -0.536 . . . . 5.02 111.745 -175.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 112.73 121.76 3.9 Favored Glycine 0 N--CA 1.426 -2.028 0 N-CA-C 108.998 -1.641 . . . . 1.63 108.998 -174.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . 0.572 ' HA ' ' SG ' ' B' ' 60' ' ' CYS . 13.4 p90 -98.12 144.94 27.07 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 117.422 0.611 . . . . 1.71 111.318 -179.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 27' ' ' TYR . . . . . 0.473 ' CE2' ' HB2' ' B' ' 61' ' ' ALA . 19.4 m-85 -125.64 105.05 8.72 Favored 'General case' 0 C--O 1.218 -0.581 0 N-CA-C 113.003 0.742 . . . . 3.67 113.003 -175.236 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 28' ' ' PHE . . . . . 0.48 ' CD2' ' HG ' ' B' ' 17' ' ' LEU . 53.8 p90 -150.67 23.6 0.79 Allowed 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 121.471 0.653 . . . . 2.44 109.84 162.512 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 27.5 m -139.89 105.81 5.19 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 108.874 -0.787 . . . . 3.85 108.874 -177.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 -123.22 159.33 54.98 Favored Pre-proline 0 C--N 1.296 -1.761 0 N-CA-C 108.111 -1.07 . . . . 4.27 108.111 -176.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -82.21 9.77 3.84 Favored 'Trans proline' 0 C--O 1.252 1.222 0 C-N-CA 122.765 2.31 . . . . 4.2 111.177 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . 76.67 152.77 0.13 Allowed 'General case' 0 N--CA 1.422 -1.859 0 C-N-CA 126.968 2.107 . . . . 5.12 109.89 179.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 29.9 m -150.16 175.09 12.07 Favored 'General case' 1 N--CA 1.356 -5.128 0 N-CA-C 102.811 -3.033 . . . . 6.93 102.811 -176.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -81.3 -27.03 35.23 Favored 'General case' 0 C--N 1.26 -3.31 0 CA-C-N 120.303 1.411 . . . . 12.14 107.795 -178.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 21.3 t -93.35 6.29 6.54 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-O 122.304 1.05 . . . . 9.9 108.656 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 34.0 t -156.04 69.34 0.65 Allowed 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 106.937 -1.505 . . . . 6.82 106.937 -177.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -56.68 -41.85 78.02 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 114.038 -1.437 . . . . 10.71 111.262 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 -60.44 109.5 1.02 Allowed 'General case' 0 N--CA 1.431 -1.398 0 O-C-N 124.085 0.865 . . . . 8.6 110.576 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 14.9 m -71.3 -35.65 71.36 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 107.817 -1.179 . . . . 5.79 107.817 176.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 -123.44 130.6 52.94 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 106.918 -1.512 . . . . 6.57 106.918 170.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . 0.428 ' O ' ' HB2' ' B' ' 28' ' ' PHE . . . -114.67 164.69 12.06 Favored Glycine 0 N--CA 1.413 -2.882 0 N-CA-C 109.685 -1.366 . . . . 2.62 109.685 -176.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . 0.262 23.0 pt 59.8 -27.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 C-N-CA 127.849 2.46 . . . . 2.28 115.583 178.136 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . 0.474 ' O ' ' HB2' ' B' ' 47' ' ' CYS . 2.5 p -53.98 -41.29 48.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 C-N-CA 124.566 1.146 . . . . 2.6 112.738 177.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -95.47 -25.84 16.07 Favored 'General case' 0 N--CA 1.419 -1.997 0 N-CA-C 109.048 -0.723 . . . . 3.36 109.048 -173.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 22.0 tp10 -61.11 -56.66 18.34 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 114.651 -1.159 . . . . 3.08 108.441 176.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 46' ' ' CYS . . . . . . . . . . . . . 56.5 m -84.83 2.59 41.73 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.069 -0.514 . . . . 2.23 111.945 -177.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 47' ' ' CYS . . . . . 0.474 ' HB2' ' O ' ' B' ' 43' ' ' VAL . 49.7 t -78.89 -48.0 15.45 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 120.257 -0.577 . . . . 2.48 109.537 176.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -101.66 -2.27 30.75 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.053 -0.521 . . . . 2.97 111.81 -176.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 21.0 mmt180 -132.56 162.89 30.12 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.896 -1.15 . . . . 4.65 107.896 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 1.9 p -102.4 127.66 49.33 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 108.371 -0.974 . . . . 2.86 108.371 176.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 85.2 m -106.81 171.35 7.41 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.568 0.699 . . . . 2.11 112.257 -172.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -126.35 158.33 36.15 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 105.839 -1.911 . . . . 2.67 105.839 173.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . 0.853 ' HB3' ' HA ' ' A' 1600 ' ' SER . 2.6 pt? -60.71 -21.19 62.64 Favored 'General case' 0 CA--C 1.501 -0.936 0 N-CA-C 114.693 1.368 . . . . 2.36 114.693 -167.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.31 -29.46 65.91 Favored 'General case' 0 CA--C 1.514 -0.415 0 O-C-N 123.509 0.505 . . . . 1.92 111.282 -176.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 64.9 tp -65.06 -54.82 24.18 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 115.636 -0.711 . . . . 2.35 110.16 178.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 1.3 pp -76.04 -32.69 59.46 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 116.588 -0.278 . . . . 2.01 111.483 -175.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -55.51 -49.01 73.73 Favored 'General case' 0 C--N 1.318 -0.803 0 O-C-N 123.83 0.706 . . . . 2.27 110.553 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 10.9 t -86.78 -17.41 33.58 Favored 'General case' 0 CA--C 1.567 1.607 0 N-CA-C 112.405 0.52 . . . . 2.67 112.405 -177.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -86.67 -37.52 17.92 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.52 -0.737 . . . . 3.2 109.961 -178.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 60' ' ' CYS . . . . . 0.572 ' SG ' ' HA ' ' B' ' 26' ' ' PHE . 6.6 t -82.35 171.2 14.47 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.466 -0.788 . . . . 2.3 111.461 -178.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 61' ' ' ALA . . . . . 0.872 ' HA ' ' HD2' ' B' ' 65' ' ' LYS . . . -85.05 113.77 21.71 Favored 'General case' 0 N--CA 1.422 -1.831 0 N-CA-C 106.906 -1.516 . . . . 3.19 106.906 175.031 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 62' ' ' THR . . . . . 0.662 ' H ' ' HB2' ' B' ' 65' ' ' LYS . 2.9 p -125.07 159.98 56.7 Favored Pre-proline 0 C--N 1.279 -2.478 0 CA-C-O 118.639 -0.696 . . . . 4.14 110.086 -176.427 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -45.71 -44.52 17.69 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 122.613 2.208 . . . . 5.59 113.464 178.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -107.17 42.8 1.25 Allowed 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 116.005 -0.543 . . . . 5.51 110.718 178.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . 0.872 ' HD2' ' HA ' ' B' ' 61' ' ' ALA . 48.8 tttm -64.92 140.49 58.87 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.689 -0.687 . . . . 8.8 111.036 179.089 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 66' ' ' SER . . . . . 0.413 ' O ' ' HG2' ' B' ' 65' ' ' LYS . 46.9 m -90.26 171.97 9.11 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 109.208 -0.664 . . . . 8.12 109.208 176.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.297 -1.688 0 N-CA-C 106.304 -1.739 . . . . 10.21 106.304 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 26.7 ptt? . . . . . 0 N--CA 1.47 0.526 0 CA-C-O 120.462 0.172 . . . . 9.74 110.808 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 51.1 tptt -142.56 83.83 1.83 Allowed 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 108.695 -0.854 . . . . 9.32 108.695 -174.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 30.6 t -142.02 37.21 1.58 Allowed 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 105.98 -1.859 . . . . 5.97 105.98 -177.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1511 ' ' ASN . . . . . . . . . . . . . 16.3 m120 -98.99 1.51 45.52 Favored 'General case' 0 C--N 1.284 -2.251 0 CA-C-N 113.506 -1.679 . . . . 3.48 112.531 -172.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1512 ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -81.08 -57.23 3.62 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 108.159 -1.052 . . . . 5.95 108.159 176.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 6.3 p-80 -164.39 130.2 2.9 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-O 121.122 0.487 . . . . 6.14 111.707 177.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 12.9 t70 -97.11 -137.28 0.26 Allowed 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 103.829 -2.656 . . . . 5.06 103.829 171.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 34.3 t70 -70.62 -74.15 0.15 Allowed 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 119.779 1.172 . . . . 2.9 108.893 173.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 12.6 t -150.89 61.38 0.92 Allowed 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 106.431 -1.692 . . . . 1.41 106.431 172.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 26.1 pt20 -165.13 162.92 20.43 Favored 'General case' 0 N--CA 1.419 -1.998 0 N-CA-C 106.485 -1.672 . . . . 2.18 106.485 -175.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1518 ' ' VAL . . . . . 0.559 HG22 ' HB2' ' A' 1583 ' ' TYR . 0.0 OUTLIER -154.59 146.05 13.61 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 O-C-N 123.896 0.747 . . . . 1.52 110.449 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A 1519 ' ' THR . . . . . . . . . . . . . 49.9 m -98.09 137.69 36.51 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 115.965 -0.561 . . . . 1.36 109.561 176.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1520 ' ' ASN . . . . . 0.498 ' ND2' ' OH ' ' A' 1583 ' ' TYR . 21.2 t-20 -79.31 117.27 66.09 Favored Pre-proline 0 N--CA 1.43 -1.46 0 N-CA-C 108.6 -0.889 . . . . 2.02 108.6 174.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -69.56 -10.79 29.62 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 122.687 2.258 . . . . 1.82 113.586 -176.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 19.7 m -82.47 -44.22 16.27 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 120.77 0.319 . . . . 1.89 111.809 -178.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1523 ' ' THR . . . . . . . . . . . . . 9.0 t -122.16 -3.23 9.03 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 119.459 -0.896 . . . . 1.99 112.24 -177.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 80.46 16.34 76.15 Favored Glycine 0 C--O 1.238 0.344 0 C-N-CA 120.691 -0.766 . . . . 1.19 112.708 175.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 81.1 t60 -80.69 125.3 29.87 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 120.832 0.348 . . . . 1.82 110.546 -178.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 1.2 tm? -90.38 108.39 19.75 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 114.921 -1.036 . . . . 1.3 108.981 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -87.9 111.32 21.31 Favored 'General case' 0 CA--C 1.499 -0.981 0 N-CA-C 107.981 -1.118 . . . . 0.8 107.981 177.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -101.71 134.72 44.42 Favored 'General case' 0 N--CA 1.404 -2.737 0 N-CA-C 107.123 -1.436 . . . . 1.17 107.123 174.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 3.4 mm? -100.94 5.15 43.12 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-O 122.017 0.913 . . . . 1.29 108.687 177.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 4.0 m -64.82 -32.91 74.82 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.102 -1.408 . . . . 0.91 109.75 178.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1531 ' ' SER . . . . . 0.578 ' HB2' HD13 ' A' 1644 ' ' LEU . 46.0 m -66.28 -25.74 67.01 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.952 -0.567 . . . . 1.98 111.238 177.162 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 90.1 mt -97.11 -1.11 45.9 Favored 'General case' 0 C--O 1.215 -0.72 0 CA-C-O 121.194 0.521 . . . . 1.34 110.463 176.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1533 ' ' SER . . . . . . . . . . . . . 46.8 t -85.25 175.03 9.18 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.329 0.585 . . . . 1.93 110.145 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . 170.33 169.15 33.12 Favored Glycine 0 C--N 1.299 -1.512 0 N-CA-C 109.019 -1.633 . . . . 1.1 109.019 -179.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -92.5 -35.38 13.65 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 117.239 0.519 . . . . 5.21 110.518 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1536 ' ' ALA . . . . . 0.636 ' HA ' ' HG2' ' A' 1557 ' ' GLU . . . -77.35 -35.43 54.65 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 121.376 0.608 . . . . 1.94 109.919 -179.018 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 91.59 -149.98 20.1 Favored Glycine 0 N--CA 1.42 -2.399 0 CA-C-N 115.274 -0.876 . . . . 1.08 111.78 176.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -137.41 149.32 46.84 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.654 -0.869 . . . . 1.07 108.654 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1539 ' ' THR . . . . . 0.45 ' HA ' ' O ' ' A' 1548 ' ' VAL . 4.0 m -125.08 122.11 36.26 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 109.326 -0.62 . . . . 1.46 109.326 -177.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1540 ' ' ALA . . . . . 0.499 ' HB2' ' CG1' ' A' 1548 ' ' VAL . . . -115.38 150.18 36.77 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 108.113 -1.069 . . . . 1.19 108.113 -178.428 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -93.35 138.78 31.36 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 121.108 0.48 . . . . 1.37 111.179 -176.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1542 ' ' TYR . . . . . 0.838 ' HE1' ' HG ' ' A' 1626 ' ' LEU . 1.5 t80 -121.77 -101.33 0.41 Allowed 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 107.625 -1.25 . . . . 1.38 107.625 -179.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1543 ' ' SER . . . . . 0.469 ' H ' ' HB3' ' A' 1542 ' ' TYR . 32.8 t -66.8 159.75 27.39 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 107.304 -1.369 . . . . 1.98 107.304 172.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1544 ' ' LYS . . . . . 0.421 ' HZ2' ' CG ' ' B' ' 23' ' ' ASP . 62.7 mttp -59.38 -37.05 76.93 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-N 119.921 1.237 . . . . 3.96 113.619 -175.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 14.7 t -100.83 15.19 29.25 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 110.104 -0.332 . . . . 2.81 110.104 178.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1546 ' ' GLY . . . . . 0.432 ' HA2' ' OE1' ' A' 1569 ' ' GLN . . . -130.42 147.95 18.44 Favored Glycine 0 CA--C 1.54 1.633 0 C-N-CA 120.03 -1.081 . . . . 1.68 114.092 -174.074 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 22.6 m -136.67 176.94 6.85 Favored 'Isoleucine or valine' 0 C--O 1.252 1.235 0 CA-C-N 117.488 0.644 . . . . 1.38 110.573 -178.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1548 ' ' VAL . . . . . 0.846 ' HB ' ' CE1' ' A' 1567 ' ' PHE . 7.3 p -127.1 136.63 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 CA-C-N 115.034 -0.985 . . . . 1.24 109.913 175.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1549 ' ' TYR . . . . . 0.581 ' HB2' ' HB3' ' A' 1566 ' ' CYS . 62.0 m-85 -101.63 116.04 31.87 Favored 'General case' 0 C--N 1.293 -1.854 0 C-N-CA 124.812 1.245 . . . . 1.29 108.186 177.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 8.6 ptp -125.43 146.39 49.64 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 120.189 -0.604 . . . . 1.47 110.455 175.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 8.2 p -129.46 119.79 24.36 Favored 'General case' 0 C--N 1.281 -2.398 0 CA-C-N 115.763 -0.653 . . . . 1.4 109.579 174.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1552 ' ' ILE . . . . . . . . . . . . . 38.7 mm -81.5 116.97 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.668 0 C-N-CA 120.84 -0.344 . . . . 1.11 110.238 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 64.3 m 69.84 26.94 4.66 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.108 0.963 . . . . 1.4 111.649 175.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . -172.3 -167.67 32.67 Favored Glycine 0 CA--C 1.482 -2.004 0 C-N-CA 120.098 -1.048 . . . . 0.4 111.233 -177.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -107.94 135.79 48.73 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-O 121.165 0.507 . . . . 1.62 111.374 -178.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -78.93 129.2 34.24 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.632 -0.713 . . . . 1.12 109.37 -174.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1557 ' ' GLU . . . . . 0.636 ' HG2' ' HA ' ' A' 1536 ' ' ALA . 5.3 pt-20 -73.33 -12.73 60.93 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.633 0.975 . . . . 2.49 113.633 -174.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 9.7 m120 -89.19 -2.74 58.63 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 120.48 -0.488 . . . . 1.38 110.373 -173.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1559 ' ' CYS . . . . . 0.604 ' SG ' ' HD2' ' A' 1560 ' ' PRO . 34.2 t -135.81 155.82 77.73 Favored Pre-proline 0 C--N 1.308 -1.196 0 N-CA-C 108.255 -1.017 . . . . 1.21 108.255 -175.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1560 ' ' PRO . . . . . 0.604 ' HD2' ' SG ' ' A' 1559 ' ' CYS . 69.1 Cg_exo -29.06 132.83 0.04 OUTLIER 'Trans proline' 0 C--N 1.379 2.134 1 C-N-CA 125.7 4.267 . . . . 0.98 114.73 176.175 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A 1561 ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' 1560 ' ' PRO . 9.6 Cg_endo -48.77 127.62 17.0 Favored 'Trans proline' 0 CA--C 1.547 1.147 0 C-N-CA 124.443 3.428 . . . . 1.15 114.306 -178.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 101.05 1.05 54.79 Favored Glycine 0 CA--C 1.525 0.672 0 CA-C-N 115.589 -0.732 . . . . 0.55 114.78 176.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1563 ' ' VAL . . . . . 0.466 HG11 ' SG ' ' A' 1559 ' ' CYS . 7.7 p -102.26 137.73 29.13 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 C-N-CA 119.626 -0.83 . . . . 1.53 111.18 -175.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -100.05 -31.86 5.79 Favored Glycine 0 CA--C 1.521 0.417 0 CA-C-N 115.526 -0.761 . . . . 0.29 112.681 -178.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -127.53 128.61 45.93 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 108.473 -0.936 . . . . 1.08 108.473 178.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1566 ' ' CYS . . . . . 0.581 ' HB3' ' HB2' ' A' 1549 ' ' TYR . 45.2 t -145.76 124.88 12.86 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 110.376 -0.231 . . . . 0.43 110.376 -176.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1567 ' ' PHE . . . . . 0.846 ' CE1' ' HB ' ' A' 1548 ' ' VAL . 9.7 m-85 -110.51 160.36 16.69 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 122.597 0.359 . . . . 1.3 110.296 175.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . 100.19 156.01 27.92 Favored Glycine 1 N--CA 1.394 -4.159 0 C-N-CA 119.353 -1.403 . . . . 1.43 112.026 171.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1569 ' ' GLN . . . . . 0.432 ' OE1' ' HA2' ' A' 1546 ' ' GLY . 2.3 mp0 -84.92 -23.5 28.83 Favored 'General case' 0 C--N 1.284 -2.272 0 N-CA-C 107.571 -1.27 . . . . 3.09 107.571 179.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 24.3 p -82.65 -11.7 58.18 Favored 'General case' 0 N--CA 1.423 -1.781 0 CA-C-N 115.353 -0.839 . . . . 2.52 111.68 176.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1571 ' ' ARG . . . . . 0.445 ' HB3' ' SG ' ' A' 1559 ' ' CYS . 4.8 mpt_? 73.76 75.21 0.13 Allowed 'General case' 0 CA--C 1.506 -0.726 0 C-N-CA 124.311 1.044 . . . . 3.19 111.251 178.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 61.5 mt -98.46 121.65 49.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 CA-C-N 114.074 -1.421 . . . . 1.51 109.505 -177.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1573 ' ' SER . . . . . 0.445 ' HB3' ' HB3' ' A' 1596 ' ' SER . 17.7 t -65.55 124.79 23.27 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.532 -0.758 . . . . 0.96 110.866 -178.468 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1574 ' ' VAL . . . . . 0.548 HG21 ' HD2' ' A' 1567 ' ' PHE . 32.8 m -126.48 20.21 3.51 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-O 121.866 0.841 . . . . 1.6 110.746 178.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 164.23 113.54 0.29 Allowed Glycine 0 N--CA 1.425 -2.034 0 CA-C-N 114.607 -1.179 . . . . 0.34 111.779 177.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 56.7 tttp -72.27 136.12 46.21 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 107.721 -1.214 . . . . 2.68 107.721 178.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -69.04 141.42 54.83 Favored 'General case' 0 C--N 1.314 -0.975 0 O-C-N 123.486 0.491 . . . . 1.08 111.59 -175.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 9.4 p30 -161.32 175.74 11.93 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 105.138 -2.171 . . . . 1.95 105.138 176.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 7.2 ptpp? -132.54 42.88 3.05 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 119.001 0.818 . . . . 3.11 110.951 -173.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 47.2 ttt180 -85.34 76.77 10.08 Favored 'General case' 0 N--CA 1.427 -1.6 0 N-CA-C 108.495 -0.928 . . . . 4.04 108.495 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1581 ' ' LEU . . . . . 0.557 HD13 ' CG2' ' A' 1518 ' ' VAL . 0.4 OUTLIER -70.15 121.36 17.38 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 114.846 -1.07 . . . . 1.32 108.541 179.446 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 58.2 mtp180 -116.03 120.68 39.89 Favored 'General case' 0 C--N 1.287 -2.13 0 C-N-CA 120.611 -0.436 . . . . 3.4 111.31 177.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1583 ' ' TYR . . . . . 0.559 ' HB2' HG22 ' A' 1518 ' ' VAL . 62.1 t80 -94.0 109.43 21.17 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 109.412 -0.588 . . . . 1.26 109.412 175.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1584 ' ' VAL . . . . . 0.528 ' O ' ' HB ' ' A' 1587 ' ' VAL . 11.9 m -128.22 89.57 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-O 121.518 0.675 . . . . 1.71 111.968 -179.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 34.6 t70 53.1 71.54 0.48 Allowed 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 124.359 1.063 . . . . 1.17 112.942 174.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 9.2 pt20 67.74 12.81 9.02 Favored 'General case' 0 N--CA 1.508 2.465 0 C-N-CA 127.46 2.304 . . . . 2.43 111.319 178.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1587 ' ' VAL . . . . . 0.528 ' HB ' ' O ' ' A' 1584 ' ' VAL . 39.5 t -116.86 120.66 65.71 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.152 0 CA-C-N 114.55 -1.204 . . . . 1.16 109.51 177.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1588 ' ' LEU . . . . . 0.863 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 1.8 mm? -100.46 107.81 19.63 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 105.122 -2.177 . . . . 1.11 105.122 176.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -112.89 134.74 54.27 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 112.875 0.694 . . . . 1.74 112.875 -172.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 18.6 mt -124.75 112.49 16.79 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 114.103 -1.408 . . . . 1.4 108.193 175.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 7.0 p -101.58 127.39 54.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-O 121.268 0.556 . . . . 1.7 109.61 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1592 ' ' TYR . . . . . . . . . . . . . 13.4 m-30 -114.46 101.37 9.08 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 109.467 -0.568 . . . . 1.08 109.467 -177.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 15.4 pttp -109.29 -178.16 3.49 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 114.661 -1.154 . . . . 2.21 108.138 -175.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 8.2 m-20 63.82 44.78 4.72 Favored 'General case' 0 C--N 1.319 -0.752 0 O-C-N 124.128 0.892 . . . . 1.11 110.765 179.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -79.44 -166.34 32.05 Favored Glycine 0 N--CA 1.437 -1.236 0 CA-C-N 115.0 -1.0 . . . . 0.78 110.917 176.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1596 ' ' SER . . . . . 0.647 ' HB2' ' HD2' ' A' 1597 ' ' PRO . 79.1 p -86.68 167.53 22.15 Favored Pre-proline 0 C--N 1.297 -1.679 0 C-N-CA 120.209 -0.596 . . . . 1.36 109.842 -177.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1597 ' ' PRO . . . . . 0.781 ' HG3' ' HB3' ' B' ' 6' ' ' GLU . 12.2 Cg_endo -56.05 120.4 8.21 Favored 'Trans proline' 0 C--N 1.364 1.349 0 C-N-CA 122.592 2.195 . . . . 1.4 111.048 178.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1598 ' ' CYS . . . . . 0.46 ' HA ' ' HD3' ' A' 1599 ' ' PRO . 44.1 t -83.98 123.97 75.09 Favored Pre-proline 0 C--N 1.286 -2.195 0 CA-C-N 114.369 -1.287 . . . . 0.75 110.12 -177.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1599 ' ' PRO . . . . . 0.487 ' HD2' ' OH ' ' A' 1606 ' ' TYR . 3.1 Cg_exo -80.01 2.7 8.22 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 123.551 2.834 . . . . 1.7 112.679 178.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1600 ' ' SER . . . . . 0.422 ' HB2' ' SG ' ' A' 1634 ' ' CYS . 14.8 m -77.54 -55.98 4.91 Favored 'General case' 0 N--CA 1.42 -1.971 0 N-CA-C 108.465 -0.939 . . . . 2.8 108.465 173.155 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1601 ' ' LYS . . . . . 0.565 ' HE3' HD11 ' A' 1604 ' ' LEU . 16.9 ttpp -119.58 117.18 27.67 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 105.836 -1.913 . . . . 3.45 105.836 173.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 12.9 p -63.14 116.35 5.32 Favored 'General case' 0 N--CA 1.422 -1.868 0 N-CA-C 113.189 0.811 . . . . 2.44 113.189 -170.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 105.47 -6.24 41.73 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 121.313 -0.47 . . . . 1.2 112.229 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1604 ' ' LEU . . . . . 0.587 HD23 ' SG ' ' A' 1634 ' ' CYS . 10.9 tp -91.52 170.45 9.93 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.399 -0.963 . . . . 2.38 108.399 -178.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 15.1 m -126.45 149.75 49.1 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 108.446 -0.946 . . . . 1.96 108.446 -179.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1606 ' ' TYR . . . . . 0.534 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 63.8 m-85 -71.0 158.1 37.09 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 122.679 0.391 . . . . 1.06 111.682 177.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -156.49 125.45 5.98 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 109.346 -0.613 . . . . 2.0 109.346 178.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1608 ' ' SER . . . . . . . . . . . . . 30.4 m -107.93 132.68 53.22 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-N 115.995 -0.548 . . . . 1.61 109.808 -178.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 31.6 t -111.6 108.17 24.8 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 109.261 -0.644 . . . . 1.09 109.261 178.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 75.6 mt -96.31 113.86 31.72 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 N-CA-C 108.917 -0.771 . . . . 1.2 108.917 -178.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 48.9 m -116.02 119.88 37.3 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 115.942 -0.572 . . . . 1.89 111.749 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1612 ' ' PHE . . . . . 0.863 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 74.6 m-85 -98.26 122.16 41.08 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.961 -1.126 . . . . 0.28 107.961 175.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 45.5 t -117.95 137.42 51.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 109.588 -0.523 . . . . 1.23 109.588 -176.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 3.5 t -52.99 112.4 0.85 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.131 0.894 . . . . 0.77 112.275 176.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1615 ' ' ARG . . . . . 0.709 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 27.9 tpt180 -133.13 93.4 22.74 Favored Pre-proline 0 C--N 1.325 -0.468 0 N-CA-C 110.224 -0.287 . . . . 2.92 110.224 174.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1616 ' ' PRO . . . . . 0.569 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 13.1 Cg_exo -70.53 -24.16 26.47 Favored 'Trans proline' 0 CA--C 1.545 1.052 0 C-N-CA 122.063 1.842 . . . . 1.22 112.428 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -85.25 43.49 1.02 Allowed 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 125.151 1.38 . . . . 3.05 110.954 179.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -33.34 117.48 0.29 Allowed 'General case' 0 C--O 1.241 0.638 0 C-N-CA 126.293 1.837 . . . . 1.55 113.2 178.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . -155.79 -135.21 1.96 Allowed Glycine 0 N--CA 1.433 -1.558 0 N-CA-C 109.078 -1.609 . . . . 1.16 109.078 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -81.86 21.09 0.98 Allowed 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.285 1.99 . . . . 1.06 112.523 -179.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1621 ' ' THR . . . . . 0.752 ' HB ' ' HB2' ' A' 1641 ' ' HIS . 46.7 p -99.17 -15.99 18.74 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 114.917 -1.038 . . . . 1.58 109.528 178.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 52.1 t30 -89.89 56.34 3.45 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 122.389 1.09 . . . . 0.88 109.369 -173.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 18.6 ptp180 -157.25 139.54 10.4 Favored Pre-proline 0 N--CA 1.427 -1.595 0 CA-C-N 114.665 -1.152 . . . . 3.82 108.248 -177.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.71 97.16 0.26 Allowed 'Trans proline' 0 C--O 1.238 0.506 0 C-N-CA 122.873 2.382 . . . . 0.77 111.687 -178.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 76.8 mtm -97.44 136.88 37.25 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 116.105 -0.498 . . . . 1.43 110.274 -178.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1626 ' ' LEU . . . . . 0.838 ' HG ' ' HE1' ' A' 1542 ' ' TYR . 0.4 OUTLIER -88.16 112.63 22.94 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 107.397 -1.335 . . . . 1.43 107.397 -179.44 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A 1627 ' ' ILE . . . . . 0.813 HD13 ' HB2' ' A' 1639 ' ' SER . 3.3 mm -72.82 -57.45 7.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 C-N-CA 123.651 0.78 . . . . 1.23 109.908 -177.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 30.6 t -163.42 151.38 13.3 Favored 'General case' 0 N--CA 1.415 -2.18 0 CA-C-N 114.657 -1.156 . . . . 1.88 107.936 -172.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1629 ' ' LEU . . . . . 0.839 HD12 ' HG ' ' A' 1636 ' ' LEU . 35.2 tp -122.44 95.62 4.71 Favored 'General case' 0 N--CA 1.419 -2.022 0 N-CA-C 107.225 -1.398 . . . . 1.92 107.225 178.017 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 15.8 t70 -75.54 97.44 3.73 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.461 -1.311 . . . . 1.09 107.461 177.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 62.0 mttp -66.83 -22.09 66.01 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 112.857 0.688 . . . . 3.98 112.857 -176.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -72.61 -36.11 68.0 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.556 0.694 . . . . 2.6 109.699 -178.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 69.6 p -102.72 -4.77 24.55 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.682 -0.69 . . . . 1.35 110.821 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1634 ' ' CYS . . . . . 0.587 ' SG ' HD23 ' A' 1604 ' ' LEU . 74.9 m 55.34 37.16 28.49 Favored 'General case' 0 C--N 1.356 0.853 0 C-N-CA 125.231 1.413 . . . . 0.53 111.811 -178.45 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1635 ' ' THR . . . . . . . . . . . . . 40.0 m -106.43 129.28 54.44 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 115.151 -0.931 . . . . 1.11 109.555 -178.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1636 ' ' LEU . . . . . 0.839 ' HG ' HD12 ' A' 1629 ' ' LEU . 0.3 OUTLIER -111.39 135.88 51.32 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 107.287 -1.375 . . . . 1.56 107.287 -177.663 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -112.19 131.31 55.55 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 120.798 -0.361 . . . . 0.54 111.2 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1638 ' ' PHE . . . . . 0.488 ' CE1' HD21 ' A' 1626 ' ' LEU . 98.4 m-85 -123.23 130.89 53.36 Favored 'General case' 0 C--O 1.243 0.726 0 N-CA-C 108.241 -1.022 . . . . 0.64 108.241 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1639 ' ' SER . . . . . 0.813 ' HB2' HD13 ' A' 1627 ' ' ILE . 11.7 t -115.9 148.47 39.97 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 107.645 -1.243 . . . . 1.34 107.645 178.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 3.2 t90 -152.36 107.82 3.3 Favored 'General case' 0 N--CA 1.414 -2.251 0 N-CA-C 104.984 -2.228 . . . . 0.8 104.984 -179.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1641 ' ' HIS . . . . . 0.752 ' HB2' ' HB ' ' A' 1621 ' ' THR . 17.4 m-70 -102.87 107.93 18.95 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 109.358 -0.608 . . . . 1.14 109.358 -177.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1642 ' ' THR . . . . . . . . . . . . . 7.9 t -140.74 148.06 51.24 Favored Pre-proline 0 C--N 1.301 -1.521 0 CA-C-N 115.049 -0.978 . . . . 1.11 109.731 -171.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1643 ' ' PRO . . . . . 0.569 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 56.9 Cg_endo -80.4 -11.17 13.23 Favored 'Trans proline' 0 C--N 1.365 1.423 0 C-N-CA 122.314 2.009 . . . . 0.78 112.365 178.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1644 ' ' LEU . . . . . 0.578 HD13 ' HB2' ' A' 1531 ' ' SER . 7.4 tt -67.08 -25.82 66.42 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 108.407 -0.96 . . . . 1.66 108.407 176.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -103.09 23.36 12.46 Favored 'General case' 0 N--CA 1.424 -1.746 0 CA-C-N 114.833 -1.076 . . . . 1.29 109.735 -175.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 37.9 t -122.08 146.8 46.85 Favored 'General case' 0 N--CA 1.423 -1.797 0 CA-C-N 115.203 -0.908 . . . . 1.48 109.588 -179.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1647 ' ' GLU . . . . . 0.476 ' OE2' ' OH ' ' A' 1583 ' ' TYR . 0.1 OUTLIER -100.56 123.86 44.6 Favored Pre-proline 0 C--N 1.295 -1.8 0 N-CA-C 108.25 -1.019 . . . . 3.14 108.25 176.198 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A 1648 ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -71.04 148.94 57.9 Favored 'Trans proline' 0 C--O 1.248 1.016 0 C-N-CA 122.855 2.37 . . . . 2.92 114.016 -173.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 7.6 tp10 . . . . . 0 N--CA 1.427 -1.624 0 N-CA-C 107.237 -1.394 . . . . 4.72 107.237 177.12 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.494 0 N-CA-C 109.023 -0.732 . . . . 10.26 109.023 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -121.94 120.21 33.79 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.993 -0.743 . . . . 7.94 108.993 -178.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 26.8 ptt180 -84.92 128.48 60.33 Favored Pre-proline 0 C--N 1.297 -1.711 0 CA-C-N 115.44 -0.8 . . . . 6.56 109.546 178.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -85.42 22.51 0.94 Allowed 'Trans proline' 0 C--O 1.239 0.55 0 C-N-CA 123.196 2.597 . . . . 5.51 111.051 178.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 7.9 t -148.77 110.98 4.64 Favored 'General case' 0 N--CA 1.409 -2.498 0 N-CA-C 106.36 -1.718 . . . . 4.91 106.36 -177.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . 0.781 ' HB3' ' HG3' ' A' 1597 ' ' PRO . 6.7 mm-40 -79.97 -35.99 36.74 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.617 0.722 . . . . 4.23 110.53 -177.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 10.1 p -105.21 142.55 34.78 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 106.205 -1.776 . . . . 3.48 106.205 172.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 49.4 mt -125.58 143.4 51.03 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.977 -0.689 . . . . 4.35 110.318 -173.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 9' ' ' CYS . . . . . 0.464 ' HB3' ' HB2' ' B' ' 47' ' ' CYS . 6.0 p -88.76 135.98 33.24 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-O 120.78 0.324 . . . . 2.84 110.192 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.59 -121.82 4.51 Favored Glycine 0 N--CA 1.424 -2.154 0 N-CA-C 110.023 -1.231 . . . . 2.28 110.023 -179.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . 0.446 ' HA2' HG12 ' B' ' 14' ' ' VAL . . . -60.32 -45.17 96.64 Favored Glycine 0 C--O 1.201 -1.934 0 O-C-N 124.06 0.506 . . . . 1.94 113.01 -177.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 44.4 mp0 -61.38 -39.17 89.67 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.781 0.8 . . . . 2.55 111.154 -179.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . 0.413 HD21 ' HB3' ' B' ' 46' ' ' CYS . 0.1 OUTLIER -71.26 -40.9 70.7 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.03 -0.986 . . . . 2.82 110.141 -178.818 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . 0.446 HG12 ' HA2' ' B' ' 11' ' ' GLY . 5.1 p -76.83 -32.05 19.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 C-N-CA 120.019 -0.672 . . . . 2.5 110.485 -178.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -68.6 -36.08 78.2 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 116.175 -0.466 . . . . 2.04 111.832 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 11.7 p -69.99 -40.29 75.42 Favored 'General case' 0 C--O 1.262 1.75 0 O-C-N 121.899 -0.501 . . . . 2.31 110.149 177.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.481 ' HB3' ' HB3' ' B' ' 26' ' ' PHE . 3.7 mm? -54.66 -49.88 69.55 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 115.546 -0.752 . . . . 2.27 111.052 172.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -65.97 -33.35 75.63 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.828 -0.624 . . . . 2.39 111.265 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 19' ' ' PHE . . . . . 0.464 ' HE1' ' CD1' ' A' 1567 ' ' PHE . 74.1 t80 -50.63 -57.47 8.16 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 123.038 0.535 . . . . 1.0 111.751 178.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 15.0 p -99.54 -22.4 4.78 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.984 0 C-N-CA 118.389 -1.324 . . . . 1.83 113.298 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 21' ' ' CYS . . . . . 0.438 ' HB2' ' O ' ' B' ' 17' ' ' LEU . 86.2 m -104.85 27.26 8.25 Favored 'General case' 0 C--N 1.316 -0.886 0 O-C-N 121.518 -0.739 . . . . 1.66 112.665 -178.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -53.17 -52.43 40.31 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 121.509 -0.377 . . . . 1.53 114.037 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . 0.421 ' CG ' ' HZ2' ' A' 1544 ' ' LYS . 2.6 m-20 -74.7 -23.59 58.63 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 113.614 0.968 . . . . 2.72 113.614 -179.051 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . 0.538 ' HD2' ' SG ' ' B' ' 60' ' ' CYS . 41.5 ttm180 -87.87 -35.45 17.74 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.68 -0.808 . . . . 5.02 110.507 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.83 168.46 23.38 Favored Glycine 0 N--CA 1.423 -2.214 0 N-CA-C 110.279 -1.128 . . . . 1.63 110.279 -178.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . 0.481 ' HB3' ' HB3' ' B' ' 17' ' ' LEU . 3.2 p90 -122.22 138.94 54.31 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 116.954 0.377 . . . . 1.71 110.197 175.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 27' ' ' TYR . . . . . 0.815 ' HB2' ' HA ' ' B' ' 61' ' ' ALA . 3.2 m-85 -122.0 -91.15 0.56 Allowed 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 118.876 -0.583 . . . . 3.67 110.133 -177.339 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 28' ' ' PHE . . . . . . . . . . . . . 51.7 p90 50.52 9.73 0.05 OUTLIER 'General case' 0 N--CA 1.507 2.397 0 N-CA-C 115.752 1.76 . . . . 2.44 115.752 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 32.3 t -149.11 81.46 1.43 Allowed 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 106.136 -1.801 . . . . 3.85 106.136 178.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . 0.507 ' HB2' ' O ' ' B' ' 32' ' ' ALA . 38.6 mtp180 -123.17 175.54 2.67 Favored Pre-proline 0 C--N 1.299 -1.609 0 N-CA-C 107.905 -1.146 . . . . 4.27 107.905 -173.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.87 -35.94 98.63 Favored 'Trans proline' 0 C--N 1.35 0.633 0 CA-C-N 120.867 1.345 . . . . 4.2 111.008 174.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 32' ' ' ALA . . . . . 0.507 ' O ' ' HB2' ' B' ' 30' ' ' ARG . . . -142.8 -166.42 2.28 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 108.287 -1.005 . . . . 5.12 108.287 179.12 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 16.3 t -155.35 157.66 37.48 Favored 'General case' 0 N--CA 1.391 -3.398 0 N-CA-C 103.711 -2.7 . . . . 6.93 103.711 -178.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 14.9 tpp180 -85.38 2.63 43.51 Favored 'General case' 0 C--N 1.267 -3.014 0 CA-C-O 121.866 0.841 . . . . 12.14 110.291 -174.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 51.3 t -98.34 -15.14 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 108.205 -1.035 . . . . 9.9 108.205 172.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 49.7 m 52.04 33.44 11.97 Favored 'General case' 0 C--N 1.362 1.148 0 CA-C-N 114.102 -1.408 . . . . 6.82 111.208 -175.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 39.6 ttm180 -89.31 -51.52 5.52 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 114.078 -1.419 . . . . 10.71 110.636 -174.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 20.9 tpt85 -164.66 149.48 9.64 Favored 'General case' 0 N--CA 1.423 -1.823 0 N-CA-C 104.616 -2.364 . . . . 8.6 104.616 -173.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 20.8 m -63.67 -21.2 66.26 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 123.596 0.56 . . . . 5.79 111.483 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 56.6 mtm180 -128.99 136.18 49.98 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 107.445 -1.317 . . . . 6.57 107.445 174.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . -119.98 173.84 15.36 Favored Glycine 0 C--N 1.286 -2.25 0 N-CA-C 109.384 -1.486 . . . . 2.62 109.384 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 22.5 pt 62.01 -37.62 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 C-N-CA 127.48 2.312 . . . . 2.28 116.182 175.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . 0.405 ' O ' ' HB2' ' B' ' 47' ' ' CYS . 2.5 p -50.03 -50.31 19.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 114.751 1.389 . . . . 2.6 114.751 -176.043 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -93.74 -27.66 16.37 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.98 -0.748 . . . . 3.36 108.98 -174.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . 0.462 ' O ' ' HB2' ' B' ' 49' ' ' ARG . 41.7 mt-10 -61.2 -56.62 18.62 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.863 -1.062 . . . . 3.08 110.127 178.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 46' ' ' CYS . . . . . 0.481 ' HB2' ' HB3' ' B' ' 51' ' ' CYS . 48.3 t -83.67 -3.91 58.15 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 116.117 -0.492 . . . . 2.23 111.276 -176.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 47' ' ' CYS . . . . . 0.464 ' HB2' ' HB3' ' B' ' 9' ' ' CYS . 34.3 t -80.42 -38.87 29.36 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 118.905 -1.118 . . . . 2.48 110.29 176.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -111.55 9.29 21.19 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 112.609 0.596 . . . . 2.97 112.609 -175.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . 0.462 ' HB2' ' O ' ' B' ' 45' ' ' GLU . 63.1 mtp180 -146.88 -177.89 5.9 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 105.874 -1.899 . . . . 4.65 105.874 177.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 11.2 t -106.05 145.32 31.55 Favored 'General case' 0 C--N 1.278 -2.524 0 N-CA-C 106.157 -1.794 . . . . 2.86 106.157 177.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . 0.481 ' HB3' ' HB2' ' B' ' 46' ' ' CYS . 23.4 p -118.17 143.11 46.77 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 110.45 -0.204 . . . . 2.11 110.45 -175.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -94.59 163.15 13.5 Favored 'General case' 0 C--O 1.253 1.248 0 N-CA-C 107.414 -1.328 . . . . 2.67 107.414 173.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -66.75 -9.26 34.85 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 120.756 0.313 . . . . 2.36 110.938 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.63 -15.96 44.2 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.167 0.987 . . . . 1.92 110.541 176.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . 0.656 ' O ' ' HB2' ' B' ' 59' ' ' TYR . 49.1 mt -98.56 -55.78 2.64 Favored 'General case' 0 C--O 1.2 -1.545 0 CA-C-O 120.971 0.415 . . . . 2.35 111.404 174.046 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 1.7 pp -74.73 -33.28 62.34 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 114.537 1.31 . . . . 2.01 114.537 -170.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -76.85 -32.5 57.57 Favored 'General case' 0 CA--C 1.559 1.293 0 C-N-CA 120.31 -0.556 . . . . 2.27 110.768 178.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 73.9 p -75.37 -50.99 14.22 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 120.844 0.354 . . . . 2.67 111.165 177.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 59' ' ' TYR . . . . . 0.656 ' HB2' ' O ' ' B' ' 55' ' ' LEU . 0.3 OUTLIER -65.17 -64.67 0.81 Allowed 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 108.76 -0.83 . . . . 3.2 108.76 -178.725 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 60' ' ' CYS . . . . . 0.538 ' SG ' ' HD2' ' B' ' 24' ' ' ARG . 43.6 t 45.16 -86.32 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 125.32 1.448 . . . . 2.3 113.441 176.059 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 61' ' ' ALA . . . . . 0.815 ' HA ' ' HB2' ' B' ' 27' ' ' TYR . . . -142.22 -64.82 0.42 Allowed 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 106.913 -1.514 . . . . 3.19 106.913 179.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 13.4 p -130.95 147.36 66.0 Favored Pre-proline 0 N--CA 1.412 -2.335 0 N-CA-C 106.531 -1.655 . . . . 4.14 106.531 179.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -81.93 0.6 9.74 Favored 'Trans proline' 0 C--O 1.237 0.433 0 C-N-CA 122.768 2.312 . . . . 5.59 112.982 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 72.51 50.68 0.18 Allowed 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 125.504 1.522 . . . . 5.51 110.652 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -160.73 132.6 5.89 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 105.197 -2.149 . . . . 8.8 105.197 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 67.7 m -114.41 155.78 25.71 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 113.361 0.874 . . . . 8.12 113.361 -172.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 . . . . . 0 N--CA 1.434 -1.259 0 N-CA-C 108.245 -1.02 . . . . 10.21 108.245 178.267 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 23.8 mmt . . . . . 0 CA--C 1.5 -0.972 0 N-CA-C 109.113 -0.699 . . . . 9.74 109.113 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 61.5 tttp -85.88 71.51 10.63 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.926 0.869 . . . . 9.32 109.19 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1510 ' ' SER . . . . . 0.5 ' OG ' ' HG2' ' A' 1512 ' ' GLU . 35.6 t -164.02 154.06 14.78 Favored 'General case' 0 N--CA 1.426 -1.665 0 N-CA-C 107.948 -1.13 . . . . 5.97 107.948 -179.369 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1511 ' ' ASN . . . . . 0.41 ' O ' ' HA ' ' A' 1518 ' ' VAL . 30.4 p-10 -90.04 -2.51 58.13 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.946 -0.57 . . . . 3.48 110.83 -179.07 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1512 ' ' GLU . . . . . 0.5 ' HG2' ' OG ' ' A' 1510 ' ' SER . 13.1 pt-20 -101.07 155.95 17.69 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.049 -0.722 . . . . 5.95 109.049 178.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1513 ' ' HIS . . . . . 0.426 ' HB2' ' HG3' ' A' 1517 ' ' GLN . 64.5 m-70 -137.49 7.19 2.8 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 113.506 0.928 . . . . 6.14 113.506 -174.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1514 ' ' ASP . . . . . 0.6 ' O ' ' HE2' ' A' 1579 ' ' LYS . 27.9 t70 72.59 -22.56 0.22 Allowed 'General case' 0 N--CA 1.507 2.416 0 C-N-CA 124.868 1.267 . . . . 5.06 112.387 -178.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1515 ' ' ASP . . . . . 0.403 ' H ' ' C ' ' A' 1513 ' ' HIS . 50.3 m-20 -88.91 36.04 0.8 Allowed 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.605 -0.684 . . . . 2.9 111.799 -177.166 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1516 ' ' CYS . . . . . 0.511 ' HA ' ' HB2' ' A' 1581 ' ' LEU . 95.6 m 52.53 50.49 18.11 Favored 'General case' 0 CA--C 1.497 -1.083 0 CA-C-O 121.717 0.77 . . . . 1.41 112.029 -178.141 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1517 ' ' GLN . . . . . 0.426 ' HG3' ' HB2' ' A' 1513 ' ' HIS . 4.1 pt20 -150.91 130.35 12.93 Favored 'General case' 0 N--CA 1.407 -2.591 0 CA-C-N 115.049 -0.978 . . . . 2.18 109.76 -176.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1518 ' ' VAL . . . . . 0.455 HG22 ' HB2' ' A' 1583 ' ' TYR . 3.0 m -137.54 142.32 37.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-N 115.274 -0.876 . . . . 1.52 110.18 -178.011 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1519 ' ' THR . . . . . . . . . . . . . 44.3 m -107.17 141.97 37.61 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 116.312 -0.404 . . . . 1.36 111.511 -178.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1520 ' ' ASN . . . . . 0.518 ' OD1' HG22 ' A' 1523 ' ' THR . 6.4 t-20 -89.52 120.78 69.61 Favored Pre-proline 0 N--CA 1.441 -0.915 0 N-CA-C 108.58 -0.896 . . . . 2.02 108.58 173.179 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -62.66 -27.69 76.23 Favored 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 123.22 2.614 . . . . 1.82 113.927 -176.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 15.0 m -68.14 -47.66 67.49 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 112.939 0.718 . . . . 1.89 112.939 -175.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1523 ' ' THR . . . . . 0.518 HG22 ' OD1' ' A' 1520 ' ' ASN . 11.8 t -118.8 2.64 11.63 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 119.785 -0.766 . . . . 1.99 111.833 -173.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 63.42 34.0 88.77 Favored Glycine 0 CA--C 1.504 -0.632 0 CA-C-N 115.749 -0.66 . . . . 1.19 112.007 178.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1525 ' ' HIS . . . . . 0.451 ' HB2' HG21 ' A' 1523 ' ' THR . 32.7 t-80 -94.22 127.27 39.96 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 120.095 -0.642 . . . . 1.82 109.46 -177.453 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 3.1 tm? -90.88 117.37 29.44 Favored 'General case' 0 C--N 1.289 -2.065 0 CA-C-N 115.019 -0.991 . . . . 1.3 108.956 -177.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -95.51 126.07 40.55 Favored 'General case' 0 N--CA 1.432 -1.33 0 C-N-CA 119.749 -0.78 . . . . 0.8 110.577 173.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 10.5 t70 -115.92 126.98 54.61 Favored 'General case' 0 C--N 1.309 -1.16 0 O-C-N 123.738 0.649 . . . . 1.17 109.727 175.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1529 ' ' LEU . . . . . 0.494 ' HG ' HD23 ' A' 1581 ' ' LEU . 3.4 mm? -106.9 2.35 25.27 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 120.982 0.42 . . . . 1.29 111.149 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 3.8 m -71.78 -14.28 61.94 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.145 0.497 . . . . 0.91 111.796 -176.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 6.1 p -70.0 -31.62 69.38 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.634 0.73 . . . . 1.98 110.831 179.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 77.5 mt -84.97 7.06 22.53 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.025 -0.989 . . . . 1.34 110.713 -179.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1533 ' ' SER . . . . . 0.43 ' HA ' ' HB ' ' A' 1552 ' ' ILE . 19.7 t -74.97 172.47 12.24 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.683 0.754 . . . . 1.93 111.118 -179.423 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -176.94 141.24 5.31 Favored Glycine 0 N--CA 1.422 -2.24 0 N-CA-C 108.141 -1.984 . . . . 1.1 108.141 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 11.5 tpp180 -92.2 -31.66 15.37 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 120.954 0.407 . . . . 5.21 111.454 -176.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -80.61 -37.36 31.27 Favored 'General case' 0 CA--C 1.502 -0.904 0 N-CA-C 108.164 -1.051 . . . . 1.94 108.164 177.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1537 ' ' GLY . . . . . 0.411 ' HA3' ' ND2' ' A' 1556 ' ' ASN . . . 110.04 -177.37 19.73 Favored Glycine 0 N--CA 1.406 -3.304 0 CA-C-N 114.792 -1.094 . . . . 1.08 111.938 174.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -121.68 142.56 50.03 Favored 'General case' 0 C--N 1.277 -2.571 0 N-CA-C 106.954 -1.499 . . . . 1.07 106.954 178.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 3.3 p -105.33 129.78 53.59 Favored 'General case' 0 C--N 1.292 -1.903 0 O-C-N 123.652 0.595 . . . . 1.46 110.764 179.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1540 ' ' ALA . . . . . 0.455 ' HB1' ' CG1' ' A' 1548 ' ' VAL . . . -121.83 144.56 48.75 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.615 -1.254 . . . . 1.19 107.615 176.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -80.84 126.57 31.5 Favored 'General case' 0 N--CA 1.431 -1.377 0 O-C-N 123.643 0.589 . . . . 1.37 109.545 -176.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1542 ' ' TYR . . . . . 0.545 ' CE1' ' HG ' ' A' 1626 ' ' LEU . 10.6 t80 -131.73 -102.09 0.28 Allowed 'General case' 0 N--CA 1.419 -2.0 0 CA-C-N 115.484 -0.78 . . . . 1.38 109.733 -175.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1543 ' ' SER . . . . . . . . . . . . . 43.1 t -77.57 155.32 31.6 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.651 -0.87 . . . . 1.98 108.651 178.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -55.76 -42.16 75.06 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 119.175 0.898 . . . . 3.96 111.002 178.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 41.8 m -106.24 30.72 5.69 Favored 'General case' 0 N--CA 1.407 -2.609 0 CA-C-O 121.078 0.466 . . . . 2.81 110.795 -176.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . -170.71 113.53 0.5 Allowed Glycine 0 N--CA 1.433 -1.514 0 C-N-CA 119.643 -1.265 . . . . 1.68 113.336 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 30.9 m -94.02 167.52 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 N-CA-C 107.794 -1.187 . . . . 1.38 107.794 175.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1548 ' ' VAL . . . . . 0.467 HG22 ' CD1' ' A' 1567 ' ' PHE . 10.9 p -107.7 131.05 58.98 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.178 0 C-N-CA 119.448 -0.901 . . . . 1.24 109.476 178.105 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -97.74 127.19 43.52 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.129 -1.063 . . . . 1.29 108.129 178.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 25.6 ptm -143.82 137.52 28.04 Favored 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 120.377 -0.529 . . . . 1.47 112.005 -178.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 11.2 p -127.7 125.78 40.67 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 115.397 -0.82 . . . . 1.4 109.76 176.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1552 ' ' ILE . . . . . 0.43 ' HB ' ' HA ' ' A' 1533 ' ' SER . 42.4 mm -80.98 116.68 25.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 N-CA-C 109.817 -0.438 . . . . 1.11 109.817 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1553 ' ' CYS . . . . . 0.48 ' SG ' HD12 ' A' 1590 ' ' LEU . 85.6 m 62.59 31.81 16.69 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 112.813 0.672 . . . . 1.4 112.813 173.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . -166.55 175.2 41.98 Favored Glycine 0 N--CA 1.417 -2.591 0 N-CA-C 108.201 -1.96 . . . . 0.4 108.201 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -98.18 148.76 23.26 Favored 'General case' 0 C--N 1.289 -2.049 0 C-N-CA 119.91 -0.716 . . . . 1.62 110.925 -179.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1556 ' ' ASN . . . . . 0.411 ' ND2' ' HA3' ' A' 1537 ' ' GLY . 25.7 t-20 -92.44 125.21 36.99 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 108.384 -0.969 . . . . 1.12 108.384 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -81.07 4.88 18.33 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 114.4 1.259 . . . . 2.49 114.4 -175.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -95.95 -4.21 43.77 Favored 'General case' 0 C--N 1.317 -0.838 0 O-C-N 121.638 -0.664 . . . . 1.38 111.234 -179.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1559 ' ' CYS . . . . . 0.777 ' SG ' ' HD2' ' A' 1560 ' ' PRO . 17.6 t -136.87 162.93 53.06 Favored Pre-proline 0 C--N 1.302 -1.489 0 N-CA-C 106.84 -1.541 . . . . 1.21 106.84 -177.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1560 ' ' PRO . . . . . 0.777 ' HD2' ' SG ' ' A' 1559 ' ' CYS . 45.5 Cg_exo -28.46 128.53 0.04 OUTLIER 'Trans proline' 0 C--N 1.384 2.444 0 C-N-CA 124.982 3.788 . . . . 0.98 115.25 176.215 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -48.96 122.68 8.66 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 124.067 3.178 . . . . 1.15 113.826 -178.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 98.94 14.68 35.88 Favored Glycine 0 C--N 1.311 -0.814 0 CA-C-N 115.63 -0.714 . . . . 0.55 114.328 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1563 ' ' VAL . . . . . 0.601 HG22 ' HB2' ' A' 1573 ' ' SER . 9.9 p -104.66 144.43 14.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.885 -0.773 . . . . 1.53 110.662 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -102.39 -33.3 4.57 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 121.213 -0.518 . . . . 0.29 113.033 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -130.15 139.6 50.86 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.79 -0.448 . . . . 1.08 109.79 178.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 45.7 t -159.16 133.23 7.6 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 119.529 -0.272 . . . . 0.43 110.724 -177.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1567 ' ' PHE . . . . . 0.467 ' CD1' HG22 ' A' 1548 ' ' VAL . 28.5 m-85 -84.89 139.64 31.72 Favored 'General case' 0 C--O 1.249 1.047 0 N-CA-C 108.458 -0.942 . . . . 1.3 108.458 171.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -82.47 39.43 2.66 Favored Glycine 0 N--CA 1.442 -0.933 0 C-N-CA 121.703 -0.284 . . . . 1.43 113.783 -175.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -76.51 -71.42 0.39 Allowed 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 108.661 -0.866 . . . . 3.09 108.661 174.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 2.9 p -132.52 33.31 3.81 Favored 'General case' 0 C--N 1.308 -1.209 0 C-N-CA 122.935 0.494 . . . . 2.52 110.278 174.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1571 ' ' ARG . . . . . 0.497 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 3.1 mpt_? 61.9 60.08 1.61 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.9 0.857 . . . . 3.19 109.442 -173.072 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 39.9 mt -96.26 101.72 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 107.748 -1.204 . . . . 1.51 107.748 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1573 ' ' SER . . . . . 0.601 ' HB2' HG22 ' A' 1563 ' ' VAL . 94.1 p -63.31 129.39 40.05 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 114.321 -1.309 . . . . 0.96 111.288 -176.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1574 ' ' VAL . . . . . 0.457 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 35.1 m -120.14 16.77 6.47 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-O 121.511 0.672 . . . . 1.6 112.054 -176.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 173.27 118.24 0.49 Allowed Glycine 0 N--CA 1.428 -1.9 0 CA-C-N 115.414 -0.812 . . . . 0.34 111.135 176.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 55.3 tttp -70.42 139.27 51.78 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 107.805 -1.183 . . . . 2.68 107.805 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -68.5 98.79 0.89 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.207 0.447 . . . . 1.08 112.207 -175.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1578 ' ' ASN . . . . . 0.553 ' O ' ' HE1' ' A' 1592 ' ' TYR . 84.5 m-20 -115.67 157.61 23.97 Favored 'General case' 0 C--O 1.206 -1.223 0 N-CA-C 106.926 -1.509 . . . . 1.95 106.926 175.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1579 ' ' LYS . . . . . 0.6 ' HE2' ' O ' ' A' 1514 ' ' ASP . 28.2 mtmm -122.97 42.07 3.29 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 122.167 0.984 . . . . 3.11 108.512 -178.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 25.9 ttm180 -90.4 76.9 6.64 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 122.257 1.027 . . . . 4.04 109.313 -173.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1581 ' ' LEU . . . . . 0.511 ' HB2' ' HA ' ' A' 1516 ' ' CYS . 0.3 OUTLIER -65.87 133.02 50.06 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 113.184 -1.825 . . . . 1.32 109.517 -178.518 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A 1582 ' ' ARG . . . . . 0.721 ' HB2' ' HB3' ' A' 1589 ' ' GLN . 94.5 mtt180 -120.52 141.17 50.48 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 109.765 -0.458 . . . . 3.4 109.765 175.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1583 ' ' TYR . . . . . 0.536 ' OH ' ' OE1' ' A' 1647 ' ' GLU . 16.2 t80 -114.94 102.37 9.9 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 109.512 -0.551 . . . . 1.26 109.512 177.155 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1584 ' ' VAL . . . . . 0.549 ' O ' ' HB ' ' A' 1587 ' ' VAL . 27.8 m -123.68 91.15 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.763 -0.653 . . . . 1.71 111.868 -177.358 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1585 ' ' ASP . . . . . 0.404 ' O ' ' HG2' ' A' 1586 ' ' GLN . 24.0 t70 56.5 62.62 2.24 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.896 0.878 . . . . 1.17 111.576 176.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1586 ' ' GLN . . . . . 0.404 ' HG2' ' O ' ' A' 1585 ' ' ASP . 9.0 pt20 68.89 2.22 3.45 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 127.628 2.371 . . . . 2.43 111.547 178.033 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1587 ' ' VAL . . . . . 0.549 ' HB ' ' O ' ' A' 1584 ' ' VAL . 25.0 t -92.11 123.49 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.116 0 CA-C-N 115.329 -0.85 . . . . 1.16 109.406 175.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1588 ' ' LEU . . . . . 0.648 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 3.6 mm? -99.51 108.25 20.64 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.089 -1.078 . . . . 1.11 108.089 179.17 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1589 ' ' GLN . . . . . 0.721 ' HB3' ' HB2' ' A' 1582 ' ' ARG . 4.0 tp-100 -100.41 133.46 44.8 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 115.233 -0.894 . . . . 1.74 111.376 -174.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1590 ' ' LEU . . . . . 0.48 HD12 ' SG ' ' A' 1553 ' ' CYS . 0.4 OUTLIER -130.94 92.48 3.23 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 105.843 -1.91 . . . . 1.4 105.843 175.066 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 8.3 p -93.77 125.94 46.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 CA-C-O 121.835 0.826 . . . . 1.7 112.906 -174.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1592 ' ' TYR . . . . . 0.553 ' HE1' ' O ' ' A' 1578 ' ' ASN . 17.5 m-30 -112.49 138.26 49.51 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 107.76 -1.2 . . . . 1.08 107.76 176.116 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 22.7 pttm -148.54 -178.53 6.38 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.082 -1.081 . . . . 2.21 108.082 178.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 11.0 m-20 60.74 50.45 5.48 Favored 'General case' 0 C--O 1.242 0.701 0 O-C-N 124.223 0.952 . . . . 1.11 110.978 176.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -78.35 -112.48 0.19 Allowed Glycine 0 N--CA 1.433 -1.561 0 N-CA-C 110.272 -1.131 . . . . 0.78 110.272 178.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1596 ' ' SER . . . . . . . . . . . . . 56.2 p -124.98 159.69 57.81 Favored Pre-proline 0 C--N 1.274 -2.675 0 N-CA-C 107.691 -1.226 . . . . 1.36 107.691 174.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -54.73 124.75 16.98 Favored 'Trans proline' 0 C--N 1.358 1.028 0 C-N-CA 122.386 2.057 . . . . 1.4 110.339 177.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1598 ' ' CYS . . . . . 0.615 ' HA ' ' CE2' ' A' 1606 ' ' TYR . 21.7 t -58.47 115.96 13.4 Favored Pre-proline 0 C--N 1.308 -1.239 0 N-CA-C 108.775 -0.824 . . . . 0.75 108.775 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1599 ' ' PRO . . . . . 0.65 ' HB2' ' HB ' ' B' ' 16' ' ' THR . 31.8 Cg_exo -60.87 -23.96 78.11 Favored 'Trans proline' 0 C--N 1.361 1.21 0 C-N-CA 123.016 2.477 . . . . 1.7 112.676 -176.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1600 ' ' SER . . . . . 0.606 ' HB3' ' HB3' ' B' ' 53' ' ' LEU . 44.3 m -80.52 -14.66 58.06 Favored 'General case' 0 CA--C 1.566 1.571 0 N-CA-C 113.033 0.753 . . . . 2.8 113.033 177.452 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1601 ' ' LYS . . . . . 0.419 ' HG3' HD12 ' A' 1604 ' ' LEU . 3.2 tppp? -160.76 116.07 2.21 Favored 'General case' 0 C--O 1.24 0.588 0 O-C-N 121.698 -0.626 . . . . 3.45 110.797 -176.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1602 ' ' SER . . . . . 0.442 ' OG ' ' HB3' ' B' ' 6' ' ' GLU . 38.3 t -69.74 141.95 53.36 Favored 'General case' 0 N--CA 1.416 -2.15 0 N-CA-C 108.457 -0.942 . . . . 2.44 108.457 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 99.26 -17.6 57.68 Favored Glycine 0 C--N 1.3 -1.439 0 C-N-CA 121.222 -0.513 . . . . 1.2 112.72 179.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1604 ' ' LEU . . . . . 0.419 HD12 ' HG3' ' A' 1601 ' ' LYS . 8.9 mp -102.57 145.9 28.93 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 123.212 0.605 . . . . 2.38 110.561 178.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 31.5 t -121.59 153.6 37.85 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 106.757 -1.571 . . . . 1.96 106.757 175.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1606 ' ' TYR . . . . . 0.615 ' CE2' ' HA ' ' A' 1598 ' ' CYS . 49.1 m-85 -78.56 155.07 29.88 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 116.522 -0.308 . . . . 1.06 111.558 178.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? -150.16 145.1 26.09 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 106.943 -1.502 . . . . 2.0 106.943 175.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1608 ' ' SER . . . . . . . . . . . . . 17.2 m -120.0 120.91 37.69 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 107.789 -1.189 . . . . 1.61 107.789 -178.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 21.3 t -99.99 103.87 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 CA-C-O 121.118 0.485 . . . . 1.09 109.701 178.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 83.1 mt -96.69 106.27 18.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 C-N-CA 123.845 0.858 . . . . 1.2 109.171 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 14.4 t -106.98 113.94 27.72 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 108.392 -0.966 . . . . 1.89 108.392 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1612 ' ' PHE . . . . . 0.648 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 60.0 m-85 -81.8 121.51 26.52 Favored 'General case' 0 C--O 1.258 1.551 0 N-CA-C 109.477 -0.564 . . . . 0.28 109.477 176.08 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 46.4 t -111.54 129.86 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-N 114.798 -1.092 . . . . 1.23 109.862 -174.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 22.1 t -61.14 110.86 1.5 Allowed 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.112 -0.949 . . . . 0.77 111.884 178.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1615 ' ' ARG . . . . . 0.611 ' HG3' ' HB3' ' A' 1617 ' ' GLU . 32.5 tpt180 -137.48 95.76 11.27 Favored Pre-proline 0 N--CA 1.438 -1.033 0 N-CA-C 109.246 -0.65 . . . . 2.92 109.246 173.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1616 ' ' PRO . . . . . 0.778 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 39.5 Cg_exo -61.45 -21.26 71.43 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 122.86 2.373 . . . . 1.22 113.387 -178.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1617 ' ' GLU . . . . . 0.611 ' HB3' ' HG3' ' A' 1615 ' ' ARG . 38.9 tt0 -49.44 -41.12 39.07 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 125.586 1.554 . . . . 3.05 112.451 176.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . 43.58 81.03 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.527 0.731 . . . . 1.55 112.564 -177.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1619 ' ' GLY . . . . . 0.41 ' HA3' ' HD2' ' A' 1620 ' ' PRO . . . -153.45 -134.33 1.98 Allowed Glycine 0 C--N 1.274 -2.907 0 C-N-CA 120.581 -0.819 . . . . 1.16 111.569 -177.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1620 ' ' PRO . . . . . 0.41 ' HD2' ' HA3' ' A' 1619 ' ' GLY . 42.3 Cg_endo -66.88 1.09 3.01 Favored 'Trans proline' 0 CA--C 1.55 1.298 0 C-N-CA 122.656 2.237 . . . . 1.06 114.465 -179.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1621 ' ' THR . . . . . 0.778 ' HB ' ' HB2' ' A' 1641 ' ' HIS . 2.7 p -98.67 -13.66 20.19 Favored 'General case' 0 N--CA 1.419 -1.979 0 C-N-CA 124.13 0.972 . . . . 1.58 109.727 178.061 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 53.0 t30 -86.03 69.2 10.5 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.956 -1.02 . . . . 0.88 108.566 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1623 ' ' ARG . . . . . 0.462 ' O ' ' HG3' ' A' 1625 ' ' MET . 11.5 ptp180 -166.23 140.63 3.62 Favored Pre-proline 0 C--N 1.296 -1.744 0 N-CA-C 107.537 -1.283 . . . . 3.82 107.537 -178.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -58.07 104.71 0.18 Allowed 'Trans proline' 0 C--O 1.238 0.515 0 C-N-CA 122.92 2.413 . . . . 0.77 110.885 178.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1625 ' ' MET . . . . . 0.462 ' HG3' ' O ' ' A' 1623 ' ' ARG . 94.2 mtp -98.75 131.27 45.02 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.476 -0.935 . . . . 1.43 108.476 -176.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1626 ' ' LEU . . . . . 0.545 ' HG ' ' CE1' ' A' 1542 ' ' TYR . 1.0 OUTLIER -86.82 111.86 21.17 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 106.938 -1.505 . . . . 1.43 106.938 -178.031 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A 1627 ' ' ILE . . . . . 0.516 HD12 ' HB2' ' A' 1639 ' ' SER . 37.8 mm -73.07 -56.89 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.883 0 N-CA-C 108.902 -0.777 . . . . 1.23 108.902 -178.472 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 23.8 t -171.88 162.21 6.01 Favored 'General case' 0 N--CA 1.417 -2.124 0 N-CA-C 107.839 -1.171 . . . . 1.88 107.839 -175.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1629 ' ' LEU . . . . . 0.5 HD12 ' CD1' ' A' 1636 ' ' LEU . 5.7 tp -112.11 109.2 18.78 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 107.731 -1.211 . . . . 1.92 107.731 175.112 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1630 ' ' ASP . . . . . 0.509 ' HB3' ' HB ' ' A' 1635 ' ' THR . 13.4 t70 -75.02 85.91 2.31 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 106.16 -1.793 . . . . 1.09 106.16 173.205 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1631 ' ' LYS . . . . . 0.568 ' HG3' HD12 ' B' ' 53' ' ' LEU . 21.6 tptm -64.65 -19.8 65.92 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 114.229 -1.351 . . . . 3.98 112.702 -173.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1632 ' ' GLN . . . . . 0.4 HE21 ' HB3' ' A' 1632 ' ' GLN . 3.2 mt-30 -76.19 -31.67 58.6 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 119.599 -0.841 . . . . 2.6 110.376 -176.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 59.6 p -107.26 -10.46 15.81 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 116.116 -0.493 . . . . 1.35 111.631 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 65.9 m 67.23 49.26 1.09 Allowed 'General case' 0 C--N 1.36 1.054 0 CA-C-O 122.76 1.267 . . . . 0.53 109.975 -178.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1635 ' ' THR . . . . . 0.509 ' HB ' ' HB3' ' A' 1630 ' ' ASP . 93.3 m -109.87 130.0 55.58 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 113.854 -1.521 . . . . 1.11 109.088 -177.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1636 ' ' LEU . . . . . 0.5 ' CD1' HD12 ' A' 1629 ' ' LEU . 0.2 OUTLIER -105.68 135.82 46.39 Favored 'General case' 0 CA--C 1.504 -0.802 0 N-CA-C 108.009 -1.108 . . . . 1.56 108.009 177.68 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -109.37 125.59 52.53 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 109.556 -0.535 . . . . 0.54 109.556 177.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -125.11 136.89 54.07 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.307 -0.627 . . . . 0.64 109.307 -178.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1639 ' ' SER . . . . . 0.516 ' HB2' HD12 ' A' 1627 ' ' ILE . 33.1 t -116.8 154.87 29.94 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 107.285 -1.376 . . . . 1.34 107.285 175.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 2.7 t90 -150.38 108.21 3.7 Favored 'General case' 0 N--CA 1.417 -2.087 0 N-CA-C 104.882 -2.266 . . . . 0.8 104.882 178.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1641 ' ' HIS . . . . . 0.778 ' HB2' ' HB ' ' A' 1621 ' ' THR . 51.2 m-70 -95.06 104.63 16.51 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 121.281 0.562 . . . . 1.14 109.941 -175.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1642 ' ' THR . . . . . . . . . . . . . 8.6 t -142.38 148.99 49.72 Favored Pre-proline 0 C--N 1.3 -1.584 0 CA-C-N 115.67 -0.696 . . . . 1.11 109.674 -173.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1643 ' ' PRO . . . . . 0.778 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 77.7 Cg_endo -78.87 -6.41 15.12 Favored 'Trans proline' 0 C--N 1.369 1.626 0 C-N-CA 122.483 2.122 . . . . 0.78 112.586 179.412 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 8.2 tt -70.21 -25.35 63.36 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.1 -0.704 . . . . 1.66 109.1 178.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -95.29 17.12 14.98 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.962 -1.017 . . . . 1.29 110.342 -178.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1646 ' ' CYS . . . . . 0.511 ' SG ' ' HA ' ' A' 1643 ' ' PRO . 95.7 m -96.28 145.59 25.45 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 109.716 -0.476 . . . . 1.48 109.716 177.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1647 ' ' GLU . . . . . 0.536 ' OE1' ' OH ' ' A' 1583 ' ' TYR . 35.4 tt0 -101.61 118.22 60.19 Favored Pre-proline 0 C--N 1.297 -1.684 0 N-CA-C 108.654 -0.869 . . . . 3.14 108.654 -177.42 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1648 ' ' PRO . . . . . 0.414 ' HG2' ' CD2' ' A' 1525 ' ' HIS . 97.4 Cg_exo -47.11 116.31 1.68 Allowed 'Trans proline' 0 C--N 1.358 1.074 0 C-N-CA 124.226 3.284 . . . . 2.92 114.824 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 42.2 tt0 . . . . . 0 N--CA 1.439 -0.989 0 N-CA-C 107.53 -1.285 . . . . 4.72 107.53 176.941 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.36 0 N-CA-C 109.614 -0.513 . . . . 10.26 109.614 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 2' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -108.7 134.28 51.64 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 109.35 -0.611 . . . . 7.94 109.35 -178.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 -116.6 139.75 25.87 Favored Pre-proline 0 C--N 1.28 -2.437 0 N-CA-C 107.897 -1.149 . . . . 6.56 107.897 177.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -57.48 -17.05 25.93 Favored 'Trans proline' 0 C--N 1.371 1.731 0 C-N-CA 124.114 3.209 . . . . 5.51 113.461 -177.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 5' ' ' SER . . . . . 0.405 ' HB3' ' O ' ' B' ' 7' ' ' THR . 49.0 m -125.52 92.61 3.65 Favored 'General case' 0 N--CA 1.412 -2.365 0 N-CA-C 107.629 -1.249 . . . . 4.91 107.629 172.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . 0.442 ' HB3' ' OG ' ' A' 1602 ' ' SER . 51.8 mt-10 -71.45 -32.95 68.91 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 106.987 -1.486 . . . . 4.23 106.987 176.174 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 7' ' ' THR . . . . . 0.607 ' HB ' ' SG ' ' B' ' 46' ' ' CYS . 1.4 p -94.91 142.67 27.21 Favored 'General case' 0 N--CA 1.402 -2.852 0 N-CA-C 107.297 -1.371 . . . . 3.48 107.297 172.357 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . 0.683 ' HG ' ' HB2' ' B' ' 12' ' ' GLU . 1.5 mm? -80.09 128.87 34.01 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 116.313 -0.403 . . . . 4.35 110.099 -170.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 99.1 m -63.82 -30.37 71.47 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 114.269 1.211 . . . . 2.84 114.269 179.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . 0.481 ' O ' HG13 ' B' ' 14' ' ' VAL . . . -150.17 -61.67 0.01 OUTLIER Glycine 0 N--CA 1.417 -2.593 0 C-N-CA 119.491 -1.338 . . . . 2.28 112.708 -177.516 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -44.79 -74.67 0.2 Allowed Glycine 0 N--CA 1.473 1.153 0 N-CA-C 115.626 1.011 . . . . 1.94 115.626 -170.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . 0.683 ' HB2' ' HG ' ' B' ' 8' ' ' LEU . 44.9 mt-10 -75.0 -17.14 60.57 Favored 'General case' 0 C--N 1.314 -0.966 0 O-C-N 122.317 -0.519 . . . . 2.55 111.578 -179.068 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . 0.477 ' O ' HD22 ' B' ' 17' ' ' LEU . 36.7 tp -71.98 -53.73 12.1 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-O 120.884 0.373 . . . . 2.82 110.284 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . 0.481 HG13 ' O ' ' B' ' 10' ' ' GLY . 13.7 p -70.64 -23.54 24.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-O 121.5 0.667 . . . . 2.5 109.796 -179.465 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -72.49 -42.43 64.87 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.815 -0.629 . . . . 2.04 111.233 175.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 16' ' ' THR . . . . . 0.65 ' HB ' ' HB2' ' A' 1599 ' ' PRO . 15.1 t -67.43 -30.14 69.81 Favored 'General case' 0 C--O 1.248 1.005 0 CA-C-N 118.674 0.67 . . . . 2.31 110.727 176.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.477 HD22 ' O ' ' B' ' 13' ' ' LEU . 3.3 mm? -51.97 -51.69 55.48 Favored 'General case' 0 C--O 1.212 -0.918 0 O-C-N 123.637 0.586 . . . . 2.27 109.89 168.077 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.69 -33.69 69.01 Favored 'General case' 0 C--O 1.214 -0.793 0 CA-C-N 116.014 -0.539 . . . . 2.39 110.213 -178.417 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -47.97 -64.09 0.89 Allowed 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 113.084 0.772 . . . . 1.0 113.084 177.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 10.1 p -91.93 -14.52 8.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 C-N-CA 118.588 -1.245 . . . . 1.83 111.62 -176.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 21' ' ' CYS . . . . . 0.555 ' HB2' ' HB3' ' B' ' 26' ' ' PHE . 61.9 m -106.95 17.51 23.0 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 119.806 -0.758 . . . . 1.66 112.659 -178.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -53.01 -44.14 62.03 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 121.226 -0.512 . . . . 1.53 112.43 174.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -82.22 -52.5 6.9 Favored 'General case' 0 C--N 1.314 -0.937 0 O-C-N 122.627 -0.337 . . . . 2.72 111.718 178.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 44.9 ttp180 -69.09 -29.04 67.06 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.38 0.882 . . . . 5.02 113.38 -175.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.09 133.03 7.14 Favored Glycine 0 N--CA 1.435 -1.37 0 N-CA-C 109.826 -1.309 . . . . 1.63 109.826 -177.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . 0.555 ' HB3' ' HB2' ' B' ' 21' ' ' CYS . 22.9 p90 -107.68 112.98 25.94 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 117.448 0.624 . . . . 1.71 110.235 -179.028 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -135.74 133.77 38.35 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.149 -1.056 . . . . 3.67 108.149 -177.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 28' ' ' PHE . . . . . 0.446 ' HA ' ' HE1' ' B' ' 59' ' ' TYR . 18.0 p90 -147.88 19.15 1.14 Allowed 'General case' 0 C--N 1.315 -0.895 0 O-C-N 123.293 0.371 . . . . 2.44 111.501 -178.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 51.2 m -156.53 84.31 0.97 Allowed 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.033 -0.728 . . . . 3.85 109.033 -178.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . 0.689 ' O ' ' HA ' ' B' ' 39' ' ' SER . 48.0 mtt-85 -116.59 154.55 49.21 Favored Pre-proline 0 C--N 1.314 -0.964 0 N-CA-C 108.45 -0.945 . . . . 4.27 108.45 -176.244 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.32 -48.59 15.04 Favored 'Trans proline' 0 C--O 1.256 1.387 0 C-N-CA 121.581 1.521 . . . . 4.2 111.731 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -160.32 146.01 15.14 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 115.15 -0.932 . . . . 5.12 108.513 179.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 33' ' ' SER . . . . . 0.479 ' HB3' ' HB3' ' B' ' 36' ' ' SER . 30.4 t -168.65 166.4 11.84 Favored 'General case' 0 N--CA 1.399 -2.984 0 N-CA-C 103.492 -2.781 . . . . 6.93 103.492 -176.228 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 26.2 tpt180 -90.76 -4.69 56.49 Favored 'General case' 0 C--N 1.258 -3.378 0 CA-C-O 121.598 0.713 . . . . 12.14 109.211 -175.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . 0.647 HG21 HG23 ' B' ' 62' ' ' THR . 11.9 t -121.68 -8.49 9.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 122.08 0.943 . . . . 9.9 108.479 177.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 36' ' ' SER . . . . . 0.96 ' HG ' ' HH ' ' B' ' 59' ' ' TYR . 32.7 t -151.9 63.54 0.85 Allowed 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 107.229 -1.397 . . . . 6.82 107.229 -174.389 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -82.19 6.96 14.94 Favored 'General case' 0 C--O 1.245 0.838 0 CA-C-N 115.55 -0.75 . . . . 10.71 112.51 -178.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 20.1 tpp180 -114.69 140.31 48.96 Favored 'General case' 0 N--CA 1.417 -2.107 0 N-CA-C 105.024 -2.213 . . . . 8.6 105.024 177.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 39' ' ' SER . . . . . 0.689 ' HA ' ' O ' ' B' ' 30' ' ' ARG . 23.8 m -64.94 -8.81 17.21 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 114.33 1.233 . . . . 5.79 114.33 -174.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 26.6 ptt180 -150.89 148.5 28.51 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 107.853 -1.165 . . . . 6.57 107.853 174.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . -149.96 160.65 28.6 Favored Glycine 0 N--CA 1.414 -2.789 0 N-CA-C 110.685 -0.966 . . . . 2.62 110.685 176.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . 0.291 17.5 pt 65.55 -36.22 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 128.318 2.647 . . . . 2.28 115.12 175.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 2.5 p -52.27 -41.02 32.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 123.532 0.733 . . . . 2.6 112.926 178.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -87.81 -47.43 8.61 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 109.368 -0.604 . . . . 3.36 109.368 -176.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -54.49 -44.5 72.73 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 114.985 -1.007 . . . . 3.08 111.676 -179.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 46' ' ' CYS . . . . . 0.607 ' SG ' ' HB ' ' B' ' 7' ' ' THR . 22.9 t -86.22 -15.68 40.1 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.029 0.442 . . . . 2.23 111.246 -176.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 49.5 t -75.17 -37.97 61.06 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.235 0.54 . . . . 2.48 110.991 178.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -105.75 -12.79 15.76 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 113.766 1.024 . . . . 2.97 113.766 -177.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 56.6 mtm180 -138.61 158.24 44.62 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.703 -0.851 . . . . 4.65 108.703 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 16.0 t -80.27 114.91 19.51 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.782 -0.822 . . . . 2.86 108.782 -177.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . 0.429 ' H ' HG22 ' B' ' 7' ' ' THR . 32.0 p -89.42 143.61 26.69 Favored 'General case' 0 N--CA 1.421 -1.904 0 N-CA-C 108.247 -1.02 . . . . 2.11 108.247 -176.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -92.81 150.03 20.89 Favored 'General case' 0 N--CA 1.421 -1.884 0 N-CA-C 107.322 -1.362 . . . . 2.67 107.322 174.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . 0.606 ' HB3' ' HB3' ' A' 1600 ' ' SER . 3.9 pp -70.35 -9.16 55.4 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 113.199 0.814 . . . . 2.36 113.199 -171.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.24 -33.67 65.44 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.313 -0.995 . . . . 1.92 108.313 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 54.0 tp -60.67 -49.34 77.93 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-N 114.851 -1.068 . . . . 2.35 109.293 177.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 3.3 pp -73.83 -29.27 62.04 Favored 'General case' 0 N--CA 1.412 -2.353 0 C-N-CA 120.295 -0.562 . . . . 2.01 111.584 -176.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -63.98 -52.77 58.09 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.059 0.457 . . . . 2.27 110.929 -179.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 13.6 t -77.61 -23.07 49.94 Favored 'General case' 0 CA--C 1.557 1.214 0 CA-C-N 116.039 -0.528 . . . . 2.67 111.958 -177.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 59' ' ' TYR . . . . . 0.96 ' HH ' ' HG ' ' B' ' 36' ' ' SER . 10.2 t80 -81.67 -34.4 30.73 Favored 'General case' 0 C--O 1.243 0.732 0 N-CA-C 108.817 -0.808 . . . . 3.2 108.817 179.227 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 9.6 t -73.79 80.03 1.59 Allowed 'General case' 0 C--O 1.248 1.018 0 CA-C-N 115.269 -0.878 . . . . 2.3 111.733 -178.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . 76.07 151.7 0.12 Allowed 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 125.02 1.328 . . . . 3.19 113.938 173.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 62' ' ' THR . . . . . 0.647 HG23 HG21 ' B' ' 35' ' ' VAL . 4.7 p -127.98 139.3 34.99 Favored Pre-proline 0 N--CA 1.42 -1.942 0 CA-C-N 114.499 -1.228 . . . . 4.14 109.696 179.213 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -55.39 -28.23 62.34 Favored 'Trans proline' 0 CA--C 1.509 -0.727 0 C-N-CA 124.583 3.522 . . . . 5.59 115.415 -172.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -121.79 24.01 9.87 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 120.911 -0.315 . . . . 5.51 111.666 -179.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . 0.627 ' HB3' ' HG1' ' B' ' 62' ' ' THR . 22.0 tptm -156.9 28.56 0.31 Allowed 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 122.018 0.913 . . . . 8.8 109.905 -178.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 50.1 m -153.71 35.44 0.45 Allowed 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 121.464 0.65 . . . . 8.12 109.362 176.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 . . . . . 0 N--CA 1.423 -1.805 0 N-CA-C 108.16 -1.052 . . . . 10.21 108.16 -175.642 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 15.6 tpt . . . . . 0 CA--C 1.512 -0.49 0 N-CA-C 109.299 -0.63 . . . . 9.74 109.299 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A 1509 ' ' LYS . . . . . 0.762 ' HG2' ' HB2' ' A' 1526 ' ' LEU . 97.7 mttt -76.5 81.7 3.2 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 123.067 0.547 . . . . 9.32 110.827 -179.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 65.7 m -136.52 140.98 43.38 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.793 -0.64 . . . . 5.97 109.784 178.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1511 ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -86.71 67.12 9.75 Favored 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 109.299 -0.63 . . . . 3.48 109.299 176.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1512 ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -78.22 -31.4 49.32 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 115.67 -0.695 . . . . 5.95 110.181 -177.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 74.9 m-70 71.5 -64.41 0.39 Allowed 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 114.894 -1.048 . . . . 6.14 112.312 177.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1514 ' ' ASP . . . . . 0.436 ' HA ' ' O ' ' A' 1579 ' ' LYS . 26.7 t70 -68.37 -7.06 28.04 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.473 1.109 . . . . 5.06 112.515 -173.446 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 25.3 t70 -107.81 16.73 23.29 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.14 -0.975 . . . . 2.9 109.759 176.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1516 ' ' CYS . . . . . 0.647 ' HA ' ' HB2' ' A' 1581 ' ' LEU . 69.2 m 59.05 49.57 9.28 Favored 'General case' 0 C--O 1.246 0.884 0 N-CA-C 114.393 1.257 . . . . 1.41 114.393 -179.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -156.45 134.66 11.32 Favored 'General case' 0 N--CA 1.427 -1.599 0 CA-C-N 115.22 -0.9 . . . . 2.18 110.819 175.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1518 ' ' VAL . . . . . 0.547 HG22 ' HB2' ' A' 1583 ' ' TYR . 5.6 m -141.21 145.25 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 C-N-CA 124.411 1.085 . . . . 1.52 109.892 -178.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1519 ' ' THR . . . . . 0.449 ' OG1' HD21 ' A' 1526 ' ' LEU . 25.8 m -114.89 137.1 52.37 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 109.239 -0.652 . . . . 1.36 109.239 177.253 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1520 ' ' ASN . . . . . 0.518 ' OD1' HG21 ' A' 1523 ' ' THR . 26.8 t-20 -91.36 110.75 44.92 Favored Pre-proline 0 C--N 1.3 -1.556 0 N-CA-C 108.088 -1.078 . . . . 2.02 108.088 173.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -65.32 -19.08 61.86 Favored 'Trans proline' 0 N--CA 1.478 0.601 0 C-N-CA 123.464 2.776 . . . . 1.82 113.246 -173.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1522 ' ' SER . . . . . 0.486 ' HB2' ' OD1' ' A' 1520 ' ' ASN . 18.0 m -70.08 -44.58 68.79 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-N 115.849 -0.614 . . . . 1.89 111.259 -178.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1523 ' ' THR . . . . . 0.518 HG21 ' OD1' ' A' 1520 ' ' ASN . 9.6 t -119.01 6.86 11.33 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.54 0.686 . . . . 1.99 111.067 -175.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 57.83 36.02 77.88 Favored Glycine 0 CA--C 1.511 -0.199 0 CA-C-N 115.104 -0.953 . . . . 1.19 113.798 177.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 13.0 t-160 -100.72 122.14 42.86 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 120.537 -0.465 . . . . 1.82 110.578 -179.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1526 ' ' LEU . . . . . 0.762 ' HB2' ' HG2' ' A' 1509 ' ' LYS . 2.2 tm? -96.92 114.61 26.25 Favored 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 124.76 1.224 . . . . 1.3 109.522 -179.149 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -91.24 115.28 27.9 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 116.777 -0.192 . . . . 0.8 111.167 176.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 6.3 t70 -101.74 115.02 29.62 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 108.094 -1.076 . . . . 1.17 108.094 174.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1529 ' ' LEU . . . . . 0.405 ' HB2' ' HB3' ' A' 1516 ' ' CYS . 3.6 mm? -101.07 4.17 42.0 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.346 0.593 . . . . 1.29 110.129 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1530 ' ' SER . . . . . 0.424 ' HA ' ' OG ' ' A' 1533 ' ' SER . 1.2 m -67.01 -30.19 70.22 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.16 -0.927 . . . . 0.91 109.011 179.174 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 30.9 m -61.38 -27.76 68.75 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 114.962 -1.017 . . . . 1.98 111.008 178.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 83.1 mt -99.09 -1.08 40.43 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 120.696 0.284 . . . . 1.34 110.819 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1533 ' ' SER . . . . . 0.424 ' OG ' ' HA ' ' A' 1530 ' ' SER . 19.6 m -75.0 158.92 32.44 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 120.736 0.303 . . . . 1.93 110.877 -177.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . 176.71 146.48 6.09 Favored Glycine 0 N--CA 1.443 -0.833 0 N-CA-C 110.867 -0.893 . . . . 1.1 110.867 -179.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -92.62 -29.07 16.32 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 123.205 0.602 . . . . 5.21 111.036 -177.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -75.83 -38.89 57.64 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.864 0.84 . . . . 1.94 108.986 177.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 94.87 -165.52 25.66 Favored Glycine 0 N--CA 1.422 -2.283 0 CA-C-N 114.939 -1.028 . . . . 1.08 114.081 172.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -128.34 153.69 46.75 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 107.267 -1.383 . . . . 1.07 107.267 -178.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 3.0 p -112.56 136.11 52.48 Favored 'General case' 0 C--N 1.31 -1.149 0 O-C-N 123.539 0.525 . . . . 1.46 111.388 -177.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1540 ' ' ALA . . . . . 0.401 ' HB1' ' CG1' ' A' 1548 ' ' VAL . . . -128.22 148.62 50.63 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.517 -0.92 . . . . 1.19 108.517 175.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -82.4 135.86 35.08 Favored 'General case' 0 C--N 1.315 -0.9 0 O-C-N 123.556 0.535 . . . . 1.37 111.494 -176.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1542 ' ' TYR . . . . . 0.416 ' CE2' ' HG ' ' A' 1626 ' ' LEU . 2.4 t80 -134.11 -101.32 0.24 Allowed 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 115.628 -0.714 . . . . 1.38 109.434 179.33 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1543 ' ' SER . . . . . 0.41 ' H ' ' HB3' ' A' 1542 ' ' TYR . 39.8 t -72.32 160.42 32.4 Favored 'General case' 0 C--O 1.246 0.92 0 CA-C-N 115.907 -0.588 . . . . 1.98 110.569 -178.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1544 ' ' LYS . . . . . 0.418 ' HE2' ' HA ' ' B' ' 23' ' ' ASP . 24.3 ttmm -53.61 -40.3 65.64 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.958 0.409 . . . . 3.96 111.634 -178.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 45.6 m -104.32 12.02 34.07 Favored 'General case' 0 N--CA 1.413 -2.294 0 N-CA-C 112.42 0.526 . . . . 2.81 112.42 -174.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . -155.42 147.69 16.92 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 117.822 -2.132 . . . . 1.68 115.683 -173.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 35.1 m -113.0 172.94 2.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 108.557 -0.905 . . . . 1.38 108.557 178.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1548 ' ' VAL . . . . . 0.44 ' HA ' ' HA ' ' A' 1567 ' ' PHE . 14.9 p -115.69 141.39 33.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 109.125 -0.694 . . . . 1.24 109.125 176.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -103.74 129.5 51.12 Favored 'General case' 0 CA--C 1.491 -1.327 0 N-CA-C 109.32 -0.622 . . . . 1.29 109.32 176.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 23.1 ptm -139.66 128.62 23.54 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 115.435 -0.802 . . . . 1.47 110.494 -179.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1551 ' ' SER . . . . . 0.427 ' HB3' HD21 ' A' 1556 ' ' ASN . 15.4 p -112.12 131.46 55.44 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 115.773 -0.649 . . . . 1.4 109.721 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1552 ' ' ILE . . . . . . . . . . . . . 46.9 mm -91.0 121.11 41.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 N-CA-C 109.529 -0.545 . . . . 1.11 109.529 -178.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1553 ' ' CYS . . . . . 0.461 ' O ' ' HE2' ' A' 1579 ' ' LYS . 72.7 m 60.33 42.84 14.32 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 121.73 0.776 . . . . 1.4 112.058 175.077 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 177.64 171.88 41.56 Favored Glycine 0 N--CA 1.417 -2.62 0 N-CA-C 110.312 -1.115 . . . . 0.4 110.312 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -87.33 153.45 21.45 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 109.441 -0.577 . . . . 1.62 109.441 179.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1556 ' ' ASN . . . . . 0.427 HD21 ' HB3' ' A' 1551 ' ' SER . 18.4 t-20 -102.06 120.98 41.3 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 108.815 -0.809 . . . . 1.12 108.815 -177.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -78.87 13.85 1.57 Allowed 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 113.549 0.944 . . . . 2.49 113.549 -174.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 54.6 m-80 -96.08 -12.54 24.69 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 120.214 -0.595 . . . . 1.38 110.368 177.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1559 ' ' CYS . . . . . 0.751 ' SG ' ' HD2' ' A' 1560 ' ' PRO . 3.8 t -136.77 164.09 44.95 Favored Pre-proline 0 C--N 1.307 -1.253 0 CA-C-O 117.154 -1.403 . . . . 1.21 107.555 -175.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1560 ' ' PRO . . . . . 0.751 ' HD2' ' SG ' ' A' 1559 ' ' CYS . 37.9 Cg_exo -28.5 140.96 0.02 OUTLIER 'Trans proline' 0 C--N 1.381 2.249 1 C-N-CA 125.549 4.166 . . . . 0.98 116.341 177.657 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -53.04 127.4 24.86 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 124.017 3.144 . . . . 1.15 114.194 -177.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 93.58 7.05 62.01 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-N 115.755 -0.657 . . . . 0.55 114.345 177.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1563 ' ' VAL . . . . . 0.607 HG13 ' HB3' ' A' 1559 ' ' CYS . 5.5 p -99.3 141.98 15.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 O-C-N 121.929 -0.748 . . . . 1.53 110.401 -179.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -104.68 -28.71 5.58 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-N 116.339 -0.391 . . . . 0.29 112.99 178.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -130.56 131.78 45.21 Favored 'General case' 0 C--O 1.245 0.827 0 O-C-N 122.294 -0.533 . . . . 1.08 110.794 179.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 44.3 t -159.81 141.32 12.81 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.785 -0.82 . . . . 0.43 108.785 -178.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1567 ' ' PHE . . . . . 0.517 ' HB2' ' OG1' ' A' 1570 ' ' THR . 93.9 m-85 -86.91 146.51 26.15 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.776 -0.824 . . . . 1.3 108.776 178.211 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -68.71 -20.67 74.34 Favored Glycine 0 C--O 1.222 -0.625 0 N-CA-C 115.269 0.868 . . . . 1.43 115.269 -172.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 35.7 mm-40 -96.8 -30.68 13.03 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 117.535 0.667 . . . . 3.09 112.048 176.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1570 ' ' THR . . . . . 0.569 ' HA ' ' OD2' ' B' ' 15' ' ' ASP . 46.8 p -81.92 -32.0 31.07 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 115.236 1.569 . . . . 2.52 115.236 -163.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 69.78 -2.63 1.93 Allowed 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.984 0.914 . . . . 3.19 109.993 -172.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 28.5 mt -86.32 132.73 31.47 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 CA-C-O 121.473 0.654 . . . . 1.51 110.834 -171.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 17.6 t -78.65 116.53 19.07 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 114.446 -1.252 . . . . 0.96 109.589 179.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1574 ' ' VAL . . . . . 0.512 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 23.2 m -114.22 8.36 7.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-O 121.316 0.579 . . . . 1.6 111.437 -178.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . -174.45 112.63 0.42 Allowed Glycine 0 N--CA 1.428 -1.898 0 C-N-CA 120.35 -0.929 . . . . 0.34 111.527 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1576 ' ' LYS . . . . . 0.433 ' HB3' ' O ' ' A' 1593 ' ' LYS . 87.0 tttt -71.07 134.67 47.24 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.406 -0.961 . . . . 2.68 108.406 177.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -68.11 131.35 45.26 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-O 120.942 0.401 . . . . 1.08 110.465 -178.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -150.16 165.26 33.41 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 104.394 -2.447 . . . . 1.95 104.394 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1579 ' ' LYS . . . . . 0.461 ' HE2' ' O ' ' A' 1553 ' ' CYS . 97.4 mttt -130.83 40.1 3.52 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 108.675 -0.861 . . . . 3.11 108.675 -178.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -92.99 76.63 4.72 Favored 'General case' 0 N--CA 1.418 -2.073 0 CA-C-O 122.181 0.991 . . . . 4.04 109.893 -171.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1581 ' ' LEU . . . . . 0.647 ' HB2' ' HA ' ' A' 1516 ' ' CYS . 1.0 OUTLIER -63.71 125.93 25.92 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 113.18 -1.827 . . . . 1.32 109.173 178.856 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 78.3 mtp180 -125.28 139.99 53.22 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 115.919 -0.582 . . . . 3.4 109.719 175.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1583 ' ' TYR . . . . . 0.621 ' CE1' ' HA ' ' A' 1586 ' ' GLN . 64.6 t80 -112.52 110.73 21.08 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 108.757 -0.831 . . . . 1.26 108.757 -178.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1584 ' ' VAL . . . . . 0.517 ' O ' ' HB ' ' A' 1587 ' ' VAL . 10.9 m -122.52 88.99 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-O 121.36 0.6 . . . . 1.71 112.142 -178.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 38.6 t70 55.13 65.09 1.59 Allowed 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 115.09 -0.959 . . . . 1.17 111.083 178.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1586 ' ' GLN . . . . . 0.621 ' HA ' ' CE1' ' A' 1583 ' ' TYR 0.291 11.6 pt20 64.69 15.37 9.7 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 126.826 2.05 . . . . 2.43 112.631 177.562 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A 1587 ' ' VAL . . . . . 0.517 ' HB ' ' O ' ' A' 1584 ' ' VAL . 41.9 t -110.63 121.28 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.338 0 CA-C-N 114.219 -1.355 . . . . 1.16 108.265 175.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1588 ' ' LEU . . . . . 0.819 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 2.6 mm? -95.83 114.65 26.4 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 106.688 -1.597 . . . . 1.11 106.688 179.054 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -126.77 125.19 41.33 Favored 'General case' 0 C--N 1.289 -2.031 0 C-N-CA 119.177 -1.009 . . . . 1.74 112.674 -175.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 19.1 mt -107.88 126.76 53.05 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 113.993 -1.458 . . . . 1.4 107.178 175.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 48.5 t -115.47 122.04 68.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 C-N-CA 119.879 -0.728 . . . . 1.7 109.893 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1592 ' ' TYR . . . . . . . . . . . . . 15.7 m-30 -105.49 94.74 5.37 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.932 -1.136 . . . . 1.08 107.932 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1593 ' ' LYS . . . . . 0.433 ' O ' ' HB3' ' A' 1576 ' ' LYS . 49.6 pttt -105.07 172.46 6.78 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 115.997 -0.547 . . . . 2.21 109.672 -176.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 70.1 m-20 57.11 52.79 8.6 Favored 'General case' 0 CA--C 1.51 -0.568 0 O-C-N 124.502 1.126 . . . . 1.11 111.554 178.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -71.88 -113.18 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 110.364 -1.095 . . . . 0.78 110.364 176.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1596 ' ' SER . . . . . 0.649 ' HB3' ' HD2' ' A' 1597 ' ' PRO . 72.2 m -133.43 168.68 16.72 Favored Pre-proline 0 C--N 1.284 -2.262 0 O-C-N 121.317 -1.108 . . . . 1.36 111.155 172.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1597 ' ' PRO . . . . . 0.649 ' HD2' ' HB3' ' A' 1596 ' ' SER . 2.5 Cg_endo -40.28 127.1 2.14 Favored 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 124.118 3.212 . . . . 1.4 114.058 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1598 ' ' CYS . . . . . 0.518 ' SG ' ' HB2' ' A' 1600 ' ' SER . 48.3 t -92.14 123.15 63.5 Favored Pre-proline 0 C--N 1.287 -2.124 0 CA-C-N 114.526 -1.215 . . . . 0.75 109.825 -179.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1599 ' ' PRO . . . . . 0.447 ' O ' ' HA ' ' B' ' 52' ' ' ASP . 17.2 Cg_exo -71.48 -27.99 18.33 Favored 'Trans proline' 0 C--O 1.211 -0.87 0 C-N-CA 122.206 1.937 . . . . 1.7 111.158 174.271 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1600 ' ' SER . . . . . 0.853 ' HA ' ' HB2' ' B' ' 53' ' ' LEU . 7.4 m -61.07 -47.16 87.64 Favored 'General case' 0 CA--C 1.555 1.145 0 CA-C-N 116.358 -0.383 . . . . 2.8 110.667 178.096 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1601 ' ' LYS . . . . . . . . . . . . . 5.4 tppp? -126.31 111.14 14.18 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 107.407 -1.331 . . . . 3.45 107.407 174.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 35.2 t -71.27 122.13 19.7 Favored 'General case' 0 N--CA 1.419 -2.001 0 C-N-CA 122.469 0.308 . . . . 2.44 110.223 -171.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 104.76 -10.15 48.57 Favored Glycine 0 N--CA 1.441 -1.032 0 N-CA-C 111.472 -0.651 . . . . 1.2 111.472 179.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1604 ' ' LEU . . . . . 0.486 HD23 ' SG ' ' A' 1634 ' ' CYS . 9.2 tp -101.09 168.63 9.47 Favored 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 107.832 -1.173 . . . . 2.38 107.832 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 20.2 m -129.64 146.93 51.39 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 109.117 -0.697 . . . . 1.96 109.117 178.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1606 ' ' TYR . . . . . 0.586 ' HD1' HD13 ' A' 1636 ' ' LEU . 67.0 m-85 -64.64 162.69 15.2 Favored 'General case' 0 C--O 1.251 1.182 0 N-CA-C 113.213 0.82 . . . . 1.06 113.213 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1607 ' ' LYS . . . . . 0.523 ' HE3' HG22 ' A' 1635 ' ' THR . 33.3 ttpt -158.54 130.78 6.86 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.067 -0.969 . . . . 2.0 109.194 -177.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1608 ' ' SER . . . . . . . . . . . . . 19.9 m -107.34 130.18 54.82 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 109.48 -0.563 . . . . 1.61 109.48 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 39.0 t -110.63 109.19 27.55 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 N-CA-C 108.687 -0.857 . . . . 1.09 108.687 178.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 62.1 mt -101.18 110.16 27.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 115.762 -0.654 . . . . 1.2 109.632 -177.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 27.9 t -111.59 115.09 28.58 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 115.61 -0.723 . . . . 1.89 110.361 -178.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1612 ' ' PHE . . . . . 0.819 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 71.9 m-85 -89.53 122.74 32.98 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 107.96 -1.126 . . . . 0.28 107.96 175.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 43.9 t -116.19 138.72 45.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 109.333 -0.617 . . . . 1.23 109.333 -176.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 40.5 t -66.77 119.02 11.13 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 123.998 0.919 . . . . 0.77 111.252 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1615 ' ' ARG . . . . . 0.814 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 20.2 tpt180 -122.16 96.72 46.21 Favored Pre-proline 0 N--CA 1.446 -0.663 0 N-CA-C 109.856 -0.424 . . . . 2.92 109.856 176.422 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1616 ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -66.6 -40.48 13.44 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.251 1.967 . . . . 1.22 110.607 176.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -80.6 43.28 0.65 Allowed 'General case' 0 C--O 1.241 0.647 0 C-N-CA 124.3 1.04 . . . . 3.05 111.272 176.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1618 ' ' ALA . . . . . 0.586 ' HB2' ' HG3' ' A' 1643 ' ' PRO . . . -39.51 124.68 1.65 Allowed 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 125.617 1.567 . . . . 1.55 113.166 -178.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1619 ' ' GLY . . . . . 0.482 ' C ' ' H ' ' A' 1621 ' ' THR . . . -154.63 -140.37 3.01 Favored Glycine 0 N--CA 1.43 -1.734 0 N-CA-C 108.431 -1.868 . . . . 1.16 108.431 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.36 20.14 0.36 Allowed 'Trans proline' 0 N--CA 1.486 1.062 0 C-N-CA 122.904 2.402 . . . . 1.06 112.827 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1621 ' ' THR . . . . . 0.836 ' HB ' ' HB2' ' A' 1641 ' ' HIS . 56.9 p -91.18 -14.21 31.49 Favored 'General case' 0 C--N 1.292 -1.922 0 C-N-CA 124.86 1.264 . . . . 1.58 108.975 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -87.93 68.26 9.22 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.963 -1.017 . . . . 0.88 109.002 -174.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 3.5 ptp180 -167.38 139.33 2.64 Favored Pre-proline 0 C--N 1.317 -0.821 0 C-N-CA 124.435 1.094 . . . . 3.82 108.561 179.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.99 109.62 1.54 Allowed 'Trans proline' 0 C--O 1.238 0.522 0 C-N-CA 122.757 2.305 . . . . 0.77 111.584 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 72.3 mtm -113.74 140.87 47.91 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 116.467 -0.333 . . . . 1.43 111.255 -178.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1626 ' ' LEU . . . . . 0.416 ' HG ' ' CE2' ' A' 1542 ' ' TYR . 1.8 tm? -78.48 119.78 22.27 Favored 'General case' 0 C--O 1.244 0.787 0 N-CA-C 107.358 -1.349 . . . . 1.43 107.358 179.149 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1627 ' ' ILE . . . . . 0.654 HD13 ' HB2' ' A' 1639 ' ' SER . 42.3 mm -80.16 -55.28 9.17 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 N-CA-C 108.833 -0.803 . . . . 1.23 108.833 178.448 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 22.7 t -173.82 158.4 3.23 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 106.933 -1.506 . . . . 1.88 106.933 -177.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1629 ' ' LEU . . . . . 0.798 ' HG ' ' HG ' ' A' 1636 ' ' LEU . 3.4 tt -115.58 113.02 23.04 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 104.312 -2.477 . . . . 1.92 104.312 175.165 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 16.4 t70 -69.48 103.95 2.19 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 108.602 -0.888 . . . . 1.09 108.602 176.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -61.94 -23.96 66.69 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 125.239 1.415 . . . . 3.98 113.319 -172.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 18.0 mm100 -86.13 -38.65 17.52 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 120.85 -0.34 . . . . 2.6 111.533 -177.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 67.0 p -103.88 2.27 32.39 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 112.657 0.614 . . . . 1.35 112.657 -174.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1634 ' ' CYS . . . . . 0.486 ' SG ' HD23 ' A' 1604 ' ' LEU . 81.4 m 57.47 35.67 26.13 Favored 'General case' 0 C--N 1.369 1.425 0 C-N-CA 123.96 0.904 . . . . 0.53 111.443 177.245 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1635 ' ' THR . . . . . 0.523 HG22 ' HE3' ' A' 1607 ' ' LYS . 90.8 m -107.85 126.86 53.17 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 115.155 -0.93 . . . . 1.11 109.97 -176.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1636 ' ' LEU . . . . . 0.798 ' HG ' ' HG ' ' A' 1629 ' ' LEU . 0.8 OUTLIER -107.07 122.15 45.9 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 108.588 -0.893 . . . . 1.56 108.588 -175.66 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -101.87 133.25 46.93 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 120.81 0.338 . . . . 0.54 111.465 -178.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -129.25 145.07 51.42 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.67 -0.696 . . . . 0.64 109.895 -178.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1639 ' ' SER . . . . . 0.654 ' HB2' HD13 ' A' 1627 ' ' ILE . 8.4 t -125.9 157.34 37.95 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 109.567 -0.531 . . . . 1.34 109.567 177.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 3.2 t90 -156.58 108.41 2.48 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 104.923 -2.251 . . . . 0.8 104.923 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1641 ' ' HIS . . . . . 0.836 ' HB2' ' HB ' ' A' 1621 ' ' THR . 18.1 m-70 -101.5 104.53 15.45 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 109.283 -0.636 . . . . 1.14 109.283 -178.254 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1642 ' ' THR . . . . . . . . . . . . . 3.2 t -133.64 150.11 73.93 Favored Pre-proline 0 C--N 1.3 -1.554 0 CA-C-N 115.186 -0.916 . . . . 1.11 110.608 -171.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1643 ' ' PRO . . . . . 0.586 ' HG3' ' HB2' ' A' 1618 ' ' ALA . 7.6 Cg_exo -73.63 -7.36 20.1 Favored 'Trans proline' 0 C--N 1.385 2.463 0 C-N-CA 122.44 2.094 . . . . 0.78 112.327 173.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 10.5 tt -66.95 -26.68 66.95 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.439 0.637 . . . . 1.66 109.814 179.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -92.39 9.87 32.36 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.193 -0.912 . . . . 1.29 109.82 179.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1646 ' ' CYS . . . . . 0.432 ' SG ' ' HA ' ' A' 1643 ' ' PRO . 72.9 m -111.86 146.92 36.85 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-N 115.958 -0.565 . . . . 1.48 110.416 -178.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -79.33 129.95 70.43 Favored Pre-proline 0 N--CA 1.424 -1.739 0 N-CA-C 106.57 -1.641 . . . . 3.14 106.57 173.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1648 ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -64.47 120.07 7.27 Favored 'Trans proline' 0 C--O 1.245 0.828 0 C-N-CA 122.269 1.979 . . . . 2.92 112.625 -177.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 . . . . . 0 C--O 1.254 1.301 0 N-CA-C 108.34 -0.985 . . . . 4.72 108.34 177.672 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.598 0 CA-C-O 121.108 0.48 . . . . 10.26 109.959 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 2' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -95.06 110.7 22.59 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 121.271 0.558 . . . . 7.94 109.715 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 3' ' ' ARG . . . . . 0.512 HH11 ' HA ' ' B' ' 8' ' ' LEU . 40.0 ptt180 -80.2 150.09 70.6 Favored Pre-proline 0 C--N 1.3 -1.566 0 N-CA-C 107.782 -1.192 . . . . 6.56 107.782 178.028 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -73.06 28.48 0.29 Allowed 'Trans proline' 0 N--CA 1.48 0.701 0 C-N-CA 123.391 2.727 . . . . 5.51 113.52 -178.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 5' ' ' SER . . . . . 0.509 ' H ' ' C ' ' B' ' 3' ' ' ARG . 60.6 p 53.92 3.67 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 127.896 2.478 . . . . 4.91 115.639 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -91.6 -40.74 11.16 Favored 'General case' 0 C--N 1.31 -1.125 0 O-C-N 122.232 -0.292 . . . . 4.23 111.09 -177.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 7' ' ' THR . . . . . 0.448 ' O ' ' HD2' ' B' ' 3' ' ' ARG . 7.1 p -111.33 132.54 54.32 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-N 115.882 -0.599 . . . . 3.48 111.473 -173.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . 0.649 ' HB2' ' HG3' ' B' ' 12' ' ' GLU . 9.4 mp -96.99 132.07 43.17 Favored 'General case' 0 N--CA 1.439 -0.978 0 C-N-CA 122.374 0.27 . . . . 4.35 110.921 179.007 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 9' ' ' CYS . . . . . 0.57 ' HA ' HD22 ' B' ' 13' ' ' LEU . 56.0 m -86.22 140.34 30.22 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 108.567 -0.901 . . . . 2.84 108.567 -178.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . 0.413 ' O ' HG12 ' B' ' 14' ' ' VAL . . . 90.73 -77.02 1.51 Allowed Glycine 0 N--CA 1.431 -1.642 0 C-N-CA 120.484 -0.865 . . . . 2.28 111.301 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -59.96 -67.09 2.32 Favored Glycine 0 CA--C 1.5 -0.871 0 CA-C-O 119.504 -0.609 . . . . 1.94 113.069 -175.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . 0.649 ' HG3' ' HB2' ' B' ' 8' ' ' LEU . 54.1 mt-10 -62.59 -29.14 70.38 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 117.371 0.585 . . . . 2.55 110.886 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . 0.57 HD22 ' HA ' ' B' ' 9' ' ' CYS . 1.2 mm? -59.38 -62.36 1.93 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.857 -0.61 . . . . 2.82 111.879 177.191 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . 0.413 HG12 ' O ' ' B' ' 10' ' ' GLY . 10.9 p -69.45 -28.74 39.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 115.834 -0.621 . . . . 2.5 110.494 -176.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 15' ' ' ASP . . . . . 0.569 ' OD2' ' HA ' ' A' 1570 ' ' THR . 31.7 t70 -70.71 -45.98 63.93 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 113.85 1.055 . . . . 2.04 113.85 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 20.3 p -63.95 -39.85 95.09 Favored 'General case' 0 C--O 1.275 2.422 0 CA-C-O 121.859 0.838 . . . . 2.31 109.935 178.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.444 ' HB3' ' HB3' ' B' ' 26' ' ' PHE . 11.2 mp -59.52 -48.34 82.03 Favored 'General case' 0 N--CA 1.416 -2.15 0 CA-C-N 114.947 -1.024 . . . . 2.27 110.689 172.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -56.74 -29.47 62.56 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.499 0.72 . . . . 2.39 111.942 174.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -58.1 -56.63 19.57 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-O 119.335 -0.365 . . . . 1.0 111.374 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 10.3 p -99.71 -17.62 6.64 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.309 0 C-N-CA 117.557 -1.657 . . . . 1.83 112.706 177.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 21' ' ' CYS . . . . . 0.593 ' HA ' ' HB3' ' B' ' 24' ' ' ARG . 58.9 m -112.22 30.77 6.78 Favored 'General case' 0 C--N 1.293 -1.849 0 O-C-N 121.717 -0.614 . . . . 1.66 112.0 -176.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.19 -64.47 4.24 Favored Glycine 0 C--O 1.241 0.571 0 C-N-CA 120.347 -0.93 . . . . 1.53 111.762 177.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . 0.418 ' HA ' ' HE2' ' A' 1544 ' ' LYS . 31.6 t70 -69.73 -34.8 74.35 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 122.674 0.39 . . . . 2.72 111.086 175.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . 0.593 ' HB3' ' HA ' ' B' ' 21' ' ' CYS . 8.6 tpm_? -64.57 -35.74 81.96 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 124.24 1.016 . . . . 5.02 112.399 -177.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.81 149.59 23.42 Favored Glycine 0 N--CA 1.423 -2.204 0 N-CA-C 110.853 -0.899 . . . . 1.63 110.853 -179.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . 0.444 ' HB3' ' HB3' ' B' ' 17' ' ' LEU . 0.3 OUTLIER -131.41 136.18 47.8 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 111.917 0.34 . . . . 1.71 111.917 178.769 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -139.84 78.65 1.67 Allowed 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.785 -0.45 . . . . 3.67 109.785 176.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 28' ' ' PHE . . . . . 0.572 ' O ' ' HA3' ' B' ' 41' ' ' GLY . 11.1 p90 -94.15 -20.67 19.67 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.794 0.807 . . . . 2.44 109.102 178.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 50.0 m -86.65 84.94 7.29 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 121.357 0.599 . . . . 3.85 111.041 -178.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 76.0 mtt-85 -95.2 112.94 60.3 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-N 115.832 -0.622 . . . . 4.27 109.783 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -69.08 -54.87 0.22 Allowed 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 121.369 1.38 . . . . 4.2 109.397 172.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -153.0 160.51 43.02 Favored 'General case' 0 N--CA 1.417 -2.107 0 N-CA-C 106.663 -1.606 . . . . 5.12 106.663 176.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 68.2 m -159.48 163.48 35.26 Favored 'General case' 0 N--CA 1.394 -3.236 0 N-CA-C 101.837 -3.394 . . . . 6.93 101.837 178.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 52.8 ttp180 -93.03 -4.35 52.71 Favored 'General case' 0 C--N 1.273 -2.754 0 CA-C-O 121.604 0.716 . . . . 12.14 111.276 -170.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 53.3 t -118.6 -9.33 11.64 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-O 122.75 1.262 . . . . 9.9 108.028 175.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 8.6 t -143.21 77.6 1.57 Allowed 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 105.155 -2.165 . . . . 6.82 105.155 179.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -80.42 -2.47 45.85 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 114.295 -1.32 . . . . 10.71 111.157 -175.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -98.68 144.85 27.49 Favored 'General case' 0 N--CA 1.425 -1.686 0 N-CA-C 107.014 -1.476 . . . . 8.6 107.014 179.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 20.7 m -81.17 74.22 8.18 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 121.91 0.862 . . . . 5.79 110.759 -178.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 23.0 ttm180 -135.98 136.62 40.51 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 115.187 -0.915 . . . . 6.57 108.856 177.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . 0.572 ' HA3' ' O ' ' B' ' 28' ' ' PHE . . . -156.43 77.43 0.2 Allowed Glycine 0 N--CA 1.398 -3.882 0 N-CA-C 106.337 -2.705 . . . . 2.62 106.337 176.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . 0.453 ' HA ' ' HG2' ' B' ' 45' ' ' GLU . 31.2 pt 60.24 -8.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 C-N-CA 127.786 2.434 . . . . 2.28 114.904 -179.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . 0.472 ' H ' ' C ' ' B' ' 41' ' ' GLY . 9.8 p -62.48 -34.1 62.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 C-N-CA 123.301 0.64 . . . . 2.6 112.42 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -84.07 -24.69 30.28 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 118.089 -1.444 . . . . 3.36 108.803 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . 0.453 ' HG2' ' HA ' ' B' ' 42' ' ' ILE . 32.2 mm-40 -67.66 -62.39 1.44 Allowed 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.377 -0.829 . . . . 3.08 109.154 -179.115 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 46' ' ' CYS . . . . . . . . . . . . . 21.1 m -76.39 -22.74 54.4 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 113.996 1.11 . . . . 2.23 113.996 -171.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 85.0 m -76.67 -1.66 28.9 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 121.201 -0.937 . . . . 2.48 112.594 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -133.94 -47.57 0.79 Allowed 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 112.467 0.543 . . . . 2.97 112.467 177.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 56.7 mtt-85 -104.53 168.9 8.78 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 120.889 0.375 . . . . 4.65 110.029 178.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 37.1 t -90.95 109.98 21.22 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 107.629 -1.249 . . . . 2.86 107.629 176.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . 0.544 ' HB2' HD22 ' B' ' 55' ' ' LEU . 21.8 p -90.93 135.48 33.71 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.851 -0.796 . . . . 2.11 108.851 -177.249 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . 0.447 ' HA ' ' O ' ' A' 1599 ' ' PRO . 3.7 p30 -98.66 172.05 7.73 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 113.376 0.88 . . . . 2.67 113.376 -176.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . 0.853 ' HB2' ' HA ' ' A' 1600 ' ' SER . 41.9 tp -51.12 -40.48 58.57 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 113.298 0.851 . . . . 2.36 113.298 -174.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . 0.4 ' O ' HG21 ' B' ' 58' ' ' THR . . . -54.94 -46.39 74.95 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 123.623 0.577 . . . . 1.92 111.575 -172.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . 0.544 HD22 ' HB2' ' B' ' 51' ' ' CYS . 48.0 tp -62.49 -58.0 9.16 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 114.925 -1.034 . . . . 2.35 110.516 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 3.9 pp -69.11 -34.1 74.54 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 112.692 0.627 . . . . 2.01 112.692 -172.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -76.24 -40.37 52.18 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 112.204 0.446 . . . . 2.27 112.204 -179.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 58' ' ' THR . . . . . 0.4 HG21 ' O ' ' B' ' 54' ' ' ALA . 7.0 t -77.71 -11.52 59.88 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 118.653 -1.219 . . . . 2.67 110.635 176.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 59' ' ' TYR . . . . . 0.442 ' OH ' ' HA2' ' B' ' 41' ' ' GLY . 17.6 t80 -85.59 -72.03 0.51 Allowed 'General case' 0 N--CA 1.426 -1.673 0 N-CA-C 106.477 -1.675 . . . . 3.2 106.477 175.21 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 41.3 t 38.38 -88.47 0.01 OUTLIER 'General case' 0 C--O 1.253 1.245 0 C-N-CA 126.071 1.748 . . . . 2.3 114.559 174.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -152.49 -55.38 0.13 Allowed 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 106.971 -1.492 . . . . 3.19 106.971 177.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 4.0 p -77.99 134.65 63.79 Favored Pre-proline 0 N--CA 1.408 -2.566 0 CA-C-N 114.381 -1.281 . . . . 4.14 108.582 172.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -74.39 -20.5 18.33 Favored 'Trans proline' 0 C--O 1.238 0.489 0 C-N-CA 122.616 2.211 . . . . 5.59 114.152 -174.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -142.88 83.92 1.82 Allowed 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 120.861 0.362 . . . . 5.51 110.712 179.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 54.1 tttp -71.18 129.71 39.62 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 109.135 -0.691 . . . . 8.8 109.135 175.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 29.8 m -121.05 -40.1 2.64 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.216 -1.031 . . . . 8.12 108.216 177.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 . . . . . 0 N--CA 1.429 -1.514 0 N-CA-C 105.168 -2.16 . . . . 10.21 105.168 178.547 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 3.9 mpp? . . . . . 0 CA--C 1.506 -0.73 0 N-CA-C 108.075 -1.083 . . . . 9.74 108.075 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A 1509 ' ' LYS . . . . . 0.495 ' HD3' ' HA ' ' A' 1521 ' ' PRO . 24.5 ttmm -153.68 58.9 0.74 Allowed 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 106.7 -1.593 . . . . 9.32 106.7 179.194 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 13.8 m -53.63 104.82 0.11 Allowed 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.0 -1.455 . . . . 5.97 112.822 -174.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1511 ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -104.54 97.68 7.55 Favored 'General case' 0 N--CA 1.425 -1.679 0 N-CA-C 107.035 -1.469 . . . . 3.48 107.035 175.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1512 ' ' GLU . . . . . 0.483 ' O ' HG11 ' A' 1518 ' ' VAL . 43.8 mt-10 -84.44 173.23 11.04 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 114.117 -1.401 . . . . 5.95 110.455 -172.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 60.2 m80 -146.42 -11.95 0.47 Allowed 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.397 0.888 . . . . 6.14 113.397 -178.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -104.6 -0.17 27.92 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 112.1 0.407 . . . . 5.06 112.1 -173.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -120.43 22.78 11.16 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 111.687 0.254 . . . . 2.9 111.687 -178.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1516 ' ' CYS . . . . . 0.594 ' HA ' ' HB2' ' A' 1581 ' ' LEU . 59.8 m 56.34 41.49 28.98 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-O 121.267 0.556 . . . . 1.41 110.951 -177.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -150.77 130.11 12.86 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 108.884 -0.784 . . . . 2.18 108.884 -179.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1518 ' ' VAL . . . . . 0.483 HG11 ' O ' ' A' 1512 ' ' GLU . 3.3 m -136.03 138.22 47.66 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 O-C-N 124.13 0.894 . . . . 1.52 110.47 -177.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1519 ' ' THR . . . . . . . . . . . . . 44.2 m -104.8 136.13 44.89 Favored 'General case' 0 C--N 1.281 -2.397 0 N-CA-C 107.612 -1.255 . . . . 1.36 107.612 175.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1520 ' ' ASN . . . . . 0.502 ' OD1' ' HB2' ' A' 1522 ' ' SER . 21.3 t-20 -91.23 115.76 65.06 Favored Pre-proline 0 C--N 1.287 -2.126 0 N-CA-C 108.816 -0.809 . . . . 2.02 108.816 174.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1521 ' ' PRO . . . . . 0.495 ' HA ' ' HD3' ' A' 1509 ' ' LYS . 35.9 Cg_endo -66.34 -15.52 48.37 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.998 2.465 . . . . 1.82 113.713 -176.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1522 ' ' SER . . . . . 0.502 ' HB2' ' OD1' ' A' 1520 ' ' ASN . 30.2 m -75.98 -44.76 38.2 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 111.772 0.286 . . . . 1.89 111.772 -179.142 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1523 ' ' THR . . . . . 0.459 HG21 ' OD1' ' A' 1520 ' ' ASN . 11.1 t -118.44 -1.26 11.27 Favored 'General case' 0 CA--C 1.556 1.178 0 CA-C-O 121.506 0.669 . . . . 1.99 112.092 -175.131 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 67.3 33.66 83.1 Favored Glycine 0 CA--C 1.503 -0.718 0 CA-C-N 115.829 -0.623 . . . . 1.19 112.937 176.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -98.68 121.9 41.22 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 109.626 -0.509 . . . . 1.82 109.626 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 1.9 tm? -94.12 111.84 23.6 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.208 -0.905 . . . . 1.3 108.804 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -83.48 114.57 21.57 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 120.676 0.274 . . . . 0.8 111.445 174.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 22.4 t70 -102.91 101.13 11.14 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.112 -1.07 . . . . 1.17 108.112 176.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1529 ' ' LEU . . . . . 0.468 ' HB2' ' O ' ' A' 1516 ' ' CYS . 4.2 mm? -83.88 -7.91 59.32 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 116.294 -0.412 . . . . 1.29 110.823 -177.017 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1530 ' ' SER . . . . . 0.602 ' HA ' ' OG ' ' A' 1533 ' ' SER . 17.1 m -66.48 -16.79 64.39 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.913 -0.585 . . . . 0.91 111.369 178.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 41.2 t -67.32 -29.06 68.53 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 109.327 -0.62 . . . . 1.98 109.327 173.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 81.3 mt -96.93 -10.33 26.58 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 116.451 -0.341 . . . . 1.34 111.061 -176.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1533 ' ' SER . . . . . 0.602 ' OG ' ' HA ' ' A' 1530 ' ' SER . 19.0 m -61.74 154.89 24.3 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.33 0.586 . . . . 1.93 110.718 178.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -171.13 131.2 2.14 Favored Glycine 0 C--N 1.286 -2.223 0 N-CA-C 109.443 -1.463 . . . . 1.1 109.443 -177.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 24.3 ttt180 -92.47 -34.49 14.08 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 112.337 0.495 . . . . 5.21 112.337 -172.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -59.7 -57.1 14.41 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.524 0.678 . . . . 1.94 110.571 -178.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 130.53 164.13 11.21 Favored Glycine 0 N--CA 1.409 -3.122 0 CA-C-N 115.433 -0.803 . . . . 1.08 111.999 173.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -120.51 138.91 53.58 Favored 'General case' 0 C--N 1.276 -2.617 0 N-CA-C 106.804 -1.554 . . . . 1.07 106.804 178.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 28.1 p -108.79 123.69 49.43 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 123.499 0.499 . . . . 1.46 110.783 -179.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1540 ' ' ALA . . . . . 0.436 ' HB1' ' CG1' ' A' 1548 ' ' VAL . . . -114.73 138.98 50.07 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 108.423 -0.955 . . . . 1.19 108.423 177.216 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -75.11 140.16 43.24 Favored 'General case' 0 CA--C 1.502 -0.872 0 O-C-N 123.93 0.769 . . . . 1.37 110.188 -177.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1542 ' ' TYR . . . . . 0.609 ' HE2' HD11 ' A' 1626 ' ' LEU . 1.7 t80 -152.53 -100.87 0.05 Allowed 'General case' 0 N--CA 1.424 -1.769 0 CA-C-N 115.954 -0.566 . . . . 1.38 110.25 -176.049 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1543 ' ' SER . . . . . 0.415 ' H ' ' HB3' ' A' 1542 ' ' TYR . 12.6 m -70.44 156.24 39.62 Favored 'General case' 0 N--CA 1.428 -1.544 0 C-N-CA 123.731 0.812 . . . . 1.98 109.735 -176.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 27.5 tptp -62.65 -22.07 66.16 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 125.502 1.521 . . . . 3.96 111.34 -173.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 34.3 t -137.94 37.65 2.37 Favored 'General case' 0 N--CA 1.427 -1.589 0 CA-C-N 115.746 -0.661 . . . . 2.81 109.6 -178.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1546 ' ' GLY . . . . . 0.489 ' HA3' ' HG2' ' A' 1569 ' ' GLN . . . -176.42 129.56 1.52 Allowed Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 119.025 -1.56 . . . . 1.68 113.974 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 35.9 m -102.75 162.68 3.76 Favored 'Isoleucine or valine' 0 C--O 1.251 1.175 0 N-CA-C 108.806 -0.812 . . . . 1.38 108.806 175.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1548 ' ' VAL . . . . . 0.451 ' HA ' ' HA ' ' A' 1567 ' ' PHE . 13.6 p -101.4 132.3 47.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 109.618 -0.512 . . . . 1.24 109.618 178.297 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -97.8 126.03 42.95 Favored 'General case' 0 CA--C 1.494 -1.202 0 C-N-CA 123.695 0.798 . . . . 1.29 109.435 177.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 24.0 ptm -139.2 135.48 34.02 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.311 -0.858 . . . . 1.47 111.42 -178.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 74.8 m -124.15 134.72 53.25 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.379 -0.828 . . . . 1.4 109.42 175.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1552 ' ' ILE . . . . . . . . . . . . . 46.4 mm -88.19 121.82 39.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 116.281 -0.418 . . . . 1.11 111.385 -175.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 34.0 t 66.04 25.35 10.92 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.615 1.166 . . . . 1.4 111.632 173.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . -167.51 174.99 42.63 Favored Glycine 0 N--CA 1.418 -2.552 0 N-CA-C 109.323 -1.511 . . . . 0.4 109.323 -179.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -95.63 155.94 16.53 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.081 0.467 . . . . 1.62 110.558 -178.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -104.25 134.84 46.8 Favored 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 107.258 -1.386 . . . . 1.12 107.258 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -95.93 7.96 44.94 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 112.943 0.719 . . . . 2.49 112.943 -172.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -83.04 -13.91 54.92 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.786 0.803 . . . . 1.38 109.533 177.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1559 ' ' CYS . . . . . 0.743 ' SG ' ' HD2' ' A' 1560 ' ' PRO . 9.3 t -131.89 162.16 58.2 Favored Pre-proline 0 C--N 1.293 -1.864 0 N-CA-C 106.039 -1.838 . . . . 1.21 106.039 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1560 ' ' PRO . . . . . 0.743 ' HD2' ' SG ' ' A' 1559 ' ' CYS . 41.8 Cg_exo -28.9 145.81 0.02 OUTLIER 'Trans proline' 0 CA--C 1.565 2.064 1 C-N-CA 125.301 4.001 . . . . 0.98 116.563 175.602 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.28 128.07 27.2 Favored 'Trans proline' 0 C--O 1.245 0.849 0 C-N-CA 123.56 2.84 . . . . 1.15 112.283 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 102.61 -9.73 55.74 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 116.139 -0.482 . . . . 0.55 112.354 -179.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1563 ' ' VAL . . . . . 0.508 HG12 ' HB3' ' A' 1559 ' ' CYS . 3.0 t -79.46 125.38 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 N-CA-C 112.665 0.617 . . . . 1.53 112.665 -178.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -98.6 -36.18 4.66 Favored Glycine 0 C--N 1.315 -0.616 0 CA-C-N 115.338 -0.847 . . . . 0.29 111.518 176.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -132.18 128.18 37.47 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 109.332 -0.618 . . . . 1.08 109.332 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1566 ' ' CYS . . . . . 0.453 ' HB2' HG12 ' A' 1563 ' ' VAL . 42.2 t -157.27 139.34 14.41 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 110.197 -0.297 . . . . 0.43 110.197 -177.032 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1567 ' ' PHE . . . . . 0.451 ' HA ' ' HA ' ' A' 1548 ' ' VAL . 37.8 m-85 -84.96 143.83 28.71 Favored 'General case' 0 C--O 1.245 0.846 0 N-CA-C 109.577 -0.527 . . . . 1.3 109.577 174.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -87.38 17.34 44.03 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.865 -0.683 . . . . 1.43 112.75 -175.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1569 ' ' GLN . . . . . 0.586 ' HB3' ' OD1' ' B' ' 15' ' ' ASP . 27.3 mt-30 -70.22 -69.97 0.32 Allowed 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 122.257 0.223 . . . . 3.09 110.507 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 13.8 t -130.41 29.74 4.81 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-O 121.604 0.716 . . . . 2.52 110.82 173.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 7.7 mmt180 65.29 55.17 1.1 Allowed 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 114.83 -1.077 . . . . 3.19 109.83 178.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 29.6 mt -95.97 115.74 35.95 Favored 'Isoleucine or valine' 0 C--O 1.246 0.907 0 CA-C-N 114.413 -1.267 . . . . 1.51 108.83 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 29.6 t -85.17 140.71 30.71 Favored 'General case' 0 C--O 1.245 0.855 0 CA-C-O 121.575 0.702 . . . . 0.96 110.845 -176.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1574 ' ' VAL . . . . . 0.594 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 35.7 m -126.2 15.49 3.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 CA-C-N 115.523 -0.762 . . . . 1.6 110.954 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 170.1 129.27 1.09 Allowed Glycine 0 N--CA 1.424 -2.154 0 C-N-CA 119.14 -1.505 . . . . 0.34 112.812 177.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 86.8 tttt -77.9 142.95 38.1 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 108.277 -1.009 . . . . 2.68 108.277 176.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -73.78 91.49 1.94 Allowed 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 123.036 0.534 . . . . 1.08 110.883 -178.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -109.85 171.63 7.33 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 108.273 -1.01 . . . . 1.95 108.273 178.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 62.3 mttp -124.05 44.61 2.69 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.688 -0.856 . . . . 3.11 108.688 -177.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 43.6 ttp180 -86.92 77.88 9.14 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 114.904 -1.044 . . . . 4.04 109.622 -177.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1581 ' ' LEU . . . . . 0.594 ' HB2' ' HA ' ' A' 1516 ' ' CYS . 0.5 OUTLIER -84.33 123.06 29.76 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.602 -1.181 . . . . 1.32 108.976 -179.053 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -126.35 140.37 52.56 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 110.108 -0.33 . . . . 3.4 110.108 173.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1583 ' ' TYR . . . . . 0.451 ' CE1' ' HA ' ' A' 1586 ' ' GLN . 51.0 t80 -106.35 111.63 24.3 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 108.975 -0.75 . . . . 1.26 108.975 177.089 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1584 ' ' VAL . . . . . 0.607 ' O ' ' HB ' ' A' 1587 ' ' VAL . 6.8 m -130.01 95.72 2.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 112.289 0.477 . . . . 1.71 112.289 -178.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 37.0 t70 57.99 65.81 1.23 Allowed 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 121.774 0.797 . . . . 1.17 111.929 174.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1586 ' ' GLN . . . . . 0.451 ' HA ' ' CE1' ' A' 1583 ' ' TYR 0.254 30.2 pt20 60.67 20.72 10.68 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 127.021 2.128 . . . . 2.43 111.847 177.993 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A 1587 ' ' VAL . . . . . 0.607 ' HB ' ' O ' ' A' 1584 ' ' VAL . 18.3 t -117.32 121.0 66.64 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.606 0 CA-C-N 113.593 -1.64 . . . . 1.16 109.922 176.497 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1588 ' ' LEU . . . . . 0.821 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 2.7 mm? -95.59 115.58 27.63 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 106.061 -1.829 . . . . 1.11 106.061 175.282 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -118.01 126.44 52.31 Favored 'General case' 0 C--N 1.277 -2.558 0 C-N-CA 119.844 -0.743 . . . . 1.74 112.445 -174.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 11.9 mt -114.0 117.41 31.25 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 125.414 1.486 . . . . 1.4 107.043 175.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 26.9 t -104.88 128.89 58.26 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 C-N-CA 119.734 -0.786 . . . . 1.7 109.62 -178.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1592 ' ' TYR . . . . . 0.534 ' HB2' ' HB3' ' A' 1608 ' ' SER . 14.4 m-30 -117.58 96.13 5.26 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.901 -0.777 . . . . 1.08 108.901 178.166 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 38.8 pttt -111.4 175.62 5.35 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.823 -0.751 . . . . 2.21 109.876 177.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 33.3 m-20 67.48 60.23 0.48 Allowed 'General case' 0 CA--C 1.502 -0.889 0 C-N-CA 124.318 1.047 . . . . 1.11 110.904 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -91.11 -104.74 1.34 Allowed Glycine 0 N--CA 1.424 -2.153 0 N-CA-C 109.469 -1.452 . . . . 0.78 109.469 177.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1596 ' ' SER . . . . . . . . . . . . . 48.4 m -120.69 156.16 56.35 Favored Pre-proline 0 C--N 1.286 -2.172 0 N-CA-C 107.697 -1.223 . . . . 1.36 107.697 175.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -53.94 120.92 8.7 Favored 'Trans proline' 0 C--N 1.357 0.991 0 C-N-CA 122.927 2.418 . . . . 1.4 110.276 173.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1598 ' ' CYS . . . . . 0.444 ' HA ' ' HD3' ' A' 1599 ' ' PRO . 48.9 t -79.8 126.42 80.25 Favored Pre-proline 0 C--N 1.28 -2.453 0 CA-C-N 114.385 -1.279 . . . . 0.75 110.578 -175.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1599 ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' 1598 ' ' CYS . 12.2 Cg_exo -73.52 -15.72 24.55 Favored 'Trans proline' 0 C--O 1.212 -0.784 0 C-N-CA 122.942 2.428 . . . . 1.7 112.051 177.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1600 ' ' SER . . . . . 0.657 ' HA ' ' HB2' ' B' ' 53' ' ' LEU . 15.4 m -65.77 -31.85 73.06 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-O 120.67 0.271 . . . . 2.8 111.416 177.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1601 ' ' LYS . . . . . 0.443 ' HA ' ' HB2' ' B' ' 52' ' ' ASP . 22.9 ttmm -150.62 120.74 7.22 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 108.084 -1.08 . . . . 3.45 108.084 175.374 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 8.0 m -59.02 123.54 16.93 Favored 'General case' 0 N--CA 1.428 -1.548 0 C-N-CA 124.241 1.017 . . . . 2.44 112.707 -171.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1603 ' ' GLY . . . . . 0.448 ' HA3' ' O ' ' B' ' 1' ' ' ALA . . . 84.06 23.18 53.02 Favored Glycine 0 CA--C 1.499 -0.961 0 CA-C-N 116.167 -0.47 . . . . 1.2 112.482 175.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1604 ' ' LEU . . . . . 0.464 HD23 ' SG ' ' A' 1634 ' ' CYS . 11.5 tp -119.67 165.93 13.86 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 106.854 -1.535 . . . . 2.38 106.854 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 22.9 t -124.82 154.37 41.1 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.628 -0.878 . . . . 1.96 108.628 -177.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1606 ' ' TYR . . . . . 0.594 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 58.1 m-85 -74.86 163.58 27.5 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 116.011 -0.541 . . . . 1.06 109.892 176.273 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -160.33 128.26 4.61 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-N 116.338 -0.392 . . . . 2.0 109.944 -176.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1608 ' ' SER . . . . . 0.534 ' HB3' ' HB2' ' A' 1592 ' ' TYR . 34.5 t -104.95 126.3 51.87 Favored 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 108.447 -0.946 . . . . 1.61 108.447 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 25.8 t -110.61 99.21 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.66 0 N-CA-C 107.864 -1.161 . . . . 1.09 107.864 177.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 77.1 mt -90.29 120.64 39.47 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 CA-C-N 115.014 -0.994 . . . . 1.2 108.917 -177.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 43.9 m -124.67 123.97 41.18 Favored 'General case' 0 C--N 1.287 -2.11 0 CA-C-N 115.863 -0.608 . . . . 1.89 112.025 -178.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1612 ' ' PHE . . . . . 0.821 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 75.5 m-85 -97.97 123.14 41.83 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.42 -0.956 . . . . 0.28 108.42 176.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 44.7 t -113.51 134.96 54.6 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 O-C-N 123.589 0.556 . . . . 1.23 110.621 -174.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -54.07 112.56 0.99 Allowed 'General case' 0 C--O 1.241 0.623 0 C-N-CA 124.265 1.026 . . . . 0.77 111.679 175.054 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1615 ' ' ARG . . . . . 0.537 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 23.0 tpt180 -126.0 88.95 53.35 Favored Pre-proline 0 N--CA 1.443 -0.798 0 N-CA-C 107.881 -1.155 . . . . 2.92 107.881 174.11 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1616 ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -72.57 -19.59 24.45 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 122.341 2.027 . . . . 1.22 113.325 -174.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -87.29 -10.8 51.39 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.612 -0.267 . . . . 3.05 111.552 179.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . 63.05 -172.53 0.16 Allowed 'General case' 0 CA--C 1.546 0.794 0 O-C-N 123.904 0.753 . . . . 1.55 109.087 -172.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . 147.64 -165.27 28.78 Favored Glycine 0 N--CA 1.424 -2.107 0 C-N-CA 120.292 -0.956 . . . . 1.16 112.565 175.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -87.23 19.14 1.43 Allowed 'Trans proline' 0 C--O 1.237 0.45 0 C-N-CA 123.614 2.876 . . . . 1.06 113.726 -174.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1621 ' ' THR . . . . . . . . . . . . . 24.1 p -114.62 12.46 17.22 Favored 'General case' 0 C--N 1.285 -2.212 0 CA-C-O 122.173 0.987 . . . . 1.58 109.744 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -89.55 66.71 7.38 Favored 'General case' 0 C--O 1.246 0.92 0 N-CA-C 106.682 -1.599 . . . . 0.88 106.682 178.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -170.5 140.79 1.52 Allowed Pre-proline 0 N--CA 1.428 -1.531 0 N-CA-C 106.849 -1.538 . . . . 3.82 106.849 -173.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -57.63 107.56 0.31 Allowed 'Trans proline' 0 CA--C 1.545 1.058 0 C-N-CA 122.511 2.141 . . . . 0.77 111.571 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 81.4 mtp -114.18 148.08 37.85 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.576 -0.898 . . . . 1.43 108.576 -178.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1626 ' ' LEU . . . . . 0.609 HD11 ' HE2' ' A' 1542 ' ' TYR . 7.2 tt -101.9 138.31 39.04 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.132 -0.692 . . . . 1.43 109.132 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1627 ' ' ILE . . . . . 0.759 HD12 ' HB2' ' A' 1639 ' ' SER . 38.4 mm -85.09 -63.09 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.214 -0.812 0 CA-C-N 115.375 -0.829 . . . . 1.23 109.701 -178.069 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 52.2 m -161.88 152.11 17.08 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 106.897 -1.52 . . . . 1.88 106.897 -176.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1629 ' ' LEU . . . . . 0.615 HD12 ' HG ' ' A' 1636 ' ' LEU . 44.4 tp -105.42 110.3 22.59 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 107.885 -1.154 . . . . 1.92 107.885 175.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 18.6 t70 -82.75 95.41 7.86 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 118.388 -1.325 . . . . 1.09 107.651 175.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 21.8 pttm -76.14 7.24 4.35 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 114.739 -1.119 . . . . 3.98 113.467 -174.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -95.68 -45.0 7.2 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 108.794 -0.817 . . . . 2.6 108.794 173.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 73.5 p -96.92 -1.68 45.31 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-N 115.368 -0.833 . . . . 1.35 111.342 -177.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1634 ' ' CYS . . . . . 0.574 ' SG ' ' HB2' ' A' 1600 ' ' SER . 74.7 m 60.73 35.04 19.78 Favored 'General case' 0 C--N 1.364 1.196 0 C-N-CA 124.043 0.937 . . . . 0.53 110.746 178.146 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1635 ' ' THR . . . . . . . . . . . . . 57.2 m -105.96 128.56 53.89 Favored 'General case' 0 N--CA 1.418 -2.029 0 CA-C-N 114.973 -1.012 . . . . 1.11 109.987 -176.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1636 ' ' LEU . . . . . 0.615 ' HG ' HD12 ' A' 1629 ' ' LEU . 0.9 OUTLIER -110.11 119.57 39.7 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 108.223 -1.028 . . . . 1.56 108.223 -177.376 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -99.52 129.18 45.67 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 116.293 -0.412 . . . . 0.54 110.257 -177.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -126.26 143.41 51.16 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.838 -0.619 . . . . 0.64 109.833 -178.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1639 ' ' SER . . . . . 0.759 ' HB2' HD12 ' A' 1627 ' ' ILE . 23.0 t -124.39 159.97 29.22 Favored 'General case' 0 C--N 1.31 -1.13 0 C-N-CA 124.284 1.033 . . . . 1.34 108.524 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 2.9 t90 -156.71 111.75 2.84 Favored 'General case' 0 N--CA 1.418 -2.073 0 N-CA-C 104.26 -2.496 . . . . 0.8 104.26 179.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1641 ' ' HIS . . . . . 0.537 ' HB3' ' HB2' ' A' 1615 ' ' ARG . 62.2 m-70 -97.63 110.01 22.65 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 108.926 -0.768 . . . . 1.14 108.926 -177.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1642 ' ' THR . . . . . . . . . . . . . 4.6 t -139.11 148.69 58.41 Favored Pre-proline 0 C--N 1.292 -1.931 0 CA-C-N 115.302 -0.863 . . . . 1.11 110.869 -171.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1643 ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -78.36 -6.17 15.4 Favored 'Trans proline' 0 C--N 1.364 1.39 0 C-N-CA 122.467 2.111 . . . . 0.78 112.168 176.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 7.3 tt -68.41 -31.04 70.09 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 108.915 -0.772 . . . . 1.66 108.915 176.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -86.08 4.08 39.69 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.195 -0.911 . . . . 1.29 111.284 -174.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 1.3 t -123.69 144.09 49.86 Favored 'General case' 0 N--CA 1.424 -1.77 0 C-N-CA 119.263 -0.975 . . . . 1.48 110.403 -178.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -124.64 135.49 26.69 Favored Pre-proline 0 C--N 1.302 -1.468 0 C-N-CA 122.554 0.342 . . . . 3.14 110.182 174.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1648 ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -73.41 146.46 39.81 Favored 'Trans proline' 0 C--O 1.253 1.225 0 C-N-CA 122.278 1.985 . . . . 2.92 111.162 178.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 . . . . . 0 C--N 1.311 -1.091 0 CA-C-N 116.444 -0.343 . . . . 4.72 110.382 -179.039 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . 0.448 ' O ' ' HA3' ' A' 1603 ' ' GLY . . . . . . . . 0 CA--C 1.514 -0.417 0 CA-C-O 121.027 0.442 . . . . 10.26 109.999 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 2' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -150.32 102.22 3.05 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 106.856 -1.535 . . . . 7.94 106.856 177.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -94.02 122.34 62.08 Favored Pre-proline 0 C--N 1.293 -1.875 0 N-CA-C 112.898 0.703 . . . . 6.56 112.898 -175.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -90.47 16.72 1.6 Allowed 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.972 2.448 . . . . 5.51 111.785 173.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 66.4 m -163.17 174.27 12.38 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 124.947 1.299 . . . . 4.91 108.07 -177.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 77.48 -2.21 2.6 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 126.484 1.914 . . . . 4.23 110.013 -176.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 14.0 p -92.7 122.81 35.47 Favored 'General case' 0 N--CA 1.405 -2.72 0 N-CA-C 106.596 -1.631 . . . . 3.48 106.596 175.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . 0.753 ' HB2' ' HG3' ' B' ' 12' ' ' GLU . 8.1 mp -77.09 100.34 5.67 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 109.65 -0.5 . . . . 4.35 109.65 -178.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 9.5 m -50.76 -19.27 0.91 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.038 1.735 . . . . 2.84 114.242 -175.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . 0.477 ' O ' HG11 ' B' ' 14' ' ' VAL . . . -122.17 -60.43 0.21 Allowed Glycine 0 N--CA 1.424 -2.11 0 N-CA-C 111.005 -0.838 . . . . 2.28 111.005 178.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -52.07 -55.11 22.94 Favored Glycine 0 N--CA 1.464 0.518 0 N-CA-C 115.344 0.898 . . . . 1.94 115.344 -174.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . 0.753 ' HG3' ' HB2' ' B' ' 8' ' ' LEU . 60.3 mt-10 -78.36 -30.65 48.13 Favored 'General case' 0 CA--C 1.499 -0.998 0 CA-C-N 117.013 0.407 . . . . 2.55 110.3 -177.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . 0.545 ' O ' HD22 ' B' ' 17' ' ' LEU . 0.8 OUTLIER -58.16 -62.05 2.11 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-N 115.489 -0.778 . . . . 2.82 111.288 178.669 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . 0.477 HG11 ' O ' ' B' ' 10' ' ' GLY . 14.2 p -64.72 -29.18 46.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-N 116.107 -0.497 . . . . 2.5 111.244 -177.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 15' ' ' ASP . . . . . 0.586 ' OD1' ' HB3' ' A' 1569 ' ' GLN . 33.6 t70 -73.83 -37.95 64.69 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 113.11 0.782 . . . . 2.04 113.11 178.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 14.8 t -69.85 -32.17 70.41 Favored 'General case' 0 C--O 1.254 1.306 0 CA-C-N 119.432 1.014 . . . . 2.31 109.485 175.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.614 HD21 HD12 ' B' ' 42' ' ' ILE . 3.8 mm? -56.12 -44.28 78.98 Favored 'General case' 0 C--O 1.208 -1.118 0 CA-C-N 115.431 -0.804 . . . . 2.27 108.995 169.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -77.18 -21.72 53.53 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.27 -0.877 . . . . 2.39 112.006 -178.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -64.35 -56.67 12.85 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 116.349 -0.387 . . . . 1.0 110.239 178.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 15.0 p -98.66 -20.93 5.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 118.519 -1.273 . . . . 1.83 112.555 -177.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 21' ' ' CYS . . . . . 0.577 ' HB2' ' HB3' ' B' ' 26' ' ' PHE . 64.0 m -105.2 19.24 20.94 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 119.445 -0.902 . . . . 1.66 110.758 179.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.67 -56.58 24.49 Favored Glycine 0 C--N 1.31 -0.888 0 C-N-CA 120.382 -0.913 . . . . 1.53 112.254 178.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -70.34 -38.08 74.79 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.783 0.325 . . . . 2.72 111.307 177.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 43.2 ttp180 -72.68 -39.02 67.39 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 113.888 1.069 . . . . 5.02 113.888 -176.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 112.09 112.87 3.26 Favored Glycine 0 N--CA 1.429 -1.77 0 N-CA-C 109.157 -1.577 . . . . 1.63 109.157 -175.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . 0.577 ' HB3' ' HB2' ' B' ' 21' ' ' CYS . 39.8 p90 -92.2 134.73 34.6 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 120.696 -0.402 . . . . 1.71 110.895 -178.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -148.35 116.72 6.54 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.984 -0.747 . . . . 3.67 108.984 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 28' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -117.07 -20.23 9.4 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 120.521 -0.472 . . . . 2.44 111.909 175.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 29' ' ' SER . . . . . 0.499 ' HA ' ' HA ' ' B' ' 40' ' ' ARG . 25.1 m -92.03 63.06 4.35 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 121.965 0.888 . . . . 3.85 109.378 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 11.7 mtp180 -108.08 141.92 24.18 Favored Pre-proline 0 C--N 1.304 -1.383 0 N-CA-C 106.699 -1.593 . . . . 4.27 106.699 -177.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . 0.709 ' HA ' ' HA ' ' B' ' 39' ' ' SER . 56.9 Cg_endo -71.79 -11.52 27.82 Favored 'Trans proline' 0 C--O 1.25 1.123 0 C-N-CA 123.345 2.696 . . . . 4.2 113.259 -175.222 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . 64.57 15.66 9.79 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 125.077 1.351 . . . . 5.12 113.52 172.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 41.1 t 167.18 165.05 0.03 OUTLIER 'General case' 0 N--CA 1.414 -2.227 0 N-CA-C 104.119 -2.548 . . . . 6.93 104.119 -178.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 20.8 tpp180 -89.97 3.29 53.57 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 107.988 -1.116 . . . . 12.14 107.988 177.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 46.5 t -89.85 -9.09 10.66 Favored 'Isoleucine or valine' 0 C--O 1.246 0.877 0 CA-C-N 114.476 -1.238 . . . . 9.9 108.839 173.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 18.7 m 56.8 42.07 27.17 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 113.659 -1.609 . . . . 6.82 111.321 176.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 19.0 mmm180 -40.32 -66.98 0.26 Allowed 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 114.239 -1.346 . . . . 10.71 111.659 175.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . 0.724 HH21 ' HH ' ' B' ' 59' ' ' TYR . 45.3 ttp180 -136.78 121.51 18.57 Favored 'General case' 0 N--CA 1.41 -2.448 0 N-CA-C 106.448 -1.686 . . . . 8.6 106.448 175.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 39' ' ' SER . . . . . 0.709 ' HA ' ' HA ' ' B' ' 31' ' ' PRO . 25.8 m -102.1 36.7 2.04 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.971 0.891 . . . . 5.79 111.145 -174.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . 0.499 ' HA ' ' HA ' ' B' ' 29' ' ' SER . 29.8 ptt180 -166.57 161.76 16.19 Favored 'General case' 0 N--CA 1.421 -1.893 0 N-CA-C 106.467 -1.679 . . . . 6.57 106.467 178.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . -167.72 167.74 40.21 Favored Glycine 0 C--N 1.284 -2.357 0 N-CA-C 110.236 -1.146 . . . . 2.62 110.236 175.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . 0.614 HD12 HD21 ' B' ' 17' ' ' LEU . 15.0 pt 59.87 -33.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 C-N-CA 128.097 2.559 . . . . 2.28 116.731 176.198 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . 0.472 ' O ' ' HB2' ' B' ' 47' ' ' CYS . 2.7 p -52.57 -41.38 36.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 113.55 0.944 . . . . 2.6 113.55 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -94.72 -31.0 13.99 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 108.574 -0.899 . . . . 3.36 108.574 -174.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -56.92 -50.97 70.96 Favored 'General case' 0 C--O 1.206 -1.194 0 CA-C-N 115.35 -0.841 . . . . 3.08 109.638 174.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 46' ' ' CYS . . . . . 0.522 ' HB3' HD23 ' B' ' 13' ' ' LEU . 9.1 t -89.96 2.46 55.08 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.524 0.678 . . . . 2.23 111.17 -175.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 47' ' ' CYS . . . . . 0.472 ' HB2' ' O ' ' B' ' 43' ' ' VAL . 45.6 t -85.61 -52.41 5.83 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 116.331 -0.395 . . . . 2.48 110.459 177.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -104.59 13.02 32.37 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.289 0.566 . . . . 2.97 111.571 -175.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 28.7 mtp85 -155.86 -170.11 3.3 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 125.64 1.576 . . . . 4.65 107.477 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 21.3 t -121.9 129.13 52.31 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 109.188 -0.671 . . . . 2.86 109.188 -176.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . 0.447 ' HB3' ' HB2' ' B' ' 46' ' ' CYS . 26.7 p -99.71 149.89 22.86 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.943 -0.762 . . . . 2.11 108.943 -177.101 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . 0.443 ' HB2' ' HA ' ' A' 1601 ' ' LYS . 3.0 p-10 -116.57 174.62 5.97 Favored 'General case' 0 C--O 1.251 1.164 0 C-N-CA 120.348 -0.541 . . . . 2.67 110.829 170.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . 0.657 ' HB2' ' HA ' ' A' 1600 ' ' SER . 34.3 tp -54.61 -43.13 71.93 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 113.342 0.867 . . . . 2.36 113.342 -173.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . 0.404 ' O ' HG21 ' B' ' 58' ' ' THR . . . -55.39 -31.82 62.13 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.225 0.61 . . . . 1.92 112.341 -171.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 61.9 tp -72.41 -58.08 3.67 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 115.491 -0.777 . . . . 2.35 110.244 179.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 2.0 pp -70.2 -32.18 69.98 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 111.827 0.306 . . . . 2.01 111.827 -175.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -60.61 -48.54 81.33 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 116.291 -0.413 . . . . 2.27 111.262 179.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 58' ' ' THR . . . . . 0.404 HG21 ' O ' ' B' ' 54' ' ' ALA . 6.4 t -88.37 -8.7 54.63 Favored 'General case' 0 CA--C 1.569 1.697 0 CA-C-O 120.867 0.365 . . . . 2.67 111.895 -177.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 59' ' ' TYR . . . . . 0.724 ' HH ' HH21 ' B' ' 38' ' ' ARG . 16.7 t80 -95.05 -33.4 12.72 Favored 'General case' 0 N--CA 1.441 -0.878 0 O-C-N 121.291 -0.88 . . . . 3.2 109.839 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 60' ' ' CYS . . . . . 0.512 ' SG ' ' HA ' ' B' ' 26' ' ' PHE . 38.8 t -82.63 102.96 11.8 Favored 'General case' 0 C--O 1.255 1.391 0 CA-C-N 115.783 -0.644 . . . . 2.3 110.963 -176.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . 66.22 177.07 0.22 Allowed 'General case' 0 C--N 1.344 0.329 0 O-C-N 124.566 1.166 . . . . 3.19 110.333 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 62' ' ' THR . . . . . 0.911 ' HB ' ' HB3' ' B' ' 65' ' ' LYS . 14.4 p -139.8 116.91 8.33 Favored Pre-proline 0 C--N 1.298 -1.648 0 O-C-N 121.816 -0.553 . . . . 4.14 111.304 -177.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -66.22 -40.15 16.0 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.652 2.901 . . . . 5.59 114.404 -169.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -133.06 31.4 3.86 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-O 121.28 0.562 . . . . 5.51 110.416 178.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . 0.911 ' HB3' ' HB ' ' B' ' 62' ' ' THR . 28.6 tptp -125.86 -24.74 3.74 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 116.196 -0.456 . . . . 8.8 111.247 -175.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 12.2 t -175.04 64.91 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.644 -0.872 . . . . 8.12 108.644 179.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 . . . . . 0 C--O 1.253 1.257 0 N-CA-C 108.559 -0.904 . . . . 10.21 108.559 177.47 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.305 0 N-CA-C 109.033 -0.728 . . . . 9.74 109.033 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 50.8 tttp -120.94 -1.11 9.93 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.865 0.841 . . . . 9.32 110.749 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 48.0 t -66.95 -34.86 78.69 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 107.442 -1.318 . . . . 5.97 107.442 173.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1511 ' ' ASN . . . . . 0.471 ' ND2' ' H ' ' A' 1519 ' ' THR . 3.0 p-10 -136.34 128.18 29.23 Favored 'General case' 0 N--CA 1.42 -1.932 0 CA-C-N 114.562 -1.199 . . . . 3.48 107.88 175.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1512 ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -124.44 -52.16 1.72 Allowed 'General case' 0 C--N 1.283 -2.299 0 N-CA-C 106.839 -1.541 . . . . 5.95 106.839 173.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 8.7 p80 -173.9 94.66 0.1 Allowed 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 125.038 1.335 . . . . 6.14 108.524 175.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -85.33 -70.86 0.56 Allowed 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.938 -0.705 . . . . 5.06 110.691 -177.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1515 ' ' ASP . . . . . 0.423 ' O ' ' HB2' ' A' 1581 ' ' LEU . 17.5 m-20 -142.49 -82.15 0.2 Allowed 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 108.88 -0.785 . . . . 2.9 108.88 179.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1516 ' ' CYS . . . . . 0.769 ' HB3' ' HB2' ' A' 1529 ' ' LEU . 83.0 m -126.46 46.58 2.43 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 107.048 -1.464 . . . . 1.41 107.048 176.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1517 ' ' GLN . . . . . 0.462 ' HA ' ' O ' ' A' 1527 ' ' PHE . 14.0 pt20 -151.72 133.92 15.18 Favored 'General case' 0 N--CA 1.425 -1.712 0 CA-C-N 114.836 -1.074 . . . . 2.18 109.483 -175.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1518 ' ' VAL . . . . . 0.473 HG23 ' HB2' ' A' 1583 ' ' TYR . 2.3 m -150.26 136.96 12.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 C-N-CA 124.361 1.064 . . . . 1.52 109.497 175.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1519 ' ' THR . . . . . 0.471 ' H ' ' ND2' ' A' 1511 ' ' ASN . 43.4 m -111.81 134.51 53.33 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 108.797 -0.816 . . . . 1.36 108.797 178.008 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -90.38 124.13 63.69 Favored Pre-proline 0 C--N 1.298 -1.647 0 N-CA-C 109.184 -0.673 . . . . 2.02 109.184 176.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -68.8 -15.69 40.89 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 123.072 2.515 . . . . 1.82 113.725 -174.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 22.5 m -80.62 -50.45 9.95 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-O 120.593 0.235 . . . . 1.89 111.478 -177.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1523 ' ' THR . . . . . . . . . . . . . 5.6 t -103.96 -11.75 17.25 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 119.878 -0.729 . . . . 1.99 111.867 -176.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 75.09 25.92 67.74 Favored Glycine 0 CA--C 1.506 -0.529 0 CA-C-N 116.275 -0.42 . . . . 1.19 112.639 177.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 84.8 t60 -92.81 127.4 38.3 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 120.487 -0.485 . . . . 1.82 110.424 -177.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 2.0 tm? -92.71 110.93 22.37 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 114.444 -1.253 . . . . 1.3 108.354 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1527 ' ' PHE . . . . . 0.462 ' O ' ' HA ' ' A' 1517 ' ' GLN . 93.3 m-85 -85.07 119.55 25.59 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 120.463 -0.495 . . . . 0.8 109.723 173.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 24.1 t70 -115.39 114.21 24.8 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.44 -0.8 . . . . 1.17 109.417 178.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1529 ' ' LEU . . . . . 0.769 ' HB2' ' HB3' ' A' 1516 ' ' CYS . 2.8 mm? -102.41 -0.83 31.91 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 108.849 -0.797 . . . . 1.29 108.849 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -68.59 -32.35 72.19 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.627 0.727 . . . . 0.91 109.16 -178.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 31.5 t -64.81 -12.7 50.84 Favored 'General case' 0 CA--C 1.554 1.123 0 CA-C-N 114.881 -1.054 . . . . 1.98 110.858 177.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 90.5 mt -92.77 -3.13 55.27 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 122.02 -0.425 . . . . 1.34 110.703 177.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1533 ' ' SER . . . . . 0.968 ' HA ' ' HB1' ' A' 1536 ' ' ALA . 14.4 t -95.2 -179.62 4.86 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 109.526 -0.546 . . . . 1.93 109.526 179.149 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . 83.92 -65.73 4.05 Favored Glycine 0 C--N 1.312 -0.761 0 N-CA-C 109.609 -1.396 . . . . 1.1 109.609 -174.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 42.4 ttp180 -83.89 -2.24 56.06 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 124.424 1.09 . . . . 5.21 109.192 174.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1536 ' ' ALA . . . . . 0.968 ' HB1' ' HA ' ' A' 1533 ' ' SER . . . -46.84 -22.28 0.29 Allowed 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 127.551 2.34 . . . . 1.94 116.66 -175.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . -72.61 103.53 1.36 Allowed Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.361 -0.923 . . . . 1.08 111.208 178.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -119.93 149.34 42.27 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 120.93 0.395 . . . . 1.07 110.777 -178.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 9.9 p -112.94 117.48 32.2 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 115.458 -0.792 . . . . 1.46 110.38 179.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1540 ' ' ALA . . . . . 0.44 ' HB3' ' CG1' ' A' 1548 ' ' VAL . . . -112.54 146.68 38.1 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.953 -0.758 . . . . 1.19 108.953 177.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -86.28 151.68 23.39 Favored 'General case' 0 C--N 1.311 -1.081 0 O-C-N 123.22 0.325 . . . . 1.37 111.022 -175.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1542 ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -159.15 -101.93 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 109.511 -0.551 . . . . 1.38 109.511 -178.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1543 ' ' SER . . . . . . . . . . . . . 2.2 p -68.59 172.22 6.53 Favored 'General case' 0 CA--C 1.562 1.409 0 C-N-CA 124.641 1.176 . . . . 1.98 110.302 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -94.55 4.59 53.66 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 113.561 0.948 . . . . 3.96 113.561 -165.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 7.3 t -129.8 21.33 5.46 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.43 -0.908 . . . . 2.81 110.208 -178.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 169.25 179.73 41.37 Favored Glycine 0 N--CA 1.424 -2.127 0 C-N-CA 119.801 -1.19 . . . . 1.68 112.153 179.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 28.0 m -122.07 176.1 4.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 109.148 -0.686 . . . . 1.38 109.148 -177.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1548 ' ' VAL . . . . . 0.44 ' CG1' ' HB3' ' A' 1540 ' ' ALA . 14.9 p -103.62 128.12 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 N-CA-C 108.538 -0.912 . . . . 1.24 108.538 175.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -92.32 131.07 37.81 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.656 -0.868 . . . . 1.29 108.656 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 23.5 ptm -144.98 140.65 28.34 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 116.051 -0.522 . . . . 1.47 110.587 -178.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 12.3 p -131.95 125.96 32.89 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 115.824 -0.626 . . . . 1.4 111.551 177.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1552 ' ' ILE . . . . . 0.66 ' H ' ' HB2' ' A' 1536 ' ' ALA . 49.5 mm -82.63 124.5 39.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.556 -0.535 . . . . 1.11 109.556 177.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1553 ' ' CYS . . . . . 0.547 ' HB2' ' HB2' ' A' 1533 ' ' SER . 60.2 m 59.35 49.7 8.56 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.598 0.713 . . . . 1.4 110.696 177.118 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 168.92 172.14 35.4 Favored Glycine 0 N--CA 1.42 -2.401 0 N-CA-C 109.76 -1.336 . . . . 0.4 109.76 178.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -100.01 150.15 22.73 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 109.562 -0.532 . . . . 1.62 109.562 178.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -91.81 130.97 37.49 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.696 -0.684 . . . . 1.12 109.984 -174.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -67.34 -7.29 23.57 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 113.969 1.1 . . . . 2.49 113.969 -174.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -93.12 -4.72 51.75 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 120.302 -0.559 . . . . 1.38 112.065 -175.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1559 ' ' CYS . . . . . 0.729 ' SG ' ' HD2' ' A' 1560 ' ' PRO . 3.1 t -137.37 162.52 54.64 Favored Pre-proline 0 C--N 1.293 -1.871 0 N-CA-C 108.08 -1.082 . . . . 1.21 108.08 -178.479 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1560 ' ' PRO . . . . . 0.729 ' HD2' ' SG ' ' A' 1559 ' ' CYS . 16.6 Cg_exo -32.91 145.82 0.03 OUTLIER 'Trans proline' 0 CA--C 1.563 1.964 0 C-N-CA 125.175 3.916 . . . . 0.98 115.536 175.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.03 124.06 14.85 Favored 'Trans proline' 0 C--O 1.25 1.106 0 C-N-CA 123.236 2.624 . . . . 1.15 111.803 178.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 107.08 -5.66 36.41 Favored Glycine 0 N--CA 1.44 -1.072 0 CA-C-N 115.615 -0.72 . . . . 0.55 111.878 -177.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1563 ' ' VAL . . . . . 0.7 HG13 ' HB3' ' A' 1559 ' ' CYS . 10.6 t -84.36 120.64 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.227 0 CA-C-O 121.217 0.532 . . . . 1.53 112.33 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -96.8 -31.3 7.09 Favored Glycine 0 C--N 1.303 -1.298 0 CA-C-N 115.146 -0.934 . . . . 0.29 111.535 177.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -136.18 135.26 39.01 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 109.474 -0.565 . . . . 1.08 109.474 177.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1566 ' ' CYS . . . . . 0.482 ' HB2' HG13 ' A' 1563 ' ' VAL . 53.9 t -157.84 140.2 14.48 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 110.149 -0.315 . . . . 0.43 110.149 -176.443 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1567 ' ' PHE . . . . . 0.485 ' CE2' HG13 ' A' 1574 ' ' VAL . 64.1 m-85 -85.34 133.5 34.14 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 107.954 -1.128 . . . . 1.3 107.954 174.531 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -75.03 -9.73 83.96 Favored Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 115.561 0.984 . . . . 1.43 115.561 -171.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1569 ' ' GLN . . . . . 0.543 ' NE2' HE22 ' B' ' 18' ' ' GLN . 16.3 mt-30 -70.52 -69.4 0.36 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 117.258 0.529 . . . . 3.09 110.908 -177.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -97.85 2.08 48.91 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 113.394 0.887 . . . . 2.52 113.394 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 10.4 mmt85 58.63 41.9 21.4 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.0 -1.0 . . . . 3.19 110.444 178.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 32.3 mt -88.51 129.58 39.42 Favored 'Isoleucine or valine' 0 C--O 1.247 0.945 0 N-CA-C 108.085 -1.08 . . . . 1.51 108.085 177.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 30.0 t -81.09 131.65 35.31 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.391 0.615 . . . . 0.96 110.852 -177.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1574 ' ' VAL . . . . . 0.658 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 33.9 m -118.95 15.12 6.96 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 CA-C-N 115.981 -0.554 . . . . 1.6 111.346 -179.253 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 176.95 126.23 0.95 Allowed Glycine 0 N--CA 1.423 -2.223 0 C-N-CA 119.58 -1.295 . . . . 0.34 111.814 176.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 49.8 tttp -81.99 135.35 35.37 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 107.271 -1.381 . . . . 2.68 107.271 177.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -70.28 96.99 1.17 Allowed 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 122.956 0.502 . . . . 1.08 110.785 -176.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -110.49 173.65 6.23 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 108.72 -0.845 . . . . 1.95 108.72 177.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1579 ' ' LYS . . . . . 0.585 ' HB2' ' HZ2' ' A' 1579 ' ' LYS . 9.8 mtmp? -136.53 53.74 1.91 Allowed 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 107.662 -1.236 . . . . 3.11 107.662 -177.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 49.1 ttp180 -107.0 76.19 1.08 Allowed 'General case' 0 N--CA 1.419 -1.984 0 CA-C-N 114.497 -1.228 . . . . 4.04 108.027 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1581 ' ' LEU . . . . . 0.562 HD23 ' HA ' ' A' 1516 ' ' CYS . 0.3 OUTLIER -69.18 126.27 29.27 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.632 -1.167 . . . . 1.32 108.923 179.915 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 60.8 mtp180 -124.72 131.12 53.48 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 120.315 -0.554 . . . . 3.4 110.649 173.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1583 ' ' TYR . . . . . 0.5 ' CE1' ' HA ' ' A' 1586 ' ' GLN . 45.1 t80 -100.93 108.31 20.02 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 108.803 -0.814 . . . . 1.26 108.803 178.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1584 ' ' VAL . . . . . 0.594 ' O ' ' HB ' ' A' 1587 ' ' VAL . 15.5 m -127.4 91.82 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 CA-C-N 115.918 -0.583 . . . . 1.71 111.993 -178.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 32.8 t70 59.18 66.91 0.97 Allowed 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 124.039 0.936 . . . . 1.17 111.221 175.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1586 ' ' GLN . . . . . 0.5 ' HA ' ' CE1' ' A' 1583 ' ' TYR 0.267 28.5 pt20 61.41 14.75 6.02 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 127.074 2.15 . . . . 2.43 112.605 178.895 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A 1587 ' ' VAL . . . . . 0.594 ' HB ' ' O ' ' A' 1584 ' ' VAL . 15.7 t -110.44 120.82 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.325 0 CA-C-N 114.222 -1.354 . . . . 1.16 109.436 177.263 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1588 ' ' LEU . . . . . 0.966 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 2.2 mm? -97.79 107.76 20.33 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 106.556 -1.646 . . . . 1.11 106.556 177.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -105.22 120.72 42.24 Favored 'General case' 0 C--N 1.282 -2.36 0 CA-C-O 121.204 0.526 . . . . 1.74 111.544 -176.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 2.3 mt -107.78 108.5 19.73 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 106.196 -1.779 . . . . 1.4 106.196 172.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 7.8 p -97.39 131.14 44.92 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 CA-C-O 121.192 0.52 . . . . 1.7 110.62 -175.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1592 ' ' TYR . . . . . . . . . . . . . 13.1 m-30 -122.57 95.87 4.81 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 107.947 -1.131 . . . . 1.08 107.947 177.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1593 ' ' LYS . . . . . 0.517 ' HB3' ' HG3' ' A' 1607 ' ' LYS . 48.0 pttt -117.68 175.95 5.41 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.816 -0.754 . . . . 2.21 110.007 -176.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 7.4 m-20 57.11 42.32 25.93 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 124.697 1.248 . . . . 1.11 111.885 177.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -68.42 -95.97 0.04 OUTLIER Glycine 0 C--N 1.332 0.323 0 N-CA-C 110.627 -0.989 . . . . 0.78 110.627 178.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1596 ' ' SER . . . . . . . . . . . . . 79.1 p -122.06 158.48 55.04 Favored Pre-proline 0 C--N 1.288 -2.083 0 N-CA-C 107.691 -1.226 . . . . 1.36 107.691 172.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -57.67 137.63 82.14 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.323 2.016 . . . . 1.4 111.257 178.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1598 ' ' CYS . . . . . 0.493 ' HA ' ' CE2' ' A' 1606 ' ' TYR . 12.0 t -75.0 107.5 4.0 Favored Pre-proline 0 C--N 1.304 -1.399 0 N-CA-C 104.865 -2.272 . . . . 0.75 104.865 177.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1599 ' ' PRO . . . . . 0.497 ' HA ' ' O ' ' B' ' 6' ' ' GLU . 92.1 Cg_exo -44.22 -59.18 1.17 Allowed 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 123.973 3.115 . . . . 1.7 114.814 -169.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1600 ' ' SER . . . . . . . . . . . . . 8.1 m -87.77 12.92 11.66 Favored 'General case' 0 N--CA 1.402 -2.866 0 N-CA-C 112.827 0.676 . . . . 2.8 112.827 -174.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1601 ' ' LYS . . . . . 0.733 ' HE3' ' HB3' ' B' ' 53' ' ' LEU . 96.0 mttt -142.43 69.62 1.32 Allowed 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 122.506 1.146 . . . . 3.45 109.063 174.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 7.2 m -46.71 123.68 5.32 Favored 'General case' 0 N--CA 1.413 -2.315 0 C-N-CA 127.669 2.388 . . . . 2.44 112.326 -177.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 103.96 -21.95 36.62 Favored Glycine 0 N--CA 1.436 -1.348 0 N-CA-C 111.7 -0.56 . . . . 1.2 111.7 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1604 ' ' LEU . . . . . 0.514 HD13 ' HB3' ' A' 1601 ' ' LYS . 46.9 mt -94.11 152.46 18.74 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.019 -1.104 . . . . 2.38 108.019 179.195 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 26.6 m -131.75 145.24 51.5 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 108.078 -1.082 . . . . 1.96 108.078 178.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1606 ' ' TYR . . . . . 0.658 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 91.4 m-85 -64.37 155.99 30.64 Favored 'General case' 0 C--O 1.254 1.327 0 CA-C-N 116.231 -0.44 . . . . 1.06 111.656 -177.364 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1607 ' ' LYS . . . . . 0.517 ' HG3' ' HB3' ' A' 1593 ' ' LYS . 13.0 ttmm -151.89 127.79 10.31 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.502 -0.772 . . . . 2.0 109.553 -173.149 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1608 ' ' SER . . . . . . . . . . . . . 35.1 m -108.79 119.25 39.0 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 108.773 -0.825 . . . . 1.61 108.773 177.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 45.3 t -101.39 104.82 16.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 107.729 -1.211 . . . . 1.09 107.729 178.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 73.9 mt -94.54 111.05 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 N-CA-C 108.621 -0.881 . . . . 1.2 108.621 -178.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 34.3 t -109.12 110.33 21.55 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 115.398 -0.819 . . . . 1.89 110.927 -176.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1612 ' ' PHE . . . . . 0.966 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 63.0 m-85 -86.35 119.69 26.89 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.702 -0.851 . . . . 0.28 108.702 175.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 44.6 t -117.8 137.92 50.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-N 115.954 -0.566 . . . . 1.23 109.72 -176.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 24.4 t -67.93 111.22 4.24 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 123.758 0.823 . . . . 0.77 112.596 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1615 ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -138.43 105.46 7.76 Favored Pre-proline 0 N--CA 1.434 -1.225 0 N-CA-C 109.464 -0.569 . . . . 2.92 109.464 169.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1616 ' ' PRO . . . . . 0.737 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 35.9 Cg_exo -64.3 -10.62 24.42 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 123.224 2.616 . . . . 1.22 113.716 179.505 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -87.14 42.58 1.04 Allowed 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 125.09 1.356 . . . . 3.05 110.9 -177.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -36.58 119.12 0.61 Allowed 'General case' 0 C--O 1.241 0.607 0 C-N-CA 125.531 1.532 . . . . 1.55 112.738 -178.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . -178.83 -138.4 3.18 Favored Glycine 0 N--CA 1.425 -2.054 0 N-CA-C 110.505 -1.038 . . . . 1.16 110.505 -175.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -66.77 3.31 1.55 Allowed 'Trans proline' 0 N--CA 1.487 1.106 0 C-N-CA 123.516 2.81 . . . . 1.06 115.463 -175.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1621 ' ' THR . . . . . 0.517 ' HB ' ' HB2' ' A' 1641 ' ' HIS . 23.0 p -105.62 -4.52 21.01 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.657 0.741 . . . . 1.58 110.053 176.392 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 47.0 t30 -92.81 51.72 1.75 Allowed 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 123.215 1.483 . . . . 0.88 108.219 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1623 ' ' ARG . . . . . 0.484 ' O ' ' HG3' ' A' 1625 ' ' MET . 4.7 ptp180 -150.81 141.56 14.75 Favored Pre-proline 0 C--N 1.294 -1.819 0 N-CA-C 105.777 -1.934 . . . . 3.82 105.777 -176.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -57.0 106.77 0.24 Allowed 'Trans proline' 0 C--O 1.245 0.83 0 C-N-CA 122.374 2.049 . . . . 0.77 111.121 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1625 ' ' MET . . . . . 0.484 ' HG3' ' O ' ' A' 1623 ' ' ARG . 93.5 mtp -100.13 128.56 46.19 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 109.051 -0.722 . . . . 1.43 109.051 -176.319 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 1.8 tm? -87.1 112.51 21.98 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 106.741 -1.577 . . . . 1.43 106.741 -178.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1627 ' ' ILE . . . . . 0.729 HD13 ' HB2' ' A' 1639 ' ' SER . 39.3 mm -72.13 -55.24 14.01 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.613 0 N-CA-C 108.351 -0.981 . . . . 1.23 108.351 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 22.4 t -179.18 173.99 1.09 Allowed 'General case' 0 N--CA 1.422 -1.833 0 N-CA-C 106.286 -1.746 . . . . 1.88 106.286 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1629 ' ' LEU . . . . . 0.76 ' HG ' ' HG ' ' A' 1636 ' ' LEU . 3.8 tt -122.07 110.72 16.13 Favored 'General case' 0 N--CA 1.409 -2.51 0 N-CA-C 104.582 -2.377 . . . . 1.92 104.582 177.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 13.1 t70 -69.21 87.14 0.41 Allowed 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 107.728 -1.212 . . . . 1.09 107.728 176.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1631 ' ' LYS . . . . . 0.509 ' H ' ' HD2' ' A' 1631 ' ' LYS . 0.0 OUTLIER -54.96 -20.71 9.66 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.32 1.048 . . . . 3.98 113.116 -179.278 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A 1632 ' ' GLN . . . . . 0.411 ' HA ' ' NZ ' ' A' 1601 ' ' LYS . 0.3 OUTLIER -71.5 -45.68 61.81 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.441 -0.577 . . . . 2.6 109.441 -177.954 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 44.5 p -102.01 -5.21 24.87 Favored 'General case' 0 CA--C 1.557 1.212 0 N-CA-C 112.928 0.714 . . . . 1.35 112.928 -177.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 58.1 m 65.88 35.67 6.47 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.126 0.97 . . . . 0.53 109.767 -176.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1635 ' ' THR . . . . . 0.489 HG21 ' HD2' ' A' 1607 ' ' LYS . 86.1 m -100.96 129.04 46.75 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.662 -1.154 . . . . 1.11 110.211 -177.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1636 ' ' LEU . . . . . 0.76 ' HG ' ' HG ' ' A' 1629 ' ' LEU . 1.1 mp -107.97 122.36 46.67 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.837 -0.801 . . . . 1.56 108.837 -179.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -100.91 130.01 46.85 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 116.353 -0.385 . . . . 0.54 111.267 -178.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -127.97 130.63 48.7 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.789 -0.641 . . . . 0.64 109.478 -179.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1639 ' ' SER . . . . . 0.729 ' HB2' HD13 ' A' 1627 ' ' ILE . 10.1 t -106.61 156.67 18.35 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.821 -1.178 . . . . 1.34 107.821 178.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 2.0 t90 -156.14 108.62 2.6 Favored 'General case' 0 N--CA 1.423 -1.816 0 N-CA-C 105.689 -1.967 . . . . 0.8 105.689 178.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1641 ' ' HIS . . . . . 0.517 ' HB2' ' HB ' ' A' 1621 ' ' THR . 59.1 m-70 -101.75 102.74 13.42 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 110.018 -0.364 . . . . 1.14 110.018 -175.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1642 ' ' THR . . . . . . . . . . . . . 3.6 t -132.69 149.78 73.94 Favored Pre-proline 0 C--N 1.299 -1.627 0 CA-C-N 115.357 -0.838 . . . . 1.11 109.834 -173.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1643 ' ' PRO . . . . . 0.737 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 71.6 Cg_endo -79.72 -0.12 10.45 Favored 'Trans proline' 0 C--N 1.365 1.4 0 C-N-CA 122.461 2.108 . . . . 0.78 112.139 176.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 11.5 tp -67.12 -28.75 68.4 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.916 0.865 . . . . 1.66 109.038 175.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -89.61 15.61 9.21 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 114.892 -1.049 . . . . 1.29 110.502 -178.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1646 ' ' CYS . . . . . 0.51 ' SG ' ' HA ' ' A' 1643 ' ' PRO . 39.9 m -118.67 146.32 44.79 Favored 'General case' 0 N--CA 1.419 -1.985 0 N-CA-C 106.991 -1.485 . . . . 1.48 106.991 178.252 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.06 115.1 50.79 Favored Pre-proline 0 C--N 1.305 -1.343 0 C-N-CA 119.884 -0.727 . . . . 3.14 109.813 177.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1648 ' ' PRO . . . . . 0.498 ' O ' ' HB2' ' A' 1649 ' ' GLU . 72.7 Cg_endo -80.03 95.65 1.02 Allowed 'Trans proline' 0 C--O 1.253 1.263 0 C-N-CA 121.947 1.765 . . . . 2.92 112.293 -179.25 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1649 ' ' GLU . . . . . 0.498 ' HB2' ' O ' ' A' 1648 ' ' PRO . 0.5 OUTLIER . . . . . 0 C--O 1.243 0.745 0 N-CA-C 105.07 -2.196 . . . . 4.72 105.07 177.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.619 0 N-CA-C 108.791 -0.818 . . . . 10.26 108.791 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 2' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -116.72 131.62 56.9 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 115.227 -0.897 . . . . 7.94 108.631 -176.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -104.99 144.91 29.7 Favored Pre-proline 0 C--N 1.283 -2.321 0 N-CA-C 108.538 -0.912 . . . . 6.56 108.538 178.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -75.21 51.81 2.96 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.975 2.45 . . . . 5.51 111.258 178.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 14.5 m -132.28 72.43 1.49 Allowed 'General case' 0 N--CA 1.411 -2.387 0 CA-C-N 113.932 -1.485 . . . . 4.91 107.956 -178.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . 0.497 ' O ' ' HA ' ' A' 1599 ' ' PRO . 3.2 mp0 -68.24 -35.54 78.09 Favored 'General case' 0 CA--C 1.497 -1.086 0 N-CA-C 107.645 -1.242 . . . . 4.23 107.645 174.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 7' ' ' THR . . . . . 0.778 HG21 ' H ' ' B' ' 51' ' ' CYS . 19.5 p -88.62 99.67 12.5 Favored 'General case' 0 C--N 1.285 -2.233 0 CA-C-N 113.909 -1.496 . . . . 3.48 109.542 177.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . 0.47 ' CB ' ' HG3' ' B' ' 12' ' ' GLU . 6.9 mp -84.01 162.67 20.31 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 121.03 0.443 . . . . 4.35 110.525 179.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 32.3 t -118.15 163.24 16.94 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 109.249 -0.648 . . . . 2.84 109.249 -173.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.29 -128.8 9.26 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 121.032 -0.604 . . . . 2.28 112.861 177.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.12 -23.92 64.55 Favored Glycine 0 C--O 1.223 -0.562 0 N-CA-C 114.143 0.417 . . . . 1.94 114.143 -175.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . 0.47 ' HG3' ' CB ' ' B' ' 8' ' ' LEU . 49.9 mm-40 -67.0 -37.84 84.94 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.428 0.633 . . . . 2.55 109.725 179.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.2 -49.77 58.64 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 115.227 -0.897 . . . . 2.82 109.613 -177.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 8.2 p -67.41 -32.46 57.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 C-N-CA 119.961 -0.695 . . . . 2.5 111.273 179.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -70.9 -40.05 72.41 Favored 'General case' 0 C--O 1.212 -0.896 0 C-N-CA 119.219 -0.992 . . . . 2.04 112.785 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 16.5 p -63.82 -40.75 97.36 Favored 'General case' 0 C--O 1.265 1.917 0 CA-C-N 118.444 0.566 . . . . 2.31 110.052 177.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.518 HD22 HD13 ' B' ' 42' ' ' ILE . 3.9 mm? -53.34 -53.86 44.83 Favored 'General case' 0 C--O 1.211 -0.929 0 CA-C-N 115.26 -0.882 . . . . 2.27 110.574 171.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . 0.543 HE22 ' NE2' ' A' 1569 ' ' GLN . 0.8 OUTLIER -68.89 -20.97 64.26 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 113.001 0.741 . . . . 2.39 113.001 -179.137 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -59.86 -62.67 1.7 Allowed 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 120.927 0.394 . . . . 1.0 110.665 178.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 14.1 p -92.56 -26.09 4.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 C-N-CA 119.119 -1.032 . . . . 1.83 111.33 -177.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 21' ' ' CYS . . . . . 0.449 ' HB2' ' O ' ' B' ' 17' ' ' LEU . 62.6 m -95.98 12.1 31.64 Favored 'General case' 0 N--CA 1.437 -1.111 0 C-N-CA 120.326 -0.55 . . . . 1.66 111.594 -177.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -56.7 -47.47 84.95 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 111.715 -0.554 . . . . 1.53 111.715 173.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -72.24 -14.4 61.77 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 122.816 0.447 . . . . 2.72 111.624 175.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 12.3 tpp180 -100.21 -60.04 1.6 Allowed 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.831 0.824 . . . . 5.02 112.649 -171.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 131.5 152.4 7.21 Favored Glycine 0 N--CA 1.423 -2.232 0 N-CA-C 105.856 -2.897 . . . . 1.63 105.856 -171.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -142.57 141.1 31.95 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 118.832 1.316 . . . . 1.71 111.59 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 27' ' ' TYR . . . . . 0.432 ' HE1' ' HD3' ' B' ' 30' ' ' ARG . 49.3 p90 -161.87 134.61 5.99 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 108.12 -1.067 . . . . 3.67 108.12 175.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 28' ' ' PHE . . . . . 0.428 ' CD1' ' HG ' ' B' ' 17' ' ' LEU . 24.2 p90 -151.25 39.84 0.68 Allowed 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 122.105 0.955 . . . . 2.44 110.503 -177.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 29' ' ' SER . . . . . 0.425 ' HA ' ' HA ' ' B' ' 40' ' ' ARG . 54.5 m -143.52 66.07 1.31 Allowed 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.696 -0.628 . . . . 3.85 110.633 177.34 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . 0.432 ' HD3' ' HE1' ' B' ' 27' ' ' TYR . 82.8 mtm180 -99.38 108.23 49.21 Favored Pre-proline 0 C--N 1.311 -1.094 0 N-CA-C 106.973 -1.491 . . . . 4.27 106.973 178.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . 0.606 ' HB3' ' HA ' ' B' ' 36' ' ' SER . 16.5 Cg_exo -69.12 -22.6 34.77 Favored 'Trans proline' 0 C--O 1.248 1.013 0 C-N-CA 122.511 2.141 . . . . 4.2 113.723 -178.433 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . 62.91 18.23 10.65 Favored 'General case' 0 C--N 1.356 0.888 0 C-N-CA 125.324 1.45 . . . . 5.12 112.693 176.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 33' ' ' SER . . . . . 0.438 ' O ' ' HB2' ' B' ' 31' ' ' PRO . 47.3 t 171.64 155.49 0.08 Allowed 'General case' 0 N--CA 1.413 -2.303 0 N-CA-C 104.016 -2.587 . . . . 6.93 104.016 -178.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -84.83 1.85 45.07 Favored 'General case' 0 C--N 1.278 -2.519 0 CA-C-O 122.176 0.988 . . . . 12.14 108.833 -178.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 23.9 t -87.2 -10.88 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-O 122.406 1.098 . . . . 9.9 108.742 173.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 36' ' ' SER . . . . . 0.606 ' HA ' ' HB3' ' B' ' 31' ' ' PRO . 16.7 t 65.34 41.54 4.28 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 113.951 -1.477 . . . . 6.82 109.873 176.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 32.5 mmt180 -42.55 -55.25 3.58 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 113.611 -1.631 . . . . 10.71 109.554 173.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . 0.587 ' O ' ' HA ' ' B' ' 31' ' ' PRO . 84.0 mtt180 -84.69 102.09 12.69 Favored 'General case' 0 N--CA 1.414 -2.254 0 N-CA-C 107.204 -1.406 . . . . 8.6 107.204 171.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 25.5 m -81.75 75.4 8.7 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 108.991 -0.744 . . . . 5.79 108.991 177.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . 0.425 ' HA ' ' HA ' ' B' ' 29' ' ' SER . 71.7 mtp180 65.15 169.55 0.2 Allowed 'General case' 0 CA--C 1.559 1.299 0 C-N-CA 126.101 1.761 . . . . 6.57 110.587 -176.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . -128.52 150.57 18.64 Favored Glycine 0 N--CA 1.418 -2.565 0 N-CA-C 110.279 -1.128 . . . . 2.62 110.279 -178.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . 0.518 HD13 HD22 ' B' ' 17' ' ' LEU 0.255 11.8 pt 60.52 -33.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 128.421 2.689 . . . . 2.28 115.346 179.155 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . 0.634 ' O ' ' HB2' ' B' ' 47' ' ' CYS . 6.8 p -56.03 -44.2 77.75 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.452 0 N-CA-C 113.2 0.815 . . . . 2.6 113.2 -178.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -94.73 -31.21 13.89 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.321 -0.992 . . . . 3.36 108.321 -173.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . 0.511 ' O ' ' HB2' ' B' ' 49' ' ' ARG . 28.7 tt0 -67.57 -13.4 62.03 Favored 'General case' 0 CA--C 1.555 1.14 0 CA-C-N 114.728 -1.124 . . . . 3.08 109.924 177.329 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 46' ' ' CYS . . . . . 0.42 ' SG ' ' HB ' ' B' ' 7' ' ' THR . 45.5 t -117.86 -14.19 10.08 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-O 121.397 0.618 . . . . 2.23 110.165 174.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 47' ' ' CYS . . . . . 0.634 ' HB2' ' O ' ' B' ' 43' ' ' VAL . 27.3 t -70.04 -44.55 68.99 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.967 -0.383 . . . . 2.48 109.967 -177.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -119.65 23.3 11.23 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.422 -0.354 . . . . 2.97 110.712 -178.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . 0.511 ' HB2' ' O ' ' B' ' 45' ' ' GLU . 68.4 mtt180 -145.36 162.38 37.4 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 108.393 -0.965 . . . . 4.65 108.393 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 22.4 t -85.18 109.16 18.1 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 106.523 -1.658 . . . . 2.86 106.523 173.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . 0.778 ' H ' HG21 ' B' ' 7' ' ' THR . 15.8 p -101.67 144.89 29.83 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 108.001 -1.111 . . . . 2.11 108.001 -176.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -93.13 144.61 25.1 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.419 0.628 . . . . 2.67 109.434 177.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . 0.733 ' HB3' ' HE3' ' A' 1601 ' ' LYS . 48.8 tp -58.46 -27.88 64.8 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.098 1.359 . . . . 2.36 111.363 -179.027 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.32 -39.23 75.4 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.425 -0.807 . . . . 1.92 111.122 178.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 31.3 tp -56.38 -54.63 43.29 Favored 'General case' 0 CA--C 1.516 -0.331 0 O-C-N 124.272 0.983 . . . . 2.35 111.323 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 2.4 pp -73.85 -28.53 61.64 Favored 'General case' 0 N--CA 1.427 -1.61 0 C-N-CA 121.099 -0.24 . . . . 2.01 111.427 -176.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -63.5 -50.47 69.5 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 123.512 0.507 . . . . 2.27 110.711 177.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 14.6 t -80.11 -7.91 59.13 Favored 'General case' 0 CA--C 1.557 1.224 0 CA-C-O 121.092 0.473 . . . . 2.67 111.076 -179.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 59' ' ' TYR . . . . . 0.433 ' HB3' ' H ' ' B' ' 60' ' ' CYS . 15.3 t80 -89.07 -80.13 0.3 Allowed 'General case' 0 N--CA 1.42 -1.973 0 N-CA-C 106.891 -1.522 . . . . 3.2 106.891 176.076 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 60' ' ' CYS . . . . . 0.433 ' H ' ' HB3' ' B' ' 59' ' ' TYR . 43.5 t 47.59 -79.62 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 126.067 1.747 . . . . 2.3 113.869 -178.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -162.65 -45.74 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 105.759 -1.941 . . . . 3.19 105.759 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 2.1 p -133.03 135.19 25.39 Favored Pre-proline 0 N--CA 1.403 -2.806 0 CA-C-N 112.731 -2.031 . . . . 4.14 106.604 175.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -69.05 -31.35 23.87 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 123.141 2.561 . . . . 5.59 116.939 -170.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -150.91 73.74 1.13 Allowed 'General case' 0 C--N 1.294 -1.831 0 C-N-CA 120.312 -0.555 . . . . 5.51 112.026 -178.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -98.56 -7.83 27.54 Favored 'General case' 0 N--CA 1.427 -1.587 0 C-N-CA 120.711 -0.396 . . . . 8.8 111.305 175.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 19.9 m -60.12 -44.17 95.08 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.543 -0.91 . . . . 8.12 108.543 175.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 . . . . . 0 N--CA 1.428 -1.572 0 N-CA-C 106.903 -1.517 . . . . 10.21 106.903 176.921 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 64.9 mtm . . . . . 0 CA--C 1.511 -0.543 0 N-CA-C 108.379 -0.971 . . . . 9.74 108.379 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A 1509 ' ' LYS . . . . . 0.889 ' HD2' ' HB2' ' A' 1514 ' ' ASP . 3.3 mmmp? 77.01 -29.13 0.17 Allowed 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 125.16 1.384 . . . . 9.32 113.956 175.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 15.3 m -98.29 3.16 48.72 Favored 'General case' 0 C--N 1.277 -2.571 0 CA-C-N 115.586 -0.734 . . . . 5.97 110.745 -177.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1511 ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -93.33 -55.48 3.29 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 116.216 -0.447 . . . . 3.48 110.717 -178.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1512 ' ' GLU . . . . . 0.568 ' HG2' ' HA ' ' A' 1518 ' ' VAL . 0.7 OUTLIER -106.2 -60.19 1.68 Allowed 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 122.248 1.023 . . . . 5.95 109.361 176.746 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 11.9 t-160 160.12 -28.74 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.896 0 C-N-CA 128.287 2.635 . . . . 6.14 104.225 -172.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1514 ' ' ASP . . . . . 0.889 ' HB2' ' HD2' ' A' 1509 ' ' LYS . 0.7 OUTLIER 56.06 42.1 28.84 Favored 'General case' 0 CA--C 1.507 -0.694 0 C-N-CA 128.332 2.653 . . . . 5.06 111.932 172.654 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 13.3 t70 -102.76 70.3 1.11 Allowed 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.126 -0.943 . . . . 2.9 109.448 -176.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1516 ' ' CYS . . . . . 0.661 ' HA ' HD21 ' A' 1581 ' ' LEU . 96.0 m 62.35 20.86 12.13 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.756 0.822 . . . . 1.41 112.952 -176.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -155.8 130.83 9.31 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 108.404 -0.961 . . . . 2.18 108.404 177.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1518 ' ' VAL . . . . . 0.568 ' HA ' ' HG2' ' A' 1512 ' ' GLU . 0.5 OUTLIER -144.14 145.58 21.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 C-N-CA 123.575 0.75 . . . . 1.52 110.066 -178.706 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A 1519 ' ' THR . . . . . . . . . . . . . 27.1 m -114.48 142.49 46.32 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 109.86 -0.422 . . . . 1.36 109.86 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1520 ' ' ASN . . . . . 0.497 ' OD1' HG23 ' A' 1523 ' ' THR . 18.1 t-20 -87.68 113.36 54.06 Favored Pre-proline 0 C--N 1.307 -1.257 0 N-CA-C 107.632 -1.248 . . . . 2.02 107.632 171.577 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -69.44 -7.49 21.09 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.949 2.433 . . . . 1.82 113.351 -174.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1522 ' ' SER . . . . . 0.484 ' HB2' ' OD1' ' A' 1520 ' ' ASN . 42.9 m -79.26 -45.98 18.7 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 121.116 -0.234 . . . . 1.89 110.95 178.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1523 ' ' THR . . . . . 0.497 HG23 ' OD1' ' A' 1520 ' ' ASN . 7.7 t -111.0 -15.37 13.76 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 120.358 -0.537 . . . . 1.99 112.3 -176.19 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 83.52 25.82 45.4 Favored Glycine 0 C--O 1.225 -0.457 0 C-N-CA 121.041 -0.6 . . . . 1.19 113.195 176.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -92.81 125.14 37.27 Favored 'General case' 0 C--N 1.309 -1.158 0 C-N-CA 120.589 -0.445 . . . . 1.82 110.074 -178.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 2.7 tm? -94.91 116.62 28.94 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 124.071 0.948 . . . . 1.3 109.447 -178.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -92.54 131.39 37.7 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 120.22 -0.592 . . . . 0.8 109.976 173.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 17.3 t70 -120.13 121.06 37.98 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.589 -0.893 . . . . 1.17 108.589 174.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1529 ' ' LEU . . . . . 0.546 ' HG ' HD23 ' A' 1581 ' ' LEU . 3.1 mm? -100.98 5.82 43.29 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 121.332 0.587 . . . . 1.29 110.509 -176.19 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 2.4 m -73.45 -24.75 60.27 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.715 -0.675 . . . . 0.91 110.235 -178.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 23.0 t -66.7 -28.75 68.69 Favored 'General case' 0 CA--C 1.555 1.149 0 CA-C-O 121.366 0.603 . . . . 1.98 110.38 178.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1532 ' ' LEU . . . . . 0.472 ' HG ' HD21 ' A' 1644 ' ' LEU . 95.5 mt -90.92 3.19 55.26 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.071 0.462 . . . . 1.34 110.925 178.177 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1533 ' ' SER . . . . . . . . . . . . . 13.1 t -80.91 176.49 9.77 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.496 0.665 . . . . 1.93 109.622 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . 150.79 153.77 6.26 Favored Glycine 0 N--CA 1.423 -2.195 0 N-CA-C 110.998 -0.841 . . . . 1.1 110.998 -176.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -78.71 -31.97 46.68 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 121.016 0.436 . . . . 5.21 110.604 -178.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -78.11 -29.5 48.97 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.211 0.529 . . . . 1.94 110.723 -179.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 74.34 -141.52 28.98 Favored Glycine 0 N--CA 1.426 -2.028 0 C-N-CA 120.871 -0.681 . . . . 1.08 112.232 177.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -145.18 144.99 31.16 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.82 -1.178 . . . . 1.07 107.82 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 2.6 m -106.62 133.37 51.4 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.317 0.58 . . . . 1.46 110.193 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1540 ' ' ALA . . . . . 0.675 ' HB3' ' HG2' ' A' 1624 ' ' PRO . . . -127.13 140.84 51.98 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.606 -0.887 . . . . 1.19 108.606 178.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -84.08 142.79 30.16 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 123.518 0.511 . . . . 1.37 110.631 -179.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1542 ' ' TYR . . . . . 0.463 ' HD2' ' HE1' ' A' 1567 ' ' PHE . 0.3 OUTLIER -129.53 -101.8 0.32 Allowed 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 107.899 -1.149 . . . . 1.38 107.899 177.713 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A 1543 ' ' SER . . . . . 0.419 ' H ' ' HB3' ' A' 1542 ' ' TYR . 12.5 t -75.2 178.25 5.89 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 109.869 -0.419 . . . . 1.98 109.869 178.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 60.7 tttp -52.61 -44.13 65.8 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.804 0.841 . . . . 3.96 113.235 -173.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 11.1 t -123.01 32.33 5.73 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 107.329 -1.36 . . . . 2.81 107.329 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . -126.6 111.23 1.36 Allowed Glycine 0 N--CA 1.43 -1.707 0 CA-C-N 115.114 -0.948 . . . . 1.68 113.133 -174.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 20.4 m -110.31 157.45 10.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 N-CA-C 108.331 -0.988 . . . . 1.38 108.331 175.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1548 ' ' VAL . . . . . 0.492 ' HA ' ' HA ' ' A' 1567 ' ' PHE . 10.2 p -114.68 132.28 64.3 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 N-CA-C 109.369 -0.604 . . . . 1.24 109.369 177.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -101.1 117.51 35.16 Favored 'General case' 0 CA--C 1.488 -1.405 0 N-CA-C 108.714 -0.847 . . . . 1.29 108.714 178.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 13.0 ptp -129.53 139.41 51.54 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-N 115.824 -0.626 . . . . 1.47 110.402 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 7.1 p -117.48 120.61 38.63 Favored 'General case' 0 C--N 1.274 -2.678 0 CA-C-N 115.016 -0.993 . . . . 1.4 108.459 176.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1552 ' ' ILE . . . . . 0.414 ' HB ' ' O ' ' A' 1532 ' ' LEU . 38.6 mm -77.5 120.85 28.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 C-N-CA 120.672 -0.411 . . . . 1.11 110.571 -177.264 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 38.1 t 67.61 39.43 2.78 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 122.282 1.039 . . . . 1.4 109.314 174.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 176.86 -169.86 42.4 Favored Glycine 0 N--CA 1.422 -2.288 0 C-N-CA 120.436 -0.888 . . . . 0.4 111.258 -178.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -113.53 151.5 31.48 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 120.967 0.413 . . . . 1.62 111.53 -176.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -99.23 146.38 26.25 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 114.676 -1.147 . . . . 1.12 109.107 -176.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -92.45 4.94 52.47 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 112.374 0.509 . . . . 2.49 112.374 -170.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -93.63 -7.77 42.97 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 121.594 -0.691 . . . . 1.38 111.655 -179.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1559 ' ' CYS . . . . . 0.465 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 78.7 m -136.6 165.96 31.29 Favored Pre-proline 0 C--N 1.297 -1.682 0 CA-C-O 118.398 -0.811 . . . . 1.21 109.849 -178.166 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1560 ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 7.7 Cg_exo -36.5 118.57 0.2 Allowed 'Trans proline' 0 C--N 1.367 1.518 0 C-N-CA 124.561 3.508 . . . . 0.98 113.951 176.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -44.74 130.66 9.89 Favored 'Trans proline' 0 C--N 1.362 1.255 0 C-N-CA 124.59 3.527 . . . . 1.15 112.18 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 111.79 -6.69 27.7 Favored Glycine 0 N--CA 1.435 -1.408 0 CA-C-N 115.906 -0.588 . . . . 0.55 112.404 -177.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1563 ' ' VAL . . . . . . . . . . . . . 7.5 p -105.27 137.19 35.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 O-C-N 122.109 -0.642 . . . . 1.53 111.496 -178.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -99.54 -32.68 5.63 Favored Glycine 0 C--N 1.322 -0.241 0 CA-C-N 115.615 -0.72 . . . . 0.29 112.771 -178.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -122.88 126.21 46.88 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 109.479 -0.563 . . . . 1.08 109.479 178.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 46.5 t -153.73 148.38 26.32 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.842 -0.799 . . . . 0.43 108.842 -179.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1567 ' ' PHE . . . . . 0.721 ' HB2' ' HG1' ' A' 1570 ' ' THR . 96.7 m-85 -92.11 158.78 16.01 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 119.732 -0.787 . . . . 1.3 109.548 176.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -62.6 -75.92 0.29 Allowed Glycine 0 C--O 1.245 0.81 0 N-CA-C 115.183 0.833 . . . . 1.43 115.183 -173.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -67.18 -34.48 77.62 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 113.159 0.799 . . . . 3.09 113.159 -173.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1570 ' ' THR . . . . . 0.783 ' HB ' HG13 ' A' 1572 ' ' ILE . 45.9 p -67.81 -35.17 78.15 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 112.429 0.529 . . . . 2.52 112.429 -177.019 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 18.1 mmt180 64.55 8.88 4.66 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.672 1.189 . . . . 3.19 110.746 -174.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1572 ' ' ILE . . . . . 0.783 HG13 ' HB ' ' A' 1570 ' ' THR . 18.1 mt -74.61 127.29 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-O 121.301 0.572 . . . . 1.51 111.438 -175.404 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 13.0 t -74.79 118.21 17.5 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 114.922 -1.035 . . . . 0.96 108.656 177.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1574 ' ' VAL . . . . . 0.549 ' HA ' ' CB ' ' A' 1606 ' ' TYR . 24.8 m -114.58 20.29 6.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 C-N-CA 119.738 -0.785 . . . . 1.6 111.933 -179.168 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 161.44 119.75 0.52 Allowed Glycine 0 N--CA 1.432 -1.602 0 C-N-CA 120.327 -0.94 . . . . 0.34 112.451 176.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 57.7 tttm -64.66 139.89 58.81 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.843 -0.429 . . . . 2.68 109.843 178.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -71.73 144.34 49.31 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 115.477 -0.783 . . . . 1.08 110.057 -179.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 22.2 p30 -161.31 179.01 8.66 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 107.853 -1.166 . . . . 1.95 107.853 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 17.7 pttm -134.04 46.53 2.51 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-O 122.941 1.353 . . . . 3.11 108.784 177.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 64.7 ttt180 -101.48 99.88 10.26 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-N 113.383 -1.735 . . . . 4.04 107.75 -175.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1581 ' ' LEU . . . . . 0.661 HD21 ' HA ' ' A' 1516 ' ' CYS . 0.3 OUTLIER -93.53 137.58 32.68 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.855 -0.795 . . . . 1.32 108.855 -175.58 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 75.6 mtp180 -123.91 124.77 43.35 Favored 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 120.652 -0.419 . . . . 3.4 111.045 171.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1583 ' ' TYR . . . . . . . . . . . . . 71.1 t80 -96.31 112.78 24.4 Favored 'General case' 0 CA--C 1.49 -1.364 0 N-CA-C 107.239 -1.393 . . . . 1.26 107.239 173.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1584 ' ' VAL . . . . . 0.536 ' O ' ' HB ' ' A' 1587 ' ' VAL . 20.3 t -128.39 92.33 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 N-CA-C 109.501 -0.555 . . . . 1.71 109.501 -178.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 32.6 t70 50.83 69.2 0.67 Allowed 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 124.905 1.282 . . . . 1.17 112.041 175.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 3.0 pt20 71.37 -8.04 1.09 Allowed 'General case' 0 N--CA 1.504 2.271 0 C-N-CA 128.498 2.719 . . . . 2.43 112.197 178.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1587 ' ' VAL . . . . . 0.536 ' HB ' ' O ' ' A' 1584 ' ' VAL . 13.8 t -91.68 120.31 40.54 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.23 0 CA-C-N 115.263 -0.881 . . . . 1.16 110.106 178.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1588 ' ' LEU . . . . . 0.791 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 3.2 mm? -91.06 107.66 19.35 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 105.923 -1.88 . . . . 1.11 105.923 174.49 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -111.08 131.07 55.38 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-O 121.694 0.759 . . . . 1.74 112.515 -173.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 15.0 mt -123.86 104.76 9.14 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 114.0 -1.455 . . . . 1.4 107.699 173.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1591 ' ' VAL . . . . . 0.478 HG21 HG22 ' A' 1609 ' ' VAL . 6.3 p -97.53 128.57 48.72 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 N-CA-C 108.799 -0.815 . . . . 1.7 108.799 179.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1592 ' ' TYR . . . . . 0.479 ' O ' ' HA ' ' A' 1607 ' ' LYS . 15.9 m-30 -115.19 102.65 10.09 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.673 -0.862 . . . . 1.08 108.673 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 57.8 pttt -109.9 176.43 5.07 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.244 -0.65 . . . . 2.21 109.244 -178.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 21.8 m-20 61.0 51.11 4.67 Favored 'General case' 0 C--N 1.312 -1.037 0 O-C-N 124.095 0.872 . . . . 1.11 112.158 177.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -83.09 -134.51 2.28 Favored Glycine 0 N--CA 1.425 -2.098 0 N-CA-C 109.629 -1.389 . . . . 0.78 109.629 172.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1596 ' ' SER . . . . . . . . . . . . . 29.9 p -100.33 157.96 32.85 Favored Pre-proline 0 C--N 1.29 -1.994 0 O-C-N 122.036 -0.685 . . . . 1.36 109.648 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1597 ' ' PRO . . . . . 0.464 ' HA ' ' O ' ' A' 1604 ' ' LEU . 73.4 Cg_exo -52.01 123.6 12.86 Favored 'Trans proline' 0 C--N 1.36 1.167 0 C-N-CA 123.059 2.506 . . . . 1.4 112.234 177.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1598 ' ' CYS . . . . . 0.624 ' HA ' ' CE1' ' A' 1606 ' ' TYR . 43.7 t -77.94 117.84 68.42 Favored Pre-proline 0 C--N 1.299 -1.627 0 CA-C-N 114.959 -1.018 . . . . 0.75 109.659 -178.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -63.93 -30.31 67.23 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.914 2.409 . . . . 1.7 111.855 178.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1600 ' ' SER . . . . . 0.599 ' HA ' ' HB2' ' B' ' 53' ' ' LEU . 14.4 m -61.65 -49.27 77.23 Favored 'General case' 0 C--O 1.25 1.083 0 CA-C-N 116.009 -0.542 . . . . 2.8 110.852 178.264 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1601 ' ' LYS . . . . . 0.66 ' HG2' HD21 ' A' 1604 ' ' LEU . 0.6 OUTLIER -120.81 98.49 6.03 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 107.114 -1.439 . . . . 3.45 107.114 -178.958 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 19.3 m -57.96 119.32 6.55 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 113.822 1.045 . . . . 2.44 113.822 -171.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 98.96 -8.45 61.19 Favored Glycine 0 CA--C 1.499 -0.964 0 N-CA-C 111.595 -0.602 . . . . 1.2 111.595 177.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1604 ' ' LEU . . . . . 0.66 HD21 ' HG2' ' A' 1601 ' ' LYS . 8.8 tp -90.97 170.98 9.6 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.735 -1.209 . . . . 2.38 107.735 -179.222 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 32.5 t -130.48 150.93 51.47 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 108.644 -0.873 . . . . 1.96 108.644 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1606 ' ' TYR . . . . . 0.624 ' CE1' ' HA ' ' A' 1598 ' ' CYS . 57.8 m-85 -71.48 157.76 37.46 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.744 -0.662 . . . . 1.06 110.856 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1607 ' ' LYS . . . . . 0.479 ' HA ' ' O ' ' A' 1592 ' ' TYR . 75.7 tttt -157.39 125.44 5.47 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 109.21 -0.663 . . . . 2.0 109.21 -173.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1608 ' ' SER . . . . . . . . . . . . . 28.5 m -112.48 132.05 55.26 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-N 116.278 -0.419 . . . . 1.61 109.933 -178.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1609 ' ' VAL . . . . . 0.478 HG22 HG21 ' A' 1591 ' ' VAL . 39.8 t -109.35 108.59 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.507 0 N-CA-C 108.448 -0.945 . . . . 1.09 108.448 177.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 68.7 mt -95.24 126.66 47.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 N-CA-C 108.06 -1.089 . . . . 1.2 108.06 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 23.4 m -127.26 118.47 24.3 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 116.138 -0.483 . . . . 1.89 110.911 -178.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1612 ' ' PHE . . . . . 0.791 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 70.0 m-85 -95.55 128.02 42.07 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.912 -0.585 . . . . 0.28 109.596 177.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1613 ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' 1641 ' ' HIS . 66.2 t -122.7 138.84 51.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 CA-C-N 115.402 -0.817 . . . . 1.23 109.443 -177.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1614 ' ' CYS . . . . . 0.694 ' HB2' ' HA ' ' A' 1646 ' ' CYS . 4.0 t -52.07 119.82 4.75 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 124.352 1.061 . . . . 0.77 113.169 176.394 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1615 ' ' ARG . . . . . 0.756 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 22.2 tpt180 -135.29 89.66 22.63 Favored Pre-proline 0 N--CA 1.439 -0.993 0 N-CA-C 107.739 -1.208 . . . . 2.92 107.739 170.09 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1616 ' ' PRO . . . . . 0.567 ' HD3' ' SG ' ' A' 1614 ' ' CYS . 51.3 Cg_endo -68.94 -23.06 35.06 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.195 1.93 . . . . 1.22 113.425 -172.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -94.86 -3.56 48.61 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.527 -0.306 . . . . 3.05 111.051 -179.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . 59.51 -165.85 0.19 Allowed 'General case' 0 CA--C 1.554 1.108 0 N-CA-C 109.455 -0.572 . . . . 1.55 109.455 -173.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . 135.3 -163.54 24.88 Favored Glycine 0 N--CA 1.415 -2.739 0 C-N-CA 120.961 -0.637 . . . . 1.16 112.403 174.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -61.3 -8.24 10.02 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 124.243 3.295 . . . . 1.06 115.069 -177.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1621 ' ' THR . . . . . . . . . . . . . 19.0 p -96.43 -0.65 48.9 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-O 121.199 0.523 . . . . 1.58 111.369 -177.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 41.4 t30 -87.25 63.43 7.79 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 122.243 1.02 . . . . 0.88 109.059 178.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 -172.76 140.07 0.95 Allowed Pre-proline 0 C--N 1.304 -1.387 0 N-CA-C 107.443 -1.318 . . . . 3.82 107.443 -177.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1624 ' ' PRO . . . . . 0.675 ' HG2' ' HB3' ' A' 1540 ' ' ALA . 35.1 Cg_endo -64.08 99.72 0.29 Allowed 'Trans proline' 0 C--O 1.246 0.917 0 C-N-CA 122.859 2.372 . . . . 0.77 112.355 -176.243 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 70.7 mtm -98.07 133.49 42.45 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.99 -0.55 . . . . 1.43 110.703 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 1.4 tm? -74.58 116.62 15.48 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 108.15 -1.056 . . . . 1.43 108.15 -178.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1627 ' ' ILE . . . . . 0.448 HD11 ' HB2' ' A' 1639 ' ' SER . 43.1 mm -79.56 -55.63 8.83 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 N-CA-C 108.378 -0.971 . . . . 1.23 108.378 177.41 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 77.9 p -164.72 150.27 10.03 Favored 'General case' 0 N--CA 1.419 -1.982 0 CA-C-N 114.833 -1.076 . . . . 1.88 109.537 -179.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1629 ' ' LEU . . . . . 0.846 HD11 ' HG ' ' A' 1636 ' ' LEU . 27.8 tp -119.14 112.31 19.36 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 106.885 -1.524 . . . . 1.92 106.885 172.188 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 33.1 t70 -78.4 128.86 34.24 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 117.549 -1.661 . . . . 1.09 111.628 177.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1631 ' ' LYS . . . . . 0.491 ' HD3' ' N ' ' A' 1631 ' ' LYS . 0.1 OUTLIER -66.05 -28.96 69.24 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 112.726 -2.034 . . . . 3.98 113.108 -175.564 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 11.1 mm100 -103.0 -35.44 8.55 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 119.918 -0.713 . . . . 2.6 112.134 -174.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 73.9 p -91.99 -6.59 50.92 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-O 120.8 0.333 . . . . 1.35 111.605 -178.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 64.1 m 54.06 33.51 17.83 Favored 'General case' 0 C--N 1.362 1.147 0 C-N-CA 124.669 1.187 . . . . 0.53 111.898 176.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1635 ' ' THR . . . . . . . . . . . . . 29.2 m -100.53 132.1 46.09 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 115.624 -0.716 . . . . 1.11 109.37 -178.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1636 ' ' LEU . . . . . 0.846 ' HG ' HD11 ' A' 1629 ' ' LEU . 0.6 OUTLIER -111.08 124.11 51.54 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 107.919 -1.141 . . . . 1.56 107.919 -177.604 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -106.5 129.38 54.47 Favored 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 120.997 -0.281 . . . . 0.54 110.494 -179.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -125.36 134.9 52.01 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.197 -0.456 . . . . 0.64 110.269 -178.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1639 ' ' SER . . . . . 0.448 ' HB2' HD11 ' A' 1627 ' ' ILE . 31.0 t -110.29 148.81 31.18 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 107.663 -1.236 . . . . 1.34 107.663 176.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 2.6 t90 -152.69 114.27 4.29 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 105.951 -1.87 . . . . 0.8 105.951 -178.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1641 ' ' HIS . . . . . 0.756 ' HB3' ' HB2' ' A' 1615 ' ' ARG . 8.9 m-70 -105.04 115.56 30.48 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 108.889 -0.782 . . . . 1.14 108.889 -178.197 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1642 ' ' THR . . . . . . . . . . . . . 3.0 t -137.24 150.59 69.51 Favored Pre-proline 0 C--N 1.3 -1.547 0 C-N-CA 123.065 0.546 . . . . 1.11 110.445 -172.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1643 ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.49 -18.38 17.74 Favored 'Trans proline' 0 C--N 1.367 1.524 0 C-N-CA 122.622 2.215 . . . . 0.78 113.328 178.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1644 ' ' LEU . . . . . 0.472 HD21 ' HG ' ' A' 1532 ' ' LEU . 3.8 pp -84.45 -1.47 55.72 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 119.806 -0.757 . . . . 1.66 111.729 -178.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -120.06 28.66 7.95 Favored 'General case' 0 CA--C 1.498 -1.048 0 CA-C-O 122.103 0.954 . . . . 1.29 109.531 -178.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1646 ' ' CYS . . . . . 0.694 ' HA ' ' HB2' ' A' 1614 ' ' CYS . 45.9 t -105.7 140.87 38.1 Favored 'General case' 0 N--CA 1.41 -2.471 0 CA-C-N 114.842 -1.072 . . . . 1.48 109.835 -177.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -100.83 123.3 46.03 Favored Pre-proline 0 N--CA 1.419 -2.018 0 N-CA-C 104.928 -2.249 . . . . 3.14 104.928 175.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1648 ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -27.69 103.61 0.02 OUTLIER 'Trans proline' 0 C--N 1.367 1.51 1 C-N-CA 125.943 4.429 . . . . 2.92 116.304 -171.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 . . . . . 0 C--O 1.251 1.175 0 CA-C-N 114.981 -1.009 . . . . 4.72 109.215 178.073 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.683 0 N-CA-C 108.573 -0.899 . . . . 10.26 108.573 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 2' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -126.82 131.95 51.12 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.714 -0.847 . . . . 7.94 108.714 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -114.15 144.54 31.83 Favored Pre-proline 0 C--N 1.294 -1.812 0 N-CA-C 108.606 -0.887 . . . . 6.56 108.606 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -76.58 55.72 4.88 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 123.095 2.53 . . . . 5.51 112.734 178.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 13.4 m 60.15 9.58 1.93 Allowed 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 127.108 2.163 . . . . 4.91 115.519 171.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 64.2 24.96 13.52 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.859 1.263 . . . . 4.23 110.586 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 3.7 p -130.65 116.15 17.69 Favored 'General case' 0 C--N 1.283 -2.287 0 CA-C-N 113.433 -1.712 . . . . 3.48 108.404 177.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . 0.491 ' HB2' ' H ' ' B' ' 12' ' ' GLU . 78.9 mt -64.59 113.99 4.09 Favored 'General case' 0 C--O 1.247 0.965 0 N-CA-C 108.761 -0.829 . . . . 4.35 108.761 177.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 20.1 m -50.47 -21.57 1.54 Allowed 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.986 1.314 . . . . 2.84 114.24 -174.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . 0.421 ' O ' HG12 ' B' ' 14' ' ' VAL . . . -117.62 -65.7 0.34 Allowed Glycine 0 N--CA 1.425 -2.071 0 C-N-CA 120.518 -0.849 . . . . 2.28 111.433 179.142 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -55.72 -55.07 30.72 Favored Glycine 0 C--O 1.24 0.502 0 N-CA-C 114.388 0.515 . . . . 1.94 114.388 -174.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . 0.491 ' H ' ' HB2' ' B' ' 8' ' ' LEU . 55.8 mt-10 -74.25 -32.49 62.98 Favored 'General case' 0 CA--C 1.505 -0.775 0 C-N-CA 120.69 -0.404 . . . . 2.55 111.282 -177.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . 0.452 HD11 ' HA ' ' B' ' 13' ' ' LEU . 1.1 mm? -58.1 -59.0 5.96 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.175 0.512 . . . . 2.82 111.411 178.006 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . 0.421 HG12 ' O ' ' B' ' 10' ' ' GLY . 13.0 p -68.89 -35.33 68.84 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 CA-C-N 115.857 -0.61 . . . . 2.5 111.882 -176.131 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -78.34 -26.69 46.85 Favored 'General case' 0 C--O 1.213 -0.866 0 N-CA-C 114.105 1.15 . . . . 2.04 114.105 -179.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 19.6 p -67.09 -36.6 82.33 Favored 'General case' 0 C--O 1.256 1.437 0 CA-C-N 119.692 1.133 . . . . 2.31 108.819 174.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.711 ' HB3' ' HB3' ' B' ' 26' ' ' PHE . 10.4 mp -60.77 -47.85 84.43 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-N 114.978 -1.01 . . . . 2.27 111.335 171.312 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -63.09 -33.3 75.15 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.036 0.446 . . . . 2.39 110.07 179.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -55.52 -59.25 5.09 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 112.905 0.706 . . . . 1.0 112.905 -179.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 9.8 p -98.51 -20.21 5.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 C-N-CA 117.314 -1.755 . . . . 1.83 112.068 -179.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 21' ' ' CYS . . . . . 0.469 ' HB2' ' O ' ' B' ' 17' ' ' LEU . 69.4 m -99.66 1.25 43.33 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 113.473 0.916 . . . . 1.66 113.473 -175.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -49.29 -36.59 22.94 Favored Glycine 0 N--CA 1.483 1.806 0 N-CA-C 114.789 0.676 . . . . 1.53 114.789 -178.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -52.05 -46.91 65.28 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.873 0.869 . . . . 2.72 111.891 176.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . 0.403 ' HD3' ' O ' ' B' ' 62' ' ' THR . 42.8 ttm180 -97.56 -43.47 7.22 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.277 0.56 . . . . 5.02 111.348 178.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 128.19 165.54 11.84 Favored Glycine 0 N--CA 1.425 -2.082 0 N-CA-C 110.19 -1.164 . . . . 1.63 110.19 -179.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . 0.711 ' HB3' ' HB3' ' B' ' 17' ' ' LEU . 3.4 p90 -98.25 128.01 44.48 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 117.163 0.481 . . . . 1.71 109.83 175.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 27' ' ' TYR . . . . . 0.591 ' HB2' ' HA ' ' B' ' 61' ' ' ALA . 53.6 m-85 -132.78 72.92 1.5 Allowed 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 121.577 0.703 . . . . 3.67 110.482 -176.354 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 28' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -104.43 -3.83 23.55 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.123 -0.944 . . . . 2.44 109.282 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 29' ' ' SER . . . . . 0.569 ' HA ' ' HG2' ' B' ' 40' ' ' ARG . 14.9 m -101.9 51.49 0.83 Allowed 'General case' 0 N--CA 1.441 -0.904 0 CA-C-O 121.922 0.868 . . . . 3.85 109.082 -176.059 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 73.8 mtp180 -102.33 113.84 65.69 Favored Pre-proline 0 C--N 1.299 -1.601 0 CA-C-N 115.312 -0.858 . . . . 4.27 108.884 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . 0.409 ' HA ' ' O ' ' B' ' 38' ' ' ARG . 20.0 Cg_exo -62.46 -25.34 75.92 Favored 'Trans proline' 0 C--O 1.249 1.031 0 C-N-CA 123.305 2.67 . . . . 4.2 113.357 -177.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . 61.08 16.47 7.13 Favored 'General case' 0 C--N 1.36 1.061 0 C-N-CA 125.71 1.604 . . . . 5.12 112.837 174.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 29.4 t 175.14 157.43 0.18 Allowed 'General case' 0 N--CA 1.389 -3.522 0 N-CA-C 104.464 -2.421 . . . . 6.93 104.464 -177.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 46.7 ttt180 -87.6 -1.66 58.09 Favored 'General case' 0 C--N 1.271 -2.84 0 N-CA-C 108.52 -0.918 . . . . 12.14 108.52 -177.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 51.4 t -87.09 -5.46 10.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 114.649 -1.159 . . . . 9.9 109.403 178.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 20.4 t 64.61 29.21 13.13 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.1 -0.954 . . . . 6.82 109.294 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 55.6 ttp180 -57.08 -49.79 74.77 Favored 'General case' 0 N--CA 1.436 -1.175 0 CA-C-N 114.641 -1.163 . . . . 10.71 111.149 -177.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . 0.409 ' O ' ' HA ' ' B' ' 31' ' ' PRO . 11.8 tpp85 -85.42 102.97 13.89 Favored 'General case' 0 N--CA 1.423 -1.824 0 N-CA-C 107.228 -1.397 . . . . 8.6 107.228 174.114 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 17.8 m -97.19 72.79 2.46 Favored 'General case' 0 C--O 1.258 1.526 0 N-CA-C 108.985 -0.746 . . . . 5.79 108.985 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . 0.569 ' HG2' ' HA ' ' B' ' 29' ' ' SER . 91.8 mtt180 62.71 130.26 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 126.18 1.792 . . . . 6.57 112.652 -174.07 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . -96.48 170.9 27.35 Favored Glycine 0 N--CA 1.438 -1.2 0 N-CA-C 110.139 -1.184 . . . . 2.62 110.139 178.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . 0.27 18.4 pt 60.84 -30.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 C-N-CA 127.185 2.194 . . . . 2.28 116.314 178.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 2.7 p -48.97 -46.23 16.61 Favored 'Isoleucine or valine' 0 C--O 1.245 0.837 0 N-CA-C 114.047 1.128 . . . . 2.6 114.047 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -96.69 -30.61 13.13 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 108.579 -0.897 . . . . 3.36 108.579 -172.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -64.72 -42.4 95.26 Favored 'General case' 0 C--O 1.214 -0.798 0 CA-C-N 114.869 -1.059 . . . . 3.08 111.179 177.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 46' ' ' CYS . . . . . 0.428 ' HA ' ' O ' ' B' ' 49' ' ' ARG . 35.7 t -89.33 -3.12 58.6 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.447 0.642 . . . . 2.23 110.703 -179.468 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 41.9 t -83.41 -50.42 8.33 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.638 0.732 . . . . 2.48 109.491 175.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -88.67 -20.04 25.4 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.866 0.691 . . . . 2.97 112.866 -177.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . 0.428 ' O ' ' HA ' ' B' ' 46' ' ' CYS . 36.1 mmt180 -130.68 150.31 51.93 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 106.68 -1.6 . . . . 4.65 106.68 177.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 22.1 t -79.96 127.5 32.34 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 106.827 -1.545 . . . . 2.86 106.827 178.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 24.3 p -90.52 139.21 30.91 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 109.36 -0.607 . . . . 2.11 109.36 -173.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -85.87 165.0 17.16 Favored 'General case' 0 C--O 1.249 1.07 0 C-N-CA 120.566 -0.454 . . . . 2.67 110.305 177.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . 0.599 ' HB2' ' HA ' ' A' 1600 ' ' SER . 63.5 tp -53.2 -45.02 68.43 Favored 'General case' 0 C--N 1.321 -0.663 0 O-C-N 123.479 0.487 . . . . 2.36 111.649 178.141 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.89 -32.41 63.69 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.368 -0.833 . . . . 1.92 113.184 -171.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 65.9 tp -70.42 -57.65 4.58 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 121.012 0.434 . . . . 2.35 110.295 179.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 2.9 pp -71.97 -25.25 61.79 Favored 'General case' 0 C--O 1.213 -0.867 0 CA-C-N 116.043 -0.526 . . . . 2.01 111.195 -174.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -64.82 -55.6 18.62 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 122.638 0.375 . . . . 2.27 110.162 178.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 13.2 t -78.89 -27.42 43.91 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 119.331 -0.947 . . . . 2.67 112.06 -177.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -71.66 -57.19 4.6 Favored 'General case' 0 C--O 1.219 -0.527 0 N-CA-C 107.02 -1.474 . . . . 3.2 107.02 178.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 9.9 t 22.44 -82.59 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 117.121 2.267 . . . . 2.3 117.121 174.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 61' ' ' ALA . . . . . 0.591 ' HA ' ' HB2' ' B' ' 27' ' ' TYR . . . -144.18 -168.77 2.96 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-O 121.854 0.835 . . . . 3.19 110.719 -170.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 62' ' ' THR . . . . . 0.403 ' O ' ' HD3' ' B' ' 24' ' ' ARG . 4.4 t -145.34 148.72 38.63 Favored Pre-proline 0 N--CA 1.406 -2.648 0 N-CA-C 104.547 -2.39 . . . . 4.14 104.547 176.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -51.28 -31.18 36.18 Favored 'Trans proline' 0 N--CA 1.477 0.545 0 C-N-CA 123.666 2.911 . . . . 5.59 116.518 -165.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 58.22 33.4 23.12 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 126.443 1.897 . . . . 5.51 112.429 173.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 47.7 tttm 62.5 132.78 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.449 1.499 . . . . 8.8 112.221 -175.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 22.4 m -89.35 151.64 21.96 Favored 'General case' 0 N--CA 1.427 -1.603 0 N-CA-C 108.083 -1.081 . . . . 8.12 108.083 176.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 . . . . . 0 C--N 1.305 -1.327 0 N-CA-C 108.138 -1.06 . . . . 10.21 108.138 -178.21 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 27.3 m-20 . . . . . 0 N--CA 1.471 0.588 0 N-CA-C 110.857 -0.053 . . . . 2.8999999999999999 110.857 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A 1516 ' ' CYS . . . . . 0.439 ' SG ' ' HB2' ' A' 1579 ' ' LYS . 77.8 m 54.11 35.84 23.3 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 113.876 1.065 . . . . 1.1899999999999999 113.876 -176.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -143.6 129.33 19.3 Favored 'General case' 0 N--CA 1.434 -1.267 0 C-N-CA 120.07 -0.652 . . . . 1.52 109.662 176.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1518 ' ' VAL . . . . . 0.427 HG22 HD22 ' A' 1581 ' ' LEU . 2.5 m -138.57 137.89 42.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 CA-C-N 115.379 -0.828 . . . . 0.93999999999999995 111.366 -175.523 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1519 ' ' THR . . . . . . . . . . . . . 6.3 m -98.15 136.85 37.78 Favored 'General case' 0 C--N 1.277 -2.579 0 CA-C-N 115.465 -0.789 . . . . 0.89000000000000001 109.476 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -77.35 117.71 67.2 Favored Pre-proline 0 N--CA 1.428 -1.537 0 N-CA-C 108.808 -0.812 . . . . 1.74 108.808 176.134 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -69.47 -13.49 35.49 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 122.491 2.127 . . . . 1.5800000000000001 113.795 -177.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 15.0 m -82.41 -36.74 26.4 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 112.498 0.555 . . . . 1.6499999999999999 112.498 -177.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1523 ' ' THR . . . . . . . . . . . . . 12.4 t -137.1 3.48 2.65 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 119.599 -0.84 . . . . 1.6100000000000001 112.215 -176.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 72.39 28.72 67.31 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.755 -0.736 . . . . 1.1299999999999999 112.599 177.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 62.3 t-80 -85.18 119.81 25.98 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.797 -0.816 . . . . 1.26 108.797 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 2.6 tm? -87.15 112.47 21.98 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 109.032 -0.729 . . . . 0.68000000000000005 109.032 -178.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -91.4 114.28 26.77 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 109.82 -0.437 . . . . 0.65000000000000002 109.82 175.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 17.5 t70 -110.07 116.41 31.52 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.813 -0.81 . . . . 1.1699999999999999 108.813 175.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1529 ' ' LEU . . . . . 0.6 ' HG ' HD11 ' A' 1581 ' ' LEU . 3.3 mm? -97.49 0.6 47.85 Favored 'General case' 0 N--CA 1.423 -1.817 0 CA-C-O 121.083 0.468 . . . . 0.59999999999999998 110.301 -177.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1530 ' ' SER . . . . . 0.555 ' HA ' ' OG ' ' A' 1533 ' ' SER . 2.2 m -70.19 -19.31 63.18 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 122.193 0.997 . . . . 0.83999999999999997 109.419 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1531 ' ' SER . . . . . 0.413 ' HB2' HD11 ' A' 1644 ' ' LEU . 21.2 m -68.68 -18.4 64.26 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 114.931 -1.031 . . . . 1.5900000000000001 110.238 175.422 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 82.6 mt -102.93 -6.73 22.13 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 122.322 -0.236 . . . . 0.65000000000000002 110.979 178.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1533 ' ' SER . . . . . 0.672 ' HA ' ' HB ' ' A' 1552 ' ' ILE . 30.2 m -60.97 162.5 6.93 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-O 120.947 0.403 . . . . 1.52 111.286 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . 170.72 151.61 7.64 Favored Glycine 0 N--CA 1.426 -1.991 0 C-N-CA 120.513 -0.851 . . . . 1.1000000000000001 111.107 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 33.8 ttt85 -87.21 -30.75 20.74 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 122.946 0.498 . . . . 4.6200000000000001 111.377 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -78.37 -35.82 46.81 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.727 -0.842 . . . . 1.45 108.727 177.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 80.7 -140.16 21.48 Favored Glycine 0 N--CA 1.409 -3.109 0 CA-C-N 114.535 -1.211 . . . . 0.84999999999999998 112.324 173.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -142.21 143.14 32.77 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 106.454 -1.684 . . . . 0.93000000000000005 106.454 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 1.2 m -108.59 130.19 55.31 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 108.793 -0.817 . . . . 1.03 108.793 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1540 ' ' ALA . . . . . 0.456 ' HB2' ' HG2' ' A' 1624 ' ' PRO . . . -124.71 147.33 48.67 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.999 -0.741 . . . . 0.5 108.999 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -91.17 128.18 36.89 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 120.794 0.331 . . . . 0.73999999999999999 110.225 -177.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1542 ' ' TYR . . . . . 0.556 ' CE2' ' HG ' ' A' 1626 ' ' LEU . 2.3 t80 -113.02 -99.32 0.43 Allowed 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.015 -1.105 . . . . 0.98999999999999999 108.015 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1543 ' ' SER . . . . . 0.431 ' H ' ' HB3' ' A' 1542 ' ' TYR . 4.5 m -69.81 159.19 34.07 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 108.372 -0.973 . . . . 1.9099999999999999 108.372 178.005 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 97.4 mttt -50.6 -42.69 56.19 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.269 0.841 . . . . 3.5899999999999999 113.269 -177.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 19.9 m -106.53 28.5 7.77 Favored 'General case' 0 N--CA 1.416 -2.137 0 C-N-CA 122.189 0.196 . . . . 2.46 111.487 -177.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . -144.04 149.18 21.2 Favored Glycine 0 C--O 1.245 0.819 0 C-N-CA 119.425 -1.369 . . . . 1.26 113.868 -177.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 19.8 m -130.87 152.06 36.95 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.979 0 N-CA-C 108.564 -0.902 . . . . 0.79000000000000004 108.564 177.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 10.3 p -108.68 134.63 50.0 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 N-CA-C 109.35 -0.611 . . . . 0.57999999999999996 109.35 178.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -93.62 133.89 36.48 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 107.148 -1.427 . . . . 1.0800000000000001 107.148 176.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 25.3 ptm -148.23 127.84 13.28 Favored 'General case' 0 C--N 1.282 -2.33 0 O-C-N 123.771 0.669 . . . . 0.78000000000000003 109.836 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 5.0 p -119.0 134.42 55.2 Favored 'General case' 0 C--N 1.27 -2.856 0 CA-C-N 115.318 -0.855 . . . . 0.96999999999999997 109.222 177.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1552 ' ' ILE . . . . . 0.672 ' HB ' ' HA ' ' A' 1533 ' ' SER . 46.3 mm -82.64 116.45 26.88 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 N-CA-C 109.527 -0.546 . . . . 0.41999999999999998 109.527 -177.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 62.3 m 63.61 11.42 5.7 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.552 1.141 . . . . 1.3999999999999999 113.701 173.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . -146.36 176.41 25.3 Favored Glycine 0 N--CA 1.42 -2.392 0 N-CA-C 108.972 -1.651 . . . . 0.34999999999999998 108.972 -177.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -99.34 145.34 27.45 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 117.214 0.507 . . . . 1.6200000000000001 110.853 -178.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -91.12 131.43 36.69 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 108.092 -1.077 . . . . 0.87 108.092 -176.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -81.7 -2.87 52.06 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 113.709 1.003 . . . . 2.4900000000000002 113.709 -175.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -84.59 -6.44 59.37 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.381 -0.528 . . . . 1.3799999999999999 110.781 -178.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1559 ' ' CYS . . . . . 0.632 ' SG ' ' HD2' ' A' 1560 ' ' PRO . 29.5 t -136.02 153.92 77.23 Favored Pre-proline 0 C--N 1.299 -1.612 0 N-CA-C 107.352 -1.351 . . . . 1.21 107.352 -178.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1560 ' ' PRO . . . . . 0.632 ' HD2' ' SG ' ' A' 1559 ' ' CYS . 7.7 Cg_exo -28.61 134.18 0.03 OUTLIER 'Trans proline' 0 CA--C 1.562 1.899 1 C-N-CA 125.471 4.114 . . . . 0.70999999999999996 115.585 175.718 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A 1561 ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' 1560 ' ' PRO . 4.9 Cg_endo -46.95 126.45 11.17 Favored 'Trans proline' 0 C--O 1.249 1.036 0 C-N-CA 124.818 3.679 . . . . 0.80000000000000004 114.196 -178.05 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 105.62 -11.96 46.53 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 115.583 -0.735 . . . . 0.46000000000000002 112.802 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1563 ' ' VAL . . . . . 0.669 HG11 ' HB2' ' A' 1566 ' ' CYS . 3.6 t -80.28 125.19 38.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 N-CA-C 112.904 0.705 . . . . 0.97999999999999998 112.904 -178.027 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -96.73 -34.81 5.6 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.226 -0.897 . . . . 0.28000000000000003 111.306 176.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -133.77 133.91 42.29 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 109.393 -0.595 . . . . 0.28000000000000003 109.393 178.057 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1566 ' ' CYS . . . . . 0.669 ' HB2' HG11 ' A' 1563 ' ' VAL . 52.8 t -159.51 136.67 9.62 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 119.652 -0.213 . . . . 0.42999999999999999 110.489 -174.384 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1567 ' ' PHE . . . . . 0.413 ' CE2' HG11 ' A' 1574 ' ' VAL . 74.9 m-85 -84.54 137.91 33.06 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.142 -1.058 . . . . 1.03 108.142 173.392 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -89.33 11.79 68.65 Favored Glycine 0 N--CA 1.435 -1.37 0 N-CA-C 117.15 1.62 . . . . 1.1299999999999999 117.15 -168.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1569 ' ' GLN . . . . . 0.429 ' HB2' ' OD2' ' B' ' 15' ' ' ASP . 0.8 OUTLIER -75.27 -70.59 0.41 Allowed 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 119.035 1.418 . . . . 2.5800000000000001 110.049 176.661 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 58.7 p -100.4 -4.68 28.51 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 119.809 -0.757 . . . . 2.1699999999999999 112.873 176.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1571 ' ' ARG . . . . . . . . . . . . 0.269 5.0 mpt_? 74.32 59.08 0.08 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.978 1.311 . . . . 2.6200000000000001 112.595 -178.128 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 21.4 mt -90.6 131.2 38.41 Favored 'Isoleucine or valine' 0 C--O 1.243 0.742 0 CA-C-N 114.34 -1.3 . . . . 0.92000000000000004 107.676 176.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 31.2 t -86.22 130.3 34.57 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.158 0.504 . . . . 0.80000000000000004 110.642 -175.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1574 ' ' VAL . . . . . 0.549 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 25.4 m -117.8 16.12 7.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-O 121.532 0.682 . . . . 0.97999999999999998 111.063 179.139 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 166.34 129.75 1.09 Allowed Glycine 0 N--CA 1.431 -1.684 0 CA-C-N 115.274 -0.876 . . . . 0.28999999999999998 111.8 176.249 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 29.6 ttpp -78.74 145.36 34.48 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 107.5 -1.296 . . . . 2.1899999999999999 107.5 176.34 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -66.88 80.0 0.11 Allowed 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 124.006 0.922 . . . . 0.60999999999999999 112.783 -175.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1578 ' ' ASN . . . . . 0.419 ' O ' ' HE1' ' A' 1592 ' ' TYR . 89.6 m-20 -96.06 -172.63 2.61 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 107.636 -1.246 . . . . 1.95 107.636 177.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1579 ' ' LYS . . . . . 0.439 ' HB2' ' SG ' ' A' 1516 ' ' CYS . 15.5 ptpt -149.9 46.71 0.93 Allowed 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 121.882 0.848 . . . . 2.6800000000000002 110.416 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 57.0 ttp180 -95.13 84.77 4.15 Favored 'General case' 0 N--CA 1.418 -2.066 0 CA-C-N 115.224 -0.898 . . . . 3.4700000000000002 109.117 -175.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1581 ' ' LEU . . . . . 0.6 HD11 ' HG ' ' A' 1529 ' ' LEU . 2.4 tt -91.56 130.82 37.32 Favored 'General case' 0 C--N 1.294 -1.848 0 CA-C-N 114.135 -1.393 . . . . 0.64000000000000001 109.618 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 46.6 mtm180 -125.67 141.09 52.19 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 116.074 -0.512 . . . . 2.8500000000000001 110.235 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1583 ' ' TYR . . . . . . . . . . . . . 46.0 t80 -103.85 105.05 15.13 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.872 -0.788 . . . . 0.85999999999999999 108.872 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1584 ' ' VAL . . . . . 0.519 ' O ' ' HB ' ' A' 1587 ' ' VAL . 15.5 m -123.51 91.04 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 CA-C-N 115.571 -0.74 . . . . 1.05 112.349 -175.1 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1585 ' ' ASP . . . . . 0.422 ' O ' ' HG2' ' A' 1586 ' ' GLN . 37.5 t70 57.62 66.79 1.06 Allowed 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.693 0.797 . . . . 1.1699999999999999 111.357 175.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1586 ' ' GLN . . . . . 0.422 ' HG2' ' O ' ' A' 1585 ' ' ASP . 14.4 pt20 70.63 -3.56 1.89 Allowed 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 128.178 2.591 . . . . 1.8600000000000001 111.525 178.154 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1587 ' ' VAL . . . . . 0.519 ' HB ' ' O ' ' A' 1584 ' ' VAL . 24.7 t -97.76 120.9 47.69 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.521 0 CA-C-N 115.158 -0.928 . . . . 0.48999999999999999 110.787 -177.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1588 ' ' LEU . . . . . 1.017 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 2.9 mm? -91.64 107.22 19.06 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 107.074 -1.454 . . . . 0.35999999999999999 107.074 175.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1589 ' ' GLN . . . . . 0.486 ' O ' ' HA ' ' A' 1581 ' ' LEU . 33.8 tt0 -98.74 126.63 44.41 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 109.558 -0.534 . . . . 1.74 109.558 -176.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1590 ' ' LEU . . . . . 0.677 ' HB3' ' HB ' ' A' 1610 ' ' ILE . 1.4 tt -121.4 100.05 6.82 Favored 'General case' 0 C--N 1.275 -2.652 0 N-CA-C 104.79 -2.3 . . . . 0.71999999999999997 104.79 175.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 5.1 p -97.99 131.98 43.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 C-N-CA 120.232 -0.587 . . . . 1.01 111.809 -174.546 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1592 ' ' TYR . . . . . 0.566 ' O ' ' HG3' ' A' 1607 ' ' LYS . 21.2 m-85 -116.43 142.56 46.71 Favored 'General case' 0 CA--C 1.504 -0.814 0 N-CA-C 107.824 -1.176 . . . . 0.5 107.824 176.607 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 10.4 ptmm? -147.61 -179.0 6.56 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 106.336 -1.728 . . . . 1.5900000000000001 106.336 -175.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 16.5 m-20 61.61 47.27 6.57 Favored 'General case' 0 CA--C 1.508 -0.646 0 O-C-N 124.323 1.014 . . . . 1.1100000000000001 110.478 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -83.43 -140.68 4.18 Favored Glycine 0 N--CA 1.432 -1.578 0 N-CA-C 109.954 -1.258 . . . . 0.78000000000000003 109.954 178.162 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1596 ' ' SER . . . . . . . . . . . . . 59.8 p -102.99 156.2 35.62 Favored Pre-proline 0 C--N 1.281 -2.393 0 N-CA-C 107.627 -1.249 . . . . 1.0700000000000001 107.627 176.195 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1597 ' ' PRO . . . . . 0.539 ' HA ' ' O ' ' A' 1604 ' ' LEU . 54.0 Cg_exo -54.58 123.81 14.58 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 122.386 2.058 . . . . 1.01 111.322 178.266 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1598 ' ' CYS . . . . . 0.459 ' HA ' ' HD3' ' A' 1599 ' ' PRO . 31.9 t -74.63 120.47 81.67 Favored Pre-proline 0 C--N 1.303 -1.436 0 N-CA-C 108.62 -0.882 . . . . 0.75 108.62 -178.388 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1599 ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' 1598 ' ' CYS . 26.1 Cg_exo -62.71 -19.32 67.94 Favored 'Trans proline' 0 N--CA 1.484 0.915 0 C-N-CA 123.585 2.857 . . . . 1.7 112.966 -176.081 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1600 ' ' SER . . . . . 0.541 ' HA ' ' HB2' ' B' ' 53' ' ' LEU . 6.4 m -58.66 -37.67 76.5 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 124.938 1.295 . . . . 2.2599999999999998 111.95 178.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1601 ' ' LYS . . . . . 0.447 ' HE2' ' N ' ' A' 1602 ' ' SER . 0.0 OUTLIER -148.5 108.4 4.04 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 104.47 -2.418 . . . . 3.0099999999999998 104.47 -179.503 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A 1602 ' ' SER . . . . . 0.447 ' N ' ' HE2' ' A' 1601 ' ' LYS . 8.4 t -57.42 117.35 4.03 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 123.02 0.528 . . . . 2.0699999999999998 110.927 -174.056 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 106.18 -7.11 40.33 Favored Glycine 0 N--CA 1.437 -1.24 0 C-N-CA 120.828 -0.701 . . . . 1.0800000000000001 112.481 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1604 ' ' LEU . . . . . 0.571 HD23 ' SG ' ' A' 1634 ' ' CYS . 10.7 tp -84.77 163.09 19.34 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.169 -1.419 . . . . 1.8400000000000001 107.169 178.221 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 19.0 t -127.27 153.86 45.61 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.426 -0.953 . . . . 1.4099999999999999 108.426 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1606 ' ' TYR . . . . . 0.549 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 57.5 m-85 -80.95 166.38 20.89 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.786 -0.45 . . . . 0.59999999999999998 109.786 176.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1607 ' ' LYS . . . . . 0.566 ' HG3' ' O ' ' A' 1592 ' ' TYR . 36.5 ttpt -160.74 131.74 5.51 Favored 'General case' 0 CA--C 1.503 -0.83 0 N-CA-C 109.922 -0.399 . . . . 1.45 109.922 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1608 ' ' SER . . . . . . . . . . . . . 22.2 m -113.05 123.35 50.1 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 108.81 -0.811 . . . . 1.1499999999999999 108.81 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 41.5 t -107.91 110.21 31.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 108.909 -0.775 . . . . 0.25 108.909 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1610 ' ' ILE . . . . . 0.677 ' HB ' ' HB3' ' A' 1590 ' ' LEU . 20.3 mm -89.63 128.45 41.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 106.23 -1.767 . . . . 0.45000000000000001 106.23 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 23.1 t -127.1 101.11 6.39 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-O 121.386 0.612 . . . . 1.26 109.576 -177.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1612 ' ' PHE . . . . . 1.017 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 60.4 m-85 -86.18 130.18 34.61 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.468 -0.787 . . . . 0.26000000000000001 111.07 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 54.4 t -127.09 139.32 52.24 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.003 0 C-N-CA 123.132 0.573 . . . . 0.5 110.709 -177.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1614 ' ' CYS . . . . . 0.536 ' SG ' ' HD3' ' A' 1616 ' ' PRO . 2.0 t -60.73 111.47 1.64 Allowed 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 125.234 1.414 . . . . 0.77000000000000002 112.402 177.294 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1615 ' ' ARG . . . . . 0.648 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 22.2 tpt180 -128.3 86.86 56.82 Favored Pre-proline 0 C--N 1.316 -0.861 0 N-CA-C 108.292 -1.003 . . . . 2.5299999999999998 108.292 172.036 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1616 ' ' PRO . . . . . 0.621 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 43.3 Cg_endo -67.72 -23.62 41.98 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 122.272 1.981 . . . . 1.1000000000000001 113.389 -174.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -86.3 -4.97 59.27 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 121.03 -0.268 . . . . 3.0499999999999998 111.078 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . 58.34 -162.69 0.22 Allowed 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 123.351 0.661 . . . . 1.55 109.704 -176.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . 139.75 -161.8 26.24 Favored Glycine 0 N--CA 1.411 -3.003 0 C-N-CA 120.279 -0.962 . . . . 0.93000000000000005 111.522 178.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -83.26 15.45 2.1 Favored 'Trans proline' 0 C--N 1.321 -0.878 0 C-N-CA 123.277 2.651 . . . . 0.88 112.762 -178.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1621 ' ' THR . . . . . . . . . . . . . 20.6 p -106.11 1.39 26.26 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 115.564 -0.743 . . . . 0.96999999999999997 110.454 -178.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -86.74 65.84 9.19 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 107.158 -1.423 . . . . 0.71999999999999997 107.158 176.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1623 ' ' ARG . . . . . 0.478 ' O ' ' HG3' ' A' 1625 ' ' MET . 14.2 ptm180 -170.17 140.93 1.65 Allowed Pre-proline 0 C--N 1.291 -1.951 0 N-CA-C 106.566 -1.642 . . . . 3.2599999999999998 106.566 -175.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1624 ' ' PRO . . . . . 0.456 ' HG2' ' HB2' ' A' 1540 ' ' ALA . 15.4 Cg_endo -55.71 106.51 0.2 Allowed 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 122.78 2.32 . . . . 0.58999999999999997 111.627 -178.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1625 ' ' MET . . . . . 0.708 ' HB2' ' HB3' ' A' 1639 ' ' SER . 93.2 mtp -98.64 109.36 22.13 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.732 -0.84 . . . . 1.3700000000000001 108.732 -177.107 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1626 ' ' LEU . . . . . 0.556 ' HG ' ' CE2' ' A' 1542 ' ' TYR . 0.3 OUTLIER -71.84 115.39 10.99 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 106.685 -1.598 . . . . 0.89000000000000001 106.685 -179.68 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A 1627 ' ' ILE . . . . . 0.88 HD11 ' HB2' ' A' 1639 ' ' SER . 44.4 mm -70.82 -53.56 21.42 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.119 0 N-CA-C 108.767 -0.827 . . . . 0.57999999999999996 108.767 -178.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 19.7 t -179.41 162.42 1.15 Allowed 'General case' 0 N--CA 1.422 -1.862 0 N-CA-C 107.435 -1.32 . . . . 1.3899999999999999 107.435 -176.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1629 ' ' LEU . . . . . . . . . . . . . 43.2 tp -112.75 115.5 28.62 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 107.423 -1.325 . . . . 1.25 107.423 176.26 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 12.0 t70 -68.6 107.52 2.99 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 107.503 -1.295 . . . . 1.0900000000000001 107.503 174.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1631 ' ' LYS . . . . . 0.526 ' HD2' HD21 ' B' ' 53' ' ' LEU . 4.0 tppp? -56.6 -37.63 70.91 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.168 -1.378 . . . . 3.6000000000000001 114.38 -169.753 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 81.5 mm-40 -89.22 -29.11 19.5 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 119.684 -0.807 . . . . 2.6000000000000001 112.449 -174.43 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 60.2 p -100.6 -2.57 32.5 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 113.471 0.915 . . . . 0.75 113.471 -174.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1634 ' ' CYS . . . . . 0.571 ' SG ' HD23 ' A' 1604 ' ' LEU . 71.0 m 58.31 37.56 25.98 Favored 'General case' 0 C--N 1.367 1.355 0 CA-C-O 121.849 0.833 . . . . 0.53000000000000003 111.541 178.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1635 ' ' THR . . . . . . . . . . . . . 88.5 m -105.45 124.12 49.01 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 114.964 -1.017 . . . . 0.46000000000000002 109.905 -178.26 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1636 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -104.39 133.07 49.89 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 107.527 -1.286 . . . . 0.85999999999999999 107.527 -177.701 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1637 ' ' PHE . . . . . 0.47 ' HB2' ' HB ' ' A' 1627 ' ' ILE . 85.8 m-85 -108.35 137.07 46.94 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.844 -0.428 . . . . 0.45000000000000001 109.844 178.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -129.58 130.53 45.81 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 109.859 -0.422 . . . . 0.5 109.859 -175.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1639 ' ' SER . . . . . 0.88 ' HB2' HD11 ' A' 1627 ' ' ILE . 11.3 t -106.59 154.67 20.57 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.102 -1.444 . . . . 1.04 107.102 176.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1640 ' ' TRP . . . . . 0.402 ' CH2' ' HD3' ' A' 1624 ' ' PRO . 1.8 t90 -156.44 114.94 3.36 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 106.113 -1.81 . . . . 0.68000000000000005 106.113 178.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1641 ' ' HIS . . . . . 0.648 ' HB3' ' HB2' ' A' 1615 ' ' ARG . 38.4 m-70 -105.13 112.31 25.39 Favored 'General case' 0 C--N 1.288 -2.105 0 C-N-CA 119.861 -0.736 . . . . 0.90000000000000002 110.201 -177.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1642 ' ' THR . . . . . . . . . . . . . 4.4 t -142.69 148.94 48.44 Favored Pre-proline 0 C--N 1.307 -1.258 0 CA-C-N 115.731 -0.668 . . . . 0.47999999999999998 110.375 -175.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1643 ' ' PRO . . . . . 0.621 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 73.5 Cg_endo -79.45 -5.33 14.14 Favored 'Trans proline' 0 C--N 1.367 1.544 0 C-N-CA 122.51 2.14 . . . . 0.66000000000000003 112.54 176.62 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1644 ' ' LEU . . . . . 0.413 HD11 ' HB2' ' A' 1531 ' ' SER . 7.6 tt -75.41 -23.21 57.0 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.829 0.823 . . . . 0.96999999999999997 109.614 177.423 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -103.0 28.41 6.26 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.006 -0.997 . . . . 0.83999999999999997 111.395 -174.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 28.6 t -120.56 149.87 41.76 Favored 'General case' 0 C--N 1.287 -2.147 0 C-N-CA 119.971 -0.692 . . . . 1.1899999999999999 110.57 -175.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.419 -2.016 0 N-CA-C 107.655 -1.239 . . . . 3.1400000000000001 107.655 172.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 10' ' ' GLY . . . . . 0.462 ' O ' HG12 ' B' ' 14' ' ' VAL . . . . . . . . 0 N--CA 1.417 -2.578 0 N-CA-C 109.742 -1.343 . . . . 2.0899999999999999 109.742 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -47.38 -70.53 0.69 Allowed Glycine 0 C--O 1.224 -0.495 0 N-CA-C 115.205 0.842 . . . . 1.8400000000000001 115.205 -177.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -65.79 -35.4 80.59 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-N 117.814 0.807 . . . . 2.5499999999999998 110.621 -177.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 13' ' ' LEU . . . . . 0.58 HD21 ' HB2' ' B' ' 46' ' ' CYS . 5.7 mt -58.73 -60.75 3.34 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 113.306 0.854 . . . . 2.3500000000000001 113.306 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 14' ' ' VAL . . . . . 0.462 HG12 ' O ' ' B' ' 10' ' ' GLY . 7.7 p -74.99 -30.37 23.47 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 C-N-CA 120.017 -0.673 . . . . 2.1099999999999999 111.773 -176.031 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 15' ' ' ASP . . . . . 0.429 ' OD2' ' HB2' ' A' 1569 ' ' GLN . 18.2 t0 -67.5 -42.27 83.16 Favored 'General case' 0 C--O 1.207 -1.137 0 C-N-CA 119.483 -0.887 . . . . 2.04 111.426 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 23.8 p -61.51 -40.77 95.8 Favored 'General case' 0 C--O 1.25 1.104 0 CA-C-N 118.292 0.496 . . . . 1.8400000000000001 110.718 177.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.536 ' O ' ' HB2' ' B' ' 21' ' ' CYS . 4.3 mm? -58.5 -51.21 70.81 Favored 'General case' 0 C--O 1.21 -1.022 0 CA-C-N 115.86 -0.609 . . . . 1.74 111.309 174.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -69.07 -29.12 67.17 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 116.349 -0.387 . . . . 2.3900000000000001 111.268 -177.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -61.22 -61.09 2.8 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.949 -0.568 . . . . 0.95999999999999996 112.248 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 14.2 p -97.9 -13.39 8.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 C-N-CA 118.604 -1.238 . . . . 1.3700000000000001 111.686 -176.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 21' ' ' CYS . . . . . 0.536 ' HB2' ' O ' ' B' ' 17' ' ' LEU . 73.3 m -106.38 14.43 27.35 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.341 -0.849 . . . . 1.6599999999999999 112.652 178.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -52.14 -45.39 57.26 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 121.252 -0.499 . . . . 1.53 112.899 176.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -79.19 -42.89 25.02 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.398 0.518 . . . . 2.7200000000000002 112.398 177.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 6.3 tpm_? -71.25 -33.86 70.21 Favored 'General case' 0 C--O 1.244 0.799 0 N-CA-C 112.864 0.69 . . . . 4.3300000000000001 112.864 -174.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.92 139.43 8.05 Favored Glycine 0 N--CA 1.424 -2.153 0 N-CA-C 108.551 -1.82 . . . . 1.53 108.551 -175.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 26' ' ' PHE . . . . . 0.464 ' HB2' ' HB3' ' B' ' 17' ' ' LEU . 50.9 p90 -128.4 122.78 32.21 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 117.523 0.662 . . . . 1.6499999999999999 110.484 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -163.04 96.14 0.89 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.28 0.562 . . . . 3.4199999999999999 111.553 178.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 28' ' ' PHE . . . . . 0.436 ' HA ' ' HE1' ' B' ' 59' ' ' TYR . 42.5 p90 . . . . . 0 N--CA 1.44 -0.948 0 CA-C-O 121.358 0.599 . . . . 2.2599999999999998 110.398 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 41' ' ' GLY . . . . . 0.42 ' N ' ' HH ' ' B' ' 59' ' ' TYR . . . . . . . . 0 N--CA 1.419 -2.434 0 N-CA-C 111.583 -0.607 . . . . 2.3700000000000001 111.583 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 14.4 pt 61.61 -24.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 C-N-CA 128.245 2.618 . . . . 2.0699999999999998 116.488 174.066 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 2.8 p -51.34 -51.35 24.3 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 N-CA-C 114.612 1.338 . . . . 2.2400000000000002 114.612 -178.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -92.65 -29.64 16.0 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.074 -1.084 . . . . 3.3599999999999999 108.074 -176.123 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 45' ' ' GLU . . . . . 0.722 ' O ' ' HG2' ' B' ' 49' ' ' ARG . 40.6 mt-10 -59.96 -66.67 0.48 Allowed 'General case' 0 N--CA 1.432 -1.371 0 CA-C-N 114.968 -1.015 . . . . 3.0800000000000001 109.385 177.048 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 46' ' ' CYS . . . . . 0.58 ' HB2' HD21 ' B' ' 13' ' ' LEU . 72.1 m -76.72 1.24 17.72 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 112.787 0.662 . . . . 2.23 112.787 -175.136 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 41.1 t -82.47 -50.41 8.88 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 119.496 -0.882 . . . . 2.3700000000000001 109.105 171.122 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -102.75 -20.87 14.19 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 114.38 1.252 . . . . 2.8199999999999998 114.38 -173.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 49' ' ' ARG . . . . . 0.722 ' HG2' ' O ' ' B' ' 45' ' ' GLU . 17.2 ptp180 -113.05 165.75 12.07 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 108.142 -1.058 . . . . 4.0899999999999999 108.142 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 28.1 t -86.19 139.72 30.81 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 108.242 -1.021 . . . . 2.6699999999999999 108.242 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 95.6 m -124.25 159.9 29.17 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-O 121.599 0.714 . . . . 2.1099999999999999 111.88 -175.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -106.4 149.05 27.39 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 107.167 -1.42 . . . . 2.6699999999999999 107.167 175.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 53' ' ' LEU . . . . . 0.541 ' HB2' ' HA ' ' A' 1600 ' ' SER . 55.0 tp -56.34 -27.99 57.62 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 124.905 1.282 . . . . 1.8999999999999999 112.047 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 54' ' ' ALA . . . . . 0.624 ' O ' HG22 ' B' ' 58' ' ' THR . . . -58.17 -47.83 82.17 Favored 'General case' 0 CA--C 1.516 -0.352 0 O-C-N 123.2 0.312 . . . . 1.52 110.841 -178.332 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 55' ' ' LEU . . . . . 0.441 ' O ' ' HB2' ' B' ' 59' ' ' TYR . 58.7 tp -54.24 -50.97 65.95 Favored 'General case' 0 CA--C 1.509 -0.604 0 C-N-CA 123.847 0.859 . . . . 1.97 111.308 -178.353 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 56' ' ' LEU . . . . . 0.406 HD11 HD12 ' B' ' 53' ' ' LEU . 3.4 pp -74.15 -36.07 64.1 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-N 116.07 -0.514 . . . . 1.53 111.555 -174.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -68.63 -48.76 63.25 Favored 'General case' 0 N--CA 1.439 -0.976 0 O-C-N 123.495 0.497 . . . . 2.27 111.357 -178.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 58' ' ' THR . . . . . 0.624 HG22 ' O ' ' B' ' 54' ' ' ALA . 9.2 t -74.08 -15.27 61.06 Favored 'General case' 0 C--O 1.246 0.909 0 C-N-CA 120.186 -0.606 . . . . 2.3300000000000001 111.73 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 59' ' ' TYR . . . . . 0.441 ' HB2' ' O ' ' B' ' 55' ' ' LEU . 8.6 t80 -80.34 -76.32 0.23 Allowed 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 105.807 -1.923 . . . . 2.8599999999999999 105.807 174.389 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 47.2 t . . . . . 0 CA--C 1.557 1.235 0 C-N-CA 125.096 1.359 . . . . 2.2999999999999998 112.604 176.233 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A 1515 ' ' ASP . . . . . 0.411 ' HB3' ' H ' ' A' 1516 ' ' CYS . 5.5 m-20 . . . . . 0 CA--C 1.516 -0.357 0 CA-C-O 121.334 0.588 . . . . 2.8999999999999999 111.626 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1516 ' ' CYS . . . . . 0.427 ' HA ' ' HB2' ' A' 1581 ' ' LEU . 6.4 p -76.05 66.32 2.21 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 124.034 0.933 . . . . 1.1899999999999999 111.976 -177.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1517 ' ' GLN . . . . . 0.45 ' HA ' ' O ' ' A' 1527 ' ' PHE . 3.9 pt20 -154.93 130.95 10.18 Favored 'General case' 0 N--CA 1.421 -1.89 0 CA-C-N 115.355 -0.838 . . . . 1.52 109.638 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1518 ' ' VAL . . . . . 0.483 HG21 ' HB2' ' A' 1583 ' ' TYR . 9.6 m -135.0 144.39 34.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 C-N-CA 123.183 0.593 . . . . 0.93999999999999995 111.188 -177.211 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1519 ' ' THR . . . . . . . . . . . . . 24.6 m -111.26 133.61 53.46 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 109.384 -0.599 . . . . 0.89000000000000001 109.384 178.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -94.63 123.83 56.9 Favored Pre-proline 0 C--N 1.309 -1.152 0 N-CA-C 109.838 -0.43 . . . . 1.74 109.838 175.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -65.33 -16.17 53.27 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.288 2.658 . . . . 1.5800000000000001 114.638 -176.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 50.2 m -83.04 -49.64 9.34 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 111.985 0.365 . . . . 1.6499999999999999 111.985 -177.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1523 ' ' THR . . . . . . . . . . . . . 4.4 t -101.75 -9.1 21.13 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.686 0.755 . . . . 1.6100000000000001 111.337 -177.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 64.85 35.03 91.43 Favored Glycine 0 CA--C 1.488 -1.64 0 CA-C-N 115.291 -0.868 . . . . 1.1299999999999999 111.772 178.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 22.3 t-80 -99.45 123.1 43.43 Favored 'General case' 0 N--CA 1.422 -1.83 0 C-N-CA 119.979 -0.688 . . . . 1.26 110.218 -177.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 1.7 tm? -88.34 106.99 18.6 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 114.423 -1.262 . . . . 0.68000000000000005 108.011 177.028 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1527 ' ' PHE . . . . . 0.45 ' O ' ' HA ' ' A' 1517 ' ' GLN . 85.8 m-85 -89.07 112.83 23.88 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.052 -0.721 . . . . 0.65000000000000002 109.052 175.789 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 22.0 t70 -110.9 114.52 27.92 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.886 -0.783 . . . . 1.1699999999999999 108.886 177.054 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 3.5 mm? -90.69 -4.06 57.03 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.288 0.566 . . . . 0.59999999999999998 110.205 -174.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 7.2 m -61.66 -20.32 63.29 Favored 'General case' 0 C--O 1.219 -0.544 0 CA-C-N 114.976 -1.011 . . . . 0.83999999999999997 110.685 178.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 19.5 m -65.99 -19.52 65.89 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 120.754 0.311 . . . . 1.5900000000000001 111.606 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1532 ' ' LEU . . . . . 0.401 ' HB2' HG21 ' A' 1552 ' ' ILE . 73.4 mt -98.51 11.37 38.48 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.675 0.274 . . . . 0.65000000000000002 111.513 -178.206 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1533 ' ' SER . . . . . . . . . . . . . 25.4 p -66.13 155.97 35.35 Favored 'General case' 0 C--O 1.252 1.229 0 CA-C-O 121.385 0.612 . . . . 1.52 112.426 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -175.86 142.53 6.12 Favored Glycine 0 N--CA 1.428 -1.864 0 N-CA-C 109.727 -1.349 . . . . 1.1000000000000001 109.727 178.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 44.0 ttm180 -89.26 -37.9 14.61 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 123.688 0.287 . . . . 4.6200000000000001 110.841 -177.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -71.36 -33.92 69.99 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-O 122.017 0.913 . . . . 1.45 109.274 178.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 96.89 -171.44 27.29 Favored Glycine 0 N--CA 1.417 -2.626 0 CA-C-N 114.865 -1.061 . . . . 0.84999999999999998 113.05 172.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -124.86 143.97 50.55 Favored 'General case' 0 C--N 1.279 -2.487 0 N-CA-C 107.845 -1.168 . . . . 0.93000000000000005 107.845 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 19.7 p -106.2 130.76 54.01 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 123.852 0.72 . . . . 1.03 110.319 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1540 ' ' ALA . . . . . 0.46 ' HB3' ' CG1' ' A' 1548 ' ' VAL . . . -118.97 140.92 49.2 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 107.944 -1.132 . . . . 0.5 107.944 177.087 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -79.24 139.63 37.86 Favored 'General case' 0 C--N 1.316 -0.875 0 O-C-N 123.726 0.641 . . . . 0.73999999999999999 109.872 -178.023 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1542 ' ' TYR . . . . . 0.473 ' HB3' ' H ' ' A' 1543 ' ' SER . 0.5 OUTLIER -149.89 -102.72 0.07 Allowed 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.953 -0.758 . . . . 0.98999999999999999 108.953 -178.603 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A 1543 ' ' SER . . . . . 0.473 ' H ' ' HB3' ' A' 1542 ' ' TYR . 16.2 m -67.91 152.8 44.98 Favored 'General case' 0 N--CA 1.432 -1.342 0 C-N-CA 124.008 0.923 . . . . 1.9099999999999999 109.364 -179.276 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.49 -27.24 69.14 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.453 -0.794 . . . . 3.5899999999999999 112.326 -171.47 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 20.3 m -123.25 33.09 5.47 Favored 'General case' 0 N--CA 1.397 -3.087 0 N-CA-C 109.588 -0.523 . . . . 2.46 109.588 176.064 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . -162.73 130.75 2.32 Favored Glycine 0 N--CA 1.438 -1.203 0 C-N-CA 118.528 -1.796 . . . . 1.26 115.172 -177.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 27.8 m -112.44 160.9 11.65 Favored 'Isoleucine or valine' 0 C--O 1.252 1.184 0 N-CA-C 108.44 -0.948 . . . . 0.79000000000000004 108.44 177.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1548 ' ' VAL . . . . . 0.46 ' CG1' ' HB3' ' A' 1540 ' ' ALA . 14.8 p -106.85 134.84 47.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 C-N-CA 120.477 -0.489 . . . . 0.57999999999999996 110.258 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -93.07 130.98 38.5 Favored 'General case' 0 CA--C 1.484 -1.562 0 N-CA-C 108.637 -0.875 . . . . 1.0800000000000001 108.637 175.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1550 ' ' MET . . . . . 0.425 ' HA ' ' O ' ' A' 1564 ' ' GLY . 15.2 ptp -137.44 137.03 38.33 Favored 'General case' 0 C--N 1.284 -2.27 0 CA-C-N 115.63 -0.714 . . . . 0.78000000000000003 111.315 175.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 11.6 p -117.63 113.8 22.45 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 115.261 -0.881 . . . . 0.96999999999999997 108.965 176.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1552 ' ' ILE . . . . . 0.401 HG21 ' HB2' ' A' 1532 ' ' LEU . 48.9 mm -77.71 119.39 26.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 N-CA-C 110.016 -0.364 . . . . 0.41999999999999998 110.016 -177.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 77.4 m 64.42 44.36 4.2 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 124.041 0.838 . . . . 1.3999999999999999 110.932 177.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 174.81 -179.49 46.08 Favored Glycine 0 N--CA 1.432 -1.575 0 C-N-CA 120.42 -0.895 . . . . 0.34999999999999998 111.279 -179.018 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -104.64 158.63 16.37 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 120.617 0.246 . . . . 1.6200000000000001 110.656 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -119.06 111.17 17.96 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.25 -1.019 . . . . 0.87 108.25 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -69.77 2.9 2.9 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 114.169 1.174 . . . . 2.4900000000000002 114.169 -173.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -76.34 -15.73 59.9 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 120.154 -0.618 . . . . 1.3799999999999999 110.029 178.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1559 ' ' CYS . . . . . 0.705 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 71.1 m -132.5 174.57 4.56 Favored Pre-proline 0 C--N 1.302 -1.482 0 CA-C-O 117.717 -1.135 . . . . 1.21 110.238 -178.463 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1560 ' ' PRO . . . . . 0.705 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 22.9 Cg_exo -28.75 128.7 0.04 OUTLIER 'Trans proline' 0 C--N 1.396 3.072 1 C-N-CA 125.506 4.137 . . . . 0.70999999999999996 114.733 178.629 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -43.64 119.87 2.02 Favored 'Trans proline' 0 C--O 1.247 0.942 0 C-N-CA 124.547 3.498 . . . . 0.80000000000000004 114.21 -177.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 87.43 23.62 39.41 Favored Glycine 0 N--CA 1.437 -1.29 0 CA-C-N 115.515 -0.766 . . . . 0.46000000000000002 113.368 177.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1563 ' ' VAL . . . . . 0.459 HG11 ' HB2' ' A' 1559 ' ' CYS . 5.5 p -100.98 144.11 13.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 117.94 0.87 . . . . 0.97999999999999998 109.852 -178.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1564 ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' 1550 ' ' MET . . . -106.07 -30.35 4.52 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 121.235 -0.507 . . . . 0.28000000000000003 113.252 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -128.26 130.14 47.45 Favored 'General case' 0 C--O 1.247 0.964 0 CA-C-N 117.307 0.553 . . . . 0.28000000000000003 109.867 178.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1566 ' ' CYS . . . . . 0.443 ' SG ' ' HA ' ' A' 1571 ' ' ARG . 9.9 t -157.72 141.05 15.38 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 116.372 -0.376 . . . . 0.42999999999999999 111.32 -176.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1567 ' ' PHE . . . . . 0.506 ' CE2' HG11 ' A' 1574 ' ' VAL . 74.3 m-85 -88.08 138.38 31.5 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 108.646 -0.872 . . . . 1.03 108.646 175.214 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -72.77 -9.08 74.31 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 117.854 1.902 . . . . 1.1299999999999999 117.854 -168.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -80.16 -70.61 0.51 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 119.997 1.899 . . . . 2.5800000000000001 112.412 -176.327 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1570 ' ' THR . . . . . 0.448 HG21 ' HA ' ' B' ' 12' ' ' GLU . 19.1 p -91.96 -3.69 55.57 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 119.862 -0.735 . . . . 2.1699999999999999 112.782 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1571 ' ' ARG . . . . . 0.443 ' HA ' ' SG ' ' A' 1566 ' ' CYS . 10.8 mmt85 65.49 44.11 3.17 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.59 1.156 . . . . 2.6200000000000001 111.051 177.012 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 40.7 mt -74.66 137.23 23.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-N 115.914 -0.585 . . . . 0.92000000000000004 109.461 178.017 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 26.7 t -83.3 120.45 25.86 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 109.377 -0.601 . . . . 0.80000000000000004 109.377 -179.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1574 ' ' VAL . . . . . 0.606 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 32.6 m -118.3 10.18 6.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 C-N-CA 119.368 -0.933 . . . . 0.97999999999999998 111.377 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 173.99 113.71 0.33 Allowed Glycine 0 N--CA 1.419 -2.482 0 N-CA-C 110.122 -1.191 . . . . 0.28999999999999998 110.122 178.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1576 ' ' LYS . . . . . 0.515 ' HE2' ' O ' ' A' 1594 ' ' ASP . 24.9 ttmm -73.93 155.47 38.65 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.681 -1.229 . . . . 2.1899999999999999 107.681 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -67.13 77.55 0.14 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.77 0.795 . . . . 0.60999999999999999 111.865 -177.27 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1578 ' ' ASN . . . . . 0.475 ' HB3' ' HD1' ' A' 1592 ' ' TYR . 14.5 t-20 -91.2 -175.73 4.37 Favored 'General case' 0 C--N 1.29 -2.01 0 C-N-CA 125.583 1.553 . . . . 1.95 107.41 -178.446 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 22.2 pttp -158.58 52.48 0.41 Allowed 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.839 0.828 . . . . 2.6800000000000002 110.008 176.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1580 ' ' ARG . . . . . 0.522 ' HB3' HG12 ' A' 1591 ' ' VAL . 0.1 OUTLIER -97.48 87.31 4.07 Favored 'General case' 0 N--CA 1.413 -2.314 0 N-CA-C 108.287 -1.005 . . . . 3.4700000000000002 108.287 -176.509 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A 1581 ' ' LEU . . . . . 0.513 ' HA ' ' O ' ' A' 1589 ' ' GLN . 0.4 OUTLIER -86.37 126.16 34.16 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.999 -1.001 . . . . 0.64000000000000001 109.05 -177.341 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -124.51 140.94 52.48 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 109.159 -0.682 . . . . 2.8500000000000001 109.159 175.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1583 ' ' TYR . . . . . 0.667 ' CE1' ' HA ' ' A' 1586 ' ' GLN . 67.9 t80 -105.81 97.38 7.21 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 107.004 -1.48 . . . . 0.85999999999999999 107.004 176.158 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1584 ' ' VAL . . . . . 0.537 ' O ' ' HB ' ' A' 1587 ' ' VAL . 15.7 m -111.81 89.69 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.234 0 CA-C-N 115.338 -0.846 . . . . 1.05 112.373 -173.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 29.3 t70 56.88 64.45 1.65 Allowed 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 115.246 -0.888 . . . . 1.1699999999999999 109.961 179.081 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1586 ' ' GLN . . . . . 0.667 ' HA ' ' CE1' ' A' 1583 ' ' TYR 0.26 29.9 pt20 63.09 15.22 8.31 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 126.926 2.09 . . . . 1.8600000000000001 112.897 177.596 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A 1587 ' ' VAL . . . . . 0.537 ' HB ' ' O ' ' A' 1584 ' ' VAL . 29.1 t -108.89 129.39 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.024 0 CA-C-N 114.418 -1.265 . . . . 0.48999999999999999 109.128 176.223 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1588 ' ' LEU . . . . . 0.962 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 2.9 mm? -97.57 108.22 20.89 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.644 -0.873 . . . . 0.35999999999999999 108.644 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1589 ' ' GLN . . . . . 0.513 ' O ' ' HA ' ' A' 1581 ' ' LEU . 35.1 tt0 -100.97 118.32 36.75 Favored 'General case' 0 C--N 1.281 -2.375 0 CA-C-N 116.136 -0.484 . . . . 1.74 111.416 -177.33 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1590 ' ' LEU . . . . . 0.411 ' HG ' ' CD2' ' A' 1581 ' ' LEU . 1.6 mt -108.51 97.68 7.31 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 106.603 -1.628 . . . . 0.71999999999999997 106.603 170.066 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1591 ' ' VAL . . . . . 0.522 HG12 ' HB3' ' A' 1580 ' ' ARG . 8.9 p -94.59 133.44 35.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 CA-C-N 116.275 -0.421 . . . . 1.01 110.084 -177.518 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1592 ' ' TYR . . . . . 0.475 ' HD1' ' HB3' ' A' 1578 ' ' ASN . 14.7 m-30 -118.52 114.22 22.49 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.277 -1.009 . . . . 0.5 108.277 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 21.3 pttp -115.53 178.92 4.12 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 110.303 -0.258 . . . . 1.5900000000000001 110.303 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1594 ' ' ASP . . . . . 0.515 ' O ' ' HE2' ' A' 1576 ' ' LYS . 8.7 m-20 68.35 36.6 3.0 Favored 'General case' 0 CA--C 1.506 -0.728 0 C-N-CA 124.028 0.931 . . . . 1.1100000000000001 112.134 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -72.82 -158.32 4.34 Favored Glycine 0 N--CA 1.443 -0.861 0 N-CA-C 109.675 -1.37 . . . . 0.78000000000000003 109.675 173.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1596 ' ' SER . . . . . . . . . . . . . 41.0 p -87.92 148.64 43.85 Favored Pre-proline 0 C--N 1.28 -2.455 0 C-N-CA 118.292 -1.363 . . . . 1.0700000000000001 109.304 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -48.01 131.47 21.42 Favored 'Trans proline' 0 C--O 1.241 0.647 0 C-N-CA 123.423 2.748 . . . . 1.01 111.726 176.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1598 ' ' CYS . . . . . 0.494 ' HA ' ' CE2' ' A' 1606 ' ' TYR . 49.4 t -76.67 127.1 85.02 Favored Pre-proline 0 C--N 1.294 -1.805 0 CA-C-N 114.834 -1.075 . . . . 0.75 110.191 -175.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1599 ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' 1598 ' ' CYS . 20.1 Cg_exo -69.4 -34.03 16.64 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.021 2.481 . . . . 1.7 111.24 176.2 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1600 ' ' SER . . . . . 0.442 ' HB2' ' SG ' ' A' 1598 ' ' CYS . 9.6 m -57.69 -43.15 84.9 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 123.665 0.786 . . . . 2.2599999999999998 111.294 178.056 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1601 ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -145.54 123.54 12.07 Favored 'General case' 0 N--CA 1.423 -1.788 0 N-CA-C 109.006 -0.738 . . . . 3.0099999999999998 109.006 178.602 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 10.0 m -78.85 148.59 32.77 Favored 'General case' 0 N--CA 1.407 -2.623 0 C-N-CA 123.229 0.612 . . . . 2.0699999999999998 110.186 -175.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 105.96 -14.61 44.82 Favored Glycine 0 C--N 1.306 -1.136 0 CA-C-N 116.082 -0.508 . . . . 1.0800000000000001 113.304 176.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1604 ' ' LEU . . . . . 0.458 HD21 ' HB2' ' A' 1634 ' ' CYS . 0.0 OUTLIER -135.74 147.36 48.4 Favored 'General case' 0 N--CA 1.406 -2.629 0 CA-C-O 121.423 0.63 . . . . 1.8400000000000001 112.202 -179.68 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 10.3 p -96.17 153.37 17.83 Favored 'General case' 0 C--N 1.308 -1.239 0 C-N-CA 124.297 1.039 . . . . 1.4099999999999999 110.06 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1606 ' ' TYR . . . . . 0.606 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 51.7 m-85 -60.46 154.12 21.45 Favored 'General case' 0 C--O 1.25 1.102 0 O-C-N 123.287 0.367 . . . . 0.59999999999999998 111.07 176.376 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -151.86 126.77 9.67 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 108.795 -0.817 . . . . 1.45 108.795 -176.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1608 ' ' SER . . . . . . . . . . . . . 40.1 m -105.72 130.29 53.76 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 116.269 -0.423 . . . . 1.1499999999999999 110.202 -177.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 28.2 t -109.15 108.26 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.999 0 N-CA-C 107.845 -1.169 . . . . 0.25 107.845 177.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 64.5 mt -97.77 103.92 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.797 0 N-CA-C 107.598 -1.26 . . . . 0.45000000000000001 107.598 179.132 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 23.2 t -99.93 107.82 19.9 Favored 'General case' 0 C--N 1.282 -2.341 0 CA-C-N 114.231 -1.35 . . . . 1.26 110.154 -174.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1612 ' ' PHE . . . . . 0.962 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 68.0 m-85 -90.61 118.2 29.87 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.439 -0.801 . . . . 0.26000000000000001 109.752 178.312 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 43.1 t -122.65 139.22 50.17 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 108.531 -0.915 . . . . 0.5 108.531 -177.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 9.0 t -66.88 117.59 9.19 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 124.054 0.942 . . . . 0.77000000000000002 112.564 -177.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1615 ' ' ARG . . . . . 0.741 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 13.5 tpt180 -137.75 91.16 13.86 Favored Pre-proline 0 N--CA 1.442 -0.835 0 N-CA-C 107.951 -1.129 . . . . 2.5299999999999998 107.951 172.333 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1616 ' ' PRO . . . . . 0.752 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 45.7 Cg_endo -67.24 -15.68 46.65 Favored 'Trans proline' 0 N--CA 1.486 1.056 0 C-N-CA 122.754 2.303 . . . . 1.1000000000000001 113.503 -174.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -58.18 -38.98 77.74 Favored 'General case' 0 C--O 1.242 0.697 0 C-N-CA 124.75 1.22 . . . . 3.0499999999999998 111.056 178.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . 51.19 96.59 0.01 OUTLIER 'General case' 0 C--O 1.248 0.989 0 C-N-CA 124.363 1.065 . . . . 1.55 113.057 178.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1619 ' ' GLY . . . . . 0.405 ' HA3' ' HD2' ' A' 1620 ' ' PRO . . . -151.1 -143.7 3.77 Favored Glycine 0 C--N 1.29 -1.998 0 N-CA-C 110.679 -0.969 . . . . 0.93000000000000005 110.679 -179.17 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1620 ' ' PRO . . . . . 0.405 ' HD2' ' HA3' ' A' 1619 ' ' GLY . 38.9 Cg_endo -67.01 2.77 1.92 Allowed 'Trans proline' 0 N--CA 1.488 1.172 0 C-N-CA 123.039 2.492 . . . . 0.88 114.832 -178.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1621 ' ' THR . . . . . 0.425 HG22 ' HB2' ' A' 1641 ' ' HIS . 8.0 m -102.72 -3.4 26.56 Favored 'General case' 0 N--CA 1.42 -1.959 0 CA-C-O 122.057 0.932 . . . . 0.96999999999999997 108.953 -179.274 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 43.8 t30 -87.22 61.9 6.97 Favored 'General case' 0 C--O 1.246 0.872 0 CA-C-O 122.488 1.137 . . . . 0.71999999999999997 108.666 178.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -165.87 138.7 3.39 Favored Pre-proline 0 C--N 1.303 -1.446 0 CA-C-N 113.733 -1.576 . . . . 3.2599999999999998 106.984 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -65.11 111.69 1.84 Allowed 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 122.393 2.062 . . . . 0.58999999999999997 111.19 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 72.5 mtm -115.29 143.9 44.56 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 116.531 -0.304 . . . . 1.3700000000000001 110.59 -178.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1626 ' ' LEU . . . . . 0.456 ' HG ' ' CE2' ' A' 1542 ' ' TYR . 1.6 tm? -80.95 117.38 21.53 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.152 -1.055 . . . . 0.89000000000000001 108.152 -178.326 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 50.7 mm -77.87 -58.1 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 CA-C-O 121.296 0.569 . . . . 0.57999999999999996 109.727 178.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 66.8 m -163.92 149.8 11.13 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.007 -1.108 . . . . 1.3899999999999999 108.007 -178.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1629 ' ' LEU . . . . . 0.82 HD13 ' HG ' ' A' 1636 ' ' LEU . 30.0 tp -111.87 110.47 20.83 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 107.557 -1.275 . . . . 1.25 107.557 175.202 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 17.5 t70 -70.54 117.46 12.1 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 107.347 -1.353 . . . . 1.0900000000000001 107.347 175.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 95.3 mttt -82.15 -11.13 58.9 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.875 -0.602 . . . . 3.6000000000000001 111.904 -169.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -95.86 -43.56 7.79 Favored 'General case' 0 N--CA 1.418 -2.065 0 C-N-CA 120.373 -0.531 . . . . 2.6000000000000001 110.928 -175.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 45.5 p -96.42 -0.38 49.29 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 116.253 -0.43 . . . . 0.75 110.929 178.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1634 ' ' CYS . . . . . 0.458 ' HB2' HD21 ' A' 1604 ' ' LEU . 60.9 m 51.24 39.39 23.7 Favored 'General case' 0 C--N 1.374 1.636 0 C-N-CA 124.921 1.288 . . . . 0.53000000000000003 112.195 176.186 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1635 ' ' THR . . . . . . . . . . . . . 90.7 m -100.9 128.08 47.09 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 114.09 -1.414 . . . . 0.46000000000000002 108.288 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1636 ' ' LEU . . . . . 0.82 ' HG ' HD13 ' A' 1629 ' ' LEU . 0.6 OUTLIER -105.23 122.16 45.35 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.365 -0.606 . . . . 0.85999999999999999 109.365 -174.497 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -99.91 116.91 33.08 Favored 'General case' 0 C--O 1.244 0.812 0 CA-C-O 121.293 0.568 . . . . 0.45000000000000001 111.848 -178.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -117.26 134.81 54.36 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 115.105 -0.952 . . . . 0.5 109.361 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1639 ' ' SER . . . . . . . . . . . . . 71.6 m -119.73 138.94 53.0 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 116.219 -0.446 . . . . 1.04 109.902 176.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1640 ' ' TRP . . . . . 0.479 ' CE3' ' HE1' ' A' 1612 ' ' PHE . 3.7 t90 -138.36 103.72 4.98 Favored 'General case' 0 N--CA 1.424 -1.753 0 N-CA-C 103.942 -2.614 . . . . 0.68000000000000005 103.942 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1641 ' ' HIS . . . . . 0.741 ' HB3' ' HB2' ' A' 1615 ' ' ARG . 28.3 m-70 -95.56 98.77 10.76 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.863 0.84 . . . . 0.90000000000000002 109.757 -176.668 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1642 ' ' THR . . . . . . . . . . . . . 3.1 t -124.26 150.83 64.95 Favored Pre-proline 0 C--N 1.299 -1.594 0 CA-C-N 113.732 -1.576 . . . . 0.47999999999999998 110.388 -170.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1643 ' ' PRO . . . . . 0.752 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 59.8 Cg_endo -77.21 -5.54 15.81 Favored 'Trans proline' 0 C--N 1.364 1.36 0 C-N-CA 122.487 2.125 . . . . 0.66000000000000003 112.729 175.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 9.0 tt -69.48 -27.45 65.23 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.307 -0.627 . . . . 0.96999999999999997 109.307 177.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -90.35 14.97 11.43 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.47 -0.786 . . . . 0.83999999999999997 110.713 -177.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1646 ' ' CYS . . . . . 0.612 ' SG ' ' HA ' ' A' 1643 ' ' PRO . 78.3 m -99.69 156.33 17.14 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 109.614 -0.513 . . . . 1.1899999999999999 109.614 178.52 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.289 -2.034 0 N-CA-C 107.294 -1.373 . . . . 3.1400000000000001 107.294 175.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.14 0 CA-C-O 120.48 -0.067 . . . . 2.0899999999999999 113.252 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -51.26 -52.32 32.56 Favored Glycine 0 C--O 1.214 -1.128 0 C-N-CA 123.697 0.665 . . . . 1.8400000000000001 114.469 -176.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 12' ' ' GLU . . . . . 0.448 ' HA ' HG21 ' A' 1570 ' ' THR . 1.6 mp0 -57.41 -42.74 82.9 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 122.816 0.446 . . . . 2.5499999999999998 110.917 -178.357 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 13' ' ' LEU . . . . . 0.424 ' HG ' ' SG ' ' B' ' 46' ' ' CYS . 1.1 tt -61.39 -52.61 63.88 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 115.371 -0.831 . . . . 2.3500000000000001 109.853 -178.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 22.2 m -72.72 -30.37 33.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.37 0 C-N-CA 119.531 -0.867 . . . . 2.1099999999999999 111.869 -176.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -69.34 -42.82 74.79 Favored 'General case' 0 C--O 1.203 -1.375 0 C-N-CA 120.728 -0.389 . . . . 2.04 111.94 177.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 25.3 p -62.85 -38.8 92.24 Favored 'General case' 0 C--O 1.258 1.523 0 CA-C-O 121.446 0.641 . . . . 1.8400000000000001 110.054 176.041 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.563 ' HB3' ' HB3' ' B' ' 26' ' ' PHE . 3.6 mm? -56.75 -49.73 74.37 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-N 115.317 -0.856 . . . . 1.74 111.012 171.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -66.64 -32.37 73.65 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 124.384 1.074 . . . . 2.3900000000000001 109.809 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -52.84 -57.67 9.43 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 116.023 -0.535 . . . . 0.95999999999999996 111.939 178.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 13.0 p -98.87 -26.24 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 C-N-CA 118.204 -1.398 . . . . 1.3700000000000001 112.854 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 85.1 m -106.92 1.08 24.3 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 113.597 0.962 . . . . 1.6599999999999999 113.597 -177.026 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -55.86 -24.17 40.57 Favored Glycine 0 N--CA 1.479 1.558 0 N-CA-C 116.969 1.548 . . . . 1.53 116.969 -173.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -58.77 -40.73 84.77 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 118.136 0.968 . . . . 2.7200000000000002 109.699 175.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 25.2 tpp180 -90.45 -48.57 7.02 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 108.07 -1.085 . . . . 4.3300000000000001 108.07 177.005 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 130.33 -152.05 19.65 Favored Glycine 0 N--CA 1.424 -2.144 0 N-CA-C 109.84 -1.304 . . . . 1.53 109.84 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 26' ' ' PHE . . . . . 0.563 ' HB3' ' HB3' ' B' ' 17' ' ' LEU . 23.2 p90 -137.83 139.28 39.86 Favored 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 108.956 -0.757 . . . . 1.6499999999999999 108.956 176.07 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -125.74 -67.78 0.86 Allowed 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 112.827 0.677 . . . . 3.4199999999999999 112.827 -176.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 28' ' ' PHE . . . . . . . . . . . . . 50.4 p90 . . . . . 0 N--CA 1.509 2.511 0 N-CA-C 117.319 2.34 . . . . 2.2599999999999998 117.319 171.195 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.416 -2.686 0 N-CA-C 111.583 -0.607 . . . . 2.3700000000000001 111.583 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . 0.263 10.6 pt 64.44 -33.92 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.213 -0.835 0 C-N-CA 128.651 2.78 . . . . 2.0699999999999998 114.9 177.355 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.436 ' O ' ' HB2' ' B' ' 47' ' ' CYS . 2.4 p -48.03 -44.49 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 C-N-CA 123.833 0.853 . . . . 2.2400000000000002 112.896 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -97.14 -38.35 9.76 Favored 'General case' 0 N--CA 1.415 -2.211 0 CA-C-N 115.606 -0.725 . . . . 3.3599999999999999 109.506 -172.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -61.54 -47.46 85.46 Favored 'General case' 0 C--O 1.197 -1.702 0 CA-C-N 116.002 -0.544 . . . . 3.0800000000000001 110.725 178.119 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 46' ' ' CYS . . . . . 0.424 ' SG ' ' HG ' ' B' ' 13' ' ' LEU . 42.6 t -78.01 -16.27 58.24 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 121.222 0.534 . . . . 2.23 109.823 -178.16 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 47' ' ' CYS . . . . . 0.436 ' HB2' ' O ' ' B' ' 43' ' ' VAL . 44.3 t -79.66 -48.01 14.44 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 116.216 -0.447 . . . . 2.3700000000000001 110.857 177.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -98.42 -25.8 14.68 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 113.678 0.992 . . . . 2.8199999999999998 113.678 -176.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -110.26 -179.8 3.88 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.333 -0.988 . . . . 4.0899999999999999 108.333 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 8.2 t -93.05 132.5 37.11 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 106.771 -1.566 . . . . 2.6699999999999999 106.771 176.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 1.6 p -111.38 137.44 49.15 Favored 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 123.205 0.602 . . . . 2.1099999999999999 110.887 -175.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -112.0 177.72 4.55 Favored 'General case' 0 C--O 1.244 0.764 0 N-CA-C 112.489 0.551 . . . . 2.6699999999999999 112.489 -178.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 53' ' ' LEU . . . . . 0.418 ' O ' ' HG ' ' B' ' 56' ' ' LEU . 52.6 tp -51.24 -53.89 31.01 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 125.125 1.37 . . . . 1.8999999999999999 113.601 -178.478 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.72 -41.05 73.31 Favored 'General case' 0 C--O 1.244 0.793 0 C-N-CA 124.023 0.929 . . . . 1.52 112.456 -170.397 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 61.3 tp -63.47 -46.22 87.23 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 114.921 -1.036 . . . . 1.97 111.957 -178.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 56' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' B' ' 53' ' ' LEU . 3.3 pp -79.66 -24.64 41.67 Favored 'General case' 0 N--CA 1.41 -2.459 0 C-N-CA 119.765 -0.774 . . . . 1.53 111.143 -176.518 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -70.6 -43.68 68.85 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 116.082 -0.508 . . . . 2.27 110.616 178.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 24.2 p -63.58 -43.12 97.9 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-N 116.25 -0.432 . . . . 2.3300000000000001 111.848 179.093 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -73.31 -59.61 2.63 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 116.739 -0.21 . . . . 2.8599999999999999 110.505 178.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 41.8 t . . . . . 0 CA--C 1.555 1.141 0 C-N-CA 125.029 1.332 . . . . 2.2999999999999998 113.984 179.115 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 7.0 t70 . . . . . 0 N--CA 1.442 -0.857 0 N-CA-C 104.138 -2.541 . . . . 2.8999999999999999 104.138 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A 1516 ' ' CYS . . . . . 0.927 ' HB3' ' HB2' ' A' 1529 ' ' LEU . 72.6 m -79.89 60.41 3.48 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 123.35 0.66 . . . . 1.1899999999999999 112.247 -174.218 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1517 ' ' GLN . . . . . 0.485 ' HA ' ' O ' ' A' 1527 ' ' PHE . 16.5 pt20 -164.41 129.33 2.73 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-O 121.392 0.615 . . . . 1.52 110.905 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 2.9 m -148.56 143.59 18.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-N 114.726 -1.125 . . . . 0.93999999999999995 109.725 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1519 ' ' THR . . . . . . . . . . . . . 91.6 m -114.04 121.49 44.0 Favored 'General case' 0 N--CA 1.423 -1.787 0 N-CA-C 108.173 -1.047 . . . . 0.89000000000000001 108.173 174.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1520 ' ' ASN . . . . . 0.454 ' HA ' ' HD3' ' A' 1521 ' ' PRO . 26.3 t-20 -80.26 121.93 82.25 Favored Pre-proline 0 C--N 1.294 -1.82 0 N-CA-C 109.33 -0.619 . . . . 1.74 109.33 177.516 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1521 ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' 1520 ' ' ASN . 12.6 Cg_exo -69.75 -19.61 35.96 Favored 'Trans proline' 0 CA--C 1.529 0.227 0 C-N-CA 123.051 2.5 . . . . 1.5800000000000001 113.509 -175.361 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1522 ' ' SER . . . . . 0.419 ' HB2' ' OD1' ' A' 1520 ' ' ASN . 22.5 m -72.33 -32.21 66.32 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 120.836 0.35 . . . . 1.6499999999999999 111.094 -179.414 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1523 ' ' THR . . . . . 0.705 HG21 ' HG3' ' A' 1647 ' ' GLU . 8.8 t -124.87 -9.46 7.23 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 119.433 -0.907 . . . . 1.6100000000000001 112.14 -177.13 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 68.73 34.34 77.79 Favored Glycine 0 CA--C 1.501 -0.795 0 CA-C-N 115.828 -0.623 . . . . 1.1299999999999999 113.399 176.33 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 9.7 t-160 -107.03 121.16 43.93 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 119.163 -1.015 . . . . 1.26 111.415 178.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 2.3 tm? -82.47 115.99 21.72 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 114.494 -1.23 . . . . 0.68000000000000005 108.688 176.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1527 ' ' PHE . . . . . 0.485 ' O ' ' HA ' ' A' 1517 ' ' GLN . 96.8 m-85 -96.32 121.69 38.39 Favored 'General case' 0 C--N 1.31 -1.149 0 O-C-N 122.158 -0.339 . . . . 0.65000000000000002 110.494 174.231 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 10.3 t70 -105.49 109.83 21.94 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 106.923 -1.51 . . . . 1.1699999999999999 106.923 175.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1529 ' ' LEU . . . . . 0.927 ' HB2' ' HB3' ' A' 1516 ' ' CYS . 3.7 mm? -90.69 -3.5 57.43 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 121.282 0.563 . . . . 0.59999999999999998 110.22 -177.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 16.0 m -72.84 -15.56 61.62 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.624 -0.716 . . . . 0.83999999999999997 109.632 178.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1531 ' ' SER . . . . . 0.416 ' HB2' HD11 ' A' 1644 ' ' LEU . 14.8 m -66.38 -22.39 66.25 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-O 121.287 0.565 . . . . 1.5900000000000001 109.709 173.276 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 80.4 mt -101.5 3.96 40.7 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.18 -0.464 . . . . 0.65000000000000002 111.315 177.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1533 ' ' SER . . . . . . . . . . . . . 46.2 t -60.07 158.68 10.68 Favored 'General case' 0 C--O 1.245 0.825 0 CA-C-O 121.959 0.885 . . . . 1.52 111.682 -177.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -178.53 116.09 0.52 Allowed Glycine 0 C--N 1.278 -2.667 0 CA-C-N 114.237 -1.347 . . . . 1.1000000000000001 110.132 -175.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -92.79 -36.75 12.7 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 112.373 0.509 . . . . 4.6200000000000001 112.373 -176.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -59.52 -54.42 46.73 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-O 121.262 0.553 . . . . 1.45 110.372 -176.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 136.09 152.99 6.47 Favored Glycine 0 N--CA 1.413 -2.886 0 C-N-CA 120.535 -0.84 . . . . 0.84999999999999998 113.382 173.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -114.51 139.56 49.46 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 106.151 -1.796 . . . . 0.93000000000000005 106.151 174.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 5.1 p -106.58 128.71 54.35 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.21 0.528 . . . . 1.03 111.858 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -123.95 141.03 52.4 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 107.991 -1.115 . . . . 0.5 107.991 176.256 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -82.95 128.98 34.96 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 120.773 0.321 . . . . 0.73999999999999999 110.72 -177.183 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1542 ' ' TYR . . . . . 0.578 ' CE2' ' HG ' ' A' 1626 ' ' LEU . 2.0 t80 -121.1 -100.6 0.43 Allowed 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 107.626 -1.25 . . . . 0.98999999999999999 107.626 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1543 ' ' SER . . . . . 0.441 ' H ' ' HB3' ' A' 1542 ' ' TYR . 8.0 m -66.35 164.06 16.89 Favored 'General case' 0 N--CA 1.437 -1.123 0 C-N-CA 122.815 0.446 . . . . 1.9099999999999999 110.808 -178.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 23.4 tptm -56.83 -41.54 78.05 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 118.103 0.41 . . . . 3.5899999999999999 111.132 -176.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 49.9 m -110.88 34.41 4.02 Favored 'General case' 0 N--CA 1.412 -2.352 0 N-CA-C 109.621 -0.511 . . . . 2.46 109.621 178.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . -144.63 134.48 5.67 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 118.808 -1.663 . . . . 1.26 115.335 -176.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 28.1 m -121.68 148.4 25.16 Favored 'Isoleucine or valine' 0 C--O 1.247 0.944 0 N-CA-C 108.561 -0.903 . . . . 0.79000000000000004 108.561 174.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 11.9 p -104.05 137.11 34.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 N-CA-C 109.747 -0.464 . . . . 0.57999999999999996 109.747 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -98.01 125.07 42.78 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.834 -0.802 . . . . 1.0800000000000001 108.834 175.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 23.3 ptm -136.17 133.67 37.41 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 115.539 -0.755 . . . . 0.78000000000000003 110.342 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 12.7 p -117.69 137.53 52.61 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.549 -0.75 . . . . 0.96999999999999997 109.627 176.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1552 ' ' ILE . . . . . . . . . . . . . 42.4 mm -96.83 118.53 43.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 110.37 -0.233 . . . . 0.41999999999999998 110.37 -177.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 75.4 m 65.84 24.76 11.31 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-O 122.199 1.0 . . . . 1.3999999999999999 112.047 175.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . -164.51 -177.73 37.38 Favored Glycine 0 N--CA 1.406 -3.337 0 CA-C-N 114.261 -1.336 . . . . 0.34999999999999998 110.004 -178.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -109.39 145.35 36.25 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-O 121.043 0.449 . . . . 1.6200000000000001 110.933 -176.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -81.41 145.25 30.89 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.345 -0.843 . . . . 0.87 111.809 -172.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -84.96 10.07 12.78 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 123.819 0.848 . . . . 2.4900000000000002 113.176 -171.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -119.41 -10.73 9.63 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 119.586 -0.846 . . . . 1.3799999999999999 112.562 -176.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1559 ' ' CYS . . . . . 0.529 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 83.4 m -132.26 164.26 44.54 Favored Pre-proline 0 C--N 1.296 -1.755 0 CA-C-O 117.877 -1.058 . . . . 1.21 110.04 -177.144 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1560 ' ' PRO . . . . . 0.529 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 12.0 Cg_exo -31.11 131.59 0.06 OUTLIER 'Trans proline' 0 C--N 1.376 2.001 1 C-N-CA 125.536 4.157 . . . . 0.70999999999999996 115.489 -179.418 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -49.34 128.34 20.03 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 123.77 2.98 . . . . 0.80000000000000004 111.731 179.08 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 102.3 -3.86 51.18 Favored Glycine 0 N--CA 1.43 -1.73 0 CA-C-N 116.018 -0.537 . . . . 0.46000000000000002 113.765 -178.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1563 ' ' VAL . . . . . . . . . . . . . 5.2 p -98.52 138.21 23.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 118.362 1.081 . . . . 0.97999999999999998 111.291 -178.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -102.11 -31.16 5.44 Favored Glycine 0 CA--C 1.522 0.491 0 CA-C-N 115.693 -0.685 . . . . 0.28000000000000003 113.172 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -129.28 130.81 46.66 Favored 'General case' 0 N--CA 1.445 -0.723 0 O-C-N 122.528 -0.395 . . . . 0.28000000000000003 109.967 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 44.0 t -157.02 138.61 14.05 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 110.018 -0.364 . . . . 0.42999999999999999 110.018 -176.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -85.28 137.67 32.82 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 108.87 -0.789 . . . . 1.03 108.87 174.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -72.33 -18.61 78.3 Favored Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 116.983 1.553 . . . . 1.1299999999999999 116.983 -167.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -73.23 -70.24 0.38 Allowed 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 118.362 1.081 . . . . 2.5800000000000001 111.246 -175.193 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.16 -2.47 58.07 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.198 -0.91 . . . . 2.1699999999999999 112.755 -176.559 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 9.9 mmt85 60.04 36.76 21.38 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 114.923 -1.035 . . . . 2.6200000000000001 110.519 178.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 30.6 mt -74.97 125.24 34.25 Favored 'Isoleucine or valine' 0 C--O 1.245 0.867 0 CA-C-N 115.909 -0.587 . . . . 0.92000000000000004 109.761 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 21.9 t -74.48 125.09 27.81 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 114.995 -1.002 . . . . 0.80000000000000004 109.812 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1574 ' ' VAL . . . . . 0.664 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 33.6 m -122.19 16.51 5.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 C-N-CA 120.009 -0.676 . . . . 0.97999999999999998 112.026 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 167.82 122.72 0.63 Allowed Glycine 0 N--CA 1.432 -1.594 0 C-N-CA 119.977 -1.106 . . . . 0.28999999999999998 112.618 175.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 4.1 ttmp? -71.64 142.1 49.93 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.23 -1.026 . . . . 2.1899999999999999 108.23 177.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -72.83 88.23 1.32 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.29 0.567 . . . . 0.60999999999999999 110.965 -177.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -109.56 150.79 27.66 Favored 'General case' 0 C--N 1.29 -1.978 0 N-CA-C 107.283 -1.377 . . . . 1.95 107.283 179.048 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -105.15 45.71 0.95 Allowed 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 106.275 -1.75 . . . . 2.6800000000000002 106.275 -177.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 56.3 ttt180 -84.97 76.59 10.25 Favored 'General case' 0 N--CA 1.411 -2.376 0 CA-C-N 113.638 -1.619 . . . . 3.4700000000000002 108.775 -173.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1581 ' ' LEU . . . . . 0.401 HD21 ' HG ' ' A' 1529 ' ' LEU . 0.4 OUTLIER -81.42 127.58 32.94 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 113.596 -1.638 . . . . 0.64000000000000001 108.875 -178.567 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -127.08 140.96 51.9 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-N 116.098 -0.501 . . . . 2.8500000000000001 110.215 172.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1583 ' ' TYR . . . . . 0.597 ' CZ ' ' HA ' ' A' 1586 ' ' GLN . 39.6 t80 -99.88 105.56 17.31 Favored 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 106.903 -1.517 . . . . 0.85999999999999999 106.903 175.519 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1584 ' ' VAL . . . . . 0.643 ' O ' ' HB ' ' A' 1587 ' ' VAL . 7.5 p -129.51 97.39 3.46 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.333 0 CA-C-O 121.614 0.721 . . . . 1.05 111.061 -175.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 36.3 t70 64.01 49.36 2.78 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-O 122.456 1.122 . . . . 1.1699999999999999 110.771 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1586 ' ' GLN . . . . . 0.597 ' HA ' ' CZ ' ' A' 1583 ' ' TYR . 18.9 pt20 65.39 9.26 5.59 Favored 'General case' 0 N--CA 1.5 2.059 0 C-N-CA 127.026 2.131 . . . . 1.8600000000000001 111.09 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1587 ' ' VAL . . . . . 0.643 ' HB ' ' O ' ' A' 1584 ' ' VAL . 38.1 t -96.81 122.76 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.75 0 CA-C-N 114.303 -1.317 . . . . 0.48999999999999999 108.331 178.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1588 ' ' LEU . . . . . 0.487 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 3.0 mm? -93.15 107.76 19.5 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 106.562 -1.644 . . . . 0.35999999999999999 106.562 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -120.63 125.1 46.87 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 113.296 0.851 . . . . 1.74 113.296 -172.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1590 ' ' LEU . . . . . 0.478 HD21 ' SG ' ' A' 1516 ' ' CYS . 16.6 mt -101.69 126.27 48.51 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 113.84 -1.527 . . . . 0.71999999999999997 107.282 176.156 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 47.2 t -112.0 120.36 62.17 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.997 0 C-N-CA 119.438 -0.905 . . . . 1.01 111.026 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1592 ' ' TYR . . . . . 0.43 ' HB2' ' HB2' ' A' 1608 ' ' SER . 13.5 m-30 -105.32 95.83 6.1 Favored 'General case' 0 CA--C 1.486 -1.485 0 N-CA-C 107.866 -1.161 . . . . 0.5 107.866 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 12.3 ptmm? -107.5 170.22 8.11 Favored 'General case' 0 C--N 1.283 -2.312 0 CA-C-N 115.02 -0.991 . . . . 1.5900000000000001 111.597 -175.007 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 24.0 m-20 57.24 56.06 5.44 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 125.454 1.502 . . . . 1.1100000000000001 112.448 177.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -74.88 -115.62 0.09 OUTLIER Glycine 0 CA--C 1.528 0.893 0 C-N-CA 120.33 -0.938 . . . . 0.78000000000000003 111.143 173.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1596 ' ' SER . . . . . . . . . . . . . 78.2 p -115.32 169.76 6.4 Favored Pre-proline 0 C--N 1.296 -1.744 0 O-C-N 121.857 -0.79 . . . . 1.0700000000000001 109.164 176.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -70.03 122.62 9.22 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 122.932 2.421 . . . . 1.01 112.354 177.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1598 ' ' CYS . . . . . 0.472 ' HA ' ' HD3' ' A' 1599 ' ' PRO . 34.3 t -76.44 141.16 69.34 Favored Pre-proline 0 C--N 1.292 -1.916 0 CA-C-N 114.671 -1.15 . . . . 0.75 109.202 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1599 ' ' PRO . . . . . 0.573 ' HD3' ' OH ' ' A' 1606 ' ' TYR . 8.1 Cg_exo -72.04 -7.84 21.8 Favored 'Trans proline' 0 C--N 1.371 1.731 0 C-N-CA 123.608 2.872 . . . . 1.7 113.25 -175.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1600 ' ' SER . . . . . 0.67 ' HA ' ' HB3' ' B' ' 53' ' ' LEU . 22.8 p -61.17 -51.22 69.97 Favored 'General case' 0 C--O 1.258 1.535 0 CA-C-O 121.76 0.79 . . . . 2.2599999999999998 109.733 174.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1601 ' ' LYS . . . . . 0.447 ' HB3' ' HG ' ' A' 1604 ' ' LEU . 49.9 tptt -155.14 117.96 4.33 Favored 'General case' 0 N--CA 1.387 -3.614 0 N-CA-C 106.533 -1.654 . . . . 3.0099999999999998 106.533 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 4.7 p -60.09 131.27 50.3 Favored 'General case' 0 N--CA 1.409 -2.478 0 N-CA-C 109.139 -0.689 . . . . 2.0699999999999998 109.139 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 106.83 -20.99 32.92 Favored Glycine 0 C--N 1.296 -1.687 0 C-N-CA 121.065 -0.588 . . . . 1.0800000000000001 111.837 -174.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1604 ' ' LEU . . . . . 0.447 ' HG ' ' HB3' ' A' 1601 ' ' LYS . 69.5 mt -81.55 124.46 29.52 Favored 'General case' 0 CA--C 1.503 -0.837 0 N-CA-C 107.728 -1.212 . . . . 1.8400000000000001 107.728 172.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 4.9 p -101.26 143.46 31.3 Favored 'General case' 0 C--N 1.28 -2.415 0 CA-C-O 120.643 0.259 . . . . 1.4099999999999999 110.61 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1606 ' ' TYR . . . . . 0.664 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 96.2 m-85 -68.39 153.28 44.06 Favored 'General case' 0 C--O 1.255 1.356 0 N-CA-C 109.598 -0.519 . . . . 0.59999999999999998 109.598 177.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -151.5 127.48 10.38 Favored 'General case' 0 N--CA 1.437 -1.104 0 O-C-N 123.673 0.608 . . . . 1.45 109.952 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1608 ' ' SER . . . . . 0.448 ' HB3' ' HE2' ' A' 1638 ' ' PHE . 38.6 m -104.64 122.04 44.8 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 108.522 -0.918 . . . . 1.1499999999999999 108.522 -179.017 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 41.0 t -104.68 108.06 23.94 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 109.304 -0.628 . . . . 0.25 109.304 -177.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1610 ' ' ILE . . . . . 0.466 ' HB ' ' HB2' ' A' 1590 ' ' LEU . 69.5 mt -97.27 110.18 24.66 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 115.588 -0.733 . . . . 0.45000000000000001 109.323 -178.511 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 7.0 t -113.56 108.01 16.58 Favored 'General case' 0 C--N 1.282 -2.345 0 CA-C-N 115.143 -0.935 . . . . 1.26 110.114 -174.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1612 ' ' PHE . . . . . 0.487 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 64.1 m-85 -84.9 118.9 24.8 Favored 'General case' 0 C--O 1.254 1.332 0 CA-C-N 115.99 -0.55 . . . . 0.26000000000000001 109.557 177.258 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1613 ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' 1641 ' ' HIS . 21.5 t -110.69 124.91 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.577 0 CA-C-N 115.595 -0.73 . . . . 0.5 110.366 -175.061 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 22.2 t -58.88 110.64 1.06 Allowed 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 114.571 -1.195 . . . . 0.77000000000000002 111.895 177.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1615 ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' 1615 ' ' ARG . 22.4 ttt180 -137.59 98.59 9.82 Favored Pre-proline 0 C--N 1.316 -0.884 0 N-CA-C 110.25 -0.278 . . . . 2.5299999999999998 110.25 171.096 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1616 ' ' PRO . . . . . 0.848 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 34.6 Cg_exo -61.22 -30.55 88.58 Favored 'Trans proline' 0 CA--C 1.55 1.282 0 C-N-CA 122.139 1.892 . . . . 1.1000000000000001 111.989 176.647 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -77.05 44.17 0.39 Allowed 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.116 1.367 . . . . 3.0499999999999998 113.61 178.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -32.69 130.31 0.19 Allowed 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 126.781 2.032 . . . . 1.55 113.476 176.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . -163.86 -142.16 3.33 Favored Glycine 0 N--CA 1.425 -2.089 0 N-CA-C 109.958 -1.257 . . . . 0.93000000000000005 109.958 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -80.34 15.06 1.81 Allowed 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 122.95 2.433 . . . . 0.88 112.655 -178.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1621 ' ' THR . . . . . . . . . . . . . 17.1 p -102.48 -6.71 22.61 Favored 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 124.791 1.237 . . . . 0.96999999999999997 108.625 179.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 48.9 t30 -94.66 61.89 2.7 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.392 -1.277 . . . . 0.71999999999999997 108.659 -176.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -162.28 138.74 5.96 Favored Pre-proline 0 N--CA 1.428 -1.535 0 CA-C-N 113.795 -1.548 . . . . 3.2599999999999998 107.427 -179.175 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1624 ' ' PRO . . . . . 0.434 ' HA ' ' O ' ' A' 1639 ' ' SER . 37.1 Cg_endo -65.92 108.2 1.25 Allowed 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 122.556 2.171 . . . . 0.58999999999999997 112.17 -177.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 63.8 mtm -116.11 147.42 41.35 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.455 -0.339 . . . . 1.3700000000000001 110.543 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1626 ' ' LEU . . . . . 0.578 ' HG ' ' CE2' ' A' 1542 ' ' TYR . 0.4 OUTLIER -85.41 114.95 22.85 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.452 -1.314 . . . . 0.89000000000000001 107.452 -178.354 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A 1627 ' ' ILE . . . . . 0.488 HD11 ' HB2' ' A' 1639 ' ' SER . 44.3 mm -72.53 -54.51 16.01 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.217 0 N-CA-C 109.191 -0.67 . . . . 0.57999999999999996 109.191 -178.166 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 28.0 p -173.44 154.04 2.5 Favored 'General case' 0 N--CA 1.423 -1.808 0 CA-C-N 114.752 -1.113 . . . . 1.3899999999999999 109.281 -173.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1629 ' ' LEU . . . . . 0.473 HD13 ' HG ' ' A' 1636 ' ' LEU . 54.2 tp -106.29 117.57 34.38 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 108.434 -0.95 . . . . 1.25 108.434 174.413 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1630 ' ' ASP . . . . . 0.437 ' HB3' ' HB ' ' A' 1635 ' ' THR . 8.6 t70 -73.75 99.09 3.06 Favored 'General case' 0 CA--C 1.496 -1.108 0 N-CA-C 103.317 -2.846 . . . . 1.0900000000000001 103.317 167.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -80.76 -10.31 59.74 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 114.192 -1.367 . . . . 3.6000000000000001 110.395 -166.128 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 56.8 tp60 -86.11 -45.95 10.9 Favored 'General case' 0 N--CA 1.426 -1.66 0 CA-C-N 115.584 -0.735 . . . . 2.6000000000000001 110.874 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 70.5 p -95.91 -3.79 44.67 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-O 120.812 0.339 . . . . 0.75 111.571 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 60.9 m 63.7 51.17 2.51 Favored 'General case' 0 C--N 1.355 0.823 0 C-N-CA 124.743 1.217 . . . . 0.53000000000000003 111.744 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1635 ' ' THR . . . . . 0.437 ' HB ' ' HB3' ' A' 1630 ' ' ASP . 32.4 m -113.42 123.14 49.35 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 114.101 -1.409 . . . . 0.46000000000000002 109.026 -176.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1636 ' ' LEU . . . . . 0.473 ' HG ' HD13 ' A' 1629 ' ' LEU . 1.0 OUTLIER -105.44 129.78 53.67 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 108.557 -0.905 . . . . 0.85999999999999999 108.557 -175.383 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -105.72 135.45 47.12 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 120.83 -0.348 . . . . 0.45000000000000001 111.259 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1638 ' ' PHE . . . . . 0.448 ' HE2' ' HB3' ' A' 1608 ' ' SER . 96.9 m-85 -128.46 137.18 51.69 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 124.09 0.956 . . . . 0.5 108.719 -178.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1639 ' ' SER . . . . . 0.488 ' HB2' HD11 ' A' 1627 ' ' ILE . 17.9 t -124.56 155.1 39.61 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 108.327 -0.99 . . . . 1.04 108.327 177.173 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1640 ' ' TRP . . . . . 0.462 ' CE3' ' HE1' ' A' 1612 ' ' PHE . 3.6 t90 -155.54 104.35 2.36 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 104.689 -2.337 . . . . 0.68000000000000005 104.689 -178.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1641 ' ' HIS . . . . . 0.422 ' HA ' ' O ' ' A' 1613 ' ' VAL . 38.8 m-70 -93.63 100.59 12.81 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 121.201 0.524 . . . . 0.90000000000000002 109.834 -176.599 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1642 ' ' THR . . . . . . . . . . . . . 3.6 t -134.06 147.33 63.52 Favored Pre-proline 0 C--N 1.292 -1.905 0 CA-C-N 115.002 -0.999 . . . . 0.47999999999999998 109.377 -173.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1643 ' ' PRO . . . . . 0.848 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 50.1 Cg_endo -76.93 -2.65 12.9 Favored 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 122.069 1.846 . . . . 0.66000000000000003 112.416 176.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1644 ' ' LEU . . . . . 0.416 HD11 ' HB2' ' A' 1531 ' ' SER . 9.3 tt -69.42 -28.82 66.47 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 108.876 -0.787 . . . . 0.96999999999999997 108.876 177.053 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -88.26 21.27 2.89 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.591 -0.731 . . . . 0.83999999999999997 110.732 -178.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1646 ' ' CYS . . . . . 0.487 ' SG ' ' HA ' ' A' 1643 ' ' PRO . 75.1 m -113.03 152.13 29.86 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 116.139 -0.482 . . . . 1.1899999999999999 110.279 -179.3 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1647 ' ' GLU . . . . . 0.705 ' HG3' HG21 ' A' 1523 ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.421 -1.922 0 N-CA-C 107.592 -1.262 . . . . 3.1400000000000001 107.592 174.082 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.39 0 CA-C-O 120.554 -0.026 . . . . 2.0899999999999999 113.037 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 11' ' ' GLY . . . . . 0.45 ' HA2' HG12 ' B' ' 14' ' ' VAL . . . -60.28 -27.99 66.26 Favored Glycine 0 N--CA 1.461 0.319 0 N-CA-C 112.127 -0.389 . . . . 1.8400000000000001 112.127 178.623 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -65.53 -29.9 70.59 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.302 0.572 . . . . 2.5499999999999998 110.003 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 13' ' ' LEU . . . . . 0.524 HD21 ' HB3' ' B' ' 46' ' ' CYS . 0.2 OUTLIER -72.79 -50.93 21.21 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.619 0.723 . . . . 2.3500000000000001 109.433 179.944 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 14' ' ' VAL . . . . . 0.45 HG12 ' HA2' ' B' ' 11' ' ' GLY . 9.1 p -68.08 -37.73 78.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-N 115.665 -0.698 . . . . 2.1099999999999999 112.254 -176.482 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -76.24 -22.27 55.37 Favored 'General case' 0 C--O 1.212 -0.907 0 N-CA-C 113.608 0.966 . . . . 2.04 113.608 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 9.7 p -71.55 -39.35 70.73 Favored 'General case' 0 C--O 1.262 1.753 0 O-C-N 120.959 -1.088 . . . . 1.8400000000000001 109.268 174.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.494 ' HB3' ' HB2' ' B' ' 26' ' ' PHE . 4.3 mm? -52.71 -47.31 67.4 Favored 'General case' 0 C--O 1.216 -0.666 0 CA-C-N 114.938 -1.028 . . . . 1.74 109.535 169.183 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -63.44 -42.89 98.67 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.485 1.114 . . . . 2.3900000000000001 110.084 178.508 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -48.76 -54.96 12.9 Favored 'General case' 0 C--O 1.245 0.823 0 N-CA-C 112.943 0.72 . . . . 0.95999999999999996 112.943 -177.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 14.8 p -98.74 -26.15 3.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 C-N-CA 117.713 -1.595 . . . . 1.3700000000000001 112.361 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 21' ' ' CYS . . . . . 0.445 ' HB2' ' O ' ' B' ' 17' ' ' LEU . 74.7 m -102.28 18.91 19.79 Favored 'General case' 0 C--N 1.308 -1.227 0 O-C-N 121.403 -0.81 . . . . 1.6599999999999999 112.683 -175.408 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -57.35 -46.17 92.09 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 121.056 -0.593 . . . . 1.53 113.656 178.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -72.99 -39.16 66.3 Favored 'General case' 0 C--N 1.32 -0.708 0 O-C-N 122.669 -0.312 . . . . 2.7200000000000002 111.507 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 24' ' ' ARG . . . . . 0.427 ' HD2' ' SG ' ' B' ' 60' ' ' CYS . 40.7 ttm180 -76.44 -38.48 55.44 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.334 0.588 . . . . 4.3300000000000001 111.597 -177.462 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.35 151.72 9.69 Favored Glycine 0 N--CA 1.423 -2.2 0 N-CA-C 107.95 -2.06 . . . . 1.53 107.95 -174.444 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 26' ' ' PHE . . . . . 0.494 ' HB2' ' HB3' ' B' ' 17' ' ' LEU . 45.6 p90 -138.09 146.82 43.37 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 117.549 0.675 . . . . 1.6499999999999999 110.229 -179.089 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -170.63 136.75 1.27 Allowed 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 110.205 -0.294 . . . . 3.4199999999999999 110.205 174.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 28' ' ' PHE . . . . . . . . . . . . . 22.5 p90 . . . . . 0 C--N 1.308 -1.21 0 N-CA-C 112.347 0.499 . . . . 2.2599999999999998 112.347 173.583 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.559 0 CA-C-O 118.765 -1.02 . . . . 2.3700000000000001 115.311 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 42' ' ' ILE . . . . . 0.421 HD11 HD21 ' B' ' 17' ' ' LEU . 42.9 pt 52.89 -18.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.527 3.405 0 N-CA-C 118.289 2.7 . . . . 2.0699999999999998 118.289 170.174 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 4.4 p -49.06 -40.58 13.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 C-N-CA 125.551 1.54 . . . . 2.2400000000000002 114.673 -175.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -91.01 -34.11 15.27 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 109.497 -0.557 . . . . 3.3599999999999999 109.497 -173.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 45' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' B' ' 49' ' ' ARG . 11.1 mp0 -64.7 -50.89 65.2 Favored 'General case' 0 C--O 1.192 -1.925 0 CA-C-N 115.758 -0.655 . . . . 3.0800000000000001 110.118 178.601 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 46' ' ' CYS . . . . . 0.524 ' HB3' HD21 ' B' ' 13' ' ' LEU . 31.8 t -73.59 -22.77 59.94 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 119.821 -0.752 . . . . 2.23 110.7 -176.096 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 54.1 t -77.88 -39.34 43.52 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.364 -0.38 . . . . 2.3700000000000001 111.994 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -119.05 6.03 11.31 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.904 1.076 . . . . 2.8199999999999998 113.904 -176.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 49' ' ' ARG . . . . . 0.454 ' HB2' ' O ' ' B' ' 45' ' ' GLU . 98.7 mtt180 -130.51 169.55 15.41 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 106.754 -1.573 . . . . 4.0899999999999999 106.754 176.096 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 45.9 m -87.35 99.94 12.36 Favored 'General case' 0 N--CA 1.415 -2.183 0 N-CA-C 108.86 -0.792 . . . . 2.6699999999999999 108.86 177.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 2.6 p -84.67 142.65 29.74 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.835 -1.172 . . . . 2.1099999999999999 107.835 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -106.29 171.51 7.31 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 119.763 -0.775 . . . . 2.6699999999999999 110.672 176.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 53' ' ' LEU . . . . . 0.67 ' HB3' ' HA ' ' A' 1600 ' ' SER . 1.9 pt? -62.32 -37.1 84.29 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 113.886 1.069 . . . . 1.8999999999999999 113.886 -176.699 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 54' ' ' ALA . . . . . 0.414 ' O ' HG22 ' B' ' 58' ' ' THR . . . -58.31 -36.37 73.25 Favored 'General case' 0 CA--C 1.504 -0.792 0 C-N-CA 122.615 0.366 . . . . 1.52 111.857 -173.492 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 55' ' ' LEU . . . . . 0.519 ' O ' ' HB2' ' B' ' 59' ' ' TYR . 60.2 tp -60.67 -56.58 19.57 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.59 -0.732 . . . . 1.97 111.101 -177.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 3.2 pp -72.64 -26.76 61.77 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-O 120.831 0.348 . . . . 1.53 110.879 -177.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -69.08 -55.4 10.87 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 115.306 -0.861 . . . . 2.27 111.444 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 58' ' ' THR . . . . . 0.414 HG22 ' O ' ' B' ' 54' ' ' ALA . 13.0 t -78.05 -17.39 57.09 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 119.877 -0.729 . . . . 2.3300000000000001 111.801 -178.503 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 59' ' ' TYR . . . . . 0.519 ' HB2' ' O ' ' B' ' 55' ' ' LEU . 6.3 t80 -77.08 -74.16 0.26 Allowed 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 106.219 -1.771 . . . . 2.8599999999999999 106.219 176.017 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 60' ' ' CYS . . . . . 0.427 ' SG ' ' HD2' ' B' ' 24' ' ' ARG . 36.6 t . . . . . 0 CA--C 1.557 1.218 0 C-N-CA 125.529 1.532 . . . . 2.2999999999999998 114.536 175.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1515 ' ' ASP . . . . . 0.435 ' HA ' ' HD3' ' A' 1579 ' ' LYS . 4.5 m-20 . . . . . 0 N--CA 1.505 2.308 0 N-CA-C 113.663 0.986 . . . . 2.8999999999999999 113.663 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1516 ' ' CYS . . . . . 0.485 ' HB3' ' HB2' ' A' 1529 ' ' LEU . 71.2 m -144.55 78.61 1.58 Allowed 'General case' 0 C--O 1.251 1.165 0 CA-C-O 120.894 0.378 . . . . 1.1899999999999999 111.278 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1517 ' ' GLN . . . . . 0.409 ' HA ' ' O ' ' A' 1527 ' ' PHE . 11.2 pt20 -157.32 130.22 7.63 Favored 'General case' 0 N--CA 1.422 -1.874 0 N-CA-C 108.982 -0.748 . . . . 1.52 108.982 175.629 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1518 ' ' VAL . . . . . 0.418 ' CG2' HD12 ' A' 1581 ' ' LEU . 5.9 m -131.79 135.63 58.45 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.16 0 CA-C-O 121.143 0.497 . . . . 0.93999999999999995 110.936 -178.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1519 ' ' THR . . . . . . . . . . . . . 23.5 m -106.46 129.63 54.4 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 107.202 -1.407 . . . . 0.89000000000000001 107.202 176.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1520 ' ' ASN . . . . . 0.45 ' OD1' HG22 ' A' 1523 ' ' THR . 23.9 t-20 -89.02 112.47 51.17 Favored Pre-proline 0 C--N 1.287 -2.152 0 N-CA-C 108.247 -1.019 . . . . 1.74 108.247 176.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.69 -9.99 25.82 Favored 'Trans proline' 0 C--N 1.333 -0.237 0 C-N-CA 122.813 2.342 . . . . 1.5800000000000001 113.257 -175.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1522 ' ' SER . . . . . 0.444 ' HB2' ' OD1' ' A' 1520 ' ' ASN . 24.6 m -74.13 -39.06 63.57 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 116.426 -0.352 . . . . 1.6499999999999999 110.437 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1523 ' ' THR . . . . . 0.45 HG22 ' OD1' ' A' 1520 ' ' ASN . 9.7 t -122.58 -10.03 8.4 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 120.314 -0.554 . . . . 1.6100000000000001 112.268 -179.425 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 81.06 22.6 60.77 Favored Glycine 0 C--N 1.32 -0.361 0 O-C-N 122.334 -0.229 . . . . 1.1299999999999999 113.593 176.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1525 ' ' HIS . . . . . 0.567 ' CE1' ' HB3' ' A' 1647 ' ' GLU . 11.8 t-160 -93.65 125.26 38.17 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 120.535 -0.466 . . . . 1.26 110.69 -178.24 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 2.5 tm? -94.28 116.52 28.92 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 114.866 -1.061 . . . . 0.68000000000000005 109.764 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1527 ' ' PHE . . . . . 0.409 ' O ' ' HA ' ' A' 1517 ' ' GLN . 96.7 m-85 -92.71 119.09 31.75 Favored 'General case' 0 C--N 1.317 -0.808 0 O-C-N 122.296 -0.252 . . . . 0.65000000000000002 110.438 173.082 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 14.2 t70 -103.92 110.67 22.9 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 109.123 -0.695 . . . . 1.1699999999999999 109.123 178.045 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1529 ' ' LEU . . . . . 0.485 ' HB2' ' HB3' ' A' 1516 ' ' CYS . 3.6 mm? -99.01 3.16 46.85 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 121.326 0.584 . . . . 0.59999999999999998 109.973 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 1.1 m -64.55 -29.66 70.69 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.049 -0.978 . . . . 0.83999999999999997 109.344 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 23.1 t -62.26 -32.27 72.95 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.244 -0.889 . . . . 1.5900000000000001 110.482 178.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 81.3 mt -96.28 1.37 51.98 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.255 -0.43 . . . . 0.65000000000000002 110.944 -176.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1533 ' ' SER . . . . . . . . . . . . . 16.7 m -75.0 161.46 29.45 Favored 'General case' 0 C--O 1.256 1.42 0 CA-C-O 121.294 0.569 . . . . 1.52 111.982 -177.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -178.59 139.8 4.22 Favored Glycine 0 N--CA 1.429 -1.82 0 CA-C-N 115.623 -0.717 . . . . 1.1000000000000001 111.532 178.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1535 ' ' ARG . . . . . 0.486 ' O ' ' HD3' ' A' 1535 ' ' ARG . 0.8 OUTLIER -92.92 -30.37 15.43 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 123.514 0.726 . . . . 4.6200000000000001 109.252 -179.588 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -73.2 -34.11 65.78 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 121.582 0.706 . . . . 1.45 109.697 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 106.26 -177.47 22.3 Favored Glycine 0 N--CA 1.417 -2.574 0 CA-C-N 115.322 -0.854 . . . . 0.84999999999999998 113.497 172.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -138.28 145.7 41.58 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 106.92 -1.511 . . . . 0.93000000000000005 106.92 178.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 20.2 p -102.58 124.18 47.66 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 123.513 0.508 . . . . 1.03 110.526 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1540 ' ' ALA . . . . . 0.722 ' HB3' HG23 ' A' 1548 ' ' VAL . . . -117.37 134.89 54.3 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 109.087 -0.709 . . . . 0.5 109.087 178.384 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -88.13 124.47 33.82 Favored 'General case' 0 N--CA 1.439 -0.976 0 O-C-N 123.663 0.602 . . . . 0.73999999999999999 110.71 -178.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1542 ' ' TYR . . . . . 0.54 ' HD2' ' CZ ' ' A' 1567 ' ' PHE . 2.2 t80 -123.5 -101.34 0.4 Allowed 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.235 -0.893 . . . . 0.98999999999999999 109.675 -179.436 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1543 ' ' SER . . . . . . . . . . . . . 14.6 m -62.98 159.77 16.34 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 118.735 -0.65 . . . . 1.9099999999999999 109.601 177.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 63.2 tttp -50.49 -40.87 52.32 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 112.902 0.705 . . . . 3.5899999999999999 112.902 -175.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 27.3 t -116.98 34.43 5.11 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 108.47 -0.937 . . . . 2.46 108.47 177.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . -128.34 118.84 2.91 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.078 -1.058 . . . . 1.26 114.312 -175.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 28.1 m -124.66 137.61 56.82 Favored 'Isoleucine or valine' 0 C--O 1.254 1.325 0 CA-C-O 121.027 0.441 . . . . 0.79000000000000004 109.939 176.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1548 ' ' VAL . . . . . 0.722 HG23 ' HB3' ' A' 1540 ' ' ALA . 0.0 OUTLIER -95.88 132.69 39.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-N 115.818 -0.628 . . . . 0.57999999999999996 110.862 175.68 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A 1549 ' ' TYR . . . . . 0.419 ' HB3' ' ND2' ' A' 1556 ' ' ASN . 51.8 m-85 -96.33 99.8 11.46 Favored 'General case' 0 N--CA 1.423 -1.776 0 N-CA-C 106.756 -1.572 . . . . 1.0800000000000001 106.756 171.419 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 6.4 ptp -110.75 142.15 43.09 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 115.392 -0.822 . . . . 0.78000000000000003 111.589 -178.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 12.3 p -118.34 110.64 17.73 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-N 115.719 -0.673 . . . . 0.96999999999999997 109.428 176.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1552 ' ' ILE . . . . . . . . . . . . . 41.6 mm -75.49 119.6 23.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 109.465 -0.569 . . . . 0.41999999999999998 109.465 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 56.8 m 64.41 41.68 5.61 Favored 'General case' 0 C--O 1.25 1.101 0 CA-C-O 121.97 0.891 . . . . 1.3999999999999999 111.994 174.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 174.84 -178.02 46.73 Favored Glycine 0 N--CA 1.421 -2.36 0 N-CA-C 109.452 -1.459 . . . . 0.34999999999999998 109.452 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -109.54 146.08 35.24 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-O 120.882 0.372 . . . . 1.6200000000000001 110.224 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1556 ' ' ASN . . . . . 0.419 ' ND2' ' HB3' ' A' 1549 ' ' TYR . 45.2 t-20 -94.92 139.49 31.25 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 115.672 -0.695 . . . . 0.87 109.166 -175.688 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1557 ' ' GLU . . . . . 0.417 ' HB3' ' CZ ' ' A' 1535 ' ' ARG . 12.9 pt-20 -77.92 -13.45 59.88 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 122.932 0.493 . . . . 2.4900000000000002 112.304 -176.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -73.87 -8.25 55.37 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.38 0.511 . . . . 1.3799999999999999 112.38 -177.006 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1559 ' ' CYS . . . . . 0.775 ' SG ' ' HD2' ' A' 1560 ' ' PRO . 1.6 t -137.72 169.41 13.07 Favored Pre-proline 0 C--N 1.288 -2.106 0 N-CA-C 106.747 -1.575 . . . . 1.21 106.747 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1560 ' ' PRO . . . . . 0.775 ' HD2' ' SG ' ' A' 1559 ' ' CYS . 14.2 Cg_exo -38.58 149.51 0.08 OUTLIER 'Trans proline' 0 CA--C 1.557 1.644 0 C-N-CA 124.003 3.135 . . . . 0.70999999999999996 114.699 174.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1561 ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' 1560 ' ' PRO . 52.2 Cg_exo -58.05 125.59 19.02 Favored 'Trans proline' 0 C--O 1.242 0.72 0 C-N-CA 123.151 2.567 . . . . 0.80000000000000004 110.85 178.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 106.91 -7.28 38.13 Favored Glycine 0 N--CA 1.433 -1.517 0 CA-C-N 115.926 -0.579 . . . . 0.46000000000000002 112.828 -178.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1563 ' ' VAL . . . . . 0.692 HG11 ' HB2' ' A' 1566 ' ' CYS . 9.8 t -79.37 121.8 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.836 0 N-CA-C 112.712 0.634 . . . . 0.97999999999999998 112.712 -179.054 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -97.3 -34.75 5.49 Favored Glycine 0 C--N 1.306 -1.086 0 CA-C-N 114.918 -1.037 . . . . 0.28000000000000003 111.023 176.059 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -131.4 125.17 31.91 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 109.653 -0.499 . . . . 0.28000000000000003 109.653 178.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1566 ' ' CYS . . . . . 0.692 ' HB2' HG11 ' A' 1563 ' ' VAL . 49.4 t -150.78 138.46 19.77 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 110.115 -0.328 . . . . 0.42999999999999999 110.115 -179.322 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1567 ' ' PHE . . . . . 0.956 ' HB3' ' HG2' ' A' 1569 ' ' GLN . 23.8 m-85 -85.74 139.62 31.19 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.812 -0.81 . . . . 1.03 108.812 172.335 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -87.57 23.32 13.04 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.211 -0.995 . . . . 1.1299999999999999 111.245 -178.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1569 ' ' GLN . . . . . 0.956 ' HG2' ' HB3' ' A' 1567 ' ' PHE . 9.9 mm100 -67.71 -70.81 0.24 Allowed 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 122.912 0.485 . . . . 2.5800000000000001 110.361 -177.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 14.3 t -131.85 34.74 3.83 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-O 122.539 1.161 . . . . 2.1699999999999999 108.19 173.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 22.9 mmt180 63.56 61.02 1.05 Allowed 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 113.747 -1.569 . . . . 2.6200000000000001 109.803 -178.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 34.8 mt -104.26 115.4 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-N 116.242 -0.436 . . . . 0.92000000000000004 110.529 -177.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1573 ' ' SER . . . . . 0.559 ' HB3' ' HB2' ' A' 1596 ' ' SER . 28.6 t -80.13 142.02 35.19 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 120.957 0.408 . . . . 0.80000000000000004 110.71 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1574 ' ' VAL . . . . . 0.499 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 27.0 m -133.04 17.12 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 O-C-N 122.031 -0.418 . . . . 0.97999999999999998 111.673 178.288 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 172.97 131.57 1.4 Allowed Glycine 0 N--CA 1.428 -1.843 0 C-N-CA 119.193 -1.48 . . . . 0.28999999999999998 111.981 178.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -85.37 143.84 28.39 Favored 'General case' 0 N--CA 1.427 -1.578 0 N-CA-C 108.142 -1.058 . . . . 2.1899999999999999 108.142 178.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -68.43 92.23 0.43 Allowed 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 115.456 -0.793 . . . . 0.60999999999999999 111.8 -177.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -100.94 173.9 6.27 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 107.205 -1.406 . . . . 1.95 107.205 172.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1579 ' ' LYS . . . . . 0.435 ' HD3' ' HA ' ' A' 1515 ' ' ASP . 16.7 ptpt -142.8 54.5 1.39 Allowed 'General case' 0 C--N 1.294 -1.815 0 CA-C-O 122.395 1.093 . . . . 2.6800000000000002 109.502 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1580 ' ' ARG . . . . . 0.423 ' NH1' HH21 ' A' 1582 ' ' ARG . 69.5 ttt180 -105.99 77.11 1.22 Allowed 'General case' 0 N--CA 1.419 -2.015 0 CA-C-N 114.953 -1.021 . . . . 3.4700000000000002 109.7 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1581 ' ' LEU . . . . . 0.455 HD11 HD12 ' A' 1588 ' ' LEU . 0.5 OUTLIER -63.28 126.08 26.24 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.047 -0.979 . . . . 0.64000000000000001 109.304 177.436 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A 1582 ' ' ARG . . . . . 0.553 ' HB2' ' HB3' ' A' 1589 ' ' GLN . 91.3 mtt180 -121.73 144.69 48.65 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 116.032 -0.531 . . . . 2.8500000000000001 110.137 177.095 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1583 ' ' TYR . . . . . 0.604 ' CE1' ' HA ' ' A' 1586 ' ' GLN . 61.9 t80 -115.09 108.76 17.07 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.896 -0.409 . . . . 0.85999999999999999 109.896 178.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1584 ' ' VAL . . . . . 0.535 ' O ' ' HB ' ' A' 1587 ' ' VAL . 13.1 m -124.81 89.56 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.61 0.719 . . . . 1.05 112.275 -178.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 21.0 t70 55.75 58.66 4.31 Favored 'General case' 0 N--CA 1.505 2.299 0 C-N-CA 124.739 1.215 . . . . 1.1699999999999999 110.874 178.181 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1586 ' ' GLN . . . . . 0.604 ' HA ' ' CE1' ' A' 1583 ' ' TYR 0.352 12.9 pt20 63.92 17.66 10.69 Favored 'General case' 0 CA--C 1.503 -0.863 0 C-N-CA 127.513 2.325 . . . . 1.8600000000000001 112.805 179.463 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A 1587 ' ' VAL . . . . . 0.535 ' HB ' ' O ' ' A' 1584 ' ' VAL . 39.5 t -102.0 120.48 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.235 0 N-CA-C 106.723 -1.584 . . . . 0.48999999999999999 106.723 170.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1588 ' ' LEU . . . . . 0.967 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 2.5 mm? -96.6 108.03 20.56 Favored 'General case' 0 C--N 1.283 -2.283 0 N-CA-C 107.38 -1.341 . . . . 0.35999999999999999 107.38 -179.191 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1589 ' ' GLN . . . . . 0.553 ' HB3' ' HB2' ' A' 1582 ' ' ARG . 34.4 tt0 -100.07 131.16 46.19 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 116.022 -0.535 . . . . 1.74 112.075 -173.55 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 12.1 mt -125.71 102.15 7.2 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 106.711 -1.589 . . . . 0.71999999999999997 106.711 170.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 7.8 p -95.96 126.02 48.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 CA-C-O 121.39 0.614 . . . . 1.01 110.184 -177.235 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1592 ' ' TYR . . . . . . . . . . . . . 13.0 m-30 -117.25 110.69 18.43 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 107.966 -1.124 . . . . 0.5 107.966 -178.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 47.4 pttt -130.56 -179.13 5.1 Favored 'General case' 0 C--N 1.281 -2.381 0 CA-C-N 115.625 -0.716 . . . . 1.5900000000000001 109.375 -177.116 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 19.9 m-20 61.66 43.33 9.97 Favored 'General case' 0 CA--C 1.507 -0.701 0 O-C-N 124.383 1.052 . . . . 1.1100000000000001 110.264 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -90.81 -134.43 5.92 Favored Glycine 0 N--CA 1.432 -1.623 0 CA-C-N 114.594 -1.184 . . . . 0.78000000000000003 110.942 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1596 ' ' SER . . . . . 0.559 ' HB2' ' HB3' ' A' 1573 ' ' SER . 33.1 t -86.31 148.24 46.68 Favored Pre-proline 0 C--N 1.303 -1.424 0 N-CA-C 108.583 -0.895 . . . . 1.0700000000000001 108.583 -178.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -63.11 140.12 76.53 Favored 'Trans proline' 0 N--CA 1.443 -1.496 0 C-N-CA 122.499 2.133 . . . . 1.01 109.711 174.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1598 ' ' CYS . . . . . 0.547 ' HA ' ' CE2' ' A' 1606 ' ' TYR . 49.4 t -79.58 110.18 14.52 Favored Pre-proline 0 C--N 1.294 -1.817 0 N-CA-C 107.721 -1.215 . . . . 0.75 107.721 -178.1 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -58.59 -34.11 98.62 Favored 'Trans proline' 0 C--N 1.358 1.044 0 C-N-CA 123.191 2.594 . . . . 1.7 112.007 -176.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1600 ' ' SER . . . . . 0.756 ' HB3' ' HB2' ' B' ' 53' ' ' LEU . 4.8 m -60.62 -22.44 63.79 Favored 'General case' 0 CA--C 1.56 1.334 0 C-N-CA 125.271 1.428 . . . . 2.2599999999999998 113.171 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1601 ' ' LYS . . . . . 0.502 ' HE2' ' OD2' ' B' ' 52' ' ' ASP . 4.9 tppp? -157.4 120.62 4.04 Favored 'General case' 0 C--O 1.241 0.622 0 O-C-N 121.952 -0.468 . . . . 3.0099999999999998 110.339 178.045 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 19.8 m -70.18 133.93 47.58 Favored 'General case' 0 N--CA 1.414 -2.273 0 N-CA-C 109.686 -0.487 . . . . 2.0699999999999998 109.686 -177.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 105.51 -16.89 44.01 Favored Glycine 0 C--N 1.301 -1.377 0 CA-C-N 116.072 -0.513 . . . . 1.0800000000000001 112.343 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1604 ' ' LEU . . . . . 0.468 HD12 ' HB3' ' A' 1601 ' ' LYS . 56.9 mt -102.95 138.76 39.4 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 122.164 -0.61 . . . . 1.8400000000000001 110.451 -179.35 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 20.5 m -115.92 147.04 41.54 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 107.698 -1.223 . . . . 1.4099999999999999 107.698 175.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1606 ' ' TYR . . . . . 0.547 ' CE2' ' HA ' ' A' 1598 ' ' CYS . 54.4 m-85 -70.14 150.21 46.75 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 116.687 -0.233 . . . . 0.59999999999999998 111.543 -178.373 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 6.6 ttpm? -148.07 135.51 20.6 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.771 -0.826 . . . . 1.45 108.771 177.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1608 ' ' SER . . . . . . . . . . . . . 2.6 p -119.1 126.42 51.6 Favored 'General case' 0 C--N 1.281 -2.387 0 CA-C-N 115.384 -0.826 . . . . 1.1499999999999999 109.83 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 39.1 t -107.51 105.16 18.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 109.52 -0.548 . . . . 0.25 109.52 -178.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1610 ' ' ILE . . . . . 0.407 ' HA ' ' HB2' ' A' 1638 ' ' PHE . 92.9 mt -89.97 119.38 36.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 107.972 -1.121 . . . . 0.45000000000000001 107.972 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 20.0 m -124.55 116.0 21.76 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-N 115.85 -0.614 . . . . 1.26 110.494 -177.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1612 ' ' PHE . . . . . 0.967 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 75.5 m-85 -85.62 122.82 30.28 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.606 -0.887 . . . . 0.26000000000000001 108.606 176.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 58.8 t -111.62 135.58 50.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 CA-C-N 115.382 -0.826 . . . . 0.5 109.576 -174.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 39.5 t -68.3 107.54 2.86 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.246 -0.888 . . . . 0.77000000000000002 110.587 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1615 ' ' ARG . . . . . 0.436 ' CB ' ' HB3' ' A' 1641 ' ' HIS . 32.7 tpt180 -132.35 94.28 23.48 Favored Pre-proline 0 N--CA 1.437 -1.107 0 N-CA-C 108.746 -0.835 . . . . 2.5299999999999998 108.746 176.588 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1616 ' ' PRO . . . . . 0.793 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 18.6 Cg_exo -66.89 -26.17 44.58 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 122.034 1.823 . . . . 1.1000000000000001 112.397 -177.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -77.87 43.31 0.42 Allowed 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 125.067 1.347 . . . . 3.0499999999999998 112.977 178.136 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -31.99 126.24 0.26 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.726 1.611 . . . . 1.55 113.171 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . -167.19 -141.17 3.08 Favored Glycine 0 N--CA 1.412 -2.906 0 N-CA-C 109.175 -1.57 . . . . 0.93000000000000005 109.175 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -75.49 8.77 2.45 Favored 'Trans proline' 0 CA--C 1.533 0.437 0 C-N-CA 122.525 2.15 . . . . 0.88 113.337 -176.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1621 ' ' THR . . . . . 0.678 ' HB ' ' HB2' ' A' 1641 ' ' HIS . 14.4 p -96.18 -10.48 28.02 Favored 'General case' 0 C--N 1.292 -1.905 0 C-N-CA 124.102 0.961 . . . . 0.96999999999999997 109.971 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 52.9 t30 -85.86 65.34 9.08 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 114.945 -1.025 . . . . 0.71999999999999997 109.38 -178.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1623 ' ' ARG . . . . . 0.524 ' O ' ' HG3' ' A' 1625 ' ' MET . 10.8 ptp180 -165.34 141.84 4.61 Favored Pre-proline 0 C--N 1.31 -1.126 0 N-CA-C 107.78 -1.193 . . . . 3.2599999999999998 107.78 -175.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1624 ' ' PRO . . . . . 0.445 ' HG3' ' CZ3' ' A' 1640 ' ' TRP . 23.5 Cg_exo -56.11 107.37 0.25 Allowed 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.551 2.167 . . . . 0.58999999999999997 111.005 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1625 ' ' MET . . . . . 0.524 ' HG3' ' O ' ' A' 1623 ' ' ARG . 89.8 mtp -107.05 132.46 52.94 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.345 -0.613 . . . . 1.3700000000000001 109.345 -177.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.4 114.06 22.17 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 106.406 -1.702 . . . . 0.89000000000000001 106.406 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1627 ' ' ILE . . . . . 0.752 HD11 ' HB2' ' A' 1639 ' ' SER . 45.2 mm -69.4 -55.1 16.42 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.139 0 N-CA-C 109.027 -0.731 . . . . 0.57999999999999996 109.027 -179.046 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 11.8 t -176.44 152.88 1.12 Allowed 'General case' 0 N--CA 1.425 -1.704 0 N-CA-C 108.616 -0.883 . . . . 1.3899999999999999 108.616 -176.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1629 ' ' LEU . . . . . 0.594 HD13 HD23 ' A' 1636 ' ' LEU . 19.0 tp -99.89 109.51 21.89 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.304 -0.862 . . . . 1.25 109.408 175.242 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 20.6 t70 -73.03 98.79 2.6 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 106.372 -1.714 . . . . 1.0900000000000001 106.372 170.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1631 ' ' LYS . . . . . 0.715 ' HD3' ' H ' ' A' 1631 ' ' LYS . 0.2 OUTLIER -73.31 -16.21 61.38 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 113.73 1.011 . . . . 3.6000000000000001 113.73 -172.989 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 89.7 mm-40 -73.56 -36.63 65.63 Favored 'General case' 0 CA--C 1.498 -1.052 0 C-N-CA 120.41 -0.516 . . . . 2.6000000000000001 111.193 178.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 58.9 p -108.01 -6.15 16.72 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 115.886 -0.597 . . . . 0.75 112.432 -176.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 82.5 m 63.73 47.08 3.77 Favored 'General case' 0 C--N 1.36 1.03 0 C-N-CA 124.368 1.067 . . . . 0.53000000000000003 109.754 -178.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1635 ' ' THR . . . . . . . . . . . . . 56.1 m -115.36 133.17 56.29 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.92 -1.036 . . . . 0.46000000000000002 110.808 -175.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1636 ' ' LEU . . . . . 0.594 HD23 HD13 ' A' 1629 ' ' LEU . 15.7 mt -110.14 135.75 50.44 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.996 -0.742 . . . . 0.85999999999999999 108.996 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -109.55 133.15 53.43 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 109.421 -0.585 . . . . 0.45000000000000001 109.421 176.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1638 ' ' PHE . . . . . 0.407 ' HB2' ' HA ' ' A' 1610 ' ' ILE . 97.3 m-85 -123.34 135.39 54.16 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 116.137 -0.483 . . . . 0.5 110.021 -178.197 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1639 ' ' SER . . . . . 0.752 ' HB2' HD11 ' A' 1627 ' ' ILE . 23.3 t -115.62 156.17 26.32 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 107.221 -1.399 . . . . 1.04 107.221 175.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1640 ' ' TRP . . . . . 0.445 ' CZ3' ' HG3' ' A' 1624 ' ' PRO . 3.1 t90 -151.5 106.21 3.25 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 103.973 -2.603 . . . . 0.68000000000000005 103.973 177.484 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1641 ' ' HIS . . . . . 0.678 ' HB2' ' HB ' ' A' 1621 ' ' THR . 12.3 m-70 -93.39 103.45 15.67 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.694 -0.854 . . . . 0.90000000000000002 108.694 -173.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1642 ' ' THR . . . . . . . . . . . . . 15.3 t -142.21 145.33 35.06 Favored Pre-proline 0 CA--C 1.558 1.277 0 C-N-CA 120.776 -0.369 . . . . 0.47999999999999998 110.341 -172.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1643 ' ' PRO . . . . . 0.793 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 72.6 Cg_endo -78.42 -5.5 14.96 Favored 'Trans proline' 0 C--N 1.372 1.793 0 C-N-CA 122.303 2.002 . . . . 0.66000000000000003 112.233 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 9.2 tt -66.49 -24.44 66.41 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.104 -0.702 . . . . 0.96999999999999997 109.104 177.094 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -92.7 16.2 12.78 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.251 -0.886 . . . . 0.83999999999999997 110.566 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 58.6 m -121.79 145.87 47.62 Favored 'General case' 0 N--CA 1.424 -1.748 0 O-C-N 122.28 -0.262 . . . . 1.1899999999999999 110.998 -178.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1647 ' ' GLU . . . . . 0.567 ' HB3' ' CE1' ' A' 1525 ' ' HIS . 0.4 OUTLIER . . . . . 0 C--N 1.296 -1.729 0 N-CA-C 108.509 -0.923 . . . . 3.1400000000000001 108.509 167.14 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 10' ' ' GLY . . . . . 0.48 ' O ' HG12 ' B' ' 14' ' ' VAL . . . . . . . . 0 N--CA 1.412 -2.962 0 N-CA-C 110.07 -1.212 . . . . 2.0899999999999999 110.07 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 11' ' ' GLY . . . . . 0.566 ' O ' ' HB2' ' B' ' 15' ' ' ASP . . . -56.32 -62.38 6.4 Favored Glycine 0 N--CA 1.44 -1.05 0 O-C-N 124.687 0.875 . . . . 1.8400000000000001 113.325 -176.419 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -74.12 -30.04 62.12 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.981 0.391 . . . . 2.5499999999999998 111.222 -176.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 13' ' ' LEU . . . . . 0.45 ' O ' HD23 ' B' ' 17' ' ' LEU . 67.1 mt -56.67 -64.86 0.73 Allowed 'General case' 0 N--CA 1.468 0.446 0 O-C-N 123.374 0.421 . . . . 2.3500000000000001 111.09 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 14' ' ' VAL . . . . . 0.48 HG12 ' O ' ' B' ' 10' ' ' GLY . 14.0 p -65.38 -29.85 48.45 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 CA-C-O 121.355 0.598 . . . . 2.1099999999999999 110.269 -178.413 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 15' ' ' ASP . . . . . 0.566 ' HB2' ' O ' ' B' ' 11' ' ' GLY . 4.0 t70 -66.69 -48.38 69.44 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-N 115.422 -0.808 . . . . 2.04 112.251 -177.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 13.4 t -65.91 -31.87 73.05 Favored 'General case' 0 C--O 1.256 1.414 0 CA-C-N 118.099 0.409 . . . . 1.8400000000000001 110.82 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.63 ' HB3' ' HB3' ' B' ' 26' ' ' PHE . 4.1 mm? -58.6 -48.79 79.78 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.423 0.63 . . . . 1.74 110.374 174.243 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -80.22 -15.1 57.76 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.549 0.69 . . . . 2.3900000000000001 110.902 -178.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -65.07 -52.76 53.85 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 116.094 -0.503 . . . . 0.95999999999999996 110.786 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 30.7 m -98.43 -24.95 4.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 C-N-CA 118.666 -1.214 . . . . 1.3700000000000001 112.141 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 21' ' ' CYS . . . . . 0.425 ' HB2' ' O ' ' B' ' 17' ' ' LEU . 95.9 m -105.03 19.84 19.9 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 120.681 -0.407 . . . . 1.6599999999999999 111.841 -177.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -49.22 -40.89 30.21 Favored Glycine 0 N--CA 1.474 1.168 0 N-CA-C 115.093 0.797 . . . . 1.53 115.093 -178.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -71.4 -32.35 68.32 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 112.476 0.547 . . . . 2.7200000000000002 112.476 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 21.0 ttm180 -93.12 -41.12 10.11 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 120.738 -0.385 . . . . 4.3300000000000001 111.852 -175.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 120.25 -176.15 16.12 Favored Glycine 0 N--CA 1.436 -1.355 0 N-CA-C 110.191 -1.164 . . . . 1.53 110.191 -177.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 26' ' ' PHE . . . . . 0.63 ' HB3' ' HB3' ' B' ' 17' ' ' LEU . 12.9 p90 -132.4 127.78 36.15 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 116.914 0.357 . . . . 1.6499999999999999 110.277 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -131.09 84.04 2.15 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.089 0.471 . . . . 3.4199999999999999 112.103 -175.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 28' ' ' PHE . . . . . . . . . . . . . 33.4 p90 . . . . . 0 C--N 1.302 -1.491 0 CA-C-O 122.367 1.08 . . . . 2.2599999999999998 108.806 177.232 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.206 0 CA-C-O 119.094 -0.837 . . . . 2.3700000000000001 113.253 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 42' ' ' ILE . . . . . 0.619 ' HA ' ' HG2' ' B' ' 45' ' ' GLU . 27.5 pt 52.75 26.94 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.38 1.899 0 C-N-CA 126.549 1.94 . . . . 2.0699999999999998 112.739 179.019 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 1.4 p -103.05 -44.42 9.75 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.921 0 CA-C-N 113.771 -1.559 . . . . 2.2400000000000002 112.638 -173.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -83.72 -22.06 32.11 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.758 -1.201 . . . . 3.3599999999999999 107.758 -178.065 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 45' ' ' GLU . . . . . 0.619 ' HG2' ' HA ' ' B' ' 42' ' ' ILE . 1.5 pm0 -77.53 -28.36 51.95 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 114.241 -1.345 . . . . 3.0800000000000001 112.22 173.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 46' ' ' CYS . . . . . . . . . . . . . 12.1 t -112.77 -3.25 14.24 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 118.729 -1.188 . . . . 2.23 112.793 -177.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 43.3 t -86.77 -53.34 4.98 Favored 'General case' 0 C--N 1.314 -0.975 0 O-C-N 121.201 -0.937 . . . . 2.3700000000000001 110.958 175.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -91.71 -5.73 53.19 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.31 0.576 . . . . 2.8199999999999998 111.902 -176.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -139.5 152.16 46.73 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 106.348 -1.723 . . . . 4.0899999999999999 106.348 179.144 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 32.3 t -80.3 139.59 36.56 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 106.209 -1.774 . . . . 2.6699999999999999 106.209 175.011 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 51' ' ' CYS . . . . . 0.593 ' HB2' HD23 ' B' ' 55' ' ' LEU . 25.7 p -105.46 138.18 42.08 Favored 'General case' 0 N--CA 1.422 -1.855 0 N-CA-C 108.6 -0.889 . . . . 2.1099999999999999 108.6 -175.641 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 52' ' ' ASP . . . . . 0.502 ' OD2' ' HE2' ' A' 1601 ' ' LYS . 3.5 m-20 -66.33 139.44 58.04 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.944 -0.761 . . . . 2.6699999999999999 108.944 177.313 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 53' ' ' LEU . . . . . 0.756 ' HB2' ' HB3' ' A' 1600 ' ' SER . 36.0 tp -55.18 -30.86 60.77 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.246 -1.343 . . . . 1.8999999999999999 110.555 177.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.48 -45.44 84.84 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 123.688 0.795 . . . . 1.52 110.431 177.362 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 55' ' ' LEU . . . . . 0.593 HD23 ' HB2' ' B' ' 51' ' ' CYS . 44.9 tp -58.77 -50.57 73.43 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 123.936 0.895 . . . . 1.97 110.52 -179.242 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 3.1 pp -74.11 -33.08 63.47 Favored 'General case' 0 N--CA 1.424 -1.74 0 C-N-CA 120.716 -0.394 . . . . 1.53 111.842 -175.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -66.75 -49.45 65.92 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.117 0.484 . . . . 2.27 110.812 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 7.2 t -73.75 -24.46 59.88 Favored 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 120.294 -0.562 . . . . 2.3300000000000001 111.039 -177.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -76.7 -67.48 0.7 Allowed 'General case' 0 C--O 1.241 0.611 0 N-CA-C 107.576 -1.268 . . . . 2.8599999999999999 107.576 176.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 42.9 t . . . . . 0 CA--C 1.549 0.926 0 C-N-CA 125.311 1.444 . . . . 2.2999999999999998 113.881 175.732 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 14.6 t70 . . . . . 0 N--CA 1.442 -0.843 0 N-CA-C 106.006 -1.85 . . . . 2.8999999999999999 106.006 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 21.7 t -90.31 73.32 7.07 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 107.154 -1.424 . . . . 1.1899999999999999 107.154 178.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -166.7 172.34 10.66 Favored 'General case' 0 N--CA 1.423 -1.822 0 N-CA-C 104.949 -2.241 . . . . 1.52 104.949 -174.299 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 10.6 p -168.27 137.07 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 CA-C-O 121.414 0.626 . . . . 0.93999999999999995 110.531 177.295 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1519 ' ' THR . . . . . . . . . . . . . 35.4 m -92.92 135.85 33.78 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 115.809 -0.632 . . . . 0.89000000000000001 109.973 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -86.23 124.94 69.45 Favored Pre-proline 0 N--CA 1.414 -2.231 0 CA-C-N 116.226 -0.443 . . . . 1.74 110.106 176.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.76 -13.62 24.4 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.991 2.461 . . . . 1.5800000000000001 113.602 -175.122 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 14.1 m -80.38 -41.62 24.31 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 116.657 -0.247 . . . . 1.6499999999999999 111.442 -177.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1523 ' ' THR . . . . . . . . . . . . . 6.6 t -125.43 2.8 7.7 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 119.502 -0.879 . . . . 1.6100000000000001 112.662 -175.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 65.35 28.12 73.22 Favored Glycine 0 CA--C 1.503 -0.697 0 C-N-CA 121.129 -0.558 . . . . 1.1299999999999999 112.423 178.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 18.9 t-80 -98.2 127.65 44.26 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 121.268 0.556 . . . . 1.26 109.593 -179.091 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 2.8 tm? -86.03 118.5 25.54 Favored 'General case' 0 C--N 1.288 -2.078 0 CA-C-N 114.171 -1.377 . . . . 0.68000000000000005 109.825 -177.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1527 ' ' PHE . . . . . 0.572 ' HE2' ' HE2' ' A' 1583 ' ' TYR . 30.6 m-85 -90.39 128.07 36.38 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 109.333 -0.617 . . . . 0.65000000000000002 109.333 170.597 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 23.0 t70 -115.16 123.67 49.5 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 123.709 0.631 . . . . 1.1699999999999999 109.768 178.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 3.0 mm? -100.34 -5.94 26.57 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-O 121.565 0.698 . . . . 0.59999999999999998 109.798 -178.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1530 ' ' SER . . . . . 0.453 ' HA ' ' OG ' ' A' 1533 ' ' SER . 1.1 m -70.67 -18.17 62.84 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.381 -0.827 . . . . 0.83999999999999997 109.704 -177.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 40.5 m -62.81 -19.21 63.84 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 115.369 -0.832 . . . . 1.5900000000000001 110.228 176.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1532 ' ' LEU . . . . . 0.468 ' HB2' HG21 ' A' 1552 ' ' ILE . 75.9 mt -105.87 3.86 29.06 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 120.672 0.272 . . . . 0.65000000000000002 111.147 177.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1533 ' ' SER . . . . . 0.453 ' OG ' ' HA ' ' A' 1530 ' ' SER . 50.2 m -68.11 155.46 39.54 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 121.472 0.653 . . . . 1.52 111.792 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . 173.68 149.57 7.04 Favored Glycine 0 N--CA 1.422 -2.248 0 N-CA-C 109.373 -1.491 . . . . 1.1000000000000001 109.373 -177.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 41.7 ttp180 -89.52 -21.29 22.99 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.189 0.519 . . . . 4.6200000000000001 109.922 -177.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -81.02 -40.91 23.52 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 109.172 -0.677 . . . . 1.45 109.172 176.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 91.94 -151.16 20.64 Favored Glycine 0 N--CA 1.42 -2.424 0 CA-C-N 115.651 -0.704 . . . . 0.84999999999999998 113.976 171.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -135.04 145.07 47.66 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 107.78 -1.192 . . . . 0.93000000000000005 107.78 -177.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 15.5 p -111.45 127.69 55.76 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 123.903 0.752 . . . . 1.03 110.526 179.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1540 ' ' ALA . . . . . 0.708 ' HB2' ' HG2' ' A' 1624 ' ' PRO . . . -120.14 142.95 48.47 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 108.367 -0.975 . . . . 0.5 108.367 175.379 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -80.93 136.97 36.12 Favored 'General case' 0 C--N 1.314 -0.937 0 O-C-N 123.817 0.698 . . . . 0.73999999999999999 110.354 -176.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1542 ' ' TYR . . . . . 0.867 ' HE2' ' HG ' ' A' 1626 ' ' LEU . 3.1 t80 -149.21 -99.08 0.07 Allowed 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 115.984 -0.553 . . . . 0.98999999999999999 109.743 -174.158 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1543 ' ' SER . . . . . . . . . . . . . 30.0 t -72.31 151.48 42.73 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 109.04 -0.726 . . . . 1.9099999999999999 109.04 -177.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1544 ' ' LYS . . . . . 0.583 ' HD2' ' HA ' ' B' ' 23' ' ' ASP . 62.7 tttp -57.95 -22.35 48.56 Favored 'General case' 0 C--N 1.346 0.416 0 C-N-CA 125.326 1.45 . . . . 3.5899999999999999 112.318 -174.371 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 34.5 t -132.21 19.93 4.44 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 116.271 -0.422 . . . . 2.46 109.985 -178.175 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1546 ' ' GLY . . . . . 0.495 ' HA3' ' OE1' ' A' 1569 ' ' GLN . . . -159.14 127.93 1.93 Allowed Glycine 0 N--CA 1.439 -1.115 0 C-N-CA 118.816 -1.659 . . . . 1.26 113.988 -176.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 26.9 m -100.91 164.64 2.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 108.154 -1.054 . . . . 0.79000000000000004 108.154 176.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1548 ' ' VAL . . . . . 0.494 ' CG1' ' HB3' ' A' 1540 ' ' ALA . 10.2 p -102.15 130.85 51.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 109.614 -0.513 . . . . 0.57999999999999996 109.614 178.189 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -101.96 118.5 37.05 Favored 'General case' 0 CA--C 1.497 -1.068 0 C-N-CA 123.462 0.705 . . . . 1.0800000000000001 109.287 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1550 ' ' MET . . . . . 0.522 ' SD ' ' HZ3' ' A' 1640 ' ' TRP . 8.9 ptp -127.81 144.93 51.07 Favored 'General case' 0 C--N 1.29 -2.011 0 C-N-CA 120.182 -0.607 . . . . 0.78000000000000003 111.46 175.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 8.3 p -119.34 123.36 43.99 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 115.59 -0.732 . . . . 0.96999999999999997 109.177 175.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1552 ' ' ILE . . . . . 0.474 HG22 ' SG ' ' A' 1553 ' ' CYS . 46.6 mm -81.24 114.09 21.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 C-N-CA 121.152 -0.219 . . . . 0.41999999999999998 110.671 -177.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1553 ' ' CYS . . . . . 0.474 ' SG ' HG22 ' A' 1552 ' ' ILE . 31.1 m 66.91 38.38 3.67 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.62 0.768 . . . . 1.3999999999999999 110.563 173.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . -177.41 -173.25 42.75 Favored Glycine 0 N--CA 1.417 -2.582 0 N-CA-C 109.343 -1.503 . . . . 0.34999999999999998 109.343 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -110.38 148.62 31.63 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-O 121.095 0.474 . . . . 1.6200000000000001 110.469 -178.215 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -99.09 131.1 45.38 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.656 -0.868 . . . . 0.87 108.656 -176.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -81.71 1.59 33.67 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 113.355 0.872 . . . . 2.4900000000000002 113.355 -174.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 51.9 m-80 -83.39 -7.48 59.56 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 120.429 -0.508 . . . . 1.3799999999999999 111.391 -179.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1559 ' ' CYS . . . . . 0.674 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 98.0 m -136.72 175.13 3.74 Favored Pre-proline 0 C--N 1.31 -1.127 0 CA-C-O 117.931 -1.033 . . . . 1.21 110.041 179.275 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1560 ' ' PRO . . . . . 0.674 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 4.3 Cg_exo -40.27 137.72 1.39 Allowed 'Trans proline' 0 C--N 1.387 2.559 0 C-N-CA 123.917 3.078 . . . . 0.70999999999999996 113.516 177.536 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1561 ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' 1560 ' ' PRO . 71.6 Cg_exo -53.99 127.16 24.52 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 123.624 2.882 . . . . 0.80000000000000004 112.845 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 102.29 6.7 47.6 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-N 115.85 -0.613 . . . . 0.46000000000000002 113.028 -178.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1563 ' ' VAL . . . . . 0.604 HG11 ' HB2' ' A' 1566 ' ' CYS . 2.8 t -96.08 124.64 48.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 C-N-CA 123.171 0.588 . . . . 0.97999999999999998 111.648 -177.099 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -97.26 -33.56 5.92 Favored Glycine 0 N--CA 1.44 -1.048 0 CA-C-N 115.34 -0.846 . . . . 0.28000000000000003 111.747 178.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -129.9 125.54 35.79 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 109.62 -0.511 . . . . 0.28000000000000003 109.62 178.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1566 ' ' CYS . . . . . 0.604 ' HB2' HG11 ' A' 1563 ' ' VAL . 43.7 t -151.24 139.73 20.52 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 120.664 0.269 . . . . 0.42999999999999999 110.878 -179.053 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1567 ' ' PHE . . . . . 0.46 ' HB3' ' HG2' ' A' 1569 ' ' GLN . 10.9 m-85 -91.4 143.0 27.07 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 122.427 -0.17 . . . . 1.03 110.682 173.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -90.36 41.16 2.96 Favored Glycine 0 N--CA 1.431 -1.651 0 C-N-CA 120.54 -0.838 . . . . 1.1299999999999999 111.821 -176.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1569 ' ' GLN . . . . . 0.495 ' OE1' ' HA3' ' A' 1546 ' ' GLY . 8.4 mm100 -80.33 -72.19 0.42 Allowed 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 108.838 -0.801 . . . . 2.5800000000000001 108.838 177.532 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 19.0 p -133.37 35.14 3.46 Favored 'General case' 0 N--CA 1.433 -1.31 0 C-N-CA 123.869 0.868 . . . . 2.1699999999999999 110.198 176.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 11.6 mmt180 67.61 63.02 0.42 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.743 1.217 . . . . 2.6200000000000001 108.791 -174.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 31.1 mt -105.89 111.53 35.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 CA-C-N 115.946 -0.57 . . . . 0.92000000000000004 110.814 -176.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 31.2 t -81.98 139.15 34.73 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.597 -0.729 . . . . 0.80000000000000004 111.052 -177.216 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1574 ' ' VAL . . . . . 0.569 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 34.6 m -132.13 12.98 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-O 121.163 0.506 . . . . 0.97999999999999998 111.329 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 178.98 122.62 0.77 Allowed Glycine 0 N--CA 1.423 -2.186 0 C-N-CA 120.158 -1.02 . . . . 0.28999999999999998 111.761 177.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 29.5 ttpp -81.0 146.47 30.66 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 107.558 -1.275 . . . . 2.1899999999999999 107.558 178.148 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -68.28 90.29 0.35 Allowed 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.232 0.539 . . . . 0.60999999999999999 112.295 -175.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -107.37 179.69 4.18 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.414 -1.328 . . . . 1.95 107.414 176.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 60.0 mttp -138.47 48.13 1.95 Allowed 'General case' 0 CA--C 1.49 -1.341 0 N-CA-C 109.181 -0.674 . . . . 2.6800000000000002 109.181 178.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1580 ' ' ARG . . . . . 0.529 ' HB3' HG12 ' A' 1591 ' ' VAL . 31.1 ttm180 -87.21 76.97 9.12 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.839 -0.745 . . . . 3.4700000000000002 109.286 -177.276 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1581 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.13 124.98 31.01 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 114.478 -1.237 . . . . 0.64000000000000001 108.65 -179.482 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -127.89 138.46 52.68 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 116.342 -0.39 . . . . 2.8500000000000001 110.125 172.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1583 ' ' TYR . . . . . 0.572 ' HE2' ' HE2' ' A' 1527 ' ' PHE . 32.6 t80 -95.97 115.56 27.62 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 107.084 -1.45 . . . . 0.85999999999999999 107.084 176.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1584 ' ' VAL . . . . . 0.726 ' O ' ' HB ' ' A' 1587 ' ' VAL . 6.3 p -138.76 102.0 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.044 0 C-N-CA 120.529 -0.468 . . . . 1.05 111.646 -176.488 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 19.4 t70 58.58 56.45 4.26 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 122.381 1.086 . . . . 1.1699999999999999 110.658 179.005 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1586 ' ' GLN . . . . . 0.444 ' HA ' ' CZ ' ' A' 1583 ' ' TYR . 11.1 pt20 58.84 10.79 1.62 Allowed 'General case' 0 N--CA 1.499 1.993 0 C-N-CA 127.472 2.309 . . . . 1.8600000000000001 112.32 -178.555 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1587 ' ' VAL . . . . . 0.726 ' HB ' ' O ' ' A' 1584 ' ' VAL . 2.8 t -97.02 124.61 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.245 0 CA-C-N 114.573 -1.194 . . . . 0.48999999999999999 109.846 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1588 ' ' LEU . . . . . 0.915 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 4.1 mm? -90.41 108.92 20.08 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 107.239 -1.393 . . . . 0.35999999999999999 107.239 175.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -109.52 122.0 46.45 Favored 'General case' 0 C--N 1.287 -2.114 0 C-N-CA 119.47 -0.892 . . . . 1.74 111.443 -176.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1590 ' ' LEU . . . . . 0.676 ' HB3' ' HB ' ' A' 1610 ' ' ILE . 44.8 tp -113.44 109.93 19.48 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 106.18 -1.785 . . . . 0.71999999999999997 106.18 177.158 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1591 ' ' VAL . . . . . 0.529 HG12 ' HB3' ' A' 1580 ' ' ARG . 4.6 p -102.52 129.04 54.68 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 119.619 -0.832 . . . . 1.01 110.599 -177.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1592 ' ' TYR . . . . . 0.431 ' O ' ' HG3' ' A' 1607 ' ' LYS . 13.2 m-30 -117.37 126.91 53.46 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.437 -1.32 . . . . 0.5 107.437 177.024 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 12.9 ptmm? -140.6 176.69 8.58 Favored 'General case' 0 C--N 1.278 -2.515 0 N-CA-C 108.619 -0.882 . . . . 1.5900000000000001 108.619 -174.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 9.3 m-20 58.58 41.8 21.76 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 124.599 1.187 . . . . 1.1100000000000001 111.81 178.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -76.14 -98.8 0.14 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.15 -1.024 . . . . 0.78000000000000003 110.954 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1596 ' ' SER . . . . . . . . . . . . . 12.4 t -120.97 152.44 56.43 Favored Pre-proline 0 C--N 1.285 -2.208 0 N-CA-C 105.61 -1.996 . . . . 1.0700000000000001 105.61 174.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -61.84 139.12 78.27 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 122.376 2.05 . . . . 1.01 110.767 175.316 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 39.2 t -81.79 102.95 1.73 Allowed Pre-proline 0 C--N 1.302 -1.494 0 N-CA-C 106.658 -1.608 . . . . 0.75 106.658 178.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -62.11 -39.47 49.05 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 123.106 2.538 . . . . 1.7 113.184 -170.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1600 ' ' SER . . . . . . . . . . . . . 8.7 m -69.12 -15.09 63.34 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.47 -0.786 . . . . 2.2599999999999998 112.817 -177.364 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1601 ' ' LYS . . . . . 0.458 ' HG2' HD22 ' A' 1604 ' ' LEU . 13.7 tppt? -135.31 87.91 2.37 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 107.318 -1.364 . . . . 3.0099999999999998 107.318 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 14.9 m -44.66 114.47 0.71 Allowed 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 125.896 1.678 . . . . 2.0699999999999998 114.456 -174.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 100.64 10.53 43.57 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 114.415 0.526 . . . . 1.0800000000000001 114.415 175.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1604 ' ' LEU . . . . . 0.458 HD22 ' HG2' ' A' 1601 ' ' LYS . 9.2 mp -110.57 156.25 21.19 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 117.28 0.54 . . . . 1.8400000000000001 111.197 178.535 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 16.5 m -121.34 147.8 45.2 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.514 -1.291 . . . . 1.4099999999999999 107.514 173.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1606 ' ' TYR . . . . . 0.569 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 85.8 m-85 -71.91 149.99 44.61 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 110.377 -0.231 . . . . 0.59999999999999998 110.377 177.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1607 ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' A' 1592 ' ' TYR . 6.1 ttpm? -146.94 135.86 22.32 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 123.856 0.723 . . . . 1.45 109.455 178.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1608 ' ' SER . . . . . . . . . . . . . 19.2 m -114.36 125.58 54.03 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 108.645 -0.872 . . . . 1.1499999999999999 108.645 -178.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 39.1 t -105.59 108.26 24.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 108.808 -0.812 . . . . 0.25 108.808 178.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1610 ' ' ILE . . . . . 0.676 ' HB ' ' HB3' ' A' 1590 ' ' LEU . 79.1 mt -95.08 118.87 42.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 108.583 -0.895 . . . . 0.45000000000000001 108.583 -178.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 26.6 t -117.24 110.52 18.22 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 108.972 -0.751 . . . . 1.26 108.972 -178.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1612 ' ' PHE . . . . . 0.915 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 70.8 m-85 -86.7 122.95 31.32 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.654 -0.869 . . . . 0.26000000000000001 108.654 177.521 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 44.8 t -116.53 135.37 57.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.457 0 CA-C-N 115.433 -0.803 . . . . 0.5 110.144 -174.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1614 ' ' CYS . . . . . 0.422 ' HB2' ' HA ' ' A' 1646 ' ' CYS . 4.9 t -54.53 111.11 0.73 Allowed 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 124.573 1.149 . . . . 0.77000000000000002 113.095 177.126 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1615 ' ' ARG . . . . . 0.687 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 18.6 tpt180 -137.29 91.04 14.78 Favored Pre-proline 0 N--CA 1.441 -0.911 0 N-CA-C 108.815 -0.809 . . . . 2.5299999999999998 108.815 169.145 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1616 ' ' PRO . . . . . 0.445 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 18.8 Cg_exo -66.68 -23.49 48.95 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.251 1.967 . . . . 1.1000000000000001 112.996 -175.484 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -71.5 -22.83 61.74 Favored 'General case' 0 N--CA 1.432 -1.35 0 C-N-CA 122.923 0.489 . . . . 3.0499999999999998 111.822 178.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . 63.61 -156.52 0.32 Allowed 'General case' 0 C--N 1.359 1.006 0 N-CA-C 108.155 -1.054 . . . . 1.55 108.155 -174.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . 116.43 -157.3 15.12 Favored Glycine 0 N--CA 1.414 -2.773 0 C-N-CA 120.202 -0.999 . . . . 0.93000000000000005 112.484 176.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -78.45 13.94 1.73 Allowed 'Trans proline' 0 C--N 1.325 -0.67 0 C-N-CA 123.683 2.922 . . . . 0.88 113.053 -175.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1621 ' ' THR . . . . . 0.708 ' HB ' ' HB2' ' A' 1641 ' ' HIS . 16.5 p -105.39 -7.84 18.54 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 115.002 -0.999 . . . . 0.96999999999999997 109.598 178.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 56.6 t30 -87.79 65.68 8.49 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.444 -0.947 . . . . 0.71999999999999997 108.444 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -166.72 141.53 3.47 Favored Pre-proline 0 C--N 1.307 -1.255 0 N-CA-C 107.743 -1.206 . . . . 3.2599999999999998 107.743 -175.169 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1624 ' ' PRO . . . . . 0.708 ' HG2' ' HB2' ' A' 1540 ' ' ALA . 21.3 Cg_endo -60.87 104.58 0.28 Allowed 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.532 2.154 . . . . 0.58999999999999997 111.408 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 85.3 mtp -101.98 135.46 43.5 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.824 -0.806 . . . . 1.3700000000000001 108.824 -178.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1626 ' ' LEU . . . . . 0.867 ' HG ' ' HE2' ' A' 1542 ' ' TYR . 0.3 OUTLIER -87.63 118.68 27.28 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 107.9 -1.148 . . . . 0.89000000000000001 107.9 -176.357 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A 1627 ' ' ILE . . . . . 0.787 HD11 ' HB2' ' A' 1639 ' ' SER . 39.9 mm -79.41 -50.28 18.41 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.879 0 N-CA-C 108.925 -0.768 . . . . 0.57999999999999996 108.925 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 17.1 t -172.41 161.18 5.09 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 108.827 -0.805 . . . . 1.3899999999999999 108.827 -176.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1629 ' ' LEU . . . . . 0.763 HD13 HD23 ' A' 1636 ' ' LEU . 13.6 tp -117.51 106.49 13.22 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.0 -1.111 . . . . 1.25 108.0 176.424 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 18.0 t70 -72.2 107.42 4.84 Favored 'General case' 0 CA--C 1.487 -1.478 0 N-CA-C 105.849 -1.908 . . . . 1.0900000000000001 105.849 174.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1631 ' ' LYS . . . . . 0.513 ' HB3' HD21 ' B' ' 53' ' ' LEU . 54.4 mtmt -72.5 -35.42 68.15 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 115.173 -0.921 . . . . 3.6000000000000001 111.138 -171.154 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 62.0 tp60 -70.77 -38.99 73.48 Favored 'General case' 0 N--CA 1.417 -2.091 0 C-N-CA 120.412 -0.515 . . . . 2.6000000000000001 112.089 -173.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 47.4 p -97.38 -0.87 45.6 Favored 'General case' 0 CA--C 1.566 1.562 0 N-CA-C 112.593 0.59 . . . . 0.75 112.593 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 84.5 m 59.61 52.77 5.41 Favored 'General case' 0 C--N 1.374 1.64 0 C-N-CA 124.709 1.204 . . . . 0.53000000000000003 111.153 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1635 ' ' THR . . . . . . . . . . . . . 92.5 m -125.21 133.5 52.72 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.727 -0.67 . . . . 0.46000000000000002 111.994 -175.36 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1636 ' ' LEU . . . . . 0.763 HD23 HD13 ' A' 1629 ' ' LEU . 9.7 mt -104.7 136.03 44.99 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.37 -0.974 . . . . 0.85999999999999999 108.37 -179.278 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1637 ' ' PHE . . . . . 0.418 ' HB2' ' HB ' ' A' 1627 ' ' ILE . 58.6 m-85 -108.59 129.72 55.31 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 109.113 -0.699 . . . . 0.45000000000000001 109.113 177.241 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -120.11 142.56 48.8 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 116.225 -0.443 . . . . 0.5 110.935 -178.026 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1639 ' ' SER . . . . . 0.787 ' HB2' HD11 ' A' 1627 ' ' ILE . 31.8 t -117.44 153.45 33.07 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 107.068 -1.456 . . . . 1.04 107.068 173.212 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1640 ' ' TRP . . . . . 0.522 ' HZ3' ' SD ' ' A' 1550 ' ' MET . 2.1 t90 -154.1 105.79 2.75 Favored 'General case' 0 N--CA 1.42 -1.973 0 N-CA-C 105.163 -2.162 . . . . 0.68000000000000005 105.163 179.228 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1641 ' ' HIS . . . . . 0.708 ' HB2' ' HB ' ' A' 1621 ' ' THR . 38.1 m-70 -95.19 105.03 16.93 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 108.868 -0.79 . . . . 0.90000000000000002 108.868 -175.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1642 ' ' THR . . . . . . . . . . . . . 14.3 t -141.97 152.41 61.88 Favored Pre-proline 0 CA--C 1.559 1.298 0 N-CA-C 108.846 -0.798 . . . . 0.47999999999999998 108.846 -171.325 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1643 ' ' PRO . . . . . 0.445 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 73.7 Cg_endo -75.1 -24.31 12.79 Favored 'Trans proline' 0 C--N 1.367 1.522 0 C-N-CA 122.715 2.277 . . . . 0.66000000000000003 114.139 -178.698 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 3.3 pp -75.73 -4.93 43.16 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 119.935 -0.706 . . . . 0.96999999999999997 111.672 -177.182 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -116.15 23.87 11.85 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-O 122.318 1.056 . . . . 0.83999999999999997 109.005 -178.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1646 ' ' CYS . . . . . 0.422 ' HA ' ' HB2' ' A' 1614 ' ' CYS . 52.9 t -115.67 140.46 49.17 Favored 'General case' 0 N--CA 1.401 -2.884 0 CA-C-N 115.0 -1.0 . . . . 1.1899999999999999 110.511 -177.052 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 27.3 tt0 . . . . . 0 N--CA 1.427 -1.601 0 N-CA-C 106.309 -1.737 . . . . 3.1400000000000001 106.309 172.653 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.427 -1.925 0 CA-C-O 120.792 0.107 . . . . 2.0899999999999999 113.173 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -56.04 -42.77 87.83 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 115.236 0.854 . . . . 1.8400000000000001 115.236 -173.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -63.2 -49.12 75.5 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.434 0.635 . . . . 2.5499999999999998 110.39 -176.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 13.6 tp -66.99 -49.45 65.33 Favored 'General case' 0 C--O 1.252 1.203 0 CA-C-N 115.015 -0.993 . . . . 2.3500000000000001 111.196 -175.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 14.3 p -64.68 -37.66 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 C-N-CA 120.399 -0.52 . . . . 2.1099999999999999 110.944 -178.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -77.17 -17.56 58.47 Favored 'General case' 0 C--O 1.196 -1.734 0 C-N-CA 118.08 -1.448 . . . . 2.04 111.358 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 92.0 m -62.5 -41.31 98.74 Favored 'General case' 0 C--O 1.272 2.267 0 O-C-N 121.302 -0.874 . . . . 1.8400000000000001 108.983 173.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.891 HD21 HD11 ' B' ' 42' ' ' ILE . 10.7 mp -63.4 -42.67 98.78 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 115.568 -0.742 . . . . 1.74 110.99 176.13 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -75.55 -11.85 60.1 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.02 -0.991 . . . . 2.3900000000000001 111.267 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -67.95 -55.24 13.47 Favored 'General case' 0 C--N 1.314 -0.967 0 O-C-N 121.892 -0.505 . . . . 0.95999999999999996 109.686 176.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 12.6 p -98.52 -17.5 6.68 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 C-N-CA 118.112 -1.435 . . . . 1.3700000000000001 112.487 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 83.8 m -116.81 30.62 7.22 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.457 -0.777 . . . . 1.6599999999999999 111.586 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -55.0 -57.11 19.78 Favored Glycine 0 C--N 1.342 0.894 0 N-CA-C 114.082 0.393 . . . . 1.53 114.082 -179.295 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.583 ' HA ' ' HD2' ' A' 1544 ' ' LYS . 17.6 t70 -65.93 -32.85 74.59 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-O 121.063 0.459 . . . . 2.7200000000000002 111.182 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 21.3 tpp180 -69.53 -47.99 61.93 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.79 -0.641 . . . . 4.3300000000000001 111.186 -178.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 111.43 170.49 18.95 Favored Glycine 0 N--CA 1.427 -1.961 0 N-CA-C 108.797 -1.721 . . . . 1.53 108.797 -175.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -135.6 140.63 44.75 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 117.399 0.6 . . . . 1.6499999999999999 111.598 178.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -136.51 141.99 43.46 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.77 -0.455 . . . . 3.4199999999999999 109.77 178.204 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 28' ' ' PHE . . . . . 0.457 ' CD2' ' HB ' ' B' ' 43' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.243 0.712 0 N-CA-C 112.321 0.489 . . . . 2.2599999999999998 112.321 178.238 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.401 -3.694 0 N-CA-C 110.142 -1.183 . . . . 2.3700000000000001 110.142 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 42' ' ' ILE . . . . . 0.891 HD11 HD21 ' B' ' 17' ' ' LEU . 28.3 pt -84.96 -22.53 7.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 113.152 0.797 . . . . 2.0699999999999998 113.152 -170.524 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.457 ' HB ' ' CD2' ' B' ' 28' ' ' PHE . 2.9 p -58.69 -42.64 85.68 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.418 0 N-CA-C 112.399 0.518 . . . . 2.2400000000000002 112.399 -177.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -83.14 -27.23 30.26 Favored 'General case' 0 N--CA 1.425 -1.681 0 N-CA-C 109.193 -0.669 . . . . 3.3599999999999999 109.193 -174.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 45' ' ' GLU . . . . . 0.4 ' O ' ' HB2' ' B' ' 49' ' ' ARG . 46.9 mm-40 -70.01 -29.62 66.73 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 115.293 -0.867 . . . . 3.0800000000000001 111.932 177.586 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 46' ' ' CYS . . . . . . . . . . . . . 36.3 t -98.07 -16.27 19.66 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 121.252 0.548 . . . . 2.23 111.058 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 42.8 t -77.3 -36.32 54.22 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.111 0.481 . . . . 2.3700000000000001 110.654 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -109.81 -9.92 14.79 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 113.218 0.821 . . . . 2.8199999999999998 113.218 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 49' ' ' ARG . . . . . 0.4 ' HB2' ' O ' ' B' ' 45' ' ' GLU . 28.0 mmt180 -135.64 151.09 49.88 Favored 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 106.037 -1.838 . . . . 4.0899999999999999 106.037 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 14.7 m -76.04 117.73 18.06 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 108.981 -0.748 . . . . 2.6699999999999999 108.981 -178.171 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 28.1 p -92.71 135.33 34.2 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 108.67 -0.863 . . . . 2.1099999999999999 108.67 -176.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -87.54 139.66 30.31 Favored 'General case' 0 N--CA 1.416 -2.155 0 N-CA-C 109.03 -0.73 . . . . 2.6699999999999999 109.03 177.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 53' ' ' LEU . . . . . 0.513 HD21 ' HB3' ' A' 1631 ' ' LYS . 61.0 tp -36.07 -39.86 0.19 Allowed 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 127.469 2.308 . . . . 1.8999999999999999 113.952 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.42 -40.82 83.51 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 123.868 0.73 . . . . 1.52 111.796 -176.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 50.8 tp -58.56 -47.53 83.91 Favored 'General case' 0 C--O 1.22 -0.47 0 O-C-N 123.802 0.689 . . . . 1.97 111.03 -177.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 3.9 pp -80.45 -35.29 35.17 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 116.145 -0.479 . . . . 1.53 111.513 -174.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -67.33 -44.25 79.57 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 116.031 -0.532 . . . . 2.27 111.456 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 6.3 t -76.1 -31.29 58.62 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 119.598 -0.841 . . . . 2.3300000000000001 111.251 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -69.12 -60.42 2.37 Favored 'General case' 0 C--O 1.244 0.775 0 N-CA-C 107.772 -1.196 . . . . 2.8599999999999999 107.772 178.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 37.0 t . . . . . 0 CA--C 1.537 0.465 0 C-N-CA 125.303 1.441 . . . . 2.2999999999999998 112.473 175.967 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A 1515 ' ' ASP . . . . . 0.543 ' O ' ' HB3' ' A' 1579 ' ' LYS . 14.3 t70 . . . . . 0 N--CA 1.437 -1.081 0 N-CA-C 106.649 -1.612 . . . . 2.8999999999999999 106.649 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1516 ' ' CYS . . . . . 0.486 ' SG ' HD23 ' A' 1581 ' ' LEU . 46.9 t -148.92 79.18 1.41 Allowed 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.787 -1.19 . . . . 1.1899999999999999 107.787 176.159 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -168.07 151.04 5.68 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 105.938 -1.875 . . . . 1.52 105.938 -173.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1518 ' ' VAL . . . . . 0.454 ' CG2' HD12 ' A' 1581 ' ' LEU . 2.9 m -144.89 142.58 22.95 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-O 120.885 0.374 . . . . 0.93999999999999995 111.442 -176.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1519 ' ' THR . . . . . . . . . . . . . 33.8 m -95.79 139.29 32.23 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 109.497 -0.557 . . . . 0.89000000000000001 109.497 177.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -76.95 116.13 54.51 Favored Pre-proline 0 C--O 1.244 0.787 0 N-CA-C 108.501 -0.926 . . . . 1.74 108.501 176.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -60.81 -24.85 80.01 Favored 'Trans proline' 0 C--O 1.243 0.728 0 C-N-CA 123.43 2.753 . . . . 1.5800000000000001 113.807 -177.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 33.7 m -74.33 -31.17 62.34 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 113.348 0.87 . . . . 1.6499999999999999 113.348 -175.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1523 ' ' THR . . . . . . . . . . . . . 8.9 t -137.65 -10.74 1.6 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 118.617 -1.233 . . . . 1.6100000000000001 113.455 -176.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 82.45 31.07 31.54 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 119.897 -1.144 . . . . 1.1299999999999999 112.173 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 25.1 t-80 -97.74 131.2 44.49 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.641 -0.874 . . . . 1.26 108.641 178.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 2.8 tm? -89.67 121.71 32.1 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.718 -0.674 . . . . 0.68000000000000005 111.515 -175.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -91.81 127.84 37.41 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 108.544 -0.91 . . . . 0.65000000000000002 108.544 168.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 15.2 t70 -120.64 113.89 20.9 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 109.055 -0.72 . . . . 1.1699999999999999 109.055 177.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1529 ' ' LEU . . . . . 0.451 ' HG ' HD21 ' A' 1581 ' ' LEU . 3.7 mm? -97.13 -0.25 47.32 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 121.578 0.704 . . . . 0.59999999999999998 109.931 -178.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 1.5 m -65.87 -25.74 67.32 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.841 -1.072 . . . . 0.83999999999999997 109.945 -178.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 40.5 t -61.09 -24.06 65.95 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 123.224 0.61 . . . . 1.5900000000000001 110.816 178.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1532 ' ' LEU . . . . . 0.559 ' HB2' HG21 ' A' 1552 ' ' ILE . 73.0 mt -97.49 8.61 44.29 Favored 'General case' 0 C--N 1.32 -0.674 0 O-C-N 122.106 -0.371 . . . . 0.65000000000000002 111.729 -177.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1533 ' ' SER . . . . . . . . . . . . . 77.2 p -68.66 174.19 4.48 Favored 'General case' 0 C--O 1.251 1.174 0 CA-C-O 121.454 0.645 . . . . 1.52 111.818 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . 171.81 150.9 7.43 Favored Glycine 0 N--CA 1.419 -2.493 0 N-CA-C 109.956 -1.258 . . . . 1.1000000000000001 109.956 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1535 ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' 1535 ' ' ARG . 22.9 ttt180 -87.42 -30.0 21.04 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.08 0.467 . . . . 4.6200000000000001 110.802 -178.283 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -90.16 -35.82 15.17 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.579 0.704 . . . . 1.45 109.439 178.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 92.89 -150.99 20.24 Favored Glycine 0 N--CA 1.409 -3.123 0 CA-C-N 115.403 -0.817 . . . . 0.84999999999999998 112.329 173.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -128.82 153.33 47.54 Favored 'General case' 0 C--N 1.281 -2.396 0 N-CA-C 106.435 -1.691 . . . . 0.93000000000000005 106.435 -178.113 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 4.1 m -128.46 134.79 48.83 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 109.399 -0.593 . . . . 1.03 109.399 -175.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1540 ' ' ALA . . . . . 0.597 ' HB3' HG12 ' A' 1548 ' ' VAL . . . -129.93 143.61 50.89 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 115.758 -0.656 . . . . 0.5 109.488 -177.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -88.99 121.4 31.31 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.346 0.593 . . . . 0.73999999999999999 110.517 -177.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1542 ' ' TYR . . . . . 0.59 ' CE2' ' HG ' ' A' 1626 ' ' LEU . 0.9 OUTLIER -111.49 -101.86 0.4 Allowed 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.464 -1.31 . . . . 0.98999999999999999 107.464 -179.326 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A 1543 ' ' SER . . . . . 0.427 ' H ' ' HB3' ' A' 1542 ' ' TYR . 7.7 m -73.34 162.5 29.26 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 118.984 -0.532 . . . . 1.9099999999999999 109.941 178.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -50.17 -42.93 51.95 Favored 'General case' 0 C--O 1.25 1.091 0 N-CA-C 113.388 0.884 . . . . 3.5899999999999999 113.388 -178.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 23.3 t -100.67 15.1 29.33 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 110.516 -0.179 . . . . 2.46 110.516 -178.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . -132.7 131.29 6.12 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 118.81 -1.662 . . . . 1.26 116.726 -170.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 15.1 m -121.39 149.83 24.49 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 108.794 -0.817 . . . . 0.79000000000000004 108.794 171.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1548 ' ' VAL . . . . . 0.597 HG12 ' HB3' ' A' 1540 ' ' ALA . 7.8 p -104.87 137.74 32.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 109.319 -0.622 . . . . 0.57999999999999996 109.319 177.675 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -103.86 126.95 51.35 Favored 'General case' 0 N--CA 1.424 -1.755 0 CA-C-N 115.642 -0.708 . . . . 1.0800000000000001 109.15 175.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1550 ' ' MET . . . . . 0.407 ' HA ' ' O ' ' A' 1564 ' ' GLY . 5.5 ppp? -144.24 138.5 28.04 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 115.082 -0.963 . . . . 0.78000000000000003 110.27 -175.296 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 7.1 p -125.48 134.41 52.06 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 115.926 -0.579 . . . . 0.96999999999999997 109.855 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1552 ' ' ILE . . . . . 0.559 HG21 ' HB2' ' A' 1532 ' ' LEU . 49.5 mm -82.24 114.94 23.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-N 116.625 -0.261 . . . . 0.41999999999999998 111.36 -177.597 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 74.8 m 71.33 16.51 6.09 Favored 'General case' 0 CA--C 1.509 -0.6 0 C-N-CA 124.036 0.934 . . . . 1.3999999999999999 113.057 171.032 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . -163.17 -175.26 33.99 Favored Glycine 0 N--CA 1.403 -3.5 0 C-N-CA 120.127 -1.035 . . . . 0.34999999999999998 110.98 -176.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1555 ' ' GLU . . . . . 0.466 ' H ' ' CD ' ' A' 1555 ' ' GLU . 0.3 OUTLIER -91.36 148.57 22.23 Favored 'General case' 0 C--N 1.282 -2.351 0 C-N-CA 124.102 0.961 . . . . 1.6200000000000001 111.755 -176.205 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 46.2 t-20 -114.46 129.85 56.68 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.729 -1.212 . . . . 0.87 107.729 178.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -79.93 2.18 24.48 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.025 0.75 . . . . 2.4900000000000002 113.025 -173.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -74.24 -16.68 60.95 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 112.37 0.507 . . . . 1.3799999999999999 112.37 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1559 ' ' CYS . . . . . 0.719 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 88.9 m -137.75 173.49 5.34 Favored Pre-proline 0 C--N 1.306 -1.289 0 CA-C-O 117.811 -1.09 . . . . 1.21 111.003 179.088 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1560 ' ' PRO . . . . . 0.719 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 7.3 Cg_exo -31.83 131.59 0.08 OUTLIER 'Trans proline' 0 C--N 1.393 2.917 0 C-N-CA 124.801 3.668 . . . . 0.70999999999999996 114.735 177.079 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1561 ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' 1560 ' ' PRO . 83.6 Cg_exo -48.56 125.75 13.04 Favored 'Trans proline' 0 C--O 1.25 1.08 0 C-N-CA 124.553 3.502 . . . . 0.80000000000000004 114.452 -174.703 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 93.88 23.94 21.61 Favored Glycine 0 N--CA 1.432 -1.575 0 CA-C-N 115.284 -0.871 . . . . 0.46000000000000002 112.451 178.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1563 ' ' VAL . . . . . 0.531 HG11 ' HB2' ' A' 1559 ' ' CYS . 4.0 p -109.6 139.85 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 C-N-CA 119.773 -0.771 . . . . 0.97999999999999998 110.543 -177.4 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1564 ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' 1550 ' ' MET . . . -104.41 -27.29 6.18 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 121.156 -0.545 . . . . 0.28000000000000003 113.279 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -135.46 129.95 33.99 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 117.144 0.472 . . . . 0.28000000000000003 110.188 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 31.7 t -160.3 137.61 9.42 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 122.465 0.306 . . . . 0.42999999999999999 110.48 -178.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1567 ' ' PHE . . . . . 0.429 ' HA ' ' HA ' ' A' 1548 ' ' VAL . 76.2 m-85 -85.62 138.88 31.85 Favored 'General case' 0 C--O 1.247 0.963 0 N-CA-C 108.142 -1.058 . . . . 1.03 108.142 173.555 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -82.36 38.19 2.6 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.937 -0.649 . . . . 1.1299999999999999 112.92 -176.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1569 ' ' GLN . . . . . 0.498 ' HB3' ' OD1' ' B' ' 15' ' ' ASP . 16.4 mm100 -83.48 -72.3 0.46 Allowed 'General case' 0 N--CA 1.443 -0.804 0 CA-C-O 121.045 0.45 . . . . 2.5800000000000001 110.341 176.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 5.5 t -132.44 34.24 3.74 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-O 122.194 0.997 . . . . 2.1699999999999999 109.217 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 61.32 55.86 2.8 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 124.902 1.281 . . . . 2.6200000000000001 110.029 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 19.6 mt -97.17 114.37 34.01 Favored 'Isoleucine or valine' 0 C--O 1.244 0.805 0 N-CA-C 109.211 -0.662 . . . . 0.92000000000000004 109.211 -177.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1573 ' ' SER . . . . . 0.748 ' HB3' ' HB2' ' A' 1596 ' ' SER . 19.5 t -74.39 130.73 40.2 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.552 0.692 . . . . 0.80000000000000004 110.918 -178.651 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1574 ' ' VAL . . . . . 0.6 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 34.8 m -123.41 10.93 5.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 CA-C-O 121.33 0.586 . . . . 0.97999999999999998 110.607 177.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 177.4 118.95 0.57 Allowed Glycine 0 N--CA 1.428 -1.852 0 C-N-CA 120.589 -0.815 . . . . 0.28999999999999998 111.652 177.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1576 ' ' LYS . . . . . 0.453 ' HE3' ' HB2' ' A' 1576 ' ' LYS . 37.8 ttmt -74.62 148.32 40.81 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.978 -1.119 . . . . 2.1899999999999999 107.978 178.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -75.74 83.98 2.72 Favored 'General case' 0 CA--C 1.499 -0.998 0 CA-C-O 121.456 0.646 . . . . 0.60999999999999999 111.756 -175.234 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -99.06 166.04 11.45 Favored 'General case' 0 C--N 1.281 -2.39 0 N-CA-C 108.213 -1.032 . . . . 1.95 108.213 178.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1579 ' ' LYS . . . . . 0.543 ' HB3' ' O ' ' A' 1515 ' ' ASP . 67.3 mttm -120.32 42.09 3.06 Favored 'General case' 0 C--N 1.286 -2.158 0 CA-C-O 122.601 1.191 . . . . 2.6800000000000002 107.869 -176.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 43.5 ttt180 -93.65 75.84 4.34 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 114.188 -1.369 . . . . 3.4700000000000002 108.41 -173.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1581 ' ' LEU . . . . . 0.486 HD23 ' SG ' ' A' 1516 ' ' CYS . 0.6 OUTLIER -84.3 125.07 31.92 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 113.549 -1.66 . . . . 0.64000000000000001 108.196 -178.566 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 60.8 mtm180 -125.73 138.51 53.87 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 116.457 -0.338 . . . . 2.8500000000000001 111.289 178.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1583 ' ' TYR . . . . . . . . . . . . . 48.5 t80 -112.86 110.41 20.49 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 122.31 0.244 . . . . 0.85999999999999999 110.48 -178.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1584 ' ' VAL . . . . . 0.566 ' O ' ' HB ' ' A' 1587 ' ' VAL . 15.4 m -129.69 93.23 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.265 0.555 . . . . 1.05 112.431 -178.052 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 26.9 t70 59.75 65.94 1.06 Allowed 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 123.805 0.842 . . . . 1.1699999999999999 111.137 174.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1586 ' ' GLN . . . . . . . . . . . . 0.254 8.7 pt20 66.1 5.43 3.56 Favored 'General case' 0 N--CA 1.503 2.197 0 C-N-CA 127.163 2.185 . . . . 1.8600000000000001 112.11 178.482 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1587 ' ' VAL . . . . . 0.566 ' HB ' ' O ' ' A' 1584 ' ' VAL . 36.0 t -104.0 120.14 53.75 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.749 0 CA-C-N 114.789 -1.096 . . . . 0.48999999999999999 109.378 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1588 ' ' LEU . . . . . 0.811 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 2.6 mm? -96.16 107.58 19.93 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 106.135 -1.802 . . . . 0.35999999999999999 106.135 176.063 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1589 ' ' GLN . . . . . 0.508 ' HA ' ' O ' ' A' 1610 ' ' ILE . 34.3 tt0 -107.96 116.45 31.99 Favored 'General case' 0 N--CA 1.409 -2.49 0 CA-C-O 121.955 0.883 . . . . 1.74 110.368 -176.562 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1590 ' ' LEU . . . . . 0.514 ' HB3' ' HB ' ' A' 1610 ' ' ILE . 1.1 tt -107.64 107.42 18.22 Favored 'General case' 0 C--N 1.28 -2.418 0 N-CA-C 105.009 -2.219 . . . . 0.71999999999999997 105.009 -178.228 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 4.2 p -101.72 129.63 52.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 C-N-CA 119.572 -0.851 . . . . 1.01 111.403 -174.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1592 ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -119.4 105.74 11.58 Favored 'General case' 0 CA--C 1.496 -1.118 0 N-CA-C 108.502 -0.925 . . . . 0.5 108.502 177.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1593 ' ' LYS . . . . . 0.635 ' HB3' ' HD3' ' A' 1607 ' ' LYS . 18.4 pttp -126.43 174.76 8.38 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 109.428 -0.582 . . . . 1.5900000000000001 109.428 -179.095 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 9.8 m-20 58.98 36.79 24.59 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 124.677 1.235 . . . . 1.1100000000000001 110.996 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -73.52 -88.08 0.19 Allowed Glycine 0 N--CA 1.44 -1.082 0 N-CA-C 110.412 -1.075 . . . . 0.78000000000000003 110.412 178.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1596 ' ' SER . . . . . 0.748 ' HB2' ' HB3' ' A' 1573 ' ' SER . 47.0 t -132.25 144.73 54.31 Favored Pre-proline 0 N--CA 1.416 -2.139 0 N-CA-C 107.788 -1.19 . . . . 1.0700000000000001 107.788 175.613 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1597 ' ' PRO . . . . . 0.561 ' HA ' ' HA ' ' A' 1605 ' ' SER . 18.0 Cg_endo -58.89 130.78 38.33 Favored 'Trans proline' 0 C--O 1.24 0.578 0 C-N-CA 123.829 3.019 . . . . 1.01 112.462 179.345 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1598 ' ' CYS . . . . . 0.433 ' SG ' ' HB2' ' A' 1600 ' ' SER . 47.4 t -72.65 120.53 81.18 Favored Pre-proline 0 C--N 1.289 -2.041 0 CA-C-N 114.516 -1.22 . . . . 0.75 109.309 -174.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -65.13 -32.32 52.86 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.684 2.256 . . . . 1.7 110.635 178.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1600 ' ' SER . . . . . 0.769 ' HB3' HD13 ' B' ' 53' ' ' LEU . 7.1 m -64.47 -45.97 85.07 Favored 'General case' 0 N--CA 1.419 -1.983 0 CA-C-N 115.297 -0.865 . . . . 2.2599999999999998 110.713 176.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1601 ' ' LYS . . . . . 0.583 ' HG2' HD21 ' A' 1604 ' ' LEU . 0.0 OUTLIER -121.9 93.54 4.03 Favored 'General case' 0 N--CA 1.429 -1.513 0 O-C-N 121.374 -0.828 . . . . 3.0099999999999998 108.919 -178.942 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 7.0 m -55.8 125.04 19.6 Favored 'General case' 0 N--CA 1.426 -1.646 0 C-N-CA 124.316 1.046 . . . . 2.0699999999999998 111.28 -177.189 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 106.03 -8.5 42.25 Favored Glycine 0 C--N 1.313 -0.702 0 C-N-CA 121.126 -0.559 . . . . 1.0800000000000001 114.403 174.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1604 ' ' LEU . . . . . 0.583 HD21 ' HG2' ' A' 1601 ' ' LYS . 4.2 pp -128.35 155.7 44.27 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-N 118.218 1.009 . . . . 1.8400000000000001 110.237 176.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1605 ' ' SER . . . . . 0.561 ' HA ' ' HA ' ' A' 1597 ' ' PRO . 7.7 p -103.19 152.83 21.0 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 123.042 0.537 . . . . 1.4099999999999999 111.357 -176.114 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1606 ' ' TYR . . . . . 0.6 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 58.5 m-85 -63.34 161.3 14.28 Favored 'General case' 0 C--O 1.25 1.083 0 CA-C-N 116.4 -0.364 . . . . 0.59999999999999998 110.906 175.519 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1607 ' ' LYS . . . . . 0.635 ' HD3' ' HB3' ' A' 1593 ' ' LYS . 24.5 ttpp -155.89 125.4 6.31 Favored 'General case' 0 CA--C 1.5 -0.968 0 CA-C-N 116.291 -0.413 . . . . 1.45 110.333 -178.427 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1608 ' ' SER . . . . . . . . . . . . . 22.3 m -105.4 127.04 52.77 Favored 'General case' 0 C--N 1.286 -2.185 0 N-CA-C 108.444 -0.947 . . . . 1.1499999999999999 108.444 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 39.6 t -111.0 108.72 26.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 109.183 -0.673 . . . . 0.25 109.183 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1610 ' ' ILE . . . . . 0.514 ' HB ' ' HB3' ' A' 1590 ' ' LEU . 25.7 mm -89.67 123.41 41.86 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 106.776 -1.564 . . . . 0.45000000000000001 106.776 -178.528 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 21.5 p -122.09 105.42 10.26 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 120.517 -0.473 . . . . 1.26 111.031 177.196 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1612 ' ' PHE . . . . . 0.811 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 68.1 m-85 -86.16 119.69 26.72 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.71 -0.848 . . . . 0.26000000000000001 108.71 177.083 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 45.9 t -114.2 134.53 56.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 108.514 -0.921 . . . . 0.5 108.514 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 12.2 t -59.64 114.74 2.89 Favored 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 123.964 0.906 . . . . 0.77000000000000002 112.403 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1615 ' ' ARG . . . . . 0.725 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 0.0 OUTLIER -132.2 89.52 37.23 Favored Pre-proline 0 N--CA 1.446 -0.66 0 N-CA-C 106.967 -1.494 . . . . 2.5299999999999998 106.967 172.783 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A 1616 ' ' PRO . . . . . 0.626 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 34.4 Cg_exo -59.46 -32.84 97.04 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 123.077 2.518 . . . . 1.1000000000000001 114.629 -173.136 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -77.23 -5.49 49.49 Favored 'General case' 0 C--O 1.252 1.228 0 N-CA-C 111.931 0.345 . . . . 3.0499999999999998 111.931 -178.277 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . 58.49 -143.11 0.64 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.23 0.612 . . . . 1.55 109.98 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . 110.47 -157.64 14.89 Favored Glycine 0 N--CA 1.416 -2.681 0 CA-C-N 119.532 1.06 . . . . 0.93000000000000005 111.821 178.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -80.55 13.63 2.22 Favored 'Trans proline' 0 C--N 1.323 -0.799 0 C-N-CA 123.455 2.77 . . . . 0.88 113.249 -177.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1621 ' ' THR . . . . . 0.901 ' HB ' ' HB2' ' A' 1641 ' ' HIS . 36.2 p -96.16 -14.46 22.77 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 115.48 -0.782 . . . . 0.96999999999999997 110.049 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1622 ' ' ASN . . . . . 0.414 ' OD1' ' HB ' ' A' 1642 ' ' THR . 55.1 t30 -88.73 62.66 6.55 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 122.057 0.932 . . . . 0.71999999999999997 110.148 -175.324 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1623 ' ' ARG . . . . . 0.409 ' HE ' ' HB3' ' A' 1623 ' ' ARG . 6.7 ptp180 -168.53 139.73 2.15 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-N 114.155 -1.384 . . . . 3.2599999999999998 108.169 -178.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -63.35 119.1 6.03 Favored 'Trans proline' 0 C--O 1.25 1.111 0 C-N-CA 122.762 2.308 . . . . 0.58999999999999997 113.353 -174.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 76.8 mtm -116.68 138.44 51.45 Favored 'General case' 0 C--O 1.245 0.865 0 N-CA-C 108.79 -0.819 . . . . 1.3700000000000001 108.79 175.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1626 ' ' LEU . . . . . 0.59 ' HG ' ' CE2' ' A' 1542 ' ' TYR . 0.4 OUTLIER -88.16 118.71 27.93 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 107.661 -1.237 . . . . 0.89000000000000001 107.661 -176.455 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A 1627 ' ' ILE . . . . . 0.68 HD11 ' HB2' ' A' 1639 ' ' SER . 33.3 mm -78.3 -53.18 14.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.392 -0.596 . . . . 0.57999999999999996 109.392 -178.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 8.4 t -167.85 152.08 6.42 Favored 'General case' 0 N--CA 1.416 -2.136 0 N-CA-C 108.652 -0.87 . . . . 1.3899999999999999 108.652 -174.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1629 ' ' LEU . . . . . 0.859 HD23 ' HG ' ' A' 1636 ' ' LEU . 1.8 tm? -121.64 102.17 8.06 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 105.741 -1.948 . . . . 1.25 105.741 176.223 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 31.9 t70 -70.63 124.18 23.64 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 120.118 -0.633 . . . . 1.0900000000000001 109.784 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1631 ' ' LYS . . . . . 0.454 ' HB2' HD21 ' B' ' 53' ' ' LEU . 16.6 ptpt -79.38 -10.89 59.9 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 112.654 0.612 . . . . 3.6000000000000001 112.654 -171.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -100.62 -34.71 9.77 Favored 'General case' 0 N--CA 1.421 -1.878 0 C-N-CA 120.221 -0.592 . . . . 2.6000000000000001 111.515 -175.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 40.8 p -103.3 -6.86 21.58 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.05 0.452 . . . . 0.75 111.795 177.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 78.7 m 56.37 35.97 26.75 Favored 'General case' 0 C--N 1.361 1.085 0 C-N-CA 124.396 1.078 . . . . 0.53000000000000003 111.982 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1635 ' ' THR . . . . . . . . . . . . . 59.5 m -99.54 132.08 45.11 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-N 114.218 -1.355 . . . . 0.46000000000000002 109.996 178.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1636 ' ' LEU . . . . . 0.859 ' HG ' HD23 ' A' 1629 ' ' LEU . 0.8 OUTLIER -108.53 132.51 53.76 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.861 -1.533 . . . . 0.85999999999999999 106.861 -178.39 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A 1637 ' ' PHE . . . . . 0.413 ' HB2' ' HB ' ' A' 1627 ' ' ILE . 94.3 m-85 -107.04 135.56 48.38 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 110.153 -0.314 . . . . 0.45000000000000001 110.153 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -128.59 129.17 45.55 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.069 -0.514 . . . . 0.5 110.09 -175.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1639 ' ' SER . . . . . 0.68 ' HB2' HD11 ' A' 1627 ' ' ILE . 22.7 t -108.48 149.38 28.87 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.445 -0.946 . . . . 1.04 108.445 178.002 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 2.1 t90 -156.46 115.74 3.47 Favored 'General case' 0 N--CA 1.425 -1.714 0 N-CA-C 105.032 -2.21 . . . . 0.68000000000000005 105.032 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1641 ' ' HIS . . . . . 0.901 ' HB2' ' HB ' ' A' 1621 ' ' THR . 18.9 m-70 -112.86 107.91 16.68 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 120.528 -0.469 . . . . 0.90000000000000002 110.257 -177.507 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1642 ' ' THR . . . . . 0.414 ' HB ' ' OD1' ' A' 1622 ' ' ASN . 7.3 t -138.19 152.01 70.84 Favored Pre-proline 0 C--N 1.296 -1.727 0 CA-C-N 114.744 -1.116 . . . . 0.47999999999999998 109.63 -171.083 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1643 ' ' PRO . . . . . 0.626 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 74.1 Cg_endo -79.49 -7.98 14.87 Favored 'Trans proline' 0 C--N 1.372 1.767 0 C-N-CA 122.496 2.131 . . . . 0.66000000000000003 112.167 177.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 8.7 tt -68.11 -23.1 64.88 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-O 121.491 0.662 . . . . 0.96999999999999997 109.549 177.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -93.51 5.65 50.87 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.706 -0.679 . . . . 0.83999999999999997 110.948 -177.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1646 ' ' CYS . . . . . 0.472 ' SG ' ' HA ' ' A' 1643 ' ' PRO . 72.2 m -93.82 142.77 26.99 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 120.804 0.335 . . . . 1.1899999999999999 111.501 -177.557 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 . . . . . 0 C--N 1.297 -1.687 0 C-N-CA 123.691 0.796 . . . . 3.1400000000000001 108.887 178.339 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.426 -2.003 0 N-CA-C 111.278 -0.729 . . . . 2.0899999999999999 111.278 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -101.03 -64.18 0.78 Allowed Glycine 0 C--N 1.306 -1.134 0 N-CA-C 115.03 0.772 . . . . 1.8400000000000001 115.03 -177.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -71.07 -45.08 64.42 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.894 0.702 . . . . 2.5499999999999998 112.894 -170.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 12.5 tp -45.52 -57.88 3.8 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 123.729 0.643 . . . . 2.3500000000000001 112.562 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 13.2 p -70.89 -31.35 45.2 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 CA-C-N 115.726 -0.67 . . . . 2.1099999999999999 111.386 -177.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 15' ' ' ASP . . . . . 0.498 ' OD1' ' HB3' ' A' 1569 ' ' GLN . 3.3 t0 -72.95 -40.53 65.3 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 119.271 -0.972 . . . . 2.04 111.766 -176.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 12.4 t -65.0 -32.09 73.65 Favored 'General case' 0 C--O 1.254 1.293 0 O-C-N 121.302 -0.874 . . . . 1.8400000000000001 109.773 176.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.53 ' O ' ' HB2' ' B' ' 21' ' ' CYS . 9.5 mt -67.05 -23.03 65.84 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-N 115.663 -0.699 . . . . 1.74 112.58 172.66 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -91.47 -17.7 25.32 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 121.643 0.735 . . . . 2.3900000000000001 109.552 176.121 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -68.64 -60.23 2.56 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.819 -0.628 . . . . 0.95999999999999996 111.699 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 12.5 p -94.43 -20.28 6.21 Favored 'Isoleucine or valine' 0 C--O 1.242 0.671 0 C-N-CA 118.128 -1.429 . . . . 1.3700000000000001 111.841 -178.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 21' ' ' CYS . . . . . 0.53 ' HB2' ' O ' ' B' ' 17' ' ' LEU . 7.7 m -107.07 18.3 21.92 Favored 'General case' 0 C--O 1.201 -1.453 0 C-N-CA 120.022 -0.671 . . . . 1.6599999999999999 109.822 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.53 -44.65 97.5 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 115.702 1.041 . . . . 1.53 115.702 -178.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -76.46 -48.5 19.41 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 117.483 0.642 . . . . 2.7200000000000002 111.62 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 35.9 ttp180 -73.84 -25.35 60.03 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.316 0.579 . . . . 4.3300000000000001 111.746 -175.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.16 144.15 10.09 Favored Glycine 0 N--CA 1.425 -2.062 0 N-CA-C 110.9 -0.88 . . . . 1.53 110.9 177.059 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -88.1 124.09 33.44 Favored 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 120.035 -0.666 . . . . 1.6499999999999999 109.354 175.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -128.55 76.61 1.72 Allowed 'General case' 0 CA--C 1.497 -1.081 0 CA-C-O 121.618 0.723 . . . . 3.4199999999999999 110.418 -173.157 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 28' ' ' PHE . . . . . 0.512 ' HB2' HG12 ' B' ' 42' ' ' ILE . 12.9 p90 . . . . . 0 C--N 1.289 -2.03 0 CA-C-N 115.455 -0.793 . . . . 2.2599999999999998 110.808 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.387 -4.6 0 N-CA-C 107.653 -2.179 . . . . 2.3700000000000001 107.653 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 42' ' ' ILE . . . . . 0.512 HG12 ' HB2' ' B' ' 28' ' ' PHE . 33.4 pt -69.93 -4.61 4.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 111.943 0.349 . . . . 2.0699999999999998 111.943 -175.099 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 2.5 p -52.81 -40.63 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 CA-C-N 115.661 -0.699 . . . . 2.2400000000000002 110.08 169.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -92.51 -19.28 22.14 Favored 'General case' 0 N--CA 1.419 -2.003 0 O-C-N 121.294 -0.879 . . . . 3.3599999999999999 108.941 -175.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 45' ' ' GLU . . . . . 0.437 ' CB ' ' HA ' ' B' ' 42' ' ' ILE . 6.4 tp10 -81.28 -2.47 49.06 Favored 'General case' 0 CA--C 1.555 1.161 0 CA-C-N 114.46 -1.245 . . . . 3.0800000000000001 109.517 -178.185 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 46' ' ' CYS . . . . . . . . . . . . . 88.8 m -133.84 -20.3 1.99 Allowed 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.249 0.833 . . . . 2.23 113.249 178.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 98.4 m -80.94 -9.84 59.79 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 119.576 -0.85 . . . . 2.3700000000000001 113.178 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -133.7 20.5 3.88 Favored 'General case' 0 C--N 1.319 -0.727 0 O-C-N 121.498 -0.751 . . . . 2.8199999999999998 111.773 178.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -169.68 174.7 5.66 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 106.772 -1.566 . . . . 4.0899999999999999 106.772 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 22.8 t -101.0 143.69 30.84 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-O 121.444 0.64 . . . . 2.6699999999999999 110.763 -174.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 26.4 p -145.0 151.09 38.03 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-N 115.44 -0.8 . . . . 2.1099999999999999 108.908 178.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 52' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' 1600 ' ' SER . 4.4 p-10 -127.55 -173.99 3.06 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.6 -0.727 . . . . 2.6699999999999999 109.232 174.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 53' ' ' LEU . . . . . 0.769 HD13 ' HB3' ' A' 1600 ' ' SER . 46.3 tp -35.58 -39.88 0.15 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 128.088 2.555 . . . . 1.8999999999999999 115.503 -174.256 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -49.32 -59.39 3.74 Favored 'General case' 0 CA--C 1.502 -0.888 0 C-N-CA 123.865 0.866 . . . . 1.52 112.129 -172.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 67.6 tp -59.78 -41.78 91.86 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 125.132 1.373 . . . . 1.97 112.803 -176.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 2.6 pp -83.54 -22.48 32.38 Favored 'General case' 0 N--CA 1.422 -1.827 0 C-N-CA 118.654 -1.219 . . . . 1.53 112.257 -173.399 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -86.48 -33.7 20.27 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 119.397 -0.921 . . . . 2.27 111.186 173.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 18.0 p -60.56 -44.01 96.65 Favored 'General case' 0 C--N 1.357 0.916 0 CA-C-N 118.02 0.373 . . . . 2.3300000000000001 110.08 176.143 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -82.16 -81.55 0.15 Allowed 'General case' 0 N--CA 1.428 -1.528 0 C-N-CA 119.507 -0.877 . . . . 2.8599999999999999 109.505 173.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 41.3 t . . . . . 0 N--CA 1.474 0.732 0 C-N-CA 123.69 0.796 . . . . 2.2999999999999998 111.652 -178.333 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 12.7 t70 . . . . . 0 CA--C 1.515 -0.376 0 N-CA-C 106.857 -1.535 . . . . 2.8999999999999999 106.857 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 12.9 m -139.84 81.77 1.84 Allowed 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.546 -0.752 . . . . 1.1899999999999999 110.204 173.206 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1517 ' ' GLN . . . . . 0.405 ' HA ' ' O ' ' A' 1527 ' ' PHE . 4.1 pt20 -162.65 130.34 3.8 Favored 'General case' 0 N--CA 1.417 -2.106 0 N-CA-C 108.19 -1.041 . . . . 1.52 108.19 -179.044 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1518 ' ' VAL . . . . . 0.526 ' CG2' HD12 ' A' 1581 ' ' LEU . 4.3 m -129.72 136.97 57.9 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.125 0 CA-C-O 121.276 0.56 . . . . 0.93999999999999995 110.789 -176.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1519 ' ' THR . . . . . 0.429 ' OG1' HD23 ' A' 1526 ' ' LEU . 23.8 m -112.33 132.42 54.99 Favored 'General case' 0 C--N 1.286 -2.164 0 CA-C-N 115.584 -0.734 . . . . 0.89000000000000001 109.398 -178.591 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1520 ' ' ASN . . . . . 0.418 ' OD1' HG22 ' A' 1523 ' ' THR . 27.0 t-20 -86.8 110.19 30.45 Favored Pre-proline 0 N--CA 1.423 -1.804 0 N-CA-C 107.845 -1.168 . . . . 1.74 107.845 174.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -68.54 -16.29 42.58 Favored 'Trans proline' 0 N--CA 1.466 -0.136 0 C-N-CA 122.852 2.368 . . . . 1.5800000000000001 112.775 -174.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1522 ' ' SER . . . . . 0.409 ' HB2' ' OD1' ' A' 1520 ' ' ASN . 15.2 m -71.76 -31.63 66.85 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 116.042 -0.526 . . . . 1.6499999999999999 111.458 -178.479 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1523 ' ' THR . . . . . 0.418 HG22 ' OD1' ' A' 1520 ' ' ASN . 7.5 t -132.99 -4.06 3.14 Favored 'General case' 0 CA--C 1.56 1.345 0 C-N-CA 119.377 -0.929 . . . . 1.6100000000000001 112.675 179.308 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 77.39 20.79 74.22 Favored Glycine 0 CA--C 1.497 -1.037 0 O-C-N 121.898 -0.501 . . . . 1.1299999999999999 113.089 177.118 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -87.75 118.2 27.1 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 109.006 -0.739 . . . . 1.26 109.006 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1526 ' ' LEU . . . . . 0.429 HD23 ' OG1' ' A' 1519 ' ' THR . 1.0 OUTLIER -100.12 114.81 28.44 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-N 114.22 -1.355 . . . . 0.68000000000000005 110.458 -175.153 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A 1527 ' ' PHE . . . . . 0.405 ' O ' ' HA ' ' A' 1517 ' ' GLN . 96.3 m-85 -93.75 113.61 25.71 Favored 'General case' 0 CA--C 1.508 -0.665 0 N-CA-C 109.375 -0.602 . . . . 0.65000000000000002 109.375 176.491 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 19.9 t70 -104.4 119.17 38.37 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 120.073 -0.651 . . . . 1.1699999999999999 110.487 175.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1529 ' ' LEU . . . . . 0.761 ' HG ' HD21 ' A' 1581 ' ' LEU . 3.0 mm? -104.23 1.96 31.11 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.751 -0.659 . . . . 0.59999999999999998 109.645 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 3.1 m -67.07 -24.42 65.97 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 108.641 -0.874 . . . . 0.83999999999999997 108.641 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 22.8 t -61.18 -27.11 68.18 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 115.093 -0.958 . . . . 1.5900000000000001 110.295 175.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 81.9 mt -95.28 0.67 54.05 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 122.094 -0.379 . . . . 0.65000000000000002 111.691 -177.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1533 ' ' SER . . . . . 0.537 ' HA ' ' O ' ' A' 1552 ' ' ILE . 34.3 t -70.94 171.04 11.46 Favored 'General case' 0 C--O 1.26 1.646 0 CA-C-O 121.577 0.703 . . . . 1.52 111.405 -178.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . 170.56 152.03 7.86 Favored Glycine 0 N--CA 1.43 -1.739 0 CA-C-N 115.278 -0.874 . . . . 1.1000000000000001 111.423 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 23.2 ttt180 -89.37 -32.75 17.15 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 123.682 0.793 . . . . 4.6200000000000001 110.524 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -83.59 -34.27 25.18 Favored 'General case' 0 C--O 1.245 0.816 0 CA-C-O 121.606 0.717 . . . . 1.45 109.41 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 92.24 -150.04 19.96 Favored Glycine 0 N--CA 1.415 -2.707 0 CA-C-N 115.057 -0.974 . . . . 0.84999999999999998 111.905 174.049 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -138.06 152.22 48.61 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 107.338 -1.356 . . . . 0.93000000000000005 107.338 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 2.6 p -108.19 128.47 54.74 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 123.628 0.58 . . . . 1.03 110.673 179.147 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1540 ' ' ALA . . . . . 0.488 ' HB3' ' CG1' ' A' 1548 ' ' VAL . . . -117.31 140.93 48.93 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.31 -0.996 . . . . 0.5 108.31 175.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -79.92 127.55 32.39 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 116.09 -0.505 . . . . 0.73999999999999999 109.986 -177.26 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1542 ' ' TYR . . . . . 0.403 ' CE1' ' HG ' ' A' 1626 ' ' LEU . 4.6 t80 -111.44 -99.5 0.41 Allowed 'General case' 0 N--CA 1.417 -2.112 0 N-CA-C 105.832 -1.914 . . . . 0.98999999999999999 105.832 178.484 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1543 ' ' SER . . . . . . . . . . . . . 4.9 m -70.71 173.91 6.62 Favored 'General case' 0 N--CA 1.414 -2.25 0 N-CA-C 108.611 -0.885 . . . . 1.9099999999999999 108.611 172.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -68.8 -37.9 79.56 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.093 -1.004 . . . . 3.5899999999999999 109.512 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 38.9 m -107.26 35.53 3.02 Favored 'General case' 0 N--CA 1.408 -2.549 0 CA-C-N 115.25 -0.886 . . . . 2.46 110.079 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . -155.66 121.94 1.15 Allowed Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.055 -1.069 . . . . 1.26 114.044 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 34.7 m -112.85 149.89 15.18 Favored 'Isoleucine or valine' 0 C--O 1.253 1.28 0 CA-C-O 121.502 0.668 . . . . 0.79000000000000004 110.672 176.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1548 ' ' VAL . . . . . 0.488 ' CG1' ' HB3' ' A' 1540 ' ' ALA . 10.3 p -102.18 139.23 23.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 109.078 -0.712 . . . . 0.57999999999999996 109.078 177.625 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1549 ' ' TYR . . . . . 0.528 ' HB3' ' ND2' ' A' 1556 ' ' ASN . 58.0 m-85 -97.46 129.74 44.62 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 123.173 0.589 . . . . 1.0800000000000001 109.8 178.199 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 24.9 ptm -144.35 127.41 16.53 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-N 115.538 -0.756 . . . . 0.78000000000000003 110.228 -178.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 7.4 p -112.68 117.0 31.05 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 115.514 -0.766 . . . . 0.96999999999999997 109.177 178.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1552 ' ' ILE . . . . . 0.537 ' O ' ' HA ' ' A' 1533 ' ' SER . 41.3 mm -74.83 113.66 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.374 0 N-CA-C 109.845 -0.428 . . . . 0.41999999999999998 109.845 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 75.6 m 66.13 45.56 2.32 Favored 'General case' 0 CA--C 1.493 -1.231 0 O-C-N 124.229 0.956 . . . . 1.3999999999999999 111.745 174.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . -179.72 177.05 47.98 Favored Glycine 0 N--CA 1.406 -3.318 0 C-N-CA 119.306 -1.426 . . . . 0.34999999999999998 111.184 177.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -95.75 141.05 29.68 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 109.469 -0.567 . . . . 1.6200000000000001 109.469 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1556 ' ' ASN . . . . . 0.528 ' ND2' ' HB3' ' A' 1549 ' ' TYR . 44.4 t-20 -92.75 124.68 36.93 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 109.03 -0.729 . . . . 0.87 109.03 -177.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -67.41 -5.89 16.72 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.188 0.81 . . . . 2.4900000000000002 113.188 -176.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -98.62 0.18 44.3 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 112.09 0.404 . . . . 1.3799999999999999 112.09 -174.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1559 ' ' CYS . . . . . 0.47 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 20.4 m -137.82 170.39 10.62 Favored Pre-proline 0 C--N 1.307 -1.277 0 CA-C-O 117.966 -1.016 . . . . 1.21 111.068 177.547 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1560 ' ' PRO . . . . . 0.482 ' HA ' ' HD3' ' A' 1561 ' ' PRO . 64.4 Cg_exo -29.6 134.96 0.04 OUTLIER 'Trans proline' 0 C--N 1.392 2.855 0 C-N-CA 125.006 3.804 . . . . 0.70999999999999996 114.063 174.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1561 ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' 1560 ' ' PRO . 52.3 Cg_exo -53.82 126.72 22.85 Favored 'Trans proline' 0 C--O 1.242 0.701 0 C-N-CA 123.616 2.877 . . . . 0.80000000000000004 113.799 -175.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 89.56 18.56 51.77 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 115.677 -0.692 . . . . 0.46000000000000002 113.664 175.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1563 ' ' VAL . . . . . . . . . . . . . 4.1 p -109.44 140.34 28.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 117.74 0.77 . . . . 0.97999999999999998 110.151 -177.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -101.27 -30.03 6.13 Favored Glycine 0 C--N 1.315 -0.635 0 CA-C-N 116.035 -0.529 . . . . 0.28000000000000003 112.9 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -128.17 126.99 42.14 Favored 'General case' 0 C--N 1.313 -0.997 0 O-C-N 122.414 -0.463 . . . . 0.28000000000000003 109.906 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 9.4 t -160.44 141.7 12.19 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 122.894 0.478 . . . . 0.42999999999999999 110.154 -176.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1567 ' ' PHE . . . . . 0.434 ' HE1' HG21 ' A' 1574 ' ' VAL . 85.9 m-85 -85.78 132.93 34.03 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.744 -0.836 . . . . 1.03 108.744 176.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -81.56 14.14 31.44 Favored Glycine 0 C--N 1.342 0.878 0 C-N-CA 120.494 -0.86 . . . . 1.1299999999999999 113.45 -173.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1569 ' ' GLN . . . . . 0.4 ' HB3' ' OD1' ' B' ' 15' ' ' ASP . 16.2 mm100 -84.64 -70.17 0.6 Allowed 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.188 0.518 . . . . 2.5800000000000001 110.993 177.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1570 ' ' THR . . . . . 0.453 HG21 ' HA ' ' B' ' 12' ' ' GLU . 1.1 p -108.56 10.76 27.07 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 113.019 0.748 . . . . 2.1699999999999999 113.019 -174.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 11.8 mmt180 59.52 36.54 22.92 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.451 -0.795 . . . . 2.6200000000000001 110.383 178.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 45.0 mt -83.2 125.73 40.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 109.584 -0.524 . . . . 0.92000000000000004 109.584 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 37.2 t -78.11 129.02 34.69 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.47 -0.786 . . . . 0.80000000000000004 110.444 -176.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1574 ' ' VAL . . . . . 0.434 HG21 ' HE1' ' A' 1567 ' ' PHE . 1.4 t -112.85 -19.13 7.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 N-CA-C 112.857 0.688 . . . . 0.97999999999999998 112.857 -177.397 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . -179.9 127.62 1.14 Allowed Glycine 0 C--N 1.305 -1.174 0 C-N-CA 119.172 -1.49 . . . . 0.28999999999999998 112.576 -179.165 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -63.99 149.32 47.62 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 123.869 0.868 . . . . 2.1899999999999999 109.99 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -64.93 83.42 0.04 OUTLIER 'General case' 0 C--O 1.244 0.769 0 C-N-CA 123.494 0.718 . . . . 0.60999999999999999 111.352 177.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1578 ' ' ASN . . . . . 0.41 ' HB3' ' CD1' ' A' 1592 ' ' TYR . 45.5 t30 -89.18 150.39 22.7 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 106.966 -1.494 . . . . 1.95 106.966 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -137.5 51.09 1.94 Allowed 'General case' 0 C--N 1.287 -2.149 0 CA-C-O 122.911 1.339 . . . . 2.6800000000000002 109.132 -172.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -123.66 81.31 1.89 Allowed 'General case' 0 N--CA 1.412 -2.342 0 CA-C-N 113.754 -1.566 . . . . 3.4700000000000002 108.83 -176.058 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1581 ' ' LEU . . . . . 0.761 HD21 ' HG ' ' A' 1529 ' ' LEU . 0.5 OUTLIER -63.65 125.04 22.97 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 113.154 -1.839 . . . . 0.64000000000000001 110.266 -177.834 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A 1582 ' ' ARG . . . . . 0.631 ' HB2' ' HB3' ' A' 1589 ' ' GLN . 92.5 mtt180 -112.45 140.34 47.27 Favored 'General case' 0 C--N 1.293 -1.874 0 O-C-N 121.657 -0.652 . . . . 2.8500000000000001 111.274 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1583 ' ' TYR . . . . . 0.669 ' HE1' ' HA ' ' A' 1586 ' ' GLN . 32.7 t80 -113.28 104.17 12.06 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 109.287 -0.634 . . . . 0.85999999999999999 109.287 177.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1584 ' ' VAL . . . . . 0.511 ' O ' ' HB ' ' A' 1587 ' ' VAL . 16.8 m -125.18 89.43 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-N 115.519 -0.764 . . . . 1.05 112.572 -175.464 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 37.2 t70 61.0 51.17 4.64 Favored 'General case' 0 N--CA 1.502 2.155 0 CA-C-O 122.205 1.002 . . . . 1.1699999999999999 110.498 177.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1586 ' ' GLN . . . . . 0.669 ' HA ' ' HE1' ' A' 1583 ' ' TYR 0.288 28.4 pt20 65.2 20.65 11.98 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 126.929 2.091 . . . . 1.8600000000000001 111.703 179.157 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A 1587 ' ' VAL . . . . . 0.511 ' HB ' ' O ' ' A' 1584 ' ' VAL . 45.4 t -108.96 121.62 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.406 0 CA-C-N 113.775 -1.557 . . . . 0.48999999999999999 106.881 172.608 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1588 ' ' LEU . . . . . 0.765 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 2.4 mm? -95.36 113.22 24.86 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 107.576 -1.268 . . . . 0.35999999999999999 107.576 -177.362 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1589 ' ' GLN . . . . . 0.631 ' HB3' ' HB2' ' A' 1582 ' ' ARG . 35.9 tt0 -107.97 140.08 41.65 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.559 0.695 . . . . 1.74 112.484 -172.662 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 29.6 mt -133.12 93.16 3.13 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 114.065 -1.425 . . . . 0.71999999999999997 107.807 173.28 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 5.4 p -89.39 122.33 40.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.867 -0.79 . . . . 1.01 108.867 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1592 ' ' TYR . . . . . 0.443 ' HB2' ' HB3' ' A' 1608 ' ' SER . 12.9 m-30 -111.84 102.96 11.19 Favored 'General case' 0 C--N 1.29 -2.017 0 O-C-N 121.672 -0.643 . . . . 0.5 110.096 -177.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -104.21 178.99 4.4 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 109.852 -0.425 . . . . 1.5900000000000001 109.852 177.281 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 17.1 m-20 68.9 55.22 0.45 Allowed 'General case' 0 C--O 1.246 0.883 0 C-N-CA 123.763 0.825 . . . . 1.1100000000000001 112.497 178.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -88.54 -122.41 1.94 Allowed Glycine 0 N--CA 1.43 -1.765 0 N-CA-C 109.781 -1.328 . . . . 0.78000000000000003 109.781 174.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1596 ' ' SER . . . . . . . . . . . . . 43.9 p -108.35 153.91 41.72 Favored Pre-proline 0 C--N 1.294 -1.843 0 N-CA-C 108.734 -0.839 . . . . 1.0700000000000001 108.734 176.285 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.23 120.51 8.45 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 122.448 2.099 . . . . 1.01 110.509 176.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 43.3 t -78.94 129.2 74.06 Favored Pre-proline 0 C--N 1.289 -2.034 0 CA-C-N 115.173 -0.921 . . . . 0.75 109.949 -174.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -71.37 -14.16 30.92 Favored 'Trans proline' 0 C--O 1.247 0.968 0 C-N-CA 122.852 2.368 . . . . 1.7 113.316 -178.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1600 ' ' SER . . . . . . . . . . . . . 4.7 m -75.62 -52.85 9.63 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 116.45 -0.341 . . . . 2.2599999999999998 110.627 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1601 ' ' LYS . . . . . 0.804 ' HA ' ' HE3' ' A' 1601 ' ' LYS . 1.1 tpmt? -116.09 101.95 9.19 Favored 'General case' 0 N--CA 1.401 -2.894 0 N-CA-C 106.359 -1.719 . . . . 3.0099999999999998 106.359 178.174 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 16.9 m -58.38 119.85 7.7 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 123.213 0.605 . . . . 2.0699999999999998 110.245 -178.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 102.16 -1.61 50.93 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 111.524 -0.631 . . . . 1.0800000000000001 111.524 -178.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1604 ' ' LEU . . . . . 0.428 HD23 ' SG ' ' A' 1634 ' ' CYS . 8.8 tp -102.97 164.19 11.76 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 107.985 -1.117 . . . . 1.8400000000000001 107.985 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 31.1 t -131.03 150.58 52.08 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 107.724 -1.213 . . . . 1.4099999999999999 107.724 -178.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1606 ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -67.62 155.5 39.02 Favored 'General case' 0 C--O 1.245 0.854 0 N-CA-C 109.578 -0.527 . . . . 0.59999999999999998 109.578 177.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 26.2 pttm -154.67 137.58 15.41 Favored 'General case' 0 N--CA 1.44 -0.928 0 C-N-CA 120.061 -0.656 . . . . 1.45 110.691 178.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1608 ' ' SER . . . . . 0.443 ' HB3' ' HB2' ' A' 1592 ' ' TYR . 41.4 t -107.61 122.84 47.51 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 114.949 -1.023 . . . . 1.1499999999999999 110.244 -176.021 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 22.5 t -104.79 98.51 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 108.618 -0.882 . . . . 0.25 108.618 176.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 80.2 mt -90.95 116.72 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.653 0 N-CA-C 107.693 -1.225 . . . . 0.45000000000000001 107.693 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 10.8 p -121.45 114.84 21.83 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 115.616 -0.72 . . . . 1.26 111.547 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1612 ' ' PHE . . . . . 0.765 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 65.9 m-85 -87.4 123.69 32.61 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 108.213 -1.032 . . . . 0.26000000000000001 108.213 175.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 46.9 t -114.24 134.15 58.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 116.182 -0.463 . . . . 0.5 109.987 -175.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1614 ' ' CYS . . . . . 0.467 ' HA ' ' HB2' ' A' 1646 ' ' CYS . 0.9 OUTLIER -50.94 111.24 0.52 Allowed 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.347 1.059 . . . . 0.77000000000000002 112.479 175.724 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A 1615 ' ' ARG . . . . . 0.555 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 30.1 tpt180 -134.44 91.31 22.45 Favored Pre-proline 0 N--CA 1.446 -0.668 0 C-N-CA 120.283 -0.567 . . . . 2.5299999999999998 109.933 173.468 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1616 ' ' PRO . . . . . 0.504 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 17.2 Cg_exo -66.76 -28.38 43.64 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.393 2.062 . . . . 1.1000000000000001 112.442 -179.145 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1617 ' ' GLU . . . . . 0.49 ' OE1' ' HD2' ' A' 1616 ' ' PRO . 17.9 mp0 -59.73 -39.81 85.96 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 123.928 0.891 . . . . 3.0499999999999998 110.638 178.465 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . 49.04 86.54 0.03 OUTLIER 'General case' 0 C--O 1.246 0.874 0 C-N-CA 124.44 1.096 . . . . 1.55 113.581 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . -118.23 -151.31 9.11 Favored Glycine 0 C--N 1.281 -2.499 0 N-CA-C 110.221 -1.152 . . . . 0.93000000000000005 110.221 178.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.97 10.25 0.91 Allowed 'Trans proline' 0 N--CA 1.486 1.054 0 C-N-CA 122.964 2.443 . . . . 0.88 114.166 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1621 ' ' THR . . . . . . . . . . . . . 14.5 p -100.68 6.93 44.14 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 122.012 0.91 . . . . 0.96999999999999997 110.435 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -85.06 65.28 9.15 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 106.67 -1.604 . . . . 0.71999999999999997 106.67 175.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -169.96 139.56 1.59 Allowed Pre-proline 0 N--CA 1.435 -1.195 0 C-N-CA 124.849 1.26 . . . . 3.2599999999999998 107.647 -177.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1624 ' ' PRO . . . . . 0.52 ' HA ' ' O ' ' A' 1639 ' ' SER . 50.6 Cg_endo -67.93 106.91 1.4 Allowed 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.885 2.39 . . . . 0.58999999999999997 112.327 -176.408 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 72.1 mtm -105.63 147.36 28.55 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 120.779 -0.368 . . . . 1.3700000000000001 110.885 178.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1626 ' ' LEU . . . . . 0.403 ' HG ' ' CE1' ' A' 1542 ' ' TYR . 1.9 tm? -82.55 118.16 23.07 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 106.727 -1.582 . . . . 0.89000000000000001 106.727 -178.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 42.9 mm -80.46 -54.08 11.38 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.783 0 N-CA-C 108.61 -0.885 . . . . 0.57999999999999996 108.61 178.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 34.4 t -164.9 159.14 17.94 Favored 'General case' 0 N--CA 1.411 -2.384 0 N-CA-C 107.287 -1.375 . . . . 1.3899999999999999 107.287 -177.163 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1629 ' ' LEU . . . . . 0.984 ' HG ' ' HG ' ' A' 1636 ' ' LEU . 1.6 tt -135.77 102.77 5.18 Favored 'General case' 0 N--CA 1.414 -2.252 0 N-CA-C 105.082 -2.192 . . . . 1.25 105.082 177.077 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 25.3 t70 -78.35 107.33 10.9 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.041 -1.466 . . . . 1.0900000000000001 107.041 175.058 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1631 ' ' LYS . . . . . 0.458 ' HG2' HD22 ' A' 1629 ' ' LEU . 37.2 mtmm -78.62 -5.35 52.66 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 113.213 0.82 . . . . 3.6000000000000001 113.213 -173.671 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 10.8 mm100 -89.67 -40.74 12.36 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 119.132 -1.027 . . . . 2.6000000000000001 108.503 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 74.4 p -89.77 -5.14 57.25 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 115.034 -0.985 . . . . 0.75 109.438 177.143 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1634 ' ' CYS . . . . . 0.428 ' SG ' HD23 ' A' 1604 ' ' LEU . 27.9 m 58.0 41.03 24.92 Favored 'General case' 0 C--N 1.362 1.138 0 C-N-CA 125.073 1.349 . . . . 0.53000000000000003 110.906 174.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1635 ' ' THR . . . . . . . . . . . . . 74.9 m -112.4 127.65 56.08 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 114.743 -1.117 . . . . 0.46000000000000002 110.523 -174.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1636 ' ' LEU . . . . . 0.984 ' HG ' ' HG ' ' A' 1629 ' ' LEU . 0.3 OUTLIER -113.77 131.97 56.02 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.485 -0.932 . . . . 0.85999999999999999 108.485 -176.634 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -111.62 129.27 56.13 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 116.692 -0.231 . . . . 0.45000000000000001 110.458 -178.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -126.77 132.39 51.08 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 116.054 -0.521 . . . . 0.5 109.733 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1639 ' ' SER . . . . . 0.52 ' O ' ' HA ' ' A' 1624 ' ' PRO . 22.8 t -115.43 152.95 31.96 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.326 -0.99 . . . . 1.04 108.326 178.212 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 3.1 t90 -151.2 111.12 4.07 Favored 'General case' 0 N--CA 1.414 -2.256 0 N-CA-C 104.205 -2.517 . . . . 0.68000000000000005 104.205 -177.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1641 ' ' HIS . . . . . 0.555 ' HB3' ' HB2' ' A' 1615 ' ' ARG . 42.7 m-70 -97.9 110.27 22.87 Favored 'General case' 0 C--N 1.293 -1.873 0 C-N-CA 120.097 -0.641 . . . . 0.90000000000000002 109.365 -177.28 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1642 ' ' THR . . . . . . . . . . . . . 4.6 t -142.63 146.94 40.46 Favored Pre-proline 0 C--N 1.296 -1.719 0 CA-C-N 115.158 -0.928 . . . . 0.47999999999999998 110.123 -172.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1643 ' ' PRO . . . . . 0.504 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 37.6 Cg_endo -79.68 -11.11 14.22 Favored 'Trans proline' 0 C--N 1.368 1.565 0 C-N-CA 121.991 1.794 . . . . 0.66000000000000003 112.874 177.348 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 7.1 tt -68.37 -29.93 68.75 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 122.295 1.045 . . . . 0.96999999999999997 108.199 178.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -97.06 20.87 10.59 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 114.167 -1.379 . . . . 0.83999999999999997 109.405 -177.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1646 ' ' CYS . . . . . 0.467 ' HB2' ' HA ' ' A' 1614 ' ' CYS . 49.6 t -122.1 158.32 29.53 Favored 'General case' 0 N--CA 1.42 -1.957 0 CA-C-N 115.967 -0.561 . . . . 1.1899999999999999 109.601 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 . . . . . 0 C--N 1.299 -1.624 0 N-CA-C 105.753 -1.943 . . . . 3.1400000000000001 105.753 175.545 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.455 0 N-CA-C 111.499 -0.641 . . . . 2.0899999999999999 111.499 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.34 -68.28 1.72 Allowed Glycine 0 N--CA 1.445 -0.716 0 O-C-N 123.923 0.425 . . . . 1.8400000000000001 113.204 -178.328 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 12' ' ' GLU . . . . . 0.453 ' HA ' HG21 ' A' 1570 ' ' THR . 4.7 mm-40 -61.24 -32.75 72.55 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.176 -0.676 . . . . 2.5499999999999998 109.176 -178.168 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 13' ' ' LEU . . . . . 0.415 ' O ' HD23 ' B' ' 17' ' ' LEU . 0.1 OUTLIER -53.34 -66.53 0.37 Allowed 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 114.761 -1.109 . . . . 2.3500000000000001 109.245 -179.559 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 18.9 m -75.21 -16.7 15.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 C-N-CA 119.384 -0.927 . . . . 2.1099999999999999 110.701 -177.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 15' ' ' ASP . . . . . 0.4 ' OD1' ' HB3' ' A' 1569 ' ' GLN . 12.0 t70 -73.27 -49.72 26.16 Favored 'General case' 0 C--O 1.184 -2.368 0 C-N-CA 118.844 -1.142 . . . . 2.04 112.497 179.271 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 21.9 p -56.15 -44.83 79.64 Favored 'General case' 0 C--O 1.263 1.778 0 CA-C-N 118.693 0.679 . . . . 1.8400000000000001 109.628 176.105 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.563 ' HB3' ' CB ' ' B' ' 26' ' ' PHE . 4.1 mm? -50.37 -55.1 17.12 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 114.344 -1.298 . . . . 1.74 112.346 172.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -77.46 -21.91 52.17 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.23 0.538 . . . . 2.3900000000000001 111.996 -178.272 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -55.55 -52.67 62.95 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 124.034 0.934 . . . . 0.95999999999999996 110.777 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 12.9 p -98.56 -24.07 4.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 C-N-CA 118.272 -1.371 . . . . 1.3700000000000001 112.365 -178.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 34.5 m -104.56 19.64 20.01 Favored 'General case' 0 C--N 1.309 -1.166 0 O-C-N 121.871 -0.518 . . . . 1.6599999999999999 111.935 -174.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -49.17 -34.19 16.71 Favored Glycine 0 N--CA 1.469 0.875 0 N-CA-C 116.852 1.501 . . . . 1.53 116.852 -175.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -74.99 -34.47 61.97 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 117.773 0.787 . . . . 2.7200000000000002 112.641 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 20.6 tpp180 -93.1 -39.47 11.04 Favored 'General case' 0 C--N 1.314 -0.949 0 O-C-N 122.064 -0.398 . . . . 4.3300000000000001 111.195 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.94 -168.17 13.26 Favored Glycine 0 N--CA 1.433 -1.534 0 N-CA-C 109.078 -1.609 . . . . 1.53 109.078 -177.045 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 26' ' ' PHE . . . . . 0.563 ' CB ' ' HB3' ' B' ' 17' ' ' LEU . 18.0 p90 -129.73 128.6 42.81 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 117.69 0.745 . . . . 1.6499999999999999 111.098 179.245 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -142.02 129.33 21.12 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 109.491 -0.559 . . . . 3.4199999999999999 109.491 -176.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 28' ' ' PHE . . . . . 0.537 ' HA ' ' HE1' ' B' ' 59' ' ' TYR . 6.7 p90 . . . . . 0 C--N 1.306 -1.304 0 N-CA-C 107.283 -1.377 . . . . 2.2599999999999998 107.283 -177.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.424 -2.131 0 N-CA-C 108.288 -1.925 . . . . 2.3700000000000001 108.288 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 42' ' ' ILE . . . . . 0.506 ' HB ' HD21 ' B' ' 55' ' ' LEU . 15.0 pt 55.05 8.26 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.42 0 C-N-CA 126.906 2.082 . . . . 2.0699999999999998 112.578 -177.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.491 ' O ' ' HB2' ' B' ' 47' ' ' CYS . 9.0 p -80.25 -35.48 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.312 0 CA-C-N 114.796 -1.093 . . . . 2.2400000000000002 111.95 -173.307 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -84.63 -38.37 19.94 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 106.593 -1.632 . . . . 3.3599999999999999 106.593 177.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -64.97 -19.38 65.95 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 113.886 -1.506 . . . . 3.0800000000000001 111.798 -177.187 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 46' ' ' CYS . . . . . . . . . . . . . 41.9 t -118.06 -0.21 11.68 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 119.779 -0.769 . . . . 2.23 110.888 175.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 47' ' ' CYS . . . . . 0.491 ' HB2' ' O ' ' B' ' 43' ' ' VAL . 51.9 t -83.91 -60.05 2.23 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 121.941 -0.474 . . . . 2.3700000000000001 111.998 177.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -96.48 4.24 52.23 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-O 121.228 0.537 . . . . 2.8199999999999998 110.222 -175.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 8.2 mmt180 -130.29 161.78 30.47 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 105.294 -2.113 . . . . 4.0899999999999999 105.294 -176.206 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 9.3 t -97.32 115.48 27.75 Favored 'General case' 0 C--N 1.278 -2.505 0 N-CA-C 105.086 -2.19 . . . . 2.6699999999999999 105.086 174.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 31.9 p -88.89 137.48 32.28 Favored 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 109.294 -0.632 . . . . 2.1099999999999999 109.294 -172.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -85.09 146.87 26.93 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 107.855 -1.165 . . . . 2.6699999999999999 107.855 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -62.23 -22.52 66.02 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.058 -0.974 . . . . 1.8999999999999999 112.508 -174.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.75 -38.19 69.5 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.19 0.519 . . . . 1.52 109.969 178.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 55' ' ' LEU . . . . . 0.506 HD21 ' HB ' ' B' ' 42' ' ' ILE . 34.6 tp -54.66 -63.4 1.16 Allowed 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 114.371 -1.286 . . . . 1.97 111.576 179.319 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 56' ' ' LEU . . . . . 0.423 HD13 ' N ' ' B' ' 57' ' ' GLU . 0.0 OUTLIER -75.09 -27.37 59.87 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 120.267 -0.573 . . . . 1.53 111.656 -176.341 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 57' ' ' GLU . . . . . 0.423 ' N ' HD13 ' B' ' 56' ' ' LEU . 11.6 tp10 -59.93 -44.91 94.06 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 109.912 -0.403 . . . . 2.27 109.912 177.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 11.7 t -80.48 -10.81 59.73 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 120.419 -0.512 . . . . 2.3300000000000001 110.752 177.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 59' ' ' TYR . . . . . 0.537 ' HE1' ' HA ' ' B' ' 28' ' ' PHE . 1.1 t80 -94.72 -70.77 0.69 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 119.504 -0.878 . . . . 2.8599999999999999 108.865 -178.776 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 54.0 t . . . . . 0 C--N 1.308 -1.209 0 C-N-CA 125.809 1.644 . . . . 2.2999999999999998 114.955 177.319 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 17.0 t70 . . . . . 0 N--CA 1.45 -0.471 0 CA-C-O 121.09 0.471 . . . . 2.8999999999999999 110.134 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A 1516 ' ' CYS . . . . . 0.708 ' HA ' ' HB2' ' A' 1581 ' ' LEU . 91.6 m 64.21 46.93 3.39 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 115.057 1.503 . . . . 1.1899999999999999 115.057 175.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -150.1 129.88 13.28 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 107.122 -1.436 . . . . 1.52 107.122 172.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1518 ' ' VAL . . . . . 0.688 HG21 ' HB2' ' A' 1583 ' ' TYR . 5.3 m -131.12 140.52 48.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 CA-C-O 121.249 0.547 . . . . 0.93999999999999995 111.542 -174.305 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1519 ' ' THR . . . . . . . . . . . . . 20.5 m -108.44 140.58 41.54 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 115.452 -0.795 . . . . 0.89000000000000001 109.064 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1520 ' ' ASN . . . . . 0.663 HD22 ' HE2' ' A' 1583 ' ' TYR . 25.9 t-20 -93.62 114.59 63.38 Favored Pre-proline 0 C--N 1.305 -1.347 0 N-CA-C 107.876 -1.157 . . . . 1.74 107.876 172.054 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -63.94 -21.3 68.74 Favored 'Trans proline' 0 N--CA 1.477 0.536 0 C-N-CA 123.208 2.605 . . . . 1.5800000000000001 114.032 -174.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 14.2 m -75.56 -41.54 54.53 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-O 120.646 0.26 . . . . 1.6499999999999999 111.498 -177.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1523 ' ' THR . . . . . 0.521 HG22 ' OD1' ' A' 1520 ' ' ASN . 2.7 t -107.94 -20.57 13.14 Favored 'General case' 0 CA--C 1.561 1.391 0 CA-C-O 121.345 0.593 . . . . 1.6100000000000001 111.96 -178.156 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 83.1 22.51 57.2 Favored Glycine 0 CA--C 1.505 -0.533 0 O-C-N 122.092 -0.38 . . . . 1.1299999999999999 113.482 175.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 55.1 t-80 -95.36 132.82 39.98 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 120.981 0.42 . . . . 1.26 110.114 -178.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 2.7 tm? -101.47 116.38 32.65 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 114.902 -1.045 . . . . 0.68000000000000005 109.51 -177.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -87.35 118.12 26.58 Favored 'General case' 0 C--N 1.318 -0.804 0 O-C-N 122.068 -0.395 . . . . 0.65000000000000002 111.108 173.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 8.7 t70 -98.01 113.67 25.59 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 108.27 -1.011 . . . . 1.1699999999999999 108.27 176.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1529 ' ' LEU . . . . . 0.715 ' HG ' HD21 ' A' 1581 ' ' LEU . 3.5 mm? -101.87 -6.7 23.23 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 121.111 0.481 . . . . 0.59999999999999998 110.051 177.48 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 6.1 m -62.63 -22.15 66.21 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.498 -0.774 . . . . 0.83999999999999997 112.45 -177.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 16.2 t -66.12 -32.53 74.03 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 121.317 0.58 . . . . 1.5900000000000001 110.036 177.35 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 7.9 mt -89.03 -7.62 55.57 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.253 -0.647 . . . . 0.65000000000000002 109.253 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1533 ' ' SER . . . . . 0.437 ' HA ' ' HB ' ' A' 1552 ' ' ILE . 24.5 t -76.99 176.28 8.79 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.379 -0.6 . . . . 1.52 109.379 179.153 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . 152.71 174.77 23.51 Favored Glycine 0 N--CA 1.422 -2.24 0 N-CA-C 110.193 -1.163 . . . . 1.1000000000000001 110.193 -177.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 33.2 ttm180 -92.31 -29.73 16.21 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 121.161 0.505 . . . . 4.6200000000000001 110.095 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -76.55 -53.08 8.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.206 0.527 . . . . 1.45 110.96 -178.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 93.83 -150.16 19.73 Favored Glycine 0 N--CA 1.425 -2.067 0 C-N-CA 120.624 -0.798 . . . . 0.84999999999999998 111.883 177.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -136.8 151.49 49.23 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.377 -0.971 . . . . 0.93000000000000005 108.377 -177.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 17.7 p -112.81 139.55 48.34 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 116.266 -0.424 . . . . 1.03 109.952 177.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1540 ' ' ALA . . . . . 0.462 ' HB3' ' CG1' ' A' 1548 ' ' VAL . . . -125.25 143.41 50.96 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 107.943 -1.132 . . . . 0.5 107.943 172.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -84.67 151.94 24.12 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 108.552 -0.907 . . . . 0.73999999999999999 108.552 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1542 ' ' TYR . . . . . 0.703 ' HE2' ' HG ' ' A' 1626 ' ' LEU . 1.8 t80 -162.95 -100.74 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 121.62 0.724 . . . . 0.98999999999999999 109.914 -174.274 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1543 ' ' SER . . . . . 0.466 ' H ' ' HB3' ' A' 1542 ' ' TYR . 31.2 t -73.93 159.41 32.81 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 124.568 1.147 . . . . 1.9099999999999999 110.404 -173.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 13.2 tppt? -74.98 -3.71 33.9 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 109.329 -0.619 . . . . 3.5899999999999999 109.329 178.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1545 ' ' SER . . . . . 0.46 ' HB2' ' HG2' ' B' ' 18' ' ' GLN . 15.3 t -77.62 -43.3 31.97 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 108.884 -0.784 . . . . 2.46 108.884 176.137 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 165.72 -148.84 14.45 Favored Glycine 0 N--CA 1.41 -3.066 0 N-CA-C 110.872 -0.891 . . . . 1.26 110.872 -175.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 34.6 m -109.11 179.41 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.281 2.761 0 CA-C-O 122.118 0.961 . . . . 0.79000000000000004 111.975 -172.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1548 ' ' VAL . . . . . 0.868 ' HB ' ' CE1' ' A' 1567 ' ' PHE . 7.8 p -112.01 130.85 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.941 0 CA-C-N 113.193 -1.821 . . . . 0.57999999999999996 108.362 173.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -95.06 134.81 37.35 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.938 -1.134 . . . . 1.0800000000000001 107.938 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 24.1 ptm -150.93 118.73 6.17 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 121.767 0.794 . . . . 0.78000000000000003 111.337 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 5.4 p -112.4 118.31 34.85 Favored 'General case' 0 C--N 1.28 -2.428 0 CA-C-N 114.507 -1.224 . . . . 0.96999999999999997 109.973 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1552 ' ' ILE . . . . . 0.437 ' HB ' ' HA ' ' A' 1533 ' ' SER . 46.0 mm -71.95 114.63 10.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.503 -0.317 . . . . 0.41999999999999998 110.585 -178.58 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 72.0 m 60.9 29.43 19.01 Favored 'General case' 0 CA--C 1.511 -0.533 0 C-N-CA 124.532 1.133 . . . . 1.3999999999999999 113.401 175.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . -161.04 177.75 37.28 Favored Glycine 0 N--CA 1.417 -2.601 0 N-CA-C 109.412 -1.475 . . . . 0.34999999999999998 109.412 -179.135 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -107.97 140.73 40.68 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-O 121.127 0.489 . . . . 1.6200000000000001 111.684 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -87.21 140.5 29.48 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 107.426 -1.324 . . . . 0.87 107.426 178.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -94.41 3.45 55.16 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 113.587 0.958 . . . . 2.4900000000000002 113.587 -173.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -88.62 -4.65 58.52 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 121.552 0.692 . . . . 1.3799999999999999 110.575 -178.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1559 ' ' CYS . . . . . 0.625 ' SG ' ' HD2' ' A' 1560 ' ' PRO . 20.2 t -136.31 157.48 75.39 Favored Pre-proline 0 C--N 1.298 -1.633 0 N-CA-C 106.229 -1.767 . . . . 1.21 106.229 -178.059 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1560 ' ' PRO . . . . . 0.632 ' HD2' ' HB3' ' A' 1571 ' ' ARG . 31.6 Cg_exo -29.05 134.77 0.04 OUTLIER 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 125.104 3.869 . . . . 0.70999999999999996 115.428 177.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1561 ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' 1560 ' ' PRO . 86.1 Cg_exo -49.13 124.44 11.62 Favored 'Trans proline' 0 C--O 1.247 0.948 0 C-N-CA 124.176 3.251 . . . . 0.80000000000000004 112.792 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 101.76 7.32 48.1 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 116.004 -0.544 . . . . 0.46000000000000002 113.302 -177.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1563 ' ' VAL . . . . . 0.608 HG11 ' HB2' ' A' 1566 ' ' CYS . 2.3 t -85.93 124.56 40.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 112.185 0.439 . . . . 0.97999999999999998 112.185 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -97.71 -37.61 4.42 Favored Glycine 0 C--N 1.31 -0.916 0 N-CA-C 110.702 -0.959 . . . . 0.28000000000000003 110.702 174.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -130.25 137.3 49.94 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.021 -0.733 . . . . 0.28000000000000003 109.021 177.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1566 ' ' CYS . . . . . 0.608 ' HB2' HG11 ' A' 1563 ' ' VAL . 42.4 t -156.96 135.29 11.3 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 121.243 -0.183 . . . . 0.42999999999999999 111.201 -177.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1567 ' ' PHE . . . . . 0.868 ' CE1' ' HB ' ' A' 1548 ' ' VAL . 9.5 m-85 -112.9 163.76 14.25 Favored 'General case' 0 C--O 1.245 0.857 0 C-N-CA 123.308 0.643 . . . . 1.03 110.491 173.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . 94.31 169.53 37.61 Favored Glycine 0 N--CA 1.399 -3.831 0 C-N-CA 118.831 -1.652 . . . . 1.1299999999999999 114.324 164.189 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 10.5 mm100 -89.6 -30.14 18.37 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 114.242 -0.979 . . . . 2.5800000000000001 108.985 177.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 66.3 p -85.09 2.65 42.49 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.555 -0.748 . . . . 2.1699999999999999 112.74 -177.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1571 ' ' ARG . . . . . 0.632 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 2.2 mpt_? 67.6 69.07 0.36 Allowed 'General case' 0 C--N 1.348 0.518 0 CA-C-N 114.704 -1.134 . . . . 2.6200000000000001 110.831 175.197 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 32.0 mt -96.59 106.02 17.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-N 115.582 -0.735 . . . . 0.92000000000000004 109.727 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 30.9 t -66.81 130.07 41.97 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-N 114.732 -1.122 . . . . 0.80000000000000004 110.379 -177.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1574 ' ' VAL . . . . . 0.6 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 34.4 m -123.55 20.92 4.56 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.336 0 CA-C-O 121.535 0.683 . . . . 0.97999999999999998 110.607 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 169.43 124.17 0.72 Allowed Glycine 0 N--CA 1.418 -2.546 0 CA-C-N 114.915 -1.039 . . . . 0.28999999999999998 111.329 176.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -75.53 141.94 42.9 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.079 -0.711 . . . . 2.1899999999999999 109.079 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -69.9 84.19 0.49 Allowed 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 123.404 0.681 . . . . 0.60999999999999999 112.708 -177.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -93.68 168.18 11.18 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 115.569 -0.741 . . . . 1.95 109.346 176.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 55.1 mttm -129.31 41.92 3.38 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.519 -0.919 . . . . 2.6800000000000002 108.519 -176.103 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 46.4 ttm-85 -105.98 77.65 1.26 Allowed 'General case' 0 N--CA 1.403 -2.786 0 CA-C-N 115.314 -0.857 . . . . 3.4700000000000002 109.841 -175.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1581 ' ' LEU . . . . . 0.715 HD21 ' HG ' ' A' 1529 ' ' LEU . 1.2 tm? -65.47 124.97 23.69 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 113.798 -1.546 . . . . 0.64000000000000001 107.49 175.563 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 63.9 mtp180 -118.54 141.0 49.01 Favored 'General case' 0 C--N 1.289 -2.048 0 C-N-CA 120.853 -0.339 . . . . 2.8500000000000001 110.706 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1583 ' ' TYR . . . . . 0.688 ' HB2' HG21 ' A' 1518 ' ' VAL . 64.0 t80 -120.01 109.01 14.99 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 109.249 -0.648 . . . . 0.85999999999999999 109.249 -179.217 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1584 ' ' VAL . . . . . 0.501 ' O ' ' HB ' ' A' 1587 ' ' VAL . 9.4 m -128.7 94.9 2.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-N 115.8 -0.636 . . . . 1.05 111.752 -179.08 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 12.3 t70 56.53 60.91 2.88 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 123.851 0.86 . . . . 1.1699999999999999 110.714 176.183 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1586 ' ' GLN . . . . . 0.427 ' HA ' ' HE1' ' A' 1583 ' ' TYR 0.313 10.0 pt20 65.24 12.08 7.75 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 126.828 2.051 . . . . 1.8600000000000001 113.147 178.972 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A 1587 ' ' VAL . . . . . 0.501 ' HB ' ' O ' ' A' 1584 ' ' VAL . 39.6 t -101.78 120.07 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.95 0 N-CA-C 107.588 -1.264 . . . . 0.48999999999999999 107.588 174.077 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1588 ' ' LEU . . . . . 0.731 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 2.9 mm? -96.82 110.35 22.85 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 106.009 -1.848 . . . . 0.35999999999999999 106.009 177.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1589 ' ' GLN . . . . . 0.43 ' HA ' ' O ' ' A' 1610 ' ' ILE . 28.5 tt0 -125.48 132.16 52.71 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-O 121.672 0.748 . . . . 1.74 112.767 -171.48 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 11.7 mt -115.1 128.31 56.14 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 107.27 -1.381 . . . . 0.71999999999999997 107.27 175.429 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 59.3 t -119.03 118.9 59.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 C-N-CA 119.66 -0.816 . . . . 1.01 110.511 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1592 ' ' TYR . . . . . 0.47 ' O ' ' HA ' ' A' 1607 ' ' LYS . 16.8 m-30 -106.18 95.2 5.61 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 115.65 -0.705 . . . . 0.5 109.104 -179.003 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1593 ' ' LYS . . . . . 0.535 ' HB3' ' HD3' ' A' 1607 ' ' LYS . 0.0 OUTLIER -109.28 163.07 13.71 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 116.685 -0.234 . . . . 1.5900000000000001 111.332 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 6.4 m-20 66.12 55.84 0.87 Allowed 'General case' 0 C--N 1.318 -0.787 0 O-C-N 124.472 1.108 . . . . 1.1100000000000001 112.003 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -83.55 -107.27 0.53 Allowed Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 110.029 -1.228 . . . . 0.78000000000000003 110.029 174.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1596 ' ' SER . . . . . . . . . . . . . 85.8 p -102.41 148.82 36.0 Favored Pre-proline 0 C--O 1.261 1.7 0 N-CA-C 108.847 -0.797 . . . . 1.0700000000000001 108.847 175.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -63.66 122.8 11.02 Favored 'Trans proline' 0 N--CA 1.446 -1.269 0 C-N-CA 122.751 2.3 . . . . 1.01 108.998 174.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 17.0 t -78.83 110.46 14.42 Favored Pre-proline 0 C--N 1.301 -1.534 0 N-CA-C 108.621 -0.881 . . . . 0.75 108.621 -172.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.07 -12.22 35.23 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 122.843 2.362 . . . . 1.7 112.839 -173.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1600 ' ' SER . . . . . 0.806 ' HB3' ' HB2' ' B' ' 53' ' ' LEU . 18.0 m -61.56 -31.06 71.08 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.929 0.891 . . . . 2.2599999999999998 111.907 178.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1601 ' ' LYS . . . . . 0.584 ' HB3' HD22 ' A' 1604 ' ' LEU . 41.0 ttmt -161.06 122.0 2.85 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 107.445 -1.317 . . . . 3.0099999999999998 107.445 176.414 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 15.1 m -59.05 131.26 50.51 Favored 'General case' 0 N--CA 1.424 -1.73 0 C-N-CA 123.028 0.531 . . . . 2.0699999999999998 111.39 -176.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 105.37 -3.96 40.4 Favored Glycine 0 C--N 1.309 -0.951 0 CA-C-N 116.258 -0.428 . . . . 1.0800000000000001 112.768 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1604 ' ' LEU . . . . . 0.584 HD22 ' HB3' ' A' 1601 ' ' LYS . 10.3 mp -100.45 157.77 16.4 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 122.462 -0.434 . . . . 1.8400000000000001 111.551 -178.595 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 33.8 m -146.88 143.93 28.91 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 108.312 -0.996 . . . . 1.4099999999999999 108.312 175.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1606 ' ' TYR . . . . . 0.6 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 76.1 m-85 -69.53 151.63 45.77 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 116.334 -0.394 . . . . 0.59999999999999998 110.928 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1607 ' ' LYS . . . . . 0.535 ' HD3' ' HB3' ' A' 1593 ' ' LYS . 36.6 ttpt -150.95 130.33 12.87 Favored 'General case' 0 N--CA 1.441 -0.878 0 O-C-N 124.007 0.817 . . . . 1.45 109.824 -175.595 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1608 ' ' SER . . . . . 0.465 ' HB3' ' HB2' ' A' 1592 ' ' TYR . 37.3 t -105.38 120.11 40.76 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 108.939 -0.763 . . . . 1.1499999999999999 108.939 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 22.8 t -105.32 107.3 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 N-CA-C 107.831 -1.174 . . . . 0.25 107.831 177.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1610 ' ' ILE . . . . . 0.43 ' O ' ' HA ' ' A' 1589 ' ' GLN . 64.3 mt -101.91 111.73 32.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 CA-C-N 115.676 -0.693 . . . . 0.45000000000000001 110.046 -176.326 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 21.4 p -111.64 117.84 34.03 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.928 -0.578 . . . . 1.26 112.153 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1612 ' ' PHE . . . . . 0.731 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 78.0 m-85 -93.08 124.34 36.99 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.19 -1.041 . . . . 0.26000000000000001 108.19 177.046 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 49.1 t -118.74 137.23 53.39 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 116.544 -0.298 . . . . 0.5 110.984 -175.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 3.5 t -59.69 103.0 0.17 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.668 1.187 . . . . 0.77000000000000002 112.633 177.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1615 ' ' ARG . . . . . 0.541 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 20.8 mmt180 -138.49 112.58 8.53 Favored Pre-proline 0 C--N 1.32 -0.693 0 O-C-N 122.369 -0.207 . . . . 2.5299999999999998 111.224 171.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1616 ' ' PRO . . . . . 0.601 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 37.3 Cg_endo -74.06 -1.71 11.27 Favored 'Trans proline' 0 N--CA 1.489 1.213 0 C-N-CA 122.902 2.401 . . . . 1.1000000000000001 113.213 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -89.5 41.7 1.05 Allowed 'General case' 0 C--N 1.291 -1.959 0 C-N-CA 124.936 1.294 . . . . 3.0499999999999998 110.83 -177.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -41.54 123.79 2.28 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.86 1.664 . . . . 1.55 112.647 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1619 ' ' GLY . . . . . 0.438 ' HA3' ' HD2' ' A' 1620 ' ' PRO . . . 171.03 -135.8 3.65 Favored Glycine 0 CA--C 1.48 -2.151 0 N-CA-C 110.13 -1.188 . . . . 0.93000000000000005 110.13 -177.347 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1620 ' ' PRO . . . . . 0.438 ' HD2' ' HA3' ' A' 1619 ' ' GLY . 35.1 Cg_endo -64.12 -2.46 4.76 Favored 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 123.342 2.695 . . . . 0.88 115.231 -177.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1621 ' ' THR . . . . . 0.663 ' HB ' ' HB2' ' A' 1641 ' ' HIS . 13.0 p -98.82 -11.4 21.82 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 121.728 0.775 . . . . 0.96999999999999997 109.677 178.226 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 48.0 t30 -93.48 64.9 3.7 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 122.457 1.122 . . . . 0.71999999999999997 108.333 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -166.97 140.47 3.05 Favored Pre-proline 0 C--N 1.3 -1.55 0 N-CA-C 106.422 -1.695 . . . . 3.2599999999999998 106.422 -178.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -59.45 110.26 0.69 Allowed 'Trans proline' 0 C--O 1.243 0.766 0 C-N-CA 122.56 2.174 . . . . 0.58999999999999997 111.527 -178.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 74.9 mtm -110.14 141.77 42.57 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 116.078 -0.51 . . . . 1.3700000000000001 110.066 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1626 ' ' LEU . . . . . 0.703 ' HG ' ' HE2' ' A' 1542 ' ' TYR . 1.4 tm? -86.2 119.06 26.08 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 108.141 -1.059 . . . . 0.89000000000000001 108.141 -176.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1627 ' ' ILE . . . . . 0.66 HD11 ' HB2' ' A' 1639 ' ' SER . 44.5 mm -79.69 -55.42 9.2 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 CA-C-O 121.513 0.673 . . . . 0.57999999999999996 109.434 178.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 22.6 t -163.72 148.41 10.62 Favored 'General case' 0 N--CA 1.419 -2.01 0 N-CA-C 107.969 -1.123 . . . . 1.3899999999999999 107.969 -176.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1629 ' ' LEU . . . . . 0.76 HD13 ' HG ' ' A' 1636 ' ' LEU . 50.3 tp -116.91 105.43 12.33 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.662 -0.866 . . . . 1.25 108.662 176.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 12.5 t70 -84.32 106.24 15.78 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.015 -1.476 . . . . 1.0900000000000001 107.015 176.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1631 ' ' LYS . . . . . 0.409 ' HE3' ' HB3' ' A' 1631 ' ' LYS . 14.4 mmmt -85.74 -3.43 58.89 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 112.86 0.689 . . . . 3.6000000000000001 112.86 -175.533 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -87.69 -33.63 18.69 Favored 'General case' 0 N--CA 1.421 -1.888 0 O-C-N 123.43 0.456 . . . . 2.6000000000000001 109.804 -177.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 40.3 p -102.37 -16.34 16.25 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.096 0.474 . . . . 0.75 110.29 173.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1634 ' ' CYS . . . . . 0.471 ' O ' ' HA ' ' A' 1606 ' ' TYR . 60.2 m 72.56 37.57 0.87 Allowed 'General case' 0 C--N 1.355 0.845 0 C-N-CA 125.203 1.401 . . . . 0.53000000000000003 111.307 179.233 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1635 ' ' THR . . . . . . . . . . . . . 94.7 m -103.23 134.03 47.32 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 115.253 -0.885 . . . . 0.46000000000000002 109.697 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1636 ' ' LEU . . . . . 0.76 ' HG ' HD13 ' A' 1629 ' ' LEU . 0.5 OUTLIER -114.97 124.39 51.55 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.548 -0.908 . . . . 0.85999999999999999 108.548 -177.826 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -104.37 130.73 52.22 Favored 'General case' 0 C--O 1.25 1.101 0 N-CA-C 110.37 -0.233 . . . . 0.45000000000000001 110.37 -178.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -127.81 137.99 52.57 Favored 'General case' 0 C--O 1.251 1.135 0 CA-C-O 121.065 0.46 . . . . 0.5 110.48 -178.189 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1639 ' ' SER . . . . . 0.66 ' HB2' HD11 ' A' 1627 ' ' ILE . 21.4 t -116.08 157.95 23.93 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.148 -1.056 . . . . 1.04 108.148 177.083 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 2.3 t90 -156.34 113.21 3.14 Favored 'General case' 0 N--CA 1.409 -2.497 0 N-CA-C 105.349 -2.093 . . . . 0.68000000000000005 105.349 -177.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1641 ' ' HIS . . . . . 0.663 ' HB2' ' HB ' ' A' 1621 ' ' THR . 13.0 m170 -104.01 105.29 15.42 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 109.485 -0.561 . . . . 0.90000000000000002 109.485 -176.341 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1642 ' ' THR . . . . . . . . . . . . . 11.3 t -142.95 145.13 31.99 Favored Pre-proline 0 C--N 1.306 -1.3 0 CA-C-N 116.111 -0.495 . . . . 0.47999999999999998 109.881 -173.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1643 ' ' PRO . . . . . 0.601 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 73.4 Cg_endo -76.49 -10.37 18.82 Favored 'Trans proline' 0 C--N 1.366 1.5 0 C-N-CA 122.595 2.197 . . . . 0.66000000000000003 112.136 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 7.7 tt -69.0 -24.31 64.21 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.396 0.617 . . . . 0.96999999999999997 109.896 177.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -100.1 17.44 21.13 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 122.123 0.963 . . . . 0.83999999999999997 109.21 -176.161 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 20.1 t -121.46 155.04 35.75 Favored 'General case' 0 N--CA 1.41 -2.451 0 N-CA-C 107.761 -1.2 . . . . 1.1899999999999999 107.761 -178.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 31.7 tt0 . . . . . 0 C--N 1.298 -1.633 0 N-CA-C 108.57 -0.9 . . . . 3.1400000000000001 108.57 179.182 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.859 0 N-CA-C 111.92 -0.472 . . . . 2.0899999999999999 111.92 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -75.57 -17.69 80.05 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 121.418 -0.42 . . . . 1.8400000000000001 113.627 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -66.96 -27.29 67.34 Favored 'General case' 0 C--O 1.215 -0.722 0 N-CA-C 109.387 -0.597 . . . . 2.5499999999999998 109.387 -176.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 13' ' ' LEU . . . . . 0.445 ' O ' HD12 ' B' ' 17' ' ' LEU . 32.1 mt -66.85 -61.42 1.96 Allowed 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 115.059 -0.973 . . . . 2.3500000000000001 108.907 -179.05 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 9.9 p -64.39 -40.76 90.17 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.525 0 CA-C-N 114.853 -1.067 . . . . 2.1099999999999999 112.097 -176.016 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -74.47 -26.5 60.07 Favored 'General case' 0 CA--C 1.557 1.246 0 N-CA-C 113.961 1.097 . . . . 2.04 113.961 -176.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 20.4 p -75.0 -43.25 54.98 Favored 'General case' 0 C--O 1.248 0.974 0 O-C-N 121.066 -1.022 . . . . 1.8400000000000001 109.144 175.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.576 ' O ' ' HB2' ' B' ' 21' ' ' CYS . 0.9 OUTLIER -56.06 -40.91 74.26 Favored 'General case' 0 N--CA 1.42 -1.951 0 CA-C-N 114.863 -1.062 . . . . 1.74 111.513 169.471 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 18' ' ' GLN . . . . . 0.46 ' HG2' ' HB2' ' A' 1545 ' ' SER . 8.8 tt0 -71.86 -24.85 61.75 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 121.127 0.489 . . . . 2.3900000000000001 109.718 179.341 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -64.07 -62.68 1.47 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.036 -0.529 . . . . 0.95999999999999996 112.109 178.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 12.6 p -94.65 -20.32 6.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 C-N-CA 118.53 -1.268 . . . . 1.3700000000000001 111.909 -177.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 21' ' ' CYS . . . . . 0.576 ' HB2' ' O ' ' B' ' 17' ' ' LEU . 96.1 m -102.94 18.46 21.56 Favored 'General case' 0 C--N 1.312 -1.027 0 O-C-N 121.834 -0.541 . . . . 1.6599999999999999 111.448 178.266 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -54.02 -50.25 55.87 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 121.355 -0.45 . . . . 1.53 113.219 178.064 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -75.86 -11.13 59.92 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 122.548 0.339 . . . . 2.7200000000000002 111.591 178.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 24' ' ' ARG . . . . . 0.551 ' HG2' ' SG ' ' B' ' 60' ' ' CYS . 21.1 tpp180 -91.53 -50.13 5.94 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.715 0.769 . . . . 4.3300000000000001 110.434 -178.235 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 115.79 157.6 11.32 Favored Glycine 0 N--CA 1.417 -2.593 0 N-CA-C 107.949 -2.06 . . . . 1.53 107.949 -173.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -119.23 137.58 53.56 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 117.943 0.871 . . . . 1.6499999999999999 111.453 177.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -128.89 -54.25 1.22 Allowed 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 107.684 -1.228 . . . . 3.4199999999999999 107.684 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 28' ' ' PHE . . . . . . . . . . . . . 43.4 p90 . . . . . 0 N--CA 1.498 1.958 0 C-N-CA 128.06 2.544 . . . . 2.2599999999999998 117.776 172.55 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.492 -1.375 0 N-CA-C 112.722 -0.151 . . . . 2.3700000000000001 112.722 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 42' ' ' ILE . . . . . 0.535 HD11 HD11 ' B' ' 17' ' ' LEU . 41.4 pt -85.73 -17.55 9.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 O-C-N 122.701 -0.293 . . . . 2.0699999999999998 111.349 -177.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.432 HG23 ' CD1' ' B' ' 13' ' ' LEU . 14.9 p -53.05 -41.39 41.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 N-CA-C 114.456 1.28 . . . . 2.2400000000000002 114.456 -172.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -74.01 -31.92 63.15 Favored 'General case' 0 C--O 1.244 0.793 0 C-N-CA 118.933 -1.107 . . . . 3.3599999999999999 108.876 -175.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -85.22 -14.27 47.33 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 114.869 -1.06 . . . . 3.0800000000000001 112.296 -176.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 46' ' ' CYS . . . . . . . . . . . . . 81.2 m -104.4 -22.76 13.27 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 112.669 0.618 . . . . 2.23 112.669 175.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 95.9 m -79.39 -49.0 13.03 Favored 'General case' 0 C--O 1.239 0.544 0 O-C-N 121.759 -0.588 . . . . 2.3700000000000001 112.27 178.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -97.38 -7.91 30.75 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.115 0.483 . . . . 2.8199999999999998 111.471 -177.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 52.9 mtp180 -139.65 177.64 7.8 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 115.946 -0.57 . . . . 4.0899999999999999 109.483 -176.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 50.9 m -106.46 135.92 47.12 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 115.475 -0.784 . . . . 2.6699999999999999 109.372 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 51' ' ' CYS . . . . . 0.469 ' HB2' HD23 ' B' ' 55' ' ' LEU . 11.7 p -120.63 138.98 53.63 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 109.647 -0.501 . . . . 2.1099999999999999 109.647 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -82.49 142.77 31.61 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.062 0.458 . . . . 2.6699999999999999 109.768 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 53' ' ' LEU . . . . . 0.806 ' HB2' ' HB3' ' A' 1600 ' ' SER . 66.2 tp -37.69 -42.0 0.53 Allowed 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 127.186 2.194 . . . . 1.8999999999999999 113.808 -177.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 54' ' ' ALA . . . . . 0.601 ' O ' HG22 ' B' ' 58' ' ' THR . . . -53.27 -38.97 63.54 Favored 'General case' 0 C--N 1.318 -0.789 0 O-C-N 124.423 1.077 . . . . 1.52 111.635 -177.386 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 55' ' ' LEU . . . . . 0.469 HD23 ' HB2' ' B' ' 51' ' ' CYS . 53.6 tp -59.67 -56.32 23.34 Favored 'General case' 0 C--O 1.213 -0.827 0 O-C-N 124.146 0.903 . . . . 1.97 110.599 -178.044 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 3.3 pp -69.8 -31.04 68.73 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 116.309 -0.405 . . . . 1.53 110.967 -174.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -66.84 -51.65 53.07 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.891 -0.595 . . . . 2.27 111.575 178.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 58' ' ' THR . . . . . 0.601 HG22 ' O ' ' B' ' 54' ' ' ALA . 12.0 t -83.63 -13.24 54.72 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 112.901 0.704 . . . . 2.3300000000000001 112.901 -177.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -85.61 -72.33 0.49 Allowed 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 105.929 -1.878 . . . . 2.8599999999999999 105.929 175.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 60' ' ' CYS . . . . . 0.551 ' SG ' ' HG2' ' B' ' 24' ' ' ARG . 43.7 t . . . . . 0 CA--C 1.568 1.669 0 N-CA-C 114.554 1.316 . . . . 2.2999999999999998 114.554 172.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1515 ' ' ASP . . . . . 0.46 ' HB3' ' HG2' ' A' 1517 ' ' GLN . 23.0 t70 . . . . . 0 N--CA 1.416 -2.164 0 N-CA-C 106.014 -1.847 . . . . 2.8999999999999999 106.014 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 34.9 t -91.09 69.25 6.19 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 107.953 -1.129 . . . . 1.1899999999999999 107.953 -175.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1517 ' ' GLN . . . . . 0.46 ' HG2' ' HB3' ' A' 1515 ' ' ASP . 9.8 pt20 -165.23 148.18 8.13 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-N 114.591 -1.186 . . . . 1.52 108.953 -174.179 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1518 ' ' VAL . . . . . 0.465 ' CG2' HD12 ' A' 1581 ' ' LEU . 3.7 m -145.74 143.06 21.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 C-N-CA 123.344 0.657 . . . . 0.93999999999999995 110.051 177.319 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1519 ' ' THR . . . . . . . . . . . . . 42.6 m -93.83 139.82 30.41 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 116.017 -0.538 . . . . 0.89000000000000001 109.762 177.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1520 ' ' ASN . . . . . 0.523 ' OD1' HG22 ' A' 1523 ' ' THR . 16.4 t-20 -75.29 117.89 66.57 Favored Pre-proline 0 N--CA 1.428 -1.575 0 N-CA-C 107.712 -1.218 . . . . 1.74 107.712 174.108 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.39 -17.71 49.39 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 122.782 2.321 . . . . 1.5800000000000001 113.529 -176.157 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 10.7 m -80.98 -42.97 20.36 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 112.216 0.451 . . . . 1.6499999999999999 112.216 -176.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1523 ' ' THR . . . . . 0.523 HG22 ' OD1' ' A' 1520 ' ' ASN . 6.2 t -120.99 -8.47 9.35 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.674 0.62 . . . . 1.6100000000000001 112.674 -175.525 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 80.39 24.29 59.25 Favored Glycine 0 C--O 1.239 0.446 0 C-N-CA 120.339 -0.934 . . . . 1.1299999999999999 112.826 177.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -89.93 123.17 33.62 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 109.369 -0.604 . . . . 1.26 109.369 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 2.2 tm? -87.58 113.12 22.98 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 123.623 0.769 . . . . 0.68000000000000005 109.237 -177.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -88.87 114.01 25.03 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 109.705 -0.48 . . . . 0.65000000000000002 109.705 176.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 14.6 t70 -101.62 110.37 22.35 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.342 -0.984 . . . . 1.1699999999999999 108.342 177.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1529 ' ' LEU . . . . . 0.444 ' HG ' HD21 ' A' 1581 ' ' LEU . 3.3 mm? -92.11 -2.42 56.62 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.986 0.898 . . . . 0.59999999999999998 109.309 -177.262 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 2.9 m -73.98 -10.27 59.47 Favored 'General case' 0 C--O 1.215 -0.737 0 CA-C-N 114.48 -1.236 . . . . 0.83999999999999997 109.615 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1531 ' ' SER . . . . . 0.585 ' HB2' HD11 ' A' 1644 ' ' LEU . 19.0 m -72.3 -16.97 61.9 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 109.027 -0.731 . . . . 1.5900000000000001 109.027 176.038 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1532 ' ' LEU . . . . . 0.42 ' O ' ' HB ' ' A' 1552 ' ' ILE . 67.9 mt -107.05 5.59 28.18 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.253 -0.885 . . . . 0.65000000000000002 110.891 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1533 ' ' SER . . . . . 0.447 ' HA ' ' O ' ' A' 1552 ' ' ILE . 69.3 p -67.5 164.34 19.09 Favored 'General case' 0 C--O 1.249 1.062 0 CA-C-O 121.367 0.604 . . . . 1.52 111.614 -178.144 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -170.81 142.0 6.84 Favored Glycine 0 N--CA 1.418 -2.561 0 C-N-CA 120.343 -0.932 . . . . 1.1000000000000001 111.151 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1535 ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' 1535 ' ' ARG . 23.1 ttt180 -92.86 -36.41 12.84 Favored 'General case' 0 C--N 1.292 -1.911 0 C-N-CA 122.688 0.395 . . . . 4.6200000000000001 111.156 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -82.93 -36.72 25.0 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.721 0.772 . . . . 1.45 109.421 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1537 ' ' GLY . . . . . 0.408 ' HA3' ' ND2' ' A' 1556 ' ' ASN . . . 97.36 179.19 34.02 Favored Glycine 0 N--CA 1.418 -2.555 0 CA-C-N 114.918 -1.037 . . . . 0.84999999999999998 112.476 173.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -119.84 147.23 44.93 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 107.675 -1.231 . . . . 0.93000000000000005 107.675 178.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 5.5 p -103.37 117.68 35.04 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.334 0.587 . . . . 1.03 111.963 -177.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1540 ' ' ALA . . . . . 0.448 ' HB3' ' CG1' ' A' 1548 ' ' VAL . . . -108.16 121.78 45.55 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 107.927 -1.138 . . . . 0.5 107.927 176.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -70.92 134.07 46.94 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 116.144 -0.48 . . . . 0.73999999999999999 110.761 -178.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1542 ' ' TYR . . . . . 0.47 ' HB3' ' H ' ' A' 1543 ' ' SER . 1.2 t80 -126.94 -99.94 0.37 Allowed 'General case' 0 N--CA 1.418 -2.054 0 N-CA-C 106.564 -1.643 . . . . 0.98999999999999999 106.564 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1543 ' ' SER . . . . . 0.47 ' H ' ' HB3' ' A' 1542 ' ' TYR . 3.3 m -66.06 159.22 26.46 Favored 'General case' 0 N--CA 1.416 -2.126 0 C-N-CA 123.223 0.609 . . . . 1.9099999999999999 110.236 178.642 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -51.23 -44.3 61.66 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.373 0.533 . . . . 3.5899999999999999 112.094 -178.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 7.5 t -117.41 37.64 3.83 Favored 'General case' 0 N--CA 1.424 -1.759 0 N-CA-C 108.999 -0.741 . . . . 2.46 108.999 178.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . -147.44 109.36 0.47 Allowed Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 120.083 -1.056 . . . . 1.26 113.934 -177.087 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 36.0 m -98.89 160.63 3.21 Favored 'Isoleucine or valine' 0 C--O 1.252 1.187 0 N-CA-C 108.876 -0.786 . . . . 0.79000000000000004 108.876 175.13 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1548 ' ' VAL . . . . . 0.505 ' HB ' ' CE1' ' A' 1567 ' ' PHE . 10.9 p -109.33 131.76 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.675 0 N-CA-C 107.647 -1.242 . . . . 0.57999999999999996 107.647 174.51 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -93.27 125.54 37.92 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.988 -1.115 . . . . 1.0800000000000001 107.988 178.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 24.0 ptm -136.39 134.29 37.64 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 120.033 -0.667 . . . . 0.78000000000000003 112.169 -177.165 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 11.9 p -123.41 125.04 44.24 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-N 115.073 -0.967 . . . . 0.96999999999999997 109.73 177.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1552 ' ' ILE . . . . . 0.447 ' O ' ' HA ' ' A' 1533 ' ' SER . 47.9 mm -84.18 124.46 39.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 N-CA-C 109.86 -0.422 . . . . 0.41999999999999998 109.86 -179.04 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1553 ' ' CYS . . . . . 0.434 ' SG ' HG22 ' A' 1552 ' ' ILE . 56.6 m 64.43 26.07 13.44 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.896 0.878 . . . . 1.3999999999999999 112.231 174.329 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . -172.07 -179.23 42.86 Favored Glycine 0 N--CA 1.431 -1.643 0 N-CA-C 110.308 -1.117 . . . . 0.34999999999999998 110.308 -178.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -101.34 145.56 28.74 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 121.283 0.563 . . . . 1.6200000000000001 111.825 -177.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1556 ' ' ASN . . . . . 0.408 ' ND2' ' HA3' ' A' 1537 ' ' GLY . 24.6 t-20 -92.57 137.45 32.35 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.014 -0.994 . . . . 0.87 108.845 -177.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -80.43 -8.83 59.69 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.354 0.872 . . . . 2.4900000000000002 113.354 -172.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -83.62 -9.06 59.15 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 120.946 0.403 . . . . 1.3799999999999999 112.026 -175.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1559 ' ' CYS . . . . . 0.755 ' HB3' HG11 ' A' 1563 ' ' VAL . 9.3 t -136.87 153.71 75.72 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 108.164 -1.05 . . . . 1.21 108.164 -177.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1560 ' ' PRO . . . . . 0.575 ' HD2' ' SG ' ' A' 1559 ' ' CYS . 23.7 Cg_exo -28.84 135.51 0.03 OUTLIER 'Trans proline' 0 C--N 1.379 2.183 1 C-N-CA 125.988 4.459 . . . . 0.70999999999999996 115.133 178.293 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -45.93 120.95 3.85 Favored 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 125.104 3.87 . . . . 0.80000000000000004 114.125 -177.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 101.73 21.75 10.94 Favored Glycine 0 CA--C 1.531 1.081 0 CA-C-N 115.826 -0.625 . . . . 0.46000000000000002 113.045 -176.432 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1563 ' ' VAL . . . . . 0.755 HG11 ' HB3' ' A' 1559 ' ' CYS . 2.3 t -102.02 124.29 55.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 O-C-N 122.162 -0.61 . . . . 0.97999999999999998 110.931 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -97.3 -35.76 5.14 Favored Glycine 0 C--N 1.3 -1.447 0 N-CA-C 110.495 -1.042 . . . . 0.28000000000000003 110.495 175.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -138.58 132.89 31.79 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.202 -0.666 . . . . 0.28000000000000003 109.202 177.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1566 ' ' CYS . . . . . 0.417 ' HB2' HG11 ' A' 1563 ' ' VAL . 53.0 t -156.42 139.3 15.28 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.459 -0.571 . . . . 0.42999999999999999 109.459 -177.308 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1567 ' ' PHE . . . . . 0.505 ' CE1' ' HB ' ' A' 1548 ' ' VAL . 67.3 m-85 -87.3 147.94 25.29 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.294 -0.562 . . . . 1.03 110.0 177.308 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -89.34 40.34 3.06 Favored Glycine 0 N--CA 1.437 -1.265 0 C-N-CA 120.393 -0.908 . . . . 1.1299999999999999 113.363 -175.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1569 ' ' GLN . . . . . 0.419 ' HB2' ' OD2' ' B' ' 15' ' ' ASP . 28.3 mm-40 -95.16 -71.61 0.66 Allowed 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 119.874 -0.731 . . . . 2.5800000000000001 110.449 175.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 81.6 p -130.69 40.65 3.47 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 118.638 0.653 . . . . 2.1699999999999999 112.354 175.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 13.0 mmt85 63.6 49.76 2.96 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 123.923 0.889 . . . . 2.6200000000000001 111.114 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 26.0 mm -98.53 113.72 34.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 N-CA-C 109.149 -0.686 . . . . 0.92000000000000004 109.149 -178.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1573 ' ' SER . . . . . 0.51 ' HB3' ' OG ' ' A' 1596 ' ' SER . 31.6 t -86.11 142.16 28.88 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 121.713 0.768 . . . . 0.80000000000000004 110.402 -176.591 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1574 ' ' VAL . . . . . 0.651 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 30.5 m -124.17 15.09 4.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 CA-C-N 115.495 -0.775 . . . . 0.97999999999999998 110.237 179.139 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . -179.44 123.48 0.85 Allowed Glycine 0 N--CA 1.417 -2.58 0 C-N-CA 118.825 -1.655 . . . . 0.28999999999999998 112.21 177.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1576 ' ' LYS . . . . . 0.437 ' HB2' ' O ' ' A' 1594 ' ' ASP . 57.7 tttp -77.26 134.29 38.61 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 108.013 -1.106 . . . . 2.1899999999999999 108.013 176.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -70.72 117.47 12.28 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.889 -0.596 . . . . 0.60999999999999999 110.74 -177.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -133.56 174.88 9.94 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 106.913 -1.514 . . . . 1.95 106.913 177.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -123.93 45.83 2.39 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 106.184 -1.784 . . . . 2.6800000000000002 106.184 178.077 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.86 88.01 3.9 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 113.527 -1.669 . . . . 3.4700000000000002 107.579 -172.544 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1581 ' ' LEU . . . . . 0.465 HD12 ' CG2' ' A' 1518 ' ' VAL . 0.2 OUTLIER -89.73 133.51 34.65 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.228 -1.027 . . . . 0.64000000000000001 108.228 -177.684 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -122.93 138.57 54.63 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 109.992 -0.373 . . . . 2.8500000000000001 109.992 174.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1583 ' ' TYR . . . . . . . . . . . . . 50.0 t80 -109.43 111.9 23.71 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 107.624 -1.25 . . . . 0.85999999999999999 107.624 177.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1584 ' ' VAL . . . . . 0.623 ' O ' ' HB ' ' A' 1587 ' ' VAL . 14.7 m -131.96 99.02 3.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 112.602 0.594 . . . . 1.05 112.602 -177.249 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 37.4 t70 52.5 66.23 1.28 Allowed 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 124.297 1.039 . . . . 1.1699999999999999 111.605 175.282 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1586 ' ' GLN . . . . . . . . . . . . 0.255 30.1 pt20 65.14 12.4 7.95 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 127.515 2.326 . . . . 1.8600000000000001 112.426 177.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1587 ' ' VAL . . . . . 0.623 ' HB ' ' O ' ' A' 1584 ' ' VAL . 13.9 t -110.51 128.28 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 CA-C-N 114.751 -1.113 . . . . 0.48999999999999999 110.681 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1588 ' ' LEU . . . . . 0.822 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 3.2 mm? -95.28 107.98 20.12 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 106.613 -1.625 . . . . 0.35999999999999999 106.613 176.006 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -115.48 116.77 28.76 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-O 121.672 0.748 . . . . 1.74 112.692 -174.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1590 ' ' LEU . . . . . 0.448 ' HG ' HD22 ' A' 1581 ' ' LEU . 5.7 mt -100.18 108.06 20.08 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 114.197 -1.365 . . . . 0.71999999999999997 107.38 172.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 10.0 p -99.09 126.82 52.24 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.15 0 CA-C-O 121.531 0.681 . . . . 1.01 110.089 -179.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1592 ' ' TYR . . . . . 0.404 ' O ' ' HA ' ' A' 1607 ' ' LYS . 12.4 m-30 -113.28 99.21 7.63 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 109.317 -0.623 . . . . 0.5 109.317 177.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 60.1 pttt -111.41 179.39 4.04 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.585 -0.895 . . . . 1.5900000000000001 108.585 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1594 ' ' ASP . . . . . 0.437 ' O ' ' HB2' ' A' 1576 ' ' LYS . 32.3 m-20 57.82 45.9 17.83 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.108 0.963 . . . . 1.1100000000000001 110.955 178.514 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -79.59 -95.3 0.33 Allowed Glycine 0 CA--C 1.498 -0.979 0 N-CA-C 109.791 -1.324 . . . . 0.78000000000000003 109.791 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1596 ' ' SER . . . . . 0.51 ' OG ' ' HB3' ' A' 1573 ' ' SER . 72.2 m -124.94 149.35 62.83 Favored Pre-proline 0 C--N 1.273 -2.736 0 N-CA-C 107.216 -1.402 . . . . 1.0700000000000001 107.216 173.425 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -61.92 138.4 73.44 Favored 'Trans proline' 0 N--CA 1.445 -1.367 0 C-N-CA 122.273 1.982 . . . . 1.01 109.229 174.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1598 ' ' CYS . . . . . 0.51 ' HA ' ' CE2' ' A' 1606 ' ' TYR . 5.0 t -70.02 113.47 17.91 Favored Pre-proline 0 C--N 1.296 -1.718 0 N-CA-C 106.954 -1.499 . . . . 0.75 106.954 -178.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1599 ' ' PRO . . . . . 0.461 ' HD3' ' HE2' ' A' 1606 ' ' TYR . 24.2 Cg_exo -62.89 -33.78 74.08 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.984 2.456 . . . . 1.7 113.008 -173.145 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1600 ' ' SER . . . . . 0.674 ' HB2' ' HG ' ' B' ' 53' ' ' LEU . 5.2 m -86.18 7.6 24.39 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 116.307 -0.406 . . . . 2.2599999999999998 112.061 178.125 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1601 ' ' LYS . . . . . 0.565 ' HG2' HD22 ' A' 1604 ' ' LEU . 3.0 tppp? -161.5 96.4 1.05 Allowed 'General case' 0 C--O 1.251 1.141 0 O-C-N 121.743 -0.598 . . . . 3.0099999999999998 110.316 175.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 13.0 t -66.76 126.05 27.79 Favored 'General case' 0 N--CA 1.401 -2.886 0 N-CA-C 108.649 -0.871 . . . . 2.0699999999999998 108.649 -176.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 106.2 -6.5 39.69 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 116.443 -0.344 . . . . 1.0800000000000001 112.334 -177.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1604 ' ' LEU . . . . . 0.565 HD22 ' HG2' ' A' 1601 ' ' LYS . 7.5 mp -106.34 155.97 18.98 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 122.94 0.496 . . . . 1.8400000000000001 109.981 176.303 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 44.8 t -135.24 151.06 50.25 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 107.99 -1.115 . . . . 1.4099999999999999 107.99 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1606 ' ' TYR . . . . . 0.651 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 90.8 m-85 -80.45 150.86 29.58 Favored 'General case' 0 N--CA 1.419 -2.012 0 N-CA-C 108.903 -0.777 . . . . 0.59999999999999998 108.903 176.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1607 ' ' LYS . . . . . 0.404 ' HA ' ' O ' ' A' 1592 ' ' TYR . 33.8 ttpt -150.82 127.46 10.85 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 123.623 0.577 . . . . 1.45 109.716 -175.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1608 ' ' SER . . . . . 0.402 ' HB2' ' HB2' ' A' 1592 ' ' TYR . 20.7 m -105.35 115.96 31.15 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 109.437 -0.579 . . . . 1.1499999999999999 109.437 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 38.4 t -98.41 107.07 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 108.103 -1.073 . . . . 0.25 108.103 176.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 70.5 mt -100.25 101.37 12.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 CA-C-N 115.765 -0.652 . . . . 0.45000000000000001 109.304 -179.205 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 5.9 p -100.2 119.02 37.71 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.619 0.723 . . . . 1.26 112.694 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1612 ' ' PHE . . . . . 0.822 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 72.0 m-85 -94.51 122.27 36.91 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.131 -0.94 . . . . 0.26000000000000001 109.744 177.126 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 42.0 t -119.99 138.67 49.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-N 115.397 -0.819 . . . . 0.5 109.475 -175.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 13.2 t -58.75 113.54 2.09 Favored 'General case' 0 C--O 1.243 0.732 0 C-N-CA 124.352 1.061 . . . . 0.77000000000000002 111.856 178.28 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1615 ' ' ARG . . . . . 0.697 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 23.7 tpt180 -136.64 97.46 11.43 Favored Pre-proline 0 N--CA 1.431 -1.386 0 N-CA-C 109.272 -0.64 . . . . 2.5299999999999998 109.272 175.562 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1616 ' ' PRO . . . . . 0.464 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 60.5 Cg_endo -73.62 -14.9 24.62 Favored 'Trans proline' 0 N--CA 1.487 1.138 0 C-N-CA 122.551 2.167 . . . . 1.1000000000000001 112.846 -177.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -91.82 42.68 1.11 Allowed 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 124.704 1.201 . . . . 3.0499999999999998 110.333 -176.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -30.72 127.96 0.14 Allowed 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 126.648 1.979 . . . . 1.55 113.591 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1619 ' ' GLY . . . . . 0.426 ' HA3' ' HD2' ' A' 1620 ' ' PRO . . . 178.63 -145.14 6.66 Favored Glycine 0 N--CA 1.428 -1.843 0 N-CA-C 109.846 -1.302 . . . . 0.93000000000000005 109.846 -178.117 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1620 ' ' PRO . . . . . 0.426 ' HD2' ' HA3' ' A' 1619 ' ' GLY . 27.2 Cg_endo -61.44 -4.07 3.91 Favored 'Trans proline' 0 CA--C 1.556 1.581 0 C-N-CA 123.568 2.846 . . . . 0.88 115.756 -177.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1621 ' ' THR . . . . . . . . . . . . . 23.3 p -91.96 -10.06 40.75 Favored 'General case' 0 C--O 1.247 0.939 0 O-C-N 121.563 -0.711 . . . . 0.96999999999999997 110.662 176.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 47.1 t30 -90.43 58.66 4.07 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 122.338 1.066 . . . . 0.71999999999999997 109.378 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -163.69 139.43 5.13 Favored Pre-proline 0 C--N 1.309 -1.192 0 CA-C-N 114.455 -1.248 . . . . 3.2599999999999998 107.916 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -65.11 102.04 0.43 Allowed 'Trans proline' 0 C--O 1.239 0.528 0 C-N-CA 123.314 2.676 . . . . 0.58999999999999997 112.837 -175.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 75.3 mtm -107.34 146.59 31.39 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.897 -0.592 . . . . 1.3700000000000001 111.049 -178.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 1.6 tm? -86.76 115.34 24.13 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 107.438 -1.319 . . . . 0.89000000000000001 107.438 -176.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 49.2 mm -79.16 -56.49 7.02 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-O 121.26 0.552 . . . . 0.57999999999999996 109.792 179.277 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 66.5 m -161.36 147.22 14.12 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.513 -0.767 . . . . 1.3899999999999999 109.704 -177.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1629 ' ' LEU . . . . . 0.823 HD13 ' HG ' ' A' 1636 ' ' LEU . 42.7 tp -113.92 112.85 24.01 Favored 'General case' 0 N--CA 1.424 -1.737 0 N-CA-C 107.428 -1.323 . . . . 1.25 107.428 172.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 30.6 t70 -85.93 110.75 19.66 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.68 -1.23 . . . . 1.0900000000000001 107.68 174.001 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1631 ' ' LYS . . . . . 0.659 ' HB3' HD22 ' B' ' 53' ' ' LEU . 0.1 OUTLIER -73.72 -31.6 63.47 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.761 -0.654 . . . . 3.6000000000000001 110.086 -174.037 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -70.16 -36.82 74.99 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-N 115.481 -0.781 . . . . 2.6000000000000001 112.863 -173.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 54.8 p -101.32 -6.52 24.01 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.032 0.444 . . . . 0.75 110.7 175.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1634 ' ' CYS . . . . . 0.501 ' O ' ' HA ' ' A' 1606 ' ' TYR . 32.7 m 63.27 40.85 8.33 Favored 'General case' 0 C--N 1.364 1.209 0 C-N-CA 124.546 1.138 . . . . 0.53000000000000003 109.961 -178.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1635 ' ' THR . . . . . . . . . . . . . 55.9 m -106.24 133.71 50.51 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.924 -1.034 . . . . 0.46000000000000002 110.356 -176.165 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1636 ' ' LEU . . . . . 0.823 ' HG ' HD13 ' A' 1629 ' ' LEU . 0.7 OUTLIER -116.85 131.69 56.89 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.443 -0.577 . . . . 0.85999999999999999 109.443 -177.709 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -111.23 128.09 55.81 Favored 'General case' 0 C--O 1.252 1.199 0 CA-C-O 120.821 0.343 . . . . 0.45000000000000001 111.012 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -125.61 131.82 52.62 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.92 -0.77 . . . . 0.5 108.92 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1639 ' ' SER . . . . . . . . . . . . . 64.6 m -115.46 140.7 48.9 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 122.892 0.477 . . . . 1.04 109.857 178.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 3.1 t90 -142.35 114.29 8.12 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 104.327 -2.471 . . . . 0.68000000000000005 104.327 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1641 ' ' HIS . . . . . 0.697 ' HB3' ' HB2' ' A' 1615 ' ' ARG . 31.5 m-70 -106.26 112.44 25.46 Favored 'General case' 0 C--N 1.293 -1.886 0 C-N-CA 119.916 -0.714 . . . . 0.90000000000000002 110.005 -177.193 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1642 ' ' THR . . . . . . . . . . . . . 3.9 t -142.46 150.42 54.56 Favored Pre-proline 0 C--N 1.302 -1.491 0 CA-C-N 115.615 -0.72 . . . . 0.47999999999999998 109.512 -172.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1643 ' ' PRO . . . . . 0.464 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 71.9 Cg_endo -77.07 -10.75 17.93 Favored 'Trans proline' 0 C--N 1.362 1.251 0 C-N-CA 122.411 2.074 . . . . 0.66000000000000003 111.464 176.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1644 ' ' LEU . . . . . 0.585 HD11 ' HB2' ' A' 1531 ' ' SER . 7.3 tt -68.36 -24.33 64.79 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.712 0.805 . . . . 0.96999999999999997 110.493 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -95.04 6.96 47.61 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 122.187 0.994 . . . . 0.83999999999999997 109.619 -177.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 15.6 t -123.9 159.11 30.4 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-N 114.404 -1.271 . . . . 1.1899999999999999 108.579 -175.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 31.7 tt0 . . . . . 0 C--N 1.308 -1.208 0 N-CA-C 108.455 -0.943 . . . . 3.1400000000000001 108.455 169.573 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.549 0 N-CA-C 112.071 -0.411 . . . . 2.0899999999999999 112.071 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.98 -21.95 73.77 Favored Glycine 0 C--N 1.311 -0.847 0 C-N-CA 121.72 -0.276 . . . . 1.8400000000000001 113.353 179.135 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -71.46 -20.83 62.04 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.728 0.775 . . . . 2.5499999999999998 109.265 -176.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 13' ' ' LEU . . . . . 0.443 ' O ' HD23 ' B' ' 17' ' ' LEU . 62.1 mt -68.14 -49.59 60.09 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 115.059 -0.973 . . . . 2.3500000000000001 108.419 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 8.5 p -77.66 -18.12 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 CA-C-N 115.111 -0.95 . . . . 2.1099999999999999 110.488 -176.052 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 15' ' ' ASP . . . . . 0.419 ' OD2' ' HB2' ' A' 1569 ' ' GLN . 12.5 t70 -62.83 -67.53 0.41 Allowed 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 109.535 -0.543 . . . . 2.04 109.535 176.215 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 15.2 t -61.13 -36.6 80.18 Favored 'General case' 0 C--O 1.25 1.125 0 O-C-N 123.635 0.584 . . . . 1.8400000000000001 111.226 -176.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.572 HD21 HD11 ' B' ' 42' ' ' ILE . 4.0 mm? -57.37 -49.6 75.64 Favored 'General case' 0 C--O 1.215 -0.757 0 N-CA-C 113.109 0.781 . . . . 1.74 113.109 175.079 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -84.75 -14.97 46.66 Favored 'General case' 0 C--N 1.317 -0.809 0 O-C-N 121.583 -0.698 . . . . 2.3900000000000001 111.034 -178.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -63.86 -54.66 31.34 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 116.314 -0.403 . . . . 0.95999999999999996 111.017 176.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 16.0 m -98.18 -14.52 7.73 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.691 0 C-N-CA 118.911 -1.116 . . . . 1.3700000000000001 112.319 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 21' ' ' CYS . . . . . 0.503 ' HB2' ' O ' ' B' ' 17' ' ' LEU . 68.7 m -114.49 23.03 13.12 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 120.358 -0.537 . . . . 1.6599999999999999 111.666 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -52.22 -40.49 52.5 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 114.557 0.583 . . . . 1.53 114.557 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -86.12 -31.93 21.59 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 113.753 1.019 . . . . 2.7200000000000002 113.753 -178.056 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -90.52 -25.03 20.46 Favored 'General case' 0 C--O 1.248 0.991 0 CA-C-O 121.353 0.597 . . . . 4.3300000000000001 111.44 -176.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 109.29 163.06 19.97 Favored Glycine 0 N--CA 1.439 -1.132 0 N-CA-C 110.183 -1.167 . . . . 1.53 110.183 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -123.62 131.11 53.54 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 117.52 0.66 . . . . 1.6499999999999999 110.96 179.119 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -136.71 80.84 1.84 Allowed 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 111.754 0.279 . . . . 3.4199999999999999 111.754 -177.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 28' ' ' PHE . . . . . 0.548 ' HA ' ' HE2' ' B' ' 59' ' ' TYR . 34.3 p90 . . . . . 0 C--N 1.304 -1.378 0 CA-C-O 121.7 0.762 . . . . 2.2599999999999998 109.674 173.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.409 -3.146 0 N-CA-C 110.248 -1.141 . . . . 2.3700000000000001 110.248 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 42' ' ' ILE . . . . . 0.572 HD11 HD21 ' B' ' 17' ' ' LEU . 10.2 pt 59.65 -28.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 C-N-CA 127.737 2.415 . . . . 2.0699999999999998 116.491 176.019 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 43' ' ' VAL . . . . . . . . . . . . 0.26 2.7 p -51.41 -49.53 31.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 114.958 1.466 . . . . 2.2400000000000002 114.958 -175.381 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -96.12 -26.0 15.65 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.357 -0.979 . . . . 3.3599999999999999 108.357 -176.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 45' ' ' GLU . . . . . 0.528 ' O ' ' HB2' ' B' ' 49' ' ' ARG . 9.5 tp10 -60.9 -43.72 98.12 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 114.933 -1.03 . . . . 3.0800000000000001 109.428 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 46' ' ' CYS . . . . . 0.4 ' HA ' ' O ' ' B' ' 49' ' ' ARG . 10.1 t -94.48 -14.62 24.97 Favored 'General case' 0 C--N 1.314 -0.956 0 O-C-N 121.988 -0.445 . . . . 2.23 111.736 -177.203 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 52.2 t -66.75 -47.74 71.29 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.141 -0.623 . . . . 2.3700000000000001 110.181 179.135 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -105.71 -12.77 15.78 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 113.152 0.797 . . . . 2.8199999999999998 113.152 -177.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 49' ' ' ARG . . . . . 0.528 ' HB2' ' O ' ' B' ' 45' ' ' GLU . 64.7 mtt180 -125.6 158.68 34.05 Favored 'General case' 0 CA--C 1.498 -1.036 0 N-CA-C 108.35 -0.981 . . . . 4.0899999999999999 108.35 178.552 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 23.0 t -84.61 123.55 30.45 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 109.562 -0.533 . . . . 2.6699999999999999 109.562 -177.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 51' ' ' CYS . . . . . 0.473 ' HB2' HD23 ' B' ' 55' ' ' LEU . 29.4 p -105.81 133.52 50.41 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 108.316 -0.994 . . . . 2.1099999999999999 108.316 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -80.27 147.37 31.21 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.685 -1.228 . . . . 2.6699999999999999 107.685 177.127 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 53' ' ' LEU . . . . . 0.803 ' H ' HD12 ' B' ' 53' ' ' LEU . 3.0 mp -52.49 -29.04 22.92 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 125.789 1.635 . . . . 1.8999999999999999 112.185 -175.272 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 54' ' ' ALA . . . . . 0.42 ' O ' HG22 ' B' ' 58' ' ' THR . . . -61.96 -37.81 86.15 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 123.581 0.551 . . . . 1.52 110.772 -178.61 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 55' ' ' LEU . . . . . 0.473 HD23 ' HB2' ' B' ' 51' ' ' CYS . 50.5 tp -59.93 -50.59 73.17 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-N 115.787 -0.642 . . . . 1.97 110.617 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 3.9 pp -75.54 -32.76 60.57 Favored 'General case' 0 N--CA 1.422 -1.85 0 CA-C-N 116.202 -0.453 . . . . 1.53 111.99 -174.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -71.24 -42.44 68.84 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 112.195 0.442 . . . . 2.27 112.195 -176.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 58' ' ' THR . . . . . 0.42 HG22 ' O ' ' B' ' 54' ' ' ALA . 12.2 t -78.09 -25.4 47.58 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 118.83 -1.148 . . . . 2.3300000000000001 111.742 176.236 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 59' ' ' TYR . . . . . 0.548 ' HE2' ' HA ' ' B' ' 28' ' ' PHE . 30.2 t80 -67.5 -68.55 0.37 Allowed 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 106.576 -1.639 . . . . 2.8599999999999999 106.576 176.667 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 42.0 t . . . . . 0 CA--C 1.559 1.311 0 C-N-CA 125.391 1.476 . . . . 2.2999999999999998 114.213 173.274 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 14.0 t70 . . . . . 0 N--CA 1.435 -1.195 0 N-CA-C 105.395 -2.076 . . . . 2.8999999999999999 105.395 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A 1516 ' ' CYS . . . . . 0.561 ' HA ' ' HB2' ' A' 1581 ' ' LEU . 91.1 m -88.5 66.5 8.26 Favored 'General case' 0 C--N 1.283 -2.293 0 CA-C-O 121.68 0.752 . . . . 1.1899999999999999 110.926 -177.306 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -152.22 130.86 12.3 Favored 'General case' 0 N--CA 1.415 -2.206 0 CA-C-N 114.666 -1.152 . . . . 1.52 109.301 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1518 ' ' VAL . . . . . 0.569 HG21 ' HB2' ' A' 1583 ' ' TYR . 2.9 m -145.12 142.9 22.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 C-N-CA 123.926 0.89 . . . . 0.93999999999999995 110.153 -179.067 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1519 ' ' THR . . . . . . . . . . . . . 18.9 m -101.81 145.34 29.31 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 116.301 -0.409 . . . . 0.89000000000000001 111.026 -177.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1520 ' ' ASN . . . . . 0.404 ' OD1' HG22 ' A' 1523 ' ' THR . 24.5 t-20 -76.2 111.88 17.72 Favored Pre-proline 0 N--CA 1.433 -1.289 0 N-CA-C 106.389 -1.708 . . . . 1.74 106.389 170.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -74.21 0.46 8.44 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.491 2.127 . . . . 1.5800000000000001 113.736 -174.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 19.6 m -91.15 -43.22 10.01 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 116.256 -0.429 . . . . 1.6499999999999999 111.603 177.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1523 ' ' THR . . . . . 0.404 HG22 ' OD1' ' A' 1520 ' ' ASN . 4.9 t -119.24 -8.86 10.05 Favored 'General case' 0 C--O 1.244 0.79 0 C-N-CA 119.943 -0.703 . . . . 1.6100000000000001 112.43 -177.41 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 85.95 20.37 55.73 Favored Glycine 0 C--N 1.317 -0.494 0 C-N-CA 120.423 -0.894 . . . . 1.1299999999999999 113.095 177.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 24.3 t-80 -84.35 123.63 30.4 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.057 0.455 . . . . 1.26 110.574 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 2.9 tm? -94.71 119.32 33.14 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 115.336 -0.847 . . . . 0.68000000000000005 110.943 -175.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -91.64 130.83 37.38 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 109.604 -0.517 . . . . 0.65000000000000002 109.604 169.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 16.3 t70 -125.64 122.56 36.75 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.452 -1.314 . . . . 1.1699999999999999 107.452 173.272 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 3.7 mm? -93.86 5.87 50.26 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 113.683 0.994 . . . . 0.59999999999999998 113.683 -170.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1530 ' ' SER . . . . . 0.571 ' HA ' ' OG ' ' A' 1533 ' ' SER . 3.6 m -66.16 -7.94 21.03 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 113.804 1.039 . . . . 0.83999999999999997 113.804 -174.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 8.5 t -69.22 -31.88 70.76 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 109.391 -0.596 . . . . 1.5900000000000001 109.391 179.035 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 81.1 mt -95.38 -7.03 39.63 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.069 0.461 . . . . 0.65000000000000002 110.795 -178.063 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1533 ' ' SER . . . . . 0.571 ' OG ' ' HA ' ' A' 1530 ' ' SER . 24.5 m -66.97 161.3 24.55 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.85 -0.614 . . . . 1.52 111.433 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . 155.86 159.82 9.61 Favored Glycine 0 N--CA 1.423 -2.174 0 N-CA-C 109.811 -1.316 . . . . 1.1000000000000001 109.811 -176.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1535 ' ' ARG . . . . . 0.428 ' O ' ' HA ' ' A' 1556 ' ' ASN . 42.2 ttp180 -92.26 -31.16 15.52 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 109.972 -0.381 . . . . 4.6200000000000001 109.972 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -66.67 -34.01 76.91 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 121.126 0.488 . . . . 1.45 110.878 -177.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 73.75 -157.29 51.48 Favored Glycine 0 N--CA 1.428 -1.85 0 CA-C-N 115.042 -0.981 . . . . 0.84999999999999998 113.676 172.174 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -137.26 152.05 49.38 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.84 -1.17 . . . . 0.93000000000000005 107.84 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 27.0 p -112.73 139.75 48.09 Favored 'General case' 0 C--N 1.308 -1.215 0 O-C-N 123.489 0.493 . . . . 1.03 111.177 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1540 ' ' ALA . . . . . 0.478 ' HB3' HG12 ' A' 1548 ' ' VAL . . . -131.35 135.14 46.99 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 108.409 -0.96 . . . . 0.5 108.409 174.577 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -73.58 141.7 46.62 Favored 'General case' 0 C--O 1.243 0.719 0 C-N-CA 122.601 0.36 . . . . 0.73999999999999999 110.866 -178.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1542 ' ' TYR . . . . . 0.481 ' HB3' ' H ' ' A' 1543 ' ' SER . 1.3 t80 -149.43 -101.14 0.07 Allowed 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 109.285 -0.635 . . . . 0.98999999999999999 109.285 -176.383 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1543 ' ' SER . . . . . 0.481 ' H ' ' HB3' ' A' 1542 ' ' TYR . 4.3 m -63.95 160.24 18.17 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.468 1.107 . . . . 1.9099999999999999 111.225 -178.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 52.3 tptt -50.76 -41.38 56.67 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 113.611 0.967 . . . . 3.5899999999999999 113.611 -173.081 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 11.9 t -128.75 37.93 4.03 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 108.785 -0.82 . . . . 2.46 108.785 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1546 ' ' GLY . . . . . 0.583 ' HA3' ' HG2' ' A' 1569 ' ' GLN . . . -147.96 120.34 1.21 Allowed Glycine 0 N--CA 1.428 -1.859 0 C-N-CA 119.555 -1.307 . . . . 1.26 113.573 -177.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 29.3 m -99.89 152.58 4.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 107.001 -1.481 . . . . 0.79000000000000004 107.001 174.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1548 ' ' VAL . . . . . 0.478 HG12 ' HB3' ' A' 1540 ' ' ALA . 12.3 p -92.76 134.42 30.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.865 0 C-N-CA 119.922 -0.711 . . . . 0.57999999999999996 109.202 178.192 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -99.87 129.13 45.93 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 115.355 -0.839 . . . . 1.0800000000000001 108.763 177.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 25.8 ptm -144.14 126.27 15.55 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 115.453 -0.794 . . . . 0.78000000000000003 110.972 -176.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 5.3 p -118.55 132.89 56.2 Favored 'General case' 0 C--N 1.282 -2.355 0 CA-C-N 115.002 -0.999 . . . . 0.96999999999999997 109.795 179.047 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1552 ' ' ILE . . . . . . . . . . . . . 46.8 mm -83.28 112.15 20.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 120.477 0.18 . . . . 0.41999999999999998 111.159 -176.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 57.9 m 64.99 29.6 12.17 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.622 1.169 . . . . 1.3999999999999999 112.093 174.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . -167.01 -174.8 36.55 Favored Glycine 0 N--CA 1.409 -3.113 0 N-CA-C 108.961 -1.656 . . . . 0.34999999999999998 108.961 -178.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -109.78 152.86 25.16 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-N 116.845 0.323 . . . . 1.6200000000000001 111.724 -175.31 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1556 ' ' ASN . . . . . 0.428 ' HA ' ' O ' ' A' 1535 ' ' ARG . 26.7 t-20 -103.29 138.63 39.81 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.008 -1.108 . . . . 0.87 108.008 178.64 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -85.97 2.33 46.66 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 114.06 1.133 . . . . 2.4900000000000002 114.06 -171.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -91.03 -1.81 57.75 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 120.491 -0.484 . . . . 1.3799999999999999 111.027 -178.484 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1559 ' ' CYS . . . . . 0.62 ' SG ' ' HD2' ' A' 1560 ' ' PRO . 16.0 t -137.43 151.74 71.81 Favored Pre-proline 0 C--N 1.304 -1.373 0 N-CA-C 106.648 -1.612 . . . . 1.21 106.648 178.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1560 ' ' PRO . . . . . 0.62 ' HD2' ' SG ' ' A' 1559 ' ' CYS . 13.3 Cg_exo -30.6 132.13 0.05 OUTLIER 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 125.226 3.95 . . . . 0.70999999999999996 114.655 178.393 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -45.02 129.25 9.86 Favored 'Trans proline' 0 C--N 1.364 1.385 0 C-N-CA 124.768 3.645 . . . . 0.80000000000000004 113.332 -177.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 96.6 18.98 28.67 Favored Glycine 0 C--N 1.313 -0.727 0 CA-C-N 116.204 -0.453 . . . . 0.46000000000000002 113.14 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1563 ' ' VAL . . . . . 0.596 HG11 ' HB2' ' A' 1566 ' ' CYS . 2.3 t -106.61 124.51 62.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 C-N-CA 123.02 0.528 . . . . 0.97999999999999998 111.661 -178.744 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -97.27 -33.97 5.77 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 115.242 -0.89 . . . . 0.28000000000000003 111.814 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -133.94 129.59 36.51 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 109.018 -0.734 . . . . 0.28000000000000003 109.018 177.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1566 ' ' CYS . . . . . 0.596 ' HB2' HG11 ' A' 1563 ' ' VAL . 48.5 t -158.32 138.11 12.09 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 110.52 -0.178 . . . . 0.42999999999999999 110.52 -176.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -84.72 135.45 34.14 Favored 'General case' 0 C--O 1.245 0.859 0 N-CA-C 108.428 -0.953 . . . . 1.03 108.428 173.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -91.79 27.71 9.55 Favored Glycine 0 N--CA 1.422 -2.286 0 N-CA-C 115.88 1.112 . . . . 1.1299999999999999 115.88 -170.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1569 ' ' GLN . . . . . 0.605 ' HB2' ' OD2' ' B' ' 15' ' ' ASP . 20.8 mt-30 -77.49 -69.04 0.56 Allowed 'General case' 0 C--O 1.241 0.617 0 C-N-CA 117.349 -1.74 . . . . 2.5800000000000001 109.579 171.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 71.0 p -114.33 15.7 17.98 Favored 'General case' 0 CA--C 1.553 1.058 0 N-CA-C 112.809 0.67 . . . . 2.1699999999999999 112.809 177.491 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? 66.43 68.78 0.43 Allowed 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.923 1.289 . . . . 2.6200000000000001 112.703 -179.333 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 18.8 mt -106.3 122.61 60.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 114.727 -1.124 . . . . 0.92000000000000004 108.793 177.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 35.7 t -83.2 138.53 33.59 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.669 0.747 . . . . 0.80000000000000004 111.244 -174.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1574 ' ' VAL . . . . . 0.589 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 27.1 m -123.39 18.05 5.03 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 CA-C-N 115.661 -0.699 . . . . 0.97999999999999998 110.392 178.211 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 167.52 126.44 0.84 Allowed Glycine 0 N--CA 1.422 -2.253 0 CA-C-N 115.113 -0.949 . . . . 0.28999999999999998 112.383 175.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 53.9 tttm -68.64 146.03 53.38 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.525 -0.917 . . . . 2.1899999999999999 108.525 177.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -73.48 79.45 1.43 Allowed 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.208 0.528 . . . . 0.60999999999999999 111.566 -178.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -96.35 -177.6 4.02 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 109.263 -0.643 . . . . 1.95 109.263 178.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 66.7 mttm -132.38 47.56 2.5 Favored 'General case' 0 CA--C 1.485 -1.548 0 N-CA-C 105.28 -2.119 . . . . 2.6800000000000002 105.28 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.49 76.62 5.83 Favored 'General case' 0 N--CA 1.415 -2.197 0 CA-C-N 113.773 -1.558 . . . . 3.4700000000000002 108.593 -171.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1581 ' ' LEU . . . . . 0.561 ' HB2' ' HA ' ' A' 1516 ' ' CYS . 0.3 OUTLIER -86.14 129.58 34.8 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.608 -1.178 . . . . 0.64000000000000001 108.691 -179.309 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A 1582 ' ' ARG . . . . . 0.547 ' HB2' ' HB3' ' A' 1589 ' ' GLN . 70.3 mtp180 -124.15 137.26 54.57 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 116.522 -0.308 . . . . 2.8500000000000001 110.273 173.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1583 ' ' TYR . . . . . 0.569 ' HB2' HG21 ' A' 1518 ' ' VAL . 66.9 t80 -105.62 104.37 14.07 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 107.853 -1.165 . . . . 0.85999999999999999 107.853 177.385 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1584 ' ' VAL . . . . . 0.529 ' O ' ' HB ' ' A' 1587 ' ' VAL . 16.7 m -121.2 89.51 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 112.81 0.67 . . . . 1.05 112.81 -175.202 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 17.4 t70 56.91 57.9 4.38 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.119 0.968 . . . . 1.1699999999999999 110.134 177.059 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1586 ' ' GLN . . . . . 0.53 ' HA ' ' CE1' ' A' 1583 ' ' TYR 0.296 9.1 pt20 68.87 4.67 4.58 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 128.196 2.598 . . . . 1.8600000000000001 112.637 179.116 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A 1587 ' ' VAL . . . . . 0.529 ' HB ' ' O ' ' A' 1584 ' ' VAL . 23.1 t -93.71 124.03 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.012 0 N-CA-C 108.491 -0.929 . . . . 0.48999999999999999 108.491 174.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1588 ' ' LEU . . . . . 0.859 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 3.4 mm? -92.73 107.77 19.47 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.157 -1.053 . . . . 0.35999999999999999 108.157 178.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1589 ' ' GLN . . . . . 0.547 ' HB3' ' HB2' ' A' 1582 ' ' ARG . 35.5 tt0 -99.05 123.65 43.5 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 116.025 -0.534 . . . . 1.74 110.23 -178.031 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1590 ' ' LEU . . . . . 0.476 ' HB3' ' HB ' ' A' 1610 ' ' ILE . 0.7 OUTLIER -117.83 96.02 5.18 Favored 'General case' 0 C--N 1.284 -2.27 0 N-CA-C 105.065 -2.198 . . . . 0.71999999999999997 105.065 174.885 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 8.4 p -96.31 132.16 41.29 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 CA-C-O 121.317 0.579 . . . . 1.01 111.665 -175.081 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1592 ' ' TYR . . . . . . . . . . . . . 14.2 m-30 -121.51 122.18 39.15 Favored 'General case' 0 CA--C 1.496 -1.12 0 N-CA-C 108.306 -0.998 . . . . 0.5 108.306 176.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 58.4 pttt -131.09 179.04 6.24 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 108.98 -0.748 . . . . 1.5900000000000001 108.98 177.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 19.9 m-20 62.17 53.2 2.97 Favored 'General case' 0 C--O 1.249 1.049 0 O-C-N 124.286 0.992 . . . . 1.1100000000000001 110.864 178.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -85.67 -105.23 0.71 Allowed Glycine 0 N--CA 1.429 -1.796 0 N-CA-C 109.558 -1.417 . . . . 0.78000000000000003 109.558 177.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1596 ' ' SER . . . . . . . . . . . . . 36.3 p -129.11 153.63 80.37 Favored Pre-proline 0 C--N 1.282 -2.331 0 N-CA-C 107.753 -1.202 . . . . 1.0700000000000001 107.753 174.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 90.7 Cg_exo -50.67 133.76 39.21 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.287 2.658 . . . . 1.01 113.509 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1598 ' ' CYS . . . . . 0.517 ' HA ' ' CE2' ' A' 1606 ' ' TYR . 44.4 t -81.83 119.27 74.89 Favored Pre-proline 0 C--N 1.283 -2.285 0 CA-C-N 113.875 -1.512 . . . . 0.75 109.018 -178.234 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1599 ' ' PRO . . . . . 0.488 ' HD2' ' OH ' ' A' 1606 ' ' TYR . 40.2 Cg_exo -60.43 -23.92 76.34 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 123.097 2.532 . . . . 1.7 112.965 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1600 ' ' SER . . . . . 0.741 ' HA ' ' HB2' ' B' ' 53' ' ' LEU . 19.5 m -54.37 -44.81 72.54 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 123.364 0.665 . . . . 2.2599999999999998 111.782 178.503 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1601 ' ' LYS . . . . . 0.548 ' HB3' HD12 ' A' 1604 ' ' LEU . 4.5 tppp? -148.24 127.88 13.31 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.97 -0.752 . . . . 3.0099999999999998 108.97 179.409 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 20.4 m -65.48 129.48 39.9 Favored 'General case' 0 N--CA 1.412 -2.345 0 N-CA-C 108.796 -0.816 . . . . 2.0699999999999998 108.796 -178.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 105.25 -10.87 47.53 Favored Glycine 0 N--CA 1.436 -1.359 0 C-N-CA 120.496 -0.859 . . . . 1.0800000000000001 112.499 178.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1604 ' ' LEU . . . . . 0.548 HD12 ' HB3' ' A' 1601 ' ' LYS . 67.6 mt -99.33 150.19 22.38 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.667 -0.494 . . . . 1.8400000000000001 109.667 178.356 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 22.4 t -123.4 153.15 40.79 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.555 -1.276 . . . . 1.4099999999999999 107.555 177.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1606 ' ' TYR . . . . . 0.589 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 49.6 m-85 -73.77 158.48 34.52 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 116.171 -0.468 . . . . 0.59999999999999998 111.903 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 20.0 ttpp -156.26 125.87 6.31 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.808 -0.633 . . . . 1.45 110.502 -178.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1608 ' ' SER . . . . . . . . . . . . . 20.0 m -106.45 129.86 54.35 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 109.015 -0.735 . . . . 1.1499999999999999 109.015 -179.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 26.2 t -114.21 102.41 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.598 0 N-CA-C 108.508 -0.923 . . . . 0.25 108.508 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1610 ' ' ILE . . . . . 0.476 ' HB ' ' HB3' ' A' 1590 ' ' LEU . 85.4 mt -90.11 113.8 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.662 0 N-CA-C 108.709 -0.848 . . . . 0.45000000000000001 108.709 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 34.5 m -109.64 106.76 16.56 Favored 'General case' 0 C--N 1.283 -2.288 0 CA-C-N 114.855 -1.066 . . . . 1.26 110.249 -178.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1612 ' ' PHE . . . . . 0.859 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 45.7 m-85 -80.27 119.24 22.76 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.88 -0.6 . . . . 0.26000000000000001 109.79 176.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1613 ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' 1641 ' ' HIS . 54.1 t -109.64 128.83 65.39 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-N 115.004 -0.998 . . . . 0.5 110.927 -174.149 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 5.8 t -55.19 109.44 0.53 Allowed 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 125.012 1.325 . . . . 0.77000000000000002 112.97 176.219 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1615 ' ' ARG . . . . . 0.808 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 4.3 tpt180 -129.08 94.36 34.07 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 106.963 -1.495 . . . . 2.5299999999999998 106.963 169.579 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1616 ' ' PRO . . . . . 0.631 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 37.6 Cg_endo -63.47 -32.41 70.9 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 122.789 2.326 . . . . 1.1000000000000001 115.999 -169.264 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -85.94 -18.16 33.44 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.211 -0.595 . . . . 3.0499999999999998 111.646 -176.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . 68.65 113.15 0.04 OUTLIER 'General case' 0 C--N 1.358 0.949 0 C-N-CA 125.23 1.412 . . . . 1.55 110.937 -174.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . -131.25 -155.87 8.3 Favored Glycine 0 N--CA 1.422 -2.292 0 C-N-CA 119.976 -1.107 . . . . 0.93000000000000005 111.208 -177.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -82.43 20.88 1.05 Allowed 'Trans proline' 0 C--O 1.235 0.375 0 C-N-CA 123.253 2.635 . . . . 0.88 113.588 -174.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1621 ' ' THR . . . . . . . . . . . . . 22.4 p -116.71 14.4 15.33 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-O 121.901 0.858 . . . . 0.96999999999999997 109.717 178.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 42.6 t30 -90.68 58.9 4.04 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 122.802 1.287 . . . . 0.71999999999999997 108.325 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1623 ' ' ARG . . . . . 0.412 ' HE ' ' HB2' ' A' 1623 ' ' ARG . 3.5 ptm180 -168.05 140.55 2.51 Favored Pre-proline 0 N--CA 1.428 -1.551 0 CA-C-N 113.486 -1.688 . . . . 3.2599999999999998 107.003 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1624 ' ' PRO . . . . . 0.451 ' HA ' ' O ' ' A' 1639 ' ' SER . 35.7 Cg_endo -61.98 103.99 0.31 Allowed 'Trans proline' 0 C--O 1.243 0.733 0 C-N-CA 123.133 2.555 . . . . 0.58999999999999997 113.012 -176.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 69.9 mtm -99.66 144.92 28.18 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.988 -0.551 . . . . 1.3700000000000001 109.869 176.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 1.5 tm? -86.89 115.33 24.23 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 106.883 -1.525 . . . . 0.89000000000000001 106.883 -176.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1627 ' ' ILE . . . . . 0.753 HD11 ' HB2' ' A' 1639 ' ' SER . 38.6 mm -75.94 -58.35 4.67 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.605 0 CA-C-O 121.589 0.709 . . . . 0.57999999999999996 109.186 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 40.3 m -164.18 151.3 11.78 Favored 'General case' 0 N--CA 1.427 -1.575 0 N-CA-C 107.639 -1.245 . . . . 1.3899999999999999 107.639 -174.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1629 ' ' LEU . . . . . 0.712 HD13 ' HG ' ' A' 1636 ' ' LEU . 33.0 tp -116.05 104.7 11.83 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 107.102 -1.444 . . . . 1.25 107.102 172.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 14.3 t70 -75.35 100.99 4.58 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.082 -1.047 . . . . 1.0900000000000001 108.63 178.072 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1631 ' ' LYS . . . . . 0.794 ' HD3' ' H ' ' A' 1631 ' ' LYS . 0.0 OUTLIER -65.31 -8.48 18.35 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 114.336 1.236 . . . . 3.6000000000000001 114.336 -175.677 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -96.06 -37.89 10.43 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 119.409 -0.916 . . . . 2.6000000000000001 110.909 -179.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 66.9 p -94.74 -16.4 23.07 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 116.026 -0.534 . . . . 0.75 110.798 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 74.5 m 68.59 35.76 3.08 Favored 'General case' 0 C--N 1.353 0.73 0 C-N-CA 124.572 1.149 . . . . 0.53000000000000003 110.698 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1635 ' ' THR . . . . . . . . . . . . . 41.3 m -99.19 131.79 44.97 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 114.455 -1.248 . . . . 0.46000000000000002 109.693 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1636 ' ' LEU . . . . . 0.712 ' HG ' HD13 ' A' 1629 ' ' LEU . 0.5 OUTLIER -110.24 121.62 45.72 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.638 -1.245 . . . . 0.85999999999999999 107.638 -179.018 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -101.93 129.46 48.2 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 120.898 0.38 . . . . 0.45000000000000001 110.836 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -125.83 137.37 53.76 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.312 -0.858 . . . . 0.5 109.82 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1639 ' ' SER . . . . . 0.753 ' HB2' HD11 ' A' 1627 ' ' ILE . 16.5 t -117.81 150.8 38.55 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.288 -1.004 . . . . 1.04 108.288 178.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 2.8 t90 -152.55 113.63 4.2 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 104.868 -2.271 . . . . 0.68000000000000005 104.868 -179.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1641 ' ' HIS . . . . . 0.808 ' HB3' ' HB2' ' A' 1615 ' ' ARG . 10.6 m-70 -101.2 111.13 23.26 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-O 121.357 0.599 . . . . 0.90000000000000002 109.79 -176.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1642 ' ' THR . . . . . . . . . . . . . 3.2 t -142.57 148.14 45.56 Favored Pre-proline 0 C--N 1.297 -1.71 0 CA-C-N 115.148 -0.933 . . . . 0.47999999999999998 109.278 -174.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1643 ' ' PRO . . . . . 0.631 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 58.9 Cg_endo -79.42 -14.41 13.06 Favored 'Trans proline' 0 C--N 1.363 1.318 0 C-N-CA 122.28 1.987 . . . . 0.66000000000000003 112.847 178.58 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 8.2 tt -70.76 -26.93 63.58 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.796 -0.816 . . . . 0.96999999999999997 108.796 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1645 ' ' ALA . . . . . 0.414 ' CB ' ' HB3' ' A' 1612 ' ' PHE . . . -99.09 28.42 4.44 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 114.718 -1.128 . . . . 0.83999999999999997 110.44 -177.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 47.7 t -121.57 140.95 51.58 Favored 'General case' 0 N--CA 1.419 -1.997 0 N-CA-C 108.794 -0.817 . . . . 1.1899999999999999 108.794 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 16.8 tp10 . . . . . 0 N--CA 1.421 -1.921 0 N-CA-C 107.629 -1.249 . . . . 3.1400000000000001 107.629 177.208 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.806 0 N-CA-C 110.911 -0.875 . . . . 2.0899999999999999 110.911 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -57.16 -64.66 4.2 Favored Glycine 0 C--N 1.33 0.24 0 N-CA-C 113.919 0.328 . . . . 1.8400000000000001 113.919 -177.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -63.96 -32.32 73.81 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 109.349 -0.611 . . . . 2.5499999999999998 109.349 -178.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 13' ' ' LEU . . . . . 0.478 ' O ' HD23 ' B' ' 17' ' ' LEU . 0.1 OUTLIER -60.29 -59.56 5.22 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 114.441 -1.254 . . . . 2.3500000000000001 109.214 -178.926 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 14.2 p -69.21 -33.31 57.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 112.259 0.466 . . . . 2.1099999999999999 112.259 -176.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 15' ' ' ASP . . . . . 0.605 ' OD2' ' HB2' ' A' 1569 ' ' GLN . 11.9 t0 -59.86 -53.34 59.09 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 120.164 -0.614 . . . . 2.04 109.444 179.299 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 34.5 m -57.29 -51.14 70.56 Favored 'General case' 0 CA--C 1.566 1.571 0 C-N-CA 123.983 0.913 . . . . 1.8400000000000001 111.322 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.542 ' HG ' ' HD2' ' B' ' 28' ' ' PHE . 4.2 mm? -53.72 -46.98 70.99 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.628 -0.715 . . . . 1.74 112.214 176.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -83.15 -10.67 58.51 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-O 121.554 0.692 . . . . 2.3900000000000001 111.558 -177.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -68.5 -56.78 7.22 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.719 -0.673 . . . . 0.95999999999999996 110.283 177.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 15.0 p -95.32 -22.83 5.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 C-N-CA 118.571 -1.252 . . . . 1.3700000000000001 112.063 -176.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 60.3 m -108.81 27.01 9.89 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 120.197 -0.601 . . . . 1.6599999999999999 110.13 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -54.16 -54.82 29.53 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 121.171 -0.538 . . . . 1.53 113.125 178.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -71.97 -43.11 65.69 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 112.168 0.433 . . . . 2.7200000000000002 112.168 178.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 39.1 ttm180 -67.73 -49.36 62.96 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 112.452 0.538 . . . . 4.3300000000000001 112.452 -175.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 125.84 140.86 5.43 Favored Glycine 0 N--CA 1.437 -1.244 0 N-CA-C 110.002 -1.239 . . . . 1.53 110.002 -175.251 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 26' ' ' PHE . . . . . 0.473 ' HB2' ' HB3' ' B' ' 17' ' ' LEU . 30.6 p90 -113.69 130.22 56.45 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 117.121 0.46 . . . . 1.6499999999999999 109.99 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -133.45 73.64 1.52 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.679 0.622 . . . . 3.4199999999999999 112.679 -177.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 28' ' ' PHE . . . . . 0.542 ' HD2' ' HG ' ' B' ' 17' ' ' LEU . 34.3 p90 . . . . . 0 C--N 1.306 -1.295 0 C-N-CA 119.223 -0.991 . . . . 2.2599999999999998 109.013 173.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.407 -3.259 0 N-CA-C 109.773 -1.331 . . . . 2.3700000000000001 109.773 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 42' ' ' ILE . . . . . 0.538 HD11 HD21 ' B' ' 17' ' ' LEU . 20.0 pt 61.51 -30.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 C-N-CA 127.953 2.501 . . . . 2.0699999999999998 114.821 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.63 ' O ' ' HB2' ' B' ' 47' ' ' CYS . 2.6 p -49.88 -43.01 19.27 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 114.236 1.199 . . . . 2.2400000000000002 114.236 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -96.28 -35.04 11.39 Favored 'General case' 0 N--CA 1.429 -1.523 0 C-N-CA 120.207 -0.597 . . . . 3.3599999999999999 109.566 -175.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 45' ' ' GLU . . . . . 0.427 ' HG3' ' HD2' ' B' ' 49' ' ' ARG . 33.7 tt0 -63.87 -45.4 89.59 Favored 'General case' 0 C--O 1.202 -1.431 0 CA-C-N 115.905 -0.589 . . . . 3.0800000000000001 109.769 179.276 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 46' ' ' CYS . . . . . . . . . . . . . 29.3 m -85.16 -4.16 59.06 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.216 0.531 . . . . 2.23 110.88 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 47' ' ' CYS . . . . . 0.63 ' HB2' ' O ' ' B' ' 43' ' ' VAL . 42.2 t -77.62 -45.36 25.35 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.523 0.677 . . . . 2.3700000000000001 109.195 175.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -105.23 -10.25 17.19 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 113.236 0.828 . . . . 2.8199999999999998 113.236 -176.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 49' ' ' ARG . . . . . 0.427 ' HD2' ' HG3' ' B' ' 45' ' ' GLU . 93.0 mtt180 -129.47 171.31 12.69 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 106.956 -1.498 . . . . 4.0899999999999999 106.956 177.563 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 22.7 t -99.71 148.11 24.72 Favored 'General case' 0 N--CA 1.426 -1.66 0 N-CA-C 107.609 -1.256 . . . . 2.6699999999999999 107.609 173.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 76.9 m -125.98 142.01 51.71 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 109.553 -0.536 . . . . 2.1099999999999999 109.553 -175.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -81.77 161.79 23.15 Favored 'General case' 0 C--O 1.243 0.725 0 O-C-N 123.15 0.281 . . . . 2.6699999999999999 110.88 176.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 53' ' ' LEU . . . . . 0.741 ' HB2' ' HA ' ' A' 1600 ' ' SER . 62.7 tp -55.33 -36.23 66.04 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 122.508 0.323 . . . . 1.8999999999999999 111.405 178.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.9 -26.51 65.96 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 123.648 0.779 . . . . 1.52 112.556 -174.151 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 52.6 tp -74.44 -54.56 7.32 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 109.551 -0.537 . . . . 1.97 109.551 177.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 56' ' ' LEU . . . . . 0.5 ' O ' ' HB2' ' B' ' 60' ' ' CYS . 2.8 pp -70.92 -33.32 70.41 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-N 115.923 -0.58 . . . . 1.53 111.392 -174.421 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -54.47 -51.39 65.2 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 123.663 0.602 . . . . 2.27 111.318 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 8.9 t -82.7 -28.29 30.65 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 112.492 0.553 . . . . 2.3300000000000001 112.492 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -78.38 -36.27 46.13 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 121.807 -0.558 . . . . 2.8599999999999999 110.695 -175.265 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 60' ' ' CYS . . . . . 0.5 ' HB2' ' O ' ' B' ' 56' ' ' LEU . 12.0 t . . . . . 0 N--CA 1.493 1.69 0 C-N-CA 126.011 1.724 . . . . 2.2999999999999998 111.84 -178.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 26.5 p-10 . . . . . 0 N--CA 1.414 -2.234 0 N-CA-C 107.068 -1.456 . . . . 2.8999999999999999 107.068 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 11.8 m -87.06 51.07 2.14 Favored 'General case' 0 C--N 1.276 -2.628 0 CA-C-N 115.703 -0.68 . . . . 1.1899999999999999 110.271 -174.219 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1517 ' ' GLN . . . . . 0.416 ' HA ' ' O ' ' A' 1527 ' ' PHE . 10.8 pt20 -162.98 132.05 4.09 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-O 121.23 0.538 . . . . 1.52 111.381 -174.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 6.6 m -135.46 144.79 33.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 CA-C-N 116.083 -0.508 . . . . 0.93999999999999995 110.038 179.472 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1519 ' ' THR . . . . . . . . . . . . . 28.9 m -114.65 134.52 55.0 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.386 -0.598 . . . . 0.89000000000000001 109.386 177.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1520 ' ' ASN . . . . . 0.529 ' OD1' HG22 ' A' 1523 ' ' THR . 13.9 t-20 -89.98 115.23 63.46 Favored Pre-proline 0 N--CA 1.43 -1.429 0 N-CA-C 108.322 -0.992 . . . . 1.74 108.322 175.291 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -66.54 -16.51 51.09 Favored 'Trans proline' 0 CA--C 1.533 0.439 0 C-N-CA 122.898 2.399 . . . . 1.5800000000000001 113.514 -175.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1522 ' ' SER . . . . . 0.45 ' HB2' ' OD1' ' A' 1520 ' ' ASN . 15.9 m -71.8 -50.05 33.26 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 116.439 -0.346 . . . . 1.6499999999999999 111.393 -179.067 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1523 ' ' THR . . . . . 0.529 HG22 ' OD1' ' A' 1520 ' ' ASN . 9.9 t -111.62 -1.86 15.61 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 120.479 -0.488 . . . . 1.6100000000000001 111.524 -176.254 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 66.58 33.26 84.0 Favored Glycine 0 CA--C 1.501 -0.817 0 CA-C-N 115.737 -0.665 . . . . 1.1299999999999999 112.41 177.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 55.5 t-80 -94.85 123.73 38.48 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 119.971 -0.692 . . . . 1.26 109.408 -178.56 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 2.0 tm? -93.71 111.52 23.22 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.101 -1.074 . . . . 0.68000000000000005 108.101 179.398 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1527 ' ' PHE . . . . . 0.416 ' O ' ' HA ' ' A' 1517 ' ' GLN . 74.0 m-85 -94.0 115.32 27.65 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.92 -0.488 . . . . 0.65000000000000002 110.217 176.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 20.5 t70 -104.78 113.3 26.8 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 109.188 -0.671 . . . . 1.1699999999999999 109.188 176.384 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1529 ' ' LEU . . . . . 0.507 ' HG ' HD21 ' A' 1581 ' ' LEU . 3.0 mm? -102.31 2.33 36.76 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 108.727 -0.842 . . . . 0.59999999999999998 108.727 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 2.1 m -66.98 -27.97 67.88 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.659 -0.7 . . . . 0.83999999999999997 109.886 -177.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 27.7 t -69.85 -18.41 63.43 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.866 -0.606 . . . . 1.5900000000000001 110.637 178.467 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1532 ' ' LEU . . . . . 0.491 ' O ' ' HB ' ' A' 1552 ' ' ILE . 74.8 mt -94.76 0.83 55.27 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.323 0.583 . . . . 0.65000000000000002 110.192 -178.52 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1533 ' ' SER . . . . . . . . . . . . . 41.5 m -77.72 164.72 25.01 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 109.351 -0.611 . . . . 1.52 109.351 175.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -179.62 155.01 14.62 Favored Glycine 0 N--CA 1.421 -2.362 0 N-CA-C 108.386 -1.886 . . . . 1.1000000000000001 108.386 178.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 58.0 ttp180 -86.49 -29.27 22.89 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 121.092 0.472 . . . . 4.6200000000000001 110.852 -177.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -88.01 -29.42 20.73 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.445 0.641 . . . . 1.45 110.021 177.077 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 94.06 -155.77 22.06 Favored Glycine 0 N--CA 1.418 -2.514 0 CA-C-N 115.299 -0.864 . . . . 0.84999999999999998 111.645 175.029 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -130.49 148.39 52.29 Favored 'General case' 0 C--N 1.278 -2.535 0 N-CA-C 107.546 -1.279 . . . . 0.93000000000000005 107.546 177.671 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 7.3 p -109.15 132.73 53.84 Favored 'General case' 0 C--N 1.292 -1.913 0 O-C-N 123.677 0.611 . . . . 1.03 111.001 -176.397 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1540 ' ' ALA . . . . . 0.444 ' HB3' ' CG1' ' A' 1548 ' ' VAL . . . -125.65 144.34 50.64 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.9 -1.148 . . . . 0.5 107.9 175.281 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -77.35 132.04 38.38 Favored 'General case' 0 C--N 1.313 -1.008 0 O-C-N 123.556 0.535 . . . . 0.73999999999999999 110.312 -177.056 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1542 ' ' TYR . . . . . 0.722 ' HE2' ' HG ' ' A' 1626 ' ' LEU . 9.3 t80 -136.76 -99.79 0.21 Allowed 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.326 -0.99 . . . . 0.98999999999999999 108.326 -178.499 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1543 ' ' SER . . . . . 0.406 ' H ' ' HB3' ' A' 1542 ' ' TYR . 47.7 t -86.84 160.82 18.62 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-O 121.602 0.715 . . . . 1.9099999999999999 109.726 -175.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -72.39 -18.52 61.72 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.637 -0.71 . . . . 3.5899999999999999 110.724 -178.231 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 13.2 t -87.63 -41.07 13.67 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.156 0.503 . . . . 2.46 110.22 -178.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . -153.27 159.05 28.34 Favored Glycine 0 N--CA 1.431 -1.69 0 C-N-CA 120.708 -0.758 . . . . 1.26 112.021 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 33.7 m -94.59 -179.41 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 107.929 -1.137 . . . . 0.79000000000000004 107.929 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1548 ' ' VAL . . . . . 0.444 ' CG1' ' HB3' ' A' 1540 ' ' ALA . 14.2 p -104.37 135.94 39.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 C-N-CA 119.716 -0.794 . . . . 0.57999999999999996 109.561 177.132 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1549 ' ' TYR . . . . . 0.429 ' HB3' ' ND2' ' A' 1556 ' ' ASN . 86.1 m-85 -102.05 129.28 48.33 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 108.81 -0.811 . . . . 1.0800000000000001 108.81 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 26.1 ptm -148.43 132.96 17.7 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 116.045 -0.525 . . . . 0.78000000000000003 111.484 -178.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 6.8 p -118.89 126.47 51.87 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 115.775 -0.648 . . . . 0.96999999999999997 110.041 178.515 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1552 ' ' ILE . . . . . 0.491 ' HB ' ' O ' ' A' 1532 ' ' LEU . 36.0 mm -77.6 112.46 15.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 112.362 0.505 . . . . 0.41999999999999998 112.362 -177.174 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 46.3 t 62.12 32.12 17.54 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.398 1.079 . . . . 1.3999999999999999 110.977 174.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . -163.96 174.28 40.08 Favored Glycine 0 N--CA 1.422 -2.281 0 N-CA-C 108.947 -1.661 . . . . 0.34999999999999998 108.947 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -100.54 155.0 18.09 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 117.48 0.64 . . . . 1.6200000000000001 110.761 -178.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1556 ' ' ASN . . . . . 0.429 ' ND2' ' HB3' ' A' 1549 ' ' TYR . 49.8 t-20 -108.4 132.74 53.45 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 115.05 -0.977 . . . . 0.87 109.236 -176.248 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -82.72 1.83 36.77 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.599 0.592 . . . . 2.4900000000000002 112.599 -176.33 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -78.89 -19.95 50.63 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.326 0.584 . . . . 1.3799999999999999 110.273 176.219 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1559 ' ' CYS . . . . . 0.645 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 76.1 m -132.71 172.42 7.41 Favored Pre-proline 0 C--N 1.299 -1.612 0 CA-C-O 117.795 -1.098 . . . . 1.21 109.871 -178.038 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1560 ' ' PRO . . . . . 0.645 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 18.1 Cg_exo -36.84 148.22 0.06 OUTLIER 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 124.296 3.33 . . . . 0.70999999999999996 115.747 178.489 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -58.73 127.72 25.49 Favored 'Trans proline' 0 C--O 1.254 1.292 0 C-N-CA 123.626 2.884 . . . . 0.80000000000000004 112.113 178.353 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 92.45 9.12 61.95 Favored Glycine 0 N--CA 1.438 -1.213 0 CA-C-N 115.942 -0.572 . . . . 0.46000000000000002 112.124 -179.38 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1563 ' ' VAL . . . . . 0.567 ' HB ' ' O ' ' A' 1560 ' ' PRO . 2.8 t -96.09 124.55 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.339 0 CA-C-O 121.021 0.438 . . . . 0.97999999999999998 111.231 179.522 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -101.73 -31.95 5.27 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 115.147 -0.933 . . . . 0.28000000000000003 112.069 178.467 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -128.62 129.8 46.39 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 109.669 -0.493 . . . . 0.28000000000000003 109.669 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 11.4 t -159.52 136.48 9.48 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 116.409 -0.36 . . . . 0.42999999999999999 110.395 -176.361 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -89.71 149.89 22.56 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 121.991 -0.443 . . . . 1.03 110.763 177.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -89.05 20.81 30.9 Favored Glycine 0 N--CA 1.438 -1.227 0 CA-C-N 116.69 -0.232 . . . . 1.1299999999999999 113.492 -177.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1569 ' ' GLN . . . . . 0.551 ' HG3' ' HD1' ' B' ' 19' ' ' PHE . 15.8 mm100 -68.22 -69.94 0.29 Allowed 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.579 -0.897 . . . . 2.5800000000000001 108.579 173.573 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 6.0 p -130.09 28.49 5.02 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.28 0.562 . . . . 2.1699999999999999 111.056 175.359 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 12.6 mmt85 60.56 48.1 7.81 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 115.157 -0.929 . . . . 2.6200000000000001 110.808 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 40.2 mt -93.38 129.12 44.28 Favored 'Isoleucine or valine' 0 C--O 1.247 0.964 0 CA-C-N 115.392 -0.822 . . . . 0.92000000000000004 110.039 179.376 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 29.0 t -80.74 148.95 29.88 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 123.605 0.762 . . . . 0.80000000000000004 111.416 -178.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1574 ' ' VAL . . . . . . . . . . . . . 29.8 m -134.78 12.6 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 115.859 -0.609 . . . . 0.97999999999999998 110.522 176.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 175.52 131.64 1.48 Allowed Glycine 0 N--CA 1.423 -2.214 0 C-N-CA 119.46 -1.352 . . . . 0.28999999999999998 112.627 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1576 ' ' LYS . . . . . 0.415 ' HE3' ' HB2' ' A' 1576 ' ' LYS . 39.0 ttmt -74.79 147.69 41.01 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.759 -0.83 . . . . 2.1899999999999999 108.759 177.623 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -73.93 79.26 1.65 Allowed 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 115.813 -0.63 . . . . 0.60999999999999999 111.136 -178.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -89.77 146.65 24.32 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 115.657 -0.701 . . . . 1.95 110.393 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -111.15 45.96 1.13 Allowed 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.527 -1.286 . . . . 2.6800000000000002 107.527 -176.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -101.42 76.78 1.72 Allowed 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 114.007 -1.451 . . . . 3.4700000000000002 107.401 -176.5 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1581 ' ' LEU . . . . . 0.507 HD21 ' HG ' ' A' 1529 ' ' LEU . 0.4 OUTLIER -74.11 124.06 25.59 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.309 -1.367 . . . . 0.64000000000000001 107.309 178.531 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -126.22 140.93 52.16 Favored 'General case' 0 C--N 1.288 -2.099 0 C-N-CA 119.92 -0.712 . . . . 2.8500000000000001 111.617 177.344 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1583 ' ' TYR . . . . . 0.456 ' CE1' ' HA ' ' A' 1586 ' ' GLN . 72.4 t80 -108.43 123.24 48.56 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.044 -1.095 . . . . 0.85999999999999999 108.044 178.608 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1584 ' ' VAL . . . . . 0.561 ' O ' ' HB ' ' A' 1587 ' ' VAL . 12.5 p -149.25 110.91 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-O 121.433 0.635 . . . . 1.05 111.044 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 30.7 t70 56.99 55.23 6.26 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 125.247 1.419 . . . . 1.1699999999999999 111.257 -178.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1586 ' ' GLN . . . . . 0.456 ' HA ' ' CE1' ' A' 1583 ' ' TYR . 13.7 pt20 60.72 9.51 2.22 Favored 'General case' 0 N--CA 1.499 2.015 0 C-N-CA 126.864 2.066 . . . . 1.8600000000000001 112.498 177.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1587 ' ' VAL . . . . . 0.561 ' HB ' ' O ' ' A' 1584 ' ' VAL . 20.5 t -102.08 127.88 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.327 0 CA-C-N 113.877 -1.51 . . . . 0.48999999999999999 109.326 178.563 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1588 ' ' LEU . . . . . 0.943 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 2.4 mm? -92.34 117.48 29.95 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 106.605 -1.628 . . . . 0.35999999999999999 106.605 178.158 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -119.88 133.32 55.62 Favored 'General case' 0 C--N 1.283 -2.302 0 CA-C-O 121.806 0.813 . . . . 1.74 111.86 -176.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 11.2 mt -121.25 112.21 18.34 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 106.807 -1.553 . . . . 0.71999999999999997 106.807 173.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 6.1 p -101.39 125.36 55.42 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.33 0 C-N-CA 119.92 -0.712 . . . . 1.01 109.683 -178.173 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1592 ' ' TYR . . . . . 0.647 ' HB2' ' HB2' ' A' 1608 ' ' SER . 14.1 m-30 -107.23 136.45 47.04 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 108.345 -0.983 . . . . 0.5 108.345 178.736 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 13.2 ptmm? -150.47 177.41 10.03 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 108.192 -1.04 . . . . 1.5900000000000001 108.192 -172.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 28.4 m-20 59.56 63.93 1.43 Allowed 'General case' 0 C--N 1.317 -0.835 0 O-C-N 124.591 1.182 . . . . 1.1100000000000001 111.163 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -112.81 -126.13 4.52 Favored Glycine 0 N--CA 1.424 -2.103 0 N-CA-C 109.877 -1.289 . . . . 0.78000000000000003 109.877 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1596 ' ' SER . . . . . 0.427 ' HA ' ' HD3' ' A' 1597 ' ' PRO . 49.7 m -87.4 140.51 32.07 Favored Pre-proline 0 C--N 1.295 -1.765 0 N-CA-C 109.311 -0.626 . . . . 1.0700000000000001 109.311 177.359 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1597 ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' 1596 ' ' SER . 38.2 Cg_exo -62.51 119.95 7.27 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 122.293 1.995 . . . . 1.01 108.275 173.473 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1598 ' ' CYS . . . . . 0.481 ' HA ' ' HD3' ' A' 1599 ' ' PRO . 37.8 t -77.33 128.2 81.06 Favored Pre-proline 0 C--N 1.294 -1.825 0 CA-C-N 115.728 -0.669 . . . . 0.75 109.612 -173.131 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1599 ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' 1598 ' ' CYS . 16.9 Cg_exo -68.35 -28.46 33.05 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.46 2.773 . . . . 1.7 112.639 -176.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1600 ' ' SER . . . . . . . . . . . . . 2.0 m -59.94 -42.55 94.27 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 123.748 0.819 . . . . 2.2599999999999998 111.935 -178.182 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1601 ' ' LYS . . . . . 0.543 ' HB3' HD22 ' A' 1604 ' ' LEU . 3.8 tppp? -131.54 105.21 7.41 Favored 'General case' 0 N--CA 1.407 -2.613 0 N-CA-C 107.207 -1.405 . . . . 3.0099999999999998 107.207 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 36.8 p -51.76 121.75 7.07 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 123.531 0.52 . . . . 2.0699999999999998 111.972 179.241 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 92.44 11.41 59.58 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.93 -0.652 . . . . 1.0800000000000001 112.369 178.616 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1604 ' ' LEU . . . . . 0.543 HD22 ' HB3' ' A' 1601 ' ' LYS . 9.4 tp -109.56 160.25 16.41 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.913 -1.143 . . . . 1.8400000000000001 107.913 179.079 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 29.5 t -123.51 157.48 33.48 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 109.073 -0.714 . . . . 1.4099999999999999 109.073 177.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1606 ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -71.97 153.5 41.77 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 108.118 -1.067 . . . . 0.59999999999999998 108.118 172.617 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.42 126.4 7.72 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.216 0.531 . . . . 1.45 110.533 -175.237 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1608 ' ' SER . . . . . 0.647 ' HB2' ' HB2' ' A' 1592 ' ' TYR . 16.4 m -105.07 128.58 53.41 Favored 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 115.323 -0.853 . . . . 1.1499999999999999 109.129 -175.236 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 34.4 t -111.22 101.74 12.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 CA-C-O 121.268 0.556 . . . . 0.25 109.795 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1610 ' ' ILE . . . . . 0.43 ' HA ' ' HB2' ' A' 1638 ' ' PHE . 96.8 mt -91.62 117.57 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.608 0 N-CA-C 108.84 -0.8 . . . . 0.45000000000000001 108.84 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 32.7 m -120.38 116.72 26.04 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.69 -0.686 . . . . 1.26 110.902 -178.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1612 ' ' PHE . . . . . 0.943 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 70.7 m-85 -90.41 122.69 33.5 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.787 -0.642 . . . . 0.26000000000000001 109.386 177.701 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 43.7 t -113.39 140.89 31.25 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 CA-C-N 115.306 -0.861 . . . . 0.5 109.308 -176.111 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 35.3 t -71.91 111.23 6.98 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.162 -0.472 . . . . 0.77000000000000002 111.308 -178.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1615 ' ' ARG . . . . . 0.728 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 19.8 tpt180 -124.92 87.39 55.32 Favored Pre-proline 0 CA--C 1.54 0.585 0 N-CA-C 109.331 -0.618 . . . . 2.5299999999999998 109.331 174.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1616 ' ' PRO . . . . . 0.459 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 39.3 Cg_exo -62.8 -35.06 70.41 Favored 'Trans proline' 0 N--CA 1.483 0.855 0 C-N-CA 123.128 2.552 . . . . 1.1000000000000001 114.365 -173.674 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -79.09 -13.24 59.87 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 112.491 0.552 . . . . 3.0499999999999998 112.491 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . 66.57 -168.12 0.21 Allowed 'General case' 0 C--N 1.318 -0.775 0 O-C-N 124.507 1.13 . . . . 1.55 109.266 -174.152 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . 148.42 -163.39 28.96 Favored Glycine 0 N--CA 1.413 -2.835 0 N-CA-C 110.394 -1.082 . . . . 0.93000000000000005 110.394 179.371 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -82.65 21.42 1.0 Allowed 'Trans proline' 0 C--N 1.327 -0.574 0 C-N-CA 123.755 2.97 . . . . 0.88 111.971 -176.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1621 ' ' THR . . . . . 0.633 ' HB ' ' HB2' ' A' 1641 ' ' HIS . 18.6 p -108.08 -0.5 21.13 Favored 'General case' 0 C--N 1.282 -2.353 0 CA-C-N 113.933 -1.485 . . . . 0.96999999999999997 109.899 -178.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -88.46 56.85 3.96 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 122.332 1.063 . . . . 0.71999999999999997 109.258 -177.11 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1623 ' ' ARG . . . . . 0.563 ' O ' ' HG3' ' A' 1625 ' ' MET . 27.4 ptt180 -165.96 141.09 3.93 Favored Pre-proline 0 C--N 1.29 -1.996 0 N-CA-C 106.449 -1.685 . . . . 3.2599999999999998 106.449 -178.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -53.81 104.55 0.11 Allowed 'Trans proline' 0 CA--C 1.534 0.49 0 C-N-CA 123.187 2.591 . . . . 0.58999999999999997 111.901 -178.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1625 ' ' MET . . . . . 0.563 ' HG3' ' O ' ' A' 1623 ' ' ARG . 92.1 mtp -98.3 110.2 22.83 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.335 -0.987 . . . . 1.3700000000000001 108.335 -176.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1626 ' ' LEU . . . . . 0.722 ' HG ' ' HE2' ' A' 1542 ' ' TYR . 0.7 OUTLIER -72.92 112.87 9.35 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 106.756 -1.572 . . . . 0.89000000000000001 106.756 179.615 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A 1627 ' ' ILE . . . . . 0.573 HD11 ' HB2' ' A' 1639 ' ' SER . 31.0 mm -73.14 -57.54 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 N-CA-C 108.993 -0.743 . . . . 0.57999999999999996 108.993 -178.196 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 49.9 m -163.99 152.39 13.19 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.598 -0.728 . . . . 1.3899999999999999 109.416 -174.4 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1629 ' ' LEU . . . . . 0.952 HD13 ' HG ' ' A' 1636 ' ' LEU . 23.0 tp -117.35 100.71 7.86 Favored 'General case' 0 N--CA 1.426 -1.659 0 N-CA-C 107.345 -1.354 . . . . 1.25 107.345 171.318 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 20.6 t70 -74.23 114.23 12.34 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.47 -0.937 . . . . 1.0900000000000001 108.47 178.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1631 ' ' LYS . . . . . 0.565 ' HB3' HD23 ' B' ' 53' ' ' LEU . 65.2 mttp -66.66 -20.78 66.06 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 113.759 1.022 . . . . 3.6000000000000001 113.759 -175.074 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -88.66 -42.18 12.15 Favored 'General case' 0 CA--C 1.495 -1.143 0 CA-C-O 121.506 0.67 . . . . 2.6000000000000001 111.311 -175.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 73.3 p -93.12 -8.2 43.32 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-N 115.34 -0.846 . . . . 0.75 110.792 -177.614 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1634 ' ' CYS . . . . . 0.494 ' SG ' HD23 ' A' 1604 ' ' LEU . 39.4 m 57.94 33.07 22.79 Favored 'General case' 0 C--N 1.361 1.084 0 C-N-CA 124.753 1.221 . . . . 0.53000000000000003 110.908 175.166 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1635 ' ' THR . . . . . . . . . . . . . 64.3 m -104.89 130.76 52.98 Favored 'General case' 0 N--CA 1.425 -1.703 0 CA-C-N 114.219 -1.355 . . . . 0.46000000000000002 109.313 -177.226 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1636 ' ' LEU . . . . . 0.952 ' HG ' HD13 ' A' 1629 ' ' LEU . 0.6 OUTLIER -111.43 126.47 54.98 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 106.522 -1.659 . . . . 0.85999999999999999 106.522 -178.736 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A 1637 ' ' PHE . . . . . 0.508 ' HB2' ' HB ' ' A' 1627 ' ' ILE . 87.8 m-85 -102.09 138.83 38.52 Favored 'General case' 0 C--N 1.293 -1.879 0 C-N-CA 120.915 -0.314 . . . . 0.45000000000000001 110.315 -178.435 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1638 ' ' PHE . . . . . 0.461 ' HE1' ' HB3' ' A' 1608 ' ' SER . 96.0 m-85 -131.57 134.49 46.12 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 108.671 -0.862 . . . . 0.5 108.671 -177.771 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1639 ' ' SER . . . . . 0.573 ' HB2' HD11 ' A' 1627 ' ' ILE . 22.6 t -116.85 152.36 34.61 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 107.542 -1.281 . . . . 1.04 107.542 175.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 2.9 t90 -153.35 109.79 3.37 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 104.535 -2.394 . . . . 0.68000000000000005 104.535 178.085 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1641 ' ' HIS . . . . . 0.728 ' HB3' ' HB2' ' A' 1615 ' ' ARG . 33.3 m-70 -102.04 109.27 20.94 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 109.006 -0.738 . . . . 0.90000000000000002 109.006 -176.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1642 ' ' THR . . . . . . . . . . . . . 3.9 t -138.05 148.93 62.14 Favored Pre-proline 0 C--N 1.302 -1.482 0 CA-C-N 115.948 -0.569 . . . . 0.47999999999999998 109.768 -174.018 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1643 ' ' PRO . . . . . 0.478 ' HA ' ' SG ' ' A' 1646 ' ' CYS . 53.3 Cg_endo -78.97 -3.21 13.04 Favored 'Trans proline' 0 C--N 1.368 1.564 0 C-N-CA 122.034 1.823 . . . . 0.66000000000000003 111.956 175.441 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 5.8 tp -63.96 -30.84 71.89 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.919 0.866 . . . . 0.96999999999999997 108.756 176.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -89.78 13.09 15.25 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.307 -1.315 . . . . 0.83999999999999997 110.455 -179.199 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1646 ' ' CYS . . . . . 0.478 ' SG ' ' HA ' ' A' 1643 ' ' PRO . 62.7 m -121.43 154.72 36.17 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 109.724 -0.472 . . . . 1.1899999999999999 109.724 -179.006 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 42.5 tt0 . . . . . 0 C--N 1.297 -1.711 0 N-CA-C 105.031 -2.211 . . . . 3.1400000000000001 105.031 168.563 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.423 -2.182 0 N-CA-C 110.407 -1.077 . . . . 2.0899999999999999 110.407 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 11' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' B' ' 15' ' ' ASP . . . -57.01 -56.82 23.0 Favored Glycine 0 CA--C 1.511 -0.217 0 CA-C-N 115.415 -0.393 . . . . 1.8400000000000001 113.863 -176.434 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 12' ' ' GLU . . . . . 0.496 ' HA ' ' CB ' ' B' ' 15' ' ' ASP . 39.3 mt-10 -84.2 -14.94 48.73 Favored 'General case' 0 CA--C 1.489 -1.378 0 CA-C-N 117.259 0.53 . . . . 2.5499999999999998 110.475 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.57 -53.22 45.02 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 107.139 -1.43 . . . . 2.3500000000000001 107.139 179.467 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 22.2 m -74.55 -22.88 17.76 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 C-N-CA 119.672 -0.811 . . . . 2.1099999999999999 110.098 178.334 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 15' ' ' ASP . . . . . 0.496 ' CB ' ' HA ' ' B' ' 12' ' ' GLU . 15.7 t70 -64.41 -51.22 64.31 Favored 'General case' 0 C--O 1.217 -0.653 0 CA-C-N 116.008 -0.542 . . . . 2.04 110.939 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 22.6 p -65.82 -46.46 78.53 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.392 0.677 . . . . 1.8400000000000001 111.004 178.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.491 HD21 HD11 ' B' ' 42' ' ' ILE . 3.6 mm? -48.99 -49.82 38.89 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.904 0.882 . . . . 1.74 111.887 171.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -79.58 -15.64 57.3 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.279 -0.873 . . . . 2.3900000000000001 110.992 -179.074 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 19' ' ' PHE . . . . . 0.551 ' HD1' ' HG3' ' A' 1569 ' ' GLN . 88.0 t80 -64.42 -55.96 17.43 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 116.219 -0.446 . . . . 0.95999999999999996 110.65 178.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 8.4 p -95.58 -26.56 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.357 0 C-N-CA 119.024 -1.071 . . . . 1.3700000000000001 111.547 -177.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 89.2 m -116.36 18.72 15.11 Favored 'General case' 0 C--O 1.212 -0.869 0 N-CA-C 113.229 0.826 . . . . 1.6599999999999999 113.229 -177.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -54.87 -37.59 62.6 Favored Glycine 0 N--CA 1.472 1.05 0 N-CA-C 114.813 0.685 . . . . 1.53 114.813 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -69.0 -27.2 65.48 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 123.08 0.552 . . . . 2.7200000000000002 111.176 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 16.3 tpp180 -91.68 -44.72 8.85 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.038 0.447 . . . . 4.3300000000000001 110.328 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 129.38 177.1 14.7 Favored Glycine 0 N--CA 1.436 -1.352 0 N-CA-C 109.359 -1.496 . . . . 1.53 109.359 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -137.92 122.36 18.36 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 117.91 0.855 . . . . 1.6499999999999999 110.394 175.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -133.32 80.88 1.9 Allowed 'General case' 0 C--O 1.21 -1.003 0 N-CA-C 113.359 0.874 . . . . 3.4199999999999999 113.359 -175.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 28' ' ' PHE . . . . . . . . . . . . . 32.8 p90 . . . . . 0 C--N 1.307 -1.277 0 C-N-CA 119.931 -0.707 . . . . 2.2599999999999998 109.733 169.007 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 41' ' ' GLY . . . . . 0.401 ' C ' ' H ' ' B' ' 43' ' ' VAL . . . . . . . . 0 N--CA 1.429 -1.777 0 N-CA-C 109.423 -1.471 . . . . 2.3700000000000001 109.423 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 42' ' ' ILE . . . . . 0.491 HD11 HD21 ' B' ' 17' ' ' LEU 0.258 13.3 pt 61.61 -21.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 C-N-CA 127.663 2.385 . . . . 2.0699999999999998 115.295 178.471 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.633 ' O ' ' HB2' ' B' ' 47' ' ' CYS . 2.3 p -49.78 -47.12 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.775 0 N-CA-C 113.23 0.826 . . . . 2.2400000000000002 113.23 178.075 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -86.9 -30.95 21.0 Favored 'General case' 0 N--CA 1.427 -1.624 0 N-CA-C 109.228 -0.656 . . . . 3.3599999999999999 109.228 -177.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -66.16 -23.03 66.4 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.499 -0.773 . . . . 3.0800000000000001 112.027 -179.213 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 46' ' ' CYS . . . . . . . . . . . . . 63.7 m -114.34 2.07 14.63 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.967 0.413 . . . . 2.23 111.05 175.211 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 47' ' ' CYS . . . . . 0.633 ' HB2' ' O ' ' B' ' 43' ' ' VAL . 36.4 t -82.07 -50.45 9.07 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.561 0.696 . . . . 2.3700000000000001 110.377 -179.411 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -116.16 15.75 15.98 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.408 0.623 . . . . 2.8199999999999998 110.322 -176.042 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 22.2 mmm180 -146.64 152.74 39.37 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.065 -1.087 . . . . 4.0899999999999999 108.065 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 7.3 p -94.37 131.06 40.42 Favored 'General case' 0 C--N 1.282 -2.355 0 N-CA-C 108.661 -0.866 . . . . 2.6699999999999999 108.661 174.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 13.4 p -118.62 140.05 50.52 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 109.07 -0.715 . . . . 2.1099999999999999 109.07 -173.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -61.71 147.03 47.41 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 107.858 -1.164 . . . . 2.6699999999999999 107.858 177.395 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 53' ' ' LEU . . . . . 0.565 HD23 ' HB3' ' A' 1631 ' ' LYS . 14.8 tp -71.08 -16.79 62.6 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.103 -1.073 . . . . 1.8999999999999999 108.103 -178.473 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 54' ' ' ALA . . . . . 0.412 ' O ' ' HB3' ' B' ' 57' ' ' GLU . . . -60.11 -27.19 66.82 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 114.522 -1.217 . . . . 1.52 110.702 174.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 10.5 tp -60.49 -60.75 3.31 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 115.827 -0.624 . . . . 1.97 110.392 177.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.12 -17.43 61.98 Favored 'General case' 0 C--O 1.214 -0.806 0 CA-C-N 115.827 -0.624 . . . . 1.53 111.683 -175.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 57' ' ' GLU . . . . . 0.412 ' HB3' ' O ' ' B' ' 54' ' ' ALA . 9.1 tp10 -60.49 -56.72 17.97 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 109.026 -0.731 . . . . 2.27 109.026 172.511 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 9.0 t -80.5 -14.69 58.04 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 115.993 -0.548 . . . . 2.3300000000000001 112.268 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -82.73 -60.19 2.26 Favored 'General case' 0 N--CA 1.427 -1.61 0 N-CA-C 107.824 -1.176 . . . . 2.8599999999999999 107.824 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 33.6 t . . . . . 0 C--N 1.32 -0.681 0 C-N-CA 126.908 2.083 . . . . 2.2999999999999998 113.482 176.095 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A 1515 ' ' ASP . . . . . 0.493 ' HA ' ' HD2' ' A' 1579 ' ' LYS . 9.8 t70 . . . . . 0 N--CA 1.442 -0.868 0 N-CA-C 106.801 -1.555 . . . . 2.8999999999999999 106.801 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1516 ' ' CYS . . . . . 0.567 ' O ' ' HB2' ' A' 1529 ' ' LEU . 16.7 m 63.16 33.9 14.0 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 115.128 -0.942 . . . . 1.1899999999999999 110.387 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -166.66 162.76 16.58 Favored 'General case' 0 CA--C 1.479 -1.76 0 N-CA-C 107.813 -1.181 . . . . 1.52 107.813 -177.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1518 ' ' VAL . . . . . 0.424 HG11 HD12 ' A' 1581 ' ' LEU . 9.8 p -162.0 147.23 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.945 0 O-C-N 123.68 0.613 . . . . 0.93999999999999995 109.535 -174.572 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1519 ' ' THR . . . . . . . . . . . . . 25.0 m -115.86 124.96 51.98 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 109.295 -0.632 . . . . 0.89000000000000001 109.295 177.175 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1520 ' ' ASN . . . . . 0.422 ' OD1' HG22 ' A' 1523 ' ' THR . 24.2 t-20 -86.95 122.41 71.27 Favored Pre-proline 0 N--CA 1.439 -0.979 0 O-C-N 123.427 0.454 . . . . 1.74 109.922 177.361 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.72 -19.9 53.09 Favored 'Trans proline' 0 CA--C 1.533 0.466 0 C-N-CA 123.218 2.612 . . . . 1.5800000000000001 114.541 -175.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 50.7 m -76.7 -39.94 50.4 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 112.157 0.429 . . . . 1.6499999999999999 112.157 -177.484 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1523 ' ' THR . . . . . 0.693 HG21 ' HG3' ' A' 1647 ' ' GLU . 5.0 t -114.31 -6.48 12.96 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.813 0.816 . . . . 1.6100000000000001 111.43 -178.076 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 64.54 30.49 78.03 Favored Glycine 0 CA--C 1.499 -0.913 0 CA-C-N 115.368 -0.833 . . . . 1.1299999999999999 112.28 177.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 35.7 t-80 -98.26 125.28 43.28 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 109.644 -0.502 . . . . 1.26 109.644 -175.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 1.7 tm? -90.88 109.15 20.36 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 108.323 -0.992 . . . . 0.68000000000000005 108.323 177.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -85.69 114.53 22.74 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 110.067 -0.345 . . . . 0.65000000000000002 110.067 176.008 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 25.5 t70 -99.46 107.74 20.02 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 109.23 -0.656 . . . . 1.1699999999999999 109.23 177.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1529 ' ' LEU . . . . . 0.567 ' HB2' ' O ' ' A' 1516 ' ' CYS . 3.4 mm? -90.11 -0.13 57.45 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.718 0.771 . . . . 0.59999999999999998 109.363 -178.379 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.24 -26.54 63.89 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.077 -0.965 . . . . 0.83999999999999997 108.771 178.506 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 40.5 t -60.38 -26.82 66.94 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.927 0.891 . . . . 1.5900000000000001 109.848 174.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 51.3 mt -98.38 0.51 45.54 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.557 -0.747 . . . . 0.65000000000000002 110.984 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1533 ' ' SER . . . . . . . . . . . . . 33.6 t -72.31 174.75 6.87 Favored 'General case' 0 C--O 1.245 0.825 0 CA-C-O 121.635 0.731 . . . . 1.52 111.329 -177.174 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . 179.81 145.17 6.26 Favored Glycine 0 N--CA 1.425 -2.046 0 N-CA-C 109.218 -1.553 . . . . 1.1000000000000001 109.218 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 -74.3 -43.36 57.09 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 120.695 0.284 . . . . 4.6200000000000001 111.585 -177.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -84.14 -38.84 20.2 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.465 0.65 . . . . 1.45 109.288 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 105.19 -138.77 14.39 Favored Glycine 0 N--CA 1.409 -3.143 0 CA-C-N 115.134 -0.939 . . . . 0.84999999999999998 111.476 177.415 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -140.33 154.14 46.66 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 107.619 -1.252 . . . . 0.93000000000000005 107.619 -177.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1539 ' ' THR . . . . . 0.456 HG22 ' HB ' ' A' 1547 ' ' VAL . 1.3 m -121.31 124.99 45.92 Favored 'General case' 0 N--CA 1.426 -1.646 0 N-CA-C 108.68 -0.859 . . . . 1.03 108.68 -178.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -119.75 140.18 51.12 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 115.815 -0.629 . . . . 0.5 109.559 -177.273 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -82.57 113.42 20.27 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.605 -0.725 . . . . 0.73999999999999999 110.509 -179.277 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1542 ' ' TYR . . . . . 0.569 ' CE2' ' HG ' ' A' 1626 ' ' LEU . 0.3 OUTLIER -104.36 -101.07 0.31 Allowed 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 106.019 -1.845 . . . . 0.98999999999999999 106.019 177.613 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A 1543 ' ' SER . . . . . 0.441 ' H ' ' HB3' ' A' 1542 ' ' TYR . 2.1 m -68.57 168.69 12.44 Favored 'General case' 0 N--CA 1.425 -1.721 0 C-N-CA 124.137 0.975 . . . . 1.9099999999999999 110.744 178.036 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 59.6 tttp -60.12 -41.49 92.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 118.694 0.679 . . . . 3.5899999999999999 112.261 -176.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 33.5 t -116.78 20.68 13.83 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 109.567 -0.531 . . . . 2.46 109.567 -177.294 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . -131.73 104.22 0.56 Allowed Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 120.646 -0.788 . . . . 1.26 113.231 -175.223 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1547 ' ' VAL . . . . . 0.456 ' HB ' HG22 ' A' 1539 ' ' THR . 28.0 m -96.84 151.1 4.2 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-O 121.176 0.512 . . . . 0.79000000000000004 110.109 175.706 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 14.2 p -105.2 138.49 29.91 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 CA-C-N 115.913 -0.585 . . . . 0.57999999999999996 109.528 178.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -105.71 128.34 53.62 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 123.492 0.717 . . . . 1.0800000000000001 109.678 176.06 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 23.5 ptm -141.8 119.46 11.75 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 115.331 -0.85 . . . . 0.78000000000000003 110.695 -177.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 11.4 p -103.67 119.58 39.2 Favored 'General case' 0 C--N 1.276 -2.609 0 CA-C-N 114.883 -1.053 . . . . 0.96999999999999997 110.184 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1552 ' ' ILE . . . . . 0.748 HG13 ' HZ3' ' A' 1640 ' ' TRP . 39.4 mm -83.22 119.44 32.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 108.999 -0.741 . . . . 0.41999999999999998 108.999 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 28.2 t 62.02 46.39 6.55 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-O 122.053 0.93 . . . . 1.3999999999999999 110.544 177.608 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 175.93 178.01 45.4 Favored Glycine 0 N--CA 1.407 -3.238 0 N-CA-C 109.431 -1.467 . . . . 0.34999999999999998 109.431 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -106.11 154.9 20.01 Favored 'General case' 0 C--N 1.285 -2.236 0 CA-C-O 121.046 0.451 . . . . 1.6200000000000001 110.415 -178.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -93.21 138.11 31.92 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 108.283 -1.006 . . . . 0.87 108.283 178.137 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -99.98 0.57 41.32 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 114.889 1.44 . . . . 2.4900000000000002 114.889 -169.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 9.6 p30 -105.01 5.26 32.46 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 122.273 1.035 . . . . 1.3799999999999999 110.134 178.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1559 ' ' CYS . . . . . 0.602 ' SG ' ' HD2' ' A' 1560 ' ' PRO . 34.5 t -132.15 152.99 81.15 Favored Pre-proline 0 C--N 1.288 -2.068 0 N-CA-C 106.211 -1.774 . . . . 1.21 106.211 178.158 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1560 ' ' PRO . . . . . 0.602 ' HD2' ' SG ' ' A' 1559 ' ' CYS . 49.6 Cg_exo -28.34 121.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.379 2.176 1 C-N-CA 125.575 4.184 . . . . 0.70999999999999996 115.211 179.154 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A 1561 ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' 1560 ' ' PRO . 6.0 Cg_endo -44.72 130.2 9.63 Favored 'Trans proline' 0 C--N 1.357 1.01 0 C-N-CA 125.075 3.85 . . . . 0.80000000000000004 114.126 -176.646 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 98.64 -2.15 58.64 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.974 -0.557 . . . . 0.46000000000000002 113.753 178.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1563 ' ' VAL . . . . . 0.411 HG21 ' HA ' ' A' 1573 ' ' SER . 8.7 p -93.8 140.38 16.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 O-C-N 121.93 -0.747 . . . . 0.97999999999999998 110.637 -177.486 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -102.34 -30.56 5.59 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 121.213 -0.518 . . . . 0.28000000000000003 112.869 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -124.32 127.89 48.3 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 109.403 -0.591 . . . . 0.28000000000000003 109.403 178.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1566 ' ' CYS . . . . . 0.425 ' SG ' ' HA ' ' A' 1571 ' ' ARG . 43.5 t -155.04 142.75 19.85 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 110.254 -0.276 . . . . 0.42999999999999999 110.254 -178.58 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1567 ' ' PHE . . . . . 0.527 ' CE2' HG11 ' A' 1574 ' ' VAL . 54.9 m-85 -85.6 130.53 34.55 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 107.796 -1.187 . . . . 1.03 107.796 172.402 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -61.14 -31.16 75.82 Favored Glycine 0 C--N 1.35 1.314 0 N-CA-C 114.545 0.578 . . . . 1.1299999999999999 114.545 -171.516 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1569 ' ' GLN . . . . . 0.467 ' HB3' ' OD2' ' B' ' 15' ' ' ASP . 11.3 mm100 -69.54 -54.56 13.54 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.594 0.711 . . . . 2.5800000000000001 111.986 177.454 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1570 ' ' THR . . . . . 0.602 ' HB ' HG13 ' A' 1572 ' ' ILE . 58.3 p -81.47 -29.11 33.85 Favored 'General case' 0 N--CA 1.421 -1.878 0 N-CA-C 114.382 1.253 . . . . 2.1699999999999999 114.382 -167.387 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1571 ' ' ARG . . . . . 0.425 ' HA ' ' SG ' ' A' 1566 ' ' CYS . 3.1 mpt_? 59.35 28.94 18.42 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.189 0.519 . . . . 2.6200000000000001 110.691 -172.562 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1572 ' ' ILE . . . . . 0.602 HG13 ' HB ' ' A' 1570 ' ' THR . 19.2 mt -94.58 129.15 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.832 0 N-CA-C 107.89 -1.152 . . . . 0.92000000000000004 107.89 177.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1573 ' ' SER . . . . . 0.411 ' HA ' HG21 ' A' 1563 ' ' VAL . 15.1 t -69.27 113.8 6.94 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.327 -0.851 . . . . 0.80000000000000004 109.68 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1574 ' ' VAL . . . . . 0.758 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 19.7 m -110.38 17.92 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 CA-C-O 121.893 0.854 . . . . 0.97999999999999998 110.8 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 161.46 115.64 0.37 Allowed Glycine 0 N--CA 1.427 -1.957 0 CA-C-N 114.779 -1.1 . . . . 0.28999999999999998 111.042 177.212 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -73.66 146.39 44.57 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.881 -0.785 . . . . 2.1899999999999999 108.881 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -71.36 90.52 0.95 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.028 0.442 . . . . 0.60999999999999999 111.585 -178.056 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -103.37 170.24 8.07 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.08 -1.081 . . . . 1.95 108.08 175.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1579 ' ' LYS . . . . . 0.493 ' HD2' ' HA ' ' A' 1515 ' ' ASP . 15.4 pttm -130.11 40.46 3.54 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.755 0.788 . . . . 2.6800000000000002 110.698 -178.65 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 75.0 ttt180 -89.82 100.49 13.29 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 113.561 -1.654 . . . . 3.4700000000000002 107.933 -174.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1581 ' ' LEU . . . . . 0.445 HD21 ' HG ' ' A' 1529 ' ' LEU . 0.2 OUTLIER -101.76 126.55 48.64 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.713 -0.676 . . . . 0.64000000000000001 109.425 -174.806 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -125.2 138.95 54.12 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 120.532 -0.467 . . . . 2.8500000000000001 110.914 176.498 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1583 ' ' TYR . . . . . 0.447 ' CE1' ' HA ' ' A' 1586 ' ' GLN . 88.3 t80 -106.25 108.41 19.91 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.724 -0.843 . . . . 0.85999999999999999 108.724 178.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1584 ' ' VAL . . . . . 0.616 ' O ' ' HB ' ' A' 1587 ' ' VAL . 14.2 m -126.98 93.49 2.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 CA-C-O 121.48 0.657 . . . . 1.05 112.108 -178.612 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 36.6 t70 57.89 64.37 1.55 Allowed 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.853 0.861 . . . . 1.1699999999999999 110.691 179.063 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1586 ' ' GLN . . . . . 0.447 ' HA ' ' CE1' ' A' 1583 ' ' TYR 0.272 30.1 pt20 58.72 20.55 7.95 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 126.45 1.9 . . . . 1.8600000000000001 112.384 178.527 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A 1587 ' ' VAL . . . . . 0.616 ' HB ' ' O ' ' A' 1584 ' ' VAL . 22.5 t -107.24 120.26 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.493 0 CA-C-N 114.038 -1.437 . . . . 0.48999999999999999 107.751 174.11 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1588 ' ' LEU . . . . . 0.865 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 3.3 mm? -95.62 109.03 21.34 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 105.824 -1.917 . . . . 0.35999999999999999 105.824 176.014 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -111.02 116.81 31.81 Favored 'General case' 0 C--N 1.266 -3.056 0 C-N-CA 119.962 -0.695 . . . . 1.74 110.961 -175.278 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.87 99.48 9.69 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 104.888 -2.264 . . . . 0.71999999999999997 104.888 176.758 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 8.9 p -89.41 127.01 42.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 C-N-CA 119.64 -0.824 . . . . 1.01 112.308 -174.299 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1592 ' ' TYR . . . . . 0.658 ' HB2' ' HB3' ' A' 1608 ' ' SER . 12.8 m-30 -106.95 142.75 36.07 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.443 -1.317 . . . . 0.5 107.443 173.404 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 10.6 ptmm? -158.08 -172.24 3.83 Favored 'General case' 0 C--N 1.283 -2.308 0 N-CA-C 106.043 -1.836 . . . . 1.5900000000000001 106.043 -175.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 36.4 m-20 66.46 45.56 2.1 Favored 'General case' 0 C--O 1.239 0.503 0 O-C-N 124.006 0.816 . . . . 1.1100000000000001 109.116 177.045 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -86.76 -175.06 49.39 Favored Glycine 0 N--CA 1.435 -1.379 0 CA-C-N 114.892 -1.049 . . . . 0.78000000000000003 111.582 -178.227 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1596 ' ' SER . . . . . 0.742 ' HB2' ' HD2' ' A' 1597 ' ' PRO . 62.9 p -95.31 173.86 4.02 Favored Pre-proline 0 C--N 1.291 -1.968 0 CA-C-O 118.672 -0.68 . . . . 1.0700000000000001 109.457 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1597 ' ' PRO . . . . . 0.742 ' HD2' ' HB2' ' A' 1596 ' ' SER . 10.3 Cg_endo -50.85 127.11 20.29 Favored 'Trans proline' 0 C--N 1.361 1.197 0 C-N-CA 122.785 2.323 . . . . 1.01 113.676 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1598 ' ' CYS . . . . . 0.696 ' HA ' ' HE1' ' A' 1606 ' ' TYR . 49.5 t -81.16 118.74 73.6 Favored Pre-proline 0 C--N 1.284 -2.269 0 CA-C-N 113.718 -1.583 . . . . 0.75 107.888 178.038 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1599 ' ' PRO . . . . . 0.707 ' HD2' ' HE1' ' A' 1606 ' ' TYR . 6.9 Cg_endo -52.12 -21.16 12.13 Favored 'Trans proline' 0 C--N 1.366 1.483 0 C-N-CA 124.357 3.371 . . . . 1.7 114.362 -178.379 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1600 ' ' SER . . . . . 0.417 ' HA ' ' HB2' ' B' ' 53' ' ' LEU . 7.8 m -55.72 -45.63 77.91 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 123.815 0.846 . . . . 2.2599999999999998 110.438 177.066 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1601 ' ' LYS . . . . . 0.483 ' HE2' HD11 ' A' 1604 ' ' LEU . 36.5 ttpt -162.84 127.43 3.08 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 108.395 -0.965 . . . . 3.0099999999999998 108.395 178.242 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 14.2 p -58.36 132.02 52.4 Favored 'General case' 0 N--CA 1.415 -2.191 0 N-CA-C 109.26 -0.644 . . . . 2.0699999999999998 109.26 177.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 106.54 -17.38 39.74 Favored Glycine 0 C--N 1.303 -1.265 0 C-N-CA 121.329 -0.463 . . . . 1.0800000000000001 112.354 -176.498 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1604 ' ' LEU . . . . . 0.503 ' HB2' ' HB3' ' A' 1598 ' ' CYS . 60.2 mt -91.83 152.06 20.29 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 107.254 -1.387 . . . . 1.8400000000000001 107.254 173.565 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 37.9 m -135.87 142.93 44.81 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 108.628 -0.878 . . . . 1.4099999999999999 108.628 179.043 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1606 ' ' TYR . . . . . 0.758 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 71.5 m-85 -73.22 158.95 34.22 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 112.141 0.423 . . . . 0.59999999999999998 112.141 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -147.89 152.72 38.07 Favored 'General case' 0 N--CA 1.421 -1.914 0 N-CA-C 106.38 -1.711 . . . . 1.45 106.38 172.504 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1608 ' ' SER . . . . . 0.658 ' HB3' ' HB2' ' A' 1592 ' ' TYR . 28.0 t -122.5 123.08 40.45 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 109.038 -0.727 . . . . 1.1499999999999999 109.038 -174.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 30.8 t -105.09 98.1 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.748 0 N-CA-C 108.846 -0.798 . . . . 0.25 108.846 179.296 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 84.1 mt -89.63 106.11 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.787 0 N-CA-C 108.1 -1.074 . . . . 0.45000000000000001 108.1 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 17.0 m -104.54 114.48 28.73 Favored 'General case' 0 N--CA 1.421 -1.917 0 CA-C-N 115.007 -0.997 . . . . 1.26 111.01 -175.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1612 ' ' PHE . . . . . 0.865 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 69.3 m-85 -91.33 108.41 19.87 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.054 -0.721 . . . . 0.26000000000000001 109.054 176.283 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1613 ' ' VAL . . . . . 0.879 ' HB ' ' HB3' ' A' 1641 ' ' HIS . 33.5 t -103.96 144.16 14.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 CA-C-N 114.774 -1.103 . . . . 0.5 109.233 -176.103 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 39.1 t -69.88 108.31 3.93 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 123.809 0.844 . . . . 0.77000000000000002 110.982 179.202 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1615 ' ' ARG . . . . . 0.574 ' HB2' ' HB2' ' A' 1641 ' ' HIS . 25.3 tpt180 -135.69 91.69 17.8 Favored Pre-proline 0 N--CA 1.435 -1.214 0 C-N-CA 119.584 -0.846 . . . . 2.5299999999999998 109.671 173.452 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1616 ' ' PRO . . . . . 0.934 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 19.2 Cg_exo -65.7 -22.21 57.72 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.392 2.061 . . . . 1.1000000000000001 113.535 -176.59 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -57.96 -38.48 76.1 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 123.94 0.896 . . . . 3.0499999999999998 112.221 179.04 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . 64.93 -172.63 0.18 Allowed 'General case' 0 C--N 1.358 0.946 0 O-C-N 123.916 0.76 . . . . 1.55 109.61 -176.084 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . 119.09 -159.5 14.5 Favored Glycine 0 N--CA 1.426 -2.018 0 C-N-CA 120.222 -0.989 . . . . 0.93000000000000005 112.632 177.097 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 94.9 Cg_exo -56.38 -11.73 6.84 Favored 'Trans proline' 0 N--CA 1.5 1.911 0 C-N-CA 124.893 3.728 . . . . 0.88 114.211 178.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1621 ' ' THR . . . . . . . . . . . . . 19.0 p -87.6 -9.37 54.52 Favored 'General case' 0 C--N 1.282 -2.364 0 C-N-CA 124.396 1.079 . . . . 0.96999999999999997 110.869 -179.174 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 49.2 t30 -88.02 58.36 4.77 Favored 'General case' 0 C--O 1.253 1.266 0 CA-C-O 122.729 1.252 . . . . 0.71999999999999997 110.16 -178.174 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1623 ' ' ARG . . . . . 0.43 ' HA ' ' HD3' ' A' 1624 ' ' PRO . 34.7 ptt180 -159.82 138.81 7.97 Favored Pre-proline 0 C--N 1.303 -1.415 0 CA-C-N 113.839 -1.528 . . . . 3.2599999999999998 107.183 178.569 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1624 ' ' PRO . . . . . 0.445 ' HG3' ' CE3' ' A' 1640 ' ' TRP . 7.1 Cg_exo -69.43 111.23 2.69 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.333 2.022 . . . . 0.58999999999999997 111.172 -178.371 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 74.7 mtm -114.0 147.83 37.96 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 116.415 -0.357 . . . . 1.3700000000000001 110.337 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1626 ' ' LEU . . . . . 0.569 ' HG ' ' CE2' ' A' 1542 ' ' TYR . 0.3 OUTLIER -85.89 113.95 22.43 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 107.954 -1.128 . . . . 0.89000000000000001 107.954 -176.56 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 42.0 mm -76.36 -54.85 12.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 N-CA-C 109.262 -0.644 . . . . 0.57999999999999996 109.262 -177.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 70.5 m -163.83 152.27 13.4 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.468 -0.938 . . . . 1.3899999999999999 108.468 -173.234 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1629 ' ' LEU . . . . . 0.584 ' HG ' ' CD2' ' A' 1636 ' ' LEU . 2.5 tt -114.25 110.91 20.67 Favored 'General case' 0 N--CA 1.416 -2.172 0 N-CA-C 106.531 -1.655 . . . . 1.25 106.531 179.397 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 14.8 t70 -77.81 95.35 4.68 Favored 'General case' 0 CA--C 1.494 -1.198 0 N-CA-C 106.919 -1.512 . . . . 1.0900000000000001 106.919 173.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1631 ' ' LYS . . . . . 0.69 ' HD3' ' H ' ' A' 1631 ' ' LYS . 0.0 OUTLIER -75.96 2.86 11.48 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 114.419 1.266 . . . . 3.6000000000000001 114.419 -172.768 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 79.8 mm-40 -88.36 -41.93 12.52 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.709 -0.848 . . . . 2.6000000000000001 108.709 175.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 67.6 p -100.48 -15.62 17.82 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-N 115.118 -0.946 . . . . 0.75 111.065 -177.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 83.3 m 70.25 35.05 2.18 Favored 'General case' 0 C--N 1.351 0.662 0 C-N-CA 125.053 1.341 . . . . 0.53000000000000003 110.891 -179.141 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1635 ' ' THR . . . . . . . . . . . . . 90.0 m -90.96 121.87 33.16 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 113.727 -1.579 . . . . 0.46000000000000002 109.088 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1636 ' ' LEU . . . . . 0.584 ' CD2' ' HG ' ' A' 1629 ' ' LEU . 26.2 mt -98.58 130.7 45.13 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 109.483 -0.562 . . . . 0.85999999999999999 109.483 178.691 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -101.77 116.48 32.82 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 116.076 -0.511 . . . . 0.45000000000000001 111.137 177.396 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -114.19 140.73 48.3 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 109.529 -0.545 . . . . 0.5 109.529 176.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1639 ' ' SER . . . . . 0.432 ' O ' ' HA ' ' A' 1624 ' ' PRO . 48.0 t -119.86 129.16 54.26 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 108.512 -0.921 . . . . 1.04 108.512 173.388 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1640 ' ' TRP . . . . . 0.748 ' HZ3' HG13 ' A' 1552 ' ' ILE . 6.3 t90 -133.74 93.5 3.13 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 104.217 -2.512 . . . . 0.68000000000000005 104.217 173.301 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1641 ' ' HIS . . . . . 0.879 ' HB3' ' HB ' ' A' 1613 ' ' VAL 0.317 0.1 OUTLIER -101.64 95.17 6.27 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-O 122.474 1.13 . . . . 0.90000000000000002 113.085 -175.612 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A 1642 ' ' THR . . . . . . . . . . . . . 3.1 t -114.77 153.02 46.91 Favored Pre-proline 0 C--N 1.299 -1.609 0 CA-C-N 112.542 -2.117 . . . . 0.47999999999999998 108.583 -177.318 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1643 ' ' PRO . . . . . 0.934 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 49.7 Cg_endo -68.94 -4.89 14.37 Favored 'Trans proline' 0 C--N 1.369 1.65 0 C-N-CA 123.269 2.646 . . . . 0.66000000000000003 113.366 -178.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 8.2 tt -65.35 -30.29 71.11 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.969 -0.382 . . . . 0.96999999999999997 109.969 176.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -84.2 21.7 1.35 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.377 0.608 . . . . 0.83999999999999997 111.513 -175.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 33.3 m -121.22 136.52 54.96 Favored 'General case' 0 N--CA 1.415 -2.193 0 N-CA-C 107.629 -1.248 . . . . 1.1899999999999999 107.629 178.433 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1647 ' ' GLU . . . . . 0.693 ' HG3' HG21 ' A' 1523 ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.301 -1.531 0 N-CA-C 109.529 -0.545 . . . . 3.1400000000000001 109.529 177.399 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.225 0 N-CA-C 112.856 -0.098 . . . . 2.0899999999999999 112.856 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.94 -36.88 92.88 Favored Glycine 0 C--O 1.22 -0.765 0 CA-C-N 115.557 -0.322 . . . . 1.8400000000000001 112.924 -177.169 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -68.18 -28.34 67.18 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 111.915 0.339 . . . . 2.5499999999999998 111.915 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.65 -53.54 13.27 Favored 'General case' 0 N--CA 1.42 -1.959 0 N-CA-C 109.486 -0.561 . . . . 2.3500000000000001 109.486 -177.664 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 3.8 p -63.58 -35.42 72.64 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-N 115.561 -0.745 . . . . 2.1099999999999999 111.133 177.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 15' ' ' ASP . . . . . 0.467 ' OD2' ' HB3' ' A' 1569 ' ' GLN . 14.8 t0 -72.32 -37.07 69.01 Favored 'General case' 0 CA--C 1.557 1.248 0 N-CA-C 112.209 0.448 . . . . 2.04 112.209 -179.411 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 14.9 t -68.78 -37.7 79.49 Favored 'General case' 0 C--O 1.254 1.316 0 CA-C-N 119.079 0.854 . . . . 1.8400000000000001 110.117 175.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.605 HD21 HD11 ' B' ' 42' ' ' ILE . 3.2 mm? -49.37 -52.66 26.82 Favored 'General case' 0 C--N 1.355 0.823 0 CA-C-O 121.358 0.599 . . . . 1.74 110.197 168.16 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -66.97 -23.8 65.98 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 123.659 0.784 . . . . 2.3900000000000001 112.385 -177.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -62.9 -62.85 1.44 Allowed 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 116.467 -0.333 . . . . 0.95999999999999996 110.938 175.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 14.4 p -91.32 -15.92 8.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 C-N-CA 117.609 -1.636 . . . . 1.3700000000000001 112.791 -175.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 59.1 m -99.8 10.17 41.77 Favored 'General case' 0 C--O 1.206 -1.227 0 O-C-N 121.099 -1.0 . . . . 1.6599999999999999 111.318 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -53.42 -28.36 35.85 Favored Glycine 0 CA--C 1.54 1.617 0 N-CA-C 116.632 1.413 . . . . 1.53 116.632 -178.278 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -72.56 -49.0 35.53 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 118.305 1.053 . . . . 2.7200000000000002 111.891 -179.284 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.15 -38.58 15.23 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.37 0.605 . . . . 4.3300000000000001 109.803 -179.154 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 124.23 164.52 11.98 Favored Glycine 0 N--CA 1.428 -1.892 0 N-CA-C 107.62 -2.192 . . . . 1.53 107.62 -174.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 26' ' ' PHE . . . . . 0.424 ' CB ' ' HB3' ' B' ' 17' ' ' LEU . 17.4 p90 -95.69 129.79 42.78 Favored 'General case' 0 C--N 1.286 -2.177 0 CA-C-N 118.779 1.29 . . . . 1.6499999999999999 110.067 179.012 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -129.98 59.31 1.63 Allowed 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 112.939 0.718 . . . . 3.4199999999999999 112.939 -174.478 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 28' ' ' PHE . . . . . 0.651 ' HA ' ' HE2' ' B' ' 59' ' ' TYR . 32.6 p90 . . . . . 0 C--N 1.313 -0.996 0 C-N-CA 119.048 -1.061 . . . . 2.2599999999999998 108.485 173.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 41' ' ' GLY . . . . . 0.415 ' C ' ' H ' ' B' ' 43' ' ' VAL . . . . . . . . 0 CA--C 1.476 -2.401 0 N-CA-C 109.723 -1.351 . . . . 2.3700000000000001 109.723 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 42' ' ' ILE . . . . . 0.605 HD11 HD21 ' B' ' 17' ' ' LEU . 16.1 pt 58.1 -26.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 C-N-CA 127.346 2.258 . . . . 2.0699999999999998 115.74 179.529 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.415 ' H ' ' C ' ' B' ' 41' ' ' GLY . 2.7 p -48.12 -46.95 13.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 114.71 1.374 . . . . 2.2400000000000002 114.71 -177.737 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -87.79 -29.75 20.76 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.913 -1.143 . . . . 3.3599999999999999 107.913 -174.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 45' ' ' GLU . . . . . 0.559 ' O ' ' HB2' ' B' ' 49' ' ' ARG . 30.2 mt-10 -75.82 -10.06 59.12 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 113.963 -1.471 . . . . 3.0800000000000001 112.179 -177.685 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 46' ' ' CYS . . . . . . . . . . . . . 21.5 t -119.42 -21.92 7.25 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-O 121.056 0.455 . . . . 2.23 110.285 176.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 49.7 t -74.28 -47.62 33.73 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.333 -0.547 . . . . 2.3700000000000001 111.433 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -119.09 7.61 11.4 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 120.1 -0.64 . . . . 2.8199999999999998 110.987 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 49' ' ' ARG . . . . . 0.559 ' HB2' ' O ' ' B' ' 45' ' ' GLU . 36.0 mmt180 -128.0 156.68 42.33 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.301 -1.37 . . . . 4.0899999999999999 107.301 -177.123 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 14.0 p -78.3 110.75 13.61 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 109.855 -0.424 . . . . 2.6699999999999999 109.855 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 3.0 p -100.87 126.75 47.5 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 115.59 -0.732 . . . . 2.1099999999999999 110.365 -177.091 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -101.8 135.62 43.04 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.772 -1.195 . . . . 2.6699999999999999 107.772 178.173 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 53' ' ' LEU . . . . . 0.436 HD21 ' HG3' ' A' 1631 ' ' LYS . 56.9 tp -36.47 -37.91 0.14 Allowed 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 126.613 1.965 . . . . 1.8999999999999999 114.834 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.95 -29.97 63.64 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 123.483 0.49 . . . . 1.52 111.374 -177.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 53.1 tp -68.58 -57.0 6.39 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-N 115.863 -0.608 . . . . 1.97 110.048 177.55 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 1.9 pp -71.28 -27.18 63.24 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 116.496 -0.32 . . . . 1.53 111.559 -174.232 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -71.95 -46.11 58.68 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 111.835 0.309 . . . . 2.27 111.835 178.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 11.2 t -77.66 -30.09 51.93 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 118.619 -1.233 . . . . 2.3300000000000001 111.601 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 59' ' ' TYR . . . . . 0.651 ' HE2' ' HA ' ' B' ' 28' ' ' PHE . 11.1 t80 -70.66 -64.51 0.88 Allowed 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 106.278 -1.749 . . . . 2.8599999999999999 106.278 177.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 54.1 t . . . . . 0 N--CA 1.477 0.886 0 C-N-CA 127.208 2.203 . . . . 2.2999999999999998 115.762 173.725 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 16.4 t70 . . . . . 0 CA--C 1.531 0.225 0 CA-C-O 120.546 0.213 . . . . 2.8999999999999999 111.331 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A 1516 ' ' CYS . . . . . 0.634 ' SG ' ' HB2' ' A' 1529 ' ' LEU . 30.8 t -138.83 55.59 1.72 Allowed 'General case' 0 C--O 1.25 1.113 0 N-CA-C 108.312 -0.995 . . . . 1.1899999999999999 108.312 -179.06 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -169.06 149.04 4.18 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 115.565 -0.743 . . . . 1.52 109.06 -174.203 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 4.8 m -149.43 142.37 17.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 C-N-CA 124.227 1.011 . . . . 0.93999999999999995 110.585 178.346 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1519 ' ' THR . . . . . . . . . . . . . 31.9 m -106.16 137.35 44.25 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.915 -0.402 . . . . 0.89000000000000001 109.915 177.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 52.6 t-20 -82.68 110.33 21.72 Favored Pre-proline 0 C--O 1.245 0.829 0 N-CA-C 107.009 -1.478 . . . . 1.74 107.009 174.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.23 -14.69 43.94 Favored 'Trans proline' 0 N--CA 1.474 0.376 0 C-N-CA 123.173 2.582 . . . . 1.5800000000000001 113.148 -174.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 28.3 m -75.04 -33.87 61.81 Favored 'General case' 0 N--CA 1.425 -1.702 0 CA-C-N 116.307 -0.406 . . . . 1.6499999999999999 111.844 -179.228 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1523 ' ' THR . . . . . . . . . . . . . 12.5 t -136.19 -5.3 2.1 Favored 'General case' 0 CA--C 1.564 1.484 0 C-N-CA 118.132 -1.427 . . . . 1.6100000000000001 113.418 -175.357 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 85.75 8.31 80.03 Favored Glycine 0 CA--C 1.494 -1.252 0 C-N-CA 120.632 -0.794 . . . . 1.1299999999999999 114.048 176.331 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 51.9 t-80 -76.27 123.27 25.64 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.706 -0.85 . . . . 1.26 108.706 177.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -103.2 116.91 33.37 Favored 'General case' 0 C--N 1.268 -2.965 0 CA-C-N 114.796 -1.093 . . . . 0.68000000000000005 109.008 -176.564 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -88.86 118.38 28.53 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 109.989 -0.375 . . . . 0.65000000000000002 109.989 175.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 7.7 t70 -110.72 126.25 54.37 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.111 -1.44 . . . . 1.1699999999999999 107.111 174.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1529 ' ' LEU . . . . . 0.634 ' HB2' ' SG ' ' A' 1516 ' ' CYS . 2.9 mm? -103.21 20.47 17.65 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 111.88 0.326 . . . . 0.59999999999999998 111.88 -174.643 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 6.9 m -66.74 -23.84 66.15 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 113.369 0.878 . . . . 0.83999999999999997 113.369 -175.271 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 33.6 t -72.29 -30.1 64.49 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-O 121.534 0.683 . . . . 1.5900000000000001 109.196 178.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1532 ' ' LEU . . . . . 0.522 HD12 HD12 ' A' 1529 ' ' LEU . 59.9 mt -88.9 -18.31 27.82 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.387 -0.824 . . . . 0.65000000000000002 109.792 -179.294 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1533 ' ' SER . . . . . 0.532 ' HA ' ' HB ' ' A' 1552 ' ' ILE . 34.8 t -75.46 171.57 14.02 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.61 -0.723 . . . . 1.52 110.288 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . 159.94 150.37 5.83 Favored Glycine 0 N--CA 1.424 -2.159 0 N-CA-C 110.106 -1.197 . . . . 1.1000000000000001 110.106 -178.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 35.6 ttp180 -92.02 -13.69 30.56 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 121.475 0.655 . . . . 4.6200000000000001 109.843 -179.102 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -79.66 -39.03 32.33 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 121.364 0.602 . . . . 1.45 109.977 178.164 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 90.62 -171.89 36.82 Favored Glycine 0 N--CA 1.424 -2.118 0 CA-C-N 115.054 -0.975 . . . . 0.84999999999999998 111.136 176.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -132.84 146.57 51.93 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 108.281 -1.007 . . . . 0.93000000000000005 108.281 178.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 31.1 p -102.43 123.46 46.25 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 123.491 0.494 . . . . 1.03 111.77 -178.28 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1540 ' ' ALA . . . . . 0.406 ' HB3' ' CG1' ' A' 1548 ' ' VAL . . . -115.29 135.15 54.46 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.255 -0.646 . . . . 0.5 109.255 177.223 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -70.59 134.58 47.75 Favored 'General case' 0 C--O 1.249 1.032 0 CA-C-N 115.567 -0.742 . . . . 0.73999999999999999 110.901 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1542 ' ' TYR . . . . . 0.587 ' CE2' ' HG ' ' A' 1626 ' ' LEU . 7.1 t80 -133.24 -100.84 0.26 Allowed 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.787 -0.82 . . . . 0.98999999999999999 108.787 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1543 ' ' SER . . . . . 0.43 ' H ' ' HB3' ' A' 1542 ' ' TYR . 13.6 t -92.63 179.95 5.35 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 109.763 -0.458 . . . . 1.9099999999999999 109.763 -176.279 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 20.2 pttp -75.21 -23.65 57.66 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 120.976 0.417 . . . . 3.5899999999999999 111.416 -177.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1545 ' ' SER . . . . . 0.656 ' HB2' ' HG2' ' A' 1569 ' ' GLN . 5.2 p -65.49 -36.94 85.36 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 124.325 1.05 . . . . 2.46 112.751 -176.369 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 178.73 -167.1 37.27 Favored Glycine 0 N--CA 1.425 -2.098 0 C-N-CA 120.874 -0.679 . . . . 1.26 112.216 -178.574 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 27.2 m -113.58 166.46 7.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 109.82 -0.437 . . . . 0.79000000000000004 109.82 -176.45 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1548 ' ' VAL . . . . . 0.406 ' CG1' ' HB3' ' A' 1540 ' ' ALA . 13.1 p -102.26 131.0 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 N-CA-C 108.911 -0.774 . . . . 0.57999999999999996 108.911 177.593 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -92.16 134.84 34.48 Favored 'General case' 0 CA--C 1.481 -1.673 0 CA-C-N 115.504 -0.771 . . . . 1.0800000000000001 109.223 178.108 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 24.0 ptm -146.64 116.06 7.08 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 115.478 -0.783 . . . . 0.78000000000000003 111.057 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 8.5 p -106.39 124.13 49.12 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-N 115.145 -0.934 . . . . 0.96999999999999997 110.214 178.031 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1552 ' ' ILE . . . . . 0.532 ' HB ' ' HA ' ' A' 1533 ' ' SER . 43.5 mm -81.92 119.1 30.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 109.99 -0.374 . . . . 0.41999999999999998 109.99 -179.009 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 57.8 m 60.9 41.94 13.69 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 123.937 0.773 . . . . 1.3999999999999999 111.366 176.255 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . -178.0 174.23 46.63 Favored Glycine 0 N--CA 1.422 -2.274 0 N-CA-C 109.961 -1.256 . . . . 0.34999999999999998 109.961 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -100.16 150.8 22.14 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 120.856 0.36 . . . . 1.6200000000000001 110.405 -179.137 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -98.81 139.28 34.72 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.0 -0.741 . . . . 0.87 109.0 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -85.12 -3.63 58.87 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 113.108 0.781 . . . . 2.4900000000000002 113.108 -172.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -93.67 1.73 56.52 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 120.547 -0.461 . . . . 1.3799999999999999 110.816 -176.094 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1559 ' ' CYS . . . . . 0.727 ' SG ' ' HD2' ' A' 1560 ' ' PRO . 13.3 t -137.59 166.34 27.27 Favored Pre-proline 0 C--N 1.3 -1.562 0 N-CA-C 106.542 -1.651 . . . . 1.21 106.542 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1560 ' ' PRO . . . . . 0.727 ' HD2' ' SG ' ' A' 1559 ' ' CYS . 16.3 Cg_exo -33.83 145.3 0.04 OUTLIER 'Trans proline' 0 C--N 1.379 2.173 0 C-N-CA 124.542 3.494 . . . . 0.70999999999999996 114.627 173.169 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1561 ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' 1560 ' ' PRO . 43.0 Cg_exo -58.94 127.44 24.31 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 123.223 2.615 . . . . 0.80000000000000004 112.841 -177.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 94.5 13.21 54.56 Favored Glycine 0 C--N 1.311 -0.812 0 N-CA-C 115.166 0.826 . . . . 0.46000000000000002 115.166 176.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1563 ' ' VAL . . . . . 0.893 HG21 ' HB2' ' A' 1573 ' ' SER . 9.9 p -109.08 140.19 28.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-N 118.242 1.021 . . . . 0.97999999999999998 110.95 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -100.7 -32.98 5.21 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 120.984 -0.627 . . . . 0.28000000000000003 113.272 -177.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -123.35 128.76 50.36 Favored 'General case' 0 C--O 1.244 0.806 0 N-CA-C 109.569 -0.53 . . . . 0.28000000000000003 109.569 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 50.6 t -163.48 144.82 9.33 Favored 'General case' 0 C--O 1.206 -1.194 0 C-N-CA 121.249 -0.18 . . . . 0.42999999999999999 110.889 -175.54 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -85.72 143.61 28.26 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 118.05 0.386 . . . . 1.03 110.178 174.315 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -88.89 8.16 80.35 Favored Glycine 0 N--CA 1.443 -0.861 0 N-CA-C 116.239 1.256 . . . . 1.1299999999999999 116.239 -170.473 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1569 ' ' GLN . . . . . 0.656 ' HG2' ' HB2' ' A' 1545 ' ' SER . 0.4 OUTLIER -78.48 -67.39 0.74 Allowed 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 118.328 1.064 . . . . 2.5800000000000001 110.319 177.612 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 15.2 p -111.99 7.45 19.86 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.817 -1.083 . . . . 2.1699999999999999 113.568 -175.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1571 ' ' ARG . . . . . 0.5 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 0.0 OUTLIER 64.68 44.34 3.87 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 122.964 0.506 . . . . 2.6200000000000001 111.757 -178.91 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 42.6 mt -83.06 112.39 20.67 Favored 'Isoleucine or valine' 0 C--O 1.246 0.902 0 N-CA-C 107.973 -1.121 . . . . 0.92000000000000004 107.973 174.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1573 ' ' SER . . . . . 0.893 ' HB2' HG21 ' A' 1563 ' ' VAL . 91.0 p -80.14 134.57 36.17 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.557 -0.747 . . . . 0.80000000000000004 111.416 -174.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1574 ' ' VAL . . . . . 0.516 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 33.2 m -118.11 9.11 6.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 O-C-N 121.32 -0.862 . . . . 0.97999999999999998 112.42 -178.612 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 175.33 123.88 0.78 Allowed Glycine 0 N--CA 1.433 -1.515 0 C-N-CA 120.331 -0.938 . . . . 0.28999999999999998 111.403 176.213 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -69.24 153.34 43.82 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.043 -0.725 . . . . 2.1899999999999999 109.043 -178.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -74.46 88.61 2.11 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-O 121.115 0.483 . . . . 0.60999999999999999 110.258 -177.151 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -97.07 160.05 14.56 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 115.106 -0.952 . . . . 1.95 110.464 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 24.2 pttm -120.51 45.29 2.25 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 122.878 1.323 . . . . 2.6800000000000002 108.363 -178.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 24.0 ttm180 -103.6 76.36 1.39 Allowed 'General case' 0 N--CA 1.412 -2.331 0 CA-C-N 113.956 -1.475 . . . . 3.4700000000000002 108.54 -173.502 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1581 ' ' LEU . . . . . 0.56 HD11 HD12 ' A' 1588 ' ' LEU . 0.2 OUTLIER -82.35 124.7 30.23 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 114.146 -1.388 . . . . 0.64000000000000001 107.534 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A 1582 ' ' ARG . . . . . 0.492 ' HB2' ' HB3' ' A' 1589 ' ' GLN . 64.3 mtp180 -122.56 143.4 49.76 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 116.768 -0.196 . . . . 2.8500000000000001 110.599 176.798 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1583 ' ' TYR . . . . . 0.403 ' HE1' ' HA ' ' A' 1586 ' ' GLN . 74.9 t80 -113.35 107.57 16.04 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 109.323 -0.621 . . . . 0.85999999999999999 109.323 177.472 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1584 ' ' VAL . . . . . 0.622 ' O ' ' HB ' ' A' 1587 ' ' VAL . 9.7 m -121.63 90.01 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 CA-C-N 115.722 -0.672 . . . . 1.05 111.153 -177.593 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 31.1 t70 53.51 72.63 0.42 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.053 0.941 . . . . 1.1699999999999999 111.761 178.262 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1586 ' ' GLN . . . . . 0.403 ' HA ' ' HE1' ' A' 1583 ' ' TYR . 13.9 pt20 57.21 26.39 12.17 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 125.818 1.647 . . . . 1.8600000000000001 111.296 176.672 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1587 ' ' VAL . . . . . 0.622 ' HB ' ' O ' ' A' 1584 ' ' VAL . 24.6 t -124.23 120.88 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.32 0 CA-C-N 113.769 -1.56 . . . . 0.48999999999999999 108.117 175.341 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1588 ' ' LEU . . . . . 0.812 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 2.9 mm? -95.05 117.36 30.04 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.09 -1.448 . . . . 0.35999999999999999 107.09 178.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1589 ' ' GLN . . . . . 0.492 ' HB3' ' HB2' ' A' 1582 ' ' ARG . 35.3 tt0 -106.56 127.42 53.31 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 116.02 -0.536 . . . . 1.74 111.454 -175.495 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1590 ' ' LEU . . . . . 0.449 ' HG ' HD22 ' A' 1581 ' ' LEU . 11.2 mt -121.49 101.6 7.72 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 107.463 -1.31 . . . . 0.71999999999999997 107.463 170.387 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 6.4 p -96.92 124.68 49.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 CA-C-O 121.494 0.664 . . . . 1.01 109.966 -178.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1592 ' ' TYR . . . . . 0.469 ' HB2' ' HB3' ' A' 1608 ' ' SER . 14.4 m-30 -115.55 105.05 12.35 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.269 -1.012 . . . . 0.5 108.269 -179.053 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 20.7 pttp -115.27 -178.94 3.49 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 109.759 -0.46 . . . . 1.5900000000000001 109.759 -179.069 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 36.2 m-20 65.16 42.42 4.06 Favored 'General case' 0 C--O 1.247 0.962 0 O-C-N 124.28 0.987 . . . . 1.1100000000000001 110.405 177.57 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -75.88 -145.64 1.57 Allowed Glycine 0 N--CA 1.438 -1.217 0 CA-C-N 114.798 -1.092 . . . . 0.78000000000000003 111.007 174.302 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1596 ' ' SER . . . . . 0.412 ' HA ' ' HD3' ' A' 1597 ' ' PRO . 72.0 p -88.94 146.47 36.7 Favored Pre-proline 0 C--N 1.284 -2.278 0 N-CA-C 108.444 -0.947 . . . . 1.0700000000000001 108.444 179.163 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1597 ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' 1596 ' ' SER . 50.2 Cg_exo -57.49 120.74 8.85 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.646 2.23 . . . . 1.01 109.308 174.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 42.4 t -73.25 132.21 82.29 Favored Pre-proline 0 C--N 1.288 -2.084 0 CA-C-N 114.663 -1.153 . . . . 0.75 112.425 -169.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1599 ' ' PRO . . . . . 0.48 ' HD2' ' OH ' ' A' 1606 ' ' TYR . 14.7 Cg_exo -72.44 80.2 1.7 Allowed 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 123.122 2.548 . . . . 1.7 109.338 171.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1600 ' ' SER . . . . . 0.851 ' HA ' ' HB2' ' B' ' 53' ' ' LEU . 50.6 m -160.62 -67.29 0.07 Allowed 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 126.613 1.965 . . . . 2.2599999999999998 110.004 -178.218 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1601 ' ' LYS . . . . . 0.477 ' O ' ' HG ' ' A' 1604 ' ' LEU . 81.4 tttt -140.11 112.04 7.53 Favored 'General case' 0 N--CA 1.398 -3.05 0 N-CA-C 106.398 -1.704 . . . . 3.0099999999999998 106.398 178.714 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 15.4 m -49.52 133.05 20.95 Favored 'General case' 0 N--CA 1.425 -1.72 0 C-N-CA 124.599 1.16 . . . . 2.0699999999999998 112.549 -177.1 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 106.5 -21.49 32.6 Favored Glycine 0 C--N 1.304 -1.215 0 CA-C-N 115.91 -0.586 . . . . 1.0800000000000001 113.945 177.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1604 ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' 1601 ' ' LYS . 4.3 pp -103.21 145.98 29.12 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 118.387 1.094 . . . . 1.8400000000000001 111.238 178.124 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 22.8 p -111.77 155.89 22.81 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.624 -0.716 . . . . 1.4099999999999999 110.797 -175.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1606 ' ' TYR . . . . . 0.516 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 63.9 m-85 -64.25 161.7 16.07 Favored 'General case' 0 C--O 1.249 1.046 0 CA-C-N 116.075 -0.511 . . . . 0.59999999999999998 110.493 173.594 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -161.38 130.17 4.5 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-O 120.882 0.372 . . . . 1.45 111.145 -178.555 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1608 ' ' SER . . . . . 0.469 ' HB3' ' HB2' ' A' 1592 ' ' TYR . 38.0 t -105.23 123.03 47.15 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 115.376 -0.829 . . . . 1.1499999999999999 109.723 -177.472 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 24.1 t -107.55 100.75 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 107.946 -1.131 . . . . 0.25 107.946 175.554 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 89.7 mt -89.77 112.19 24.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 108.317 -0.994 . . . . 0.45000000000000001 108.317 -179.016 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 40.1 m -112.86 110.68 20.93 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 115.043 -0.98 . . . . 1.26 111.355 -177.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1612 ' ' PHE . . . . . 0.812 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 62.8 m-85 -83.42 115.85 22.23 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.793 -0.817 . . . . 0.26000000000000001 108.793 175.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 84.1 t -110.31 135.75 48.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 O-C-N 123.651 0.594 . . . . 0.5 110.572 -174.316 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 41.4 t -72.13 98.24 2.08 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 124.069 0.948 . . . . 0.77000000000000002 111.686 -178.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1615 ' ' ARG . . . . . 0.747 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 9.5 mmt180 -138.11 99.31 9.07 Favored Pre-proline 0 N--CA 1.431 -1.404 0 CA-C-N 116.058 -0.519 . . . . 2.5299999999999998 109.812 175.31 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1616 ' ' PRO . . . . . 0.424 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 16.4 Cg_exo -75.26 39.57 0.62 Allowed 'Trans proline' 0 N--CA 1.488 1.188 0 C-N-CA 123.37 2.713 . . . . 1.1000000000000001 112.412 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1617 ' ' GLU . . . . . 0.52 ' OE1' ' HD2' ' A' 1615 ' ' ARG . 42.9 mt-10 -110.57 40.46 1.98 Allowed 'General case' 0 C--N 1.272 -2.772 0 N-CA-C 108.076 -1.083 . . . . 3.0499999999999998 108.076 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -41.48 115.45 0.63 Allowed 'General case' 0 C--O 1.244 0.765 0 C-N-CA 126.288 1.835 . . . . 1.55 113.867 -175.39 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . 173.42 -127.16 1.31 Allowed Glycine 0 N--CA 1.412 -2.929 0 N-CA-C 108.149 -1.981 . . . . 0.93000000000000005 108.149 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -77.2 7.03 3.9 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 122.545 2.163 . . . . 0.88 112.657 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1621 ' ' THR . . . . . 0.482 ' HB ' ' HB2' ' A' 1641 ' ' HIS . 3.8 p -91.11 -27.17 18.73 Favored 'General case' 0 C--N 1.288 -2.081 0 C-N-CA 124.924 1.29 . . . . 0.96999999999999997 108.203 176.812 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 51.2 t30 -87.01 56.78 4.16 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.387 -1.278 . . . . 0.71999999999999997 108.566 -176.176 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -157.99 139.54 9.84 Favored Pre-proline 0 C--N 1.302 -1.493 0 CA-C-N 114.632 -1.167 . . . . 3.2599999999999998 108.443 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1624 ' ' PRO . . . . . 0.414 ' HA ' ' O ' ' A' 1639 ' ' SER . 53.5 Cg_endo -68.28 110.91 2.35 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.898 2.399 . . . . 0.58999999999999997 112.01 -177.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 75.8 mtm -111.98 142.95 43.76 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 120.69 -0.404 . . . . 1.3700000000000001 110.187 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1626 ' ' LEU . . . . . 0.587 ' HG ' ' CE2' ' A' 1542 ' ' TYR . 0.8 OUTLIER -81.78 112.88 19.34 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 108.34 -0.985 . . . . 0.89000000000000001 108.34 -175.412 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 44.2 mm -81.12 -52.25 14.32 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 CA-C-O 121.31 0.576 . . . . 0.57999999999999996 109.852 -178.179 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 50.9 m -159.56 145.42 15.99 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.541 -0.754 . . . . 1.3899999999999999 109.772 -176.29 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1629 ' ' LEU . . . . . 1.014 HD13 ' HG ' ' A' 1636 ' ' LEU . 23.0 tp -129.7 95.13 3.9 Favored 'General case' 0 N--CA 1.421 -1.879 0 N-CA-C 107.785 -1.191 . . . . 1.25 107.785 171.498 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 27.5 t70 -68.0 122.11 17.52 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 107.121 -1.437 . . . . 1.0900000000000001 107.121 175.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 26.0 tptp -89.36 -0.17 57.28 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 119.882 -0.727 . . . . 3.6000000000000001 110.709 -171.561 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 56.6 tp60 -96.17 -41.08 8.88 Favored 'General case' 0 N--CA 1.426 -1.643 0 C-N-CA 119.884 -0.726 . . . . 2.6000000000000001 109.933 179.234 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 22.9 p -89.39 -22.05 22.76 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.4 0.619 . . . . 0.75 110.596 175.244 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 68.3 m 63.64 36.63 10.73 Favored 'General case' 0 C--N 1.354 0.771 0 C-N-CA 124.965 1.306 . . . . 0.53000000000000003 111.824 178.064 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1635 ' ' THR . . . . . . . . . . . . . 38.6 m -100.35 130.5 46.46 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 108.028 -1.101 . . . . 0.46000000000000002 108.028 178.341 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1636 ' ' LEU . . . . . 1.014 ' HG ' HD13 ' A' 1629 ' ' LEU . 0.6 OUTLIER -109.38 129.96 55.51 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 108.712 -0.847 . . . . 0.85999999999999999 108.712 -176.373 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -106.86 121.59 44.72 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 120.901 0.382 . . . . 0.45000000000000001 110.811 -179.306 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -119.09 127.78 53.7 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.293 -0.867 . . . . 0.5 108.794 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1639 ' ' SER . . . . . 0.414 ' O ' ' HA ' ' A' 1624 ' ' PRO . 59.1 m -114.23 144.09 43.78 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.293 -1.003 . . . . 1.04 108.293 177.287 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 2.8 t90 -141.39 107.95 5.33 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 103.792 -2.67 . . . . 0.68000000000000005 103.792 -177.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1641 ' ' HIS . . . . . 0.747 ' HB3' ' HB2' ' A' 1615 ' ' ARG . 16.4 m170 -93.61 103.25 15.43 Favored 'General case' 0 C--N 1.287 -2.129 0 C-N-CA 120.706 -0.397 . . . . 0.90000000000000002 110.487 -174.529 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1642 ' ' THR . . . . . . . . . . . . . 15.0 t -142.62 145.77 35.62 Favored Pre-proline 0 CA--C 1.565 1.529 0 N-CA-C 109.304 -0.628 . . . . 0.47999999999999998 109.304 -174.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1643 ' ' PRO . . . . . 0.424 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 56.3 Cg_endo -72.57 -13.74 27.43 Favored 'Trans proline' 0 C--N 1.37 1.681 0 C-N-CA 122.635 2.224 . . . . 0.66000000000000003 112.885 -179.027 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 9.1 tt -65.23 -19.24 65.88 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.37 0.605 . . . . 0.96999999999999997 110.399 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -78.24 -7.2 56.86 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.58 -0.737 . . . . 0.83999999999999997 112.241 -179.286 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 1.2 m -108.93 156.46 19.67 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 121.474 0.654 . . . . 1.1899999999999999 111.869 178.45 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.292 -1.919 0 N-CA-C 107.531 -1.285 . . . . 3.1400000000000001 107.531 169.335 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.972 0 CA-C-O 120.339 -0.145 . . . . 2.0899999999999999 113.307 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -59.31 -39.16 94.33 Favored Glycine 0 N--CA 1.461 0.343 0 O-C-N 123.654 0.267 . . . . 1.8400000000000001 113.202 -176.334 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 18.0 mp0 -65.61 -40.44 92.62 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 124.213 1.005 . . . . 2.5499999999999998 110.067 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 13' ' ' LEU . . . . . 0.431 HD21 ' HB3' ' B' ' 46' ' ' CYS . 0.1 OUTLIER -65.15 -51.62 60.06 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.206 -0.906 . . . . 2.3500000000000001 108.571 -178.884 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 7.6 p -63.42 -37.61 80.01 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 CA-C-N 116.405 -0.361 . . . . 2.1099999999999999 111.655 179.272 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -68.1 -32.81 73.37 Favored 'General case' 0 C--O 1.193 -1.907 0 C-N-CA 120.088 -0.645 . . . . 2.04 111.859 177.18 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 96.5 m -59.16 -49.73 76.73 Favored 'General case' 0 C--O 1.279 2.613 0 CA-C-O 121.551 0.691 . . . . 1.8400000000000001 109.62 174.142 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.702 HD21 HD11 ' B' ' 42' ' ' ILE . 4.6 mm? -51.52 -48.46 62.96 Favored 'General case' 0 C--O 1.222 -0.365 0 CA-C-N 114.472 -1.24 . . . . 1.74 110.416 174.134 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 18' ' ' GLN . . . . . 0.489 ' CD ' ' HB3' ' A' 1545 ' ' SER . 9.7 tt0 -78.11 -15.2 59.08 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.584 -0.734 . . . . 2.3900000000000001 112.264 -176.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -66.75 -48.46 69.04 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.727 -0.471 . . . . 0.95999999999999996 109.727 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 23.8 m -92.77 -29.11 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 117.49 -1.684 . . . . 1.3700000000000001 111.995 176.228 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 63.0 m -96.94 25.19 5.52 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 112.203 0.445 . . . . 1.6599999999999999 112.203 -178.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -54.3 -58.43 13.01 Favored Glycine 0 N--CA 1.472 1.085 0 C-N-CA 120.997 -0.62 . . . . 1.53 112.735 179.019 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -80.77 -3.63 51.63 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 121.027 0.441 . . . . 2.7200000000000002 111.27 178.406 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -99.08 -55.25 2.75 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 112.157 0.429 . . . . 4.3300000000000001 112.157 -173.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 122.09 143.67 6.59 Favored Glycine 0 C--N 1.301 -1.37 0 N-CA-C 108.64 -1.784 . . . . 1.53 108.64 -173.441 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 26' ' ' PHE . . . . . 0.413 ' HB2' ' HB3' ' B' ' 17' ' ' LEU . 41.6 p90 -132.33 146.36 51.92 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 117.52 0.66 . . . . 1.6499999999999999 110.785 -177.191 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 15.4 p90 -160.97 91.36 0.88 Allowed 'General case' 0 CA--C 1.547 0.865 0 CA-C-O 121.245 0.545 . . . . 3.4199999999999999 111.923 178.094 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 28' ' ' PHE . . . . . . . . . . . . . 36.1 p90 . . . . . 0 C--O 1.238 0.482 0 O-C-N 121.187 -0.946 . . . . 2.2599999999999998 110.932 -179.973 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 41' ' ' GLY . . . . . 0.595 ' N ' ' HH ' ' B' ' 59' ' ' TYR . . . . . . . . 0 N--CA 1.415 -2.73 0 N-CA-C 109.336 -1.506 . . . . 2.3700000000000001 109.336 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 42' ' ' ILE . . . . . 0.702 HD11 HD21 ' B' ' 17' ' ' LEU . 11.1 pt 64.6 -24.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 C-N-CA 128.581 2.752 . . . . 2.0699999999999998 113.866 179.016 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.588 ' O ' ' HB2' ' B' ' 47' ' ' CYS . 2.0 p -50.56 -45.01 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 C-N-CA 124.628 1.171 . . . . 2.2400000000000002 113.362 177.582 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -93.89 -39.98 10.4 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.418 -0.956 . . . . 3.3599999999999999 108.418 -174.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 45' ' ' GLU . . . . . 0.493 ' O ' ' HB2' ' B' ' 49' ' ' ARG . 3.1 mp0 -55.25 -44.66 75.74 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 113.968 -1.469 . . . . 3.0800000000000001 111.261 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 46' ' ' CYS . . . . . 0.431 ' HB3' HD21 ' B' ' 13' ' ' LEU . 13.1 t -94.8 -2.16 51.45 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.356 0.598 . . . . 2.23 110.717 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 47' ' ' CYS . . . . . 0.588 ' HB2' ' O ' ' B' ' 43' ' ' VAL . 45.4 t -78.54 -56.88 4.09 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.374 -0.602 . . . . 2.3700000000000001 109.374 177.227 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -90.97 -12.07 37.07 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.406 0.521 . . . . 2.8199999999999998 112.406 -175.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 49' ' ' ARG . . . . . 0.493 ' HB2' ' O ' ' B' ' 45' ' ' GLU . 72.4 mtp180 -129.95 -171.07 2.43 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 107.904 -1.147 . . . . 4.0899999999999999 107.904 -178.372 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 8.3 t -110.81 129.79 55.76 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 106.278 -1.749 . . . . 2.6699999999999999 106.278 178.068 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 14.7 p -96.44 131.73 42.71 Favored 'General case' 0 N--CA 1.428 -1.57 0 CA-C-O 120.949 0.404 . . . . 2.1099999999999999 110.148 -174.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -74.68 154.42 38.46 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-N 115.806 -0.634 . . . . 2.6699999999999999 110.763 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 53' ' ' LEU . . . . . 0.851 ' HB2' ' HA ' ' A' 1600 ' ' SER . 34.1 tp -55.45 -43.65 75.63 Favored 'General case' 0 C--N 1.309 -1.194 0 O-C-N 123.585 0.553 . . . . 1.8999999999999999 110.605 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -52.64 -36.75 57.23 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 124.958 1.303 . . . . 1.52 112.043 -176.129 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 64.2 tp -70.27 -57.88 4.38 Favored 'General case' 0 N--CA 1.427 -1.621 0 CA-C-N 115.451 -0.795 . . . . 1.97 110.676 -179.017 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 56' ' ' LEU . . . . . 0.441 ' O ' ' HB2' ' B' ' 60' ' ' CYS . 3.0 pp -68.78 -33.87 74.59 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 111.867 0.321 . . . . 1.53 111.867 -174.44 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -54.43 -60.64 3.07 Favored 'General case' 0 C--N 1.318 -0.771 0 O-C-N 123.947 0.779 . . . . 2.27 111.679 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 12.4 t -80.74 -25.55 37.96 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 119.974 -0.69 . . . . 2.3300000000000001 111.995 -175.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 59' ' ' TYR . . . . . 0.595 ' HH ' ' N ' ' B' ' 41' ' ' GLY . 25.3 t80 -71.7 -40.53 69.45 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 109.096 -0.705 . . . . 2.8599999999999999 109.096 -179.288 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 60' ' ' CYS . . . . . 0.441 ' HB2' ' O ' ' B' ' 56' ' ' LEU . 30.4 t . . . . . 0 N--CA 1.485 1.297 0 O-C-N 124.72 1.262 . . . . 2.2999999999999998 111.335 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1515 ' ' ASP . . . . . 0.423 ' HB3' ' HE2' ' A' 1579 ' ' LYS . 29.5 m-20 . . . . . 0 CA--C 1.505 -0.776 0 N-CA-C 109.047 -0.723 . . . . 2.8999999999999999 109.047 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1516 ' ' CYS . . . . . 0.493 ' HA ' ' HB2' ' A' 1581 ' ' LEU . 83.7 m -138.64 41.75 2.17 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 116.214 -0.448 . . . . 1.1899999999999999 111.024 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1517 ' ' GLN . . . . . 0.409 ' HA ' ' O ' ' A' 1527 ' ' PHE . 3.5 pt20 -149.13 137.16 20.66 Favored 'General case' 0 N--CA 1.428 -1.564 0 C-N-CA 120.351 -0.539 . . . . 1.52 109.9 178.277 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1518 ' ' VAL . . . . . 0.533 HG21 ' HB2' ' A' 1583 ' ' TYR . 10.4 m -140.67 141.06 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 123.16 0.584 . . . . 0.93999999999999995 110.204 178.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1519 ' ' THR . . . . . . . . . . . . . 9.6 m -101.04 131.2 47.05 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 115.77 -0.65 . . . . 0.89000000000000001 109.343 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1520 ' ' ASN . . . . . 0.422 ' OD1' HG22 ' A' 1523 ' ' THR . 26.5 t-20 -83.49 118.27 71.04 Favored Pre-proline 0 N--CA 1.426 -1.661 0 N-CA-C 109.332 -0.618 . . . . 1.74 109.332 176.315 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.14 -16.82 49.88 Favored 'Trans proline' 0 C--O 1.239 0.572 0 C-N-CA 123.224 2.616 . . . . 1.5800000000000001 113.906 -177.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 74.2 m -77.2 -46.34 23.62 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 112.28 0.474 . . . . 1.6499999999999999 112.28 -179.411 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1523 ' ' THR . . . . . 0.422 HG22 ' OD1' ' A' 1520 ' ' ASN . 5.7 t -109.68 -14.43 14.34 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 119.547 -0.861 . . . . 1.6100000000000001 111.626 -178.065 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 79.55 31.68 40.25 Favored Glycine 0 N--CA 1.44 -1.044 0 N-CA-C 111.352 -0.699 . . . . 1.1299999999999999 111.352 178.596 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1525 ' ' HIS . . . . . 0.401 ' HB2' ' OE2' ' A' 1647 ' ' GLU . 5.2 t-80 -98.22 120.9 39.43 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.623 -0.88 . . . . 1.26 108.623 -178.345 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 1.9 tm? -86.31 112.66 21.62 Favored 'General case' 0 C--N 1.285 -2.212 0 N-CA-C 107.022 -1.473 . . . . 0.68000000000000005 107.022 176.128 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1527 ' ' PHE . . . . . 0.409 ' O ' ' HA ' ' A' 1517 ' ' GLN . 50.1 m-85 -99.79 120.01 39.06 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 109.194 -0.669 . . . . 0.65000000000000002 109.194 177.332 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 23.1 t70 -112.64 118.09 34.09 Favored 'General case' 0 CA--C 1.482 -1.657 0 N-CA-C 108.652 -0.87 . . . . 1.1699999999999999 108.652 177.127 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 6.0 mp -107.38 5.8 27.73 Favored 'General case' 0 N--CA 1.412 -2.353 0 CA-C-O 121.571 0.7 . . . . 0.59999999999999998 110.769 -177.449 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 1.5 m -72.72 -11.08 60.48 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.838 -1.074 . . . . 0.83999999999999997 109.089 178.364 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 24.7 m -75.49 -23.63 56.81 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 115.3 -0.864 . . . . 1.5900000000000001 109.712 176.234 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 97.9 mt -87.1 -5.16 59.12 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.258 0.552 . . . . 0.65000000000000002 110.312 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1533 ' ' SER . . . . . 0.488 ' HA ' ' HB ' ' A' 1552 ' ' ILE . 21.0 m -70.53 166.76 19.86 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.842 -0.617 . . . . 1.52 111.862 -178.208 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . 173.47 164.15 28.24 Favored Glycine 0 N--CA 1.436 -1.301 0 N-CA-C 110.069 -1.212 . . . . 1.1000000000000001 110.069 -179.089 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 44.6 ttp180 -92.57 -33.66 14.34 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 121.028 0.442 . . . . 4.6200000000000001 110.197 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -82.06 -30.83 31.14 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 116.088 -0.505 . . . . 1.45 110.597 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 84.51 -145.65 22.11 Favored Glycine 0 N--CA 1.422 -2.255 0 CA-C-N 115.5 -0.773 . . . . 0.84999999999999998 113.634 170.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -137.3 153.18 50.34 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 124.98 1.312 . . . . 0.93000000000000005 107.548 -178.083 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 8.6 p -115.28 136.93 52.58 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 123.632 0.582 . . . . 1.03 110.508 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1540 ' ' ALA . . . . . 0.447 ' HB3' HG12 ' A' 1548 ' ' VAL . . . -132.61 136.36 46.47 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.969 -1.123 . . . . 0.5 107.969 175.387 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -84.73 129.31 34.84 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.275 0.559 . . . . 0.73999999999999999 110.589 -176.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1542 ' ' TYR . . . . . 0.623 ' CE2' ' HG ' ' A' 1626 ' ' LEU . 1.6 t80 -120.04 -100.58 0.43 Allowed 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.588 -1.264 . . . . 0.98999999999999999 107.588 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1543 ' ' SER . . . . . 0.502 ' H ' ' HB3' ' A' 1542 ' ' TYR . 5.2 m -71.94 161.52 30.81 Favored 'General case' 0 N--CA 1.421 -1.91 0 C-N-CA 124.373 1.069 . . . . 1.9099999999999999 108.838 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1544 ' ' LYS . . . . . 0.82 ' HG3' ' HB3' ' B' ' 23' ' ' ASP . 39.0 mmtm -72.57 -1.11 14.78 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.398 0.888 . . . . 3.5899999999999999 113.398 -177.299 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 22.6 t -139.82 37.98 1.99 Allowed 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 108.937 -0.764 . . . . 2.46 108.937 176.201 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . -172.29 126.58 1.29 Allowed Glycine 0 N--CA 1.434 -1.494 0 C-N-CA 119.555 -1.307 . . . . 1.26 114.166 -178.569 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 26.8 m -109.1 150.53 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.568 0 N-CA-C 107.184 -1.413 . . . . 0.79000000000000004 107.184 174.424 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1548 ' ' VAL . . . . . 0.447 HG12 ' HB3' ' A' 1540 ' ' ALA . 10.0 p -97.46 130.4 46.18 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 C-N-CA 120.171 -0.612 . . . . 0.57999999999999996 109.403 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -94.22 131.53 39.71 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 108.358 -0.978 . . . . 1.0800000000000001 108.358 176.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 26.2 ptm -145.59 127.03 14.99 Favored 'General case' 0 C--N 1.286 -2.183 0 CA-C-N 115.471 -0.786 . . . . 0.78000000000000003 110.983 -177.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 69.1 m -118.15 128.48 54.77 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 115.769 -0.65 . . . . 0.96999999999999997 109.968 177.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1552 ' ' ILE . . . . . 0.488 ' HB ' ' HA ' ' A' 1533 ' ' SER . 50.7 mm -77.35 125.34 37.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 109.16 -0.682 . . . . 0.41999999999999998 109.16 -179.581 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 75.8 m 59.08 39.42 23.26 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.589 0.755 . . . . 1.3999999999999999 112.045 175.517 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . -179.99 178.51 48.56 Favored Glycine 0 N--CA 1.42 -2.376 0 C-N-CA 120.096 -1.049 . . . . 0.34999999999999998 110.919 -177.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1555 ' ' GLU . . . . . 0.403 ' OE1' ' HA ' ' A' 1561 ' ' PRO . 14.6 pt-20 -96.85 160.78 14.17 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 109.337 -0.616 . . . . 1.6200000000000001 109.337 179.54 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -103.48 130.29 50.81 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 109.891 -0.411 . . . . 0.87 109.891 -178.392 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -73.3 2.1 8.15 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.676 0.991 . . . . 2.4900000000000002 113.676 -175.018 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -101.71 1.31 37.33 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.91 -0.494 . . . . 1.3799999999999999 110.427 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1559 ' ' CYS . . . . . 0.613 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 16.1 m -137.03 175.26 3.62 Favored Pre-proline 0 C--N 1.303 -1.421 0 CA-C-O 118.647 -0.692 . . . . 1.21 112.07 -177.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1560 ' ' PRO . . . . . 0.613 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 21.9 Cg_exo -38.76 142.93 0.27 Allowed 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 124.063 3.175 . . . . 0.70999999999999996 114.562 175.389 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1561 ' ' PRO . . . . . 0.502 ' HD3' ' HA ' ' A' 1560 ' ' PRO . 31.6 Cg_exo -61.51 126.69 19.77 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.533 2.155 . . . . 0.80000000000000004 111.018 176.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 100.33 -9.0 59.09 Favored Glycine 0 C--N 1.31 -0.87 0 N-CA-C 114.345 0.498 . . . . 0.46000000000000002 114.345 178.177 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1563 ' ' VAL . . . . . 0.607 HG12 ' O ' ' A' 1560 ' ' PRO . 9.8 p -99.9 134.92 37.7 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 O-C-N 121.6 -0.941 . . . . 0.97999999999999998 111.294 -177.418 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -95.35 -31.39 7.57 Favored Glycine 0 N--CA 1.453 -0.191 0 CA-C-N 115.725 -0.67 . . . . 0.28000000000000003 112.854 -177.457 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -124.14 125.62 44.77 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 109.71 -0.478 . . . . 0.28000000000000003 109.71 178.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 4.5 t -159.36 141.42 13.52 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 116.492 -0.322 . . . . 0.42999999999999999 110.361 -177.119 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1567 ' ' PHE . . . . . 0.516 ' HE1' HG21 ' A' 1574 ' ' VAL . 84.0 m-85 -86.24 139.91 30.6 Favored 'General case' 0 C--O 1.245 0.828 0 N-CA-C 109.61 -0.515 . . . . 1.03 109.61 175.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -86.3 29.85 4.64 Favored Glycine 0 CA--C 1.508 -0.361 0 C-N-CA 120.856 -0.687 . . . . 1.1299999999999999 112.454 -175.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1569 ' ' GLN . . . . . 0.599 ' HB3' ' OD1' ' B' ' 15' ' ' ASP . 27.7 mt-30 -83.3 -70.58 0.55 Allowed 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 110.281 -0.266 . . . . 2.5800000000000001 110.281 177.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 8.3 t -130.96 32.31 4.34 Favored 'General case' 0 CA--C 1.557 1.228 0 CA-C-O 121.563 0.697 . . . . 2.1699999999999999 111.107 176.164 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1571 ' ' ARG . . . . . 0.413 ' HB3' ' HD3' ' A' 1560 ' ' PRO . 15.2 mmt85 64.64 48.86 2.45 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 124.213 1.005 . . . . 2.6200000000000001 110.895 178.689 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 27.8 mt -89.36 120.22 37.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 109.552 -0.536 . . . . 0.92000000000000004 109.552 -178.674 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1573 ' ' SER . . . . . 0.412 ' HB3' ' HB3' ' A' 1596 ' ' SER . 29.5 t -76.13 128.72 35.54 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.392 -0.822 . . . . 0.80000000000000004 111.009 -177.414 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1574 ' ' VAL . . . . . 0.516 HG21 ' HE1' ' A' 1567 ' ' PHE . 0.9 OUTLIER -112.15 -16.57 9.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 115.884 -0.598 . . . . 0.97999999999999998 112.084 -179.918 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 179.11 124.5 0.88 Allowed Glycine 0 N--CA 1.435 -1.403 0 C-N-CA 119.34 -1.409 . . . . 0.28999999999999998 112.4 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 22.2 ttmm -61.65 145.99 50.46 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 123.683 0.793 . . . . 2.1899999999999999 109.399 178.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -59.63 119.92 8.49 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 108.834 -0.802 . . . . 0.60999999999999999 108.834 175.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 60.2 t30 -132.49 147.12 52.36 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.474 -1.306 . . . . 1.95 107.474 -174.66 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1579 ' ' LYS . . . . . 0.423 ' HE2' ' HB3' ' A' 1515 ' ' ASP . 56.4 mtpt -132.27 57.66 1.78 Allowed 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 122.298 1.047 . . . . 2.6800000000000002 108.772 -175.352 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 31.2 ttm180 -117.69 76.56 1.07 Allowed 'General case' 0 N--CA 1.413 -2.311 0 CA-C-N 114.775 -1.102 . . . . 3.4700000000000002 108.051 -176.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1581 ' ' LEU . . . . . 0.493 ' HB2' ' HA ' ' A' 1516 ' ' CYS . 0.6 OUTLIER -64.23 125.72 25.45 Favored 'General case' 0 C--O 1.252 1.196 0 CA-C-N 114.266 -1.334 . . . . 0.64000000000000001 109.975 -178.103 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A 1582 ' ' ARG . . . . . 0.424 ' HD2' ' OE1' ' A' 1589 ' ' GLN . 91.6 mtt180 -124.48 138.23 54.36 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.865 -0.607 . . . . 2.8500000000000001 110.391 177.734 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1583 ' ' TYR . . . . . 0.533 ' HB2' HG21 ' A' 1518 ' ' VAL . 46.0 t80 -110.8 107.26 16.71 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 107.303 -1.369 . . . . 0.85999999999999999 107.303 174.798 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1584 ' ' VAL . . . . . 0.49 ' O ' ' HB ' ' A' 1587 ' ' VAL . 16.5 m -120.97 90.1 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 CA-C-N 115.9 -0.591 . . . . 1.05 112.065 -176.768 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 29.6 t70 58.02 57.66 3.97 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.892 0.853 . . . . 1.1699999999999999 110.555 178.171 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1586 ' ' GLN . . . . . 0.47 ' HA ' ' CZ ' ' A' 1583 ' ' TYR . 19.7 pt20 73.99 -7.64 1.58 Allowed 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 128.243 2.617 . . . . 1.8600000000000001 111.476 178.595 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1587 ' ' VAL . . . . . 0.49 ' HB ' ' O ' ' A' 1584 ' ' VAL . 30.5 t -88.07 124.9 41.46 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.444 0 CA-C-N 115.719 -0.673 . . . . 0.48999999999999999 109.337 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1588 ' ' LEU . . . . . 0.736 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 3.3 mm? -93.93 120.85 34.74 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 107.581 -1.266 . . . . 0.35999999999999999 107.581 179.403 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1589 ' ' GLN . . . . . 0.424 ' OE1' ' HD2' ' A' 1582 ' ' ARG . 35.8 tt0 -116.78 135.65 53.59 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 112.63 0.604 . . . . 1.74 112.63 -173.757 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 18.3 mt -129.96 99.25 5.03 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 125.373 1.469 . . . . 0.71999999999999997 107.224 172.107 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 7.5 p -95.81 125.87 48.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 109.527 -0.546 . . . . 1.01 109.527 -178.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1592 ' ' TYR . . . . . 0.603 ' HB2' ' HB3' ' A' 1608 ' ' SER . 15.8 m-30 -110.76 107.1 16.51 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 108.592 -0.892 . . . . 0.5 108.592 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 19.5 pttp -109.68 168.77 9.17 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 115.557 -0.747 . . . . 1.5900000000000001 110.057 -177.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 15.3 m-20 66.29 78.89 0.25 Allowed 'General case' 0 CA--C 1.507 -0.681 0 C-N-CA 124.488 1.115 . . . . 1.1100000000000001 110.69 -178.616 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -98.99 -122.07 4.65 Favored Glycine 0 C--N 1.287 -2.143 0 N-CA-C 109.703 -1.359 . . . . 0.78000000000000003 109.703 175.112 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1596 ' ' SER . . . . . 0.412 ' HB3' ' HB3' ' A' 1573 ' ' SER . 50.7 p -120.29 164.68 21.3 Favored Pre-proline 0 C--N 1.297 -1.683 0 N-CA-C 107.927 -1.138 . . . . 1.0700000000000001 107.927 175.365 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.16 119.94 7.53 Favored 'Trans proline' 0 C--N 1.361 1.214 0 C-N-CA 122.317 2.012 . . . . 1.01 112.306 -178.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1598 ' ' CYS . . . . . 0.434 ' HA ' ' HD3' ' A' 1599 ' ' PRO . 44.5 t -81.08 125.21 80.18 Favored Pre-proline 0 C--N 1.292 -1.901 0 CA-C-N 115.129 -0.941 . . . . 0.75 109.182 -179.227 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1599 ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' 1598 ' ' CYS . 14.9 Cg_exo -71.1 -15.15 32.16 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 123.429 2.753 . . . . 1.7 112.995 -178.444 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1600 ' ' SER . . . . . 0.836 ' HA ' ' HB3' ' B' ' 53' ' ' LEU . 10.6 m -59.0 -40.89 86.28 Favored 'General case' 0 N--CA 1.434 -1.257 0 C-N-CA 123.296 0.638 . . . . 2.2599999999999998 111.635 177.295 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1601 ' ' LYS . . . . . . . . . . . . . 18.5 ttmm -145.9 127.18 14.84 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 106.832 -1.544 . . . . 3.0099999999999998 106.832 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 19.2 m -61.94 117.18 5.59 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 112.176 0.435 . . . . 2.0699999999999998 112.176 -174.232 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 95.16 14.68 47.62 Favored Glycine 0 C--O 1.241 0.539 0 C-N-CA 121.404 -0.427 . . . . 1.0800000000000001 112.846 178.369 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1604 ' ' LEU . . . . . 0.605 HD23 ' SG ' ' A' 1634 ' ' CYS . 12.5 tp -108.16 157.11 18.59 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.861 -1.163 . . . . 1.8400000000000001 107.861 -178.567 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 33.4 t -120.53 154.32 35.5 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.965 -0.754 . . . . 1.4099999999999999 108.965 -178.112 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1606 ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -76.35 158.26 31.63 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.901 -0.777 . . . . 0.59999999999999998 108.901 174.143 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 56.7 pttt -158.4 140.81 14.28 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 120.397 -0.521 . . . . 1.45 110.976 175.529 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1608 ' ' SER . . . . . 0.603 ' HB3' ' HB2' ' A' 1592 ' ' TYR . 45.4 t -105.68 127.88 53.33 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 115.168 -0.924 . . . . 1.1499999999999999 109.894 -175.325 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 40.8 t -113.72 101.75 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 N-CA-C 108.905 -0.776 . . . . 0.25 108.905 176.636 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 80.4 mt -91.87 114.53 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.611 0 N-CA-C 107.85 -1.167 . . . . 0.45000000000000001 107.85 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 8.1 t -116.9 111.59 19.86 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 115.401 -0.818 . . . . 1.26 109.703 -176.594 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1612 ' ' PHE . . . . . 0.736 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 71.2 m-85 -90.86 118.36 30.21 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.733 -0.667 . . . . 0.26000000000000001 110.036 179.066 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 47.6 t -120.69 138.0 52.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.721 -0.672 . . . . 0.5 110.575 -174.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1614 ' ' CYS . . . . . 0.415 ' HA ' ' HB2' ' A' 1646 ' ' CYS . 15.3 t -51.49 114.87 1.36 Allowed 'General case' 0 C--O 1.247 0.929 0 C-N-CA 125.409 1.484 . . . . 0.77000000000000002 113.088 176.412 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1615 ' ' ARG . . . . . 0.817 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 18.8 tpt180 -128.22 96.6 30.77 Favored Pre-proline 0 N--CA 1.436 -1.139 0 N-CA-C 109.243 -0.651 . . . . 2.5299999999999998 109.243 173.251 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1616 ' ' PRO . . . . . 0.447 ' HD2' ' OE1' ' A' 1617 ' ' GLU . 31.7 Cg_exo -62.43 -37.42 59.98 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 121.909 1.739 . . . . 1.1000000000000001 111.311 175.517 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1617 ' ' GLU . . . . . 0.447 ' OE1' ' HD2' ' A' 1616 ' ' PRO . 2.6 mp0 -77.82 44.39 0.46 Allowed 'General case' 0 C--O 1.24 0.571 0 C-N-CA 124.89 1.276 . . . . 3.0499999999999998 112.059 178.152 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -37.15 132.63 0.72 Allowed 'General case' 0 C--O 1.244 0.792 0 C-N-CA 125.296 1.438 . . . . 1.55 112.613 178.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1619 ' ' GLY . . . . . 0.442 ' HA3' ' HD2' ' A' 1620 ' ' PRO . . . 172.46 -137.33 4.18 Favored Glycine 0 N--CA 1.423 -2.221 0 N-CA-C 110.195 -1.162 . . . . 0.93000000000000005 110.195 -177.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1620 ' ' PRO . . . . . 0.442 ' HD2' ' HA3' ' A' 1619 ' ' GLY . 36.3 Cg_endo -63.68 -1.46 3.33 Favored 'Trans proline' 0 CA--C 1.551 1.335 0 C-N-CA 123.269 2.646 . . . . 0.88 114.852 -178.254 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1621 ' ' THR . . . . . 0.632 ' HB ' ' HB2' ' A' 1641 ' ' HIS . 5.2 p -89.96 -11.82 40.55 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 121.807 0.813 . . . . 0.96999999999999997 109.785 177.739 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 48.5 t30 -92.66 55.34 2.43 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 122.679 1.228 . . . . 0.71999999999999997 109.599 -178.062 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -156.59 139.19 10.55 Favored Pre-proline 0 C--N 1.3 -1.55 0 N-CA-C 106.514 -1.661 . . . . 3.2599999999999998 106.514 178.534 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -61.72 113.9 2.03 Favored 'Trans proline' 0 C--O 1.245 0.863 0 C-N-CA 122.881 2.387 . . . . 0.58999999999999997 112.123 -176.402 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 75.3 mtm -117.17 140.13 49.91 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 116.508 -0.314 . . . . 1.3700000000000001 110.603 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1626 ' ' LEU . . . . . 0.623 ' HG ' ' CE2' ' A' 1542 ' ' TYR . 0.3 OUTLIER -87.99 115.18 25.28 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 107.681 -1.229 . . . . 0.89000000000000001 107.681 -175.463 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 48.8 mm -80.12 -49.46 18.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 CA-C-N 116.249 -0.432 . . . . 0.57999999999999996 109.839 -178.471 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 33.1 t -167.78 149.53 5.51 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.545 -0.752 . . . . 1.3899999999999999 110.134 -175.256 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1629 ' ' LEU . . . . . 0.612 HD13 ' HG ' ' A' 1636 ' ' LEU . 48.0 tp -112.63 105.59 13.8 Favored 'General case' 0 N--CA 1.418 -2.053 0 N-CA-C 107.116 -1.439 . . . . 1.25 107.116 173.217 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 30.4 t70 -76.92 114.38 15.63 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.462 -0.895 . . . . 1.0900000000000001 108.994 178.312 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1631 ' ' LYS . . . . . 0.411 ' HB3' HD11 ' B' ' 53' ' ' LEU . 98.7 mttt -66.91 -21.1 66.0 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 113.445 0.905 . . . . 3.6000000000000001 113.445 -174.478 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -86.32 -35.26 19.98 Favored 'General case' 0 CA--C 1.497 -1.071 0 CA-C-O 121.343 0.592 . . . . 2.6000000000000001 111.348 -177.152 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 53.5 p -104.9 -7.03 19.62 Favored 'General case' 0 C--N 1.285 -2.198 0 CA-C-N 115.741 -0.663 . . . . 0.75 112.391 -175.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1634 ' ' CYS . . . . . 0.605 ' SG ' HD23 ' A' 1604 ' ' LEU . 75.0 m 56.38 34.61 24.48 Favored 'General case' 0 C--N 1.363 1.156 0 C-N-CA 124.284 1.033 . . . . 0.53000000000000003 110.934 -177.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1635 ' ' THR . . . . . . . . . . . . . 88.2 m -99.03 129.26 45.3 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-N 114.193 -1.367 . . . . 0.46000000000000002 109.979 -177.235 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1636 ' ' LEU . . . . . 0.612 ' HG ' HD13 ' A' 1629 ' ' LEU . 1.5 mp -108.02 121.33 44.58 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 107.542 -1.281 . . . . 0.85999999999999999 107.542 -179.613 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -95.02 131.22 41.22 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 120.685 0.279 . . . . 0.45000000000000001 110.542 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -126.26 119.34 27.17 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.716 -0.675 . . . . 0.5 109.343 -176.599 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1639 ' ' SER . . . . . . . . . . . . . 59.7 m -103.15 138.15 40.36 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 115.781 -0.645 . . . . 1.04 109.567 175.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 2.8 t90 -141.85 113.19 7.61 Favored 'General case' 0 N--CA 1.422 -1.84 0 N-CA-C 103.95 -2.611 . . . . 0.68000000000000005 103.95 178.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1641 ' ' HIS . . . . . 0.817 ' HB3' ' HB2' ' A' 1615 ' ' ARG . 18.1 m-70 -107.08 111.04 23.31 Favored 'General case' 0 C--N 1.286 -2.182 0 C-N-CA 120.067 -0.653 . . . . 0.90000000000000002 110.402 -174.517 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1642 ' ' THR . . . . . . . . . . . . . 4.9 t -142.75 150.07 52.36 Favored Pre-proline 0 C--N 1.306 -1.29 0 CA-C-N 115.479 -0.782 . . . . 0.47999999999999998 109.683 -174.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1643 ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -76.64 -6.39 16.9 Favored 'Trans proline' 0 C--N 1.366 1.483 0 C-N-CA 122.281 1.987 . . . . 0.66000000000000003 112.316 175.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 8.6 tt -64.45 -30.27 71.31 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.435 0.636 . . . . 0.96999999999999997 109.445 177.49 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -94.51 8.03 43.58 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.051 -0.977 . . . . 0.83999999999999997 109.828 -177.134 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1646 ' ' CYS . . . . . 0.415 ' HB2' ' HA ' ' A' 1614 ' ' CYS . 33.7 t -122.09 158.54 29.03 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 115.532 -0.758 . . . . 1.1899999999999999 109.496 -173.759 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1647 ' ' GLU . . . . . 0.401 ' OE2' ' HB2' ' A' 1525 ' ' HIS . 8.6 tp10 . . . . . 0 N--CA 1.417 -2.094 0 N-CA-C 106.728 -1.582 . . . . 3.1400000000000001 106.728 171.333 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.421 -2.343 0 N-CA-C 110.576 -1.01 . . . . 2.0899999999999999 110.576 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.22 -62.67 4.48 Favored Glycine 0 N--CA 1.444 -0.806 0 O-C-N 123.98 0.459 . . . . 1.8400000000000001 112.972 -179.147 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 77.7 mt-10 -69.53 -27.06 64.84 Favored 'General case' 0 CA--C 1.496 -1.108 0 C-N-CA 120.186 -0.606 . . . . 2.5499999999999998 109.416 177.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 13' ' ' LEU . . . . . 0.505 ' O ' HD23 ' B' ' 17' ' ' LEU . 0.1 OUTLIER -57.32 -57.89 10.64 Favored 'General case' 0 C--O 1.212 -0.898 0 CA-C-N 115.651 -0.704 . . . . 2.3500000000000001 109.726 176.319 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 13.7 p -66.07 -34.09 67.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.981 -0.288 . . . . 2.1099999999999999 111.148 -178.191 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 15' ' ' ASP . . . . . 0.599 ' OD1' ' HB3' ' A' 1569 ' ' GLN . 29.3 t70 -71.22 -40.84 70.85 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 113.658 0.984 . . . . 2.04 113.658 -177.817 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 21.6 p -66.8 -40.92 88.28 Favored 'General case' 0 C--O 1.262 1.739 0 CA-C-O 121.644 0.735 . . . . 1.8400000000000001 109.917 176.192 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.505 HD23 ' O ' ' B' ' 13' ' ' LEU . 4.1 mm? -52.95 -50.12 64.69 Favored 'General case' 0 C--O 1.213 -0.824 0 CA-C-N 114.896 -1.047 . . . . 1.74 110.598 170.693 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -67.09 -25.68 66.34 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 123.841 0.857 . . . . 2.3900000000000001 111.777 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -58.59 -55.27 37.25 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 116.019 -0.537 . . . . 0.95999999999999996 110.982 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 14.7 p -99.08 -22.19 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.07 0 C-N-CA 118.105 -1.438 . . . . 1.3700000000000001 112.819 178.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 21' ' ' CYS . . . . . 0.503 ' HB2' ' HB3' ' B' ' 26' ' ' PHE . 57.9 m -103.36 24.89 10.29 Favored 'General case' 0 C--N 1.315 -0.914 0 O-C-N 121.555 -0.716 . . . . 1.6599999999999999 110.881 -178.666 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.69 -67.79 2.01 Favored Glycine 0 N--CA 1.461 0.345 0 C-N-CA 121.424 -0.417 . . . . 1.53 113.414 -177.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.82 ' HB3' ' HG3' ' A' 1544 ' ' LYS . 8.8 p-10 -76.88 -4.16 42.3 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 122.826 0.45 . . . . 2.7200000000000002 111.646 179.449 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 21.1 tpp180 -97.48 -42.71 7.58 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 116.02 -0.536 . . . . 4.3300000000000001 111.745 -175.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 112.73 121.76 3.9 Favored Glycine 0 N--CA 1.426 -2.028 0 N-CA-C 108.998 -1.641 . . . . 1.53 108.998 -174.738 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 26' ' ' PHE . . . . . 0.609 ' HA ' ' SG ' ' B' ' 60' ' ' CYS . 13.4 p90 -98.12 144.94 27.07 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 117.422 0.611 . . . . 1.6499999999999999 111.318 -179.208 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -125.64 105.05 8.72 Favored 'General case' 0 C--O 1.218 -0.581 0 N-CA-C 113.003 0.742 . . . . 3.4199999999999999 113.003 -175.236 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 28' ' ' PHE . . . . . 0.499 ' CD2' ' HG ' ' B' ' 17' ' ' LEU . 53.8 p90 . . . . . 0 C--N 1.311 -1.08 0 CA-C-O 121.471 0.653 . . . . 2.2599999999999998 109.84 162.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 41' ' ' GLY . . . . . 0.433 ' O ' ' HB2' ' B' ' 28' ' ' PHE . . . . . . . . 0 N--CA 1.413 -2.882 0 N-CA-C 109.685 -1.366 . . . . 2.3700000000000001 109.685 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . 0.262 23.0 pt 59.8 -27.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 C-N-CA 127.849 2.46 . . . . 2.0699999999999998 115.583 178.136 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.495 ' O ' ' HB2' ' B' ' 47' ' ' CYS . 2.5 p -53.98 -41.29 48.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 C-N-CA 124.566 1.146 . . . . 2.2400000000000002 112.738 177.138 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -95.47 -25.84 16.07 Favored 'General case' 0 N--CA 1.419 -1.997 0 N-CA-C 109.048 -0.723 . . . . 3.3599999999999999 109.048 -173.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 22.0 tp10 -61.11 -56.66 18.34 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 114.651 -1.159 . . . . 3.0800000000000001 108.441 176.59 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 46' ' ' CYS . . . . . . . . . . . . . 56.5 m -84.83 2.59 41.73 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.069 -0.514 . . . . 2.23 111.945 -177.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 47' ' ' CYS . . . . . 0.495 ' HB2' ' O ' ' B' ' 43' ' ' VAL . 49.7 t -78.89 -48.0 15.45 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 120.257 -0.577 . . . . 2.3700000000000001 109.537 176.365 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -101.66 -2.27 30.75 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.053 -0.521 . . . . 2.8199999999999998 111.81 -176.165 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 21.0 mmt180 -132.56 162.89 30.12 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.896 -1.15 . . . . 4.0899999999999999 107.896 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 1.9 p -102.4 127.66 49.33 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 108.371 -0.974 . . . . 2.6699999999999999 108.371 176.322 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 85.2 m -106.81 171.35 7.41 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.568 0.699 . . . . 2.1099999999999999 112.257 -172.393 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -126.35 158.33 36.15 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 105.839 -1.911 . . . . 2.6699999999999999 105.839 173.517 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 53' ' ' LEU . . . . . 0.836 ' HB3' ' HA ' ' A' 1600 ' ' SER . 2.6 pt? -60.71 -21.19 62.64 Favored 'General case' 0 CA--C 1.501 -0.936 0 N-CA-C 114.693 1.368 . . . . 1.8999999999999999 114.693 -167.785 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 54' ' ' ALA . . . . . 0.408 ' O ' HG22 ' B' ' 58' ' ' THR . . . -58.31 -29.46 65.91 Favored 'General case' 0 CA--C 1.514 -0.415 0 O-C-N 123.509 0.505 . . . . 1.52 111.282 -176.449 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 55' ' ' LEU . . . . . 0.401 ' O ' ' HB2' ' B' ' 59' ' ' TYR . 64.9 tp -65.06 -54.82 24.18 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 115.636 -0.711 . . . . 1.97 110.16 178.569 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 1.3 pp -76.04 -32.69 59.46 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 116.588 -0.278 . . . . 1.53 111.483 -175.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -55.51 -49.01 73.73 Favored 'General case' 0 C--N 1.318 -0.803 0 O-C-N 123.83 0.706 . . . . 2.27 110.553 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 58' ' ' THR . . . . . 0.408 HG22 ' O ' ' B' ' 54' ' ' ALA . 10.9 t -86.78 -17.41 33.58 Favored 'General case' 0 CA--C 1.567 1.607 0 N-CA-C 112.405 0.52 . . . . 2.3300000000000001 112.405 -177.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 59' ' ' TYR . . . . . 0.401 ' HB2' ' O ' ' B' ' 55' ' ' LEU . 10.8 t80 -86.67 -37.52 17.92 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.52 -0.737 . . . . 2.8599999999999999 109.961 -178.007 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 60' ' ' CYS . . . . . 0.609 ' SG ' ' HA ' ' B' ' 26' ' ' PHE . 6.6 t . . . . . 0 C--N 1.312 -1.057 0 CA-C-N 115.466 -0.788 . . . . 2.2999999999999998 111.461 -178.682 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 34.3 t70 . . . . . 0 C--O 1.218 -0.596 0 N-CA-C 108.893 -0.78 . . . . 2.8999999999999999 108.893 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 12.6 t -150.89 61.38 0.92 Allowed 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 106.431 -1.692 . . . . 1.1899999999999999 106.431 172.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 26.1 pt20 -165.13 162.92 20.43 Favored 'General case' 0 N--CA 1.419 -1.998 0 N-CA-C 106.485 -1.672 . . . . 1.52 106.485 -175.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1518 ' ' VAL . . . . . 0.668 HG21 ' HB2' ' A' 1583 ' ' TYR . 0.0 OUTLIER -154.59 146.05 13.61 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 O-C-N 123.896 0.747 . . . . 0.93999999999999995 110.449 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A 1519 ' ' THR . . . . . . . . . . . . . 49.9 m -98.09 137.69 36.51 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 115.965 -0.561 . . . . 0.89000000000000001 109.561 176.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1520 ' ' ASN . . . . . 0.498 ' ND2' ' OH ' ' A' 1583 ' ' TYR . 21.2 t-20 -79.31 117.27 66.09 Favored Pre-proline 0 N--CA 1.43 -1.46 0 N-CA-C 108.6 -0.889 . . . . 1.74 108.6 174.572 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -69.56 -10.79 29.62 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 122.687 2.258 . . . . 1.5800000000000001 113.586 -176.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 19.7 m -82.47 -44.22 16.27 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 120.77 0.319 . . . . 1.6499999999999999 111.809 -178.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1523 ' ' THR . . . . . . . . . . . . . 9.0 t -122.16 -3.23 9.03 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 119.459 -0.896 . . . . 1.6100000000000001 112.24 -177.299 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 80.46 16.34 76.15 Favored Glycine 0 C--O 1.238 0.344 0 C-N-CA 120.691 -0.766 . . . . 1.1299999999999999 112.708 175.417 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 53.9 t-80 -80.69 125.3 29.87 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 120.832 0.348 . . . . 1.26 110.546 -178.004 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 1.2 tm? -90.38 108.39 19.75 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 114.921 -1.036 . . . . 0.68000000000000005 108.981 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -87.9 111.32 21.31 Favored 'General case' 0 CA--C 1.499 -0.981 0 N-CA-C 107.981 -1.118 . . . . 0.65000000000000002 107.981 177.597 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -101.71 134.72 44.42 Favored 'General case' 0 N--CA 1.404 -2.737 0 N-CA-C 107.123 -1.436 . . . . 1.1699999999999999 107.123 174.093 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 3.4 mm? -100.94 5.15 43.12 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-O 122.017 0.913 . . . . 0.59999999999999998 108.687 177.34 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 4.0 m -64.82 -32.91 74.82 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.102 -1.408 . . . . 0.83999999999999997 109.75 178.132 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1531 ' ' SER . . . . . 0.611 ' HB2' HD11 ' A' 1644 ' ' LEU . 46.0 m -66.28 -25.74 67.01 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.952 -0.567 . . . . 1.5900000000000001 111.238 177.162 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 90.1 mt -97.11 -1.11 45.9 Favored 'General case' 0 C--O 1.215 -0.72 0 CA-C-O 121.194 0.521 . . . . 0.65000000000000002 110.463 176.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1533 ' ' SER . . . . . . . . . . . . . 46.8 t -85.25 175.03 9.18 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.329 0.585 . . . . 1.52 110.145 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . 170.33 169.15 33.12 Favored Glycine 0 C--N 1.299 -1.512 0 N-CA-C 109.019 -1.633 . . . . 1.1000000000000001 109.019 -179.318 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -92.5 -35.38 13.65 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 117.239 0.519 . . . . 4.6200000000000001 110.518 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1536 ' ' ALA . . . . . 0.626 ' HA ' ' HG2' ' A' 1557 ' ' GLU . . . -77.35 -35.43 54.65 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 121.376 0.608 . . . . 1.45 109.919 -179.018 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 91.59 -149.98 20.1 Favored Glycine 0 N--CA 1.42 -2.399 0 CA-C-N 115.274 -0.876 . . . . 0.84999999999999998 111.78 176.156 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -137.41 149.32 46.84 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.654 -0.869 . . . . 0.93000000000000005 108.654 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1539 ' ' THR . . . . . 0.456 ' HA ' ' O ' ' A' 1548 ' ' VAL . 4.0 m -125.08 122.11 36.26 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 109.326 -0.62 . . . . 1.03 109.326 -177.44 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1540 ' ' ALA . . . . . 0.521 ' HB3' ' CG1' ' A' 1548 ' ' VAL . . . -115.38 150.18 36.77 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 108.113 -1.069 . . . . 0.5 108.113 -178.428 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -93.35 138.78 31.36 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 121.108 0.48 . . . . 0.73999999999999999 111.179 -176.268 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1542 ' ' TYR . . . . . 0.828 ' HE1' ' HG ' ' A' 1626 ' ' LEU . 1.5 t80 -121.77 -101.33 0.41 Allowed 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 107.625 -1.25 . . . . 0.98999999999999999 107.625 -179.484 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1543 ' ' SER . . . . . 0.422 ' H ' ' HB3' ' A' 1542 ' ' TYR . 32.8 t -66.8 159.75 27.39 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 107.304 -1.369 . . . . 1.9099999999999999 107.304 172.365 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 62.7 mttp -59.38 -37.05 76.93 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-N 119.921 1.237 . . . . 3.5899999999999999 113.619 -175.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 14.7 t -100.83 15.19 29.25 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 110.104 -0.332 . . . . 2.46 110.104 178.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1546 ' ' GLY . . . . . 0.498 ' HA2' ' OE1' ' A' 1569 ' ' GLN . . . -130.42 147.95 18.44 Favored Glycine 0 CA--C 1.54 1.633 0 C-N-CA 120.03 -1.081 . . . . 1.26 114.092 -174.074 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 22.6 m -136.67 176.94 6.85 Favored 'Isoleucine or valine' 0 C--O 1.252 1.235 0 CA-C-N 117.488 0.644 . . . . 0.79000000000000004 110.573 -178.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1548 ' ' VAL . . . . . 0.84 ' HB ' ' CE1' ' A' 1567 ' ' PHE . 7.3 p -127.1 136.63 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 CA-C-N 115.034 -0.985 . . . . 0.57999999999999996 109.913 175.408 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1549 ' ' TYR . . . . . 0.599 ' HB2' ' HB3' ' A' 1566 ' ' CYS . 62.0 m-85 -101.63 116.04 31.87 Favored 'General case' 0 C--N 1.293 -1.854 0 C-N-CA 124.812 1.245 . . . . 1.0800000000000001 108.186 177.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 8.6 ptp -125.43 146.39 49.64 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 120.189 -0.604 . . . . 0.78000000000000003 110.455 175.219 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 8.2 p -129.46 119.79 24.36 Favored 'General case' 0 C--N 1.281 -2.398 0 CA-C-N 115.763 -0.653 . . . . 0.96999999999999997 109.579 174.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1552 ' ' ILE . . . . . . . . . . . . . 38.7 mm -81.5 116.97 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.668 0 C-N-CA 120.84 -0.344 . . . . 0.41999999999999998 110.238 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 64.3 m 69.84 26.94 4.66 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.108 0.963 . . . . 1.3999999999999999 111.649 175.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . -172.3 -167.67 32.67 Favored Glycine 0 CA--C 1.482 -2.004 0 C-N-CA 120.098 -1.048 . . . . 0.34999999999999998 111.233 -177.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -107.94 135.79 48.73 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-O 121.165 0.507 . . . . 1.6200000000000001 111.374 -178.048 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -78.93 129.2 34.24 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.632 -0.713 . . . . 0.87 109.37 -174.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1557 ' ' GLU . . . . . 0.626 ' HG2' ' HA ' ' A' 1536 ' ' ALA . 5.3 pt-20 -73.33 -12.73 60.93 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.633 0.975 . . . . 2.4900000000000002 113.633 -174.522 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 9.7 m120 -89.19 -2.74 58.63 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 120.48 -0.488 . . . . 1.3799999999999999 110.373 -173.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1559 ' ' CYS . . . . . 0.59 ' SG ' ' HD2' ' A' 1560 ' ' PRO . 34.2 t -135.81 155.82 77.73 Favored Pre-proline 0 C--N 1.308 -1.196 0 N-CA-C 108.255 -1.017 . . . . 1.21 108.255 -175.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1560 ' ' PRO . . . . . 0.59 ' HD2' ' SG ' ' A' 1559 ' ' CYS . 69.1 Cg_exo -29.06 132.83 0.04 OUTLIER 'Trans proline' 0 C--N 1.379 2.134 1 C-N-CA 125.7 4.267 . . . . 0.70999999999999996 114.73 176.175 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A 1561 ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' 1560 ' ' PRO . 9.6 Cg_endo -48.77 127.62 17.0 Favored 'Trans proline' 0 CA--C 1.547 1.147 0 C-N-CA 124.443 3.428 . . . . 0.80000000000000004 114.306 -178.121 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 101.05 1.05 54.79 Favored Glycine 0 CA--C 1.525 0.672 0 CA-C-N 115.589 -0.732 . . . . 0.46000000000000002 114.78 176.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1563 ' ' VAL . . . . . 0.475 HG11 ' SG ' ' A' 1559 ' ' CYS . 7.7 p -102.26 137.73 29.13 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 C-N-CA 119.626 -0.83 . . . . 0.97999999999999998 111.18 -175.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -100.05 -31.86 5.79 Favored Glycine 0 CA--C 1.521 0.417 0 CA-C-N 115.526 -0.761 . . . . 0.28000000000000003 112.681 -178.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -127.53 128.61 45.93 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 108.473 -0.936 . . . . 0.28000000000000003 108.473 178.357 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1566 ' ' CYS . . . . . 0.599 ' HB3' ' HB2' ' A' 1549 ' ' TYR . 45.2 t -145.76 124.88 12.86 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 110.376 -0.231 . . . . 0.42999999999999999 110.376 -176.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1567 ' ' PHE . . . . . 0.84 ' CE1' ' HB ' ' A' 1548 ' ' VAL . 9.7 m-85 -110.51 160.36 16.69 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 122.597 0.359 . . . . 1.03 110.296 175.343 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . 100.19 156.01 27.92 Favored Glycine 1 N--CA 1.394 -4.159 0 C-N-CA 119.353 -1.403 . . . . 1.1299999999999999 112.026 171.227 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1569 ' ' GLN . . . . . 0.498 ' OE1' ' HA2' ' A' 1546 ' ' GLY . 2.3 mp0 -84.92 -23.5 28.83 Favored 'General case' 0 C--N 1.284 -2.272 0 N-CA-C 107.571 -1.27 . . . . 2.5800000000000001 107.571 179.48 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 24.3 p -82.65 -11.7 58.18 Favored 'General case' 0 N--CA 1.423 -1.781 0 CA-C-N 115.353 -0.839 . . . . 2.1699999999999999 111.68 176.2 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1571 ' ' ARG . . . . . 0.452 ' HG3' ' CE2' ' A' 1549 ' ' TYR . 4.8 mpt_? 73.76 75.21 0.13 Allowed 'General case' 0 CA--C 1.506 -0.726 0 C-N-CA 124.311 1.044 . . . . 2.6200000000000001 111.251 178.238 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 61.5 mt -98.46 121.65 49.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 CA-C-N 114.074 -1.421 . . . . 0.92000000000000004 109.505 -177.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1573 ' ' SER . . . . . 0.452 ' HB3' ' HB3' ' A' 1596 ' ' SER . 17.7 t -65.55 124.79 23.27 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.532 -0.758 . . . . 0.80000000000000004 110.866 -178.468 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1574 ' ' VAL . . . . . 0.59 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 32.8 m -126.48 20.21 3.51 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-O 121.866 0.841 . . . . 0.97999999999999998 110.746 178.272 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 164.23 113.54 0.29 Allowed Glycine 0 N--CA 1.425 -2.034 0 CA-C-N 114.607 -1.179 . . . . 0.28999999999999998 111.779 177.397 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 56.7 tttp -72.27 136.12 46.21 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 107.721 -1.214 . . . . 2.1899999999999999 107.721 178.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -69.04 141.42 54.83 Favored 'General case' 0 C--N 1.314 -0.975 0 O-C-N 123.486 0.491 . . . . 0.60999999999999999 111.59 -175.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 9.4 p30 -161.32 175.74 11.93 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 105.138 -2.171 . . . . 1.95 105.138 176.538 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 7.2 ptpp? -132.54 42.88 3.05 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 119.001 0.818 . . . . 2.6800000000000002 110.951 -173.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 47.2 ttt180 -85.34 76.77 10.08 Favored 'General case' 0 N--CA 1.427 -1.6 0 N-CA-C 108.495 -0.928 . . . . 3.4700000000000002 108.495 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1581 ' ' LEU . . . . . 0.493 HD12 ' CG2' ' A' 1518 ' ' VAL . 0.4 OUTLIER -70.15 121.36 17.38 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 114.846 -1.07 . . . . 0.64000000000000001 108.541 179.446 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 58.2 mtp180 -116.03 120.68 39.89 Favored 'General case' 0 C--N 1.287 -2.13 0 C-N-CA 120.611 -0.436 . . . . 2.8500000000000001 111.31 177.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1583 ' ' TYR . . . . . 0.668 ' HB2' HG21 ' A' 1518 ' ' VAL . 62.1 t80 -94.0 109.43 21.17 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 109.412 -0.588 . . . . 0.85999999999999999 109.412 175.73 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1584 ' ' VAL . . . . . 0.535 ' O ' ' HB ' ' A' 1587 ' ' VAL . 11.9 m -128.22 89.57 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-O 121.518 0.675 . . . . 1.05 111.968 -179.581 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 34.6 t70 53.1 71.54 0.48 Allowed 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 124.359 1.063 . . . . 1.1699999999999999 112.942 174.411 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 9.2 pt20 67.74 12.81 9.02 Favored 'General case' 0 N--CA 1.508 2.465 0 C-N-CA 127.46 2.304 . . . . 1.8600000000000001 111.319 178.157 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1587 ' ' VAL . . . . . 0.535 ' HB ' ' O ' ' A' 1584 ' ' VAL . 39.5 t -116.86 120.66 65.71 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.152 0 CA-C-N 114.55 -1.204 . . . . 0.48999999999999999 109.51 177.695 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1588 ' ' LEU . . . . . 0.886 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 1.8 mm? -100.46 107.81 19.63 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 105.122 -2.177 . . . . 0.35999999999999999 105.122 176.238 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -112.89 134.74 54.27 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 112.875 0.694 . . . . 1.74 112.875 -172.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 18.6 mt -124.75 112.49 16.79 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 114.103 -1.408 . . . . 0.71999999999999997 108.193 175.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 7.0 p -101.58 127.39 54.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-O 121.268 0.556 . . . . 1.01 109.61 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1592 ' ' TYR . . . . . . . . . . . . . 13.4 m-30 -114.46 101.37 9.08 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 109.467 -0.568 . . . . 0.5 109.467 -177.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 15.4 pttp -109.29 -178.16 3.49 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 114.661 -1.154 . . . . 1.5900000000000001 108.138 -175.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 8.2 m-20 63.82 44.78 4.72 Favored 'General case' 0 C--N 1.319 -0.752 0 O-C-N 124.128 0.892 . . . . 1.1100000000000001 110.765 179.161 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -79.44 -166.34 32.05 Favored Glycine 0 N--CA 1.437 -1.236 0 CA-C-N 115.0 -1.0 . . . . 0.78000000000000003 110.917 176.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1596 ' ' SER . . . . . 0.656 ' HB2' ' HD2' ' A' 1597 ' ' PRO . 79.1 p -86.68 167.53 22.15 Favored Pre-proline 0 C--N 1.297 -1.679 0 C-N-CA 120.209 -0.596 . . . . 1.0700000000000001 109.842 -177.579 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1597 ' ' PRO . . . . . 0.656 ' HD2' ' HB2' ' A' 1596 ' ' SER . 12.2 Cg_endo -56.05 120.4 8.21 Favored 'Trans proline' 0 C--N 1.364 1.349 0 C-N-CA 122.592 2.195 . . . . 1.01 111.048 178.509 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1598 ' ' CYS . . . . . 0.478 ' HA ' ' HD3' ' A' 1599 ' ' PRO . 44.1 t -83.98 123.97 75.09 Favored Pre-proline 0 C--N 1.286 -2.195 0 CA-C-N 114.369 -1.287 . . . . 0.75 110.12 -177.451 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1599 ' ' PRO . . . . . 0.519 ' HD2' ' OH ' ' A' 1606 ' ' TYR . 3.1 Cg_exo -80.01 2.7 8.22 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 123.551 2.834 . . . . 1.7 112.679 178.352 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1600 ' ' SER . . . . . 0.436 ' HA ' ' HB3' ' B' ' 53' ' ' LEU . 14.8 m -77.54 -55.98 4.91 Favored 'General case' 0 N--CA 1.42 -1.971 0 N-CA-C 108.465 -0.939 . . . . 2.2599999999999998 108.465 173.155 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1601 ' ' LYS . . . . . 0.567 ' HE3' HD13 ' A' 1604 ' ' LEU . 16.9 ttpp -119.58 117.18 27.67 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 105.836 -1.913 . . . . 3.0099999999999998 105.836 173.759 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 12.9 p -63.14 116.35 5.32 Favored 'General case' 0 N--CA 1.422 -1.868 0 N-CA-C 113.189 0.811 . . . . 2.0699999999999998 113.189 -170.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 105.47 -6.24 41.73 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 121.313 -0.47 . . . . 1.0800000000000001 112.229 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1604 ' ' LEU . . . . . 0.595 HD23 ' SG ' ' A' 1634 ' ' CYS . 10.9 tp -91.52 170.45 9.93 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.399 -0.963 . . . . 1.8400000000000001 108.399 -178.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 15.1 m -126.45 149.75 49.1 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 108.446 -0.946 . . . . 1.4099999999999999 108.446 -179.095 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1606 ' ' TYR . . . . . 0.59 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 63.8 m-85 -71.0 158.1 37.09 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 122.679 0.391 . . . . 0.59999999999999998 111.682 177.718 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -156.49 125.45 5.98 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 109.346 -0.613 . . . . 1.45 109.346 178.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1608 ' ' SER . . . . . . . . . . . . . 30.4 m -107.93 132.68 53.22 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-N 115.995 -0.548 . . . . 1.1499999999999999 109.808 -178.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 31.6 t -111.6 108.17 24.8 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 109.261 -0.644 . . . . 0.25 109.261 178.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 75.6 mt -96.31 113.86 31.72 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 N-CA-C 108.917 -0.771 . . . . 0.45000000000000001 108.917 -178.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 48.9 m -116.02 119.88 37.3 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 115.942 -0.572 . . . . 1.26 111.749 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1612 ' ' PHE . . . . . 0.886 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 74.6 m-85 -98.26 122.16 41.08 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.961 -1.126 . . . . 0.26000000000000001 107.961 175.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 45.5 t -117.95 137.42 51.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 109.588 -0.523 . . . . 0.5 109.588 -176.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 3.5 t -52.99 112.4 0.85 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.131 0.894 . . . . 0.77000000000000002 112.275 176.365 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1615 ' ' ARG . . . . . 0.712 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 27.9 tpt180 -133.13 93.4 22.74 Favored Pre-proline 0 C--N 1.325 -0.468 0 N-CA-C 110.224 -0.287 . . . . 2.5299999999999998 110.224 174.619 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1616 ' ' PRO . . . . . 0.592 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 13.1 Cg_exo -70.53 -24.16 26.47 Favored 'Trans proline' 0 CA--C 1.545 1.052 0 C-N-CA 122.063 1.842 . . . . 1.1000000000000001 112.428 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -85.25 43.49 1.02 Allowed 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 125.151 1.38 . . . . 3.0499999999999998 110.954 179.062 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -33.34 117.48 0.29 Allowed 'General case' 0 C--O 1.241 0.638 0 C-N-CA 126.293 1.837 . . . . 1.55 113.2 178.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . -155.79 -135.21 1.96 Allowed Glycine 0 N--CA 1.433 -1.558 0 N-CA-C 109.078 -1.609 . . . . 0.93000000000000005 109.078 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -81.86 21.09 0.98 Allowed 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.285 1.99 . . . . 0.88 112.523 -179.032 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1621 ' ' THR . . . . . 0.738 ' HB ' ' HB2' ' A' 1641 ' ' HIS . 46.7 p -99.17 -15.99 18.74 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 114.917 -1.038 . . . . 0.96999999999999997 109.528 178.823 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 52.1 t30 -89.89 56.34 3.45 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 122.389 1.09 . . . . 0.71999999999999997 109.369 -173.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 18.6 ptp180 -157.25 139.54 10.4 Favored Pre-proline 0 N--CA 1.427 -1.595 0 CA-C-N 114.665 -1.152 . . . . 3.2599999999999998 108.248 -177.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.71 97.16 0.26 Allowed 'Trans proline' 0 C--O 1.238 0.506 0 C-N-CA 122.873 2.382 . . . . 0.58999999999999997 111.687 -178.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 76.8 mtm -97.44 136.88 37.25 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 116.105 -0.498 . . . . 1.3700000000000001 110.274 -178.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1626 ' ' LEU . . . . . 0.828 ' HG ' ' HE1' ' A' 1542 ' ' TYR . 0.4 OUTLIER -88.16 112.63 22.94 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 107.397 -1.335 . . . . 0.89000000000000001 107.397 -179.44 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A 1627 ' ' ILE . . . . . 0.839 HD11 ' HB2' ' A' 1639 ' ' SER . 3.3 mm -72.82 -57.45 7.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 C-N-CA 123.651 0.78 . . . . 0.57999999999999996 109.908 -177.366 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 30.6 t -163.42 151.38 13.3 Favored 'General case' 0 N--CA 1.415 -2.18 0 CA-C-N 114.657 -1.156 . . . . 1.3899999999999999 107.936 -172.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1629 ' ' LEU . . . . . 0.881 HD13 ' HG ' ' A' 1636 ' ' LEU . 35.2 tp -122.44 95.62 4.71 Favored 'General case' 0 N--CA 1.419 -2.022 0 N-CA-C 107.225 -1.398 . . . . 1.25 107.225 178.017 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 15.8 t70 -75.54 97.44 3.73 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.461 -1.311 . . . . 1.0900000000000001 107.461 177.46 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 62.0 mttp -66.83 -22.09 66.01 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 112.857 0.688 . . . . 3.6000000000000001 112.857 -176.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -72.61 -36.11 68.0 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.556 0.694 . . . . 2.6000000000000001 109.699 -178.092 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 69.6 p -102.72 -4.77 24.55 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.682 -0.69 . . . . 0.75 110.821 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1634 ' ' CYS . . . . . 0.595 ' SG ' HD23 ' A' 1604 ' ' LEU . 74.9 m 55.34 37.16 28.49 Favored 'General case' 0 C--N 1.356 0.853 0 C-N-CA 125.231 1.413 . . . . 0.53000000000000003 111.811 -178.45 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1635 ' ' THR . . . . . . . . . . . . . 40.0 m -106.43 129.28 54.44 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 115.151 -0.931 . . . . 0.46000000000000002 109.555 -178.371 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1636 ' ' LEU . . . . . 0.881 ' HG ' HD13 ' A' 1629 ' ' LEU . 0.3 OUTLIER -111.39 135.88 51.32 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 107.287 -1.375 . . . . 0.85999999999999999 107.287 -177.663 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -112.19 131.31 55.55 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 120.798 -0.361 . . . . 0.45000000000000001 111.2 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1638 ' ' PHE . . . . . 0.442 ' CE1' HD23 ' A' 1626 ' ' LEU . 98.4 m-85 -123.23 130.89 53.36 Favored 'General case' 0 C--O 1.243 0.726 0 N-CA-C 108.241 -1.022 . . . . 0.5 108.241 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1639 ' ' SER . . . . . 0.839 ' HB2' HD11 ' A' 1627 ' ' ILE . 11.7 t -115.9 148.47 39.97 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 107.645 -1.243 . . . . 1.04 107.645 178.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 3.2 t90 -152.36 107.82 3.3 Favored 'General case' 0 N--CA 1.414 -2.251 0 N-CA-C 104.984 -2.228 . . . . 0.68000000000000005 104.984 -179.022 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1641 ' ' HIS . . . . . 0.738 ' HB2' ' HB ' ' A' 1621 ' ' THR . 23.2 m80 -102.87 107.93 18.95 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 109.358 -0.608 . . . . 0.90000000000000002 109.358 -177.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1642 ' ' THR . . . . . . . . . . . . . 7.9 t -140.74 148.06 51.24 Favored Pre-proline 0 C--N 1.301 -1.521 0 CA-C-N 115.049 -0.978 . . . . 0.47999999999999998 109.731 -171.543 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1643 ' ' PRO . . . . . 0.592 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 56.9 Cg_endo -80.4 -11.17 13.23 Favored 'Trans proline' 0 C--N 1.365 1.423 0 C-N-CA 122.314 2.009 . . . . 0.66000000000000003 112.365 178.543 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1644 ' ' LEU . . . . . 0.611 HD11 ' HB2' ' A' 1531 ' ' SER . 7.4 tt -67.08 -25.82 66.42 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 108.407 -0.96 . . . . 0.96999999999999997 108.407 176.594 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -103.09 23.36 12.46 Favored 'General case' 0 N--CA 1.424 -1.746 0 CA-C-N 114.833 -1.076 . . . . 0.83999999999999997 109.735 -175.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 37.9 t -122.08 146.8 46.85 Favored 'General case' 0 N--CA 1.423 -1.797 0 CA-C-N 115.203 -0.908 . . . . 1.1899999999999999 109.588 -179.066 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1647 ' ' GLU . . . . . 0.433 ' OE2' ' OH ' ' A' 1583 ' ' TYR . 0.1 OUTLIER . . . . . 0 C--N 1.295 -1.8 0 N-CA-C 108.25 -1.019 . . . . 3.1400000000000001 108.25 176.198 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.424 -2.154 0 N-CA-C 110.023 -1.231 . . . . 2.0899999999999999 110.023 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 11' ' ' GLY . . . . . 0.446 ' HA2' HG12 ' B' ' 14' ' ' VAL . . . -60.32 -45.17 96.64 Favored Glycine 0 C--O 1.201 -1.934 0 O-C-N 124.06 0.506 . . . . 1.8400000000000001 113.01 -177.703 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 44.4 mp0 -61.38 -39.17 89.67 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.781 0.8 . . . . 2.5499999999999998 111.154 -179.213 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 13' ' ' LEU . . . . . 0.417 HD21 ' HB3' ' B' ' 46' ' ' CYS . 0.1 OUTLIER -71.26 -40.9 70.7 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.03 -0.986 . . . . 2.3500000000000001 110.141 -178.818 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 14' ' ' VAL . . . . . 0.446 HG12 ' HA2' ' B' ' 11' ' ' GLY . 5.1 p -76.83 -32.05 19.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 C-N-CA 120.019 -0.672 . . . . 2.1099999999999999 110.485 -178.326 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -68.6 -36.08 78.2 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 116.175 -0.466 . . . . 2.04 111.832 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 11.7 p -69.99 -40.29 75.42 Favored 'General case' 0 C--O 1.262 1.75 0 O-C-N 121.899 -0.501 . . . . 1.8400000000000001 110.149 177.292 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.473 ' HB3' ' HB3' ' B' ' 26' ' ' PHE . 3.7 mm? -54.66 -49.88 69.55 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 115.546 -0.752 . . . . 1.74 111.052 172.271 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -65.97 -33.35 75.63 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.828 -0.624 . . . . 2.3900000000000001 111.265 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 19' ' ' PHE . . . . . 0.467 ' HE1' ' CD1' ' A' 1567 ' ' PHE . 74.1 t80 -50.63 -57.47 8.16 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 123.038 0.535 . . . . 0.95999999999999996 111.751 178.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 15.0 p -99.54 -22.4 4.78 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.984 0 C-N-CA 118.389 -1.324 . . . . 1.3700000000000001 113.298 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 21' ' ' CYS . . . . . 0.441 ' HB2' ' O ' ' B' ' 17' ' ' LEU . 86.2 m -104.85 27.26 8.25 Favored 'General case' 0 C--N 1.316 -0.886 0 O-C-N 121.518 -0.739 . . . . 1.6599999999999999 112.665 -178.415 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -53.17 -52.43 40.31 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 121.509 -0.377 . . . . 1.53 114.037 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -74.7 -23.59 58.63 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 113.614 0.968 . . . . 2.7200000000000002 113.614 -179.051 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 24' ' ' ARG . . . . . 0.551 ' HD2' ' SG ' ' B' ' 60' ' ' CYS . 41.5 ttm180 -87.87 -35.45 17.74 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.68 -0.808 . . . . 4.3300000000000001 110.507 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.83 168.46 23.38 Favored Glycine 0 N--CA 1.423 -2.214 0 N-CA-C 110.279 -1.128 . . . . 1.53 110.279 -178.453 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 26' ' ' PHE . . . . . 0.473 ' HB3' ' HB3' ' B' ' 17' ' ' LEU . 3.2 p90 -122.22 138.94 54.31 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 116.954 0.377 . . . . 1.6499999999999999 110.197 175.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -122.0 -91.15 0.56 Allowed 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 118.876 -0.583 . . . . 3.4199999999999999 110.133 -177.339 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 28' ' ' PHE . . . . . . . . . . . . . 51.7 p90 . . . . . 0 N--CA 1.507 2.397 0 N-CA-C 115.752 1.76 . . . . 2.2599999999999998 115.752 179.592 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 41' ' ' GLY . . . . . 0.409 ' O ' HG12 ' B' ' 42' ' ' ILE . . . . . . . . 0 CA--C 1.489 -1.594 0 N-CA-C 109.384 -1.486 . . . . 2.3700000000000001 109.384 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 42' ' ' ILE . . . . . 0.417 HG22 ' HB3' ' B' ' 55' ' ' LEU . 22.5 pt 62.01 -37.62 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 C-N-CA 127.48 2.312 . . . . 2.0699999999999998 116.182 175.59 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.428 ' O ' ' HB2' ' B' ' 47' ' ' CYS . 2.5 p -50.03 -50.31 19.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 114.751 1.389 . . . . 2.2400000000000002 114.751 -176.043 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -93.74 -27.66 16.37 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.98 -0.748 . . . . 3.3599999999999999 108.98 -174.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 45' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' B' ' 49' ' ' ARG . 41.7 mt-10 -61.2 -56.62 18.62 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.863 -1.062 . . . . 3.0800000000000001 110.127 178.249 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 46' ' ' CYS . . . . . 0.438 ' HB2' ' HB3' ' B' ' 51' ' ' CYS . 48.3 t -83.67 -3.91 58.15 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 116.117 -0.492 . . . . 2.23 111.276 -176.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 47' ' ' CYS . . . . . 0.428 ' HB2' ' O ' ' B' ' 43' ' ' VAL . 34.3 t -80.42 -38.87 29.36 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 118.905 -1.118 . . . . 2.3700000000000001 110.29 176.249 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -111.55 9.29 21.19 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 112.609 0.596 . . . . 2.8199999999999998 112.609 -175.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 49' ' ' ARG . . . . . 0.466 ' HB2' ' O ' ' B' ' 45' ' ' GLU . 63.1 mtp180 -146.88 -177.89 5.9 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 105.874 -1.899 . . . . 4.0899999999999999 105.874 177.692 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 11.2 t -106.05 145.32 31.55 Favored 'General case' 0 C--N 1.278 -2.524 0 N-CA-C 106.157 -1.794 . . . . 2.6699999999999999 106.157 177.538 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 51' ' ' CYS . . . . . 0.438 ' HB3' ' HB2' ' B' ' 46' ' ' CYS . 23.4 p -118.17 143.11 46.77 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 110.45 -0.204 . . . . 2.1099999999999999 110.45 -175.16 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -94.59 163.15 13.5 Favored 'General case' 0 C--O 1.253 1.248 0 N-CA-C 107.414 -1.328 . . . . 2.6699999999999999 107.414 173.017 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 53' ' ' LEU . . . . . 0.436 ' HB3' ' HA ' ' A' 1600 ' ' SER . 2.6 pt? -66.75 -9.26 34.85 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 120.756 0.313 . . . . 1.8999999999999999 110.938 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.63 -15.96 44.2 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.167 0.987 . . . . 1.52 110.541 176.214 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 55' ' ' LEU . . . . . 0.655 ' O ' ' HB2' ' B' ' 59' ' ' TYR . 49.1 mt -98.56 -55.78 2.64 Favored 'General case' 0 C--O 1.2 -1.545 0 CA-C-O 120.971 0.415 . . . . 1.97 111.404 174.046 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 56' ' ' LEU . . . . . 0.413 ' HG ' ' HA ' ' B' ' 53' ' ' LEU . 1.7 pp -74.73 -33.28 62.34 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 114.537 1.31 . . . . 1.53 114.537 -170.705 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -76.85 -32.5 57.57 Favored 'General case' 0 CA--C 1.559 1.293 0 C-N-CA 120.31 -0.556 . . . . 2.27 110.768 178.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 73.9 p -75.37 -50.99 14.22 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 120.844 0.354 . . . . 2.3300000000000001 111.165 177.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 59' ' ' TYR . . . . . 0.655 ' HB2' ' O ' ' B' ' 55' ' ' LEU . 0.3 OUTLIER -65.17 -64.67 0.81 Allowed 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 108.76 -0.83 . . . . 2.8599999999999999 108.76 -178.725 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 60' ' ' CYS . . . . . 0.551 ' SG ' ' HD2' ' B' ' 24' ' ' ARG . 43.6 t . . . . . 0 N--CA 1.482 1.174 0 C-N-CA 125.32 1.448 . . . . 2.2999999999999998 113.441 176.059 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 50.3 m-20 . . . . . 0 C--O 1.237 0.4 0 N-CA-C 111.799 0.296 . . . . 2.8999999999999999 111.799 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A 1516 ' ' CYS . . . . . 0.523 ' HA ' ' HB2' ' A' 1581 ' ' LEU . 95.6 m 52.53 50.49 18.11 Favored 'General case' 0 CA--C 1.497 -1.083 0 CA-C-O 121.717 0.77 . . . . 1.1899999999999999 112.029 -178.141 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1517 ' ' GLN . . . . . 0.414 ' HA ' ' O ' ' A' 1527 ' ' PHE . 13.1 pt20 -150.91 130.35 12.93 Favored 'General case' 0 N--CA 1.407 -2.591 0 CA-C-N 115.049 -0.978 . . . . 1.52 109.76 -176.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1518 ' ' VAL . . . . . 0.517 HG21 ' HB2' ' A' 1583 ' ' TYR . 3.0 m -137.54 142.32 37.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-N 115.274 -0.876 . . . . 0.93999999999999995 110.18 -178.011 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1519 ' ' THR . . . . . . . . . . . . . 44.3 m -107.17 141.97 37.61 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 116.312 -0.404 . . . . 0.89000000000000001 111.511 -178.047 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1520 ' ' ASN . . . . . 0.512 ' OD1' HG22 ' A' 1523 ' ' THR . 6.4 t-20 -89.52 120.78 69.61 Favored Pre-proline 0 N--CA 1.441 -0.915 0 N-CA-C 108.58 -0.896 . . . . 1.74 108.58 173.179 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -62.66 -27.69 76.23 Favored 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 123.22 2.614 . . . . 1.5800000000000001 113.927 -176.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 15.0 m -68.14 -47.66 67.49 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 112.939 0.718 . . . . 1.6499999999999999 112.939 -175.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1523 ' ' THR . . . . . 0.512 HG22 ' OD1' ' A' 1520 ' ' ASN . 11.8 t -118.8 2.64 11.63 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 119.785 -0.766 . . . . 1.6100000000000001 111.833 -173.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 63.42 34.0 88.77 Favored Glycine 0 CA--C 1.504 -0.632 0 CA-C-N 115.749 -0.66 . . . . 1.1299999999999999 112.007 178.609 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1525 ' ' HIS . . . . . 0.466 ' HB2' HG23 ' A' 1523 ' ' THR . 32.7 t-80 -94.22 127.27 39.96 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 120.095 -0.642 . . . . 1.26 109.46 -177.453 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 3.1 tm? -90.88 117.37 29.44 Favored 'General case' 0 C--N 1.289 -2.065 0 CA-C-N 115.019 -0.991 . . . . 0.68000000000000005 108.956 -177.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1527 ' ' PHE . . . . . 0.414 ' O ' ' HA ' ' A' 1517 ' ' GLN . 39.0 m-85 -95.51 126.07 40.55 Favored 'General case' 0 N--CA 1.432 -1.33 0 C-N-CA 119.749 -0.78 . . . . 0.65000000000000002 110.577 173.204 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 10.5 t70 -115.92 126.98 54.61 Favored 'General case' 0 C--N 1.309 -1.16 0 O-C-N 123.738 0.649 . . . . 1.1699999999999999 109.727 175.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1529 ' ' LEU . . . . . 0.551 ' HG ' HD21 ' A' 1581 ' ' LEU . 3.4 mm? -106.9 2.35 25.27 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 120.982 0.42 . . . . 0.59999999999999998 111.149 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 3.8 m -71.78 -14.28 61.94 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.145 0.497 . . . . 0.83999999999999997 111.796 -176.313 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 6.1 p -70.0 -31.62 69.38 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.634 0.73 . . . . 1.5900000000000001 110.831 179.081 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 77.5 mt -84.97 7.06 22.53 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.025 -0.989 . . . . 0.65000000000000002 110.713 -179.182 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1533 ' ' SER . . . . . 0.443 ' HA ' ' HB ' ' A' 1552 ' ' ILE . 19.7 t -74.97 172.47 12.24 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.683 0.754 . . . . 1.52 111.118 -179.423 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -176.94 141.24 5.31 Favored Glycine 0 N--CA 1.422 -2.24 0 N-CA-C 108.141 -1.984 . . . . 1.1000000000000001 108.141 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 11.5 tpp180 -92.2 -31.66 15.37 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 120.954 0.407 . . . . 4.6200000000000001 111.454 -176.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -80.61 -37.36 31.27 Favored 'General case' 0 CA--C 1.502 -0.904 0 N-CA-C 108.164 -1.051 . . . . 1.45 108.164 177.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1537 ' ' GLY . . . . . 0.424 ' HA3' ' ND2' ' A' 1556 ' ' ASN . . . 110.04 -177.37 19.73 Favored Glycine 0 N--CA 1.406 -3.304 0 CA-C-N 114.792 -1.094 . . . . 0.84999999999999998 111.938 174.627 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -121.68 142.56 50.03 Favored 'General case' 0 C--N 1.277 -2.571 0 N-CA-C 106.954 -1.499 . . . . 0.93000000000000005 106.954 178.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 3.3 p -105.33 129.78 53.59 Favored 'General case' 0 C--N 1.292 -1.903 0 O-C-N 123.652 0.595 . . . . 1.03 110.764 179.129 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1540 ' ' ALA . . . . . 0.466 ' HB3' ' CG1' ' A' 1548 ' ' VAL . . . -121.83 144.56 48.75 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.615 -1.254 . . . . 0.5 107.615 176.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -80.84 126.57 31.5 Favored 'General case' 0 N--CA 1.431 -1.377 0 O-C-N 123.643 0.589 . . . . 0.73999999999999999 109.545 -176.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1542 ' ' TYR . . . . . 0.538 ' CE1' ' HG ' ' A' 1626 ' ' LEU . 10.6 t80 -131.73 -102.09 0.28 Allowed 'General case' 0 N--CA 1.419 -2.0 0 CA-C-N 115.484 -0.78 . . . . 0.98999999999999999 109.733 -175.804 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1543 ' ' SER . . . . . . . . . . . . . 43.1 t -77.57 155.32 31.6 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.651 -0.87 . . . . 1.9099999999999999 108.651 178.094 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -55.76 -42.16 75.06 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 119.175 0.898 . . . . 3.5899999999999999 111.002 178.378 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 41.8 m -106.24 30.72 5.69 Favored 'General case' 0 N--CA 1.407 -2.609 0 CA-C-O 121.078 0.466 . . . . 2.46 110.795 -176.199 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . -170.71 113.53 0.5 Allowed Glycine 0 N--CA 1.433 -1.514 0 C-N-CA 119.643 -1.265 . . . . 1.26 113.336 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 30.9 m -94.02 167.52 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 N-CA-C 107.794 -1.187 . . . . 0.79000000000000004 107.794 175.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1548 ' ' VAL . . . . . 0.466 ' CG1' ' HB3' ' A' 1540 ' ' ALA . 10.9 p -107.7 131.05 58.98 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.178 0 C-N-CA 119.448 -0.901 . . . . 0.57999999999999996 109.476 178.105 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -97.74 127.19 43.52 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.129 -1.063 . . . . 1.0800000000000001 108.129 178.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 25.6 ptm -143.82 137.52 28.04 Favored 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 120.377 -0.529 . . . . 0.78000000000000003 112.005 -178.055 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 11.2 p -127.7 125.78 40.67 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 115.397 -0.82 . . . . 0.96999999999999997 109.76 176.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1552 ' ' ILE . . . . . 0.443 ' HB ' ' HA ' ' A' 1533 ' ' SER . 42.4 mm -80.98 116.68 25.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 N-CA-C 109.817 -0.438 . . . . 0.41999999999999998 109.817 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1553 ' ' CYS . . . . . 0.49 ' SG ' HD11 ' A' 1590 ' ' LEU . 85.6 m 62.59 31.81 16.69 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 112.813 0.672 . . . . 1.3999999999999999 112.813 173.36 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . -166.55 175.2 41.98 Favored Glycine 0 N--CA 1.417 -2.591 0 N-CA-C 108.201 -1.96 . . . . 0.34999999999999998 108.201 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -98.18 148.76 23.26 Favored 'General case' 0 C--N 1.289 -2.049 0 C-N-CA 119.91 -0.716 . . . . 1.6200000000000001 110.925 -179.256 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1556 ' ' ASN . . . . . 0.424 ' ND2' ' HA3' ' A' 1537 ' ' GLY . 25.7 t-20 -92.44 125.21 36.99 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 108.384 -0.969 . . . . 0.87 108.384 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -81.07 4.88 18.33 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 114.4 1.259 . . . . 2.4900000000000002 114.4 -175.665 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -95.95 -4.21 43.77 Favored 'General case' 0 C--N 1.317 -0.838 0 O-C-N 121.638 -0.664 . . . . 1.3799999999999999 111.234 -179.257 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1559 ' ' CYS . . . . . 0.765 ' SG ' ' HD2' ' A' 1560 ' ' PRO . 17.6 t -136.87 162.93 53.06 Favored Pre-proline 0 C--N 1.302 -1.489 0 N-CA-C 106.84 -1.541 . . . . 1.21 106.84 -177.708 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1560 ' ' PRO . . . . . 0.765 ' HD2' ' SG ' ' A' 1559 ' ' CYS . 45.5 Cg_exo -28.46 128.53 0.04 OUTLIER 'Trans proline' 0 C--N 1.384 2.444 0 C-N-CA 124.982 3.788 . . . . 0.70999999999999996 115.25 176.215 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1561 ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' 1560 ' ' PRO . 85.9 Cg_exo -48.96 122.68 8.66 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 124.067 3.178 . . . . 0.80000000000000004 113.826 -178.314 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 98.94 14.68 35.88 Favored Glycine 0 C--N 1.311 -0.814 0 CA-C-N 115.63 -0.714 . . . . 0.46000000000000002 114.328 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1563 ' ' VAL . . . . . 0.535 HG21 ' HB2' ' A' 1573 ' ' SER . 9.9 p -104.66 144.43 14.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.885 -0.773 . . . . 0.97999999999999998 110.662 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -102.39 -33.3 4.57 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 121.213 -0.518 . . . . 0.28000000000000003 113.033 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -130.15 139.6 50.86 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.79 -0.448 . . . . 0.28000000000000003 109.79 178.591 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 45.7 t -159.16 133.23 7.6 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 119.529 -0.272 . . . . 0.42999999999999999 110.724 -177.246 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -84.89 139.64 31.72 Favored 'General case' 0 C--O 1.249 1.047 0 N-CA-C 108.458 -0.942 . . . . 1.03 108.458 171.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -82.47 39.43 2.66 Favored Glycine 0 N--CA 1.442 -0.933 0 C-N-CA 121.703 -0.284 . . . . 1.1299999999999999 113.783 -175.567 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -76.51 -71.42 0.39 Allowed 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 108.661 -0.866 . . . . 2.5800000000000001 108.661 174.542 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 2.9 p -132.52 33.31 3.81 Favored 'General case' 0 C--N 1.308 -1.209 0 C-N-CA 122.935 0.494 . . . . 2.1699999999999999 110.278 174.615 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1571 ' ' ARG . . . . . 0.542 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 3.1 mpt_? 61.9 60.08 1.61 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.9 0.857 . . . . 2.6200000000000001 109.442 -173.072 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 39.9 mt -96.26 101.72 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 107.748 -1.204 . . . . 0.92000000000000004 107.748 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1573 ' ' SER . . . . . 0.535 ' HB2' HG21 ' A' 1563 ' ' VAL . 94.1 p -63.31 129.39 40.05 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 114.321 -1.309 . . . . 0.80000000000000004 111.288 -176.656 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1574 ' ' VAL . . . . . 0.494 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 35.1 m -120.14 16.77 6.47 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-O 121.511 0.672 . . . . 0.97999999999999998 112.054 -176.577 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 173.27 118.24 0.49 Allowed Glycine 0 N--CA 1.428 -1.9 0 CA-C-N 115.414 -0.812 . . . . 0.28999999999999998 111.135 176.27 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 55.3 tttp -70.42 139.27 51.78 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 107.805 -1.183 . . . . 2.1899999999999999 107.805 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -68.5 98.79 0.89 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.207 0.447 . . . . 0.60999999999999999 112.207 -175.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1578 ' ' ASN . . . . . 0.555 ' O ' ' HE1' ' A' 1592 ' ' TYR . 84.5 m-20 -115.67 157.61 23.97 Favored 'General case' 0 C--O 1.206 -1.223 0 N-CA-C 106.926 -1.509 . . . . 1.95 106.926 175.049 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1579 ' ' LYS . . . . . 0.437 ' HB3' ' SG ' ' A' 1516 ' ' CYS . 28.2 mtmm -122.97 42.07 3.29 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 122.167 0.984 . . . . 2.6800000000000002 108.512 -178.689 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 25.9 ttm180 -90.4 76.9 6.64 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 122.257 1.027 . . . . 3.4700000000000002 109.313 -173.571 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1581 ' ' LEU . . . . . 0.551 HD21 ' HG ' ' A' 1529 ' ' LEU . 0.3 OUTLIER -65.87 133.02 50.06 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 113.184 -1.825 . . . . 0.64000000000000001 109.517 -178.518 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A 1582 ' ' ARG . . . . . 0.752 ' HB2' ' HB3' ' A' 1589 ' ' GLN . 94.5 mtt180 -120.52 141.17 50.48 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 109.765 -0.458 . . . . 2.8500000000000001 109.765 175.504 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1583 ' ' TYR . . . . . 0.524 ' OH ' ' OE1' ' A' 1647 ' ' GLU . 16.2 t80 -114.94 102.37 9.9 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 109.512 -0.551 . . . . 0.85999999999999999 109.512 177.155 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1584 ' ' VAL . . . . . 0.556 ' O ' ' HB ' ' A' 1587 ' ' VAL . 27.8 m -123.68 91.15 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.763 -0.653 . . . . 1.05 111.868 -177.358 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1585 ' ' ASP . . . . . 0.42 ' O ' ' HG2' ' A' 1586 ' ' GLN . 24.0 t70 56.5 62.62 2.24 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.896 0.878 . . . . 1.1699999999999999 111.576 176.509 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1586 ' ' GLN . . . . . 0.42 ' HG2' ' O ' ' A' 1585 ' ' ASP . 9.0 pt20 68.89 2.22 3.45 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 127.628 2.371 . . . . 1.8600000000000001 111.547 178.033 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1587 ' ' VAL . . . . . 0.556 ' HB ' ' O ' ' A' 1584 ' ' VAL . 25.0 t -92.11 123.49 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.116 0 CA-C-N 115.329 -0.85 . . . . 0.48999999999999999 109.406 175.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1588 ' ' LEU . . . . . 0.671 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 3.6 mm? -99.51 108.25 20.64 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.089 -1.078 . . . . 0.35999999999999999 108.089 179.17 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1589 ' ' GLN . . . . . 0.752 ' HB3' ' HB2' ' A' 1582 ' ' ARG . 4.0 tp-100 -100.41 133.46 44.8 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 115.233 -0.894 . . . . 1.74 111.376 -174.823 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1590 ' ' LEU . . . . . 0.49 HD11 ' SG ' ' A' 1553 ' ' CYS . 0.4 OUTLIER -130.94 92.48 3.23 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 105.843 -1.91 . . . . 0.71999999999999997 105.843 175.066 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 8.3 p -93.77 125.94 46.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 CA-C-O 121.835 0.826 . . . . 1.01 112.906 -174.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1592 ' ' TYR . . . . . 0.555 ' HE1' ' O ' ' A' 1578 ' ' ASN . 17.5 m-30 -112.49 138.26 49.51 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 107.76 -1.2 . . . . 0.5 107.76 176.116 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 22.7 pttm -148.54 -178.53 6.38 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.082 -1.081 . . . . 1.5900000000000001 108.082 178.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 11.0 m-20 60.74 50.45 5.48 Favored 'General case' 0 C--O 1.242 0.701 0 O-C-N 124.223 0.952 . . . . 1.1100000000000001 110.978 176.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -78.35 -112.48 0.19 Allowed Glycine 0 N--CA 1.433 -1.561 0 N-CA-C 110.272 -1.131 . . . . 0.78000000000000003 110.272 178.374 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1596 ' ' SER . . . . . . . . . . . . . 56.2 p -124.98 159.69 57.81 Favored Pre-proline 0 C--N 1.274 -2.675 0 N-CA-C 107.691 -1.226 . . . . 1.0700000000000001 107.691 174.406 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -54.73 124.75 16.98 Favored 'Trans proline' 0 C--N 1.358 1.028 0 C-N-CA 122.386 2.057 . . . . 1.01 110.339 177.408 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1598 ' ' CYS . . . . . 0.619 ' HA ' ' CE2' ' A' 1606 ' ' TYR . 21.7 t -58.47 115.96 13.4 Favored Pre-proline 0 C--N 1.308 -1.239 0 N-CA-C 108.775 -0.824 . . . . 0.75 108.775 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1599 ' ' PRO . . . . . 0.663 ' HB2' ' HB ' ' B' ' 16' ' ' THR . 31.8 Cg_exo -60.87 -23.96 78.11 Favored 'Trans proline' 0 C--N 1.361 1.21 0 C-N-CA 123.016 2.477 . . . . 1.7 112.676 -176.349 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1600 ' ' SER . . . . . 0.63 ' HB3' ' HB3' ' B' ' 53' ' ' LEU . 44.3 m -80.52 -14.66 58.06 Favored 'General case' 0 CA--C 1.566 1.571 0 N-CA-C 113.033 0.753 . . . . 2.2599999999999998 113.033 177.452 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1601 ' ' LYS . . . . . 0.45 ' HG3' HD13 ' A' 1604 ' ' LEU . 3.2 tppp? -160.76 116.07 2.21 Favored 'General case' 0 C--O 1.24 0.588 0 O-C-N 121.698 -0.626 . . . . 3.0099999999999998 110.797 -176.688 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 38.3 t -69.74 141.95 53.36 Favored 'General case' 0 N--CA 1.416 -2.15 0 N-CA-C 108.457 -0.942 . . . . 2.0699999999999998 108.457 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 99.26 -17.6 57.68 Favored Glycine 0 C--N 1.3 -1.439 0 C-N-CA 121.222 -0.513 . . . . 1.0800000000000001 112.72 179.028 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1604 ' ' LEU . . . . . 0.45 HD13 ' HG3' ' A' 1601 ' ' LYS . 8.9 mp -102.57 145.9 28.93 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 123.212 0.605 . . . . 1.8400000000000001 110.561 178.658 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 31.5 t -121.59 153.6 37.85 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 106.757 -1.571 . . . . 1.4099999999999999 106.757 175.309 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1606 ' ' TYR . . . . . 0.619 ' CE2' ' HA ' ' A' 1598 ' ' CYS . 49.1 m-85 -78.56 155.07 29.88 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 116.522 -0.308 . . . . 0.59999999999999998 111.558 178.209 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1607 ' ' LYS . . . . . 0.415 ' O ' HD22 ' A' 1636 ' ' LEU . 8.0 ptpp? -150.16 145.1 26.09 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 106.943 -1.502 . . . . 1.45 106.943 175.09 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1608 ' ' SER . . . . . . . . . . . . . 17.2 m -120.0 120.91 37.69 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 107.789 -1.189 . . . . 1.1499999999999999 107.789 -178.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 21.3 t -99.99 103.87 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 CA-C-O 121.118 0.485 . . . . 0.25 109.701 178.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 83.1 mt -96.69 106.27 18.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 C-N-CA 123.845 0.858 . . . . 0.45000000000000001 109.171 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 14.4 t -106.98 113.94 27.72 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 108.392 -0.966 . . . . 1.26 108.392 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1612 ' ' PHE . . . . . 0.671 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 60.0 m-85 -81.8 121.51 26.52 Favored 'General case' 0 C--O 1.258 1.551 0 N-CA-C 109.477 -0.564 . . . . 0.26000000000000001 109.477 176.08 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 46.4 t -111.54 129.86 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-N 114.798 -1.092 . . . . 0.5 109.862 -174.031 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 22.1 t -61.14 110.86 1.5 Allowed 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.112 -0.949 . . . . 0.77000000000000002 111.884 178.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1615 ' ' ARG . . . . . 0.635 ' HG3' ' HB3' ' A' 1617 ' ' GLU . 32.5 tpt180 -137.48 95.76 11.27 Favored Pre-proline 0 N--CA 1.438 -1.033 0 N-CA-C 109.246 -0.65 . . . . 2.5299999999999998 109.246 173.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1616 ' ' PRO . . . . . 0.843 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 39.5 Cg_exo -61.45 -21.26 71.43 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 122.86 2.373 . . . . 1.1000000000000001 113.387 -178.313 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1617 ' ' GLU . . . . . 0.635 ' HB3' ' HG3' ' A' 1615 ' ' ARG . 38.9 tt0 -49.44 -41.12 39.07 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 125.586 1.554 . . . . 3.0499999999999998 112.451 176.8 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . 43.58 81.03 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.527 0.731 . . . . 1.55 112.564 -177.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . -153.45 -134.33 1.98 Allowed Glycine 0 C--N 1.274 -2.907 0 C-N-CA 120.581 -0.819 . . . . 0.93000000000000005 111.569 -177.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -66.88 1.09 3.01 Favored 'Trans proline' 0 CA--C 1.55 1.298 0 C-N-CA 122.656 2.237 . . . . 0.88 114.465 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1621 ' ' THR . . . . . 0.753 ' HB ' ' HB2' ' A' 1641 ' ' HIS . 2.7 p -98.67 -13.66 20.19 Favored 'General case' 0 N--CA 1.419 -1.979 0 C-N-CA 124.13 0.972 . . . . 0.96999999999999997 109.727 178.061 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 53.0 t30 -86.03 69.2 10.5 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.956 -1.02 . . . . 0.71999999999999997 108.566 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1623 ' ' ARG . . . . . 0.472 ' O ' ' HG3' ' A' 1625 ' ' MET . 11.5 ptp180 -166.23 140.63 3.62 Favored Pre-proline 0 C--N 1.296 -1.744 0 N-CA-C 107.537 -1.283 . . . . 3.2599999999999998 107.537 -178.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -58.07 104.71 0.18 Allowed 'Trans proline' 0 C--O 1.238 0.515 0 C-N-CA 122.92 2.413 . . . . 0.58999999999999997 110.885 178.314 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1625 ' ' MET . . . . . 0.472 ' HG3' ' O ' ' A' 1623 ' ' ARG . 94.2 mtp -98.75 131.27 45.02 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.476 -0.935 . . . . 1.3700000000000001 108.476 -176.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1626 ' ' LEU . . . . . 0.538 ' HG ' ' CE1' ' A' 1542 ' ' TYR . 1.0 OUTLIER -86.82 111.86 21.17 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 106.938 -1.505 . . . . 0.89000000000000001 106.938 -178.031 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A 1627 ' ' ILE . . . . . 0.564 HD11 ' HB2' ' A' 1639 ' ' SER . 37.8 mm -73.07 -56.89 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.883 0 N-CA-C 108.902 -0.777 . . . . 0.57999999999999996 108.902 -178.472 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 23.8 t -171.88 162.21 6.01 Favored 'General case' 0 N--CA 1.417 -2.124 0 N-CA-C 107.839 -1.171 . . . . 1.3899999999999999 107.839 -175.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1629 ' ' LEU . . . . . 0.495 HD13 ' CD1' ' A' 1636 ' ' LEU . 5.7 tp -112.11 109.2 18.78 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 107.731 -1.211 . . . . 1.25 107.731 175.112 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1630 ' ' ASP . . . . . 0.533 ' HB3' ' HB ' ' A' 1635 ' ' THR . 13.4 t70 -75.02 85.91 2.31 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 106.16 -1.793 . . . . 1.0900000000000001 106.16 173.205 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1631 ' ' LYS . . . . . 0.477 ' HG3' HD13 ' B' ' 53' ' ' LEU . 21.6 tptm -64.65 -19.8 65.92 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 114.229 -1.351 . . . . 3.6000000000000001 112.702 -173.304 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -76.19 -31.67 58.6 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 119.599 -0.841 . . . . 2.6000000000000001 110.376 -176.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 59.6 p -107.26 -10.46 15.81 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 116.116 -0.493 . . . . 0.75 111.631 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 65.9 m 67.23 49.26 1.09 Allowed 'General case' 0 C--N 1.36 1.054 0 CA-C-O 122.76 1.267 . . . . 0.53000000000000003 109.975 -178.117 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1635 ' ' THR . . . . . 0.533 ' HB ' ' HB3' ' A' 1630 ' ' ASP . 93.3 m -109.87 130.0 55.58 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 113.854 -1.521 . . . . 0.46000000000000002 109.088 -177.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1636 ' ' LEU . . . . . 0.495 ' CD1' HD13 ' A' 1629 ' ' LEU . 0.2 OUTLIER -105.68 135.82 46.39 Favored 'General case' 0 CA--C 1.504 -0.802 0 N-CA-C 108.009 -1.108 . . . . 0.85999999999999999 108.009 177.68 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -109.37 125.59 52.53 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 109.556 -0.535 . . . . 0.45000000000000001 109.556 177.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -125.11 136.89 54.07 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.307 -0.627 . . . . 0.5 109.307 -178.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1639 ' ' SER . . . . . 0.564 ' HB2' HD11 ' A' 1627 ' ' ILE . 33.1 t -116.8 154.87 29.94 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 107.285 -1.376 . . . . 1.04 107.285 175.675 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 2.7 t90 -150.38 108.21 3.7 Favored 'General case' 0 N--CA 1.417 -2.087 0 N-CA-C 104.882 -2.266 . . . . 0.68000000000000005 104.882 178.775 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1641 ' ' HIS . . . . . 0.753 ' HB2' ' HB ' ' A' 1621 ' ' THR . 51.2 m-70 -95.06 104.63 16.51 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 121.281 0.562 . . . . 0.90000000000000002 109.941 -175.476 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1642 ' ' THR . . . . . . . . . . . . . 8.6 t -142.38 148.99 49.72 Favored Pre-proline 0 C--N 1.3 -1.584 0 CA-C-N 115.67 -0.696 . . . . 0.47999999999999998 109.674 -173.36 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1643 ' ' PRO . . . . . 0.843 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 77.7 Cg_endo -78.87 -6.41 15.12 Favored 'Trans proline' 0 C--N 1.369 1.626 0 C-N-CA 122.483 2.122 . . . . 0.66000000000000003 112.586 179.412 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 8.2 tt -70.21 -25.35 63.36 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.1 -0.704 . . . . 0.96999999999999997 109.1 178.244 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -95.29 17.12 14.98 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.962 -1.017 . . . . 0.83999999999999997 110.342 -178.137 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1646 ' ' CYS . . . . . 0.538 ' SG ' ' HA ' ' A' 1643 ' ' PRO . 95.7 m -96.28 145.59 25.45 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 109.716 -0.476 . . . . 1.1899999999999999 109.716 177.744 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1647 ' ' GLU . . . . . 0.524 ' OE1' ' OH ' ' A' 1583 ' ' TYR . 35.4 tt0 . . . . . 0 C--N 1.297 -1.684 0 N-CA-C 108.654 -0.869 . . . . 3.1400000000000001 108.654 -177.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 10' ' ' GLY . . . . . 0.499 ' O ' HG12 ' B' ' 14' ' ' VAL . . . . . . . . 0 N--CA 1.417 -2.593 0 CA-C-O 119.087 -0.841 . . . . 2.0899999999999999 112.708 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -44.79 -74.67 0.2 Allowed Glycine 0 N--CA 1.473 1.153 0 N-CA-C 115.626 1.011 . . . . 1.8400000000000001 115.626 -170.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -75.0 -17.14 60.57 Favored 'General case' 0 C--N 1.314 -0.966 0 O-C-N 122.317 -0.519 . . . . 2.5499999999999998 111.578 -179.068 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 13' ' ' LEU . . . . . 0.472 ' O ' HD23 ' B' ' 17' ' ' LEU . 36.7 tp -71.98 -53.73 12.1 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-O 120.884 0.373 . . . . 2.3500000000000001 110.284 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 14' ' ' VAL . . . . . 0.499 HG12 ' O ' ' B' ' 10' ' ' GLY . 13.7 p -70.64 -23.54 24.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-O 121.5 0.667 . . . . 2.1099999999999999 109.796 -179.465 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -72.49 -42.43 64.87 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.815 -0.629 . . . . 2.04 111.233 175.259 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 16' ' ' THR . . . . . 0.663 ' HB ' ' HB2' ' A' 1599 ' ' PRO . 15.1 t -67.43 -30.14 69.81 Favored 'General case' 0 C--O 1.248 1.005 0 CA-C-N 118.674 0.67 . . . . 1.8400000000000001 110.727 176.659 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.472 HD23 ' O ' ' B' ' 13' ' ' LEU . 3.3 mm? -51.97 -51.69 55.48 Favored 'General case' 0 C--O 1.212 -0.918 0 O-C-N 123.637 0.586 . . . . 1.74 109.89 168.077 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.69 -33.69 69.01 Favored 'General case' 0 C--O 1.214 -0.793 0 CA-C-N 116.014 -0.539 . . . . 2.3900000000000001 110.213 -178.417 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -47.97 -64.09 0.89 Allowed 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 113.084 0.772 . . . . 0.95999999999999996 113.084 177.012 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 10.1 p -91.93 -14.52 8.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 C-N-CA 118.588 -1.245 . . . . 1.3700000000000001 111.62 -176.143 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 21' ' ' CYS . . . . . 0.577 ' HB2' ' HB3' ' B' ' 26' ' ' PHE . 61.9 m -106.95 17.51 23.0 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 119.806 -0.758 . . . . 1.6599999999999999 112.659 -178.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -53.01 -44.14 62.03 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 121.226 -0.512 . . . . 1.53 112.43 174.103 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -82.22 -52.5 6.9 Favored 'General case' 0 C--N 1.314 -0.937 0 O-C-N 122.627 -0.337 . . . . 2.7200000000000002 111.718 178.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 44.9 ttp180 -69.09 -29.04 67.06 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.38 0.882 . . . . 4.3300000000000001 113.38 -175.309 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.09 133.03 7.14 Favored Glycine 0 N--CA 1.435 -1.37 0 N-CA-C 109.826 -1.309 . . . . 1.53 109.826 -177.254 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 26' ' ' PHE . . . . . 0.577 ' HB3' ' HB2' ' B' ' 21' ' ' CYS . 22.9 p90 -107.68 112.98 25.94 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 117.448 0.624 . . . . 1.6499999999999999 110.235 -179.028 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -135.74 133.77 38.35 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.149 -1.056 . . . . 3.4199999999999999 108.149 -177.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 28' ' ' PHE . . . . . 0.433 ' HA ' ' HE1' ' B' ' 59' ' ' TYR . 18.0 p90 . . . . . 0 C--N 1.315 -0.895 0 O-C-N 123.293 0.371 . . . . 2.2599999999999998 111.501 -178.304 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.414 -2.789 0 N-CA-C 110.685 -0.966 . . . . 2.3700000000000001 110.685 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . 0.291 17.5 pt 65.55 -36.22 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 128.318 2.647 . . . . 2.0699999999999998 115.12 175.526 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 2.5 p -52.27 -41.02 32.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 123.532 0.733 . . . . 2.2400000000000002 112.926 178.724 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -87.81 -47.43 8.61 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 109.368 -0.604 . . . . 3.3599999999999999 109.368 -176.28 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -54.49 -44.5 72.73 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 114.985 -1.007 . . . . 3.0800000000000001 111.676 -179.134 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 46' ' ' CYS . . . . . . . . . . . . . 22.9 t -86.22 -15.68 40.1 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.029 0.442 . . . . 2.23 111.246 -176.468 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 49.5 t -75.17 -37.97 61.06 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.235 0.54 . . . . 2.3700000000000001 110.991 178.051 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -105.75 -12.79 15.76 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 113.766 1.024 . . . . 2.8199999999999998 113.766 -177.229 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 56.6 mtm180 -138.61 158.24 44.62 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.703 -0.851 . . . . 4.0899999999999999 108.703 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 16.0 t -80.27 114.91 19.51 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.782 -0.822 . . . . 2.6699999999999999 108.782 -177.435 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 32.0 p -89.42 143.61 26.69 Favored 'General case' 0 N--CA 1.421 -1.904 0 N-CA-C 108.247 -1.02 . . . . 2.1099999999999999 108.247 -176.207 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -92.81 150.03 20.89 Favored 'General case' 0 N--CA 1.421 -1.884 0 N-CA-C 107.322 -1.362 . . . . 2.6699999999999999 107.322 174.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 53' ' ' LEU . . . . . 0.63 ' HB3' ' HB3' ' A' 1600 ' ' SER . 3.9 pp -70.35 -9.16 55.4 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 113.199 0.814 . . . . 1.8999999999999999 113.199 -171.841 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.24 -33.67 65.44 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.313 -0.995 . . . . 1.52 108.313 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 54.0 tp -60.67 -49.34 77.93 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-N 114.851 -1.068 . . . . 1.97 109.293 177.163 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 3.3 pp -73.83 -29.27 62.04 Favored 'General case' 0 N--CA 1.412 -2.353 0 C-N-CA 120.295 -0.562 . . . . 1.53 111.584 -176.323 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -63.98 -52.77 58.09 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.059 0.457 . . . . 2.27 110.929 -179.489 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 13.6 t -77.61 -23.07 49.94 Favored 'General case' 0 CA--C 1.557 1.214 0 CA-C-N 116.039 -0.528 . . . . 2.3300000000000001 111.958 -177.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 59' ' ' TYR . . . . . 0.433 ' HE1' ' HA ' ' B' ' 28' ' ' PHE . 10.2 t80 -81.67 -34.4 30.73 Favored 'General case' 0 C--O 1.243 0.732 0 N-CA-C 108.817 -0.808 . . . . 2.8599999999999999 108.817 179.227 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 9.6 t . . . . . 0 C--O 1.248 1.018 0 CA-C-N 115.269 -0.878 . . . . 2.2999999999999998 111.733 -178.234 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 25.3 t70 . . . . . 0 CA--C 1.544 0.727 0 CA-C-O 121.96 0.886 . . . . 2.8999999999999999 109.759 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A 1516 ' ' CYS . . . . . 0.646 ' HA ' ' HB2' ' A' 1581 ' ' LEU . 69.2 m 59.05 49.57 9.28 Favored 'General case' 0 C--O 1.246 0.884 0 N-CA-C 114.393 1.257 . . . . 1.1899999999999999 114.393 -179.39 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -156.45 134.66 11.32 Favored 'General case' 0 N--CA 1.427 -1.599 0 CA-C-N 115.22 -0.9 . . . . 1.52 110.819 175.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1518 ' ' VAL . . . . . 0.643 HG21 ' HB2' ' A' 1583 ' ' TYR . 5.6 m -141.21 145.25 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 C-N-CA 124.411 1.085 . . . . 0.93999999999999995 109.892 -178.766 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1519 ' ' THR . . . . . 0.42 ' OG1' HD23 ' A' 1526 ' ' LEU . 25.8 m -114.89 137.1 52.37 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 109.239 -0.652 . . . . 0.89000000000000001 109.239 177.253 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1520 ' ' ASN . . . . . 0.529 ' OD1' HG22 ' A' 1523 ' ' THR . 26.8 t-20 -91.36 110.75 44.92 Favored Pre-proline 0 C--N 1.3 -1.556 0 N-CA-C 108.088 -1.078 . . . . 1.74 108.088 173.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -65.32 -19.08 61.86 Favored 'Trans proline' 0 N--CA 1.478 0.601 0 C-N-CA 123.464 2.776 . . . . 1.5800000000000001 113.246 -173.687 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1522 ' ' SER . . . . . 0.465 ' HB2' ' OD1' ' A' 1520 ' ' ASN . 18.0 m -70.08 -44.58 68.79 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-N 115.849 -0.614 . . . . 1.6499999999999999 111.259 -178.831 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1523 ' ' THR . . . . . 0.529 HG22 ' OD1' ' A' 1520 ' ' ASN . 9.6 t -119.01 6.86 11.33 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.54 0.686 . . . . 1.6100000000000001 111.067 -175.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 57.83 36.02 77.88 Favored Glycine 0 CA--C 1.511 -0.199 0 CA-C-N 115.104 -0.953 . . . . 1.1299999999999999 113.798 177.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 13.0 t-160 -100.72 122.14 42.86 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 120.537 -0.465 . . . . 1.26 110.578 -179.181 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1526 ' ' LEU . . . . . 0.42 HD23 ' OG1' ' A' 1519 ' ' THR . 2.2 tm? -96.92 114.61 26.25 Favored 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 124.76 1.224 . . . . 0.68000000000000005 109.522 -179.149 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -91.24 115.28 27.9 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 116.777 -0.192 . . . . 0.65000000000000002 111.167 176.023 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 6.3 t70 -101.74 115.02 29.62 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 108.094 -1.076 . . . . 1.1699999999999999 108.094 174.321 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1529 ' ' LEU . . . . . 0.432 ' HB2' ' HB3' ' A' 1516 ' ' CYS . 3.6 mm? -101.07 4.17 42.0 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.346 0.593 . . . . 0.59999999999999998 110.129 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1530 ' ' SER . . . . . 0.427 ' HA ' ' OG ' ' A' 1533 ' ' SER . 1.2 m -67.01 -30.19 70.22 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.16 -0.927 . . . . 0.83999999999999997 109.011 179.174 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 30.9 m -61.38 -27.76 68.75 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 114.962 -1.017 . . . . 1.5900000000000001 111.008 178.036 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 83.1 mt -99.09 -1.08 40.43 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 120.696 0.284 . . . . 0.65000000000000002 110.819 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1533 ' ' SER . . . . . 0.427 ' OG ' ' HA ' ' A' 1530 ' ' SER . 19.6 m -75.0 158.92 32.44 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 120.736 0.303 . . . . 1.52 110.877 -177.473 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . 176.71 146.48 6.09 Favored Glycine 0 N--CA 1.443 -0.833 0 N-CA-C 110.867 -0.893 . . . . 1.1000000000000001 110.867 -179.318 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1535 ' ' ARG . . . . . 0.401 ' O ' ' HA ' ' A' 1556 ' ' ASN . 36.8 ttm180 -92.62 -29.07 16.32 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 123.205 0.602 . . . . 4.6200000000000001 111.036 -177.045 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -75.83 -38.89 57.64 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.864 0.84 . . . . 1.45 108.986 177.347 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 94.87 -165.52 25.66 Favored Glycine 0 N--CA 1.422 -2.283 0 CA-C-N 114.939 -1.028 . . . . 0.84999999999999998 114.081 172.012 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -128.34 153.69 46.75 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 107.267 -1.383 . . . . 0.93000000000000005 107.267 -178.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 3.0 p -112.56 136.11 52.48 Favored 'General case' 0 C--N 1.31 -1.149 0 O-C-N 123.539 0.525 . . . . 1.03 111.388 -177.464 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1540 ' ' ALA . . . . . 0.41 ' HB3' ' CG1' ' A' 1548 ' ' VAL . . . -128.22 148.62 50.63 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.517 -0.92 . . . . 0.5 108.517 175.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -82.4 135.86 35.08 Favored 'General case' 0 C--N 1.315 -0.9 0 O-C-N 123.556 0.535 . . . . 0.73999999999999999 111.494 -176.56 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1542 ' ' TYR . . . . . 0.517 ' HB3' ' H ' ' A' 1543 ' ' SER . 2.4 t80 -134.11 -101.32 0.24 Allowed 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 115.628 -0.714 . . . . 0.98999999999999999 109.434 179.33 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1543 ' ' SER . . . . . 0.517 ' H ' ' HB3' ' A' 1542 ' ' TYR . 39.8 t -72.32 160.42 32.4 Favored 'General case' 0 C--O 1.246 0.92 0 CA-C-N 115.907 -0.588 . . . . 1.9099999999999999 110.569 -178.565 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1544 ' ' LYS . . . . . 0.44 ' HE2' ' HA ' ' B' ' 23' ' ' ASP . 24.3 ttmm -53.61 -40.3 65.64 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.958 0.409 . . . . 3.5899999999999999 111.634 -178.677 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 45.6 m -104.32 12.02 34.07 Favored 'General case' 0 N--CA 1.413 -2.294 0 N-CA-C 112.42 0.526 . . . . 2.46 112.42 -174.618 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . -155.42 147.69 16.92 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 117.822 -2.132 . . . . 1.26 115.683 -173.186 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 35.1 m -113.0 172.94 2.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 108.557 -0.905 . . . . 0.79000000000000004 108.557 178.344 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1548 ' ' VAL . . . . . 0.502 ' HA ' ' HA ' ' A' 1567 ' ' PHE . 14.9 p -115.69 141.39 33.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 109.125 -0.694 . . . . 0.57999999999999996 109.125 176.405 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -103.74 129.5 51.12 Favored 'General case' 0 CA--C 1.491 -1.327 0 N-CA-C 109.32 -0.622 . . . . 1.0800000000000001 109.32 176.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 23.1 ptm -139.66 128.62 23.54 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 115.435 -0.802 . . . . 0.78000000000000003 110.494 -179.28 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1551 ' ' SER . . . . . 0.452 ' HB3' HD22 ' A' 1556 ' ' ASN . 15.4 p -112.12 131.46 55.44 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 115.773 -0.649 . . . . 0.96999999999999997 109.721 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1552 ' ' ILE . . . . . . . . . . . . . 46.9 mm -91.0 121.11 41.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 N-CA-C 109.529 -0.545 . . . . 0.41999999999999998 109.529 -178.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1553 ' ' CYS . . . . . 0.47 ' O ' ' HE2' ' A' 1579 ' ' LYS . 72.7 m 60.33 42.84 14.32 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 121.73 0.776 . . . . 1.3999999999999999 112.058 175.077 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 177.64 171.88 41.56 Favored Glycine 0 N--CA 1.417 -2.62 0 N-CA-C 110.312 -1.115 . . . . 0.34999999999999998 110.312 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -87.33 153.45 21.45 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 109.441 -0.577 . . . . 1.6200000000000001 109.441 179.22 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1556 ' ' ASN . . . . . 0.452 HD22 ' HB3' ' A' 1551 ' ' SER . 18.4 t-20 -102.06 120.98 41.3 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 108.815 -0.809 . . . . 0.87 108.815 -177.766 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -78.87 13.85 1.57 Allowed 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 113.549 0.944 . . . . 2.4900000000000002 113.549 -174.538 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 54.6 m-80 -96.08 -12.54 24.69 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 120.214 -0.595 . . . . 1.3799999999999999 110.368 177.504 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1559 ' ' CYS . . . . . 0.748 ' SG ' ' HD2' ' A' 1560 ' ' PRO . 3.8 t -136.77 164.09 44.95 Favored Pre-proline 0 C--N 1.307 -1.253 0 CA-C-O 117.154 -1.403 . . . . 1.21 107.555 -175.838 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1560 ' ' PRO . . . . . 0.748 ' HD2' ' SG ' ' A' 1559 ' ' CYS . 37.9 Cg_exo -28.5 140.96 0.02 OUTLIER 'Trans proline' 0 C--N 1.381 2.249 1 C-N-CA 125.549 4.166 . . . . 0.70999999999999996 116.341 177.657 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A 1561 ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' 1560 ' ' PRO . 73.9 Cg_exo -53.04 127.4 24.86 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 124.017 3.144 . . . . 0.80000000000000004 114.194 -177.722 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 93.58 7.05 62.01 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-N 115.755 -0.657 . . . . 0.46000000000000002 114.345 177.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1563 ' ' VAL . . . . . 0.614 HG11 ' HB3' ' A' 1559 ' ' CYS . 5.5 p -99.3 141.98 15.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 O-C-N 121.929 -0.748 . . . . 0.97999999999999998 110.401 -179.53 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -104.68 -28.71 5.58 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-N 116.339 -0.391 . . . . 0.28000000000000003 112.99 178.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -130.56 131.78 45.21 Favored 'General case' 0 C--O 1.245 0.827 0 O-C-N 122.294 -0.533 . . . . 0.28000000000000003 110.794 179.33 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 44.3 t -159.81 141.32 12.81 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.785 -0.82 . . . . 0.42999999999999999 108.785 -178.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1567 ' ' PHE . . . . . 0.52 ' HB2' ' OG1' ' A' 1570 ' ' THR . 93.9 m-85 -86.91 146.51 26.15 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.776 -0.824 . . . . 1.03 108.776 178.211 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -68.71 -20.67 74.34 Favored Glycine 0 C--O 1.222 -0.625 0 N-CA-C 115.269 0.868 . . . . 1.1299999999999999 115.269 -172.57 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 35.7 mm-40 -96.8 -30.68 13.03 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 117.535 0.667 . . . . 2.5800000000000001 112.048 176.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1570 ' ' THR . . . . . 0.521 ' HA ' ' OD2' ' B' ' 15' ' ' ASP . 46.8 p -81.92 -32.0 31.07 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 115.236 1.569 . . . . 2.1699999999999999 115.236 -163.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 69.78 -2.63 1.93 Allowed 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.984 0.914 . . . . 2.6200000000000001 109.993 -172.44 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 28.5 mt -86.32 132.73 31.47 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 CA-C-O 121.473 0.654 . . . . 0.92000000000000004 110.834 -171.72 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 17.6 t -78.65 116.53 19.07 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 114.446 -1.252 . . . . 0.80000000000000004 109.589 179.152 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1574 ' ' VAL . . . . . 0.567 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 23.2 m -114.22 8.36 7.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-O 121.316 0.579 . . . . 0.97999999999999998 111.437 -178.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . -174.45 112.63 0.42 Allowed Glycine 0 N--CA 1.428 -1.898 0 C-N-CA 120.35 -0.929 . . . . 0.28999999999999998 111.527 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1576 ' ' LYS . . . . . 0.442 ' HB3' ' O ' ' A' 1593 ' ' LYS . 87.0 tttt -71.07 134.67 47.24 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.406 -0.961 . . . . 2.1899999999999999 108.406 177.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -68.11 131.35 45.26 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-O 120.942 0.401 . . . . 0.60999999999999999 110.465 -178.343 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -150.16 165.26 33.41 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 104.394 -2.447 . . . . 1.95 104.394 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1579 ' ' LYS . . . . . 0.47 ' HE2' ' O ' ' A' 1553 ' ' CYS . 97.4 mttt -130.83 40.1 3.52 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 108.675 -0.861 . . . . 2.6800000000000002 108.675 -178.306 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -92.99 76.63 4.72 Favored 'General case' 0 N--CA 1.418 -2.073 0 CA-C-O 122.181 0.991 . . . . 3.4700000000000002 109.893 -171.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1581 ' ' LEU . . . . . 0.646 ' HB2' ' HA ' ' A' 1516 ' ' CYS . 1.0 OUTLIER -63.71 125.93 25.92 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 113.18 -1.827 . . . . 0.64000000000000001 109.173 178.856 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A 1582 ' ' ARG . . . . . 0.417 ' N ' HD13 ' A' 1581 ' ' LEU . 78.3 mtp180 -125.28 139.99 53.22 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 115.919 -0.582 . . . . 2.8500000000000001 109.719 175.383 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1583 ' ' TYR . . . . . 0.643 ' HB2' HG21 ' A' 1518 ' ' VAL . 64.6 t80 -112.52 110.73 21.08 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 108.757 -0.831 . . . . 0.85999999999999999 108.757 -178.294 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1584 ' ' VAL . . . . . 0.519 ' O ' ' HB ' ' A' 1587 ' ' VAL . 10.9 m -122.52 88.99 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-O 121.36 0.6 . . . . 1.05 112.142 -178.353 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 38.6 t70 55.13 65.09 1.59 Allowed 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 115.09 -0.959 . . . . 1.1699999999999999 111.083 178.028 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1586 ' ' GLN . . . . . 0.586 ' HA ' ' CE1' ' A' 1583 ' ' TYR 0.291 11.6 pt20 64.69 15.37 9.7 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 126.826 2.05 . . . . 1.8600000000000001 112.631 177.562 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A 1587 ' ' VAL . . . . . 0.519 ' HB ' ' O ' ' A' 1584 ' ' VAL . 41.9 t -110.63 121.28 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.338 0 CA-C-N 114.219 -1.355 . . . . 0.48999999999999999 108.265 175.367 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1588 ' ' LEU . . . . . 0.834 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 2.6 mm? -95.83 114.65 26.4 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 106.688 -1.597 . . . . 0.35999999999999999 106.688 179.054 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -126.77 125.19 41.33 Favored 'General case' 0 C--N 1.289 -2.031 0 C-N-CA 119.177 -1.009 . . . . 1.74 112.674 -175.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1590 ' ' LEU . . . . . 0.457 ' HB2' ' HB ' ' A' 1610 ' ' ILE . 19.1 mt -107.88 126.76 53.05 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 113.993 -1.458 . . . . 0.71999999999999997 107.178 175.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 48.5 t -115.47 122.04 68.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 C-N-CA 119.879 -0.728 . . . . 1.01 109.893 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1592 ' ' TYR . . . . . 0.4 ' O ' ' HA ' ' A' 1607 ' ' LYS . 15.7 m-30 -105.49 94.74 5.37 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.932 -1.136 . . . . 0.5 107.932 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1593 ' ' LYS . . . . . 0.442 ' O ' ' HB3' ' A' 1576 ' ' LYS . 49.6 pttt -105.07 172.46 6.78 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 115.997 -0.547 . . . . 1.5900000000000001 109.672 -176.433 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 70.1 m-20 57.11 52.79 8.6 Favored 'General case' 0 CA--C 1.51 -0.568 0 O-C-N 124.502 1.126 . . . . 1.1100000000000001 111.554 178.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -71.88 -113.18 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 110.364 -1.095 . . . . 0.78000000000000003 110.364 176.388 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1596 ' ' SER . . . . . 0.641 ' HB3' ' HD2' ' A' 1597 ' ' PRO . 72.2 m -133.43 168.68 16.72 Favored Pre-proline 0 C--N 1.284 -2.262 0 O-C-N 121.317 -1.108 . . . . 1.0700000000000001 111.155 172.761 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1597 ' ' PRO . . . . . 0.641 ' HD2' ' HB3' ' A' 1596 ' ' SER . 2.5 Cg_endo -40.28 127.1 2.14 Favored 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 124.118 3.212 . . . . 1.01 114.058 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1598 ' ' CYS . . . . . 0.515 ' SG ' ' HB2' ' A' 1600 ' ' SER . 48.3 t -92.14 123.15 63.5 Favored Pre-proline 0 C--N 1.287 -2.124 0 CA-C-N 114.526 -1.215 . . . . 0.75 109.825 -179.38 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1599 ' ' PRO . . . . . 0.465 ' O ' ' HA ' ' B' ' 52' ' ' ASP . 17.2 Cg_exo -71.48 -27.99 18.33 Favored 'Trans proline' 0 C--O 1.211 -0.87 0 C-N-CA 122.206 1.937 . . . . 1.7 111.158 174.271 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1600 ' ' SER . . . . . 0.898 ' HA ' ' HB2' ' B' ' 53' ' ' LEU . 7.4 m -61.07 -47.16 87.64 Favored 'General case' 0 CA--C 1.555 1.145 0 CA-C-N 116.358 -0.383 . . . . 2.2599999999999998 110.667 178.096 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1601 ' ' LYS . . . . . . . . . . . . . 5.4 tppp? -126.31 111.14 14.18 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 107.407 -1.331 . . . . 3.0099999999999998 107.407 174.102 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 35.2 t -71.27 122.13 19.7 Favored 'General case' 0 N--CA 1.419 -2.001 0 C-N-CA 122.469 0.308 . . . . 2.0699999999999998 110.223 -171.511 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 104.76 -10.15 48.57 Favored Glycine 0 N--CA 1.441 -1.032 0 N-CA-C 111.472 -0.651 . . . . 1.0800000000000001 111.472 179.287 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1604 ' ' LEU . . . . . 0.483 HD23 ' SG ' ' A' 1634 ' ' CYS . 9.2 tp -101.09 168.63 9.47 Favored 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 107.832 -1.173 . . . . 1.8400000000000001 107.832 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 20.2 m -129.64 146.93 51.39 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 109.117 -0.697 . . . . 1.4099999999999999 109.117 178.183 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1606 ' ' TYR . . . . . 0.609 ' HD1' HD11 ' A' 1636 ' ' LEU . 67.0 m-85 -64.64 162.69 15.2 Favored 'General case' 0 C--O 1.251 1.182 0 N-CA-C 113.213 0.82 . . . . 0.59999999999999998 113.213 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1607 ' ' LYS . . . . . 0.521 ' HE3' HG23 ' A' 1635 ' ' THR . 33.3 ttpt -158.54 130.78 6.86 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.067 -0.969 . . . . 1.45 109.194 -177.633 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1608 ' ' SER . . . . . . . . . . . . . 19.9 m -107.34 130.18 54.82 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 109.48 -0.563 . . . . 1.1499999999999999 109.48 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 39.0 t -110.63 109.19 27.55 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 N-CA-C 108.687 -0.857 . . . . 0.25 108.687 178.504 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1610 ' ' ILE . . . . . 0.457 ' HB ' ' HB2' ' A' 1590 ' ' LEU . 62.1 mt -101.18 110.16 27.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 115.762 -0.654 . . . . 0.45000000000000001 109.632 -177.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 27.9 t -111.59 115.09 28.58 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 115.61 -0.723 . . . . 1.26 110.361 -178.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1612 ' ' PHE . . . . . 0.834 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 71.9 m-85 -89.53 122.74 32.98 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 107.96 -1.126 . . . . 0.26000000000000001 107.96 175.67 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1613 ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' 1641 ' ' HIS . 43.9 t -116.19 138.72 45.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 109.333 -0.617 . . . . 0.5 109.333 -176.651 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 40.5 t -66.77 119.02 11.13 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 123.998 0.919 . . . . 0.77000000000000002 111.252 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1615 ' ' ARG . . . . . 0.83 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 20.2 tpt180 -122.16 96.72 46.21 Favored Pre-proline 0 N--CA 1.446 -0.663 0 N-CA-C 109.856 -0.424 . . . . 2.5299999999999998 109.856 176.422 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1616 ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -66.6 -40.48 13.44 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.251 1.967 . . . . 1.1000000000000001 110.607 176.017 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -80.6 43.28 0.65 Allowed 'General case' 0 C--O 1.241 0.647 0 C-N-CA 124.3 1.04 . . . . 3.0499999999999998 111.272 176.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1618 ' ' ALA . . . . . 0.632 ' HB2' ' HG3' ' A' 1643 ' ' PRO . . . -39.51 124.68 1.65 Allowed 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 125.617 1.567 . . . . 1.55 113.166 -178.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1619 ' ' GLY . . . . . 0.447 ' C ' ' H ' ' A' 1621 ' ' THR . . . -154.63 -140.37 3.01 Favored Glycine 0 N--CA 1.43 -1.734 0 N-CA-C 108.431 -1.868 . . . . 0.93000000000000005 108.431 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.36 20.14 0.36 Allowed 'Trans proline' 0 N--CA 1.486 1.062 0 C-N-CA 122.904 2.402 . . . . 0.88 112.827 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1621 ' ' THR . . . . . 0.833 ' HB ' ' HB2' ' A' 1641 ' ' HIS . 56.9 p -91.18 -14.21 31.49 Favored 'General case' 0 C--N 1.292 -1.922 0 C-N-CA 124.86 1.264 . . . . 0.96999999999999997 108.975 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -87.93 68.26 9.22 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.963 -1.017 . . . . 0.71999999999999997 109.002 -174.498 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 3.5 ptp180 -167.38 139.33 2.64 Favored Pre-proline 0 C--N 1.317 -0.821 0 C-N-CA 124.435 1.094 . . . . 3.2599999999999998 108.561 179.378 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1624 ' ' PRO . . . . . 0.445 ' HA ' ' O ' ' A' 1639 ' ' SER . 37.5 Cg_endo -65.99 109.62 1.54 Allowed 'Trans proline' 0 C--O 1.238 0.522 0 C-N-CA 122.757 2.305 . . . . 0.58999999999999997 111.584 -179.304 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 72.3 mtm -113.74 140.87 47.91 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 116.467 -0.333 . . . . 1.3700000000000001 111.255 -178.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 1.8 tm? -78.48 119.78 22.27 Favored 'General case' 0 C--O 1.244 0.787 0 N-CA-C 107.358 -1.349 . . . . 0.89000000000000001 107.358 179.149 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1627 ' ' ILE . . . . . 0.706 HD11 ' HB2' ' A' 1639 ' ' SER . 42.3 mm -80.16 -55.28 9.17 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 N-CA-C 108.833 -0.803 . . . . 0.57999999999999996 108.833 178.448 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 22.7 t -173.82 158.4 3.23 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 106.933 -1.506 . . . . 1.3899999999999999 106.933 -177.495 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1629 ' ' LEU . . . . . 0.82 ' HG ' ' HG ' ' A' 1636 ' ' LEU . 3.4 tt -115.58 113.02 23.04 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 104.312 -2.477 . . . . 1.25 104.312 175.165 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 16.4 t70 -69.48 103.95 2.19 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 108.602 -0.888 . . . . 1.0900000000000001 108.602 176.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -61.94 -23.96 66.69 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 125.239 1.415 . . . . 3.6000000000000001 113.319 -172.385 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 90.2 mm-40 -86.13 -38.65 17.52 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 120.85 -0.34 . . . . 2.6000000000000001 111.533 -177.109 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 67.0 p -103.88 2.27 32.39 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 112.657 0.614 . . . . 0.75 112.657 -174.09 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1634 ' ' CYS . . . . . 0.483 ' SG ' HD23 ' A' 1604 ' ' LEU . 81.4 m 57.47 35.67 26.13 Favored 'General case' 0 C--N 1.369 1.425 0 C-N-CA 123.96 0.904 . . . . 0.53000000000000003 111.443 177.245 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1635 ' ' THR . . . . . 0.521 HG23 ' HE3' ' A' 1607 ' ' LYS . 90.8 m -107.85 126.86 53.17 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 115.155 -0.93 . . . . 0.46000000000000002 109.97 -176.794 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1636 ' ' LEU . . . . . 0.82 ' HG ' ' HG ' ' A' 1629 ' ' LEU . 0.8 OUTLIER -107.07 122.15 45.9 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 108.588 -0.893 . . . . 0.85999999999999999 108.588 -175.66 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -101.87 133.25 46.93 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 120.81 0.338 . . . . 0.45000000000000001 111.465 -178.002 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -129.25 145.07 51.42 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.67 -0.696 . . . . 0.5 109.895 -178.055 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1639 ' ' SER . . . . . 0.706 ' HB2' HD11 ' A' 1627 ' ' ILE . 8.4 t -125.9 157.34 37.95 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 109.567 -0.531 . . . . 1.04 109.567 177.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 3.2 t90 -156.58 108.41 2.48 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 104.923 -2.251 . . . . 0.68000000000000005 104.923 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1641 ' ' HIS . . . . . 0.833 ' HB2' ' HB ' ' A' 1621 ' ' THR . 26.0 m80 -101.5 104.53 15.45 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 109.283 -0.636 . . . . 0.90000000000000002 109.283 -178.254 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1642 ' ' THR . . . . . . . . . . . . . 3.2 t -133.64 150.11 73.93 Favored Pre-proline 0 C--N 1.3 -1.554 0 CA-C-N 115.186 -0.916 . . . . 0.47999999999999998 110.608 -171.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1643 ' ' PRO . . . . . 0.632 ' HG3' ' HB2' ' A' 1618 ' ' ALA . 7.6 Cg_exo -73.63 -7.36 20.1 Favored 'Trans proline' 0 C--N 1.385 2.463 0 C-N-CA 122.44 2.094 . . . . 0.66000000000000003 112.327 173.467 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 10.5 tt -66.95 -26.68 66.95 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.439 0.637 . . . . 0.96999999999999997 109.814 179.223 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -92.39 9.87 32.36 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.193 -0.912 . . . . 0.83999999999999997 109.82 179.116 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1646 ' ' CYS . . . . . 0.459 ' SG ' ' HA ' ' A' 1643 ' ' PRO . 72.9 m -111.86 146.92 36.85 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-N 115.958 -0.565 . . . . 1.1899999999999999 110.416 -178.323 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 31.2 tt0 . . . . . 0 N--CA 1.424 -1.739 0 N-CA-C 106.57 -1.641 . . . . 3.1400000000000001 106.57 173.432 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 10' ' ' GLY . . . . . 0.431 ' O ' HG12 ' B' ' 14' ' ' VAL . . . . . . . . 0 N--CA 1.431 -1.642 0 N-CA-C 111.301 -0.719 . . . . 2.0899999999999999 111.301 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -59.96 -67.09 2.32 Favored Glycine 0 CA--C 1.5 -0.871 0 CA-C-O 119.504 -0.609 . . . . 1.8400000000000001 113.069 -175.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -62.59 -29.14 70.38 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 117.371 0.585 . . . . 2.5499999999999998 110.886 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -59.38 -62.36 1.93 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.857 -0.61 . . . . 2.3500000000000001 111.879 177.191 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 14' ' ' VAL . . . . . 0.431 HG12 ' O ' ' B' ' 10' ' ' GLY . 10.9 p -69.45 -28.74 39.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 115.834 -0.621 . . . . 2.1099999999999999 110.494 -176.71 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 15' ' ' ASP . . . . . 0.521 ' OD2' ' HA ' ' A' 1570 ' ' THR . 31.7 t70 -70.71 -45.98 63.93 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 113.85 1.055 . . . . 2.04 113.85 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 20.3 p -63.95 -39.85 95.09 Favored 'General case' 0 C--O 1.275 2.422 0 CA-C-O 121.859 0.838 . . . . 1.8400000000000001 109.935 178.035 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.462 ' HB3' ' HB3' ' B' ' 26' ' ' PHE . 11.2 mp -59.52 -48.34 82.03 Favored 'General case' 0 N--CA 1.416 -2.15 0 CA-C-N 114.947 -1.024 . . . . 1.74 110.689 172.636 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 18' ' ' GLN . . . . . 0.459 ' HB2' ' HE2' ' B' ' 26' ' ' PHE . 26.8 tt0 -56.74 -29.47 62.56 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.499 0.72 . . . . 2.3900000000000001 111.942 174.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -58.1 -56.63 19.57 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-O 119.335 -0.365 . . . . 0.95999999999999996 111.374 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 10.3 p -99.71 -17.62 6.64 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.309 0 C-N-CA 117.557 -1.657 . . . . 1.3700000000000001 112.706 177.009 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 21' ' ' CYS . . . . . 0.591 ' HA ' ' HB3' ' B' ' 24' ' ' ARG . 58.9 m -112.22 30.77 6.78 Favored 'General case' 0 C--N 1.293 -1.849 0 O-C-N 121.717 -0.614 . . . . 1.6599999999999999 112.0 -176.689 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.19 -64.47 4.24 Favored Glycine 0 C--O 1.241 0.571 0 C-N-CA 120.347 -0.93 . . . . 1.53 111.762 177.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.44 ' HA ' ' HE2' ' A' 1544 ' ' LYS . 31.6 t70 -69.73 -34.8 74.35 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 122.674 0.39 . . . . 2.7200000000000002 111.086 175.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 24' ' ' ARG . . . . . 0.591 ' HB3' ' HA ' ' B' ' 21' ' ' CYS . 8.6 tpm_? -64.57 -35.74 81.96 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 124.24 1.016 . . . . 4.3300000000000001 112.399 -177.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.81 149.59 23.42 Favored Glycine 0 N--CA 1.423 -2.204 0 N-CA-C 110.853 -0.899 . . . . 1.53 110.853 -179.389 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 26' ' ' PHE . . . . . 0.462 ' HB3' ' HB3' ' B' ' 17' ' ' LEU . 0.3 OUTLIER -131.41 136.18 47.8 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 111.917 0.34 . . . . 1.6499999999999999 111.917 178.769 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -139.84 78.65 1.67 Allowed 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.785 -0.45 . . . . 3.4199999999999999 109.785 176.37 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 28' ' ' PHE . . . . . 0.556 ' O ' ' HA3' ' B' ' 41' ' ' GLY . 11.1 p90 . . . . . 0 C--N 1.311 -1.108 0 CA-C-O 121.794 0.807 . . . . 2.2599999999999998 109.102 178.597 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 41' ' ' GLY . . . . . 0.556 ' HA3' ' O ' ' B' ' 28' ' ' PHE . . . . . . . . 0 N--CA 1.398 -3.882 0 N-CA-C 106.337 -2.705 . . . . 2.3700000000000001 106.337 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 42' ' ' ILE . . . . . 0.471 ' HA ' ' HG2' ' B' ' 45' ' ' GLU . 31.2 pt 60.24 -8.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 C-N-CA 127.786 2.434 . . . . 2.0699999999999998 114.904 -179.439 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 9.8 p -62.48 -34.1 62.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 C-N-CA 123.301 0.64 . . . . 2.2400000000000002 112.42 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -84.07 -24.69 30.28 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 118.089 -1.444 . . . . 3.3599999999999999 108.803 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 45' ' ' GLU . . . . . 0.471 ' HG2' ' HA ' ' B' ' 42' ' ' ILE . 32.2 mm-40 -67.66 -62.39 1.44 Allowed 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.377 -0.829 . . . . 3.0800000000000001 109.154 -179.115 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 46' ' ' CYS . . . . . . . . . . . . . 21.1 m -76.39 -22.74 54.4 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 113.996 1.11 . . . . 2.23 113.996 -171.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 85.0 m -76.67 -1.66 28.9 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 121.201 -0.937 . . . . 2.3700000000000001 112.594 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -133.94 -47.57 0.79 Allowed 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 112.467 0.543 . . . . 2.8199999999999998 112.467 177.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 56.7 mtt-85 -104.53 168.9 8.78 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 120.889 0.375 . . . . 4.0899999999999999 110.029 178.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 37.1 t -90.95 109.98 21.22 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 107.629 -1.249 . . . . 2.6699999999999999 107.629 176.249 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 51' ' ' CYS . . . . . 0.545 ' HB2' HD23 ' B' ' 55' ' ' LEU . 21.8 p -90.93 135.48 33.71 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.851 -0.796 . . . . 2.1099999999999999 108.851 -177.249 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 52' ' ' ASP . . . . . 0.465 ' HA ' ' O ' ' A' 1599 ' ' PRO . 3.7 p30 -98.66 172.05 7.73 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 113.376 0.88 . . . . 2.6699999999999999 113.376 -176.429 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 53' ' ' LEU . . . . . 0.898 ' HB2' ' HA ' ' A' 1600 ' ' SER . 41.9 tp -51.12 -40.48 58.57 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 113.298 0.851 . . . . 1.8999999999999999 113.298 -174.355 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 54' ' ' ALA . . . . . 0.402 ' O ' HG22 ' B' ' 58' ' ' THR . . . -54.94 -46.39 74.95 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 123.623 0.577 . . . . 1.52 111.575 -172.703 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 55' ' ' LEU . . . . . 0.545 HD23 ' HB2' ' B' ' 51' ' ' CYS . 48.0 tp -62.49 -58.0 9.16 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 114.925 -1.034 . . . . 1.97 110.516 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 3.9 pp -69.11 -34.1 74.54 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 112.692 0.627 . . . . 1.53 112.692 -172.153 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -76.24 -40.37 52.18 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 112.204 0.446 . . . . 2.27 112.204 -179.07 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 58' ' ' THR . . . . . 0.402 HG22 ' O ' ' B' ' 54' ' ' ALA . 7.0 t -77.71 -11.52 59.88 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 118.653 -1.219 . . . . 2.3300000000000001 110.635 176.543 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 59' ' ' TYR . . . . . 0.465 ' OH ' ' HA2' ' B' ' 41' ' ' GLY . 17.6 t80 -85.59 -72.03 0.51 Allowed 'General case' 0 N--CA 1.426 -1.673 0 N-CA-C 106.477 -1.675 . . . . 2.8599999999999999 106.477 175.21 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 41.3 t . . . . . 0 C--O 1.253 1.245 0 C-N-CA 126.071 1.748 . . . . 2.2999999999999998 114.559 174.782 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 15.4 m-20 . . . . . 0 CA--C 1.509 -0.625 0 N-CA-C 111.687 0.254 . . . . 2.8999999999999999 111.687 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A 1516 ' ' CYS . . . . . 0.604 ' HA ' ' HB2' ' A' 1581 ' ' LEU . 59.8 m 56.34 41.49 28.98 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-O 121.267 0.556 . . . . 1.1899999999999999 110.951 -177.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -150.77 130.11 12.86 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 108.884 -0.784 . . . . 1.52 108.884 -179.286 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1518 ' ' VAL . . . . . 0.433 HG21 ' HB2' ' A' 1583 ' ' TYR . 3.3 m -136.03 138.22 47.66 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 O-C-N 124.13 0.894 . . . . 0.93999999999999995 110.47 -177.313 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1519 ' ' THR . . . . . . . . . . . . . 44.2 m -104.8 136.13 44.89 Favored 'General case' 0 C--N 1.281 -2.397 0 N-CA-C 107.612 -1.255 . . . . 0.89000000000000001 107.612 175.034 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1520 ' ' ASN . . . . . 0.477 ' OD1' ' HB2' ' A' 1522 ' ' SER . 21.3 t-20 -91.23 115.76 65.06 Favored Pre-proline 0 C--N 1.287 -2.126 0 N-CA-C 108.816 -0.809 . . . . 1.74 108.816 174.513 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -66.34 -15.52 48.37 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.998 2.465 . . . . 1.5800000000000001 113.713 -176.338 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1522 ' ' SER . . . . . 0.477 ' HB2' ' OD1' ' A' 1520 ' ' ASN . 30.2 m -75.98 -44.76 38.2 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 111.772 0.286 . . . . 1.6499999999999999 111.772 -179.142 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1523 ' ' THR . . . . . 0.463 HG22 ' OD1' ' A' 1520 ' ' ASN . 11.1 t -118.44 -1.26 11.27 Favored 'General case' 0 CA--C 1.556 1.178 0 CA-C-O 121.506 0.669 . . . . 1.6100000000000001 112.092 -175.131 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 67.3 33.66 83.1 Favored Glycine 0 CA--C 1.503 -0.718 0 CA-C-N 115.829 -0.623 . . . . 1.1299999999999999 112.937 176.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -98.68 121.9 41.22 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 109.626 -0.509 . . . . 1.26 109.626 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 1.9 tm? -94.12 111.84 23.6 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.208 -0.905 . . . . 0.68000000000000005 108.804 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1527 ' ' PHE . . . . . 0.416 ' CE1' ' HA ' ' A' 1645 ' ' ALA . 85.0 m-85 -83.48 114.57 21.57 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 120.676 0.274 . . . . 0.65000000000000002 111.445 174.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 22.4 t70 -102.91 101.13 11.14 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.112 -1.07 . . . . 1.1699999999999999 108.112 176.121 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1529 ' ' LEU . . . . . 0.477 ' HG ' HD21 ' A' 1581 ' ' LEU . 4.2 mm? -83.88 -7.91 59.32 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 116.294 -0.412 . . . . 0.59999999999999998 110.823 -177.017 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1530 ' ' SER . . . . . 0.597 ' HA ' ' OG ' ' A' 1533 ' ' SER . 17.1 m -66.48 -16.79 64.39 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.913 -0.585 . . . . 0.83999999999999997 111.369 178.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 41.2 t -67.32 -29.06 68.53 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 109.327 -0.62 . . . . 1.5900000000000001 109.327 173.203 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 81.3 mt -96.93 -10.33 26.58 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 116.451 -0.341 . . . . 0.65000000000000002 111.061 -176.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1533 ' ' SER . . . . . 0.597 ' OG ' ' HA ' ' A' 1530 ' ' SER . 19.0 m -61.74 154.89 24.3 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.33 0.586 . . . . 1.52 110.718 178.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -171.13 131.2 2.14 Favored Glycine 0 C--N 1.286 -2.223 0 N-CA-C 109.443 -1.463 . . . . 1.1000000000000001 109.443 -177.131 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1535 ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' 1535 ' ' ARG . 24.3 ttt180 -92.47 -34.49 14.08 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 112.337 0.495 . . . . 4.6200000000000001 112.337 -172.665 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -59.7 -57.1 14.41 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.524 0.678 . . . . 1.45 110.571 -178.482 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 130.53 164.13 11.21 Favored Glycine 0 N--CA 1.409 -3.122 0 CA-C-N 115.433 -0.803 . . . . 0.84999999999999998 111.999 173.204 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -120.51 138.91 53.58 Favored 'General case' 0 C--N 1.276 -2.617 0 N-CA-C 106.804 -1.554 . . . . 0.93000000000000005 106.804 178.229 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 28.1 p -108.79 123.69 49.43 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 123.499 0.499 . . . . 1.03 110.783 -179.234 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1540 ' ' ALA . . . . . 0.445 ' HB3' ' CG1' ' A' 1548 ' ' VAL . . . -114.73 138.98 50.07 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 108.423 -0.955 . . . . 0.5 108.423 177.216 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -75.11 140.16 43.24 Favored 'General case' 0 CA--C 1.502 -0.872 0 O-C-N 123.93 0.769 . . . . 0.73999999999999999 110.188 -177.207 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1542 ' ' TYR . . . . . 0.629 ' HE2' HD13 ' A' 1626 ' ' LEU . 1.7 t80 -152.53 -100.87 0.05 Allowed 'General case' 0 N--CA 1.424 -1.769 0 CA-C-N 115.954 -0.566 . . . . 0.98999999999999999 110.25 -176.049 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1543 ' ' SER . . . . . . . . . . . . . 12.6 m -70.44 156.24 39.62 Favored 'General case' 0 N--CA 1.428 -1.544 0 C-N-CA 123.731 0.812 . . . . 1.9099999999999999 109.735 -176.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 27.5 tptp -62.65 -22.07 66.16 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 125.502 1.521 . . . . 3.5899999999999999 111.34 -173.618 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 34.3 t -137.94 37.65 2.37 Favored 'General case' 0 N--CA 1.427 -1.589 0 CA-C-N 115.746 -0.661 . . . . 2.46 109.6 -178.17 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1546 ' ' GLY . . . . . 0.54 ' HA3' ' HG2' ' A' 1569 ' ' GLN . . . -176.42 129.56 1.52 Allowed Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 119.025 -1.56 . . . . 1.26 113.974 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 35.9 m -102.75 162.68 3.76 Favored 'Isoleucine or valine' 0 C--O 1.251 1.175 0 N-CA-C 108.806 -0.812 . . . . 0.79000000000000004 108.806 175.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1548 ' ' VAL . . . . . 0.474 ' HA ' ' HA ' ' A' 1567 ' ' PHE . 13.6 p -101.4 132.3 47.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 109.618 -0.512 . . . . 0.57999999999999996 109.618 178.297 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -97.8 126.03 42.95 Favored 'General case' 0 CA--C 1.494 -1.202 0 C-N-CA 123.695 0.798 . . . . 1.0800000000000001 109.435 177.142 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 24.0 ptm -139.2 135.48 34.02 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.311 -0.858 . . . . 0.78000000000000003 111.42 -178.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 74.8 m -124.15 134.72 53.25 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.379 -0.828 . . . . 0.96999999999999997 109.42 175.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1552 ' ' ILE . . . . . . . . . . . . . 46.4 mm -88.19 121.82 39.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 116.281 -0.418 . . . . 0.41999999999999998 111.385 -175.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 34.0 t 66.04 25.35 10.92 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.615 1.166 . . . . 1.3999999999999999 111.632 173.331 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . -167.51 174.99 42.63 Favored Glycine 0 N--CA 1.418 -2.552 0 N-CA-C 109.323 -1.511 . . . . 0.34999999999999998 109.323 -179.214 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -95.63 155.94 16.53 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.081 0.467 . . . . 1.6200000000000001 110.558 -178.319 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -104.25 134.84 46.8 Favored 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 107.258 -1.386 . . . . 0.87 107.258 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -95.93 7.96 44.94 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 112.943 0.719 . . . . 2.4900000000000002 112.943 -172.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -83.04 -13.91 54.92 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.786 0.803 . . . . 1.3799999999999999 109.533 177.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1559 ' ' CYS . . . . . 0.739 ' SG ' ' HD2' ' A' 1560 ' ' PRO . 9.3 t -131.89 162.16 58.2 Favored Pre-proline 0 C--N 1.293 -1.864 0 N-CA-C 106.039 -1.838 . . . . 1.21 106.039 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1560 ' ' PRO . . . . . 0.739 ' HD2' ' SG ' ' A' 1559 ' ' CYS . 41.8 Cg_exo -28.9 145.81 0.02 OUTLIER 'Trans proline' 0 CA--C 1.565 2.064 1 C-N-CA 125.301 4.001 . . . . 0.70999999999999996 116.563 175.602 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.28 128.07 27.2 Favored 'Trans proline' 0 C--O 1.245 0.849 0 C-N-CA 123.56 2.84 . . . . 0.80000000000000004 112.283 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 102.61 -9.73 55.74 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 116.139 -0.482 . . . . 0.46000000000000002 112.354 -179.121 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1563 ' ' VAL . . . . . 0.537 HG11 ' HB2' ' A' 1566 ' ' CYS . 3.0 t -79.46 125.38 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 N-CA-C 112.665 0.617 . . . . 0.97999999999999998 112.665 -178.804 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -98.6 -36.18 4.66 Favored Glycine 0 C--N 1.315 -0.616 0 CA-C-N 115.338 -0.847 . . . . 0.28000000000000003 111.518 176.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -132.18 128.18 37.47 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 109.332 -0.618 . . . . 0.28000000000000003 109.332 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1566 ' ' CYS . . . . . 0.537 ' HB2' HG11 ' A' 1563 ' ' VAL . 42.2 t -157.27 139.34 14.41 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 110.197 -0.297 . . . . 0.42999999999999999 110.197 -177.032 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1567 ' ' PHE . . . . . 0.474 ' HA ' ' HA ' ' A' 1548 ' ' VAL . 37.8 m-85 -84.96 143.83 28.71 Favored 'General case' 0 C--O 1.245 0.846 0 N-CA-C 109.577 -0.527 . . . . 1.03 109.577 174.437 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -87.38 17.34 44.03 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.865 -0.683 . . . . 1.1299999999999999 112.75 -175.402 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1569 ' ' GLN . . . . . 0.61 ' HB3' ' OD1' ' B' ' 15' ' ' ASP . 27.3 mt-30 -70.22 -69.97 0.32 Allowed 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 122.257 0.223 . . . . 2.5800000000000001 110.507 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 13.8 t -130.41 29.74 4.81 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-O 121.604 0.716 . . . . 2.1699999999999999 110.82 173.36 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 7.7 mmt180 65.29 55.17 1.1 Allowed 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 114.83 -1.077 . . . . 2.6200000000000001 109.83 178.472 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 29.6 mt -95.97 115.74 35.95 Favored 'Isoleucine or valine' 0 C--O 1.246 0.907 0 CA-C-N 114.413 -1.267 . . . . 0.92000000000000004 108.83 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 29.6 t -85.17 140.71 30.71 Favored 'General case' 0 C--O 1.245 0.855 0 CA-C-O 121.575 0.702 . . . . 0.80000000000000004 110.845 -176.165 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1574 ' ' VAL . . . . . 0.628 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 35.7 m -126.2 15.49 3.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 CA-C-N 115.523 -0.762 . . . . 0.97999999999999998 110.954 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 170.1 129.27 1.09 Allowed Glycine 0 N--CA 1.424 -2.154 0 C-N-CA 119.14 -1.505 . . . . 0.28999999999999998 112.812 177.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 86.8 tttt -77.9 142.95 38.1 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 108.277 -1.009 . . . . 2.1899999999999999 108.277 176.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -73.78 91.49 1.94 Allowed 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 123.036 0.534 . . . . 0.60999999999999999 110.883 -178.216 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -109.85 171.63 7.33 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 108.273 -1.01 . . . . 1.95 108.273 178.058 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 62.3 mttp -124.05 44.61 2.69 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.688 -0.856 . . . . 2.6800000000000002 108.688 -177.191 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 43.6 ttp180 -86.92 77.88 9.14 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 114.904 -1.044 . . . . 3.4700000000000002 109.622 -177.019 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1581 ' ' LEU . . . . . 0.604 ' HB2' ' HA ' ' A' 1516 ' ' CYS . 0.5 OUTLIER -84.33 123.06 29.76 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.602 -1.181 . . . . 0.64000000000000001 108.976 -179.053 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -126.35 140.37 52.56 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 110.108 -0.33 . . . . 2.8500000000000001 110.108 173.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1583 ' ' TYR . . . . . 0.433 ' HB2' HG21 ' A' 1518 ' ' VAL . 51.0 t80 -106.35 111.63 24.3 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 108.975 -0.75 . . . . 0.85999999999999999 108.975 177.089 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1584 ' ' VAL . . . . . 0.613 ' O ' ' HB ' ' A' 1587 ' ' VAL . 6.8 m -130.01 95.72 2.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 112.289 0.477 . . . . 1.05 112.289 -178.529 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 37.0 t70 57.99 65.81 1.23 Allowed 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 121.774 0.797 . . . . 1.1699999999999999 111.929 174.442 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1586 ' ' GLN . . . . . . . . . . . . 0.254 30.2 pt20 60.67 20.72 10.68 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 127.021 2.128 . . . . 1.8600000000000001 111.847 177.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1587 ' ' VAL . . . . . 0.613 ' HB ' ' O ' ' A' 1584 ' ' VAL . 18.3 t -117.32 121.0 66.64 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.606 0 CA-C-N 113.593 -1.64 . . . . 0.48999999999999999 109.922 176.497 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1588 ' ' LEU . . . . . 0.838 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 2.7 mm? -95.59 115.58 27.63 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 106.061 -1.829 . . . . 0.35999999999999999 106.061 175.282 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1589 ' ' GLN . . . . . 0.424 ' HA ' ' O ' ' A' 1610 ' ' ILE . 29.8 tt0 -118.01 126.44 52.31 Favored 'General case' 0 C--N 1.277 -2.558 0 C-N-CA 119.844 -0.743 . . . . 1.74 112.445 -174.522 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 11.9 mt -114.0 117.41 31.25 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 125.414 1.486 . . . . 0.71999999999999997 107.043 175.251 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 26.9 t -104.88 128.89 58.26 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 C-N-CA 119.734 -0.786 . . . . 1.01 109.62 -178.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1592 ' ' TYR . . . . . 0.554 ' HB2' ' HB3' ' A' 1608 ' ' SER . 14.4 m-30 -117.58 96.13 5.26 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.901 -0.777 . . . . 0.5 108.901 178.166 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 38.8 pttt -111.4 175.62 5.35 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.823 -0.751 . . . . 1.5900000000000001 109.876 177.267 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 33.3 m-20 67.48 60.23 0.48 Allowed 'General case' 0 CA--C 1.502 -0.889 0 C-N-CA 124.318 1.047 . . . . 1.1100000000000001 110.904 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -91.11 -104.74 1.34 Allowed Glycine 0 N--CA 1.424 -2.153 0 N-CA-C 109.469 -1.452 . . . . 0.78000000000000003 109.469 177.35 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1596 ' ' SER . . . . . . . . . . . . . 48.4 m -120.69 156.16 56.35 Favored Pre-proline 0 C--N 1.286 -2.172 0 N-CA-C 107.697 -1.223 . . . . 1.0700000000000001 107.697 175.543 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -53.94 120.92 8.7 Favored 'Trans proline' 0 C--N 1.357 0.991 0 C-N-CA 122.927 2.418 . . . . 1.01 110.276 173.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1598 ' ' CYS . . . . . 0.476 ' HA ' ' HD3' ' A' 1599 ' ' PRO . 48.9 t -79.8 126.42 80.25 Favored Pre-proline 0 C--N 1.28 -2.453 0 CA-C-N 114.385 -1.279 . . . . 0.75 110.578 -175.53 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1599 ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' 1598 ' ' CYS . 12.2 Cg_exo -73.52 -15.72 24.55 Favored 'Trans proline' 0 C--O 1.212 -0.784 0 C-N-CA 122.942 2.428 . . . . 1.7 112.051 177.314 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1600 ' ' SER . . . . . 0.688 ' HA ' ' HB2' ' B' ' 53' ' ' LEU . 15.4 m -65.77 -31.85 73.06 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-O 120.67 0.271 . . . . 2.2599999999999998 111.416 177.483 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1601 ' ' LYS . . . . . 0.445 ' HA ' ' HB2' ' B' ' 52' ' ' ASP . 22.9 ttmm -150.62 120.74 7.22 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 108.084 -1.08 . . . . 3.0099999999999998 108.084 175.374 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 8.0 m -59.02 123.54 16.93 Favored 'General case' 0 N--CA 1.428 -1.548 0 C-N-CA 124.241 1.017 . . . . 2.0699999999999998 112.707 -171.454 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 84.06 23.18 53.02 Favored Glycine 0 CA--C 1.499 -0.961 0 CA-C-N 116.167 -0.47 . . . . 1.0800000000000001 112.482 175.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1604 ' ' LEU . . . . . 0.476 HD23 ' SG ' ' A' 1634 ' ' CYS . 11.5 tp -119.67 165.93 13.86 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 106.854 -1.535 . . . . 1.8400000000000001 106.854 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 22.9 t -124.82 154.37 41.1 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.628 -0.878 . . . . 1.4099999999999999 108.628 -177.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1606 ' ' TYR . . . . . 0.628 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 58.1 m-85 -74.86 163.58 27.5 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 116.011 -0.541 . . . . 0.59999999999999998 109.892 176.273 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -160.33 128.26 4.61 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-N 116.338 -0.392 . . . . 1.45 109.944 -176.488 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1608 ' ' SER . . . . . 0.554 ' HB3' ' HB2' ' A' 1592 ' ' TYR . 34.5 t -104.95 126.3 51.87 Favored 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 108.447 -0.946 . . . . 1.1499999999999999 108.447 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 25.8 t -110.61 99.21 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.66 0 N-CA-C 107.864 -1.161 . . . . 0.25 107.864 177.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1610 ' ' ILE . . . . . 0.424 ' O ' ' HA ' ' A' 1589 ' ' GLN . 77.1 mt -90.29 120.64 39.47 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 CA-C-N 115.014 -0.994 . . . . 0.45000000000000001 108.917 -177.377 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 43.9 m -124.67 123.97 41.18 Favored 'General case' 0 C--N 1.287 -2.11 0 CA-C-N 115.863 -0.608 . . . . 1.26 112.025 -178.429 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1612 ' ' PHE . . . . . 0.838 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 75.5 m-85 -97.97 123.14 41.83 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.42 -0.956 . . . . 0.26000000000000001 108.42 176.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 44.7 t -113.51 134.96 54.6 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 O-C-N 123.589 0.556 . . . . 0.5 110.621 -174.27 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -54.07 112.56 0.99 Allowed 'General case' 0 C--O 1.241 0.623 0 C-N-CA 124.265 1.026 . . . . 0.77000000000000002 111.679 175.054 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1615 ' ' ARG . . . . . 0.549 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 23.0 tpt180 -126.0 88.95 53.35 Favored Pre-proline 0 N--CA 1.443 -0.798 0 N-CA-C 107.881 -1.155 . . . . 2.5299999999999998 107.881 174.11 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1616 ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -72.57 -19.59 24.45 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 122.341 2.027 . . . . 1.1000000000000001 113.325 -174.055 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -87.29 -10.8 51.39 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.612 -0.267 . . . . 3.0499999999999998 111.552 179.018 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . 63.05 -172.53 0.16 Allowed 'General case' 0 CA--C 1.546 0.794 0 O-C-N 123.904 0.753 . . . . 1.55 109.087 -172.483 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . 147.64 -165.27 28.78 Favored Glycine 0 N--CA 1.424 -2.107 0 C-N-CA 120.292 -0.956 . . . . 0.93000000000000005 112.565 175.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -87.23 19.14 1.43 Allowed 'Trans proline' 0 C--O 1.237 0.45 0 C-N-CA 123.614 2.876 . . . . 0.88 113.726 -174.635 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1621 ' ' THR . . . . . . . . . . . . . 24.1 p -114.62 12.46 17.22 Favored 'General case' 0 C--N 1.285 -2.212 0 CA-C-O 122.173 0.987 . . . . 0.96999999999999997 109.744 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -89.55 66.71 7.38 Favored 'General case' 0 C--O 1.246 0.92 0 N-CA-C 106.682 -1.599 . . . . 0.71999999999999997 106.682 178.12 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1623 ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' 1623 ' ' ARG . 3.4 ptm180 -170.5 140.79 1.52 Allowed Pre-proline 0 N--CA 1.428 -1.531 0 N-CA-C 106.849 -1.538 . . . . 3.2599999999999998 106.849 -173.325 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -57.63 107.56 0.31 Allowed 'Trans proline' 0 CA--C 1.545 1.058 0 C-N-CA 122.511 2.141 . . . . 0.58999999999999997 111.571 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 81.4 mtp -114.18 148.08 37.85 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.576 -0.898 . . . . 1.3700000000000001 108.576 -178.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1626 ' ' LEU . . . . . 0.629 HD13 ' HE2' ' A' 1542 ' ' TYR . 7.2 tt -101.9 138.31 39.04 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.132 -0.692 . . . . 0.89000000000000001 109.132 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1627 ' ' ILE . . . . . 0.809 HD11 ' HB2' ' A' 1639 ' ' SER . 38.4 mm -85.09 -63.09 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.214 -0.812 0 CA-C-N 115.375 -0.829 . . . . 0.57999999999999996 109.701 -178.069 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 52.2 m -161.88 152.11 17.08 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 106.897 -1.52 . . . . 1.3899999999999999 106.897 -176.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1629 ' ' LEU . . . . . 0.627 HD13 ' HG ' ' A' 1636 ' ' LEU . 44.4 tp -105.42 110.3 22.59 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 107.885 -1.154 . . . . 1.25 107.885 175.105 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 18.6 t70 -82.75 95.41 7.86 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 118.388 -1.325 . . . . 1.0900000000000001 107.651 175.456 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 21.8 pttm -76.14 7.24 4.35 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 114.739 -1.119 . . . . 3.6000000000000001 113.467 -174.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -95.68 -45.0 7.2 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 108.794 -0.817 . . . . 2.6000000000000001 108.794 173.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 73.5 p -96.92 -1.68 45.31 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-N 115.368 -0.833 . . . . 0.75 111.342 -177.238 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1634 ' ' CYS . . . . . 0.585 ' SG ' ' HB2' ' A' 1600 ' ' SER . 74.7 m 60.73 35.04 19.78 Favored 'General case' 0 C--N 1.364 1.196 0 C-N-CA 124.043 0.937 . . . . 0.53000000000000003 110.746 178.146 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1635 ' ' THR . . . . . . . . . . . . . 57.2 m -105.96 128.56 53.89 Favored 'General case' 0 N--CA 1.418 -2.029 0 CA-C-N 114.973 -1.012 . . . . 0.46000000000000002 109.987 -176.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1636 ' ' LEU . . . . . 0.627 ' HG ' HD13 ' A' 1629 ' ' LEU . 0.9 OUTLIER -110.11 119.57 39.7 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 108.223 -1.028 . . . . 0.85999999999999999 108.223 -177.376 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -99.52 129.18 45.67 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 116.293 -0.412 . . . . 0.45000000000000001 110.257 -177.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -126.26 143.41 51.16 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.838 -0.619 . . . . 0.5 109.833 -178.551 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1639 ' ' SER . . . . . 0.809 ' HB2' HD11 ' A' 1627 ' ' ILE . 23.0 t -124.39 159.97 29.22 Favored 'General case' 0 C--N 1.31 -1.13 0 C-N-CA 124.284 1.033 . . . . 1.04 108.524 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 2.9 t90 -156.71 111.75 2.84 Favored 'General case' 0 N--CA 1.418 -2.073 0 N-CA-C 104.26 -2.496 . . . . 0.68000000000000005 104.26 179.084 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1641 ' ' HIS . . . . . 0.549 ' HB3' ' HB2' ' A' 1615 ' ' ARG . 62.2 m-70 -97.63 110.01 22.65 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 108.926 -0.768 . . . . 0.90000000000000002 108.926 -177.766 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1642 ' ' THR . . . . . . . . . . . . . 4.6 t -139.11 148.69 58.41 Favored Pre-proline 0 C--N 1.292 -1.931 0 CA-C-N 115.302 -0.863 . . . . 0.47999999999999998 110.869 -171.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1643 ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -78.36 -6.17 15.4 Favored 'Trans proline' 0 C--N 1.364 1.39 0 C-N-CA 122.467 2.111 . . . . 0.66000000000000003 112.168 176.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 7.3 tt -68.41 -31.04 70.09 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 108.915 -0.772 . . . . 0.96999999999999997 108.915 176.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1645 ' ' ALA . . . . . 0.416 ' HA ' ' CE1' ' A' 1527 ' ' PHE . . . -86.08 4.08 39.69 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.195 -0.911 . . . . 0.83999999999999997 111.284 -174.266 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 1.3 t -123.69 144.09 49.86 Favored 'General case' 0 N--CA 1.424 -1.77 0 C-N-CA 119.263 -0.975 . . . . 1.1899999999999999 110.403 -178.375 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.302 -1.468 0 C-N-CA 122.554 0.342 . . . . 3.1400000000000001 110.182 174.269 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 10' ' ' GLY . . . . . 0.489 ' O ' HG12 ' B' ' 14' ' ' VAL . . . . . . . . 0 N--CA 1.424 -2.11 0 N-CA-C 111.005 -0.838 . . . . 2.0899999999999999 111.005 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -52.07 -55.11 22.94 Favored Glycine 0 N--CA 1.464 0.518 0 N-CA-C 115.344 0.898 . . . . 1.8400000000000001 115.344 -174.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -78.36 -30.65 48.13 Favored 'General case' 0 CA--C 1.499 -0.998 0 CA-C-N 117.013 0.407 . . . . 2.5499999999999998 110.3 -177.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 13' ' ' LEU . . . . . 0.562 ' O ' HD23 ' B' ' 17' ' ' LEU . 0.8 OUTLIER -58.16 -62.05 2.11 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-N 115.489 -0.778 . . . . 2.3500000000000001 111.288 178.669 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 14' ' ' VAL . . . . . 0.489 HG12 ' O ' ' B' ' 10' ' ' GLY . 14.2 p -64.72 -29.18 46.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-N 116.107 -0.497 . . . . 2.1099999999999999 111.244 -177.387 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 15' ' ' ASP . . . . . 0.61 ' OD1' ' HB3' ' A' 1569 ' ' GLN . 33.6 t70 -73.83 -37.95 64.69 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 113.11 0.782 . . . . 2.04 113.11 178.758 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 14.8 t -69.85 -32.17 70.41 Favored 'General case' 0 C--O 1.254 1.306 0 CA-C-N 119.432 1.014 . . . . 1.8400000000000001 109.485 175.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.562 HD23 ' O ' ' B' ' 13' ' ' LEU . 3.8 mm? -56.12 -44.28 78.98 Favored 'General case' 0 C--O 1.208 -1.118 0 CA-C-N 115.431 -0.804 . . . . 1.74 108.995 169.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -77.18 -21.72 53.53 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.27 -0.877 . . . . 2.3900000000000001 112.006 -178.437 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -64.35 -56.67 12.85 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 116.349 -0.387 . . . . 0.95999999999999996 110.239 178.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 15.0 p -98.66 -20.93 5.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 118.519 -1.273 . . . . 1.3700000000000001 112.555 -177.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 21' ' ' CYS . . . . . 0.608 ' HB2' ' HB3' ' B' ' 26' ' ' PHE . 64.0 m -105.2 19.24 20.94 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 119.445 -0.902 . . . . 1.6599999999999999 110.758 179.759 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.67 -56.58 24.49 Favored Glycine 0 C--N 1.31 -0.888 0 C-N-CA 120.382 -0.913 . . . . 1.53 112.254 178.338 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -70.34 -38.08 74.79 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.783 0.325 . . . . 2.7200000000000002 111.307 177.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 43.2 ttp180 -72.68 -39.02 67.39 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 113.888 1.069 . . . . 4.3300000000000001 113.888 -176.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 112.09 112.87 3.26 Favored Glycine 0 N--CA 1.429 -1.77 0 N-CA-C 109.157 -1.577 . . . . 1.53 109.157 -175.13 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 26' ' ' PHE . . . . . 0.608 ' HB3' ' HB2' ' B' ' 21' ' ' CYS . 39.8 p90 -92.2 134.73 34.6 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 120.696 -0.402 . . . . 1.6499999999999999 110.895 -178.553 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -148.35 116.72 6.54 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.984 -0.747 . . . . 3.4199999999999999 108.984 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 28' ' ' PHE . . . . . . . . . . . . . 43.3 p90 . . . . . 0 CA--C 1.547 0.836 0 C-N-CA 120.521 -0.472 . . . . 2.2599999999999998 111.909 175.528 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.426 -1.987 0 N-CA-C 110.236 -1.146 . . . . 2.3700000000000001 110.236 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 42' ' ' ILE . . . . . 0.543 HD11 HD21 ' B' ' 17' ' ' LEU . 15.0 pt 59.87 -33.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 C-N-CA 128.097 2.559 . . . . 2.0699999999999998 116.731 176.198 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.498 ' O ' ' HB2' ' B' ' 47' ' ' CYS . 2.7 p -52.57 -41.38 36.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 113.55 0.944 . . . . 2.2400000000000002 113.55 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -94.72 -31.0 13.99 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 108.574 -0.899 . . . . 3.3599999999999999 108.574 -174.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 45' ' ' GLU . . . . . 0.401 ' HB3' ' HA ' ' B' ' 42' ' ' ILE . 8.3 tp10 -56.92 -50.97 70.96 Favored 'General case' 0 C--O 1.206 -1.194 0 CA-C-N 115.35 -0.841 . . . . 3.0800000000000001 109.638 174.414 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 46' ' ' CYS . . . . . 0.541 ' HB3' HD21 ' B' ' 13' ' ' LEU . 9.1 t -89.96 2.46 55.08 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.524 0.678 . . . . 2.23 111.17 -175.592 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 47' ' ' CYS . . . . . 0.498 ' HB2' ' O ' ' B' ' 43' ' ' VAL . 45.6 t -85.61 -52.41 5.83 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 116.331 -0.395 . . . . 2.3700000000000001 110.459 177.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -104.59 13.02 32.37 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.289 0.566 . . . . 2.8199999999999998 111.571 -175.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 49' ' ' ARG . . . . . 0.401 ' HB2' ' O ' ' B' ' 45' ' ' GLU . 28.7 mtp85 -155.86 -170.11 3.3 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 125.64 1.576 . . . . 4.0899999999999999 107.477 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 21.3 t -121.9 129.13 52.31 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 109.188 -0.671 . . . . 2.6699999999999999 109.188 -176.065 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 51' ' ' CYS . . . . . 0.413 ' HB3' ' HB2' ' B' ' 46' ' ' CYS . 26.7 p -99.71 149.89 22.86 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.943 -0.762 . . . . 2.1099999999999999 108.943 -177.101 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 52' ' ' ASP . . . . . 0.445 ' HB2' ' HA ' ' A' 1601 ' ' LYS . 3.0 p-10 -116.57 174.62 5.97 Favored 'General case' 0 C--O 1.251 1.164 0 C-N-CA 120.348 -0.541 . . . . 2.6699999999999999 110.829 170.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 53' ' ' LEU . . . . . 0.688 ' HB2' ' HA ' ' A' 1600 ' ' SER . 34.3 tp -54.61 -43.13 71.93 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 113.342 0.867 . . . . 1.8999999999999999 113.342 -173.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 54' ' ' ALA . . . . . 0.408 ' O ' HG22 ' B' ' 58' ' ' THR . . . -55.39 -31.82 62.13 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.225 0.61 . . . . 1.52 112.341 -171.311 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 61.9 tp -72.41 -58.08 3.67 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 115.491 -0.777 . . . . 1.97 110.244 179.2 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 2.0 pp -70.2 -32.18 69.98 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 111.827 0.306 . . . . 1.53 111.827 -175.245 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -60.61 -48.54 81.33 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 116.291 -0.413 . . . . 2.27 111.262 179.32 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 58' ' ' THR . . . . . 0.408 HG22 ' O ' ' B' ' 54' ' ' ALA . 6.4 t -88.37 -8.7 54.63 Favored 'General case' 0 CA--C 1.569 1.697 0 CA-C-O 120.867 0.365 . . . . 2.3300000000000001 111.895 -177.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 16.7 t80 -95.05 -33.4 12.72 Favored 'General case' 0 N--CA 1.441 -0.878 0 O-C-N 121.291 -0.88 . . . . 2.8599999999999999 109.839 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 60' ' ' CYS . . . . . 0.545 ' SG ' ' HA ' ' B' ' 26' ' ' PHE . 38.8 t . . . . . 0 C--O 1.255 1.391 0 CA-C-N 115.783 -0.644 . . . . 2.2999999999999998 110.963 -176.433 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1515 ' ' ASP . . . . . 0.438 ' O ' ' HB2' ' A' 1581 ' ' LEU . 17.5 m-20 . . . . . 0 CA--C 1.497 -1.064 0 N-CA-C 108.88 -0.785 . . . . 2.8999999999999999 108.88 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1516 ' ' CYS . . . . . 0.798 ' HB3' ' HB2' ' A' 1529 ' ' LEU . 83.0 m -126.46 46.58 2.43 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 107.048 -1.464 . . . . 1.1899999999999999 107.048 176.829 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1517 ' ' GLN . . . . . 0.482 ' HA ' ' O ' ' A' 1527 ' ' PHE . 14.0 pt20 -151.72 133.92 15.18 Favored 'General case' 0 N--CA 1.425 -1.712 0 CA-C-N 114.836 -1.074 . . . . 1.52 109.483 -175.791 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1518 ' ' VAL . . . . . 0.511 HG21 ' HB2' ' A' 1583 ' ' TYR . 2.3 m -150.26 136.96 12.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 C-N-CA 124.361 1.064 . . . . 0.93999999999999995 109.497 175.837 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1519 ' ' THR . . . . . . . . . . . . . 43.4 m -111.81 134.51 53.33 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 108.797 -0.816 . . . . 0.89000000000000001 108.797 178.008 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -90.38 124.13 63.69 Favored Pre-proline 0 C--N 1.298 -1.647 0 N-CA-C 109.184 -0.673 . . . . 1.74 109.184 176.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -68.8 -15.69 40.89 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 123.072 2.515 . . . . 1.5800000000000001 113.725 -174.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 22.5 m -80.62 -50.45 9.95 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-O 120.593 0.235 . . . . 1.6499999999999999 111.478 -177.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1523 ' ' THR . . . . . . . . . . . . . 5.6 t -103.96 -11.75 17.25 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 119.878 -0.729 . . . . 1.6100000000000001 111.867 -176.387 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 75.09 25.92 67.74 Favored Glycine 0 CA--C 1.506 -0.529 0 CA-C-N 116.275 -0.42 . . . . 1.1299999999999999 112.639 177.33 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 84.8 t60 -92.81 127.4 38.3 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 120.487 -0.485 . . . . 1.26 110.424 -177.657 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 2.0 tm? -92.71 110.93 22.37 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 114.444 -1.253 . . . . 0.68000000000000005 108.354 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1527 ' ' PHE . . . . . 0.482 ' O ' ' HA ' ' A' 1517 ' ' GLN . 93.3 m-85 -85.07 119.55 25.59 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 120.463 -0.495 . . . . 0.65000000000000002 109.723 173.678 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 24.1 t70 -115.39 114.21 24.8 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.44 -0.8 . . . . 1.1699999999999999 109.417 178.442 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1529 ' ' LEU . . . . . 0.798 ' HB2' ' HB3' ' A' 1516 ' ' CYS . 2.8 mm? -102.41 -0.83 31.91 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 108.849 -0.797 . . . . 0.59999999999999998 108.849 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -68.59 -32.35 72.19 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.627 0.727 . . . . 0.83999999999999997 109.16 -178.268 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 31.5 t -64.81 -12.7 50.84 Favored 'General case' 0 CA--C 1.554 1.123 0 CA-C-N 114.881 -1.054 . . . . 1.5900000000000001 110.858 177.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 90.5 mt -92.77 -3.13 55.27 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 122.02 -0.425 . . . . 0.65000000000000002 110.703 177.385 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1533 ' ' SER . . . . . 0.997 ' HA ' ' HB2' ' A' 1536 ' ' ALA . 14.4 t -95.2 -179.62 4.86 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 109.526 -0.546 . . . . 1.52 109.526 179.149 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . 83.92 -65.73 4.05 Favored Glycine 0 C--N 1.312 -0.761 0 N-CA-C 109.609 -1.396 . . . . 1.1000000000000001 109.609 -174.35 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 42.4 ttp180 -83.89 -2.24 56.06 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 124.424 1.09 . . . . 4.6200000000000001 109.192 174.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1536 ' ' ALA . . . . . 0.997 ' HB2' ' HA ' ' A' 1533 ' ' SER . . . -46.84 -22.28 0.29 Allowed 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 127.551 2.34 . . . . 1.45 116.66 -175.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . -72.61 103.53 1.36 Allowed Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.361 -0.923 . . . . 0.84999999999999998 111.208 178.678 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -119.93 149.34 42.27 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 120.93 0.395 . . . . 0.93000000000000005 110.777 -178.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 9.9 p -112.94 117.48 32.2 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 115.458 -0.792 . . . . 1.03 110.38 179.193 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1540 ' ' ALA . . . . . 0.444 ' HB3' ' CG1' ' A' 1548 ' ' VAL . . . -112.54 146.68 38.1 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.953 -0.758 . . . . 0.5 108.953 177.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -86.28 151.68 23.39 Favored 'General case' 0 C--N 1.311 -1.081 0 O-C-N 123.22 0.325 . . . . 0.73999999999999999 111.022 -175.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1542 ' ' TYR . . . . . 0.41 ' HB3' ' H ' ' A' 1543 ' ' SER . 0.3 OUTLIER -159.15 -101.93 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 109.511 -0.551 . . . . 0.98999999999999999 109.511 -178.777 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A 1543 ' ' SER . . . . . 0.41 ' H ' ' HB3' ' A' 1542 ' ' TYR . 2.2 p -68.59 172.22 6.53 Favored 'General case' 0 CA--C 1.562 1.409 0 C-N-CA 124.641 1.176 . . . . 1.9099999999999999 110.302 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1544 ' ' LYS . . . . . 0.525 ' H ' HE21 ' B' ' 18' ' ' GLN . 72.4 mmtt -94.55 4.59 53.66 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 113.561 0.948 . . . . 3.5899999999999999 113.561 -165.658 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 7.3 t -129.8 21.33 5.46 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.43 -0.908 . . . . 2.46 110.208 -178.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 169.25 179.73 41.37 Favored Glycine 0 N--CA 1.424 -2.127 0 C-N-CA 119.801 -1.19 . . . . 1.26 112.153 179.175 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 28.0 m -122.07 176.1 4.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 109.148 -0.686 . . . . 0.79000000000000004 109.148 -177.239 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1548 ' ' VAL . . . . . 0.444 ' CG1' ' HB3' ' A' 1540 ' ' ALA . 14.9 p -103.62 128.12 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 N-CA-C 108.538 -0.912 . . . . 0.57999999999999996 108.538 175.766 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -92.32 131.07 37.81 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.656 -0.868 . . . . 1.0800000000000001 108.656 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 23.5 ptm -144.98 140.65 28.34 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 116.051 -0.522 . . . . 0.78000000000000003 110.587 -178.273 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1551 ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' 1536 ' ' ALA . 12.3 p -131.95 125.96 32.89 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 115.824 -0.626 . . . . 0.96999999999999997 111.551 177.563 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1552 ' ' ILE . . . . . 0.69 ' H ' ' HB1' ' A' 1536 ' ' ALA . 49.5 mm -82.63 124.5 39.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.556 -0.535 . . . . 0.41999999999999998 109.556 177.402 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1553 ' ' CYS . . . . . 0.551 ' HB2' ' HB2' ' A' 1533 ' ' SER . 60.2 m 59.35 49.7 8.56 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.598 0.713 . . . . 1.3999999999999999 110.696 177.118 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 168.92 172.14 35.4 Favored Glycine 0 N--CA 1.42 -2.401 0 N-CA-C 109.76 -1.336 . . . . 0.34999999999999998 109.76 178.225 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -100.01 150.15 22.73 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 109.562 -0.532 . . . . 1.6200000000000001 109.562 178.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -91.81 130.97 37.49 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.696 -0.684 . . . . 0.87 109.984 -174.591 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -67.34 -7.29 23.57 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 113.969 1.1 . . . . 2.4900000000000002 113.969 -174.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -93.12 -4.72 51.75 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 120.302 -0.559 . . . . 1.3799999999999999 112.065 -175.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1559 ' ' CYS . . . . . 0.722 ' SG ' ' HD2' ' A' 1560 ' ' PRO . 3.1 t -137.37 162.52 54.64 Favored Pre-proline 0 C--N 1.293 -1.871 0 N-CA-C 108.08 -1.082 . . . . 1.21 108.08 -178.479 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1560 ' ' PRO . . . . . 0.722 ' HD2' ' SG ' ' A' 1559 ' ' CYS . 16.6 Cg_exo -32.91 145.82 0.03 OUTLIER 'Trans proline' 0 CA--C 1.563 1.964 0 C-N-CA 125.175 3.916 . . . . 0.70999999999999996 115.536 175.64 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.03 124.06 14.85 Favored 'Trans proline' 0 C--O 1.25 1.106 0 C-N-CA 123.236 2.624 . . . . 0.80000000000000004 111.803 178.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 107.08 -5.66 36.41 Favored Glycine 0 N--CA 1.44 -1.072 0 CA-C-N 115.615 -0.72 . . . . 0.46000000000000002 111.878 -177.245 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1563 ' ' VAL . . . . . 0.626 HG11 ' HB3' ' A' 1559 ' ' CYS . 10.6 t -84.36 120.64 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.227 0 CA-C-O 121.217 0.532 . . . . 0.97999999999999998 112.33 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -96.8 -31.3 7.09 Favored Glycine 0 C--N 1.303 -1.298 0 CA-C-N 115.146 -0.934 . . . . 0.28000000000000003 111.535 177.448 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -136.18 135.26 39.01 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 109.474 -0.565 . . . . 0.28000000000000003 109.474 177.734 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1566 ' ' CYS . . . . . 0.571 ' HB2' HG11 ' A' 1563 ' ' VAL . 53.9 t -157.84 140.2 14.48 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 110.149 -0.315 . . . . 0.42999999999999999 110.149 -176.443 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1567 ' ' PHE . . . . . 0.497 ' CE2' HG11 ' A' 1574 ' ' VAL . 64.1 m-85 -85.34 133.5 34.14 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 107.954 -1.128 . . . . 1.03 107.954 174.531 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -75.03 -9.73 83.96 Favored Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 115.561 0.984 . . . . 1.1299999999999999 115.561 -171.7 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -70.52 -69.4 0.36 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 117.258 0.529 . . . . 2.5800000000000001 110.908 -177.17 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1570 ' ' THR . . . . . 0.405 HG21 ' HA ' ' B' ' 12' ' ' GLU . 0.7 OUTLIER -97.85 2.08 48.91 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 113.394 0.887 . . . . 2.1699999999999999 113.394 -179.707 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 10.4 mmt85 58.63 41.9 21.4 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.0 -1.0 . . . . 2.6200000000000001 110.444 178.589 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 32.3 mt -88.51 129.58 39.42 Favored 'Isoleucine or valine' 0 C--O 1.247 0.945 0 N-CA-C 108.085 -1.08 . . . . 0.92000000000000004 108.085 177.327 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 30.0 t -81.09 131.65 35.31 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.391 0.615 . . . . 0.80000000000000004 110.852 -177.518 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1574 ' ' VAL . . . . . 0.714 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 33.9 m -118.95 15.12 6.96 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 CA-C-N 115.981 -0.554 . . . . 0.97999999999999998 111.346 -179.253 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 176.95 126.23 0.95 Allowed Glycine 0 N--CA 1.423 -2.223 0 C-N-CA 119.58 -1.295 . . . . 0.28999999999999998 111.814 176.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 49.8 tttp -81.99 135.35 35.37 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 107.271 -1.381 . . . . 2.1899999999999999 107.271 177.433 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -70.28 96.99 1.17 Allowed 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 122.956 0.502 . . . . 0.60999999999999999 110.785 -176.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -110.49 173.65 6.23 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 108.72 -0.845 . . . . 1.95 108.72 177.1 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1579 ' ' LYS . . . . . 0.413 ' NZ ' ' HB2' ' A' 1579 ' ' LYS . 9.8 mtmp? -136.53 53.74 1.91 Allowed 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 107.662 -1.236 . . . . 2.6800000000000002 107.662 -177.251 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1580 ' ' ARG . . . . . 0.409 ' NH2' HG11 ' A' 1591 ' ' VAL . 49.1 ttp180 -107.0 76.19 1.08 Allowed 'General case' 0 N--CA 1.419 -1.984 0 CA-C-N 114.497 -1.228 . . . . 3.4700000000000002 108.027 -179.614 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1581 ' ' LEU . . . . . 0.581 HD23 ' HA ' ' A' 1516 ' ' CYS . 0.3 OUTLIER -69.18 126.27 29.27 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.632 -1.167 . . . . 0.64000000000000001 108.923 179.915 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 60.8 mtp180 -124.72 131.12 53.48 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 120.315 -0.554 . . . . 2.8500000000000001 110.649 173.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1583 ' ' TYR . . . . . 0.511 ' HB2' HG21 ' A' 1518 ' ' VAL . 45.1 t80 -100.93 108.31 20.02 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 108.803 -0.814 . . . . 0.85999999999999999 108.803 178.754 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1584 ' ' VAL . . . . . 0.601 ' O ' ' HB ' ' A' 1587 ' ' VAL . 15.5 m -127.4 91.82 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 CA-C-N 115.918 -0.583 . . . . 1.05 111.993 -178.168 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 32.8 t70 59.18 66.91 0.97 Allowed 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 124.039 0.936 . . . . 1.1699999999999999 111.221 175.648 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1586 ' ' GLN . . . . . 0.459 ' HA ' ' CE1' ' A' 1583 ' ' TYR 0.267 28.5 pt20 61.41 14.75 6.02 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 127.074 2.15 . . . . 1.8600000000000001 112.605 178.895 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A 1587 ' ' VAL . . . . . 0.601 ' HB ' ' O ' ' A' 1584 ' ' VAL . 15.7 t -110.44 120.82 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.325 0 CA-C-N 114.222 -1.354 . . . . 0.48999999999999999 109.436 177.263 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1588 ' ' LEU . . . . . 1.001 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 2.2 mm? -97.79 107.76 20.33 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 106.556 -1.646 . . . . 0.35999999999999999 106.556 177.756 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -105.22 120.72 42.24 Favored 'General case' 0 C--N 1.282 -2.36 0 CA-C-O 121.204 0.526 . . . . 1.74 111.544 -176.223 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 2.3 mt -107.78 108.5 19.73 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 106.196 -1.779 . . . . 0.71999999999999997 106.196 172.644 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1591 ' ' VAL . . . . . 0.409 HG11 ' NH2' ' A' 1580 ' ' ARG . 7.8 p -97.39 131.14 44.92 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 CA-C-O 121.192 0.52 . . . . 1.01 110.62 -175.543 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1592 ' ' TYR . . . . . 0.412 ' O ' ' HA ' ' A' 1607 ' ' LYS . 13.1 m-30 -122.57 95.87 4.81 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 107.947 -1.131 . . . . 0.5 107.947 177.173 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1593 ' ' LYS . . . . . 0.521 ' HB3' ' HG3' ' A' 1607 ' ' LYS . 48.0 pttt -117.68 175.95 5.41 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.816 -0.754 . . . . 1.5900000000000001 110.007 -176.825 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 7.4 m-20 57.11 42.32 25.93 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 124.697 1.248 . . . . 1.1100000000000001 111.885 177.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -68.42 -95.97 0.04 OUTLIER Glycine 0 C--N 1.332 0.323 0 N-CA-C 110.627 -0.989 . . . . 0.78000000000000003 110.627 178.394 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1596 ' ' SER . . . . . . . . . . . . . 79.1 p -122.06 158.48 55.04 Favored Pre-proline 0 C--N 1.288 -2.083 0 N-CA-C 107.691 -1.226 . . . . 1.0700000000000001 107.691 172.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -57.67 137.63 82.14 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.323 2.016 . . . . 1.01 111.257 178.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1598 ' ' CYS . . . . . 0.503 ' HA ' ' CE2' ' A' 1606 ' ' TYR . 12.0 t -75.0 107.5 4.0 Favored Pre-proline 0 C--N 1.304 -1.399 0 N-CA-C 104.865 -2.272 . . . . 0.75 104.865 177.769 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 92.1 Cg_exo -44.22 -59.18 1.17 Allowed 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 123.973 3.115 . . . . 1.7 114.814 -169.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1600 ' ' SER . . . . . . . . . . . . . 8.1 m -87.77 12.92 11.66 Favored 'General case' 0 N--CA 1.402 -2.866 0 N-CA-C 112.827 0.676 . . . . 2.2599999999999998 112.827 -174.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1601 ' ' LYS . . . . . 0.757 ' HE3' ' HB3' ' B' ' 53' ' ' LEU . 96.0 mttt -142.43 69.62 1.32 Allowed 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 122.506 1.146 . . . . 3.0099999999999998 109.063 174.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 7.2 m -46.71 123.68 5.32 Favored 'General case' 0 N--CA 1.413 -2.315 0 C-N-CA 127.669 2.388 . . . . 2.0699999999999998 112.326 -177.361 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 103.96 -21.95 36.62 Favored Glycine 0 N--CA 1.436 -1.348 0 N-CA-C 111.7 -0.56 . . . . 1.0800000000000001 111.7 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1604 ' ' LEU . . . . . 0.538 HD12 ' HB3' ' A' 1601 ' ' LYS . 46.9 mt -94.11 152.46 18.74 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.019 -1.104 . . . . 1.8400000000000001 108.019 179.195 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 26.6 m -131.75 145.24 51.5 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 108.078 -1.082 . . . . 1.4099999999999999 108.078 178.178 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1606 ' ' TYR . . . . . 0.714 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 91.4 m-85 -64.37 155.99 30.64 Favored 'General case' 0 C--O 1.254 1.327 0 CA-C-N 116.231 -0.44 . . . . 0.59999999999999998 111.656 -177.364 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1607 ' ' LYS . . . . . 0.521 ' HG3' ' HB3' ' A' 1593 ' ' LYS . 13.0 ttmm -151.89 127.79 10.31 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.502 -0.772 . . . . 1.45 109.553 -173.149 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1608 ' ' SER . . . . . . . . . . . . . 35.1 m -108.79 119.25 39.0 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 108.773 -0.825 . . . . 1.1499999999999999 108.773 177.404 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 45.3 t -101.39 104.82 16.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 107.729 -1.211 . . . . 0.25 107.729 178.072 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 73.9 mt -94.54 111.05 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 N-CA-C 108.621 -0.881 . . . . 0.45000000000000001 108.621 -178.655 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 34.3 t -109.12 110.33 21.55 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 115.398 -0.819 . . . . 1.26 110.927 -176.223 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1612 ' ' PHE . . . . . 1.001 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 63.0 m-85 -86.35 119.69 26.89 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.702 -0.851 . . . . 0.26000000000000001 108.702 175.526 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 44.6 t -117.8 137.92 50.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-N 115.954 -0.566 . . . . 0.5 109.72 -176.174 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 24.4 t -67.93 111.22 4.24 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 123.758 0.823 . . . . 0.77000000000000002 112.596 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1615 ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -138.43 105.46 7.76 Favored Pre-proline 0 N--CA 1.434 -1.225 0 N-CA-C 109.464 -0.569 . . . . 2.5299999999999998 109.464 169.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1616 ' ' PRO . . . . . 0.757 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 35.9 Cg_exo -64.3 -10.62 24.42 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 123.224 2.616 . . . . 1.1000000000000001 113.716 179.505 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -87.14 42.58 1.04 Allowed 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 125.09 1.356 . . . . 3.0499999999999998 110.9 -177.67 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -36.58 119.12 0.61 Allowed 'General case' 0 C--O 1.241 0.607 0 C-N-CA 125.531 1.532 . . . . 1.55 112.738 -178.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . -178.83 -138.4 3.18 Favored Glycine 0 N--CA 1.425 -2.054 0 N-CA-C 110.505 -1.038 . . . . 0.93000000000000005 110.505 -175.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -66.77 3.31 1.55 Allowed 'Trans proline' 0 N--CA 1.487 1.106 0 C-N-CA 123.516 2.81 . . . . 0.88 115.463 -175.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1621 ' ' THR . . . . . 0.526 ' HB ' ' HB2' ' A' 1641 ' ' HIS . 23.0 p -105.62 -4.52 21.01 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.657 0.741 . . . . 0.96999999999999997 110.053 176.392 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 47.0 t30 -92.81 51.72 1.75 Allowed 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 123.215 1.483 . . . . 0.71999999999999997 108.219 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1623 ' ' ARG . . . . . 0.493 ' O ' ' HG3' ' A' 1625 ' ' MET . 4.7 ptp180 -150.81 141.56 14.75 Favored Pre-proline 0 C--N 1.294 -1.819 0 N-CA-C 105.777 -1.934 . . . . 3.2599999999999998 105.777 -176.425 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -57.0 106.77 0.24 Allowed 'Trans proline' 0 C--O 1.245 0.83 0 C-N-CA 122.374 2.049 . . . . 0.58999999999999997 111.121 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1625 ' ' MET . . . . . 0.493 ' HG3' ' O ' ' A' 1623 ' ' ARG . 93.5 mtp -100.13 128.56 46.19 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 109.051 -0.722 . . . . 1.3700000000000001 109.051 -176.319 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 1.8 tm? -87.1 112.51 21.98 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 106.741 -1.577 . . . . 0.89000000000000001 106.741 -178.419 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1627 ' ' ILE . . . . . 0.764 HD11 ' HB2' ' A' 1639 ' ' SER . 39.3 mm -72.13 -55.24 14.01 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.613 0 N-CA-C 108.351 -0.981 . . . . 0.57999999999999996 108.351 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 22.4 t -179.18 173.99 1.09 Allowed 'General case' 0 N--CA 1.422 -1.833 0 N-CA-C 106.286 -1.746 . . . . 1.3899999999999999 106.286 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1629 ' ' LEU . . . . . 0.78 ' HG ' ' HG ' ' A' 1636 ' ' LEU . 3.8 tt -122.07 110.72 16.13 Favored 'General case' 0 N--CA 1.409 -2.51 0 N-CA-C 104.582 -2.377 . . . . 1.25 104.582 177.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 13.1 t70 -69.21 87.14 0.41 Allowed 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 107.728 -1.212 . . . . 1.0900000000000001 107.728 176.498 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1631 ' ' LYS . . . . . 0.618 ' HD2' ' H ' ' A' 1631 ' ' LYS . 0.0 OUTLIER -54.96 -20.71 9.66 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.32 1.048 . . . . 3.6000000000000001 113.116 -179.278 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A 1632 ' ' GLN . . . . . 0.415 ' HA ' ' NZ ' ' A' 1601 ' ' LYS . 0.3 OUTLIER -71.5 -45.68 61.81 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.441 -0.577 . . . . 2.6000000000000001 109.441 -177.954 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 44.5 p -102.01 -5.21 24.87 Favored 'General case' 0 CA--C 1.557 1.212 0 N-CA-C 112.928 0.714 . . . . 0.75 112.928 -177.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 58.1 m 65.88 35.67 6.47 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.126 0.97 . . . . 0.53000000000000003 109.767 -176.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1635 ' ' THR . . . . . 0.5 HG23 ' HD2' ' A' 1607 ' ' LYS . 86.1 m -100.96 129.04 46.75 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.662 -1.154 . . . . 0.46000000000000002 110.211 -177.636 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1636 ' ' LEU . . . . . 0.78 ' HG ' ' HG ' ' A' 1629 ' ' LEU . 1.1 mp -107.97 122.36 46.67 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.837 -0.801 . . . . 0.85999999999999999 108.837 -179.268 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -100.91 130.01 46.85 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 116.353 -0.385 . . . . 0.45000000000000001 111.267 -178.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -127.97 130.63 48.7 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.789 -0.641 . . . . 0.5 109.478 -179.186 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1639 ' ' SER . . . . . 0.764 ' HB2' HD11 ' A' 1627 ' ' ILE . 10.1 t -106.61 156.67 18.35 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.821 -1.178 . . . . 1.04 107.821 178.268 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 2.0 t90 -156.14 108.62 2.6 Favored 'General case' 0 N--CA 1.423 -1.816 0 N-CA-C 105.689 -1.967 . . . . 0.68000000000000005 105.689 178.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1641 ' ' HIS . . . . . 0.526 ' HB2' ' HB ' ' A' 1621 ' ' THR . 59.1 m-70 -101.75 102.74 13.42 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 110.018 -0.364 . . . . 0.90000000000000002 110.018 -175.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1642 ' ' THR . . . . . . . . . . . . . 3.6 t -132.69 149.78 73.94 Favored Pre-proline 0 C--N 1.299 -1.627 0 CA-C-N 115.357 -0.838 . . . . 0.47999999999999998 109.834 -173.732 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1643 ' ' PRO . . . . . 0.757 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 71.6 Cg_endo -79.72 -0.12 10.45 Favored 'Trans proline' 0 C--N 1.365 1.4 0 C-N-CA 122.461 2.108 . . . . 0.66000000000000003 112.139 176.378 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 11.5 tp -67.12 -28.75 68.4 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.916 0.865 . . . . 0.96999999999999997 109.038 175.202 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -89.61 15.61 9.21 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 114.892 -1.049 . . . . 0.83999999999999997 110.502 -178.185 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1646 ' ' CYS . . . . . 0.537 ' SG ' ' HA ' ' A' 1643 ' ' PRO . 39.9 m -118.67 146.32 44.79 Favored 'General case' 0 N--CA 1.419 -1.985 0 N-CA-C 106.991 -1.485 . . . . 1.1899999999999999 106.991 178.252 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.305 -1.343 0 C-N-CA 119.884 -0.727 . . . . 3.1400000000000001 109.813 177.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.893 0 N-CA-C 112.861 -0.095 . . . . 2.0899999999999999 112.861 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.12 -23.92 64.55 Favored Glycine 0 C--O 1.223 -0.562 0 N-CA-C 114.143 0.417 . . . . 1.8400000000000001 114.143 -175.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 12' ' ' GLU . . . . . 0.405 ' HA ' HG21 ' A' 1570 ' ' THR . 49.9 mm-40 -67.0 -37.84 84.94 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.428 0.633 . . . . 2.5499999999999998 109.725 179.552 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 13' ' ' LEU . . . . . 0.419 ' HG ' ' HA ' ' B' ' 43' ' ' VAL . 0.1 OUTLIER -68.2 -49.77 58.64 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 115.227 -0.897 . . . . 2.3500000000000001 109.613 -177.776 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 8.2 p -67.41 -32.46 57.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 C-N-CA 119.961 -0.695 . . . . 2.1099999999999999 111.273 179.167 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -70.9 -40.05 72.41 Favored 'General case' 0 C--O 1.212 -0.896 0 C-N-CA 119.219 -0.992 . . . . 2.04 112.785 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 16.5 p -63.82 -40.75 97.36 Favored 'General case' 0 C--O 1.265 1.917 0 CA-C-N 118.444 0.566 . . . . 1.8400000000000001 110.052 177.497 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.542 HD21 HD11 ' B' ' 42' ' ' ILE . 3.9 mm? -53.34 -53.86 44.83 Favored 'General case' 0 C--O 1.211 -0.929 0 CA-C-N 115.26 -0.882 . . . . 1.74 110.574 171.277 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 18' ' ' GLN . . . . . 0.525 HE21 ' H ' ' A' 1544 ' ' LYS . 9.9 tm0? -68.89 -20.97 64.26 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 113.001 0.741 . . . . 2.3900000000000001 113.001 -179.137 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -59.86 -62.67 1.7 Allowed 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 120.927 0.394 . . . . 0.95999999999999996 110.665 178.559 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 14.1 p -92.56 -26.09 4.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 C-N-CA 119.119 -1.032 . . . . 1.3700000000000001 111.33 -177.394 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 21' ' ' CYS . . . . . 0.443 ' HB2' ' O ' ' B' ' 17' ' ' LEU . 62.6 m -95.98 12.1 31.64 Favored 'General case' 0 N--CA 1.437 -1.111 0 C-N-CA 120.326 -0.55 . . . . 1.6599999999999999 111.594 -177.591 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -56.7 -47.47 84.95 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 111.715 -0.554 . . . . 1.53 111.715 173.1 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -72.24 -14.4 61.77 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 122.816 0.447 . . . . 2.7200000000000002 111.624 175.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 12.3 tpp180 -100.21 -60.04 1.6 Allowed 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.831 0.824 . . . . 4.3300000000000001 112.649 -171.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 131.5 152.4 7.21 Favored Glycine 0 N--CA 1.423 -2.232 0 N-CA-C 105.856 -2.897 . . . . 1.53 105.856 -171.306 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -142.57 141.1 31.95 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 118.832 1.316 . . . . 1.6499999999999999 111.59 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -161.87 134.61 5.99 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 108.12 -1.067 . . . . 3.4199999999999999 108.12 175.174 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 28' ' ' PHE . . . . . 0.434 ' CD1' ' HG ' ' B' ' 17' ' ' LEU . 24.2 p90 . . . . . 0 C--N 1.311 -1.07 0 CA-C-O 122.105 0.955 . . . . 2.2599999999999998 110.503 -177.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.418 -2.565 0 N-CA-C 110.279 -1.128 . . . . 2.3700000000000001 110.279 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 42' ' ' ILE . . . . . 0.542 HD11 HD21 ' B' ' 17' ' ' LEU 0.255 11.8 pt 60.52 -33.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 128.421 2.689 . . . . 2.0699999999999998 115.346 179.155 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.656 ' O ' ' HB2' ' B' ' 47' ' ' CYS . 6.8 p -56.03 -44.2 77.75 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.452 0 N-CA-C 113.2 0.815 . . . . 2.2400000000000002 113.2 -178.774 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -94.73 -31.21 13.89 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.321 -0.992 . . . . 3.3599999999999999 108.321 -173.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 45' ' ' GLU . . . . . 0.515 ' O ' ' HB2' ' B' ' 49' ' ' ARG . 28.7 tt0 -67.57 -13.4 62.03 Favored 'General case' 0 CA--C 1.555 1.14 0 CA-C-N 114.728 -1.124 . . . . 3.0800000000000001 109.924 177.329 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 46' ' ' CYS . . . . . . . . . . . . . 45.5 t -117.86 -14.19 10.08 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-O 121.397 0.618 . . . . 2.23 110.165 174.554 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 47' ' ' CYS . . . . . 0.656 ' HB2' ' O ' ' B' ' 43' ' ' VAL . 27.3 t -70.04 -44.55 68.99 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.967 -0.383 . . . . 2.3700000000000001 109.967 -177.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -119.65 23.3 11.23 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.422 -0.354 . . . . 2.8199999999999998 110.712 -178.138 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 49' ' ' ARG . . . . . 0.515 ' HB2' ' O ' ' B' ' 45' ' ' GLU . 68.4 mtt180 -145.36 162.38 37.4 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 108.393 -0.965 . . . . 4.0899999999999999 108.393 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 22.4 t -85.18 109.16 18.1 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 106.523 -1.658 . . . . 2.6699999999999999 106.523 173.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 15.8 p -101.67 144.89 29.83 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 108.001 -1.111 . . . . 2.1099999999999999 108.001 -176.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -93.13 144.61 25.1 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.419 0.628 . . . . 2.6699999999999999 109.434 177.403 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 53' ' ' LEU . . . . . 0.757 ' HB3' ' HE3' ' A' 1601 ' ' LYS . 48.8 tp -58.46 -27.88 64.8 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.098 1.359 . . . . 1.8999999999999999 111.363 -179.027 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.32 -39.23 75.4 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.425 -0.807 . . . . 1.52 111.122 178.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 31.3 tp -56.38 -54.63 43.29 Favored 'General case' 0 CA--C 1.516 -0.331 0 O-C-N 124.272 0.983 . . . . 1.97 111.323 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 2.4 pp -73.85 -28.53 61.64 Favored 'General case' 0 N--CA 1.427 -1.61 0 C-N-CA 121.099 -0.24 . . . . 1.53 111.427 -176.423 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -63.5 -50.47 69.5 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 123.512 0.507 . . . . 2.27 110.711 177.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 14.6 t -80.11 -7.91 59.13 Favored 'General case' 0 CA--C 1.557 1.224 0 CA-C-O 121.092 0.473 . . . . 2.3300000000000001 111.076 -179.177 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 59' ' ' TYR . . . . . 0.405 ' HB3' ' H ' ' B' ' 60' ' ' CYS . 15.3 t80 -89.07 -80.13 0.3 Allowed 'General case' 0 N--CA 1.42 -1.973 0 N-CA-C 106.891 -1.522 . . . . 2.8599999999999999 106.891 176.076 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 60' ' ' CYS . . . . . 0.405 ' H ' ' HB3' ' B' ' 59' ' ' TYR . 43.5 t . . . . . 0 CA--C 1.554 1.12 0 C-N-CA 126.067 1.747 . . . . 2.2999999999999998 113.869 -178.508 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 13.3 t70 . . . . . 0 C--O 1.225 -0.203 0 CA-C-O 121.4 0.619 . . . . 2.8999999999999999 109.448 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A 1516 ' ' CYS . . . . . 0.692 ' HA ' HD23 ' A' 1581 ' ' LEU . 96.0 m 62.35 20.86 12.13 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.756 0.822 . . . . 1.1899999999999999 112.952 -176.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -155.8 130.83 9.31 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 108.404 -0.961 . . . . 1.52 108.404 177.099 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1518 ' ' VAL . . . . . 0.465 HG21 ' HB2' ' A' 1583 ' ' TYR . 0.5 OUTLIER -144.14 145.58 21.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 C-N-CA 123.575 0.75 . . . . 0.93999999999999995 110.066 -178.706 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A 1519 ' ' THR . . . . . . . . . . . . . 27.1 m -114.48 142.49 46.32 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 109.86 -0.422 . . . . 0.89000000000000001 109.86 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1520 ' ' ASN . . . . . 0.489 ' OD1' HG22 ' A' 1523 ' ' THR . 18.1 t-20 -87.68 113.36 54.06 Favored Pre-proline 0 C--N 1.307 -1.257 0 N-CA-C 107.632 -1.248 . . . . 1.74 107.632 171.577 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -69.44 -7.49 21.09 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.949 2.433 . . . . 1.5800000000000001 113.351 -174.704 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1522 ' ' SER . . . . . 0.455 ' HB2' ' OD1' ' A' 1520 ' ' ASN . 42.9 m -79.26 -45.98 18.7 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 121.116 -0.234 . . . . 1.6499999999999999 110.95 178.517 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1523 ' ' THR . . . . . 0.489 HG22 ' OD1' ' A' 1520 ' ' ASN . 7.7 t -111.0 -15.37 13.76 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 120.358 -0.537 . . . . 1.6100000000000001 112.3 -176.19 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 83.52 25.82 45.4 Favored Glycine 0 C--O 1.225 -0.457 0 C-N-CA 121.041 -0.6 . . . . 1.1299999999999999 113.195 176.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -92.81 125.14 37.27 Favored 'General case' 0 C--N 1.309 -1.158 0 C-N-CA 120.589 -0.445 . . . . 1.26 110.074 -178.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 2.7 tm? -94.91 116.62 28.94 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 124.071 0.948 . . . . 0.68000000000000005 109.447 -178.179 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -92.54 131.39 37.7 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 120.22 -0.592 . . . . 0.65000000000000002 109.976 173.048 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 17.3 t70 -120.13 121.06 37.98 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.589 -0.893 . . . . 1.1699999999999999 108.589 174.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1529 ' ' LEU . . . . . 0.578 ' HG ' HD21 ' A' 1581 ' ' LEU . 3.1 mm? -100.98 5.82 43.29 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 121.332 0.587 . . . . 0.59999999999999998 110.509 -176.19 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 2.4 m -73.45 -24.75 60.27 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.715 -0.675 . . . . 0.83999999999999997 110.235 -178.221 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 23.0 t -66.7 -28.75 68.69 Favored 'General case' 0 CA--C 1.555 1.149 0 CA-C-O 121.366 0.603 . . . . 1.5900000000000001 110.38 178.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1532 ' ' LEU . . . . . 0.482 ' HG ' HD21 ' A' 1644 ' ' LEU . 95.5 mt -90.92 3.19 55.26 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.071 0.462 . . . . 0.65000000000000002 110.925 178.177 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1533 ' ' SER . . . . . . . . . . . . . 13.1 t -80.91 176.49 9.77 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.496 0.665 . . . . 1.52 109.622 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . 150.79 153.77 6.26 Favored Glycine 0 N--CA 1.423 -2.195 0 N-CA-C 110.998 -0.841 . . . . 1.1000000000000001 110.998 -176.582 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -78.71 -31.97 46.68 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 121.016 0.436 . . . . 4.6200000000000001 110.604 -178.569 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -78.11 -29.5 48.97 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.211 0.529 . . . . 1.45 110.723 -179.22 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 74.34 -141.52 28.98 Favored Glycine 0 N--CA 1.426 -2.028 0 C-N-CA 120.871 -0.681 . . . . 0.84999999999999998 112.232 177.291 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -145.18 144.99 31.16 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.82 -1.178 . . . . 0.93000000000000005 107.82 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 2.6 m -106.62 133.37 51.4 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.317 0.58 . . . . 1.03 110.193 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1540 ' ' ALA . . . . . 0.69 ' HB2' ' HG2' ' A' 1624 ' ' PRO . . . -127.13 140.84 51.98 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.606 -0.887 . . . . 0.5 108.606 178.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -84.08 142.79 30.16 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 123.518 0.511 . . . . 0.73999999999999999 110.631 -179.168 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1542 ' ' TYR . . . . . 0.458 ' HD2' ' HE1' ' A' 1567 ' ' PHE . 0.3 OUTLIER -129.53 -101.8 0.32 Allowed 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 107.899 -1.149 . . . . 0.98999999999999999 107.899 177.713 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A 1543 ' ' SER . . . . . . . . . . . . . 12.5 t -75.2 178.25 5.89 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 109.869 -0.419 . . . . 1.9099999999999999 109.869 178.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 60.7 tttp -52.61 -44.13 65.8 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.804 0.841 . . . . 3.5899999999999999 113.235 -173.177 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 11.1 t -123.01 32.33 5.73 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 107.329 -1.36 . . . . 2.46 107.329 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . -126.6 111.23 1.36 Allowed Glycine 0 N--CA 1.43 -1.707 0 CA-C-N 115.114 -0.948 . . . . 1.26 113.133 -174.04 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 20.4 m -110.31 157.45 10.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 N-CA-C 108.331 -0.988 . . . . 0.79000000000000004 108.331 175.46 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1548 ' ' VAL . . . . . 0.527 ' HA ' ' HA ' ' A' 1567 ' ' PHE . 10.2 p -114.68 132.28 64.3 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 N-CA-C 109.369 -0.604 . . . . 0.57999999999999996 109.369 177.13 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -101.1 117.51 35.16 Favored 'General case' 0 CA--C 1.488 -1.405 0 N-CA-C 108.714 -0.847 . . . . 1.0800000000000001 108.714 178.283 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 13.0 ptp -129.53 139.41 51.54 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-N 115.824 -0.626 . . . . 0.78000000000000003 110.402 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 7.1 p -117.48 120.61 38.63 Favored 'General case' 0 C--N 1.274 -2.678 0 CA-C-N 115.016 -0.993 . . . . 0.96999999999999997 108.459 176.64 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1552 ' ' ILE . . . . . 0.423 ' HB ' ' O ' ' A' 1532 ' ' LEU . 38.6 mm -77.5 120.85 28.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 C-N-CA 120.672 -0.411 . . . . 0.41999999999999998 110.571 -177.264 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 38.1 t 67.61 39.43 2.78 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 122.282 1.039 . . . . 1.3999999999999999 109.314 174.03 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 176.86 -169.86 42.4 Favored Glycine 0 N--CA 1.422 -2.288 0 C-N-CA 120.436 -0.888 . . . . 0.34999999999999998 111.258 -178.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -113.53 151.5 31.48 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 120.967 0.413 . . . . 1.6200000000000001 111.53 -176.245 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -99.23 146.38 26.25 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 114.676 -1.147 . . . . 0.87 109.107 -176.313 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -92.45 4.94 52.47 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 112.374 0.509 . . . . 2.4900000000000002 112.374 -170.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -93.63 -7.77 42.97 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 121.594 -0.691 . . . . 1.3799999999999999 111.655 -179.236 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1559 ' ' CYS . . . . . 0.441 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 78.7 m -136.6 165.96 31.29 Favored Pre-proline 0 C--N 1.297 -1.682 0 CA-C-O 118.398 -0.811 . . . . 1.21 109.849 -178.166 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1560 ' ' PRO . . . . . 0.441 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 7.7 Cg_exo -36.5 118.57 0.2 Allowed 'Trans proline' 0 C--N 1.367 1.518 0 C-N-CA 124.561 3.508 . . . . 0.70999999999999996 113.951 176.626 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -44.74 130.66 9.89 Favored 'Trans proline' 0 C--N 1.362 1.255 0 C-N-CA 124.59 3.527 . . . . 0.80000000000000004 112.18 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 111.79 -6.69 27.7 Favored Glycine 0 N--CA 1.435 -1.408 0 CA-C-N 115.906 -0.588 . . . . 0.46000000000000002 112.404 -177.317 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1563 ' ' VAL . . . . . . . . . . . . . 7.5 p -105.27 137.19 35.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 O-C-N 122.109 -0.642 . . . . 0.97999999999999998 111.496 -178.509 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -99.54 -32.68 5.63 Favored Glycine 0 C--N 1.322 -0.241 0 CA-C-N 115.615 -0.72 . . . . 0.28000000000000003 112.771 -178.415 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -122.88 126.21 46.88 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 109.479 -0.563 . . . . 0.28000000000000003 109.479 178.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 46.5 t -153.73 148.38 26.32 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.842 -0.799 . . . . 0.42999999999999999 108.842 -179.105 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1567 ' ' PHE . . . . . 0.637 ' HB2' ' OG1' ' A' 1570 ' ' THR . 96.7 m-85 -92.11 158.78 16.01 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 119.732 -0.787 . . . . 1.03 109.548 176.362 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -62.6 -75.92 0.29 Allowed Glycine 0 C--O 1.245 0.81 0 N-CA-C 115.183 0.833 . . . . 1.1299999999999999 115.183 -173.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -67.18 -34.48 77.62 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 113.159 0.799 . . . . 2.5800000000000001 113.159 -173.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1570 ' ' THR . . . . . 0.739 ' HB ' HG13 ' A' 1572 ' ' ILE . 45.9 p -67.81 -35.17 78.15 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 112.429 0.529 . . . . 2.1699999999999999 112.429 -177.019 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 18.1 mmt180 64.55 8.88 4.66 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.672 1.189 . . . . 2.6200000000000001 110.746 -174.291 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1572 ' ' ILE . . . . . 0.739 HG13 ' HB ' ' A' 1570 ' ' THR . 18.1 mt -74.61 127.29 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-O 121.301 0.572 . . . . 0.92000000000000004 111.438 -175.404 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 13.0 t -74.79 118.21 17.5 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 114.922 -1.035 . . . . 0.80000000000000004 108.656 177.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1574 ' ' VAL . . . . . 0.594 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 24.8 m -114.58 20.29 6.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 C-N-CA 119.738 -0.785 . . . . 0.97999999999999998 111.933 -179.168 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 161.44 119.75 0.52 Allowed Glycine 0 N--CA 1.432 -1.602 0 C-N-CA 120.327 -0.94 . . . . 0.28999999999999998 112.451 176.642 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 57.7 tttm -64.66 139.89 58.81 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.843 -0.429 . . . . 2.1899999999999999 109.843 178.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -71.73 144.34 49.31 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 115.477 -0.783 . . . . 0.60999999999999999 110.057 -179.268 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 22.2 p30 -161.31 179.01 8.66 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 107.853 -1.166 . . . . 1.95 107.853 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 17.7 pttm -134.04 46.53 2.51 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-O 122.941 1.353 . . . . 2.6800000000000002 108.784 177.457 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 64.7 ttt180 -101.48 99.88 10.26 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-N 113.383 -1.735 . . . . 3.4700000000000002 107.75 -175.083 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1581 ' ' LEU . . . . . 0.692 HD23 ' HA ' ' A' 1516 ' ' CYS . 0.3 OUTLIER -93.53 137.58 32.68 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.855 -0.795 . . . . 0.64000000000000001 108.855 -175.58 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 75.6 mtp180 -123.91 124.77 43.35 Favored 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 120.652 -0.419 . . . . 2.8500000000000001 111.045 171.162 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1583 ' ' TYR . . . . . 0.465 ' HB2' HG21 ' A' 1518 ' ' VAL . 71.1 t80 -96.31 112.78 24.4 Favored 'General case' 0 CA--C 1.49 -1.364 0 N-CA-C 107.239 -1.393 . . . . 0.85999999999999999 107.239 173.225 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1584 ' ' VAL . . . . . 0.553 ' O ' ' HB ' ' A' 1587 ' ' VAL . 20.3 t -128.39 92.33 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 N-CA-C 109.501 -0.555 . . . . 1.05 109.501 -178.411 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 32.6 t70 50.83 69.2 0.67 Allowed 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 124.905 1.282 . . . . 1.1699999999999999 112.041 175.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 9.2 pt20 71.37 -8.04 1.09 Allowed 'General case' 0 N--CA 1.504 2.271 0 C-N-CA 128.498 2.719 . . . . 1.8600000000000001 112.197 178.535 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1587 ' ' VAL . . . . . 0.553 ' HB ' ' O ' ' A' 1584 ' ' VAL . 13.8 t -91.68 120.31 40.54 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.23 0 CA-C-N 115.263 -0.881 . . . . 0.48999999999999999 110.106 178.146 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1588 ' ' LEU . . . . . 0.811 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 3.2 mm? -91.06 107.66 19.35 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 105.923 -1.88 . . . . 0.35999999999999999 105.923 174.49 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -111.08 131.07 55.38 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-O 121.694 0.759 . . . . 1.74 112.515 -173.077 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1590 ' ' LEU . . . . . 0.449 ' HB2' ' HB ' ' A' 1610 ' ' ILE . 15.0 mt -123.86 104.76 9.14 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 114.0 -1.455 . . . . 0.71999999999999997 107.699 173.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1591 ' ' VAL . . . . . 0.515 HG23 HG22 ' A' 1609 ' ' VAL . 6.3 p -97.53 128.57 48.72 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 N-CA-C 108.799 -0.815 . . . . 1.01 108.799 179.363 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1592 ' ' TYR . . . . . 0.506 ' O ' ' HA ' ' A' 1607 ' ' LYS . 15.9 m-30 -115.19 102.65 10.09 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.673 -0.862 . . . . 0.5 108.673 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 57.8 pttt -109.9 176.43 5.07 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.244 -0.65 . . . . 1.5900000000000001 109.244 -178.451 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 21.8 m-20 61.0 51.11 4.67 Favored 'General case' 0 C--N 1.312 -1.037 0 O-C-N 124.095 0.872 . . . . 1.1100000000000001 112.158 177.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -83.09 -134.51 2.28 Favored Glycine 0 N--CA 1.425 -2.098 0 N-CA-C 109.629 -1.389 . . . . 0.78000000000000003 109.629 172.634 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1596 ' ' SER . . . . . . . . . . . . . 29.9 p -100.33 157.96 32.85 Favored Pre-proline 0 C--N 1.29 -1.994 0 O-C-N 122.036 -0.685 . . . . 1.0700000000000001 109.648 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1597 ' ' PRO . . . . . 0.508 ' HA ' ' O ' ' A' 1604 ' ' LEU . 73.4 Cg_exo -52.01 123.6 12.86 Favored 'Trans proline' 0 C--N 1.36 1.167 0 C-N-CA 123.059 2.506 . . . . 1.01 112.234 177.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1598 ' ' CYS . . . . . 0.621 ' HA ' ' CE1' ' A' 1606 ' ' TYR . 43.7 t -77.94 117.84 68.42 Favored Pre-proline 0 C--N 1.299 -1.627 0 CA-C-N 114.959 -1.018 . . . . 0.75 109.659 -178.634 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -63.93 -30.31 67.23 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.914 2.409 . . . . 1.7 111.855 178.333 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1600 ' ' SER . . . . . 0.64 ' HA ' ' HB2' ' B' ' 53' ' ' LEU . 14.4 m -61.65 -49.27 77.23 Favored 'General case' 0 C--O 1.25 1.083 0 CA-C-N 116.009 -0.542 . . . . 2.2599999999999998 110.852 178.264 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1601 ' ' LYS . . . . . 0.686 ' HG2' HD22 ' A' 1604 ' ' LEU . 0.6 OUTLIER -120.81 98.49 6.03 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 107.114 -1.439 . . . . 3.0099999999999998 107.114 -178.958 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 19.3 m -57.96 119.32 6.55 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 113.822 1.045 . . . . 2.0699999999999998 113.822 -171.323 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 98.96 -8.45 61.19 Favored Glycine 0 CA--C 1.499 -0.964 0 N-CA-C 111.595 -0.602 . . . . 1.0800000000000001 111.595 177.056 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1604 ' ' LEU . . . . . 0.686 HD22 ' HG2' ' A' 1601 ' ' LYS . 8.8 tp -90.97 170.98 9.6 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.735 -1.209 . . . . 1.8400000000000001 107.735 -179.222 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 32.5 t -130.48 150.93 51.47 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 108.644 -0.873 . . . . 1.4099999999999999 108.644 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1606 ' ' TYR . . . . . 0.621 ' CE1' ' HA ' ' A' 1598 ' ' CYS . 57.8 m-85 -71.48 157.76 37.46 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.744 -0.662 . . . . 0.59999999999999998 110.856 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1607 ' ' LYS . . . . . 0.506 ' HA ' ' O ' ' A' 1592 ' ' TYR . 75.7 tttt -157.39 125.44 5.47 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 109.21 -0.663 . . . . 1.45 109.21 -173.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1608 ' ' SER . . . . . . . . . . . . . 28.5 m -112.48 132.05 55.26 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-N 116.278 -0.419 . . . . 1.1499999999999999 109.933 -178.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1609 ' ' VAL . . . . . 0.515 HG22 HG23 ' A' 1591 ' ' VAL . 39.8 t -109.35 108.59 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.507 0 N-CA-C 108.448 -0.945 . . . . 0.25 108.448 177.624 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1610 ' ' ILE . . . . . 0.449 ' HB ' ' HB2' ' A' 1590 ' ' LEU . 68.7 mt -95.24 126.66 47.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 N-CA-C 108.06 -1.089 . . . . 0.45000000000000001 108.06 179.5 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 23.4 m -127.26 118.47 24.3 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 116.138 -0.483 . . . . 1.26 110.911 -178.712 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1612 ' ' PHE . . . . . 0.811 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 70.0 m-85 -95.55 128.02 42.07 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.912 -0.585 . . . . 0.26000000000000001 109.596 177.73 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1613 ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' 1641 ' ' HIS . 66.2 t -122.7 138.84 51.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 CA-C-N 115.402 -0.817 . . . . 0.5 109.443 -177.386 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1614 ' ' CYS . . . . . 0.71 ' HB2' ' HA ' ' A' 1646 ' ' CYS . 4.0 t -52.07 119.82 4.75 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 124.352 1.061 . . . . 0.77000000000000002 113.169 176.394 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1615 ' ' ARG . . . . . 0.824 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 22.2 tpt180 -135.29 89.66 22.63 Favored Pre-proline 0 N--CA 1.439 -0.993 0 N-CA-C 107.739 -1.208 . . . . 2.5299999999999998 107.739 170.09 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1616 ' ' PRO . . . . . 0.572 ' HD3' ' SG ' ' A' 1614 ' ' CYS . 51.3 Cg_endo -68.94 -23.06 35.06 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.195 1.93 . . . . 1.1000000000000001 113.425 -172.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -94.86 -3.56 48.61 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.527 -0.306 . . . . 3.0499999999999998 111.051 -179.079 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . 59.51 -165.85 0.19 Allowed 'General case' 0 CA--C 1.554 1.108 0 N-CA-C 109.455 -0.572 . . . . 1.55 109.455 -173.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . 135.3 -163.54 24.88 Favored Glycine 0 N--CA 1.415 -2.739 0 C-N-CA 120.961 -0.637 . . . . 0.93000000000000005 112.403 174.728 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -61.3 -8.24 10.02 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 124.243 3.295 . . . . 0.88 115.069 -177.729 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1621 ' ' THR . . . . . . . . . . . . . 19.0 p -96.43 -0.65 48.9 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-O 121.199 0.523 . . . . 0.96999999999999997 111.369 -177.162 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 41.4 t30 -87.25 63.43 7.79 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 122.243 1.02 . . . . 0.71999999999999997 109.059 178.542 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 -172.76 140.07 0.95 Allowed Pre-proline 0 C--N 1.304 -1.387 0 N-CA-C 107.443 -1.318 . . . . 3.2599999999999998 107.443 -177.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1624 ' ' PRO . . . . . 0.69 ' HG2' ' HB2' ' A' 1540 ' ' ALA . 35.1 Cg_endo -64.08 99.72 0.29 Allowed 'Trans proline' 0 C--O 1.246 0.917 0 C-N-CA 122.859 2.372 . . . . 0.58999999999999997 112.355 -176.243 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 70.7 mtm -98.07 133.49 42.45 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.99 -0.55 . . . . 1.3700000000000001 110.703 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 1.4 tm? -74.58 116.62 15.48 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 108.15 -1.056 . . . . 0.89000000000000001 108.15 -178.336 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1627 ' ' ILE . . . . . 0.505 HD11 ' HB2' ' A' 1639 ' ' SER . 43.1 mm -79.56 -55.63 8.83 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 N-CA-C 108.378 -0.971 . . . . 0.57999999999999996 108.378 177.41 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 77.9 p -164.72 150.27 10.03 Favored 'General case' 0 N--CA 1.419 -1.982 0 CA-C-N 114.833 -1.076 . . . . 1.3899999999999999 109.537 -179.304 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1629 ' ' LEU . . . . . 0.865 HD13 ' HG ' ' A' 1636 ' ' LEU . 27.8 tp -119.14 112.31 19.36 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 106.885 -1.524 . . . . 1.25 106.885 172.188 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 33.1 t70 -78.4 128.86 34.24 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 117.549 -1.661 . . . . 1.0900000000000001 111.628 177.061 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1631 ' ' LYS . . . . . 0.513 ' HD3' ' H ' ' A' 1631 ' ' LYS . 0.1 OUTLIER -66.05 -28.96 69.24 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 112.726 -2.034 . . . . 3.6000000000000001 113.108 -175.564 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 60.5 mm-40 -103.0 -35.44 8.55 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 119.918 -0.713 . . . . 2.6000000000000001 112.134 -174.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 73.9 p -91.99 -6.59 50.92 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-O 120.8 0.333 . . . . 0.75 111.605 -178.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 64.1 m 54.06 33.51 17.83 Favored 'General case' 0 C--N 1.362 1.147 0 C-N-CA 124.669 1.187 . . . . 0.53000000000000003 111.898 176.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1635 ' ' THR . . . . . . . . . . . . . 29.2 m -100.53 132.1 46.09 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 115.624 -0.716 . . . . 0.46000000000000002 109.37 -178.375 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1636 ' ' LEU . . . . . 0.865 ' HG ' HD13 ' A' 1629 ' ' LEU . 0.6 OUTLIER -111.08 124.11 51.54 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 107.919 -1.141 . . . . 0.85999999999999999 107.919 -177.604 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -106.5 129.38 54.47 Favored 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 120.997 -0.281 . . . . 0.45000000000000001 110.494 -179.238 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -125.36 134.9 52.01 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.197 -0.456 . . . . 0.5 110.269 -178.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1639 ' ' SER . . . . . 0.505 ' HB2' HD11 ' A' 1627 ' ' ILE . 31.0 t -110.29 148.81 31.18 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 107.663 -1.236 . . . . 1.04 107.663 176.808 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 2.6 t90 -152.69 114.27 4.29 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 105.951 -1.87 . . . . 0.68000000000000005 105.951 -178.221 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1641 ' ' HIS . . . . . 0.824 ' HB3' ' HB2' ' A' 1615 ' ' ARG . 8.9 m-70 -105.04 115.56 30.48 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 108.889 -0.782 . . . . 0.90000000000000002 108.889 -178.197 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1642 ' ' THR . . . . . . . . . . . . . 3.0 t -137.24 150.59 69.51 Favored Pre-proline 0 C--N 1.3 -1.547 0 C-N-CA 123.065 0.546 . . . . 0.47999999999999998 110.445 -172.095 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1643 ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.49 -18.38 17.74 Favored 'Trans proline' 0 C--N 1.367 1.524 0 C-N-CA 122.622 2.215 . . . . 0.66000000000000003 113.328 178.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1644 ' ' LEU . . . . . 0.482 HD21 ' HG ' ' A' 1532 ' ' LEU . 3.8 pp -84.45 -1.47 55.72 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 119.806 -0.757 . . . . 0.96999999999999997 111.729 -178.714 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -120.06 28.66 7.95 Favored 'General case' 0 CA--C 1.498 -1.048 0 CA-C-O 122.103 0.954 . . . . 0.83999999999999997 109.531 -178.122 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1646 ' ' CYS . . . . . 0.71 ' HA ' ' HB2' ' A' 1614 ' ' CYS . 45.9 t -105.7 140.87 38.1 Favored 'General case' 0 N--CA 1.41 -2.471 0 CA-C-N 114.842 -1.072 . . . . 1.1899999999999999 109.835 -177.584 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 35.8 tt0 . . . . . 0 N--CA 1.419 -2.018 0 N-CA-C 104.928 -2.249 . . . . 3.1400000000000001 104.928 175.971 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 10' ' ' GLY . . . . . 0.439 ' O ' HG12 ' B' ' 14' ' ' VAL . . . . . . . . 0 N--CA 1.425 -2.071 0 N-CA-C 111.433 -0.667 . . . . 2.0899999999999999 111.433 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -55.72 -55.07 30.72 Favored Glycine 0 C--O 1.24 0.502 0 N-CA-C 114.388 0.515 . . . . 1.8400000000000001 114.388 -174.245 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -74.25 -32.49 62.98 Favored 'General case' 0 CA--C 1.505 -0.775 0 C-N-CA 120.69 -0.404 . . . . 2.5499999999999998 111.282 -177.668 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 13' ' ' LEU . . . . . 0.411 HD13 ' HA ' ' B' ' 13' ' ' LEU . 1.1 mm? -58.1 -59.0 5.96 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.175 0.512 . . . . 2.3500000000000001 111.411 178.006 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 14' ' ' VAL . . . . . 0.439 HG12 ' O ' ' B' ' 10' ' ' GLY . 13.0 p -68.89 -35.33 68.84 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 CA-C-N 115.857 -0.61 . . . . 2.1099999999999999 111.882 -176.131 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -78.34 -26.69 46.85 Favored 'General case' 0 C--O 1.213 -0.866 0 N-CA-C 114.105 1.15 . . . . 2.04 114.105 -179.171 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 19.6 p -67.09 -36.6 82.33 Favored 'General case' 0 C--O 1.256 1.437 0 CA-C-N 119.692 1.133 . . . . 1.8400000000000001 108.819 174.568 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.72 ' HB3' ' HB3' ' B' ' 26' ' ' PHE . 10.4 mp -60.77 -47.85 84.43 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-N 114.978 -1.01 . . . . 1.74 111.335 171.312 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -63.09 -33.3 75.15 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.036 0.446 . . . . 2.3900000000000001 110.07 179.309 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -55.52 -59.25 5.09 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 112.905 0.706 . . . . 0.95999999999999996 112.905 -179.145 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 9.8 p -98.51 -20.21 5.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 C-N-CA 117.314 -1.755 . . . . 1.3700000000000001 112.068 -179.332 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 21' ' ' CYS . . . . . 0.461 ' HB2' ' O ' ' B' ' 17' ' ' LEU . 69.4 m -99.66 1.25 43.33 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 113.473 0.916 . . . . 1.6599999999999999 113.473 -175.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -49.29 -36.59 22.94 Favored Glycine 0 N--CA 1.483 1.806 0 N-CA-C 114.789 0.676 . . . . 1.53 114.789 -178.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -52.05 -46.91 65.28 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.873 0.869 . . . . 2.7200000000000002 111.891 176.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -97.56 -43.47 7.22 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.277 0.56 . . . . 4.3300000000000001 111.348 178.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 128.19 165.54 11.84 Favored Glycine 0 N--CA 1.425 -2.082 0 N-CA-C 110.19 -1.164 . . . . 1.53 110.19 -179.136 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 26' ' ' PHE . . . . . 0.72 ' HB3' ' HB3' ' B' ' 17' ' ' LEU . 3.4 p90 -98.25 128.01 44.48 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 117.163 0.481 . . . . 1.6499999999999999 109.83 175.42 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -132.78 72.92 1.5 Allowed 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 121.577 0.703 . . . . 3.4199999999999999 110.482 -176.354 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 28' ' ' PHE . . . . . . . . . . . . . 8.4 p90 . . . . . 0 C--N 1.321 -0.66 0 CA-C-N 115.123 -0.944 . . . . 2.2599999999999998 109.282 -179.667 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.2 0 N-CA-C 110.139 -1.184 . . . . 2.3700000000000001 110.139 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . 0.27 18.4 pt 60.84 -30.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 C-N-CA 127.185 2.194 . . . . 2.0699999999999998 116.314 178.23 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 2.7 p -48.97 -46.23 16.61 Favored 'Isoleucine or valine' 0 C--O 1.245 0.837 0 N-CA-C 114.047 1.128 . . . . 2.2400000000000002 114.047 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -96.69 -30.61 13.13 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 108.579 -0.897 . . . . 3.3599999999999999 108.579 -172.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -64.72 -42.4 95.26 Favored 'General case' 0 C--O 1.214 -0.798 0 CA-C-N 114.869 -1.059 . . . . 3.0800000000000001 111.179 177.569 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 46' ' ' CYS . . . . . 0.421 ' HA ' ' O ' ' B' ' 49' ' ' ARG . 35.7 t -89.33 -3.12 58.6 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.447 0.642 . . . . 2.23 110.703 -179.468 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 41.9 t -83.41 -50.42 8.33 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.638 0.732 . . . . 2.3700000000000001 109.491 175.001 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -88.67 -20.04 25.4 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.866 0.691 . . . . 2.8199999999999998 112.866 -177.033 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 49' ' ' ARG . . . . . 0.421 ' O ' ' HA ' ' B' ' 46' ' ' CYS . 36.1 mmt180 -130.68 150.31 51.93 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 106.68 -1.6 . . . . 4.0899999999999999 106.68 177.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 22.1 t -79.96 127.5 32.34 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 106.827 -1.545 . . . . 2.6699999999999999 106.827 178.468 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 24.3 p -90.52 139.21 30.91 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 109.36 -0.607 . . . . 2.1099999999999999 109.36 -173.274 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -85.87 165.0 17.16 Favored 'General case' 0 C--O 1.249 1.07 0 C-N-CA 120.566 -0.454 . . . . 2.6699999999999999 110.305 177.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 53' ' ' LEU . . . . . 0.64 ' HB2' ' HA ' ' A' 1600 ' ' SER . 63.5 tp -53.2 -45.02 68.43 Favored 'General case' 0 C--N 1.321 -0.663 0 O-C-N 123.479 0.487 . . . . 1.8999999999999999 111.649 178.141 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.89 -32.41 63.69 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.368 -0.833 . . . . 1.52 113.184 -171.347 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 65.9 tp -70.42 -57.65 4.58 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 121.012 0.434 . . . . 1.97 110.295 179.391 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 2.9 pp -71.97 -25.25 61.79 Favored 'General case' 0 C--O 1.213 -0.867 0 CA-C-N 116.043 -0.526 . . . . 1.53 111.195 -174.474 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -64.82 -55.6 18.62 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 122.638 0.375 . . . . 2.27 110.162 178.32 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 13.2 t -78.89 -27.42 43.91 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 119.331 -0.947 . . . . 2.3300000000000001 112.06 -177.668 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -71.66 -57.19 4.6 Favored 'General case' 0 C--O 1.219 -0.527 0 N-CA-C 107.02 -1.474 . . . . 2.8599999999999999 107.02 178.482 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 9.9 t . . . . . 0 N--CA 1.488 1.464 0 N-CA-C 117.121 2.267 . . . . 2.2999999999999998 117.121 174.492 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 86.6 mtp . . . . . 0 CA--C 1.502 -0.893 0 N-CA-C 108.685 -0.857 . . . . 9.3399999999999999 108.685 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -76.71 111.76 12.57 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-N 115.619 -0.719 . . . . 9.0399999999999991 112.023 -174.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 36.0 m 71.68 130.76 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 124.895 1.278 . . . . 5.8099999999999996 113.399 175.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1511 ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -78.48 -11.94 59.98 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 109.299 -0.63 . . . . 3.4199999999999999 109.299 176.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1512 ' ' GLU . . . . . 0.543 ' HA ' HG12 ' A' 1518 ' ' VAL . 29.5 mt-10 -92.64 147.77 22.6 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 114.914 -1.039 . . . . 5.9500000000000002 108.287 176.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 50.1 m80 -155.71 141.97 18.43 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 105.394 -2.076 . . . . 5.3300000000000001 105.394 -173.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 21.1 t70 -88.11 46.48 1.39 Allowed 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 107.795 -1.187 . . . . 5.0599999999999996 107.795 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -132.43 24.4 4.44 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 114.972 -1.013 . . . . 2.8999999999999999 110.857 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1516 ' ' CYS . . . . . 0.439 ' SG ' ' HB2' ' A' 1579 ' ' LYS . 77.8 m 54.11 35.84 23.3 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 113.876 1.065 . . . . 1.1899999999999999 113.876 -176.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -143.6 129.33 19.3 Favored 'General case' 0 N--CA 1.434 -1.267 0 C-N-CA 120.07 -0.652 . . . . 1.52 109.662 176.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1518 ' ' VAL . . . . . 0.543 HG12 ' HA ' ' A' 1512 ' ' GLU . 2.5 m -138.57 137.89 42.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 CA-C-N 115.379 -0.828 . . . . 0.93999999999999995 111.366 -175.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1519 ' ' THR . . . . . . . . . . . . . 6.3 m -98.15 136.85 37.78 Favored 'General case' 0 C--N 1.277 -2.579 0 CA-C-N 115.465 -0.789 . . . . 0.89000000000000001 109.476 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -77.35 117.71 67.2 Favored Pre-proline 0 N--CA 1.428 -1.537 0 N-CA-C 108.808 -0.812 . . . . 1.74 108.808 176.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -69.47 -13.49 35.49 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 122.491 2.127 . . . . 1.5800000000000001 113.795 -177.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 15.0 m -82.41 -36.74 26.4 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 112.498 0.555 . . . . 1.6499999999999999 112.498 -177.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1523 ' ' THR . . . . . . . . . . . . . 12.4 t -137.1 3.48 2.65 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 119.599 -0.84 . . . . 1.6100000000000001 112.215 -176.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 72.39 28.72 67.31 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.755 -0.736 . . . . 1.1299999999999999 112.599 177.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 62.3 t-80 -85.18 119.81 25.98 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.797 -0.816 . . . . 1.26 108.797 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 2.6 tm? -87.15 112.47 21.98 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 109.032 -0.729 . . . . 0.68000000000000005 109.032 -178.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -91.4 114.28 26.77 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 109.82 -0.437 . . . . 0.65000000000000002 109.82 175.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 17.5 t70 -110.07 116.41 31.52 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.813 -0.81 . . . . 1.1699999999999999 108.813 175.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1529 ' ' LEU . . . . . 0.6 ' HG ' HD11 ' A' 1581 ' ' LEU . 3.3 mm? -97.49 0.6 47.85 Favored 'General case' 0 N--CA 1.423 -1.817 0 CA-C-O 121.083 0.468 . . . . 0.59999999999999998 110.301 -177.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1530 ' ' SER . . . . . 0.555 ' HA ' ' OG ' ' A' 1533 ' ' SER . 2.2 m -70.19 -19.31 63.18 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 122.193 0.997 . . . . 0.83999999999999997 109.419 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1531 ' ' SER . . . . . 0.413 ' HB2' HD11 ' A' 1644 ' ' LEU . 21.2 m -68.68 -18.4 64.26 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 114.931 -1.031 . . . . 1.5900000000000001 110.238 175.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 82.6 mt -102.93 -6.73 22.13 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 122.322 -0.236 . . . . 0.65000000000000002 110.979 178.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1533 ' ' SER . . . . . 0.672 ' HA ' ' HB ' ' A' 1552 ' ' ILE . 30.2 m -60.97 162.5 6.93 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-O 120.947 0.403 . . . . 1.52 111.286 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . 170.72 151.61 7.64 Favored Glycine 0 N--CA 1.426 -1.991 0 C-N-CA 120.513 -0.851 . . . . 1.1000000000000001 111.107 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 33.8 ttt85 -87.21 -30.75 20.74 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 122.946 0.498 . . . . 4.6200000000000001 111.377 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -78.37 -35.82 46.81 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.727 -0.842 . . . . 1.45 108.727 177.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 80.7 -140.16 21.48 Favored Glycine 0 N--CA 1.409 -3.109 0 CA-C-N 114.535 -1.211 . . . . 0.84999999999999998 112.324 173.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -142.21 143.14 32.77 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 106.454 -1.684 . . . . 0.93000000000000005 106.454 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 1.2 m -108.59 130.19 55.31 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 108.793 -0.817 . . . . 1.03 108.793 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1540 ' ' ALA . . . . . 0.456 ' HB2' ' HG2' ' A' 1624 ' ' PRO . . . -124.71 147.33 48.67 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.999 -0.741 . . . . 0.5 108.999 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -91.17 128.18 36.89 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 120.794 0.331 . . . . 0.73999999999999999 110.225 -177.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1542 ' ' TYR . . . . . 0.556 ' CE2' ' HG ' ' A' 1626 ' ' LEU . 2.3 t80 -113.02 -99.32 0.43 Allowed 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.015 -1.105 . . . . 0.98999999999999999 108.015 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1543 ' ' SER . . . . . 0.431 ' H ' ' HB3' ' A' 1542 ' ' TYR . 4.5 m -69.81 159.19 34.07 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 108.372 -0.973 . . . . 1.9099999999999999 108.372 178.005 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 97.4 mttt -50.6 -42.69 56.19 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.269 0.841 . . . . 3.5899999999999999 113.269 -177.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 19.9 m -106.53 28.5 7.77 Favored 'General case' 0 N--CA 1.416 -2.137 0 C-N-CA 122.189 0.196 . . . . 2.46 111.487 -177.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . -144.04 149.18 21.2 Favored Glycine 0 C--O 1.245 0.819 0 C-N-CA 119.425 -1.369 . . . . 1.26 113.868 -177.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 19.8 m -130.87 152.06 36.95 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.979 0 N-CA-C 108.564 -0.902 . . . . 0.79000000000000004 108.564 177.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 10.3 p -108.68 134.63 50.0 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 N-CA-C 109.35 -0.611 . . . . 0.57999999999999996 109.35 178.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -93.62 133.89 36.48 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 107.148 -1.427 . . . . 1.0800000000000001 107.148 176.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 25.3 ptm -148.23 127.84 13.28 Favored 'General case' 0 C--N 1.282 -2.33 0 O-C-N 123.771 0.669 . . . . 0.78000000000000003 109.836 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 5.0 p -119.0 134.42 55.2 Favored 'General case' 0 C--N 1.27 -2.856 0 CA-C-N 115.318 -0.855 . . . . 0.96999999999999997 109.222 177.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1552 ' ' ILE . . . . . 0.672 ' HB ' ' HA ' ' A' 1533 ' ' SER . 46.3 mm -82.64 116.45 26.88 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 N-CA-C 109.527 -0.546 . . . . 0.41999999999999998 109.527 -177.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 62.3 m 63.61 11.42 5.7 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.552 1.141 . . . . 1.3999999999999999 113.701 173.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . -146.36 176.41 25.3 Favored Glycine 0 N--CA 1.42 -2.392 0 N-CA-C 108.972 -1.651 . . . . 0.34999999999999998 108.972 -177.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -99.34 145.34 27.45 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 117.214 0.507 . . . . 1.6200000000000001 110.853 -178.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -91.12 131.43 36.69 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 108.092 -1.077 . . . . 0.87 108.092 -176.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -81.7 -2.87 52.06 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 113.709 1.003 . . . . 2.4900000000000002 113.709 -175.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -84.59 -6.44 59.37 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.381 -0.528 . . . . 1.3799999999999999 110.781 -178.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1559 ' ' CYS . . . . . 0.632 ' SG ' ' HD2' ' A' 1560 ' ' PRO . 29.5 t -136.02 153.92 77.23 Favored Pre-proline 0 C--N 1.299 -1.612 0 N-CA-C 107.352 -1.351 . . . . 1.21 107.352 -178.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1560 ' ' PRO . . . . . 0.632 ' HD2' ' SG ' ' A' 1559 ' ' CYS . 7.7 Cg_exo -28.61 134.18 0.03 OUTLIER 'Trans proline' 0 CA--C 1.562 1.899 1 C-N-CA 125.471 4.114 . . . . 0.70999999999999996 115.585 175.718 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A 1561 ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' 1560 ' ' PRO . 4.9 Cg_endo -46.95 126.45 11.17 Favored 'Trans proline' 0 C--O 1.249 1.036 0 C-N-CA 124.818 3.679 . . . . 0.80000000000000004 114.196 -178.05 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 105.62 -11.96 46.53 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 115.583 -0.735 . . . . 0.46000000000000002 112.802 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1563 ' ' VAL . . . . . 0.669 HG11 ' HB2' ' A' 1566 ' ' CYS . 3.6 t -80.28 125.19 38.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 N-CA-C 112.904 0.705 . . . . 0.97999999999999998 112.904 -178.027 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -96.73 -34.81 5.6 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.226 -0.897 . . . . 0.28000000000000003 111.306 176.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -133.77 133.91 42.29 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 109.393 -0.595 . . . . 0.28000000000000003 109.393 178.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1566 ' ' CYS . . . . . 0.669 ' HB2' HG11 ' A' 1563 ' ' VAL . 52.8 t -159.51 136.67 9.62 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 119.652 -0.213 . . . . 0.42999999999999999 110.489 -174.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1567 ' ' PHE . . . . . 0.413 ' CE2' HG11 ' A' 1574 ' ' VAL . 74.9 m-85 -84.54 137.91 33.06 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.142 -1.058 . . . . 1.03 108.142 173.392 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -89.33 11.79 68.65 Favored Glycine 0 N--CA 1.435 -1.37 0 N-CA-C 117.15 1.62 . . . . 1.1299999999999999 117.15 -168.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1569 ' ' GLN . . . . . 0.429 ' HB2' ' OD2' ' B' ' 15' ' ' ASP . 0.8 OUTLIER -75.27 -70.59 0.41 Allowed 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 119.035 1.418 . . . . 2.5800000000000001 110.049 176.661 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 58.7 p -100.4 -4.68 28.51 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 119.809 -0.757 . . . . 2.1699999999999999 112.873 176.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1571 ' ' ARG . . . . . . . . . . . . 0.269 5.0 mpt_? 74.32 59.08 0.08 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.978 1.311 . . . . 2.6200000000000001 112.595 -178.128 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 21.4 mt -90.6 131.2 38.41 Favored 'Isoleucine or valine' 0 C--O 1.243 0.742 0 CA-C-N 114.34 -1.3 . . . . 0.92000000000000004 107.676 176.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 31.2 t -86.22 130.3 34.57 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.158 0.504 . . . . 0.80000000000000004 110.642 -175.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1574 ' ' VAL . . . . . 0.549 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 25.4 m -117.8 16.12 7.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-O 121.532 0.682 . . . . 0.97999999999999998 111.063 179.139 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 166.34 129.75 1.09 Allowed Glycine 0 N--CA 1.431 -1.684 0 CA-C-N 115.274 -0.876 . . . . 0.28999999999999998 111.8 176.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 29.6 ttpp -78.74 145.36 34.48 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 107.5 -1.296 . . . . 2.1899999999999999 107.5 176.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -66.88 80.0 0.11 Allowed 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 124.006 0.922 . . . . 0.60999999999999999 112.783 -175.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1578 ' ' ASN . . . . . 0.419 ' O ' ' HE1' ' A' 1592 ' ' TYR . 89.6 m-20 -96.06 -172.63 2.61 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 107.636 -1.246 . . . . 1.95 107.636 177.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1579 ' ' LYS . . . . . 0.439 ' HB2' ' SG ' ' A' 1516 ' ' CYS . 15.5 ptpt -149.9 46.71 0.93 Allowed 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 121.882 0.848 . . . . 2.6800000000000002 110.416 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 57.0 ttp180 -95.13 84.77 4.15 Favored 'General case' 0 N--CA 1.418 -2.066 0 CA-C-N 115.224 -0.898 . . . . 3.4700000000000002 109.117 -175.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1581 ' ' LEU . . . . . 0.6 HD11 ' HG ' ' A' 1529 ' ' LEU . 2.4 tt -91.56 130.82 37.32 Favored 'General case' 0 C--N 1.294 -1.848 0 CA-C-N 114.135 -1.393 . . . . 0.64000000000000001 109.618 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 46.6 mtm180 -125.67 141.09 52.19 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 116.074 -0.512 . . . . 2.8500000000000001 110.235 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1583 ' ' TYR . . . . . . . . . . . . . 46.0 t80 -103.85 105.05 15.13 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.872 -0.788 . . . . 0.85999999999999999 108.872 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1584 ' ' VAL . . . . . 0.519 ' O ' ' HB ' ' A' 1587 ' ' VAL . 15.5 m -123.51 91.04 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 CA-C-N 115.571 -0.74 . . . . 1.05 112.349 -175.1 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1585 ' ' ASP . . . . . 0.422 ' O ' ' HG2' ' A' 1586 ' ' GLN . 37.5 t70 57.62 66.79 1.06 Allowed 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.693 0.797 . . . . 1.1699999999999999 111.357 175.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1586 ' ' GLN . . . . . 0.422 ' HG2' ' O ' ' A' 1585 ' ' ASP . 14.4 pt20 70.63 -3.56 1.89 Allowed 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 128.178 2.591 . . . . 1.8600000000000001 111.525 178.154 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1587 ' ' VAL . . . . . 0.519 ' HB ' ' O ' ' A' 1584 ' ' VAL . 24.7 t -97.76 120.9 47.69 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.521 0 CA-C-N 115.158 -0.928 . . . . 0.48999999999999999 110.787 -177.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1588 ' ' LEU . . . . . 1.017 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 2.9 mm? -91.64 107.22 19.06 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 107.074 -1.454 . . . . 0.35999999999999999 107.074 175.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1589 ' ' GLN . . . . . 0.486 ' O ' ' HA ' ' A' 1581 ' ' LEU . 33.8 tt0 -98.74 126.63 44.41 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 109.558 -0.534 . . . . 1.74 109.558 -176.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1590 ' ' LEU . . . . . 0.677 ' HB3' ' HB ' ' A' 1610 ' ' ILE . 1.4 tt -121.4 100.05 6.82 Favored 'General case' 0 C--N 1.275 -2.652 0 N-CA-C 104.79 -2.3 . . . . 0.71999999999999997 104.79 175.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 5.1 p -97.99 131.98 43.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 C-N-CA 120.232 -0.587 . . . . 1.01 111.809 -174.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1592 ' ' TYR . . . . . 0.566 ' O ' ' HG3' ' A' 1607 ' ' LYS . 21.2 m-85 -116.43 142.56 46.71 Favored 'General case' 0 CA--C 1.504 -0.814 0 N-CA-C 107.824 -1.176 . . . . 0.5 107.824 176.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 10.4 ptmm? -147.61 -179.0 6.56 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 106.336 -1.728 . . . . 1.5900000000000001 106.336 -175.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 16.5 m-20 61.61 47.27 6.57 Favored 'General case' 0 CA--C 1.508 -0.646 0 O-C-N 124.323 1.014 . . . . 1.1100000000000001 110.478 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -83.43 -140.68 4.18 Favored Glycine 0 N--CA 1.432 -1.578 0 N-CA-C 109.954 -1.258 . . . . 0.78000000000000003 109.954 178.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1596 ' ' SER . . . . . . . . . . . . . 59.8 p -102.99 156.2 35.62 Favored Pre-proline 0 C--N 1.281 -2.393 0 N-CA-C 107.627 -1.249 . . . . 1.0700000000000001 107.627 176.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1597 ' ' PRO . . . . . 0.539 ' HA ' ' O ' ' A' 1604 ' ' LEU . 54.0 Cg_exo -54.58 123.81 14.58 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 122.386 2.058 . . . . 1.01 111.322 178.266 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1598 ' ' CYS . . . . . 0.459 ' HA ' ' HD3' ' A' 1599 ' ' PRO . 31.9 t -74.63 120.47 81.67 Favored Pre-proline 0 C--N 1.303 -1.436 0 N-CA-C 108.62 -0.882 . . . . 0.75 108.62 -178.388 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1599 ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' 1598 ' ' CYS . 26.1 Cg_exo -62.71 -19.32 67.94 Favored 'Trans proline' 0 N--CA 1.484 0.915 0 C-N-CA 123.585 2.857 . . . . 1.7 112.966 -176.081 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1600 ' ' SER . . . . . 0.541 ' HA ' ' HB2' ' B' ' 53' ' ' LEU . 6.4 m -58.66 -37.67 76.5 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 124.938 1.295 . . . . 2.2599999999999998 111.95 178.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1601 ' ' LYS . . . . . 0.447 ' HE2' ' N ' ' A' 1602 ' ' SER . 0.0 OUTLIER -148.5 108.4 4.04 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 104.47 -2.418 . . . . 3.0099999999999998 104.47 -179.503 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A 1602 ' ' SER . . . . . 0.447 ' N ' ' HE2' ' A' 1601 ' ' LYS . 8.4 t -57.42 117.35 4.03 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 123.02 0.528 . . . . 2.0699999999999998 110.927 -174.056 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 106.18 -7.11 40.33 Favored Glycine 0 N--CA 1.437 -1.24 0 C-N-CA 120.828 -0.701 . . . . 1.0800000000000001 112.481 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1604 ' ' LEU . . . . . 0.571 HD23 ' SG ' ' A' 1634 ' ' CYS . 10.7 tp -84.77 163.09 19.34 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.169 -1.419 . . . . 1.8400000000000001 107.169 178.221 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 19.0 t -127.27 153.86 45.61 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.426 -0.953 . . . . 1.4099999999999999 108.426 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1606 ' ' TYR . . . . . 0.549 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 57.5 m-85 -80.95 166.38 20.89 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.786 -0.45 . . . . 0.59999999999999998 109.786 176.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1607 ' ' LYS . . . . . 0.566 ' HG3' ' O ' ' A' 1592 ' ' TYR . 36.5 ttpt -160.74 131.74 5.51 Favored 'General case' 0 CA--C 1.503 -0.83 0 N-CA-C 109.922 -0.399 . . . . 1.45 109.922 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1608 ' ' SER . . . . . . . . . . . . . 22.2 m -113.05 123.35 50.1 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 108.81 -0.811 . . . . 1.1499999999999999 108.81 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 41.5 t -107.91 110.21 31.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 108.909 -0.775 . . . . 0.25 108.909 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1610 ' ' ILE . . . . . 0.677 ' HB ' ' HB3' ' A' 1590 ' ' LEU . 20.3 mm -89.63 128.45 41.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 106.23 -1.767 . . . . 0.45000000000000001 106.23 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 23.1 t -127.1 101.11 6.39 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-O 121.386 0.612 . . . . 1.26 109.576 -177.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1612 ' ' PHE . . . . . 1.017 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 60.4 m-85 -86.18 130.18 34.61 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.468 -0.787 . . . . 0.26000000000000001 111.07 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 54.4 t -127.09 139.32 52.24 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.003 0 C-N-CA 123.132 0.573 . . . . 0.5 110.709 -177.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1614 ' ' CYS . . . . . 0.536 ' SG ' ' HD3' ' A' 1616 ' ' PRO . 2.0 t -60.73 111.47 1.64 Allowed 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 125.234 1.414 . . . . 0.77000000000000002 112.402 177.294 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1615 ' ' ARG . . . . . 0.648 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 22.2 tpt180 -128.3 86.86 56.82 Favored Pre-proline 0 C--N 1.316 -0.861 0 N-CA-C 108.292 -1.003 . . . . 2.5299999999999998 108.292 172.036 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1616 ' ' PRO . . . . . 0.621 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 43.3 Cg_endo -67.72 -23.62 41.98 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 122.272 1.981 . . . . 1.1000000000000001 113.389 -174.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -86.3 -4.97 59.27 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 121.03 -0.268 . . . . 3.0499999999999998 111.078 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . 58.34 -162.69 0.22 Allowed 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 123.351 0.661 . . . . 1.55 109.704 -176.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . 139.75 -161.8 26.24 Favored Glycine 0 N--CA 1.411 -3.003 0 C-N-CA 120.279 -0.962 . . . . 0.93000000000000005 111.522 178.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -83.26 15.45 2.1 Favored 'Trans proline' 0 C--N 1.321 -0.878 0 C-N-CA 123.277 2.651 . . . . 0.88 112.762 -178.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1621 ' ' THR . . . . . . . . . . . . . 20.6 p -106.11 1.39 26.26 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 115.564 -0.743 . . . . 0.96999999999999997 110.454 -178.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -86.74 65.84 9.19 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 107.158 -1.423 . . . . 0.71999999999999997 107.158 176.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1623 ' ' ARG . . . . . 0.478 ' O ' ' HG3' ' A' 1625 ' ' MET . 14.2 ptm180 -170.17 140.93 1.65 Allowed Pre-proline 0 C--N 1.291 -1.951 0 N-CA-C 106.566 -1.642 . . . . 3.2599999999999998 106.566 -175.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1624 ' ' PRO . . . . . 0.456 ' HG2' ' HB2' ' A' 1540 ' ' ALA . 15.4 Cg_endo -55.71 106.51 0.2 Allowed 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 122.78 2.32 . . . . 0.58999999999999997 111.627 -178.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1625 ' ' MET . . . . . 0.708 ' HB2' ' HB3' ' A' 1639 ' ' SER . 93.2 mtp -98.64 109.36 22.13 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.732 -0.84 . . . . 1.3700000000000001 108.732 -177.107 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1626 ' ' LEU . . . . . 0.556 ' HG ' ' CE2' ' A' 1542 ' ' TYR . 0.3 OUTLIER -71.84 115.39 10.99 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 106.685 -1.598 . . . . 0.89000000000000001 106.685 -179.68 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A 1627 ' ' ILE . . . . . 0.88 HD11 ' HB2' ' A' 1639 ' ' SER . 44.4 mm -70.82 -53.56 21.42 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.119 0 N-CA-C 108.767 -0.827 . . . . 0.57999999999999996 108.767 -178.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 19.7 t -179.41 162.42 1.15 Allowed 'General case' 0 N--CA 1.422 -1.862 0 N-CA-C 107.435 -1.32 . . . . 1.3899999999999999 107.435 -176.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1629 ' ' LEU . . . . . . . . . . . . . 43.2 tp -112.75 115.5 28.62 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 107.423 -1.325 . . . . 1.25 107.423 176.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 12.0 t70 -68.6 107.52 2.99 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 107.503 -1.295 . . . . 1.0900000000000001 107.503 174.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1631 ' ' LYS . . . . . 0.526 ' HD2' HD21 ' B' ' 53' ' ' LEU . 4.0 tppp? -56.6 -37.63 70.91 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.168 -1.378 . . . . 3.6000000000000001 114.38 -169.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 81.5 mm-40 -89.22 -29.11 19.5 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 119.684 -0.807 . . . . 2.6000000000000001 112.449 -174.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 60.2 p -100.6 -2.57 32.5 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 113.471 0.915 . . . . 0.75 113.471 -174.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1634 ' ' CYS . . . . . 0.571 ' SG ' HD23 ' A' 1604 ' ' LEU . 71.0 m 58.31 37.56 25.98 Favored 'General case' 0 C--N 1.367 1.355 0 CA-C-O 121.849 0.833 . . . . 0.53000000000000003 111.541 178.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1635 ' ' THR . . . . . . . . . . . . . 88.5 m -105.45 124.12 49.01 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 114.964 -1.017 . . . . 0.46000000000000002 109.905 -178.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1636 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -104.39 133.07 49.89 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 107.527 -1.286 . . . . 0.85999999999999999 107.527 -177.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1637 ' ' PHE . . . . . 0.47 ' HB2' ' HB ' ' A' 1627 ' ' ILE . 85.8 m-85 -108.35 137.07 46.94 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.844 -0.428 . . . . 0.45000000000000001 109.844 178.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -129.58 130.53 45.81 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 109.859 -0.422 . . . . 0.5 109.859 -175.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1639 ' ' SER . . . . . 0.88 ' HB2' HD11 ' A' 1627 ' ' ILE . 11.3 t -106.59 154.67 20.57 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.102 -1.444 . . . . 1.04 107.102 176.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1640 ' ' TRP . . . . . 0.402 ' CH2' ' HD3' ' A' 1624 ' ' PRO . 1.8 t90 -156.44 114.94 3.36 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 106.113 -1.81 . . . . 0.68000000000000005 106.113 178.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1641 ' ' HIS . . . . . 0.648 ' HB3' ' HB2' ' A' 1615 ' ' ARG . 38.4 m-70 -105.13 112.31 25.39 Favored 'General case' 0 C--N 1.288 -2.105 0 C-N-CA 119.861 -0.736 . . . . 0.90000000000000002 110.201 -177.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1642 ' ' THR . . . . . . . . . . . . . 4.4 t -142.69 148.94 48.44 Favored Pre-proline 0 C--N 1.307 -1.258 0 CA-C-N 115.731 -0.668 . . . . 0.47999999999999998 110.375 -175.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1643 ' ' PRO . . . . . 0.621 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 73.5 Cg_endo -79.45 -5.33 14.14 Favored 'Trans proline' 0 C--N 1.367 1.544 0 C-N-CA 122.51 2.14 . . . . 0.66000000000000003 112.54 176.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1644 ' ' LEU . . . . . 0.413 HD11 ' HB2' ' A' 1531 ' ' SER . 7.6 tt -75.41 -23.21 57.0 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.829 0.823 . . . . 0.96999999999999997 109.614 177.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -103.0 28.41 6.26 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.006 -0.997 . . . . 0.83999999999999997 111.395 -174.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 28.6 t -120.56 149.87 41.76 Favored 'General case' 0 C--N 1.287 -2.147 0 C-N-CA 119.971 -0.692 . . . . 1.1899999999999999 110.57 -175.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.42 119.47 36.13 Favored Pre-proline 0 N--CA 1.419 -2.016 0 N-CA-C 107.655 -1.239 . . . . 3.1400000000000001 107.655 172.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1648 ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.76 108.81 2.16 Favored 'Trans proline' 0 C--O 1.243 0.761 0 C-N-CA 122.803 2.336 . . . . 2.5800000000000001 114.972 -171.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 . . . . . 0 C--N 1.307 -1.272 0 N-CA-C 107.412 -1.329 . . . . 4.7199999999999998 107.412 172.889 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.337 0 N-CA-C 109.209 -0.663 . . . . 9.9700000000000006 109.209 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 2' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -128.21 135.3 49.52 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.899 -0.778 . . . . 7.6799999999999997 108.899 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 39.3 ptt180 -124.09 144.02 44.13 Favored Pre-proline 0 C--N 1.29 -2.01 0 N-CA-C 108.399 -0.963 . . . . 6.1100000000000003 108.399 -179.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -67.24 -14.25 42.37 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 123.186 2.591 . . . . 4.8399999999999999 114.808 -178.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 50.7 m -135.94 118.2 15.59 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 122.016 0.126 . . . . 4.5999999999999996 111.117 -178.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -78.77 -21.44 47.88 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-O 121.319 0.58 . . . . 4.2300000000000004 109.738 173.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 6.9 p -122.7 98.37 5.88 Favored 'General case' 0 N--CA 1.415 -2.193 0 N-CA-C 107.915 -1.143 . . . . 3.1400000000000001 107.915 172.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.613 ' HB3' ' HG3' ' B' ' 12' ' ' GLU . 29.1 tp -74.2 94.89 2.52 Favored 'General case' 0 C--O 1.25 1.125 0 N-CA-C 109.523 -0.547 . . . . 3.96 109.523 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 46.7 m -54.49 119.55 5.4 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 109.008 -0.738 . . . . 2.8399999999999999 109.008 176.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 10' ' ' GLY . . . . . 0.462 ' O ' HG12 ' B' ' 14' ' ' VAL . . . 102.22 -82.69 0.44 Allowed Glycine 0 N--CA 1.417 -2.578 0 N-CA-C 109.742 -1.343 . . . . 2.0899999999999999 109.742 -175.144 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 11' ' ' GLY . . . . . 0.438 ' HA3' HD23 ' B' ' 8' ' ' LEU . . . -47.38 -70.53 0.69 Allowed Glycine 0 C--O 1.224 -0.495 0 N-CA-C 115.205 0.842 . . . . 1.8400000000000001 115.205 -177.204 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 12' ' ' GLU . . . . . 0.613 ' HG3' ' HB3' ' B' ' 8' ' ' LEU . 44.5 mt-10 -65.79 -35.4 80.59 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-N 117.814 0.807 . . . . 2.5499999999999998 110.621 -177.209 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 13' ' ' LEU . . . . . 0.58 HD21 ' HB2' ' B' ' 46' ' ' CYS . 5.7 mt -58.73 -60.75 3.34 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 113.306 0.854 . . . . 2.3500000000000001 113.306 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 14' ' ' VAL . . . . . 0.462 HG12 ' O ' ' B' ' 10' ' ' GLY . 7.7 p -74.99 -30.37 23.47 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 C-N-CA 120.017 -0.673 . . . . 2.1099999999999999 111.773 -176.031 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 15' ' ' ASP . . . . . 0.429 ' OD2' ' HB2' ' A' 1569 ' ' GLN . 18.2 t0 -67.5 -42.27 83.16 Favored 'General case' 0 C--O 1.207 -1.137 0 C-N-CA 119.483 -0.887 . . . . 2.04 111.426 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 23.8 p -61.51 -40.77 95.8 Favored 'General case' 0 C--O 1.25 1.104 0 CA-C-N 118.292 0.496 . . . . 1.8400000000000001 110.718 177.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.536 ' O ' ' HB2' ' B' ' 21' ' ' CYS . 4.3 mm? -58.5 -51.21 70.81 Favored 'General case' 0 C--O 1.21 -1.022 0 CA-C-N 115.86 -0.609 . . . . 1.74 111.309 174.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -69.07 -29.12 67.17 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 116.349 -0.387 . . . . 2.3900000000000001 111.268 -177.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -61.22 -61.09 2.8 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.949 -0.568 . . . . 0.95999999999999996 112.248 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 14.2 p -97.9 -13.39 8.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 C-N-CA 118.604 -1.238 . . . . 1.3700000000000001 111.686 -176.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 21' ' ' CYS . . . . . 0.536 ' HB2' ' O ' ' B' ' 17' ' ' LEU . 73.3 m -106.38 14.43 27.35 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.341 -0.849 . . . . 1.6599999999999999 112.652 178.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -52.14 -45.39 57.26 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 121.252 -0.499 . . . . 1.53 112.899 176.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -79.19 -42.89 25.02 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.398 0.518 . . . . 2.7200000000000002 112.398 177.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 6.3 tpm_? -71.25 -33.86 70.21 Favored 'General case' 0 C--O 1.244 0.799 0 N-CA-C 112.864 0.69 . . . . 4.3300000000000001 112.864 -174.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 25' ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' B' ' 61' ' ' ALA . . . 110.92 139.43 8.05 Favored Glycine 0 N--CA 1.424 -2.153 0 N-CA-C 108.551 -1.82 . . . . 1.53 108.551 -175.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 26' ' ' PHE . . . . . 0.464 ' HB2' ' HB3' ' B' ' 17' ' ' LEU . 50.9 p90 -128.4 122.78 32.21 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 117.523 0.662 . . . . 1.6499999999999999 110.484 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 27' ' ' TYR . . . . . 0.432 ' CZ ' ' HB1' ' B' ' 61' ' ' ALA . 13.9 p90 -163.04 96.14 0.89 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.28 0.562 . . . . 3.4199999999999999 111.553 178.202 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 28' ' ' PHE . . . . . 0.436 ' HA ' ' HE1' ' B' ' 59' ' ' TYR . 42.5 p90 -94.13 -10.52 32.98 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-O 121.358 0.599 . . . . 2.2599999999999998 110.398 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 46.9 t -109.28 108.06 18.51 Favored 'General case' 0 N--CA 1.424 -1.733 0 N-CA-C 107.686 -1.227 . . . . 3.6800000000000002 107.686 177.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 78.3 mtm-85 -123.02 108.57 32.37 Favored Pre-proline 0 N--CA 1.442 -0.835 0 C-N-CA 120.851 -0.34 . . . . 3.8100000000000001 110.333 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -65.85 -49.06 2.41 Favored 'Trans proline' 0 C--O 1.237 0.462 0 C-N-CA 123.427 2.752 . . . . 4.0199999999999996 112.598 178.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 32' ' ' ALA . . . . . 0.801 ' HA ' ' HB3' ' B' ' 38' ' ' ARG . . . -159.41 -178.83 7.43 Favored 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 110.193 -0.299 . . . . 4.9199999999999999 110.193 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 29.6 t 169.99 150.61 0.04 OUTLIER 'General case' 0 N--CA 1.42 -1.954 0 C-N-CA 126.936 2.094 . . . . 6.7199999999999998 105.485 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 16.4 ttm180 -81.11 -1.86 46.03 Favored 'General case' 0 C--N 1.283 -2.286 0 CA-C-O 122.275 1.036 . . . . 11.630000000000001 108.699 -177.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 51.9 t -91.39 -3.8 10.67 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 CA-C-N 114.447 -1.251 . . . . 9.6099999999999994 108.823 176.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 23.1 t 62.32 31.3 17.44 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 114.805 -1.089 . . . . 6.71 109.463 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 39.3 ptt180 -92.27 11.45 25.76 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 115.064 -0.971 . . . . 10.0 111.41 -175.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 38' ' ' ARG . . . . . 0.801 ' HB3' ' HA ' ' B' ' 32' ' ' ALA . 10.2 ptt180 -66.01 80.13 0.08 Allowed 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 114.361 -1.29 . . . . 7.9400000000000004 112.236 178.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 50.8 m -141.69 115.38 9.08 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 107.656 -1.238 . . . . 5.7599999999999998 107.656 174.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -81.57 148.39 29.15 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.757 -0.831 . . . . 6.0300000000000002 108.757 175.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . -147.22 167.22 28.46 Favored Glycine 0 N--CA 1.419 -2.434 0 C-N-CA 119.668 -1.253 . . . . 2.3700000000000001 111.583 178.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 14.4 pt 61.61 -24.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 C-N-CA 128.245 2.618 . . . . 2.0699999999999998 116.488 174.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 2.8 p -51.34 -51.35 24.3 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 N-CA-C 114.612 1.338 . . . . 2.2400000000000002 114.612 -178.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -92.65 -29.64 16.0 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.074 -1.084 . . . . 3.3599999999999999 108.074 -176.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 45' ' ' GLU . . . . . 0.722 ' O ' ' HG2' ' B' ' 49' ' ' ARG . 40.6 mt-10 -59.96 -66.67 0.48 Allowed 'General case' 0 N--CA 1.432 -1.371 0 CA-C-N 114.968 -1.015 . . . . 3.0800000000000001 109.385 177.048 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 46' ' ' CYS . . . . . 0.58 ' HB2' HD21 ' B' ' 13' ' ' LEU . 72.1 m -76.72 1.24 17.72 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 112.787 0.662 . . . . 2.23 112.787 -175.136 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 41.1 t -82.47 -50.41 8.88 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 119.496 -0.882 . . . . 2.3700000000000001 109.105 171.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -102.75 -20.87 14.19 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 114.38 1.252 . . . . 2.8199999999999998 114.38 -173.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 49' ' ' ARG . . . . . 0.722 ' HG2' ' O ' ' B' ' 45' ' ' GLU . 17.2 ptp180 -113.05 165.75 12.07 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 108.142 -1.058 . . . . 4.0899999999999999 108.142 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 28.1 t -86.19 139.72 30.81 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 108.242 -1.021 . . . . 2.6699999999999999 108.242 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 95.6 m -124.25 159.9 29.17 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-O 121.599 0.714 . . . . 2.1099999999999999 111.88 -175.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -106.4 149.05 27.39 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 107.167 -1.42 . . . . 2.6699999999999999 107.167 175.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 53' ' ' LEU . . . . . 0.541 ' HB2' ' HA ' ' A' 1600 ' ' SER . 55.0 tp -56.34 -27.99 57.62 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 124.905 1.282 . . . . 1.8999999999999999 112.047 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 54' ' ' ALA . . . . . 0.624 ' O ' HG22 ' B' ' 58' ' ' THR . . . -58.17 -47.83 82.17 Favored 'General case' 0 CA--C 1.516 -0.352 0 O-C-N 123.2 0.312 . . . . 1.52 110.841 -178.332 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 55' ' ' LEU . . . . . 0.441 ' O ' ' HB2' ' B' ' 59' ' ' TYR . 58.7 tp -54.24 -50.97 65.95 Favored 'General case' 0 CA--C 1.509 -0.604 0 C-N-CA 123.847 0.859 . . . . 1.97 111.308 -178.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 56' ' ' LEU . . . . . 0.406 HD11 HD12 ' B' ' 53' ' ' LEU . 3.4 pp -74.15 -36.07 64.1 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-N 116.07 -0.514 . . . . 1.53 111.555 -174.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -68.63 -48.76 63.25 Favored 'General case' 0 N--CA 1.439 -0.976 0 O-C-N 123.495 0.497 . . . . 2.27 111.357 -178.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 58' ' ' THR . . . . . 0.624 HG22 ' O ' ' B' ' 54' ' ' ALA . 9.2 t -74.08 -15.27 61.06 Favored 'General case' 0 C--O 1.246 0.909 0 C-N-CA 120.186 -0.606 . . . . 2.3300000000000001 111.73 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 59' ' ' TYR . . . . . 0.441 ' HB2' ' O ' ' B' ' 55' ' ' LEU . 8.6 t80 -80.34 -76.32 0.23 Allowed 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 105.807 -1.923 . . . . 2.8599999999999999 105.807 174.389 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 47.2 t 58.56 -78.04 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 125.096 1.359 . . . . 2.2999999999999998 112.604 176.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 61' ' ' ALA . . . . . 0.432 ' HB1' ' CZ ' ' B' ' 27' ' ' TYR . . . -139.52 -75.73 0.35 Allowed 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 107.459 -1.311 . . . . 3.1899999999999999 107.459 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -136.37 131.78 18.65 Favored Pre-proline 0 C--N 1.307 -1.277 0 N-CA-C 109.434 -0.58 . . . . 3.6800000000000002 109.434 175.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -64.67 -24.54 62.31 Favored 'Trans proline' 0 C--O 1.237 0.453 0 C-N-CA 123.598 2.865 . . . . 5.0800000000000001 117.041 -167.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -124.7 25.39 7.5 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 112.416 0.524 . . . . 5.0999999999999996 112.416 -177.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 65' ' ' LYS . . . . . 0.418 ' HD3' ' HA ' ' B' ' 65' ' ' LYS . 24.0 mmtp -94.29 4.5 53.79 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 114.633 1.345 . . . . 8.5099999999999998 114.633 -178.178 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 43.7 m -101.91 7.48 41.49 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 121.958 0.885 . . . . 8.1199999999999992 108.707 174.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 56.7 mm-40 . . . . . 0 N--CA 1.428 -1.529 0 CA-C-N 114.477 -1.238 . . . . 10.210000000000001 109.186 -177.914 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.515 -0.37 0 N-CA-C 109.712 -0.477 . . . . 9.3399999999999999 109.712 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? -96.98 -11.13 24.96 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 122.241 1.02 . . . . 9.0399999999999991 110.356 -175.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 34.0 t -140.35 -170.3 2.95 Favored 'General case' 0 C--N 1.268 -2.964 0 N-CA-C 107.583 -1.265 . . . . 5.8099999999999996 107.583 177.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1511 ' ' ASN . . . . . . . . . . . . . 30.7 p-10 -77.72 -28.17 50.79 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.361 0.601 . . . . 3.4199999999999999 110.186 178.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1512 ' ' GLU . . . . . 0.8 ' HA ' HG12 ' A' 1518 ' ' VAL . 10.9 pt-20 -87.16 159.44 18.87 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.687 -0.688 . . . . 5.9500000000000002 111.54 -177.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1513 ' ' HIS . . . . . 0.619 ' HB2' ' HG3' ' A' 1517 ' ' GLN . 21.5 m-70 -120.13 -175.72 3.05 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 107.112 -1.44 . . . . 5.3300000000000001 107.112 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 29.0 t70 -68.99 -33.3 73.44 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 119.562 1.074 . . . . 5.0599999999999996 112.62 -175.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1515 ' ' ASP . . . . . 0.411 ' HB3' ' H ' ' A' 1516 ' ' CYS . 5.5 m-20 -106.38 -164.18 0.98 Allowed 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.334 0.588 . . . . 2.8999999999999999 111.626 177.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1516 ' ' CYS . . . . . 0.427 ' HA ' ' HB2' ' A' 1581 ' ' LEU . 6.4 p -76.05 66.32 2.21 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 124.034 0.933 . . . . 1.1899999999999999 111.976 -177.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1517 ' ' GLN . . . . . 0.619 ' HG3' ' HB2' ' A' 1513 ' ' HIS . 3.9 pt20 -154.93 130.95 10.18 Favored 'General case' 0 N--CA 1.421 -1.89 0 CA-C-N 115.355 -0.838 . . . . 1.52 109.638 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1518 ' ' VAL . . . . . 0.8 HG12 ' HA ' ' A' 1512 ' ' GLU . 9.6 m -135.0 144.39 34.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 C-N-CA 123.183 0.593 . . . . 0.93999999999999995 111.188 -177.211 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1519 ' ' THR . . . . . . . . . . . . . 24.6 m -111.26 133.61 53.46 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 109.384 -0.599 . . . . 0.89000000000000001 109.384 178.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -94.63 123.83 56.9 Favored Pre-proline 0 C--N 1.309 -1.152 0 N-CA-C 109.838 -0.43 . . . . 1.74 109.838 175.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -65.33 -16.17 53.27 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.288 2.658 . . . . 1.5800000000000001 114.638 -176.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 50.2 m -83.04 -49.64 9.34 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 111.985 0.365 . . . . 1.6499999999999999 111.985 -177.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1523 ' ' THR . . . . . . . . . . . . . 4.4 t -101.75 -9.1 21.13 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.686 0.755 . . . . 1.6100000000000001 111.337 -177.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 64.85 35.03 91.43 Favored Glycine 0 CA--C 1.488 -1.64 0 CA-C-N 115.291 -0.868 . . . . 1.1299999999999999 111.772 178.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 22.3 t-80 -99.45 123.1 43.43 Favored 'General case' 0 N--CA 1.422 -1.83 0 C-N-CA 119.979 -0.688 . . . . 1.26 110.218 -177.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 1.7 tm? -88.34 106.99 18.6 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 114.423 -1.262 . . . . 0.68000000000000005 108.011 177.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1527 ' ' PHE . . . . . 0.45 ' O ' ' HA ' ' A' 1517 ' ' GLN . 85.8 m-85 -89.07 112.83 23.88 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.052 -0.721 . . . . 0.65000000000000002 109.052 175.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 22.0 t70 -110.9 114.52 27.92 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.886 -0.783 . . . . 1.1699999999999999 108.886 177.054 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 3.5 mm? -90.69 -4.06 57.03 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.288 0.566 . . . . 0.59999999999999998 110.205 -174.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 7.2 m -61.66 -20.32 63.29 Favored 'General case' 0 C--O 1.219 -0.544 0 CA-C-N 114.976 -1.011 . . . . 0.83999999999999997 110.685 178.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 19.5 m -65.99 -19.52 65.89 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 120.754 0.311 . . . . 1.5900000000000001 111.606 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1532 ' ' LEU . . . . . 0.401 ' HB2' HG21 ' A' 1552 ' ' ILE . 73.4 mt -98.51 11.37 38.48 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.675 0.274 . . . . 0.65000000000000002 111.513 -178.206 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1533 ' ' SER . . . . . . . . . . . . . 25.4 p -66.13 155.97 35.35 Favored 'General case' 0 C--O 1.252 1.229 0 CA-C-O 121.385 0.612 . . . . 1.52 112.426 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -175.86 142.53 6.12 Favored Glycine 0 N--CA 1.428 -1.864 0 N-CA-C 109.727 -1.349 . . . . 1.1000000000000001 109.727 178.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 44.0 ttm180 -89.26 -37.9 14.61 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 123.688 0.287 . . . . 4.6200000000000001 110.841 -177.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -71.36 -33.92 69.99 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-O 122.017 0.913 . . . . 1.45 109.274 178.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 96.89 -171.44 27.29 Favored Glycine 0 N--CA 1.417 -2.626 0 CA-C-N 114.865 -1.061 . . . . 0.84999999999999998 113.05 172.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -124.86 143.97 50.55 Favored 'General case' 0 C--N 1.279 -2.487 0 N-CA-C 107.845 -1.168 . . . . 0.93000000000000005 107.845 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 19.7 p -106.2 130.76 54.01 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 123.852 0.72 . . . . 1.03 110.319 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1540 ' ' ALA . . . . . 0.46 ' HB3' ' CG1' ' A' 1548 ' ' VAL . . . -118.97 140.92 49.2 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 107.944 -1.132 . . . . 0.5 107.944 177.087 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -79.24 139.63 37.86 Favored 'General case' 0 C--N 1.316 -0.875 0 O-C-N 123.726 0.641 . . . . 0.73999999999999999 109.872 -178.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1542 ' ' TYR . . . . . 0.473 ' HB3' ' H ' ' A' 1543 ' ' SER . 0.5 OUTLIER -149.89 -102.72 0.07 Allowed 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.953 -0.758 . . . . 0.98999999999999999 108.953 -178.603 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A 1543 ' ' SER . . . . . 0.473 ' H ' ' HB3' ' A' 1542 ' ' TYR . 16.2 m -67.91 152.8 44.98 Favored 'General case' 0 N--CA 1.432 -1.342 0 C-N-CA 124.008 0.923 . . . . 1.9099999999999999 109.364 -179.276 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.49 -27.24 69.14 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.453 -0.794 . . . . 3.5899999999999999 112.326 -171.47 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 20.3 m -123.25 33.09 5.47 Favored 'General case' 0 N--CA 1.397 -3.087 0 N-CA-C 109.588 -0.523 . . . . 2.46 109.588 176.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . -162.73 130.75 2.32 Favored Glycine 0 N--CA 1.438 -1.203 0 C-N-CA 118.528 -1.796 . . . . 1.26 115.172 -177.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 27.8 m -112.44 160.9 11.65 Favored 'Isoleucine or valine' 0 C--O 1.252 1.184 0 N-CA-C 108.44 -0.948 . . . . 0.79000000000000004 108.44 177.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1548 ' ' VAL . . . . . 0.46 ' CG1' ' HB3' ' A' 1540 ' ' ALA . 14.8 p -106.85 134.84 47.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 C-N-CA 120.477 -0.489 . . . . 0.57999999999999996 110.258 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -93.07 130.98 38.5 Favored 'General case' 0 CA--C 1.484 -1.562 0 N-CA-C 108.637 -0.875 . . . . 1.0800000000000001 108.637 175.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1550 ' ' MET . . . . . 0.425 ' HA ' ' O ' ' A' 1564 ' ' GLY . 15.2 ptp -137.44 137.03 38.33 Favored 'General case' 0 C--N 1.284 -2.27 0 CA-C-N 115.63 -0.714 . . . . 0.78000000000000003 111.315 175.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 11.6 p -117.63 113.8 22.45 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 115.261 -0.881 . . . . 0.96999999999999997 108.965 176.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1552 ' ' ILE . . . . . 0.401 HG21 ' HB2' ' A' 1532 ' ' LEU . 48.9 mm -77.71 119.39 26.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 N-CA-C 110.016 -0.364 . . . . 0.41999999999999998 110.016 -177.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 77.4 m 64.42 44.36 4.2 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 124.041 0.838 . . . . 1.3999999999999999 110.932 177.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 174.81 -179.49 46.08 Favored Glycine 0 N--CA 1.432 -1.575 0 C-N-CA 120.42 -0.895 . . . . 0.34999999999999998 111.279 -179.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -104.64 158.63 16.37 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 120.617 0.246 . . . . 1.6200000000000001 110.656 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -119.06 111.17 17.96 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.25 -1.019 . . . . 0.87 108.25 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -69.77 2.9 2.9 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 114.169 1.174 . . . . 2.4900000000000002 114.169 -173.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -76.34 -15.73 59.9 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 120.154 -0.618 . . . . 1.3799999999999999 110.029 178.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1559 ' ' CYS . . . . . 0.705 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 71.1 m -132.5 174.57 4.56 Favored Pre-proline 0 C--N 1.302 -1.482 0 CA-C-O 117.717 -1.135 . . . . 1.21 110.238 -178.463 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1560 ' ' PRO . . . . . 0.705 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 22.9 Cg_exo -28.75 128.7 0.04 OUTLIER 'Trans proline' 0 C--N 1.396 3.072 1 C-N-CA 125.506 4.137 . . . . 0.70999999999999996 114.733 178.629 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -43.64 119.87 2.02 Favored 'Trans proline' 0 C--O 1.247 0.942 0 C-N-CA 124.547 3.498 . . . . 0.80000000000000004 114.21 -177.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 87.43 23.62 39.41 Favored Glycine 0 N--CA 1.437 -1.29 0 CA-C-N 115.515 -0.766 . . . . 0.46000000000000002 113.368 177.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1563 ' ' VAL . . . . . 0.459 HG11 ' HB2' ' A' 1559 ' ' CYS . 5.5 p -100.98 144.11 13.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 117.94 0.87 . . . . 0.97999999999999998 109.852 -178.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1564 ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' 1550 ' ' MET . . . -106.07 -30.35 4.52 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 121.235 -0.507 . . . . 0.28000000000000003 113.252 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -128.26 130.14 47.45 Favored 'General case' 0 C--O 1.247 0.964 0 CA-C-N 117.307 0.553 . . . . 0.28000000000000003 109.867 178.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1566 ' ' CYS . . . . . 0.443 ' SG ' ' HA ' ' A' 1571 ' ' ARG . 9.9 t -157.72 141.05 15.38 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 116.372 -0.376 . . . . 0.42999999999999999 111.32 -176.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1567 ' ' PHE . . . . . 0.506 ' CE2' HG11 ' A' 1574 ' ' VAL . 74.3 m-85 -88.08 138.38 31.5 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 108.646 -0.872 . . . . 1.03 108.646 175.214 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -72.77 -9.08 74.31 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 117.854 1.902 . . . . 1.1299999999999999 117.854 -168.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -80.16 -70.61 0.51 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 119.997 1.899 . . . . 2.5800000000000001 112.412 -176.327 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1570 ' ' THR . . . . . 0.448 HG21 ' HA ' ' B' ' 12' ' ' GLU . 19.1 p -91.96 -3.69 55.57 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 119.862 -0.735 . . . . 2.1699999999999999 112.782 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1571 ' ' ARG . . . . . 0.443 ' HA ' ' SG ' ' A' 1566 ' ' CYS . 10.8 mmt85 65.49 44.11 3.17 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.59 1.156 . . . . 2.6200000000000001 111.051 177.012 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 40.7 mt -74.66 137.23 23.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-N 115.914 -0.585 . . . . 0.92000000000000004 109.461 178.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 26.7 t -83.3 120.45 25.86 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 109.377 -0.601 . . . . 0.80000000000000004 109.377 -179.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1574 ' ' VAL . . . . . 0.606 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 32.6 m -118.3 10.18 6.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 C-N-CA 119.368 -0.933 . . . . 0.97999999999999998 111.377 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 173.99 113.71 0.33 Allowed Glycine 0 N--CA 1.419 -2.482 0 N-CA-C 110.122 -1.191 . . . . 0.28999999999999998 110.122 178.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1576 ' ' LYS . . . . . 0.515 ' HE2' ' O ' ' A' 1594 ' ' ASP . 24.9 ttmm -73.93 155.47 38.65 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.681 -1.229 . . . . 2.1899999999999999 107.681 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -67.13 77.55 0.14 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.77 0.795 . . . . 0.60999999999999999 111.865 -177.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1578 ' ' ASN . . . . . 0.475 ' HB3' ' HD1' ' A' 1592 ' ' TYR . 14.5 t-20 -91.2 -175.73 4.37 Favored 'General case' 0 C--N 1.29 -2.01 0 C-N-CA 125.583 1.553 . . . . 1.95 107.41 -178.446 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 22.2 pttp -158.58 52.48 0.41 Allowed 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.839 0.828 . . . . 2.6800000000000002 110.008 176.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1580 ' ' ARG . . . . . 0.522 ' HB3' HG12 ' A' 1591 ' ' VAL . 0.1 OUTLIER -97.48 87.31 4.07 Favored 'General case' 0 N--CA 1.413 -2.314 0 N-CA-C 108.287 -1.005 . . . . 3.4700000000000002 108.287 -176.509 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A 1581 ' ' LEU . . . . . 0.513 ' HA ' ' O ' ' A' 1589 ' ' GLN . 0.4 OUTLIER -86.37 126.16 34.16 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.999 -1.001 . . . . 0.64000000000000001 109.05 -177.341 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -124.51 140.94 52.48 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 109.159 -0.682 . . . . 2.8500000000000001 109.159 175.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1583 ' ' TYR . . . . . 0.667 ' CE1' ' HA ' ' A' 1586 ' ' GLN . 67.9 t80 -105.81 97.38 7.21 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 107.004 -1.48 . . . . 0.85999999999999999 107.004 176.158 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1584 ' ' VAL . . . . . 0.537 ' O ' ' HB ' ' A' 1587 ' ' VAL . 15.7 m -111.81 89.69 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.234 0 CA-C-N 115.338 -0.846 . . . . 1.05 112.373 -173.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 29.3 t70 56.88 64.45 1.65 Allowed 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 115.246 -0.888 . . . . 1.1699999999999999 109.961 179.081 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1586 ' ' GLN . . . . . 0.667 ' HA ' ' CE1' ' A' 1583 ' ' TYR 0.26 29.9 pt20 63.09 15.22 8.31 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 126.926 2.09 . . . . 1.8600000000000001 112.897 177.596 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A 1587 ' ' VAL . . . . . 0.537 ' HB ' ' O ' ' A' 1584 ' ' VAL . 29.1 t -108.89 129.39 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.024 0 CA-C-N 114.418 -1.265 . . . . 0.48999999999999999 109.128 176.223 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1588 ' ' LEU . . . . . 0.962 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 2.9 mm? -97.57 108.22 20.89 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.644 -0.873 . . . . 0.35999999999999999 108.644 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1589 ' ' GLN . . . . . 0.513 ' O ' ' HA ' ' A' 1581 ' ' LEU . 35.1 tt0 -100.97 118.32 36.75 Favored 'General case' 0 C--N 1.281 -2.375 0 CA-C-N 116.136 -0.484 . . . . 1.74 111.416 -177.33 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1590 ' ' LEU . . . . . 0.411 ' HG ' ' CD2' ' A' 1581 ' ' LEU . 1.6 mt -108.51 97.68 7.31 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 106.603 -1.628 . . . . 0.71999999999999997 106.603 170.066 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1591 ' ' VAL . . . . . 0.522 HG12 ' HB3' ' A' 1580 ' ' ARG . 8.9 p -94.59 133.44 35.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 CA-C-N 116.275 -0.421 . . . . 1.01 110.084 -177.518 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1592 ' ' TYR . . . . . 0.475 ' HD1' ' HB3' ' A' 1578 ' ' ASN . 14.7 m-30 -118.52 114.22 22.49 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.277 -1.009 . . . . 0.5 108.277 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 21.3 pttp -115.53 178.92 4.12 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 110.303 -0.258 . . . . 1.5900000000000001 110.303 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1594 ' ' ASP . . . . . 0.515 ' O ' ' HE2' ' A' 1576 ' ' LYS . 8.7 m-20 68.35 36.6 3.0 Favored 'General case' 0 CA--C 1.506 -0.728 0 C-N-CA 124.028 0.931 . . . . 1.1100000000000001 112.134 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -72.82 -158.32 4.34 Favored Glycine 0 N--CA 1.443 -0.861 0 N-CA-C 109.675 -1.37 . . . . 0.78000000000000003 109.675 173.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1596 ' ' SER . . . . . . . . . . . . . 41.0 p -87.92 148.64 43.85 Favored Pre-proline 0 C--N 1.28 -2.455 0 C-N-CA 118.292 -1.363 . . . . 1.0700000000000001 109.304 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1597 ' ' PRO . . . . . 0.517 ' HG2' ' HB2' ' B' ' 4' ' ' PRO . 64.4 Cg_exo -48.01 131.47 21.42 Favored 'Trans proline' 0 C--O 1.241 0.647 0 C-N-CA 123.423 2.748 . . . . 1.01 111.726 176.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1598 ' ' CYS . . . . . 0.494 ' HA ' ' CE2' ' A' 1606 ' ' TYR . 49.4 t -76.67 127.1 85.02 Favored Pre-proline 0 C--N 1.294 -1.805 0 CA-C-N 114.834 -1.075 . . . . 0.75 110.191 -175.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1599 ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' 1598 ' ' CYS . 20.1 Cg_exo -69.4 -34.03 16.64 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.021 2.481 . . . . 1.7 111.24 176.2 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1600 ' ' SER . . . . . 0.442 ' HB2' ' SG ' ' A' 1598 ' ' CYS . 9.6 m -57.69 -43.15 84.9 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 123.665 0.786 . . . . 2.2599999999999998 111.294 178.056 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1601 ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -145.54 123.54 12.07 Favored 'General case' 0 N--CA 1.423 -1.788 0 N-CA-C 109.006 -0.738 . . . . 3.0099999999999998 109.006 178.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 10.0 m -78.85 148.59 32.77 Favored 'General case' 0 N--CA 1.407 -2.623 0 C-N-CA 123.229 0.612 . . . . 2.0699999999999998 110.186 -175.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 105.96 -14.61 44.82 Favored Glycine 0 C--N 1.306 -1.136 0 CA-C-N 116.082 -0.508 . . . . 1.0800000000000001 113.304 176.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1604 ' ' LEU . . . . . 0.458 HD21 ' HB2' ' A' 1634 ' ' CYS . 0.0 OUTLIER -135.74 147.36 48.4 Favored 'General case' 0 N--CA 1.406 -2.629 0 CA-C-O 121.423 0.63 . . . . 1.8400000000000001 112.202 -179.68 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 10.3 p -96.17 153.37 17.83 Favored 'General case' 0 C--N 1.308 -1.239 0 C-N-CA 124.297 1.039 . . . . 1.4099999999999999 110.06 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1606 ' ' TYR . . . . . 0.606 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 51.7 m-85 -60.46 154.12 21.45 Favored 'General case' 0 C--O 1.25 1.102 0 O-C-N 123.287 0.367 . . . . 0.59999999999999998 111.07 176.376 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -151.86 126.77 9.67 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 108.795 -0.817 . . . . 1.45 108.795 -176.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1608 ' ' SER . . . . . . . . . . . . . 40.1 m -105.72 130.29 53.76 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 116.269 -0.423 . . . . 1.1499999999999999 110.202 -177.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 28.2 t -109.15 108.26 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.999 0 N-CA-C 107.845 -1.169 . . . . 0.25 107.845 177.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 64.5 mt -97.77 103.92 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.797 0 N-CA-C 107.598 -1.26 . . . . 0.45000000000000001 107.598 179.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 23.2 t -99.93 107.82 19.9 Favored 'General case' 0 C--N 1.282 -2.341 0 CA-C-N 114.231 -1.35 . . . . 1.26 110.154 -174.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1612 ' ' PHE . . . . . 0.962 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 68.0 m-85 -90.61 118.2 29.87 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.439 -0.801 . . . . 0.26000000000000001 109.752 178.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 43.1 t -122.65 139.22 50.17 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 108.531 -0.915 . . . . 0.5 108.531 -177.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 9.0 t -66.88 117.59 9.19 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 124.054 0.942 . . . . 0.77000000000000002 112.564 -177.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1615 ' ' ARG . . . . . 0.741 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 13.5 tpt180 -137.75 91.16 13.86 Favored Pre-proline 0 N--CA 1.442 -0.835 0 N-CA-C 107.951 -1.129 . . . . 2.5299999999999998 107.951 172.333 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1616 ' ' PRO . . . . . 0.752 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 45.7 Cg_endo -67.24 -15.68 46.65 Favored 'Trans proline' 0 N--CA 1.486 1.056 0 C-N-CA 122.754 2.303 . . . . 1.1000000000000001 113.503 -174.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -58.18 -38.98 77.74 Favored 'General case' 0 C--O 1.242 0.697 0 C-N-CA 124.75 1.22 . . . . 3.0499999999999998 111.056 178.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . 51.19 96.59 0.01 OUTLIER 'General case' 0 C--O 1.248 0.989 0 C-N-CA 124.363 1.065 . . . . 1.55 113.057 178.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1619 ' ' GLY . . . . . 0.405 ' HA3' ' HD2' ' A' 1620 ' ' PRO . . . -151.1 -143.7 3.77 Favored Glycine 0 C--N 1.29 -1.998 0 N-CA-C 110.679 -0.969 . . . . 0.93000000000000005 110.679 -179.17 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1620 ' ' PRO . . . . . 0.405 ' HD2' ' HA3' ' A' 1619 ' ' GLY . 38.9 Cg_endo -67.01 2.77 1.92 Allowed 'Trans proline' 0 N--CA 1.488 1.172 0 C-N-CA 123.039 2.492 . . . . 0.88 114.832 -178.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1621 ' ' THR . . . . . 0.425 HG22 ' HB2' ' A' 1641 ' ' HIS . 8.0 m -102.72 -3.4 26.56 Favored 'General case' 0 N--CA 1.42 -1.959 0 CA-C-O 122.057 0.932 . . . . 0.96999999999999997 108.953 -179.274 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 43.8 t30 -87.22 61.9 6.97 Favored 'General case' 0 C--O 1.246 0.872 0 CA-C-O 122.488 1.137 . . . . 0.71999999999999997 108.666 178.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -165.87 138.7 3.39 Favored Pre-proline 0 C--N 1.303 -1.446 0 CA-C-N 113.733 -1.576 . . . . 3.2599999999999998 106.984 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -65.11 111.69 1.84 Allowed 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 122.393 2.062 . . . . 0.58999999999999997 111.19 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 72.5 mtm -115.29 143.9 44.56 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 116.531 -0.304 . . . . 1.3700000000000001 110.59 -178.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1626 ' ' LEU . . . . . 0.456 ' HG ' ' CE2' ' A' 1542 ' ' TYR . 1.6 tm? -80.95 117.38 21.53 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.152 -1.055 . . . . 0.89000000000000001 108.152 -178.326 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 50.7 mm -77.87 -58.1 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 CA-C-O 121.296 0.569 . . . . 0.57999999999999996 109.727 178.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 66.8 m -163.92 149.8 11.13 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.007 -1.108 . . . . 1.3899999999999999 108.007 -178.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1629 ' ' LEU . . . . . 0.82 HD13 ' HG ' ' A' 1636 ' ' LEU . 30.0 tp -111.87 110.47 20.83 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 107.557 -1.275 . . . . 1.25 107.557 175.202 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 17.5 t70 -70.54 117.46 12.1 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 107.347 -1.353 . . . . 1.0900000000000001 107.347 175.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 95.3 mttt -82.15 -11.13 58.9 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.875 -0.602 . . . . 3.6000000000000001 111.904 -169.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -95.86 -43.56 7.79 Favored 'General case' 0 N--CA 1.418 -2.065 0 C-N-CA 120.373 -0.531 . . . . 2.6000000000000001 110.928 -175.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 45.5 p -96.42 -0.38 49.29 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 116.253 -0.43 . . . . 0.75 110.929 178.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1634 ' ' CYS . . . . . 0.458 ' HB2' HD21 ' A' 1604 ' ' LEU . 60.9 m 51.24 39.39 23.7 Favored 'General case' 0 C--N 1.374 1.636 0 C-N-CA 124.921 1.288 . . . . 0.53000000000000003 112.195 176.186 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1635 ' ' THR . . . . . . . . . . . . . 90.7 m -100.9 128.08 47.09 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 114.09 -1.414 . . . . 0.46000000000000002 108.288 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1636 ' ' LEU . . . . . 0.82 ' HG ' HD13 ' A' 1629 ' ' LEU . 0.6 OUTLIER -105.23 122.16 45.35 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.365 -0.606 . . . . 0.85999999999999999 109.365 -174.497 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -99.91 116.91 33.08 Favored 'General case' 0 C--O 1.244 0.812 0 CA-C-O 121.293 0.568 . . . . 0.45000000000000001 111.848 -178.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -117.26 134.81 54.36 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 115.105 -0.952 . . . . 0.5 109.361 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1639 ' ' SER . . . . . . . . . . . . . 71.6 m -119.73 138.94 53.0 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 116.219 -0.446 . . . . 1.04 109.902 176.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1640 ' ' TRP . . . . . 0.479 ' CE3' ' HE1' ' A' 1612 ' ' PHE . 3.7 t90 -138.36 103.72 4.98 Favored 'General case' 0 N--CA 1.424 -1.753 0 N-CA-C 103.942 -2.614 . . . . 0.68000000000000005 103.942 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1641 ' ' HIS . . . . . 0.741 ' HB3' ' HB2' ' A' 1615 ' ' ARG . 28.3 m-70 -95.56 98.77 10.76 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.863 0.84 . . . . 0.90000000000000002 109.757 -176.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1642 ' ' THR . . . . . . . . . . . . . 3.1 t -124.26 150.83 64.95 Favored Pre-proline 0 C--N 1.299 -1.594 0 CA-C-N 113.732 -1.576 . . . . 0.47999999999999998 110.388 -170.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1643 ' ' PRO . . . . . 0.752 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 59.8 Cg_endo -77.21 -5.54 15.81 Favored 'Trans proline' 0 C--N 1.364 1.36 0 C-N-CA 122.487 2.125 . . . . 0.66000000000000003 112.729 175.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 9.0 tt -69.48 -27.45 65.23 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.307 -0.627 . . . . 0.96999999999999997 109.307 177.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -90.35 14.97 11.43 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.47 -0.786 . . . . 0.83999999999999997 110.713 -177.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1646 ' ' CYS . . . . . 0.612 ' SG ' ' HA ' ' A' 1643 ' ' PRO . 78.3 m -99.69 156.33 17.14 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 109.614 -0.513 . . . . 1.1899999999999999 109.614 178.52 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -106.03 146.9 33.84 Favored Pre-proline 0 C--N 1.289 -2.034 0 N-CA-C 107.294 -1.373 . . . . 3.1400000000000001 107.294 175.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1648 ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -74.52 95.07 0.93 Allowed 'Trans proline' 0 N--CA 1.442 -1.521 0 C-N-CA 121.23 1.287 . . . . 2.5800000000000001 110.511 177.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 . . . . . 0 C--N 1.309 -1.195 0 CA-C-N 115.199 -0.909 . . . . 4.7199999999999998 108.674 179.004 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.51 -0.566 0 N-CA-C 109.904 -0.406 . . . . 9.9700000000000006 109.904 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 2' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -84.14 107.89 16.73 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.25 -1.019 . . . . 7.6799999999999997 108.25 177.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 4.5 ptp180 -108.13 128.41 25.78 Favored Pre-proline 0 C--N 1.3 -1.558 0 CA-C-N 115.451 -0.795 . . . . 6.1100000000000003 109.944 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 4' ' ' PRO . . . . . 0.517 ' HB2' ' HG2' ' A' 1597 ' ' PRO . 88.6 Cg_endo -78.16 47.05 2.26 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 123.259 2.64 . . . . 4.8399999999999999 114.159 -177.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 19.9 m 45.95 55.72 6.75 Favored 'General case' 0 C--N 1.312 -1.035 0 C-N-CA 125.703 1.601 . . . . 4.5999999999999996 113.31 176.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -90.39 -46.26 8.48 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.79 -0.818 . . . . 4.2300000000000004 108.79 178.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 62.1 p -134.9 138.09 43.79 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 107.002 -1.481 . . . . 3.1400000000000001 107.002 175.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.623 ' HB2' ' SG ' ' B' ' 46' ' ' CYS . 6.9 mp -116.43 93.48 4.24 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 109.329 -0.619 . . . . 3.96 109.329 -178.439 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 9' ' ' CYS . . . . . 0.612 ' HB2' ' HA ' ' B' ' 47' ' ' CYS . 49.2 t -116.16 109.92 18.11 Favored 'General case' 0 N--CA 1.422 -1.841 0 O-C-N 121.359 -0.838 . . . . 2.8399999999999999 110.44 -178.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.13 -121.39 6.69 Favored Glycine 0 C--N 1.304 -1.196 0 CA-C-N 115.144 -0.934 . . . . 2.0899999999999999 113.252 178.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -51.26 -52.32 32.56 Favored Glycine 0 C--O 1.214 -1.128 0 C-N-CA 123.697 0.665 . . . . 1.8400000000000001 114.469 -176.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 12' ' ' GLU . . . . . 0.448 ' HA ' HG21 ' A' 1570 ' ' THR . 1.6 mp0 -57.41 -42.74 82.9 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 122.816 0.446 . . . . 2.5499999999999998 110.917 -178.357 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 13' ' ' LEU . . . . . 0.424 ' HG ' ' SG ' ' B' ' 46' ' ' CYS . 1.1 tt -61.39 -52.61 63.88 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 115.371 -0.831 . . . . 2.3500000000000001 109.853 -178.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 22.2 m -72.72 -30.37 33.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.37 0 C-N-CA 119.531 -0.867 . . . . 2.1099999999999999 111.869 -176.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -69.34 -42.82 74.79 Favored 'General case' 0 C--O 1.203 -1.375 0 C-N-CA 120.728 -0.389 . . . . 2.04 111.94 177.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 25.3 p -62.85 -38.8 92.24 Favored 'General case' 0 C--O 1.258 1.523 0 CA-C-O 121.446 0.641 . . . . 1.8400000000000001 110.054 176.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.563 ' HB3' ' HB3' ' B' ' 26' ' ' PHE . 3.6 mm? -56.75 -49.73 74.37 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-N 115.317 -0.856 . . . . 1.74 111.012 171.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -66.64 -32.37 73.65 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 124.384 1.074 . . . . 2.3900000000000001 109.809 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -52.84 -57.67 9.43 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 116.023 -0.535 . . . . 0.95999999999999996 111.939 178.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 13.0 p -98.87 -26.24 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 C-N-CA 118.204 -1.398 . . . . 1.3700000000000001 112.854 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 85.1 m -106.92 1.08 24.3 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 113.597 0.962 . . . . 1.6599999999999999 113.597 -177.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -55.86 -24.17 40.57 Favored Glycine 0 N--CA 1.479 1.558 0 N-CA-C 116.969 1.548 . . . . 1.53 116.969 -173.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -58.77 -40.73 84.77 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 118.136 0.968 . . . . 2.7200000000000002 109.699 175.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 25.2 tpp180 -90.45 -48.57 7.02 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 108.07 -1.085 . . . . 4.3300000000000001 108.07 177.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 130.33 -152.05 19.65 Favored Glycine 0 N--CA 1.424 -2.144 0 N-CA-C 109.84 -1.304 . . . . 1.53 109.84 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 26' ' ' PHE . . . . . 0.563 ' HB3' ' HB3' ' B' ' 17' ' ' LEU . 23.2 p90 -137.83 139.28 39.86 Favored 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 108.956 -0.757 . . . . 1.6499999999999999 108.956 176.07 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -125.74 -67.78 0.86 Allowed 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 112.827 0.677 . . . . 3.4199999999999999 112.827 -176.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 28' ' ' PHE . . . . . . . . . . . . . 50.4 p90 43.82 17.74 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.511 0 N-CA-C 117.319 2.34 . . . . 2.2599999999999998 117.319 171.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 29' ' ' SER . . . . . 0.644 ' HA ' ' HA ' ' B' ' 40' ' ' ARG . 37.7 t -157.53 133.65 9.51 Favored 'General case' 0 N--CA 1.42 -1.951 0 N-CA-C 109.101 -0.703 . . . . 3.6800000000000002 109.101 -177.328 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 30' ' ' ARG . . . . . 0.651 ' HB2' ' H ' ' B' ' 39' ' ' SER . 1.1 mmp_? -123.68 108.03 31.18 Favored Pre-proline 0 C--N 1.303 -1.437 0 N-CA-C 106.148 -1.797 . . . . 3.8100000000000001 106.148 177.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -68.2 -39.3 10.54 Favored 'Trans proline' 0 C--O 1.245 0.868 0 C-N-CA 122.638 2.226 . . . . 4.0199999999999996 113.119 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -163.26 177.05 9.33 Favored 'General case' 0 N--CA 1.423 -1.822 0 N-CA-C 108.777 -0.823 . . . . 4.9199999999999999 108.777 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 33' ' ' SER . . . . . 0.479 ' CB ' ' HG2' ' B' ' 37' ' ' ARG . 15.8 t 171.45 153.69 0.07 Allowed 'General case' 0 N--CA 1.412 -2.367 0 C-N-CA 126.566 1.946 . . . . 6.7199999999999998 106.565 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 9.6 ttm180 -83.43 3.23 32.85 Favored 'General case' 0 C--N 1.282 -2.354 0 CA-C-O 122.474 1.131 . . . . 11.630000000000001 108.866 -178.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 0.525 HG21 ' HG2' ' B' ' 67' ' ' GLU . 61.3 t -100.01 -3.64 9.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-N 114.484 -1.235 . . . . 9.6099999999999994 108.538 175.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 47.0 t 61.98 30.79 18.1 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 114.57 -1.195 . . . . 6.71 109.272 -178.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 37' ' ' ARG . . . . . 0.565 ' NH1' ' HB2' ' B' ' 67' ' ' GLU . 38.7 ptt180 -85.69 11.19 11.44 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.925 -1.034 . . . . 10.0 112.608 -173.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -46.14 111.18 0.33 Allowed 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.218 0.607 . . . . 7.9400000000000004 109.92 178.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 39' ' ' SER . . . . . 0.651 ' H ' ' HB2' ' B' ' 30' ' ' ARG . 70.4 m -155.16 98.18 1.98 Allowed 'General case' 0 N--CA 1.425 -1.71 0 CA-C-O 121.142 0.496 . . . . 5.7599999999999998 109.752 -179.024 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 40' ' ' ARG . . . . . 0.644 ' HA ' ' HA ' ' B' ' 29' ' ' SER . 0.0 OUTLIER -85.69 145.24 27.38 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 107.369 -1.345 . . . . 6.0300000000000002 107.369 171.664 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . -152.46 163.4 30.29 Favored Glycine 0 N--CA 1.416 -2.686 0 C-N-CA 119.598 -1.287 . . . . 2.3700000000000001 111.583 -178.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . 0.263 10.6 pt 64.44 -33.92 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.213 -0.835 0 C-N-CA 128.651 2.78 . . . . 2.0699999999999998 114.9 177.355 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.436 ' O ' ' HB2' ' B' ' 47' ' ' CYS . 2.4 p -48.03 -44.49 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 C-N-CA 123.833 0.853 . . . . 2.2400000000000002 112.896 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -97.14 -38.35 9.76 Favored 'General case' 0 N--CA 1.415 -2.211 0 CA-C-N 115.606 -0.725 . . . . 3.3599999999999999 109.506 -172.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -61.54 -47.46 85.46 Favored 'General case' 0 C--O 1.197 -1.702 0 CA-C-N 116.002 -0.544 . . . . 3.0800000000000001 110.725 178.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 46' ' ' CYS . . . . . 0.623 ' SG ' ' HB2' ' B' ' 8' ' ' LEU . 42.6 t -78.01 -16.27 58.24 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 121.222 0.534 . . . . 2.23 109.823 -178.16 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 47' ' ' CYS . . . . . 0.612 ' HA ' ' HB2' ' B' ' 9' ' ' CYS . 44.3 t -79.66 -48.01 14.44 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 116.216 -0.447 . . . . 2.3700000000000001 110.857 177.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -98.42 -25.8 14.68 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 113.678 0.992 . . . . 2.8199999999999998 113.678 -176.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -110.26 -179.8 3.88 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.333 -0.988 . . . . 4.0899999999999999 108.333 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 8.2 t -93.05 132.5 37.11 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 106.771 -1.566 . . . . 2.6699999999999999 106.771 176.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 1.6 p -111.38 137.44 49.15 Favored 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 123.205 0.602 . . . . 2.1099999999999999 110.887 -175.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -112.0 177.72 4.55 Favored 'General case' 0 C--O 1.244 0.764 0 N-CA-C 112.489 0.551 . . . . 2.6699999999999999 112.489 -178.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 53' ' ' LEU . . . . . 0.418 ' O ' ' HG ' ' B' ' 56' ' ' LEU . 52.6 tp -51.24 -53.89 31.01 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 125.125 1.37 . . . . 1.8999999999999999 113.601 -178.478 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.72 -41.05 73.31 Favored 'General case' 0 C--O 1.244 0.793 0 C-N-CA 124.023 0.929 . . . . 1.52 112.456 -170.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 61.3 tp -63.47 -46.22 87.23 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 114.921 -1.036 . . . . 1.97 111.957 -178.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 56' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' B' ' 53' ' ' LEU . 3.3 pp -79.66 -24.64 41.67 Favored 'General case' 0 N--CA 1.41 -2.459 0 C-N-CA 119.765 -0.774 . . . . 1.53 111.143 -176.518 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -70.6 -43.68 68.85 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 116.082 -0.508 . . . . 2.27 110.616 178.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 24.2 p -63.58 -43.12 97.9 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-N 116.25 -0.432 . . . . 2.3300000000000001 111.848 179.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -73.31 -59.61 2.63 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 116.739 -0.21 . . . . 2.8599999999999999 110.505 178.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 41.8 t 46.44 -98.21 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 125.029 1.332 . . . . 2.2999999999999998 113.984 179.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -154.39 178.5 9.97 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 107.688 -1.227 . . . . 3.1899999999999999 107.688 -176.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 10.2 p -145.04 155.72 55.12 Favored Pre-proline 0 C--N 1.293 -1.87 0 N-CA-C 107.738 -1.208 . . . . 3.6800000000000002 107.738 177.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 63' ' ' PRO . . . . . 0.591 ' HG2' ' HB2' ' B' ' 66' ' ' SER . 37.6 Cg_endo -73.42 0.09 8.52 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 123.13 2.553 . . . . 5.0800000000000001 111.771 177.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 72.25 5.04 5.2 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.165 1.786 . . . . 5.0999999999999996 113.796 173.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -144.52 39.55 1.28 Allowed 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 123.218 1.485 . . . . 8.5099999999999998 107.941 178.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 66' ' ' SER . . . . . 0.591 ' HB2' ' HG2' ' B' ' 63' ' ' PRO . 25.6 t -106.01 98.55 8.22 Favored 'General case' 0 C--N 1.275 -2.643 0 CA-C-N 113.785 -1.552 . . . . 8.1199999999999992 109.088 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 67' ' ' GLU . . . . . 0.565 ' HB2' ' NH1' ' B' ' 37' ' ' ARG . 14.7 tp10 . . . . . 0 C--O 1.247 0.953 0 N-CA-C 107.993 -1.114 . . . . 10.210000000000001 107.993 176.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 88.4 mtp . . . . . 0 CA--C 1.503 -0.85 0 N-CA-C 108.847 -0.798 . . . . 9.3399999999999999 108.847 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A 1509 ' ' LYS . . . . . 0.551 ' HG3' ' OE1' ' A' 1512 ' ' GLU . 23.3 ttmm -134.81 34.4 3.15 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 122.897 1.332 . . . . 9.0399999999999991 108.904 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1510 ' ' SER . . . . . 0.44 ' HB3' ' CB ' ' A' 1519 ' ' THR . 39.5 m -85.5 -34.43 21.58 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 107.991 -1.114 . . . . 5.8099999999999996 107.991 176.047 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1511 ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -119.91 103.16 9.09 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 114.686 -1.143 . . . . 3.4199999999999999 108.751 174.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1512 ' ' GLU . . . . . 0.551 ' OE1' ' HG3' ' A' 1509 ' ' LYS . 12.4 mm-40 -78.19 -28.8 48.22 Favored 'General case' 0 CA--C 1.494 -1.193 0 N-CA-C 108.537 -0.912 . . . . 5.9500000000000002 108.537 172.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 53.9 t-80 73.8 -51.37 0.69 Allowed 'General case' 0 C--O 1.215 -0.757 0 CA-C-N 113.811 -1.54 . . . . 5.3300000000000001 111.366 176.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -103.02 32.63 3.62 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-O 121.871 0.843 . . . . 5.0599999999999996 110.654 -177.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 7.0 t70 -149.12 164.45 34.65 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 104.138 -2.541 . . . . 2.8999999999999999 104.138 175.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1516 ' ' CYS . . . . . 0.927 ' HB3' ' HB2' ' A' 1529 ' ' LEU . 72.6 m -79.89 60.41 3.48 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 123.35 0.66 . . . . 1.1899999999999999 112.247 -174.218 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1517 ' ' GLN . . . . . 0.485 ' HA ' ' O ' ' A' 1527 ' ' PHE . 16.5 pt20 -164.41 129.33 2.73 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-O 121.392 0.615 . . . . 1.52 110.905 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 2.9 m -148.56 143.59 18.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-N 114.726 -1.125 . . . . 0.93999999999999995 109.725 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1519 ' ' THR . . . . . 0.44 ' CB ' ' HB3' ' A' 1510 ' ' SER . 91.6 m -114.04 121.49 44.0 Favored 'General case' 0 N--CA 1.423 -1.787 0 N-CA-C 108.173 -1.047 . . . . 0.89000000000000001 108.173 174.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1520 ' ' ASN . . . . . 0.454 ' HA ' ' HD3' ' A' 1521 ' ' PRO . 26.3 t-20 -80.26 121.93 82.25 Favored Pre-proline 0 C--N 1.294 -1.82 0 N-CA-C 109.33 -0.619 . . . . 1.74 109.33 177.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1521 ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' 1520 ' ' ASN . 12.6 Cg_exo -69.75 -19.61 35.96 Favored 'Trans proline' 0 CA--C 1.529 0.227 0 C-N-CA 123.051 2.5 . . . . 1.5800000000000001 113.509 -175.361 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1522 ' ' SER . . . . . 0.419 ' HB2' ' OD1' ' A' 1520 ' ' ASN . 22.5 m -72.33 -32.21 66.32 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 120.836 0.35 . . . . 1.6499999999999999 111.094 -179.414 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1523 ' ' THR . . . . . 0.705 HG21 ' HG3' ' A' 1647 ' ' GLU . 8.8 t -124.87 -9.46 7.23 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 119.433 -0.907 . . . . 1.6100000000000001 112.14 -177.13 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 68.73 34.34 77.79 Favored Glycine 0 CA--C 1.501 -0.795 0 CA-C-N 115.828 -0.623 . . . . 1.1299999999999999 113.399 176.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 9.7 t-160 -107.03 121.16 43.93 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 119.163 -1.015 . . . . 1.26 111.415 178.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 2.3 tm? -82.47 115.99 21.72 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 114.494 -1.23 . . . . 0.68000000000000005 108.688 176.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1527 ' ' PHE . . . . . 0.485 ' O ' ' HA ' ' A' 1517 ' ' GLN . 96.8 m-85 -96.32 121.69 38.39 Favored 'General case' 0 C--N 1.31 -1.149 0 O-C-N 122.158 -0.339 . . . . 0.65000000000000002 110.494 174.231 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 10.3 t70 -105.49 109.83 21.94 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 106.923 -1.51 . . . . 1.1699999999999999 106.923 175.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1529 ' ' LEU . . . . . 0.927 ' HB2' ' HB3' ' A' 1516 ' ' CYS . 3.7 mm? -90.69 -3.5 57.43 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 121.282 0.563 . . . . 0.59999999999999998 110.22 -177.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 16.0 m -72.84 -15.56 61.62 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.624 -0.716 . . . . 0.83999999999999997 109.632 178.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1531 ' ' SER . . . . . 0.416 ' HB2' HD11 ' A' 1644 ' ' LEU . 14.8 m -66.38 -22.39 66.25 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-O 121.287 0.565 . . . . 1.5900000000000001 109.709 173.276 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 80.4 mt -101.5 3.96 40.7 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.18 -0.464 . . . . 0.65000000000000002 111.315 177.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1533 ' ' SER . . . . . . . . . . . . . 46.2 t -60.07 158.68 10.68 Favored 'General case' 0 C--O 1.245 0.825 0 CA-C-O 121.959 0.885 . . . . 1.52 111.682 -177.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -178.53 116.09 0.52 Allowed Glycine 0 C--N 1.278 -2.667 0 CA-C-N 114.237 -1.347 . . . . 1.1000000000000001 110.132 -175.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -92.79 -36.75 12.7 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 112.373 0.509 . . . . 4.6200000000000001 112.373 -176.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -59.52 -54.42 46.73 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-O 121.262 0.553 . . . . 1.45 110.372 -176.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 136.09 152.99 6.47 Favored Glycine 0 N--CA 1.413 -2.886 0 C-N-CA 120.535 -0.84 . . . . 0.84999999999999998 113.382 173.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -114.51 139.56 49.46 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 106.151 -1.796 . . . . 0.93000000000000005 106.151 174.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 5.1 p -106.58 128.71 54.35 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.21 0.528 . . . . 1.03 111.858 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -123.95 141.03 52.4 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 107.991 -1.115 . . . . 0.5 107.991 176.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -82.95 128.98 34.96 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 120.773 0.321 . . . . 0.73999999999999999 110.72 -177.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1542 ' ' TYR . . . . . 0.578 ' CE2' ' HG ' ' A' 1626 ' ' LEU . 2.0 t80 -121.1 -100.6 0.43 Allowed 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 107.626 -1.25 . . . . 0.98999999999999999 107.626 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1543 ' ' SER . . . . . 0.441 ' H ' ' HB3' ' A' 1542 ' ' TYR . 8.0 m -66.35 164.06 16.89 Favored 'General case' 0 N--CA 1.437 -1.123 0 C-N-CA 122.815 0.446 . . . . 1.9099999999999999 110.808 -178.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 23.4 tptm -56.83 -41.54 78.05 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 118.103 0.41 . . . . 3.5899999999999999 111.132 -176.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 49.9 m -110.88 34.41 4.02 Favored 'General case' 0 N--CA 1.412 -2.352 0 N-CA-C 109.621 -0.511 . . . . 2.46 109.621 178.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . -144.63 134.48 5.67 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 118.808 -1.663 . . . . 1.26 115.335 -176.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 28.1 m -121.68 148.4 25.16 Favored 'Isoleucine or valine' 0 C--O 1.247 0.944 0 N-CA-C 108.561 -0.903 . . . . 0.79000000000000004 108.561 174.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 11.9 p -104.05 137.11 34.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 N-CA-C 109.747 -0.464 . . . . 0.57999999999999996 109.747 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -98.01 125.07 42.78 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.834 -0.802 . . . . 1.0800000000000001 108.834 175.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 23.3 ptm -136.17 133.67 37.41 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 115.539 -0.755 . . . . 0.78000000000000003 110.342 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 12.7 p -117.69 137.53 52.61 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.549 -0.75 . . . . 0.96999999999999997 109.627 176.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1552 ' ' ILE . . . . . . . . . . . . . 42.4 mm -96.83 118.53 43.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 110.37 -0.233 . . . . 0.41999999999999998 110.37 -177.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 75.4 m 65.84 24.76 11.31 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-O 122.199 1.0 . . . . 1.3999999999999999 112.047 175.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . -164.51 -177.73 37.38 Favored Glycine 0 N--CA 1.406 -3.337 0 CA-C-N 114.261 -1.336 . . . . 0.34999999999999998 110.004 -178.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -109.39 145.35 36.25 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-O 121.043 0.449 . . . . 1.6200000000000001 110.933 -176.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -81.41 145.25 30.89 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.345 -0.843 . . . . 0.87 111.809 -172.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -84.96 10.07 12.78 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 123.819 0.848 . . . . 2.4900000000000002 113.176 -171.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -119.41 -10.73 9.63 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 119.586 -0.846 . . . . 1.3799999999999999 112.562 -176.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1559 ' ' CYS . . . . . 0.529 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 83.4 m -132.26 164.26 44.54 Favored Pre-proline 0 C--N 1.296 -1.755 0 CA-C-O 117.877 -1.058 . . . . 1.21 110.04 -177.144 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1560 ' ' PRO . . . . . 0.529 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 12.0 Cg_exo -31.11 131.59 0.06 OUTLIER 'Trans proline' 0 C--N 1.376 2.001 1 C-N-CA 125.536 4.157 . . . . 0.70999999999999996 115.489 -179.418 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -49.34 128.34 20.03 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 123.77 2.98 . . . . 0.80000000000000004 111.731 179.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 102.3 -3.86 51.18 Favored Glycine 0 N--CA 1.43 -1.73 0 CA-C-N 116.018 -0.537 . . . . 0.46000000000000002 113.765 -178.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1563 ' ' VAL . . . . . . . . . . . . . 5.2 p -98.52 138.21 23.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 118.362 1.081 . . . . 0.97999999999999998 111.291 -178.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -102.11 -31.16 5.44 Favored Glycine 0 CA--C 1.522 0.491 0 CA-C-N 115.693 -0.685 . . . . 0.28000000000000003 113.172 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -129.28 130.81 46.66 Favored 'General case' 0 N--CA 1.445 -0.723 0 O-C-N 122.528 -0.395 . . . . 0.28000000000000003 109.967 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 44.0 t -157.02 138.61 14.05 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 110.018 -0.364 . . . . 0.42999999999999999 110.018 -176.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -85.28 137.67 32.82 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 108.87 -0.789 . . . . 1.03 108.87 174.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -72.33 -18.61 78.3 Favored Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 116.983 1.553 . . . . 1.1299999999999999 116.983 -167.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -73.23 -70.24 0.38 Allowed 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 118.362 1.081 . . . . 2.5800000000000001 111.246 -175.193 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.16 -2.47 58.07 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.198 -0.91 . . . . 2.1699999999999999 112.755 -176.559 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 9.9 mmt85 60.04 36.76 21.38 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 114.923 -1.035 . . . . 2.6200000000000001 110.519 178.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 30.6 mt -74.97 125.24 34.25 Favored 'Isoleucine or valine' 0 C--O 1.245 0.867 0 CA-C-N 115.909 -0.587 . . . . 0.92000000000000004 109.761 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 21.9 t -74.48 125.09 27.81 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 114.995 -1.002 . . . . 0.80000000000000004 109.812 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1574 ' ' VAL . . . . . 0.664 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 33.6 m -122.19 16.51 5.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 C-N-CA 120.009 -0.676 . . . . 0.97999999999999998 112.026 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 167.82 122.72 0.63 Allowed Glycine 0 N--CA 1.432 -1.594 0 C-N-CA 119.977 -1.106 . . . . 0.28999999999999998 112.618 175.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 4.1 ttmp? -71.64 142.1 49.93 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.23 -1.026 . . . . 2.1899999999999999 108.23 177.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -72.83 88.23 1.32 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.29 0.567 . . . . 0.60999999999999999 110.965 -177.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -109.56 150.79 27.66 Favored 'General case' 0 C--N 1.29 -1.978 0 N-CA-C 107.283 -1.377 . . . . 1.95 107.283 179.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -105.15 45.71 0.95 Allowed 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 106.275 -1.75 . . . . 2.6800000000000002 106.275 -177.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 56.3 ttt180 -84.97 76.59 10.25 Favored 'General case' 0 N--CA 1.411 -2.376 0 CA-C-N 113.638 -1.619 . . . . 3.4700000000000002 108.775 -173.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1581 ' ' LEU . . . . . 0.401 HD21 ' HG ' ' A' 1529 ' ' LEU . 0.4 OUTLIER -81.42 127.58 32.94 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 113.596 -1.638 . . . . 0.64000000000000001 108.875 -178.567 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -127.08 140.96 51.9 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-N 116.098 -0.501 . . . . 2.8500000000000001 110.215 172.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1583 ' ' TYR . . . . . 0.597 ' CZ ' ' HA ' ' A' 1586 ' ' GLN . 39.6 t80 -99.88 105.56 17.31 Favored 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 106.903 -1.517 . . . . 0.85999999999999999 106.903 175.519 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1584 ' ' VAL . . . . . 0.643 ' O ' ' HB ' ' A' 1587 ' ' VAL . 7.5 p -129.51 97.39 3.46 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.333 0 CA-C-O 121.614 0.721 . . . . 1.05 111.061 -175.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 36.3 t70 64.01 49.36 2.78 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-O 122.456 1.122 . . . . 1.1699999999999999 110.771 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1586 ' ' GLN . . . . . 0.597 ' HA ' ' CZ ' ' A' 1583 ' ' TYR . 18.9 pt20 65.39 9.26 5.59 Favored 'General case' 0 N--CA 1.5 2.059 0 C-N-CA 127.026 2.131 . . . . 1.8600000000000001 111.09 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1587 ' ' VAL . . . . . 0.643 ' HB ' ' O ' ' A' 1584 ' ' VAL . 38.1 t -96.81 122.76 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.75 0 CA-C-N 114.303 -1.317 . . . . 0.48999999999999999 108.331 178.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1588 ' ' LEU . . . . . 0.487 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 3.0 mm? -93.15 107.76 19.5 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 106.562 -1.644 . . . . 0.35999999999999999 106.562 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -120.63 125.1 46.87 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 113.296 0.851 . . . . 1.74 113.296 -172.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1590 ' ' LEU . . . . . 0.478 HD21 ' SG ' ' A' 1516 ' ' CYS . 16.6 mt -101.69 126.27 48.51 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 113.84 -1.527 . . . . 0.71999999999999997 107.282 176.156 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 47.2 t -112.0 120.36 62.17 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.997 0 C-N-CA 119.438 -0.905 . . . . 1.01 111.026 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1592 ' ' TYR . . . . . 0.43 ' HB2' ' HB2' ' A' 1608 ' ' SER . 13.5 m-30 -105.32 95.83 6.1 Favored 'General case' 0 CA--C 1.486 -1.485 0 N-CA-C 107.866 -1.161 . . . . 0.5 107.866 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 12.3 ptmm? -107.5 170.22 8.11 Favored 'General case' 0 C--N 1.283 -2.312 0 CA-C-N 115.02 -0.991 . . . . 1.5900000000000001 111.597 -175.007 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 24.0 m-20 57.24 56.06 5.44 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 125.454 1.502 . . . . 1.1100000000000001 112.448 177.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -74.88 -115.62 0.09 OUTLIER Glycine 0 CA--C 1.528 0.893 0 C-N-CA 120.33 -0.938 . . . . 0.78000000000000003 111.143 173.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1596 ' ' SER . . . . . . . . . . . . . 78.2 p -115.32 169.76 6.4 Favored Pre-proline 0 C--N 1.296 -1.744 0 O-C-N 121.857 -0.79 . . . . 1.0700000000000001 109.164 176.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -70.03 122.62 9.22 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 122.932 2.421 . . . . 1.01 112.354 177.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1598 ' ' CYS . . . . . 0.472 ' HA ' ' HD3' ' A' 1599 ' ' PRO . 34.3 t -76.44 141.16 69.34 Favored Pre-proline 0 C--N 1.292 -1.916 0 CA-C-N 114.671 -1.15 . . . . 0.75 109.202 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1599 ' ' PRO . . . . . 0.573 ' HD3' ' OH ' ' A' 1606 ' ' TYR . 8.1 Cg_exo -72.04 -7.84 21.8 Favored 'Trans proline' 0 C--N 1.371 1.731 0 C-N-CA 123.608 2.872 . . . . 1.7 113.25 -175.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1600 ' ' SER . . . . . 0.67 ' HA ' ' HB3' ' B' ' 53' ' ' LEU . 22.8 p -61.17 -51.22 69.97 Favored 'General case' 0 C--O 1.258 1.535 0 CA-C-O 121.76 0.79 . . . . 2.2599999999999998 109.733 174.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1601 ' ' LYS . . . . . 0.447 ' HB3' ' HG ' ' A' 1604 ' ' LEU . 49.9 tptt -155.14 117.96 4.33 Favored 'General case' 0 N--CA 1.387 -3.614 0 N-CA-C 106.533 -1.654 . . . . 3.0099999999999998 106.533 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 4.7 p -60.09 131.27 50.3 Favored 'General case' 0 N--CA 1.409 -2.478 0 N-CA-C 109.139 -0.689 . . . . 2.0699999999999998 109.139 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 106.83 -20.99 32.92 Favored Glycine 0 C--N 1.296 -1.687 0 C-N-CA 121.065 -0.588 . . . . 1.0800000000000001 111.837 -174.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1604 ' ' LEU . . . . . 0.447 ' HG ' ' HB3' ' A' 1601 ' ' LYS . 69.5 mt -81.55 124.46 29.52 Favored 'General case' 0 CA--C 1.503 -0.837 0 N-CA-C 107.728 -1.212 . . . . 1.8400000000000001 107.728 172.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 4.9 p -101.26 143.46 31.3 Favored 'General case' 0 C--N 1.28 -2.415 0 CA-C-O 120.643 0.259 . . . . 1.4099999999999999 110.61 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1606 ' ' TYR . . . . . 0.664 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 96.2 m-85 -68.39 153.28 44.06 Favored 'General case' 0 C--O 1.255 1.356 0 N-CA-C 109.598 -0.519 . . . . 0.59999999999999998 109.598 177.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -151.5 127.48 10.38 Favored 'General case' 0 N--CA 1.437 -1.104 0 O-C-N 123.673 0.608 . . . . 1.45 109.952 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1608 ' ' SER . . . . . 0.448 ' HB3' ' HE2' ' A' 1638 ' ' PHE . 38.6 m -104.64 122.04 44.8 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 108.522 -0.918 . . . . 1.1499999999999999 108.522 -179.017 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 41.0 t -104.68 108.06 23.94 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 109.304 -0.628 . . . . 0.25 109.304 -177.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1610 ' ' ILE . . . . . 0.466 ' HB ' ' HB2' ' A' 1590 ' ' LEU . 69.5 mt -97.27 110.18 24.66 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 115.588 -0.733 . . . . 0.45000000000000001 109.323 -178.511 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 7.0 t -113.56 108.01 16.58 Favored 'General case' 0 C--N 1.282 -2.345 0 CA-C-N 115.143 -0.935 . . . . 1.26 110.114 -174.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1612 ' ' PHE . . . . . 0.487 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 64.1 m-85 -84.9 118.9 24.8 Favored 'General case' 0 C--O 1.254 1.332 0 CA-C-N 115.99 -0.55 . . . . 0.26000000000000001 109.557 177.258 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1613 ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' 1641 ' ' HIS . 21.5 t -110.69 124.91 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.577 0 CA-C-N 115.595 -0.73 . . . . 0.5 110.366 -175.061 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 22.2 t -58.88 110.64 1.06 Allowed 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 114.571 -1.195 . . . . 0.77000000000000002 111.895 177.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1615 ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' 1615 ' ' ARG . 22.4 ttt180 -137.59 98.59 9.82 Favored Pre-proline 0 C--N 1.316 -0.884 0 N-CA-C 110.25 -0.278 . . . . 2.5299999999999998 110.25 171.096 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1616 ' ' PRO . . . . . 0.848 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 34.6 Cg_exo -61.22 -30.55 88.58 Favored 'Trans proline' 0 CA--C 1.55 1.282 0 C-N-CA 122.139 1.892 . . . . 1.1000000000000001 111.989 176.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -77.05 44.17 0.39 Allowed 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.116 1.367 . . . . 3.0499999999999998 113.61 178.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -32.69 130.31 0.19 Allowed 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 126.781 2.032 . . . . 1.55 113.476 176.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . -163.86 -142.16 3.33 Favored Glycine 0 N--CA 1.425 -2.089 0 N-CA-C 109.958 -1.257 . . . . 0.93000000000000005 109.958 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -80.34 15.06 1.81 Allowed 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 122.95 2.433 . . . . 0.88 112.655 -178.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1621 ' ' THR . . . . . . . . . . . . . 17.1 p -102.48 -6.71 22.61 Favored 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 124.791 1.237 . . . . 0.96999999999999997 108.625 179.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 48.9 t30 -94.66 61.89 2.7 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.392 -1.277 . . . . 0.71999999999999997 108.659 -176.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -162.28 138.74 5.96 Favored Pre-proline 0 N--CA 1.428 -1.535 0 CA-C-N 113.795 -1.548 . . . . 3.2599999999999998 107.427 -179.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1624 ' ' PRO . . . . . 0.434 ' HA ' ' O ' ' A' 1639 ' ' SER . 37.1 Cg_endo -65.92 108.2 1.25 Allowed 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 122.556 2.171 . . . . 0.58999999999999997 112.17 -177.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 63.8 mtm -116.11 147.42 41.35 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.455 -0.339 . . . . 1.3700000000000001 110.543 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1626 ' ' LEU . . . . . 0.578 ' HG ' ' CE2' ' A' 1542 ' ' TYR . 0.4 OUTLIER -85.41 114.95 22.85 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.452 -1.314 . . . . 0.89000000000000001 107.452 -178.354 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A 1627 ' ' ILE . . . . . 0.488 HD11 ' HB2' ' A' 1639 ' ' SER . 44.3 mm -72.53 -54.51 16.01 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.217 0 N-CA-C 109.191 -0.67 . . . . 0.57999999999999996 109.191 -178.166 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 28.0 p -173.44 154.04 2.5 Favored 'General case' 0 N--CA 1.423 -1.808 0 CA-C-N 114.752 -1.113 . . . . 1.3899999999999999 109.281 -173.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1629 ' ' LEU . . . . . 0.473 HD13 ' HG ' ' A' 1636 ' ' LEU . 54.2 tp -106.29 117.57 34.38 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 108.434 -0.95 . . . . 1.25 108.434 174.413 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1630 ' ' ASP . . . . . 0.437 ' HB3' ' HB ' ' A' 1635 ' ' THR . 8.6 t70 -73.75 99.09 3.06 Favored 'General case' 0 CA--C 1.496 -1.108 0 N-CA-C 103.317 -2.846 . . . . 1.0900000000000001 103.317 167.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -80.76 -10.31 59.74 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 114.192 -1.367 . . . . 3.6000000000000001 110.395 -166.128 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 56.8 tp60 -86.11 -45.95 10.9 Favored 'General case' 0 N--CA 1.426 -1.66 0 CA-C-N 115.584 -0.735 . . . . 2.6000000000000001 110.874 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 70.5 p -95.91 -3.79 44.67 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-O 120.812 0.339 . . . . 0.75 111.571 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 60.9 m 63.7 51.17 2.51 Favored 'General case' 0 C--N 1.355 0.823 0 C-N-CA 124.743 1.217 . . . . 0.53000000000000003 111.744 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1635 ' ' THR . . . . . 0.437 ' HB ' ' HB3' ' A' 1630 ' ' ASP . 32.4 m -113.42 123.14 49.35 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 114.101 -1.409 . . . . 0.46000000000000002 109.026 -176.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1636 ' ' LEU . . . . . 0.473 ' HG ' HD13 ' A' 1629 ' ' LEU . 1.0 OUTLIER -105.44 129.78 53.67 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 108.557 -0.905 . . . . 0.85999999999999999 108.557 -175.383 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -105.72 135.45 47.12 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 120.83 -0.348 . . . . 0.45000000000000001 111.259 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1638 ' ' PHE . . . . . 0.448 ' HE2' ' HB3' ' A' 1608 ' ' SER . 96.9 m-85 -128.46 137.18 51.69 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 124.09 0.956 . . . . 0.5 108.719 -178.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1639 ' ' SER . . . . . 0.488 ' HB2' HD11 ' A' 1627 ' ' ILE . 17.9 t -124.56 155.1 39.61 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 108.327 -0.99 . . . . 1.04 108.327 177.173 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1640 ' ' TRP . . . . . 0.462 ' CE3' ' HE1' ' A' 1612 ' ' PHE . 3.6 t90 -155.54 104.35 2.36 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 104.689 -2.337 . . . . 0.68000000000000005 104.689 -178.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1641 ' ' HIS . . . . . 0.422 ' HA ' ' O ' ' A' 1613 ' ' VAL . 38.8 m-70 -93.63 100.59 12.81 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 121.201 0.524 . . . . 0.90000000000000002 109.834 -176.599 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1642 ' ' THR . . . . . . . . . . . . . 3.6 t -134.06 147.33 63.52 Favored Pre-proline 0 C--N 1.292 -1.905 0 CA-C-N 115.002 -0.999 . . . . 0.47999999999999998 109.377 -173.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1643 ' ' PRO . . . . . 0.848 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 50.1 Cg_endo -76.93 -2.65 12.9 Favored 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 122.069 1.846 . . . . 0.66000000000000003 112.416 176.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1644 ' ' LEU . . . . . 0.416 HD11 ' HB2' ' A' 1531 ' ' SER . 9.3 tt -69.42 -28.82 66.47 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 108.876 -0.787 . . . . 0.96999999999999997 108.876 177.053 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -88.26 21.27 2.89 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.591 -0.731 . . . . 0.83999999999999997 110.732 -178.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1646 ' ' CYS . . . . . 0.487 ' SG ' ' HA ' ' A' 1643 ' ' PRO . 75.1 m -113.03 152.13 29.86 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 116.139 -0.482 . . . . 1.1899999999999999 110.279 -179.3 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1647 ' ' GLU . . . . . 0.705 ' HG3' HG21 ' A' 1523 ' ' THR . 0.0 OUTLIER -108.97 127.23 27.67 Favored Pre-proline 0 N--CA 1.421 -1.922 0 N-CA-C 107.592 -1.262 . . . . 3.1400000000000001 107.592 174.082 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A 1648 ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -68.21 100.06 0.62 Allowed 'Trans proline' 0 CA--C 1.532 0.399 0 C-N-CA 122.585 2.19 . . . . 2.5800000000000001 113.274 -175.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 13.5 tp10 . . . . . 0 N--CA 1.431 -1.394 0 N-CA-C 106.625 -1.62 . . . . 4.7199999999999998 106.625 178.171 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.619 0 N-CA-C 109.239 -0.652 . . . . 9.9700000000000006 109.239 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 2' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -114.88 131.79 56.74 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.82 -1.178 . . . . 7.6799999999999997 107.82 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 -111.88 130.07 23.58 Favored Pre-proline 0 C--N 1.283 -2.291 0 N-CA-C 109.489 -0.559 . . . . 6.1100000000000003 109.489 177.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -57.6 -25.54 67.87 Favored 'Trans proline' 0 C--N 1.37 1.702 0 C-N-CA 123.834 3.023 . . . . 4.8399999999999999 113.367 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 23.3 m -87.17 100.07 12.4 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 105.777 -1.934 . . . . 4.5999999999999996 105.777 170.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -77.37 -21.04 53.86 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 112.421 0.526 . . . . 4.2300000000000004 112.421 -169.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 7' ' ' THR . . . . . 0.508 HG21 ' HA ' ' B' ' 50' ' ' SER . 16.9 p -98.05 146.28 25.69 Favored 'General case' 0 C--N 1.287 -2.137 0 C-N-CA 120.551 -0.46 . . . . 3.1400000000000001 110.278 177.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.527 ' HB2' ' CB ' ' B' ' 12' ' ' GLU . 1.4 pp -75.9 163.81 26.83 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 113.164 0.801 . . . . 3.96 113.164 -176.228 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 9' ' ' CYS . . . . . 0.414 ' HA ' HD23 ' B' ' 13' ' ' LEU . 48.6 t -151.27 156.08 40.1 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 120.861 -0.336 . . . . 2.8399999999999999 111.261 -174.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.91 -123.94 7.63 Favored Glycine 0 CA--C 1.508 -0.39 0 CA-C-N 116.377 -0.374 . . . . 2.0899999999999999 113.037 175.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 11' ' ' GLY . . . . . 0.45 ' HA2' HG12 ' B' ' 14' ' ' VAL . . . -60.28 -27.99 66.26 Favored Glycine 0 N--CA 1.461 0.319 0 N-CA-C 112.127 -0.389 . . . . 1.8400000000000001 112.127 178.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 12' ' ' GLU . . . . . 0.527 ' CB ' ' HB2' ' B' ' 8' ' ' LEU . 46.1 mt-10 -65.53 -29.9 70.59 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.302 0.572 . . . . 2.5499999999999998 110.003 179.213 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 13' ' ' LEU . . . . . 0.524 HD21 ' HB3' ' B' ' 46' ' ' CYS . 0.2 OUTLIER -72.79 -50.93 21.21 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.619 0.723 . . . . 2.3500000000000001 109.433 179.944 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 14' ' ' VAL . . . . . 0.45 HG12 ' HA2' ' B' ' 11' ' ' GLY . 9.1 p -68.08 -37.73 78.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-N 115.665 -0.698 . . . . 2.1099999999999999 112.254 -176.482 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -76.24 -22.27 55.37 Favored 'General case' 0 C--O 1.212 -0.907 0 N-CA-C 113.608 0.966 . . . . 2.04 113.608 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 9.7 p -71.55 -39.35 70.73 Favored 'General case' 0 C--O 1.262 1.753 0 O-C-N 120.959 -1.088 . . . . 1.8400000000000001 109.268 174.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.494 ' HB3' ' HB2' ' B' ' 26' ' ' PHE . 4.3 mm? -52.71 -47.31 67.4 Favored 'General case' 0 C--O 1.216 -0.666 0 CA-C-N 114.938 -1.028 . . . . 1.74 109.535 169.183 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -63.44 -42.89 98.67 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.485 1.114 . . . . 2.3900000000000001 110.084 178.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -48.76 -54.96 12.9 Favored 'General case' 0 C--O 1.245 0.823 0 N-CA-C 112.943 0.72 . . . . 0.95999999999999996 112.943 -177.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 14.8 p -98.74 -26.15 3.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 C-N-CA 117.713 -1.595 . . . . 1.3700000000000001 112.361 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 21' ' ' CYS . . . . . 0.445 ' HB2' ' O ' ' B' ' 17' ' ' LEU . 74.7 m -102.28 18.91 19.79 Favored 'General case' 0 C--N 1.308 -1.227 0 O-C-N 121.403 -0.81 . . . . 1.6599999999999999 112.683 -175.408 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -57.35 -46.17 92.09 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 121.056 -0.593 . . . . 1.53 113.656 178.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -72.99 -39.16 66.3 Favored 'General case' 0 C--N 1.32 -0.708 0 O-C-N 122.669 -0.312 . . . . 2.7200000000000002 111.507 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 24' ' ' ARG . . . . . 0.427 ' HD2' ' SG ' ' B' ' 60' ' ' CYS . 40.7 ttm180 -76.44 -38.48 55.44 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.334 0.588 . . . . 4.3300000000000001 111.597 -177.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.35 151.72 9.69 Favored Glycine 0 N--CA 1.423 -2.2 0 N-CA-C 107.95 -2.06 . . . . 1.53 107.95 -174.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 26' ' ' PHE . . . . . 0.494 ' HB2' ' HB3' ' B' ' 17' ' ' LEU . 45.6 p90 -138.09 146.82 43.37 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 117.549 0.675 . . . . 1.6499999999999999 110.229 -179.089 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -170.63 136.75 1.27 Allowed 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 110.205 -0.294 . . . . 3.4199999999999999 110.205 174.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 28' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -118.96 -25.44 6.26 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 112.347 0.499 . . . . 2.2599999999999998 112.347 173.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 67.9 m -80.06 138.11 36.92 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 108.785 -0.82 . . . . 3.6800000000000002 108.785 176.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 30' ' ' ARG . . . . . 0.546 ' H ' ' HB3' ' B' ' 39' ' ' SER . 29.0 mmm180 -121.72 168.81 10.46 Favored Pre-proline 0 C--N 1.298 -1.643 0 N-CA-C 109.139 -0.689 . . . . 3.8100000000000001 109.139 -174.056 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -80.24 14.27 2.0 Allowed 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 123.505 2.803 . . . . 4.0199999999999996 114.841 -175.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 32' ' ' ALA . . . . . 0.515 ' HB3' ' OG ' ' B' ' 39' ' ' SER . . . -68.03 -51.26 48.91 Favored 'General case' 0 CA--C 1.5 -0.971 0 CA-C-O 121.443 0.639 . . . . 4.9199999999999999 109.738 175.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 28.8 t -167.56 150.5 6.05 Favored 'General case' 0 N--CA 1.392 -3.344 0 N-CA-C 106.636 -1.616 . . . . 6.7199999999999998 106.636 177.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 43.0 ttp180 -91.47 3.48 54.86 Favored 'General case' 0 C--N 1.264 -3.111 0 N-CA-C 108.009 -1.108 . . . . 11.630000000000001 108.009 -177.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 47.9 t -90.17 -6.52 10.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 107.697 -1.223 . . . . 9.6099999999999994 107.697 175.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 21.8 m 66.69 30.71 8.05 Favored 'General case' 0 N--CA 1.418 -2.052 0 CA-C-N 114.176 -1.375 . . . . 6.71 112.293 175.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 21.3 mmm180 -64.26 -71.34 0.18 Allowed 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 115.599 -0.728 . . . . 10.0 111.112 175.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 51.8 mtm180 -83.24 -21.48 33.37 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-O 121.873 0.844 . . . . 7.9400000000000004 110.172 175.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 39' ' ' SER . . . . . 0.546 ' HB3' ' H ' ' B' ' 30' ' ' ARG . 19.7 m -95.16 61.07 2.4 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 114.75 -1.114 . . . . 5.7599999999999998 109.377 179.004 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 5.5 tpp180 -57.05 -48.31 78.85 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 114.375 -1.284 . . . . 6.0300000000000002 111.134 -178.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 51.01 54.14 24.02 Favored Glycine 0 C--N 1.287 -2.186 0 CA-C-O 118.765 -1.02 . . . . 2.3700000000000001 115.311 172.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 42' ' ' ILE . . . . . 0.421 HD11 HD21 ' B' ' 17' ' ' LEU . 42.9 pt 52.89 -18.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.527 3.405 0 N-CA-C 118.289 2.7 . . . . 2.0699999999999998 118.289 170.174 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 4.4 p -49.06 -40.58 13.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 C-N-CA 125.551 1.54 . . . . 2.2400000000000002 114.673 -175.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -91.01 -34.11 15.27 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 109.497 -0.557 . . . . 3.3599999999999999 109.497 -173.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 45' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' B' ' 49' ' ' ARG . 11.1 mp0 -64.7 -50.89 65.2 Favored 'General case' 0 C--O 1.192 -1.925 0 CA-C-N 115.758 -0.655 . . . . 3.0800000000000001 110.118 178.601 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 46' ' ' CYS . . . . . 0.524 ' HB3' HD21 ' B' ' 13' ' ' LEU . 31.8 t -73.59 -22.77 59.94 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 119.821 -0.752 . . . . 2.23 110.7 -176.096 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 54.1 t -77.88 -39.34 43.52 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.364 -0.38 . . . . 2.3700000000000001 111.994 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -119.05 6.03 11.31 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.904 1.076 . . . . 2.8199999999999998 113.904 -176.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 49' ' ' ARG . . . . . 0.454 ' HB2' ' O ' ' B' ' 45' ' ' GLU . 98.7 mtt180 -130.51 169.55 15.41 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 106.754 -1.573 . . . . 4.0899999999999999 106.754 176.096 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 50' ' ' SER . . . . . 0.508 ' HA ' HG21 ' B' ' 7' ' ' THR . 45.9 m -87.35 99.94 12.36 Favored 'General case' 0 N--CA 1.415 -2.183 0 N-CA-C 108.86 -0.792 . . . . 2.6699999999999999 108.86 177.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 2.6 p -84.67 142.65 29.74 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.835 -1.172 . . . . 2.1099999999999999 107.835 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -106.29 171.51 7.31 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 119.763 -0.775 . . . . 2.6699999999999999 110.672 176.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 53' ' ' LEU . . . . . 0.67 ' HB3' ' HA ' ' A' 1600 ' ' SER . 1.9 pt? -62.32 -37.1 84.29 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 113.886 1.069 . . . . 1.8999999999999999 113.886 -176.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 54' ' ' ALA . . . . . 0.414 ' O ' HG22 ' B' ' 58' ' ' THR . . . -58.31 -36.37 73.25 Favored 'General case' 0 CA--C 1.504 -0.792 0 C-N-CA 122.615 0.366 . . . . 1.52 111.857 -173.492 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 55' ' ' LEU . . . . . 0.519 ' O ' ' HB2' ' B' ' 59' ' ' TYR . 60.2 tp -60.67 -56.58 19.57 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.59 -0.732 . . . . 1.97 111.101 -177.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 3.2 pp -72.64 -26.76 61.77 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-O 120.831 0.348 . . . . 1.53 110.879 -177.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -69.08 -55.4 10.87 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 115.306 -0.861 . . . . 2.27 111.444 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 58' ' ' THR . . . . . 0.414 HG22 ' O ' ' B' ' 54' ' ' ALA . 13.0 t -78.05 -17.39 57.09 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 119.877 -0.729 . . . . 2.3300000000000001 111.801 -178.503 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 59' ' ' TYR . . . . . 0.519 ' HB2' ' O ' ' B' ' 55' ' ' LEU . 6.3 t80 -77.08 -74.16 0.26 Allowed 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 106.219 -1.771 . . . . 2.8599999999999999 106.219 176.017 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 60' ' ' CYS . . . . . 0.427 ' SG ' ' HD2' ' B' ' 24' ' ' ARG . 36.6 t 51.31 -77.09 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 125.529 1.532 . . . . 2.2999999999999998 114.536 175.417 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -161.22 -50.43 0.04 OUTLIER 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 104.789 -2.3 . . . . 3.1899999999999999 104.789 -177.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 62' ' ' THR . . . . . 0.57 HG21 ' HA ' ' B' ' 66' ' ' SER . 2.7 p -146.64 150.15 39.05 Favored Pre-proline 0 N--CA 1.411 -2.376 0 CA-C-N 112.428 -2.169 . . . . 3.6800000000000002 106.961 178.28 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -77.26 -16.92 15.22 Favored 'Trans proline' 0 C--N 1.326 -0.622 0 C-N-CA 122.725 2.283 . . . . 5.0800000000000001 113.527 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -143.7 51.1 1.34 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 120.855 0.36 . . . . 5.0999999999999996 111.549 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 65.5 tttm 68.18 143.08 0.04 OUTLIER 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 125.264 1.426 . . . . 8.5099999999999998 112.548 178.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 66' ' ' SER . . . . . 0.57 ' HA ' HG21 ' B' ' 62' ' ' THR . 15.7 m -84.15 35.29 0.53 Allowed 'General case' 0 C--O 1.243 0.714 0 O-C-N 121.894 -0.504 . . . . 8.1199999999999992 112.159 -173.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 . . . . . 0 N--CA 1.42 -1.933 0 N-CA-C 106.447 -1.686 . . . . 10.210000000000001 106.447 179.933 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 CA--C 1.501 -0.907 0 N-CA-C 108.359 -0.978 . . . . 9.3399999999999999 108.359 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 27.7 mtpp 64.3 65.04 0.68 Allowed 'General case' 0 C--O 1.226 -0.172 0 O-C-N 123.843 0.715 . . . . 9.0399999999999991 111.264 177.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 50.0 m 55.14 85.84 0.06 Allowed 'General case' 0 C--O 1.244 0.771 0 O-C-N 124.077 0.861 . . . . 5.8099999999999996 112.07 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1511 ' ' ASN . . . . . . . . . . . . . 30.8 p30 -74.14 -18.86 60.73 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.432 -0.349 . . . . 3.4199999999999999 111.318 -177.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1512 ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.62 145.42 24.56 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 121.717 0.77 . . . . 5.9500000000000002 113.077 -174.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 50.7 t-80 -170.1 145.5 2.85 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 103.063 -2.94 . . . . 5.3300000000000001 103.063 176.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1514 ' ' ASP . . . . . 0.415 ' HB2' ' HG2' ' A' 1517 ' ' GLN . 20.0 m-20 67.46 151.98 0.08 Allowed 'General case' 0 CA--C 1.567 1.607 0 C-N-CA 124.114 0.966 . . . . 5.0599999999999996 110.044 -176.099 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1515 ' ' ASP . . . . . 0.435 ' HA ' ' HD3' ' A' 1579 ' ' LYS . 4.5 m-20 -30.26 -74.37 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.308 0 N-CA-C 113.663 0.986 . . . . 2.8999999999999999 113.663 175.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1516 ' ' CYS . . . . . 0.485 ' HB3' ' HB2' ' A' 1529 ' ' LEU . 71.2 m -144.55 78.61 1.58 Allowed 'General case' 0 C--O 1.251 1.165 0 CA-C-O 120.894 0.378 . . . . 1.1899999999999999 111.278 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1517 ' ' GLN . . . . . 0.415 ' HG2' ' HB2' ' A' 1514 ' ' ASP . 11.2 pt20 -157.32 130.22 7.63 Favored 'General case' 0 N--CA 1.422 -1.874 0 N-CA-C 108.982 -0.748 . . . . 1.52 108.982 175.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1518 ' ' VAL . . . . . 0.418 ' CG2' HD12 ' A' 1581 ' ' LEU . 5.9 m -131.79 135.63 58.45 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.16 0 CA-C-O 121.143 0.497 . . . . 0.93999999999999995 110.936 -178.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1519 ' ' THR . . . . . . . . . . . . . 23.5 m -106.46 129.63 54.4 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 107.202 -1.407 . . . . 0.89000000000000001 107.202 176.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1520 ' ' ASN . . . . . 0.45 ' OD1' HG22 ' A' 1523 ' ' THR . 23.9 t-20 -89.02 112.47 51.17 Favored Pre-proline 0 C--N 1.287 -2.152 0 N-CA-C 108.247 -1.019 . . . . 1.74 108.247 176.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.69 -9.99 25.82 Favored 'Trans proline' 0 C--N 1.333 -0.237 0 C-N-CA 122.813 2.342 . . . . 1.5800000000000001 113.257 -175.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1522 ' ' SER . . . . . 0.444 ' HB2' ' OD1' ' A' 1520 ' ' ASN . 24.6 m -74.13 -39.06 63.57 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 116.426 -0.352 . . . . 1.6499999999999999 110.437 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1523 ' ' THR . . . . . 0.45 HG22 ' OD1' ' A' 1520 ' ' ASN . 9.7 t -122.58 -10.03 8.4 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 120.314 -0.554 . . . . 1.6100000000000001 112.268 -179.425 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 81.06 22.6 60.77 Favored Glycine 0 C--N 1.32 -0.361 0 O-C-N 122.334 -0.229 . . . . 1.1299999999999999 113.593 176.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1525 ' ' HIS . . . . . 0.567 ' CE1' ' HB3' ' A' 1647 ' ' GLU . 11.8 t-160 -93.65 125.26 38.17 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 120.535 -0.466 . . . . 1.26 110.69 -178.24 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 2.5 tm? -94.28 116.52 28.92 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 114.866 -1.061 . . . . 0.68000000000000005 109.764 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1527 ' ' PHE . . . . . 0.409 ' O ' ' HA ' ' A' 1517 ' ' GLN . 96.7 m-85 -92.71 119.09 31.75 Favored 'General case' 0 C--N 1.317 -0.808 0 O-C-N 122.296 -0.252 . . . . 0.65000000000000002 110.438 173.082 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 14.2 t70 -103.92 110.67 22.9 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 109.123 -0.695 . . . . 1.1699999999999999 109.123 178.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1529 ' ' LEU . . . . . 0.485 ' HB2' ' HB3' ' A' 1516 ' ' CYS . 3.6 mm? -99.01 3.16 46.85 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 121.326 0.584 . . . . 0.59999999999999998 109.973 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 1.1 m -64.55 -29.66 70.69 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.049 -0.978 . . . . 0.83999999999999997 109.344 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 23.1 t -62.26 -32.27 72.95 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.244 -0.889 . . . . 1.5900000000000001 110.482 178.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 81.3 mt -96.28 1.37 51.98 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.255 -0.43 . . . . 0.65000000000000002 110.944 -176.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1533 ' ' SER . . . . . . . . . . . . . 16.7 m -75.0 161.46 29.45 Favored 'General case' 0 C--O 1.256 1.42 0 CA-C-O 121.294 0.569 . . . . 1.52 111.982 -177.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -178.59 139.8 4.22 Favored Glycine 0 N--CA 1.429 -1.82 0 CA-C-N 115.623 -0.717 . . . . 1.1000000000000001 111.532 178.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1535 ' ' ARG . . . . . 0.486 ' O ' ' HD3' ' A' 1535 ' ' ARG . 0.8 OUTLIER -92.92 -30.37 15.43 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 123.514 0.726 . . . . 4.6200000000000001 109.252 -179.588 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -73.2 -34.11 65.78 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 121.582 0.706 . . . . 1.45 109.697 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 106.26 -177.47 22.3 Favored Glycine 0 N--CA 1.417 -2.574 0 CA-C-N 115.322 -0.854 . . . . 0.84999999999999998 113.497 172.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -138.28 145.7 41.58 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 106.92 -1.511 . . . . 0.93000000000000005 106.92 178.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 20.2 p -102.58 124.18 47.66 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 123.513 0.508 . . . . 1.03 110.526 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1540 ' ' ALA . . . . . 0.722 ' HB3' HG23 ' A' 1548 ' ' VAL . . . -117.37 134.89 54.3 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 109.087 -0.709 . . . . 0.5 109.087 178.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -88.13 124.47 33.82 Favored 'General case' 0 N--CA 1.439 -0.976 0 O-C-N 123.663 0.602 . . . . 0.73999999999999999 110.71 -178.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1542 ' ' TYR . . . . . 0.54 ' HD2' ' CZ ' ' A' 1567 ' ' PHE . 2.2 t80 -123.5 -101.34 0.4 Allowed 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.235 -0.893 . . . . 0.98999999999999999 109.675 -179.436 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1543 ' ' SER . . . . . . . . . . . . . 14.6 m -62.98 159.77 16.34 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 118.735 -0.65 . . . . 1.9099999999999999 109.601 177.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 63.2 tttp -50.49 -40.87 52.32 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 112.902 0.705 . . . . 3.5899999999999999 112.902 -175.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 27.3 t -116.98 34.43 5.11 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 108.47 -0.937 . . . . 2.46 108.47 177.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . -128.34 118.84 2.91 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.078 -1.058 . . . . 1.26 114.312 -175.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 28.1 m -124.66 137.61 56.82 Favored 'Isoleucine or valine' 0 C--O 1.254 1.325 0 CA-C-O 121.027 0.441 . . . . 0.79000000000000004 109.939 176.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1548 ' ' VAL . . . . . 0.722 HG23 ' HB3' ' A' 1540 ' ' ALA . 0.0 OUTLIER -95.88 132.69 39.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-N 115.818 -0.628 . . . . 0.57999999999999996 110.862 175.68 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A 1549 ' ' TYR . . . . . 0.419 ' HB3' ' ND2' ' A' 1556 ' ' ASN . 51.8 m-85 -96.33 99.8 11.46 Favored 'General case' 0 N--CA 1.423 -1.776 0 N-CA-C 106.756 -1.572 . . . . 1.0800000000000001 106.756 171.419 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 6.4 ptp -110.75 142.15 43.09 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 115.392 -0.822 . . . . 0.78000000000000003 111.589 -178.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 12.3 p -118.34 110.64 17.73 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-N 115.719 -0.673 . . . . 0.96999999999999997 109.428 176.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1552 ' ' ILE . . . . . . . . . . . . . 41.6 mm -75.49 119.6 23.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 109.465 -0.569 . . . . 0.41999999999999998 109.465 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 56.8 m 64.41 41.68 5.61 Favored 'General case' 0 C--O 1.25 1.101 0 CA-C-O 121.97 0.891 . . . . 1.3999999999999999 111.994 174.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 174.84 -178.02 46.73 Favored Glycine 0 N--CA 1.421 -2.36 0 N-CA-C 109.452 -1.459 . . . . 0.34999999999999998 109.452 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -109.54 146.08 35.24 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-O 120.882 0.372 . . . . 1.6200000000000001 110.224 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1556 ' ' ASN . . . . . 0.419 ' ND2' ' HB3' ' A' 1549 ' ' TYR . 45.2 t-20 -94.92 139.49 31.25 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 115.672 -0.695 . . . . 0.87 109.166 -175.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1557 ' ' GLU . . . . . 0.417 ' HB3' ' CZ ' ' A' 1535 ' ' ARG . 12.9 pt-20 -77.92 -13.45 59.88 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 122.932 0.493 . . . . 2.4900000000000002 112.304 -176.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -73.87 -8.25 55.37 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.38 0.511 . . . . 1.3799999999999999 112.38 -177.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1559 ' ' CYS . . . . . 0.775 ' SG ' ' HD2' ' A' 1560 ' ' PRO . 1.6 t -137.72 169.41 13.07 Favored Pre-proline 0 C--N 1.288 -2.106 0 N-CA-C 106.747 -1.575 . . . . 1.21 106.747 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1560 ' ' PRO . . . . . 0.775 ' HD2' ' SG ' ' A' 1559 ' ' CYS . 14.2 Cg_exo -38.58 149.51 0.08 OUTLIER 'Trans proline' 0 CA--C 1.557 1.644 0 C-N-CA 124.003 3.135 . . . . 0.70999999999999996 114.699 174.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1561 ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' 1560 ' ' PRO . 52.2 Cg_exo -58.05 125.59 19.02 Favored 'Trans proline' 0 C--O 1.242 0.72 0 C-N-CA 123.151 2.567 . . . . 0.80000000000000004 110.85 178.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 106.91 -7.28 38.13 Favored Glycine 0 N--CA 1.433 -1.517 0 CA-C-N 115.926 -0.579 . . . . 0.46000000000000002 112.828 -178.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1563 ' ' VAL . . . . . 0.692 HG11 ' HB2' ' A' 1566 ' ' CYS . 9.8 t -79.37 121.8 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.836 0 N-CA-C 112.712 0.634 . . . . 0.97999999999999998 112.712 -179.054 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -97.3 -34.75 5.49 Favored Glycine 0 C--N 1.306 -1.086 0 CA-C-N 114.918 -1.037 . . . . 0.28000000000000003 111.023 176.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -131.4 125.17 31.91 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 109.653 -0.499 . . . . 0.28000000000000003 109.653 178.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1566 ' ' CYS . . . . . 0.692 ' HB2' HG11 ' A' 1563 ' ' VAL . 49.4 t -150.78 138.46 19.77 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 110.115 -0.328 . . . . 0.42999999999999999 110.115 -179.322 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1567 ' ' PHE . . . . . 0.956 ' HB3' ' HG2' ' A' 1569 ' ' GLN . 23.8 m-85 -85.74 139.62 31.19 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.812 -0.81 . . . . 1.03 108.812 172.335 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -87.57 23.32 13.04 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.211 -0.995 . . . . 1.1299999999999999 111.245 -178.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1569 ' ' GLN . . . . . 0.956 ' HG2' ' HB3' ' A' 1567 ' ' PHE . 9.9 mm100 -67.71 -70.81 0.24 Allowed 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 122.912 0.485 . . . . 2.5800000000000001 110.361 -177.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 14.3 t -131.85 34.74 3.83 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-O 122.539 1.161 . . . . 2.1699999999999999 108.19 173.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 22.9 mmt180 63.56 61.02 1.05 Allowed 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 113.747 -1.569 . . . . 2.6200000000000001 109.803 -178.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 34.8 mt -104.26 115.4 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-N 116.242 -0.436 . . . . 0.92000000000000004 110.529 -177.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1573 ' ' SER . . . . . 0.559 ' HB3' ' HB2' ' A' 1596 ' ' SER . 28.6 t -80.13 142.02 35.19 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 120.957 0.408 . . . . 0.80000000000000004 110.71 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1574 ' ' VAL . . . . . 0.499 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 27.0 m -133.04 17.12 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 O-C-N 122.031 -0.418 . . . . 0.97999999999999998 111.673 178.288 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 172.97 131.57 1.4 Allowed Glycine 0 N--CA 1.428 -1.843 0 C-N-CA 119.193 -1.48 . . . . 0.28999999999999998 111.981 178.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -85.37 143.84 28.39 Favored 'General case' 0 N--CA 1.427 -1.578 0 N-CA-C 108.142 -1.058 . . . . 2.1899999999999999 108.142 178.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -68.43 92.23 0.43 Allowed 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 115.456 -0.793 . . . . 0.60999999999999999 111.8 -177.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -100.94 173.9 6.27 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 107.205 -1.406 . . . . 1.95 107.205 172.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1579 ' ' LYS . . . . . 0.435 ' HD3' ' HA ' ' A' 1515 ' ' ASP . 16.7 ptpt -142.8 54.5 1.39 Allowed 'General case' 0 C--N 1.294 -1.815 0 CA-C-O 122.395 1.093 . . . . 2.6800000000000002 109.502 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1580 ' ' ARG . . . . . 0.423 ' NH1' HH21 ' A' 1582 ' ' ARG . 69.5 ttt180 -105.99 77.11 1.22 Allowed 'General case' 0 N--CA 1.419 -2.015 0 CA-C-N 114.953 -1.021 . . . . 3.4700000000000002 109.7 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1581 ' ' LEU . . . . . 0.455 HD11 HD12 ' A' 1588 ' ' LEU . 0.5 OUTLIER -63.28 126.08 26.24 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.047 -0.979 . . . . 0.64000000000000001 109.304 177.436 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A 1582 ' ' ARG . . . . . 0.553 ' HB2' ' HB3' ' A' 1589 ' ' GLN . 91.3 mtt180 -121.73 144.69 48.65 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 116.032 -0.531 . . . . 2.8500000000000001 110.137 177.095 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1583 ' ' TYR . . . . . 0.604 ' CE1' ' HA ' ' A' 1586 ' ' GLN . 61.9 t80 -115.09 108.76 17.07 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.896 -0.409 . . . . 0.85999999999999999 109.896 178.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1584 ' ' VAL . . . . . 0.535 ' O ' ' HB ' ' A' 1587 ' ' VAL . 13.1 m -124.81 89.56 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.61 0.719 . . . . 1.05 112.275 -178.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 21.0 t70 55.75 58.66 4.31 Favored 'General case' 0 N--CA 1.505 2.299 0 C-N-CA 124.739 1.215 . . . . 1.1699999999999999 110.874 178.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1586 ' ' GLN . . . . . 0.604 ' HA ' ' CE1' ' A' 1583 ' ' TYR 0.352 12.9 pt20 63.92 17.66 10.69 Favored 'General case' 0 CA--C 1.503 -0.863 0 C-N-CA 127.513 2.325 . . . . 1.8600000000000001 112.805 179.463 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A 1587 ' ' VAL . . . . . 0.535 ' HB ' ' O ' ' A' 1584 ' ' VAL . 39.5 t -102.0 120.48 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.235 0 N-CA-C 106.723 -1.584 . . . . 0.48999999999999999 106.723 170.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1588 ' ' LEU . . . . . 0.967 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 2.5 mm? -96.6 108.03 20.56 Favored 'General case' 0 C--N 1.283 -2.283 0 N-CA-C 107.38 -1.341 . . . . 0.35999999999999999 107.38 -179.191 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1589 ' ' GLN . . . . . 0.553 ' HB3' ' HB2' ' A' 1582 ' ' ARG . 34.4 tt0 -100.07 131.16 46.19 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 116.022 -0.535 . . . . 1.74 112.075 -173.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 12.1 mt -125.71 102.15 7.2 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 106.711 -1.589 . . . . 0.71999999999999997 106.711 170.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 7.8 p -95.96 126.02 48.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 CA-C-O 121.39 0.614 . . . . 1.01 110.184 -177.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1592 ' ' TYR . . . . . . . . . . . . . 13.0 m-30 -117.25 110.69 18.43 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 107.966 -1.124 . . . . 0.5 107.966 -178.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 47.4 pttt -130.56 -179.13 5.1 Favored 'General case' 0 C--N 1.281 -2.381 0 CA-C-N 115.625 -0.716 . . . . 1.5900000000000001 109.375 -177.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 19.9 m-20 61.66 43.33 9.97 Favored 'General case' 0 CA--C 1.507 -0.701 0 O-C-N 124.383 1.052 . . . . 1.1100000000000001 110.264 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -90.81 -134.43 5.92 Favored Glycine 0 N--CA 1.432 -1.623 0 CA-C-N 114.594 -1.184 . . . . 0.78000000000000003 110.942 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1596 ' ' SER . . . . . 0.559 ' HB2' ' HB3' ' A' 1573 ' ' SER . 33.1 t -86.31 148.24 46.68 Favored Pre-proline 0 C--N 1.303 -1.424 0 N-CA-C 108.583 -0.895 . . . . 1.0700000000000001 108.583 -178.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -63.11 140.12 76.53 Favored 'Trans proline' 0 N--CA 1.443 -1.496 0 C-N-CA 122.499 2.133 . . . . 1.01 109.711 174.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1598 ' ' CYS . . . . . 0.547 ' HA ' ' CE2' ' A' 1606 ' ' TYR . 49.4 t -79.58 110.18 14.52 Favored Pre-proline 0 C--N 1.294 -1.817 0 N-CA-C 107.721 -1.215 . . . . 0.75 107.721 -178.1 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -58.59 -34.11 98.62 Favored 'Trans proline' 0 C--N 1.358 1.044 0 C-N-CA 123.191 2.594 . . . . 1.7 112.007 -176.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1600 ' ' SER . . . . . 0.756 ' HB3' ' HB2' ' B' ' 53' ' ' LEU . 4.8 m -60.62 -22.44 63.79 Favored 'General case' 0 CA--C 1.56 1.334 0 C-N-CA 125.271 1.428 . . . . 2.2599999999999998 113.171 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1601 ' ' LYS . . . . . 0.502 ' HE2' ' OD2' ' B' ' 52' ' ' ASP . 4.9 tppp? -157.4 120.62 4.04 Favored 'General case' 0 C--O 1.241 0.622 0 O-C-N 121.952 -0.468 . . . . 3.0099999999999998 110.339 178.045 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 19.8 m -70.18 133.93 47.58 Favored 'General case' 0 N--CA 1.414 -2.273 0 N-CA-C 109.686 -0.487 . . . . 2.0699999999999998 109.686 -177.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 105.51 -16.89 44.01 Favored Glycine 0 C--N 1.301 -1.377 0 CA-C-N 116.072 -0.513 . . . . 1.0800000000000001 112.343 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1604 ' ' LEU . . . . . 0.468 HD12 ' HB3' ' A' 1601 ' ' LYS . 56.9 mt -102.95 138.76 39.4 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 122.164 -0.61 . . . . 1.8400000000000001 110.451 -179.35 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 20.5 m -115.92 147.04 41.54 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 107.698 -1.223 . . . . 1.4099999999999999 107.698 175.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1606 ' ' TYR . . . . . 0.547 ' CE2' ' HA ' ' A' 1598 ' ' CYS . 54.4 m-85 -70.14 150.21 46.75 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 116.687 -0.233 . . . . 0.59999999999999998 111.543 -178.373 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 6.6 ttpm? -148.07 135.51 20.6 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.771 -0.826 . . . . 1.45 108.771 177.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1608 ' ' SER . . . . . . . . . . . . . 2.6 p -119.1 126.42 51.6 Favored 'General case' 0 C--N 1.281 -2.387 0 CA-C-N 115.384 -0.826 . . . . 1.1499999999999999 109.83 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 39.1 t -107.51 105.16 18.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 109.52 -0.548 . . . . 0.25 109.52 -178.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1610 ' ' ILE . . . . . 0.407 ' HA ' ' HB2' ' A' 1638 ' ' PHE . 92.9 mt -89.97 119.38 36.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 107.972 -1.121 . . . . 0.45000000000000001 107.972 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 20.0 m -124.55 116.0 21.76 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-N 115.85 -0.614 . . . . 1.26 110.494 -177.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1612 ' ' PHE . . . . . 0.967 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 75.5 m-85 -85.62 122.82 30.28 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.606 -0.887 . . . . 0.26000000000000001 108.606 176.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 58.8 t -111.62 135.58 50.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 CA-C-N 115.382 -0.826 . . . . 0.5 109.576 -174.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 39.5 t -68.3 107.54 2.86 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.246 -0.888 . . . . 0.77000000000000002 110.587 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1615 ' ' ARG . . . . . 0.436 ' CB ' ' HB3' ' A' 1641 ' ' HIS . 32.7 tpt180 -132.35 94.28 23.48 Favored Pre-proline 0 N--CA 1.437 -1.107 0 N-CA-C 108.746 -0.835 . . . . 2.5299999999999998 108.746 176.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1616 ' ' PRO . . . . . 0.793 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 18.6 Cg_exo -66.89 -26.17 44.58 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 122.034 1.823 . . . . 1.1000000000000001 112.397 -177.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -77.87 43.31 0.42 Allowed 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 125.067 1.347 . . . . 3.0499999999999998 112.977 178.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -31.99 126.24 0.26 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.726 1.611 . . . . 1.55 113.171 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . -167.19 -141.17 3.08 Favored Glycine 0 N--CA 1.412 -2.906 0 N-CA-C 109.175 -1.57 . . . . 0.93000000000000005 109.175 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -75.49 8.77 2.45 Favored 'Trans proline' 0 CA--C 1.533 0.437 0 C-N-CA 122.525 2.15 . . . . 0.88 113.337 -176.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1621 ' ' THR . . . . . 0.678 ' HB ' ' HB2' ' A' 1641 ' ' HIS . 14.4 p -96.18 -10.48 28.02 Favored 'General case' 0 C--N 1.292 -1.905 0 C-N-CA 124.102 0.961 . . . . 0.96999999999999997 109.971 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 52.9 t30 -85.86 65.34 9.08 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 114.945 -1.025 . . . . 0.71999999999999997 109.38 -178.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1623 ' ' ARG . . . . . 0.524 ' O ' ' HG3' ' A' 1625 ' ' MET . 10.8 ptp180 -165.34 141.84 4.61 Favored Pre-proline 0 C--N 1.31 -1.126 0 N-CA-C 107.78 -1.193 . . . . 3.2599999999999998 107.78 -175.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1624 ' ' PRO . . . . . 0.445 ' HG3' ' CZ3' ' A' 1640 ' ' TRP . 23.5 Cg_exo -56.11 107.37 0.25 Allowed 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.551 2.167 . . . . 0.58999999999999997 111.005 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1625 ' ' MET . . . . . 0.524 ' HG3' ' O ' ' A' 1623 ' ' ARG . 89.8 mtp -107.05 132.46 52.94 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.345 -0.613 . . . . 1.3700000000000001 109.345 -177.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.4 114.06 22.17 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 106.406 -1.702 . . . . 0.89000000000000001 106.406 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1627 ' ' ILE . . . . . 0.752 HD11 ' HB2' ' A' 1639 ' ' SER . 45.2 mm -69.4 -55.1 16.42 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.139 0 N-CA-C 109.027 -0.731 . . . . 0.57999999999999996 109.027 -179.046 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 11.8 t -176.44 152.88 1.12 Allowed 'General case' 0 N--CA 1.425 -1.704 0 N-CA-C 108.616 -0.883 . . . . 1.3899999999999999 108.616 -176.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1629 ' ' LEU . . . . . 0.594 HD13 HD23 ' A' 1636 ' ' LEU . 19.0 tp -99.89 109.51 21.89 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.304 -0.862 . . . . 1.25 109.408 175.242 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 20.6 t70 -73.03 98.79 2.6 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 106.372 -1.714 . . . . 1.0900000000000001 106.372 170.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1631 ' ' LYS . . . . . 0.715 ' HD3' ' H ' ' A' 1631 ' ' LYS . 0.2 OUTLIER -73.31 -16.21 61.38 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 113.73 1.011 . . . . 3.6000000000000001 113.73 -172.989 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 89.7 mm-40 -73.56 -36.63 65.63 Favored 'General case' 0 CA--C 1.498 -1.052 0 C-N-CA 120.41 -0.516 . . . . 2.6000000000000001 111.193 178.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 58.9 p -108.01 -6.15 16.72 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 115.886 -0.597 . . . . 0.75 112.432 -176.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 82.5 m 63.73 47.08 3.77 Favored 'General case' 0 C--N 1.36 1.03 0 C-N-CA 124.368 1.067 . . . . 0.53000000000000003 109.754 -178.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1635 ' ' THR . . . . . . . . . . . . . 56.1 m -115.36 133.17 56.29 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.92 -1.036 . . . . 0.46000000000000002 110.808 -175.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1636 ' ' LEU . . . . . 0.594 HD23 HD13 ' A' 1629 ' ' LEU . 15.7 mt -110.14 135.75 50.44 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.996 -0.742 . . . . 0.85999999999999999 108.996 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -109.55 133.15 53.43 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 109.421 -0.585 . . . . 0.45000000000000001 109.421 176.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1638 ' ' PHE . . . . . 0.407 ' HB2' ' HA ' ' A' 1610 ' ' ILE . 97.3 m-85 -123.34 135.39 54.16 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 116.137 -0.483 . . . . 0.5 110.021 -178.197 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1639 ' ' SER . . . . . 0.752 ' HB2' HD11 ' A' 1627 ' ' ILE . 23.3 t -115.62 156.17 26.32 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 107.221 -1.399 . . . . 1.04 107.221 175.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1640 ' ' TRP . . . . . 0.445 ' CZ3' ' HG3' ' A' 1624 ' ' PRO . 3.1 t90 -151.5 106.21 3.25 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 103.973 -2.603 . . . . 0.68000000000000005 103.973 177.484 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1641 ' ' HIS . . . . . 0.678 ' HB2' ' HB ' ' A' 1621 ' ' THR . 12.3 m-70 -93.39 103.45 15.67 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.694 -0.854 . . . . 0.90000000000000002 108.694 -173.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1642 ' ' THR . . . . . . . . . . . . . 15.3 t -142.21 145.33 35.06 Favored Pre-proline 0 CA--C 1.558 1.277 0 C-N-CA 120.776 -0.369 . . . . 0.47999999999999998 110.341 -172.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1643 ' ' PRO . . . . . 0.793 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 72.6 Cg_endo -78.42 -5.5 14.96 Favored 'Trans proline' 0 C--N 1.372 1.793 0 C-N-CA 122.303 2.002 . . . . 0.66000000000000003 112.233 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 9.2 tt -66.49 -24.44 66.41 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.104 -0.702 . . . . 0.96999999999999997 109.104 177.094 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -92.7 16.2 12.78 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.251 -0.886 . . . . 0.83999999999999997 110.566 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 58.6 m -121.79 145.87 47.62 Favored 'General case' 0 N--CA 1.424 -1.748 0 O-C-N 122.28 -0.262 . . . . 1.1899999999999999 110.998 -178.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1647 ' ' GLU . . . . . 0.567 ' HB3' ' CE1' ' A' 1525 ' ' HIS . 0.4 OUTLIER -116.41 126.97 27.11 Favored Pre-proline 0 C--N 1.296 -1.729 0 N-CA-C 108.509 -0.923 . . . . 3.1400000000000001 108.509 167.14 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A 1648 ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -70.27 124.17 10.62 Favored 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 122.012 1.808 . . . . 2.5800000000000001 110.679 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 . . . . . 0 C--N 1.299 -1.624 0 N-CA-C 108.951 -0.759 . . . . 4.7199999999999998 108.951 -178.877 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.721 0 N-CA-C 109.087 -0.708 . . . . 9.9700000000000006 109.087 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 2' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -74.11 129.31 37.59 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 107.077 -1.453 . . . . 7.6799999999999997 107.077 177.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 22.5 ptt180 -97.38 128.84 33.47 Favored Pre-proline 0 C--N 1.297 -1.684 0 C-N-CA 120.21 -0.596 . . . . 6.1100000000000003 111.281 -176.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -71.86 -1.43 9.93 Favored 'Trans proline' 0 N--CA 1.49 1.298 0 C-N-CA 123.993 3.128 . . . . 4.8399999999999999 113.726 -178.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 32.8 m -144.0 141.15 29.98 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 106.032 -1.84 . . . . 4.5999999999999996 106.032 179.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 6' ' ' GLU . . . . . 0.459 ' HB2' ' HB2' ' B' ' 50' ' ' SER . 72.9 mm-40 -78.65 -16.23 57.58 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 120.927 0.394 . . . . 4.2300000000000004 110.874 -178.129 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 3.5 p -130.67 113.78 14.6 Favored 'General case' 0 N--CA 1.426 -1.635 0 CA-C-N 114.785 -1.098 . . . . 3.1400000000000001 109.024 176.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.604 ' HB2' ' HG3' ' B' ' 12' ' ' GLU . 9.4 mp -70.17 136.78 50.42 Favored 'General case' 0 C--O 1.248 0.986 0 O-C-N 122.136 -0.353 . . . . 3.96 111.856 178.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 9' ' ' CYS . . . . . 0.439 ' HA ' ' CD1' ' B' ' 13' ' ' LEU . 43.7 m -83.37 85.06 7.29 Favored 'General case' 0 N--CA 1.436 -1.159 0 C-N-CA 123.74 0.816 . . . . 2.8399999999999999 111.04 -172.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 10' ' ' GLY . . . . . 0.48 ' O ' HG12 ' B' ' 14' ' ' VAL . . . 140.86 -77.59 0.3 Allowed Glycine 0 N--CA 1.412 -2.962 0 N-CA-C 110.07 -1.212 . . . . 2.0899999999999999 110.07 177.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 11' ' ' GLY . . . . . 0.566 ' O ' ' HB2' ' B' ' 15' ' ' ASP . . . -56.32 -62.38 6.4 Favored Glycine 0 N--CA 1.44 -1.05 0 O-C-N 124.687 0.875 . . . . 1.8400000000000001 113.325 -176.419 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 12' ' ' GLU . . . . . 0.604 ' HG3' ' HB2' ' B' ' 8' ' ' LEU . 44.1 mt-10 -74.12 -30.04 62.12 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.981 0.391 . . . . 2.5499999999999998 111.222 -176.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 13' ' ' LEU . . . . . 0.58 ' HG ' ' O ' ' B' ' 8' ' ' LEU . 67.1 mt -56.67 -64.86 0.73 Allowed 'General case' 0 N--CA 1.468 0.446 0 O-C-N 123.374 0.421 . . . . 2.3500000000000001 111.09 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 14' ' ' VAL . . . . . 0.48 HG12 ' O ' ' B' ' 10' ' ' GLY . 14.0 p -65.38 -29.85 48.45 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 CA-C-O 121.355 0.598 . . . . 2.1099999999999999 110.269 -178.413 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 15' ' ' ASP . . . . . 0.566 ' HB2' ' O ' ' B' ' 11' ' ' GLY . 4.0 t70 -66.69 -48.38 69.44 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-N 115.422 -0.808 . . . . 2.04 112.251 -177.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 13.4 t -65.91 -31.87 73.05 Favored 'General case' 0 C--O 1.256 1.414 0 CA-C-N 118.099 0.409 . . . . 1.8400000000000001 110.82 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.63 ' HB3' ' HB3' ' B' ' 26' ' ' PHE . 4.1 mm? -58.6 -48.79 79.78 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.423 0.63 . . . . 1.74 110.374 174.243 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -80.22 -15.1 57.76 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.549 0.69 . . . . 2.3900000000000001 110.902 -178.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -65.07 -52.76 53.85 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 116.094 -0.503 . . . . 0.95999999999999996 110.786 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 30.7 m -98.43 -24.95 4.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 C-N-CA 118.666 -1.214 . . . . 1.3700000000000001 112.141 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 21' ' ' CYS . . . . . 0.425 ' HB2' ' O ' ' B' ' 17' ' ' LEU . 95.9 m -105.03 19.84 19.9 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 120.681 -0.407 . . . . 1.6599999999999999 111.841 -177.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -49.22 -40.89 30.21 Favored Glycine 0 N--CA 1.474 1.168 0 N-CA-C 115.093 0.797 . . . . 1.53 115.093 -178.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -71.4 -32.35 68.32 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 112.476 0.547 . . . . 2.7200000000000002 112.476 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 21.0 ttm180 -93.12 -41.12 10.11 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 120.738 -0.385 . . . . 4.3300000000000001 111.852 -175.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 120.25 -176.15 16.12 Favored Glycine 0 N--CA 1.436 -1.355 0 N-CA-C 110.191 -1.164 . . . . 1.53 110.191 -177.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 26' ' ' PHE . . . . . 0.63 ' HB3' ' HB3' ' B' ' 17' ' ' LEU . 12.9 p90 -132.4 127.78 36.15 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 116.914 0.357 . . . . 1.6499999999999999 110.277 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -131.09 84.04 2.15 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.089 0.471 . . . . 3.4199999999999999 112.103 -175.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 28' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -120.19 22.49 11.37 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 122.367 1.08 . . . . 2.2599999999999998 108.806 177.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 3.3 p -80.69 41.34 0.56 Allowed 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 113.992 -1.458 . . . . 3.6800000000000002 111.928 -178.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 30' ' ' ARG . . . . . 0.407 ' HA ' ' HD3' ' B' ' 31' ' ' PRO . 29.4 mmm180 -105.28 131.66 21.57 Favored Pre-proline 0 C--N 1.306 -1.302 0 N-CA-C 107.758 -1.201 . . . . 3.8100000000000001 107.758 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 31' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' B' ' 30' ' ' ARG . 2.6 Cg_endo -86.26 13.54 2.7 Favored 'Trans proline' 0 C--O 1.248 0.991 0 C-N-CA 123.163 2.576 . . . . 4.0199999999999996 113.792 -173.199 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 32' ' ' ALA . . . . . 0.642 ' HA ' ' HB3' ' B' ' 36' ' ' SER . . . 72.9 91.9 0.09 Allowed 'General case' 0 CA--C 1.514 -0.419 0 C-N-CA 125.082 1.353 . . . . 4.9199999999999999 111.298 178.139 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 33' ' ' SER . . . . . 0.491 ' H ' ' HB3' ' B' ' 36' ' ' SER . 92.4 p -111.07 -147.5 0.42 Allowed 'General case' 1 N--CA 1.365 -4.684 0 N-CA-C 104.419 -2.437 . . . . 6.7199999999999998 104.419 -177.941 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 50.5 mtp180 -80.64 -21.0 41.84 Favored 'General case' 0 C--N 1.275 -2.649 0 CA-C-N 118.859 0.754 . . . . 11.630000000000001 109.364 175.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 24.0 t -89.83 -2.12 9.61 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 CA-C-O 122.935 1.35 . . . . 9.6099999999999994 107.965 -178.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 36' ' ' SER . . . . . 0.642 ' HB3' ' HA ' ' B' ' 32' ' ' ALA . 10.4 t -143.78 44.38 1.48 Allowed 'General case' 0 N--CA 1.411 -2.406 0 CA-C-N 114.559 -1.201 . . . . 6.71 107.802 -176.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -91.42 -7.03 51.82 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 122.18 0.991 . . . . 10.0 108.683 174.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -141.44 134.45 29.08 Favored 'General case' 0 N--CA 1.417 -2.117 1 N-CA-C 99.979 -4.082 . . . . 7.9400000000000004 99.979 176.41 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 15.8 m 60.58 56.78 2.95 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 107.199 -1.408 . . . . 5.7599999999999998 107.199 -171.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 40' ' ' ARG . . . . . 0.622 ' HB2' ' HB2' ' B' ' 32' ' ' ALA . 0.0 OUTLIER -81.25 76.5 8.19 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 114.39 -1.277 . . . . 6.0300000000000002 110.132 -177.271 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.22 7.12 56.56 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-N 115.043 -0.98 . . . . 2.3700000000000001 113.253 -172.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 42' ' ' ILE . . . . . 0.619 ' HA ' ' HG2' ' B' ' 45' ' ' GLU . 27.5 pt 52.75 26.94 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.38 1.899 0 C-N-CA 126.549 1.94 . . . . 2.0699999999999998 112.739 179.019 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 1.4 p -103.05 -44.42 9.75 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.921 0 CA-C-N 113.771 -1.559 . . . . 2.2400000000000002 112.638 -173.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -83.72 -22.06 32.11 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.758 -1.201 . . . . 3.3599999999999999 107.758 -178.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 45' ' ' GLU . . . . . 0.619 ' HG2' ' HA ' ' B' ' 42' ' ' ILE . 1.5 pm0 -77.53 -28.36 51.95 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 114.241 -1.345 . . . . 3.0800000000000001 112.22 173.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 46' ' ' CYS . . . . . . . . . . . . . 12.1 t -112.77 -3.25 14.24 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 118.729 -1.188 . . . . 2.23 112.793 -177.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 43.3 t -86.77 -53.34 4.98 Favored 'General case' 0 C--N 1.314 -0.975 0 O-C-N 121.201 -0.937 . . . . 2.3700000000000001 110.958 175.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -91.71 -5.73 53.19 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.31 0.576 . . . . 2.8199999999999998 111.902 -176.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -139.5 152.16 46.73 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 106.348 -1.723 . . . . 4.0899999999999999 106.348 179.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 50' ' ' SER . . . . . 0.459 ' HB2' ' HB2' ' B' ' 6' ' ' GLU . 32.3 t -80.3 139.59 36.56 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 106.209 -1.774 . . . . 2.6699999999999999 106.209 175.011 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 51' ' ' CYS . . . . . 0.593 ' HB2' HD23 ' B' ' 55' ' ' LEU . 25.7 p -105.46 138.18 42.08 Favored 'General case' 0 N--CA 1.422 -1.855 0 N-CA-C 108.6 -0.889 . . . . 2.1099999999999999 108.6 -175.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 52' ' ' ASP . . . . . 0.502 ' OD2' ' HE2' ' A' 1601 ' ' LYS . 3.5 m-20 -66.33 139.44 58.04 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.944 -0.761 . . . . 2.6699999999999999 108.944 177.313 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 53' ' ' LEU . . . . . 0.756 ' HB2' ' HB3' ' A' 1600 ' ' SER . 36.0 tp -55.18 -30.86 60.77 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.246 -1.343 . . . . 1.8999999999999999 110.555 177.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.48 -45.44 84.84 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 123.688 0.795 . . . . 1.52 110.431 177.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 55' ' ' LEU . . . . . 0.593 HD23 ' HB2' ' B' ' 51' ' ' CYS . 44.9 tp -58.77 -50.57 73.43 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 123.936 0.895 . . . . 1.97 110.52 -179.242 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 3.1 pp -74.11 -33.08 63.47 Favored 'General case' 0 N--CA 1.424 -1.74 0 C-N-CA 120.716 -0.394 . . . . 1.53 111.842 -175.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -66.75 -49.45 65.92 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.117 0.484 . . . . 2.27 110.812 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 7.2 t -73.75 -24.46 59.88 Favored 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 120.294 -0.562 . . . . 2.3300000000000001 111.039 -177.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -76.7 -67.48 0.7 Allowed 'General case' 0 C--O 1.241 0.611 0 N-CA-C 107.576 -1.268 . . . . 2.8599999999999999 107.576 176.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 42.9 t 59.61 -85.27 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.311 1.444 . . . . 2.2999999999999998 113.881 175.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -140.87 -88.81 0.17 Allowed 'General case' 0 N--CA 1.426 -1.627 0 N-CA-C 108.982 -0.747 . . . . 3.1899999999999999 108.982 -174.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 4.1 p -146.58 138.93 13.85 Favored Pre-proline 0 N--CA 1.415 -2.207 0 N-CA-C 107.61 -1.255 . . . . 3.6800000000000002 107.61 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -83.88 -2.11 10.17 Favored 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.73 2.287 . . . . 5.0800000000000001 112.702 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 64' ' ' ALA . . . . . 0.435 ' HA ' ' HB2' ' B' ' 67' ' ' GLU . . . -129.94 50.59 2.17 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 115.425 -0.807 . . . . 5.0999999999999996 110.295 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 47.1 tttm -92.93 -26.66 17.49 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 122.11 0.957 . . . . 8.5099999999999998 108.906 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 66.0 m -137.33 56.92 1.76 Allowed 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 114.089 -1.414 . . . . 8.1199999999999992 107.407 175.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 67' ' ' GLU . . . . . 0.435 ' HB2' ' HA ' ' B' ' 64' ' ' ALA . 6.3 tp10 . . . . . 0 N--CA 1.439 -1.024 0 CA-C-N 114.4 -1.273 . . . . 10.210000000000001 108.664 -175.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 25.2 mmt . . . . . 0 CA--C 1.496 -1.12 0 N-CA-C 108.129 -1.063 . . . . 9.3399999999999999 108.129 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 97.8 mttt -125.06 39.0 4.08 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 121.332 0.587 . . . . 9.0399999999999991 111.482 -176.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 16.3 m -77.54 -21.29 52.85 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 122.576 1.179 . . . . 5.8099999999999996 108.094 174.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1511 ' ' ASN . . . . . 0.409 ' ND2' ' HD3' ' A' 1521 ' ' PRO . 19.2 p-10 -134.85 128.34 32.51 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 105.683 -1.969 . . . . 3.4199999999999999 105.683 174.046 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1512 ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -123.24 167.59 13.55 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 120.315 -0.554 . . . . 5.9500000000000002 111.436 -178.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 39.4 p-80 -75.18 -43.75 50.46 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 112.811 0.671 . . . . 5.3300000000000001 112.811 -176.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 21.2 t70 64.92 -68.46 0.11 Allowed 'General case' 0 C--O 1.223 -0.321 0 C-N-CA 125.677 1.591 . . . . 5.0599999999999996 110.828 -171.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 14.6 t70 -111.01 -158.53 0.65 Allowed 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 106.006 -1.85 . . . . 2.8999999999999999 106.006 178.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 21.7 t -90.31 73.32 7.07 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 107.154 -1.424 . . . . 1.1899999999999999 107.154 178.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -166.7 172.34 10.66 Favored 'General case' 0 N--CA 1.423 -1.822 0 N-CA-C 104.949 -2.241 . . . . 1.52 104.949 -174.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 10.6 p -168.27 137.07 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 CA-C-O 121.414 0.626 . . . . 0.93999999999999995 110.531 177.295 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1519 ' ' THR . . . . . . . . . . . . . 35.4 m -92.92 135.85 33.78 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 115.809 -0.632 . . . . 0.89000000000000001 109.973 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -86.23 124.94 69.45 Favored Pre-proline 0 N--CA 1.414 -2.231 0 CA-C-N 116.226 -0.443 . . . . 1.74 110.106 176.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1521 ' ' PRO . . . . . 0.409 ' HD3' ' ND2' ' A' 1511 ' ' ASN . 60.3 Cg_endo -73.76 -13.62 24.4 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.991 2.461 . . . . 1.5800000000000001 113.602 -175.122 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 14.1 m -80.38 -41.62 24.31 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 116.657 -0.247 . . . . 1.6499999999999999 111.442 -177.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1523 ' ' THR . . . . . . . . . . . . . 6.6 t -125.43 2.8 7.7 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 119.502 -0.879 . . . . 1.6100000000000001 112.662 -175.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 65.35 28.12 73.22 Favored Glycine 0 CA--C 1.503 -0.697 0 C-N-CA 121.129 -0.558 . . . . 1.1299999999999999 112.423 178.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 18.9 t-80 -98.2 127.65 44.26 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 121.268 0.556 . . . . 1.26 109.593 -179.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 2.8 tm? -86.03 118.5 25.54 Favored 'General case' 0 C--N 1.288 -2.078 0 CA-C-N 114.171 -1.377 . . . . 0.68000000000000005 109.825 -177.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1527 ' ' PHE . . . . . 0.572 ' HE2' ' HE2' ' A' 1583 ' ' TYR . 30.6 m-85 -90.39 128.07 36.38 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 109.333 -0.617 . . . . 0.65000000000000002 109.333 170.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 23.0 t70 -115.16 123.67 49.5 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 123.709 0.631 . . . . 1.1699999999999999 109.768 178.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 3.0 mm? -100.34 -5.94 26.57 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-O 121.565 0.698 . . . . 0.59999999999999998 109.798 -178.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1530 ' ' SER . . . . . 0.453 ' HA ' ' OG ' ' A' 1533 ' ' SER . 1.1 m -70.67 -18.17 62.84 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.381 -0.827 . . . . 0.83999999999999997 109.704 -177.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 40.5 m -62.81 -19.21 63.84 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 115.369 -0.832 . . . . 1.5900000000000001 110.228 176.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1532 ' ' LEU . . . . . 0.468 ' HB2' HG21 ' A' 1552 ' ' ILE . 75.9 mt -105.87 3.86 29.06 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 120.672 0.272 . . . . 0.65000000000000002 111.147 177.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1533 ' ' SER . . . . . 0.453 ' OG ' ' HA ' ' A' 1530 ' ' SER . 50.2 m -68.11 155.46 39.54 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 121.472 0.653 . . . . 1.52 111.792 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . 173.68 149.57 7.04 Favored Glycine 0 N--CA 1.422 -2.248 0 N-CA-C 109.373 -1.491 . . . . 1.1000000000000001 109.373 -177.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 41.7 ttp180 -89.52 -21.29 22.99 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.189 0.519 . . . . 4.6200000000000001 109.922 -177.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -81.02 -40.91 23.52 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 109.172 -0.677 . . . . 1.45 109.172 176.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 91.94 -151.16 20.64 Favored Glycine 0 N--CA 1.42 -2.424 0 CA-C-N 115.651 -0.704 . . . . 0.84999999999999998 113.976 171.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -135.04 145.07 47.66 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 107.78 -1.192 . . . . 0.93000000000000005 107.78 -177.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 15.5 p -111.45 127.69 55.76 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 123.903 0.752 . . . . 1.03 110.526 179.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1540 ' ' ALA . . . . . 0.708 ' HB2' ' HG2' ' A' 1624 ' ' PRO . . . -120.14 142.95 48.47 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 108.367 -0.975 . . . . 0.5 108.367 175.379 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -80.93 136.97 36.12 Favored 'General case' 0 C--N 1.314 -0.937 0 O-C-N 123.817 0.698 . . . . 0.73999999999999999 110.354 -176.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1542 ' ' TYR . . . . . 0.867 ' HE2' ' HG ' ' A' 1626 ' ' LEU . 3.1 t80 -149.21 -99.08 0.07 Allowed 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 115.984 -0.553 . . . . 0.98999999999999999 109.743 -174.158 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1543 ' ' SER . . . . . . . . . . . . . 30.0 t -72.31 151.48 42.73 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 109.04 -0.726 . . . . 1.9099999999999999 109.04 -177.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1544 ' ' LYS . . . . . 0.583 ' HD2' ' HA ' ' B' ' 23' ' ' ASP . 62.7 tttp -57.95 -22.35 48.56 Favored 'General case' 0 C--N 1.346 0.416 0 C-N-CA 125.326 1.45 . . . . 3.5899999999999999 112.318 -174.371 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 34.5 t -132.21 19.93 4.44 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 116.271 -0.422 . . . . 2.46 109.985 -178.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1546 ' ' GLY . . . . . 0.495 ' HA3' ' OE1' ' A' 1569 ' ' GLN . . . -159.14 127.93 1.93 Allowed Glycine 0 N--CA 1.439 -1.115 0 C-N-CA 118.816 -1.659 . . . . 1.26 113.988 -176.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 26.9 m -100.91 164.64 2.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 108.154 -1.054 . . . . 0.79000000000000004 108.154 176.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1548 ' ' VAL . . . . . 0.494 ' CG1' ' HB3' ' A' 1540 ' ' ALA . 10.2 p -102.15 130.85 51.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 109.614 -0.513 . . . . 0.57999999999999996 109.614 178.189 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -101.96 118.5 37.05 Favored 'General case' 0 CA--C 1.497 -1.068 0 C-N-CA 123.462 0.705 . . . . 1.0800000000000001 109.287 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1550 ' ' MET . . . . . 0.522 ' SD ' ' HZ3' ' A' 1640 ' ' TRP . 8.9 ptp -127.81 144.93 51.07 Favored 'General case' 0 C--N 1.29 -2.011 0 C-N-CA 120.182 -0.607 . . . . 0.78000000000000003 111.46 175.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 8.3 p -119.34 123.36 43.99 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 115.59 -0.732 . . . . 0.96999999999999997 109.177 175.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1552 ' ' ILE . . . . . 0.474 HG22 ' SG ' ' A' 1553 ' ' CYS . 46.6 mm -81.24 114.09 21.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 C-N-CA 121.152 -0.219 . . . . 0.41999999999999998 110.671 -177.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1553 ' ' CYS . . . . . 0.474 ' SG ' HG22 ' A' 1552 ' ' ILE . 31.1 m 66.91 38.38 3.67 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.62 0.768 . . . . 1.3999999999999999 110.563 173.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . -177.41 -173.25 42.75 Favored Glycine 0 N--CA 1.417 -2.582 0 N-CA-C 109.343 -1.503 . . . . 0.34999999999999998 109.343 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -110.38 148.62 31.63 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-O 121.095 0.474 . . . . 1.6200000000000001 110.469 -178.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -99.09 131.1 45.38 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.656 -0.868 . . . . 0.87 108.656 -176.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -81.71 1.59 33.67 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 113.355 0.872 . . . . 2.4900000000000002 113.355 -174.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 51.9 m-80 -83.39 -7.48 59.56 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 120.429 -0.508 . . . . 1.3799999999999999 111.391 -179.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1559 ' ' CYS . . . . . 0.674 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 98.0 m -136.72 175.13 3.74 Favored Pre-proline 0 C--N 1.31 -1.127 0 CA-C-O 117.931 -1.033 . . . . 1.21 110.041 179.275 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1560 ' ' PRO . . . . . 0.674 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 4.3 Cg_exo -40.27 137.72 1.39 Allowed 'Trans proline' 0 C--N 1.387 2.559 0 C-N-CA 123.917 3.078 . . . . 0.70999999999999996 113.516 177.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1561 ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' 1560 ' ' PRO . 71.6 Cg_exo -53.99 127.16 24.52 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 123.624 2.882 . . . . 0.80000000000000004 112.845 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 102.29 6.7 47.6 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-N 115.85 -0.613 . . . . 0.46000000000000002 113.028 -178.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1563 ' ' VAL . . . . . 0.604 HG11 ' HB2' ' A' 1566 ' ' CYS . 2.8 t -96.08 124.64 48.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 C-N-CA 123.171 0.588 . . . . 0.97999999999999998 111.648 -177.099 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -97.26 -33.56 5.92 Favored Glycine 0 N--CA 1.44 -1.048 0 CA-C-N 115.34 -0.846 . . . . 0.28000000000000003 111.747 178.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -129.9 125.54 35.79 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 109.62 -0.511 . . . . 0.28000000000000003 109.62 178.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1566 ' ' CYS . . . . . 0.604 ' HB2' HG11 ' A' 1563 ' ' VAL . 43.7 t -151.24 139.73 20.52 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 120.664 0.269 . . . . 0.42999999999999999 110.878 -179.053 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1567 ' ' PHE . . . . . 0.46 ' HB3' ' HG2' ' A' 1569 ' ' GLN . 10.9 m-85 -91.4 143.0 27.07 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 122.427 -0.17 . . . . 1.03 110.682 173.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -90.36 41.16 2.96 Favored Glycine 0 N--CA 1.431 -1.651 0 C-N-CA 120.54 -0.838 . . . . 1.1299999999999999 111.821 -176.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1569 ' ' GLN . . . . . 0.495 ' OE1' ' HA3' ' A' 1546 ' ' GLY . 8.4 mm100 -80.33 -72.19 0.42 Allowed 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 108.838 -0.801 . . . . 2.5800000000000001 108.838 177.532 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 19.0 p -133.37 35.14 3.46 Favored 'General case' 0 N--CA 1.433 -1.31 0 C-N-CA 123.869 0.868 . . . . 2.1699999999999999 110.198 176.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 11.6 mmt180 67.61 63.02 0.42 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.743 1.217 . . . . 2.6200000000000001 108.791 -174.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 31.1 mt -105.89 111.53 35.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 CA-C-N 115.946 -0.57 . . . . 0.92000000000000004 110.814 -176.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 31.2 t -81.98 139.15 34.73 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.597 -0.729 . . . . 0.80000000000000004 111.052 -177.216 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1574 ' ' VAL . . . . . 0.569 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 34.6 m -132.13 12.98 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-O 121.163 0.506 . . . . 0.97999999999999998 111.329 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 178.98 122.62 0.77 Allowed Glycine 0 N--CA 1.423 -2.186 0 C-N-CA 120.158 -1.02 . . . . 0.28999999999999998 111.761 177.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 29.5 ttpp -81.0 146.47 30.66 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 107.558 -1.275 . . . . 2.1899999999999999 107.558 178.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -68.28 90.29 0.35 Allowed 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.232 0.539 . . . . 0.60999999999999999 112.295 -175.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -107.37 179.69 4.18 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.414 -1.328 . . . . 1.95 107.414 176.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 60.0 mttp -138.47 48.13 1.95 Allowed 'General case' 0 CA--C 1.49 -1.341 0 N-CA-C 109.181 -0.674 . . . . 2.6800000000000002 109.181 178.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1580 ' ' ARG . . . . . 0.529 ' HB3' HG12 ' A' 1591 ' ' VAL . 31.1 ttm180 -87.21 76.97 9.12 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.839 -0.745 . . . . 3.4700000000000002 109.286 -177.276 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1581 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.13 124.98 31.01 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 114.478 -1.237 . . . . 0.64000000000000001 108.65 -179.482 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -127.89 138.46 52.68 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 116.342 -0.39 . . . . 2.8500000000000001 110.125 172.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1583 ' ' TYR . . . . . 0.572 ' HE2' ' HE2' ' A' 1527 ' ' PHE . 32.6 t80 -95.97 115.56 27.62 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 107.084 -1.45 . . . . 0.85999999999999999 107.084 176.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1584 ' ' VAL . . . . . 0.726 ' O ' ' HB ' ' A' 1587 ' ' VAL . 6.3 p -138.76 102.0 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.044 0 C-N-CA 120.529 -0.468 . . . . 1.05 111.646 -176.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 19.4 t70 58.58 56.45 4.26 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 122.381 1.086 . . . . 1.1699999999999999 110.658 179.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1586 ' ' GLN . . . . . 0.444 ' HA ' ' CZ ' ' A' 1583 ' ' TYR . 11.1 pt20 58.84 10.79 1.62 Allowed 'General case' 0 N--CA 1.499 1.993 0 C-N-CA 127.472 2.309 . . . . 1.8600000000000001 112.32 -178.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1587 ' ' VAL . . . . . 0.726 ' HB ' ' O ' ' A' 1584 ' ' VAL . 2.8 t -97.02 124.61 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.245 0 CA-C-N 114.573 -1.194 . . . . 0.48999999999999999 109.846 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1588 ' ' LEU . . . . . 0.915 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 4.1 mm? -90.41 108.92 20.08 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 107.239 -1.393 . . . . 0.35999999999999999 107.239 175.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -109.52 122.0 46.45 Favored 'General case' 0 C--N 1.287 -2.114 0 C-N-CA 119.47 -0.892 . . . . 1.74 111.443 -176.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1590 ' ' LEU . . . . . 0.676 ' HB3' ' HB ' ' A' 1610 ' ' ILE . 44.8 tp -113.44 109.93 19.48 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 106.18 -1.785 . . . . 0.71999999999999997 106.18 177.158 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1591 ' ' VAL . . . . . 0.529 HG12 ' HB3' ' A' 1580 ' ' ARG . 4.6 p -102.52 129.04 54.68 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 119.619 -0.832 . . . . 1.01 110.599 -177.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1592 ' ' TYR . . . . . 0.431 ' O ' ' HG3' ' A' 1607 ' ' LYS . 13.2 m-30 -117.37 126.91 53.46 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.437 -1.32 . . . . 0.5 107.437 177.024 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 12.9 ptmm? -140.6 176.69 8.58 Favored 'General case' 0 C--N 1.278 -2.515 0 N-CA-C 108.619 -0.882 . . . . 1.5900000000000001 108.619 -174.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 9.3 m-20 58.58 41.8 21.76 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 124.599 1.187 . . . . 1.1100000000000001 111.81 178.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -76.14 -98.8 0.14 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.15 -1.024 . . . . 0.78000000000000003 110.954 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1596 ' ' SER . . . . . . . . . . . . . 12.4 t -120.97 152.44 56.43 Favored Pre-proline 0 C--N 1.285 -2.208 0 N-CA-C 105.61 -1.996 . . . . 1.0700000000000001 105.61 174.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -61.84 139.12 78.27 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 122.376 2.05 . . . . 1.01 110.767 175.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 39.2 t -81.79 102.95 1.73 Allowed Pre-proline 0 C--N 1.302 -1.494 0 N-CA-C 106.658 -1.608 . . . . 0.75 106.658 178.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -62.11 -39.47 49.05 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 123.106 2.538 . . . . 1.7 113.184 -170.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1600 ' ' SER . . . . . . . . . . . . . 8.7 m -69.12 -15.09 63.34 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.47 -0.786 . . . . 2.2599999999999998 112.817 -177.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1601 ' ' LYS . . . . . 0.458 ' HG2' HD22 ' A' 1604 ' ' LEU . 13.7 tppt? -135.31 87.91 2.37 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 107.318 -1.364 . . . . 3.0099999999999998 107.318 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 14.9 m -44.66 114.47 0.71 Allowed 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 125.896 1.678 . . . . 2.0699999999999998 114.456 -174.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 100.64 10.53 43.57 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 114.415 0.526 . . . . 1.0800000000000001 114.415 175.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1604 ' ' LEU . . . . . 0.458 HD22 ' HG2' ' A' 1601 ' ' LYS . 9.2 mp -110.57 156.25 21.19 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 117.28 0.54 . . . . 1.8400000000000001 111.197 178.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 16.5 m -121.34 147.8 45.2 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.514 -1.291 . . . . 1.4099999999999999 107.514 173.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1606 ' ' TYR . . . . . 0.569 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 85.8 m-85 -71.91 149.99 44.61 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 110.377 -0.231 . . . . 0.59999999999999998 110.377 177.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1607 ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' A' 1592 ' ' TYR . 6.1 ttpm? -146.94 135.86 22.32 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 123.856 0.723 . . . . 1.45 109.455 178.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1608 ' ' SER . . . . . . . . . . . . . 19.2 m -114.36 125.58 54.03 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 108.645 -0.872 . . . . 1.1499999999999999 108.645 -178.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 39.1 t -105.59 108.26 24.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 108.808 -0.812 . . . . 0.25 108.808 178.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1610 ' ' ILE . . . . . 0.676 ' HB ' ' HB3' ' A' 1590 ' ' LEU . 79.1 mt -95.08 118.87 42.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 108.583 -0.895 . . . . 0.45000000000000001 108.583 -178.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 26.6 t -117.24 110.52 18.22 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 108.972 -0.751 . . . . 1.26 108.972 -178.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1612 ' ' PHE . . . . . 0.915 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 70.8 m-85 -86.7 122.95 31.32 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.654 -0.869 . . . . 0.26000000000000001 108.654 177.521 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 44.8 t -116.53 135.37 57.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.457 0 CA-C-N 115.433 -0.803 . . . . 0.5 110.144 -174.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1614 ' ' CYS . . . . . 0.422 ' HB2' ' HA ' ' A' 1646 ' ' CYS . 4.9 t -54.53 111.11 0.73 Allowed 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 124.573 1.149 . . . . 0.77000000000000002 113.095 177.126 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1615 ' ' ARG . . . . . 0.687 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 18.6 tpt180 -137.29 91.04 14.78 Favored Pre-proline 0 N--CA 1.441 -0.911 0 N-CA-C 108.815 -0.809 . . . . 2.5299999999999998 108.815 169.145 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1616 ' ' PRO . . . . . 0.445 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 18.8 Cg_exo -66.68 -23.49 48.95 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.251 1.967 . . . . 1.1000000000000001 112.996 -175.484 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -71.5 -22.83 61.74 Favored 'General case' 0 N--CA 1.432 -1.35 0 C-N-CA 122.923 0.489 . . . . 3.0499999999999998 111.822 178.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . 63.61 -156.52 0.32 Allowed 'General case' 0 C--N 1.359 1.006 0 N-CA-C 108.155 -1.054 . . . . 1.55 108.155 -174.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . 116.43 -157.3 15.12 Favored Glycine 0 N--CA 1.414 -2.773 0 C-N-CA 120.202 -0.999 . . . . 0.93000000000000005 112.484 176.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -78.45 13.94 1.73 Allowed 'Trans proline' 0 C--N 1.325 -0.67 0 C-N-CA 123.683 2.922 . . . . 0.88 113.053 -175.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1621 ' ' THR . . . . . 0.708 ' HB ' ' HB2' ' A' 1641 ' ' HIS . 16.5 p -105.39 -7.84 18.54 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 115.002 -0.999 . . . . 0.96999999999999997 109.598 178.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 56.6 t30 -87.79 65.68 8.49 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.444 -0.947 . . . . 0.71999999999999997 108.444 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -166.72 141.53 3.47 Favored Pre-proline 0 C--N 1.307 -1.255 0 N-CA-C 107.743 -1.206 . . . . 3.2599999999999998 107.743 -175.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1624 ' ' PRO . . . . . 0.708 ' HG2' ' HB2' ' A' 1540 ' ' ALA . 21.3 Cg_endo -60.87 104.58 0.28 Allowed 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.532 2.154 . . . . 0.58999999999999997 111.408 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 85.3 mtp -101.98 135.46 43.5 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.824 -0.806 . . . . 1.3700000000000001 108.824 -178.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1626 ' ' LEU . . . . . 0.867 ' HG ' ' HE2' ' A' 1542 ' ' TYR . 0.3 OUTLIER -87.63 118.68 27.28 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 107.9 -1.148 . . . . 0.89000000000000001 107.9 -176.357 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A 1627 ' ' ILE . . . . . 0.787 HD11 ' HB2' ' A' 1639 ' ' SER . 39.9 mm -79.41 -50.28 18.41 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.879 0 N-CA-C 108.925 -0.768 . . . . 0.57999999999999996 108.925 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 17.1 t -172.41 161.18 5.09 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 108.827 -0.805 . . . . 1.3899999999999999 108.827 -176.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1629 ' ' LEU . . . . . 0.763 HD13 HD23 ' A' 1636 ' ' LEU . 13.6 tp -117.51 106.49 13.22 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.0 -1.111 . . . . 1.25 108.0 176.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 18.0 t70 -72.2 107.42 4.84 Favored 'General case' 0 CA--C 1.487 -1.478 0 N-CA-C 105.849 -1.908 . . . . 1.0900000000000001 105.849 174.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1631 ' ' LYS . . . . . 0.513 ' HB3' HD21 ' B' ' 53' ' ' LEU . 54.4 mtmt -72.5 -35.42 68.15 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 115.173 -0.921 . . . . 3.6000000000000001 111.138 -171.154 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 62.0 tp60 -70.77 -38.99 73.48 Favored 'General case' 0 N--CA 1.417 -2.091 0 C-N-CA 120.412 -0.515 . . . . 2.6000000000000001 112.089 -173.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 47.4 p -97.38 -0.87 45.6 Favored 'General case' 0 CA--C 1.566 1.562 0 N-CA-C 112.593 0.59 . . . . 0.75 112.593 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 84.5 m 59.61 52.77 5.41 Favored 'General case' 0 C--N 1.374 1.64 0 C-N-CA 124.709 1.204 . . . . 0.53000000000000003 111.153 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1635 ' ' THR . . . . . . . . . . . . . 92.5 m -125.21 133.5 52.72 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.727 -0.67 . . . . 0.46000000000000002 111.994 -175.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1636 ' ' LEU . . . . . 0.763 HD23 HD13 ' A' 1629 ' ' LEU . 9.7 mt -104.7 136.03 44.99 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.37 -0.974 . . . . 0.85999999999999999 108.37 -179.278 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1637 ' ' PHE . . . . . 0.418 ' HB2' ' HB ' ' A' 1627 ' ' ILE . 58.6 m-85 -108.59 129.72 55.31 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 109.113 -0.699 . . . . 0.45000000000000001 109.113 177.241 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -120.11 142.56 48.8 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 116.225 -0.443 . . . . 0.5 110.935 -178.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1639 ' ' SER . . . . . 0.787 ' HB2' HD11 ' A' 1627 ' ' ILE . 31.8 t -117.44 153.45 33.07 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 107.068 -1.456 . . . . 1.04 107.068 173.212 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1640 ' ' TRP . . . . . 0.522 ' HZ3' ' SD ' ' A' 1550 ' ' MET . 2.1 t90 -154.1 105.79 2.75 Favored 'General case' 0 N--CA 1.42 -1.973 0 N-CA-C 105.163 -2.162 . . . . 0.68000000000000005 105.163 179.228 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1641 ' ' HIS . . . . . 0.708 ' HB2' ' HB ' ' A' 1621 ' ' THR . 38.1 m-70 -95.19 105.03 16.93 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 108.868 -0.79 . . . . 0.90000000000000002 108.868 -175.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1642 ' ' THR . . . . . . . . . . . . . 14.3 t -141.97 152.41 61.88 Favored Pre-proline 0 CA--C 1.559 1.298 0 N-CA-C 108.846 -0.798 . . . . 0.47999999999999998 108.846 -171.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1643 ' ' PRO . . . . . 0.445 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 73.7 Cg_endo -75.1 -24.31 12.79 Favored 'Trans proline' 0 C--N 1.367 1.522 0 C-N-CA 122.715 2.277 . . . . 0.66000000000000003 114.139 -178.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 3.3 pp -75.73 -4.93 43.16 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 119.935 -0.706 . . . . 0.96999999999999997 111.672 -177.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -116.15 23.87 11.85 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-O 122.318 1.056 . . . . 0.83999999999999997 109.005 -178.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1646 ' ' CYS . . . . . 0.531 ' O ' ' HD3' ' A' 1648 ' ' PRO . 52.9 t -115.67 140.46 49.17 Favored 'General case' 0 N--CA 1.401 -2.884 0 CA-C-N 115.0 -1.0 . . . . 1.1899999999999999 110.511 -177.052 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -102.69 94.98 5.65 Favored Pre-proline 0 N--CA 1.427 -1.601 0 N-CA-C 106.309 -1.737 . . . . 3.1400000000000001 106.309 172.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1648 ' ' PRO . . . . . 0.531 ' HD3' ' O ' ' A' 1646 ' ' CYS . 7.5 Cg_exo -76.86 151.04 31.02 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 122.438 2.092 . . . . 2.5800000000000001 111.517 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 . . . . . 0 C--N 1.289 -2.023 0 N-CA-C 106.815 -1.55 . . . . 4.7199999999999998 106.815 177.657 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.605 0 N-CA-C 109.275 -0.639 . . . . 9.9700000000000006 109.275 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 2' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -99.01 123.33 43.23 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.773 -0.825 . . . . 7.6799999999999997 108.773 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -92.04 147.53 34.97 Favored Pre-proline 0 C--N 1.305 -1.345 0 N-CA-C 108.805 -0.813 . . . . 6.1100000000000003 108.805 178.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 4' ' ' PRO . . . . . 0.419 ' HG2' ' OG1' ' B' ' 7' ' ' THR . 81.7 Cg_endo -75.95 48.64 2.29 Favored 'Trans proline' 0 C--O 1.238 0.515 0 C-N-CA 123.487 2.792 . . . . 4.8399999999999999 113.063 -177.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 19.2 t 66.4 -63.52 0.25 Allowed 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 126.696 1.998 . . . . 4.5999999999999996 114.391 175.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -84.91 -44.03 13.54 Favored 'General case' 0 C--N 1.265 -3.075 0 N-CA-C 113.956 1.095 . . . . 4.2300000000000004 113.956 -171.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 7' ' ' THR . . . . . 0.419 ' OG1' ' HG2' ' B' ' 4' ' ' PRO . 18.0 p -94.52 153.75 17.74 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 120.711 -0.395 . . . . 3.1400000000000001 110.585 -179.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.646 HD22 ' HG3' ' B' ' 12' ' ' GLU . 4.7 mp -123.56 156.4 35.79 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.695 -0.854 . . . . 3.96 108.695 -177.07 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 38.7 m -101.12 150.66 22.7 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.75 -0.833 . . . . 2.8399999999999999 108.75 178.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.57 -137.2 13.12 Favored Glycine 0 N--CA 1.427 -1.925 0 C-N-CA 120.535 -0.841 . . . . 2.0899999999999999 113.173 177.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -56.04 -42.77 87.83 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 115.236 0.854 . . . . 1.8400000000000001 115.236 -173.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 12' ' ' GLU . . . . . 0.646 ' HG3' HD22 ' B' ' 8' ' ' LEU . 9.0 mm-40 -63.2 -49.12 75.5 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.434 0.635 . . . . 2.5499999999999998 110.39 -176.446 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 13.6 tp -66.99 -49.45 65.33 Favored 'General case' 0 C--O 1.252 1.203 0 CA-C-N 115.015 -0.993 . . . . 2.3500000000000001 111.196 -175.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 14.3 p -64.68 -37.66 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 C-N-CA 120.399 -0.52 . . . . 2.1099999999999999 110.944 -178.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -77.17 -17.56 58.47 Favored 'General case' 0 C--O 1.196 -1.734 0 C-N-CA 118.08 -1.448 . . . . 2.04 111.358 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 92.0 m -62.5 -41.31 98.74 Favored 'General case' 0 C--O 1.272 2.267 0 O-C-N 121.302 -0.874 . . . . 1.8400000000000001 108.983 173.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.891 HD21 HD11 ' B' ' 42' ' ' ILE . 10.7 mp -63.4 -42.67 98.78 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 115.568 -0.742 . . . . 1.74 110.99 176.13 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -75.55 -11.85 60.1 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.02 -0.991 . . . . 2.3900000000000001 111.267 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -67.95 -55.24 13.47 Favored 'General case' 0 C--N 1.314 -0.967 0 O-C-N 121.892 -0.505 . . . . 0.95999999999999996 109.686 176.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 12.6 p -98.52 -17.5 6.68 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 C-N-CA 118.112 -1.435 . . . . 1.3700000000000001 112.487 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 83.8 m -116.81 30.62 7.22 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.457 -0.777 . . . . 1.6599999999999999 111.586 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -55.0 -57.11 19.78 Favored Glycine 0 C--N 1.342 0.894 0 N-CA-C 114.082 0.393 . . . . 1.53 114.082 -179.295 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.583 ' HA ' ' HD2' ' A' 1544 ' ' LYS . 17.6 t70 -65.93 -32.85 74.59 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-O 121.063 0.459 . . . . 2.7200000000000002 111.182 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 21.3 tpp180 -69.53 -47.99 61.93 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.79 -0.641 . . . . 4.3300000000000001 111.186 -178.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 111.43 170.49 18.95 Favored Glycine 0 N--CA 1.427 -1.961 0 N-CA-C 108.797 -1.721 . . . . 1.53 108.797 -175.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -135.6 140.63 44.75 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 117.399 0.6 . . . . 1.6499999999999999 111.598 178.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -136.51 141.99 43.46 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.77 -0.455 . . . . 3.4199999999999999 109.77 178.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 28' ' ' PHE . . . . . 0.457 ' CD2' ' HB ' ' B' ' 43' ' ' VAL . 0.0 OUTLIER -154.52 23.45 0.47 Allowed 'General case' 0 C--O 1.243 0.712 0 N-CA-C 112.321 0.489 . . . . 2.2599999999999998 112.321 178.238 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 17.9 m -118.35 84.15 2.13 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.416 0.627 . . . . 3.6800000000000002 111.925 -172.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 30' ' ' ARG . . . . . 0.528 HH22 ' HB ' ' B' ' 35' ' ' VAL . 74.2 mtm180 -123.13 119.65 27.61 Favored Pre-proline 0 C--N 1.303 -1.455 0 N-CA-C 108.031 -1.1 . . . . 3.8100000000000001 108.031 177.129 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 31' ' ' PRO . . . . . 0.76 ' HA ' ' HA ' ' B' ' 39' ' ' SER . 31.8 Cg_exo -61.98 -27.96 80.18 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.609 2.872 . . . . 4.0199999999999996 113.451 -178.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -166.27 157.63 13.32 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 108.712 -0.847 . . . . 4.9199999999999999 108.712 177.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 36.9 t 175.47 178.64 0.16 Allowed 'General case' 0 N--CA 1.4 -2.932 0 N-CA-C 102.881 -3.007 . . . . 6.7199999999999998 102.881 -177.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 46.6 ttp180 -93.2 -8.09 43.38 Favored 'General case' 0 C--N 1.266 -3.041 0 N-CA-C 108.562 -0.903 . . . . 11.630000000000001 108.562 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 0.528 ' HB ' HH22 ' B' ' 30' ' ' ARG . 13.3 t -118.11 3.28 7.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-O 122.763 1.268 . . . . 9.6099999999999994 108.001 179.066 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 51.1 m -155.59 71.45 0.76 Allowed 'General case' 0 N--CA 1.422 -1.84 0 N-CA-C 107.143 -1.429 . . . . 6.71 107.143 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 9.7 ptp85 -80.76 6.94 11.5 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-O 122.406 1.098 . . . . 10.0 110.659 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 38' ' ' ARG . . . . . 0.489 ' C ' ' H ' ' B' ' 40' ' ' ARG . 32.8 tpt180 -110.68 159.4 17.63 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 104.565 -2.383 . . . . 7.9400000000000004 104.565 176.329 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 39' ' ' SER . . . . . 0.76 ' HA ' ' HA ' ' B' ' 31' ' ' PRO . 24.9 m -76.37 26.92 0.12 Allowed 'General case' 0 CA--C 1.549 0.915 0 CA-C-O 122.04 0.924 . . . . 5.7599999999999998 111.694 178.645 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 40' ' ' ARG . . . . . 0.489 ' H ' ' C ' ' B' ' 38' ' ' ARG . 27.8 mmt180 -149.94 155.0 39.22 Favored 'General case' 0 N--CA 1.423 -1.814 0 N-CA-C 105.184 -2.154 . . . . 6.0300000000000002 105.184 -179.199 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . -101.66 -104.6 2.77 Favored Glycine 0 N--CA 1.401 -3.694 0 N-CA-C 110.142 -1.183 . . . . 2.3700000000000001 110.142 175.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 42' ' ' ILE . . . . . 0.891 HD11 HD21 ' B' ' 17' ' ' LEU . 28.3 pt -84.96 -22.53 7.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 113.152 0.797 . . . . 2.0699999999999998 113.152 -170.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.457 ' HB ' ' CD2' ' B' ' 28' ' ' PHE . 2.9 p -58.69 -42.64 85.68 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.418 0 N-CA-C 112.399 0.518 . . . . 2.2400000000000002 112.399 -177.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -83.14 -27.23 30.26 Favored 'General case' 0 N--CA 1.425 -1.681 0 N-CA-C 109.193 -0.669 . . . . 3.3599999999999999 109.193 -174.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 45' ' ' GLU . . . . . 0.4 ' O ' ' HB2' ' B' ' 49' ' ' ARG . 46.9 mm-40 -70.01 -29.62 66.73 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 115.293 -0.867 . . . . 3.0800000000000001 111.932 177.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 46' ' ' CYS . . . . . . . . . . . . . 36.3 t -98.07 -16.27 19.66 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 121.252 0.548 . . . . 2.23 111.058 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 42.8 t -77.3 -36.32 54.22 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.111 0.481 . . . . 2.3700000000000001 110.654 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -109.81 -9.92 14.79 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 113.218 0.821 . . . . 2.8199999999999998 113.218 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 49' ' ' ARG . . . . . 0.4 ' HB2' ' O ' ' B' ' 45' ' ' GLU . 28.0 mmt180 -135.64 151.09 49.88 Favored 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 106.037 -1.838 . . . . 4.0899999999999999 106.037 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 14.7 m -76.04 117.73 18.06 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 108.981 -0.748 . . . . 2.6699999999999999 108.981 -178.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 28.1 p -92.71 135.33 34.2 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 108.67 -0.863 . . . . 2.1099999999999999 108.67 -176.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -87.54 139.66 30.31 Favored 'General case' 0 N--CA 1.416 -2.155 0 N-CA-C 109.03 -0.73 . . . . 2.6699999999999999 109.03 177.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 53' ' ' LEU . . . . . 0.513 HD21 ' HB3' ' A' 1631 ' ' LYS . 61.0 tp -36.07 -39.86 0.19 Allowed 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 127.469 2.308 . . . . 1.8999999999999999 113.952 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.42 -40.82 83.51 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 123.868 0.73 . . . . 1.52 111.796 -176.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 50.8 tp -58.56 -47.53 83.91 Favored 'General case' 0 C--O 1.22 -0.47 0 O-C-N 123.802 0.689 . . . . 1.97 111.03 -177.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 3.9 pp -80.45 -35.29 35.17 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 116.145 -0.479 . . . . 1.53 111.513 -174.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -67.33 -44.25 79.57 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 116.031 -0.532 . . . . 2.27 111.456 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 6.3 t -76.1 -31.29 58.62 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 119.598 -0.841 . . . . 2.3300000000000001 111.251 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 59' ' ' TYR . . . . . 0.438 ' CZ ' ' HA ' ' B' ' 63' ' ' PRO . 14.8 t80 -69.12 -60.42 2.37 Favored 'General case' 0 C--O 1.244 0.775 0 N-CA-C 107.772 -1.196 . . . . 2.8599999999999999 107.772 178.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 37.0 t 68.14 -64.05 0.31 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.303 1.441 . . . . 2.2999999999999998 112.473 175.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -157.35 -45.88 0.07 Allowed 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 107.492 -1.299 . . . . 3.1899999999999999 107.492 -176.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -62.84 132.67 94.9 Favored Pre-proline 0 N--CA 1.445 -0.699 0 CA-C-N 114.753 -1.112 . . . . 3.6800000000000002 111.827 175.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 63' ' ' PRO . . . . . 0.438 ' HA ' ' CZ ' ' B' ' 59' ' ' TYR . 72.0 Cg_endo -82.06 -8.1 12.04 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.997 2.465 . . . . 5.0800000000000001 114.833 -175.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -141.59 73.63 1.42 Allowed 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 109.194 -0.669 . . . . 5.0999999999999996 109.194 178.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 3.4 tmtp? -136.96 70.17 1.41 Allowed 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 107.941 -1.133 . . . . 8.5099999999999998 107.941 -178.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 11.9 p -89.65 -5.87 56.7 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 115.022 -0.99 . . . . 8.1199999999999992 110.521 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 . . . . . 0 C--N 1.309 -1.167 0 CA-C-N 114.868 -1.06 . . . . 10.210000000000001 109.691 -178.201 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 50.9 tpp . . . . . 0 N--CA 1.453 -0.288 0 CA-C-O 121.407 0.622 . . . . 9.3399999999999999 110.789 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 28.6 tptp -108.68 145.6 34.77 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 104.288 -2.486 . . . . 9.0399999999999991 104.288 173.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1510 ' ' SER . . . . . 0.417 ' CB ' ' HB3' ' A' 1521 ' ' PRO . 35.5 m -138.39 172.76 12.42 Favored 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 119.578 -0.849 . . . . 5.8099999999999996 111.138 -174.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1511 ' ' ASN . . . . . . . . . . . . . 92.4 m-20 72.17 26.82 2.7 Favored 'General case' 0 C--N 1.34 0.172 0 C-N-CA 124.517 1.127 . . . . 3.4199999999999999 111.977 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1512 ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -74.83 161.87 29.18 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 108.259 -1.015 . . . . 5.9500000000000002 108.259 174.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 23.2 p-80 -129.96 112.68 13.75 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-O 121.446 0.641 . . . . 5.3300000000000001 111.426 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 19.3 t70 -62.38 -54.23 43.44 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 114.783 -1.099 . . . . 5.0599999999999996 108.187 174.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1515 ' ' ASP . . . . . 0.543 ' O ' ' HB3' ' A' 1579 ' ' LYS . 14.3 t70 -130.32 -75.29 0.54 Allowed 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 106.649 -1.612 . . . . 2.8999999999999999 106.649 173.208 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1516 ' ' CYS . . . . . 0.486 ' SG ' HD23 ' A' 1581 ' ' LEU . 46.9 t -148.92 79.18 1.41 Allowed 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.787 -1.19 . . . . 1.1899999999999999 107.787 176.159 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -168.07 151.04 5.68 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 105.938 -1.875 . . . . 1.52 105.938 -173.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1518 ' ' VAL . . . . . 0.454 ' CG2' HD12 ' A' 1581 ' ' LEU . 2.9 m -144.89 142.58 22.95 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-O 120.885 0.374 . . . . 0.93999999999999995 111.442 -176.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1519 ' ' THR . . . . . . . . . . . . . 33.8 m -95.79 139.29 32.23 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 109.497 -0.557 . . . . 0.89000000000000001 109.497 177.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -76.95 116.13 54.51 Favored Pre-proline 0 C--O 1.244 0.787 0 N-CA-C 108.501 -0.926 . . . . 1.74 108.501 176.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1521 ' ' PRO . . . . . 0.417 ' HB3' ' CB ' ' A' 1510 ' ' SER . 16.1 Cg_endo -60.81 -24.85 80.01 Favored 'Trans proline' 0 C--O 1.243 0.728 0 C-N-CA 123.43 2.753 . . . . 1.5800000000000001 113.807 -177.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 33.7 m -74.33 -31.17 62.34 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 113.348 0.87 . . . . 1.6499999999999999 113.348 -175.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1523 ' ' THR . . . . . . . . . . . . . 8.9 t -137.65 -10.74 1.6 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 118.617 -1.233 . . . . 1.6100000000000001 113.455 -176.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 82.45 31.07 31.54 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 119.897 -1.144 . . . . 1.1299999999999999 112.173 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 25.1 t-80 -97.74 131.2 44.49 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.641 -0.874 . . . . 1.26 108.641 178.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 2.8 tm? -89.67 121.71 32.1 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.718 -0.674 . . . . 0.68000000000000005 111.515 -175.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -91.81 127.84 37.41 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 108.544 -0.91 . . . . 0.65000000000000002 108.544 168.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 15.2 t70 -120.64 113.89 20.9 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 109.055 -0.72 . . . . 1.1699999999999999 109.055 177.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1529 ' ' LEU . . . . . 0.451 ' HG ' HD21 ' A' 1581 ' ' LEU . 3.7 mm? -97.13 -0.25 47.32 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 121.578 0.704 . . . . 0.59999999999999998 109.931 -178.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 1.5 m -65.87 -25.74 67.32 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.841 -1.072 . . . . 0.83999999999999997 109.945 -178.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 40.5 t -61.09 -24.06 65.95 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 123.224 0.61 . . . . 1.5900000000000001 110.816 178.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1532 ' ' LEU . . . . . 0.559 ' HB2' HG21 ' A' 1552 ' ' ILE . 73.0 mt -97.49 8.61 44.29 Favored 'General case' 0 C--N 1.32 -0.674 0 O-C-N 122.106 -0.371 . . . . 0.65000000000000002 111.729 -177.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1533 ' ' SER . . . . . . . . . . . . . 77.2 p -68.66 174.19 4.48 Favored 'General case' 0 C--O 1.251 1.174 0 CA-C-O 121.454 0.645 . . . . 1.52 111.818 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . 171.81 150.9 7.43 Favored Glycine 0 N--CA 1.419 -2.493 0 N-CA-C 109.956 -1.258 . . . . 1.1000000000000001 109.956 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1535 ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' 1535 ' ' ARG . 22.9 ttt180 -87.42 -30.0 21.04 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.08 0.467 . . . . 4.6200000000000001 110.802 -178.283 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -90.16 -35.82 15.17 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.579 0.704 . . . . 1.45 109.439 178.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 92.89 -150.99 20.24 Favored Glycine 0 N--CA 1.409 -3.123 0 CA-C-N 115.403 -0.817 . . . . 0.84999999999999998 112.329 173.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -128.82 153.33 47.54 Favored 'General case' 0 C--N 1.281 -2.396 0 N-CA-C 106.435 -1.691 . . . . 0.93000000000000005 106.435 -178.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 4.1 m -128.46 134.79 48.83 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 109.399 -0.593 . . . . 1.03 109.399 -175.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1540 ' ' ALA . . . . . 0.597 ' HB3' HG12 ' A' 1548 ' ' VAL . . . -129.93 143.61 50.89 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 115.758 -0.656 . . . . 0.5 109.488 -177.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -88.99 121.4 31.31 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.346 0.593 . . . . 0.73999999999999999 110.517 -177.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1542 ' ' TYR . . . . . 0.59 ' CE2' ' HG ' ' A' 1626 ' ' LEU . 0.9 OUTLIER -111.49 -101.86 0.4 Allowed 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.464 -1.31 . . . . 0.98999999999999999 107.464 -179.326 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A 1543 ' ' SER . . . . . 0.427 ' H ' ' HB3' ' A' 1542 ' ' TYR . 7.7 m -73.34 162.5 29.26 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 118.984 -0.532 . . . . 1.9099999999999999 109.941 178.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -50.17 -42.93 51.95 Favored 'General case' 0 C--O 1.25 1.091 0 N-CA-C 113.388 0.884 . . . . 3.5899999999999999 113.388 -178.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 23.3 t -100.67 15.1 29.33 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 110.516 -0.179 . . . . 2.46 110.516 -178.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . -132.7 131.29 6.12 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 118.81 -1.662 . . . . 1.26 116.726 -170.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 15.1 m -121.39 149.83 24.49 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 108.794 -0.817 . . . . 0.79000000000000004 108.794 171.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1548 ' ' VAL . . . . . 0.597 HG12 ' HB3' ' A' 1540 ' ' ALA . 7.8 p -104.87 137.74 32.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 109.319 -0.622 . . . . 0.57999999999999996 109.319 177.675 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -103.86 126.95 51.35 Favored 'General case' 0 N--CA 1.424 -1.755 0 CA-C-N 115.642 -0.708 . . . . 1.0800000000000001 109.15 175.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1550 ' ' MET . . . . . 0.407 ' HA ' ' O ' ' A' 1564 ' ' GLY . 5.5 ppp? -144.24 138.5 28.04 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 115.082 -0.963 . . . . 0.78000000000000003 110.27 -175.296 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 7.1 p -125.48 134.41 52.06 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 115.926 -0.579 . . . . 0.96999999999999997 109.855 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1552 ' ' ILE . . . . . 0.559 HG21 ' HB2' ' A' 1532 ' ' LEU . 49.5 mm -82.24 114.94 23.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-N 116.625 -0.261 . . . . 0.41999999999999998 111.36 -177.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 74.8 m 71.33 16.51 6.09 Favored 'General case' 0 CA--C 1.509 -0.6 0 C-N-CA 124.036 0.934 . . . . 1.3999999999999999 113.057 171.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . -163.17 -175.26 33.99 Favored Glycine 0 N--CA 1.403 -3.5 0 C-N-CA 120.127 -1.035 . . . . 0.34999999999999998 110.98 -176.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1555 ' ' GLU . . . . . 0.466 ' H ' ' CD ' ' A' 1555 ' ' GLU . 0.3 OUTLIER -91.36 148.57 22.23 Favored 'General case' 0 C--N 1.282 -2.351 0 C-N-CA 124.102 0.961 . . . . 1.6200000000000001 111.755 -176.205 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 46.2 t-20 -114.46 129.85 56.68 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.729 -1.212 . . . . 0.87 107.729 178.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -79.93 2.18 24.48 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.025 0.75 . . . . 2.4900000000000002 113.025 -173.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -74.24 -16.68 60.95 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 112.37 0.507 . . . . 1.3799999999999999 112.37 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1559 ' ' CYS . . . . . 0.719 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 88.9 m -137.75 173.49 5.34 Favored Pre-proline 0 C--N 1.306 -1.289 0 CA-C-O 117.811 -1.09 . . . . 1.21 111.003 179.088 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1560 ' ' PRO . . . . . 0.719 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 7.3 Cg_exo -31.83 131.59 0.08 OUTLIER 'Trans proline' 0 C--N 1.393 2.917 0 C-N-CA 124.801 3.668 . . . . 0.70999999999999996 114.735 177.079 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1561 ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' 1560 ' ' PRO . 83.6 Cg_exo -48.56 125.75 13.04 Favored 'Trans proline' 0 C--O 1.25 1.08 0 C-N-CA 124.553 3.502 . . . . 0.80000000000000004 114.452 -174.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 93.88 23.94 21.61 Favored Glycine 0 N--CA 1.432 -1.575 0 CA-C-N 115.284 -0.871 . . . . 0.46000000000000002 112.451 178.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1563 ' ' VAL . . . . . 0.531 HG11 ' HB2' ' A' 1559 ' ' CYS . 4.0 p -109.6 139.85 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 C-N-CA 119.773 -0.771 . . . . 0.97999999999999998 110.543 -177.4 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1564 ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' 1550 ' ' MET . . . -104.41 -27.29 6.18 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 121.156 -0.545 . . . . 0.28000000000000003 113.279 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -135.46 129.95 33.99 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 117.144 0.472 . . . . 0.28000000000000003 110.188 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 31.7 t -160.3 137.61 9.42 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 122.465 0.306 . . . . 0.42999999999999999 110.48 -178.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1567 ' ' PHE . . . . . 0.429 ' HA ' ' HA ' ' A' 1548 ' ' VAL . 76.2 m-85 -85.62 138.88 31.85 Favored 'General case' 0 C--O 1.247 0.963 0 N-CA-C 108.142 -1.058 . . . . 1.03 108.142 173.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -82.36 38.19 2.6 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.937 -0.649 . . . . 1.1299999999999999 112.92 -176.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1569 ' ' GLN . . . . . 0.498 ' HB3' ' OD1' ' B' ' 15' ' ' ASP . 16.4 mm100 -83.48 -72.3 0.46 Allowed 'General case' 0 N--CA 1.443 -0.804 0 CA-C-O 121.045 0.45 . . . . 2.5800000000000001 110.341 176.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 5.5 t -132.44 34.24 3.74 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-O 122.194 0.997 . . . . 2.1699999999999999 109.217 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 61.32 55.86 2.8 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 124.902 1.281 . . . . 2.6200000000000001 110.029 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 19.6 mt -97.17 114.37 34.01 Favored 'Isoleucine or valine' 0 C--O 1.244 0.805 0 N-CA-C 109.211 -0.662 . . . . 0.92000000000000004 109.211 -177.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1573 ' ' SER . . . . . 0.748 ' HB3' ' HB2' ' A' 1596 ' ' SER . 19.5 t -74.39 130.73 40.2 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.552 0.692 . . . . 0.80000000000000004 110.918 -178.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1574 ' ' VAL . . . . . 0.6 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 34.8 m -123.41 10.93 5.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 CA-C-O 121.33 0.586 . . . . 0.97999999999999998 110.607 177.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 177.4 118.95 0.57 Allowed Glycine 0 N--CA 1.428 -1.852 0 C-N-CA 120.589 -0.815 . . . . 0.28999999999999998 111.652 177.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1576 ' ' LYS . . . . . 0.453 ' HE3' ' HB2' ' A' 1576 ' ' LYS . 37.8 ttmt -74.62 148.32 40.81 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.978 -1.119 . . . . 2.1899999999999999 107.978 178.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -75.74 83.98 2.72 Favored 'General case' 0 CA--C 1.499 -0.998 0 CA-C-O 121.456 0.646 . . . . 0.60999999999999999 111.756 -175.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -99.06 166.04 11.45 Favored 'General case' 0 C--N 1.281 -2.39 0 N-CA-C 108.213 -1.032 . . . . 1.95 108.213 178.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1579 ' ' LYS . . . . . 0.543 ' HB3' ' O ' ' A' 1515 ' ' ASP . 67.3 mttm -120.32 42.09 3.06 Favored 'General case' 0 C--N 1.286 -2.158 0 CA-C-O 122.601 1.191 . . . . 2.6800000000000002 107.869 -176.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 43.5 ttt180 -93.65 75.84 4.34 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 114.188 -1.369 . . . . 3.4700000000000002 108.41 -173.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1581 ' ' LEU . . . . . 0.486 HD23 ' SG ' ' A' 1516 ' ' CYS . 0.6 OUTLIER -84.3 125.07 31.92 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 113.549 -1.66 . . . . 0.64000000000000001 108.196 -178.566 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 60.8 mtm180 -125.73 138.51 53.87 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 116.457 -0.338 . . . . 2.8500000000000001 111.289 178.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1583 ' ' TYR . . . . . . . . . . . . . 48.5 t80 -112.86 110.41 20.49 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 122.31 0.244 . . . . 0.85999999999999999 110.48 -178.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1584 ' ' VAL . . . . . 0.566 ' O ' ' HB ' ' A' 1587 ' ' VAL . 15.4 m -129.69 93.23 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.265 0.555 . . . . 1.05 112.431 -178.052 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 26.9 t70 59.75 65.94 1.06 Allowed 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 123.805 0.842 . . . . 1.1699999999999999 111.137 174.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1586 ' ' GLN . . . . . . . . . . . . 0.254 8.7 pt20 66.1 5.43 3.56 Favored 'General case' 0 N--CA 1.503 2.197 0 C-N-CA 127.163 2.185 . . . . 1.8600000000000001 112.11 178.482 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1587 ' ' VAL . . . . . 0.566 ' HB ' ' O ' ' A' 1584 ' ' VAL . 36.0 t -104.0 120.14 53.75 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.749 0 CA-C-N 114.789 -1.096 . . . . 0.48999999999999999 109.378 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1588 ' ' LEU . . . . . 0.811 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 2.6 mm? -96.16 107.58 19.93 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 106.135 -1.802 . . . . 0.35999999999999999 106.135 176.063 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1589 ' ' GLN . . . . . 0.508 ' HA ' ' O ' ' A' 1610 ' ' ILE . 34.3 tt0 -107.96 116.45 31.99 Favored 'General case' 0 N--CA 1.409 -2.49 0 CA-C-O 121.955 0.883 . . . . 1.74 110.368 -176.562 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1590 ' ' LEU . . . . . 0.514 ' HB3' ' HB ' ' A' 1610 ' ' ILE . 1.1 tt -107.64 107.42 18.22 Favored 'General case' 0 C--N 1.28 -2.418 0 N-CA-C 105.009 -2.219 . . . . 0.71999999999999997 105.009 -178.228 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 4.2 p -101.72 129.63 52.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 C-N-CA 119.572 -0.851 . . . . 1.01 111.403 -174.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1592 ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -119.4 105.74 11.58 Favored 'General case' 0 CA--C 1.496 -1.118 0 N-CA-C 108.502 -0.925 . . . . 0.5 108.502 177.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1593 ' ' LYS . . . . . 0.635 ' HB3' ' HD3' ' A' 1607 ' ' LYS . 18.4 pttp -126.43 174.76 8.38 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 109.428 -0.582 . . . . 1.5900000000000001 109.428 -179.095 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 9.8 m-20 58.98 36.79 24.59 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 124.677 1.235 . . . . 1.1100000000000001 110.996 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -73.52 -88.08 0.19 Allowed Glycine 0 N--CA 1.44 -1.082 0 N-CA-C 110.412 -1.075 . . . . 0.78000000000000003 110.412 178.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1596 ' ' SER . . . . . 0.748 ' HB2' ' HB3' ' A' 1573 ' ' SER . 47.0 t -132.25 144.73 54.31 Favored Pre-proline 0 N--CA 1.416 -2.139 0 N-CA-C 107.788 -1.19 . . . . 1.0700000000000001 107.788 175.613 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1597 ' ' PRO . . . . . 0.561 ' HA ' ' HA ' ' A' 1605 ' ' SER . 18.0 Cg_endo -58.89 130.78 38.33 Favored 'Trans proline' 0 C--O 1.24 0.578 0 C-N-CA 123.829 3.019 . . . . 1.01 112.462 179.345 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1598 ' ' CYS . . . . . 0.433 ' SG ' ' HB2' ' A' 1600 ' ' SER . 47.4 t -72.65 120.53 81.18 Favored Pre-proline 0 C--N 1.289 -2.041 0 CA-C-N 114.516 -1.22 . . . . 0.75 109.309 -174.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -65.13 -32.32 52.86 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.684 2.256 . . . . 1.7 110.635 178.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1600 ' ' SER . . . . . 0.769 ' HB3' HD13 ' B' ' 53' ' ' LEU . 7.1 m -64.47 -45.97 85.07 Favored 'General case' 0 N--CA 1.419 -1.983 0 CA-C-N 115.297 -0.865 . . . . 2.2599999999999998 110.713 176.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1601 ' ' LYS . . . . . 0.583 ' HG2' HD21 ' A' 1604 ' ' LEU . 0.0 OUTLIER -121.9 93.54 4.03 Favored 'General case' 0 N--CA 1.429 -1.513 0 O-C-N 121.374 -0.828 . . . . 3.0099999999999998 108.919 -178.942 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 7.0 m -55.8 125.04 19.6 Favored 'General case' 0 N--CA 1.426 -1.646 0 C-N-CA 124.316 1.046 . . . . 2.0699999999999998 111.28 -177.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 106.03 -8.5 42.25 Favored Glycine 0 C--N 1.313 -0.702 0 C-N-CA 121.126 -0.559 . . . . 1.0800000000000001 114.403 174.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1604 ' ' LEU . . . . . 0.583 HD21 ' HG2' ' A' 1601 ' ' LYS . 4.2 pp -128.35 155.7 44.27 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-N 118.218 1.009 . . . . 1.8400000000000001 110.237 176.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1605 ' ' SER . . . . . 0.561 ' HA ' ' HA ' ' A' 1597 ' ' PRO . 7.7 p -103.19 152.83 21.0 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 123.042 0.537 . . . . 1.4099999999999999 111.357 -176.114 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1606 ' ' TYR . . . . . 0.6 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 58.5 m-85 -63.34 161.3 14.28 Favored 'General case' 0 C--O 1.25 1.083 0 CA-C-N 116.4 -0.364 . . . . 0.59999999999999998 110.906 175.519 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1607 ' ' LYS . . . . . 0.635 ' HD3' ' HB3' ' A' 1593 ' ' LYS . 24.5 ttpp -155.89 125.4 6.31 Favored 'General case' 0 CA--C 1.5 -0.968 0 CA-C-N 116.291 -0.413 . . . . 1.45 110.333 -178.427 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1608 ' ' SER . . . . . . . . . . . . . 22.3 m -105.4 127.04 52.77 Favored 'General case' 0 C--N 1.286 -2.185 0 N-CA-C 108.444 -0.947 . . . . 1.1499999999999999 108.444 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 39.6 t -111.0 108.72 26.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 109.183 -0.673 . . . . 0.25 109.183 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1610 ' ' ILE . . . . . 0.514 ' HB ' ' HB3' ' A' 1590 ' ' LEU . 25.7 mm -89.67 123.41 41.86 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 106.776 -1.564 . . . . 0.45000000000000001 106.776 -178.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 21.5 p -122.09 105.42 10.26 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 120.517 -0.473 . . . . 1.26 111.031 177.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1612 ' ' PHE . . . . . 0.811 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 68.1 m-85 -86.16 119.69 26.72 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.71 -0.848 . . . . 0.26000000000000001 108.71 177.083 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 45.9 t -114.2 134.53 56.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 108.514 -0.921 . . . . 0.5 108.514 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 12.2 t -59.64 114.74 2.89 Favored 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 123.964 0.906 . . . . 0.77000000000000002 112.403 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1615 ' ' ARG . . . . . 0.725 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 0.0 OUTLIER -132.2 89.52 37.23 Favored Pre-proline 0 N--CA 1.446 -0.66 0 N-CA-C 106.967 -1.494 . . . . 2.5299999999999998 106.967 172.783 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A 1616 ' ' PRO . . . . . 0.626 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 34.4 Cg_exo -59.46 -32.84 97.04 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 123.077 2.518 . . . . 1.1000000000000001 114.629 -173.136 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -77.23 -5.49 49.49 Favored 'General case' 0 C--O 1.252 1.228 0 N-CA-C 111.931 0.345 . . . . 3.0499999999999998 111.931 -178.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . 58.49 -143.11 0.64 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.23 0.612 . . . . 1.55 109.98 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . 110.47 -157.64 14.89 Favored Glycine 0 N--CA 1.416 -2.681 0 CA-C-N 119.532 1.06 . . . . 0.93000000000000005 111.821 178.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -80.55 13.63 2.22 Favored 'Trans proline' 0 C--N 1.323 -0.799 0 C-N-CA 123.455 2.77 . . . . 0.88 113.249 -177.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1621 ' ' THR . . . . . 0.901 ' HB ' ' HB2' ' A' 1641 ' ' HIS . 36.2 p -96.16 -14.46 22.77 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 115.48 -0.782 . . . . 0.96999999999999997 110.049 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1622 ' ' ASN . . . . . 0.414 ' OD1' ' HB ' ' A' 1642 ' ' THR . 55.1 t30 -88.73 62.66 6.55 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 122.057 0.932 . . . . 0.71999999999999997 110.148 -175.324 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1623 ' ' ARG . . . . . 0.409 ' HE ' ' HB3' ' A' 1623 ' ' ARG . 6.7 ptp180 -168.53 139.73 2.15 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-N 114.155 -1.384 . . . . 3.2599999999999998 108.169 -178.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -63.35 119.1 6.03 Favored 'Trans proline' 0 C--O 1.25 1.111 0 C-N-CA 122.762 2.308 . . . . 0.58999999999999997 113.353 -174.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 76.8 mtm -116.68 138.44 51.45 Favored 'General case' 0 C--O 1.245 0.865 0 N-CA-C 108.79 -0.819 . . . . 1.3700000000000001 108.79 175.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1626 ' ' LEU . . . . . 0.59 ' HG ' ' CE2' ' A' 1542 ' ' TYR . 0.4 OUTLIER -88.16 118.71 27.93 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 107.661 -1.237 . . . . 0.89000000000000001 107.661 -176.455 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A 1627 ' ' ILE . . . . . 0.68 HD11 ' HB2' ' A' 1639 ' ' SER . 33.3 mm -78.3 -53.18 14.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.392 -0.596 . . . . 0.57999999999999996 109.392 -178.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 8.4 t -167.85 152.08 6.42 Favored 'General case' 0 N--CA 1.416 -2.136 0 N-CA-C 108.652 -0.87 . . . . 1.3899999999999999 108.652 -174.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1629 ' ' LEU . . . . . 0.859 HD23 ' HG ' ' A' 1636 ' ' LEU . 1.8 tm? -121.64 102.17 8.06 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 105.741 -1.948 . . . . 1.25 105.741 176.223 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 31.9 t70 -70.63 124.18 23.64 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 120.118 -0.633 . . . . 1.0900000000000001 109.784 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1631 ' ' LYS . . . . . 0.454 ' HB2' HD21 ' B' ' 53' ' ' LEU . 16.6 ptpt -79.38 -10.89 59.9 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 112.654 0.612 . . . . 3.6000000000000001 112.654 -171.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -100.62 -34.71 9.77 Favored 'General case' 0 N--CA 1.421 -1.878 0 C-N-CA 120.221 -0.592 . . . . 2.6000000000000001 111.515 -175.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 40.8 p -103.3 -6.86 21.58 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.05 0.452 . . . . 0.75 111.795 177.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 78.7 m 56.37 35.97 26.75 Favored 'General case' 0 C--N 1.361 1.085 0 C-N-CA 124.396 1.078 . . . . 0.53000000000000003 111.982 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1635 ' ' THR . . . . . . . . . . . . . 59.5 m -99.54 132.08 45.11 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-N 114.218 -1.355 . . . . 0.46000000000000002 109.996 178.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1636 ' ' LEU . . . . . 0.859 ' HG ' HD23 ' A' 1629 ' ' LEU . 0.8 OUTLIER -108.53 132.51 53.76 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.861 -1.533 . . . . 0.85999999999999999 106.861 -178.39 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A 1637 ' ' PHE . . . . . 0.413 ' HB2' ' HB ' ' A' 1627 ' ' ILE . 94.3 m-85 -107.04 135.56 48.38 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 110.153 -0.314 . . . . 0.45000000000000001 110.153 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -128.59 129.17 45.55 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.069 -0.514 . . . . 0.5 110.09 -175.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1639 ' ' SER . . . . . 0.68 ' HB2' HD11 ' A' 1627 ' ' ILE . 22.7 t -108.48 149.38 28.87 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.445 -0.946 . . . . 1.04 108.445 178.002 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 2.1 t90 -156.46 115.74 3.47 Favored 'General case' 0 N--CA 1.425 -1.714 0 N-CA-C 105.032 -2.21 . . . . 0.68000000000000005 105.032 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1641 ' ' HIS . . . . . 0.901 ' HB2' ' HB ' ' A' 1621 ' ' THR . 18.9 m-70 -112.86 107.91 16.68 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 120.528 -0.469 . . . . 0.90000000000000002 110.257 -177.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1642 ' ' THR . . . . . 0.414 ' HB ' ' OD1' ' A' 1622 ' ' ASN . 7.3 t -138.19 152.01 70.84 Favored Pre-proline 0 C--N 1.296 -1.727 0 CA-C-N 114.744 -1.116 . . . . 0.47999999999999998 109.63 -171.083 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1643 ' ' PRO . . . . . 0.626 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 74.1 Cg_endo -79.49 -7.98 14.87 Favored 'Trans proline' 0 C--N 1.372 1.767 0 C-N-CA 122.496 2.131 . . . . 0.66000000000000003 112.167 177.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 8.7 tt -68.11 -23.1 64.88 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-O 121.491 0.662 . . . . 0.96999999999999997 109.549 177.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -93.51 5.65 50.87 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.706 -0.679 . . . . 0.83999999999999997 110.948 -177.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1646 ' ' CYS . . . . . 0.472 ' SG ' ' HA ' ' A' 1643 ' ' PRO . 72.2 m -93.82 142.77 26.99 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 120.804 0.335 . . . . 1.1899999999999999 111.501 -177.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -93.2 149.23 37.09 Favored Pre-proline 0 C--N 1.297 -1.687 0 C-N-CA 123.691 0.796 . . . . 3.1400000000000001 108.887 178.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1648 ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -59.31 112.44 1.24 Allowed 'Trans proline' 0 C--O 1.238 0.521 0 C-N-CA 123.063 2.508 . . . . 2.5800000000000001 111.803 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 34.8 tt0 . . . . . 0 C--O 1.254 1.316 0 O-C-N 124.631 1.207 . . . . 4.7199999999999998 109.608 179.608 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.301 0 CA-C-O 121.335 0.588 . . . . 9.9700000000000006 109.814 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 2' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -110.27 130.1 55.61 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.059 0.457 . . . . 7.6799999999999997 110.268 -177.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 3' ' ' ARG . . . . . 0.564 ' HD3' HD21 ' B' ' 8' ' ' LEU . 14.7 ptp180 -112.72 147.24 36.71 Favored Pre-proline 0 C--N 1.302 -1.47 0 N-CA-C 107.944 -1.132 . . . . 6.1100000000000003 107.944 177.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -80.09 15.11 1.76 Allowed 'Trans proline' 0 C--O 1.244 0.802 0 C-N-CA 123.136 2.557 . . . . 4.8399999999999999 113.933 -174.08 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 5' ' ' SER . . . . . 0.431 ' HB2' ' HG ' ' B' ' 8' ' ' LEU . 50.7 m -140.4 117.43 11.16 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 115.461 -0.79 . . . . 4.5999999999999996 109.973 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -86.09 -35.96 19.92 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.757 -0.831 . . . . 4.2300000000000004 108.757 174.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 17.3 p -110.05 99.33 8.44 Favored 'General case' 0 N--CA 1.424 -1.739 0 N-CA-C 106.073 -1.825 . . . . 3.1400000000000001 106.073 168.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.564 HD21 ' HD3' ' B' ' 3' ' ' ARG . 5.4 mp -79.37 103.68 9.47 Favored 'General case' 0 C--O 1.247 0.942 0 N-CA-C 113.025 0.75 . . . . 3.96 113.025 -170.347 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 83.3 m -84.98 146.76 27.05 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-O 120.839 0.352 . . . . 2.8399999999999999 110.454 177.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.77 -62.64 0.3 Allowed Glycine 0 N--CA 1.426 -2.003 0 N-CA-C 111.278 -0.729 . . . . 2.0899999999999999 111.278 178.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -101.03 -64.18 0.78 Allowed Glycine 0 C--N 1.306 -1.134 0 N-CA-C 115.03 0.772 . . . . 1.8400000000000001 115.03 -177.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 12' ' ' GLU . . . . . 0.468 ' HG3' HD22 ' B' ' 8' ' ' LEU . 25.8 mm-40 -71.07 -45.08 64.42 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.894 0.702 . . . . 2.5499999999999998 112.894 -170.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 12.5 tp -45.52 -57.88 3.8 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 123.729 0.643 . . . . 2.3500000000000001 112.562 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 13.2 p -70.89 -31.35 45.2 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 CA-C-N 115.726 -0.67 . . . . 2.1099999999999999 111.386 -177.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 15' ' ' ASP . . . . . 0.498 ' OD1' ' HB3' ' A' 1569 ' ' GLN . 3.3 t0 -72.95 -40.53 65.3 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 119.271 -0.972 . . . . 2.04 111.766 -176.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 12.4 t -65.0 -32.09 73.65 Favored 'General case' 0 C--O 1.254 1.293 0 O-C-N 121.302 -0.874 . . . . 1.8400000000000001 109.773 176.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.53 ' O ' ' HB2' ' B' ' 21' ' ' CYS . 9.5 mt -67.05 -23.03 65.84 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-N 115.663 -0.699 . . . . 1.74 112.58 172.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -91.47 -17.7 25.32 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 121.643 0.735 . . . . 2.3900000000000001 109.552 176.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -68.64 -60.23 2.56 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.819 -0.628 . . . . 0.95999999999999996 111.699 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 12.5 p -94.43 -20.28 6.21 Favored 'Isoleucine or valine' 0 C--O 1.242 0.671 0 C-N-CA 118.128 -1.429 . . . . 1.3700000000000001 111.841 -178.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 21' ' ' CYS . . . . . 0.53 ' HB2' ' O ' ' B' ' 17' ' ' LEU . 7.7 m -107.07 18.3 21.92 Favored 'General case' 0 C--O 1.201 -1.453 0 C-N-CA 120.022 -0.671 . . . . 1.6599999999999999 109.822 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.53 -44.65 97.5 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 115.702 1.041 . . . . 1.53 115.702 -178.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -76.46 -48.5 19.41 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 117.483 0.642 . . . . 2.7200000000000002 111.62 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 24' ' ' ARG . . . . . 0.64 ' HE ' ' HB3' ' B' ' 61' ' ' ALA . 35.9 ttp180 -73.84 -25.35 60.03 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.316 0.579 . . . . 4.3300000000000001 111.746 -175.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 25' ' ' GLY . . . . . 0.506 ' O ' ' HB2' ' B' ' 61' ' ' ALA . . . 110.16 144.15 10.09 Favored Glycine 0 N--CA 1.425 -2.062 0 N-CA-C 110.9 -0.88 . . . . 1.53 110.9 177.059 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -88.1 124.09 33.44 Favored 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 120.035 -0.666 . . . . 1.6499999999999999 109.354 175.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 27' ' ' TYR . . . . . 0.652 ' HB2' ' HA ' ' B' ' 61' ' ' ALA . 27.7 m-85 -128.55 76.61 1.72 Allowed 'General case' 0 CA--C 1.497 -1.081 0 CA-C-O 121.618 0.723 . . . . 3.4199999999999999 110.418 -173.157 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 28' ' ' PHE . . . . . 0.512 ' HB2' HG12 ' B' ' 42' ' ' ILE . 12.9 p90 -114.12 8.65 17.03 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 115.455 -0.793 . . . . 2.2599999999999998 110.808 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 7.4 p -107.05 46.26 0.94 Allowed 'General case' 0 N--CA 1.423 -1.786 0 CA-C-N 115.061 -0.972 . . . . 3.6800000000000002 109.289 177.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 22.6 mmm180 -122.39 107.11 34.85 Favored Pre-proline 0 C--O 1.214 -0.772 0 N-CA-C 107.302 -1.37 . . . . 3.8100000000000001 107.302 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 31' ' ' PRO . . . . . 0.58 ' HA ' ' O ' ' B' ' 39' ' ' SER . 2.6 Cg_endo -98.7 12.38 0.74 Allowed 'Trans proline' 0 C--O 1.249 1.069 0 C-N-CA 122.919 2.413 . . . . 4.0199999999999996 113.208 178.422 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 32' ' ' ALA . . . . . 0.698 ' HB3' ' HB3' ' B' ' 38' ' ' ARG . . . 68.19 -0.54 2.1 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.917 1.687 . . . . 4.9199999999999999 114.508 177.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 44.6 t 173.55 -177.98 0.08 Allowed 'General case' 0 N--CA 1.416 -2.172 0 N-CA-C 103.973 -2.602 . . . . 6.7199999999999998 103.973 -178.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 61.3 ttt180 -102.34 10.09 39.38 Favored 'General case' 0 C--N 1.28 -2.439 0 CA-C-O 122.18 0.99 . . . . 11.630000000000001 109.095 -177.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 22.5 t -91.87 -10.67 9.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 122.424 1.106 . . . . 9.6099999999999994 108.105 173.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 36' ' ' SER . . . . . 0.496 ' HA ' ' HB2' ' B' ' 31' ' ' PRO . 87.4 p 59.01 33.21 22.89 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 125.903 1.681 . . . . 6.71 113.963 172.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 18.2 mmt180 -73.13 -53.56 10.71 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.648 -0.705 . . . . 10.0 112.611 177.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 38' ' ' ARG . . . . . 0.698 ' HB3' ' HB3' ' B' ' 32' ' ' ALA . 60.4 ttt180 -89.52 86.66 6.81 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 120.939 -0.304 . . . . 7.9400000000000004 110.573 -175.387 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 39' ' ' SER . . . . . 0.58 ' O ' ' HA ' ' B' ' 31' ' ' PRO . 16.6 m 67.15 87.17 0.12 Allowed 'General case' 0 C--O 1.204 -1.323 0 CA-C-N 114.947 -1.024 . . . . 5.7599999999999998 111.992 177.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 40' ' ' ARG . . . . . 0.514 ' HD2' ' HB3' ' B' ' 44' ' ' GLU . 0.1 OUTLIER -64.18 -2.97 2.35 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 113.046 0.758 . . . . 6.0300000000000002 113.046 179.543 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 126.97 119.66 2.28 Favored Glycine 1 N--CA 1.387 -4.6 0 N-CA-C 107.653 -2.179 . . . . 2.3700000000000001 107.653 -174.42 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 42' ' ' ILE . . . . . 0.512 HG12 ' HB2' ' B' ' 28' ' ' PHE . 33.4 pt -69.93 -4.61 4.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 111.943 0.349 . . . . 2.0699999999999998 111.943 -175.099 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 2.5 p -52.81 -40.63 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 CA-C-N 115.661 -0.699 . . . . 2.2400000000000002 110.08 169.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 44' ' ' GLU . . . . . 0.514 ' HB3' ' HD2' ' B' ' 40' ' ' ARG . 28.1 tt0 -92.51 -19.28 22.14 Favored 'General case' 0 N--CA 1.419 -2.003 0 O-C-N 121.294 -0.879 . . . . 3.3599999999999999 108.941 -175.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 45' ' ' GLU . . . . . 0.437 ' CB ' ' HA ' ' B' ' 42' ' ' ILE . 6.4 tp10 -81.28 -2.47 49.06 Favored 'General case' 0 CA--C 1.555 1.161 0 CA-C-N 114.46 -1.245 . . . . 3.0800000000000001 109.517 -178.185 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 46' ' ' CYS . . . . . . . . . . . . . 88.8 m -133.84 -20.3 1.99 Allowed 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.249 0.833 . . . . 2.23 113.249 178.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 98.4 m -80.94 -9.84 59.79 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 119.576 -0.85 . . . . 2.3700000000000001 113.178 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -133.7 20.5 3.88 Favored 'General case' 0 C--N 1.319 -0.727 0 O-C-N 121.498 -0.751 . . . . 2.8199999999999998 111.773 178.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -169.68 174.7 5.66 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 106.772 -1.566 . . . . 4.0899999999999999 106.772 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 22.8 t -101.0 143.69 30.84 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-O 121.444 0.64 . . . . 2.6699999999999999 110.763 -174.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 26.4 p -145.0 151.09 38.03 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-N 115.44 -0.8 . . . . 2.1099999999999999 108.908 178.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 52' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' 1600 ' ' SER . 4.4 p-10 -127.55 -173.99 3.06 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.6 -0.727 . . . . 2.6699999999999999 109.232 174.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 53' ' ' LEU . . . . . 0.769 HD13 ' HB3' ' A' 1600 ' ' SER . 46.3 tp -35.58 -39.88 0.15 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 128.088 2.555 . . . . 1.8999999999999999 115.503 -174.256 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -49.32 -59.39 3.74 Favored 'General case' 0 CA--C 1.502 -0.888 0 C-N-CA 123.865 0.866 . . . . 1.52 112.129 -172.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 67.6 tp -59.78 -41.78 91.86 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 125.132 1.373 . . . . 1.97 112.803 -176.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 2.6 pp -83.54 -22.48 32.38 Favored 'General case' 0 N--CA 1.422 -1.827 0 C-N-CA 118.654 -1.219 . . . . 1.53 112.257 -173.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -86.48 -33.7 20.27 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 119.397 -0.921 . . . . 2.27 111.186 173.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 18.0 p -60.56 -44.01 96.65 Favored 'General case' 0 C--N 1.357 0.916 0 CA-C-N 118.02 0.373 . . . . 2.3300000000000001 110.08 176.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -82.16 -81.55 0.15 Allowed 'General case' 0 N--CA 1.428 -1.528 0 C-N-CA 119.507 -0.877 . . . . 2.8599999999999999 109.505 173.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 41.3 t 58.47 -77.37 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.69 0.796 . . . . 2.2999999999999998 111.652 -178.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 61' ' ' ALA . . . . . 0.652 ' HA ' ' HB2' ' B' ' 27' ' ' TYR . . . -162.3 168.96 21.44 Favored 'General case' 0 N--CA 1.42 -1.97 0 N-CA-C 106.568 -1.641 . . . . 3.1899999999999999 106.568 -178.322 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 14.6 p -99.66 137.45 20.24 Favored Pre-proline 0 C--N 1.275 -2.657 0 CA-C-O 120.852 0.358 . . . . 3.6800000000000002 110.037 178.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -75.99 -12.45 19.62 Favored 'Trans proline' 0 CA--C 1.53 0.283 0 C-N-CA 122.851 2.367 . . . . 5.0800000000000001 111.497 178.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -137.72 97.25 3.39 Favored 'General case' 0 N--CA 1.419 -1.981 0 N-CA-C 105.498 -2.038 . . . . 5.0999999999999996 105.498 175.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -63.33 149.31 46.06 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.766 -1.107 . . . . 8.5099999999999998 110.012 -175.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 6.8 t -105.94 150.44 25.67 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 106.774 -1.565 . . . . 8.1199999999999992 106.774 178.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.299 -1.612 0 N-CA-C 109.98 -0.378 . . . . 10.210000000000001 109.98 177.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 24.7 ptm . . . . . 0 C--O 1.236 0.39 0 N-CA-C 109.854 -0.424 . . . . 9.3399999999999999 109.854 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 63.7 mttp -82.58 65.71 7.84 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.555 0.693 . . . . 9.0399999999999991 111.944 -178.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 27.3 m -98.42 -26.86 14.33 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.299 -1.0 . . . . 5.8099999999999996 108.299 174.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1511 ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -87.51 -16.26 35.21 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.785 -1.098 . . . . 3.4199999999999999 110.191 178.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1512 ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -117.04 140.49 49.42 Favored 'General case' 0 N--CA 1.41 -2.474 0 N-CA-C 107.166 -1.42 . . . . 5.9500000000000002 107.166 179.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 21.8 t60 -155.25 -25.06 0.11 Allowed 'General case' 0 C--N 1.283 -2.301 0 CA-C-N 116.273 -0.421 . . . . 5.3300000000000001 109.988 -173.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 30.8 t70 -163.79 -68.5 0.04 OUTLIER 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 109.536 -0.542 . . . . 5.0599999999999996 109.536 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 12.7 t70 -144.88 -74.49 0.24 Allowed 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 106.857 -1.535 . . . . 2.8999999999999999 106.857 177.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 12.9 m -139.84 81.77 1.84 Allowed 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.546 -0.752 . . . . 1.1899999999999999 110.204 173.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1517 ' ' GLN . . . . . 0.405 ' HA ' ' O ' ' A' 1527 ' ' PHE . 4.1 pt20 -162.65 130.34 3.8 Favored 'General case' 0 N--CA 1.417 -2.106 0 N-CA-C 108.19 -1.041 . . . . 1.52 108.19 -179.044 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1518 ' ' VAL . . . . . 0.526 ' CG2' HD12 ' A' 1581 ' ' LEU . 4.3 m -129.72 136.97 57.9 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.125 0 CA-C-O 121.276 0.56 . . . . 0.93999999999999995 110.789 -176.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1519 ' ' THR . . . . . 0.429 ' OG1' HD23 ' A' 1526 ' ' LEU . 23.8 m -112.33 132.42 54.99 Favored 'General case' 0 C--N 1.286 -2.164 0 CA-C-N 115.584 -0.734 . . . . 0.89000000000000001 109.398 -178.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1520 ' ' ASN . . . . . 0.418 ' OD1' HG22 ' A' 1523 ' ' THR . 27.0 t-20 -86.8 110.19 30.45 Favored Pre-proline 0 N--CA 1.423 -1.804 0 N-CA-C 107.845 -1.168 . . . . 1.74 107.845 174.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -68.54 -16.29 42.58 Favored 'Trans proline' 0 N--CA 1.466 -0.136 0 C-N-CA 122.852 2.368 . . . . 1.5800000000000001 112.775 -174.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1522 ' ' SER . . . . . 0.409 ' HB2' ' OD1' ' A' 1520 ' ' ASN . 15.2 m -71.76 -31.63 66.85 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 116.042 -0.526 . . . . 1.6499999999999999 111.458 -178.479 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1523 ' ' THR . . . . . 0.418 HG22 ' OD1' ' A' 1520 ' ' ASN . 7.5 t -132.99 -4.06 3.14 Favored 'General case' 0 CA--C 1.56 1.345 0 C-N-CA 119.377 -0.929 . . . . 1.6100000000000001 112.675 179.308 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 77.39 20.79 74.22 Favored Glycine 0 CA--C 1.497 -1.037 0 O-C-N 121.898 -0.501 . . . . 1.1299999999999999 113.089 177.118 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -87.75 118.2 27.1 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 109.006 -0.739 . . . . 1.26 109.006 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1526 ' ' LEU . . . . . 0.429 HD23 ' OG1' ' A' 1519 ' ' THR . 1.0 OUTLIER -100.12 114.81 28.44 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-N 114.22 -1.355 . . . . 0.68000000000000005 110.458 -175.153 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A 1527 ' ' PHE . . . . . 0.405 ' O ' ' HA ' ' A' 1517 ' ' GLN . 96.3 m-85 -93.75 113.61 25.71 Favored 'General case' 0 CA--C 1.508 -0.665 0 N-CA-C 109.375 -0.602 . . . . 0.65000000000000002 109.375 176.491 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 19.9 t70 -104.4 119.17 38.37 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 120.073 -0.651 . . . . 1.1699999999999999 110.487 175.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1529 ' ' LEU . . . . . 0.761 ' HG ' HD21 ' A' 1581 ' ' LEU . 3.0 mm? -104.23 1.96 31.11 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.751 -0.659 . . . . 0.59999999999999998 109.645 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 3.1 m -67.07 -24.42 65.97 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 108.641 -0.874 . . . . 0.83999999999999997 108.641 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 22.8 t -61.18 -27.11 68.18 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 115.093 -0.958 . . . . 1.5900000000000001 110.295 175.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 81.9 mt -95.28 0.67 54.05 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 122.094 -0.379 . . . . 0.65000000000000002 111.691 -177.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1533 ' ' SER . . . . . 0.537 ' HA ' ' O ' ' A' 1552 ' ' ILE . 34.3 t -70.94 171.04 11.46 Favored 'General case' 0 C--O 1.26 1.646 0 CA-C-O 121.577 0.703 . . . . 1.52 111.405 -178.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . 170.56 152.03 7.86 Favored Glycine 0 N--CA 1.43 -1.739 0 CA-C-N 115.278 -0.874 . . . . 1.1000000000000001 111.423 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 23.2 ttt180 -89.37 -32.75 17.15 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 123.682 0.793 . . . . 4.6200000000000001 110.524 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -83.59 -34.27 25.18 Favored 'General case' 0 C--O 1.245 0.816 0 CA-C-O 121.606 0.717 . . . . 1.45 109.41 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 92.24 -150.04 19.96 Favored Glycine 0 N--CA 1.415 -2.707 0 CA-C-N 115.057 -0.974 . . . . 0.84999999999999998 111.905 174.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -138.06 152.22 48.61 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 107.338 -1.356 . . . . 0.93000000000000005 107.338 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 2.6 p -108.19 128.47 54.74 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 123.628 0.58 . . . . 1.03 110.673 179.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1540 ' ' ALA . . . . . 0.488 ' HB3' ' CG1' ' A' 1548 ' ' VAL . . . -117.31 140.93 48.93 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.31 -0.996 . . . . 0.5 108.31 175.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -79.92 127.55 32.39 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 116.09 -0.505 . . . . 0.73999999999999999 109.986 -177.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1542 ' ' TYR . . . . . 0.403 ' CE1' ' HG ' ' A' 1626 ' ' LEU . 4.6 t80 -111.44 -99.5 0.41 Allowed 'General case' 0 N--CA 1.417 -2.112 0 N-CA-C 105.832 -1.914 . . . . 0.98999999999999999 105.832 178.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1543 ' ' SER . . . . . . . . . . . . . 4.9 m -70.71 173.91 6.62 Favored 'General case' 0 N--CA 1.414 -2.25 0 N-CA-C 108.611 -0.885 . . . . 1.9099999999999999 108.611 172.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -68.8 -37.9 79.56 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.093 -1.004 . . . . 3.5899999999999999 109.512 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 38.9 m -107.26 35.53 3.02 Favored 'General case' 0 N--CA 1.408 -2.549 0 CA-C-N 115.25 -0.886 . . . . 2.46 110.079 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . -155.66 121.94 1.15 Allowed Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.055 -1.069 . . . . 1.26 114.044 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 34.7 m -112.85 149.89 15.18 Favored 'Isoleucine or valine' 0 C--O 1.253 1.28 0 CA-C-O 121.502 0.668 . . . . 0.79000000000000004 110.672 176.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1548 ' ' VAL . . . . . 0.488 ' CG1' ' HB3' ' A' 1540 ' ' ALA . 10.3 p -102.18 139.23 23.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 109.078 -0.712 . . . . 0.57999999999999996 109.078 177.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1549 ' ' TYR . . . . . 0.528 ' HB3' ' ND2' ' A' 1556 ' ' ASN . 58.0 m-85 -97.46 129.74 44.62 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 123.173 0.589 . . . . 1.0800000000000001 109.8 178.199 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 24.9 ptm -144.35 127.41 16.53 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-N 115.538 -0.756 . . . . 0.78000000000000003 110.228 -178.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 7.4 p -112.68 117.0 31.05 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 115.514 -0.766 . . . . 0.96999999999999997 109.177 178.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1552 ' ' ILE . . . . . 0.537 ' O ' ' HA ' ' A' 1533 ' ' SER . 41.3 mm -74.83 113.66 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.374 0 N-CA-C 109.845 -0.428 . . . . 0.41999999999999998 109.845 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 75.6 m 66.13 45.56 2.32 Favored 'General case' 0 CA--C 1.493 -1.231 0 O-C-N 124.229 0.956 . . . . 1.3999999999999999 111.745 174.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . -179.72 177.05 47.98 Favored Glycine 0 N--CA 1.406 -3.318 0 C-N-CA 119.306 -1.426 . . . . 0.34999999999999998 111.184 177.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -95.75 141.05 29.68 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 109.469 -0.567 . . . . 1.6200000000000001 109.469 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1556 ' ' ASN . . . . . 0.528 ' ND2' ' HB3' ' A' 1549 ' ' TYR . 44.4 t-20 -92.75 124.68 36.93 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 109.03 -0.729 . . . . 0.87 109.03 -177.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -67.41 -5.89 16.72 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.188 0.81 . . . . 2.4900000000000002 113.188 -176.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -98.62 0.18 44.3 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 112.09 0.404 . . . . 1.3799999999999999 112.09 -174.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1559 ' ' CYS . . . . . 0.47 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 20.4 m -137.82 170.39 10.62 Favored Pre-proline 0 C--N 1.307 -1.277 0 CA-C-O 117.966 -1.016 . . . . 1.21 111.068 177.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1560 ' ' PRO . . . . . 0.482 ' HA ' ' HD3' ' A' 1561 ' ' PRO . 64.4 Cg_exo -29.6 134.96 0.04 OUTLIER 'Trans proline' 0 C--N 1.392 2.855 0 C-N-CA 125.006 3.804 . . . . 0.70999999999999996 114.063 174.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1561 ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' 1560 ' ' PRO . 52.3 Cg_exo -53.82 126.72 22.85 Favored 'Trans proline' 0 C--O 1.242 0.701 0 C-N-CA 123.616 2.877 . . . . 0.80000000000000004 113.799 -175.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 89.56 18.56 51.77 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 115.677 -0.692 . . . . 0.46000000000000002 113.664 175.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1563 ' ' VAL . . . . . . . . . . . . . 4.1 p -109.44 140.34 28.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 117.74 0.77 . . . . 0.97999999999999998 110.151 -177.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -101.27 -30.03 6.13 Favored Glycine 0 C--N 1.315 -0.635 0 CA-C-N 116.035 -0.529 . . . . 0.28000000000000003 112.9 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -128.17 126.99 42.14 Favored 'General case' 0 C--N 1.313 -0.997 0 O-C-N 122.414 -0.463 . . . . 0.28000000000000003 109.906 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 9.4 t -160.44 141.7 12.19 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 122.894 0.478 . . . . 0.42999999999999999 110.154 -176.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1567 ' ' PHE . . . . . 0.434 ' HE1' HG21 ' A' 1574 ' ' VAL . 85.9 m-85 -85.78 132.93 34.03 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.744 -0.836 . . . . 1.03 108.744 176.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -81.56 14.14 31.44 Favored Glycine 0 C--N 1.342 0.878 0 C-N-CA 120.494 -0.86 . . . . 1.1299999999999999 113.45 -173.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1569 ' ' GLN . . . . . 0.4 ' HB3' ' OD1' ' B' ' 15' ' ' ASP . 16.2 mm100 -84.64 -70.17 0.6 Allowed 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.188 0.518 . . . . 2.5800000000000001 110.993 177.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1570 ' ' THR . . . . . 0.453 HG21 ' HA ' ' B' ' 12' ' ' GLU . 1.1 p -108.56 10.76 27.07 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 113.019 0.748 . . . . 2.1699999999999999 113.019 -174.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 11.8 mmt180 59.52 36.54 22.92 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.451 -0.795 . . . . 2.6200000000000001 110.383 178.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 45.0 mt -83.2 125.73 40.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 109.584 -0.524 . . . . 0.92000000000000004 109.584 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 37.2 t -78.11 129.02 34.69 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.47 -0.786 . . . . 0.80000000000000004 110.444 -176.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1574 ' ' VAL . . . . . 0.434 HG21 ' HE1' ' A' 1567 ' ' PHE . 1.4 t -112.85 -19.13 7.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 N-CA-C 112.857 0.688 . . . . 0.97999999999999998 112.857 -177.397 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . -179.9 127.62 1.14 Allowed Glycine 0 C--N 1.305 -1.174 0 C-N-CA 119.172 -1.49 . . . . 0.28999999999999998 112.576 -179.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -63.99 149.32 47.62 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 123.869 0.868 . . . . 2.1899999999999999 109.99 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -64.93 83.42 0.04 OUTLIER 'General case' 0 C--O 1.244 0.769 0 C-N-CA 123.494 0.718 . . . . 0.60999999999999999 111.352 177.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1578 ' ' ASN . . . . . 0.41 ' HB3' ' CD1' ' A' 1592 ' ' TYR . 45.5 t30 -89.18 150.39 22.7 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 106.966 -1.494 . . . . 1.95 106.966 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -137.5 51.09 1.94 Allowed 'General case' 0 C--N 1.287 -2.149 0 CA-C-O 122.911 1.339 . . . . 2.6800000000000002 109.132 -172.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -123.66 81.31 1.89 Allowed 'General case' 0 N--CA 1.412 -2.342 0 CA-C-N 113.754 -1.566 . . . . 3.4700000000000002 108.83 -176.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1581 ' ' LEU . . . . . 0.761 HD21 ' HG ' ' A' 1529 ' ' LEU . 0.5 OUTLIER -63.65 125.04 22.97 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 113.154 -1.839 . . . . 0.64000000000000001 110.266 -177.834 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A 1582 ' ' ARG . . . . . 0.631 ' HB2' ' HB3' ' A' 1589 ' ' GLN . 92.5 mtt180 -112.45 140.34 47.27 Favored 'General case' 0 C--N 1.293 -1.874 0 O-C-N 121.657 -0.652 . . . . 2.8500000000000001 111.274 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1583 ' ' TYR . . . . . 0.669 ' HE1' ' HA ' ' A' 1586 ' ' GLN . 32.7 t80 -113.28 104.17 12.06 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 109.287 -0.634 . . . . 0.85999999999999999 109.287 177.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1584 ' ' VAL . . . . . 0.511 ' O ' ' HB ' ' A' 1587 ' ' VAL . 16.8 m -125.18 89.43 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-N 115.519 -0.764 . . . . 1.05 112.572 -175.464 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 37.2 t70 61.0 51.17 4.64 Favored 'General case' 0 N--CA 1.502 2.155 0 CA-C-O 122.205 1.002 . . . . 1.1699999999999999 110.498 177.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1586 ' ' GLN . . . . . 0.669 ' HA ' ' HE1' ' A' 1583 ' ' TYR 0.288 28.4 pt20 65.2 20.65 11.98 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 126.929 2.091 . . . . 1.8600000000000001 111.703 179.157 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A 1587 ' ' VAL . . . . . 0.511 ' HB ' ' O ' ' A' 1584 ' ' VAL . 45.4 t -108.96 121.62 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.406 0 CA-C-N 113.775 -1.557 . . . . 0.48999999999999999 106.881 172.608 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1588 ' ' LEU . . . . . 0.765 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 2.4 mm? -95.36 113.22 24.86 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 107.576 -1.268 . . . . 0.35999999999999999 107.576 -177.362 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1589 ' ' GLN . . . . . 0.631 ' HB3' ' HB2' ' A' 1582 ' ' ARG . 35.9 tt0 -107.97 140.08 41.65 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.559 0.695 . . . . 1.74 112.484 -172.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 29.6 mt -133.12 93.16 3.13 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 114.065 -1.425 . . . . 0.71999999999999997 107.807 173.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 5.4 p -89.39 122.33 40.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.867 -0.79 . . . . 1.01 108.867 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1592 ' ' TYR . . . . . 0.443 ' HB2' ' HB3' ' A' 1608 ' ' SER . 12.9 m-30 -111.84 102.96 11.19 Favored 'General case' 0 C--N 1.29 -2.017 0 O-C-N 121.672 -0.643 . . . . 0.5 110.096 -177.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -104.21 178.99 4.4 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 109.852 -0.425 . . . . 1.5900000000000001 109.852 177.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 17.1 m-20 68.9 55.22 0.45 Allowed 'General case' 0 C--O 1.246 0.883 0 C-N-CA 123.763 0.825 . . . . 1.1100000000000001 112.497 178.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -88.54 -122.41 1.94 Allowed Glycine 0 N--CA 1.43 -1.765 0 N-CA-C 109.781 -1.328 . . . . 0.78000000000000003 109.781 174.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1596 ' ' SER . . . . . . . . . . . . . 43.9 p -108.35 153.91 41.72 Favored Pre-proline 0 C--N 1.294 -1.843 0 N-CA-C 108.734 -0.839 . . . . 1.0700000000000001 108.734 176.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.23 120.51 8.45 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 122.448 2.099 . . . . 1.01 110.509 176.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 43.3 t -78.94 129.2 74.06 Favored Pre-proline 0 C--N 1.289 -2.034 0 CA-C-N 115.173 -0.921 . . . . 0.75 109.949 -174.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -71.37 -14.16 30.92 Favored 'Trans proline' 0 C--O 1.247 0.968 0 C-N-CA 122.852 2.368 . . . . 1.7 113.316 -178.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1600 ' ' SER . . . . . . . . . . . . . 4.7 m -75.62 -52.85 9.63 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 116.45 -0.341 . . . . 2.2599999999999998 110.627 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1601 ' ' LYS . . . . . 0.804 ' HA ' ' HE3' ' A' 1601 ' ' LYS . 1.1 tpmt? -116.09 101.95 9.19 Favored 'General case' 0 N--CA 1.401 -2.894 0 N-CA-C 106.359 -1.719 . . . . 3.0099999999999998 106.359 178.174 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 16.9 m -58.38 119.85 7.7 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 123.213 0.605 . . . . 2.0699999999999998 110.245 -178.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 102.16 -1.61 50.93 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 111.524 -0.631 . . . . 1.0800000000000001 111.524 -178.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1604 ' ' LEU . . . . . 0.428 HD23 ' SG ' ' A' 1634 ' ' CYS . 8.8 tp -102.97 164.19 11.76 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 107.985 -1.117 . . . . 1.8400000000000001 107.985 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 31.1 t -131.03 150.58 52.08 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 107.724 -1.213 . . . . 1.4099999999999999 107.724 -178.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1606 ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -67.62 155.5 39.02 Favored 'General case' 0 C--O 1.245 0.854 0 N-CA-C 109.578 -0.527 . . . . 0.59999999999999998 109.578 177.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 26.2 pttm -154.67 137.58 15.41 Favored 'General case' 0 N--CA 1.44 -0.928 0 C-N-CA 120.061 -0.656 . . . . 1.45 110.691 178.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1608 ' ' SER . . . . . 0.443 ' HB3' ' HB2' ' A' 1592 ' ' TYR . 41.4 t -107.61 122.84 47.51 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 114.949 -1.023 . . . . 1.1499999999999999 110.244 -176.021 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 22.5 t -104.79 98.51 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 108.618 -0.882 . . . . 0.25 108.618 176.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 80.2 mt -90.95 116.72 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.653 0 N-CA-C 107.693 -1.225 . . . . 0.45000000000000001 107.693 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 10.8 p -121.45 114.84 21.83 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 115.616 -0.72 . . . . 1.26 111.547 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1612 ' ' PHE . . . . . 0.765 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 65.9 m-85 -87.4 123.69 32.61 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 108.213 -1.032 . . . . 0.26000000000000001 108.213 175.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 46.9 t -114.24 134.15 58.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 116.182 -0.463 . . . . 0.5 109.987 -175.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1614 ' ' CYS . . . . . 0.467 ' HA ' ' HB2' ' A' 1646 ' ' CYS . 0.9 OUTLIER -50.94 111.24 0.52 Allowed 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.347 1.059 . . . . 0.77000000000000002 112.479 175.724 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A 1615 ' ' ARG . . . . . 0.555 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 30.1 tpt180 -134.44 91.31 22.45 Favored Pre-proline 0 N--CA 1.446 -0.668 0 C-N-CA 120.283 -0.567 . . . . 2.5299999999999998 109.933 173.468 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1616 ' ' PRO . . . . . 0.504 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 17.2 Cg_exo -66.76 -28.38 43.64 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.393 2.062 . . . . 1.1000000000000001 112.442 -179.145 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1617 ' ' GLU . . . . . 0.49 ' OE1' ' HD2' ' A' 1616 ' ' PRO . 17.9 mp0 -59.73 -39.81 85.96 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 123.928 0.891 . . . . 3.0499999999999998 110.638 178.465 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . 49.04 86.54 0.03 OUTLIER 'General case' 0 C--O 1.246 0.874 0 C-N-CA 124.44 1.096 . . . . 1.55 113.581 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . -118.23 -151.31 9.11 Favored Glycine 0 C--N 1.281 -2.499 0 N-CA-C 110.221 -1.152 . . . . 0.93000000000000005 110.221 178.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.97 10.25 0.91 Allowed 'Trans proline' 0 N--CA 1.486 1.054 0 C-N-CA 122.964 2.443 . . . . 0.88 114.166 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1621 ' ' THR . . . . . . . . . . . . . 14.5 p -100.68 6.93 44.14 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 122.012 0.91 . . . . 0.96999999999999997 110.435 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -85.06 65.28 9.15 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 106.67 -1.604 . . . . 0.71999999999999997 106.67 175.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -169.96 139.56 1.59 Allowed Pre-proline 0 N--CA 1.435 -1.195 0 C-N-CA 124.849 1.26 . . . . 3.2599999999999998 107.647 -177.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1624 ' ' PRO . . . . . 0.52 ' HA ' ' O ' ' A' 1639 ' ' SER . 50.6 Cg_endo -67.93 106.91 1.4 Allowed 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.885 2.39 . . . . 0.58999999999999997 112.327 -176.408 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 72.1 mtm -105.63 147.36 28.55 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 120.779 -0.368 . . . . 1.3700000000000001 110.885 178.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1626 ' ' LEU . . . . . 0.403 ' HG ' ' CE1' ' A' 1542 ' ' TYR . 1.9 tm? -82.55 118.16 23.07 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 106.727 -1.582 . . . . 0.89000000000000001 106.727 -178.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 42.9 mm -80.46 -54.08 11.38 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.783 0 N-CA-C 108.61 -0.885 . . . . 0.57999999999999996 108.61 178.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 34.4 t -164.9 159.14 17.94 Favored 'General case' 0 N--CA 1.411 -2.384 0 N-CA-C 107.287 -1.375 . . . . 1.3899999999999999 107.287 -177.163 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1629 ' ' LEU . . . . . 0.984 ' HG ' ' HG ' ' A' 1636 ' ' LEU . 1.6 tt -135.77 102.77 5.18 Favored 'General case' 0 N--CA 1.414 -2.252 0 N-CA-C 105.082 -2.192 . . . . 1.25 105.082 177.077 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 25.3 t70 -78.35 107.33 10.9 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.041 -1.466 . . . . 1.0900000000000001 107.041 175.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1631 ' ' LYS . . . . . 0.458 ' HG2' HD22 ' A' 1629 ' ' LEU . 37.2 mtmm -78.62 -5.35 52.66 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 113.213 0.82 . . . . 3.6000000000000001 113.213 -173.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 10.8 mm100 -89.67 -40.74 12.36 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 119.132 -1.027 . . . . 2.6000000000000001 108.503 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 74.4 p -89.77 -5.14 57.25 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 115.034 -0.985 . . . . 0.75 109.438 177.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1634 ' ' CYS . . . . . 0.428 ' SG ' HD23 ' A' 1604 ' ' LEU . 27.9 m 58.0 41.03 24.92 Favored 'General case' 0 C--N 1.362 1.138 0 C-N-CA 125.073 1.349 . . . . 0.53000000000000003 110.906 174.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1635 ' ' THR . . . . . . . . . . . . . 74.9 m -112.4 127.65 56.08 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 114.743 -1.117 . . . . 0.46000000000000002 110.523 -174.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1636 ' ' LEU . . . . . 0.984 ' HG ' ' HG ' ' A' 1629 ' ' LEU . 0.3 OUTLIER -113.77 131.97 56.02 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.485 -0.932 . . . . 0.85999999999999999 108.485 -176.634 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -111.62 129.27 56.13 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 116.692 -0.231 . . . . 0.45000000000000001 110.458 -178.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -126.77 132.39 51.08 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 116.054 -0.521 . . . . 0.5 109.733 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1639 ' ' SER . . . . . 0.52 ' O ' ' HA ' ' A' 1624 ' ' PRO . 22.8 t -115.43 152.95 31.96 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.326 -0.99 . . . . 1.04 108.326 178.212 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 3.1 t90 -151.2 111.12 4.07 Favored 'General case' 0 N--CA 1.414 -2.256 0 N-CA-C 104.205 -2.517 . . . . 0.68000000000000005 104.205 -177.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1641 ' ' HIS . . . . . 0.555 ' HB3' ' HB2' ' A' 1615 ' ' ARG . 42.7 m-70 -97.9 110.27 22.87 Favored 'General case' 0 C--N 1.293 -1.873 0 C-N-CA 120.097 -0.641 . . . . 0.90000000000000002 109.365 -177.28 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1642 ' ' THR . . . . . . . . . . . . . 4.6 t -142.63 146.94 40.46 Favored Pre-proline 0 C--N 1.296 -1.719 0 CA-C-N 115.158 -0.928 . . . . 0.47999999999999998 110.123 -172.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1643 ' ' PRO . . . . . 0.504 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 37.6 Cg_endo -79.68 -11.11 14.22 Favored 'Trans proline' 0 C--N 1.368 1.565 0 C-N-CA 121.991 1.794 . . . . 0.66000000000000003 112.874 177.348 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 7.1 tt -68.37 -29.93 68.75 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 122.295 1.045 . . . . 0.96999999999999997 108.199 178.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -97.06 20.87 10.59 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 114.167 -1.379 . . . . 0.83999999999999997 109.405 -177.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1646 ' ' CYS . . . . . 0.467 ' HB2' ' HA ' ' A' 1614 ' ' CYS . 49.6 t -122.1 158.32 29.53 Favored 'General case' 0 N--CA 1.42 -1.957 0 CA-C-N 115.967 -0.561 . . . . 1.1899999999999999 109.601 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -115.21 117.88 40.67 Favored Pre-proline 0 C--N 1.299 -1.624 0 N-CA-C 105.753 -1.943 . . . . 3.1400000000000001 105.753 175.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1648 ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.28 96.82 0.65 Allowed 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.394 2.063 . . . . 2.5800000000000001 112.784 -175.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 43.6 tt0 . . . . . 0 C--O 1.257 1.458 0 N-CA-C 108.316 -0.994 . . . . 4.7199999999999998 108.316 177.207 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.621 0 N-CA-C 109.668 -0.493 . . . . 9.9700000000000006 109.668 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 2' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -96.89 128.02 43.44 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 109.016 -0.735 . . . . 7.6799999999999997 109.016 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 3' ' ' ARG . . . . . 0.528 ' HD2' HD21 ' B' ' 8' ' ' LEU . 38.2 ptt180 -98.51 142.33 24.4 Favored Pre-proline 0 C--N 1.296 -1.753 0 N-CA-C 108.864 -0.791 . . . . 6.1100000000000003 108.864 -178.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -51.15 -27.03 21.07 Favored 'Trans proline' 0 C--N 1.365 1.395 0 C-N-CA 124.763 3.642 . . . . 4.8399999999999999 115.386 -174.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 62.5 m -126.96 115.43 19.24 Favored 'General case' 0 N--CA 1.426 -1.662 0 N-CA-C 108.47 -0.937 . . . . 4.5999999999999996 108.47 174.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -63.33 -32.34 73.74 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 107.991 -1.114 . . . . 4.2300000000000004 107.991 176.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 13.7 p -111.31 99.46 8.26 Favored 'General case' 0 N--CA 1.41 -2.446 0 CA-C-N 114.505 -1.225 . . . . 3.1400000000000001 108.712 176.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.528 HD21 ' HD2' ' B' ' 3' ' ' ARG . 86.6 mt -60.72 141.34 56.98 Favored 'General case' 0 C--O 1.246 0.917 0 N-CA-C 110.229 -0.286 . . . . 3.96 110.229 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 5.4 m -76.41 22.36 0.17 Allowed 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.434 0.901 . . . . 2.8399999999999999 113.434 -169.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -156.7 -60.99 0.01 OUTLIER Glycine 0 N--CA 1.434 -1.455 0 C-N-CA 120.771 -0.728 . . . . 2.0899999999999999 111.499 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.34 -68.28 1.72 Allowed Glycine 0 N--CA 1.445 -0.716 0 O-C-N 123.923 0.425 . . . . 1.8400000000000001 113.204 -178.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 12' ' ' GLU . . . . . 0.486 ' HG2' ' HB2' ' B' ' 8' ' ' LEU . 4.7 mm-40 -61.24 -32.75 72.55 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.176 -0.676 . . . . 2.5499999999999998 109.176 -178.168 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 13' ' ' LEU . . . . . 0.415 ' O ' HD23 ' B' ' 17' ' ' LEU . 0.1 OUTLIER -53.34 -66.53 0.37 Allowed 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 114.761 -1.109 . . . . 2.3500000000000001 109.245 -179.559 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 18.9 m -75.21 -16.7 15.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 C-N-CA 119.384 -0.927 . . . . 2.1099999999999999 110.701 -177.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 15' ' ' ASP . . . . . 0.4 ' OD1' ' HB3' ' A' 1569 ' ' GLN . 12.0 t70 -73.27 -49.72 26.16 Favored 'General case' 0 C--O 1.184 -2.368 0 C-N-CA 118.844 -1.142 . . . . 2.04 112.497 179.271 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 21.9 p -56.15 -44.83 79.64 Favored 'General case' 0 C--O 1.263 1.778 0 CA-C-N 118.693 0.679 . . . . 1.8400000000000001 109.628 176.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.563 ' HB3' ' CB ' ' B' ' 26' ' ' PHE . 4.1 mm? -50.37 -55.1 17.12 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 114.344 -1.298 . . . . 1.74 112.346 172.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -77.46 -21.91 52.17 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.23 0.538 . . . . 2.3900000000000001 111.996 -178.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -55.55 -52.67 62.95 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 124.034 0.934 . . . . 0.95999999999999996 110.777 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 12.9 p -98.56 -24.07 4.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 C-N-CA 118.272 -1.371 . . . . 1.3700000000000001 112.365 -178.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 34.5 m -104.56 19.64 20.01 Favored 'General case' 0 C--N 1.309 -1.166 0 O-C-N 121.871 -0.518 . . . . 1.6599999999999999 111.935 -174.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -49.17 -34.19 16.71 Favored Glycine 0 N--CA 1.469 0.875 0 N-CA-C 116.852 1.501 . . . . 1.53 116.852 -175.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -74.99 -34.47 61.97 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 117.773 0.787 . . . . 2.7200000000000002 112.641 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 20.6 tpp180 -93.1 -39.47 11.04 Favored 'General case' 0 C--N 1.314 -0.949 0 O-C-N 122.064 -0.398 . . . . 4.3300000000000001 111.195 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.94 -168.17 13.26 Favored Glycine 0 N--CA 1.433 -1.534 0 N-CA-C 109.078 -1.609 . . . . 1.53 109.078 -177.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 26' ' ' PHE . . . . . 0.563 ' CB ' ' HB3' ' B' ' 17' ' ' LEU . 18.0 p90 -129.73 128.6 42.81 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 117.69 0.745 . . . . 1.6499999999999999 111.098 179.245 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -142.02 129.33 21.12 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 109.491 -0.559 . . . . 3.4199999999999999 109.491 -176.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 28' ' ' PHE . . . . . 0.702 ' HD2' ' H ' ' B' ' 41' ' ' GLY . 6.7 p90 -140.06 42.92 1.94 Allowed 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.283 -1.377 . . . . 2.2599999999999998 107.283 -177.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 6.0 m -67.72 106.86 2.37 Favored 'General case' 0 N--CA 1.42 -1.959 0 CA-C-N 113.104 -1.862 . . . . 3.6800000000000002 113.02 -172.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 30' ' ' ARG . . . . . 0.72 ' O ' ' HA ' ' B' ' 39' ' ' SER . 3.1 mmp_? -113.19 114.36 48.45 Favored Pre-proline 0 C--N 1.308 -1.232 0 N-CA-C 105.449 -2.056 . . . . 3.8100000000000001 105.449 170.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -54.97 -33.28 82.23 Favored 'Trans proline' 0 C--O 1.243 0.764 0 C-N-CA 123.762 2.974 . . . . 4.0199999999999996 113.909 -171.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . 69.13 -78.52 0.04 OUTLIER 'General case' 0 N--CA 1.433 -1.283 0 C-N-CA 125.427 1.491 . . . . 4.9199999999999999 112.092 176.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 33' ' ' SER . . . . . 0.469 ' HB3' ' OG ' ' B' ' 36' ' ' SER . 31.0 t -177.16 166.34 2.36 Favored 'General case' 0 N--CA 1.398 -3.033 0 N-CA-C 104.816 -2.29 . . . . 6.7199999999999998 104.816 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 39.5 ttt180 -99.35 7.08 45.88 Favored 'General case' 0 C--N 1.284 -2.268 0 CA-C-O 122.361 1.076 . . . . 11.630000000000001 108.307 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 39.1 t -106.61 -13.56 9.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 107.09 -1.448 . . . . 9.6099999999999994 107.09 175.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 36' ' ' SER . . . . . 0.469 ' OG ' ' HB3' ' B' ' 33' ' ' SER . 5.3 p -144.76 67.4 1.25 Allowed 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 113.777 -1.556 . . . . 6.71 107.228 178.024 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -49.44 11.72 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 129.513 3.125 . . . . 10.0 117.834 -172.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 28.1 mtm180 -76.78 85.21 3.38 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-N 119.109 0.868 . . . . 7.9400000000000004 110.967 -170.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 39' ' ' SER . . . . . 0.72 ' HA ' ' O ' ' B' ' 30' ' ' ARG . 33.9 p -77.15 61.66 2.1 Favored 'General case' 0 C--O 1.249 1.054 0 CA-C-O 122.803 1.287 . . . . 5.7599999999999998 111.751 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 40' ' ' ARG . . . . . 0.457 ' HB2' ' HE2' ' B' ' 28' ' ' PHE . 36.0 ptt180 -148.23 162.34 39.67 Favored 'General case' 0 C--N 1.285 -2.226 0 CA-C-N 113.85 -1.523 . . . . 6.0300000000000002 109.27 -175.229 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 41' ' ' GLY . . . . . 0.702 ' H ' ' HD2' ' B' ' 28' ' ' PHE . . . -161.53 178.01 37.6 Favored Glycine 0 N--CA 1.424 -2.131 0 N-CA-C 108.288 -1.925 . . . . 2.3700000000000001 108.288 -175.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 42' ' ' ILE . . . . . 0.506 ' HB ' HD21 ' B' ' 55' ' ' LEU . 15.0 pt 55.05 8.26 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.42 0 C-N-CA 126.906 2.082 . . . . 2.0699999999999998 112.578 -177.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.491 ' O ' ' HB2' ' B' ' 47' ' ' CYS . 9.0 p -80.25 -35.48 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.312 0 CA-C-N 114.796 -1.093 . . . . 2.2400000000000002 111.95 -173.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -84.63 -38.37 19.94 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 106.593 -1.632 . . . . 3.3599999999999999 106.593 177.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -64.97 -19.38 65.95 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 113.886 -1.506 . . . . 3.0800000000000001 111.798 -177.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 46' ' ' CYS . . . . . . . . . . . . . 41.9 t -118.06 -0.21 11.68 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 119.779 -0.769 . . . . 2.23 110.888 175.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 47' ' ' CYS . . . . . 0.491 ' HB2' ' O ' ' B' ' 43' ' ' VAL . 51.9 t -83.91 -60.05 2.23 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 121.941 -0.474 . . . . 2.3700000000000001 111.998 177.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -96.48 4.24 52.23 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-O 121.228 0.537 . . . . 2.8199999999999998 110.222 -175.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 8.2 mmt180 -130.29 161.78 30.47 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 105.294 -2.113 . . . . 4.0899999999999999 105.294 -176.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 9.3 t -97.32 115.48 27.75 Favored 'General case' 0 C--N 1.278 -2.505 0 N-CA-C 105.086 -2.19 . . . . 2.6699999999999999 105.086 174.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 31.9 p -88.89 137.48 32.28 Favored 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 109.294 -0.632 . . . . 2.1099999999999999 109.294 -172.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -85.09 146.87 26.93 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 107.855 -1.165 . . . . 2.6699999999999999 107.855 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -62.23 -22.52 66.02 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.058 -0.974 . . . . 1.8999999999999999 112.508 -174.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.75 -38.19 69.5 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.19 0.519 . . . . 1.52 109.969 178.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 55' ' ' LEU . . . . . 0.506 HD21 ' HB ' ' B' ' 42' ' ' ILE . 34.6 tp -54.66 -63.4 1.16 Allowed 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 114.371 -1.286 . . . . 1.97 111.576 179.319 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 56' ' ' LEU . . . . . 0.423 HD13 ' N ' ' B' ' 57' ' ' GLU . 0.0 OUTLIER -75.09 -27.37 59.87 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 120.267 -0.573 . . . . 1.53 111.656 -176.341 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 57' ' ' GLU . . . . . 0.423 ' N ' HD13 ' B' ' 56' ' ' LEU . 11.6 tp10 -59.93 -44.91 94.06 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 109.912 -0.403 . . . . 2.27 109.912 177.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 11.7 t -80.48 -10.81 59.73 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 120.419 -0.512 . . . . 2.3300000000000001 110.752 177.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 59' ' ' TYR . . . . . 0.537 ' HE1' ' HA ' ' B' ' 28' ' ' PHE . 1.1 t80 -94.72 -70.77 0.69 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 119.504 -0.878 . . . . 2.8599999999999999 108.865 -178.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 54.0 t 56.11 -94.04 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.209 0 C-N-CA 125.809 1.644 . . . . 2.2999999999999998 114.955 177.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -165.4 163.61 19.74 Favored 'General case' 0 N--CA 1.423 -1.792 0 N-CA-C 107.973 -1.121 . . . . 3.1899999999999999 107.973 -173.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 8.5 p -142.34 138.64 16.72 Favored Pre-proline 0 C--N 1.29 -1.988 0 N-CA-C 107.609 -1.256 . . . . 3.6800000000000002 107.609 177.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -74.77 -18.67 19.15 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.814 2.343 . . . . 5.0800000000000001 113.638 -177.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -126.5 62.77 1.28 Allowed 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 116.405 -0.361 . . . . 5.0999999999999996 111.333 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 61.4 tttp 67.38 148.77 0.05 Allowed 'General case' 0 CA--C 1.559 1.309 0 C-N-CA 124.974 1.31 . . . . 8.5099999999999998 112.501 176.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 13.4 m -103.55 103.12 13.03 Favored 'General case' 0 C--N 1.313 -0.986 0 O-C-N 121.183 -0.948 . . . . 8.1199999999999992 111.698 -177.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 . . . . . 0 C--N 1.307 -1.252 0 N-CA-C 107.852 -1.166 . . . . 10.210000000000001 107.852 173.32 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 49.8 ttm . . . . . 0 C--O 1.237 0.4 0 N-CA-C 109.075 -0.713 . . . . 9.3399999999999999 109.075 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 86.6 tttt -157.8 88.2 0.97 Allowed 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 108.082 -1.081 . . . . 9.0399999999999991 108.082 179.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 49.5 m -160.27 -35.86 0.05 Allowed 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 121.39 0.614 . . . . 5.8099999999999996 111.516 -178.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1511 ' ' ASN . . . . . 0.539 ' HB3' ' HA ' ' A' 1582 ' ' ARG . 15.6 m120 -127.9 60.25 1.46 Allowed 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 121.263 0.554 . . . . 3.4199999999999999 110.233 -172.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1512 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.75 142.02 20.53 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.729 -0.669 . . . . 5.9500000000000002 109.955 178.357 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 20.0 t-80 -179.28 -49.4 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.229 0 O-C-N 124.402 1.064 . . . . 5.3300000000000001 109.415 -176.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 7.5 t70 -141.4 177.52 8.06 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 107.939 -1.134 . . . . 5.0599999999999996 107.939 -176.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 17.0 t70 -79.82 87.2 5.3 Favored 'General case' 0 C--N 1.289 -2.037 0 C-N-CA 125.341 1.457 . . . . 2.8999999999999999 110.134 -175.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1516 ' ' CYS . . . . . 0.708 ' HA ' ' HB2' ' A' 1581 ' ' LEU . 91.6 m 64.21 46.93 3.39 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 115.057 1.503 . . . . 1.1899999999999999 115.057 175.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -150.1 129.88 13.28 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 107.122 -1.436 . . . . 1.52 107.122 172.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1518 ' ' VAL . . . . . 0.688 HG21 ' HB2' ' A' 1583 ' ' TYR . 5.3 m -131.12 140.52 48.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 CA-C-O 121.249 0.547 . . . . 0.93999999999999995 111.542 -174.305 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1519 ' ' THR . . . . . . . . . . . . . 20.5 m -108.44 140.58 41.54 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 115.452 -0.795 . . . . 0.89000000000000001 109.064 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1520 ' ' ASN . . . . . 0.663 HD22 ' HE2' ' A' 1583 ' ' TYR . 25.9 t-20 -93.62 114.59 63.38 Favored Pre-proline 0 C--N 1.305 -1.347 0 N-CA-C 107.876 -1.157 . . . . 1.74 107.876 172.054 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -63.94 -21.3 68.74 Favored 'Trans proline' 0 N--CA 1.477 0.536 0 C-N-CA 123.208 2.605 . . . . 1.5800000000000001 114.032 -174.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 14.2 m -75.56 -41.54 54.53 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-O 120.646 0.26 . . . . 1.6499999999999999 111.498 -177.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1523 ' ' THR . . . . . 0.521 HG22 ' OD1' ' A' 1520 ' ' ASN . 2.7 t -107.94 -20.57 13.14 Favored 'General case' 0 CA--C 1.561 1.391 0 CA-C-O 121.345 0.593 . . . . 1.6100000000000001 111.96 -178.156 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 83.1 22.51 57.2 Favored Glycine 0 CA--C 1.505 -0.533 0 O-C-N 122.092 -0.38 . . . . 1.1299999999999999 113.482 175.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 55.1 t-80 -95.36 132.82 39.98 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 120.981 0.42 . . . . 1.26 110.114 -178.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 2.7 tm? -101.47 116.38 32.65 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 114.902 -1.045 . . . . 0.68000000000000005 109.51 -177.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -87.35 118.12 26.58 Favored 'General case' 0 C--N 1.318 -0.804 0 O-C-N 122.068 -0.395 . . . . 0.65000000000000002 111.108 173.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 8.7 t70 -98.01 113.67 25.59 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 108.27 -1.011 . . . . 1.1699999999999999 108.27 176.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1529 ' ' LEU . . . . . 0.715 ' HG ' HD21 ' A' 1581 ' ' LEU . 3.5 mm? -101.87 -6.7 23.23 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 121.111 0.481 . . . . 0.59999999999999998 110.051 177.48 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 6.1 m -62.63 -22.15 66.21 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.498 -0.774 . . . . 0.83999999999999997 112.45 -177.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 16.2 t -66.12 -32.53 74.03 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 121.317 0.58 . . . . 1.5900000000000001 110.036 177.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 7.9 mt -89.03 -7.62 55.57 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.253 -0.647 . . . . 0.65000000000000002 109.253 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1533 ' ' SER . . . . . 0.437 ' HA ' ' HB ' ' A' 1552 ' ' ILE . 24.5 t -76.99 176.28 8.79 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.379 -0.6 . . . . 1.52 109.379 179.153 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . 152.71 174.77 23.51 Favored Glycine 0 N--CA 1.422 -2.24 0 N-CA-C 110.193 -1.163 . . . . 1.1000000000000001 110.193 -177.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 33.2 ttm180 -92.31 -29.73 16.21 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 121.161 0.505 . . . . 4.6200000000000001 110.095 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -76.55 -53.08 8.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.206 0.527 . . . . 1.45 110.96 -178.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 93.83 -150.16 19.73 Favored Glycine 0 N--CA 1.425 -2.067 0 C-N-CA 120.624 -0.798 . . . . 0.84999999999999998 111.883 177.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -136.8 151.49 49.23 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.377 -0.971 . . . . 0.93000000000000005 108.377 -177.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 17.7 p -112.81 139.55 48.34 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 116.266 -0.424 . . . . 1.03 109.952 177.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1540 ' ' ALA . . . . . 0.462 ' HB3' ' CG1' ' A' 1548 ' ' VAL . . . -125.25 143.41 50.96 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 107.943 -1.132 . . . . 0.5 107.943 172.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -84.67 151.94 24.12 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 108.552 -0.907 . . . . 0.73999999999999999 108.552 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1542 ' ' TYR . . . . . 0.703 ' HE2' ' HG ' ' A' 1626 ' ' LEU . 1.8 t80 -162.95 -100.74 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 121.62 0.724 . . . . 0.98999999999999999 109.914 -174.274 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1543 ' ' SER . . . . . 0.466 ' H ' ' HB3' ' A' 1542 ' ' TYR . 31.2 t -73.93 159.41 32.81 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 124.568 1.147 . . . . 1.9099999999999999 110.404 -173.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 13.2 tppt? -74.98 -3.71 33.9 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 109.329 -0.619 . . . . 3.5899999999999999 109.329 178.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1545 ' ' SER . . . . . 0.46 ' HB2' ' HG2' ' B' ' 18' ' ' GLN . 15.3 t -77.62 -43.3 31.97 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 108.884 -0.784 . . . . 2.46 108.884 176.137 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 165.72 -148.84 14.45 Favored Glycine 0 N--CA 1.41 -3.066 0 N-CA-C 110.872 -0.891 . . . . 1.26 110.872 -175.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 34.6 m -109.11 179.41 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.281 2.761 0 CA-C-O 122.118 0.961 . . . . 0.79000000000000004 111.975 -172.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1548 ' ' VAL . . . . . 0.868 ' HB ' ' CE1' ' A' 1567 ' ' PHE . 7.8 p -112.01 130.85 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.941 0 CA-C-N 113.193 -1.821 . . . . 0.57999999999999996 108.362 173.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -95.06 134.81 37.35 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.938 -1.134 . . . . 1.0800000000000001 107.938 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 24.1 ptm -150.93 118.73 6.17 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 121.767 0.794 . . . . 0.78000000000000003 111.337 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 5.4 p -112.4 118.31 34.85 Favored 'General case' 0 C--N 1.28 -2.428 0 CA-C-N 114.507 -1.224 . . . . 0.96999999999999997 109.973 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1552 ' ' ILE . . . . . 0.437 ' HB ' ' HA ' ' A' 1533 ' ' SER . 46.0 mm -71.95 114.63 10.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.503 -0.317 . . . . 0.41999999999999998 110.585 -178.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 72.0 m 60.9 29.43 19.01 Favored 'General case' 0 CA--C 1.511 -0.533 0 C-N-CA 124.532 1.133 . . . . 1.3999999999999999 113.401 175.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . -161.04 177.75 37.28 Favored Glycine 0 N--CA 1.417 -2.601 0 N-CA-C 109.412 -1.475 . . . . 0.34999999999999998 109.412 -179.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -107.97 140.73 40.68 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-O 121.127 0.489 . . . . 1.6200000000000001 111.684 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -87.21 140.5 29.48 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 107.426 -1.324 . . . . 0.87 107.426 178.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -94.41 3.45 55.16 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 113.587 0.958 . . . . 2.4900000000000002 113.587 -173.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -88.62 -4.65 58.52 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 121.552 0.692 . . . . 1.3799999999999999 110.575 -178.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1559 ' ' CYS . . . . . 0.625 ' SG ' ' HD2' ' A' 1560 ' ' PRO . 20.2 t -136.31 157.48 75.39 Favored Pre-proline 0 C--N 1.298 -1.633 0 N-CA-C 106.229 -1.767 . . . . 1.21 106.229 -178.059 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1560 ' ' PRO . . . . . 0.632 ' HD2' ' HB3' ' A' 1571 ' ' ARG . 31.6 Cg_exo -29.05 134.77 0.04 OUTLIER 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 125.104 3.869 . . . . 0.70999999999999996 115.428 177.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1561 ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' 1560 ' ' PRO . 86.1 Cg_exo -49.13 124.44 11.62 Favored 'Trans proline' 0 C--O 1.247 0.948 0 C-N-CA 124.176 3.251 . . . . 0.80000000000000004 112.792 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 101.76 7.32 48.1 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 116.004 -0.544 . . . . 0.46000000000000002 113.302 -177.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1563 ' ' VAL . . . . . 0.608 HG11 ' HB2' ' A' 1566 ' ' CYS . 2.3 t -85.93 124.56 40.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 112.185 0.439 . . . . 0.97999999999999998 112.185 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -97.71 -37.61 4.42 Favored Glycine 0 C--N 1.31 -0.916 0 N-CA-C 110.702 -0.959 . . . . 0.28000000000000003 110.702 174.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -130.25 137.3 49.94 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.021 -0.733 . . . . 0.28000000000000003 109.021 177.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1566 ' ' CYS . . . . . 0.608 ' HB2' HG11 ' A' 1563 ' ' VAL . 42.4 t -156.96 135.29 11.3 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 121.243 -0.183 . . . . 0.42999999999999999 111.201 -177.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1567 ' ' PHE . . . . . 0.868 ' CE1' ' HB ' ' A' 1548 ' ' VAL . 9.5 m-85 -112.9 163.76 14.25 Favored 'General case' 0 C--O 1.245 0.857 0 C-N-CA 123.308 0.643 . . . . 1.03 110.491 173.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . 94.31 169.53 37.61 Favored Glycine 0 N--CA 1.399 -3.831 0 C-N-CA 118.831 -1.652 . . . . 1.1299999999999999 114.324 164.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 10.5 mm100 -89.6 -30.14 18.37 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 114.242 -0.979 . . . . 2.5800000000000001 108.985 177.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 66.3 p -85.09 2.65 42.49 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.555 -0.748 . . . . 2.1699999999999999 112.74 -177.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1571 ' ' ARG . . . . . 0.632 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 2.2 mpt_? 67.6 69.07 0.36 Allowed 'General case' 0 C--N 1.348 0.518 0 CA-C-N 114.704 -1.134 . . . . 2.6200000000000001 110.831 175.197 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 32.0 mt -96.59 106.02 17.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-N 115.582 -0.735 . . . . 0.92000000000000004 109.727 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 30.9 t -66.81 130.07 41.97 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-N 114.732 -1.122 . . . . 0.80000000000000004 110.379 -177.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1574 ' ' VAL . . . . . 0.6 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 34.4 m -123.55 20.92 4.56 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.336 0 CA-C-O 121.535 0.683 . . . . 0.97999999999999998 110.607 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 169.43 124.17 0.72 Allowed Glycine 0 N--CA 1.418 -2.546 0 CA-C-N 114.915 -1.039 . . . . 0.28999999999999998 111.329 176.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -75.53 141.94 42.9 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.079 -0.711 . . . . 2.1899999999999999 109.079 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -69.9 84.19 0.49 Allowed 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 123.404 0.681 . . . . 0.60999999999999999 112.708 -177.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -93.68 168.18 11.18 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 115.569 -0.741 . . . . 1.95 109.346 176.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 55.1 mttm -129.31 41.92 3.38 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.519 -0.919 . . . . 2.6800000000000002 108.519 -176.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 46.4 ttm-85 -105.98 77.65 1.26 Allowed 'General case' 0 N--CA 1.403 -2.786 0 CA-C-N 115.314 -0.857 . . . . 3.4700000000000002 109.841 -175.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1581 ' ' LEU . . . . . 0.715 HD21 ' HG ' ' A' 1529 ' ' LEU . 1.2 tm? -65.47 124.97 23.69 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 113.798 -1.546 . . . . 0.64000000000000001 107.49 175.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1582 ' ' ARG . . . . . 0.539 ' HA ' ' HB3' ' A' 1511 ' ' ASN . 63.9 mtp180 -118.54 141.0 49.01 Favored 'General case' 0 C--N 1.289 -2.048 0 C-N-CA 120.853 -0.339 . . . . 2.8500000000000001 110.706 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1583 ' ' TYR . . . . . 0.688 ' HB2' HG21 ' A' 1518 ' ' VAL . 64.0 t80 -120.01 109.01 14.99 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 109.249 -0.648 . . . . 0.85999999999999999 109.249 -179.217 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1584 ' ' VAL . . . . . 0.501 ' O ' ' HB ' ' A' 1587 ' ' VAL . 9.4 m -128.7 94.9 2.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-N 115.8 -0.636 . . . . 1.05 111.752 -179.08 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 12.3 t70 56.53 60.91 2.88 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 123.851 0.86 . . . . 1.1699999999999999 110.714 176.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1586 ' ' GLN . . . . . 0.427 ' HA ' ' HE1' ' A' 1583 ' ' TYR 0.313 10.0 pt20 65.24 12.08 7.75 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 126.828 2.051 . . . . 1.8600000000000001 113.147 178.972 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A 1587 ' ' VAL . . . . . 0.501 ' HB ' ' O ' ' A' 1584 ' ' VAL . 39.6 t -101.78 120.07 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.95 0 N-CA-C 107.588 -1.264 . . . . 0.48999999999999999 107.588 174.077 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1588 ' ' LEU . . . . . 0.731 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 2.9 mm? -96.82 110.35 22.85 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 106.009 -1.848 . . . . 0.35999999999999999 106.009 177.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1589 ' ' GLN . . . . . 0.43 ' HA ' ' O ' ' A' 1610 ' ' ILE . 28.5 tt0 -125.48 132.16 52.71 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-O 121.672 0.748 . . . . 1.74 112.767 -171.48 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 11.7 mt -115.1 128.31 56.14 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 107.27 -1.381 . . . . 0.71999999999999997 107.27 175.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 59.3 t -119.03 118.9 59.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 C-N-CA 119.66 -0.816 . . . . 1.01 110.511 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1592 ' ' TYR . . . . . 0.47 ' O ' ' HA ' ' A' 1607 ' ' LYS . 16.8 m-30 -106.18 95.2 5.61 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 115.65 -0.705 . . . . 0.5 109.104 -179.003 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1593 ' ' LYS . . . . . 0.535 ' HB3' ' HD3' ' A' 1607 ' ' LYS . 0.0 OUTLIER -109.28 163.07 13.71 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 116.685 -0.234 . . . . 1.5900000000000001 111.332 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 6.4 m-20 66.12 55.84 0.87 Allowed 'General case' 0 C--N 1.318 -0.787 0 O-C-N 124.472 1.108 . . . . 1.1100000000000001 112.003 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -83.55 -107.27 0.53 Allowed Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 110.029 -1.228 . . . . 0.78000000000000003 110.029 174.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1596 ' ' SER . . . . . . . . . . . . . 85.8 p -102.41 148.82 36.0 Favored Pre-proline 0 C--O 1.261 1.7 0 N-CA-C 108.847 -0.797 . . . . 1.0700000000000001 108.847 175.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1597 ' ' PRO . . . . . 0.545 ' HB2' ' HG2' ' B' ' 6' ' ' GLU . 31.6 Cg_exo -63.66 122.8 11.02 Favored 'Trans proline' 0 N--CA 1.446 -1.269 0 C-N-CA 122.751 2.3 . . . . 1.01 108.998 174.367 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 17.0 t -78.83 110.46 14.42 Favored Pre-proline 0 C--N 1.301 -1.534 0 N-CA-C 108.621 -0.881 . . . . 0.75 108.621 -172.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1599 ' ' PRO . . . . . 0.58 ' HB2' HD22 ' B' ' 8' ' ' LEU . 37.1 Cg_endo -67.07 -12.22 35.23 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 122.843 2.362 . . . . 1.7 112.839 -173.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1600 ' ' SER . . . . . 0.806 ' HB3' ' HB2' ' B' ' 53' ' ' LEU . 18.0 m -61.56 -31.06 71.08 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.929 0.891 . . . . 2.2599999999999998 111.907 178.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1601 ' ' LYS . . . . . 0.584 ' HB3' HD22 ' A' 1604 ' ' LEU . 41.0 ttmt -161.06 122.0 2.85 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 107.445 -1.317 . . . . 3.0099999999999998 107.445 176.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 15.1 m -59.05 131.26 50.51 Favored 'General case' 0 N--CA 1.424 -1.73 0 C-N-CA 123.028 0.531 . . . . 2.0699999999999998 111.39 -176.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 105.37 -3.96 40.4 Favored Glycine 0 C--N 1.309 -0.951 0 CA-C-N 116.258 -0.428 . . . . 1.0800000000000001 112.768 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1604 ' ' LEU . . . . . 0.584 HD22 ' HB3' ' A' 1601 ' ' LYS . 10.3 mp -100.45 157.77 16.4 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 122.462 -0.434 . . . . 1.8400000000000001 111.551 -178.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 33.8 m -146.88 143.93 28.91 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 108.312 -0.996 . . . . 1.4099999999999999 108.312 175.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1606 ' ' TYR . . . . . 0.6 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 76.1 m-85 -69.53 151.63 45.77 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 116.334 -0.394 . . . . 0.59999999999999998 110.928 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1607 ' ' LYS . . . . . 0.535 ' HD3' ' HB3' ' A' 1593 ' ' LYS . 36.6 ttpt -150.95 130.33 12.87 Favored 'General case' 0 N--CA 1.441 -0.878 0 O-C-N 124.007 0.817 . . . . 1.45 109.824 -175.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1608 ' ' SER . . . . . 0.465 ' HB3' ' HB2' ' A' 1592 ' ' TYR . 37.3 t -105.38 120.11 40.76 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 108.939 -0.763 . . . . 1.1499999999999999 108.939 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 22.8 t -105.32 107.3 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 N-CA-C 107.831 -1.174 . . . . 0.25 107.831 177.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1610 ' ' ILE . . . . . 0.43 ' O ' ' HA ' ' A' 1589 ' ' GLN . 64.3 mt -101.91 111.73 32.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 CA-C-N 115.676 -0.693 . . . . 0.45000000000000001 110.046 -176.326 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 21.4 p -111.64 117.84 34.03 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.928 -0.578 . . . . 1.26 112.153 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1612 ' ' PHE . . . . . 0.731 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 78.0 m-85 -93.08 124.34 36.99 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.19 -1.041 . . . . 0.26000000000000001 108.19 177.046 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 49.1 t -118.74 137.23 53.39 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 116.544 -0.298 . . . . 0.5 110.984 -175.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 3.5 t -59.69 103.0 0.17 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.668 1.187 . . . . 0.77000000000000002 112.633 177.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1615 ' ' ARG . . . . . 0.541 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 20.8 mmt180 -138.49 112.58 8.53 Favored Pre-proline 0 C--N 1.32 -0.693 0 O-C-N 122.369 -0.207 . . . . 2.5299999999999998 111.224 171.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1616 ' ' PRO . . . . . 0.601 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 37.3 Cg_endo -74.06 -1.71 11.27 Favored 'Trans proline' 0 N--CA 1.489 1.213 0 C-N-CA 122.902 2.401 . . . . 1.1000000000000001 113.213 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -89.5 41.7 1.05 Allowed 'General case' 0 C--N 1.291 -1.959 0 C-N-CA 124.936 1.294 . . . . 3.0499999999999998 110.83 -177.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -41.54 123.79 2.28 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.86 1.664 . . . . 1.55 112.647 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1619 ' ' GLY . . . . . 0.438 ' HA3' ' HD2' ' A' 1620 ' ' PRO . . . 171.03 -135.8 3.65 Favored Glycine 0 CA--C 1.48 -2.151 0 N-CA-C 110.13 -1.188 . . . . 0.93000000000000005 110.13 -177.347 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1620 ' ' PRO . . . . . 0.438 ' HD2' ' HA3' ' A' 1619 ' ' GLY . 35.1 Cg_endo -64.12 -2.46 4.76 Favored 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 123.342 2.695 . . . . 0.88 115.231 -177.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1621 ' ' THR . . . . . 0.663 ' HB ' ' HB2' ' A' 1641 ' ' HIS . 13.0 p -98.82 -11.4 21.82 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 121.728 0.775 . . . . 0.96999999999999997 109.677 178.226 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 48.0 t30 -93.48 64.9 3.7 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 122.457 1.122 . . . . 0.71999999999999997 108.333 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -166.97 140.47 3.05 Favored Pre-proline 0 C--N 1.3 -1.55 0 N-CA-C 106.422 -1.695 . . . . 3.2599999999999998 106.422 -178.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -59.45 110.26 0.69 Allowed 'Trans proline' 0 C--O 1.243 0.766 0 C-N-CA 122.56 2.174 . . . . 0.58999999999999997 111.527 -178.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 74.9 mtm -110.14 141.77 42.57 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 116.078 -0.51 . . . . 1.3700000000000001 110.066 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1626 ' ' LEU . . . . . 0.703 ' HG ' ' HE2' ' A' 1542 ' ' TYR . 1.4 tm? -86.2 119.06 26.08 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 108.141 -1.059 . . . . 0.89000000000000001 108.141 -176.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1627 ' ' ILE . . . . . 0.66 HD11 ' HB2' ' A' 1639 ' ' SER . 44.5 mm -79.69 -55.42 9.2 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 CA-C-O 121.513 0.673 . . . . 0.57999999999999996 109.434 178.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 22.6 t -163.72 148.41 10.62 Favored 'General case' 0 N--CA 1.419 -2.01 0 N-CA-C 107.969 -1.123 . . . . 1.3899999999999999 107.969 -176.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1629 ' ' LEU . . . . . 0.76 HD13 ' HG ' ' A' 1636 ' ' LEU . 50.3 tp -116.91 105.43 12.33 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.662 -0.866 . . . . 1.25 108.662 176.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 12.5 t70 -84.32 106.24 15.78 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.015 -1.476 . . . . 1.0900000000000001 107.015 176.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1631 ' ' LYS . . . . . 0.409 ' HE3' ' HB3' ' A' 1631 ' ' LYS . 14.4 mmmt -85.74 -3.43 58.89 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 112.86 0.689 . . . . 3.6000000000000001 112.86 -175.533 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -87.69 -33.63 18.69 Favored 'General case' 0 N--CA 1.421 -1.888 0 O-C-N 123.43 0.456 . . . . 2.6000000000000001 109.804 -177.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 40.3 p -102.37 -16.34 16.25 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.096 0.474 . . . . 0.75 110.29 173.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1634 ' ' CYS . . . . . 0.471 ' O ' ' HA ' ' A' 1606 ' ' TYR . 60.2 m 72.56 37.57 0.87 Allowed 'General case' 0 C--N 1.355 0.845 0 C-N-CA 125.203 1.401 . . . . 0.53000000000000003 111.307 179.233 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1635 ' ' THR . . . . . . . . . . . . . 94.7 m -103.23 134.03 47.32 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 115.253 -0.885 . . . . 0.46000000000000002 109.697 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1636 ' ' LEU . . . . . 0.76 ' HG ' HD13 ' A' 1629 ' ' LEU . 0.5 OUTLIER -114.97 124.39 51.55 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.548 -0.908 . . . . 0.85999999999999999 108.548 -177.826 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -104.37 130.73 52.22 Favored 'General case' 0 C--O 1.25 1.101 0 N-CA-C 110.37 -0.233 . . . . 0.45000000000000001 110.37 -178.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -127.81 137.99 52.57 Favored 'General case' 0 C--O 1.251 1.135 0 CA-C-O 121.065 0.46 . . . . 0.5 110.48 -178.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1639 ' ' SER . . . . . 0.66 ' HB2' HD11 ' A' 1627 ' ' ILE . 21.4 t -116.08 157.95 23.93 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.148 -1.056 . . . . 1.04 108.148 177.083 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 2.3 t90 -156.34 113.21 3.14 Favored 'General case' 0 N--CA 1.409 -2.497 0 N-CA-C 105.349 -2.093 . . . . 0.68000000000000005 105.349 -177.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1641 ' ' HIS . . . . . 0.663 ' HB2' ' HB ' ' A' 1621 ' ' THR . 13.0 m170 -104.01 105.29 15.42 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 109.485 -0.561 . . . . 0.90000000000000002 109.485 -176.341 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1642 ' ' THR . . . . . . . . . . . . . 11.3 t -142.95 145.13 31.99 Favored Pre-proline 0 C--N 1.306 -1.3 0 CA-C-N 116.111 -0.495 . . . . 0.47999999999999998 109.881 -173.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1643 ' ' PRO . . . . . 0.601 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 73.4 Cg_endo -76.49 -10.37 18.82 Favored 'Trans proline' 0 C--N 1.366 1.5 0 C-N-CA 122.595 2.197 . . . . 0.66000000000000003 112.136 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 7.7 tt -69.0 -24.31 64.21 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.396 0.617 . . . . 0.96999999999999997 109.896 177.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -100.1 17.44 21.13 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 122.123 0.963 . . . . 0.83999999999999997 109.21 -176.161 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 20.1 t -121.46 155.04 35.75 Favored 'General case' 0 N--CA 1.41 -2.451 0 N-CA-C 107.761 -1.2 . . . . 1.1899999999999999 107.761 -178.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -95.82 119.0 65.62 Favored Pre-proline 0 C--N 1.298 -1.633 0 N-CA-C 108.57 -0.9 . . . . 3.1400000000000001 108.57 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1648 ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -50.02 113.09 0.86 Allowed 'Trans proline' 0 C--N 1.364 1.392 0 C-N-CA 123.345 2.697 . . . . 2.5800000000000001 112.306 177.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 . . . . . 0 C--N 1.299 -1.611 0 N-CA-C 105.987 -1.857 . . . . 4.7199999999999998 105.987 -177.924 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.512 -0.511 0 N-CA-C 109.392 -0.596 . . . . 9.9700000000000006 109.392 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 2' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -122.73 129.77 52.16 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 106.831 -1.544 . . . . 7.6799999999999997 106.831 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 3' ' ' ARG . . . . . 0.492 ' HG3' ' HG3' ' B' ' 6' ' ' GLU . 29.8 ptt180 -126.66 126.2 24.48 Favored Pre-proline 0 C--N 1.298 -1.663 0 CA-C-O 120.944 0.402 . . . . 6.1100000000000003 110.303 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -63.28 -11.09 23.7 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 123.483 2.789 . . . . 4.8399999999999999 113.741 -175.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 5.9 m -66.05 -19.21 65.78 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.511 0.672 . . . . 4.5999999999999996 111.239 177.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 6' ' ' GLU . . . . . 0.545 ' HG2' ' HB2' ' A' 1597 ' ' PRO . 37.1 mt-10 -98.87 1.83 46.11 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 115.445 -0.798 . . . . 4.2300000000000004 110.74 -178.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 64.9 p -110.94 98.15 7.35 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 106.121 -1.807 . . . . 3.1400000000000001 106.121 175.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.722 HD23 ' H ' ' B' ' 8' ' ' LEU . 1.9 pt? -72.1 137.68 47.24 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 122.632 0.373 . . . . 3.96 111.64 -173.196 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 6.5 t -150.73 167.51 27.17 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 109.011 -0.737 . . . . 2.8399999999999999 109.011 177.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.95 -123.98 16.24 Favored Glycine 0 C--O 1.246 0.859 0 C-N-CA 121.263 -0.494 . . . . 2.0899999999999999 111.92 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -75.57 -17.69 80.05 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 121.418 -0.42 . . . . 1.8400000000000001 113.627 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -66.96 -27.29 67.34 Favored 'General case' 0 C--O 1.215 -0.722 0 N-CA-C 109.387 -0.597 . . . . 2.5499999999999998 109.387 -176.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 13' ' ' LEU . . . . . 0.445 ' O ' HD12 ' B' ' 17' ' ' LEU . 32.1 mt -66.85 -61.42 1.96 Allowed 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 115.059 -0.973 . . . . 2.3500000000000001 108.907 -179.05 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 9.9 p -64.39 -40.76 90.17 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.525 0 CA-C-N 114.853 -1.067 . . . . 2.1099999999999999 112.097 -176.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -74.47 -26.5 60.07 Favored 'General case' 0 CA--C 1.557 1.246 0 N-CA-C 113.961 1.097 . . . . 2.04 113.961 -176.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 20.4 p -75.0 -43.25 54.98 Favored 'General case' 0 C--O 1.248 0.974 0 O-C-N 121.066 -1.022 . . . . 1.8400000000000001 109.144 175.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.576 ' O ' ' HB2' ' B' ' 21' ' ' CYS . 0.9 OUTLIER -56.06 -40.91 74.26 Favored 'General case' 0 N--CA 1.42 -1.951 0 CA-C-N 114.863 -1.062 . . . . 1.74 111.513 169.471 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 18' ' ' GLN . . . . . 0.46 ' HG2' ' HB2' ' A' 1545 ' ' SER . 8.8 tt0 -71.86 -24.85 61.75 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 121.127 0.489 . . . . 2.3900000000000001 109.718 179.341 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -64.07 -62.68 1.47 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.036 -0.529 . . . . 0.95999999999999996 112.109 178.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 12.6 p -94.65 -20.32 6.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 C-N-CA 118.53 -1.268 . . . . 1.3700000000000001 111.909 -177.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 21' ' ' CYS . . . . . 0.576 ' HB2' ' O ' ' B' ' 17' ' ' LEU . 96.1 m -102.94 18.46 21.56 Favored 'General case' 0 C--N 1.312 -1.027 0 O-C-N 121.834 -0.541 . . . . 1.6599999999999999 111.448 178.266 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -54.02 -50.25 55.87 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 121.355 -0.45 . . . . 1.53 113.219 178.064 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -75.86 -11.13 59.92 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 122.548 0.339 . . . . 2.7200000000000002 111.591 178.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 24' ' ' ARG . . . . . 0.551 ' HG2' ' SG ' ' B' ' 60' ' ' CYS . 21.1 tpp180 -91.53 -50.13 5.94 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.715 0.769 . . . . 4.3300000000000001 110.434 -178.235 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 115.79 157.6 11.32 Favored Glycine 0 N--CA 1.417 -2.593 0 N-CA-C 107.949 -2.06 . . . . 1.53 107.949 -173.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -119.23 137.58 53.56 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 117.943 0.871 . . . . 1.6499999999999999 111.453 177.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 27' ' ' TYR . . . . . 0.78 ' HB2' ' HA ' ' B' ' 61' ' ' ALA . 3.5 m-85 -128.89 -54.25 1.22 Allowed 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 107.684 -1.228 . . . . 3.4199999999999999 107.684 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 28' ' ' PHE . . . . . . . . . . . . . 43.4 p90 43.93 12.71 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 128.06 2.544 . . . . 2.2599999999999998 117.776 172.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 16.6 m -153.1 150.98 29.68 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 106.85 -1.537 . . . . 3.6800000000000002 106.85 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 9.4 mmm180 -122.83 124.81 26.53 Favored Pre-proline 0 C--N 1.302 -1.473 0 N-CA-C 105.634 -1.987 . . . . 3.8100000000000001 105.634 174.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 31' ' ' PRO . . . . . 0.561 ' HA ' ' HB3' ' B' ' 39' ' ' SER . 76.0 Cg_exo -53.21 -34.05 67.64 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 123.899 3.066 . . . . 4.0199999999999996 112.668 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -154.94 151.24 28.29 Favored 'General case' 0 N--CA 1.42 -1.943 0 N-CA-C 109.489 -0.56 . . . . 4.9199999999999999 109.489 176.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 9.0 t 177.85 167.79 0.71 Allowed 'General case' 0 N--CA 1.402 -2.833 0 N-CA-C 103.868 -2.641 . . . . 6.7199999999999998 103.868 -178.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 25.1 ttt180 -96.31 2.22 52.64 Favored 'General case' 0 C--N 1.279 -2.459 0 CA-C-O 122.271 1.034 . . . . 11.630000000000001 108.583 177.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 42.9 t -110.23 -21.94 5.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 114.39 -1.277 . . . . 9.6099999999999994 107.653 175.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 42.5 p -147.57 73.32 1.27 Allowed 'General case' 0 N--CA 1.408 -2.533 0 CA-C-N 114.376 -1.283 . . . . 6.71 109.691 178.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -74.2 -4.29 35.04 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-O 121.976 0.894 . . . . 10.0 109.605 172.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 38' ' ' ARG . . . . . 0.548 ' HG3' ' HG3' ' B' ' 40' ' ' ARG . 24.2 tpp180 -95.12 137.58 33.98 Favored 'General case' 0 N--CA 1.424 -1.766 0 N-CA-C 104.281 -2.489 . . . . 7.9400000000000004 104.281 174.333 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 39' ' ' SER . . . . . 0.561 ' HB3' ' HA ' ' B' ' 31' ' ' PRO . 4.6 p -83.92 56.27 3.62 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 123.26 1.505 . . . . 5.7599999999999998 111.587 -178.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 40' ' ' ARG . . . . . 0.548 ' HG3' ' HG3' ' B' ' 38' ' ' ARG . 58.9 mtp180 -144.83 164.38 31.23 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 103.709 -2.7 . . . . 6.0300000000000002 103.709 -178.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . -135.32 -87.62 0.25 Allowed Glycine 0 C--N 1.295 -1.743 0 C-N-CA 119.054 -1.546 . . . . 2.3700000000000001 112.722 -177.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 42' ' ' ILE . . . . . 0.535 HD11 HD11 ' B' ' 17' ' ' LEU . 41.4 pt -85.73 -17.55 9.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 O-C-N 122.701 -0.293 . . . . 2.0699999999999998 111.349 -177.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.49 ' CG1' ' HB3' ' B' ' 40' ' ' ARG . 14.9 p -53.05 -41.39 41.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 N-CA-C 114.456 1.28 . . . . 2.2400000000000002 114.456 -172.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -74.01 -31.92 63.15 Favored 'General case' 0 C--O 1.244 0.793 0 C-N-CA 118.933 -1.107 . . . . 3.3599999999999999 108.876 -175.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -85.22 -14.27 47.33 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 114.869 -1.06 . . . . 3.0800000000000001 112.296 -176.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 46' ' ' CYS . . . . . . . . . . . . . 81.2 m -104.4 -22.76 13.27 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 112.669 0.618 . . . . 2.23 112.669 175.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 95.9 m -79.39 -49.0 13.03 Favored 'General case' 0 C--O 1.239 0.544 0 O-C-N 121.759 -0.588 . . . . 2.3700000000000001 112.27 178.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -97.38 -7.91 30.75 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.115 0.483 . . . . 2.8199999999999998 111.471 -177.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 52.9 mtp180 -139.65 177.64 7.8 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 115.946 -0.57 . . . . 4.0899999999999999 109.483 -176.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 50.9 m -106.46 135.92 47.12 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 115.475 -0.784 . . . . 2.6699999999999999 109.372 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 51' ' ' CYS . . . . . 0.469 ' HB2' HD23 ' B' ' 55' ' ' LEU . 11.7 p -120.63 138.98 53.63 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 109.647 -0.501 . . . . 2.1099999999999999 109.647 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -82.49 142.77 31.61 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.062 0.458 . . . . 2.6699999999999999 109.768 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 53' ' ' LEU . . . . . 0.806 ' HB2' ' HB3' ' A' 1600 ' ' SER . 66.2 tp -37.69 -42.0 0.53 Allowed 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 127.186 2.194 . . . . 1.8999999999999999 113.808 -177.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 54' ' ' ALA . . . . . 0.601 ' O ' HG22 ' B' ' 58' ' ' THR . . . -53.27 -38.97 63.54 Favored 'General case' 0 C--N 1.318 -0.789 0 O-C-N 124.423 1.077 . . . . 1.52 111.635 -177.386 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 55' ' ' LEU . . . . . 0.469 HD23 ' HB2' ' B' ' 51' ' ' CYS . 53.6 tp -59.67 -56.32 23.34 Favored 'General case' 0 C--O 1.213 -0.827 0 O-C-N 124.146 0.903 . . . . 1.97 110.599 -178.044 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 3.3 pp -69.8 -31.04 68.73 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 116.309 -0.405 . . . . 1.53 110.967 -174.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -66.84 -51.65 53.07 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.891 -0.595 . . . . 2.27 111.575 178.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 58' ' ' THR . . . . . 0.601 HG22 ' O ' ' B' ' 54' ' ' ALA . 12.0 t -83.63 -13.24 54.72 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 112.901 0.704 . . . . 2.3300000000000001 112.901 -177.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -85.61 -72.33 0.49 Allowed 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 105.929 -1.878 . . . . 2.8599999999999999 105.929 175.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 60' ' ' CYS . . . . . 0.551 ' SG ' ' HG2' ' B' ' 24' ' ' ARG . 43.7 t 51.36 -86.88 0.01 OUTLIER 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 114.554 1.316 . . . . 2.2999999999999998 114.554 172.046 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 61' ' ' ALA . . . . . 0.78 ' HA ' ' HB2' ' B' ' 27' ' ' TYR . . . -130.42 -63.74 0.87 Allowed 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 107.407 -1.331 . . . . 3.1899999999999999 107.407 -177.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 1.5 p -119.64 141.87 31.83 Favored Pre-proline 0 N--CA 1.407 -2.589 0 CA-C-N 114.441 -1.254 . . . . 3.6800000000000002 107.711 175.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 63' ' ' PRO . . . . . 0.445 ' HA ' ' O ' ' B' ' 58' ' ' THR . 36.3 Cg_endo -70.12 -7.69 21.79 Favored 'Trans proline' 0 C--O 1.25 1.109 0 C-N-CA 122.985 2.456 . . . . 5.0800000000000001 113.24 -175.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 64' ' ' ALA . . . . . 0.629 ' HA ' ' OE1' ' B' ' 67' ' ' GLU . . . 70.19 22.07 5.68 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 125.567 1.547 . . . . 5.0999999999999996 112.544 175.138 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -135.71 6.95 3.23 Favored 'General case' 0 N--CA 1.416 -2.125 0 CA-C-N 115.558 -0.747 . . . . 8.5099999999999998 111.105 -177.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 33.9 p -138.44 22.98 2.74 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.143 0.497 . . . . 8.1199999999999992 111.286 -175.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 67' ' ' GLU . . . . . 0.629 ' OE1' ' HA ' ' B' ' 64' ' ' ALA . 2.8 mp0 . . . . . 0 N--CA 1.432 -1.364 0 N-CA-C 108.031 -1.1 . . . . 10.210000000000001 108.031 -177.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 64.3 mtt . . . . . 0 CA--C 1.505 -0.754 0 N-CA-C 109.097 -0.705 . . . . 9.3399999999999999 109.097 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A 1509 ' ' LYS . . . . . 0.666 ' O ' ' HB ' ' A' 1519 ' ' THR . 51.5 mtpt -89.51 15.69 8.93 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 120.728 0.299 . . . . 9.0399999999999991 110.978 177.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1510 ' ' SER . . . . . 0.598 ' HA ' ' O ' ' A' 1519 ' ' THR . 8.1 p -90.67 -72.89 0.55 Allowed 'General case' 0 N--CA 1.433 -1.316 0 CA-C-O 121.066 0.46 . . . . 5.8099999999999996 111.685 -179.05 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1511 ' ' ASN . . . . . . . . . . . . . 14.1 m120 -78.39 75.37 4.91 Favored 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 123.541 0.736 . . . . 3.4199999999999999 110.198 178.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1512 ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -88.29 -28.36 21.12 Favored 'General case' 0 C--N 1.305 -1.37 0 CA-C-N 115.627 -0.715 . . . . 5.9500000000000002 110.405 -178.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -128.67 141.83 51.22 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 108.459 -0.941 . . . . 5.3300000000000001 108.459 -176.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -73.48 46.43 0.2 Allowed 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 125.995 1.718 . . . . 5.0599999999999996 110.496 176.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1515 ' ' ASP . . . . . 0.46 ' HB3' ' HG2' ' A' 1517 ' ' GLN . 23.0 t70 -130.98 177.7 7.24 Favored 'General case' 0 C--N 1.28 -2.436 0 N-CA-C 106.014 -1.847 . . . . 2.8999999999999999 106.014 -174.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 34.9 t -91.09 69.25 6.19 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 107.953 -1.129 . . . . 1.1899999999999999 107.953 -175.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1517 ' ' GLN . . . . . 0.46 ' HG2' ' HB3' ' A' 1515 ' ' ASP . 9.8 pt20 -165.23 148.18 8.13 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-N 114.591 -1.186 . . . . 1.52 108.953 -174.179 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1518 ' ' VAL . . . . . 0.465 ' CG2' HD12 ' A' 1581 ' ' LEU . 3.7 m -145.74 143.06 21.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 C-N-CA 123.344 0.657 . . . . 0.93999999999999995 110.051 177.319 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1519 ' ' THR . . . . . 0.666 ' HB ' ' O ' ' A' 1509 ' ' LYS . 42.6 m -93.83 139.82 30.41 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 116.017 -0.538 . . . . 0.89000000000000001 109.762 177.178 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1520 ' ' ASN . . . . . 0.523 ' OD1' HG22 ' A' 1523 ' ' THR . 16.4 t-20 -75.29 117.89 66.57 Favored Pre-proline 0 N--CA 1.428 -1.575 0 N-CA-C 107.712 -1.218 . . . . 1.74 107.712 174.108 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.39 -17.71 49.39 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 122.782 2.321 . . . . 1.5800000000000001 113.529 -176.157 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 10.7 m -80.98 -42.97 20.36 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 112.216 0.451 . . . . 1.6499999999999999 112.216 -176.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1523 ' ' THR . . . . . 0.523 HG22 ' OD1' ' A' 1520 ' ' ASN . 6.2 t -120.99 -8.47 9.35 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.674 0.62 . . . . 1.6100000000000001 112.674 -175.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 80.39 24.29 59.25 Favored Glycine 0 C--O 1.239 0.446 0 C-N-CA 120.339 -0.934 . . . . 1.1299999999999999 112.826 177.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -89.93 123.17 33.62 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 109.369 -0.604 . . . . 1.26 109.369 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 2.2 tm? -87.58 113.12 22.98 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 123.623 0.769 . . . . 0.68000000000000005 109.237 -177.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -88.87 114.01 25.03 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 109.705 -0.48 . . . . 0.65000000000000002 109.705 176.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 14.6 t70 -101.62 110.37 22.35 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.342 -0.984 . . . . 1.1699999999999999 108.342 177.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1529 ' ' LEU . . . . . 0.444 ' HG ' HD21 ' A' 1581 ' ' LEU . 3.3 mm? -92.11 -2.42 56.62 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.986 0.898 . . . . 0.59999999999999998 109.309 -177.262 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 2.9 m -73.98 -10.27 59.47 Favored 'General case' 0 C--O 1.215 -0.737 0 CA-C-N 114.48 -1.236 . . . . 0.83999999999999997 109.615 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1531 ' ' SER . . . . . 0.585 ' HB2' HD11 ' A' 1644 ' ' LEU . 19.0 m -72.3 -16.97 61.9 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 109.027 -0.731 . . . . 1.5900000000000001 109.027 176.038 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1532 ' ' LEU . . . . . 0.42 ' O ' ' HB ' ' A' 1552 ' ' ILE . 67.9 mt -107.05 5.59 28.18 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.253 -0.885 . . . . 0.65000000000000002 110.891 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1533 ' ' SER . . . . . 0.447 ' HA ' ' O ' ' A' 1552 ' ' ILE . 69.3 p -67.5 164.34 19.09 Favored 'General case' 0 C--O 1.249 1.062 0 CA-C-O 121.367 0.604 . . . . 1.52 111.614 -178.144 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -170.81 142.0 6.84 Favored Glycine 0 N--CA 1.418 -2.561 0 C-N-CA 120.343 -0.932 . . . . 1.1000000000000001 111.151 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1535 ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' 1535 ' ' ARG . 23.1 ttt180 -92.86 -36.41 12.84 Favored 'General case' 0 C--N 1.292 -1.911 0 C-N-CA 122.688 0.395 . . . . 4.6200000000000001 111.156 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -82.93 -36.72 25.0 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.721 0.772 . . . . 1.45 109.421 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1537 ' ' GLY . . . . . 0.408 ' HA3' ' ND2' ' A' 1556 ' ' ASN . . . 97.36 179.19 34.02 Favored Glycine 0 N--CA 1.418 -2.555 0 CA-C-N 114.918 -1.037 . . . . 0.84999999999999998 112.476 173.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -119.84 147.23 44.93 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 107.675 -1.231 . . . . 0.93000000000000005 107.675 178.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 5.5 p -103.37 117.68 35.04 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.334 0.587 . . . . 1.03 111.963 -177.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1540 ' ' ALA . . . . . 0.448 ' HB3' ' CG1' ' A' 1548 ' ' VAL . . . -108.16 121.78 45.55 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 107.927 -1.138 . . . . 0.5 107.927 176.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -70.92 134.07 46.94 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 116.144 -0.48 . . . . 0.73999999999999999 110.761 -178.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1542 ' ' TYR . . . . . 0.47 ' HB3' ' H ' ' A' 1543 ' ' SER . 1.2 t80 -126.94 -99.94 0.37 Allowed 'General case' 0 N--CA 1.418 -2.054 0 N-CA-C 106.564 -1.643 . . . . 0.98999999999999999 106.564 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1543 ' ' SER . . . . . 0.47 ' H ' ' HB3' ' A' 1542 ' ' TYR . 3.3 m -66.06 159.22 26.46 Favored 'General case' 0 N--CA 1.416 -2.126 0 C-N-CA 123.223 0.609 . . . . 1.9099999999999999 110.236 178.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -51.23 -44.3 61.66 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.373 0.533 . . . . 3.5899999999999999 112.094 -178.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 7.5 t -117.41 37.64 3.83 Favored 'General case' 0 N--CA 1.424 -1.759 0 N-CA-C 108.999 -0.741 . . . . 2.46 108.999 178.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . -147.44 109.36 0.47 Allowed Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 120.083 -1.056 . . . . 1.26 113.934 -177.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 36.0 m -98.89 160.63 3.21 Favored 'Isoleucine or valine' 0 C--O 1.252 1.187 0 N-CA-C 108.876 -0.786 . . . . 0.79000000000000004 108.876 175.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1548 ' ' VAL . . . . . 0.505 ' HB ' ' CE1' ' A' 1567 ' ' PHE . 10.9 p -109.33 131.76 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.675 0 N-CA-C 107.647 -1.242 . . . . 0.57999999999999996 107.647 174.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -93.27 125.54 37.92 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.988 -1.115 . . . . 1.0800000000000001 107.988 178.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 24.0 ptm -136.39 134.29 37.64 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 120.033 -0.667 . . . . 0.78000000000000003 112.169 -177.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 11.9 p -123.41 125.04 44.24 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-N 115.073 -0.967 . . . . 0.96999999999999997 109.73 177.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1552 ' ' ILE . . . . . 0.447 ' O ' ' HA ' ' A' 1533 ' ' SER . 47.9 mm -84.18 124.46 39.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 N-CA-C 109.86 -0.422 . . . . 0.41999999999999998 109.86 -179.04 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1553 ' ' CYS . . . . . 0.434 ' SG ' HG22 ' A' 1552 ' ' ILE . 56.6 m 64.43 26.07 13.44 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.896 0.878 . . . . 1.3999999999999999 112.231 174.329 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . -172.07 -179.23 42.86 Favored Glycine 0 N--CA 1.431 -1.643 0 N-CA-C 110.308 -1.117 . . . . 0.34999999999999998 110.308 -178.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -101.34 145.56 28.74 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 121.283 0.563 . . . . 1.6200000000000001 111.825 -177.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1556 ' ' ASN . . . . . 0.408 ' ND2' ' HA3' ' A' 1537 ' ' GLY . 24.6 t-20 -92.57 137.45 32.35 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.014 -0.994 . . . . 0.87 108.845 -177.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -80.43 -8.83 59.69 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.354 0.872 . . . . 2.4900000000000002 113.354 -172.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -83.62 -9.06 59.15 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 120.946 0.403 . . . . 1.3799999999999999 112.026 -175.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1559 ' ' CYS . . . . . 0.755 ' HB3' HG11 ' A' 1563 ' ' VAL . 9.3 t -136.87 153.71 75.72 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 108.164 -1.05 . . . . 1.21 108.164 -177.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1560 ' ' PRO . . . . . 0.575 ' HD2' ' SG ' ' A' 1559 ' ' CYS . 23.7 Cg_exo -28.84 135.51 0.03 OUTLIER 'Trans proline' 0 C--N 1.379 2.183 1 C-N-CA 125.988 4.459 . . . . 0.70999999999999996 115.133 178.293 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -45.93 120.95 3.85 Favored 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 125.104 3.87 . . . . 0.80000000000000004 114.125 -177.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 101.73 21.75 10.94 Favored Glycine 0 CA--C 1.531 1.081 0 CA-C-N 115.826 -0.625 . . . . 0.46000000000000002 113.045 -176.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1563 ' ' VAL . . . . . 0.755 HG11 ' HB3' ' A' 1559 ' ' CYS . 2.3 t -102.02 124.29 55.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 O-C-N 122.162 -0.61 . . . . 0.97999999999999998 110.931 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -97.3 -35.76 5.14 Favored Glycine 0 C--N 1.3 -1.447 0 N-CA-C 110.495 -1.042 . . . . 0.28000000000000003 110.495 175.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -138.58 132.89 31.79 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.202 -0.666 . . . . 0.28000000000000003 109.202 177.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1566 ' ' CYS . . . . . 0.417 ' HB2' HG11 ' A' 1563 ' ' VAL . 53.0 t -156.42 139.3 15.28 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.459 -0.571 . . . . 0.42999999999999999 109.459 -177.308 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1567 ' ' PHE . . . . . 0.505 ' CE1' ' HB ' ' A' 1548 ' ' VAL . 67.3 m-85 -87.3 147.94 25.29 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.294 -0.562 . . . . 1.03 110.0 177.308 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -89.34 40.34 3.06 Favored Glycine 0 N--CA 1.437 -1.265 0 C-N-CA 120.393 -0.908 . . . . 1.1299999999999999 113.363 -175.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1569 ' ' GLN . . . . . 0.419 ' HB2' ' OD2' ' B' ' 15' ' ' ASP . 28.3 mm-40 -95.16 -71.61 0.66 Allowed 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 119.874 -0.731 . . . . 2.5800000000000001 110.449 175.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 81.6 p -130.69 40.65 3.47 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 118.638 0.653 . . . . 2.1699999999999999 112.354 175.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 13.0 mmt85 63.6 49.76 2.96 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 123.923 0.889 . . . . 2.6200000000000001 111.114 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 26.0 mm -98.53 113.72 34.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 N-CA-C 109.149 -0.686 . . . . 0.92000000000000004 109.149 -178.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1573 ' ' SER . . . . . 0.51 ' HB3' ' OG ' ' A' 1596 ' ' SER . 31.6 t -86.11 142.16 28.88 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 121.713 0.768 . . . . 0.80000000000000004 110.402 -176.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1574 ' ' VAL . . . . . 0.651 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 30.5 m -124.17 15.09 4.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 CA-C-N 115.495 -0.775 . . . . 0.97999999999999998 110.237 179.139 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . -179.44 123.48 0.85 Allowed Glycine 0 N--CA 1.417 -2.58 0 C-N-CA 118.825 -1.655 . . . . 0.28999999999999998 112.21 177.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1576 ' ' LYS . . . . . 0.437 ' HB2' ' O ' ' A' 1594 ' ' ASP . 57.7 tttp -77.26 134.29 38.61 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 108.013 -1.106 . . . . 2.1899999999999999 108.013 176.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -70.72 117.47 12.28 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.889 -0.596 . . . . 0.60999999999999999 110.74 -177.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -133.56 174.88 9.94 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 106.913 -1.514 . . . . 1.95 106.913 177.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -123.93 45.83 2.39 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 106.184 -1.784 . . . . 2.6800000000000002 106.184 178.077 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.86 88.01 3.9 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 113.527 -1.669 . . . . 3.4700000000000002 107.579 -172.544 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1581 ' ' LEU . . . . . 0.465 HD12 ' CG2' ' A' 1518 ' ' VAL . 0.2 OUTLIER -89.73 133.51 34.65 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.228 -1.027 . . . . 0.64000000000000001 108.228 -177.684 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -122.93 138.57 54.63 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 109.992 -0.373 . . . . 2.8500000000000001 109.992 174.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1583 ' ' TYR . . . . . . . . . . . . . 50.0 t80 -109.43 111.9 23.71 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 107.624 -1.25 . . . . 0.85999999999999999 107.624 177.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1584 ' ' VAL . . . . . 0.623 ' O ' ' HB ' ' A' 1587 ' ' VAL . 14.7 m -131.96 99.02 3.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 112.602 0.594 . . . . 1.05 112.602 -177.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 37.4 t70 52.5 66.23 1.28 Allowed 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 124.297 1.039 . . . . 1.1699999999999999 111.605 175.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1586 ' ' GLN . . . . . . . . . . . . 0.255 30.1 pt20 65.14 12.4 7.95 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 127.515 2.326 . . . . 1.8600000000000001 112.426 177.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1587 ' ' VAL . . . . . 0.623 ' HB ' ' O ' ' A' 1584 ' ' VAL . 13.9 t -110.51 128.28 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 CA-C-N 114.751 -1.113 . . . . 0.48999999999999999 110.681 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1588 ' ' LEU . . . . . 0.822 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 3.2 mm? -95.28 107.98 20.12 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 106.613 -1.625 . . . . 0.35999999999999999 106.613 176.006 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -115.48 116.77 28.76 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-O 121.672 0.748 . . . . 1.74 112.692 -174.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1590 ' ' LEU . . . . . 0.448 ' HG ' HD22 ' A' 1581 ' ' LEU . 5.7 mt -100.18 108.06 20.08 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 114.197 -1.365 . . . . 0.71999999999999997 107.38 172.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 10.0 p -99.09 126.82 52.24 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.15 0 CA-C-O 121.531 0.681 . . . . 1.01 110.089 -179.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1592 ' ' TYR . . . . . 0.404 ' O ' ' HA ' ' A' 1607 ' ' LYS . 12.4 m-30 -113.28 99.21 7.63 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 109.317 -0.623 . . . . 0.5 109.317 177.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 60.1 pttt -111.41 179.39 4.04 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.585 -0.895 . . . . 1.5900000000000001 108.585 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1594 ' ' ASP . . . . . 0.437 ' O ' ' HB2' ' A' 1576 ' ' LYS . 32.3 m-20 57.82 45.9 17.83 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.108 0.963 . . . . 1.1100000000000001 110.955 178.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -79.59 -95.3 0.33 Allowed Glycine 0 CA--C 1.498 -0.979 0 N-CA-C 109.791 -1.324 . . . . 0.78000000000000003 109.791 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1596 ' ' SER . . . . . 0.51 ' OG ' ' HB3' ' A' 1573 ' ' SER . 72.2 m -124.94 149.35 62.83 Favored Pre-proline 0 C--N 1.273 -2.736 0 N-CA-C 107.216 -1.402 . . . . 1.0700000000000001 107.216 173.425 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -61.92 138.4 73.44 Favored 'Trans proline' 0 N--CA 1.445 -1.367 0 C-N-CA 122.273 1.982 . . . . 1.01 109.229 174.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1598 ' ' CYS . . . . . 0.51 ' HA ' ' CE2' ' A' 1606 ' ' TYR . 5.0 t -70.02 113.47 17.91 Favored Pre-proline 0 C--N 1.296 -1.718 0 N-CA-C 106.954 -1.499 . . . . 0.75 106.954 -178.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1599 ' ' PRO . . . . . 0.646 ' HB2' HD23 ' B' ' 8' ' ' LEU . 24.2 Cg_exo -62.89 -33.78 74.08 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.984 2.456 . . . . 1.7 113.008 -173.145 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1600 ' ' SER . . . . . 0.674 ' HB2' ' HG ' ' B' ' 53' ' ' LEU . 5.2 m -86.18 7.6 24.39 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 116.307 -0.406 . . . . 2.2599999999999998 112.061 178.125 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1601 ' ' LYS . . . . . 0.565 ' HG2' HD22 ' A' 1604 ' ' LEU . 3.0 tppp? -161.5 96.4 1.05 Allowed 'General case' 0 C--O 1.251 1.141 0 O-C-N 121.743 -0.598 . . . . 3.0099999999999998 110.316 175.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 13.0 t -66.76 126.05 27.79 Favored 'General case' 0 N--CA 1.401 -2.886 0 N-CA-C 108.649 -0.871 . . . . 2.0699999999999998 108.649 -176.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 106.2 -6.5 39.69 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 116.443 -0.344 . . . . 1.0800000000000001 112.334 -177.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1604 ' ' LEU . . . . . 0.565 HD22 ' HG2' ' A' 1601 ' ' LYS . 7.5 mp -106.34 155.97 18.98 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 122.94 0.496 . . . . 1.8400000000000001 109.981 176.303 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 44.8 t -135.24 151.06 50.25 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 107.99 -1.115 . . . . 1.4099999999999999 107.99 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1606 ' ' TYR . . . . . 0.651 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 90.8 m-85 -80.45 150.86 29.58 Favored 'General case' 0 N--CA 1.419 -2.012 0 N-CA-C 108.903 -0.777 . . . . 0.59999999999999998 108.903 176.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1607 ' ' LYS . . . . . 0.404 ' HA ' ' O ' ' A' 1592 ' ' TYR . 33.8 ttpt -150.82 127.46 10.85 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 123.623 0.577 . . . . 1.45 109.716 -175.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1608 ' ' SER . . . . . 0.402 ' HB2' ' HB2' ' A' 1592 ' ' TYR . 20.7 m -105.35 115.96 31.15 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 109.437 -0.579 . . . . 1.1499999999999999 109.437 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 38.4 t -98.41 107.07 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 108.103 -1.073 . . . . 0.25 108.103 176.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 70.5 mt -100.25 101.37 12.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 CA-C-N 115.765 -0.652 . . . . 0.45000000000000001 109.304 -179.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 5.9 p -100.2 119.02 37.71 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.619 0.723 . . . . 1.26 112.694 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1612 ' ' PHE . . . . . 0.822 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 72.0 m-85 -94.51 122.27 36.91 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.131 -0.94 . . . . 0.26000000000000001 109.744 177.126 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 42.0 t -119.99 138.67 49.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-N 115.397 -0.819 . . . . 0.5 109.475 -175.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 13.2 t -58.75 113.54 2.09 Favored 'General case' 0 C--O 1.243 0.732 0 C-N-CA 124.352 1.061 . . . . 0.77000000000000002 111.856 178.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1615 ' ' ARG . . . . . 0.697 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 23.7 tpt180 -136.64 97.46 11.43 Favored Pre-proline 0 N--CA 1.431 -1.386 0 N-CA-C 109.272 -0.64 . . . . 2.5299999999999998 109.272 175.562 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1616 ' ' PRO . . . . . 0.464 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 60.5 Cg_endo -73.62 -14.9 24.62 Favored 'Trans proline' 0 N--CA 1.487 1.138 0 C-N-CA 122.551 2.167 . . . . 1.1000000000000001 112.846 -177.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -91.82 42.68 1.11 Allowed 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 124.704 1.201 . . . . 3.0499999999999998 110.333 -176.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -30.72 127.96 0.14 Allowed 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 126.648 1.979 . . . . 1.55 113.591 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1619 ' ' GLY . . . . . 0.426 ' HA3' ' HD2' ' A' 1620 ' ' PRO . . . 178.63 -145.14 6.66 Favored Glycine 0 N--CA 1.428 -1.843 0 N-CA-C 109.846 -1.302 . . . . 0.93000000000000005 109.846 -178.117 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1620 ' ' PRO . . . . . 0.426 ' HD2' ' HA3' ' A' 1619 ' ' GLY . 27.2 Cg_endo -61.44 -4.07 3.91 Favored 'Trans proline' 0 CA--C 1.556 1.581 0 C-N-CA 123.568 2.846 . . . . 0.88 115.756 -177.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1621 ' ' THR . . . . . . . . . . . . . 23.3 p -91.96 -10.06 40.75 Favored 'General case' 0 C--O 1.247 0.939 0 O-C-N 121.563 -0.711 . . . . 0.96999999999999997 110.662 176.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 47.1 t30 -90.43 58.66 4.07 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 122.338 1.066 . . . . 0.71999999999999997 109.378 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -163.69 139.43 5.13 Favored Pre-proline 0 C--N 1.309 -1.192 0 CA-C-N 114.455 -1.248 . . . . 3.2599999999999998 107.916 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -65.11 102.04 0.43 Allowed 'Trans proline' 0 C--O 1.239 0.528 0 C-N-CA 123.314 2.676 . . . . 0.58999999999999997 112.837 -175.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 75.3 mtm -107.34 146.59 31.39 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.897 -0.592 . . . . 1.3700000000000001 111.049 -178.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 1.6 tm? -86.76 115.34 24.13 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 107.438 -1.319 . . . . 0.89000000000000001 107.438 -176.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 49.2 mm -79.16 -56.49 7.02 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-O 121.26 0.552 . . . . 0.57999999999999996 109.792 179.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 66.5 m -161.36 147.22 14.12 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.513 -0.767 . . . . 1.3899999999999999 109.704 -177.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1629 ' ' LEU . . . . . 0.823 HD13 ' HG ' ' A' 1636 ' ' LEU . 42.7 tp -113.92 112.85 24.01 Favored 'General case' 0 N--CA 1.424 -1.737 0 N-CA-C 107.428 -1.323 . . . . 1.25 107.428 172.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 30.6 t70 -85.93 110.75 19.66 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.68 -1.23 . . . . 1.0900000000000001 107.68 174.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1631 ' ' LYS . . . . . 0.659 ' HB3' HD22 ' B' ' 53' ' ' LEU . 0.1 OUTLIER -73.72 -31.6 63.47 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.761 -0.654 . . . . 3.6000000000000001 110.086 -174.037 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -70.16 -36.82 74.99 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-N 115.481 -0.781 . . . . 2.6000000000000001 112.863 -173.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 54.8 p -101.32 -6.52 24.01 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.032 0.444 . . . . 0.75 110.7 175.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1634 ' ' CYS . . . . . 0.501 ' O ' ' HA ' ' A' 1606 ' ' TYR . 32.7 m 63.27 40.85 8.33 Favored 'General case' 0 C--N 1.364 1.209 0 C-N-CA 124.546 1.138 . . . . 0.53000000000000003 109.961 -178.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1635 ' ' THR . . . . . . . . . . . . . 55.9 m -106.24 133.71 50.51 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.924 -1.034 . . . . 0.46000000000000002 110.356 -176.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1636 ' ' LEU . . . . . 0.823 ' HG ' HD13 ' A' 1629 ' ' LEU . 0.7 OUTLIER -116.85 131.69 56.89 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.443 -0.577 . . . . 0.85999999999999999 109.443 -177.709 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -111.23 128.09 55.81 Favored 'General case' 0 C--O 1.252 1.199 0 CA-C-O 120.821 0.343 . . . . 0.45000000000000001 111.012 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -125.61 131.82 52.62 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.92 -0.77 . . . . 0.5 108.92 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1639 ' ' SER . . . . . . . . . . . . . 64.6 m -115.46 140.7 48.9 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 122.892 0.477 . . . . 1.04 109.857 178.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 3.1 t90 -142.35 114.29 8.12 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 104.327 -2.471 . . . . 0.68000000000000005 104.327 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1641 ' ' HIS . . . . . 0.697 ' HB3' ' HB2' ' A' 1615 ' ' ARG . 31.5 m-70 -106.26 112.44 25.46 Favored 'General case' 0 C--N 1.293 -1.886 0 C-N-CA 119.916 -0.714 . . . . 0.90000000000000002 110.005 -177.193 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1642 ' ' THR . . . . . . . . . . . . . 3.9 t -142.46 150.42 54.56 Favored Pre-proline 0 C--N 1.302 -1.491 0 CA-C-N 115.615 -0.72 . . . . 0.47999999999999998 109.512 -172.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1643 ' ' PRO . . . . . 0.464 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 71.9 Cg_endo -77.07 -10.75 17.93 Favored 'Trans proline' 0 C--N 1.362 1.251 0 C-N-CA 122.411 2.074 . . . . 0.66000000000000003 111.464 176.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1644 ' ' LEU . . . . . 0.585 HD11 ' HB2' ' A' 1531 ' ' SER . 7.3 tt -68.36 -24.33 64.79 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.712 0.805 . . . . 0.96999999999999997 110.493 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -95.04 6.96 47.61 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 122.187 0.994 . . . . 0.83999999999999997 109.619 -177.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 15.6 t -123.9 159.11 30.4 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-N 114.404 -1.271 . . . . 1.1899999999999999 108.579 -175.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -98.58 103.28 17.83 Favored Pre-proline 0 C--N 1.308 -1.208 0 N-CA-C 108.455 -0.943 . . . . 3.1400000000000001 108.455 169.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1648 ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -87.44 94.57 0.46 Allowed 'Trans proline' 0 N--CA 1.444 -1.409 0 C-N-CA 121.845 1.697 . . . . 2.5800000000000001 111.498 178.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 10.0 tp10 . . . . . 0 C--N 1.311 -1.071 0 N-CA-C 105.73 -1.952 . . . . 4.7199999999999998 105.73 179.223 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.845 0 N-CA-C 109.528 -0.545 . . . . 9.9700000000000006 109.528 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 2' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -106.22 134.9 48.62 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.23 -1.396 . . . . 7.6799999999999997 107.23 177.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 47.1 ptt85 -120.36 151.15 53.17 Favored Pre-proline 0 C--N 1.294 -1.831 0 N-CA-C 108.119 -1.067 . . . . 6.1100000000000003 108.119 -179.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.65 1.68 4.15 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.371 2.714 . . . . 4.8399999999999999 115.008 -175.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 19.4 m 59.0 39.67 23.22 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.229 1.412 . . . . 4.5999999999999996 111.897 176.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -67.69 -37.41 82.26 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 121.613 0.72 . . . . 4.2300000000000004 110.847 -176.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 60.3 p -122.8 169.97 10.56 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 104.834 -2.284 . . . . 3.1400000000000001 104.834 175.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.646 HD23 ' HB2' ' A' 1599 ' ' PRO . 4.5 pp -99.49 133.25 44.08 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 120.007 1.276 . . . . 3.96 112.949 -175.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 9' ' ' CYS . . . . . 0.421 ' HB2' ' HA ' ' B' ' 47' ' ' CYS . 36.5 t -153.47 160.19 42.49 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 108.081 -1.081 . . . . 2.8399999999999999 108.081 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.59 -125.85 10.58 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 112.071 -0.411 . . . . 2.0899999999999999 112.071 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.98 -21.95 73.77 Favored Glycine 0 C--N 1.311 -0.847 0 C-N-CA 121.72 -0.276 . . . . 1.8400000000000001 113.353 179.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -71.46 -20.83 62.04 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.728 0.775 . . . . 2.5499999999999998 109.265 -176.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 13' ' ' LEU . . . . . 0.511 HD23 HD12 ' B' ' 8' ' ' LEU . 62.1 mt -68.14 -49.59 60.09 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 115.059 -0.973 . . . . 2.3500000000000001 108.419 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 8.5 p -77.66 -18.12 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 CA-C-N 115.111 -0.95 . . . . 2.1099999999999999 110.488 -176.052 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 15' ' ' ASP . . . . . 0.419 ' OD2' ' HB2' ' A' 1569 ' ' GLN . 12.5 t70 -62.83 -67.53 0.41 Allowed 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 109.535 -0.543 . . . . 2.04 109.535 176.215 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 15.2 t -61.13 -36.6 80.18 Favored 'General case' 0 C--O 1.25 1.125 0 O-C-N 123.635 0.584 . . . . 1.8400000000000001 111.226 -176.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.572 HD21 HD11 ' B' ' 42' ' ' ILE . 4.0 mm? -57.37 -49.6 75.64 Favored 'General case' 0 C--O 1.215 -0.757 0 N-CA-C 113.109 0.781 . . . . 1.74 113.109 175.079 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -84.75 -14.97 46.66 Favored 'General case' 0 C--N 1.317 -0.809 0 O-C-N 121.583 -0.698 . . . . 2.3900000000000001 111.034 -178.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -63.86 -54.66 31.34 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 116.314 -0.403 . . . . 0.95999999999999996 111.017 176.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 16.0 m -98.18 -14.52 7.73 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.691 0 C-N-CA 118.911 -1.116 . . . . 1.3700000000000001 112.319 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 21' ' ' CYS . . . . . 0.503 ' HB2' ' O ' ' B' ' 17' ' ' LEU . 68.7 m -114.49 23.03 13.12 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 120.358 -0.537 . . . . 1.6599999999999999 111.666 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -52.22 -40.49 52.5 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 114.557 0.583 . . . . 1.53 114.557 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -86.12 -31.93 21.59 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 113.753 1.019 . . . . 2.7200000000000002 113.753 -178.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 24' ' ' ARG . . . . . 0.415 ' HD3' ' OG1' ' B' ' 62' ' ' THR . 43.6 ttm180 -90.52 -25.03 20.46 Favored 'General case' 0 C--O 1.248 0.991 0 CA-C-O 121.353 0.597 . . . . 4.3300000000000001 111.44 -176.539 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 25' ' ' GLY . . . . . 0.414 ' O ' ' HB2' ' B' ' 61' ' ' ALA . . . 109.29 163.06 19.97 Favored Glycine 0 N--CA 1.439 -1.132 0 N-CA-C 110.183 -1.167 . . . . 1.53 110.183 -179.091 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -123.62 131.11 53.54 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 117.52 0.66 . . . . 1.6499999999999999 110.96 179.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 27' ' ' TYR . . . . . 0.434 ' HB2' ' HA ' ' B' ' 61' ' ' ALA . 26.9 m-85 -136.71 80.84 1.84 Allowed 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 111.754 0.279 . . . . 3.4199999999999999 111.754 -177.26 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 28' ' ' PHE . . . . . 0.548 ' HA ' ' HE2' ' B' ' 59' ' ' TYR . 34.3 p90 -90.74 -17.62 26.39 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.7 0.762 . . . . 2.2599999999999998 109.674 173.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 8.1 m -100.67 129.13 46.54 Favored 'General case' 0 N--CA 1.428 -1.543 0 N-CA-C 107.303 -1.369 . . . . 3.6800000000000002 107.303 176.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 30' ' ' ARG . . . . . 0.409 ' HB2' ' O ' ' B' ' 39' ' ' SER . 20.9 mmt180 -105.78 158.31 32.68 Favored Pre-proline 0 C--N 1.305 -1.35 0 N-CA-C 107.537 -1.283 . . . . 3.8100000000000001 107.537 -178.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -59.4 -50.49 8.24 Favored 'Trans proline' 0 C--O 1.25 1.076 0 C-N-CA 121.232 1.288 . . . . 4.0199999999999996 113.319 -174.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 32' ' ' ALA . . . . . 0.712 ' HB3' ' HA ' ' B' ' 37' ' ' ARG . . . 69.62 -76.34 0.06 Allowed 'General case' 0 CA--C 1.507 -0.695 0 C-N-CA 125.281 1.433 . . . . 4.9199999999999999 111.811 177.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 29.6 t 173.02 164.37 0.13 Allowed 'General case' 0 N--CA 1.396 -3.169 0 N-CA-C 103.548 -2.76 . . . . 6.7199999999999998 103.548 178.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -93.21 -3.01 54.58 Favored 'General case' 0 C--N 1.27 -2.852 0 N-CA-C 108.364 -0.976 . . . . 11.630000000000001 108.364 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 41.0 t -110.14 -17.61 8.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 122.196 0.998 . . . . 9.6099999999999994 108.721 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 13.0 p -148.69 63.53 1.07 Allowed 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 114.593 -1.185 . . . . 6.71 109.17 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 37' ' ' ARG . . . . . 0.712 ' HA ' ' HB3' ' B' ' 32' ' ' ALA . 27.1 ptt180 -73.06 12.07 0.6 Allowed 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 115.06 1.504 . . . . 10.0 115.06 -176.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -82.41 66.65 8.1 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.584 0.707 . . . . 7.9400000000000004 112.826 -174.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 39' ' ' SER . . . . . 0.502 ' HB2' ' HB2' ' B' ' 32' ' ' ALA . 39.5 m -150.55 89.0 1.52 Allowed 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 108.351 -0.981 . . . . 5.7599999999999998 108.351 173.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 66.3 mtm180 -132.11 149.13 52.48 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 106.236 -1.764 . . . . 6.0300000000000002 106.236 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . -116.34 155.99 15.9 Favored Glycine 0 N--CA 1.409 -3.146 0 C-N-CA 119.468 -1.349 . . . . 2.3700000000000001 110.248 -177.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 42' ' ' ILE . . . . . 0.572 HD11 HD21 ' B' ' 17' ' ' LEU . 10.2 pt 59.65 -28.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 C-N-CA 127.737 2.415 . . . . 2.0699999999999998 116.491 176.019 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 43' ' ' VAL . . . . . . . . . . . . 0.26 2.7 p -51.41 -49.53 31.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 114.958 1.466 . . . . 2.2400000000000002 114.958 -175.381 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -96.12 -26.0 15.65 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.357 -0.979 . . . . 3.3599999999999999 108.357 -176.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 45' ' ' GLU . . . . . 0.528 ' O ' ' HB2' ' B' ' 49' ' ' ARG . 9.5 tp10 -60.9 -43.72 98.12 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 114.933 -1.03 . . . . 3.0800000000000001 109.428 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 46' ' ' CYS . . . . . 0.4 ' HA ' ' O ' ' B' ' 49' ' ' ARG . 10.1 t -94.48 -14.62 24.97 Favored 'General case' 0 C--N 1.314 -0.956 0 O-C-N 121.988 -0.445 . . . . 2.23 111.736 -177.203 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 47' ' ' CYS . . . . . 0.421 ' HA ' ' HB2' ' B' ' 9' ' ' CYS . 52.2 t -66.75 -47.74 71.29 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.141 -0.623 . . . . 2.3700000000000001 110.181 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -105.71 -12.77 15.78 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 113.152 0.797 . . . . 2.8199999999999998 113.152 -177.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 49' ' ' ARG . . . . . 0.528 ' HB2' ' O ' ' B' ' 45' ' ' GLU . 64.7 mtt180 -125.6 158.68 34.05 Favored 'General case' 0 CA--C 1.498 -1.036 0 N-CA-C 108.35 -0.981 . . . . 4.0899999999999999 108.35 178.552 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 23.0 t -84.61 123.55 30.45 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 109.562 -0.533 . . . . 2.6699999999999999 109.562 -177.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 51' ' ' CYS . . . . . 0.473 ' HB2' HD23 ' B' ' 55' ' ' LEU . 29.4 p -105.81 133.52 50.41 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 108.316 -0.994 . . . . 2.1099999999999999 108.316 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -80.27 147.37 31.21 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.685 -1.228 . . . . 2.6699999999999999 107.685 177.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 53' ' ' LEU . . . . . 0.803 ' H ' HD12 ' B' ' 53' ' ' LEU . 3.0 mp -52.49 -29.04 22.92 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 125.789 1.635 . . . . 1.8999999999999999 112.185 -175.272 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 54' ' ' ALA . . . . . 0.42 ' O ' HG22 ' B' ' 58' ' ' THR . . . -61.96 -37.81 86.15 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 123.581 0.551 . . . . 1.52 110.772 -178.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 55' ' ' LEU . . . . . 0.473 HD23 ' HB2' ' B' ' 51' ' ' CYS . 50.5 tp -59.93 -50.59 73.17 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-N 115.787 -0.642 . . . . 1.97 110.617 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 3.9 pp -75.54 -32.76 60.57 Favored 'General case' 0 N--CA 1.422 -1.85 0 CA-C-N 116.202 -0.453 . . . . 1.53 111.99 -174.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -71.24 -42.44 68.84 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 112.195 0.442 . . . . 2.27 112.195 -176.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 58' ' ' THR . . . . . 0.42 HG22 ' O ' ' B' ' 54' ' ' ALA . 12.2 t -78.09 -25.4 47.58 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 118.83 -1.148 . . . . 2.3300000000000001 111.742 176.236 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 59' ' ' TYR . . . . . 0.548 ' HE2' ' HA ' ' B' ' 28' ' ' PHE . 30.2 t80 -67.5 -68.55 0.37 Allowed 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 106.576 -1.639 . . . . 2.8599999999999999 106.576 176.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 42.0 t 52.2 -85.17 0.01 OUTLIER 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 125.391 1.476 . . . . 2.2999999999999998 114.213 173.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 61' ' ' ALA . . . . . 0.434 ' HA ' ' HB2' ' B' ' 27' ' ' TYR . . . -143.9 -84.27 0.15 Allowed 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 105.548 -2.019 . . . . 3.1899999999999999 105.548 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 62' ' ' THR . . . . . 0.415 ' OG1' ' HD3' ' B' ' 24' ' ' ARG . 3.3 p -81.27 138.32 48.71 Favored Pre-proline 0 N--CA 1.405 -2.687 0 N-CA-C 107.396 -1.335 . . . . 3.6800000000000002 107.396 168.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -79.68 3.92 7.13 Favored 'Trans proline' 0 C--O 1.245 0.837 0 C-N-CA 122.93 2.42 . . . . 5.0800000000000001 112.519 -176.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 64.23 46.42 3.57 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-N 113.517 -1.674 . . . . 5.0999999999999996 109.815 177.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -116.55 131.99 56.8 Favored 'General case' 0 N--CA 1.423 -1.822 0 CA-C-N 114.463 -1.244 . . . . 8.5099999999999998 109.472 -177.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 9.3 p -87.77 62.15 6.82 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 121.505 0.669 . . . . 8.1199999999999992 110.381 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 . . . . . 0 N--CA 1.433 -1.312 0 N-CA-C 107.34 -1.356 . . . . 10.210000000000001 107.34 179.724 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 87.7 mtp . . . . . 0 C--O 1.237 0.427 0 N-CA-C 108.134 -1.061 . . . . 9.3399999999999999 108.134 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A 1509 ' ' LYS . . . . . 0.603 ' HA ' ' HB3' ' A' 1512 ' ' GLU . 55.7 pttt -135.51 24.73 3.45 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 114.345 1.239 . . . . 9.0399999999999991 114.345 -170.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1510 ' ' SER . . . . . 0.593 ' HB3' ' HB ' ' A' 1519 ' ' THR . 50.0 m -99.99 -28.91 12.84 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.891 0.853 . . . . 5.8099999999999996 109.136 175.015 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1511 ' ' ASN . . . . . . . . . . . . . 17.7 m120 -123.46 31.43 5.94 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.046 -0.979 . . . . 3.4199999999999999 108.826 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1512 ' ' GLU . . . . . 0.603 ' HB3' ' HA ' ' A' 1509 ' ' LYS . 16.4 pt-20 -71.0 169.79 14.16 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-N 114.979 -1.01 . . . . 5.9500000000000002 109.444 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 27.3 m170 -120.03 92.39 3.77 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 109.507 -0.553 . . . . 5.3300000000000001 109.507 -177.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 19.3 t70 -134.44 -53.75 0.83 Allowed 'General case' 0 C--N 1.286 -2.193 0 C-N-CA 120.289 -0.564 . . . . 5.0599999999999996 111.431 179.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 14.0 t70 -127.48 -175.9 3.59 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 105.395 -2.076 . . . . 2.8999999999999999 105.395 177.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1516 ' ' CYS . . . . . 0.561 ' HA ' ' HB2' ' A' 1581 ' ' LEU . 91.1 m -88.5 66.5 8.26 Favored 'General case' 0 C--N 1.283 -2.293 0 CA-C-O 121.68 0.752 . . . . 1.1899999999999999 110.926 -177.306 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -152.22 130.86 12.3 Favored 'General case' 0 N--CA 1.415 -2.206 0 CA-C-N 114.666 -1.152 . . . . 1.52 109.301 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1518 ' ' VAL . . . . . 0.569 HG21 ' HB2' ' A' 1583 ' ' TYR . 2.9 m -145.12 142.9 22.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 C-N-CA 123.926 0.89 . . . . 0.93999999999999995 110.153 -179.067 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1519 ' ' THR . . . . . 0.593 ' HB ' ' HB3' ' A' 1510 ' ' SER . 18.9 m -101.81 145.34 29.31 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 116.301 -0.409 . . . . 0.89000000000000001 111.026 -177.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1520 ' ' ASN . . . . . 0.404 ' OD1' HG22 ' A' 1523 ' ' THR . 24.5 t-20 -76.2 111.88 17.72 Favored Pre-proline 0 N--CA 1.433 -1.289 0 N-CA-C 106.389 -1.708 . . . . 1.74 106.389 170.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -74.21 0.46 8.44 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.491 2.127 . . . . 1.5800000000000001 113.736 -174.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 19.6 m -91.15 -43.22 10.01 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 116.256 -0.429 . . . . 1.6499999999999999 111.603 177.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1523 ' ' THR . . . . . 0.404 HG22 ' OD1' ' A' 1520 ' ' ASN . 4.9 t -119.24 -8.86 10.05 Favored 'General case' 0 C--O 1.244 0.79 0 C-N-CA 119.943 -0.703 . . . . 1.6100000000000001 112.43 -177.41 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 85.95 20.37 55.73 Favored Glycine 0 C--N 1.317 -0.494 0 C-N-CA 120.423 -0.894 . . . . 1.1299999999999999 113.095 177.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 24.3 t-80 -84.35 123.63 30.4 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.057 0.455 . . . . 1.26 110.574 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 2.9 tm? -94.71 119.32 33.14 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 115.336 -0.847 . . . . 0.68000000000000005 110.943 -175.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -91.64 130.83 37.38 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 109.604 -0.517 . . . . 0.65000000000000002 109.604 169.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 16.3 t70 -125.64 122.56 36.75 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.452 -1.314 . . . . 1.1699999999999999 107.452 173.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 3.7 mm? -93.86 5.87 50.26 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 113.683 0.994 . . . . 0.59999999999999998 113.683 -170.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1530 ' ' SER . . . . . 0.571 ' HA ' ' OG ' ' A' 1533 ' ' SER . 3.6 m -66.16 -7.94 21.03 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 113.804 1.039 . . . . 0.83999999999999997 113.804 -174.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 8.5 t -69.22 -31.88 70.76 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 109.391 -0.596 . . . . 1.5900000000000001 109.391 179.035 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 81.1 mt -95.38 -7.03 39.63 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.069 0.461 . . . . 0.65000000000000002 110.795 -178.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1533 ' ' SER . . . . . 0.571 ' OG ' ' HA ' ' A' 1530 ' ' SER . 24.5 m -66.97 161.3 24.55 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.85 -0.614 . . . . 1.52 111.433 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . 155.86 159.82 9.61 Favored Glycine 0 N--CA 1.423 -2.174 0 N-CA-C 109.811 -1.316 . . . . 1.1000000000000001 109.811 -176.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1535 ' ' ARG . . . . . 0.428 ' O ' ' HA ' ' A' 1556 ' ' ASN . 42.2 ttp180 -92.26 -31.16 15.52 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 109.972 -0.381 . . . . 4.6200000000000001 109.972 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -66.67 -34.01 76.91 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 121.126 0.488 . . . . 1.45 110.878 -177.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 73.75 -157.29 51.48 Favored Glycine 0 N--CA 1.428 -1.85 0 CA-C-N 115.042 -0.981 . . . . 0.84999999999999998 113.676 172.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -137.26 152.05 49.38 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.84 -1.17 . . . . 0.93000000000000005 107.84 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 27.0 p -112.73 139.75 48.09 Favored 'General case' 0 C--N 1.308 -1.215 0 O-C-N 123.489 0.493 . . . . 1.03 111.177 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1540 ' ' ALA . . . . . 0.478 ' HB3' HG12 ' A' 1548 ' ' VAL . . . -131.35 135.14 46.99 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 108.409 -0.96 . . . . 0.5 108.409 174.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -73.58 141.7 46.62 Favored 'General case' 0 C--O 1.243 0.719 0 C-N-CA 122.601 0.36 . . . . 0.73999999999999999 110.866 -178.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1542 ' ' TYR . . . . . 0.481 ' HB3' ' H ' ' A' 1543 ' ' SER . 1.3 t80 -149.43 -101.14 0.07 Allowed 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 109.285 -0.635 . . . . 0.98999999999999999 109.285 -176.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1543 ' ' SER . . . . . 0.481 ' H ' ' HB3' ' A' 1542 ' ' TYR . 4.3 m -63.95 160.24 18.17 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.468 1.107 . . . . 1.9099999999999999 111.225 -178.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 52.3 tptt -50.76 -41.38 56.67 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 113.611 0.967 . . . . 3.5899999999999999 113.611 -173.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 11.9 t -128.75 37.93 4.03 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 108.785 -0.82 . . . . 2.46 108.785 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1546 ' ' GLY . . . . . 0.583 ' HA3' ' HG2' ' A' 1569 ' ' GLN . . . -147.96 120.34 1.21 Allowed Glycine 0 N--CA 1.428 -1.859 0 C-N-CA 119.555 -1.307 . . . . 1.26 113.573 -177.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 29.3 m -99.89 152.58 4.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 107.001 -1.481 . . . . 0.79000000000000004 107.001 174.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1548 ' ' VAL . . . . . 0.478 HG12 ' HB3' ' A' 1540 ' ' ALA . 12.3 p -92.76 134.42 30.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.865 0 C-N-CA 119.922 -0.711 . . . . 0.57999999999999996 109.202 178.192 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -99.87 129.13 45.93 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 115.355 -0.839 . . . . 1.0800000000000001 108.763 177.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 25.8 ptm -144.14 126.27 15.55 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 115.453 -0.794 . . . . 0.78000000000000003 110.972 -176.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 5.3 p -118.55 132.89 56.2 Favored 'General case' 0 C--N 1.282 -2.355 0 CA-C-N 115.002 -0.999 . . . . 0.96999999999999997 109.795 179.047 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1552 ' ' ILE . . . . . . . . . . . . . 46.8 mm -83.28 112.15 20.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 120.477 0.18 . . . . 0.41999999999999998 111.159 -176.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 57.9 m 64.99 29.6 12.17 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.622 1.169 . . . . 1.3999999999999999 112.093 174.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . -167.01 -174.8 36.55 Favored Glycine 0 N--CA 1.409 -3.113 0 N-CA-C 108.961 -1.656 . . . . 0.34999999999999998 108.961 -178.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -109.78 152.86 25.16 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-N 116.845 0.323 . . . . 1.6200000000000001 111.724 -175.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1556 ' ' ASN . . . . . 0.428 ' HA ' ' O ' ' A' 1535 ' ' ARG . 26.7 t-20 -103.29 138.63 39.81 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.008 -1.108 . . . . 0.87 108.008 178.64 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -85.97 2.33 46.66 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 114.06 1.133 . . . . 2.4900000000000002 114.06 -171.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -91.03 -1.81 57.75 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 120.491 -0.484 . . . . 1.3799999999999999 111.027 -178.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1559 ' ' CYS . . . . . 0.62 ' SG ' ' HD2' ' A' 1560 ' ' PRO . 16.0 t -137.43 151.74 71.81 Favored Pre-proline 0 C--N 1.304 -1.373 0 N-CA-C 106.648 -1.612 . . . . 1.21 106.648 178.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1560 ' ' PRO . . . . . 0.62 ' HD2' ' SG ' ' A' 1559 ' ' CYS . 13.3 Cg_exo -30.6 132.13 0.05 OUTLIER 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 125.226 3.95 . . . . 0.70999999999999996 114.655 178.393 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -45.02 129.25 9.86 Favored 'Trans proline' 0 C--N 1.364 1.385 0 C-N-CA 124.768 3.645 . . . . 0.80000000000000004 113.332 -177.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 96.6 18.98 28.67 Favored Glycine 0 C--N 1.313 -0.727 0 CA-C-N 116.204 -0.453 . . . . 0.46000000000000002 113.14 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1563 ' ' VAL . . . . . 0.596 HG11 ' HB2' ' A' 1566 ' ' CYS . 2.3 t -106.61 124.51 62.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 C-N-CA 123.02 0.528 . . . . 0.97999999999999998 111.661 -178.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -97.27 -33.97 5.77 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 115.242 -0.89 . . . . 0.28000000000000003 111.814 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -133.94 129.59 36.51 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 109.018 -0.734 . . . . 0.28000000000000003 109.018 177.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1566 ' ' CYS . . . . . 0.596 ' HB2' HG11 ' A' 1563 ' ' VAL . 48.5 t -158.32 138.11 12.09 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 110.52 -0.178 . . . . 0.42999999999999999 110.52 -176.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -84.72 135.45 34.14 Favored 'General case' 0 C--O 1.245 0.859 0 N-CA-C 108.428 -0.953 . . . . 1.03 108.428 173.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -91.79 27.71 9.55 Favored Glycine 0 N--CA 1.422 -2.286 0 N-CA-C 115.88 1.112 . . . . 1.1299999999999999 115.88 -170.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1569 ' ' GLN . . . . . 0.605 ' HB2' ' OD2' ' B' ' 15' ' ' ASP . 20.8 mt-30 -77.49 -69.04 0.56 Allowed 'General case' 0 C--O 1.241 0.617 0 C-N-CA 117.349 -1.74 . . . . 2.5800000000000001 109.579 171.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 71.0 p -114.33 15.7 17.98 Favored 'General case' 0 CA--C 1.553 1.058 0 N-CA-C 112.809 0.67 . . . . 2.1699999999999999 112.809 177.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? 66.43 68.78 0.43 Allowed 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.923 1.289 . . . . 2.6200000000000001 112.703 -179.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 18.8 mt -106.3 122.61 60.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 114.727 -1.124 . . . . 0.92000000000000004 108.793 177.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 35.7 t -83.2 138.53 33.59 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.669 0.747 . . . . 0.80000000000000004 111.244 -174.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1574 ' ' VAL . . . . . 0.589 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 27.1 m -123.39 18.05 5.03 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 CA-C-N 115.661 -0.699 . . . . 0.97999999999999998 110.392 178.211 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 167.52 126.44 0.84 Allowed Glycine 0 N--CA 1.422 -2.253 0 CA-C-N 115.113 -0.949 . . . . 0.28999999999999998 112.383 175.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 53.9 tttm -68.64 146.03 53.38 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.525 -0.917 . . . . 2.1899999999999999 108.525 177.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -73.48 79.45 1.43 Allowed 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.208 0.528 . . . . 0.60999999999999999 111.566 -178.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -96.35 -177.6 4.02 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 109.263 -0.643 . . . . 1.95 109.263 178.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 66.7 mttm -132.38 47.56 2.5 Favored 'General case' 0 CA--C 1.485 -1.548 0 N-CA-C 105.28 -2.119 . . . . 2.6800000000000002 105.28 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.49 76.62 5.83 Favored 'General case' 0 N--CA 1.415 -2.197 0 CA-C-N 113.773 -1.558 . . . . 3.4700000000000002 108.593 -171.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1581 ' ' LEU . . . . . 0.561 ' HB2' ' HA ' ' A' 1516 ' ' CYS . 0.3 OUTLIER -86.14 129.58 34.8 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.608 -1.178 . . . . 0.64000000000000001 108.691 -179.309 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A 1582 ' ' ARG . . . . . 0.547 ' HB2' ' HB3' ' A' 1589 ' ' GLN . 70.3 mtp180 -124.15 137.26 54.57 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 116.522 -0.308 . . . . 2.8500000000000001 110.273 173.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1583 ' ' TYR . . . . . 0.569 ' HB2' HG21 ' A' 1518 ' ' VAL . 66.9 t80 -105.62 104.37 14.07 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 107.853 -1.165 . . . . 0.85999999999999999 107.853 177.385 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1584 ' ' VAL . . . . . 0.529 ' O ' ' HB ' ' A' 1587 ' ' VAL . 16.7 m -121.2 89.51 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 112.81 0.67 . . . . 1.05 112.81 -175.202 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 17.4 t70 56.91 57.9 4.38 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.119 0.968 . . . . 1.1699999999999999 110.134 177.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1586 ' ' GLN . . . . . 0.53 ' HA ' ' CE1' ' A' 1583 ' ' TYR 0.296 9.1 pt20 68.87 4.67 4.58 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 128.196 2.598 . . . . 1.8600000000000001 112.637 179.116 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A 1587 ' ' VAL . . . . . 0.529 ' HB ' ' O ' ' A' 1584 ' ' VAL . 23.1 t -93.71 124.03 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.012 0 N-CA-C 108.491 -0.929 . . . . 0.48999999999999999 108.491 174.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1588 ' ' LEU . . . . . 0.859 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 3.4 mm? -92.73 107.77 19.47 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.157 -1.053 . . . . 0.35999999999999999 108.157 178.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1589 ' ' GLN . . . . . 0.547 ' HB3' ' HB2' ' A' 1582 ' ' ARG . 35.5 tt0 -99.05 123.65 43.5 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 116.025 -0.534 . . . . 1.74 110.23 -178.031 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1590 ' ' LEU . . . . . 0.476 ' HB3' ' HB ' ' A' 1610 ' ' ILE . 0.7 OUTLIER -117.83 96.02 5.18 Favored 'General case' 0 C--N 1.284 -2.27 0 N-CA-C 105.065 -2.198 . . . . 0.71999999999999997 105.065 174.885 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 8.4 p -96.31 132.16 41.29 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 CA-C-O 121.317 0.579 . . . . 1.01 111.665 -175.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1592 ' ' TYR . . . . . . . . . . . . . 14.2 m-30 -121.51 122.18 39.15 Favored 'General case' 0 CA--C 1.496 -1.12 0 N-CA-C 108.306 -0.998 . . . . 0.5 108.306 176.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 58.4 pttt -131.09 179.04 6.24 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 108.98 -0.748 . . . . 1.5900000000000001 108.98 177.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 19.9 m-20 62.17 53.2 2.97 Favored 'General case' 0 C--O 1.249 1.049 0 O-C-N 124.286 0.992 . . . . 1.1100000000000001 110.864 178.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -85.67 -105.23 0.71 Allowed Glycine 0 N--CA 1.429 -1.796 0 N-CA-C 109.558 -1.417 . . . . 0.78000000000000003 109.558 177.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1596 ' ' SER . . . . . . . . . . . . . 36.3 p -129.11 153.63 80.37 Favored Pre-proline 0 C--N 1.282 -2.331 0 N-CA-C 107.753 -1.202 . . . . 1.0700000000000001 107.753 174.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 90.7 Cg_exo -50.67 133.76 39.21 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.287 2.658 . . . . 1.01 113.509 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1598 ' ' CYS . . . . . 0.517 ' HA ' ' CE2' ' A' 1606 ' ' TYR . 44.4 t -81.83 119.27 74.89 Favored Pre-proline 0 C--N 1.283 -2.285 0 CA-C-N 113.875 -1.512 . . . . 0.75 109.018 -178.234 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1599 ' ' PRO . . . . . 0.488 ' HD2' ' OH ' ' A' 1606 ' ' TYR . 40.2 Cg_exo -60.43 -23.92 76.34 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 123.097 2.532 . . . . 1.7 112.965 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1600 ' ' SER . . . . . 0.741 ' HA ' ' HB2' ' B' ' 53' ' ' LEU . 19.5 m -54.37 -44.81 72.54 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 123.364 0.665 . . . . 2.2599999999999998 111.782 178.503 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1601 ' ' LYS . . . . . 0.548 ' HB3' HD12 ' A' 1604 ' ' LEU . 4.5 tppp? -148.24 127.88 13.31 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.97 -0.752 . . . . 3.0099999999999998 108.97 179.409 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 20.4 m -65.48 129.48 39.9 Favored 'General case' 0 N--CA 1.412 -2.345 0 N-CA-C 108.796 -0.816 . . . . 2.0699999999999998 108.796 -178.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 105.25 -10.87 47.53 Favored Glycine 0 N--CA 1.436 -1.359 0 C-N-CA 120.496 -0.859 . . . . 1.0800000000000001 112.499 178.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1604 ' ' LEU . . . . . 0.548 HD12 ' HB3' ' A' 1601 ' ' LYS . 67.6 mt -99.33 150.19 22.38 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.667 -0.494 . . . . 1.8400000000000001 109.667 178.356 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 22.4 t -123.4 153.15 40.79 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.555 -1.276 . . . . 1.4099999999999999 107.555 177.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1606 ' ' TYR . . . . . 0.589 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 49.6 m-85 -73.77 158.48 34.52 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 116.171 -0.468 . . . . 0.59999999999999998 111.903 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 20.0 ttpp -156.26 125.87 6.31 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.808 -0.633 . . . . 1.45 110.502 -178.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1608 ' ' SER . . . . . . . . . . . . . 20.0 m -106.45 129.86 54.35 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 109.015 -0.735 . . . . 1.1499999999999999 109.015 -179.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 26.2 t -114.21 102.41 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.598 0 N-CA-C 108.508 -0.923 . . . . 0.25 108.508 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1610 ' ' ILE . . . . . 0.476 ' HB ' ' HB3' ' A' 1590 ' ' LEU . 85.4 mt -90.11 113.8 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.662 0 N-CA-C 108.709 -0.848 . . . . 0.45000000000000001 108.709 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 34.5 m -109.64 106.76 16.56 Favored 'General case' 0 C--N 1.283 -2.288 0 CA-C-N 114.855 -1.066 . . . . 1.26 110.249 -178.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1612 ' ' PHE . . . . . 0.859 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 45.7 m-85 -80.27 119.24 22.76 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.88 -0.6 . . . . 0.26000000000000001 109.79 176.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1613 ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' 1641 ' ' HIS . 54.1 t -109.64 128.83 65.39 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-N 115.004 -0.998 . . . . 0.5 110.927 -174.149 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 5.8 t -55.19 109.44 0.53 Allowed 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 125.012 1.325 . . . . 0.77000000000000002 112.97 176.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1615 ' ' ARG . . . . . 0.808 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 4.3 tpt180 -129.08 94.36 34.07 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 106.963 -1.495 . . . . 2.5299999999999998 106.963 169.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1616 ' ' PRO . . . . . 0.631 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 37.6 Cg_endo -63.47 -32.41 70.9 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 122.789 2.326 . . . . 1.1000000000000001 115.999 -169.264 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -85.94 -18.16 33.44 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.211 -0.595 . . . . 3.0499999999999998 111.646 -176.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . 68.65 113.15 0.04 OUTLIER 'General case' 0 C--N 1.358 0.949 0 C-N-CA 125.23 1.412 . . . . 1.55 110.937 -174.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . -131.25 -155.87 8.3 Favored Glycine 0 N--CA 1.422 -2.292 0 C-N-CA 119.976 -1.107 . . . . 0.93000000000000005 111.208 -177.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -82.43 20.88 1.05 Allowed 'Trans proline' 0 C--O 1.235 0.375 0 C-N-CA 123.253 2.635 . . . . 0.88 113.588 -174.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1621 ' ' THR . . . . . . . . . . . . . 22.4 p -116.71 14.4 15.33 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-O 121.901 0.858 . . . . 0.96999999999999997 109.717 178.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 42.6 t30 -90.68 58.9 4.04 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 122.802 1.287 . . . . 0.71999999999999997 108.325 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1623 ' ' ARG . . . . . 0.412 ' HE ' ' HB2' ' A' 1623 ' ' ARG . 3.5 ptm180 -168.05 140.55 2.51 Favored Pre-proline 0 N--CA 1.428 -1.551 0 CA-C-N 113.486 -1.688 . . . . 3.2599999999999998 107.003 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1624 ' ' PRO . . . . . 0.451 ' HA ' ' O ' ' A' 1639 ' ' SER . 35.7 Cg_endo -61.98 103.99 0.31 Allowed 'Trans proline' 0 C--O 1.243 0.733 0 C-N-CA 123.133 2.555 . . . . 0.58999999999999997 113.012 -176.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 69.9 mtm -99.66 144.92 28.18 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.988 -0.551 . . . . 1.3700000000000001 109.869 176.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 1.5 tm? -86.89 115.33 24.23 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 106.883 -1.525 . . . . 0.89000000000000001 106.883 -176.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1627 ' ' ILE . . . . . 0.753 HD11 ' HB2' ' A' 1639 ' ' SER . 38.6 mm -75.94 -58.35 4.67 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.605 0 CA-C-O 121.589 0.709 . . . . 0.57999999999999996 109.186 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 40.3 m -164.18 151.3 11.78 Favored 'General case' 0 N--CA 1.427 -1.575 0 N-CA-C 107.639 -1.245 . . . . 1.3899999999999999 107.639 -174.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1629 ' ' LEU . . . . . 0.712 HD13 ' HG ' ' A' 1636 ' ' LEU . 33.0 tp -116.05 104.7 11.83 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 107.102 -1.444 . . . . 1.25 107.102 172.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 14.3 t70 -75.35 100.99 4.58 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.082 -1.047 . . . . 1.0900000000000001 108.63 178.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1631 ' ' LYS . . . . . 0.794 ' HD3' ' H ' ' A' 1631 ' ' LYS . 0.0 OUTLIER -65.31 -8.48 18.35 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 114.336 1.236 . . . . 3.6000000000000001 114.336 -175.677 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -96.06 -37.89 10.43 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 119.409 -0.916 . . . . 2.6000000000000001 110.909 -179.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 66.9 p -94.74 -16.4 23.07 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 116.026 -0.534 . . . . 0.75 110.798 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 74.5 m 68.59 35.76 3.08 Favored 'General case' 0 C--N 1.353 0.73 0 C-N-CA 124.572 1.149 . . . . 0.53000000000000003 110.698 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1635 ' ' THR . . . . . . . . . . . . . 41.3 m -99.19 131.79 44.97 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 114.455 -1.248 . . . . 0.46000000000000002 109.693 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1636 ' ' LEU . . . . . 0.712 ' HG ' HD13 ' A' 1629 ' ' LEU . 0.5 OUTLIER -110.24 121.62 45.72 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.638 -1.245 . . . . 0.85999999999999999 107.638 -179.018 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -101.93 129.46 48.2 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 120.898 0.38 . . . . 0.45000000000000001 110.836 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -125.83 137.37 53.76 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.312 -0.858 . . . . 0.5 109.82 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1639 ' ' SER . . . . . 0.753 ' HB2' HD11 ' A' 1627 ' ' ILE . 16.5 t -117.81 150.8 38.55 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.288 -1.004 . . . . 1.04 108.288 178.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 2.8 t90 -152.55 113.63 4.2 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 104.868 -2.271 . . . . 0.68000000000000005 104.868 -179.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1641 ' ' HIS . . . . . 0.808 ' HB3' ' HB2' ' A' 1615 ' ' ARG . 10.6 m-70 -101.2 111.13 23.26 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-O 121.357 0.599 . . . . 0.90000000000000002 109.79 -176.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1642 ' ' THR . . . . . . . . . . . . . 3.2 t -142.57 148.14 45.56 Favored Pre-proline 0 C--N 1.297 -1.71 0 CA-C-N 115.148 -0.933 . . . . 0.47999999999999998 109.278 -174.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1643 ' ' PRO . . . . . 0.631 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 58.9 Cg_endo -79.42 -14.41 13.06 Favored 'Trans proline' 0 C--N 1.363 1.318 0 C-N-CA 122.28 1.987 . . . . 0.66000000000000003 112.847 178.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 8.2 tt -70.76 -26.93 63.58 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.796 -0.816 . . . . 0.96999999999999997 108.796 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1645 ' ' ALA . . . . . 0.414 ' CB ' ' HB3' ' A' 1612 ' ' PHE . . . -99.09 28.42 4.44 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 114.718 -1.128 . . . . 0.83999999999999997 110.44 -177.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 47.7 t -121.57 140.95 51.58 Favored 'General case' 0 N--CA 1.419 -1.997 0 N-CA-C 108.794 -0.817 . . . . 1.1899999999999999 108.794 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -89.56 108.55 25.78 Favored Pre-proline 0 N--CA 1.421 -1.921 0 N-CA-C 107.629 -1.249 . . . . 3.1400000000000001 107.629 177.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1648 ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -69.51 106.22 1.58 Allowed 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 122.667 2.245 . . . . 2.5800000000000001 112.337 -173.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 9.6 tp10 . . . . . 0 C--N 1.297 -1.676 0 N-CA-C 107.787 -1.19 . . . . 4.7199999999999998 107.787 179.295 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.467 0 CA-C-O 121.039 0.447 . . . . 9.9700000000000006 110.423 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 2' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -134.2 137.89 44.73 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.31 -0.996 . . . . 7.6799999999999997 108.31 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -107.65 137.07 19.61 Favored Pre-proline 0 C--N 1.302 -1.494 0 N-CA-C 109.068 -0.716 . . . . 6.1100000000000003 109.068 -178.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -77.52 7.63 3.73 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.836 2.358 . . . . 4.8399999999999999 112.389 177.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 5' ' ' SER . . . . . 0.462 ' HB2' HD21 ' B' ' 8' ' ' LEU . 31.8 p -123.06 57.73 1.12 Allowed 'General case' 0 N--CA 1.425 -1.682 0 C-N-CA 124.019 0.927 . . . . 4.5999999999999996 109.78 -176.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -68.93 -38.68 79.66 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.827 -0.624 . . . . 4.2300000000000004 111.101 -177.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 19.4 p -127.07 99.61 5.77 Favored 'General case' 0 N--CA 1.421 -1.906 0 CA-C-N 115.513 -0.767 . . . . 3.1400000000000001 110.375 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.484 ' HB2' ' H ' ' B' ' 12' ' ' GLU . 91.0 mt -76.91 145.18 38.39 Favored 'General case' 0 C--O 1.249 1.062 0 N-CA-C 109.487 -0.56 . . . . 3.96 109.487 178.151 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 8.2 m -87.05 62.84 7.59 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 122.006 0.908 . . . . 2.8399999999999999 109.469 -173.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.32 -69.13 0.29 Allowed Glycine 0 C--N 1.293 -1.845 0 CA-C-N 114.753 -1.112 . . . . 2.0899999999999999 110.911 -178.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -57.16 -64.66 4.2 Favored Glycine 0 C--N 1.33 0.24 0 N-CA-C 113.919 0.328 . . . . 1.8400000000000001 113.919 -177.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 12' ' ' GLU . . . . . 0.484 ' H ' ' HB2' ' B' ' 8' ' ' LEU . 19.3 mm-40 -63.96 -32.32 73.81 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 109.349 -0.611 . . . . 2.5499999999999998 109.349 -178.387 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 13' ' ' LEU . . . . . 0.478 ' O ' HD23 ' B' ' 17' ' ' LEU . 0.1 OUTLIER -60.29 -59.56 5.22 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 114.441 -1.254 . . . . 2.3500000000000001 109.214 -178.926 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 14.2 p -69.21 -33.31 57.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 112.259 0.466 . . . . 2.1099999999999999 112.259 -176.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 15' ' ' ASP . . . . . 0.605 ' OD2' ' HB2' ' A' 1569 ' ' GLN . 11.9 t0 -59.86 -53.34 59.09 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 120.164 -0.614 . . . . 2.04 109.444 179.299 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 34.5 m -57.29 -51.14 70.56 Favored 'General case' 0 CA--C 1.566 1.571 0 C-N-CA 123.983 0.913 . . . . 1.8400000000000001 111.322 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.542 ' HG ' ' HD2' ' B' ' 28' ' ' PHE . 4.2 mm? -53.72 -46.98 70.99 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.628 -0.715 . . . . 1.74 112.214 176.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -83.15 -10.67 58.51 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-O 121.554 0.692 . . . . 2.3900000000000001 111.558 -177.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -68.5 -56.78 7.22 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.719 -0.673 . . . . 0.95999999999999996 110.283 177.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 15.0 p -95.32 -22.83 5.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 C-N-CA 118.571 -1.252 . . . . 1.3700000000000001 112.063 -176.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 60.3 m -108.81 27.01 9.89 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 120.197 -0.601 . . . . 1.6599999999999999 110.13 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -54.16 -54.82 29.53 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 121.171 -0.538 . . . . 1.53 113.125 178.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -71.97 -43.11 65.69 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 112.168 0.433 . . . . 2.7200000000000002 112.168 178.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 24' ' ' ARG . . . . . 0.491 ' HD2' ' HB3' ' B' ' 61' ' ' ALA . 39.1 ttm180 -67.73 -49.36 62.96 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 112.452 0.538 . . . . 4.3300000000000001 112.452 -175.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 125.84 140.86 5.43 Favored Glycine 0 N--CA 1.437 -1.244 0 N-CA-C 110.002 -1.239 . . . . 1.53 110.002 -175.251 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 26' ' ' PHE . . . . . 0.473 ' HB2' ' HB3' ' B' ' 17' ' ' LEU . 30.6 p90 -113.69 130.22 56.45 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 117.121 0.46 . . . . 1.6499999999999999 109.99 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -133.45 73.64 1.52 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.679 0.622 . . . . 3.4199999999999999 112.679 -177.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 28' ' ' PHE . . . . . 0.542 ' HD2' ' HG ' ' B' ' 17' ' ' LEU . 34.3 p90 -93.7 -22.9 18.45 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.223 -0.991 . . . . 2.2599999999999998 109.013 173.425 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 13.4 t -104.09 92.63 4.46 Favored 'General case' 0 N--CA 1.424 -1.725 0 CA-C-N 115.402 -0.817 . . . . 3.6800000000000002 108.946 -175.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 27.0 mtm180 -123.38 162.72 38.43 Favored Pre-proline 0 C--N 1.31 -1.136 0 CA-C-N 115.958 -0.565 . . . . 3.8100000000000001 109.584 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -76.71 -7.85 17.8 Favored 'Trans proline' 0 C--N 1.355 0.906 0 C-N-CA 123.339 2.692 . . . . 4.0199999999999996 113.216 177.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 32' ' ' ALA . . . . . 0.582 ' HA ' ' HA ' ' B' ' 39' ' ' SER . . . -169.51 168.33 9.4 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 105.5 -2.037 . . . . 4.9199999999999999 105.5 178.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 22.9 t -144.06 -157.55 0.79 Allowed 'General case' 1 N--CA 1.369 -4.502 0 N-CA-C 106.519 -1.66 . . . . 6.7199999999999998 106.519 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 62.0 mtp180 -63.95 -24.46 67.74 Favored 'General case' 0 C--N 1.255 -3.505 0 C-N-CA 123.977 0.911 . . . . 11.630000000000001 113.096 -177.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 7.3 p -119.45 8.17 6.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-O 122.82 1.295 . . . . 9.6099999999999994 112.398 -173.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 48.4 t 67.66 -57.56 0.45 Allowed 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 113.495 -1.684 . . . . 6.71 113.087 179.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 14.9 tpp180 -44.54 -51.25 9.08 Favored 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 127.289 2.236 . . . . 10.0 111.449 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 23.2 mmm180 -91.04 108.27 19.75 Favored 'General case' 0 N--CA 1.391 -3.419 0 N-CA-C 105.677 -1.972 . . . . 7.9400000000000004 105.677 175.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 39' ' ' SER . . . . . 0.582 ' HA ' ' HA ' ' B' ' 32' ' ' ALA . 19.2 m -74.61 -43.24 56.43 Favored 'General case' 0 N--CA 1.427 -1.62 0 N-CA-C 108.513 -0.921 . . . . 5.7599999999999998 108.513 177.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 67.6 mtt180 -107.67 149.87 27.59 Favored 'General case' 0 N--CA 1.412 -2.344 0 N-CA-C 106.257 -1.757 . . . . 6.0300000000000002 106.257 177.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . -121.15 160.63 15.43 Favored Glycine 0 N--CA 1.407 -3.259 0 N-CA-C 109.773 -1.331 . . . . 2.3700000000000001 109.773 -176.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 42' ' ' ILE . . . . . 0.538 HD11 HD21 ' B' ' 17' ' ' LEU . 20.0 pt 61.51 -30.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 C-N-CA 127.953 2.501 . . . . 2.0699999999999998 114.821 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.63 ' O ' ' HB2' ' B' ' 47' ' ' CYS . 2.6 p -49.88 -43.01 19.27 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 114.236 1.199 . . . . 2.2400000000000002 114.236 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -96.28 -35.04 11.39 Favored 'General case' 0 N--CA 1.429 -1.523 0 C-N-CA 120.207 -0.597 . . . . 3.3599999999999999 109.566 -175.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 45' ' ' GLU . . . . . 0.427 ' HG3' ' HD2' ' B' ' 49' ' ' ARG . 33.7 tt0 -63.87 -45.4 89.59 Favored 'General case' 0 C--O 1.202 -1.431 0 CA-C-N 115.905 -0.589 . . . . 3.0800000000000001 109.769 179.276 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 46' ' ' CYS . . . . . . . . . . . . . 29.3 m -85.16 -4.16 59.06 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.216 0.531 . . . . 2.23 110.88 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 47' ' ' CYS . . . . . 0.63 ' HB2' ' O ' ' B' ' 43' ' ' VAL . 42.2 t -77.62 -45.36 25.35 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.523 0.677 . . . . 2.3700000000000001 109.195 175.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -105.23 -10.25 17.19 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 113.236 0.828 . . . . 2.8199999999999998 113.236 -176.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 49' ' ' ARG . . . . . 0.427 ' HD2' ' HG3' ' B' ' 45' ' ' GLU . 93.0 mtt180 -129.47 171.31 12.69 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 106.956 -1.498 . . . . 4.0899999999999999 106.956 177.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 22.7 t -99.71 148.11 24.72 Favored 'General case' 0 N--CA 1.426 -1.66 0 N-CA-C 107.609 -1.256 . . . . 2.6699999999999999 107.609 173.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 76.9 m -125.98 142.01 51.71 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 109.553 -0.536 . . . . 2.1099999999999999 109.553 -175.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -81.77 161.79 23.15 Favored 'General case' 0 C--O 1.243 0.725 0 O-C-N 123.15 0.281 . . . . 2.6699999999999999 110.88 176.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 53' ' ' LEU . . . . . 0.741 ' HB2' ' HA ' ' A' 1600 ' ' SER . 62.7 tp -55.33 -36.23 66.04 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 122.508 0.323 . . . . 1.8999999999999999 111.405 178.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.9 -26.51 65.96 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 123.648 0.779 . . . . 1.52 112.556 -174.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 52.6 tp -74.44 -54.56 7.32 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 109.551 -0.537 . . . . 1.97 109.551 177.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 56' ' ' LEU . . . . . 0.5 ' O ' ' HB2' ' B' ' 60' ' ' CYS . 2.8 pp -70.92 -33.32 70.41 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-N 115.923 -0.58 . . . . 1.53 111.392 -174.421 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -54.47 -51.39 65.2 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 123.663 0.602 . . . . 2.27 111.318 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 8.9 t -82.7 -28.29 30.65 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 112.492 0.553 . . . . 2.3300000000000001 112.492 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -78.38 -36.27 46.13 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 121.807 -0.558 . . . . 2.8599999999999999 110.695 -175.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 60' ' ' CYS . . . . . 0.5 ' HB2' ' O ' ' B' ' 56' ' ' LEU . 12.0 t -39.87 -62.41 0.72 Allowed 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 126.011 1.724 . . . . 2.2999999999999998 111.84 -178.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 61' ' ' ALA . . . . . 0.491 ' HB3' ' HD2' ' B' ' 24' ' ' ARG . . . -176.44 172.67 2.19 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 105.437 -2.061 . . . . 3.1899999999999999 105.437 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 19.6 p -135.09 152.21 76.7 Favored Pre-proline 0 C--N 1.29 -1.993 0 N-CA-C 109.015 -0.735 . . . . 3.6800000000000002 109.015 -173.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -59.92 -8.89 8.59 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 123.481 2.787 . . . . 5.0800000000000001 112.933 176.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 73.47 28.11 1.77 Allowed 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 126.282 1.833 . . . . 5.0999999999999996 112.535 173.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -98.38 -7.81 28.1 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 107.341 -1.355 . . . . 8.5099999999999998 107.341 176.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 43.5 p -118.23 -174.77 2.72 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 114.263 -1.335 . . . . 8.1199999999999992 108.33 176.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 . . . . . 0 C--N 1.311 -1.076 0 N-CA-C 108.275 -1.009 . . . . 10.210000000000001 108.275 177.779 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 23.6 ptp . . . . . 0 N--CA 1.473 0.712 0 CA-C-O 119.351 -0.357 . . . . 9.3399999999999999 111.136 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 64.8 tttp 56.36 73.97 0.42 Allowed 'General case' 0 C--O 1.245 0.862 0 CA-C-O 122.427 1.108 . . . . 9.0399999999999991 110.478 -178.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 28.9 m -145.83 149.65 34.71 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 107.815 -1.179 . . . . 5.8099999999999996 107.815 -177.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1511 ' ' ASN . . . . . . . . . . . . . 2.8 m-20 59.86 57.36 3.14 Favored 'General case' 0 C--O 1.246 0.887 0 CA-C-O 121.829 0.823 . . . . 3.4199999999999999 109.596 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1512 ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -76.86 -28.42 55.43 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 114.531 -1.213 . . . . 5.9500000000000002 110.843 -175.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 27.6 t-80 81.35 142.7 0.07 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.891 1.676 . . . . 5.3300000000000001 111.102 -178.342 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 18.5 t70 78.02 8.41 2.42 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.182 1.393 . . . . 5.0599999999999996 109.698 178.334 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 26.5 p-10 -121.98 138.8 54.29 Favored 'General case' 0 N--CA 1.414 -2.234 0 N-CA-C 107.068 -1.456 . . . . 2.8999999999999999 107.068 176.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 11.8 m -87.06 51.07 2.14 Favored 'General case' 0 C--N 1.276 -2.628 0 CA-C-N 115.703 -0.68 . . . . 1.1899999999999999 110.271 -174.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1517 ' ' GLN . . . . . 0.416 ' HA ' ' O ' ' A' 1527 ' ' PHE . 10.8 pt20 -162.98 132.05 4.09 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-O 121.23 0.538 . . . . 1.52 111.381 -174.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 6.6 m -135.46 144.79 33.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 CA-C-N 116.083 -0.508 . . . . 0.93999999999999995 110.038 179.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1519 ' ' THR . . . . . . . . . . . . . 28.9 m -114.65 134.52 55.0 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.386 -0.598 . . . . 0.89000000000000001 109.386 177.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1520 ' ' ASN . . . . . 0.529 ' OD1' HG22 ' A' 1523 ' ' THR . 13.9 t-20 -89.98 115.23 63.46 Favored Pre-proline 0 N--CA 1.43 -1.429 0 N-CA-C 108.322 -0.992 . . . . 1.74 108.322 175.291 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -66.54 -16.51 51.09 Favored 'Trans proline' 0 CA--C 1.533 0.439 0 C-N-CA 122.898 2.399 . . . . 1.5800000000000001 113.514 -175.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1522 ' ' SER . . . . . 0.45 ' HB2' ' OD1' ' A' 1520 ' ' ASN . 15.9 m -71.8 -50.05 33.26 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 116.439 -0.346 . . . . 1.6499999999999999 111.393 -179.067 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1523 ' ' THR . . . . . 0.529 HG22 ' OD1' ' A' 1520 ' ' ASN . 9.9 t -111.62 -1.86 15.61 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 120.479 -0.488 . . . . 1.6100000000000001 111.524 -176.254 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 66.58 33.26 84.0 Favored Glycine 0 CA--C 1.501 -0.817 0 CA-C-N 115.737 -0.665 . . . . 1.1299999999999999 112.41 177.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 55.5 t-80 -94.85 123.73 38.48 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 119.971 -0.692 . . . . 1.26 109.408 -178.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 2.0 tm? -93.71 111.52 23.22 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.101 -1.074 . . . . 0.68000000000000005 108.101 179.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1527 ' ' PHE . . . . . 0.416 ' O ' ' HA ' ' A' 1517 ' ' GLN . 74.0 m-85 -94.0 115.32 27.65 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.92 -0.488 . . . . 0.65000000000000002 110.217 176.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 20.5 t70 -104.78 113.3 26.8 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 109.188 -0.671 . . . . 1.1699999999999999 109.188 176.384 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1529 ' ' LEU . . . . . 0.507 ' HG ' HD21 ' A' 1581 ' ' LEU . 3.0 mm? -102.31 2.33 36.76 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 108.727 -0.842 . . . . 0.59999999999999998 108.727 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 2.1 m -66.98 -27.97 67.88 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.659 -0.7 . . . . 0.83999999999999997 109.886 -177.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 27.7 t -69.85 -18.41 63.43 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.866 -0.606 . . . . 1.5900000000000001 110.637 178.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1532 ' ' LEU . . . . . 0.491 ' O ' ' HB ' ' A' 1552 ' ' ILE . 74.8 mt -94.76 0.83 55.27 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.323 0.583 . . . . 0.65000000000000002 110.192 -178.52 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1533 ' ' SER . . . . . . . . . . . . . 41.5 m -77.72 164.72 25.01 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 109.351 -0.611 . . . . 1.52 109.351 175.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -179.62 155.01 14.62 Favored Glycine 0 N--CA 1.421 -2.362 0 N-CA-C 108.386 -1.886 . . . . 1.1000000000000001 108.386 178.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 58.0 ttp180 -86.49 -29.27 22.89 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 121.092 0.472 . . . . 4.6200000000000001 110.852 -177.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -88.01 -29.42 20.73 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.445 0.641 . . . . 1.45 110.021 177.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 94.06 -155.77 22.06 Favored Glycine 0 N--CA 1.418 -2.514 0 CA-C-N 115.299 -0.864 . . . . 0.84999999999999998 111.645 175.029 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -130.49 148.39 52.29 Favored 'General case' 0 C--N 1.278 -2.535 0 N-CA-C 107.546 -1.279 . . . . 0.93000000000000005 107.546 177.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 7.3 p -109.15 132.73 53.84 Favored 'General case' 0 C--N 1.292 -1.913 0 O-C-N 123.677 0.611 . . . . 1.03 111.001 -176.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1540 ' ' ALA . . . . . 0.444 ' HB3' ' CG1' ' A' 1548 ' ' VAL . . . -125.65 144.34 50.64 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.9 -1.148 . . . . 0.5 107.9 175.281 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -77.35 132.04 38.38 Favored 'General case' 0 C--N 1.313 -1.008 0 O-C-N 123.556 0.535 . . . . 0.73999999999999999 110.312 -177.056 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1542 ' ' TYR . . . . . 0.722 ' HE2' ' HG ' ' A' 1626 ' ' LEU . 9.3 t80 -136.76 -99.79 0.21 Allowed 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.326 -0.99 . . . . 0.98999999999999999 108.326 -178.499 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1543 ' ' SER . . . . . 0.406 ' H ' ' HB3' ' A' 1542 ' ' TYR . 47.7 t -86.84 160.82 18.62 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-O 121.602 0.715 . . . . 1.9099999999999999 109.726 -175.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -72.39 -18.52 61.72 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.637 -0.71 . . . . 3.5899999999999999 110.724 -178.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 13.2 t -87.63 -41.07 13.67 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.156 0.503 . . . . 2.46 110.22 -178.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . -153.27 159.05 28.34 Favored Glycine 0 N--CA 1.431 -1.69 0 C-N-CA 120.708 -0.758 . . . . 1.26 112.021 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 33.7 m -94.59 -179.41 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 107.929 -1.137 . . . . 0.79000000000000004 107.929 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1548 ' ' VAL . . . . . 0.444 ' CG1' ' HB3' ' A' 1540 ' ' ALA . 14.2 p -104.37 135.94 39.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 C-N-CA 119.716 -0.794 . . . . 0.57999999999999996 109.561 177.132 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1549 ' ' TYR . . . . . 0.429 ' HB3' ' ND2' ' A' 1556 ' ' ASN . 86.1 m-85 -102.05 129.28 48.33 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 108.81 -0.811 . . . . 1.0800000000000001 108.81 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 26.1 ptm -148.43 132.96 17.7 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 116.045 -0.525 . . . . 0.78000000000000003 111.484 -178.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 6.8 p -118.89 126.47 51.87 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 115.775 -0.648 . . . . 0.96999999999999997 110.041 178.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1552 ' ' ILE . . . . . 0.491 ' HB ' ' O ' ' A' 1532 ' ' LEU . 36.0 mm -77.6 112.46 15.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 112.362 0.505 . . . . 0.41999999999999998 112.362 -177.174 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 46.3 t 62.12 32.12 17.54 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.398 1.079 . . . . 1.3999999999999999 110.977 174.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . -163.96 174.28 40.08 Favored Glycine 0 N--CA 1.422 -2.281 0 N-CA-C 108.947 -1.661 . . . . 0.34999999999999998 108.947 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -100.54 155.0 18.09 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 117.48 0.64 . . . . 1.6200000000000001 110.761 -178.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1556 ' ' ASN . . . . . 0.429 ' ND2' ' HB3' ' A' 1549 ' ' TYR . 49.8 t-20 -108.4 132.74 53.45 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 115.05 -0.977 . . . . 0.87 109.236 -176.248 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -82.72 1.83 36.77 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.599 0.592 . . . . 2.4900000000000002 112.599 -176.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -78.89 -19.95 50.63 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.326 0.584 . . . . 1.3799999999999999 110.273 176.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1559 ' ' CYS . . . . . 0.645 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 76.1 m -132.71 172.42 7.41 Favored Pre-proline 0 C--N 1.299 -1.612 0 CA-C-O 117.795 -1.098 . . . . 1.21 109.871 -178.038 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1560 ' ' PRO . . . . . 0.645 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 18.1 Cg_exo -36.84 148.22 0.06 OUTLIER 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 124.296 3.33 . . . . 0.70999999999999996 115.747 178.489 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -58.73 127.72 25.49 Favored 'Trans proline' 0 C--O 1.254 1.292 0 C-N-CA 123.626 2.884 . . . . 0.80000000000000004 112.113 178.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 92.45 9.12 61.95 Favored Glycine 0 N--CA 1.438 -1.213 0 CA-C-N 115.942 -0.572 . . . . 0.46000000000000002 112.124 -179.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1563 ' ' VAL . . . . . 0.567 ' HB ' ' O ' ' A' 1560 ' ' PRO . 2.8 t -96.09 124.55 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.339 0 CA-C-O 121.021 0.438 . . . . 0.97999999999999998 111.231 179.522 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -101.73 -31.95 5.27 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 115.147 -0.933 . . . . 0.28000000000000003 112.069 178.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -128.62 129.8 46.39 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 109.669 -0.493 . . . . 0.28000000000000003 109.669 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 11.4 t -159.52 136.48 9.48 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 116.409 -0.36 . . . . 0.42999999999999999 110.395 -176.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -89.71 149.89 22.56 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 121.991 -0.443 . . . . 1.03 110.763 177.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -89.05 20.81 30.9 Favored Glycine 0 N--CA 1.438 -1.227 0 CA-C-N 116.69 -0.232 . . . . 1.1299999999999999 113.492 -177.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1569 ' ' GLN . . . . . 0.551 ' HG3' ' HD1' ' B' ' 19' ' ' PHE . 15.8 mm100 -68.22 -69.94 0.29 Allowed 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.579 -0.897 . . . . 2.5800000000000001 108.579 173.573 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 6.0 p -130.09 28.49 5.02 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.28 0.562 . . . . 2.1699999999999999 111.056 175.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 12.6 mmt85 60.56 48.1 7.81 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 115.157 -0.929 . . . . 2.6200000000000001 110.808 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 40.2 mt -93.38 129.12 44.28 Favored 'Isoleucine or valine' 0 C--O 1.247 0.964 0 CA-C-N 115.392 -0.822 . . . . 0.92000000000000004 110.039 179.376 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 29.0 t -80.74 148.95 29.88 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 123.605 0.762 . . . . 0.80000000000000004 111.416 -178.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1574 ' ' VAL . . . . . . . . . . . . . 29.8 m -134.78 12.6 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 115.859 -0.609 . . . . 0.97999999999999998 110.522 176.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 175.52 131.64 1.48 Allowed Glycine 0 N--CA 1.423 -2.214 0 C-N-CA 119.46 -1.352 . . . . 0.28999999999999998 112.627 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1576 ' ' LYS . . . . . 0.415 ' HE3' ' HB2' ' A' 1576 ' ' LYS . 39.0 ttmt -74.79 147.69 41.01 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.759 -0.83 . . . . 2.1899999999999999 108.759 177.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -73.93 79.26 1.65 Allowed 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 115.813 -0.63 . . . . 0.60999999999999999 111.136 -178.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -89.77 146.65 24.32 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 115.657 -0.701 . . . . 1.95 110.393 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -111.15 45.96 1.13 Allowed 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.527 -1.286 . . . . 2.6800000000000002 107.527 -176.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -101.42 76.78 1.72 Allowed 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 114.007 -1.451 . . . . 3.4700000000000002 107.401 -176.5 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1581 ' ' LEU . . . . . 0.507 HD21 ' HG ' ' A' 1529 ' ' LEU . 0.4 OUTLIER -74.11 124.06 25.59 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.309 -1.367 . . . . 0.64000000000000001 107.309 178.531 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -126.22 140.93 52.16 Favored 'General case' 0 C--N 1.288 -2.099 0 C-N-CA 119.92 -0.712 . . . . 2.8500000000000001 111.617 177.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1583 ' ' TYR . . . . . 0.456 ' CE1' ' HA ' ' A' 1586 ' ' GLN . 72.4 t80 -108.43 123.24 48.56 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.044 -1.095 . . . . 0.85999999999999999 108.044 178.608 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1584 ' ' VAL . . . . . 0.561 ' O ' ' HB ' ' A' 1587 ' ' VAL . 12.5 p -149.25 110.91 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-O 121.433 0.635 . . . . 1.05 111.044 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 30.7 t70 56.99 55.23 6.26 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 125.247 1.419 . . . . 1.1699999999999999 111.257 -178.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1586 ' ' GLN . . . . . 0.456 ' HA ' ' CE1' ' A' 1583 ' ' TYR . 13.7 pt20 60.72 9.51 2.22 Favored 'General case' 0 N--CA 1.499 2.015 0 C-N-CA 126.864 2.066 . . . . 1.8600000000000001 112.498 177.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1587 ' ' VAL . . . . . 0.561 ' HB ' ' O ' ' A' 1584 ' ' VAL . 20.5 t -102.08 127.88 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.327 0 CA-C-N 113.877 -1.51 . . . . 0.48999999999999999 109.326 178.563 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1588 ' ' LEU . . . . . 0.943 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 2.4 mm? -92.34 117.48 29.95 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 106.605 -1.628 . . . . 0.35999999999999999 106.605 178.158 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -119.88 133.32 55.62 Favored 'General case' 0 C--N 1.283 -2.302 0 CA-C-O 121.806 0.813 . . . . 1.74 111.86 -176.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 11.2 mt -121.25 112.21 18.34 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 106.807 -1.553 . . . . 0.71999999999999997 106.807 173.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 6.1 p -101.39 125.36 55.42 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.33 0 C-N-CA 119.92 -0.712 . . . . 1.01 109.683 -178.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1592 ' ' TYR . . . . . 0.647 ' HB2' ' HB2' ' A' 1608 ' ' SER . 14.1 m-30 -107.23 136.45 47.04 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 108.345 -0.983 . . . . 0.5 108.345 178.736 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 13.2 ptmm? -150.47 177.41 10.03 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 108.192 -1.04 . . . . 1.5900000000000001 108.192 -172.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 28.4 m-20 59.56 63.93 1.43 Allowed 'General case' 0 C--N 1.317 -0.835 0 O-C-N 124.591 1.182 . . . . 1.1100000000000001 111.163 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -112.81 -126.13 4.52 Favored Glycine 0 N--CA 1.424 -2.103 0 N-CA-C 109.877 -1.289 . . . . 0.78000000000000003 109.877 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1596 ' ' SER . . . . . 0.427 ' HA ' ' HD3' ' A' 1597 ' ' PRO . 49.7 m -87.4 140.51 32.07 Favored Pre-proline 0 C--N 1.295 -1.765 0 N-CA-C 109.311 -0.626 . . . . 1.0700000000000001 109.311 177.359 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1597 ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' 1596 ' ' SER . 38.2 Cg_exo -62.51 119.95 7.27 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 122.293 1.995 . . . . 1.01 108.275 173.473 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1598 ' ' CYS . . . . . 0.481 ' HA ' ' HD3' ' A' 1599 ' ' PRO . 37.8 t -77.33 128.2 81.06 Favored Pre-proline 0 C--N 1.294 -1.825 0 CA-C-N 115.728 -0.669 . . . . 0.75 109.612 -173.131 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1599 ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' 1598 ' ' CYS . 16.9 Cg_exo -68.35 -28.46 33.05 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.46 2.773 . . . . 1.7 112.639 -176.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1600 ' ' SER . . . . . . . . . . . . . 2.0 m -59.94 -42.55 94.27 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 123.748 0.819 . . . . 2.2599999999999998 111.935 -178.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1601 ' ' LYS . . . . . 0.543 ' HB3' HD22 ' A' 1604 ' ' LEU . 3.8 tppp? -131.54 105.21 7.41 Favored 'General case' 0 N--CA 1.407 -2.613 0 N-CA-C 107.207 -1.405 . . . . 3.0099999999999998 107.207 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 36.8 p -51.76 121.75 7.07 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 123.531 0.52 . . . . 2.0699999999999998 111.972 179.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 92.44 11.41 59.58 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.93 -0.652 . . . . 1.0800000000000001 112.369 178.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1604 ' ' LEU . . . . . 0.543 HD22 ' HB3' ' A' 1601 ' ' LYS . 9.4 tp -109.56 160.25 16.41 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.913 -1.143 . . . . 1.8400000000000001 107.913 179.079 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 29.5 t -123.51 157.48 33.48 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 109.073 -0.714 . . . . 1.4099999999999999 109.073 177.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1606 ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -71.97 153.5 41.77 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 108.118 -1.067 . . . . 0.59999999999999998 108.118 172.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.42 126.4 7.72 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.216 0.531 . . . . 1.45 110.533 -175.237 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1608 ' ' SER . . . . . 0.647 ' HB2' ' HB2' ' A' 1592 ' ' TYR . 16.4 m -105.07 128.58 53.41 Favored 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 115.323 -0.853 . . . . 1.1499999999999999 109.129 -175.236 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 34.4 t -111.22 101.74 12.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 CA-C-O 121.268 0.556 . . . . 0.25 109.795 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1610 ' ' ILE . . . . . 0.43 ' HA ' ' HB2' ' A' 1638 ' ' PHE . 96.8 mt -91.62 117.57 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.608 0 N-CA-C 108.84 -0.8 . . . . 0.45000000000000001 108.84 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 32.7 m -120.38 116.72 26.04 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.69 -0.686 . . . . 1.26 110.902 -178.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1612 ' ' PHE . . . . . 0.943 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 70.7 m-85 -90.41 122.69 33.5 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.787 -0.642 . . . . 0.26000000000000001 109.386 177.701 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 43.7 t -113.39 140.89 31.25 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 CA-C-N 115.306 -0.861 . . . . 0.5 109.308 -176.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 35.3 t -71.91 111.23 6.98 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.162 -0.472 . . . . 0.77000000000000002 111.308 -178.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1615 ' ' ARG . . . . . 0.728 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 19.8 tpt180 -124.92 87.39 55.32 Favored Pre-proline 0 CA--C 1.54 0.585 0 N-CA-C 109.331 -0.618 . . . . 2.5299999999999998 109.331 174.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1616 ' ' PRO . . . . . 0.459 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 39.3 Cg_exo -62.8 -35.06 70.41 Favored 'Trans proline' 0 N--CA 1.483 0.855 0 C-N-CA 123.128 2.552 . . . . 1.1000000000000001 114.365 -173.674 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -79.09 -13.24 59.87 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 112.491 0.552 . . . . 3.0499999999999998 112.491 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . 66.57 -168.12 0.21 Allowed 'General case' 0 C--N 1.318 -0.775 0 O-C-N 124.507 1.13 . . . . 1.55 109.266 -174.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . 148.42 -163.39 28.96 Favored Glycine 0 N--CA 1.413 -2.835 0 N-CA-C 110.394 -1.082 . . . . 0.93000000000000005 110.394 179.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -82.65 21.42 1.0 Allowed 'Trans proline' 0 C--N 1.327 -0.574 0 C-N-CA 123.755 2.97 . . . . 0.88 111.971 -176.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1621 ' ' THR . . . . . 0.633 ' HB ' ' HB2' ' A' 1641 ' ' HIS . 18.6 p -108.08 -0.5 21.13 Favored 'General case' 0 C--N 1.282 -2.353 0 CA-C-N 113.933 -1.485 . . . . 0.96999999999999997 109.899 -178.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -88.46 56.85 3.96 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 122.332 1.063 . . . . 0.71999999999999997 109.258 -177.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1623 ' ' ARG . . . . . 0.563 ' O ' ' HG3' ' A' 1625 ' ' MET . 27.4 ptt180 -165.96 141.09 3.93 Favored Pre-proline 0 C--N 1.29 -1.996 0 N-CA-C 106.449 -1.685 . . . . 3.2599999999999998 106.449 -178.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -53.81 104.55 0.11 Allowed 'Trans proline' 0 CA--C 1.534 0.49 0 C-N-CA 123.187 2.591 . . . . 0.58999999999999997 111.901 -178.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1625 ' ' MET . . . . . 0.563 ' HG3' ' O ' ' A' 1623 ' ' ARG . 92.1 mtp -98.3 110.2 22.83 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.335 -0.987 . . . . 1.3700000000000001 108.335 -176.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1626 ' ' LEU . . . . . 0.722 ' HG ' ' HE2' ' A' 1542 ' ' TYR . 0.7 OUTLIER -72.92 112.87 9.35 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 106.756 -1.572 . . . . 0.89000000000000001 106.756 179.615 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A 1627 ' ' ILE . . . . . 0.573 HD11 ' HB2' ' A' 1639 ' ' SER . 31.0 mm -73.14 -57.54 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 N-CA-C 108.993 -0.743 . . . . 0.57999999999999996 108.993 -178.196 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 49.9 m -163.99 152.39 13.19 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.598 -0.728 . . . . 1.3899999999999999 109.416 -174.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1629 ' ' LEU . . . . . 0.952 HD13 ' HG ' ' A' 1636 ' ' LEU . 23.0 tp -117.35 100.71 7.86 Favored 'General case' 0 N--CA 1.426 -1.659 0 N-CA-C 107.345 -1.354 . . . . 1.25 107.345 171.318 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 20.6 t70 -74.23 114.23 12.34 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.47 -0.937 . . . . 1.0900000000000001 108.47 178.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1631 ' ' LYS . . . . . 0.565 ' HB3' HD23 ' B' ' 53' ' ' LEU . 65.2 mttp -66.66 -20.78 66.06 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 113.759 1.022 . . . . 3.6000000000000001 113.759 -175.074 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -88.66 -42.18 12.15 Favored 'General case' 0 CA--C 1.495 -1.143 0 CA-C-O 121.506 0.67 . . . . 2.6000000000000001 111.311 -175.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 73.3 p -93.12 -8.2 43.32 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-N 115.34 -0.846 . . . . 0.75 110.792 -177.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1634 ' ' CYS . . . . . 0.494 ' SG ' HD23 ' A' 1604 ' ' LEU . 39.4 m 57.94 33.07 22.79 Favored 'General case' 0 C--N 1.361 1.084 0 C-N-CA 124.753 1.221 . . . . 0.53000000000000003 110.908 175.166 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1635 ' ' THR . . . . . . . . . . . . . 64.3 m -104.89 130.76 52.98 Favored 'General case' 0 N--CA 1.425 -1.703 0 CA-C-N 114.219 -1.355 . . . . 0.46000000000000002 109.313 -177.226 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1636 ' ' LEU . . . . . 0.952 ' HG ' HD13 ' A' 1629 ' ' LEU . 0.6 OUTLIER -111.43 126.47 54.98 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 106.522 -1.659 . . . . 0.85999999999999999 106.522 -178.736 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A 1637 ' ' PHE . . . . . 0.508 ' HB2' ' HB ' ' A' 1627 ' ' ILE . 87.8 m-85 -102.09 138.83 38.52 Favored 'General case' 0 C--N 1.293 -1.879 0 C-N-CA 120.915 -0.314 . . . . 0.45000000000000001 110.315 -178.435 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1638 ' ' PHE . . . . . 0.461 ' HE1' ' HB3' ' A' 1608 ' ' SER . 96.0 m-85 -131.57 134.49 46.12 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 108.671 -0.862 . . . . 0.5 108.671 -177.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1639 ' ' SER . . . . . 0.573 ' HB2' HD11 ' A' 1627 ' ' ILE . 22.6 t -116.85 152.36 34.61 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 107.542 -1.281 . . . . 1.04 107.542 175.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 2.9 t90 -153.35 109.79 3.37 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 104.535 -2.394 . . . . 0.68000000000000005 104.535 178.085 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1641 ' ' HIS . . . . . 0.728 ' HB3' ' HB2' ' A' 1615 ' ' ARG . 33.3 m-70 -102.04 109.27 20.94 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 109.006 -0.738 . . . . 0.90000000000000002 109.006 -176.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1642 ' ' THR . . . . . . . . . . . . . 3.9 t -138.05 148.93 62.14 Favored Pre-proline 0 C--N 1.302 -1.482 0 CA-C-N 115.948 -0.569 . . . . 0.47999999999999998 109.768 -174.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1643 ' ' PRO . . . . . 0.478 ' HA ' ' SG ' ' A' 1646 ' ' CYS . 53.3 Cg_endo -78.97 -3.21 13.04 Favored 'Trans proline' 0 C--N 1.368 1.564 0 C-N-CA 122.034 1.823 . . . . 0.66000000000000003 111.956 175.441 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 5.8 tp -63.96 -30.84 71.89 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.919 0.866 . . . . 0.96999999999999997 108.756 176.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -89.78 13.09 15.25 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.307 -1.315 . . . . 0.83999999999999997 110.455 -179.199 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1646 ' ' CYS . . . . . 0.478 ' SG ' ' HA ' ' A' 1643 ' ' PRO . 62.7 m -121.43 154.72 36.17 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 109.724 -0.472 . . . . 1.1899999999999999 109.724 -179.006 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -91.53 123.1 64.7 Favored Pre-proline 0 C--N 1.297 -1.711 0 N-CA-C 105.031 -2.211 . . . . 3.1400000000000001 105.031 168.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1648 ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -62.4 117.3 4.16 Favored 'Trans proline' 0 C--O 1.238 0.512 0 C-N-CA 122.783 2.322 . . . . 2.5800000000000001 112.893 -174.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 . . . . . 0 C--N 1.316 -0.877 0 N-CA-C 108.692 -0.855 . . . . 4.7199999999999998 108.692 -179.522 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.987 0 CA-C-O 121.642 0.734 . . . . 9.9700000000000006 109.958 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 2' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -94.32 138.62 32.08 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 107.876 -1.157 . . . . 7.6799999999999997 107.876 179.046 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 15.5 ptt180 -111.27 121.82 39.38 Favored Pre-proline 0 C--N 1.291 -1.975 0 N-CA-C 109.424 -0.584 . . . . 6.1100000000000003 109.424 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -62.63 -27.01 75.86 Favored 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 122.868 2.378 . . . . 4.8399999999999999 113.642 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 29.3 m -105.9 106.36 16.83 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 107.779 -1.193 . . . . 4.5999999999999996 107.779 175.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -102.17 23.25 11.91 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.721 0.772 . . . . 4.2300000000000004 109.666 -177.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 20.8 p -122.59 98.74 6.05 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-N 114.441 -1.254 . . . . 3.1400000000000001 109.891 174.415 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.562 ' HG ' ' OE1' ' B' ' 12' ' ' GLU . 84.4 mt -69.0 132.64 46.98 Favored 'General case' 0 C--O 1.251 1.168 0 N-CA-C 109.09 -0.707 . . . . 3.96 109.09 174.374 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 11.8 m -80.54 71.9 7.41 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 121.714 0.768 . . . . 2.8399999999999999 109.95 -176.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 10' ' ' GLY . . . . . 0.437 ' H ' ' HB2' ' B' ' 13' ' ' LEU . . . 151.19 -74.24 0.26 Allowed Glycine 0 N--CA 1.423 -2.182 0 CA-C-N 114.448 -1.251 . . . . 2.0899999999999999 110.407 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 11' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' B' ' 15' ' ' ASP . . . -57.01 -56.82 23.0 Favored Glycine 0 CA--C 1.511 -0.217 0 CA-C-N 115.415 -0.393 . . . . 1.8400000000000001 113.863 -176.434 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 12' ' ' GLU . . . . . 0.562 ' OE1' ' HG ' ' B' ' 8' ' ' LEU . 39.3 mt-10 -84.2 -14.94 48.73 Favored 'General case' 0 CA--C 1.489 -1.378 0 CA-C-N 117.259 0.53 . . . . 2.5499999999999998 110.475 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 13' ' ' LEU . . . . . 0.437 ' HB2' ' H ' ' B' ' 10' ' ' GLY . 0.1 OUTLIER -65.57 -53.22 45.02 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 107.139 -1.43 . . . . 2.3500000000000001 107.139 179.467 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 22.2 m -74.55 -22.88 17.76 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 C-N-CA 119.672 -0.811 . . . . 2.1099999999999999 110.098 178.334 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 15' ' ' ASP . . . . . 0.496 ' CB ' ' HA ' ' B' ' 12' ' ' GLU . 15.7 t70 -64.41 -51.22 64.31 Favored 'General case' 0 C--O 1.217 -0.653 0 CA-C-N 116.008 -0.542 . . . . 2.04 110.939 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 22.6 p -65.82 -46.46 78.53 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.392 0.677 . . . . 1.8400000000000001 111.004 178.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.491 HD21 HD11 ' B' ' 42' ' ' ILE . 3.6 mm? -48.99 -49.82 38.89 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.904 0.882 . . . . 1.74 111.887 171.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -79.58 -15.64 57.3 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.279 -0.873 . . . . 2.3900000000000001 110.992 -179.074 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 19' ' ' PHE . . . . . 0.551 ' HD1' ' HG3' ' A' 1569 ' ' GLN . 88.0 t80 -64.42 -55.96 17.43 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 116.219 -0.446 . . . . 0.95999999999999996 110.65 178.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 8.4 p -95.58 -26.56 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.357 0 C-N-CA 119.024 -1.071 . . . . 1.3700000000000001 111.547 -177.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 89.2 m -116.36 18.72 15.11 Favored 'General case' 0 C--O 1.212 -0.869 0 N-CA-C 113.229 0.826 . . . . 1.6599999999999999 113.229 -177.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -54.87 -37.59 62.6 Favored Glycine 0 N--CA 1.472 1.05 0 N-CA-C 114.813 0.685 . . . . 1.53 114.813 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -69.0 -27.2 65.48 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 123.08 0.552 . . . . 2.7200000000000002 111.176 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 16.3 tpp180 -91.68 -44.72 8.85 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.038 0.447 . . . . 4.3300000000000001 110.328 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 25' ' ' GLY . . . . . 0.424 ' O ' ' HB2' ' B' ' 61' ' ' ALA . . . 129.38 177.1 14.7 Favored Glycine 0 N--CA 1.436 -1.352 0 N-CA-C 109.359 -1.496 . . . . 1.53 109.359 -179.571 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -137.92 122.36 18.36 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 117.91 0.855 . . . . 1.6499999999999999 110.394 175.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -133.32 80.88 1.9 Allowed 'General case' 0 C--O 1.21 -1.003 0 N-CA-C 113.359 0.874 . . . . 3.4199999999999999 113.359 -175.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 28' ' ' PHE . . . . . 0.525 ' O ' ' HA ' ' B' ' 40' ' ' ARG . 32.8 p90 -101.49 -4.66 26.38 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.931 -0.707 . . . . 2.2599999999999998 109.733 169.007 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 5.4 m -92.03 89.11 6.82 Favored 'General case' 0 N--CA 1.422 -1.829 0 N-CA-C 106.662 -1.607 . . . . 3.6800000000000002 106.662 175.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 78.6 mtt-85 -118.57 162.14 32.1 Favored Pre-proline 0 C--N 1.297 -1.707 0 N-CA-C 109.375 -0.602 . . . . 3.8100000000000001 109.375 -174.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_exo -61.17 -51.65 4.26 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 N-CA-C 109.012 -1.188 . . . . 4.0199999999999996 109.012 173.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -157.2 169.58 24.44 Favored 'General case' 0 N--CA 1.415 -2.189 0 N-CA-C 108.065 -1.087 . . . . 4.9199999999999999 108.065 176.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 33' ' ' SER . . . . . 0.682 ' HB3' ' HB2' ' B' ' 36' ' ' SER . 13.7 t 179.66 161.05 0.84 Allowed 'General case' 0 N--CA 1.397 -3.114 0 N-CA-C 104.243 -2.503 . . . . 6.7199999999999998 104.243 -179.335 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 34.5 ttm180 -90.78 -0.73 57.8 Favored 'General case' 0 C--N 1.271 -2.819 0 N-CA-C 107.819 -1.178 . . . . 11.630000000000001 107.819 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 24.5 t -113.8 -9.97 12.18 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 107.568 -1.271 . . . . 9.6099999999999994 107.568 175.458 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 36' ' ' SER . . . . . 0.682 ' HB2' ' HB3' ' B' ' 33' ' ' SER . 21.5 m -145.42 62.1 1.28 Allowed 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 122.25 1.024 . . . . 6.71 109.306 -177.634 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -79.2 -5.72 54.91 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.705 -1.134 . . . . 10.0 112.653 -178.034 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 32.5 tpt180 -111.25 32.03 5.64 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 107.075 -1.454 . . . . 7.9400000000000004 107.075 176.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 22.6 t 71.27 -50.3 0.69 Allowed 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.774 1.63 . . . . 5.7599999999999998 110.747 -176.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 40' ' ' ARG . . . . . 0.525 ' HA ' ' O ' ' B' ' 28' ' ' PHE . 70.9 mtm180 -99.49 140.81 33.13 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 108.767 -0.827 . . . . 6.0300000000000002 108.767 178.512 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 41' ' ' GLY . . . . . 0.401 ' C ' ' H ' ' B' ' 43' ' ' VAL . . . -118.52 163.24 13.1 Favored Glycine 0 N--CA 1.429 -1.777 0 N-CA-C 109.423 -1.471 . . . . 2.3700000000000001 109.423 177.529 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 42' ' ' ILE . . . . . 0.491 HD11 HD21 ' B' ' 17' ' ' LEU 0.258 13.3 pt 61.61 -21.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 C-N-CA 127.663 2.385 . . . . 2.0699999999999998 115.295 178.471 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.633 ' O ' ' HB2' ' B' ' 47' ' ' CYS . 2.3 p -49.78 -47.12 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.775 0 N-CA-C 113.23 0.826 . . . . 2.2400000000000002 113.23 178.075 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -86.9 -30.95 21.0 Favored 'General case' 0 N--CA 1.427 -1.624 0 N-CA-C 109.228 -0.656 . . . . 3.3599999999999999 109.228 -177.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -66.16 -23.03 66.4 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.499 -0.773 . . . . 3.0800000000000001 112.027 -179.213 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 46' ' ' CYS . . . . . . . . . . . . . 63.7 m -114.34 2.07 14.63 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.967 0.413 . . . . 2.23 111.05 175.211 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 47' ' ' CYS . . . . . 0.633 ' HB2' ' O ' ' B' ' 43' ' ' VAL . 36.4 t -82.07 -50.45 9.07 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.561 0.696 . . . . 2.3700000000000001 110.377 -179.411 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -116.16 15.75 15.98 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.408 0.623 . . . . 2.8199999999999998 110.322 -176.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 22.2 mmm180 -146.64 152.74 39.37 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.065 -1.087 . . . . 4.0899999999999999 108.065 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 7.3 p -94.37 131.06 40.42 Favored 'General case' 0 C--N 1.282 -2.355 0 N-CA-C 108.661 -0.866 . . . . 2.6699999999999999 108.661 174.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 13.4 p -118.62 140.05 50.52 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 109.07 -0.715 . . . . 2.1099999999999999 109.07 -173.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -61.71 147.03 47.41 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 107.858 -1.164 . . . . 2.6699999999999999 107.858 177.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 53' ' ' LEU . . . . . 0.565 HD23 ' HB3' ' A' 1631 ' ' LYS . 14.8 tp -71.08 -16.79 62.6 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.103 -1.073 . . . . 1.8999999999999999 108.103 -178.473 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 54' ' ' ALA . . . . . 0.412 ' O ' ' HB3' ' B' ' 57' ' ' GLU . . . -60.11 -27.19 66.82 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 114.522 -1.217 . . . . 1.52 110.702 174.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 10.5 tp -60.49 -60.75 3.31 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 115.827 -0.624 . . . . 1.97 110.392 177.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.12 -17.43 61.98 Favored 'General case' 0 C--O 1.214 -0.806 0 CA-C-N 115.827 -0.624 . . . . 1.53 111.683 -175.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 57' ' ' GLU . . . . . 0.412 ' HB3' ' O ' ' B' ' 54' ' ' ALA . 9.1 tp10 -60.49 -56.72 17.97 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 109.026 -0.731 . . . . 2.27 109.026 172.511 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 9.0 t -80.5 -14.69 58.04 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 115.993 -0.548 . . . . 2.3300000000000001 112.268 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -82.73 -60.19 2.26 Favored 'General case' 0 N--CA 1.427 -1.61 0 N-CA-C 107.824 -1.176 . . . . 2.8599999999999999 107.824 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 33.6 t 56.67 -77.78 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 126.908 2.083 . . . . 2.2999999999999998 113.482 176.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 61' ' ' ALA . . . . . 0.424 ' HB2' ' O ' ' B' ' 25' ' ' GLY . . . -165.86 -56.42 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 104.519 -2.4 . . . . 3.1899999999999999 104.519 -174.584 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 4.3 p -113.68 148.98 40.96 Favored Pre-proline 0 N--CA 1.395 -3.205 0 CA-C-N 112.412 -2.176 . . . . 3.6800000000000002 106.338 173.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -82.51 12.7 2.79 Favored 'Trans proline' 0 N--CA 1.484 0.914 0 C-N-CA 123.502 2.801 . . . . 5.0800000000000001 112.63 -174.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 69.3 54.51 0.42 Allowed 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 113.625 -1.625 . . . . 5.0999999999999996 108.54 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 51.9 tttp 72.24 134.82 0.04 OUTLIER 'General case' 0 N--CA 1.434 -1.237 0 C-N-CA 126.961 2.104 . . . . 8.5099999999999998 110.805 -177.061 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 17.9 t -126.26 57.16 1.41 Allowed 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.193 -1.41 . . . . 8.1199999999999992 107.193 -179.216 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 . . . . . 0 C--O 1.247 0.969 0 CA-C-N 114.491 -1.231 . . . . 10.210000000000001 111.018 -176.837 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 60.9 mtm . . . . . 0 CA--C 1.517 -0.304 0 N-CA-C 108.962 -0.755 . . . . 9.3399999999999999 108.962 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A 1509 ' ' LYS . . . . . 0.767 ' HD2' ' HB3' ' A' 1512 ' ' GLU . 33.1 ttmt -128.85 148.57 50.9 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 108.834 -0.802 . . . . 9.0399999999999991 108.834 -177.417 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 15.4 m -95.71 126.81 41.24 Favored 'General case' 0 N--CA 1.423 -1.782 0 N-CA-C 110.336 -0.246 . . . . 5.8099999999999996 110.336 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1511 ' ' ASN . . . . . . . . . . . . . 4.6 m-20 49.52 69.27 0.61 Allowed 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 115.121 1.526 . . . . 3.4199999999999999 115.121 174.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1512 ' ' GLU . . . . . 0.767 ' HB3' ' HD2' ' A' 1509 ' ' LYS . 4.0 pt-20 -108.97 167.92 9.74 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 119.554 -0.858 . . . . 5.9500000000000002 110.863 176.451 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 10.4 t-80 53.67 53.69 11.08 Favored 'General case' 0 CA--C 1.51 -0.595 0 C-N-CA 125.745 1.618 . . . . 5.3300000000000001 110.242 176.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 36.2 t70 -63.98 70.09 0.02 OUTLIER 'General case' 0 C--N 1.291 -1.955 0 CA-C-N 113.063 -1.88 . . . . 5.0599999999999996 110.787 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1515 ' ' ASP . . . . . 0.493 ' HA ' ' HD2' ' A' 1579 ' ' LYS . 9.8 t70 -134.47 70.52 1.45 Allowed 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 106.801 -1.555 . . . . 2.8999999999999999 106.801 179.066 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1516 ' ' CYS . . . . . 0.567 ' O ' ' HB2' ' A' 1529 ' ' LEU . 16.7 m 63.16 33.9 14.0 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 115.128 -0.942 . . . . 1.1899999999999999 110.387 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -166.66 162.76 16.58 Favored 'General case' 0 CA--C 1.479 -1.76 0 N-CA-C 107.813 -1.181 . . . . 1.52 107.813 -177.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1518 ' ' VAL . . . . . 0.424 HG11 HD12 ' A' 1581 ' ' LEU . 9.8 p -162.0 147.23 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.945 0 O-C-N 123.68 0.613 . . . . 0.93999999999999995 109.535 -174.572 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1519 ' ' THR . . . . . . . . . . . . . 25.0 m -115.86 124.96 51.98 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 109.295 -0.632 . . . . 0.89000000000000001 109.295 177.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1520 ' ' ASN . . . . . 0.422 ' OD1' HG22 ' A' 1523 ' ' THR . 24.2 t-20 -86.95 122.41 71.27 Favored Pre-proline 0 N--CA 1.439 -0.979 0 O-C-N 123.427 0.454 . . . . 1.74 109.922 177.361 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.72 -19.9 53.09 Favored 'Trans proline' 0 CA--C 1.533 0.466 0 C-N-CA 123.218 2.612 . . . . 1.5800000000000001 114.541 -175.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 50.7 m -76.7 -39.94 50.4 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 112.157 0.429 . . . . 1.6499999999999999 112.157 -177.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1523 ' ' THR . . . . . 0.693 HG21 ' HG3' ' A' 1647 ' ' GLU . 5.0 t -114.31 -6.48 12.96 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.813 0.816 . . . . 1.6100000000000001 111.43 -178.076 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 64.54 30.49 78.03 Favored Glycine 0 CA--C 1.499 -0.913 0 CA-C-N 115.368 -0.833 . . . . 1.1299999999999999 112.28 177.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 35.7 t-80 -98.26 125.28 43.28 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 109.644 -0.502 . . . . 1.26 109.644 -175.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 1.7 tm? -90.88 109.15 20.36 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 108.323 -0.992 . . . . 0.68000000000000005 108.323 177.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -85.69 114.53 22.74 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 110.067 -0.345 . . . . 0.65000000000000002 110.067 176.008 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 25.5 t70 -99.46 107.74 20.02 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 109.23 -0.656 . . . . 1.1699999999999999 109.23 177.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1529 ' ' LEU . . . . . 0.567 ' HB2' ' O ' ' A' 1516 ' ' CYS . 3.4 mm? -90.11 -0.13 57.45 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.718 0.771 . . . . 0.59999999999999998 109.363 -178.379 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.24 -26.54 63.89 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.077 -0.965 . . . . 0.83999999999999997 108.771 178.506 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 40.5 t -60.38 -26.82 66.94 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.927 0.891 . . . . 1.5900000000000001 109.848 174.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 51.3 mt -98.38 0.51 45.54 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.557 -0.747 . . . . 0.65000000000000002 110.984 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1533 ' ' SER . . . . . . . . . . . . . 33.6 t -72.31 174.75 6.87 Favored 'General case' 0 C--O 1.245 0.825 0 CA-C-O 121.635 0.731 . . . . 1.52 111.329 -177.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . 179.81 145.17 6.26 Favored Glycine 0 N--CA 1.425 -2.046 0 N-CA-C 109.218 -1.553 . . . . 1.1000000000000001 109.218 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 -74.3 -43.36 57.09 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 120.695 0.284 . . . . 4.6200000000000001 111.585 -177.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -84.14 -38.84 20.2 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.465 0.65 . . . . 1.45 109.288 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 105.19 -138.77 14.39 Favored Glycine 0 N--CA 1.409 -3.143 0 CA-C-N 115.134 -0.939 . . . . 0.84999999999999998 111.476 177.415 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -140.33 154.14 46.66 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 107.619 -1.252 . . . . 0.93000000000000005 107.619 -177.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1539 ' ' THR . . . . . 0.456 HG22 ' HB ' ' A' 1547 ' ' VAL . 1.3 m -121.31 124.99 45.92 Favored 'General case' 0 N--CA 1.426 -1.646 0 N-CA-C 108.68 -0.859 . . . . 1.03 108.68 -178.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -119.75 140.18 51.12 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 115.815 -0.629 . . . . 0.5 109.559 -177.273 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -82.57 113.42 20.27 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.605 -0.725 . . . . 0.73999999999999999 110.509 -179.277 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1542 ' ' TYR . . . . . 0.569 ' CE2' ' HG ' ' A' 1626 ' ' LEU . 0.3 OUTLIER -104.36 -101.07 0.31 Allowed 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 106.019 -1.845 . . . . 0.98999999999999999 106.019 177.613 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A 1543 ' ' SER . . . . . 0.441 ' H ' ' HB3' ' A' 1542 ' ' TYR . 2.1 m -68.57 168.69 12.44 Favored 'General case' 0 N--CA 1.425 -1.721 0 C-N-CA 124.137 0.975 . . . . 1.9099999999999999 110.744 178.036 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 59.6 tttp -60.12 -41.49 92.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 118.694 0.679 . . . . 3.5899999999999999 112.261 -176.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 33.5 t -116.78 20.68 13.83 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 109.567 -0.531 . . . . 2.46 109.567 -177.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . -131.73 104.22 0.56 Allowed Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 120.646 -0.788 . . . . 1.26 113.231 -175.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1547 ' ' VAL . . . . . 0.456 ' HB ' HG22 ' A' 1539 ' ' THR . 28.0 m -96.84 151.1 4.2 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-O 121.176 0.512 . . . . 0.79000000000000004 110.109 175.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 14.2 p -105.2 138.49 29.91 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 CA-C-N 115.913 -0.585 . . . . 0.57999999999999996 109.528 178.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -105.71 128.34 53.62 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 123.492 0.717 . . . . 1.0800000000000001 109.678 176.06 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 23.5 ptm -141.8 119.46 11.75 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 115.331 -0.85 . . . . 0.78000000000000003 110.695 -177.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 11.4 p -103.67 119.58 39.2 Favored 'General case' 0 C--N 1.276 -2.609 0 CA-C-N 114.883 -1.053 . . . . 0.96999999999999997 110.184 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1552 ' ' ILE . . . . . 0.748 HG13 ' HZ3' ' A' 1640 ' ' TRP . 39.4 mm -83.22 119.44 32.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 108.999 -0.741 . . . . 0.41999999999999998 108.999 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 28.2 t 62.02 46.39 6.55 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-O 122.053 0.93 . . . . 1.3999999999999999 110.544 177.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 175.93 178.01 45.4 Favored Glycine 0 N--CA 1.407 -3.238 0 N-CA-C 109.431 -1.467 . . . . 0.34999999999999998 109.431 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -106.11 154.9 20.01 Favored 'General case' 0 C--N 1.285 -2.236 0 CA-C-O 121.046 0.451 . . . . 1.6200000000000001 110.415 -178.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -93.21 138.11 31.92 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 108.283 -1.006 . . . . 0.87 108.283 178.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -99.98 0.57 41.32 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 114.889 1.44 . . . . 2.4900000000000002 114.889 -169.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 9.6 p30 -105.01 5.26 32.46 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 122.273 1.035 . . . . 1.3799999999999999 110.134 178.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1559 ' ' CYS . . . . . 0.602 ' SG ' ' HD2' ' A' 1560 ' ' PRO . 34.5 t -132.15 152.99 81.15 Favored Pre-proline 0 C--N 1.288 -2.068 0 N-CA-C 106.211 -1.774 . . . . 1.21 106.211 178.158 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1560 ' ' PRO . . . . . 0.602 ' HD2' ' SG ' ' A' 1559 ' ' CYS . 49.6 Cg_exo -28.34 121.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.379 2.176 1 C-N-CA 125.575 4.184 . . . . 0.70999999999999996 115.211 179.154 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A 1561 ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' 1560 ' ' PRO . 6.0 Cg_endo -44.72 130.2 9.63 Favored 'Trans proline' 0 C--N 1.357 1.01 0 C-N-CA 125.075 3.85 . . . . 0.80000000000000004 114.126 -176.646 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 98.64 -2.15 58.64 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.974 -0.557 . . . . 0.46000000000000002 113.753 178.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1563 ' ' VAL . . . . . 0.411 HG21 ' HA ' ' A' 1573 ' ' SER . 8.7 p -93.8 140.38 16.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 O-C-N 121.93 -0.747 . . . . 0.97999999999999998 110.637 -177.486 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -102.34 -30.56 5.59 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 121.213 -0.518 . . . . 0.28000000000000003 112.869 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -124.32 127.89 48.3 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 109.403 -0.591 . . . . 0.28000000000000003 109.403 178.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1566 ' ' CYS . . . . . 0.425 ' SG ' ' HA ' ' A' 1571 ' ' ARG . 43.5 t -155.04 142.75 19.85 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 110.254 -0.276 . . . . 0.42999999999999999 110.254 -178.58 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1567 ' ' PHE . . . . . 0.527 ' CE2' HG11 ' A' 1574 ' ' VAL . 54.9 m-85 -85.6 130.53 34.55 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 107.796 -1.187 . . . . 1.03 107.796 172.402 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -61.14 -31.16 75.82 Favored Glycine 0 C--N 1.35 1.314 0 N-CA-C 114.545 0.578 . . . . 1.1299999999999999 114.545 -171.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1569 ' ' GLN . . . . . 0.467 ' HB3' ' OD2' ' B' ' 15' ' ' ASP . 11.3 mm100 -69.54 -54.56 13.54 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.594 0.711 . . . . 2.5800000000000001 111.986 177.454 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1570 ' ' THR . . . . . 0.602 ' HB ' HG13 ' A' 1572 ' ' ILE . 58.3 p -81.47 -29.11 33.85 Favored 'General case' 0 N--CA 1.421 -1.878 0 N-CA-C 114.382 1.253 . . . . 2.1699999999999999 114.382 -167.387 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1571 ' ' ARG . . . . . 0.425 ' HA ' ' SG ' ' A' 1566 ' ' CYS . 3.1 mpt_? 59.35 28.94 18.42 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.189 0.519 . . . . 2.6200000000000001 110.691 -172.562 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1572 ' ' ILE . . . . . 0.602 HG13 ' HB ' ' A' 1570 ' ' THR . 19.2 mt -94.58 129.15 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.832 0 N-CA-C 107.89 -1.152 . . . . 0.92000000000000004 107.89 177.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1573 ' ' SER . . . . . 0.411 ' HA ' HG21 ' A' 1563 ' ' VAL . 15.1 t -69.27 113.8 6.94 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.327 -0.851 . . . . 0.80000000000000004 109.68 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1574 ' ' VAL . . . . . 0.758 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 19.7 m -110.38 17.92 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 CA-C-O 121.893 0.854 . . . . 0.97999999999999998 110.8 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 161.46 115.64 0.37 Allowed Glycine 0 N--CA 1.427 -1.957 0 CA-C-N 114.779 -1.1 . . . . 0.28999999999999998 111.042 177.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -73.66 146.39 44.57 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.881 -0.785 . . . . 2.1899999999999999 108.881 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -71.36 90.52 0.95 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.028 0.442 . . . . 0.60999999999999999 111.585 -178.056 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -103.37 170.24 8.07 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.08 -1.081 . . . . 1.95 108.08 175.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1579 ' ' LYS . . . . . 0.493 ' HD2' ' HA ' ' A' 1515 ' ' ASP . 15.4 pttm -130.11 40.46 3.54 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.755 0.788 . . . . 2.6800000000000002 110.698 -178.65 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 75.0 ttt180 -89.82 100.49 13.29 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 113.561 -1.654 . . . . 3.4700000000000002 107.933 -174.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1581 ' ' LEU . . . . . 0.445 HD21 ' HG ' ' A' 1529 ' ' LEU . 0.2 OUTLIER -101.76 126.55 48.64 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.713 -0.676 . . . . 0.64000000000000001 109.425 -174.806 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -125.2 138.95 54.12 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 120.532 -0.467 . . . . 2.8500000000000001 110.914 176.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1583 ' ' TYR . . . . . 0.447 ' CE1' ' HA ' ' A' 1586 ' ' GLN . 88.3 t80 -106.25 108.41 19.91 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.724 -0.843 . . . . 0.85999999999999999 108.724 178.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1584 ' ' VAL . . . . . 0.616 ' O ' ' HB ' ' A' 1587 ' ' VAL . 14.2 m -126.98 93.49 2.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 CA-C-O 121.48 0.657 . . . . 1.05 112.108 -178.612 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 36.6 t70 57.89 64.37 1.55 Allowed 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.853 0.861 . . . . 1.1699999999999999 110.691 179.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1586 ' ' GLN . . . . . 0.447 ' HA ' ' CE1' ' A' 1583 ' ' TYR 0.272 30.1 pt20 58.72 20.55 7.95 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 126.45 1.9 . . . . 1.8600000000000001 112.384 178.527 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A 1587 ' ' VAL . . . . . 0.616 ' HB ' ' O ' ' A' 1584 ' ' VAL . 22.5 t -107.24 120.26 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.493 0 CA-C-N 114.038 -1.437 . . . . 0.48999999999999999 107.751 174.11 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1588 ' ' LEU . . . . . 0.865 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 3.3 mm? -95.62 109.03 21.34 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 105.824 -1.917 . . . . 0.35999999999999999 105.824 176.014 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -111.02 116.81 31.81 Favored 'General case' 0 C--N 1.266 -3.056 0 C-N-CA 119.962 -0.695 . . . . 1.74 110.961 -175.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.87 99.48 9.69 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 104.888 -2.264 . . . . 0.71999999999999997 104.888 176.758 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 8.9 p -89.41 127.01 42.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 C-N-CA 119.64 -0.824 . . . . 1.01 112.308 -174.299 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1592 ' ' TYR . . . . . 0.658 ' HB2' ' HB3' ' A' 1608 ' ' SER . 12.8 m-30 -106.95 142.75 36.07 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.443 -1.317 . . . . 0.5 107.443 173.404 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 10.6 ptmm? -158.08 -172.24 3.83 Favored 'General case' 0 C--N 1.283 -2.308 0 N-CA-C 106.043 -1.836 . . . . 1.5900000000000001 106.043 -175.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 36.4 m-20 66.46 45.56 2.1 Favored 'General case' 0 C--O 1.239 0.503 0 O-C-N 124.006 0.816 . . . . 1.1100000000000001 109.116 177.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -86.76 -175.06 49.39 Favored Glycine 0 N--CA 1.435 -1.379 0 CA-C-N 114.892 -1.049 . . . . 0.78000000000000003 111.582 -178.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1596 ' ' SER . . . . . 0.742 ' HB2' ' HD2' ' A' 1597 ' ' PRO . 62.9 p -95.31 173.86 4.02 Favored Pre-proline 0 C--N 1.291 -1.968 0 CA-C-O 118.672 -0.68 . . . . 1.0700000000000001 109.457 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1597 ' ' PRO . . . . . 0.742 ' HD2' ' HB2' ' A' 1596 ' ' SER . 10.3 Cg_endo -50.85 127.11 20.29 Favored 'Trans proline' 0 C--N 1.361 1.197 0 C-N-CA 122.785 2.323 . . . . 1.01 113.676 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1598 ' ' CYS . . . . . 0.696 ' HA ' ' HE1' ' A' 1606 ' ' TYR . 49.5 t -81.16 118.74 73.6 Favored Pre-proline 0 C--N 1.284 -2.269 0 CA-C-N 113.718 -1.583 . . . . 0.75 107.888 178.038 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1599 ' ' PRO . . . . . 0.707 ' HD2' ' HE1' ' A' 1606 ' ' TYR . 6.9 Cg_endo -52.12 -21.16 12.13 Favored 'Trans proline' 0 C--N 1.366 1.483 0 C-N-CA 124.357 3.371 . . . . 1.7 114.362 -178.379 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1600 ' ' SER . . . . . 0.417 ' HA ' ' HB2' ' B' ' 53' ' ' LEU . 7.8 m -55.72 -45.63 77.91 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 123.815 0.846 . . . . 2.2599999999999998 110.438 177.066 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1601 ' ' LYS . . . . . 0.483 ' HE2' HD11 ' A' 1604 ' ' LEU . 36.5 ttpt -162.84 127.43 3.08 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 108.395 -0.965 . . . . 3.0099999999999998 108.395 178.242 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 14.2 p -58.36 132.02 52.4 Favored 'General case' 0 N--CA 1.415 -2.191 0 N-CA-C 109.26 -0.644 . . . . 2.0699999999999998 109.26 177.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 106.54 -17.38 39.74 Favored Glycine 0 C--N 1.303 -1.265 0 C-N-CA 121.329 -0.463 . . . . 1.0800000000000001 112.354 -176.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1604 ' ' LEU . . . . . 0.503 ' HB2' ' HB3' ' A' 1598 ' ' CYS . 60.2 mt -91.83 152.06 20.29 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 107.254 -1.387 . . . . 1.8400000000000001 107.254 173.565 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 37.9 m -135.87 142.93 44.81 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 108.628 -0.878 . . . . 1.4099999999999999 108.628 179.043 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1606 ' ' TYR . . . . . 0.758 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 71.5 m-85 -73.22 158.95 34.22 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 112.141 0.423 . . . . 0.59999999999999998 112.141 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -147.89 152.72 38.07 Favored 'General case' 0 N--CA 1.421 -1.914 0 N-CA-C 106.38 -1.711 . . . . 1.45 106.38 172.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1608 ' ' SER . . . . . 0.658 ' HB3' ' HB2' ' A' 1592 ' ' TYR . 28.0 t -122.5 123.08 40.45 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 109.038 -0.727 . . . . 1.1499999999999999 109.038 -174.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 30.8 t -105.09 98.1 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.748 0 N-CA-C 108.846 -0.798 . . . . 0.25 108.846 179.296 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 84.1 mt -89.63 106.11 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.787 0 N-CA-C 108.1 -1.074 . . . . 0.45000000000000001 108.1 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 17.0 m -104.54 114.48 28.73 Favored 'General case' 0 N--CA 1.421 -1.917 0 CA-C-N 115.007 -0.997 . . . . 1.26 111.01 -175.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1612 ' ' PHE . . . . . 0.865 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 69.3 m-85 -91.33 108.41 19.87 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.054 -0.721 . . . . 0.26000000000000001 109.054 176.283 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1613 ' ' VAL . . . . . 0.879 ' HB ' ' HB3' ' A' 1641 ' ' HIS . 33.5 t -103.96 144.16 14.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 CA-C-N 114.774 -1.103 . . . . 0.5 109.233 -176.103 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 39.1 t -69.88 108.31 3.93 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 123.809 0.844 . . . . 0.77000000000000002 110.982 179.202 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1615 ' ' ARG . . . . . 0.574 ' HB2' ' HB2' ' A' 1641 ' ' HIS . 25.3 tpt180 -135.69 91.69 17.8 Favored Pre-proline 0 N--CA 1.435 -1.214 0 C-N-CA 119.584 -0.846 . . . . 2.5299999999999998 109.671 173.452 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1616 ' ' PRO . . . . . 0.934 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 19.2 Cg_exo -65.7 -22.21 57.72 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.392 2.061 . . . . 1.1000000000000001 113.535 -176.59 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -57.96 -38.48 76.1 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 123.94 0.896 . . . . 3.0499999999999998 112.221 179.04 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . 64.93 -172.63 0.18 Allowed 'General case' 0 C--N 1.358 0.946 0 O-C-N 123.916 0.76 . . . . 1.55 109.61 -176.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . 119.09 -159.5 14.5 Favored Glycine 0 N--CA 1.426 -2.018 0 C-N-CA 120.222 -0.989 . . . . 0.93000000000000005 112.632 177.097 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 94.9 Cg_exo -56.38 -11.73 6.84 Favored 'Trans proline' 0 N--CA 1.5 1.911 0 C-N-CA 124.893 3.728 . . . . 0.88 114.211 178.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1621 ' ' THR . . . . . . . . . . . . . 19.0 p -87.6 -9.37 54.52 Favored 'General case' 0 C--N 1.282 -2.364 0 C-N-CA 124.396 1.079 . . . . 0.96999999999999997 110.869 -179.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 49.2 t30 -88.02 58.36 4.77 Favored 'General case' 0 C--O 1.253 1.266 0 CA-C-O 122.729 1.252 . . . . 0.71999999999999997 110.16 -178.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1623 ' ' ARG . . . . . 0.43 ' HA ' ' HD3' ' A' 1624 ' ' PRO . 34.7 ptt180 -159.82 138.81 7.97 Favored Pre-proline 0 C--N 1.303 -1.415 0 CA-C-N 113.839 -1.528 . . . . 3.2599999999999998 107.183 178.569 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1624 ' ' PRO . . . . . 0.445 ' HG3' ' CE3' ' A' 1640 ' ' TRP . 7.1 Cg_exo -69.43 111.23 2.69 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.333 2.022 . . . . 0.58999999999999997 111.172 -178.371 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 74.7 mtm -114.0 147.83 37.96 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 116.415 -0.357 . . . . 1.3700000000000001 110.337 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1626 ' ' LEU . . . . . 0.569 ' HG ' ' CE2' ' A' 1542 ' ' TYR . 0.3 OUTLIER -85.89 113.95 22.43 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 107.954 -1.128 . . . . 0.89000000000000001 107.954 -176.56 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 42.0 mm -76.36 -54.85 12.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 N-CA-C 109.262 -0.644 . . . . 0.57999999999999996 109.262 -177.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 70.5 m -163.83 152.27 13.4 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.468 -0.938 . . . . 1.3899999999999999 108.468 -173.234 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1629 ' ' LEU . . . . . 0.584 ' HG ' ' CD2' ' A' 1636 ' ' LEU . 2.5 tt -114.25 110.91 20.67 Favored 'General case' 0 N--CA 1.416 -2.172 0 N-CA-C 106.531 -1.655 . . . . 1.25 106.531 179.397 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 14.8 t70 -77.81 95.35 4.68 Favored 'General case' 0 CA--C 1.494 -1.198 0 N-CA-C 106.919 -1.512 . . . . 1.0900000000000001 106.919 173.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1631 ' ' LYS . . . . . 0.69 ' HD3' ' H ' ' A' 1631 ' ' LYS . 0.0 OUTLIER -75.96 2.86 11.48 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 114.419 1.266 . . . . 3.6000000000000001 114.419 -172.768 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 79.8 mm-40 -88.36 -41.93 12.52 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.709 -0.848 . . . . 2.6000000000000001 108.709 175.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 67.6 p -100.48 -15.62 17.82 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-N 115.118 -0.946 . . . . 0.75 111.065 -177.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 83.3 m 70.25 35.05 2.18 Favored 'General case' 0 C--N 1.351 0.662 0 C-N-CA 125.053 1.341 . . . . 0.53000000000000003 110.891 -179.141 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1635 ' ' THR . . . . . . . . . . . . . 90.0 m -90.96 121.87 33.16 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 113.727 -1.579 . . . . 0.46000000000000002 109.088 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1636 ' ' LEU . . . . . 0.584 ' CD2' ' HG ' ' A' 1629 ' ' LEU . 26.2 mt -98.58 130.7 45.13 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 109.483 -0.562 . . . . 0.85999999999999999 109.483 178.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -101.77 116.48 32.82 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 116.076 -0.511 . . . . 0.45000000000000001 111.137 177.396 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -114.19 140.73 48.3 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 109.529 -0.545 . . . . 0.5 109.529 176.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1639 ' ' SER . . . . . 0.432 ' O ' ' HA ' ' A' 1624 ' ' PRO . 48.0 t -119.86 129.16 54.26 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 108.512 -0.921 . . . . 1.04 108.512 173.388 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1640 ' ' TRP . . . . . 0.748 ' HZ3' HG13 ' A' 1552 ' ' ILE . 6.3 t90 -133.74 93.5 3.13 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 104.217 -2.512 . . . . 0.68000000000000005 104.217 173.301 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1641 ' ' HIS . . . . . 0.879 ' HB3' ' HB ' ' A' 1613 ' ' VAL 0.317 0.1 OUTLIER -101.64 95.17 6.27 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-O 122.474 1.13 . . . . 0.90000000000000002 113.085 -175.612 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A 1642 ' ' THR . . . . . . . . . . . . . 3.1 t -114.77 153.02 46.91 Favored Pre-proline 0 C--N 1.299 -1.609 0 CA-C-N 112.542 -2.117 . . . . 0.47999999999999998 108.583 -177.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1643 ' ' PRO . . . . . 0.934 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 49.7 Cg_endo -68.94 -4.89 14.37 Favored 'Trans proline' 0 C--N 1.369 1.65 0 C-N-CA 123.269 2.646 . . . . 0.66000000000000003 113.366 -178.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 8.2 tt -65.35 -30.29 71.11 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.969 -0.382 . . . . 0.96999999999999997 109.969 176.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -84.2 21.7 1.35 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.377 0.608 . . . . 0.83999999999999997 111.513 -175.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 33.3 m -121.22 136.52 54.96 Favored 'General case' 0 N--CA 1.415 -2.193 0 N-CA-C 107.629 -1.248 . . . . 1.1899999999999999 107.629 178.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1647 ' ' GLU . . . . . 0.693 ' HG3' HG21 ' A' 1523 ' ' THR . 0.1 OUTLIER -107.94 142.26 24.88 Favored Pre-proline 0 C--N 1.301 -1.531 0 N-CA-C 109.529 -0.545 . . . . 3.1400000000000001 109.529 177.399 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A 1648 ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -62.73 109.28 0.86 Allowed 'Trans proline' 0 C--O 1.244 0.811 0 C-N-CA 122.82 2.346 . . . . 2.5800000000000001 113.102 -178.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 8.9 tp10 . . . . . 0 C--N 1.304 -1.401 0 N-CA-C 107.152 -1.425 . . . . 4.7199999999999998 107.152 177.766 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.731 0 N-CA-C 108.895 -0.78 . . . . 9.9700000000000006 108.895 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 2' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -141.53 147.07 37.17 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.775 -0.824 . . . . 7.6799999999999997 108.775 -177.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 -139.64 149.26 59.06 Favored Pre-proline 0 C--N 1.302 -1.495 0 N-CA-C 107.899 -1.149 . . . . 6.1100000000000003 107.899 176.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -44.16 -47.79 10.19 Favored 'Trans proline' 0 C--O 1.243 0.762 0 C-N-CA 123.853 3.036 . . . . 4.8399999999999999 113.009 -177.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 15.9 t -118.95 102.13 8.54 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 106.678 -1.601 . . . . 4.5999999999999996 106.678 178.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -72.33 -25.84 61.7 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.137 0.494 . . . . 4.2300000000000004 110.64 -176.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 20.8 p -105.79 166.36 10.53 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.473 -0.936 . . . . 3.1400000000000001 108.473 174.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.488 HD13 ' HB3' ' B' ' 12' ' ' GLU . 79.5 mt -85.39 136.07 33.61 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 110.19 -0.3 . . . . 3.96 110.19 -177.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 9' ' ' CYS . . . . . 0.459 ' HA ' HD12 ' B' ' 13' ' ' LEU . 49.1 t -139.03 152.06 47.29 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 109.206 -0.664 . . . . 2.8399999999999999 109.206 -179.13 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.14 -124.26 6.87 Favored Glycine 0 N--CA 1.438 -1.225 0 C-N-CA 120.907 -0.663 . . . . 2.0899999999999999 112.856 177.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.94 -36.88 92.88 Favored Glycine 0 C--O 1.22 -0.765 0 CA-C-N 115.557 -0.322 . . . . 1.8400000000000001 112.924 -177.169 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 12' ' ' GLU . . . . . 0.488 ' HB3' HD13 ' B' ' 8' ' ' LEU . 6.3 mp0 -68.18 -28.34 67.18 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 111.915 0.339 . . . . 2.5499999999999998 111.915 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 13' ' ' LEU . . . . . 0.459 HD12 ' HA ' ' B' ' 9' ' ' CYS . 0.7 OUTLIER -71.65 -53.54 13.27 Favored 'General case' 0 N--CA 1.42 -1.959 0 N-CA-C 109.486 -0.561 . . . . 2.3500000000000001 109.486 -177.664 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 3.8 p -63.58 -35.42 72.64 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-N 115.561 -0.745 . . . . 2.1099999999999999 111.133 177.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 15' ' ' ASP . . . . . 0.467 ' OD2' ' HB3' ' A' 1569 ' ' GLN . 14.8 t0 -72.32 -37.07 69.01 Favored 'General case' 0 CA--C 1.557 1.248 0 N-CA-C 112.209 0.448 . . . . 2.04 112.209 -179.411 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 14.9 t -68.78 -37.7 79.49 Favored 'General case' 0 C--O 1.254 1.316 0 CA-C-N 119.079 0.854 . . . . 1.8400000000000001 110.117 175.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.605 HD21 HD11 ' B' ' 42' ' ' ILE . 3.2 mm? -49.37 -52.66 26.82 Favored 'General case' 0 C--N 1.355 0.823 0 CA-C-O 121.358 0.599 . . . . 1.74 110.197 168.16 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -66.97 -23.8 65.98 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 123.659 0.784 . . . . 2.3900000000000001 112.385 -177.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -62.9 -62.85 1.44 Allowed 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 116.467 -0.333 . . . . 0.95999999999999996 110.938 175.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 14.4 p -91.32 -15.92 8.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 C-N-CA 117.609 -1.636 . . . . 1.3700000000000001 112.791 -175.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 59.1 m -99.8 10.17 41.77 Favored 'General case' 0 C--O 1.206 -1.227 0 O-C-N 121.099 -1.0 . . . . 1.6599999999999999 111.318 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -53.42 -28.36 35.85 Favored Glycine 0 CA--C 1.54 1.617 0 N-CA-C 116.632 1.413 . . . . 1.53 116.632 -178.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -72.56 -49.0 35.53 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 118.305 1.053 . . . . 2.7200000000000002 111.891 -179.284 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.15 -38.58 15.23 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.37 0.605 . . . . 4.3300000000000001 109.803 -179.154 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 25' ' ' GLY . . . . . 0.424 ' O ' ' HB2' ' B' ' 61' ' ' ALA . . . 124.23 164.52 11.98 Favored Glycine 0 N--CA 1.428 -1.892 0 N-CA-C 107.62 -2.192 . . . . 1.53 107.62 -174.624 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 26' ' ' PHE . . . . . 0.424 ' CB ' ' HB3' ' B' ' 17' ' ' LEU . 17.4 p90 -95.69 129.79 42.78 Favored 'General case' 0 C--N 1.286 -2.177 0 CA-C-N 118.779 1.29 . . . . 1.6499999999999999 110.067 179.012 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 27' ' ' TYR . . . . . 0.744 ' HB2' ' HA ' ' B' ' 61' ' ' ALA . 24.9 m-85 -129.98 59.31 1.63 Allowed 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 112.939 0.718 . . . . 3.4199999999999999 112.939 -174.478 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 28' ' ' PHE . . . . . 0.651 ' HA ' ' HE2' ' B' ' 59' ' ' TYR . 32.6 p90 -92.05 -9.09 44.01 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 119.048 -1.061 . . . . 2.2599999999999998 108.485 173.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 29' ' ' SER . . . . . 0.617 ' HA ' ' HG2' ' B' ' 40' ' ' ARG . 22.7 p -85.33 50.62 1.99 Allowed 'General case' 0 N--CA 1.428 -1.566 0 CA-C-N 115.298 -0.864 . . . . 3.6800000000000002 110.215 179.346 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -89.96 116.41 66.29 Favored Pre-proline 0 N--CA 1.434 -1.236 0 N-CA-C 107.857 -1.164 . . . . 3.8100000000000001 107.857 178.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 31' ' ' PRO . . . . . 0.694 ' HA ' ' HA ' ' B' ' 39' ' ' SER . 50.0 Cg_exo -54.06 -31.83 66.32 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.945 3.097 . . . . 4.0199999999999996 114.799 -172.596 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -162.01 151.71 16.35 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-O 121.388 0.613 . . . . 4.9199999999999999 110.925 177.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 88.3 p -168.17 -170.63 1.34 Allowed 'General case' 0 N--CA 1.411 -2.376 0 N-CA-C 101.773 -3.417 . . . . 6.7199999999999998 101.773 177.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -104.18 -1.31 27.38 Favored 'General case' 0 C--N 1.267 -3.004 0 CA-C-O 121.783 0.802 . . . . 11.630000000000001 109.434 178.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 38.9 t -105.79 -19.71 6.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 107.724 -1.213 . . . . 9.6099999999999994 107.724 177.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 33.3 m -144.71 85.25 1.76 Allowed 'General case' 0 N--CA 1.398 -3.025 0 CA-C-N 114.58 -1.191 . . . . 6.71 108.307 177.124 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -71.05 -3.58 20.46 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 115.317 -0.856 . . . . 10.0 111.425 173.133 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -90.87 152.25 20.82 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 106.822 -1.547 . . . . 7.9400000000000004 106.822 173.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 39' ' ' SER . . . . . 0.694 ' HA ' ' HA ' ' B' ' 31' ' ' PRO . 33.3 t -67.31 -3.44 8.05 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.887 0.699 . . . . 5.7599999999999998 112.887 -175.513 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 40' ' ' ARG . . . . . 0.617 ' HG2' ' HA ' ' B' ' 29' ' ' SER . 79.2 mtt180 -144.04 130.34 19.79 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 107.577 -1.268 . . . . 6.0300000000000002 107.577 172.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 41' ' ' GLY . . . . . 0.415 ' C ' ' H ' ' B' ' 43' ' ' VAL . . . -103.58 177.19 24.59 Favored Glycine 0 CA--C 1.476 -2.401 0 N-CA-C 109.723 -1.351 . . . . 2.3700000000000001 109.723 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 42' ' ' ILE . . . . . 0.605 HD11 HD21 ' B' ' 17' ' ' LEU . 16.1 pt 58.1 -26.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 C-N-CA 127.346 2.258 . . . . 2.0699999999999998 115.74 179.529 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.415 ' H ' ' C ' ' B' ' 41' ' ' GLY . 2.7 p -48.12 -46.95 13.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 114.71 1.374 . . . . 2.2400000000000002 114.71 -177.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -87.79 -29.75 20.76 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.913 -1.143 . . . . 3.3599999999999999 107.913 -174.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 45' ' ' GLU . . . . . 0.559 ' O ' ' HB2' ' B' ' 49' ' ' ARG . 30.2 mt-10 -75.82 -10.06 59.12 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 113.963 -1.471 . . . . 3.0800000000000001 112.179 -177.685 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 46' ' ' CYS . . . . . . . . . . . . . 21.5 t -119.42 -21.92 7.25 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-O 121.056 0.455 . . . . 2.23 110.285 176.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 49.7 t -74.28 -47.62 33.73 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.333 -0.547 . . . . 2.3700000000000001 111.433 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -119.09 7.61 11.4 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 120.1 -0.64 . . . . 2.8199999999999998 110.987 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 49' ' ' ARG . . . . . 0.559 ' HB2' ' O ' ' B' ' 45' ' ' GLU . 36.0 mmt180 -128.0 156.68 42.33 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.301 -1.37 . . . . 4.0899999999999999 107.301 -177.123 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 14.0 p -78.3 110.75 13.61 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 109.855 -0.424 . . . . 2.6699999999999999 109.855 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 3.0 p -100.87 126.75 47.5 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 115.59 -0.732 . . . . 2.1099999999999999 110.365 -177.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -101.8 135.62 43.04 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.772 -1.195 . . . . 2.6699999999999999 107.772 178.173 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 53' ' ' LEU . . . . . 0.436 HD21 ' HG3' ' A' 1631 ' ' LYS . 56.9 tp -36.47 -37.91 0.14 Allowed 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 126.613 1.965 . . . . 1.8999999999999999 114.834 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.95 -29.97 63.64 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 123.483 0.49 . . . . 1.52 111.374 -177.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 53.1 tp -68.58 -57.0 6.39 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-N 115.863 -0.608 . . . . 1.97 110.048 177.55 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 1.9 pp -71.28 -27.18 63.24 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 116.496 -0.32 . . . . 1.53 111.559 -174.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -71.95 -46.11 58.68 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 111.835 0.309 . . . . 2.27 111.835 178.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 11.2 t -77.66 -30.09 51.93 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 118.619 -1.233 . . . . 2.3300000000000001 111.601 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 59' ' ' TYR . . . . . 0.651 ' HE2' ' HA ' ' B' ' 28' ' ' PHE . 11.1 t80 -70.66 -64.51 0.88 Allowed 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 106.278 -1.749 . . . . 2.8599999999999999 106.278 177.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 54.1 t 33.42 -87.02 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 127.208 2.203 . . . . 2.2999999999999998 115.762 173.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 61' ' ' ALA . . . . . 0.744 ' HA ' ' HB2' ' B' ' 27' ' ' TYR . . . -144.49 151.92 39.86 Favored 'General case' 0 N--CA 1.42 -1.945 0 N-CA-C 108.212 -1.033 . . . . 3.1899999999999999 108.212 -176.017 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 6.7 p -85.21 131.38 48.54 Favored Pre-proline 0 N--CA 1.416 -2.157 0 N-CA-C 109.042 -0.725 . . . . 3.6800000000000002 109.042 -178.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -73.24 -32.93 7.79 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 123.002 2.468 . . . . 5.0800000000000001 115.308 -172.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -149.32 55.43 0.98 Allowed 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.432 0.634 . . . . 5.0999999999999996 109.932 -178.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 45.6 tttp -162.97 130.5 3.64 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 115.795 -0.639 . . . . 8.5099999999999998 109.426 -177.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 15.0 m -134.85 11.99 3.66 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.692 0.758 . . . . 8.1199999999999992 109.692 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 . . . . . 0 C--O 1.253 1.279 0 CA-C-N 114.909 -1.042 . . . . 10.210000000000001 109.121 -179.396 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 77.0 mtp . . . . . 0 C--O 1.24 0.599 0 CA-C-O 120.59 0.234 . . . . 9.3399999999999999 110.414 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -110.12 89.29 2.98 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 108.564 -0.902 . . . . 9.0399999999999991 108.564 178.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1510 ' ' SER . . . . . 0.634 ' HA ' ' HG3' ' A' 1521 ' ' PRO . 51.3 m 70.76 156.25 0.15 Allowed 'General case' 0 C--O 1.242 0.665 0 C-N-CA 124.568 1.147 . . . . 5.8099999999999996 111.785 -177.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1511 ' ' ASN . . . . . 0.635 ' OD1' ' HB3' ' A' 1583 ' ' TYR . 82.6 m-20 68.05 96.52 0.06 Allowed 'General case' 0 C--O 1.248 0.993 0 N-CA-C 115.051 1.5 . . . . 3.4199999999999999 115.051 169.432 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1512 ' ' GLU . . . . . 0.538 ' O ' HG12 ' A' 1518 ' ' VAL . 29.9 mm-40 -78.5 169.62 17.95 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.549 -0.751 . . . . 5.9500000000000002 109.364 169.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 13.9 p-80 -144.43 103.49 3.97 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-O 121.5 0.667 . . . . 5.3300000000000001 112.06 -179.168 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 22.2 t70 -96.07 -69.1 0.77 Allowed 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 115.538 -0.756 . . . . 5.0599999999999996 109.214 176.271 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 16.4 t70 -150.84 -63.38 0.19 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.998 -0.546 . . . . 2.8999999999999999 111.331 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1516 ' ' CYS . . . . . 0.634 ' SG ' ' HB2' ' A' 1529 ' ' LEU . 30.8 t -138.83 55.59 1.72 Allowed 'General case' 0 C--O 1.25 1.113 0 N-CA-C 108.312 -0.995 . . . . 1.1899999999999999 108.312 -179.06 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -169.06 149.04 4.18 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 115.565 -0.743 . . . . 1.52 109.06 -174.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1518 ' ' VAL . . . . . 0.538 HG12 ' O ' ' A' 1512 ' ' GLU . 4.8 m -149.43 142.37 17.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 C-N-CA 124.227 1.011 . . . . 0.93999999999999995 110.585 178.346 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1519 ' ' THR . . . . . . . . . . . . . 31.9 m -106.16 137.35 44.25 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.915 -0.402 . . . . 0.89000000000000001 109.915 177.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 52.6 t-20 -82.68 110.33 21.72 Favored Pre-proline 0 C--O 1.245 0.829 0 N-CA-C 107.009 -1.478 . . . . 1.74 107.009 174.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1521 ' ' PRO . . . . . 0.634 ' HG3' ' HA ' ' A' 1510 ' ' SER . 42.5 Cg_endo -67.23 -14.69 43.94 Favored 'Trans proline' 0 N--CA 1.474 0.376 0 C-N-CA 123.173 2.582 . . . . 1.5800000000000001 113.148 -174.501 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 28.3 m -75.04 -33.87 61.81 Favored 'General case' 0 N--CA 1.425 -1.702 0 CA-C-N 116.307 -0.406 . . . . 1.6499999999999999 111.844 -179.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1523 ' ' THR . . . . . . . . . . . . . 12.5 t -136.19 -5.3 2.1 Favored 'General case' 0 CA--C 1.564 1.484 0 C-N-CA 118.132 -1.427 . . . . 1.6100000000000001 113.418 -175.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 85.75 8.31 80.03 Favored Glycine 0 CA--C 1.494 -1.252 0 C-N-CA 120.632 -0.794 . . . . 1.1299999999999999 114.048 176.331 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 51.9 t-80 -76.27 123.27 25.64 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.706 -0.85 . . . . 1.26 108.706 177.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -103.2 116.91 33.37 Favored 'General case' 0 C--N 1.268 -2.965 0 CA-C-N 114.796 -1.093 . . . . 0.68000000000000005 109.008 -176.564 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -88.86 118.38 28.53 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 109.989 -0.375 . . . . 0.65000000000000002 109.989 175.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 7.7 t70 -110.72 126.25 54.37 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.111 -1.44 . . . . 1.1699999999999999 107.111 174.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1529 ' ' LEU . . . . . 0.634 ' HB2' ' SG ' ' A' 1516 ' ' CYS . 2.9 mm? -103.21 20.47 17.65 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 111.88 0.326 . . . . 0.59999999999999998 111.88 -174.643 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 6.9 m -66.74 -23.84 66.15 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 113.369 0.878 . . . . 0.83999999999999997 113.369 -175.271 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 33.6 t -72.29 -30.1 64.49 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-O 121.534 0.683 . . . . 1.5900000000000001 109.196 178.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1532 ' ' LEU . . . . . 0.522 HD12 HD12 ' A' 1529 ' ' LEU . 59.9 mt -88.9 -18.31 27.82 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.387 -0.824 . . . . 0.65000000000000002 109.792 -179.294 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1533 ' ' SER . . . . . 0.532 ' HA ' ' HB ' ' A' 1552 ' ' ILE . 34.8 t -75.46 171.57 14.02 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.61 -0.723 . . . . 1.52 110.288 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . 159.94 150.37 5.83 Favored Glycine 0 N--CA 1.424 -2.159 0 N-CA-C 110.106 -1.197 . . . . 1.1000000000000001 110.106 -178.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 35.6 ttp180 -92.02 -13.69 30.56 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 121.475 0.655 . . . . 4.6200000000000001 109.843 -179.102 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -79.66 -39.03 32.33 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 121.364 0.602 . . . . 1.45 109.977 178.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 90.62 -171.89 36.82 Favored Glycine 0 N--CA 1.424 -2.118 0 CA-C-N 115.054 -0.975 . . . . 0.84999999999999998 111.136 176.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -132.84 146.57 51.93 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 108.281 -1.007 . . . . 0.93000000000000005 108.281 178.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 31.1 p -102.43 123.46 46.25 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 123.491 0.494 . . . . 1.03 111.77 -178.28 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1540 ' ' ALA . . . . . 0.406 ' HB3' ' CG1' ' A' 1548 ' ' VAL . . . -115.29 135.15 54.46 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.255 -0.646 . . . . 0.5 109.255 177.223 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -70.59 134.58 47.75 Favored 'General case' 0 C--O 1.249 1.032 0 CA-C-N 115.567 -0.742 . . . . 0.73999999999999999 110.901 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1542 ' ' TYR . . . . . 0.587 ' CE2' ' HG ' ' A' 1626 ' ' LEU . 7.1 t80 -133.24 -100.84 0.26 Allowed 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.787 -0.82 . . . . 0.98999999999999999 108.787 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1543 ' ' SER . . . . . 0.43 ' H ' ' HB3' ' A' 1542 ' ' TYR . 13.6 t -92.63 179.95 5.35 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 109.763 -0.458 . . . . 1.9099999999999999 109.763 -176.279 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 20.2 pttp -75.21 -23.65 57.66 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 120.976 0.417 . . . . 3.5899999999999999 111.416 -177.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1545 ' ' SER . . . . . 0.656 ' HB2' ' HG2' ' A' 1569 ' ' GLN . 5.2 p -65.49 -36.94 85.36 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 124.325 1.05 . . . . 2.46 112.751 -176.369 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 178.73 -167.1 37.27 Favored Glycine 0 N--CA 1.425 -2.098 0 C-N-CA 120.874 -0.679 . . . . 1.26 112.216 -178.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 27.2 m -113.58 166.46 7.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 109.82 -0.437 . . . . 0.79000000000000004 109.82 -176.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1548 ' ' VAL . . . . . 0.406 ' CG1' ' HB3' ' A' 1540 ' ' ALA . 13.1 p -102.26 131.0 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 N-CA-C 108.911 -0.774 . . . . 0.57999999999999996 108.911 177.593 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -92.16 134.84 34.48 Favored 'General case' 0 CA--C 1.481 -1.673 0 CA-C-N 115.504 -0.771 . . . . 1.0800000000000001 109.223 178.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 24.0 ptm -146.64 116.06 7.08 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 115.478 -0.783 . . . . 0.78000000000000003 111.057 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 8.5 p -106.39 124.13 49.12 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-N 115.145 -0.934 . . . . 0.96999999999999997 110.214 178.031 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1552 ' ' ILE . . . . . 0.532 ' HB ' ' HA ' ' A' 1533 ' ' SER . 43.5 mm -81.92 119.1 30.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 109.99 -0.374 . . . . 0.41999999999999998 109.99 -179.009 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 57.8 m 60.9 41.94 13.69 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 123.937 0.773 . . . . 1.3999999999999999 111.366 176.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . -178.0 174.23 46.63 Favored Glycine 0 N--CA 1.422 -2.274 0 N-CA-C 109.961 -1.256 . . . . 0.34999999999999998 109.961 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -100.16 150.8 22.14 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 120.856 0.36 . . . . 1.6200000000000001 110.405 -179.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -98.81 139.28 34.72 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.0 -0.741 . . . . 0.87 109.0 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -85.12 -3.63 58.87 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 113.108 0.781 . . . . 2.4900000000000002 113.108 -172.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -93.67 1.73 56.52 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 120.547 -0.461 . . . . 1.3799999999999999 110.816 -176.094 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1559 ' ' CYS . . . . . 0.727 ' SG ' ' HD2' ' A' 1560 ' ' PRO . 13.3 t -137.59 166.34 27.27 Favored Pre-proline 0 C--N 1.3 -1.562 0 N-CA-C 106.542 -1.651 . . . . 1.21 106.542 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1560 ' ' PRO . . . . . 0.727 ' HD2' ' SG ' ' A' 1559 ' ' CYS . 16.3 Cg_exo -33.83 145.3 0.04 OUTLIER 'Trans proline' 0 C--N 1.379 2.173 0 C-N-CA 124.542 3.494 . . . . 0.70999999999999996 114.627 173.169 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1561 ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' 1560 ' ' PRO . 43.0 Cg_exo -58.94 127.44 24.31 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 123.223 2.615 . . . . 0.80000000000000004 112.841 -177.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 94.5 13.21 54.56 Favored Glycine 0 C--N 1.311 -0.812 0 N-CA-C 115.166 0.826 . . . . 0.46000000000000002 115.166 176.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1563 ' ' VAL . . . . . 0.893 HG21 ' HB2' ' A' 1573 ' ' SER . 9.9 p -109.08 140.19 28.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-N 118.242 1.021 . . . . 0.97999999999999998 110.95 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -100.7 -32.98 5.21 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 120.984 -0.627 . . . . 0.28000000000000003 113.272 -177.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -123.35 128.76 50.36 Favored 'General case' 0 C--O 1.244 0.806 0 N-CA-C 109.569 -0.53 . . . . 0.28000000000000003 109.569 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 50.6 t -163.48 144.82 9.33 Favored 'General case' 0 C--O 1.206 -1.194 0 C-N-CA 121.249 -0.18 . . . . 0.42999999999999999 110.889 -175.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -85.72 143.61 28.26 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 118.05 0.386 . . . . 1.03 110.178 174.315 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -88.89 8.16 80.35 Favored Glycine 0 N--CA 1.443 -0.861 0 N-CA-C 116.239 1.256 . . . . 1.1299999999999999 116.239 -170.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1569 ' ' GLN . . . . . 0.656 ' HG2' ' HB2' ' A' 1545 ' ' SER . 0.4 OUTLIER -78.48 -67.39 0.74 Allowed 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 118.328 1.064 . . . . 2.5800000000000001 110.319 177.612 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 15.2 p -111.99 7.45 19.86 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.817 -1.083 . . . . 2.1699999999999999 113.568 -175.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1571 ' ' ARG . . . . . 0.5 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 0.0 OUTLIER 64.68 44.34 3.87 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 122.964 0.506 . . . . 2.6200000000000001 111.757 -178.91 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 42.6 mt -83.06 112.39 20.67 Favored 'Isoleucine or valine' 0 C--O 1.246 0.902 0 N-CA-C 107.973 -1.121 . . . . 0.92000000000000004 107.973 174.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1573 ' ' SER . . . . . 0.893 ' HB2' HG21 ' A' 1563 ' ' VAL . 91.0 p -80.14 134.57 36.17 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.557 -0.747 . . . . 0.80000000000000004 111.416 -174.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1574 ' ' VAL . . . . . 0.516 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 33.2 m -118.11 9.11 6.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 O-C-N 121.32 -0.862 . . . . 0.97999999999999998 112.42 -178.612 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 175.33 123.88 0.78 Allowed Glycine 0 N--CA 1.433 -1.515 0 C-N-CA 120.331 -0.938 . . . . 0.28999999999999998 111.403 176.213 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -69.24 153.34 43.82 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.043 -0.725 . . . . 2.1899999999999999 109.043 -178.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -74.46 88.61 2.11 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-O 121.115 0.483 . . . . 0.60999999999999999 110.258 -177.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -97.07 160.05 14.56 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 115.106 -0.952 . . . . 1.95 110.464 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 24.2 pttm -120.51 45.29 2.25 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 122.878 1.323 . . . . 2.6800000000000002 108.363 -178.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 24.0 ttm180 -103.6 76.36 1.39 Allowed 'General case' 0 N--CA 1.412 -2.331 0 CA-C-N 113.956 -1.475 . . . . 3.4700000000000002 108.54 -173.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1581 ' ' LEU . . . . . 0.56 HD11 HD12 ' A' 1588 ' ' LEU . 0.2 OUTLIER -82.35 124.7 30.23 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 114.146 -1.388 . . . . 0.64000000000000001 107.534 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A 1582 ' ' ARG . . . . . 0.492 ' HB2' ' HB3' ' A' 1589 ' ' GLN . 64.3 mtp180 -122.56 143.4 49.76 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 116.768 -0.196 . . . . 2.8500000000000001 110.599 176.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1583 ' ' TYR . . . . . 0.635 ' HB3' ' OD1' ' A' 1511 ' ' ASN . 74.9 t80 -113.35 107.57 16.04 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 109.323 -0.621 . . . . 0.85999999999999999 109.323 177.472 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1584 ' ' VAL . . . . . 0.622 ' O ' ' HB ' ' A' 1587 ' ' VAL . 9.7 m -121.63 90.01 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 CA-C-N 115.722 -0.672 . . . . 1.05 111.153 -177.593 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 31.1 t70 53.51 72.63 0.42 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.053 0.941 . . . . 1.1699999999999999 111.761 178.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1586 ' ' GLN . . . . . 0.403 ' HA ' ' HE1' ' A' 1583 ' ' TYR . 13.9 pt20 57.21 26.39 12.17 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 125.818 1.647 . . . . 1.8600000000000001 111.296 176.672 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1587 ' ' VAL . . . . . 0.622 ' HB ' ' O ' ' A' 1584 ' ' VAL . 24.6 t -124.23 120.88 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.32 0 CA-C-N 113.769 -1.56 . . . . 0.48999999999999999 108.117 175.341 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1588 ' ' LEU . . . . . 0.812 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 2.9 mm? -95.05 117.36 30.04 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.09 -1.448 . . . . 0.35999999999999999 107.09 178.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1589 ' ' GLN . . . . . 0.492 ' HB3' ' HB2' ' A' 1582 ' ' ARG . 35.3 tt0 -106.56 127.42 53.31 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 116.02 -0.536 . . . . 1.74 111.454 -175.495 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1590 ' ' LEU . . . . . 0.449 ' HG ' HD22 ' A' 1581 ' ' LEU . 11.2 mt -121.49 101.6 7.72 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 107.463 -1.31 . . . . 0.71999999999999997 107.463 170.387 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 6.4 p -96.92 124.68 49.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 CA-C-O 121.494 0.664 . . . . 1.01 109.966 -178.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1592 ' ' TYR . . . . . 0.469 ' HB2' ' HB3' ' A' 1608 ' ' SER . 14.4 m-30 -115.55 105.05 12.35 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.269 -1.012 . . . . 0.5 108.269 -179.053 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 20.7 pttp -115.27 -178.94 3.49 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 109.759 -0.46 . . . . 1.5900000000000001 109.759 -179.069 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 36.2 m-20 65.16 42.42 4.06 Favored 'General case' 0 C--O 1.247 0.962 0 O-C-N 124.28 0.987 . . . . 1.1100000000000001 110.405 177.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -75.88 -145.64 1.57 Allowed Glycine 0 N--CA 1.438 -1.217 0 CA-C-N 114.798 -1.092 . . . . 0.78000000000000003 111.007 174.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1596 ' ' SER . . . . . 0.412 ' HA ' ' HD3' ' A' 1597 ' ' PRO . 72.0 p -88.94 146.47 36.7 Favored Pre-proline 0 C--N 1.284 -2.278 0 N-CA-C 108.444 -0.947 . . . . 1.0700000000000001 108.444 179.163 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1597 ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' 1596 ' ' SER . 50.2 Cg_exo -57.49 120.74 8.85 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.646 2.23 . . . . 1.01 109.308 174.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 42.4 t -73.25 132.21 82.29 Favored Pre-proline 0 C--N 1.288 -2.084 0 CA-C-N 114.663 -1.153 . . . . 0.75 112.425 -169.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1599 ' ' PRO . . . . . 0.48 ' HD2' ' OH ' ' A' 1606 ' ' TYR . 14.7 Cg_exo -72.44 80.2 1.7 Allowed 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 123.122 2.548 . . . . 1.7 109.338 171.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1600 ' ' SER . . . . . 0.851 ' HA ' ' HB2' ' B' ' 53' ' ' LEU . 50.6 m -160.62 -67.29 0.07 Allowed 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 126.613 1.965 . . . . 2.2599999999999998 110.004 -178.218 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1601 ' ' LYS . . . . . 0.477 ' O ' ' HG ' ' A' 1604 ' ' LEU . 81.4 tttt -140.11 112.04 7.53 Favored 'General case' 0 N--CA 1.398 -3.05 0 N-CA-C 106.398 -1.704 . . . . 3.0099999999999998 106.398 178.714 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 15.4 m -49.52 133.05 20.95 Favored 'General case' 0 N--CA 1.425 -1.72 0 C-N-CA 124.599 1.16 . . . . 2.0699999999999998 112.549 -177.1 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 106.5 -21.49 32.6 Favored Glycine 0 C--N 1.304 -1.215 0 CA-C-N 115.91 -0.586 . . . . 1.0800000000000001 113.945 177.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1604 ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' 1601 ' ' LYS . 4.3 pp -103.21 145.98 29.12 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 118.387 1.094 . . . . 1.8400000000000001 111.238 178.124 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 22.8 p -111.77 155.89 22.81 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.624 -0.716 . . . . 1.4099999999999999 110.797 -175.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1606 ' ' TYR . . . . . 0.516 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 63.9 m-85 -64.25 161.7 16.07 Favored 'General case' 0 C--O 1.249 1.046 0 CA-C-N 116.075 -0.511 . . . . 0.59999999999999998 110.493 173.594 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -161.38 130.17 4.5 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-O 120.882 0.372 . . . . 1.45 111.145 -178.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1608 ' ' SER . . . . . 0.469 ' HB3' ' HB2' ' A' 1592 ' ' TYR . 38.0 t -105.23 123.03 47.15 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 115.376 -0.829 . . . . 1.1499999999999999 109.723 -177.472 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 24.1 t -107.55 100.75 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 107.946 -1.131 . . . . 0.25 107.946 175.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 89.7 mt -89.77 112.19 24.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 108.317 -0.994 . . . . 0.45000000000000001 108.317 -179.016 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 40.1 m -112.86 110.68 20.93 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 115.043 -0.98 . . . . 1.26 111.355 -177.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1612 ' ' PHE . . . . . 0.812 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 62.8 m-85 -83.42 115.85 22.23 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.793 -0.817 . . . . 0.26000000000000001 108.793 175.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 84.1 t -110.31 135.75 48.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 O-C-N 123.651 0.594 . . . . 0.5 110.572 -174.316 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 41.4 t -72.13 98.24 2.08 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 124.069 0.948 . . . . 0.77000000000000002 111.686 -178.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1615 ' ' ARG . . . . . 0.747 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 9.5 mmt180 -138.11 99.31 9.07 Favored Pre-proline 0 N--CA 1.431 -1.404 0 CA-C-N 116.058 -0.519 . . . . 2.5299999999999998 109.812 175.31 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1616 ' ' PRO . . . . . 0.424 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 16.4 Cg_exo -75.26 39.57 0.62 Allowed 'Trans proline' 0 N--CA 1.488 1.188 0 C-N-CA 123.37 2.713 . . . . 1.1000000000000001 112.412 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1617 ' ' GLU . . . . . 0.52 ' OE1' ' HD2' ' A' 1615 ' ' ARG . 42.9 mt-10 -110.57 40.46 1.98 Allowed 'General case' 0 C--N 1.272 -2.772 0 N-CA-C 108.076 -1.083 . . . . 3.0499999999999998 108.076 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -41.48 115.45 0.63 Allowed 'General case' 0 C--O 1.244 0.765 0 C-N-CA 126.288 1.835 . . . . 1.55 113.867 -175.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . 173.42 -127.16 1.31 Allowed Glycine 0 N--CA 1.412 -2.929 0 N-CA-C 108.149 -1.981 . . . . 0.93000000000000005 108.149 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -77.2 7.03 3.9 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 122.545 2.163 . . . . 0.88 112.657 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1621 ' ' THR . . . . . 0.482 ' HB ' ' HB2' ' A' 1641 ' ' HIS . 3.8 p -91.11 -27.17 18.73 Favored 'General case' 0 C--N 1.288 -2.081 0 C-N-CA 124.924 1.29 . . . . 0.96999999999999997 108.203 176.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 51.2 t30 -87.01 56.78 4.16 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.387 -1.278 . . . . 0.71999999999999997 108.566 -176.176 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -157.99 139.54 9.84 Favored Pre-proline 0 C--N 1.302 -1.493 0 CA-C-N 114.632 -1.167 . . . . 3.2599999999999998 108.443 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1624 ' ' PRO . . . . . 0.414 ' HA ' ' O ' ' A' 1639 ' ' SER . 53.5 Cg_endo -68.28 110.91 2.35 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.898 2.399 . . . . 0.58999999999999997 112.01 -177.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 75.8 mtm -111.98 142.95 43.76 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 120.69 -0.404 . . . . 1.3700000000000001 110.187 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1626 ' ' LEU . . . . . 0.587 ' HG ' ' CE2' ' A' 1542 ' ' TYR . 0.8 OUTLIER -81.78 112.88 19.34 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 108.34 -0.985 . . . . 0.89000000000000001 108.34 -175.412 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 44.2 mm -81.12 -52.25 14.32 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 CA-C-O 121.31 0.576 . . . . 0.57999999999999996 109.852 -178.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 50.9 m -159.56 145.42 15.99 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.541 -0.754 . . . . 1.3899999999999999 109.772 -176.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1629 ' ' LEU . . . . . 1.014 HD13 ' HG ' ' A' 1636 ' ' LEU . 23.0 tp -129.7 95.13 3.9 Favored 'General case' 0 N--CA 1.421 -1.879 0 N-CA-C 107.785 -1.191 . . . . 1.25 107.785 171.498 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 27.5 t70 -68.0 122.11 17.52 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 107.121 -1.437 . . . . 1.0900000000000001 107.121 175.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 26.0 tptp -89.36 -0.17 57.28 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 119.882 -0.727 . . . . 3.6000000000000001 110.709 -171.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 56.6 tp60 -96.17 -41.08 8.88 Favored 'General case' 0 N--CA 1.426 -1.643 0 C-N-CA 119.884 -0.726 . . . . 2.6000000000000001 109.933 179.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 22.9 p -89.39 -22.05 22.76 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.4 0.619 . . . . 0.75 110.596 175.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 68.3 m 63.64 36.63 10.73 Favored 'General case' 0 C--N 1.354 0.771 0 C-N-CA 124.965 1.306 . . . . 0.53000000000000003 111.824 178.064 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1635 ' ' THR . . . . . . . . . . . . . 38.6 m -100.35 130.5 46.46 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 108.028 -1.101 . . . . 0.46000000000000002 108.028 178.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1636 ' ' LEU . . . . . 1.014 ' HG ' HD13 ' A' 1629 ' ' LEU . 0.6 OUTLIER -109.38 129.96 55.51 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 108.712 -0.847 . . . . 0.85999999999999999 108.712 -176.373 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -106.86 121.59 44.72 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 120.901 0.382 . . . . 0.45000000000000001 110.811 -179.306 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -119.09 127.78 53.7 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.293 -0.867 . . . . 0.5 108.794 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1639 ' ' SER . . . . . 0.414 ' O ' ' HA ' ' A' 1624 ' ' PRO . 59.1 m -114.23 144.09 43.78 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.293 -1.003 . . . . 1.04 108.293 177.287 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 2.8 t90 -141.39 107.95 5.33 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 103.792 -2.67 . . . . 0.68000000000000005 103.792 -177.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1641 ' ' HIS . . . . . 0.747 ' HB3' ' HB2' ' A' 1615 ' ' ARG . 16.4 m170 -93.61 103.25 15.43 Favored 'General case' 0 C--N 1.287 -2.129 0 C-N-CA 120.706 -0.397 . . . . 0.90000000000000002 110.487 -174.529 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1642 ' ' THR . . . . . . . . . . . . . 15.0 t -142.62 145.77 35.62 Favored Pre-proline 0 CA--C 1.565 1.529 0 N-CA-C 109.304 -0.628 . . . . 0.47999999999999998 109.304 -174.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1643 ' ' PRO . . . . . 0.424 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 56.3 Cg_endo -72.57 -13.74 27.43 Favored 'Trans proline' 0 C--N 1.37 1.681 0 C-N-CA 122.635 2.224 . . . . 0.66000000000000003 112.885 -179.027 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 9.1 tt -65.23 -19.24 65.88 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.37 0.605 . . . . 0.96999999999999997 110.399 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -78.24 -7.2 56.86 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.58 -0.737 . . . . 0.83999999999999997 112.241 -179.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 1.2 m -108.93 156.46 19.67 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 121.474 0.654 . . . . 1.1899999999999999 111.869 178.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -108.96 142.96 26.64 Favored Pre-proline 0 C--N 1.292 -1.919 0 N-CA-C 107.531 -1.285 . . . . 3.1400000000000001 107.531 169.335 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1648 ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -60.27 112.86 1.44 Allowed 'Trans proline' 0 N--CA 1.464 -0.214 0 C-N-CA 122.62 2.213 . . . . 2.5800000000000001 111.924 -178.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 7.5 tp10 . . . . . 0 C--N 1.302 -1.487 0 N-CA-C 107.558 -1.275 . . . . 4.7199999999999998 107.558 179.999 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 -0.293 0 N-CA-C 109.362 -0.607 . . . . 9.9700000000000006 109.362 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 2' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -98.85 134.27 41.96 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.612 -0.884 . . . . 7.6799999999999997 108.612 -178.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -107.19 126.83 29.17 Favored Pre-proline 0 C--N 1.302 -1.481 0 N-CA-C 109.92 -0.4 . . . . 6.1100000000000003 109.92 178.424 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 4' ' ' PRO . . . . . 0.655 ' HB2' ' HG2' ' B' ' 6' ' ' GLU . 31.4 Cg_endo -65.76 -15.0 47.38 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 122.149 1.899 . . . . 4.8399999999999999 112.968 176.258 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 32.8 m 58.38 30.03 19.03 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 125.02 1.328 . . . . 4.5999999999999996 112.015 178.011 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 6' ' ' GLU . . . . . 0.655 ' HG2' ' HB2' ' B' ' 4' ' ' PRO . 42.8 mm-40 -75.86 -37.17 59.21 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 121.725 0.774 . . . . 4.2300000000000004 108.918 -178.406 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 19.7 p -118.75 121.61 40.49 Favored 'General case' 0 N--CA 1.416 -2.166 0 N-CA-C 106.701 -1.592 . . . . 3.1400000000000001 106.701 175.114 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.622 HD13 ' HG2' ' B' ' 12' ' ' GLU . 6.2 mp -94.83 145.17 25.08 Favored 'General case' 0 N--CA 1.428 -1.562 0 C-N-CA 119.154 -1.019 . . . . 3.96 109.736 -178.782 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 8.7 m -91.89 56.39 2.91 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 121.27 0.557 . . . . 2.8399999999999999 111.203 -168.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -171.87 -107.76 0.2 Allowed Glycine 0 C--N 1.298 -1.571 0 C-N-CA 120.224 -0.989 . . . . 2.0899999999999999 113.307 -179.283 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -59.31 -39.16 94.33 Favored Glycine 0 N--CA 1.461 0.343 0 O-C-N 123.654 0.267 . . . . 1.8400000000000001 113.202 -176.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 12' ' ' GLU . . . . . 0.622 ' HG2' HD13 ' B' ' 8' ' ' LEU . 18.0 mp0 -65.61 -40.44 92.62 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 124.213 1.005 . . . . 2.5499999999999998 110.067 179.16 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 13' ' ' LEU . . . . . 0.431 HD21 ' HB3' ' B' ' 46' ' ' CYS . 0.1 OUTLIER -65.15 -51.62 60.06 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.206 -0.906 . . . . 2.3500000000000001 108.571 -178.884 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 7.6 p -63.42 -37.61 80.01 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 CA-C-N 116.405 -0.361 . . . . 2.1099999999999999 111.655 179.272 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -68.1 -32.81 73.37 Favored 'General case' 0 C--O 1.193 -1.907 0 C-N-CA 120.088 -0.645 . . . . 2.04 111.859 177.18 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 96.5 m -59.16 -49.73 76.73 Favored 'General case' 0 C--O 1.279 2.613 0 CA-C-O 121.551 0.691 . . . . 1.8400000000000001 109.62 174.142 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.702 HD21 HD11 ' B' ' 42' ' ' ILE . 4.6 mm? -51.52 -48.46 62.96 Favored 'General case' 0 C--O 1.222 -0.365 0 CA-C-N 114.472 -1.24 . . . . 1.74 110.416 174.134 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 18' ' ' GLN . . . . . 0.489 ' CD ' ' HB3' ' A' 1545 ' ' SER . 9.7 tt0 -78.11 -15.2 59.08 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.584 -0.734 . . . . 2.3900000000000001 112.264 -176.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -66.75 -48.46 69.04 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.727 -0.471 . . . . 0.95999999999999996 109.727 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 23.8 m -92.77 -29.11 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 117.49 -1.684 . . . . 1.3700000000000001 111.995 176.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 63.0 m -96.94 25.19 5.52 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 112.203 0.445 . . . . 1.6599999999999999 112.203 -178.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -54.3 -58.43 13.01 Favored Glycine 0 N--CA 1.472 1.085 0 C-N-CA 120.997 -0.62 . . . . 1.53 112.735 179.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -80.77 -3.63 51.63 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 121.027 0.441 . . . . 2.7200000000000002 111.27 178.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -99.08 -55.25 2.75 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 112.157 0.429 . . . . 4.3300000000000001 112.157 -173.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 122.09 143.67 6.59 Favored Glycine 0 C--N 1.301 -1.37 0 N-CA-C 108.64 -1.784 . . . . 1.53 108.64 -173.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 26' ' ' PHE . . . . . 0.413 ' HB2' ' HB3' ' B' ' 17' ' ' LEU . 41.6 p90 -132.33 146.36 51.92 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 117.52 0.66 . . . . 1.6499999999999999 110.785 -177.191 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 27' ' ' TYR . . . . . 0.644 ' HE2' ' HE2' ' B' ' 65' ' ' LYS . 15.4 p90 -160.97 91.36 0.88 Allowed 'General case' 0 CA--C 1.547 0.865 0 CA-C-O 121.245 0.545 . . . . 3.4199999999999999 111.923 178.094 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 28' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -103.31 2.5 34.21 Favored 'General case' 0 C--O 1.238 0.482 0 O-C-N 121.187 -0.946 . . . . 2.2599999999999998 110.932 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 67.5 m -150.43 88.0 1.48 Allowed 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 109.223 -0.658 . . . . 3.6800000000000002 109.223 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 30' ' ' ARG . . . . . 0.833 ' HB2' ' HB3' ' B' ' 39' ' ' SER . 47.9 mtp180 -100.49 153.52 37.7 Favored Pre-proline 0 C--N 1.304 -1.38 0 N-CA-C 106.309 -1.738 . . . . 3.8100000000000001 106.309 -177.018 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -58.44 -51.55 7.19 Favored 'Trans proline' 0 C--O 1.243 0.755 0 C-N-CA 121.427 1.418 . . . . 4.0199999999999996 112.52 -175.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -176.55 167.3 2.71 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 106.725 -1.583 . . . . 4.9199999999999999 106.725 -178.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 25.6 m -152.05 157.61 41.89 Favored 'General case' 0 N--CA 1.394 -3.246 0 N-CA-C 101.988 -3.338 . . . . 6.7199999999999998 101.988 178.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 33.5 ttm180 -92.5 -3.5 55.05 Favored 'General case' 0 C--N 1.284 -2.256 0 CA-C-O 121.749 0.785 . . . . 11.630000000000001 112.639 -169.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 63.6 t -115.87 -29.22 2.15 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.234 0 N-CA-C 108.117 -1.068 . . . . 9.6099999999999994 108.117 177.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 22.1 t -134.66 75.62 1.59 Allowed 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 107.466 -1.309 . . . . 6.71 107.466 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 28.8 ptt180 -64.73 -15.85 62.1 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 113.617 0.969 . . . . 10.0 113.617 -178.202 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 31.8 tpt180 -98.1 69.96 2.06 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 106.563 -1.643 . . . . 7.9400000000000004 106.563 176.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 39' ' ' SER . . . . . 0.833 ' HB3' ' HB2' ' B' ' 30' ' ' ARG . 20.3 m -81.44 26.69 0.45 Allowed 'General case' 0 C--N 1.283 -2.315 0 CA-C-N 113.519 -1.673 . . . . 5.7599999999999998 113.141 -174.581 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 -140.02 141.84 36.29 Favored 'General case' 0 N--CA 1.431 -1.393 0 O-C-N 121.875 -0.516 . . . . 6.0300000000000002 110.245 176.095 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 41' ' ' GLY . . . . . 0.427 ' C ' ' H ' ' B' ' 43' ' ' VAL . . . -166.59 -175.81 37.14 Favored Glycine 0 N--CA 1.415 -2.73 0 N-CA-C 109.336 -1.506 . . . . 2.3700000000000001 109.336 -178.277 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 42' ' ' ILE . . . . . 0.702 HD11 HD21 ' B' ' 17' ' ' LEU . 11.1 pt 64.6 -24.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 C-N-CA 128.581 2.752 . . . . 2.0699999999999998 113.866 179.016 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.588 ' O ' ' HB2' ' B' ' 47' ' ' CYS . 2.0 p -50.56 -45.01 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 C-N-CA 124.628 1.171 . . . . 2.2400000000000002 113.362 177.582 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -93.89 -39.98 10.4 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.418 -0.956 . . . . 3.3599999999999999 108.418 -174.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 45' ' ' GLU . . . . . 0.493 ' O ' ' HB2' ' B' ' 49' ' ' ARG . 3.1 mp0 -55.25 -44.66 75.74 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 113.968 -1.469 . . . . 3.0800000000000001 111.261 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 46' ' ' CYS . . . . . 0.431 ' HB3' HD21 ' B' ' 13' ' ' LEU . 13.1 t -94.8 -2.16 51.45 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.356 0.598 . . . . 2.23 110.717 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 47' ' ' CYS . . . . . 0.588 ' HB2' ' O ' ' B' ' 43' ' ' VAL . 45.4 t -78.54 -56.88 4.09 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.374 -0.602 . . . . 2.3700000000000001 109.374 177.227 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -90.97 -12.07 37.07 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.406 0.521 . . . . 2.8199999999999998 112.406 -175.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 49' ' ' ARG . . . . . 0.493 ' HB2' ' O ' ' B' ' 45' ' ' GLU . 72.4 mtp180 -129.95 -171.07 2.43 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 107.904 -1.147 . . . . 4.0899999999999999 107.904 -178.372 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 8.3 t -110.81 129.79 55.76 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 106.278 -1.749 . . . . 2.6699999999999999 106.278 178.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 14.7 p -96.44 131.73 42.71 Favored 'General case' 0 N--CA 1.428 -1.57 0 CA-C-O 120.949 0.404 . . . . 2.1099999999999999 110.148 -174.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -74.68 154.42 38.46 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-N 115.806 -0.634 . . . . 2.6699999999999999 110.763 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 53' ' ' LEU . . . . . 0.851 ' HB2' ' HA ' ' A' 1600 ' ' SER . 34.1 tp -55.45 -43.65 75.63 Favored 'General case' 0 C--N 1.309 -1.194 0 O-C-N 123.585 0.553 . . . . 1.8999999999999999 110.605 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -52.64 -36.75 57.23 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 124.958 1.303 . . . . 1.52 112.043 -176.129 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 64.2 tp -70.27 -57.88 4.38 Favored 'General case' 0 N--CA 1.427 -1.621 0 CA-C-N 115.451 -0.795 . . . . 1.97 110.676 -179.017 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 56' ' ' LEU . . . . . 0.441 ' O ' ' HB2' ' B' ' 60' ' ' CYS . 3.0 pp -68.78 -33.87 74.59 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 111.867 0.321 . . . . 1.53 111.867 -174.44 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -54.43 -60.64 3.07 Favored 'General case' 0 C--N 1.318 -0.771 0 O-C-N 123.947 0.779 . . . . 2.27 111.679 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 12.4 t -80.74 -25.55 37.96 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 119.974 -0.69 . . . . 2.3300000000000001 111.995 -175.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -71.7 -40.53 69.45 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 109.096 -0.705 . . . . 2.8599999999999999 109.096 -179.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 60' ' ' CYS . . . . . 0.441 ' HB2' ' O ' ' B' ' 56' ' ' LEU . 30.4 t -47.12 -68.71 0.17 Allowed 'General case' 0 N--CA 1.485 1.297 0 O-C-N 124.72 1.262 . . . . 2.2999999999999998 111.335 179.513 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . 175.59 172.76 0.31 Allowed 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 105.548 -2.019 . . . . 3.1899999999999999 105.548 -177.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 18.4 p -108.34 154.88 41.16 Favored Pre-proline 0 C--N 1.279 -2.497 0 N-CA-C 109.136 -0.69 . . . . 3.6800000000000002 109.136 -178.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_exo -54.34 -31.21 66.44 Favored 'Trans proline' 0 C--O 1.243 0.768 0 C-N-CA 123.108 2.539 . . . . 5.0800000000000001 110.98 176.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -106.55 67.29 0.72 Allowed 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.128 -1.064 . . . . 5.0999999999999996 108.128 174.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 65' ' ' LYS . . . . . 0.644 ' HE2' ' HE2' ' B' ' 27' ' ' TYR . 64.6 tttm -51.23 -34.88 34.24 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 125.338 1.455 . . . . 8.5099999999999998 112.55 -178.005 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 20.0 m -119.65 -71.18 0.75 Allowed 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 108.232 -1.025 . . . . 8.1199999999999992 108.232 176.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 . . . . . 0 CA--C 1.493 -1.231 0 N-CA-C 106.179 -1.786 . . . . 10.210000000000001 106.179 -179.924 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 27.1 ttt . . . . . 0 N--CA 1.466 0.339 0 N-CA-C 108.578 -0.897 . . . . 9.3399999999999999 108.578 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 25.3 ttmm -159.5 73.28 0.56 Allowed 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 108.801 -0.814 . . . . 9.0399999999999991 108.801 -174.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 47.4 t 71.36 145.34 0.07 Allowed 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.675 1.19 . . . . 5.8099999999999996 113.395 176.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1511 ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -93.79 3.77 54.93 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.918 -0.583 . . . . 3.4199999999999999 110.143 174.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1512 ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 59.69 161.53 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 126.873 2.069 . . . . 5.9500000000000002 115.732 178.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 55.7 p-80 -149.63 84.76 1.42 Allowed 'General case' 0 N--CA 1.431 -1.378 0 CA-C-O 122.587 1.184 . . . . 5.3300000000000001 110.68 176.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1514 ' ' ASP . . . . . 0.402 ' CG ' ' H ' ' A' 1515 ' ' ASP . 21.0 t70 -105.2 -152.98 0.48 Allowed 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 105.378 -2.082 . . . . 5.0599999999999996 105.378 177.485 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1515 ' ' ASP . . . . . 0.423 ' HB3' ' HE2' ' A' 1579 ' ' LYS . 29.5 m-20 -76.56 -70.81 0.43 Allowed 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 118.98 0.809 . . . . 2.8999999999999999 109.047 179.115 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1516 ' ' CYS . . . . . 0.493 ' HA ' ' HB2' ' A' 1581 ' ' LEU . 83.7 m -138.64 41.75 2.17 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 116.214 -0.448 . . . . 1.1899999999999999 111.024 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1517 ' ' GLN . . . . . 0.409 ' HA ' ' O ' ' A' 1527 ' ' PHE . 3.5 pt20 -149.13 137.16 20.66 Favored 'General case' 0 N--CA 1.428 -1.564 0 C-N-CA 120.351 -0.539 . . . . 1.52 109.9 178.277 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1518 ' ' VAL . . . . . 0.533 HG21 ' HB2' ' A' 1583 ' ' TYR . 10.4 m -140.67 141.06 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 123.16 0.584 . . . . 0.93999999999999995 110.204 178.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1519 ' ' THR . . . . . . . . . . . . . 9.6 m -101.04 131.2 47.05 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 115.77 -0.65 . . . . 0.89000000000000001 109.343 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1520 ' ' ASN . . . . . 0.422 ' OD1' HG22 ' A' 1523 ' ' THR . 26.5 t-20 -83.49 118.27 71.04 Favored Pre-proline 0 N--CA 1.426 -1.661 0 N-CA-C 109.332 -0.618 . . . . 1.74 109.332 176.315 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.14 -16.82 49.88 Favored 'Trans proline' 0 C--O 1.239 0.572 0 C-N-CA 123.224 2.616 . . . . 1.5800000000000001 113.906 -177.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 74.2 m -77.2 -46.34 23.62 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 112.28 0.474 . . . . 1.6499999999999999 112.28 -179.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1523 ' ' THR . . . . . 0.422 HG22 ' OD1' ' A' 1520 ' ' ASN . 5.7 t -109.68 -14.43 14.34 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 119.547 -0.861 . . . . 1.6100000000000001 111.626 -178.065 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 79.55 31.68 40.25 Favored Glycine 0 N--CA 1.44 -1.044 0 N-CA-C 111.352 -0.699 . . . . 1.1299999999999999 111.352 178.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1525 ' ' HIS . . . . . 0.401 ' HB2' ' OE2' ' A' 1647 ' ' GLU . 5.2 t-80 -98.22 120.9 39.43 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.623 -0.88 . . . . 1.26 108.623 -178.345 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 1.9 tm? -86.31 112.66 21.62 Favored 'General case' 0 C--N 1.285 -2.212 0 N-CA-C 107.022 -1.473 . . . . 0.68000000000000005 107.022 176.128 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1527 ' ' PHE . . . . . 0.409 ' O ' ' HA ' ' A' 1517 ' ' GLN . 50.1 m-85 -99.79 120.01 39.06 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 109.194 -0.669 . . . . 0.65000000000000002 109.194 177.332 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 23.1 t70 -112.64 118.09 34.09 Favored 'General case' 0 CA--C 1.482 -1.657 0 N-CA-C 108.652 -0.87 . . . . 1.1699999999999999 108.652 177.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 6.0 mp -107.38 5.8 27.73 Favored 'General case' 0 N--CA 1.412 -2.353 0 CA-C-O 121.571 0.7 . . . . 0.59999999999999998 110.769 -177.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 1.5 m -72.72 -11.08 60.48 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.838 -1.074 . . . . 0.83999999999999997 109.089 178.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 24.7 m -75.49 -23.63 56.81 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 115.3 -0.864 . . . . 1.5900000000000001 109.712 176.234 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 97.9 mt -87.1 -5.16 59.12 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.258 0.552 . . . . 0.65000000000000002 110.312 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1533 ' ' SER . . . . . 0.488 ' HA ' ' HB ' ' A' 1552 ' ' ILE . 21.0 m -70.53 166.76 19.86 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.842 -0.617 . . . . 1.52 111.862 -178.208 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . 173.47 164.15 28.24 Favored Glycine 0 N--CA 1.436 -1.301 0 N-CA-C 110.069 -1.212 . . . . 1.1000000000000001 110.069 -179.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 44.6 ttp180 -92.57 -33.66 14.34 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 121.028 0.442 . . . . 4.6200000000000001 110.197 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -82.06 -30.83 31.14 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 116.088 -0.505 . . . . 1.45 110.597 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 84.51 -145.65 22.11 Favored Glycine 0 N--CA 1.422 -2.255 0 CA-C-N 115.5 -0.773 . . . . 0.84999999999999998 113.634 170.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -137.3 153.18 50.34 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 124.98 1.312 . . . . 0.93000000000000005 107.548 -178.083 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 8.6 p -115.28 136.93 52.58 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 123.632 0.582 . . . . 1.03 110.508 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1540 ' ' ALA . . . . . 0.447 ' HB3' HG12 ' A' 1548 ' ' VAL . . . -132.61 136.36 46.47 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.969 -1.123 . . . . 0.5 107.969 175.387 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -84.73 129.31 34.84 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.275 0.559 . . . . 0.73999999999999999 110.589 -176.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1542 ' ' TYR . . . . . 0.623 ' CE2' ' HG ' ' A' 1626 ' ' LEU . 1.6 t80 -120.04 -100.58 0.43 Allowed 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.588 -1.264 . . . . 0.98999999999999999 107.588 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1543 ' ' SER . . . . . 0.502 ' H ' ' HB3' ' A' 1542 ' ' TYR . 5.2 m -71.94 161.52 30.81 Favored 'General case' 0 N--CA 1.421 -1.91 0 C-N-CA 124.373 1.069 . . . . 1.9099999999999999 108.838 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1544 ' ' LYS . . . . . 0.82 ' HG3' ' HB3' ' B' ' 23' ' ' ASP . 39.0 mmtm -72.57 -1.11 14.78 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.398 0.888 . . . . 3.5899999999999999 113.398 -177.299 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 22.6 t -139.82 37.98 1.99 Allowed 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 108.937 -0.764 . . . . 2.46 108.937 176.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . -172.29 126.58 1.29 Allowed Glycine 0 N--CA 1.434 -1.494 0 C-N-CA 119.555 -1.307 . . . . 1.26 114.166 -178.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 26.8 m -109.1 150.53 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.568 0 N-CA-C 107.184 -1.413 . . . . 0.79000000000000004 107.184 174.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1548 ' ' VAL . . . . . 0.447 HG12 ' HB3' ' A' 1540 ' ' ALA . 10.0 p -97.46 130.4 46.18 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 C-N-CA 120.171 -0.612 . . . . 0.57999999999999996 109.403 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -94.22 131.53 39.71 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 108.358 -0.978 . . . . 1.0800000000000001 108.358 176.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 26.2 ptm -145.59 127.03 14.99 Favored 'General case' 0 C--N 1.286 -2.183 0 CA-C-N 115.471 -0.786 . . . . 0.78000000000000003 110.983 -177.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 69.1 m -118.15 128.48 54.77 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 115.769 -0.65 . . . . 0.96999999999999997 109.968 177.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1552 ' ' ILE . . . . . 0.488 ' HB ' ' HA ' ' A' 1533 ' ' SER . 50.7 mm -77.35 125.34 37.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 109.16 -0.682 . . . . 0.41999999999999998 109.16 -179.581 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 75.8 m 59.08 39.42 23.26 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.589 0.755 . . . . 1.3999999999999999 112.045 175.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . -179.99 178.51 48.56 Favored Glycine 0 N--CA 1.42 -2.376 0 C-N-CA 120.096 -1.049 . . . . 0.34999999999999998 110.919 -177.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1555 ' ' GLU . . . . . 0.403 ' OE1' ' HA ' ' A' 1561 ' ' PRO . 14.6 pt-20 -96.85 160.78 14.17 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 109.337 -0.616 . . . . 1.6200000000000001 109.337 179.54 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -103.48 130.29 50.81 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 109.891 -0.411 . . . . 0.87 109.891 -178.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -73.3 2.1 8.15 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.676 0.991 . . . . 2.4900000000000002 113.676 -175.018 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -101.71 1.31 37.33 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.91 -0.494 . . . . 1.3799999999999999 110.427 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1559 ' ' CYS . . . . . 0.613 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 16.1 m -137.03 175.26 3.62 Favored Pre-proline 0 C--N 1.303 -1.421 0 CA-C-O 118.647 -0.692 . . . . 1.21 112.07 -177.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1560 ' ' PRO . . . . . 0.613 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 21.9 Cg_exo -38.76 142.93 0.27 Allowed 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 124.063 3.175 . . . . 0.70999999999999996 114.562 175.389 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1561 ' ' PRO . . . . . 0.502 ' HD3' ' HA ' ' A' 1560 ' ' PRO . 31.6 Cg_exo -61.51 126.69 19.77 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.533 2.155 . . . . 0.80000000000000004 111.018 176.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 100.33 -9.0 59.09 Favored Glycine 0 C--N 1.31 -0.87 0 N-CA-C 114.345 0.498 . . . . 0.46000000000000002 114.345 178.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1563 ' ' VAL . . . . . 0.607 HG12 ' O ' ' A' 1560 ' ' PRO . 9.8 p -99.9 134.92 37.7 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 O-C-N 121.6 -0.941 . . . . 0.97999999999999998 111.294 -177.418 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -95.35 -31.39 7.57 Favored Glycine 0 N--CA 1.453 -0.191 0 CA-C-N 115.725 -0.67 . . . . 0.28000000000000003 112.854 -177.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -124.14 125.62 44.77 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 109.71 -0.478 . . . . 0.28000000000000003 109.71 178.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 4.5 t -159.36 141.42 13.52 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 116.492 -0.322 . . . . 0.42999999999999999 110.361 -177.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1567 ' ' PHE . . . . . 0.516 ' HE1' HG21 ' A' 1574 ' ' VAL . 84.0 m-85 -86.24 139.91 30.6 Favored 'General case' 0 C--O 1.245 0.828 0 N-CA-C 109.61 -0.515 . . . . 1.03 109.61 175.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -86.3 29.85 4.64 Favored Glycine 0 CA--C 1.508 -0.361 0 C-N-CA 120.856 -0.687 . . . . 1.1299999999999999 112.454 -175.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1569 ' ' GLN . . . . . 0.599 ' HB3' ' OD1' ' B' ' 15' ' ' ASP . 27.7 mt-30 -83.3 -70.58 0.55 Allowed 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 110.281 -0.266 . . . . 2.5800000000000001 110.281 177.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 8.3 t -130.96 32.31 4.34 Favored 'General case' 0 CA--C 1.557 1.228 0 CA-C-O 121.563 0.697 . . . . 2.1699999999999999 111.107 176.164 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1571 ' ' ARG . . . . . 0.413 ' HB3' ' HD3' ' A' 1560 ' ' PRO . 15.2 mmt85 64.64 48.86 2.45 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 124.213 1.005 . . . . 2.6200000000000001 110.895 178.689 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 27.8 mt -89.36 120.22 37.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 109.552 -0.536 . . . . 0.92000000000000004 109.552 -178.674 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1573 ' ' SER . . . . . 0.412 ' HB3' ' HB3' ' A' 1596 ' ' SER . 29.5 t -76.13 128.72 35.54 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.392 -0.822 . . . . 0.80000000000000004 111.009 -177.414 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1574 ' ' VAL . . . . . 0.516 HG21 ' HE1' ' A' 1567 ' ' PHE . 0.9 OUTLIER -112.15 -16.57 9.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 115.884 -0.598 . . . . 0.97999999999999998 112.084 -179.918 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 179.11 124.5 0.88 Allowed Glycine 0 N--CA 1.435 -1.403 0 C-N-CA 119.34 -1.409 . . . . 0.28999999999999998 112.4 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 22.2 ttmm -61.65 145.99 50.46 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 123.683 0.793 . . . . 2.1899999999999999 109.399 178.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -59.63 119.92 8.49 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 108.834 -0.802 . . . . 0.60999999999999999 108.834 175.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 60.2 t30 -132.49 147.12 52.36 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.474 -1.306 . . . . 1.95 107.474 -174.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1579 ' ' LYS . . . . . 0.423 ' HE2' ' HB3' ' A' 1515 ' ' ASP . 56.4 mtpt -132.27 57.66 1.78 Allowed 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 122.298 1.047 . . . . 2.6800000000000002 108.772 -175.352 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 31.2 ttm180 -117.69 76.56 1.07 Allowed 'General case' 0 N--CA 1.413 -2.311 0 CA-C-N 114.775 -1.102 . . . . 3.4700000000000002 108.051 -176.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1581 ' ' LEU . . . . . 0.493 ' HB2' ' HA ' ' A' 1516 ' ' CYS . 0.6 OUTLIER -64.23 125.72 25.45 Favored 'General case' 0 C--O 1.252 1.196 0 CA-C-N 114.266 -1.334 . . . . 0.64000000000000001 109.975 -178.103 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A 1582 ' ' ARG . . . . . 0.424 ' HD2' ' OE1' ' A' 1589 ' ' GLN . 91.6 mtt180 -124.48 138.23 54.36 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.865 -0.607 . . . . 2.8500000000000001 110.391 177.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1583 ' ' TYR . . . . . 0.533 ' HB2' HG21 ' A' 1518 ' ' VAL . 46.0 t80 -110.8 107.26 16.71 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 107.303 -1.369 . . . . 0.85999999999999999 107.303 174.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1584 ' ' VAL . . . . . 0.49 ' O ' ' HB ' ' A' 1587 ' ' VAL . 16.5 m -120.97 90.1 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 CA-C-N 115.9 -0.591 . . . . 1.05 112.065 -176.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 29.6 t70 58.02 57.66 3.97 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.892 0.853 . . . . 1.1699999999999999 110.555 178.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1586 ' ' GLN . . . . . 0.47 ' HA ' ' CZ ' ' A' 1583 ' ' TYR . 19.7 pt20 73.99 -7.64 1.58 Allowed 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 128.243 2.617 . . . . 1.8600000000000001 111.476 178.595 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1587 ' ' VAL . . . . . 0.49 ' HB ' ' O ' ' A' 1584 ' ' VAL . 30.5 t -88.07 124.9 41.46 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.444 0 CA-C-N 115.719 -0.673 . . . . 0.48999999999999999 109.337 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1588 ' ' LEU . . . . . 0.736 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 3.3 mm? -93.93 120.85 34.74 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 107.581 -1.266 . . . . 0.35999999999999999 107.581 179.403 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1589 ' ' GLN . . . . . 0.424 ' OE1' ' HD2' ' A' 1582 ' ' ARG . 35.8 tt0 -116.78 135.65 53.59 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 112.63 0.604 . . . . 1.74 112.63 -173.757 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 18.3 mt -129.96 99.25 5.03 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 125.373 1.469 . . . . 0.71999999999999997 107.224 172.107 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 7.5 p -95.81 125.87 48.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 109.527 -0.546 . . . . 1.01 109.527 -178.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1592 ' ' TYR . . . . . 0.603 ' HB2' ' HB3' ' A' 1608 ' ' SER . 15.8 m-30 -110.76 107.1 16.51 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 108.592 -0.892 . . . . 0.5 108.592 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 19.5 pttp -109.68 168.77 9.17 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 115.557 -0.747 . . . . 1.5900000000000001 110.057 -177.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 15.3 m-20 66.29 78.89 0.25 Allowed 'General case' 0 CA--C 1.507 -0.681 0 C-N-CA 124.488 1.115 . . . . 1.1100000000000001 110.69 -178.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -98.99 -122.07 4.65 Favored Glycine 0 C--N 1.287 -2.143 0 N-CA-C 109.703 -1.359 . . . . 0.78000000000000003 109.703 175.112 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1596 ' ' SER . . . . . 0.412 ' HB3' ' HB3' ' A' 1573 ' ' SER . 50.7 p -120.29 164.68 21.3 Favored Pre-proline 0 C--N 1.297 -1.683 0 N-CA-C 107.927 -1.138 . . . . 1.0700000000000001 107.927 175.365 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.16 119.94 7.53 Favored 'Trans proline' 0 C--N 1.361 1.214 0 C-N-CA 122.317 2.012 . . . . 1.01 112.306 -178.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1598 ' ' CYS . . . . . 0.434 ' HA ' ' HD3' ' A' 1599 ' ' PRO . 44.5 t -81.08 125.21 80.18 Favored Pre-proline 0 C--N 1.292 -1.901 0 CA-C-N 115.129 -0.941 . . . . 0.75 109.182 -179.227 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1599 ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' 1598 ' ' CYS . 14.9 Cg_exo -71.1 -15.15 32.16 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 123.429 2.753 . . . . 1.7 112.995 -178.444 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1600 ' ' SER . . . . . 0.836 ' HA ' ' HB3' ' B' ' 53' ' ' LEU . 10.6 m -59.0 -40.89 86.28 Favored 'General case' 0 N--CA 1.434 -1.257 0 C-N-CA 123.296 0.638 . . . . 2.2599999999999998 111.635 177.295 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1601 ' ' LYS . . . . . . . . . . . . . 18.5 ttmm -145.9 127.18 14.84 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 106.832 -1.544 . . . . 3.0099999999999998 106.832 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 19.2 m -61.94 117.18 5.59 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 112.176 0.435 . . . . 2.0699999999999998 112.176 -174.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 95.16 14.68 47.62 Favored Glycine 0 C--O 1.241 0.539 0 C-N-CA 121.404 -0.427 . . . . 1.0800000000000001 112.846 178.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1604 ' ' LEU . . . . . 0.605 HD23 ' SG ' ' A' 1634 ' ' CYS . 12.5 tp -108.16 157.11 18.59 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.861 -1.163 . . . . 1.8400000000000001 107.861 -178.567 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 33.4 t -120.53 154.32 35.5 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.965 -0.754 . . . . 1.4099999999999999 108.965 -178.112 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1606 ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -76.35 158.26 31.63 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.901 -0.777 . . . . 0.59999999999999998 108.901 174.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 56.7 pttt -158.4 140.81 14.28 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 120.397 -0.521 . . . . 1.45 110.976 175.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1608 ' ' SER . . . . . 0.603 ' HB3' ' HB2' ' A' 1592 ' ' TYR . 45.4 t -105.68 127.88 53.33 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 115.168 -0.924 . . . . 1.1499999999999999 109.894 -175.325 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 40.8 t -113.72 101.75 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 N-CA-C 108.905 -0.776 . . . . 0.25 108.905 176.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 80.4 mt -91.87 114.53 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.611 0 N-CA-C 107.85 -1.167 . . . . 0.45000000000000001 107.85 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 8.1 t -116.9 111.59 19.86 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 115.401 -0.818 . . . . 1.26 109.703 -176.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1612 ' ' PHE . . . . . 0.736 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 71.2 m-85 -90.86 118.36 30.21 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.733 -0.667 . . . . 0.26000000000000001 110.036 179.066 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 47.6 t -120.69 138.0 52.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.721 -0.672 . . . . 0.5 110.575 -174.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1614 ' ' CYS . . . . . 0.415 ' HA ' ' HB2' ' A' 1646 ' ' CYS . 15.3 t -51.49 114.87 1.36 Allowed 'General case' 0 C--O 1.247 0.929 0 C-N-CA 125.409 1.484 . . . . 0.77000000000000002 113.088 176.412 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1615 ' ' ARG . . . . . 0.817 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 18.8 tpt180 -128.22 96.6 30.77 Favored Pre-proline 0 N--CA 1.436 -1.139 0 N-CA-C 109.243 -0.651 . . . . 2.5299999999999998 109.243 173.251 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1616 ' ' PRO . . . . . 0.447 ' HD2' ' OE1' ' A' 1617 ' ' GLU . 31.7 Cg_exo -62.43 -37.42 59.98 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 121.909 1.739 . . . . 1.1000000000000001 111.311 175.517 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1617 ' ' GLU . . . . . 0.447 ' OE1' ' HD2' ' A' 1616 ' ' PRO . 2.6 mp0 -77.82 44.39 0.46 Allowed 'General case' 0 C--O 1.24 0.571 0 C-N-CA 124.89 1.276 . . . . 3.0499999999999998 112.059 178.152 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -37.15 132.63 0.72 Allowed 'General case' 0 C--O 1.244 0.792 0 C-N-CA 125.296 1.438 . . . . 1.55 112.613 178.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1619 ' ' GLY . . . . . 0.442 ' HA3' ' HD2' ' A' 1620 ' ' PRO . . . 172.46 -137.33 4.18 Favored Glycine 0 N--CA 1.423 -2.221 0 N-CA-C 110.195 -1.162 . . . . 0.93000000000000005 110.195 -177.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1620 ' ' PRO . . . . . 0.442 ' HD2' ' HA3' ' A' 1619 ' ' GLY . 36.3 Cg_endo -63.68 -1.46 3.33 Favored 'Trans proline' 0 CA--C 1.551 1.335 0 C-N-CA 123.269 2.646 . . . . 0.88 114.852 -178.254 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1621 ' ' THR . . . . . 0.632 ' HB ' ' HB2' ' A' 1641 ' ' HIS . 5.2 p -89.96 -11.82 40.55 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 121.807 0.813 . . . . 0.96999999999999997 109.785 177.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 48.5 t30 -92.66 55.34 2.43 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 122.679 1.228 . . . . 0.71999999999999997 109.599 -178.062 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -156.59 139.19 10.55 Favored Pre-proline 0 C--N 1.3 -1.55 0 N-CA-C 106.514 -1.661 . . . . 3.2599999999999998 106.514 178.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -61.72 113.9 2.03 Favored 'Trans proline' 0 C--O 1.245 0.863 0 C-N-CA 122.881 2.387 . . . . 0.58999999999999997 112.123 -176.402 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 75.3 mtm -117.17 140.13 49.91 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 116.508 -0.314 . . . . 1.3700000000000001 110.603 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1626 ' ' LEU . . . . . 0.623 ' HG ' ' CE2' ' A' 1542 ' ' TYR . 0.3 OUTLIER -87.99 115.18 25.28 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 107.681 -1.229 . . . . 0.89000000000000001 107.681 -175.463 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 48.8 mm -80.12 -49.46 18.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 CA-C-N 116.249 -0.432 . . . . 0.57999999999999996 109.839 -178.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 33.1 t -167.78 149.53 5.51 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.545 -0.752 . . . . 1.3899999999999999 110.134 -175.256 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1629 ' ' LEU . . . . . 0.612 HD13 ' HG ' ' A' 1636 ' ' LEU . 48.0 tp -112.63 105.59 13.8 Favored 'General case' 0 N--CA 1.418 -2.053 0 N-CA-C 107.116 -1.439 . . . . 1.25 107.116 173.217 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 30.4 t70 -76.92 114.38 15.63 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.462 -0.895 . . . . 1.0900000000000001 108.994 178.312 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1631 ' ' LYS . . . . . 0.411 ' HB3' HD11 ' B' ' 53' ' ' LEU . 98.7 mttt -66.91 -21.1 66.0 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 113.445 0.905 . . . . 3.6000000000000001 113.445 -174.478 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -86.32 -35.26 19.98 Favored 'General case' 0 CA--C 1.497 -1.071 0 CA-C-O 121.343 0.592 . . . . 2.6000000000000001 111.348 -177.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 53.5 p -104.9 -7.03 19.62 Favored 'General case' 0 C--N 1.285 -2.198 0 CA-C-N 115.741 -0.663 . . . . 0.75 112.391 -175.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1634 ' ' CYS . . . . . 0.605 ' SG ' HD23 ' A' 1604 ' ' LEU . 75.0 m 56.38 34.61 24.48 Favored 'General case' 0 C--N 1.363 1.156 0 C-N-CA 124.284 1.033 . . . . 0.53000000000000003 110.934 -177.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1635 ' ' THR . . . . . . . . . . . . . 88.2 m -99.03 129.26 45.3 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-N 114.193 -1.367 . . . . 0.46000000000000002 109.979 -177.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1636 ' ' LEU . . . . . 0.612 ' HG ' HD13 ' A' 1629 ' ' LEU . 1.5 mp -108.02 121.33 44.58 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 107.542 -1.281 . . . . 0.85999999999999999 107.542 -179.613 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -95.02 131.22 41.22 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 120.685 0.279 . . . . 0.45000000000000001 110.542 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -126.26 119.34 27.17 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.716 -0.675 . . . . 0.5 109.343 -176.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1639 ' ' SER . . . . . . . . . . . . . 59.7 m -103.15 138.15 40.36 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 115.781 -0.645 . . . . 1.04 109.567 175.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 2.8 t90 -141.85 113.19 7.61 Favored 'General case' 0 N--CA 1.422 -1.84 0 N-CA-C 103.95 -2.611 . . . . 0.68000000000000005 103.95 178.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1641 ' ' HIS . . . . . 0.817 ' HB3' ' HB2' ' A' 1615 ' ' ARG . 18.1 m-70 -107.08 111.04 23.31 Favored 'General case' 0 C--N 1.286 -2.182 0 C-N-CA 120.067 -0.653 . . . . 0.90000000000000002 110.402 -174.517 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1642 ' ' THR . . . . . . . . . . . . . 4.9 t -142.75 150.07 52.36 Favored Pre-proline 0 C--N 1.306 -1.29 0 CA-C-N 115.479 -0.782 . . . . 0.47999999999999998 109.683 -174.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1643 ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -76.64 -6.39 16.9 Favored 'Trans proline' 0 C--N 1.366 1.483 0 C-N-CA 122.281 1.987 . . . . 0.66000000000000003 112.316 175.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 8.6 tt -64.45 -30.27 71.31 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.435 0.636 . . . . 0.96999999999999997 109.445 177.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -94.51 8.03 43.58 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.051 -0.977 . . . . 0.83999999999999997 109.828 -177.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1646 ' ' CYS . . . . . 0.561 ' O ' ' HD3' ' A' 1648 ' ' PRO . 33.7 t -122.09 158.54 29.03 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 115.532 -0.758 . . . . 1.1899999999999999 109.496 -173.759 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1647 ' ' GLU . . . . . 0.401 ' OE2' ' HB2' ' A' 1525 ' ' HIS . 8.6 tp10 -99.85 96.09 4.45 Favored Pre-proline 0 N--CA 1.417 -2.094 0 N-CA-C 106.728 -1.582 . . . . 3.1400000000000001 106.728 171.333 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1648 ' ' PRO . . . . . 0.561 ' HD3' ' O ' ' A' 1646 ' ' CYS . 23.2 Cg_exo -67.29 118.02 5.26 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 122.56 2.173 . . . . 2.5800000000000001 111.804 -179.031 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 32.8 tt0 . . . . . 0 C--N 1.292 -1.893 0 N-CA-C 106.003 -1.851 . . . . 4.7199999999999998 106.003 176.135 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.142 0 CA-C-O 121.816 0.817 . . . . 9.9700000000000006 109.992 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 2' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -142.38 136.25 29.41 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 107.275 -1.38 . . . . 7.6799999999999997 107.275 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 20.4 ptp180 -89.01 110.03 35.03 Favored Pre-proline 0 C--N 1.307 -1.254 0 O-C-N 123.126 0.266 . . . . 6.1100000000000003 110.416 -179.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -66.88 -17.08 51.48 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 121.675 1.584 . . . . 4.8399999999999999 113.167 178.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 66.9 m 51.69 23.74 2.1 Favored 'General case' 0 C--O 1.25 1.083 0 C-N-CA 125.576 1.55 . . . . 4.5999999999999996 113.613 177.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 57.78 30.08 18.43 Favored 'General case' 0 C--N 1.349 0.558 0 CA-C-N 114.105 -1.407 . . . . 4.2300000000000004 110.492 178.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 20.3 p -133.33 131.55 40.26 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 114.821 -1.081 . . . . 3.1400000000000001 111.313 -179.304 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.779 ' HB2' ' HG3' ' B' ' 12' ' ' GLU . 4.2 mm? -90.46 115.4 27.59 Favored 'General case' 0 C--O 1.251 1.151 0 N-CA-C 109.31 -0.626 . . . . 3.96 109.31 173.028 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 57.4 m -74.72 85.12 2.14 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.761 0.791 . . . . 2.8399999999999999 110.998 -176.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.7 -50.66 0.87 Allowed Glycine 0 N--CA 1.421 -2.343 0 N-CA-C 110.576 -1.01 . . . . 2.0899999999999999 110.576 178.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.22 -62.67 4.48 Favored Glycine 0 N--CA 1.444 -0.806 0 O-C-N 123.98 0.459 . . . . 1.8400000000000001 112.972 -179.147 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 12' ' ' GLU . . . . . 0.779 ' HG3' ' HB2' ' B' ' 8' ' ' LEU . 77.7 mt-10 -69.53 -27.06 64.84 Favored 'General case' 0 CA--C 1.496 -1.108 0 C-N-CA 120.186 -0.606 . . . . 2.5499999999999998 109.416 177.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 13' ' ' LEU . . . . . 0.505 ' O ' HD23 ' B' ' 17' ' ' LEU . 0.1 OUTLIER -57.32 -57.89 10.64 Favored 'General case' 0 C--O 1.212 -0.898 0 CA-C-N 115.651 -0.704 . . . . 2.3500000000000001 109.726 176.319 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 13.7 p -66.07 -34.09 67.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.981 -0.288 . . . . 2.1099999999999999 111.148 -178.191 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 15' ' ' ASP . . . . . 0.599 ' OD1' ' HB3' ' A' 1569 ' ' GLN . 29.3 t70 -71.22 -40.84 70.85 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 113.658 0.984 . . . . 2.04 113.658 -177.817 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 21.6 p -66.8 -40.92 88.28 Favored 'General case' 0 C--O 1.262 1.739 0 CA-C-O 121.644 0.735 . . . . 1.8400000000000001 109.917 176.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.505 HD23 ' O ' ' B' ' 13' ' ' LEU . 4.1 mm? -52.95 -50.12 64.69 Favored 'General case' 0 C--O 1.213 -0.824 0 CA-C-N 114.896 -1.047 . . . . 1.74 110.598 170.693 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -67.09 -25.68 66.34 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 123.841 0.857 . . . . 2.3900000000000001 111.777 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -58.59 -55.27 37.25 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 116.019 -0.537 . . . . 0.95999999999999996 110.982 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 14.7 p -99.08 -22.19 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.07 0 C-N-CA 118.105 -1.438 . . . . 1.3700000000000001 112.819 178.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 21' ' ' CYS . . . . . 0.503 ' HB2' ' HB3' ' B' ' 26' ' ' PHE . 57.9 m -103.36 24.89 10.29 Favored 'General case' 0 C--N 1.315 -0.914 0 O-C-N 121.555 -0.716 . . . . 1.6599999999999999 110.881 -178.666 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.69 -67.79 2.01 Favored Glycine 0 N--CA 1.461 0.345 0 C-N-CA 121.424 -0.417 . . . . 1.53 113.414 -177.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.82 ' HB3' ' HG3' ' A' 1544 ' ' LYS . 8.8 p-10 -76.88 -4.16 42.3 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 122.826 0.45 . . . . 2.7200000000000002 111.646 179.449 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 24' ' ' ARG . . . . . 0.511 ' HG2' ' O ' ' B' ' 61' ' ' ALA . 21.1 tpp180 -97.48 -42.71 7.58 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 116.02 -0.536 . . . . 4.3300000000000001 111.745 -175.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 112.73 121.76 3.9 Favored Glycine 0 N--CA 1.426 -2.028 0 N-CA-C 108.998 -1.641 . . . . 1.53 108.998 -174.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 26' ' ' PHE . . . . . 0.609 ' HA ' ' SG ' ' B' ' 60' ' ' CYS . 13.4 p90 -98.12 144.94 27.07 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 117.422 0.611 . . . . 1.6499999999999999 111.318 -179.208 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 27' ' ' TYR . . . . . 0.491 ' CE2' ' HB2' ' B' ' 61' ' ' ALA . 19.4 m-85 -125.64 105.05 8.72 Favored 'General case' 0 C--O 1.218 -0.581 0 N-CA-C 113.003 0.742 . . . . 3.4199999999999999 113.003 -175.236 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 28' ' ' PHE . . . . . 0.499 ' CD2' ' HG ' ' B' ' 17' ' ' LEU . 53.8 p90 -150.67 23.6 0.79 Allowed 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 121.471 0.653 . . . . 2.2599999999999998 109.84 162.512 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 27.5 m -139.89 105.81 5.19 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 108.874 -0.787 . . . . 3.6800000000000002 108.874 -177.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 -123.22 159.33 54.98 Favored Pre-proline 0 C--N 1.296 -1.761 0 N-CA-C 108.111 -1.07 . . . . 3.8100000000000001 108.111 -176.058 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -82.21 9.77 3.84 Favored 'Trans proline' 0 C--O 1.252 1.222 0 C-N-CA 122.765 2.31 . . . . 4.0199999999999996 111.177 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . 76.67 152.77 0.13 Allowed 'General case' 0 N--CA 1.422 -1.859 0 C-N-CA 126.968 2.107 . . . . 4.9199999999999999 109.89 179.035 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 29.9 m -150.16 175.09 12.07 Favored 'General case' 1 N--CA 1.356 -5.128 0 N-CA-C 102.811 -3.033 . . . . 6.7199999999999998 102.811 -176.648 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -81.3 -27.03 35.23 Favored 'General case' 0 C--N 1.26 -3.31 0 CA-C-N 120.303 1.411 . . . . 11.630000000000001 107.795 -178.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 21.3 t -93.35 6.29 6.54 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-O 122.304 1.05 . . . . 9.6099999999999994 108.656 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 34.0 t -156.04 69.34 0.65 Allowed 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 106.937 -1.505 . . . . 6.71 106.937 -177.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -56.68 -41.85 78.02 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 114.038 -1.437 . . . . 10.0 111.262 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 -60.44 109.5 1.02 Allowed 'General case' 0 N--CA 1.431 -1.398 0 O-C-N 124.085 0.865 . . . . 7.9400000000000004 110.576 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 14.9 m -71.3 -35.65 71.36 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 107.817 -1.179 . . . . 5.7599999999999998 107.817 176.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 -123.44 130.6 52.94 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 106.918 -1.512 . . . . 6.0300000000000002 106.918 170.174 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 41' ' ' GLY . . . . . 0.433 ' O ' ' HB2' ' B' ' 28' ' ' PHE . . . -114.67 164.69 12.06 Favored Glycine 0 N--CA 1.413 -2.882 0 N-CA-C 109.685 -1.366 . . . . 2.3700000000000001 109.685 -176.12 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . 0.262 23.0 pt 59.8 -27.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 C-N-CA 127.849 2.46 . . . . 2.0699999999999998 115.583 178.136 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.495 ' O ' ' HB2' ' B' ' 47' ' ' CYS . 2.5 p -53.98 -41.29 48.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 C-N-CA 124.566 1.146 . . . . 2.2400000000000002 112.738 177.138 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -95.47 -25.84 16.07 Favored 'General case' 0 N--CA 1.419 -1.997 0 N-CA-C 109.048 -0.723 . . . . 3.3599999999999999 109.048 -173.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 22.0 tp10 -61.11 -56.66 18.34 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 114.651 -1.159 . . . . 3.0800000000000001 108.441 176.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 46' ' ' CYS . . . . . . . . . . . . . 56.5 m -84.83 2.59 41.73 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.069 -0.514 . . . . 2.23 111.945 -177.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 47' ' ' CYS . . . . . 0.495 ' HB2' ' O ' ' B' ' 43' ' ' VAL . 49.7 t -78.89 -48.0 15.45 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 120.257 -0.577 . . . . 2.3700000000000001 109.537 176.365 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -101.66 -2.27 30.75 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.053 -0.521 . . . . 2.8199999999999998 111.81 -176.165 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 21.0 mmt180 -132.56 162.89 30.12 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.896 -1.15 . . . . 4.0899999999999999 107.896 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 1.9 p -102.4 127.66 49.33 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 108.371 -0.974 . . . . 2.6699999999999999 108.371 176.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 85.2 m -106.81 171.35 7.41 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.568 0.699 . . . . 2.1099999999999999 112.257 -172.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -126.35 158.33 36.15 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 105.839 -1.911 . . . . 2.6699999999999999 105.839 173.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 53' ' ' LEU . . . . . 0.836 ' HB3' ' HA ' ' A' 1600 ' ' SER . 2.6 pt? -60.71 -21.19 62.64 Favored 'General case' 0 CA--C 1.501 -0.936 0 N-CA-C 114.693 1.368 . . . . 1.8999999999999999 114.693 -167.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 54' ' ' ALA . . . . . 0.408 ' O ' HG22 ' B' ' 58' ' ' THR . . . -58.31 -29.46 65.91 Favored 'General case' 0 CA--C 1.514 -0.415 0 O-C-N 123.509 0.505 . . . . 1.52 111.282 -176.449 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 55' ' ' LEU . . . . . 0.401 ' O ' ' HB2' ' B' ' 59' ' ' TYR . 64.9 tp -65.06 -54.82 24.18 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 115.636 -0.711 . . . . 1.97 110.16 178.569 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 1.3 pp -76.04 -32.69 59.46 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 116.588 -0.278 . . . . 1.53 111.483 -175.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -55.51 -49.01 73.73 Favored 'General case' 0 C--N 1.318 -0.803 0 O-C-N 123.83 0.706 . . . . 2.27 110.553 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 58' ' ' THR . . . . . 0.408 HG22 ' O ' ' B' ' 54' ' ' ALA . 10.9 t -86.78 -17.41 33.58 Favored 'General case' 0 CA--C 1.567 1.607 0 N-CA-C 112.405 0.52 . . . . 2.3300000000000001 112.405 -177.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 59' ' ' TYR . . . . . 0.401 ' HB2' ' O ' ' B' ' 55' ' ' LEU . 10.8 t80 -86.67 -37.52 17.92 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.52 -0.737 . . . . 2.8599999999999999 109.961 -178.007 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 60' ' ' CYS . . . . . 0.609 ' SG ' ' HA ' ' B' ' 26' ' ' PHE . 6.6 t -82.35 171.2 14.47 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.466 -0.788 . . . . 2.2999999999999998 111.461 -178.682 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 61' ' ' ALA . . . . . 0.911 ' HA ' ' HD2' ' B' ' 65' ' ' LYS . . . -85.05 113.77 21.71 Favored 'General case' 0 N--CA 1.422 -1.831 0 N-CA-C 106.906 -1.516 . . . . 3.1899999999999999 106.906 175.031 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 62' ' ' THR . . . . . 0.702 ' H ' ' HB2' ' B' ' 65' ' ' LYS . 2.9 p -125.07 159.98 56.7 Favored Pre-proline 0 C--N 1.279 -2.478 0 CA-C-O 118.639 -0.696 . . . . 3.6800000000000002 110.086 -176.427 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -45.71 -44.52 17.69 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 122.613 2.208 . . . . 5.0800000000000001 113.464 178.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -107.17 42.8 1.25 Allowed 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 116.005 -0.543 . . . . 5.0999999999999996 110.718 178.36 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 65' ' ' LYS . . . . . 0.911 ' HD2' ' HA ' ' B' ' 61' ' ' ALA . 48.8 tttm -64.92 140.49 58.87 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.689 -0.687 . . . . 8.5099999999999998 111.036 179.089 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 66' ' ' SER . . . . . 0.43 ' O ' ' HG2' ' B' ' 65' ' ' LYS . 46.9 m -90.26 171.97 9.11 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 109.208 -0.664 . . . . 8.1199999999999992 109.208 176.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.297 -1.688 0 N-CA-C 106.304 -1.739 . . . . 10.210000000000001 106.304 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 26.7 ptt? . . . . . 0 N--CA 1.47 0.526 0 CA-C-O 120.462 0.172 . . . . 9.3399999999999999 110.808 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 51.1 tptt -142.56 83.83 1.83 Allowed 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 108.695 -0.854 . . . . 9.0399999999999991 108.695 -174.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 30.6 t -142.02 37.21 1.58 Allowed 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 105.98 -1.859 . . . . 5.8099999999999996 105.98 -177.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1511 ' ' ASN . . . . . . . . . . . . . 16.3 m120 -98.99 1.51 45.52 Favored 'General case' 0 C--N 1.284 -2.251 0 CA-C-N 113.506 -1.679 . . . . 3.4199999999999999 112.531 -172.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1512 ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -81.08 -57.23 3.62 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 108.159 -1.052 . . . . 5.9500000000000002 108.159 176.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 6.3 p-80 -164.39 130.2 2.9 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-O 121.122 0.487 . . . . 5.3300000000000001 111.707 177.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 12.9 t70 -97.11 -137.28 0.26 Allowed 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 103.829 -2.656 . . . . 5.0599999999999996 103.829 171.28 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 34.3 t70 -70.62 -74.15 0.15 Allowed 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 119.779 1.172 . . . . 2.8999999999999999 108.893 173.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 12.6 t -150.89 61.38 0.92 Allowed 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 106.431 -1.692 . . . . 1.1899999999999999 106.431 172.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 26.1 pt20 -165.13 162.92 20.43 Favored 'General case' 0 N--CA 1.419 -1.998 0 N-CA-C 106.485 -1.672 . . . . 1.52 106.485 -175.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1518 ' ' VAL . . . . . 0.668 HG21 ' HB2' ' A' 1583 ' ' TYR . 0.0 OUTLIER -154.59 146.05 13.61 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 O-C-N 123.896 0.747 . . . . 0.93999999999999995 110.449 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A 1519 ' ' THR . . . . . . . . . . . . . 49.9 m -98.09 137.69 36.51 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 115.965 -0.561 . . . . 0.89000000000000001 109.561 176.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1520 ' ' ASN . . . . . 0.498 ' ND2' ' OH ' ' A' 1583 ' ' TYR . 21.2 t-20 -79.31 117.27 66.09 Favored Pre-proline 0 N--CA 1.43 -1.46 0 N-CA-C 108.6 -0.889 . . . . 1.74 108.6 174.572 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -69.56 -10.79 29.62 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 122.687 2.258 . . . . 1.5800000000000001 113.586 -176.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 19.7 m -82.47 -44.22 16.27 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 120.77 0.319 . . . . 1.6499999999999999 111.809 -178.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1523 ' ' THR . . . . . . . . . . . . . 9.0 t -122.16 -3.23 9.03 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 119.459 -0.896 . . . . 1.6100000000000001 112.24 -177.299 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 80.46 16.34 76.15 Favored Glycine 0 C--O 1.238 0.344 0 C-N-CA 120.691 -0.766 . . . . 1.1299999999999999 112.708 175.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 53.9 t-80 -80.69 125.3 29.87 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 120.832 0.348 . . . . 1.26 110.546 -178.004 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 1.2 tm? -90.38 108.39 19.75 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 114.921 -1.036 . . . . 0.68000000000000005 108.981 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -87.9 111.32 21.31 Favored 'General case' 0 CA--C 1.499 -0.981 0 N-CA-C 107.981 -1.118 . . . . 0.65000000000000002 107.981 177.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -101.71 134.72 44.42 Favored 'General case' 0 N--CA 1.404 -2.737 0 N-CA-C 107.123 -1.436 . . . . 1.1699999999999999 107.123 174.093 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 3.4 mm? -100.94 5.15 43.12 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-O 122.017 0.913 . . . . 0.59999999999999998 108.687 177.34 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 4.0 m -64.82 -32.91 74.82 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.102 -1.408 . . . . 0.83999999999999997 109.75 178.132 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1531 ' ' SER . . . . . 0.611 ' HB2' HD11 ' A' 1644 ' ' LEU . 46.0 m -66.28 -25.74 67.01 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.952 -0.567 . . . . 1.5900000000000001 111.238 177.162 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 90.1 mt -97.11 -1.11 45.9 Favored 'General case' 0 C--O 1.215 -0.72 0 CA-C-O 121.194 0.521 . . . . 0.65000000000000002 110.463 176.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1533 ' ' SER . . . . . . . . . . . . . 46.8 t -85.25 175.03 9.18 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.329 0.585 . . . . 1.52 110.145 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . 170.33 169.15 33.12 Favored Glycine 0 C--N 1.299 -1.512 0 N-CA-C 109.019 -1.633 . . . . 1.1000000000000001 109.019 -179.318 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -92.5 -35.38 13.65 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 117.239 0.519 . . . . 4.6200000000000001 110.518 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1536 ' ' ALA . . . . . 0.626 ' HA ' ' HG2' ' A' 1557 ' ' GLU . . . -77.35 -35.43 54.65 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 121.376 0.608 . . . . 1.45 109.919 -179.018 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 91.59 -149.98 20.1 Favored Glycine 0 N--CA 1.42 -2.399 0 CA-C-N 115.274 -0.876 . . . . 0.84999999999999998 111.78 176.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -137.41 149.32 46.84 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.654 -0.869 . . . . 0.93000000000000005 108.654 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1539 ' ' THR . . . . . 0.456 ' HA ' ' O ' ' A' 1548 ' ' VAL . 4.0 m -125.08 122.11 36.26 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 109.326 -0.62 . . . . 1.03 109.326 -177.44 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1540 ' ' ALA . . . . . 0.521 ' HB3' ' CG1' ' A' 1548 ' ' VAL . . . -115.38 150.18 36.77 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 108.113 -1.069 . . . . 0.5 108.113 -178.428 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -93.35 138.78 31.36 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 121.108 0.48 . . . . 0.73999999999999999 111.179 -176.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1542 ' ' TYR . . . . . 0.828 ' HE1' ' HG ' ' A' 1626 ' ' LEU . 1.5 t80 -121.77 -101.33 0.41 Allowed 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 107.625 -1.25 . . . . 0.98999999999999999 107.625 -179.484 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1543 ' ' SER . . . . . 0.422 ' H ' ' HB3' ' A' 1542 ' ' TYR . 32.8 t -66.8 159.75 27.39 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 107.304 -1.369 . . . . 1.9099999999999999 107.304 172.365 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 62.7 mttp -59.38 -37.05 76.93 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-N 119.921 1.237 . . . . 3.5899999999999999 113.619 -175.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 14.7 t -100.83 15.19 29.25 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 110.104 -0.332 . . . . 2.46 110.104 178.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1546 ' ' GLY . . . . . 0.498 ' HA2' ' OE1' ' A' 1569 ' ' GLN . . . -130.42 147.95 18.44 Favored Glycine 0 CA--C 1.54 1.633 0 C-N-CA 120.03 -1.081 . . . . 1.26 114.092 -174.074 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 22.6 m -136.67 176.94 6.85 Favored 'Isoleucine or valine' 0 C--O 1.252 1.235 0 CA-C-N 117.488 0.644 . . . . 0.79000000000000004 110.573 -178.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1548 ' ' VAL . . . . . 0.84 ' HB ' ' CE1' ' A' 1567 ' ' PHE . 7.3 p -127.1 136.63 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 CA-C-N 115.034 -0.985 . . . . 0.57999999999999996 109.913 175.408 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1549 ' ' TYR . . . . . 0.599 ' HB2' ' HB3' ' A' 1566 ' ' CYS . 62.0 m-85 -101.63 116.04 31.87 Favored 'General case' 0 C--N 1.293 -1.854 0 C-N-CA 124.812 1.245 . . . . 1.0800000000000001 108.186 177.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 8.6 ptp -125.43 146.39 49.64 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 120.189 -0.604 . . . . 0.78000000000000003 110.455 175.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 8.2 p -129.46 119.79 24.36 Favored 'General case' 0 C--N 1.281 -2.398 0 CA-C-N 115.763 -0.653 . . . . 0.96999999999999997 109.579 174.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1552 ' ' ILE . . . . . . . . . . . . . 38.7 mm -81.5 116.97 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.668 0 C-N-CA 120.84 -0.344 . . . . 0.41999999999999998 110.238 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 64.3 m 69.84 26.94 4.66 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.108 0.963 . . . . 1.3999999999999999 111.649 175.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . -172.3 -167.67 32.67 Favored Glycine 0 CA--C 1.482 -2.004 0 C-N-CA 120.098 -1.048 . . . . 0.34999999999999998 111.233 -177.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -107.94 135.79 48.73 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-O 121.165 0.507 . . . . 1.6200000000000001 111.374 -178.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -78.93 129.2 34.24 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.632 -0.713 . . . . 0.87 109.37 -174.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1557 ' ' GLU . . . . . 0.626 ' HG2' ' HA ' ' A' 1536 ' ' ALA . 5.3 pt-20 -73.33 -12.73 60.93 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.633 0.975 . . . . 2.4900000000000002 113.633 -174.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 9.7 m120 -89.19 -2.74 58.63 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 120.48 -0.488 . . . . 1.3799999999999999 110.373 -173.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1559 ' ' CYS . . . . . 0.59 ' SG ' ' HD2' ' A' 1560 ' ' PRO . 34.2 t -135.81 155.82 77.73 Favored Pre-proline 0 C--N 1.308 -1.196 0 N-CA-C 108.255 -1.017 . . . . 1.21 108.255 -175.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1560 ' ' PRO . . . . . 0.59 ' HD2' ' SG ' ' A' 1559 ' ' CYS . 69.1 Cg_exo -29.06 132.83 0.04 OUTLIER 'Trans proline' 0 C--N 1.379 2.134 1 C-N-CA 125.7 4.267 . . . . 0.70999999999999996 114.73 176.175 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A 1561 ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' 1560 ' ' PRO . 9.6 Cg_endo -48.77 127.62 17.0 Favored 'Trans proline' 0 CA--C 1.547 1.147 0 C-N-CA 124.443 3.428 . . . . 0.80000000000000004 114.306 -178.121 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 101.05 1.05 54.79 Favored Glycine 0 CA--C 1.525 0.672 0 CA-C-N 115.589 -0.732 . . . . 0.46000000000000002 114.78 176.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1563 ' ' VAL . . . . . 0.475 HG11 ' SG ' ' A' 1559 ' ' CYS . 7.7 p -102.26 137.73 29.13 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 C-N-CA 119.626 -0.83 . . . . 0.97999999999999998 111.18 -175.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -100.05 -31.86 5.79 Favored Glycine 0 CA--C 1.521 0.417 0 CA-C-N 115.526 -0.761 . . . . 0.28000000000000003 112.681 -178.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -127.53 128.61 45.93 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 108.473 -0.936 . . . . 0.28000000000000003 108.473 178.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1566 ' ' CYS . . . . . 0.599 ' HB3' ' HB2' ' A' 1549 ' ' TYR . 45.2 t -145.76 124.88 12.86 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 110.376 -0.231 . . . . 0.42999999999999999 110.376 -176.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1567 ' ' PHE . . . . . 0.84 ' CE1' ' HB ' ' A' 1548 ' ' VAL . 9.7 m-85 -110.51 160.36 16.69 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 122.597 0.359 . . . . 1.03 110.296 175.343 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . 100.19 156.01 27.92 Favored Glycine 1 N--CA 1.394 -4.159 0 C-N-CA 119.353 -1.403 . . . . 1.1299999999999999 112.026 171.227 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1569 ' ' GLN . . . . . 0.498 ' OE1' ' HA2' ' A' 1546 ' ' GLY . 2.3 mp0 -84.92 -23.5 28.83 Favored 'General case' 0 C--N 1.284 -2.272 0 N-CA-C 107.571 -1.27 . . . . 2.5800000000000001 107.571 179.48 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 24.3 p -82.65 -11.7 58.18 Favored 'General case' 0 N--CA 1.423 -1.781 0 CA-C-N 115.353 -0.839 . . . . 2.1699999999999999 111.68 176.2 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1571 ' ' ARG . . . . . 0.452 ' HG3' ' CE2' ' A' 1549 ' ' TYR . 4.8 mpt_? 73.76 75.21 0.13 Allowed 'General case' 0 CA--C 1.506 -0.726 0 C-N-CA 124.311 1.044 . . . . 2.6200000000000001 111.251 178.238 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 61.5 mt -98.46 121.65 49.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 CA-C-N 114.074 -1.421 . . . . 0.92000000000000004 109.505 -177.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1573 ' ' SER . . . . . 0.452 ' HB3' ' HB3' ' A' 1596 ' ' SER . 17.7 t -65.55 124.79 23.27 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.532 -0.758 . . . . 0.80000000000000004 110.866 -178.468 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1574 ' ' VAL . . . . . 0.59 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 32.8 m -126.48 20.21 3.51 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-O 121.866 0.841 . . . . 0.97999999999999998 110.746 178.272 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 164.23 113.54 0.29 Allowed Glycine 0 N--CA 1.425 -2.034 0 CA-C-N 114.607 -1.179 . . . . 0.28999999999999998 111.779 177.397 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 56.7 tttp -72.27 136.12 46.21 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 107.721 -1.214 . . . . 2.1899999999999999 107.721 178.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -69.04 141.42 54.83 Favored 'General case' 0 C--N 1.314 -0.975 0 O-C-N 123.486 0.491 . . . . 0.60999999999999999 111.59 -175.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 9.4 p30 -161.32 175.74 11.93 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 105.138 -2.171 . . . . 1.95 105.138 176.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 7.2 ptpp? -132.54 42.88 3.05 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 119.001 0.818 . . . . 2.6800000000000002 110.951 -173.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 47.2 ttt180 -85.34 76.77 10.08 Favored 'General case' 0 N--CA 1.427 -1.6 0 N-CA-C 108.495 -0.928 . . . . 3.4700000000000002 108.495 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1581 ' ' LEU . . . . . 0.493 HD12 ' CG2' ' A' 1518 ' ' VAL . 0.4 OUTLIER -70.15 121.36 17.38 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 114.846 -1.07 . . . . 0.64000000000000001 108.541 179.446 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 58.2 mtp180 -116.03 120.68 39.89 Favored 'General case' 0 C--N 1.287 -2.13 0 C-N-CA 120.611 -0.436 . . . . 2.8500000000000001 111.31 177.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1583 ' ' TYR . . . . . 0.668 ' HB2' HG21 ' A' 1518 ' ' VAL . 62.1 t80 -94.0 109.43 21.17 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 109.412 -0.588 . . . . 0.85999999999999999 109.412 175.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1584 ' ' VAL . . . . . 0.535 ' O ' ' HB ' ' A' 1587 ' ' VAL . 11.9 m -128.22 89.57 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-O 121.518 0.675 . . . . 1.05 111.968 -179.581 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 34.6 t70 53.1 71.54 0.48 Allowed 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 124.359 1.063 . . . . 1.1699999999999999 112.942 174.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 9.2 pt20 67.74 12.81 9.02 Favored 'General case' 0 N--CA 1.508 2.465 0 C-N-CA 127.46 2.304 . . . . 1.8600000000000001 111.319 178.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1587 ' ' VAL . . . . . 0.535 ' HB ' ' O ' ' A' 1584 ' ' VAL . 39.5 t -116.86 120.66 65.71 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.152 0 CA-C-N 114.55 -1.204 . . . . 0.48999999999999999 109.51 177.695 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1588 ' ' LEU . . . . . 0.886 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 1.8 mm? -100.46 107.81 19.63 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 105.122 -2.177 . . . . 0.35999999999999999 105.122 176.238 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -112.89 134.74 54.27 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 112.875 0.694 . . . . 1.74 112.875 -172.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 18.6 mt -124.75 112.49 16.79 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 114.103 -1.408 . . . . 0.71999999999999997 108.193 175.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 7.0 p -101.58 127.39 54.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-O 121.268 0.556 . . . . 1.01 109.61 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1592 ' ' TYR . . . . . . . . . . . . . 13.4 m-30 -114.46 101.37 9.08 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 109.467 -0.568 . . . . 0.5 109.467 -177.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 15.4 pttp -109.29 -178.16 3.49 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 114.661 -1.154 . . . . 1.5900000000000001 108.138 -175.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 8.2 m-20 63.82 44.78 4.72 Favored 'General case' 0 C--N 1.319 -0.752 0 O-C-N 124.128 0.892 . . . . 1.1100000000000001 110.765 179.161 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -79.44 -166.34 32.05 Favored Glycine 0 N--CA 1.437 -1.236 0 CA-C-N 115.0 -1.0 . . . . 0.78000000000000003 110.917 176.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1596 ' ' SER . . . . . 0.656 ' HB2' ' HD2' ' A' 1597 ' ' PRO . 79.1 p -86.68 167.53 22.15 Favored Pre-proline 0 C--N 1.297 -1.679 0 C-N-CA 120.209 -0.596 . . . . 1.0700000000000001 109.842 -177.579 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1597 ' ' PRO . . . . . 0.799 ' HG3' ' HB3' ' B' ' 6' ' ' GLU . 12.2 Cg_endo -56.05 120.4 8.21 Favored 'Trans proline' 0 C--N 1.364 1.349 0 C-N-CA 122.592 2.195 . . . . 1.01 111.048 178.509 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1598 ' ' CYS . . . . . 0.478 ' HA ' ' HD3' ' A' 1599 ' ' PRO . 44.1 t -83.98 123.97 75.09 Favored Pre-proline 0 C--N 1.286 -2.195 0 CA-C-N 114.369 -1.287 . . . . 0.75 110.12 -177.451 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1599 ' ' PRO . . . . . 0.519 ' HD2' ' OH ' ' A' 1606 ' ' TYR . 3.1 Cg_exo -80.01 2.7 8.22 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 123.551 2.834 . . . . 1.7 112.679 178.352 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1600 ' ' SER . . . . . 0.436 ' HA ' ' HB3' ' B' ' 53' ' ' LEU . 14.8 m -77.54 -55.98 4.91 Favored 'General case' 0 N--CA 1.42 -1.971 0 N-CA-C 108.465 -0.939 . . . . 2.2599999999999998 108.465 173.155 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1601 ' ' LYS . . . . . 0.567 ' HE3' HD13 ' A' 1604 ' ' LEU . 16.9 ttpp -119.58 117.18 27.67 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 105.836 -1.913 . . . . 3.0099999999999998 105.836 173.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 12.9 p -63.14 116.35 5.32 Favored 'General case' 0 N--CA 1.422 -1.868 0 N-CA-C 113.189 0.811 . . . . 2.0699999999999998 113.189 -170.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 105.47 -6.24 41.73 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 121.313 -0.47 . . . . 1.0800000000000001 112.229 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1604 ' ' LEU . . . . . 0.595 HD23 ' SG ' ' A' 1634 ' ' CYS . 10.9 tp -91.52 170.45 9.93 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.399 -0.963 . . . . 1.8400000000000001 108.399 -178.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 15.1 m -126.45 149.75 49.1 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 108.446 -0.946 . . . . 1.4099999999999999 108.446 -179.095 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1606 ' ' TYR . . . . . 0.59 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 63.8 m-85 -71.0 158.1 37.09 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 122.679 0.391 . . . . 0.59999999999999998 111.682 177.718 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -156.49 125.45 5.98 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 109.346 -0.613 . . . . 1.45 109.346 178.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1608 ' ' SER . . . . . . . . . . . . . 30.4 m -107.93 132.68 53.22 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-N 115.995 -0.548 . . . . 1.1499999999999999 109.808 -178.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 31.6 t -111.6 108.17 24.8 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 109.261 -0.644 . . . . 0.25 109.261 178.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 75.6 mt -96.31 113.86 31.72 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 N-CA-C 108.917 -0.771 . . . . 0.45000000000000001 108.917 -178.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 48.9 m -116.02 119.88 37.3 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 115.942 -0.572 . . . . 1.26 111.749 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1612 ' ' PHE . . . . . 0.886 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 74.6 m-85 -98.26 122.16 41.08 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.961 -1.126 . . . . 0.26000000000000001 107.961 175.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 45.5 t -117.95 137.42 51.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 109.588 -0.523 . . . . 0.5 109.588 -176.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 3.5 t -52.99 112.4 0.85 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.131 0.894 . . . . 0.77000000000000002 112.275 176.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1615 ' ' ARG . . . . . 0.712 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 27.9 tpt180 -133.13 93.4 22.74 Favored Pre-proline 0 C--N 1.325 -0.468 0 N-CA-C 110.224 -0.287 . . . . 2.5299999999999998 110.224 174.619 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1616 ' ' PRO . . . . . 0.592 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 13.1 Cg_exo -70.53 -24.16 26.47 Favored 'Trans proline' 0 CA--C 1.545 1.052 0 C-N-CA 122.063 1.842 . . . . 1.1000000000000001 112.428 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -85.25 43.49 1.02 Allowed 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 125.151 1.38 . . . . 3.0499999999999998 110.954 179.062 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -33.34 117.48 0.29 Allowed 'General case' 0 C--O 1.241 0.638 0 C-N-CA 126.293 1.837 . . . . 1.55 113.2 178.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . -155.79 -135.21 1.96 Allowed Glycine 0 N--CA 1.433 -1.558 0 N-CA-C 109.078 -1.609 . . . . 0.93000000000000005 109.078 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -81.86 21.09 0.98 Allowed 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.285 1.99 . . . . 0.88 112.523 -179.032 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1621 ' ' THR . . . . . 0.738 ' HB ' ' HB2' ' A' 1641 ' ' HIS . 46.7 p -99.17 -15.99 18.74 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 114.917 -1.038 . . . . 0.96999999999999997 109.528 178.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 52.1 t30 -89.89 56.34 3.45 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 122.389 1.09 . . . . 0.71999999999999997 109.369 -173.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 18.6 ptp180 -157.25 139.54 10.4 Favored Pre-proline 0 N--CA 1.427 -1.595 0 CA-C-N 114.665 -1.152 . . . . 3.2599999999999998 108.248 -177.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.71 97.16 0.26 Allowed 'Trans proline' 0 C--O 1.238 0.506 0 C-N-CA 122.873 2.382 . . . . 0.58999999999999997 111.687 -178.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 76.8 mtm -97.44 136.88 37.25 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 116.105 -0.498 . . . . 1.3700000000000001 110.274 -178.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1626 ' ' LEU . . . . . 0.828 ' HG ' ' HE1' ' A' 1542 ' ' TYR . 0.4 OUTLIER -88.16 112.63 22.94 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 107.397 -1.335 . . . . 0.89000000000000001 107.397 -179.44 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A 1627 ' ' ILE . . . . . 0.839 HD11 ' HB2' ' A' 1639 ' ' SER . 3.3 mm -72.82 -57.45 7.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 C-N-CA 123.651 0.78 . . . . 0.57999999999999996 109.908 -177.366 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 30.6 t -163.42 151.38 13.3 Favored 'General case' 0 N--CA 1.415 -2.18 0 CA-C-N 114.657 -1.156 . . . . 1.3899999999999999 107.936 -172.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1629 ' ' LEU . . . . . 0.881 HD13 ' HG ' ' A' 1636 ' ' LEU . 35.2 tp -122.44 95.62 4.71 Favored 'General case' 0 N--CA 1.419 -2.022 0 N-CA-C 107.225 -1.398 . . . . 1.25 107.225 178.017 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 15.8 t70 -75.54 97.44 3.73 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.461 -1.311 . . . . 1.0900000000000001 107.461 177.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 62.0 mttp -66.83 -22.09 66.01 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 112.857 0.688 . . . . 3.6000000000000001 112.857 -176.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -72.61 -36.11 68.0 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.556 0.694 . . . . 2.6000000000000001 109.699 -178.092 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 69.6 p -102.72 -4.77 24.55 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.682 -0.69 . . . . 0.75 110.821 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1634 ' ' CYS . . . . . 0.595 ' SG ' HD23 ' A' 1604 ' ' LEU . 74.9 m 55.34 37.16 28.49 Favored 'General case' 0 C--N 1.356 0.853 0 C-N-CA 125.231 1.413 . . . . 0.53000000000000003 111.811 -178.45 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1635 ' ' THR . . . . . . . . . . . . . 40.0 m -106.43 129.28 54.44 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 115.151 -0.931 . . . . 0.46000000000000002 109.555 -178.371 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1636 ' ' LEU . . . . . 0.881 ' HG ' HD13 ' A' 1629 ' ' LEU . 0.3 OUTLIER -111.39 135.88 51.32 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 107.287 -1.375 . . . . 0.85999999999999999 107.287 -177.663 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -112.19 131.31 55.55 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 120.798 -0.361 . . . . 0.45000000000000001 111.2 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1638 ' ' PHE . . . . . 0.442 ' CE1' HD23 ' A' 1626 ' ' LEU . 98.4 m-85 -123.23 130.89 53.36 Favored 'General case' 0 C--O 1.243 0.726 0 N-CA-C 108.241 -1.022 . . . . 0.5 108.241 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1639 ' ' SER . . . . . 0.839 ' HB2' HD11 ' A' 1627 ' ' ILE . 11.7 t -115.9 148.47 39.97 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 107.645 -1.243 . . . . 1.04 107.645 178.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 3.2 t90 -152.36 107.82 3.3 Favored 'General case' 0 N--CA 1.414 -2.251 0 N-CA-C 104.984 -2.228 . . . . 0.68000000000000005 104.984 -179.022 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1641 ' ' HIS . . . . . 0.738 ' HB2' ' HB ' ' A' 1621 ' ' THR . 23.2 m80 -102.87 107.93 18.95 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 109.358 -0.608 . . . . 0.90000000000000002 109.358 -177.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1642 ' ' THR . . . . . . . . . . . . . 7.9 t -140.74 148.06 51.24 Favored Pre-proline 0 C--N 1.301 -1.521 0 CA-C-N 115.049 -0.978 . . . . 0.47999999999999998 109.731 -171.543 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1643 ' ' PRO . . . . . 0.592 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 56.9 Cg_endo -80.4 -11.17 13.23 Favored 'Trans proline' 0 C--N 1.365 1.423 0 C-N-CA 122.314 2.009 . . . . 0.66000000000000003 112.365 178.543 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1644 ' ' LEU . . . . . 0.611 HD11 ' HB2' ' A' 1531 ' ' SER . 7.4 tt -67.08 -25.82 66.42 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 108.407 -0.96 . . . . 0.96999999999999997 108.407 176.594 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -103.09 23.36 12.46 Favored 'General case' 0 N--CA 1.424 -1.746 0 CA-C-N 114.833 -1.076 . . . . 0.83999999999999997 109.735 -175.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 37.9 t -122.08 146.8 46.85 Favored 'General case' 0 N--CA 1.423 -1.797 0 CA-C-N 115.203 -0.908 . . . . 1.1899999999999999 109.588 -179.066 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1647 ' ' GLU . . . . . 0.433 ' OE2' ' OH ' ' A' 1583 ' ' TYR . 0.1 OUTLIER -100.56 123.86 44.6 Favored Pre-proline 0 C--N 1.295 -1.8 0 N-CA-C 108.25 -1.019 . . . . 3.1400000000000001 108.25 176.198 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A 1648 ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -71.04 148.94 57.9 Favored 'Trans proline' 0 C--O 1.248 1.016 0 C-N-CA 122.855 2.37 . . . . 2.5800000000000001 114.016 -173.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 7.6 tp10 . . . . . 0 N--CA 1.427 -1.624 0 N-CA-C 107.237 -1.394 . . . . 4.7199999999999998 107.237 177.12 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.494 0 N-CA-C 109.023 -0.732 . . . . 9.9700000000000006 109.023 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 2' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -121.94 120.21 33.79 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.993 -0.743 . . . . 7.6799999999999997 108.993 -178.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 26.8 ptt180 -84.92 128.48 60.33 Favored Pre-proline 0 C--N 1.297 -1.711 0 CA-C-N 115.44 -0.8 . . . . 6.1100000000000003 109.546 178.261 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -85.42 22.51 0.94 Allowed 'Trans proline' 0 C--O 1.239 0.55 0 C-N-CA 123.196 2.597 . . . . 4.8399999999999999 111.051 178.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 7.9 t -148.77 110.98 4.64 Favored 'General case' 0 N--CA 1.409 -2.498 0 N-CA-C 106.36 -1.718 . . . . 4.5999999999999996 106.36 -177.034 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 6' ' ' GLU . . . . . 0.799 ' HB3' ' HG3' ' A' 1597 ' ' PRO . 6.7 mm-40 -79.97 -35.99 36.74 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.617 0.722 . . . . 4.2300000000000004 110.53 -177.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 10.1 p -105.21 142.55 34.78 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 106.205 -1.776 . . . . 3.1400000000000001 106.205 172.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 49.4 mt -125.58 143.4 51.03 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.977 -0.689 . . . . 3.96 110.318 -173.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 9' ' ' CYS . . . . . 0.542 ' HB3' ' HB2' ' B' ' 47' ' ' CYS . 6.0 p -88.76 135.98 33.24 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-O 120.78 0.324 . . . . 2.8399999999999999 110.192 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.59 -121.82 4.51 Favored Glycine 0 N--CA 1.424 -2.154 0 N-CA-C 110.023 -1.231 . . . . 2.0899999999999999 110.023 -179.052 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 11' ' ' GLY . . . . . 0.446 ' HA2' HG12 ' B' ' 14' ' ' VAL . . . -60.32 -45.17 96.64 Favored Glycine 0 C--O 1.201 -1.934 0 O-C-N 124.06 0.506 . . . . 1.8400000000000001 113.01 -177.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 44.4 mp0 -61.38 -39.17 89.67 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.781 0.8 . . . . 2.5499999999999998 111.154 -179.213 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 13' ' ' LEU . . . . . 0.417 HD21 ' HB3' ' B' ' 46' ' ' CYS . 0.1 OUTLIER -71.26 -40.9 70.7 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.03 -0.986 . . . . 2.3500000000000001 110.141 -178.818 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 14' ' ' VAL . . . . . 0.446 HG12 ' HA2' ' B' ' 11' ' ' GLY . 5.1 p -76.83 -32.05 19.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 C-N-CA 120.019 -0.672 . . . . 2.1099999999999999 110.485 -178.326 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -68.6 -36.08 78.2 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 116.175 -0.466 . . . . 2.04 111.832 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 11.7 p -69.99 -40.29 75.42 Favored 'General case' 0 C--O 1.262 1.75 0 O-C-N 121.899 -0.501 . . . . 1.8400000000000001 110.149 177.292 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.473 ' HB3' ' HB3' ' B' ' 26' ' ' PHE . 3.7 mm? -54.66 -49.88 69.55 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 115.546 -0.752 . . . . 1.74 111.052 172.271 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -65.97 -33.35 75.63 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.828 -0.624 . . . . 2.3900000000000001 111.265 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 19' ' ' PHE . . . . . 0.467 ' HE1' ' CD1' ' A' 1567 ' ' PHE . 74.1 t80 -50.63 -57.47 8.16 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 123.038 0.535 . . . . 0.95999999999999996 111.751 178.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 15.0 p -99.54 -22.4 4.78 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.984 0 C-N-CA 118.389 -1.324 . . . . 1.3700000000000001 113.298 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 21' ' ' CYS . . . . . 0.441 ' HB2' ' O ' ' B' ' 17' ' ' LEU . 86.2 m -104.85 27.26 8.25 Favored 'General case' 0 C--N 1.316 -0.886 0 O-C-N 121.518 -0.739 . . . . 1.6599999999999999 112.665 -178.415 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -53.17 -52.43 40.31 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 121.509 -0.377 . . . . 1.53 114.037 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -74.7 -23.59 58.63 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 113.614 0.968 . . . . 2.7200000000000002 113.614 -179.051 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 24' ' ' ARG . . . . . 0.551 ' HD2' ' SG ' ' B' ' 60' ' ' CYS . 41.5 ttm180 -87.87 -35.45 17.74 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.68 -0.808 . . . . 4.3300000000000001 110.507 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.83 168.46 23.38 Favored Glycine 0 N--CA 1.423 -2.214 0 N-CA-C 110.279 -1.128 . . . . 1.53 110.279 -178.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 26' ' ' PHE . . . . . 0.473 ' HB3' ' HB3' ' B' ' 17' ' ' LEU . 3.2 p90 -122.22 138.94 54.31 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 116.954 0.377 . . . . 1.6499999999999999 110.197 175.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 27' ' ' TYR . . . . . 0.764 ' HB2' ' HA ' ' B' ' 61' ' ' ALA . 3.2 m-85 -122.0 -91.15 0.56 Allowed 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 118.876 -0.583 . . . . 3.4199999999999999 110.133 -177.339 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 28' ' ' PHE . . . . . . . . . . . . . 51.7 p90 50.52 9.73 0.05 OUTLIER 'General case' 0 N--CA 1.507 2.397 0 N-CA-C 115.752 1.76 . . . . 2.2599999999999998 115.752 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 32.3 t -149.11 81.46 1.43 Allowed 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 106.136 -1.801 . . . . 3.6800000000000002 106.136 178.024 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 30' ' ' ARG . . . . . 0.522 ' HB2' ' O ' ' B' ' 32' ' ' ALA . 38.6 mtp180 -123.17 175.54 2.67 Favored Pre-proline 0 C--N 1.299 -1.609 0 N-CA-C 107.905 -1.146 . . . . 3.8100000000000001 107.905 -173.314 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.87 -35.94 98.63 Favored 'Trans proline' 0 C--N 1.35 0.633 0 CA-C-N 120.867 1.345 . . . . 4.0199999999999996 111.008 174.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 32' ' ' ALA . . . . . 0.522 ' O ' ' HB2' ' B' ' 30' ' ' ARG . . . -142.8 -166.42 2.28 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 108.287 -1.005 . . . . 4.9199999999999999 108.287 179.12 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 16.3 t -155.35 157.66 37.48 Favored 'General case' 0 N--CA 1.391 -3.398 0 N-CA-C 103.711 -2.7 . . . . 6.7199999999999998 103.711 -178.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 14.9 tpp180 -85.38 2.63 43.51 Favored 'General case' 0 C--N 1.267 -3.014 0 CA-C-O 121.866 0.841 . . . . 11.630000000000001 110.291 -174.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 51.3 t -98.34 -15.14 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 108.205 -1.035 . . . . 9.6099999999999994 108.205 172.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 49.7 m 52.04 33.44 11.97 Favored 'General case' 0 C--N 1.362 1.148 0 CA-C-N 114.102 -1.408 . . . . 6.71 111.208 -175.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 39.6 ttm180 -89.31 -51.52 5.52 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 114.078 -1.419 . . . . 10.0 110.636 -174.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 20.9 tpt85 -164.66 149.48 9.64 Favored 'General case' 0 N--CA 1.423 -1.823 0 N-CA-C 104.616 -2.364 . . . . 7.9400000000000004 104.616 -173.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 20.8 m -63.67 -21.2 66.26 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 123.596 0.56 . . . . 5.7599999999999998 111.483 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 56.6 mtm180 -128.99 136.18 49.98 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 107.445 -1.317 . . . . 6.0300000000000002 107.445 174.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 41' ' ' GLY . . . . . 0.409 ' O ' HG12 ' B' ' 42' ' ' ILE . . . -119.98 173.84 15.36 Favored Glycine 0 C--N 1.286 -2.25 0 N-CA-C 109.384 -1.486 . . . . 2.3700000000000001 109.384 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 42' ' ' ILE . . . . . 0.417 HG22 ' HB3' ' B' ' 55' ' ' LEU . 22.5 pt 62.01 -37.62 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 C-N-CA 127.48 2.312 . . . . 2.0699999999999998 116.182 175.59 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.428 ' O ' ' HB2' ' B' ' 47' ' ' CYS . 2.5 p -50.03 -50.31 19.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 114.751 1.389 . . . . 2.2400000000000002 114.751 -176.043 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -93.74 -27.66 16.37 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.98 -0.748 . . . . 3.3599999999999999 108.98 -174.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 45' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' B' ' 49' ' ' ARG . 41.7 mt-10 -61.2 -56.62 18.62 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.863 -1.062 . . . . 3.0800000000000001 110.127 178.249 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 46' ' ' CYS . . . . . 0.438 ' HB2' ' HB3' ' B' ' 51' ' ' CYS . 48.3 t -83.67 -3.91 58.15 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 116.117 -0.492 . . . . 2.23 111.276 -176.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 47' ' ' CYS . . . . . 0.542 ' HB2' ' HB3' ' B' ' 9' ' ' CYS . 34.3 t -80.42 -38.87 29.36 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 118.905 -1.118 . . . . 2.3700000000000001 110.29 176.249 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -111.55 9.29 21.19 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 112.609 0.596 . . . . 2.8199999999999998 112.609 -175.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 49' ' ' ARG . . . . . 0.466 ' HB2' ' O ' ' B' ' 45' ' ' GLU . 63.1 mtp180 -146.88 -177.89 5.9 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 105.874 -1.899 . . . . 4.0899999999999999 105.874 177.692 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 11.2 t -106.05 145.32 31.55 Favored 'General case' 0 C--N 1.278 -2.524 0 N-CA-C 106.157 -1.794 . . . . 2.6699999999999999 106.157 177.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 51' ' ' CYS . . . . . 0.438 ' HB3' ' HB2' ' B' ' 46' ' ' CYS . 23.4 p -118.17 143.11 46.77 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 110.45 -0.204 . . . . 2.1099999999999999 110.45 -175.16 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -94.59 163.15 13.5 Favored 'General case' 0 C--O 1.253 1.248 0 N-CA-C 107.414 -1.328 . . . . 2.6699999999999999 107.414 173.017 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 53' ' ' LEU . . . . . 0.436 ' HB3' ' HA ' ' A' 1600 ' ' SER . 2.6 pt? -66.75 -9.26 34.85 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 120.756 0.313 . . . . 1.8999999999999999 110.938 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.63 -15.96 44.2 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.167 0.987 . . . . 1.52 110.541 176.214 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 55' ' ' LEU . . . . . 0.655 ' O ' ' HB2' ' B' ' 59' ' ' TYR . 49.1 mt -98.56 -55.78 2.64 Favored 'General case' 0 C--O 1.2 -1.545 0 CA-C-O 120.971 0.415 . . . . 1.97 111.404 174.046 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 56' ' ' LEU . . . . . 0.413 ' HG ' ' HA ' ' B' ' 53' ' ' LEU . 1.7 pp -74.73 -33.28 62.34 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 114.537 1.31 . . . . 1.53 114.537 -170.705 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -76.85 -32.5 57.57 Favored 'General case' 0 CA--C 1.559 1.293 0 C-N-CA 120.31 -0.556 . . . . 2.27 110.768 178.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 73.9 p -75.37 -50.99 14.22 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 120.844 0.354 . . . . 2.3300000000000001 111.165 177.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 59' ' ' TYR . . . . . 0.655 ' HB2' ' O ' ' B' ' 55' ' ' LEU . 0.3 OUTLIER -65.17 -64.67 0.81 Allowed 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 108.76 -0.83 . . . . 2.8599999999999999 108.76 -178.725 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 60' ' ' CYS . . . . . 0.551 ' SG ' ' HD2' ' B' ' 24' ' ' ARG . 43.6 t 45.16 -86.32 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 125.32 1.448 . . . . 2.2999999999999998 113.441 176.059 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 61' ' ' ALA . . . . . 0.764 ' HA ' ' HB2' ' B' ' 27' ' ' TYR . . . -142.22 -64.82 0.42 Allowed 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 106.913 -1.514 . . . . 3.1899999999999999 106.913 179.347 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 13.4 p -130.95 147.36 66.0 Favored Pre-proline 0 N--CA 1.412 -2.335 0 N-CA-C 106.531 -1.655 . . . . 3.6800000000000002 106.531 179.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -81.93 0.6 9.74 Favored 'Trans proline' 0 C--O 1.237 0.433 0 C-N-CA 122.768 2.312 . . . . 5.0800000000000001 112.982 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 72.51 50.68 0.18 Allowed 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 125.504 1.522 . . . . 5.0999999999999996 110.652 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -160.73 132.6 5.89 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 105.197 -2.149 . . . . 8.5099999999999998 105.197 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 67.7 m -114.41 155.78 25.71 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 113.361 0.874 . . . . 8.1199999999999992 113.361 -172.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 . . . . . 0 N--CA 1.434 -1.259 0 N-CA-C 108.245 -1.02 . . . . 10.210000000000001 108.245 178.267 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 23.8 mmt . . . . . 0 CA--C 1.5 -0.972 0 N-CA-C 109.113 -0.699 . . . . 9.3399999999999999 109.113 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 61.5 tttp -85.88 71.51 10.63 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.926 0.869 . . . . 9.0399999999999991 109.19 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1510 ' ' SER . . . . . 0.507 ' OG ' ' HG2' ' A' 1512 ' ' GLU . 35.6 t -164.02 154.06 14.78 Favored 'General case' 0 N--CA 1.426 -1.665 0 N-CA-C 107.948 -1.13 . . . . 5.8099999999999996 107.948 -179.369 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1511 ' ' ASN . . . . . 0.425 ' O ' ' HA ' ' A' 1518 ' ' VAL . 30.4 p-10 -90.04 -2.51 58.13 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.946 -0.57 . . . . 3.4199999999999999 110.83 -179.07 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1512 ' ' GLU . . . . . 0.507 ' HG2' ' OG ' ' A' 1510 ' ' SER . 13.1 pt-20 -101.07 155.95 17.69 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.049 -0.722 . . . . 5.9500000000000002 109.049 178.382 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1513 ' ' HIS . . . . . 0.445 ' HB2' ' HG3' ' A' 1517 ' ' GLN . 64.5 m-70 -137.49 7.19 2.8 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 113.506 0.928 . . . . 5.3300000000000001 113.506 -174.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1514 ' ' ASP . . . . . 0.605 ' O ' ' HE2' ' A' 1579 ' ' LYS . 27.9 t70 72.59 -22.56 0.22 Allowed 'General case' 0 N--CA 1.507 2.416 0 C-N-CA 124.868 1.267 . . . . 5.0599999999999996 112.387 -178.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -88.91 36.04 0.8 Allowed 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.605 -0.684 . . . . 2.8999999999999999 111.799 -177.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1516 ' ' CYS . . . . . 0.523 ' HA ' ' HB2' ' A' 1581 ' ' LEU . 95.6 m 52.53 50.49 18.11 Favored 'General case' 0 CA--C 1.497 -1.083 0 CA-C-O 121.717 0.77 . . . . 1.1899999999999999 112.029 -178.141 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1517 ' ' GLN . . . . . 0.445 ' HG3' ' HB2' ' A' 1513 ' ' HIS . 13.1 pt20 -150.91 130.35 12.93 Favored 'General case' 0 N--CA 1.407 -2.591 0 CA-C-N 115.049 -0.978 . . . . 1.52 109.76 -176.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1518 ' ' VAL . . . . . 0.517 HG21 ' HB2' ' A' 1583 ' ' TYR . 3.0 m -137.54 142.32 37.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-N 115.274 -0.876 . . . . 0.93999999999999995 110.18 -178.011 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1519 ' ' THR . . . . . . . . . . . . . 44.3 m -107.17 141.97 37.61 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 116.312 -0.404 . . . . 0.89000000000000001 111.511 -178.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1520 ' ' ASN . . . . . 0.512 ' OD1' HG22 ' A' 1523 ' ' THR . 6.4 t-20 -89.52 120.78 69.61 Favored Pre-proline 0 N--CA 1.441 -0.915 0 N-CA-C 108.58 -0.896 . . . . 1.74 108.58 173.179 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -62.66 -27.69 76.23 Favored 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 123.22 2.614 . . . . 1.5800000000000001 113.927 -176.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 15.0 m -68.14 -47.66 67.49 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 112.939 0.718 . . . . 1.6499999999999999 112.939 -175.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1523 ' ' THR . . . . . 0.512 HG22 ' OD1' ' A' 1520 ' ' ASN . 11.8 t -118.8 2.64 11.63 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 119.785 -0.766 . . . . 1.6100000000000001 111.833 -173.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 63.42 34.0 88.77 Favored Glycine 0 CA--C 1.504 -0.632 0 CA-C-N 115.749 -0.66 . . . . 1.1299999999999999 112.007 178.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1525 ' ' HIS . . . . . 0.466 ' HB2' HG23 ' A' 1523 ' ' THR . 32.7 t-80 -94.22 127.27 39.96 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 120.095 -0.642 . . . . 1.26 109.46 -177.453 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 3.1 tm? -90.88 117.37 29.44 Favored 'General case' 0 C--N 1.289 -2.065 0 CA-C-N 115.019 -0.991 . . . . 0.68000000000000005 108.956 -177.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1527 ' ' PHE . . . . . 0.414 ' O ' ' HA ' ' A' 1517 ' ' GLN . 39.0 m-85 -95.51 126.07 40.55 Favored 'General case' 0 N--CA 1.432 -1.33 0 C-N-CA 119.749 -0.78 . . . . 0.65000000000000002 110.577 173.204 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 10.5 t70 -115.92 126.98 54.61 Favored 'General case' 0 C--N 1.309 -1.16 0 O-C-N 123.738 0.649 . . . . 1.1699999999999999 109.727 175.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1529 ' ' LEU . . . . . 0.551 ' HG ' HD21 ' A' 1581 ' ' LEU . 3.4 mm? -106.9 2.35 25.27 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 120.982 0.42 . . . . 0.59999999999999998 111.149 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 3.8 m -71.78 -14.28 61.94 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.145 0.497 . . . . 0.83999999999999997 111.796 -176.313 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 6.1 p -70.0 -31.62 69.38 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.634 0.73 . . . . 1.5900000000000001 110.831 179.081 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 77.5 mt -84.97 7.06 22.53 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.025 -0.989 . . . . 0.65000000000000002 110.713 -179.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1533 ' ' SER . . . . . 0.443 ' HA ' ' HB ' ' A' 1552 ' ' ILE . 19.7 t -74.97 172.47 12.24 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.683 0.754 . . . . 1.52 111.118 -179.423 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -176.94 141.24 5.31 Favored Glycine 0 N--CA 1.422 -2.24 0 N-CA-C 108.141 -1.984 . . . . 1.1000000000000001 108.141 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 11.5 tpp180 -92.2 -31.66 15.37 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 120.954 0.407 . . . . 4.6200000000000001 111.454 -176.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -80.61 -37.36 31.27 Favored 'General case' 0 CA--C 1.502 -0.904 0 N-CA-C 108.164 -1.051 . . . . 1.45 108.164 177.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1537 ' ' GLY . . . . . 0.424 ' HA3' ' ND2' ' A' 1556 ' ' ASN . . . 110.04 -177.37 19.73 Favored Glycine 0 N--CA 1.406 -3.304 0 CA-C-N 114.792 -1.094 . . . . 0.84999999999999998 111.938 174.627 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -121.68 142.56 50.03 Favored 'General case' 0 C--N 1.277 -2.571 0 N-CA-C 106.954 -1.499 . . . . 0.93000000000000005 106.954 178.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 3.3 p -105.33 129.78 53.59 Favored 'General case' 0 C--N 1.292 -1.903 0 O-C-N 123.652 0.595 . . . . 1.03 110.764 179.129 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1540 ' ' ALA . . . . . 0.466 ' HB3' ' CG1' ' A' 1548 ' ' VAL . . . -121.83 144.56 48.75 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.615 -1.254 . . . . 0.5 107.615 176.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -80.84 126.57 31.5 Favored 'General case' 0 N--CA 1.431 -1.377 0 O-C-N 123.643 0.589 . . . . 0.73999999999999999 109.545 -176.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1542 ' ' TYR . . . . . 0.538 ' CE1' ' HG ' ' A' 1626 ' ' LEU . 10.6 t80 -131.73 -102.09 0.28 Allowed 'General case' 0 N--CA 1.419 -2.0 0 CA-C-N 115.484 -0.78 . . . . 0.98999999999999999 109.733 -175.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1543 ' ' SER . . . . . . . . . . . . . 43.1 t -77.57 155.32 31.6 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.651 -0.87 . . . . 1.9099999999999999 108.651 178.094 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -55.76 -42.16 75.06 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 119.175 0.898 . . . . 3.5899999999999999 111.002 178.378 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 41.8 m -106.24 30.72 5.69 Favored 'General case' 0 N--CA 1.407 -2.609 0 CA-C-O 121.078 0.466 . . . . 2.46 110.795 -176.199 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . -170.71 113.53 0.5 Allowed Glycine 0 N--CA 1.433 -1.514 0 C-N-CA 119.643 -1.265 . . . . 1.26 113.336 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 30.9 m -94.02 167.52 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 N-CA-C 107.794 -1.187 . . . . 0.79000000000000004 107.794 175.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1548 ' ' VAL . . . . . 0.466 ' CG1' ' HB3' ' A' 1540 ' ' ALA . 10.9 p -107.7 131.05 58.98 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.178 0 C-N-CA 119.448 -0.901 . . . . 0.57999999999999996 109.476 178.105 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -97.74 127.19 43.52 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.129 -1.063 . . . . 1.0800000000000001 108.129 178.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 25.6 ptm -143.82 137.52 28.04 Favored 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 120.377 -0.529 . . . . 0.78000000000000003 112.005 -178.055 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 11.2 p -127.7 125.78 40.67 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 115.397 -0.82 . . . . 0.96999999999999997 109.76 176.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1552 ' ' ILE . . . . . 0.443 ' HB ' ' HA ' ' A' 1533 ' ' SER . 42.4 mm -80.98 116.68 25.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 N-CA-C 109.817 -0.438 . . . . 0.41999999999999998 109.817 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1553 ' ' CYS . . . . . 0.49 ' SG ' HD11 ' A' 1590 ' ' LEU . 85.6 m 62.59 31.81 16.69 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 112.813 0.672 . . . . 1.3999999999999999 112.813 173.36 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . -166.55 175.2 41.98 Favored Glycine 0 N--CA 1.417 -2.591 0 N-CA-C 108.201 -1.96 . . . . 0.34999999999999998 108.201 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -98.18 148.76 23.26 Favored 'General case' 0 C--N 1.289 -2.049 0 C-N-CA 119.91 -0.716 . . . . 1.6200000000000001 110.925 -179.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1556 ' ' ASN . . . . . 0.424 ' ND2' ' HA3' ' A' 1537 ' ' GLY . 25.7 t-20 -92.44 125.21 36.99 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 108.384 -0.969 . . . . 0.87 108.384 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -81.07 4.88 18.33 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 114.4 1.259 . . . . 2.4900000000000002 114.4 -175.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -95.95 -4.21 43.77 Favored 'General case' 0 C--N 1.317 -0.838 0 O-C-N 121.638 -0.664 . . . . 1.3799999999999999 111.234 -179.257 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1559 ' ' CYS . . . . . 0.765 ' SG ' ' HD2' ' A' 1560 ' ' PRO . 17.6 t -136.87 162.93 53.06 Favored Pre-proline 0 C--N 1.302 -1.489 0 N-CA-C 106.84 -1.541 . . . . 1.21 106.84 -177.708 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1560 ' ' PRO . . . . . 0.765 ' HD2' ' SG ' ' A' 1559 ' ' CYS . 45.5 Cg_exo -28.46 128.53 0.04 OUTLIER 'Trans proline' 0 C--N 1.384 2.444 0 C-N-CA 124.982 3.788 . . . . 0.70999999999999996 115.25 176.215 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1561 ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' 1560 ' ' PRO . 85.9 Cg_exo -48.96 122.68 8.66 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 124.067 3.178 . . . . 0.80000000000000004 113.826 -178.314 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 98.94 14.68 35.88 Favored Glycine 0 C--N 1.311 -0.814 0 CA-C-N 115.63 -0.714 . . . . 0.46000000000000002 114.328 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1563 ' ' VAL . . . . . 0.535 HG21 ' HB2' ' A' 1573 ' ' SER . 9.9 p -104.66 144.43 14.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.885 -0.773 . . . . 0.97999999999999998 110.662 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -102.39 -33.3 4.57 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 121.213 -0.518 . . . . 0.28000000000000003 113.033 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -130.15 139.6 50.86 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.79 -0.448 . . . . 0.28000000000000003 109.79 178.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 45.7 t -159.16 133.23 7.6 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 119.529 -0.272 . . . . 0.42999999999999999 110.724 -177.246 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -84.89 139.64 31.72 Favored 'General case' 0 C--O 1.249 1.047 0 N-CA-C 108.458 -0.942 . . . . 1.03 108.458 171.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -82.47 39.43 2.66 Favored Glycine 0 N--CA 1.442 -0.933 0 C-N-CA 121.703 -0.284 . . . . 1.1299999999999999 113.783 -175.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -76.51 -71.42 0.39 Allowed 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 108.661 -0.866 . . . . 2.5800000000000001 108.661 174.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 2.9 p -132.52 33.31 3.81 Favored 'General case' 0 C--N 1.308 -1.209 0 C-N-CA 122.935 0.494 . . . . 2.1699999999999999 110.278 174.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1571 ' ' ARG . . . . . 0.542 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 3.1 mpt_? 61.9 60.08 1.61 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.9 0.857 . . . . 2.6200000000000001 109.442 -173.072 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 39.9 mt -96.26 101.72 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 107.748 -1.204 . . . . 0.92000000000000004 107.748 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1573 ' ' SER . . . . . 0.535 ' HB2' HG21 ' A' 1563 ' ' VAL . 94.1 p -63.31 129.39 40.05 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 114.321 -1.309 . . . . 0.80000000000000004 111.288 -176.656 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1574 ' ' VAL . . . . . 0.494 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 35.1 m -120.14 16.77 6.47 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-O 121.511 0.672 . . . . 0.97999999999999998 112.054 -176.577 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 173.27 118.24 0.49 Allowed Glycine 0 N--CA 1.428 -1.9 0 CA-C-N 115.414 -0.812 . . . . 0.28999999999999998 111.135 176.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 55.3 tttp -70.42 139.27 51.78 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 107.805 -1.183 . . . . 2.1899999999999999 107.805 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -68.5 98.79 0.89 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.207 0.447 . . . . 0.60999999999999999 112.207 -175.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1578 ' ' ASN . . . . . 0.555 ' O ' ' HE1' ' A' 1592 ' ' TYR . 84.5 m-20 -115.67 157.61 23.97 Favored 'General case' 0 C--O 1.206 -1.223 0 N-CA-C 106.926 -1.509 . . . . 1.95 106.926 175.049 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1579 ' ' LYS . . . . . 0.605 ' HE2' ' O ' ' A' 1514 ' ' ASP . 28.2 mtmm -122.97 42.07 3.29 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 122.167 0.984 . . . . 2.6800000000000002 108.512 -178.689 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 25.9 ttm180 -90.4 76.9 6.64 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 122.257 1.027 . . . . 3.4700000000000002 109.313 -173.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1581 ' ' LEU . . . . . 0.551 HD21 ' HG ' ' A' 1529 ' ' LEU . 0.3 OUTLIER -65.87 133.02 50.06 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 113.184 -1.825 . . . . 0.64000000000000001 109.517 -178.518 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A 1582 ' ' ARG . . . . . 0.752 ' HB2' ' HB3' ' A' 1589 ' ' GLN . 94.5 mtt180 -120.52 141.17 50.48 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 109.765 -0.458 . . . . 2.8500000000000001 109.765 175.504 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1583 ' ' TYR . . . . . 0.524 ' OH ' ' OE1' ' A' 1647 ' ' GLU . 16.2 t80 -114.94 102.37 9.9 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 109.512 -0.551 . . . . 0.85999999999999999 109.512 177.155 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1584 ' ' VAL . . . . . 0.556 ' O ' ' HB ' ' A' 1587 ' ' VAL . 27.8 m -123.68 91.15 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.763 -0.653 . . . . 1.05 111.868 -177.358 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1585 ' ' ASP . . . . . 0.42 ' O ' ' HG2' ' A' 1586 ' ' GLN . 24.0 t70 56.5 62.62 2.24 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.896 0.878 . . . . 1.1699999999999999 111.576 176.509 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1586 ' ' GLN . . . . . 0.42 ' HG2' ' O ' ' A' 1585 ' ' ASP . 9.0 pt20 68.89 2.22 3.45 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 127.628 2.371 . . . . 1.8600000000000001 111.547 178.033 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1587 ' ' VAL . . . . . 0.556 ' HB ' ' O ' ' A' 1584 ' ' VAL . 25.0 t -92.11 123.49 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.116 0 CA-C-N 115.329 -0.85 . . . . 0.48999999999999999 109.406 175.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1588 ' ' LEU . . . . . 0.671 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 3.6 mm? -99.51 108.25 20.64 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.089 -1.078 . . . . 0.35999999999999999 108.089 179.17 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1589 ' ' GLN . . . . . 0.752 ' HB3' ' HB2' ' A' 1582 ' ' ARG . 4.0 tp-100 -100.41 133.46 44.8 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 115.233 -0.894 . . . . 1.74 111.376 -174.823 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1590 ' ' LEU . . . . . 0.49 HD11 ' SG ' ' A' 1553 ' ' CYS . 0.4 OUTLIER -130.94 92.48 3.23 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 105.843 -1.91 . . . . 0.71999999999999997 105.843 175.066 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 8.3 p -93.77 125.94 46.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 CA-C-O 121.835 0.826 . . . . 1.01 112.906 -174.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1592 ' ' TYR . . . . . 0.555 ' HE1' ' O ' ' A' 1578 ' ' ASN . 17.5 m-30 -112.49 138.26 49.51 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 107.76 -1.2 . . . . 0.5 107.76 176.116 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 22.7 pttm -148.54 -178.53 6.38 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.082 -1.081 . . . . 1.5900000000000001 108.082 178.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 11.0 m-20 60.74 50.45 5.48 Favored 'General case' 0 C--O 1.242 0.701 0 O-C-N 124.223 0.952 . . . . 1.1100000000000001 110.978 176.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -78.35 -112.48 0.19 Allowed Glycine 0 N--CA 1.433 -1.561 0 N-CA-C 110.272 -1.131 . . . . 0.78000000000000003 110.272 178.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1596 ' ' SER . . . . . . . . . . . . . 56.2 p -124.98 159.69 57.81 Favored Pre-proline 0 C--N 1.274 -2.675 0 N-CA-C 107.691 -1.226 . . . . 1.0700000000000001 107.691 174.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -54.73 124.75 16.98 Favored 'Trans proline' 0 C--N 1.358 1.028 0 C-N-CA 122.386 2.057 . . . . 1.01 110.339 177.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1598 ' ' CYS . . . . . 0.619 ' HA ' ' CE2' ' A' 1606 ' ' TYR . 21.7 t -58.47 115.96 13.4 Favored Pre-proline 0 C--N 1.308 -1.239 0 N-CA-C 108.775 -0.824 . . . . 0.75 108.775 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1599 ' ' PRO . . . . . 0.663 ' HB2' ' HB ' ' B' ' 16' ' ' THR . 31.8 Cg_exo -60.87 -23.96 78.11 Favored 'Trans proline' 0 C--N 1.361 1.21 0 C-N-CA 123.016 2.477 . . . . 1.7 112.676 -176.349 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1600 ' ' SER . . . . . 0.63 ' HB3' ' HB3' ' B' ' 53' ' ' LEU . 44.3 m -80.52 -14.66 58.06 Favored 'General case' 0 CA--C 1.566 1.571 0 N-CA-C 113.033 0.753 . . . . 2.2599999999999998 113.033 177.452 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1601 ' ' LYS . . . . . 0.45 ' HG3' HD13 ' A' 1604 ' ' LEU . 3.2 tppp? -160.76 116.07 2.21 Favored 'General case' 0 C--O 1.24 0.588 0 O-C-N 121.698 -0.626 . . . . 3.0099999999999998 110.797 -176.688 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1602 ' ' SER . . . . . 0.455 ' OG ' ' HB3' ' B' ' 6' ' ' GLU . 38.3 t -69.74 141.95 53.36 Favored 'General case' 0 N--CA 1.416 -2.15 0 N-CA-C 108.457 -0.942 . . . . 2.0699999999999998 108.457 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 99.26 -17.6 57.68 Favored Glycine 0 C--N 1.3 -1.439 0 C-N-CA 121.222 -0.513 . . . . 1.0800000000000001 112.72 179.028 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1604 ' ' LEU . . . . . 0.45 HD13 ' HG3' ' A' 1601 ' ' LYS . 8.9 mp -102.57 145.9 28.93 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 123.212 0.605 . . . . 1.8400000000000001 110.561 178.658 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 31.5 t -121.59 153.6 37.85 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 106.757 -1.571 . . . . 1.4099999999999999 106.757 175.309 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1606 ' ' TYR . . . . . 0.619 ' CE2' ' HA ' ' A' 1598 ' ' CYS . 49.1 m-85 -78.56 155.07 29.88 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 116.522 -0.308 . . . . 0.59999999999999998 111.558 178.209 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1607 ' ' LYS . . . . . 0.415 ' O ' HD22 ' A' 1636 ' ' LEU . 8.0 ptpp? -150.16 145.1 26.09 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 106.943 -1.502 . . . . 1.45 106.943 175.09 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1608 ' ' SER . . . . . . . . . . . . . 17.2 m -120.0 120.91 37.69 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 107.789 -1.189 . . . . 1.1499999999999999 107.789 -178.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 21.3 t -99.99 103.87 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 CA-C-O 121.118 0.485 . . . . 0.25 109.701 178.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 83.1 mt -96.69 106.27 18.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 C-N-CA 123.845 0.858 . . . . 0.45000000000000001 109.171 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 14.4 t -106.98 113.94 27.72 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 108.392 -0.966 . . . . 1.26 108.392 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1612 ' ' PHE . . . . . 0.671 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 60.0 m-85 -81.8 121.51 26.52 Favored 'General case' 0 C--O 1.258 1.551 0 N-CA-C 109.477 -0.564 . . . . 0.26000000000000001 109.477 176.08 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 46.4 t -111.54 129.86 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-N 114.798 -1.092 . . . . 0.5 109.862 -174.031 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 22.1 t -61.14 110.86 1.5 Allowed 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.112 -0.949 . . . . 0.77000000000000002 111.884 178.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1615 ' ' ARG . . . . . 0.635 ' HG3' ' HB3' ' A' 1617 ' ' GLU . 32.5 tpt180 -137.48 95.76 11.27 Favored Pre-proline 0 N--CA 1.438 -1.033 0 N-CA-C 109.246 -0.65 . . . . 2.5299999999999998 109.246 173.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1616 ' ' PRO . . . . . 0.843 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 39.5 Cg_exo -61.45 -21.26 71.43 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 122.86 2.373 . . . . 1.1000000000000001 113.387 -178.313 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1617 ' ' GLU . . . . . 0.635 ' HB3' ' HG3' ' A' 1615 ' ' ARG . 38.9 tt0 -49.44 -41.12 39.07 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 125.586 1.554 . . . . 3.0499999999999998 112.451 176.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . 43.58 81.03 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.527 0.731 . . . . 1.55 112.564 -177.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . -153.45 -134.33 1.98 Allowed Glycine 0 C--N 1.274 -2.907 0 C-N-CA 120.581 -0.819 . . . . 0.93000000000000005 111.569 -177.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -66.88 1.09 3.01 Favored 'Trans proline' 0 CA--C 1.55 1.298 0 C-N-CA 122.656 2.237 . . . . 0.88 114.465 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1621 ' ' THR . . . . . 0.753 ' HB ' ' HB2' ' A' 1641 ' ' HIS . 2.7 p -98.67 -13.66 20.19 Favored 'General case' 0 N--CA 1.419 -1.979 0 C-N-CA 124.13 0.972 . . . . 0.96999999999999997 109.727 178.061 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 53.0 t30 -86.03 69.2 10.5 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.956 -1.02 . . . . 0.71999999999999997 108.566 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1623 ' ' ARG . . . . . 0.472 ' O ' ' HG3' ' A' 1625 ' ' MET . 11.5 ptp180 -166.23 140.63 3.62 Favored Pre-proline 0 C--N 1.296 -1.744 0 N-CA-C 107.537 -1.283 . . . . 3.2599999999999998 107.537 -178.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -58.07 104.71 0.18 Allowed 'Trans proline' 0 C--O 1.238 0.515 0 C-N-CA 122.92 2.413 . . . . 0.58999999999999997 110.885 178.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1625 ' ' MET . . . . . 0.472 ' HG3' ' O ' ' A' 1623 ' ' ARG . 94.2 mtp -98.75 131.27 45.02 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.476 -0.935 . . . . 1.3700000000000001 108.476 -176.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1626 ' ' LEU . . . . . 0.538 ' HG ' ' CE1' ' A' 1542 ' ' TYR . 1.0 OUTLIER -86.82 111.86 21.17 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 106.938 -1.505 . . . . 0.89000000000000001 106.938 -178.031 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A 1627 ' ' ILE . . . . . 0.564 HD11 ' HB2' ' A' 1639 ' ' SER . 37.8 mm -73.07 -56.89 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.883 0 N-CA-C 108.902 -0.777 . . . . 0.57999999999999996 108.902 -178.472 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 23.8 t -171.88 162.21 6.01 Favored 'General case' 0 N--CA 1.417 -2.124 0 N-CA-C 107.839 -1.171 . . . . 1.3899999999999999 107.839 -175.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1629 ' ' LEU . . . . . 0.495 HD13 ' CD1' ' A' 1636 ' ' LEU . 5.7 tp -112.11 109.2 18.78 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 107.731 -1.211 . . . . 1.25 107.731 175.112 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1630 ' ' ASP . . . . . 0.533 ' HB3' ' HB ' ' A' 1635 ' ' THR . 13.4 t70 -75.02 85.91 2.31 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 106.16 -1.793 . . . . 1.0900000000000001 106.16 173.205 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1631 ' ' LYS . . . . . 0.477 ' HG3' HD13 ' B' ' 53' ' ' LEU . 21.6 tptm -64.65 -19.8 65.92 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 114.229 -1.351 . . . . 3.6000000000000001 112.702 -173.304 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -76.19 -31.67 58.6 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 119.599 -0.841 . . . . 2.6000000000000001 110.376 -176.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 59.6 p -107.26 -10.46 15.81 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 116.116 -0.493 . . . . 0.75 111.631 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 65.9 m 67.23 49.26 1.09 Allowed 'General case' 0 C--N 1.36 1.054 0 CA-C-O 122.76 1.267 . . . . 0.53000000000000003 109.975 -178.117 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1635 ' ' THR . . . . . 0.533 ' HB ' ' HB3' ' A' 1630 ' ' ASP . 93.3 m -109.87 130.0 55.58 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 113.854 -1.521 . . . . 0.46000000000000002 109.088 -177.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1636 ' ' LEU . . . . . 0.495 ' CD1' HD13 ' A' 1629 ' ' LEU . 0.2 OUTLIER -105.68 135.82 46.39 Favored 'General case' 0 CA--C 1.504 -0.802 0 N-CA-C 108.009 -1.108 . . . . 0.85999999999999999 108.009 177.68 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -109.37 125.59 52.53 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 109.556 -0.535 . . . . 0.45000000000000001 109.556 177.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -125.11 136.89 54.07 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.307 -0.627 . . . . 0.5 109.307 -178.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1639 ' ' SER . . . . . 0.564 ' HB2' HD11 ' A' 1627 ' ' ILE . 33.1 t -116.8 154.87 29.94 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 107.285 -1.376 . . . . 1.04 107.285 175.675 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 2.7 t90 -150.38 108.21 3.7 Favored 'General case' 0 N--CA 1.417 -2.087 0 N-CA-C 104.882 -2.266 . . . . 0.68000000000000005 104.882 178.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1641 ' ' HIS . . . . . 0.753 ' HB2' ' HB ' ' A' 1621 ' ' THR . 51.2 m-70 -95.06 104.63 16.51 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 121.281 0.562 . . . . 0.90000000000000002 109.941 -175.476 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1642 ' ' THR . . . . . . . . . . . . . 8.6 t -142.38 148.99 49.72 Favored Pre-proline 0 C--N 1.3 -1.584 0 CA-C-N 115.67 -0.696 . . . . 0.47999999999999998 109.674 -173.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1643 ' ' PRO . . . . . 0.843 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 77.7 Cg_endo -78.87 -6.41 15.12 Favored 'Trans proline' 0 C--N 1.369 1.626 0 C-N-CA 122.483 2.122 . . . . 0.66000000000000003 112.586 179.412 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 8.2 tt -70.21 -25.35 63.36 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.1 -0.704 . . . . 0.96999999999999997 109.1 178.244 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -95.29 17.12 14.98 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.962 -1.017 . . . . 0.83999999999999997 110.342 -178.137 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1646 ' ' CYS . . . . . 0.538 ' SG ' ' HA ' ' A' 1643 ' ' PRO . 95.7 m -96.28 145.59 25.45 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 109.716 -0.476 . . . . 1.1899999999999999 109.716 177.744 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1647 ' ' GLU . . . . . 0.524 ' OE1' ' OH ' ' A' 1583 ' ' TYR . 35.4 tt0 -101.61 118.22 60.19 Favored Pre-proline 0 C--N 1.297 -1.684 0 N-CA-C 108.654 -0.869 . . . . 3.1400000000000001 108.654 -177.42 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1648 ' ' PRO . . . . . 0.434 ' HG2' ' CD2' ' A' 1525 ' ' HIS . 97.4 Cg_exo -47.11 116.31 1.68 Allowed 'Trans proline' 0 C--N 1.358 1.074 0 C-N-CA 124.226 3.284 . . . . 2.5800000000000001 114.824 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 42.2 tt0 . . . . . 0 N--CA 1.439 -0.989 0 N-CA-C 107.53 -1.285 . . . . 4.7199999999999998 107.53 176.941 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.36 0 N-CA-C 109.614 -0.513 . . . . 9.9700000000000006 109.614 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 2' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -108.7 134.28 51.64 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 109.35 -0.611 . . . . 7.6799999999999997 109.35 -178.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 -116.6 139.75 25.87 Favored Pre-proline 0 C--N 1.28 -2.437 0 N-CA-C 107.897 -1.149 . . . . 6.1100000000000003 107.897 177.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -57.48 -17.05 25.93 Favored 'Trans proline' 0 C--N 1.371 1.731 0 C-N-CA 124.114 3.209 . . . . 4.8399999999999999 113.461 -177.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 5' ' ' SER . . . . . 0.418 ' HB3' ' O ' ' B' ' 7' ' ' THR . 49.0 m -125.52 92.61 3.65 Favored 'General case' 0 N--CA 1.412 -2.365 0 N-CA-C 107.629 -1.249 . . . . 4.5999999999999996 107.629 172.368 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 6' ' ' GLU . . . . . 0.455 ' HB3' ' OG ' ' A' 1602 ' ' SER . 51.8 mt-10 -71.45 -32.95 68.91 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 106.987 -1.486 . . . . 4.2300000000000004 106.987 176.174 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 7' ' ' THR . . . . . 0.617 ' HB ' ' SG ' ' B' ' 46' ' ' CYS . 1.4 p -94.91 142.67 27.21 Favored 'General case' 0 N--CA 1.402 -2.852 0 N-CA-C 107.297 -1.371 . . . . 3.1400000000000001 107.297 172.357 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.736 ' HG ' ' HB2' ' B' ' 12' ' ' GLU . 1.5 mm? -80.09 128.87 34.01 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 116.313 -0.403 . . . . 3.96 110.099 -170.752 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 99.1 m -63.82 -30.37 71.47 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 114.269 1.211 . . . . 2.8399999999999999 114.269 179.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 10' ' ' GLY . . . . . 0.499 ' O ' HG12 ' B' ' 14' ' ' VAL . . . -150.17 -61.67 0.01 OUTLIER Glycine 0 N--CA 1.417 -2.593 0 C-N-CA 119.491 -1.338 . . . . 2.0899999999999999 112.708 -177.516 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -44.79 -74.67 0.2 Allowed Glycine 0 N--CA 1.473 1.153 0 N-CA-C 115.626 1.011 . . . . 1.8400000000000001 115.626 -170.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 12' ' ' GLU . . . . . 0.736 ' HB2' ' HG ' ' B' ' 8' ' ' LEU . 44.9 mt-10 -75.0 -17.14 60.57 Favored 'General case' 0 C--N 1.314 -0.966 0 O-C-N 122.317 -0.519 . . . . 2.5499999999999998 111.578 -179.068 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 13' ' ' LEU . . . . . 0.472 ' O ' HD23 ' B' ' 17' ' ' LEU . 36.7 tp -71.98 -53.73 12.1 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-O 120.884 0.373 . . . . 2.3500000000000001 110.284 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 14' ' ' VAL . . . . . 0.499 HG12 ' O ' ' B' ' 10' ' ' GLY . 13.7 p -70.64 -23.54 24.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-O 121.5 0.667 . . . . 2.1099999999999999 109.796 -179.465 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -72.49 -42.43 64.87 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.815 -0.629 . . . . 2.04 111.233 175.259 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 16' ' ' THR . . . . . 0.663 ' HB ' ' HB2' ' A' 1599 ' ' PRO . 15.1 t -67.43 -30.14 69.81 Favored 'General case' 0 C--O 1.248 1.005 0 CA-C-N 118.674 0.67 . . . . 1.8400000000000001 110.727 176.659 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.472 HD23 ' O ' ' B' ' 13' ' ' LEU . 3.3 mm? -51.97 -51.69 55.48 Favored 'General case' 0 C--O 1.212 -0.918 0 O-C-N 123.637 0.586 . . . . 1.74 109.89 168.077 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.69 -33.69 69.01 Favored 'General case' 0 C--O 1.214 -0.793 0 CA-C-N 116.014 -0.539 . . . . 2.3900000000000001 110.213 -178.417 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -47.97 -64.09 0.89 Allowed 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 113.084 0.772 . . . . 0.95999999999999996 113.084 177.012 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 10.1 p -91.93 -14.52 8.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 C-N-CA 118.588 -1.245 . . . . 1.3700000000000001 111.62 -176.143 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 21' ' ' CYS . . . . . 0.577 ' HB2' ' HB3' ' B' ' 26' ' ' PHE . 61.9 m -106.95 17.51 23.0 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 119.806 -0.758 . . . . 1.6599999999999999 112.659 -178.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -53.01 -44.14 62.03 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 121.226 -0.512 . . . . 1.53 112.43 174.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -82.22 -52.5 6.9 Favored 'General case' 0 C--N 1.314 -0.937 0 O-C-N 122.627 -0.337 . . . . 2.7200000000000002 111.718 178.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 44.9 ttp180 -69.09 -29.04 67.06 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.38 0.882 . . . . 4.3300000000000001 113.38 -175.309 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.09 133.03 7.14 Favored Glycine 0 N--CA 1.435 -1.37 0 N-CA-C 109.826 -1.309 . . . . 1.53 109.826 -177.254 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 26' ' ' PHE . . . . . 0.577 ' HB3' ' HB2' ' B' ' 21' ' ' CYS . 22.9 p90 -107.68 112.98 25.94 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 117.448 0.624 . . . . 1.6499999999999999 110.235 -179.028 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -135.74 133.77 38.35 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.149 -1.056 . . . . 3.4199999999999999 108.149 -177.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 28' ' ' PHE . . . . . 0.433 ' HA ' ' HE1' ' B' ' 59' ' ' TYR . 18.0 p90 -147.88 19.15 1.14 Allowed 'General case' 0 C--N 1.315 -0.895 0 O-C-N 123.293 0.371 . . . . 2.2599999999999998 111.501 -178.304 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 51.2 m -156.53 84.31 0.97 Allowed 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.033 -0.728 . . . . 3.6800000000000002 109.033 -178.368 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 30' ' ' ARG . . . . . 0.699 ' O ' ' HA ' ' B' ' 39' ' ' SER . 48.0 mtt-85 -116.59 154.55 49.21 Favored Pre-proline 0 C--N 1.314 -0.964 0 N-CA-C 108.45 -0.945 . . . . 3.8100000000000001 108.45 -176.244 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.32 -48.59 15.04 Favored 'Trans proline' 0 C--O 1.256 1.387 0 C-N-CA 121.581 1.521 . . . . 4.0199999999999996 111.731 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -160.32 146.01 15.14 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 115.15 -0.932 . . . . 4.9199999999999999 108.513 179.296 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 33' ' ' SER . . . . . 0.435 ' HB3' ' HB3' ' B' ' 36' ' ' SER . 30.4 t -168.65 166.4 11.84 Favored 'General case' 0 N--CA 1.399 -2.984 0 N-CA-C 103.492 -2.781 . . . . 6.7199999999999998 103.492 -176.228 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 26.2 tpt180 -90.76 -4.69 56.49 Favored 'General case' 0 C--N 1.258 -3.378 0 CA-C-O 121.598 0.713 . . . . 11.630000000000001 109.211 -175.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 0.669 HG21 HG21 ' B' ' 62' ' ' THR . 11.9 t -121.68 -8.49 9.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 122.08 0.943 . . . . 9.6099999999999994 108.479 177.426 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 36' ' ' SER . . . . . 0.435 ' HB3' ' HB3' ' B' ' 33' ' ' SER . 32.7 t -151.9 63.54 0.85 Allowed 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 107.229 -1.397 . . . . 6.71 107.229 -174.389 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -82.19 6.96 14.94 Favored 'General case' 0 C--O 1.245 0.838 0 CA-C-N 115.55 -0.75 . . . . 10.0 112.51 -178.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 20.1 tpp180 -114.69 140.31 48.96 Favored 'General case' 0 N--CA 1.417 -2.107 0 N-CA-C 105.024 -2.213 . . . . 7.9400000000000004 105.024 177.022 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 39' ' ' SER . . . . . 0.699 ' HA ' ' O ' ' B' ' 30' ' ' ARG . 23.8 m -64.94 -8.81 17.21 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 114.33 1.233 . . . . 5.7599999999999998 114.33 -174.529 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 26.6 ptt180 -150.89 148.5 28.51 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 107.853 -1.165 . . . . 6.0300000000000002 107.853 174.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . -149.96 160.65 28.6 Favored Glycine 0 N--CA 1.414 -2.789 0 N-CA-C 110.685 -0.966 . . . . 2.3700000000000001 110.685 176.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . 0.291 17.5 pt 65.55 -36.22 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 128.318 2.647 . . . . 2.0699999999999998 115.12 175.526 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 2.5 p -52.27 -41.02 32.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 123.532 0.733 . . . . 2.2400000000000002 112.926 178.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -87.81 -47.43 8.61 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 109.368 -0.604 . . . . 3.3599999999999999 109.368 -176.28 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -54.49 -44.5 72.73 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 114.985 -1.007 . . . . 3.0800000000000001 111.676 -179.134 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 46' ' ' CYS . . . . . 0.617 ' SG ' ' HB ' ' B' ' 7' ' ' THR . 22.9 t -86.22 -15.68 40.1 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.029 0.442 . . . . 2.23 111.246 -176.468 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 49.5 t -75.17 -37.97 61.06 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.235 0.54 . . . . 2.3700000000000001 110.991 178.051 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -105.75 -12.79 15.76 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 113.766 1.024 . . . . 2.8199999999999998 113.766 -177.229 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 56.6 mtm180 -138.61 158.24 44.62 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.703 -0.851 . . . . 4.0899999999999999 108.703 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 16.0 t -80.27 114.91 19.51 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.782 -0.822 . . . . 2.6699999999999999 108.782 -177.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 51' ' ' CYS . . . . . 0.424 ' H ' HG21 ' B' ' 7' ' ' THR . 32.0 p -89.42 143.61 26.69 Favored 'General case' 0 N--CA 1.421 -1.904 0 N-CA-C 108.247 -1.02 . . . . 2.1099999999999999 108.247 -176.207 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -92.81 150.03 20.89 Favored 'General case' 0 N--CA 1.421 -1.884 0 N-CA-C 107.322 -1.362 . . . . 2.6699999999999999 107.322 174.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 53' ' ' LEU . . . . . 0.63 ' HB3' ' HB3' ' A' 1600 ' ' SER . 3.9 pp -70.35 -9.16 55.4 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 113.199 0.814 . . . . 1.8999999999999999 113.199 -171.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.24 -33.67 65.44 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.313 -0.995 . . . . 1.52 108.313 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 54.0 tp -60.67 -49.34 77.93 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-N 114.851 -1.068 . . . . 1.97 109.293 177.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 3.3 pp -73.83 -29.27 62.04 Favored 'General case' 0 N--CA 1.412 -2.353 0 C-N-CA 120.295 -0.562 . . . . 1.53 111.584 -176.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -63.98 -52.77 58.09 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.059 0.457 . . . . 2.27 110.929 -179.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 13.6 t -77.61 -23.07 49.94 Favored 'General case' 0 CA--C 1.557 1.214 0 CA-C-N 116.039 -0.528 . . . . 2.3300000000000001 111.958 -177.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 59' ' ' TYR . . . . . 0.433 ' HE1' ' HA ' ' B' ' 28' ' ' PHE . 10.2 t80 -81.67 -34.4 30.73 Favored 'General case' 0 C--O 1.243 0.732 0 N-CA-C 108.817 -0.808 . . . . 2.8599999999999999 108.817 179.227 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 9.6 t -73.79 80.03 1.59 Allowed 'General case' 0 C--O 1.248 1.018 0 CA-C-N 115.269 -0.878 . . . . 2.2999999999999998 111.733 -178.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . 76.07 151.7 0.12 Allowed 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 125.02 1.328 . . . . 3.1899999999999999 113.938 173.053 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 62' ' ' THR . . . . . 0.669 HG21 HG21 ' B' ' 35' ' ' VAL . 4.7 p -127.98 139.3 34.99 Favored Pre-proline 0 N--CA 1.42 -1.942 0 CA-C-N 114.499 -1.228 . . . . 3.6800000000000002 109.696 179.213 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -55.39 -28.23 62.34 Favored 'Trans proline' 0 CA--C 1.509 -0.727 0 C-N-CA 124.583 3.522 . . . . 5.0800000000000001 115.415 -172.269 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -121.79 24.01 9.87 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 120.911 -0.315 . . . . 5.0999999999999996 111.666 -179.154 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 65' ' ' LYS . . . . . 0.523 ' HB3' ' OG1' ' B' ' 62' ' ' THR . 22.0 tptm -156.9 28.56 0.31 Allowed 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 122.018 0.913 . . . . 8.5099999999999998 109.905 -178.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 50.1 m -153.71 35.44 0.45 Allowed 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 121.464 0.65 . . . . 8.1199999999999992 109.362 176.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 . . . . . 0 N--CA 1.423 -1.805 0 N-CA-C 108.16 -1.052 . . . . 10.210000000000001 108.16 -175.642 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 15.6 tpt . . . . . 0 CA--C 1.512 -0.49 0 N-CA-C 109.299 -0.63 . . . . 9.3399999999999999 109.299 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A 1509 ' ' LYS . . . . . 0.763 ' HG2' ' HB2' ' A' 1526 ' ' LEU . 97.7 mttt -76.5 81.7 3.2 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 123.067 0.547 . . . . 9.0399999999999991 110.827 -179.219 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 65.7 m -136.52 140.98 43.38 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.793 -0.64 . . . . 5.8099999999999996 109.784 178.008 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1511 ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -86.71 67.12 9.75 Favored 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 109.299 -0.63 . . . . 3.4199999999999999 109.299 176.053 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1512 ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -78.22 -31.4 49.32 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 115.67 -0.695 . . . . 5.9500000000000002 110.181 -177.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 74.9 m-70 71.5 -64.41 0.39 Allowed 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 114.894 -1.048 . . . . 5.3300000000000001 112.312 177.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1514 ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' A' 1579 ' ' LYS . 26.7 t70 -68.37 -7.06 28.04 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.473 1.109 . . . . 5.0599999999999996 112.515 -173.446 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 25.3 t70 -107.81 16.73 23.29 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.14 -0.975 . . . . 2.8999999999999999 109.759 176.064 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1516 ' ' CYS . . . . . 0.646 ' HA ' ' HB2' ' A' 1581 ' ' LEU . 69.2 m 59.05 49.57 9.28 Favored 'General case' 0 C--O 1.246 0.884 0 N-CA-C 114.393 1.257 . . . . 1.1899999999999999 114.393 -179.39 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -156.45 134.66 11.32 Favored 'General case' 0 N--CA 1.427 -1.599 0 CA-C-N 115.22 -0.9 . . . . 1.52 110.819 175.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1518 ' ' VAL . . . . . 0.643 HG21 ' HB2' ' A' 1583 ' ' TYR . 5.6 m -141.21 145.25 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 C-N-CA 124.411 1.085 . . . . 0.93999999999999995 109.892 -178.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1519 ' ' THR . . . . . 0.42 ' OG1' HD23 ' A' 1526 ' ' LEU . 25.8 m -114.89 137.1 52.37 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 109.239 -0.652 . . . . 0.89000000000000001 109.239 177.253 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1520 ' ' ASN . . . . . 0.529 ' OD1' HG22 ' A' 1523 ' ' THR . 26.8 t-20 -91.36 110.75 44.92 Favored Pre-proline 0 C--N 1.3 -1.556 0 N-CA-C 108.088 -1.078 . . . . 1.74 108.088 173.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -65.32 -19.08 61.86 Favored 'Trans proline' 0 N--CA 1.478 0.601 0 C-N-CA 123.464 2.776 . . . . 1.5800000000000001 113.246 -173.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1522 ' ' SER . . . . . 0.465 ' HB2' ' OD1' ' A' 1520 ' ' ASN . 18.0 m -70.08 -44.58 68.79 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-N 115.849 -0.614 . . . . 1.6499999999999999 111.259 -178.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1523 ' ' THR . . . . . 0.529 HG22 ' OD1' ' A' 1520 ' ' ASN . 9.6 t -119.01 6.86 11.33 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.54 0.686 . . . . 1.6100000000000001 111.067 -175.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 57.83 36.02 77.88 Favored Glycine 0 CA--C 1.511 -0.199 0 CA-C-N 115.104 -0.953 . . . . 1.1299999999999999 113.798 177.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 13.0 t-160 -100.72 122.14 42.86 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 120.537 -0.465 . . . . 1.26 110.578 -179.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1526 ' ' LEU . . . . . 0.763 ' HB2' ' HG2' ' A' 1509 ' ' LYS . 2.2 tm? -96.92 114.61 26.25 Favored 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 124.76 1.224 . . . . 0.68000000000000005 109.522 -179.149 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -91.24 115.28 27.9 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 116.777 -0.192 . . . . 0.65000000000000002 111.167 176.023 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 6.3 t70 -101.74 115.02 29.62 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 108.094 -1.076 . . . . 1.1699999999999999 108.094 174.321 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1529 ' ' LEU . . . . . 0.432 ' HB2' ' HB3' ' A' 1516 ' ' CYS . 3.6 mm? -101.07 4.17 42.0 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.346 0.593 . . . . 0.59999999999999998 110.129 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1530 ' ' SER . . . . . 0.427 ' HA ' ' OG ' ' A' 1533 ' ' SER . 1.2 m -67.01 -30.19 70.22 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.16 -0.927 . . . . 0.83999999999999997 109.011 179.174 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 30.9 m -61.38 -27.76 68.75 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 114.962 -1.017 . . . . 1.5900000000000001 111.008 178.036 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 83.1 mt -99.09 -1.08 40.43 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 120.696 0.284 . . . . 0.65000000000000002 110.819 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1533 ' ' SER . . . . . 0.427 ' OG ' ' HA ' ' A' 1530 ' ' SER . 19.6 m -75.0 158.92 32.44 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 120.736 0.303 . . . . 1.52 110.877 -177.473 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . 176.71 146.48 6.09 Favored Glycine 0 N--CA 1.443 -0.833 0 N-CA-C 110.867 -0.893 . . . . 1.1000000000000001 110.867 -179.318 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1535 ' ' ARG . . . . . 0.401 ' O ' ' HA ' ' A' 1556 ' ' ASN . 36.8 ttm180 -92.62 -29.07 16.32 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 123.205 0.602 . . . . 4.6200000000000001 111.036 -177.045 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -75.83 -38.89 57.64 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.864 0.84 . . . . 1.45 108.986 177.347 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 94.87 -165.52 25.66 Favored Glycine 0 N--CA 1.422 -2.283 0 CA-C-N 114.939 -1.028 . . . . 0.84999999999999998 114.081 172.012 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -128.34 153.69 46.75 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 107.267 -1.383 . . . . 0.93000000000000005 107.267 -178.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 3.0 p -112.56 136.11 52.48 Favored 'General case' 0 C--N 1.31 -1.149 0 O-C-N 123.539 0.525 . . . . 1.03 111.388 -177.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1540 ' ' ALA . . . . . 0.41 ' HB3' ' CG1' ' A' 1548 ' ' VAL . . . -128.22 148.62 50.63 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.517 -0.92 . . . . 0.5 108.517 175.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -82.4 135.86 35.08 Favored 'General case' 0 C--N 1.315 -0.9 0 O-C-N 123.556 0.535 . . . . 0.73999999999999999 111.494 -176.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1542 ' ' TYR . . . . . 0.517 ' HB3' ' H ' ' A' 1543 ' ' SER . 2.4 t80 -134.11 -101.32 0.24 Allowed 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 115.628 -0.714 . . . . 0.98999999999999999 109.434 179.33 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1543 ' ' SER . . . . . 0.517 ' H ' ' HB3' ' A' 1542 ' ' TYR . 39.8 t -72.32 160.42 32.4 Favored 'General case' 0 C--O 1.246 0.92 0 CA-C-N 115.907 -0.588 . . . . 1.9099999999999999 110.569 -178.565 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1544 ' ' LYS . . . . . 0.44 ' HE2' ' HA ' ' B' ' 23' ' ' ASP . 24.3 ttmm -53.61 -40.3 65.64 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.958 0.409 . . . . 3.5899999999999999 111.634 -178.677 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 45.6 m -104.32 12.02 34.07 Favored 'General case' 0 N--CA 1.413 -2.294 0 N-CA-C 112.42 0.526 . . . . 2.46 112.42 -174.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . -155.42 147.69 16.92 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 117.822 -2.132 . . . . 1.26 115.683 -173.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 35.1 m -113.0 172.94 2.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 108.557 -0.905 . . . . 0.79000000000000004 108.557 178.344 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1548 ' ' VAL . . . . . 0.502 ' HA ' ' HA ' ' A' 1567 ' ' PHE . 14.9 p -115.69 141.39 33.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 109.125 -0.694 . . . . 0.57999999999999996 109.125 176.405 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -103.74 129.5 51.12 Favored 'General case' 0 CA--C 1.491 -1.327 0 N-CA-C 109.32 -0.622 . . . . 1.0800000000000001 109.32 176.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 23.1 ptm -139.66 128.62 23.54 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 115.435 -0.802 . . . . 0.78000000000000003 110.494 -179.28 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1551 ' ' SER . . . . . 0.452 ' HB3' HD22 ' A' 1556 ' ' ASN . 15.4 p -112.12 131.46 55.44 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 115.773 -0.649 . . . . 0.96999999999999997 109.721 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1552 ' ' ILE . . . . . . . . . . . . . 46.9 mm -91.0 121.11 41.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 N-CA-C 109.529 -0.545 . . . . 0.41999999999999998 109.529 -178.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1553 ' ' CYS . . . . . 0.47 ' O ' ' HE2' ' A' 1579 ' ' LYS . 72.7 m 60.33 42.84 14.32 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 121.73 0.776 . . . . 1.3999999999999999 112.058 175.077 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 177.64 171.88 41.56 Favored Glycine 0 N--CA 1.417 -2.62 0 N-CA-C 110.312 -1.115 . . . . 0.34999999999999998 110.312 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -87.33 153.45 21.45 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 109.441 -0.577 . . . . 1.6200000000000001 109.441 179.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1556 ' ' ASN . . . . . 0.452 HD22 ' HB3' ' A' 1551 ' ' SER . 18.4 t-20 -102.06 120.98 41.3 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 108.815 -0.809 . . . . 0.87 108.815 -177.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -78.87 13.85 1.57 Allowed 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 113.549 0.944 . . . . 2.4900000000000002 113.549 -174.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 54.6 m-80 -96.08 -12.54 24.69 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 120.214 -0.595 . . . . 1.3799999999999999 110.368 177.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1559 ' ' CYS . . . . . 0.748 ' SG ' ' HD2' ' A' 1560 ' ' PRO . 3.8 t -136.77 164.09 44.95 Favored Pre-proline 0 C--N 1.307 -1.253 0 CA-C-O 117.154 -1.403 . . . . 1.21 107.555 -175.838 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1560 ' ' PRO . . . . . 0.748 ' HD2' ' SG ' ' A' 1559 ' ' CYS . 37.9 Cg_exo -28.5 140.96 0.02 OUTLIER 'Trans proline' 0 C--N 1.381 2.249 1 C-N-CA 125.549 4.166 . . . . 0.70999999999999996 116.341 177.657 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A 1561 ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' 1560 ' ' PRO . 73.9 Cg_exo -53.04 127.4 24.86 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 124.017 3.144 . . . . 0.80000000000000004 114.194 -177.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 93.58 7.05 62.01 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-N 115.755 -0.657 . . . . 0.46000000000000002 114.345 177.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1563 ' ' VAL . . . . . 0.614 HG11 ' HB3' ' A' 1559 ' ' CYS . 5.5 p -99.3 141.98 15.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 O-C-N 121.929 -0.748 . . . . 0.97999999999999998 110.401 -179.53 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -104.68 -28.71 5.58 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-N 116.339 -0.391 . . . . 0.28000000000000003 112.99 178.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -130.56 131.78 45.21 Favored 'General case' 0 C--O 1.245 0.827 0 O-C-N 122.294 -0.533 . . . . 0.28000000000000003 110.794 179.33 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 44.3 t -159.81 141.32 12.81 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.785 -0.82 . . . . 0.42999999999999999 108.785 -178.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1567 ' ' PHE . . . . . 0.52 ' HB2' ' OG1' ' A' 1570 ' ' THR . 93.9 m-85 -86.91 146.51 26.15 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.776 -0.824 . . . . 1.03 108.776 178.211 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -68.71 -20.67 74.34 Favored Glycine 0 C--O 1.222 -0.625 0 N-CA-C 115.269 0.868 . . . . 1.1299999999999999 115.269 -172.57 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 35.7 mm-40 -96.8 -30.68 13.03 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 117.535 0.667 . . . . 2.5800000000000001 112.048 176.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1570 ' ' THR . . . . . 0.521 ' HA ' ' OD2' ' B' ' 15' ' ' ASP . 46.8 p -81.92 -32.0 31.07 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 115.236 1.569 . . . . 2.1699999999999999 115.236 -163.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 69.78 -2.63 1.93 Allowed 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.984 0.914 . . . . 2.6200000000000001 109.993 -172.44 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 28.5 mt -86.32 132.73 31.47 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 CA-C-O 121.473 0.654 . . . . 0.92000000000000004 110.834 -171.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 17.6 t -78.65 116.53 19.07 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 114.446 -1.252 . . . . 0.80000000000000004 109.589 179.152 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1574 ' ' VAL . . . . . 0.567 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 23.2 m -114.22 8.36 7.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-O 121.316 0.579 . . . . 0.97999999999999998 111.437 -178.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . -174.45 112.63 0.42 Allowed Glycine 0 N--CA 1.428 -1.898 0 C-N-CA 120.35 -0.929 . . . . 0.28999999999999998 111.527 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1576 ' ' LYS . . . . . 0.442 ' HB3' ' O ' ' A' 1593 ' ' LYS . 87.0 tttt -71.07 134.67 47.24 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.406 -0.961 . . . . 2.1899999999999999 108.406 177.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -68.11 131.35 45.26 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-O 120.942 0.401 . . . . 0.60999999999999999 110.465 -178.343 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -150.16 165.26 33.41 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 104.394 -2.447 . . . . 1.95 104.394 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1579 ' ' LYS . . . . . 0.47 ' HE2' ' O ' ' A' 1553 ' ' CYS . 97.4 mttt -130.83 40.1 3.52 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 108.675 -0.861 . . . . 2.6800000000000002 108.675 -178.306 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -92.99 76.63 4.72 Favored 'General case' 0 N--CA 1.418 -2.073 0 CA-C-O 122.181 0.991 . . . . 3.4700000000000002 109.893 -171.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1581 ' ' LEU . . . . . 0.646 ' HB2' ' HA ' ' A' 1516 ' ' CYS . 1.0 OUTLIER -63.71 125.93 25.92 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 113.18 -1.827 . . . . 0.64000000000000001 109.173 178.856 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A 1582 ' ' ARG . . . . . 0.417 ' N ' HD13 ' A' 1581 ' ' LEU . 78.3 mtp180 -125.28 139.99 53.22 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 115.919 -0.582 . . . . 2.8500000000000001 109.719 175.383 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1583 ' ' TYR . . . . . 0.643 ' HB2' HG21 ' A' 1518 ' ' VAL . 64.6 t80 -112.52 110.73 21.08 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 108.757 -0.831 . . . . 0.85999999999999999 108.757 -178.294 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1584 ' ' VAL . . . . . 0.519 ' O ' ' HB ' ' A' 1587 ' ' VAL . 10.9 m -122.52 88.99 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-O 121.36 0.6 . . . . 1.05 112.142 -178.353 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 38.6 t70 55.13 65.09 1.59 Allowed 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 115.09 -0.959 . . . . 1.1699999999999999 111.083 178.028 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1586 ' ' GLN . . . . . 0.586 ' HA ' ' CE1' ' A' 1583 ' ' TYR 0.291 11.6 pt20 64.69 15.37 9.7 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 126.826 2.05 . . . . 1.8600000000000001 112.631 177.562 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A 1587 ' ' VAL . . . . . 0.519 ' HB ' ' O ' ' A' 1584 ' ' VAL . 41.9 t -110.63 121.28 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.338 0 CA-C-N 114.219 -1.355 . . . . 0.48999999999999999 108.265 175.367 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1588 ' ' LEU . . . . . 0.834 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 2.6 mm? -95.83 114.65 26.4 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 106.688 -1.597 . . . . 0.35999999999999999 106.688 179.054 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -126.77 125.19 41.33 Favored 'General case' 0 C--N 1.289 -2.031 0 C-N-CA 119.177 -1.009 . . . . 1.74 112.674 -175.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1590 ' ' LEU . . . . . 0.457 ' HB2' ' HB ' ' A' 1610 ' ' ILE . 19.1 mt -107.88 126.76 53.05 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 113.993 -1.458 . . . . 0.71999999999999997 107.178 175.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 48.5 t -115.47 122.04 68.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 C-N-CA 119.879 -0.728 . . . . 1.01 109.893 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1592 ' ' TYR . . . . . 0.4 ' O ' ' HA ' ' A' 1607 ' ' LYS . 15.7 m-30 -105.49 94.74 5.37 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.932 -1.136 . . . . 0.5 107.932 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1593 ' ' LYS . . . . . 0.442 ' O ' ' HB3' ' A' 1576 ' ' LYS . 49.6 pttt -105.07 172.46 6.78 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 115.997 -0.547 . . . . 1.5900000000000001 109.672 -176.433 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 70.1 m-20 57.11 52.79 8.6 Favored 'General case' 0 CA--C 1.51 -0.568 0 O-C-N 124.502 1.126 . . . . 1.1100000000000001 111.554 178.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -71.88 -113.18 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 110.364 -1.095 . . . . 0.78000000000000003 110.364 176.388 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1596 ' ' SER . . . . . 0.641 ' HB3' ' HD2' ' A' 1597 ' ' PRO . 72.2 m -133.43 168.68 16.72 Favored Pre-proline 0 C--N 1.284 -2.262 0 O-C-N 121.317 -1.108 . . . . 1.0700000000000001 111.155 172.761 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1597 ' ' PRO . . . . . 0.641 ' HD2' ' HB3' ' A' 1596 ' ' SER . 2.5 Cg_endo -40.28 127.1 2.14 Favored 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 124.118 3.212 . . . . 1.01 114.058 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1598 ' ' CYS . . . . . 0.515 ' SG ' ' HB2' ' A' 1600 ' ' SER . 48.3 t -92.14 123.15 63.5 Favored Pre-proline 0 C--N 1.287 -2.124 0 CA-C-N 114.526 -1.215 . . . . 0.75 109.825 -179.38 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1599 ' ' PRO . . . . . 0.465 ' O ' ' HA ' ' B' ' 52' ' ' ASP . 17.2 Cg_exo -71.48 -27.99 18.33 Favored 'Trans proline' 0 C--O 1.211 -0.87 0 C-N-CA 122.206 1.937 . . . . 1.7 111.158 174.271 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1600 ' ' SER . . . . . 0.898 ' HA ' ' HB2' ' B' ' 53' ' ' LEU . 7.4 m -61.07 -47.16 87.64 Favored 'General case' 0 CA--C 1.555 1.145 0 CA-C-N 116.358 -0.383 . . . . 2.2599999999999998 110.667 178.096 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1601 ' ' LYS . . . . . . . . . . . . . 5.4 tppp? -126.31 111.14 14.18 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 107.407 -1.331 . . . . 3.0099999999999998 107.407 174.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 35.2 t -71.27 122.13 19.7 Favored 'General case' 0 N--CA 1.419 -2.001 0 C-N-CA 122.469 0.308 . . . . 2.0699999999999998 110.223 -171.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 104.76 -10.15 48.57 Favored Glycine 0 N--CA 1.441 -1.032 0 N-CA-C 111.472 -0.651 . . . . 1.0800000000000001 111.472 179.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1604 ' ' LEU . . . . . 0.483 HD23 ' SG ' ' A' 1634 ' ' CYS . 9.2 tp -101.09 168.63 9.47 Favored 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 107.832 -1.173 . . . . 1.8400000000000001 107.832 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 20.2 m -129.64 146.93 51.39 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 109.117 -0.697 . . . . 1.4099999999999999 109.117 178.183 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1606 ' ' TYR . . . . . 0.609 ' HD1' HD11 ' A' 1636 ' ' LEU . 67.0 m-85 -64.64 162.69 15.2 Favored 'General case' 0 C--O 1.251 1.182 0 N-CA-C 113.213 0.82 . . . . 0.59999999999999998 113.213 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1607 ' ' LYS . . . . . 0.521 ' HE3' HG23 ' A' 1635 ' ' THR . 33.3 ttpt -158.54 130.78 6.86 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.067 -0.969 . . . . 1.45 109.194 -177.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1608 ' ' SER . . . . . . . . . . . . . 19.9 m -107.34 130.18 54.82 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 109.48 -0.563 . . . . 1.1499999999999999 109.48 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 39.0 t -110.63 109.19 27.55 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 N-CA-C 108.687 -0.857 . . . . 0.25 108.687 178.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1610 ' ' ILE . . . . . 0.457 ' HB ' ' HB2' ' A' 1590 ' ' LEU . 62.1 mt -101.18 110.16 27.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 115.762 -0.654 . . . . 0.45000000000000001 109.632 -177.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 27.9 t -111.59 115.09 28.58 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 115.61 -0.723 . . . . 1.26 110.361 -178.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1612 ' ' PHE . . . . . 0.834 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 71.9 m-85 -89.53 122.74 32.98 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 107.96 -1.126 . . . . 0.26000000000000001 107.96 175.67 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1613 ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' 1641 ' ' HIS . 43.9 t -116.19 138.72 45.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 109.333 -0.617 . . . . 0.5 109.333 -176.651 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 40.5 t -66.77 119.02 11.13 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 123.998 0.919 . . . . 0.77000000000000002 111.252 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1615 ' ' ARG . . . . . 0.83 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 20.2 tpt180 -122.16 96.72 46.21 Favored Pre-proline 0 N--CA 1.446 -0.663 0 N-CA-C 109.856 -0.424 . . . . 2.5299999999999998 109.856 176.422 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1616 ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -66.6 -40.48 13.44 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.251 1.967 . . . . 1.1000000000000001 110.607 176.017 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -80.6 43.28 0.65 Allowed 'General case' 0 C--O 1.241 0.647 0 C-N-CA 124.3 1.04 . . . . 3.0499999999999998 111.272 176.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1618 ' ' ALA . . . . . 0.632 ' HB2' ' HG3' ' A' 1643 ' ' PRO . . . -39.51 124.68 1.65 Allowed 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 125.617 1.567 . . . . 1.55 113.166 -178.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1619 ' ' GLY . . . . . 0.447 ' C ' ' H ' ' A' 1621 ' ' THR . . . -154.63 -140.37 3.01 Favored Glycine 0 N--CA 1.43 -1.734 0 N-CA-C 108.431 -1.868 . . . . 0.93000000000000005 108.431 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.36 20.14 0.36 Allowed 'Trans proline' 0 N--CA 1.486 1.062 0 C-N-CA 122.904 2.402 . . . . 0.88 112.827 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1621 ' ' THR . . . . . 0.833 ' HB ' ' HB2' ' A' 1641 ' ' HIS . 56.9 p -91.18 -14.21 31.49 Favored 'General case' 0 C--N 1.292 -1.922 0 C-N-CA 124.86 1.264 . . . . 0.96999999999999997 108.975 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -87.93 68.26 9.22 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.963 -1.017 . . . . 0.71999999999999997 109.002 -174.498 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 3.5 ptp180 -167.38 139.33 2.64 Favored Pre-proline 0 C--N 1.317 -0.821 0 C-N-CA 124.435 1.094 . . . . 3.2599999999999998 108.561 179.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1624 ' ' PRO . . . . . 0.445 ' HA ' ' O ' ' A' 1639 ' ' SER . 37.5 Cg_endo -65.99 109.62 1.54 Allowed 'Trans proline' 0 C--O 1.238 0.522 0 C-N-CA 122.757 2.305 . . . . 0.58999999999999997 111.584 -179.304 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 72.3 mtm -113.74 140.87 47.91 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 116.467 -0.333 . . . . 1.3700000000000001 111.255 -178.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 1.8 tm? -78.48 119.78 22.27 Favored 'General case' 0 C--O 1.244 0.787 0 N-CA-C 107.358 -1.349 . . . . 0.89000000000000001 107.358 179.149 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1627 ' ' ILE . . . . . 0.706 HD11 ' HB2' ' A' 1639 ' ' SER . 42.3 mm -80.16 -55.28 9.17 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 N-CA-C 108.833 -0.803 . . . . 0.57999999999999996 108.833 178.448 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 22.7 t -173.82 158.4 3.23 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 106.933 -1.506 . . . . 1.3899999999999999 106.933 -177.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1629 ' ' LEU . . . . . 0.82 ' HG ' ' HG ' ' A' 1636 ' ' LEU . 3.4 tt -115.58 113.02 23.04 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 104.312 -2.477 . . . . 1.25 104.312 175.165 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 16.4 t70 -69.48 103.95 2.19 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 108.602 -0.888 . . . . 1.0900000000000001 108.602 176.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -61.94 -23.96 66.69 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 125.239 1.415 . . . . 3.6000000000000001 113.319 -172.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 90.2 mm-40 -86.13 -38.65 17.52 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 120.85 -0.34 . . . . 2.6000000000000001 111.533 -177.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 67.0 p -103.88 2.27 32.39 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 112.657 0.614 . . . . 0.75 112.657 -174.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1634 ' ' CYS . . . . . 0.483 ' SG ' HD23 ' A' 1604 ' ' LEU . 81.4 m 57.47 35.67 26.13 Favored 'General case' 0 C--N 1.369 1.425 0 C-N-CA 123.96 0.904 . . . . 0.53000000000000003 111.443 177.245 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1635 ' ' THR . . . . . 0.521 HG23 ' HE3' ' A' 1607 ' ' LYS . 90.8 m -107.85 126.86 53.17 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 115.155 -0.93 . . . . 0.46000000000000002 109.97 -176.794 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1636 ' ' LEU . . . . . 0.82 ' HG ' ' HG ' ' A' 1629 ' ' LEU . 0.8 OUTLIER -107.07 122.15 45.9 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 108.588 -0.893 . . . . 0.85999999999999999 108.588 -175.66 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -101.87 133.25 46.93 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 120.81 0.338 . . . . 0.45000000000000001 111.465 -178.002 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -129.25 145.07 51.42 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.67 -0.696 . . . . 0.5 109.895 -178.055 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1639 ' ' SER . . . . . 0.706 ' HB2' HD11 ' A' 1627 ' ' ILE . 8.4 t -125.9 157.34 37.95 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 109.567 -0.531 . . . . 1.04 109.567 177.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 3.2 t90 -156.58 108.41 2.48 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 104.923 -2.251 . . . . 0.68000000000000005 104.923 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1641 ' ' HIS . . . . . 0.833 ' HB2' ' HB ' ' A' 1621 ' ' THR . 26.0 m80 -101.5 104.53 15.45 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 109.283 -0.636 . . . . 0.90000000000000002 109.283 -178.254 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1642 ' ' THR . . . . . . . . . . . . . 3.2 t -133.64 150.11 73.93 Favored Pre-proline 0 C--N 1.3 -1.554 0 CA-C-N 115.186 -0.916 . . . . 0.47999999999999998 110.608 -171.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1643 ' ' PRO . . . . . 0.632 ' HG3' ' HB2' ' A' 1618 ' ' ALA . 7.6 Cg_exo -73.63 -7.36 20.1 Favored 'Trans proline' 0 C--N 1.385 2.463 0 C-N-CA 122.44 2.094 . . . . 0.66000000000000003 112.327 173.467 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 10.5 tt -66.95 -26.68 66.95 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.439 0.637 . . . . 0.96999999999999997 109.814 179.223 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -92.39 9.87 32.36 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.193 -0.912 . . . . 0.83999999999999997 109.82 179.116 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1646 ' ' CYS . . . . . 0.459 ' SG ' ' HA ' ' A' 1643 ' ' PRO . 72.9 m -111.86 146.92 36.85 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-N 115.958 -0.565 . . . . 1.1899999999999999 110.416 -178.323 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -79.33 129.95 70.43 Favored Pre-proline 0 N--CA 1.424 -1.739 0 N-CA-C 106.57 -1.641 . . . . 3.1400000000000001 106.57 173.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1648 ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -64.47 120.07 7.27 Favored 'Trans proline' 0 C--O 1.245 0.828 0 C-N-CA 122.269 1.979 . . . . 2.5800000000000001 112.625 -177.179 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 . . . . . 0 C--O 1.254 1.301 0 N-CA-C 108.34 -0.985 . . . . 4.7199999999999998 108.34 177.672 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.598 0 CA-C-O 121.108 0.48 . . . . 9.9700000000000006 109.959 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 2' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -95.06 110.7 22.59 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 121.271 0.558 . . . . 7.6799999999999997 109.715 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 3' ' ' ARG . . . . . 0.546 HH11 ' HA ' ' B' ' 8' ' ' LEU . 40.0 ptt180 -80.2 150.09 70.6 Favored Pre-proline 0 C--N 1.3 -1.566 0 N-CA-C 107.782 -1.192 . . . . 6.1100000000000003 107.782 178.028 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 4' ' ' PRO . . . . . 0.401 ' O ' ' HG2' ' B' ' 6' ' ' GLU . 68.0 Cg_endo -73.06 28.48 0.29 Allowed 'Trans proline' 0 N--CA 1.48 0.701 0 C-N-CA 123.391 2.727 . . . . 4.8399999999999999 113.52 -178.377 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 5' ' ' SER . . . . . 0.452 ' H ' ' C ' ' B' ' 3' ' ' ARG . 60.6 p 53.92 3.67 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 127.896 2.478 . . . . 4.5999999999999996 115.639 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 6' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' B' ' 4' ' ' PRO . 20.3 mm-40 -91.6 -40.74 11.16 Favored 'General case' 0 C--N 1.31 -1.125 0 O-C-N 122.232 -0.292 . . . . 4.2300000000000004 111.09 -177.486 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 7' ' ' THR . . . . . 0.465 ' O ' ' HD2' ' B' ' 3' ' ' ARG . 7.1 p -111.33 132.54 54.32 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-N 115.882 -0.599 . . . . 3.1400000000000001 111.473 -173.613 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.662 ' HB2' ' HG3' ' B' ' 12' ' ' GLU . 9.4 mp -96.99 132.07 43.17 Favored 'General case' 0 N--CA 1.439 -0.978 0 C-N-CA 122.374 0.27 . . . . 3.96 110.921 179.007 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 9' ' ' CYS . . . . . 0.589 ' HA ' HD23 ' B' ' 13' ' ' LEU . 56.0 m -86.22 140.34 30.22 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 108.567 -0.901 . . . . 2.8399999999999999 108.567 -178.567 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 10' ' ' GLY . . . . . 0.431 ' O ' HG12 ' B' ' 14' ' ' VAL . . . 90.73 -77.02 1.51 Allowed Glycine 0 N--CA 1.431 -1.642 0 C-N-CA 120.484 -0.865 . . . . 2.0899999999999999 111.301 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -59.96 -67.09 2.32 Favored Glycine 0 CA--C 1.5 -0.871 0 CA-C-O 119.504 -0.609 . . . . 1.8400000000000001 113.069 -175.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 12' ' ' GLU . . . . . 0.662 ' HG3' ' HB2' ' B' ' 8' ' ' LEU . 54.1 mt-10 -62.59 -29.14 70.38 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 117.371 0.585 . . . . 2.5499999999999998 110.886 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 13' ' ' LEU . . . . . 0.589 HD23 ' HA ' ' B' ' 9' ' ' CYS . 1.2 mm? -59.38 -62.36 1.93 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.857 -0.61 . . . . 2.3500000000000001 111.879 177.191 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 14' ' ' VAL . . . . . 0.431 HG12 ' O ' ' B' ' 10' ' ' GLY . 10.9 p -69.45 -28.74 39.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 115.834 -0.621 . . . . 2.1099999999999999 110.494 -176.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 15' ' ' ASP . . . . . 0.521 ' OD2' ' HA ' ' A' 1570 ' ' THR . 31.7 t70 -70.71 -45.98 63.93 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 113.85 1.055 . . . . 2.04 113.85 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 20.3 p -63.95 -39.85 95.09 Favored 'General case' 0 C--O 1.275 2.422 0 CA-C-O 121.859 0.838 . . . . 1.8400000000000001 109.935 178.035 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.462 ' HB3' ' HB3' ' B' ' 26' ' ' PHE . 11.2 mp -59.52 -48.34 82.03 Favored 'General case' 0 N--CA 1.416 -2.15 0 CA-C-N 114.947 -1.024 . . . . 1.74 110.689 172.636 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 18' ' ' GLN . . . . . 0.459 ' HB2' ' HE2' ' B' ' 26' ' ' PHE . 26.8 tt0 -56.74 -29.47 62.56 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.499 0.72 . . . . 2.3900000000000001 111.942 174.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -58.1 -56.63 19.57 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-O 119.335 -0.365 . . . . 0.95999999999999996 111.374 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 10.3 p -99.71 -17.62 6.64 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.309 0 C-N-CA 117.557 -1.657 . . . . 1.3700000000000001 112.706 177.009 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 21' ' ' CYS . . . . . 0.591 ' HA ' ' HB3' ' B' ' 24' ' ' ARG . 58.9 m -112.22 30.77 6.78 Favored 'General case' 0 C--N 1.293 -1.849 0 O-C-N 121.717 -0.614 . . . . 1.6599999999999999 112.0 -176.689 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.19 -64.47 4.24 Favored Glycine 0 C--O 1.241 0.571 0 C-N-CA 120.347 -0.93 . . . . 1.53 111.762 177.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.44 ' HA ' ' HE2' ' A' 1544 ' ' LYS . 31.6 t70 -69.73 -34.8 74.35 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 122.674 0.39 . . . . 2.7200000000000002 111.086 175.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 24' ' ' ARG . . . . . 0.591 ' HB3' ' HA ' ' B' ' 21' ' ' CYS . 8.6 tpm_? -64.57 -35.74 81.96 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 124.24 1.016 . . . . 4.3300000000000001 112.399 -177.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.81 149.59 23.42 Favored Glycine 0 N--CA 1.423 -2.204 0 N-CA-C 110.853 -0.899 . . . . 1.53 110.853 -179.389 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 26' ' ' PHE . . . . . 0.462 ' HB3' ' HB3' ' B' ' 17' ' ' LEU . 0.3 OUTLIER -131.41 136.18 47.8 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 111.917 0.34 . . . . 1.6499999999999999 111.917 178.769 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -139.84 78.65 1.67 Allowed 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.785 -0.45 . . . . 3.4199999999999999 109.785 176.37 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 28' ' ' PHE . . . . . 0.556 ' O ' ' HA3' ' B' ' 41' ' ' GLY . 11.1 p90 -94.15 -20.67 19.67 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.794 0.807 . . . . 2.2599999999999998 109.102 178.597 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 50.0 m -86.65 84.94 7.29 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 121.357 0.599 . . . . 3.6800000000000002 111.041 -178.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 76.0 mtt-85 -95.2 112.94 60.3 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-N 115.832 -0.622 . . . . 3.8100000000000001 109.783 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -69.08 -54.87 0.22 Allowed 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 121.369 1.38 . . . . 4.0199999999999996 109.397 172.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -153.0 160.51 43.02 Favored 'General case' 0 N--CA 1.417 -2.107 0 N-CA-C 106.663 -1.606 . . . . 4.9199999999999999 106.663 176.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 68.2 m -159.48 163.48 35.26 Favored 'General case' 0 N--CA 1.394 -3.236 0 N-CA-C 101.837 -3.394 . . . . 6.7199999999999998 101.837 178.191 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 52.8 ttp180 -93.03 -4.35 52.71 Favored 'General case' 0 C--N 1.273 -2.754 0 CA-C-O 121.604 0.716 . . . . 11.630000000000001 111.276 -170.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 53.3 t -118.6 -9.33 11.64 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-O 122.75 1.262 . . . . 9.6099999999999994 108.028 175.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 8.6 t -143.21 77.6 1.57 Allowed 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 105.155 -2.165 . . . . 6.71 105.155 179.049 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 37' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' B' ' 37' ' ' ARG . 11.8 ptm180 -80.42 -2.47 45.85 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 114.295 -1.32 . . . . 10.0 111.157 -175.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -98.68 144.85 27.49 Favored 'General case' 0 N--CA 1.425 -1.686 0 N-CA-C 107.014 -1.476 . . . . 7.9400000000000004 107.014 179.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 20.7 m -81.17 74.22 8.18 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 121.91 0.862 . . . . 5.7599999999999998 110.759 -178.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 23.0 ttm180 -135.98 136.62 40.51 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 115.187 -0.915 . . . . 6.0300000000000002 108.856 177.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 41' ' ' GLY . . . . . 0.556 ' HA3' ' O ' ' B' ' 28' ' ' PHE . . . -156.43 77.43 0.2 Allowed Glycine 0 N--CA 1.398 -3.882 0 N-CA-C 106.337 -2.705 . . . . 2.3700000000000001 106.337 176.146 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 42' ' ' ILE . . . . . 0.471 ' HA ' ' HG2' ' B' ' 45' ' ' GLU . 31.2 pt 60.24 -8.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 C-N-CA 127.786 2.434 . . . . 2.0699999999999998 114.904 -179.439 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 9.8 p -62.48 -34.1 62.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 C-N-CA 123.301 0.64 . . . . 2.2400000000000002 112.42 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -84.07 -24.69 30.28 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 118.089 -1.444 . . . . 3.3599999999999999 108.803 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 45' ' ' GLU . . . . . 0.471 ' HG2' ' HA ' ' B' ' 42' ' ' ILE . 32.2 mm-40 -67.66 -62.39 1.44 Allowed 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.377 -0.829 . . . . 3.0800000000000001 109.154 -179.115 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 46' ' ' CYS . . . . . . . . . . . . . 21.1 m -76.39 -22.74 54.4 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 113.996 1.11 . . . . 2.23 113.996 -171.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 85.0 m -76.67 -1.66 28.9 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 121.201 -0.937 . . . . 2.3700000000000001 112.594 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -133.94 -47.57 0.79 Allowed 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 112.467 0.543 . . . . 2.8199999999999998 112.467 177.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 56.7 mtt-85 -104.53 168.9 8.78 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 120.889 0.375 . . . . 4.0899999999999999 110.029 178.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 37.1 t -90.95 109.98 21.22 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 107.629 -1.249 . . . . 2.6699999999999999 107.629 176.249 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 51' ' ' CYS . . . . . 0.545 ' HB2' HD23 ' B' ' 55' ' ' LEU . 21.8 p -90.93 135.48 33.71 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.851 -0.796 . . . . 2.1099999999999999 108.851 -177.249 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 52' ' ' ASP . . . . . 0.465 ' HA ' ' O ' ' A' 1599 ' ' PRO . 3.7 p30 -98.66 172.05 7.73 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 113.376 0.88 . . . . 2.6699999999999999 113.376 -176.429 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 53' ' ' LEU . . . . . 0.898 ' HB2' ' HA ' ' A' 1600 ' ' SER . 41.9 tp -51.12 -40.48 58.57 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 113.298 0.851 . . . . 1.8999999999999999 113.298 -174.355 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 54' ' ' ALA . . . . . 0.402 ' O ' HG22 ' B' ' 58' ' ' THR . . . -54.94 -46.39 74.95 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 123.623 0.577 . . . . 1.52 111.575 -172.703 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 55' ' ' LEU . . . . . 0.545 HD23 ' HB2' ' B' ' 51' ' ' CYS . 48.0 tp -62.49 -58.0 9.16 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 114.925 -1.034 . . . . 1.97 110.516 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 3.9 pp -69.11 -34.1 74.54 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 112.692 0.627 . . . . 1.53 112.692 -172.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -76.24 -40.37 52.18 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 112.204 0.446 . . . . 2.27 112.204 -179.07 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 58' ' ' THR . . . . . 0.402 HG22 ' O ' ' B' ' 54' ' ' ALA . 7.0 t -77.71 -11.52 59.88 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 118.653 -1.219 . . . . 2.3300000000000001 110.635 176.543 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 59' ' ' TYR . . . . . 0.465 ' OH ' ' HA2' ' B' ' 41' ' ' GLY . 17.6 t80 -85.59 -72.03 0.51 Allowed 'General case' 0 N--CA 1.426 -1.673 0 N-CA-C 106.477 -1.675 . . . . 2.8599999999999999 106.477 175.21 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 41.3 t 38.38 -88.47 0.01 OUTLIER 'General case' 0 C--O 1.253 1.245 0 C-N-CA 126.071 1.748 . . . . 2.2999999999999998 114.559 174.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -152.49 -55.38 0.13 Allowed 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 106.971 -1.492 . . . . 3.1899999999999999 106.971 177.533 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 4.0 p -77.99 134.65 63.79 Favored Pre-proline 0 N--CA 1.408 -2.566 0 CA-C-N 114.381 -1.281 . . . . 3.6800000000000002 108.582 172.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -74.39 -20.5 18.33 Favored 'Trans proline' 0 C--O 1.238 0.489 0 C-N-CA 122.616 2.211 . . . . 5.0800000000000001 114.152 -174.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -142.88 83.92 1.82 Allowed 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 120.861 0.362 . . . . 5.0999999999999996 110.712 179.254 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 54.1 tttp -71.18 129.71 39.62 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 109.135 -0.691 . . . . 8.5099999999999998 109.135 175.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 29.8 m -121.05 -40.1 2.64 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.216 -1.031 . . . . 8.1199999999999992 108.216 177.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 . . . . . 0 N--CA 1.429 -1.514 0 N-CA-C 105.168 -2.16 . . . . 10.210000000000001 105.168 178.547 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 3.9 mpp? . . . . . 0 CA--C 1.506 -0.73 0 N-CA-C 108.075 -1.083 . . . . 9.3399999999999999 108.075 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A 1509 ' ' LYS . . . . . 0.523 ' HD3' ' HA ' ' A' 1521 ' ' PRO . 24.5 ttmm -153.68 58.9 0.74 Allowed 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 106.7 -1.593 . . . . 9.0399999999999991 106.7 179.194 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 13.8 m -53.63 104.82 0.11 Allowed 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.0 -1.455 . . . . 5.8099999999999996 112.822 -174.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1511 ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -104.54 97.68 7.55 Favored 'General case' 0 N--CA 1.425 -1.679 0 N-CA-C 107.035 -1.469 . . . . 3.4199999999999999 107.035 175.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1512 ' ' GLU . . . . . 0.489 ' O ' HG12 ' A' 1518 ' ' VAL . 43.8 mt-10 -84.44 173.23 11.04 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 114.117 -1.401 . . . . 5.9500000000000002 110.455 -172.756 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 60.2 m80 -146.42 -11.95 0.47 Allowed 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.397 0.888 . . . . 5.3300000000000001 113.397 -178.261 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -104.6 -0.17 27.92 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 112.1 0.407 . . . . 5.0599999999999996 112.1 -173.054 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -120.43 22.78 11.16 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 111.687 0.254 . . . . 2.8999999999999999 111.687 -178.106 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1516 ' ' CYS . . . . . 0.604 ' HA ' ' HB2' ' A' 1581 ' ' LEU . 59.8 m 56.34 41.49 28.98 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-O 121.267 0.556 . . . . 1.1899999999999999 110.951 -177.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -150.77 130.11 12.86 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 108.884 -0.784 . . . . 1.52 108.884 -179.286 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1518 ' ' VAL . . . . . 0.489 HG12 ' O ' ' A' 1512 ' ' GLU . 3.3 m -136.03 138.22 47.66 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 O-C-N 124.13 0.894 . . . . 0.93999999999999995 110.47 -177.313 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1519 ' ' THR . . . . . . . . . . . . . 44.2 m -104.8 136.13 44.89 Favored 'General case' 0 C--N 1.281 -2.397 0 N-CA-C 107.612 -1.255 . . . . 0.89000000000000001 107.612 175.034 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1520 ' ' ASN . . . . . 0.477 ' OD1' ' HB2' ' A' 1522 ' ' SER . 21.3 t-20 -91.23 115.76 65.06 Favored Pre-proline 0 C--N 1.287 -2.126 0 N-CA-C 108.816 -0.809 . . . . 1.74 108.816 174.513 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1521 ' ' PRO . . . . . 0.523 ' HA ' ' HD3' ' A' 1509 ' ' LYS . 35.9 Cg_endo -66.34 -15.52 48.37 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.998 2.465 . . . . 1.5800000000000001 113.713 -176.338 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1522 ' ' SER . . . . . 0.477 ' HB2' ' OD1' ' A' 1520 ' ' ASN . 30.2 m -75.98 -44.76 38.2 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 111.772 0.286 . . . . 1.6499999999999999 111.772 -179.142 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1523 ' ' THR . . . . . 0.463 HG22 ' OD1' ' A' 1520 ' ' ASN . 11.1 t -118.44 -1.26 11.27 Favored 'General case' 0 CA--C 1.556 1.178 0 CA-C-O 121.506 0.669 . . . . 1.6100000000000001 112.092 -175.131 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 67.3 33.66 83.1 Favored Glycine 0 CA--C 1.503 -0.718 0 CA-C-N 115.829 -0.623 . . . . 1.1299999999999999 112.937 176.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -98.68 121.9 41.22 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 109.626 -0.509 . . . . 1.26 109.626 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 1.9 tm? -94.12 111.84 23.6 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.208 -0.905 . . . . 0.68000000000000005 108.804 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1527 ' ' PHE . . . . . 0.416 ' CE1' ' HA ' ' A' 1645 ' ' ALA . 85.0 m-85 -83.48 114.57 21.57 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 120.676 0.274 . . . . 0.65000000000000002 111.445 174.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 22.4 t70 -102.91 101.13 11.14 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.112 -1.07 . . . . 1.1699999999999999 108.112 176.121 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1529 ' ' LEU . . . . . 0.477 ' HG ' HD21 ' A' 1581 ' ' LEU . 4.2 mm? -83.88 -7.91 59.32 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 116.294 -0.412 . . . . 0.59999999999999998 110.823 -177.017 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1530 ' ' SER . . . . . 0.597 ' HA ' ' OG ' ' A' 1533 ' ' SER . 17.1 m -66.48 -16.79 64.39 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.913 -0.585 . . . . 0.83999999999999997 111.369 178.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 41.2 t -67.32 -29.06 68.53 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 109.327 -0.62 . . . . 1.5900000000000001 109.327 173.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 81.3 mt -96.93 -10.33 26.58 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 116.451 -0.341 . . . . 0.65000000000000002 111.061 -176.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1533 ' ' SER . . . . . 0.597 ' OG ' ' HA ' ' A' 1530 ' ' SER . 19.0 m -61.74 154.89 24.3 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.33 0.586 . . . . 1.52 110.718 178.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -171.13 131.2 2.14 Favored Glycine 0 C--N 1.286 -2.223 0 N-CA-C 109.443 -1.463 . . . . 1.1000000000000001 109.443 -177.131 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1535 ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' 1535 ' ' ARG . 24.3 ttt180 -92.47 -34.49 14.08 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 112.337 0.495 . . . . 4.6200000000000001 112.337 -172.665 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -59.7 -57.1 14.41 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.524 0.678 . . . . 1.45 110.571 -178.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 130.53 164.13 11.21 Favored Glycine 0 N--CA 1.409 -3.122 0 CA-C-N 115.433 -0.803 . . . . 0.84999999999999998 111.999 173.204 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -120.51 138.91 53.58 Favored 'General case' 0 C--N 1.276 -2.617 0 N-CA-C 106.804 -1.554 . . . . 0.93000000000000005 106.804 178.229 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 28.1 p -108.79 123.69 49.43 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 123.499 0.499 . . . . 1.03 110.783 -179.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1540 ' ' ALA . . . . . 0.445 ' HB3' ' CG1' ' A' 1548 ' ' VAL . . . -114.73 138.98 50.07 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 108.423 -0.955 . . . . 0.5 108.423 177.216 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -75.11 140.16 43.24 Favored 'General case' 0 CA--C 1.502 -0.872 0 O-C-N 123.93 0.769 . . . . 0.73999999999999999 110.188 -177.207 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1542 ' ' TYR . . . . . 0.629 ' HE2' HD13 ' A' 1626 ' ' LEU . 1.7 t80 -152.53 -100.87 0.05 Allowed 'General case' 0 N--CA 1.424 -1.769 0 CA-C-N 115.954 -0.566 . . . . 0.98999999999999999 110.25 -176.049 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1543 ' ' SER . . . . . . . . . . . . . 12.6 m -70.44 156.24 39.62 Favored 'General case' 0 N--CA 1.428 -1.544 0 C-N-CA 123.731 0.812 . . . . 1.9099999999999999 109.735 -176.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 27.5 tptp -62.65 -22.07 66.16 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 125.502 1.521 . . . . 3.5899999999999999 111.34 -173.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 34.3 t -137.94 37.65 2.37 Favored 'General case' 0 N--CA 1.427 -1.589 0 CA-C-N 115.746 -0.661 . . . . 2.46 109.6 -178.17 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1546 ' ' GLY . . . . . 0.54 ' HA3' ' HG2' ' A' 1569 ' ' GLN . . . -176.42 129.56 1.52 Allowed Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 119.025 -1.56 . . . . 1.26 113.974 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 35.9 m -102.75 162.68 3.76 Favored 'Isoleucine or valine' 0 C--O 1.251 1.175 0 N-CA-C 108.806 -0.812 . . . . 0.79000000000000004 108.806 175.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1548 ' ' VAL . . . . . 0.474 ' HA ' ' HA ' ' A' 1567 ' ' PHE . 13.6 p -101.4 132.3 47.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 109.618 -0.512 . . . . 0.57999999999999996 109.618 178.297 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -97.8 126.03 42.95 Favored 'General case' 0 CA--C 1.494 -1.202 0 C-N-CA 123.695 0.798 . . . . 1.0800000000000001 109.435 177.142 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 24.0 ptm -139.2 135.48 34.02 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.311 -0.858 . . . . 0.78000000000000003 111.42 -178.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 74.8 m -124.15 134.72 53.25 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.379 -0.828 . . . . 0.96999999999999997 109.42 175.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1552 ' ' ILE . . . . . . . . . . . . . 46.4 mm -88.19 121.82 39.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 116.281 -0.418 . . . . 0.41999999999999998 111.385 -175.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 34.0 t 66.04 25.35 10.92 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.615 1.166 . . . . 1.3999999999999999 111.632 173.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . -167.51 174.99 42.63 Favored Glycine 0 N--CA 1.418 -2.552 0 N-CA-C 109.323 -1.511 . . . . 0.34999999999999998 109.323 -179.214 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -95.63 155.94 16.53 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.081 0.467 . . . . 1.6200000000000001 110.558 -178.319 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -104.25 134.84 46.8 Favored 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 107.258 -1.386 . . . . 0.87 107.258 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -95.93 7.96 44.94 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 112.943 0.719 . . . . 2.4900000000000002 112.943 -172.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -83.04 -13.91 54.92 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.786 0.803 . . . . 1.3799999999999999 109.533 177.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1559 ' ' CYS . . . . . 0.739 ' SG ' ' HD2' ' A' 1560 ' ' PRO . 9.3 t -131.89 162.16 58.2 Favored Pre-proline 0 C--N 1.293 -1.864 0 N-CA-C 106.039 -1.838 . . . . 1.21 106.039 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1560 ' ' PRO . . . . . 0.739 ' HD2' ' SG ' ' A' 1559 ' ' CYS . 41.8 Cg_exo -28.9 145.81 0.02 OUTLIER 'Trans proline' 0 CA--C 1.565 2.064 1 C-N-CA 125.301 4.001 . . . . 0.70999999999999996 116.563 175.602 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.28 128.07 27.2 Favored 'Trans proline' 0 C--O 1.245 0.849 0 C-N-CA 123.56 2.84 . . . . 0.80000000000000004 112.283 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 102.61 -9.73 55.74 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 116.139 -0.482 . . . . 0.46000000000000002 112.354 -179.121 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1563 ' ' VAL . . . . . 0.537 HG11 ' HB2' ' A' 1566 ' ' CYS . 3.0 t -79.46 125.38 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 N-CA-C 112.665 0.617 . . . . 0.97999999999999998 112.665 -178.804 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -98.6 -36.18 4.66 Favored Glycine 0 C--N 1.315 -0.616 0 CA-C-N 115.338 -0.847 . . . . 0.28000000000000003 111.518 176.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -132.18 128.18 37.47 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 109.332 -0.618 . . . . 0.28000000000000003 109.332 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1566 ' ' CYS . . . . . 0.537 ' HB2' HG11 ' A' 1563 ' ' VAL . 42.2 t -157.27 139.34 14.41 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 110.197 -0.297 . . . . 0.42999999999999999 110.197 -177.032 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1567 ' ' PHE . . . . . 0.474 ' HA ' ' HA ' ' A' 1548 ' ' VAL . 37.8 m-85 -84.96 143.83 28.71 Favored 'General case' 0 C--O 1.245 0.846 0 N-CA-C 109.577 -0.527 . . . . 1.03 109.577 174.437 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -87.38 17.34 44.03 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.865 -0.683 . . . . 1.1299999999999999 112.75 -175.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1569 ' ' GLN . . . . . 0.61 ' HB3' ' OD1' ' B' ' 15' ' ' ASP . 27.3 mt-30 -70.22 -69.97 0.32 Allowed 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 122.257 0.223 . . . . 2.5800000000000001 110.507 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 13.8 t -130.41 29.74 4.81 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-O 121.604 0.716 . . . . 2.1699999999999999 110.82 173.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 7.7 mmt180 65.29 55.17 1.1 Allowed 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 114.83 -1.077 . . . . 2.6200000000000001 109.83 178.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 29.6 mt -95.97 115.74 35.95 Favored 'Isoleucine or valine' 0 C--O 1.246 0.907 0 CA-C-N 114.413 -1.267 . . . . 0.92000000000000004 108.83 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 29.6 t -85.17 140.71 30.71 Favored 'General case' 0 C--O 1.245 0.855 0 CA-C-O 121.575 0.702 . . . . 0.80000000000000004 110.845 -176.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1574 ' ' VAL . . . . . 0.628 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 35.7 m -126.2 15.49 3.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 CA-C-N 115.523 -0.762 . . . . 0.97999999999999998 110.954 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 170.1 129.27 1.09 Allowed Glycine 0 N--CA 1.424 -2.154 0 C-N-CA 119.14 -1.505 . . . . 0.28999999999999998 112.812 177.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 86.8 tttt -77.9 142.95 38.1 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 108.277 -1.009 . . . . 2.1899999999999999 108.277 176.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -73.78 91.49 1.94 Allowed 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 123.036 0.534 . . . . 0.60999999999999999 110.883 -178.216 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -109.85 171.63 7.33 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 108.273 -1.01 . . . . 1.95 108.273 178.058 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 62.3 mttp -124.05 44.61 2.69 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.688 -0.856 . . . . 2.6800000000000002 108.688 -177.191 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 43.6 ttp180 -86.92 77.88 9.14 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 114.904 -1.044 . . . . 3.4700000000000002 109.622 -177.019 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1581 ' ' LEU . . . . . 0.604 ' HB2' ' HA ' ' A' 1516 ' ' CYS . 0.5 OUTLIER -84.33 123.06 29.76 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.602 -1.181 . . . . 0.64000000000000001 108.976 -179.053 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -126.35 140.37 52.56 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 110.108 -0.33 . . . . 2.8500000000000001 110.108 173.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1583 ' ' TYR . . . . . 0.433 ' HB2' HG21 ' A' 1518 ' ' VAL . 51.0 t80 -106.35 111.63 24.3 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 108.975 -0.75 . . . . 0.85999999999999999 108.975 177.089 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1584 ' ' VAL . . . . . 0.613 ' O ' ' HB ' ' A' 1587 ' ' VAL . 6.8 m -130.01 95.72 2.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 112.289 0.477 . . . . 1.05 112.289 -178.529 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 37.0 t70 57.99 65.81 1.23 Allowed 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 121.774 0.797 . . . . 1.1699999999999999 111.929 174.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1586 ' ' GLN . . . . . . . . . . . . 0.254 30.2 pt20 60.67 20.72 10.68 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 127.021 2.128 . . . . 1.8600000000000001 111.847 177.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1587 ' ' VAL . . . . . 0.613 ' HB ' ' O ' ' A' 1584 ' ' VAL . 18.3 t -117.32 121.0 66.64 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.606 0 CA-C-N 113.593 -1.64 . . . . 0.48999999999999999 109.922 176.497 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1588 ' ' LEU . . . . . 0.838 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 2.7 mm? -95.59 115.58 27.63 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 106.061 -1.829 . . . . 0.35999999999999999 106.061 175.282 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1589 ' ' GLN . . . . . 0.424 ' HA ' ' O ' ' A' 1610 ' ' ILE . 29.8 tt0 -118.01 126.44 52.31 Favored 'General case' 0 C--N 1.277 -2.558 0 C-N-CA 119.844 -0.743 . . . . 1.74 112.445 -174.522 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 11.9 mt -114.0 117.41 31.25 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 125.414 1.486 . . . . 0.71999999999999997 107.043 175.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 26.9 t -104.88 128.89 58.26 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 C-N-CA 119.734 -0.786 . . . . 1.01 109.62 -178.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1592 ' ' TYR . . . . . 0.554 ' HB2' ' HB3' ' A' 1608 ' ' SER . 14.4 m-30 -117.58 96.13 5.26 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.901 -0.777 . . . . 0.5 108.901 178.166 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 38.8 pttt -111.4 175.62 5.35 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.823 -0.751 . . . . 1.5900000000000001 109.876 177.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 33.3 m-20 67.48 60.23 0.48 Allowed 'General case' 0 CA--C 1.502 -0.889 0 C-N-CA 124.318 1.047 . . . . 1.1100000000000001 110.904 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -91.11 -104.74 1.34 Allowed Glycine 0 N--CA 1.424 -2.153 0 N-CA-C 109.469 -1.452 . . . . 0.78000000000000003 109.469 177.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1596 ' ' SER . . . . . . . . . . . . . 48.4 m -120.69 156.16 56.35 Favored Pre-proline 0 C--N 1.286 -2.172 0 N-CA-C 107.697 -1.223 . . . . 1.0700000000000001 107.697 175.543 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -53.94 120.92 8.7 Favored 'Trans proline' 0 C--N 1.357 0.991 0 C-N-CA 122.927 2.418 . . . . 1.01 110.276 173.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1598 ' ' CYS . . . . . 0.476 ' HA ' ' HD3' ' A' 1599 ' ' PRO . 48.9 t -79.8 126.42 80.25 Favored Pre-proline 0 C--N 1.28 -2.453 0 CA-C-N 114.385 -1.279 . . . . 0.75 110.578 -175.53 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1599 ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' 1598 ' ' CYS . 12.2 Cg_exo -73.52 -15.72 24.55 Favored 'Trans proline' 0 C--O 1.212 -0.784 0 C-N-CA 122.942 2.428 . . . . 1.7 112.051 177.314 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1600 ' ' SER . . . . . 0.688 ' HA ' ' HB2' ' B' ' 53' ' ' LEU . 15.4 m -65.77 -31.85 73.06 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-O 120.67 0.271 . . . . 2.2599999999999998 111.416 177.483 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1601 ' ' LYS . . . . . 0.445 ' HA ' ' HB2' ' B' ' 52' ' ' ASP . 22.9 ttmm -150.62 120.74 7.22 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 108.084 -1.08 . . . . 3.0099999999999998 108.084 175.374 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 8.0 m -59.02 123.54 16.93 Favored 'General case' 0 N--CA 1.428 -1.548 0 C-N-CA 124.241 1.017 . . . . 2.0699999999999998 112.707 -171.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1603 ' ' GLY . . . . . 0.48 ' HA3' ' O ' ' B' ' 1' ' ' ALA . . . 84.06 23.18 53.02 Favored Glycine 0 CA--C 1.499 -0.961 0 CA-C-N 116.167 -0.47 . . . . 1.0800000000000001 112.482 175.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1604 ' ' LEU . . . . . 0.476 HD23 ' SG ' ' A' 1634 ' ' CYS . 11.5 tp -119.67 165.93 13.86 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 106.854 -1.535 . . . . 1.8400000000000001 106.854 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 22.9 t -124.82 154.37 41.1 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.628 -0.878 . . . . 1.4099999999999999 108.628 -177.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1606 ' ' TYR . . . . . 0.628 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 58.1 m-85 -74.86 163.58 27.5 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 116.011 -0.541 . . . . 0.59999999999999998 109.892 176.273 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -160.33 128.26 4.61 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-N 116.338 -0.392 . . . . 1.45 109.944 -176.488 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1608 ' ' SER . . . . . 0.554 ' HB3' ' HB2' ' A' 1592 ' ' TYR . 34.5 t -104.95 126.3 51.87 Favored 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 108.447 -0.946 . . . . 1.1499999999999999 108.447 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 25.8 t -110.61 99.21 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.66 0 N-CA-C 107.864 -1.161 . . . . 0.25 107.864 177.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1610 ' ' ILE . . . . . 0.424 ' O ' ' HA ' ' A' 1589 ' ' GLN . 77.1 mt -90.29 120.64 39.47 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 CA-C-N 115.014 -0.994 . . . . 0.45000000000000001 108.917 -177.377 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 43.9 m -124.67 123.97 41.18 Favored 'General case' 0 C--N 1.287 -2.11 0 CA-C-N 115.863 -0.608 . . . . 1.26 112.025 -178.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1612 ' ' PHE . . . . . 0.838 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 75.5 m-85 -97.97 123.14 41.83 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.42 -0.956 . . . . 0.26000000000000001 108.42 176.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 44.7 t -113.51 134.96 54.6 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 O-C-N 123.589 0.556 . . . . 0.5 110.621 -174.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -54.07 112.56 0.99 Allowed 'General case' 0 C--O 1.241 0.623 0 C-N-CA 124.265 1.026 . . . . 0.77000000000000002 111.679 175.054 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1615 ' ' ARG . . . . . 0.549 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 23.0 tpt180 -126.0 88.95 53.35 Favored Pre-proline 0 N--CA 1.443 -0.798 0 N-CA-C 107.881 -1.155 . . . . 2.5299999999999998 107.881 174.11 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1616 ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -72.57 -19.59 24.45 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 122.341 2.027 . . . . 1.1000000000000001 113.325 -174.055 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -87.29 -10.8 51.39 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.612 -0.267 . . . . 3.0499999999999998 111.552 179.018 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . 63.05 -172.53 0.16 Allowed 'General case' 0 CA--C 1.546 0.794 0 O-C-N 123.904 0.753 . . . . 1.55 109.087 -172.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . 147.64 -165.27 28.78 Favored Glycine 0 N--CA 1.424 -2.107 0 C-N-CA 120.292 -0.956 . . . . 0.93000000000000005 112.565 175.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -87.23 19.14 1.43 Allowed 'Trans proline' 0 C--O 1.237 0.45 0 C-N-CA 123.614 2.876 . . . . 0.88 113.726 -174.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1621 ' ' THR . . . . . . . . . . . . . 24.1 p -114.62 12.46 17.22 Favored 'General case' 0 C--N 1.285 -2.212 0 CA-C-O 122.173 0.987 . . . . 0.96999999999999997 109.744 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -89.55 66.71 7.38 Favored 'General case' 0 C--O 1.246 0.92 0 N-CA-C 106.682 -1.599 . . . . 0.71999999999999997 106.682 178.12 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1623 ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' 1623 ' ' ARG . 3.4 ptm180 -170.5 140.79 1.52 Allowed Pre-proline 0 N--CA 1.428 -1.531 0 N-CA-C 106.849 -1.538 . . . . 3.2599999999999998 106.849 -173.325 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -57.63 107.56 0.31 Allowed 'Trans proline' 0 CA--C 1.545 1.058 0 C-N-CA 122.511 2.141 . . . . 0.58999999999999997 111.571 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 81.4 mtp -114.18 148.08 37.85 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.576 -0.898 . . . . 1.3700000000000001 108.576 -178.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1626 ' ' LEU . . . . . 0.629 HD13 ' HE2' ' A' 1542 ' ' TYR . 7.2 tt -101.9 138.31 39.04 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.132 -0.692 . . . . 0.89000000000000001 109.132 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1627 ' ' ILE . . . . . 0.809 HD11 ' HB2' ' A' 1639 ' ' SER . 38.4 mm -85.09 -63.09 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.214 -0.812 0 CA-C-N 115.375 -0.829 . . . . 0.57999999999999996 109.701 -178.069 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 52.2 m -161.88 152.11 17.08 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 106.897 -1.52 . . . . 1.3899999999999999 106.897 -176.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1629 ' ' LEU . . . . . 0.627 HD13 ' HG ' ' A' 1636 ' ' LEU . 44.4 tp -105.42 110.3 22.59 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 107.885 -1.154 . . . . 1.25 107.885 175.105 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 18.6 t70 -82.75 95.41 7.86 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 118.388 -1.325 . . . . 1.0900000000000001 107.651 175.456 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 21.8 pttm -76.14 7.24 4.35 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 114.739 -1.119 . . . . 3.6000000000000001 113.467 -174.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -95.68 -45.0 7.2 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 108.794 -0.817 . . . . 2.6000000000000001 108.794 173.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 73.5 p -96.92 -1.68 45.31 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-N 115.368 -0.833 . . . . 0.75 111.342 -177.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1634 ' ' CYS . . . . . 0.585 ' SG ' ' HB2' ' A' 1600 ' ' SER . 74.7 m 60.73 35.04 19.78 Favored 'General case' 0 C--N 1.364 1.196 0 C-N-CA 124.043 0.937 . . . . 0.53000000000000003 110.746 178.146 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1635 ' ' THR . . . . . . . . . . . . . 57.2 m -105.96 128.56 53.89 Favored 'General case' 0 N--CA 1.418 -2.029 0 CA-C-N 114.973 -1.012 . . . . 0.46000000000000002 109.987 -176.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1636 ' ' LEU . . . . . 0.627 ' HG ' HD13 ' A' 1629 ' ' LEU . 0.9 OUTLIER -110.11 119.57 39.7 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 108.223 -1.028 . . . . 0.85999999999999999 108.223 -177.376 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -99.52 129.18 45.67 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 116.293 -0.412 . . . . 0.45000000000000001 110.257 -177.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -126.26 143.41 51.16 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.838 -0.619 . . . . 0.5 109.833 -178.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1639 ' ' SER . . . . . 0.809 ' HB2' HD11 ' A' 1627 ' ' ILE . 23.0 t -124.39 159.97 29.22 Favored 'General case' 0 C--N 1.31 -1.13 0 C-N-CA 124.284 1.033 . . . . 1.04 108.524 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 2.9 t90 -156.71 111.75 2.84 Favored 'General case' 0 N--CA 1.418 -2.073 0 N-CA-C 104.26 -2.496 . . . . 0.68000000000000005 104.26 179.084 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1641 ' ' HIS . . . . . 0.549 ' HB3' ' HB2' ' A' 1615 ' ' ARG . 62.2 m-70 -97.63 110.01 22.65 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 108.926 -0.768 . . . . 0.90000000000000002 108.926 -177.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1642 ' ' THR . . . . . . . . . . . . . 4.6 t -139.11 148.69 58.41 Favored Pre-proline 0 C--N 1.292 -1.931 0 CA-C-N 115.302 -0.863 . . . . 0.47999999999999998 110.869 -171.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1643 ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -78.36 -6.17 15.4 Favored 'Trans proline' 0 C--N 1.364 1.39 0 C-N-CA 122.467 2.111 . . . . 0.66000000000000003 112.168 176.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 7.3 tt -68.41 -31.04 70.09 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 108.915 -0.772 . . . . 0.96999999999999997 108.915 176.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1645 ' ' ALA . . . . . 0.416 ' HA ' ' CE1' ' A' 1527 ' ' PHE . . . -86.08 4.08 39.69 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.195 -0.911 . . . . 0.83999999999999997 111.284 -174.266 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 1.3 t -123.69 144.09 49.86 Favored 'General case' 0 N--CA 1.424 -1.77 0 C-N-CA 119.263 -0.975 . . . . 1.1899999999999999 110.403 -178.375 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -124.64 135.49 26.69 Favored Pre-proline 0 C--N 1.302 -1.468 0 C-N-CA 122.554 0.342 . . . . 3.1400000000000001 110.182 174.269 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1648 ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -73.41 146.46 39.81 Favored 'Trans proline' 0 C--O 1.253 1.225 0 C-N-CA 122.278 1.985 . . . . 2.5800000000000001 111.162 178.054 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 . . . . . 0 C--N 1.311 -1.091 0 CA-C-N 116.444 -0.343 . . . . 4.7199999999999998 110.382 -179.039 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 1' ' ' ALA . . . . . 0.48 ' O ' ' HA3' ' A' 1603 ' ' GLY . . . . . . . . 0 CA--C 1.514 -0.417 0 CA-C-O 121.027 0.442 . . . . 9.9700000000000006 109.999 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 2' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -150.32 102.22 3.05 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 106.856 -1.535 . . . . 7.6799999999999997 106.856 177.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -94.02 122.34 62.08 Favored Pre-proline 0 C--N 1.293 -1.875 0 N-CA-C 112.898 0.703 . . . . 6.1100000000000003 112.898 -175.135 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -90.47 16.72 1.6 Allowed 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.972 2.448 . . . . 4.8399999999999999 111.785 173.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 66.4 m -163.17 174.27 12.38 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 124.947 1.299 . . . . 4.5999999999999996 108.07 -177.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 77.48 -2.21 2.6 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 126.484 1.914 . . . . 4.2300000000000004 110.013 -176.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 14.0 p -92.7 122.81 35.47 Favored 'General case' 0 N--CA 1.405 -2.72 0 N-CA-C 106.596 -1.631 . . . . 3.1400000000000001 106.596 175.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.761 ' HB2' ' HG3' ' B' ' 12' ' ' GLU . 8.1 mp -77.09 100.34 5.67 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 109.65 -0.5 . . . . 3.96 109.65 -178.705 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 9.5 m -50.76 -19.27 0.91 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.038 1.735 . . . . 2.8399999999999999 114.242 -175.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 10' ' ' GLY . . . . . 0.489 ' O ' HG12 ' B' ' 14' ' ' VAL . . . -122.17 -60.43 0.21 Allowed Glycine 0 N--CA 1.424 -2.11 0 N-CA-C 111.005 -0.838 . . . . 2.0899999999999999 111.005 178.578 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -52.07 -55.11 22.94 Favored Glycine 0 N--CA 1.464 0.518 0 N-CA-C 115.344 0.898 . . . . 1.8400000000000001 115.344 -174.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 12' ' ' GLU . . . . . 0.761 ' HG3' ' HB2' ' B' ' 8' ' ' LEU . 60.3 mt-10 -78.36 -30.65 48.13 Favored 'General case' 0 CA--C 1.499 -0.998 0 CA-C-N 117.013 0.407 . . . . 2.5499999999999998 110.3 -177.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 13' ' ' LEU . . . . . 0.562 ' O ' HD23 ' B' ' 17' ' ' LEU . 0.8 OUTLIER -58.16 -62.05 2.11 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-N 115.489 -0.778 . . . . 2.3500000000000001 111.288 178.669 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 14' ' ' VAL . . . . . 0.489 HG12 ' O ' ' B' ' 10' ' ' GLY . 14.2 p -64.72 -29.18 46.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-N 116.107 -0.497 . . . . 2.1099999999999999 111.244 -177.387 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 15' ' ' ASP . . . . . 0.61 ' OD1' ' HB3' ' A' 1569 ' ' GLN . 33.6 t70 -73.83 -37.95 64.69 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 113.11 0.782 . . . . 2.04 113.11 178.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 14.8 t -69.85 -32.17 70.41 Favored 'General case' 0 C--O 1.254 1.306 0 CA-C-N 119.432 1.014 . . . . 1.8400000000000001 109.485 175.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.562 HD23 ' O ' ' B' ' 13' ' ' LEU . 3.8 mm? -56.12 -44.28 78.98 Favored 'General case' 0 C--O 1.208 -1.118 0 CA-C-N 115.431 -0.804 . . . . 1.74 108.995 169.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -77.18 -21.72 53.53 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.27 -0.877 . . . . 2.3900000000000001 112.006 -178.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -64.35 -56.67 12.85 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 116.349 -0.387 . . . . 0.95999999999999996 110.239 178.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 15.0 p -98.66 -20.93 5.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 118.519 -1.273 . . . . 1.3700000000000001 112.555 -177.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 21' ' ' CYS . . . . . 0.608 ' HB2' ' HB3' ' B' ' 26' ' ' PHE . 64.0 m -105.2 19.24 20.94 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 119.445 -0.902 . . . . 1.6599999999999999 110.758 179.759 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.67 -56.58 24.49 Favored Glycine 0 C--N 1.31 -0.888 0 C-N-CA 120.382 -0.913 . . . . 1.53 112.254 178.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -70.34 -38.08 74.79 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.783 0.325 . . . . 2.7200000000000002 111.307 177.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 43.2 ttp180 -72.68 -39.02 67.39 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 113.888 1.069 . . . . 4.3300000000000001 113.888 -176.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 112.09 112.87 3.26 Favored Glycine 0 N--CA 1.429 -1.77 0 N-CA-C 109.157 -1.577 . . . . 1.53 109.157 -175.13 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 26' ' ' PHE . . . . . 0.608 ' HB3' ' HB2' ' B' ' 21' ' ' CYS . 39.8 p90 -92.2 134.73 34.6 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 120.696 -0.402 . . . . 1.6499999999999999 110.895 -178.553 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -148.35 116.72 6.54 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.984 -0.747 . . . . 3.4199999999999999 108.984 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 28' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -117.07 -20.23 9.4 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 120.521 -0.472 . . . . 2.2599999999999998 111.909 175.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 29' ' ' SER . . . . . 0.509 ' HA ' ' HA ' ' B' ' 40' ' ' ARG . 25.1 m -92.03 63.06 4.35 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 121.965 0.888 . . . . 3.6800000000000002 109.378 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 11.7 mtp180 -108.08 141.92 24.18 Favored Pre-proline 0 C--N 1.304 -1.383 0 N-CA-C 106.699 -1.593 . . . . 3.8100000000000001 106.699 -177.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 31' ' ' PRO . . . . . 0.727 ' HA ' ' HA ' ' B' ' 39' ' ' SER . 56.9 Cg_endo -71.79 -11.52 27.82 Favored 'Trans proline' 0 C--O 1.25 1.123 0 C-N-CA 123.345 2.696 . . . . 4.0199999999999996 113.259 -175.222 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . 64.57 15.66 9.79 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 125.077 1.351 . . . . 4.9199999999999999 113.52 172.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 41.1 t 167.18 165.05 0.03 OUTLIER 'General case' 0 N--CA 1.414 -2.227 0 N-CA-C 104.119 -2.548 . . . . 6.7199999999999998 104.119 -178.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 20.8 tpp180 -89.97 3.29 53.57 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 107.988 -1.116 . . . . 11.630000000000001 107.988 177.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 46.5 t -89.85 -9.09 10.66 Favored 'Isoleucine or valine' 0 C--O 1.246 0.877 0 CA-C-N 114.476 -1.238 . . . . 9.6099999999999994 108.839 173.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 18.7 m 56.8 42.07 27.17 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 113.659 -1.609 . . . . 6.71 111.321 176.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 19.0 mmm180 -40.32 -66.98 0.26 Allowed 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 114.239 -1.346 . . . . 10.0 111.659 175.397 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 45.3 ttp180 -136.78 121.51 18.57 Favored 'General case' 0 N--CA 1.41 -2.448 0 N-CA-C 106.448 -1.686 . . . . 7.9400000000000004 106.448 175.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 39' ' ' SER . . . . . 0.727 ' HA ' ' HA ' ' B' ' 31' ' ' PRO . 25.8 m -102.1 36.7 2.04 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.971 0.891 . . . . 5.7599999999999998 111.145 -174.723 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 40' ' ' ARG . . . . . 0.509 ' HA ' ' HA ' ' B' ' 29' ' ' SER . 29.8 ptt180 -166.57 161.76 16.19 Favored 'General case' 0 N--CA 1.421 -1.893 0 N-CA-C 106.467 -1.679 . . . . 6.0300000000000002 106.467 178.546 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . -167.72 167.74 40.21 Favored Glycine 0 C--N 1.284 -2.357 0 N-CA-C 110.236 -1.146 . . . . 2.3700000000000001 110.236 175.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 42' ' ' ILE . . . . . 0.543 HD11 HD21 ' B' ' 17' ' ' LEU . 15.0 pt 59.87 -33.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 C-N-CA 128.097 2.559 . . . . 2.0699999999999998 116.731 176.198 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.498 ' O ' ' HB2' ' B' ' 47' ' ' CYS . 2.7 p -52.57 -41.38 36.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 113.55 0.944 . . . . 2.2400000000000002 113.55 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -94.72 -31.0 13.99 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 108.574 -0.899 . . . . 3.3599999999999999 108.574 -174.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 45' ' ' GLU . . . . . 0.401 ' HB3' ' HA ' ' B' ' 42' ' ' ILE . 8.3 tp10 -56.92 -50.97 70.96 Favored 'General case' 0 C--O 1.206 -1.194 0 CA-C-N 115.35 -0.841 . . . . 3.0800000000000001 109.638 174.414 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 46' ' ' CYS . . . . . 0.541 ' HB3' HD21 ' B' ' 13' ' ' LEU . 9.1 t -89.96 2.46 55.08 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.524 0.678 . . . . 2.23 111.17 -175.592 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 47' ' ' CYS . . . . . 0.498 ' HB2' ' O ' ' B' ' 43' ' ' VAL . 45.6 t -85.61 -52.41 5.83 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 116.331 -0.395 . . . . 2.3700000000000001 110.459 177.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -104.59 13.02 32.37 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.289 0.566 . . . . 2.8199999999999998 111.571 -175.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 49' ' ' ARG . . . . . 0.401 ' HB2' ' O ' ' B' ' 45' ' ' GLU . 28.7 mtp85 -155.86 -170.11 3.3 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 125.64 1.576 . . . . 4.0899999999999999 107.477 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 21.3 t -121.9 129.13 52.31 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 109.188 -0.671 . . . . 2.6699999999999999 109.188 -176.065 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 51' ' ' CYS . . . . . 0.413 ' HB3' ' HB2' ' B' ' 46' ' ' CYS . 26.7 p -99.71 149.89 22.86 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.943 -0.762 . . . . 2.1099999999999999 108.943 -177.101 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 52' ' ' ASP . . . . . 0.445 ' HB2' ' HA ' ' A' 1601 ' ' LYS . 3.0 p-10 -116.57 174.62 5.97 Favored 'General case' 0 C--O 1.251 1.164 0 C-N-CA 120.348 -0.541 . . . . 2.6699999999999999 110.829 170.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 53' ' ' LEU . . . . . 0.688 ' HB2' ' HA ' ' A' 1600 ' ' SER . 34.3 tp -54.61 -43.13 71.93 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 113.342 0.867 . . . . 1.8999999999999999 113.342 -173.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 54' ' ' ALA . . . . . 0.408 ' O ' HG22 ' B' ' 58' ' ' THR . . . -55.39 -31.82 62.13 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.225 0.61 . . . . 1.52 112.341 -171.311 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 61.9 tp -72.41 -58.08 3.67 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 115.491 -0.777 . . . . 1.97 110.244 179.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 2.0 pp -70.2 -32.18 69.98 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 111.827 0.306 . . . . 1.53 111.827 -175.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -60.61 -48.54 81.33 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 116.291 -0.413 . . . . 2.27 111.262 179.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 58' ' ' THR . . . . . 0.408 HG22 ' O ' ' B' ' 54' ' ' ALA . 6.4 t -88.37 -8.7 54.63 Favored 'General case' 0 CA--C 1.569 1.697 0 CA-C-O 120.867 0.365 . . . . 2.3300000000000001 111.895 -177.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 16.7 t80 -95.05 -33.4 12.72 Favored 'General case' 0 N--CA 1.441 -0.878 0 O-C-N 121.291 -0.88 . . . . 2.8599999999999999 109.839 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 60' ' ' CYS . . . . . 0.545 ' SG ' ' HA ' ' B' ' 26' ' ' PHE . 38.8 t -82.63 102.96 11.8 Favored 'General case' 0 C--O 1.255 1.391 0 CA-C-N 115.783 -0.644 . . . . 2.2999999999999998 110.963 -176.433 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . 66.22 177.07 0.22 Allowed 'General case' 0 C--N 1.344 0.329 0 O-C-N 124.566 1.166 . . . . 3.1899999999999999 110.333 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 62' ' ' THR . . . . . 0.972 ' HB ' ' HB3' ' B' ' 65' ' ' LYS . 14.4 p -139.8 116.91 8.33 Favored Pre-proline 0 C--N 1.298 -1.648 0 O-C-N 121.816 -0.553 . . . . 3.6800000000000002 111.304 -177.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -66.22 -40.15 16.0 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.652 2.901 . . . . 5.0800000000000001 114.404 -169.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -133.06 31.4 3.86 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-O 121.28 0.562 . . . . 5.0999999999999996 110.416 178.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 65' ' ' LYS . . . . . 0.972 ' HB3' ' HB ' ' B' ' 62' ' ' THR . 28.6 tptp -125.86 -24.74 3.74 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 116.196 -0.456 . . . . 8.5099999999999998 111.247 -175.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 12.2 t -175.04 64.91 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.644 -0.872 . . . . 8.1199999999999992 108.644 179.404 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 . . . . . 0 C--O 1.253 1.257 0 N-CA-C 108.559 -0.904 . . . . 10.210000000000001 108.559 177.47 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.305 0 N-CA-C 109.033 -0.728 . . . . 9.3399999999999999 109.033 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 50.8 tttp -120.94 -1.11 9.93 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.865 0.841 . . . . 9.0399999999999991 110.749 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 48.0 t -66.95 -34.86 78.69 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 107.442 -1.318 . . . . 5.8099999999999996 107.442 173.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1511 ' ' ASN . . . . . 0.569 ' ND2' ' HB ' ' A' 1519 ' ' THR . 8.4 p30 -136.34 128.18 29.23 Favored 'General case' 0 N--CA 1.42 -1.932 0 CA-C-N 114.562 -1.199 . . . . 3.4199999999999999 107.88 175.282 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1512 ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -124.44 -52.16 1.72 Allowed 'General case' 0 C--N 1.283 -2.299 0 N-CA-C 106.839 -1.541 . . . . 5.9500000000000002 106.839 173.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 8.7 p80 -173.9 94.66 0.1 Allowed 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 125.038 1.335 . . . . 5.3300000000000001 108.524 175.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -85.33 -70.86 0.56 Allowed 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.938 -0.705 . . . . 5.0599999999999996 110.691 -177.171 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1515 ' ' ASP . . . . . 0.438 ' O ' ' HB2' ' A' 1581 ' ' LEU . 17.5 m-20 -142.49 -82.15 0.2 Allowed 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 108.88 -0.785 . . . . 2.8999999999999999 108.88 179.468 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1516 ' ' CYS . . . . . 0.798 ' HB3' ' HB2' ' A' 1529 ' ' LEU . 83.0 m -126.46 46.58 2.43 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 107.048 -1.464 . . . . 1.1899999999999999 107.048 176.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1517 ' ' GLN . . . . . 0.482 ' HA ' ' O ' ' A' 1527 ' ' PHE . 14.0 pt20 -151.72 133.92 15.18 Favored 'General case' 0 N--CA 1.425 -1.712 0 CA-C-N 114.836 -1.074 . . . . 1.52 109.483 -175.791 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1518 ' ' VAL . . . . . 0.511 HG21 ' HB2' ' A' 1583 ' ' TYR . 2.3 m -150.26 136.96 12.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 C-N-CA 124.361 1.064 . . . . 0.93999999999999995 109.497 175.837 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1519 ' ' THR . . . . . 0.569 ' HB ' ' ND2' ' A' 1511 ' ' ASN . 43.4 m -111.81 134.51 53.33 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 108.797 -0.816 . . . . 0.89000000000000001 108.797 178.008 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -90.38 124.13 63.69 Favored Pre-proline 0 C--N 1.298 -1.647 0 N-CA-C 109.184 -0.673 . . . . 1.74 109.184 176.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -68.8 -15.69 40.89 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 123.072 2.515 . . . . 1.5800000000000001 113.725 -174.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 22.5 m -80.62 -50.45 9.95 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-O 120.593 0.235 . . . . 1.6499999999999999 111.478 -177.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1523 ' ' THR . . . . . . . . . . . . . 5.6 t -103.96 -11.75 17.25 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 119.878 -0.729 . . . . 1.6100000000000001 111.867 -176.387 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 75.09 25.92 67.74 Favored Glycine 0 CA--C 1.506 -0.529 0 CA-C-N 116.275 -0.42 . . . . 1.1299999999999999 112.639 177.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 84.8 t60 -92.81 127.4 38.3 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 120.487 -0.485 . . . . 1.26 110.424 -177.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 2.0 tm? -92.71 110.93 22.37 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 114.444 -1.253 . . . . 0.68000000000000005 108.354 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1527 ' ' PHE . . . . . 0.482 ' O ' ' HA ' ' A' 1517 ' ' GLN . 93.3 m-85 -85.07 119.55 25.59 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 120.463 -0.495 . . . . 0.65000000000000002 109.723 173.678 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 24.1 t70 -115.39 114.21 24.8 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.44 -0.8 . . . . 1.1699999999999999 109.417 178.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1529 ' ' LEU . . . . . 0.798 ' HB2' ' HB3' ' A' 1516 ' ' CYS . 2.8 mm? -102.41 -0.83 31.91 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 108.849 -0.797 . . . . 0.59999999999999998 108.849 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -68.59 -32.35 72.19 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.627 0.727 . . . . 0.83999999999999997 109.16 -178.268 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 31.5 t -64.81 -12.7 50.84 Favored 'General case' 0 CA--C 1.554 1.123 0 CA-C-N 114.881 -1.054 . . . . 1.5900000000000001 110.858 177.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 90.5 mt -92.77 -3.13 55.27 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 122.02 -0.425 . . . . 0.65000000000000002 110.703 177.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1533 ' ' SER . . . . . 0.997 ' HA ' ' HB2' ' A' 1536 ' ' ALA . 14.4 t -95.2 -179.62 4.86 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 109.526 -0.546 . . . . 1.52 109.526 179.149 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . 83.92 -65.73 4.05 Favored Glycine 0 C--N 1.312 -0.761 0 N-CA-C 109.609 -1.396 . . . . 1.1000000000000001 109.609 -174.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 42.4 ttp180 -83.89 -2.24 56.06 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 124.424 1.09 . . . . 4.6200000000000001 109.192 174.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1536 ' ' ALA . . . . . 0.997 ' HB2' ' HA ' ' A' 1533 ' ' SER . . . -46.84 -22.28 0.29 Allowed 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 127.551 2.34 . . . . 1.45 116.66 -175.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . -72.61 103.53 1.36 Allowed Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.361 -0.923 . . . . 0.84999999999999998 111.208 178.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -119.93 149.34 42.27 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 120.93 0.395 . . . . 0.93000000000000005 110.777 -178.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 9.9 p -112.94 117.48 32.2 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 115.458 -0.792 . . . . 1.03 110.38 179.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1540 ' ' ALA . . . . . 0.444 ' HB3' ' CG1' ' A' 1548 ' ' VAL . . . -112.54 146.68 38.1 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.953 -0.758 . . . . 0.5 108.953 177.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -86.28 151.68 23.39 Favored 'General case' 0 C--N 1.311 -1.081 0 O-C-N 123.22 0.325 . . . . 0.73999999999999999 111.022 -175.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1542 ' ' TYR . . . . . 0.41 ' HB3' ' H ' ' A' 1543 ' ' SER . 0.3 OUTLIER -159.15 -101.93 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 109.511 -0.551 . . . . 0.98999999999999999 109.511 -178.777 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A 1543 ' ' SER . . . . . 0.41 ' H ' ' HB3' ' A' 1542 ' ' TYR . 2.2 p -68.59 172.22 6.53 Favored 'General case' 0 CA--C 1.562 1.409 0 C-N-CA 124.641 1.176 . . . . 1.9099999999999999 110.302 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1544 ' ' LYS . . . . . 0.525 ' H ' HE21 ' B' ' 18' ' ' GLN . 72.4 mmtt -94.55 4.59 53.66 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 113.561 0.948 . . . . 3.5899999999999999 113.561 -165.658 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 7.3 t -129.8 21.33 5.46 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.43 -0.908 . . . . 2.46 110.208 -178.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 169.25 179.73 41.37 Favored Glycine 0 N--CA 1.424 -2.127 0 C-N-CA 119.801 -1.19 . . . . 1.26 112.153 179.175 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 28.0 m -122.07 176.1 4.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 109.148 -0.686 . . . . 0.79000000000000004 109.148 -177.239 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1548 ' ' VAL . . . . . 0.444 ' CG1' ' HB3' ' A' 1540 ' ' ALA . 14.9 p -103.62 128.12 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 N-CA-C 108.538 -0.912 . . . . 0.57999999999999996 108.538 175.766 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -92.32 131.07 37.81 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.656 -0.868 . . . . 1.0800000000000001 108.656 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 23.5 ptm -144.98 140.65 28.34 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 116.051 -0.522 . . . . 0.78000000000000003 110.587 -178.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1551 ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' 1536 ' ' ALA . 12.3 p -131.95 125.96 32.89 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 115.824 -0.626 . . . . 0.96999999999999997 111.551 177.563 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1552 ' ' ILE . . . . . 0.69 ' H ' ' HB1' ' A' 1536 ' ' ALA . 49.5 mm -82.63 124.5 39.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.556 -0.535 . . . . 0.41999999999999998 109.556 177.402 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1553 ' ' CYS . . . . . 0.551 ' HB2' ' HB2' ' A' 1533 ' ' SER . 60.2 m 59.35 49.7 8.56 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.598 0.713 . . . . 1.3999999999999999 110.696 177.118 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 168.92 172.14 35.4 Favored Glycine 0 N--CA 1.42 -2.401 0 N-CA-C 109.76 -1.336 . . . . 0.34999999999999998 109.76 178.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -100.01 150.15 22.73 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 109.562 -0.532 . . . . 1.6200000000000001 109.562 178.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -91.81 130.97 37.49 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.696 -0.684 . . . . 0.87 109.984 -174.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -67.34 -7.29 23.57 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 113.969 1.1 . . . . 2.4900000000000002 113.969 -174.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -93.12 -4.72 51.75 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 120.302 -0.559 . . . . 1.3799999999999999 112.065 -175.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1559 ' ' CYS . . . . . 0.722 ' SG ' ' HD2' ' A' 1560 ' ' PRO . 3.1 t -137.37 162.52 54.64 Favored Pre-proline 0 C--N 1.293 -1.871 0 N-CA-C 108.08 -1.082 . . . . 1.21 108.08 -178.479 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1560 ' ' PRO . . . . . 0.722 ' HD2' ' SG ' ' A' 1559 ' ' CYS . 16.6 Cg_exo -32.91 145.82 0.03 OUTLIER 'Trans proline' 0 CA--C 1.563 1.964 0 C-N-CA 125.175 3.916 . . . . 0.70999999999999996 115.536 175.64 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.03 124.06 14.85 Favored 'Trans proline' 0 C--O 1.25 1.106 0 C-N-CA 123.236 2.624 . . . . 0.80000000000000004 111.803 178.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 107.08 -5.66 36.41 Favored Glycine 0 N--CA 1.44 -1.072 0 CA-C-N 115.615 -0.72 . . . . 0.46000000000000002 111.878 -177.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1563 ' ' VAL . . . . . 0.626 HG11 ' HB3' ' A' 1559 ' ' CYS . 10.6 t -84.36 120.64 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.227 0 CA-C-O 121.217 0.532 . . . . 0.97999999999999998 112.33 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -96.8 -31.3 7.09 Favored Glycine 0 C--N 1.303 -1.298 0 CA-C-N 115.146 -0.934 . . . . 0.28000000000000003 111.535 177.448 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -136.18 135.26 39.01 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 109.474 -0.565 . . . . 0.28000000000000003 109.474 177.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1566 ' ' CYS . . . . . 0.571 ' HB2' HG11 ' A' 1563 ' ' VAL . 53.9 t -157.84 140.2 14.48 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 110.149 -0.315 . . . . 0.42999999999999999 110.149 -176.443 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1567 ' ' PHE . . . . . 0.497 ' CE2' HG11 ' A' 1574 ' ' VAL . 64.1 m-85 -85.34 133.5 34.14 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 107.954 -1.128 . . . . 1.03 107.954 174.531 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -75.03 -9.73 83.96 Favored Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 115.561 0.984 . . . . 1.1299999999999999 115.561 -171.7 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -70.52 -69.4 0.36 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 117.258 0.529 . . . . 2.5800000000000001 110.908 -177.17 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1570 ' ' THR . . . . . 0.405 HG21 ' HA ' ' B' ' 12' ' ' GLU . 0.7 OUTLIER -97.85 2.08 48.91 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 113.394 0.887 . . . . 2.1699999999999999 113.394 -179.707 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 10.4 mmt85 58.63 41.9 21.4 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.0 -1.0 . . . . 2.6200000000000001 110.444 178.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 32.3 mt -88.51 129.58 39.42 Favored 'Isoleucine or valine' 0 C--O 1.247 0.945 0 N-CA-C 108.085 -1.08 . . . . 0.92000000000000004 108.085 177.327 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 30.0 t -81.09 131.65 35.31 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.391 0.615 . . . . 0.80000000000000004 110.852 -177.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1574 ' ' VAL . . . . . 0.714 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 33.9 m -118.95 15.12 6.96 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 CA-C-N 115.981 -0.554 . . . . 0.97999999999999998 111.346 -179.253 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 176.95 126.23 0.95 Allowed Glycine 0 N--CA 1.423 -2.223 0 C-N-CA 119.58 -1.295 . . . . 0.28999999999999998 111.814 176.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 49.8 tttp -81.99 135.35 35.37 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 107.271 -1.381 . . . . 2.1899999999999999 107.271 177.433 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -70.28 96.99 1.17 Allowed 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 122.956 0.502 . . . . 0.60999999999999999 110.785 -176.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -110.49 173.65 6.23 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 108.72 -0.845 . . . . 1.95 108.72 177.1 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1579 ' ' LYS . . . . . 0.413 ' NZ ' ' HB2' ' A' 1579 ' ' LYS . 9.8 mtmp? -136.53 53.74 1.91 Allowed 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 107.662 -1.236 . . . . 2.6800000000000002 107.662 -177.251 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1580 ' ' ARG . . . . . 0.409 ' NH2' HG11 ' A' 1591 ' ' VAL . 49.1 ttp180 -107.0 76.19 1.08 Allowed 'General case' 0 N--CA 1.419 -1.984 0 CA-C-N 114.497 -1.228 . . . . 3.4700000000000002 108.027 -179.614 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1581 ' ' LEU . . . . . 0.581 HD23 ' HA ' ' A' 1516 ' ' CYS . 0.3 OUTLIER -69.18 126.27 29.27 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.632 -1.167 . . . . 0.64000000000000001 108.923 179.915 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 60.8 mtp180 -124.72 131.12 53.48 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 120.315 -0.554 . . . . 2.8500000000000001 110.649 173.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1583 ' ' TYR . . . . . 0.511 ' HB2' HG21 ' A' 1518 ' ' VAL . 45.1 t80 -100.93 108.31 20.02 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 108.803 -0.814 . . . . 0.85999999999999999 108.803 178.754 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1584 ' ' VAL . . . . . 0.601 ' O ' ' HB ' ' A' 1587 ' ' VAL . 15.5 m -127.4 91.82 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 CA-C-N 115.918 -0.583 . . . . 1.05 111.993 -178.168 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 32.8 t70 59.18 66.91 0.97 Allowed 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 124.039 0.936 . . . . 1.1699999999999999 111.221 175.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1586 ' ' GLN . . . . . 0.459 ' HA ' ' CE1' ' A' 1583 ' ' TYR 0.267 28.5 pt20 61.41 14.75 6.02 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 127.074 2.15 . . . . 1.8600000000000001 112.605 178.895 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A 1587 ' ' VAL . . . . . 0.601 ' HB ' ' O ' ' A' 1584 ' ' VAL . 15.7 t -110.44 120.82 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.325 0 CA-C-N 114.222 -1.354 . . . . 0.48999999999999999 109.436 177.263 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1588 ' ' LEU . . . . . 1.001 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 2.2 mm? -97.79 107.76 20.33 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 106.556 -1.646 . . . . 0.35999999999999999 106.556 177.756 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -105.22 120.72 42.24 Favored 'General case' 0 C--N 1.282 -2.36 0 CA-C-O 121.204 0.526 . . . . 1.74 111.544 -176.223 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 2.3 mt -107.78 108.5 19.73 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 106.196 -1.779 . . . . 0.71999999999999997 106.196 172.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1591 ' ' VAL . . . . . 0.409 HG11 ' NH2' ' A' 1580 ' ' ARG . 7.8 p -97.39 131.14 44.92 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 CA-C-O 121.192 0.52 . . . . 1.01 110.62 -175.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1592 ' ' TYR . . . . . 0.412 ' O ' ' HA ' ' A' 1607 ' ' LYS . 13.1 m-30 -122.57 95.87 4.81 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 107.947 -1.131 . . . . 0.5 107.947 177.173 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1593 ' ' LYS . . . . . 0.521 ' HB3' ' HG3' ' A' 1607 ' ' LYS . 48.0 pttt -117.68 175.95 5.41 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.816 -0.754 . . . . 1.5900000000000001 110.007 -176.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 7.4 m-20 57.11 42.32 25.93 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 124.697 1.248 . . . . 1.1100000000000001 111.885 177.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -68.42 -95.97 0.04 OUTLIER Glycine 0 C--N 1.332 0.323 0 N-CA-C 110.627 -0.989 . . . . 0.78000000000000003 110.627 178.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1596 ' ' SER . . . . . . . . . . . . . 79.1 p -122.06 158.48 55.04 Favored Pre-proline 0 C--N 1.288 -2.083 0 N-CA-C 107.691 -1.226 . . . . 1.0700000000000001 107.691 172.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -57.67 137.63 82.14 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.323 2.016 . . . . 1.01 111.257 178.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1598 ' ' CYS . . . . . 0.503 ' HA ' ' CE2' ' A' 1606 ' ' TYR . 12.0 t -75.0 107.5 4.0 Favored Pre-proline 0 C--N 1.304 -1.399 0 N-CA-C 104.865 -2.272 . . . . 0.75 104.865 177.769 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1599 ' ' PRO . . . . . 0.438 ' HA ' ' O ' ' B' ' 6' ' ' GLU . 92.1 Cg_exo -44.22 -59.18 1.17 Allowed 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 123.973 3.115 . . . . 1.7 114.814 -169.311 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1600 ' ' SER . . . . . . . . . . . . . 8.1 m -87.77 12.92 11.66 Favored 'General case' 0 N--CA 1.402 -2.866 0 N-CA-C 112.827 0.676 . . . . 2.2599999999999998 112.827 -174.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1601 ' ' LYS . . . . . 0.757 ' HE3' ' HB3' ' B' ' 53' ' ' LEU . 96.0 mttt -142.43 69.62 1.32 Allowed 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 122.506 1.146 . . . . 3.0099999999999998 109.063 174.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 7.2 m -46.71 123.68 5.32 Favored 'General case' 0 N--CA 1.413 -2.315 0 C-N-CA 127.669 2.388 . . . . 2.0699999999999998 112.326 -177.361 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 103.96 -21.95 36.62 Favored Glycine 0 N--CA 1.436 -1.348 0 N-CA-C 111.7 -0.56 . . . . 1.0800000000000001 111.7 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1604 ' ' LEU . . . . . 0.538 HD12 ' HB3' ' A' 1601 ' ' LYS . 46.9 mt -94.11 152.46 18.74 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.019 -1.104 . . . . 1.8400000000000001 108.019 179.195 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 26.6 m -131.75 145.24 51.5 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 108.078 -1.082 . . . . 1.4099999999999999 108.078 178.178 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1606 ' ' TYR . . . . . 0.714 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 91.4 m-85 -64.37 155.99 30.64 Favored 'General case' 0 C--O 1.254 1.327 0 CA-C-N 116.231 -0.44 . . . . 0.59999999999999998 111.656 -177.364 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1607 ' ' LYS . . . . . 0.521 ' HG3' ' HB3' ' A' 1593 ' ' LYS . 13.0 ttmm -151.89 127.79 10.31 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.502 -0.772 . . . . 1.45 109.553 -173.149 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1608 ' ' SER . . . . . . . . . . . . . 35.1 m -108.79 119.25 39.0 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 108.773 -0.825 . . . . 1.1499999999999999 108.773 177.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 45.3 t -101.39 104.82 16.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 107.729 -1.211 . . . . 0.25 107.729 178.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 73.9 mt -94.54 111.05 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 N-CA-C 108.621 -0.881 . . . . 0.45000000000000001 108.621 -178.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 34.3 t -109.12 110.33 21.55 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 115.398 -0.819 . . . . 1.26 110.927 -176.223 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1612 ' ' PHE . . . . . 1.001 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 63.0 m-85 -86.35 119.69 26.89 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.702 -0.851 . . . . 0.26000000000000001 108.702 175.526 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 44.6 t -117.8 137.92 50.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-N 115.954 -0.566 . . . . 0.5 109.72 -176.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 24.4 t -67.93 111.22 4.24 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 123.758 0.823 . . . . 0.77000000000000002 112.596 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1615 ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -138.43 105.46 7.76 Favored Pre-proline 0 N--CA 1.434 -1.225 0 N-CA-C 109.464 -0.569 . . . . 2.5299999999999998 109.464 169.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1616 ' ' PRO . . . . . 0.757 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 35.9 Cg_exo -64.3 -10.62 24.42 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 123.224 2.616 . . . . 1.1000000000000001 113.716 179.505 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -87.14 42.58 1.04 Allowed 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 125.09 1.356 . . . . 3.0499999999999998 110.9 -177.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -36.58 119.12 0.61 Allowed 'General case' 0 C--O 1.241 0.607 0 C-N-CA 125.531 1.532 . . . . 1.55 112.738 -178.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . -178.83 -138.4 3.18 Favored Glycine 0 N--CA 1.425 -2.054 0 N-CA-C 110.505 -1.038 . . . . 0.93000000000000005 110.505 -175.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -66.77 3.31 1.55 Allowed 'Trans proline' 0 N--CA 1.487 1.106 0 C-N-CA 123.516 2.81 . . . . 0.88 115.463 -175.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1621 ' ' THR . . . . . 0.526 ' HB ' ' HB2' ' A' 1641 ' ' HIS . 23.0 p -105.62 -4.52 21.01 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.657 0.741 . . . . 0.96999999999999997 110.053 176.392 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 47.0 t30 -92.81 51.72 1.75 Allowed 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 123.215 1.483 . . . . 0.71999999999999997 108.219 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1623 ' ' ARG . . . . . 0.493 ' O ' ' HG3' ' A' 1625 ' ' MET . 4.7 ptp180 -150.81 141.56 14.75 Favored Pre-proline 0 C--N 1.294 -1.819 0 N-CA-C 105.777 -1.934 . . . . 3.2599999999999998 105.777 -176.425 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -57.0 106.77 0.24 Allowed 'Trans proline' 0 C--O 1.245 0.83 0 C-N-CA 122.374 2.049 . . . . 0.58999999999999997 111.121 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1625 ' ' MET . . . . . 0.493 ' HG3' ' O ' ' A' 1623 ' ' ARG . 93.5 mtp -100.13 128.56 46.19 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 109.051 -0.722 . . . . 1.3700000000000001 109.051 -176.319 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 1.8 tm? -87.1 112.51 21.98 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 106.741 -1.577 . . . . 0.89000000000000001 106.741 -178.419 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1627 ' ' ILE . . . . . 0.764 HD11 ' HB2' ' A' 1639 ' ' SER . 39.3 mm -72.13 -55.24 14.01 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.613 0 N-CA-C 108.351 -0.981 . . . . 0.57999999999999996 108.351 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 22.4 t -179.18 173.99 1.09 Allowed 'General case' 0 N--CA 1.422 -1.833 0 N-CA-C 106.286 -1.746 . . . . 1.3899999999999999 106.286 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1629 ' ' LEU . . . . . 0.78 ' HG ' ' HG ' ' A' 1636 ' ' LEU . 3.8 tt -122.07 110.72 16.13 Favored 'General case' 0 N--CA 1.409 -2.51 0 N-CA-C 104.582 -2.377 . . . . 1.25 104.582 177.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 13.1 t70 -69.21 87.14 0.41 Allowed 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 107.728 -1.212 . . . . 1.0900000000000001 107.728 176.498 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1631 ' ' LYS . . . . . 0.618 ' HD2' ' H ' ' A' 1631 ' ' LYS . 0.0 OUTLIER -54.96 -20.71 9.66 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.32 1.048 . . . . 3.6000000000000001 113.116 -179.278 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A 1632 ' ' GLN . . . . . 0.415 ' HA ' ' NZ ' ' A' 1601 ' ' LYS . 0.3 OUTLIER -71.5 -45.68 61.81 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.441 -0.577 . . . . 2.6000000000000001 109.441 -177.954 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 44.5 p -102.01 -5.21 24.87 Favored 'General case' 0 CA--C 1.557 1.212 0 N-CA-C 112.928 0.714 . . . . 0.75 112.928 -177.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 58.1 m 65.88 35.67 6.47 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.126 0.97 . . . . 0.53000000000000003 109.767 -176.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1635 ' ' THR . . . . . 0.5 HG23 ' HD2' ' A' 1607 ' ' LYS . 86.1 m -100.96 129.04 46.75 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.662 -1.154 . . . . 0.46000000000000002 110.211 -177.636 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1636 ' ' LEU . . . . . 0.78 ' HG ' ' HG ' ' A' 1629 ' ' LEU . 1.1 mp -107.97 122.36 46.67 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.837 -0.801 . . . . 0.85999999999999999 108.837 -179.268 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -100.91 130.01 46.85 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 116.353 -0.385 . . . . 0.45000000000000001 111.267 -178.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -127.97 130.63 48.7 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.789 -0.641 . . . . 0.5 109.478 -179.186 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1639 ' ' SER . . . . . 0.764 ' HB2' HD11 ' A' 1627 ' ' ILE . 10.1 t -106.61 156.67 18.35 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.821 -1.178 . . . . 1.04 107.821 178.268 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 2.0 t90 -156.14 108.62 2.6 Favored 'General case' 0 N--CA 1.423 -1.816 0 N-CA-C 105.689 -1.967 . . . . 0.68000000000000005 105.689 178.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1641 ' ' HIS . . . . . 0.526 ' HB2' ' HB ' ' A' 1621 ' ' THR . 59.1 m-70 -101.75 102.74 13.42 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 110.018 -0.364 . . . . 0.90000000000000002 110.018 -175.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1642 ' ' THR . . . . . . . . . . . . . 3.6 t -132.69 149.78 73.94 Favored Pre-proline 0 C--N 1.299 -1.627 0 CA-C-N 115.357 -0.838 . . . . 0.47999999999999998 109.834 -173.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1643 ' ' PRO . . . . . 0.757 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 71.6 Cg_endo -79.72 -0.12 10.45 Favored 'Trans proline' 0 C--N 1.365 1.4 0 C-N-CA 122.461 2.108 . . . . 0.66000000000000003 112.139 176.378 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 11.5 tp -67.12 -28.75 68.4 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.916 0.865 . . . . 0.96999999999999997 109.038 175.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -89.61 15.61 9.21 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 114.892 -1.049 . . . . 0.83999999999999997 110.502 -178.185 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1646 ' ' CYS . . . . . 0.537 ' SG ' ' HA ' ' A' 1643 ' ' PRO . 39.9 m -118.67 146.32 44.79 Favored 'General case' 0 N--CA 1.419 -1.985 0 N-CA-C 106.991 -1.485 . . . . 1.1899999999999999 106.991 178.252 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.06 115.1 50.79 Favored Pre-proline 0 C--N 1.305 -1.343 0 C-N-CA 119.884 -0.727 . . . . 3.1400000000000001 109.813 177.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1648 ' ' PRO . . . . . 0.507 ' O ' ' HB2' ' A' 1649 ' ' GLU . 72.7 Cg_endo -80.03 95.65 1.02 Allowed 'Trans proline' 0 C--O 1.253 1.263 0 C-N-CA 121.947 1.765 . . . . 2.5800000000000001 112.293 -179.25 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1649 ' ' GLU . . . . . 0.507 ' HB2' ' O ' ' A' 1648 ' ' PRO . 0.5 OUTLIER . . . . . 0 C--O 1.243 0.745 0 N-CA-C 105.07 -2.196 . . . . 4.7199999999999998 105.07 177.527 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.619 0 N-CA-C 108.791 -0.818 . . . . 9.9700000000000006 108.791 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 2' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -116.72 131.62 56.9 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 115.227 -0.897 . . . . 7.6799999999999997 108.631 -176.312 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -104.99 144.91 29.7 Favored Pre-proline 0 C--N 1.283 -2.321 0 N-CA-C 108.538 -0.912 . . . . 6.1100000000000003 108.538 178.48 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -75.21 51.81 2.96 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.975 2.45 . . . . 4.8399999999999999 111.258 178.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 14.5 m -132.28 72.43 1.49 Allowed 'General case' 0 N--CA 1.411 -2.387 0 CA-C-N 113.932 -1.485 . . . . 4.5999999999999996 107.956 -178.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 6' ' ' GLU . . . . . 0.438 ' O ' ' HA ' ' A' 1599 ' ' PRO . 3.2 mp0 -68.24 -35.54 78.09 Favored 'General case' 0 CA--C 1.497 -1.086 0 N-CA-C 107.645 -1.242 . . . . 4.2300000000000004 107.645 174.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 7' ' ' THR . . . . . 0.867 HG21 ' H ' ' B' ' 51' ' ' CYS . 19.5 p -88.62 99.67 12.5 Favored 'General case' 0 C--N 1.285 -2.233 0 CA-C-N 113.909 -1.496 . . . . 3.1400000000000001 109.542 177.448 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.49 ' CB ' ' HG3' ' B' ' 12' ' ' GLU . 6.9 mp -84.01 162.67 20.31 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 121.03 0.443 . . . . 3.96 110.525 179.608 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 32.3 t -118.15 163.24 16.94 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 109.249 -0.648 . . . . 2.8399999999999999 109.249 -173.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.29 -128.8 9.26 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 121.032 -0.604 . . . . 2.0899999999999999 112.861 177.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.12 -23.92 64.55 Favored Glycine 0 C--O 1.223 -0.562 0 N-CA-C 114.143 0.417 . . . . 1.8400000000000001 114.143 -175.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 12' ' ' GLU . . . . . 0.49 ' HG3' ' CB ' ' B' ' 8' ' ' LEU . 49.9 mm-40 -67.0 -37.84 84.94 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.428 0.633 . . . . 2.5499999999999998 109.725 179.552 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 13' ' ' LEU . . . . . 0.419 ' HG ' ' HA ' ' B' ' 43' ' ' VAL . 0.1 OUTLIER -68.2 -49.77 58.64 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 115.227 -0.897 . . . . 2.3500000000000001 109.613 -177.776 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 8.2 p -67.41 -32.46 57.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 C-N-CA 119.961 -0.695 . . . . 2.1099999999999999 111.273 179.167 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -70.9 -40.05 72.41 Favored 'General case' 0 C--O 1.212 -0.896 0 C-N-CA 119.219 -0.992 . . . . 2.04 112.785 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 16.5 p -63.82 -40.75 97.36 Favored 'General case' 0 C--O 1.265 1.917 0 CA-C-N 118.444 0.566 . . . . 1.8400000000000001 110.052 177.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.542 HD21 HD11 ' B' ' 42' ' ' ILE . 3.9 mm? -53.34 -53.86 44.83 Favored 'General case' 0 C--O 1.211 -0.929 0 CA-C-N 115.26 -0.882 . . . . 1.74 110.574 171.277 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 18' ' ' GLN . . . . . 0.525 HE21 ' H ' ' A' 1544 ' ' LYS . 9.9 tm0? -68.89 -20.97 64.26 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 113.001 0.741 . . . . 2.3900000000000001 113.001 -179.137 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -59.86 -62.67 1.7 Allowed 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 120.927 0.394 . . . . 0.95999999999999996 110.665 178.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 14.1 p -92.56 -26.09 4.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 C-N-CA 119.119 -1.032 . . . . 1.3700000000000001 111.33 -177.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 21' ' ' CYS . . . . . 0.443 ' HB2' ' O ' ' B' ' 17' ' ' LEU . 62.6 m -95.98 12.1 31.64 Favored 'General case' 0 N--CA 1.437 -1.111 0 C-N-CA 120.326 -0.55 . . . . 1.6599999999999999 111.594 -177.591 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -56.7 -47.47 84.95 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 111.715 -0.554 . . . . 1.53 111.715 173.1 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -72.24 -14.4 61.77 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 122.816 0.447 . . . . 2.7200000000000002 111.624 175.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 12.3 tpp180 -100.21 -60.04 1.6 Allowed 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.831 0.824 . . . . 4.3300000000000001 112.649 -171.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 131.5 152.4 7.21 Favored Glycine 0 N--CA 1.423 -2.232 0 N-CA-C 105.856 -2.897 . . . . 1.53 105.856 -171.306 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -142.57 141.1 31.95 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 118.832 1.316 . . . . 1.6499999999999999 111.59 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 27' ' ' TYR . . . . . 0.433 ' HE1' ' HD3' ' B' ' 30' ' ' ARG . 49.3 p90 -161.87 134.61 5.99 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 108.12 -1.067 . . . . 3.4199999999999999 108.12 175.174 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 28' ' ' PHE . . . . . 0.434 ' CD1' ' HG ' ' B' ' 17' ' ' LEU . 24.2 p90 -151.25 39.84 0.68 Allowed 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 122.105 0.955 . . . . 2.2599999999999998 110.503 -177.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 29' ' ' SER . . . . . 0.497 ' HA ' ' HA ' ' B' ' 40' ' ' ARG . 54.5 m -143.52 66.07 1.31 Allowed 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.696 -0.628 . . . . 3.6800000000000002 110.633 177.34 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 30' ' ' ARG . . . . . 0.433 ' HD3' ' HE1' ' B' ' 27' ' ' TYR . 82.8 mtm180 -99.38 108.23 49.21 Favored Pre-proline 0 C--N 1.311 -1.094 0 N-CA-C 106.973 -1.491 . . . . 3.8100000000000001 106.973 178.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 31' ' ' PRO . . . . . 0.663 ' HB3' ' HA ' ' B' ' 36' ' ' SER . 16.5 Cg_exo -69.12 -22.6 34.77 Favored 'Trans proline' 0 C--O 1.248 1.013 0 C-N-CA 122.511 2.141 . . . . 4.0199999999999996 113.723 -178.433 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . 62.91 18.23 10.65 Favored 'General case' 0 C--N 1.356 0.888 0 C-N-CA 125.324 1.45 . . . . 4.9199999999999999 112.693 176.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 33' ' ' SER . . . . . 0.456 ' O ' ' HB2' ' B' ' 31' ' ' PRO . 47.3 t 171.64 155.49 0.08 Allowed 'General case' 0 N--CA 1.413 -2.303 0 N-CA-C 104.016 -2.587 . . . . 6.7199999999999998 104.016 -178.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -84.83 1.85 45.07 Favored 'General case' 0 C--N 1.278 -2.519 0 CA-C-O 122.176 0.988 . . . . 11.630000000000001 108.833 -178.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 23.9 t -87.2 -10.88 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-O 122.406 1.098 . . . . 9.6099999999999994 108.742 173.371 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 36' ' ' SER . . . . . 0.663 ' HA ' ' HB3' ' B' ' 31' ' ' PRO . 16.7 t 65.34 41.54 4.28 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 113.951 -1.477 . . . . 6.71 109.873 176.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 32.5 mmt180 -42.55 -55.25 3.58 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 113.611 -1.631 . . . . 10.0 109.554 173.349 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 38' ' ' ARG . . . . . 0.583 ' O ' ' HA ' ' B' ' 31' ' ' PRO . 84.0 mtt180 -84.69 102.09 12.69 Favored 'General case' 0 N--CA 1.414 -2.254 0 N-CA-C 107.204 -1.406 . . . . 7.9400000000000004 107.204 171.563 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 25.5 m -81.75 75.4 8.7 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 108.991 -0.744 . . . . 5.7599999999999998 108.991 177.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 40' ' ' ARG . . . . . 0.497 ' HA ' ' HA ' ' B' ' 29' ' ' SER . 71.7 mtp180 65.15 169.55 0.2 Allowed 'General case' 0 CA--C 1.559 1.299 0 C-N-CA 126.101 1.761 . . . . 6.0300000000000002 110.587 -176.47 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . -128.52 150.57 18.64 Favored Glycine 0 N--CA 1.418 -2.565 0 N-CA-C 110.279 -1.128 . . . . 2.3700000000000001 110.279 -178.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 42' ' ' ILE . . . . . 0.542 HD11 HD21 ' B' ' 17' ' ' LEU 0.255 11.8 pt 60.52 -33.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 128.421 2.689 . . . . 2.0699999999999998 115.346 179.155 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.656 ' O ' ' HB2' ' B' ' 47' ' ' CYS . 6.8 p -56.03 -44.2 77.75 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.452 0 N-CA-C 113.2 0.815 . . . . 2.2400000000000002 113.2 -178.774 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -94.73 -31.21 13.89 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.321 -0.992 . . . . 3.3599999999999999 108.321 -173.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 45' ' ' GLU . . . . . 0.515 ' O ' ' HB2' ' B' ' 49' ' ' ARG . 28.7 tt0 -67.57 -13.4 62.03 Favored 'General case' 0 CA--C 1.555 1.14 0 CA-C-N 114.728 -1.124 . . . . 3.0800000000000001 109.924 177.329 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 46' ' ' CYS . . . . . 0.425 ' SG ' ' HB ' ' B' ' 7' ' ' THR . 45.5 t -117.86 -14.19 10.08 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-O 121.397 0.618 . . . . 2.23 110.165 174.554 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 47' ' ' CYS . . . . . 0.656 ' HB2' ' O ' ' B' ' 43' ' ' VAL . 27.3 t -70.04 -44.55 68.99 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.967 -0.383 . . . . 2.3700000000000001 109.967 -177.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -119.65 23.3 11.23 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.422 -0.354 . . . . 2.8199999999999998 110.712 -178.138 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 49' ' ' ARG . . . . . 0.515 ' HB2' ' O ' ' B' ' 45' ' ' GLU . 68.4 mtt180 -145.36 162.38 37.4 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 108.393 -0.965 . . . . 4.0899999999999999 108.393 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 22.4 t -85.18 109.16 18.1 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 106.523 -1.658 . . . . 2.6699999999999999 106.523 173.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 51' ' ' CYS . . . . . 0.867 ' H ' HG21 ' B' ' 7' ' ' THR . 15.8 p -101.67 144.89 29.83 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 108.001 -1.111 . . . . 2.1099999999999999 108.001 -176.575 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -93.13 144.61 25.1 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.419 0.628 . . . . 2.6699999999999999 109.434 177.403 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 53' ' ' LEU . . . . . 0.757 ' HB3' ' HE3' ' A' 1601 ' ' LYS . 48.8 tp -58.46 -27.88 64.8 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.098 1.359 . . . . 1.8999999999999999 111.363 -179.027 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.32 -39.23 75.4 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.425 -0.807 . . . . 1.52 111.122 178.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 31.3 tp -56.38 -54.63 43.29 Favored 'General case' 0 CA--C 1.516 -0.331 0 O-C-N 124.272 0.983 . . . . 1.97 111.323 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 2.4 pp -73.85 -28.53 61.64 Favored 'General case' 0 N--CA 1.427 -1.61 0 C-N-CA 121.099 -0.24 . . . . 1.53 111.427 -176.423 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -63.5 -50.47 69.5 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 123.512 0.507 . . . . 2.27 110.711 177.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 14.6 t -80.11 -7.91 59.13 Favored 'General case' 0 CA--C 1.557 1.224 0 CA-C-O 121.092 0.473 . . . . 2.3300000000000001 111.076 -179.177 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 59' ' ' TYR . . . . . 0.405 ' HB3' ' H ' ' B' ' 60' ' ' CYS . 15.3 t80 -89.07 -80.13 0.3 Allowed 'General case' 0 N--CA 1.42 -1.973 0 N-CA-C 106.891 -1.522 . . . . 2.8599999999999999 106.891 176.076 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 60' ' ' CYS . . . . . 0.405 ' H ' ' HB3' ' B' ' 59' ' ' TYR . 43.5 t 47.59 -79.62 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 126.067 1.747 . . . . 2.2999999999999998 113.869 -178.508 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -162.65 -45.74 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 105.759 -1.941 . . . . 3.1899999999999999 105.759 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 2.1 p -133.03 135.19 25.39 Favored Pre-proline 0 N--CA 1.403 -2.806 0 CA-C-N 112.731 -2.031 . . . . 3.6800000000000002 106.604 175.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -69.05 -31.35 23.87 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 123.141 2.561 . . . . 5.0800000000000001 116.939 -170.244 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -150.91 73.74 1.13 Allowed 'General case' 0 C--N 1.294 -1.831 0 C-N-CA 120.312 -0.555 . . . . 5.0999999999999996 112.026 -178.418 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -98.56 -7.83 27.54 Favored 'General case' 0 N--CA 1.427 -1.587 0 C-N-CA 120.711 -0.396 . . . . 8.5099999999999998 111.305 175.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 19.9 m -60.12 -44.17 95.08 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.543 -0.91 . . . . 8.1199999999999992 108.543 175.244 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 . . . . . 0 N--CA 1.428 -1.572 0 N-CA-C 106.903 -1.517 . . . . 10.210000000000001 106.903 176.921 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 64.9 mtm . . . . . 0 CA--C 1.511 -0.543 0 N-CA-C 108.379 -0.971 . . . . 9.3399999999999999 108.379 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A 1509 ' ' LYS . . . . . 0.914 ' HD2' ' HB2' ' A' 1514 ' ' ASP . 3.3 mmmp? 77.01 -29.13 0.17 Allowed 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 125.16 1.384 . . . . 9.0399999999999991 113.956 175.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 15.3 m -98.29 3.16 48.72 Favored 'General case' 0 C--N 1.277 -2.571 0 CA-C-N 115.586 -0.734 . . . . 5.8099999999999996 110.745 -177.385 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1511 ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -93.33 -55.48 3.29 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 116.216 -0.447 . . . . 3.4199999999999999 110.717 -178.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1512 ' ' GLU . . . . . 0.581 ' HG2' ' HA ' ' A' 1518 ' ' VAL . 0.7 OUTLIER -106.2 -60.19 1.68 Allowed 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 122.248 1.023 . . . . 5.9500000000000002 109.361 176.746 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 11.9 t-160 160.12 -28.74 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.896 0 C-N-CA 128.287 2.635 . . . . 5.3300000000000001 104.225 -172.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1514 ' ' ASP . . . . . 0.914 ' HB2' ' HD2' ' A' 1509 ' ' LYS . 0.7 OUTLIER 56.06 42.1 28.84 Favored 'General case' 0 CA--C 1.507 -0.694 0 C-N-CA 128.332 2.653 . . . . 5.0599999999999996 111.932 172.654 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 13.3 t70 -102.76 70.3 1.11 Allowed 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.126 -0.943 . . . . 2.8999999999999999 109.448 -176.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1516 ' ' CYS . . . . . 0.692 ' HA ' HD23 ' A' 1581 ' ' LEU . 96.0 m 62.35 20.86 12.13 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.756 0.822 . . . . 1.1899999999999999 112.952 -176.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -155.8 130.83 9.31 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 108.404 -0.961 . . . . 1.52 108.404 177.099 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1518 ' ' VAL . . . . . 0.581 ' HA ' ' HG2' ' A' 1512 ' ' GLU . 0.5 OUTLIER -144.14 145.58 21.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 C-N-CA 123.575 0.75 . . . . 0.93999999999999995 110.066 -178.706 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A 1519 ' ' THR . . . . . 0.407 ' H ' ' HG2' ' A' 1512 ' ' GLU . 27.1 m -114.48 142.49 46.32 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 109.86 -0.422 . . . . 0.89000000000000001 109.86 -179.615 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1520 ' ' ASN . . . . . 0.489 ' OD1' HG22 ' A' 1523 ' ' THR . 18.1 t-20 -87.68 113.36 54.06 Favored Pre-proline 0 C--N 1.307 -1.257 0 N-CA-C 107.632 -1.248 . . . . 1.74 107.632 171.577 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -69.44 -7.49 21.09 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.949 2.433 . . . . 1.5800000000000001 113.351 -174.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1522 ' ' SER . . . . . 0.455 ' HB2' ' OD1' ' A' 1520 ' ' ASN . 42.9 m -79.26 -45.98 18.7 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 121.116 -0.234 . . . . 1.6499999999999999 110.95 178.517 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1523 ' ' THR . . . . . 0.489 HG22 ' OD1' ' A' 1520 ' ' ASN . 7.7 t -111.0 -15.37 13.76 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 120.358 -0.537 . . . . 1.6100000000000001 112.3 -176.19 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 83.52 25.82 45.4 Favored Glycine 0 C--O 1.225 -0.457 0 C-N-CA 121.041 -0.6 . . . . 1.1299999999999999 113.195 176.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -92.81 125.14 37.27 Favored 'General case' 0 C--N 1.309 -1.158 0 C-N-CA 120.589 -0.445 . . . . 1.26 110.074 -178.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 2.7 tm? -94.91 116.62 28.94 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 124.071 0.948 . . . . 0.68000000000000005 109.447 -178.179 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -92.54 131.39 37.7 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 120.22 -0.592 . . . . 0.65000000000000002 109.976 173.048 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 17.3 t70 -120.13 121.06 37.98 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.589 -0.893 . . . . 1.1699999999999999 108.589 174.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1529 ' ' LEU . . . . . 0.578 ' HG ' HD21 ' A' 1581 ' ' LEU . 3.1 mm? -100.98 5.82 43.29 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 121.332 0.587 . . . . 0.59999999999999998 110.509 -176.19 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 2.4 m -73.45 -24.75 60.27 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.715 -0.675 . . . . 0.83999999999999997 110.235 -178.221 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 23.0 t -66.7 -28.75 68.69 Favored 'General case' 0 CA--C 1.555 1.149 0 CA-C-O 121.366 0.603 . . . . 1.5900000000000001 110.38 178.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1532 ' ' LEU . . . . . 0.482 ' HG ' HD21 ' A' 1644 ' ' LEU . 95.5 mt -90.92 3.19 55.26 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.071 0.462 . . . . 0.65000000000000002 110.925 178.177 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1533 ' ' SER . . . . . . . . . . . . . 13.1 t -80.91 176.49 9.77 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.496 0.665 . . . . 1.52 109.622 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . 150.79 153.77 6.26 Favored Glycine 0 N--CA 1.423 -2.195 0 N-CA-C 110.998 -0.841 . . . . 1.1000000000000001 110.998 -176.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -78.71 -31.97 46.68 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 121.016 0.436 . . . . 4.6200000000000001 110.604 -178.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -78.11 -29.5 48.97 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.211 0.529 . . . . 1.45 110.723 -179.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 74.34 -141.52 28.98 Favored Glycine 0 N--CA 1.426 -2.028 0 C-N-CA 120.871 -0.681 . . . . 0.84999999999999998 112.232 177.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -145.18 144.99 31.16 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.82 -1.178 . . . . 0.93000000000000005 107.82 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 2.6 m -106.62 133.37 51.4 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.317 0.58 . . . . 1.03 110.193 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1540 ' ' ALA . . . . . 0.69 ' HB2' ' HG2' ' A' 1624 ' ' PRO . . . -127.13 140.84 51.98 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.606 -0.887 . . . . 0.5 108.606 178.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -84.08 142.79 30.16 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 123.518 0.511 . . . . 0.73999999999999999 110.631 -179.168 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1542 ' ' TYR . . . . . 0.458 ' HD2' ' HE1' ' A' 1567 ' ' PHE . 0.3 OUTLIER -129.53 -101.8 0.32 Allowed 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 107.899 -1.149 . . . . 0.98999999999999999 107.899 177.713 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A 1543 ' ' SER . . . . . . . . . . . . . 12.5 t -75.2 178.25 5.89 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 109.869 -0.419 . . . . 1.9099999999999999 109.869 178.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 60.7 tttp -52.61 -44.13 65.8 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.804 0.841 . . . . 3.5899999999999999 113.235 -173.177 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 11.1 t -123.01 32.33 5.73 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 107.329 -1.36 . . . . 2.46 107.329 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . -126.6 111.23 1.36 Allowed Glycine 0 N--CA 1.43 -1.707 0 CA-C-N 115.114 -0.948 . . . . 1.26 113.133 -174.04 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 20.4 m -110.31 157.45 10.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 N-CA-C 108.331 -0.988 . . . . 0.79000000000000004 108.331 175.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1548 ' ' VAL . . . . . 0.527 ' HA ' ' HA ' ' A' 1567 ' ' PHE . 10.2 p -114.68 132.28 64.3 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 N-CA-C 109.369 -0.604 . . . . 0.57999999999999996 109.369 177.13 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -101.1 117.51 35.16 Favored 'General case' 0 CA--C 1.488 -1.405 0 N-CA-C 108.714 -0.847 . . . . 1.0800000000000001 108.714 178.283 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 13.0 ptp -129.53 139.41 51.54 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-N 115.824 -0.626 . . . . 0.78000000000000003 110.402 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 7.1 p -117.48 120.61 38.63 Favored 'General case' 0 C--N 1.274 -2.678 0 CA-C-N 115.016 -0.993 . . . . 0.96999999999999997 108.459 176.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1552 ' ' ILE . . . . . 0.423 ' HB ' ' O ' ' A' 1532 ' ' LEU . 38.6 mm -77.5 120.85 28.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 C-N-CA 120.672 -0.411 . . . . 0.41999999999999998 110.571 -177.264 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 38.1 t 67.61 39.43 2.78 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 122.282 1.039 . . . . 1.3999999999999999 109.314 174.03 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 176.86 -169.86 42.4 Favored Glycine 0 N--CA 1.422 -2.288 0 C-N-CA 120.436 -0.888 . . . . 0.34999999999999998 111.258 -178.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -113.53 151.5 31.48 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 120.967 0.413 . . . . 1.6200000000000001 111.53 -176.245 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -99.23 146.38 26.25 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 114.676 -1.147 . . . . 0.87 109.107 -176.313 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -92.45 4.94 52.47 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 112.374 0.509 . . . . 2.4900000000000002 112.374 -170.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -93.63 -7.77 42.97 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 121.594 -0.691 . . . . 1.3799999999999999 111.655 -179.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1559 ' ' CYS . . . . . 0.441 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 78.7 m -136.6 165.96 31.29 Favored Pre-proline 0 C--N 1.297 -1.682 0 CA-C-O 118.398 -0.811 . . . . 1.21 109.849 -178.166 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1560 ' ' PRO . . . . . 0.441 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 7.7 Cg_exo -36.5 118.57 0.2 Allowed 'Trans proline' 0 C--N 1.367 1.518 0 C-N-CA 124.561 3.508 . . . . 0.70999999999999996 113.951 176.626 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -44.74 130.66 9.89 Favored 'Trans proline' 0 C--N 1.362 1.255 0 C-N-CA 124.59 3.527 . . . . 0.80000000000000004 112.18 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 111.79 -6.69 27.7 Favored Glycine 0 N--CA 1.435 -1.408 0 CA-C-N 115.906 -0.588 . . . . 0.46000000000000002 112.404 -177.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1563 ' ' VAL . . . . . . . . . . . . . 7.5 p -105.27 137.19 35.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 O-C-N 122.109 -0.642 . . . . 0.97999999999999998 111.496 -178.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -99.54 -32.68 5.63 Favored Glycine 0 C--N 1.322 -0.241 0 CA-C-N 115.615 -0.72 . . . . 0.28000000000000003 112.771 -178.415 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -122.88 126.21 46.88 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 109.479 -0.563 . . . . 0.28000000000000003 109.479 178.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 46.5 t -153.73 148.38 26.32 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.842 -0.799 . . . . 0.42999999999999999 108.842 -179.105 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1567 ' ' PHE . . . . . 0.637 ' HB2' ' OG1' ' A' 1570 ' ' THR . 96.7 m-85 -92.11 158.78 16.01 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 119.732 -0.787 . . . . 1.03 109.548 176.362 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -62.6 -75.92 0.29 Allowed Glycine 0 C--O 1.245 0.81 0 N-CA-C 115.183 0.833 . . . . 1.1299999999999999 115.183 -173.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -67.18 -34.48 77.62 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 113.159 0.799 . . . . 2.5800000000000001 113.159 -173.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1570 ' ' THR . . . . . 0.739 ' HB ' HG13 ' A' 1572 ' ' ILE . 45.9 p -67.81 -35.17 78.15 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 112.429 0.529 . . . . 2.1699999999999999 112.429 -177.019 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 18.1 mmt180 64.55 8.88 4.66 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.672 1.189 . . . . 2.6200000000000001 110.746 -174.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1572 ' ' ILE . . . . . 0.739 HG13 ' HB ' ' A' 1570 ' ' THR . 18.1 mt -74.61 127.29 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-O 121.301 0.572 . . . . 0.92000000000000004 111.438 -175.404 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 13.0 t -74.79 118.21 17.5 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 114.922 -1.035 . . . . 0.80000000000000004 108.656 177.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1574 ' ' VAL . . . . . 0.594 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 24.8 m -114.58 20.29 6.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 C-N-CA 119.738 -0.785 . . . . 0.97999999999999998 111.933 -179.168 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 161.44 119.75 0.52 Allowed Glycine 0 N--CA 1.432 -1.602 0 C-N-CA 120.327 -0.94 . . . . 0.28999999999999998 112.451 176.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 57.7 tttm -64.66 139.89 58.81 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.843 -0.429 . . . . 2.1899999999999999 109.843 178.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -71.73 144.34 49.31 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 115.477 -0.783 . . . . 0.60999999999999999 110.057 -179.268 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 22.2 p30 -161.31 179.01 8.66 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 107.853 -1.166 . . . . 1.95 107.853 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 17.7 pttm -134.04 46.53 2.51 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-O 122.941 1.353 . . . . 2.6800000000000002 108.784 177.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 64.7 ttt180 -101.48 99.88 10.26 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-N 113.383 -1.735 . . . . 3.4700000000000002 107.75 -175.083 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1581 ' ' LEU . . . . . 0.692 HD23 ' HA ' ' A' 1516 ' ' CYS . 0.3 OUTLIER -93.53 137.58 32.68 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.855 -0.795 . . . . 0.64000000000000001 108.855 -175.58 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 75.6 mtp180 -123.91 124.77 43.35 Favored 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 120.652 -0.419 . . . . 2.8500000000000001 111.045 171.162 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1583 ' ' TYR . . . . . 0.465 ' HB2' HG21 ' A' 1518 ' ' VAL . 71.1 t80 -96.31 112.78 24.4 Favored 'General case' 0 CA--C 1.49 -1.364 0 N-CA-C 107.239 -1.393 . . . . 0.85999999999999999 107.239 173.225 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1584 ' ' VAL . . . . . 0.553 ' O ' ' HB ' ' A' 1587 ' ' VAL . 20.3 t -128.39 92.33 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 N-CA-C 109.501 -0.555 . . . . 1.05 109.501 -178.411 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 32.6 t70 50.83 69.2 0.67 Allowed 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 124.905 1.282 . . . . 1.1699999999999999 112.041 175.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 9.2 pt20 71.37 -8.04 1.09 Allowed 'General case' 0 N--CA 1.504 2.271 0 C-N-CA 128.498 2.719 . . . . 1.8600000000000001 112.197 178.535 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1587 ' ' VAL . . . . . 0.553 ' HB ' ' O ' ' A' 1584 ' ' VAL . 13.8 t -91.68 120.31 40.54 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.23 0 CA-C-N 115.263 -0.881 . . . . 0.48999999999999999 110.106 178.146 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1588 ' ' LEU . . . . . 0.811 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 3.2 mm? -91.06 107.66 19.35 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 105.923 -1.88 . . . . 0.35999999999999999 105.923 174.49 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -111.08 131.07 55.38 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-O 121.694 0.759 . . . . 1.74 112.515 -173.077 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1590 ' ' LEU . . . . . 0.449 ' HB2' ' HB ' ' A' 1610 ' ' ILE . 15.0 mt -123.86 104.76 9.14 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 114.0 -1.455 . . . . 0.71999999999999997 107.699 173.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1591 ' ' VAL . . . . . 0.515 HG23 HG22 ' A' 1609 ' ' VAL . 6.3 p -97.53 128.57 48.72 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 N-CA-C 108.799 -0.815 . . . . 1.01 108.799 179.363 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1592 ' ' TYR . . . . . 0.506 ' O ' ' HA ' ' A' 1607 ' ' LYS . 15.9 m-30 -115.19 102.65 10.09 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.673 -0.862 . . . . 0.5 108.673 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 57.8 pttt -109.9 176.43 5.07 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.244 -0.65 . . . . 1.5900000000000001 109.244 -178.451 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 21.8 m-20 61.0 51.11 4.67 Favored 'General case' 0 C--N 1.312 -1.037 0 O-C-N 124.095 0.872 . . . . 1.1100000000000001 112.158 177.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -83.09 -134.51 2.28 Favored Glycine 0 N--CA 1.425 -2.098 0 N-CA-C 109.629 -1.389 . . . . 0.78000000000000003 109.629 172.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1596 ' ' SER . . . . . . . . . . . . . 29.9 p -100.33 157.96 32.85 Favored Pre-proline 0 C--N 1.29 -1.994 0 O-C-N 122.036 -0.685 . . . . 1.0700000000000001 109.648 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1597 ' ' PRO . . . . . 0.508 ' HA ' ' O ' ' A' 1604 ' ' LEU . 73.4 Cg_exo -52.01 123.6 12.86 Favored 'Trans proline' 0 C--N 1.36 1.167 0 C-N-CA 123.059 2.506 . . . . 1.01 112.234 177.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1598 ' ' CYS . . . . . 0.621 ' HA ' ' CE1' ' A' 1606 ' ' TYR . 43.7 t -77.94 117.84 68.42 Favored Pre-proline 0 C--N 1.299 -1.627 0 CA-C-N 114.959 -1.018 . . . . 0.75 109.659 -178.634 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -63.93 -30.31 67.23 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.914 2.409 . . . . 1.7 111.855 178.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1600 ' ' SER . . . . . 0.64 ' HA ' ' HB2' ' B' ' 53' ' ' LEU . 14.4 m -61.65 -49.27 77.23 Favored 'General case' 0 C--O 1.25 1.083 0 CA-C-N 116.009 -0.542 . . . . 2.2599999999999998 110.852 178.264 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1601 ' ' LYS . . . . . 0.686 ' HG2' HD22 ' A' 1604 ' ' LEU . 0.6 OUTLIER -120.81 98.49 6.03 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 107.114 -1.439 . . . . 3.0099999999999998 107.114 -178.958 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 19.3 m -57.96 119.32 6.55 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 113.822 1.045 . . . . 2.0699999999999998 113.822 -171.323 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 98.96 -8.45 61.19 Favored Glycine 0 CA--C 1.499 -0.964 0 N-CA-C 111.595 -0.602 . . . . 1.0800000000000001 111.595 177.056 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1604 ' ' LEU . . . . . 0.686 HD22 ' HG2' ' A' 1601 ' ' LYS . 8.8 tp -90.97 170.98 9.6 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.735 -1.209 . . . . 1.8400000000000001 107.735 -179.222 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 32.5 t -130.48 150.93 51.47 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 108.644 -0.873 . . . . 1.4099999999999999 108.644 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1606 ' ' TYR . . . . . 0.621 ' CE1' ' HA ' ' A' 1598 ' ' CYS . 57.8 m-85 -71.48 157.76 37.46 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.744 -0.662 . . . . 0.59999999999999998 110.856 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1607 ' ' LYS . . . . . 0.506 ' HA ' ' O ' ' A' 1592 ' ' TYR . 75.7 tttt -157.39 125.44 5.47 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 109.21 -0.663 . . . . 1.45 109.21 -173.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1608 ' ' SER . . . . . . . . . . . . . 28.5 m -112.48 132.05 55.26 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-N 116.278 -0.419 . . . . 1.1499999999999999 109.933 -178.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1609 ' ' VAL . . . . . 0.515 HG22 HG23 ' A' 1591 ' ' VAL . 39.8 t -109.35 108.59 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.507 0 N-CA-C 108.448 -0.945 . . . . 0.25 108.448 177.624 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1610 ' ' ILE . . . . . 0.449 ' HB ' ' HB2' ' A' 1590 ' ' LEU . 68.7 mt -95.24 126.66 47.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 N-CA-C 108.06 -1.089 . . . . 0.45000000000000001 108.06 179.5 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 23.4 m -127.26 118.47 24.3 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 116.138 -0.483 . . . . 1.26 110.911 -178.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1612 ' ' PHE . . . . . 0.811 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 70.0 m-85 -95.55 128.02 42.07 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.912 -0.585 . . . . 0.26000000000000001 109.596 177.73 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1613 ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' 1641 ' ' HIS . 66.2 t -122.7 138.84 51.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 CA-C-N 115.402 -0.817 . . . . 0.5 109.443 -177.386 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1614 ' ' CYS . . . . . 0.71 ' HB2' ' HA ' ' A' 1646 ' ' CYS . 4.0 t -52.07 119.82 4.75 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 124.352 1.061 . . . . 0.77000000000000002 113.169 176.394 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1615 ' ' ARG . . . . . 0.824 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 22.2 tpt180 -135.29 89.66 22.63 Favored Pre-proline 0 N--CA 1.439 -0.993 0 N-CA-C 107.739 -1.208 . . . . 2.5299999999999998 107.739 170.09 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1616 ' ' PRO . . . . . 0.572 ' HD3' ' SG ' ' A' 1614 ' ' CYS . 51.3 Cg_endo -68.94 -23.06 35.06 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.195 1.93 . . . . 1.1000000000000001 113.425 -172.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -94.86 -3.56 48.61 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.527 -0.306 . . . . 3.0499999999999998 111.051 -179.079 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . 59.51 -165.85 0.19 Allowed 'General case' 0 CA--C 1.554 1.108 0 N-CA-C 109.455 -0.572 . . . . 1.55 109.455 -173.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . 135.3 -163.54 24.88 Favored Glycine 0 N--CA 1.415 -2.739 0 C-N-CA 120.961 -0.637 . . . . 0.93000000000000005 112.403 174.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -61.3 -8.24 10.02 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 124.243 3.295 . . . . 0.88 115.069 -177.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1621 ' ' THR . . . . . . . . . . . . . 19.0 p -96.43 -0.65 48.9 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-O 121.199 0.523 . . . . 0.96999999999999997 111.369 -177.162 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 41.4 t30 -87.25 63.43 7.79 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 122.243 1.02 . . . . 0.71999999999999997 109.059 178.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 -172.76 140.07 0.95 Allowed Pre-proline 0 C--N 1.304 -1.387 0 N-CA-C 107.443 -1.318 . . . . 3.2599999999999998 107.443 -177.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1624 ' ' PRO . . . . . 0.69 ' HG2' ' HB2' ' A' 1540 ' ' ALA . 35.1 Cg_endo -64.08 99.72 0.29 Allowed 'Trans proline' 0 C--O 1.246 0.917 0 C-N-CA 122.859 2.372 . . . . 0.58999999999999997 112.355 -176.243 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 70.7 mtm -98.07 133.49 42.45 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.99 -0.55 . . . . 1.3700000000000001 110.703 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 1.4 tm? -74.58 116.62 15.48 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 108.15 -1.056 . . . . 0.89000000000000001 108.15 -178.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1627 ' ' ILE . . . . . 0.505 HD11 ' HB2' ' A' 1639 ' ' SER . 43.1 mm -79.56 -55.63 8.83 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 N-CA-C 108.378 -0.971 . . . . 0.57999999999999996 108.378 177.41 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 77.9 p -164.72 150.27 10.03 Favored 'General case' 0 N--CA 1.419 -1.982 0 CA-C-N 114.833 -1.076 . . . . 1.3899999999999999 109.537 -179.304 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1629 ' ' LEU . . . . . 0.865 HD13 ' HG ' ' A' 1636 ' ' LEU . 27.8 tp -119.14 112.31 19.36 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 106.885 -1.524 . . . . 1.25 106.885 172.188 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 33.1 t70 -78.4 128.86 34.24 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 117.549 -1.661 . . . . 1.0900000000000001 111.628 177.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1631 ' ' LYS . . . . . 0.513 ' HD3' ' H ' ' A' 1631 ' ' LYS . 0.1 OUTLIER -66.05 -28.96 69.24 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 112.726 -2.034 . . . . 3.6000000000000001 113.108 -175.564 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 60.5 mm-40 -103.0 -35.44 8.55 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 119.918 -0.713 . . . . 2.6000000000000001 112.134 -174.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 73.9 p -91.99 -6.59 50.92 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-O 120.8 0.333 . . . . 0.75 111.605 -178.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 64.1 m 54.06 33.51 17.83 Favored 'General case' 0 C--N 1.362 1.147 0 C-N-CA 124.669 1.187 . . . . 0.53000000000000003 111.898 176.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1635 ' ' THR . . . . . . . . . . . . . 29.2 m -100.53 132.1 46.09 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 115.624 -0.716 . . . . 0.46000000000000002 109.37 -178.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1636 ' ' LEU . . . . . 0.865 ' HG ' HD13 ' A' 1629 ' ' LEU . 0.6 OUTLIER -111.08 124.11 51.54 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 107.919 -1.141 . . . . 0.85999999999999999 107.919 -177.604 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -106.5 129.38 54.47 Favored 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 120.997 -0.281 . . . . 0.45000000000000001 110.494 -179.238 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -125.36 134.9 52.01 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.197 -0.456 . . . . 0.5 110.269 -178.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1639 ' ' SER . . . . . 0.505 ' HB2' HD11 ' A' 1627 ' ' ILE . 31.0 t -110.29 148.81 31.18 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 107.663 -1.236 . . . . 1.04 107.663 176.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 2.6 t90 -152.69 114.27 4.29 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 105.951 -1.87 . . . . 0.68000000000000005 105.951 -178.221 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1641 ' ' HIS . . . . . 0.824 ' HB3' ' HB2' ' A' 1615 ' ' ARG . 8.9 m-70 -105.04 115.56 30.48 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 108.889 -0.782 . . . . 0.90000000000000002 108.889 -178.197 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1642 ' ' THR . . . . . . . . . . . . . 3.0 t -137.24 150.59 69.51 Favored Pre-proline 0 C--N 1.3 -1.547 0 C-N-CA 123.065 0.546 . . . . 0.47999999999999998 110.445 -172.095 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1643 ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.49 -18.38 17.74 Favored 'Trans proline' 0 C--N 1.367 1.524 0 C-N-CA 122.622 2.215 . . . . 0.66000000000000003 113.328 178.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1644 ' ' LEU . . . . . 0.482 HD21 ' HG ' ' A' 1532 ' ' LEU . 3.8 pp -84.45 -1.47 55.72 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 119.806 -0.757 . . . . 0.96999999999999997 111.729 -178.714 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -120.06 28.66 7.95 Favored 'General case' 0 CA--C 1.498 -1.048 0 CA-C-O 122.103 0.954 . . . . 0.83999999999999997 109.531 -178.122 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1646 ' ' CYS . . . . . 0.71 ' HA ' ' HB2' ' A' 1614 ' ' CYS . 45.9 t -105.7 140.87 38.1 Favored 'General case' 0 N--CA 1.41 -2.471 0 CA-C-N 114.842 -1.072 . . . . 1.1899999999999999 109.835 -177.584 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -100.83 123.3 46.03 Favored Pre-proline 0 N--CA 1.419 -2.018 0 N-CA-C 104.928 -2.249 . . . . 3.1400000000000001 104.928 175.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1648 ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -27.69 103.61 0.02 OUTLIER 'Trans proline' 0 C--N 1.367 1.51 1 C-N-CA 125.943 4.429 . . . . 2.5800000000000001 116.304 -171.771 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 . . . . . 0 C--O 1.251 1.175 0 CA-C-N 114.981 -1.009 . . . . 4.7199999999999998 109.215 178.073 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.683 0 N-CA-C 108.573 -0.899 . . . . 9.9700000000000006 108.573 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 2' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -126.82 131.95 51.12 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.714 -0.847 . . . . 7.6799999999999997 108.714 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -114.15 144.54 31.83 Favored Pre-proline 0 C--N 1.294 -1.812 0 N-CA-C 108.606 -0.887 . . . . 6.1100000000000003 108.606 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -76.58 55.72 4.88 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 123.095 2.53 . . . . 4.8399999999999999 112.734 178.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 13.4 m 60.15 9.58 1.93 Allowed 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 127.108 2.163 . . . . 4.5999999999999996 115.519 171.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 64.2 24.96 13.52 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.859 1.263 . . . . 4.2300000000000004 110.586 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 3.7 p -130.65 116.15 17.69 Favored 'General case' 0 C--N 1.283 -2.287 0 CA-C-N 113.433 -1.712 . . . . 3.1400000000000001 108.404 177.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.58 ' HB2' ' H ' ' B' ' 12' ' ' GLU . 78.9 mt -64.59 113.99 4.09 Favored 'General case' 0 C--O 1.247 0.965 0 N-CA-C 108.761 -0.829 . . . . 3.96 108.761 177.673 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 20.1 m -50.47 -21.57 1.54 Allowed 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.986 1.314 . . . . 2.8399999999999999 114.24 -174.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 10' ' ' GLY . . . . . 0.439 ' O ' HG12 ' B' ' 14' ' ' VAL . . . -117.62 -65.7 0.34 Allowed Glycine 0 N--CA 1.425 -2.071 0 C-N-CA 120.518 -0.849 . . . . 2.0899999999999999 111.433 179.142 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -55.72 -55.07 30.72 Favored Glycine 0 C--O 1.24 0.502 0 N-CA-C 114.388 0.515 . . . . 1.8400000000000001 114.388 -174.245 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 12' ' ' GLU . . . . . 0.58 ' H ' ' HB2' ' B' ' 8' ' ' LEU . 55.8 mt-10 -74.25 -32.49 62.98 Favored 'General case' 0 CA--C 1.505 -0.775 0 C-N-CA 120.69 -0.404 . . . . 2.5499999999999998 111.282 -177.668 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 13' ' ' LEU . . . . . 0.411 HD13 ' HA ' ' B' ' 13' ' ' LEU . 1.1 mm? -58.1 -59.0 5.96 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.175 0.512 . . . . 2.3500000000000001 111.411 178.006 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 14' ' ' VAL . . . . . 0.439 HG12 ' O ' ' B' ' 10' ' ' GLY . 13.0 p -68.89 -35.33 68.84 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 CA-C-N 115.857 -0.61 . . . . 2.1099999999999999 111.882 -176.131 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -78.34 -26.69 46.85 Favored 'General case' 0 C--O 1.213 -0.866 0 N-CA-C 114.105 1.15 . . . . 2.04 114.105 -179.171 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 19.6 p -67.09 -36.6 82.33 Favored 'General case' 0 C--O 1.256 1.437 0 CA-C-N 119.692 1.133 . . . . 1.8400000000000001 108.819 174.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.72 ' HB3' ' HB3' ' B' ' 26' ' ' PHE . 10.4 mp -60.77 -47.85 84.43 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-N 114.978 -1.01 . . . . 1.74 111.335 171.312 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -63.09 -33.3 75.15 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.036 0.446 . . . . 2.3900000000000001 110.07 179.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -55.52 -59.25 5.09 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 112.905 0.706 . . . . 0.95999999999999996 112.905 -179.145 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 9.8 p -98.51 -20.21 5.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 C-N-CA 117.314 -1.755 . . . . 1.3700000000000001 112.068 -179.332 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 21' ' ' CYS . . . . . 0.461 ' HB2' ' O ' ' B' ' 17' ' ' LEU . 69.4 m -99.66 1.25 43.33 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 113.473 0.916 . . . . 1.6599999999999999 113.473 -175.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -49.29 -36.59 22.94 Favored Glycine 0 N--CA 1.483 1.806 0 N-CA-C 114.789 0.676 . . . . 1.53 114.789 -178.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -52.05 -46.91 65.28 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.873 0.869 . . . . 2.7200000000000002 111.891 176.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 24' ' ' ARG . . . . . 0.408 ' HD3' ' O ' ' B' ' 62' ' ' THR . 42.8 ttm180 -97.56 -43.47 7.22 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.277 0.56 . . . . 4.3300000000000001 111.348 178.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 128.19 165.54 11.84 Favored Glycine 0 N--CA 1.425 -2.082 0 N-CA-C 110.19 -1.164 . . . . 1.53 110.19 -179.136 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 26' ' ' PHE . . . . . 0.72 ' HB3' ' HB3' ' B' ' 17' ' ' LEU . 3.4 p90 -98.25 128.01 44.48 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 117.163 0.481 . . . . 1.6499999999999999 109.83 175.42 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 27' ' ' TYR . . . . . 0.629 ' HB2' ' HA ' ' B' ' 61' ' ' ALA . 53.6 m-85 -132.78 72.92 1.5 Allowed 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 121.577 0.703 . . . . 3.4199999999999999 110.482 -176.354 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 28' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -104.43 -3.83 23.55 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.123 -0.944 . . . . 2.2599999999999998 109.282 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 29' ' ' SER . . . . . 0.593 ' HA ' ' HG2' ' B' ' 40' ' ' ARG . 14.9 m -101.9 51.49 0.83 Allowed 'General case' 0 N--CA 1.441 -0.904 0 CA-C-O 121.922 0.868 . . . . 3.6800000000000002 109.082 -176.059 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 30' ' ' ARG . . . . . 0.401 ' HA ' ' HD3' ' B' ' 31' ' ' PRO . 73.8 mtp180 -102.33 113.84 65.69 Favored Pre-proline 0 C--N 1.299 -1.601 0 CA-C-N 115.312 -0.858 . . . . 3.8100000000000001 108.884 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 31' ' ' PRO . . . . . 0.451 ' HA ' ' O ' ' B' ' 38' ' ' ARG . 20.0 Cg_exo -62.46 -25.34 75.92 Favored 'Trans proline' 0 C--O 1.249 1.031 0 C-N-CA 123.305 2.67 . . . . 4.0199999999999996 113.357 -177.413 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . 61.08 16.47 7.13 Favored 'General case' 0 C--N 1.36 1.061 0 C-N-CA 125.71 1.604 . . . . 4.9199999999999999 112.837 174.274 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 33' ' ' SER . . . . . 0.402 ' O ' ' HB2' ' B' ' 31' ' ' PRO . 29.4 t 175.14 157.43 0.18 Allowed 'General case' 0 N--CA 1.389 -3.522 0 N-CA-C 104.464 -2.421 . . . . 6.7199999999999998 104.464 -177.185 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 46.7 ttt180 -87.6 -1.66 58.09 Favored 'General case' 0 C--N 1.271 -2.84 0 N-CA-C 108.52 -0.918 . . . . 11.630000000000001 108.52 -177.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 51.4 t -87.09 -5.46 10.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 114.649 -1.159 . . . . 9.6099999999999994 109.403 178.302 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 20.4 t 64.61 29.21 13.13 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.1 -0.954 . . . . 6.71 109.294 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 55.6 ttp180 -57.08 -49.79 74.77 Favored 'General case' 0 N--CA 1.436 -1.175 0 CA-C-N 114.641 -1.163 . . . . 10.0 111.149 -177.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 38' ' ' ARG . . . . . 0.451 ' O ' ' HA ' ' B' ' 31' ' ' PRO . 11.8 tpp85 -85.42 102.97 13.89 Favored 'General case' 0 N--CA 1.423 -1.824 0 N-CA-C 107.228 -1.397 . . . . 7.9400000000000004 107.228 174.114 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 17.8 m -97.19 72.79 2.46 Favored 'General case' 0 C--O 1.258 1.526 0 N-CA-C 108.985 -0.746 . . . . 5.7599999999999998 108.985 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 40' ' ' ARG . . . . . 0.593 ' HG2' ' HA ' ' B' ' 29' ' ' SER . 91.8 mtt180 62.71 130.26 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 126.18 1.792 . . . . 6.0300000000000002 112.652 -174.07 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . -96.48 170.9 27.35 Favored Glycine 0 N--CA 1.438 -1.2 0 N-CA-C 110.139 -1.184 . . . . 2.3700000000000001 110.139 178.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . 0.27 18.4 pt 60.84 -30.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 C-N-CA 127.185 2.194 . . . . 2.0699999999999998 116.314 178.23 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 2.7 p -48.97 -46.23 16.61 Favored 'Isoleucine or valine' 0 C--O 1.245 0.837 0 N-CA-C 114.047 1.128 . . . . 2.2400000000000002 114.047 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -96.69 -30.61 13.13 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 108.579 -0.897 . . . . 3.3599999999999999 108.579 -172.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -64.72 -42.4 95.26 Favored 'General case' 0 C--O 1.214 -0.798 0 CA-C-N 114.869 -1.059 . . . . 3.0800000000000001 111.179 177.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 46' ' ' CYS . . . . . 0.421 ' HA ' ' O ' ' B' ' 49' ' ' ARG . 35.7 t -89.33 -3.12 58.6 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.447 0.642 . . . . 2.23 110.703 -179.468 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 41.9 t -83.41 -50.42 8.33 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.638 0.732 . . . . 2.3700000000000001 109.491 175.001 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -88.67 -20.04 25.4 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.866 0.691 . . . . 2.8199999999999998 112.866 -177.033 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 49' ' ' ARG . . . . . 0.421 ' O ' ' HA ' ' B' ' 46' ' ' CYS . 36.1 mmt180 -130.68 150.31 51.93 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 106.68 -1.6 . . . . 4.0899999999999999 106.68 177.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 22.1 t -79.96 127.5 32.34 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 106.827 -1.545 . . . . 2.6699999999999999 106.827 178.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 24.3 p -90.52 139.21 30.91 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 109.36 -0.607 . . . . 2.1099999999999999 109.36 -173.274 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -85.87 165.0 17.16 Favored 'General case' 0 C--O 1.249 1.07 0 C-N-CA 120.566 -0.454 . . . . 2.6699999999999999 110.305 177.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 53' ' ' LEU . . . . . 0.64 ' HB2' ' HA ' ' A' 1600 ' ' SER . 63.5 tp -53.2 -45.02 68.43 Favored 'General case' 0 C--N 1.321 -0.663 0 O-C-N 123.479 0.487 . . . . 1.8999999999999999 111.649 178.141 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.89 -32.41 63.69 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.368 -0.833 . . . . 1.52 113.184 -171.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 65.9 tp -70.42 -57.65 4.58 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 121.012 0.434 . . . . 1.97 110.295 179.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 2.9 pp -71.97 -25.25 61.79 Favored 'General case' 0 C--O 1.213 -0.867 0 CA-C-N 116.043 -0.526 . . . . 1.53 111.195 -174.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -64.82 -55.6 18.62 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 122.638 0.375 . . . . 2.27 110.162 178.32 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 13.2 t -78.89 -27.42 43.91 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 119.331 -0.947 . . . . 2.3300000000000001 112.06 -177.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -71.66 -57.19 4.6 Favored 'General case' 0 C--O 1.219 -0.527 0 N-CA-C 107.02 -1.474 . . . . 2.8599999999999999 107.02 178.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 9.9 t 22.44 -82.59 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 117.121 2.267 . . . . 2.2999999999999998 117.121 174.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 61' ' ' ALA . . . . . 0.629 ' HA ' ' HB2' ' B' ' 27' ' ' TYR . . . -144.18 -168.77 2.96 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-O 121.854 0.835 . . . . 3.1899999999999999 110.719 -170.573 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 62' ' ' THR . . . . . 0.408 ' O ' ' HD3' ' B' ' 24' ' ' ARG . 4.4 t -145.34 148.72 38.63 Favored Pre-proline 0 N--CA 1.406 -2.648 0 N-CA-C 104.547 -2.39 . . . . 3.6800000000000002 104.547 176.406 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -51.28 -31.18 36.18 Favored 'Trans proline' 0 N--CA 1.477 0.545 0 C-N-CA 123.666 2.911 . . . . 5.0800000000000001 116.518 -165.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 58.22 33.4 23.12 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 126.443 1.897 . . . . 5.0999999999999996 112.429 173.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 47.7 tttm 62.5 132.78 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.449 1.499 . . . . 8.5099999999999998 112.221 -175.367 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 22.4 m -89.35 151.64 21.96 Favored 'General case' 0 N--CA 1.427 -1.603 0 N-CA-C 108.083 -1.081 . . . . 8.1199999999999992 108.083 176.004 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 . . . . . 0 C--N 1.305 -1.327 0 N-CA-C 108.138 -1.06 . . . . 10.210000000000001 108.138 -178.21 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 27.3 m-20 . . . . . 0 N--CA 1.471 0.588 0 N-CA-C 110.857 -0.053 . . . . 2.9 110.857 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A 1516 ' ' CYS . . . . . 0.439 ' SG ' ' HB2' ' A' 1579 ' ' LYS . 77.8 m 54.11 35.84 23.3 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 113.876 1.065 . . . . 1.19 113.876 -176.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -143.6 129.33 19.3 Favored 'General case' 0 N--CA 1.434 -1.267 0 C-N-CA 120.07 -0.652 . . . . 1.52 109.662 176.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1518 ' ' VAL . . . . . 0.427 HG22 HD22 ' A' 1581 ' ' LEU . 2.5 m -138.57 137.89 42.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 CA-C-N 115.379 -0.828 . . . . 0.94 111.366 -175.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1519 ' ' THR . . . . . . . . . . . . . 6.3 m -98.15 136.85 37.78 Favored 'General case' 0 C--N 1.277 -2.579 0 CA-C-N 115.465 -0.789 . . . . 0.89 109.476 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -77.35 117.71 67.2 Favored Pre-proline 0 N--CA 1.428 -1.537 0 N-CA-C 108.808 -0.812 . . . . 1.74 108.808 176.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -69.47 -13.49 35.49 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 122.491 2.127 . . . . 1.58 113.795 -177.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 15.0 m -82.41 -36.74 26.4 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 112.498 0.555 . . . . 1.65 112.498 -177.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1523 ' ' THR . . . . . . . . . . . . . 12.4 t -137.1 3.48 2.65 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 119.599 -0.84 . . . . 1.61 112.215 -176.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 72.39 28.72 67.31 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.755 -0.736 . . . . 1.13 112.599 177.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 62.3 t-80 -85.18 119.81 25.98 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.797 -0.816 . . . . 1.26 108.797 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 2.6 tm? -87.15 112.47 21.98 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 109.032 -0.729 . . . . 0.68 109.032 -178.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -91.4 114.28 26.77 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 109.82 -0.437 . . . . 0.65 109.82 175.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 17.5 t70 -110.07 116.41 31.52 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.813 -0.81 . . . . 1.17 108.813 175.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1529 ' ' LEU . . . . . 0.6 ' HG ' HD11 ' A' 1581 ' ' LEU . 3.3 mm? -97.49 0.6 47.85 Favored 'General case' 0 N--CA 1.423 -1.817 0 CA-C-O 121.083 0.468 . . . . 0.6 110.301 -177.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1530 ' ' SER . . . . . 0.555 ' HA ' ' OG ' ' A' 1533 ' ' SER . 2.2 m -70.19 -19.31 63.18 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 122.193 0.997 . . . . 0.84 109.419 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1531 ' ' SER . . . . . 0.413 ' HB2' HD11 ' A' 1644 ' ' LEU . 21.2 m -68.68 -18.4 64.26 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 114.931 -1.031 . . . . 1.59 110.238 175.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 82.6 mt -102.93 -6.73 22.13 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 122.322 -0.236 . . . . 0.65 110.979 178.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1533 ' ' SER . . . . . 0.672 ' HA ' ' HB ' ' A' 1552 ' ' ILE . 30.2 m -60.97 162.5 6.93 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-O 120.947 0.403 . . . . 1.52 111.286 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . 170.72 151.61 7.64 Favored Glycine 0 N--CA 1.426 -1.991 0 C-N-CA 120.513 -0.851 . . . . 1.1 111.107 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 33.8 ttt85 -87.21 -30.75 20.74 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 122.946 0.498 . . . . 4.62 111.377 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -78.37 -35.82 46.81 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.727 -0.842 . . . . 1.45 108.727 177.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 80.7 -140.16 21.48 Favored Glycine 0 N--CA 1.409 -3.109 0 CA-C-N 114.535 -1.211 . . . . 0.85 112.324 173.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -142.21 143.14 32.77 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 106.454 -1.684 . . . . 0.93 106.454 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 1.2 m -108.59 130.19 55.31 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 108.793 -0.817 . . . . 1.03 108.793 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1540 ' ' ALA . . . . . 0.456 ' HB2' ' HG2' ' A' 1624 ' ' PRO . . . -124.71 147.33 48.67 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.999 -0.741 . . . . 0.5 108.999 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -91.17 128.18 36.89 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 120.794 0.331 . . . . 0.74 110.225 -177.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1542 ' ' TYR . . . . . 0.556 ' CE2' ' HG ' ' A' 1626 ' ' LEU . 2.3 t80 -113.02 -99.32 0.43 Allowed 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.015 -1.105 . . . . 0.99 108.015 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1543 ' ' SER . . . . . 0.431 ' H ' ' HB3' ' A' 1542 ' ' TYR . 4.5 m -69.81 159.19 34.07 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 108.372 -0.973 . . . . 1.91 108.372 178.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 97.4 mttt -50.6 -42.69 56.19 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.269 0.841 . . . . 3.59 113.269 -177.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 19.9 m -106.53 28.5 7.77 Favored 'General case' 0 N--CA 1.416 -2.137 0 C-N-CA 122.189 0.196 . . . . 2.46 111.487 -177.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . -144.04 149.18 21.2 Favored Glycine 0 C--O 1.245 0.819 0 C-N-CA 119.425 -1.369 . . . . 1.26 113.868 -177.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 19.8 m -130.87 152.06 36.95 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.979 0 N-CA-C 108.564 -0.902 . . . . 0.79 108.564 177.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 10.3 p -108.68 134.63 50.0 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 N-CA-C 109.35 -0.611 . . . . 0.58 109.35 178.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -93.62 133.89 36.48 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 107.148 -1.427 . . . . 1.08 107.148 176.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 25.3 ptm -148.23 127.84 13.28 Favored 'General case' 0 C--N 1.282 -2.33 0 O-C-N 123.771 0.669 . . . . 0.78 109.836 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 5.0 p -119.0 134.42 55.2 Favored 'General case' 0 C--N 1.27 -2.856 0 CA-C-N 115.318 -0.855 . . . . 0.97 109.222 177.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1552 ' ' ILE . . . . . 0.672 ' HB ' ' HA ' ' A' 1533 ' ' SER . 46.3 mm -82.64 116.45 26.88 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 N-CA-C 109.527 -0.546 . . . . 0.42 109.527 -177.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 62.3 m 63.61 11.42 5.7 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.552 1.141 . . . . 1.4 113.701 173.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . -146.36 176.41 25.3 Favored Glycine 0 N--CA 1.42 -2.392 0 N-CA-C 108.972 -1.651 . . . . 0.35 108.972 -177.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -99.34 145.34 27.45 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 117.214 0.507 . . . . 1.62 110.853 -178.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -91.12 131.43 36.69 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 108.092 -1.077 . . . . 0.87 108.092 -176.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -81.7 -2.87 52.06 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 113.709 1.003 . . . . 2.49 113.709 -175.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -84.59 -6.44 59.37 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.381 -0.528 . . . . 1.38 110.781 -178.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1559 ' ' CYS . . . . . 0.632 ' SG ' ' HD2' ' A' 1560 ' ' PRO . 29.5 t -136.02 153.92 77.23 Favored Pre-proline 0 C--N 1.299 -1.612 0 N-CA-C 107.352 -1.351 . . . . 1.21 107.352 -178.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1560 ' ' PRO . . . . . 0.632 ' HD2' ' SG ' ' A' 1559 ' ' CYS . 7.7 Cg_exo -28.61 134.18 0.03 OUTLIER 'Trans proline' 0 CA--C 1.562 1.899 1 C-N-CA 125.471 4.114 . . . . 0.71 115.585 175.718 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A 1561 ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' 1560 ' ' PRO . 4.9 Cg_endo -46.95 126.45 11.17 Favored 'Trans proline' 0 C--O 1.249 1.036 0 C-N-CA 124.818 3.679 . . . . 0.8 114.196 -178.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 105.62 -11.96 46.53 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 115.583 -0.735 . . . . 0.46 112.802 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1563 ' ' VAL . . . . . 0.669 HG11 ' HB2' ' A' 1566 ' ' CYS . 3.6 t -80.28 125.19 38.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 N-CA-C 112.904 0.705 . . . . 0.98 112.904 -178.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -96.73 -34.81 5.6 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.226 -0.897 . . . . 0.28 111.306 176.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -133.77 133.91 42.29 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 109.393 -0.595 . . . . 0.28 109.393 178.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1566 ' ' CYS . . . . . 0.669 ' HB2' HG11 ' A' 1563 ' ' VAL . 52.8 t -159.51 136.67 9.62 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 119.652 -0.213 . . . . 0.43 110.489 -174.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1567 ' ' PHE . . . . . 0.413 ' CE2' HG11 ' A' 1574 ' ' VAL . 74.9 m-85 -84.54 137.91 33.06 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.142 -1.058 . . . . 1.03 108.142 173.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -89.33 11.79 68.65 Favored Glycine 0 N--CA 1.435 -1.37 0 N-CA-C 117.15 1.62 . . . . 1.13 117.15 -168.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1569 ' ' GLN . . . . . 0.492 ' HG2' HE21 ' B' ' 18' ' ' GLN . 0.8 OUTLIER -75.27 -70.59 0.41 Allowed 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 119.035 1.418 . . . . 2.58 110.049 176.661 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 58.7 p -100.4 -4.68 28.51 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 119.809 -0.757 . . . . 2.17 112.873 176.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1571 ' ' ARG . . . . . . . . . . . . 0.269 5.0 mpt_? 74.32 59.08 0.08 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.978 1.311 . . . . 2.62 112.595 -178.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 21.4 mt -90.6 131.2 38.41 Favored 'Isoleucine or valine' 0 C--O 1.243 0.742 0 CA-C-N 114.34 -1.3 . . . . 0.92 107.676 176.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 31.2 t -86.22 130.3 34.57 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.158 0.504 . . . . 0.8 110.642 -175.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1574 ' ' VAL . . . . . 0.549 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 25.4 m -117.8 16.12 7.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-O 121.532 0.682 . . . . 0.98 111.063 179.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 166.34 129.75 1.09 Allowed Glycine 0 N--CA 1.431 -1.684 0 CA-C-N 115.274 -0.876 . . . . 0.29 111.8 176.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 29.6 ttpp -78.74 145.36 34.48 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 107.5 -1.296 . . . . 2.19 107.5 176.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -66.88 80.0 0.11 Allowed 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 124.006 0.922 . . . . 0.61 112.783 -175.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1578 ' ' ASN . . . . . 0.419 ' O ' ' HE1' ' A' 1592 ' ' TYR . 89.6 m-20 -96.06 -172.63 2.61 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 107.636 -1.246 . . . . 1.95 107.636 177.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1579 ' ' LYS . . . . . 0.439 ' HB2' ' SG ' ' A' 1516 ' ' CYS . 15.5 ptpt -149.9 46.71 0.93 Allowed 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 121.882 0.848 . . . . 2.68 110.416 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 57.0 ttp180 -95.13 84.77 4.15 Favored 'General case' 0 N--CA 1.418 -2.066 0 CA-C-N 115.224 -0.898 . . . . 3.47 109.117 -175.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1581 ' ' LEU . . . . . 0.6 HD11 ' HG ' ' A' 1529 ' ' LEU . 2.4 tt -91.56 130.82 37.32 Favored 'General case' 0 C--N 1.294 -1.848 0 CA-C-N 114.135 -1.393 . . . . 0.64 109.618 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 46.6 mtm180 -125.67 141.09 52.19 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 116.074 -0.512 . . . . 2.85 110.235 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1583 ' ' TYR . . . . . . . . . . . . . 46.0 t80 -103.85 105.05 15.13 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.872 -0.788 . . . . 0.86 108.872 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1584 ' ' VAL . . . . . 0.519 ' O ' ' HB ' ' A' 1587 ' ' VAL . 15.5 m -123.51 91.04 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 CA-C-N 115.571 -0.74 . . . . 1.05 112.349 -175.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1585 ' ' ASP . . . . . 0.422 ' O ' ' HG2' ' A' 1586 ' ' GLN . 37.5 t70 57.62 66.79 1.06 Allowed 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.693 0.797 . . . . 1.17 111.357 175.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1586 ' ' GLN . . . . . 0.422 ' HG2' ' O ' ' A' 1585 ' ' ASP . 14.4 pt20 70.63 -3.56 1.89 Allowed 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 128.178 2.591 . . . . 1.86 111.525 178.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1587 ' ' VAL . . . . . 0.519 ' HB ' ' O ' ' A' 1584 ' ' VAL . 24.7 t -97.76 120.9 47.69 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.521 0 CA-C-N 115.158 -0.928 . . . . 0.49 110.787 -177.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1588 ' ' LEU . . . . . 1.017 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 2.9 mm? -91.64 107.22 19.06 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 107.074 -1.454 . . . . 0.36 107.074 175.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1589 ' ' GLN . . . . . 0.486 ' O ' ' HA ' ' A' 1581 ' ' LEU . 33.8 tt0 -98.74 126.63 44.41 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 109.558 -0.534 . . . . 1.74 109.558 -176.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1590 ' ' LEU . . . . . 0.677 ' HB3' ' HB ' ' A' 1610 ' ' ILE . 1.4 tt -121.4 100.05 6.82 Favored 'General case' 0 C--N 1.275 -2.652 0 N-CA-C 104.79 -2.3 . . . . 0.72 104.79 175.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 5.1 p -97.99 131.98 43.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 C-N-CA 120.232 -0.587 . . . . 1.01 111.809 -174.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1592 ' ' TYR . . . . . 0.566 ' O ' ' HG3' ' A' 1607 ' ' LYS . 21.2 m-85 -116.43 142.56 46.71 Favored 'General case' 0 CA--C 1.504 -0.814 0 N-CA-C 107.824 -1.176 . . . . 0.5 107.824 176.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 10.4 ptmm? -147.61 -179.0 6.56 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 106.336 -1.728 . . . . 1.59 106.336 -175.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 16.5 m-20 61.61 47.27 6.57 Favored 'General case' 0 CA--C 1.508 -0.646 0 O-C-N 124.323 1.014 . . . . 1.11 110.478 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -83.43 -140.68 4.18 Favored Glycine 0 N--CA 1.432 -1.578 0 N-CA-C 109.954 -1.258 . . . . 0.78 109.954 178.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1596 ' ' SER . . . . . . . . . . . . . 59.8 p -102.99 156.2 35.62 Favored Pre-proline 0 C--N 1.281 -2.393 0 N-CA-C 107.627 -1.249 . . . . 1.07 107.627 176.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1597 ' ' PRO . . . . . 0.539 ' HA ' ' O ' ' A' 1604 ' ' LEU . 54.0 Cg_exo -54.58 123.81 14.58 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 122.386 2.058 . . . . 1.01 111.322 178.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1598 ' ' CYS . . . . . 0.459 ' HA ' ' HD3' ' A' 1599 ' ' PRO . 31.9 t -74.63 120.47 81.67 Favored Pre-proline 0 C--N 1.303 -1.436 0 N-CA-C 108.62 -0.882 . . . . 0.75 108.62 -178.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1599 ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' 1598 ' ' CYS . 26.1 Cg_exo -62.71 -19.32 67.94 Favored 'Trans proline' 0 N--CA 1.484 0.915 0 C-N-CA 123.585 2.857 . . . . 1.7 112.966 -176.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1600 ' ' SER . . . . . 0.541 ' HA ' ' HB2' ' B' ' 53' ' ' LEU . 6.4 m -58.66 -37.67 76.5 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 124.938 1.295 . . . . 2.26 111.95 178.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1601 ' ' LYS . . . . . 0.447 ' HE2' ' N ' ' A' 1602 ' ' SER . 0.0 OUTLIER -148.5 108.4 4.04 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 104.47 -2.418 . . . . 3.01 104.47 -179.503 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A 1602 ' ' SER . . . . . 0.447 ' N ' ' HE2' ' A' 1601 ' ' LYS . 8.4 t -57.42 117.35 4.03 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 123.02 0.528 . . . . 2.07 110.927 -174.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 106.18 -7.11 40.33 Favored Glycine 0 N--CA 1.437 -1.24 0 C-N-CA 120.828 -0.701 . . . . 1.08 112.481 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1604 ' ' LEU . . . . . 0.571 HD23 ' SG ' ' A' 1634 ' ' CYS . 10.7 tp -84.77 163.09 19.34 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.169 -1.419 . . . . 1.84 107.169 178.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 19.0 t -127.27 153.86 45.61 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.426 -0.953 . . . . 1.41 108.426 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1606 ' ' TYR . . . . . 0.549 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 57.5 m-85 -80.95 166.38 20.89 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.786 -0.45 . . . . 0.6 109.786 176.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1607 ' ' LYS . . . . . 0.566 ' HG3' ' O ' ' A' 1592 ' ' TYR . 36.5 ttpt -160.74 131.74 5.51 Favored 'General case' 0 CA--C 1.503 -0.83 0 N-CA-C 109.922 -0.399 . . . . 1.45 109.922 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1608 ' ' SER . . . . . . . . . . . . . 22.2 m -113.05 123.35 50.1 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 108.81 -0.811 . . . . 1.15 108.81 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 41.5 t -107.91 110.21 31.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 108.909 -0.775 . . . . 0.25 108.909 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1610 ' ' ILE . . . . . 0.677 ' HB ' ' HB3' ' A' 1590 ' ' LEU . 20.3 mm -89.63 128.45 41.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 106.23 -1.767 . . . . 0.45 106.23 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 23.1 t -127.1 101.11 6.39 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-O 121.386 0.612 . . . . 1.26 109.576 -177.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1612 ' ' PHE . . . . . 1.017 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 60.4 m-85 -86.18 130.18 34.61 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.468 -0.787 . . . . 0.26 111.07 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 54.4 t -127.09 139.32 52.24 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.003 0 C-N-CA 123.132 0.573 . . . . 0.5 110.709 -177.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1614 ' ' CYS . . . . . 0.536 ' SG ' ' HD3' ' A' 1616 ' ' PRO . 2.0 t -60.73 111.47 1.64 Allowed 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 125.234 1.414 . . . . 0.77 112.402 177.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1615 ' ' ARG . . . . . 0.648 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 22.2 tpt180 -128.3 86.86 56.82 Favored Pre-proline 0 C--N 1.316 -0.861 0 N-CA-C 108.292 -1.003 . . . . 2.53 108.292 172.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1616 ' ' PRO . . . . . 0.621 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 43.3 Cg_endo -67.72 -23.62 41.98 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 122.272 1.981 . . . . 1.1 113.389 -174.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -86.3 -4.97 59.27 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 121.03 -0.268 . . . . 3.05 111.078 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . 58.34 -162.69 0.22 Allowed 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 123.351 0.661 . . . . 1.55 109.704 -176.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . 139.75 -161.8 26.24 Favored Glycine 0 N--CA 1.411 -3.003 0 C-N-CA 120.279 -0.962 . . . . 0.93 111.522 178.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -83.26 15.45 2.1 Favored 'Trans proline' 0 C--N 1.321 -0.878 0 C-N-CA 123.277 2.651 . . . . 0.88 112.762 -178.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1621 ' ' THR . . . . . . . . . . . . . 20.6 p -106.11 1.39 26.26 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 115.564 -0.743 . . . . 0.97 110.454 -178.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -86.74 65.84 9.19 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 107.158 -1.423 . . . . 0.72 107.158 176.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1623 ' ' ARG . . . . . 0.478 ' O ' ' HG3' ' A' 1625 ' ' MET . 14.2 ptm180 -170.17 140.93 1.65 Allowed Pre-proline 0 C--N 1.291 -1.951 0 N-CA-C 106.566 -1.642 . . . . 3.26 106.566 -175.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1624 ' ' PRO . . . . . 0.456 ' HG2' ' HB2' ' A' 1540 ' ' ALA . 15.4 Cg_endo -55.71 106.51 0.2 Allowed 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 122.78 2.32 . . . . 0.59 111.627 -178.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1625 ' ' MET . . . . . 0.708 ' HB2' ' HB3' ' A' 1639 ' ' SER . 93.2 mtp -98.64 109.36 22.13 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.732 -0.84 . . . . 1.37 108.732 -177.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1626 ' ' LEU . . . . . 0.556 ' HG ' ' CE2' ' A' 1542 ' ' TYR . 0.3 OUTLIER -71.84 115.39 10.99 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 106.685 -1.598 . . . . 0.89 106.685 -179.68 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A 1627 ' ' ILE . . . . . 0.88 HD11 ' HB2' ' A' 1639 ' ' SER . 44.4 mm -70.82 -53.56 21.42 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.119 0 N-CA-C 108.767 -0.827 . . . . 0.58 108.767 -178.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 19.7 t -179.41 162.42 1.15 Allowed 'General case' 0 N--CA 1.422 -1.862 0 N-CA-C 107.435 -1.32 . . . . 1.39 107.435 -176.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1629 ' ' LEU . . . . . . . . . . . . . 43.2 tp -112.75 115.5 28.62 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 107.423 -1.325 . . . . 1.25 107.423 176.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 12.0 t70 -68.6 107.52 2.99 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 107.503 -1.295 . . . . 1.09 107.503 174.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1631 ' ' LYS . . . . . 0.526 ' HD2' HD21 ' B' ' 53' ' ' LEU . 4.0 tppp? -56.6 -37.63 70.91 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.168 -1.378 . . . . 3.6 114.38 -169.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -89.22 -29.11 19.5 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 119.684 -0.807 . . . . 2.6 112.449 -174.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 60.2 p -100.6 -2.57 32.5 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 113.471 0.915 . . . . 0.75 113.471 -174.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1634 ' ' CYS . . . . . 0.571 ' SG ' HD23 ' A' 1604 ' ' LEU . 71.0 m 58.31 37.56 25.98 Favored 'General case' 0 C--N 1.367 1.355 0 CA-C-O 121.849 0.833 . . . . 0.53 111.541 178.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1635 ' ' THR . . . . . . . . . . . . . 88.5 m -105.45 124.12 49.01 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 114.964 -1.017 . . . . 0.46 109.905 -178.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1636 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -104.39 133.07 49.89 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 107.527 -1.286 . . . . 0.86 107.527 -177.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1637 ' ' PHE . . . . . 0.47 ' HB2' ' HB ' ' A' 1627 ' ' ILE . 85.8 m-85 -108.35 137.07 46.94 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.844 -0.428 . . . . 0.45 109.844 178.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -129.58 130.53 45.81 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 109.859 -0.422 . . . . 0.5 109.859 -175.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1639 ' ' SER . . . . . 0.88 ' HB2' HD11 ' A' 1627 ' ' ILE . 11.3 t -106.59 154.67 20.57 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.102 -1.444 . . . . 1.04 107.102 176.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1640 ' ' TRP . . . . . 0.402 ' CH2' ' HD3' ' A' 1624 ' ' PRO . 1.8 t90 -156.44 114.94 3.36 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 106.113 -1.81 . . . . 0.68 106.113 178.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1641 ' ' HIS . . . . . 0.648 ' HB3' ' HB2' ' A' 1615 ' ' ARG . 38.4 m-70 -105.13 112.31 25.39 Favored 'General case' 0 C--N 1.288 -2.105 0 C-N-CA 119.861 -0.736 . . . . 0.9 110.201 -177.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1642 ' ' THR . . . . . . . . . . . . . 4.4 t -142.69 148.94 48.44 Favored Pre-proline 0 C--N 1.307 -1.258 0 CA-C-N 115.731 -0.668 . . . . 0.48 110.375 -175.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1643 ' ' PRO . . . . . 0.621 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 73.5 Cg_endo -79.45 -5.33 14.14 Favored 'Trans proline' 0 C--N 1.367 1.544 0 C-N-CA 122.51 2.14 . . . . 0.66 112.54 176.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1644 ' ' LEU . . . . . 0.413 HD11 ' HB2' ' A' 1531 ' ' SER . 7.6 tt -75.41 -23.21 57.0 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.829 0.823 . . . . 0.97 109.614 177.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -103.0 28.41 6.26 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.006 -0.997 . . . . 0.84 111.395 -174.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 28.6 t -120.56 149.87 41.76 Favored 'General case' 0 C--N 1.287 -2.147 0 C-N-CA 119.971 -0.692 . . . . 1.19 110.57 -175.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.419 -2.016 0 N-CA-C 107.655 -1.239 . . . . 3.14 107.655 172.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . 0.462 ' O ' HG12 ' B' ' 14' ' ' VAL . . . . . . . . 0 N--CA 1.417 -2.578 0 N-CA-C 109.742 -1.343 . . . . 2.09 109.742 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -47.38 -70.53 0.69 Allowed Glycine 0 C--O 1.224 -0.495 0 N-CA-C 115.205 0.842 . . . . 1.84 115.205 -177.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -65.79 -35.4 80.59 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-N 117.814 0.807 . . . . 2.55 110.621 -177.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' LEU . . . . . 0.58 HD21 ' HB2' ' B' ' 46' ' ' CYS . 5.7 mt -58.73 -60.75 3.34 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 113.306 0.854 . . . . 2.35 113.306 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . 0.462 HG12 ' O ' ' B' ' 10' ' ' GLY . 7.7 p -74.99 -30.37 23.47 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 C-N-CA 120.017 -0.673 . . . . 2.11 111.773 -176.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' ASP . . . . . 0.429 ' OD2' ' HB2' ' A' 1569 ' ' GLN . 18.2 t0 -67.5 -42.27 83.16 Favored 'General case' 0 C--O 1.207 -1.137 0 C-N-CA 119.483 -0.887 . . . . 2.04 111.426 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 23.8 p -61.51 -40.77 95.8 Favored 'General case' 0 C--O 1.25 1.104 0 CA-C-N 118.292 0.496 . . . . 1.84 110.718 177.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.536 ' O ' ' HB2' ' B' ' 21' ' ' CYS . 4.3 mm? -58.5 -51.21 70.81 Favored 'General case' 0 C--O 1.21 -1.022 0 CA-C-N 115.86 -0.609 . . . . 1.74 111.309 174.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' GLN . . . . . 0.492 HE21 ' HG2' ' A' 1569 ' ' GLN . 29.5 tt0 -69.07 -29.12 67.17 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 116.349 -0.387 . . . . 2.39 111.268 -177.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -61.22 -61.09 2.8 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.949 -0.568 . . . . 0.96 112.248 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 14.2 p -97.9 -13.39 8.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 C-N-CA 118.604 -1.238 . . . . 1.37 111.686 -176.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' CYS . . . . . 0.536 ' HB2' ' O ' ' B' ' 17' ' ' LEU . 73.3 m -106.38 14.43 27.35 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.341 -0.849 . . . . 1.66 112.652 178.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -52.14 -45.39 57.26 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 121.252 -0.499 . . . . 1.53 112.899 176.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -79.19 -42.89 25.02 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.398 0.518 . . . . 2.72 112.398 177.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 6.3 tpm_? -71.25 -33.86 70.21 Favored 'General case' 0 C--O 1.244 0.799 0 N-CA-C 112.864 0.69 . . . . 4.33 112.864 -174.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.92 139.43 8.05 Favored Glycine 0 N--CA 1.424 -2.153 0 N-CA-C 108.551 -1.82 . . . . 1.53 108.551 -175.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . 0.464 ' HB2' ' HB3' ' B' ' 17' ' ' LEU . 50.9 p90 -128.4 122.78 32.21 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 117.523 0.662 . . . . 1.65 110.484 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -163.04 96.14 0.89 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.28 0.562 . . . . 3.42 111.553 178.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' PHE . . . . . 0.436 ' HA ' ' HE1' ' B' ' 59' ' ' TYR . 42.5 p90 . . . . . 0 N--CA 1.44 -0.948 0 CA-C-O 121.358 0.599 . . . . 2.26 110.398 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . 0.42 ' N ' ' HH ' ' B' ' 59' ' ' TYR . . . . . . . . 0 N--CA 1.419 -2.434 0 N-CA-C 111.583 -0.607 . . . . 2.37 111.583 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 14.4 pt 61.61 -24.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 C-N-CA 128.245 2.618 . . . . 2.07 116.488 174.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 2.8 p -51.34 -51.35 24.3 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 N-CA-C 114.612 1.338 . . . . 2.24 114.612 -178.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -92.65 -29.64 16.0 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.074 -1.084 . . . . 3.36 108.074 -176.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . 0.722 ' O ' ' HG2' ' B' ' 49' ' ' ARG . 40.6 mt-10 -59.96 -66.67 0.48 Allowed 'General case' 0 N--CA 1.432 -1.371 0 CA-C-N 114.968 -1.015 . . . . 3.08 109.385 177.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' CYS . . . . . 0.58 ' HB2' HD21 ' B' ' 13' ' ' LEU . 72.1 m -76.72 1.24 17.72 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 112.787 0.662 . . . . 2.23 112.787 -175.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 41.1 t -82.47 -50.41 8.88 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 119.496 -0.882 . . . . 2.37 109.105 171.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -102.75 -20.87 14.19 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 114.38 1.252 . . . . 2.82 114.38 -173.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . 0.722 ' HG2' ' O ' ' B' ' 45' ' ' GLU . 17.2 ptp180 -113.05 165.75 12.07 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 108.142 -1.058 . . . . 4.09 108.142 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 28.1 t -86.19 139.72 30.81 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 108.242 -1.021 . . . . 2.67 108.242 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 95.6 m -124.25 159.9 29.17 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-O 121.599 0.714 . . . . 2.11 111.88 -175.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -106.4 149.05 27.39 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 107.167 -1.42 . . . . 2.67 107.167 175.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . 0.541 ' HB2' ' HA ' ' A' 1600 ' ' SER . 55.0 tp -56.34 -27.99 57.62 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 124.905 1.282 . . . . 1.9 112.047 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . 0.624 ' O ' HG22 ' B' ' 58' ' ' THR . . . -58.17 -47.83 82.17 Favored 'General case' 0 CA--C 1.516 -0.352 0 O-C-N 123.2 0.312 . . . . 1.52 110.841 -178.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . 0.441 ' O ' ' HB2' ' B' ' 59' ' ' TYR . 58.7 tp -54.24 -50.97 65.95 Favored 'General case' 0 CA--C 1.509 -0.604 0 C-N-CA 123.847 0.859 . . . . 1.97 111.308 -178.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.406 HD11 HD12 ' B' ' 53' ' ' LEU . 3.4 pp -74.15 -36.07 64.1 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-N 116.07 -0.514 . . . . 1.53 111.555 -174.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -68.63 -48.76 63.25 Favored 'General case' 0 N--CA 1.439 -0.976 0 O-C-N 123.495 0.497 . . . . 2.27 111.357 -178.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 58' ' ' THR . . . . . 0.624 HG22 ' O ' ' B' ' 54' ' ' ALA . 9.2 t -74.08 -15.27 61.06 Favored 'General case' 0 C--O 1.246 0.909 0 C-N-CA 120.186 -0.606 . . . . 2.33 111.73 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 59' ' ' TYR . . . . . 0.441 ' HB2' ' O ' ' B' ' 55' ' ' LEU . 8.6 t80 -80.34 -76.32 0.23 Allowed 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 105.807 -1.923 . . . . 2.86 105.807 174.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 47.2 t . . . . . 0 CA--C 1.557 1.235 0 C-N-CA 125.096 1.359 . . . . 2.3 112.604 176.233 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A 1515 ' ' ASP . . . . . 0.411 ' HB3' ' H ' ' A' 1516 ' ' CYS . 5.5 m-20 . . . . . 0 CA--C 1.516 -0.357 0 CA-C-O 121.334 0.588 . . . . 2.9 111.626 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1516 ' ' CYS . . . . . 0.427 ' HA ' ' HB2' ' A' 1581 ' ' LEU . 6.4 p -76.05 66.32 2.21 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 124.034 0.933 . . . . 1.19 111.976 -177.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1517 ' ' GLN . . . . . 0.45 ' HA ' ' O ' ' A' 1527 ' ' PHE . 3.9 pt20 -154.93 130.95 10.18 Favored 'General case' 0 N--CA 1.421 -1.89 0 CA-C-N 115.355 -0.838 . . . . 1.52 109.638 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1518 ' ' VAL . . . . . 0.483 HG21 ' HB2' ' A' 1583 ' ' TYR . 9.6 m -135.0 144.39 34.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 C-N-CA 123.183 0.593 . . . . 0.94 111.188 -177.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1519 ' ' THR . . . . . . . . . . . . . 24.6 m -111.26 133.61 53.46 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 109.384 -0.599 . . . . 0.89 109.384 178.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -94.63 123.83 56.9 Favored Pre-proline 0 C--N 1.309 -1.152 0 N-CA-C 109.838 -0.43 . . . . 1.74 109.838 175.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -65.33 -16.17 53.27 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.288 2.658 . . . . 1.58 114.638 -176.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 50.2 m -83.04 -49.64 9.34 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 111.985 0.365 . . . . 1.65 111.985 -177.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1523 ' ' THR . . . . . . . . . . . . . 4.4 t -101.75 -9.1 21.13 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.686 0.755 . . . . 1.61 111.337 -177.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 64.85 35.03 91.43 Favored Glycine 0 CA--C 1.488 -1.64 0 CA-C-N 115.291 -0.868 . . . . 1.13 111.772 178.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 22.3 t-80 -99.45 123.1 43.43 Favored 'General case' 0 N--CA 1.422 -1.83 0 C-N-CA 119.979 -0.688 . . . . 1.26 110.218 -177.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 1.7 tm? -88.34 106.99 18.6 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 114.423 -1.262 . . . . 0.68 108.011 177.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1527 ' ' PHE . . . . . 0.45 ' O ' ' HA ' ' A' 1517 ' ' GLN . 85.8 m-85 -89.07 112.83 23.88 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.052 -0.721 . . . . 0.65 109.052 175.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 22.0 t70 -110.9 114.52 27.92 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.886 -0.783 . . . . 1.17 108.886 177.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 3.5 mm? -90.69 -4.06 57.03 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.288 0.566 . . . . 0.6 110.205 -174.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 7.2 m -61.66 -20.32 63.29 Favored 'General case' 0 C--O 1.219 -0.544 0 CA-C-N 114.976 -1.011 . . . . 0.84 110.685 178.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 19.5 m -65.99 -19.52 65.89 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 120.754 0.311 . . . . 1.59 111.606 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1532 ' ' LEU . . . . . 0.401 ' HB2' HG21 ' A' 1552 ' ' ILE . 73.4 mt -98.51 11.37 38.48 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.675 0.274 . . . . 0.65 111.513 -178.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1533 ' ' SER . . . . . . . . . . . . . 25.4 p -66.13 155.97 35.35 Favored 'General case' 0 C--O 1.252 1.229 0 CA-C-O 121.385 0.612 . . . . 1.52 112.426 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -175.86 142.53 6.12 Favored Glycine 0 N--CA 1.428 -1.864 0 N-CA-C 109.727 -1.349 . . . . 1.1 109.727 178.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 44.0 ttm180 -89.26 -37.9 14.61 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 123.688 0.287 . . . . 4.62 110.841 -177.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -71.36 -33.92 69.99 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-O 122.017 0.913 . . . . 1.45 109.274 178.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 96.89 -171.44 27.29 Favored Glycine 0 N--CA 1.417 -2.626 0 CA-C-N 114.865 -1.061 . . . . 0.85 113.05 172.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -124.86 143.97 50.55 Favored 'General case' 0 C--N 1.279 -2.487 0 N-CA-C 107.845 -1.168 . . . . 0.93 107.845 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 19.7 p -106.2 130.76 54.01 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 123.852 0.72 . . . . 1.03 110.319 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1540 ' ' ALA . . . . . 0.46 ' HB3' ' CG1' ' A' 1548 ' ' VAL . . . -118.97 140.92 49.2 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 107.944 -1.132 . . . . 0.5 107.944 177.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -79.24 139.63 37.86 Favored 'General case' 0 C--N 1.316 -0.875 0 O-C-N 123.726 0.641 . . . . 0.74 109.872 -178.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1542 ' ' TYR . . . . . 0.473 ' HB3' ' H ' ' A' 1543 ' ' SER . 0.5 OUTLIER -149.89 -102.72 0.07 Allowed 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.953 -0.758 . . . . 0.99 108.953 -178.603 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A 1543 ' ' SER . . . . . 0.473 ' H ' ' HB3' ' A' 1542 ' ' TYR . 16.2 m -67.91 152.8 44.98 Favored 'General case' 0 N--CA 1.432 -1.342 0 C-N-CA 124.008 0.923 . . . . 1.91 109.364 -179.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.49 -27.24 69.14 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.453 -0.794 . . . . 3.59 112.326 -171.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 20.3 m -123.25 33.09 5.47 Favored 'General case' 0 N--CA 1.397 -3.087 0 N-CA-C 109.588 -0.523 . . . . 2.46 109.588 176.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . -162.73 130.75 2.32 Favored Glycine 0 N--CA 1.438 -1.203 0 C-N-CA 118.528 -1.796 . . . . 1.26 115.172 -177.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 27.8 m -112.44 160.9 11.65 Favored 'Isoleucine or valine' 0 C--O 1.252 1.184 0 N-CA-C 108.44 -0.948 . . . . 0.79 108.44 177.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1548 ' ' VAL . . . . . 0.46 ' CG1' ' HB3' ' A' 1540 ' ' ALA . 14.8 p -106.85 134.84 47.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 C-N-CA 120.477 -0.489 . . . . 0.58 110.258 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -93.07 130.98 38.5 Favored 'General case' 0 CA--C 1.484 -1.562 0 N-CA-C 108.637 -0.875 . . . . 1.08 108.637 175.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1550 ' ' MET . . . . . 0.425 ' HA ' ' O ' ' A' 1564 ' ' GLY . 15.2 ptp -137.44 137.03 38.33 Favored 'General case' 0 C--N 1.284 -2.27 0 CA-C-N 115.63 -0.714 . . . . 0.78 111.315 175.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 11.6 p -117.63 113.8 22.45 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 115.261 -0.881 . . . . 0.97 108.965 176.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1552 ' ' ILE . . . . . 0.401 HG21 ' HB2' ' A' 1532 ' ' LEU . 48.9 mm -77.71 119.39 26.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 N-CA-C 110.016 -0.364 . . . . 0.42 110.016 -177.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 77.4 m 64.42 44.36 4.2 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 124.041 0.838 . . . . 1.4 110.932 177.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 174.81 -179.49 46.08 Favored Glycine 0 N--CA 1.432 -1.575 0 C-N-CA 120.42 -0.895 . . . . 0.35 111.279 -179.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -104.64 158.63 16.37 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 120.617 0.246 . . . . 1.62 110.656 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -119.06 111.17 17.96 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.25 -1.019 . . . . 0.87 108.25 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -69.77 2.9 2.9 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 114.169 1.174 . . . . 2.49 114.169 -173.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -76.34 -15.73 59.9 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 120.154 -0.618 . . . . 1.38 110.029 178.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1559 ' ' CYS . . . . . 0.705 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 71.1 m -132.5 174.57 4.56 Favored Pre-proline 0 C--N 1.302 -1.482 0 CA-C-O 117.717 -1.135 . . . . 1.21 110.238 -178.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1560 ' ' PRO . . . . . 0.705 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 22.9 Cg_exo -28.75 128.7 0.04 OUTLIER 'Trans proline' 0 C--N 1.396 3.072 1 C-N-CA 125.506 4.137 . . . . 0.71 114.733 178.629 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -43.64 119.87 2.02 Favored 'Trans proline' 0 C--O 1.247 0.942 0 C-N-CA 124.547 3.498 . . . . 0.8 114.21 -177.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 87.43 23.62 39.41 Favored Glycine 0 N--CA 1.437 -1.29 0 CA-C-N 115.515 -0.766 . . . . 0.46 113.368 177.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1563 ' ' VAL . . . . . 0.459 HG11 ' HB2' ' A' 1559 ' ' CYS . 5.5 p -100.98 144.11 13.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 117.94 0.87 . . . . 0.98 109.852 -178.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1564 ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' 1550 ' ' MET . . . -106.07 -30.35 4.52 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 121.235 -0.507 . . . . 0.28 113.252 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -128.26 130.14 47.45 Favored 'General case' 0 C--O 1.247 0.964 0 CA-C-N 117.307 0.553 . . . . 0.28 109.867 178.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1566 ' ' CYS . . . . . 0.443 ' SG ' ' HA ' ' A' 1571 ' ' ARG . 9.9 t -157.72 141.05 15.38 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 116.372 -0.376 . . . . 0.43 111.32 -176.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1567 ' ' PHE . . . . . 0.506 ' CE2' HG11 ' A' 1574 ' ' VAL . 74.3 m-85 -88.08 138.38 31.5 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 108.646 -0.872 . . . . 1.03 108.646 175.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -72.77 -9.08 74.31 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 117.854 1.902 . . . . 1.13 117.854 -168.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -80.16 -70.61 0.51 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 119.997 1.899 . . . . 2.58 112.412 -176.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1570 ' ' THR . . . . . 0.448 HG21 ' HA ' ' B' ' 12' ' ' GLU . 19.1 p -91.96 -3.69 55.57 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 119.862 -0.735 . . . . 2.17 112.782 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1571 ' ' ARG . . . . . 0.443 ' HA ' ' SG ' ' A' 1566 ' ' CYS . 10.8 mmt85 65.49 44.11 3.17 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.59 1.156 . . . . 2.62 111.051 177.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 40.7 mt -74.66 137.23 23.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-N 115.914 -0.585 . . . . 0.92 109.461 178.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 26.7 t -83.3 120.45 25.86 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 109.377 -0.601 . . . . 0.8 109.377 -179.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1574 ' ' VAL . . . . . 0.606 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 32.6 m -118.3 10.18 6.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 C-N-CA 119.368 -0.933 . . . . 0.98 111.377 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 173.99 113.71 0.33 Allowed Glycine 0 N--CA 1.419 -2.482 0 N-CA-C 110.122 -1.191 . . . . 0.29 110.122 178.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1576 ' ' LYS . . . . . 0.515 ' HE2' ' O ' ' A' 1594 ' ' ASP . 24.9 ttmm -73.93 155.47 38.65 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.681 -1.229 . . . . 2.19 107.681 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -67.13 77.55 0.14 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.77 0.795 . . . . 0.61 111.865 -177.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1578 ' ' ASN . . . . . 0.475 ' HB3' ' HD1' ' A' 1592 ' ' TYR . 14.5 t-20 -91.2 -175.73 4.37 Favored 'General case' 0 C--N 1.29 -2.01 0 C-N-CA 125.583 1.553 . . . . 1.95 107.41 -178.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 22.2 pttp -158.58 52.48 0.41 Allowed 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.839 0.828 . . . . 2.68 110.008 176.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1580 ' ' ARG . . . . . 0.522 ' HB3' HG12 ' A' 1591 ' ' VAL . 0.1 OUTLIER -97.48 87.31 4.07 Favored 'General case' 0 N--CA 1.413 -2.314 0 N-CA-C 108.287 -1.005 . . . . 3.47 108.287 -176.509 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A 1581 ' ' LEU . . . . . 0.513 ' HA ' ' O ' ' A' 1589 ' ' GLN . 0.4 OUTLIER -86.37 126.16 34.16 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.999 -1.001 . . . . 0.64 109.05 -177.341 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -124.51 140.94 52.48 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 109.159 -0.682 . . . . 2.85 109.159 175.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1583 ' ' TYR . . . . . 0.667 ' CE1' ' HA ' ' A' 1586 ' ' GLN . 67.9 t80 -105.81 97.38 7.21 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 107.004 -1.48 . . . . 0.86 107.004 176.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1584 ' ' VAL . . . . . 0.537 ' O ' ' HB ' ' A' 1587 ' ' VAL . 15.7 m -111.81 89.69 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.234 0 CA-C-N 115.338 -0.846 . . . . 1.05 112.373 -173.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 29.3 t70 56.88 64.45 1.65 Allowed 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 115.246 -0.888 . . . . 1.17 109.961 179.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1586 ' ' GLN . . . . . 0.667 ' HA ' ' CE1' ' A' 1583 ' ' TYR 0.26 4.2 pt20 63.09 15.22 8.31 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 126.926 2.09 . . . . 1.86 112.897 177.596 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A 1587 ' ' VAL . . . . . 0.537 ' HB ' ' O ' ' A' 1584 ' ' VAL . 29.1 t -108.89 129.39 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.024 0 CA-C-N 114.418 -1.265 . . . . 0.49 109.128 176.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1588 ' ' LEU . . . . . 0.962 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 2.9 mm? -97.57 108.22 20.89 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.644 -0.873 . . . . 0.36 108.644 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1589 ' ' GLN . . . . . 0.513 ' O ' ' HA ' ' A' 1581 ' ' LEU . 35.1 tt0 -100.97 118.32 36.75 Favored 'General case' 0 C--N 1.281 -2.375 0 CA-C-N 116.136 -0.484 . . . . 1.74 111.416 -177.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1590 ' ' LEU . . . . . 0.411 ' HG ' ' CD2' ' A' 1581 ' ' LEU . 1.6 mt -108.51 97.68 7.31 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 106.603 -1.628 . . . . 0.72 106.603 170.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1591 ' ' VAL . . . . . 0.522 HG12 ' HB3' ' A' 1580 ' ' ARG . 8.9 p -94.59 133.44 35.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 CA-C-N 116.275 -0.421 . . . . 1.01 110.084 -177.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1592 ' ' TYR . . . . . 0.475 ' HD1' ' HB3' ' A' 1578 ' ' ASN . 14.7 m-30 -118.52 114.22 22.49 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.277 -1.009 . . . . 0.5 108.277 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 21.3 pttp -115.53 178.92 4.12 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 110.303 -0.258 . . . . 1.59 110.303 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1594 ' ' ASP . . . . . 0.515 ' O ' ' HE2' ' A' 1576 ' ' LYS . 8.7 m-20 68.35 36.6 3.0 Favored 'General case' 0 CA--C 1.506 -0.728 0 C-N-CA 124.028 0.931 . . . . 1.11 112.134 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -72.82 -158.32 4.34 Favored Glycine 0 N--CA 1.443 -0.861 0 N-CA-C 109.675 -1.37 . . . . 0.78 109.675 173.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1596 ' ' SER . . . . . . . . . . . . . 41.0 p -87.92 148.64 43.85 Favored Pre-proline 0 C--N 1.28 -2.455 0 C-N-CA 118.292 -1.363 . . . . 1.07 109.304 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -48.01 131.47 21.42 Favored 'Trans proline' 0 C--O 1.241 0.647 0 C-N-CA 123.423 2.748 . . . . 1.01 111.726 176.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1598 ' ' CYS . . . . . 0.494 ' HA ' ' CE2' ' A' 1606 ' ' TYR . 49.4 t -76.67 127.1 85.02 Favored Pre-proline 0 C--N 1.294 -1.805 0 CA-C-N 114.834 -1.075 . . . . 0.75 110.191 -175.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1599 ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' 1598 ' ' CYS . 20.1 Cg_exo -69.4 -34.03 16.64 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.021 2.481 . . . . 1.7 111.24 176.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1600 ' ' SER . . . . . 0.442 ' HB2' ' SG ' ' A' 1598 ' ' CYS . 9.6 m -57.69 -43.15 84.9 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 123.665 0.786 . . . . 2.26 111.294 178.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1601 ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -145.54 123.54 12.07 Favored 'General case' 0 N--CA 1.423 -1.788 0 N-CA-C 109.006 -0.738 . . . . 3.01 109.006 178.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 10.0 m -78.85 148.59 32.77 Favored 'General case' 0 N--CA 1.407 -2.623 0 C-N-CA 123.229 0.612 . . . . 2.07 110.186 -175.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 105.96 -14.61 44.82 Favored Glycine 0 C--N 1.306 -1.136 0 CA-C-N 116.082 -0.508 . . . . 1.08 113.304 176.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1604 ' ' LEU . . . . . 0.458 HD21 ' HB2' ' A' 1634 ' ' CYS . 0.0 OUTLIER -135.74 147.36 48.4 Favored 'General case' 0 N--CA 1.406 -2.629 0 CA-C-O 121.423 0.63 . . . . 1.84 112.202 -179.68 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 10.3 p -96.17 153.37 17.83 Favored 'General case' 0 C--N 1.308 -1.239 0 C-N-CA 124.297 1.039 . . . . 1.41 110.06 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1606 ' ' TYR . . . . . 0.606 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 51.7 m-85 -60.46 154.12 21.45 Favored 'General case' 0 C--O 1.25 1.102 0 O-C-N 123.287 0.367 . . . . 0.6 111.07 176.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -151.86 126.77 9.67 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 108.795 -0.817 . . . . 1.45 108.795 -176.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1608 ' ' SER . . . . . . . . . . . . . 40.1 m -105.72 130.29 53.76 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 116.269 -0.423 . . . . 1.15 110.202 -177.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 28.2 t -109.15 108.26 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.999 0 N-CA-C 107.845 -1.169 . . . . 0.25 107.845 177.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 64.5 mt -97.77 103.92 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.797 0 N-CA-C 107.598 -1.26 . . . . 0.45 107.598 179.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 23.2 t -99.93 107.82 19.9 Favored 'General case' 0 C--N 1.282 -2.341 0 CA-C-N 114.231 -1.35 . . . . 1.26 110.154 -174.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1612 ' ' PHE . . . . . 0.962 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 68.0 m-85 -90.61 118.2 29.87 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.439 -0.801 . . . . 0.26 109.752 178.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 43.1 t -122.65 139.22 50.17 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 108.531 -0.915 . . . . 0.5 108.531 -177.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 9.0 t -66.88 117.59 9.19 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 124.054 0.942 . . . . 0.77 112.564 -177.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1615 ' ' ARG . . . . . 0.741 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 13.5 tpt180 -137.75 91.16 13.86 Favored Pre-proline 0 N--CA 1.442 -0.835 0 N-CA-C 107.951 -1.129 . . . . 2.53 107.951 172.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1616 ' ' PRO . . . . . 0.752 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 45.7 Cg_endo -67.24 -15.68 46.65 Favored 'Trans proline' 0 N--CA 1.486 1.056 0 C-N-CA 122.754 2.303 . . . . 1.1 113.503 -174.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -58.18 -38.98 77.74 Favored 'General case' 0 C--O 1.242 0.697 0 C-N-CA 124.75 1.22 . . . . 3.05 111.056 178.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . 51.19 96.59 0.01 OUTLIER 'General case' 0 C--O 1.248 0.989 0 C-N-CA 124.363 1.065 . . . . 1.55 113.057 178.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1619 ' ' GLY . . . . . 0.405 ' HA3' ' HD2' ' A' 1620 ' ' PRO . . . -151.1 -143.7 3.77 Favored Glycine 0 C--N 1.29 -1.998 0 N-CA-C 110.679 -0.969 . . . . 0.93 110.679 -179.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1620 ' ' PRO . . . . . 0.405 ' HD2' ' HA3' ' A' 1619 ' ' GLY . 38.9 Cg_endo -67.01 2.77 1.92 Allowed 'Trans proline' 0 N--CA 1.488 1.172 0 C-N-CA 123.039 2.492 . . . . 0.88 114.832 -178.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1621 ' ' THR . . . . . 0.425 HG22 ' HB2' ' A' 1641 ' ' HIS . 8.0 m -102.72 -3.4 26.56 Favored 'General case' 0 N--CA 1.42 -1.959 0 CA-C-O 122.057 0.932 . . . . 0.97 108.953 -179.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 43.8 t30 -87.22 61.9 6.97 Favored 'General case' 0 C--O 1.246 0.872 0 CA-C-O 122.488 1.137 . . . . 0.72 108.666 178.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -165.87 138.7 3.39 Favored Pre-proline 0 C--N 1.303 -1.446 0 CA-C-N 113.733 -1.576 . . . . 3.26 106.984 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -65.11 111.69 1.84 Allowed 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 122.393 2.062 . . . . 0.59 111.19 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 72.5 mtm -115.29 143.9 44.56 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 116.531 -0.304 . . . . 1.37 110.59 -178.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1626 ' ' LEU . . . . . 0.456 ' HG ' ' CE2' ' A' 1542 ' ' TYR . 1.6 tm? -80.95 117.38 21.53 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.152 -1.055 . . . . 0.89 108.152 -178.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 50.7 mm -77.87 -58.1 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 CA-C-O 121.296 0.569 . . . . 0.58 109.727 178.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 66.8 m -163.92 149.8 11.13 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.007 -1.108 . . . . 1.39 108.007 -178.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1629 ' ' LEU . . . . . 0.82 HD13 ' HG ' ' A' 1636 ' ' LEU . 30.0 tp -111.87 110.47 20.83 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 107.557 -1.275 . . . . 1.25 107.557 175.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 17.5 t70 -70.54 117.46 12.1 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 107.347 -1.353 . . . . 1.09 107.347 175.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 95.3 mttt -82.15 -11.13 58.9 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.875 -0.602 . . . . 3.6 111.904 -169.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -95.86 -43.56 7.79 Favored 'General case' 0 N--CA 1.418 -2.065 0 C-N-CA 120.373 -0.531 . . . . 2.6 110.928 -175.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 45.5 p -96.42 -0.38 49.29 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 116.253 -0.43 . . . . 0.75 110.929 178.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1634 ' ' CYS . . . . . 0.458 ' HB2' HD21 ' A' 1604 ' ' LEU . 60.9 m 51.24 39.39 23.7 Favored 'General case' 0 C--N 1.374 1.636 0 C-N-CA 124.921 1.288 . . . . 0.53 112.195 176.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1635 ' ' THR . . . . . . . . . . . . . 90.7 m -100.9 128.08 47.09 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 114.09 -1.414 . . . . 0.46 108.288 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1636 ' ' LEU . . . . . 0.82 ' HG ' HD13 ' A' 1629 ' ' LEU . 0.6 OUTLIER -105.23 122.16 45.35 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.365 -0.606 . . . . 0.86 109.365 -174.497 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -99.91 116.91 33.08 Favored 'General case' 0 C--O 1.244 0.812 0 CA-C-O 121.293 0.568 . . . . 0.45 111.848 -178.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -117.26 134.81 54.36 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 115.105 -0.952 . . . . 0.5 109.361 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1639 ' ' SER . . . . . . . . . . . . . 71.6 m -119.73 138.94 53.0 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 116.219 -0.446 . . . . 1.04 109.902 176.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1640 ' ' TRP . . . . . 0.479 ' CE3' ' HE1' ' A' 1612 ' ' PHE . 3.7 t90 -138.36 103.72 4.98 Favored 'General case' 0 N--CA 1.424 -1.753 0 N-CA-C 103.942 -2.614 . . . . 0.68 103.942 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1641 ' ' HIS . . . . . 0.741 ' HB3' ' HB2' ' A' 1615 ' ' ARG . 28.3 m-70 -95.56 98.77 10.76 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.863 0.84 . . . . 0.9 109.757 -176.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1642 ' ' THR . . . . . . . . . . . . . 3.1 t -124.26 150.83 64.95 Favored Pre-proline 0 C--N 1.299 -1.594 0 CA-C-N 113.732 -1.576 . . . . 0.48 110.388 -170.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1643 ' ' PRO . . . . . 0.752 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 59.8 Cg_endo -77.21 -5.54 15.81 Favored 'Trans proline' 0 C--N 1.364 1.36 0 C-N-CA 122.487 2.125 . . . . 0.66 112.729 175.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 9.0 tt -69.48 -27.45 65.23 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.307 -0.627 . . . . 0.97 109.307 177.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -90.35 14.97 11.43 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.47 -0.786 . . . . 0.84 110.713 -177.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1646 ' ' CYS . . . . . 0.612 ' SG ' ' HA ' ' A' 1643 ' ' PRO . 78.3 m -99.69 156.33 17.14 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 109.614 -0.513 . . . . 1.19 109.614 178.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.289 -2.034 0 N-CA-C 107.294 -1.373 . . . . 3.14 107.294 175.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.14 0 CA-C-O 120.48 -0.067 . . . . 2.09 113.252 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -51.26 -52.32 32.56 Favored Glycine 0 C--O 1.214 -1.128 0 C-N-CA 123.697 0.665 . . . . 1.84 114.469 -176.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . 0.448 ' HA ' HG21 ' A' 1570 ' ' THR . 1.6 mp0 -57.41 -42.74 82.9 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 122.816 0.446 . . . . 2.55 110.917 -178.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' LEU . . . . . 0.424 ' HG ' ' SG ' ' B' ' 46' ' ' CYS . 1.1 tt -61.39 -52.61 63.88 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 115.371 -0.831 . . . . 2.35 109.853 -178.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 22.2 m -72.72 -30.37 33.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.37 0 C-N-CA 119.531 -0.867 . . . . 2.11 111.869 -176.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -69.34 -42.82 74.79 Favored 'General case' 0 C--O 1.203 -1.375 0 C-N-CA 120.728 -0.389 . . . . 2.04 111.94 177.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 25.3 p -62.85 -38.8 92.24 Favored 'General case' 0 C--O 1.258 1.523 0 CA-C-O 121.446 0.641 . . . . 1.84 110.054 176.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.563 ' HB3' ' HB3' ' B' ' 26' ' ' PHE . 3.6 mm? -56.75 -49.73 74.37 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-N 115.317 -0.856 . . . . 1.74 111.012 171.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -66.64 -32.37 73.65 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 124.384 1.074 . . . . 2.39 109.809 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -52.84 -57.67 9.43 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 116.023 -0.535 . . . . 0.96 111.939 178.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 13.0 p -98.87 -26.24 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 C-N-CA 118.204 -1.398 . . . . 1.37 112.854 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 85.1 m -106.92 1.08 24.3 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 113.597 0.962 . . . . 1.66 113.597 -177.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -55.86 -24.17 40.57 Favored Glycine 0 N--CA 1.479 1.558 0 N-CA-C 116.969 1.548 . . . . 1.53 116.969 -173.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -58.77 -40.73 84.77 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 118.136 0.968 . . . . 2.72 109.699 175.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 25.2 tpp180 -90.45 -48.57 7.02 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 108.07 -1.085 . . . . 4.33 108.07 177.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 130.33 -152.05 19.65 Favored Glycine 0 N--CA 1.424 -2.144 0 N-CA-C 109.84 -1.304 . . . . 1.53 109.84 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . 0.563 ' HB3' ' HB3' ' B' ' 17' ' ' LEU . 23.2 p90 -137.83 139.28 39.86 Favored 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 108.956 -0.757 . . . . 1.65 108.956 176.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -125.74 -67.78 0.86 Allowed 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 112.827 0.677 . . . . 3.42 112.827 -176.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' PHE . . . . . . . . . . . . . 50.4 p90 . . . . . 0 N--CA 1.509 2.511 0 N-CA-C 117.319 2.34 . . . . 2.26 117.319 171.195 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.416 -2.686 0 N-CA-C 111.583 -0.607 . . . . 2.37 111.583 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . 0.263 10.6 pt 64.44 -33.92 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.213 -0.835 0 C-N-CA 128.651 2.78 . . . . 2.07 114.9 177.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.436 ' O ' ' HB2' ' B' ' 47' ' ' CYS . 2.4 p -48.03 -44.49 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 C-N-CA 123.833 0.853 . . . . 2.24 112.896 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -97.14 -38.35 9.76 Favored 'General case' 0 N--CA 1.415 -2.211 0 CA-C-N 115.606 -0.725 . . . . 3.36 109.506 -172.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -61.54 -47.46 85.46 Favored 'General case' 0 C--O 1.197 -1.702 0 CA-C-N 116.002 -0.544 . . . . 3.08 110.725 178.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' CYS . . . . . 0.424 ' SG ' ' HG ' ' B' ' 13' ' ' LEU . 42.6 t -78.01 -16.27 58.24 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 121.222 0.534 . . . . 2.23 109.823 -178.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' CYS . . . . . 0.436 ' HB2' ' O ' ' B' ' 43' ' ' VAL . 44.3 t -79.66 -48.01 14.44 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 116.216 -0.447 . . . . 2.37 110.857 177.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -98.42 -25.8 14.68 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 113.678 0.992 . . . . 2.82 113.678 -176.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -110.26 -179.8 3.88 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.333 -0.988 . . . . 4.09 108.333 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 8.2 t -93.05 132.5 37.11 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 106.771 -1.566 . . . . 2.67 106.771 176.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 1.6 p -111.38 137.44 49.15 Favored 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 123.205 0.602 . . . . 2.11 110.887 -175.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -112.0 177.72 4.55 Favored 'General case' 0 C--O 1.244 0.764 0 N-CA-C 112.489 0.551 . . . . 2.67 112.489 -178.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . 0.418 ' O ' ' HG ' ' B' ' 56' ' ' LEU . 52.6 tp -51.24 -53.89 31.01 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 125.125 1.37 . . . . 1.9 113.601 -178.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.72 -41.05 73.31 Favored 'General case' 0 C--O 1.244 0.793 0 C-N-CA 124.023 0.929 . . . . 1.52 112.456 -170.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 61.3 tp -63.47 -46.22 87.23 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 114.921 -1.036 . . . . 1.97 111.957 -178.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' B' ' 53' ' ' LEU . 3.3 pp -79.66 -24.64 41.67 Favored 'General case' 0 N--CA 1.41 -2.459 0 C-N-CA 119.765 -0.774 . . . . 1.53 111.143 -176.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -70.6 -43.68 68.85 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 116.082 -0.508 . . . . 2.27 110.616 178.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 24.2 p -63.58 -43.12 97.9 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-N 116.25 -0.432 . . . . 2.33 111.848 179.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -73.31 -59.61 2.63 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 116.739 -0.21 . . . . 2.86 110.505 178.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 41.8 t . . . . . 0 CA--C 1.555 1.141 0 C-N-CA 125.029 1.332 . . . . 2.3 113.984 179.115 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 7.0 t70 . . . . . 0 N--CA 1.442 -0.857 0 N-CA-C 104.138 -2.541 . . . . 2.9 104.138 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A 1516 ' ' CYS . . . . . 0.927 ' HB3' ' HB2' ' A' 1529 ' ' LEU . 72.6 m -79.89 60.41 3.48 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 123.35 0.66 . . . . 1.19 112.247 -174.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1517 ' ' GLN . . . . . 0.485 ' HA ' ' O ' ' A' 1527 ' ' PHE . 16.5 pt20 -164.41 129.33 2.73 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-O 121.392 0.615 . . . . 1.52 110.905 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 2.9 m -148.56 143.59 18.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-N 114.726 -1.125 . . . . 0.94 109.725 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1519 ' ' THR . . . . . . . . . . . . . 91.6 m -114.04 121.49 44.0 Favored 'General case' 0 N--CA 1.423 -1.787 0 N-CA-C 108.173 -1.047 . . . . 0.89 108.173 174.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1520 ' ' ASN . . . . . 0.454 ' HA ' ' HD3' ' A' 1521 ' ' PRO . 26.3 t-20 -80.26 121.93 82.25 Favored Pre-proline 0 C--N 1.294 -1.82 0 N-CA-C 109.33 -0.619 . . . . 1.74 109.33 177.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1521 ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' 1520 ' ' ASN . 12.6 Cg_exo -69.75 -19.61 35.96 Favored 'Trans proline' 0 CA--C 1.529 0.227 0 C-N-CA 123.051 2.5 . . . . 1.58 113.509 -175.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1522 ' ' SER . . . . . 0.419 ' HB2' ' OD1' ' A' 1520 ' ' ASN . 22.5 m -72.33 -32.21 66.32 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 120.836 0.35 . . . . 1.65 111.094 -179.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1523 ' ' THR . . . . . 0.705 HG21 ' HG3' ' A' 1647 ' ' GLU . 8.8 t -124.87 -9.46 7.23 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 119.433 -0.907 . . . . 1.61 112.14 -177.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 68.73 34.34 77.79 Favored Glycine 0 CA--C 1.501 -0.795 0 CA-C-N 115.828 -0.623 . . . . 1.13 113.399 176.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 9.7 t-160 -107.03 121.16 43.93 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 119.163 -1.015 . . . . 1.26 111.415 178.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 2.3 tm? -82.47 115.99 21.72 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 114.494 -1.23 . . . . 0.68 108.688 176.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1527 ' ' PHE . . . . . 0.485 ' O ' ' HA ' ' A' 1517 ' ' GLN . 96.8 m-85 -96.32 121.69 38.39 Favored 'General case' 0 C--N 1.31 -1.149 0 O-C-N 122.158 -0.339 . . . . 0.65 110.494 174.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 10.3 t70 -105.49 109.83 21.94 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 106.923 -1.51 . . . . 1.17 106.923 175.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1529 ' ' LEU . . . . . 0.927 ' HB2' ' HB3' ' A' 1516 ' ' CYS . 3.7 mm? -90.69 -3.5 57.43 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 121.282 0.563 . . . . 0.6 110.22 -177.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 16.0 m -72.84 -15.56 61.62 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.624 -0.716 . . . . 0.84 109.632 178.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1531 ' ' SER . . . . . 0.416 ' HB2' HD11 ' A' 1644 ' ' LEU . 14.8 m -66.38 -22.39 66.25 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-O 121.287 0.565 . . . . 1.59 109.709 173.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 80.4 mt -101.5 3.96 40.7 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.18 -0.464 . . . . 0.65 111.315 177.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1533 ' ' SER . . . . . . . . . . . . . 46.2 t -60.07 158.68 10.68 Favored 'General case' 0 C--O 1.245 0.825 0 CA-C-O 121.959 0.885 . . . . 1.52 111.682 -177.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -178.53 116.09 0.52 Allowed Glycine 0 C--N 1.278 -2.667 0 CA-C-N 114.237 -1.347 . . . . 1.1 110.132 -175.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -92.79 -36.75 12.7 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 112.373 0.509 . . . . 4.62 112.373 -176.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -59.52 -54.42 46.73 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-O 121.262 0.553 . . . . 1.45 110.372 -176.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 136.09 152.99 6.47 Favored Glycine 0 N--CA 1.413 -2.886 0 C-N-CA 120.535 -0.84 . . . . 0.85 113.382 173.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -114.51 139.56 49.46 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 106.151 -1.796 . . . . 0.93 106.151 174.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 5.1 p -106.58 128.71 54.35 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.21 0.528 . . . . 1.03 111.858 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -123.95 141.03 52.4 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 107.991 -1.115 . . . . 0.5 107.991 176.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -82.95 128.98 34.96 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 120.773 0.321 . . . . 0.74 110.72 -177.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1542 ' ' TYR . . . . . 0.578 ' CE2' ' HG ' ' A' 1626 ' ' LEU . 2.0 t80 -121.1 -100.6 0.43 Allowed 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 107.626 -1.25 . . . . 0.99 107.626 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1543 ' ' SER . . . . . 0.441 ' H ' ' HB3' ' A' 1542 ' ' TYR . 8.0 m -66.35 164.06 16.89 Favored 'General case' 0 N--CA 1.437 -1.123 0 C-N-CA 122.815 0.446 . . . . 1.91 110.808 -178.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 23.4 tptm -56.83 -41.54 78.05 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 118.103 0.41 . . . . 3.59 111.132 -176.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 49.9 m -110.88 34.41 4.02 Favored 'General case' 0 N--CA 1.412 -2.352 0 N-CA-C 109.621 -0.511 . . . . 2.46 109.621 178.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . -144.63 134.48 5.67 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 118.808 -1.663 . . . . 1.26 115.335 -176.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 28.1 m -121.68 148.4 25.16 Favored 'Isoleucine or valine' 0 C--O 1.247 0.944 0 N-CA-C 108.561 -0.903 . . . . 0.79 108.561 174.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 11.9 p -104.05 137.11 34.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 N-CA-C 109.747 -0.464 . . . . 0.58 109.747 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -98.01 125.07 42.78 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.834 -0.802 . . . . 1.08 108.834 175.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 23.3 ptm -136.17 133.67 37.41 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 115.539 -0.755 . . . . 0.78 110.342 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 12.7 p -117.69 137.53 52.61 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.549 -0.75 . . . . 0.97 109.627 176.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1552 ' ' ILE . . . . . . . . . . . . . 42.4 mm -96.83 118.53 43.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 110.37 -0.233 . . . . 0.42 110.37 -177.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 75.4 m 65.84 24.76 11.31 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-O 122.199 1.0 . . . . 1.4 112.047 175.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . -164.51 -177.73 37.38 Favored Glycine 0 N--CA 1.406 -3.337 0 CA-C-N 114.261 -1.336 . . . . 0.35 110.004 -178.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -109.39 145.35 36.25 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-O 121.043 0.449 . . . . 1.62 110.933 -176.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -81.41 145.25 30.89 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.345 -0.843 . . . . 0.87 111.809 -172.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -84.96 10.07 12.78 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 123.819 0.848 . . . . 2.49 113.176 -171.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -119.41 -10.73 9.63 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 119.586 -0.846 . . . . 1.38 112.562 -176.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1559 ' ' CYS . . . . . 0.529 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 83.4 m -132.26 164.26 44.54 Favored Pre-proline 0 C--N 1.296 -1.755 0 CA-C-O 117.877 -1.058 . . . . 1.21 110.04 -177.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1560 ' ' PRO . . . . . 0.529 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 12.0 Cg_exo -31.11 131.59 0.06 OUTLIER 'Trans proline' 0 C--N 1.376 2.001 1 C-N-CA 125.536 4.157 . . . . 0.71 115.489 -179.418 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -49.34 128.34 20.03 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 123.77 2.98 . . . . 0.8 111.731 179.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 102.3 -3.86 51.18 Favored Glycine 0 N--CA 1.43 -1.73 0 CA-C-N 116.018 -0.537 . . . . 0.46 113.765 -178.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1563 ' ' VAL . . . . . . . . . . . . . 5.2 p -98.52 138.21 23.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 118.362 1.081 . . . . 0.98 111.291 -178.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -102.11 -31.16 5.44 Favored Glycine 0 CA--C 1.522 0.491 0 CA-C-N 115.693 -0.685 . . . . 0.28 113.172 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -129.28 130.81 46.66 Favored 'General case' 0 N--CA 1.445 -0.723 0 O-C-N 122.528 -0.395 . . . . 0.28 109.967 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 44.0 t -157.02 138.61 14.05 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 110.018 -0.364 . . . . 0.43 110.018 -176.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -85.28 137.67 32.82 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 108.87 -0.789 . . . . 1.03 108.87 174.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -72.33 -18.61 78.3 Favored Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 116.983 1.553 . . . . 1.13 116.983 -167.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -73.23 -70.24 0.38 Allowed 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 118.362 1.081 . . . . 2.58 111.246 -175.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.16 -2.47 58.07 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.198 -0.91 . . . . 2.17 112.755 -176.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 9.9 mmt85 60.04 36.76 21.38 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 114.923 -1.035 . . . . 2.62 110.519 178.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 30.6 mt -74.97 125.24 34.25 Favored 'Isoleucine or valine' 0 C--O 1.245 0.867 0 CA-C-N 115.909 -0.587 . . . . 0.92 109.761 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 21.9 t -74.48 125.09 27.81 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 114.995 -1.002 . . . . 0.8 109.812 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1574 ' ' VAL . . . . . 0.664 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 33.6 m -122.19 16.51 5.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 C-N-CA 120.009 -0.676 . . . . 0.98 112.026 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 167.82 122.72 0.63 Allowed Glycine 0 N--CA 1.432 -1.594 0 C-N-CA 119.977 -1.106 . . . . 0.29 112.618 175.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 4.1 ttmp? -71.64 142.1 49.93 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.23 -1.026 . . . . 2.19 108.23 177.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -72.83 88.23 1.32 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.29 0.567 . . . . 0.61 110.965 -177.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -109.56 150.79 27.66 Favored 'General case' 0 C--N 1.29 -1.978 0 N-CA-C 107.283 -1.377 . . . . 1.95 107.283 179.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -105.15 45.71 0.95 Allowed 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 106.275 -1.75 . . . . 2.68 106.275 -177.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 56.3 ttt180 -84.97 76.59 10.25 Favored 'General case' 0 N--CA 1.411 -2.376 0 CA-C-N 113.638 -1.619 . . . . 3.47 108.775 -173.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1581 ' ' LEU . . . . . 0.401 HD21 ' HG ' ' A' 1529 ' ' LEU . 0.4 OUTLIER -81.42 127.58 32.94 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 113.596 -1.638 . . . . 0.64 108.875 -178.567 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -127.08 140.96 51.9 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-N 116.098 -0.501 . . . . 2.85 110.215 172.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1583 ' ' TYR . . . . . 0.597 ' CZ ' ' HA ' ' A' 1586 ' ' GLN . 39.6 t80 -99.88 105.56 17.31 Favored 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 106.903 -1.517 . . . . 0.86 106.903 175.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1584 ' ' VAL . . . . . 0.643 ' O ' ' HB ' ' A' 1587 ' ' VAL . 7.5 p -129.51 97.39 3.46 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.333 0 CA-C-O 121.614 0.721 . . . . 1.05 111.061 -175.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 36.3 t70 64.01 49.36 2.78 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-O 122.456 1.122 . . . . 1.17 110.771 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1586 ' ' GLN . . . . . 0.597 ' HA ' ' CZ ' ' A' 1583 ' ' TYR . 1.8 pt20 65.39 9.26 5.59 Favored 'General case' 0 N--CA 1.5 2.059 0 C-N-CA 127.026 2.131 . . . . 1.86 111.09 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1587 ' ' VAL . . . . . 0.643 ' HB ' ' O ' ' A' 1584 ' ' VAL . 38.1 t -96.81 122.76 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.75 0 CA-C-N 114.303 -1.317 . . . . 0.49 108.331 178.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1588 ' ' LEU . . . . . 0.487 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 3.0 mm? -93.15 107.76 19.5 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 106.562 -1.644 . . . . 0.36 106.562 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -120.63 125.1 46.87 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 113.296 0.851 . . . . 1.74 113.296 -172.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1590 ' ' LEU . . . . . 0.478 HD21 ' SG ' ' A' 1516 ' ' CYS . 16.6 mt -101.69 126.27 48.51 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 113.84 -1.527 . . . . 0.72 107.282 176.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 47.2 t -112.0 120.36 62.17 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.997 0 C-N-CA 119.438 -0.905 . . . . 1.01 111.026 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1592 ' ' TYR . . . . . 0.43 ' HB2' ' HB2' ' A' 1608 ' ' SER . 13.5 m-30 -105.32 95.83 6.1 Favored 'General case' 0 CA--C 1.486 -1.485 0 N-CA-C 107.866 -1.161 . . . . 0.5 107.866 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 12.3 ptmm? -107.5 170.22 8.11 Favored 'General case' 0 C--N 1.283 -2.312 0 CA-C-N 115.02 -0.991 . . . . 1.59 111.597 -175.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 24.0 m-20 57.24 56.06 5.44 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 125.454 1.502 . . . . 1.11 112.448 177.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -74.88 -115.62 0.09 OUTLIER Glycine 0 CA--C 1.528 0.893 0 C-N-CA 120.33 -0.938 . . . . 0.78 111.143 173.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1596 ' ' SER . . . . . . . . . . . . . 78.2 p -115.32 169.76 6.4 Favored Pre-proline 0 C--N 1.296 -1.744 0 O-C-N 121.857 -0.79 . . . . 1.07 109.164 176.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -70.03 122.62 9.22 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 122.932 2.421 . . . . 1.01 112.354 177.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1598 ' ' CYS . . . . . 0.472 ' HA ' ' HD3' ' A' 1599 ' ' PRO . 34.3 t -76.44 141.16 69.34 Favored Pre-proline 0 C--N 1.292 -1.916 0 CA-C-N 114.671 -1.15 . . . . 0.75 109.202 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1599 ' ' PRO . . . . . 0.573 ' HD3' ' OH ' ' A' 1606 ' ' TYR . 8.1 Cg_exo -72.04 -7.84 21.8 Favored 'Trans proline' 0 C--N 1.371 1.731 0 C-N-CA 123.608 2.872 . . . . 1.7 113.25 -175.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1600 ' ' SER . . . . . 0.67 ' HA ' ' HB3' ' B' ' 53' ' ' LEU . 22.8 p -61.17 -51.22 69.97 Favored 'General case' 0 C--O 1.258 1.535 0 CA-C-O 121.76 0.79 . . . . 2.26 109.733 174.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1601 ' ' LYS . . . . . 0.447 ' HB3' ' HG ' ' A' 1604 ' ' LEU . 49.9 tptt -155.14 117.96 4.33 Favored 'General case' 0 N--CA 1.387 -3.614 0 N-CA-C 106.533 -1.654 . . . . 3.01 106.533 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 4.7 p -60.09 131.27 50.3 Favored 'General case' 0 N--CA 1.409 -2.478 0 N-CA-C 109.139 -0.689 . . . . 2.07 109.139 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 106.83 -20.99 32.92 Favored Glycine 0 C--N 1.296 -1.687 0 C-N-CA 121.065 -0.588 . . . . 1.08 111.837 -174.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1604 ' ' LEU . . . . . 0.447 ' HG ' ' HB3' ' A' 1601 ' ' LYS . 69.5 mt -81.55 124.46 29.52 Favored 'General case' 0 CA--C 1.503 -0.837 0 N-CA-C 107.728 -1.212 . . . . 1.84 107.728 172.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 4.9 p -101.26 143.46 31.3 Favored 'General case' 0 C--N 1.28 -2.415 0 CA-C-O 120.643 0.259 . . . . 1.41 110.61 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1606 ' ' TYR . . . . . 0.664 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 96.2 m-85 -68.39 153.28 44.06 Favored 'General case' 0 C--O 1.255 1.356 0 N-CA-C 109.598 -0.519 . . . . 0.6 109.598 177.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -151.5 127.48 10.38 Favored 'General case' 0 N--CA 1.437 -1.104 0 O-C-N 123.673 0.608 . . . . 1.45 109.952 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1608 ' ' SER . . . . . 0.448 ' HB3' ' HE2' ' A' 1638 ' ' PHE . 38.6 m -104.64 122.04 44.8 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 108.522 -0.918 . . . . 1.15 108.522 -179.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 41.0 t -104.68 108.06 23.94 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 109.304 -0.628 . . . . 0.25 109.304 -177.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1610 ' ' ILE . . . . . 0.466 ' HB ' ' HB2' ' A' 1590 ' ' LEU . 69.5 mt -97.27 110.18 24.66 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 115.588 -0.733 . . . . 0.45 109.323 -178.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 7.0 t -113.56 108.01 16.58 Favored 'General case' 0 C--N 1.282 -2.345 0 CA-C-N 115.143 -0.935 . . . . 1.26 110.114 -174.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1612 ' ' PHE . . . . . 0.487 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 64.1 m-85 -84.9 118.9 24.8 Favored 'General case' 0 C--O 1.254 1.332 0 CA-C-N 115.99 -0.55 . . . . 0.26 109.557 177.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1613 ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' 1641 ' ' HIS . 21.5 t -110.69 124.91 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.577 0 CA-C-N 115.595 -0.73 . . . . 0.5 110.366 -175.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 22.2 t -58.88 110.64 1.06 Allowed 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 114.571 -1.195 . . . . 0.77 111.895 177.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1615 ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' 1615 ' ' ARG . 22.4 ttt180 -137.59 98.59 9.82 Favored Pre-proline 0 C--N 1.316 -0.884 0 N-CA-C 110.25 -0.278 . . . . 2.53 110.25 171.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1616 ' ' PRO . . . . . 0.848 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 34.6 Cg_exo -61.22 -30.55 88.58 Favored 'Trans proline' 0 CA--C 1.55 1.282 0 C-N-CA 122.139 1.892 . . . . 1.1 111.989 176.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -77.05 44.17 0.39 Allowed 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.116 1.367 . . . . 3.05 113.61 178.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -32.69 130.31 0.19 Allowed 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 126.781 2.032 . . . . 1.55 113.476 176.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . -163.86 -142.16 3.33 Favored Glycine 0 N--CA 1.425 -2.089 0 N-CA-C 109.958 -1.257 . . . . 0.93 109.958 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -80.34 15.06 1.81 Allowed 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 122.95 2.433 . . . . 0.88 112.655 -178.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1621 ' ' THR . . . . . . . . . . . . . 17.1 p -102.48 -6.71 22.61 Favored 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 124.791 1.237 . . . . 0.97 108.625 179.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 48.9 t30 -94.66 61.89 2.7 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.392 -1.277 . . . . 0.72 108.659 -176.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -162.28 138.74 5.96 Favored Pre-proline 0 N--CA 1.428 -1.535 0 CA-C-N 113.795 -1.548 . . . . 3.26 107.427 -179.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1624 ' ' PRO . . . . . 0.434 ' HA ' ' O ' ' A' 1639 ' ' SER . 37.1 Cg_endo -65.92 108.2 1.25 Allowed 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 122.556 2.171 . . . . 0.59 112.17 -177.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 63.8 mtm -116.11 147.42 41.35 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.455 -0.339 . . . . 1.37 110.543 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1626 ' ' LEU . . . . . 0.578 ' HG ' ' CE2' ' A' 1542 ' ' TYR . 0.4 OUTLIER -85.41 114.95 22.85 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.452 -1.314 . . . . 0.89 107.452 -178.354 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A 1627 ' ' ILE . . . . . 0.488 HD11 ' HB2' ' A' 1639 ' ' SER . 44.3 mm -72.53 -54.51 16.01 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.217 0 N-CA-C 109.191 -0.67 . . . . 0.58 109.191 -178.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 28.0 p -173.44 154.04 2.5 Favored 'General case' 0 N--CA 1.423 -1.808 0 CA-C-N 114.752 -1.113 . . . . 1.39 109.281 -173.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1629 ' ' LEU . . . . . 0.473 HD13 ' HG ' ' A' 1636 ' ' LEU . 54.2 tp -106.29 117.57 34.38 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 108.434 -0.95 . . . . 1.25 108.434 174.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1630 ' ' ASP . . . . . 0.437 ' HB3' ' HB ' ' A' 1635 ' ' THR . 8.6 t70 -73.75 99.09 3.06 Favored 'General case' 0 CA--C 1.496 -1.108 0 N-CA-C 103.317 -2.846 . . . . 1.09 103.317 167.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -80.76 -10.31 59.74 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 114.192 -1.367 . . . . 3.6 110.395 -166.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -86.11 -45.95 10.9 Favored 'General case' 0 N--CA 1.426 -1.66 0 CA-C-N 115.584 -0.735 . . . . 2.6 110.874 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 70.5 p -95.91 -3.79 44.67 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-O 120.812 0.339 . . . . 0.75 111.571 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 60.9 m 63.7 51.17 2.51 Favored 'General case' 0 C--N 1.355 0.823 0 C-N-CA 124.743 1.217 . . . . 0.53 111.744 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1635 ' ' THR . . . . . 0.437 ' HB ' ' HB3' ' A' 1630 ' ' ASP . 32.4 m -113.42 123.14 49.35 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 114.101 -1.409 . . . . 0.46 109.026 -176.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1636 ' ' LEU . . . . . 0.473 ' HG ' HD13 ' A' 1629 ' ' LEU . 1.0 OUTLIER -105.44 129.78 53.67 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 108.557 -0.905 . . . . 0.86 108.557 -175.383 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -105.72 135.45 47.12 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 120.83 -0.348 . . . . 0.45 111.259 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1638 ' ' PHE . . . . . 0.448 ' HE2' ' HB3' ' A' 1608 ' ' SER . 96.9 m-85 -128.46 137.18 51.69 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 124.09 0.956 . . . . 0.5 108.719 -178.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1639 ' ' SER . . . . . 0.488 ' HB2' HD11 ' A' 1627 ' ' ILE . 17.9 t -124.56 155.1 39.61 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 108.327 -0.99 . . . . 1.04 108.327 177.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1640 ' ' TRP . . . . . 0.462 ' CE3' ' HE1' ' A' 1612 ' ' PHE . 3.6 t90 -155.54 104.35 2.36 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 104.689 -2.337 . . . . 0.68 104.689 -178.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1641 ' ' HIS . . . . . 0.422 ' HA ' ' O ' ' A' 1613 ' ' VAL . 38.8 m-70 -93.63 100.59 12.81 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 121.201 0.524 . . . . 0.9 109.834 -176.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1642 ' ' THR . . . . . . . . . . . . . 3.6 t -134.06 147.33 63.52 Favored Pre-proline 0 C--N 1.292 -1.905 0 CA-C-N 115.002 -0.999 . . . . 0.48 109.377 -173.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1643 ' ' PRO . . . . . 0.848 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 50.1 Cg_endo -76.93 -2.65 12.9 Favored 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 122.069 1.846 . . . . 0.66 112.416 176.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1644 ' ' LEU . . . . . 0.416 HD11 ' HB2' ' A' 1531 ' ' SER . 9.3 tt -69.42 -28.82 66.47 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 108.876 -0.787 . . . . 0.97 108.876 177.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -88.26 21.27 2.89 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.591 -0.731 . . . . 0.84 110.732 -178.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1646 ' ' CYS . . . . . 0.487 ' SG ' ' HA ' ' A' 1643 ' ' PRO . 75.1 m -113.03 152.13 29.86 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 116.139 -0.482 . . . . 1.19 110.279 -179.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1647 ' ' GLU . . . . . 0.705 ' HG3' HG21 ' A' 1523 ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.421 -1.922 0 N-CA-C 107.592 -1.262 . . . . 3.14 107.592 174.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.39 0 CA-C-O 120.554 -0.026 . . . . 2.09 113.037 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . 0.45 ' HA2' HG12 ' B' ' 14' ' ' VAL . . . -60.28 -27.99 66.26 Favored Glycine 0 N--CA 1.461 0.319 0 N-CA-C 112.127 -0.389 . . . . 1.84 112.127 178.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -65.53 -29.9 70.59 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.302 0.572 . . . . 2.55 110.003 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' LEU . . . . . 0.524 HD21 ' HB3' ' B' ' 46' ' ' CYS . 0.2 OUTLIER -72.79 -50.93 21.21 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.619 0.723 . . . . 2.35 109.433 179.944 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . 0.45 HG12 ' HA2' ' B' ' 11' ' ' GLY . 9.1 p -68.08 -37.73 78.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-N 115.665 -0.698 . . . . 2.11 112.254 -176.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -76.24 -22.27 55.37 Favored 'General case' 0 C--O 1.212 -0.907 0 N-CA-C 113.608 0.966 . . . . 2.04 113.608 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 9.7 p -71.55 -39.35 70.73 Favored 'General case' 0 C--O 1.262 1.753 0 O-C-N 120.959 -1.088 . . . . 1.84 109.268 174.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.494 ' HB3' ' HB2' ' B' ' 26' ' ' PHE . 4.3 mm? -52.71 -47.31 67.4 Favored 'General case' 0 C--O 1.216 -0.666 0 CA-C-N 114.938 -1.028 . . . . 1.74 109.535 169.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -63.44 -42.89 98.67 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.485 1.114 . . . . 2.39 110.084 178.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -48.76 -54.96 12.9 Favored 'General case' 0 C--O 1.245 0.823 0 N-CA-C 112.943 0.72 . . . . 0.96 112.943 -177.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 14.8 p -98.74 -26.15 3.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 C-N-CA 117.713 -1.595 . . . . 1.37 112.361 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' CYS . . . . . 0.445 ' HB2' ' O ' ' B' ' 17' ' ' LEU . 74.7 m -102.28 18.91 19.79 Favored 'General case' 0 C--N 1.308 -1.227 0 O-C-N 121.403 -0.81 . . . . 1.66 112.683 -175.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -57.35 -46.17 92.09 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 121.056 -0.593 . . . . 1.53 113.656 178.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -72.99 -39.16 66.3 Favored 'General case' 0 C--N 1.32 -0.708 0 O-C-N 122.669 -0.312 . . . . 2.72 111.507 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . 0.427 ' HD2' ' SG ' ' B' ' 60' ' ' CYS . 40.7 ttm180 -76.44 -38.48 55.44 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.334 0.588 . . . . 4.33 111.597 -177.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.35 151.72 9.69 Favored Glycine 0 N--CA 1.423 -2.2 0 N-CA-C 107.95 -2.06 . . . . 1.53 107.95 -174.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . 0.494 ' HB2' ' HB3' ' B' ' 17' ' ' LEU . 45.6 p90 -138.09 146.82 43.37 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 117.549 0.675 . . . . 1.65 110.229 -179.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -170.63 136.75 1.27 Allowed 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 110.205 -0.294 . . . . 3.42 110.205 174.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' PHE . . . . . . . . . . . . . 22.5 p90 . . . . . 0 C--N 1.308 -1.21 0 N-CA-C 112.347 0.499 . . . . 2.26 112.347 173.583 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.559 0 CA-C-O 118.765 -1.02 . . . . 2.37 115.311 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . 0.421 HD11 HD21 ' B' ' 17' ' ' LEU . 42.9 pt 52.89 -18.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.527 3.405 0 N-CA-C 118.289 2.7 . . . . 2.07 118.289 170.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 4.4 p -49.06 -40.58 13.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 C-N-CA 125.551 1.54 . . . . 2.24 114.673 -175.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -91.01 -34.11 15.27 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 109.497 -0.557 . . . . 3.36 109.497 -173.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' B' ' 49' ' ' ARG . 11.1 mp0 -64.7 -50.89 65.2 Favored 'General case' 0 C--O 1.192 -1.925 0 CA-C-N 115.758 -0.655 . . . . 3.08 110.118 178.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' CYS . . . . . 0.524 ' HB3' HD21 ' B' ' 13' ' ' LEU . 31.8 t -73.59 -22.77 59.94 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 119.821 -0.752 . . . . 2.23 110.7 -176.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 54.1 t -77.88 -39.34 43.52 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.364 -0.38 . . . . 2.37 111.994 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -119.05 6.03 11.31 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.904 1.076 . . . . 2.82 113.904 -176.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . 0.454 ' HB2' ' O ' ' B' ' 45' ' ' GLU . 98.7 mtt180 -130.51 169.55 15.41 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 106.754 -1.573 . . . . 4.09 106.754 176.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 45.9 m -87.35 99.94 12.36 Favored 'General case' 0 N--CA 1.415 -2.183 0 N-CA-C 108.86 -0.792 . . . . 2.67 108.86 177.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 2.6 p -84.67 142.65 29.74 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.835 -1.172 . . . . 2.11 107.835 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -106.29 171.51 7.31 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 119.763 -0.775 . . . . 2.67 110.672 176.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . 0.67 ' HB3' ' HA ' ' A' 1600 ' ' SER . 1.9 pt? -62.32 -37.1 84.29 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 113.886 1.069 . . . . 1.9 113.886 -176.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . 0.414 ' O ' HG22 ' B' ' 58' ' ' THR . . . -58.31 -36.37 73.25 Favored 'General case' 0 CA--C 1.504 -0.792 0 C-N-CA 122.615 0.366 . . . . 1.52 111.857 -173.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . 0.519 ' O ' ' HB2' ' B' ' 59' ' ' TYR . 60.2 tp -60.67 -56.58 19.57 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.59 -0.732 . . . . 1.97 111.101 -177.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 3.2 pp -72.64 -26.76 61.77 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-O 120.831 0.348 . . . . 1.53 110.879 -177.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -69.08 -55.4 10.87 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 115.306 -0.861 . . . . 2.27 111.444 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 58' ' ' THR . . . . . 0.414 HG22 ' O ' ' B' ' 54' ' ' ALA . 13.0 t -78.05 -17.39 57.09 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 119.877 -0.729 . . . . 2.33 111.801 -178.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 59' ' ' TYR . . . . . 0.519 ' HB2' ' O ' ' B' ' 55' ' ' LEU . 6.3 t80 -77.08 -74.16 0.26 Allowed 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 106.219 -1.771 . . . . 2.86 106.219 176.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 60' ' ' CYS . . . . . 0.427 ' SG ' ' HD2' ' B' ' 24' ' ' ARG . 36.6 t . . . . . 0 CA--C 1.557 1.218 0 C-N-CA 125.529 1.532 . . . . 2.3 114.536 175.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1515 ' ' ASP . . . . . 0.435 ' HA ' ' HD3' ' A' 1579 ' ' LYS . 4.5 m-20 . . . . . 0 N--CA 1.505 2.308 0 N-CA-C 113.663 0.986 . . . . 2.9 113.663 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1516 ' ' CYS . . . . . 0.485 ' HB3' ' HB2' ' A' 1529 ' ' LEU . 71.2 m -144.55 78.61 1.58 Allowed 'General case' 0 C--O 1.251 1.165 0 CA-C-O 120.894 0.378 . . . . 1.19 111.278 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1517 ' ' GLN . . . . . 0.409 ' HA ' ' O ' ' A' 1527 ' ' PHE . 11.2 pt20 -157.32 130.22 7.63 Favored 'General case' 0 N--CA 1.422 -1.874 0 N-CA-C 108.982 -0.748 . . . . 1.52 108.982 175.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1518 ' ' VAL . . . . . 0.418 ' CG2' HD12 ' A' 1581 ' ' LEU . 5.9 m -131.79 135.63 58.45 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.16 0 CA-C-O 121.143 0.497 . . . . 0.94 110.936 -178.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1519 ' ' THR . . . . . . . . . . . . . 23.5 m -106.46 129.63 54.4 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 107.202 -1.407 . . . . 0.89 107.202 176.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1520 ' ' ASN . . . . . 0.45 ' OD1' HG22 ' A' 1523 ' ' THR . 23.9 t-20 -89.02 112.47 51.17 Favored Pre-proline 0 C--N 1.287 -2.152 0 N-CA-C 108.247 -1.019 . . . . 1.74 108.247 176.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.69 -9.99 25.82 Favored 'Trans proline' 0 C--N 1.333 -0.237 0 C-N-CA 122.813 2.342 . . . . 1.58 113.257 -175.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1522 ' ' SER . . . . . 0.444 ' HB2' ' OD1' ' A' 1520 ' ' ASN . 24.6 m -74.13 -39.06 63.57 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 116.426 -0.352 . . . . 1.65 110.437 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1523 ' ' THR . . . . . 0.45 HG22 ' OD1' ' A' 1520 ' ' ASN . 9.7 t -122.58 -10.03 8.4 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 120.314 -0.554 . . . . 1.61 112.268 -179.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 81.06 22.6 60.77 Favored Glycine 0 C--N 1.32 -0.361 0 O-C-N 122.334 -0.229 . . . . 1.13 113.593 176.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1525 ' ' HIS . . . . . 0.567 ' CE1' ' HB3' ' A' 1647 ' ' GLU . 11.8 t-160 -93.65 125.26 38.17 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 120.535 -0.466 . . . . 1.26 110.69 -178.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 2.5 tm? -94.28 116.52 28.92 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 114.866 -1.061 . . . . 0.68 109.764 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1527 ' ' PHE . . . . . 0.409 ' O ' ' HA ' ' A' 1517 ' ' GLN . 96.7 m-85 -92.71 119.09 31.75 Favored 'General case' 0 C--N 1.317 -0.808 0 O-C-N 122.296 -0.252 . . . . 0.65 110.438 173.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 14.2 t70 -103.92 110.67 22.9 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 109.123 -0.695 . . . . 1.17 109.123 178.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1529 ' ' LEU . . . . . 0.485 ' HB2' ' HB3' ' A' 1516 ' ' CYS . 3.6 mm? -99.01 3.16 46.85 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 121.326 0.584 . . . . 0.6 109.973 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 1.1 m -64.55 -29.66 70.69 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.049 -0.978 . . . . 0.84 109.344 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 23.1 t -62.26 -32.27 72.95 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.244 -0.889 . . . . 1.59 110.482 178.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 81.3 mt -96.28 1.37 51.98 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.255 -0.43 . . . . 0.65 110.944 -176.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1533 ' ' SER . . . . . . . . . . . . . 16.7 m -75.0 161.46 29.45 Favored 'General case' 0 C--O 1.256 1.42 0 CA-C-O 121.294 0.569 . . . . 1.52 111.982 -177.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -178.59 139.8 4.22 Favored Glycine 0 N--CA 1.429 -1.82 0 CA-C-N 115.623 -0.717 . . . . 1.1 111.532 178.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1535 ' ' ARG . . . . . 0.486 ' HD3' ' O ' ' A' 1535 ' ' ARG . 0.8 OUTLIER -92.92 -30.37 15.43 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 123.514 0.726 . . . . 4.62 109.252 -179.588 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -73.2 -34.11 65.78 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 121.582 0.706 . . . . 1.45 109.697 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 106.26 -177.47 22.3 Favored Glycine 0 N--CA 1.417 -2.574 0 CA-C-N 115.322 -0.854 . . . . 0.85 113.497 172.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -138.28 145.7 41.58 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 106.92 -1.511 . . . . 0.93 106.92 178.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 20.2 p -102.58 124.18 47.66 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 123.513 0.508 . . . . 1.03 110.526 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1540 ' ' ALA . . . . . 0.722 ' HB3' HG23 ' A' 1548 ' ' VAL . . . -117.37 134.89 54.3 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 109.087 -0.709 . . . . 0.5 109.087 178.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -88.13 124.47 33.82 Favored 'General case' 0 N--CA 1.439 -0.976 0 O-C-N 123.663 0.602 . . . . 0.74 110.71 -178.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1542 ' ' TYR . . . . . 0.54 ' HD2' ' CZ ' ' A' 1567 ' ' PHE . 2.2 t80 -123.5 -101.34 0.4 Allowed 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.235 -0.893 . . . . 0.99 109.675 -179.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1543 ' ' SER . . . . . . . . . . . . . 14.6 m -62.98 159.77 16.34 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 118.735 -0.65 . . . . 1.91 109.601 177.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 63.2 tttp -50.49 -40.87 52.32 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 112.902 0.705 . . . . 3.59 112.902 -175.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 27.3 t -116.98 34.43 5.11 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 108.47 -0.937 . . . . 2.46 108.47 177.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . -128.34 118.84 2.91 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.078 -1.058 . . . . 1.26 114.312 -175.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 28.1 m -124.66 137.61 56.82 Favored 'Isoleucine or valine' 0 C--O 1.254 1.325 0 CA-C-O 121.027 0.441 . . . . 0.79 109.939 176.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1548 ' ' VAL . . . . . 0.722 HG23 ' HB3' ' A' 1540 ' ' ALA . 0.0 OUTLIER -95.88 132.69 39.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-N 115.818 -0.628 . . . . 0.58 110.862 175.68 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A 1549 ' ' TYR . . . . . 0.419 ' HB3' ' ND2' ' A' 1556 ' ' ASN . 51.8 m-85 -96.33 99.8 11.46 Favored 'General case' 0 N--CA 1.423 -1.776 0 N-CA-C 106.756 -1.572 . . . . 1.08 106.756 171.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 6.4 ptp -110.75 142.15 43.09 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 115.392 -0.822 . . . . 0.78 111.589 -178.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 12.3 p -118.34 110.64 17.73 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-N 115.719 -0.673 . . . . 0.97 109.428 176.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1552 ' ' ILE . . . . . . . . . . . . . 41.6 mm -75.49 119.6 23.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 109.465 -0.569 . . . . 0.42 109.465 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 56.8 m 64.41 41.68 5.61 Favored 'General case' 0 C--O 1.25 1.101 0 CA-C-O 121.97 0.891 . . . . 1.4 111.994 174.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 174.84 -178.02 46.73 Favored Glycine 0 N--CA 1.421 -2.36 0 N-CA-C 109.452 -1.459 . . . . 0.35 109.452 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -109.54 146.08 35.24 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-O 120.882 0.372 . . . . 1.62 110.224 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1556 ' ' ASN . . . . . 0.419 ' ND2' ' HB3' ' A' 1549 ' ' TYR . 45.2 t-20 -94.92 139.49 31.25 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 115.672 -0.695 . . . . 0.87 109.166 -175.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1557 ' ' GLU . . . . . 0.417 ' HB3' ' CZ ' ' A' 1535 ' ' ARG . 12.9 pt-20 -77.92 -13.45 59.88 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 122.932 0.493 . . . . 2.49 112.304 -176.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -73.87 -8.25 55.37 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.38 0.511 . . . . 1.38 112.38 -177.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1559 ' ' CYS . . . . . 0.775 ' SG ' ' HD2' ' A' 1560 ' ' PRO . 1.6 t -137.72 169.41 13.07 Favored Pre-proline 0 C--N 1.288 -2.106 0 N-CA-C 106.747 -1.575 . . . . 1.21 106.747 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1560 ' ' PRO . . . . . 0.775 ' HD2' ' SG ' ' A' 1559 ' ' CYS . 14.2 Cg_exo -38.58 149.51 0.08 OUTLIER 'Trans proline' 0 CA--C 1.557 1.644 0 C-N-CA 124.003 3.135 . . . . 0.71 114.699 174.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1561 ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' 1560 ' ' PRO . 52.2 Cg_exo -58.05 125.59 19.02 Favored 'Trans proline' 0 C--O 1.242 0.72 0 C-N-CA 123.151 2.567 . . . . 0.8 110.85 178.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 106.91 -7.28 38.13 Favored Glycine 0 N--CA 1.433 -1.517 0 CA-C-N 115.926 -0.579 . . . . 0.46 112.828 -178.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1563 ' ' VAL . . . . . 0.692 HG11 ' HB2' ' A' 1566 ' ' CYS . 9.8 t -79.37 121.8 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.836 0 N-CA-C 112.712 0.634 . . . . 0.98 112.712 -179.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -97.3 -34.75 5.49 Favored Glycine 0 C--N 1.306 -1.086 0 CA-C-N 114.918 -1.037 . . . . 0.28 111.023 176.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -131.4 125.17 31.91 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 109.653 -0.499 . . . . 0.28 109.653 178.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1566 ' ' CYS . . . . . 0.692 ' HB2' HG11 ' A' 1563 ' ' VAL . 49.4 t -150.78 138.46 19.77 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 110.115 -0.328 . . . . 0.43 110.115 -179.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1567 ' ' PHE . . . . . 0.956 ' HB3' ' HG2' ' A' 1569 ' ' GLN . 23.8 m-85 -85.74 139.62 31.19 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.812 -0.81 . . . . 1.03 108.812 172.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -87.57 23.32 13.04 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.211 -0.995 . . . . 1.13 111.245 -178.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1569 ' ' GLN . . . . . 0.956 ' HG2' ' HB3' ' A' 1567 ' ' PHE . 9.9 mm100 -67.71 -70.81 0.24 Allowed 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 122.912 0.485 . . . . 2.58 110.361 -177.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 14.3 t -131.85 34.74 3.83 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-O 122.539 1.161 . . . . 2.17 108.19 173.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 22.9 mmt180 63.56 61.02 1.05 Allowed 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 113.747 -1.569 . . . . 2.62 109.803 -178.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 34.8 mt -104.26 115.4 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-N 116.242 -0.436 . . . . 0.92 110.529 -177.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1573 ' ' SER . . . . . 0.559 ' HB3' ' HB2' ' A' 1596 ' ' SER . 28.6 t -80.13 142.02 35.19 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 120.957 0.408 . . . . 0.8 110.71 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1574 ' ' VAL . . . . . 0.499 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 27.0 m -133.04 17.12 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 O-C-N 122.031 -0.418 . . . . 0.98 111.673 178.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 172.97 131.57 1.4 Allowed Glycine 0 N--CA 1.428 -1.843 0 C-N-CA 119.193 -1.48 . . . . 0.29 111.981 178.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -85.37 143.84 28.39 Favored 'General case' 0 N--CA 1.427 -1.578 0 N-CA-C 108.142 -1.058 . . . . 2.19 108.142 178.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -68.43 92.23 0.43 Allowed 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 115.456 -0.793 . . . . 0.61 111.8 -177.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -100.94 173.9 6.27 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 107.205 -1.406 . . . . 1.95 107.205 172.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1579 ' ' LYS . . . . . 0.435 ' HD3' ' HA ' ' A' 1515 ' ' ASP . 16.7 ptpt -142.8 54.5 1.39 Allowed 'General case' 0 C--N 1.294 -1.815 0 CA-C-O 122.395 1.093 . . . . 2.68 109.502 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1580 ' ' ARG . . . . . 0.423 ' NH1' HH21 ' A' 1582 ' ' ARG . 69.5 ttt180 -105.99 77.11 1.22 Allowed 'General case' 0 N--CA 1.419 -2.015 0 CA-C-N 114.953 -1.021 . . . . 3.47 109.7 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1581 ' ' LEU . . . . . 0.455 HD11 HD12 ' A' 1588 ' ' LEU . 0.5 OUTLIER -63.28 126.08 26.24 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.047 -0.979 . . . . 0.64 109.304 177.436 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A 1582 ' ' ARG . . . . . 0.553 ' HB2' ' HB3' ' A' 1589 ' ' GLN . 91.3 mtt180 -121.73 144.69 48.65 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 116.032 -0.531 . . . . 2.85 110.137 177.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1583 ' ' TYR . . . . . 0.604 ' CE1' ' HA ' ' A' 1586 ' ' GLN . 61.9 t80 -115.09 108.76 17.07 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.896 -0.409 . . . . 0.86 109.896 178.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1584 ' ' VAL . . . . . 0.535 ' O ' ' HB ' ' A' 1587 ' ' VAL . 13.1 m -124.81 89.56 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.61 0.719 . . . . 1.05 112.275 -178.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 21.0 t70 55.75 58.66 4.31 Favored 'General case' 0 N--CA 1.505 2.299 0 C-N-CA 124.739 1.215 . . . . 1.17 110.874 178.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1586 ' ' GLN . . . . . 0.604 ' HA ' ' CE1' ' A' 1583 ' ' TYR 0.352 3.9 pt20 63.92 17.66 10.69 Favored 'General case' 0 CA--C 1.503 -0.863 0 C-N-CA 127.513 2.325 . . . . 1.86 112.805 179.463 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A 1587 ' ' VAL . . . . . 0.535 ' HB ' ' O ' ' A' 1584 ' ' VAL . 39.5 t -102.0 120.48 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.235 0 N-CA-C 106.723 -1.584 . . . . 0.49 106.723 170.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1588 ' ' LEU . . . . . 0.967 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 2.5 mm? -96.6 108.03 20.56 Favored 'General case' 0 C--N 1.283 -2.283 0 N-CA-C 107.38 -1.341 . . . . 0.36 107.38 -179.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1589 ' ' GLN . . . . . 0.553 ' HB3' ' HB2' ' A' 1582 ' ' ARG . 34.4 tt0 -100.07 131.16 46.19 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 116.022 -0.535 . . . . 1.74 112.075 -173.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 12.1 mt -125.71 102.15 7.2 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 106.711 -1.589 . . . . 0.72 106.711 170.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 7.8 p -95.96 126.02 48.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 CA-C-O 121.39 0.614 . . . . 1.01 110.184 -177.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1592 ' ' TYR . . . . . . . . . . . . . 13.0 m-30 -117.25 110.69 18.43 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 107.966 -1.124 . . . . 0.5 107.966 -178.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 47.4 pttt -130.56 -179.13 5.1 Favored 'General case' 0 C--N 1.281 -2.381 0 CA-C-N 115.625 -0.716 . . . . 1.59 109.375 -177.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 19.9 m-20 61.66 43.33 9.97 Favored 'General case' 0 CA--C 1.507 -0.701 0 O-C-N 124.383 1.052 . . . . 1.11 110.264 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -90.81 -134.43 5.92 Favored Glycine 0 N--CA 1.432 -1.623 0 CA-C-N 114.594 -1.184 . . . . 0.78 110.942 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1596 ' ' SER . . . . . 0.559 ' HB2' ' HB3' ' A' 1573 ' ' SER . 33.1 t -86.31 148.24 46.68 Favored Pre-proline 0 C--N 1.303 -1.424 0 N-CA-C 108.583 -0.895 . . . . 1.07 108.583 -178.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -63.11 140.12 76.53 Favored 'Trans proline' 0 N--CA 1.443 -1.496 0 C-N-CA 122.499 2.133 . . . . 1.01 109.711 174.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1598 ' ' CYS . . . . . 0.547 ' HA ' ' CE2' ' A' 1606 ' ' TYR . 49.4 t -79.58 110.18 14.52 Favored Pre-proline 0 C--N 1.294 -1.817 0 N-CA-C 107.721 -1.215 . . . . 0.75 107.721 -178.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -58.59 -34.11 98.62 Favored 'Trans proline' 0 C--N 1.358 1.044 0 C-N-CA 123.191 2.594 . . . . 1.7 112.007 -176.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1600 ' ' SER . . . . . 0.756 ' HB3' ' HB2' ' B' ' 53' ' ' LEU . 4.8 m -60.62 -22.44 63.79 Favored 'General case' 0 CA--C 1.56 1.334 0 C-N-CA 125.271 1.428 . . . . 2.26 113.171 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1601 ' ' LYS . . . . . 0.502 ' HE2' ' OD2' ' B' ' 52' ' ' ASP . 4.9 tppp? -157.4 120.62 4.04 Favored 'General case' 0 C--O 1.241 0.622 0 O-C-N 121.952 -0.468 . . . . 3.01 110.339 178.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 19.8 m -70.18 133.93 47.58 Favored 'General case' 0 N--CA 1.414 -2.273 0 N-CA-C 109.686 -0.487 . . . . 2.07 109.686 -177.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 105.51 -16.89 44.01 Favored Glycine 0 C--N 1.301 -1.377 0 CA-C-N 116.072 -0.513 . . . . 1.08 112.343 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1604 ' ' LEU . . . . . 0.468 HD12 ' HB3' ' A' 1601 ' ' LYS . 56.9 mt -102.95 138.76 39.4 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 122.164 -0.61 . . . . 1.84 110.451 -179.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 20.5 m -115.92 147.04 41.54 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 107.698 -1.223 . . . . 1.41 107.698 175.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1606 ' ' TYR . . . . . 0.547 ' CE2' ' HA ' ' A' 1598 ' ' CYS . 54.4 m-85 -70.14 150.21 46.75 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 116.687 -0.233 . . . . 0.6 111.543 -178.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 6.6 ttpm? -148.07 135.51 20.6 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.771 -0.826 . . . . 1.45 108.771 177.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1608 ' ' SER . . . . . . . . . . . . . 2.6 p -119.1 126.42 51.6 Favored 'General case' 0 C--N 1.281 -2.387 0 CA-C-N 115.384 -0.826 . . . . 1.15 109.83 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 39.1 t -107.51 105.16 18.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 109.52 -0.548 . . . . 0.25 109.52 -178.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1610 ' ' ILE . . . . . 0.407 ' HA ' ' HB2' ' A' 1638 ' ' PHE . 92.9 mt -89.97 119.38 36.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 107.972 -1.121 . . . . 0.45 107.972 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 20.0 m -124.55 116.0 21.76 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-N 115.85 -0.614 . . . . 1.26 110.494 -177.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1612 ' ' PHE . . . . . 0.967 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 75.5 m-85 -85.62 122.82 30.28 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.606 -0.887 . . . . 0.26 108.606 176.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 58.8 t -111.62 135.58 50.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 CA-C-N 115.382 -0.826 . . . . 0.5 109.576 -174.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 39.5 t -68.3 107.54 2.86 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.246 -0.888 . . . . 0.77 110.587 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1615 ' ' ARG . . . . . 0.436 ' CB ' ' HB3' ' A' 1641 ' ' HIS . 32.7 tpt180 -132.35 94.28 23.48 Favored Pre-proline 0 N--CA 1.437 -1.107 0 N-CA-C 108.746 -0.835 . . . . 2.53 108.746 176.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1616 ' ' PRO . . . . . 0.793 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 18.6 Cg_exo -66.89 -26.17 44.58 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 122.034 1.823 . . . . 1.1 112.397 -177.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -77.87 43.31 0.42 Allowed 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 125.067 1.347 . . . . 3.05 112.977 178.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -31.99 126.24 0.26 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.726 1.611 . . . . 1.55 113.171 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . -167.19 -141.17 3.08 Favored Glycine 0 N--CA 1.412 -2.906 0 N-CA-C 109.175 -1.57 . . . . 0.93 109.175 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -75.49 8.77 2.45 Favored 'Trans proline' 0 CA--C 1.533 0.437 0 C-N-CA 122.525 2.15 . . . . 0.88 113.337 -176.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1621 ' ' THR . . . . . 0.678 ' HB ' ' HB2' ' A' 1641 ' ' HIS . 14.4 p -96.18 -10.48 28.02 Favored 'General case' 0 C--N 1.292 -1.905 0 C-N-CA 124.102 0.961 . . . . 0.97 109.971 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 52.9 t30 -85.86 65.34 9.08 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 114.945 -1.025 . . . . 0.72 109.38 -178.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1623 ' ' ARG . . . . . 0.524 ' O ' ' HG3' ' A' 1625 ' ' MET . 10.8 ptp180 -165.34 141.84 4.61 Favored Pre-proline 0 C--N 1.31 -1.126 0 N-CA-C 107.78 -1.193 . . . . 3.26 107.78 -175.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1624 ' ' PRO . . . . . 0.445 ' HG3' ' CZ3' ' A' 1640 ' ' TRP . 23.5 Cg_exo -56.11 107.37 0.25 Allowed 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.551 2.167 . . . . 0.59 111.005 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1625 ' ' MET . . . . . 0.524 ' HG3' ' O ' ' A' 1623 ' ' ARG . 89.8 mtp -107.05 132.46 52.94 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.345 -0.613 . . . . 1.37 109.345 -177.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.4 114.06 22.17 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 106.406 -1.702 . . . . 0.89 106.406 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1627 ' ' ILE . . . . . 0.752 HD11 ' HB2' ' A' 1639 ' ' SER . 45.2 mm -69.4 -55.1 16.42 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.139 0 N-CA-C 109.027 -0.731 . . . . 0.58 109.027 -179.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 11.8 t -176.44 152.88 1.12 Allowed 'General case' 0 N--CA 1.425 -1.704 0 N-CA-C 108.616 -0.883 . . . . 1.39 108.616 -176.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1629 ' ' LEU . . . . . 0.594 HD13 HD23 ' A' 1636 ' ' LEU . 19.0 tp -99.89 109.51 21.89 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.304 -0.862 . . . . 1.25 109.408 175.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 20.6 t70 -73.03 98.79 2.6 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 106.372 -1.714 . . . . 1.09 106.372 170.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1631 ' ' LYS . . . . . 0.715 ' HD3' ' H ' ' A' 1631 ' ' LYS . 0.2 OUTLIER -73.31 -16.21 61.38 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 113.73 1.011 . . . . 3.6 113.73 -172.989 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 16.7 mm100 -73.56 -36.63 65.63 Favored 'General case' 0 CA--C 1.498 -1.052 0 C-N-CA 120.41 -0.516 . . . . 2.6 111.193 178.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 58.9 p -108.01 -6.15 16.72 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 115.886 -0.597 . . . . 0.75 112.432 -176.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 82.5 m 63.73 47.08 3.77 Favored 'General case' 0 C--N 1.36 1.03 0 C-N-CA 124.368 1.067 . . . . 0.53 109.754 -178.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1635 ' ' THR . . . . . . . . . . . . . 56.1 m -115.36 133.17 56.29 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.92 -1.036 . . . . 0.46 110.808 -175.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1636 ' ' LEU . . . . . 0.594 HD23 HD13 ' A' 1629 ' ' LEU . 15.7 mt -110.14 135.75 50.44 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.996 -0.742 . . . . 0.86 108.996 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -109.55 133.15 53.43 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 109.421 -0.585 . . . . 0.45 109.421 176.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1638 ' ' PHE . . . . . 0.407 ' HB2' ' HA ' ' A' 1610 ' ' ILE . 97.3 m-85 -123.34 135.39 54.16 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 116.137 -0.483 . . . . 0.5 110.021 -178.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1639 ' ' SER . . . . . 0.752 ' HB2' HD11 ' A' 1627 ' ' ILE . 23.3 t -115.62 156.17 26.32 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 107.221 -1.399 . . . . 1.04 107.221 175.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1640 ' ' TRP . . . . . 0.445 ' CZ3' ' HG3' ' A' 1624 ' ' PRO . 3.1 t90 -151.5 106.21 3.25 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 103.973 -2.603 . . . . 0.68 103.973 177.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1641 ' ' HIS . . . . . 0.678 ' HB2' ' HB ' ' A' 1621 ' ' THR . 12.3 m-70 -93.39 103.45 15.67 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.694 -0.854 . . . . 0.9 108.694 -173.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1642 ' ' THR . . . . . . . . . . . . . 15.3 t -142.21 145.33 35.06 Favored Pre-proline 0 CA--C 1.558 1.277 0 C-N-CA 120.776 -0.369 . . . . 0.48 110.341 -172.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1643 ' ' PRO . . . . . 0.793 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 72.6 Cg_endo -78.42 -5.5 14.96 Favored 'Trans proline' 0 C--N 1.372 1.793 0 C-N-CA 122.303 2.002 . . . . 0.66 112.233 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 9.2 tt -66.49 -24.44 66.41 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.104 -0.702 . . . . 0.97 109.104 177.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -92.7 16.2 12.78 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.251 -0.886 . . . . 0.84 110.566 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 58.6 m -121.79 145.87 47.62 Favored 'General case' 0 N--CA 1.424 -1.748 0 O-C-N 122.28 -0.262 . . . . 1.19 110.998 -178.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1647 ' ' GLU . . . . . 0.567 ' HB3' ' CE1' ' A' 1525 ' ' HIS . 0.4 OUTLIER . . . . . 0 C--N 1.296 -1.729 0 N-CA-C 108.509 -0.923 . . . . 3.14 108.509 167.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . 0.48 ' O ' HG12 ' B' ' 14' ' ' VAL . . . . . . . . 0 N--CA 1.412 -2.962 0 N-CA-C 110.07 -1.212 . . . . 2.09 110.07 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . 0.566 ' O ' ' HB2' ' B' ' 15' ' ' ASP . . . -56.32 -62.38 6.4 Favored Glycine 0 N--CA 1.44 -1.05 0 O-C-N 124.687 0.875 . . . . 1.84 113.325 -176.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -74.12 -30.04 62.12 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.981 0.391 . . . . 2.55 111.222 -176.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' LEU . . . . . 0.45 ' O ' HD23 ' B' ' 17' ' ' LEU . 67.1 mt -56.67 -64.86 0.73 Allowed 'General case' 0 N--CA 1.468 0.446 0 O-C-N 123.374 0.421 . . . . 2.35 111.09 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . 0.48 HG12 ' O ' ' B' ' 10' ' ' GLY . 14.0 p -65.38 -29.85 48.45 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 CA-C-O 121.355 0.598 . . . . 2.11 110.269 -178.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' ASP . . . . . 0.566 ' HB2' ' O ' ' B' ' 11' ' ' GLY . 4.0 t70 -66.69 -48.38 69.44 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-N 115.422 -0.808 . . . . 2.04 112.251 -177.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 13.4 t -65.91 -31.87 73.05 Favored 'General case' 0 C--O 1.256 1.414 0 CA-C-N 118.099 0.409 . . . . 1.84 110.82 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.63 ' HB3' ' HB3' ' B' ' 26' ' ' PHE . 4.1 mm? -58.6 -48.79 79.78 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.423 0.63 . . . . 1.74 110.374 174.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -80.22 -15.1 57.76 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.549 0.69 . . . . 2.39 110.902 -178.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -65.07 -52.76 53.85 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 116.094 -0.503 . . . . 0.96 110.786 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 30.7 m -98.43 -24.95 4.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 C-N-CA 118.666 -1.214 . . . . 1.37 112.141 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' CYS . . . . . 0.425 ' HB2' ' O ' ' B' ' 17' ' ' LEU . 95.9 m -105.03 19.84 19.9 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 120.681 -0.407 . . . . 1.66 111.841 -177.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -49.22 -40.89 30.21 Favored Glycine 0 N--CA 1.474 1.168 0 N-CA-C 115.093 0.797 . . . . 1.53 115.093 -178.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -71.4 -32.35 68.32 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 112.476 0.547 . . . . 2.72 112.476 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 21.0 ttm180 -93.12 -41.12 10.11 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 120.738 -0.385 . . . . 4.33 111.852 -175.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 120.25 -176.15 16.12 Favored Glycine 0 N--CA 1.436 -1.355 0 N-CA-C 110.191 -1.164 . . . . 1.53 110.191 -177.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . 0.63 ' HB3' ' HB3' ' B' ' 17' ' ' LEU . 12.9 p90 -132.4 127.78 36.15 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 116.914 0.357 . . . . 1.65 110.277 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -131.09 84.04 2.15 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.089 0.471 . . . . 3.42 112.103 -175.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' PHE . . . . . . . . . . . . . 33.4 p90 . . . . . 0 C--N 1.302 -1.491 0 CA-C-O 122.367 1.08 . . . . 2.26 108.806 177.232 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.206 0 CA-C-O 119.094 -0.837 . . . . 2.37 113.253 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . 0.619 ' HA ' ' HG2' ' B' ' 45' ' ' GLU . 27.5 pt 52.75 26.94 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.38 1.899 0 C-N-CA 126.549 1.94 . . . . 2.07 112.739 179.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 1.4 p -103.05 -44.42 9.75 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.921 0 CA-C-N 113.771 -1.559 . . . . 2.24 112.638 -173.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -83.72 -22.06 32.11 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.758 -1.201 . . . . 3.36 107.758 -178.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . 0.619 ' HG2' ' HA ' ' B' ' 42' ' ' ILE . 1.5 pm0 -77.53 -28.36 51.95 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 114.241 -1.345 . . . . 3.08 112.22 173.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' CYS . . . . . . . . . . . . . 12.1 t -112.77 -3.25 14.24 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 118.729 -1.188 . . . . 2.23 112.793 -177.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 43.3 t -86.77 -53.34 4.98 Favored 'General case' 0 C--N 1.314 -0.975 0 O-C-N 121.201 -0.937 . . . . 2.37 110.958 175.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -91.71 -5.73 53.19 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.31 0.576 . . . . 2.82 111.902 -176.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -139.5 152.16 46.73 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 106.348 -1.723 . . . . 4.09 106.348 179.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 32.3 t -80.3 139.59 36.56 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 106.209 -1.774 . . . . 2.67 106.209 175.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . 0.593 ' HB2' HD23 ' B' ' 55' ' ' LEU . 25.7 p -105.46 138.18 42.08 Favored 'General case' 0 N--CA 1.422 -1.855 0 N-CA-C 108.6 -0.889 . . . . 2.11 108.6 -175.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . 0.502 ' OD2' ' HE2' ' A' 1601 ' ' LYS . 3.5 m-20 -66.33 139.44 58.04 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.944 -0.761 . . . . 2.67 108.944 177.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . 0.756 ' HB2' ' HB3' ' A' 1600 ' ' SER . 36.0 tp -55.18 -30.86 60.77 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.246 -1.343 . . . . 1.9 110.555 177.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.48 -45.44 84.84 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 123.688 0.795 . . . . 1.52 110.431 177.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . 0.593 HD23 ' HB2' ' B' ' 51' ' ' CYS . 44.9 tp -58.77 -50.57 73.43 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 123.936 0.895 . . . . 1.97 110.52 -179.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 3.1 pp -74.11 -33.08 63.47 Favored 'General case' 0 N--CA 1.424 -1.74 0 C-N-CA 120.716 -0.394 . . . . 1.53 111.842 -175.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -66.75 -49.45 65.92 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.117 0.484 . . . . 2.27 110.812 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 7.2 t -73.75 -24.46 59.88 Favored 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 120.294 -0.562 . . . . 2.33 111.039 -177.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -76.7 -67.48 0.7 Allowed 'General case' 0 C--O 1.241 0.611 0 N-CA-C 107.576 -1.268 . . . . 2.86 107.576 176.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 42.9 t . . . . . 0 CA--C 1.549 0.926 0 C-N-CA 125.311 1.444 . . . . 2.3 113.881 175.732 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 14.6 t70 . . . . . 0 N--CA 1.442 -0.843 0 N-CA-C 106.006 -1.85 . . . . 2.9 106.006 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 21.7 t -90.31 73.32 7.07 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 107.154 -1.424 . . . . 1.19 107.154 178.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -166.7 172.34 10.66 Favored 'General case' 0 N--CA 1.423 -1.822 0 N-CA-C 104.949 -2.241 . . . . 1.52 104.949 -174.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 10.6 p -168.27 137.07 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 CA-C-O 121.414 0.626 . . . . 0.94 110.531 177.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1519 ' ' THR . . . . . . . . . . . . . 35.4 m -92.92 135.85 33.78 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 115.809 -0.632 . . . . 0.89 109.973 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -86.23 124.94 69.45 Favored Pre-proline 0 N--CA 1.414 -2.231 0 CA-C-N 116.226 -0.443 . . . . 1.74 110.106 176.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.76 -13.62 24.4 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.991 2.461 . . . . 1.58 113.602 -175.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 14.1 m -80.38 -41.62 24.31 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 116.657 -0.247 . . . . 1.65 111.442 -177.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1523 ' ' THR . . . . . . . . . . . . . 6.6 t -125.43 2.8 7.7 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 119.502 -0.879 . . . . 1.61 112.662 -175.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 65.35 28.12 73.22 Favored Glycine 0 CA--C 1.503 -0.697 0 C-N-CA 121.129 -0.558 . . . . 1.13 112.423 178.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 18.9 t-80 -98.2 127.65 44.26 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 121.268 0.556 . . . . 1.26 109.593 -179.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 2.8 tm? -86.03 118.5 25.54 Favored 'General case' 0 C--N 1.288 -2.078 0 CA-C-N 114.171 -1.377 . . . . 0.68 109.825 -177.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1527 ' ' PHE . . . . . 0.572 ' HE2' ' HE2' ' A' 1583 ' ' TYR . 30.6 m-85 -90.39 128.07 36.38 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 109.333 -0.617 . . . . 0.65 109.333 170.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 23.0 t70 -115.16 123.67 49.5 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 123.709 0.631 . . . . 1.17 109.768 178.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 3.0 mm? -100.34 -5.94 26.57 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-O 121.565 0.698 . . . . 0.6 109.798 -178.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1530 ' ' SER . . . . . 0.453 ' HA ' ' OG ' ' A' 1533 ' ' SER . 1.1 m -70.67 -18.17 62.84 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.381 -0.827 . . . . 0.84 109.704 -177.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 40.5 m -62.81 -19.21 63.84 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 115.369 -0.832 . . . . 1.59 110.228 176.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1532 ' ' LEU . . . . . 0.468 ' HB2' HG21 ' A' 1552 ' ' ILE . 75.9 mt -105.87 3.86 29.06 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 120.672 0.272 . . . . 0.65 111.147 177.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1533 ' ' SER . . . . . 0.453 ' OG ' ' HA ' ' A' 1530 ' ' SER . 50.2 m -68.11 155.46 39.54 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 121.472 0.653 . . . . 1.52 111.792 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . 173.68 149.57 7.04 Favored Glycine 0 N--CA 1.422 -2.248 0 N-CA-C 109.373 -1.491 . . . . 1.1 109.373 -177.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 41.7 ttp180 -89.52 -21.29 22.99 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.189 0.519 . . . . 4.62 109.922 -177.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -81.02 -40.91 23.52 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 109.172 -0.677 . . . . 1.45 109.172 176.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 91.94 -151.16 20.64 Favored Glycine 0 N--CA 1.42 -2.424 0 CA-C-N 115.651 -0.704 . . . . 0.85 113.976 171.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -135.04 145.07 47.66 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 107.78 -1.192 . . . . 0.93 107.78 -177.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 15.5 p -111.45 127.69 55.76 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 123.903 0.752 . . . . 1.03 110.526 179.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1540 ' ' ALA . . . . . 0.708 ' HB2' ' HG2' ' A' 1624 ' ' PRO . . . -120.14 142.95 48.47 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 108.367 -0.975 . . . . 0.5 108.367 175.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -80.93 136.97 36.12 Favored 'General case' 0 C--N 1.314 -0.937 0 O-C-N 123.817 0.698 . . . . 0.74 110.354 -176.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1542 ' ' TYR . . . . . 0.867 ' HE2' ' HG ' ' A' 1626 ' ' LEU . 3.1 t80 -149.21 -99.08 0.07 Allowed 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 115.984 -0.553 . . . . 0.99 109.743 -174.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1543 ' ' SER . . . . . . . . . . . . . 30.0 t -72.31 151.48 42.73 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 109.04 -0.726 . . . . 1.91 109.04 -177.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1544 ' ' LYS . . . . . 0.583 ' HD2' ' HA ' ' B' ' 23' ' ' ASP . 62.7 tttp -57.95 -22.35 48.56 Favored 'General case' 0 C--N 1.346 0.416 0 C-N-CA 125.326 1.45 . . . . 3.59 112.318 -174.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 34.5 t -132.21 19.93 4.44 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 116.271 -0.422 . . . . 2.46 109.985 -178.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1546 ' ' GLY . . . . . 0.495 ' HA3' ' OE1' ' A' 1569 ' ' GLN . . . -159.14 127.93 1.93 Allowed Glycine 0 N--CA 1.439 -1.115 0 C-N-CA 118.816 -1.659 . . . . 1.26 113.988 -176.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 26.9 m -100.91 164.64 2.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 108.154 -1.054 . . . . 0.79 108.154 176.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1548 ' ' VAL . . . . . 0.494 ' CG1' ' HB3' ' A' 1540 ' ' ALA . 10.2 p -102.15 130.85 51.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 109.614 -0.513 . . . . 0.58 109.614 178.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -101.96 118.5 37.05 Favored 'General case' 0 CA--C 1.497 -1.068 0 C-N-CA 123.462 0.705 . . . . 1.08 109.287 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1550 ' ' MET . . . . . 0.522 ' SD ' ' HZ3' ' A' 1640 ' ' TRP . 8.9 ptp -127.81 144.93 51.07 Favored 'General case' 0 C--N 1.29 -2.011 0 C-N-CA 120.182 -0.607 . . . . 0.78 111.46 175.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 8.3 p -119.34 123.36 43.99 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 115.59 -0.732 . . . . 0.97 109.177 175.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1552 ' ' ILE . . . . . 0.474 HG22 ' SG ' ' A' 1553 ' ' CYS . 46.6 mm -81.24 114.09 21.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 C-N-CA 121.152 -0.219 . . . . 0.42 110.671 -177.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1553 ' ' CYS . . . . . 0.474 ' SG ' HG22 ' A' 1552 ' ' ILE . 31.1 m 66.91 38.38 3.67 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.62 0.768 . . . . 1.4 110.563 173.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . -177.41 -173.25 42.75 Favored Glycine 0 N--CA 1.417 -2.582 0 N-CA-C 109.343 -1.503 . . . . 0.35 109.343 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -110.38 148.62 31.63 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-O 121.095 0.474 . . . . 1.62 110.469 -178.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -99.09 131.1 45.38 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.656 -0.868 . . . . 0.87 108.656 -176.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -81.71 1.59 33.67 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 113.355 0.872 . . . . 2.49 113.355 -174.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 51.9 m-80 -83.39 -7.48 59.56 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 120.429 -0.508 . . . . 1.38 111.391 -179.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1559 ' ' CYS . . . . . 0.674 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 98.0 m -136.72 175.13 3.74 Favored Pre-proline 0 C--N 1.31 -1.127 0 CA-C-O 117.931 -1.033 . . . . 1.21 110.041 179.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1560 ' ' PRO . . . . . 0.674 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 4.3 Cg_exo -40.27 137.72 1.39 Allowed 'Trans proline' 0 C--N 1.387 2.559 0 C-N-CA 123.917 3.078 . . . . 0.71 113.516 177.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1561 ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' 1560 ' ' PRO . 71.6 Cg_exo -53.99 127.16 24.52 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 123.624 2.882 . . . . 0.8 112.845 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 102.29 6.7 47.6 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-N 115.85 -0.613 . . . . 0.46 113.028 -178.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1563 ' ' VAL . . . . . 0.604 HG11 ' HB2' ' A' 1566 ' ' CYS . 2.8 t -96.08 124.64 48.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 C-N-CA 123.171 0.588 . . . . 0.98 111.648 -177.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -97.26 -33.56 5.92 Favored Glycine 0 N--CA 1.44 -1.048 0 CA-C-N 115.34 -0.846 . . . . 0.28 111.747 178.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -129.9 125.54 35.79 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 109.62 -0.511 . . . . 0.28 109.62 178.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1566 ' ' CYS . . . . . 0.604 ' HB2' HG11 ' A' 1563 ' ' VAL . 43.7 t -151.24 139.73 20.52 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 120.664 0.269 . . . . 0.43 110.878 -179.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1567 ' ' PHE . . . . . 0.46 ' HB3' ' HG2' ' A' 1569 ' ' GLN . 10.9 m-85 -91.4 143.0 27.07 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 122.427 -0.17 . . . . 1.03 110.682 173.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -90.36 41.16 2.96 Favored Glycine 0 N--CA 1.431 -1.651 0 C-N-CA 120.54 -0.838 . . . . 1.13 111.821 -176.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1569 ' ' GLN . . . . . 0.495 ' OE1' ' HA3' ' A' 1546 ' ' GLY . 8.4 mm100 -80.33 -72.19 0.42 Allowed 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 108.838 -0.801 . . . . 2.58 108.838 177.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 19.0 p -133.37 35.14 3.46 Favored 'General case' 0 N--CA 1.433 -1.31 0 C-N-CA 123.869 0.868 . . . . 2.17 110.198 176.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 11.6 mmt180 67.61 63.02 0.42 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.743 1.217 . . . . 2.62 108.791 -174.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 31.1 mt -105.89 111.53 35.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 CA-C-N 115.946 -0.57 . . . . 0.92 110.814 -176.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 31.2 t -81.98 139.15 34.73 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.597 -0.729 . . . . 0.8 111.052 -177.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1574 ' ' VAL . . . . . 0.569 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 34.6 m -132.13 12.98 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-O 121.163 0.506 . . . . 0.98 111.329 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 178.98 122.62 0.77 Allowed Glycine 0 N--CA 1.423 -2.186 0 C-N-CA 120.158 -1.02 . . . . 0.29 111.761 177.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 29.5 ttpp -81.0 146.47 30.66 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 107.558 -1.275 . . . . 2.19 107.558 178.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -68.28 90.29 0.35 Allowed 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.232 0.539 . . . . 0.61 112.295 -175.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -107.37 179.69 4.18 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.414 -1.328 . . . . 1.95 107.414 176.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 60.0 mttp -138.47 48.13 1.95 Allowed 'General case' 0 CA--C 1.49 -1.341 0 N-CA-C 109.181 -0.674 . . . . 2.68 109.181 178.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1580 ' ' ARG . . . . . 0.529 ' HB3' HG12 ' A' 1591 ' ' VAL . 31.1 ttm180 -87.21 76.97 9.12 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.839 -0.745 . . . . 3.47 109.286 -177.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1581 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.13 124.98 31.01 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 114.478 -1.237 . . . . 0.64 108.65 -179.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -127.89 138.46 52.68 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 116.342 -0.39 . . . . 2.85 110.125 172.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1583 ' ' TYR . . . . . 0.572 ' HE2' ' HE2' ' A' 1527 ' ' PHE . 32.6 t80 -95.97 115.56 27.62 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 107.084 -1.45 . . . . 0.86 107.084 176.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1584 ' ' VAL . . . . . 0.726 ' O ' ' HB ' ' A' 1587 ' ' VAL . 6.3 p -138.76 102.0 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.044 0 C-N-CA 120.529 -0.468 . . . . 1.05 111.646 -176.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 19.4 t70 58.58 56.45 4.26 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 122.381 1.086 . . . . 1.17 110.658 179.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1586 ' ' GLN . . . . . 0.444 ' HA ' ' CZ ' ' A' 1583 ' ' TYR . 11.1 pt20 58.84 10.79 1.62 Allowed 'General case' 0 N--CA 1.499 1.993 0 C-N-CA 127.472 2.309 . . . . 1.86 112.32 -178.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1587 ' ' VAL . . . . . 0.726 ' HB ' ' O ' ' A' 1584 ' ' VAL . 2.8 t -97.02 124.61 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.245 0 CA-C-N 114.573 -1.194 . . . . 0.49 109.846 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1588 ' ' LEU . . . . . 0.915 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 4.1 mm? -90.41 108.92 20.08 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 107.239 -1.393 . . . . 0.36 107.239 175.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -109.52 122.0 46.45 Favored 'General case' 0 C--N 1.287 -2.114 0 C-N-CA 119.47 -0.892 . . . . 1.74 111.443 -176.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1590 ' ' LEU . . . . . 0.676 ' HB3' ' HB ' ' A' 1610 ' ' ILE . 44.8 tp -113.44 109.93 19.48 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 106.18 -1.785 . . . . 0.72 106.18 177.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1591 ' ' VAL . . . . . 0.529 HG12 ' HB3' ' A' 1580 ' ' ARG . 4.6 p -102.52 129.04 54.68 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 119.619 -0.832 . . . . 1.01 110.599 -177.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1592 ' ' TYR . . . . . 0.431 ' O ' ' HG3' ' A' 1607 ' ' LYS . 13.2 m-30 -117.37 126.91 53.46 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.437 -1.32 . . . . 0.5 107.437 177.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 12.9 ptmm? -140.6 176.69 8.58 Favored 'General case' 0 C--N 1.278 -2.515 0 N-CA-C 108.619 -0.882 . . . . 1.59 108.619 -174.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 9.3 m-20 58.58 41.8 21.76 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 124.599 1.187 . . . . 1.11 111.81 178.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -76.14 -98.8 0.14 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.15 -1.024 . . . . 0.78 110.954 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1596 ' ' SER . . . . . . . . . . . . . 12.4 t -120.97 152.44 56.43 Favored Pre-proline 0 C--N 1.285 -2.208 0 N-CA-C 105.61 -1.996 . . . . 1.07 105.61 174.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -61.84 139.12 78.27 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 122.376 2.05 . . . . 1.01 110.767 175.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 39.2 t -81.79 102.95 1.73 Allowed Pre-proline 0 C--N 1.302 -1.494 0 N-CA-C 106.658 -1.608 . . . . 0.75 106.658 178.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -62.11 -39.47 49.05 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 123.106 2.538 . . . . 1.7 113.184 -170.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1600 ' ' SER . . . . . . . . . . . . . 8.7 m -69.12 -15.09 63.34 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.47 -0.786 . . . . 2.26 112.817 -177.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1601 ' ' LYS . . . . . 0.458 ' HG2' HD22 ' A' 1604 ' ' LEU . 13.7 tppt? -135.31 87.91 2.37 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 107.318 -1.364 . . . . 3.01 107.318 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 14.9 m -44.66 114.47 0.71 Allowed 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 125.896 1.678 . . . . 2.07 114.456 -174.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 100.64 10.53 43.57 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 114.415 0.526 . . . . 1.08 114.415 175.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1604 ' ' LEU . . . . . 0.458 HD22 ' HG2' ' A' 1601 ' ' LYS . 9.2 mp -110.57 156.25 21.19 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 117.28 0.54 . . . . 1.84 111.197 178.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 16.5 m -121.34 147.8 45.2 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.514 -1.291 . . . . 1.41 107.514 173.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1606 ' ' TYR . . . . . 0.569 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 85.8 m-85 -71.91 149.99 44.61 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 110.377 -0.231 . . . . 0.6 110.377 177.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1607 ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' A' 1592 ' ' TYR . 6.1 ttpm? -146.94 135.86 22.32 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 123.856 0.723 . . . . 1.45 109.455 178.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1608 ' ' SER . . . . . . . . . . . . . 19.2 m -114.36 125.58 54.03 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 108.645 -0.872 . . . . 1.15 108.645 -178.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 39.1 t -105.59 108.26 24.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 108.808 -0.812 . . . . 0.25 108.808 178.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1610 ' ' ILE . . . . . 0.676 ' HB ' ' HB3' ' A' 1590 ' ' LEU . 79.1 mt -95.08 118.87 42.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 108.583 -0.895 . . . . 0.45 108.583 -178.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 26.6 t -117.24 110.52 18.22 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 108.972 -0.751 . . . . 1.26 108.972 -178.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1612 ' ' PHE . . . . . 0.915 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 70.8 m-85 -86.7 122.95 31.32 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.654 -0.869 . . . . 0.26 108.654 177.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 44.8 t -116.53 135.37 57.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.457 0 CA-C-N 115.433 -0.803 . . . . 0.5 110.144 -174.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1614 ' ' CYS . . . . . 0.422 ' HB2' ' HA ' ' A' 1646 ' ' CYS . 4.9 t -54.53 111.11 0.73 Allowed 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 124.573 1.149 . . . . 0.77 113.095 177.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1615 ' ' ARG . . . . . 0.687 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 18.6 tpt180 -137.29 91.04 14.78 Favored Pre-proline 0 N--CA 1.441 -0.911 0 N-CA-C 108.815 -0.809 . . . . 2.53 108.815 169.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1616 ' ' PRO . . . . . 0.445 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 18.8 Cg_exo -66.68 -23.49 48.95 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.251 1.967 . . . . 1.1 112.996 -175.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -71.5 -22.83 61.74 Favored 'General case' 0 N--CA 1.432 -1.35 0 C-N-CA 122.923 0.489 . . . . 3.05 111.822 178.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . 63.61 -156.52 0.32 Allowed 'General case' 0 C--N 1.359 1.006 0 N-CA-C 108.155 -1.054 . . . . 1.55 108.155 -174.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . 116.43 -157.3 15.12 Favored Glycine 0 N--CA 1.414 -2.773 0 C-N-CA 120.202 -0.999 . . . . 0.93 112.484 176.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -78.45 13.94 1.73 Allowed 'Trans proline' 0 C--N 1.325 -0.67 0 C-N-CA 123.683 2.922 . . . . 0.88 113.053 -175.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1621 ' ' THR . . . . . 0.708 ' HB ' ' HB2' ' A' 1641 ' ' HIS . 16.5 p -105.39 -7.84 18.54 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 115.002 -0.999 . . . . 0.97 109.598 178.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 56.6 t30 -87.79 65.68 8.49 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.444 -0.947 . . . . 0.72 108.444 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -166.72 141.53 3.47 Favored Pre-proline 0 C--N 1.307 -1.255 0 N-CA-C 107.743 -1.206 . . . . 3.26 107.743 -175.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1624 ' ' PRO . . . . . 0.708 ' HG2' ' HB2' ' A' 1540 ' ' ALA . 21.3 Cg_endo -60.87 104.58 0.28 Allowed 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.532 2.154 . . . . 0.59 111.408 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 85.3 mtp -101.98 135.46 43.5 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.824 -0.806 . . . . 1.37 108.824 -178.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1626 ' ' LEU . . . . . 0.867 ' HG ' ' HE2' ' A' 1542 ' ' TYR . 0.3 OUTLIER -87.63 118.68 27.28 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 107.9 -1.148 . . . . 0.89 107.9 -176.357 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A 1627 ' ' ILE . . . . . 0.787 HD11 ' HB2' ' A' 1639 ' ' SER . 39.9 mm -79.41 -50.28 18.41 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.879 0 N-CA-C 108.925 -0.768 . . . . 0.58 108.925 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 17.1 t -172.41 161.18 5.09 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 108.827 -0.805 . . . . 1.39 108.827 -176.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1629 ' ' LEU . . . . . 0.763 HD13 HD23 ' A' 1636 ' ' LEU . 13.6 tp -117.51 106.49 13.22 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.0 -1.111 . . . . 1.25 108.0 176.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 18.0 t70 -72.2 107.42 4.84 Favored 'General case' 0 CA--C 1.487 -1.478 0 N-CA-C 105.849 -1.908 . . . . 1.09 105.849 174.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1631 ' ' LYS . . . . . 0.513 ' HB3' HD21 ' B' ' 53' ' ' LEU . 54.4 mtmt -72.5 -35.42 68.15 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 115.173 -0.921 . . . . 3.6 111.138 -171.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -70.77 -38.99 73.48 Favored 'General case' 0 N--CA 1.417 -2.091 0 C-N-CA 120.412 -0.515 . . . . 2.6 112.089 -173.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 47.4 p -97.38 -0.87 45.6 Favored 'General case' 0 CA--C 1.566 1.562 0 N-CA-C 112.593 0.59 . . . . 0.75 112.593 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 84.5 m 59.61 52.77 5.41 Favored 'General case' 0 C--N 1.374 1.64 0 C-N-CA 124.709 1.204 . . . . 0.53 111.153 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1635 ' ' THR . . . . . . . . . . . . . 92.5 m -125.21 133.5 52.72 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.727 -0.67 . . . . 0.46 111.994 -175.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1636 ' ' LEU . . . . . 0.763 HD23 HD13 ' A' 1629 ' ' LEU . 9.7 mt -104.7 136.03 44.99 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.37 -0.974 . . . . 0.86 108.37 -179.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1637 ' ' PHE . . . . . 0.418 ' HB2' ' HB ' ' A' 1627 ' ' ILE . 58.6 m-85 -108.59 129.72 55.31 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 109.113 -0.699 . . . . 0.45 109.113 177.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -120.11 142.56 48.8 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 116.225 -0.443 . . . . 0.5 110.935 -178.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1639 ' ' SER . . . . . 0.787 ' HB2' HD11 ' A' 1627 ' ' ILE . 31.8 t -117.44 153.45 33.07 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 107.068 -1.456 . . . . 1.04 107.068 173.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1640 ' ' TRP . . . . . 0.522 ' HZ3' ' SD ' ' A' 1550 ' ' MET . 2.1 t90 -154.1 105.79 2.75 Favored 'General case' 0 N--CA 1.42 -1.973 0 N-CA-C 105.163 -2.162 . . . . 0.68 105.163 179.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1641 ' ' HIS . . . . . 0.708 ' HB2' ' HB ' ' A' 1621 ' ' THR . 38.1 m-70 -95.19 105.03 16.93 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 108.868 -0.79 . . . . 0.9 108.868 -175.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1642 ' ' THR . . . . . . . . . . . . . 14.3 t -141.97 152.41 61.88 Favored Pre-proline 0 CA--C 1.559 1.298 0 N-CA-C 108.846 -0.798 . . . . 0.48 108.846 -171.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1643 ' ' PRO . . . . . 0.445 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 73.7 Cg_endo -75.1 -24.31 12.79 Favored 'Trans proline' 0 C--N 1.367 1.522 0 C-N-CA 122.715 2.277 . . . . 0.66 114.139 -178.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 3.3 pp -75.73 -4.93 43.16 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 119.935 -0.706 . . . . 0.97 111.672 -177.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -116.15 23.87 11.85 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-O 122.318 1.056 . . . . 0.84 109.005 -178.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1646 ' ' CYS . . . . . 0.422 ' HA ' ' HB2' ' A' 1614 ' ' CYS . 52.9 t -115.67 140.46 49.17 Favored 'General case' 0 N--CA 1.401 -2.884 0 CA-C-N 115.0 -1.0 . . . . 1.19 110.511 -177.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 27.3 tt0 . . . . . 0 N--CA 1.427 -1.601 0 N-CA-C 106.309 -1.737 . . . . 3.14 106.309 172.653 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.427 -1.925 0 CA-C-O 120.792 0.107 . . . . 2.09 113.173 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -56.04 -42.77 87.83 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 115.236 0.854 . . . . 1.84 115.236 -173.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -63.2 -49.12 75.5 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.434 0.635 . . . . 2.55 110.39 -176.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 13.6 tp -66.99 -49.45 65.33 Favored 'General case' 0 C--O 1.252 1.203 0 CA-C-N 115.015 -0.993 . . . . 2.35 111.196 -175.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 14.3 p -64.68 -37.66 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 C-N-CA 120.399 -0.52 . . . . 2.11 110.944 -178.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -77.17 -17.56 58.47 Favored 'General case' 0 C--O 1.196 -1.734 0 C-N-CA 118.08 -1.448 . . . . 2.04 111.358 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 92.0 m -62.5 -41.31 98.74 Favored 'General case' 0 C--O 1.272 2.267 0 O-C-N 121.302 -0.874 . . . . 1.84 108.983 173.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.891 HD21 HD11 ' B' ' 42' ' ' ILE . 10.7 mp -63.4 -42.67 98.78 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 115.568 -0.742 . . . . 1.74 110.99 176.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -75.55 -11.85 60.1 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.02 -0.991 . . . . 2.39 111.267 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -67.95 -55.24 13.47 Favored 'General case' 0 C--N 1.314 -0.967 0 O-C-N 121.892 -0.505 . . . . 0.96 109.686 176.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 12.6 p -98.52 -17.5 6.68 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 C-N-CA 118.112 -1.435 . . . . 1.37 112.487 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 83.8 m -116.81 30.62 7.22 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.457 -0.777 . . . . 1.66 111.586 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -55.0 -57.11 19.78 Favored Glycine 0 C--N 1.342 0.894 0 N-CA-C 114.082 0.393 . . . . 1.53 114.082 -179.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.583 ' HA ' ' HD2' ' A' 1544 ' ' LYS . 17.6 t70 -65.93 -32.85 74.59 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-O 121.063 0.459 . . . . 2.72 111.182 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 21.3 tpp180 -69.53 -47.99 61.93 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.79 -0.641 . . . . 4.33 111.186 -178.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 111.43 170.49 18.95 Favored Glycine 0 N--CA 1.427 -1.961 0 N-CA-C 108.797 -1.721 . . . . 1.53 108.797 -175.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -135.6 140.63 44.75 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 117.399 0.6 . . . . 1.65 111.598 178.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -136.51 141.99 43.46 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.77 -0.455 . . . . 3.42 109.77 178.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' PHE . . . . . 0.457 ' CD2' ' HB ' ' B' ' 43' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.243 0.712 0 N-CA-C 112.321 0.489 . . . . 2.26 112.321 178.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.401 -3.694 0 N-CA-C 110.142 -1.183 . . . . 2.37 110.142 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . 0.891 HD11 HD21 ' B' ' 17' ' ' LEU . 28.3 pt -84.96 -22.53 7.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 113.152 0.797 . . . . 2.07 113.152 -170.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.457 ' HB ' ' CD2' ' B' ' 28' ' ' PHE . 2.9 p -58.69 -42.64 85.68 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.418 0 N-CA-C 112.399 0.518 . . . . 2.24 112.399 -177.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -83.14 -27.23 30.26 Favored 'General case' 0 N--CA 1.425 -1.681 0 N-CA-C 109.193 -0.669 . . . . 3.36 109.193 -174.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . 0.4 ' O ' ' HB2' ' B' ' 49' ' ' ARG . 46.9 mm-40 -70.01 -29.62 66.73 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 115.293 -0.867 . . . . 3.08 111.932 177.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' CYS . . . . . . . . . . . . . 36.3 t -98.07 -16.27 19.66 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 121.252 0.548 . . . . 2.23 111.058 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 42.8 t -77.3 -36.32 54.22 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.111 0.481 . . . . 2.37 110.654 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -109.81 -9.92 14.79 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 113.218 0.821 . . . . 2.82 113.218 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . 0.4 ' HB2' ' O ' ' B' ' 45' ' ' GLU . 28.0 mmt180 -135.64 151.09 49.88 Favored 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 106.037 -1.838 . . . . 4.09 106.037 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 14.7 m -76.04 117.73 18.06 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 108.981 -0.748 . . . . 2.67 108.981 -178.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 28.1 p -92.71 135.33 34.2 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 108.67 -0.863 . . . . 2.11 108.67 -176.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -87.54 139.66 30.31 Favored 'General case' 0 N--CA 1.416 -2.155 0 N-CA-C 109.03 -0.73 . . . . 2.67 109.03 177.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . 0.513 HD21 ' HB3' ' A' 1631 ' ' LYS . 61.0 tp -36.07 -39.86 0.19 Allowed 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 127.469 2.308 . . . . 1.9 113.952 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.42 -40.82 83.51 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 123.868 0.73 . . . . 1.52 111.796 -176.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 50.8 tp -58.56 -47.53 83.91 Favored 'General case' 0 C--O 1.22 -0.47 0 O-C-N 123.802 0.689 . . . . 1.97 111.03 -177.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 3.9 pp -80.45 -35.29 35.17 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 116.145 -0.479 . . . . 1.53 111.513 -174.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -67.33 -44.25 79.57 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 116.031 -0.532 . . . . 2.27 111.456 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 6.3 t -76.1 -31.29 58.62 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 119.598 -0.841 . . . . 2.33 111.251 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -69.12 -60.42 2.37 Favored 'General case' 0 C--O 1.244 0.775 0 N-CA-C 107.772 -1.196 . . . . 2.86 107.772 178.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 37.0 t . . . . . 0 CA--C 1.537 0.465 0 C-N-CA 125.303 1.441 . . . . 2.3 112.473 175.967 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A 1515 ' ' ASP . . . . . 0.543 ' O ' ' HB3' ' A' 1579 ' ' LYS . 14.3 t70 . . . . . 0 N--CA 1.437 -1.081 0 N-CA-C 106.649 -1.612 . . . . 2.9 106.649 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1516 ' ' CYS . . . . . 0.486 ' SG ' HD23 ' A' 1581 ' ' LEU . 46.9 t -148.92 79.18 1.41 Allowed 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.787 -1.19 . . . . 1.19 107.787 176.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -168.07 151.04 5.68 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 105.938 -1.875 . . . . 1.52 105.938 -173.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1518 ' ' VAL . . . . . 0.454 ' CG2' HD12 ' A' 1581 ' ' LEU . 2.9 m -144.89 142.58 22.95 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-O 120.885 0.374 . . . . 0.94 111.442 -176.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1519 ' ' THR . . . . . . . . . . . . . 33.8 m -95.79 139.29 32.23 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 109.497 -0.557 . . . . 0.89 109.497 177.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -76.95 116.13 54.51 Favored Pre-proline 0 C--O 1.244 0.787 0 N-CA-C 108.501 -0.926 . . . . 1.74 108.501 176.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -60.81 -24.85 80.01 Favored 'Trans proline' 0 C--O 1.243 0.728 0 C-N-CA 123.43 2.753 . . . . 1.58 113.807 -177.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 33.7 m -74.33 -31.17 62.34 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 113.348 0.87 . . . . 1.65 113.348 -175.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1523 ' ' THR . . . . . . . . . . . . . 8.9 t -137.65 -10.74 1.6 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 118.617 -1.233 . . . . 1.61 113.455 -176.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 82.45 31.07 31.54 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 119.897 -1.144 . . . . 1.13 112.173 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 25.1 t-80 -97.74 131.2 44.49 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.641 -0.874 . . . . 1.26 108.641 178.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 2.8 tm? -89.67 121.71 32.1 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.718 -0.674 . . . . 0.68 111.515 -175.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -91.81 127.84 37.41 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 108.544 -0.91 . . . . 0.65 108.544 168.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 15.2 t70 -120.64 113.89 20.9 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 109.055 -0.72 . . . . 1.17 109.055 177.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1529 ' ' LEU . . . . . 0.451 ' HG ' HD21 ' A' 1581 ' ' LEU . 3.7 mm? -97.13 -0.25 47.32 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 121.578 0.704 . . . . 0.6 109.931 -178.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 1.5 m -65.87 -25.74 67.32 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.841 -1.072 . . . . 0.84 109.945 -178.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 40.5 t -61.09 -24.06 65.95 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 123.224 0.61 . . . . 1.59 110.816 178.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1532 ' ' LEU . . . . . 0.559 ' HB2' HG21 ' A' 1552 ' ' ILE . 73.0 mt -97.49 8.61 44.29 Favored 'General case' 0 C--N 1.32 -0.674 0 O-C-N 122.106 -0.371 . . . . 0.65 111.729 -177.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1533 ' ' SER . . . . . . . . . . . . . 77.2 p -68.66 174.19 4.48 Favored 'General case' 0 C--O 1.251 1.174 0 CA-C-O 121.454 0.645 . . . . 1.52 111.818 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . 171.81 150.9 7.43 Favored Glycine 0 N--CA 1.419 -2.493 0 N-CA-C 109.956 -1.258 . . . . 1.1 109.956 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1535 ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' 1535 ' ' ARG . 22.9 ttt180 -87.42 -30.0 21.04 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.08 0.467 . . . . 4.62 110.802 -178.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -90.16 -35.82 15.17 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.579 0.704 . . . . 1.45 109.439 178.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 92.89 -150.99 20.24 Favored Glycine 0 N--CA 1.409 -3.123 0 CA-C-N 115.403 -0.817 . . . . 0.85 112.329 173.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -128.82 153.33 47.54 Favored 'General case' 0 C--N 1.281 -2.396 0 N-CA-C 106.435 -1.691 . . . . 0.93 106.435 -178.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 4.1 m -128.46 134.79 48.83 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 109.399 -0.593 . . . . 1.03 109.399 -175.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1540 ' ' ALA . . . . . 0.597 ' HB3' HG12 ' A' 1548 ' ' VAL . . . -129.93 143.61 50.89 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 115.758 -0.656 . . . . 0.5 109.488 -177.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -88.99 121.4 31.31 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.346 0.593 . . . . 0.74 110.517 -177.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1542 ' ' TYR . . . . . 0.59 ' CE2' ' HG ' ' A' 1626 ' ' LEU . 0.9 OUTLIER -111.49 -101.86 0.4 Allowed 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.464 -1.31 . . . . 0.99 107.464 -179.326 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A 1543 ' ' SER . . . . . 0.427 ' H ' ' HB3' ' A' 1542 ' ' TYR . 7.7 m -73.34 162.5 29.26 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 118.984 -0.532 . . . . 1.91 109.941 178.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -50.17 -42.93 51.95 Favored 'General case' 0 C--O 1.25 1.091 0 N-CA-C 113.388 0.884 . . . . 3.59 113.388 -178.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 23.3 t -100.67 15.1 29.33 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 110.516 -0.179 . . . . 2.46 110.516 -178.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . -132.7 131.29 6.12 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 118.81 -1.662 . . . . 1.26 116.726 -170.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 15.1 m -121.39 149.83 24.49 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 108.794 -0.817 . . . . 0.79 108.794 171.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1548 ' ' VAL . . . . . 0.597 HG12 ' HB3' ' A' 1540 ' ' ALA . 7.8 p -104.87 137.74 32.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 109.319 -0.622 . . . . 0.58 109.319 177.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -103.86 126.95 51.35 Favored 'General case' 0 N--CA 1.424 -1.755 0 CA-C-N 115.642 -0.708 . . . . 1.08 109.15 175.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1550 ' ' MET . . . . . 0.407 ' HA ' ' O ' ' A' 1564 ' ' GLY . 5.5 ppp? -144.24 138.5 28.04 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 115.082 -0.963 . . . . 0.78 110.27 -175.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 7.1 p -125.48 134.41 52.06 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 115.926 -0.579 . . . . 0.97 109.855 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1552 ' ' ILE . . . . . 0.559 HG21 ' HB2' ' A' 1532 ' ' LEU . 49.5 mm -82.24 114.94 23.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-N 116.625 -0.261 . . . . 0.42 111.36 -177.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 74.8 m 71.33 16.51 6.09 Favored 'General case' 0 CA--C 1.509 -0.6 0 C-N-CA 124.036 0.934 . . . . 1.4 113.057 171.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . -163.17 -175.26 33.99 Favored Glycine 0 N--CA 1.403 -3.5 0 C-N-CA 120.127 -1.035 . . . . 0.35 110.98 -176.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1555 ' ' GLU . . . . . 0.466 ' H ' ' CD ' ' A' 1555 ' ' GLU . 0.3 OUTLIER -91.36 148.57 22.23 Favored 'General case' 0 C--N 1.282 -2.351 0 C-N-CA 124.102 0.961 . . . . 1.62 111.755 -176.205 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 46.2 t-20 -114.46 129.85 56.68 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.729 -1.212 . . . . 0.87 107.729 178.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -79.93 2.18 24.48 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.025 0.75 . . . . 2.49 113.025 -173.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -74.24 -16.68 60.95 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 112.37 0.507 . . . . 1.38 112.37 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1559 ' ' CYS . . . . . 0.719 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 88.9 m -137.75 173.49 5.34 Favored Pre-proline 0 C--N 1.306 -1.289 0 CA-C-O 117.811 -1.09 . . . . 1.21 111.003 179.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1560 ' ' PRO . . . . . 0.719 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 7.3 Cg_exo -31.83 131.59 0.08 OUTLIER 'Trans proline' 0 C--N 1.393 2.917 0 C-N-CA 124.801 3.668 . . . . 0.71 114.735 177.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1561 ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' 1560 ' ' PRO . 83.6 Cg_exo -48.56 125.75 13.04 Favored 'Trans proline' 0 C--O 1.25 1.08 0 C-N-CA 124.553 3.502 . . . . 0.8 114.452 -174.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 93.88 23.94 21.61 Favored Glycine 0 N--CA 1.432 -1.575 0 CA-C-N 115.284 -0.871 . . . . 0.46 112.451 178.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1563 ' ' VAL . . . . . 0.531 HG11 ' HB2' ' A' 1559 ' ' CYS . 4.0 p -109.6 139.85 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 C-N-CA 119.773 -0.771 . . . . 0.98 110.543 -177.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1564 ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' 1550 ' ' MET . . . -104.41 -27.29 6.18 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 121.156 -0.545 . . . . 0.28 113.279 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -135.46 129.95 33.99 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 117.144 0.472 . . . . 0.28 110.188 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 31.7 t -160.3 137.61 9.42 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 122.465 0.306 . . . . 0.43 110.48 -178.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1567 ' ' PHE . . . . . 0.429 ' HA ' ' HA ' ' A' 1548 ' ' VAL . 76.2 m-85 -85.62 138.88 31.85 Favored 'General case' 0 C--O 1.247 0.963 0 N-CA-C 108.142 -1.058 . . . . 1.03 108.142 173.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -82.36 38.19 2.6 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.937 -0.649 . . . . 1.13 112.92 -176.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1569 ' ' GLN . . . . . 0.498 ' HB3' ' OD1' ' B' ' 15' ' ' ASP . 16.4 mm100 -83.48 -72.3 0.46 Allowed 'General case' 0 N--CA 1.443 -0.804 0 CA-C-O 121.045 0.45 . . . . 2.58 110.341 176.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 5.5 t -132.44 34.24 3.74 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-O 122.194 0.997 . . . . 2.17 109.217 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 61.32 55.86 2.8 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 124.902 1.281 . . . . 2.62 110.029 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 19.6 mt -97.17 114.37 34.01 Favored 'Isoleucine or valine' 0 C--O 1.244 0.805 0 N-CA-C 109.211 -0.662 . . . . 0.92 109.211 -177.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1573 ' ' SER . . . . . 0.748 ' HB3' ' HB2' ' A' 1596 ' ' SER . 19.5 t -74.39 130.73 40.2 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.552 0.692 . . . . 0.8 110.918 -178.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1574 ' ' VAL . . . . . 0.6 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 34.8 m -123.41 10.93 5.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 CA-C-O 121.33 0.586 . . . . 0.98 110.607 177.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 177.4 118.95 0.57 Allowed Glycine 0 N--CA 1.428 -1.852 0 C-N-CA 120.589 -0.815 . . . . 0.29 111.652 177.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1576 ' ' LYS . . . . . 0.453 ' HE3' ' HB2' ' A' 1576 ' ' LYS . 37.8 ttmt -74.62 148.32 40.81 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.978 -1.119 . . . . 2.19 107.978 178.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -75.74 83.98 2.72 Favored 'General case' 0 CA--C 1.499 -0.998 0 CA-C-O 121.456 0.646 . . . . 0.61 111.756 -175.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -99.06 166.04 11.45 Favored 'General case' 0 C--N 1.281 -2.39 0 N-CA-C 108.213 -1.032 . . . . 1.95 108.213 178.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1579 ' ' LYS . . . . . 0.543 ' HB3' ' O ' ' A' 1515 ' ' ASP . 67.3 mttm -120.32 42.09 3.06 Favored 'General case' 0 C--N 1.286 -2.158 0 CA-C-O 122.601 1.191 . . . . 2.68 107.869 -176.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 43.5 ttt180 -93.65 75.84 4.34 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 114.188 -1.369 . . . . 3.47 108.41 -173.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1581 ' ' LEU . . . . . 0.486 HD23 ' SG ' ' A' 1516 ' ' CYS . 0.6 OUTLIER -84.3 125.07 31.92 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 113.549 -1.66 . . . . 0.64 108.196 -178.566 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 60.8 mtm180 -125.73 138.51 53.87 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 116.457 -0.338 . . . . 2.85 111.289 178.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1583 ' ' TYR . . . . . . . . . . . . . 48.5 t80 -112.86 110.41 20.49 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 122.31 0.244 . . . . 0.86 110.48 -178.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1584 ' ' VAL . . . . . 0.566 ' O ' ' HB ' ' A' 1587 ' ' VAL . 15.4 m -129.69 93.23 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.265 0.555 . . . . 1.05 112.431 -178.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 26.9 t70 59.75 65.94 1.06 Allowed 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 123.805 0.842 . . . . 1.17 111.137 174.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1586 ' ' GLN . . . . . . . . . . . . 0.254 8.7 pt20 66.1 5.43 3.56 Favored 'General case' 0 N--CA 1.503 2.197 0 C-N-CA 127.163 2.185 . . . . 1.86 112.11 178.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1587 ' ' VAL . . . . . 0.566 ' HB ' ' O ' ' A' 1584 ' ' VAL . 36.0 t -104.0 120.14 53.75 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.749 0 CA-C-N 114.789 -1.096 . . . . 0.49 109.378 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1588 ' ' LEU . . . . . 0.811 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 2.6 mm? -96.16 107.58 19.93 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 106.135 -1.802 . . . . 0.36 106.135 176.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1589 ' ' GLN . . . . . 0.508 ' HA ' ' O ' ' A' 1610 ' ' ILE . 27.8 tt0 -107.96 116.45 31.99 Favored 'General case' 0 N--CA 1.409 -2.49 0 CA-C-O 121.955 0.883 . . . . 1.74 110.368 -176.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1590 ' ' LEU . . . . . 0.514 ' HB3' ' HB ' ' A' 1610 ' ' ILE . 1.1 tt -107.64 107.42 18.22 Favored 'General case' 0 C--N 1.28 -2.418 0 N-CA-C 105.009 -2.219 . . . . 0.72 105.009 -178.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 4.2 p -101.72 129.63 52.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 C-N-CA 119.572 -0.851 . . . . 1.01 111.403 -174.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1592 ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -119.4 105.74 11.58 Favored 'General case' 0 CA--C 1.496 -1.118 0 N-CA-C 108.502 -0.925 . . . . 0.5 108.502 177.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1593 ' ' LYS . . . . . 0.635 ' HB3' ' HD3' ' A' 1607 ' ' LYS . 18.4 pttp -126.43 174.76 8.38 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 109.428 -0.582 . . . . 1.59 109.428 -179.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 9.8 m-20 58.98 36.79 24.59 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 124.677 1.235 . . . . 1.11 110.996 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -73.52 -88.08 0.19 Allowed Glycine 0 N--CA 1.44 -1.082 0 N-CA-C 110.412 -1.075 . . . . 0.78 110.412 178.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1596 ' ' SER . . . . . 0.748 ' HB2' ' HB3' ' A' 1573 ' ' SER . 47.0 t -132.25 144.73 54.31 Favored Pre-proline 0 N--CA 1.416 -2.139 0 N-CA-C 107.788 -1.19 . . . . 1.07 107.788 175.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1597 ' ' PRO . . . . . 0.561 ' HA ' ' HA ' ' A' 1605 ' ' SER . 18.0 Cg_endo -58.89 130.78 38.33 Favored 'Trans proline' 0 C--O 1.24 0.578 0 C-N-CA 123.829 3.019 . . . . 1.01 112.462 179.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1598 ' ' CYS . . . . . 0.433 ' SG ' ' HB2' ' A' 1600 ' ' SER . 47.4 t -72.65 120.53 81.18 Favored Pre-proline 0 C--N 1.289 -2.041 0 CA-C-N 114.516 -1.22 . . . . 0.75 109.309 -174.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -65.13 -32.32 52.86 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.684 2.256 . . . . 1.7 110.635 178.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1600 ' ' SER . . . . . 0.769 ' HB3' HD13 ' B' ' 53' ' ' LEU . 7.1 m -64.47 -45.97 85.07 Favored 'General case' 0 N--CA 1.419 -1.983 0 CA-C-N 115.297 -0.865 . . . . 2.26 110.713 176.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1601 ' ' LYS . . . . . 0.583 ' HG2' HD21 ' A' 1604 ' ' LEU . 0.0 OUTLIER -121.9 93.54 4.03 Favored 'General case' 0 N--CA 1.429 -1.513 0 O-C-N 121.374 -0.828 . . . . 3.01 108.919 -178.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 7.0 m -55.8 125.04 19.6 Favored 'General case' 0 N--CA 1.426 -1.646 0 C-N-CA 124.316 1.046 . . . . 2.07 111.28 -177.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 106.03 -8.5 42.25 Favored Glycine 0 C--N 1.313 -0.702 0 C-N-CA 121.126 -0.559 . . . . 1.08 114.403 174.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1604 ' ' LEU . . . . . 0.583 HD21 ' HG2' ' A' 1601 ' ' LYS . 4.2 pp -128.35 155.7 44.27 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-N 118.218 1.009 . . . . 1.84 110.237 176.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1605 ' ' SER . . . . . 0.561 ' HA ' ' HA ' ' A' 1597 ' ' PRO . 7.7 p -103.19 152.83 21.0 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 123.042 0.537 . . . . 1.41 111.357 -176.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1606 ' ' TYR . . . . . 0.6 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 58.5 m-85 -63.34 161.3 14.28 Favored 'General case' 0 C--O 1.25 1.083 0 CA-C-N 116.4 -0.364 . . . . 0.6 110.906 175.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1607 ' ' LYS . . . . . 0.635 ' HD3' ' HB3' ' A' 1593 ' ' LYS . 24.5 ttpp -155.89 125.4 6.31 Favored 'General case' 0 CA--C 1.5 -0.968 0 CA-C-N 116.291 -0.413 . . . . 1.45 110.333 -178.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1608 ' ' SER . . . . . . . . . . . . . 22.3 m -105.4 127.04 52.77 Favored 'General case' 0 C--N 1.286 -2.185 0 N-CA-C 108.444 -0.947 . . . . 1.15 108.444 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 39.6 t -111.0 108.72 26.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 109.183 -0.673 . . . . 0.25 109.183 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1610 ' ' ILE . . . . . 0.514 ' HB ' ' HB3' ' A' 1590 ' ' LEU . 25.7 mm -89.67 123.41 41.86 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 106.776 -1.564 . . . . 0.45 106.776 -178.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 21.5 p -122.09 105.42 10.26 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 120.517 -0.473 . . . . 1.26 111.031 177.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1612 ' ' PHE . . . . . 0.811 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 68.1 m-85 -86.16 119.69 26.72 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.71 -0.848 . . . . 0.26 108.71 177.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 45.9 t -114.2 134.53 56.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 108.514 -0.921 . . . . 0.5 108.514 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 12.2 t -59.64 114.74 2.89 Favored 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 123.964 0.906 . . . . 0.77 112.403 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1615 ' ' ARG . . . . . 0.725 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 0.0 OUTLIER -132.2 89.52 37.23 Favored Pre-proline 0 N--CA 1.446 -0.66 0 N-CA-C 106.967 -1.494 . . . . 2.53 106.967 172.783 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A 1616 ' ' PRO . . . . . 0.626 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 34.4 Cg_exo -59.46 -32.84 97.04 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 123.077 2.518 . . . . 1.1 114.629 -173.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -77.23 -5.49 49.49 Favored 'General case' 0 C--O 1.252 1.228 0 N-CA-C 111.931 0.345 . . . . 3.05 111.931 -178.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . 58.49 -143.11 0.64 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.23 0.612 . . . . 1.55 109.98 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . 110.47 -157.64 14.89 Favored Glycine 0 N--CA 1.416 -2.681 0 CA-C-N 119.532 1.06 . . . . 0.93 111.821 178.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -80.55 13.63 2.22 Favored 'Trans proline' 0 C--N 1.323 -0.799 0 C-N-CA 123.455 2.77 . . . . 0.88 113.249 -177.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1621 ' ' THR . . . . . 0.901 ' HB ' ' HB2' ' A' 1641 ' ' HIS . 36.2 p -96.16 -14.46 22.77 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 115.48 -0.782 . . . . 0.97 110.049 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1622 ' ' ASN . . . . . 0.414 ' OD1' ' HB ' ' A' 1642 ' ' THR . 55.1 t30 -88.73 62.66 6.55 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 122.057 0.932 . . . . 0.72 110.148 -175.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1623 ' ' ARG . . . . . 0.409 ' HE ' ' HB3' ' A' 1623 ' ' ARG . 6.7 ptp180 -168.53 139.73 2.15 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-N 114.155 -1.384 . . . . 3.26 108.169 -178.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -63.35 119.1 6.03 Favored 'Trans proline' 0 C--O 1.25 1.111 0 C-N-CA 122.762 2.308 . . . . 0.59 113.353 -174.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 76.8 mtm -116.68 138.44 51.45 Favored 'General case' 0 C--O 1.245 0.865 0 N-CA-C 108.79 -0.819 . . . . 1.37 108.79 175.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1626 ' ' LEU . . . . . 0.59 ' HG ' ' CE2' ' A' 1542 ' ' TYR . 0.4 OUTLIER -88.16 118.71 27.93 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 107.661 -1.237 . . . . 0.89 107.661 -176.455 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A 1627 ' ' ILE . . . . . 0.68 HD11 ' HB2' ' A' 1639 ' ' SER . 33.3 mm -78.3 -53.18 14.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.392 -0.596 . . . . 0.58 109.392 -178.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 8.4 t -167.85 152.08 6.42 Favored 'General case' 0 N--CA 1.416 -2.136 0 N-CA-C 108.652 -0.87 . . . . 1.39 108.652 -174.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1629 ' ' LEU . . . . . 0.859 HD23 ' HG ' ' A' 1636 ' ' LEU . 1.8 tm? -121.64 102.17 8.06 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 105.741 -1.948 . . . . 1.25 105.741 176.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 31.9 t70 -70.63 124.18 23.64 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 120.118 -0.633 . . . . 1.09 109.784 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1631 ' ' LYS . . . . . 0.454 ' HB2' HD21 ' B' ' 53' ' ' LEU . 16.6 ptpt -79.38 -10.89 59.9 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 112.654 0.612 . . . . 3.6 112.654 -171.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -100.62 -34.71 9.77 Favored 'General case' 0 N--CA 1.421 -1.878 0 C-N-CA 120.221 -0.592 . . . . 2.6 111.515 -175.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 40.8 p -103.3 -6.86 21.58 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.05 0.452 . . . . 0.75 111.795 177.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 78.7 m 56.37 35.97 26.75 Favored 'General case' 0 C--N 1.361 1.085 0 C-N-CA 124.396 1.078 . . . . 0.53 111.982 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1635 ' ' THR . . . . . . . . . . . . . 59.5 m -99.54 132.08 45.11 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-N 114.218 -1.355 . . . . 0.46 109.996 178.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1636 ' ' LEU . . . . . 0.859 ' HG ' HD23 ' A' 1629 ' ' LEU . 0.8 OUTLIER -108.53 132.51 53.76 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.861 -1.533 . . . . 0.86 106.861 -178.39 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A 1637 ' ' PHE . . . . . 0.413 ' HB2' ' HB ' ' A' 1627 ' ' ILE . 94.3 m-85 -107.04 135.56 48.38 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 110.153 -0.314 . . . . 0.45 110.153 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -128.59 129.17 45.55 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.069 -0.514 . . . . 0.5 110.09 -175.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1639 ' ' SER . . . . . 0.68 ' HB2' HD11 ' A' 1627 ' ' ILE . 22.7 t -108.48 149.38 28.87 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.445 -0.946 . . . . 1.04 108.445 178.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 2.1 t90 -156.46 115.74 3.47 Favored 'General case' 0 N--CA 1.425 -1.714 0 N-CA-C 105.032 -2.21 . . . . 0.68 105.032 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1641 ' ' HIS . . . . . 0.901 ' HB2' ' HB ' ' A' 1621 ' ' THR . 18.9 m-70 -112.86 107.91 16.68 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 120.528 -0.469 . . . . 0.9 110.257 -177.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1642 ' ' THR . . . . . 0.414 ' HB ' ' OD1' ' A' 1622 ' ' ASN . 7.3 t -138.19 152.01 70.84 Favored Pre-proline 0 C--N 1.296 -1.727 0 CA-C-N 114.744 -1.116 . . . . 0.48 109.63 -171.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1643 ' ' PRO . . . . . 0.626 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 74.1 Cg_endo -79.49 -7.98 14.87 Favored 'Trans proline' 0 C--N 1.372 1.767 0 C-N-CA 122.496 2.131 . . . . 0.66 112.167 177.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 8.7 tt -68.11 -23.1 64.88 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-O 121.491 0.662 . . . . 0.97 109.549 177.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -93.51 5.65 50.87 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.706 -0.679 . . . . 0.84 110.948 -177.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1646 ' ' CYS . . . . . 0.472 ' SG ' ' HA ' ' A' 1643 ' ' PRO . 72.2 m -93.82 142.77 26.99 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 120.804 0.335 . . . . 1.19 111.501 -177.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 . . . . . 0 C--N 1.297 -1.687 0 C-N-CA 123.691 0.796 . . . . 3.14 108.887 178.339 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.426 -2.003 0 N-CA-C 111.278 -0.729 . . . . 2.09 111.278 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -101.03 -64.18 0.78 Allowed Glycine 0 C--N 1.306 -1.134 0 N-CA-C 115.03 0.772 . . . . 1.84 115.03 -177.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -71.07 -45.08 64.42 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.894 0.702 . . . . 2.55 112.894 -170.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 12.5 tp -45.52 -57.88 3.8 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 123.729 0.643 . . . . 2.35 112.562 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 13.2 p -70.89 -31.35 45.2 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 CA-C-N 115.726 -0.67 . . . . 2.11 111.386 -177.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' ASP . . . . . 0.498 ' OD1' ' HB3' ' A' 1569 ' ' GLN . 3.3 t0 -72.95 -40.53 65.3 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 119.271 -0.972 . . . . 2.04 111.766 -176.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 12.4 t -65.0 -32.09 73.65 Favored 'General case' 0 C--O 1.254 1.293 0 O-C-N 121.302 -0.874 . . . . 1.84 109.773 176.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.53 ' O ' ' HB2' ' B' ' 21' ' ' CYS . 9.5 mt -67.05 -23.03 65.84 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-N 115.663 -0.699 . . . . 1.74 112.58 172.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -91.47 -17.7 25.32 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 121.643 0.735 . . . . 2.39 109.552 176.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -68.64 -60.23 2.56 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.819 -0.628 . . . . 0.96 111.699 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 12.5 p -94.43 -20.28 6.21 Favored 'Isoleucine or valine' 0 C--O 1.242 0.671 0 C-N-CA 118.128 -1.429 . . . . 1.37 111.841 -178.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' CYS . . . . . 0.53 ' HB2' ' O ' ' B' ' 17' ' ' LEU . 7.7 m -107.07 18.3 21.92 Favored 'General case' 0 C--O 1.201 -1.453 0 C-N-CA 120.022 -0.671 . . . . 1.66 109.822 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.53 -44.65 97.5 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 115.702 1.041 . . . . 1.53 115.702 -178.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -76.46 -48.5 19.41 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 117.483 0.642 . . . . 2.72 111.62 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 35.9 ttp180 -73.84 -25.35 60.03 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.316 0.579 . . . . 4.33 111.746 -175.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.16 144.15 10.09 Favored Glycine 0 N--CA 1.425 -2.062 0 N-CA-C 110.9 -0.88 . . . . 1.53 110.9 177.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -88.1 124.09 33.44 Favored 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 120.035 -0.666 . . . . 1.65 109.354 175.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -128.55 76.61 1.72 Allowed 'General case' 0 CA--C 1.497 -1.081 0 CA-C-O 121.618 0.723 . . . . 3.42 110.418 -173.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' PHE . . . . . 0.512 ' HB2' HG12 ' B' ' 42' ' ' ILE . 12.9 p90 . . . . . 0 C--N 1.289 -2.03 0 CA-C-N 115.455 -0.793 . . . . 2.26 110.808 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.387 -4.6 0 N-CA-C 107.653 -2.179 . . . . 2.37 107.653 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . 0.512 HG12 ' HB2' ' B' ' 28' ' ' PHE . 33.4 pt -69.93 -4.61 4.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 111.943 0.349 . . . . 2.07 111.943 -175.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 2.5 p -52.81 -40.63 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 CA-C-N 115.661 -0.699 . . . . 2.24 110.08 169.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -92.51 -19.28 22.14 Favored 'General case' 0 N--CA 1.419 -2.003 0 O-C-N 121.294 -0.879 . . . . 3.36 108.941 -175.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . 0.437 ' CB ' ' HA ' ' B' ' 42' ' ' ILE . 6.4 tp10 -81.28 -2.47 49.06 Favored 'General case' 0 CA--C 1.555 1.161 0 CA-C-N 114.46 -1.245 . . . . 3.08 109.517 -178.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' CYS . . . . . . . . . . . . . 88.8 m -133.84 -20.3 1.99 Allowed 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.249 0.833 . . . . 2.23 113.249 178.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 98.4 m -80.94 -9.84 59.79 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 119.576 -0.85 . . . . 2.37 113.178 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -133.7 20.5 3.88 Favored 'General case' 0 C--N 1.319 -0.727 0 O-C-N 121.498 -0.751 . . . . 2.82 111.773 178.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -169.68 174.7 5.66 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 106.772 -1.566 . . . . 4.09 106.772 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 22.8 t -101.0 143.69 30.84 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-O 121.444 0.64 . . . . 2.67 110.763 -174.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 26.4 p -145.0 151.09 38.03 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-N 115.44 -0.8 . . . . 2.11 108.908 178.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' 1600 ' ' SER . 4.4 p-10 -127.55 -173.99 3.06 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.6 -0.727 . . . . 2.67 109.232 174.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . 0.769 HD13 ' HB3' ' A' 1600 ' ' SER . 46.3 tp -35.58 -39.88 0.15 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 128.088 2.555 . . . . 1.9 115.503 -174.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -49.32 -59.39 3.74 Favored 'General case' 0 CA--C 1.502 -0.888 0 C-N-CA 123.865 0.866 . . . . 1.52 112.129 -172.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 67.6 tp -59.78 -41.78 91.86 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 125.132 1.373 . . . . 1.97 112.803 -176.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 2.6 pp -83.54 -22.48 32.38 Favored 'General case' 0 N--CA 1.422 -1.827 0 C-N-CA 118.654 -1.219 . . . . 1.53 112.257 -173.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -86.48 -33.7 20.27 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 119.397 -0.921 . . . . 2.27 111.186 173.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 18.0 p -60.56 -44.01 96.65 Favored 'General case' 0 C--N 1.357 0.916 0 CA-C-N 118.02 0.373 . . . . 2.33 110.08 176.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -82.16 -81.55 0.15 Allowed 'General case' 0 N--CA 1.428 -1.528 0 C-N-CA 119.507 -0.877 . . . . 2.86 109.505 173.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 41.3 t . . . . . 0 N--CA 1.474 0.732 0 C-N-CA 123.69 0.796 . . . . 2.3 111.652 -178.333 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 12.7 t70 . . . . . 0 CA--C 1.515 -0.376 0 N-CA-C 106.857 -1.535 . . . . 2.9 106.857 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 12.9 m -139.84 81.77 1.84 Allowed 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.546 -0.752 . . . . 1.19 110.204 173.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1517 ' ' GLN . . . . . 0.405 ' HA ' ' O ' ' A' 1527 ' ' PHE . 4.1 pt20 -162.65 130.34 3.8 Favored 'General case' 0 N--CA 1.417 -2.106 0 N-CA-C 108.19 -1.041 . . . . 1.52 108.19 -179.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1518 ' ' VAL . . . . . 0.526 ' CG2' HD12 ' A' 1581 ' ' LEU . 4.3 m -129.72 136.97 57.9 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.125 0 CA-C-O 121.276 0.56 . . . . 0.94 110.789 -176.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1519 ' ' THR . . . . . 0.429 ' OG1' HD23 ' A' 1526 ' ' LEU . 23.8 m -112.33 132.42 54.99 Favored 'General case' 0 C--N 1.286 -2.164 0 CA-C-N 115.584 -0.734 . . . . 0.89 109.398 -178.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1520 ' ' ASN . . . . . 0.418 ' OD1' HG22 ' A' 1523 ' ' THR . 27.0 t-20 -86.8 110.19 30.45 Favored Pre-proline 0 N--CA 1.423 -1.804 0 N-CA-C 107.845 -1.168 . . . . 1.74 107.845 174.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -68.54 -16.29 42.58 Favored 'Trans proline' 0 N--CA 1.466 -0.136 0 C-N-CA 122.852 2.368 . . . . 1.58 112.775 -174.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1522 ' ' SER . . . . . 0.409 ' HB2' ' OD1' ' A' 1520 ' ' ASN . 15.2 m -71.76 -31.63 66.85 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 116.042 -0.526 . . . . 1.65 111.458 -178.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1523 ' ' THR . . . . . 0.418 HG22 ' OD1' ' A' 1520 ' ' ASN . 7.5 t -132.99 -4.06 3.14 Favored 'General case' 0 CA--C 1.56 1.345 0 C-N-CA 119.377 -0.929 . . . . 1.61 112.675 179.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 77.39 20.79 74.22 Favored Glycine 0 CA--C 1.497 -1.037 0 O-C-N 121.898 -0.501 . . . . 1.13 113.089 177.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -87.75 118.2 27.1 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 109.006 -0.739 . . . . 1.26 109.006 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1526 ' ' LEU . . . . . 0.429 HD23 ' OG1' ' A' 1519 ' ' THR . 1.0 OUTLIER -100.12 114.81 28.44 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-N 114.22 -1.355 . . . . 0.68 110.458 -175.153 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A 1527 ' ' PHE . . . . . 0.405 ' O ' ' HA ' ' A' 1517 ' ' GLN . 96.3 m-85 -93.75 113.61 25.71 Favored 'General case' 0 CA--C 1.508 -0.665 0 N-CA-C 109.375 -0.602 . . . . 0.65 109.375 176.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 19.9 t70 -104.4 119.17 38.37 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 120.073 -0.651 . . . . 1.17 110.487 175.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1529 ' ' LEU . . . . . 0.761 ' HG ' HD21 ' A' 1581 ' ' LEU . 3.0 mm? -104.23 1.96 31.11 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.751 -0.659 . . . . 0.6 109.645 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 3.1 m -67.07 -24.42 65.97 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 108.641 -0.874 . . . . 0.84 108.641 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 22.8 t -61.18 -27.11 68.18 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 115.093 -0.958 . . . . 1.59 110.295 175.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 81.9 mt -95.28 0.67 54.05 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 122.094 -0.379 . . . . 0.65 111.691 -177.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1533 ' ' SER . . . . . 0.537 ' HA ' ' O ' ' A' 1552 ' ' ILE . 34.3 t -70.94 171.04 11.46 Favored 'General case' 0 C--O 1.26 1.646 0 CA-C-O 121.577 0.703 . . . . 1.52 111.405 -178.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . 170.56 152.03 7.86 Favored Glycine 0 N--CA 1.43 -1.739 0 CA-C-N 115.278 -0.874 . . . . 1.1 111.423 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 23.2 ttt180 -89.37 -32.75 17.15 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 123.682 0.793 . . . . 4.62 110.524 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -83.59 -34.27 25.18 Favored 'General case' 0 C--O 1.245 0.816 0 CA-C-O 121.606 0.717 . . . . 1.45 109.41 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 92.24 -150.04 19.96 Favored Glycine 0 N--CA 1.415 -2.707 0 CA-C-N 115.057 -0.974 . . . . 0.85 111.905 174.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -138.06 152.22 48.61 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 107.338 -1.356 . . . . 0.93 107.338 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 2.6 p -108.19 128.47 54.74 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 123.628 0.58 . . . . 1.03 110.673 179.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1540 ' ' ALA . . . . . 0.488 ' HB3' ' CG1' ' A' 1548 ' ' VAL . . . -117.31 140.93 48.93 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.31 -0.996 . . . . 0.5 108.31 175.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -79.92 127.55 32.39 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 116.09 -0.505 . . . . 0.74 109.986 -177.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1542 ' ' TYR . . . . . 0.403 ' CE1' ' HG ' ' A' 1626 ' ' LEU . 4.6 t80 -111.44 -99.5 0.41 Allowed 'General case' 0 N--CA 1.417 -2.112 0 N-CA-C 105.832 -1.914 . . . . 0.99 105.832 178.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1543 ' ' SER . . . . . . . . . . . . . 4.9 m -70.71 173.91 6.62 Favored 'General case' 0 N--CA 1.414 -2.25 0 N-CA-C 108.611 -0.885 . . . . 1.91 108.611 172.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -68.8 -37.9 79.56 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.093 -1.004 . . . . 3.59 109.512 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 38.9 m -107.26 35.53 3.02 Favored 'General case' 0 N--CA 1.408 -2.549 0 CA-C-N 115.25 -0.886 . . . . 2.46 110.079 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . -155.66 121.94 1.15 Allowed Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.055 -1.069 . . . . 1.26 114.044 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 34.7 m -112.85 149.89 15.18 Favored 'Isoleucine or valine' 0 C--O 1.253 1.28 0 CA-C-O 121.502 0.668 . . . . 0.79 110.672 176.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1548 ' ' VAL . . . . . 0.488 ' CG1' ' HB3' ' A' 1540 ' ' ALA . 10.3 p -102.18 139.23 23.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 109.078 -0.712 . . . . 0.58 109.078 177.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1549 ' ' TYR . . . . . 0.528 ' HB3' ' ND2' ' A' 1556 ' ' ASN . 58.0 m-85 -97.46 129.74 44.62 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 123.173 0.589 . . . . 1.08 109.8 178.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 24.9 ptm -144.35 127.41 16.53 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-N 115.538 -0.756 . . . . 0.78 110.228 -178.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 7.4 p -112.68 117.0 31.05 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 115.514 -0.766 . . . . 0.97 109.177 178.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1552 ' ' ILE . . . . . 0.537 ' O ' ' HA ' ' A' 1533 ' ' SER . 41.3 mm -74.83 113.66 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.374 0 N-CA-C 109.845 -0.428 . . . . 0.42 109.845 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 75.6 m 66.13 45.56 2.32 Favored 'General case' 0 CA--C 1.493 -1.231 0 O-C-N 124.229 0.956 . . . . 1.4 111.745 174.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . -179.72 177.05 47.98 Favored Glycine 0 N--CA 1.406 -3.318 0 C-N-CA 119.306 -1.426 . . . . 0.35 111.184 177.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -95.75 141.05 29.68 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 109.469 -0.567 . . . . 1.62 109.469 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1556 ' ' ASN . . . . . 0.528 ' ND2' ' HB3' ' A' 1549 ' ' TYR . 44.4 t-20 -92.75 124.68 36.93 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 109.03 -0.729 . . . . 0.87 109.03 -177.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -67.41 -5.89 16.72 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.188 0.81 . . . . 2.49 113.188 -176.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -98.62 0.18 44.3 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 112.09 0.404 . . . . 1.38 112.09 -174.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1559 ' ' CYS . . . . . 0.47 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 20.4 m -137.82 170.39 10.62 Favored Pre-proline 0 C--N 1.307 -1.277 0 CA-C-O 117.966 -1.016 . . . . 1.21 111.068 177.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1560 ' ' PRO . . . . . 0.482 ' HA ' ' HD3' ' A' 1561 ' ' PRO . 64.4 Cg_exo -29.6 134.96 0.04 OUTLIER 'Trans proline' 0 C--N 1.392 2.855 0 C-N-CA 125.006 3.804 . . . . 0.71 114.063 174.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1561 ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' 1560 ' ' PRO . 52.3 Cg_exo -53.82 126.72 22.85 Favored 'Trans proline' 0 C--O 1.242 0.701 0 C-N-CA 123.616 2.877 . . . . 0.8 113.799 -175.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 89.56 18.56 51.77 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 115.677 -0.692 . . . . 0.46 113.664 175.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1563 ' ' VAL . . . . . . . . . . . . . 4.1 p -109.44 140.34 28.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 117.74 0.77 . . . . 0.98 110.151 -177.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -101.27 -30.03 6.13 Favored Glycine 0 C--N 1.315 -0.635 0 CA-C-N 116.035 -0.529 . . . . 0.28 112.9 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -128.17 126.99 42.14 Favored 'General case' 0 C--N 1.313 -0.997 0 O-C-N 122.414 -0.463 . . . . 0.28 109.906 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 9.4 t -160.44 141.7 12.19 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 122.894 0.478 . . . . 0.43 110.154 -176.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1567 ' ' PHE . . . . . 0.434 ' HE1' HG21 ' A' 1574 ' ' VAL . 85.9 m-85 -85.78 132.93 34.03 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.744 -0.836 . . . . 1.03 108.744 176.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -81.56 14.14 31.44 Favored Glycine 0 C--N 1.342 0.878 0 C-N-CA 120.494 -0.86 . . . . 1.13 113.45 -173.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1569 ' ' GLN . . . . . 0.4 ' HB3' ' OD1' ' B' ' 15' ' ' ASP . 16.2 mm100 -84.64 -70.17 0.6 Allowed 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.188 0.518 . . . . 2.58 110.993 177.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1570 ' ' THR . . . . . 0.453 HG21 ' HA ' ' B' ' 12' ' ' GLU . 1.1 p -108.56 10.76 27.07 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 113.019 0.748 . . . . 2.17 113.019 -174.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 11.8 mmt180 59.52 36.54 22.92 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.451 -0.795 . . . . 2.62 110.383 178.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 45.0 mt -83.2 125.73 40.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 109.584 -0.524 . . . . 0.92 109.584 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 37.2 t -78.11 129.02 34.69 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.47 -0.786 . . . . 0.8 110.444 -176.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1574 ' ' VAL . . . . . 0.434 HG21 ' HE1' ' A' 1567 ' ' PHE . 1.4 t -112.85 -19.13 7.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 N-CA-C 112.857 0.688 . . . . 0.98 112.857 -177.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . -179.9 127.62 1.14 Allowed Glycine 0 C--N 1.305 -1.174 0 C-N-CA 119.172 -1.49 . . . . 0.29 112.576 -179.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -63.99 149.32 47.62 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 123.869 0.868 . . . . 2.19 109.99 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -64.93 83.42 0.04 OUTLIER 'General case' 0 C--O 1.244 0.769 0 C-N-CA 123.494 0.718 . . . . 0.61 111.352 177.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1578 ' ' ASN . . . . . 0.41 ' HB3' ' CD1' ' A' 1592 ' ' TYR . 45.5 t30 -89.18 150.39 22.7 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 106.966 -1.494 . . . . 1.95 106.966 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -137.5 51.09 1.94 Allowed 'General case' 0 C--N 1.287 -2.149 0 CA-C-O 122.911 1.339 . . . . 2.68 109.132 -172.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -123.66 81.31 1.89 Allowed 'General case' 0 N--CA 1.412 -2.342 0 CA-C-N 113.754 -1.566 . . . . 3.47 108.83 -176.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1581 ' ' LEU . . . . . 0.761 HD21 ' HG ' ' A' 1529 ' ' LEU . 0.5 OUTLIER -63.65 125.04 22.97 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 113.154 -1.839 . . . . 0.64 110.266 -177.834 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A 1582 ' ' ARG . . . . . 0.631 ' HB2' ' HB3' ' A' 1589 ' ' GLN . 92.5 mtt180 -112.45 140.34 47.27 Favored 'General case' 0 C--N 1.293 -1.874 0 O-C-N 121.657 -0.652 . . . . 2.85 111.274 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1583 ' ' TYR . . . . . 0.669 ' HE1' ' HA ' ' A' 1586 ' ' GLN . 32.7 t80 -113.28 104.17 12.06 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 109.287 -0.634 . . . . 0.86 109.287 177.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1584 ' ' VAL . . . . . 0.511 ' O ' ' HB ' ' A' 1587 ' ' VAL . 16.8 m -125.18 89.43 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-N 115.519 -0.764 . . . . 1.05 112.572 -175.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 37.2 t70 61.0 51.17 4.64 Favored 'General case' 0 N--CA 1.502 2.155 0 CA-C-O 122.205 1.002 . . . . 1.17 110.498 177.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1586 ' ' GLN . . . . . 0.669 ' HA ' ' HE1' ' A' 1583 ' ' TYR 0.288 28.4 pt20 65.2 20.65 11.98 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 126.929 2.091 . . . . 1.86 111.703 179.157 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A 1587 ' ' VAL . . . . . 0.511 ' HB ' ' O ' ' A' 1584 ' ' VAL . 45.4 t -108.96 121.62 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.406 0 CA-C-N 113.775 -1.557 . . . . 0.49 106.881 172.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1588 ' ' LEU . . . . . 0.765 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 2.4 mm? -95.36 113.22 24.86 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 107.576 -1.268 . . . . 0.36 107.576 -177.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1589 ' ' GLN . . . . . 0.631 ' HB3' ' HB2' ' A' 1582 ' ' ARG . 35.9 tt0 -107.97 140.08 41.65 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.559 0.695 . . . . 1.74 112.484 -172.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 29.6 mt -133.12 93.16 3.13 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 114.065 -1.425 . . . . 0.72 107.807 173.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 5.4 p -89.39 122.33 40.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.867 -0.79 . . . . 1.01 108.867 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1592 ' ' TYR . . . . . 0.443 ' HB2' ' HB3' ' A' 1608 ' ' SER . 12.9 m-30 -111.84 102.96 11.19 Favored 'General case' 0 C--N 1.29 -2.017 0 O-C-N 121.672 -0.643 . . . . 0.5 110.096 -177.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -104.21 178.99 4.4 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 109.852 -0.425 . . . . 1.59 109.852 177.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 17.1 m-20 68.9 55.22 0.45 Allowed 'General case' 0 C--O 1.246 0.883 0 C-N-CA 123.763 0.825 . . . . 1.11 112.497 178.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -88.54 -122.41 1.94 Allowed Glycine 0 N--CA 1.43 -1.765 0 N-CA-C 109.781 -1.328 . . . . 0.78 109.781 174.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1596 ' ' SER . . . . . . . . . . . . . 43.9 p -108.35 153.91 41.72 Favored Pre-proline 0 C--N 1.294 -1.843 0 N-CA-C 108.734 -0.839 . . . . 1.07 108.734 176.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.23 120.51 8.45 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 122.448 2.099 . . . . 1.01 110.509 176.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 43.3 t -78.94 129.2 74.06 Favored Pre-proline 0 C--N 1.289 -2.034 0 CA-C-N 115.173 -0.921 . . . . 0.75 109.949 -174.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -71.37 -14.16 30.92 Favored 'Trans proline' 0 C--O 1.247 0.968 0 C-N-CA 122.852 2.368 . . . . 1.7 113.316 -178.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1600 ' ' SER . . . . . . . . . . . . . 4.7 m -75.62 -52.85 9.63 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 116.45 -0.341 . . . . 2.26 110.627 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1601 ' ' LYS . . . . . 0.804 ' HE3' ' HA ' ' A' 1601 ' ' LYS . 1.1 tpmt? -116.09 101.95 9.19 Favored 'General case' 0 N--CA 1.401 -2.894 0 N-CA-C 106.359 -1.719 . . . . 3.01 106.359 178.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 16.9 m -58.38 119.85 7.7 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 123.213 0.605 . . . . 2.07 110.245 -178.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 102.16 -1.61 50.93 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 111.524 -0.631 . . . . 1.08 111.524 -178.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1604 ' ' LEU . . . . . 0.428 HD23 ' SG ' ' A' 1634 ' ' CYS . 8.8 tp -102.97 164.19 11.76 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 107.985 -1.117 . . . . 1.84 107.985 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 31.1 t -131.03 150.58 52.08 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 107.724 -1.213 . . . . 1.41 107.724 -178.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1606 ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -67.62 155.5 39.02 Favored 'General case' 0 C--O 1.245 0.854 0 N-CA-C 109.578 -0.527 . . . . 0.6 109.578 177.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 26.2 pttm -154.67 137.58 15.41 Favored 'General case' 0 N--CA 1.44 -0.928 0 C-N-CA 120.061 -0.656 . . . . 1.45 110.691 178.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1608 ' ' SER . . . . . 0.443 ' HB3' ' HB2' ' A' 1592 ' ' TYR . 41.4 t -107.61 122.84 47.51 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 114.949 -1.023 . . . . 1.15 110.244 -176.021 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 22.5 t -104.79 98.51 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 108.618 -0.882 . . . . 0.25 108.618 176.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 80.2 mt -90.95 116.72 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.653 0 N-CA-C 107.693 -1.225 . . . . 0.45 107.693 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 10.8 p -121.45 114.84 21.83 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 115.616 -0.72 . . . . 1.26 111.547 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1612 ' ' PHE . . . . . 0.765 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 65.9 m-85 -87.4 123.69 32.61 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 108.213 -1.032 . . . . 0.26 108.213 175.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 46.9 t -114.24 134.15 58.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 116.182 -0.463 . . . . 0.5 109.987 -175.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1614 ' ' CYS . . . . . 0.467 ' HA ' ' HB2' ' A' 1646 ' ' CYS . 0.9 OUTLIER -50.94 111.24 0.52 Allowed 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.347 1.059 . . . . 0.77 112.479 175.724 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A 1615 ' ' ARG . . . . . 0.555 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 30.1 tpt180 -134.44 91.31 22.45 Favored Pre-proline 0 N--CA 1.446 -0.668 0 C-N-CA 120.283 -0.567 . . . . 2.53 109.933 173.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1616 ' ' PRO . . . . . 0.504 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 17.2 Cg_exo -66.76 -28.38 43.64 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.393 2.062 . . . . 1.1 112.442 -179.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1617 ' ' GLU . . . . . 0.49 ' OE1' ' HD2' ' A' 1616 ' ' PRO . 17.9 mp0 -59.73 -39.81 85.96 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 123.928 0.891 . . . . 3.05 110.638 178.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . 49.04 86.54 0.03 OUTLIER 'General case' 0 C--O 1.246 0.874 0 C-N-CA 124.44 1.096 . . . . 1.55 113.581 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . -118.23 -151.31 9.11 Favored Glycine 0 C--N 1.281 -2.499 0 N-CA-C 110.221 -1.152 . . . . 0.93 110.221 178.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.97 10.25 0.91 Allowed 'Trans proline' 0 N--CA 1.486 1.054 0 C-N-CA 122.964 2.443 . . . . 0.88 114.166 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1621 ' ' THR . . . . . . . . . . . . . 14.5 p -100.68 6.93 44.14 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 122.012 0.91 . . . . 0.97 110.435 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -85.06 65.28 9.15 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 106.67 -1.604 . . . . 0.72 106.67 175.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -169.96 139.56 1.59 Allowed Pre-proline 0 N--CA 1.435 -1.195 0 C-N-CA 124.849 1.26 . . . . 3.26 107.647 -177.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1624 ' ' PRO . . . . . 0.52 ' HA ' ' O ' ' A' 1639 ' ' SER . 50.6 Cg_endo -67.93 106.91 1.4 Allowed 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.885 2.39 . . . . 0.59 112.327 -176.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 72.1 mtm -105.63 147.36 28.55 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 120.779 -0.368 . . . . 1.37 110.885 178.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1626 ' ' LEU . . . . . 0.403 ' HG ' ' CE1' ' A' 1542 ' ' TYR . 1.9 tm? -82.55 118.16 23.07 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 106.727 -1.582 . . . . 0.89 106.727 -178.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 42.9 mm -80.46 -54.08 11.38 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.783 0 N-CA-C 108.61 -0.885 . . . . 0.58 108.61 178.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 34.4 t -164.9 159.14 17.94 Favored 'General case' 0 N--CA 1.411 -2.384 0 N-CA-C 107.287 -1.375 . . . . 1.39 107.287 -177.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1629 ' ' LEU . . . . . 0.984 ' HG ' ' HG ' ' A' 1636 ' ' LEU . 1.6 tt -135.77 102.77 5.18 Favored 'General case' 0 N--CA 1.414 -2.252 0 N-CA-C 105.082 -2.192 . . . . 1.25 105.082 177.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 25.3 t70 -78.35 107.33 10.9 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.041 -1.466 . . . . 1.09 107.041 175.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1631 ' ' LYS . . . . . 0.458 ' HG2' HD22 ' A' 1629 ' ' LEU . 37.2 mtmm -78.62 -5.35 52.66 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 113.213 0.82 . . . . 3.6 113.213 -173.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 10.8 mm100 -89.67 -40.74 12.36 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 119.132 -1.027 . . . . 2.6 108.503 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 74.4 p -89.77 -5.14 57.25 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 115.034 -0.985 . . . . 0.75 109.438 177.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1634 ' ' CYS . . . . . 0.428 ' SG ' HD23 ' A' 1604 ' ' LEU . 27.9 m 58.0 41.03 24.92 Favored 'General case' 0 C--N 1.362 1.138 0 C-N-CA 125.073 1.349 . . . . 0.53 110.906 174.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1635 ' ' THR . . . . . . . . . . . . . 74.9 m -112.4 127.65 56.08 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 114.743 -1.117 . . . . 0.46 110.523 -174.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1636 ' ' LEU . . . . . 0.984 ' HG ' ' HG ' ' A' 1629 ' ' LEU . 0.3 OUTLIER -113.77 131.97 56.02 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.485 -0.932 . . . . 0.86 108.485 -176.634 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -111.62 129.27 56.13 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 116.692 -0.231 . . . . 0.45 110.458 -178.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -126.77 132.39 51.08 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 116.054 -0.521 . . . . 0.5 109.733 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1639 ' ' SER . . . . . 0.52 ' O ' ' HA ' ' A' 1624 ' ' PRO . 22.8 t -115.43 152.95 31.96 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.326 -0.99 . . . . 1.04 108.326 178.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 3.1 t90 -151.2 111.12 4.07 Favored 'General case' 0 N--CA 1.414 -2.256 0 N-CA-C 104.205 -2.517 . . . . 0.68 104.205 -177.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1641 ' ' HIS . . . . . 0.555 ' HB3' ' HB2' ' A' 1615 ' ' ARG . 42.7 m-70 -97.9 110.27 22.87 Favored 'General case' 0 C--N 1.293 -1.873 0 C-N-CA 120.097 -0.641 . . . . 0.9 109.365 -177.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1642 ' ' THR . . . . . . . . . . . . . 4.6 t -142.63 146.94 40.46 Favored Pre-proline 0 C--N 1.296 -1.719 0 CA-C-N 115.158 -0.928 . . . . 0.48 110.123 -172.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1643 ' ' PRO . . . . . 0.504 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 37.6 Cg_endo -79.68 -11.11 14.22 Favored 'Trans proline' 0 C--N 1.368 1.565 0 C-N-CA 121.991 1.794 . . . . 0.66 112.874 177.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 7.1 tt -68.37 -29.93 68.75 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 122.295 1.045 . . . . 0.97 108.199 178.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -97.06 20.87 10.59 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 114.167 -1.379 . . . . 0.84 109.405 -177.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1646 ' ' CYS . . . . . 0.467 ' HB2' ' HA ' ' A' 1614 ' ' CYS . 49.6 t -122.1 158.32 29.53 Favored 'General case' 0 N--CA 1.42 -1.957 0 CA-C-N 115.967 -0.561 . . . . 1.19 109.601 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 . . . . . 0 C--N 1.299 -1.624 0 N-CA-C 105.753 -1.943 . . . . 3.14 105.753 175.545 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.455 0 N-CA-C 111.499 -0.641 . . . . 2.09 111.499 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.34 -68.28 1.72 Allowed Glycine 0 N--CA 1.445 -0.716 0 O-C-N 123.923 0.425 . . . . 1.84 113.204 -178.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . 0.453 ' HA ' HG21 ' A' 1570 ' ' THR . 4.7 mm-40 -61.24 -32.75 72.55 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.176 -0.676 . . . . 2.55 109.176 -178.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' LEU . . . . . 0.415 ' O ' HD23 ' B' ' 17' ' ' LEU . 0.1 OUTLIER -53.34 -66.53 0.37 Allowed 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 114.761 -1.109 . . . . 2.35 109.245 -179.559 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 18.9 m -75.21 -16.7 15.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 C-N-CA 119.384 -0.927 . . . . 2.11 110.701 -177.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' ASP . . . . . 0.4 ' OD1' ' HB3' ' A' 1569 ' ' GLN . 12.0 t70 -73.27 -49.72 26.16 Favored 'General case' 0 C--O 1.184 -2.368 0 C-N-CA 118.844 -1.142 . . . . 2.04 112.497 179.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 21.9 p -56.15 -44.83 79.64 Favored 'General case' 0 C--O 1.263 1.778 0 CA-C-N 118.693 0.679 . . . . 1.84 109.628 176.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.563 ' HB3' ' CB ' ' B' ' 26' ' ' PHE . 4.1 mm? -50.37 -55.1 17.12 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 114.344 -1.298 . . . . 1.74 112.346 172.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -77.46 -21.91 52.17 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.23 0.538 . . . . 2.39 111.996 -178.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -55.55 -52.67 62.95 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 124.034 0.934 . . . . 0.96 110.777 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 12.9 p -98.56 -24.07 4.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 C-N-CA 118.272 -1.371 . . . . 1.37 112.365 -178.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 34.5 m -104.56 19.64 20.01 Favored 'General case' 0 C--N 1.309 -1.166 0 O-C-N 121.871 -0.518 . . . . 1.66 111.935 -174.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -49.17 -34.19 16.71 Favored Glycine 0 N--CA 1.469 0.875 0 N-CA-C 116.852 1.501 . . . . 1.53 116.852 -175.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -74.99 -34.47 61.97 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 117.773 0.787 . . . . 2.72 112.641 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 20.6 tpp180 -93.1 -39.47 11.04 Favored 'General case' 0 C--N 1.314 -0.949 0 O-C-N 122.064 -0.398 . . . . 4.33 111.195 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.94 -168.17 13.26 Favored Glycine 0 N--CA 1.433 -1.534 0 N-CA-C 109.078 -1.609 . . . . 1.53 109.078 -177.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . 0.563 ' CB ' ' HB3' ' B' ' 17' ' ' LEU . 18.0 p90 -129.73 128.6 42.81 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 117.69 0.745 . . . . 1.65 111.098 179.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -142.02 129.33 21.12 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 109.491 -0.559 . . . . 3.42 109.491 -176.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' PHE . . . . . 0.537 ' HA ' ' HE1' ' B' ' 59' ' ' TYR . 6.7 p90 . . . . . 0 C--N 1.306 -1.304 0 N-CA-C 107.283 -1.377 . . . . 2.26 107.283 -177.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.424 -2.131 0 N-CA-C 108.288 -1.925 . . . . 2.37 108.288 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . 0.506 ' HB ' HD21 ' B' ' 55' ' ' LEU . 15.0 pt 55.05 8.26 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.42 0 C-N-CA 126.906 2.082 . . . . 2.07 112.578 -177.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.491 ' O ' ' HB2' ' B' ' 47' ' ' CYS . 9.0 p -80.25 -35.48 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.312 0 CA-C-N 114.796 -1.093 . . . . 2.24 111.95 -173.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -84.63 -38.37 19.94 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 106.593 -1.632 . . . . 3.36 106.593 177.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -64.97 -19.38 65.95 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 113.886 -1.506 . . . . 3.08 111.798 -177.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' CYS . . . . . . . . . . . . . 41.9 t -118.06 -0.21 11.68 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 119.779 -0.769 . . . . 2.23 110.888 175.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' CYS . . . . . 0.491 ' HB2' ' O ' ' B' ' 43' ' ' VAL . 51.9 t -83.91 -60.05 2.23 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 121.941 -0.474 . . . . 2.37 111.998 177.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -96.48 4.24 52.23 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-O 121.228 0.537 . . . . 2.82 110.222 -175.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 8.2 mmt180 -130.29 161.78 30.47 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 105.294 -2.113 . . . . 4.09 105.294 -176.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 9.3 t -97.32 115.48 27.75 Favored 'General case' 0 C--N 1.278 -2.505 0 N-CA-C 105.086 -2.19 . . . . 2.67 105.086 174.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 31.9 p -88.89 137.48 32.28 Favored 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 109.294 -0.632 . . . . 2.11 109.294 -172.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -85.09 146.87 26.93 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 107.855 -1.165 . . . . 2.67 107.855 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -62.23 -22.52 66.02 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.058 -0.974 . . . . 1.9 112.508 -174.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.75 -38.19 69.5 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.19 0.519 . . . . 1.52 109.969 178.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . 0.506 HD21 ' HB ' ' B' ' 42' ' ' ILE . 34.6 tp -54.66 -63.4 1.16 Allowed 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 114.371 -1.286 . . . . 1.97 111.576 179.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.423 HD13 ' N ' ' B' ' 57' ' ' GLU . 0.0 OUTLIER -75.09 -27.37 59.87 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 120.267 -0.573 . . . . 1.53 111.656 -176.341 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . 0.423 ' N ' HD13 ' B' ' 56' ' ' LEU . 11.6 tp10 -59.93 -44.91 94.06 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 109.912 -0.403 . . . . 2.27 109.912 177.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 11.7 t -80.48 -10.81 59.73 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 120.419 -0.512 . . . . 2.33 110.752 177.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 59' ' ' TYR . . . . . 0.537 ' HE1' ' HA ' ' B' ' 28' ' ' PHE . 1.1 t80 -94.72 -70.77 0.69 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 119.504 -0.878 . . . . 2.86 108.865 -178.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 54.0 t . . . . . 0 C--N 1.308 -1.209 0 C-N-CA 125.809 1.644 . . . . 2.3 114.955 177.319 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 17.0 t70 . . . . . 0 N--CA 1.45 -0.471 0 CA-C-O 121.09 0.471 . . . . 2.9 110.134 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A 1516 ' ' CYS . . . . . 0.708 ' HA ' ' HB2' ' A' 1581 ' ' LEU . 91.6 m 64.21 46.93 3.39 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 115.057 1.503 . . . . 1.19 115.057 175.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -150.1 129.88 13.28 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 107.122 -1.436 . . . . 1.52 107.122 172.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1518 ' ' VAL . . . . . 0.688 HG21 ' HB2' ' A' 1583 ' ' TYR . 5.3 m -131.12 140.52 48.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 CA-C-O 121.249 0.547 . . . . 0.94 111.542 -174.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1519 ' ' THR . . . . . . . . . . . . . 20.5 m -108.44 140.58 41.54 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 115.452 -0.795 . . . . 0.89 109.064 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1520 ' ' ASN . . . . . 0.663 HD22 ' HE2' ' A' 1583 ' ' TYR . 25.9 t-20 -93.62 114.59 63.38 Favored Pre-proline 0 C--N 1.305 -1.347 0 N-CA-C 107.876 -1.157 . . . . 1.74 107.876 172.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -63.94 -21.3 68.74 Favored 'Trans proline' 0 N--CA 1.477 0.536 0 C-N-CA 123.208 2.605 . . . . 1.58 114.032 -174.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 14.2 m -75.56 -41.54 54.53 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-O 120.646 0.26 . . . . 1.65 111.498 -177.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1523 ' ' THR . . . . . 0.521 HG22 ' OD1' ' A' 1520 ' ' ASN . 2.7 t -107.94 -20.57 13.14 Favored 'General case' 0 CA--C 1.561 1.391 0 CA-C-O 121.345 0.593 . . . . 1.61 111.96 -178.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 83.1 22.51 57.2 Favored Glycine 0 CA--C 1.505 -0.533 0 O-C-N 122.092 -0.38 . . . . 1.13 113.482 175.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 55.1 t-80 -95.36 132.82 39.98 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 120.981 0.42 . . . . 1.26 110.114 -178.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 2.7 tm? -101.47 116.38 32.65 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 114.902 -1.045 . . . . 0.68 109.51 -177.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -87.35 118.12 26.58 Favored 'General case' 0 C--N 1.318 -0.804 0 O-C-N 122.068 -0.395 . . . . 0.65 111.108 173.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 8.7 t70 -98.01 113.67 25.59 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 108.27 -1.011 . . . . 1.17 108.27 176.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1529 ' ' LEU . . . . . 0.715 ' HG ' HD21 ' A' 1581 ' ' LEU . 3.5 mm? -101.87 -6.7 23.23 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 121.111 0.481 . . . . 0.6 110.051 177.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 6.1 m -62.63 -22.15 66.21 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.498 -0.774 . . . . 0.84 112.45 -177.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 16.2 t -66.12 -32.53 74.03 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 121.317 0.58 . . . . 1.59 110.036 177.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 7.9 mt -89.03 -7.62 55.57 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.253 -0.647 . . . . 0.65 109.253 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1533 ' ' SER . . . . . 0.437 ' HA ' ' HB ' ' A' 1552 ' ' ILE . 24.5 t -76.99 176.28 8.79 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.379 -0.6 . . . . 1.52 109.379 179.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . 152.71 174.77 23.51 Favored Glycine 0 N--CA 1.422 -2.24 0 N-CA-C 110.193 -1.163 . . . . 1.1 110.193 -177.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 33.2 ttm180 -92.31 -29.73 16.21 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 121.161 0.505 . . . . 4.62 110.095 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -76.55 -53.08 8.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.206 0.527 . . . . 1.45 110.96 -178.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 93.83 -150.16 19.73 Favored Glycine 0 N--CA 1.425 -2.067 0 C-N-CA 120.624 -0.798 . . . . 0.85 111.883 177.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -136.8 151.49 49.23 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.377 -0.971 . . . . 0.93 108.377 -177.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 17.7 p -112.81 139.55 48.34 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 116.266 -0.424 . . . . 1.03 109.952 177.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1540 ' ' ALA . . . . . 0.462 ' HB3' ' CG1' ' A' 1548 ' ' VAL . . . -125.25 143.41 50.96 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 107.943 -1.132 . . . . 0.5 107.943 172.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -84.67 151.94 24.12 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 108.552 -0.907 . . . . 0.74 108.552 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1542 ' ' TYR . . . . . 0.703 ' HE2' ' HG ' ' A' 1626 ' ' LEU . 1.8 t80 -162.95 -100.74 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 121.62 0.724 . . . . 0.99 109.914 -174.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1543 ' ' SER . . . . . 0.466 ' H ' ' HB3' ' A' 1542 ' ' TYR . 31.2 t -73.93 159.41 32.81 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 124.568 1.147 . . . . 1.91 110.404 -173.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 13.2 tppt? -74.98 -3.71 33.9 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 109.329 -0.619 . . . . 3.59 109.329 178.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1545 ' ' SER . . . . . 0.46 ' HB2' ' HG2' ' B' ' 18' ' ' GLN . 15.3 t -77.62 -43.3 31.97 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 108.884 -0.784 . . . . 2.46 108.884 176.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 165.72 -148.84 14.45 Favored Glycine 0 N--CA 1.41 -3.066 0 N-CA-C 110.872 -0.891 . . . . 1.26 110.872 -175.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 34.6 m -109.11 179.41 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.281 2.761 0 CA-C-O 122.118 0.961 . . . . 0.79 111.975 -172.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1548 ' ' VAL . . . . . 0.868 ' HB ' ' CE1' ' A' 1567 ' ' PHE . 7.8 p -112.01 130.85 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.941 0 CA-C-N 113.193 -1.821 . . . . 0.58 108.362 173.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -95.06 134.81 37.35 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.938 -1.134 . . . . 1.08 107.938 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 24.1 ptm -150.93 118.73 6.17 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 121.767 0.794 . . . . 0.78 111.337 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 5.4 p -112.4 118.31 34.85 Favored 'General case' 0 C--N 1.28 -2.428 0 CA-C-N 114.507 -1.224 . . . . 0.97 109.973 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1552 ' ' ILE . . . . . 0.437 ' HB ' ' HA ' ' A' 1533 ' ' SER . 46.0 mm -71.95 114.63 10.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.503 -0.317 . . . . 0.42 110.585 -178.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 72.0 m 60.9 29.43 19.01 Favored 'General case' 0 CA--C 1.511 -0.533 0 C-N-CA 124.532 1.133 . . . . 1.4 113.401 175.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . -161.04 177.75 37.28 Favored Glycine 0 N--CA 1.417 -2.601 0 N-CA-C 109.412 -1.475 . . . . 0.35 109.412 -179.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -107.97 140.73 40.68 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-O 121.127 0.489 . . . . 1.62 111.684 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -87.21 140.5 29.48 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 107.426 -1.324 . . . . 0.87 107.426 178.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -94.41 3.45 55.16 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 113.587 0.958 . . . . 2.49 113.587 -173.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -88.62 -4.65 58.52 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 121.552 0.692 . . . . 1.38 110.575 -178.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1559 ' ' CYS . . . . . 0.625 ' SG ' ' HD2' ' A' 1560 ' ' PRO . 20.2 t -136.31 157.48 75.39 Favored Pre-proline 0 C--N 1.298 -1.633 0 N-CA-C 106.229 -1.767 . . . . 1.21 106.229 -178.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1560 ' ' PRO . . . . . 0.632 ' HD2' ' HB3' ' A' 1571 ' ' ARG . 31.6 Cg_exo -29.05 134.77 0.04 OUTLIER 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 125.104 3.869 . . . . 0.71 115.428 177.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1561 ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' 1560 ' ' PRO . 86.1 Cg_exo -49.13 124.44 11.62 Favored 'Trans proline' 0 C--O 1.247 0.948 0 C-N-CA 124.176 3.251 . . . . 0.8 112.792 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 101.76 7.32 48.1 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 116.004 -0.544 . . . . 0.46 113.302 -177.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1563 ' ' VAL . . . . . 0.608 HG11 ' HB2' ' A' 1566 ' ' CYS . 2.3 t -85.93 124.56 40.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 112.185 0.439 . . . . 0.98 112.185 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -97.71 -37.61 4.42 Favored Glycine 0 C--N 1.31 -0.916 0 N-CA-C 110.702 -0.959 . . . . 0.28 110.702 174.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -130.25 137.3 49.94 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.021 -0.733 . . . . 0.28 109.021 177.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1566 ' ' CYS . . . . . 0.608 ' HB2' HG11 ' A' 1563 ' ' VAL . 42.4 t -156.96 135.29 11.3 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 121.243 -0.183 . . . . 0.43 111.201 -177.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1567 ' ' PHE . . . . . 0.868 ' CE1' ' HB ' ' A' 1548 ' ' VAL . 9.5 m-85 -112.9 163.76 14.25 Favored 'General case' 0 C--O 1.245 0.857 0 C-N-CA 123.308 0.643 . . . . 1.03 110.491 173.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . 94.31 169.53 37.61 Favored Glycine 0 N--CA 1.399 -3.831 0 C-N-CA 118.831 -1.652 . . . . 1.13 114.324 164.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -89.6 -30.14 18.37 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 114.242 -0.979 . . . . 2.58 108.985 177.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 66.3 p -85.09 2.65 42.49 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.555 -0.748 . . . . 2.17 112.74 -177.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1571 ' ' ARG . . . . . 0.632 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 2.2 mpt_? 67.6 69.07 0.36 Allowed 'General case' 0 C--N 1.348 0.518 0 CA-C-N 114.704 -1.134 . . . . 2.62 110.831 175.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 32.0 mt -96.59 106.02 17.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-N 115.582 -0.735 . . . . 0.92 109.727 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 30.9 t -66.81 130.07 41.97 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-N 114.732 -1.122 . . . . 0.8 110.379 -177.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1574 ' ' VAL . . . . . 0.6 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 34.4 m -123.55 20.92 4.56 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.336 0 CA-C-O 121.535 0.683 . . . . 0.98 110.607 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 169.43 124.17 0.72 Allowed Glycine 0 N--CA 1.418 -2.546 0 CA-C-N 114.915 -1.039 . . . . 0.29 111.329 176.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -75.53 141.94 42.9 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.079 -0.711 . . . . 2.19 109.079 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -69.9 84.19 0.49 Allowed 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 123.404 0.681 . . . . 0.61 112.708 -177.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -93.68 168.18 11.18 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 115.569 -0.741 . . . . 1.95 109.346 176.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 55.1 mttm -129.31 41.92 3.38 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.519 -0.919 . . . . 2.68 108.519 -176.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 46.4 ttm-85 -105.98 77.65 1.26 Allowed 'General case' 0 N--CA 1.403 -2.786 0 CA-C-N 115.314 -0.857 . . . . 3.47 109.841 -175.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1581 ' ' LEU . . . . . 0.715 HD21 ' HG ' ' A' 1529 ' ' LEU . 1.2 tm? -65.47 124.97 23.69 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 113.798 -1.546 . . . . 0.64 107.49 175.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 63.9 mtp180 -118.54 141.0 49.01 Favored 'General case' 0 C--N 1.289 -2.048 0 C-N-CA 120.853 -0.339 . . . . 2.85 110.706 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1583 ' ' TYR . . . . . 0.688 ' HB2' HG21 ' A' 1518 ' ' VAL . 64.0 t80 -120.01 109.01 14.99 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 109.249 -0.648 . . . . 0.86 109.249 -179.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1584 ' ' VAL . . . . . 0.501 ' O ' ' HB ' ' A' 1587 ' ' VAL . 9.4 m -128.7 94.9 2.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-N 115.8 -0.636 . . . . 1.05 111.752 -179.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 12.3 t70 56.53 60.91 2.88 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 123.851 0.86 . . . . 1.17 110.714 176.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1586 ' ' GLN . . . . . 0.427 ' HA ' ' HE1' ' A' 1583 ' ' TYR 0.313 10.0 pt20 65.24 12.08 7.75 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 126.828 2.051 . . . . 1.86 113.147 178.972 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A 1587 ' ' VAL . . . . . 0.501 ' HB ' ' O ' ' A' 1584 ' ' VAL . 39.6 t -101.78 120.07 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.95 0 N-CA-C 107.588 -1.264 . . . . 0.49 107.588 174.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1588 ' ' LEU . . . . . 0.731 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 2.9 mm? -96.82 110.35 22.85 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 106.009 -1.848 . . . . 0.36 106.009 177.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1589 ' ' GLN . . . . . 0.43 ' HA ' ' O ' ' A' 1610 ' ' ILE . 28.5 tt0 -125.48 132.16 52.71 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-O 121.672 0.748 . . . . 1.74 112.767 -171.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 11.7 mt -115.1 128.31 56.14 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 107.27 -1.381 . . . . 0.72 107.27 175.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 59.3 t -119.03 118.9 59.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 C-N-CA 119.66 -0.816 . . . . 1.01 110.511 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1592 ' ' TYR . . . . . 0.47 ' O ' ' HA ' ' A' 1607 ' ' LYS . 16.8 m-30 -106.18 95.2 5.61 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 115.65 -0.705 . . . . 0.5 109.104 -179.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1593 ' ' LYS . . . . . 0.535 ' HB3' ' HD3' ' A' 1607 ' ' LYS . 0.0 OUTLIER -109.28 163.07 13.71 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 116.685 -0.234 . . . . 1.59 111.332 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 6.4 m-20 66.12 55.84 0.87 Allowed 'General case' 0 C--N 1.318 -0.787 0 O-C-N 124.472 1.108 . . . . 1.11 112.003 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -83.55 -107.27 0.53 Allowed Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 110.029 -1.228 . . . . 0.78 110.029 174.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1596 ' ' SER . . . . . . . . . . . . . 85.8 p -102.41 148.82 36.0 Favored Pre-proline 0 C--O 1.261 1.7 0 N-CA-C 108.847 -0.797 . . . . 1.07 108.847 175.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -63.66 122.8 11.02 Favored 'Trans proline' 0 N--CA 1.446 -1.269 0 C-N-CA 122.751 2.3 . . . . 1.01 108.998 174.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 17.0 t -78.83 110.46 14.42 Favored Pre-proline 0 C--N 1.301 -1.534 0 N-CA-C 108.621 -0.881 . . . . 0.75 108.621 -172.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.07 -12.22 35.23 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 122.843 2.362 . . . . 1.7 112.839 -173.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1600 ' ' SER . . . . . 0.806 ' HB3' ' HB2' ' B' ' 53' ' ' LEU . 18.0 m -61.56 -31.06 71.08 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.929 0.891 . . . . 2.26 111.907 178.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1601 ' ' LYS . . . . . 0.584 ' HB3' HD22 ' A' 1604 ' ' LEU . 41.0 ttmt -161.06 122.0 2.85 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 107.445 -1.317 . . . . 3.01 107.445 176.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 15.1 m -59.05 131.26 50.51 Favored 'General case' 0 N--CA 1.424 -1.73 0 C-N-CA 123.028 0.531 . . . . 2.07 111.39 -176.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 105.37 -3.96 40.4 Favored Glycine 0 C--N 1.309 -0.951 0 CA-C-N 116.258 -0.428 . . . . 1.08 112.768 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1604 ' ' LEU . . . . . 0.584 HD22 ' HB3' ' A' 1601 ' ' LYS . 10.3 mp -100.45 157.77 16.4 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 122.462 -0.434 . . . . 1.84 111.551 -178.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 33.8 m -146.88 143.93 28.91 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 108.312 -0.996 . . . . 1.41 108.312 175.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1606 ' ' TYR . . . . . 0.6 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 76.1 m-85 -69.53 151.63 45.77 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 116.334 -0.394 . . . . 0.6 110.928 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1607 ' ' LYS . . . . . 0.535 ' HD3' ' HB3' ' A' 1593 ' ' LYS . 36.6 ttpt -150.95 130.33 12.87 Favored 'General case' 0 N--CA 1.441 -0.878 0 O-C-N 124.007 0.817 . . . . 1.45 109.824 -175.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1608 ' ' SER . . . . . 0.465 ' HB3' ' HB2' ' A' 1592 ' ' TYR . 37.3 t -105.38 120.11 40.76 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 108.939 -0.763 . . . . 1.15 108.939 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 22.8 t -105.32 107.3 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 N-CA-C 107.831 -1.174 . . . . 0.25 107.831 177.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1610 ' ' ILE . . . . . 0.43 ' O ' ' HA ' ' A' 1589 ' ' GLN . 64.3 mt -101.91 111.73 32.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 CA-C-N 115.676 -0.693 . . . . 0.45 110.046 -176.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 21.4 p -111.64 117.84 34.03 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.928 -0.578 . . . . 1.26 112.153 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1612 ' ' PHE . . . . . 0.731 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 78.0 m-85 -93.08 124.34 36.99 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.19 -1.041 . . . . 0.26 108.19 177.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 49.1 t -118.74 137.23 53.39 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 116.544 -0.298 . . . . 0.5 110.984 -175.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 3.5 t -59.69 103.0 0.17 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.668 1.187 . . . . 0.77 112.633 177.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1615 ' ' ARG . . . . . 0.541 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 20.8 mmt180 -138.49 112.58 8.53 Favored Pre-proline 0 C--N 1.32 -0.693 0 O-C-N 122.369 -0.207 . . . . 2.53 111.224 171.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1616 ' ' PRO . . . . . 0.601 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 37.3 Cg_endo -74.06 -1.71 11.27 Favored 'Trans proline' 0 N--CA 1.489 1.213 0 C-N-CA 122.902 2.401 . . . . 1.1 113.213 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -89.5 41.7 1.05 Allowed 'General case' 0 C--N 1.291 -1.959 0 C-N-CA 124.936 1.294 . . . . 3.05 110.83 -177.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -41.54 123.79 2.28 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.86 1.664 . . . . 1.55 112.647 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1619 ' ' GLY . . . . . 0.438 ' HA3' ' HD2' ' A' 1620 ' ' PRO . . . 171.03 -135.8 3.65 Favored Glycine 0 CA--C 1.48 -2.151 0 N-CA-C 110.13 -1.188 . . . . 0.93 110.13 -177.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1620 ' ' PRO . . . . . 0.438 ' HD2' ' HA3' ' A' 1619 ' ' GLY . 35.1 Cg_endo -64.12 -2.46 4.76 Favored 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 123.342 2.695 . . . . 0.88 115.231 -177.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1621 ' ' THR . . . . . 0.663 ' HB ' ' HB2' ' A' 1641 ' ' HIS . 13.0 p -98.82 -11.4 21.82 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 121.728 0.775 . . . . 0.97 109.677 178.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 48.0 t30 -93.48 64.9 3.7 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 122.457 1.122 . . . . 0.72 108.333 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -166.97 140.47 3.05 Favored Pre-proline 0 C--N 1.3 -1.55 0 N-CA-C 106.422 -1.695 . . . . 3.26 106.422 -178.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -59.45 110.26 0.69 Allowed 'Trans proline' 0 C--O 1.243 0.766 0 C-N-CA 122.56 2.174 . . . . 0.59 111.527 -178.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 74.9 mtm -110.14 141.77 42.57 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 116.078 -0.51 . . . . 1.37 110.066 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1626 ' ' LEU . . . . . 0.703 ' HG ' ' HE2' ' A' 1542 ' ' TYR . 1.4 tm? -86.2 119.06 26.08 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 108.141 -1.059 . . . . 0.89 108.141 -176.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1627 ' ' ILE . . . . . 0.66 HD11 ' HB2' ' A' 1639 ' ' SER . 44.5 mm -79.69 -55.42 9.2 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 CA-C-O 121.513 0.673 . . . . 0.58 109.434 178.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 22.6 t -163.72 148.41 10.62 Favored 'General case' 0 N--CA 1.419 -2.01 0 N-CA-C 107.969 -1.123 . . . . 1.39 107.969 -176.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1629 ' ' LEU . . . . . 0.76 HD13 ' HG ' ' A' 1636 ' ' LEU . 50.3 tp -116.91 105.43 12.33 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.662 -0.866 . . . . 1.25 108.662 176.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 12.5 t70 -84.32 106.24 15.78 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.015 -1.476 . . . . 1.09 107.015 176.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1631 ' ' LYS . . . . . 0.409 ' HE3' ' HB3' ' A' 1631 ' ' LYS . 14.4 mmmt -85.74 -3.43 58.89 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 112.86 0.689 . . . . 3.6 112.86 -175.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -87.69 -33.63 18.69 Favored 'General case' 0 N--CA 1.421 -1.888 0 O-C-N 123.43 0.456 . . . . 2.6 109.804 -177.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 40.3 p -102.37 -16.34 16.25 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.096 0.474 . . . . 0.75 110.29 173.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1634 ' ' CYS . . . . . 0.471 ' O ' ' HA ' ' A' 1606 ' ' TYR . 60.2 m 72.56 37.57 0.87 Allowed 'General case' 0 C--N 1.355 0.845 0 C-N-CA 125.203 1.401 . . . . 0.53 111.307 179.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1635 ' ' THR . . . . . . . . . . . . . 94.7 m -103.23 134.03 47.32 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 115.253 -0.885 . . . . 0.46 109.697 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1636 ' ' LEU . . . . . 0.76 ' HG ' HD13 ' A' 1629 ' ' LEU . 0.5 OUTLIER -114.97 124.39 51.55 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.548 -0.908 . . . . 0.86 108.548 -177.826 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -104.37 130.73 52.22 Favored 'General case' 0 C--O 1.25 1.101 0 N-CA-C 110.37 -0.233 . . . . 0.45 110.37 -178.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -127.81 137.99 52.57 Favored 'General case' 0 C--O 1.251 1.135 0 CA-C-O 121.065 0.46 . . . . 0.5 110.48 -178.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1639 ' ' SER . . . . . 0.66 ' HB2' HD11 ' A' 1627 ' ' ILE . 21.4 t -116.08 157.95 23.93 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.148 -1.056 . . . . 1.04 108.148 177.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 2.3 t90 -156.34 113.21 3.14 Favored 'General case' 0 N--CA 1.409 -2.497 0 N-CA-C 105.349 -2.093 . . . . 0.68 105.349 -177.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1641 ' ' HIS . . . . . 0.663 ' HB2' ' HB ' ' A' 1621 ' ' THR . 13.0 m170 -104.01 105.29 15.42 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 109.485 -0.561 . . . . 0.9 109.485 -176.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1642 ' ' THR . . . . . . . . . . . . . 11.3 t -142.95 145.13 31.99 Favored Pre-proline 0 C--N 1.306 -1.3 0 CA-C-N 116.111 -0.495 . . . . 0.48 109.881 -173.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1643 ' ' PRO . . . . . 0.601 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 73.4 Cg_endo -76.49 -10.37 18.82 Favored 'Trans proline' 0 C--N 1.366 1.5 0 C-N-CA 122.595 2.197 . . . . 0.66 112.136 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 7.7 tt -69.0 -24.31 64.21 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.396 0.617 . . . . 0.97 109.896 177.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -100.1 17.44 21.13 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 122.123 0.963 . . . . 0.84 109.21 -176.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 20.1 t -121.46 155.04 35.75 Favored 'General case' 0 N--CA 1.41 -2.451 0 N-CA-C 107.761 -1.2 . . . . 1.19 107.761 -178.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 31.7 tt0 . . . . . 0 C--N 1.298 -1.633 0 N-CA-C 108.57 -0.9 . . . . 3.14 108.57 179.182 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.859 0 N-CA-C 111.92 -0.472 . . . . 2.09 111.92 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -75.57 -17.69 80.05 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 121.418 -0.42 . . . . 1.84 113.627 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -66.96 -27.29 67.34 Favored 'General case' 0 C--O 1.215 -0.722 0 N-CA-C 109.387 -0.597 . . . . 2.55 109.387 -176.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' LEU . . . . . 0.445 ' O ' HD12 ' B' ' 17' ' ' LEU . 32.1 mt -66.85 -61.42 1.96 Allowed 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 115.059 -0.973 . . . . 2.35 108.907 -179.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 9.9 p -64.39 -40.76 90.17 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.525 0 CA-C-N 114.853 -1.067 . . . . 2.11 112.097 -176.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -74.47 -26.5 60.07 Favored 'General case' 0 CA--C 1.557 1.246 0 N-CA-C 113.961 1.097 . . . . 2.04 113.961 -176.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 20.4 p -75.0 -43.25 54.98 Favored 'General case' 0 C--O 1.248 0.974 0 O-C-N 121.066 -1.022 . . . . 1.84 109.144 175.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.576 ' O ' ' HB2' ' B' ' 21' ' ' CYS . 0.9 OUTLIER -56.06 -40.91 74.26 Favored 'General case' 0 N--CA 1.42 -1.951 0 CA-C-N 114.863 -1.062 . . . . 1.74 111.513 169.471 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' GLN . . . . . 0.46 ' HG2' ' HB2' ' A' 1545 ' ' SER . 8.8 tt0 -71.86 -24.85 61.75 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 121.127 0.489 . . . . 2.39 109.718 179.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -64.07 -62.68 1.47 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.036 -0.529 . . . . 0.96 112.109 178.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 12.6 p -94.65 -20.32 6.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 C-N-CA 118.53 -1.268 . . . . 1.37 111.909 -177.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' CYS . . . . . 0.576 ' HB2' ' O ' ' B' ' 17' ' ' LEU . 96.1 m -102.94 18.46 21.56 Favored 'General case' 0 C--N 1.312 -1.027 0 O-C-N 121.834 -0.541 . . . . 1.66 111.448 178.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -54.02 -50.25 55.87 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 121.355 -0.45 . . . . 1.53 113.219 178.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -75.86 -11.13 59.92 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 122.548 0.339 . . . . 2.72 111.591 178.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . 0.551 ' HG2' ' SG ' ' B' ' 60' ' ' CYS . 21.1 tpp180 -91.53 -50.13 5.94 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.715 0.769 . . . . 4.33 110.434 -178.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 115.79 157.6 11.32 Favored Glycine 0 N--CA 1.417 -2.593 0 N-CA-C 107.949 -2.06 . . . . 1.53 107.949 -173.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -119.23 137.58 53.56 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 117.943 0.871 . . . . 1.65 111.453 177.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -128.89 -54.25 1.22 Allowed 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 107.684 -1.228 . . . . 3.42 107.684 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' PHE . . . . . . . . . . . . . 43.4 p90 . . . . . 0 N--CA 1.498 1.958 0 C-N-CA 128.06 2.544 . . . . 2.26 117.776 172.55 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.492 -1.375 0 N-CA-C 112.722 -0.151 . . . . 2.37 112.722 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . 0.535 HD11 HD11 ' B' ' 17' ' ' LEU . 41.4 pt -85.73 -17.55 9.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 O-C-N 122.701 -0.293 . . . . 2.07 111.349 -177.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.432 HG23 ' CD1' ' B' ' 13' ' ' LEU . 14.9 p -53.05 -41.39 41.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 N-CA-C 114.456 1.28 . . . . 2.24 114.456 -172.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -74.01 -31.92 63.15 Favored 'General case' 0 C--O 1.244 0.793 0 C-N-CA 118.933 -1.107 . . . . 3.36 108.876 -175.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -85.22 -14.27 47.33 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 114.869 -1.06 . . . . 3.08 112.296 -176.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' CYS . . . . . . . . . . . . . 81.2 m -104.4 -22.76 13.27 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 112.669 0.618 . . . . 2.23 112.669 175.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 95.9 m -79.39 -49.0 13.03 Favored 'General case' 0 C--O 1.239 0.544 0 O-C-N 121.759 -0.588 . . . . 2.37 112.27 178.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -97.38 -7.91 30.75 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.115 0.483 . . . . 2.82 111.471 -177.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 52.9 mtp180 -139.65 177.64 7.8 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 115.946 -0.57 . . . . 4.09 109.483 -176.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 50.9 m -106.46 135.92 47.12 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 115.475 -0.784 . . . . 2.67 109.372 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . 0.469 ' HB2' HD23 ' B' ' 55' ' ' LEU . 11.7 p -120.63 138.98 53.63 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 109.647 -0.501 . . . . 2.11 109.647 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -82.49 142.77 31.61 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.062 0.458 . . . . 2.67 109.768 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . 0.806 ' HB2' ' HB3' ' A' 1600 ' ' SER . 66.2 tp -37.69 -42.0 0.53 Allowed 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 127.186 2.194 . . . . 1.9 113.808 -177.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . 0.601 ' O ' HG22 ' B' ' 58' ' ' THR . . . -53.27 -38.97 63.54 Favored 'General case' 0 C--N 1.318 -0.789 0 O-C-N 124.423 1.077 . . . . 1.52 111.635 -177.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . 0.469 HD23 ' HB2' ' B' ' 51' ' ' CYS . 53.6 tp -59.67 -56.32 23.34 Favored 'General case' 0 C--O 1.213 -0.827 0 O-C-N 124.146 0.903 . . . . 1.97 110.599 -178.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 3.3 pp -69.8 -31.04 68.73 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 116.309 -0.405 . . . . 1.53 110.967 -174.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -66.84 -51.65 53.07 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.891 -0.595 . . . . 2.27 111.575 178.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 58' ' ' THR . . . . . 0.601 HG22 ' O ' ' B' ' 54' ' ' ALA . 12.0 t -83.63 -13.24 54.72 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 112.901 0.704 . . . . 2.33 112.901 -177.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -85.61 -72.33 0.49 Allowed 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 105.929 -1.878 . . . . 2.86 105.929 175.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 60' ' ' CYS . . . . . 0.551 ' SG ' ' HG2' ' B' ' 24' ' ' ARG . 43.7 t . . . . . 0 CA--C 1.568 1.669 0 N-CA-C 114.554 1.316 . . . . 2.3 114.554 172.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1515 ' ' ASP . . . . . 0.46 ' HB3' ' HG2' ' A' 1517 ' ' GLN . 23.0 t70 . . . . . 0 N--CA 1.416 -2.164 0 N-CA-C 106.014 -1.847 . . . . 2.9 106.014 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 34.9 t -91.09 69.25 6.19 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 107.953 -1.129 . . . . 1.19 107.953 -175.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1517 ' ' GLN . . . . . 0.46 ' HG2' ' HB3' ' A' 1515 ' ' ASP . 9.8 pt20 -165.23 148.18 8.13 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-N 114.591 -1.186 . . . . 1.52 108.953 -174.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1518 ' ' VAL . . . . . 0.465 ' CG2' HD12 ' A' 1581 ' ' LEU . 3.7 m -145.74 143.06 21.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 C-N-CA 123.344 0.657 . . . . 0.94 110.051 177.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1519 ' ' THR . . . . . . . . . . . . . 42.6 m -93.83 139.82 30.41 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 116.017 -0.538 . . . . 0.89 109.762 177.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1520 ' ' ASN . . . . . 0.523 ' OD1' HG22 ' A' 1523 ' ' THR . 16.4 t-20 -75.29 117.89 66.57 Favored Pre-proline 0 N--CA 1.428 -1.575 0 N-CA-C 107.712 -1.218 . . . . 1.74 107.712 174.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.39 -17.71 49.39 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 122.782 2.321 . . . . 1.58 113.529 -176.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 10.7 m -80.98 -42.97 20.36 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 112.216 0.451 . . . . 1.65 112.216 -176.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1523 ' ' THR . . . . . 0.523 HG22 ' OD1' ' A' 1520 ' ' ASN . 6.2 t -120.99 -8.47 9.35 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.674 0.62 . . . . 1.61 112.674 -175.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 80.39 24.29 59.25 Favored Glycine 0 C--O 1.239 0.446 0 C-N-CA 120.339 -0.934 . . . . 1.13 112.826 177.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -89.93 123.17 33.62 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 109.369 -0.604 . . . . 1.26 109.369 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 2.2 tm? -87.58 113.12 22.98 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 123.623 0.769 . . . . 0.68 109.237 -177.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -88.87 114.01 25.03 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 109.705 -0.48 . . . . 0.65 109.705 176.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 14.6 t70 -101.62 110.37 22.35 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.342 -0.984 . . . . 1.17 108.342 177.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1529 ' ' LEU . . . . . 0.444 ' HG ' HD21 ' A' 1581 ' ' LEU . 3.3 mm? -92.11 -2.42 56.62 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.986 0.898 . . . . 0.6 109.309 -177.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 2.9 m -73.98 -10.27 59.47 Favored 'General case' 0 C--O 1.215 -0.737 0 CA-C-N 114.48 -1.236 . . . . 0.84 109.615 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1531 ' ' SER . . . . . 0.585 ' HB2' HD11 ' A' 1644 ' ' LEU . 19.0 m -72.3 -16.97 61.9 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 109.027 -0.731 . . . . 1.59 109.027 176.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1532 ' ' LEU . . . . . 0.42 ' O ' ' HB ' ' A' 1552 ' ' ILE . 67.9 mt -107.05 5.59 28.18 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.253 -0.885 . . . . 0.65 110.891 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1533 ' ' SER . . . . . 0.447 ' HA ' ' O ' ' A' 1552 ' ' ILE . 69.3 p -67.5 164.34 19.09 Favored 'General case' 0 C--O 1.249 1.062 0 CA-C-O 121.367 0.604 . . . . 1.52 111.614 -178.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -170.81 142.0 6.84 Favored Glycine 0 N--CA 1.418 -2.561 0 C-N-CA 120.343 -0.932 . . . . 1.1 111.151 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1535 ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' 1535 ' ' ARG . 23.1 ttt180 -92.86 -36.41 12.84 Favored 'General case' 0 C--N 1.292 -1.911 0 C-N-CA 122.688 0.395 . . . . 4.62 111.156 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -82.93 -36.72 25.0 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.721 0.772 . . . . 1.45 109.421 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1537 ' ' GLY . . . . . 0.408 ' HA3' ' ND2' ' A' 1556 ' ' ASN . . . 97.36 179.19 34.02 Favored Glycine 0 N--CA 1.418 -2.555 0 CA-C-N 114.918 -1.037 . . . . 0.85 112.476 173.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -119.84 147.23 44.93 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 107.675 -1.231 . . . . 0.93 107.675 178.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 5.5 p -103.37 117.68 35.04 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.334 0.587 . . . . 1.03 111.963 -177.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1540 ' ' ALA . . . . . 0.448 ' HB3' ' CG1' ' A' 1548 ' ' VAL . . . -108.16 121.78 45.55 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 107.927 -1.138 . . . . 0.5 107.927 176.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -70.92 134.07 46.94 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 116.144 -0.48 . . . . 0.74 110.761 -178.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1542 ' ' TYR . . . . . 0.47 ' HB3' ' H ' ' A' 1543 ' ' SER . 1.2 t80 -126.94 -99.94 0.37 Allowed 'General case' 0 N--CA 1.418 -2.054 0 N-CA-C 106.564 -1.643 . . . . 0.99 106.564 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1543 ' ' SER . . . . . 0.47 ' H ' ' HB3' ' A' 1542 ' ' TYR . 3.3 m -66.06 159.22 26.46 Favored 'General case' 0 N--CA 1.416 -2.126 0 C-N-CA 123.223 0.609 . . . . 1.91 110.236 178.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -51.23 -44.3 61.66 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.373 0.533 . . . . 3.59 112.094 -178.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 7.5 t -117.41 37.64 3.83 Favored 'General case' 0 N--CA 1.424 -1.759 0 N-CA-C 108.999 -0.741 . . . . 2.46 108.999 178.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . -147.44 109.36 0.47 Allowed Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 120.083 -1.056 . . . . 1.26 113.934 -177.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 36.0 m -98.89 160.63 3.21 Favored 'Isoleucine or valine' 0 C--O 1.252 1.187 0 N-CA-C 108.876 -0.786 . . . . 0.79 108.876 175.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1548 ' ' VAL . . . . . 0.505 ' HB ' ' CE1' ' A' 1567 ' ' PHE . 10.9 p -109.33 131.76 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.675 0 N-CA-C 107.647 -1.242 . . . . 0.58 107.647 174.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -93.27 125.54 37.92 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.988 -1.115 . . . . 1.08 107.988 178.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 24.0 ptm -136.39 134.29 37.64 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 120.033 -0.667 . . . . 0.78 112.169 -177.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 11.9 p -123.41 125.04 44.24 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-N 115.073 -0.967 . . . . 0.97 109.73 177.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1552 ' ' ILE . . . . . 0.447 ' O ' ' HA ' ' A' 1533 ' ' SER . 47.9 mm -84.18 124.46 39.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 N-CA-C 109.86 -0.422 . . . . 0.42 109.86 -179.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1553 ' ' CYS . . . . . 0.434 ' SG ' HG22 ' A' 1552 ' ' ILE . 56.6 m 64.43 26.07 13.44 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.896 0.878 . . . . 1.4 112.231 174.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . -172.07 -179.23 42.86 Favored Glycine 0 N--CA 1.431 -1.643 0 N-CA-C 110.308 -1.117 . . . . 0.35 110.308 -178.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -101.34 145.56 28.74 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 121.283 0.563 . . . . 1.62 111.825 -177.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1556 ' ' ASN . . . . . 0.408 ' ND2' ' HA3' ' A' 1537 ' ' GLY . 24.6 t-20 -92.57 137.45 32.35 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.014 -0.994 . . . . 0.87 108.845 -177.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -80.43 -8.83 59.69 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.354 0.872 . . . . 2.49 113.354 -172.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -83.62 -9.06 59.15 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 120.946 0.403 . . . . 1.38 112.026 -175.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1559 ' ' CYS . . . . . 0.755 ' HB3' HG11 ' A' 1563 ' ' VAL . 9.3 t -136.87 153.71 75.72 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 108.164 -1.05 . . . . 1.21 108.164 -177.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1560 ' ' PRO . . . . . 0.575 ' HD2' ' SG ' ' A' 1559 ' ' CYS . 23.7 Cg_exo -28.84 135.51 0.03 OUTLIER 'Trans proline' 0 C--N 1.379 2.183 1 C-N-CA 125.988 4.459 . . . . 0.71 115.133 178.293 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -45.93 120.95 3.85 Favored 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 125.104 3.87 . . . . 0.8 114.125 -177.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 101.73 21.75 10.94 Favored Glycine 0 CA--C 1.531 1.081 0 CA-C-N 115.826 -0.625 . . . . 0.46 113.045 -176.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1563 ' ' VAL . . . . . 0.755 HG11 ' HB3' ' A' 1559 ' ' CYS . 2.3 t -102.02 124.29 55.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 O-C-N 122.162 -0.61 . . . . 0.98 110.931 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -97.3 -35.76 5.14 Favored Glycine 0 C--N 1.3 -1.447 0 N-CA-C 110.495 -1.042 . . . . 0.28 110.495 175.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -138.58 132.89 31.79 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.202 -0.666 . . . . 0.28 109.202 177.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1566 ' ' CYS . . . . . 0.417 ' HB2' HG11 ' A' 1563 ' ' VAL . 53.0 t -156.42 139.3 15.28 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.459 -0.571 . . . . 0.43 109.459 -177.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1567 ' ' PHE . . . . . 0.505 ' CE1' ' HB ' ' A' 1548 ' ' VAL . 67.3 m-85 -87.3 147.94 25.29 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.294 -0.562 . . . . 1.03 110.0 177.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -89.34 40.34 3.06 Favored Glycine 0 N--CA 1.437 -1.265 0 C-N-CA 120.393 -0.908 . . . . 1.13 113.363 -175.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1569 ' ' GLN . . . . . 0.419 ' HB2' ' OD2' ' B' ' 15' ' ' ASP . 28.3 mm-40 -95.16 -71.61 0.66 Allowed 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 119.874 -0.731 . . . . 2.58 110.449 175.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 81.6 p -130.69 40.65 3.47 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 118.638 0.653 . . . . 2.17 112.354 175.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 13.0 mmt85 63.6 49.76 2.96 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 123.923 0.889 . . . . 2.62 111.114 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 26.0 mm -98.53 113.72 34.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 N-CA-C 109.149 -0.686 . . . . 0.92 109.149 -178.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1573 ' ' SER . . . . . 0.51 ' HB3' ' OG ' ' A' 1596 ' ' SER . 31.6 t -86.11 142.16 28.88 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 121.713 0.768 . . . . 0.8 110.402 -176.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1574 ' ' VAL . . . . . 0.651 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 30.5 m -124.17 15.09 4.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 CA-C-N 115.495 -0.775 . . . . 0.98 110.237 179.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . -179.44 123.48 0.85 Allowed Glycine 0 N--CA 1.417 -2.58 0 C-N-CA 118.825 -1.655 . . . . 0.29 112.21 177.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1576 ' ' LYS . . . . . 0.437 ' HB2' ' O ' ' A' 1594 ' ' ASP . 57.7 tttp -77.26 134.29 38.61 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 108.013 -1.106 . . . . 2.19 108.013 176.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -70.72 117.47 12.28 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.889 -0.596 . . . . 0.61 110.74 -177.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -133.56 174.88 9.94 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 106.913 -1.514 . . . . 1.95 106.913 177.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -123.93 45.83 2.39 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 106.184 -1.784 . . . . 2.68 106.184 178.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.86 88.01 3.9 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 113.527 -1.669 . . . . 3.47 107.579 -172.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1581 ' ' LEU . . . . . 0.465 HD12 ' CG2' ' A' 1518 ' ' VAL . 0.2 OUTLIER -89.73 133.51 34.65 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.228 -1.027 . . . . 0.64 108.228 -177.684 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -122.93 138.57 54.63 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 109.992 -0.373 . . . . 2.85 109.992 174.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1583 ' ' TYR . . . . . . . . . . . . . 50.0 t80 -109.43 111.9 23.71 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 107.624 -1.25 . . . . 0.86 107.624 177.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1584 ' ' VAL . . . . . 0.623 ' O ' ' HB ' ' A' 1587 ' ' VAL . 14.7 m -131.96 99.02 3.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 112.602 0.594 . . . . 1.05 112.602 -177.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 37.4 t70 52.5 66.23 1.28 Allowed 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 124.297 1.039 . . . . 1.17 111.605 175.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1586 ' ' GLN . . . . . . . . . . . . 0.255 30.1 pt20 65.14 12.4 7.95 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 127.515 2.326 . . . . 1.86 112.426 177.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1587 ' ' VAL . . . . . 0.623 ' HB ' ' O ' ' A' 1584 ' ' VAL . 13.9 t -110.51 128.28 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 CA-C-N 114.751 -1.113 . . . . 0.49 110.681 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1588 ' ' LEU . . . . . 0.822 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 3.2 mm? -95.28 107.98 20.12 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 106.613 -1.625 . . . . 0.36 106.613 176.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -115.48 116.77 28.76 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-O 121.672 0.748 . . . . 1.74 112.692 -174.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1590 ' ' LEU . . . . . 0.448 ' HG ' HD22 ' A' 1581 ' ' LEU . 5.7 mt -100.18 108.06 20.08 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 114.197 -1.365 . . . . 0.72 107.38 172.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 10.0 p -99.09 126.82 52.24 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.15 0 CA-C-O 121.531 0.681 . . . . 1.01 110.089 -179.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1592 ' ' TYR . . . . . 0.404 ' O ' ' HA ' ' A' 1607 ' ' LYS . 12.4 m-30 -113.28 99.21 7.63 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 109.317 -0.623 . . . . 0.5 109.317 177.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 60.1 pttt -111.41 179.39 4.04 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.585 -0.895 . . . . 1.59 108.585 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1594 ' ' ASP . . . . . 0.437 ' O ' ' HB2' ' A' 1576 ' ' LYS . 32.3 m-20 57.82 45.9 17.83 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.108 0.963 . . . . 1.11 110.955 178.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -79.59 -95.3 0.33 Allowed Glycine 0 CA--C 1.498 -0.979 0 N-CA-C 109.791 -1.324 . . . . 0.78 109.791 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1596 ' ' SER . . . . . 0.51 ' OG ' ' HB3' ' A' 1573 ' ' SER . 72.2 m -124.94 149.35 62.83 Favored Pre-proline 0 C--N 1.273 -2.736 0 N-CA-C 107.216 -1.402 . . . . 1.07 107.216 173.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -61.92 138.4 73.44 Favored 'Trans proline' 0 N--CA 1.445 -1.367 0 C-N-CA 122.273 1.982 . . . . 1.01 109.229 174.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1598 ' ' CYS . . . . . 0.51 ' HA ' ' CE2' ' A' 1606 ' ' TYR . 5.0 t -70.02 113.47 17.91 Favored Pre-proline 0 C--N 1.296 -1.718 0 N-CA-C 106.954 -1.499 . . . . 0.75 106.954 -178.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1599 ' ' PRO . . . . . 0.461 ' HD3' ' HE2' ' A' 1606 ' ' TYR . 24.2 Cg_exo -62.89 -33.78 74.08 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.984 2.456 . . . . 1.7 113.008 -173.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1600 ' ' SER . . . . . 0.674 ' HB2' ' HG ' ' B' ' 53' ' ' LEU . 5.2 m -86.18 7.6 24.39 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 116.307 -0.406 . . . . 2.26 112.061 178.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1601 ' ' LYS . . . . . 0.565 ' HG2' HD22 ' A' 1604 ' ' LEU . 3.0 tppp? -161.5 96.4 1.05 Allowed 'General case' 0 C--O 1.251 1.141 0 O-C-N 121.743 -0.598 . . . . 3.01 110.316 175.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 13.0 t -66.76 126.05 27.79 Favored 'General case' 0 N--CA 1.401 -2.886 0 N-CA-C 108.649 -0.871 . . . . 2.07 108.649 -176.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 106.2 -6.5 39.69 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 116.443 -0.344 . . . . 1.08 112.334 -177.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1604 ' ' LEU . . . . . 0.565 HD22 ' HG2' ' A' 1601 ' ' LYS . 7.5 mp -106.34 155.97 18.98 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 122.94 0.496 . . . . 1.84 109.981 176.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 44.8 t -135.24 151.06 50.25 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 107.99 -1.115 . . . . 1.41 107.99 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1606 ' ' TYR . . . . . 0.651 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 90.8 m-85 -80.45 150.86 29.58 Favored 'General case' 0 N--CA 1.419 -2.012 0 N-CA-C 108.903 -0.777 . . . . 0.6 108.903 176.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1607 ' ' LYS . . . . . 0.404 ' HA ' ' O ' ' A' 1592 ' ' TYR . 33.8 ttpt -150.82 127.46 10.85 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 123.623 0.577 . . . . 1.45 109.716 -175.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1608 ' ' SER . . . . . 0.402 ' HB2' ' HB2' ' A' 1592 ' ' TYR . 20.7 m -105.35 115.96 31.15 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 109.437 -0.579 . . . . 1.15 109.437 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 38.4 t -98.41 107.07 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 108.103 -1.073 . . . . 0.25 108.103 176.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 70.5 mt -100.25 101.37 12.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 CA-C-N 115.765 -0.652 . . . . 0.45 109.304 -179.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 5.9 p -100.2 119.02 37.71 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.619 0.723 . . . . 1.26 112.694 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1612 ' ' PHE . . . . . 0.822 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 72.0 m-85 -94.51 122.27 36.91 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.131 -0.94 . . . . 0.26 109.744 177.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 42.0 t -119.99 138.67 49.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-N 115.397 -0.819 . . . . 0.5 109.475 -175.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 13.2 t -58.75 113.54 2.09 Favored 'General case' 0 C--O 1.243 0.732 0 C-N-CA 124.352 1.061 . . . . 0.77 111.856 178.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1615 ' ' ARG . . . . . 0.697 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 23.7 tpt180 -136.64 97.46 11.43 Favored Pre-proline 0 N--CA 1.431 -1.386 0 N-CA-C 109.272 -0.64 . . . . 2.53 109.272 175.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1616 ' ' PRO . . . . . 0.464 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 60.5 Cg_endo -73.62 -14.9 24.62 Favored 'Trans proline' 0 N--CA 1.487 1.138 0 C-N-CA 122.551 2.167 . . . . 1.1 112.846 -177.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -91.82 42.68 1.11 Allowed 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 124.704 1.201 . . . . 3.05 110.333 -176.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -30.72 127.96 0.14 Allowed 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 126.648 1.979 . . . . 1.55 113.591 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1619 ' ' GLY . . . . . 0.426 ' HA3' ' HD2' ' A' 1620 ' ' PRO . . . 178.63 -145.14 6.66 Favored Glycine 0 N--CA 1.428 -1.843 0 N-CA-C 109.846 -1.302 . . . . 0.93 109.846 -178.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1620 ' ' PRO . . . . . 0.426 ' HD2' ' HA3' ' A' 1619 ' ' GLY . 27.2 Cg_endo -61.44 -4.07 3.91 Favored 'Trans proline' 0 CA--C 1.556 1.581 0 C-N-CA 123.568 2.846 . . . . 0.88 115.756 -177.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1621 ' ' THR . . . . . . . . . . . . . 23.3 p -91.96 -10.06 40.75 Favored 'General case' 0 C--O 1.247 0.939 0 O-C-N 121.563 -0.711 . . . . 0.97 110.662 176.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 47.1 t30 -90.43 58.66 4.07 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 122.338 1.066 . . . . 0.72 109.378 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -163.69 139.43 5.13 Favored Pre-proline 0 C--N 1.309 -1.192 0 CA-C-N 114.455 -1.248 . . . . 3.26 107.916 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -65.11 102.04 0.43 Allowed 'Trans proline' 0 C--O 1.239 0.528 0 C-N-CA 123.314 2.676 . . . . 0.59 112.837 -175.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 75.3 mtm -107.34 146.59 31.39 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.897 -0.592 . . . . 1.37 111.049 -178.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 1.6 tm? -86.76 115.34 24.13 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 107.438 -1.319 . . . . 0.89 107.438 -176.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 49.2 mm -79.16 -56.49 7.02 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-O 121.26 0.552 . . . . 0.58 109.792 179.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 66.5 m -161.36 147.22 14.12 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.513 -0.767 . . . . 1.39 109.704 -177.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1629 ' ' LEU . . . . . 0.823 HD13 ' HG ' ' A' 1636 ' ' LEU . 42.7 tp -113.92 112.85 24.01 Favored 'General case' 0 N--CA 1.424 -1.737 0 N-CA-C 107.428 -1.323 . . . . 1.25 107.428 172.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 30.6 t70 -85.93 110.75 19.66 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.68 -1.23 . . . . 1.09 107.68 174.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1631 ' ' LYS . . . . . 0.659 ' HB3' HD22 ' B' ' 53' ' ' LEU . 0.1 OUTLIER -73.72 -31.6 63.47 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.761 -0.654 . . . . 3.6 110.086 -174.037 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -70.16 -36.82 74.99 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-N 115.481 -0.781 . . . . 2.6 112.863 -173.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 54.8 p -101.32 -6.52 24.01 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.032 0.444 . . . . 0.75 110.7 175.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1634 ' ' CYS . . . . . 0.501 ' O ' ' HA ' ' A' 1606 ' ' TYR . 32.7 m 63.27 40.85 8.33 Favored 'General case' 0 C--N 1.364 1.209 0 C-N-CA 124.546 1.138 . . . . 0.53 109.961 -178.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1635 ' ' THR . . . . . . . . . . . . . 55.9 m -106.24 133.71 50.51 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.924 -1.034 . . . . 0.46 110.356 -176.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1636 ' ' LEU . . . . . 0.823 ' HG ' HD13 ' A' 1629 ' ' LEU . 0.7 OUTLIER -116.85 131.69 56.89 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.443 -0.577 . . . . 0.86 109.443 -177.709 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -111.23 128.09 55.81 Favored 'General case' 0 C--O 1.252 1.199 0 CA-C-O 120.821 0.343 . . . . 0.45 111.012 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -125.61 131.82 52.62 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.92 -0.77 . . . . 0.5 108.92 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1639 ' ' SER . . . . . . . . . . . . . 64.6 m -115.46 140.7 48.9 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 122.892 0.477 . . . . 1.04 109.857 178.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 3.1 t90 -142.35 114.29 8.12 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 104.327 -2.471 . . . . 0.68 104.327 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1641 ' ' HIS . . . . . 0.697 ' HB3' ' HB2' ' A' 1615 ' ' ARG . 31.5 m-70 -106.26 112.44 25.46 Favored 'General case' 0 C--N 1.293 -1.886 0 C-N-CA 119.916 -0.714 . . . . 0.9 110.005 -177.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1642 ' ' THR . . . . . . . . . . . . . 3.9 t -142.46 150.42 54.56 Favored Pre-proline 0 C--N 1.302 -1.491 0 CA-C-N 115.615 -0.72 . . . . 0.48 109.512 -172.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1643 ' ' PRO . . . . . 0.464 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 71.9 Cg_endo -77.07 -10.75 17.93 Favored 'Trans proline' 0 C--N 1.362 1.251 0 C-N-CA 122.411 2.074 . . . . 0.66 111.464 176.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1644 ' ' LEU . . . . . 0.585 HD11 ' HB2' ' A' 1531 ' ' SER . 7.3 tt -68.36 -24.33 64.79 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.712 0.805 . . . . 0.97 110.493 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -95.04 6.96 47.61 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 122.187 0.994 . . . . 0.84 109.619 -177.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 15.6 t -123.9 159.11 30.4 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-N 114.404 -1.271 . . . . 1.19 108.579 -175.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 31.7 tt0 . . . . . 0 C--N 1.308 -1.208 0 N-CA-C 108.455 -0.943 . . . . 3.14 108.455 169.573 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.549 0 N-CA-C 112.071 -0.411 . . . . 2.09 112.071 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.98 -21.95 73.77 Favored Glycine 0 C--N 1.311 -0.847 0 C-N-CA 121.72 -0.276 . . . . 1.84 113.353 179.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -71.46 -20.83 62.04 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.728 0.775 . . . . 2.55 109.265 -176.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' LEU . . . . . 0.443 ' O ' HD23 ' B' ' 17' ' ' LEU . 62.1 mt -68.14 -49.59 60.09 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 115.059 -0.973 . . . . 2.35 108.419 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 8.5 p -77.66 -18.12 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 CA-C-N 115.111 -0.95 . . . . 2.11 110.488 -176.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' ASP . . . . . 0.419 ' OD2' ' HB2' ' A' 1569 ' ' GLN . 12.5 t70 -62.83 -67.53 0.41 Allowed 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 109.535 -0.543 . . . . 2.04 109.535 176.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 15.2 t -61.13 -36.6 80.18 Favored 'General case' 0 C--O 1.25 1.125 0 O-C-N 123.635 0.584 . . . . 1.84 111.226 -176.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.572 HD21 HD11 ' B' ' 42' ' ' ILE . 4.0 mm? -57.37 -49.6 75.64 Favored 'General case' 0 C--O 1.215 -0.757 0 N-CA-C 113.109 0.781 . . . . 1.74 113.109 175.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -84.75 -14.97 46.66 Favored 'General case' 0 C--N 1.317 -0.809 0 O-C-N 121.583 -0.698 . . . . 2.39 111.034 -178.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -63.86 -54.66 31.34 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 116.314 -0.403 . . . . 0.96 111.017 176.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 16.0 m -98.18 -14.52 7.73 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.691 0 C-N-CA 118.911 -1.116 . . . . 1.37 112.319 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' CYS . . . . . 0.503 ' HB2' ' O ' ' B' ' 17' ' ' LEU . 68.7 m -114.49 23.03 13.12 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 120.358 -0.537 . . . . 1.66 111.666 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -52.22 -40.49 52.5 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 114.557 0.583 . . . . 1.53 114.557 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -86.12 -31.93 21.59 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 113.753 1.019 . . . . 2.72 113.753 -178.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -90.52 -25.03 20.46 Favored 'General case' 0 C--O 1.248 0.991 0 CA-C-O 121.353 0.597 . . . . 4.33 111.44 -176.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 109.29 163.06 19.97 Favored Glycine 0 N--CA 1.439 -1.132 0 N-CA-C 110.183 -1.167 . . . . 1.53 110.183 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -123.62 131.11 53.54 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 117.52 0.66 . . . . 1.65 110.96 179.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -136.71 80.84 1.84 Allowed 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 111.754 0.279 . . . . 3.42 111.754 -177.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' PHE . . . . . 0.548 ' HA ' ' HE2' ' B' ' 59' ' ' TYR . 34.3 p90 . . . . . 0 C--N 1.304 -1.378 0 CA-C-O 121.7 0.762 . . . . 2.26 109.674 173.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.409 -3.146 0 N-CA-C 110.248 -1.141 . . . . 2.37 110.248 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . 0.572 HD11 HD21 ' B' ' 17' ' ' LEU . 10.2 pt 59.65 -28.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 C-N-CA 127.737 2.415 . . . . 2.07 116.491 176.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . . . . . . . . 0.26 2.7 p -51.41 -49.53 31.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 114.958 1.466 . . . . 2.24 114.958 -175.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -96.12 -26.0 15.65 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.357 -0.979 . . . . 3.36 108.357 -176.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . 0.528 ' O ' ' HB2' ' B' ' 49' ' ' ARG . 9.5 tp10 -60.9 -43.72 98.12 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 114.933 -1.03 . . . . 3.08 109.428 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' CYS . . . . . 0.4 ' HA ' ' O ' ' B' ' 49' ' ' ARG . 10.1 t -94.48 -14.62 24.97 Favored 'General case' 0 C--N 1.314 -0.956 0 O-C-N 121.988 -0.445 . . . . 2.23 111.736 -177.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 52.2 t -66.75 -47.74 71.29 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.141 -0.623 . . . . 2.37 110.181 179.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -105.71 -12.77 15.78 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 113.152 0.797 . . . . 2.82 113.152 -177.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . 0.528 ' HB2' ' O ' ' B' ' 45' ' ' GLU . 64.7 mtt180 -125.6 158.68 34.05 Favored 'General case' 0 CA--C 1.498 -1.036 0 N-CA-C 108.35 -0.981 . . . . 4.09 108.35 178.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 23.0 t -84.61 123.55 30.45 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 109.562 -0.533 . . . . 2.67 109.562 -177.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . 0.473 ' HB2' HD23 ' B' ' 55' ' ' LEU . 29.4 p -105.81 133.52 50.41 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 108.316 -0.994 . . . . 2.11 108.316 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -80.27 147.37 31.21 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.685 -1.228 . . . . 2.67 107.685 177.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . 0.803 ' H ' HD12 ' B' ' 53' ' ' LEU . 3.0 mp -52.49 -29.04 22.92 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 125.789 1.635 . . . . 1.9 112.185 -175.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . 0.42 ' O ' HG22 ' B' ' 58' ' ' THR . . . -61.96 -37.81 86.15 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 123.581 0.551 . . . . 1.52 110.772 -178.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . 0.473 HD23 ' HB2' ' B' ' 51' ' ' CYS . 50.5 tp -59.93 -50.59 73.17 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-N 115.787 -0.642 . . . . 1.97 110.617 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 3.9 pp -75.54 -32.76 60.57 Favored 'General case' 0 N--CA 1.422 -1.85 0 CA-C-N 116.202 -0.453 . . . . 1.53 111.99 -174.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -71.24 -42.44 68.84 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 112.195 0.442 . . . . 2.27 112.195 -176.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 58' ' ' THR . . . . . 0.42 HG22 ' O ' ' B' ' 54' ' ' ALA . 12.2 t -78.09 -25.4 47.58 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 118.83 -1.148 . . . . 2.33 111.742 176.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 59' ' ' TYR . . . . . 0.548 ' HE2' ' HA ' ' B' ' 28' ' ' PHE . 30.2 t80 -67.5 -68.55 0.37 Allowed 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 106.576 -1.639 . . . . 2.86 106.576 176.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 42.0 t . . . . . 0 CA--C 1.559 1.311 0 C-N-CA 125.391 1.476 . . . . 2.3 114.213 173.274 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 14.0 t70 . . . . . 0 N--CA 1.435 -1.195 0 N-CA-C 105.395 -2.076 . . . . 2.9 105.395 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A 1516 ' ' CYS . . . . . 0.561 ' HA ' ' HB2' ' A' 1581 ' ' LEU . 91.1 m -88.5 66.5 8.26 Favored 'General case' 0 C--N 1.283 -2.293 0 CA-C-O 121.68 0.752 . . . . 1.19 110.926 -177.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -152.22 130.86 12.3 Favored 'General case' 0 N--CA 1.415 -2.206 0 CA-C-N 114.666 -1.152 . . . . 1.52 109.301 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1518 ' ' VAL . . . . . 0.569 HG21 ' HB2' ' A' 1583 ' ' TYR . 2.9 m -145.12 142.9 22.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 C-N-CA 123.926 0.89 . . . . 0.94 110.153 -179.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1519 ' ' THR . . . . . . . . . . . . . 18.9 m -101.81 145.34 29.31 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 116.301 -0.409 . . . . 0.89 111.026 -177.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1520 ' ' ASN . . . . . 0.404 ' OD1' HG22 ' A' 1523 ' ' THR . 24.5 t-20 -76.2 111.88 17.72 Favored Pre-proline 0 N--CA 1.433 -1.289 0 N-CA-C 106.389 -1.708 . . . . 1.74 106.389 170.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -74.21 0.46 8.44 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.491 2.127 . . . . 1.58 113.736 -174.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 19.6 m -91.15 -43.22 10.01 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 116.256 -0.429 . . . . 1.65 111.603 177.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1523 ' ' THR . . . . . 0.404 HG22 ' OD1' ' A' 1520 ' ' ASN . 4.9 t -119.24 -8.86 10.05 Favored 'General case' 0 C--O 1.244 0.79 0 C-N-CA 119.943 -0.703 . . . . 1.61 112.43 -177.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 85.95 20.37 55.73 Favored Glycine 0 C--N 1.317 -0.494 0 C-N-CA 120.423 -0.894 . . . . 1.13 113.095 177.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 24.3 t-80 -84.35 123.63 30.4 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.057 0.455 . . . . 1.26 110.574 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 2.9 tm? -94.71 119.32 33.14 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 115.336 -0.847 . . . . 0.68 110.943 -175.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -91.64 130.83 37.38 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 109.604 -0.517 . . . . 0.65 109.604 169.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 16.3 t70 -125.64 122.56 36.75 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.452 -1.314 . . . . 1.17 107.452 173.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 3.7 mm? -93.86 5.87 50.26 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 113.683 0.994 . . . . 0.6 113.683 -170.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1530 ' ' SER . . . . . 0.571 ' HA ' ' OG ' ' A' 1533 ' ' SER . 3.6 m -66.16 -7.94 21.03 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 113.804 1.039 . . . . 0.84 113.804 -174.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 8.5 t -69.22 -31.88 70.76 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 109.391 -0.596 . . . . 1.59 109.391 179.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 81.1 mt -95.38 -7.03 39.63 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.069 0.461 . . . . 0.65 110.795 -178.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1533 ' ' SER . . . . . 0.571 ' OG ' ' HA ' ' A' 1530 ' ' SER . 24.5 m -66.97 161.3 24.55 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.85 -0.614 . . . . 1.52 111.433 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . 155.86 159.82 9.61 Favored Glycine 0 N--CA 1.423 -2.174 0 N-CA-C 109.811 -1.316 . . . . 1.1 109.811 -176.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1535 ' ' ARG . . . . . 0.428 ' O ' ' HA ' ' A' 1556 ' ' ASN . 42.2 ttp180 -92.26 -31.16 15.52 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 109.972 -0.381 . . . . 4.62 109.972 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -66.67 -34.01 76.91 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 121.126 0.488 . . . . 1.45 110.878 -177.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 73.75 -157.29 51.48 Favored Glycine 0 N--CA 1.428 -1.85 0 CA-C-N 115.042 -0.981 . . . . 0.85 113.676 172.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -137.26 152.05 49.38 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.84 -1.17 . . . . 0.93 107.84 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 27.0 p -112.73 139.75 48.09 Favored 'General case' 0 C--N 1.308 -1.215 0 O-C-N 123.489 0.493 . . . . 1.03 111.177 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1540 ' ' ALA . . . . . 0.478 ' HB3' HG12 ' A' 1548 ' ' VAL . . . -131.35 135.14 46.99 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 108.409 -0.96 . . . . 0.5 108.409 174.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -73.58 141.7 46.62 Favored 'General case' 0 C--O 1.243 0.719 0 C-N-CA 122.601 0.36 . . . . 0.74 110.866 -178.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1542 ' ' TYR . . . . . 0.481 ' HB3' ' H ' ' A' 1543 ' ' SER . 1.3 t80 -149.43 -101.14 0.07 Allowed 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 109.285 -0.635 . . . . 0.99 109.285 -176.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1543 ' ' SER . . . . . 0.481 ' H ' ' HB3' ' A' 1542 ' ' TYR . 4.3 m -63.95 160.24 18.17 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.468 1.107 . . . . 1.91 111.225 -178.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 52.3 tptt -50.76 -41.38 56.67 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 113.611 0.967 . . . . 3.59 113.611 -173.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 11.9 t -128.75 37.93 4.03 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 108.785 -0.82 . . . . 2.46 108.785 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1546 ' ' GLY . . . . . 0.583 ' HA3' ' HG2' ' A' 1569 ' ' GLN . . . -147.96 120.34 1.21 Allowed Glycine 0 N--CA 1.428 -1.859 0 C-N-CA 119.555 -1.307 . . . . 1.26 113.573 -177.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 29.3 m -99.89 152.58 4.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 107.001 -1.481 . . . . 0.79 107.001 174.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1548 ' ' VAL . . . . . 0.478 HG12 ' HB3' ' A' 1540 ' ' ALA . 12.3 p -92.76 134.42 30.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.865 0 C-N-CA 119.922 -0.711 . . . . 0.58 109.202 178.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -99.87 129.13 45.93 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 115.355 -0.839 . . . . 1.08 108.763 177.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 25.8 ptm -144.14 126.27 15.55 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 115.453 -0.794 . . . . 0.78 110.972 -176.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 5.3 p -118.55 132.89 56.2 Favored 'General case' 0 C--N 1.282 -2.355 0 CA-C-N 115.002 -0.999 . . . . 0.97 109.795 179.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1552 ' ' ILE . . . . . . . . . . . . . 46.8 mm -83.28 112.15 20.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 120.477 0.18 . . . . 0.42 111.159 -176.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 57.9 m 64.99 29.6 12.17 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.622 1.169 . . . . 1.4 112.093 174.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . -167.01 -174.8 36.55 Favored Glycine 0 N--CA 1.409 -3.113 0 N-CA-C 108.961 -1.656 . . . . 0.35 108.961 -178.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -109.78 152.86 25.16 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-N 116.845 0.323 . . . . 1.62 111.724 -175.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1556 ' ' ASN . . . . . 0.428 ' HA ' ' O ' ' A' 1535 ' ' ARG . 26.7 t-20 -103.29 138.63 39.81 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.008 -1.108 . . . . 0.87 108.008 178.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -85.97 2.33 46.66 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 114.06 1.133 . . . . 2.49 114.06 -171.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -91.03 -1.81 57.75 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 120.491 -0.484 . . . . 1.38 111.027 -178.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1559 ' ' CYS . . . . . 0.62 ' SG ' ' HD2' ' A' 1560 ' ' PRO . 16.0 t -137.43 151.74 71.81 Favored Pre-proline 0 C--N 1.304 -1.373 0 N-CA-C 106.648 -1.612 . . . . 1.21 106.648 178.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1560 ' ' PRO . . . . . 0.62 ' HD2' ' SG ' ' A' 1559 ' ' CYS . 13.3 Cg_exo -30.6 132.13 0.05 OUTLIER 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 125.226 3.95 . . . . 0.71 114.655 178.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -45.02 129.25 9.86 Favored 'Trans proline' 0 C--N 1.364 1.385 0 C-N-CA 124.768 3.645 . . . . 0.8 113.332 -177.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 96.6 18.98 28.67 Favored Glycine 0 C--N 1.313 -0.727 0 CA-C-N 116.204 -0.453 . . . . 0.46 113.14 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1563 ' ' VAL . . . . . 0.596 HG11 ' HB2' ' A' 1566 ' ' CYS . 2.3 t -106.61 124.51 62.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 C-N-CA 123.02 0.528 . . . . 0.98 111.661 -178.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -97.27 -33.97 5.77 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 115.242 -0.89 . . . . 0.28 111.814 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -133.94 129.59 36.51 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 109.018 -0.734 . . . . 0.28 109.018 177.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1566 ' ' CYS . . . . . 0.596 ' HB2' HG11 ' A' 1563 ' ' VAL . 48.5 t -158.32 138.11 12.09 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 110.52 -0.178 . . . . 0.43 110.52 -176.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -84.72 135.45 34.14 Favored 'General case' 0 C--O 1.245 0.859 0 N-CA-C 108.428 -0.953 . . . . 1.03 108.428 173.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -91.79 27.71 9.55 Favored Glycine 0 N--CA 1.422 -2.286 0 N-CA-C 115.88 1.112 . . . . 1.13 115.88 -170.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1569 ' ' GLN . . . . . 0.605 ' HB2' ' OD2' ' B' ' 15' ' ' ASP . 20.8 mt-30 -77.49 -69.04 0.56 Allowed 'General case' 0 C--O 1.241 0.617 0 C-N-CA 117.349 -1.74 . . . . 2.58 109.579 171.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 71.0 p -114.33 15.7 17.98 Favored 'General case' 0 CA--C 1.553 1.058 0 N-CA-C 112.809 0.67 . . . . 2.17 112.809 177.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? 66.43 68.78 0.43 Allowed 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.923 1.289 . . . . 2.62 112.703 -179.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 18.8 mt -106.3 122.61 60.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 114.727 -1.124 . . . . 0.92 108.793 177.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 35.7 t -83.2 138.53 33.59 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.669 0.747 . . . . 0.8 111.244 -174.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1574 ' ' VAL . . . . . 0.589 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 27.1 m -123.39 18.05 5.03 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 CA-C-N 115.661 -0.699 . . . . 0.98 110.392 178.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 167.52 126.44 0.84 Allowed Glycine 0 N--CA 1.422 -2.253 0 CA-C-N 115.113 -0.949 . . . . 0.29 112.383 175.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 53.9 tttm -68.64 146.03 53.38 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.525 -0.917 . . . . 2.19 108.525 177.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -73.48 79.45 1.43 Allowed 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.208 0.528 . . . . 0.61 111.566 -178.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -96.35 -177.6 4.02 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 109.263 -0.643 . . . . 1.95 109.263 178.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 66.7 mttm -132.38 47.56 2.5 Favored 'General case' 0 CA--C 1.485 -1.548 0 N-CA-C 105.28 -2.119 . . . . 2.68 105.28 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.49 76.62 5.83 Favored 'General case' 0 N--CA 1.415 -2.197 0 CA-C-N 113.773 -1.558 . . . . 3.47 108.593 -171.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1581 ' ' LEU . . . . . 0.561 ' HB2' ' HA ' ' A' 1516 ' ' CYS . 0.3 OUTLIER -86.14 129.58 34.8 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.608 -1.178 . . . . 0.64 108.691 -179.309 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A 1582 ' ' ARG . . . . . 0.547 ' HB2' ' HB3' ' A' 1589 ' ' GLN . 70.3 mtp180 -124.15 137.26 54.57 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 116.522 -0.308 . . . . 2.85 110.273 173.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1583 ' ' TYR . . . . . 0.569 ' HB2' HG21 ' A' 1518 ' ' VAL . 66.9 t80 -105.62 104.37 14.07 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 107.853 -1.165 . . . . 0.86 107.853 177.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1584 ' ' VAL . . . . . 0.529 ' O ' ' HB ' ' A' 1587 ' ' VAL . 16.7 m -121.2 89.51 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 112.81 0.67 . . . . 1.05 112.81 -175.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 17.4 t70 56.91 57.9 4.38 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.119 0.968 . . . . 1.17 110.134 177.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1586 ' ' GLN . . . . . 0.53 ' HA ' ' CE1' ' A' 1583 ' ' TYR 0.296 9.1 pt20 68.87 4.67 4.58 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 128.196 2.598 . . . . 1.86 112.637 179.116 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A 1587 ' ' VAL . . . . . 0.529 ' HB ' ' O ' ' A' 1584 ' ' VAL . 23.1 t -93.71 124.03 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.012 0 N-CA-C 108.491 -0.929 . . . . 0.49 108.491 174.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1588 ' ' LEU . . . . . 0.859 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 3.4 mm? -92.73 107.77 19.47 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.157 -1.053 . . . . 0.36 108.157 178.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1589 ' ' GLN . . . . . 0.547 ' HB3' ' HB2' ' A' 1582 ' ' ARG . 35.5 tt0 -99.05 123.65 43.5 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 116.025 -0.534 . . . . 1.74 110.23 -178.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1590 ' ' LEU . . . . . 0.476 ' HB3' ' HB ' ' A' 1610 ' ' ILE . 0.7 OUTLIER -117.83 96.02 5.18 Favored 'General case' 0 C--N 1.284 -2.27 0 N-CA-C 105.065 -2.198 . . . . 0.72 105.065 174.885 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 8.4 p -96.31 132.16 41.29 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 CA-C-O 121.317 0.579 . . . . 1.01 111.665 -175.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1592 ' ' TYR . . . . . . . . . . . . . 14.2 m-30 -121.51 122.18 39.15 Favored 'General case' 0 CA--C 1.496 -1.12 0 N-CA-C 108.306 -0.998 . . . . 0.5 108.306 176.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 58.4 pttt -131.09 179.04 6.24 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 108.98 -0.748 . . . . 1.59 108.98 177.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 19.9 m-20 62.17 53.2 2.97 Favored 'General case' 0 C--O 1.249 1.049 0 O-C-N 124.286 0.992 . . . . 1.11 110.864 178.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -85.67 -105.23 0.71 Allowed Glycine 0 N--CA 1.429 -1.796 0 N-CA-C 109.558 -1.417 . . . . 0.78 109.558 177.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1596 ' ' SER . . . . . . . . . . . . . 36.3 p -129.11 153.63 80.37 Favored Pre-proline 0 C--N 1.282 -2.331 0 N-CA-C 107.753 -1.202 . . . . 1.07 107.753 174.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 90.7 Cg_exo -50.67 133.76 39.21 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.287 2.658 . . . . 1.01 113.509 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1598 ' ' CYS . . . . . 0.517 ' HA ' ' CE2' ' A' 1606 ' ' TYR . 44.4 t -81.83 119.27 74.89 Favored Pre-proline 0 C--N 1.283 -2.285 0 CA-C-N 113.875 -1.512 . . . . 0.75 109.018 -178.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1599 ' ' PRO . . . . . 0.488 ' HD2' ' OH ' ' A' 1606 ' ' TYR . 40.2 Cg_exo -60.43 -23.92 76.34 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 123.097 2.532 . . . . 1.7 112.965 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1600 ' ' SER . . . . . 0.741 ' HA ' ' HB2' ' B' ' 53' ' ' LEU . 19.5 m -54.37 -44.81 72.54 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 123.364 0.665 . . . . 2.26 111.782 178.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1601 ' ' LYS . . . . . 0.548 ' HB3' HD12 ' A' 1604 ' ' LEU . 4.5 tppp? -148.24 127.88 13.31 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.97 -0.752 . . . . 3.01 108.97 179.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 20.4 m -65.48 129.48 39.9 Favored 'General case' 0 N--CA 1.412 -2.345 0 N-CA-C 108.796 -0.816 . . . . 2.07 108.796 -178.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 105.25 -10.87 47.53 Favored Glycine 0 N--CA 1.436 -1.359 0 C-N-CA 120.496 -0.859 . . . . 1.08 112.499 178.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1604 ' ' LEU . . . . . 0.548 HD12 ' HB3' ' A' 1601 ' ' LYS . 67.6 mt -99.33 150.19 22.38 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.667 -0.494 . . . . 1.84 109.667 178.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 22.4 t -123.4 153.15 40.79 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.555 -1.276 . . . . 1.41 107.555 177.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1606 ' ' TYR . . . . . 0.589 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 49.6 m-85 -73.77 158.48 34.52 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 116.171 -0.468 . . . . 0.6 111.903 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 20.0 ttpp -156.26 125.87 6.31 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.808 -0.633 . . . . 1.45 110.502 -178.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1608 ' ' SER . . . . . . . . . . . . . 20.0 m -106.45 129.86 54.35 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 109.015 -0.735 . . . . 1.15 109.015 -179.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 26.2 t -114.21 102.41 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.598 0 N-CA-C 108.508 -0.923 . . . . 0.25 108.508 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1610 ' ' ILE . . . . . 0.476 ' HB ' ' HB3' ' A' 1590 ' ' LEU . 85.4 mt -90.11 113.8 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.662 0 N-CA-C 108.709 -0.848 . . . . 0.45 108.709 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 34.5 m -109.64 106.76 16.56 Favored 'General case' 0 C--N 1.283 -2.288 0 CA-C-N 114.855 -1.066 . . . . 1.26 110.249 -178.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1612 ' ' PHE . . . . . 0.859 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 45.7 m-85 -80.27 119.24 22.76 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.88 -0.6 . . . . 0.26 109.79 176.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1613 ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' 1641 ' ' HIS . 54.1 t -109.64 128.83 65.39 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-N 115.004 -0.998 . . . . 0.5 110.927 -174.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 5.8 t -55.19 109.44 0.53 Allowed 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 125.012 1.325 . . . . 0.77 112.97 176.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1615 ' ' ARG . . . . . 0.808 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 4.3 tpt180 -129.08 94.36 34.07 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 106.963 -1.495 . . . . 2.53 106.963 169.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1616 ' ' PRO . . . . . 0.631 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 37.6 Cg_endo -63.47 -32.41 70.9 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 122.789 2.326 . . . . 1.1 115.999 -169.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -85.94 -18.16 33.44 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.211 -0.595 . . . . 3.05 111.646 -176.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . 68.65 113.15 0.04 OUTLIER 'General case' 0 C--N 1.358 0.949 0 C-N-CA 125.23 1.412 . . . . 1.55 110.937 -174.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . -131.25 -155.87 8.3 Favored Glycine 0 N--CA 1.422 -2.292 0 C-N-CA 119.976 -1.107 . . . . 0.93 111.208 -177.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -82.43 20.88 1.05 Allowed 'Trans proline' 0 C--O 1.235 0.375 0 C-N-CA 123.253 2.635 . . . . 0.88 113.588 -174.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1621 ' ' THR . . . . . . . . . . . . . 22.4 p -116.71 14.4 15.33 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-O 121.901 0.858 . . . . 0.97 109.717 178.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 42.6 t30 -90.68 58.9 4.04 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 122.802 1.287 . . . . 0.72 108.325 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1623 ' ' ARG . . . . . 0.412 ' HE ' ' HB2' ' A' 1623 ' ' ARG . 3.5 ptm180 -168.05 140.55 2.51 Favored Pre-proline 0 N--CA 1.428 -1.551 0 CA-C-N 113.486 -1.688 . . . . 3.26 107.003 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1624 ' ' PRO . . . . . 0.451 ' HA ' ' O ' ' A' 1639 ' ' SER . 35.7 Cg_endo -61.98 103.99 0.31 Allowed 'Trans proline' 0 C--O 1.243 0.733 0 C-N-CA 123.133 2.555 . . . . 0.59 113.012 -176.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 69.9 mtm -99.66 144.92 28.18 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.988 -0.551 . . . . 1.37 109.869 176.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 1.5 tm? -86.89 115.33 24.23 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 106.883 -1.525 . . . . 0.89 106.883 -176.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1627 ' ' ILE . . . . . 0.753 HD11 ' HB2' ' A' 1639 ' ' SER . 38.6 mm -75.94 -58.35 4.67 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.605 0 CA-C-O 121.589 0.709 . . . . 0.58 109.186 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 40.3 m -164.18 151.3 11.78 Favored 'General case' 0 N--CA 1.427 -1.575 0 N-CA-C 107.639 -1.245 . . . . 1.39 107.639 -174.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1629 ' ' LEU . . . . . 0.712 HD13 ' HG ' ' A' 1636 ' ' LEU . 33.0 tp -116.05 104.7 11.83 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 107.102 -1.444 . . . . 1.25 107.102 172.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 14.3 t70 -75.35 100.99 4.58 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.082 -1.047 . . . . 1.09 108.63 178.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1631 ' ' LYS . . . . . 0.794 ' HD3' ' H ' ' A' 1631 ' ' LYS . 0.0 OUTLIER -65.31 -8.48 18.35 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 114.336 1.236 . . . . 3.6 114.336 -175.677 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A 1632 ' ' GLN . . . . . 0.858 HE21 ' HA ' ' A' 1632 ' ' GLN . 0.0 OUTLIER -96.06 -37.89 10.43 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 119.409 -0.916 . . . . 2.6 110.909 -179.292 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 66.9 p -94.74 -16.4 23.07 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 116.026 -0.534 . . . . 0.75 110.798 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 74.5 m 68.59 35.76 3.08 Favored 'General case' 0 C--N 1.353 0.73 0 C-N-CA 124.572 1.149 . . . . 0.53 110.698 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1635 ' ' THR . . . . . . . . . . . . . 41.3 m -99.19 131.79 44.97 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 114.455 -1.248 . . . . 0.46 109.693 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1636 ' ' LEU . . . . . 0.712 ' HG ' HD13 ' A' 1629 ' ' LEU . 0.5 OUTLIER -110.24 121.62 45.72 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.638 -1.245 . . . . 0.86 107.638 -179.018 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -101.93 129.46 48.2 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 120.898 0.38 . . . . 0.45 110.836 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -125.83 137.37 53.76 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.312 -0.858 . . . . 0.5 109.82 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1639 ' ' SER . . . . . 0.753 ' HB2' HD11 ' A' 1627 ' ' ILE . 16.5 t -117.81 150.8 38.55 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.288 -1.004 . . . . 1.04 108.288 178.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 2.8 t90 -152.55 113.63 4.2 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 104.868 -2.271 . . . . 0.68 104.868 -179.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1641 ' ' HIS . . . . . 0.808 ' HB3' ' HB2' ' A' 1615 ' ' ARG . 10.6 m-70 -101.2 111.13 23.26 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-O 121.357 0.599 . . . . 0.9 109.79 -176.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1642 ' ' THR . . . . . . . . . . . . . 3.2 t -142.57 148.14 45.56 Favored Pre-proline 0 C--N 1.297 -1.71 0 CA-C-N 115.148 -0.933 . . . . 0.48 109.278 -174.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1643 ' ' PRO . . . . . 0.631 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 58.9 Cg_endo -79.42 -14.41 13.06 Favored 'Trans proline' 0 C--N 1.363 1.318 0 C-N-CA 122.28 1.987 . . . . 0.66 112.847 178.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 8.2 tt -70.76 -26.93 63.58 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.796 -0.816 . . . . 0.97 108.796 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1645 ' ' ALA . . . . . 0.414 ' CB ' ' HB3' ' A' 1612 ' ' PHE . . . -99.09 28.42 4.44 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 114.718 -1.128 . . . . 0.84 110.44 -177.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 47.7 t -121.57 140.95 51.58 Favored 'General case' 0 N--CA 1.419 -1.997 0 N-CA-C 108.794 -0.817 . . . . 1.19 108.794 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 16.8 tp10 . . . . . 0 N--CA 1.421 -1.921 0 N-CA-C 107.629 -1.249 . . . . 3.14 107.629 177.208 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.806 0 N-CA-C 110.911 -0.875 . . . . 2.09 110.911 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -57.16 -64.66 4.2 Favored Glycine 0 C--N 1.33 0.24 0 N-CA-C 113.919 0.328 . . . . 1.84 113.919 -177.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -63.96 -32.32 73.81 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 109.349 -0.611 . . . . 2.55 109.349 -178.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' LEU . . . . . 0.478 ' O ' HD23 ' B' ' 17' ' ' LEU . 0.1 OUTLIER -60.29 -59.56 5.22 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 114.441 -1.254 . . . . 2.35 109.214 -178.926 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 14.2 p -69.21 -33.31 57.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 112.259 0.466 . . . . 2.11 112.259 -176.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' ASP . . . . . 0.605 ' OD2' ' HB2' ' A' 1569 ' ' GLN . 11.9 t0 -59.86 -53.34 59.09 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 120.164 -0.614 . . . . 2.04 109.444 179.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 34.5 m -57.29 -51.14 70.56 Favored 'General case' 0 CA--C 1.566 1.571 0 C-N-CA 123.983 0.913 . . . . 1.84 111.322 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.542 ' HG ' ' HD2' ' B' ' 28' ' ' PHE . 4.2 mm? -53.72 -46.98 70.99 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.628 -0.715 . . . . 1.74 112.214 176.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -83.15 -10.67 58.51 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-O 121.554 0.692 . . . . 2.39 111.558 -177.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -68.5 -56.78 7.22 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.719 -0.673 . . . . 0.96 110.283 177.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 15.0 p -95.32 -22.83 5.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 C-N-CA 118.571 -1.252 . . . . 1.37 112.063 -176.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 60.3 m -108.81 27.01 9.89 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 120.197 -0.601 . . . . 1.66 110.13 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -54.16 -54.82 29.53 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 121.171 -0.538 . . . . 1.53 113.125 178.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -71.97 -43.11 65.69 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 112.168 0.433 . . . . 2.72 112.168 178.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 39.1 ttm180 -67.73 -49.36 62.96 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 112.452 0.538 . . . . 4.33 112.452 -175.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 125.84 140.86 5.43 Favored Glycine 0 N--CA 1.437 -1.244 0 N-CA-C 110.002 -1.239 . . . . 1.53 110.002 -175.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . 0.473 ' HB2' ' HB3' ' B' ' 17' ' ' LEU . 30.6 p90 -113.69 130.22 56.45 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 117.121 0.46 . . . . 1.65 109.99 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -133.45 73.64 1.52 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.679 0.622 . . . . 3.42 112.679 -177.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' PHE . . . . . 0.542 ' HD2' ' HG ' ' B' ' 17' ' ' LEU . 34.3 p90 . . . . . 0 C--N 1.306 -1.295 0 C-N-CA 119.223 -0.991 . . . . 2.26 109.013 173.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.407 -3.259 0 N-CA-C 109.773 -1.331 . . . . 2.37 109.773 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . 0.538 HD11 HD21 ' B' ' 17' ' ' LEU . 20.0 pt 61.51 -30.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 C-N-CA 127.953 2.501 . . . . 2.07 114.821 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.63 ' O ' ' HB2' ' B' ' 47' ' ' CYS . 2.6 p -49.88 -43.01 19.27 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 114.236 1.199 . . . . 2.24 114.236 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -96.28 -35.04 11.39 Favored 'General case' 0 N--CA 1.429 -1.523 0 C-N-CA 120.207 -0.597 . . . . 3.36 109.566 -175.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . 0.427 ' HG3' ' HD2' ' B' ' 49' ' ' ARG . 33.7 tt0 -63.87 -45.4 89.59 Favored 'General case' 0 C--O 1.202 -1.431 0 CA-C-N 115.905 -0.589 . . . . 3.08 109.769 179.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' CYS . . . . . . . . . . . . . 29.3 m -85.16 -4.16 59.06 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.216 0.531 . . . . 2.23 110.88 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' CYS . . . . . 0.63 ' HB2' ' O ' ' B' ' 43' ' ' VAL . 42.2 t -77.62 -45.36 25.35 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.523 0.677 . . . . 2.37 109.195 175.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -105.23 -10.25 17.19 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 113.236 0.828 . . . . 2.82 113.236 -176.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . 0.427 ' HD2' ' HG3' ' B' ' 45' ' ' GLU . 93.0 mtt180 -129.47 171.31 12.69 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 106.956 -1.498 . . . . 4.09 106.956 177.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 22.7 t -99.71 148.11 24.72 Favored 'General case' 0 N--CA 1.426 -1.66 0 N-CA-C 107.609 -1.256 . . . . 2.67 107.609 173.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 76.9 m -125.98 142.01 51.71 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 109.553 -0.536 . . . . 2.11 109.553 -175.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -81.77 161.79 23.15 Favored 'General case' 0 C--O 1.243 0.725 0 O-C-N 123.15 0.281 . . . . 2.67 110.88 176.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . 0.741 ' HB2' ' HA ' ' A' 1600 ' ' SER . 62.7 tp -55.33 -36.23 66.04 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 122.508 0.323 . . . . 1.9 111.405 178.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.9 -26.51 65.96 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 123.648 0.779 . . . . 1.52 112.556 -174.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 52.6 tp -74.44 -54.56 7.32 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 109.551 -0.537 . . . . 1.97 109.551 177.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.5 ' O ' ' HB2' ' B' ' 60' ' ' CYS . 2.8 pp -70.92 -33.32 70.41 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-N 115.923 -0.58 . . . . 1.53 111.392 -174.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -54.47 -51.39 65.2 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 123.663 0.602 . . . . 2.27 111.318 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 8.9 t -82.7 -28.29 30.65 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 112.492 0.553 . . . . 2.33 112.492 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -78.38 -36.27 46.13 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 121.807 -0.558 . . . . 2.86 110.695 -175.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 60' ' ' CYS . . . . . 0.5 ' HB2' ' O ' ' B' ' 56' ' ' LEU . 12.0 t . . . . . 0 N--CA 1.493 1.69 0 C-N-CA 126.011 1.724 . . . . 2.3 111.84 -178.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 26.5 p-10 . . . . . 0 N--CA 1.414 -2.234 0 N-CA-C 107.068 -1.456 . . . . 2.9 107.068 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 11.8 m -87.06 51.07 2.14 Favored 'General case' 0 C--N 1.276 -2.628 0 CA-C-N 115.703 -0.68 . . . . 1.19 110.271 -174.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1517 ' ' GLN . . . . . 0.416 ' HA ' ' O ' ' A' 1527 ' ' PHE . 3.2 pt20 -162.98 132.05 4.09 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-O 121.23 0.538 . . . . 1.52 111.381 -174.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 6.6 m -135.46 144.79 33.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 CA-C-N 116.083 -0.508 . . . . 0.94 110.038 179.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1519 ' ' THR . . . . . . . . . . . . . 28.9 m -114.65 134.52 55.0 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.386 -0.598 . . . . 0.89 109.386 177.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1520 ' ' ASN . . . . . 0.529 ' OD1' HG22 ' A' 1523 ' ' THR . 13.9 t-20 -89.98 115.23 63.46 Favored Pre-proline 0 N--CA 1.43 -1.429 0 N-CA-C 108.322 -0.992 . . . . 1.74 108.322 175.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -66.54 -16.51 51.09 Favored 'Trans proline' 0 CA--C 1.533 0.439 0 C-N-CA 122.898 2.399 . . . . 1.58 113.514 -175.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1522 ' ' SER . . . . . 0.45 ' HB2' ' OD1' ' A' 1520 ' ' ASN . 15.9 m -71.8 -50.05 33.26 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 116.439 -0.346 . . . . 1.65 111.393 -179.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1523 ' ' THR . . . . . 0.529 HG22 ' OD1' ' A' 1520 ' ' ASN . 9.9 t -111.62 -1.86 15.61 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 120.479 -0.488 . . . . 1.61 111.524 -176.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 66.58 33.26 84.0 Favored Glycine 0 CA--C 1.501 -0.817 0 CA-C-N 115.737 -0.665 . . . . 1.13 112.41 177.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 55.5 t-80 -94.85 123.73 38.48 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 119.971 -0.692 . . . . 1.26 109.408 -178.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 2.0 tm? -93.71 111.52 23.22 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.101 -1.074 . . . . 0.68 108.101 179.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1527 ' ' PHE . . . . . 0.416 ' O ' ' HA ' ' A' 1517 ' ' GLN . 74.0 m-85 -94.0 115.32 27.65 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.92 -0.488 . . . . 0.65 110.217 176.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 20.5 t70 -104.78 113.3 26.8 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 109.188 -0.671 . . . . 1.17 109.188 176.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1529 ' ' LEU . . . . . 0.507 ' HG ' HD21 ' A' 1581 ' ' LEU . 3.0 mm? -102.31 2.33 36.76 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 108.727 -0.842 . . . . 0.6 108.727 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 2.1 m -66.98 -27.97 67.88 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.659 -0.7 . . . . 0.84 109.886 -177.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 27.7 t -69.85 -18.41 63.43 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.866 -0.606 . . . . 1.59 110.637 178.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1532 ' ' LEU . . . . . 0.491 ' O ' ' HB ' ' A' 1552 ' ' ILE . 74.8 mt -94.76 0.83 55.27 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.323 0.583 . . . . 0.65 110.192 -178.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1533 ' ' SER . . . . . . . . . . . . . 41.5 m -77.72 164.72 25.01 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 109.351 -0.611 . . . . 1.52 109.351 175.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -179.62 155.01 14.62 Favored Glycine 0 N--CA 1.421 -2.362 0 N-CA-C 108.386 -1.886 . . . . 1.1 108.386 178.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 58.0 ttp180 -86.49 -29.27 22.89 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 121.092 0.472 . . . . 4.62 110.852 -177.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -88.01 -29.42 20.73 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.445 0.641 . . . . 1.45 110.021 177.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 94.06 -155.77 22.06 Favored Glycine 0 N--CA 1.418 -2.514 0 CA-C-N 115.299 -0.864 . . . . 0.85 111.645 175.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -130.49 148.39 52.29 Favored 'General case' 0 C--N 1.278 -2.535 0 N-CA-C 107.546 -1.279 . . . . 0.93 107.546 177.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 7.3 p -109.15 132.73 53.84 Favored 'General case' 0 C--N 1.292 -1.913 0 O-C-N 123.677 0.611 . . . . 1.03 111.001 -176.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1540 ' ' ALA . . . . . 0.444 ' HB3' ' CG1' ' A' 1548 ' ' VAL . . . -125.65 144.34 50.64 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.9 -1.148 . . . . 0.5 107.9 175.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -77.35 132.04 38.38 Favored 'General case' 0 C--N 1.313 -1.008 0 O-C-N 123.556 0.535 . . . . 0.74 110.312 -177.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1542 ' ' TYR . . . . . 0.722 ' HE2' ' HG ' ' A' 1626 ' ' LEU . 9.3 t80 -136.76 -99.79 0.21 Allowed 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.326 -0.99 . . . . 0.99 108.326 -178.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1543 ' ' SER . . . . . 0.406 ' H ' ' HB3' ' A' 1542 ' ' TYR . 47.7 t -86.84 160.82 18.62 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-O 121.602 0.715 . . . . 1.91 109.726 -175.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -72.39 -18.52 61.72 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.637 -0.71 . . . . 3.59 110.724 -178.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 13.2 t -87.63 -41.07 13.67 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.156 0.503 . . . . 2.46 110.22 -178.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . -153.27 159.05 28.34 Favored Glycine 0 N--CA 1.431 -1.69 0 C-N-CA 120.708 -0.758 . . . . 1.26 112.021 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 33.7 m -94.59 -179.41 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 107.929 -1.137 . . . . 0.79 107.929 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1548 ' ' VAL . . . . . 0.444 ' CG1' ' HB3' ' A' 1540 ' ' ALA . 14.2 p -104.37 135.94 39.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 C-N-CA 119.716 -0.794 . . . . 0.58 109.561 177.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1549 ' ' TYR . . . . . 0.429 ' HB3' ' ND2' ' A' 1556 ' ' ASN . 86.1 m-85 -102.05 129.28 48.33 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 108.81 -0.811 . . . . 1.08 108.81 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 26.1 ptm -148.43 132.96 17.7 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 116.045 -0.525 . . . . 0.78 111.484 -178.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 6.8 p -118.89 126.47 51.87 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 115.775 -0.648 . . . . 0.97 110.041 178.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1552 ' ' ILE . . . . . 0.491 ' HB ' ' O ' ' A' 1532 ' ' LEU . 36.0 mm -77.6 112.46 15.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 112.362 0.505 . . . . 0.42 112.362 -177.174 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 46.3 t 62.12 32.12 17.54 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.398 1.079 . . . . 1.4 110.977 174.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . -163.96 174.28 40.08 Favored Glycine 0 N--CA 1.422 -2.281 0 N-CA-C 108.947 -1.661 . . . . 0.35 108.947 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -100.54 155.0 18.09 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 117.48 0.64 . . . . 1.62 110.761 -178.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1556 ' ' ASN . . . . . 0.429 ' ND2' ' HB3' ' A' 1549 ' ' TYR . 49.8 t-20 -108.4 132.74 53.45 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 115.05 -0.977 . . . . 0.87 109.236 -176.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -82.72 1.83 36.77 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.599 0.592 . . . . 2.49 112.599 -176.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -78.89 -19.95 50.63 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.326 0.584 . . . . 1.38 110.273 176.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1559 ' ' CYS . . . . . 0.645 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 76.1 m -132.71 172.42 7.41 Favored Pre-proline 0 C--N 1.299 -1.612 0 CA-C-O 117.795 -1.098 . . . . 1.21 109.871 -178.038 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1560 ' ' PRO . . . . . 0.645 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 18.1 Cg_exo -36.84 148.22 0.06 OUTLIER 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 124.296 3.33 . . . . 0.71 115.747 178.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -58.73 127.72 25.49 Favored 'Trans proline' 0 C--O 1.254 1.292 0 C-N-CA 123.626 2.884 . . . . 0.8 112.113 178.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 92.45 9.12 61.95 Favored Glycine 0 N--CA 1.438 -1.213 0 CA-C-N 115.942 -0.572 . . . . 0.46 112.124 -179.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1563 ' ' VAL . . . . . 0.567 ' HB ' ' O ' ' A' 1560 ' ' PRO . 2.8 t -96.09 124.55 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.339 0 CA-C-O 121.021 0.438 . . . . 0.98 111.231 179.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -101.73 -31.95 5.27 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 115.147 -0.933 . . . . 0.28 112.069 178.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -128.62 129.8 46.39 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 109.669 -0.493 . . . . 0.28 109.669 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 11.4 t -159.52 136.48 9.48 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 116.409 -0.36 . . . . 0.43 110.395 -176.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -89.71 149.89 22.56 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 121.991 -0.443 . . . . 1.03 110.763 177.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -89.05 20.81 30.9 Favored Glycine 0 N--CA 1.438 -1.227 0 CA-C-N 116.69 -0.232 . . . . 1.13 113.492 -177.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1569 ' ' GLN . . . . . 0.551 ' HG3' ' HD1' ' B' ' 19' ' ' PHE . 15.8 mm100 -68.22 -69.94 0.29 Allowed 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.579 -0.897 . . . . 2.58 108.579 173.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 6.0 p -130.09 28.49 5.02 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.28 0.562 . . . . 2.17 111.056 175.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 12.6 mmt85 60.56 48.1 7.81 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 115.157 -0.929 . . . . 2.62 110.808 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 40.2 mt -93.38 129.12 44.28 Favored 'Isoleucine or valine' 0 C--O 1.247 0.964 0 CA-C-N 115.392 -0.822 . . . . 0.92 110.039 179.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 29.0 t -80.74 148.95 29.88 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 123.605 0.762 . . . . 0.8 111.416 -178.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1574 ' ' VAL . . . . . . . . . . . . . 29.8 m -134.78 12.6 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 115.859 -0.609 . . . . 0.98 110.522 176.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 175.52 131.64 1.48 Allowed Glycine 0 N--CA 1.423 -2.214 0 C-N-CA 119.46 -1.352 . . . . 0.29 112.627 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1576 ' ' LYS . . . . . 0.415 ' HE3' ' HB2' ' A' 1576 ' ' LYS . 39.0 ttmt -74.79 147.69 41.01 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.759 -0.83 . . . . 2.19 108.759 177.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -73.93 79.26 1.65 Allowed 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 115.813 -0.63 . . . . 0.61 111.136 -178.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -89.77 146.65 24.32 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 115.657 -0.701 . . . . 1.95 110.393 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -111.15 45.96 1.13 Allowed 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.527 -1.286 . . . . 2.68 107.527 -176.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -101.42 76.78 1.72 Allowed 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 114.007 -1.451 . . . . 3.47 107.401 -176.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1581 ' ' LEU . . . . . 0.507 HD21 ' HG ' ' A' 1529 ' ' LEU . 0.4 OUTLIER -74.11 124.06 25.59 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.309 -1.367 . . . . 0.64 107.309 178.531 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -126.22 140.93 52.16 Favored 'General case' 0 C--N 1.288 -2.099 0 C-N-CA 119.92 -0.712 . . . . 2.85 111.617 177.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1583 ' ' TYR . . . . . 0.456 ' CE1' ' HA ' ' A' 1586 ' ' GLN . 72.4 t80 -108.43 123.24 48.56 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.044 -1.095 . . . . 0.86 108.044 178.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1584 ' ' VAL . . . . . 0.561 ' O ' ' HB ' ' A' 1587 ' ' VAL . 12.5 p -149.25 110.91 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-O 121.433 0.635 . . . . 1.05 111.044 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 30.7 t70 56.99 55.23 6.26 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 125.247 1.419 . . . . 1.17 111.257 -178.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1586 ' ' GLN . . . . . 0.456 ' HA ' ' CE1' ' A' 1583 ' ' TYR . 13.7 pt20 60.72 9.51 2.22 Favored 'General case' 0 N--CA 1.499 2.015 0 C-N-CA 126.864 2.066 . . . . 1.86 112.498 177.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1587 ' ' VAL . . . . . 0.561 ' HB ' ' O ' ' A' 1584 ' ' VAL . 20.5 t -102.08 127.88 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.327 0 CA-C-N 113.877 -1.51 . . . . 0.49 109.326 178.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1588 ' ' LEU . . . . . 0.943 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 2.4 mm? -92.34 117.48 29.95 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 106.605 -1.628 . . . . 0.36 106.605 178.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -119.88 133.32 55.62 Favored 'General case' 0 C--N 1.283 -2.302 0 CA-C-O 121.806 0.813 . . . . 1.74 111.86 -176.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 11.2 mt -121.25 112.21 18.34 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 106.807 -1.553 . . . . 0.72 106.807 173.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 6.1 p -101.39 125.36 55.42 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.33 0 C-N-CA 119.92 -0.712 . . . . 1.01 109.683 -178.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1592 ' ' TYR . . . . . 0.647 ' HB2' ' HB2' ' A' 1608 ' ' SER . 14.1 m-30 -107.23 136.45 47.04 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 108.345 -0.983 . . . . 0.5 108.345 178.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 13.2 ptmm? -150.47 177.41 10.03 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 108.192 -1.04 . . . . 1.59 108.192 -172.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 28.4 m-20 59.56 63.93 1.43 Allowed 'General case' 0 C--N 1.317 -0.835 0 O-C-N 124.591 1.182 . . . . 1.11 111.163 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -112.81 -126.13 4.52 Favored Glycine 0 N--CA 1.424 -2.103 0 N-CA-C 109.877 -1.289 . . . . 0.78 109.877 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1596 ' ' SER . . . . . 0.427 ' HA ' ' HD3' ' A' 1597 ' ' PRO . 49.7 m -87.4 140.51 32.07 Favored Pre-proline 0 C--N 1.295 -1.765 0 N-CA-C 109.311 -0.626 . . . . 1.07 109.311 177.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1597 ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' 1596 ' ' SER . 38.2 Cg_exo -62.51 119.95 7.27 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 122.293 1.995 . . . . 1.01 108.275 173.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1598 ' ' CYS . . . . . 0.481 ' HA ' ' HD3' ' A' 1599 ' ' PRO . 37.8 t -77.33 128.2 81.06 Favored Pre-proline 0 C--N 1.294 -1.825 0 CA-C-N 115.728 -0.669 . . . . 0.75 109.612 -173.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1599 ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' 1598 ' ' CYS . 16.9 Cg_exo -68.35 -28.46 33.05 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.46 2.773 . . . . 1.7 112.639 -176.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1600 ' ' SER . . . . . . . . . . . . . 2.0 m -59.94 -42.55 94.27 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 123.748 0.819 . . . . 2.26 111.935 -178.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1601 ' ' LYS . . . . . 0.543 ' HB3' HD22 ' A' 1604 ' ' LEU . 3.8 tppp? -131.54 105.21 7.41 Favored 'General case' 0 N--CA 1.407 -2.613 0 N-CA-C 107.207 -1.405 . . . . 3.01 107.207 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 36.8 p -51.76 121.75 7.07 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 123.531 0.52 . . . . 2.07 111.972 179.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 92.44 11.41 59.58 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.93 -0.652 . . . . 1.08 112.369 178.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1604 ' ' LEU . . . . . 0.543 HD22 ' HB3' ' A' 1601 ' ' LYS . 9.4 tp -109.56 160.25 16.41 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.913 -1.143 . . . . 1.84 107.913 179.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 29.5 t -123.51 157.48 33.48 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 109.073 -0.714 . . . . 1.41 109.073 177.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1606 ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -71.97 153.5 41.77 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 108.118 -1.067 . . . . 0.6 108.118 172.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.42 126.4 7.72 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.216 0.531 . . . . 1.45 110.533 -175.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1608 ' ' SER . . . . . 0.647 ' HB2' ' HB2' ' A' 1592 ' ' TYR . 16.4 m -105.07 128.58 53.41 Favored 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 115.323 -0.853 . . . . 1.15 109.129 -175.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 34.4 t -111.22 101.74 12.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 CA-C-O 121.268 0.556 . . . . 0.25 109.795 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1610 ' ' ILE . . . . . 0.43 ' HA ' ' HB2' ' A' 1638 ' ' PHE . 96.8 mt -91.62 117.57 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.608 0 N-CA-C 108.84 -0.8 . . . . 0.45 108.84 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 32.7 m -120.38 116.72 26.04 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.69 -0.686 . . . . 1.26 110.902 -178.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1612 ' ' PHE . . . . . 0.943 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 70.7 m-85 -90.41 122.69 33.5 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.787 -0.642 . . . . 0.26 109.386 177.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 43.7 t -113.39 140.89 31.25 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 CA-C-N 115.306 -0.861 . . . . 0.5 109.308 -176.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 35.3 t -71.91 111.23 6.98 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.162 -0.472 . . . . 0.77 111.308 -178.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1615 ' ' ARG . . . . . 0.728 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 19.8 tpt180 -124.92 87.39 55.32 Favored Pre-proline 0 CA--C 1.54 0.585 0 N-CA-C 109.331 -0.618 . . . . 2.53 109.331 174.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1616 ' ' PRO . . . . . 0.459 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 39.3 Cg_exo -62.8 -35.06 70.41 Favored 'Trans proline' 0 N--CA 1.483 0.855 0 C-N-CA 123.128 2.552 . . . . 1.1 114.365 -173.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -79.09 -13.24 59.87 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 112.491 0.552 . . . . 3.05 112.491 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . 66.57 -168.12 0.21 Allowed 'General case' 0 C--N 1.318 -0.775 0 O-C-N 124.507 1.13 . . . . 1.55 109.266 -174.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . 148.42 -163.39 28.96 Favored Glycine 0 N--CA 1.413 -2.835 0 N-CA-C 110.394 -1.082 . . . . 0.93 110.394 179.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -82.65 21.42 1.0 Allowed 'Trans proline' 0 C--N 1.327 -0.574 0 C-N-CA 123.755 2.97 . . . . 0.88 111.971 -176.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1621 ' ' THR . . . . . 0.633 ' HB ' ' HB2' ' A' 1641 ' ' HIS . 18.6 p -108.08 -0.5 21.13 Favored 'General case' 0 C--N 1.282 -2.353 0 CA-C-N 113.933 -1.485 . . . . 0.97 109.899 -178.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -88.46 56.85 3.96 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 122.332 1.063 . . . . 0.72 109.258 -177.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1623 ' ' ARG . . . . . 0.563 ' O ' ' HG3' ' A' 1625 ' ' MET . 27.4 ptt180 -165.96 141.09 3.93 Favored Pre-proline 0 C--N 1.29 -1.996 0 N-CA-C 106.449 -1.685 . . . . 3.26 106.449 -178.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -53.81 104.55 0.11 Allowed 'Trans proline' 0 CA--C 1.534 0.49 0 C-N-CA 123.187 2.591 . . . . 0.59 111.901 -178.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1625 ' ' MET . . . . . 0.563 ' HG3' ' O ' ' A' 1623 ' ' ARG . 92.1 mtp -98.3 110.2 22.83 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.335 -0.987 . . . . 1.37 108.335 -176.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1626 ' ' LEU . . . . . 0.722 ' HG ' ' HE2' ' A' 1542 ' ' TYR . 0.7 OUTLIER -72.92 112.87 9.35 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 106.756 -1.572 . . . . 0.89 106.756 179.615 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A 1627 ' ' ILE . . . . . 0.573 HD11 ' HB2' ' A' 1639 ' ' SER . 31.0 mm -73.14 -57.54 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 N-CA-C 108.993 -0.743 . . . . 0.58 108.993 -178.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 49.9 m -163.99 152.39 13.19 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.598 -0.728 . . . . 1.39 109.416 -174.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1629 ' ' LEU . . . . . 0.952 HD13 ' HG ' ' A' 1636 ' ' LEU . 23.0 tp -117.35 100.71 7.86 Favored 'General case' 0 N--CA 1.426 -1.659 0 N-CA-C 107.345 -1.354 . . . . 1.25 107.345 171.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 20.6 t70 -74.23 114.23 12.34 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.47 -0.937 . . . . 1.09 108.47 178.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1631 ' ' LYS . . . . . 0.565 ' HB3' HD23 ' B' ' 53' ' ' LEU . 65.2 mttp -66.66 -20.78 66.06 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 113.759 1.022 . . . . 3.6 113.759 -175.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -88.66 -42.18 12.15 Favored 'General case' 0 CA--C 1.495 -1.143 0 CA-C-O 121.506 0.67 . . . . 2.6 111.311 -175.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 73.3 p -93.12 -8.2 43.32 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-N 115.34 -0.846 . . . . 0.75 110.792 -177.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1634 ' ' CYS . . . . . 0.494 ' SG ' HD23 ' A' 1604 ' ' LEU . 39.4 m 57.94 33.07 22.79 Favored 'General case' 0 C--N 1.361 1.084 0 C-N-CA 124.753 1.221 . . . . 0.53 110.908 175.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1635 ' ' THR . . . . . . . . . . . . . 64.3 m -104.89 130.76 52.98 Favored 'General case' 0 N--CA 1.425 -1.703 0 CA-C-N 114.219 -1.355 . . . . 0.46 109.313 -177.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1636 ' ' LEU . . . . . 0.952 ' HG ' HD13 ' A' 1629 ' ' LEU . 0.6 OUTLIER -111.43 126.47 54.98 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 106.522 -1.659 . . . . 0.86 106.522 -178.736 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A 1637 ' ' PHE . . . . . 0.508 ' HB2' ' HB ' ' A' 1627 ' ' ILE . 87.8 m-85 -102.09 138.83 38.52 Favored 'General case' 0 C--N 1.293 -1.879 0 C-N-CA 120.915 -0.314 . . . . 0.45 110.315 -178.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1638 ' ' PHE . . . . . 0.461 ' HE1' ' HB3' ' A' 1608 ' ' SER . 96.0 m-85 -131.57 134.49 46.12 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 108.671 -0.862 . . . . 0.5 108.671 -177.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1639 ' ' SER . . . . . 0.573 ' HB2' HD11 ' A' 1627 ' ' ILE . 22.6 t -116.85 152.36 34.61 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 107.542 -1.281 . . . . 1.04 107.542 175.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 2.9 t90 -153.35 109.79 3.37 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 104.535 -2.394 . . . . 0.68 104.535 178.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1641 ' ' HIS . . . . . 0.728 ' HB3' ' HB2' ' A' 1615 ' ' ARG . 33.3 m-70 -102.04 109.27 20.94 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 109.006 -0.738 . . . . 0.9 109.006 -176.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1642 ' ' THR . . . . . . . . . . . . . 3.9 t -138.05 148.93 62.14 Favored Pre-proline 0 C--N 1.302 -1.482 0 CA-C-N 115.948 -0.569 . . . . 0.48 109.768 -174.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1643 ' ' PRO . . . . . 0.478 ' HA ' ' SG ' ' A' 1646 ' ' CYS . 53.3 Cg_endo -78.97 -3.21 13.04 Favored 'Trans proline' 0 C--N 1.368 1.564 0 C-N-CA 122.034 1.823 . . . . 0.66 111.956 175.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 5.8 tp -63.96 -30.84 71.89 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.919 0.866 . . . . 0.97 108.756 176.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -89.78 13.09 15.25 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.307 -1.315 . . . . 0.84 110.455 -179.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1646 ' ' CYS . . . . . 0.478 ' SG ' ' HA ' ' A' 1643 ' ' PRO . 62.7 m -121.43 154.72 36.17 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 109.724 -0.472 . . . . 1.19 109.724 -179.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 42.5 tt0 . . . . . 0 C--N 1.297 -1.711 0 N-CA-C 105.031 -2.211 . . . . 3.14 105.031 168.563 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.423 -2.182 0 N-CA-C 110.407 -1.077 . . . . 2.09 110.407 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' B' ' 15' ' ' ASP . . . -57.01 -56.82 23.0 Favored Glycine 0 CA--C 1.511 -0.217 0 CA-C-N 115.415 -0.393 . . . . 1.84 113.863 -176.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . 0.496 ' HA ' ' CB ' ' B' ' 15' ' ' ASP . 39.3 mt-10 -84.2 -14.94 48.73 Favored 'General case' 0 CA--C 1.489 -1.378 0 CA-C-N 117.259 0.53 . . . . 2.55 110.475 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.57 -53.22 45.02 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 107.139 -1.43 . . . . 2.35 107.139 179.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 22.2 m -74.55 -22.88 17.76 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 C-N-CA 119.672 -0.811 . . . . 2.11 110.098 178.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 15' ' ' ASP . . . . . 0.496 ' CB ' ' HA ' ' B' ' 12' ' ' GLU . 15.7 t70 -64.41 -51.22 64.31 Favored 'General case' 0 C--O 1.217 -0.653 0 CA-C-N 116.008 -0.542 . . . . 2.04 110.939 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 22.6 p -65.82 -46.46 78.53 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.392 0.677 . . . . 1.84 111.004 178.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.491 HD21 HD11 ' B' ' 42' ' ' ILE . 3.6 mm? -48.99 -49.82 38.89 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.904 0.882 . . . . 1.74 111.887 171.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -79.58 -15.64 57.3 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.279 -0.873 . . . . 2.39 110.992 -179.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 19' ' ' PHE . . . . . 0.551 ' HD1' ' HG3' ' A' 1569 ' ' GLN . 88.0 t80 -64.42 -55.96 17.43 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 116.219 -0.446 . . . . 0.96 110.65 178.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 8.4 p -95.58 -26.56 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.357 0 C-N-CA 119.024 -1.071 . . . . 1.37 111.547 -177.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 89.2 m -116.36 18.72 15.11 Favored 'General case' 0 C--O 1.212 -0.869 0 N-CA-C 113.229 0.826 . . . . 1.66 113.229 -177.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -54.87 -37.59 62.6 Favored Glycine 0 N--CA 1.472 1.05 0 N-CA-C 114.813 0.685 . . . . 1.53 114.813 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -69.0 -27.2 65.48 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 123.08 0.552 . . . . 2.72 111.176 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 16.3 tpp180 -91.68 -44.72 8.85 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.038 0.447 . . . . 4.33 110.328 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 129.38 177.1 14.7 Favored Glycine 0 N--CA 1.436 -1.352 0 N-CA-C 109.359 -1.496 . . . . 1.53 109.359 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -137.92 122.36 18.36 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 117.91 0.855 . . . . 1.65 110.394 175.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -133.32 80.88 1.9 Allowed 'General case' 0 C--O 1.21 -1.003 0 N-CA-C 113.359 0.874 . . . . 3.42 113.359 -175.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 28' ' ' PHE . . . . . . . . . . . . . 32.8 p90 . . . . . 0 C--N 1.307 -1.277 0 C-N-CA 119.931 -0.707 . . . . 2.26 109.733 169.007 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . 0.401 ' C ' ' H ' ' B' ' 43' ' ' VAL . . . . . . . . 0 N--CA 1.429 -1.777 0 N-CA-C 109.423 -1.471 . . . . 2.37 109.423 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . 0.491 HD11 HD21 ' B' ' 17' ' ' LEU 0.258 13.3 pt 61.61 -21.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 C-N-CA 127.663 2.385 . . . . 2.07 115.295 178.471 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.633 ' O ' ' HB2' ' B' ' 47' ' ' CYS . 2.3 p -49.78 -47.12 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.775 0 N-CA-C 113.23 0.826 . . . . 2.24 113.23 178.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -86.9 -30.95 21.0 Favored 'General case' 0 N--CA 1.427 -1.624 0 N-CA-C 109.228 -0.656 . . . . 3.36 109.228 -177.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -66.16 -23.03 66.4 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.499 -0.773 . . . . 3.08 112.027 -179.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 46' ' ' CYS . . . . . . . . . . . . . 63.7 m -114.34 2.07 14.63 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.967 0.413 . . . . 2.23 111.05 175.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 47' ' ' CYS . . . . . 0.633 ' HB2' ' O ' ' B' ' 43' ' ' VAL . 36.4 t -82.07 -50.45 9.07 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.561 0.696 . . . . 2.37 110.377 -179.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -116.16 15.75 15.98 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.408 0.623 . . . . 2.82 110.322 -176.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 22.2 mmm180 -146.64 152.74 39.37 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.065 -1.087 . . . . 4.09 108.065 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 7.3 p -94.37 131.06 40.42 Favored 'General case' 0 C--N 1.282 -2.355 0 N-CA-C 108.661 -0.866 . . . . 2.67 108.661 174.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 13.4 p -118.62 140.05 50.52 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 109.07 -0.715 . . . . 2.11 109.07 -173.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -61.71 147.03 47.41 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 107.858 -1.164 . . . . 2.67 107.858 177.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . 0.565 HD23 ' HB3' ' A' 1631 ' ' LYS . 14.8 tp -71.08 -16.79 62.6 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.103 -1.073 . . . . 1.9 108.103 -178.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . 0.412 ' O ' ' HB3' ' B' ' 57' ' ' GLU . . . -60.11 -27.19 66.82 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 114.522 -1.217 . . . . 1.52 110.702 174.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 10.5 tp -60.49 -60.75 3.31 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 115.827 -0.624 . . . . 1.97 110.392 177.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.12 -17.43 61.98 Favored 'General case' 0 C--O 1.214 -0.806 0 CA-C-N 115.827 -0.624 . . . . 1.53 111.683 -175.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . 0.412 ' HB3' ' O ' ' B' ' 54' ' ' ALA . 9.1 tp10 -60.49 -56.72 17.97 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 109.026 -0.731 . . . . 2.27 109.026 172.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 9.0 t -80.5 -14.69 58.04 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 115.993 -0.548 . . . . 2.33 112.268 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -82.73 -60.19 2.26 Favored 'General case' 0 N--CA 1.427 -1.61 0 N-CA-C 107.824 -1.176 . . . . 2.86 107.824 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 33.6 t . . . . . 0 C--N 1.32 -0.681 0 C-N-CA 126.908 2.083 . . . . 2.3 113.482 176.095 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A 1515 ' ' ASP . . . . . 0.493 ' HA ' ' HD2' ' A' 1579 ' ' LYS . 9.8 t70 . . . . . 0 N--CA 1.442 -0.868 0 N-CA-C 106.801 -1.555 . . . . 2.9 106.801 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1516 ' ' CYS . . . . . 0.567 ' O ' ' HB2' ' A' 1529 ' ' LEU . 16.7 m 63.16 33.9 14.0 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 115.128 -0.942 . . . . 1.19 110.387 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -166.66 162.76 16.58 Favored 'General case' 0 CA--C 1.479 -1.76 0 N-CA-C 107.813 -1.181 . . . . 1.52 107.813 -177.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1518 ' ' VAL . . . . . 0.424 HG11 HD12 ' A' 1581 ' ' LEU . 9.8 p -162.0 147.23 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.945 0 O-C-N 123.68 0.613 . . . . 0.94 109.535 -174.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1519 ' ' THR . . . . . . . . . . . . . 25.0 m -115.86 124.96 51.98 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 109.295 -0.632 . . . . 0.89 109.295 177.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1520 ' ' ASN . . . . . 0.422 ' OD1' HG22 ' A' 1523 ' ' THR . 24.2 t-20 -86.95 122.41 71.27 Favored Pre-proline 0 N--CA 1.439 -0.979 0 O-C-N 123.427 0.454 . . . . 1.74 109.922 177.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.72 -19.9 53.09 Favored 'Trans proline' 0 CA--C 1.533 0.466 0 C-N-CA 123.218 2.612 . . . . 1.58 114.541 -175.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 50.7 m -76.7 -39.94 50.4 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 112.157 0.429 . . . . 1.65 112.157 -177.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1523 ' ' THR . . . . . 0.693 HG21 ' HG3' ' A' 1647 ' ' GLU . 5.0 t -114.31 -6.48 12.96 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.813 0.816 . . . . 1.61 111.43 -178.076 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 64.54 30.49 78.03 Favored Glycine 0 CA--C 1.499 -0.913 0 CA-C-N 115.368 -0.833 . . . . 1.13 112.28 177.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 35.7 t-80 -98.26 125.28 43.28 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 109.644 -0.502 . . . . 1.26 109.644 -175.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 1.7 tm? -90.88 109.15 20.36 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 108.323 -0.992 . . . . 0.68 108.323 177.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -85.69 114.53 22.74 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 110.067 -0.345 . . . . 0.65 110.067 176.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 25.5 t70 -99.46 107.74 20.02 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 109.23 -0.656 . . . . 1.17 109.23 177.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1529 ' ' LEU . . . . . 0.567 ' HB2' ' O ' ' A' 1516 ' ' CYS . 3.4 mm? -90.11 -0.13 57.45 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.718 0.771 . . . . 0.6 109.363 -178.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.24 -26.54 63.89 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.077 -0.965 . . . . 0.84 108.771 178.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 40.5 t -60.38 -26.82 66.94 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.927 0.891 . . . . 1.59 109.848 174.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 51.3 mt -98.38 0.51 45.54 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.557 -0.747 . . . . 0.65 110.984 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1533 ' ' SER . . . . . . . . . . . . . 33.6 t -72.31 174.75 6.87 Favored 'General case' 0 C--O 1.245 0.825 0 CA-C-O 121.635 0.731 . . . . 1.52 111.329 -177.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . 179.81 145.17 6.26 Favored Glycine 0 N--CA 1.425 -2.046 0 N-CA-C 109.218 -1.553 . . . . 1.1 109.218 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 -74.3 -43.36 57.09 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 120.695 0.284 . . . . 4.62 111.585 -177.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -84.14 -38.84 20.2 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.465 0.65 . . . . 1.45 109.288 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 105.19 -138.77 14.39 Favored Glycine 0 N--CA 1.409 -3.143 0 CA-C-N 115.134 -0.939 . . . . 0.85 111.476 177.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -140.33 154.14 46.66 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 107.619 -1.252 . . . . 0.93 107.619 -177.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1539 ' ' THR . . . . . 0.456 HG22 ' HB ' ' A' 1547 ' ' VAL . 1.3 m -121.31 124.99 45.92 Favored 'General case' 0 N--CA 1.426 -1.646 0 N-CA-C 108.68 -0.859 . . . . 1.03 108.68 -178.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -119.75 140.18 51.12 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 115.815 -0.629 . . . . 0.5 109.559 -177.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -82.57 113.42 20.27 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.605 -0.725 . . . . 0.74 110.509 -179.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1542 ' ' TYR . . . . . 0.569 ' CE2' ' HG ' ' A' 1626 ' ' LEU . 0.3 OUTLIER -104.36 -101.07 0.31 Allowed 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 106.019 -1.845 . . . . 0.99 106.019 177.613 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A 1543 ' ' SER . . . . . 0.441 ' H ' ' HB3' ' A' 1542 ' ' TYR . 2.1 m -68.57 168.69 12.44 Favored 'General case' 0 N--CA 1.425 -1.721 0 C-N-CA 124.137 0.975 . . . . 1.91 110.744 178.036 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 59.6 tttp -60.12 -41.49 92.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 118.694 0.679 . . . . 3.59 112.261 -176.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 33.5 t -116.78 20.68 13.83 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 109.567 -0.531 . . . . 2.46 109.567 -177.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . -131.73 104.22 0.56 Allowed Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 120.646 -0.788 . . . . 1.26 113.231 -175.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1547 ' ' VAL . . . . . 0.456 ' HB ' HG22 ' A' 1539 ' ' THR . 28.0 m -96.84 151.1 4.2 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-O 121.176 0.512 . . . . 0.79 110.109 175.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 14.2 p -105.2 138.49 29.91 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 CA-C-N 115.913 -0.585 . . . . 0.58 109.528 178.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -105.71 128.34 53.62 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 123.492 0.717 . . . . 1.08 109.678 176.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 23.5 ptm -141.8 119.46 11.75 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 115.331 -0.85 . . . . 0.78 110.695 -177.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 11.4 p -103.67 119.58 39.2 Favored 'General case' 0 C--N 1.276 -2.609 0 CA-C-N 114.883 -1.053 . . . . 0.97 110.184 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1552 ' ' ILE . . . . . 0.748 HG13 ' HZ3' ' A' 1640 ' ' TRP . 39.4 mm -83.22 119.44 32.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 108.999 -0.741 . . . . 0.42 108.999 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 28.2 t 62.02 46.39 6.55 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-O 122.053 0.93 . . . . 1.4 110.544 177.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 175.93 178.01 45.4 Favored Glycine 0 N--CA 1.407 -3.238 0 N-CA-C 109.431 -1.467 . . . . 0.35 109.431 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -106.11 154.9 20.01 Favored 'General case' 0 C--N 1.285 -2.236 0 CA-C-O 121.046 0.451 . . . . 1.62 110.415 -178.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -93.21 138.11 31.92 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 108.283 -1.006 . . . . 0.87 108.283 178.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -99.98 0.57 41.32 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 114.889 1.44 . . . . 2.49 114.889 -169.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 9.6 p30 -105.01 5.26 32.46 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 122.273 1.035 . . . . 1.38 110.134 178.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1559 ' ' CYS . . . . . 0.602 ' SG ' ' HD2' ' A' 1560 ' ' PRO . 34.5 t -132.15 152.99 81.15 Favored Pre-proline 0 C--N 1.288 -2.068 0 N-CA-C 106.211 -1.774 . . . . 1.21 106.211 178.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1560 ' ' PRO . . . . . 0.602 ' HD2' ' SG ' ' A' 1559 ' ' CYS . 49.6 Cg_exo -28.34 121.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.379 2.176 1 C-N-CA 125.575 4.184 . . . . 0.71 115.211 179.154 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A 1561 ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' 1560 ' ' PRO . 6.0 Cg_endo -44.72 130.2 9.63 Favored 'Trans proline' 0 C--N 1.357 1.01 0 C-N-CA 125.075 3.85 . . . . 0.8 114.126 -176.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 98.64 -2.15 58.64 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.974 -0.557 . . . . 0.46 113.753 178.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1563 ' ' VAL . . . . . 0.411 HG21 ' HA ' ' A' 1573 ' ' SER . 8.7 p -93.8 140.38 16.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 O-C-N 121.93 -0.747 . . . . 0.98 110.637 -177.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -102.34 -30.56 5.59 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 121.213 -0.518 . . . . 0.28 112.869 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -124.32 127.89 48.3 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 109.403 -0.591 . . . . 0.28 109.403 178.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1566 ' ' CYS . . . . . 0.425 ' SG ' ' HA ' ' A' 1571 ' ' ARG . 43.5 t -155.04 142.75 19.85 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 110.254 -0.276 . . . . 0.43 110.254 -178.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1567 ' ' PHE . . . . . 0.527 ' CE2' HG11 ' A' 1574 ' ' VAL . 54.9 m-85 -85.6 130.53 34.55 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 107.796 -1.187 . . . . 1.03 107.796 172.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -61.14 -31.16 75.82 Favored Glycine 0 C--N 1.35 1.314 0 N-CA-C 114.545 0.578 . . . . 1.13 114.545 -171.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1569 ' ' GLN . . . . . 0.467 ' HB3' ' OD2' ' B' ' 15' ' ' ASP . 11.3 mm100 -69.54 -54.56 13.54 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.594 0.711 . . . . 2.58 111.986 177.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1570 ' ' THR . . . . . 0.602 ' HB ' HG13 ' A' 1572 ' ' ILE . 58.3 p -81.47 -29.11 33.85 Favored 'General case' 0 N--CA 1.421 -1.878 0 N-CA-C 114.382 1.253 . . . . 2.17 114.382 -167.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1571 ' ' ARG . . . . . 0.425 ' HA ' ' SG ' ' A' 1566 ' ' CYS . 3.1 mpt_? 59.35 28.94 18.42 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.189 0.519 . . . . 2.62 110.691 -172.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1572 ' ' ILE . . . . . 0.602 HG13 ' HB ' ' A' 1570 ' ' THR . 19.2 mt -94.58 129.15 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.832 0 N-CA-C 107.89 -1.152 . . . . 0.92 107.89 177.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1573 ' ' SER . . . . . 0.411 ' HA ' HG21 ' A' 1563 ' ' VAL . 15.1 t -69.27 113.8 6.94 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.327 -0.851 . . . . 0.8 109.68 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1574 ' ' VAL . . . . . 0.758 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 19.7 m -110.38 17.92 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 CA-C-O 121.893 0.854 . . . . 0.98 110.8 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 161.46 115.64 0.37 Allowed Glycine 0 N--CA 1.427 -1.957 0 CA-C-N 114.779 -1.1 . . . . 0.29 111.042 177.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -73.66 146.39 44.57 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.881 -0.785 . . . . 2.19 108.881 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -71.36 90.52 0.95 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.028 0.442 . . . . 0.61 111.585 -178.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -103.37 170.24 8.07 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.08 -1.081 . . . . 1.95 108.08 175.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1579 ' ' LYS . . . . . 0.493 ' HD2' ' HA ' ' A' 1515 ' ' ASP . 15.4 pttm -130.11 40.46 3.54 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.755 0.788 . . . . 2.68 110.698 -178.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 75.0 ttt180 -89.82 100.49 13.29 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 113.561 -1.654 . . . . 3.47 107.933 -174.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1581 ' ' LEU . . . . . 0.445 HD21 ' HG ' ' A' 1529 ' ' LEU . 0.2 OUTLIER -101.76 126.55 48.64 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.713 -0.676 . . . . 0.64 109.425 -174.806 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -125.2 138.95 54.12 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 120.532 -0.467 . . . . 2.85 110.914 176.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1583 ' ' TYR . . . . . 0.447 ' CE1' ' HA ' ' A' 1586 ' ' GLN . 88.3 t80 -106.25 108.41 19.91 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.724 -0.843 . . . . 0.86 108.724 178.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1584 ' ' VAL . . . . . 0.616 ' O ' ' HB ' ' A' 1587 ' ' VAL . 14.2 m -126.98 93.49 2.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 CA-C-O 121.48 0.657 . . . . 1.05 112.108 -178.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 36.6 t70 57.89 64.37 1.55 Allowed 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.853 0.861 . . . . 1.17 110.691 179.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1586 ' ' GLN . . . . . 0.447 ' HA ' ' CE1' ' A' 1583 ' ' TYR 0.272 4.5 pt20 58.72 20.55 7.95 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 126.45 1.9 . . . . 1.86 112.384 178.527 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A 1587 ' ' VAL . . . . . 0.616 ' HB ' ' O ' ' A' 1584 ' ' VAL . 22.5 t -107.24 120.26 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.493 0 CA-C-N 114.038 -1.437 . . . . 0.49 107.751 174.11 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1588 ' ' LEU . . . . . 0.865 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 3.3 mm? -95.62 109.03 21.34 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 105.824 -1.917 . . . . 0.36 105.824 176.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -111.02 116.81 31.81 Favored 'General case' 0 C--N 1.266 -3.056 0 C-N-CA 119.962 -0.695 . . . . 1.74 110.961 -175.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.87 99.48 9.69 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 104.888 -2.264 . . . . 0.72 104.888 176.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 8.9 p -89.41 127.01 42.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 C-N-CA 119.64 -0.824 . . . . 1.01 112.308 -174.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1592 ' ' TYR . . . . . 0.658 ' HB2' ' HB3' ' A' 1608 ' ' SER . 12.8 m-30 -106.95 142.75 36.07 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.443 -1.317 . . . . 0.5 107.443 173.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 10.6 ptmm? -158.08 -172.24 3.83 Favored 'General case' 0 C--N 1.283 -2.308 0 N-CA-C 106.043 -1.836 . . . . 1.59 106.043 -175.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 36.4 m-20 66.46 45.56 2.1 Favored 'General case' 0 C--O 1.239 0.503 0 O-C-N 124.006 0.816 . . . . 1.11 109.116 177.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -86.76 -175.06 49.39 Favored Glycine 0 N--CA 1.435 -1.379 0 CA-C-N 114.892 -1.049 . . . . 0.78 111.582 -178.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1596 ' ' SER . . . . . 0.742 ' HB2' ' HD2' ' A' 1597 ' ' PRO . 62.9 p -95.31 173.86 4.02 Favored Pre-proline 0 C--N 1.291 -1.968 0 CA-C-O 118.672 -0.68 . . . . 1.07 109.457 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1597 ' ' PRO . . . . . 0.742 ' HD2' ' HB2' ' A' 1596 ' ' SER . 10.3 Cg_endo -50.85 127.11 20.29 Favored 'Trans proline' 0 C--N 1.361 1.197 0 C-N-CA 122.785 2.323 . . . . 1.01 113.676 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1598 ' ' CYS . . . . . 0.696 ' HA ' ' HE1' ' A' 1606 ' ' TYR . 49.5 t -81.16 118.74 73.6 Favored Pre-proline 0 C--N 1.284 -2.269 0 CA-C-N 113.718 -1.583 . . . . 0.75 107.888 178.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1599 ' ' PRO . . . . . 0.707 ' HD2' ' HE1' ' A' 1606 ' ' TYR . 6.9 Cg_endo -52.12 -21.16 12.13 Favored 'Trans proline' 0 C--N 1.366 1.483 0 C-N-CA 124.357 3.371 . . . . 1.7 114.362 -178.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1600 ' ' SER . . . . . 0.417 ' HA ' ' HB2' ' B' ' 53' ' ' LEU . 7.8 m -55.72 -45.63 77.91 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 123.815 0.846 . . . . 2.26 110.438 177.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1601 ' ' LYS . . . . . 0.483 ' HE2' HD11 ' A' 1604 ' ' LEU . 36.5 ttpt -162.84 127.43 3.08 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 108.395 -0.965 . . . . 3.01 108.395 178.242 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 14.2 p -58.36 132.02 52.4 Favored 'General case' 0 N--CA 1.415 -2.191 0 N-CA-C 109.26 -0.644 . . . . 2.07 109.26 177.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 106.54 -17.38 39.74 Favored Glycine 0 C--N 1.303 -1.265 0 C-N-CA 121.329 -0.463 . . . . 1.08 112.354 -176.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1604 ' ' LEU . . . . . 0.503 ' HB2' ' HB3' ' A' 1598 ' ' CYS . 60.2 mt -91.83 152.06 20.29 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 107.254 -1.387 . . . . 1.84 107.254 173.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 37.9 m -135.87 142.93 44.81 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 108.628 -0.878 . . . . 1.41 108.628 179.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1606 ' ' TYR . . . . . 0.758 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 71.5 m-85 -73.22 158.95 34.22 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 112.141 0.423 . . . . 0.6 112.141 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -147.89 152.72 38.07 Favored 'General case' 0 N--CA 1.421 -1.914 0 N-CA-C 106.38 -1.711 . . . . 1.45 106.38 172.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1608 ' ' SER . . . . . 0.658 ' HB3' ' HB2' ' A' 1592 ' ' TYR . 28.0 t -122.5 123.08 40.45 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 109.038 -0.727 . . . . 1.15 109.038 -174.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 30.8 t -105.09 98.1 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.748 0 N-CA-C 108.846 -0.798 . . . . 0.25 108.846 179.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 84.1 mt -89.63 106.11 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.787 0 N-CA-C 108.1 -1.074 . . . . 0.45 108.1 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 17.0 m -104.54 114.48 28.73 Favored 'General case' 0 N--CA 1.421 -1.917 0 CA-C-N 115.007 -0.997 . . . . 1.26 111.01 -175.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1612 ' ' PHE . . . . . 0.865 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 69.3 m-85 -91.33 108.41 19.87 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.054 -0.721 . . . . 0.26 109.054 176.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1613 ' ' VAL . . . . . 0.879 ' HB ' ' HB3' ' A' 1641 ' ' HIS . 33.5 t -103.96 144.16 14.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 CA-C-N 114.774 -1.103 . . . . 0.5 109.233 -176.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 39.1 t -69.88 108.31 3.93 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 123.809 0.844 . . . . 0.77 110.982 179.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1615 ' ' ARG . . . . . 0.574 ' HB2' ' HB2' ' A' 1641 ' ' HIS . 25.3 tpt180 -135.69 91.69 17.8 Favored Pre-proline 0 N--CA 1.435 -1.214 0 C-N-CA 119.584 -0.846 . . . . 2.53 109.671 173.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1616 ' ' PRO . . . . . 0.934 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 19.2 Cg_exo -65.7 -22.21 57.72 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.392 2.061 . . . . 1.1 113.535 -176.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -57.96 -38.48 76.1 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 123.94 0.896 . . . . 3.05 112.221 179.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . 64.93 -172.63 0.18 Allowed 'General case' 0 C--N 1.358 0.946 0 O-C-N 123.916 0.76 . . . . 1.55 109.61 -176.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . 119.09 -159.5 14.5 Favored Glycine 0 N--CA 1.426 -2.018 0 C-N-CA 120.222 -0.989 . . . . 0.93 112.632 177.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 94.9 Cg_exo -56.38 -11.73 6.84 Favored 'Trans proline' 0 N--CA 1.5 1.911 0 C-N-CA 124.893 3.728 . . . . 0.88 114.211 178.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1621 ' ' THR . . . . . . . . . . . . . 19.0 p -87.6 -9.37 54.52 Favored 'General case' 0 C--N 1.282 -2.364 0 C-N-CA 124.396 1.079 . . . . 0.97 110.869 -179.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 49.2 t30 -88.02 58.36 4.77 Favored 'General case' 0 C--O 1.253 1.266 0 CA-C-O 122.729 1.252 . . . . 0.72 110.16 -178.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1623 ' ' ARG . . . . . 0.43 ' HA ' ' HD3' ' A' 1624 ' ' PRO . 34.7 ptt180 -159.82 138.81 7.97 Favored Pre-proline 0 C--N 1.303 -1.415 0 CA-C-N 113.839 -1.528 . . . . 3.26 107.183 178.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1624 ' ' PRO . . . . . 0.445 ' HG3' ' CE3' ' A' 1640 ' ' TRP . 7.1 Cg_exo -69.43 111.23 2.69 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.333 2.022 . . . . 0.59 111.172 -178.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 74.7 mtm -114.0 147.83 37.96 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 116.415 -0.357 . . . . 1.37 110.337 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1626 ' ' LEU . . . . . 0.569 ' HG ' ' CE2' ' A' 1542 ' ' TYR . 0.3 OUTLIER -85.89 113.95 22.43 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 107.954 -1.128 . . . . 0.89 107.954 -176.56 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 42.0 mm -76.36 -54.85 12.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 N-CA-C 109.262 -0.644 . . . . 0.58 109.262 -177.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 70.5 m -163.83 152.27 13.4 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.468 -0.938 . . . . 1.39 108.468 -173.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1629 ' ' LEU . . . . . 0.584 ' HG ' ' CD2' ' A' 1636 ' ' LEU . 2.5 tt -114.25 110.91 20.67 Favored 'General case' 0 N--CA 1.416 -2.172 0 N-CA-C 106.531 -1.655 . . . . 1.25 106.531 179.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 14.8 t70 -77.81 95.35 4.68 Favored 'General case' 0 CA--C 1.494 -1.198 0 N-CA-C 106.919 -1.512 . . . . 1.09 106.919 173.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1631 ' ' LYS . . . . . 0.69 ' HD3' ' H ' ' A' 1631 ' ' LYS . 0.0 OUTLIER -75.96 2.86 11.48 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 114.419 1.266 . . . . 3.6 114.419 -172.768 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -88.36 -41.93 12.52 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.709 -0.848 . . . . 2.6 108.709 175.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 67.6 p -100.48 -15.62 17.82 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-N 115.118 -0.946 . . . . 0.75 111.065 -177.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 83.3 m 70.25 35.05 2.18 Favored 'General case' 0 C--N 1.351 0.662 0 C-N-CA 125.053 1.341 . . . . 0.53 110.891 -179.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1635 ' ' THR . . . . . . . . . . . . . 90.0 m -90.96 121.87 33.16 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 113.727 -1.579 . . . . 0.46 109.088 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1636 ' ' LEU . . . . . 0.584 ' CD2' ' HG ' ' A' 1629 ' ' LEU . 26.2 mt -98.58 130.7 45.13 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 109.483 -0.562 . . . . 0.86 109.483 178.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -101.77 116.48 32.82 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 116.076 -0.511 . . . . 0.45 111.137 177.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -114.19 140.73 48.3 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 109.529 -0.545 . . . . 0.5 109.529 176.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1639 ' ' SER . . . . . 0.432 ' O ' ' HA ' ' A' 1624 ' ' PRO . 48.0 t -119.86 129.16 54.26 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 108.512 -0.921 . . . . 1.04 108.512 173.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1640 ' ' TRP . . . . . 0.748 ' HZ3' HG13 ' A' 1552 ' ' ILE . 6.3 t90 -133.74 93.5 3.13 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 104.217 -2.512 . . . . 0.68 104.217 173.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1641 ' ' HIS . . . . . 0.879 ' HB3' ' HB ' ' A' 1613 ' ' VAL 0.317 0.1 OUTLIER -101.64 95.17 6.27 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-O 122.474 1.13 . . . . 0.9 113.085 -175.612 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A 1642 ' ' THR . . . . . . . . . . . . . 3.1 t -114.77 153.02 46.91 Favored Pre-proline 0 C--N 1.299 -1.609 0 CA-C-N 112.542 -2.117 . . . . 0.48 108.583 -177.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1643 ' ' PRO . . . . . 0.934 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 49.7 Cg_endo -68.94 -4.89 14.37 Favored 'Trans proline' 0 C--N 1.369 1.65 0 C-N-CA 123.269 2.646 . . . . 0.66 113.366 -178.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 8.2 tt -65.35 -30.29 71.11 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.969 -0.382 . . . . 0.97 109.969 176.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -84.2 21.7 1.35 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.377 0.608 . . . . 0.84 111.513 -175.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 33.3 m -121.22 136.52 54.96 Favored 'General case' 0 N--CA 1.415 -2.193 0 N-CA-C 107.629 -1.248 . . . . 1.19 107.629 178.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1647 ' ' GLU . . . . . 0.693 ' HG3' HG21 ' A' 1523 ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.301 -1.531 0 N-CA-C 109.529 -0.545 . . . . 3.14 109.529 177.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.225 0 N-CA-C 112.856 -0.098 . . . . 2.09 112.856 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.94 -36.88 92.88 Favored Glycine 0 C--O 1.22 -0.765 0 CA-C-N 115.557 -0.322 . . . . 1.84 112.924 -177.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -68.18 -28.34 67.18 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 111.915 0.339 . . . . 2.55 111.915 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.65 -53.54 13.27 Favored 'General case' 0 N--CA 1.42 -1.959 0 N-CA-C 109.486 -0.561 . . . . 2.35 109.486 -177.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 3.8 p -63.58 -35.42 72.64 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-N 115.561 -0.745 . . . . 2.11 111.133 177.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 15' ' ' ASP . . . . . 0.467 ' OD2' ' HB3' ' A' 1569 ' ' GLN . 14.8 t0 -72.32 -37.07 69.01 Favored 'General case' 0 CA--C 1.557 1.248 0 N-CA-C 112.209 0.448 . . . . 2.04 112.209 -179.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 14.9 t -68.78 -37.7 79.49 Favored 'General case' 0 C--O 1.254 1.316 0 CA-C-N 119.079 0.854 . . . . 1.84 110.117 175.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.605 HD21 HD11 ' B' ' 42' ' ' ILE . 3.2 mm? -49.37 -52.66 26.82 Favored 'General case' 0 C--N 1.355 0.823 0 CA-C-O 121.358 0.599 . . . . 1.74 110.197 168.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -66.97 -23.8 65.98 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 123.659 0.784 . . . . 2.39 112.385 -177.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -62.9 -62.85 1.44 Allowed 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 116.467 -0.333 . . . . 0.96 110.938 175.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 14.4 p -91.32 -15.92 8.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 C-N-CA 117.609 -1.636 . . . . 1.37 112.791 -175.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 59.1 m -99.8 10.17 41.77 Favored 'General case' 0 C--O 1.206 -1.227 0 O-C-N 121.099 -1.0 . . . . 1.66 111.318 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -53.42 -28.36 35.85 Favored Glycine 0 CA--C 1.54 1.617 0 N-CA-C 116.632 1.413 . . . . 1.53 116.632 -178.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -72.56 -49.0 35.53 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 118.305 1.053 . . . . 2.72 111.891 -179.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.15 -38.58 15.23 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.37 0.605 . . . . 4.33 109.803 -179.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 124.23 164.52 11.98 Favored Glycine 0 N--CA 1.428 -1.892 0 N-CA-C 107.62 -2.192 . . . . 1.53 107.62 -174.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . 0.424 ' CB ' ' HB3' ' B' ' 17' ' ' LEU . 17.4 p90 -95.69 129.79 42.78 Favored 'General case' 0 C--N 1.286 -2.177 0 CA-C-N 118.779 1.29 . . . . 1.65 110.067 179.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -129.98 59.31 1.63 Allowed 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 112.939 0.718 . . . . 3.42 112.939 -174.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 28' ' ' PHE . . . . . 0.651 ' HA ' ' HE2' ' B' ' 59' ' ' TYR . 32.6 p90 . . . . . 0 C--N 1.313 -0.996 0 C-N-CA 119.048 -1.061 . . . . 2.26 108.485 173.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . 0.415 ' C ' ' H ' ' B' ' 43' ' ' VAL . . . . . . . . 0 CA--C 1.476 -2.401 0 N-CA-C 109.723 -1.351 . . . . 2.37 109.723 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . 0.605 HD11 HD21 ' B' ' 17' ' ' LEU . 16.1 pt 58.1 -26.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 C-N-CA 127.346 2.258 . . . . 2.07 115.74 179.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.415 ' H ' ' C ' ' B' ' 41' ' ' GLY . 2.7 p -48.12 -46.95 13.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 114.71 1.374 . . . . 2.24 114.71 -177.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -87.79 -29.75 20.76 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.913 -1.143 . . . . 3.36 107.913 -174.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . 0.559 ' O ' ' HB2' ' B' ' 49' ' ' ARG . 30.2 mt-10 -75.82 -10.06 59.12 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 113.963 -1.471 . . . . 3.08 112.179 -177.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 46' ' ' CYS . . . . . . . . . . . . . 21.5 t -119.42 -21.92 7.25 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-O 121.056 0.455 . . . . 2.23 110.285 176.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 49.7 t -74.28 -47.62 33.73 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.333 -0.547 . . . . 2.37 111.433 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -119.09 7.61 11.4 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 120.1 -0.64 . . . . 2.82 110.987 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . 0.559 ' HB2' ' O ' ' B' ' 45' ' ' GLU . 36.0 mmt180 -128.0 156.68 42.33 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.301 -1.37 . . . . 4.09 107.301 -177.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 14.0 p -78.3 110.75 13.61 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 109.855 -0.424 . . . . 2.67 109.855 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 3.0 p -100.87 126.75 47.5 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 115.59 -0.732 . . . . 2.11 110.365 -177.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -101.8 135.62 43.04 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.772 -1.195 . . . . 2.67 107.772 178.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . 0.436 HD21 ' HG3' ' A' 1631 ' ' LYS . 56.9 tp -36.47 -37.91 0.14 Allowed 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 126.613 1.965 . . . . 1.9 114.834 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.95 -29.97 63.64 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 123.483 0.49 . . . . 1.52 111.374 -177.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 53.1 tp -68.58 -57.0 6.39 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-N 115.863 -0.608 . . . . 1.97 110.048 177.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 1.9 pp -71.28 -27.18 63.24 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 116.496 -0.32 . . . . 1.53 111.559 -174.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -71.95 -46.11 58.68 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 111.835 0.309 . . . . 2.27 111.835 178.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 11.2 t -77.66 -30.09 51.93 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 118.619 -1.233 . . . . 2.33 111.601 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 59' ' ' TYR . . . . . 0.651 ' HE2' ' HA ' ' B' ' 28' ' ' PHE . 11.1 t80 -70.66 -64.51 0.88 Allowed 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 106.278 -1.749 . . . . 2.86 106.278 177.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 54.1 t . . . . . 0 N--CA 1.477 0.886 0 C-N-CA 127.208 2.203 . . . . 2.3 115.762 173.725 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 16.4 t70 . . . . . 0 CA--C 1.531 0.225 0 CA-C-O 120.546 0.213 . . . . 2.9 111.331 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A 1516 ' ' CYS . . . . . 0.634 ' SG ' ' HB2' ' A' 1529 ' ' LEU . 30.8 t -138.83 55.59 1.72 Allowed 'General case' 0 C--O 1.25 1.113 0 N-CA-C 108.312 -0.995 . . . . 1.19 108.312 -179.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -169.06 149.04 4.18 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 115.565 -0.743 . . . . 1.52 109.06 -174.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 4.8 m -149.43 142.37 17.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 C-N-CA 124.227 1.011 . . . . 0.94 110.585 178.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1519 ' ' THR . . . . . . . . . . . . . 31.9 m -106.16 137.35 44.25 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.915 -0.402 . . . . 0.89 109.915 177.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 52.6 t-20 -82.68 110.33 21.72 Favored Pre-proline 0 C--O 1.245 0.829 0 N-CA-C 107.009 -1.478 . . . . 1.74 107.009 174.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.23 -14.69 43.94 Favored 'Trans proline' 0 N--CA 1.474 0.376 0 C-N-CA 123.173 2.582 . . . . 1.58 113.148 -174.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 28.3 m -75.04 -33.87 61.81 Favored 'General case' 0 N--CA 1.425 -1.702 0 CA-C-N 116.307 -0.406 . . . . 1.65 111.844 -179.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1523 ' ' THR . . . . . . . . . . . . . 12.5 t -136.19 -5.3 2.1 Favored 'General case' 0 CA--C 1.564 1.484 0 C-N-CA 118.132 -1.427 . . . . 1.61 113.418 -175.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 85.75 8.31 80.03 Favored Glycine 0 CA--C 1.494 -1.252 0 C-N-CA 120.632 -0.794 . . . . 1.13 114.048 176.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 51.9 t-80 -76.27 123.27 25.64 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.706 -0.85 . . . . 1.26 108.706 177.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -103.2 116.91 33.37 Favored 'General case' 0 C--N 1.268 -2.965 0 CA-C-N 114.796 -1.093 . . . . 0.68 109.008 -176.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -88.86 118.38 28.53 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 109.989 -0.375 . . . . 0.65 109.989 175.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 7.7 t70 -110.72 126.25 54.37 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.111 -1.44 . . . . 1.17 107.111 174.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1529 ' ' LEU . . . . . 0.634 ' HB2' ' SG ' ' A' 1516 ' ' CYS . 2.9 mm? -103.21 20.47 17.65 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 111.88 0.326 . . . . 0.6 111.88 -174.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 6.9 m -66.74 -23.84 66.15 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 113.369 0.878 . . . . 0.84 113.369 -175.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 33.6 t -72.29 -30.1 64.49 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-O 121.534 0.683 . . . . 1.59 109.196 178.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1532 ' ' LEU . . . . . 0.522 HD12 HD12 ' A' 1529 ' ' LEU . 59.9 mt -88.9 -18.31 27.82 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.387 -0.824 . . . . 0.65 109.792 -179.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1533 ' ' SER . . . . . 0.532 ' HA ' ' HB ' ' A' 1552 ' ' ILE . 34.8 t -75.46 171.57 14.02 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.61 -0.723 . . . . 1.52 110.288 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . 159.94 150.37 5.83 Favored Glycine 0 N--CA 1.424 -2.159 0 N-CA-C 110.106 -1.197 . . . . 1.1 110.106 -178.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 35.6 ttp180 -92.02 -13.69 30.56 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 121.475 0.655 . . . . 4.62 109.843 -179.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -79.66 -39.03 32.33 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 121.364 0.602 . . . . 1.45 109.977 178.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 90.62 -171.89 36.82 Favored Glycine 0 N--CA 1.424 -2.118 0 CA-C-N 115.054 -0.975 . . . . 0.85 111.136 176.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -132.84 146.57 51.93 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 108.281 -1.007 . . . . 0.93 108.281 178.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 31.1 p -102.43 123.46 46.25 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 123.491 0.494 . . . . 1.03 111.77 -178.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1540 ' ' ALA . . . . . 0.406 ' HB3' ' CG1' ' A' 1548 ' ' VAL . . . -115.29 135.15 54.46 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.255 -0.646 . . . . 0.5 109.255 177.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -70.59 134.58 47.75 Favored 'General case' 0 C--O 1.249 1.032 0 CA-C-N 115.567 -0.742 . . . . 0.74 110.901 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1542 ' ' TYR . . . . . 0.587 ' CE2' ' HG ' ' A' 1626 ' ' LEU . 7.1 t80 -133.24 -100.84 0.26 Allowed 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.787 -0.82 . . . . 0.99 108.787 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1543 ' ' SER . . . . . 0.43 ' H ' ' HB3' ' A' 1542 ' ' TYR . 13.6 t -92.63 179.95 5.35 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 109.763 -0.458 . . . . 1.91 109.763 -176.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 20.2 pttp -75.21 -23.65 57.66 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 120.976 0.417 . . . . 3.59 111.416 -177.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1545 ' ' SER . . . . . 0.656 ' HB2' ' HG2' ' A' 1569 ' ' GLN . 5.2 p -65.49 -36.94 85.36 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 124.325 1.05 . . . . 2.46 112.751 -176.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 178.73 -167.1 37.27 Favored Glycine 0 N--CA 1.425 -2.098 0 C-N-CA 120.874 -0.679 . . . . 1.26 112.216 -178.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 27.2 m -113.58 166.46 7.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 109.82 -0.437 . . . . 0.79 109.82 -176.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1548 ' ' VAL . . . . . 0.406 ' CG1' ' HB3' ' A' 1540 ' ' ALA . 13.1 p -102.26 131.0 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 N-CA-C 108.911 -0.774 . . . . 0.58 108.911 177.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -92.16 134.84 34.48 Favored 'General case' 0 CA--C 1.481 -1.673 0 CA-C-N 115.504 -0.771 . . . . 1.08 109.223 178.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 24.0 ptm -146.64 116.06 7.08 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 115.478 -0.783 . . . . 0.78 111.057 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 8.5 p -106.39 124.13 49.12 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-N 115.145 -0.934 . . . . 0.97 110.214 178.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1552 ' ' ILE . . . . . 0.532 ' HB ' ' HA ' ' A' 1533 ' ' SER . 43.5 mm -81.92 119.1 30.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 109.99 -0.374 . . . . 0.42 109.99 -179.009 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 57.8 m 60.9 41.94 13.69 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 123.937 0.773 . . . . 1.4 111.366 176.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . -178.0 174.23 46.63 Favored Glycine 0 N--CA 1.422 -2.274 0 N-CA-C 109.961 -1.256 . . . . 0.35 109.961 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -100.16 150.8 22.14 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 120.856 0.36 . . . . 1.62 110.405 -179.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -98.81 139.28 34.72 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.0 -0.741 . . . . 0.87 109.0 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -85.12 -3.63 58.87 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 113.108 0.781 . . . . 2.49 113.108 -172.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -93.67 1.73 56.52 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 120.547 -0.461 . . . . 1.38 110.816 -176.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1559 ' ' CYS . . . . . 0.727 ' SG ' ' HD2' ' A' 1560 ' ' PRO . 13.3 t -137.59 166.34 27.27 Favored Pre-proline 0 C--N 1.3 -1.562 0 N-CA-C 106.542 -1.651 . . . . 1.21 106.542 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1560 ' ' PRO . . . . . 0.727 ' HD2' ' SG ' ' A' 1559 ' ' CYS . 16.3 Cg_exo -33.83 145.3 0.04 OUTLIER 'Trans proline' 0 C--N 1.379 2.173 0 C-N-CA 124.542 3.494 . . . . 0.71 114.627 173.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1561 ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' 1560 ' ' PRO . 43.0 Cg_exo -58.94 127.44 24.31 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 123.223 2.615 . . . . 0.8 112.841 -177.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 94.5 13.21 54.56 Favored Glycine 0 C--N 1.311 -0.812 0 N-CA-C 115.166 0.826 . . . . 0.46 115.166 176.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1563 ' ' VAL . . . . . 0.893 HG21 ' HB2' ' A' 1573 ' ' SER . 9.9 p -109.08 140.19 28.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-N 118.242 1.021 . . . . 0.98 110.95 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -100.7 -32.98 5.21 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 120.984 -0.627 . . . . 0.28 113.272 -177.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -123.35 128.76 50.36 Favored 'General case' 0 C--O 1.244 0.806 0 N-CA-C 109.569 -0.53 . . . . 0.28 109.569 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 50.6 t -163.48 144.82 9.33 Favored 'General case' 0 C--O 1.206 -1.194 0 C-N-CA 121.249 -0.18 . . . . 0.43 110.889 -175.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -85.72 143.61 28.26 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 118.05 0.386 . . . . 1.03 110.178 174.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -88.89 8.16 80.35 Favored Glycine 0 N--CA 1.443 -0.861 0 N-CA-C 116.239 1.256 . . . . 1.13 116.239 -170.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1569 ' ' GLN . . . . . 0.656 ' HG2' ' HB2' ' A' 1545 ' ' SER . 0.4 OUTLIER -78.48 -67.39 0.74 Allowed 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 118.328 1.064 . . . . 2.58 110.319 177.612 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 15.2 p -111.99 7.45 19.86 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.817 -1.083 . . . . 2.17 113.568 -175.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1571 ' ' ARG . . . . . 0.5 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 0.0 OUTLIER 64.68 44.34 3.87 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 122.964 0.506 . . . . 2.62 111.757 -178.91 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 42.6 mt -83.06 112.39 20.67 Favored 'Isoleucine or valine' 0 C--O 1.246 0.902 0 N-CA-C 107.973 -1.121 . . . . 0.92 107.973 174.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1573 ' ' SER . . . . . 0.893 ' HB2' HG21 ' A' 1563 ' ' VAL . 91.0 p -80.14 134.57 36.17 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.557 -0.747 . . . . 0.8 111.416 -174.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1574 ' ' VAL . . . . . 0.516 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 33.2 m -118.11 9.11 6.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 O-C-N 121.32 -0.862 . . . . 0.98 112.42 -178.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 175.33 123.88 0.78 Allowed Glycine 0 N--CA 1.433 -1.515 0 C-N-CA 120.331 -0.938 . . . . 0.29 111.403 176.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -69.24 153.34 43.82 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.043 -0.725 . . . . 2.19 109.043 -178.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -74.46 88.61 2.11 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-O 121.115 0.483 . . . . 0.61 110.258 -177.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -97.07 160.05 14.56 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 115.106 -0.952 . . . . 1.95 110.464 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 24.2 pttm -120.51 45.29 2.25 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 122.878 1.323 . . . . 2.68 108.363 -178.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 24.0 ttm180 -103.6 76.36 1.39 Allowed 'General case' 0 N--CA 1.412 -2.331 0 CA-C-N 113.956 -1.475 . . . . 3.47 108.54 -173.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1581 ' ' LEU . . . . . 0.56 HD11 HD12 ' A' 1588 ' ' LEU . 0.2 OUTLIER -82.35 124.7 30.23 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 114.146 -1.388 . . . . 0.64 107.534 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A 1582 ' ' ARG . . . . . 0.492 ' HB2' ' HB3' ' A' 1589 ' ' GLN . 64.3 mtp180 -122.56 143.4 49.76 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 116.768 -0.196 . . . . 2.85 110.599 176.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1583 ' ' TYR . . . . . 0.403 ' HE1' ' HA ' ' A' 1586 ' ' GLN . 74.9 t80 -113.35 107.57 16.04 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 109.323 -0.621 . . . . 0.86 109.323 177.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1584 ' ' VAL . . . . . 0.622 ' O ' ' HB ' ' A' 1587 ' ' VAL . 9.7 m -121.63 90.01 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 CA-C-N 115.722 -0.672 . . . . 1.05 111.153 -177.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 31.1 t70 53.51 72.63 0.42 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.053 0.941 . . . . 1.17 111.761 178.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1586 ' ' GLN . . . . . 0.403 ' HA ' ' HE1' ' A' 1583 ' ' TYR . 4.2 pt20 57.21 26.39 12.17 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 125.818 1.647 . . . . 1.86 111.296 176.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1587 ' ' VAL . . . . . 0.622 ' HB ' ' O ' ' A' 1584 ' ' VAL . 24.6 t -124.23 120.88 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.32 0 CA-C-N 113.769 -1.56 . . . . 0.49 108.117 175.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1588 ' ' LEU . . . . . 0.812 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 2.9 mm? -95.05 117.36 30.04 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.09 -1.448 . . . . 0.36 107.09 178.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1589 ' ' GLN . . . . . 0.492 ' HB3' ' HB2' ' A' 1582 ' ' ARG . 35.3 tt0 -106.56 127.42 53.31 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 116.02 -0.536 . . . . 1.74 111.454 -175.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1590 ' ' LEU . . . . . 0.449 ' HG ' HD22 ' A' 1581 ' ' LEU . 11.2 mt -121.49 101.6 7.72 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 107.463 -1.31 . . . . 0.72 107.463 170.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 6.4 p -96.92 124.68 49.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 CA-C-O 121.494 0.664 . . . . 1.01 109.966 -178.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1592 ' ' TYR . . . . . 0.469 ' HB2' ' HB3' ' A' 1608 ' ' SER . 14.4 m-30 -115.55 105.05 12.35 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.269 -1.012 . . . . 0.5 108.269 -179.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 20.7 pttp -115.27 -178.94 3.49 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 109.759 -0.46 . . . . 1.59 109.759 -179.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 36.2 m-20 65.16 42.42 4.06 Favored 'General case' 0 C--O 1.247 0.962 0 O-C-N 124.28 0.987 . . . . 1.11 110.405 177.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -75.88 -145.64 1.57 Allowed Glycine 0 N--CA 1.438 -1.217 0 CA-C-N 114.798 -1.092 . . . . 0.78 111.007 174.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1596 ' ' SER . . . . . 0.412 ' HA ' ' HD3' ' A' 1597 ' ' PRO . 72.0 p -88.94 146.47 36.7 Favored Pre-proline 0 C--N 1.284 -2.278 0 N-CA-C 108.444 -0.947 . . . . 1.07 108.444 179.163 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1597 ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' 1596 ' ' SER . 50.2 Cg_exo -57.49 120.74 8.85 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.646 2.23 . . . . 1.01 109.308 174.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 42.4 t -73.25 132.21 82.29 Favored Pre-proline 0 C--N 1.288 -2.084 0 CA-C-N 114.663 -1.153 . . . . 0.75 112.425 -169.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1599 ' ' PRO . . . . . 0.48 ' HD2' ' OH ' ' A' 1606 ' ' TYR . 14.7 Cg_exo -72.44 80.2 1.7 Allowed 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 123.122 2.548 . . . . 1.7 109.338 171.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1600 ' ' SER . . . . . 0.851 ' HA ' ' HB2' ' B' ' 53' ' ' LEU . 50.6 m -160.62 -67.29 0.07 Allowed 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 126.613 1.965 . . . . 2.26 110.004 -178.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1601 ' ' LYS . . . . . 0.477 ' O ' ' HG ' ' A' 1604 ' ' LEU . 81.4 tttt -140.11 112.04 7.53 Favored 'General case' 0 N--CA 1.398 -3.05 0 N-CA-C 106.398 -1.704 . . . . 3.01 106.398 178.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 15.4 m -49.52 133.05 20.95 Favored 'General case' 0 N--CA 1.425 -1.72 0 C-N-CA 124.599 1.16 . . . . 2.07 112.549 -177.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 106.5 -21.49 32.6 Favored Glycine 0 C--N 1.304 -1.215 0 CA-C-N 115.91 -0.586 . . . . 1.08 113.945 177.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1604 ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' 1601 ' ' LYS . 4.3 pp -103.21 145.98 29.12 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 118.387 1.094 . . . . 1.84 111.238 178.124 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 22.8 p -111.77 155.89 22.81 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.624 -0.716 . . . . 1.41 110.797 -175.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1606 ' ' TYR . . . . . 0.516 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 63.9 m-85 -64.25 161.7 16.07 Favored 'General case' 0 C--O 1.249 1.046 0 CA-C-N 116.075 -0.511 . . . . 0.6 110.493 173.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -161.38 130.17 4.5 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-O 120.882 0.372 . . . . 1.45 111.145 -178.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1608 ' ' SER . . . . . 0.469 ' HB3' ' HB2' ' A' 1592 ' ' TYR . 38.0 t -105.23 123.03 47.15 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 115.376 -0.829 . . . . 1.15 109.723 -177.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 24.1 t -107.55 100.75 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 107.946 -1.131 . . . . 0.25 107.946 175.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 89.7 mt -89.77 112.19 24.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 108.317 -0.994 . . . . 0.45 108.317 -179.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 40.1 m -112.86 110.68 20.93 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 115.043 -0.98 . . . . 1.26 111.355 -177.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1612 ' ' PHE . . . . . 0.812 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 62.8 m-85 -83.42 115.85 22.23 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.793 -0.817 . . . . 0.26 108.793 175.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 84.1 t -110.31 135.75 48.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 O-C-N 123.651 0.594 . . . . 0.5 110.572 -174.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 41.4 t -72.13 98.24 2.08 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 124.069 0.948 . . . . 0.77 111.686 -178.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1615 ' ' ARG . . . . . 0.747 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 9.5 mmt180 -138.11 99.31 9.07 Favored Pre-proline 0 N--CA 1.431 -1.404 0 CA-C-N 116.058 -0.519 . . . . 2.53 109.812 175.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1616 ' ' PRO . . . . . 0.424 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 16.4 Cg_exo -75.26 39.57 0.62 Allowed 'Trans proline' 0 N--CA 1.488 1.188 0 C-N-CA 123.37 2.713 . . . . 1.1 112.412 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1617 ' ' GLU . . . . . 0.52 ' OE1' ' HD2' ' A' 1615 ' ' ARG . 42.9 mt-10 -110.57 40.46 1.98 Allowed 'General case' 0 C--N 1.272 -2.772 0 N-CA-C 108.076 -1.083 . . . . 3.05 108.076 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -41.48 115.45 0.63 Allowed 'General case' 0 C--O 1.244 0.765 0 C-N-CA 126.288 1.835 . . . . 1.55 113.867 -175.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . 173.42 -127.16 1.31 Allowed Glycine 0 N--CA 1.412 -2.929 0 N-CA-C 108.149 -1.981 . . . . 0.93 108.149 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -77.2 7.03 3.9 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 122.545 2.163 . . . . 0.88 112.657 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1621 ' ' THR . . . . . 0.482 ' HB ' ' HB2' ' A' 1641 ' ' HIS . 3.8 p -91.11 -27.17 18.73 Favored 'General case' 0 C--N 1.288 -2.081 0 C-N-CA 124.924 1.29 . . . . 0.97 108.203 176.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 51.2 t30 -87.01 56.78 4.16 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.387 -1.278 . . . . 0.72 108.566 -176.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -157.99 139.54 9.84 Favored Pre-proline 0 C--N 1.302 -1.493 0 CA-C-N 114.632 -1.167 . . . . 3.26 108.443 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1624 ' ' PRO . . . . . 0.414 ' HA ' ' O ' ' A' 1639 ' ' SER . 53.5 Cg_endo -68.28 110.91 2.35 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.898 2.399 . . . . 0.59 112.01 -177.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 75.8 mtm -111.98 142.95 43.76 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 120.69 -0.404 . . . . 1.37 110.187 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1626 ' ' LEU . . . . . 0.587 ' HG ' ' CE2' ' A' 1542 ' ' TYR . 0.8 OUTLIER -81.78 112.88 19.34 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 108.34 -0.985 . . . . 0.89 108.34 -175.412 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 44.2 mm -81.12 -52.25 14.32 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 CA-C-O 121.31 0.576 . . . . 0.58 109.852 -178.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 50.9 m -159.56 145.42 15.99 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.541 -0.754 . . . . 1.39 109.772 -176.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1629 ' ' LEU . . . . . 1.014 HD13 ' HG ' ' A' 1636 ' ' LEU . 23.0 tp -129.7 95.13 3.9 Favored 'General case' 0 N--CA 1.421 -1.879 0 N-CA-C 107.785 -1.191 . . . . 1.25 107.785 171.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 27.5 t70 -68.0 122.11 17.52 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 107.121 -1.437 . . . . 1.09 107.121 175.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 26.0 tptp -89.36 -0.17 57.28 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 119.882 -0.727 . . . . 3.6 110.709 -171.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -96.17 -41.08 8.88 Favored 'General case' 0 N--CA 1.426 -1.643 0 C-N-CA 119.884 -0.726 . . . . 2.6 109.933 179.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 22.9 p -89.39 -22.05 22.76 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.4 0.619 . . . . 0.75 110.596 175.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 68.3 m 63.64 36.63 10.73 Favored 'General case' 0 C--N 1.354 0.771 0 C-N-CA 124.965 1.306 . . . . 0.53 111.824 178.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1635 ' ' THR . . . . . . . . . . . . . 38.6 m -100.35 130.5 46.46 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 108.028 -1.101 . . . . 0.46 108.028 178.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1636 ' ' LEU . . . . . 1.014 ' HG ' HD13 ' A' 1629 ' ' LEU . 0.6 OUTLIER -109.38 129.96 55.51 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 108.712 -0.847 . . . . 0.86 108.712 -176.373 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -106.86 121.59 44.72 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 120.901 0.382 . . . . 0.45 110.811 -179.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -119.09 127.78 53.7 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.293 -0.867 . . . . 0.5 108.794 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1639 ' ' SER . . . . . 0.414 ' O ' ' HA ' ' A' 1624 ' ' PRO . 59.1 m -114.23 144.09 43.78 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.293 -1.003 . . . . 1.04 108.293 177.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 2.8 t90 -141.39 107.95 5.33 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 103.792 -2.67 . . . . 0.68 103.792 -177.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1641 ' ' HIS . . . . . 0.747 ' HB3' ' HB2' ' A' 1615 ' ' ARG . 16.4 m170 -93.61 103.25 15.43 Favored 'General case' 0 C--N 1.287 -2.129 0 C-N-CA 120.706 -0.397 . . . . 0.9 110.487 -174.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1642 ' ' THR . . . . . . . . . . . . . 15.0 t -142.62 145.77 35.62 Favored Pre-proline 0 CA--C 1.565 1.529 0 N-CA-C 109.304 -0.628 . . . . 0.48 109.304 -174.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1643 ' ' PRO . . . . . 0.424 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 56.3 Cg_endo -72.57 -13.74 27.43 Favored 'Trans proline' 0 C--N 1.37 1.681 0 C-N-CA 122.635 2.224 . . . . 0.66 112.885 -179.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 9.1 tt -65.23 -19.24 65.88 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.37 0.605 . . . . 0.97 110.399 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -78.24 -7.2 56.86 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.58 -0.737 . . . . 0.84 112.241 -179.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 1.2 m -108.93 156.46 19.67 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 121.474 0.654 . . . . 1.19 111.869 178.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.292 -1.919 0 N-CA-C 107.531 -1.285 . . . . 3.14 107.531 169.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.972 0 CA-C-O 120.339 -0.145 . . . . 2.09 113.307 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -59.31 -39.16 94.33 Favored Glycine 0 N--CA 1.461 0.343 0 O-C-N 123.654 0.267 . . . . 1.84 113.202 -176.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 18.0 mp0 -65.61 -40.44 92.62 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 124.213 1.005 . . . . 2.55 110.067 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 13' ' ' LEU . . . . . 0.431 HD21 ' HB3' ' B' ' 46' ' ' CYS . 0.1 OUTLIER -65.15 -51.62 60.06 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.206 -0.906 . . . . 2.35 108.571 -178.884 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 7.6 p -63.42 -37.61 80.01 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 CA-C-N 116.405 -0.361 . . . . 2.11 111.655 179.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -68.1 -32.81 73.37 Favored 'General case' 0 C--O 1.193 -1.907 0 C-N-CA 120.088 -0.645 . . . . 2.04 111.859 177.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 96.5 m -59.16 -49.73 76.73 Favored 'General case' 0 C--O 1.279 2.613 0 CA-C-O 121.551 0.691 . . . . 1.84 109.62 174.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.702 HD21 HD11 ' B' ' 42' ' ' ILE . 4.6 mm? -51.52 -48.46 62.96 Favored 'General case' 0 C--O 1.222 -0.365 0 CA-C-N 114.472 -1.24 . . . . 1.74 110.416 174.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 18' ' ' GLN . . . . . 0.489 ' CD ' ' HB3' ' A' 1545 ' ' SER . 9.7 tt0 -78.11 -15.2 59.08 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.584 -0.734 . . . . 2.39 112.264 -176.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -66.75 -48.46 69.04 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.727 -0.471 . . . . 0.96 109.727 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 23.8 m -92.77 -29.11 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 117.49 -1.684 . . . . 1.37 111.995 176.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 63.0 m -96.94 25.19 5.52 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 112.203 0.445 . . . . 1.66 112.203 -178.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -54.3 -58.43 13.01 Favored Glycine 0 N--CA 1.472 1.085 0 C-N-CA 120.997 -0.62 . . . . 1.53 112.735 179.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -80.77 -3.63 51.63 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 121.027 0.441 . . . . 2.72 111.27 178.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -99.08 -55.25 2.75 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 112.157 0.429 . . . . 4.33 112.157 -173.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 122.09 143.67 6.59 Favored Glycine 0 C--N 1.301 -1.37 0 N-CA-C 108.64 -1.784 . . . . 1.53 108.64 -173.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . 0.413 ' HB2' ' HB3' ' B' ' 17' ' ' LEU . 41.6 p90 -132.33 146.36 51.92 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 117.52 0.66 . . . . 1.65 110.785 -177.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 15.4 p90 -160.97 91.36 0.88 Allowed 'General case' 0 CA--C 1.547 0.865 0 CA-C-O 121.245 0.545 . . . . 3.42 111.923 178.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 28' ' ' PHE . . . . . . . . . . . . . 36.1 p90 . . . . . 0 C--O 1.238 0.482 0 O-C-N 121.187 -0.946 . . . . 2.26 110.932 -179.973 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . 0.595 ' N ' ' HH ' ' B' ' 59' ' ' TYR . . . . . . . . 0 N--CA 1.415 -2.73 0 N-CA-C 109.336 -1.506 . . . . 2.37 109.336 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . 0.702 HD11 HD21 ' B' ' 17' ' ' LEU . 11.1 pt 64.6 -24.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 C-N-CA 128.581 2.752 . . . . 2.07 113.866 179.016 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.588 ' O ' ' HB2' ' B' ' 47' ' ' CYS . 2.0 p -50.56 -45.01 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 C-N-CA 124.628 1.171 . . . . 2.24 113.362 177.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -93.89 -39.98 10.4 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.418 -0.956 . . . . 3.36 108.418 -174.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . 0.493 ' O ' ' HB2' ' B' ' 49' ' ' ARG . 3.1 mp0 -55.25 -44.66 75.74 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 113.968 -1.469 . . . . 3.08 111.261 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 46' ' ' CYS . . . . . 0.431 ' HB3' HD21 ' B' ' 13' ' ' LEU . 13.1 t -94.8 -2.16 51.45 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.356 0.598 . . . . 2.23 110.717 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 47' ' ' CYS . . . . . 0.588 ' HB2' ' O ' ' B' ' 43' ' ' VAL . 45.4 t -78.54 -56.88 4.09 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.374 -0.602 . . . . 2.37 109.374 177.227 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -90.97 -12.07 37.07 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.406 0.521 . . . . 2.82 112.406 -175.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . 0.493 ' HB2' ' O ' ' B' ' 45' ' ' GLU . 72.4 mtp180 -129.95 -171.07 2.43 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 107.904 -1.147 . . . . 4.09 107.904 -178.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 8.3 t -110.81 129.79 55.76 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 106.278 -1.749 . . . . 2.67 106.278 178.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 14.7 p -96.44 131.73 42.71 Favored 'General case' 0 N--CA 1.428 -1.57 0 CA-C-O 120.949 0.404 . . . . 2.11 110.148 -174.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -74.68 154.42 38.46 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-N 115.806 -0.634 . . . . 2.67 110.763 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . 0.851 ' HB2' ' HA ' ' A' 1600 ' ' SER . 34.1 tp -55.45 -43.65 75.63 Favored 'General case' 0 C--N 1.309 -1.194 0 O-C-N 123.585 0.553 . . . . 1.9 110.605 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -52.64 -36.75 57.23 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 124.958 1.303 . . . . 1.52 112.043 -176.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 64.2 tp -70.27 -57.88 4.38 Favored 'General case' 0 N--CA 1.427 -1.621 0 CA-C-N 115.451 -0.795 . . . . 1.97 110.676 -179.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.441 ' O ' ' HB2' ' B' ' 60' ' ' CYS . 3.0 pp -68.78 -33.87 74.59 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 111.867 0.321 . . . . 1.53 111.867 -174.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -54.43 -60.64 3.07 Favored 'General case' 0 C--N 1.318 -0.771 0 O-C-N 123.947 0.779 . . . . 2.27 111.679 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 12.4 t -80.74 -25.55 37.96 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 119.974 -0.69 . . . . 2.33 111.995 -175.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 59' ' ' TYR . . . . . 0.595 ' HH ' ' N ' ' B' ' 41' ' ' GLY . 25.3 t80 -71.7 -40.53 69.45 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 109.096 -0.705 . . . . 2.86 109.096 -179.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 60' ' ' CYS . . . . . 0.441 ' HB2' ' O ' ' B' ' 56' ' ' LEU . 30.4 t . . . . . 0 N--CA 1.485 1.297 0 O-C-N 124.72 1.262 . . . . 2.3 111.335 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1515 ' ' ASP . . . . . 0.423 ' HB3' ' HE2' ' A' 1579 ' ' LYS . 29.5 m-20 . . . . . 0 CA--C 1.505 -0.776 0 N-CA-C 109.047 -0.723 . . . . 2.9 109.047 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1516 ' ' CYS . . . . . 0.493 ' HA ' ' HB2' ' A' 1581 ' ' LEU . 83.7 m -138.64 41.75 2.17 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 116.214 -0.448 . . . . 1.19 111.024 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1517 ' ' GLN . . . . . 0.409 ' HA ' ' O ' ' A' 1527 ' ' PHE . 3.5 pt20 -149.13 137.16 20.66 Favored 'General case' 0 N--CA 1.428 -1.564 0 C-N-CA 120.351 -0.539 . . . . 1.52 109.9 178.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1518 ' ' VAL . . . . . 0.533 HG21 ' HB2' ' A' 1583 ' ' TYR . 10.4 m -140.67 141.06 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 123.16 0.584 . . . . 0.94 110.204 178.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1519 ' ' THR . . . . . . . . . . . . . 9.6 m -101.04 131.2 47.05 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 115.77 -0.65 . . . . 0.89 109.343 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1520 ' ' ASN . . . . . 0.422 ' OD1' HG22 ' A' 1523 ' ' THR . 26.5 t-20 -83.49 118.27 71.04 Favored Pre-proline 0 N--CA 1.426 -1.661 0 N-CA-C 109.332 -0.618 . . . . 1.74 109.332 176.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.14 -16.82 49.88 Favored 'Trans proline' 0 C--O 1.239 0.572 0 C-N-CA 123.224 2.616 . . . . 1.58 113.906 -177.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 74.2 m -77.2 -46.34 23.62 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 112.28 0.474 . . . . 1.65 112.28 -179.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1523 ' ' THR . . . . . 0.422 HG22 ' OD1' ' A' 1520 ' ' ASN . 5.7 t -109.68 -14.43 14.34 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 119.547 -0.861 . . . . 1.61 111.626 -178.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 79.55 31.68 40.25 Favored Glycine 0 N--CA 1.44 -1.044 0 N-CA-C 111.352 -0.699 . . . . 1.13 111.352 178.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1525 ' ' HIS . . . . . 0.401 ' HB2' ' OE2' ' A' 1647 ' ' GLU . 5.2 t-80 -98.22 120.9 39.43 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.623 -0.88 . . . . 1.26 108.623 -178.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 1.9 tm? -86.31 112.66 21.62 Favored 'General case' 0 C--N 1.285 -2.212 0 N-CA-C 107.022 -1.473 . . . . 0.68 107.022 176.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1527 ' ' PHE . . . . . 0.409 ' O ' ' HA ' ' A' 1517 ' ' GLN . 50.1 m-85 -99.79 120.01 39.06 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 109.194 -0.669 . . . . 0.65 109.194 177.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 23.1 t70 -112.64 118.09 34.09 Favored 'General case' 0 CA--C 1.482 -1.657 0 N-CA-C 108.652 -0.87 . . . . 1.17 108.652 177.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 6.0 mp -107.38 5.8 27.73 Favored 'General case' 0 N--CA 1.412 -2.353 0 CA-C-O 121.571 0.7 . . . . 0.6 110.769 -177.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 1.5 m -72.72 -11.08 60.48 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.838 -1.074 . . . . 0.84 109.089 178.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 24.7 m -75.49 -23.63 56.81 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 115.3 -0.864 . . . . 1.59 109.712 176.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 97.9 mt -87.1 -5.16 59.12 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.258 0.552 . . . . 0.65 110.312 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1533 ' ' SER . . . . . 0.488 ' HA ' ' HB ' ' A' 1552 ' ' ILE . 21.0 m -70.53 166.76 19.86 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.842 -0.617 . . . . 1.52 111.862 -178.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . 173.47 164.15 28.24 Favored Glycine 0 N--CA 1.436 -1.301 0 N-CA-C 110.069 -1.212 . . . . 1.1 110.069 -179.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 44.6 ttp180 -92.57 -33.66 14.34 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 121.028 0.442 . . . . 4.62 110.197 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -82.06 -30.83 31.14 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 116.088 -0.505 . . . . 1.45 110.597 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 84.51 -145.65 22.11 Favored Glycine 0 N--CA 1.422 -2.255 0 CA-C-N 115.5 -0.773 . . . . 0.85 113.634 170.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -137.3 153.18 50.34 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 124.98 1.312 . . . . 0.93 107.548 -178.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 8.6 p -115.28 136.93 52.58 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 123.632 0.582 . . . . 1.03 110.508 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1540 ' ' ALA . . . . . 0.447 ' HB3' HG12 ' A' 1548 ' ' VAL . . . -132.61 136.36 46.47 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.969 -1.123 . . . . 0.5 107.969 175.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -84.73 129.31 34.84 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.275 0.559 . . . . 0.74 110.589 -176.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1542 ' ' TYR . . . . . 0.623 ' CE2' ' HG ' ' A' 1626 ' ' LEU . 1.6 t80 -120.04 -100.58 0.43 Allowed 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.588 -1.264 . . . . 0.99 107.588 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1543 ' ' SER . . . . . 0.502 ' H ' ' HB3' ' A' 1542 ' ' TYR . 5.2 m -71.94 161.52 30.81 Favored 'General case' 0 N--CA 1.421 -1.91 0 C-N-CA 124.373 1.069 . . . . 1.91 108.838 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1544 ' ' LYS . . . . . 0.82 ' HG3' ' HB3' ' B' ' 23' ' ' ASP . 39.0 mmtm -72.57 -1.11 14.78 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.398 0.888 . . . . 3.59 113.398 -177.299 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 22.6 t -139.82 37.98 1.99 Allowed 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 108.937 -0.764 . . . . 2.46 108.937 176.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . -172.29 126.58 1.29 Allowed Glycine 0 N--CA 1.434 -1.494 0 C-N-CA 119.555 -1.307 . . . . 1.26 114.166 -178.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 26.8 m -109.1 150.53 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.568 0 N-CA-C 107.184 -1.413 . . . . 0.79 107.184 174.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1548 ' ' VAL . . . . . 0.447 HG12 ' HB3' ' A' 1540 ' ' ALA . 10.0 p -97.46 130.4 46.18 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 C-N-CA 120.171 -0.612 . . . . 0.58 109.403 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -94.22 131.53 39.71 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 108.358 -0.978 . . . . 1.08 108.358 176.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 26.2 ptm -145.59 127.03 14.99 Favored 'General case' 0 C--N 1.286 -2.183 0 CA-C-N 115.471 -0.786 . . . . 0.78 110.983 -177.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 69.1 m -118.15 128.48 54.77 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 115.769 -0.65 . . . . 0.97 109.968 177.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1552 ' ' ILE . . . . . 0.488 ' HB ' ' HA ' ' A' 1533 ' ' SER . 50.7 mm -77.35 125.34 37.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 109.16 -0.682 . . . . 0.42 109.16 -179.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 75.8 m 59.08 39.42 23.26 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.589 0.755 . . . . 1.4 112.045 175.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . -179.99 178.51 48.56 Favored Glycine 0 N--CA 1.42 -2.376 0 C-N-CA 120.096 -1.049 . . . . 0.35 110.919 -177.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1555 ' ' GLU . . . . . 0.403 ' OE1' ' HA ' ' A' 1561 ' ' PRO . 14.6 pt-20 -96.85 160.78 14.17 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 109.337 -0.616 . . . . 1.62 109.337 179.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -103.48 130.29 50.81 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 109.891 -0.411 . . . . 0.87 109.891 -178.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -73.3 2.1 8.15 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.676 0.991 . . . . 2.49 113.676 -175.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -101.71 1.31 37.33 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.91 -0.494 . . . . 1.38 110.427 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1559 ' ' CYS . . . . . 0.613 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 16.1 m -137.03 175.26 3.62 Favored Pre-proline 0 C--N 1.303 -1.421 0 CA-C-O 118.647 -0.692 . . . . 1.21 112.07 -177.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1560 ' ' PRO . . . . . 0.613 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 21.9 Cg_exo -38.76 142.93 0.27 Allowed 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 124.063 3.175 . . . . 0.71 114.562 175.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1561 ' ' PRO . . . . . 0.502 ' HD3' ' HA ' ' A' 1560 ' ' PRO . 31.6 Cg_exo -61.51 126.69 19.77 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.533 2.155 . . . . 0.8 111.018 176.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 100.33 -9.0 59.09 Favored Glycine 0 C--N 1.31 -0.87 0 N-CA-C 114.345 0.498 . . . . 0.46 114.345 178.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1563 ' ' VAL . . . . . 0.607 HG12 ' O ' ' A' 1560 ' ' PRO . 9.8 p -99.9 134.92 37.7 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 O-C-N 121.6 -0.941 . . . . 0.98 111.294 -177.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -95.35 -31.39 7.57 Favored Glycine 0 N--CA 1.453 -0.191 0 CA-C-N 115.725 -0.67 . . . . 0.28 112.854 -177.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -124.14 125.62 44.77 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 109.71 -0.478 . . . . 0.28 109.71 178.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 4.5 t -159.36 141.42 13.52 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 116.492 -0.322 . . . . 0.43 110.361 -177.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1567 ' ' PHE . . . . . 0.516 ' HE1' HG21 ' A' 1574 ' ' VAL . 84.0 m-85 -86.24 139.91 30.6 Favored 'General case' 0 C--O 1.245 0.828 0 N-CA-C 109.61 -0.515 . . . . 1.03 109.61 175.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -86.3 29.85 4.64 Favored Glycine 0 CA--C 1.508 -0.361 0 C-N-CA 120.856 -0.687 . . . . 1.13 112.454 -175.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1569 ' ' GLN . . . . . 0.599 ' HB3' ' OD1' ' B' ' 15' ' ' ASP . 27.7 mt-30 -83.3 -70.58 0.55 Allowed 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 110.281 -0.266 . . . . 2.58 110.281 177.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 8.3 t -130.96 32.31 4.34 Favored 'General case' 0 CA--C 1.557 1.228 0 CA-C-O 121.563 0.697 . . . . 2.17 111.107 176.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1571 ' ' ARG . . . . . 0.413 ' HB3' ' HD3' ' A' 1560 ' ' PRO . 15.2 mmt85 64.64 48.86 2.45 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 124.213 1.005 . . . . 2.62 110.895 178.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 27.8 mt -89.36 120.22 37.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 109.552 -0.536 . . . . 0.92 109.552 -178.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1573 ' ' SER . . . . . 0.412 ' HB3' ' HB3' ' A' 1596 ' ' SER . 29.5 t -76.13 128.72 35.54 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.392 -0.822 . . . . 0.8 111.009 -177.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1574 ' ' VAL . . . . . 0.516 HG21 ' HE1' ' A' 1567 ' ' PHE . 0.9 OUTLIER -112.15 -16.57 9.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 115.884 -0.598 . . . . 0.98 112.084 -179.918 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 179.11 124.5 0.88 Allowed Glycine 0 N--CA 1.435 -1.403 0 C-N-CA 119.34 -1.409 . . . . 0.29 112.4 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 22.2 ttmm -61.65 145.99 50.46 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 123.683 0.793 . . . . 2.19 109.399 178.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -59.63 119.92 8.49 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 108.834 -0.802 . . . . 0.61 108.834 175.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 60.2 t30 -132.49 147.12 52.36 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.474 -1.306 . . . . 1.95 107.474 -174.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1579 ' ' LYS . . . . . 0.423 ' HE2' ' HB3' ' A' 1515 ' ' ASP . 56.4 mtpt -132.27 57.66 1.78 Allowed 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 122.298 1.047 . . . . 2.68 108.772 -175.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 31.2 ttm180 -117.69 76.56 1.07 Allowed 'General case' 0 N--CA 1.413 -2.311 0 CA-C-N 114.775 -1.102 . . . . 3.47 108.051 -176.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1581 ' ' LEU . . . . . 0.493 ' HB2' ' HA ' ' A' 1516 ' ' CYS . 0.6 OUTLIER -64.23 125.72 25.45 Favored 'General case' 0 C--O 1.252 1.196 0 CA-C-N 114.266 -1.334 . . . . 0.64 109.975 -178.103 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A 1582 ' ' ARG . . . . . 0.424 ' HD2' ' OE1' ' A' 1589 ' ' GLN . 91.6 mtt180 -124.48 138.23 54.36 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.865 -0.607 . . . . 2.85 110.391 177.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1583 ' ' TYR . . . . . 0.533 ' HB2' HG21 ' A' 1518 ' ' VAL . 46.0 t80 -110.8 107.26 16.71 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 107.303 -1.369 . . . . 0.86 107.303 174.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1584 ' ' VAL . . . . . 0.49 ' O ' ' HB ' ' A' 1587 ' ' VAL . 16.5 m -120.97 90.1 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 CA-C-N 115.9 -0.591 . . . . 1.05 112.065 -176.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 29.6 t70 58.02 57.66 3.97 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.892 0.853 . . . . 1.17 110.555 178.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1586 ' ' GLN . . . . . 0.47 ' HA ' ' CZ ' ' A' 1583 ' ' TYR . 2.1 pt20 73.99 -7.64 1.58 Allowed 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 128.243 2.617 . . . . 1.86 111.476 178.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1587 ' ' VAL . . . . . 0.49 ' HB ' ' O ' ' A' 1584 ' ' VAL . 30.5 t -88.07 124.9 41.46 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.444 0 CA-C-N 115.719 -0.673 . . . . 0.49 109.337 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1588 ' ' LEU . . . . . 0.736 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 3.3 mm? -93.93 120.85 34.74 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 107.581 -1.266 . . . . 0.36 107.581 179.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1589 ' ' GLN . . . . . 0.424 ' OE1' ' HD2' ' A' 1582 ' ' ARG . 35.8 tt0 -116.78 135.65 53.59 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 112.63 0.604 . . . . 1.74 112.63 -173.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 18.3 mt -129.96 99.25 5.03 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 125.373 1.469 . . . . 0.72 107.224 172.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 7.5 p -95.81 125.87 48.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 109.527 -0.546 . . . . 1.01 109.527 -178.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1592 ' ' TYR . . . . . 0.603 ' HB2' ' HB3' ' A' 1608 ' ' SER . 15.8 m-30 -110.76 107.1 16.51 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 108.592 -0.892 . . . . 0.5 108.592 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 19.5 pttp -109.68 168.77 9.17 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 115.557 -0.747 . . . . 1.59 110.057 -177.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 15.3 m-20 66.29 78.89 0.25 Allowed 'General case' 0 CA--C 1.507 -0.681 0 C-N-CA 124.488 1.115 . . . . 1.11 110.69 -178.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -98.99 -122.07 4.65 Favored Glycine 0 C--N 1.287 -2.143 0 N-CA-C 109.703 -1.359 . . . . 0.78 109.703 175.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1596 ' ' SER . . . . . 0.412 ' HB3' ' HB3' ' A' 1573 ' ' SER . 50.7 p -120.29 164.68 21.3 Favored Pre-proline 0 C--N 1.297 -1.683 0 N-CA-C 107.927 -1.138 . . . . 1.07 107.927 175.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.16 119.94 7.53 Favored 'Trans proline' 0 C--N 1.361 1.214 0 C-N-CA 122.317 2.012 . . . . 1.01 112.306 -178.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1598 ' ' CYS . . . . . 0.434 ' HA ' ' HD3' ' A' 1599 ' ' PRO . 44.5 t -81.08 125.21 80.18 Favored Pre-proline 0 C--N 1.292 -1.901 0 CA-C-N 115.129 -0.941 . . . . 0.75 109.182 -179.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1599 ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' 1598 ' ' CYS . 14.9 Cg_exo -71.1 -15.15 32.16 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 123.429 2.753 . . . . 1.7 112.995 -178.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1600 ' ' SER . . . . . 0.836 ' HA ' ' HB3' ' B' ' 53' ' ' LEU . 10.6 m -59.0 -40.89 86.28 Favored 'General case' 0 N--CA 1.434 -1.257 0 C-N-CA 123.296 0.638 . . . . 2.26 111.635 177.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1601 ' ' LYS . . . . . . . . . . . . . 18.5 ttmm -145.9 127.18 14.84 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 106.832 -1.544 . . . . 3.01 106.832 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 19.2 m -61.94 117.18 5.59 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 112.176 0.435 . . . . 2.07 112.176 -174.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 95.16 14.68 47.62 Favored Glycine 0 C--O 1.241 0.539 0 C-N-CA 121.404 -0.427 . . . . 1.08 112.846 178.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1604 ' ' LEU . . . . . 0.605 HD23 ' SG ' ' A' 1634 ' ' CYS . 12.5 tp -108.16 157.11 18.59 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.861 -1.163 . . . . 1.84 107.861 -178.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 33.4 t -120.53 154.32 35.5 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.965 -0.754 . . . . 1.41 108.965 -178.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1606 ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -76.35 158.26 31.63 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.901 -0.777 . . . . 0.6 108.901 174.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 56.7 pttt -158.4 140.81 14.28 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 120.397 -0.521 . . . . 1.45 110.976 175.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1608 ' ' SER . . . . . 0.603 ' HB3' ' HB2' ' A' 1592 ' ' TYR . 45.4 t -105.68 127.88 53.33 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 115.168 -0.924 . . . . 1.15 109.894 -175.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 40.8 t -113.72 101.75 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 N-CA-C 108.905 -0.776 . . . . 0.25 108.905 176.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 80.4 mt -91.87 114.53 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.611 0 N-CA-C 107.85 -1.167 . . . . 0.45 107.85 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 8.1 t -116.9 111.59 19.86 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 115.401 -0.818 . . . . 1.26 109.703 -176.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1612 ' ' PHE . . . . . 0.736 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 71.2 m-85 -90.86 118.36 30.21 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.733 -0.667 . . . . 0.26 110.036 179.066 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 47.6 t -120.69 138.0 52.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.721 -0.672 . . . . 0.5 110.575 -174.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1614 ' ' CYS . . . . . 0.415 ' HA ' ' HB2' ' A' 1646 ' ' CYS . 15.3 t -51.49 114.87 1.36 Allowed 'General case' 0 C--O 1.247 0.929 0 C-N-CA 125.409 1.484 . . . . 0.77 113.088 176.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1615 ' ' ARG . . . . . 0.817 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 18.8 tpt180 -128.22 96.6 30.77 Favored Pre-proline 0 N--CA 1.436 -1.139 0 N-CA-C 109.243 -0.651 . . . . 2.53 109.243 173.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1616 ' ' PRO . . . . . 0.447 ' HD2' ' OE1' ' A' 1617 ' ' GLU . 31.7 Cg_exo -62.43 -37.42 59.98 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 121.909 1.739 . . . . 1.1 111.311 175.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1617 ' ' GLU . . . . . 0.447 ' OE1' ' HD2' ' A' 1616 ' ' PRO . 2.6 mp0 -77.82 44.39 0.46 Allowed 'General case' 0 C--O 1.24 0.571 0 C-N-CA 124.89 1.276 . . . . 3.05 112.059 178.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -37.15 132.63 0.72 Allowed 'General case' 0 C--O 1.244 0.792 0 C-N-CA 125.296 1.438 . . . . 1.55 112.613 178.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1619 ' ' GLY . . . . . 0.442 ' HA3' ' HD2' ' A' 1620 ' ' PRO . . . 172.46 -137.33 4.18 Favored Glycine 0 N--CA 1.423 -2.221 0 N-CA-C 110.195 -1.162 . . . . 0.93 110.195 -177.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1620 ' ' PRO . . . . . 0.442 ' HD2' ' HA3' ' A' 1619 ' ' GLY . 36.3 Cg_endo -63.68 -1.46 3.33 Favored 'Trans proline' 0 CA--C 1.551 1.335 0 C-N-CA 123.269 2.646 . . . . 0.88 114.852 -178.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1621 ' ' THR . . . . . 0.632 ' HB ' ' HB2' ' A' 1641 ' ' HIS . 5.2 p -89.96 -11.82 40.55 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 121.807 0.813 . . . . 0.97 109.785 177.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 48.5 t30 -92.66 55.34 2.43 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 122.679 1.228 . . . . 0.72 109.599 -178.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -156.59 139.19 10.55 Favored Pre-proline 0 C--N 1.3 -1.55 0 N-CA-C 106.514 -1.661 . . . . 3.26 106.514 178.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -61.72 113.9 2.03 Favored 'Trans proline' 0 C--O 1.245 0.863 0 C-N-CA 122.881 2.387 . . . . 0.59 112.123 -176.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 75.3 mtm -117.17 140.13 49.91 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 116.508 -0.314 . . . . 1.37 110.603 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1626 ' ' LEU . . . . . 0.623 ' HG ' ' CE2' ' A' 1542 ' ' TYR . 0.3 OUTLIER -87.99 115.18 25.28 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 107.681 -1.229 . . . . 0.89 107.681 -175.463 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 48.8 mm -80.12 -49.46 18.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 CA-C-N 116.249 -0.432 . . . . 0.58 109.839 -178.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 33.1 t -167.78 149.53 5.51 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.545 -0.752 . . . . 1.39 110.134 -175.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1629 ' ' LEU . . . . . 0.612 HD13 ' HG ' ' A' 1636 ' ' LEU . 48.0 tp -112.63 105.59 13.8 Favored 'General case' 0 N--CA 1.418 -2.053 0 N-CA-C 107.116 -1.439 . . . . 1.25 107.116 173.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 30.4 t70 -76.92 114.38 15.63 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.462 -0.895 . . . . 1.09 108.994 178.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1631 ' ' LYS . . . . . 0.411 ' HB3' HD11 ' B' ' 53' ' ' LEU . 98.7 mttt -66.91 -21.1 66.0 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 113.445 0.905 . . . . 3.6 113.445 -174.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -86.32 -35.26 19.98 Favored 'General case' 0 CA--C 1.497 -1.071 0 CA-C-O 121.343 0.592 . . . . 2.6 111.348 -177.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 53.5 p -104.9 -7.03 19.62 Favored 'General case' 0 C--N 1.285 -2.198 0 CA-C-N 115.741 -0.663 . . . . 0.75 112.391 -175.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1634 ' ' CYS . . . . . 0.605 ' SG ' HD23 ' A' 1604 ' ' LEU . 75.0 m 56.38 34.61 24.48 Favored 'General case' 0 C--N 1.363 1.156 0 C-N-CA 124.284 1.033 . . . . 0.53 110.934 -177.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1635 ' ' THR . . . . . . . . . . . . . 88.2 m -99.03 129.26 45.3 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-N 114.193 -1.367 . . . . 0.46 109.979 -177.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1636 ' ' LEU . . . . . 0.612 ' HG ' HD13 ' A' 1629 ' ' LEU . 1.5 mp -108.02 121.33 44.58 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 107.542 -1.281 . . . . 0.86 107.542 -179.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -95.02 131.22 41.22 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 120.685 0.279 . . . . 0.45 110.542 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -126.26 119.34 27.17 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.716 -0.675 . . . . 0.5 109.343 -176.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1639 ' ' SER . . . . . . . . . . . . . 59.7 m -103.15 138.15 40.36 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 115.781 -0.645 . . . . 1.04 109.567 175.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 2.8 t90 -141.85 113.19 7.61 Favored 'General case' 0 N--CA 1.422 -1.84 0 N-CA-C 103.95 -2.611 . . . . 0.68 103.95 178.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1641 ' ' HIS . . . . . 0.817 ' HB3' ' HB2' ' A' 1615 ' ' ARG . 18.1 m-70 -107.08 111.04 23.31 Favored 'General case' 0 C--N 1.286 -2.182 0 C-N-CA 120.067 -0.653 . . . . 0.9 110.402 -174.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1642 ' ' THR . . . . . . . . . . . . . 4.9 t -142.75 150.07 52.36 Favored Pre-proline 0 C--N 1.306 -1.29 0 CA-C-N 115.479 -0.782 . . . . 0.48 109.683 -174.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1643 ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -76.64 -6.39 16.9 Favored 'Trans proline' 0 C--N 1.366 1.483 0 C-N-CA 122.281 1.987 . . . . 0.66 112.316 175.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 8.6 tt -64.45 -30.27 71.31 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.435 0.636 . . . . 0.97 109.445 177.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -94.51 8.03 43.58 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.051 -0.977 . . . . 0.84 109.828 -177.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1646 ' ' CYS . . . . . 0.415 ' HB2' ' HA ' ' A' 1614 ' ' CYS . 33.7 t -122.09 158.54 29.03 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 115.532 -0.758 . . . . 1.19 109.496 -173.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1647 ' ' GLU . . . . . 0.401 ' OE2' ' HB2' ' A' 1525 ' ' HIS . 8.6 tp10 . . . . . 0 N--CA 1.417 -2.094 0 N-CA-C 106.728 -1.582 . . . . 3.14 106.728 171.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.421 -2.343 0 N-CA-C 110.576 -1.01 . . . . 2.09 110.576 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.22 -62.67 4.48 Favored Glycine 0 N--CA 1.444 -0.806 0 O-C-N 123.98 0.459 . . . . 1.84 112.972 -179.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 77.7 mt-10 -69.53 -27.06 64.84 Favored 'General case' 0 CA--C 1.496 -1.108 0 C-N-CA 120.186 -0.606 . . . . 2.55 109.416 177.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 13' ' ' LEU . . . . . 0.505 ' O ' HD23 ' B' ' 17' ' ' LEU . 0.1 OUTLIER -57.32 -57.89 10.64 Favored 'General case' 0 C--O 1.212 -0.898 0 CA-C-N 115.651 -0.704 . . . . 2.35 109.726 176.319 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 13.7 p -66.07 -34.09 67.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.981 -0.288 . . . . 2.11 111.148 -178.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 15' ' ' ASP . . . . . 0.599 ' OD1' ' HB3' ' A' 1569 ' ' GLN . 29.3 t70 -71.22 -40.84 70.85 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 113.658 0.984 . . . . 2.04 113.658 -177.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 21.6 p -66.8 -40.92 88.28 Favored 'General case' 0 C--O 1.262 1.739 0 CA-C-O 121.644 0.735 . . . . 1.84 109.917 176.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.505 HD23 ' O ' ' B' ' 13' ' ' LEU . 4.1 mm? -52.95 -50.12 64.69 Favored 'General case' 0 C--O 1.213 -0.824 0 CA-C-N 114.896 -1.047 . . . . 1.74 110.598 170.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -67.09 -25.68 66.34 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 123.841 0.857 . . . . 2.39 111.777 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -58.59 -55.27 37.25 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 116.019 -0.537 . . . . 0.96 110.982 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 14.7 p -99.08 -22.19 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.07 0 C-N-CA 118.105 -1.438 . . . . 1.37 112.819 178.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 21' ' ' CYS . . . . . 0.503 ' HB2' ' HB3' ' B' ' 26' ' ' PHE . 57.9 m -103.36 24.89 10.29 Favored 'General case' 0 C--N 1.315 -0.914 0 O-C-N 121.555 -0.716 . . . . 1.66 110.881 -178.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.69 -67.79 2.01 Favored Glycine 0 N--CA 1.461 0.345 0 C-N-CA 121.424 -0.417 . . . . 1.53 113.414 -177.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.82 ' HB3' ' HG3' ' A' 1544 ' ' LYS . 8.8 p-10 -76.88 -4.16 42.3 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 122.826 0.45 . . . . 2.72 111.646 179.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 21.1 tpp180 -97.48 -42.71 7.58 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 116.02 -0.536 . . . . 4.33 111.745 -175.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 112.73 121.76 3.9 Favored Glycine 0 N--CA 1.426 -2.028 0 N-CA-C 108.998 -1.641 . . . . 1.53 108.998 -174.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . 0.609 ' HA ' ' SG ' ' B' ' 60' ' ' CYS . 13.4 p90 -98.12 144.94 27.07 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 117.422 0.611 . . . . 1.65 111.318 -179.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -125.64 105.05 8.72 Favored 'General case' 0 C--O 1.218 -0.581 0 N-CA-C 113.003 0.742 . . . . 3.42 113.003 -175.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 28' ' ' PHE . . . . . 0.499 ' CD2' ' HG ' ' B' ' 17' ' ' LEU . 53.8 p90 . . . . . 0 C--N 1.311 -1.08 0 CA-C-O 121.471 0.653 . . . . 2.26 109.84 162.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . 0.433 ' O ' ' HB2' ' B' ' 28' ' ' PHE . . . . . . . . 0 N--CA 1.413 -2.882 0 N-CA-C 109.685 -1.366 . . . . 2.37 109.685 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . 0.262 23.0 pt 59.8 -27.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 C-N-CA 127.849 2.46 . . . . 2.07 115.583 178.136 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.495 ' O ' ' HB2' ' B' ' 47' ' ' CYS . 2.5 p -53.98 -41.29 48.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 C-N-CA 124.566 1.146 . . . . 2.24 112.738 177.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -95.47 -25.84 16.07 Favored 'General case' 0 N--CA 1.419 -1.997 0 N-CA-C 109.048 -0.723 . . . . 3.36 109.048 -173.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 22.0 tp10 -61.11 -56.66 18.34 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 114.651 -1.159 . . . . 3.08 108.441 176.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 46' ' ' CYS . . . . . . . . . . . . . 56.5 m -84.83 2.59 41.73 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.069 -0.514 . . . . 2.23 111.945 -177.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 47' ' ' CYS . . . . . 0.495 ' HB2' ' O ' ' B' ' 43' ' ' VAL . 49.7 t -78.89 -48.0 15.45 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 120.257 -0.577 . . . . 2.37 109.537 176.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -101.66 -2.27 30.75 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.053 -0.521 . . . . 2.82 111.81 -176.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 21.0 mmt180 -132.56 162.89 30.12 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.896 -1.15 . . . . 4.09 107.896 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 1.9 p -102.4 127.66 49.33 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 108.371 -0.974 . . . . 2.67 108.371 176.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 85.2 m -106.81 171.35 7.41 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.568 0.699 . . . . 2.11 112.257 -172.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -126.35 158.33 36.15 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 105.839 -1.911 . . . . 2.67 105.839 173.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . 0.836 ' HB3' ' HA ' ' A' 1600 ' ' SER . 2.6 pt? -60.71 -21.19 62.64 Favored 'General case' 0 CA--C 1.501 -0.936 0 N-CA-C 114.693 1.368 . . . . 1.9 114.693 -167.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . 0.408 ' O ' HG22 ' B' ' 58' ' ' THR . . . -58.31 -29.46 65.91 Favored 'General case' 0 CA--C 1.514 -0.415 0 O-C-N 123.509 0.505 . . . . 1.52 111.282 -176.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . 0.401 ' O ' ' HB2' ' B' ' 59' ' ' TYR . 64.9 tp -65.06 -54.82 24.18 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 115.636 -0.711 . . . . 1.97 110.16 178.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 1.3 pp -76.04 -32.69 59.46 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 116.588 -0.278 . . . . 1.53 111.483 -175.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -55.51 -49.01 73.73 Favored 'General case' 0 C--N 1.318 -0.803 0 O-C-N 123.83 0.706 . . . . 2.27 110.553 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 58' ' ' THR . . . . . 0.408 HG22 ' O ' ' B' ' 54' ' ' ALA . 10.9 t -86.78 -17.41 33.58 Favored 'General case' 0 CA--C 1.567 1.607 0 N-CA-C 112.405 0.52 . . . . 2.33 112.405 -177.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 59' ' ' TYR . . . . . 0.401 ' HB2' ' O ' ' B' ' 55' ' ' LEU . 10.8 t80 -86.67 -37.52 17.92 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.52 -0.737 . . . . 2.86 109.961 -178.007 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 60' ' ' CYS . . . . . 0.609 ' SG ' ' HA ' ' B' ' 26' ' ' PHE . 6.6 t . . . . . 0 C--N 1.312 -1.057 0 CA-C-N 115.466 -0.788 . . . . 2.3 111.461 -178.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 34.3 t70 . . . . . 0 C--O 1.218 -0.596 0 N-CA-C 108.893 -0.78 . . . . 2.9 108.893 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 12.6 t -150.89 61.38 0.92 Allowed 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 106.431 -1.692 . . . . 1.19 106.431 172.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 26.1 pt20 -165.13 162.92 20.43 Favored 'General case' 0 N--CA 1.419 -1.998 0 N-CA-C 106.485 -1.672 . . . . 1.52 106.485 -175.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1518 ' ' VAL . . . . . 0.668 HG21 ' HB2' ' A' 1583 ' ' TYR . 0.0 OUTLIER -154.59 146.05 13.61 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 O-C-N 123.896 0.747 . . . . 0.94 110.449 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A 1519 ' ' THR . . . . . . . . . . . . . 49.9 m -98.09 137.69 36.51 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 115.965 -0.561 . . . . 0.89 109.561 176.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1520 ' ' ASN . . . . . 0.498 ' ND2' ' OH ' ' A' 1583 ' ' TYR . 21.2 t-20 -79.31 117.27 66.09 Favored Pre-proline 0 N--CA 1.43 -1.46 0 N-CA-C 108.6 -0.889 . . . . 1.74 108.6 174.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -69.56 -10.79 29.62 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 122.687 2.258 . . . . 1.58 113.586 -176.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 19.7 m -82.47 -44.22 16.27 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 120.77 0.319 . . . . 1.65 111.809 -178.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1523 ' ' THR . . . . . . . . . . . . . 9.0 t -122.16 -3.23 9.03 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 119.459 -0.896 . . . . 1.61 112.24 -177.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 80.46 16.34 76.15 Favored Glycine 0 C--O 1.238 0.344 0 C-N-CA 120.691 -0.766 . . . . 1.13 112.708 175.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 81.1 t60 -80.69 125.3 29.87 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 120.832 0.348 . . . . 1.26 110.546 -178.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 1.2 tm? -90.38 108.39 19.75 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 114.921 -1.036 . . . . 0.68 108.981 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -87.9 111.32 21.31 Favored 'General case' 0 CA--C 1.499 -0.981 0 N-CA-C 107.981 -1.118 . . . . 0.65 107.981 177.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -101.71 134.72 44.42 Favored 'General case' 0 N--CA 1.404 -2.737 0 N-CA-C 107.123 -1.436 . . . . 1.17 107.123 174.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 3.4 mm? -100.94 5.15 43.12 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-O 122.017 0.913 . . . . 0.6 108.687 177.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 4.0 m -64.82 -32.91 74.82 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.102 -1.408 . . . . 0.84 109.75 178.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1531 ' ' SER . . . . . 0.611 ' HB2' HD11 ' A' 1644 ' ' LEU . 46.0 m -66.28 -25.74 67.01 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.952 -0.567 . . . . 1.59 111.238 177.162 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 90.1 mt -97.11 -1.11 45.9 Favored 'General case' 0 C--O 1.215 -0.72 0 CA-C-O 121.194 0.521 . . . . 0.65 110.463 176.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1533 ' ' SER . . . . . . . . . . . . . 46.8 t -85.25 175.03 9.18 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.329 0.585 . . . . 1.52 110.145 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . 170.33 169.15 33.12 Favored Glycine 0 C--N 1.299 -1.512 0 N-CA-C 109.019 -1.633 . . . . 1.1 109.019 -179.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -92.5 -35.38 13.65 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 117.239 0.519 . . . . 4.62 110.518 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1536 ' ' ALA . . . . . 0.626 ' HA ' ' HG2' ' A' 1557 ' ' GLU . . . -77.35 -35.43 54.65 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 121.376 0.608 . . . . 1.45 109.919 -179.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 91.59 -149.98 20.1 Favored Glycine 0 N--CA 1.42 -2.399 0 CA-C-N 115.274 -0.876 . . . . 0.85 111.78 176.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -137.41 149.32 46.84 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.654 -0.869 . . . . 0.93 108.654 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1539 ' ' THR . . . . . 0.456 ' HA ' ' O ' ' A' 1548 ' ' VAL . 4.0 m -125.08 122.11 36.26 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 109.326 -0.62 . . . . 1.03 109.326 -177.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1540 ' ' ALA . . . . . 0.521 ' HB3' ' CG1' ' A' 1548 ' ' VAL . . . -115.38 150.18 36.77 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 108.113 -1.069 . . . . 0.5 108.113 -178.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -93.35 138.78 31.36 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 121.108 0.48 . . . . 0.74 111.179 -176.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1542 ' ' TYR . . . . . 0.828 ' HE1' ' HG ' ' A' 1626 ' ' LEU . 1.5 t80 -121.77 -101.33 0.41 Allowed 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 107.625 -1.25 . . . . 0.99 107.625 -179.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1543 ' ' SER . . . . . 0.422 ' H ' ' HB3' ' A' 1542 ' ' TYR . 32.8 t -66.8 159.75 27.39 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 107.304 -1.369 . . . . 1.91 107.304 172.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 62.7 mttp -59.38 -37.05 76.93 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-N 119.921 1.237 . . . . 3.59 113.619 -175.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 14.7 t -100.83 15.19 29.25 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 110.104 -0.332 . . . . 2.46 110.104 178.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1546 ' ' GLY . . . . . 0.498 ' HA2' ' OE1' ' A' 1569 ' ' GLN . . . -130.42 147.95 18.44 Favored Glycine 0 CA--C 1.54 1.633 0 C-N-CA 120.03 -1.081 . . . . 1.26 114.092 -174.074 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 22.6 m -136.67 176.94 6.85 Favored 'Isoleucine or valine' 0 C--O 1.252 1.235 0 CA-C-N 117.488 0.644 . . . . 0.79 110.573 -178.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1548 ' ' VAL . . . . . 0.84 ' HB ' ' CE1' ' A' 1567 ' ' PHE . 7.3 p -127.1 136.63 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 CA-C-N 115.034 -0.985 . . . . 0.58 109.913 175.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1549 ' ' TYR . . . . . 0.599 ' HB2' ' HB3' ' A' 1566 ' ' CYS . 62.0 m-85 -101.63 116.04 31.87 Favored 'General case' 0 C--N 1.293 -1.854 0 C-N-CA 124.812 1.245 . . . . 1.08 108.186 177.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 8.6 ptp -125.43 146.39 49.64 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 120.189 -0.604 . . . . 0.78 110.455 175.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 8.2 p -129.46 119.79 24.36 Favored 'General case' 0 C--N 1.281 -2.398 0 CA-C-N 115.763 -0.653 . . . . 0.97 109.579 174.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1552 ' ' ILE . . . . . . . . . . . . . 38.7 mm -81.5 116.97 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.668 0 C-N-CA 120.84 -0.344 . . . . 0.42 110.238 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 64.3 m 69.84 26.94 4.66 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.108 0.963 . . . . 1.4 111.649 175.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . -172.3 -167.67 32.67 Favored Glycine 0 CA--C 1.482 -2.004 0 C-N-CA 120.098 -1.048 . . . . 0.35 111.233 -177.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -107.94 135.79 48.73 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-O 121.165 0.507 . . . . 1.62 111.374 -178.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -78.93 129.2 34.24 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.632 -0.713 . . . . 0.87 109.37 -174.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1557 ' ' GLU . . . . . 0.626 ' HG2' ' HA ' ' A' 1536 ' ' ALA . 5.3 pt-20 -73.33 -12.73 60.93 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.633 0.975 . . . . 2.49 113.633 -174.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 9.7 m120 -89.19 -2.74 58.63 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 120.48 -0.488 . . . . 1.38 110.373 -173.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1559 ' ' CYS . . . . . 0.59 ' SG ' ' HD2' ' A' 1560 ' ' PRO . 34.2 t -135.81 155.82 77.73 Favored Pre-proline 0 C--N 1.308 -1.196 0 N-CA-C 108.255 -1.017 . . . . 1.21 108.255 -175.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1560 ' ' PRO . . . . . 0.59 ' HD2' ' SG ' ' A' 1559 ' ' CYS . 69.1 Cg_exo -29.06 132.83 0.04 OUTLIER 'Trans proline' 0 C--N 1.379 2.134 1 C-N-CA 125.7 4.267 . . . . 0.71 114.73 176.175 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A 1561 ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' 1560 ' ' PRO . 9.6 Cg_endo -48.77 127.62 17.0 Favored 'Trans proline' 0 CA--C 1.547 1.147 0 C-N-CA 124.443 3.428 . . . . 0.8 114.306 -178.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 101.05 1.05 54.79 Favored Glycine 0 CA--C 1.525 0.672 0 CA-C-N 115.589 -0.732 . . . . 0.46 114.78 176.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1563 ' ' VAL . . . . . 0.475 HG11 ' SG ' ' A' 1559 ' ' CYS . 7.7 p -102.26 137.73 29.13 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 C-N-CA 119.626 -0.83 . . . . 0.98 111.18 -175.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -100.05 -31.86 5.79 Favored Glycine 0 CA--C 1.521 0.417 0 CA-C-N 115.526 -0.761 . . . . 0.28 112.681 -178.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -127.53 128.61 45.93 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 108.473 -0.936 . . . . 0.28 108.473 178.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1566 ' ' CYS . . . . . 0.599 ' HB3' ' HB2' ' A' 1549 ' ' TYR . 45.2 t -145.76 124.88 12.86 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 110.376 -0.231 . . . . 0.43 110.376 -176.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1567 ' ' PHE . . . . . 0.84 ' CE1' ' HB ' ' A' 1548 ' ' VAL . 9.7 m-85 -110.51 160.36 16.69 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 122.597 0.359 . . . . 1.03 110.296 175.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . 100.19 156.01 27.92 Favored Glycine 1 N--CA 1.394 -4.159 0 C-N-CA 119.353 -1.403 . . . . 1.13 112.026 171.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1569 ' ' GLN . . . . . 0.498 ' OE1' ' HA2' ' A' 1546 ' ' GLY . 2.3 mp0 -84.92 -23.5 28.83 Favored 'General case' 0 C--N 1.284 -2.272 0 N-CA-C 107.571 -1.27 . . . . 2.58 107.571 179.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 24.3 p -82.65 -11.7 58.18 Favored 'General case' 0 N--CA 1.423 -1.781 0 CA-C-N 115.353 -0.839 . . . . 2.17 111.68 176.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1571 ' ' ARG . . . . . 0.452 ' HG3' ' CE2' ' A' 1549 ' ' TYR . 4.8 mpt_? 73.76 75.21 0.13 Allowed 'General case' 0 CA--C 1.506 -0.726 0 C-N-CA 124.311 1.044 . . . . 2.62 111.251 178.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 61.5 mt -98.46 121.65 49.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 CA-C-N 114.074 -1.421 . . . . 0.92 109.505 -177.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1573 ' ' SER . . . . . 0.452 ' HB3' ' HB3' ' A' 1596 ' ' SER . 17.7 t -65.55 124.79 23.27 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.532 -0.758 . . . . 0.8 110.866 -178.468 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1574 ' ' VAL . . . . . 0.59 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 32.8 m -126.48 20.21 3.51 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-O 121.866 0.841 . . . . 0.98 110.746 178.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 164.23 113.54 0.29 Allowed Glycine 0 N--CA 1.425 -2.034 0 CA-C-N 114.607 -1.179 . . . . 0.29 111.779 177.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 56.7 tttp -72.27 136.12 46.21 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 107.721 -1.214 . . . . 2.19 107.721 178.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -69.04 141.42 54.83 Favored 'General case' 0 C--N 1.314 -0.975 0 O-C-N 123.486 0.491 . . . . 0.61 111.59 -175.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 9.4 p30 -161.32 175.74 11.93 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 105.138 -2.171 . . . . 1.95 105.138 176.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 7.2 ptpp? -132.54 42.88 3.05 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 119.001 0.818 . . . . 2.68 110.951 -173.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 47.2 ttt180 -85.34 76.77 10.08 Favored 'General case' 0 N--CA 1.427 -1.6 0 N-CA-C 108.495 -0.928 . . . . 3.47 108.495 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1581 ' ' LEU . . . . . 0.493 HD12 ' CG2' ' A' 1518 ' ' VAL . 0.4 OUTLIER -70.15 121.36 17.38 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 114.846 -1.07 . . . . 0.64 108.541 179.446 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 58.2 mtp180 -116.03 120.68 39.89 Favored 'General case' 0 C--N 1.287 -2.13 0 C-N-CA 120.611 -0.436 . . . . 2.85 111.31 177.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1583 ' ' TYR . . . . . 0.668 ' HB2' HG21 ' A' 1518 ' ' VAL . 62.1 t80 -94.0 109.43 21.17 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 109.412 -0.588 . . . . 0.86 109.412 175.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1584 ' ' VAL . . . . . 0.535 ' O ' ' HB ' ' A' 1587 ' ' VAL . 11.9 m -128.22 89.57 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-O 121.518 0.675 . . . . 1.05 111.968 -179.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 34.6 t70 53.1 71.54 0.48 Allowed 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 124.359 1.063 . . . . 1.17 112.942 174.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 9.2 pt20 67.74 12.81 9.02 Favored 'General case' 0 N--CA 1.508 2.465 0 C-N-CA 127.46 2.304 . . . . 1.86 111.319 178.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1587 ' ' VAL . . . . . 0.535 ' HB ' ' O ' ' A' 1584 ' ' VAL . 39.5 t -116.86 120.66 65.71 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.152 0 CA-C-N 114.55 -1.204 . . . . 0.49 109.51 177.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1588 ' ' LEU . . . . . 0.886 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 1.8 mm? -100.46 107.81 19.63 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 105.122 -2.177 . . . . 0.36 105.122 176.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -112.89 134.74 54.27 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 112.875 0.694 . . . . 1.74 112.875 -172.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 18.6 mt -124.75 112.49 16.79 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 114.103 -1.408 . . . . 0.72 108.193 175.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 7.0 p -101.58 127.39 54.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-O 121.268 0.556 . . . . 1.01 109.61 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1592 ' ' TYR . . . . . . . . . . . . . 13.4 m-30 -114.46 101.37 9.08 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 109.467 -0.568 . . . . 0.5 109.467 -177.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 15.4 pttp -109.29 -178.16 3.49 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 114.661 -1.154 . . . . 1.59 108.138 -175.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 8.2 m-20 63.82 44.78 4.72 Favored 'General case' 0 C--N 1.319 -0.752 0 O-C-N 124.128 0.892 . . . . 1.11 110.765 179.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -79.44 -166.34 32.05 Favored Glycine 0 N--CA 1.437 -1.236 0 CA-C-N 115.0 -1.0 . . . . 0.78 110.917 176.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1596 ' ' SER . . . . . 0.656 ' HB2' ' HD2' ' A' 1597 ' ' PRO . 79.1 p -86.68 167.53 22.15 Favored Pre-proline 0 C--N 1.297 -1.679 0 C-N-CA 120.209 -0.596 . . . . 1.07 109.842 -177.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1597 ' ' PRO . . . . . 0.656 ' HD2' ' HB2' ' A' 1596 ' ' SER . 12.2 Cg_endo -56.05 120.4 8.21 Favored 'Trans proline' 0 C--N 1.364 1.349 0 C-N-CA 122.592 2.195 . . . . 1.01 111.048 178.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1598 ' ' CYS . . . . . 0.478 ' HA ' ' HD3' ' A' 1599 ' ' PRO . 44.1 t -83.98 123.97 75.09 Favored Pre-proline 0 C--N 1.286 -2.195 0 CA-C-N 114.369 -1.287 . . . . 0.75 110.12 -177.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1599 ' ' PRO . . . . . 0.519 ' HD2' ' OH ' ' A' 1606 ' ' TYR . 3.1 Cg_exo -80.01 2.7 8.22 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 123.551 2.834 . . . . 1.7 112.679 178.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1600 ' ' SER . . . . . 0.436 ' HA ' ' HB3' ' B' ' 53' ' ' LEU . 14.8 m -77.54 -55.98 4.91 Favored 'General case' 0 N--CA 1.42 -1.971 0 N-CA-C 108.465 -0.939 . . . . 2.26 108.465 173.155 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1601 ' ' LYS . . . . . 0.567 ' HE3' HD13 ' A' 1604 ' ' LEU . 16.9 ttpp -119.58 117.18 27.67 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 105.836 -1.913 . . . . 3.01 105.836 173.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 12.9 p -63.14 116.35 5.32 Favored 'General case' 0 N--CA 1.422 -1.868 0 N-CA-C 113.189 0.811 . . . . 2.07 113.189 -170.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 105.47 -6.24 41.73 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 121.313 -0.47 . . . . 1.08 112.229 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1604 ' ' LEU . . . . . 0.595 HD23 ' SG ' ' A' 1634 ' ' CYS . 10.9 tp -91.52 170.45 9.93 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.399 -0.963 . . . . 1.84 108.399 -178.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 15.1 m -126.45 149.75 49.1 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 108.446 -0.946 . . . . 1.41 108.446 -179.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1606 ' ' TYR . . . . . 0.59 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 63.8 m-85 -71.0 158.1 37.09 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 122.679 0.391 . . . . 0.6 111.682 177.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -156.49 125.45 5.98 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 109.346 -0.613 . . . . 1.45 109.346 178.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1608 ' ' SER . . . . . . . . . . . . . 30.4 m -107.93 132.68 53.22 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-N 115.995 -0.548 . . . . 1.15 109.808 -178.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 31.6 t -111.6 108.17 24.8 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 109.261 -0.644 . . . . 0.25 109.261 178.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 75.6 mt -96.31 113.86 31.72 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 N-CA-C 108.917 -0.771 . . . . 0.45 108.917 -178.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 48.9 m -116.02 119.88 37.3 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 115.942 -0.572 . . . . 1.26 111.749 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1612 ' ' PHE . . . . . 0.886 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 74.6 m-85 -98.26 122.16 41.08 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.961 -1.126 . . . . 0.26 107.961 175.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 45.5 t -117.95 137.42 51.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 109.588 -0.523 . . . . 0.5 109.588 -176.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 3.5 t -52.99 112.4 0.85 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.131 0.894 . . . . 0.77 112.275 176.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1615 ' ' ARG . . . . . 0.712 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 27.9 tpt180 -133.13 93.4 22.74 Favored Pre-proline 0 C--N 1.325 -0.468 0 N-CA-C 110.224 -0.287 . . . . 2.53 110.224 174.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1616 ' ' PRO . . . . . 0.592 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 13.1 Cg_exo -70.53 -24.16 26.47 Favored 'Trans proline' 0 CA--C 1.545 1.052 0 C-N-CA 122.063 1.842 . . . . 1.1 112.428 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -85.25 43.49 1.02 Allowed 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 125.151 1.38 . . . . 3.05 110.954 179.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -33.34 117.48 0.29 Allowed 'General case' 0 C--O 1.241 0.638 0 C-N-CA 126.293 1.837 . . . . 1.55 113.2 178.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . -155.79 -135.21 1.96 Allowed Glycine 0 N--CA 1.433 -1.558 0 N-CA-C 109.078 -1.609 . . . . 0.93 109.078 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -81.86 21.09 0.98 Allowed 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.285 1.99 . . . . 0.88 112.523 -179.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1621 ' ' THR . . . . . 0.738 ' HB ' ' HB2' ' A' 1641 ' ' HIS . 46.7 p -99.17 -15.99 18.74 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 114.917 -1.038 . . . . 0.97 109.528 178.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 52.1 t30 -89.89 56.34 3.45 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 122.389 1.09 . . . . 0.72 109.369 -173.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 18.6 ptp180 -157.25 139.54 10.4 Favored Pre-proline 0 N--CA 1.427 -1.595 0 CA-C-N 114.665 -1.152 . . . . 3.26 108.248 -177.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.71 97.16 0.26 Allowed 'Trans proline' 0 C--O 1.238 0.506 0 C-N-CA 122.873 2.382 . . . . 0.59 111.687 -178.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 76.8 mtm -97.44 136.88 37.25 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 116.105 -0.498 . . . . 1.37 110.274 -178.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1626 ' ' LEU . . . . . 0.828 ' HG ' ' HE1' ' A' 1542 ' ' TYR . 0.4 OUTLIER -88.16 112.63 22.94 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 107.397 -1.335 . . . . 0.89 107.397 -179.44 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A 1627 ' ' ILE . . . . . 0.839 HD11 ' HB2' ' A' 1639 ' ' SER . 3.3 mm -72.82 -57.45 7.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 C-N-CA 123.651 0.78 . . . . 0.58 109.908 -177.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 30.6 t -163.42 151.38 13.3 Favored 'General case' 0 N--CA 1.415 -2.18 0 CA-C-N 114.657 -1.156 . . . . 1.39 107.936 -172.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1629 ' ' LEU . . . . . 0.881 HD13 ' HG ' ' A' 1636 ' ' LEU . 35.2 tp -122.44 95.62 4.71 Favored 'General case' 0 N--CA 1.419 -2.022 0 N-CA-C 107.225 -1.398 . . . . 1.25 107.225 178.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 15.8 t70 -75.54 97.44 3.73 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.461 -1.311 . . . . 1.09 107.461 177.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 62.0 mttp -66.83 -22.09 66.01 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 112.857 0.688 . . . . 3.6 112.857 -176.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -72.61 -36.11 68.0 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.556 0.694 . . . . 2.6 109.699 -178.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 69.6 p -102.72 -4.77 24.55 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.682 -0.69 . . . . 0.75 110.821 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1634 ' ' CYS . . . . . 0.595 ' SG ' HD23 ' A' 1604 ' ' LEU . 74.9 m 55.34 37.16 28.49 Favored 'General case' 0 C--N 1.356 0.853 0 C-N-CA 125.231 1.413 . . . . 0.53 111.811 -178.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1635 ' ' THR . . . . . . . . . . . . . 40.0 m -106.43 129.28 54.44 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 115.151 -0.931 . . . . 0.46 109.555 -178.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1636 ' ' LEU . . . . . 0.881 ' HG ' HD13 ' A' 1629 ' ' LEU . 0.3 OUTLIER -111.39 135.88 51.32 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 107.287 -1.375 . . . . 0.86 107.287 -177.663 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -112.19 131.31 55.55 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 120.798 -0.361 . . . . 0.45 111.2 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1638 ' ' PHE . . . . . 0.442 ' CE1' HD23 ' A' 1626 ' ' LEU . 98.4 m-85 -123.23 130.89 53.36 Favored 'General case' 0 C--O 1.243 0.726 0 N-CA-C 108.241 -1.022 . . . . 0.5 108.241 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1639 ' ' SER . . . . . 0.839 ' HB2' HD11 ' A' 1627 ' ' ILE . 11.7 t -115.9 148.47 39.97 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 107.645 -1.243 . . . . 1.04 107.645 178.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 3.2 t90 -152.36 107.82 3.3 Favored 'General case' 0 N--CA 1.414 -2.251 0 N-CA-C 104.984 -2.228 . . . . 0.68 104.984 -179.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1641 ' ' HIS . . . . . 0.738 ' HB2' ' HB ' ' A' 1621 ' ' THR . 17.4 m-70 -102.87 107.93 18.95 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 109.358 -0.608 . . . . 0.9 109.358 -177.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1642 ' ' THR . . . . . . . . . . . . . 7.9 t -140.74 148.06 51.24 Favored Pre-proline 0 C--N 1.301 -1.521 0 CA-C-N 115.049 -0.978 . . . . 0.48 109.731 -171.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1643 ' ' PRO . . . . . 0.592 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 56.9 Cg_endo -80.4 -11.17 13.23 Favored 'Trans proline' 0 C--N 1.365 1.423 0 C-N-CA 122.314 2.009 . . . . 0.66 112.365 178.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1644 ' ' LEU . . . . . 0.611 HD11 ' HB2' ' A' 1531 ' ' SER . 7.4 tt -67.08 -25.82 66.42 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 108.407 -0.96 . . . . 0.97 108.407 176.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -103.09 23.36 12.46 Favored 'General case' 0 N--CA 1.424 -1.746 0 CA-C-N 114.833 -1.076 . . . . 0.84 109.735 -175.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 37.9 t -122.08 146.8 46.85 Favored 'General case' 0 N--CA 1.423 -1.797 0 CA-C-N 115.203 -0.908 . . . . 1.19 109.588 -179.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1647 ' ' GLU . . . . . 0.433 ' OE2' ' OH ' ' A' 1583 ' ' TYR . 0.1 OUTLIER . . . . . 0 C--N 1.295 -1.8 0 N-CA-C 108.25 -1.019 . . . . 3.14 108.25 176.198 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.424 -2.154 0 N-CA-C 110.023 -1.231 . . . . 2.09 110.023 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . 0.446 ' HA2' HG12 ' B' ' 14' ' ' VAL . . . -60.32 -45.17 96.64 Favored Glycine 0 C--O 1.201 -1.934 0 O-C-N 124.06 0.506 . . . . 1.84 113.01 -177.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 44.4 mp0 -61.38 -39.17 89.67 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.781 0.8 . . . . 2.55 111.154 -179.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 13' ' ' LEU . . . . . 0.417 HD21 ' HB3' ' B' ' 46' ' ' CYS . 0.1 OUTLIER -71.26 -40.9 70.7 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.03 -0.986 . . . . 2.35 110.141 -178.818 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . 0.446 HG12 ' HA2' ' B' ' 11' ' ' GLY . 5.1 p -76.83 -32.05 19.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 C-N-CA 120.019 -0.672 . . . . 2.11 110.485 -178.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -68.6 -36.08 78.2 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 116.175 -0.466 . . . . 2.04 111.832 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 11.7 p -69.99 -40.29 75.42 Favored 'General case' 0 C--O 1.262 1.75 0 O-C-N 121.899 -0.501 . . . . 1.84 110.149 177.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.473 ' HB3' ' HB3' ' B' ' 26' ' ' PHE . 3.7 mm? -54.66 -49.88 69.55 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 115.546 -0.752 . . . . 1.74 111.052 172.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -65.97 -33.35 75.63 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.828 -0.624 . . . . 2.39 111.265 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 19' ' ' PHE . . . . . 0.467 ' HE1' ' CD1' ' A' 1567 ' ' PHE . 74.1 t80 -50.63 -57.47 8.16 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 123.038 0.535 . . . . 0.96 111.751 178.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 15.0 p -99.54 -22.4 4.78 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.984 0 C-N-CA 118.389 -1.324 . . . . 1.37 113.298 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 21' ' ' CYS . . . . . 0.441 ' HB2' ' O ' ' B' ' 17' ' ' LEU . 86.2 m -104.85 27.26 8.25 Favored 'General case' 0 C--N 1.316 -0.886 0 O-C-N 121.518 -0.739 . . . . 1.66 112.665 -178.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -53.17 -52.43 40.31 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 121.509 -0.377 . . . . 1.53 114.037 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -74.7 -23.59 58.63 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 113.614 0.968 . . . . 2.72 113.614 -179.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . 0.551 ' HD2' ' SG ' ' B' ' 60' ' ' CYS . 41.5 ttm180 -87.87 -35.45 17.74 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.68 -0.808 . . . . 4.33 110.507 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.83 168.46 23.38 Favored Glycine 0 N--CA 1.423 -2.214 0 N-CA-C 110.279 -1.128 . . . . 1.53 110.279 -178.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . 0.473 ' HB3' ' HB3' ' B' ' 17' ' ' LEU . 3.2 p90 -122.22 138.94 54.31 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 116.954 0.377 . . . . 1.65 110.197 175.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -122.0 -91.15 0.56 Allowed 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 118.876 -0.583 . . . . 3.42 110.133 -177.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 28' ' ' PHE . . . . . . . . . . . . . 51.7 p90 . . . . . 0 N--CA 1.507 2.397 0 N-CA-C 115.752 1.76 . . . . 2.26 115.752 179.592 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . 0.409 ' O ' HG12 ' B' ' 42' ' ' ILE . . . . . . . . 0 CA--C 1.489 -1.594 0 N-CA-C 109.384 -1.486 . . . . 2.37 109.384 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . 0.417 HG22 ' HB3' ' B' ' 55' ' ' LEU . 22.5 pt 62.01 -37.62 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 C-N-CA 127.48 2.312 . . . . 2.07 116.182 175.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.428 ' O ' ' HB2' ' B' ' 47' ' ' CYS . 2.5 p -50.03 -50.31 19.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 114.751 1.389 . . . . 2.24 114.751 -176.043 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -93.74 -27.66 16.37 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.98 -0.748 . . . . 3.36 108.98 -174.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' B' ' 49' ' ' ARG . 41.7 mt-10 -61.2 -56.62 18.62 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.863 -1.062 . . . . 3.08 110.127 178.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 46' ' ' CYS . . . . . 0.438 ' HB2' ' HB3' ' B' ' 51' ' ' CYS . 48.3 t -83.67 -3.91 58.15 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 116.117 -0.492 . . . . 2.23 111.276 -176.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 47' ' ' CYS . . . . . 0.428 ' HB2' ' O ' ' B' ' 43' ' ' VAL . 34.3 t -80.42 -38.87 29.36 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 118.905 -1.118 . . . . 2.37 110.29 176.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -111.55 9.29 21.19 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 112.609 0.596 . . . . 2.82 112.609 -175.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . 0.466 ' HB2' ' O ' ' B' ' 45' ' ' GLU . 63.1 mtp180 -146.88 -177.89 5.9 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 105.874 -1.899 . . . . 4.09 105.874 177.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 11.2 t -106.05 145.32 31.55 Favored 'General case' 0 C--N 1.278 -2.524 0 N-CA-C 106.157 -1.794 . . . . 2.67 106.157 177.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . 0.438 ' HB3' ' HB2' ' B' ' 46' ' ' CYS . 23.4 p -118.17 143.11 46.77 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 110.45 -0.204 . . . . 2.11 110.45 -175.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -94.59 163.15 13.5 Favored 'General case' 0 C--O 1.253 1.248 0 N-CA-C 107.414 -1.328 . . . . 2.67 107.414 173.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . 0.436 ' HB3' ' HA ' ' A' 1600 ' ' SER . 2.6 pt? -66.75 -9.26 34.85 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 120.756 0.313 . . . . 1.9 110.938 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.63 -15.96 44.2 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.167 0.987 . . . . 1.52 110.541 176.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . 0.655 ' O ' ' HB2' ' B' ' 59' ' ' TYR . 49.1 mt -98.56 -55.78 2.64 Favored 'General case' 0 C--O 1.2 -1.545 0 CA-C-O 120.971 0.415 . . . . 1.97 111.404 174.046 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.413 ' HG ' ' HA ' ' B' ' 53' ' ' LEU . 1.7 pp -74.73 -33.28 62.34 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 114.537 1.31 . . . . 1.53 114.537 -170.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -76.85 -32.5 57.57 Favored 'General case' 0 CA--C 1.559 1.293 0 C-N-CA 120.31 -0.556 . . . . 2.27 110.768 178.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 73.9 p -75.37 -50.99 14.22 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 120.844 0.354 . . . . 2.33 111.165 177.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 59' ' ' TYR . . . . . 0.655 ' HB2' ' O ' ' B' ' 55' ' ' LEU . 0.3 OUTLIER -65.17 -64.67 0.81 Allowed 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 108.76 -0.83 . . . . 2.86 108.76 -178.725 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 60' ' ' CYS . . . . . 0.551 ' SG ' ' HD2' ' B' ' 24' ' ' ARG . 43.6 t . . . . . 0 N--CA 1.482 1.174 0 C-N-CA 125.32 1.448 . . . . 2.3 113.441 176.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 50.3 m-20 . . . . . 0 C--O 1.237 0.4 0 N-CA-C 111.799 0.296 . . . . 2.9 111.799 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A 1516 ' ' CYS . . . . . 0.523 ' HA ' ' HB2' ' A' 1581 ' ' LEU . 95.6 m 52.53 50.49 18.11 Favored 'General case' 0 CA--C 1.497 -1.083 0 CA-C-O 121.717 0.77 . . . . 1.19 112.029 -178.141 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1517 ' ' GLN . . . . . 0.414 ' HA ' ' O ' ' A' 1527 ' ' PHE . 4.1 pt20 -150.91 130.35 12.93 Favored 'General case' 0 N--CA 1.407 -2.591 0 CA-C-N 115.049 -0.978 . . . . 1.52 109.76 -176.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1518 ' ' VAL . . . . . 0.517 HG21 ' HB2' ' A' 1583 ' ' TYR . 3.0 m -137.54 142.32 37.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-N 115.274 -0.876 . . . . 0.94 110.18 -178.011 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1519 ' ' THR . . . . . . . . . . . . . 44.3 m -107.17 141.97 37.61 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 116.312 -0.404 . . . . 0.89 111.511 -178.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1520 ' ' ASN . . . . . 0.512 ' OD1' HG22 ' A' 1523 ' ' THR . 6.4 t-20 -89.52 120.78 69.61 Favored Pre-proline 0 N--CA 1.441 -0.915 0 N-CA-C 108.58 -0.896 . . . . 1.74 108.58 173.179 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -62.66 -27.69 76.23 Favored 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 123.22 2.614 . . . . 1.58 113.927 -176.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 15.0 m -68.14 -47.66 67.49 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 112.939 0.718 . . . . 1.65 112.939 -175.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1523 ' ' THR . . . . . 0.512 HG22 ' OD1' ' A' 1520 ' ' ASN . 11.8 t -118.8 2.64 11.63 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 119.785 -0.766 . . . . 1.61 111.833 -173.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 63.42 34.0 88.77 Favored Glycine 0 CA--C 1.504 -0.632 0 CA-C-N 115.749 -0.66 . . . . 1.13 112.007 178.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1525 ' ' HIS . . . . . 0.466 ' HB2' HG23 ' A' 1523 ' ' THR . 32.7 t-80 -94.22 127.27 39.96 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 120.095 -0.642 . . . . 1.26 109.46 -177.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 3.1 tm? -90.88 117.37 29.44 Favored 'General case' 0 C--N 1.289 -2.065 0 CA-C-N 115.019 -0.991 . . . . 0.68 108.956 -177.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1527 ' ' PHE . . . . . 0.414 ' O ' ' HA ' ' A' 1517 ' ' GLN . 39.0 m-85 -95.51 126.07 40.55 Favored 'General case' 0 N--CA 1.432 -1.33 0 C-N-CA 119.749 -0.78 . . . . 0.65 110.577 173.204 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 10.5 t70 -115.92 126.98 54.61 Favored 'General case' 0 C--N 1.309 -1.16 0 O-C-N 123.738 0.649 . . . . 1.17 109.727 175.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1529 ' ' LEU . . . . . 0.551 ' HG ' HD21 ' A' 1581 ' ' LEU . 3.4 mm? -106.9 2.35 25.27 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 120.982 0.42 . . . . 0.6 111.149 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 3.8 m -71.78 -14.28 61.94 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.145 0.497 . . . . 0.84 111.796 -176.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 6.1 p -70.0 -31.62 69.38 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.634 0.73 . . . . 1.59 110.831 179.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 77.5 mt -84.97 7.06 22.53 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.025 -0.989 . . . . 0.65 110.713 -179.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1533 ' ' SER . . . . . 0.443 ' HA ' ' HB ' ' A' 1552 ' ' ILE . 19.7 t -74.97 172.47 12.24 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.683 0.754 . . . . 1.52 111.118 -179.423 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -176.94 141.24 5.31 Favored Glycine 0 N--CA 1.422 -2.24 0 N-CA-C 108.141 -1.984 . . . . 1.1 108.141 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 11.5 tpp180 -92.2 -31.66 15.37 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 120.954 0.407 . . . . 4.62 111.454 -176.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -80.61 -37.36 31.27 Favored 'General case' 0 CA--C 1.502 -0.904 0 N-CA-C 108.164 -1.051 . . . . 1.45 108.164 177.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1537 ' ' GLY . . . . . 0.424 ' HA3' ' ND2' ' A' 1556 ' ' ASN . . . 110.04 -177.37 19.73 Favored Glycine 0 N--CA 1.406 -3.304 0 CA-C-N 114.792 -1.094 . . . . 0.85 111.938 174.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -121.68 142.56 50.03 Favored 'General case' 0 C--N 1.277 -2.571 0 N-CA-C 106.954 -1.499 . . . . 0.93 106.954 178.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 3.3 p -105.33 129.78 53.59 Favored 'General case' 0 C--N 1.292 -1.903 0 O-C-N 123.652 0.595 . . . . 1.03 110.764 179.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1540 ' ' ALA . . . . . 0.466 ' HB3' ' CG1' ' A' 1548 ' ' VAL . . . -121.83 144.56 48.75 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.615 -1.254 . . . . 0.5 107.615 176.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -80.84 126.57 31.5 Favored 'General case' 0 N--CA 1.431 -1.377 0 O-C-N 123.643 0.589 . . . . 0.74 109.545 -176.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1542 ' ' TYR . . . . . 0.538 ' CE1' ' HG ' ' A' 1626 ' ' LEU . 10.6 t80 -131.73 -102.09 0.28 Allowed 'General case' 0 N--CA 1.419 -2.0 0 CA-C-N 115.484 -0.78 . . . . 0.99 109.733 -175.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1543 ' ' SER . . . . . . . . . . . . . 43.1 t -77.57 155.32 31.6 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.651 -0.87 . . . . 1.91 108.651 178.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -55.76 -42.16 75.06 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 119.175 0.898 . . . . 3.59 111.002 178.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 41.8 m -106.24 30.72 5.69 Favored 'General case' 0 N--CA 1.407 -2.609 0 CA-C-O 121.078 0.466 . . . . 2.46 110.795 -176.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . -170.71 113.53 0.5 Allowed Glycine 0 N--CA 1.433 -1.514 0 C-N-CA 119.643 -1.265 . . . . 1.26 113.336 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 30.9 m -94.02 167.52 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 N-CA-C 107.794 -1.187 . . . . 0.79 107.794 175.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1548 ' ' VAL . . . . . 0.466 ' CG1' ' HB3' ' A' 1540 ' ' ALA . 10.9 p -107.7 131.05 58.98 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.178 0 C-N-CA 119.448 -0.901 . . . . 0.58 109.476 178.105 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -97.74 127.19 43.52 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.129 -1.063 . . . . 1.08 108.129 178.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 25.6 ptm -143.82 137.52 28.04 Favored 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 120.377 -0.529 . . . . 0.78 112.005 -178.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 11.2 p -127.7 125.78 40.67 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 115.397 -0.82 . . . . 0.97 109.76 176.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1552 ' ' ILE . . . . . 0.443 ' HB ' ' HA ' ' A' 1533 ' ' SER . 42.4 mm -80.98 116.68 25.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 N-CA-C 109.817 -0.438 . . . . 0.42 109.817 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1553 ' ' CYS . . . . . 0.49 ' SG ' HD11 ' A' 1590 ' ' LEU . 85.6 m 62.59 31.81 16.69 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 112.813 0.672 . . . . 1.4 112.813 173.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . -166.55 175.2 41.98 Favored Glycine 0 N--CA 1.417 -2.591 0 N-CA-C 108.201 -1.96 . . . . 0.35 108.201 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -98.18 148.76 23.26 Favored 'General case' 0 C--N 1.289 -2.049 0 C-N-CA 119.91 -0.716 . . . . 1.62 110.925 -179.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1556 ' ' ASN . . . . . 0.424 ' ND2' ' HA3' ' A' 1537 ' ' GLY . 25.7 t-20 -92.44 125.21 36.99 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 108.384 -0.969 . . . . 0.87 108.384 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -81.07 4.88 18.33 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 114.4 1.259 . . . . 2.49 114.4 -175.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -95.95 -4.21 43.77 Favored 'General case' 0 C--N 1.317 -0.838 0 O-C-N 121.638 -0.664 . . . . 1.38 111.234 -179.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1559 ' ' CYS . . . . . 0.765 ' SG ' ' HD2' ' A' 1560 ' ' PRO . 17.6 t -136.87 162.93 53.06 Favored Pre-proline 0 C--N 1.302 -1.489 0 N-CA-C 106.84 -1.541 . . . . 1.21 106.84 -177.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1560 ' ' PRO . . . . . 0.765 ' HD2' ' SG ' ' A' 1559 ' ' CYS . 45.5 Cg_exo -28.46 128.53 0.04 OUTLIER 'Trans proline' 0 C--N 1.384 2.444 0 C-N-CA 124.982 3.788 . . . . 0.71 115.25 176.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1561 ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' 1560 ' ' PRO . 85.9 Cg_exo -48.96 122.68 8.66 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 124.067 3.178 . . . . 0.8 113.826 -178.314 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 98.94 14.68 35.88 Favored Glycine 0 C--N 1.311 -0.814 0 CA-C-N 115.63 -0.714 . . . . 0.46 114.328 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1563 ' ' VAL . . . . . 0.535 HG21 ' HB2' ' A' 1573 ' ' SER . 9.9 p -104.66 144.43 14.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.885 -0.773 . . . . 0.98 110.662 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -102.39 -33.3 4.57 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 121.213 -0.518 . . . . 0.28 113.033 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -130.15 139.6 50.86 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.79 -0.448 . . . . 0.28 109.79 178.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 45.7 t -159.16 133.23 7.6 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 119.529 -0.272 . . . . 0.43 110.724 -177.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -84.89 139.64 31.72 Favored 'General case' 0 C--O 1.249 1.047 0 N-CA-C 108.458 -0.942 . . . . 1.03 108.458 171.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -82.47 39.43 2.66 Favored Glycine 0 N--CA 1.442 -0.933 0 C-N-CA 121.703 -0.284 . . . . 1.13 113.783 -175.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -76.51 -71.42 0.39 Allowed 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 108.661 -0.866 . . . . 2.58 108.661 174.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 2.9 p -132.52 33.31 3.81 Favored 'General case' 0 C--N 1.308 -1.209 0 C-N-CA 122.935 0.494 . . . . 2.17 110.278 174.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1571 ' ' ARG . . . . . 0.542 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 3.1 mpt_? 61.9 60.08 1.61 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.9 0.857 . . . . 2.62 109.442 -173.072 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 39.9 mt -96.26 101.72 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 107.748 -1.204 . . . . 0.92 107.748 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1573 ' ' SER . . . . . 0.535 ' HB2' HG21 ' A' 1563 ' ' VAL . 94.1 p -63.31 129.39 40.05 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 114.321 -1.309 . . . . 0.8 111.288 -176.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1574 ' ' VAL . . . . . 0.494 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 35.1 m -120.14 16.77 6.47 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-O 121.511 0.672 . . . . 0.98 112.054 -176.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 173.27 118.24 0.49 Allowed Glycine 0 N--CA 1.428 -1.9 0 CA-C-N 115.414 -0.812 . . . . 0.29 111.135 176.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 55.3 tttp -70.42 139.27 51.78 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 107.805 -1.183 . . . . 2.19 107.805 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -68.5 98.79 0.89 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.207 0.447 . . . . 0.61 112.207 -175.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1578 ' ' ASN . . . . . 0.555 ' O ' ' HE1' ' A' 1592 ' ' TYR . 84.5 m-20 -115.67 157.61 23.97 Favored 'General case' 0 C--O 1.206 -1.223 0 N-CA-C 106.926 -1.509 . . . . 1.95 106.926 175.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1579 ' ' LYS . . . . . 0.437 ' HB3' ' SG ' ' A' 1516 ' ' CYS . 28.2 mtmm -122.97 42.07 3.29 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 122.167 0.984 . . . . 2.68 108.512 -178.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 25.9 ttm180 -90.4 76.9 6.64 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 122.257 1.027 . . . . 3.47 109.313 -173.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1581 ' ' LEU . . . . . 0.551 HD21 ' HG ' ' A' 1529 ' ' LEU . 0.3 OUTLIER -65.87 133.02 50.06 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 113.184 -1.825 . . . . 0.64 109.517 -178.518 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A 1582 ' ' ARG . . . . . 0.752 ' HB2' ' HB3' ' A' 1589 ' ' GLN . 94.5 mtt180 -120.52 141.17 50.48 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 109.765 -0.458 . . . . 2.85 109.765 175.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1583 ' ' TYR . . . . . 0.524 ' OH ' ' OE1' ' A' 1647 ' ' GLU . 16.2 t80 -114.94 102.37 9.9 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 109.512 -0.551 . . . . 0.86 109.512 177.155 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1584 ' ' VAL . . . . . 0.556 ' O ' ' HB ' ' A' 1587 ' ' VAL . 27.8 m -123.68 91.15 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.763 -0.653 . . . . 1.05 111.868 -177.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1585 ' ' ASP . . . . . 0.42 ' O ' ' HG2' ' A' 1586 ' ' GLN . 24.0 t70 56.5 62.62 2.24 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.896 0.878 . . . . 1.17 111.576 176.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1586 ' ' GLN . . . . . 0.42 ' HG2' ' O ' ' A' 1585 ' ' ASP . 9.0 pt20 68.89 2.22 3.45 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 127.628 2.371 . . . . 1.86 111.547 178.033 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1587 ' ' VAL . . . . . 0.556 ' HB ' ' O ' ' A' 1584 ' ' VAL . 25.0 t -92.11 123.49 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.116 0 CA-C-N 115.329 -0.85 . . . . 0.49 109.406 175.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1588 ' ' LEU . . . . . 0.671 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 3.6 mm? -99.51 108.25 20.64 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.089 -1.078 . . . . 0.36 108.089 179.17 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1589 ' ' GLN . . . . . 0.752 ' HB3' ' HB2' ' A' 1582 ' ' ARG . 4.0 tp-100 -100.41 133.46 44.8 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 115.233 -0.894 . . . . 1.74 111.376 -174.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1590 ' ' LEU . . . . . 0.49 HD11 ' SG ' ' A' 1553 ' ' CYS . 0.4 OUTLIER -130.94 92.48 3.23 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 105.843 -1.91 . . . . 0.72 105.843 175.066 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 8.3 p -93.77 125.94 46.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 CA-C-O 121.835 0.826 . . . . 1.01 112.906 -174.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1592 ' ' TYR . . . . . 0.555 ' HE1' ' O ' ' A' 1578 ' ' ASN . 17.5 m-30 -112.49 138.26 49.51 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 107.76 -1.2 . . . . 0.5 107.76 176.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 22.7 pttm -148.54 -178.53 6.38 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.082 -1.081 . . . . 1.59 108.082 178.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 11.0 m-20 60.74 50.45 5.48 Favored 'General case' 0 C--O 1.242 0.701 0 O-C-N 124.223 0.952 . . . . 1.11 110.978 176.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -78.35 -112.48 0.19 Allowed Glycine 0 N--CA 1.433 -1.561 0 N-CA-C 110.272 -1.131 . . . . 0.78 110.272 178.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1596 ' ' SER . . . . . . . . . . . . . 56.2 p -124.98 159.69 57.81 Favored Pre-proline 0 C--N 1.274 -2.675 0 N-CA-C 107.691 -1.226 . . . . 1.07 107.691 174.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -54.73 124.75 16.98 Favored 'Trans proline' 0 C--N 1.358 1.028 0 C-N-CA 122.386 2.057 . . . . 1.01 110.339 177.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1598 ' ' CYS . . . . . 0.619 ' HA ' ' CE2' ' A' 1606 ' ' TYR . 21.7 t -58.47 115.96 13.4 Favored Pre-proline 0 C--N 1.308 -1.239 0 N-CA-C 108.775 -0.824 . . . . 0.75 108.775 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1599 ' ' PRO . . . . . 0.663 ' HB2' ' HB ' ' B' ' 16' ' ' THR . 31.8 Cg_exo -60.87 -23.96 78.11 Favored 'Trans proline' 0 C--N 1.361 1.21 0 C-N-CA 123.016 2.477 . . . . 1.7 112.676 -176.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1600 ' ' SER . . . . . 0.63 ' HB3' ' HB3' ' B' ' 53' ' ' LEU . 44.3 m -80.52 -14.66 58.06 Favored 'General case' 0 CA--C 1.566 1.571 0 N-CA-C 113.033 0.753 . . . . 2.26 113.033 177.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1601 ' ' LYS . . . . . 0.45 ' HG3' HD13 ' A' 1604 ' ' LEU . 3.2 tppp? -160.76 116.07 2.21 Favored 'General case' 0 C--O 1.24 0.588 0 O-C-N 121.698 -0.626 . . . . 3.01 110.797 -176.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 38.3 t -69.74 141.95 53.36 Favored 'General case' 0 N--CA 1.416 -2.15 0 N-CA-C 108.457 -0.942 . . . . 2.07 108.457 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 99.26 -17.6 57.68 Favored Glycine 0 C--N 1.3 -1.439 0 C-N-CA 121.222 -0.513 . . . . 1.08 112.72 179.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1604 ' ' LEU . . . . . 0.45 HD13 ' HG3' ' A' 1601 ' ' LYS . 8.9 mp -102.57 145.9 28.93 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 123.212 0.605 . . . . 1.84 110.561 178.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 31.5 t -121.59 153.6 37.85 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 106.757 -1.571 . . . . 1.41 106.757 175.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1606 ' ' TYR . . . . . 0.619 ' CE2' ' HA ' ' A' 1598 ' ' CYS . 49.1 m-85 -78.56 155.07 29.88 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 116.522 -0.308 . . . . 0.6 111.558 178.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1607 ' ' LYS . . . . . 0.415 ' O ' HD22 ' A' 1636 ' ' LEU . 8.0 ptpp? -150.16 145.1 26.09 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 106.943 -1.502 . . . . 1.45 106.943 175.09 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1608 ' ' SER . . . . . . . . . . . . . 17.2 m -120.0 120.91 37.69 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 107.789 -1.189 . . . . 1.15 107.789 -178.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 21.3 t -99.99 103.87 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 CA-C-O 121.118 0.485 . . . . 0.25 109.701 178.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 83.1 mt -96.69 106.27 18.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 C-N-CA 123.845 0.858 . . . . 0.45 109.171 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 14.4 t -106.98 113.94 27.72 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 108.392 -0.966 . . . . 1.26 108.392 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1612 ' ' PHE . . . . . 0.671 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 60.0 m-85 -81.8 121.51 26.52 Favored 'General case' 0 C--O 1.258 1.551 0 N-CA-C 109.477 -0.564 . . . . 0.26 109.477 176.08 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 46.4 t -111.54 129.86 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-N 114.798 -1.092 . . . . 0.5 109.862 -174.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 22.1 t -61.14 110.86 1.5 Allowed 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.112 -0.949 . . . . 0.77 111.884 178.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1615 ' ' ARG . . . . . 0.635 ' HG3' ' HB3' ' A' 1617 ' ' GLU . 32.5 tpt180 -137.48 95.76 11.27 Favored Pre-proline 0 N--CA 1.438 -1.033 0 N-CA-C 109.246 -0.65 . . . . 2.53 109.246 173.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1616 ' ' PRO . . . . . 0.843 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 39.5 Cg_exo -61.45 -21.26 71.43 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 122.86 2.373 . . . . 1.1 113.387 -178.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1617 ' ' GLU . . . . . 0.635 ' HB3' ' HG3' ' A' 1615 ' ' ARG . 38.9 tt0 -49.44 -41.12 39.07 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 125.586 1.554 . . . . 3.05 112.451 176.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . 43.58 81.03 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.527 0.731 . . . . 1.55 112.564 -177.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . -153.45 -134.33 1.98 Allowed Glycine 0 C--N 1.274 -2.907 0 C-N-CA 120.581 -0.819 . . . . 0.93 111.569 -177.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -66.88 1.09 3.01 Favored 'Trans proline' 0 CA--C 1.55 1.298 0 C-N-CA 122.656 2.237 . . . . 0.88 114.465 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1621 ' ' THR . . . . . 0.753 ' HB ' ' HB2' ' A' 1641 ' ' HIS . 2.7 p -98.67 -13.66 20.19 Favored 'General case' 0 N--CA 1.419 -1.979 0 C-N-CA 124.13 0.972 . . . . 0.97 109.727 178.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 53.0 t30 -86.03 69.2 10.5 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.956 -1.02 . . . . 0.72 108.566 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1623 ' ' ARG . . . . . 0.472 ' O ' ' HG3' ' A' 1625 ' ' MET . 11.5 ptp180 -166.23 140.63 3.62 Favored Pre-proline 0 C--N 1.296 -1.744 0 N-CA-C 107.537 -1.283 . . . . 3.26 107.537 -178.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -58.07 104.71 0.18 Allowed 'Trans proline' 0 C--O 1.238 0.515 0 C-N-CA 122.92 2.413 . . . . 0.59 110.885 178.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1625 ' ' MET . . . . . 0.472 ' HG3' ' O ' ' A' 1623 ' ' ARG . 94.2 mtp -98.75 131.27 45.02 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.476 -0.935 . . . . 1.37 108.476 -176.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1626 ' ' LEU . . . . . 0.538 ' HG ' ' CE1' ' A' 1542 ' ' TYR . 1.0 OUTLIER -86.82 111.86 21.17 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 106.938 -1.505 . . . . 0.89 106.938 -178.031 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A 1627 ' ' ILE . . . . . 0.564 HD11 ' HB2' ' A' 1639 ' ' SER . 37.8 mm -73.07 -56.89 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.883 0 N-CA-C 108.902 -0.777 . . . . 0.58 108.902 -178.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 23.8 t -171.88 162.21 6.01 Favored 'General case' 0 N--CA 1.417 -2.124 0 N-CA-C 107.839 -1.171 . . . . 1.39 107.839 -175.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1629 ' ' LEU . . . . . 0.495 HD13 ' CD1' ' A' 1636 ' ' LEU . 5.7 tp -112.11 109.2 18.78 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 107.731 -1.211 . . . . 1.25 107.731 175.112 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1630 ' ' ASP . . . . . 0.533 ' HB3' ' HB ' ' A' 1635 ' ' THR . 13.4 t70 -75.02 85.91 2.31 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 106.16 -1.793 . . . . 1.09 106.16 173.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1631 ' ' LYS . . . . . 0.477 ' HG3' HD13 ' B' ' 53' ' ' LEU . 21.6 tptm -64.65 -19.8 65.92 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 114.229 -1.351 . . . . 3.6 112.702 -173.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1632 ' ' GLN . . . . . 0.41 HE21 ' HB3' ' A' 1632 ' ' GLN . 3.2 mt-30 -76.19 -31.67 58.6 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 119.599 -0.841 . . . . 2.6 110.376 -176.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 59.6 p -107.26 -10.46 15.81 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 116.116 -0.493 . . . . 0.75 111.631 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 65.9 m 67.23 49.26 1.09 Allowed 'General case' 0 C--N 1.36 1.054 0 CA-C-O 122.76 1.267 . . . . 0.53 109.975 -178.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1635 ' ' THR . . . . . 0.533 ' HB ' ' HB3' ' A' 1630 ' ' ASP . 93.3 m -109.87 130.0 55.58 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 113.854 -1.521 . . . . 0.46 109.088 -177.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1636 ' ' LEU . . . . . 0.495 ' CD1' HD13 ' A' 1629 ' ' LEU . 0.2 OUTLIER -105.68 135.82 46.39 Favored 'General case' 0 CA--C 1.504 -0.802 0 N-CA-C 108.009 -1.108 . . . . 0.86 108.009 177.68 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -109.37 125.59 52.53 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 109.556 -0.535 . . . . 0.45 109.556 177.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -125.11 136.89 54.07 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.307 -0.627 . . . . 0.5 109.307 -178.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1639 ' ' SER . . . . . 0.564 ' HB2' HD11 ' A' 1627 ' ' ILE . 33.1 t -116.8 154.87 29.94 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 107.285 -1.376 . . . . 1.04 107.285 175.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 2.7 t90 -150.38 108.21 3.7 Favored 'General case' 0 N--CA 1.417 -2.087 0 N-CA-C 104.882 -2.266 . . . . 0.68 104.882 178.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1641 ' ' HIS . . . . . 0.753 ' HB2' ' HB ' ' A' 1621 ' ' THR . 51.2 m-70 -95.06 104.63 16.51 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 121.281 0.562 . . . . 0.9 109.941 -175.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1642 ' ' THR . . . . . . . . . . . . . 8.6 t -142.38 148.99 49.72 Favored Pre-proline 0 C--N 1.3 -1.584 0 CA-C-N 115.67 -0.696 . . . . 0.48 109.674 -173.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1643 ' ' PRO . . . . . 0.843 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 77.7 Cg_endo -78.87 -6.41 15.12 Favored 'Trans proline' 0 C--N 1.369 1.626 0 C-N-CA 122.483 2.122 . . . . 0.66 112.586 179.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 8.2 tt -70.21 -25.35 63.36 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.1 -0.704 . . . . 0.97 109.1 178.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -95.29 17.12 14.98 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.962 -1.017 . . . . 0.84 110.342 -178.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1646 ' ' CYS . . . . . 0.538 ' SG ' ' HA ' ' A' 1643 ' ' PRO . 95.7 m -96.28 145.59 25.45 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 109.716 -0.476 . . . . 1.19 109.716 177.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1647 ' ' GLU . . . . . 0.524 ' OE1' ' OH ' ' A' 1583 ' ' TYR . 35.4 tt0 . . . . . 0 C--N 1.297 -1.684 0 N-CA-C 108.654 -0.869 . . . . 3.14 108.654 -177.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . 0.499 ' O ' HG12 ' B' ' 14' ' ' VAL . . . . . . . . 0 N--CA 1.417 -2.593 0 CA-C-O 119.087 -0.841 . . . . 2.09 112.708 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -44.79 -74.67 0.2 Allowed Glycine 0 N--CA 1.473 1.153 0 N-CA-C 115.626 1.011 . . . . 1.84 115.626 -170.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -75.0 -17.14 60.57 Favored 'General case' 0 C--N 1.314 -0.966 0 O-C-N 122.317 -0.519 . . . . 2.55 111.578 -179.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 13' ' ' LEU . . . . . 0.472 ' O ' HD23 ' B' ' 17' ' ' LEU . 36.7 tp -71.98 -53.73 12.1 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-O 120.884 0.373 . . . . 2.35 110.284 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . 0.499 HG12 ' O ' ' B' ' 10' ' ' GLY . 13.7 p -70.64 -23.54 24.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-O 121.5 0.667 . . . . 2.11 109.796 -179.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -72.49 -42.43 64.87 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.815 -0.629 . . . . 2.04 111.233 175.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . 0.663 ' HB ' ' HB2' ' A' 1599 ' ' PRO . 15.1 t -67.43 -30.14 69.81 Favored 'General case' 0 C--O 1.248 1.005 0 CA-C-N 118.674 0.67 . . . . 1.84 110.727 176.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.472 HD23 ' O ' ' B' ' 13' ' ' LEU . 3.3 mm? -51.97 -51.69 55.48 Favored 'General case' 0 C--O 1.212 -0.918 0 O-C-N 123.637 0.586 . . . . 1.74 109.89 168.077 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.69 -33.69 69.01 Favored 'General case' 0 C--O 1.214 -0.793 0 CA-C-N 116.014 -0.539 . . . . 2.39 110.213 -178.417 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -47.97 -64.09 0.89 Allowed 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 113.084 0.772 . . . . 0.96 113.084 177.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 10.1 p -91.93 -14.52 8.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 C-N-CA 118.588 -1.245 . . . . 1.37 111.62 -176.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 21' ' ' CYS . . . . . 0.577 ' HB2' ' HB3' ' B' ' 26' ' ' PHE . 61.9 m -106.95 17.51 23.0 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 119.806 -0.758 . . . . 1.66 112.659 -178.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -53.01 -44.14 62.03 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 121.226 -0.512 . . . . 1.53 112.43 174.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -82.22 -52.5 6.9 Favored 'General case' 0 C--N 1.314 -0.937 0 O-C-N 122.627 -0.337 . . . . 2.72 111.718 178.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 44.9 ttp180 -69.09 -29.04 67.06 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.38 0.882 . . . . 4.33 113.38 -175.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.09 133.03 7.14 Favored Glycine 0 N--CA 1.435 -1.37 0 N-CA-C 109.826 -1.309 . . . . 1.53 109.826 -177.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . 0.577 ' HB3' ' HB2' ' B' ' 21' ' ' CYS . 22.9 p90 -107.68 112.98 25.94 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 117.448 0.624 . . . . 1.65 110.235 -179.028 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -135.74 133.77 38.35 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.149 -1.056 . . . . 3.42 108.149 -177.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 28' ' ' PHE . . . . . 0.433 ' HA ' ' HE1' ' B' ' 59' ' ' TYR . 18.0 p90 . . . . . 0 C--N 1.315 -0.895 0 O-C-N 123.293 0.371 . . . . 2.26 111.501 -178.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.414 -2.789 0 N-CA-C 110.685 -0.966 . . . . 2.37 110.685 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . 0.291 17.5 pt 65.55 -36.22 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 128.318 2.647 . . . . 2.07 115.12 175.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 2.5 p -52.27 -41.02 32.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 123.532 0.733 . . . . 2.24 112.926 178.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -87.81 -47.43 8.61 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 109.368 -0.604 . . . . 3.36 109.368 -176.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -54.49 -44.5 72.73 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 114.985 -1.007 . . . . 3.08 111.676 -179.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 46' ' ' CYS . . . . . . . . . . . . . 22.9 t -86.22 -15.68 40.1 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.029 0.442 . . . . 2.23 111.246 -176.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 49.5 t -75.17 -37.97 61.06 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.235 0.54 . . . . 2.37 110.991 178.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -105.75 -12.79 15.76 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 113.766 1.024 . . . . 2.82 113.766 -177.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 56.6 mtm180 -138.61 158.24 44.62 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.703 -0.851 . . . . 4.09 108.703 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 16.0 t -80.27 114.91 19.51 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.782 -0.822 . . . . 2.67 108.782 -177.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 32.0 p -89.42 143.61 26.69 Favored 'General case' 0 N--CA 1.421 -1.904 0 N-CA-C 108.247 -1.02 . . . . 2.11 108.247 -176.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -92.81 150.03 20.89 Favored 'General case' 0 N--CA 1.421 -1.884 0 N-CA-C 107.322 -1.362 . . . . 2.67 107.322 174.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . 0.63 ' HB3' ' HB3' ' A' 1600 ' ' SER . 3.9 pp -70.35 -9.16 55.4 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 113.199 0.814 . . . . 1.9 113.199 -171.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.24 -33.67 65.44 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.313 -0.995 . . . . 1.52 108.313 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 54.0 tp -60.67 -49.34 77.93 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-N 114.851 -1.068 . . . . 1.97 109.293 177.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 3.3 pp -73.83 -29.27 62.04 Favored 'General case' 0 N--CA 1.412 -2.353 0 C-N-CA 120.295 -0.562 . . . . 1.53 111.584 -176.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -63.98 -52.77 58.09 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.059 0.457 . . . . 2.27 110.929 -179.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 13.6 t -77.61 -23.07 49.94 Favored 'General case' 0 CA--C 1.557 1.214 0 CA-C-N 116.039 -0.528 . . . . 2.33 111.958 -177.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 59' ' ' TYR . . . . . 0.433 ' HE1' ' HA ' ' B' ' 28' ' ' PHE . 10.2 t80 -81.67 -34.4 30.73 Favored 'General case' 0 C--O 1.243 0.732 0 N-CA-C 108.817 -0.808 . . . . 2.86 108.817 179.227 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 9.6 t . . . . . 0 C--O 1.248 1.018 0 CA-C-N 115.269 -0.878 . . . . 2.3 111.733 -178.234 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 25.3 t70 . . . . . 0 CA--C 1.544 0.727 0 CA-C-O 121.96 0.886 . . . . 2.9 109.759 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A 1516 ' ' CYS . . . . . 0.646 ' HA ' ' HB2' ' A' 1581 ' ' LEU . 69.2 m 59.05 49.57 9.28 Favored 'General case' 0 C--O 1.246 0.884 0 N-CA-C 114.393 1.257 . . . . 1.19 114.393 -179.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -156.45 134.66 11.32 Favored 'General case' 0 N--CA 1.427 -1.599 0 CA-C-N 115.22 -0.9 . . . . 1.52 110.819 175.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1518 ' ' VAL . . . . . 0.643 HG21 ' HB2' ' A' 1583 ' ' TYR . 5.6 m -141.21 145.25 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 C-N-CA 124.411 1.085 . . . . 0.94 109.892 -178.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1519 ' ' THR . . . . . 0.42 ' OG1' HD23 ' A' 1526 ' ' LEU . 25.8 m -114.89 137.1 52.37 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 109.239 -0.652 . . . . 0.89 109.239 177.253 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1520 ' ' ASN . . . . . 0.529 ' OD1' HG22 ' A' 1523 ' ' THR . 26.8 t-20 -91.36 110.75 44.92 Favored Pre-proline 0 C--N 1.3 -1.556 0 N-CA-C 108.088 -1.078 . . . . 1.74 108.088 173.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -65.32 -19.08 61.86 Favored 'Trans proline' 0 N--CA 1.478 0.601 0 C-N-CA 123.464 2.776 . . . . 1.58 113.246 -173.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1522 ' ' SER . . . . . 0.465 ' HB2' ' OD1' ' A' 1520 ' ' ASN . 18.0 m -70.08 -44.58 68.79 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-N 115.849 -0.614 . . . . 1.65 111.259 -178.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1523 ' ' THR . . . . . 0.529 HG22 ' OD1' ' A' 1520 ' ' ASN . 9.6 t -119.01 6.86 11.33 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.54 0.686 . . . . 1.61 111.067 -175.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 57.83 36.02 77.88 Favored Glycine 0 CA--C 1.511 -0.199 0 CA-C-N 115.104 -0.953 . . . . 1.13 113.798 177.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 13.0 t-160 -100.72 122.14 42.86 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 120.537 -0.465 . . . . 1.26 110.578 -179.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1526 ' ' LEU . . . . . 0.42 HD23 ' OG1' ' A' 1519 ' ' THR . 2.2 tm? -96.92 114.61 26.25 Favored 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 124.76 1.224 . . . . 0.68 109.522 -179.149 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -91.24 115.28 27.9 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 116.777 -0.192 . . . . 0.65 111.167 176.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 6.3 t70 -101.74 115.02 29.62 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 108.094 -1.076 . . . . 1.17 108.094 174.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1529 ' ' LEU . . . . . 0.432 ' HB2' ' HB3' ' A' 1516 ' ' CYS . 3.6 mm? -101.07 4.17 42.0 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.346 0.593 . . . . 0.6 110.129 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1530 ' ' SER . . . . . 0.427 ' HA ' ' OG ' ' A' 1533 ' ' SER . 1.2 m -67.01 -30.19 70.22 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.16 -0.927 . . . . 0.84 109.011 179.174 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 30.9 m -61.38 -27.76 68.75 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 114.962 -1.017 . . . . 1.59 111.008 178.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 83.1 mt -99.09 -1.08 40.43 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 120.696 0.284 . . . . 0.65 110.819 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1533 ' ' SER . . . . . 0.427 ' OG ' ' HA ' ' A' 1530 ' ' SER . 19.6 m -75.0 158.92 32.44 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 120.736 0.303 . . . . 1.52 110.877 -177.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . 176.71 146.48 6.09 Favored Glycine 0 N--CA 1.443 -0.833 0 N-CA-C 110.867 -0.893 . . . . 1.1 110.867 -179.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1535 ' ' ARG . . . . . 0.401 ' O ' ' HA ' ' A' 1556 ' ' ASN . 36.8 ttm180 -92.62 -29.07 16.32 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 123.205 0.602 . . . . 4.62 111.036 -177.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -75.83 -38.89 57.64 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.864 0.84 . . . . 1.45 108.986 177.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 94.87 -165.52 25.66 Favored Glycine 0 N--CA 1.422 -2.283 0 CA-C-N 114.939 -1.028 . . . . 0.85 114.081 172.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -128.34 153.69 46.75 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 107.267 -1.383 . . . . 0.93 107.267 -178.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 3.0 p -112.56 136.11 52.48 Favored 'General case' 0 C--N 1.31 -1.149 0 O-C-N 123.539 0.525 . . . . 1.03 111.388 -177.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1540 ' ' ALA . . . . . 0.41 ' HB3' ' CG1' ' A' 1548 ' ' VAL . . . -128.22 148.62 50.63 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.517 -0.92 . . . . 0.5 108.517 175.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -82.4 135.86 35.08 Favored 'General case' 0 C--N 1.315 -0.9 0 O-C-N 123.556 0.535 . . . . 0.74 111.494 -176.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1542 ' ' TYR . . . . . 0.517 ' HB3' ' H ' ' A' 1543 ' ' SER . 2.4 t80 -134.11 -101.32 0.24 Allowed 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 115.628 -0.714 . . . . 0.99 109.434 179.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1543 ' ' SER . . . . . 0.517 ' H ' ' HB3' ' A' 1542 ' ' TYR . 39.8 t -72.32 160.42 32.4 Favored 'General case' 0 C--O 1.246 0.92 0 CA-C-N 115.907 -0.588 . . . . 1.91 110.569 -178.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1544 ' ' LYS . . . . . 0.44 ' HE2' ' HA ' ' B' ' 23' ' ' ASP . 24.3 ttmm -53.61 -40.3 65.64 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.958 0.409 . . . . 3.59 111.634 -178.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 45.6 m -104.32 12.02 34.07 Favored 'General case' 0 N--CA 1.413 -2.294 0 N-CA-C 112.42 0.526 . . . . 2.46 112.42 -174.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . -155.42 147.69 16.92 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 117.822 -2.132 . . . . 1.26 115.683 -173.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 35.1 m -113.0 172.94 2.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 108.557 -0.905 . . . . 0.79 108.557 178.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1548 ' ' VAL . . . . . 0.502 ' HA ' ' HA ' ' A' 1567 ' ' PHE . 14.9 p -115.69 141.39 33.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 109.125 -0.694 . . . . 0.58 109.125 176.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -103.74 129.5 51.12 Favored 'General case' 0 CA--C 1.491 -1.327 0 N-CA-C 109.32 -0.622 . . . . 1.08 109.32 176.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 23.1 ptm -139.66 128.62 23.54 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 115.435 -0.802 . . . . 0.78 110.494 -179.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1551 ' ' SER . . . . . 0.452 ' HB3' HD22 ' A' 1556 ' ' ASN . 15.4 p -112.12 131.46 55.44 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 115.773 -0.649 . . . . 0.97 109.721 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1552 ' ' ILE . . . . . . . . . . . . . 46.9 mm -91.0 121.11 41.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 N-CA-C 109.529 -0.545 . . . . 0.42 109.529 -178.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1553 ' ' CYS . . . . . 0.47 ' O ' ' HE2' ' A' 1579 ' ' LYS . 72.7 m 60.33 42.84 14.32 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 121.73 0.776 . . . . 1.4 112.058 175.077 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 177.64 171.88 41.56 Favored Glycine 0 N--CA 1.417 -2.62 0 N-CA-C 110.312 -1.115 . . . . 0.35 110.312 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -87.33 153.45 21.45 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 109.441 -0.577 . . . . 1.62 109.441 179.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1556 ' ' ASN . . . . . 0.452 HD22 ' HB3' ' A' 1551 ' ' SER . 18.4 t-20 -102.06 120.98 41.3 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 108.815 -0.809 . . . . 0.87 108.815 -177.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -78.87 13.85 1.57 Allowed 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 113.549 0.944 . . . . 2.49 113.549 -174.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 54.6 m-80 -96.08 -12.54 24.69 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 120.214 -0.595 . . . . 1.38 110.368 177.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1559 ' ' CYS . . . . . 0.748 ' SG ' ' HD2' ' A' 1560 ' ' PRO . 3.8 t -136.77 164.09 44.95 Favored Pre-proline 0 C--N 1.307 -1.253 0 CA-C-O 117.154 -1.403 . . . . 1.21 107.555 -175.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1560 ' ' PRO . . . . . 0.748 ' HD2' ' SG ' ' A' 1559 ' ' CYS . 37.9 Cg_exo -28.5 140.96 0.02 OUTLIER 'Trans proline' 0 C--N 1.381 2.249 1 C-N-CA 125.549 4.166 . . . . 0.71 116.341 177.657 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A 1561 ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' 1560 ' ' PRO . 73.9 Cg_exo -53.04 127.4 24.86 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 124.017 3.144 . . . . 0.8 114.194 -177.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 93.58 7.05 62.01 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-N 115.755 -0.657 . . . . 0.46 114.345 177.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1563 ' ' VAL . . . . . 0.614 HG11 ' HB3' ' A' 1559 ' ' CYS . 5.5 p -99.3 141.98 15.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 O-C-N 121.929 -0.748 . . . . 0.98 110.401 -179.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -104.68 -28.71 5.58 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-N 116.339 -0.391 . . . . 0.28 112.99 178.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -130.56 131.78 45.21 Favored 'General case' 0 C--O 1.245 0.827 0 O-C-N 122.294 -0.533 . . . . 0.28 110.794 179.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 44.3 t -159.81 141.32 12.81 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.785 -0.82 . . . . 0.43 108.785 -178.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1567 ' ' PHE . . . . . 0.52 ' HB2' ' OG1' ' A' 1570 ' ' THR . 93.9 m-85 -86.91 146.51 26.15 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.776 -0.824 . . . . 1.03 108.776 178.211 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -68.71 -20.67 74.34 Favored Glycine 0 C--O 1.222 -0.625 0 N-CA-C 115.269 0.868 . . . . 1.13 115.269 -172.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 35.7 mm-40 -96.8 -30.68 13.03 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 117.535 0.667 . . . . 2.58 112.048 176.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1570 ' ' THR . . . . . 0.521 ' HA ' ' OD2' ' B' ' 15' ' ' ASP . 46.8 p -81.92 -32.0 31.07 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 115.236 1.569 . . . . 2.17 115.236 -163.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 69.78 -2.63 1.93 Allowed 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.984 0.914 . . . . 2.62 109.993 -172.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 28.5 mt -86.32 132.73 31.47 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 CA-C-O 121.473 0.654 . . . . 0.92 110.834 -171.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 17.6 t -78.65 116.53 19.07 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 114.446 -1.252 . . . . 0.8 109.589 179.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1574 ' ' VAL . . . . . 0.567 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 23.2 m -114.22 8.36 7.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-O 121.316 0.579 . . . . 0.98 111.437 -178.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . -174.45 112.63 0.42 Allowed Glycine 0 N--CA 1.428 -1.898 0 C-N-CA 120.35 -0.929 . . . . 0.29 111.527 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1576 ' ' LYS . . . . . 0.442 ' HB3' ' O ' ' A' 1593 ' ' LYS . 87.0 tttt -71.07 134.67 47.24 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.406 -0.961 . . . . 2.19 108.406 177.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -68.11 131.35 45.26 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-O 120.942 0.401 . . . . 0.61 110.465 -178.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -150.16 165.26 33.41 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 104.394 -2.447 . . . . 1.95 104.394 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1579 ' ' LYS . . . . . 0.47 ' HE2' ' O ' ' A' 1553 ' ' CYS . 97.4 mttt -130.83 40.1 3.52 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 108.675 -0.861 . . . . 2.68 108.675 -178.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -92.99 76.63 4.72 Favored 'General case' 0 N--CA 1.418 -2.073 0 CA-C-O 122.181 0.991 . . . . 3.47 109.893 -171.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1581 ' ' LEU . . . . . 0.646 ' HB2' ' HA ' ' A' 1516 ' ' CYS . 1.0 OUTLIER -63.71 125.93 25.92 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 113.18 -1.827 . . . . 0.64 109.173 178.856 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A 1582 ' ' ARG . . . . . 0.417 ' N ' HD13 ' A' 1581 ' ' LEU . 78.3 mtp180 -125.28 139.99 53.22 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 115.919 -0.582 . . . . 2.85 109.719 175.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1583 ' ' TYR . . . . . 0.643 ' HB2' HG21 ' A' 1518 ' ' VAL . 64.6 t80 -112.52 110.73 21.08 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 108.757 -0.831 . . . . 0.86 108.757 -178.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1584 ' ' VAL . . . . . 0.519 ' O ' ' HB ' ' A' 1587 ' ' VAL . 10.9 m -122.52 88.99 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-O 121.36 0.6 . . . . 1.05 112.142 -178.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 38.6 t70 55.13 65.09 1.59 Allowed 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 115.09 -0.959 . . . . 1.17 111.083 178.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1586 ' ' GLN . . . . . 0.586 ' HA ' ' CE1' ' A' 1583 ' ' TYR 0.291 11.6 pt20 64.69 15.37 9.7 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 126.826 2.05 . . . . 1.86 112.631 177.562 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A 1587 ' ' VAL . . . . . 0.519 ' HB ' ' O ' ' A' 1584 ' ' VAL . 41.9 t -110.63 121.28 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.338 0 CA-C-N 114.219 -1.355 . . . . 0.49 108.265 175.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1588 ' ' LEU . . . . . 0.834 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 2.6 mm? -95.83 114.65 26.4 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 106.688 -1.597 . . . . 0.36 106.688 179.054 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -126.77 125.19 41.33 Favored 'General case' 0 C--N 1.289 -2.031 0 C-N-CA 119.177 -1.009 . . . . 1.74 112.674 -175.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1590 ' ' LEU . . . . . 0.457 ' HB2' ' HB ' ' A' 1610 ' ' ILE . 19.1 mt -107.88 126.76 53.05 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 113.993 -1.458 . . . . 0.72 107.178 175.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 48.5 t -115.47 122.04 68.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 C-N-CA 119.879 -0.728 . . . . 1.01 109.893 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1592 ' ' TYR . . . . . 0.4 ' O ' ' HA ' ' A' 1607 ' ' LYS . 15.7 m-30 -105.49 94.74 5.37 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.932 -1.136 . . . . 0.5 107.932 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1593 ' ' LYS . . . . . 0.442 ' O ' ' HB3' ' A' 1576 ' ' LYS . 49.6 pttt -105.07 172.46 6.78 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 115.997 -0.547 . . . . 1.59 109.672 -176.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 70.1 m-20 57.11 52.79 8.6 Favored 'General case' 0 CA--C 1.51 -0.568 0 O-C-N 124.502 1.126 . . . . 1.11 111.554 178.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -71.88 -113.18 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 110.364 -1.095 . . . . 0.78 110.364 176.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1596 ' ' SER . . . . . 0.641 ' HB3' ' HD2' ' A' 1597 ' ' PRO . 72.2 m -133.43 168.68 16.72 Favored Pre-proline 0 C--N 1.284 -2.262 0 O-C-N 121.317 -1.108 . . . . 1.07 111.155 172.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1597 ' ' PRO . . . . . 0.641 ' HD2' ' HB3' ' A' 1596 ' ' SER . 2.5 Cg_endo -40.28 127.1 2.14 Favored 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 124.118 3.212 . . . . 1.01 114.058 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1598 ' ' CYS . . . . . 0.515 ' SG ' ' HB2' ' A' 1600 ' ' SER . 48.3 t -92.14 123.15 63.5 Favored Pre-proline 0 C--N 1.287 -2.124 0 CA-C-N 114.526 -1.215 . . . . 0.75 109.825 -179.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1599 ' ' PRO . . . . . 0.465 ' O ' ' HA ' ' B' ' 52' ' ' ASP . 17.2 Cg_exo -71.48 -27.99 18.33 Favored 'Trans proline' 0 C--O 1.211 -0.87 0 C-N-CA 122.206 1.937 . . . . 1.7 111.158 174.271 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1600 ' ' SER . . . . . 0.898 ' HA ' ' HB2' ' B' ' 53' ' ' LEU . 7.4 m -61.07 -47.16 87.64 Favored 'General case' 0 CA--C 1.555 1.145 0 CA-C-N 116.358 -0.383 . . . . 2.26 110.667 178.096 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1601 ' ' LYS . . . . . . . . . . . . . 5.4 tppp? -126.31 111.14 14.18 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 107.407 -1.331 . . . . 3.01 107.407 174.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 35.2 t -71.27 122.13 19.7 Favored 'General case' 0 N--CA 1.419 -2.001 0 C-N-CA 122.469 0.308 . . . . 2.07 110.223 -171.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 104.76 -10.15 48.57 Favored Glycine 0 N--CA 1.441 -1.032 0 N-CA-C 111.472 -0.651 . . . . 1.08 111.472 179.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1604 ' ' LEU . . . . . 0.483 HD23 ' SG ' ' A' 1634 ' ' CYS . 9.2 tp -101.09 168.63 9.47 Favored 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 107.832 -1.173 . . . . 1.84 107.832 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 20.2 m -129.64 146.93 51.39 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 109.117 -0.697 . . . . 1.41 109.117 178.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1606 ' ' TYR . . . . . 0.609 ' HD1' HD11 ' A' 1636 ' ' LEU . 67.0 m-85 -64.64 162.69 15.2 Favored 'General case' 0 C--O 1.251 1.182 0 N-CA-C 113.213 0.82 . . . . 0.6 113.213 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1607 ' ' LYS . . . . . 0.521 ' HE3' HG23 ' A' 1635 ' ' THR . 33.3 ttpt -158.54 130.78 6.86 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.067 -0.969 . . . . 1.45 109.194 -177.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1608 ' ' SER . . . . . . . . . . . . . 19.9 m -107.34 130.18 54.82 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 109.48 -0.563 . . . . 1.15 109.48 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 39.0 t -110.63 109.19 27.55 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 N-CA-C 108.687 -0.857 . . . . 0.25 108.687 178.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1610 ' ' ILE . . . . . 0.457 ' HB ' ' HB2' ' A' 1590 ' ' LEU . 62.1 mt -101.18 110.16 27.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 115.762 -0.654 . . . . 0.45 109.632 -177.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 27.9 t -111.59 115.09 28.58 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 115.61 -0.723 . . . . 1.26 110.361 -178.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1612 ' ' PHE . . . . . 0.834 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 71.9 m-85 -89.53 122.74 32.98 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 107.96 -1.126 . . . . 0.26 107.96 175.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1613 ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' 1641 ' ' HIS . 43.9 t -116.19 138.72 45.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 109.333 -0.617 . . . . 0.5 109.333 -176.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 40.5 t -66.77 119.02 11.13 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 123.998 0.919 . . . . 0.77 111.252 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1615 ' ' ARG . . . . . 0.83 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 20.2 tpt180 -122.16 96.72 46.21 Favored Pre-proline 0 N--CA 1.446 -0.663 0 N-CA-C 109.856 -0.424 . . . . 2.53 109.856 176.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1616 ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -66.6 -40.48 13.44 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.251 1.967 . . . . 1.1 110.607 176.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -80.6 43.28 0.65 Allowed 'General case' 0 C--O 1.241 0.647 0 C-N-CA 124.3 1.04 . . . . 3.05 111.272 176.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1618 ' ' ALA . . . . . 0.632 ' HB2' ' HG3' ' A' 1643 ' ' PRO . . . -39.51 124.68 1.65 Allowed 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 125.617 1.567 . . . . 1.55 113.166 -178.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1619 ' ' GLY . . . . . 0.447 ' C ' ' H ' ' A' 1621 ' ' THR . . . -154.63 -140.37 3.01 Favored Glycine 0 N--CA 1.43 -1.734 0 N-CA-C 108.431 -1.868 . . . . 0.93 108.431 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.36 20.14 0.36 Allowed 'Trans proline' 0 N--CA 1.486 1.062 0 C-N-CA 122.904 2.402 . . . . 0.88 112.827 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1621 ' ' THR . . . . . 0.833 ' HB ' ' HB2' ' A' 1641 ' ' HIS . 56.9 p -91.18 -14.21 31.49 Favored 'General case' 0 C--N 1.292 -1.922 0 C-N-CA 124.86 1.264 . . . . 0.97 108.975 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -87.93 68.26 9.22 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.963 -1.017 . . . . 0.72 109.002 -174.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 3.5 ptp180 -167.38 139.33 2.64 Favored Pre-proline 0 C--N 1.317 -0.821 0 C-N-CA 124.435 1.094 . . . . 3.26 108.561 179.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1624 ' ' PRO . . . . . 0.445 ' HA ' ' O ' ' A' 1639 ' ' SER . 37.5 Cg_endo -65.99 109.62 1.54 Allowed 'Trans proline' 0 C--O 1.238 0.522 0 C-N-CA 122.757 2.305 . . . . 0.59 111.584 -179.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 72.3 mtm -113.74 140.87 47.91 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 116.467 -0.333 . . . . 1.37 111.255 -178.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 1.8 tm? -78.48 119.78 22.27 Favored 'General case' 0 C--O 1.244 0.787 0 N-CA-C 107.358 -1.349 . . . . 0.89 107.358 179.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1627 ' ' ILE . . . . . 0.706 HD11 ' HB2' ' A' 1639 ' ' SER . 42.3 mm -80.16 -55.28 9.17 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 N-CA-C 108.833 -0.803 . . . . 0.58 108.833 178.448 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 22.7 t -173.82 158.4 3.23 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 106.933 -1.506 . . . . 1.39 106.933 -177.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1629 ' ' LEU . . . . . 0.82 ' HG ' ' HG ' ' A' 1636 ' ' LEU . 3.4 tt -115.58 113.02 23.04 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 104.312 -2.477 . . . . 1.25 104.312 175.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 16.4 t70 -69.48 103.95 2.19 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 108.602 -0.888 . . . . 1.09 108.602 176.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -61.94 -23.96 66.69 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 125.239 1.415 . . . . 3.6 113.319 -172.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 18.0 mm100 -86.13 -38.65 17.52 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 120.85 -0.34 . . . . 2.6 111.533 -177.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 67.0 p -103.88 2.27 32.39 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 112.657 0.614 . . . . 0.75 112.657 -174.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1634 ' ' CYS . . . . . 0.483 ' SG ' HD23 ' A' 1604 ' ' LEU . 81.4 m 57.47 35.67 26.13 Favored 'General case' 0 C--N 1.369 1.425 0 C-N-CA 123.96 0.904 . . . . 0.53 111.443 177.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1635 ' ' THR . . . . . 0.521 HG23 ' HE3' ' A' 1607 ' ' LYS . 90.8 m -107.85 126.86 53.17 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 115.155 -0.93 . . . . 0.46 109.97 -176.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1636 ' ' LEU . . . . . 0.82 ' HG ' ' HG ' ' A' 1629 ' ' LEU . 0.8 OUTLIER -107.07 122.15 45.9 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 108.588 -0.893 . . . . 0.86 108.588 -175.66 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -101.87 133.25 46.93 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 120.81 0.338 . . . . 0.45 111.465 -178.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -129.25 145.07 51.42 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.67 -0.696 . . . . 0.5 109.895 -178.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1639 ' ' SER . . . . . 0.706 ' HB2' HD11 ' A' 1627 ' ' ILE . 8.4 t -125.9 157.34 37.95 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 109.567 -0.531 . . . . 1.04 109.567 177.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 3.2 t90 -156.58 108.41 2.48 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 104.923 -2.251 . . . . 0.68 104.923 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1641 ' ' HIS . . . . . 0.833 ' HB2' ' HB ' ' A' 1621 ' ' THR . 18.1 m-70 -101.5 104.53 15.45 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 109.283 -0.636 . . . . 0.9 109.283 -178.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1642 ' ' THR . . . . . . . . . . . . . 3.2 t -133.64 150.11 73.93 Favored Pre-proline 0 C--N 1.3 -1.554 0 CA-C-N 115.186 -0.916 . . . . 0.48 110.608 -171.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1643 ' ' PRO . . . . . 0.632 ' HG3' ' HB2' ' A' 1618 ' ' ALA . 7.6 Cg_exo -73.63 -7.36 20.1 Favored 'Trans proline' 0 C--N 1.385 2.463 0 C-N-CA 122.44 2.094 . . . . 0.66 112.327 173.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 10.5 tt -66.95 -26.68 66.95 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.439 0.637 . . . . 0.97 109.814 179.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -92.39 9.87 32.36 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.193 -0.912 . . . . 0.84 109.82 179.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1646 ' ' CYS . . . . . 0.459 ' SG ' ' HA ' ' A' 1643 ' ' PRO . 72.9 m -111.86 146.92 36.85 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-N 115.958 -0.565 . . . . 1.19 110.416 -178.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 31.2 tt0 . . . . . 0 N--CA 1.424 -1.739 0 N-CA-C 106.57 -1.641 . . . . 3.14 106.57 173.432 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . 0.431 ' O ' HG12 ' B' ' 14' ' ' VAL . . . . . . . . 0 N--CA 1.431 -1.642 0 N-CA-C 111.301 -0.719 . . . . 2.09 111.301 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -59.96 -67.09 2.32 Favored Glycine 0 CA--C 1.5 -0.871 0 CA-C-O 119.504 -0.609 . . . . 1.84 113.069 -175.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -62.59 -29.14 70.38 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 117.371 0.585 . . . . 2.55 110.886 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -59.38 -62.36 1.93 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.857 -0.61 . . . . 2.35 111.879 177.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . 0.431 HG12 ' O ' ' B' ' 10' ' ' GLY . 10.9 p -69.45 -28.74 39.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 115.834 -0.621 . . . . 2.11 110.494 -176.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 15' ' ' ASP . . . . . 0.521 ' OD2' ' HA ' ' A' 1570 ' ' THR . 31.7 t70 -70.71 -45.98 63.93 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 113.85 1.055 . . . . 2.04 113.85 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 20.3 p -63.95 -39.85 95.09 Favored 'General case' 0 C--O 1.275 2.422 0 CA-C-O 121.859 0.838 . . . . 1.84 109.935 178.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.462 ' HB3' ' HB3' ' B' ' 26' ' ' PHE . 11.2 mp -59.52 -48.34 82.03 Favored 'General case' 0 N--CA 1.416 -2.15 0 CA-C-N 114.947 -1.024 . . . . 1.74 110.689 172.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 18' ' ' GLN . . . . . 0.459 ' HB2' ' HE2' ' B' ' 26' ' ' PHE . 26.8 tt0 -56.74 -29.47 62.56 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.499 0.72 . . . . 2.39 111.942 174.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -58.1 -56.63 19.57 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-O 119.335 -0.365 . . . . 0.96 111.374 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 10.3 p -99.71 -17.62 6.64 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.309 0 C-N-CA 117.557 -1.657 . . . . 1.37 112.706 177.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 21' ' ' CYS . . . . . 0.591 ' HA ' ' HB3' ' B' ' 24' ' ' ARG . 58.9 m -112.22 30.77 6.78 Favored 'General case' 0 C--N 1.293 -1.849 0 O-C-N 121.717 -0.614 . . . . 1.66 112.0 -176.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.19 -64.47 4.24 Favored Glycine 0 C--O 1.241 0.571 0 C-N-CA 120.347 -0.93 . . . . 1.53 111.762 177.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.44 ' HA ' ' HE2' ' A' 1544 ' ' LYS . 31.6 t70 -69.73 -34.8 74.35 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 122.674 0.39 . . . . 2.72 111.086 175.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . 0.591 ' HB3' ' HA ' ' B' ' 21' ' ' CYS . 8.6 tpm_? -64.57 -35.74 81.96 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 124.24 1.016 . . . . 4.33 112.399 -177.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.81 149.59 23.42 Favored Glycine 0 N--CA 1.423 -2.204 0 N-CA-C 110.853 -0.899 . . . . 1.53 110.853 -179.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . 0.462 ' HB3' ' HB3' ' B' ' 17' ' ' LEU . 0.3 OUTLIER -131.41 136.18 47.8 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 111.917 0.34 . . . . 1.65 111.917 178.769 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -139.84 78.65 1.67 Allowed 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.785 -0.45 . . . . 3.42 109.785 176.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 28' ' ' PHE . . . . . 0.556 ' O ' ' HA3' ' B' ' 41' ' ' GLY . 11.1 p90 . . . . . 0 C--N 1.311 -1.108 0 CA-C-O 121.794 0.807 . . . . 2.26 109.102 178.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . 0.556 ' HA3' ' O ' ' B' ' 28' ' ' PHE . . . . . . . . 0 N--CA 1.398 -3.882 0 N-CA-C 106.337 -2.705 . . . . 2.37 106.337 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . 0.471 ' HA ' ' HG2' ' B' ' 45' ' ' GLU . 31.2 pt 60.24 -8.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 C-N-CA 127.786 2.434 . . . . 2.07 114.904 -179.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 9.8 p -62.48 -34.1 62.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 C-N-CA 123.301 0.64 . . . . 2.24 112.42 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -84.07 -24.69 30.28 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 118.089 -1.444 . . . . 3.36 108.803 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . 0.471 ' HG2' ' HA ' ' B' ' 42' ' ' ILE . 32.2 mm-40 -67.66 -62.39 1.44 Allowed 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.377 -0.829 . . . . 3.08 109.154 -179.115 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 46' ' ' CYS . . . . . . . . . . . . . 21.1 m -76.39 -22.74 54.4 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 113.996 1.11 . . . . 2.23 113.996 -171.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 85.0 m -76.67 -1.66 28.9 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 121.201 -0.937 . . . . 2.37 112.594 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -133.94 -47.57 0.79 Allowed 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 112.467 0.543 . . . . 2.82 112.467 177.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 56.7 mtt-85 -104.53 168.9 8.78 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 120.889 0.375 . . . . 4.09 110.029 178.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 37.1 t -90.95 109.98 21.22 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 107.629 -1.249 . . . . 2.67 107.629 176.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . 0.545 ' HB2' HD23 ' B' ' 55' ' ' LEU . 21.8 p -90.93 135.48 33.71 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.851 -0.796 . . . . 2.11 108.851 -177.249 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . 0.465 ' HA ' ' O ' ' A' 1599 ' ' PRO . 3.7 p30 -98.66 172.05 7.73 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 113.376 0.88 . . . . 2.67 113.376 -176.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . 0.898 ' HB2' ' HA ' ' A' 1600 ' ' SER . 41.9 tp -51.12 -40.48 58.57 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 113.298 0.851 . . . . 1.9 113.298 -174.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . 0.402 ' O ' HG22 ' B' ' 58' ' ' THR . . . -54.94 -46.39 74.95 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 123.623 0.577 . . . . 1.52 111.575 -172.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . 0.545 HD23 ' HB2' ' B' ' 51' ' ' CYS . 48.0 tp -62.49 -58.0 9.16 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 114.925 -1.034 . . . . 1.97 110.516 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 3.9 pp -69.11 -34.1 74.54 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 112.692 0.627 . . . . 1.53 112.692 -172.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -76.24 -40.37 52.18 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 112.204 0.446 . . . . 2.27 112.204 -179.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 58' ' ' THR . . . . . 0.402 HG22 ' O ' ' B' ' 54' ' ' ALA . 7.0 t -77.71 -11.52 59.88 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 118.653 -1.219 . . . . 2.33 110.635 176.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 59' ' ' TYR . . . . . 0.465 ' OH ' ' HA2' ' B' ' 41' ' ' GLY . 17.6 t80 -85.59 -72.03 0.51 Allowed 'General case' 0 N--CA 1.426 -1.673 0 N-CA-C 106.477 -1.675 . . . . 2.86 106.477 175.21 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 41.3 t . . . . . 0 C--O 1.253 1.245 0 C-N-CA 126.071 1.748 . . . . 2.3 114.559 174.782 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 15.4 m-20 . . . . . 0 CA--C 1.509 -0.625 0 N-CA-C 111.687 0.254 . . . . 2.9 111.687 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A 1516 ' ' CYS . . . . . 0.604 ' HA ' ' HB2' ' A' 1581 ' ' LEU . 59.8 m 56.34 41.49 28.98 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-O 121.267 0.556 . . . . 1.19 110.951 -177.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -150.77 130.11 12.86 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 108.884 -0.784 . . . . 1.52 108.884 -179.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1518 ' ' VAL . . . . . 0.433 HG21 ' HB2' ' A' 1583 ' ' TYR . 3.3 m -136.03 138.22 47.66 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 O-C-N 124.13 0.894 . . . . 0.94 110.47 -177.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1519 ' ' THR . . . . . . . . . . . . . 44.2 m -104.8 136.13 44.89 Favored 'General case' 0 C--N 1.281 -2.397 0 N-CA-C 107.612 -1.255 . . . . 0.89 107.612 175.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1520 ' ' ASN . . . . . 0.477 ' OD1' ' HB2' ' A' 1522 ' ' SER . 21.3 t-20 -91.23 115.76 65.06 Favored Pre-proline 0 C--N 1.287 -2.126 0 N-CA-C 108.816 -0.809 . . . . 1.74 108.816 174.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -66.34 -15.52 48.37 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.998 2.465 . . . . 1.58 113.713 -176.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1522 ' ' SER . . . . . 0.477 ' HB2' ' OD1' ' A' 1520 ' ' ASN . 30.2 m -75.98 -44.76 38.2 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 111.772 0.286 . . . . 1.65 111.772 -179.142 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1523 ' ' THR . . . . . 0.463 HG22 ' OD1' ' A' 1520 ' ' ASN . 11.1 t -118.44 -1.26 11.27 Favored 'General case' 0 CA--C 1.556 1.178 0 CA-C-O 121.506 0.669 . . . . 1.61 112.092 -175.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 67.3 33.66 83.1 Favored Glycine 0 CA--C 1.503 -0.718 0 CA-C-N 115.829 -0.623 . . . . 1.13 112.937 176.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -98.68 121.9 41.22 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 109.626 -0.509 . . . . 1.26 109.626 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 1.9 tm? -94.12 111.84 23.6 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.208 -0.905 . . . . 0.68 108.804 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1527 ' ' PHE . . . . . 0.416 ' CE1' ' HA ' ' A' 1645 ' ' ALA . 85.0 m-85 -83.48 114.57 21.57 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 120.676 0.274 . . . . 0.65 111.445 174.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 22.4 t70 -102.91 101.13 11.14 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.112 -1.07 . . . . 1.17 108.112 176.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1529 ' ' LEU . . . . . 0.477 ' HG ' HD21 ' A' 1581 ' ' LEU . 4.2 mm? -83.88 -7.91 59.32 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 116.294 -0.412 . . . . 0.6 110.823 -177.017 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1530 ' ' SER . . . . . 0.597 ' HA ' ' OG ' ' A' 1533 ' ' SER . 17.1 m -66.48 -16.79 64.39 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.913 -0.585 . . . . 0.84 111.369 178.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 41.2 t -67.32 -29.06 68.53 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 109.327 -0.62 . . . . 1.59 109.327 173.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 81.3 mt -96.93 -10.33 26.58 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 116.451 -0.341 . . . . 0.65 111.061 -176.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1533 ' ' SER . . . . . 0.597 ' OG ' ' HA ' ' A' 1530 ' ' SER . 19.0 m -61.74 154.89 24.3 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.33 0.586 . . . . 1.52 110.718 178.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -171.13 131.2 2.14 Favored Glycine 0 C--N 1.286 -2.223 0 N-CA-C 109.443 -1.463 . . . . 1.1 109.443 -177.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1535 ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' 1535 ' ' ARG . 24.3 ttt180 -92.47 -34.49 14.08 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 112.337 0.495 . . . . 4.62 112.337 -172.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -59.7 -57.1 14.41 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.524 0.678 . . . . 1.45 110.571 -178.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 130.53 164.13 11.21 Favored Glycine 0 N--CA 1.409 -3.122 0 CA-C-N 115.433 -0.803 . . . . 0.85 111.999 173.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -120.51 138.91 53.58 Favored 'General case' 0 C--N 1.276 -2.617 0 N-CA-C 106.804 -1.554 . . . . 0.93 106.804 178.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 28.1 p -108.79 123.69 49.43 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 123.499 0.499 . . . . 1.03 110.783 -179.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1540 ' ' ALA . . . . . 0.445 ' HB3' ' CG1' ' A' 1548 ' ' VAL . . . -114.73 138.98 50.07 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 108.423 -0.955 . . . . 0.5 108.423 177.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -75.11 140.16 43.24 Favored 'General case' 0 CA--C 1.502 -0.872 0 O-C-N 123.93 0.769 . . . . 0.74 110.188 -177.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1542 ' ' TYR . . . . . 0.629 ' HE2' HD13 ' A' 1626 ' ' LEU . 1.7 t80 -152.53 -100.87 0.05 Allowed 'General case' 0 N--CA 1.424 -1.769 0 CA-C-N 115.954 -0.566 . . . . 0.99 110.25 -176.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1543 ' ' SER . . . . . . . . . . . . . 12.6 m -70.44 156.24 39.62 Favored 'General case' 0 N--CA 1.428 -1.544 0 C-N-CA 123.731 0.812 . . . . 1.91 109.735 -176.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 27.5 tptp -62.65 -22.07 66.16 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 125.502 1.521 . . . . 3.59 111.34 -173.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 34.3 t -137.94 37.65 2.37 Favored 'General case' 0 N--CA 1.427 -1.589 0 CA-C-N 115.746 -0.661 . . . . 2.46 109.6 -178.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1546 ' ' GLY . . . . . 0.54 ' HA3' ' HG2' ' A' 1569 ' ' GLN . . . -176.42 129.56 1.52 Allowed Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 119.025 -1.56 . . . . 1.26 113.974 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 35.9 m -102.75 162.68 3.76 Favored 'Isoleucine or valine' 0 C--O 1.251 1.175 0 N-CA-C 108.806 -0.812 . . . . 0.79 108.806 175.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1548 ' ' VAL . . . . . 0.474 ' HA ' ' HA ' ' A' 1567 ' ' PHE . 13.6 p -101.4 132.3 47.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 109.618 -0.512 . . . . 0.58 109.618 178.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -97.8 126.03 42.95 Favored 'General case' 0 CA--C 1.494 -1.202 0 C-N-CA 123.695 0.798 . . . . 1.08 109.435 177.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 24.0 ptm -139.2 135.48 34.02 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.311 -0.858 . . . . 0.78 111.42 -178.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 74.8 m -124.15 134.72 53.25 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.379 -0.828 . . . . 0.97 109.42 175.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1552 ' ' ILE . . . . . . . . . . . . . 46.4 mm -88.19 121.82 39.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 116.281 -0.418 . . . . 0.42 111.385 -175.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 34.0 t 66.04 25.35 10.92 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.615 1.166 . . . . 1.4 111.632 173.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . -167.51 174.99 42.63 Favored Glycine 0 N--CA 1.418 -2.552 0 N-CA-C 109.323 -1.511 . . . . 0.35 109.323 -179.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -95.63 155.94 16.53 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.081 0.467 . . . . 1.62 110.558 -178.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -104.25 134.84 46.8 Favored 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 107.258 -1.386 . . . . 0.87 107.258 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -95.93 7.96 44.94 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 112.943 0.719 . . . . 2.49 112.943 -172.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -83.04 -13.91 54.92 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.786 0.803 . . . . 1.38 109.533 177.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1559 ' ' CYS . . . . . 0.739 ' SG ' ' HD2' ' A' 1560 ' ' PRO . 9.3 t -131.89 162.16 58.2 Favored Pre-proline 0 C--N 1.293 -1.864 0 N-CA-C 106.039 -1.838 . . . . 1.21 106.039 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1560 ' ' PRO . . . . . 0.739 ' HD2' ' SG ' ' A' 1559 ' ' CYS . 41.8 Cg_exo -28.9 145.81 0.02 OUTLIER 'Trans proline' 0 CA--C 1.565 2.064 1 C-N-CA 125.301 4.001 . . . . 0.71 116.563 175.602 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.28 128.07 27.2 Favored 'Trans proline' 0 C--O 1.245 0.849 0 C-N-CA 123.56 2.84 . . . . 0.8 112.283 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 102.61 -9.73 55.74 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 116.139 -0.482 . . . . 0.46 112.354 -179.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1563 ' ' VAL . . . . . 0.537 HG11 ' HB2' ' A' 1566 ' ' CYS . 3.0 t -79.46 125.38 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 N-CA-C 112.665 0.617 . . . . 0.98 112.665 -178.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -98.6 -36.18 4.66 Favored Glycine 0 C--N 1.315 -0.616 0 CA-C-N 115.338 -0.847 . . . . 0.28 111.518 176.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -132.18 128.18 37.47 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 109.332 -0.618 . . . . 0.28 109.332 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1566 ' ' CYS . . . . . 0.537 ' HB2' HG11 ' A' 1563 ' ' VAL . 42.2 t -157.27 139.34 14.41 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 110.197 -0.297 . . . . 0.43 110.197 -177.032 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1567 ' ' PHE . . . . . 0.474 ' HA ' ' HA ' ' A' 1548 ' ' VAL . 37.8 m-85 -84.96 143.83 28.71 Favored 'General case' 0 C--O 1.245 0.846 0 N-CA-C 109.577 -0.527 . . . . 1.03 109.577 174.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -87.38 17.34 44.03 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.865 -0.683 . . . . 1.13 112.75 -175.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1569 ' ' GLN . . . . . 0.61 ' HB3' ' OD1' ' B' ' 15' ' ' ASP . 27.3 mt-30 -70.22 -69.97 0.32 Allowed 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 122.257 0.223 . . . . 2.58 110.507 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 13.8 t -130.41 29.74 4.81 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-O 121.604 0.716 . . . . 2.17 110.82 173.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 7.7 mmt180 65.29 55.17 1.1 Allowed 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 114.83 -1.077 . . . . 2.62 109.83 178.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 29.6 mt -95.97 115.74 35.95 Favored 'Isoleucine or valine' 0 C--O 1.246 0.907 0 CA-C-N 114.413 -1.267 . . . . 0.92 108.83 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 29.6 t -85.17 140.71 30.71 Favored 'General case' 0 C--O 1.245 0.855 0 CA-C-O 121.575 0.702 . . . . 0.8 110.845 -176.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1574 ' ' VAL . . . . . 0.628 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 35.7 m -126.2 15.49 3.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 CA-C-N 115.523 -0.762 . . . . 0.98 110.954 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 170.1 129.27 1.09 Allowed Glycine 0 N--CA 1.424 -2.154 0 C-N-CA 119.14 -1.505 . . . . 0.29 112.812 177.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 86.8 tttt -77.9 142.95 38.1 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 108.277 -1.009 . . . . 2.19 108.277 176.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -73.78 91.49 1.94 Allowed 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 123.036 0.534 . . . . 0.61 110.883 -178.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -109.85 171.63 7.33 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 108.273 -1.01 . . . . 1.95 108.273 178.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 62.3 mttp -124.05 44.61 2.69 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.688 -0.856 . . . . 2.68 108.688 -177.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 43.6 ttp180 -86.92 77.88 9.14 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 114.904 -1.044 . . . . 3.47 109.622 -177.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1581 ' ' LEU . . . . . 0.604 ' HB2' ' HA ' ' A' 1516 ' ' CYS . 0.5 OUTLIER -84.33 123.06 29.76 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.602 -1.181 . . . . 0.64 108.976 -179.053 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -126.35 140.37 52.56 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 110.108 -0.33 . . . . 2.85 110.108 173.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1583 ' ' TYR . . . . . 0.433 ' HB2' HG21 ' A' 1518 ' ' VAL . 51.0 t80 -106.35 111.63 24.3 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 108.975 -0.75 . . . . 0.86 108.975 177.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1584 ' ' VAL . . . . . 0.613 ' O ' ' HB ' ' A' 1587 ' ' VAL . 6.8 m -130.01 95.72 2.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 112.289 0.477 . . . . 1.05 112.289 -178.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 37.0 t70 57.99 65.81 1.23 Allowed 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 121.774 0.797 . . . . 1.17 111.929 174.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1586 ' ' GLN . . . . . . . . . . . . 0.254 30.2 pt20 60.67 20.72 10.68 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 127.021 2.128 . . . . 1.86 111.847 177.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1587 ' ' VAL . . . . . 0.613 ' HB ' ' O ' ' A' 1584 ' ' VAL . 18.3 t -117.32 121.0 66.64 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.606 0 CA-C-N 113.593 -1.64 . . . . 0.49 109.922 176.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1588 ' ' LEU . . . . . 0.838 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 2.7 mm? -95.59 115.58 27.63 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 106.061 -1.829 . . . . 0.36 106.061 175.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1589 ' ' GLN . . . . . 0.424 ' HA ' ' O ' ' A' 1610 ' ' ILE . 29.8 tt0 -118.01 126.44 52.31 Favored 'General case' 0 C--N 1.277 -2.558 0 C-N-CA 119.844 -0.743 . . . . 1.74 112.445 -174.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 11.9 mt -114.0 117.41 31.25 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 125.414 1.486 . . . . 0.72 107.043 175.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 26.9 t -104.88 128.89 58.26 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 C-N-CA 119.734 -0.786 . . . . 1.01 109.62 -178.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1592 ' ' TYR . . . . . 0.554 ' HB2' ' HB3' ' A' 1608 ' ' SER . 14.4 m-30 -117.58 96.13 5.26 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.901 -0.777 . . . . 0.5 108.901 178.166 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 38.8 pttt -111.4 175.62 5.35 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.823 -0.751 . . . . 1.59 109.876 177.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 33.3 m-20 67.48 60.23 0.48 Allowed 'General case' 0 CA--C 1.502 -0.889 0 C-N-CA 124.318 1.047 . . . . 1.11 110.904 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -91.11 -104.74 1.34 Allowed Glycine 0 N--CA 1.424 -2.153 0 N-CA-C 109.469 -1.452 . . . . 0.78 109.469 177.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1596 ' ' SER . . . . . . . . . . . . . 48.4 m -120.69 156.16 56.35 Favored Pre-proline 0 C--N 1.286 -2.172 0 N-CA-C 107.697 -1.223 . . . . 1.07 107.697 175.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -53.94 120.92 8.7 Favored 'Trans proline' 0 C--N 1.357 0.991 0 C-N-CA 122.927 2.418 . . . . 1.01 110.276 173.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1598 ' ' CYS . . . . . 0.476 ' HA ' ' HD3' ' A' 1599 ' ' PRO . 48.9 t -79.8 126.42 80.25 Favored Pre-proline 0 C--N 1.28 -2.453 0 CA-C-N 114.385 -1.279 . . . . 0.75 110.578 -175.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1599 ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' 1598 ' ' CYS . 12.2 Cg_exo -73.52 -15.72 24.55 Favored 'Trans proline' 0 C--O 1.212 -0.784 0 C-N-CA 122.942 2.428 . . . . 1.7 112.051 177.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1600 ' ' SER . . . . . 0.688 ' HA ' ' HB2' ' B' ' 53' ' ' LEU . 15.4 m -65.77 -31.85 73.06 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-O 120.67 0.271 . . . . 2.26 111.416 177.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1601 ' ' LYS . . . . . 0.445 ' HA ' ' HB2' ' B' ' 52' ' ' ASP . 22.9 ttmm -150.62 120.74 7.22 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 108.084 -1.08 . . . . 3.01 108.084 175.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 8.0 m -59.02 123.54 16.93 Favored 'General case' 0 N--CA 1.428 -1.548 0 C-N-CA 124.241 1.017 . . . . 2.07 112.707 -171.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 84.06 23.18 53.02 Favored Glycine 0 CA--C 1.499 -0.961 0 CA-C-N 116.167 -0.47 . . . . 1.08 112.482 175.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1604 ' ' LEU . . . . . 0.476 HD23 ' SG ' ' A' 1634 ' ' CYS . 11.5 tp -119.67 165.93 13.86 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 106.854 -1.535 . . . . 1.84 106.854 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 22.9 t -124.82 154.37 41.1 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.628 -0.878 . . . . 1.41 108.628 -177.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1606 ' ' TYR . . . . . 0.628 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 58.1 m-85 -74.86 163.58 27.5 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 116.011 -0.541 . . . . 0.6 109.892 176.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -160.33 128.26 4.61 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-N 116.338 -0.392 . . . . 1.45 109.944 -176.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1608 ' ' SER . . . . . 0.554 ' HB3' ' HB2' ' A' 1592 ' ' TYR . 34.5 t -104.95 126.3 51.87 Favored 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 108.447 -0.946 . . . . 1.15 108.447 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 25.8 t -110.61 99.21 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.66 0 N-CA-C 107.864 -1.161 . . . . 0.25 107.864 177.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1610 ' ' ILE . . . . . 0.424 ' O ' ' HA ' ' A' 1589 ' ' GLN . 77.1 mt -90.29 120.64 39.47 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 CA-C-N 115.014 -0.994 . . . . 0.45 108.917 -177.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 43.9 m -124.67 123.97 41.18 Favored 'General case' 0 C--N 1.287 -2.11 0 CA-C-N 115.863 -0.608 . . . . 1.26 112.025 -178.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1612 ' ' PHE . . . . . 0.838 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 75.5 m-85 -97.97 123.14 41.83 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.42 -0.956 . . . . 0.26 108.42 176.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 44.7 t -113.51 134.96 54.6 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 O-C-N 123.589 0.556 . . . . 0.5 110.621 -174.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -54.07 112.56 0.99 Allowed 'General case' 0 C--O 1.241 0.623 0 C-N-CA 124.265 1.026 . . . . 0.77 111.679 175.054 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1615 ' ' ARG . . . . . 0.549 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 23.0 tpt180 -126.0 88.95 53.35 Favored Pre-proline 0 N--CA 1.443 -0.798 0 N-CA-C 107.881 -1.155 . . . . 2.53 107.881 174.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1616 ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -72.57 -19.59 24.45 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 122.341 2.027 . . . . 1.1 113.325 -174.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -87.29 -10.8 51.39 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.612 -0.267 . . . . 3.05 111.552 179.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . 63.05 -172.53 0.16 Allowed 'General case' 0 CA--C 1.546 0.794 0 O-C-N 123.904 0.753 . . . . 1.55 109.087 -172.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . 147.64 -165.27 28.78 Favored Glycine 0 N--CA 1.424 -2.107 0 C-N-CA 120.292 -0.956 . . . . 0.93 112.565 175.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -87.23 19.14 1.43 Allowed 'Trans proline' 0 C--O 1.237 0.45 0 C-N-CA 123.614 2.876 . . . . 0.88 113.726 -174.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1621 ' ' THR . . . . . . . . . . . . . 24.1 p -114.62 12.46 17.22 Favored 'General case' 0 C--N 1.285 -2.212 0 CA-C-O 122.173 0.987 . . . . 0.97 109.744 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -89.55 66.71 7.38 Favored 'General case' 0 C--O 1.246 0.92 0 N-CA-C 106.682 -1.599 . . . . 0.72 106.682 178.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1623 ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' 1623 ' ' ARG . 3.4 ptm180 -170.5 140.79 1.52 Allowed Pre-proline 0 N--CA 1.428 -1.531 0 N-CA-C 106.849 -1.538 . . . . 3.26 106.849 -173.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -57.63 107.56 0.31 Allowed 'Trans proline' 0 CA--C 1.545 1.058 0 C-N-CA 122.511 2.141 . . . . 0.59 111.571 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 81.4 mtp -114.18 148.08 37.85 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.576 -0.898 . . . . 1.37 108.576 -178.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1626 ' ' LEU . . . . . 0.629 HD13 ' HE2' ' A' 1542 ' ' TYR . 7.2 tt -101.9 138.31 39.04 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.132 -0.692 . . . . 0.89 109.132 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1627 ' ' ILE . . . . . 0.809 HD11 ' HB2' ' A' 1639 ' ' SER . 38.4 mm -85.09 -63.09 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.214 -0.812 0 CA-C-N 115.375 -0.829 . . . . 0.58 109.701 -178.069 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 52.2 m -161.88 152.11 17.08 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 106.897 -1.52 . . . . 1.39 106.897 -176.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1629 ' ' LEU . . . . . 0.627 HD13 ' HG ' ' A' 1636 ' ' LEU . 44.4 tp -105.42 110.3 22.59 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 107.885 -1.154 . . . . 1.25 107.885 175.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 18.6 t70 -82.75 95.41 7.86 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 118.388 -1.325 . . . . 1.09 107.651 175.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 21.8 pttm -76.14 7.24 4.35 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 114.739 -1.119 . . . . 3.6 113.467 -174.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -95.68 -45.0 7.2 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 108.794 -0.817 . . . . 2.6 108.794 173.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 73.5 p -96.92 -1.68 45.31 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-N 115.368 -0.833 . . . . 0.75 111.342 -177.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1634 ' ' CYS . . . . . 0.585 ' SG ' ' HB2' ' A' 1600 ' ' SER . 74.7 m 60.73 35.04 19.78 Favored 'General case' 0 C--N 1.364 1.196 0 C-N-CA 124.043 0.937 . . . . 0.53 110.746 178.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1635 ' ' THR . . . . . . . . . . . . . 57.2 m -105.96 128.56 53.89 Favored 'General case' 0 N--CA 1.418 -2.029 0 CA-C-N 114.973 -1.012 . . . . 0.46 109.987 -176.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1636 ' ' LEU . . . . . 0.627 ' HG ' HD13 ' A' 1629 ' ' LEU . 0.9 OUTLIER -110.11 119.57 39.7 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 108.223 -1.028 . . . . 0.86 108.223 -177.376 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -99.52 129.18 45.67 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 116.293 -0.412 . . . . 0.45 110.257 -177.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -126.26 143.41 51.16 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.838 -0.619 . . . . 0.5 109.833 -178.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1639 ' ' SER . . . . . 0.809 ' HB2' HD11 ' A' 1627 ' ' ILE . 23.0 t -124.39 159.97 29.22 Favored 'General case' 0 C--N 1.31 -1.13 0 C-N-CA 124.284 1.033 . . . . 1.04 108.524 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 2.9 t90 -156.71 111.75 2.84 Favored 'General case' 0 N--CA 1.418 -2.073 0 N-CA-C 104.26 -2.496 . . . . 0.68 104.26 179.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1641 ' ' HIS . . . . . 0.549 ' HB3' ' HB2' ' A' 1615 ' ' ARG . 62.2 m-70 -97.63 110.01 22.65 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 108.926 -0.768 . . . . 0.9 108.926 -177.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1642 ' ' THR . . . . . . . . . . . . . 4.6 t -139.11 148.69 58.41 Favored Pre-proline 0 C--N 1.292 -1.931 0 CA-C-N 115.302 -0.863 . . . . 0.48 110.869 -171.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1643 ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -78.36 -6.17 15.4 Favored 'Trans proline' 0 C--N 1.364 1.39 0 C-N-CA 122.467 2.111 . . . . 0.66 112.168 176.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 7.3 tt -68.41 -31.04 70.09 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 108.915 -0.772 . . . . 0.97 108.915 176.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1645 ' ' ALA . . . . . 0.416 ' HA ' ' CE1' ' A' 1527 ' ' PHE . . . -86.08 4.08 39.69 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.195 -0.911 . . . . 0.84 111.284 -174.266 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 1.3 t -123.69 144.09 49.86 Favored 'General case' 0 N--CA 1.424 -1.77 0 C-N-CA 119.263 -0.975 . . . . 1.19 110.403 -178.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.302 -1.468 0 C-N-CA 122.554 0.342 . . . . 3.14 110.182 174.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . 0.489 ' O ' HG12 ' B' ' 14' ' ' VAL . . . . . . . . 0 N--CA 1.424 -2.11 0 N-CA-C 111.005 -0.838 . . . . 2.09 111.005 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -52.07 -55.11 22.94 Favored Glycine 0 N--CA 1.464 0.518 0 N-CA-C 115.344 0.898 . . . . 1.84 115.344 -174.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -78.36 -30.65 48.13 Favored 'General case' 0 CA--C 1.499 -0.998 0 CA-C-N 117.013 0.407 . . . . 2.55 110.3 -177.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 13' ' ' LEU . . . . . 0.562 ' O ' HD23 ' B' ' 17' ' ' LEU . 0.8 OUTLIER -58.16 -62.05 2.11 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-N 115.489 -0.778 . . . . 2.35 111.288 178.669 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . 0.489 HG12 ' O ' ' B' ' 10' ' ' GLY . 14.2 p -64.72 -29.18 46.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-N 116.107 -0.497 . . . . 2.11 111.244 -177.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 15' ' ' ASP . . . . . 0.61 ' OD1' ' HB3' ' A' 1569 ' ' GLN . 33.6 t70 -73.83 -37.95 64.69 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 113.11 0.782 . . . . 2.04 113.11 178.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 14.8 t -69.85 -32.17 70.41 Favored 'General case' 0 C--O 1.254 1.306 0 CA-C-N 119.432 1.014 . . . . 1.84 109.485 175.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.562 HD23 ' O ' ' B' ' 13' ' ' LEU . 3.8 mm? -56.12 -44.28 78.98 Favored 'General case' 0 C--O 1.208 -1.118 0 CA-C-N 115.431 -0.804 . . . . 1.74 108.995 169.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -77.18 -21.72 53.53 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.27 -0.877 . . . . 2.39 112.006 -178.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -64.35 -56.67 12.85 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 116.349 -0.387 . . . . 0.96 110.239 178.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 15.0 p -98.66 -20.93 5.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 118.519 -1.273 . . . . 1.37 112.555 -177.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 21' ' ' CYS . . . . . 0.608 ' HB2' ' HB3' ' B' ' 26' ' ' PHE . 64.0 m -105.2 19.24 20.94 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 119.445 -0.902 . . . . 1.66 110.758 179.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.67 -56.58 24.49 Favored Glycine 0 C--N 1.31 -0.888 0 C-N-CA 120.382 -0.913 . . . . 1.53 112.254 178.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -70.34 -38.08 74.79 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.783 0.325 . . . . 2.72 111.307 177.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 43.2 ttp180 -72.68 -39.02 67.39 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 113.888 1.069 . . . . 4.33 113.888 -176.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 112.09 112.87 3.26 Favored Glycine 0 N--CA 1.429 -1.77 0 N-CA-C 109.157 -1.577 . . . . 1.53 109.157 -175.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . 0.608 ' HB3' ' HB2' ' B' ' 21' ' ' CYS . 39.8 p90 -92.2 134.73 34.6 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 120.696 -0.402 . . . . 1.65 110.895 -178.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -148.35 116.72 6.54 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.984 -0.747 . . . . 3.42 108.984 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 28' ' ' PHE . . . . . . . . . . . . . 43.3 p90 . . . . . 0 CA--C 1.547 0.836 0 C-N-CA 120.521 -0.472 . . . . 2.26 111.909 175.528 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.426 -1.987 0 N-CA-C 110.236 -1.146 . . . . 2.37 110.236 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . 0.543 HD11 HD21 ' B' ' 17' ' ' LEU . 15.0 pt 59.87 -33.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 C-N-CA 128.097 2.559 . . . . 2.07 116.731 176.198 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.498 ' O ' ' HB2' ' B' ' 47' ' ' CYS . 2.7 p -52.57 -41.38 36.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 113.55 0.944 . . . . 2.24 113.55 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -94.72 -31.0 13.99 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 108.574 -0.899 . . . . 3.36 108.574 -174.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . 0.401 ' HB3' ' HA ' ' B' ' 42' ' ' ILE . 8.3 tp10 -56.92 -50.97 70.96 Favored 'General case' 0 C--O 1.206 -1.194 0 CA-C-N 115.35 -0.841 . . . . 3.08 109.638 174.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 46' ' ' CYS . . . . . 0.541 ' HB3' HD21 ' B' ' 13' ' ' LEU . 9.1 t -89.96 2.46 55.08 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.524 0.678 . . . . 2.23 111.17 -175.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 47' ' ' CYS . . . . . 0.498 ' HB2' ' O ' ' B' ' 43' ' ' VAL . 45.6 t -85.61 -52.41 5.83 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 116.331 -0.395 . . . . 2.37 110.459 177.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -104.59 13.02 32.37 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.289 0.566 . . . . 2.82 111.571 -175.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . 0.401 ' HB2' ' O ' ' B' ' 45' ' ' GLU . 28.7 mtp85 -155.86 -170.11 3.3 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 125.64 1.576 . . . . 4.09 107.477 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 21.3 t -121.9 129.13 52.31 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 109.188 -0.671 . . . . 2.67 109.188 -176.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . 0.413 ' HB3' ' HB2' ' B' ' 46' ' ' CYS . 26.7 p -99.71 149.89 22.86 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.943 -0.762 . . . . 2.11 108.943 -177.101 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . 0.445 ' HB2' ' HA ' ' A' 1601 ' ' LYS . 3.0 p-10 -116.57 174.62 5.97 Favored 'General case' 0 C--O 1.251 1.164 0 C-N-CA 120.348 -0.541 . . . . 2.67 110.829 170.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . 0.688 ' HB2' ' HA ' ' A' 1600 ' ' SER . 34.3 tp -54.61 -43.13 71.93 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 113.342 0.867 . . . . 1.9 113.342 -173.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . 0.408 ' O ' HG22 ' B' ' 58' ' ' THR . . . -55.39 -31.82 62.13 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.225 0.61 . . . . 1.52 112.341 -171.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 61.9 tp -72.41 -58.08 3.67 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 115.491 -0.777 . . . . 1.97 110.244 179.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 2.0 pp -70.2 -32.18 69.98 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 111.827 0.306 . . . . 1.53 111.827 -175.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -60.61 -48.54 81.33 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 116.291 -0.413 . . . . 2.27 111.262 179.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 58' ' ' THR . . . . . 0.408 HG22 ' O ' ' B' ' 54' ' ' ALA . 6.4 t -88.37 -8.7 54.63 Favored 'General case' 0 CA--C 1.569 1.697 0 CA-C-O 120.867 0.365 . . . . 2.33 111.895 -177.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 16.7 t80 -95.05 -33.4 12.72 Favored 'General case' 0 N--CA 1.441 -0.878 0 O-C-N 121.291 -0.88 . . . . 2.86 109.839 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 60' ' ' CYS . . . . . 0.545 ' SG ' ' HA ' ' B' ' 26' ' ' PHE . 38.8 t . . . . . 0 C--O 1.255 1.391 0 CA-C-N 115.783 -0.644 . . . . 2.3 110.963 -176.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1515 ' ' ASP . . . . . 0.438 ' O ' ' HB2' ' A' 1581 ' ' LEU . 17.5 m-20 . . . . . 0 CA--C 1.497 -1.064 0 N-CA-C 108.88 -0.785 . . . . 2.9 108.88 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1516 ' ' CYS . . . . . 0.798 ' HB3' ' HB2' ' A' 1529 ' ' LEU . 83.0 m -126.46 46.58 2.43 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 107.048 -1.464 . . . . 1.19 107.048 176.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1517 ' ' GLN . . . . . 0.482 ' HA ' ' O ' ' A' 1527 ' ' PHE . 14.0 pt20 -151.72 133.92 15.18 Favored 'General case' 0 N--CA 1.425 -1.712 0 CA-C-N 114.836 -1.074 . . . . 1.52 109.483 -175.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1518 ' ' VAL . . . . . 0.511 HG21 ' HB2' ' A' 1583 ' ' TYR . 2.3 m -150.26 136.96 12.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 C-N-CA 124.361 1.064 . . . . 0.94 109.497 175.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1519 ' ' THR . . . . . . . . . . . . . 43.4 m -111.81 134.51 53.33 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 108.797 -0.816 . . . . 0.89 108.797 178.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -90.38 124.13 63.69 Favored Pre-proline 0 C--N 1.298 -1.647 0 N-CA-C 109.184 -0.673 . . . . 1.74 109.184 176.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -68.8 -15.69 40.89 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 123.072 2.515 . . . . 1.58 113.725 -174.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 22.5 m -80.62 -50.45 9.95 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-O 120.593 0.235 . . . . 1.65 111.478 -177.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1523 ' ' THR . . . . . . . . . . . . . 5.6 t -103.96 -11.75 17.25 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 119.878 -0.729 . . . . 1.61 111.867 -176.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 75.09 25.92 67.74 Favored Glycine 0 CA--C 1.506 -0.529 0 CA-C-N 116.275 -0.42 . . . . 1.13 112.639 177.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 84.8 t60 -92.81 127.4 38.3 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 120.487 -0.485 . . . . 1.26 110.424 -177.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 2.0 tm? -92.71 110.93 22.37 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 114.444 -1.253 . . . . 0.68 108.354 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1527 ' ' PHE . . . . . 0.482 ' O ' ' HA ' ' A' 1517 ' ' GLN . 93.3 m-85 -85.07 119.55 25.59 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 120.463 -0.495 . . . . 0.65 109.723 173.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 24.1 t70 -115.39 114.21 24.8 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.44 -0.8 . . . . 1.17 109.417 178.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1529 ' ' LEU . . . . . 0.798 ' HB2' ' HB3' ' A' 1516 ' ' CYS . 2.8 mm? -102.41 -0.83 31.91 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 108.849 -0.797 . . . . 0.6 108.849 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -68.59 -32.35 72.19 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.627 0.727 . . . . 0.84 109.16 -178.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 31.5 t -64.81 -12.7 50.84 Favored 'General case' 0 CA--C 1.554 1.123 0 CA-C-N 114.881 -1.054 . . . . 1.59 110.858 177.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 90.5 mt -92.77 -3.13 55.27 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 122.02 -0.425 . . . . 0.65 110.703 177.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1533 ' ' SER . . . . . 0.997 ' HA ' ' HB2' ' A' 1536 ' ' ALA . 14.4 t -95.2 -179.62 4.86 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 109.526 -0.546 . . . . 1.52 109.526 179.149 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . 83.92 -65.73 4.05 Favored Glycine 0 C--N 1.312 -0.761 0 N-CA-C 109.609 -1.396 . . . . 1.1 109.609 -174.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 42.4 ttp180 -83.89 -2.24 56.06 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 124.424 1.09 . . . . 4.62 109.192 174.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1536 ' ' ALA . . . . . 0.997 ' HB2' ' HA ' ' A' 1533 ' ' SER . . . -46.84 -22.28 0.29 Allowed 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 127.551 2.34 . . . . 1.45 116.66 -175.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . -72.61 103.53 1.36 Allowed Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.361 -0.923 . . . . 0.85 111.208 178.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -119.93 149.34 42.27 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 120.93 0.395 . . . . 0.93 110.777 -178.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 9.9 p -112.94 117.48 32.2 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 115.458 -0.792 . . . . 1.03 110.38 179.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1540 ' ' ALA . . . . . 0.444 ' HB3' ' CG1' ' A' 1548 ' ' VAL . . . -112.54 146.68 38.1 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.953 -0.758 . . . . 0.5 108.953 177.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -86.28 151.68 23.39 Favored 'General case' 0 C--N 1.311 -1.081 0 O-C-N 123.22 0.325 . . . . 0.74 111.022 -175.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1542 ' ' TYR . . . . . 0.41 ' HB3' ' H ' ' A' 1543 ' ' SER . 0.3 OUTLIER -159.15 -101.93 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 109.511 -0.551 . . . . 0.99 109.511 -178.777 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A 1543 ' ' SER . . . . . 0.41 ' H ' ' HB3' ' A' 1542 ' ' TYR . 2.2 p -68.59 172.22 6.53 Favored 'General case' 0 CA--C 1.562 1.409 0 C-N-CA 124.641 1.176 . . . . 1.91 110.302 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -94.55 4.59 53.66 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 113.561 0.948 . . . . 3.59 113.561 -165.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 7.3 t -129.8 21.33 5.46 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.43 -0.908 . . . . 2.46 110.208 -178.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 169.25 179.73 41.37 Favored Glycine 0 N--CA 1.424 -2.127 0 C-N-CA 119.801 -1.19 . . . . 1.26 112.153 179.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 28.0 m -122.07 176.1 4.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 109.148 -0.686 . . . . 0.79 109.148 -177.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1548 ' ' VAL . . . . . 0.444 ' CG1' ' HB3' ' A' 1540 ' ' ALA . 14.9 p -103.62 128.12 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 N-CA-C 108.538 -0.912 . . . . 0.58 108.538 175.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -92.32 131.07 37.81 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.656 -0.868 . . . . 1.08 108.656 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 23.5 ptm -144.98 140.65 28.34 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 116.051 -0.522 . . . . 0.78 110.587 -178.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1551 ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' 1536 ' ' ALA . 12.3 p -131.95 125.96 32.89 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 115.824 -0.626 . . . . 0.97 111.551 177.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1552 ' ' ILE . . . . . 0.69 ' H ' ' HB1' ' A' 1536 ' ' ALA . 49.5 mm -82.63 124.5 39.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.556 -0.535 . . . . 0.42 109.556 177.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1553 ' ' CYS . . . . . 0.551 ' HB2' ' HB2' ' A' 1533 ' ' SER . 60.2 m 59.35 49.7 8.56 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.598 0.713 . . . . 1.4 110.696 177.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 168.92 172.14 35.4 Favored Glycine 0 N--CA 1.42 -2.401 0 N-CA-C 109.76 -1.336 . . . . 0.35 109.76 178.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -100.01 150.15 22.73 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 109.562 -0.532 . . . . 1.62 109.562 178.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -91.81 130.97 37.49 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.696 -0.684 . . . . 0.87 109.984 -174.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -67.34 -7.29 23.57 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 113.969 1.1 . . . . 2.49 113.969 -174.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -93.12 -4.72 51.75 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 120.302 -0.559 . . . . 1.38 112.065 -175.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1559 ' ' CYS . . . . . 0.722 ' SG ' ' HD2' ' A' 1560 ' ' PRO . 3.1 t -137.37 162.52 54.64 Favored Pre-proline 0 C--N 1.293 -1.871 0 N-CA-C 108.08 -1.082 . . . . 1.21 108.08 -178.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1560 ' ' PRO . . . . . 0.722 ' HD2' ' SG ' ' A' 1559 ' ' CYS . 16.6 Cg_exo -32.91 145.82 0.03 OUTLIER 'Trans proline' 0 CA--C 1.563 1.964 0 C-N-CA 125.175 3.916 . . . . 0.71 115.536 175.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.03 124.06 14.85 Favored 'Trans proline' 0 C--O 1.25 1.106 0 C-N-CA 123.236 2.624 . . . . 0.8 111.803 178.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 107.08 -5.66 36.41 Favored Glycine 0 N--CA 1.44 -1.072 0 CA-C-N 115.615 -0.72 . . . . 0.46 111.878 -177.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1563 ' ' VAL . . . . . 0.626 HG11 ' HB3' ' A' 1559 ' ' CYS . 10.6 t -84.36 120.64 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.227 0 CA-C-O 121.217 0.532 . . . . 0.98 112.33 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -96.8 -31.3 7.09 Favored Glycine 0 C--N 1.303 -1.298 0 CA-C-N 115.146 -0.934 . . . . 0.28 111.535 177.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -136.18 135.26 39.01 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 109.474 -0.565 . . . . 0.28 109.474 177.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1566 ' ' CYS . . . . . 0.571 ' HB2' HG11 ' A' 1563 ' ' VAL . 53.9 t -157.84 140.2 14.48 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 110.149 -0.315 . . . . 0.43 110.149 -176.443 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1567 ' ' PHE . . . . . 0.497 ' CE2' HG11 ' A' 1574 ' ' VAL . 64.1 m-85 -85.34 133.5 34.14 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 107.954 -1.128 . . . . 1.03 107.954 174.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -75.03 -9.73 83.96 Favored Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 115.561 0.984 . . . . 1.13 115.561 -171.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1569 ' ' GLN . . . . . 0.568 ' NE2' HE22 ' B' ' 18' ' ' GLN . 16.3 mt-30 -70.52 -69.4 0.36 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 117.258 0.529 . . . . 2.58 110.908 -177.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1570 ' ' THR . . . . . 0.405 HG21 ' HA ' ' B' ' 12' ' ' GLU . 0.7 OUTLIER -97.85 2.08 48.91 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 113.394 0.887 . . . . 2.17 113.394 -179.707 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 10.4 mmt85 58.63 41.9 21.4 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.0 -1.0 . . . . 2.62 110.444 178.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 32.3 mt -88.51 129.58 39.42 Favored 'Isoleucine or valine' 0 C--O 1.247 0.945 0 N-CA-C 108.085 -1.08 . . . . 0.92 108.085 177.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 30.0 t -81.09 131.65 35.31 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.391 0.615 . . . . 0.8 110.852 -177.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1574 ' ' VAL . . . . . 0.714 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 33.9 m -118.95 15.12 6.96 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 CA-C-N 115.981 -0.554 . . . . 0.98 111.346 -179.253 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 176.95 126.23 0.95 Allowed Glycine 0 N--CA 1.423 -2.223 0 C-N-CA 119.58 -1.295 . . . . 0.29 111.814 176.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 49.8 tttp -81.99 135.35 35.37 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 107.271 -1.381 . . . . 2.19 107.271 177.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -70.28 96.99 1.17 Allowed 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 122.956 0.502 . . . . 0.61 110.785 -176.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -110.49 173.65 6.23 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 108.72 -0.845 . . . . 1.95 108.72 177.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1579 ' ' LYS . . . . . 0.413 ' NZ ' ' HB2' ' A' 1579 ' ' LYS . 9.8 mtmp? -136.53 53.74 1.91 Allowed 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 107.662 -1.236 . . . . 2.68 107.662 -177.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1580 ' ' ARG . . . . . 0.409 ' NH2' HG11 ' A' 1591 ' ' VAL . 49.1 ttp180 -107.0 76.19 1.08 Allowed 'General case' 0 N--CA 1.419 -1.984 0 CA-C-N 114.497 -1.228 . . . . 3.47 108.027 -179.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1581 ' ' LEU . . . . . 0.581 HD23 ' HA ' ' A' 1516 ' ' CYS . 0.3 OUTLIER -69.18 126.27 29.27 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.632 -1.167 . . . . 0.64 108.923 179.915 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 60.8 mtp180 -124.72 131.12 53.48 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 120.315 -0.554 . . . . 2.85 110.649 173.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1583 ' ' TYR . . . . . 0.511 ' HB2' HG21 ' A' 1518 ' ' VAL . 45.1 t80 -100.93 108.31 20.02 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 108.803 -0.814 . . . . 0.86 108.803 178.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1584 ' ' VAL . . . . . 0.601 ' O ' ' HB ' ' A' 1587 ' ' VAL . 15.5 m -127.4 91.82 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 CA-C-N 115.918 -0.583 . . . . 1.05 111.993 -178.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 32.8 t70 59.18 66.91 0.97 Allowed 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 124.039 0.936 . . . . 1.17 111.221 175.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1586 ' ' GLN . . . . . 0.459 ' HA ' ' CE1' ' A' 1583 ' ' TYR 0.267 28.5 pt20 61.41 14.75 6.02 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 127.074 2.15 . . . . 1.86 112.605 178.895 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A 1587 ' ' VAL . . . . . 0.601 ' HB ' ' O ' ' A' 1584 ' ' VAL . 15.7 t -110.44 120.82 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.325 0 CA-C-N 114.222 -1.354 . . . . 0.49 109.436 177.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1588 ' ' LEU . . . . . 1.001 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 2.2 mm? -97.79 107.76 20.33 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 106.556 -1.646 . . . . 0.36 106.556 177.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -105.22 120.72 42.24 Favored 'General case' 0 C--N 1.282 -2.36 0 CA-C-O 121.204 0.526 . . . . 1.74 111.544 -176.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 2.3 mt -107.78 108.5 19.73 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 106.196 -1.779 . . . . 0.72 106.196 172.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1591 ' ' VAL . . . . . 0.409 HG11 ' NH2' ' A' 1580 ' ' ARG . 7.8 p -97.39 131.14 44.92 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 CA-C-O 121.192 0.52 . . . . 1.01 110.62 -175.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1592 ' ' TYR . . . . . 0.412 ' O ' ' HA ' ' A' 1607 ' ' LYS . 13.1 m-30 -122.57 95.87 4.81 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 107.947 -1.131 . . . . 0.5 107.947 177.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1593 ' ' LYS . . . . . 0.521 ' HB3' ' HG3' ' A' 1607 ' ' LYS . 48.0 pttt -117.68 175.95 5.41 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.816 -0.754 . . . . 1.59 110.007 -176.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 7.4 m-20 57.11 42.32 25.93 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 124.697 1.248 . . . . 1.11 111.885 177.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -68.42 -95.97 0.04 OUTLIER Glycine 0 C--N 1.332 0.323 0 N-CA-C 110.627 -0.989 . . . . 0.78 110.627 178.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1596 ' ' SER . . . . . . . . . . . . . 79.1 p -122.06 158.48 55.04 Favored Pre-proline 0 C--N 1.288 -2.083 0 N-CA-C 107.691 -1.226 . . . . 1.07 107.691 172.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -57.67 137.63 82.14 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.323 2.016 . . . . 1.01 111.257 178.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1598 ' ' CYS . . . . . 0.503 ' HA ' ' CE2' ' A' 1606 ' ' TYR . 12.0 t -75.0 107.5 4.0 Favored Pre-proline 0 C--N 1.304 -1.399 0 N-CA-C 104.865 -2.272 . . . . 0.75 104.865 177.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 92.1 Cg_exo -44.22 -59.18 1.17 Allowed 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 123.973 3.115 . . . . 1.7 114.814 -169.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1600 ' ' SER . . . . . . . . . . . . . 8.1 m -87.77 12.92 11.66 Favored 'General case' 0 N--CA 1.402 -2.866 0 N-CA-C 112.827 0.676 . . . . 2.26 112.827 -174.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1601 ' ' LYS . . . . . 0.757 ' HE3' ' HB3' ' B' ' 53' ' ' LEU . 96.0 mttt -142.43 69.62 1.32 Allowed 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 122.506 1.146 . . . . 3.01 109.063 174.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 7.2 m -46.71 123.68 5.32 Favored 'General case' 0 N--CA 1.413 -2.315 0 C-N-CA 127.669 2.388 . . . . 2.07 112.326 -177.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 103.96 -21.95 36.62 Favored Glycine 0 N--CA 1.436 -1.348 0 N-CA-C 111.7 -0.56 . . . . 1.08 111.7 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1604 ' ' LEU . . . . . 0.538 HD12 ' HB3' ' A' 1601 ' ' LYS . 46.9 mt -94.11 152.46 18.74 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.019 -1.104 . . . . 1.84 108.019 179.195 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 26.6 m -131.75 145.24 51.5 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 108.078 -1.082 . . . . 1.41 108.078 178.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1606 ' ' TYR . . . . . 0.714 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 91.4 m-85 -64.37 155.99 30.64 Favored 'General case' 0 C--O 1.254 1.327 0 CA-C-N 116.231 -0.44 . . . . 0.6 111.656 -177.364 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1607 ' ' LYS . . . . . 0.521 ' HG3' ' HB3' ' A' 1593 ' ' LYS . 13.0 ttmm -151.89 127.79 10.31 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.502 -0.772 . . . . 1.45 109.553 -173.149 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1608 ' ' SER . . . . . . . . . . . . . 35.1 m -108.79 119.25 39.0 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 108.773 -0.825 . . . . 1.15 108.773 177.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 45.3 t -101.39 104.82 16.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 107.729 -1.211 . . . . 0.25 107.729 178.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 73.9 mt -94.54 111.05 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 N-CA-C 108.621 -0.881 . . . . 0.45 108.621 -178.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 34.3 t -109.12 110.33 21.55 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 115.398 -0.819 . . . . 1.26 110.927 -176.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1612 ' ' PHE . . . . . 1.001 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 63.0 m-85 -86.35 119.69 26.89 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.702 -0.851 . . . . 0.26 108.702 175.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 44.6 t -117.8 137.92 50.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-N 115.954 -0.566 . . . . 0.5 109.72 -176.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 24.4 t -67.93 111.22 4.24 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 123.758 0.823 . . . . 0.77 112.596 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1615 ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -138.43 105.46 7.76 Favored Pre-proline 0 N--CA 1.434 -1.225 0 N-CA-C 109.464 -0.569 . . . . 2.53 109.464 169.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1616 ' ' PRO . . . . . 0.757 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 35.9 Cg_exo -64.3 -10.62 24.42 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 123.224 2.616 . . . . 1.1 113.716 179.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -87.14 42.58 1.04 Allowed 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 125.09 1.356 . . . . 3.05 110.9 -177.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -36.58 119.12 0.61 Allowed 'General case' 0 C--O 1.241 0.607 0 C-N-CA 125.531 1.532 . . . . 1.55 112.738 -178.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . -178.83 -138.4 3.18 Favored Glycine 0 N--CA 1.425 -2.054 0 N-CA-C 110.505 -1.038 . . . . 0.93 110.505 -175.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -66.77 3.31 1.55 Allowed 'Trans proline' 0 N--CA 1.487 1.106 0 C-N-CA 123.516 2.81 . . . . 0.88 115.463 -175.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1621 ' ' THR . . . . . 0.526 ' HB ' ' HB2' ' A' 1641 ' ' HIS . 23.0 p -105.62 -4.52 21.01 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.657 0.741 . . . . 0.97 110.053 176.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 47.0 t30 -92.81 51.72 1.75 Allowed 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 123.215 1.483 . . . . 0.72 108.219 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1623 ' ' ARG . . . . . 0.493 ' O ' ' HG3' ' A' 1625 ' ' MET . 4.7 ptp180 -150.81 141.56 14.75 Favored Pre-proline 0 C--N 1.294 -1.819 0 N-CA-C 105.777 -1.934 . . . . 3.26 105.777 -176.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -57.0 106.77 0.24 Allowed 'Trans proline' 0 C--O 1.245 0.83 0 C-N-CA 122.374 2.049 . . . . 0.59 111.121 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1625 ' ' MET . . . . . 0.493 ' HG3' ' O ' ' A' 1623 ' ' ARG . 93.5 mtp -100.13 128.56 46.19 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 109.051 -0.722 . . . . 1.37 109.051 -176.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 1.8 tm? -87.1 112.51 21.98 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 106.741 -1.577 . . . . 0.89 106.741 -178.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1627 ' ' ILE . . . . . 0.764 HD11 ' HB2' ' A' 1639 ' ' SER . 39.3 mm -72.13 -55.24 14.01 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.613 0 N-CA-C 108.351 -0.981 . . . . 0.58 108.351 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 22.4 t -179.18 173.99 1.09 Allowed 'General case' 0 N--CA 1.422 -1.833 0 N-CA-C 106.286 -1.746 . . . . 1.39 106.286 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1629 ' ' LEU . . . . . 0.78 ' HG ' ' HG ' ' A' 1636 ' ' LEU . 3.8 tt -122.07 110.72 16.13 Favored 'General case' 0 N--CA 1.409 -2.51 0 N-CA-C 104.582 -2.377 . . . . 1.25 104.582 177.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 13.1 t70 -69.21 87.14 0.41 Allowed 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 107.728 -1.212 . . . . 1.09 107.728 176.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1631 ' ' LYS . . . . . 0.618 ' H ' ' HD2' ' A' 1631 ' ' LYS . 0.0 OUTLIER -54.96 -20.71 9.66 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.32 1.048 . . . . 3.6 113.116 -179.278 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A 1632 ' ' GLN . . . . . 0.415 ' HA ' ' NZ ' ' A' 1601 ' ' LYS . 0.3 OUTLIER -71.5 -45.68 61.81 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.441 -0.577 . . . . 2.6 109.441 -177.954 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 44.5 p -102.01 -5.21 24.87 Favored 'General case' 0 CA--C 1.557 1.212 0 N-CA-C 112.928 0.714 . . . . 0.75 112.928 -177.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 58.1 m 65.88 35.67 6.47 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.126 0.97 . . . . 0.53 109.767 -176.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1635 ' ' THR . . . . . 0.5 HG23 ' HD2' ' A' 1607 ' ' LYS . 86.1 m -100.96 129.04 46.75 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.662 -1.154 . . . . 0.46 110.211 -177.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1636 ' ' LEU . . . . . 0.78 ' HG ' ' HG ' ' A' 1629 ' ' LEU . 1.1 mp -107.97 122.36 46.67 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.837 -0.801 . . . . 0.86 108.837 -179.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -100.91 130.01 46.85 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 116.353 -0.385 . . . . 0.45 111.267 -178.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -127.97 130.63 48.7 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.789 -0.641 . . . . 0.5 109.478 -179.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1639 ' ' SER . . . . . 0.764 ' HB2' HD11 ' A' 1627 ' ' ILE . 10.1 t -106.61 156.67 18.35 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.821 -1.178 . . . . 1.04 107.821 178.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 2.0 t90 -156.14 108.62 2.6 Favored 'General case' 0 N--CA 1.423 -1.816 0 N-CA-C 105.689 -1.967 . . . . 0.68 105.689 178.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1641 ' ' HIS . . . . . 0.526 ' HB2' ' HB ' ' A' 1621 ' ' THR . 59.1 m-70 -101.75 102.74 13.42 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 110.018 -0.364 . . . . 0.9 110.018 -175.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1642 ' ' THR . . . . . . . . . . . . . 3.6 t -132.69 149.78 73.94 Favored Pre-proline 0 C--N 1.299 -1.627 0 CA-C-N 115.357 -0.838 . . . . 0.48 109.834 -173.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1643 ' ' PRO . . . . . 0.757 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 71.6 Cg_endo -79.72 -0.12 10.45 Favored 'Trans proline' 0 C--N 1.365 1.4 0 C-N-CA 122.461 2.108 . . . . 0.66 112.139 176.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 11.5 tp -67.12 -28.75 68.4 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.916 0.865 . . . . 0.97 109.038 175.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -89.61 15.61 9.21 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 114.892 -1.049 . . . . 0.84 110.502 -178.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1646 ' ' CYS . . . . . 0.537 ' SG ' ' HA ' ' A' 1643 ' ' PRO . 39.9 m -118.67 146.32 44.79 Favored 'General case' 0 N--CA 1.419 -1.985 0 N-CA-C 106.991 -1.485 . . . . 1.19 106.991 178.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.305 -1.343 0 C-N-CA 119.884 -0.727 . . . . 3.14 109.813 177.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.893 0 N-CA-C 112.861 -0.095 . . . . 2.09 112.861 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.12 -23.92 64.55 Favored Glycine 0 C--O 1.223 -0.562 0 N-CA-C 114.143 0.417 . . . . 1.84 114.143 -175.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . 0.405 ' HA ' HG21 ' A' 1570 ' ' THR . 49.9 mm-40 -67.0 -37.84 84.94 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.428 0.633 . . . . 2.55 109.725 179.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 13' ' ' LEU . . . . . 0.419 ' HG ' ' HA ' ' B' ' 43' ' ' VAL . 0.1 OUTLIER -68.2 -49.77 58.64 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 115.227 -0.897 . . . . 2.35 109.613 -177.776 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 8.2 p -67.41 -32.46 57.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 C-N-CA 119.961 -0.695 . . . . 2.11 111.273 179.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -70.9 -40.05 72.41 Favored 'General case' 0 C--O 1.212 -0.896 0 C-N-CA 119.219 -0.992 . . . . 2.04 112.785 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 16.5 p -63.82 -40.75 97.36 Favored 'General case' 0 C--O 1.265 1.917 0 CA-C-N 118.444 0.566 . . . . 1.84 110.052 177.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.542 HD21 HD11 ' B' ' 42' ' ' ILE . 3.9 mm? -53.34 -53.86 44.83 Favored 'General case' 0 C--O 1.211 -0.929 0 CA-C-N 115.26 -0.882 . . . . 1.74 110.574 171.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 18' ' ' GLN . . . . . 0.568 HE22 ' NE2' ' A' 1569 ' ' GLN . 0.8 OUTLIER -68.89 -20.97 64.26 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 113.001 0.741 . . . . 2.39 113.001 -179.137 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -59.86 -62.67 1.7 Allowed 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 120.927 0.394 . . . . 0.96 110.665 178.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 14.1 p -92.56 -26.09 4.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 C-N-CA 119.119 -1.032 . . . . 1.37 111.33 -177.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 21' ' ' CYS . . . . . 0.443 ' HB2' ' O ' ' B' ' 17' ' ' LEU . 62.6 m -95.98 12.1 31.64 Favored 'General case' 0 N--CA 1.437 -1.111 0 C-N-CA 120.326 -0.55 . . . . 1.66 111.594 -177.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -56.7 -47.47 84.95 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 111.715 -0.554 . . . . 1.53 111.715 173.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -72.24 -14.4 61.77 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 122.816 0.447 . . . . 2.72 111.624 175.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 12.3 tpp180 -100.21 -60.04 1.6 Allowed 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.831 0.824 . . . . 4.33 112.649 -171.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 131.5 152.4 7.21 Favored Glycine 0 N--CA 1.423 -2.232 0 N-CA-C 105.856 -2.897 . . . . 1.53 105.856 -171.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -142.57 141.1 31.95 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 118.832 1.316 . . . . 1.65 111.59 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -161.87 134.61 5.99 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 108.12 -1.067 . . . . 3.42 108.12 175.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 28' ' ' PHE . . . . . 0.434 ' CD1' ' HG ' ' B' ' 17' ' ' LEU . 24.2 p90 . . . . . 0 C--N 1.311 -1.07 0 CA-C-O 122.105 0.955 . . . . 2.26 110.503 -177.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.418 -2.565 0 N-CA-C 110.279 -1.128 . . . . 2.37 110.279 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . 0.542 HD11 HD21 ' B' ' 17' ' ' LEU 0.255 11.8 pt 60.52 -33.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 128.421 2.689 . . . . 2.07 115.346 179.155 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.656 ' O ' ' HB2' ' B' ' 47' ' ' CYS . 6.8 p -56.03 -44.2 77.75 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.452 0 N-CA-C 113.2 0.815 . . . . 2.24 113.2 -178.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -94.73 -31.21 13.89 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.321 -0.992 . . . . 3.36 108.321 -173.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . 0.515 ' O ' ' HB2' ' B' ' 49' ' ' ARG . 28.7 tt0 -67.57 -13.4 62.03 Favored 'General case' 0 CA--C 1.555 1.14 0 CA-C-N 114.728 -1.124 . . . . 3.08 109.924 177.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 46' ' ' CYS . . . . . . . . . . . . . 45.5 t -117.86 -14.19 10.08 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-O 121.397 0.618 . . . . 2.23 110.165 174.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 47' ' ' CYS . . . . . 0.656 ' HB2' ' O ' ' B' ' 43' ' ' VAL . 27.3 t -70.04 -44.55 68.99 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.967 -0.383 . . . . 2.37 109.967 -177.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -119.65 23.3 11.23 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.422 -0.354 . . . . 2.82 110.712 -178.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . 0.515 ' HB2' ' O ' ' B' ' 45' ' ' GLU . 68.4 mtt180 -145.36 162.38 37.4 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 108.393 -0.965 . . . . 4.09 108.393 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 22.4 t -85.18 109.16 18.1 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 106.523 -1.658 . . . . 2.67 106.523 173.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 15.8 p -101.67 144.89 29.83 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 108.001 -1.111 . . . . 2.11 108.001 -176.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -93.13 144.61 25.1 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.419 0.628 . . . . 2.67 109.434 177.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . 0.757 ' HB3' ' HE3' ' A' 1601 ' ' LYS . 48.8 tp -58.46 -27.88 64.8 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.098 1.359 . . . . 1.9 111.363 -179.027 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.32 -39.23 75.4 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.425 -0.807 . . . . 1.52 111.122 178.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 31.3 tp -56.38 -54.63 43.29 Favored 'General case' 0 CA--C 1.516 -0.331 0 O-C-N 124.272 0.983 . . . . 1.97 111.323 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 2.4 pp -73.85 -28.53 61.64 Favored 'General case' 0 N--CA 1.427 -1.61 0 C-N-CA 121.099 -0.24 . . . . 1.53 111.427 -176.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -63.5 -50.47 69.5 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 123.512 0.507 . . . . 2.27 110.711 177.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 14.6 t -80.11 -7.91 59.13 Favored 'General case' 0 CA--C 1.557 1.224 0 CA-C-O 121.092 0.473 . . . . 2.33 111.076 -179.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 59' ' ' TYR . . . . . 0.405 ' HB3' ' H ' ' B' ' 60' ' ' CYS . 15.3 t80 -89.07 -80.13 0.3 Allowed 'General case' 0 N--CA 1.42 -1.973 0 N-CA-C 106.891 -1.522 . . . . 2.86 106.891 176.076 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 60' ' ' CYS . . . . . 0.405 ' H ' ' HB3' ' B' ' 59' ' ' TYR . 43.5 t . . . . . 0 CA--C 1.554 1.12 0 C-N-CA 126.067 1.747 . . . . 2.3 113.869 -178.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 13.3 t70 . . . . . 0 C--O 1.225 -0.203 0 CA-C-O 121.4 0.619 . . . . 2.9 109.448 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A 1516 ' ' CYS . . . . . 0.692 ' HA ' HD23 ' A' 1581 ' ' LEU . 96.0 m 62.35 20.86 12.13 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.756 0.822 . . . . 1.19 112.952 -176.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -155.8 130.83 9.31 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 108.404 -0.961 . . . . 1.52 108.404 177.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1518 ' ' VAL . . . . . 0.465 HG21 ' HB2' ' A' 1583 ' ' TYR . 0.5 OUTLIER -144.14 145.58 21.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 C-N-CA 123.575 0.75 . . . . 0.94 110.066 -178.706 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A 1519 ' ' THR . . . . . . . . . . . . . 27.1 m -114.48 142.49 46.32 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 109.86 -0.422 . . . . 0.89 109.86 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1520 ' ' ASN . . . . . 0.489 ' OD1' HG22 ' A' 1523 ' ' THR . 18.1 t-20 -87.68 113.36 54.06 Favored Pre-proline 0 C--N 1.307 -1.257 0 N-CA-C 107.632 -1.248 . . . . 1.74 107.632 171.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -69.44 -7.49 21.09 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.949 2.433 . . . . 1.58 113.351 -174.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1522 ' ' SER . . . . . 0.455 ' HB2' ' OD1' ' A' 1520 ' ' ASN . 42.9 m -79.26 -45.98 18.7 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 121.116 -0.234 . . . . 1.65 110.95 178.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1523 ' ' THR . . . . . 0.489 HG22 ' OD1' ' A' 1520 ' ' ASN . 7.7 t -111.0 -15.37 13.76 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 120.358 -0.537 . . . . 1.61 112.3 -176.19 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 83.52 25.82 45.4 Favored Glycine 0 C--O 1.225 -0.457 0 C-N-CA 121.041 -0.6 . . . . 1.13 113.195 176.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -92.81 125.14 37.27 Favored 'General case' 0 C--N 1.309 -1.158 0 C-N-CA 120.589 -0.445 . . . . 1.26 110.074 -178.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 2.7 tm? -94.91 116.62 28.94 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 124.071 0.948 . . . . 0.68 109.447 -178.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -92.54 131.39 37.7 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 120.22 -0.592 . . . . 0.65 109.976 173.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 17.3 t70 -120.13 121.06 37.98 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.589 -0.893 . . . . 1.17 108.589 174.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1529 ' ' LEU . . . . . 0.578 ' HG ' HD21 ' A' 1581 ' ' LEU . 3.1 mm? -100.98 5.82 43.29 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 121.332 0.587 . . . . 0.6 110.509 -176.19 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 2.4 m -73.45 -24.75 60.27 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.715 -0.675 . . . . 0.84 110.235 -178.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 23.0 t -66.7 -28.75 68.69 Favored 'General case' 0 CA--C 1.555 1.149 0 CA-C-O 121.366 0.603 . . . . 1.59 110.38 178.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1532 ' ' LEU . . . . . 0.482 ' HG ' HD21 ' A' 1644 ' ' LEU . 95.5 mt -90.92 3.19 55.26 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.071 0.462 . . . . 0.65 110.925 178.177 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1533 ' ' SER . . . . . . . . . . . . . 13.1 t -80.91 176.49 9.77 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.496 0.665 . . . . 1.52 109.622 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . 150.79 153.77 6.26 Favored Glycine 0 N--CA 1.423 -2.195 0 N-CA-C 110.998 -0.841 . . . . 1.1 110.998 -176.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -78.71 -31.97 46.68 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 121.016 0.436 . . . . 4.62 110.604 -178.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -78.11 -29.5 48.97 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.211 0.529 . . . . 1.45 110.723 -179.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 74.34 -141.52 28.98 Favored Glycine 0 N--CA 1.426 -2.028 0 C-N-CA 120.871 -0.681 . . . . 0.85 112.232 177.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -145.18 144.99 31.16 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.82 -1.178 . . . . 0.93 107.82 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 2.6 m -106.62 133.37 51.4 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.317 0.58 . . . . 1.03 110.193 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1540 ' ' ALA . . . . . 0.69 ' HB2' ' HG2' ' A' 1624 ' ' PRO . . . -127.13 140.84 51.98 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.606 -0.887 . . . . 0.5 108.606 178.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -84.08 142.79 30.16 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 123.518 0.511 . . . . 0.74 110.631 -179.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1542 ' ' TYR . . . . . 0.458 ' HD2' ' HE1' ' A' 1567 ' ' PHE . 0.3 OUTLIER -129.53 -101.8 0.32 Allowed 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 107.899 -1.149 . . . . 0.99 107.899 177.713 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A 1543 ' ' SER . . . . . . . . . . . . . 12.5 t -75.2 178.25 5.89 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 109.869 -0.419 . . . . 1.91 109.869 178.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 60.7 tttp -52.61 -44.13 65.8 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.804 0.841 . . . . 3.59 113.235 -173.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 11.1 t -123.01 32.33 5.73 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 107.329 -1.36 . . . . 2.46 107.329 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . -126.6 111.23 1.36 Allowed Glycine 0 N--CA 1.43 -1.707 0 CA-C-N 115.114 -0.948 . . . . 1.26 113.133 -174.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 20.4 m -110.31 157.45 10.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 N-CA-C 108.331 -0.988 . . . . 0.79 108.331 175.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1548 ' ' VAL . . . . . 0.527 ' HA ' ' HA ' ' A' 1567 ' ' PHE . 10.2 p -114.68 132.28 64.3 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 N-CA-C 109.369 -0.604 . . . . 0.58 109.369 177.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -101.1 117.51 35.16 Favored 'General case' 0 CA--C 1.488 -1.405 0 N-CA-C 108.714 -0.847 . . . . 1.08 108.714 178.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 13.0 ptp -129.53 139.41 51.54 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-N 115.824 -0.626 . . . . 0.78 110.402 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 7.1 p -117.48 120.61 38.63 Favored 'General case' 0 C--N 1.274 -2.678 0 CA-C-N 115.016 -0.993 . . . . 0.97 108.459 176.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1552 ' ' ILE . . . . . 0.423 ' HB ' ' O ' ' A' 1532 ' ' LEU . 38.6 mm -77.5 120.85 28.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 C-N-CA 120.672 -0.411 . . . . 0.42 110.571 -177.264 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 38.1 t 67.61 39.43 2.78 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 122.282 1.039 . . . . 1.4 109.314 174.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 176.86 -169.86 42.4 Favored Glycine 0 N--CA 1.422 -2.288 0 C-N-CA 120.436 -0.888 . . . . 0.35 111.258 -178.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -113.53 151.5 31.48 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 120.967 0.413 . . . . 1.62 111.53 -176.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -99.23 146.38 26.25 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 114.676 -1.147 . . . . 0.87 109.107 -176.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -92.45 4.94 52.47 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 112.374 0.509 . . . . 2.49 112.374 -170.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -93.63 -7.77 42.97 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 121.594 -0.691 . . . . 1.38 111.655 -179.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1559 ' ' CYS . . . . . 0.441 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 78.7 m -136.6 165.96 31.29 Favored Pre-proline 0 C--N 1.297 -1.682 0 CA-C-O 118.398 -0.811 . . . . 1.21 109.849 -178.166 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1560 ' ' PRO . . . . . 0.441 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 7.7 Cg_exo -36.5 118.57 0.2 Allowed 'Trans proline' 0 C--N 1.367 1.518 0 C-N-CA 124.561 3.508 . . . . 0.71 113.951 176.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -44.74 130.66 9.89 Favored 'Trans proline' 0 C--N 1.362 1.255 0 C-N-CA 124.59 3.527 . . . . 0.8 112.18 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 111.79 -6.69 27.7 Favored Glycine 0 N--CA 1.435 -1.408 0 CA-C-N 115.906 -0.588 . . . . 0.46 112.404 -177.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1563 ' ' VAL . . . . . . . . . . . . . 7.5 p -105.27 137.19 35.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 O-C-N 122.109 -0.642 . . . . 0.98 111.496 -178.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -99.54 -32.68 5.63 Favored Glycine 0 C--N 1.322 -0.241 0 CA-C-N 115.615 -0.72 . . . . 0.28 112.771 -178.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -122.88 126.21 46.88 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 109.479 -0.563 . . . . 0.28 109.479 178.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 46.5 t -153.73 148.38 26.32 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.842 -0.799 . . . . 0.43 108.842 -179.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1567 ' ' PHE . . . . . 0.637 ' HB2' ' OG1' ' A' 1570 ' ' THR . 96.7 m-85 -92.11 158.78 16.01 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 119.732 -0.787 . . . . 1.03 109.548 176.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -62.6 -75.92 0.29 Allowed Glycine 0 C--O 1.245 0.81 0 N-CA-C 115.183 0.833 . . . . 1.13 115.183 -173.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -67.18 -34.48 77.62 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 113.159 0.799 . . . . 2.58 113.159 -173.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1570 ' ' THR . . . . . 0.739 ' HB ' HG13 ' A' 1572 ' ' ILE . 45.9 p -67.81 -35.17 78.15 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 112.429 0.529 . . . . 2.17 112.429 -177.019 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 18.1 mmt180 64.55 8.88 4.66 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.672 1.189 . . . . 2.62 110.746 -174.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1572 ' ' ILE . . . . . 0.739 HG13 ' HB ' ' A' 1570 ' ' THR . 18.1 mt -74.61 127.29 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-O 121.301 0.572 . . . . 0.92 111.438 -175.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 13.0 t -74.79 118.21 17.5 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 114.922 -1.035 . . . . 0.8 108.656 177.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1574 ' ' VAL . . . . . 0.594 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 24.8 m -114.58 20.29 6.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 C-N-CA 119.738 -0.785 . . . . 0.98 111.933 -179.168 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 161.44 119.75 0.52 Allowed Glycine 0 N--CA 1.432 -1.602 0 C-N-CA 120.327 -0.94 . . . . 0.29 112.451 176.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 57.7 tttm -64.66 139.89 58.81 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.843 -0.429 . . . . 2.19 109.843 178.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -71.73 144.34 49.31 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 115.477 -0.783 . . . . 0.61 110.057 -179.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 22.2 p30 -161.31 179.01 8.66 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 107.853 -1.166 . . . . 1.95 107.853 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 17.7 pttm -134.04 46.53 2.51 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-O 122.941 1.353 . . . . 2.68 108.784 177.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 64.7 ttt180 -101.48 99.88 10.26 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-N 113.383 -1.735 . . . . 3.47 107.75 -175.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1581 ' ' LEU . . . . . 0.692 HD23 ' HA ' ' A' 1516 ' ' CYS . 0.3 OUTLIER -93.53 137.58 32.68 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.855 -0.795 . . . . 0.64 108.855 -175.58 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 75.6 mtp180 -123.91 124.77 43.35 Favored 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 120.652 -0.419 . . . . 2.85 111.045 171.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1583 ' ' TYR . . . . . 0.465 ' HB2' HG21 ' A' 1518 ' ' VAL . 71.1 t80 -96.31 112.78 24.4 Favored 'General case' 0 CA--C 1.49 -1.364 0 N-CA-C 107.239 -1.393 . . . . 0.86 107.239 173.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1584 ' ' VAL . . . . . 0.553 ' O ' ' HB ' ' A' 1587 ' ' VAL . 20.3 t -128.39 92.33 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 N-CA-C 109.501 -0.555 . . . . 1.05 109.501 -178.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 32.6 t70 50.83 69.2 0.67 Allowed 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 124.905 1.282 . . . . 1.17 112.041 175.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 3.0 pt20 71.37 -8.04 1.09 Allowed 'General case' 0 N--CA 1.504 2.271 0 C-N-CA 128.498 2.719 . . . . 1.86 112.197 178.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1587 ' ' VAL . . . . . 0.553 ' HB ' ' O ' ' A' 1584 ' ' VAL . 13.8 t -91.68 120.31 40.54 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.23 0 CA-C-N 115.263 -0.881 . . . . 0.49 110.106 178.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1588 ' ' LEU . . . . . 0.811 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 3.2 mm? -91.06 107.66 19.35 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 105.923 -1.88 . . . . 0.36 105.923 174.49 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -111.08 131.07 55.38 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-O 121.694 0.759 . . . . 1.74 112.515 -173.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1590 ' ' LEU . . . . . 0.449 ' HB2' ' HB ' ' A' 1610 ' ' ILE . 15.0 mt -123.86 104.76 9.14 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 114.0 -1.455 . . . . 0.72 107.699 173.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1591 ' ' VAL . . . . . 0.515 HG23 HG22 ' A' 1609 ' ' VAL . 6.3 p -97.53 128.57 48.72 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 N-CA-C 108.799 -0.815 . . . . 1.01 108.799 179.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1592 ' ' TYR . . . . . 0.506 ' O ' ' HA ' ' A' 1607 ' ' LYS . 15.9 m-30 -115.19 102.65 10.09 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.673 -0.862 . . . . 0.5 108.673 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 57.8 pttt -109.9 176.43 5.07 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.244 -0.65 . . . . 1.59 109.244 -178.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 21.8 m-20 61.0 51.11 4.67 Favored 'General case' 0 C--N 1.312 -1.037 0 O-C-N 124.095 0.872 . . . . 1.11 112.158 177.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -83.09 -134.51 2.28 Favored Glycine 0 N--CA 1.425 -2.098 0 N-CA-C 109.629 -1.389 . . . . 0.78 109.629 172.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1596 ' ' SER . . . . . . . . . . . . . 29.9 p -100.33 157.96 32.85 Favored Pre-proline 0 C--N 1.29 -1.994 0 O-C-N 122.036 -0.685 . . . . 1.07 109.648 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1597 ' ' PRO . . . . . 0.508 ' HA ' ' O ' ' A' 1604 ' ' LEU . 73.4 Cg_exo -52.01 123.6 12.86 Favored 'Trans proline' 0 C--N 1.36 1.167 0 C-N-CA 123.059 2.506 . . . . 1.01 112.234 177.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1598 ' ' CYS . . . . . 0.621 ' HA ' ' CE1' ' A' 1606 ' ' TYR . 43.7 t -77.94 117.84 68.42 Favored Pre-proline 0 C--N 1.299 -1.627 0 CA-C-N 114.959 -1.018 . . . . 0.75 109.659 -178.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -63.93 -30.31 67.23 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.914 2.409 . . . . 1.7 111.855 178.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1600 ' ' SER . . . . . 0.64 ' HA ' ' HB2' ' B' ' 53' ' ' LEU . 14.4 m -61.65 -49.27 77.23 Favored 'General case' 0 C--O 1.25 1.083 0 CA-C-N 116.009 -0.542 . . . . 2.26 110.852 178.264 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1601 ' ' LYS . . . . . 0.686 ' HG2' HD22 ' A' 1604 ' ' LEU . 0.6 OUTLIER -120.81 98.49 6.03 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 107.114 -1.439 . . . . 3.01 107.114 -178.958 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 19.3 m -57.96 119.32 6.55 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 113.822 1.045 . . . . 2.07 113.822 -171.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 98.96 -8.45 61.19 Favored Glycine 0 CA--C 1.499 -0.964 0 N-CA-C 111.595 -0.602 . . . . 1.08 111.595 177.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1604 ' ' LEU . . . . . 0.686 HD22 ' HG2' ' A' 1601 ' ' LYS . 8.8 tp -90.97 170.98 9.6 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.735 -1.209 . . . . 1.84 107.735 -179.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 32.5 t -130.48 150.93 51.47 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 108.644 -0.873 . . . . 1.41 108.644 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1606 ' ' TYR . . . . . 0.621 ' CE1' ' HA ' ' A' 1598 ' ' CYS . 57.8 m-85 -71.48 157.76 37.46 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.744 -0.662 . . . . 0.6 110.856 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1607 ' ' LYS . . . . . 0.506 ' HA ' ' O ' ' A' 1592 ' ' TYR . 75.7 tttt -157.39 125.44 5.47 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 109.21 -0.663 . . . . 1.45 109.21 -173.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1608 ' ' SER . . . . . . . . . . . . . 28.5 m -112.48 132.05 55.26 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-N 116.278 -0.419 . . . . 1.15 109.933 -178.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1609 ' ' VAL . . . . . 0.515 HG22 HG23 ' A' 1591 ' ' VAL . 39.8 t -109.35 108.59 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.507 0 N-CA-C 108.448 -0.945 . . . . 0.25 108.448 177.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1610 ' ' ILE . . . . . 0.449 ' HB ' ' HB2' ' A' 1590 ' ' LEU . 68.7 mt -95.24 126.66 47.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 N-CA-C 108.06 -1.089 . . . . 0.45 108.06 179.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 23.4 m -127.26 118.47 24.3 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 116.138 -0.483 . . . . 1.26 110.911 -178.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1612 ' ' PHE . . . . . 0.811 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 70.0 m-85 -95.55 128.02 42.07 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.912 -0.585 . . . . 0.26 109.596 177.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1613 ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' 1641 ' ' HIS . 66.2 t -122.7 138.84 51.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 CA-C-N 115.402 -0.817 . . . . 0.5 109.443 -177.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1614 ' ' CYS . . . . . 0.71 ' HB2' ' HA ' ' A' 1646 ' ' CYS . 4.0 t -52.07 119.82 4.75 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 124.352 1.061 . . . . 0.77 113.169 176.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1615 ' ' ARG . . . . . 0.824 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 22.2 tpt180 -135.29 89.66 22.63 Favored Pre-proline 0 N--CA 1.439 -0.993 0 N-CA-C 107.739 -1.208 . . . . 2.53 107.739 170.09 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1616 ' ' PRO . . . . . 0.572 ' HD3' ' SG ' ' A' 1614 ' ' CYS . 51.3 Cg_endo -68.94 -23.06 35.06 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.195 1.93 . . . . 1.1 113.425 -172.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -94.86 -3.56 48.61 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.527 -0.306 . . . . 3.05 111.051 -179.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . 59.51 -165.85 0.19 Allowed 'General case' 0 CA--C 1.554 1.108 0 N-CA-C 109.455 -0.572 . . . . 1.55 109.455 -173.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . 135.3 -163.54 24.88 Favored Glycine 0 N--CA 1.415 -2.739 0 C-N-CA 120.961 -0.637 . . . . 0.93 112.403 174.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -61.3 -8.24 10.02 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 124.243 3.295 . . . . 0.88 115.069 -177.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1621 ' ' THR . . . . . . . . . . . . . 19.0 p -96.43 -0.65 48.9 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-O 121.199 0.523 . . . . 0.97 111.369 -177.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 41.4 t30 -87.25 63.43 7.79 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 122.243 1.02 . . . . 0.72 109.059 178.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 -172.76 140.07 0.95 Allowed Pre-proline 0 C--N 1.304 -1.387 0 N-CA-C 107.443 -1.318 . . . . 3.26 107.443 -177.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1624 ' ' PRO . . . . . 0.69 ' HG2' ' HB2' ' A' 1540 ' ' ALA . 35.1 Cg_endo -64.08 99.72 0.29 Allowed 'Trans proline' 0 C--O 1.246 0.917 0 C-N-CA 122.859 2.372 . . . . 0.59 112.355 -176.243 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 70.7 mtm -98.07 133.49 42.45 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.99 -0.55 . . . . 1.37 110.703 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 1.4 tm? -74.58 116.62 15.48 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 108.15 -1.056 . . . . 0.89 108.15 -178.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1627 ' ' ILE . . . . . 0.505 HD11 ' HB2' ' A' 1639 ' ' SER . 43.1 mm -79.56 -55.63 8.83 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 N-CA-C 108.378 -0.971 . . . . 0.58 108.378 177.41 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 77.9 p -164.72 150.27 10.03 Favored 'General case' 0 N--CA 1.419 -1.982 0 CA-C-N 114.833 -1.076 . . . . 1.39 109.537 -179.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1629 ' ' LEU . . . . . 0.865 HD13 ' HG ' ' A' 1636 ' ' LEU . 27.8 tp -119.14 112.31 19.36 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 106.885 -1.524 . . . . 1.25 106.885 172.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 33.1 t70 -78.4 128.86 34.24 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 117.549 -1.661 . . . . 1.09 111.628 177.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1631 ' ' LYS . . . . . 0.513 ' HD3' ' H ' ' A' 1631 ' ' LYS . 0.1 OUTLIER -66.05 -28.96 69.24 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 112.726 -2.034 . . . . 3.6 113.108 -175.564 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 11.1 mm100 -103.0 -35.44 8.55 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 119.918 -0.713 . . . . 2.6 112.134 -174.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 73.9 p -91.99 -6.59 50.92 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-O 120.8 0.333 . . . . 0.75 111.605 -178.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 64.1 m 54.06 33.51 17.83 Favored 'General case' 0 C--N 1.362 1.147 0 C-N-CA 124.669 1.187 . . . . 0.53 111.898 176.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1635 ' ' THR . . . . . . . . . . . . . 29.2 m -100.53 132.1 46.09 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 115.624 -0.716 . . . . 0.46 109.37 -178.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1636 ' ' LEU . . . . . 0.865 ' HG ' HD13 ' A' 1629 ' ' LEU . 0.6 OUTLIER -111.08 124.11 51.54 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 107.919 -1.141 . . . . 0.86 107.919 -177.604 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -106.5 129.38 54.47 Favored 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 120.997 -0.281 . . . . 0.45 110.494 -179.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -125.36 134.9 52.01 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.197 -0.456 . . . . 0.5 110.269 -178.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1639 ' ' SER . . . . . 0.505 ' HB2' HD11 ' A' 1627 ' ' ILE . 31.0 t -110.29 148.81 31.18 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 107.663 -1.236 . . . . 1.04 107.663 176.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 2.6 t90 -152.69 114.27 4.29 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 105.951 -1.87 . . . . 0.68 105.951 -178.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1641 ' ' HIS . . . . . 0.824 ' HB3' ' HB2' ' A' 1615 ' ' ARG . 8.9 m-70 -105.04 115.56 30.48 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 108.889 -0.782 . . . . 0.9 108.889 -178.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1642 ' ' THR . . . . . . . . . . . . . 3.0 t -137.24 150.59 69.51 Favored Pre-proline 0 C--N 1.3 -1.547 0 C-N-CA 123.065 0.546 . . . . 0.48 110.445 -172.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1643 ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.49 -18.38 17.74 Favored 'Trans proline' 0 C--N 1.367 1.524 0 C-N-CA 122.622 2.215 . . . . 0.66 113.328 178.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1644 ' ' LEU . . . . . 0.482 HD21 ' HG ' ' A' 1532 ' ' LEU . 3.8 pp -84.45 -1.47 55.72 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 119.806 -0.757 . . . . 0.97 111.729 -178.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -120.06 28.66 7.95 Favored 'General case' 0 CA--C 1.498 -1.048 0 CA-C-O 122.103 0.954 . . . . 0.84 109.531 -178.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1646 ' ' CYS . . . . . 0.71 ' HA ' ' HB2' ' A' 1614 ' ' CYS . 45.9 t -105.7 140.87 38.1 Favored 'General case' 0 N--CA 1.41 -2.471 0 CA-C-N 114.842 -1.072 . . . . 1.19 109.835 -177.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 35.8 tt0 . . . . . 0 N--CA 1.419 -2.018 0 N-CA-C 104.928 -2.249 . . . . 3.14 104.928 175.971 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . 0.439 ' O ' HG12 ' B' ' 14' ' ' VAL . . . . . . . . 0 N--CA 1.425 -2.071 0 N-CA-C 111.433 -0.667 . . . . 2.09 111.433 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -55.72 -55.07 30.72 Favored Glycine 0 C--O 1.24 0.502 0 N-CA-C 114.388 0.515 . . . . 1.84 114.388 -174.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -74.25 -32.49 62.98 Favored 'General case' 0 CA--C 1.505 -0.775 0 C-N-CA 120.69 -0.404 . . . . 2.55 111.282 -177.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 13' ' ' LEU . . . . . 0.411 HD13 ' HA ' ' B' ' 13' ' ' LEU . 1.1 mm? -58.1 -59.0 5.96 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.175 0.512 . . . . 2.35 111.411 178.006 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . 0.439 HG12 ' O ' ' B' ' 10' ' ' GLY . 13.0 p -68.89 -35.33 68.84 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 CA-C-N 115.857 -0.61 . . . . 2.11 111.882 -176.131 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -78.34 -26.69 46.85 Favored 'General case' 0 C--O 1.213 -0.866 0 N-CA-C 114.105 1.15 . . . . 2.04 114.105 -179.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 19.6 p -67.09 -36.6 82.33 Favored 'General case' 0 C--O 1.256 1.437 0 CA-C-N 119.692 1.133 . . . . 1.84 108.819 174.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.72 ' HB3' ' HB3' ' B' ' 26' ' ' PHE . 10.4 mp -60.77 -47.85 84.43 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-N 114.978 -1.01 . . . . 1.74 111.335 171.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -63.09 -33.3 75.15 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.036 0.446 . . . . 2.39 110.07 179.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -55.52 -59.25 5.09 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 112.905 0.706 . . . . 0.96 112.905 -179.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 9.8 p -98.51 -20.21 5.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 C-N-CA 117.314 -1.755 . . . . 1.37 112.068 -179.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 21' ' ' CYS . . . . . 0.461 ' HB2' ' O ' ' B' ' 17' ' ' LEU . 69.4 m -99.66 1.25 43.33 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 113.473 0.916 . . . . 1.66 113.473 -175.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -49.29 -36.59 22.94 Favored Glycine 0 N--CA 1.483 1.806 0 N-CA-C 114.789 0.676 . . . . 1.53 114.789 -178.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -52.05 -46.91 65.28 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.873 0.869 . . . . 2.72 111.891 176.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -97.56 -43.47 7.22 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.277 0.56 . . . . 4.33 111.348 178.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 128.19 165.54 11.84 Favored Glycine 0 N--CA 1.425 -2.082 0 N-CA-C 110.19 -1.164 . . . . 1.53 110.19 -179.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . 0.72 ' HB3' ' HB3' ' B' ' 17' ' ' LEU . 3.4 p90 -98.25 128.01 44.48 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 117.163 0.481 . . . . 1.65 109.83 175.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -132.78 72.92 1.5 Allowed 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 121.577 0.703 . . . . 3.42 110.482 -176.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 28' ' ' PHE . . . . . . . . . . . . . 8.4 p90 . . . . . 0 C--N 1.321 -0.66 0 CA-C-N 115.123 -0.944 . . . . 2.26 109.282 -179.667 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.2 0 N-CA-C 110.139 -1.184 . . . . 2.37 110.139 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . 0.27 18.4 pt 60.84 -30.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 C-N-CA 127.185 2.194 . . . . 2.07 116.314 178.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 2.7 p -48.97 -46.23 16.61 Favored 'Isoleucine or valine' 0 C--O 1.245 0.837 0 N-CA-C 114.047 1.128 . . . . 2.24 114.047 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -96.69 -30.61 13.13 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 108.579 -0.897 . . . . 3.36 108.579 -172.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -64.72 -42.4 95.26 Favored 'General case' 0 C--O 1.214 -0.798 0 CA-C-N 114.869 -1.059 . . . . 3.08 111.179 177.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 46' ' ' CYS . . . . . 0.421 ' HA ' ' O ' ' B' ' 49' ' ' ARG . 35.7 t -89.33 -3.12 58.6 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.447 0.642 . . . . 2.23 110.703 -179.468 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 41.9 t -83.41 -50.42 8.33 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.638 0.732 . . . . 2.37 109.491 175.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -88.67 -20.04 25.4 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.866 0.691 . . . . 2.82 112.866 -177.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . 0.421 ' O ' ' HA ' ' B' ' 46' ' ' CYS . 36.1 mmt180 -130.68 150.31 51.93 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 106.68 -1.6 . . . . 4.09 106.68 177.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 22.1 t -79.96 127.5 32.34 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 106.827 -1.545 . . . . 2.67 106.827 178.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 24.3 p -90.52 139.21 30.91 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 109.36 -0.607 . . . . 2.11 109.36 -173.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -85.87 165.0 17.16 Favored 'General case' 0 C--O 1.249 1.07 0 C-N-CA 120.566 -0.454 . . . . 2.67 110.305 177.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . 0.64 ' HB2' ' HA ' ' A' 1600 ' ' SER . 63.5 tp -53.2 -45.02 68.43 Favored 'General case' 0 C--N 1.321 -0.663 0 O-C-N 123.479 0.487 . . . . 1.9 111.649 178.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.89 -32.41 63.69 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.368 -0.833 . . . . 1.52 113.184 -171.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 65.9 tp -70.42 -57.65 4.58 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 121.012 0.434 . . . . 1.97 110.295 179.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 2.9 pp -71.97 -25.25 61.79 Favored 'General case' 0 C--O 1.213 -0.867 0 CA-C-N 116.043 -0.526 . . . . 1.53 111.195 -174.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -64.82 -55.6 18.62 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 122.638 0.375 . . . . 2.27 110.162 178.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 13.2 t -78.89 -27.42 43.91 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 119.331 -0.947 . . . . 2.33 112.06 -177.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -71.66 -57.19 4.6 Favored 'General case' 0 C--O 1.219 -0.527 0 N-CA-C 107.02 -1.474 . . . . 2.86 107.02 178.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 9.9 t . . . . . 0 N--CA 1.488 1.464 0 N-CA-C 117.121 2.267 . . . . 2.3 117.121 174.492 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 86.6 mtp . . . . . 0 CA--C 1.502 -0.893 0 N-CA-C 108.685 -0.857 . . . . 9.34 108.685 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -76.71 111.76 12.57 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-N 115.619 -0.719 . . . . 9.04 112.023 -174.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 36.0 m 71.68 130.76 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 124.895 1.278 . . . . 5.81 113.399 175.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1511 ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -78.48 -11.94 59.98 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 109.299 -0.63 . . . . 3.42 109.299 176.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1512 ' ' GLU . . . . . 0.543 ' HA ' HG12 ' A' 1518 ' ' VAL . 29.5 mt-10 -92.64 147.77 22.6 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 114.914 -1.039 . . . . 5.95 108.287 176.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 50.1 m80 -155.71 141.97 18.43 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 105.394 -2.076 . . . . 5.33 105.394 -173.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 21.1 t70 -88.11 46.48 1.39 Allowed 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 107.795 -1.187 . . . . 5.06 107.795 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -132.43 24.4 4.44 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 114.972 -1.013 . . . . 2.9 110.857 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1516 ' ' CYS . . . . . 0.439 ' SG ' ' HB2' ' A' 1579 ' ' LYS . 77.8 m 54.11 35.84 23.3 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 113.876 1.065 . . . . 1.19 113.876 -176.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -143.6 129.33 19.3 Favored 'General case' 0 N--CA 1.434 -1.267 0 C-N-CA 120.07 -0.652 . . . . 1.52 109.662 176.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1518 ' ' VAL . . . . . 0.543 HG12 ' HA ' ' A' 1512 ' ' GLU . 2.5 m -138.57 137.89 42.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 CA-C-N 115.379 -0.828 . . . . 0.94 111.366 -175.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1519 ' ' THR . . . . . . . . . . . . . 6.3 m -98.15 136.85 37.78 Favored 'General case' 0 C--N 1.277 -2.579 0 CA-C-N 115.465 -0.789 . . . . 0.89 109.476 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -77.35 117.71 67.2 Favored Pre-proline 0 N--CA 1.428 -1.537 0 N-CA-C 108.808 -0.812 . . . . 1.74 108.808 176.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -69.47 -13.49 35.49 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 122.491 2.127 . . . . 1.58 113.795 -177.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 15.0 m -82.41 -36.74 26.4 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 112.498 0.555 . . . . 1.65 112.498 -177.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1523 ' ' THR . . . . . . . . . . . . . 12.4 t -137.1 3.48 2.65 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 119.599 -0.84 . . . . 1.61 112.215 -176.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 72.39 28.72 67.31 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.755 -0.736 . . . . 1.13 112.599 177.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 62.3 t-80 -85.18 119.81 25.98 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.797 -0.816 . . . . 1.26 108.797 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 2.6 tm? -87.15 112.47 21.98 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 109.032 -0.729 . . . . 0.68 109.032 -178.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -91.4 114.28 26.77 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 109.82 -0.437 . . . . 0.65 109.82 175.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 17.5 t70 -110.07 116.41 31.52 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.813 -0.81 . . . . 1.17 108.813 175.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1529 ' ' LEU . . . . . 0.6 ' HG ' HD11 ' A' 1581 ' ' LEU . 3.3 mm? -97.49 0.6 47.85 Favored 'General case' 0 N--CA 1.423 -1.817 0 CA-C-O 121.083 0.468 . . . . 0.6 110.301 -177.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1530 ' ' SER . . . . . 0.555 ' HA ' ' OG ' ' A' 1533 ' ' SER . 2.2 m -70.19 -19.31 63.18 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 122.193 0.997 . . . . 0.84 109.419 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1531 ' ' SER . . . . . 0.413 ' HB2' HD11 ' A' 1644 ' ' LEU . 21.2 m -68.68 -18.4 64.26 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 114.931 -1.031 . . . . 1.59 110.238 175.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 82.6 mt -102.93 -6.73 22.13 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 122.322 -0.236 . . . . 0.65 110.979 178.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1533 ' ' SER . . . . . 0.672 ' HA ' ' HB ' ' A' 1552 ' ' ILE . 30.2 m -60.97 162.5 6.93 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-O 120.947 0.403 . . . . 1.52 111.286 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . 170.72 151.61 7.64 Favored Glycine 0 N--CA 1.426 -1.991 0 C-N-CA 120.513 -0.851 . . . . 1.1 111.107 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 33.8 ttt85 -87.21 -30.75 20.74 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 122.946 0.498 . . . . 4.62 111.377 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -78.37 -35.82 46.81 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.727 -0.842 . . . . 1.45 108.727 177.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 80.7 -140.16 21.48 Favored Glycine 0 N--CA 1.409 -3.109 0 CA-C-N 114.535 -1.211 . . . . 0.85 112.324 173.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -142.21 143.14 32.77 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 106.454 -1.684 . . . . 0.93 106.454 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 1.2 m -108.59 130.19 55.31 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 108.793 -0.817 . . . . 1.03 108.793 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1540 ' ' ALA . . . . . 0.456 ' HB2' ' HG2' ' A' 1624 ' ' PRO . . . -124.71 147.33 48.67 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.999 -0.741 . . . . 0.5 108.999 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -91.17 128.18 36.89 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 120.794 0.331 . . . . 0.74 110.225 -177.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1542 ' ' TYR . . . . . 0.556 ' CE2' ' HG ' ' A' 1626 ' ' LEU . 2.3 t80 -113.02 -99.32 0.43 Allowed 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.015 -1.105 . . . . 0.99 108.015 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1543 ' ' SER . . . . . 0.431 ' H ' ' HB3' ' A' 1542 ' ' TYR . 4.5 m -69.81 159.19 34.07 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 108.372 -0.973 . . . . 1.91 108.372 178.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 97.4 mttt -50.6 -42.69 56.19 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.269 0.841 . . . . 3.59 113.269 -177.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 19.9 m -106.53 28.5 7.77 Favored 'General case' 0 N--CA 1.416 -2.137 0 C-N-CA 122.189 0.196 . . . . 2.46 111.487 -177.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . -144.04 149.18 21.2 Favored Glycine 0 C--O 1.245 0.819 0 C-N-CA 119.425 -1.369 . . . . 1.26 113.868 -177.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 19.8 m -130.87 152.06 36.95 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.979 0 N-CA-C 108.564 -0.902 . . . . 0.79 108.564 177.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 10.3 p -108.68 134.63 50.0 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 N-CA-C 109.35 -0.611 . . . . 0.58 109.35 178.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -93.62 133.89 36.48 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 107.148 -1.427 . . . . 1.08 107.148 176.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 25.3 ptm -148.23 127.84 13.28 Favored 'General case' 0 C--N 1.282 -2.33 0 O-C-N 123.771 0.669 . . . . 0.78 109.836 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 5.0 p -119.0 134.42 55.2 Favored 'General case' 0 C--N 1.27 -2.856 0 CA-C-N 115.318 -0.855 . . . . 0.97 109.222 177.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1552 ' ' ILE . . . . . 0.672 ' HB ' ' HA ' ' A' 1533 ' ' SER . 46.3 mm -82.64 116.45 26.88 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 N-CA-C 109.527 -0.546 . . . . 0.42 109.527 -177.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 62.3 m 63.61 11.42 5.7 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.552 1.141 . . . . 1.4 113.701 173.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . -146.36 176.41 25.3 Favored Glycine 0 N--CA 1.42 -2.392 0 N-CA-C 108.972 -1.651 . . . . 0.35 108.972 -177.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -99.34 145.34 27.45 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 117.214 0.507 . . . . 1.62 110.853 -178.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -91.12 131.43 36.69 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 108.092 -1.077 . . . . 0.87 108.092 -176.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -81.7 -2.87 52.06 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 113.709 1.003 . . . . 2.49 113.709 -175.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -84.59 -6.44 59.37 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.381 -0.528 . . . . 1.38 110.781 -178.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1559 ' ' CYS . . . . . 0.632 ' SG ' ' HD2' ' A' 1560 ' ' PRO . 29.5 t -136.02 153.92 77.23 Favored Pre-proline 0 C--N 1.299 -1.612 0 N-CA-C 107.352 -1.351 . . . . 1.21 107.352 -178.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1560 ' ' PRO . . . . . 0.632 ' HD2' ' SG ' ' A' 1559 ' ' CYS . 7.7 Cg_exo -28.61 134.18 0.03 OUTLIER 'Trans proline' 0 CA--C 1.562 1.899 1 C-N-CA 125.471 4.114 . . . . 0.71 115.585 175.718 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A 1561 ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' 1560 ' ' PRO . 4.9 Cg_endo -46.95 126.45 11.17 Favored 'Trans proline' 0 C--O 1.249 1.036 0 C-N-CA 124.818 3.679 . . . . 0.8 114.196 -178.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 105.62 -11.96 46.53 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 115.583 -0.735 . . . . 0.46 112.802 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1563 ' ' VAL . . . . . 0.669 HG11 ' HB2' ' A' 1566 ' ' CYS . 3.6 t -80.28 125.19 38.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 N-CA-C 112.904 0.705 . . . . 0.98 112.904 -178.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -96.73 -34.81 5.6 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.226 -0.897 . . . . 0.28 111.306 176.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -133.77 133.91 42.29 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 109.393 -0.595 . . . . 0.28 109.393 178.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1566 ' ' CYS . . . . . 0.669 ' HB2' HG11 ' A' 1563 ' ' VAL . 52.8 t -159.51 136.67 9.62 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 119.652 -0.213 . . . . 0.43 110.489 -174.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1567 ' ' PHE . . . . . 0.413 ' CE2' HG11 ' A' 1574 ' ' VAL . 74.9 m-85 -84.54 137.91 33.06 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.142 -1.058 . . . . 1.03 108.142 173.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -89.33 11.79 68.65 Favored Glycine 0 N--CA 1.435 -1.37 0 N-CA-C 117.15 1.62 . . . . 1.13 117.15 -168.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1569 ' ' GLN . . . . . 0.492 ' HG2' HE21 ' B' ' 18' ' ' GLN . 0.8 OUTLIER -75.27 -70.59 0.41 Allowed 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 119.035 1.418 . . . . 2.58 110.049 176.661 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 58.7 p -100.4 -4.68 28.51 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 119.809 -0.757 . . . . 2.17 112.873 176.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1571 ' ' ARG . . . . . . . . . . . . 0.269 5.0 mpt_? 74.32 59.08 0.08 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.978 1.311 . . . . 2.62 112.595 -178.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 21.4 mt -90.6 131.2 38.41 Favored 'Isoleucine or valine' 0 C--O 1.243 0.742 0 CA-C-N 114.34 -1.3 . . . . 0.92 107.676 176.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 31.2 t -86.22 130.3 34.57 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.158 0.504 . . . . 0.8 110.642 -175.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1574 ' ' VAL . . . . . 0.549 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 25.4 m -117.8 16.12 7.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-O 121.532 0.682 . . . . 0.98 111.063 179.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 166.34 129.75 1.09 Allowed Glycine 0 N--CA 1.431 -1.684 0 CA-C-N 115.274 -0.876 . . . . 0.29 111.8 176.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 29.6 ttpp -78.74 145.36 34.48 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 107.5 -1.296 . . . . 2.19 107.5 176.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -66.88 80.0 0.11 Allowed 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 124.006 0.922 . . . . 0.61 112.783 -175.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1578 ' ' ASN . . . . . 0.419 ' O ' ' HE1' ' A' 1592 ' ' TYR . 89.6 m-20 -96.06 -172.63 2.61 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 107.636 -1.246 . . . . 1.95 107.636 177.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1579 ' ' LYS . . . . . 0.439 ' HB2' ' SG ' ' A' 1516 ' ' CYS . 15.5 ptpt -149.9 46.71 0.93 Allowed 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 121.882 0.848 . . . . 2.68 110.416 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 57.0 ttp180 -95.13 84.77 4.15 Favored 'General case' 0 N--CA 1.418 -2.066 0 CA-C-N 115.224 -0.898 . . . . 3.47 109.117 -175.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1581 ' ' LEU . . . . . 0.6 HD11 ' HG ' ' A' 1529 ' ' LEU . 2.4 tt -91.56 130.82 37.32 Favored 'General case' 0 C--N 1.294 -1.848 0 CA-C-N 114.135 -1.393 . . . . 0.64 109.618 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 46.6 mtm180 -125.67 141.09 52.19 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 116.074 -0.512 . . . . 2.85 110.235 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1583 ' ' TYR . . . . . . . . . . . . . 46.0 t80 -103.85 105.05 15.13 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.872 -0.788 . . . . 0.86 108.872 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1584 ' ' VAL . . . . . 0.519 ' O ' ' HB ' ' A' 1587 ' ' VAL . 15.5 m -123.51 91.04 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 CA-C-N 115.571 -0.74 . . . . 1.05 112.349 -175.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1585 ' ' ASP . . . . . 0.422 ' O ' ' HG2' ' A' 1586 ' ' GLN . 37.5 t70 57.62 66.79 1.06 Allowed 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.693 0.797 . . . . 1.17 111.357 175.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1586 ' ' GLN . . . . . 0.422 ' HG2' ' O ' ' A' 1585 ' ' ASP . 14.4 pt20 70.63 -3.56 1.89 Allowed 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 128.178 2.591 . . . . 1.86 111.525 178.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1587 ' ' VAL . . . . . 0.519 ' HB ' ' O ' ' A' 1584 ' ' VAL . 24.7 t -97.76 120.9 47.69 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.521 0 CA-C-N 115.158 -0.928 . . . . 0.49 110.787 -177.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1588 ' ' LEU . . . . . 1.017 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 2.9 mm? -91.64 107.22 19.06 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 107.074 -1.454 . . . . 0.36 107.074 175.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1589 ' ' GLN . . . . . 0.486 ' O ' ' HA ' ' A' 1581 ' ' LEU . 33.8 tt0 -98.74 126.63 44.41 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 109.558 -0.534 . . . . 1.74 109.558 -176.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1590 ' ' LEU . . . . . 0.677 ' HB3' ' HB ' ' A' 1610 ' ' ILE . 1.4 tt -121.4 100.05 6.82 Favored 'General case' 0 C--N 1.275 -2.652 0 N-CA-C 104.79 -2.3 . . . . 0.72 104.79 175.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 5.1 p -97.99 131.98 43.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 C-N-CA 120.232 -0.587 . . . . 1.01 111.809 -174.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1592 ' ' TYR . . . . . 0.566 ' O ' ' HG3' ' A' 1607 ' ' LYS . 21.2 m-85 -116.43 142.56 46.71 Favored 'General case' 0 CA--C 1.504 -0.814 0 N-CA-C 107.824 -1.176 . . . . 0.5 107.824 176.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 10.4 ptmm? -147.61 -179.0 6.56 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 106.336 -1.728 . . . . 1.59 106.336 -175.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 16.5 m-20 61.61 47.27 6.57 Favored 'General case' 0 CA--C 1.508 -0.646 0 O-C-N 124.323 1.014 . . . . 1.11 110.478 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -83.43 -140.68 4.18 Favored Glycine 0 N--CA 1.432 -1.578 0 N-CA-C 109.954 -1.258 . . . . 0.78 109.954 178.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1596 ' ' SER . . . . . . . . . . . . . 59.8 p -102.99 156.2 35.62 Favored Pre-proline 0 C--N 1.281 -2.393 0 N-CA-C 107.627 -1.249 . . . . 1.07 107.627 176.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1597 ' ' PRO . . . . . 0.539 ' HA ' ' O ' ' A' 1604 ' ' LEU . 54.0 Cg_exo -54.58 123.81 14.58 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 122.386 2.058 . . . . 1.01 111.322 178.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1598 ' ' CYS . . . . . 0.459 ' HA ' ' HD3' ' A' 1599 ' ' PRO . 31.9 t -74.63 120.47 81.67 Favored Pre-proline 0 C--N 1.303 -1.436 0 N-CA-C 108.62 -0.882 . . . . 0.75 108.62 -178.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1599 ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' 1598 ' ' CYS . 26.1 Cg_exo -62.71 -19.32 67.94 Favored 'Trans proline' 0 N--CA 1.484 0.915 0 C-N-CA 123.585 2.857 . . . . 1.7 112.966 -176.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1600 ' ' SER . . . . . 0.541 ' HA ' ' HB2' ' B' ' 53' ' ' LEU . 6.4 m -58.66 -37.67 76.5 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 124.938 1.295 . . . . 2.26 111.95 178.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1601 ' ' LYS . . . . . 0.447 ' HE2' ' N ' ' A' 1602 ' ' SER . 0.0 OUTLIER -148.5 108.4 4.04 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 104.47 -2.418 . . . . 3.01 104.47 -179.503 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A 1602 ' ' SER . . . . . 0.447 ' N ' ' HE2' ' A' 1601 ' ' LYS . 8.4 t -57.42 117.35 4.03 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 123.02 0.528 . . . . 2.07 110.927 -174.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 106.18 -7.11 40.33 Favored Glycine 0 N--CA 1.437 -1.24 0 C-N-CA 120.828 -0.701 . . . . 1.08 112.481 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1604 ' ' LEU . . . . . 0.571 HD23 ' SG ' ' A' 1634 ' ' CYS . 10.7 tp -84.77 163.09 19.34 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.169 -1.419 . . . . 1.84 107.169 178.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 19.0 t -127.27 153.86 45.61 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.426 -0.953 . . . . 1.41 108.426 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1606 ' ' TYR . . . . . 0.549 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 57.5 m-85 -80.95 166.38 20.89 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.786 -0.45 . . . . 0.6 109.786 176.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1607 ' ' LYS . . . . . 0.566 ' HG3' ' O ' ' A' 1592 ' ' TYR . 36.5 ttpt -160.74 131.74 5.51 Favored 'General case' 0 CA--C 1.503 -0.83 0 N-CA-C 109.922 -0.399 . . . . 1.45 109.922 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1608 ' ' SER . . . . . . . . . . . . . 22.2 m -113.05 123.35 50.1 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 108.81 -0.811 . . . . 1.15 108.81 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 41.5 t -107.91 110.21 31.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 108.909 -0.775 . . . . 0.25 108.909 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1610 ' ' ILE . . . . . 0.677 ' HB ' ' HB3' ' A' 1590 ' ' LEU . 20.3 mm -89.63 128.45 41.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 106.23 -1.767 . . . . 0.45 106.23 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 23.1 t -127.1 101.11 6.39 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-O 121.386 0.612 . . . . 1.26 109.576 -177.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1612 ' ' PHE . . . . . 1.017 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 60.4 m-85 -86.18 130.18 34.61 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.468 -0.787 . . . . 0.26 111.07 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 54.4 t -127.09 139.32 52.24 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.003 0 C-N-CA 123.132 0.573 . . . . 0.5 110.709 -177.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1614 ' ' CYS . . . . . 0.536 ' SG ' ' HD3' ' A' 1616 ' ' PRO . 2.0 t -60.73 111.47 1.64 Allowed 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 125.234 1.414 . . . . 0.77 112.402 177.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1615 ' ' ARG . . . . . 0.648 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 22.2 tpt180 -128.3 86.86 56.82 Favored Pre-proline 0 C--N 1.316 -0.861 0 N-CA-C 108.292 -1.003 . . . . 2.53 108.292 172.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1616 ' ' PRO . . . . . 0.621 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 43.3 Cg_endo -67.72 -23.62 41.98 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 122.272 1.981 . . . . 1.1 113.389 -174.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -86.3 -4.97 59.27 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 121.03 -0.268 . . . . 3.05 111.078 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . 58.34 -162.69 0.22 Allowed 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 123.351 0.661 . . . . 1.55 109.704 -176.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . 139.75 -161.8 26.24 Favored Glycine 0 N--CA 1.411 -3.003 0 C-N-CA 120.279 -0.962 . . . . 0.93 111.522 178.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -83.26 15.45 2.1 Favored 'Trans proline' 0 C--N 1.321 -0.878 0 C-N-CA 123.277 2.651 . . . . 0.88 112.762 -178.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1621 ' ' THR . . . . . . . . . . . . . 20.6 p -106.11 1.39 26.26 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 115.564 -0.743 . . . . 0.97 110.454 -178.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -86.74 65.84 9.19 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 107.158 -1.423 . . . . 0.72 107.158 176.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1623 ' ' ARG . . . . . 0.478 ' O ' ' HG3' ' A' 1625 ' ' MET . 14.2 ptm180 -170.17 140.93 1.65 Allowed Pre-proline 0 C--N 1.291 -1.951 0 N-CA-C 106.566 -1.642 . . . . 3.26 106.566 -175.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1624 ' ' PRO . . . . . 0.456 ' HG2' ' HB2' ' A' 1540 ' ' ALA . 15.4 Cg_endo -55.71 106.51 0.2 Allowed 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 122.78 2.32 . . . . 0.59 111.627 -178.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1625 ' ' MET . . . . . 0.708 ' HB2' ' HB3' ' A' 1639 ' ' SER . 93.2 mtp -98.64 109.36 22.13 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.732 -0.84 . . . . 1.37 108.732 -177.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1626 ' ' LEU . . . . . 0.556 ' HG ' ' CE2' ' A' 1542 ' ' TYR . 0.3 OUTLIER -71.84 115.39 10.99 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 106.685 -1.598 . . . . 0.89 106.685 -179.68 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A 1627 ' ' ILE . . . . . 0.88 HD11 ' HB2' ' A' 1639 ' ' SER . 44.4 mm -70.82 -53.56 21.42 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.119 0 N-CA-C 108.767 -0.827 . . . . 0.58 108.767 -178.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 19.7 t -179.41 162.42 1.15 Allowed 'General case' 0 N--CA 1.422 -1.862 0 N-CA-C 107.435 -1.32 . . . . 1.39 107.435 -176.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1629 ' ' LEU . . . . . . . . . . . . . 43.2 tp -112.75 115.5 28.62 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 107.423 -1.325 . . . . 1.25 107.423 176.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 12.0 t70 -68.6 107.52 2.99 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 107.503 -1.295 . . . . 1.09 107.503 174.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1631 ' ' LYS . . . . . 0.526 ' HD2' HD21 ' B' ' 53' ' ' LEU . 4.0 tppp? -56.6 -37.63 70.91 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.168 -1.378 . . . . 3.6 114.38 -169.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -89.22 -29.11 19.5 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 119.684 -0.807 . . . . 2.6 112.449 -174.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 60.2 p -100.6 -2.57 32.5 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 113.471 0.915 . . . . 0.75 113.471 -174.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1634 ' ' CYS . . . . . 0.571 ' SG ' HD23 ' A' 1604 ' ' LEU . 71.0 m 58.31 37.56 25.98 Favored 'General case' 0 C--N 1.367 1.355 0 CA-C-O 121.849 0.833 . . . . 0.53 111.541 178.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1635 ' ' THR . . . . . . . . . . . . . 88.5 m -105.45 124.12 49.01 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 114.964 -1.017 . . . . 0.46 109.905 -178.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1636 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -104.39 133.07 49.89 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 107.527 -1.286 . . . . 0.86 107.527 -177.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1637 ' ' PHE . . . . . 0.47 ' HB2' ' HB ' ' A' 1627 ' ' ILE . 85.8 m-85 -108.35 137.07 46.94 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.844 -0.428 . . . . 0.45 109.844 178.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -129.58 130.53 45.81 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 109.859 -0.422 . . . . 0.5 109.859 -175.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1639 ' ' SER . . . . . 0.88 ' HB2' HD11 ' A' 1627 ' ' ILE . 11.3 t -106.59 154.67 20.57 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.102 -1.444 . . . . 1.04 107.102 176.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1640 ' ' TRP . . . . . 0.402 ' CH2' ' HD3' ' A' 1624 ' ' PRO . 1.8 t90 -156.44 114.94 3.36 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 106.113 -1.81 . . . . 0.68 106.113 178.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1641 ' ' HIS . . . . . 0.648 ' HB3' ' HB2' ' A' 1615 ' ' ARG . 38.4 m-70 -105.13 112.31 25.39 Favored 'General case' 0 C--N 1.288 -2.105 0 C-N-CA 119.861 -0.736 . . . . 0.9 110.201 -177.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1642 ' ' THR . . . . . . . . . . . . . 4.4 t -142.69 148.94 48.44 Favored Pre-proline 0 C--N 1.307 -1.258 0 CA-C-N 115.731 -0.668 . . . . 0.48 110.375 -175.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1643 ' ' PRO . . . . . 0.621 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 73.5 Cg_endo -79.45 -5.33 14.14 Favored 'Trans proline' 0 C--N 1.367 1.544 0 C-N-CA 122.51 2.14 . . . . 0.66 112.54 176.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1644 ' ' LEU . . . . . 0.413 HD11 ' HB2' ' A' 1531 ' ' SER . 7.6 tt -75.41 -23.21 57.0 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.829 0.823 . . . . 0.97 109.614 177.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -103.0 28.41 6.26 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.006 -0.997 . . . . 0.84 111.395 -174.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 28.6 t -120.56 149.87 41.76 Favored 'General case' 0 C--N 1.287 -2.147 0 C-N-CA 119.971 -0.692 . . . . 1.19 110.57 -175.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.42 119.47 36.13 Favored Pre-proline 0 N--CA 1.419 -2.016 0 N-CA-C 107.655 -1.239 . . . . 3.14 107.655 172.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1648 ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.76 108.81 2.16 Favored 'Trans proline' 0 C--O 1.243 0.761 0 C-N-CA 122.803 2.336 . . . . 2.58 114.972 -171.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 . . . . . 0 C--N 1.307 -1.272 0 N-CA-C 107.412 -1.329 . . . . 4.72 107.412 172.889 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.337 0 N-CA-C 109.209 -0.663 . . . . 9.97 109.209 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -128.21 135.3 49.52 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.899 -0.778 . . . . 7.68 108.899 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 39.3 ptt180 -124.09 144.02 44.13 Favored Pre-proline 0 C--N 1.29 -2.01 0 N-CA-C 108.399 -0.963 . . . . 6.11 108.399 -179.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -67.24 -14.25 42.37 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 123.186 2.591 . . . . 4.84 114.808 -178.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 50.7 m -135.94 118.2 15.59 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 122.016 0.126 . . . . 4.6 111.117 -178.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -78.77 -21.44 47.88 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-O 121.319 0.58 . . . . 4.23 109.738 173.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 6.9 p -122.7 98.37 5.88 Favored 'General case' 0 N--CA 1.415 -2.193 0 N-CA-C 107.915 -1.143 . . . . 3.14 107.915 172.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.613 ' HB3' ' HG3' ' B' ' 12' ' ' GLU . 29.1 tp -74.2 94.89 2.52 Favored 'General case' 0 C--O 1.25 1.125 0 N-CA-C 109.523 -0.547 . . . . 3.96 109.523 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 46.7 m -54.49 119.55 5.4 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 109.008 -0.738 . . . . 2.84 109.008 176.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . 0.462 ' O ' HG12 ' B' ' 14' ' ' VAL . . . 102.22 -82.69 0.44 Allowed Glycine 0 N--CA 1.417 -2.578 0 N-CA-C 109.742 -1.343 . . . . 2.09 109.742 -175.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . 0.438 ' HA3' HD23 ' B' ' 8' ' ' LEU . . . -47.38 -70.53 0.69 Allowed Glycine 0 C--O 1.224 -0.495 0 N-CA-C 115.205 0.842 . . . . 1.84 115.205 -177.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . 0.613 ' HG3' ' HB3' ' B' ' 8' ' ' LEU . 44.5 mt-10 -65.79 -35.4 80.59 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-N 117.814 0.807 . . . . 2.55 110.621 -177.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . 0.58 HD21 ' HB2' ' B' ' 46' ' ' CYS . 5.7 mt -58.73 -60.75 3.34 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 113.306 0.854 . . . . 2.35 113.306 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . 0.462 HG12 ' O ' ' B' ' 10' ' ' GLY . 7.7 p -74.99 -30.37 23.47 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 C-N-CA 120.017 -0.673 . . . . 2.11 111.773 -176.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' ASP . . . . . 0.429 ' OD2' ' HB2' ' A' 1569 ' ' GLN . 18.2 t0 -67.5 -42.27 83.16 Favored 'General case' 0 C--O 1.207 -1.137 0 C-N-CA 119.483 -0.887 . . . . 2.04 111.426 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 23.8 p -61.51 -40.77 95.8 Favored 'General case' 0 C--O 1.25 1.104 0 CA-C-N 118.292 0.496 . . . . 1.84 110.718 177.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.536 ' O ' ' HB2' ' B' ' 21' ' ' CYS . 4.3 mm? -58.5 -51.21 70.81 Favored 'General case' 0 C--O 1.21 -1.022 0 CA-C-N 115.86 -0.609 . . . . 1.74 111.309 174.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . 0.492 HE21 ' HG2' ' A' 1569 ' ' GLN . 29.5 tt0 -69.07 -29.12 67.17 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 116.349 -0.387 . . . . 2.39 111.268 -177.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -61.22 -61.09 2.8 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.949 -0.568 . . . . 0.96 112.248 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 14.2 p -97.9 -13.39 8.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 C-N-CA 118.604 -1.238 . . . . 1.37 111.686 -176.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' CYS . . . . . 0.536 ' HB2' ' O ' ' B' ' 17' ' ' LEU . 73.3 m -106.38 14.43 27.35 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.341 -0.849 . . . . 1.66 112.652 178.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -52.14 -45.39 57.26 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 121.252 -0.499 . . . . 1.53 112.899 176.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -79.19 -42.89 25.02 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.398 0.518 . . . . 2.72 112.398 177.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 6.3 tpm_? -71.25 -33.86 70.21 Favored 'General case' 0 C--O 1.244 0.799 0 N-CA-C 112.864 0.69 . . . . 4.33 112.864 -174.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' B' ' 61' ' ' ALA . . . 110.92 139.43 8.05 Favored Glycine 0 N--CA 1.424 -2.153 0 N-CA-C 108.551 -1.82 . . . . 1.53 108.551 -175.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . 0.464 ' HB2' ' HB3' ' B' ' 17' ' ' LEU . 50.9 p90 -128.4 122.78 32.21 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 117.523 0.662 . . . . 1.65 110.484 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' TYR . . . . . 0.432 ' CZ ' ' HB1' ' B' ' 61' ' ' ALA . 13.9 p90 -163.04 96.14 0.89 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.28 0.562 . . . . 3.42 111.553 178.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' PHE . . . . . 0.436 ' HA ' ' HE1' ' B' ' 59' ' ' TYR . 42.5 p90 -94.13 -10.52 32.98 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-O 121.358 0.599 . . . . 2.26 110.398 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 46.9 t -109.28 108.06 18.51 Favored 'General case' 0 N--CA 1.424 -1.733 0 N-CA-C 107.686 -1.227 . . . . 3.68 107.686 177.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 78.3 mtm-85 -123.02 108.57 32.37 Favored Pre-proline 0 N--CA 1.442 -0.835 0 C-N-CA 120.851 -0.34 . . . . 3.81 110.333 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -65.85 -49.06 2.41 Favored 'Trans proline' 0 C--O 1.237 0.462 0 C-N-CA 123.427 2.752 . . . . 4.02 112.598 178.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' ALA . . . . . 0.801 ' HA ' ' HB3' ' B' ' 38' ' ' ARG . . . -159.41 -178.83 7.43 Favored 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 110.193 -0.299 . . . . 4.92 110.193 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 29.6 t 169.99 150.61 0.04 OUTLIER 'General case' 0 N--CA 1.42 -1.954 0 C-N-CA 126.936 2.094 . . . . 6.72 105.485 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 16.4 ttm180 -81.11 -1.86 46.03 Favored 'General case' 0 C--N 1.283 -2.286 0 CA-C-O 122.275 1.036 . . . . 11.63 108.699 -177.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 51.9 t -91.39 -3.8 10.67 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 CA-C-N 114.447 -1.251 . . . . 9.61 108.823 176.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 23.1 t 62.32 31.3 17.44 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 114.805 -1.089 . . . . 6.71 109.463 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 39.3 ptt180 -92.27 11.45 25.76 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 115.064 -0.971 . . . . 10.0 111.41 -175.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . 0.801 ' HB3' ' HA ' ' B' ' 32' ' ' ALA . 10.2 ptt180 -66.01 80.13 0.08 Allowed 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 114.361 -1.29 . . . . 7.94 112.236 178.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 50.8 m -141.69 115.38 9.08 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 107.656 -1.238 . . . . 5.76 107.656 174.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -81.57 148.39 29.15 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.757 -0.831 . . . . 6.03 108.757 175.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . -147.22 167.22 28.46 Favored Glycine 0 N--CA 1.419 -2.434 0 C-N-CA 119.668 -1.253 . . . . 2.37 111.583 178.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 14.4 pt 61.61 -24.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 C-N-CA 128.245 2.618 . . . . 2.07 116.488 174.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 2.8 p -51.34 -51.35 24.3 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 N-CA-C 114.612 1.338 . . . . 2.24 114.612 -178.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -92.65 -29.64 16.0 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.074 -1.084 . . . . 3.36 108.074 -176.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . 0.722 ' O ' ' HG2' ' B' ' 49' ' ' ARG . 40.6 mt-10 -59.96 -66.67 0.48 Allowed 'General case' 0 N--CA 1.432 -1.371 0 CA-C-N 114.968 -1.015 . . . . 3.08 109.385 177.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' CYS . . . . . 0.58 ' HB2' HD21 ' B' ' 13' ' ' LEU . 72.1 m -76.72 1.24 17.72 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 112.787 0.662 . . . . 2.23 112.787 -175.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 41.1 t -82.47 -50.41 8.88 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 119.496 -0.882 . . . . 2.37 109.105 171.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -102.75 -20.87 14.19 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 114.38 1.252 . . . . 2.82 114.38 -173.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . 0.722 ' HG2' ' O ' ' B' ' 45' ' ' GLU . 17.2 ptp180 -113.05 165.75 12.07 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 108.142 -1.058 . . . . 4.09 108.142 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 28.1 t -86.19 139.72 30.81 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 108.242 -1.021 . . . . 2.67 108.242 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 95.6 m -124.25 159.9 29.17 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-O 121.599 0.714 . . . . 2.11 111.88 -175.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -106.4 149.05 27.39 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 107.167 -1.42 . . . . 2.67 107.167 175.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . 0.541 ' HB2' ' HA ' ' A' 1600 ' ' SER . 55.0 tp -56.34 -27.99 57.62 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 124.905 1.282 . . . . 1.9 112.047 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . 0.624 ' O ' HG22 ' B' ' 58' ' ' THR . . . -58.17 -47.83 82.17 Favored 'General case' 0 CA--C 1.516 -0.352 0 O-C-N 123.2 0.312 . . . . 1.52 110.841 -178.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . 0.441 ' O ' ' HB2' ' B' ' 59' ' ' TYR . 58.7 tp -54.24 -50.97 65.95 Favored 'General case' 0 CA--C 1.509 -0.604 0 C-N-CA 123.847 0.859 . . . . 1.97 111.308 -178.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.406 HD11 HD12 ' B' ' 53' ' ' LEU . 3.4 pp -74.15 -36.07 64.1 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-N 116.07 -0.514 . . . . 1.53 111.555 -174.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -68.63 -48.76 63.25 Favored 'General case' 0 N--CA 1.439 -0.976 0 O-C-N 123.495 0.497 . . . . 2.27 111.357 -178.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' THR . . . . . 0.624 HG22 ' O ' ' B' ' 54' ' ' ALA . 9.2 t -74.08 -15.27 61.06 Favored 'General case' 0 C--O 1.246 0.909 0 C-N-CA 120.186 -0.606 . . . . 2.33 111.73 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' TYR . . . . . 0.441 ' HB2' ' O ' ' B' ' 55' ' ' LEU . 8.6 t80 -80.34 -76.32 0.23 Allowed 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 105.807 -1.923 . . . . 2.86 105.807 174.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 47.2 t 58.56 -78.04 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 125.096 1.359 . . . . 2.3 112.604 176.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' ALA . . . . . 0.432 ' HB1' ' CZ ' ' B' ' 27' ' ' TYR . . . -139.52 -75.73 0.35 Allowed 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 107.459 -1.311 . . . . 3.19 107.459 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -136.37 131.78 18.65 Favored Pre-proline 0 C--N 1.307 -1.277 0 N-CA-C 109.434 -0.58 . . . . 3.68 109.434 175.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -64.67 -24.54 62.31 Favored 'Trans proline' 0 C--O 1.237 0.453 0 C-N-CA 123.598 2.865 . . . . 5.08 117.041 -167.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -124.7 25.39 7.5 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 112.416 0.524 . . . . 5.1 112.416 -177.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . 0.418 ' HD3' ' HA ' ' B' ' 65' ' ' LYS . 24.0 mmtp -94.29 4.5 53.79 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 114.633 1.345 . . . . 8.51 114.633 -178.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 43.7 m -101.91 7.48 41.49 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 121.958 0.885 . . . . 8.12 108.707 174.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 56.7 mm-40 . . . . . 0 N--CA 1.428 -1.529 0 CA-C-N 114.477 -1.238 . . . . 10.21 109.186 -177.914 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.515 -0.37 0 N-CA-C 109.712 -0.477 . . . . 9.34 109.712 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? -96.98 -11.13 24.96 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 122.241 1.02 . . . . 9.04 110.356 -175.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 34.0 t -140.35 -170.3 2.95 Favored 'General case' 0 C--N 1.268 -2.964 0 N-CA-C 107.583 -1.265 . . . . 5.81 107.583 177.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1511 ' ' ASN . . . . . . . . . . . . . 30.7 p-10 -77.72 -28.17 50.79 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.361 0.601 . . . . 3.42 110.186 178.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1512 ' ' GLU . . . . . 0.8 ' HA ' HG12 ' A' 1518 ' ' VAL . 10.9 pt-20 -87.16 159.44 18.87 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.687 -0.688 . . . . 5.95 111.54 -177.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1513 ' ' HIS . . . . . 0.619 ' HB2' ' HG3' ' A' 1517 ' ' GLN . 21.5 m-70 -120.13 -175.72 3.05 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 107.112 -1.44 . . . . 5.33 107.112 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 29.0 t70 -68.99 -33.3 73.44 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 119.562 1.074 . . . . 5.06 112.62 -175.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1515 ' ' ASP . . . . . 0.411 ' HB3' ' H ' ' A' 1516 ' ' CYS . 5.5 m-20 -106.38 -164.18 0.98 Allowed 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.334 0.588 . . . . 2.9 111.626 177.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1516 ' ' CYS . . . . . 0.427 ' HA ' ' HB2' ' A' 1581 ' ' LEU . 6.4 p -76.05 66.32 2.21 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 124.034 0.933 . . . . 1.19 111.976 -177.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1517 ' ' GLN . . . . . 0.619 ' HG3' ' HB2' ' A' 1513 ' ' HIS . 3.9 pt20 -154.93 130.95 10.18 Favored 'General case' 0 N--CA 1.421 -1.89 0 CA-C-N 115.355 -0.838 . . . . 1.52 109.638 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1518 ' ' VAL . . . . . 0.8 HG12 ' HA ' ' A' 1512 ' ' GLU . 9.6 m -135.0 144.39 34.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 C-N-CA 123.183 0.593 . . . . 0.94 111.188 -177.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1519 ' ' THR . . . . . . . . . . . . . 24.6 m -111.26 133.61 53.46 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 109.384 -0.599 . . . . 0.89 109.384 178.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -94.63 123.83 56.9 Favored Pre-proline 0 C--N 1.309 -1.152 0 N-CA-C 109.838 -0.43 . . . . 1.74 109.838 175.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -65.33 -16.17 53.27 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.288 2.658 . . . . 1.58 114.638 -176.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 50.2 m -83.04 -49.64 9.34 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 111.985 0.365 . . . . 1.65 111.985 -177.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1523 ' ' THR . . . . . . . . . . . . . 4.4 t -101.75 -9.1 21.13 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.686 0.755 . . . . 1.61 111.337 -177.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 64.85 35.03 91.43 Favored Glycine 0 CA--C 1.488 -1.64 0 CA-C-N 115.291 -0.868 . . . . 1.13 111.772 178.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 22.3 t-80 -99.45 123.1 43.43 Favored 'General case' 0 N--CA 1.422 -1.83 0 C-N-CA 119.979 -0.688 . . . . 1.26 110.218 -177.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 1.7 tm? -88.34 106.99 18.6 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 114.423 -1.262 . . . . 0.68 108.011 177.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1527 ' ' PHE . . . . . 0.45 ' O ' ' HA ' ' A' 1517 ' ' GLN . 85.8 m-85 -89.07 112.83 23.88 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.052 -0.721 . . . . 0.65 109.052 175.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 22.0 t70 -110.9 114.52 27.92 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.886 -0.783 . . . . 1.17 108.886 177.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 3.5 mm? -90.69 -4.06 57.03 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.288 0.566 . . . . 0.6 110.205 -174.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 7.2 m -61.66 -20.32 63.29 Favored 'General case' 0 C--O 1.219 -0.544 0 CA-C-N 114.976 -1.011 . . . . 0.84 110.685 178.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 19.5 m -65.99 -19.52 65.89 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 120.754 0.311 . . . . 1.59 111.606 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1532 ' ' LEU . . . . . 0.401 ' HB2' HG21 ' A' 1552 ' ' ILE . 73.4 mt -98.51 11.37 38.48 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.675 0.274 . . . . 0.65 111.513 -178.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1533 ' ' SER . . . . . . . . . . . . . 25.4 p -66.13 155.97 35.35 Favored 'General case' 0 C--O 1.252 1.229 0 CA-C-O 121.385 0.612 . . . . 1.52 112.426 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -175.86 142.53 6.12 Favored Glycine 0 N--CA 1.428 -1.864 0 N-CA-C 109.727 -1.349 . . . . 1.1 109.727 178.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 44.0 ttm180 -89.26 -37.9 14.61 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 123.688 0.287 . . . . 4.62 110.841 -177.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -71.36 -33.92 69.99 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-O 122.017 0.913 . . . . 1.45 109.274 178.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 96.89 -171.44 27.29 Favored Glycine 0 N--CA 1.417 -2.626 0 CA-C-N 114.865 -1.061 . . . . 0.85 113.05 172.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -124.86 143.97 50.55 Favored 'General case' 0 C--N 1.279 -2.487 0 N-CA-C 107.845 -1.168 . . . . 0.93 107.845 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 19.7 p -106.2 130.76 54.01 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 123.852 0.72 . . . . 1.03 110.319 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1540 ' ' ALA . . . . . 0.46 ' HB3' ' CG1' ' A' 1548 ' ' VAL . . . -118.97 140.92 49.2 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 107.944 -1.132 . . . . 0.5 107.944 177.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -79.24 139.63 37.86 Favored 'General case' 0 C--N 1.316 -0.875 0 O-C-N 123.726 0.641 . . . . 0.74 109.872 -178.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1542 ' ' TYR . . . . . 0.473 ' HB3' ' H ' ' A' 1543 ' ' SER . 0.5 OUTLIER -149.89 -102.72 0.07 Allowed 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.953 -0.758 . . . . 0.99 108.953 -178.603 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A 1543 ' ' SER . . . . . 0.473 ' H ' ' HB3' ' A' 1542 ' ' TYR . 16.2 m -67.91 152.8 44.98 Favored 'General case' 0 N--CA 1.432 -1.342 0 C-N-CA 124.008 0.923 . . . . 1.91 109.364 -179.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.49 -27.24 69.14 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.453 -0.794 . . . . 3.59 112.326 -171.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 20.3 m -123.25 33.09 5.47 Favored 'General case' 0 N--CA 1.397 -3.087 0 N-CA-C 109.588 -0.523 . . . . 2.46 109.588 176.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . -162.73 130.75 2.32 Favored Glycine 0 N--CA 1.438 -1.203 0 C-N-CA 118.528 -1.796 . . . . 1.26 115.172 -177.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 27.8 m -112.44 160.9 11.65 Favored 'Isoleucine or valine' 0 C--O 1.252 1.184 0 N-CA-C 108.44 -0.948 . . . . 0.79 108.44 177.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1548 ' ' VAL . . . . . 0.46 ' CG1' ' HB3' ' A' 1540 ' ' ALA . 14.8 p -106.85 134.84 47.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 C-N-CA 120.477 -0.489 . . . . 0.58 110.258 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -93.07 130.98 38.5 Favored 'General case' 0 CA--C 1.484 -1.562 0 N-CA-C 108.637 -0.875 . . . . 1.08 108.637 175.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1550 ' ' MET . . . . . 0.425 ' HA ' ' O ' ' A' 1564 ' ' GLY . 15.2 ptp -137.44 137.03 38.33 Favored 'General case' 0 C--N 1.284 -2.27 0 CA-C-N 115.63 -0.714 . . . . 0.78 111.315 175.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 11.6 p -117.63 113.8 22.45 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 115.261 -0.881 . . . . 0.97 108.965 176.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1552 ' ' ILE . . . . . 0.401 HG21 ' HB2' ' A' 1532 ' ' LEU . 48.9 mm -77.71 119.39 26.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 N-CA-C 110.016 -0.364 . . . . 0.42 110.016 -177.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 77.4 m 64.42 44.36 4.2 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 124.041 0.838 . . . . 1.4 110.932 177.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 174.81 -179.49 46.08 Favored Glycine 0 N--CA 1.432 -1.575 0 C-N-CA 120.42 -0.895 . . . . 0.35 111.279 -179.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -104.64 158.63 16.37 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 120.617 0.246 . . . . 1.62 110.656 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -119.06 111.17 17.96 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.25 -1.019 . . . . 0.87 108.25 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -69.77 2.9 2.9 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 114.169 1.174 . . . . 2.49 114.169 -173.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -76.34 -15.73 59.9 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 120.154 -0.618 . . . . 1.38 110.029 178.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1559 ' ' CYS . . . . . 0.705 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 71.1 m -132.5 174.57 4.56 Favored Pre-proline 0 C--N 1.302 -1.482 0 CA-C-O 117.717 -1.135 . . . . 1.21 110.238 -178.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1560 ' ' PRO . . . . . 0.705 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 22.9 Cg_exo -28.75 128.7 0.04 OUTLIER 'Trans proline' 0 C--N 1.396 3.072 1 C-N-CA 125.506 4.137 . . . . 0.71 114.733 178.629 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -43.64 119.87 2.02 Favored 'Trans proline' 0 C--O 1.247 0.942 0 C-N-CA 124.547 3.498 . . . . 0.8 114.21 -177.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 87.43 23.62 39.41 Favored Glycine 0 N--CA 1.437 -1.29 0 CA-C-N 115.515 -0.766 . . . . 0.46 113.368 177.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1563 ' ' VAL . . . . . 0.459 HG11 ' HB2' ' A' 1559 ' ' CYS . 5.5 p -100.98 144.11 13.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 117.94 0.87 . . . . 0.98 109.852 -178.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1564 ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' 1550 ' ' MET . . . -106.07 -30.35 4.52 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 121.235 -0.507 . . . . 0.28 113.252 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -128.26 130.14 47.45 Favored 'General case' 0 C--O 1.247 0.964 0 CA-C-N 117.307 0.553 . . . . 0.28 109.867 178.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1566 ' ' CYS . . . . . 0.443 ' SG ' ' HA ' ' A' 1571 ' ' ARG . 9.9 t -157.72 141.05 15.38 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 116.372 -0.376 . . . . 0.43 111.32 -176.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1567 ' ' PHE . . . . . 0.506 ' CE2' HG11 ' A' 1574 ' ' VAL . 74.3 m-85 -88.08 138.38 31.5 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 108.646 -0.872 . . . . 1.03 108.646 175.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -72.77 -9.08 74.31 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 117.854 1.902 . . . . 1.13 117.854 -168.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -80.16 -70.61 0.51 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 119.997 1.899 . . . . 2.58 112.412 -176.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1570 ' ' THR . . . . . 0.448 HG21 ' HA ' ' B' ' 12' ' ' GLU . 19.1 p -91.96 -3.69 55.57 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 119.862 -0.735 . . . . 2.17 112.782 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1571 ' ' ARG . . . . . 0.443 ' HA ' ' SG ' ' A' 1566 ' ' CYS . 10.8 mmt85 65.49 44.11 3.17 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.59 1.156 . . . . 2.62 111.051 177.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 40.7 mt -74.66 137.23 23.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-N 115.914 -0.585 . . . . 0.92 109.461 178.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 26.7 t -83.3 120.45 25.86 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 109.377 -0.601 . . . . 0.8 109.377 -179.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1574 ' ' VAL . . . . . 0.606 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 32.6 m -118.3 10.18 6.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 C-N-CA 119.368 -0.933 . . . . 0.98 111.377 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 173.99 113.71 0.33 Allowed Glycine 0 N--CA 1.419 -2.482 0 N-CA-C 110.122 -1.191 . . . . 0.29 110.122 178.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1576 ' ' LYS . . . . . 0.515 ' HE2' ' O ' ' A' 1594 ' ' ASP . 24.9 ttmm -73.93 155.47 38.65 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.681 -1.229 . . . . 2.19 107.681 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -67.13 77.55 0.14 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.77 0.795 . . . . 0.61 111.865 -177.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1578 ' ' ASN . . . . . 0.475 ' HB3' ' HD1' ' A' 1592 ' ' TYR . 14.5 t-20 -91.2 -175.73 4.37 Favored 'General case' 0 C--N 1.29 -2.01 0 C-N-CA 125.583 1.553 . . . . 1.95 107.41 -178.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 22.2 pttp -158.58 52.48 0.41 Allowed 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.839 0.828 . . . . 2.68 110.008 176.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1580 ' ' ARG . . . . . 0.522 ' HB3' HG12 ' A' 1591 ' ' VAL . 0.1 OUTLIER -97.48 87.31 4.07 Favored 'General case' 0 N--CA 1.413 -2.314 0 N-CA-C 108.287 -1.005 . . . . 3.47 108.287 -176.509 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A 1581 ' ' LEU . . . . . 0.513 ' HA ' ' O ' ' A' 1589 ' ' GLN . 0.4 OUTLIER -86.37 126.16 34.16 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.999 -1.001 . . . . 0.64 109.05 -177.341 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -124.51 140.94 52.48 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 109.159 -0.682 . . . . 2.85 109.159 175.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1583 ' ' TYR . . . . . 0.667 ' CE1' ' HA ' ' A' 1586 ' ' GLN . 67.9 t80 -105.81 97.38 7.21 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 107.004 -1.48 . . . . 0.86 107.004 176.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1584 ' ' VAL . . . . . 0.537 ' O ' ' HB ' ' A' 1587 ' ' VAL . 15.7 m -111.81 89.69 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.234 0 CA-C-N 115.338 -0.846 . . . . 1.05 112.373 -173.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 29.3 t70 56.88 64.45 1.65 Allowed 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 115.246 -0.888 . . . . 1.17 109.961 179.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1586 ' ' GLN . . . . . 0.667 ' HA ' ' CE1' ' A' 1583 ' ' TYR 0.26 4.2 pt20 63.09 15.22 8.31 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 126.926 2.09 . . . . 1.86 112.897 177.596 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A 1587 ' ' VAL . . . . . 0.537 ' HB ' ' O ' ' A' 1584 ' ' VAL . 29.1 t -108.89 129.39 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.024 0 CA-C-N 114.418 -1.265 . . . . 0.49 109.128 176.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1588 ' ' LEU . . . . . 0.962 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 2.9 mm? -97.57 108.22 20.89 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.644 -0.873 . . . . 0.36 108.644 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1589 ' ' GLN . . . . . 0.513 ' O ' ' HA ' ' A' 1581 ' ' LEU . 35.1 tt0 -100.97 118.32 36.75 Favored 'General case' 0 C--N 1.281 -2.375 0 CA-C-N 116.136 -0.484 . . . . 1.74 111.416 -177.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1590 ' ' LEU . . . . . 0.411 ' HG ' ' CD2' ' A' 1581 ' ' LEU . 1.6 mt -108.51 97.68 7.31 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 106.603 -1.628 . . . . 0.72 106.603 170.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1591 ' ' VAL . . . . . 0.522 HG12 ' HB3' ' A' 1580 ' ' ARG . 8.9 p -94.59 133.44 35.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 CA-C-N 116.275 -0.421 . . . . 1.01 110.084 -177.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1592 ' ' TYR . . . . . 0.475 ' HD1' ' HB3' ' A' 1578 ' ' ASN . 14.7 m-30 -118.52 114.22 22.49 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.277 -1.009 . . . . 0.5 108.277 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 21.3 pttp -115.53 178.92 4.12 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 110.303 -0.258 . . . . 1.59 110.303 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1594 ' ' ASP . . . . . 0.515 ' O ' ' HE2' ' A' 1576 ' ' LYS . 8.7 m-20 68.35 36.6 3.0 Favored 'General case' 0 CA--C 1.506 -0.728 0 C-N-CA 124.028 0.931 . . . . 1.11 112.134 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -72.82 -158.32 4.34 Favored Glycine 0 N--CA 1.443 -0.861 0 N-CA-C 109.675 -1.37 . . . . 0.78 109.675 173.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1596 ' ' SER . . . . . . . . . . . . . 41.0 p -87.92 148.64 43.85 Favored Pre-proline 0 C--N 1.28 -2.455 0 C-N-CA 118.292 -1.363 . . . . 1.07 109.304 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1597 ' ' PRO . . . . . 0.517 ' HG2' ' HB2' ' B' ' 4' ' ' PRO . 64.4 Cg_exo -48.01 131.47 21.42 Favored 'Trans proline' 0 C--O 1.241 0.647 0 C-N-CA 123.423 2.748 . . . . 1.01 111.726 176.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1598 ' ' CYS . . . . . 0.494 ' HA ' ' CE2' ' A' 1606 ' ' TYR . 49.4 t -76.67 127.1 85.02 Favored Pre-proline 0 C--N 1.294 -1.805 0 CA-C-N 114.834 -1.075 . . . . 0.75 110.191 -175.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1599 ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' 1598 ' ' CYS . 20.1 Cg_exo -69.4 -34.03 16.64 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.021 2.481 . . . . 1.7 111.24 176.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1600 ' ' SER . . . . . 0.442 ' HB2' ' SG ' ' A' 1598 ' ' CYS . 9.6 m -57.69 -43.15 84.9 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 123.665 0.786 . . . . 2.26 111.294 178.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1601 ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -145.54 123.54 12.07 Favored 'General case' 0 N--CA 1.423 -1.788 0 N-CA-C 109.006 -0.738 . . . . 3.01 109.006 178.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 10.0 m -78.85 148.59 32.77 Favored 'General case' 0 N--CA 1.407 -2.623 0 C-N-CA 123.229 0.612 . . . . 2.07 110.186 -175.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 105.96 -14.61 44.82 Favored Glycine 0 C--N 1.306 -1.136 0 CA-C-N 116.082 -0.508 . . . . 1.08 113.304 176.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1604 ' ' LEU . . . . . 0.458 HD21 ' HB2' ' A' 1634 ' ' CYS . 0.0 OUTLIER -135.74 147.36 48.4 Favored 'General case' 0 N--CA 1.406 -2.629 0 CA-C-O 121.423 0.63 . . . . 1.84 112.202 -179.68 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 10.3 p -96.17 153.37 17.83 Favored 'General case' 0 C--N 1.308 -1.239 0 C-N-CA 124.297 1.039 . . . . 1.41 110.06 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1606 ' ' TYR . . . . . 0.606 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 51.7 m-85 -60.46 154.12 21.45 Favored 'General case' 0 C--O 1.25 1.102 0 O-C-N 123.287 0.367 . . . . 0.6 111.07 176.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -151.86 126.77 9.67 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 108.795 -0.817 . . . . 1.45 108.795 -176.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1608 ' ' SER . . . . . . . . . . . . . 40.1 m -105.72 130.29 53.76 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 116.269 -0.423 . . . . 1.15 110.202 -177.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 28.2 t -109.15 108.26 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.999 0 N-CA-C 107.845 -1.169 . . . . 0.25 107.845 177.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 64.5 mt -97.77 103.92 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.797 0 N-CA-C 107.598 -1.26 . . . . 0.45 107.598 179.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 23.2 t -99.93 107.82 19.9 Favored 'General case' 0 C--N 1.282 -2.341 0 CA-C-N 114.231 -1.35 . . . . 1.26 110.154 -174.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1612 ' ' PHE . . . . . 0.962 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 68.0 m-85 -90.61 118.2 29.87 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.439 -0.801 . . . . 0.26 109.752 178.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 43.1 t -122.65 139.22 50.17 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 108.531 -0.915 . . . . 0.5 108.531 -177.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 9.0 t -66.88 117.59 9.19 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 124.054 0.942 . . . . 0.77 112.564 -177.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1615 ' ' ARG . . . . . 0.741 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 13.5 tpt180 -137.75 91.16 13.86 Favored Pre-proline 0 N--CA 1.442 -0.835 0 N-CA-C 107.951 -1.129 . . . . 2.53 107.951 172.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1616 ' ' PRO . . . . . 0.752 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 45.7 Cg_endo -67.24 -15.68 46.65 Favored 'Trans proline' 0 N--CA 1.486 1.056 0 C-N-CA 122.754 2.303 . . . . 1.1 113.503 -174.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -58.18 -38.98 77.74 Favored 'General case' 0 C--O 1.242 0.697 0 C-N-CA 124.75 1.22 . . . . 3.05 111.056 178.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . 51.19 96.59 0.01 OUTLIER 'General case' 0 C--O 1.248 0.989 0 C-N-CA 124.363 1.065 . . . . 1.55 113.057 178.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1619 ' ' GLY . . . . . 0.405 ' HA3' ' HD2' ' A' 1620 ' ' PRO . . . -151.1 -143.7 3.77 Favored Glycine 0 C--N 1.29 -1.998 0 N-CA-C 110.679 -0.969 . . . . 0.93 110.679 -179.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1620 ' ' PRO . . . . . 0.405 ' HD2' ' HA3' ' A' 1619 ' ' GLY . 38.9 Cg_endo -67.01 2.77 1.92 Allowed 'Trans proline' 0 N--CA 1.488 1.172 0 C-N-CA 123.039 2.492 . . . . 0.88 114.832 -178.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1621 ' ' THR . . . . . 0.425 HG22 ' HB2' ' A' 1641 ' ' HIS . 8.0 m -102.72 -3.4 26.56 Favored 'General case' 0 N--CA 1.42 -1.959 0 CA-C-O 122.057 0.932 . . . . 0.97 108.953 -179.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 43.8 t30 -87.22 61.9 6.97 Favored 'General case' 0 C--O 1.246 0.872 0 CA-C-O 122.488 1.137 . . . . 0.72 108.666 178.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -165.87 138.7 3.39 Favored Pre-proline 0 C--N 1.303 -1.446 0 CA-C-N 113.733 -1.576 . . . . 3.26 106.984 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -65.11 111.69 1.84 Allowed 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 122.393 2.062 . . . . 0.59 111.19 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 72.5 mtm -115.29 143.9 44.56 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 116.531 -0.304 . . . . 1.37 110.59 -178.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1626 ' ' LEU . . . . . 0.456 ' HG ' ' CE2' ' A' 1542 ' ' TYR . 1.6 tm? -80.95 117.38 21.53 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.152 -1.055 . . . . 0.89 108.152 -178.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 50.7 mm -77.87 -58.1 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 CA-C-O 121.296 0.569 . . . . 0.58 109.727 178.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 66.8 m -163.92 149.8 11.13 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.007 -1.108 . . . . 1.39 108.007 -178.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1629 ' ' LEU . . . . . 0.82 HD13 ' HG ' ' A' 1636 ' ' LEU . 30.0 tp -111.87 110.47 20.83 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 107.557 -1.275 . . . . 1.25 107.557 175.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 17.5 t70 -70.54 117.46 12.1 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 107.347 -1.353 . . . . 1.09 107.347 175.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 95.3 mttt -82.15 -11.13 58.9 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.875 -0.602 . . . . 3.6 111.904 -169.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -95.86 -43.56 7.79 Favored 'General case' 0 N--CA 1.418 -2.065 0 C-N-CA 120.373 -0.531 . . . . 2.6 110.928 -175.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 45.5 p -96.42 -0.38 49.29 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 116.253 -0.43 . . . . 0.75 110.929 178.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1634 ' ' CYS . . . . . 0.458 ' HB2' HD21 ' A' 1604 ' ' LEU . 60.9 m 51.24 39.39 23.7 Favored 'General case' 0 C--N 1.374 1.636 0 C-N-CA 124.921 1.288 . . . . 0.53 112.195 176.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1635 ' ' THR . . . . . . . . . . . . . 90.7 m -100.9 128.08 47.09 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 114.09 -1.414 . . . . 0.46 108.288 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1636 ' ' LEU . . . . . 0.82 ' HG ' HD13 ' A' 1629 ' ' LEU . 0.6 OUTLIER -105.23 122.16 45.35 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.365 -0.606 . . . . 0.86 109.365 -174.497 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -99.91 116.91 33.08 Favored 'General case' 0 C--O 1.244 0.812 0 CA-C-O 121.293 0.568 . . . . 0.45 111.848 -178.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -117.26 134.81 54.36 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 115.105 -0.952 . . . . 0.5 109.361 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1639 ' ' SER . . . . . . . . . . . . . 71.6 m -119.73 138.94 53.0 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 116.219 -0.446 . . . . 1.04 109.902 176.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1640 ' ' TRP . . . . . 0.479 ' CE3' ' HE1' ' A' 1612 ' ' PHE . 3.7 t90 -138.36 103.72 4.98 Favored 'General case' 0 N--CA 1.424 -1.753 0 N-CA-C 103.942 -2.614 . . . . 0.68 103.942 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1641 ' ' HIS . . . . . 0.741 ' HB3' ' HB2' ' A' 1615 ' ' ARG . 28.3 m-70 -95.56 98.77 10.76 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.863 0.84 . . . . 0.9 109.757 -176.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1642 ' ' THR . . . . . . . . . . . . . 3.1 t -124.26 150.83 64.95 Favored Pre-proline 0 C--N 1.299 -1.594 0 CA-C-N 113.732 -1.576 . . . . 0.48 110.388 -170.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1643 ' ' PRO . . . . . 0.752 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 59.8 Cg_endo -77.21 -5.54 15.81 Favored 'Trans proline' 0 C--N 1.364 1.36 0 C-N-CA 122.487 2.125 . . . . 0.66 112.729 175.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 9.0 tt -69.48 -27.45 65.23 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.307 -0.627 . . . . 0.97 109.307 177.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -90.35 14.97 11.43 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.47 -0.786 . . . . 0.84 110.713 -177.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1646 ' ' CYS . . . . . 0.612 ' SG ' ' HA ' ' A' 1643 ' ' PRO . 78.3 m -99.69 156.33 17.14 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 109.614 -0.513 . . . . 1.19 109.614 178.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -106.03 146.9 33.84 Favored Pre-proline 0 C--N 1.289 -2.034 0 N-CA-C 107.294 -1.373 . . . . 3.14 107.294 175.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1648 ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -74.52 95.07 0.93 Allowed 'Trans proline' 0 N--CA 1.442 -1.521 0 C-N-CA 121.23 1.287 . . . . 2.58 110.511 177.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 . . . . . 0 C--N 1.309 -1.195 0 CA-C-N 115.199 -0.909 . . . . 4.72 108.674 179.004 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.51 -0.566 0 N-CA-C 109.904 -0.406 . . . . 9.97 109.904 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -84.14 107.89 16.73 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.25 -1.019 . . . . 7.68 108.25 177.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 4.5 ptp180 -108.13 128.41 25.78 Favored Pre-proline 0 C--N 1.3 -1.558 0 CA-C-N 115.451 -0.795 . . . . 6.11 109.944 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . 0.517 ' HB2' ' HG2' ' A' 1597 ' ' PRO . 88.6 Cg_endo -78.16 47.05 2.26 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 123.259 2.64 . . . . 4.84 114.159 -177.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 19.9 m 45.95 55.72 6.75 Favored 'General case' 0 C--N 1.312 -1.035 0 C-N-CA 125.703 1.601 . . . . 4.6 113.31 176.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -90.39 -46.26 8.48 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.79 -0.818 . . . . 4.23 108.79 178.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 62.1 p -134.9 138.09 43.79 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 107.002 -1.481 . . . . 3.14 107.002 175.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.623 ' HB2' ' SG ' ' B' ' 46' ' ' CYS . 6.9 mp -116.43 93.48 4.24 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 109.329 -0.619 . . . . 3.96 109.329 -178.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' CYS . . . . . 0.612 ' HB2' ' HA ' ' B' ' 47' ' ' CYS . 49.2 t -116.16 109.92 18.11 Favored 'General case' 0 N--CA 1.422 -1.841 0 O-C-N 121.359 -0.838 . . . . 2.84 110.44 -178.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.13 -121.39 6.69 Favored Glycine 0 C--N 1.304 -1.196 0 CA-C-N 115.144 -0.934 . . . . 2.09 113.252 178.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -51.26 -52.32 32.56 Favored Glycine 0 C--O 1.214 -1.128 0 C-N-CA 123.697 0.665 . . . . 1.84 114.469 -176.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . 0.448 ' HA ' HG21 ' A' 1570 ' ' THR . 1.6 mp0 -57.41 -42.74 82.9 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 122.816 0.446 . . . . 2.55 110.917 -178.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . 0.424 ' HG ' ' SG ' ' B' ' 46' ' ' CYS . 1.1 tt -61.39 -52.61 63.88 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 115.371 -0.831 . . . . 2.35 109.853 -178.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 22.2 m -72.72 -30.37 33.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.37 0 C-N-CA 119.531 -0.867 . . . . 2.11 111.869 -176.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -69.34 -42.82 74.79 Favored 'General case' 0 C--O 1.203 -1.375 0 C-N-CA 120.728 -0.389 . . . . 2.04 111.94 177.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 25.3 p -62.85 -38.8 92.24 Favored 'General case' 0 C--O 1.258 1.523 0 CA-C-O 121.446 0.641 . . . . 1.84 110.054 176.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.563 ' HB3' ' HB3' ' B' ' 26' ' ' PHE . 3.6 mm? -56.75 -49.73 74.37 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-N 115.317 -0.856 . . . . 1.74 111.012 171.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -66.64 -32.37 73.65 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 124.384 1.074 . . . . 2.39 109.809 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -52.84 -57.67 9.43 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 116.023 -0.535 . . . . 0.96 111.939 178.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 13.0 p -98.87 -26.24 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 C-N-CA 118.204 -1.398 . . . . 1.37 112.854 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 85.1 m -106.92 1.08 24.3 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 113.597 0.962 . . . . 1.66 113.597 -177.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -55.86 -24.17 40.57 Favored Glycine 0 N--CA 1.479 1.558 0 N-CA-C 116.969 1.548 . . . . 1.53 116.969 -173.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -58.77 -40.73 84.77 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 118.136 0.968 . . . . 2.72 109.699 175.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 25.2 tpp180 -90.45 -48.57 7.02 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 108.07 -1.085 . . . . 4.33 108.07 177.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 130.33 -152.05 19.65 Favored Glycine 0 N--CA 1.424 -2.144 0 N-CA-C 109.84 -1.304 . . . . 1.53 109.84 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . 0.563 ' HB3' ' HB3' ' B' ' 17' ' ' LEU . 23.2 p90 -137.83 139.28 39.86 Favored 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 108.956 -0.757 . . . . 1.65 108.956 176.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -125.74 -67.78 0.86 Allowed 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 112.827 0.677 . . . . 3.42 112.827 -176.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' PHE . . . . . . . . . . . . . 50.4 p90 43.82 17.74 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.511 0 N-CA-C 117.319 2.34 . . . . 2.26 117.319 171.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' SER . . . . . 0.644 ' HA ' ' HA ' ' B' ' 40' ' ' ARG . 37.7 t -157.53 133.65 9.51 Favored 'General case' 0 N--CA 1.42 -1.951 0 N-CA-C 109.101 -0.703 . . . . 3.68 109.101 -177.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . 0.651 ' HB2' ' H ' ' B' ' 39' ' ' SER . 1.1 mmp_? -123.68 108.03 31.18 Favored Pre-proline 0 C--N 1.303 -1.437 0 N-CA-C 106.148 -1.797 . . . . 3.81 106.148 177.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -68.2 -39.3 10.54 Favored 'Trans proline' 0 C--O 1.245 0.868 0 C-N-CA 122.638 2.226 . . . . 4.02 113.119 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -163.26 177.05 9.33 Favored 'General case' 0 N--CA 1.423 -1.822 0 N-CA-C 108.777 -0.823 . . . . 4.92 108.777 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . 0.479 ' CB ' ' HG2' ' B' ' 37' ' ' ARG . 15.8 t 171.45 153.69 0.07 Allowed 'General case' 0 N--CA 1.412 -2.367 0 C-N-CA 126.566 1.946 . . . . 6.72 106.565 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 9.6 ttm180 -83.43 3.23 32.85 Favored 'General case' 0 C--N 1.282 -2.354 0 CA-C-O 122.474 1.131 . . . . 11.63 108.866 -178.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 0.525 HG21 ' HG2' ' B' ' 67' ' ' GLU . 61.3 t -100.01 -3.64 9.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-N 114.484 -1.235 . . . . 9.61 108.538 175.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 47.0 t 61.98 30.79 18.1 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 114.57 -1.195 . . . . 6.71 109.272 -178.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . 0.565 ' NH1' ' HB2' ' B' ' 67' ' ' GLU . 38.7 ptt180 -85.69 11.19 11.44 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.925 -1.034 . . . . 10.0 112.608 -173.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -46.14 111.18 0.33 Allowed 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.218 0.607 . . . . 7.94 109.92 178.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . 0.651 ' H ' ' HB2' ' B' ' 30' ' ' ARG . 70.4 m -155.16 98.18 1.98 Allowed 'General case' 0 N--CA 1.425 -1.71 0 CA-C-O 121.142 0.496 . . . . 5.76 109.752 -179.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . 0.644 ' HA ' ' HA ' ' B' ' 29' ' ' SER . 0.0 OUTLIER -85.69 145.24 27.38 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 107.369 -1.345 . . . . 6.03 107.369 171.664 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . -152.46 163.4 30.29 Favored Glycine 0 N--CA 1.416 -2.686 0 C-N-CA 119.598 -1.287 . . . . 2.37 111.583 -178.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . 0.263 10.6 pt 64.44 -33.92 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.213 -0.835 0 C-N-CA 128.651 2.78 . . . . 2.07 114.9 177.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.436 ' O ' ' HB2' ' B' ' 47' ' ' CYS . 2.4 p -48.03 -44.49 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 C-N-CA 123.833 0.853 . . . . 2.24 112.896 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -97.14 -38.35 9.76 Favored 'General case' 0 N--CA 1.415 -2.211 0 CA-C-N 115.606 -0.725 . . . . 3.36 109.506 -172.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -61.54 -47.46 85.46 Favored 'General case' 0 C--O 1.197 -1.702 0 CA-C-N 116.002 -0.544 . . . . 3.08 110.725 178.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' CYS . . . . . 0.623 ' SG ' ' HB2' ' B' ' 8' ' ' LEU . 42.6 t -78.01 -16.27 58.24 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 121.222 0.534 . . . . 2.23 109.823 -178.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' CYS . . . . . 0.612 ' HA ' ' HB2' ' B' ' 9' ' ' CYS . 44.3 t -79.66 -48.01 14.44 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 116.216 -0.447 . . . . 2.37 110.857 177.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -98.42 -25.8 14.68 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 113.678 0.992 . . . . 2.82 113.678 -176.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -110.26 -179.8 3.88 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.333 -0.988 . . . . 4.09 108.333 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 8.2 t -93.05 132.5 37.11 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 106.771 -1.566 . . . . 2.67 106.771 176.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 1.6 p -111.38 137.44 49.15 Favored 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 123.205 0.602 . . . . 2.11 110.887 -175.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -112.0 177.72 4.55 Favored 'General case' 0 C--O 1.244 0.764 0 N-CA-C 112.489 0.551 . . . . 2.67 112.489 -178.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . 0.418 ' O ' ' HG ' ' B' ' 56' ' ' LEU . 52.6 tp -51.24 -53.89 31.01 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 125.125 1.37 . . . . 1.9 113.601 -178.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.72 -41.05 73.31 Favored 'General case' 0 C--O 1.244 0.793 0 C-N-CA 124.023 0.929 . . . . 1.52 112.456 -170.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 61.3 tp -63.47 -46.22 87.23 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 114.921 -1.036 . . . . 1.97 111.957 -178.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' B' ' 53' ' ' LEU . 3.3 pp -79.66 -24.64 41.67 Favored 'General case' 0 N--CA 1.41 -2.459 0 C-N-CA 119.765 -0.774 . . . . 1.53 111.143 -176.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -70.6 -43.68 68.85 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 116.082 -0.508 . . . . 2.27 110.616 178.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 24.2 p -63.58 -43.12 97.9 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-N 116.25 -0.432 . . . . 2.33 111.848 179.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -73.31 -59.61 2.63 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 116.739 -0.21 . . . . 2.86 110.505 178.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 41.8 t 46.44 -98.21 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 125.029 1.332 . . . . 2.3 113.984 179.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -154.39 178.5 9.97 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 107.688 -1.227 . . . . 3.19 107.688 -176.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 10.2 p -145.04 155.72 55.12 Favored Pre-proline 0 C--N 1.293 -1.87 0 N-CA-C 107.738 -1.208 . . . . 3.68 107.738 177.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . 0.591 ' HG2' ' HB2' ' B' ' 66' ' ' SER . 37.6 Cg_endo -73.42 0.09 8.52 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 123.13 2.553 . . . . 5.08 111.771 177.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 72.25 5.04 5.2 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.165 1.786 . . . . 5.1 113.796 173.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -144.52 39.55 1.28 Allowed 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 123.218 1.485 . . . . 8.51 107.941 178.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . 0.591 ' HB2' ' HG2' ' B' ' 63' ' ' PRO . 25.6 t -106.01 98.55 8.22 Favored 'General case' 0 C--N 1.275 -2.643 0 CA-C-N 113.785 -1.552 . . . . 8.12 109.088 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . 0.565 ' HB2' ' NH1' ' B' ' 37' ' ' ARG . 14.7 tp10 . . . . . 0 C--O 1.247 0.953 0 N-CA-C 107.993 -1.114 . . . . 10.21 107.993 176.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 88.4 mtp . . . . . 0 CA--C 1.503 -0.85 0 N-CA-C 108.847 -0.798 . . . . 9.34 108.847 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A 1509 ' ' LYS . . . . . 0.551 ' HG3' ' OE1' ' A' 1512 ' ' GLU . 23.3 ttmm -134.81 34.4 3.15 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 122.897 1.332 . . . . 9.04 108.904 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1510 ' ' SER . . . . . 0.44 ' HB3' ' CB ' ' A' 1519 ' ' THR . 39.5 m -85.5 -34.43 21.58 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 107.991 -1.114 . . . . 5.81 107.991 176.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1511 ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -119.91 103.16 9.09 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 114.686 -1.143 . . . . 3.42 108.751 174.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1512 ' ' GLU . . . . . 0.551 ' OE1' ' HG3' ' A' 1509 ' ' LYS . 12.4 mm-40 -78.19 -28.8 48.22 Favored 'General case' 0 CA--C 1.494 -1.193 0 N-CA-C 108.537 -0.912 . . . . 5.95 108.537 172.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 53.9 t-80 73.8 -51.37 0.69 Allowed 'General case' 0 C--O 1.215 -0.757 0 CA-C-N 113.811 -1.54 . . . . 5.33 111.366 176.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -103.02 32.63 3.62 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-O 121.871 0.843 . . . . 5.06 110.654 -177.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 7.0 t70 -149.12 164.45 34.65 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 104.138 -2.541 . . . . 2.9 104.138 175.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1516 ' ' CYS . . . . . 0.927 ' HB3' ' HB2' ' A' 1529 ' ' LEU . 72.6 m -79.89 60.41 3.48 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 123.35 0.66 . . . . 1.19 112.247 -174.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1517 ' ' GLN . . . . . 0.485 ' HA ' ' O ' ' A' 1527 ' ' PHE . 16.5 pt20 -164.41 129.33 2.73 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-O 121.392 0.615 . . . . 1.52 110.905 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 2.9 m -148.56 143.59 18.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-N 114.726 -1.125 . . . . 0.94 109.725 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1519 ' ' THR . . . . . 0.44 ' CB ' ' HB3' ' A' 1510 ' ' SER . 91.6 m -114.04 121.49 44.0 Favored 'General case' 0 N--CA 1.423 -1.787 0 N-CA-C 108.173 -1.047 . . . . 0.89 108.173 174.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1520 ' ' ASN . . . . . 0.454 ' HA ' ' HD3' ' A' 1521 ' ' PRO . 26.3 t-20 -80.26 121.93 82.25 Favored Pre-proline 0 C--N 1.294 -1.82 0 N-CA-C 109.33 -0.619 . . . . 1.74 109.33 177.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1521 ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' 1520 ' ' ASN . 12.6 Cg_exo -69.75 -19.61 35.96 Favored 'Trans proline' 0 CA--C 1.529 0.227 0 C-N-CA 123.051 2.5 . . . . 1.58 113.509 -175.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1522 ' ' SER . . . . . 0.419 ' HB2' ' OD1' ' A' 1520 ' ' ASN . 22.5 m -72.33 -32.21 66.32 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 120.836 0.35 . . . . 1.65 111.094 -179.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1523 ' ' THR . . . . . 0.705 HG21 ' HG3' ' A' 1647 ' ' GLU . 8.8 t -124.87 -9.46 7.23 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 119.433 -0.907 . . . . 1.61 112.14 -177.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 68.73 34.34 77.79 Favored Glycine 0 CA--C 1.501 -0.795 0 CA-C-N 115.828 -0.623 . . . . 1.13 113.399 176.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 9.7 t-160 -107.03 121.16 43.93 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 119.163 -1.015 . . . . 1.26 111.415 178.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 2.3 tm? -82.47 115.99 21.72 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 114.494 -1.23 . . . . 0.68 108.688 176.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1527 ' ' PHE . . . . . 0.485 ' O ' ' HA ' ' A' 1517 ' ' GLN . 96.8 m-85 -96.32 121.69 38.39 Favored 'General case' 0 C--N 1.31 -1.149 0 O-C-N 122.158 -0.339 . . . . 0.65 110.494 174.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 10.3 t70 -105.49 109.83 21.94 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 106.923 -1.51 . . . . 1.17 106.923 175.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1529 ' ' LEU . . . . . 0.927 ' HB2' ' HB3' ' A' 1516 ' ' CYS . 3.7 mm? -90.69 -3.5 57.43 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 121.282 0.563 . . . . 0.6 110.22 -177.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 16.0 m -72.84 -15.56 61.62 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.624 -0.716 . . . . 0.84 109.632 178.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1531 ' ' SER . . . . . 0.416 ' HB2' HD11 ' A' 1644 ' ' LEU . 14.8 m -66.38 -22.39 66.25 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-O 121.287 0.565 . . . . 1.59 109.709 173.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 80.4 mt -101.5 3.96 40.7 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.18 -0.464 . . . . 0.65 111.315 177.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1533 ' ' SER . . . . . . . . . . . . . 46.2 t -60.07 158.68 10.68 Favored 'General case' 0 C--O 1.245 0.825 0 CA-C-O 121.959 0.885 . . . . 1.52 111.682 -177.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -178.53 116.09 0.52 Allowed Glycine 0 C--N 1.278 -2.667 0 CA-C-N 114.237 -1.347 . . . . 1.1 110.132 -175.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -92.79 -36.75 12.7 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 112.373 0.509 . . . . 4.62 112.373 -176.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -59.52 -54.42 46.73 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-O 121.262 0.553 . . . . 1.45 110.372 -176.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 136.09 152.99 6.47 Favored Glycine 0 N--CA 1.413 -2.886 0 C-N-CA 120.535 -0.84 . . . . 0.85 113.382 173.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -114.51 139.56 49.46 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 106.151 -1.796 . . . . 0.93 106.151 174.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 5.1 p -106.58 128.71 54.35 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.21 0.528 . . . . 1.03 111.858 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -123.95 141.03 52.4 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 107.991 -1.115 . . . . 0.5 107.991 176.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -82.95 128.98 34.96 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 120.773 0.321 . . . . 0.74 110.72 -177.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1542 ' ' TYR . . . . . 0.578 ' CE2' ' HG ' ' A' 1626 ' ' LEU . 2.0 t80 -121.1 -100.6 0.43 Allowed 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 107.626 -1.25 . . . . 0.99 107.626 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1543 ' ' SER . . . . . 0.441 ' H ' ' HB3' ' A' 1542 ' ' TYR . 8.0 m -66.35 164.06 16.89 Favored 'General case' 0 N--CA 1.437 -1.123 0 C-N-CA 122.815 0.446 . . . . 1.91 110.808 -178.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 23.4 tptm -56.83 -41.54 78.05 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 118.103 0.41 . . . . 3.59 111.132 -176.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 49.9 m -110.88 34.41 4.02 Favored 'General case' 0 N--CA 1.412 -2.352 0 N-CA-C 109.621 -0.511 . . . . 2.46 109.621 178.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . -144.63 134.48 5.67 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 118.808 -1.663 . . . . 1.26 115.335 -176.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 28.1 m -121.68 148.4 25.16 Favored 'Isoleucine or valine' 0 C--O 1.247 0.944 0 N-CA-C 108.561 -0.903 . . . . 0.79 108.561 174.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 11.9 p -104.05 137.11 34.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 N-CA-C 109.747 -0.464 . . . . 0.58 109.747 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -98.01 125.07 42.78 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.834 -0.802 . . . . 1.08 108.834 175.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 23.3 ptm -136.17 133.67 37.41 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 115.539 -0.755 . . . . 0.78 110.342 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 12.7 p -117.69 137.53 52.61 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.549 -0.75 . . . . 0.97 109.627 176.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1552 ' ' ILE . . . . . . . . . . . . . 42.4 mm -96.83 118.53 43.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 110.37 -0.233 . . . . 0.42 110.37 -177.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 75.4 m 65.84 24.76 11.31 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-O 122.199 1.0 . . . . 1.4 112.047 175.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . -164.51 -177.73 37.38 Favored Glycine 0 N--CA 1.406 -3.337 0 CA-C-N 114.261 -1.336 . . . . 0.35 110.004 -178.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -109.39 145.35 36.25 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-O 121.043 0.449 . . . . 1.62 110.933 -176.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -81.41 145.25 30.89 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.345 -0.843 . . . . 0.87 111.809 -172.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -84.96 10.07 12.78 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 123.819 0.848 . . . . 2.49 113.176 -171.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -119.41 -10.73 9.63 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 119.586 -0.846 . . . . 1.38 112.562 -176.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1559 ' ' CYS . . . . . 0.529 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 83.4 m -132.26 164.26 44.54 Favored Pre-proline 0 C--N 1.296 -1.755 0 CA-C-O 117.877 -1.058 . . . . 1.21 110.04 -177.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1560 ' ' PRO . . . . . 0.529 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 12.0 Cg_exo -31.11 131.59 0.06 OUTLIER 'Trans proline' 0 C--N 1.376 2.001 1 C-N-CA 125.536 4.157 . . . . 0.71 115.489 -179.418 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -49.34 128.34 20.03 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 123.77 2.98 . . . . 0.8 111.731 179.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 102.3 -3.86 51.18 Favored Glycine 0 N--CA 1.43 -1.73 0 CA-C-N 116.018 -0.537 . . . . 0.46 113.765 -178.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1563 ' ' VAL . . . . . . . . . . . . . 5.2 p -98.52 138.21 23.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 118.362 1.081 . . . . 0.98 111.291 -178.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -102.11 -31.16 5.44 Favored Glycine 0 CA--C 1.522 0.491 0 CA-C-N 115.693 -0.685 . . . . 0.28 113.172 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -129.28 130.81 46.66 Favored 'General case' 0 N--CA 1.445 -0.723 0 O-C-N 122.528 -0.395 . . . . 0.28 109.967 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 44.0 t -157.02 138.61 14.05 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 110.018 -0.364 . . . . 0.43 110.018 -176.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -85.28 137.67 32.82 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 108.87 -0.789 . . . . 1.03 108.87 174.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -72.33 -18.61 78.3 Favored Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 116.983 1.553 . . . . 1.13 116.983 -167.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -73.23 -70.24 0.38 Allowed 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 118.362 1.081 . . . . 2.58 111.246 -175.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.16 -2.47 58.07 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.198 -0.91 . . . . 2.17 112.755 -176.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 9.9 mmt85 60.04 36.76 21.38 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 114.923 -1.035 . . . . 2.62 110.519 178.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 30.6 mt -74.97 125.24 34.25 Favored 'Isoleucine or valine' 0 C--O 1.245 0.867 0 CA-C-N 115.909 -0.587 . . . . 0.92 109.761 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 21.9 t -74.48 125.09 27.81 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 114.995 -1.002 . . . . 0.8 109.812 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1574 ' ' VAL . . . . . 0.664 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 33.6 m -122.19 16.51 5.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 C-N-CA 120.009 -0.676 . . . . 0.98 112.026 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 167.82 122.72 0.63 Allowed Glycine 0 N--CA 1.432 -1.594 0 C-N-CA 119.977 -1.106 . . . . 0.29 112.618 175.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 4.1 ttmp? -71.64 142.1 49.93 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.23 -1.026 . . . . 2.19 108.23 177.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -72.83 88.23 1.32 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.29 0.567 . . . . 0.61 110.965 -177.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -109.56 150.79 27.66 Favored 'General case' 0 C--N 1.29 -1.978 0 N-CA-C 107.283 -1.377 . . . . 1.95 107.283 179.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -105.15 45.71 0.95 Allowed 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 106.275 -1.75 . . . . 2.68 106.275 -177.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 56.3 ttt180 -84.97 76.59 10.25 Favored 'General case' 0 N--CA 1.411 -2.376 0 CA-C-N 113.638 -1.619 . . . . 3.47 108.775 -173.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1581 ' ' LEU . . . . . 0.401 HD21 ' HG ' ' A' 1529 ' ' LEU . 0.4 OUTLIER -81.42 127.58 32.94 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 113.596 -1.638 . . . . 0.64 108.875 -178.567 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -127.08 140.96 51.9 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-N 116.098 -0.501 . . . . 2.85 110.215 172.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1583 ' ' TYR . . . . . 0.597 ' CZ ' ' HA ' ' A' 1586 ' ' GLN . 39.6 t80 -99.88 105.56 17.31 Favored 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 106.903 -1.517 . . . . 0.86 106.903 175.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1584 ' ' VAL . . . . . 0.643 ' O ' ' HB ' ' A' 1587 ' ' VAL . 7.5 p -129.51 97.39 3.46 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.333 0 CA-C-O 121.614 0.721 . . . . 1.05 111.061 -175.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 36.3 t70 64.01 49.36 2.78 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-O 122.456 1.122 . . . . 1.17 110.771 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1586 ' ' GLN . . . . . 0.597 ' HA ' ' CZ ' ' A' 1583 ' ' TYR . 1.8 pt20 65.39 9.26 5.59 Favored 'General case' 0 N--CA 1.5 2.059 0 C-N-CA 127.026 2.131 . . . . 1.86 111.09 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1587 ' ' VAL . . . . . 0.643 ' HB ' ' O ' ' A' 1584 ' ' VAL . 38.1 t -96.81 122.76 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.75 0 CA-C-N 114.303 -1.317 . . . . 0.49 108.331 178.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1588 ' ' LEU . . . . . 0.487 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 3.0 mm? -93.15 107.76 19.5 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 106.562 -1.644 . . . . 0.36 106.562 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -120.63 125.1 46.87 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 113.296 0.851 . . . . 1.74 113.296 -172.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1590 ' ' LEU . . . . . 0.478 HD21 ' SG ' ' A' 1516 ' ' CYS . 16.6 mt -101.69 126.27 48.51 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 113.84 -1.527 . . . . 0.72 107.282 176.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 47.2 t -112.0 120.36 62.17 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.997 0 C-N-CA 119.438 -0.905 . . . . 1.01 111.026 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1592 ' ' TYR . . . . . 0.43 ' HB2' ' HB2' ' A' 1608 ' ' SER . 13.5 m-30 -105.32 95.83 6.1 Favored 'General case' 0 CA--C 1.486 -1.485 0 N-CA-C 107.866 -1.161 . . . . 0.5 107.866 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 12.3 ptmm? -107.5 170.22 8.11 Favored 'General case' 0 C--N 1.283 -2.312 0 CA-C-N 115.02 -0.991 . . . . 1.59 111.597 -175.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 24.0 m-20 57.24 56.06 5.44 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 125.454 1.502 . . . . 1.11 112.448 177.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -74.88 -115.62 0.09 OUTLIER Glycine 0 CA--C 1.528 0.893 0 C-N-CA 120.33 -0.938 . . . . 0.78 111.143 173.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1596 ' ' SER . . . . . . . . . . . . . 78.2 p -115.32 169.76 6.4 Favored Pre-proline 0 C--N 1.296 -1.744 0 O-C-N 121.857 -0.79 . . . . 1.07 109.164 176.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -70.03 122.62 9.22 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 122.932 2.421 . . . . 1.01 112.354 177.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1598 ' ' CYS . . . . . 0.472 ' HA ' ' HD3' ' A' 1599 ' ' PRO . 34.3 t -76.44 141.16 69.34 Favored Pre-proline 0 C--N 1.292 -1.916 0 CA-C-N 114.671 -1.15 . . . . 0.75 109.202 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1599 ' ' PRO . . . . . 0.573 ' HD3' ' OH ' ' A' 1606 ' ' TYR . 8.1 Cg_exo -72.04 -7.84 21.8 Favored 'Trans proline' 0 C--N 1.371 1.731 0 C-N-CA 123.608 2.872 . . . . 1.7 113.25 -175.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1600 ' ' SER . . . . . 0.67 ' HA ' ' HB3' ' B' ' 53' ' ' LEU . 22.8 p -61.17 -51.22 69.97 Favored 'General case' 0 C--O 1.258 1.535 0 CA-C-O 121.76 0.79 . . . . 2.26 109.733 174.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1601 ' ' LYS . . . . . 0.447 ' HB3' ' HG ' ' A' 1604 ' ' LEU . 49.9 tptt -155.14 117.96 4.33 Favored 'General case' 0 N--CA 1.387 -3.614 0 N-CA-C 106.533 -1.654 . . . . 3.01 106.533 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 4.7 p -60.09 131.27 50.3 Favored 'General case' 0 N--CA 1.409 -2.478 0 N-CA-C 109.139 -0.689 . . . . 2.07 109.139 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 106.83 -20.99 32.92 Favored Glycine 0 C--N 1.296 -1.687 0 C-N-CA 121.065 -0.588 . . . . 1.08 111.837 -174.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1604 ' ' LEU . . . . . 0.447 ' HG ' ' HB3' ' A' 1601 ' ' LYS . 69.5 mt -81.55 124.46 29.52 Favored 'General case' 0 CA--C 1.503 -0.837 0 N-CA-C 107.728 -1.212 . . . . 1.84 107.728 172.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 4.9 p -101.26 143.46 31.3 Favored 'General case' 0 C--N 1.28 -2.415 0 CA-C-O 120.643 0.259 . . . . 1.41 110.61 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1606 ' ' TYR . . . . . 0.664 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 96.2 m-85 -68.39 153.28 44.06 Favored 'General case' 0 C--O 1.255 1.356 0 N-CA-C 109.598 -0.519 . . . . 0.6 109.598 177.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -151.5 127.48 10.38 Favored 'General case' 0 N--CA 1.437 -1.104 0 O-C-N 123.673 0.608 . . . . 1.45 109.952 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1608 ' ' SER . . . . . 0.448 ' HB3' ' HE2' ' A' 1638 ' ' PHE . 38.6 m -104.64 122.04 44.8 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 108.522 -0.918 . . . . 1.15 108.522 -179.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 41.0 t -104.68 108.06 23.94 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 109.304 -0.628 . . . . 0.25 109.304 -177.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1610 ' ' ILE . . . . . 0.466 ' HB ' ' HB2' ' A' 1590 ' ' LEU . 69.5 mt -97.27 110.18 24.66 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 115.588 -0.733 . . . . 0.45 109.323 -178.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 7.0 t -113.56 108.01 16.58 Favored 'General case' 0 C--N 1.282 -2.345 0 CA-C-N 115.143 -0.935 . . . . 1.26 110.114 -174.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1612 ' ' PHE . . . . . 0.487 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 64.1 m-85 -84.9 118.9 24.8 Favored 'General case' 0 C--O 1.254 1.332 0 CA-C-N 115.99 -0.55 . . . . 0.26 109.557 177.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1613 ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' 1641 ' ' HIS . 21.5 t -110.69 124.91 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.577 0 CA-C-N 115.595 -0.73 . . . . 0.5 110.366 -175.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 22.2 t -58.88 110.64 1.06 Allowed 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 114.571 -1.195 . . . . 0.77 111.895 177.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1615 ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' 1615 ' ' ARG . 22.4 ttt180 -137.59 98.59 9.82 Favored Pre-proline 0 C--N 1.316 -0.884 0 N-CA-C 110.25 -0.278 . . . . 2.53 110.25 171.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1616 ' ' PRO . . . . . 0.848 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 34.6 Cg_exo -61.22 -30.55 88.58 Favored 'Trans proline' 0 CA--C 1.55 1.282 0 C-N-CA 122.139 1.892 . . . . 1.1 111.989 176.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -77.05 44.17 0.39 Allowed 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.116 1.367 . . . . 3.05 113.61 178.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -32.69 130.31 0.19 Allowed 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 126.781 2.032 . . . . 1.55 113.476 176.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . -163.86 -142.16 3.33 Favored Glycine 0 N--CA 1.425 -2.089 0 N-CA-C 109.958 -1.257 . . . . 0.93 109.958 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -80.34 15.06 1.81 Allowed 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 122.95 2.433 . . . . 0.88 112.655 -178.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1621 ' ' THR . . . . . . . . . . . . . 17.1 p -102.48 -6.71 22.61 Favored 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 124.791 1.237 . . . . 0.97 108.625 179.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 48.9 t30 -94.66 61.89 2.7 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.392 -1.277 . . . . 0.72 108.659 -176.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -162.28 138.74 5.96 Favored Pre-proline 0 N--CA 1.428 -1.535 0 CA-C-N 113.795 -1.548 . . . . 3.26 107.427 -179.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1624 ' ' PRO . . . . . 0.434 ' HA ' ' O ' ' A' 1639 ' ' SER . 37.1 Cg_endo -65.92 108.2 1.25 Allowed 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 122.556 2.171 . . . . 0.59 112.17 -177.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 63.8 mtm -116.11 147.42 41.35 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.455 -0.339 . . . . 1.37 110.543 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1626 ' ' LEU . . . . . 0.578 ' HG ' ' CE2' ' A' 1542 ' ' TYR . 0.4 OUTLIER -85.41 114.95 22.85 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.452 -1.314 . . . . 0.89 107.452 -178.354 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A 1627 ' ' ILE . . . . . 0.488 HD11 ' HB2' ' A' 1639 ' ' SER . 44.3 mm -72.53 -54.51 16.01 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.217 0 N-CA-C 109.191 -0.67 . . . . 0.58 109.191 -178.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 28.0 p -173.44 154.04 2.5 Favored 'General case' 0 N--CA 1.423 -1.808 0 CA-C-N 114.752 -1.113 . . . . 1.39 109.281 -173.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1629 ' ' LEU . . . . . 0.473 HD13 ' HG ' ' A' 1636 ' ' LEU . 54.2 tp -106.29 117.57 34.38 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 108.434 -0.95 . . . . 1.25 108.434 174.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1630 ' ' ASP . . . . . 0.437 ' HB3' ' HB ' ' A' 1635 ' ' THR . 8.6 t70 -73.75 99.09 3.06 Favored 'General case' 0 CA--C 1.496 -1.108 0 N-CA-C 103.317 -2.846 . . . . 1.09 103.317 167.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -80.76 -10.31 59.74 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 114.192 -1.367 . . . . 3.6 110.395 -166.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -86.11 -45.95 10.9 Favored 'General case' 0 N--CA 1.426 -1.66 0 CA-C-N 115.584 -0.735 . . . . 2.6 110.874 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 70.5 p -95.91 -3.79 44.67 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-O 120.812 0.339 . . . . 0.75 111.571 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 60.9 m 63.7 51.17 2.51 Favored 'General case' 0 C--N 1.355 0.823 0 C-N-CA 124.743 1.217 . . . . 0.53 111.744 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1635 ' ' THR . . . . . 0.437 ' HB ' ' HB3' ' A' 1630 ' ' ASP . 32.4 m -113.42 123.14 49.35 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 114.101 -1.409 . . . . 0.46 109.026 -176.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1636 ' ' LEU . . . . . 0.473 ' HG ' HD13 ' A' 1629 ' ' LEU . 1.0 OUTLIER -105.44 129.78 53.67 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 108.557 -0.905 . . . . 0.86 108.557 -175.383 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -105.72 135.45 47.12 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 120.83 -0.348 . . . . 0.45 111.259 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1638 ' ' PHE . . . . . 0.448 ' HE2' ' HB3' ' A' 1608 ' ' SER . 96.9 m-85 -128.46 137.18 51.69 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 124.09 0.956 . . . . 0.5 108.719 -178.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1639 ' ' SER . . . . . 0.488 ' HB2' HD11 ' A' 1627 ' ' ILE . 17.9 t -124.56 155.1 39.61 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 108.327 -0.99 . . . . 1.04 108.327 177.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1640 ' ' TRP . . . . . 0.462 ' CE3' ' HE1' ' A' 1612 ' ' PHE . 3.6 t90 -155.54 104.35 2.36 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 104.689 -2.337 . . . . 0.68 104.689 -178.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1641 ' ' HIS . . . . . 0.422 ' HA ' ' O ' ' A' 1613 ' ' VAL . 38.8 m-70 -93.63 100.59 12.81 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 121.201 0.524 . . . . 0.9 109.834 -176.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1642 ' ' THR . . . . . . . . . . . . . 3.6 t -134.06 147.33 63.52 Favored Pre-proline 0 C--N 1.292 -1.905 0 CA-C-N 115.002 -0.999 . . . . 0.48 109.377 -173.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1643 ' ' PRO . . . . . 0.848 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 50.1 Cg_endo -76.93 -2.65 12.9 Favored 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 122.069 1.846 . . . . 0.66 112.416 176.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1644 ' ' LEU . . . . . 0.416 HD11 ' HB2' ' A' 1531 ' ' SER . 9.3 tt -69.42 -28.82 66.47 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 108.876 -0.787 . . . . 0.97 108.876 177.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -88.26 21.27 2.89 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.591 -0.731 . . . . 0.84 110.732 -178.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1646 ' ' CYS . . . . . 0.487 ' SG ' ' HA ' ' A' 1643 ' ' PRO . 75.1 m -113.03 152.13 29.86 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 116.139 -0.482 . . . . 1.19 110.279 -179.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1647 ' ' GLU . . . . . 0.705 ' HG3' HG21 ' A' 1523 ' ' THR . 0.0 OUTLIER -108.97 127.23 27.67 Favored Pre-proline 0 N--CA 1.421 -1.922 0 N-CA-C 107.592 -1.262 . . . . 3.14 107.592 174.082 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A 1648 ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -68.21 100.06 0.62 Allowed 'Trans proline' 0 CA--C 1.532 0.399 0 C-N-CA 122.585 2.19 . . . . 2.58 113.274 -175.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 13.5 tp10 . . . . . 0 N--CA 1.431 -1.394 0 N-CA-C 106.625 -1.62 . . . . 4.72 106.625 178.171 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.619 0 N-CA-C 109.239 -0.652 . . . . 9.97 109.239 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -114.88 131.79 56.74 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.82 -1.178 . . . . 7.68 107.82 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 -111.88 130.07 23.58 Favored Pre-proline 0 C--N 1.283 -2.291 0 N-CA-C 109.489 -0.559 . . . . 6.11 109.489 177.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -57.6 -25.54 67.87 Favored 'Trans proline' 0 C--N 1.37 1.702 0 C-N-CA 123.834 3.023 . . . . 4.84 113.367 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 23.3 m -87.17 100.07 12.4 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 105.777 -1.934 . . . . 4.6 105.777 170.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -77.37 -21.04 53.86 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 112.421 0.526 . . . . 4.23 112.421 -169.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . 0.508 HG21 ' HA ' ' B' ' 50' ' ' SER . 16.9 p -98.05 146.28 25.69 Favored 'General case' 0 C--N 1.287 -2.137 0 C-N-CA 120.551 -0.46 . . . . 3.14 110.278 177.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.527 ' HB2' ' CB ' ' B' ' 12' ' ' GLU . 1.4 pp -75.9 163.81 26.83 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 113.164 0.801 . . . . 3.96 113.164 -176.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' CYS . . . . . 0.414 ' HA ' HD23 ' B' ' 13' ' ' LEU . 48.6 t -151.27 156.08 40.1 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 120.861 -0.336 . . . . 2.84 111.261 -174.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.91 -123.94 7.63 Favored Glycine 0 CA--C 1.508 -0.39 0 CA-C-N 116.377 -0.374 . . . . 2.09 113.037 175.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . 0.45 ' HA2' HG12 ' B' ' 14' ' ' VAL . . . -60.28 -27.99 66.26 Favored Glycine 0 N--CA 1.461 0.319 0 N-CA-C 112.127 -0.389 . . . . 1.84 112.127 178.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . 0.527 ' CB ' ' HB2' ' B' ' 8' ' ' LEU . 46.1 mt-10 -65.53 -29.9 70.59 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.302 0.572 . . . . 2.55 110.003 179.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . 0.524 HD21 ' HB3' ' B' ' 46' ' ' CYS . 0.2 OUTLIER -72.79 -50.93 21.21 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.619 0.723 . . . . 2.35 109.433 179.944 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . 0.45 HG12 ' HA2' ' B' ' 11' ' ' GLY . 9.1 p -68.08 -37.73 78.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-N 115.665 -0.698 . . . . 2.11 112.254 -176.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -76.24 -22.27 55.37 Favored 'General case' 0 C--O 1.212 -0.907 0 N-CA-C 113.608 0.966 . . . . 2.04 113.608 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 9.7 p -71.55 -39.35 70.73 Favored 'General case' 0 C--O 1.262 1.753 0 O-C-N 120.959 -1.088 . . . . 1.84 109.268 174.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.494 ' HB3' ' HB2' ' B' ' 26' ' ' PHE . 4.3 mm? -52.71 -47.31 67.4 Favored 'General case' 0 C--O 1.216 -0.666 0 CA-C-N 114.938 -1.028 . . . . 1.74 109.535 169.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -63.44 -42.89 98.67 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.485 1.114 . . . . 2.39 110.084 178.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -48.76 -54.96 12.9 Favored 'General case' 0 C--O 1.245 0.823 0 N-CA-C 112.943 0.72 . . . . 0.96 112.943 -177.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 14.8 p -98.74 -26.15 3.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 C-N-CA 117.713 -1.595 . . . . 1.37 112.361 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' CYS . . . . . 0.445 ' HB2' ' O ' ' B' ' 17' ' ' LEU . 74.7 m -102.28 18.91 19.79 Favored 'General case' 0 C--N 1.308 -1.227 0 O-C-N 121.403 -0.81 . . . . 1.66 112.683 -175.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -57.35 -46.17 92.09 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 121.056 -0.593 . . . . 1.53 113.656 178.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -72.99 -39.16 66.3 Favored 'General case' 0 C--N 1.32 -0.708 0 O-C-N 122.669 -0.312 . . . . 2.72 111.507 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . 0.427 ' HD2' ' SG ' ' B' ' 60' ' ' CYS . 40.7 ttm180 -76.44 -38.48 55.44 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.334 0.588 . . . . 4.33 111.597 -177.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.35 151.72 9.69 Favored Glycine 0 N--CA 1.423 -2.2 0 N-CA-C 107.95 -2.06 . . . . 1.53 107.95 -174.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . 0.494 ' HB2' ' HB3' ' B' ' 17' ' ' LEU . 45.6 p90 -138.09 146.82 43.37 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 117.549 0.675 . . . . 1.65 110.229 -179.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -170.63 136.75 1.27 Allowed 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 110.205 -0.294 . . . . 3.42 110.205 174.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -118.96 -25.44 6.26 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 112.347 0.499 . . . . 2.26 112.347 173.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 67.9 m -80.06 138.11 36.92 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 108.785 -0.82 . . . . 3.68 108.785 176.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . 0.546 ' H ' ' HB3' ' B' ' 39' ' ' SER . 29.0 mmm180 -121.72 168.81 10.46 Favored Pre-proline 0 C--N 1.298 -1.643 0 N-CA-C 109.139 -0.689 . . . . 3.81 109.139 -174.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -80.24 14.27 2.0 Allowed 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 123.505 2.803 . . . . 4.02 114.841 -175.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' ALA . . . . . 0.515 ' HB3' ' OG ' ' B' ' 39' ' ' SER . . . -68.03 -51.26 48.91 Favored 'General case' 0 CA--C 1.5 -0.971 0 CA-C-O 121.443 0.639 . . . . 4.92 109.738 175.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 28.8 t -167.56 150.5 6.05 Favored 'General case' 0 N--CA 1.392 -3.344 0 N-CA-C 106.636 -1.616 . . . . 6.72 106.636 177.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 43.0 ttp180 -91.47 3.48 54.86 Favored 'General case' 0 C--N 1.264 -3.111 0 N-CA-C 108.009 -1.108 . . . . 11.63 108.009 -177.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 47.9 t -90.17 -6.52 10.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 107.697 -1.223 . . . . 9.61 107.697 175.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 21.8 m 66.69 30.71 8.05 Favored 'General case' 0 N--CA 1.418 -2.052 0 CA-C-N 114.176 -1.375 . . . . 6.71 112.293 175.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 21.3 mmm180 -64.26 -71.34 0.18 Allowed 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 115.599 -0.728 . . . . 10.0 111.112 175.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 51.8 mtm180 -83.24 -21.48 33.37 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-O 121.873 0.844 . . . . 7.94 110.172 175.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . 0.546 ' HB3' ' H ' ' B' ' 30' ' ' ARG . 19.7 m -95.16 61.07 2.4 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 114.75 -1.114 . . . . 5.76 109.377 179.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 5.5 tpp180 -57.05 -48.31 78.85 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 114.375 -1.284 . . . . 6.03 111.134 -178.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 51.01 54.14 24.02 Favored Glycine 0 C--N 1.287 -2.186 0 CA-C-O 118.765 -1.02 . . . . 2.37 115.311 172.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . 0.421 HD11 HD21 ' B' ' 17' ' ' LEU . 42.9 pt 52.89 -18.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.527 3.405 0 N-CA-C 118.289 2.7 . . . . 2.07 118.289 170.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 4.4 p -49.06 -40.58 13.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 C-N-CA 125.551 1.54 . . . . 2.24 114.673 -175.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -91.01 -34.11 15.27 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 109.497 -0.557 . . . . 3.36 109.497 -173.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' B' ' 49' ' ' ARG . 11.1 mp0 -64.7 -50.89 65.2 Favored 'General case' 0 C--O 1.192 -1.925 0 CA-C-N 115.758 -0.655 . . . . 3.08 110.118 178.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' CYS . . . . . 0.524 ' HB3' HD21 ' B' ' 13' ' ' LEU . 31.8 t -73.59 -22.77 59.94 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 119.821 -0.752 . . . . 2.23 110.7 -176.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 54.1 t -77.88 -39.34 43.52 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.364 -0.38 . . . . 2.37 111.994 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -119.05 6.03 11.31 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.904 1.076 . . . . 2.82 113.904 -176.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . 0.454 ' HB2' ' O ' ' B' ' 45' ' ' GLU . 98.7 mtt180 -130.51 169.55 15.41 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 106.754 -1.573 . . . . 4.09 106.754 176.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . 0.508 ' HA ' HG21 ' B' ' 7' ' ' THR . 45.9 m -87.35 99.94 12.36 Favored 'General case' 0 N--CA 1.415 -2.183 0 N-CA-C 108.86 -0.792 . . . . 2.67 108.86 177.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 2.6 p -84.67 142.65 29.74 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.835 -1.172 . . . . 2.11 107.835 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -106.29 171.51 7.31 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 119.763 -0.775 . . . . 2.67 110.672 176.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . 0.67 ' HB3' ' HA ' ' A' 1600 ' ' SER . 1.9 pt? -62.32 -37.1 84.29 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 113.886 1.069 . . . . 1.9 113.886 -176.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . 0.414 ' O ' HG22 ' B' ' 58' ' ' THR . . . -58.31 -36.37 73.25 Favored 'General case' 0 CA--C 1.504 -0.792 0 C-N-CA 122.615 0.366 . . . . 1.52 111.857 -173.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . 0.519 ' O ' ' HB2' ' B' ' 59' ' ' TYR . 60.2 tp -60.67 -56.58 19.57 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.59 -0.732 . . . . 1.97 111.101 -177.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 3.2 pp -72.64 -26.76 61.77 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-O 120.831 0.348 . . . . 1.53 110.879 -177.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -69.08 -55.4 10.87 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 115.306 -0.861 . . . . 2.27 111.444 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 58' ' ' THR . . . . . 0.414 HG22 ' O ' ' B' ' 54' ' ' ALA . 13.0 t -78.05 -17.39 57.09 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 119.877 -0.729 . . . . 2.33 111.801 -178.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 59' ' ' TYR . . . . . 0.519 ' HB2' ' O ' ' B' ' 55' ' ' LEU . 6.3 t80 -77.08 -74.16 0.26 Allowed 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 106.219 -1.771 . . . . 2.86 106.219 176.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 60' ' ' CYS . . . . . 0.427 ' SG ' ' HD2' ' B' ' 24' ' ' ARG . 36.6 t 51.31 -77.09 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 125.529 1.532 . . . . 2.3 114.536 175.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -161.22 -50.43 0.04 OUTLIER 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 104.789 -2.3 . . . . 3.19 104.789 -177.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 62' ' ' THR . . . . . 0.57 HG21 ' HA ' ' B' ' 66' ' ' SER . 2.7 p -146.64 150.15 39.05 Favored Pre-proline 0 N--CA 1.411 -2.376 0 CA-C-N 112.428 -2.169 . . . . 3.68 106.961 178.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -77.26 -16.92 15.22 Favored 'Trans proline' 0 C--N 1.326 -0.622 0 C-N-CA 122.725 2.283 . . . . 5.08 113.527 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -143.7 51.1 1.34 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 120.855 0.36 . . . . 5.1 111.549 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 65.5 tttm 68.18 143.08 0.04 OUTLIER 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 125.264 1.426 . . . . 8.51 112.548 178.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . 0.57 ' HA ' HG21 ' B' ' 62' ' ' THR . 15.7 m -84.15 35.29 0.53 Allowed 'General case' 0 C--O 1.243 0.714 0 O-C-N 121.894 -0.504 . . . . 8.12 112.159 -173.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 . . . . . 0 N--CA 1.42 -1.933 0 N-CA-C 106.447 -1.686 . . . . 10.21 106.447 179.933 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 CA--C 1.501 -0.907 0 N-CA-C 108.359 -0.978 . . . . 9.34 108.359 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 27.7 mtpp 64.3 65.04 0.68 Allowed 'General case' 0 C--O 1.226 -0.172 0 O-C-N 123.843 0.715 . . . . 9.04 111.264 177.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 50.0 m 55.14 85.84 0.06 Allowed 'General case' 0 C--O 1.244 0.771 0 O-C-N 124.077 0.861 . . . . 5.81 112.07 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1511 ' ' ASN . . . . . 0.546 HD22 ' N ' ' A' 1512 ' ' GLU . 0.2 OUTLIER -74.14 -18.86 60.73 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.432 -0.349 . . . . 3.42 111.318 -177.794 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A 1512 ' ' GLU . . . . . 0.546 ' N ' HD22 ' A' 1511 ' ' ASN . 0.5 OUTLIER -93.62 145.42 24.56 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 121.717 0.77 . . . . 5.95 113.077 -174.641 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 50.7 t-80 -170.1 145.5 2.85 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 103.063 -2.94 . . . . 5.33 103.063 176.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1514 ' ' ASP . . . . . 0.415 ' HB2' ' HG2' ' A' 1517 ' ' GLN . 20.0 m-20 67.46 151.98 0.08 Allowed 'General case' 0 CA--C 1.567 1.607 0 C-N-CA 124.114 0.966 . . . . 5.06 110.044 -176.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1515 ' ' ASP . . . . . 0.435 ' HA ' ' HD3' ' A' 1579 ' ' LYS . 4.5 m-20 -30.26 -74.37 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.308 0 N-CA-C 113.663 0.986 . . . . 2.9 113.663 175.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1516 ' ' CYS . . . . . 0.485 ' HB3' ' HB2' ' A' 1529 ' ' LEU . 71.2 m -144.55 78.61 1.58 Allowed 'General case' 0 C--O 1.251 1.165 0 CA-C-O 120.894 0.378 . . . . 1.19 111.278 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1517 ' ' GLN . . . . . 0.415 ' HG2' ' HB2' ' A' 1514 ' ' ASP . 11.2 pt20 -157.32 130.22 7.63 Favored 'General case' 0 N--CA 1.422 -1.874 0 N-CA-C 108.982 -0.748 . . . . 1.52 108.982 175.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1518 ' ' VAL . . . . . 0.418 ' CG2' HD12 ' A' 1581 ' ' LEU . 5.9 m -131.79 135.63 58.45 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.16 0 CA-C-O 121.143 0.497 . . . . 0.94 110.936 -178.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1519 ' ' THR . . . . . . . . . . . . . 23.5 m -106.46 129.63 54.4 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 107.202 -1.407 . . . . 0.89 107.202 176.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1520 ' ' ASN . . . . . 0.45 ' OD1' HG22 ' A' 1523 ' ' THR . 23.9 t-20 -89.02 112.47 51.17 Favored Pre-proline 0 C--N 1.287 -2.152 0 N-CA-C 108.247 -1.019 . . . . 1.74 108.247 176.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.69 -9.99 25.82 Favored 'Trans proline' 0 C--N 1.333 -0.237 0 C-N-CA 122.813 2.342 . . . . 1.58 113.257 -175.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1522 ' ' SER . . . . . 0.444 ' HB2' ' OD1' ' A' 1520 ' ' ASN . 24.6 m -74.13 -39.06 63.57 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 116.426 -0.352 . . . . 1.65 110.437 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1523 ' ' THR . . . . . 0.45 HG22 ' OD1' ' A' 1520 ' ' ASN . 9.7 t -122.58 -10.03 8.4 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 120.314 -0.554 . . . . 1.61 112.268 -179.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 81.06 22.6 60.77 Favored Glycine 0 C--N 1.32 -0.361 0 O-C-N 122.334 -0.229 . . . . 1.13 113.593 176.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1525 ' ' HIS . . . . . 0.567 ' CE1' ' HB3' ' A' 1647 ' ' GLU . 11.8 t-160 -93.65 125.26 38.17 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 120.535 -0.466 . . . . 1.26 110.69 -178.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 2.5 tm? -94.28 116.52 28.92 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 114.866 -1.061 . . . . 0.68 109.764 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1527 ' ' PHE . . . . . 0.409 ' O ' ' HA ' ' A' 1517 ' ' GLN . 96.7 m-85 -92.71 119.09 31.75 Favored 'General case' 0 C--N 1.317 -0.808 0 O-C-N 122.296 -0.252 . . . . 0.65 110.438 173.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 14.2 t70 -103.92 110.67 22.9 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 109.123 -0.695 . . . . 1.17 109.123 178.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1529 ' ' LEU . . . . . 0.485 ' HB2' ' HB3' ' A' 1516 ' ' CYS . 3.6 mm? -99.01 3.16 46.85 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 121.326 0.584 . . . . 0.6 109.973 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 1.1 m -64.55 -29.66 70.69 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.049 -0.978 . . . . 0.84 109.344 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 23.1 t -62.26 -32.27 72.95 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.244 -0.889 . . . . 1.59 110.482 178.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 81.3 mt -96.28 1.37 51.98 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.255 -0.43 . . . . 0.65 110.944 -176.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1533 ' ' SER . . . . . . . . . . . . . 16.7 m -75.0 161.46 29.45 Favored 'General case' 0 C--O 1.256 1.42 0 CA-C-O 121.294 0.569 . . . . 1.52 111.982 -177.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -178.59 139.8 4.22 Favored Glycine 0 N--CA 1.429 -1.82 0 CA-C-N 115.623 -0.717 . . . . 1.1 111.532 178.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1535 ' ' ARG . . . . . 0.486 ' HD3' ' O ' ' A' 1535 ' ' ARG . 0.8 OUTLIER -92.92 -30.37 15.43 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 123.514 0.726 . . . . 4.62 109.252 -179.588 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -73.2 -34.11 65.78 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 121.582 0.706 . . . . 1.45 109.697 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 106.26 -177.47 22.3 Favored Glycine 0 N--CA 1.417 -2.574 0 CA-C-N 115.322 -0.854 . . . . 0.85 113.497 172.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -138.28 145.7 41.58 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 106.92 -1.511 . . . . 0.93 106.92 178.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 20.2 p -102.58 124.18 47.66 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 123.513 0.508 . . . . 1.03 110.526 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1540 ' ' ALA . . . . . 0.722 ' HB3' HG23 ' A' 1548 ' ' VAL . . . -117.37 134.89 54.3 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 109.087 -0.709 . . . . 0.5 109.087 178.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -88.13 124.47 33.82 Favored 'General case' 0 N--CA 1.439 -0.976 0 O-C-N 123.663 0.602 . . . . 0.74 110.71 -178.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1542 ' ' TYR . . . . . 0.54 ' HD2' ' CZ ' ' A' 1567 ' ' PHE . 2.2 t80 -123.5 -101.34 0.4 Allowed 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.235 -0.893 . . . . 0.99 109.675 -179.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1543 ' ' SER . . . . . . . . . . . . . 14.6 m -62.98 159.77 16.34 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 118.735 -0.65 . . . . 1.91 109.601 177.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 63.2 tttp -50.49 -40.87 52.32 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 112.902 0.705 . . . . 3.59 112.902 -175.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 27.3 t -116.98 34.43 5.11 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 108.47 -0.937 . . . . 2.46 108.47 177.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . -128.34 118.84 2.91 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.078 -1.058 . . . . 1.26 114.312 -175.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 28.1 m -124.66 137.61 56.82 Favored 'Isoleucine or valine' 0 C--O 1.254 1.325 0 CA-C-O 121.027 0.441 . . . . 0.79 109.939 176.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1548 ' ' VAL . . . . . 0.722 HG23 ' HB3' ' A' 1540 ' ' ALA . 0.0 OUTLIER -95.88 132.69 39.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-N 115.818 -0.628 . . . . 0.58 110.862 175.68 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A 1549 ' ' TYR . . . . . 0.419 ' HB3' ' ND2' ' A' 1556 ' ' ASN . 51.8 m-85 -96.33 99.8 11.46 Favored 'General case' 0 N--CA 1.423 -1.776 0 N-CA-C 106.756 -1.572 . . . . 1.08 106.756 171.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 6.4 ptp -110.75 142.15 43.09 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 115.392 -0.822 . . . . 0.78 111.589 -178.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 12.3 p -118.34 110.64 17.73 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-N 115.719 -0.673 . . . . 0.97 109.428 176.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1552 ' ' ILE . . . . . . . . . . . . . 41.6 mm -75.49 119.6 23.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 109.465 -0.569 . . . . 0.42 109.465 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 56.8 m 64.41 41.68 5.61 Favored 'General case' 0 C--O 1.25 1.101 0 CA-C-O 121.97 0.891 . . . . 1.4 111.994 174.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 174.84 -178.02 46.73 Favored Glycine 0 N--CA 1.421 -2.36 0 N-CA-C 109.452 -1.459 . . . . 0.35 109.452 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -109.54 146.08 35.24 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-O 120.882 0.372 . . . . 1.62 110.224 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1556 ' ' ASN . . . . . 0.419 ' ND2' ' HB3' ' A' 1549 ' ' TYR . 45.2 t-20 -94.92 139.49 31.25 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 115.672 -0.695 . . . . 0.87 109.166 -175.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1557 ' ' GLU . . . . . 0.417 ' HB3' ' CZ ' ' A' 1535 ' ' ARG . 12.9 pt-20 -77.92 -13.45 59.88 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 122.932 0.493 . . . . 2.49 112.304 -176.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -73.87 -8.25 55.37 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.38 0.511 . . . . 1.38 112.38 -177.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1559 ' ' CYS . . . . . 0.775 ' SG ' ' HD2' ' A' 1560 ' ' PRO . 1.6 t -137.72 169.41 13.07 Favored Pre-proline 0 C--N 1.288 -2.106 0 N-CA-C 106.747 -1.575 . . . . 1.21 106.747 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1560 ' ' PRO . . . . . 0.775 ' HD2' ' SG ' ' A' 1559 ' ' CYS . 14.2 Cg_exo -38.58 149.51 0.08 OUTLIER 'Trans proline' 0 CA--C 1.557 1.644 0 C-N-CA 124.003 3.135 . . . . 0.71 114.699 174.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1561 ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' 1560 ' ' PRO . 52.2 Cg_exo -58.05 125.59 19.02 Favored 'Trans proline' 0 C--O 1.242 0.72 0 C-N-CA 123.151 2.567 . . . . 0.8 110.85 178.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 106.91 -7.28 38.13 Favored Glycine 0 N--CA 1.433 -1.517 0 CA-C-N 115.926 -0.579 . . . . 0.46 112.828 -178.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1563 ' ' VAL . . . . . 0.692 HG11 ' HB2' ' A' 1566 ' ' CYS . 9.8 t -79.37 121.8 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.836 0 N-CA-C 112.712 0.634 . . . . 0.98 112.712 -179.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -97.3 -34.75 5.49 Favored Glycine 0 C--N 1.306 -1.086 0 CA-C-N 114.918 -1.037 . . . . 0.28 111.023 176.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -131.4 125.17 31.91 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 109.653 -0.499 . . . . 0.28 109.653 178.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1566 ' ' CYS . . . . . 0.692 ' HB2' HG11 ' A' 1563 ' ' VAL . 49.4 t -150.78 138.46 19.77 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 110.115 -0.328 . . . . 0.43 110.115 -179.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1567 ' ' PHE . . . . . 0.956 ' HB3' ' HG2' ' A' 1569 ' ' GLN . 23.8 m-85 -85.74 139.62 31.19 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.812 -0.81 . . . . 1.03 108.812 172.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -87.57 23.32 13.04 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.211 -0.995 . . . . 1.13 111.245 -178.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1569 ' ' GLN . . . . . 0.956 ' HG2' ' HB3' ' A' 1567 ' ' PHE . 9.9 mm100 -67.71 -70.81 0.24 Allowed 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 122.912 0.485 . . . . 2.58 110.361 -177.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 14.3 t -131.85 34.74 3.83 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-O 122.539 1.161 . . . . 2.17 108.19 173.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 22.9 mmt180 63.56 61.02 1.05 Allowed 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 113.747 -1.569 . . . . 2.62 109.803 -178.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 34.8 mt -104.26 115.4 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-N 116.242 -0.436 . . . . 0.92 110.529 -177.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1573 ' ' SER . . . . . 0.559 ' HB3' ' HB2' ' A' 1596 ' ' SER . 28.6 t -80.13 142.02 35.19 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 120.957 0.408 . . . . 0.8 110.71 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1574 ' ' VAL . . . . . 0.499 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 27.0 m -133.04 17.12 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 O-C-N 122.031 -0.418 . . . . 0.98 111.673 178.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 172.97 131.57 1.4 Allowed Glycine 0 N--CA 1.428 -1.843 0 C-N-CA 119.193 -1.48 . . . . 0.29 111.981 178.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -85.37 143.84 28.39 Favored 'General case' 0 N--CA 1.427 -1.578 0 N-CA-C 108.142 -1.058 . . . . 2.19 108.142 178.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -68.43 92.23 0.43 Allowed 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 115.456 -0.793 . . . . 0.61 111.8 -177.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -100.94 173.9 6.27 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 107.205 -1.406 . . . . 1.95 107.205 172.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1579 ' ' LYS . . . . . 0.435 ' HD3' ' HA ' ' A' 1515 ' ' ASP . 16.7 ptpt -142.8 54.5 1.39 Allowed 'General case' 0 C--N 1.294 -1.815 0 CA-C-O 122.395 1.093 . . . . 2.68 109.502 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1580 ' ' ARG . . . . . 0.423 ' NH1' HH21 ' A' 1582 ' ' ARG . 69.5 ttt180 -105.99 77.11 1.22 Allowed 'General case' 0 N--CA 1.419 -2.015 0 CA-C-N 114.953 -1.021 . . . . 3.47 109.7 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1581 ' ' LEU . . . . . 0.455 HD11 HD12 ' A' 1588 ' ' LEU . 0.5 OUTLIER -63.28 126.08 26.24 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.047 -0.979 . . . . 0.64 109.304 177.436 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A 1582 ' ' ARG . . . . . 0.553 ' HB2' ' HB3' ' A' 1589 ' ' GLN . 91.3 mtt180 -121.73 144.69 48.65 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 116.032 -0.531 . . . . 2.85 110.137 177.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1583 ' ' TYR . . . . . 0.604 ' CE1' ' HA ' ' A' 1586 ' ' GLN . 61.9 t80 -115.09 108.76 17.07 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.896 -0.409 . . . . 0.86 109.896 178.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1584 ' ' VAL . . . . . 0.535 ' O ' ' HB ' ' A' 1587 ' ' VAL . 13.1 m -124.81 89.56 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.61 0.719 . . . . 1.05 112.275 -178.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 21.0 t70 55.75 58.66 4.31 Favored 'General case' 0 N--CA 1.505 2.299 0 C-N-CA 124.739 1.215 . . . . 1.17 110.874 178.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1586 ' ' GLN . . . . . 0.604 ' HA ' ' CE1' ' A' 1583 ' ' TYR 0.352 3.9 pt20 63.92 17.66 10.69 Favored 'General case' 0 CA--C 1.503 -0.863 0 C-N-CA 127.513 2.325 . . . . 1.86 112.805 179.463 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A 1587 ' ' VAL . . . . . 0.535 ' HB ' ' O ' ' A' 1584 ' ' VAL . 39.5 t -102.0 120.48 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.235 0 N-CA-C 106.723 -1.584 . . . . 0.49 106.723 170.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1588 ' ' LEU . . . . . 0.967 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 2.5 mm? -96.6 108.03 20.56 Favored 'General case' 0 C--N 1.283 -2.283 0 N-CA-C 107.38 -1.341 . . . . 0.36 107.38 -179.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1589 ' ' GLN . . . . . 0.553 ' HB3' ' HB2' ' A' 1582 ' ' ARG . 34.4 tt0 -100.07 131.16 46.19 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 116.022 -0.535 . . . . 1.74 112.075 -173.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 12.1 mt -125.71 102.15 7.2 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 106.711 -1.589 . . . . 0.72 106.711 170.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 7.8 p -95.96 126.02 48.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 CA-C-O 121.39 0.614 . . . . 1.01 110.184 -177.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1592 ' ' TYR . . . . . . . . . . . . . 13.0 m-30 -117.25 110.69 18.43 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 107.966 -1.124 . . . . 0.5 107.966 -178.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 47.4 pttt -130.56 -179.13 5.1 Favored 'General case' 0 C--N 1.281 -2.381 0 CA-C-N 115.625 -0.716 . . . . 1.59 109.375 -177.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 19.9 m-20 61.66 43.33 9.97 Favored 'General case' 0 CA--C 1.507 -0.701 0 O-C-N 124.383 1.052 . . . . 1.11 110.264 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -90.81 -134.43 5.92 Favored Glycine 0 N--CA 1.432 -1.623 0 CA-C-N 114.594 -1.184 . . . . 0.78 110.942 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1596 ' ' SER . . . . . 0.559 ' HB2' ' HB3' ' A' 1573 ' ' SER . 33.1 t -86.31 148.24 46.68 Favored Pre-proline 0 C--N 1.303 -1.424 0 N-CA-C 108.583 -0.895 . . . . 1.07 108.583 -178.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -63.11 140.12 76.53 Favored 'Trans proline' 0 N--CA 1.443 -1.496 0 C-N-CA 122.499 2.133 . . . . 1.01 109.711 174.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1598 ' ' CYS . . . . . 0.547 ' HA ' ' CE2' ' A' 1606 ' ' TYR . 49.4 t -79.58 110.18 14.52 Favored Pre-proline 0 C--N 1.294 -1.817 0 N-CA-C 107.721 -1.215 . . . . 0.75 107.721 -178.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -58.59 -34.11 98.62 Favored 'Trans proline' 0 C--N 1.358 1.044 0 C-N-CA 123.191 2.594 . . . . 1.7 112.007 -176.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1600 ' ' SER . . . . . 0.756 ' HB3' ' HB2' ' B' ' 53' ' ' LEU . 4.8 m -60.62 -22.44 63.79 Favored 'General case' 0 CA--C 1.56 1.334 0 C-N-CA 125.271 1.428 . . . . 2.26 113.171 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1601 ' ' LYS . . . . . 0.502 ' HE2' ' OD2' ' B' ' 52' ' ' ASP . 4.9 tppp? -157.4 120.62 4.04 Favored 'General case' 0 C--O 1.241 0.622 0 O-C-N 121.952 -0.468 . . . . 3.01 110.339 178.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 19.8 m -70.18 133.93 47.58 Favored 'General case' 0 N--CA 1.414 -2.273 0 N-CA-C 109.686 -0.487 . . . . 2.07 109.686 -177.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 105.51 -16.89 44.01 Favored Glycine 0 C--N 1.301 -1.377 0 CA-C-N 116.072 -0.513 . . . . 1.08 112.343 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1604 ' ' LEU . . . . . 0.468 HD12 ' HB3' ' A' 1601 ' ' LYS . 56.9 mt -102.95 138.76 39.4 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 122.164 -0.61 . . . . 1.84 110.451 -179.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 20.5 m -115.92 147.04 41.54 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 107.698 -1.223 . . . . 1.41 107.698 175.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1606 ' ' TYR . . . . . 0.547 ' CE2' ' HA ' ' A' 1598 ' ' CYS . 54.4 m-85 -70.14 150.21 46.75 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 116.687 -0.233 . . . . 0.6 111.543 -178.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 6.6 ttpm? -148.07 135.51 20.6 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.771 -0.826 . . . . 1.45 108.771 177.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1608 ' ' SER . . . . . . . . . . . . . 2.6 p -119.1 126.42 51.6 Favored 'General case' 0 C--N 1.281 -2.387 0 CA-C-N 115.384 -0.826 . . . . 1.15 109.83 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 39.1 t -107.51 105.16 18.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 109.52 -0.548 . . . . 0.25 109.52 -178.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1610 ' ' ILE . . . . . 0.407 ' HA ' ' HB2' ' A' 1638 ' ' PHE . 92.9 mt -89.97 119.38 36.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 107.972 -1.121 . . . . 0.45 107.972 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 20.0 m -124.55 116.0 21.76 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-N 115.85 -0.614 . . . . 1.26 110.494 -177.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1612 ' ' PHE . . . . . 0.967 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 75.5 m-85 -85.62 122.82 30.28 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.606 -0.887 . . . . 0.26 108.606 176.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 58.8 t -111.62 135.58 50.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 CA-C-N 115.382 -0.826 . . . . 0.5 109.576 -174.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 39.5 t -68.3 107.54 2.86 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.246 -0.888 . . . . 0.77 110.587 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1615 ' ' ARG . . . . . 0.436 ' CB ' ' HB3' ' A' 1641 ' ' HIS . 32.7 tpt180 -132.35 94.28 23.48 Favored Pre-proline 0 N--CA 1.437 -1.107 0 N-CA-C 108.746 -0.835 . . . . 2.53 108.746 176.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1616 ' ' PRO . . . . . 0.793 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 18.6 Cg_exo -66.89 -26.17 44.58 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 122.034 1.823 . . . . 1.1 112.397 -177.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -77.87 43.31 0.42 Allowed 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 125.067 1.347 . . . . 3.05 112.977 178.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -31.99 126.24 0.26 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.726 1.611 . . . . 1.55 113.171 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . -167.19 -141.17 3.08 Favored Glycine 0 N--CA 1.412 -2.906 0 N-CA-C 109.175 -1.57 . . . . 0.93 109.175 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -75.49 8.77 2.45 Favored 'Trans proline' 0 CA--C 1.533 0.437 0 C-N-CA 122.525 2.15 . . . . 0.88 113.337 -176.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1621 ' ' THR . . . . . 0.678 ' HB ' ' HB2' ' A' 1641 ' ' HIS . 14.4 p -96.18 -10.48 28.02 Favored 'General case' 0 C--N 1.292 -1.905 0 C-N-CA 124.102 0.961 . . . . 0.97 109.971 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 52.9 t30 -85.86 65.34 9.08 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 114.945 -1.025 . . . . 0.72 109.38 -178.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1623 ' ' ARG . . . . . 0.524 ' O ' ' HG3' ' A' 1625 ' ' MET . 10.8 ptp180 -165.34 141.84 4.61 Favored Pre-proline 0 C--N 1.31 -1.126 0 N-CA-C 107.78 -1.193 . . . . 3.26 107.78 -175.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1624 ' ' PRO . . . . . 0.445 ' HG3' ' CZ3' ' A' 1640 ' ' TRP . 23.5 Cg_exo -56.11 107.37 0.25 Allowed 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.551 2.167 . . . . 0.59 111.005 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1625 ' ' MET . . . . . 0.524 ' HG3' ' O ' ' A' 1623 ' ' ARG . 89.8 mtp -107.05 132.46 52.94 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.345 -0.613 . . . . 1.37 109.345 -177.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.4 114.06 22.17 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 106.406 -1.702 . . . . 0.89 106.406 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1627 ' ' ILE . . . . . 0.752 HD11 ' HB2' ' A' 1639 ' ' SER . 45.2 mm -69.4 -55.1 16.42 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.139 0 N-CA-C 109.027 -0.731 . . . . 0.58 109.027 -179.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 11.8 t -176.44 152.88 1.12 Allowed 'General case' 0 N--CA 1.425 -1.704 0 N-CA-C 108.616 -0.883 . . . . 1.39 108.616 -176.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1629 ' ' LEU . . . . . 0.594 HD13 HD23 ' A' 1636 ' ' LEU . 19.0 tp -99.89 109.51 21.89 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.304 -0.862 . . . . 1.25 109.408 175.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 20.6 t70 -73.03 98.79 2.6 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 106.372 -1.714 . . . . 1.09 106.372 170.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1631 ' ' LYS . . . . . 0.715 ' HD3' ' H ' ' A' 1631 ' ' LYS . 0.2 OUTLIER -73.31 -16.21 61.38 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 113.73 1.011 . . . . 3.6 113.73 -172.989 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 16.7 mm100 -73.56 -36.63 65.63 Favored 'General case' 0 CA--C 1.498 -1.052 0 C-N-CA 120.41 -0.516 . . . . 2.6 111.193 178.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 58.9 p -108.01 -6.15 16.72 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 115.886 -0.597 . . . . 0.75 112.432 -176.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 82.5 m 63.73 47.08 3.77 Favored 'General case' 0 C--N 1.36 1.03 0 C-N-CA 124.368 1.067 . . . . 0.53 109.754 -178.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1635 ' ' THR . . . . . . . . . . . . . 56.1 m -115.36 133.17 56.29 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.92 -1.036 . . . . 0.46 110.808 -175.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1636 ' ' LEU . . . . . 0.594 HD23 HD13 ' A' 1629 ' ' LEU . 15.7 mt -110.14 135.75 50.44 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.996 -0.742 . . . . 0.86 108.996 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -109.55 133.15 53.43 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 109.421 -0.585 . . . . 0.45 109.421 176.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1638 ' ' PHE . . . . . 0.407 ' HB2' ' HA ' ' A' 1610 ' ' ILE . 97.3 m-85 -123.34 135.39 54.16 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 116.137 -0.483 . . . . 0.5 110.021 -178.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1639 ' ' SER . . . . . 0.752 ' HB2' HD11 ' A' 1627 ' ' ILE . 23.3 t -115.62 156.17 26.32 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 107.221 -1.399 . . . . 1.04 107.221 175.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1640 ' ' TRP . . . . . 0.445 ' CZ3' ' HG3' ' A' 1624 ' ' PRO . 3.1 t90 -151.5 106.21 3.25 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 103.973 -2.603 . . . . 0.68 103.973 177.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1641 ' ' HIS . . . . . 0.678 ' HB2' ' HB ' ' A' 1621 ' ' THR . 12.3 m-70 -93.39 103.45 15.67 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.694 -0.854 . . . . 0.9 108.694 -173.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1642 ' ' THR . . . . . . . . . . . . . 15.3 t -142.21 145.33 35.06 Favored Pre-proline 0 CA--C 1.558 1.277 0 C-N-CA 120.776 -0.369 . . . . 0.48 110.341 -172.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1643 ' ' PRO . . . . . 0.793 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 72.6 Cg_endo -78.42 -5.5 14.96 Favored 'Trans proline' 0 C--N 1.372 1.793 0 C-N-CA 122.303 2.002 . . . . 0.66 112.233 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 9.2 tt -66.49 -24.44 66.41 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.104 -0.702 . . . . 0.97 109.104 177.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -92.7 16.2 12.78 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.251 -0.886 . . . . 0.84 110.566 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 58.6 m -121.79 145.87 47.62 Favored 'General case' 0 N--CA 1.424 -1.748 0 O-C-N 122.28 -0.262 . . . . 1.19 110.998 -178.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1647 ' ' GLU . . . . . 0.567 ' HB3' ' CE1' ' A' 1525 ' ' HIS . 0.4 OUTLIER -116.41 126.97 27.11 Favored Pre-proline 0 C--N 1.296 -1.729 0 N-CA-C 108.509 -0.923 . . . . 3.14 108.509 167.14 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A 1648 ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -70.27 124.17 10.62 Favored 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 122.012 1.808 . . . . 2.58 110.679 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 . . . . . 0 C--N 1.299 -1.624 0 N-CA-C 108.951 -0.759 . . . . 4.72 108.951 -178.877 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.721 0 N-CA-C 109.087 -0.708 . . . . 9.97 109.087 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -74.11 129.31 37.59 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 107.077 -1.453 . . . . 7.68 107.077 177.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 22.5 ptt180 -97.38 128.84 33.47 Favored Pre-proline 0 C--N 1.297 -1.684 0 C-N-CA 120.21 -0.596 . . . . 6.11 111.281 -176.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -71.86 -1.43 9.93 Favored 'Trans proline' 0 N--CA 1.49 1.298 0 C-N-CA 123.993 3.128 . . . . 4.84 113.726 -178.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 32.8 m -144.0 141.15 29.98 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 106.032 -1.84 . . . . 4.6 106.032 179.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . 0.459 ' HB2' ' HB2' ' B' ' 50' ' ' SER . 72.9 mm-40 -78.65 -16.23 57.58 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 120.927 0.394 . . . . 4.23 110.874 -178.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 3.5 p -130.67 113.78 14.6 Favored 'General case' 0 N--CA 1.426 -1.635 0 CA-C-N 114.785 -1.098 . . . . 3.14 109.024 176.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.604 ' HB2' ' HG3' ' B' ' 12' ' ' GLU . 9.4 mp -70.17 136.78 50.42 Favored 'General case' 0 C--O 1.248 0.986 0 O-C-N 122.136 -0.353 . . . . 3.96 111.856 178.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' CYS . . . . . 0.439 ' HA ' ' CD1' ' B' ' 13' ' ' LEU . 43.7 m -83.37 85.06 7.29 Favored 'General case' 0 N--CA 1.436 -1.159 0 C-N-CA 123.74 0.816 . . . . 2.84 111.04 -172.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . 0.48 ' O ' HG12 ' B' ' 14' ' ' VAL . . . 140.86 -77.59 0.3 Allowed Glycine 0 N--CA 1.412 -2.962 0 N-CA-C 110.07 -1.212 . . . . 2.09 110.07 177.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . 0.566 ' O ' ' HB2' ' B' ' 15' ' ' ASP . . . -56.32 -62.38 6.4 Favored Glycine 0 N--CA 1.44 -1.05 0 O-C-N 124.687 0.875 . . . . 1.84 113.325 -176.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . 0.604 ' HG3' ' HB2' ' B' ' 8' ' ' LEU . 44.1 mt-10 -74.12 -30.04 62.12 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.981 0.391 . . . . 2.55 111.222 -176.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . 0.58 ' HG ' ' O ' ' B' ' 8' ' ' LEU . 67.1 mt -56.67 -64.86 0.73 Allowed 'General case' 0 N--CA 1.468 0.446 0 O-C-N 123.374 0.421 . . . . 2.35 111.09 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . 0.48 HG12 ' O ' ' B' ' 10' ' ' GLY . 14.0 p -65.38 -29.85 48.45 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 CA-C-O 121.355 0.598 . . . . 2.11 110.269 -178.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' ASP . . . . . 0.566 ' HB2' ' O ' ' B' ' 11' ' ' GLY . 4.0 t70 -66.69 -48.38 69.44 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-N 115.422 -0.808 . . . . 2.04 112.251 -177.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 13.4 t -65.91 -31.87 73.05 Favored 'General case' 0 C--O 1.256 1.414 0 CA-C-N 118.099 0.409 . . . . 1.84 110.82 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.63 ' HB3' ' HB3' ' B' ' 26' ' ' PHE . 4.1 mm? -58.6 -48.79 79.78 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.423 0.63 . . . . 1.74 110.374 174.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -80.22 -15.1 57.76 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.549 0.69 . . . . 2.39 110.902 -178.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -65.07 -52.76 53.85 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 116.094 -0.503 . . . . 0.96 110.786 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 30.7 m -98.43 -24.95 4.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 C-N-CA 118.666 -1.214 . . . . 1.37 112.141 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' CYS . . . . . 0.425 ' HB2' ' O ' ' B' ' 17' ' ' LEU . 95.9 m -105.03 19.84 19.9 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 120.681 -0.407 . . . . 1.66 111.841 -177.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -49.22 -40.89 30.21 Favored Glycine 0 N--CA 1.474 1.168 0 N-CA-C 115.093 0.797 . . . . 1.53 115.093 -178.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -71.4 -32.35 68.32 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 112.476 0.547 . . . . 2.72 112.476 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 21.0 ttm180 -93.12 -41.12 10.11 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 120.738 -0.385 . . . . 4.33 111.852 -175.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 120.25 -176.15 16.12 Favored Glycine 0 N--CA 1.436 -1.355 0 N-CA-C 110.191 -1.164 . . . . 1.53 110.191 -177.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . 0.63 ' HB3' ' HB3' ' B' ' 17' ' ' LEU . 12.9 p90 -132.4 127.78 36.15 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 116.914 0.357 . . . . 1.65 110.277 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -131.09 84.04 2.15 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.089 0.471 . . . . 3.42 112.103 -175.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -120.19 22.49 11.37 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 122.367 1.08 . . . . 2.26 108.806 177.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 3.3 p -80.69 41.34 0.56 Allowed 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 113.992 -1.458 . . . . 3.68 111.928 -178.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . 0.407 ' HA ' ' HD3' ' B' ' 31' ' ' PRO . 29.4 mmm180 -105.28 131.66 21.57 Favored Pre-proline 0 C--N 1.306 -1.302 0 N-CA-C 107.758 -1.201 . . . . 3.81 107.758 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' B' ' 30' ' ' ARG . 2.6 Cg_endo -86.26 13.54 2.7 Favored 'Trans proline' 0 C--O 1.248 0.991 0 C-N-CA 123.163 2.576 . . . . 4.02 113.792 -173.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' ALA . . . . . 0.642 ' HA ' ' HB3' ' B' ' 36' ' ' SER . . . 72.9 91.9 0.09 Allowed 'General case' 0 CA--C 1.514 -0.419 0 C-N-CA 125.082 1.353 . . . . 4.92 111.298 178.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . 0.491 ' H ' ' HB3' ' B' ' 36' ' ' SER . 92.4 p -111.07 -147.5 0.42 Allowed 'General case' 1 N--CA 1.365 -4.684 0 N-CA-C 104.419 -2.437 . . . . 6.72 104.419 -177.941 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 50.5 mtp180 -80.64 -21.0 41.84 Favored 'General case' 0 C--N 1.275 -2.649 0 CA-C-N 118.859 0.754 . . . . 11.63 109.364 175.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 24.0 t -89.83 -2.12 9.61 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 CA-C-O 122.935 1.35 . . . . 9.61 107.965 -178.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . 0.642 ' HB3' ' HA ' ' B' ' 32' ' ' ALA . 10.4 t -143.78 44.38 1.48 Allowed 'General case' 0 N--CA 1.411 -2.406 0 CA-C-N 114.559 -1.201 . . . . 6.71 107.802 -176.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -91.42 -7.03 51.82 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 122.18 0.991 . . . . 10.0 108.683 174.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -141.44 134.45 29.08 Favored 'General case' 0 N--CA 1.417 -2.117 1 N-CA-C 99.979 -4.082 . . . . 7.94 99.979 176.41 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 15.8 m 60.58 56.78 2.95 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 107.199 -1.408 . . . . 5.76 107.199 -171.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . 0.622 ' HB2' ' HB2' ' B' ' 32' ' ' ALA . 0.0 OUTLIER -81.25 76.5 8.19 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 114.39 -1.277 . . . . 6.03 110.132 -177.271 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.22 7.12 56.56 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-N 115.043 -0.98 . . . . 2.37 113.253 -172.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . 0.619 ' HA ' ' HG2' ' B' ' 45' ' ' GLU . 27.5 pt 52.75 26.94 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.38 1.899 0 C-N-CA 126.549 1.94 . . . . 2.07 112.739 179.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 1.4 p -103.05 -44.42 9.75 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.921 0 CA-C-N 113.771 -1.559 . . . . 2.24 112.638 -173.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -83.72 -22.06 32.11 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.758 -1.201 . . . . 3.36 107.758 -178.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . 0.619 ' HG2' ' HA ' ' B' ' 42' ' ' ILE . 1.5 pm0 -77.53 -28.36 51.95 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 114.241 -1.345 . . . . 3.08 112.22 173.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' CYS . . . . . . . . . . . . . 12.1 t -112.77 -3.25 14.24 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 118.729 -1.188 . . . . 2.23 112.793 -177.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 43.3 t -86.77 -53.34 4.98 Favored 'General case' 0 C--N 1.314 -0.975 0 O-C-N 121.201 -0.937 . . . . 2.37 110.958 175.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -91.71 -5.73 53.19 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.31 0.576 . . . . 2.82 111.902 -176.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -139.5 152.16 46.73 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 106.348 -1.723 . . . . 4.09 106.348 179.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . 0.459 ' HB2' ' HB2' ' B' ' 6' ' ' GLU . 32.3 t -80.3 139.59 36.56 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 106.209 -1.774 . . . . 2.67 106.209 175.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . 0.593 ' HB2' HD23 ' B' ' 55' ' ' LEU . 25.7 p -105.46 138.18 42.08 Favored 'General case' 0 N--CA 1.422 -1.855 0 N-CA-C 108.6 -0.889 . . . . 2.11 108.6 -175.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . 0.502 ' OD2' ' HE2' ' A' 1601 ' ' LYS . 3.5 m-20 -66.33 139.44 58.04 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.944 -0.761 . . . . 2.67 108.944 177.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . 0.756 ' HB2' ' HB3' ' A' 1600 ' ' SER . 36.0 tp -55.18 -30.86 60.77 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.246 -1.343 . . . . 1.9 110.555 177.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.48 -45.44 84.84 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 123.688 0.795 . . . . 1.52 110.431 177.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . 0.593 HD23 ' HB2' ' B' ' 51' ' ' CYS . 44.9 tp -58.77 -50.57 73.43 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 123.936 0.895 . . . . 1.97 110.52 -179.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 3.1 pp -74.11 -33.08 63.47 Favored 'General case' 0 N--CA 1.424 -1.74 0 C-N-CA 120.716 -0.394 . . . . 1.53 111.842 -175.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -66.75 -49.45 65.92 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.117 0.484 . . . . 2.27 110.812 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 7.2 t -73.75 -24.46 59.88 Favored 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 120.294 -0.562 . . . . 2.33 111.039 -177.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -76.7 -67.48 0.7 Allowed 'General case' 0 C--O 1.241 0.611 0 N-CA-C 107.576 -1.268 . . . . 2.86 107.576 176.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 42.9 t 59.61 -85.27 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.311 1.444 . . . . 2.3 113.881 175.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -140.87 -88.81 0.17 Allowed 'General case' 0 N--CA 1.426 -1.627 0 N-CA-C 108.982 -0.747 . . . . 3.19 108.982 -174.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 4.1 p -146.58 138.93 13.85 Favored Pre-proline 0 N--CA 1.415 -2.207 0 N-CA-C 107.61 -1.255 . . . . 3.68 107.61 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -83.88 -2.11 10.17 Favored 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.73 2.287 . . . . 5.08 112.702 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . 0.435 ' HA ' ' HB2' ' B' ' 67' ' ' GLU . . . -129.94 50.59 2.17 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 115.425 -0.807 . . . . 5.1 110.295 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 47.1 tttm -92.93 -26.66 17.49 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 122.11 0.957 . . . . 8.51 108.906 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 66.0 m -137.33 56.92 1.76 Allowed 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 114.089 -1.414 . . . . 8.12 107.407 175.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . 0.435 ' HB2' ' HA ' ' B' ' 64' ' ' ALA . 6.3 tp10 . . . . . 0 N--CA 1.439 -1.024 0 CA-C-N 114.4 -1.273 . . . . 10.21 108.664 -175.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 25.2 mmt . . . . . 0 CA--C 1.496 -1.12 0 N-CA-C 108.129 -1.063 . . . . 9.34 108.129 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 97.8 mttt -125.06 39.0 4.08 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 121.332 0.587 . . . . 9.04 111.482 -176.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 16.3 m -77.54 -21.29 52.85 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 122.576 1.179 . . . . 5.81 108.094 174.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1511 ' ' ASN . . . . . 0.409 ' ND2' ' HD3' ' A' 1521 ' ' PRO . 19.2 p-10 -134.85 128.34 32.51 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 105.683 -1.969 . . . . 3.42 105.683 174.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1512 ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -123.24 167.59 13.55 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 120.315 -0.554 . . . . 5.95 111.436 -178.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 39.4 p-80 -75.18 -43.75 50.46 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 112.811 0.671 . . . . 5.33 112.811 -176.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 21.2 t70 64.92 -68.46 0.11 Allowed 'General case' 0 C--O 1.223 -0.321 0 C-N-CA 125.677 1.591 . . . . 5.06 110.828 -171.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 14.6 t70 -111.01 -158.53 0.65 Allowed 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 106.006 -1.85 . . . . 2.9 106.006 178.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 21.7 t -90.31 73.32 7.07 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 107.154 -1.424 . . . . 1.19 107.154 178.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -166.7 172.34 10.66 Favored 'General case' 0 N--CA 1.423 -1.822 0 N-CA-C 104.949 -2.241 . . . . 1.52 104.949 -174.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 10.6 p -168.27 137.07 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 CA-C-O 121.414 0.626 . . . . 0.94 110.531 177.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1519 ' ' THR . . . . . . . . . . . . . 35.4 m -92.92 135.85 33.78 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 115.809 -0.632 . . . . 0.89 109.973 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -86.23 124.94 69.45 Favored Pre-proline 0 N--CA 1.414 -2.231 0 CA-C-N 116.226 -0.443 . . . . 1.74 110.106 176.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1521 ' ' PRO . . . . . 0.409 ' HD3' ' ND2' ' A' 1511 ' ' ASN . 60.3 Cg_endo -73.76 -13.62 24.4 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.991 2.461 . . . . 1.58 113.602 -175.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 14.1 m -80.38 -41.62 24.31 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 116.657 -0.247 . . . . 1.65 111.442 -177.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1523 ' ' THR . . . . . . . . . . . . . 6.6 t -125.43 2.8 7.7 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 119.502 -0.879 . . . . 1.61 112.662 -175.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 65.35 28.12 73.22 Favored Glycine 0 CA--C 1.503 -0.697 0 C-N-CA 121.129 -0.558 . . . . 1.13 112.423 178.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 18.9 t-80 -98.2 127.65 44.26 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 121.268 0.556 . . . . 1.26 109.593 -179.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 2.8 tm? -86.03 118.5 25.54 Favored 'General case' 0 C--N 1.288 -2.078 0 CA-C-N 114.171 -1.377 . . . . 0.68 109.825 -177.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1527 ' ' PHE . . . . . 0.572 ' HE2' ' HE2' ' A' 1583 ' ' TYR . 30.6 m-85 -90.39 128.07 36.38 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 109.333 -0.617 . . . . 0.65 109.333 170.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 23.0 t70 -115.16 123.67 49.5 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 123.709 0.631 . . . . 1.17 109.768 178.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 3.0 mm? -100.34 -5.94 26.57 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-O 121.565 0.698 . . . . 0.6 109.798 -178.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1530 ' ' SER . . . . . 0.453 ' HA ' ' OG ' ' A' 1533 ' ' SER . 1.1 m -70.67 -18.17 62.84 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.381 -0.827 . . . . 0.84 109.704 -177.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 40.5 m -62.81 -19.21 63.84 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 115.369 -0.832 . . . . 1.59 110.228 176.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1532 ' ' LEU . . . . . 0.468 ' HB2' HG21 ' A' 1552 ' ' ILE . 75.9 mt -105.87 3.86 29.06 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 120.672 0.272 . . . . 0.65 111.147 177.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1533 ' ' SER . . . . . 0.453 ' OG ' ' HA ' ' A' 1530 ' ' SER . 50.2 m -68.11 155.46 39.54 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 121.472 0.653 . . . . 1.52 111.792 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . 173.68 149.57 7.04 Favored Glycine 0 N--CA 1.422 -2.248 0 N-CA-C 109.373 -1.491 . . . . 1.1 109.373 -177.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 41.7 ttp180 -89.52 -21.29 22.99 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.189 0.519 . . . . 4.62 109.922 -177.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -81.02 -40.91 23.52 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 109.172 -0.677 . . . . 1.45 109.172 176.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 91.94 -151.16 20.64 Favored Glycine 0 N--CA 1.42 -2.424 0 CA-C-N 115.651 -0.704 . . . . 0.85 113.976 171.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -135.04 145.07 47.66 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 107.78 -1.192 . . . . 0.93 107.78 -177.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 15.5 p -111.45 127.69 55.76 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 123.903 0.752 . . . . 1.03 110.526 179.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1540 ' ' ALA . . . . . 0.708 ' HB2' ' HG2' ' A' 1624 ' ' PRO . . . -120.14 142.95 48.47 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 108.367 -0.975 . . . . 0.5 108.367 175.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -80.93 136.97 36.12 Favored 'General case' 0 C--N 1.314 -0.937 0 O-C-N 123.817 0.698 . . . . 0.74 110.354 -176.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1542 ' ' TYR . . . . . 0.867 ' HE2' ' HG ' ' A' 1626 ' ' LEU . 3.1 t80 -149.21 -99.08 0.07 Allowed 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 115.984 -0.553 . . . . 0.99 109.743 -174.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1543 ' ' SER . . . . . . . . . . . . . 30.0 t -72.31 151.48 42.73 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 109.04 -0.726 . . . . 1.91 109.04 -177.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1544 ' ' LYS . . . . . 0.583 ' HD2' ' HA ' ' B' ' 23' ' ' ASP . 62.7 tttp -57.95 -22.35 48.56 Favored 'General case' 0 C--N 1.346 0.416 0 C-N-CA 125.326 1.45 . . . . 3.59 112.318 -174.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 34.5 t -132.21 19.93 4.44 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 116.271 -0.422 . . . . 2.46 109.985 -178.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1546 ' ' GLY . . . . . 0.495 ' HA3' ' OE1' ' A' 1569 ' ' GLN . . . -159.14 127.93 1.93 Allowed Glycine 0 N--CA 1.439 -1.115 0 C-N-CA 118.816 -1.659 . . . . 1.26 113.988 -176.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 26.9 m -100.91 164.64 2.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 108.154 -1.054 . . . . 0.79 108.154 176.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1548 ' ' VAL . . . . . 0.494 ' CG1' ' HB3' ' A' 1540 ' ' ALA . 10.2 p -102.15 130.85 51.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 109.614 -0.513 . . . . 0.58 109.614 178.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -101.96 118.5 37.05 Favored 'General case' 0 CA--C 1.497 -1.068 0 C-N-CA 123.462 0.705 . . . . 1.08 109.287 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1550 ' ' MET . . . . . 0.522 ' SD ' ' HZ3' ' A' 1640 ' ' TRP . 8.9 ptp -127.81 144.93 51.07 Favored 'General case' 0 C--N 1.29 -2.011 0 C-N-CA 120.182 -0.607 . . . . 0.78 111.46 175.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 8.3 p -119.34 123.36 43.99 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 115.59 -0.732 . . . . 0.97 109.177 175.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1552 ' ' ILE . . . . . 0.474 HG22 ' SG ' ' A' 1553 ' ' CYS . 46.6 mm -81.24 114.09 21.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 C-N-CA 121.152 -0.219 . . . . 0.42 110.671 -177.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1553 ' ' CYS . . . . . 0.474 ' SG ' HG22 ' A' 1552 ' ' ILE . 31.1 m 66.91 38.38 3.67 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.62 0.768 . . . . 1.4 110.563 173.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . -177.41 -173.25 42.75 Favored Glycine 0 N--CA 1.417 -2.582 0 N-CA-C 109.343 -1.503 . . . . 0.35 109.343 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -110.38 148.62 31.63 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-O 121.095 0.474 . . . . 1.62 110.469 -178.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -99.09 131.1 45.38 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.656 -0.868 . . . . 0.87 108.656 -176.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -81.71 1.59 33.67 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 113.355 0.872 . . . . 2.49 113.355 -174.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 51.9 m-80 -83.39 -7.48 59.56 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 120.429 -0.508 . . . . 1.38 111.391 -179.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1559 ' ' CYS . . . . . 0.674 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 98.0 m -136.72 175.13 3.74 Favored Pre-proline 0 C--N 1.31 -1.127 0 CA-C-O 117.931 -1.033 . . . . 1.21 110.041 179.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1560 ' ' PRO . . . . . 0.674 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 4.3 Cg_exo -40.27 137.72 1.39 Allowed 'Trans proline' 0 C--N 1.387 2.559 0 C-N-CA 123.917 3.078 . . . . 0.71 113.516 177.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1561 ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' 1560 ' ' PRO . 71.6 Cg_exo -53.99 127.16 24.52 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 123.624 2.882 . . . . 0.8 112.845 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 102.29 6.7 47.6 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-N 115.85 -0.613 . . . . 0.46 113.028 -178.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1563 ' ' VAL . . . . . 0.604 HG11 ' HB2' ' A' 1566 ' ' CYS . 2.8 t -96.08 124.64 48.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 C-N-CA 123.171 0.588 . . . . 0.98 111.648 -177.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -97.26 -33.56 5.92 Favored Glycine 0 N--CA 1.44 -1.048 0 CA-C-N 115.34 -0.846 . . . . 0.28 111.747 178.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -129.9 125.54 35.79 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 109.62 -0.511 . . . . 0.28 109.62 178.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1566 ' ' CYS . . . . . 0.604 ' HB2' HG11 ' A' 1563 ' ' VAL . 43.7 t -151.24 139.73 20.52 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 120.664 0.269 . . . . 0.43 110.878 -179.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1567 ' ' PHE . . . . . 0.46 ' HB3' ' HG2' ' A' 1569 ' ' GLN . 10.9 m-85 -91.4 143.0 27.07 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 122.427 -0.17 . . . . 1.03 110.682 173.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -90.36 41.16 2.96 Favored Glycine 0 N--CA 1.431 -1.651 0 C-N-CA 120.54 -0.838 . . . . 1.13 111.821 -176.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1569 ' ' GLN . . . . . 0.495 ' OE1' ' HA3' ' A' 1546 ' ' GLY . 8.4 mm100 -80.33 -72.19 0.42 Allowed 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 108.838 -0.801 . . . . 2.58 108.838 177.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 19.0 p -133.37 35.14 3.46 Favored 'General case' 0 N--CA 1.433 -1.31 0 C-N-CA 123.869 0.868 . . . . 2.17 110.198 176.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 11.6 mmt180 67.61 63.02 0.42 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.743 1.217 . . . . 2.62 108.791 -174.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 31.1 mt -105.89 111.53 35.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 CA-C-N 115.946 -0.57 . . . . 0.92 110.814 -176.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 31.2 t -81.98 139.15 34.73 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.597 -0.729 . . . . 0.8 111.052 -177.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1574 ' ' VAL . . . . . 0.569 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 34.6 m -132.13 12.98 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-O 121.163 0.506 . . . . 0.98 111.329 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 178.98 122.62 0.77 Allowed Glycine 0 N--CA 1.423 -2.186 0 C-N-CA 120.158 -1.02 . . . . 0.29 111.761 177.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 29.5 ttpp -81.0 146.47 30.66 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 107.558 -1.275 . . . . 2.19 107.558 178.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -68.28 90.29 0.35 Allowed 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.232 0.539 . . . . 0.61 112.295 -175.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -107.37 179.69 4.18 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.414 -1.328 . . . . 1.95 107.414 176.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 60.0 mttp -138.47 48.13 1.95 Allowed 'General case' 0 CA--C 1.49 -1.341 0 N-CA-C 109.181 -0.674 . . . . 2.68 109.181 178.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1580 ' ' ARG . . . . . 0.529 ' HB3' HG12 ' A' 1591 ' ' VAL . 31.1 ttm180 -87.21 76.97 9.12 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.839 -0.745 . . . . 3.47 109.286 -177.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1581 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.13 124.98 31.01 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 114.478 -1.237 . . . . 0.64 108.65 -179.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -127.89 138.46 52.68 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 116.342 -0.39 . . . . 2.85 110.125 172.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1583 ' ' TYR . . . . . 0.572 ' HE2' ' HE2' ' A' 1527 ' ' PHE . 32.6 t80 -95.97 115.56 27.62 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 107.084 -1.45 . . . . 0.86 107.084 176.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1584 ' ' VAL . . . . . 0.726 ' O ' ' HB ' ' A' 1587 ' ' VAL . 6.3 p -138.76 102.0 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.044 0 C-N-CA 120.529 -0.468 . . . . 1.05 111.646 -176.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 19.4 t70 58.58 56.45 4.26 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 122.381 1.086 . . . . 1.17 110.658 179.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1586 ' ' GLN . . . . . 0.444 ' HA ' ' CZ ' ' A' 1583 ' ' TYR . 11.1 pt20 58.84 10.79 1.62 Allowed 'General case' 0 N--CA 1.499 1.993 0 C-N-CA 127.472 2.309 . . . . 1.86 112.32 -178.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1587 ' ' VAL . . . . . 0.726 ' HB ' ' O ' ' A' 1584 ' ' VAL . 2.8 t -97.02 124.61 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.245 0 CA-C-N 114.573 -1.194 . . . . 0.49 109.846 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1588 ' ' LEU . . . . . 0.915 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 4.1 mm? -90.41 108.92 20.08 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 107.239 -1.393 . . . . 0.36 107.239 175.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -109.52 122.0 46.45 Favored 'General case' 0 C--N 1.287 -2.114 0 C-N-CA 119.47 -0.892 . . . . 1.74 111.443 -176.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1590 ' ' LEU . . . . . 0.676 ' HB3' ' HB ' ' A' 1610 ' ' ILE . 44.8 tp -113.44 109.93 19.48 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 106.18 -1.785 . . . . 0.72 106.18 177.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1591 ' ' VAL . . . . . 0.529 HG12 ' HB3' ' A' 1580 ' ' ARG . 4.6 p -102.52 129.04 54.68 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 119.619 -0.832 . . . . 1.01 110.599 -177.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1592 ' ' TYR . . . . . 0.431 ' O ' ' HG3' ' A' 1607 ' ' LYS . 13.2 m-30 -117.37 126.91 53.46 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.437 -1.32 . . . . 0.5 107.437 177.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 12.9 ptmm? -140.6 176.69 8.58 Favored 'General case' 0 C--N 1.278 -2.515 0 N-CA-C 108.619 -0.882 . . . . 1.59 108.619 -174.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 9.3 m-20 58.58 41.8 21.76 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 124.599 1.187 . . . . 1.11 111.81 178.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -76.14 -98.8 0.14 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.15 -1.024 . . . . 0.78 110.954 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1596 ' ' SER . . . . . . . . . . . . . 12.4 t -120.97 152.44 56.43 Favored Pre-proline 0 C--N 1.285 -2.208 0 N-CA-C 105.61 -1.996 . . . . 1.07 105.61 174.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -61.84 139.12 78.27 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 122.376 2.05 . . . . 1.01 110.767 175.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 39.2 t -81.79 102.95 1.73 Allowed Pre-proline 0 C--N 1.302 -1.494 0 N-CA-C 106.658 -1.608 . . . . 0.75 106.658 178.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -62.11 -39.47 49.05 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 123.106 2.538 . . . . 1.7 113.184 -170.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1600 ' ' SER . . . . . . . . . . . . . 8.7 m -69.12 -15.09 63.34 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.47 -0.786 . . . . 2.26 112.817 -177.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1601 ' ' LYS . . . . . 0.458 ' HG2' HD22 ' A' 1604 ' ' LEU . 13.7 tppt? -135.31 87.91 2.37 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 107.318 -1.364 . . . . 3.01 107.318 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 14.9 m -44.66 114.47 0.71 Allowed 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 125.896 1.678 . . . . 2.07 114.456 -174.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 100.64 10.53 43.57 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 114.415 0.526 . . . . 1.08 114.415 175.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1604 ' ' LEU . . . . . 0.458 HD22 ' HG2' ' A' 1601 ' ' LYS . 9.2 mp -110.57 156.25 21.19 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 117.28 0.54 . . . . 1.84 111.197 178.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 16.5 m -121.34 147.8 45.2 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.514 -1.291 . . . . 1.41 107.514 173.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1606 ' ' TYR . . . . . 0.569 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 85.8 m-85 -71.91 149.99 44.61 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 110.377 -0.231 . . . . 0.6 110.377 177.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1607 ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' A' 1592 ' ' TYR . 6.1 ttpm? -146.94 135.86 22.32 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 123.856 0.723 . . . . 1.45 109.455 178.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1608 ' ' SER . . . . . . . . . . . . . 19.2 m -114.36 125.58 54.03 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 108.645 -0.872 . . . . 1.15 108.645 -178.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 39.1 t -105.59 108.26 24.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 108.808 -0.812 . . . . 0.25 108.808 178.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1610 ' ' ILE . . . . . 0.676 ' HB ' ' HB3' ' A' 1590 ' ' LEU . 79.1 mt -95.08 118.87 42.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 108.583 -0.895 . . . . 0.45 108.583 -178.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 26.6 t -117.24 110.52 18.22 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 108.972 -0.751 . . . . 1.26 108.972 -178.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1612 ' ' PHE . . . . . 0.915 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 70.8 m-85 -86.7 122.95 31.32 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.654 -0.869 . . . . 0.26 108.654 177.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 44.8 t -116.53 135.37 57.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.457 0 CA-C-N 115.433 -0.803 . . . . 0.5 110.144 -174.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1614 ' ' CYS . . . . . 0.422 ' HB2' ' HA ' ' A' 1646 ' ' CYS . 4.9 t -54.53 111.11 0.73 Allowed 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 124.573 1.149 . . . . 0.77 113.095 177.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1615 ' ' ARG . . . . . 0.687 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 18.6 tpt180 -137.29 91.04 14.78 Favored Pre-proline 0 N--CA 1.441 -0.911 0 N-CA-C 108.815 -0.809 . . . . 2.53 108.815 169.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1616 ' ' PRO . . . . . 0.445 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 18.8 Cg_exo -66.68 -23.49 48.95 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.251 1.967 . . . . 1.1 112.996 -175.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -71.5 -22.83 61.74 Favored 'General case' 0 N--CA 1.432 -1.35 0 C-N-CA 122.923 0.489 . . . . 3.05 111.822 178.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . 63.61 -156.52 0.32 Allowed 'General case' 0 C--N 1.359 1.006 0 N-CA-C 108.155 -1.054 . . . . 1.55 108.155 -174.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . 116.43 -157.3 15.12 Favored Glycine 0 N--CA 1.414 -2.773 0 C-N-CA 120.202 -0.999 . . . . 0.93 112.484 176.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -78.45 13.94 1.73 Allowed 'Trans proline' 0 C--N 1.325 -0.67 0 C-N-CA 123.683 2.922 . . . . 0.88 113.053 -175.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1621 ' ' THR . . . . . 0.708 ' HB ' ' HB2' ' A' 1641 ' ' HIS . 16.5 p -105.39 -7.84 18.54 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 115.002 -0.999 . . . . 0.97 109.598 178.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 56.6 t30 -87.79 65.68 8.49 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.444 -0.947 . . . . 0.72 108.444 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -166.72 141.53 3.47 Favored Pre-proline 0 C--N 1.307 -1.255 0 N-CA-C 107.743 -1.206 . . . . 3.26 107.743 -175.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1624 ' ' PRO . . . . . 0.708 ' HG2' ' HB2' ' A' 1540 ' ' ALA . 21.3 Cg_endo -60.87 104.58 0.28 Allowed 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.532 2.154 . . . . 0.59 111.408 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 85.3 mtp -101.98 135.46 43.5 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.824 -0.806 . . . . 1.37 108.824 -178.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1626 ' ' LEU . . . . . 0.867 ' HG ' ' HE2' ' A' 1542 ' ' TYR . 0.3 OUTLIER -87.63 118.68 27.28 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 107.9 -1.148 . . . . 0.89 107.9 -176.357 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A 1627 ' ' ILE . . . . . 0.787 HD11 ' HB2' ' A' 1639 ' ' SER . 39.9 mm -79.41 -50.28 18.41 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.879 0 N-CA-C 108.925 -0.768 . . . . 0.58 108.925 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 17.1 t -172.41 161.18 5.09 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 108.827 -0.805 . . . . 1.39 108.827 -176.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1629 ' ' LEU . . . . . 0.763 HD13 HD23 ' A' 1636 ' ' LEU . 13.6 tp -117.51 106.49 13.22 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.0 -1.111 . . . . 1.25 108.0 176.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 18.0 t70 -72.2 107.42 4.84 Favored 'General case' 0 CA--C 1.487 -1.478 0 N-CA-C 105.849 -1.908 . . . . 1.09 105.849 174.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1631 ' ' LYS . . . . . 0.513 ' HB3' HD21 ' B' ' 53' ' ' LEU . 54.4 mtmt -72.5 -35.42 68.15 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 115.173 -0.921 . . . . 3.6 111.138 -171.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -70.77 -38.99 73.48 Favored 'General case' 0 N--CA 1.417 -2.091 0 C-N-CA 120.412 -0.515 . . . . 2.6 112.089 -173.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 47.4 p -97.38 -0.87 45.6 Favored 'General case' 0 CA--C 1.566 1.562 0 N-CA-C 112.593 0.59 . . . . 0.75 112.593 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 84.5 m 59.61 52.77 5.41 Favored 'General case' 0 C--N 1.374 1.64 0 C-N-CA 124.709 1.204 . . . . 0.53 111.153 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1635 ' ' THR . . . . . . . . . . . . . 92.5 m -125.21 133.5 52.72 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.727 -0.67 . . . . 0.46 111.994 -175.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1636 ' ' LEU . . . . . 0.763 HD23 HD13 ' A' 1629 ' ' LEU . 9.7 mt -104.7 136.03 44.99 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.37 -0.974 . . . . 0.86 108.37 -179.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1637 ' ' PHE . . . . . 0.418 ' HB2' ' HB ' ' A' 1627 ' ' ILE . 58.6 m-85 -108.59 129.72 55.31 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 109.113 -0.699 . . . . 0.45 109.113 177.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -120.11 142.56 48.8 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 116.225 -0.443 . . . . 0.5 110.935 -178.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1639 ' ' SER . . . . . 0.787 ' HB2' HD11 ' A' 1627 ' ' ILE . 31.8 t -117.44 153.45 33.07 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 107.068 -1.456 . . . . 1.04 107.068 173.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1640 ' ' TRP . . . . . 0.522 ' HZ3' ' SD ' ' A' 1550 ' ' MET . 2.1 t90 -154.1 105.79 2.75 Favored 'General case' 0 N--CA 1.42 -1.973 0 N-CA-C 105.163 -2.162 . . . . 0.68 105.163 179.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1641 ' ' HIS . . . . . 0.708 ' HB2' ' HB ' ' A' 1621 ' ' THR . 38.1 m-70 -95.19 105.03 16.93 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 108.868 -0.79 . . . . 0.9 108.868 -175.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1642 ' ' THR . . . . . . . . . . . . . 14.3 t -141.97 152.41 61.88 Favored Pre-proline 0 CA--C 1.559 1.298 0 N-CA-C 108.846 -0.798 . . . . 0.48 108.846 -171.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1643 ' ' PRO . . . . . 0.445 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 73.7 Cg_endo -75.1 -24.31 12.79 Favored 'Trans proline' 0 C--N 1.367 1.522 0 C-N-CA 122.715 2.277 . . . . 0.66 114.139 -178.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 3.3 pp -75.73 -4.93 43.16 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 119.935 -0.706 . . . . 0.97 111.672 -177.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -116.15 23.87 11.85 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-O 122.318 1.056 . . . . 0.84 109.005 -178.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1646 ' ' CYS . . . . . 0.531 ' O ' ' HD3' ' A' 1648 ' ' PRO . 52.9 t -115.67 140.46 49.17 Favored 'General case' 0 N--CA 1.401 -2.884 0 CA-C-N 115.0 -1.0 . . . . 1.19 110.511 -177.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -102.69 94.98 5.65 Favored Pre-proline 0 N--CA 1.427 -1.601 0 N-CA-C 106.309 -1.737 . . . . 3.14 106.309 172.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1648 ' ' PRO . . . . . 0.531 ' HD3' ' O ' ' A' 1646 ' ' CYS . 7.5 Cg_exo -76.86 151.04 31.02 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 122.438 2.092 . . . . 2.58 111.517 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 . . . . . 0 C--N 1.289 -2.023 0 N-CA-C 106.815 -1.55 . . . . 4.72 106.815 177.657 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.605 0 N-CA-C 109.275 -0.639 . . . . 9.97 109.275 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -99.01 123.33 43.23 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.773 -0.825 . . . . 7.68 108.773 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -92.04 147.53 34.97 Favored Pre-proline 0 C--N 1.305 -1.345 0 N-CA-C 108.805 -0.813 . . . . 6.11 108.805 178.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . 0.419 ' HG2' ' OG1' ' B' ' 7' ' ' THR . 81.7 Cg_endo -75.95 48.64 2.29 Favored 'Trans proline' 0 C--O 1.238 0.515 0 C-N-CA 123.487 2.792 . . . . 4.84 113.063 -177.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 19.2 t 66.4 -63.52 0.25 Allowed 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 126.696 1.998 . . . . 4.6 114.391 175.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -84.91 -44.03 13.54 Favored 'General case' 0 C--N 1.265 -3.075 0 N-CA-C 113.956 1.095 . . . . 4.23 113.956 -171.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . 0.419 ' OG1' ' HG2' ' B' ' 4' ' ' PRO . 18.0 p -94.52 153.75 17.74 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 120.711 -0.395 . . . . 3.14 110.585 -179.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.646 HD22 ' HG3' ' B' ' 12' ' ' GLU . 4.7 mp -123.56 156.4 35.79 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.695 -0.854 . . . . 3.96 108.695 -177.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 38.7 m -101.12 150.66 22.7 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.75 -0.833 . . . . 2.84 108.75 178.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.57 -137.2 13.12 Favored Glycine 0 N--CA 1.427 -1.925 0 C-N-CA 120.535 -0.841 . . . . 2.09 113.173 177.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -56.04 -42.77 87.83 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 115.236 0.854 . . . . 1.84 115.236 -173.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . 0.646 ' HG3' HD22 ' B' ' 8' ' ' LEU . 9.0 mm-40 -63.2 -49.12 75.5 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.434 0.635 . . . . 2.55 110.39 -176.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 13.6 tp -66.99 -49.45 65.33 Favored 'General case' 0 C--O 1.252 1.203 0 CA-C-N 115.015 -0.993 . . . . 2.35 111.196 -175.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 14.3 p -64.68 -37.66 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 C-N-CA 120.399 -0.52 . . . . 2.11 110.944 -178.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -77.17 -17.56 58.47 Favored 'General case' 0 C--O 1.196 -1.734 0 C-N-CA 118.08 -1.448 . . . . 2.04 111.358 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 92.0 m -62.5 -41.31 98.74 Favored 'General case' 0 C--O 1.272 2.267 0 O-C-N 121.302 -0.874 . . . . 1.84 108.983 173.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.891 HD21 HD11 ' B' ' 42' ' ' ILE . 10.7 mp -63.4 -42.67 98.78 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 115.568 -0.742 . . . . 1.74 110.99 176.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -75.55 -11.85 60.1 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.02 -0.991 . . . . 2.39 111.267 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -67.95 -55.24 13.47 Favored 'General case' 0 C--N 1.314 -0.967 0 O-C-N 121.892 -0.505 . . . . 0.96 109.686 176.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 12.6 p -98.52 -17.5 6.68 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 C-N-CA 118.112 -1.435 . . . . 1.37 112.487 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 83.8 m -116.81 30.62 7.22 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.457 -0.777 . . . . 1.66 111.586 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -55.0 -57.11 19.78 Favored Glycine 0 C--N 1.342 0.894 0 N-CA-C 114.082 0.393 . . . . 1.53 114.082 -179.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.583 ' HA ' ' HD2' ' A' 1544 ' ' LYS . 17.6 t70 -65.93 -32.85 74.59 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-O 121.063 0.459 . . . . 2.72 111.182 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 21.3 tpp180 -69.53 -47.99 61.93 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.79 -0.641 . . . . 4.33 111.186 -178.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 111.43 170.49 18.95 Favored Glycine 0 N--CA 1.427 -1.961 0 N-CA-C 108.797 -1.721 . . . . 1.53 108.797 -175.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -135.6 140.63 44.75 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 117.399 0.6 . . . . 1.65 111.598 178.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -136.51 141.99 43.46 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.77 -0.455 . . . . 3.42 109.77 178.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' PHE . . . . . 0.457 ' CD2' ' HB ' ' B' ' 43' ' ' VAL . 0.0 OUTLIER -154.52 23.45 0.47 Allowed 'General case' 0 C--O 1.243 0.712 0 N-CA-C 112.321 0.489 . . . . 2.26 112.321 178.238 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 17.9 m -118.35 84.15 2.13 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.416 0.627 . . . . 3.68 111.925 -172.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . 0.528 HH22 ' HB ' ' B' ' 35' ' ' VAL . 74.2 mtm180 -123.13 119.65 27.61 Favored Pre-proline 0 C--N 1.303 -1.455 0 N-CA-C 108.031 -1.1 . . . . 3.81 108.031 177.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . 0.76 ' HA ' ' HA ' ' B' ' 39' ' ' SER . 31.8 Cg_exo -61.98 -27.96 80.18 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.609 2.872 . . . . 4.02 113.451 -178.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -166.27 157.63 13.32 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 108.712 -0.847 . . . . 4.92 108.712 177.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 36.9 t 175.47 178.64 0.16 Allowed 'General case' 0 N--CA 1.4 -2.932 0 N-CA-C 102.881 -3.007 . . . . 6.72 102.881 -177.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 46.6 ttp180 -93.2 -8.09 43.38 Favored 'General case' 0 C--N 1.266 -3.041 0 N-CA-C 108.562 -0.903 . . . . 11.63 108.562 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 0.528 ' HB ' HH22 ' B' ' 30' ' ' ARG . 13.3 t -118.11 3.28 7.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-O 122.763 1.268 . . . . 9.61 108.001 179.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 51.1 m -155.59 71.45 0.76 Allowed 'General case' 0 N--CA 1.422 -1.84 0 N-CA-C 107.143 -1.429 . . . . 6.71 107.143 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 9.7 ptp85 -80.76 6.94 11.5 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-O 122.406 1.098 . . . . 10.0 110.659 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . 0.489 ' C ' ' H ' ' B' ' 40' ' ' ARG . 32.8 tpt180 -110.68 159.4 17.63 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 104.565 -2.383 . . . . 7.94 104.565 176.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . 0.76 ' HA ' ' HA ' ' B' ' 31' ' ' PRO . 24.9 m -76.37 26.92 0.12 Allowed 'General case' 0 CA--C 1.549 0.915 0 CA-C-O 122.04 0.924 . . . . 5.76 111.694 178.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . 0.489 ' H ' ' C ' ' B' ' 38' ' ' ARG . 27.8 mmt180 -149.94 155.0 39.22 Favored 'General case' 0 N--CA 1.423 -1.814 0 N-CA-C 105.184 -2.154 . . . . 6.03 105.184 -179.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . -101.66 -104.6 2.77 Favored Glycine 0 N--CA 1.401 -3.694 0 N-CA-C 110.142 -1.183 . . . . 2.37 110.142 175.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . 0.891 HD11 HD21 ' B' ' 17' ' ' LEU . 28.3 pt -84.96 -22.53 7.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 113.152 0.797 . . . . 2.07 113.152 -170.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.457 ' HB ' ' CD2' ' B' ' 28' ' ' PHE . 2.9 p -58.69 -42.64 85.68 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.418 0 N-CA-C 112.399 0.518 . . . . 2.24 112.399 -177.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -83.14 -27.23 30.26 Favored 'General case' 0 N--CA 1.425 -1.681 0 N-CA-C 109.193 -0.669 . . . . 3.36 109.193 -174.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . 0.4 ' O ' ' HB2' ' B' ' 49' ' ' ARG . 46.9 mm-40 -70.01 -29.62 66.73 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 115.293 -0.867 . . . . 3.08 111.932 177.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' CYS . . . . . . . . . . . . . 36.3 t -98.07 -16.27 19.66 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 121.252 0.548 . . . . 2.23 111.058 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 42.8 t -77.3 -36.32 54.22 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.111 0.481 . . . . 2.37 110.654 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -109.81 -9.92 14.79 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 113.218 0.821 . . . . 2.82 113.218 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . 0.4 ' HB2' ' O ' ' B' ' 45' ' ' GLU . 28.0 mmt180 -135.64 151.09 49.88 Favored 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 106.037 -1.838 . . . . 4.09 106.037 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 14.7 m -76.04 117.73 18.06 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 108.981 -0.748 . . . . 2.67 108.981 -178.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 28.1 p -92.71 135.33 34.2 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 108.67 -0.863 . . . . 2.11 108.67 -176.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -87.54 139.66 30.31 Favored 'General case' 0 N--CA 1.416 -2.155 0 N-CA-C 109.03 -0.73 . . . . 2.67 109.03 177.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . 0.513 HD21 ' HB3' ' A' 1631 ' ' LYS . 61.0 tp -36.07 -39.86 0.19 Allowed 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 127.469 2.308 . . . . 1.9 113.952 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.42 -40.82 83.51 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 123.868 0.73 . . . . 1.52 111.796 -176.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 50.8 tp -58.56 -47.53 83.91 Favored 'General case' 0 C--O 1.22 -0.47 0 O-C-N 123.802 0.689 . . . . 1.97 111.03 -177.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 3.9 pp -80.45 -35.29 35.17 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 116.145 -0.479 . . . . 1.53 111.513 -174.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -67.33 -44.25 79.57 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 116.031 -0.532 . . . . 2.27 111.456 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 6.3 t -76.1 -31.29 58.62 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 119.598 -0.841 . . . . 2.33 111.251 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 59' ' ' TYR . . . . . 0.438 ' CZ ' ' HA ' ' B' ' 63' ' ' PRO . 14.8 t80 -69.12 -60.42 2.37 Favored 'General case' 0 C--O 1.244 0.775 0 N-CA-C 107.772 -1.196 . . . . 2.86 107.772 178.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 37.0 t 68.14 -64.05 0.31 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.303 1.441 . . . . 2.3 112.473 175.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -157.35 -45.88 0.07 Allowed 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 107.492 -1.299 . . . . 3.19 107.492 -176.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -62.84 132.67 94.9 Favored Pre-proline 0 N--CA 1.445 -0.699 0 CA-C-N 114.753 -1.112 . . . . 3.68 111.827 175.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . 0.438 ' HA ' ' CZ ' ' B' ' 59' ' ' TYR . 72.0 Cg_endo -82.06 -8.1 12.04 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.997 2.465 . . . . 5.08 114.833 -175.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -141.59 73.63 1.42 Allowed 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 109.194 -0.669 . . . . 5.1 109.194 178.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 3.4 tmtp? -136.96 70.17 1.41 Allowed 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 107.941 -1.133 . . . . 8.51 107.941 -178.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 11.9 p -89.65 -5.87 56.7 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 115.022 -0.99 . . . . 8.12 110.521 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 . . . . . 0 C--N 1.309 -1.167 0 CA-C-N 114.868 -1.06 . . . . 10.21 109.691 -178.201 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 50.9 tpp . . . . . 0 N--CA 1.453 -0.288 0 CA-C-O 121.407 0.622 . . . . 9.34 110.789 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 28.6 tptp -108.68 145.6 34.77 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 104.288 -2.486 . . . . 9.04 104.288 173.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1510 ' ' SER . . . . . 0.417 ' CB ' ' HB3' ' A' 1521 ' ' PRO . 35.5 m -138.39 172.76 12.42 Favored 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 119.578 -0.849 . . . . 5.81 111.138 -174.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1511 ' ' ASN . . . . . . . . . . . . . 15.4 m120 72.17 26.82 2.7 Favored 'General case' 0 C--N 1.34 0.172 0 C-N-CA 124.517 1.127 . . . . 3.42 111.977 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1512 ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -74.83 161.87 29.18 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 108.259 -1.015 . . . . 5.95 108.259 174.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 23.2 p-80 -129.96 112.68 13.75 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-O 121.446 0.641 . . . . 5.33 111.426 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 19.3 t70 -62.38 -54.23 43.44 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 114.783 -1.099 . . . . 5.06 108.187 174.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1515 ' ' ASP . . . . . 0.543 ' O ' ' HB3' ' A' 1579 ' ' LYS . 14.3 t70 -130.32 -75.29 0.54 Allowed 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 106.649 -1.612 . . . . 2.9 106.649 173.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1516 ' ' CYS . . . . . 0.486 ' SG ' HD23 ' A' 1581 ' ' LEU . 46.9 t -148.92 79.18 1.41 Allowed 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.787 -1.19 . . . . 1.19 107.787 176.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -168.07 151.04 5.68 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 105.938 -1.875 . . . . 1.52 105.938 -173.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1518 ' ' VAL . . . . . 0.454 ' CG2' HD12 ' A' 1581 ' ' LEU . 2.9 m -144.89 142.58 22.95 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-O 120.885 0.374 . . . . 0.94 111.442 -176.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1519 ' ' THR . . . . . . . . . . . . . 33.8 m -95.79 139.29 32.23 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 109.497 -0.557 . . . . 0.89 109.497 177.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -76.95 116.13 54.51 Favored Pre-proline 0 C--O 1.244 0.787 0 N-CA-C 108.501 -0.926 . . . . 1.74 108.501 176.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1521 ' ' PRO . . . . . 0.417 ' HB3' ' CB ' ' A' 1510 ' ' SER . 16.1 Cg_endo -60.81 -24.85 80.01 Favored 'Trans proline' 0 C--O 1.243 0.728 0 C-N-CA 123.43 2.753 . . . . 1.58 113.807 -177.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 33.7 m -74.33 -31.17 62.34 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 113.348 0.87 . . . . 1.65 113.348 -175.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1523 ' ' THR . . . . . . . . . . . . . 8.9 t -137.65 -10.74 1.6 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 118.617 -1.233 . . . . 1.61 113.455 -176.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 82.45 31.07 31.54 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 119.897 -1.144 . . . . 1.13 112.173 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 25.1 t-80 -97.74 131.2 44.49 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.641 -0.874 . . . . 1.26 108.641 178.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 2.8 tm? -89.67 121.71 32.1 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.718 -0.674 . . . . 0.68 111.515 -175.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -91.81 127.84 37.41 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 108.544 -0.91 . . . . 0.65 108.544 168.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 15.2 t70 -120.64 113.89 20.9 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 109.055 -0.72 . . . . 1.17 109.055 177.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1529 ' ' LEU . . . . . 0.451 ' HG ' HD21 ' A' 1581 ' ' LEU . 3.7 mm? -97.13 -0.25 47.32 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 121.578 0.704 . . . . 0.6 109.931 -178.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 1.5 m -65.87 -25.74 67.32 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.841 -1.072 . . . . 0.84 109.945 -178.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 40.5 t -61.09 -24.06 65.95 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 123.224 0.61 . . . . 1.59 110.816 178.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1532 ' ' LEU . . . . . 0.559 ' HB2' HG21 ' A' 1552 ' ' ILE . 73.0 mt -97.49 8.61 44.29 Favored 'General case' 0 C--N 1.32 -0.674 0 O-C-N 122.106 -0.371 . . . . 0.65 111.729 -177.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1533 ' ' SER . . . . . . . . . . . . . 77.2 p -68.66 174.19 4.48 Favored 'General case' 0 C--O 1.251 1.174 0 CA-C-O 121.454 0.645 . . . . 1.52 111.818 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . 171.81 150.9 7.43 Favored Glycine 0 N--CA 1.419 -2.493 0 N-CA-C 109.956 -1.258 . . . . 1.1 109.956 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1535 ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' 1535 ' ' ARG . 22.9 ttt180 -87.42 -30.0 21.04 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.08 0.467 . . . . 4.62 110.802 -178.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -90.16 -35.82 15.17 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.579 0.704 . . . . 1.45 109.439 178.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 92.89 -150.99 20.24 Favored Glycine 0 N--CA 1.409 -3.123 0 CA-C-N 115.403 -0.817 . . . . 0.85 112.329 173.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -128.82 153.33 47.54 Favored 'General case' 0 C--N 1.281 -2.396 0 N-CA-C 106.435 -1.691 . . . . 0.93 106.435 -178.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 4.1 m -128.46 134.79 48.83 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 109.399 -0.593 . . . . 1.03 109.399 -175.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1540 ' ' ALA . . . . . 0.597 ' HB3' HG12 ' A' 1548 ' ' VAL . . . -129.93 143.61 50.89 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 115.758 -0.656 . . . . 0.5 109.488 -177.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -88.99 121.4 31.31 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.346 0.593 . . . . 0.74 110.517 -177.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1542 ' ' TYR . . . . . 0.59 ' CE2' ' HG ' ' A' 1626 ' ' LEU . 0.9 OUTLIER -111.49 -101.86 0.4 Allowed 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.464 -1.31 . . . . 0.99 107.464 -179.326 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A 1543 ' ' SER . . . . . 0.427 ' H ' ' HB3' ' A' 1542 ' ' TYR . 7.7 m -73.34 162.5 29.26 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 118.984 -0.532 . . . . 1.91 109.941 178.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -50.17 -42.93 51.95 Favored 'General case' 0 C--O 1.25 1.091 0 N-CA-C 113.388 0.884 . . . . 3.59 113.388 -178.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 23.3 t -100.67 15.1 29.33 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 110.516 -0.179 . . . . 2.46 110.516 -178.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . -132.7 131.29 6.12 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 118.81 -1.662 . . . . 1.26 116.726 -170.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 15.1 m -121.39 149.83 24.49 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 108.794 -0.817 . . . . 0.79 108.794 171.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1548 ' ' VAL . . . . . 0.597 HG12 ' HB3' ' A' 1540 ' ' ALA . 7.8 p -104.87 137.74 32.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 109.319 -0.622 . . . . 0.58 109.319 177.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -103.86 126.95 51.35 Favored 'General case' 0 N--CA 1.424 -1.755 0 CA-C-N 115.642 -0.708 . . . . 1.08 109.15 175.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1550 ' ' MET . . . . . 0.407 ' HA ' ' O ' ' A' 1564 ' ' GLY . 5.5 ppp? -144.24 138.5 28.04 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 115.082 -0.963 . . . . 0.78 110.27 -175.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 7.1 p -125.48 134.41 52.06 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 115.926 -0.579 . . . . 0.97 109.855 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1552 ' ' ILE . . . . . 0.559 HG21 ' HB2' ' A' 1532 ' ' LEU . 49.5 mm -82.24 114.94 23.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-N 116.625 -0.261 . . . . 0.42 111.36 -177.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 74.8 m 71.33 16.51 6.09 Favored 'General case' 0 CA--C 1.509 -0.6 0 C-N-CA 124.036 0.934 . . . . 1.4 113.057 171.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . -163.17 -175.26 33.99 Favored Glycine 0 N--CA 1.403 -3.5 0 C-N-CA 120.127 -1.035 . . . . 0.35 110.98 -176.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1555 ' ' GLU . . . . . 0.466 ' H ' ' CD ' ' A' 1555 ' ' GLU . 0.3 OUTLIER -91.36 148.57 22.23 Favored 'General case' 0 C--N 1.282 -2.351 0 C-N-CA 124.102 0.961 . . . . 1.62 111.755 -176.205 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 46.2 t-20 -114.46 129.85 56.68 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.729 -1.212 . . . . 0.87 107.729 178.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -79.93 2.18 24.48 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.025 0.75 . . . . 2.49 113.025 -173.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -74.24 -16.68 60.95 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 112.37 0.507 . . . . 1.38 112.37 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1559 ' ' CYS . . . . . 0.719 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 88.9 m -137.75 173.49 5.34 Favored Pre-proline 0 C--N 1.306 -1.289 0 CA-C-O 117.811 -1.09 . . . . 1.21 111.003 179.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1560 ' ' PRO . . . . . 0.719 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 7.3 Cg_exo -31.83 131.59 0.08 OUTLIER 'Trans proline' 0 C--N 1.393 2.917 0 C-N-CA 124.801 3.668 . . . . 0.71 114.735 177.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1561 ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' 1560 ' ' PRO . 83.6 Cg_exo -48.56 125.75 13.04 Favored 'Trans proline' 0 C--O 1.25 1.08 0 C-N-CA 124.553 3.502 . . . . 0.8 114.452 -174.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 93.88 23.94 21.61 Favored Glycine 0 N--CA 1.432 -1.575 0 CA-C-N 115.284 -0.871 . . . . 0.46 112.451 178.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1563 ' ' VAL . . . . . 0.531 HG11 ' HB2' ' A' 1559 ' ' CYS . 4.0 p -109.6 139.85 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 C-N-CA 119.773 -0.771 . . . . 0.98 110.543 -177.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1564 ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' 1550 ' ' MET . . . -104.41 -27.29 6.18 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 121.156 -0.545 . . . . 0.28 113.279 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -135.46 129.95 33.99 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 117.144 0.472 . . . . 0.28 110.188 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 31.7 t -160.3 137.61 9.42 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 122.465 0.306 . . . . 0.43 110.48 -178.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1567 ' ' PHE . . . . . 0.429 ' HA ' ' HA ' ' A' 1548 ' ' VAL . 76.2 m-85 -85.62 138.88 31.85 Favored 'General case' 0 C--O 1.247 0.963 0 N-CA-C 108.142 -1.058 . . . . 1.03 108.142 173.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -82.36 38.19 2.6 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.937 -0.649 . . . . 1.13 112.92 -176.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1569 ' ' GLN . . . . . 0.498 ' HB3' ' OD1' ' B' ' 15' ' ' ASP . 16.4 mm100 -83.48 -72.3 0.46 Allowed 'General case' 0 N--CA 1.443 -0.804 0 CA-C-O 121.045 0.45 . . . . 2.58 110.341 176.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 5.5 t -132.44 34.24 3.74 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-O 122.194 0.997 . . . . 2.17 109.217 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 61.32 55.86 2.8 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 124.902 1.281 . . . . 2.62 110.029 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 19.6 mt -97.17 114.37 34.01 Favored 'Isoleucine or valine' 0 C--O 1.244 0.805 0 N-CA-C 109.211 -0.662 . . . . 0.92 109.211 -177.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1573 ' ' SER . . . . . 0.748 ' HB3' ' HB2' ' A' 1596 ' ' SER . 19.5 t -74.39 130.73 40.2 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.552 0.692 . . . . 0.8 110.918 -178.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1574 ' ' VAL . . . . . 0.6 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 34.8 m -123.41 10.93 5.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 CA-C-O 121.33 0.586 . . . . 0.98 110.607 177.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 177.4 118.95 0.57 Allowed Glycine 0 N--CA 1.428 -1.852 0 C-N-CA 120.589 -0.815 . . . . 0.29 111.652 177.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1576 ' ' LYS . . . . . 0.453 ' HE3' ' HB2' ' A' 1576 ' ' LYS . 37.8 ttmt -74.62 148.32 40.81 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.978 -1.119 . . . . 2.19 107.978 178.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -75.74 83.98 2.72 Favored 'General case' 0 CA--C 1.499 -0.998 0 CA-C-O 121.456 0.646 . . . . 0.61 111.756 -175.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -99.06 166.04 11.45 Favored 'General case' 0 C--N 1.281 -2.39 0 N-CA-C 108.213 -1.032 . . . . 1.95 108.213 178.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1579 ' ' LYS . . . . . 0.543 ' HB3' ' O ' ' A' 1515 ' ' ASP . 67.3 mttm -120.32 42.09 3.06 Favored 'General case' 0 C--N 1.286 -2.158 0 CA-C-O 122.601 1.191 . . . . 2.68 107.869 -176.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 43.5 ttt180 -93.65 75.84 4.34 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 114.188 -1.369 . . . . 3.47 108.41 -173.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1581 ' ' LEU . . . . . 0.486 HD23 ' SG ' ' A' 1516 ' ' CYS . 0.6 OUTLIER -84.3 125.07 31.92 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 113.549 -1.66 . . . . 0.64 108.196 -178.566 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 60.8 mtm180 -125.73 138.51 53.87 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 116.457 -0.338 . . . . 2.85 111.289 178.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1583 ' ' TYR . . . . . . . . . . . . . 48.5 t80 -112.86 110.41 20.49 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 122.31 0.244 . . . . 0.86 110.48 -178.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1584 ' ' VAL . . . . . 0.566 ' O ' ' HB ' ' A' 1587 ' ' VAL . 15.4 m -129.69 93.23 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.265 0.555 . . . . 1.05 112.431 -178.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 26.9 t70 59.75 65.94 1.06 Allowed 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 123.805 0.842 . . . . 1.17 111.137 174.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1586 ' ' GLN . . . . . . . . . . . . 0.254 8.7 pt20 66.1 5.43 3.56 Favored 'General case' 0 N--CA 1.503 2.197 0 C-N-CA 127.163 2.185 . . . . 1.86 112.11 178.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1587 ' ' VAL . . . . . 0.566 ' HB ' ' O ' ' A' 1584 ' ' VAL . 36.0 t -104.0 120.14 53.75 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.749 0 CA-C-N 114.789 -1.096 . . . . 0.49 109.378 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1588 ' ' LEU . . . . . 0.811 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 2.6 mm? -96.16 107.58 19.93 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 106.135 -1.802 . . . . 0.36 106.135 176.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1589 ' ' GLN . . . . . 0.508 ' HA ' ' O ' ' A' 1610 ' ' ILE . 27.8 tt0 -107.96 116.45 31.99 Favored 'General case' 0 N--CA 1.409 -2.49 0 CA-C-O 121.955 0.883 . . . . 1.74 110.368 -176.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1590 ' ' LEU . . . . . 0.514 ' HB3' ' HB ' ' A' 1610 ' ' ILE . 1.1 tt -107.64 107.42 18.22 Favored 'General case' 0 C--N 1.28 -2.418 0 N-CA-C 105.009 -2.219 . . . . 0.72 105.009 -178.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 4.2 p -101.72 129.63 52.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 C-N-CA 119.572 -0.851 . . . . 1.01 111.403 -174.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1592 ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -119.4 105.74 11.58 Favored 'General case' 0 CA--C 1.496 -1.118 0 N-CA-C 108.502 -0.925 . . . . 0.5 108.502 177.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1593 ' ' LYS . . . . . 0.635 ' HB3' ' HD3' ' A' 1607 ' ' LYS . 18.4 pttp -126.43 174.76 8.38 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 109.428 -0.582 . . . . 1.59 109.428 -179.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 9.8 m-20 58.98 36.79 24.59 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 124.677 1.235 . . . . 1.11 110.996 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -73.52 -88.08 0.19 Allowed Glycine 0 N--CA 1.44 -1.082 0 N-CA-C 110.412 -1.075 . . . . 0.78 110.412 178.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1596 ' ' SER . . . . . 0.748 ' HB2' ' HB3' ' A' 1573 ' ' SER . 47.0 t -132.25 144.73 54.31 Favored Pre-proline 0 N--CA 1.416 -2.139 0 N-CA-C 107.788 -1.19 . . . . 1.07 107.788 175.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1597 ' ' PRO . . . . . 0.561 ' HA ' ' HA ' ' A' 1605 ' ' SER . 18.0 Cg_endo -58.89 130.78 38.33 Favored 'Trans proline' 0 C--O 1.24 0.578 0 C-N-CA 123.829 3.019 . . . . 1.01 112.462 179.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1598 ' ' CYS . . . . . 0.433 ' SG ' ' HB2' ' A' 1600 ' ' SER . 47.4 t -72.65 120.53 81.18 Favored Pre-proline 0 C--N 1.289 -2.041 0 CA-C-N 114.516 -1.22 . . . . 0.75 109.309 -174.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -65.13 -32.32 52.86 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.684 2.256 . . . . 1.7 110.635 178.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1600 ' ' SER . . . . . 0.769 ' HB3' HD13 ' B' ' 53' ' ' LEU . 7.1 m -64.47 -45.97 85.07 Favored 'General case' 0 N--CA 1.419 -1.983 0 CA-C-N 115.297 -0.865 . . . . 2.26 110.713 176.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1601 ' ' LYS . . . . . 0.583 ' HG2' HD21 ' A' 1604 ' ' LEU . 0.0 OUTLIER -121.9 93.54 4.03 Favored 'General case' 0 N--CA 1.429 -1.513 0 O-C-N 121.374 -0.828 . . . . 3.01 108.919 -178.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 7.0 m -55.8 125.04 19.6 Favored 'General case' 0 N--CA 1.426 -1.646 0 C-N-CA 124.316 1.046 . . . . 2.07 111.28 -177.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 106.03 -8.5 42.25 Favored Glycine 0 C--N 1.313 -0.702 0 C-N-CA 121.126 -0.559 . . . . 1.08 114.403 174.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1604 ' ' LEU . . . . . 0.583 HD21 ' HG2' ' A' 1601 ' ' LYS . 4.2 pp -128.35 155.7 44.27 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-N 118.218 1.009 . . . . 1.84 110.237 176.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1605 ' ' SER . . . . . 0.561 ' HA ' ' HA ' ' A' 1597 ' ' PRO . 7.7 p -103.19 152.83 21.0 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 123.042 0.537 . . . . 1.41 111.357 -176.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1606 ' ' TYR . . . . . 0.6 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 58.5 m-85 -63.34 161.3 14.28 Favored 'General case' 0 C--O 1.25 1.083 0 CA-C-N 116.4 -0.364 . . . . 0.6 110.906 175.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1607 ' ' LYS . . . . . 0.635 ' HD3' ' HB3' ' A' 1593 ' ' LYS . 24.5 ttpp -155.89 125.4 6.31 Favored 'General case' 0 CA--C 1.5 -0.968 0 CA-C-N 116.291 -0.413 . . . . 1.45 110.333 -178.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1608 ' ' SER . . . . . . . . . . . . . 22.3 m -105.4 127.04 52.77 Favored 'General case' 0 C--N 1.286 -2.185 0 N-CA-C 108.444 -0.947 . . . . 1.15 108.444 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 39.6 t -111.0 108.72 26.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 109.183 -0.673 . . . . 0.25 109.183 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1610 ' ' ILE . . . . . 0.514 ' HB ' ' HB3' ' A' 1590 ' ' LEU . 25.7 mm -89.67 123.41 41.86 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 106.776 -1.564 . . . . 0.45 106.776 -178.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 21.5 p -122.09 105.42 10.26 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 120.517 -0.473 . . . . 1.26 111.031 177.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1612 ' ' PHE . . . . . 0.811 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 68.1 m-85 -86.16 119.69 26.72 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.71 -0.848 . . . . 0.26 108.71 177.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 45.9 t -114.2 134.53 56.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 108.514 -0.921 . . . . 0.5 108.514 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 12.2 t -59.64 114.74 2.89 Favored 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 123.964 0.906 . . . . 0.77 112.403 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1615 ' ' ARG . . . . . 0.725 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 0.0 OUTLIER -132.2 89.52 37.23 Favored Pre-proline 0 N--CA 1.446 -0.66 0 N-CA-C 106.967 -1.494 . . . . 2.53 106.967 172.783 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A 1616 ' ' PRO . . . . . 0.626 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 34.4 Cg_exo -59.46 -32.84 97.04 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 123.077 2.518 . . . . 1.1 114.629 -173.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -77.23 -5.49 49.49 Favored 'General case' 0 C--O 1.252 1.228 0 N-CA-C 111.931 0.345 . . . . 3.05 111.931 -178.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . 58.49 -143.11 0.64 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.23 0.612 . . . . 1.55 109.98 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . 110.47 -157.64 14.89 Favored Glycine 0 N--CA 1.416 -2.681 0 CA-C-N 119.532 1.06 . . . . 0.93 111.821 178.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -80.55 13.63 2.22 Favored 'Trans proline' 0 C--N 1.323 -0.799 0 C-N-CA 123.455 2.77 . . . . 0.88 113.249 -177.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1621 ' ' THR . . . . . 0.901 ' HB ' ' HB2' ' A' 1641 ' ' HIS . 36.2 p -96.16 -14.46 22.77 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 115.48 -0.782 . . . . 0.97 110.049 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1622 ' ' ASN . . . . . 0.414 ' OD1' ' HB ' ' A' 1642 ' ' THR . 55.1 t30 -88.73 62.66 6.55 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 122.057 0.932 . . . . 0.72 110.148 -175.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1623 ' ' ARG . . . . . 0.409 ' HE ' ' HB3' ' A' 1623 ' ' ARG . 6.7 ptp180 -168.53 139.73 2.15 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-N 114.155 -1.384 . . . . 3.26 108.169 -178.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -63.35 119.1 6.03 Favored 'Trans proline' 0 C--O 1.25 1.111 0 C-N-CA 122.762 2.308 . . . . 0.59 113.353 -174.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 76.8 mtm -116.68 138.44 51.45 Favored 'General case' 0 C--O 1.245 0.865 0 N-CA-C 108.79 -0.819 . . . . 1.37 108.79 175.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1626 ' ' LEU . . . . . 0.59 ' HG ' ' CE2' ' A' 1542 ' ' TYR . 0.4 OUTLIER -88.16 118.71 27.93 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 107.661 -1.237 . . . . 0.89 107.661 -176.455 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A 1627 ' ' ILE . . . . . 0.68 HD11 ' HB2' ' A' 1639 ' ' SER . 33.3 mm -78.3 -53.18 14.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.392 -0.596 . . . . 0.58 109.392 -178.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 8.4 t -167.85 152.08 6.42 Favored 'General case' 0 N--CA 1.416 -2.136 0 N-CA-C 108.652 -0.87 . . . . 1.39 108.652 -174.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1629 ' ' LEU . . . . . 0.859 HD23 ' HG ' ' A' 1636 ' ' LEU . 1.8 tm? -121.64 102.17 8.06 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 105.741 -1.948 . . . . 1.25 105.741 176.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 31.9 t70 -70.63 124.18 23.64 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 120.118 -0.633 . . . . 1.09 109.784 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1631 ' ' LYS . . . . . 0.454 ' HB2' HD21 ' B' ' 53' ' ' LEU . 16.6 ptpt -79.38 -10.89 59.9 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 112.654 0.612 . . . . 3.6 112.654 -171.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -100.62 -34.71 9.77 Favored 'General case' 0 N--CA 1.421 -1.878 0 C-N-CA 120.221 -0.592 . . . . 2.6 111.515 -175.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 40.8 p -103.3 -6.86 21.58 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.05 0.452 . . . . 0.75 111.795 177.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 78.7 m 56.37 35.97 26.75 Favored 'General case' 0 C--N 1.361 1.085 0 C-N-CA 124.396 1.078 . . . . 0.53 111.982 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1635 ' ' THR . . . . . . . . . . . . . 59.5 m -99.54 132.08 45.11 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-N 114.218 -1.355 . . . . 0.46 109.996 178.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1636 ' ' LEU . . . . . 0.859 ' HG ' HD23 ' A' 1629 ' ' LEU . 0.8 OUTLIER -108.53 132.51 53.76 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.861 -1.533 . . . . 0.86 106.861 -178.39 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A 1637 ' ' PHE . . . . . 0.413 ' HB2' ' HB ' ' A' 1627 ' ' ILE . 94.3 m-85 -107.04 135.56 48.38 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 110.153 -0.314 . . . . 0.45 110.153 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -128.59 129.17 45.55 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.069 -0.514 . . . . 0.5 110.09 -175.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1639 ' ' SER . . . . . 0.68 ' HB2' HD11 ' A' 1627 ' ' ILE . 22.7 t -108.48 149.38 28.87 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.445 -0.946 . . . . 1.04 108.445 178.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 2.1 t90 -156.46 115.74 3.47 Favored 'General case' 0 N--CA 1.425 -1.714 0 N-CA-C 105.032 -2.21 . . . . 0.68 105.032 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1641 ' ' HIS . . . . . 0.901 ' HB2' ' HB ' ' A' 1621 ' ' THR . 18.9 m-70 -112.86 107.91 16.68 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 120.528 -0.469 . . . . 0.9 110.257 -177.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1642 ' ' THR . . . . . 0.414 ' HB ' ' OD1' ' A' 1622 ' ' ASN . 7.3 t -138.19 152.01 70.84 Favored Pre-proline 0 C--N 1.296 -1.727 0 CA-C-N 114.744 -1.116 . . . . 0.48 109.63 -171.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1643 ' ' PRO . . . . . 0.626 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 74.1 Cg_endo -79.49 -7.98 14.87 Favored 'Trans proline' 0 C--N 1.372 1.767 0 C-N-CA 122.496 2.131 . . . . 0.66 112.167 177.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 8.7 tt -68.11 -23.1 64.88 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-O 121.491 0.662 . . . . 0.97 109.549 177.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -93.51 5.65 50.87 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.706 -0.679 . . . . 0.84 110.948 -177.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1646 ' ' CYS . . . . . 0.472 ' SG ' ' HA ' ' A' 1643 ' ' PRO . 72.2 m -93.82 142.77 26.99 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 120.804 0.335 . . . . 1.19 111.501 -177.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -93.2 149.23 37.09 Favored Pre-proline 0 C--N 1.297 -1.687 0 C-N-CA 123.691 0.796 . . . . 3.14 108.887 178.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1648 ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -59.31 112.44 1.24 Allowed 'Trans proline' 0 C--O 1.238 0.521 0 C-N-CA 123.063 2.508 . . . . 2.58 111.803 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 34.8 tt0 . . . . . 0 C--O 1.254 1.316 0 O-C-N 124.631 1.207 . . . . 4.72 109.608 179.608 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.301 0 CA-C-O 121.335 0.588 . . . . 9.97 109.814 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -110.27 130.1 55.61 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.059 0.457 . . . . 7.68 110.268 -177.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' ARG . . . . . 0.564 ' HD3' HD21 ' B' ' 8' ' ' LEU . 14.7 ptp180 -112.72 147.24 36.71 Favored Pre-proline 0 C--N 1.302 -1.47 0 N-CA-C 107.944 -1.132 . . . . 6.11 107.944 177.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -80.09 15.11 1.76 Allowed 'Trans proline' 0 C--O 1.244 0.802 0 C-N-CA 123.136 2.557 . . . . 4.84 113.933 -174.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . 0.431 ' HB2' ' HG ' ' B' ' 8' ' ' LEU . 50.7 m -140.4 117.43 11.16 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 115.461 -0.79 . . . . 4.6 109.973 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -86.09 -35.96 19.92 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.757 -0.831 . . . . 4.23 108.757 174.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 17.3 p -110.05 99.33 8.44 Favored 'General case' 0 N--CA 1.424 -1.739 0 N-CA-C 106.073 -1.825 . . . . 3.14 106.073 168.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.564 HD21 ' HD3' ' B' ' 3' ' ' ARG . 5.4 mp -79.37 103.68 9.47 Favored 'General case' 0 C--O 1.247 0.942 0 N-CA-C 113.025 0.75 . . . . 3.96 113.025 -170.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 83.3 m -84.98 146.76 27.05 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-O 120.839 0.352 . . . . 2.84 110.454 177.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.77 -62.64 0.3 Allowed Glycine 0 N--CA 1.426 -2.003 0 N-CA-C 111.278 -0.729 . . . . 2.09 111.278 178.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -101.03 -64.18 0.78 Allowed Glycine 0 C--N 1.306 -1.134 0 N-CA-C 115.03 0.772 . . . . 1.84 115.03 -177.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . 0.468 ' HG3' HD22 ' B' ' 8' ' ' LEU . 25.8 mm-40 -71.07 -45.08 64.42 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.894 0.702 . . . . 2.55 112.894 -170.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 12.5 tp -45.52 -57.88 3.8 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 123.729 0.643 . . . . 2.35 112.562 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 13.2 p -70.89 -31.35 45.2 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 CA-C-N 115.726 -0.67 . . . . 2.11 111.386 -177.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' ASP . . . . . 0.498 ' OD1' ' HB3' ' A' 1569 ' ' GLN . 3.3 t0 -72.95 -40.53 65.3 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 119.271 -0.972 . . . . 2.04 111.766 -176.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 12.4 t -65.0 -32.09 73.65 Favored 'General case' 0 C--O 1.254 1.293 0 O-C-N 121.302 -0.874 . . . . 1.84 109.773 176.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.53 ' O ' ' HB2' ' B' ' 21' ' ' CYS . 9.5 mt -67.05 -23.03 65.84 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-N 115.663 -0.699 . . . . 1.74 112.58 172.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -91.47 -17.7 25.32 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 121.643 0.735 . . . . 2.39 109.552 176.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -68.64 -60.23 2.56 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.819 -0.628 . . . . 0.96 111.699 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 12.5 p -94.43 -20.28 6.21 Favored 'Isoleucine or valine' 0 C--O 1.242 0.671 0 C-N-CA 118.128 -1.429 . . . . 1.37 111.841 -178.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' CYS . . . . . 0.53 ' HB2' ' O ' ' B' ' 17' ' ' LEU . 7.7 m -107.07 18.3 21.92 Favored 'General case' 0 C--O 1.201 -1.453 0 C-N-CA 120.022 -0.671 . . . . 1.66 109.822 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.53 -44.65 97.5 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 115.702 1.041 . . . . 1.53 115.702 -178.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -76.46 -48.5 19.41 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 117.483 0.642 . . . . 2.72 111.62 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . 0.64 ' HE ' ' HB3' ' B' ' 61' ' ' ALA . 35.9 ttp180 -73.84 -25.35 60.03 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.316 0.579 . . . . 4.33 111.746 -175.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . 0.506 ' O ' ' HB2' ' B' ' 61' ' ' ALA . . . 110.16 144.15 10.09 Favored Glycine 0 N--CA 1.425 -2.062 0 N-CA-C 110.9 -0.88 . . . . 1.53 110.9 177.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -88.1 124.09 33.44 Favored 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 120.035 -0.666 . . . . 1.65 109.354 175.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' TYR . . . . . 0.652 ' HB2' ' HA ' ' B' ' 61' ' ' ALA . 27.7 m-85 -128.55 76.61 1.72 Allowed 'General case' 0 CA--C 1.497 -1.081 0 CA-C-O 121.618 0.723 . . . . 3.42 110.418 -173.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' PHE . . . . . 0.512 ' HB2' HG12 ' B' ' 42' ' ' ILE . 12.9 p90 -114.12 8.65 17.03 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 115.455 -0.793 . . . . 2.26 110.808 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 7.4 p -107.05 46.26 0.94 Allowed 'General case' 0 N--CA 1.423 -1.786 0 CA-C-N 115.061 -0.972 . . . . 3.68 109.289 177.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 22.6 mmm180 -122.39 107.11 34.85 Favored Pre-proline 0 C--O 1.214 -0.772 0 N-CA-C 107.302 -1.37 . . . . 3.81 107.302 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . 0.58 ' HA ' ' O ' ' B' ' 39' ' ' SER . 2.6 Cg_endo -98.7 12.38 0.74 Allowed 'Trans proline' 0 C--O 1.249 1.069 0 C-N-CA 122.919 2.413 . . . . 4.02 113.208 178.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' ALA . . . . . 0.698 ' HB3' ' HB3' ' B' ' 38' ' ' ARG . . . 68.19 -0.54 2.1 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.917 1.687 . . . . 4.92 114.508 177.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 44.6 t 173.55 -177.98 0.08 Allowed 'General case' 0 N--CA 1.416 -2.172 0 N-CA-C 103.973 -2.602 . . . . 6.72 103.973 -178.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 61.3 ttt180 -102.34 10.09 39.38 Favored 'General case' 0 C--N 1.28 -2.439 0 CA-C-O 122.18 0.99 . . . . 11.63 109.095 -177.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 22.5 t -91.87 -10.67 9.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 122.424 1.106 . . . . 9.61 108.105 173.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . 0.496 ' HA ' ' HB2' ' B' ' 31' ' ' PRO . 87.4 p 59.01 33.21 22.89 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 125.903 1.681 . . . . 6.71 113.963 172.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 18.2 mmt180 -73.13 -53.56 10.71 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.648 -0.705 . . . . 10.0 112.611 177.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . 0.698 ' HB3' ' HB3' ' B' ' 32' ' ' ALA . 60.4 ttt180 -89.52 86.66 6.81 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 120.939 -0.304 . . . . 7.94 110.573 -175.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . 0.58 ' O ' ' HA ' ' B' ' 31' ' ' PRO . 16.6 m 67.15 87.17 0.12 Allowed 'General case' 0 C--O 1.204 -1.323 0 CA-C-N 114.947 -1.024 . . . . 5.76 111.992 177.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . 0.514 ' HD2' ' HB3' ' B' ' 44' ' ' GLU . 0.1 OUTLIER -64.18 -2.97 2.35 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 113.046 0.758 . . . . 6.03 113.046 179.543 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 126.97 119.66 2.28 Favored Glycine 1 N--CA 1.387 -4.6 0 N-CA-C 107.653 -2.179 . . . . 2.37 107.653 -174.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . 0.512 HG12 ' HB2' ' B' ' 28' ' ' PHE . 33.4 pt -69.93 -4.61 4.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 111.943 0.349 . . . . 2.07 111.943 -175.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 2.5 p -52.81 -40.63 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 CA-C-N 115.661 -0.699 . . . . 2.24 110.08 169.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' GLU . . . . . 0.514 ' HB3' ' HD2' ' B' ' 40' ' ' ARG . 28.1 tt0 -92.51 -19.28 22.14 Favored 'General case' 0 N--CA 1.419 -2.003 0 O-C-N 121.294 -0.879 . . . . 3.36 108.941 -175.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . 0.437 ' CB ' ' HA ' ' B' ' 42' ' ' ILE . 6.4 tp10 -81.28 -2.47 49.06 Favored 'General case' 0 CA--C 1.555 1.161 0 CA-C-N 114.46 -1.245 . . . . 3.08 109.517 -178.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' CYS . . . . . . . . . . . . . 88.8 m -133.84 -20.3 1.99 Allowed 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.249 0.833 . . . . 2.23 113.249 178.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 98.4 m -80.94 -9.84 59.79 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 119.576 -0.85 . . . . 2.37 113.178 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -133.7 20.5 3.88 Favored 'General case' 0 C--N 1.319 -0.727 0 O-C-N 121.498 -0.751 . . . . 2.82 111.773 178.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -169.68 174.7 5.66 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 106.772 -1.566 . . . . 4.09 106.772 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 22.8 t -101.0 143.69 30.84 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-O 121.444 0.64 . . . . 2.67 110.763 -174.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 26.4 p -145.0 151.09 38.03 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-N 115.44 -0.8 . . . . 2.11 108.908 178.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' 1600 ' ' SER . 4.4 p-10 -127.55 -173.99 3.06 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.6 -0.727 . . . . 2.67 109.232 174.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . 0.769 HD13 ' HB3' ' A' 1600 ' ' SER . 46.3 tp -35.58 -39.88 0.15 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 128.088 2.555 . . . . 1.9 115.503 -174.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -49.32 -59.39 3.74 Favored 'General case' 0 CA--C 1.502 -0.888 0 C-N-CA 123.865 0.866 . . . . 1.52 112.129 -172.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 67.6 tp -59.78 -41.78 91.86 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 125.132 1.373 . . . . 1.97 112.803 -176.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 2.6 pp -83.54 -22.48 32.38 Favored 'General case' 0 N--CA 1.422 -1.827 0 C-N-CA 118.654 -1.219 . . . . 1.53 112.257 -173.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -86.48 -33.7 20.27 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 119.397 -0.921 . . . . 2.27 111.186 173.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 18.0 p -60.56 -44.01 96.65 Favored 'General case' 0 C--N 1.357 0.916 0 CA-C-N 118.02 0.373 . . . . 2.33 110.08 176.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -82.16 -81.55 0.15 Allowed 'General case' 0 N--CA 1.428 -1.528 0 C-N-CA 119.507 -0.877 . . . . 2.86 109.505 173.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 41.3 t 58.47 -77.37 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.69 0.796 . . . . 2.3 111.652 -178.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 61' ' ' ALA . . . . . 0.652 ' HA ' ' HB2' ' B' ' 27' ' ' TYR . . . -162.3 168.96 21.44 Favored 'General case' 0 N--CA 1.42 -1.97 0 N-CA-C 106.568 -1.641 . . . . 3.19 106.568 -178.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 14.6 p -99.66 137.45 20.24 Favored Pre-proline 0 C--N 1.275 -2.657 0 CA-C-O 120.852 0.358 . . . . 3.68 110.037 178.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -75.99 -12.45 19.62 Favored 'Trans proline' 0 CA--C 1.53 0.283 0 C-N-CA 122.851 2.367 . . . . 5.08 111.497 178.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -137.72 97.25 3.39 Favored 'General case' 0 N--CA 1.419 -1.981 0 N-CA-C 105.498 -2.038 . . . . 5.1 105.498 175.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -63.33 149.31 46.06 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.766 -1.107 . . . . 8.51 110.012 -175.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 6.8 t -105.94 150.44 25.67 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 106.774 -1.565 . . . . 8.12 106.774 178.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.299 -1.612 0 N-CA-C 109.98 -0.378 . . . . 10.21 109.98 177.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 24.7 ptm . . . . . 0 C--O 1.236 0.39 0 N-CA-C 109.854 -0.424 . . . . 9.34 109.854 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 63.7 mttp -82.58 65.71 7.84 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.555 0.693 . . . . 9.04 111.944 -178.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 27.3 m -98.42 -26.86 14.33 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.299 -1.0 . . . . 5.81 108.299 174.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1511 ' ' ASN . . . . . . . . . . . . . 14.4 m120 -87.51 -16.26 35.21 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.785 -1.098 . . . . 3.42 110.191 178.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1512 ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -117.04 140.49 49.42 Favored 'General case' 0 N--CA 1.41 -2.474 0 N-CA-C 107.166 -1.42 . . . . 5.95 107.166 179.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 21.8 t60 -155.25 -25.06 0.11 Allowed 'General case' 0 C--N 1.283 -2.301 0 CA-C-N 116.273 -0.421 . . . . 5.33 109.988 -173.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 30.8 t70 -163.79 -68.5 0.04 OUTLIER 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 109.536 -0.542 . . . . 5.06 109.536 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 12.7 t70 -144.88 -74.49 0.24 Allowed 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 106.857 -1.535 . . . . 2.9 106.857 177.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 12.9 m -139.84 81.77 1.84 Allowed 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.546 -0.752 . . . . 1.19 110.204 173.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1517 ' ' GLN . . . . . 0.405 ' HA ' ' O ' ' A' 1527 ' ' PHE . 4.1 pt20 -162.65 130.34 3.8 Favored 'General case' 0 N--CA 1.417 -2.106 0 N-CA-C 108.19 -1.041 . . . . 1.52 108.19 -179.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1518 ' ' VAL . . . . . 0.526 ' CG2' HD12 ' A' 1581 ' ' LEU . 4.3 m -129.72 136.97 57.9 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.125 0 CA-C-O 121.276 0.56 . . . . 0.94 110.789 -176.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1519 ' ' THR . . . . . 0.429 ' OG1' HD23 ' A' 1526 ' ' LEU . 23.8 m -112.33 132.42 54.99 Favored 'General case' 0 C--N 1.286 -2.164 0 CA-C-N 115.584 -0.734 . . . . 0.89 109.398 -178.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1520 ' ' ASN . . . . . 0.418 ' OD1' HG22 ' A' 1523 ' ' THR . 27.0 t-20 -86.8 110.19 30.45 Favored Pre-proline 0 N--CA 1.423 -1.804 0 N-CA-C 107.845 -1.168 . . . . 1.74 107.845 174.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -68.54 -16.29 42.58 Favored 'Trans proline' 0 N--CA 1.466 -0.136 0 C-N-CA 122.852 2.368 . . . . 1.58 112.775 -174.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1522 ' ' SER . . . . . 0.409 ' HB2' ' OD1' ' A' 1520 ' ' ASN . 15.2 m -71.76 -31.63 66.85 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 116.042 -0.526 . . . . 1.65 111.458 -178.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1523 ' ' THR . . . . . 0.418 HG22 ' OD1' ' A' 1520 ' ' ASN . 7.5 t -132.99 -4.06 3.14 Favored 'General case' 0 CA--C 1.56 1.345 0 C-N-CA 119.377 -0.929 . . . . 1.61 112.675 179.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 77.39 20.79 74.22 Favored Glycine 0 CA--C 1.497 -1.037 0 O-C-N 121.898 -0.501 . . . . 1.13 113.089 177.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -87.75 118.2 27.1 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 109.006 -0.739 . . . . 1.26 109.006 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1526 ' ' LEU . . . . . 0.429 HD23 ' OG1' ' A' 1519 ' ' THR . 1.0 OUTLIER -100.12 114.81 28.44 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-N 114.22 -1.355 . . . . 0.68 110.458 -175.153 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A 1527 ' ' PHE . . . . . 0.405 ' O ' ' HA ' ' A' 1517 ' ' GLN . 96.3 m-85 -93.75 113.61 25.71 Favored 'General case' 0 CA--C 1.508 -0.665 0 N-CA-C 109.375 -0.602 . . . . 0.65 109.375 176.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 19.9 t70 -104.4 119.17 38.37 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 120.073 -0.651 . . . . 1.17 110.487 175.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1529 ' ' LEU . . . . . 0.761 ' HG ' HD21 ' A' 1581 ' ' LEU . 3.0 mm? -104.23 1.96 31.11 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.751 -0.659 . . . . 0.6 109.645 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 3.1 m -67.07 -24.42 65.97 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 108.641 -0.874 . . . . 0.84 108.641 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 22.8 t -61.18 -27.11 68.18 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 115.093 -0.958 . . . . 1.59 110.295 175.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 81.9 mt -95.28 0.67 54.05 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 122.094 -0.379 . . . . 0.65 111.691 -177.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1533 ' ' SER . . . . . 0.537 ' HA ' ' O ' ' A' 1552 ' ' ILE . 34.3 t -70.94 171.04 11.46 Favored 'General case' 0 C--O 1.26 1.646 0 CA-C-O 121.577 0.703 . . . . 1.52 111.405 -178.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . 170.56 152.03 7.86 Favored Glycine 0 N--CA 1.43 -1.739 0 CA-C-N 115.278 -0.874 . . . . 1.1 111.423 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 23.2 ttt180 -89.37 -32.75 17.15 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 123.682 0.793 . . . . 4.62 110.524 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -83.59 -34.27 25.18 Favored 'General case' 0 C--O 1.245 0.816 0 CA-C-O 121.606 0.717 . . . . 1.45 109.41 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 92.24 -150.04 19.96 Favored Glycine 0 N--CA 1.415 -2.707 0 CA-C-N 115.057 -0.974 . . . . 0.85 111.905 174.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -138.06 152.22 48.61 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 107.338 -1.356 . . . . 0.93 107.338 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 2.6 p -108.19 128.47 54.74 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 123.628 0.58 . . . . 1.03 110.673 179.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1540 ' ' ALA . . . . . 0.488 ' HB3' ' CG1' ' A' 1548 ' ' VAL . . . -117.31 140.93 48.93 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.31 -0.996 . . . . 0.5 108.31 175.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -79.92 127.55 32.39 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 116.09 -0.505 . . . . 0.74 109.986 -177.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1542 ' ' TYR . . . . . 0.403 ' CE1' ' HG ' ' A' 1626 ' ' LEU . 4.6 t80 -111.44 -99.5 0.41 Allowed 'General case' 0 N--CA 1.417 -2.112 0 N-CA-C 105.832 -1.914 . . . . 0.99 105.832 178.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1543 ' ' SER . . . . . . . . . . . . . 4.9 m -70.71 173.91 6.62 Favored 'General case' 0 N--CA 1.414 -2.25 0 N-CA-C 108.611 -0.885 . . . . 1.91 108.611 172.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -68.8 -37.9 79.56 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.093 -1.004 . . . . 3.59 109.512 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 38.9 m -107.26 35.53 3.02 Favored 'General case' 0 N--CA 1.408 -2.549 0 CA-C-N 115.25 -0.886 . . . . 2.46 110.079 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . -155.66 121.94 1.15 Allowed Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.055 -1.069 . . . . 1.26 114.044 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 34.7 m -112.85 149.89 15.18 Favored 'Isoleucine or valine' 0 C--O 1.253 1.28 0 CA-C-O 121.502 0.668 . . . . 0.79 110.672 176.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1548 ' ' VAL . . . . . 0.488 ' CG1' ' HB3' ' A' 1540 ' ' ALA . 10.3 p -102.18 139.23 23.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 109.078 -0.712 . . . . 0.58 109.078 177.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1549 ' ' TYR . . . . . 0.528 ' HB3' ' ND2' ' A' 1556 ' ' ASN . 58.0 m-85 -97.46 129.74 44.62 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 123.173 0.589 . . . . 1.08 109.8 178.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 24.9 ptm -144.35 127.41 16.53 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-N 115.538 -0.756 . . . . 0.78 110.228 -178.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 7.4 p -112.68 117.0 31.05 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 115.514 -0.766 . . . . 0.97 109.177 178.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1552 ' ' ILE . . . . . 0.537 ' O ' ' HA ' ' A' 1533 ' ' SER . 41.3 mm -74.83 113.66 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.374 0 N-CA-C 109.845 -0.428 . . . . 0.42 109.845 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 75.6 m 66.13 45.56 2.32 Favored 'General case' 0 CA--C 1.493 -1.231 0 O-C-N 124.229 0.956 . . . . 1.4 111.745 174.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . -179.72 177.05 47.98 Favored Glycine 0 N--CA 1.406 -3.318 0 C-N-CA 119.306 -1.426 . . . . 0.35 111.184 177.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -95.75 141.05 29.68 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 109.469 -0.567 . . . . 1.62 109.469 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1556 ' ' ASN . . . . . 0.528 ' ND2' ' HB3' ' A' 1549 ' ' TYR . 44.4 t-20 -92.75 124.68 36.93 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 109.03 -0.729 . . . . 0.87 109.03 -177.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -67.41 -5.89 16.72 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.188 0.81 . . . . 2.49 113.188 -176.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -98.62 0.18 44.3 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 112.09 0.404 . . . . 1.38 112.09 -174.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1559 ' ' CYS . . . . . 0.47 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 20.4 m -137.82 170.39 10.62 Favored Pre-proline 0 C--N 1.307 -1.277 0 CA-C-O 117.966 -1.016 . . . . 1.21 111.068 177.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1560 ' ' PRO . . . . . 0.482 ' HA ' ' HD3' ' A' 1561 ' ' PRO . 64.4 Cg_exo -29.6 134.96 0.04 OUTLIER 'Trans proline' 0 C--N 1.392 2.855 0 C-N-CA 125.006 3.804 . . . . 0.71 114.063 174.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1561 ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' 1560 ' ' PRO . 52.3 Cg_exo -53.82 126.72 22.85 Favored 'Trans proline' 0 C--O 1.242 0.701 0 C-N-CA 123.616 2.877 . . . . 0.8 113.799 -175.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 89.56 18.56 51.77 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 115.677 -0.692 . . . . 0.46 113.664 175.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1563 ' ' VAL . . . . . . . . . . . . . 4.1 p -109.44 140.34 28.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 117.74 0.77 . . . . 0.98 110.151 -177.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -101.27 -30.03 6.13 Favored Glycine 0 C--N 1.315 -0.635 0 CA-C-N 116.035 -0.529 . . . . 0.28 112.9 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -128.17 126.99 42.14 Favored 'General case' 0 C--N 1.313 -0.997 0 O-C-N 122.414 -0.463 . . . . 0.28 109.906 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 9.4 t -160.44 141.7 12.19 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 122.894 0.478 . . . . 0.43 110.154 -176.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1567 ' ' PHE . . . . . 0.434 ' HE1' HG21 ' A' 1574 ' ' VAL . 85.9 m-85 -85.78 132.93 34.03 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.744 -0.836 . . . . 1.03 108.744 176.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -81.56 14.14 31.44 Favored Glycine 0 C--N 1.342 0.878 0 C-N-CA 120.494 -0.86 . . . . 1.13 113.45 -173.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1569 ' ' GLN . . . . . 0.4 ' HB3' ' OD1' ' B' ' 15' ' ' ASP . 16.2 mm100 -84.64 -70.17 0.6 Allowed 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.188 0.518 . . . . 2.58 110.993 177.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1570 ' ' THR . . . . . 0.453 HG21 ' HA ' ' B' ' 12' ' ' GLU . 1.1 p -108.56 10.76 27.07 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 113.019 0.748 . . . . 2.17 113.019 -174.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 11.8 mmt180 59.52 36.54 22.92 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.451 -0.795 . . . . 2.62 110.383 178.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 45.0 mt -83.2 125.73 40.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 109.584 -0.524 . . . . 0.92 109.584 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 37.2 t -78.11 129.02 34.69 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.47 -0.786 . . . . 0.8 110.444 -176.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1574 ' ' VAL . . . . . 0.434 HG21 ' HE1' ' A' 1567 ' ' PHE . 1.4 t -112.85 -19.13 7.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 N-CA-C 112.857 0.688 . . . . 0.98 112.857 -177.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . -179.9 127.62 1.14 Allowed Glycine 0 C--N 1.305 -1.174 0 C-N-CA 119.172 -1.49 . . . . 0.29 112.576 -179.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -63.99 149.32 47.62 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 123.869 0.868 . . . . 2.19 109.99 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -64.93 83.42 0.04 OUTLIER 'General case' 0 C--O 1.244 0.769 0 C-N-CA 123.494 0.718 . . . . 0.61 111.352 177.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1578 ' ' ASN . . . . . 0.41 ' HB3' ' CD1' ' A' 1592 ' ' TYR . 45.5 t30 -89.18 150.39 22.7 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 106.966 -1.494 . . . . 1.95 106.966 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -137.5 51.09 1.94 Allowed 'General case' 0 C--N 1.287 -2.149 0 CA-C-O 122.911 1.339 . . . . 2.68 109.132 -172.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -123.66 81.31 1.89 Allowed 'General case' 0 N--CA 1.412 -2.342 0 CA-C-N 113.754 -1.566 . . . . 3.47 108.83 -176.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1581 ' ' LEU . . . . . 0.761 HD21 ' HG ' ' A' 1529 ' ' LEU . 0.5 OUTLIER -63.65 125.04 22.97 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 113.154 -1.839 . . . . 0.64 110.266 -177.834 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A 1582 ' ' ARG . . . . . 0.631 ' HB2' ' HB3' ' A' 1589 ' ' GLN . 92.5 mtt180 -112.45 140.34 47.27 Favored 'General case' 0 C--N 1.293 -1.874 0 O-C-N 121.657 -0.652 . . . . 2.85 111.274 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1583 ' ' TYR . . . . . 0.669 ' HE1' ' HA ' ' A' 1586 ' ' GLN . 32.7 t80 -113.28 104.17 12.06 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 109.287 -0.634 . . . . 0.86 109.287 177.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1584 ' ' VAL . . . . . 0.511 ' O ' ' HB ' ' A' 1587 ' ' VAL . 16.8 m -125.18 89.43 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-N 115.519 -0.764 . . . . 1.05 112.572 -175.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 37.2 t70 61.0 51.17 4.64 Favored 'General case' 0 N--CA 1.502 2.155 0 CA-C-O 122.205 1.002 . . . . 1.17 110.498 177.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1586 ' ' GLN . . . . . 0.669 ' HA ' ' HE1' ' A' 1583 ' ' TYR 0.288 28.4 pt20 65.2 20.65 11.98 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 126.929 2.091 . . . . 1.86 111.703 179.157 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A 1587 ' ' VAL . . . . . 0.511 ' HB ' ' O ' ' A' 1584 ' ' VAL . 45.4 t -108.96 121.62 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.406 0 CA-C-N 113.775 -1.557 . . . . 0.49 106.881 172.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1588 ' ' LEU . . . . . 0.765 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 2.4 mm? -95.36 113.22 24.86 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 107.576 -1.268 . . . . 0.36 107.576 -177.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1589 ' ' GLN . . . . . 0.631 ' HB3' ' HB2' ' A' 1582 ' ' ARG . 35.9 tt0 -107.97 140.08 41.65 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.559 0.695 . . . . 1.74 112.484 -172.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 29.6 mt -133.12 93.16 3.13 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 114.065 -1.425 . . . . 0.72 107.807 173.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 5.4 p -89.39 122.33 40.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.867 -0.79 . . . . 1.01 108.867 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1592 ' ' TYR . . . . . 0.443 ' HB2' ' HB3' ' A' 1608 ' ' SER . 12.9 m-30 -111.84 102.96 11.19 Favored 'General case' 0 C--N 1.29 -2.017 0 O-C-N 121.672 -0.643 . . . . 0.5 110.096 -177.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -104.21 178.99 4.4 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 109.852 -0.425 . . . . 1.59 109.852 177.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 17.1 m-20 68.9 55.22 0.45 Allowed 'General case' 0 C--O 1.246 0.883 0 C-N-CA 123.763 0.825 . . . . 1.11 112.497 178.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -88.54 -122.41 1.94 Allowed Glycine 0 N--CA 1.43 -1.765 0 N-CA-C 109.781 -1.328 . . . . 0.78 109.781 174.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1596 ' ' SER . . . . . . . . . . . . . 43.9 p -108.35 153.91 41.72 Favored Pre-proline 0 C--N 1.294 -1.843 0 N-CA-C 108.734 -0.839 . . . . 1.07 108.734 176.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.23 120.51 8.45 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 122.448 2.099 . . . . 1.01 110.509 176.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 43.3 t -78.94 129.2 74.06 Favored Pre-proline 0 C--N 1.289 -2.034 0 CA-C-N 115.173 -0.921 . . . . 0.75 109.949 -174.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -71.37 -14.16 30.92 Favored 'Trans proline' 0 C--O 1.247 0.968 0 C-N-CA 122.852 2.368 . . . . 1.7 113.316 -178.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1600 ' ' SER . . . . . . . . . . . . . 4.7 m -75.62 -52.85 9.63 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 116.45 -0.341 . . . . 2.26 110.627 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1601 ' ' LYS . . . . . 0.804 ' HE3' ' HA ' ' A' 1601 ' ' LYS . 1.1 tpmt? -116.09 101.95 9.19 Favored 'General case' 0 N--CA 1.401 -2.894 0 N-CA-C 106.359 -1.719 . . . . 3.01 106.359 178.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 16.9 m -58.38 119.85 7.7 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 123.213 0.605 . . . . 2.07 110.245 -178.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 102.16 -1.61 50.93 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 111.524 -0.631 . . . . 1.08 111.524 -178.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1604 ' ' LEU . . . . . 0.428 HD23 ' SG ' ' A' 1634 ' ' CYS . 8.8 tp -102.97 164.19 11.76 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 107.985 -1.117 . . . . 1.84 107.985 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 31.1 t -131.03 150.58 52.08 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 107.724 -1.213 . . . . 1.41 107.724 -178.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1606 ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -67.62 155.5 39.02 Favored 'General case' 0 C--O 1.245 0.854 0 N-CA-C 109.578 -0.527 . . . . 0.6 109.578 177.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 26.2 pttm -154.67 137.58 15.41 Favored 'General case' 0 N--CA 1.44 -0.928 0 C-N-CA 120.061 -0.656 . . . . 1.45 110.691 178.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1608 ' ' SER . . . . . 0.443 ' HB3' ' HB2' ' A' 1592 ' ' TYR . 41.4 t -107.61 122.84 47.51 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 114.949 -1.023 . . . . 1.15 110.244 -176.021 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 22.5 t -104.79 98.51 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 108.618 -0.882 . . . . 0.25 108.618 176.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 80.2 mt -90.95 116.72 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.653 0 N-CA-C 107.693 -1.225 . . . . 0.45 107.693 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 10.8 p -121.45 114.84 21.83 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 115.616 -0.72 . . . . 1.26 111.547 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1612 ' ' PHE . . . . . 0.765 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 65.9 m-85 -87.4 123.69 32.61 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 108.213 -1.032 . . . . 0.26 108.213 175.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 46.9 t -114.24 134.15 58.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 116.182 -0.463 . . . . 0.5 109.987 -175.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1614 ' ' CYS . . . . . 0.467 ' HA ' ' HB2' ' A' 1646 ' ' CYS . 0.9 OUTLIER -50.94 111.24 0.52 Allowed 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.347 1.059 . . . . 0.77 112.479 175.724 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A 1615 ' ' ARG . . . . . 0.555 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 30.1 tpt180 -134.44 91.31 22.45 Favored Pre-proline 0 N--CA 1.446 -0.668 0 C-N-CA 120.283 -0.567 . . . . 2.53 109.933 173.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1616 ' ' PRO . . . . . 0.504 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 17.2 Cg_exo -66.76 -28.38 43.64 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.393 2.062 . . . . 1.1 112.442 -179.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1617 ' ' GLU . . . . . 0.49 ' OE1' ' HD2' ' A' 1616 ' ' PRO . 17.9 mp0 -59.73 -39.81 85.96 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 123.928 0.891 . . . . 3.05 110.638 178.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . 49.04 86.54 0.03 OUTLIER 'General case' 0 C--O 1.246 0.874 0 C-N-CA 124.44 1.096 . . . . 1.55 113.581 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . -118.23 -151.31 9.11 Favored Glycine 0 C--N 1.281 -2.499 0 N-CA-C 110.221 -1.152 . . . . 0.93 110.221 178.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.97 10.25 0.91 Allowed 'Trans proline' 0 N--CA 1.486 1.054 0 C-N-CA 122.964 2.443 . . . . 0.88 114.166 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1621 ' ' THR . . . . . . . . . . . . . 14.5 p -100.68 6.93 44.14 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 122.012 0.91 . . . . 0.97 110.435 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -85.06 65.28 9.15 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 106.67 -1.604 . . . . 0.72 106.67 175.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -169.96 139.56 1.59 Allowed Pre-proline 0 N--CA 1.435 -1.195 0 C-N-CA 124.849 1.26 . . . . 3.26 107.647 -177.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1624 ' ' PRO . . . . . 0.52 ' HA ' ' O ' ' A' 1639 ' ' SER . 50.6 Cg_endo -67.93 106.91 1.4 Allowed 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.885 2.39 . . . . 0.59 112.327 -176.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 72.1 mtm -105.63 147.36 28.55 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 120.779 -0.368 . . . . 1.37 110.885 178.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1626 ' ' LEU . . . . . 0.403 ' HG ' ' CE1' ' A' 1542 ' ' TYR . 1.9 tm? -82.55 118.16 23.07 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 106.727 -1.582 . . . . 0.89 106.727 -178.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 42.9 mm -80.46 -54.08 11.38 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.783 0 N-CA-C 108.61 -0.885 . . . . 0.58 108.61 178.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 34.4 t -164.9 159.14 17.94 Favored 'General case' 0 N--CA 1.411 -2.384 0 N-CA-C 107.287 -1.375 . . . . 1.39 107.287 -177.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1629 ' ' LEU . . . . . 0.984 ' HG ' ' HG ' ' A' 1636 ' ' LEU . 1.6 tt -135.77 102.77 5.18 Favored 'General case' 0 N--CA 1.414 -2.252 0 N-CA-C 105.082 -2.192 . . . . 1.25 105.082 177.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 25.3 t70 -78.35 107.33 10.9 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.041 -1.466 . . . . 1.09 107.041 175.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1631 ' ' LYS . . . . . 0.458 ' HG2' HD22 ' A' 1629 ' ' LEU . 37.2 mtmm -78.62 -5.35 52.66 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 113.213 0.82 . . . . 3.6 113.213 -173.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 10.8 mm100 -89.67 -40.74 12.36 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 119.132 -1.027 . . . . 2.6 108.503 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 74.4 p -89.77 -5.14 57.25 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 115.034 -0.985 . . . . 0.75 109.438 177.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1634 ' ' CYS . . . . . 0.428 ' SG ' HD23 ' A' 1604 ' ' LEU . 27.9 m 58.0 41.03 24.92 Favored 'General case' 0 C--N 1.362 1.138 0 C-N-CA 125.073 1.349 . . . . 0.53 110.906 174.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1635 ' ' THR . . . . . . . . . . . . . 74.9 m -112.4 127.65 56.08 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 114.743 -1.117 . . . . 0.46 110.523 -174.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1636 ' ' LEU . . . . . 0.984 ' HG ' ' HG ' ' A' 1629 ' ' LEU . 0.3 OUTLIER -113.77 131.97 56.02 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.485 -0.932 . . . . 0.86 108.485 -176.634 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -111.62 129.27 56.13 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 116.692 -0.231 . . . . 0.45 110.458 -178.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -126.77 132.39 51.08 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 116.054 -0.521 . . . . 0.5 109.733 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1639 ' ' SER . . . . . 0.52 ' O ' ' HA ' ' A' 1624 ' ' PRO . 22.8 t -115.43 152.95 31.96 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.326 -0.99 . . . . 1.04 108.326 178.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 3.1 t90 -151.2 111.12 4.07 Favored 'General case' 0 N--CA 1.414 -2.256 0 N-CA-C 104.205 -2.517 . . . . 0.68 104.205 -177.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1641 ' ' HIS . . . . . 0.555 ' HB3' ' HB2' ' A' 1615 ' ' ARG . 42.7 m-70 -97.9 110.27 22.87 Favored 'General case' 0 C--N 1.293 -1.873 0 C-N-CA 120.097 -0.641 . . . . 0.9 109.365 -177.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1642 ' ' THR . . . . . . . . . . . . . 4.6 t -142.63 146.94 40.46 Favored Pre-proline 0 C--N 1.296 -1.719 0 CA-C-N 115.158 -0.928 . . . . 0.48 110.123 -172.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1643 ' ' PRO . . . . . 0.504 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 37.6 Cg_endo -79.68 -11.11 14.22 Favored 'Trans proline' 0 C--N 1.368 1.565 0 C-N-CA 121.991 1.794 . . . . 0.66 112.874 177.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 7.1 tt -68.37 -29.93 68.75 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 122.295 1.045 . . . . 0.97 108.199 178.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -97.06 20.87 10.59 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 114.167 -1.379 . . . . 0.84 109.405 -177.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1646 ' ' CYS . . . . . 0.467 ' HB2' ' HA ' ' A' 1614 ' ' CYS . 49.6 t -122.1 158.32 29.53 Favored 'General case' 0 N--CA 1.42 -1.957 0 CA-C-N 115.967 -0.561 . . . . 1.19 109.601 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -115.21 117.88 40.67 Favored Pre-proline 0 C--N 1.299 -1.624 0 N-CA-C 105.753 -1.943 . . . . 3.14 105.753 175.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1648 ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.28 96.82 0.65 Allowed 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.394 2.063 . . . . 2.58 112.784 -175.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 43.6 tt0 . . . . . 0 C--O 1.257 1.458 0 N-CA-C 108.316 -0.994 . . . . 4.72 108.316 177.207 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.621 0 N-CA-C 109.668 -0.493 . . . . 9.97 109.668 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -96.89 128.02 43.44 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 109.016 -0.735 . . . . 7.68 109.016 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' ARG . . . . . 0.528 ' HD2' HD21 ' B' ' 8' ' ' LEU . 38.2 ptt180 -98.51 142.33 24.4 Favored Pre-proline 0 C--N 1.296 -1.753 0 N-CA-C 108.864 -0.791 . . . . 6.11 108.864 -178.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -51.15 -27.03 21.07 Favored 'Trans proline' 0 C--N 1.365 1.395 0 C-N-CA 124.763 3.642 . . . . 4.84 115.386 -174.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 62.5 m -126.96 115.43 19.24 Favored 'General case' 0 N--CA 1.426 -1.662 0 N-CA-C 108.47 -0.937 . . . . 4.6 108.47 174.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -63.33 -32.34 73.74 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 107.991 -1.114 . . . . 4.23 107.991 176.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 13.7 p -111.31 99.46 8.26 Favored 'General case' 0 N--CA 1.41 -2.446 0 CA-C-N 114.505 -1.225 . . . . 3.14 108.712 176.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.528 HD21 ' HD2' ' B' ' 3' ' ' ARG . 86.6 mt -60.72 141.34 56.98 Favored 'General case' 0 C--O 1.246 0.917 0 N-CA-C 110.229 -0.286 . . . . 3.96 110.229 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 5.4 m -76.41 22.36 0.17 Allowed 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.434 0.901 . . . . 2.84 113.434 -169.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -156.7 -60.99 0.01 OUTLIER Glycine 0 N--CA 1.434 -1.455 0 C-N-CA 120.771 -0.728 . . . . 2.09 111.499 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.34 -68.28 1.72 Allowed Glycine 0 N--CA 1.445 -0.716 0 O-C-N 123.923 0.425 . . . . 1.84 113.204 -178.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . 0.486 ' HG2' ' HB2' ' B' ' 8' ' ' LEU . 4.7 mm-40 -61.24 -32.75 72.55 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.176 -0.676 . . . . 2.55 109.176 -178.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . 0.415 ' O ' HD23 ' B' ' 17' ' ' LEU . 0.1 OUTLIER -53.34 -66.53 0.37 Allowed 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 114.761 -1.109 . . . . 2.35 109.245 -179.559 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 18.9 m -75.21 -16.7 15.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 C-N-CA 119.384 -0.927 . . . . 2.11 110.701 -177.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' ASP . . . . . 0.4 ' OD1' ' HB3' ' A' 1569 ' ' GLN . 12.0 t70 -73.27 -49.72 26.16 Favored 'General case' 0 C--O 1.184 -2.368 0 C-N-CA 118.844 -1.142 . . . . 2.04 112.497 179.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 21.9 p -56.15 -44.83 79.64 Favored 'General case' 0 C--O 1.263 1.778 0 CA-C-N 118.693 0.679 . . . . 1.84 109.628 176.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.563 ' HB3' ' CB ' ' B' ' 26' ' ' PHE . 4.1 mm? -50.37 -55.1 17.12 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 114.344 -1.298 . . . . 1.74 112.346 172.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -77.46 -21.91 52.17 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.23 0.538 . . . . 2.39 111.996 -178.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -55.55 -52.67 62.95 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 124.034 0.934 . . . . 0.96 110.777 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 12.9 p -98.56 -24.07 4.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 C-N-CA 118.272 -1.371 . . . . 1.37 112.365 -178.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 34.5 m -104.56 19.64 20.01 Favored 'General case' 0 C--N 1.309 -1.166 0 O-C-N 121.871 -0.518 . . . . 1.66 111.935 -174.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -49.17 -34.19 16.71 Favored Glycine 0 N--CA 1.469 0.875 0 N-CA-C 116.852 1.501 . . . . 1.53 116.852 -175.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -74.99 -34.47 61.97 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 117.773 0.787 . . . . 2.72 112.641 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 20.6 tpp180 -93.1 -39.47 11.04 Favored 'General case' 0 C--N 1.314 -0.949 0 O-C-N 122.064 -0.398 . . . . 4.33 111.195 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.94 -168.17 13.26 Favored Glycine 0 N--CA 1.433 -1.534 0 N-CA-C 109.078 -1.609 . . . . 1.53 109.078 -177.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . 0.563 ' CB ' ' HB3' ' B' ' 17' ' ' LEU . 18.0 p90 -129.73 128.6 42.81 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 117.69 0.745 . . . . 1.65 111.098 179.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -142.02 129.33 21.12 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 109.491 -0.559 . . . . 3.42 109.491 -176.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' PHE . . . . . 0.702 ' HD2' ' H ' ' B' ' 41' ' ' GLY . 6.7 p90 -140.06 42.92 1.94 Allowed 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.283 -1.377 . . . . 2.26 107.283 -177.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 6.0 m -67.72 106.86 2.37 Favored 'General case' 0 N--CA 1.42 -1.959 0 CA-C-N 113.104 -1.862 . . . . 3.68 113.02 -172.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . 0.72 ' O ' ' HA ' ' B' ' 39' ' ' SER . 3.1 mmp_? -113.19 114.36 48.45 Favored Pre-proline 0 C--N 1.308 -1.232 0 N-CA-C 105.449 -2.056 . . . . 3.81 105.449 170.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -54.97 -33.28 82.23 Favored 'Trans proline' 0 C--O 1.243 0.764 0 C-N-CA 123.762 2.974 . . . . 4.02 113.909 -171.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . 69.13 -78.52 0.04 OUTLIER 'General case' 0 N--CA 1.433 -1.283 0 C-N-CA 125.427 1.491 . . . . 4.92 112.092 176.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . 0.469 ' HB3' ' OG ' ' B' ' 36' ' ' SER . 31.0 t -177.16 166.34 2.36 Favored 'General case' 0 N--CA 1.398 -3.033 0 N-CA-C 104.816 -2.29 . . . . 6.72 104.816 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 39.5 ttt180 -99.35 7.08 45.88 Favored 'General case' 0 C--N 1.284 -2.268 0 CA-C-O 122.361 1.076 . . . . 11.63 108.307 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 39.1 t -106.61 -13.56 9.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 107.09 -1.448 . . . . 9.61 107.09 175.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . 0.469 ' OG ' ' HB3' ' B' ' 33' ' ' SER . 5.3 p -144.76 67.4 1.25 Allowed 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 113.777 -1.556 . . . . 6.71 107.228 178.024 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -49.44 11.72 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 129.513 3.125 . . . . 10.0 117.834 -172.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 28.1 mtm180 -76.78 85.21 3.38 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-N 119.109 0.868 . . . . 7.94 110.967 -170.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . 0.72 ' HA ' ' O ' ' B' ' 30' ' ' ARG . 33.9 p -77.15 61.66 2.1 Favored 'General case' 0 C--O 1.249 1.054 0 CA-C-O 122.803 1.287 . . . . 5.76 111.751 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . 0.457 ' HB2' ' HE2' ' B' ' 28' ' ' PHE . 36.0 ptt180 -148.23 162.34 39.67 Favored 'General case' 0 C--N 1.285 -2.226 0 CA-C-N 113.85 -1.523 . . . . 6.03 109.27 -175.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . 0.702 ' H ' ' HD2' ' B' ' 28' ' ' PHE . . . -161.53 178.01 37.6 Favored Glycine 0 N--CA 1.424 -2.131 0 N-CA-C 108.288 -1.925 . . . . 2.37 108.288 -175.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . 0.506 ' HB ' HD21 ' B' ' 55' ' ' LEU . 15.0 pt 55.05 8.26 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.42 0 C-N-CA 126.906 2.082 . . . . 2.07 112.578 -177.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.491 ' O ' ' HB2' ' B' ' 47' ' ' CYS . 9.0 p -80.25 -35.48 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.312 0 CA-C-N 114.796 -1.093 . . . . 2.24 111.95 -173.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -84.63 -38.37 19.94 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 106.593 -1.632 . . . . 3.36 106.593 177.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -64.97 -19.38 65.95 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 113.886 -1.506 . . . . 3.08 111.798 -177.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' CYS . . . . . . . . . . . . . 41.9 t -118.06 -0.21 11.68 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 119.779 -0.769 . . . . 2.23 110.888 175.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' CYS . . . . . 0.491 ' HB2' ' O ' ' B' ' 43' ' ' VAL . 51.9 t -83.91 -60.05 2.23 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 121.941 -0.474 . . . . 2.37 111.998 177.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -96.48 4.24 52.23 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-O 121.228 0.537 . . . . 2.82 110.222 -175.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 8.2 mmt180 -130.29 161.78 30.47 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 105.294 -2.113 . . . . 4.09 105.294 -176.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 9.3 t -97.32 115.48 27.75 Favored 'General case' 0 C--N 1.278 -2.505 0 N-CA-C 105.086 -2.19 . . . . 2.67 105.086 174.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 31.9 p -88.89 137.48 32.28 Favored 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 109.294 -0.632 . . . . 2.11 109.294 -172.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -85.09 146.87 26.93 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 107.855 -1.165 . . . . 2.67 107.855 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -62.23 -22.52 66.02 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.058 -0.974 . . . . 1.9 112.508 -174.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.75 -38.19 69.5 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.19 0.519 . . . . 1.52 109.969 178.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . 0.506 HD21 ' HB ' ' B' ' 42' ' ' ILE . 34.6 tp -54.66 -63.4 1.16 Allowed 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 114.371 -1.286 . . . . 1.97 111.576 179.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.423 HD13 ' N ' ' B' ' 57' ' ' GLU . 0.0 OUTLIER -75.09 -27.37 59.87 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 120.267 -0.573 . . . . 1.53 111.656 -176.341 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . 0.423 ' N ' HD13 ' B' ' 56' ' ' LEU . 11.6 tp10 -59.93 -44.91 94.06 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 109.912 -0.403 . . . . 2.27 109.912 177.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 11.7 t -80.48 -10.81 59.73 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 120.419 -0.512 . . . . 2.33 110.752 177.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 59' ' ' TYR . . . . . 0.537 ' HE1' ' HA ' ' B' ' 28' ' ' PHE . 1.1 t80 -94.72 -70.77 0.69 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 119.504 -0.878 . . . . 2.86 108.865 -178.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 54.0 t 56.11 -94.04 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.209 0 C-N-CA 125.809 1.644 . . . . 2.3 114.955 177.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -165.4 163.61 19.74 Favored 'General case' 0 N--CA 1.423 -1.792 0 N-CA-C 107.973 -1.121 . . . . 3.19 107.973 -173.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 8.5 p -142.34 138.64 16.72 Favored Pre-proline 0 C--N 1.29 -1.988 0 N-CA-C 107.609 -1.256 . . . . 3.68 107.609 177.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -74.77 -18.67 19.15 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.814 2.343 . . . . 5.08 113.638 -177.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -126.5 62.77 1.28 Allowed 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 116.405 -0.361 . . . . 5.1 111.333 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 61.4 tttp 67.38 148.77 0.05 Allowed 'General case' 0 CA--C 1.559 1.309 0 C-N-CA 124.974 1.31 . . . . 8.51 112.501 176.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 13.4 m -103.55 103.12 13.03 Favored 'General case' 0 C--N 1.313 -0.986 0 O-C-N 121.183 -0.948 . . . . 8.12 111.698 -177.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 . . . . . 0 C--N 1.307 -1.252 0 N-CA-C 107.852 -1.166 . . . . 10.21 107.852 173.32 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 49.8 ttm . . . . . 0 C--O 1.237 0.4 0 N-CA-C 109.075 -0.713 . . . . 9.34 109.075 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 86.6 tttt -157.8 88.2 0.97 Allowed 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 108.082 -1.081 . . . . 9.04 108.082 179.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 49.5 m -160.27 -35.86 0.05 Allowed 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 121.39 0.614 . . . . 5.81 111.516 -178.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1511 ' ' ASN . . . . . 0.539 ' HB3' ' HA ' ' A' 1582 ' ' ARG . 15.6 m120 -127.9 60.25 1.46 Allowed 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 121.263 0.554 . . . . 3.42 110.233 -172.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1512 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.75 142.02 20.53 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.729 -0.669 . . . . 5.95 109.955 178.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 20.0 t-80 -179.28 -49.4 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.229 0 O-C-N 124.402 1.064 . . . . 5.33 109.415 -176.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 7.5 t70 -141.4 177.52 8.06 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 107.939 -1.134 . . . . 5.06 107.939 -176.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 17.0 t70 -79.82 87.2 5.3 Favored 'General case' 0 C--N 1.289 -2.037 0 C-N-CA 125.341 1.457 . . . . 2.9 110.134 -175.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1516 ' ' CYS . . . . . 0.708 ' HA ' ' HB2' ' A' 1581 ' ' LEU . 91.6 m 64.21 46.93 3.39 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 115.057 1.503 . . . . 1.19 115.057 175.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -150.1 129.88 13.28 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 107.122 -1.436 . . . . 1.52 107.122 172.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1518 ' ' VAL . . . . . 0.688 HG21 ' HB2' ' A' 1583 ' ' TYR . 5.3 m -131.12 140.52 48.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 CA-C-O 121.249 0.547 . . . . 0.94 111.542 -174.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1519 ' ' THR . . . . . . . . . . . . . 20.5 m -108.44 140.58 41.54 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 115.452 -0.795 . . . . 0.89 109.064 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1520 ' ' ASN . . . . . 0.663 HD22 ' HE2' ' A' 1583 ' ' TYR . 25.9 t-20 -93.62 114.59 63.38 Favored Pre-proline 0 C--N 1.305 -1.347 0 N-CA-C 107.876 -1.157 . . . . 1.74 107.876 172.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -63.94 -21.3 68.74 Favored 'Trans proline' 0 N--CA 1.477 0.536 0 C-N-CA 123.208 2.605 . . . . 1.58 114.032 -174.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 14.2 m -75.56 -41.54 54.53 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-O 120.646 0.26 . . . . 1.65 111.498 -177.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1523 ' ' THR . . . . . 0.521 HG22 ' OD1' ' A' 1520 ' ' ASN . 2.7 t -107.94 -20.57 13.14 Favored 'General case' 0 CA--C 1.561 1.391 0 CA-C-O 121.345 0.593 . . . . 1.61 111.96 -178.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 83.1 22.51 57.2 Favored Glycine 0 CA--C 1.505 -0.533 0 O-C-N 122.092 -0.38 . . . . 1.13 113.482 175.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 55.1 t-80 -95.36 132.82 39.98 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 120.981 0.42 . . . . 1.26 110.114 -178.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 2.7 tm? -101.47 116.38 32.65 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 114.902 -1.045 . . . . 0.68 109.51 -177.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -87.35 118.12 26.58 Favored 'General case' 0 C--N 1.318 -0.804 0 O-C-N 122.068 -0.395 . . . . 0.65 111.108 173.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 8.7 t70 -98.01 113.67 25.59 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 108.27 -1.011 . . . . 1.17 108.27 176.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1529 ' ' LEU . . . . . 0.715 ' HG ' HD21 ' A' 1581 ' ' LEU . 3.5 mm? -101.87 -6.7 23.23 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 121.111 0.481 . . . . 0.6 110.051 177.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 6.1 m -62.63 -22.15 66.21 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.498 -0.774 . . . . 0.84 112.45 -177.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 16.2 t -66.12 -32.53 74.03 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 121.317 0.58 . . . . 1.59 110.036 177.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 7.9 mt -89.03 -7.62 55.57 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.253 -0.647 . . . . 0.65 109.253 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1533 ' ' SER . . . . . 0.437 ' HA ' ' HB ' ' A' 1552 ' ' ILE . 24.5 t -76.99 176.28 8.79 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.379 -0.6 . . . . 1.52 109.379 179.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . 152.71 174.77 23.51 Favored Glycine 0 N--CA 1.422 -2.24 0 N-CA-C 110.193 -1.163 . . . . 1.1 110.193 -177.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 33.2 ttm180 -92.31 -29.73 16.21 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 121.161 0.505 . . . . 4.62 110.095 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -76.55 -53.08 8.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.206 0.527 . . . . 1.45 110.96 -178.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 93.83 -150.16 19.73 Favored Glycine 0 N--CA 1.425 -2.067 0 C-N-CA 120.624 -0.798 . . . . 0.85 111.883 177.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -136.8 151.49 49.23 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.377 -0.971 . . . . 0.93 108.377 -177.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 17.7 p -112.81 139.55 48.34 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 116.266 -0.424 . . . . 1.03 109.952 177.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1540 ' ' ALA . . . . . 0.462 ' HB3' ' CG1' ' A' 1548 ' ' VAL . . . -125.25 143.41 50.96 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 107.943 -1.132 . . . . 0.5 107.943 172.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -84.67 151.94 24.12 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 108.552 -0.907 . . . . 0.74 108.552 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1542 ' ' TYR . . . . . 0.703 ' HE2' ' HG ' ' A' 1626 ' ' LEU . 1.8 t80 -162.95 -100.74 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 121.62 0.724 . . . . 0.99 109.914 -174.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1543 ' ' SER . . . . . 0.466 ' H ' ' HB3' ' A' 1542 ' ' TYR . 31.2 t -73.93 159.41 32.81 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 124.568 1.147 . . . . 1.91 110.404 -173.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 13.2 tppt? -74.98 -3.71 33.9 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 109.329 -0.619 . . . . 3.59 109.329 178.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1545 ' ' SER . . . . . 0.46 ' HB2' ' HG2' ' B' ' 18' ' ' GLN . 15.3 t -77.62 -43.3 31.97 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 108.884 -0.784 . . . . 2.46 108.884 176.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 165.72 -148.84 14.45 Favored Glycine 0 N--CA 1.41 -3.066 0 N-CA-C 110.872 -0.891 . . . . 1.26 110.872 -175.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 34.6 m -109.11 179.41 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.281 2.761 0 CA-C-O 122.118 0.961 . . . . 0.79 111.975 -172.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1548 ' ' VAL . . . . . 0.868 ' HB ' ' CE1' ' A' 1567 ' ' PHE . 7.8 p -112.01 130.85 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.941 0 CA-C-N 113.193 -1.821 . . . . 0.58 108.362 173.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -95.06 134.81 37.35 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.938 -1.134 . . . . 1.08 107.938 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 24.1 ptm -150.93 118.73 6.17 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 121.767 0.794 . . . . 0.78 111.337 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 5.4 p -112.4 118.31 34.85 Favored 'General case' 0 C--N 1.28 -2.428 0 CA-C-N 114.507 -1.224 . . . . 0.97 109.973 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1552 ' ' ILE . . . . . 0.437 ' HB ' ' HA ' ' A' 1533 ' ' SER . 46.0 mm -71.95 114.63 10.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.503 -0.317 . . . . 0.42 110.585 -178.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 72.0 m 60.9 29.43 19.01 Favored 'General case' 0 CA--C 1.511 -0.533 0 C-N-CA 124.532 1.133 . . . . 1.4 113.401 175.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . -161.04 177.75 37.28 Favored Glycine 0 N--CA 1.417 -2.601 0 N-CA-C 109.412 -1.475 . . . . 0.35 109.412 -179.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -107.97 140.73 40.68 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-O 121.127 0.489 . . . . 1.62 111.684 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -87.21 140.5 29.48 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 107.426 -1.324 . . . . 0.87 107.426 178.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -94.41 3.45 55.16 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 113.587 0.958 . . . . 2.49 113.587 -173.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -88.62 -4.65 58.52 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 121.552 0.692 . . . . 1.38 110.575 -178.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1559 ' ' CYS . . . . . 0.625 ' SG ' ' HD2' ' A' 1560 ' ' PRO . 20.2 t -136.31 157.48 75.39 Favored Pre-proline 0 C--N 1.298 -1.633 0 N-CA-C 106.229 -1.767 . . . . 1.21 106.229 -178.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1560 ' ' PRO . . . . . 0.632 ' HD2' ' HB3' ' A' 1571 ' ' ARG . 31.6 Cg_exo -29.05 134.77 0.04 OUTLIER 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 125.104 3.869 . . . . 0.71 115.428 177.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1561 ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' 1560 ' ' PRO . 86.1 Cg_exo -49.13 124.44 11.62 Favored 'Trans proline' 0 C--O 1.247 0.948 0 C-N-CA 124.176 3.251 . . . . 0.8 112.792 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 101.76 7.32 48.1 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 116.004 -0.544 . . . . 0.46 113.302 -177.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1563 ' ' VAL . . . . . 0.608 HG11 ' HB2' ' A' 1566 ' ' CYS . 2.3 t -85.93 124.56 40.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 112.185 0.439 . . . . 0.98 112.185 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -97.71 -37.61 4.42 Favored Glycine 0 C--N 1.31 -0.916 0 N-CA-C 110.702 -0.959 . . . . 0.28 110.702 174.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -130.25 137.3 49.94 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.021 -0.733 . . . . 0.28 109.021 177.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1566 ' ' CYS . . . . . 0.608 ' HB2' HG11 ' A' 1563 ' ' VAL . 42.4 t -156.96 135.29 11.3 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 121.243 -0.183 . . . . 0.43 111.201 -177.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1567 ' ' PHE . . . . . 0.868 ' CE1' ' HB ' ' A' 1548 ' ' VAL . 9.5 m-85 -112.9 163.76 14.25 Favored 'General case' 0 C--O 1.245 0.857 0 C-N-CA 123.308 0.643 . . . . 1.03 110.491 173.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . 94.31 169.53 37.61 Favored Glycine 0 N--CA 1.399 -3.831 0 C-N-CA 118.831 -1.652 . . . . 1.13 114.324 164.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -89.6 -30.14 18.37 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 114.242 -0.979 . . . . 2.58 108.985 177.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 66.3 p -85.09 2.65 42.49 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.555 -0.748 . . . . 2.17 112.74 -177.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1571 ' ' ARG . . . . . 0.632 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 2.2 mpt_? 67.6 69.07 0.36 Allowed 'General case' 0 C--N 1.348 0.518 0 CA-C-N 114.704 -1.134 . . . . 2.62 110.831 175.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 32.0 mt -96.59 106.02 17.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-N 115.582 -0.735 . . . . 0.92 109.727 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 30.9 t -66.81 130.07 41.97 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-N 114.732 -1.122 . . . . 0.8 110.379 -177.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1574 ' ' VAL . . . . . 0.6 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 34.4 m -123.55 20.92 4.56 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.336 0 CA-C-O 121.535 0.683 . . . . 0.98 110.607 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 169.43 124.17 0.72 Allowed Glycine 0 N--CA 1.418 -2.546 0 CA-C-N 114.915 -1.039 . . . . 0.29 111.329 176.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -75.53 141.94 42.9 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.079 -0.711 . . . . 2.19 109.079 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -69.9 84.19 0.49 Allowed 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 123.404 0.681 . . . . 0.61 112.708 -177.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -93.68 168.18 11.18 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 115.569 -0.741 . . . . 1.95 109.346 176.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 55.1 mttm -129.31 41.92 3.38 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.519 -0.919 . . . . 2.68 108.519 -176.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 46.4 ttm-85 -105.98 77.65 1.26 Allowed 'General case' 0 N--CA 1.403 -2.786 0 CA-C-N 115.314 -0.857 . . . . 3.47 109.841 -175.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1581 ' ' LEU . . . . . 0.715 HD21 ' HG ' ' A' 1529 ' ' LEU . 1.2 tm? -65.47 124.97 23.69 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 113.798 -1.546 . . . . 0.64 107.49 175.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1582 ' ' ARG . . . . . 0.539 ' HA ' ' HB3' ' A' 1511 ' ' ASN . 63.9 mtp180 -118.54 141.0 49.01 Favored 'General case' 0 C--N 1.289 -2.048 0 C-N-CA 120.853 -0.339 . . . . 2.85 110.706 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1583 ' ' TYR . . . . . 0.688 ' HB2' HG21 ' A' 1518 ' ' VAL . 64.0 t80 -120.01 109.01 14.99 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 109.249 -0.648 . . . . 0.86 109.249 -179.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1584 ' ' VAL . . . . . 0.501 ' O ' ' HB ' ' A' 1587 ' ' VAL . 9.4 m -128.7 94.9 2.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-N 115.8 -0.636 . . . . 1.05 111.752 -179.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 12.3 t70 56.53 60.91 2.88 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 123.851 0.86 . . . . 1.17 110.714 176.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1586 ' ' GLN . . . . . 0.427 ' HA ' ' HE1' ' A' 1583 ' ' TYR 0.313 10.0 pt20 65.24 12.08 7.75 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 126.828 2.051 . . . . 1.86 113.147 178.972 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A 1587 ' ' VAL . . . . . 0.501 ' HB ' ' O ' ' A' 1584 ' ' VAL . 39.6 t -101.78 120.07 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.95 0 N-CA-C 107.588 -1.264 . . . . 0.49 107.588 174.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1588 ' ' LEU . . . . . 0.731 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 2.9 mm? -96.82 110.35 22.85 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 106.009 -1.848 . . . . 0.36 106.009 177.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1589 ' ' GLN . . . . . 0.43 ' HA ' ' O ' ' A' 1610 ' ' ILE . 28.5 tt0 -125.48 132.16 52.71 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-O 121.672 0.748 . . . . 1.74 112.767 -171.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 11.7 mt -115.1 128.31 56.14 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 107.27 -1.381 . . . . 0.72 107.27 175.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 59.3 t -119.03 118.9 59.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 C-N-CA 119.66 -0.816 . . . . 1.01 110.511 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1592 ' ' TYR . . . . . 0.47 ' O ' ' HA ' ' A' 1607 ' ' LYS . 16.8 m-30 -106.18 95.2 5.61 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 115.65 -0.705 . . . . 0.5 109.104 -179.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1593 ' ' LYS . . . . . 0.535 ' HB3' ' HD3' ' A' 1607 ' ' LYS . 0.0 OUTLIER -109.28 163.07 13.71 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 116.685 -0.234 . . . . 1.59 111.332 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 6.4 m-20 66.12 55.84 0.87 Allowed 'General case' 0 C--N 1.318 -0.787 0 O-C-N 124.472 1.108 . . . . 1.11 112.003 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -83.55 -107.27 0.53 Allowed Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 110.029 -1.228 . . . . 0.78 110.029 174.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1596 ' ' SER . . . . . . . . . . . . . 85.8 p -102.41 148.82 36.0 Favored Pre-proline 0 C--O 1.261 1.7 0 N-CA-C 108.847 -0.797 . . . . 1.07 108.847 175.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1597 ' ' PRO . . . . . 0.545 ' HB2' ' HG2' ' B' ' 6' ' ' GLU . 31.6 Cg_exo -63.66 122.8 11.02 Favored 'Trans proline' 0 N--CA 1.446 -1.269 0 C-N-CA 122.751 2.3 . . . . 1.01 108.998 174.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 17.0 t -78.83 110.46 14.42 Favored Pre-proline 0 C--N 1.301 -1.534 0 N-CA-C 108.621 -0.881 . . . . 0.75 108.621 -172.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1599 ' ' PRO . . . . . 0.58 ' HB2' HD22 ' B' ' 8' ' ' LEU . 37.1 Cg_endo -67.07 -12.22 35.23 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 122.843 2.362 . . . . 1.7 112.839 -173.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1600 ' ' SER . . . . . 0.806 ' HB3' ' HB2' ' B' ' 53' ' ' LEU . 18.0 m -61.56 -31.06 71.08 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.929 0.891 . . . . 2.26 111.907 178.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1601 ' ' LYS . . . . . 0.584 ' HB3' HD22 ' A' 1604 ' ' LEU . 41.0 ttmt -161.06 122.0 2.85 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 107.445 -1.317 . . . . 3.01 107.445 176.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 15.1 m -59.05 131.26 50.51 Favored 'General case' 0 N--CA 1.424 -1.73 0 C-N-CA 123.028 0.531 . . . . 2.07 111.39 -176.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 105.37 -3.96 40.4 Favored Glycine 0 C--N 1.309 -0.951 0 CA-C-N 116.258 -0.428 . . . . 1.08 112.768 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1604 ' ' LEU . . . . . 0.584 HD22 ' HB3' ' A' 1601 ' ' LYS . 10.3 mp -100.45 157.77 16.4 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 122.462 -0.434 . . . . 1.84 111.551 -178.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 33.8 m -146.88 143.93 28.91 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 108.312 -0.996 . . . . 1.41 108.312 175.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1606 ' ' TYR . . . . . 0.6 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 76.1 m-85 -69.53 151.63 45.77 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 116.334 -0.394 . . . . 0.6 110.928 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1607 ' ' LYS . . . . . 0.535 ' HD3' ' HB3' ' A' 1593 ' ' LYS . 36.6 ttpt -150.95 130.33 12.87 Favored 'General case' 0 N--CA 1.441 -0.878 0 O-C-N 124.007 0.817 . . . . 1.45 109.824 -175.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1608 ' ' SER . . . . . 0.465 ' HB3' ' HB2' ' A' 1592 ' ' TYR . 37.3 t -105.38 120.11 40.76 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 108.939 -0.763 . . . . 1.15 108.939 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 22.8 t -105.32 107.3 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 N-CA-C 107.831 -1.174 . . . . 0.25 107.831 177.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1610 ' ' ILE . . . . . 0.43 ' O ' ' HA ' ' A' 1589 ' ' GLN . 64.3 mt -101.91 111.73 32.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 CA-C-N 115.676 -0.693 . . . . 0.45 110.046 -176.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 21.4 p -111.64 117.84 34.03 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.928 -0.578 . . . . 1.26 112.153 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1612 ' ' PHE . . . . . 0.731 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 78.0 m-85 -93.08 124.34 36.99 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.19 -1.041 . . . . 0.26 108.19 177.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 49.1 t -118.74 137.23 53.39 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 116.544 -0.298 . . . . 0.5 110.984 -175.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 3.5 t -59.69 103.0 0.17 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.668 1.187 . . . . 0.77 112.633 177.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1615 ' ' ARG . . . . . 0.541 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 20.8 mmt180 -138.49 112.58 8.53 Favored Pre-proline 0 C--N 1.32 -0.693 0 O-C-N 122.369 -0.207 . . . . 2.53 111.224 171.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1616 ' ' PRO . . . . . 0.601 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 37.3 Cg_endo -74.06 -1.71 11.27 Favored 'Trans proline' 0 N--CA 1.489 1.213 0 C-N-CA 122.902 2.401 . . . . 1.1 113.213 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -89.5 41.7 1.05 Allowed 'General case' 0 C--N 1.291 -1.959 0 C-N-CA 124.936 1.294 . . . . 3.05 110.83 -177.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -41.54 123.79 2.28 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.86 1.664 . . . . 1.55 112.647 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1619 ' ' GLY . . . . . 0.438 ' HA3' ' HD2' ' A' 1620 ' ' PRO . . . 171.03 -135.8 3.65 Favored Glycine 0 CA--C 1.48 -2.151 0 N-CA-C 110.13 -1.188 . . . . 0.93 110.13 -177.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1620 ' ' PRO . . . . . 0.438 ' HD2' ' HA3' ' A' 1619 ' ' GLY . 35.1 Cg_endo -64.12 -2.46 4.76 Favored 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 123.342 2.695 . . . . 0.88 115.231 -177.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1621 ' ' THR . . . . . 0.663 ' HB ' ' HB2' ' A' 1641 ' ' HIS . 13.0 p -98.82 -11.4 21.82 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 121.728 0.775 . . . . 0.97 109.677 178.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 48.0 t30 -93.48 64.9 3.7 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 122.457 1.122 . . . . 0.72 108.333 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -166.97 140.47 3.05 Favored Pre-proline 0 C--N 1.3 -1.55 0 N-CA-C 106.422 -1.695 . . . . 3.26 106.422 -178.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -59.45 110.26 0.69 Allowed 'Trans proline' 0 C--O 1.243 0.766 0 C-N-CA 122.56 2.174 . . . . 0.59 111.527 -178.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 74.9 mtm -110.14 141.77 42.57 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 116.078 -0.51 . . . . 1.37 110.066 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1626 ' ' LEU . . . . . 0.703 ' HG ' ' HE2' ' A' 1542 ' ' TYR . 1.4 tm? -86.2 119.06 26.08 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 108.141 -1.059 . . . . 0.89 108.141 -176.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1627 ' ' ILE . . . . . 0.66 HD11 ' HB2' ' A' 1639 ' ' SER . 44.5 mm -79.69 -55.42 9.2 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 CA-C-O 121.513 0.673 . . . . 0.58 109.434 178.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 22.6 t -163.72 148.41 10.62 Favored 'General case' 0 N--CA 1.419 -2.01 0 N-CA-C 107.969 -1.123 . . . . 1.39 107.969 -176.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1629 ' ' LEU . . . . . 0.76 HD13 ' HG ' ' A' 1636 ' ' LEU . 50.3 tp -116.91 105.43 12.33 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.662 -0.866 . . . . 1.25 108.662 176.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 12.5 t70 -84.32 106.24 15.78 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.015 -1.476 . . . . 1.09 107.015 176.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1631 ' ' LYS . . . . . 0.409 ' HE3' ' HB3' ' A' 1631 ' ' LYS . 14.4 mmmt -85.74 -3.43 58.89 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 112.86 0.689 . . . . 3.6 112.86 -175.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -87.69 -33.63 18.69 Favored 'General case' 0 N--CA 1.421 -1.888 0 O-C-N 123.43 0.456 . . . . 2.6 109.804 -177.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 40.3 p -102.37 -16.34 16.25 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.096 0.474 . . . . 0.75 110.29 173.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1634 ' ' CYS . . . . . 0.471 ' O ' ' HA ' ' A' 1606 ' ' TYR . 60.2 m 72.56 37.57 0.87 Allowed 'General case' 0 C--N 1.355 0.845 0 C-N-CA 125.203 1.401 . . . . 0.53 111.307 179.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1635 ' ' THR . . . . . . . . . . . . . 94.7 m -103.23 134.03 47.32 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 115.253 -0.885 . . . . 0.46 109.697 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1636 ' ' LEU . . . . . 0.76 ' HG ' HD13 ' A' 1629 ' ' LEU . 0.5 OUTLIER -114.97 124.39 51.55 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.548 -0.908 . . . . 0.86 108.548 -177.826 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -104.37 130.73 52.22 Favored 'General case' 0 C--O 1.25 1.101 0 N-CA-C 110.37 -0.233 . . . . 0.45 110.37 -178.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -127.81 137.99 52.57 Favored 'General case' 0 C--O 1.251 1.135 0 CA-C-O 121.065 0.46 . . . . 0.5 110.48 -178.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1639 ' ' SER . . . . . 0.66 ' HB2' HD11 ' A' 1627 ' ' ILE . 21.4 t -116.08 157.95 23.93 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.148 -1.056 . . . . 1.04 108.148 177.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 2.3 t90 -156.34 113.21 3.14 Favored 'General case' 0 N--CA 1.409 -2.497 0 N-CA-C 105.349 -2.093 . . . . 0.68 105.349 -177.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1641 ' ' HIS . . . . . 0.663 ' HB2' ' HB ' ' A' 1621 ' ' THR . 13.0 m170 -104.01 105.29 15.42 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 109.485 -0.561 . . . . 0.9 109.485 -176.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1642 ' ' THR . . . . . . . . . . . . . 11.3 t -142.95 145.13 31.99 Favored Pre-proline 0 C--N 1.306 -1.3 0 CA-C-N 116.111 -0.495 . . . . 0.48 109.881 -173.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1643 ' ' PRO . . . . . 0.601 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 73.4 Cg_endo -76.49 -10.37 18.82 Favored 'Trans proline' 0 C--N 1.366 1.5 0 C-N-CA 122.595 2.197 . . . . 0.66 112.136 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 7.7 tt -69.0 -24.31 64.21 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.396 0.617 . . . . 0.97 109.896 177.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -100.1 17.44 21.13 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 122.123 0.963 . . . . 0.84 109.21 -176.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 20.1 t -121.46 155.04 35.75 Favored 'General case' 0 N--CA 1.41 -2.451 0 N-CA-C 107.761 -1.2 . . . . 1.19 107.761 -178.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -95.82 119.0 65.62 Favored Pre-proline 0 C--N 1.298 -1.633 0 N-CA-C 108.57 -0.9 . . . . 3.14 108.57 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1648 ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -50.02 113.09 0.86 Allowed 'Trans proline' 0 C--N 1.364 1.392 0 C-N-CA 123.345 2.697 . . . . 2.58 112.306 177.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 . . . . . 0 C--N 1.299 -1.611 0 N-CA-C 105.987 -1.857 . . . . 4.72 105.987 -177.924 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.512 -0.511 0 N-CA-C 109.392 -0.596 . . . . 9.97 109.392 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -122.73 129.77 52.16 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 106.831 -1.544 . . . . 7.68 106.831 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' ARG . . . . . 0.492 ' HG3' ' HG3' ' B' ' 6' ' ' GLU . 29.8 ptt180 -126.66 126.2 24.48 Favored Pre-proline 0 C--N 1.298 -1.663 0 CA-C-O 120.944 0.402 . . . . 6.11 110.303 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -63.28 -11.09 23.7 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 123.483 2.789 . . . . 4.84 113.741 -175.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 5.9 m -66.05 -19.21 65.78 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.511 0.672 . . . . 4.6 111.239 177.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . 0.545 ' HG2' ' HB2' ' A' 1597 ' ' PRO . 37.1 mt-10 -98.87 1.83 46.11 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 115.445 -0.798 . . . . 4.23 110.74 -178.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 64.9 p -110.94 98.15 7.35 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 106.121 -1.807 . . . . 3.14 106.121 175.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.722 ' H ' HD23 ' B' ' 8' ' ' LEU . 1.9 pt? -72.1 137.68 47.24 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 122.632 0.373 . . . . 3.96 111.64 -173.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 6.5 t -150.73 167.51 27.17 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 109.011 -0.737 . . . . 2.84 109.011 177.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.95 -123.98 16.24 Favored Glycine 0 C--O 1.246 0.859 0 C-N-CA 121.263 -0.494 . . . . 2.09 111.92 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -75.57 -17.69 80.05 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 121.418 -0.42 . . . . 1.84 113.627 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -66.96 -27.29 67.34 Favored 'General case' 0 C--O 1.215 -0.722 0 N-CA-C 109.387 -0.597 . . . . 2.55 109.387 -176.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . 0.445 ' O ' HD12 ' B' ' 17' ' ' LEU . 32.1 mt -66.85 -61.42 1.96 Allowed 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 115.059 -0.973 . . . . 2.35 108.907 -179.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 9.9 p -64.39 -40.76 90.17 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.525 0 CA-C-N 114.853 -1.067 . . . . 2.11 112.097 -176.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -74.47 -26.5 60.07 Favored 'General case' 0 CA--C 1.557 1.246 0 N-CA-C 113.961 1.097 . . . . 2.04 113.961 -176.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 20.4 p -75.0 -43.25 54.98 Favored 'General case' 0 C--O 1.248 0.974 0 O-C-N 121.066 -1.022 . . . . 1.84 109.144 175.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.576 ' O ' ' HB2' ' B' ' 21' ' ' CYS . 0.9 OUTLIER -56.06 -40.91 74.26 Favored 'General case' 0 N--CA 1.42 -1.951 0 CA-C-N 114.863 -1.062 . . . . 1.74 111.513 169.471 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . 0.46 ' HG2' ' HB2' ' A' 1545 ' ' SER . 8.8 tt0 -71.86 -24.85 61.75 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 121.127 0.489 . . . . 2.39 109.718 179.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -64.07 -62.68 1.47 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.036 -0.529 . . . . 0.96 112.109 178.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 12.6 p -94.65 -20.32 6.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 C-N-CA 118.53 -1.268 . . . . 1.37 111.909 -177.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' CYS . . . . . 0.576 ' HB2' ' O ' ' B' ' 17' ' ' LEU . 96.1 m -102.94 18.46 21.56 Favored 'General case' 0 C--N 1.312 -1.027 0 O-C-N 121.834 -0.541 . . . . 1.66 111.448 178.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -54.02 -50.25 55.87 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 121.355 -0.45 . . . . 1.53 113.219 178.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -75.86 -11.13 59.92 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 122.548 0.339 . . . . 2.72 111.591 178.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . 0.551 ' HG2' ' SG ' ' B' ' 60' ' ' CYS . 21.1 tpp180 -91.53 -50.13 5.94 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.715 0.769 . . . . 4.33 110.434 -178.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 115.79 157.6 11.32 Favored Glycine 0 N--CA 1.417 -2.593 0 N-CA-C 107.949 -2.06 . . . . 1.53 107.949 -173.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -119.23 137.58 53.56 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 117.943 0.871 . . . . 1.65 111.453 177.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' TYR . . . . . 0.78 ' HB2' ' HA ' ' B' ' 61' ' ' ALA . 3.5 m-85 -128.89 -54.25 1.22 Allowed 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 107.684 -1.228 . . . . 3.42 107.684 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' PHE . . . . . . . . . . . . . 43.4 p90 43.93 12.71 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 128.06 2.544 . . . . 2.26 117.776 172.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 16.6 m -153.1 150.98 29.68 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 106.85 -1.537 . . . . 3.68 106.85 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 9.4 mmm180 -122.83 124.81 26.53 Favored Pre-proline 0 C--N 1.302 -1.473 0 N-CA-C 105.634 -1.987 . . . . 3.81 105.634 174.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . 0.561 ' HA ' ' HB3' ' B' ' 39' ' ' SER . 76.0 Cg_exo -53.21 -34.05 67.64 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 123.899 3.066 . . . . 4.02 112.668 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -154.94 151.24 28.29 Favored 'General case' 0 N--CA 1.42 -1.943 0 N-CA-C 109.489 -0.56 . . . . 4.92 109.489 176.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 9.0 t 177.85 167.79 0.71 Allowed 'General case' 0 N--CA 1.402 -2.833 0 N-CA-C 103.868 -2.641 . . . . 6.72 103.868 -178.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 25.1 ttt180 -96.31 2.22 52.64 Favored 'General case' 0 C--N 1.279 -2.459 0 CA-C-O 122.271 1.034 . . . . 11.63 108.583 177.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 42.9 t -110.23 -21.94 5.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 114.39 -1.277 . . . . 9.61 107.653 175.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 42.5 p -147.57 73.32 1.27 Allowed 'General case' 0 N--CA 1.408 -2.533 0 CA-C-N 114.376 -1.283 . . . . 6.71 109.691 178.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -74.2 -4.29 35.04 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-O 121.976 0.894 . . . . 10.0 109.605 172.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . 0.548 ' HG3' ' HG3' ' B' ' 40' ' ' ARG . 24.2 tpp180 -95.12 137.58 33.98 Favored 'General case' 0 N--CA 1.424 -1.766 0 N-CA-C 104.281 -2.489 . . . . 7.94 104.281 174.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . 0.561 ' HB3' ' HA ' ' B' ' 31' ' ' PRO . 4.6 p -83.92 56.27 3.62 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 123.26 1.505 . . . . 5.76 111.587 -178.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . 0.548 ' HG3' ' HG3' ' B' ' 38' ' ' ARG . 58.9 mtp180 -144.83 164.38 31.23 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 103.709 -2.7 . . . . 6.03 103.709 -178.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . -135.32 -87.62 0.25 Allowed Glycine 0 C--N 1.295 -1.743 0 C-N-CA 119.054 -1.546 . . . . 2.37 112.722 -177.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . 0.535 HD11 HD11 ' B' ' 17' ' ' LEU . 41.4 pt -85.73 -17.55 9.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 O-C-N 122.701 -0.293 . . . . 2.07 111.349 -177.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.49 ' CG1' ' HB3' ' B' ' 40' ' ' ARG . 14.9 p -53.05 -41.39 41.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 N-CA-C 114.456 1.28 . . . . 2.24 114.456 -172.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -74.01 -31.92 63.15 Favored 'General case' 0 C--O 1.244 0.793 0 C-N-CA 118.933 -1.107 . . . . 3.36 108.876 -175.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -85.22 -14.27 47.33 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 114.869 -1.06 . . . . 3.08 112.296 -176.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' CYS . . . . . . . . . . . . . 81.2 m -104.4 -22.76 13.27 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 112.669 0.618 . . . . 2.23 112.669 175.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 95.9 m -79.39 -49.0 13.03 Favored 'General case' 0 C--O 1.239 0.544 0 O-C-N 121.759 -0.588 . . . . 2.37 112.27 178.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -97.38 -7.91 30.75 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.115 0.483 . . . . 2.82 111.471 -177.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 52.9 mtp180 -139.65 177.64 7.8 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 115.946 -0.57 . . . . 4.09 109.483 -176.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 50.9 m -106.46 135.92 47.12 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 115.475 -0.784 . . . . 2.67 109.372 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . 0.469 ' HB2' HD23 ' B' ' 55' ' ' LEU . 11.7 p -120.63 138.98 53.63 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 109.647 -0.501 . . . . 2.11 109.647 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -82.49 142.77 31.61 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.062 0.458 . . . . 2.67 109.768 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . 0.806 ' HB2' ' HB3' ' A' 1600 ' ' SER . 66.2 tp -37.69 -42.0 0.53 Allowed 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 127.186 2.194 . . . . 1.9 113.808 -177.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . 0.601 ' O ' HG22 ' B' ' 58' ' ' THR . . . -53.27 -38.97 63.54 Favored 'General case' 0 C--N 1.318 -0.789 0 O-C-N 124.423 1.077 . . . . 1.52 111.635 -177.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . 0.469 HD23 ' HB2' ' B' ' 51' ' ' CYS . 53.6 tp -59.67 -56.32 23.34 Favored 'General case' 0 C--O 1.213 -0.827 0 O-C-N 124.146 0.903 . . . . 1.97 110.599 -178.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 3.3 pp -69.8 -31.04 68.73 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 116.309 -0.405 . . . . 1.53 110.967 -174.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -66.84 -51.65 53.07 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.891 -0.595 . . . . 2.27 111.575 178.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 58' ' ' THR . . . . . 0.601 HG22 ' O ' ' B' ' 54' ' ' ALA . 12.0 t -83.63 -13.24 54.72 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 112.901 0.704 . . . . 2.33 112.901 -177.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -85.61 -72.33 0.49 Allowed 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 105.929 -1.878 . . . . 2.86 105.929 175.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 60' ' ' CYS . . . . . 0.551 ' SG ' ' HG2' ' B' ' 24' ' ' ARG . 43.7 t 51.36 -86.88 0.01 OUTLIER 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 114.554 1.316 . . . . 2.3 114.554 172.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 61' ' ' ALA . . . . . 0.78 ' HA ' ' HB2' ' B' ' 27' ' ' TYR . . . -130.42 -63.74 0.87 Allowed 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 107.407 -1.331 . . . . 3.19 107.407 -177.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 1.5 p -119.64 141.87 31.83 Favored Pre-proline 0 N--CA 1.407 -2.589 0 CA-C-N 114.441 -1.254 . . . . 3.68 107.711 175.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . 0.445 ' HA ' ' O ' ' B' ' 58' ' ' THR . 36.3 Cg_endo -70.12 -7.69 21.79 Favored 'Trans proline' 0 C--O 1.25 1.109 0 C-N-CA 122.985 2.456 . . . . 5.08 113.24 -175.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . 0.629 ' HA ' ' OE1' ' B' ' 67' ' ' GLU . . . 70.19 22.07 5.68 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 125.567 1.547 . . . . 5.1 112.544 175.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -135.71 6.95 3.23 Favored 'General case' 0 N--CA 1.416 -2.125 0 CA-C-N 115.558 -0.747 . . . . 8.51 111.105 -177.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 33.9 p -138.44 22.98 2.74 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.143 0.497 . . . . 8.12 111.286 -175.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . 0.629 ' OE1' ' HA ' ' B' ' 64' ' ' ALA . 2.8 mp0 . . . . . 0 N--CA 1.432 -1.364 0 N-CA-C 108.031 -1.1 . . . . 10.21 108.031 -177.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 64.3 mtt . . . . . 0 CA--C 1.505 -0.754 0 N-CA-C 109.097 -0.705 . . . . 9.34 109.097 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A 1509 ' ' LYS . . . . . 0.666 ' O ' ' HB ' ' A' 1519 ' ' THR . 51.5 mtpt -89.51 15.69 8.93 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 120.728 0.299 . . . . 9.04 110.978 177.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1510 ' ' SER . . . . . 0.598 ' HA ' ' O ' ' A' 1519 ' ' THR . 8.1 p -90.67 -72.89 0.55 Allowed 'General case' 0 N--CA 1.433 -1.316 0 CA-C-O 121.066 0.46 . . . . 5.81 111.685 -179.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1511 ' ' ASN . . . . . . . . . . . . . 14.1 m120 -78.39 75.37 4.91 Favored 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 123.541 0.736 . . . . 3.42 110.198 178.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1512 ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -88.29 -28.36 21.12 Favored 'General case' 0 C--N 1.305 -1.37 0 CA-C-N 115.627 -0.715 . . . . 5.95 110.405 -178.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -128.67 141.83 51.22 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 108.459 -0.941 . . . . 5.33 108.459 -176.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -73.48 46.43 0.2 Allowed 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 125.995 1.718 . . . . 5.06 110.496 176.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1515 ' ' ASP . . . . . 0.46 ' HB3' ' HG2' ' A' 1517 ' ' GLN . 23.0 t70 -130.98 177.7 7.24 Favored 'General case' 0 C--N 1.28 -2.436 0 N-CA-C 106.014 -1.847 . . . . 2.9 106.014 -174.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 34.9 t -91.09 69.25 6.19 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 107.953 -1.129 . . . . 1.19 107.953 -175.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1517 ' ' GLN . . . . . 0.46 ' HG2' ' HB3' ' A' 1515 ' ' ASP . 9.8 pt20 -165.23 148.18 8.13 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-N 114.591 -1.186 . . . . 1.52 108.953 -174.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1518 ' ' VAL . . . . . 0.465 ' CG2' HD12 ' A' 1581 ' ' LEU . 3.7 m -145.74 143.06 21.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 C-N-CA 123.344 0.657 . . . . 0.94 110.051 177.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1519 ' ' THR . . . . . 0.666 ' HB ' ' O ' ' A' 1509 ' ' LYS . 42.6 m -93.83 139.82 30.41 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 116.017 -0.538 . . . . 0.89 109.762 177.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1520 ' ' ASN . . . . . 0.523 ' OD1' HG22 ' A' 1523 ' ' THR . 16.4 t-20 -75.29 117.89 66.57 Favored Pre-proline 0 N--CA 1.428 -1.575 0 N-CA-C 107.712 -1.218 . . . . 1.74 107.712 174.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.39 -17.71 49.39 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 122.782 2.321 . . . . 1.58 113.529 -176.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 10.7 m -80.98 -42.97 20.36 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 112.216 0.451 . . . . 1.65 112.216 -176.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1523 ' ' THR . . . . . 0.523 HG22 ' OD1' ' A' 1520 ' ' ASN . 6.2 t -120.99 -8.47 9.35 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.674 0.62 . . . . 1.61 112.674 -175.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 80.39 24.29 59.25 Favored Glycine 0 C--O 1.239 0.446 0 C-N-CA 120.339 -0.934 . . . . 1.13 112.826 177.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -89.93 123.17 33.62 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 109.369 -0.604 . . . . 1.26 109.369 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 2.2 tm? -87.58 113.12 22.98 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 123.623 0.769 . . . . 0.68 109.237 -177.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -88.87 114.01 25.03 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 109.705 -0.48 . . . . 0.65 109.705 176.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 14.6 t70 -101.62 110.37 22.35 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.342 -0.984 . . . . 1.17 108.342 177.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1529 ' ' LEU . . . . . 0.444 ' HG ' HD21 ' A' 1581 ' ' LEU . 3.3 mm? -92.11 -2.42 56.62 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.986 0.898 . . . . 0.6 109.309 -177.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 2.9 m -73.98 -10.27 59.47 Favored 'General case' 0 C--O 1.215 -0.737 0 CA-C-N 114.48 -1.236 . . . . 0.84 109.615 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1531 ' ' SER . . . . . 0.585 ' HB2' HD11 ' A' 1644 ' ' LEU . 19.0 m -72.3 -16.97 61.9 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 109.027 -0.731 . . . . 1.59 109.027 176.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1532 ' ' LEU . . . . . 0.42 ' O ' ' HB ' ' A' 1552 ' ' ILE . 67.9 mt -107.05 5.59 28.18 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.253 -0.885 . . . . 0.65 110.891 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1533 ' ' SER . . . . . 0.447 ' HA ' ' O ' ' A' 1552 ' ' ILE . 69.3 p -67.5 164.34 19.09 Favored 'General case' 0 C--O 1.249 1.062 0 CA-C-O 121.367 0.604 . . . . 1.52 111.614 -178.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -170.81 142.0 6.84 Favored Glycine 0 N--CA 1.418 -2.561 0 C-N-CA 120.343 -0.932 . . . . 1.1 111.151 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1535 ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' 1535 ' ' ARG . 23.1 ttt180 -92.86 -36.41 12.84 Favored 'General case' 0 C--N 1.292 -1.911 0 C-N-CA 122.688 0.395 . . . . 4.62 111.156 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -82.93 -36.72 25.0 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.721 0.772 . . . . 1.45 109.421 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1537 ' ' GLY . . . . . 0.408 ' HA3' ' ND2' ' A' 1556 ' ' ASN . . . 97.36 179.19 34.02 Favored Glycine 0 N--CA 1.418 -2.555 0 CA-C-N 114.918 -1.037 . . . . 0.85 112.476 173.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -119.84 147.23 44.93 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 107.675 -1.231 . . . . 0.93 107.675 178.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 5.5 p -103.37 117.68 35.04 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.334 0.587 . . . . 1.03 111.963 -177.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1540 ' ' ALA . . . . . 0.448 ' HB3' ' CG1' ' A' 1548 ' ' VAL . . . -108.16 121.78 45.55 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 107.927 -1.138 . . . . 0.5 107.927 176.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -70.92 134.07 46.94 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 116.144 -0.48 . . . . 0.74 110.761 -178.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1542 ' ' TYR . . . . . 0.47 ' HB3' ' H ' ' A' 1543 ' ' SER . 1.2 t80 -126.94 -99.94 0.37 Allowed 'General case' 0 N--CA 1.418 -2.054 0 N-CA-C 106.564 -1.643 . . . . 0.99 106.564 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1543 ' ' SER . . . . . 0.47 ' H ' ' HB3' ' A' 1542 ' ' TYR . 3.3 m -66.06 159.22 26.46 Favored 'General case' 0 N--CA 1.416 -2.126 0 C-N-CA 123.223 0.609 . . . . 1.91 110.236 178.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -51.23 -44.3 61.66 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.373 0.533 . . . . 3.59 112.094 -178.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 7.5 t -117.41 37.64 3.83 Favored 'General case' 0 N--CA 1.424 -1.759 0 N-CA-C 108.999 -0.741 . . . . 2.46 108.999 178.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . -147.44 109.36 0.47 Allowed Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 120.083 -1.056 . . . . 1.26 113.934 -177.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 36.0 m -98.89 160.63 3.21 Favored 'Isoleucine or valine' 0 C--O 1.252 1.187 0 N-CA-C 108.876 -0.786 . . . . 0.79 108.876 175.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1548 ' ' VAL . . . . . 0.505 ' HB ' ' CE1' ' A' 1567 ' ' PHE . 10.9 p -109.33 131.76 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.675 0 N-CA-C 107.647 -1.242 . . . . 0.58 107.647 174.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -93.27 125.54 37.92 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.988 -1.115 . . . . 1.08 107.988 178.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 24.0 ptm -136.39 134.29 37.64 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 120.033 -0.667 . . . . 0.78 112.169 -177.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 11.9 p -123.41 125.04 44.24 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-N 115.073 -0.967 . . . . 0.97 109.73 177.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1552 ' ' ILE . . . . . 0.447 ' O ' ' HA ' ' A' 1533 ' ' SER . 47.9 mm -84.18 124.46 39.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 N-CA-C 109.86 -0.422 . . . . 0.42 109.86 -179.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1553 ' ' CYS . . . . . 0.434 ' SG ' HG22 ' A' 1552 ' ' ILE . 56.6 m 64.43 26.07 13.44 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.896 0.878 . . . . 1.4 112.231 174.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . -172.07 -179.23 42.86 Favored Glycine 0 N--CA 1.431 -1.643 0 N-CA-C 110.308 -1.117 . . . . 0.35 110.308 -178.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -101.34 145.56 28.74 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 121.283 0.563 . . . . 1.62 111.825 -177.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1556 ' ' ASN . . . . . 0.408 ' ND2' ' HA3' ' A' 1537 ' ' GLY . 24.6 t-20 -92.57 137.45 32.35 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.014 -0.994 . . . . 0.87 108.845 -177.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -80.43 -8.83 59.69 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.354 0.872 . . . . 2.49 113.354 -172.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -83.62 -9.06 59.15 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 120.946 0.403 . . . . 1.38 112.026 -175.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1559 ' ' CYS . . . . . 0.755 ' HB3' HG11 ' A' 1563 ' ' VAL . 9.3 t -136.87 153.71 75.72 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 108.164 -1.05 . . . . 1.21 108.164 -177.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1560 ' ' PRO . . . . . 0.575 ' HD2' ' SG ' ' A' 1559 ' ' CYS . 23.7 Cg_exo -28.84 135.51 0.03 OUTLIER 'Trans proline' 0 C--N 1.379 2.183 1 C-N-CA 125.988 4.459 . . . . 0.71 115.133 178.293 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -45.93 120.95 3.85 Favored 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 125.104 3.87 . . . . 0.8 114.125 -177.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 101.73 21.75 10.94 Favored Glycine 0 CA--C 1.531 1.081 0 CA-C-N 115.826 -0.625 . . . . 0.46 113.045 -176.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1563 ' ' VAL . . . . . 0.755 HG11 ' HB3' ' A' 1559 ' ' CYS . 2.3 t -102.02 124.29 55.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 O-C-N 122.162 -0.61 . . . . 0.98 110.931 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -97.3 -35.76 5.14 Favored Glycine 0 C--N 1.3 -1.447 0 N-CA-C 110.495 -1.042 . . . . 0.28 110.495 175.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -138.58 132.89 31.79 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.202 -0.666 . . . . 0.28 109.202 177.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1566 ' ' CYS . . . . . 0.417 ' HB2' HG11 ' A' 1563 ' ' VAL . 53.0 t -156.42 139.3 15.28 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.459 -0.571 . . . . 0.43 109.459 -177.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1567 ' ' PHE . . . . . 0.505 ' CE1' ' HB ' ' A' 1548 ' ' VAL . 67.3 m-85 -87.3 147.94 25.29 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.294 -0.562 . . . . 1.03 110.0 177.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -89.34 40.34 3.06 Favored Glycine 0 N--CA 1.437 -1.265 0 C-N-CA 120.393 -0.908 . . . . 1.13 113.363 -175.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1569 ' ' GLN . . . . . 0.419 ' HB2' ' OD2' ' B' ' 15' ' ' ASP . 28.3 mm-40 -95.16 -71.61 0.66 Allowed 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 119.874 -0.731 . . . . 2.58 110.449 175.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 81.6 p -130.69 40.65 3.47 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 118.638 0.653 . . . . 2.17 112.354 175.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 13.0 mmt85 63.6 49.76 2.96 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 123.923 0.889 . . . . 2.62 111.114 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 26.0 mm -98.53 113.72 34.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 N-CA-C 109.149 -0.686 . . . . 0.92 109.149 -178.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1573 ' ' SER . . . . . 0.51 ' HB3' ' OG ' ' A' 1596 ' ' SER . 31.6 t -86.11 142.16 28.88 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 121.713 0.768 . . . . 0.8 110.402 -176.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1574 ' ' VAL . . . . . 0.651 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 30.5 m -124.17 15.09 4.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 CA-C-N 115.495 -0.775 . . . . 0.98 110.237 179.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . -179.44 123.48 0.85 Allowed Glycine 0 N--CA 1.417 -2.58 0 C-N-CA 118.825 -1.655 . . . . 0.29 112.21 177.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1576 ' ' LYS . . . . . 0.437 ' HB2' ' O ' ' A' 1594 ' ' ASP . 57.7 tttp -77.26 134.29 38.61 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 108.013 -1.106 . . . . 2.19 108.013 176.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -70.72 117.47 12.28 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.889 -0.596 . . . . 0.61 110.74 -177.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -133.56 174.88 9.94 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 106.913 -1.514 . . . . 1.95 106.913 177.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -123.93 45.83 2.39 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 106.184 -1.784 . . . . 2.68 106.184 178.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.86 88.01 3.9 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 113.527 -1.669 . . . . 3.47 107.579 -172.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1581 ' ' LEU . . . . . 0.465 HD12 ' CG2' ' A' 1518 ' ' VAL . 0.2 OUTLIER -89.73 133.51 34.65 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.228 -1.027 . . . . 0.64 108.228 -177.684 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -122.93 138.57 54.63 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 109.992 -0.373 . . . . 2.85 109.992 174.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1583 ' ' TYR . . . . . . . . . . . . . 50.0 t80 -109.43 111.9 23.71 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 107.624 -1.25 . . . . 0.86 107.624 177.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1584 ' ' VAL . . . . . 0.623 ' O ' ' HB ' ' A' 1587 ' ' VAL . 14.7 m -131.96 99.02 3.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 112.602 0.594 . . . . 1.05 112.602 -177.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 37.4 t70 52.5 66.23 1.28 Allowed 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 124.297 1.039 . . . . 1.17 111.605 175.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1586 ' ' GLN . . . . . . . . . . . . 0.255 30.1 pt20 65.14 12.4 7.95 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 127.515 2.326 . . . . 1.86 112.426 177.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1587 ' ' VAL . . . . . 0.623 ' HB ' ' O ' ' A' 1584 ' ' VAL . 13.9 t -110.51 128.28 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 CA-C-N 114.751 -1.113 . . . . 0.49 110.681 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1588 ' ' LEU . . . . . 0.822 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 3.2 mm? -95.28 107.98 20.12 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 106.613 -1.625 . . . . 0.36 106.613 176.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -115.48 116.77 28.76 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-O 121.672 0.748 . . . . 1.74 112.692 -174.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1590 ' ' LEU . . . . . 0.448 ' HG ' HD22 ' A' 1581 ' ' LEU . 5.7 mt -100.18 108.06 20.08 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 114.197 -1.365 . . . . 0.72 107.38 172.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 10.0 p -99.09 126.82 52.24 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.15 0 CA-C-O 121.531 0.681 . . . . 1.01 110.089 -179.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1592 ' ' TYR . . . . . 0.404 ' O ' ' HA ' ' A' 1607 ' ' LYS . 12.4 m-30 -113.28 99.21 7.63 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 109.317 -0.623 . . . . 0.5 109.317 177.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 60.1 pttt -111.41 179.39 4.04 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.585 -0.895 . . . . 1.59 108.585 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1594 ' ' ASP . . . . . 0.437 ' O ' ' HB2' ' A' 1576 ' ' LYS . 32.3 m-20 57.82 45.9 17.83 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.108 0.963 . . . . 1.11 110.955 178.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -79.59 -95.3 0.33 Allowed Glycine 0 CA--C 1.498 -0.979 0 N-CA-C 109.791 -1.324 . . . . 0.78 109.791 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1596 ' ' SER . . . . . 0.51 ' OG ' ' HB3' ' A' 1573 ' ' SER . 72.2 m -124.94 149.35 62.83 Favored Pre-proline 0 C--N 1.273 -2.736 0 N-CA-C 107.216 -1.402 . . . . 1.07 107.216 173.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -61.92 138.4 73.44 Favored 'Trans proline' 0 N--CA 1.445 -1.367 0 C-N-CA 122.273 1.982 . . . . 1.01 109.229 174.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1598 ' ' CYS . . . . . 0.51 ' HA ' ' CE2' ' A' 1606 ' ' TYR . 5.0 t -70.02 113.47 17.91 Favored Pre-proline 0 C--N 1.296 -1.718 0 N-CA-C 106.954 -1.499 . . . . 0.75 106.954 -178.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1599 ' ' PRO . . . . . 0.646 ' HB2' HD23 ' B' ' 8' ' ' LEU . 24.2 Cg_exo -62.89 -33.78 74.08 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.984 2.456 . . . . 1.7 113.008 -173.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1600 ' ' SER . . . . . 0.674 ' HB2' ' HG ' ' B' ' 53' ' ' LEU . 5.2 m -86.18 7.6 24.39 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 116.307 -0.406 . . . . 2.26 112.061 178.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1601 ' ' LYS . . . . . 0.565 ' HG2' HD22 ' A' 1604 ' ' LEU . 3.0 tppp? -161.5 96.4 1.05 Allowed 'General case' 0 C--O 1.251 1.141 0 O-C-N 121.743 -0.598 . . . . 3.01 110.316 175.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 13.0 t -66.76 126.05 27.79 Favored 'General case' 0 N--CA 1.401 -2.886 0 N-CA-C 108.649 -0.871 . . . . 2.07 108.649 -176.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 106.2 -6.5 39.69 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 116.443 -0.344 . . . . 1.08 112.334 -177.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1604 ' ' LEU . . . . . 0.565 HD22 ' HG2' ' A' 1601 ' ' LYS . 7.5 mp -106.34 155.97 18.98 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 122.94 0.496 . . . . 1.84 109.981 176.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 44.8 t -135.24 151.06 50.25 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 107.99 -1.115 . . . . 1.41 107.99 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1606 ' ' TYR . . . . . 0.651 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 90.8 m-85 -80.45 150.86 29.58 Favored 'General case' 0 N--CA 1.419 -2.012 0 N-CA-C 108.903 -0.777 . . . . 0.6 108.903 176.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1607 ' ' LYS . . . . . 0.404 ' HA ' ' O ' ' A' 1592 ' ' TYR . 33.8 ttpt -150.82 127.46 10.85 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 123.623 0.577 . . . . 1.45 109.716 -175.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1608 ' ' SER . . . . . 0.402 ' HB2' ' HB2' ' A' 1592 ' ' TYR . 20.7 m -105.35 115.96 31.15 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 109.437 -0.579 . . . . 1.15 109.437 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 38.4 t -98.41 107.07 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 108.103 -1.073 . . . . 0.25 108.103 176.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 70.5 mt -100.25 101.37 12.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 CA-C-N 115.765 -0.652 . . . . 0.45 109.304 -179.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 5.9 p -100.2 119.02 37.71 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.619 0.723 . . . . 1.26 112.694 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1612 ' ' PHE . . . . . 0.822 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 72.0 m-85 -94.51 122.27 36.91 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.131 -0.94 . . . . 0.26 109.744 177.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 42.0 t -119.99 138.67 49.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-N 115.397 -0.819 . . . . 0.5 109.475 -175.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 13.2 t -58.75 113.54 2.09 Favored 'General case' 0 C--O 1.243 0.732 0 C-N-CA 124.352 1.061 . . . . 0.77 111.856 178.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1615 ' ' ARG . . . . . 0.697 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 23.7 tpt180 -136.64 97.46 11.43 Favored Pre-proline 0 N--CA 1.431 -1.386 0 N-CA-C 109.272 -0.64 . . . . 2.53 109.272 175.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1616 ' ' PRO . . . . . 0.464 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 60.5 Cg_endo -73.62 -14.9 24.62 Favored 'Trans proline' 0 N--CA 1.487 1.138 0 C-N-CA 122.551 2.167 . . . . 1.1 112.846 -177.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -91.82 42.68 1.11 Allowed 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 124.704 1.201 . . . . 3.05 110.333 -176.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -30.72 127.96 0.14 Allowed 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 126.648 1.979 . . . . 1.55 113.591 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1619 ' ' GLY . . . . . 0.426 ' HA3' ' HD2' ' A' 1620 ' ' PRO . . . 178.63 -145.14 6.66 Favored Glycine 0 N--CA 1.428 -1.843 0 N-CA-C 109.846 -1.302 . . . . 0.93 109.846 -178.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1620 ' ' PRO . . . . . 0.426 ' HD2' ' HA3' ' A' 1619 ' ' GLY . 27.2 Cg_endo -61.44 -4.07 3.91 Favored 'Trans proline' 0 CA--C 1.556 1.581 0 C-N-CA 123.568 2.846 . . . . 0.88 115.756 -177.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1621 ' ' THR . . . . . . . . . . . . . 23.3 p -91.96 -10.06 40.75 Favored 'General case' 0 C--O 1.247 0.939 0 O-C-N 121.563 -0.711 . . . . 0.97 110.662 176.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 47.1 t30 -90.43 58.66 4.07 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 122.338 1.066 . . . . 0.72 109.378 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -163.69 139.43 5.13 Favored Pre-proline 0 C--N 1.309 -1.192 0 CA-C-N 114.455 -1.248 . . . . 3.26 107.916 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -65.11 102.04 0.43 Allowed 'Trans proline' 0 C--O 1.239 0.528 0 C-N-CA 123.314 2.676 . . . . 0.59 112.837 -175.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 75.3 mtm -107.34 146.59 31.39 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.897 -0.592 . . . . 1.37 111.049 -178.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 1.6 tm? -86.76 115.34 24.13 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 107.438 -1.319 . . . . 0.89 107.438 -176.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 49.2 mm -79.16 -56.49 7.02 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-O 121.26 0.552 . . . . 0.58 109.792 179.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 66.5 m -161.36 147.22 14.12 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.513 -0.767 . . . . 1.39 109.704 -177.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1629 ' ' LEU . . . . . 0.823 HD13 ' HG ' ' A' 1636 ' ' LEU . 42.7 tp -113.92 112.85 24.01 Favored 'General case' 0 N--CA 1.424 -1.737 0 N-CA-C 107.428 -1.323 . . . . 1.25 107.428 172.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 30.6 t70 -85.93 110.75 19.66 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.68 -1.23 . . . . 1.09 107.68 174.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1631 ' ' LYS . . . . . 0.659 ' HB3' HD22 ' B' ' 53' ' ' LEU . 0.1 OUTLIER -73.72 -31.6 63.47 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.761 -0.654 . . . . 3.6 110.086 -174.037 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -70.16 -36.82 74.99 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-N 115.481 -0.781 . . . . 2.6 112.863 -173.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 54.8 p -101.32 -6.52 24.01 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.032 0.444 . . . . 0.75 110.7 175.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1634 ' ' CYS . . . . . 0.501 ' O ' ' HA ' ' A' 1606 ' ' TYR . 32.7 m 63.27 40.85 8.33 Favored 'General case' 0 C--N 1.364 1.209 0 C-N-CA 124.546 1.138 . . . . 0.53 109.961 -178.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1635 ' ' THR . . . . . . . . . . . . . 55.9 m -106.24 133.71 50.51 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.924 -1.034 . . . . 0.46 110.356 -176.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1636 ' ' LEU . . . . . 0.823 ' HG ' HD13 ' A' 1629 ' ' LEU . 0.7 OUTLIER -116.85 131.69 56.89 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.443 -0.577 . . . . 0.86 109.443 -177.709 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -111.23 128.09 55.81 Favored 'General case' 0 C--O 1.252 1.199 0 CA-C-O 120.821 0.343 . . . . 0.45 111.012 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -125.61 131.82 52.62 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.92 -0.77 . . . . 0.5 108.92 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1639 ' ' SER . . . . . . . . . . . . . 64.6 m -115.46 140.7 48.9 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 122.892 0.477 . . . . 1.04 109.857 178.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 3.1 t90 -142.35 114.29 8.12 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 104.327 -2.471 . . . . 0.68 104.327 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1641 ' ' HIS . . . . . 0.697 ' HB3' ' HB2' ' A' 1615 ' ' ARG . 31.5 m-70 -106.26 112.44 25.46 Favored 'General case' 0 C--N 1.293 -1.886 0 C-N-CA 119.916 -0.714 . . . . 0.9 110.005 -177.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1642 ' ' THR . . . . . . . . . . . . . 3.9 t -142.46 150.42 54.56 Favored Pre-proline 0 C--N 1.302 -1.491 0 CA-C-N 115.615 -0.72 . . . . 0.48 109.512 -172.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1643 ' ' PRO . . . . . 0.464 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 71.9 Cg_endo -77.07 -10.75 17.93 Favored 'Trans proline' 0 C--N 1.362 1.251 0 C-N-CA 122.411 2.074 . . . . 0.66 111.464 176.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1644 ' ' LEU . . . . . 0.585 HD11 ' HB2' ' A' 1531 ' ' SER . 7.3 tt -68.36 -24.33 64.79 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.712 0.805 . . . . 0.97 110.493 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -95.04 6.96 47.61 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 122.187 0.994 . . . . 0.84 109.619 -177.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 15.6 t -123.9 159.11 30.4 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-N 114.404 -1.271 . . . . 1.19 108.579 -175.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -98.58 103.28 17.83 Favored Pre-proline 0 C--N 1.308 -1.208 0 N-CA-C 108.455 -0.943 . . . . 3.14 108.455 169.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1648 ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -87.44 94.57 0.46 Allowed 'Trans proline' 0 N--CA 1.444 -1.409 0 C-N-CA 121.845 1.697 . . . . 2.58 111.498 178.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 10.0 tp10 . . . . . 0 C--N 1.311 -1.071 0 N-CA-C 105.73 -1.952 . . . . 4.72 105.73 179.223 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.845 0 N-CA-C 109.528 -0.545 . . . . 9.97 109.528 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -106.22 134.9 48.62 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.23 -1.396 . . . . 7.68 107.23 177.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 47.1 ptt85 -120.36 151.15 53.17 Favored Pre-proline 0 C--N 1.294 -1.831 0 N-CA-C 108.119 -1.067 . . . . 6.11 108.119 -179.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.65 1.68 4.15 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.371 2.714 . . . . 4.84 115.008 -175.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 19.4 m 59.0 39.67 23.22 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.229 1.412 . . . . 4.6 111.897 176.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -67.69 -37.41 82.26 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 121.613 0.72 . . . . 4.23 110.847 -176.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 60.3 p -122.8 169.97 10.56 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 104.834 -2.284 . . . . 3.14 104.834 175.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.646 HD23 ' HB2' ' A' 1599 ' ' PRO . 4.5 pp -99.49 133.25 44.08 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 120.007 1.276 . . . . 3.96 112.949 -175.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' CYS . . . . . 0.421 ' HB2' ' HA ' ' B' ' 47' ' ' CYS . 36.5 t -153.47 160.19 42.49 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 108.081 -1.081 . . . . 2.84 108.081 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.59 -125.85 10.58 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 112.071 -0.411 . . . . 2.09 112.071 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.98 -21.95 73.77 Favored Glycine 0 C--N 1.311 -0.847 0 C-N-CA 121.72 -0.276 . . . . 1.84 113.353 179.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -71.46 -20.83 62.04 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.728 0.775 . . . . 2.55 109.265 -176.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . 0.511 HD23 HD12 ' B' ' 8' ' ' LEU . 62.1 mt -68.14 -49.59 60.09 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 115.059 -0.973 . . . . 2.35 108.419 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 8.5 p -77.66 -18.12 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 CA-C-N 115.111 -0.95 . . . . 2.11 110.488 -176.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' ASP . . . . . 0.419 ' OD2' ' HB2' ' A' 1569 ' ' GLN . 12.5 t70 -62.83 -67.53 0.41 Allowed 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 109.535 -0.543 . . . . 2.04 109.535 176.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 15.2 t -61.13 -36.6 80.18 Favored 'General case' 0 C--O 1.25 1.125 0 O-C-N 123.635 0.584 . . . . 1.84 111.226 -176.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.572 HD21 HD11 ' B' ' 42' ' ' ILE . 4.0 mm? -57.37 -49.6 75.64 Favored 'General case' 0 C--O 1.215 -0.757 0 N-CA-C 113.109 0.781 . . . . 1.74 113.109 175.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -84.75 -14.97 46.66 Favored 'General case' 0 C--N 1.317 -0.809 0 O-C-N 121.583 -0.698 . . . . 2.39 111.034 -178.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -63.86 -54.66 31.34 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 116.314 -0.403 . . . . 0.96 111.017 176.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 16.0 m -98.18 -14.52 7.73 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.691 0 C-N-CA 118.911 -1.116 . . . . 1.37 112.319 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' CYS . . . . . 0.503 ' HB2' ' O ' ' B' ' 17' ' ' LEU . 68.7 m -114.49 23.03 13.12 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 120.358 -0.537 . . . . 1.66 111.666 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -52.22 -40.49 52.5 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 114.557 0.583 . . . . 1.53 114.557 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -86.12 -31.93 21.59 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 113.753 1.019 . . . . 2.72 113.753 -178.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . 0.415 ' HD3' ' OG1' ' B' ' 62' ' ' THR . 43.6 ttm180 -90.52 -25.03 20.46 Favored 'General case' 0 C--O 1.248 0.991 0 CA-C-O 121.353 0.597 . . . . 4.33 111.44 -176.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . 0.414 ' O ' ' HB2' ' B' ' 61' ' ' ALA . . . 109.29 163.06 19.97 Favored Glycine 0 N--CA 1.439 -1.132 0 N-CA-C 110.183 -1.167 . . . . 1.53 110.183 -179.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -123.62 131.11 53.54 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 117.52 0.66 . . . . 1.65 110.96 179.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' TYR . . . . . 0.434 ' HB2' ' HA ' ' B' ' 61' ' ' ALA . 26.9 m-85 -136.71 80.84 1.84 Allowed 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 111.754 0.279 . . . . 3.42 111.754 -177.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' PHE . . . . . 0.548 ' HA ' ' HE2' ' B' ' 59' ' ' TYR . 34.3 p90 -90.74 -17.62 26.39 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.7 0.762 . . . . 2.26 109.674 173.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 8.1 m -100.67 129.13 46.54 Favored 'General case' 0 N--CA 1.428 -1.543 0 N-CA-C 107.303 -1.369 . . . . 3.68 107.303 176.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . 0.409 ' HB2' ' O ' ' B' ' 39' ' ' SER . 20.9 mmt180 -105.78 158.31 32.68 Favored Pre-proline 0 C--N 1.305 -1.35 0 N-CA-C 107.537 -1.283 . . . . 3.81 107.537 -178.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -59.4 -50.49 8.24 Favored 'Trans proline' 0 C--O 1.25 1.076 0 C-N-CA 121.232 1.288 . . . . 4.02 113.319 -174.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' ALA . . . . . 0.712 ' HB3' ' HA ' ' B' ' 37' ' ' ARG . . . 69.62 -76.34 0.06 Allowed 'General case' 0 CA--C 1.507 -0.695 0 C-N-CA 125.281 1.433 . . . . 4.92 111.811 177.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 29.6 t 173.02 164.37 0.13 Allowed 'General case' 0 N--CA 1.396 -3.169 0 N-CA-C 103.548 -2.76 . . . . 6.72 103.548 178.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -93.21 -3.01 54.58 Favored 'General case' 0 C--N 1.27 -2.852 0 N-CA-C 108.364 -0.976 . . . . 11.63 108.364 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 41.0 t -110.14 -17.61 8.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 122.196 0.998 . . . . 9.61 108.721 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 13.0 p -148.69 63.53 1.07 Allowed 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 114.593 -1.185 . . . . 6.71 109.17 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . 0.712 ' HA ' ' HB3' ' B' ' 32' ' ' ALA . 27.1 ptt180 -73.06 12.07 0.6 Allowed 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 115.06 1.504 . . . . 10.0 115.06 -176.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -82.41 66.65 8.1 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.584 0.707 . . . . 7.94 112.826 -174.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . 0.502 ' HB2' ' HB2' ' B' ' 32' ' ' ALA . 39.5 m -150.55 89.0 1.52 Allowed 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 108.351 -0.981 . . . . 5.76 108.351 173.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 66.3 mtm180 -132.11 149.13 52.48 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 106.236 -1.764 . . . . 6.03 106.236 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . -116.34 155.99 15.9 Favored Glycine 0 N--CA 1.409 -3.146 0 C-N-CA 119.468 -1.349 . . . . 2.37 110.248 -177.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . 0.572 HD11 HD21 ' B' ' 17' ' ' LEU . 10.2 pt 59.65 -28.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 C-N-CA 127.737 2.415 . . . . 2.07 116.491 176.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . . . . . . . . 0.26 2.7 p -51.41 -49.53 31.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 114.958 1.466 . . . . 2.24 114.958 -175.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -96.12 -26.0 15.65 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.357 -0.979 . . . . 3.36 108.357 -176.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . 0.528 ' O ' ' HB2' ' B' ' 49' ' ' ARG . 9.5 tp10 -60.9 -43.72 98.12 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 114.933 -1.03 . . . . 3.08 109.428 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' CYS . . . . . 0.4 ' HA ' ' O ' ' B' ' 49' ' ' ARG . 10.1 t -94.48 -14.62 24.97 Favored 'General case' 0 C--N 1.314 -0.956 0 O-C-N 121.988 -0.445 . . . . 2.23 111.736 -177.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' CYS . . . . . 0.421 ' HA ' ' HB2' ' B' ' 9' ' ' CYS . 52.2 t -66.75 -47.74 71.29 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.141 -0.623 . . . . 2.37 110.181 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -105.71 -12.77 15.78 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 113.152 0.797 . . . . 2.82 113.152 -177.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . 0.528 ' HB2' ' O ' ' B' ' 45' ' ' GLU . 64.7 mtt180 -125.6 158.68 34.05 Favored 'General case' 0 CA--C 1.498 -1.036 0 N-CA-C 108.35 -0.981 . . . . 4.09 108.35 178.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 23.0 t -84.61 123.55 30.45 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 109.562 -0.533 . . . . 2.67 109.562 -177.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . 0.473 ' HB2' HD23 ' B' ' 55' ' ' LEU . 29.4 p -105.81 133.52 50.41 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 108.316 -0.994 . . . . 2.11 108.316 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -80.27 147.37 31.21 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.685 -1.228 . . . . 2.67 107.685 177.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . 0.803 ' H ' HD12 ' B' ' 53' ' ' LEU . 3.0 mp -52.49 -29.04 22.92 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 125.789 1.635 . . . . 1.9 112.185 -175.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . 0.42 ' O ' HG22 ' B' ' 58' ' ' THR . . . -61.96 -37.81 86.15 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 123.581 0.551 . . . . 1.52 110.772 -178.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . 0.473 HD23 ' HB2' ' B' ' 51' ' ' CYS . 50.5 tp -59.93 -50.59 73.17 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-N 115.787 -0.642 . . . . 1.97 110.617 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 3.9 pp -75.54 -32.76 60.57 Favored 'General case' 0 N--CA 1.422 -1.85 0 CA-C-N 116.202 -0.453 . . . . 1.53 111.99 -174.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -71.24 -42.44 68.84 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 112.195 0.442 . . . . 2.27 112.195 -176.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 58' ' ' THR . . . . . 0.42 HG22 ' O ' ' B' ' 54' ' ' ALA . 12.2 t -78.09 -25.4 47.58 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 118.83 -1.148 . . . . 2.33 111.742 176.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 59' ' ' TYR . . . . . 0.548 ' HE2' ' HA ' ' B' ' 28' ' ' PHE . 30.2 t80 -67.5 -68.55 0.37 Allowed 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 106.576 -1.639 . . . . 2.86 106.576 176.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 42.0 t 52.2 -85.17 0.01 OUTLIER 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 125.391 1.476 . . . . 2.3 114.213 173.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 61' ' ' ALA . . . . . 0.434 ' HA ' ' HB2' ' B' ' 27' ' ' TYR . . . -143.9 -84.27 0.15 Allowed 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 105.548 -2.019 . . . . 3.19 105.548 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 62' ' ' THR . . . . . 0.415 ' OG1' ' HD3' ' B' ' 24' ' ' ARG . 3.3 p -81.27 138.32 48.71 Favored Pre-proline 0 N--CA 1.405 -2.687 0 N-CA-C 107.396 -1.335 . . . . 3.68 107.396 168.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -79.68 3.92 7.13 Favored 'Trans proline' 0 C--O 1.245 0.837 0 C-N-CA 122.93 2.42 . . . . 5.08 112.519 -176.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 64.23 46.42 3.57 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-N 113.517 -1.674 . . . . 5.1 109.815 177.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -116.55 131.99 56.8 Favored 'General case' 0 N--CA 1.423 -1.822 0 CA-C-N 114.463 -1.244 . . . . 8.51 109.472 -177.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 9.3 p -87.77 62.15 6.82 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 121.505 0.669 . . . . 8.12 110.381 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 . . . . . 0 N--CA 1.433 -1.312 0 N-CA-C 107.34 -1.356 . . . . 10.21 107.34 179.724 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 87.7 mtp . . . . . 0 C--O 1.237 0.427 0 N-CA-C 108.134 -1.061 . . . . 9.34 108.134 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A 1509 ' ' LYS . . . . . 0.603 ' HA ' ' HB3' ' A' 1512 ' ' GLU . 55.7 pttt -135.51 24.73 3.45 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 114.345 1.239 . . . . 9.04 114.345 -170.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1510 ' ' SER . . . . . 0.593 ' HB3' ' HB ' ' A' 1519 ' ' THR . 50.0 m -99.99 -28.91 12.84 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.891 0.853 . . . . 5.81 109.136 175.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1511 ' ' ASN . . . . . . . . . . . . . 17.7 m120 -123.46 31.43 5.94 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.046 -0.979 . . . . 3.42 108.826 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1512 ' ' GLU . . . . . 0.603 ' HB3' ' HA ' ' A' 1509 ' ' LYS . 16.4 pt-20 -71.0 169.79 14.16 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-N 114.979 -1.01 . . . . 5.95 109.444 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 27.3 m170 -120.03 92.39 3.77 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 109.507 -0.553 . . . . 5.33 109.507 -177.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 19.3 t70 -134.44 -53.75 0.83 Allowed 'General case' 0 C--N 1.286 -2.193 0 C-N-CA 120.289 -0.564 . . . . 5.06 111.431 179.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 14.0 t70 -127.48 -175.9 3.59 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 105.395 -2.076 . . . . 2.9 105.395 177.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1516 ' ' CYS . . . . . 0.561 ' HA ' ' HB2' ' A' 1581 ' ' LEU . 91.1 m -88.5 66.5 8.26 Favored 'General case' 0 C--N 1.283 -2.293 0 CA-C-O 121.68 0.752 . . . . 1.19 110.926 -177.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -152.22 130.86 12.3 Favored 'General case' 0 N--CA 1.415 -2.206 0 CA-C-N 114.666 -1.152 . . . . 1.52 109.301 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1518 ' ' VAL . . . . . 0.569 HG21 ' HB2' ' A' 1583 ' ' TYR . 2.9 m -145.12 142.9 22.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 C-N-CA 123.926 0.89 . . . . 0.94 110.153 -179.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1519 ' ' THR . . . . . 0.593 ' HB ' ' HB3' ' A' 1510 ' ' SER . 18.9 m -101.81 145.34 29.31 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 116.301 -0.409 . . . . 0.89 111.026 -177.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1520 ' ' ASN . . . . . 0.404 ' OD1' HG22 ' A' 1523 ' ' THR . 24.5 t-20 -76.2 111.88 17.72 Favored Pre-proline 0 N--CA 1.433 -1.289 0 N-CA-C 106.389 -1.708 . . . . 1.74 106.389 170.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -74.21 0.46 8.44 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.491 2.127 . . . . 1.58 113.736 -174.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 19.6 m -91.15 -43.22 10.01 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 116.256 -0.429 . . . . 1.65 111.603 177.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1523 ' ' THR . . . . . 0.404 HG22 ' OD1' ' A' 1520 ' ' ASN . 4.9 t -119.24 -8.86 10.05 Favored 'General case' 0 C--O 1.244 0.79 0 C-N-CA 119.943 -0.703 . . . . 1.61 112.43 -177.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 85.95 20.37 55.73 Favored Glycine 0 C--N 1.317 -0.494 0 C-N-CA 120.423 -0.894 . . . . 1.13 113.095 177.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 24.3 t-80 -84.35 123.63 30.4 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.057 0.455 . . . . 1.26 110.574 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 2.9 tm? -94.71 119.32 33.14 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 115.336 -0.847 . . . . 0.68 110.943 -175.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -91.64 130.83 37.38 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 109.604 -0.517 . . . . 0.65 109.604 169.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 16.3 t70 -125.64 122.56 36.75 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.452 -1.314 . . . . 1.17 107.452 173.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 3.7 mm? -93.86 5.87 50.26 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 113.683 0.994 . . . . 0.6 113.683 -170.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1530 ' ' SER . . . . . 0.571 ' HA ' ' OG ' ' A' 1533 ' ' SER . 3.6 m -66.16 -7.94 21.03 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 113.804 1.039 . . . . 0.84 113.804 -174.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 8.5 t -69.22 -31.88 70.76 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 109.391 -0.596 . . . . 1.59 109.391 179.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 81.1 mt -95.38 -7.03 39.63 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.069 0.461 . . . . 0.65 110.795 -178.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1533 ' ' SER . . . . . 0.571 ' OG ' ' HA ' ' A' 1530 ' ' SER . 24.5 m -66.97 161.3 24.55 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.85 -0.614 . . . . 1.52 111.433 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . 155.86 159.82 9.61 Favored Glycine 0 N--CA 1.423 -2.174 0 N-CA-C 109.811 -1.316 . . . . 1.1 109.811 -176.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1535 ' ' ARG . . . . . 0.428 ' O ' ' HA ' ' A' 1556 ' ' ASN . 42.2 ttp180 -92.26 -31.16 15.52 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 109.972 -0.381 . . . . 4.62 109.972 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -66.67 -34.01 76.91 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 121.126 0.488 . . . . 1.45 110.878 -177.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 73.75 -157.29 51.48 Favored Glycine 0 N--CA 1.428 -1.85 0 CA-C-N 115.042 -0.981 . . . . 0.85 113.676 172.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -137.26 152.05 49.38 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.84 -1.17 . . . . 0.93 107.84 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 27.0 p -112.73 139.75 48.09 Favored 'General case' 0 C--N 1.308 -1.215 0 O-C-N 123.489 0.493 . . . . 1.03 111.177 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1540 ' ' ALA . . . . . 0.478 ' HB3' HG12 ' A' 1548 ' ' VAL . . . -131.35 135.14 46.99 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 108.409 -0.96 . . . . 0.5 108.409 174.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -73.58 141.7 46.62 Favored 'General case' 0 C--O 1.243 0.719 0 C-N-CA 122.601 0.36 . . . . 0.74 110.866 -178.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1542 ' ' TYR . . . . . 0.481 ' HB3' ' H ' ' A' 1543 ' ' SER . 1.3 t80 -149.43 -101.14 0.07 Allowed 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 109.285 -0.635 . . . . 0.99 109.285 -176.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1543 ' ' SER . . . . . 0.481 ' H ' ' HB3' ' A' 1542 ' ' TYR . 4.3 m -63.95 160.24 18.17 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.468 1.107 . . . . 1.91 111.225 -178.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 52.3 tptt -50.76 -41.38 56.67 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 113.611 0.967 . . . . 3.59 113.611 -173.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 11.9 t -128.75 37.93 4.03 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 108.785 -0.82 . . . . 2.46 108.785 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1546 ' ' GLY . . . . . 0.583 ' HA3' ' HG2' ' A' 1569 ' ' GLN . . . -147.96 120.34 1.21 Allowed Glycine 0 N--CA 1.428 -1.859 0 C-N-CA 119.555 -1.307 . . . . 1.26 113.573 -177.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 29.3 m -99.89 152.58 4.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 107.001 -1.481 . . . . 0.79 107.001 174.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1548 ' ' VAL . . . . . 0.478 HG12 ' HB3' ' A' 1540 ' ' ALA . 12.3 p -92.76 134.42 30.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.865 0 C-N-CA 119.922 -0.711 . . . . 0.58 109.202 178.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -99.87 129.13 45.93 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 115.355 -0.839 . . . . 1.08 108.763 177.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 25.8 ptm -144.14 126.27 15.55 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 115.453 -0.794 . . . . 0.78 110.972 -176.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 5.3 p -118.55 132.89 56.2 Favored 'General case' 0 C--N 1.282 -2.355 0 CA-C-N 115.002 -0.999 . . . . 0.97 109.795 179.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1552 ' ' ILE . . . . . . . . . . . . . 46.8 mm -83.28 112.15 20.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 120.477 0.18 . . . . 0.42 111.159 -176.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 57.9 m 64.99 29.6 12.17 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.622 1.169 . . . . 1.4 112.093 174.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . -167.01 -174.8 36.55 Favored Glycine 0 N--CA 1.409 -3.113 0 N-CA-C 108.961 -1.656 . . . . 0.35 108.961 -178.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -109.78 152.86 25.16 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-N 116.845 0.323 . . . . 1.62 111.724 -175.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1556 ' ' ASN . . . . . 0.428 ' HA ' ' O ' ' A' 1535 ' ' ARG . 26.7 t-20 -103.29 138.63 39.81 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.008 -1.108 . . . . 0.87 108.008 178.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -85.97 2.33 46.66 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 114.06 1.133 . . . . 2.49 114.06 -171.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -91.03 -1.81 57.75 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 120.491 -0.484 . . . . 1.38 111.027 -178.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1559 ' ' CYS . . . . . 0.62 ' SG ' ' HD2' ' A' 1560 ' ' PRO . 16.0 t -137.43 151.74 71.81 Favored Pre-proline 0 C--N 1.304 -1.373 0 N-CA-C 106.648 -1.612 . . . . 1.21 106.648 178.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1560 ' ' PRO . . . . . 0.62 ' HD2' ' SG ' ' A' 1559 ' ' CYS . 13.3 Cg_exo -30.6 132.13 0.05 OUTLIER 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 125.226 3.95 . . . . 0.71 114.655 178.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -45.02 129.25 9.86 Favored 'Trans proline' 0 C--N 1.364 1.385 0 C-N-CA 124.768 3.645 . . . . 0.8 113.332 -177.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 96.6 18.98 28.67 Favored Glycine 0 C--N 1.313 -0.727 0 CA-C-N 116.204 -0.453 . . . . 0.46 113.14 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1563 ' ' VAL . . . . . 0.596 HG11 ' HB2' ' A' 1566 ' ' CYS . 2.3 t -106.61 124.51 62.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 C-N-CA 123.02 0.528 . . . . 0.98 111.661 -178.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -97.27 -33.97 5.77 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 115.242 -0.89 . . . . 0.28 111.814 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -133.94 129.59 36.51 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 109.018 -0.734 . . . . 0.28 109.018 177.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1566 ' ' CYS . . . . . 0.596 ' HB2' HG11 ' A' 1563 ' ' VAL . 48.5 t -158.32 138.11 12.09 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 110.52 -0.178 . . . . 0.43 110.52 -176.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -84.72 135.45 34.14 Favored 'General case' 0 C--O 1.245 0.859 0 N-CA-C 108.428 -0.953 . . . . 1.03 108.428 173.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -91.79 27.71 9.55 Favored Glycine 0 N--CA 1.422 -2.286 0 N-CA-C 115.88 1.112 . . . . 1.13 115.88 -170.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1569 ' ' GLN . . . . . 0.605 ' HB2' ' OD2' ' B' ' 15' ' ' ASP . 20.8 mt-30 -77.49 -69.04 0.56 Allowed 'General case' 0 C--O 1.241 0.617 0 C-N-CA 117.349 -1.74 . . . . 2.58 109.579 171.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 71.0 p -114.33 15.7 17.98 Favored 'General case' 0 CA--C 1.553 1.058 0 N-CA-C 112.809 0.67 . . . . 2.17 112.809 177.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? 66.43 68.78 0.43 Allowed 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.923 1.289 . . . . 2.62 112.703 -179.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 18.8 mt -106.3 122.61 60.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 114.727 -1.124 . . . . 0.92 108.793 177.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 35.7 t -83.2 138.53 33.59 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.669 0.747 . . . . 0.8 111.244 -174.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1574 ' ' VAL . . . . . 0.589 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 27.1 m -123.39 18.05 5.03 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 CA-C-N 115.661 -0.699 . . . . 0.98 110.392 178.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 167.52 126.44 0.84 Allowed Glycine 0 N--CA 1.422 -2.253 0 CA-C-N 115.113 -0.949 . . . . 0.29 112.383 175.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 53.9 tttm -68.64 146.03 53.38 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.525 -0.917 . . . . 2.19 108.525 177.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -73.48 79.45 1.43 Allowed 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.208 0.528 . . . . 0.61 111.566 -178.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -96.35 -177.6 4.02 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 109.263 -0.643 . . . . 1.95 109.263 178.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 66.7 mttm -132.38 47.56 2.5 Favored 'General case' 0 CA--C 1.485 -1.548 0 N-CA-C 105.28 -2.119 . . . . 2.68 105.28 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.49 76.62 5.83 Favored 'General case' 0 N--CA 1.415 -2.197 0 CA-C-N 113.773 -1.558 . . . . 3.47 108.593 -171.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1581 ' ' LEU . . . . . 0.561 ' HB2' ' HA ' ' A' 1516 ' ' CYS . 0.3 OUTLIER -86.14 129.58 34.8 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.608 -1.178 . . . . 0.64 108.691 -179.309 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A 1582 ' ' ARG . . . . . 0.547 ' HB2' ' HB3' ' A' 1589 ' ' GLN . 70.3 mtp180 -124.15 137.26 54.57 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 116.522 -0.308 . . . . 2.85 110.273 173.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1583 ' ' TYR . . . . . 0.569 ' HB2' HG21 ' A' 1518 ' ' VAL . 66.9 t80 -105.62 104.37 14.07 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 107.853 -1.165 . . . . 0.86 107.853 177.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1584 ' ' VAL . . . . . 0.529 ' O ' ' HB ' ' A' 1587 ' ' VAL . 16.7 m -121.2 89.51 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 112.81 0.67 . . . . 1.05 112.81 -175.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 17.4 t70 56.91 57.9 4.38 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.119 0.968 . . . . 1.17 110.134 177.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1586 ' ' GLN . . . . . 0.53 ' HA ' ' CE1' ' A' 1583 ' ' TYR 0.296 9.1 pt20 68.87 4.67 4.58 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 128.196 2.598 . . . . 1.86 112.637 179.116 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A 1587 ' ' VAL . . . . . 0.529 ' HB ' ' O ' ' A' 1584 ' ' VAL . 23.1 t -93.71 124.03 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.012 0 N-CA-C 108.491 -0.929 . . . . 0.49 108.491 174.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1588 ' ' LEU . . . . . 0.859 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 3.4 mm? -92.73 107.77 19.47 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.157 -1.053 . . . . 0.36 108.157 178.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1589 ' ' GLN . . . . . 0.547 ' HB3' ' HB2' ' A' 1582 ' ' ARG . 35.5 tt0 -99.05 123.65 43.5 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 116.025 -0.534 . . . . 1.74 110.23 -178.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1590 ' ' LEU . . . . . 0.476 ' HB3' ' HB ' ' A' 1610 ' ' ILE . 0.7 OUTLIER -117.83 96.02 5.18 Favored 'General case' 0 C--N 1.284 -2.27 0 N-CA-C 105.065 -2.198 . . . . 0.72 105.065 174.885 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 8.4 p -96.31 132.16 41.29 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 CA-C-O 121.317 0.579 . . . . 1.01 111.665 -175.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1592 ' ' TYR . . . . . . . . . . . . . 14.2 m-30 -121.51 122.18 39.15 Favored 'General case' 0 CA--C 1.496 -1.12 0 N-CA-C 108.306 -0.998 . . . . 0.5 108.306 176.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 58.4 pttt -131.09 179.04 6.24 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 108.98 -0.748 . . . . 1.59 108.98 177.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 19.9 m-20 62.17 53.2 2.97 Favored 'General case' 0 C--O 1.249 1.049 0 O-C-N 124.286 0.992 . . . . 1.11 110.864 178.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -85.67 -105.23 0.71 Allowed Glycine 0 N--CA 1.429 -1.796 0 N-CA-C 109.558 -1.417 . . . . 0.78 109.558 177.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1596 ' ' SER . . . . . . . . . . . . . 36.3 p -129.11 153.63 80.37 Favored Pre-proline 0 C--N 1.282 -2.331 0 N-CA-C 107.753 -1.202 . . . . 1.07 107.753 174.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 90.7 Cg_exo -50.67 133.76 39.21 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.287 2.658 . . . . 1.01 113.509 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1598 ' ' CYS . . . . . 0.517 ' HA ' ' CE2' ' A' 1606 ' ' TYR . 44.4 t -81.83 119.27 74.89 Favored Pre-proline 0 C--N 1.283 -2.285 0 CA-C-N 113.875 -1.512 . . . . 0.75 109.018 -178.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1599 ' ' PRO . . . . . 0.488 ' HD2' ' OH ' ' A' 1606 ' ' TYR . 40.2 Cg_exo -60.43 -23.92 76.34 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 123.097 2.532 . . . . 1.7 112.965 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1600 ' ' SER . . . . . 0.741 ' HA ' ' HB2' ' B' ' 53' ' ' LEU . 19.5 m -54.37 -44.81 72.54 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 123.364 0.665 . . . . 2.26 111.782 178.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1601 ' ' LYS . . . . . 0.548 ' HB3' HD12 ' A' 1604 ' ' LEU . 4.5 tppp? -148.24 127.88 13.31 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.97 -0.752 . . . . 3.01 108.97 179.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 20.4 m -65.48 129.48 39.9 Favored 'General case' 0 N--CA 1.412 -2.345 0 N-CA-C 108.796 -0.816 . . . . 2.07 108.796 -178.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 105.25 -10.87 47.53 Favored Glycine 0 N--CA 1.436 -1.359 0 C-N-CA 120.496 -0.859 . . . . 1.08 112.499 178.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1604 ' ' LEU . . . . . 0.548 HD12 ' HB3' ' A' 1601 ' ' LYS . 67.6 mt -99.33 150.19 22.38 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.667 -0.494 . . . . 1.84 109.667 178.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 22.4 t -123.4 153.15 40.79 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.555 -1.276 . . . . 1.41 107.555 177.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1606 ' ' TYR . . . . . 0.589 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 49.6 m-85 -73.77 158.48 34.52 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 116.171 -0.468 . . . . 0.6 111.903 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 20.0 ttpp -156.26 125.87 6.31 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.808 -0.633 . . . . 1.45 110.502 -178.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1608 ' ' SER . . . . . . . . . . . . . 20.0 m -106.45 129.86 54.35 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 109.015 -0.735 . . . . 1.15 109.015 -179.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 26.2 t -114.21 102.41 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.598 0 N-CA-C 108.508 -0.923 . . . . 0.25 108.508 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1610 ' ' ILE . . . . . 0.476 ' HB ' ' HB3' ' A' 1590 ' ' LEU . 85.4 mt -90.11 113.8 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.662 0 N-CA-C 108.709 -0.848 . . . . 0.45 108.709 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 34.5 m -109.64 106.76 16.56 Favored 'General case' 0 C--N 1.283 -2.288 0 CA-C-N 114.855 -1.066 . . . . 1.26 110.249 -178.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1612 ' ' PHE . . . . . 0.859 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 45.7 m-85 -80.27 119.24 22.76 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.88 -0.6 . . . . 0.26 109.79 176.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1613 ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' 1641 ' ' HIS . 54.1 t -109.64 128.83 65.39 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-N 115.004 -0.998 . . . . 0.5 110.927 -174.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 5.8 t -55.19 109.44 0.53 Allowed 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 125.012 1.325 . . . . 0.77 112.97 176.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1615 ' ' ARG . . . . . 0.808 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 4.3 tpt180 -129.08 94.36 34.07 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 106.963 -1.495 . . . . 2.53 106.963 169.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1616 ' ' PRO . . . . . 0.631 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 37.6 Cg_endo -63.47 -32.41 70.9 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 122.789 2.326 . . . . 1.1 115.999 -169.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -85.94 -18.16 33.44 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.211 -0.595 . . . . 3.05 111.646 -176.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . 68.65 113.15 0.04 OUTLIER 'General case' 0 C--N 1.358 0.949 0 C-N-CA 125.23 1.412 . . . . 1.55 110.937 -174.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . -131.25 -155.87 8.3 Favored Glycine 0 N--CA 1.422 -2.292 0 C-N-CA 119.976 -1.107 . . . . 0.93 111.208 -177.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -82.43 20.88 1.05 Allowed 'Trans proline' 0 C--O 1.235 0.375 0 C-N-CA 123.253 2.635 . . . . 0.88 113.588 -174.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1621 ' ' THR . . . . . . . . . . . . . 22.4 p -116.71 14.4 15.33 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-O 121.901 0.858 . . . . 0.97 109.717 178.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 42.6 t30 -90.68 58.9 4.04 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 122.802 1.287 . . . . 0.72 108.325 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1623 ' ' ARG . . . . . 0.412 ' HE ' ' HB2' ' A' 1623 ' ' ARG . 3.5 ptm180 -168.05 140.55 2.51 Favored Pre-proline 0 N--CA 1.428 -1.551 0 CA-C-N 113.486 -1.688 . . . . 3.26 107.003 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1624 ' ' PRO . . . . . 0.451 ' HA ' ' O ' ' A' 1639 ' ' SER . 35.7 Cg_endo -61.98 103.99 0.31 Allowed 'Trans proline' 0 C--O 1.243 0.733 0 C-N-CA 123.133 2.555 . . . . 0.59 113.012 -176.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 69.9 mtm -99.66 144.92 28.18 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.988 -0.551 . . . . 1.37 109.869 176.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 1.5 tm? -86.89 115.33 24.23 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 106.883 -1.525 . . . . 0.89 106.883 -176.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1627 ' ' ILE . . . . . 0.753 HD11 ' HB2' ' A' 1639 ' ' SER . 38.6 mm -75.94 -58.35 4.67 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.605 0 CA-C-O 121.589 0.709 . . . . 0.58 109.186 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 40.3 m -164.18 151.3 11.78 Favored 'General case' 0 N--CA 1.427 -1.575 0 N-CA-C 107.639 -1.245 . . . . 1.39 107.639 -174.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1629 ' ' LEU . . . . . 0.712 HD13 ' HG ' ' A' 1636 ' ' LEU . 33.0 tp -116.05 104.7 11.83 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 107.102 -1.444 . . . . 1.25 107.102 172.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 14.3 t70 -75.35 100.99 4.58 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.082 -1.047 . . . . 1.09 108.63 178.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1631 ' ' LYS . . . . . 0.794 ' HD3' ' H ' ' A' 1631 ' ' LYS . 0.0 OUTLIER -65.31 -8.48 18.35 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 114.336 1.236 . . . . 3.6 114.336 -175.677 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A 1632 ' ' GLN . . . . . 0.858 HE21 ' HA ' ' A' 1632 ' ' GLN . 0.0 OUTLIER -96.06 -37.89 10.43 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 119.409 -0.916 . . . . 2.6 110.909 -179.292 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 66.9 p -94.74 -16.4 23.07 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 116.026 -0.534 . . . . 0.75 110.798 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 74.5 m 68.59 35.76 3.08 Favored 'General case' 0 C--N 1.353 0.73 0 C-N-CA 124.572 1.149 . . . . 0.53 110.698 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1635 ' ' THR . . . . . . . . . . . . . 41.3 m -99.19 131.79 44.97 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 114.455 -1.248 . . . . 0.46 109.693 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1636 ' ' LEU . . . . . 0.712 ' HG ' HD13 ' A' 1629 ' ' LEU . 0.5 OUTLIER -110.24 121.62 45.72 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.638 -1.245 . . . . 0.86 107.638 -179.018 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -101.93 129.46 48.2 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 120.898 0.38 . . . . 0.45 110.836 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -125.83 137.37 53.76 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.312 -0.858 . . . . 0.5 109.82 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1639 ' ' SER . . . . . 0.753 ' HB2' HD11 ' A' 1627 ' ' ILE . 16.5 t -117.81 150.8 38.55 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.288 -1.004 . . . . 1.04 108.288 178.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 2.8 t90 -152.55 113.63 4.2 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 104.868 -2.271 . . . . 0.68 104.868 -179.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1641 ' ' HIS . . . . . 0.808 ' HB3' ' HB2' ' A' 1615 ' ' ARG . 10.6 m-70 -101.2 111.13 23.26 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-O 121.357 0.599 . . . . 0.9 109.79 -176.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1642 ' ' THR . . . . . . . . . . . . . 3.2 t -142.57 148.14 45.56 Favored Pre-proline 0 C--N 1.297 -1.71 0 CA-C-N 115.148 -0.933 . . . . 0.48 109.278 -174.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1643 ' ' PRO . . . . . 0.631 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 58.9 Cg_endo -79.42 -14.41 13.06 Favored 'Trans proline' 0 C--N 1.363 1.318 0 C-N-CA 122.28 1.987 . . . . 0.66 112.847 178.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 8.2 tt -70.76 -26.93 63.58 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.796 -0.816 . . . . 0.97 108.796 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1645 ' ' ALA . . . . . 0.414 ' CB ' ' HB3' ' A' 1612 ' ' PHE . . . -99.09 28.42 4.44 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 114.718 -1.128 . . . . 0.84 110.44 -177.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 47.7 t -121.57 140.95 51.58 Favored 'General case' 0 N--CA 1.419 -1.997 0 N-CA-C 108.794 -0.817 . . . . 1.19 108.794 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -89.56 108.55 25.78 Favored Pre-proline 0 N--CA 1.421 -1.921 0 N-CA-C 107.629 -1.249 . . . . 3.14 107.629 177.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1648 ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -69.51 106.22 1.58 Allowed 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 122.667 2.245 . . . . 2.58 112.337 -173.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 9.6 tp10 . . . . . 0 C--N 1.297 -1.676 0 N-CA-C 107.787 -1.19 . . . . 4.72 107.787 179.295 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.467 0 CA-C-O 121.039 0.447 . . . . 9.97 110.423 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -134.2 137.89 44.73 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.31 -0.996 . . . . 7.68 108.31 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -107.65 137.07 19.61 Favored Pre-proline 0 C--N 1.302 -1.494 0 N-CA-C 109.068 -0.716 . . . . 6.11 109.068 -178.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -77.52 7.63 3.73 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.836 2.358 . . . . 4.84 112.389 177.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . 0.462 ' HB2' HD21 ' B' ' 8' ' ' LEU . 31.8 p -123.06 57.73 1.12 Allowed 'General case' 0 N--CA 1.425 -1.682 0 C-N-CA 124.019 0.927 . . . . 4.6 109.78 -176.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -68.93 -38.68 79.66 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.827 -0.624 . . . . 4.23 111.101 -177.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 19.4 p -127.07 99.61 5.77 Favored 'General case' 0 N--CA 1.421 -1.906 0 CA-C-N 115.513 -0.767 . . . . 3.14 110.375 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.484 ' HB2' ' H ' ' B' ' 12' ' ' GLU . 91.0 mt -76.91 145.18 38.39 Favored 'General case' 0 C--O 1.249 1.062 0 N-CA-C 109.487 -0.56 . . . . 3.96 109.487 178.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 8.2 m -87.05 62.84 7.59 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 122.006 0.908 . . . . 2.84 109.469 -173.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.32 -69.13 0.29 Allowed Glycine 0 C--N 1.293 -1.845 0 CA-C-N 114.753 -1.112 . . . . 2.09 110.911 -178.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -57.16 -64.66 4.2 Favored Glycine 0 C--N 1.33 0.24 0 N-CA-C 113.919 0.328 . . . . 1.84 113.919 -177.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . 0.484 ' H ' ' HB2' ' B' ' 8' ' ' LEU . 19.3 mm-40 -63.96 -32.32 73.81 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 109.349 -0.611 . . . . 2.55 109.349 -178.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . 0.478 ' O ' HD23 ' B' ' 17' ' ' LEU . 0.1 OUTLIER -60.29 -59.56 5.22 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 114.441 -1.254 . . . . 2.35 109.214 -178.926 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 14.2 p -69.21 -33.31 57.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 112.259 0.466 . . . . 2.11 112.259 -176.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' ASP . . . . . 0.605 ' OD2' ' HB2' ' A' 1569 ' ' GLN . 11.9 t0 -59.86 -53.34 59.09 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 120.164 -0.614 . . . . 2.04 109.444 179.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 34.5 m -57.29 -51.14 70.56 Favored 'General case' 0 CA--C 1.566 1.571 0 C-N-CA 123.983 0.913 . . . . 1.84 111.322 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.542 ' HG ' ' HD2' ' B' ' 28' ' ' PHE . 4.2 mm? -53.72 -46.98 70.99 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.628 -0.715 . . . . 1.74 112.214 176.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -83.15 -10.67 58.51 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-O 121.554 0.692 . . . . 2.39 111.558 -177.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -68.5 -56.78 7.22 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.719 -0.673 . . . . 0.96 110.283 177.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 15.0 p -95.32 -22.83 5.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 C-N-CA 118.571 -1.252 . . . . 1.37 112.063 -176.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 60.3 m -108.81 27.01 9.89 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 120.197 -0.601 . . . . 1.66 110.13 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -54.16 -54.82 29.53 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 121.171 -0.538 . . . . 1.53 113.125 178.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -71.97 -43.11 65.69 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 112.168 0.433 . . . . 2.72 112.168 178.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . 0.491 ' HD2' ' HB3' ' B' ' 61' ' ' ALA . 39.1 ttm180 -67.73 -49.36 62.96 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 112.452 0.538 . . . . 4.33 112.452 -175.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 125.84 140.86 5.43 Favored Glycine 0 N--CA 1.437 -1.244 0 N-CA-C 110.002 -1.239 . . . . 1.53 110.002 -175.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . 0.473 ' HB2' ' HB3' ' B' ' 17' ' ' LEU . 30.6 p90 -113.69 130.22 56.45 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 117.121 0.46 . . . . 1.65 109.99 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -133.45 73.64 1.52 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.679 0.622 . . . . 3.42 112.679 -177.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' PHE . . . . . 0.542 ' HD2' ' HG ' ' B' ' 17' ' ' LEU . 34.3 p90 -93.7 -22.9 18.45 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.223 -0.991 . . . . 2.26 109.013 173.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 13.4 t -104.09 92.63 4.46 Favored 'General case' 0 N--CA 1.424 -1.725 0 CA-C-N 115.402 -0.817 . . . . 3.68 108.946 -175.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 27.0 mtm180 -123.38 162.72 38.43 Favored Pre-proline 0 C--N 1.31 -1.136 0 CA-C-N 115.958 -0.565 . . . . 3.81 109.584 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -76.71 -7.85 17.8 Favored 'Trans proline' 0 C--N 1.355 0.906 0 C-N-CA 123.339 2.692 . . . . 4.02 113.216 177.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' ALA . . . . . 0.582 ' HA ' ' HA ' ' B' ' 39' ' ' SER . . . -169.51 168.33 9.4 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 105.5 -2.037 . . . . 4.92 105.5 178.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 22.9 t -144.06 -157.55 0.79 Allowed 'General case' 1 N--CA 1.369 -4.502 0 N-CA-C 106.519 -1.66 . . . . 6.72 106.519 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 62.0 mtp180 -63.95 -24.46 67.74 Favored 'General case' 0 C--N 1.255 -3.505 0 C-N-CA 123.977 0.911 . . . . 11.63 113.096 -177.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 7.3 p -119.45 8.17 6.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-O 122.82 1.295 . . . . 9.61 112.398 -173.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 48.4 t 67.66 -57.56 0.45 Allowed 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 113.495 -1.684 . . . . 6.71 113.087 179.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 14.9 tpp180 -44.54 -51.25 9.08 Favored 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 127.289 2.236 . . . . 10.0 111.449 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 23.2 mmm180 -91.04 108.27 19.75 Favored 'General case' 0 N--CA 1.391 -3.419 0 N-CA-C 105.677 -1.972 . . . . 7.94 105.677 175.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . 0.582 ' HA ' ' HA ' ' B' ' 32' ' ' ALA . 19.2 m -74.61 -43.24 56.43 Favored 'General case' 0 N--CA 1.427 -1.62 0 N-CA-C 108.513 -0.921 . . . . 5.76 108.513 177.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 67.6 mtt180 -107.67 149.87 27.59 Favored 'General case' 0 N--CA 1.412 -2.344 0 N-CA-C 106.257 -1.757 . . . . 6.03 106.257 177.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . -121.15 160.63 15.43 Favored Glycine 0 N--CA 1.407 -3.259 0 N-CA-C 109.773 -1.331 . . . . 2.37 109.773 -176.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . 0.538 HD11 HD21 ' B' ' 17' ' ' LEU . 20.0 pt 61.51 -30.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 C-N-CA 127.953 2.501 . . . . 2.07 114.821 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.63 ' O ' ' HB2' ' B' ' 47' ' ' CYS . 2.6 p -49.88 -43.01 19.27 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 114.236 1.199 . . . . 2.24 114.236 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -96.28 -35.04 11.39 Favored 'General case' 0 N--CA 1.429 -1.523 0 C-N-CA 120.207 -0.597 . . . . 3.36 109.566 -175.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . 0.427 ' HG3' ' HD2' ' B' ' 49' ' ' ARG . 33.7 tt0 -63.87 -45.4 89.59 Favored 'General case' 0 C--O 1.202 -1.431 0 CA-C-N 115.905 -0.589 . . . . 3.08 109.769 179.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' CYS . . . . . . . . . . . . . 29.3 m -85.16 -4.16 59.06 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.216 0.531 . . . . 2.23 110.88 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' CYS . . . . . 0.63 ' HB2' ' O ' ' B' ' 43' ' ' VAL . 42.2 t -77.62 -45.36 25.35 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.523 0.677 . . . . 2.37 109.195 175.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -105.23 -10.25 17.19 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 113.236 0.828 . . . . 2.82 113.236 -176.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . 0.427 ' HD2' ' HG3' ' B' ' 45' ' ' GLU . 93.0 mtt180 -129.47 171.31 12.69 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 106.956 -1.498 . . . . 4.09 106.956 177.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 22.7 t -99.71 148.11 24.72 Favored 'General case' 0 N--CA 1.426 -1.66 0 N-CA-C 107.609 -1.256 . . . . 2.67 107.609 173.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 76.9 m -125.98 142.01 51.71 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 109.553 -0.536 . . . . 2.11 109.553 -175.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -81.77 161.79 23.15 Favored 'General case' 0 C--O 1.243 0.725 0 O-C-N 123.15 0.281 . . . . 2.67 110.88 176.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . 0.741 ' HB2' ' HA ' ' A' 1600 ' ' SER . 62.7 tp -55.33 -36.23 66.04 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 122.508 0.323 . . . . 1.9 111.405 178.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.9 -26.51 65.96 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 123.648 0.779 . . . . 1.52 112.556 -174.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 52.6 tp -74.44 -54.56 7.32 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 109.551 -0.537 . . . . 1.97 109.551 177.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.5 ' O ' ' HB2' ' B' ' 60' ' ' CYS . 2.8 pp -70.92 -33.32 70.41 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-N 115.923 -0.58 . . . . 1.53 111.392 -174.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -54.47 -51.39 65.2 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 123.663 0.602 . . . . 2.27 111.318 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 8.9 t -82.7 -28.29 30.65 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 112.492 0.553 . . . . 2.33 112.492 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -78.38 -36.27 46.13 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 121.807 -0.558 . . . . 2.86 110.695 -175.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 60' ' ' CYS . . . . . 0.5 ' HB2' ' O ' ' B' ' 56' ' ' LEU . 12.0 t -39.87 -62.41 0.72 Allowed 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 126.011 1.724 . . . . 2.3 111.84 -178.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 61' ' ' ALA . . . . . 0.491 ' HB3' ' HD2' ' B' ' 24' ' ' ARG . . . -176.44 172.67 2.19 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 105.437 -2.061 . . . . 3.19 105.437 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 19.6 p -135.09 152.21 76.7 Favored Pre-proline 0 C--N 1.29 -1.993 0 N-CA-C 109.015 -0.735 . . . . 3.68 109.015 -173.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -59.92 -8.89 8.59 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 123.481 2.787 . . . . 5.08 112.933 176.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 73.47 28.11 1.77 Allowed 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 126.282 1.833 . . . . 5.1 112.535 173.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -98.38 -7.81 28.1 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 107.341 -1.355 . . . . 8.51 107.341 176.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 43.5 p -118.23 -174.77 2.72 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 114.263 -1.335 . . . . 8.12 108.33 176.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 . . . . . 0 C--N 1.311 -1.076 0 N-CA-C 108.275 -1.009 . . . . 10.21 108.275 177.779 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 23.6 ptp . . . . . 0 N--CA 1.473 0.712 0 CA-C-O 119.351 -0.357 . . . . 9.34 111.136 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 64.8 tttp 56.36 73.97 0.42 Allowed 'General case' 0 C--O 1.245 0.862 0 CA-C-O 122.427 1.108 . . . . 9.04 110.478 -178.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 28.9 m -145.83 149.65 34.71 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 107.815 -1.179 . . . . 5.81 107.815 -177.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1511 ' ' ASN . . . . . . . . . . . . . 2.8 m-20 59.86 57.36 3.14 Favored 'General case' 0 C--O 1.246 0.887 0 CA-C-O 121.829 0.823 . . . . 3.42 109.596 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1512 ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -76.86 -28.42 55.43 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 114.531 -1.213 . . . . 5.95 110.843 -175.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 27.6 t-80 81.35 142.7 0.07 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.891 1.676 . . . . 5.33 111.102 -178.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 18.5 t70 78.02 8.41 2.42 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.182 1.393 . . . . 5.06 109.698 178.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 26.5 p-10 -121.98 138.8 54.29 Favored 'General case' 0 N--CA 1.414 -2.234 0 N-CA-C 107.068 -1.456 . . . . 2.9 107.068 176.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 11.8 m -87.06 51.07 2.14 Favored 'General case' 0 C--N 1.276 -2.628 0 CA-C-N 115.703 -0.68 . . . . 1.19 110.271 -174.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1517 ' ' GLN . . . . . 0.416 ' HA ' ' O ' ' A' 1527 ' ' PHE . 3.2 pt20 -162.98 132.05 4.09 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-O 121.23 0.538 . . . . 1.52 111.381 -174.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 6.6 m -135.46 144.79 33.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 CA-C-N 116.083 -0.508 . . . . 0.94 110.038 179.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1519 ' ' THR . . . . . . . . . . . . . 28.9 m -114.65 134.52 55.0 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.386 -0.598 . . . . 0.89 109.386 177.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1520 ' ' ASN . . . . . 0.529 ' OD1' HG22 ' A' 1523 ' ' THR . 13.9 t-20 -89.98 115.23 63.46 Favored Pre-proline 0 N--CA 1.43 -1.429 0 N-CA-C 108.322 -0.992 . . . . 1.74 108.322 175.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -66.54 -16.51 51.09 Favored 'Trans proline' 0 CA--C 1.533 0.439 0 C-N-CA 122.898 2.399 . . . . 1.58 113.514 -175.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1522 ' ' SER . . . . . 0.45 ' HB2' ' OD1' ' A' 1520 ' ' ASN . 15.9 m -71.8 -50.05 33.26 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 116.439 -0.346 . . . . 1.65 111.393 -179.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1523 ' ' THR . . . . . 0.529 HG22 ' OD1' ' A' 1520 ' ' ASN . 9.9 t -111.62 -1.86 15.61 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 120.479 -0.488 . . . . 1.61 111.524 -176.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 66.58 33.26 84.0 Favored Glycine 0 CA--C 1.501 -0.817 0 CA-C-N 115.737 -0.665 . . . . 1.13 112.41 177.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 55.5 t-80 -94.85 123.73 38.48 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 119.971 -0.692 . . . . 1.26 109.408 -178.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 2.0 tm? -93.71 111.52 23.22 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.101 -1.074 . . . . 0.68 108.101 179.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1527 ' ' PHE . . . . . 0.416 ' O ' ' HA ' ' A' 1517 ' ' GLN . 74.0 m-85 -94.0 115.32 27.65 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.92 -0.488 . . . . 0.65 110.217 176.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 20.5 t70 -104.78 113.3 26.8 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 109.188 -0.671 . . . . 1.17 109.188 176.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1529 ' ' LEU . . . . . 0.507 ' HG ' HD21 ' A' 1581 ' ' LEU . 3.0 mm? -102.31 2.33 36.76 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 108.727 -0.842 . . . . 0.6 108.727 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 2.1 m -66.98 -27.97 67.88 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.659 -0.7 . . . . 0.84 109.886 -177.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 27.7 t -69.85 -18.41 63.43 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.866 -0.606 . . . . 1.59 110.637 178.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1532 ' ' LEU . . . . . 0.491 ' O ' ' HB ' ' A' 1552 ' ' ILE . 74.8 mt -94.76 0.83 55.27 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.323 0.583 . . . . 0.65 110.192 -178.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1533 ' ' SER . . . . . . . . . . . . . 41.5 m -77.72 164.72 25.01 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 109.351 -0.611 . . . . 1.52 109.351 175.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -179.62 155.01 14.62 Favored Glycine 0 N--CA 1.421 -2.362 0 N-CA-C 108.386 -1.886 . . . . 1.1 108.386 178.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 58.0 ttp180 -86.49 -29.27 22.89 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 121.092 0.472 . . . . 4.62 110.852 -177.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -88.01 -29.42 20.73 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.445 0.641 . . . . 1.45 110.021 177.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 94.06 -155.77 22.06 Favored Glycine 0 N--CA 1.418 -2.514 0 CA-C-N 115.299 -0.864 . . . . 0.85 111.645 175.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -130.49 148.39 52.29 Favored 'General case' 0 C--N 1.278 -2.535 0 N-CA-C 107.546 -1.279 . . . . 0.93 107.546 177.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 7.3 p -109.15 132.73 53.84 Favored 'General case' 0 C--N 1.292 -1.913 0 O-C-N 123.677 0.611 . . . . 1.03 111.001 -176.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1540 ' ' ALA . . . . . 0.444 ' HB3' ' CG1' ' A' 1548 ' ' VAL . . . -125.65 144.34 50.64 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.9 -1.148 . . . . 0.5 107.9 175.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -77.35 132.04 38.38 Favored 'General case' 0 C--N 1.313 -1.008 0 O-C-N 123.556 0.535 . . . . 0.74 110.312 -177.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1542 ' ' TYR . . . . . 0.722 ' HE2' ' HG ' ' A' 1626 ' ' LEU . 9.3 t80 -136.76 -99.79 0.21 Allowed 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.326 -0.99 . . . . 0.99 108.326 -178.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1543 ' ' SER . . . . . 0.406 ' H ' ' HB3' ' A' 1542 ' ' TYR . 47.7 t -86.84 160.82 18.62 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-O 121.602 0.715 . . . . 1.91 109.726 -175.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -72.39 -18.52 61.72 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.637 -0.71 . . . . 3.59 110.724 -178.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 13.2 t -87.63 -41.07 13.67 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.156 0.503 . . . . 2.46 110.22 -178.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . -153.27 159.05 28.34 Favored Glycine 0 N--CA 1.431 -1.69 0 C-N-CA 120.708 -0.758 . . . . 1.26 112.021 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 33.7 m -94.59 -179.41 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 107.929 -1.137 . . . . 0.79 107.929 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1548 ' ' VAL . . . . . 0.444 ' CG1' ' HB3' ' A' 1540 ' ' ALA . 14.2 p -104.37 135.94 39.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 C-N-CA 119.716 -0.794 . . . . 0.58 109.561 177.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1549 ' ' TYR . . . . . 0.429 ' HB3' ' ND2' ' A' 1556 ' ' ASN . 86.1 m-85 -102.05 129.28 48.33 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 108.81 -0.811 . . . . 1.08 108.81 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 26.1 ptm -148.43 132.96 17.7 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 116.045 -0.525 . . . . 0.78 111.484 -178.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 6.8 p -118.89 126.47 51.87 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 115.775 -0.648 . . . . 0.97 110.041 178.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1552 ' ' ILE . . . . . 0.491 ' HB ' ' O ' ' A' 1532 ' ' LEU . 36.0 mm -77.6 112.46 15.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 112.362 0.505 . . . . 0.42 112.362 -177.174 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 46.3 t 62.12 32.12 17.54 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.398 1.079 . . . . 1.4 110.977 174.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . -163.96 174.28 40.08 Favored Glycine 0 N--CA 1.422 -2.281 0 N-CA-C 108.947 -1.661 . . . . 0.35 108.947 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -100.54 155.0 18.09 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 117.48 0.64 . . . . 1.62 110.761 -178.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1556 ' ' ASN . . . . . 0.429 ' ND2' ' HB3' ' A' 1549 ' ' TYR . 49.8 t-20 -108.4 132.74 53.45 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 115.05 -0.977 . . . . 0.87 109.236 -176.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -82.72 1.83 36.77 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.599 0.592 . . . . 2.49 112.599 -176.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -78.89 -19.95 50.63 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.326 0.584 . . . . 1.38 110.273 176.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1559 ' ' CYS . . . . . 0.645 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 76.1 m -132.71 172.42 7.41 Favored Pre-proline 0 C--N 1.299 -1.612 0 CA-C-O 117.795 -1.098 . . . . 1.21 109.871 -178.038 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1560 ' ' PRO . . . . . 0.645 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 18.1 Cg_exo -36.84 148.22 0.06 OUTLIER 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 124.296 3.33 . . . . 0.71 115.747 178.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -58.73 127.72 25.49 Favored 'Trans proline' 0 C--O 1.254 1.292 0 C-N-CA 123.626 2.884 . . . . 0.8 112.113 178.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 92.45 9.12 61.95 Favored Glycine 0 N--CA 1.438 -1.213 0 CA-C-N 115.942 -0.572 . . . . 0.46 112.124 -179.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1563 ' ' VAL . . . . . 0.567 ' HB ' ' O ' ' A' 1560 ' ' PRO . 2.8 t -96.09 124.55 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.339 0 CA-C-O 121.021 0.438 . . . . 0.98 111.231 179.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -101.73 -31.95 5.27 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 115.147 -0.933 . . . . 0.28 112.069 178.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -128.62 129.8 46.39 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 109.669 -0.493 . . . . 0.28 109.669 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 11.4 t -159.52 136.48 9.48 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 116.409 -0.36 . . . . 0.43 110.395 -176.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -89.71 149.89 22.56 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 121.991 -0.443 . . . . 1.03 110.763 177.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -89.05 20.81 30.9 Favored Glycine 0 N--CA 1.438 -1.227 0 CA-C-N 116.69 -0.232 . . . . 1.13 113.492 -177.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1569 ' ' GLN . . . . . 0.551 ' HG3' ' HD1' ' B' ' 19' ' ' PHE . 15.8 mm100 -68.22 -69.94 0.29 Allowed 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.579 -0.897 . . . . 2.58 108.579 173.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 6.0 p -130.09 28.49 5.02 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.28 0.562 . . . . 2.17 111.056 175.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 12.6 mmt85 60.56 48.1 7.81 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 115.157 -0.929 . . . . 2.62 110.808 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 40.2 mt -93.38 129.12 44.28 Favored 'Isoleucine or valine' 0 C--O 1.247 0.964 0 CA-C-N 115.392 -0.822 . . . . 0.92 110.039 179.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 29.0 t -80.74 148.95 29.88 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 123.605 0.762 . . . . 0.8 111.416 -178.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1574 ' ' VAL . . . . . . . . . . . . . 29.8 m -134.78 12.6 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 115.859 -0.609 . . . . 0.98 110.522 176.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 175.52 131.64 1.48 Allowed Glycine 0 N--CA 1.423 -2.214 0 C-N-CA 119.46 -1.352 . . . . 0.29 112.627 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1576 ' ' LYS . . . . . 0.415 ' HE3' ' HB2' ' A' 1576 ' ' LYS . 39.0 ttmt -74.79 147.69 41.01 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.759 -0.83 . . . . 2.19 108.759 177.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -73.93 79.26 1.65 Allowed 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 115.813 -0.63 . . . . 0.61 111.136 -178.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -89.77 146.65 24.32 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 115.657 -0.701 . . . . 1.95 110.393 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -111.15 45.96 1.13 Allowed 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.527 -1.286 . . . . 2.68 107.527 -176.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -101.42 76.78 1.72 Allowed 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 114.007 -1.451 . . . . 3.47 107.401 -176.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1581 ' ' LEU . . . . . 0.507 HD21 ' HG ' ' A' 1529 ' ' LEU . 0.4 OUTLIER -74.11 124.06 25.59 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.309 -1.367 . . . . 0.64 107.309 178.531 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -126.22 140.93 52.16 Favored 'General case' 0 C--N 1.288 -2.099 0 C-N-CA 119.92 -0.712 . . . . 2.85 111.617 177.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1583 ' ' TYR . . . . . 0.456 ' CE1' ' HA ' ' A' 1586 ' ' GLN . 72.4 t80 -108.43 123.24 48.56 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.044 -1.095 . . . . 0.86 108.044 178.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1584 ' ' VAL . . . . . 0.561 ' O ' ' HB ' ' A' 1587 ' ' VAL . 12.5 p -149.25 110.91 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-O 121.433 0.635 . . . . 1.05 111.044 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 30.7 t70 56.99 55.23 6.26 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 125.247 1.419 . . . . 1.17 111.257 -178.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1586 ' ' GLN . . . . . 0.456 ' HA ' ' CE1' ' A' 1583 ' ' TYR . 13.7 pt20 60.72 9.51 2.22 Favored 'General case' 0 N--CA 1.499 2.015 0 C-N-CA 126.864 2.066 . . . . 1.86 112.498 177.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1587 ' ' VAL . . . . . 0.561 ' HB ' ' O ' ' A' 1584 ' ' VAL . 20.5 t -102.08 127.88 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.327 0 CA-C-N 113.877 -1.51 . . . . 0.49 109.326 178.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1588 ' ' LEU . . . . . 0.943 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 2.4 mm? -92.34 117.48 29.95 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 106.605 -1.628 . . . . 0.36 106.605 178.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -119.88 133.32 55.62 Favored 'General case' 0 C--N 1.283 -2.302 0 CA-C-O 121.806 0.813 . . . . 1.74 111.86 -176.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 11.2 mt -121.25 112.21 18.34 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 106.807 -1.553 . . . . 0.72 106.807 173.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 6.1 p -101.39 125.36 55.42 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.33 0 C-N-CA 119.92 -0.712 . . . . 1.01 109.683 -178.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1592 ' ' TYR . . . . . 0.647 ' HB2' ' HB2' ' A' 1608 ' ' SER . 14.1 m-30 -107.23 136.45 47.04 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 108.345 -0.983 . . . . 0.5 108.345 178.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 13.2 ptmm? -150.47 177.41 10.03 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 108.192 -1.04 . . . . 1.59 108.192 -172.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 28.4 m-20 59.56 63.93 1.43 Allowed 'General case' 0 C--N 1.317 -0.835 0 O-C-N 124.591 1.182 . . . . 1.11 111.163 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -112.81 -126.13 4.52 Favored Glycine 0 N--CA 1.424 -2.103 0 N-CA-C 109.877 -1.289 . . . . 0.78 109.877 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1596 ' ' SER . . . . . 0.427 ' HA ' ' HD3' ' A' 1597 ' ' PRO . 49.7 m -87.4 140.51 32.07 Favored Pre-proline 0 C--N 1.295 -1.765 0 N-CA-C 109.311 -0.626 . . . . 1.07 109.311 177.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1597 ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' 1596 ' ' SER . 38.2 Cg_exo -62.51 119.95 7.27 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 122.293 1.995 . . . . 1.01 108.275 173.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1598 ' ' CYS . . . . . 0.481 ' HA ' ' HD3' ' A' 1599 ' ' PRO . 37.8 t -77.33 128.2 81.06 Favored Pre-proline 0 C--N 1.294 -1.825 0 CA-C-N 115.728 -0.669 . . . . 0.75 109.612 -173.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1599 ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' 1598 ' ' CYS . 16.9 Cg_exo -68.35 -28.46 33.05 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.46 2.773 . . . . 1.7 112.639 -176.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1600 ' ' SER . . . . . . . . . . . . . 2.0 m -59.94 -42.55 94.27 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 123.748 0.819 . . . . 2.26 111.935 -178.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1601 ' ' LYS . . . . . 0.543 ' HB3' HD22 ' A' 1604 ' ' LEU . 3.8 tppp? -131.54 105.21 7.41 Favored 'General case' 0 N--CA 1.407 -2.613 0 N-CA-C 107.207 -1.405 . . . . 3.01 107.207 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 36.8 p -51.76 121.75 7.07 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 123.531 0.52 . . . . 2.07 111.972 179.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 92.44 11.41 59.58 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.93 -0.652 . . . . 1.08 112.369 178.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1604 ' ' LEU . . . . . 0.543 HD22 ' HB3' ' A' 1601 ' ' LYS . 9.4 tp -109.56 160.25 16.41 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.913 -1.143 . . . . 1.84 107.913 179.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 29.5 t -123.51 157.48 33.48 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 109.073 -0.714 . . . . 1.41 109.073 177.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1606 ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -71.97 153.5 41.77 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 108.118 -1.067 . . . . 0.6 108.118 172.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.42 126.4 7.72 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.216 0.531 . . . . 1.45 110.533 -175.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1608 ' ' SER . . . . . 0.647 ' HB2' ' HB2' ' A' 1592 ' ' TYR . 16.4 m -105.07 128.58 53.41 Favored 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 115.323 -0.853 . . . . 1.15 109.129 -175.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 34.4 t -111.22 101.74 12.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 CA-C-O 121.268 0.556 . . . . 0.25 109.795 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1610 ' ' ILE . . . . . 0.43 ' HA ' ' HB2' ' A' 1638 ' ' PHE . 96.8 mt -91.62 117.57 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.608 0 N-CA-C 108.84 -0.8 . . . . 0.45 108.84 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 32.7 m -120.38 116.72 26.04 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.69 -0.686 . . . . 1.26 110.902 -178.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1612 ' ' PHE . . . . . 0.943 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 70.7 m-85 -90.41 122.69 33.5 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.787 -0.642 . . . . 0.26 109.386 177.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 43.7 t -113.39 140.89 31.25 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 CA-C-N 115.306 -0.861 . . . . 0.5 109.308 -176.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 35.3 t -71.91 111.23 6.98 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.162 -0.472 . . . . 0.77 111.308 -178.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1615 ' ' ARG . . . . . 0.728 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 19.8 tpt180 -124.92 87.39 55.32 Favored Pre-proline 0 CA--C 1.54 0.585 0 N-CA-C 109.331 -0.618 . . . . 2.53 109.331 174.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1616 ' ' PRO . . . . . 0.459 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 39.3 Cg_exo -62.8 -35.06 70.41 Favored 'Trans proline' 0 N--CA 1.483 0.855 0 C-N-CA 123.128 2.552 . . . . 1.1 114.365 -173.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -79.09 -13.24 59.87 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 112.491 0.552 . . . . 3.05 112.491 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . 66.57 -168.12 0.21 Allowed 'General case' 0 C--N 1.318 -0.775 0 O-C-N 124.507 1.13 . . . . 1.55 109.266 -174.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . 148.42 -163.39 28.96 Favored Glycine 0 N--CA 1.413 -2.835 0 N-CA-C 110.394 -1.082 . . . . 0.93 110.394 179.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -82.65 21.42 1.0 Allowed 'Trans proline' 0 C--N 1.327 -0.574 0 C-N-CA 123.755 2.97 . . . . 0.88 111.971 -176.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1621 ' ' THR . . . . . 0.633 ' HB ' ' HB2' ' A' 1641 ' ' HIS . 18.6 p -108.08 -0.5 21.13 Favored 'General case' 0 C--N 1.282 -2.353 0 CA-C-N 113.933 -1.485 . . . . 0.97 109.899 -178.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -88.46 56.85 3.96 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 122.332 1.063 . . . . 0.72 109.258 -177.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1623 ' ' ARG . . . . . 0.563 ' O ' ' HG3' ' A' 1625 ' ' MET . 27.4 ptt180 -165.96 141.09 3.93 Favored Pre-proline 0 C--N 1.29 -1.996 0 N-CA-C 106.449 -1.685 . . . . 3.26 106.449 -178.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -53.81 104.55 0.11 Allowed 'Trans proline' 0 CA--C 1.534 0.49 0 C-N-CA 123.187 2.591 . . . . 0.59 111.901 -178.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1625 ' ' MET . . . . . 0.563 ' HG3' ' O ' ' A' 1623 ' ' ARG . 92.1 mtp -98.3 110.2 22.83 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.335 -0.987 . . . . 1.37 108.335 -176.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1626 ' ' LEU . . . . . 0.722 ' HG ' ' HE2' ' A' 1542 ' ' TYR . 0.7 OUTLIER -72.92 112.87 9.35 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 106.756 -1.572 . . . . 0.89 106.756 179.615 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A 1627 ' ' ILE . . . . . 0.573 HD11 ' HB2' ' A' 1639 ' ' SER . 31.0 mm -73.14 -57.54 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 N-CA-C 108.993 -0.743 . . . . 0.58 108.993 -178.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 49.9 m -163.99 152.39 13.19 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.598 -0.728 . . . . 1.39 109.416 -174.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1629 ' ' LEU . . . . . 0.952 HD13 ' HG ' ' A' 1636 ' ' LEU . 23.0 tp -117.35 100.71 7.86 Favored 'General case' 0 N--CA 1.426 -1.659 0 N-CA-C 107.345 -1.354 . . . . 1.25 107.345 171.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 20.6 t70 -74.23 114.23 12.34 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.47 -0.937 . . . . 1.09 108.47 178.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1631 ' ' LYS . . . . . 0.565 ' HB3' HD23 ' B' ' 53' ' ' LEU . 65.2 mttp -66.66 -20.78 66.06 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 113.759 1.022 . . . . 3.6 113.759 -175.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -88.66 -42.18 12.15 Favored 'General case' 0 CA--C 1.495 -1.143 0 CA-C-O 121.506 0.67 . . . . 2.6 111.311 -175.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 73.3 p -93.12 -8.2 43.32 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-N 115.34 -0.846 . . . . 0.75 110.792 -177.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1634 ' ' CYS . . . . . 0.494 ' SG ' HD23 ' A' 1604 ' ' LEU . 39.4 m 57.94 33.07 22.79 Favored 'General case' 0 C--N 1.361 1.084 0 C-N-CA 124.753 1.221 . . . . 0.53 110.908 175.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1635 ' ' THR . . . . . . . . . . . . . 64.3 m -104.89 130.76 52.98 Favored 'General case' 0 N--CA 1.425 -1.703 0 CA-C-N 114.219 -1.355 . . . . 0.46 109.313 -177.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1636 ' ' LEU . . . . . 0.952 ' HG ' HD13 ' A' 1629 ' ' LEU . 0.6 OUTLIER -111.43 126.47 54.98 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 106.522 -1.659 . . . . 0.86 106.522 -178.736 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A 1637 ' ' PHE . . . . . 0.508 ' HB2' ' HB ' ' A' 1627 ' ' ILE . 87.8 m-85 -102.09 138.83 38.52 Favored 'General case' 0 C--N 1.293 -1.879 0 C-N-CA 120.915 -0.314 . . . . 0.45 110.315 -178.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1638 ' ' PHE . . . . . 0.461 ' HE1' ' HB3' ' A' 1608 ' ' SER . 96.0 m-85 -131.57 134.49 46.12 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 108.671 -0.862 . . . . 0.5 108.671 -177.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1639 ' ' SER . . . . . 0.573 ' HB2' HD11 ' A' 1627 ' ' ILE . 22.6 t -116.85 152.36 34.61 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 107.542 -1.281 . . . . 1.04 107.542 175.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 2.9 t90 -153.35 109.79 3.37 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 104.535 -2.394 . . . . 0.68 104.535 178.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1641 ' ' HIS . . . . . 0.728 ' HB3' ' HB2' ' A' 1615 ' ' ARG . 33.3 m-70 -102.04 109.27 20.94 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 109.006 -0.738 . . . . 0.9 109.006 -176.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1642 ' ' THR . . . . . . . . . . . . . 3.9 t -138.05 148.93 62.14 Favored Pre-proline 0 C--N 1.302 -1.482 0 CA-C-N 115.948 -0.569 . . . . 0.48 109.768 -174.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1643 ' ' PRO . . . . . 0.478 ' HA ' ' SG ' ' A' 1646 ' ' CYS . 53.3 Cg_endo -78.97 -3.21 13.04 Favored 'Trans proline' 0 C--N 1.368 1.564 0 C-N-CA 122.034 1.823 . . . . 0.66 111.956 175.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 5.8 tp -63.96 -30.84 71.89 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.919 0.866 . . . . 0.97 108.756 176.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -89.78 13.09 15.25 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.307 -1.315 . . . . 0.84 110.455 -179.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1646 ' ' CYS . . . . . 0.478 ' SG ' ' HA ' ' A' 1643 ' ' PRO . 62.7 m -121.43 154.72 36.17 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 109.724 -0.472 . . . . 1.19 109.724 -179.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -91.53 123.1 64.7 Favored Pre-proline 0 C--N 1.297 -1.711 0 N-CA-C 105.031 -2.211 . . . . 3.14 105.031 168.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1648 ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -62.4 117.3 4.16 Favored 'Trans proline' 0 C--O 1.238 0.512 0 C-N-CA 122.783 2.322 . . . . 2.58 112.893 -174.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 . . . . . 0 C--N 1.316 -0.877 0 N-CA-C 108.692 -0.855 . . . . 4.72 108.692 -179.522 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.987 0 CA-C-O 121.642 0.734 . . . . 9.97 109.958 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -94.32 138.62 32.08 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 107.876 -1.157 . . . . 7.68 107.876 179.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 15.5 ptt180 -111.27 121.82 39.38 Favored Pre-proline 0 C--N 1.291 -1.975 0 N-CA-C 109.424 -0.584 . . . . 6.11 109.424 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -62.63 -27.01 75.86 Favored 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 122.868 2.378 . . . . 4.84 113.642 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 29.3 m -105.9 106.36 16.83 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 107.779 -1.193 . . . . 4.6 107.779 175.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -102.17 23.25 11.91 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.721 0.772 . . . . 4.23 109.666 -177.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 20.8 p -122.59 98.74 6.05 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-N 114.441 -1.254 . . . . 3.14 109.891 174.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.562 ' HG ' ' OE1' ' B' ' 12' ' ' GLU . 84.4 mt -69.0 132.64 46.98 Favored 'General case' 0 C--O 1.251 1.168 0 N-CA-C 109.09 -0.707 . . . . 3.96 109.09 174.374 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 11.8 m -80.54 71.9 7.41 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 121.714 0.768 . . . . 2.84 109.95 -176.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . 0.437 ' H ' ' HB2' ' B' ' 13' ' ' LEU . . . 151.19 -74.24 0.26 Allowed Glycine 0 N--CA 1.423 -2.182 0 CA-C-N 114.448 -1.251 . . . . 2.09 110.407 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' B' ' 15' ' ' ASP . . . -57.01 -56.82 23.0 Favored Glycine 0 CA--C 1.511 -0.217 0 CA-C-N 115.415 -0.393 . . . . 1.84 113.863 -176.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . 0.562 ' OE1' ' HG ' ' B' ' 8' ' ' LEU . 39.3 mt-10 -84.2 -14.94 48.73 Favored 'General case' 0 CA--C 1.489 -1.378 0 CA-C-N 117.259 0.53 . . . . 2.55 110.475 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . 0.437 ' HB2' ' H ' ' B' ' 10' ' ' GLY . 0.1 OUTLIER -65.57 -53.22 45.02 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 107.139 -1.43 . . . . 2.35 107.139 179.467 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 22.2 m -74.55 -22.88 17.76 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 C-N-CA 119.672 -0.811 . . . . 2.11 110.098 178.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 15' ' ' ASP . . . . . 0.496 ' CB ' ' HA ' ' B' ' 12' ' ' GLU . 15.7 t70 -64.41 -51.22 64.31 Favored 'General case' 0 C--O 1.217 -0.653 0 CA-C-N 116.008 -0.542 . . . . 2.04 110.939 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 22.6 p -65.82 -46.46 78.53 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.392 0.677 . . . . 1.84 111.004 178.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.491 HD21 HD11 ' B' ' 42' ' ' ILE . 3.6 mm? -48.99 -49.82 38.89 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.904 0.882 . . . . 1.74 111.887 171.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -79.58 -15.64 57.3 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.279 -0.873 . . . . 2.39 110.992 -179.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 19' ' ' PHE . . . . . 0.551 ' HD1' ' HG3' ' A' 1569 ' ' GLN . 88.0 t80 -64.42 -55.96 17.43 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 116.219 -0.446 . . . . 0.96 110.65 178.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 8.4 p -95.58 -26.56 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.357 0 C-N-CA 119.024 -1.071 . . . . 1.37 111.547 -177.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 89.2 m -116.36 18.72 15.11 Favored 'General case' 0 C--O 1.212 -0.869 0 N-CA-C 113.229 0.826 . . . . 1.66 113.229 -177.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -54.87 -37.59 62.6 Favored Glycine 0 N--CA 1.472 1.05 0 N-CA-C 114.813 0.685 . . . . 1.53 114.813 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -69.0 -27.2 65.48 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 123.08 0.552 . . . . 2.72 111.176 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 16.3 tpp180 -91.68 -44.72 8.85 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.038 0.447 . . . . 4.33 110.328 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . 0.424 ' O ' ' HB2' ' B' ' 61' ' ' ALA . . . 129.38 177.1 14.7 Favored Glycine 0 N--CA 1.436 -1.352 0 N-CA-C 109.359 -1.496 . . . . 1.53 109.359 -179.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -137.92 122.36 18.36 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 117.91 0.855 . . . . 1.65 110.394 175.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -133.32 80.88 1.9 Allowed 'General case' 0 C--O 1.21 -1.003 0 N-CA-C 113.359 0.874 . . . . 3.42 113.359 -175.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 28' ' ' PHE . . . . . 0.525 ' O ' ' HA ' ' B' ' 40' ' ' ARG . 32.8 p90 -101.49 -4.66 26.38 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.931 -0.707 . . . . 2.26 109.733 169.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 5.4 m -92.03 89.11 6.82 Favored 'General case' 0 N--CA 1.422 -1.829 0 N-CA-C 106.662 -1.607 . . . . 3.68 106.662 175.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 78.6 mtt-85 -118.57 162.14 32.1 Favored Pre-proline 0 C--N 1.297 -1.707 0 N-CA-C 109.375 -0.602 . . . . 3.81 109.375 -174.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_exo -61.17 -51.65 4.26 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 N-CA-C 109.012 -1.188 . . . . 4.02 109.012 173.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -157.2 169.58 24.44 Favored 'General case' 0 N--CA 1.415 -2.189 0 N-CA-C 108.065 -1.087 . . . . 4.92 108.065 176.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . 0.682 ' HB3' ' HB2' ' B' ' 36' ' ' SER . 13.7 t 179.66 161.05 0.84 Allowed 'General case' 0 N--CA 1.397 -3.114 0 N-CA-C 104.243 -2.503 . . . . 6.72 104.243 -179.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 34.5 ttm180 -90.78 -0.73 57.8 Favored 'General case' 0 C--N 1.271 -2.819 0 N-CA-C 107.819 -1.178 . . . . 11.63 107.819 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 24.5 t -113.8 -9.97 12.18 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 107.568 -1.271 . . . . 9.61 107.568 175.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . 0.682 ' HB2' ' HB3' ' B' ' 33' ' ' SER . 21.5 m -145.42 62.1 1.28 Allowed 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 122.25 1.024 . . . . 6.71 109.306 -177.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -79.2 -5.72 54.91 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.705 -1.134 . . . . 10.0 112.653 -178.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 32.5 tpt180 -111.25 32.03 5.64 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 107.075 -1.454 . . . . 7.94 107.075 176.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 22.6 t 71.27 -50.3 0.69 Allowed 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.774 1.63 . . . . 5.76 110.747 -176.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . 0.525 ' HA ' ' O ' ' B' ' 28' ' ' PHE . 70.9 mtm180 -99.49 140.81 33.13 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 108.767 -0.827 . . . . 6.03 108.767 178.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . 0.401 ' C ' ' H ' ' B' ' 43' ' ' VAL . . . -118.52 163.24 13.1 Favored Glycine 0 N--CA 1.429 -1.777 0 N-CA-C 109.423 -1.471 . . . . 2.37 109.423 177.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . 0.491 HD11 HD21 ' B' ' 17' ' ' LEU 0.258 13.3 pt 61.61 -21.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 C-N-CA 127.663 2.385 . . . . 2.07 115.295 178.471 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.633 ' O ' ' HB2' ' B' ' 47' ' ' CYS . 2.3 p -49.78 -47.12 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.775 0 N-CA-C 113.23 0.826 . . . . 2.24 113.23 178.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -86.9 -30.95 21.0 Favored 'General case' 0 N--CA 1.427 -1.624 0 N-CA-C 109.228 -0.656 . . . . 3.36 109.228 -177.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -66.16 -23.03 66.4 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.499 -0.773 . . . . 3.08 112.027 -179.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 46' ' ' CYS . . . . . . . . . . . . . 63.7 m -114.34 2.07 14.63 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.967 0.413 . . . . 2.23 111.05 175.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 47' ' ' CYS . . . . . 0.633 ' HB2' ' O ' ' B' ' 43' ' ' VAL . 36.4 t -82.07 -50.45 9.07 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.561 0.696 . . . . 2.37 110.377 -179.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -116.16 15.75 15.98 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.408 0.623 . . . . 2.82 110.322 -176.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 22.2 mmm180 -146.64 152.74 39.37 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.065 -1.087 . . . . 4.09 108.065 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 7.3 p -94.37 131.06 40.42 Favored 'General case' 0 C--N 1.282 -2.355 0 N-CA-C 108.661 -0.866 . . . . 2.67 108.661 174.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 13.4 p -118.62 140.05 50.52 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 109.07 -0.715 . . . . 2.11 109.07 -173.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -61.71 147.03 47.41 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 107.858 -1.164 . . . . 2.67 107.858 177.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . 0.565 HD23 ' HB3' ' A' 1631 ' ' LYS . 14.8 tp -71.08 -16.79 62.6 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.103 -1.073 . . . . 1.9 108.103 -178.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . 0.412 ' O ' ' HB3' ' B' ' 57' ' ' GLU . . . -60.11 -27.19 66.82 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 114.522 -1.217 . . . . 1.52 110.702 174.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 10.5 tp -60.49 -60.75 3.31 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 115.827 -0.624 . . . . 1.97 110.392 177.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.12 -17.43 61.98 Favored 'General case' 0 C--O 1.214 -0.806 0 CA-C-N 115.827 -0.624 . . . . 1.53 111.683 -175.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . 0.412 ' HB3' ' O ' ' B' ' 54' ' ' ALA . 9.1 tp10 -60.49 -56.72 17.97 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 109.026 -0.731 . . . . 2.27 109.026 172.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 9.0 t -80.5 -14.69 58.04 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 115.993 -0.548 . . . . 2.33 112.268 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -82.73 -60.19 2.26 Favored 'General case' 0 N--CA 1.427 -1.61 0 N-CA-C 107.824 -1.176 . . . . 2.86 107.824 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 33.6 t 56.67 -77.78 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 126.908 2.083 . . . . 2.3 113.482 176.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 61' ' ' ALA . . . . . 0.424 ' HB2' ' O ' ' B' ' 25' ' ' GLY . . . -165.86 -56.42 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 104.519 -2.4 . . . . 3.19 104.519 -174.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 4.3 p -113.68 148.98 40.96 Favored Pre-proline 0 N--CA 1.395 -3.205 0 CA-C-N 112.412 -2.176 . . . . 3.68 106.338 173.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -82.51 12.7 2.79 Favored 'Trans proline' 0 N--CA 1.484 0.914 0 C-N-CA 123.502 2.801 . . . . 5.08 112.63 -174.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 69.3 54.51 0.42 Allowed 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 113.625 -1.625 . . . . 5.1 108.54 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 51.9 tttp 72.24 134.82 0.04 OUTLIER 'General case' 0 N--CA 1.434 -1.237 0 C-N-CA 126.961 2.104 . . . . 8.51 110.805 -177.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 17.9 t -126.26 57.16 1.41 Allowed 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.193 -1.41 . . . . 8.12 107.193 -179.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 . . . . . 0 C--O 1.247 0.969 0 CA-C-N 114.491 -1.231 . . . . 10.21 111.018 -176.837 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 60.9 mtm . . . . . 0 CA--C 1.517 -0.304 0 N-CA-C 108.962 -0.755 . . . . 9.34 108.962 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A 1509 ' ' LYS . . . . . 0.767 ' HD2' ' HB3' ' A' 1512 ' ' GLU . 33.1 ttmt -128.85 148.57 50.9 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 108.834 -0.802 . . . . 9.04 108.834 -177.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 15.4 m -95.71 126.81 41.24 Favored 'General case' 0 N--CA 1.423 -1.782 0 N-CA-C 110.336 -0.246 . . . . 5.81 110.336 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1511 ' ' ASN . . . . . . . . . . . . . 4.6 m-20 49.52 69.27 0.61 Allowed 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 115.121 1.526 . . . . 3.42 115.121 174.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1512 ' ' GLU . . . . . 0.767 ' HB3' ' HD2' ' A' 1509 ' ' LYS . 4.0 pt-20 -108.97 167.92 9.74 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 119.554 -0.858 . . . . 5.95 110.863 176.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 10.4 t-80 53.67 53.69 11.08 Favored 'General case' 0 CA--C 1.51 -0.595 0 C-N-CA 125.745 1.618 . . . . 5.33 110.242 176.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 36.2 t70 -63.98 70.09 0.02 OUTLIER 'General case' 0 C--N 1.291 -1.955 0 CA-C-N 113.063 -1.88 . . . . 5.06 110.787 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1515 ' ' ASP . . . . . 0.493 ' HA ' ' HD2' ' A' 1579 ' ' LYS . 9.8 t70 -134.47 70.52 1.45 Allowed 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 106.801 -1.555 . . . . 2.9 106.801 179.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1516 ' ' CYS . . . . . 0.567 ' O ' ' HB2' ' A' 1529 ' ' LEU . 16.7 m 63.16 33.9 14.0 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 115.128 -0.942 . . . . 1.19 110.387 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -166.66 162.76 16.58 Favored 'General case' 0 CA--C 1.479 -1.76 0 N-CA-C 107.813 -1.181 . . . . 1.52 107.813 -177.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1518 ' ' VAL . . . . . 0.424 HG11 HD12 ' A' 1581 ' ' LEU . 9.8 p -162.0 147.23 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.945 0 O-C-N 123.68 0.613 . . . . 0.94 109.535 -174.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1519 ' ' THR . . . . . . . . . . . . . 25.0 m -115.86 124.96 51.98 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 109.295 -0.632 . . . . 0.89 109.295 177.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1520 ' ' ASN . . . . . 0.422 ' OD1' HG22 ' A' 1523 ' ' THR . 24.2 t-20 -86.95 122.41 71.27 Favored Pre-proline 0 N--CA 1.439 -0.979 0 O-C-N 123.427 0.454 . . . . 1.74 109.922 177.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.72 -19.9 53.09 Favored 'Trans proline' 0 CA--C 1.533 0.466 0 C-N-CA 123.218 2.612 . . . . 1.58 114.541 -175.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 50.7 m -76.7 -39.94 50.4 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 112.157 0.429 . . . . 1.65 112.157 -177.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1523 ' ' THR . . . . . 0.693 HG21 ' HG3' ' A' 1647 ' ' GLU . 5.0 t -114.31 -6.48 12.96 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.813 0.816 . . . . 1.61 111.43 -178.076 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 64.54 30.49 78.03 Favored Glycine 0 CA--C 1.499 -0.913 0 CA-C-N 115.368 -0.833 . . . . 1.13 112.28 177.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 35.7 t-80 -98.26 125.28 43.28 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 109.644 -0.502 . . . . 1.26 109.644 -175.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 1.7 tm? -90.88 109.15 20.36 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 108.323 -0.992 . . . . 0.68 108.323 177.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -85.69 114.53 22.74 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 110.067 -0.345 . . . . 0.65 110.067 176.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 25.5 t70 -99.46 107.74 20.02 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 109.23 -0.656 . . . . 1.17 109.23 177.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1529 ' ' LEU . . . . . 0.567 ' HB2' ' O ' ' A' 1516 ' ' CYS . 3.4 mm? -90.11 -0.13 57.45 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.718 0.771 . . . . 0.6 109.363 -178.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.24 -26.54 63.89 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.077 -0.965 . . . . 0.84 108.771 178.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 40.5 t -60.38 -26.82 66.94 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.927 0.891 . . . . 1.59 109.848 174.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 51.3 mt -98.38 0.51 45.54 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.557 -0.747 . . . . 0.65 110.984 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1533 ' ' SER . . . . . . . . . . . . . 33.6 t -72.31 174.75 6.87 Favored 'General case' 0 C--O 1.245 0.825 0 CA-C-O 121.635 0.731 . . . . 1.52 111.329 -177.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . 179.81 145.17 6.26 Favored Glycine 0 N--CA 1.425 -2.046 0 N-CA-C 109.218 -1.553 . . . . 1.1 109.218 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 -74.3 -43.36 57.09 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 120.695 0.284 . . . . 4.62 111.585 -177.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -84.14 -38.84 20.2 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.465 0.65 . . . . 1.45 109.288 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 105.19 -138.77 14.39 Favored Glycine 0 N--CA 1.409 -3.143 0 CA-C-N 115.134 -0.939 . . . . 0.85 111.476 177.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -140.33 154.14 46.66 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 107.619 -1.252 . . . . 0.93 107.619 -177.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1539 ' ' THR . . . . . 0.456 HG22 ' HB ' ' A' 1547 ' ' VAL . 1.3 m -121.31 124.99 45.92 Favored 'General case' 0 N--CA 1.426 -1.646 0 N-CA-C 108.68 -0.859 . . . . 1.03 108.68 -178.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -119.75 140.18 51.12 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 115.815 -0.629 . . . . 0.5 109.559 -177.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -82.57 113.42 20.27 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.605 -0.725 . . . . 0.74 110.509 -179.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1542 ' ' TYR . . . . . 0.569 ' CE2' ' HG ' ' A' 1626 ' ' LEU . 0.3 OUTLIER -104.36 -101.07 0.31 Allowed 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 106.019 -1.845 . . . . 0.99 106.019 177.613 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A 1543 ' ' SER . . . . . 0.441 ' H ' ' HB3' ' A' 1542 ' ' TYR . 2.1 m -68.57 168.69 12.44 Favored 'General case' 0 N--CA 1.425 -1.721 0 C-N-CA 124.137 0.975 . . . . 1.91 110.744 178.036 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 59.6 tttp -60.12 -41.49 92.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 118.694 0.679 . . . . 3.59 112.261 -176.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 33.5 t -116.78 20.68 13.83 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 109.567 -0.531 . . . . 2.46 109.567 -177.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . -131.73 104.22 0.56 Allowed Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 120.646 -0.788 . . . . 1.26 113.231 -175.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1547 ' ' VAL . . . . . 0.456 ' HB ' HG22 ' A' 1539 ' ' THR . 28.0 m -96.84 151.1 4.2 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-O 121.176 0.512 . . . . 0.79 110.109 175.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 14.2 p -105.2 138.49 29.91 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 CA-C-N 115.913 -0.585 . . . . 0.58 109.528 178.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -105.71 128.34 53.62 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 123.492 0.717 . . . . 1.08 109.678 176.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 23.5 ptm -141.8 119.46 11.75 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 115.331 -0.85 . . . . 0.78 110.695 -177.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 11.4 p -103.67 119.58 39.2 Favored 'General case' 0 C--N 1.276 -2.609 0 CA-C-N 114.883 -1.053 . . . . 0.97 110.184 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1552 ' ' ILE . . . . . 0.748 HG13 ' HZ3' ' A' 1640 ' ' TRP . 39.4 mm -83.22 119.44 32.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 108.999 -0.741 . . . . 0.42 108.999 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 28.2 t 62.02 46.39 6.55 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-O 122.053 0.93 . . . . 1.4 110.544 177.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 175.93 178.01 45.4 Favored Glycine 0 N--CA 1.407 -3.238 0 N-CA-C 109.431 -1.467 . . . . 0.35 109.431 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -106.11 154.9 20.01 Favored 'General case' 0 C--N 1.285 -2.236 0 CA-C-O 121.046 0.451 . . . . 1.62 110.415 -178.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -93.21 138.11 31.92 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 108.283 -1.006 . . . . 0.87 108.283 178.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -99.98 0.57 41.32 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 114.889 1.44 . . . . 2.49 114.889 -169.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 9.6 p30 -105.01 5.26 32.46 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 122.273 1.035 . . . . 1.38 110.134 178.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1559 ' ' CYS . . . . . 0.602 ' SG ' ' HD2' ' A' 1560 ' ' PRO . 34.5 t -132.15 152.99 81.15 Favored Pre-proline 0 C--N 1.288 -2.068 0 N-CA-C 106.211 -1.774 . . . . 1.21 106.211 178.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1560 ' ' PRO . . . . . 0.602 ' HD2' ' SG ' ' A' 1559 ' ' CYS . 49.6 Cg_exo -28.34 121.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.379 2.176 1 C-N-CA 125.575 4.184 . . . . 0.71 115.211 179.154 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A 1561 ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' 1560 ' ' PRO . 6.0 Cg_endo -44.72 130.2 9.63 Favored 'Trans proline' 0 C--N 1.357 1.01 0 C-N-CA 125.075 3.85 . . . . 0.8 114.126 -176.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 98.64 -2.15 58.64 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.974 -0.557 . . . . 0.46 113.753 178.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1563 ' ' VAL . . . . . 0.411 HG21 ' HA ' ' A' 1573 ' ' SER . 8.7 p -93.8 140.38 16.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 O-C-N 121.93 -0.747 . . . . 0.98 110.637 -177.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -102.34 -30.56 5.59 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 121.213 -0.518 . . . . 0.28 112.869 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -124.32 127.89 48.3 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 109.403 -0.591 . . . . 0.28 109.403 178.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1566 ' ' CYS . . . . . 0.425 ' SG ' ' HA ' ' A' 1571 ' ' ARG . 43.5 t -155.04 142.75 19.85 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 110.254 -0.276 . . . . 0.43 110.254 -178.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1567 ' ' PHE . . . . . 0.527 ' CE2' HG11 ' A' 1574 ' ' VAL . 54.9 m-85 -85.6 130.53 34.55 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 107.796 -1.187 . . . . 1.03 107.796 172.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -61.14 -31.16 75.82 Favored Glycine 0 C--N 1.35 1.314 0 N-CA-C 114.545 0.578 . . . . 1.13 114.545 -171.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1569 ' ' GLN . . . . . 0.467 ' HB3' ' OD2' ' B' ' 15' ' ' ASP . 11.3 mm100 -69.54 -54.56 13.54 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.594 0.711 . . . . 2.58 111.986 177.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1570 ' ' THR . . . . . 0.602 ' HB ' HG13 ' A' 1572 ' ' ILE . 58.3 p -81.47 -29.11 33.85 Favored 'General case' 0 N--CA 1.421 -1.878 0 N-CA-C 114.382 1.253 . . . . 2.17 114.382 -167.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1571 ' ' ARG . . . . . 0.425 ' HA ' ' SG ' ' A' 1566 ' ' CYS . 3.1 mpt_? 59.35 28.94 18.42 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.189 0.519 . . . . 2.62 110.691 -172.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1572 ' ' ILE . . . . . 0.602 HG13 ' HB ' ' A' 1570 ' ' THR . 19.2 mt -94.58 129.15 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.832 0 N-CA-C 107.89 -1.152 . . . . 0.92 107.89 177.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1573 ' ' SER . . . . . 0.411 ' HA ' HG21 ' A' 1563 ' ' VAL . 15.1 t -69.27 113.8 6.94 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.327 -0.851 . . . . 0.8 109.68 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1574 ' ' VAL . . . . . 0.758 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 19.7 m -110.38 17.92 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 CA-C-O 121.893 0.854 . . . . 0.98 110.8 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 161.46 115.64 0.37 Allowed Glycine 0 N--CA 1.427 -1.957 0 CA-C-N 114.779 -1.1 . . . . 0.29 111.042 177.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -73.66 146.39 44.57 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.881 -0.785 . . . . 2.19 108.881 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -71.36 90.52 0.95 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.028 0.442 . . . . 0.61 111.585 -178.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -103.37 170.24 8.07 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.08 -1.081 . . . . 1.95 108.08 175.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1579 ' ' LYS . . . . . 0.493 ' HD2' ' HA ' ' A' 1515 ' ' ASP . 15.4 pttm -130.11 40.46 3.54 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.755 0.788 . . . . 2.68 110.698 -178.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 75.0 ttt180 -89.82 100.49 13.29 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 113.561 -1.654 . . . . 3.47 107.933 -174.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1581 ' ' LEU . . . . . 0.445 HD21 ' HG ' ' A' 1529 ' ' LEU . 0.2 OUTLIER -101.76 126.55 48.64 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.713 -0.676 . . . . 0.64 109.425 -174.806 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -125.2 138.95 54.12 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 120.532 -0.467 . . . . 2.85 110.914 176.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1583 ' ' TYR . . . . . 0.447 ' CE1' ' HA ' ' A' 1586 ' ' GLN . 88.3 t80 -106.25 108.41 19.91 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.724 -0.843 . . . . 0.86 108.724 178.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1584 ' ' VAL . . . . . 0.616 ' O ' ' HB ' ' A' 1587 ' ' VAL . 14.2 m -126.98 93.49 2.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 CA-C-O 121.48 0.657 . . . . 1.05 112.108 -178.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 36.6 t70 57.89 64.37 1.55 Allowed 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.853 0.861 . . . . 1.17 110.691 179.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1586 ' ' GLN . . . . . 0.447 ' HA ' ' CE1' ' A' 1583 ' ' TYR 0.272 4.5 pt20 58.72 20.55 7.95 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 126.45 1.9 . . . . 1.86 112.384 178.527 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A 1587 ' ' VAL . . . . . 0.616 ' HB ' ' O ' ' A' 1584 ' ' VAL . 22.5 t -107.24 120.26 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.493 0 CA-C-N 114.038 -1.437 . . . . 0.49 107.751 174.11 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1588 ' ' LEU . . . . . 0.865 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 3.3 mm? -95.62 109.03 21.34 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 105.824 -1.917 . . . . 0.36 105.824 176.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -111.02 116.81 31.81 Favored 'General case' 0 C--N 1.266 -3.056 0 C-N-CA 119.962 -0.695 . . . . 1.74 110.961 -175.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.87 99.48 9.69 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 104.888 -2.264 . . . . 0.72 104.888 176.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 8.9 p -89.41 127.01 42.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 C-N-CA 119.64 -0.824 . . . . 1.01 112.308 -174.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1592 ' ' TYR . . . . . 0.658 ' HB2' ' HB3' ' A' 1608 ' ' SER . 12.8 m-30 -106.95 142.75 36.07 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.443 -1.317 . . . . 0.5 107.443 173.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 10.6 ptmm? -158.08 -172.24 3.83 Favored 'General case' 0 C--N 1.283 -2.308 0 N-CA-C 106.043 -1.836 . . . . 1.59 106.043 -175.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 36.4 m-20 66.46 45.56 2.1 Favored 'General case' 0 C--O 1.239 0.503 0 O-C-N 124.006 0.816 . . . . 1.11 109.116 177.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -86.76 -175.06 49.39 Favored Glycine 0 N--CA 1.435 -1.379 0 CA-C-N 114.892 -1.049 . . . . 0.78 111.582 -178.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1596 ' ' SER . . . . . 0.742 ' HB2' ' HD2' ' A' 1597 ' ' PRO . 62.9 p -95.31 173.86 4.02 Favored Pre-proline 0 C--N 1.291 -1.968 0 CA-C-O 118.672 -0.68 . . . . 1.07 109.457 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1597 ' ' PRO . . . . . 0.742 ' HD2' ' HB2' ' A' 1596 ' ' SER . 10.3 Cg_endo -50.85 127.11 20.29 Favored 'Trans proline' 0 C--N 1.361 1.197 0 C-N-CA 122.785 2.323 . . . . 1.01 113.676 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1598 ' ' CYS . . . . . 0.696 ' HA ' ' HE1' ' A' 1606 ' ' TYR . 49.5 t -81.16 118.74 73.6 Favored Pre-proline 0 C--N 1.284 -2.269 0 CA-C-N 113.718 -1.583 . . . . 0.75 107.888 178.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1599 ' ' PRO . . . . . 0.707 ' HD2' ' HE1' ' A' 1606 ' ' TYR . 6.9 Cg_endo -52.12 -21.16 12.13 Favored 'Trans proline' 0 C--N 1.366 1.483 0 C-N-CA 124.357 3.371 . . . . 1.7 114.362 -178.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1600 ' ' SER . . . . . 0.417 ' HA ' ' HB2' ' B' ' 53' ' ' LEU . 7.8 m -55.72 -45.63 77.91 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 123.815 0.846 . . . . 2.26 110.438 177.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1601 ' ' LYS . . . . . 0.483 ' HE2' HD11 ' A' 1604 ' ' LEU . 36.5 ttpt -162.84 127.43 3.08 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 108.395 -0.965 . . . . 3.01 108.395 178.242 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 14.2 p -58.36 132.02 52.4 Favored 'General case' 0 N--CA 1.415 -2.191 0 N-CA-C 109.26 -0.644 . . . . 2.07 109.26 177.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 106.54 -17.38 39.74 Favored Glycine 0 C--N 1.303 -1.265 0 C-N-CA 121.329 -0.463 . . . . 1.08 112.354 -176.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1604 ' ' LEU . . . . . 0.503 ' HB2' ' HB3' ' A' 1598 ' ' CYS . 60.2 mt -91.83 152.06 20.29 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 107.254 -1.387 . . . . 1.84 107.254 173.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 37.9 m -135.87 142.93 44.81 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 108.628 -0.878 . . . . 1.41 108.628 179.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1606 ' ' TYR . . . . . 0.758 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 71.5 m-85 -73.22 158.95 34.22 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 112.141 0.423 . . . . 0.6 112.141 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -147.89 152.72 38.07 Favored 'General case' 0 N--CA 1.421 -1.914 0 N-CA-C 106.38 -1.711 . . . . 1.45 106.38 172.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1608 ' ' SER . . . . . 0.658 ' HB3' ' HB2' ' A' 1592 ' ' TYR . 28.0 t -122.5 123.08 40.45 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 109.038 -0.727 . . . . 1.15 109.038 -174.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 30.8 t -105.09 98.1 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.748 0 N-CA-C 108.846 -0.798 . . . . 0.25 108.846 179.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 84.1 mt -89.63 106.11 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.787 0 N-CA-C 108.1 -1.074 . . . . 0.45 108.1 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 17.0 m -104.54 114.48 28.73 Favored 'General case' 0 N--CA 1.421 -1.917 0 CA-C-N 115.007 -0.997 . . . . 1.26 111.01 -175.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1612 ' ' PHE . . . . . 0.865 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 69.3 m-85 -91.33 108.41 19.87 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.054 -0.721 . . . . 0.26 109.054 176.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1613 ' ' VAL . . . . . 0.879 ' HB ' ' HB3' ' A' 1641 ' ' HIS . 33.5 t -103.96 144.16 14.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 CA-C-N 114.774 -1.103 . . . . 0.5 109.233 -176.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 39.1 t -69.88 108.31 3.93 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 123.809 0.844 . . . . 0.77 110.982 179.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1615 ' ' ARG . . . . . 0.574 ' HB2' ' HB2' ' A' 1641 ' ' HIS . 25.3 tpt180 -135.69 91.69 17.8 Favored Pre-proline 0 N--CA 1.435 -1.214 0 C-N-CA 119.584 -0.846 . . . . 2.53 109.671 173.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1616 ' ' PRO . . . . . 0.934 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 19.2 Cg_exo -65.7 -22.21 57.72 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.392 2.061 . . . . 1.1 113.535 -176.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -57.96 -38.48 76.1 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 123.94 0.896 . . . . 3.05 112.221 179.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . 64.93 -172.63 0.18 Allowed 'General case' 0 C--N 1.358 0.946 0 O-C-N 123.916 0.76 . . . . 1.55 109.61 -176.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . 119.09 -159.5 14.5 Favored Glycine 0 N--CA 1.426 -2.018 0 C-N-CA 120.222 -0.989 . . . . 0.93 112.632 177.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 94.9 Cg_exo -56.38 -11.73 6.84 Favored 'Trans proline' 0 N--CA 1.5 1.911 0 C-N-CA 124.893 3.728 . . . . 0.88 114.211 178.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1621 ' ' THR . . . . . . . . . . . . . 19.0 p -87.6 -9.37 54.52 Favored 'General case' 0 C--N 1.282 -2.364 0 C-N-CA 124.396 1.079 . . . . 0.97 110.869 -179.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 49.2 t30 -88.02 58.36 4.77 Favored 'General case' 0 C--O 1.253 1.266 0 CA-C-O 122.729 1.252 . . . . 0.72 110.16 -178.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1623 ' ' ARG . . . . . 0.43 ' HA ' ' HD3' ' A' 1624 ' ' PRO . 34.7 ptt180 -159.82 138.81 7.97 Favored Pre-proline 0 C--N 1.303 -1.415 0 CA-C-N 113.839 -1.528 . . . . 3.26 107.183 178.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1624 ' ' PRO . . . . . 0.445 ' HG3' ' CE3' ' A' 1640 ' ' TRP . 7.1 Cg_exo -69.43 111.23 2.69 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.333 2.022 . . . . 0.59 111.172 -178.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 74.7 mtm -114.0 147.83 37.96 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 116.415 -0.357 . . . . 1.37 110.337 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1626 ' ' LEU . . . . . 0.569 ' HG ' ' CE2' ' A' 1542 ' ' TYR . 0.3 OUTLIER -85.89 113.95 22.43 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 107.954 -1.128 . . . . 0.89 107.954 -176.56 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 42.0 mm -76.36 -54.85 12.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 N-CA-C 109.262 -0.644 . . . . 0.58 109.262 -177.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 70.5 m -163.83 152.27 13.4 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.468 -0.938 . . . . 1.39 108.468 -173.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1629 ' ' LEU . . . . . 0.584 ' HG ' ' CD2' ' A' 1636 ' ' LEU . 2.5 tt -114.25 110.91 20.67 Favored 'General case' 0 N--CA 1.416 -2.172 0 N-CA-C 106.531 -1.655 . . . . 1.25 106.531 179.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 14.8 t70 -77.81 95.35 4.68 Favored 'General case' 0 CA--C 1.494 -1.198 0 N-CA-C 106.919 -1.512 . . . . 1.09 106.919 173.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1631 ' ' LYS . . . . . 0.69 ' HD3' ' H ' ' A' 1631 ' ' LYS . 0.0 OUTLIER -75.96 2.86 11.48 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 114.419 1.266 . . . . 3.6 114.419 -172.768 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -88.36 -41.93 12.52 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.709 -0.848 . . . . 2.6 108.709 175.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 67.6 p -100.48 -15.62 17.82 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-N 115.118 -0.946 . . . . 0.75 111.065 -177.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 83.3 m 70.25 35.05 2.18 Favored 'General case' 0 C--N 1.351 0.662 0 C-N-CA 125.053 1.341 . . . . 0.53 110.891 -179.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1635 ' ' THR . . . . . . . . . . . . . 90.0 m -90.96 121.87 33.16 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 113.727 -1.579 . . . . 0.46 109.088 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1636 ' ' LEU . . . . . 0.584 ' CD2' ' HG ' ' A' 1629 ' ' LEU . 26.2 mt -98.58 130.7 45.13 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 109.483 -0.562 . . . . 0.86 109.483 178.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -101.77 116.48 32.82 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 116.076 -0.511 . . . . 0.45 111.137 177.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -114.19 140.73 48.3 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 109.529 -0.545 . . . . 0.5 109.529 176.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1639 ' ' SER . . . . . 0.432 ' O ' ' HA ' ' A' 1624 ' ' PRO . 48.0 t -119.86 129.16 54.26 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 108.512 -0.921 . . . . 1.04 108.512 173.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1640 ' ' TRP . . . . . 0.748 ' HZ3' HG13 ' A' 1552 ' ' ILE . 6.3 t90 -133.74 93.5 3.13 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 104.217 -2.512 . . . . 0.68 104.217 173.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1641 ' ' HIS . . . . . 0.879 ' HB3' ' HB ' ' A' 1613 ' ' VAL 0.317 0.1 OUTLIER -101.64 95.17 6.27 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-O 122.474 1.13 . . . . 0.9 113.085 -175.612 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A 1642 ' ' THR . . . . . . . . . . . . . 3.1 t -114.77 153.02 46.91 Favored Pre-proline 0 C--N 1.299 -1.609 0 CA-C-N 112.542 -2.117 . . . . 0.48 108.583 -177.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1643 ' ' PRO . . . . . 0.934 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 49.7 Cg_endo -68.94 -4.89 14.37 Favored 'Trans proline' 0 C--N 1.369 1.65 0 C-N-CA 123.269 2.646 . . . . 0.66 113.366 -178.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 8.2 tt -65.35 -30.29 71.11 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.969 -0.382 . . . . 0.97 109.969 176.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -84.2 21.7 1.35 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.377 0.608 . . . . 0.84 111.513 -175.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 33.3 m -121.22 136.52 54.96 Favored 'General case' 0 N--CA 1.415 -2.193 0 N-CA-C 107.629 -1.248 . . . . 1.19 107.629 178.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1647 ' ' GLU . . . . . 0.693 ' HG3' HG21 ' A' 1523 ' ' THR . 0.1 OUTLIER -107.94 142.26 24.88 Favored Pre-proline 0 C--N 1.301 -1.531 0 N-CA-C 109.529 -0.545 . . . . 3.14 109.529 177.399 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A 1648 ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -62.73 109.28 0.86 Allowed 'Trans proline' 0 C--O 1.244 0.811 0 C-N-CA 122.82 2.346 . . . . 2.58 113.102 -178.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 8.9 tp10 . . . . . 0 C--N 1.304 -1.401 0 N-CA-C 107.152 -1.425 . . . . 4.72 107.152 177.766 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.731 0 N-CA-C 108.895 -0.78 . . . . 9.97 108.895 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -141.53 147.07 37.17 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.775 -0.824 . . . . 7.68 108.775 -177.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 -139.64 149.26 59.06 Favored Pre-proline 0 C--N 1.302 -1.495 0 N-CA-C 107.899 -1.149 . . . . 6.11 107.899 176.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -44.16 -47.79 10.19 Favored 'Trans proline' 0 C--O 1.243 0.762 0 C-N-CA 123.853 3.036 . . . . 4.84 113.009 -177.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 15.9 t -118.95 102.13 8.54 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 106.678 -1.601 . . . . 4.6 106.678 178.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -72.33 -25.84 61.7 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.137 0.494 . . . . 4.23 110.64 -176.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 20.8 p -105.79 166.36 10.53 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.473 -0.936 . . . . 3.14 108.473 174.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.488 HD13 ' HB3' ' B' ' 12' ' ' GLU . 79.5 mt -85.39 136.07 33.61 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 110.19 -0.3 . . . . 3.96 110.19 -177.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 9' ' ' CYS . . . . . 0.459 ' HA ' HD12 ' B' ' 13' ' ' LEU . 49.1 t -139.03 152.06 47.29 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 109.206 -0.664 . . . . 2.84 109.206 -179.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.14 -124.26 6.87 Favored Glycine 0 N--CA 1.438 -1.225 0 C-N-CA 120.907 -0.663 . . . . 2.09 112.856 177.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.94 -36.88 92.88 Favored Glycine 0 C--O 1.22 -0.765 0 CA-C-N 115.557 -0.322 . . . . 1.84 112.924 -177.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . 0.488 ' HB3' HD13 ' B' ' 8' ' ' LEU . 6.3 mp0 -68.18 -28.34 67.18 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 111.915 0.339 . . . . 2.55 111.915 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . 0.459 HD12 ' HA ' ' B' ' 9' ' ' CYS . 0.7 OUTLIER -71.65 -53.54 13.27 Favored 'General case' 0 N--CA 1.42 -1.959 0 N-CA-C 109.486 -0.561 . . . . 2.35 109.486 -177.664 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 3.8 p -63.58 -35.42 72.64 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-N 115.561 -0.745 . . . . 2.11 111.133 177.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 15' ' ' ASP . . . . . 0.467 ' OD2' ' HB3' ' A' 1569 ' ' GLN . 14.8 t0 -72.32 -37.07 69.01 Favored 'General case' 0 CA--C 1.557 1.248 0 N-CA-C 112.209 0.448 . . . . 2.04 112.209 -179.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 14.9 t -68.78 -37.7 79.49 Favored 'General case' 0 C--O 1.254 1.316 0 CA-C-N 119.079 0.854 . . . . 1.84 110.117 175.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.605 HD21 HD11 ' B' ' 42' ' ' ILE . 3.2 mm? -49.37 -52.66 26.82 Favored 'General case' 0 C--N 1.355 0.823 0 CA-C-O 121.358 0.599 . . . . 1.74 110.197 168.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -66.97 -23.8 65.98 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 123.659 0.784 . . . . 2.39 112.385 -177.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -62.9 -62.85 1.44 Allowed 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 116.467 -0.333 . . . . 0.96 110.938 175.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 14.4 p -91.32 -15.92 8.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 C-N-CA 117.609 -1.636 . . . . 1.37 112.791 -175.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 59.1 m -99.8 10.17 41.77 Favored 'General case' 0 C--O 1.206 -1.227 0 O-C-N 121.099 -1.0 . . . . 1.66 111.318 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -53.42 -28.36 35.85 Favored Glycine 0 CA--C 1.54 1.617 0 N-CA-C 116.632 1.413 . . . . 1.53 116.632 -178.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -72.56 -49.0 35.53 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 118.305 1.053 . . . . 2.72 111.891 -179.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.15 -38.58 15.23 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.37 0.605 . . . . 4.33 109.803 -179.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . 0.424 ' O ' ' HB2' ' B' ' 61' ' ' ALA . . . 124.23 164.52 11.98 Favored Glycine 0 N--CA 1.428 -1.892 0 N-CA-C 107.62 -2.192 . . . . 1.53 107.62 -174.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . 0.424 ' CB ' ' HB3' ' B' ' 17' ' ' LEU . 17.4 p90 -95.69 129.79 42.78 Favored 'General case' 0 C--N 1.286 -2.177 0 CA-C-N 118.779 1.29 . . . . 1.65 110.067 179.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 27' ' ' TYR . . . . . 0.744 ' HB2' ' HA ' ' B' ' 61' ' ' ALA . 24.9 m-85 -129.98 59.31 1.63 Allowed 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 112.939 0.718 . . . . 3.42 112.939 -174.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 28' ' ' PHE . . . . . 0.651 ' HA ' ' HE2' ' B' ' 59' ' ' TYR . 32.6 p90 -92.05 -9.09 44.01 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 119.048 -1.061 . . . . 2.26 108.485 173.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 29' ' ' SER . . . . . 0.617 ' HA ' ' HG2' ' B' ' 40' ' ' ARG . 22.7 p -85.33 50.62 1.99 Allowed 'General case' 0 N--CA 1.428 -1.566 0 CA-C-N 115.298 -0.864 . . . . 3.68 110.215 179.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -89.96 116.41 66.29 Favored Pre-proline 0 N--CA 1.434 -1.236 0 N-CA-C 107.857 -1.164 . . . . 3.81 107.857 178.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . 0.694 ' HA ' ' HA ' ' B' ' 39' ' ' SER . 50.0 Cg_exo -54.06 -31.83 66.32 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.945 3.097 . . . . 4.02 114.799 -172.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -162.01 151.71 16.35 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-O 121.388 0.613 . . . . 4.92 110.925 177.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 88.3 p -168.17 -170.63 1.34 Allowed 'General case' 0 N--CA 1.411 -2.376 0 N-CA-C 101.773 -3.417 . . . . 6.72 101.773 177.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -104.18 -1.31 27.38 Favored 'General case' 0 C--N 1.267 -3.004 0 CA-C-O 121.783 0.802 . . . . 11.63 109.434 178.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 38.9 t -105.79 -19.71 6.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 107.724 -1.213 . . . . 9.61 107.724 177.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 33.3 m -144.71 85.25 1.76 Allowed 'General case' 0 N--CA 1.398 -3.025 0 CA-C-N 114.58 -1.191 . . . . 6.71 108.307 177.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -71.05 -3.58 20.46 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 115.317 -0.856 . . . . 10.0 111.425 173.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -90.87 152.25 20.82 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 106.822 -1.547 . . . . 7.94 106.822 173.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . 0.694 ' HA ' ' HA ' ' B' ' 31' ' ' PRO . 33.3 t -67.31 -3.44 8.05 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.887 0.699 . . . . 5.76 112.887 -175.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . 0.617 ' HG2' ' HA ' ' B' ' 29' ' ' SER . 79.2 mtt180 -144.04 130.34 19.79 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 107.577 -1.268 . . . . 6.03 107.577 172.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . 0.415 ' C ' ' H ' ' B' ' 43' ' ' VAL . . . -103.58 177.19 24.59 Favored Glycine 0 CA--C 1.476 -2.401 0 N-CA-C 109.723 -1.351 . . . . 2.37 109.723 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . 0.605 HD11 HD21 ' B' ' 17' ' ' LEU . 16.1 pt 58.1 -26.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 C-N-CA 127.346 2.258 . . . . 2.07 115.74 179.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.415 ' H ' ' C ' ' B' ' 41' ' ' GLY . 2.7 p -48.12 -46.95 13.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 114.71 1.374 . . . . 2.24 114.71 -177.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -87.79 -29.75 20.76 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.913 -1.143 . . . . 3.36 107.913 -174.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . 0.559 ' O ' ' HB2' ' B' ' 49' ' ' ARG . 30.2 mt-10 -75.82 -10.06 59.12 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 113.963 -1.471 . . . . 3.08 112.179 -177.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 46' ' ' CYS . . . . . . . . . . . . . 21.5 t -119.42 -21.92 7.25 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-O 121.056 0.455 . . . . 2.23 110.285 176.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 49.7 t -74.28 -47.62 33.73 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.333 -0.547 . . . . 2.37 111.433 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -119.09 7.61 11.4 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 120.1 -0.64 . . . . 2.82 110.987 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . 0.559 ' HB2' ' O ' ' B' ' 45' ' ' GLU . 36.0 mmt180 -128.0 156.68 42.33 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.301 -1.37 . . . . 4.09 107.301 -177.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 14.0 p -78.3 110.75 13.61 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 109.855 -0.424 . . . . 2.67 109.855 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 3.0 p -100.87 126.75 47.5 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 115.59 -0.732 . . . . 2.11 110.365 -177.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -101.8 135.62 43.04 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.772 -1.195 . . . . 2.67 107.772 178.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . 0.436 HD21 ' HG3' ' A' 1631 ' ' LYS . 56.9 tp -36.47 -37.91 0.14 Allowed 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 126.613 1.965 . . . . 1.9 114.834 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.95 -29.97 63.64 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 123.483 0.49 . . . . 1.52 111.374 -177.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 53.1 tp -68.58 -57.0 6.39 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-N 115.863 -0.608 . . . . 1.97 110.048 177.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 1.9 pp -71.28 -27.18 63.24 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 116.496 -0.32 . . . . 1.53 111.559 -174.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -71.95 -46.11 58.68 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 111.835 0.309 . . . . 2.27 111.835 178.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 11.2 t -77.66 -30.09 51.93 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 118.619 -1.233 . . . . 2.33 111.601 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 59' ' ' TYR . . . . . 0.651 ' HE2' ' HA ' ' B' ' 28' ' ' PHE . 11.1 t80 -70.66 -64.51 0.88 Allowed 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 106.278 -1.749 . . . . 2.86 106.278 177.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 54.1 t 33.42 -87.02 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 127.208 2.203 . . . . 2.3 115.762 173.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 61' ' ' ALA . . . . . 0.744 ' HA ' ' HB2' ' B' ' 27' ' ' TYR . . . -144.49 151.92 39.86 Favored 'General case' 0 N--CA 1.42 -1.945 0 N-CA-C 108.212 -1.033 . . . . 3.19 108.212 -176.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 6.7 p -85.21 131.38 48.54 Favored Pre-proline 0 N--CA 1.416 -2.157 0 N-CA-C 109.042 -0.725 . . . . 3.68 109.042 -178.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -73.24 -32.93 7.79 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 123.002 2.468 . . . . 5.08 115.308 -172.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -149.32 55.43 0.98 Allowed 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.432 0.634 . . . . 5.1 109.932 -178.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 45.6 tttp -162.97 130.5 3.64 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 115.795 -0.639 . . . . 8.51 109.426 -177.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 15.0 m -134.85 11.99 3.66 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.692 0.758 . . . . 8.12 109.692 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 . . . . . 0 C--O 1.253 1.279 0 CA-C-N 114.909 -1.042 . . . . 10.21 109.121 -179.396 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 77.0 mtp . . . . . 0 C--O 1.24 0.599 0 CA-C-O 120.59 0.234 . . . . 9.34 110.414 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -110.12 89.29 2.98 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 108.564 -0.902 . . . . 9.04 108.564 178.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1510 ' ' SER . . . . . 0.634 ' HA ' ' HG3' ' A' 1521 ' ' PRO . 51.3 m 70.76 156.25 0.15 Allowed 'General case' 0 C--O 1.242 0.665 0 C-N-CA 124.568 1.147 . . . . 5.81 111.785 -177.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1511 ' ' ASN . . . . . 0.635 ' OD1' ' HB3' ' A' 1583 ' ' TYR . 82.6 m-20 68.05 96.52 0.06 Allowed 'General case' 0 C--O 1.248 0.993 0 N-CA-C 115.051 1.5 . . . . 3.42 115.051 169.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1512 ' ' GLU . . . . . 0.538 ' O ' HG12 ' A' 1518 ' ' VAL . 29.9 mm-40 -78.5 169.62 17.95 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.549 -0.751 . . . . 5.95 109.364 169.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 13.9 p-80 -144.43 103.49 3.97 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-O 121.5 0.667 . . . . 5.33 112.06 -179.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 22.2 t70 -96.07 -69.1 0.77 Allowed 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 115.538 -0.756 . . . . 5.06 109.214 176.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 16.4 t70 -150.84 -63.38 0.19 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.998 -0.546 . . . . 2.9 111.331 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1516 ' ' CYS . . . . . 0.634 ' SG ' ' HB2' ' A' 1529 ' ' LEU . 30.8 t -138.83 55.59 1.72 Allowed 'General case' 0 C--O 1.25 1.113 0 N-CA-C 108.312 -0.995 . . . . 1.19 108.312 -179.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -169.06 149.04 4.18 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 115.565 -0.743 . . . . 1.52 109.06 -174.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1518 ' ' VAL . . . . . 0.538 HG12 ' O ' ' A' 1512 ' ' GLU . 4.8 m -149.43 142.37 17.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 C-N-CA 124.227 1.011 . . . . 0.94 110.585 178.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1519 ' ' THR . . . . . . . . . . . . . 31.9 m -106.16 137.35 44.25 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.915 -0.402 . . . . 0.89 109.915 177.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 52.6 t-20 -82.68 110.33 21.72 Favored Pre-proline 0 C--O 1.245 0.829 0 N-CA-C 107.009 -1.478 . . . . 1.74 107.009 174.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1521 ' ' PRO . . . . . 0.634 ' HG3' ' HA ' ' A' 1510 ' ' SER . 42.5 Cg_endo -67.23 -14.69 43.94 Favored 'Trans proline' 0 N--CA 1.474 0.376 0 C-N-CA 123.173 2.582 . . . . 1.58 113.148 -174.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 28.3 m -75.04 -33.87 61.81 Favored 'General case' 0 N--CA 1.425 -1.702 0 CA-C-N 116.307 -0.406 . . . . 1.65 111.844 -179.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1523 ' ' THR . . . . . . . . . . . . . 12.5 t -136.19 -5.3 2.1 Favored 'General case' 0 CA--C 1.564 1.484 0 C-N-CA 118.132 -1.427 . . . . 1.61 113.418 -175.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 85.75 8.31 80.03 Favored Glycine 0 CA--C 1.494 -1.252 0 C-N-CA 120.632 -0.794 . . . . 1.13 114.048 176.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 51.9 t-80 -76.27 123.27 25.64 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.706 -0.85 . . . . 1.26 108.706 177.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -103.2 116.91 33.37 Favored 'General case' 0 C--N 1.268 -2.965 0 CA-C-N 114.796 -1.093 . . . . 0.68 109.008 -176.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -88.86 118.38 28.53 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 109.989 -0.375 . . . . 0.65 109.989 175.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 7.7 t70 -110.72 126.25 54.37 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.111 -1.44 . . . . 1.17 107.111 174.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1529 ' ' LEU . . . . . 0.634 ' HB2' ' SG ' ' A' 1516 ' ' CYS . 2.9 mm? -103.21 20.47 17.65 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 111.88 0.326 . . . . 0.6 111.88 -174.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 6.9 m -66.74 -23.84 66.15 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 113.369 0.878 . . . . 0.84 113.369 -175.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 33.6 t -72.29 -30.1 64.49 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-O 121.534 0.683 . . . . 1.59 109.196 178.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1532 ' ' LEU . . . . . 0.522 HD12 HD12 ' A' 1529 ' ' LEU . 59.9 mt -88.9 -18.31 27.82 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.387 -0.824 . . . . 0.65 109.792 -179.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1533 ' ' SER . . . . . 0.532 ' HA ' ' HB ' ' A' 1552 ' ' ILE . 34.8 t -75.46 171.57 14.02 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.61 -0.723 . . . . 1.52 110.288 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . 159.94 150.37 5.83 Favored Glycine 0 N--CA 1.424 -2.159 0 N-CA-C 110.106 -1.197 . . . . 1.1 110.106 -178.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 35.6 ttp180 -92.02 -13.69 30.56 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 121.475 0.655 . . . . 4.62 109.843 -179.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -79.66 -39.03 32.33 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 121.364 0.602 . . . . 1.45 109.977 178.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 90.62 -171.89 36.82 Favored Glycine 0 N--CA 1.424 -2.118 0 CA-C-N 115.054 -0.975 . . . . 0.85 111.136 176.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -132.84 146.57 51.93 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 108.281 -1.007 . . . . 0.93 108.281 178.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 31.1 p -102.43 123.46 46.25 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 123.491 0.494 . . . . 1.03 111.77 -178.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1540 ' ' ALA . . . . . 0.406 ' HB3' ' CG1' ' A' 1548 ' ' VAL . . . -115.29 135.15 54.46 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.255 -0.646 . . . . 0.5 109.255 177.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -70.59 134.58 47.75 Favored 'General case' 0 C--O 1.249 1.032 0 CA-C-N 115.567 -0.742 . . . . 0.74 110.901 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1542 ' ' TYR . . . . . 0.587 ' CE2' ' HG ' ' A' 1626 ' ' LEU . 7.1 t80 -133.24 -100.84 0.26 Allowed 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.787 -0.82 . . . . 0.99 108.787 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1543 ' ' SER . . . . . 0.43 ' H ' ' HB3' ' A' 1542 ' ' TYR . 13.6 t -92.63 179.95 5.35 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 109.763 -0.458 . . . . 1.91 109.763 -176.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 20.2 pttp -75.21 -23.65 57.66 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 120.976 0.417 . . . . 3.59 111.416 -177.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1545 ' ' SER . . . . . 0.656 ' HB2' ' HG2' ' A' 1569 ' ' GLN . 5.2 p -65.49 -36.94 85.36 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 124.325 1.05 . . . . 2.46 112.751 -176.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 178.73 -167.1 37.27 Favored Glycine 0 N--CA 1.425 -2.098 0 C-N-CA 120.874 -0.679 . . . . 1.26 112.216 -178.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 27.2 m -113.58 166.46 7.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 109.82 -0.437 . . . . 0.79 109.82 -176.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1548 ' ' VAL . . . . . 0.406 ' CG1' ' HB3' ' A' 1540 ' ' ALA . 13.1 p -102.26 131.0 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 N-CA-C 108.911 -0.774 . . . . 0.58 108.911 177.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -92.16 134.84 34.48 Favored 'General case' 0 CA--C 1.481 -1.673 0 CA-C-N 115.504 -0.771 . . . . 1.08 109.223 178.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 24.0 ptm -146.64 116.06 7.08 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 115.478 -0.783 . . . . 0.78 111.057 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 8.5 p -106.39 124.13 49.12 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-N 115.145 -0.934 . . . . 0.97 110.214 178.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1552 ' ' ILE . . . . . 0.532 ' HB ' ' HA ' ' A' 1533 ' ' SER . 43.5 mm -81.92 119.1 30.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 109.99 -0.374 . . . . 0.42 109.99 -179.009 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 57.8 m 60.9 41.94 13.69 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 123.937 0.773 . . . . 1.4 111.366 176.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . -178.0 174.23 46.63 Favored Glycine 0 N--CA 1.422 -2.274 0 N-CA-C 109.961 -1.256 . . . . 0.35 109.961 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -100.16 150.8 22.14 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 120.856 0.36 . . . . 1.62 110.405 -179.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -98.81 139.28 34.72 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.0 -0.741 . . . . 0.87 109.0 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -85.12 -3.63 58.87 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 113.108 0.781 . . . . 2.49 113.108 -172.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -93.67 1.73 56.52 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 120.547 -0.461 . . . . 1.38 110.816 -176.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1559 ' ' CYS . . . . . 0.727 ' SG ' ' HD2' ' A' 1560 ' ' PRO . 13.3 t -137.59 166.34 27.27 Favored Pre-proline 0 C--N 1.3 -1.562 0 N-CA-C 106.542 -1.651 . . . . 1.21 106.542 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1560 ' ' PRO . . . . . 0.727 ' HD2' ' SG ' ' A' 1559 ' ' CYS . 16.3 Cg_exo -33.83 145.3 0.04 OUTLIER 'Trans proline' 0 C--N 1.379 2.173 0 C-N-CA 124.542 3.494 . . . . 0.71 114.627 173.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1561 ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' 1560 ' ' PRO . 43.0 Cg_exo -58.94 127.44 24.31 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 123.223 2.615 . . . . 0.8 112.841 -177.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 94.5 13.21 54.56 Favored Glycine 0 C--N 1.311 -0.812 0 N-CA-C 115.166 0.826 . . . . 0.46 115.166 176.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1563 ' ' VAL . . . . . 0.893 HG21 ' HB2' ' A' 1573 ' ' SER . 9.9 p -109.08 140.19 28.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-N 118.242 1.021 . . . . 0.98 110.95 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -100.7 -32.98 5.21 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 120.984 -0.627 . . . . 0.28 113.272 -177.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -123.35 128.76 50.36 Favored 'General case' 0 C--O 1.244 0.806 0 N-CA-C 109.569 -0.53 . . . . 0.28 109.569 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 50.6 t -163.48 144.82 9.33 Favored 'General case' 0 C--O 1.206 -1.194 0 C-N-CA 121.249 -0.18 . . . . 0.43 110.889 -175.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -85.72 143.61 28.26 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 118.05 0.386 . . . . 1.03 110.178 174.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -88.89 8.16 80.35 Favored Glycine 0 N--CA 1.443 -0.861 0 N-CA-C 116.239 1.256 . . . . 1.13 116.239 -170.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1569 ' ' GLN . . . . . 0.656 ' HG2' ' HB2' ' A' 1545 ' ' SER . 0.4 OUTLIER -78.48 -67.39 0.74 Allowed 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 118.328 1.064 . . . . 2.58 110.319 177.612 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 15.2 p -111.99 7.45 19.86 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.817 -1.083 . . . . 2.17 113.568 -175.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1571 ' ' ARG . . . . . 0.5 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 0.0 OUTLIER 64.68 44.34 3.87 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 122.964 0.506 . . . . 2.62 111.757 -178.91 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 42.6 mt -83.06 112.39 20.67 Favored 'Isoleucine or valine' 0 C--O 1.246 0.902 0 N-CA-C 107.973 -1.121 . . . . 0.92 107.973 174.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1573 ' ' SER . . . . . 0.893 ' HB2' HG21 ' A' 1563 ' ' VAL . 91.0 p -80.14 134.57 36.17 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.557 -0.747 . . . . 0.8 111.416 -174.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1574 ' ' VAL . . . . . 0.516 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 33.2 m -118.11 9.11 6.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 O-C-N 121.32 -0.862 . . . . 0.98 112.42 -178.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 175.33 123.88 0.78 Allowed Glycine 0 N--CA 1.433 -1.515 0 C-N-CA 120.331 -0.938 . . . . 0.29 111.403 176.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -69.24 153.34 43.82 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.043 -0.725 . . . . 2.19 109.043 -178.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -74.46 88.61 2.11 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-O 121.115 0.483 . . . . 0.61 110.258 -177.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -97.07 160.05 14.56 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 115.106 -0.952 . . . . 1.95 110.464 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 24.2 pttm -120.51 45.29 2.25 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 122.878 1.323 . . . . 2.68 108.363 -178.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 24.0 ttm180 -103.6 76.36 1.39 Allowed 'General case' 0 N--CA 1.412 -2.331 0 CA-C-N 113.956 -1.475 . . . . 3.47 108.54 -173.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1581 ' ' LEU . . . . . 0.56 HD11 HD12 ' A' 1588 ' ' LEU . 0.2 OUTLIER -82.35 124.7 30.23 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 114.146 -1.388 . . . . 0.64 107.534 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A 1582 ' ' ARG . . . . . 0.492 ' HB2' ' HB3' ' A' 1589 ' ' GLN . 64.3 mtp180 -122.56 143.4 49.76 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 116.768 -0.196 . . . . 2.85 110.599 176.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1583 ' ' TYR . . . . . 0.635 ' HB3' ' OD1' ' A' 1511 ' ' ASN . 74.9 t80 -113.35 107.57 16.04 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 109.323 -0.621 . . . . 0.86 109.323 177.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1584 ' ' VAL . . . . . 0.622 ' O ' ' HB ' ' A' 1587 ' ' VAL . 9.7 m -121.63 90.01 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 CA-C-N 115.722 -0.672 . . . . 1.05 111.153 -177.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 31.1 t70 53.51 72.63 0.42 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.053 0.941 . . . . 1.17 111.761 178.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1586 ' ' GLN . . . . . 0.403 ' HA ' ' HE1' ' A' 1583 ' ' TYR . 4.2 pt20 57.21 26.39 12.17 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 125.818 1.647 . . . . 1.86 111.296 176.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1587 ' ' VAL . . . . . 0.622 ' HB ' ' O ' ' A' 1584 ' ' VAL . 24.6 t -124.23 120.88 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.32 0 CA-C-N 113.769 -1.56 . . . . 0.49 108.117 175.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1588 ' ' LEU . . . . . 0.812 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 2.9 mm? -95.05 117.36 30.04 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.09 -1.448 . . . . 0.36 107.09 178.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1589 ' ' GLN . . . . . 0.492 ' HB3' ' HB2' ' A' 1582 ' ' ARG . 35.3 tt0 -106.56 127.42 53.31 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 116.02 -0.536 . . . . 1.74 111.454 -175.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1590 ' ' LEU . . . . . 0.449 ' HG ' HD22 ' A' 1581 ' ' LEU . 11.2 mt -121.49 101.6 7.72 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 107.463 -1.31 . . . . 0.72 107.463 170.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 6.4 p -96.92 124.68 49.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 CA-C-O 121.494 0.664 . . . . 1.01 109.966 -178.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1592 ' ' TYR . . . . . 0.469 ' HB2' ' HB3' ' A' 1608 ' ' SER . 14.4 m-30 -115.55 105.05 12.35 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.269 -1.012 . . . . 0.5 108.269 -179.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 20.7 pttp -115.27 -178.94 3.49 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 109.759 -0.46 . . . . 1.59 109.759 -179.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 36.2 m-20 65.16 42.42 4.06 Favored 'General case' 0 C--O 1.247 0.962 0 O-C-N 124.28 0.987 . . . . 1.11 110.405 177.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -75.88 -145.64 1.57 Allowed Glycine 0 N--CA 1.438 -1.217 0 CA-C-N 114.798 -1.092 . . . . 0.78 111.007 174.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1596 ' ' SER . . . . . 0.412 ' HA ' ' HD3' ' A' 1597 ' ' PRO . 72.0 p -88.94 146.47 36.7 Favored Pre-proline 0 C--N 1.284 -2.278 0 N-CA-C 108.444 -0.947 . . . . 1.07 108.444 179.163 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1597 ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' 1596 ' ' SER . 50.2 Cg_exo -57.49 120.74 8.85 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.646 2.23 . . . . 1.01 109.308 174.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 42.4 t -73.25 132.21 82.29 Favored Pre-proline 0 C--N 1.288 -2.084 0 CA-C-N 114.663 -1.153 . . . . 0.75 112.425 -169.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1599 ' ' PRO . . . . . 0.48 ' HD2' ' OH ' ' A' 1606 ' ' TYR . 14.7 Cg_exo -72.44 80.2 1.7 Allowed 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 123.122 2.548 . . . . 1.7 109.338 171.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1600 ' ' SER . . . . . 0.851 ' HA ' ' HB2' ' B' ' 53' ' ' LEU . 50.6 m -160.62 -67.29 0.07 Allowed 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 126.613 1.965 . . . . 2.26 110.004 -178.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1601 ' ' LYS . . . . . 0.477 ' O ' ' HG ' ' A' 1604 ' ' LEU . 81.4 tttt -140.11 112.04 7.53 Favored 'General case' 0 N--CA 1.398 -3.05 0 N-CA-C 106.398 -1.704 . . . . 3.01 106.398 178.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 15.4 m -49.52 133.05 20.95 Favored 'General case' 0 N--CA 1.425 -1.72 0 C-N-CA 124.599 1.16 . . . . 2.07 112.549 -177.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 106.5 -21.49 32.6 Favored Glycine 0 C--N 1.304 -1.215 0 CA-C-N 115.91 -0.586 . . . . 1.08 113.945 177.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1604 ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' 1601 ' ' LYS . 4.3 pp -103.21 145.98 29.12 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 118.387 1.094 . . . . 1.84 111.238 178.124 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 22.8 p -111.77 155.89 22.81 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.624 -0.716 . . . . 1.41 110.797 -175.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1606 ' ' TYR . . . . . 0.516 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 63.9 m-85 -64.25 161.7 16.07 Favored 'General case' 0 C--O 1.249 1.046 0 CA-C-N 116.075 -0.511 . . . . 0.6 110.493 173.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -161.38 130.17 4.5 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-O 120.882 0.372 . . . . 1.45 111.145 -178.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1608 ' ' SER . . . . . 0.469 ' HB3' ' HB2' ' A' 1592 ' ' TYR . 38.0 t -105.23 123.03 47.15 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 115.376 -0.829 . . . . 1.15 109.723 -177.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 24.1 t -107.55 100.75 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 107.946 -1.131 . . . . 0.25 107.946 175.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 89.7 mt -89.77 112.19 24.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 108.317 -0.994 . . . . 0.45 108.317 -179.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 40.1 m -112.86 110.68 20.93 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 115.043 -0.98 . . . . 1.26 111.355 -177.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1612 ' ' PHE . . . . . 0.812 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 62.8 m-85 -83.42 115.85 22.23 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.793 -0.817 . . . . 0.26 108.793 175.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 84.1 t -110.31 135.75 48.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 O-C-N 123.651 0.594 . . . . 0.5 110.572 -174.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 41.4 t -72.13 98.24 2.08 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 124.069 0.948 . . . . 0.77 111.686 -178.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1615 ' ' ARG . . . . . 0.747 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 9.5 mmt180 -138.11 99.31 9.07 Favored Pre-proline 0 N--CA 1.431 -1.404 0 CA-C-N 116.058 -0.519 . . . . 2.53 109.812 175.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1616 ' ' PRO . . . . . 0.424 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 16.4 Cg_exo -75.26 39.57 0.62 Allowed 'Trans proline' 0 N--CA 1.488 1.188 0 C-N-CA 123.37 2.713 . . . . 1.1 112.412 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1617 ' ' GLU . . . . . 0.52 ' OE1' ' HD2' ' A' 1615 ' ' ARG . 42.9 mt-10 -110.57 40.46 1.98 Allowed 'General case' 0 C--N 1.272 -2.772 0 N-CA-C 108.076 -1.083 . . . . 3.05 108.076 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -41.48 115.45 0.63 Allowed 'General case' 0 C--O 1.244 0.765 0 C-N-CA 126.288 1.835 . . . . 1.55 113.867 -175.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . 173.42 -127.16 1.31 Allowed Glycine 0 N--CA 1.412 -2.929 0 N-CA-C 108.149 -1.981 . . . . 0.93 108.149 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -77.2 7.03 3.9 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 122.545 2.163 . . . . 0.88 112.657 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1621 ' ' THR . . . . . 0.482 ' HB ' ' HB2' ' A' 1641 ' ' HIS . 3.8 p -91.11 -27.17 18.73 Favored 'General case' 0 C--N 1.288 -2.081 0 C-N-CA 124.924 1.29 . . . . 0.97 108.203 176.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 51.2 t30 -87.01 56.78 4.16 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.387 -1.278 . . . . 0.72 108.566 -176.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -157.99 139.54 9.84 Favored Pre-proline 0 C--N 1.302 -1.493 0 CA-C-N 114.632 -1.167 . . . . 3.26 108.443 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1624 ' ' PRO . . . . . 0.414 ' HA ' ' O ' ' A' 1639 ' ' SER . 53.5 Cg_endo -68.28 110.91 2.35 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.898 2.399 . . . . 0.59 112.01 -177.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 75.8 mtm -111.98 142.95 43.76 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 120.69 -0.404 . . . . 1.37 110.187 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1626 ' ' LEU . . . . . 0.587 ' HG ' ' CE2' ' A' 1542 ' ' TYR . 0.8 OUTLIER -81.78 112.88 19.34 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 108.34 -0.985 . . . . 0.89 108.34 -175.412 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 44.2 mm -81.12 -52.25 14.32 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 CA-C-O 121.31 0.576 . . . . 0.58 109.852 -178.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 50.9 m -159.56 145.42 15.99 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.541 -0.754 . . . . 1.39 109.772 -176.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1629 ' ' LEU . . . . . 1.014 HD13 ' HG ' ' A' 1636 ' ' LEU . 23.0 tp -129.7 95.13 3.9 Favored 'General case' 0 N--CA 1.421 -1.879 0 N-CA-C 107.785 -1.191 . . . . 1.25 107.785 171.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 27.5 t70 -68.0 122.11 17.52 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 107.121 -1.437 . . . . 1.09 107.121 175.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 26.0 tptp -89.36 -0.17 57.28 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 119.882 -0.727 . . . . 3.6 110.709 -171.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -96.17 -41.08 8.88 Favored 'General case' 0 N--CA 1.426 -1.643 0 C-N-CA 119.884 -0.726 . . . . 2.6 109.933 179.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 22.9 p -89.39 -22.05 22.76 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.4 0.619 . . . . 0.75 110.596 175.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 68.3 m 63.64 36.63 10.73 Favored 'General case' 0 C--N 1.354 0.771 0 C-N-CA 124.965 1.306 . . . . 0.53 111.824 178.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1635 ' ' THR . . . . . . . . . . . . . 38.6 m -100.35 130.5 46.46 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 108.028 -1.101 . . . . 0.46 108.028 178.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1636 ' ' LEU . . . . . 1.014 ' HG ' HD13 ' A' 1629 ' ' LEU . 0.6 OUTLIER -109.38 129.96 55.51 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 108.712 -0.847 . . . . 0.86 108.712 -176.373 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -106.86 121.59 44.72 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 120.901 0.382 . . . . 0.45 110.811 -179.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -119.09 127.78 53.7 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.293 -0.867 . . . . 0.5 108.794 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1639 ' ' SER . . . . . 0.414 ' O ' ' HA ' ' A' 1624 ' ' PRO . 59.1 m -114.23 144.09 43.78 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.293 -1.003 . . . . 1.04 108.293 177.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 2.8 t90 -141.39 107.95 5.33 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 103.792 -2.67 . . . . 0.68 103.792 -177.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1641 ' ' HIS . . . . . 0.747 ' HB3' ' HB2' ' A' 1615 ' ' ARG . 16.4 m170 -93.61 103.25 15.43 Favored 'General case' 0 C--N 1.287 -2.129 0 C-N-CA 120.706 -0.397 . . . . 0.9 110.487 -174.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1642 ' ' THR . . . . . . . . . . . . . 15.0 t -142.62 145.77 35.62 Favored Pre-proline 0 CA--C 1.565 1.529 0 N-CA-C 109.304 -0.628 . . . . 0.48 109.304 -174.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1643 ' ' PRO . . . . . 0.424 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 56.3 Cg_endo -72.57 -13.74 27.43 Favored 'Trans proline' 0 C--N 1.37 1.681 0 C-N-CA 122.635 2.224 . . . . 0.66 112.885 -179.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 9.1 tt -65.23 -19.24 65.88 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.37 0.605 . . . . 0.97 110.399 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -78.24 -7.2 56.86 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.58 -0.737 . . . . 0.84 112.241 -179.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 1.2 m -108.93 156.46 19.67 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 121.474 0.654 . . . . 1.19 111.869 178.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -108.96 142.96 26.64 Favored Pre-proline 0 C--N 1.292 -1.919 0 N-CA-C 107.531 -1.285 . . . . 3.14 107.531 169.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1648 ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -60.27 112.86 1.44 Allowed 'Trans proline' 0 N--CA 1.464 -0.214 0 C-N-CA 122.62 2.213 . . . . 2.58 111.924 -178.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 7.5 tp10 . . . . . 0 C--N 1.302 -1.487 0 N-CA-C 107.558 -1.275 . . . . 4.72 107.558 179.999 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 -0.293 0 N-CA-C 109.362 -0.607 . . . . 9.97 109.362 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -98.85 134.27 41.96 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.612 -0.884 . . . . 7.68 108.612 -178.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -107.19 126.83 29.17 Favored Pre-proline 0 C--N 1.302 -1.481 0 N-CA-C 109.92 -0.4 . . . . 6.11 109.92 178.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . 0.655 ' HB2' ' HG2' ' B' ' 6' ' ' GLU . 31.4 Cg_endo -65.76 -15.0 47.38 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 122.149 1.899 . . . . 4.84 112.968 176.258 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 32.8 m 58.38 30.03 19.03 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 125.02 1.328 . . . . 4.6 112.015 178.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . 0.655 ' HG2' ' HB2' ' B' ' 4' ' ' PRO . 42.8 mm-40 -75.86 -37.17 59.21 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 121.725 0.774 . . . . 4.23 108.918 -178.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 19.7 p -118.75 121.61 40.49 Favored 'General case' 0 N--CA 1.416 -2.166 0 N-CA-C 106.701 -1.592 . . . . 3.14 106.701 175.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.622 HD13 ' HG2' ' B' ' 12' ' ' GLU . 6.2 mp -94.83 145.17 25.08 Favored 'General case' 0 N--CA 1.428 -1.562 0 C-N-CA 119.154 -1.019 . . . . 3.96 109.736 -178.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 8.7 m -91.89 56.39 2.91 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 121.27 0.557 . . . . 2.84 111.203 -168.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -171.87 -107.76 0.2 Allowed Glycine 0 C--N 1.298 -1.571 0 C-N-CA 120.224 -0.989 . . . . 2.09 113.307 -179.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -59.31 -39.16 94.33 Favored Glycine 0 N--CA 1.461 0.343 0 O-C-N 123.654 0.267 . . . . 1.84 113.202 -176.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . 0.622 ' HG2' HD13 ' B' ' 8' ' ' LEU . 18.0 mp0 -65.61 -40.44 92.62 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 124.213 1.005 . . . . 2.55 110.067 179.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . 0.431 HD21 ' HB3' ' B' ' 46' ' ' CYS . 0.1 OUTLIER -65.15 -51.62 60.06 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.206 -0.906 . . . . 2.35 108.571 -178.884 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 7.6 p -63.42 -37.61 80.01 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 CA-C-N 116.405 -0.361 . . . . 2.11 111.655 179.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -68.1 -32.81 73.37 Favored 'General case' 0 C--O 1.193 -1.907 0 C-N-CA 120.088 -0.645 . . . . 2.04 111.859 177.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 96.5 m -59.16 -49.73 76.73 Favored 'General case' 0 C--O 1.279 2.613 0 CA-C-O 121.551 0.691 . . . . 1.84 109.62 174.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.702 HD21 HD11 ' B' ' 42' ' ' ILE . 4.6 mm? -51.52 -48.46 62.96 Favored 'General case' 0 C--O 1.222 -0.365 0 CA-C-N 114.472 -1.24 . . . . 1.74 110.416 174.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . 0.489 ' CD ' ' HB3' ' A' 1545 ' ' SER . 9.7 tt0 -78.11 -15.2 59.08 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.584 -0.734 . . . . 2.39 112.264 -176.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -66.75 -48.46 69.04 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.727 -0.471 . . . . 0.96 109.727 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 23.8 m -92.77 -29.11 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 117.49 -1.684 . . . . 1.37 111.995 176.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 63.0 m -96.94 25.19 5.52 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 112.203 0.445 . . . . 1.66 112.203 -178.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -54.3 -58.43 13.01 Favored Glycine 0 N--CA 1.472 1.085 0 C-N-CA 120.997 -0.62 . . . . 1.53 112.735 179.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -80.77 -3.63 51.63 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 121.027 0.441 . . . . 2.72 111.27 178.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -99.08 -55.25 2.75 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 112.157 0.429 . . . . 4.33 112.157 -173.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 122.09 143.67 6.59 Favored Glycine 0 C--N 1.301 -1.37 0 N-CA-C 108.64 -1.784 . . . . 1.53 108.64 -173.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . 0.413 ' HB2' ' HB3' ' B' ' 17' ' ' LEU . 41.6 p90 -132.33 146.36 51.92 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 117.52 0.66 . . . . 1.65 110.785 -177.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 27' ' ' TYR . . . . . 0.644 ' HE2' ' HE2' ' B' ' 65' ' ' LYS . 15.4 p90 -160.97 91.36 0.88 Allowed 'General case' 0 CA--C 1.547 0.865 0 CA-C-O 121.245 0.545 . . . . 3.42 111.923 178.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 28' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -103.31 2.5 34.21 Favored 'General case' 0 C--O 1.238 0.482 0 O-C-N 121.187 -0.946 . . . . 2.26 110.932 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 67.5 m -150.43 88.0 1.48 Allowed 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 109.223 -0.658 . . . . 3.68 109.223 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . 0.833 ' HB2' ' HB3' ' B' ' 39' ' ' SER . 47.9 mtp180 -100.49 153.52 37.7 Favored Pre-proline 0 C--N 1.304 -1.38 0 N-CA-C 106.309 -1.738 . . . . 3.81 106.309 -177.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -58.44 -51.55 7.19 Favored 'Trans proline' 0 C--O 1.243 0.755 0 C-N-CA 121.427 1.418 . . . . 4.02 112.52 -175.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -176.55 167.3 2.71 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 106.725 -1.583 . . . . 4.92 106.725 -178.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 25.6 m -152.05 157.61 41.89 Favored 'General case' 0 N--CA 1.394 -3.246 0 N-CA-C 101.988 -3.338 . . . . 6.72 101.988 178.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 33.5 ttm180 -92.5 -3.5 55.05 Favored 'General case' 0 C--N 1.284 -2.256 0 CA-C-O 121.749 0.785 . . . . 11.63 112.639 -169.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 63.6 t -115.87 -29.22 2.15 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.234 0 N-CA-C 108.117 -1.068 . . . . 9.61 108.117 177.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 22.1 t -134.66 75.62 1.59 Allowed 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 107.466 -1.309 . . . . 6.71 107.466 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 28.8 ptt180 -64.73 -15.85 62.1 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 113.617 0.969 . . . . 10.0 113.617 -178.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 31.8 tpt180 -98.1 69.96 2.06 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 106.563 -1.643 . . . . 7.94 106.563 176.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . 0.833 ' HB3' ' HB2' ' B' ' 30' ' ' ARG . 20.3 m -81.44 26.69 0.45 Allowed 'General case' 0 C--N 1.283 -2.315 0 CA-C-N 113.519 -1.673 . . . . 5.76 113.141 -174.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 -140.02 141.84 36.29 Favored 'General case' 0 N--CA 1.431 -1.393 0 O-C-N 121.875 -0.516 . . . . 6.03 110.245 176.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . 0.427 ' C ' ' H ' ' B' ' 43' ' ' VAL . . . -166.59 -175.81 37.14 Favored Glycine 0 N--CA 1.415 -2.73 0 N-CA-C 109.336 -1.506 . . . . 2.37 109.336 -178.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . 0.702 HD11 HD21 ' B' ' 17' ' ' LEU . 11.1 pt 64.6 -24.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 C-N-CA 128.581 2.752 . . . . 2.07 113.866 179.016 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.588 ' O ' ' HB2' ' B' ' 47' ' ' CYS . 2.0 p -50.56 -45.01 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 C-N-CA 124.628 1.171 . . . . 2.24 113.362 177.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -93.89 -39.98 10.4 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.418 -0.956 . . . . 3.36 108.418 -174.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . 0.493 ' O ' ' HB2' ' B' ' 49' ' ' ARG . 3.1 mp0 -55.25 -44.66 75.74 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 113.968 -1.469 . . . . 3.08 111.261 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 46' ' ' CYS . . . . . 0.431 ' HB3' HD21 ' B' ' 13' ' ' LEU . 13.1 t -94.8 -2.16 51.45 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.356 0.598 . . . . 2.23 110.717 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 47' ' ' CYS . . . . . 0.588 ' HB2' ' O ' ' B' ' 43' ' ' VAL . 45.4 t -78.54 -56.88 4.09 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.374 -0.602 . . . . 2.37 109.374 177.227 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -90.97 -12.07 37.07 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.406 0.521 . . . . 2.82 112.406 -175.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . 0.493 ' HB2' ' O ' ' B' ' 45' ' ' GLU . 72.4 mtp180 -129.95 -171.07 2.43 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 107.904 -1.147 . . . . 4.09 107.904 -178.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 8.3 t -110.81 129.79 55.76 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 106.278 -1.749 . . . . 2.67 106.278 178.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 14.7 p -96.44 131.73 42.71 Favored 'General case' 0 N--CA 1.428 -1.57 0 CA-C-O 120.949 0.404 . . . . 2.11 110.148 -174.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -74.68 154.42 38.46 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-N 115.806 -0.634 . . . . 2.67 110.763 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . 0.851 ' HB2' ' HA ' ' A' 1600 ' ' SER . 34.1 tp -55.45 -43.65 75.63 Favored 'General case' 0 C--N 1.309 -1.194 0 O-C-N 123.585 0.553 . . . . 1.9 110.605 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -52.64 -36.75 57.23 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 124.958 1.303 . . . . 1.52 112.043 -176.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 64.2 tp -70.27 -57.88 4.38 Favored 'General case' 0 N--CA 1.427 -1.621 0 CA-C-N 115.451 -0.795 . . . . 1.97 110.676 -179.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.441 ' O ' ' HB2' ' B' ' 60' ' ' CYS . 3.0 pp -68.78 -33.87 74.59 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 111.867 0.321 . . . . 1.53 111.867 -174.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -54.43 -60.64 3.07 Favored 'General case' 0 C--N 1.318 -0.771 0 O-C-N 123.947 0.779 . . . . 2.27 111.679 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 12.4 t -80.74 -25.55 37.96 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 119.974 -0.69 . . . . 2.33 111.995 -175.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -71.7 -40.53 69.45 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 109.096 -0.705 . . . . 2.86 109.096 -179.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 60' ' ' CYS . . . . . 0.441 ' HB2' ' O ' ' B' ' 56' ' ' LEU . 30.4 t -47.12 -68.71 0.17 Allowed 'General case' 0 N--CA 1.485 1.297 0 O-C-N 124.72 1.262 . . . . 2.3 111.335 179.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . 175.59 172.76 0.31 Allowed 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 105.548 -2.019 . . . . 3.19 105.548 -177.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 18.4 p -108.34 154.88 41.16 Favored Pre-proline 0 C--N 1.279 -2.497 0 N-CA-C 109.136 -0.69 . . . . 3.68 109.136 -178.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_exo -54.34 -31.21 66.44 Favored 'Trans proline' 0 C--O 1.243 0.768 0 C-N-CA 123.108 2.539 . . . . 5.08 110.98 176.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -106.55 67.29 0.72 Allowed 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.128 -1.064 . . . . 5.1 108.128 174.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . 0.644 ' HE2' ' HE2' ' B' ' 27' ' ' TYR . 64.6 tttm -51.23 -34.88 34.24 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 125.338 1.455 . . . . 8.51 112.55 -178.005 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 20.0 m -119.65 -71.18 0.75 Allowed 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 108.232 -1.025 . . . . 8.12 108.232 176.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 . . . . . 0 CA--C 1.493 -1.231 0 N-CA-C 106.179 -1.786 . . . . 10.21 106.179 -179.924 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 27.1 ttt . . . . . 0 N--CA 1.466 0.339 0 N-CA-C 108.578 -0.897 . . . . 9.34 108.578 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 25.3 ttmm -159.5 73.28 0.56 Allowed 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 108.801 -0.814 . . . . 9.04 108.801 -174.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 47.4 t 71.36 145.34 0.07 Allowed 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.675 1.19 . . . . 5.81 113.395 176.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1511 ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -93.79 3.77 54.93 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.918 -0.583 . . . . 3.42 110.143 174.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1512 ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 59.69 161.53 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 126.873 2.069 . . . . 5.95 115.732 178.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 55.7 p-80 -149.63 84.76 1.42 Allowed 'General case' 0 N--CA 1.431 -1.378 0 CA-C-O 122.587 1.184 . . . . 5.33 110.68 176.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1514 ' ' ASP . . . . . 0.402 ' CG ' ' H ' ' A' 1515 ' ' ASP . 21.0 t70 -105.2 -152.98 0.48 Allowed 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 105.378 -2.082 . . . . 5.06 105.378 177.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1515 ' ' ASP . . . . . 0.423 ' HB3' ' HE2' ' A' 1579 ' ' LYS . 29.5 m-20 -76.56 -70.81 0.43 Allowed 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 118.98 0.809 . . . . 2.9 109.047 179.115 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1516 ' ' CYS . . . . . 0.493 ' HA ' ' HB2' ' A' 1581 ' ' LEU . 83.7 m -138.64 41.75 2.17 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 116.214 -0.448 . . . . 1.19 111.024 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1517 ' ' GLN . . . . . 0.409 ' HA ' ' O ' ' A' 1527 ' ' PHE . 3.5 pt20 -149.13 137.16 20.66 Favored 'General case' 0 N--CA 1.428 -1.564 0 C-N-CA 120.351 -0.539 . . . . 1.52 109.9 178.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1518 ' ' VAL . . . . . 0.533 HG21 ' HB2' ' A' 1583 ' ' TYR . 10.4 m -140.67 141.06 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 123.16 0.584 . . . . 0.94 110.204 178.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1519 ' ' THR . . . . . . . . . . . . . 9.6 m -101.04 131.2 47.05 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 115.77 -0.65 . . . . 0.89 109.343 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1520 ' ' ASN . . . . . 0.422 ' OD1' HG22 ' A' 1523 ' ' THR . 26.5 t-20 -83.49 118.27 71.04 Favored Pre-proline 0 N--CA 1.426 -1.661 0 N-CA-C 109.332 -0.618 . . . . 1.74 109.332 176.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.14 -16.82 49.88 Favored 'Trans proline' 0 C--O 1.239 0.572 0 C-N-CA 123.224 2.616 . . . . 1.58 113.906 -177.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 74.2 m -77.2 -46.34 23.62 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 112.28 0.474 . . . . 1.65 112.28 -179.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1523 ' ' THR . . . . . 0.422 HG22 ' OD1' ' A' 1520 ' ' ASN . 5.7 t -109.68 -14.43 14.34 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 119.547 -0.861 . . . . 1.61 111.626 -178.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 79.55 31.68 40.25 Favored Glycine 0 N--CA 1.44 -1.044 0 N-CA-C 111.352 -0.699 . . . . 1.13 111.352 178.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1525 ' ' HIS . . . . . 0.401 ' HB2' ' OE2' ' A' 1647 ' ' GLU . 5.2 t-80 -98.22 120.9 39.43 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.623 -0.88 . . . . 1.26 108.623 -178.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 1.9 tm? -86.31 112.66 21.62 Favored 'General case' 0 C--N 1.285 -2.212 0 N-CA-C 107.022 -1.473 . . . . 0.68 107.022 176.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1527 ' ' PHE . . . . . 0.409 ' O ' ' HA ' ' A' 1517 ' ' GLN . 50.1 m-85 -99.79 120.01 39.06 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 109.194 -0.669 . . . . 0.65 109.194 177.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 23.1 t70 -112.64 118.09 34.09 Favored 'General case' 0 CA--C 1.482 -1.657 0 N-CA-C 108.652 -0.87 . . . . 1.17 108.652 177.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 6.0 mp -107.38 5.8 27.73 Favored 'General case' 0 N--CA 1.412 -2.353 0 CA-C-O 121.571 0.7 . . . . 0.6 110.769 -177.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 1.5 m -72.72 -11.08 60.48 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.838 -1.074 . . . . 0.84 109.089 178.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 24.7 m -75.49 -23.63 56.81 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 115.3 -0.864 . . . . 1.59 109.712 176.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 97.9 mt -87.1 -5.16 59.12 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.258 0.552 . . . . 0.65 110.312 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1533 ' ' SER . . . . . 0.488 ' HA ' ' HB ' ' A' 1552 ' ' ILE . 21.0 m -70.53 166.76 19.86 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.842 -0.617 . . . . 1.52 111.862 -178.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . 173.47 164.15 28.24 Favored Glycine 0 N--CA 1.436 -1.301 0 N-CA-C 110.069 -1.212 . . . . 1.1 110.069 -179.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 44.6 ttp180 -92.57 -33.66 14.34 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 121.028 0.442 . . . . 4.62 110.197 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -82.06 -30.83 31.14 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 116.088 -0.505 . . . . 1.45 110.597 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 84.51 -145.65 22.11 Favored Glycine 0 N--CA 1.422 -2.255 0 CA-C-N 115.5 -0.773 . . . . 0.85 113.634 170.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -137.3 153.18 50.34 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 124.98 1.312 . . . . 0.93 107.548 -178.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 8.6 p -115.28 136.93 52.58 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 123.632 0.582 . . . . 1.03 110.508 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1540 ' ' ALA . . . . . 0.447 ' HB3' HG12 ' A' 1548 ' ' VAL . . . -132.61 136.36 46.47 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.969 -1.123 . . . . 0.5 107.969 175.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -84.73 129.31 34.84 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.275 0.559 . . . . 0.74 110.589 -176.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1542 ' ' TYR . . . . . 0.623 ' CE2' ' HG ' ' A' 1626 ' ' LEU . 1.6 t80 -120.04 -100.58 0.43 Allowed 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.588 -1.264 . . . . 0.99 107.588 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1543 ' ' SER . . . . . 0.502 ' H ' ' HB3' ' A' 1542 ' ' TYR . 5.2 m -71.94 161.52 30.81 Favored 'General case' 0 N--CA 1.421 -1.91 0 C-N-CA 124.373 1.069 . . . . 1.91 108.838 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1544 ' ' LYS . . . . . 0.82 ' HG3' ' HB3' ' B' ' 23' ' ' ASP . 39.0 mmtm -72.57 -1.11 14.78 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.398 0.888 . . . . 3.59 113.398 -177.299 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 22.6 t -139.82 37.98 1.99 Allowed 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 108.937 -0.764 . . . . 2.46 108.937 176.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . -172.29 126.58 1.29 Allowed Glycine 0 N--CA 1.434 -1.494 0 C-N-CA 119.555 -1.307 . . . . 1.26 114.166 -178.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 26.8 m -109.1 150.53 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.568 0 N-CA-C 107.184 -1.413 . . . . 0.79 107.184 174.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1548 ' ' VAL . . . . . 0.447 HG12 ' HB3' ' A' 1540 ' ' ALA . 10.0 p -97.46 130.4 46.18 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 C-N-CA 120.171 -0.612 . . . . 0.58 109.403 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -94.22 131.53 39.71 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 108.358 -0.978 . . . . 1.08 108.358 176.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 26.2 ptm -145.59 127.03 14.99 Favored 'General case' 0 C--N 1.286 -2.183 0 CA-C-N 115.471 -0.786 . . . . 0.78 110.983 -177.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 69.1 m -118.15 128.48 54.77 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 115.769 -0.65 . . . . 0.97 109.968 177.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1552 ' ' ILE . . . . . 0.488 ' HB ' ' HA ' ' A' 1533 ' ' SER . 50.7 mm -77.35 125.34 37.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 109.16 -0.682 . . . . 0.42 109.16 -179.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 75.8 m 59.08 39.42 23.26 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.589 0.755 . . . . 1.4 112.045 175.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . -179.99 178.51 48.56 Favored Glycine 0 N--CA 1.42 -2.376 0 C-N-CA 120.096 -1.049 . . . . 0.35 110.919 -177.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1555 ' ' GLU . . . . . 0.403 ' OE1' ' HA ' ' A' 1561 ' ' PRO . 14.6 pt-20 -96.85 160.78 14.17 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 109.337 -0.616 . . . . 1.62 109.337 179.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -103.48 130.29 50.81 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 109.891 -0.411 . . . . 0.87 109.891 -178.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -73.3 2.1 8.15 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.676 0.991 . . . . 2.49 113.676 -175.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -101.71 1.31 37.33 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.91 -0.494 . . . . 1.38 110.427 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1559 ' ' CYS . . . . . 0.613 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 16.1 m -137.03 175.26 3.62 Favored Pre-proline 0 C--N 1.303 -1.421 0 CA-C-O 118.647 -0.692 . . . . 1.21 112.07 -177.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1560 ' ' PRO . . . . . 0.613 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 21.9 Cg_exo -38.76 142.93 0.27 Allowed 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 124.063 3.175 . . . . 0.71 114.562 175.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1561 ' ' PRO . . . . . 0.502 ' HD3' ' HA ' ' A' 1560 ' ' PRO . 31.6 Cg_exo -61.51 126.69 19.77 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.533 2.155 . . . . 0.8 111.018 176.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 100.33 -9.0 59.09 Favored Glycine 0 C--N 1.31 -0.87 0 N-CA-C 114.345 0.498 . . . . 0.46 114.345 178.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1563 ' ' VAL . . . . . 0.607 HG12 ' O ' ' A' 1560 ' ' PRO . 9.8 p -99.9 134.92 37.7 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 O-C-N 121.6 -0.941 . . . . 0.98 111.294 -177.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -95.35 -31.39 7.57 Favored Glycine 0 N--CA 1.453 -0.191 0 CA-C-N 115.725 -0.67 . . . . 0.28 112.854 -177.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -124.14 125.62 44.77 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 109.71 -0.478 . . . . 0.28 109.71 178.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 4.5 t -159.36 141.42 13.52 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 116.492 -0.322 . . . . 0.43 110.361 -177.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1567 ' ' PHE . . . . . 0.516 ' HE1' HG21 ' A' 1574 ' ' VAL . 84.0 m-85 -86.24 139.91 30.6 Favored 'General case' 0 C--O 1.245 0.828 0 N-CA-C 109.61 -0.515 . . . . 1.03 109.61 175.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -86.3 29.85 4.64 Favored Glycine 0 CA--C 1.508 -0.361 0 C-N-CA 120.856 -0.687 . . . . 1.13 112.454 -175.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1569 ' ' GLN . . . . . 0.599 ' HB3' ' OD1' ' B' ' 15' ' ' ASP . 27.7 mt-30 -83.3 -70.58 0.55 Allowed 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 110.281 -0.266 . . . . 2.58 110.281 177.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 8.3 t -130.96 32.31 4.34 Favored 'General case' 0 CA--C 1.557 1.228 0 CA-C-O 121.563 0.697 . . . . 2.17 111.107 176.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1571 ' ' ARG . . . . . 0.413 ' HB3' ' HD3' ' A' 1560 ' ' PRO . 15.2 mmt85 64.64 48.86 2.45 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 124.213 1.005 . . . . 2.62 110.895 178.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 27.8 mt -89.36 120.22 37.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 109.552 -0.536 . . . . 0.92 109.552 -178.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1573 ' ' SER . . . . . 0.412 ' HB3' ' HB3' ' A' 1596 ' ' SER . 29.5 t -76.13 128.72 35.54 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.392 -0.822 . . . . 0.8 111.009 -177.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1574 ' ' VAL . . . . . 0.516 HG21 ' HE1' ' A' 1567 ' ' PHE . 0.9 OUTLIER -112.15 -16.57 9.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 115.884 -0.598 . . . . 0.98 112.084 -179.918 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 179.11 124.5 0.88 Allowed Glycine 0 N--CA 1.435 -1.403 0 C-N-CA 119.34 -1.409 . . . . 0.29 112.4 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 22.2 ttmm -61.65 145.99 50.46 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 123.683 0.793 . . . . 2.19 109.399 178.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -59.63 119.92 8.49 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 108.834 -0.802 . . . . 0.61 108.834 175.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 60.2 t30 -132.49 147.12 52.36 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.474 -1.306 . . . . 1.95 107.474 -174.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1579 ' ' LYS . . . . . 0.423 ' HE2' ' HB3' ' A' 1515 ' ' ASP . 56.4 mtpt -132.27 57.66 1.78 Allowed 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 122.298 1.047 . . . . 2.68 108.772 -175.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 31.2 ttm180 -117.69 76.56 1.07 Allowed 'General case' 0 N--CA 1.413 -2.311 0 CA-C-N 114.775 -1.102 . . . . 3.47 108.051 -176.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1581 ' ' LEU . . . . . 0.493 ' HB2' ' HA ' ' A' 1516 ' ' CYS . 0.6 OUTLIER -64.23 125.72 25.45 Favored 'General case' 0 C--O 1.252 1.196 0 CA-C-N 114.266 -1.334 . . . . 0.64 109.975 -178.103 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A 1582 ' ' ARG . . . . . 0.424 ' HD2' ' OE1' ' A' 1589 ' ' GLN . 91.6 mtt180 -124.48 138.23 54.36 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.865 -0.607 . . . . 2.85 110.391 177.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1583 ' ' TYR . . . . . 0.533 ' HB2' HG21 ' A' 1518 ' ' VAL . 46.0 t80 -110.8 107.26 16.71 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 107.303 -1.369 . . . . 0.86 107.303 174.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1584 ' ' VAL . . . . . 0.49 ' O ' ' HB ' ' A' 1587 ' ' VAL . 16.5 m -120.97 90.1 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 CA-C-N 115.9 -0.591 . . . . 1.05 112.065 -176.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 29.6 t70 58.02 57.66 3.97 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.892 0.853 . . . . 1.17 110.555 178.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1586 ' ' GLN . . . . . 0.47 ' HA ' ' CZ ' ' A' 1583 ' ' TYR . 2.1 pt20 73.99 -7.64 1.58 Allowed 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 128.243 2.617 . . . . 1.86 111.476 178.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1587 ' ' VAL . . . . . 0.49 ' HB ' ' O ' ' A' 1584 ' ' VAL . 30.5 t -88.07 124.9 41.46 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.444 0 CA-C-N 115.719 -0.673 . . . . 0.49 109.337 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1588 ' ' LEU . . . . . 0.736 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 3.3 mm? -93.93 120.85 34.74 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 107.581 -1.266 . . . . 0.36 107.581 179.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1589 ' ' GLN . . . . . 0.424 ' OE1' ' HD2' ' A' 1582 ' ' ARG . 35.8 tt0 -116.78 135.65 53.59 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 112.63 0.604 . . . . 1.74 112.63 -173.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 18.3 mt -129.96 99.25 5.03 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 125.373 1.469 . . . . 0.72 107.224 172.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 7.5 p -95.81 125.87 48.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 109.527 -0.546 . . . . 1.01 109.527 -178.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1592 ' ' TYR . . . . . 0.603 ' HB2' ' HB3' ' A' 1608 ' ' SER . 15.8 m-30 -110.76 107.1 16.51 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 108.592 -0.892 . . . . 0.5 108.592 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 19.5 pttp -109.68 168.77 9.17 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 115.557 -0.747 . . . . 1.59 110.057 -177.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 15.3 m-20 66.29 78.89 0.25 Allowed 'General case' 0 CA--C 1.507 -0.681 0 C-N-CA 124.488 1.115 . . . . 1.11 110.69 -178.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -98.99 -122.07 4.65 Favored Glycine 0 C--N 1.287 -2.143 0 N-CA-C 109.703 -1.359 . . . . 0.78 109.703 175.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1596 ' ' SER . . . . . 0.412 ' HB3' ' HB3' ' A' 1573 ' ' SER . 50.7 p -120.29 164.68 21.3 Favored Pre-proline 0 C--N 1.297 -1.683 0 N-CA-C 107.927 -1.138 . . . . 1.07 107.927 175.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.16 119.94 7.53 Favored 'Trans proline' 0 C--N 1.361 1.214 0 C-N-CA 122.317 2.012 . . . . 1.01 112.306 -178.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1598 ' ' CYS . . . . . 0.434 ' HA ' ' HD3' ' A' 1599 ' ' PRO . 44.5 t -81.08 125.21 80.18 Favored Pre-proline 0 C--N 1.292 -1.901 0 CA-C-N 115.129 -0.941 . . . . 0.75 109.182 -179.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1599 ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' 1598 ' ' CYS . 14.9 Cg_exo -71.1 -15.15 32.16 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 123.429 2.753 . . . . 1.7 112.995 -178.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1600 ' ' SER . . . . . 0.836 ' HA ' ' HB3' ' B' ' 53' ' ' LEU . 10.6 m -59.0 -40.89 86.28 Favored 'General case' 0 N--CA 1.434 -1.257 0 C-N-CA 123.296 0.638 . . . . 2.26 111.635 177.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1601 ' ' LYS . . . . . . . . . . . . . 18.5 ttmm -145.9 127.18 14.84 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 106.832 -1.544 . . . . 3.01 106.832 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 19.2 m -61.94 117.18 5.59 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 112.176 0.435 . . . . 2.07 112.176 -174.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 95.16 14.68 47.62 Favored Glycine 0 C--O 1.241 0.539 0 C-N-CA 121.404 -0.427 . . . . 1.08 112.846 178.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1604 ' ' LEU . . . . . 0.605 HD23 ' SG ' ' A' 1634 ' ' CYS . 12.5 tp -108.16 157.11 18.59 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.861 -1.163 . . . . 1.84 107.861 -178.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 33.4 t -120.53 154.32 35.5 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.965 -0.754 . . . . 1.41 108.965 -178.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1606 ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -76.35 158.26 31.63 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.901 -0.777 . . . . 0.6 108.901 174.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 56.7 pttt -158.4 140.81 14.28 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 120.397 -0.521 . . . . 1.45 110.976 175.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1608 ' ' SER . . . . . 0.603 ' HB3' ' HB2' ' A' 1592 ' ' TYR . 45.4 t -105.68 127.88 53.33 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 115.168 -0.924 . . . . 1.15 109.894 -175.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 40.8 t -113.72 101.75 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 N-CA-C 108.905 -0.776 . . . . 0.25 108.905 176.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 80.4 mt -91.87 114.53 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.611 0 N-CA-C 107.85 -1.167 . . . . 0.45 107.85 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 8.1 t -116.9 111.59 19.86 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 115.401 -0.818 . . . . 1.26 109.703 -176.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1612 ' ' PHE . . . . . 0.736 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 71.2 m-85 -90.86 118.36 30.21 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.733 -0.667 . . . . 0.26 110.036 179.066 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 47.6 t -120.69 138.0 52.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.721 -0.672 . . . . 0.5 110.575 -174.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1614 ' ' CYS . . . . . 0.415 ' HA ' ' HB2' ' A' 1646 ' ' CYS . 15.3 t -51.49 114.87 1.36 Allowed 'General case' 0 C--O 1.247 0.929 0 C-N-CA 125.409 1.484 . . . . 0.77 113.088 176.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1615 ' ' ARG . . . . . 0.817 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 18.8 tpt180 -128.22 96.6 30.77 Favored Pre-proline 0 N--CA 1.436 -1.139 0 N-CA-C 109.243 -0.651 . . . . 2.53 109.243 173.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1616 ' ' PRO . . . . . 0.447 ' HD2' ' OE1' ' A' 1617 ' ' GLU . 31.7 Cg_exo -62.43 -37.42 59.98 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 121.909 1.739 . . . . 1.1 111.311 175.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1617 ' ' GLU . . . . . 0.447 ' OE1' ' HD2' ' A' 1616 ' ' PRO . 2.6 mp0 -77.82 44.39 0.46 Allowed 'General case' 0 C--O 1.24 0.571 0 C-N-CA 124.89 1.276 . . . . 3.05 112.059 178.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -37.15 132.63 0.72 Allowed 'General case' 0 C--O 1.244 0.792 0 C-N-CA 125.296 1.438 . . . . 1.55 112.613 178.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1619 ' ' GLY . . . . . 0.442 ' HA3' ' HD2' ' A' 1620 ' ' PRO . . . 172.46 -137.33 4.18 Favored Glycine 0 N--CA 1.423 -2.221 0 N-CA-C 110.195 -1.162 . . . . 0.93 110.195 -177.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1620 ' ' PRO . . . . . 0.442 ' HD2' ' HA3' ' A' 1619 ' ' GLY . 36.3 Cg_endo -63.68 -1.46 3.33 Favored 'Trans proline' 0 CA--C 1.551 1.335 0 C-N-CA 123.269 2.646 . . . . 0.88 114.852 -178.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1621 ' ' THR . . . . . 0.632 ' HB ' ' HB2' ' A' 1641 ' ' HIS . 5.2 p -89.96 -11.82 40.55 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 121.807 0.813 . . . . 0.97 109.785 177.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 48.5 t30 -92.66 55.34 2.43 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 122.679 1.228 . . . . 0.72 109.599 -178.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -156.59 139.19 10.55 Favored Pre-proline 0 C--N 1.3 -1.55 0 N-CA-C 106.514 -1.661 . . . . 3.26 106.514 178.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -61.72 113.9 2.03 Favored 'Trans proline' 0 C--O 1.245 0.863 0 C-N-CA 122.881 2.387 . . . . 0.59 112.123 -176.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 75.3 mtm -117.17 140.13 49.91 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 116.508 -0.314 . . . . 1.37 110.603 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1626 ' ' LEU . . . . . 0.623 ' HG ' ' CE2' ' A' 1542 ' ' TYR . 0.3 OUTLIER -87.99 115.18 25.28 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 107.681 -1.229 . . . . 0.89 107.681 -175.463 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 48.8 mm -80.12 -49.46 18.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 CA-C-N 116.249 -0.432 . . . . 0.58 109.839 -178.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 33.1 t -167.78 149.53 5.51 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.545 -0.752 . . . . 1.39 110.134 -175.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1629 ' ' LEU . . . . . 0.612 HD13 ' HG ' ' A' 1636 ' ' LEU . 48.0 tp -112.63 105.59 13.8 Favored 'General case' 0 N--CA 1.418 -2.053 0 N-CA-C 107.116 -1.439 . . . . 1.25 107.116 173.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 30.4 t70 -76.92 114.38 15.63 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.462 -0.895 . . . . 1.09 108.994 178.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1631 ' ' LYS . . . . . 0.411 ' HB3' HD11 ' B' ' 53' ' ' LEU . 98.7 mttt -66.91 -21.1 66.0 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 113.445 0.905 . . . . 3.6 113.445 -174.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -86.32 -35.26 19.98 Favored 'General case' 0 CA--C 1.497 -1.071 0 CA-C-O 121.343 0.592 . . . . 2.6 111.348 -177.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 53.5 p -104.9 -7.03 19.62 Favored 'General case' 0 C--N 1.285 -2.198 0 CA-C-N 115.741 -0.663 . . . . 0.75 112.391 -175.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1634 ' ' CYS . . . . . 0.605 ' SG ' HD23 ' A' 1604 ' ' LEU . 75.0 m 56.38 34.61 24.48 Favored 'General case' 0 C--N 1.363 1.156 0 C-N-CA 124.284 1.033 . . . . 0.53 110.934 -177.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1635 ' ' THR . . . . . . . . . . . . . 88.2 m -99.03 129.26 45.3 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-N 114.193 -1.367 . . . . 0.46 109.979 -177.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1636 ' ' LEU . . . . . 0.612 ' HG ' HD13 ' A' 1629 ' ' LEU . 1.5 mp -108.02 121.33 44.58 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 107.542 -1.281 . . . . 0.86 107.542 -179.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -95.02 131.22 41.22 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 120.685 0.279 . . . . 0.45 110.542 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -126.26 119.34 27.17 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.716 -0.675 . . . . 0.5 109.343 -176.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1639 ' ' SER . . . . . . . . . . . . . 59.7 m -103.15 138.15 40.36 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 115.781 -0.645 . . . . 1.04 109.567 175.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 2.8 t90 -141.85 113.19 7.61 Favored 'General case' 0 N--CA 1.422 -1.84 0 N-CA-C 103.95 -2.611 . . . . 0.68 103.95 178.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1641 ' ' HIS . . . . . 0.817 ' HB3' ' HB2' ' A' 1615 ' ' ARG . 18.1 m-70 -107.08 111.04 23.31 Favored 'General case' 0 C--N 1.286 -2.182 0 C-N-CA 120.067 -0.653 . . . . 0.9 110.402 -174.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1642 ' ' THR . . . . . . . . . . . . . 4.9 t -142.75 150.07 52.36 Favored Pre-proline 0 C--N 1.306 -1.29 0 CA-C-N 115.479 -0.782 . . . . 0.48 109.683 -174.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1643 ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -76.64 -6.39 16.9 Favored 'Trans proline' 0 C--N 1.366 1.483 0 C-N-CA 122.281 1.987 . . . . 0.66 112.316 175.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 8.6 tt -64.45 -30.27 71.31 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.435 0.636 . . . . 0.97 109.445 177.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -94.51 8.03 43.58 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.051 -0.977 . . . . 0.84 109.828 -177.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1646 ' ' CYS . . . . . 0.561 ' O ' ' HD3' ' A' 1648 ' ' PRO . 33.7 t -122.09 158.54 29.03 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 115.532 -0.758 . . . . 1.19 109.496 -173.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1647 ' ' GLU . . . . . 0.401 ' OE2' ' HB2' ' A' 1525 ' ' HIS . 8.6 tp10 -99.85 96.09 4.45 Favored Pre-proline 0 N--CA 1.417 -2.094 0 N-CA-C 106.728 -1.582 . . . . 3.14 106.728 171.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1648 ' ' PRO . . . . . 0.561 ' HD3' ' O ' ' A' 1646 ' ' CYS . 23.2 Cg_exo -67.29 118.02 5.26 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 122.56 2.173 . . . . 2.58 111.804 -179.031 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 32.8 tt0 . . . . . 0 C--N 1.292 -1.893 0 N-CA-C 106.003 -1.851 . . . . 4.72 106.003 176.135 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.142 0 CA-C-O 121.816 0.817 . . . . 9.97 109.992 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -142.38 136.25 29.41 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 107.275 -1.38 . . . . 7.68 107.275 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 20.4 ptp180 -89.01 110.03 35.03 Favored Pre-proline 0 C--N 1.307 -1.254 0 O-C-N 123.126 0.266 . . . . 6.11 110.416 -179.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -66.88 -17.08 51.48 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 121.675 1.584 . . . . 4.84 113.167 178.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 66.9 m 51.69 23.74 2.1 Favored 'General case' 0 C--O 1.25 1.083 0 C-N-CA 125.576 1.55 . . . . 4.6 113.613 177.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 57.78 30.08 18.43 Favored 'General case' 0 C--N 1.349 0.558 0 CA-C-N 114.105 -1.407 . . . . 4.23 110.492 178.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 20.3 p -133.33 131.55 40.26 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 114.821 -1.081 . . . . 3.14 111.313 -179.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.779 ' HB2' ' HG3' ' B' ' 12' ' ' GLU . 4.2 mm? -90.46 115.4 27.59 Favored 'General case' 0 C--O 1.251 1.151 0 N-CA-C 109.31 -0.626 . . . . 3.96 109.31 173.028 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 57.4 m -74.72 85.12 2.14 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.761 0.791 . . . . 2.84 110.998 -176.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.7 -50.66 0.87 Allowed Glycine 0 N--CA 1.421 -2.343 0 N-CA-C 110.576 -1.01 . . . . 2.09 110.576 178.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.22 -62.67 4.48 Favored Glycine 0 N--CA 1.444 -0.806 0 O-C-N 123.98 0.459 . . . . 1.84 112.972 -179.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . 0.779 ' HG3' ' HB2' ' B' ' 8' ' ' LEU . 77.7 mt-10 -69.53 -27.06 64.84 Favored 'General case' 0 CA--C 1.496 -1.108 0 C-N-CA 120.186 -0.606 . . . . 2.55 109.416 177.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . 0.505 ' O ' HD23 ' B' ' 17' ' ' LEU . 0.1 OUTLIER -57.32 -57.89 10.64 Favored 'General case' 0 C--O 1.212 -0.898 0 CA-C-N 115.651 -0.704 . . . . 2.35 109.726 176.319 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 13.7 p -66.07 -34.09 67.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.981 -0.288 . . . . 2.11 111.148 -178.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 15' ' ' ASP . . . . . 0.599 ' OD1' ' HB3' ' A' 1569 ' ' GLN . 29.3 t70 -71.22 -40.84 70.85 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 113.658 0.984 . . . . 2.04 113.658 -177.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 21.6 p -66.8 -40.92 88.28 Favored 'General case' 0 C--O 1.262 1.739 0 CA-C-O 121.644 0.735 . . . . 1.84 109.917 176.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.505 HD23 ' O ' ' B' ' 13' ' ' LEU . 4.1 mm? -52.95 -50.12 64.69 Favored 'General case' 0 C--O 1.213 -0.824 0 CA-C-N 114.896 -1.047 . . . . 1.74 110.598 170.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -67.09 -25.68 66.34 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 123.841 0.857 . . . . 2.39 111.777 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -58.59 -55.27 37.25 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 116.019 -0.537 . . . . 0.96 110.982 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 14.7 p -99.08 -22.19 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.07 0 C-N-CA 118.105 -1.438 . . . . 1.37 112.819 178.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 21' ' ' CYS . . . . . 0.503 ' HB2' ' HB3' ' B' ' 26' ' ' PHE . 57.9 m -103.36 24.89 10.29 Favored 'General case' 0 C--N 1.315 -0.914 0 O-C-N 121.555 -0.716 . . . . 1.66 110.881 -178.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.69 -67.79 2.01 Favored Glycine 0 N--CA 1.461 0.345 0 C-N-CA 121.424 -0.417 . . . . 1.53 113.414 -177.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.82 ' HB3' ' HG3' ' A' 1544 ' ' LYS . 8.8 p-10 -76.88 -4.16 42.3 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 122.826 0.45 . . . . 2.72 111.646 179.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . 0.511 ' HG2' ' O ' ' B' ' 61' ' ' ALA . 21.1 tpp180 -97.48 -42.71 7.58 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 116.02 -0.536 . . . . 4.33 111.745 -175.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 112.73 121.76 3.9 Favored Glycine 0 N--CA 1.426 -2.028 0 N-CA-C 108.998 -1.641 . . . . 1.53 108.998 -174.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . 0.609 ' HA ' ' SG ' ' B' ' 60' ' ' CYS . 13.4 p90 -98.12 144.94 27.07 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 117.422 0.611 . . . . 1.65 111.318 -179.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 27' ' ' TYR . . . . . 0.491 ' CE2' ' HB2' ' B' ' 61' ' ' ALA . 19.4 m-85 -125.64 105.05 8.72 Favored 'General case' 0 C--O 1.218 -0.581 0 N-CA-C 113.003 0.742 . . . . 3.42 113.003 -175.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 28' ' ' PHE . . . . . 0.499 ' CD2' ' HG ' ' B' ' 17' ' ' LEU . 53.8 p90 -150.67 23.6 0.79 Allowed 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 121.471 0.653 . . . . 2.26 109.84 162.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 27.5 m -139.89 105.81 5.19 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 108.874 -0.787 . . . . 3.68 108.874 -177.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 -123.22 159.33 54.98 Favored Pre-proline 0 C--N 1.296 -1.761 0 N-CA-C 108.111 -1.07 . . . . 3.81 108.111 -176.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -82.21 9.77 3.84 Favored 'Trans proline' 0 C--O 1.252 1.222 0 C-N-CA 122.765 2.31 . . . . 4.02 111.177 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . 76.67 152.77 0.13 Allowed 'General case' 0 N--CA 1.422 -1.859 0 C-N-CA 126.968 2.107 . . . . 4.92 109.89 179.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 29.9 m -150.16 175.09 12.07 Favored 'General case' 1 N--CA 1.356 -5.128 0 N-CA-C 102.811 -3.033 . . . . 6.72 102.811 -176.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -81.3 -27.03 35.23 Favored 'General case' 0 C--N 1.26 -3.31 0 CA-C-N 120.303 1.411 . . . . 11.63 107.795 -178.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 21.3 t -93.35 6.29 6.54 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-O 122.304 1.05 . . . . 9.61 108.656 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 34.0 t -156.04 69.34 0.65 Allowed 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 106.937 -1.505 . . . . 6.71 106.937 -177.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -56.68 -41.85 78.02 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 114.038 -1.437 . . . . 10.0 111.262 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 -60.44 109.5 1.02 Allowed 'General case' 0 N--CA 1.431 -1.398 0 O-C-N 124.085 0.865 . . . . 7.94 110.576 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 14.9 m -71.3 -35.65 71.36 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 107.817 -1.179 . . . . 5.76 107.817 176.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 -123.44 130.6 52.94 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 106.918 -1.512 . . . . 6.03 106.918 170.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . 0.433 ' O ' ' HB2' ' B' ' 28' ' ' PHE . . . -114.67 164.69 12.06 Favored Glycine 0 N--CA 1.413 -2.882 0 N-CA-C 109.685 -1.366 . . . . 2.37 109.685 -176.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . 0.262 23.0 pt 59.8 -27.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 C-N-CA 127.849 2.46 . . . . 2.07 115.583 178.136 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.495 ' O ' ' HB2' ' B' ' 47' ' ' CYS . 2.5 p -53.98 -41.29 48.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 C-N-CA 124.566 1.146 . . . . 2.24 112.738 177.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -95.47 -25.84 16.07 Favored 'General case' 0 N--CA 1.419 -1.997 0 N-CA-C 109.048 -0.723 . . . . 3.36 109.048 -173.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 22.0 tp10 -61.11 -56.66 18.34 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 114.651 -1.159 . . . . 3.08 108.441 176.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 46' ' ' CYS . . . . . . . . . . . . . 56.5 m -84.83 2.59 41.73 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.069 -0.514 . . . . 2.23 111.945 -177.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 47' ' ' CYS . . . . . 0.495 ' HB2' ' O ' ' B' ' 43' ' ' VAL . 49.7 t -78.89 -48.0 15.45 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 120.257 -0.577 . . . . 2.37 109.537 176.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -101.66 -2.27 30.75 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.053 -0.521 . . . . 2.82 111.81 -176.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 21.0 mmt180 -132.56 162.89 30.12 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.896 -1.15 . . . . 4.09 107.896 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 1.9 p -102.4 127.66 49.33 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 108.371 -0.974 . . . . 2.67 108.371 176.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 85.2 m -106.81 171.35 7.41 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.568 0.699 . . . . 2.11 112.257 -172.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -126.35 158.33 36.15 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 105.839 -1.911 . . . . 2.67 105.839 173.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . 0.836 ' HB3' ' HA ' ' A' 1600 ' ' SER . 2.6 pt? -60.71 -21.19 62.64 Favored 'General case' 0 CA--C 1.501 -0.936 0 N-CA-C 114.693 1.368 . . . . 1.9 114.693 -167.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . 0.408 ' O ' HG22 ' B' ' 58' ' ' THR . . . -58.31 -29.46 65.91 Favored 'General case' 0 CA--C 1.514 -0.415 0 O-C-N 123.509 0.505 . . . . 1.52 111.282 -176.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . 0.401 ' O ' ' HB2' ' B' ' 59' ' ' TYR . 64.9 tp -65.06 -54.82 24.18 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 115.636 -0.711 . . . . 1.97 110.16 178.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 1.3 pp -76.04 -32.69 59.46 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 116.588 -0.278 . . . . 1.53 111.483 -175.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -55.51 -49.01 73.73 Favored 'General case' 0 C--N 1.318 -0.803 0 O-C-N 123.83 0.706 . . . . 2.27 110.553 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 58' ' ' THR . . . . . 0.408 HG22 ' O ' ' B' ' 54' ' ' ALA . 10.9 t -86.78 -17.41 33.58 Favored 'General case' 0 CA--C 1.567 1.607 0 N-CA-C 112.405 0.52 . . . . 2.33 112.405 -177.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 59' ' ' TYR . . . . . 0.401 ' HB2' ' O ' ' B' ' 55' ' ' LEU . 10.8 t80 -86.67 -37.52 17.92 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.52 -0.737 . . . . 2.86 109.961 -178.007 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 60' ' ' CYS . . . . . 0.609 ' SG ' ' HA ' ' B' ' 26' ' ' PHE . 6.6 t -82.35 171.2 14.47 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.466 -0.788 . . . . 2.3 111.461 -178.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 61' ' ' ALA . . . . . 0.911 ' HA ' ' HD2' ' B' ' 65' ' ' LYS . . . -85.05 113.77 21.71 Favored 'General case' 0 N--CA 1.422 -1.831 0 N-CA-C 106.906 -1.516 . . . . 3.19 106.906 175.031 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 62' ' ' THR . . . . . 0.702 ' H ' ' HB2' ' B' ' 65' ' ' LYS . 2.9 p -125.07 159.98 56.7 Favored Pre-proline 0 C--N 1.279 -2.478 0 CA-C-O 118.639 -0.696 . . . . 3.68 110.086 -176.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -45.71 -44.52 17.69 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 122.613 2.208 . . . . 5.08 113.464 178.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -107.17 42.8 1.25 Allowed 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 116.005 -0.543 . . . . 5.1 110.718 178.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . 0.911 ' HD2' ' HA ' ' B' ' 61' ' ' ALA . 48.8 tttm -64.92 140.49 58.87 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.689 -0.687 . . . . 8.51 111.036 179.089 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . 0.43 ' O ' ' HG2' ' B' ' 65' ' ' LYS . 46.9 m -90.26 171.97 9.11 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 109.208 -0.664 . . . . 8.12 109.208 176.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.297 -1.688 0 N-CA-C 106.304 -1.739 . . . . 10.21 106.304 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 26.7 ptt? . . . . . 0 N--CA 1.47 0.526 0 CA-C-O 120.462 0.172 . . . . 9.34 110.808 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 51.1 tptt -142.56 83.83 1.83 Allowed 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 108.695 -0.854 . . . . 9.04 108.695 -174.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 30.6 t -142.02 37.21 1.58 Allowed 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 105.98 -1.859 . . . . 5.81 105.98 -177.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1511 ' ' ASN . . . . . . . . . . . . . 16.3 m120 -98.99 1.51 45.52 Favored 'General case' 0 C--N 1.284 -2.251 0 CA-C-N 113.506 -1.679 . . . . 3.42 112.531 -172.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1512 ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -81.08 -57.23 3.62 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 108.159 -1.052 . . . . 5.95 108.159 176.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 6.3 p-80 -164.39 130.2 2.9 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-O 121.122 0.487 . . . . 5.33 111.707 177.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 12.9 t70 -97.11 -137.28 0.26 Allowed 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 103.829 -2.656 . . . . 5.06 103.829 171.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 34.3 t70 -70.62 -74.15 0.15 Allowed 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 119.779 1.172 . . . . 2.9 108.893 173.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 12.6 t -150.89 61.38 0.92 Allowed 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 106.431 -1.692 . . . . 1.19 106.431 172.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 26.1 pt20 -165.13 162.92 20.43 Favored 'General case' 0 N--CA 1.419 -1.998 0 N-CA-C 106.485 -1.672 . . . . 1.52 106.485 -175.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1518 ' ' VAL . . . . . 0.668 HG21 ' HB2' ' A' 1583 ' ' TYR . 0.0 OUTLIER -154.59 146.05 13.61 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 O-C-N 123.896 0.747 . . . . 0.94 110.449 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A 1519 ' ' THR . . . . . . . . . . . . . 49.9 m -98.09 137.69 36.51 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 115.965 -0.561 . . . . 0.89 109.561 176.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1520 ' ' ASN . . . . . 0.498 ' ND2' ' OH ' ' A' 1583 ' ' TYR . 21.2 t-20 -79.31 117.27 66.09 Favored Pre-proline 0 N--CA 1.43 -1.46 0 N-CA-C 108.6 -0.889 . . . . 1.74 108.6 174.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -69.56 -10.79 29.62 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 122.687 2.258 . . . . 1.58 113.586 -176.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 19.7 m -82.47 -44.22 16.27 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 120.77 0.319 . . . . 1.65 111.809 -178.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1523 ' ' THR . . . . . . . . . . . . . 9.0 t -122.16 -3.23 9.03 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 119.459 -0.896 . . . . 1.61 112.24 -177.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 80.46 16.34 76.15 Favored Glycine 0 C--O 1.238 0.344 0 C-N-CA 120.691 -0.766 . . . . 1.13 112.708 175.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 81.1 t60 -80.69 125.3 29.87 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 120.832 0.348 . . . . 1.26 110.546 -178.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 1.2 tm? -90.38 108.39 19.75 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 114.921 -1.036 . . . . 0.68 108.981 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -87.9 111.32 21.31 Favored 'General case' 0 CA--C 1.499 -0.981 0 N-CA-C 107.981 -1.118 . . . . 0.65 107.981 177.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -101.71 134.72 44.42 Favored 'General case' 0 N--CA 1.404 -2.737 0 N-CA-C 107.123 -1.436 . . . . 1.17 107.123 174.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 3.4 mm? -100.94 5.15 43.12 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-O 122.017 0.913 . . . . 0.6 108.687 177.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 4.0 m -64.82 -32.91 74.82 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.102 -1.408 . . . . 0.84 109.75 178.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1531 ' ' SER . . . . . 0.611 ' HB2' HD11 ' A' 1644 ' ' LEU . 46.0 m -66.28 -25.74 67.01 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.952 -0.567 . . . . 1.59 111.238 177.162 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 90.1 mt -97.11 -1.11 45.9 Favored 'General case' 0 C--O 1.215 -0.72 0 CA-C-O 121.194 0.521 . . . . 0.65 110.463 176.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1533 ' ' SER . . . . . . . . . . . . . 46.8 t -85.25 175.03 9.18 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.329 0.585 . . . . 1.52 110.145 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . 170.33 169.15 33.12 Favored Glycine 0 C--N 1.299 -1.512 0 N-CA-C 109.019 -1.633 . . . . 1.1 109.019 -179.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -92.5 -35.38 13.65 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 117.239 0.519 . . . . 4.62 110.518 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1536 ' ' ALA . . . . . 0.626 ' HA ' ' HG2' ' A' 1557 ' ' GLU . . . -77.35 -35.43 54.65 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 121.376 0.608 . . . . 1.45 109.919 -179.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 91.59 -149.98 20.1 Favored Glycine 0 N--CA 1.42 -2.399 0 CA-C-N 115.274 -0.876 . . . . 0.85 111.78 176.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -137.41 149.32 46.84 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.654 -0.869 . . . . 0.93 108.654 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1539 ' ' THR . . . . . 0.456 ' HA ' ' O ' ' A' 1548 ' ' VAL . 4.0 m -125.08 122.11 36.26 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 109.326 -0.62 . . . . 1.03 109.326 -177.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1540 ' ' ALA . . . . . 0.521 ' HB3' ' CG1' ' A' 1548 ' ' VAL . . . -115.38 150.18 36.77 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 108.113 -1.069 . . . . 0.5 108.113 -178.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -93.35 138.78 31.36 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 121.108 0.48 . . . . 0.74 111.179 -176.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1542 ' ' TYR . . . . . 0.828 ' HE1' ' HG ' ' A' 1626 ' ' LEU . 1.5 t80 -121.77 -101.33 0.41 Allowed 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 107.625 -1.25 . . . . 0.99 107.625 -179.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1543 ' ' SER . . . . . 0.422 ' H ' ' HB3' ' A' 1542 ' ' TYR . 32.8 t -66.8 159.75 27.39 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 107.304 -1.369 . . . . 1.91 107.304 172.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 62.7 mttp -59.38 -37.05 76.93 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-N 119.921 1.237 . . . . 3.59 113.619 -175.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 14.7 t -100.83 15.19 29.25 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 110.104 -0.332 . . . . 2.46 110.104 178.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1546 ' ' GLY . . . . . 0.498 ' HA2' ' OE1' ' A' 1569 ' ' GLN . . . -130.42 147.95 18.44 Favored Glycine 0 CA--C 1.54 1.633 0 C-N-CA 120.03 -1.081 . . . . 1.26 114.092 -174.074 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 22.6 m -136.67 176.94 6.85 Favored 'Isoleucine or valine' 0 C--O 1.252 1.235 0 CA-C-N 117.488 0.644 . . . . 0.79 110.573 -178.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1548 ' ' VAL . . . . . 0.84 ' HB ' ' CE1' ' A' 1567 ' ' PHE . 7.3 p -127.1 136.63 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 CA-C-N 115.034 -0.985 . . . . 0.58 109.913 175.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1549 ' ' TYR . . . . . 0.599 ' HB2' ' HB3' ' A' 1566 ' ' CYS . 62.0 m-85 -101.63 116.04 31.87 Favored 'General case' 0 C--N 1.293 -1.854 0 C-N-CA 124.812 1.245 . . . . 1.08 108.186 177.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 8.6 ptp -125.43 146.39 49.64 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 120.189 -0.604 . . . . 0.78 110.455 175.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 8.2 p -129.46 119.79 24.36 Favored 'General case' 0 C--N 1.281 -2.398 0 CA-C-N 115.763 -0.653 . . . . 0.97 109.579 174.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1552 ' ' ILE . . . . . . . . . . . . . 38.7 mm -81.5 116.97 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.668 0 C-N-CA 120.84 -0.344 . . . . 0.42 110.238 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 64.3 m 69.84 26.94 4.66 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.108 0.963 . . . . 1.4 111.649 175.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . -172.3 -167.67 32.67 Favored Glycine 0 CA--C 1.482 -2.004 0 C-N-CA 120.098 -1.048 . . . . 0.35 111.233 -177.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -107.94 135.79 48.73 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-O 121.165 0.507 . . . . 1.62 111.374 -178.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -78.93 129.2 34.24 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.632 -0.713 . . . . 0.87 109.37 -174.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1557 ' ' GLU . . . . . 0.626 ' HG2' ' HA ' ' A' 1536 ' ' ALA . 5.3 pt-20 -73.33 -12.73 60.93 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.633 0.975 . . . . 2.49 113.633 -174.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 9.7 m120 -89.19 -2.74 58.63 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 120.48 -0.488 . . . . 1.38 110.373 -173.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1559 ' ' CYS . . . . . 0.59 ' SG ' ' HD2' ' A' 1560 ' ' PRO . 34.2 t -135.81 155.82 77.73 Favored Pre-proline 0 C--N 1.308 -1.196 0 N-CA-C 108.255 -1.017 . . . . 1.21 108.255 -175.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1560 ' ' PRO . . . . . 0.59 ' HD2' ' SG ' ' A' 1559 ' ' CYS . 69.1 Cg_exo -29.06 132.83 0.04 OUTLIER 'Trans proline' 0 C--N 1.379 2.134 1 C-N-CA 125.7 4.267 . . . . 0.71 114.73 176.175 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A 1561 ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' 1560 ' ' PRO . 9.6 Cg_endo -48.77 127.62 17.0 Favored 'Trans proline' 0 CA--C 1.547 1.147 0 C-N-CA 124.443 3.428 . . . . 0.8 114.306 -178.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 101.05 1.05 54.79 Favored Glycine 0 CA--C 1.525 0.672 0 CA-C-N 115.589 -0.732 . . . . 0.46 114.78 176.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1563 ' ' VAL . . . . . 0.475 HG11 ' SG ' ' A' 1559 ' ' CYS . 7.7 p -102.26 137.73 29.13 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 C-N-CA 119.626 -0.83 . . . . 0.98 111.18 -175.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -100.05 -31.86 5.79 Favored Glycine 0 CA--C 1.521 0.417 0 CA-C-N 115.526 -0.761 . . . . 0.28 112.681 -178.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -127.53 128.61 45.93 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 108.473 -0.936 . . . . 0.28 108.473 178.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1566 ' ' CYS . . . . . 0.599 ' HB3' ' HB2' ' A' 1549 ' ' TYR . 45.2 t -145.76 124.88 12.86 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 110.376 -0.231 . . . . 0.43 110.376 -176.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1567 ' ' PHE . . . . . 0.84 ' CE1' ' HB ' ' A' 1548 ' ' VAL . 9.7 m-85 -110.51 160.36 16.69 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 122.597 0.359 . . . . 1.03 110.296 175.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . 100.19 156.01 27.92 Favored Glycine 1 N--CA 1.394 -4.159 0 C-N-CA 119.353 -1.403 . . . . 1.13 112.026 171.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1569 ' ' GLN . . . . . 0.498 ' OE1' ' HA2' ' A' 1546 ' ' GLY . 2.3 mp0 -84.92 -23.5 28.83 Favored 'General case' 0 C--N 1.284 -2.272 0 N-CA-C 107.571 -1.27 . . . . 2.58 107.571 179.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 24.3 p -82.65 -11.7 58.18 Favored 'General case' 0 N--CA 1.423 -1.781 0 CA-C-N 115.353 -0.839 . . . . 2.17 111.68 176.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1571 ' ' ARG . . . . . 0.452 ' HG3' ' CE2' ' A' 1549 ' ' TYR . 4.8 mpt_? 73.76 75.21 0.13 Allowed 'General case' 0 CA--C 1.506 -0.726 0 C-N-CA 124.311 1.044 . . . . 2.62 111.251 178.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 61.5 mt -98.46 121.65 49.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 CA-C-N 114.074 -1.421 . . . . 0.92 109.505 -177.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1573 ' ' SER . . . . . 0.452 ' HB3' ' HB3' ' A' 1596 ' ' SER . 17.7 t -65.55 124.79 23.27 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.532 -0.758 . . . . 0.8 110.866 -178.468 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1574 ' ' VAL . . . . . 0.59 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 32.8 m -126.48 20.21 3.51 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-O 121.866 0.841 . . . . 0.98 110.746 178.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 164.23 113.54 0.29 Allowed Glycine 0 N--CA 1.425 -2.034 0 CA-C-N 114.607 -1.179 . . . . 0.29 111.779 177.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 56.7 tttp -72.27 136.12 46.21 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 107.721 -1.214 . . . . 2.19 107.721 178.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -69.04 141.42 54.83 Favored 'General case' 0 C--N 1.314 -0.975 0 O-C-N 123.486 0.491 . . . . 0.61 111.59 -175.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 9.4 p30 -161.32 175.74 11.93 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 105.138 -2.171 . . . . 1.95 105.138 176.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 7.2 ptpp? -132.54 42.88 3.05 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 119.001 0.818 . . . . 2.68 110.951 -173.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 47.2 ttt180 -85.34 76.77 10.08 Favored 'General case' 0 N--CA 1.427 -1.6 0 N-CA-C 108.495 -0.928 . . . . 3.47 108.495 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1581 ' ' LEU . . . . . 0.493 HD12 ' CG2' ' A' 1518 ' ' VAL . 0.4 OUTLIER -70.15 121.36 17.38 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 114.846 -1.07 . . . . 0.64 108.541 179.446 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 58.2 mtp180 -116.03 120.68 39.89 Favored 'General case' 0 C--N 1.287 -2.13 0 C-N-CA 120.611 -0.436 . . . . 2.85 111.31 177.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1583 ' ' TYR . . . . . 0.668 ' HB2' HG21 ' A' 1518 ' ' VAL . 62.1 t80 -94.0 109.43 21.17 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 109.412 -0.588 . . . . 0.86 109.412 175.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1584 ' ' VAL . . . . . 0.535 ' O ' ' HB ' ' A' 1587 ' ' VAL . 11.9 m -128.22 89.57 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-O 121.518 0.675 . . . . 1.05 111.968 -179.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 34.6 t70 53.1 71.54 0.48 Allowed 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 124.359 1.063 . . . . 1.17 112.942 174.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 9.2 pt20 67.74 12.81 9.02 Favored 'General case' 0 N--CA 1.508 2.465 0 C-N-CA 127.46 2.304 . . . . 1.86 111.319 178.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1587 ' ' VAL . . . . . 0.535 ' HB ' ' O ' ' A' 1584 ' ' VAL . 39.5 t -116.86 120.66 65.71 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.152 0 CA-C-N 114.55 -1.204 . . . . 0.49 109.51 177.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1588 ' ' LEU . . . . . 0.886 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 1.8 mm? -100.46 107.81 19.63 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 105.122 -2.177 . . . . 0.36 105.122 176.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -112.89 134.74 54.27 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 112.875 0.694 . . . . 1.74 112.875 -172.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 18.6 mt -124.75 112.49 16.79 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 114.103 -1.408 . . . . 0.72 108.193 175.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 7.0 p -101.58 127.39 54.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-O 121.268 0.556 . . . . 1.01 109.61 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1592 ' ' TYR . . . . . . . . . . . . . 13.4 m-30 -114.46 101.37 9.08 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 109.467 -0.568 . . . . 0.5 109.467 -177.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 15.4 pttp -109.29 -178.16 3.49 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 114.661 -1.154 . . . . 1.59 108.138 -175.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 8.2 m-20 63.82 44.78 4.72 Favored 'General case' 0 C--N 1.319 -0.752 0 O-C-N 124.128 0.892 . . . . 1.11 110.765 179.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -79.44 -166.34 32.05 Favored Glycine 0 N--CA 1.437 -1.236 0 CA-C-N 115.0 -1.0 . . . . 0.78 110.917 176.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1596 ' ' SER . . . . . 0.656 ' HB2' ' HD2' ' A' 1597 ' ' PRO . 79.1 p -86.68 167.53 22.15 Favored Pre-proline 0 C--N 1.297 -1.679 0 C-N-CA 120.209 -0.596 . . . . 1.07 109.842 -177.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1597 ' ' PRO . . . . . 0.799 ' HG3' ' HB3' ' B' ' 6' ' ' GLU . 12.2 Cg_endo -56.05 120.4 8.21 Favored 'Trans proline' 0 C--N 1.364 1.349 0 C-N-CA 122.592 2.195 . . . . 1.01 111.048 178.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1598 ' ' CYS . . . . . 0.478 ' HA ' ' HD3' ' A' 1599 ' ' PRO . 44.1 t -83.98 123.97 75.09 Favored Pre-proline 0 C--N 1.286 -2.195 0 CA-C-N 114.369 -1.287 . . . . 0.75 110.12 -177.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1599 ' ' PRO . . . . . 0.519 ' HD2' ' OH ' ' A' 1606 ' ' TYR . 3.1 Cg_exo -80.01 2.7 8.22 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 123.551 2.834 . . . . 1.7 112.679 178.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1600 ' ' SER . . . . . 0.436 ' HA ' ' HB3' ' B' ' 53' ' ' LEU . 14.8 m -77.54 -55.98 4.91 Favored 'General case' 0 N--CA 1.42 -1.971 0 N-CA-C 108.465 -0.939 . . . . 2.26 108.465 173.155 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1601 ' ' LYS . . . . . 0.567 ' HE3' HD13 ' A' 1604 ' ' LEU . 16.9 ttpp -119.58 117.18 27.67 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 105.836 -1.913 . . . . 3.01 105.836 173.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 12.9 p -63.14 116.35 5.32 Favored 'General case' 0 N--CA 1.422 -1.868 0 N-CA-C 113.189 0.811 . . . . 2.07 113.189 -170.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 105.47 -6.24 41.73 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 121.313 -0.47 . . . . 1.08 112.229 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1604 ' ' LEU . . . . . 0.595 HD23 ' SG ' ' A' 1634 ' ' CYS . 10.9 tp -91.52 170.45 9.93 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.399 -0.963 . . . . 1.84 108.399 -178.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 15.1 m -126.45 149.75 49.1 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 108.446 -0.946 . . . . 1.41 108.446 -179.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1606 ' ' TYR . . . . . 0.59 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 63.8 m-85 -71.0 158.1 37.09 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 122.679 0.391 . . . . 0.6 111.682 177.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -156.49 125.45 5.98 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 109.346 -0.613 . . . . 1.45 109.346 178.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1608 ' ' SER . . . . . . . . . . . . . 30.4 m -107.93 132.68 53.22 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-N 115.995 -0.548 . . . . 1.15 109.808 -178.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 31.6 t -111.6 108.17 24.8 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 109.261 -0.644 . . . . 0.25 109.261 178.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 75.6 mt -96.31 113.86 31.72 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 N-CA-C 108.917 -0.771 . . . . 0.45 108.917 -178.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 48.9 m -116.02 119.88 37.3 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 115.942 -0.572 . . . . 1.26 111.749 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1612 ' ' PHE . . . . . 0.886 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 74.6 m-85 -98.26 122.16 41.08 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.961 -1.126 . . . . 0.26 107.961 175.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 45.5 t -117.95 137.42 51.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 109.588 -0.523 . . . . 0.5 109.588 -176.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 3.5 t -52.99 112.4 0.85 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.131 0.894 . . . . 0.77 112.275 176.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1615 ' ' ARG . . . . . 0.712 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 27.9 tpt180 -133.13 93.4 22.74 Favored Pre-proline 0 C--N 1.325 -0.468 0 N-CA-C 110.224 -0.287 . . . . 2.53 110.224 174.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1616 ' ' PRO . . . . . 0.592 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 13.1 Cg_exo -70.53 -24.16 26.47 Favored 'Trans proline' 0 CA--C 1.545 1.052 0 C-N-CA 122.063 1.842 . . . . 1.1 112.428 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -85.25 43.49 1.02 Allowed 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 125.151 1.38 . . . . 3.05 110.954 179.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -33.34 117.48 0.29 Allowed 'General case' 0 C--O 1.241 0.638 0 C-N-CA 126.293 1.837 . . . . 1.55 113.2 178.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . -155.79 -135.21 1.96 Allowed Glycine 0 N--CA 1.433 -1.558 0 N-CA-C 109.078 -1.609 . . . . 0.93 109.078 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -81.86 21.09 0.98 Allowed 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.285 1.99 . . . . 0.88 112.523 -179.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1621 ' ' THR . . . . . 0.738 ' HB ' ' HB2' ' A' 1641 ' ' HIS . 46.7 p -99.17 -15.99 18.74 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 114.917 -1.038 . . . . 0.97 109.528 178.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 52.1 t30 -89.89 56.34 3.45 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 122.389 1.09 . . . . 0.72 109.369 -173.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 18.6 ptp180 -157.25 139.54 10.4 Favored Pre-proline 0 N--CA 1.427 -1.595 0 CA-C-N 114.665 -1.152 . . . . 3.26 108.248 -177.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.71 97.16 0.26 Allowed 'Trans proline' 0 C--O 1.238 0.506 0 C-N-CA 122.873 2.382 . . . . 0.59 111.687 -178.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 76.8 mtm -97.44 136.88 37.25 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 116.105 -0.498 . . . . 1.37 110.274 -178.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1626 ' ' LEU . . . . . 0.828 ' HG ' ' HE1' ' A' 1542 ' ' TYR . 0.4 OUTLIER -88.16 112.63 22.94 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 107.397 -1.335 . . . . 0.89 107.397 -179.44 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A 1627 ' ' ILE . . . . . 0.839 HD11 ' HB2' ' A' 1639 ' ' SER . 3.3 mm -72.82 -57.45 7.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 C-N-CA 123.651 0.78 . . . . 0.58 109.908 -177.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 30.6 t -163.42 151.38 13.3 Favored 'General case' 0 N--CA 1.415 -2.18 0 CA-C-N 114.657 -1.156 . . . . 1.39 107.936 -172.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1629 ' ' LEU . . . . . 0.881 HD13 ' HG ' ' A' 1636 ' ' LEU . 35.2 tp -122.44 95.62 4.71 Favored 'General case' 0 N--CA 1.419 -2.022 0 N-CA-C 107.225 -1.398 . . . . 1.25 107.225 178.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 15.8 t70 -75.54 97.44 3.73 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.461 -1.311 . . . . 1.09 107.461 177.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 62.0 mttp -66.83 -22.09 66.01 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 112.857 0.688 . . . . 3.6 112.857 -176.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -72.61 -36.11 68.0 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.556 0.694 . . . . 2.6 109.699 -178.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 69.6 p -102.72 -4.77 24.55 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.682 -0.69 . . . . 0.75 110.821 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1634 ' ' CYS . . . . . 0.595 ' SG ' HD23 ' A' 1604 ' ' LEU . 74.9 m 55.34 37.16 28.49 Favored 'General case' 0 C--N 1.356 0.853 0 C-N-CA 125.231 1.413 . . . . 0.53 111.811 -178.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1635 ' ' THR . . . . . . . . . . . . . 40.0 m -106.43 129.28 54.44 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 115.151 -0.931 . . . . 0.46 109.555 -178.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1636 ' ' LEU . . . . . 0.881 ' HG ' HD13 ' A' 1629 ' ' LEU . 0.3 OUTLIER -111.39 135.88 51.32 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 107.287 -1.375 . . . . 0.86 107.287 -177.663 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -112.19 131.31 55.55 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 120.798 -0.361 . . . . 0.45 111.2 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1638 ' ' PHE . . . . . 0.442 ' CE1' HD23 ' A' 1626 ' ' LEU . 98.4 m-85 -123.23 130.89 53.36 Favored 'General case' 0 C--O 1.243 0.726 0 N-CA-C 108.241 -1.022 . . . . 0.5 108.241 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1639 ' ' SER . . . . . 0.839 ' HB2' HD11 ' A' 1627 ' ' ILE . 11.7 t -115.9 148.47 39.97 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 107.645 -1.243 . . . . 1.04 107.645 178.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 3.2 t90 -152.36 107.82 3.3 Favored 'General case' 0 N--CA 1.414 -2.251 0 N-CA-C 104.984 -2.228 . . . . 0.68 104.984 -179.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1641 ' ' HIS . . . . . 0.738 ' HB2' ' HB ' ' A' 1621 ' ' THR . 17.4 m-70 -102.87 107.93 18.95 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 109.358 -0.608 . . . . 0.9 109.358 -177.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1642 ' ' THR . . . . . . . . . . . . . 7.9 t -140.74 148.06 51.24 Favored Pre-proline 0 C--N 1.301 -1.521 0 CA-C-N 115.049 -0.978 . . . . 0.48 109.731 -171.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1643 ' ' PRO . . . . . 0.592 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 56.9 Cg_endo -80.4 -11.17 13.23 Favored 'Trans proline' 0 C--N 1.365 1.423 0 C-N-CA 122.314 2.009 . . . . 0.66 112.365 178.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1644 ' ' LEU . . . . . 0.611 HD11 ' HB2' ' A' 1531 ' ' SER . 7.4 tt -67.08 -25.82 66.42 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 108.407 -0.96 . . . . 0.97 108.407 176.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -103.09 23.36 12.46 Favored 'General case' 0 N--CA 1.424 -1.746 0 CA-C-N 114.833 -1.076 . . . . 0.84 109.735 -175.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 37.9 t -122.08 146.8 46.85 Favored 'General case' 0 N--CA 1.423 -1.797 0 CA-C-N 115.203 -0.908 . . . . 1.19 109.588 -179.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1647 ' ' GLU . . . . . 0.433 ' OE2' ' OH ' ' A' 1583 ' ' TYR . 0.1 OUTLIER -100.56 123.86 44.6 Favored Pre-proline 0 C--N 1.295 -1.8 0 N-CA-C 108.25 -1.019 . . . . 3.14 108.25 176.198 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A 1648 ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -71.04 148.94 57.9 Favored 'Trans proline' 0 C--O 1.248 1.016 0 C-N-CA 122.855 2.37 . . . . 2.58 114.016 -173.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 7.6 tp10 . . . . . 0 N--CA 1.427 -1.624 0 N-CA-C 107.237 -1.394 . . . . 4.72 107.237 177.12 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.494 0 N-CA-C 109.023 -0.732 . . . . 9.97 109.023 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -121.94 120.21 33.79 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.993 -0.743 . . . . 7.68 108.993 -178.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 26.8 ptt180 -84.92 128.48 60.33 Favored Pre-proline 0 C--N 1.297 -1.711 0 CA-C-N 115.44 -0.8 . . . . 6.11 109.546 178.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -85.42 22.51 0.94 Allowed 'Trans proline' 0 C--O 1.239 0.55 0 C-N-CA 123.196 2.597 . . . . 4.84 111.051 178.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 7.9 t -148.77 110.98 4.64 Favored 'General case' 0 N--CA 1.409 -2.498 0 N-CA-C 106.36 -1.718 . . . . 4.6 106.36 -177.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . 0.799 ' HB3' ' HG3' ' A' 1597 ' ' PRO . 6.7 mm-40 -79.97 -35.99 36.74 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.617 0.722 . . . . 4.23 110.53 -177.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 10.1 p -105.21 142.55 34.78 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 106.205 -1.776 . . . . 3.14 106.205 172.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 49.4 mt -125.58 143.4 51.03 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.977 -0.689 . . . . 3.96 110.318 -173.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 9' ' ' CYS . . . . . 0.542 ' HB3' ' HB2' ' B' ' 47' ' ' CYS . 6.0 p -88.76 135.98 33.24 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-O 120.78 0.324 . . . . 2.84 110.192 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.59 -121.82 4.51 Favored Glycine 0 N--CA 1.424 -2.154 0 N-CA-C 110.023 -1.231 . . . . 2.09 110.023 -179.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . 0.446 ' HA2' HG12 ' B' ' 14' ' ' VAL . . . -60.32 -45.17 96.64 Favored Glycine 0 C--O 1.201 -1.934 0 O-C-N 124.06 0.506 . . . . 1.84 113.01 -177.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 44.4 mp0 -61.38 -39.17 89.67 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.781 0.8 . . . . 2.55 111.154 -179.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . 0.417 HD21 ' HB3' ' B' ' 46' ' ' CYS . 0.1 OUTLIER -71.26 -40.9 70.7 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.03 -0.986 . . . . 2.35 110.141 -178.818 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . 0.446 HG12 ' HA2' ' B' ' 11' ' ' GLY . 5.1 p -76.83 -32.05 19.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 C-N-CA 120.019 -0.672 . . . . 2.11 110.485 -178.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -68.6 -36.08 78.2 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 116.175 -0.466 . . . . 2.04 111.832 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 11.7 p -69.99 -40.29 75.42 Favored 'General case' 0 C--O 1.262 1.75 0 O-C-N 121.899 -0.501 . . . . 1.84 110.149 177.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.473 ' HB3' ' HB3' ' B' ' 26' ' ' PHE . 3.7 mm? -54.66 -49.88 69.55 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 115.546 -0.752 . . . . 1.74 111.052 172.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -65.97 -33.35 75.63 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.828 -0.624 . . . . 2.39 111.265 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 19' ' ' PHE . . . . . 0.467 ' HE1' ' CD1' ' A' 1567 ' ' PHE . 74.1 t80 -50.63 -57.47 8.16 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 123.038 0.535 . . . . 0.96 111.751 178.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 15.0 p -99.54 -22.4 4.78 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.984 0 C-N-CA 118.389 -1.324 . . . . 1.37 113.298 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 21' ' ' CYS . . . . . 0.441 ' HB2' ' O ' ' B' ' 17' ' ' LEU . 86.2 m -104.85 27.26 8.25 Favored 'General case' 0 C--N 1.316 -0.886 0 O-C-N 121.518 -0.739 . . . . 1.66 112.665 -178.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -53.17 -52.43 40.31 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 121.509 -0.377 . . . . 1.53 114.037 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -74.7 -23.59 58.63 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 113.614 0.968 . . . . 2.72 113.614 -179.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . 0.551 ' HD2' ' SG ' ' B' ' 60' ' ' CYS . 41.5 ttm180 -87.87 -35.45 17.74 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.68 -0.808 . . . . 4.33 110.507 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.83 168.46 23.38 Favored Glycine 0 N--CA 1.423 -2.214 0 N-CA-C 110.279 -1.128 . . . . 1.53 110.279 -178.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . 0.473 ' HB3' ' HB3' ' B' ' 17' ' ' LEU . 3.2 p90 -122.22 138.94 54.31 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 116.954 0.377 . . . . 1.65 110.197 175.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 27' ' ' TYR . . . . . 0.764 ' HB2' ' HA ' ' B' ' 61' ' ' ALA . 3.2 m-85 -122.0 -91.15 0.56 Allowed 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 118.876 -0.583 . . . . 3.42 110.133 -177.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 28' ' ' PHE . . . . . . . . . . . . . 51.7 p90 50.52 9.73 0.05 OUTLIER 'General case' 0 N--CA 1.507 2.397 0 N-CA-C 115.752 1.76 . . . . 2.26 115.752 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 32.3 t -149.11 81.46 1.43 Allowed 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 106.136 -1.801 . . . . 3.68 106.136 178.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . 0.522 ' HB2' ' O ' ' B' ' 32' ' ' ALA . 38.6 mtp180 -123.17 175.54 2.67 Favored Pre-proline 0 C--N 1.299 -1.609 0 N-CA-C 107.905 -1.146 . . . . 3.81 107.905 -173.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.87 -35.94 98.63 Favored 'Trans proline' 0 C--N 1.35 0.633 0 CA-C-N 120.867 1.345 . . . . 4.02 111.008 174.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 32' ' ' ALA . . . . . 0.522 ' O ' ' HB2' ' B' ' 30' ' ' ARG . . . -142.8 -166.42 2.28 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 108.287 -1.005 . . . . 4.92 108.287 179.12 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 16.3 t -155.35 157.66 37.48 Favored 'General case' 0 N--CA 1.391 -3.398 0 N-CA-C 103.711 -2.7 . . . . 6.72 103.711 -178.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 14.9 tpp180 -85.38 2.63 43.51 Favored 'General case' 0 C--N 1.267 -3.014 0 CA-C-O 121.866 0.841 . . . . 11.63 110.291 -174.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 51.3 t -98.34 -15.14 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 108.205 -1.035 . . . . 9.61 108.205 172.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 49.7 m 52.04 33.44 11.97 Favored 'General case' 0 C--N 1.362 1.148 0 CA-C-N 114.102 -1.408 . . . . 6.71 111.208 -175.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 39.6 ttm180 -89.31 -51.52 5.52 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 114.078 -1.419 . . . . 10.0 110.636 -174.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 20.9 tpt85 -164.66 149.48 9.64 Favored 'General case' 0 N--CA 1.423 -1.823 0 N-CA-C 104.616 -2.364 . . . . 7.94 104.616 -173.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 20.8 m -63.67 -21.2 66.26 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 123.596 0.56 . . . . 5.76 111.483 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 56.6 mtm180 -128.99 136.18 49.98 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 107.445 -1.317 . . . . 6.03 107.445 174.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . 0.409 ' O ' HG12 ' B' ' 42' ' ' ILE . . . -119.98 173.84 15.36 Favored Glycine 0 C--N 1.286 -2.25 0 N-CA-C 109.384 -1.486 . . . . 2.37 109.384 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . 0.417 HG22 ' HB3' ' B' ' 55' ' ' LEU . 22.5 pt 62.01 -37.62 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 C-N-CA 127.48 2.312 . . . . 2.07 116.182 175.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.428 ' O ' ' HB2' ' B' ' 47' ' ' CYS . 2.5 p -50.03 -50.31 19.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 114.751 1.389 . . . . 2.24 114.751 -176.043 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -93.74 -27.66 16.37 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.98 -0.748 . . . . 3.36 108.98 -174.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' B' ' 49' ' ' ARG . 41.7 mt-10 -61.2 -56.62 18.62 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.863 -1.062 . . . . 3.08 110.127 178.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 46' ' ' CYS . . . . . 0.438 ' HB2' ' HB3' ' B' ' 51' ' ' CYS . 48.3 t -83.67 -3.91 58.15 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 116.117 -0.492 . . . . 2.23 111.276 -176.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 47' ' ' CYS . . . . . 0.542 ' HB2' ' HB3' ' B' ' 9' ' ' CYS . 34.3 t -80.42 -38.87 29.36 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 118.905 -1.118 . . . . 2.37 110.29 176.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -111.55 9.29 21.19 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 112.609 0.596 . . . . 2.82 112.609 -175.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . 0.466 ' HB2' ' O ' ' B' ' 45' ' ' GLU . 63.1 mtp180 -146.88 -177.89 5.9 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 105.874 -1.899 . . . . 4.09 105.874 177.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 11.2 t -106.05 145.32 31.55 Favored 'General case' 0 C--N 1.278 -2.524 0 N-CA-C 106.157 -1.794 . . . . 2.67 106.157 177.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . 0.438 ' HB3' ' HB2' ' B' ' 46' ' ' CYS . 23.4 p -118.17 143.11 46.77 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 110.45 -0.204 . . . . 2.11 110.45 -175.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -94.59 163.15 13.5 Favored 'General case' 0 C--O 1.253 1.248 0 N-CA-C 107.414 -1.328 . . . . 2.67 107.414 173.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . 0.436 ' HB3' ' HA ' ' A' 1600 ' ' SER . 2.6 pt? -66.75 -9.26 34.85 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 120.756 0.313 . . . . 1.9 110.938 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.63 -15.96 44.2 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.167 0.987 . . . . 1.52 110.541 176.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . 0.655 ' O ' ' HB2' ' B' ' 59' ' ' TYR . 49.1 mt -98.56 -55.78 2.64 Favored 'General case' 0 C--O 1.2 -1.545 0 CA-C-O 120.971 0.415 . . . . 1.97 111.404 174.046 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.413 ' HG ' ' HA ' ' B' ' 53' ' ' LEU . 1.7 pp -74.73 -33.28 62.34 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 114.537 1.31 . . . . 1.53 114.537 -170.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -76.85 -32.5 57.57 Favored 'General case' 0 CA--C 1.559 1.293 0 C-N-CA 120.31 -0.556 . . . . 2.27 110.768 178.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 73.9 p -75.37 -50.99 14.22 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 120.844 0.354 . . . . 2.33 111.165 177.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 59' ' ' TYR . . . . . 0.655 ' HB2' ' O ' ' B' ' 55' ' ' LEU . 0.3 OUTLIER -65.17 -64.67 0.81 Allowed 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 108.76 -0.83 . . . . 2.86 108.76 -178.725 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 60' ' ' CYS . . . . . 0.551 ' SG ' ' HD2' ' B' ' 24' ' ' ARG . 43.6 t 45.16 -86.32 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 125.32 1.448 . . . . 2.3 113.441 176.059 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 61' ' ' ALA . . . . . 0.764 ' HA ' ' HB2' ' B' ' 27' ' ' TYR . . . -142.22 -64.82 0.42 Allowed 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 106.913 -1.514 . . . . 3.19 106.913 179.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 13.4 p -130.95 147.36 66.0 Favored Pre-proline 0 N--CA 1.412 -2.335 0 N-CA-C 106.531 -1.655 . . . . 3.68 106.531 179.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -81.93 0.6 9.74 Favored 'Trans proline' 0 C--O 1.237 0.433 0 C-N-CA 122.768 2.312 . . . . 5.08 112.982 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 72.51 50.68 0.18 Allowed 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 125.504 1.522 . . . . 5.1 110.652 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -160.73 132.6 5.89 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 105.197 -2.149 . . . . 8.51 105.197 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 67.7 m -114.41 155.78 25.71 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 113.361 0.874 . . . . 8.12 113.361 -172.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 . . . . . 0 N--CA 1.434 -1.259 0 N-CA-C 108.245 -1.02 . . . . 10.21 108.245 178.267 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 23.8 mmt . . . . . 0 CA--C 1.5 -0.972 0 N-CA-C 109.113 -0.699 . . . . 9.34 109.113 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 61.5 tttp -85.88 71.51 10.63 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.926 0.869 . . . . 9.04 109.19 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1510 ' ' SER . . . . . 0.507 ' OG ' ' HG2' ' A' 1512 ' ' GLU . 35.6 t -164.02 154.06 14.78 Favored 'General case' 0 N--CA 1.426 -1.665 0 N-CA-C 107.948 -1.13 . . . . 5.81 107.948 -179.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1511 ' ' ASN . . . . . 0.425 ' O ' ' HA ' ' A' 1518 ' ' VAL . 30.4 p-10 -90.04 -2.51 58.13 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.946 -0.57 . . . . 3.42 110.83 -179.07 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1512 ' ' GLU . . . . . 0.507 ' HG2' ' OG ' ' A' 1510 ' ' SER . 13.1 pt-20 -101.07 155.95 17.69 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.049 -0.722 . . . . 5.95 109.049 178.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1513 ' ' HIS . . . . . 0.445 ' HB2' ' HG3' ' A' 1517 ' ' GLN . 64.5 m-70 -137.49 7.19 2.8 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 113.506 0.928 . . . . 5.33 113.506 -174.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1514 ' ' ASP . . . . . 0.605 ' O ' ' HE2' ' A' 1579 ' ' LYS . 27.9 t70 72.59 -22.56 0.22 Allowed 'General case' 0 N--CA 1.507 2.416 0 C-N-CA 124.868 1.267 . . . . 5.06 112.387 -178.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -88.91 36.04 0.8 Allowed 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.605 -0.684 . . . . 2.9 111.799 -177.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1516 ' ' CYS . . . . . 0.523 ' HA ' ' HB2' ' A' 1581 ' ' LEU . 95.6 m 52.53 50.49 18.11 Favored 'General case' 0 CA--C 1.497 -1.083 0 CA-C-O 121.717 0.77 . . . . 1.19 112.029 -178.141 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1517 ' ' GLN . . . . . 0.445 ' HG3' ' HB2' ' A' 1513 ' ' HIS . 4.1 pt20 -150.91 130.35 12.93 Favored 'General case' 0 N--CA 1.407 -2.591 0 CA-C-N 115.049 -0.978 . . . . 1.52 109.76 -176.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1518 ' ' VAL . . . . . 0.517 HG21 ' HB2' ' A' 1583 ' ' TYR . 3.0 m -137.54 142.32 37.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-N 115.274 -0.876 . . . . 0.94 110.18 -178.011 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1519 ' ' THR . . . . . . . . . . . . . 44.3 m -107.17 141.97 37.61 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 116.312 -0.404 . . . . 0.89 111.511 -178.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1520 ' ' ASN . . . . . 0.512 ' OD1' HG22 ' A' 1523 ' ' THR . 6.4 t-20 -89.52 120.78 69.61 Favored Pre-proline 0 N--CA 1.441 -0.915 0 N-CA-C 108.58 -0.896 . . . . 1.74 108.58 173.179 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -62.66 -27.69 76.23 Favored 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 123.22 2.614 . . . . 1.58 113.927 -176.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 15.0 m -68.14 -47.66 67.49 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 112.939 0.718 . . . . 1.65 112.939 -175.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1523 ' ' THR . . . . . 0.512 HG22 ' OD1' ' A' 1520 ' ' ASN . 11.8 t -118.8 2.64 11.63 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 119.785 -0.766 . . . . 1.61 111.833 -173.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 63.42 34.0 88.77 Favored Glycine 0 CA--C 1.504 -0.632 0 CA-C-N 115.749 -0.66 . . . . 1.13 112.007 178.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1525 ' ' HIS . . . . . 0.466 ' HB2' HG23 ' A' 1523 ' ' THR . 32.7 t-80 -94.22 127.27 39.96 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 120.095 -0.642 . . . . 1.26 109.46 -177.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 3.1 tm? -90.88 117.37 29.44 Favored 'General case' 0 C--N 1.289 -2.065 0 CA-C-N 115.019 -0.991 . . . . 0.68 108.956 -177.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1527 ' ' PHE . . . . . 0.414 ' O ' ' HA ' ' A' 1517 ' ' GLN . 39.0 m-85 -95.51 126.07 40.55 Favored 'General case' 0 N--CA 1.432 -1.33 0 C-N-CA 119.749 -0.78 . . . . 0.65 110.577 173.204 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 10.5 t70 -115.92 126.98 54.61 Favored 'General case' 0 C--N 1.309 -1.16 0 O-C-N 123.738 0.649 . . . . 1.17 109.727 175.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1529 ' ' LEU . . . . . 0.551 ' HG ' HD21 ' A' 1581 ' ' LEU . 3.4 mm? -106.9 2.35 25.27 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 120.982 0.42 . . . . 0.6 111.149 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 3.8 m -71.78 -14.28 61.94 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.145 0.497 . . . . 0.84 111.796 -176.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 6.1 p -70.0 -31.62 69.38 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.634 0.73 . . . . 1.59 110.831 179.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 77.5 mt -84.97 7.06 22.53 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.025 -0.989 . . . . 0.65 110.713 -179.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1533 ' ' SER . . . . . 0.443 ' HA ' ' HB ' ' A' 1552 ' ' ILE . 19.7 t -74.97 172.47 12.24 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.683 0.754 . . . . 1.52 111.118 -179.423 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -176.94 141.24 5.31 Favored Glycine 0 N--CA 1.422 -2.24 0 N-CA-C 108.141 -1.984 . . . . 1.1 108.141 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 11.5 tpp180 -92.2 -31.66 15.37 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 120.954 0.407 . . . . 4.62 111.454 -176.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -80.61 -37.36 31.27 Favored 'General case' 0 CA--C 1.502 -0.904 0 N-CA-C 108.164 -1.051 . . . . 1.45 108.164 177.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1537 ' ' GLY . . . . . 0.424 ' HA3' ' ND2' ' A' 1556 ' ' ASN . . . 110.04 -177.37 19.73 Favored Glycine 0 N--CA 1.406 -3.304 0 CA-C-N 114.792 -1.094 . . . . 0.85 111.938 174.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -121.68 142.56 50.03 Favored 'General case' 0 C--N 1.277 -2.571 0 N-CA-C 106.954 -1.499 . . . . 0.93 106.954 178.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 3.3 p -105.33 129.78 53.59 Favored 'General case' 0 C--N 1.292 -1.903 0 O-C-N 123.652 0.595 . . . . 1.03 110.764 179.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1540 ' ' ALA . . . . . 0.466 ' HB3' ' CG1' ' A' 1548 ' ' VAL . . . -121.83 144.56 48.75 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.615 -1.254 . . . . 0.5 107.615 176.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -80.84 126.57 31.5 Favored 'General case' 0 N--CA 1.431 -1.377 0 O-C-N 123.643 0.589 . . . . 0.74 109.545 -176.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1542 ' ' TYR . . . . . 0.538 ' CE1' ' HG ' ' A' 1626 ' ' LEU . 10.6 t80 -131.73 -102.09 0.28 Allowed 'General case' 0 N--CA 1.419 -2.0 0 CA-C-N 115.484 -0.78 . . . . 0.99 109.733 -175.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1543 ' ' SER . . . . . . . . . . . . . 43.1 t -77.57 155.32 31.6 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.651 -0.87 . . . . 1.91 108.651 178.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -55.76 -42.16 75.06 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 119.175 0.898 . . . . 3.59 111.002 178.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 41.8 m -106.24 30.72 5.69 Favored 'General case' 0 N--CA 1.407 -2.609 0 CA-C-O 121.078 0.466 . . . . 2.46 110.795 -176.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . -170.71 113.53 0.5 Allowed Glycine 0 N--CA 1.433 -1.514 0 C-N-CA 119.643 -1.265 . . . . 1.26 113.336 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 30.9 m -94.02 167.52 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 N-CA-C 107.794 -1.187 . . . . 0.79 107.794 175.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1548 ' ' VAL . . . . . 0.466 ' CG1' ' HB3' ' A' 1540 ' ' ALA . 10.9 p -107.7 131.05 58.98 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.178 0 C-N-CA 119.448 -0.901 . . . . 0.58 109.476 178.105 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -97.74 127.19 43.52 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.129 -1.063 . . . . 1.08 108.129 178.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 25.6 ptm -143.82 137.52 28.04 Favored 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 120.377 -0.529 . . . . 0.78 112.005 -178.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 11.2 p -127.7 125.78 40.67 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 115.397 -0.82 . . . . 0.97 109.76 176.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1552 ' ' ILE . . . . . 0.443 ' HB ' ' HA ' ' A' 1533 ' ' SER . 42.4 mm -80.98 116.68 25.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 N-CA-C 109.817 -0.438 . . . . 0.42 109.817 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1553 ' ' CYS . . . . . 0.49 ' SG ' HD11 ' A' 1590 ' ' LEU . 85.6 m 62.59 31.81 16.69 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 112.813 0.672 . . . . 1.4 112.813 173.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . -166.55 175.2 41.98 Favored Glycine 0 N--CA 1.417 -2.591 0 N-CA-C 108.201 -1.96 . . . . 0.35 108.201 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -98.18 148.76 23.26 Favored 'General case' 0 C--N 1.289 -2.049 0 C-N-CA 119.91 -0.716 . . . . 1.62 110.925 -179.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1556 ' ' ASN . . . . . 0.424 ' ND2' ' HA3' ' A' 1537 ' ' GLY . 25.7 t-20 -92.44 125.21 36.99 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 108.384 -0.969 . . . . 0.87 108.384 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -81.07 4.88 18.33 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 114.4 1.259 . . . . 2.49 114.4 -175.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -95.95 -4.21 43.77 Favored 'General case' 0 C--N 1.317 -0.838 0 O-C-N 121.638 -0.664 . . . . 1.38 111.234 -179.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1559 ' ' CYS . . . . . 0.765 ' SG ' ' HD2' ' A' 1560 ' ' PRO . 17.6 t -136.87 162.93 53.06 Favored Pre-proline 0 C--N 1.302 -1.489 0 N-CA-C 106.84 -1.541 . . . . 1.21 106.84 -177.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1560 ' ' PRO . . . . . 0.765 ' HD2' ' SG ' ' A' 1559 ' ' CYS . 45.5 Cg_exo -28.46 128.53 0.04 OUTLIER 'Trans proline' 0 C--N 1.384 2.444 0 C-N-CA 124.982 3.788 . . . . 0.71 115.25 176.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1561 ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' 1560 ' ' PRO . 85.9 Cg_exo -48.96 122.68 8.66 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 124.067 3.178 . . . . 0.8 113.826 -178.314 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 98.94 14.68 35.88 Favored Glycine 0 C--N 1.311 -0.814 0 CA-C-N 115.63 -0.714 . . . . 0.46 114.328 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1563 ' ' VAL . . . . . 0.535 HG21 ' HB2' ' A' 1573 ' ' SER . 9.9 p -104.66 144.43 14.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.885 -0.773 . . . . 0.98 110.662 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -102.39 -33.3 4.57 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 121.213 -0.518 . . . . 0.28 113.033 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -130.15 139.6 50.86 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.79 -0.448 . . . . 0.28 109.79 178.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 45.7 t -159.16 133.23 7.6 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 119.529 -0.272 . . . . 0.43 110.724 -177.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -84.89 139.64 31.72 Favored 'General case' 0 C--O 1.249 1.047 0 N-CA-C 108.458 -0.942 . . . . 1.03 108.458 171.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -82.47 39.43 2.66 Favored Glycine 0 N--CA 1.442 -0.933 0 C-N-CA 121.703 -0.284 . . . . 1.13 113.783 -175.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -76.51 -71.42 0.39 Allowed 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 108.661 -0.866 . . . . 2.58 108.661 174.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 2.9 p -132.52 33.31 3.81 Favored 'General case' 0 C--N 1.308 -1.209 0 C-N-CA 122.935 0.494 . . . . 2.17 110.278 174.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1571 ' ' ARG . . . . . 0.542 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 3.1 mpt_? 61.9 60.08 1.61 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.9 0.857 . . . . 2.62 109.442 -173.072 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 39.9 mt -96.26 101.72 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 107.748 -1.204 . . . . 0.92 107.748 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1573 ' ' SER . . . . . 0.535 ' HB2' HG21 ' A' 1563 ' ' VAL . 94.1 p -63.31 129.39 40.05 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 114.321 -1.309 . . . . 0.8 111.288 -176.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1574 ' ' VAL . . . . . 0.494 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 35.1 m -120.14 16.77 6.47 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-O 121.511 0.672 . . . . 0.98 112.054 -176.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 173.27 118.24 0.49 Allowed Glycine 0 N--CA 1.428 -1.9 0 CA-C-N 115.414 -0.812 . . . . 0.29 111.135 176.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 55.3 tttp -70.42 139.27 51.78 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 107.805 -1.183 . . . . 2.19 107.805 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -68.5 98.79 0.89 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.207 0.447 . . . . 0.61 112.207 -175.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1578 ' ' ASN . . . . . 0.555 ' O ' ' HE1' ' A' 1592 ' ' TYR . 84.5 m-20 -115.67 157.61 23.97 Favored 'General case' 0 C--O 1.206 -1.223 0 N-CA-C 106.926 -1.509 . . . . 1.95 106.926 175.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1579 ' ' LYS . . . . . 0.605 ' HE2' ' O ' ' A' 1514 ' ' ASP . 28.2 mtmm -122.97 42.07 3.29 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 122.167 0.984 . . . . 2.68 108.512 -178.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 25.9 ttm180 -90.4 76.9 6.64 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 122.257 1.027 . . . . 3.47 109.313 -173.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1581 ' ' LEU . . . . . 0.551 HD21 ' HG ' ' A' 1529 ' ' LEU . 0.3 OUTLIER -65.87 133.02 50.06 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 113.184 -1.825 . . . . 0.64 109.517 -178.518 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A 1582 ' ' ARG . . . . . 0.752 ' HB2' ' HB3' ' A' 1589 ' ' GLN . 94.5 mtt180 -120.52 141.17 50.48 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 109.765 -0.458 . . . . 2.85 109.765 175.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1583 ' ' TYR . . . . . 0.524 ' OH ' ' OE1' ' A' 1647 ' ' GLU . 16.2 t80 -114.94 102.37 9.9 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 109.512 -0.551 . . . . 0.86 109.512 177.155 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1584 ' ' VAL . . . . . 0.556 ' O ' ' HB ' ' A' 1587 ' ' VAL . 27.8 m -123.68 91.15 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.763 -0.653 . . . . 1.05 111.868 -177.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1585 ' ' ASP . . . . . 0.42 ' O ' ' HG2' ' A' 1586 ' ' GLN . 24.0 t70 56.5 62.62 2.24 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.896 0.878 . . . . 1.17 111.576 176.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1586 ' ' GLN . . . . . 0.42 ' HG2' ' O ' ' A' 1585 ' ' ASP . 9.0 pt20 68.89 2.22 3.45 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 127.628 2.371 . . . . 1.86 111.547 178.033 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1587 ' ' VAL . . . . . 0.556 ' HB ' ' O ' ' A' 1584 ' ' VAL . 25.0 t -92.11 123.49 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.116 0 CA-C-N 115.329 -0.85 . . . . 0.49 109.406 175.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1588 ' ' LEU . . . . . 0.671 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 3.6 mm? -99.51 108.25 20.64 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.089 -1.078 . . . . 0.36 108.089 179.17 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1589 ' ' GLN . . . . . 0.752 ' HB3' ' HB2' ' A' 1582 ' ' ARG . 4.0 tp-100 -100.41 133.46 44.8 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 115.233 -0.894 . . . . 1.74 111.376 -174.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1590 ' ' LEU . . . . . 0.49 HD11 ' SG ' ' A' 1553 ' ' CYS . 0.4 OUTLIER -130.94 92.48 3.23 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 105.843 -1.91 . . . . 0.72 105.843 175.066 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 8.3 p -93.77 125.94 46.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 CA-C-O 121.835 0.826 . . . . 1.01 112.906 -174.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1592 ' ' TYR . . . . . 0.555 ' HE1' ' O ' ' A' 1578 ' ' ASN . 17.5 m-30 -112.49 138.26 49.51 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 107.76 -1.2 . . . . 0.5 107.76 176.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 22.7 pttm -148.54 -178.53 6.38 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.082 -1.081 . . . . 1.59 108.082 178.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 11.0 m-20 60.74 50.45 5.48 Favored 'General case' 0 C--O 1.242 0.701 0 O-C-N 124.223 0.952 . . . . 1.11 110.978 176.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -78.35 -112.48 0.19 Allowed Glycine 0 N--CA 1.433 -1.561 0 N-CA-C 110.272 -1.131 . . . . 0.78 110.272 178.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1596 ' ' SER . . . . . . . . . . . . . 56.2 p -124.98 159.69 57.81 Favored Pre-proline 0 C--N 1.274 -2.675 0 N-CA-C 107.691 -1.226 . . . . 1.07 107.691 174.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -54.73 124.75 16.98 Favored 'Trans proline' 0 C--N 1.358 1.028 0 C-N-CA 122.386 2.057 . . . . 1.01 110.339 177.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1598 ' ' CYS . . . . . 0.619 ' HA ' ' CE2' ' A' 1606 ' ' TYR . 21.7 t -58.47 115.96 13.4 Favored Pre-proline 0 C--N 1.308 -1.239 0 N-CA-C 108.775 -0.824 . . . . 0.75 108.775 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1599 ' ' PRO . . . . . 0.663 ' HB2' ' HB ' ' B' ' 16' ' ' THR . 31.8 Cg_exo -60.87 -23.96 78.11 Favored 'Trans proline' 0 C--N 1.361 1.21 0 C-N-CA 123.016 2.477 . . . . 1.7 112.676 -176.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1600 ' ' SER . . . . . 0.63 ' HB3' ' HB3' ' B' ' 53' ' ' LEU . 44.3 m -80.52 -14.66 58.06 Favored 'General case' 0 CA--C 1.566 1.571 0 N-CA-C 113.033 0.753 . . . . 2.26 113.033 177.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1601 ' ' LYS . . . . . 0.45 ' HG3' HD13 ' A' 1604 ' ' LEU . 3.2 tppp? -160.76 116.07 2.21 Favored 'General case' 0 C--O 1.24 0.588 0 O-C-N 121.698 -0.626 . . . . 3.01 110.797 -176.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1602 ' ' SER . . . . . 0.455 ' OG ' ' HB3' ' B' ' 6' ' ' GLU . 38.3 t -69.74 141.95 53.36 Favored 'General case' 0 N--CA 1.416 -2.15 0 N-CA-C 108.457 -0.942 . . . . 2.07 108.457 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 99.26 -17.6 57.68 Favored Glycine 0 C--N 1.3 -1.439 0 C-N-CA 121.222 -0.513 . . . . 1.08 112.72 179.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1604 ' ' LEU . . . . . 0.45 HD13 ' HG3' ' A' 1601 ' ' LYS . 8.9 mp -102.57 145.9 28.93 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 123.212 0.605 . . . . 1.84 110.561 178.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 31.5 t -121.59 153.6 37.85 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 106.757 -1.571 . . . . 1.41 106.757 175.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1606 ' ' TYR . . . . . 0.619 ' CE2' ' HA ' ' A' 1598 ' ' CYS . 49.1 m-85 -78.56 155.07 29.88 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 116.522 -0.308 . . . . 0.6 111.558 178.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1607 ' ' LYS . . . . . 0.415 ' O ' HD22 ' A' 1636 ' ' LEU . 8.0 ptpp? -150.16 145.1 26.09 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 106.943 -1.502 . . . . 1.45 106.943 175.09 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1608 ' ' SER . . . . . . . . . . . . . 17.2 m -120.0 120.91 37.69 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 107.789 -1.189 . . . . 1.15 107.789 -178.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 21.3 t -99.99 103.87 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 CA-C-O 121.118 0.485 . . . . 0.25 109.701 178.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 83.1 mt -96.69 106.27 18.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 C-N-CA 123.845 0.858 . . . . 0.45 109.171 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 14.4 t -106.98 113.94 27.72 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 108.392 -0.966 . . . . 1.26 108.392 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1612 ' ' PHE . . . . . 0.671 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 60.0 m-85 -81.8 121.51 26.52 Favored 'General case' 0 C--O 1.258 1.551 0 N-CA-C 109.477 -0.564 . . . . 0.26 109.477 176.08 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 46.4 t -111.54 129.86 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-N 114.798 -1.092 . . . . 0.5 109.862 -174.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 22.1 t -61.14 110.86 1.5 Allowed 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.112 -0.949 . . . . 0.77 111.884 178.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1615 ' ' ARG . . . . . 0.635 ' HG3' ' HB3' ' A' 1617 ' ' GLU . 32.5 tpt180 -137.48 95.76 11.27 Favored Pre-proline 0 N--CA 1.438 -1.033 0 N-CA-C 109.246 -0.65 . . . . 2.53 109.246 173.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1616 ' ' PRO . . . . . 0.843 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 39.5 Cg_exo -61.45 -21.26 71.43 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 122.86 2.373 . . . . 1.1 113.387 -178.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1617 ' ' GLU . . . . . 0.635 ' HB3' ' HG3' ' A' 1615 ' ' ARG . 38.9 tt0 -49.44 -41.12 39.07 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 125.586 1.554 . . . . 3.05 112.451 176.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . 43.58 81.03 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.527 0.731 . . . . 1.55 112.564 -177.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . -153.45 -134.33 1.98 Allowed Glycine 0 C--N 1.274 -2.907 0 C-N-CA 120.581 -0.819 . . . . 0.93 111.569 -177.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -66.88 1.09 3.01 Favored 'Trans proline' 0 CA--C 1.55 1.298 0 C-N-CA 122.656 2.237 . . . . 0.88 114.465 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1621 ' ' THR . . . . . 0.753 ' HB ' ' HB2' ' A' 1641 ' ' HIS . 2.7 p -98.67 -13.66 20.19 Favored 'General case' 0 N--CA 1.419 -1.979 0 C-N-CA 124.13 0.972 . . . . 0.97 109.727 178.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 53.0 t30 -86.03 69.2 10.5 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.956 -1.02 . . . . 0.72 108.566 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1623 ' ' ARG . . . . . 0.472 ' O ' ' HG3' ' A' 1625 ' ' MET . 11.5 ptp180 -166.23 140.63 3.62 Favored Pre-proline 0 C--N 1.296 -1.744 0 N-CA-C 107.537 -1.283 . . . . 3.26 107.537 -178.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -58.07 104.71 0.18 Allowed 'Trans proline' 0 C--O 1.238 0.515 0 C-N-CA 122.92 2.413 . . . . 0.59 110.885 178.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1625 ' ' MET . . . . . 0.472 ' HG3' ' O ' ' A' 1623 ' ' ARG . 94.2 mtp -98.75 131.27 45.02 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.476 -0.935 . . . . 1.37 108.476 -176.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1626 ' ' LEU . . . . . 0.538 ' HG ' ' CE1' ' A' 1542 ' ' TYR . 1.0 OUTLIER -86.82 111.86 21.17 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 106.938 -1.505 . . . . 0.89 106.938 -178.031 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A 1627 ' ' ILE . . . . . 0.564 HD11 ' HB2' ' A' 1639 ' ' SER . 37.8 mm -73.07 -56.89 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.883 0 N-CA-C 108.902 -0.777 . . . . 0.58 108.902 -178.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 23.8 t -171.88 162.21 6.01 Favored 'General case' 0 N--CA 1.417 -2.124 0 N-CA-C 107.839 -1.171 . . . . 1.39 107.839 -175.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1629 ' ' LEU . . . . . 0.495 HD13 ' CD1' ' A' 1636 ' ' LEU . 5.7 tp -112.11 109.2 18.78 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 107.731 -1.211 . . . . 1.25 107.731 175.112 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1630 ' ' ASP . . . . . 0.533 ' HB3' ' HB ' ' A' 1635 ' ' THR . 13.4 t70 -75.02 85.91 2.31 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 106.16 -1.793 . . . . 1.09 106.16 173.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1631 ' ' LYS . . . . . 0.477 ' HG3' HD13 ' B' ' 53' ' ' LEU . 21.6 tptm -64.65 -19.8 65.92 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 114.229 -1.351 . . . . 3.6 112.702 -173.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1632 ' ' GLN . . . . . 0.41 HE21 ' HB3' ' A' 1632 ' ' GLN . 3.2 mt-30 -76.19 -31.67 58.6 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 119.599 -0.841 . . . . 2.6 110.376 -176.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 59.6 p -107.26 -10.46 15.81 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 116.116 -0.493 . . . . 0.75 111.631 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 65.9 m 67.23 49.26 1.09 Allowed 'General case' 0 C--N 1.36 1.054 0 CA-C-O 122.76 1.267 . . . . 0.53 109.975 -178.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1635 ' ' THR . . . . . 0.533 ' HB ' ' HB3' ' A' 1630 ' ' ASP . 93.3 m -109.87 130.0 55.58 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 113.854 -1.521 . . . . 0.46 109.088 -177.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1636 ' ' LEU . . . . . 0.495 ' CD1' HD13 ' A' 1629 ' ' LEU . 0.2 OUTLIER -105.68 135.82 46.39 Favored 'General case' 0 CA--C 1.504 -0.802 0 N-CA-C 108.009 -1.108 . . . . 0.86 108.009 177.68 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -109.37 125.59 52.53 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 109.556 -0.535 . . . . 0.45 109.556 177.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -125.11 136.89 54.07 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.307 -0.627 . . . . 0.5 109.307 -178.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1639 ' ' SER . . . . . 0.564 ' HB2' HD11 ' A' 1627 ' ' ILE . 33.1 t -116.8 154.87 29.94 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 107.285 -1.376 . . . . 1.04 107.285 175.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 2.7 t90 -150.38 108.21 3.7 Favored 'General case' 0 N--CA 1.417 -2.087 0 N-CA-C 104.882 -2.266 . . . . 0.68 104.882 178.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1641 ' ' HIS . . . . . 0.753 ' HB2' ' HB ' ' A' 1621 ' ' THR . 51.2 m-70 -95.06 104.63 16.51 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 121.281 0.562 . . . . 0.9 109.941 -175.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1642 ' ' THR . . . . . . . . . . . . . 8.6 t -142.38 148.99 49.72 Favored Pre-proline 0 C--N 1.3 -1.584 0 CA-C-N 115.67 -0.696 . . . . 0.48 109.674 -173.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1643 ' ' PRO . . . . . 0.843 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 77.7 Cg_endo -78.87 -6.41 15.12 Favored 'Trans proline' 0 C--N 1.369 1.626 0 C-N-CA 122.483 2.122 . . . . 0.66 112.586 179.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 8.2 tt -70.21 -25.35 63.36 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.1 -0.704 . . . . 0.97 109.1 178.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -95.29 17.12 14.98 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.962 -1.017 . . . . 0.84 110.342 -178.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1646 ' ' CYS . . . . . 0.538 ' SG ' ' HA ' ' A' 1643 ' ' PRO . 95.7 m -96.28 145.59 25.45 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 109.716 -0.476 . . . . 1.19 109.716 177.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1647 ' ' GLU . . . . . 0.524 ' OE1' ' OH ' ' A' 1583 ' ' TYR . 35.4 tt0 -101.61 118.22 60.19 Favored Pre-proline 0 C--N 1.297 -1.684 0 N-CA-C 108.654 -0.869 . . . . 3.14 108.654 -177.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1648 ' ' PRO . . . . . 0.434 ' HG2' ' CD2' ' A' 1525 ' ' HIS . 97.4 Cg_exo -47.11 116.31 1.68 Allowed 'Trans proline' 0 C--N 1.358 1.074 0 C-N-CA 124.226 3.284 . . . . 2.58 114.824 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 42.2 tt0 . . . . . 0 N--CA 1.439 -0.989 0 N-CA-C 107.53 -1.285 . . . . 4.72 107.53 176.941 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.36 0 N-CA-C 109.614 -0.513 . . . . 9.97 109.614 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 2' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -108.7 134.28 51.64 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 109.35 -0.611 . . . . 7.68 109.35 -178.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 -116.6 139.75 25.87 Favored Pre-proline 0 C--N 1.28 -2.437 0 N-CA-C 107.897 -1.149 . . . . 6.11 107.897 177.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -57.48 -17.05 25.93 Favored 'Trans proline' 0 C--N 1.371 1.731 0 C-N-CA 124.114 3.209 . . . . 4.84 113.461 -177.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . 0.418 ' HB3' ' O ' ' B' ' 7' ' ' THR . 49.0 m -125.52 92.61 3.65 Favored 'General case' 0 N--CA 1.412 -2.365 0 N-CA-C 107.629 -1.249 . . . . 4.6 107.629 172.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . 0.455 ' HB3' ' OG ' ' A' 1602 ' ' SER . 51.8 mt-10 -71.45 -32.95 68.91 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 106.987 -1.486 . . . . 4.23 106.987 176.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . 0.617 ' HB ' ' SG ' ' B' ' 46' ' ' CYS . 1.4 p -94.91 142.67 27.21 Favored 'General case' 0 N--CA 1.402 -2.852 0 N-CA-C 107.297 -1.371 . . . . 3.14 107.297 172.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.736 ' HG ' ' HB2' ' B' ' 12' ' ' GLU . 1.5 mm? -80.09 128.87 34.01 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 116.313 -0.403 . . . . 3.96 110.099 -170.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 99.1 m -63.82 -30.37 71.47 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 114.269 1.211 . . . . 2.84 114.269 179.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . 0.499 ' O ' HG12 ' B' ' 14' ' ' VAL . . . -150.17 -61.67 0.01 OUTLIER Glycine 0 N--CA 1.417 -2.593 0 C-N-CA 119.491 -1.338 . . . . 2.09 112.708 -177.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -44.79 -74.67 0.2 Allowed Glycine 0 N--CA 1.473 1.153 0 N-CA-C 115.626 1.011 . . . . 1.84 115.626 -170.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . 0.736 ' HB2' ' HG ' ' B' ' 8' ' ' LEU . 44.9 mt-10 -75.0 -17.14 60.57 Favored 'General case' 0 C--N 1.314 -0.966 0 O-C-N 122.317 -0.519 . . . . 2.55 111.578 -179.068 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . 0.472 ' O ' HD23 ' B' ' 17' ' ' LEU . 36.7 tp -71.98 -53.73 12.1 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-O 120.884 0.373 . . . . 2.35 110.284 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . 0.499 HG12 ' O ' ' B' ' 10' ' ' GLY . 13.7 p -70.64 -23.54 24.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-O 121.5 0.667 . . . . 2.11 109.796 -179.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -72.49 -42.43 64.87 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.815 -0.629 . . . . 2.04 111.233 175.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . 0.663 ' HB ' ' HB2' ' A' 1599 ' ' PRO . 15.1 t -67.43 -30.14 69.81 Favored 'General case' 0 C--O 1.248 1.005 0 CA-C-N 118.674 0.67 . . . . 1.84 110.727 176.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.472 HD23 ' O ' ' B' ' 13' ' ' LEU . 3.3 mm? -51.97 -51.69 55.48 Favored 'General case' 0 C--O 1.212 -0.918 0 O-C-N 123.637 0.586 . . . . 1.74 109.89 168.077 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.69 -33.69 69.01 Favored 'General case' 0 C--O 1.214 -0.793 0 CA-C-N 116.014 -0.539 . . . . 2.39 110.213 -178.417 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -47.97 -64.09 0.89 Allowed 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 113.084 0.772 . . . . 0.96 113.084 177.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 10.1 p -91.93 -14.52 8.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 C-N-CA 118.588 -1.245 . . . . 1.37 111.62 -176.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 21' ' ' CYS . . . . . 0.577 ' HB2' ' HB3' ' B' ' 26' ' ' PHE . 61.9 m -106.95 17.51 23.0 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 119.806 -0.758 . . . . 1.66 112.659 -178.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -53.01 -44.14 62.03 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 121.226 -0.512 . . . . 1.53 112.43 174.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -82.22 -52.5 6.9 Favored 'General case' 0 C--N 1.314 -0.937 0 O-C-N 122.627 -0.337 . . . . 2.72 111.718 178.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 44.9 ttp180 -69.09 -29.04 67.06 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.38 0.882 . . . . 4.33 113.38 -175.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.09 133.03 7.14 Favored Glycine 0 N--CA 1.435 -1.37 0 N-CA-C 109.826 -1.309 . . . . 1.53 109.826 -177.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . 0.577 ' HB3' ' HB2' ' B' ' 21' ' ' CYS . 22.9 p90 -107.68 112.98 25.94 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 117.448 0.624 . . . . 1.65 110.235 -179.028 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -135.74 133.77 38.35 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.149 -1.056 . . . . 3.42 108.149 -177.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 28' ' ' PHE . . . . . 0.433 ' HA ' ' HE1' ' B' ' 59' ' ' TYR . 18.0 p90 -147.88 19.15 1.14 Allowed 'General case' 0 C--N 1.315 -0.895 0 O-C-N 123.293 0.371 . . . . 2.26 111.501 -178.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 51.2 m -156.53 84.31 0.97 Allowed 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.033 -0.728 . . . . 3.68 109.033 -178.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . 0.699 ' O ' ' HA ' ' B' ' 39' ' ' SER . 48.0 mtt-85 -116.59 154.55 49.21 Favored Pre-proline 0 C--N 1.314 -0.964 0 N-CA-C 108.45 -0.945 . . . . 3.81 108.45 -176.244 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.32 -48.59 15.04 Favored 'Trans proline' 0 C--O 1.256 1.387 0 C-N-CA 121.581 1.521 . . . . 4.02 111.731 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -160.32 146.01 15.14 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 115.15 -0.932 . . . . 4.92 108.513 179.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . 0.435 ' HB3' ' HB3' ' B' ' 36' ' ' SER . 30.4 t -168.65 166.4 11.84 Favored 'General case' 0 N--CA 1.399 -2.984 0 N-CA-C 103.492 -2.781 . . . . 6.72 103.492 -176.228 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 26.2 tpt180 -90.76 -4.69 56.49 Favored 'General case' 0 C--N 1.258 -3.378 0 CA-C-O 121.598 0.713 . . . . 11.63 109.211 -175.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 0.669 HG21 HG21 ' B' ' 62' ' ' THR . 11.9 t -121.68 -8.49 9.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 122.08 0.943 . . . . 9.61 108.479 177.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . 0.435 ' HB3' ' HB3' ' B' ' 33' ' ' SER . 32.7 t -151.9 63.54 0.85 Allowed 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 107.229 -1.397 . . . . 6.71 107.229 -174.389 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -82.19 6.96 14.94 Favored 'General case' 0 C--O 1.245 0.838 0 CA-C-N 115.55 -0.75 . . . . 10.0 112.51 -178.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 20.1 tpp180 -114.69 140.31 48.96 Favored 'General case' 0 N--CA 1.417 -2.107 0 N-CA-C 105.024 -2.213 . . . . 7.94 105.024 177.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . 0.699 ' HA ' ' O ' ' B' ' 30' ' ' ARG . 23.8 m -64.94 -8.81 17.21 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 114.33 1.233 . . . . 5.76 114.33 -174.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 26.6 ptt180 -150.89 148.5 28.51 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 107.853 -1.165 . . . . 6.03 107.853 174.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . -149.96 160.65 28.6 Favored Glycine 0 N--CA 1.414 -2.789 0 N-CA-C 110.685 -0.966 . . . . 2.37 110.685 176.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . 0.291 17.5 pt 65.55 -36.22 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 128.318 2.647 . . . . 2.07 115.12 175.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 2.5 p -52.27 -41.02 32.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 123.532 0.733 . . . . 2.24 112.926 178.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -87.81 -47.43 8.61 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 109.368 -0.604 . . . . 3.36 109.368 -176.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -54.49 -44.5 72.73 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 114.985 -1.007 . . . . 3.08 111.676 -179.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 46' ' ' CYS . . . . . 0.617 ' SG ' ' HB ' ' B' ' 7' ' ' THR . 22.9 t -86.22 -15.68 40.1 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.029 0.442 . . . . 2.23 111.246 -176.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 49.5 t -75.17 -37.97 61.06 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.235 0.54 . . . . 2.37 110.991 178.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -105.75 -12.79 15.76 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 113.766 1.024 . . . . 2.82 113.766 -177.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 56.6 mtm180 -138.61 158.24 44.62 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.703 -0.851 . . . . 4.09 108.703 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 16.0 t -80.27 114.91 19.51 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.782 -0.822 . . . . 2.67 108.782 -177.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . 0.424 ' H ' HG21 ' B' ' 7' ' ' THR . 32.0 p -89.42 143.61 26.69 Favored 'General case' 0 N--CA 1.421 -1.904 0 N-CA-C 108.247 -1.02 . . . . 2.11 108.247 -176.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -92.81 150.03 20.89 Favored 'General case' 0 N--CA 1.421 -1.884 0 N-CA-C 107.322 -1.362 . . . . 2.67 107.322 174.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . 0.63 ' HB3' ' HB3' ' A' 1600 ' ' SER . 3.9 pp -70.35 -9.16 55.4 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 113.199 0.814 . . . . 1.9 113.199 -171.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.24 -33.67 65.44 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.313 -0.995 . . . . 1.52 108.313 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 54.0 tp -60.67 -49.34 77.93 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-N 114.851 -1.068 . . . . 1.97 109.293 177.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 3.3 pp -73.83 -29.27 62.04 Favored 'General case' 0 N--CA 1.412 -2.353 0 C-N-CA 120.295 -0.562 . . . . 1.53 111.584 -176.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -63.98 -52.77 58.09 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.059 0.457 . . . . 2.27 110.929 -179.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 13.6 t -77.61 -23.07 49.94 Favored 'General case' 0 CA--C 1.557 1.214 0 CA-C-N 116.039 -0.528 . . . . 2.33 111.958 -177.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 59' ' ' TYR . . . . . 0.433 ' HE1' ' HA ' ' B' ' 28' ' ' PHE . 10.2 t80 -81.67 -34.4 30.73 Favored 'General case' 0 C--O 1.243 0.732 0 N-CA-C 108.817 -0.808 . . . . 2.86 108.817 179.227 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 9.6 t -73.79 80.03 1.59 Allowed 'General case' 0 C--O 1.248 1.018 0 CA-C-N 115.269 -0.878 . . . . 2.3 111.733 -178.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . 76.07 151.7 0.12 Allowed 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 125.02 1.328 . . . . 3.19 113.938 173.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 62' ' ' THR . . . . . 0.669 HG21 HG21 ' B' ' 35' ' ' VAL . 4.7 p -127.98 139.3 34.99 Favored Pre-proline 0 N--CA 1.42 -1.942 0 CA-C-N 114.499 -1.228 . . . . 3.68 109.696 179.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -55.39 -28.23 62.34 Favored 'Trans proline' 0 CA--C 1.509 -0.727 0 C-N-CA 124.583 3.522 . . . . 5.08 115.415 -172.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -121.79 24.01 9.87 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 120.911 -0.315 . . . . 5.1 111.666 -179.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . 0.523 ' HB3' ' OG1' ' B' ' 62' ' ' THR . 22.0 tptm -156.9 28.56 0.31 Allowed 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 122.018 0.913 . . . . 8.51 109.905 -178.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 50.1 m -153.71 35.44 0.45 Allowed 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 121.464 0.65 . . . . 8.12 109.362 176.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 . . . . . 0 N--CA 1.423 -1.805 0 N-CA-C 108.16 -1.052 . . . . 10.21 108.16 -175.642 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 15.6 tpt . . . . . 0 CA--C 1.512 -0.49 0 N-CA-C 109.299 -0.63 . . . . 9.34 109.299 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A 1509 ' ' LYS . . . . . 0.763 ' HG2' ' HB2' ' A' 1526 ' ' LEU . 97.7 mttt -76.5 81.7 3.2 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 123.067 0.547 . . . . 9.04 110.827 -179.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 65.7 m -136.52 140.98 43.38 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.793 -0.64 . . . . 5.81 109.784 178.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1511 ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -86.71 67.12 9.75 Favored 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 109.299 -0.63 . . . . 3.42 109.299 176.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1512 ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -78.22 -31.4 49.32 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 115.67 -0.695 . . . . 5.95 110.181 -177.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 74.9 m-70 71.5 -64.41 0.39 Allowed 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 114.894 -1.048 . . . . 5.33 112.312 177.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1514 ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' A' 1579 ' ' LYS . 26.7 t70 -68.37 -7.06 28.04 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.473 1.109 . . . . 5.06 112.515 -173.446 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 25.3 t70 -107.81 16.73 23.29 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.14 -0.975 . . . . 2.9 109.759 176.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1516 ' ' CYS . . . . . 0.646 ' HA ' ' HB2' ' A' 1581 ' ' LEU . 69.2 m 59.05 49.57 9.28 Favored 'General case' 0 C--O 1.246 0.884 0 N-CA-C 114.393 1.257 . . . . 1.19 114.393 -179.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -156.45 134.66 11.32 Favored 'General case' 0 N--CA 1.427 -1.599 0 CA-C-N 115.22 -0.9 . . . . 1.52 110.819 175.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1518 ' ' VAL . . . . . 0.643 HG21 ' HB2' ' A' 1583 ' ' TYR . 5.6 m -141.21 145.25 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 C-N-CA 124.411 1.085 . . . . 0.94 109.892 -178.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1519 ' ' THR . . . . . 0.42 ' OG1' HD23 ' A' 1526 ' ' LEU . 25.8 m -114.89 137.1 52.37 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 109.239 -0.652 . . . . 0.89 109.239 177.253 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1520 ' ' ASN . . . . . 0.529 ' OD1' HG22 ' A' 1523 ' ' THR . 26.8 t-20 -91.36 110.75 44.92 Favored Pre-proline 0 C--N 1.3 -1.556 0 N-CA-C 108.088 -1.078 . . . . 1.74 108.088 173.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -65.32 -19.08 61.86 Favored 'Trans proline' 0 N--CA 1.478 0.601 0 C-N-CA 123.464 2.776 . . . . 1.58 113.246 -173.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1522 ' ' SER . . . . . 0.465 ' HB2' ' OD1' ' A' 1520 ' ' ASN . 18.0 m -70.08 -44.58 68.79 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-N 115.849 -0.614 . . . . 1.65 111.259 -178.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1523 ' ' THR . . . . . 0.529 HG22 ' OD1' ' A' 1520 ' ' ASN . 9.6 t -119.01 6.86 11.33 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.54 0.686 . . . . 1.61 111.067 -175.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 57.83 36.02 77.88 Favored Glycine 0 CA--C 1.511 -0.199 0 CA-C-N 115.104 -0.953 . . . . 1.13 113.798 177.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 13.0 t-160 -100.72 122.14 42.86 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 120.537 -0.465 . . . . 1.26 110.578 -179.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1526 ' ' LEU . . . . . 0.763 ' HB2' ' HG2' ' A' 1509 ' ' LYS . 2.2 tm? -96.92 114.61 26.25 Favored 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 124.76 1.224 . . . . 0.68 109.522 -179.149 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -91.24 115.28 27.9 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 116.777 -0.192 . . . . 0.65 111.167 176.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 6.3 t70 -101.74 115.02 29.62 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 108.094 -1.076 . . . . 1.17 108.094 174.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1529 ' ' LEU . . . . . 0.432 ' HB2' ' HB3' ' A' 1516 ' ' CYS . 3.6 mm? -101.07 4.17 42.0 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.346 0.593 . . . . 0.6 110.129 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1530 ' ' SER . . . . . 0.427 ' HA ' ' OG ' ' A' 1533 ' ' SER . 1.2 m -67.01 -30.19 70.22 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.16 -0.927 . . . . 0.84 109.011 179.174 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 30.9 m -61.38 -27.76 68.75 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 114.962 -1.017 . . . . 1.59 111.008 178.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 83.1 mt -99.09 -1.08 40.43 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 120.696 0.284 . . . . 0.65 110.819 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1533 ' ' SER . . . . . 0.427 ' OG ' ' HA ' ' A' 1530 ' ' SER . 19.6 m -75.0 158.92 32.44 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 120.736 0.303 . . . . 1.52 110.877 -177.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . 176.71 146.48 6.09 Favored Glycine 0 N--CA 1.443 -0.833 0 N-CA-C 110.867 -0.893 . . . . 1.1 110.867 -179.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1535 ' ' ARG . . . . . 0.401 ' O ' ' HA ' ' A' 1556 ' ' ASN . 36.8 ttm180 -92.62 -29.07 16.32 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 123.205 0.602 . . . . 4.62 111.036 -177.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -75.83 -38.89 57.64 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.864 0.84 . . . . 1.45 108.986 177.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 94.87 -165.52 25.66 Favored Glycine 0 N--CA 1.422 -2.283 0 CA-C-N 114.939 -1.028 . . . . 0.85 114.081 172.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -128.34 153.69 46.75 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 107.267 -1.383 . . . . 0.93 107.267 -178.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 3.0 p -112.56 136.11 52.48 Favored 'General case' 0 C--N 1.31 -1.149 0 O-C-N 123.539 0.525 . . . . 1.03 111.388 -177.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1540 ' ' ALA . . . . . 0.41 ' HB3' ' CG1' ' A' 1548 ' ' VAL . . . -128.22 148.62 50.63 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.517 -0.92 . . . . 0.5 108.517 175.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -82.4 135.86 35.08 Favored 'General case' 0 C--N 1.315 -0.9 0 O-C-N 123.556 0.535 . . . . 0.74 111.494 -176.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1542 ' ' TYR . . . . . 0.517 ' HB3' ' H ' ' A' 1543 ' ' SER . 2.4 t80 -134.11 -101.32 0.24 Allowed 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 115.628 -0.714 . . . . 0.99 109.434 179.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1543 ' ' SER . . . . . 0.517 ' H ' ' HB3' ' A' 1542 ' ' TYR . 39.8 t -72.32 160.42 32.4 Favored 'General case' 0 C--O 1.246 0.92 0 CA-C-N 115.907 -0.588 . . . . 1.91 110.569 -178.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1544 ' ' LYS . . . . . 0.44 ' HE2' ' HA ' ' B' ' 23' ' ' ASP . 24.3 ttmm -53.61 -40.3 65.64 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.958 0.409 . . . . 3.59 111.634 -178.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 45.6 m -104.32 12.02 34.07 Favored 'General case' 0 N--CA 1.413 -2.294 0 N-CA-C 112.42 0.526 . . . . 2.46 112.42 -174.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . -155.42 147.69 16.92 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 117.822 -2.132 . . . . 1.26 115.683 -173.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 35.1 m -113.0 172.94 2.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 108.557 -0.905 . . . . 0.79 108.557 178.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1548 ' ' VAL . . . . . 0.502 ' HA ' ' HA ' ' A' 1567 ' ' PHE . 14.9 p -115.69 141.39 33.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 109.125 -0.694 . . . . 0.58 109.125 176.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -103.74 129.5 51.12 Favored 'General case' 0 CA--C 1.491 -1.327 0 N-CA-C 109.32 -0.622 . . . . 1.08 109.32 176.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 23.1 ptm -139.66 128.62 23.54 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 115.435 -0.802 . . . . 0.78 110.494 -179.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1551 ' ' SER . . . . . 0.452 ' HB3' HD22 ' A' 1556 ' ' ASN . 15.4 p -112.12 131.46 55.44 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 115.773 -0.649 . . . . 0.97 109.721 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1552 ' ' ILE . . . . . . . . . . . . . 46.9 mm -91.0 121.11 41.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 N-CA-C 109.529 -0.545 . . . . 0.42 109.529 -178.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1553 ' ' CYS . . . . . 0.47 ' O ' ' HE2' ' A' 1579 ' ' LYS . 72.7 m 60.33 42.84 14.32 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 121.73 0.776 . . . . 1.4 112.058 175.077 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 177.64 171.88 41.56 Favored Glycine 0 N--CA 1.417 -2.62 0 N-CA-C 110.312 -1.115 . . . . 0.35 110.312 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -87.33 153.45 21.45 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 109.441 -0.577 . . . . 1.62 109.441 179.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1556 ' ' ASN . . . . . 0.452 HD22 ' HB3' ' A' 1551 ' ' SER . 18.4 t-20 -102.06 120.98 41.3 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 108.815 -0.809 . . . . 0.87 108.815 -177.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -78.87 13.85 1.57 Allowed 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 113.549 0.944 . . . . 2.49 113.549 -174.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 54.6 m-80 -96.08 -12.54 24.69 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 120.214 -0.595 . . . . 1.38 110.368 177.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1559 ' ' CYS . . . . . 0.748 ' SG ' ' HD2' ' A' 1560 ' ' PRO . 3.8 t -136.77 164.09 44.95 Favored Pre-proline 0 C--N 1.307 -1.253 0 CA-C-O 117.154 -1.403 . . . . 1.21 107.555 -175.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1560 ' ' PRO . . . . . 0.748 ' HD2' ' SG ' ' A' 1559 ' ' CYS . 37.9 Cg_exo -28.5 140.96 0.02 OUTLIER 'Trans proline' 0 C--N 1.381 2.249 1 C-N-CA 125.549 4.166 . . . . 0.71 116.341 177.657 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A 1561 ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' 1560 ' ' PRO . 73.9 Cg_exo -53.04 127.4 24.86 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 124.017 3.144 . . . . 0.8 114.194 -177.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 93.58 7.05 62.01 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-N 115.755 -0.657 . . . . 0.46 114.345 177.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1563 ' ' VAL . . . . . 0.614 HG11 ' HB3' ' A' 1559 ' ' CYS . 5.5 p -99.3 141.98 15.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 O-C-N 121.929 -0.748 . . . . 0.98 110.401 -179.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -104.68 -28.71 5.58 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-N 116.339 -0.391 . . . . 0.28 112.99 178.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -130.56 131.78 45.21 Favored 'General case' 0 C--O 1.245 0.827 0 O-C-N 122.294 -0.533 . . . . 0.28 110.794 179.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 44.3 t -159.81 141.32 12.81 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.785 -0.82 . . . . 0.43 108.785 -178.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1567 ' ' PHE . . . . . 0.52 ' HB2' ' OG1' ' A' 1570 ' ' THR . 93.9 m-85 -86.91 146.51 26.15 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.776 -0.824 . . . . 1.03 108.776 178.211 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -68.71 -20.67 74.34 Favored Glycine 0 C--O 1.222 -0.625 0 N-CA-C 115.269 0.868 . . . . 1.13 115.269 -172.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 35.7 mm-40 -96.8 -30.68 13.03 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 117.535 0.667 . . . . 2.58 112.048 176.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1570 ' ' THR . . . . . 0.521 ' HA ' ' OD2' ' B' ' 15' ' ' ASP . 46.8 p -81.92 -32.0 31.07 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 115.236 1.569 . . . . 2.17 115.236 -163.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 69.78 -2.63 1.93 Allowed 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.984 0.914 . . . . 2.62 109.993 -172.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 28.5 mt -86.32 132.73 31.47 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 CA-C-O 121.473 0.654 . . . . 0.92 110.834 -171.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 17.6 t -78.65 116.53 19.07 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 114.446 -1.252 . . . . 0.8 109.589 179.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1574 ' ' VAL . . . . . 0.567 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 23.2 m -114.22 8.36 7.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-O 121.316 0.579 . . . . 0.98 111.437 -178.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . -174.45 112.63 0.42 Allowed Glycine 0 N--CA 1.428 -1.898 0 C-N-CA 120.35 -0.929 . . . . 0.29 111.527 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1576 ' ' LYS . . . . . 0.442 ' HB3' ' O ' ' A' 1593 ' ' LYS . 87.0 tttt -71.07 134.67 47.24 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.406 -0.961 . . . . 2.19 108.406 177.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -68.11 131.35 45.26 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-O 120.942 0.401 . . . . 0.61 110.465 -178.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -150.16 165.26 33.41 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 104.394 -2.447 . . . . 1.95 104.394 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1579 ' ' LYS . . . . . 0.47 ' HE2' ' O ' ' A' 1553 ' ' CYS . 97.4 mttt -130.83 40.1 3.52 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 108.675 -0.861 . . . . 2.68 108.675 -178.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -92.99 76.63 4.72 Favored 'General case' 0 N--CA 1.418 -2.073 0 CA-C-O 122.181 0.991 . . . . 3.47 109.893 -171.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1581 ' ' LEU . . . . . 0.646 ' HB2' ' HA ' ' A' 1516 ' ' CYS . 1.0 OUTLIER -63.71 125.93 25.92 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 113.18 -1.827 . . . . 0.64 109.173 178.856 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A 1582 ' ' ARG . . . . . 0.417 ' N ' HD13 ' A' 1581 ' ' LEU . 78.3 mtp180 -125.28 139.99 53.22 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 115.919 -0.582 . . . . 2.85 109.719 175.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1583 ' ' TYR . . . . . 0.643 ' HB2' HG21 ' A' 1518 ' ' VAL . 64.6 t80 -112.52 110.73 21.08 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 108.757 -0.831 . . . . 0.86 108.757 -178.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1584 ' ' VAL . . . . . 0.519 ' O ' ' HB ' ' A' 1587 ' ' VAL . 10.9 m -122.52 88.99 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-O 121.36 0.6 . . . . 1.05 112.142 -178.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 38.6 t70 55.13 65.09 1.59 Allowed 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 115.09 -0.959 . . . . 1.17 111.083 178.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1586 ' ' GLN . . . . . 0.586 ' HA ' ' CE1' ' A' 1583 ' ' TYR 0.291 11.6 pt20 64.69 15.37 9.7 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 126.826 2.05 . . . . 1.86 112.631 177.562 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A 1587 ' ' VAL . . . . . 0.519 ' HB ' ' O ' ' A' 1584 ' ' VAL . 41.9 t -110.63 121.28 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.338 0 CA-C-N 114.219 -1.355 . . . . 0.49 108.265 175.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1588 ' ' LEU . . . . . 0.834 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 2.6 mm? -95.83 114.65 26.4 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 106.688 -1.597 . . . . 0.36 106.688 179.054 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -126.77 125.19 41.33 Favored 'General case' 0 C--N 1.289 -2.031 0 C-N-CA 119.177 -1.009 . . . . 1.74 112.674 -175.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1590 ' ' LEU . . . . . 0.457 ' HB2' ' HB ' ' A' 1610 ' ' ILE . 19.1 mt -107.88 126.76 53.05 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 113.993 -1.458 . . . . 0.72 107.178 175.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 48.5 t -115.47 122.04 68.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 C-N-CA 119.879 -0.728 . . . . 1.01 109.893 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1592 ' ' TYR . . . . . 0.4 ' O ' ' HA ' ' A' 1607 ' ' LYS . 15.7 m-30 -105.49 94.74 5.37 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.932 -1.136 . . . . 0.5 107.932 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1593 ' ' LYS . . . . . 0.442 ' O ' ' HB3' ' A' 1576 ' ' LYS . 49.6 pttt -105.07 172.46 6.78 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 115.997 -0.547 . . . . 1.59 109.672 -176.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 70.1 m-20 57.11 52.79 8.6 Favored 'General case' 0 CA--C 1.51 -0.568 0 O-C-N 124.502 1.126 . . . . 1.11 111.554 178.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -71.88 -113.18 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 110.364 -1.095 . . . . 0.78 110.364 176.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1596 ' ' SER . . . . . 0.641 ' HB3' ' HD2' ' A' 1597 ' ' PRO . 72.2 m -133.43 168.68 16.72 Favored Pre-proline 0 C--N 1.284 -2.262 0 O-C-N 121.317 -1.108 . . . . 1.07 111.155 172.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1597 ' ' PRO . . . . . 0.641 ' HD2' ' HB3' ' A' 1596 ' ' SER . 2.5 Cg_endo -40.28 127.1 2.14 Favored 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 124.118 3.212 . . . . 1.01 114.058 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1598 ' ' CYS . . . . . 0.515 ' SG ' ' HB2' ' A' 1600 ' ' SER . 48.3 t -92.14 123.15 63.5 Favored Pre-proline 0 C--N 1.287 -2.124 0 CA-C-N 114.526 -1.215 . . . . 0.75 109.825 -179.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1599 ' ' PRO . . . . . 0.465 ' O ' ' HA ' ' B' ' 52' ' ' ASP . 17.2 Cg_exo -71.48 -27.99 18.33 Favored 'Trans proline' 0 C--O 1.211 -0.87 0 C-N-CA 122.206 1.937 . . . . 1.7 111.158 174.271 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1600 ' ' SER . . . . . 0.898 ' HA ' ' HB2' ' B' ' 53' ' ' LEU . 7.4 m -61.07 -47.16 87.64 Favored 'General case' 0 CA--C 1.555 1.145 0 CA-C-N 116.358 -0.383 . . . . 2.26 110.667 178.096 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1601 ' ' LYS . . . . . . . . . . . . . 5.4 tppp? -126.31 111.14 14.18 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 107.407 -1.331 . . . . 3.01 107.407 174.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 35.2 t -71.27 122.13 19.7 Favored 'General case' 0 N--CA 1.419 -2.001 0 C-N-CA 122.469 0.308 . . . . 2.07 110.223 -171.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 104.76 -10.15 48.57 Favored Glycine 0 N--CA 1.441 -1.032 0 N-CA-C 111.472 -0.651 . . . . 1.08 111.472 179.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1604 ' ' LEU . . . . . 0.483 HD23 ' SG ' ' A' 1634 ' ' CYS . 9.2 tp -101.09 168.63 9.47 Favored 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 107.832 -1.173 . . . . 1.84 107.832 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 20.2 m -129.64 146.93 51.39 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 109.117 -0.697 . . . . 1.41 109.117 178.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1606 ' ' TYR . . . . . 0.609 ' HD1' HD11 ' A' 1636 ' ' LEU . 67.0 m-85 -64.64 162.69 15.2 Favored 'General case' 0 C--O 1.251 1.182 0 N-CA-C 113.213 0.82 . . . . 0.6 113.213 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1607 ' ' LYS . . . . . 0.521 ' HE3' HG23 ' A' 1635 ' ' THR . 33.3 ttpt -158.54 130.78 6.86 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.067 -0.969 . . . . 1.45 109.194 -177.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1608 ' ' SER . . . . . . . . . . . . . 19.9 m -107.34 130.18 54.82 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 109.48 -0.563 . . . . 1.15 109.48 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 39.0 t -110.63 109.19 27.55 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 N-CA-C 108.687 -0.857 . . . . 0.25 108.687 178.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1610 ' ' ILE . . . . . 0.457 ' HB ' ' HB2' ' A' 1590 ' ' LEU . 62.1 mt -101.18 110.16 27.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 115.762 -0.654 . . . . 0.45 109.632 -177.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 27.9 t -111.59 115.09 28.58 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 115.61 -0.723 . . . . 1.26 110.361 -178.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1612 ' ' PHE . . . . . 0.834 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 71.9 m-85 -89.53 122.74 32.98 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 107.96 -1.126 . . . . 0.26 107.96 175.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1613 ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' 1641 ' ' HIS . 43.9 t -116.19 138.72 45.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 109.333 -0.617 . . . . 0.5 109.333 -176.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 40.5 t -66.77 119.02 11.13 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 123.998 0.919 . . . . 0.77 111.252 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1615 ' ' ARG . . . . . 0.83 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 20.2 tpt180 -122.16 96.72 46.21 Favored Pre-proline 0 N--CA 1.446 -0.663 0 N-CA-C 109.856 -0.424 . . . . 2.53 109.856 176.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1616 ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -66.6 -40.48 13.44 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.251 1.967 . . . . 1.1 110.607 176.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -80.6 43.28 0.65 Allowed 'General case' 0 C--O 1.241 0.647 0 C-N-CA 124.3 1.04 . . . . 3.05 111.272 176.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1618 ' ' ALA . . . . . 0.632 ' HB2' ' HG3' ' A' 1643 ' ' PRO . . . -39.51 124.68 1.65 Allowed 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 125.617 1.567 . . . . 1.55 113.166 -178.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1619 ' ' GLY . . . . . 0.447 ' C ' ' H ' ' A' 1621 ' ' THR . . . -154.63 -140.37 3.01 Favored Glycine 0 N--CA 1.43 -1.734 0 N-CA-C 108.431 -1.868 . . . . 0.93 108.431 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.36 20.14 0.36 Allowed 'Trans proline' 0 N--CA 1.486 1.062 0 C-N-CA 122.904 2.402 . . . . 0.88 112.827 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1621 ' ' THR . . . . . 0.833 ' HB ' ' HB2' ' A' 1641 ' ' HIS . 56.9 p -91.18 -14.21 31.49 Favored 'General case' 0 C--N 1.292 -1.922 0 C-N-CA 124.86 1.264 . . . . 0.97 108.975 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -87.93 68.26 9.22 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.963 -1.017 . . . . 0.72 109.002 -174.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 3.5 ptp180 -167.38 139.33 2.64 Favored Pre-proline 0 C--N 1.317 -0.821 0 C-N-CA 124.435 1.094 . . . . 3.26 108.561 179.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1624 ' ' PRO . . . . . 0.445 ' HA ' ' O ' ' A' 1639 ' ' SER . 37.5 Cg_endo -65.99 109.62 1.54 Allowed 'Trans proline' 0 C--O 1.238 0.522 0 C-N-CA 122.757 2.305 . . . . 0.59 111.584 -179.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 72.3 mtm -113.74 140.87 47.91 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 116.467 -0.333 . . . . 1.37 111.255 -178.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 1.8 tm? -78.48 119.78 22.27 Favored 'General case' 0 C--O 1.244 0.787 0 N-CA-C 107.358 -1.349 . . . . 0.89 107.358 179.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1627 ' ' ILE . . . . . 0.706 HD11 ' HB2' ' A' 1639 ' ' SER . 42.3 mm -80.16 -55.28 9.17 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 N-CA-C 108.833 -0.803 . . . . 0.58 108.833 178.448 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 22.7 t -173.82 158.4 3.23 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 106.933 -1.506 . . . . 1.39 106.933 -177.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1629 ' ' LEU . . . . . 0.82 ' HG ' ' HG ' ' A' 1636 ' ' LEU . 3.4 tt -115.58 113.02 23.04 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 104.312 -2.477 . . . . 1.25 104.312 175.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 16.4 t70 -69.48 103.95 2.19 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 108.602 -0.888 . . . . 1.09 108.602 176.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -61.94 -23.96 66.69 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 125.239 1.415 . . . . 3.6 113.319 -172.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 18.0 mm100 -86.13 -38.65 17.52 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 120.85 -0.34 . . . . 2.6 111.533 -177.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 67.0 p -103.88 2.27 32.39 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 112.657 0.614 . . . . 0.75 112.657 -174.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1634 ' ' CYS . . . . . 0.483 ' SG ' HD23 ' A' 1604 ' ' LEU . 81.4 m 57.47 35.67 26.13 Favored 'General case' 0 C--N 1.369 1.425 0 C-N-CA 123.96 0.904 . . . . 0.53 111.443 177.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1635 ' ' THR . . . . . 0.521 HG23 ' HE3' ' A' 1607 ' ' LYS . 90.8 m -107.85 126.86 53.17 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 115.155 -0.93 . . . . 0.46 109.97 -176.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1636 ' ' LEU . . . . . 0.82 ' HG ' ' HG ' ' A' 1629 ' ' LEU . 0.8 OUTLIER -107.07 122.15 45.9 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 108.588 -0.893 . . . . 0.86 108.588 -175.66 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -101.87 133.25 46.93 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 120.81 0.338 . . . . 0.45 111.465 -178.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -129.25 145.07 51.42 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.67 -0.696 . . . . 0.5 109.895 -178.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1639 ' ' SER . . . . . 0.706 ' HB2' HD11 ' A' 1627 ' ' ILE . 8.4 t -125.9 157.34 37.95 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 109.567 -0.531 . . . . 1.04 109.567 177.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 3.2 t90 -156.58 108.41 2.48 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 104.923 -2.251 . . . . 0.68 104.923 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1641 ' ' HIS . . . . . 0.833 ' HB2' ' HB ' ' A' 1621 ' ' THR . 18.1 m-70 -101.5 104.53 15.45 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 109.283 -0.636 . . . . 0.9 109.283 -178.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1642 ' ' THR . . . . . . . . . . . . . 3.2 t -133.64 150.11 73.93 Favored Pre-proline 0 C--N 1.3 -1.554 0 CA-C-N 115.186 -0.916 . . . . 0.48 110.608 -171.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1643 ' ' PRO . . . . . 0.632 ' HG3' ' HB2' ' A' 1618 ' ' ALA . 7.6 Cg_exo -73.63 -7.36 20.1 Favored 'Trans proline' 0 C--N 1.385 2.463 0 C-N-CA 122.44 2.094 . . . . 0.66 112.327 173.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 10.5 tt -66.95 -26.68 66.95 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.439 0.637 . . . . 0.97 109.814 179.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -92.39 9.87 32.36 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.193 -0.912 . . . . 0.84 109.82 179.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1646 ' ' CYS . . . . . 0.459 ' SG ' ' HA ' ' A' 1643 ' ' PRO . 72.9 m -111.86 146.92 36.85 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-N 115.958 -0.565 . . . . 1.19 110.416 -178.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -79.33 129.95 70.43 Favored Pre-proline 0 N--CA 1.424 -1.739 0 N-CA-C 106.57 -1.641 . . . . 3.14 106.57 173.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1648 ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -64.47 120.07 7.27 Favored 'Trans proline' 0 C--O 1.245 0.828 0 C-N-CA 122.269 1.979 . . . . 2.58 112.625 -177.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 . . . . . 0 C--O 1.254 1.301 0 N-CA-C 108.34 -0.985 . . . . 4.72 108.34 177.672 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.598 0 CA-C-O 121.108 0.48 . . . . 9.97 109.959 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 2' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -95.06 110.7 22.59 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 121.271 0.558 . . . . 7.68 109.715 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 3' ' ' ARG . . . . . 0.546 HH11 ' HA ' ' B' ' 8' ' ' LEU . 40.0 ptt180 -80.2 150.09 70.6 Favored Pre-proline 0 C--N 1.3 -1.566 0 N-CA-C 107.782 -1.192 . . . . 6.11 107.782 178.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . 0.401 ' O ' ' HG2' ' B' ' 6' ' ' GLU . 68.0 Cg_endo -73.06 28.48 0.29 Allowed 'Trans proline' 0 N--CA 1.48 0.701 0 C-N-CA 123.391 2.727 . . . . 4.84 113.52 -178.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . 0.452 ' H ' ' C ' ' B' ' 3' ' ' ARG . 60.6 p 53.92 3.67 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 127.896 2.478 . . . . 4.6 115.639 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' B' ' 4' ' ' PRO . 20.3 mm-40 -91.6 -40.74 11.16 Favored 'General case' 0 C--N 1.31 -1.125 0 O-C-N 122.232 -0.292 . . . . 4.23 111.09 -177.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . 0.465 ' O ' ' HD2' ' B' ' 3' ' ' ARG . 7.1 p -111.33 132.54 54.32 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-N 115.882 -0.599 . . . . 3.14 111.473 -173.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.662 ' HB2' ' HG3' ' B' ' 12' ' ' GLU . 9.4 mp -96.99 132.07 43.17 Favored 'General case' 0 N--CA 1.439 -0.978 0 C-N-CA 122.374 0.27 . . . . 3.96 110.921 179.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 9' ' ' CYS . . . . . 0.589 ' HA ' HD23 ' B' ' 13' ' ' LEU . 56.0 m -86.22 140.34 30.22 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 108.567 -0.901 . . . . 2.84 108.567 -178.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . 0.431 ' O ' HG12 ' B' ' 14' ' ' VAL . . . 90.73 -77.02 1.51 Allowed Glycine 0 N--CA 1.431 -1.642 0 C-N-CA 120.484 -0.865 . . . . 2.09 111.301 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -59.96 -67.09 2.32 Favored Glycine 0 CA--C 1.5 -0.871 0 CA-C-O 119.504 -0.609 . . . . 1.84 113.069 -175.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . 0.662 ' HG3' ' HB2' ' B' ' 8' ' ' LEU . 54.1 mt-10 -62.59 -29.14 70.38 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 117.371 0.585 . . . . 2.55 110.886 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . 0.589 HD23 ' HA ' ' B' ' 9' ' ' CYS . 1.2 mm? -59.38 -62.36 1.93 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.857 -0.61 . . . . 2.35 111.879 177.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . 0.431 HG12 ' O ' ' B' ' 10' ' ' GLY . 10.9 p -69.45 -28.74 39.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 115.834 -0.621 . . . . 2.11 110.494 -176.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 15' ' ' ASP . . . . . 0.521 ' OD2' ' HA ' ' A' 1570 ' ' THR . 31.7 t70 -70.71 -45.98 63.93 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 113.85 1.055 . . . . 2.04 113.85 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 20.3 p -63.95 -39.85 95.09 Favored 'General case' 0 C--O 1.275 2.422 0 CA-C-O 121.859 0.838 . . . . 1.84 109.935 178.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.462 ' HB3' ' HB3' ' B' ' 26' ' ' PHE . 11.2 mp -59.52 -48.34 82.03 Favored 'General case' 0 N--CA 1.416 -2.15 0 CA-C-N 114.947 -1.024 . . . . 1.74 110.689 172.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . 0.459 ' HB2' ' HE2' ' B' ' 26' ' ' PHE . 26.8 tt0 -56.74 -29.47 62.56 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.499 0.72 . . . . 2.39 111.942 174.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -58.1 -56.63 19.57 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-O 119.335 -0.365 . . . . 0.96 111.374 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 10.3 p -99.71 -17.62 6.64 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.309 0 C-N-CA 117.557 -1.657 . . . . 1.37 112.706 177.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 21' ' ' CYS . . . . . 0.591 ' HA ' ' HB3' ' B' ' 24' ' ' ARG . 58.9 m -112.22 30.77 6.78 Favored 'General case' 0 C--N 1.293 -1.849 0 O-C-N 121.717 -0.614 . . . . 1.66 112.0 -176.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.19 -64.47 4.24 Favored Glycine 0 C--O 1.241 0.571 0 C-N-CA 120.347 -0.93 . . . . 1.53 111.762 177.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.44 ' HA ' ' HE2' ' A' 1544 ' ' LYS . 31.6 t70 -69.73 -34.8 74.35 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 122.674 0.39 . . . . 2.72 111.086 175.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . 0.591 ' HB3' ' HA ' ' B' ' 21' ' ' CYS . 8.6 tpm_? -64.57 -35.74 81.96 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 124.24 1.016 . . . . 4.33 112.399 -177.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.81 149.59 23.42 Favored Glycine 0 N--CA 1.423 -2.204 0 N-CA-C 110.853 -0.899 . . . . 1.53 110.853 -179.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . 0.462 ' HB3' ' HB3' ' B' ' 17' ' ' LEU . 0.3 OUTLIER -131.41 136.18 47.8 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 111.917 0.34 . . . . 1.65 111.917 178.769 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -139.84 78.65 1.67 Allowed 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.785 -0.45 . . . . 3.42 109.785 176.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 28' ' ' PHE . . . . . 0.556 ' O ' ' HA3' ' B' ' 41' ' ' GLY . 11.1 p90 -94.15 -20.67 19.67 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.794 0.807 . . . . 2.26 109.102 178.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 50.0 m -86.65 84.94 7.29 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 121.357 0.599 . . . . 3.68 111.041 -178.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 76.0 mtt-85 -95.2 112.94 60.3 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-N 115.832 -0.622 . . . . 3.81 109.783 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -69.08 -54.87 0.22 Allowed 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 121.369 1.38 . . . . 4.02 109.397 172.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -153.0 160.51 43.02 Favored 'General case' 0 N--CA 1.417 -2.107 0 N-CA-C 106.663 -1.606 . . . . 4.92 106.663 176.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 68.2 m -159.48 163.48 35.26 Favored 'General case' 0 N--CA 1.394 -3.236 0 N-CA-C 101.837 -3.394 . . . . 6.72 101.837 178.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 52.8 ttp180 -93.03 -4.35 52.71 Favored 'General case' 0 C--N 1.273 -2.754 0 CA-C-O 121.604 0.716 . . . . 11.63 111.276 -170.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 53.3 t -118.6 -9.33 11.64 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-O 122.75 1.262 . . . . 9.61 108.028 175.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 8.6 t -143.21 77.6 1.57 Allowed 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 105.155 -2.165 . . . . 6.71 105.155 179.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' B' ' 37' ' ' ARG . 11.8 ptm180 -80.42 -2.47 45.85 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 114.295 -1.32 . . . . 10.0 111.157 -175.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -98.68 144.85 27.49 Favored 'General case' 0 N--CA 1.425 -1.686 0 N-CA-C 107.014 -1.476 . . . . 7.94 107.014 179.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 20.7 m -81.17 74.22 8.18 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 121.91 0.862 . . . . 5.76 110.759 -178.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 23.0 ttm180 -135.98 136.62 40.51 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 115.187 -0.915 . . . . 6.03 108.856 177.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . 0.556 ' HA3' ' O ' ' B' ' 28' ' ' PHE . . . -156.43 77.43 0.2 Allowed Glycine 0 N--CA 1.398 -3.882 0 N-CA-C 106.337 -2.705 . . . . 2.37 106.337 176.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . 0.471 ' HA ' ' HG2' ' B' ' 45' ' ' GLU . 31.2 pt 60.24 -8.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 C-N-CA 127.786 2.434 . . . . 2.07 114.904 -179.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 9.8 p -62.48 -34.1 62.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 C-N-CA 123.301 0.64 . . . . 2.24 112.42 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -84.07 -24.69 30.28 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 118.089 -1.444 . . . . 3.36 108.803 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . 0.471 ' HG2' ' HA ' ' B' ' 42' ' ' ILE . 32.2 mm-40 -67.66 -62.39 1.44 Allowed 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.377 -0.829 . . . . 3.08 109.154 -179.115 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 46' ' ' CYS . . . . . . . . . . . . . 21.1 m -76.39 -22.74 54.4 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 113.996 1.11 . . . . 2.23 113.996 -171.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 85.0 m -76.67 -1.66 28.9 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 121.201 -0.937 . . . . 2.37 112.594 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -133.94 -47.57 0.79 Allowed 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 112.467 0.543 . . . . 2.82 112.467 177.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 56.7 mtt-85 -104.53 168.9 8.78 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 120.889 0.375 . . . . 4.09 110.029 178.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 37.1 t -90.95 109.98 21.22 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 107.629 -1.249 . . . . 2.67 107.629 176.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . 0.545 ' HB2' HD23 ' B' ' 55' ' ' LEU . 21.8 p -90.93 135.48 33.71 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.851 -0.796 . . . . 2.11 108.851 -177.249 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . 0.465 ' HA ' ' O ' ' A' 1599 ' ' PRO . 3.7 p30 -98.66 172.05 7.73 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 113.376 0.88 . . . . 2.67 113.376 -176.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . 0.898 ' HB2' ' HA ' ' A' 1600 ' ' SER . 41.9 tp -51.12 -40.48 58.57 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 113.298 0.851 . . . . 1.9 113.298 -174.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . 0.402 ' O ' HG22 ' B' ' 58' ' ' THR . . . -54.94 -46.39 74.95 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 123.623 0.577 . . . . 1.52 111.575 -172.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . 0.545 HD23 ' HB2' ' B' ' 51' ' ' CYS . 48.0 tp -62.49 -58.0 9.16 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 114.925 -1.034 . . . . 1.97 110.516 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 3.9 pp -69.11 -34.1 74.54 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 112.692 0.627 . . . . 1.53 112.692 -172.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -76.24 -40.37 52.18 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 112.204 0.446 . . . . 2.27 112.204 -179.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 58' ' ' THR . . . . . 0.402 HG22 ' O ' ' B' ' 54' ' ' ALA . 7.0 t -77.71 -11.52 59.88 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 118.653 -1.219 . . . . 2.33 110.635 176.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 59' ' ' TYR . . . . . 0.465 ' OH ' ' HA2' ' B' ' 41' ' ' GLY . 17.6 t80 -85.59 -72.03 0.51 Allowed 'General case' 0 N--CA 1.426 -1.673 0 N-CA-C 106.477 -1.675 . . . . 2.86 106.477 175.21 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 41.3 t 38.38 -88.47 0.01 OUTLIER 'General case' 0 C--O 1.253 1.245 0 C-N-CA 126.071 1.748 . . . . 2.3 114.559 174.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -152.49 -55.38 0.13 Allowed 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 106.971 -1.492 . . . . 3.19 106.971 177.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 4.0 p -77.99 134.65 63.79 Favored Pre-proline 0 N--CA 1.408 -2.566 0 CA-C-N 114.381 -1.281 . . . . 3.68 108.582 172.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -74.39 -20.5 18.33 Favored 'Trans proline' 0 C--O 1.238 0.489 0 C-N-CA 122.616 2.211 . . . . 5.08 114.152 -174.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -142.88 83.92 1.82 Allowed 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 120.861 0.362 . . . . 5.1 110.712 179.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 54.1 tttp -71.18 129.71 39.62 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 109.135 -0.691 . . . . 8.51 109.135 175.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 29.8 m -121.05 -40.1 2.64 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.216 -1.031 . . . . 8.12 108.216 177.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 . . . . . 0 N--CA 1.429 -1.514 0 N-CA-C 105.168 -2.16 . . . . 10.21 105.168 178.547 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 3.9 mpp? . . . . . 0 CA--C 1.506 -0.73 0 N-CA-C 108.075 -1.083 . . . . 9.34 108.075 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A 1509 ' ' LYS . . . . . 0.523 ' HD3' ' HA ' ' A' 1521 ' ' PRO . 24.5 ttmm -153.68 58.9 0.74 Allowed 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 106.7 -1.593 . . . . 9.04 106.7 179.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 13.8 m -53.63 104.82 0.11 Allowed 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.0 -1.455 . . . . 5.81 112.822 -174.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1511 ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -104.54 97.68 7.55 Favored 'General case' 0 N--CA 1.425 -1.679 0 N-CA-C 107.035 -1.469 . . . . 3.42 107.035 175.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1512 ' ' GLU . . . . . 0.489 ' O ' HG12 ' A' 1518 ' ' VAL . 43.8 mt-10 -84.44 173.23 11.04 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 114.117 -1.401 . . . . 5.95 110.455 -172.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 60.2 m80 -146.42 -11.95 0.47 Allowed 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.397 0.888 . . . . 5.33 113.397 -178.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -104.6 -0.17 27.92 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 112.1 0.407 . . . . 5.06 112.1 -173.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -120.43 22.78 11.16 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 111.687 0.254 . . . . 2.9 111.687 -178.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1516 ' ' CYS . . . . . 0.604 ' HA ' ' HB2' ' A' 1581 ' ' LEU . 59.8 m 56.34 41.49 28.98 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-O 121.267 0.556 . . . . 1.19 110.951 -177.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -150.77 130.11 12.86 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 108.884 -0.784 . . . . 1.52 108.884 -179.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1518 ' ' VAL . . . . . 0.489 HG12 ' O ' ' A' 1512 ' ' GLU . 3.3 m -136.03 138.22 47.66 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 O-C-N 124.13 0.894 . . . . 0.94 110.47 -177.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1519 ' ' THR . . . . . . . . . . . . . 44.2 m -104.8 136.13 44.89 Favored 'General case' 0 C--N 1.281 -2.397 0 N-CA-C 107.612 -1.255 . . . . 0.89 107.612 175.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1520 ' ' ASN . . . . . 0.477 ' OD1' ' HB2' ' A' 1522 ' ' SER . 21.3 t-20 -91.23 115.76 65.06 Favored Pre-proline 0 C--N 1.287 -2.126 0 N-CA-C 108.816 -0.809 . . . . 1.74 108.816 174.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1521 ' ' PRO . . . . . 0.523 ' HA ' ' HD3' ' A' 1509 ' ' LYS . 35.9 Cg_endo -66.34 -15.52 48.37 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.998 2.465 . . . . 1.58 113.713 -176.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1522 ' ' SER . . . . . 0.477 ' HB2' ' OD1' ' A' 1520 ' ' ASN . 30.2 m -75.98 -44.76 38.2 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 111.772 0.286 . . . . 1.65 111.772 -179.142 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1523 ' ' THR . . . . . 0.463 HG22 ' OD1' ' A' 1520 ' ' ASN . 11.1 t -118.44 -1.26 11.27 Favored 'General case' 0 CA--C 1.556 1.178 0 CA-C-O 121.506 0.669 . . . . 1.61 112.092 -175.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 67.3 33.66 83.1 Favored Glycine 0 CA--C 1.503 -0.718 0 CA-C-N 115.829 -0.623 . . . . 1.13 112.937 176.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -98.68 121.9 41.22 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 109.626 -0.509 . . . . 1.26 109.626 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 1.9 tm? -94.12 111.84 23.6 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.208 -0.905 . . . . 0.68 108.804 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1527 ' ' PHE . . . . . 0.416 ' CE1' ' HA ' ' A' 1645 ' ' ALA . 85.0 m-85 -83.48 114.57 21.57 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 120.676 0.274 . . . . 0.65 111.445 174.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 22.4 t70 -102.91 101.13 11.14 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.112 -1.07 . . . . 1.17 108.112 176.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1529 ' ' LEU . . . . . 0.477 ' HG ' HD21 ' A' 1581 ' ' LEU . 4.2 mm? -83.88 -7.91 59.32 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 116.294 -0.412 . . . . 0.6 110.823 -177.017 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1530 ' ' SER . . . . . 0.597 ' HA ' ' OG ' ' A' 1533 ' ' SER . 17.1 m -66.48 -16.79 64.39 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.913 -0.585 . . . . 0.84 111.369 178.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 41.2 t -67.32 -29.06 68.53 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 109.327 -0.62 . . . . 1.59 109.327 173.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 81.3 mt -96.93 -10.33 26.58 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 116.451 -0.341 . . . . 0.65 111.061 -176.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1533 ' ' SER . . . . . 0.597 ' OG ' ' HA ' ' A' 1530 ' ' SER . 19.0 m -61.74 154.89 24.3 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.33 0.586 . . . . 1.52 110.718 178.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -171.13 131.2 2.14 Favored Glycine 0 C--N 1.286 -2.223 0 N-CA-C 109.443 -1.463 . . . . 1.1 109.443 -177.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1535 ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' 1535 ' ' ARG . 24.3 ttt180 -92.47 -34.49 14.08 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 112.337 0.495 . . . . 4.62 112.337 -172.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -59.7 -57.1 14.41 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.524 0.678 . . . . 1.45 110.571 -178.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 130.53 164.13 11.21 Favored Glycine 0 N--CA 1.409 -3.122 0 CA-C-N 115.433 -0.803 . . . . 0.85 111.999 173.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -120.51 138.91 53.58 Favored 'General case' 0 C--N 1.276 -2.617 0 N-CA-C 106.804 -1.554 . . . . 0.93 106.804 178.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 28.1 p -108.79 123.69 49.43 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 123.499 0.499 . . . . 1.03 110.783 -179.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1540 ' ' ALA . . . . . 0.445 ' HB3' ' CG1' ' A' 1548 ' ' VAL . . . -114.73 138.98 50.07 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 108.423 -0.955 . . . . 0.5 108.423 177.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -75.11 140.16 43.24 Favored 'General case' 0 CA--C 1.502 -0.872 0 O-C-N 123.93 0.769 . . . . 0.74 110.188 -177.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1542 ' ' TYR . . . . . 0.629 ' HE2' HD13 ' A' 1626 ' ' LEU . 1.7 t80 -152.53 -100.87 0.05 Allowed 'General case' 0 N--CA 1.424 -1.769 0 CA-C-N 115.954 -0.566 . . . . 0.99 110.25 -176.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1543 ' ' SER . . . . . . . . . . . . . 12.6 m -70.44 156.24 39.62 Favored 'General case' 0 N--CA 1.428 -1.544 0 C-N-CA 123.731 0.812 . . . . 1.91 109.735 -176.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 27.5 tptp -62.65 -22.07 66.16 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 125.502 1.521 . . . . 3.59 111.34 -173.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 34.3 t -137.94 37.65 2.37 Favored 'General case' 0 N--CA 1.427 -1.589 0 CA-C-N 115.746 -0.661 . . . . 2.46 109.6 -178.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1546 ' ' GLY . . . . . 0.54 ' HA3' ' HG2' ' A' 1569 ' ' GLN . . . -176.42 129.56 1.52 Allowed Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 119.025 -1.56 . . . . 1.26 113.974 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 35.9 m -102.75 162.68 3.76 Favored 'Isoleucine or valine' 0 C--O 1.251 1.175 0 N-CA-C 108.806 -0.812 . . . . 0.79 108.806 175.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1548 ' ' VAL . . . . . 0.474 ' HA ' ' HA ' ' A' 1567 ' ' PHE . 13.6 p -101.4 132.3 47.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 109.618 -0.512 . . . . 0.58 109.618 178.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -97.8 126.03 42.95 Favored 'General case' 0 CA--C 1.494 -1.202 0 C-N-CA 123.695 0.798 . . . . 1.08 109.435 177.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 24.0 ptm -139.2 135.48 34.02 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.311 -0.858 . . . . 0.78 111.42 -178.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 74.8 m -124.15 134.72 53.25 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.379 -0.828 . . . . 0.97 109.42 175.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1552 ' ' ILE . . . . . . . . . . . . . 46.4 mm -88.19 121.82 39.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 116.281 -0.418 . . . . 0.42 111.385 -175.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 34.0 t 66.04 25.35 10.92 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.615 1.166 . . . . 1.4 111.632 173.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . -167.51 174.99 42.63 Favored Glycine 0 N--CA 1.418 -2.552 0 N-CA-C 109.323 -1.511 . . . . 0.35 109.323 -179.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -95.63 155.94 16.53 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.081 0.467 . . . . 1.62 110.558 -178.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -104.25 134.84 46.8 Favored 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 107.258 -1.386 . . . . 0.87 107.258 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -95.93 7.96 44.94 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 112.943 0.719 . . . . 2.49 112.943 -172.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -83.04 -13.91 54.92 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.786 0.803 . . . . 1.38 109.533 177.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1559 ' ' CYS . . . . . 0.739 ' SG ' ' HD2' ' A' 1560 ' ' PRO . 9.3 t -131.89 162.16 58.2 Favored Pre-proline 0 C--N 1.293 -1.864 0 N-CA-C 106.039 -1.838 . . . . 1.21 106.039 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1560 ' ' PRO . . . . . 0.739 ' HD2' ' SG ' ' A' 1559 ' ' CYS . 41.8 Cg_exo -28.9 145.81 0.02 OUTLIER 'Trans proline' 0 CA--C 1.565 2.064 1 C-N-CA 125.301 4.001 . . . . 0.71 116.563 175.602 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.28 128.07 27.2 Favored 'Trans proline' 0 C--O 1.245 0.849 0 C-N-CA 123.56 2.84 . . . . 0.8 112.283 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 102.61 -9.73 55.74 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 116.139 -0.482 . . . . 0.46 112.354 -179.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1563 ' ' VAL . . . . . 0.537 HG11 ' HB2' ' A' 1566 ' ' CYS . 3.0 t -79.46 125.38 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 N-CA-C 112.665 0.617 . . . . 0.98 112.665 -178.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -98.6 -36.18 4.66 Favored Glycine 0 C--N 1.315 -0.616 0 CA-C-N 115.338 -0.847 . . . . 0.28 111.518 176.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -132.18 128.18 37.47 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 109.332 -0.618 . . . . 0.28 109.332 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1566 ' ' CYS . . . . . 0.537 ' HB2' HG11 ' A' 1563 ' ' VAL . 42.2 t -157.27 139.34 14.41 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 110.197 -0.297 . . . . 0.43 110.197 -177.032 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1567 ' ' PHE . . . . . 0.474 ' HA ' ' HA ' ' A' 1548 ' ' VAL . 37.8 m-85 -84.96 143.83 28.71 Favored 'General case' 0 C--O 1.245 0.846 0 N-CA-C 109.577 -0.527 . . . . 1.03 109.577 174.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -87.38 17.34 44.03 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.865 -0.683 . . . . 1.13 112.75 -175.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1569 ' ' GLN . . . . . 0.61 ' HB3' ' OD1' ' B' ' 15' ' ' ASP . 27.3 mt-30 -70.22 -69.97 0.32 Allowed 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 122.257 0.223 . . . . 2.58 110.507 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 13.8 t -130.41 29.74 4.81 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-O 121.604 0.716 . . . . 2.17 110.82 173.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 7.7 mmt180 65.29 55.17 1.1 Allowed 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 114.83 -1.077 . . . . 2.62 109.83 178.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 29.6 mt -95.97 115.74 35.95 Favored 'Isoleucine or valine' 0 C--O 1.246 0.907 0 CA-C-N 114.413 -1.267 . . . . 0.92 108.83 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 29.6 t -85.17 140.71 30.71 Favored 'General case' 0 C--O 1.245 0.855 0 CA-C-O 121.575 0.702 . . . . 0.8 110.845 -176.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1574 ' ' VAL . . . . . 0.628 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 35.7 m -126.2 15.49 3.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 CA-C-N 115.523 -0.762 . . . . 0.98 110.954 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 170.1 129.27 1.09 Allowed Glycine 0 N--CA 1.424 -2.154 0 C-N-CA 119.14 -1.505 . . . . 0.29 112.812 177.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 86.8 tttt -77.9 142.95 38.1 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 108.277 -1.009 . . . . 2.19 108.277 176.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -73.78 91.49 1.94 Allowed 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 123.036 0.534 . . . . 0.61 110.883 -178.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -109.85 171.63 7.33 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 108.273 -1.01 . . . . 1.95 108.273 178.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 62.3 mttp -124.05 44.61 2.69 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.688 -0.856 . . . . 2.68 108.688 -177.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 43.6 ttp180 -86.92 77.88 9.14 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 114.904 -1.044 . . . . 3.47 109.622 -177.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1581 ' ' LEU . . . . . 0.604 ' HB2' ' HA ' ' A' 1516 ' ' CYS . 0.5 OUTLIER -84.33 123.06 29.76 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.602 -1.181 . . . . 0.64 108.976 -179.053 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -126.35 140.37 52.56 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 110.108 -0.33 . . . . 2.85 110.108 173.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1583 ' ' TYR . . . . . 0.433 ' HB2' HG21 ' A' 1518 ' ' VAL . 51.0 t80 -106.35 111.63 24.3 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 108.975 -0.75 . . . . 0.86 108.975 177.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1584 ' ' VAL . . . . . 0.613 ' O ' ' HB ' ' A' 1587 ' ' VAL . 6.8 m -130.01 95.72 2.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 112.289 0.477 . . . . 1.05 112.289 -178.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 37.0 t70 57.99 65.81 1.23 Allowed 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 121.774 0.797 . . . . 1.17 111.929 174.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1586 ' ' GLN . . . . . . . . . . . . 0.254 30.2 pt20 60.67 20.72 10.68 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 127.021 2.128 . . . . 1.86 111.847 177.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1587 ' ' VAL . . . . . 0.613 ' HB ' ' O ' ' A' 1584 ' ' VAL . 18.3 t -117.32 121.0 66.64 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.606 0 CA-C-N 113.593 -1.64 . . . . 0.49 109.922 176.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1588 ' ' LEU . . . . . 0.838 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 2.7 mm? -95.59 115.58 27.63 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 106.061 -1.829 . . . . 0.36 106.061 175.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1589 ' ' GLN . . . . . 0.424 ' HA ' ' O ' ' A' 1610 ' ' ILE . 29.8 tt0 -118.01 126.44 52.31 Favored 'General case' 0 C--N 1.277 -2.558 0 C-N-CA 119.844 -0.743 . . . . 1.74 112.445 -174.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 11.9 mt -114.0 117.41 31.25 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 125.414 1.486 . . . . 0.72 107.043 175.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 26.9 t -104.88 128.89 58.26 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 C-N-CA 119.734 -0.786 . . . . 1.01 109.62 -178.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1592 ' ' TYR . . . . . 0.554 ' HB2' ' HB3' ' A' 1608 ' ' SER . 14.4 m-30 -117.58 96.13 5.26 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.901 -0.777 . . . . 0.5 108.901 178.166 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 38.8 pttt -111.4 175.62 5.35 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.823 -0.751 . . . . 1.59 109.876 177.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 33.3 m-20 67.48 60.23 0.48 Allowed 'General case' 0 CA--C 1.502 -0.889 0 C-N-CA 124.318 1.047 . . . . 1.11 110.904 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -91.11 -104.74 1.34 Allowed Glycine 0 N--CA 1.424 -2.153 0 N-CA-C 109.469 -1.452 . . . . 0.78 109.469 177.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1596 ' ' SER . . . . . . . . . . . . . 48.4 m -120.69 156.16 56.35 Favored Pre-proline 0 C--N 1.286 -2.172 0 N-CA-C 107.697 -1.223 . . . . 1.07 107.697 175.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -53.94 120.92 8.7 Favored 'Trans proline' 0 C--N 1.357 0.991 0 C-N-CA 122.927 2.418 . . . . 1.01 110.276 173.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1598 ' ' CYS . . . . . 0.476 ' HA ' ' HD3' ' A' 1599 ' ' PRO . 48.9 t -79.8 126.42 80.25 Favored Pre-proline 0 C--N 1.28 -2.453 0 CA-C-N 114.385 -1.279 . . . . 0.75 110.578 -175.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1599 ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' 1598 ' ' CYS . 12.2 Cg_exo -73.52 -15.72 24.55 Favored 'Trans proline' 0 C--O 1.212 -0.784 0 C-N-CA 122.942 2.428 . . . . 1.7 112.051 177.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1600 ' ' SER . . . . . 0.688 ' HA ' ' HB2' ' B' ' 53' ' ' LEU . 15.4 m -65.77 -31.85 73.06 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-O 120.67 0.271 . . . . 2.26 111.416 177.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1601 ' ' LYS . . . . . 0.445 ' HA ' ' HB2' ' B' ' 52' ' ' ASP . 22.9 ttmm -150.62 120.74 7.22 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 108.084 -1.08 . . . . 3.01 108.084 175.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 8.0 m -59.02 123.54 16.93 Favored 'General case' 0 N--CA 1.428 -1.548 0 C-N-CA 124.241 1.017 . . . . 2.07 112.707 -171.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1603 ' ' GLY . . . . . 0.48 ' HA3' ' O ' ' B' ' 1' ' ' ALA . . . 84.06 23.18 53.02 Favored Glycine 0 CA--C 1.499 -0.961 0 CA-C-N 116.167 -0.47 . . . . 1.08 112.482 175.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1604 ' ' LEU . . . . . 0.476 HD23 ' SG ' ' A' 1634 ' ' CYS . 11.5 tp -119.67 165.93 13.86 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 106.854 -1.535 . . . . 1.84 106.854 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 22.9 t -124.82 154.37 41.1 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.628 -0.878 . . . . 1.41 108.628 -177.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1606 ' ' TYR . . . . . 0.628 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 58.1 m-85 -74.86 163.58 27.5 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 116.011 -0.541 . . . . 0.6 109.892 176.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -160.33 128.26 4.61 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-N 116.338 -0.392 . . . . 1.45 109.944 -176.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1608 ' ' SER . . . . . 0.554 ' HB3' ' HB2' ' A' 1592 ' ' TYR . 34.5 t -104.95 126.3 51.87 Favored 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 108.447 -0.946 . . . . 1.15 108.447 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 25.8 t -110.61 99.21 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.66 0 N-CA-C 107.864 -1.161 . . . . 0.25 107.864 177.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1610 ' ' ILE . . . . . 0.424 ' O ' ' HA ' ' A' 1589 ' ' GLN . 77.1 mt -90.29 120.64 39.47 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 CA-C-N 115.014 -0.994 . . . . 0.45 108.917 -177.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 43.9 m -124.67 123.97 41.18 Favored 'General case' 0 C--N 1.287 -2.11 0 CA-C-N 115.863 -0.608 . . . . 1.26 112.025 -178.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1612 ' ' PHE . . . . . 0.838 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 75.5 m-85 -97.97 123.14 41.83 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.42 -0.956 . . . . 0.26 108.42 176.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 44.7 t -113.51 134.96 54.6 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 O-C-N 123.589 0.556 . . . . 0.5 110.621 -174.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -54.07 112.56 0.99 Allowed 'General case' 0 C--O 1.241 0.623 0 C-N-CA 124.265 1.026 . . . . 0.77 111.679 175.054 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1615 ' ' ARG . . . . . 0.549 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 23.0 tpt180 -126.0 88.95 53.35 Favored Pre-proline 0 N--CA 1.443 -0.798 0 N-CA-C 107.881 -1.155 . . . . 2.53 107.881 174.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1616 ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -72.57 -19.59 24.45 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 122.341 2.027 . . . . 1.1 113.325 -174.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -87.29 -10.8 51.39 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.612 -0.267 . . . . 3.05 111.552 179.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . 63.05 -172.53 0.16 Allowed 'General case' 0 CA--C 1.546 0.794 0 O-C-N 123.904 0.753 . . . . 1.55 109.087 -172.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . 147.64 -165.27 28.78 Favored Glycine 0 N--CA 1.424 -2.107 0 C-N-CA 120.292 -0.956 . . . . 0.93 112.565 175.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -87.23 19.14 1.43 Allowed 'Trans proline' 0 C--O 1.237 0.45 0 C-N-CA 123.614 2.876 . . . . 0.88 113.726 -174.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1621 ' ' THR . . . . . . . . . . . . . 24.1 p -114.62 12.46 17.22 Favored 'General case' 0 C--N 1.285 -2.212 0 CA-C-O 122.173 0.987 . . . . 0.97 109.744 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -89.55 66.71 7.38 Favored 'General case' 0 C--O 1.246 0.92 0 N-CA-C 106.682 -1.599 . . . . 0.72 106.682 178.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1623 ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' 1623 ' ' ARG . 3.4 ptm180 -170.5 140.79 1.52 Allowed Pre-proline 0 N--CA 1.428 -1.531 0 N-CA-C 106.849 -1.538 . . . . 3.26 106.849 -173.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -57.63 107.56 0.31 Allowed 'Trans proline' 0 CA--C 1.545 1.058 0 C-N-CA 122.511 2.141 . . . . 0.59 111.571 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 81.4 mtp -114.18 148.08 37.85 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.576 -0.898 . . . . 1.37 108.576 -178.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1626 ' ' LEU . . . . . 0.629 HD13 ' HE2' ' A' 1542 ' ' TYR . 7.2 tt -101.9 138.31 39.04 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.132 -0.692 . . . . 0.89 109.132 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1627 ' ' ILE . . . . . 0.809 HD11 ' HB2' ' A' 1639 ' ' SER . 38.4 mm -85.09 -63.09 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.214 -0.812 0 CA-C-N 115.375 -0.829 . . . . 0.58 109.701 -178.069 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 52.2 m -161.88 152.11 17.08 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 106.897 -1.52 . . . . 1.39 106.897 -176.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1629 ' ' LEU . . . . . 0.627 HD13 ' HG ' ' A' 1636 ' ' LEU . 44.4 tp -105.42 110.3 22.59 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 107.885 -1.154 . . . . 1.25 107.885 175.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 18.6 t70 -82.75 95.41 7.86 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 118.388 -1.325 . . . . 1.09 107.651 175.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 21.8 pttm -76.14 7.24 4.35 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 114.739 -1.119 . . . . 3.6 113.467 -174.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -95.68 -45.0 7.2 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 108.794 -0.817 . . . . 2.6 108.794 173.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 73.5 p -96.92 -1.68 45.31 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-N 115.368 -0.833 . . . . 0.75 111.342 -177.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1634 ' ' CYS . . . . . 0.585 ' SG ' ' HB2' ' A' 1600 ' ' SER . 74.7 m 60.73 35.04 19.78 Favored 'General case' 0 C--N 1.364 1.196 0 C-N-CA 124.043 0.937 . . . . 0.53 110.746 178.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1635 ' ' THR . . . . . . . . . . . . . 57.2 m -105.96 128.56 53.89 Favored 'General case' 0 N--CA 1.418 -2.029 0 CA-C-N 114.973 -1.012 . . . . 0.46 109.987 -176.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1636 ' ' LEU . . . . . 0.627 ' HG ' HD13 ' A' 1629 ' ' LEU . 0.9 OUTLIER -110.11 119.57 39.7 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 108.223 -1.028 . . . . 0.86 108.223 -177.376 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -99.52 129.18 45.67 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 116.293 -0.412 . . . . 0.45 110.257 -177.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -126.26 143.41 51.16 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.838 -0.619 . . . . 0.5 109.833 -178.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1639 ' ' SER . . . . . 0.809 ' HB2' HD11 ' A' 1627 ' ' ILE . 23.0 t -124.39 159.97 29.22 Favored 'General case' 0 C--N 1.31 -1.13 0 C-N-CA 124.284 1.033 . . . . 1.04 108.524 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 2.9 t90 -156.71 111.75 2.84 Favored 'General case' 0 N--CA 1.418 -2.073 0 N-CA-C 104.26 -2.496 . . . . 0.68 104.26 179.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1641 ' ' HIS . . . . . 0.549 ' HB3' ' HB2' ' A' 1615 ' ' ARG . 62.2 m-70 -97.63 110.01 22.65 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 108.926 -0.768 . . . . 0.9 108.926 -177.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1642 ' ' THR . . . . . . . . . . . . . 4.6 t -139.11 148.69 58.41 Favored Pre-proline 0 C--N 1.292 -1.931 0 CA-C-N 115.302 -0.863 . . . . 0.48 110.869 -171.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1643 ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -78.36 -6.17 15.4 Favored 'Trans proline' 0 C--N 1.364 1.39 0 C-N-CA 122.467 2.111 . . . . 0.66 112.168 176.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 7.3 tt -68.41 -31.04 70.09 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 108.915 -0.772 . . . . 0.97 108.915 176.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1645 ' ' ALA . . . . . 0.416 ' HA ' ' CE1' ' A' 1527 ' ' PHE . . . -86.08 4.08 39.69 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.195 -0.911 . . . . 0.84 111.284 -174.266 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 1.3 t -123.69 144.09 49.86 Favored 'General case' 0 N--CA 1.424 -1.77 0 C-N-CA 119.263 -0.975 . . . . 1.19 110.403 -178.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -124.64 135.49 26.69 Favored Pre-proline 0 C--N 1.302 -1.468 0 C-N-CA 122.554 0.342 . . . . 3.14 110.182 174.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1648 ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -73.41 146.46 39.81 Favored 'Trans proline' 0 C--O 1.253 1.225 0 C-N-CA 122.278 1.985 . . . . 2.58 111.162 178.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 . . . . . 0 C--N 1.311 -1.091 0 CA-C-N 116.444 -0.343 . . . . 4.72 110.382 -179.039 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . 0.48 ' O ' ' HA3' ' A' 1603 ' ' GLY . . . . . . . . 0 CA--C 1.514 -0.417 0 CA-C-O 121.027 0.442 . . . . 9.97 109.999 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 2' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -150.32 102.22 3.05 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 106.856 -1.535 . . . . 7.68 106.856 177.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -94.02 122.34 62.08 Favored Pre-proline 0 C--N 1.293 -1.875 0 N-CA-C 112.898 0.703 . . . . 6.11 112.898 -175.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -90.47 16.72 1.6 Allowed 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.972 2.448 . . . . 4.84 111.785 173.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 66.4 m -163.17 174.27 12.38 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 124.947 1.299 . . . . 4.6 108.07 -177.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 77.48 -2.21 2.6 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 126.484 1.914 . . . . 4.23 110.013 -176.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 14.0 p -92.7 122.81 35.47 Favored 'General case' 0 N--CA 1.405 -2.72 0 N-CA-C 106.596 -1.631 . . . . 3.14 106.596 175.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.761 ' HB2' ' HG3' ' B' ' 12' ' ' GLU . 8.1 mp -77.09 100.34 5.67 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 109.65 -0.5 . . . . 3.96 109.65 -178.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 9.5 m -50.76 -19.27 0.91 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.038 1.735 . . . . 2.84 114.242 -175.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . 0.489 ' O ' HG12 ' B' ' 14' ' ' VAL . . . -122.17 -60.43 0.21 Allowed Glycine 0 N--CA 1.424 -2.11 0 N-CA-C 111.005 -0.838 . . . . 2.09 111.005 178.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -52.07 -55.11 22.94 Favored Glycine 0 N--CA 1.464 0.518 0 N-CA-C 115.344 0.898 . . . . 1.84 115.344 -174.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . 0.761 ' HG3' ' HB2' ' B' ' 8' ' ' LEU . 60.3 mt-10 -78.36 -30.65 48.13 Favored 'General case' 0 CA--C 1.499 -0.998 0 CA-C-N 117.013 0.407 . . . . 2.55 110.3 -177.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . 0.562 ' O ' HD23 ' B' ' 17' ' ' LEU . 0.8 OUTLIER -58.16 -62.05 2.11 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-N 115.489 -0.778 . . . . 2.35 111.288 178.669 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . 0.489 HG12 ' O ' ' B' ' 10' ' ' GLY . 14.2 p -64.72 -29.18 46.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-N 116.107 -0.497 . . . . 2.11 111.244 -177.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 15' ' ' ASP . . . . . 0.61 ' OD1' ' HB3' ' A' 1569 ' ' GLN . 33.6 t70 -73.83 -37.95 64.69 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 113.11 0.782 . . . . 2.04 113.11 178.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 14.8 t -69.85 -32.17 70.41 Favored 'General case' 0 C--O 1.254 1.306 0 CA-C-N 119.432 1.014 . . . . 1.84 109.485 175.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.562 HD23 ' O ' ' B' ' 13' ' ' LEU . 3.8 mm? -56.12 -44.28 78.98 Favored 'General case' 0 C--O 1.208 -1.118 0 CA-C-N 115.431 -0.804 . . . . 1.74 108.995 169.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -77.18 -21.72 53.53 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.27 -0.877 . . . . 2.39 112.006 -178.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -64.35 -56.67 12.85 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 116.349 -0.387 . . . . 0.96 110.239 178.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 15.0 p -98.66 -20.93 5.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 118.519 -1.273 . . . . 1.37 112.555 -177.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 21' ' ' CYS . . . . . 0.608 ' HB2' ' HB3' ' B' ' 26' ' ' PHE . 64.0 m -105.2 19.24 20.94 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 119.445 -0.902 . . . . 1.66 110.758 179.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.67 -56.58 24.49 Favored Glycine 0 C--N 1.31 -0.888 0 C-N-CA 120.382 -0.913 . . . . 1.53 112.254 178.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -70.34 -38.08 74.79 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.783 0.325 . . . . 2.72 111.307 177.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 43.2 ttp180 -72.68 -39.02 67.39 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 113.888 1.069 . . . . 4.33 113.888 -176.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 112.09 112.87 3.26 Favored Glycine 0 N--CA 1.429 -1.77 0 N-CA-C 109.157 -1.577 . . . . 1.53 109.157 -175.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . 0.608 ' HB3' ' HB2' ' B' ' 21' ' ' CYS . 39.8 p90 -92.2 134.73 34.6 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 120.696 -0.402 . . . . 1.65 110.895 -178.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -148.35 116.72 6.54 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.984 -0.747 . . . . 3.42 108.984 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 28' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -117.07 -20.23 9.4 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 120.521 -0.472 . . . . 2.26 111.909 175.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 29' ' ' SER . . . . . 0.509 ' HA ' ' HA ' ' B' ' 40' ' ' ARG . 25.1 m -92.03 63.06 4.35 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 121.965 0.888 . . . . 3.68 109.378 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 11.7 mtp180 -108.08 141.92 24.18 Favored Pre-proline 0 C--N 1.304 -1.383 0 N-CA-C 106.699 -1.593 . . . . 3.81 106.699 -177.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . 0.727 ' HA ' ' HA ' ' B' ' 39' ' ' SER . 56.9 Cg_endo -71.79 -11.52 27.82 Favored 'Trans proline' 0 C--O 1.25 1.123 0 C-N-CA 123.345 2.696 . . . . 4.02 113.259 -175.222 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . 64.57 15.66 9.79 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 125.077 1.351 . . . . 4.92 113.52 172.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 41.1 t 167.18 165.05 0.03 OUTLIER 'General case' 0 N--CA 1.414 -2.227 0 N-CA-C 104.119 -2.548 . . . . 6.72 104.119 -178.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 20.8 tpp180 -89.97 3.29 53.57 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 107.988 -1.116 . . . . 11.63 107.988 177.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 46.5 t -89.85 -9.09 10.66 Favored 'Isoleucine or valine' 0 C--O 1.246 0.877 0 CA-C-N 114.476 -1.238 . . . . 9.61 108.839 173.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 18.7 m 56.8 42.07 27.17 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 113.659 -1.609 . . . . 6.71 111.321 176.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 19.0 mmm180 -40.32 -66.98 0.26 Allowed 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 114.239 -1.346 . . . . 10.0 111.659 175.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 45.3 ttp180 -136.78 121.51 18.57 Favored 'General case' 0 N--CA 1.41 -2.448 0 N-CA-C 106.448 -1.686 . . . . 7.94 106.448 175.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . 0.727 ' HA ' ' HA ' ' B' ' 31' ' ' PRO . 25.8 m -102.1 36.7 2.04 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.971 0.891 . . . . 5.76 111.145 -174.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . 0.509 ' HA ' ' HA ' ' B' ' 29' ' ' SER . 29.8 ptt180 -166.57 161.76 16.19 Favored 'General case' 0 N--CA 1.421 -1.893 0 N-CA-C 106.467 -1.679 . . . . 6.03 106.467 178.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . -167.72 167.74 40.21 Favored Glycine 0 C--N 1.284 -2.357 0 N-CA-C 110.236 -1.146 . . . . 2.37 110.236 175.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . 0.543 HD11 HD21 ' B' ' 17' ' ' LEU . 15.0 pt 59.87 -33.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 C-N-CA 128.097 2.559 . . . . 2.07 116.731 176.198 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.498 ' O ' ' HB2' ' B' ' 47' ' ' CYS . 2.7 p -52.57 -41.38 36.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 113.55 0.944 . . . . 2.24 113.55 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -94.72 -31.0 13.99 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 108.574 -0.899 . . . . 3.36 108.574 -174.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . 0.401 ' HB3' ' HA ' ' B' ' 42' ' ' ILE . 8.3 tp10 -56.92 -50.97 70.96 Favored 'General case' 0 C--O 1.206 -1.194 0 CA-C-N 115.35 -0.841 . . . . 3.08 109.638 174.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 46' ' ' CYS . . . . . 0.541 ' HB3' HD21 ' B' ' 13' ' ' LEU . 9.1 t -89.96 2.46 55.08 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.524 0.678 . . . . 2.23 111.17 -175.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 47' ' ' CYS . . . . . 0.498 ' HB2' ' O ' ' B' ' 43' ' ' VAL . 45.6 t -85.61 -52.41 5.83 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 116.331 -0.395 . . . . 2.37 110.459 177.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -104.59 13.02 32.37 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.289 0.566 . . . . 2.82 111.571 -175.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . 0.401 ' HB2' ' O ' ' B' ' 45' ' ' GLU . 28.7 mtp85 -155.86 -170.11 3.3 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 125.64 1.576 . . . . 4.09 107.477 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 21.3 t -121.9 129.13 52.31 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 109.188 -0.671 . . . . 2.67 109.188 -176.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . 0.413 ' HB3' ' HB2' ' B' ' 46' ' ' CYS . 26.7 p -99.71 149.89 22.86 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.943 -0.762 . . . . 2.11 108.943 -177.101 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . 0.445 ' HB2' ' HA ' ' A' 1601 ' ' LYS . 3.0 p-10 -116.57 174.62 5.97 Favored 'General case' 0 C--O 1.251 1.164 0 C-N-CA 120.348 -0.541 . . . . 2.67 110.829 170.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . 0.688 ' HB2' ' HA ' ' A' 1600 ' ' SER . 34.3 tp -54.61 -43.13 71.93 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 113.342 0.867 . . . . 1.9 113.342 -173.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . 0.408 ' O ' HG22 ' B' ' 58' ' ' THR . . . -55.39 -31.82 62.13 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.225 0.61 . . . . 1.52 112.341 -171.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 61.9 tp -72.41 -58.08 3.67 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 115.491 -0.777 . . . . 1.97 110.244 179.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 2.0 pp -70.2 -32.18 69.98 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 111.827 0.306 . . . . 1.53 111.827 -175.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -60.61 -48.54 81.33 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 116.291 -0.413 . . . . 2.27 111.262 179.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 58' ' ' THR . . . . . 0.408 HG22 ' O ' ' B' ' 54' ' ' ALA . 6.4 t -88.37 -8.7 54.63 Favored 'General case' 0 CA--C 1.569 1.697 0 CA-C-O 120.867 0.365 . . . . 2.33 111.895 -177.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 16.7 t80 -95.05 -33.4 12.72 Favored 'General case' 0 N--CA 1.441 -0.878 0 O-C-N 121.291 -0.88 . . . . 2.86 109.839 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 60' ' ' CYS . . . . . 0.545 ' SG ' ' HA ' ' B' ' 26' ' ' PHE . 38.8 t -82.63 102.96 11.8 Favored 'General case' 0 C--O 1.255 1.391 0 CA-C-N 115.783 -0.644 . . . . 2.3 110.963 -176.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . 66.22 177.07 0.22 Allowed 'General case' 0 C--N 1.344 0.329 0 O-C-N 124.566 1.166 . . . . 3.19 110.333 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 62' ' ' THR . . . . . 0.972 ' HB ' ' HB3' ' B' ' 65' ' ' LYS . 14.4 p -139.8 116.91 8.33 Favored Pre-proline 0 C--N 1.298 -1.648 0 O-C-N 121.816 -0.553 . . . . 3.68 111.304 -177.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -66.22 -40.15 16.0 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.652 2.901 . . . . 5.08 114.404 -169.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -133.06 31.4 3.86 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-O 121.28 0.562 . . . . 5.1 110.416 178.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . 0.972 ' HB3' ' HB ' ' B' ' 62' ' ' THR . 28.6 tptp -125.86 -24.74 3.74 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 116.196 -0.456 . . . . 8.51 111.247 -175.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 12.2 t -175.04 64.91 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.644 -0.872 . . . . 8.12 108.644 179.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 . . . . . 0 C--O 1.253 1.257 0 N-CA-C 108.559 -0.904 . . . . 10.21 108.559 177.47 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.305 0 N-CA-C 109.033 -0.728 . . . . 9.34 109.033 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 50.8 tttp -120.94 -1.11 9.93 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.865 0.841 . . . . 9.04 110.749 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 48.0 t -66.95 -34.86 78.69 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 107.442 -1.318 . . . . 5.81 107.442 173.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1511 ' ' ASN . . . . . 0.525 ' ND2' ' H ' ' A' 1519 ' ' THR . 3.0 p-10 -136.34 128.18 29.23 Favored 'General case' 0 N--CA 1.42 -1.932 0 CA-C-N 114.562 -1.199 . . . . 3.42 107.88 175.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1512 ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -124.44 -52.16 1.72 Allowed 'General case' 0 C--N 1.283 -2.299 0 N-CA-C 106.839 -1.541 . . . . 5.95 106.839 173.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 8.7 p80 -173.9 94.66 0.1 Allowed 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 125.038 1.335 . . . . 5.33 108.524 175.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -85.33 -70.86 0.56 Allowed 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.938 -0.705 . . . . 5.06 110.691 -177.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1515 ' ' ASP . . . . . 0.438 ' O ' ' HB2' ' A' 1581 ' ' LEU . 17.5 m-20 -142.49 -82.15 0.2 Allowed 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 108.88 -0.785 . . . . 2.9 108.88 179.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1516 ' ' CYS . . . . . 0.798 ' HB3' ' HB2' ' A' 1529 ' ' LEU . 83.0 m -126.46 46.58 2.43 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 107.048 -1.464 . . . . 1.19 107.048 176.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1517 ' ' GLN . . . . . 0.482 ' HA ' ' O ' ' A' 1527 ' ' PHE . 14.0 pt20 -151.72 133.92 15.18 Favored 'General case' 0 N--CA 1.425 -1.712 0 CA-C-N 114.836 -1.074 . . . . 1.52 109.483 -175.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1518 ' ' VAL . . . . . 0.511 HG21 ' HB2' ' A' 1583 ' ' TYR . 2.3 m -150.26 136.96 12.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 C-N-CA 124.361 1.064 . . . . 0.94 109.497 175.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1519 ' ' THR . . . . . 0.525 ' H ' ' ND2' ' A' 1511 ' ' ASN . 43.4 m -111.81 134.51 53.33 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 108.797 -0.816 . . . . 0.89 108.797 178.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -90.38 124.13 63.69 Favored Pre-proline 0 C--N 1.298 -1.647 0 N-CA-C 109.184 -0.673 . . . . 1.74 109.184 176.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -68.8 -15.69 40.89 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 123.072 2.515 . . . . 1.58 113.725 -174.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 22.5 m -80.62 -50.45 9.95 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-O 120.593 0.235 . . . . 1.65 111.478 -177.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1523 ' ' THR . . . . . . . . . . . . . 5.6 t -103.96 -11.75 17.25 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 119.878 -0.729 . . . . 1.61 111.867 -176.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 75.09 25.92 67.74 Favored Glycine 0 CA--C 1.506 -0.529 0 CA-C-N 116.275 -0.42 . . . . 1.13 112.639 177.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 84.8 t60 -92.81 127.4 38.3 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 120.487 -0.485 . . . . 1.26 110.424 -177.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 2.0 tm? -92.71 110.93 22.37 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 114.444 -1.253 . . . . 0.68 108.354 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1527 ' ' PHE . . . . . 0.482 ' O ' ' HA ' ' A' 1517 ' ' GLN . 93.3 m-85 -85.07 119.55 25.59 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 120.463 -0.495 . . . . 0.65 109.723 173.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 24.1 t70 -115.39 114.21 24.8 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.44 -0.8 . . . . 1.17 109.417 178.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1529 ' ' LEU . . . . . 0.798 ' HB2' ' HB3' ' A' 1516 ' ' CYS . 2.8 mm? -102.41 -0.83 31.91 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 108.849 -0.797 . . . . 0.6 108.849 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -68.59 -32.35 72.19 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.627 0.727 . . . . 0.84 109.16 -178.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 31.5 t -64.81 -12.7 50.84 Favored 'General case' 0 CA--C 1.554 1.123 0 CA-C-N 114.881 -1.054 . . . . 1.59 110.858 177.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 90.5 mt -92.77 -3.13 55.27 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 122.02 -0.425 . . . . 0.65 110.703 177.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1533 ' ' SER . . . . . 0.997 ' HA ' ' HB2' ' A' 1536 ' ' ALA . 14.4 t -95.2 -179.62 4.86 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 109.526 -0.546 . . . . 1.52 109.526 179.149 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . 83.92 -65.73 4.05 Favored Glycine 0 C--N 1.312 -0.761 0 N-CA-C 109.609 -1.396 . . . . 1.1 109.609 -174.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 42.4 ttp180 -83.89 -2.24 56.06 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 124.424 1.09 . . . . 4.62 109.192 174.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1536 ' ' ALA . . . . . 0.997 ' HB2' ' HA ' ' A' 1533 ' ' SER . . . -46.84 -22.28 0.29 Allowed 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 127.551 2.34 . . . . 1.45 116.66 -175.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . -72.61 103.53 1.36 Allowed Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.361 -0.923 . . . . 0.85 111.208 178.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -119.93 149.34 42.27 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 120.93 0.395 . . . . 0.93 110.777 -178.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 9.9 p -112.94 117.48 32.2 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 115.458 -0.792 . . . . 1.03 110.38 179.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1540 ' ' ALA . . . . . 0.444 ' HB3' ' CG1' ' A' 1548 ' ' VAL . . . -112.54 146.68 38.1 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.953 -0.758 . . . . 0.5 108.953 177.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -86.28 151.68 23.39 Favored 'General case' 0 C--N 1.311 -1.081 0 O-C-N 123.22 0.325 . . . . 0.74 111.022 -175.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1542 ' ' TYR . . . . . 0.41 ' HB3' ' H ' ' A' 1543 ' ' SER . 0.3 OUTLIER -159.15 -101.93 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 109.511 -0.551 . . . . 0.99 109.511 -178.777 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A 1543 ' ' SER . . . . . 0.41 ' H ' ' HB3' ' A' 1542 ' ' TYR . 2.2 p -68.59 172.22 6.53 Favored 'General case' 0 CA--C 1.562 1.409 0 C-N-CA 124.641 1.176 . . . . 1.91 110.302 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -94.55 4.59 53.66 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 113.561 0.948 . . . . 3.59 113.561 -165.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 7.3 t -129.8 21.33 5.46 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.43 -0.908 . . . . 2.46 110.208 -178.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 169.25 179.73 41.37 Favored Glycine 0 N--CA 1.424 -2.127 0 C-N-CA 119.801 -1.19 . . . . 1.26 112.153 179.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 28.0 m -122.07 176.1 4.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 109.148 -0.686 . . . . 0.79 109.148 -177.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1548 ' ' VAL . . . . . 0.444 ' CG1' ' HB3' ' A' 1540 ' ' ALA . 14.9 p -103.62 128.12 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 N-CA-C 108.538 -0.912 . . . . 0.58 108.538 175.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -92.32 131.07 37.81 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.656 -0.868 . . . . 1.08 108.656 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 23.5 ptm -144.98 140.65 28.34 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 116.051 -0.522 . . . . 0.78 110.587 -178.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1551 ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' 1536 ' ' ALA . 12.3 p -131.95 125.96 32.89 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 115.824 -0.626 . . . . 0.97 111.551 177.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1552 ' ' ILE . . . . . 0.69 ' H ' ' HB1' ' A' 1536 ' ' ALA . 49.5 mm -82.63 124.5 39.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.556 -0.535 . . . . 0.42 109.556 177.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1553 ' ' CYS . . . . . 0.551 ' HB2' ' HB2' ' A' 1533 ' ' SER . 60.2 m 59.35 49.7 8.56 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.598 0.713 . . . . 1.4 110.696 177.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 168.92 172.14 35.4 Favored Glycine 0 N--CA 1.42 -2.401 0 N-CA-C 109.76 -1.336 . . . . 0.35 109.76 178.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -100.01 150.15 22.73 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 109.562 -0.532 . . . . 1.62 109.562 178.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -91.81 130.97 37.49 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.696 -0.684 . . . . 0.87 109.984 -174.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -67.34 -7.29 23.57 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 113.969 1.1 . . . . 2.49 113.969 -174.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -93.12 -4.72 51.75 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 120.302 -0.559 . . . . 1.38 112.065 -175.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1559 ' ' CYS . . . . . 0.722 ' SG ' ' HD2' ' A' 1560 ' ' PRO . 3.1 t -137.37 162.52 54.64 Favored Pre-proline 0 C--N 1.293 -1.871 0 N-CA-C 108.08 -1.082 . . . . 1.21 108.08 -178.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1560 ' ' PRO . . . . . 0.722 ' HD2' ' SG ' ' A' 1559 ' ' CYS . 16.6 Cg_exo -32.91 145.82 0.03 OUTLIER 'Trans proline' 0 CA--C 1.563 1.964 0 C-N-CA 125.175 3.916 . . . . 0.71 115.536 175.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.03 124.06 14.85 Favored 'Trans proline' 0 C--O 1.25 1.106 0 C-N-CA 123.236 2.624 . . . . 0.8 111.803 178.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 107.08 -5.66 36.41 Favored Glycine 0 N--CA 1.44 -1.072 0 CA-C-N 115.615 -0.72 . . . . 0.46 111.878 -177.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1563 ' ' VAL . . . . . 0.626 HG11 ' HB3' ' A' 1559 ' ' CYS . 10.6 t -84.36 120.64 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.227 0 CA-C-O 121.217 0.532 . . . . 0.98 112.33 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -96.8 -31.3 7.09 Favored Glycine 0 C--N 1.303 -1.298 0 CA-C-N 115.146 -0.934 . . . . 0.28 111.535 177.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -136.18 135.26 39.01 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 109.474 -0.565 . . . . 0.28 109.474 177.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1566 ' ' CYS . . . . . 0.571 ' HB2' HG11 ' A' 1563 ' ' VAL . 53.9 t -157.84 140.2 14.48 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 110.149 -0.315 . . . . 0.43 110.149 -176.443 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1567 ' ' PHE . . . . . 0.497 ' CE2' HG11 ' A' 1574 ' ' VAL . 64.1 m-85 -85.34 133.5 34.14 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 107.954 -1.128 . . . . 1.03 107.954 174.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -75.03 -9.73 83.96 Favored Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 115.561 0.984 . . . . 1.13 115.561 -171.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1569 ' ' GLN . . . . . 0.568 ' NE2' HE22 ' B' ' 18' ' ' GLN . 16.3 mt-30 -70.52 -69.4 0.36 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 117.258 0.529 . . . . 2.58 110.908 -177.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1570 ' ' THR . . . . . 0.405 HG21 ' HA ' ' B' ' 12' ' ' GLU . 0.7 OUTLIER -97.85 2.08 48.91 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 113.394 0.887 . . . . 2.17 113.394 -179.707 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 10.4 mmt85 58.63 41.9 21.4 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.0 -1.0 . . . . 2.62 110.444 178.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 32.3 mt -88.51 129.58 39.42 Favored 'Isoleucine or valine' 0 C--O 1.247 0.945 0 N-CA-C 108.085 -1.08 . . . . 0.92 108.085 177.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 30.0 t -81.09 131.65 35.31 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.391 0.615 . . . . 0.8 110.852 -177.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1574 ' ' VAL . . . . . 0.714 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 33.9 m -118.95 15.12 6.96 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 CA-C-N 115.981 -0.554 . . . . 0.98 111.346 -179.253 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 176.95 126.23 0.95 Allowed Glycine 0 N--CA 1.423 -2.223 0 C-N-CA 119.58 -1.295 . . . . 0.29 111.814 176.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 49.8 tttp -81.99 135.35 35.37 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 107.271 -1.381 . . . . 2.19 107.271 177.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -70.28 96.99 1.17 Allowed 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 122.956 0.502 . . . . 0.61 110.785 -176.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -110.49 173.65 6.23 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 108.72 -0.845 . . . . 1.95 108.72 177.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1579 ' ' LYS . . . . . 0.413 ' NZ ' ' HB2' ' A' 1579 ' ' LYS . 9.8 mtmp? -136.53 53.74 1.91 Allowed 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 107.662 -1.236 . . . . 2.68 107.662 -177.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1580 ' ' ARG . . . . . 0.409 ' NH2' HG11 ' A' 1591 ' ' VAL . 49.1 ttp180 -107.0 76.19 1.08 Allowed 'General case' 0 N--CA 1.419 -1.984 0 CA-C-N 114.497 -1.228 . . . . 3.47 108.027 -179.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1581 ' ' LEU . . . . . 0.581 HD23 ' HA ' ' A' 1516 ' ' CYS . 0.3 OUTLIER -69.18 126.27 29.27 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.632 -1.167 . . . . 0.64 108.923 179.915 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 60.8 mtp180 -124.72 131.12 53.48 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 120.315 -0.554 . . . . 2.85 110.649 173.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1583 ' ' TYR . . . . . 0.511 ' HB2' HG21 ' A' 1518 ' ' VAL . 45.1 t80 -100.93 108.31 20.02 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 108.803 -0.814 . . . . 0.86 108.803 178.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1584 ' ' VAL . . . . . 0.601 ' O ' ' HB ' ' A' 1587 ' ' VAL . 15.5 m -127.4 91.82 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 CA-C-N 115.918 -0.583 . . . . 1.05 111.993 -178.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 32.8 t70 59.18 66.91 0.97 Allowed 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 124.039 0.936 . . . . 1.17 111.221 175.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1586 ' ' GLN . . . . . 0.459 ' HA ' ' CE1' ' A' 1583 ' ' TYR 0.267 28.5 pt20 61.41 14.75 6.02 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 127.074 2.15 . . . . 1.86 112.605 178.895 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A 1587 ' ' VAL . . . . . 0.601 ' HB ' ' O ' ' A' 1584 ' ' VAL . 15.7 t -110.44 120.82 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.325 0 CA-C-N 114.222 -1.354 . . . . 0.49 109.436 177.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1588 ' ' LEU . . . . . 1.001 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 2.2 mm? -97.79 107.76 20.33 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 106.556 -1.646 . . . . 0.36 106.556 177.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -105.22 120.72 42.24 Favored 'General case' 0 C--N 1.282 -2.36 0 CA-C-O 121.204 0.526 . . . . 1.74 111.544 -176.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 2.3 mt -107.78 108.5 19.73 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 106.196 -1.779 . . . . 0.72 106.196 172.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1591 ' ' VAL . . . . . 0.409 HG11 ' NH2' ' A' 1580 ' ' ARG . 7.8 p -97.39 131.14 44.92 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 CA-C-O 121.192 0.52 . . . . 1.01 110.62 -175.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1592 ' ' TYR . . . . . 0.412 ' O ' ' HA ' ' A' 1607 ' ' LYS . 13.1 m-30 -122.57 95.87 4.81 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 107.947 -1.131 . . . . 0.5 107.947 177.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1593 ' ' LYS . . . . . 0.521 ' HB3' ' HG3' ' A' 1607 ' ' LYS . 48.0 pttt -117.68 175.95 5.41 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.816 -0.754 . . . . 1.59 110.007 -176.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 7.4 m-20 57.11 42.32 25.93 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 124.697 1.248 . . . . 1.11 111.885 177.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -68.42 -95.97 0.04 OUTLIER Glycine 0 C--N 1.332 0.323 0 N-CA-C 110.627 -0.989 . . . . 0.78 110.627 178.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1596 ' ' SER . . . . . . . . . . . . . 79.1 p -122.06 158.48 55.04 Favored Pre-proline 0 C--N 1.288 -2.083 0 N-CA-C 107.691 -1.226 . . . . 1.07 107.691 172.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -57.67 137.63 82.14 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.323 2.016 . . . . 1.01 111.257 178.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1598 ' ' CYS . . . . . 0.503 ' HA ' ' CE2' ' A' 1606 ' ' TYR . 12.0 t -75.0 107.5 4.0 Favored Pre-proline 0 C--N 1.304 -1.399 0 N-CA-C 104.865 -2.272 . . . . 0.75 104.865 177.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1599 ' ' PRO . . . . . 0.438 ' HA ' ' O ' ' B' ' 6' ' ' GLU . 92.1 Cg_exo -44.22 -59.18 1.17 Allowed 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 123.973 3.115 . . . . 1.7 114.814 -169.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1600 ' ' SER . . . . . . . . . . . . . 8.1 m -87.77 12.92 11.66 Favored 'General case' 0 N--CA 1.402 -2.866 0 N-CA-C 112.827 0.676 . . . . 2.26 112.827 -174.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1601 ' ' LYS . . . . . 0.757 ' HE3' ' HB3' ' B' ' 53' ' ' LEU . 96.0 mttt -142.43 69.62 1.32 Allowed 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 122.506 1.146 . . . . 3.01 109.063 174.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 7.2 m -46.71 123.68 5.32 Favored 'General case' 0 N--CA 1.413 -2.315 0 C-N-CA 127.669 2.388 . . . . 2.07 112.326 -177.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 103.96 -21.95 36.62 Favored Glycine 0 N--CA 1.436 -1.348 0 N-CA-C 111.7 -0.56 . . . . 1.08 111.7 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1604 ' ' LEU . . . . . 0.538 HD12 ' HB3' ' A' 1601 ' ' LYS . 46.9 mt -94.11 152.46 18.74 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.019 -1.104 . . . . 1.84 108.019 179.195 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 26.6 m -131.75 145.24 51.5 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 108.078 -1.082 . . . . 1.41 108.078 178.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1606 ' ' TYR . . . . . 0.714 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 91.4 m-85 -64.37 155.99 30.64 Favored 'General case' 0 C--O 1.254 1.327 0 CA-C-N 116.231 -0.44 . . . . 0.6 111.656 -177.364 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1607 ' ' LYS . . . . . 0.521 ' HG3' ' HB3' ' A' 1593 ' ' LYS . 13.0 ttmm -151.89 127.79 10.31 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.502 -0.772 . . . . 1.45 109.553 -173.149 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1608 ' ' SER . . . . . . . . . . . . . 35.1 m -108.79 119.25 39.0 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 108.773 -0.825 . . . . 1.15 108.773 177.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 45.3 t -101.39 104.82 16.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 107.729 -1.211 . . . . 0.25 107.729 178.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 73.9 mt -94.54 111.05 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 N-CA-C 108.621 -0.881 . . . . 0.45 108.621 -178.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 34.3 t -109.12 110.33 21.55 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 115.398 -0.819 . . . . 1.26 110.927 -176.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1612 ' ' PHE . . . . . 1.001 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 63.0 m-85 -86.35 119.69 26.89 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.702 -0.851 . . . . 0.26 108.702 175.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 44.6 t -117.8 137.92 50.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-N 115.954 -0.566 . . . . 0.5 109.72 -176.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 24.4 t -67.93 111.22 4.24 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 123.758 0.823 . . . . 0.77 112.596 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1615 ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -138.43 105.46 7.76 Favored Pre-proline 0 N--CA 1.434 -1.225 0 N-CA-C 109.464 -0.569 . . . . 2.53 109.464 169.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1616 ' ' PRO . . . . . 0.757 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 35.9 Cg_exo -64.3 -10.62 24.42 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 123.224 2.616 . . . . 1.1 113.716 179.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -87.14 42.58 1.04 Allowed 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 125.09 1.356 . . . . 3.05 110.9 -177.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -36.58 119.12 0.61 Allowed 'General case' 0 C--O 1.241 0.607 0 C-N-CA 125.531 1.532 . . . . 1.55 112.738 -178.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . -178.83 -138.4 3.18 Favored Glycine 0 N--CA 1.425 -2.054 0 N-CA-C 110.505 -1.038 . . . . 0.93 110.505 -175.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -66.77 3.31 1.55 Allowed 'Trans proline' 0 N--CA 1.487 1.106 0 C-N-CA 123.516 2.81 . . . . 0.88 115.463 -175.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1621 ' ' THR . . . . . 0.526 ' HB ' ' HB2' ' A' 1641 ' ' HIS . 23.0 p -105.62 -4.52 21.01 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.657 0.741 . . . . 0.97 110.053 176.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 47.0 t30 -92.81 51.72 1.75 Allowed 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 123.215 1.483 . . . . 0.72 108.219 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1623 ' ' ARG . . . . . 0.493 ' O ' ' HG3' ' A' 1625 ' ' MET . 4.7 ptp180 -150.81 141.56 14.75 Favored Pre-proline 0 C--N 1.294 -1.819 0 N-CA-C 105.777 -1.934 . . . . 3.26 105.777 -176.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -57.0 106.77 0.24 Allowed 'Trans proline' 0 C--O 1.245 0.83 0 C-N-CA 122.374 2.049 . . . . 0.59 111.121 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1625 ' ' MET . . . . . 0.493 ' HG3' ' O ' ' A' 1623 ' ' ARG . 93.5 mtp -100.13 128.56 46.19 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 109.051 -0.722 . . . . 1.37 109.051 -176.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 1.8 tm? -87.1 112.51 21.98 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 106.741 -1.577 . . . . 0.89 106.741 -178.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1627 ' ' ILE . . . . . 0.764 HD11 ' HB2' ' A' 1639 ' ' SER . 39.3 mm -72.13 -55.24 14.01 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.613 0 N-CA-C 108.351 -0.981 . . . . 0.58 108.351 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 22.4 t -179.18 173.99 1.09 Allowed 'General case' 0 N--CA 1.422 -1.833 0 N-CA-C 106.286 -1.746 . . . . 1.39 106.286 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1629 ' ' LEU . . . . . 0.78 ' HG ' ' HG ' ' A' 1636 ' ' LEU . 3.8 tt -122.07 110.72 16.13 Favored 'General case' 0 N--CA 1.409 -2.51 0 N-CA-C 104.582 -2.377 . . . . 1.25 104.582 177.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 13.1 t70 -69.21 87.14 0.41 Allowed 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 107.728 -1.212 . . . . 1.09 107.728 176.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1631 ' ' LYS . . . . . 0.618 ' H ' ' HD2' ' A' 1631 ' ' LYS . 0.0 OUTLIER -54.96 -20.71 9.66 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.32 1.048 . . . . 3.6 113.116 -179.278 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A 1632 ' ' GLN . . . . . 0.415 ' HA ' ' NZ ' ' A' 1601 ' ' LYS . 0.3 OUTLIER -71.5 -45.68 61.81 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.441 -0.577 . . . . 2.6 109.441 -177.954 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 44.5 p -102.01 -5.21 24.87 Favored 'General case' 0 CA--C 1.557 1.212 0 N-CA-C 112.928 0.714 . . . . 0.75 112.928 -177.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 58.1 m 65.88 35.67 6.47 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.126 0.97 . . . . 0.53 109.767 -176.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1635 ' ' THR . . . . . 0.5 HG23 ' HD2' ' A' 1607 ' ' LYS . 86.1 m -100.96 129.04 46.75 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.662 -1.154 . . . . 0.46 110.211 -177.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1636 ' ' LEU . . . . . 0.78 ' HG ' ' HG ' ' A' 1629 ' ' LEU . 1.1 mp -107.97 122.36 46.67 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.837 -0.801 . . . . 0.86 108.837 -179.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -100.91 130.01 46.85 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 116.353 -0.385 . . . . 0.45 111.267 -178.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -127.97 130.63 48.7 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.789 -0.641 . . . . 0.5 109.478 -179.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1639 ' ' SER . . . . . 0.764 ' HB2' HD11 ' A' 1627 ' ' ILE . 10.1 t -106.61 156.67 18.35 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.821 -1.178 . . . . 1.04 107.821 178.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 2.0 t90 -156.14 108.62 2.6 Favored 'General case' 0 N--CA 1.423 -1.816 0 N-CA-C 105.689 -1.967 . . . . 0.68 105.689 178.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1641 ' ' HIS . . . . . 0.526 ' HB2' ' HB ' ' A' 1621 ' ' THR . 59.1 m-70 -101.75 102.74 13.42 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 110.018 -0.364 . . . . 0.9 110.018 -175.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1642 ' ' THR . . . . . . . . . . . . . 3.6 t -132.69 149.78 73.94 Favored Pre-proline 0 C--N 1.299 -1.627 0 CA-C-N 115.357 -0.838 . . . . 0.48 109.834 -173.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1643 ' ' PRO . . . . . 0.757 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 71.6 Cg_endo -79.72 -0.12 10.45 Favored 'Trans proline' 0 C--N 1.365 1.4 0 C-N-CA 122.461 2.108 . . . . 0.66 112.139 176.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 11.5 tp -67.12 -28.75 68.4 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.916 0.865 . . . . 0.97 109.038 175.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -89.61 15.61 9.21 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 114.892 -1.049 . . . . 0.84 110.502 -178.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1646 ' ' CYS . . . . . 0.537 ' SG ' ' HA ' ' A' 1643 ' ' PRO . 39.9 m -118.67 146.32 44.79 Favored 'General case' 0 N--CA 1.419 -1.985 0 N-CA-C 106.991 -1.485 . . . . 1.19 106.991 178.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.06 115.1 50.79 Favored Pre-proline 0 C--N 1.305 -1.343 0 C-N-CA 119.884 -0.727 . . . . 3.14 109.813 177.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1648 ' ' PRO . . . . . 0.507 ' O ' ' HB2' ' A' 1649 ' ' GLU . 72.7 Cg_endo -80.03 95.65 1.02 Allowed 'Trans proline' 0 C--O 1.253 1.263 0 C-N-CA 121.947 1.765 . . . . 2.58 112.293 -179.25 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1649 ' ' GLU . . . . . 0.507 ' HB2' ' O ' ' A' 1648 ' ' PRO . 0.5 OUTLIER . . . . . 0 C--O 1.243 0.745 0 N-CA-C 105.07 -2.196 . . . . 4.72 105.07 177.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.619 0 N-CA-C 108.791 -0.818 . . . . 9.97 108.791 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 2' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -116.72 131.62 56.9 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 115.227 -0.897 . . . . 7.68 108.631 -176.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -104.99 144.91 29.7 Favored Pre-proline 0 C--N 1.283 -2.321 0 N-CA-C 108.538 -0.912 . . . . 6.11 108.538 178.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -75.21 51.81 2.96 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.975 2.45 . . . . 4.84 111.258 178.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 14.5 m -132.28 72.43 1.49 Allowed 'General case' 0 N--CA 1.411 -2.387 0 CA-C-N 113.932 -1.485 . . . . 4.6 107.956 -178.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . 0.438 ' O ' ' HA ' ' A' 1599 ' ' PRO . 3.2 mp0 -68.24 -35.54 78.09 Favored 'General case' 0 CA--C 1.497 -1.086 0 N-CA-C 107.645 -1.242 . . . . 4.23 107.645 174.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . 0.867 HG21 ' H ' ' B' ' 51' ' ' CYS . 19.5 p -88.62 99.67 12.5 Favored 'General case' 0 C--N 1.285 -2.233 0 CA-C-N 113.909 -1.496 . . . . 3.14 109.542 177.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.49 ' CB ' ' HG3' ' B' ' 12' ' ' GLU . 6.9 mp -84.01 162.67 20.31 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 121.03 0.443 . . . . 3.96 110.525 179.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 32.3 t -118.15 163.24 16.94 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 109.249 -0.648 . . . . 2.84 109.249 -173.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.29 -128.8 9.26 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 121.032 -0.604 . . . . 2.09 112.861 177.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.12 -23.92 64.55 Favored Glycine 0 C--O 1.223 -0.562 0 N-CA-C 114.143 0.417 . . . . 1.84 114.143 -175.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . 0.49 ' HG3' ' CB ' ' B' ' 8' ' ' LEU . 49.9 mm-40 -67.0 -37.84 84.94 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.428 0.633 . . . . 2.55 109.725 179.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . 0.419 ' HG ' ' HA ' ' B' ' 43' ' ' VAL . 0.1 OUTLIER -68.2 -49.77 58.64 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 115.227 -0.897 . . . . 2.35 109.613 -177.776 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 8.2 p -67.41 -32.46 57.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 C-N-CA 119.961 -0.695 . . . . 2.11 111.273 179.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -70.9 -40.05 72.41 Favored 'General case' 0 C--O 1.212 -0.896 0 C-N-CA 119.219 -0.992 . . . . 2.04 112.785 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 16.5 p -63.82 -40.75 97.36 Favored 'General case' 0 C--O 1.265 1.917 0 CA-C-N 118.444 0.566 . . . . 1.84 110.052 177.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.542 HD21 HD11 ' B' ' 42' ' ' ILE . 3.9 mm? -53.34 -53.86 44.83 Favored 'General case' 0 C--O 1.211 -0.929 0 CA-C-N 115.26 -0.882 . . . . 1.74 110.574 171.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . 0.568 HE22 ' NE2' ' A' 1569 ' ' GLN . 0.8 OUTLIER -68.89 -20.97 64.26 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 113.001 0.741 . . . . 2.39 113.001 -179.137 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -59.86 -62.67 1.7 Allowed 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 120.927 0.394 . . . . 0.96 110.665 178.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 14.1 p -92.56 -26.09 4.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 C-N-CA 119.119 -1.032 . . . . 1.37 111.33 -177.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 21' ' ' CYS . . . . . 0.443 ' HB2' ' O ' ' B' ' 17' ' ' LEU . 62.6 m -95.98 12.1 31.64 Favored 'General case' 0 N--CA 1.437 -1.111 0 C-N-CA 120.326 -0.55 . . . . 1.66 111.594 -177.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -56.7 -47.47 84.95 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 111.715 -0.554 . . . . 1.53 111.715 173.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -72.24 -14.4 61.77 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 122.816 0.447 . . . . 2.72 111.624 175.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 12.3 tpp180 -100.21 -60.04 1.6 Allowed 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.831 0.824 . . . . 4.33 112.649 -171.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 131.5 152.4 7.21 Favored Glycine 0 N--CA 1.423 -2.232 0 N-CA-C 105.856 -2.897 . . . . 1.53 105.856 -171.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -142.57 141.1 31.95 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 118.832 1.316 . . . . 1.65 111.59 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 27' ' ' TYR . . . . . 0.433 ' HE1' ' HD3' ' B' ' 30' ' ' ARG . 49.3 p90 -161.87 134.61 5.99 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 108.12 -1.067 . . . . 3.42 108.12 175.174 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 28' ' ' PHE . . . . . 0.434 ' CD1' ' HG ' ' B' ' 17' ' ' LEU . 24.2 p90 -151.25 39.84 0.68 Allowed 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 122.105 0.955 . . . . 2.26 110.503 -177.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 29' ' ' SER . . . . . 0.497 ' HA ' ' HA ' ' B' ' 40' ' ' ARG . 54.5 m -143.52 66.07 1.31 Allowed 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.696 -0.628 . . . . 3.68 110.633 177.34 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . 0.433 ' HD3' ' HE1' ' B' ' 27' ' ' TYR . 82.8 mtm180 -99.38 108.23 49.21 Favored Pre-proline 0 C--N 1.311 -1.094 0 N-CA-C 106.973 -1.491 . . . . 3.81 106.973 178.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . 0.663 ' HB3' ' HA ' ' B' ' 36' ' ' SER . 16.5 Cg_exo -69.12 -22.6 34.77 Favored 'Trans proline' 0 C--O 1.248 1.013 0 C-N-CA 122.511 2.141 . . . . 4.02 113.723 -178.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . 62.91 18.23 10.65 Favored 'General case' 0 C--N 1.356 0.888 0 C-N-CA 125.324 1.45 . . . . 4.92 112.693 176.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . 0.456 ' O ' ' HB2' ' B' ' 31' ' ' PRO . 47.3 t 171.64 155.49 0.08 Allowed 'General case' 0 N--CA 1.413 -2.303 0 N-CA-C 104.016 -2.587 . . . . 6.72 104.016 -178.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -84.83 1.85 45.07 Favored 'General case' 0 C--N 1.278 -2.519 0 CA-C-O 122.176 0.988 . . . . 11.63 108.833 -178.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 23.9 t -87.2 -10.88 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-O 122.406 1.098 . . . . 9.61 108.742 173.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . 0.663 ' HA ' ' HB3' ' B' ' 31' ' ' PRO . 16.7 t 65.34 41.54 4.28 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 113.951 -1.477 . . . . 6.71 109.873 176.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 32.5 mmt180 -42.55 -55.25 3.58 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 113.611 -1.631 . . . . 10.0 109.554 173.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . 0.583 ' O ' ' HA ' ' B' ' 31' ' ' PRO . 84.0 mtt180 -84.69 102.09 12.69 Favored 'General case' 0 N--CA 1.414 -2.254 0 N-CA-C 107.204 -1.406 . . . . 7.94 107.204 171.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 25.5 m -81.75 75.4 8.7 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 108.991 -0.744 . . . . 5.76 108.991 177.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . 0.497 ' HA ' ' HA ' ' B' ' 29' ' ' SER . 71.7 mtp180 65.15 169.55 0.2 Allowed 'General case' 0 CA--C 1.559 1.299 0 C-N-CA 126.101 1.761 . . . . 6.03 110.587 -176.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . -128.52 150.57 18.64 Favored Glycine 0 N--CA 1.418 -2.565 0 N-CA-C 110.279 -1.128 . . . . 2.37 110.279 -178.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . 0.542 HD11 HD21 ' B' ' 17' ' ' LEU 0.255 11.8 pt 60.52 -33.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 128.421 2.689 . . . . 2.07 115.346 179.155 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.656 ' O ' ' HB2' ' B' ' 47' ' ' CYS . 6.8 p -56.03 -44.2 77.75 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.452 0 N-CA-C 113.2 0.815 . . . . 2.24 113.2 -178.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -94.73 -31.21 13.89 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.321 -0.992 . . . . 3.36 108.321 -173.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . 0.515 ' O ' ' HB2' ' B' ' 49' ' ' ARG . 28.7 tt0 -67.57 -13.4 62.03 Favored 'General case' 0 CA--C 1.555 1.14 0 CA-C-N 114.728 -1.124 . . . . 3.08 109.924 177.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 46' ' ' CYS . . . . . 0.425 ' SG ' ' HB ' ' B' ' 7' ' ' THR . 45.5 t -117.86 -14.19 10.08 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-O 121.397 0.618 . . . . 2.23 110.165 174.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 47' ' ' CYS . . . . . 0.656 ' HB2' ' O ' ' B' ' 43' ' ' VAL . 27.3 t -70.04 -44.55 68.99 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.967 -0.383 . . . . 2.37 109.967 -177.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -119.65 23.3 11.23 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.422 -0.354 . . . . 2.82 110.712 -178.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . 0.515 ' HB2' ' O ' ' B' ' 45' ' ' GLU . 68.4 mtt180 -145.36 162.38 37.4 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 108.393 -0.965 . . . . 4.09 108.393 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 22.4 t -85.18 109.16 18.1 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 106.523 -1.658 . . . . 2.67 106.523 173.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . 0.867 ' H ' HG21 ' B' ' 7' ' ' THR . 15.8 p -101.67 144.89 29.83 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 108.001 -1.111 . . . . 2.11 108.001 -176.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -93.13 144.61 25.1 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.419 0.628 . . . . 2.67 109.434 177.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . 0.757 ' HB3' ' HE3' ' A' 1601 ' ' LYS . 48.8 tp -58.46 -27.88 64.8 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.098 1.359 . . . . 1.9 111.363 -179.027 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.32 -39.23 75.4 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.425 -0.807 . . . . 1.52 111.122 178.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 31.3 tp -56.38 -54.63 43.29 Favored 'General case' 0 CA--C 1.516 -0.331 0 O-C-N 124.272 0.983 . . . . 1.97 111.323 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 2.4 pp -73.85 -28.53 61.64 Favored 'General case' 0 N--CA 1.427 -1.61 0 C-N-CA 121.099 -0.24 . . . . 1.53 111.427 -176.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -63.5 -50.47 69.5 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 123.512 0.507 . . . . 2.27 110.711 177.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 14.6 t -80.11 -7.91 59.13 Favored 'General case' 0 CA--C 1.557 1.224 0 CA-C-O 121.092 0.473 . . . . 2.33 111.076 -179.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 59' ' ' TYR . . . . . 0.405 ' HB3' ' H ' ' B' ' 60' ' ' CYS . 15.3 t80 -89.07 -80.13 0.3 Allowed 'General case' 0 N--CA 1.42 -1.973 0 N-CA-C 106.891 -1.522 . . . . 2.86 106.891 176.076 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 60' ' ' CYS . . . . . 0.405 ' H ' ' HB3' ' B' ' 59' ' ' TYR . 43.5 t 47.59 -79.62 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 126.067 1.747 . . . . 2.3 113.869 -178.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -162.65 -45.74 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 105.759 -1.941 . . . . 3.19 105.759 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 2.1 p -133.03 135.19 25.39 Favored Pre-proline 0 N--CA 1.403 -2.806 0 CA-C-N 112.731 -2.031 . . . . 3.68 106.604 175.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -69.05 -31.35 23.87 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 123.141 2.561 . . . . 5.08 116.939 -170.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -150.91 73.74 1.13 Allowed 'General case' 0 C--N 1.294 -1.831 0 C-N-CA 120.312 -0.555 . . . . 5.1 112.026 -178.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -98.56 -7.83 27.54 Favored 'General case' 0 N--CA 1.427 -1.587 0 C-N-CA 120.711 -0.396 . . . . 8.51 111.305 175.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 19.9 m -60.12 -44.17 95.08 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.543 -0.91 . . . . 8.12 108.543 175.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 . . . . . 0 N--CA 1.428 -1.572 0 N-CA-C 106.903 -1.517 . . . . 10.21 106.903 176.921 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 64.9 mtm . . . . . 0 CA--C 1.511 -0.543 0 N-CA-C 108.379 -0.971 . . . . 9.34 108.379 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A 1509 ' ' LYS . . . . . 0.914 ' HD2' ' HB2' ' A' 1514 ' ' ASP . 3.3 mmmp? 77.01 -29.13 0.17 Allowed 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 125.16 1.384 . . . . 9.04 113.956 175.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 15.3 m -98.29 3.16 48.72 Favored 'General case' 0 C--N 1.277 -2.571 0 CA-C-N 115.586 -0.734 . . . . 5.81 110.745 -177.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1511 ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -93.33 -55.48 3.29 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 116.216 -0.447 . . . . 3.42 110.717 -178.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1512 ' ' GLU . . . . . 0.581 ' HG2' ' HA ' ' A' 1518 ' ' VAL . 0.7 OUTLIER -106.2 -60.19 1.68 Allowed 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 122.248 1.023 . . . . 5.95 109.361 176.746 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 11.9 t-160 160.12 -28.74 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.896 0 C-N-CA 128.287 2.635 . . . . 5.33 104.225 -172.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1514 ' ' ASP . . . . . 0.914 ' HB2' ' HD2' ' A' 1509 ' ' LYS . 0.7 OUTLIER 56.06 42.1 28.84 Favored 'General case' 0 CA--C 1.507 -0.694 0 C-N-CA 128.332 2.653 . . . . 5.06 111.932 172.654 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 13.3 t70 -102.76 70.3 1.11 Allowed 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.126 -0.943 . . . . 2.9 109.448 -176.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1516 ' ' CYS . . . . . 0.692 ' HA ' HD23 ' A' 1581 ' ' LEU . 96.0 m 62.35 20.86 12.13 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.756 0.822 . . . . 1.19 112.952 -176.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -155.8 130.83 9.31 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 108.404 -0.961 . . . . 1.52 108.404 177.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1518 ' ' VAL . . . . . 0.581 ' HA ' ' HG2' ' A' 1512 ' ' GLU . 0.5 OUTLIER -144.14 145.58 21.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 C-N-CA 123.575 0.75 . . . . 0.94 110.066 -178.706 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A 1519 ' ' THR . . . . . 0.407 ' H ' ' HG2' ' A' 1512 ' ' GLU . 27.1 m -114.48 142.49 46.32 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 109.86 -0.422 . . . . 0.89 109.86 -179.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1520 ' ' ASN . . . . . 0.489 ' OD1' HG22 ' A' 1523 ' ' THR . 18.1 t-20 -87.68 113.36 54.06 Favored Pre-proline 0 C--N 1.307 -1.257 0 N-CA-C 107.632 -1.248 . . . . 1.74 107.632 171.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -69.44 -7.49 21.09 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.949 2.433 . . . . 1.58 113.351 -174.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1522 ' ' SER . . . . . 0.455 ' HB2' ' OD1' ' A' 1520 ' ' ASN . 42.9 m -79.26 -45.98 18.7 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 121.116 -0.234 . . . . 1.65 110.95 178.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1523 ' ' THR . . . . . 0.489 HG22 ' OD1' ' A' 1520 ' ' ASN . 7.7 t -111.0 -15.37 13.76 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 120.358 -0.537 . . . . 1.61 112.3 -176.19 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 83.52 25.82 45.4 Favored Glycine 0 C--O 1.225 -0.457 0 C-N-CA 121.041 -0.6 . . . . 1.13 113.195 176.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -92.81 125.14 37.27 Favored 'General case' 0 C--N 1.309 -1.158 0 C-N-CA 120.589 -0.445 . . . . 1.26 110.074 -178.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 2.7 tm? -94.91 116.62 28.94 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 124.071 0.948 . . . . 0.68 109.447 -178.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -92.54 131.39 37.7 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 120.22 -0.592 . . . . 0.65 109.976 173.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 17.3 t70 -120.13 121.06 37.98 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.589 -0.893 . . . . 1.17 108.589 174.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1529 ' ' LEU . . . . . 0.578 ' HG ' HD21 ' A' 1581 ' ' LEU . 3.1 mm? -100.98 5.82 43.29 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 121.332 0.587 . . . . 0.6 110.509 -176.19 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 2.4 m -73.45 -24.75 60.27 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.715 -0.675 . . . . 0.84 110.235 -178.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 23.0 t -66.7 -28.75 68.69 Favored 'General case' 0 CA--C 1.555 1.149 0 CA-C-O 121.366 0.603 . . . . 1.59 110.38 178.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1532 ' ' LEU . . . . . 0.482 ' HG ' HD21 ' A' 1644 ' ' LEU . 95.5 mt -90.92 3.19 55.26 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.071 0.462 . . . . 0.65 110.925 178.177 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1533 ' ' SER . . . . . . . . . . . . . 13.1 t -80.91 176.49 9.77 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.496 0.665 . . . . 1.52 109.622 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . 150.79 153.77 6.26 Favored Glycine 0 N--CA 1.423 -2.195 0 N-CA-C 110.998 -0.841 . . . . 1.1 110.998 -176.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -78.71 -31.97 46.68 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 121.016 0.436 . . . . 4.62 110.604 -178.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -78.11 -29.5 48.97 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.211 0.529 . . . . 1.45 110.723 -179.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 74.34 -141.52 28.98 Favored Glycine 0 N--CA 1.426 -2.028 0 C-N-CA 120.871 -0.681 . . . . 0.85 112.232 177.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -145.18 144.99 31.16 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.82 -1.178 . . . . 0.93 107.82 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 2.6 m -106.62 133.37 51.4 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.317 0.58 . . . . 1.03 110.193 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1540 ' ' ALA . . . . . 0.69 ' HB2' ' HG2' ' A' 1624 ' ' PRO . . . -127.13 140.84 51.98 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.606 -0.887 . . . . 0.5 108.606 178.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -84.08 142.79 30.16 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 123.518 0.511 . . . . 0.74 110.631 -179.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1542 ' ' TYR . . . . . 0.458 ' HD2' ' HE1' ' A' 1567 ' ' PHE . 0.3 OUTLIER -129.53 -101.8 0.32 Allowed 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 107.899 -1.149 . . . . 0.99 107.899 177.713 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A 1543 ' ' SER . . . . . . . . . . . . . 12.5 t -75.2 178.25 5.89 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 109.869 -0.419 . . . . 1.91 109.869 178.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 60.7 tttp -52.61 -44.13 65.8 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.804 0.841 . . . . 3.59 113.235 -173.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 11.1 t -123.01 32.33 5.73 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 107.329 -1.36 . . . . 2.46 107.329 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . -126.6 111.23 1.36 Allowed Glycine 0 N--CA 1.43 -1.707 0 CA-C-N 115.114 -0.948 . . . . 1.26 113.133 -174.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 20.4 m -110.31 157.45 10.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 N-CA-C 108.331 -0.988 . . . . 0.79 108.331 175.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1548 ' ' VAL . . . . . 0.527 ' HA ' ' HA ' ' A' 1567 ' ' PHE . 10.2 p -114.68 132.28 64.3 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 N-CA-C 109.369 -0.604 . . . . 0.58 109.369 177.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -101.1 117.51 35.16 Favored 'General case' 0 CA--C 1.488 -1.405 0 N-CA-C 108.714 -0.847 . . . . 1.08 108.714 178.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 13.0 ptp -129.53 139.41 51.54 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-N 115.824 -0.626 . . . . 0.78 110.402 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 7.1 p -117.48 120.61 38.63 Favored 'General case' 0 C--N 1.274 -2.678 0 CA-C-N 115.016 -0.993 . . . . 0.97 108.459 176.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1552 ' ' ILE . . . . . 0.423 ' HB ' ' O ' ' A' 1532 ' ' LEU . 38.6 mm -77.5 120.85 28.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 C-N-CA 120.672 -0.411 . . . . 0.42 110.571 -177.264 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 38.1 t 67.61 39.43 2.78 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 122.282 1.039 . . . . 1.4 109.314 174.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 176.86 -169.86 42.4 Favored Glycine 0 N--CA 1.422 -2.288 0 C-N-CA 120.436 -0.888 . . . . 0.35 111.258 -178.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -113.53 151.5 31.48 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 120.967 0.413 . . . . 1.62 111.53 -176.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -99.23 146.38 26.25 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 114.676 -1.147 . . . . 0.87 109.107 -176.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -92.45 4.94 52.47 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 112.374 0.509 . . . . 2.49 112.374 -170.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -93.63 -7.77 42.97 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 121.594 -0.691 . . . . 1.38 111.655 -179.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1559 ' ' CYS . . . . . 0.441 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 78.7 m -136.6 165.96 31.29 Favored Pre-proline 0 C--N 1.297 -1.682 0 CA-C-O 118.398 -0.811 . . . . 1.21 109.849 -178.166 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1560 ' ' PRO . . . . . 0.441 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 7.7 Cg_exo -36.5 118.57 0.2 Allowed 'Trans proline' 0 C--N 1.367 1.518 0 C-N-CA 124.561 3.508 . . . . 0.71 113.951 176.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -44.74 130.66 9.89 Favored 'Trans proline' 0 C--N 1.362 1.255 0 C-N-CA 124.59 3.527 . . . . 0.8 112.18 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 111.79 -6.69 27.7 Favored Glycine 0 N--CA 1.435 -1.408 0 CA-C-N 115.906 -0.588 . . . . 0.46 112.404 -177.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1563 ' ' VAL . . . . . . . . . . . . . 7.5 p -105.27 137.19 35.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 O-C-N 122.109 -0.642 . . . . 0.98 111.496 -178.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -99.54 -32.68 5.63 Favored Glycine 0 C--N 1.322 -0.241 0 CA-C-N 115.615 -0.72 . . . . 0.28 112.771 -178.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -122.88 126.21 46.88 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 109.479 -0.563 . . . . 0.28 109.479 178.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 46.5 t -153.73 148.38 26.32 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.842 -0.799 . . . . 0.43 108.842 -179.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1567 ' ' PHE . . . . . 0.637 ' HB2' ' OG1' ' A' 1570 ' ' THR . 96.7 m-85 -92.11 158.78 16.01 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 119.732 -0.787 . . . . 1.03 109.548 176.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -62.6 -75.92 0.29 Allowed Glycine 0 C--O 1.245 0.81 0 N-CA-C 115.183 0.833 . . . . 1.13 115.183 -173.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -67.18 -34.48 77.62 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 113.159 0.799 . . . . 2.58 113.159 -173.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1570 ' ' THR . . . . . 0.739 ' HB ' HG13 ' A' 1572 ' ' ILE . 45.9 p -67.81 -35.17 78.15 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 112.429 0.529 . . . . 2.17 112.429 -177.019 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 18.1 mmt180 64.55 8.88 4.66 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.672 1.189 . . . . 2.62 110.746 -174.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1572 ' ' ILE . . . . . 0.739 HG13 ' HB ' ' A' 1570 ' ' THR . 18.1 mt -74.61 127.29 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-O 121.301 0.572 . . . . 0.92 111.438 -175.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 13.0 t -74.79 118.21 17.5 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 114.922 -1.035 . . . . 0.8 108.656 177.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1574 ' ' VAL . . . . . 0.594 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 24.8 m -114.58 20.29 6.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 C-N-CA 119.738 -0.785 . . . . 0.98 111.933 -179.168 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 161.44 119.75 0.52 Allowed Glycine 0 N--CA 1.432 -1.602 0 C-N-CA 120.327 -0.94 . . . . 0.29 112.451 176.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 57.7 tttm -64.66 139.89 58.81 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.843 -0.429 . . . . 2.19 109.843 178.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -71.73 144.34 49.31 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 115.477 -0.783 . . . . 0.61 110.057 -179.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 22.2 p30 -161.31 179.01 8.66 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 107.853 -1.166 . . . . 1.95 107.853 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 17.7 pttm -134.04 46.53 2.51 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-O 122.941 1.353 . . . . 2.68 108.784 177.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 64.7 ttt180 -101.48 99.88 10.26 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-N 113.383 -1.735 . . . . 3.47 107.75 -175.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1581 ' ' LEU . . . . . 0.692 HD23 ' HA ' ' A' 1516 ' ' CYS . 0.3 OUTLIER -93.53 137.58 32.68 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.855 -0.795 . . . . 0.64 108.855 -175.58 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 75.6 mtp180 -123.91 124.77 43.35 Favored 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 120.652 -0.419 . . . . 2.85 111.045 171.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1583 ' ' TYR . . . . . 0.465 ' HB2' HG21 ' A' 1518 ' ' VAL . 71.1 t80 -96.31 112.78 24.4 Favored 'General case' 0 CA--C 1.49 -1.364 0 N-CA-C 107.239 -1.393 . . . . 0.86 107.239 173.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1584 ' ' VAL . . . . . 0.553 ' O ' ' HB ' ' A' 1587 ' ' VAL . 20.3 t -128.39 92.33 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 N-CA-C 109.501 -0.555 . . . . 1.05 109.501 -178.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 32.6 t70 50.83 69.2 0.67 Allowed 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 124.905 1.282 . . . . 1.17 112.041 175.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 3.0 pt20 71.37 -8.04 1.09 Allowed 'General case' 0 N--CA 1.504 2.271 0 C-N-CA 128.498 2.719 . . . . 1.86 112.197 178.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1587 ' ' VAL . . . . . 0.553 ' HB ' ' O ' ' A' 1584 ' ' VAL . 13.8 t -91.68 120.31 40.54 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.23 0 CA-C-N 115.263 -0.881 . . . . 0.49 110.106 178.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1588 ' ' LEU . . . . . 0.811 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 3.2 mm? -91.06 107.66 19.35 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 105.923 -1.88 . . . . 0.36 105.923 174.49 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -111.08 131.07 55.38 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-O 121.694 0.759 . . . . 1.74 112.515 -173.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1590 ' ' LEU . . . . . 0.449 ' HB2' ' HB ' ' A' 1610 ' ' ILE . 15.0 mt -123.86 104.76 9.14 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 114.0 -1.455 . . . . 0.72 107.699 173.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1591 ' ' VAL . . . . . 0.515 HG23 HG22 ' A' 1609 ' ' VAL . 6.3 p -97.53 128.57 48.72 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 N-CA-C 108.799 -0.815 . . . . 1.01 108.799 179.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1592 ' ' TYR . . . . . 0.506 ' O ' ' HA ' ' A' 1607 ' ' LYS . 15.9 m-30 -115.19 102.65 10.09 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.673 -0.862 . . . . 0.5 108.673 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 57.8 pttt -109.9 176.43 5.07 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.244 -0.65 . . . . 1.59 109.244 -178.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 21.8 m-20 61.0 51.11 4.67 Favored 'General case' 0 C--N 1.312 -1.037 0 O-C-N 124.095 0.872 . . . . 1.11 112.158 177.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -83.09 -134.51 2.28 Favored Glycine 0 N--CA 1.425 -2.098 0 N-CA-C 109.629 -1.389 . . . . 0.78 109.629 172.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1596 ' ' SER . . . . . . . . . . . . . 29.9 p -100.33 157.96 32.85 Favored Pre-proline 0 C--N 1.29 -1.994 0 O-C-N 122.036 -0.685 . . . . 1.07 109.648 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1597 ' ' PRO . . . . . 0.508 ' HA ' ' O ' ' A' 1604 ' ' LEU . 73.4 Cg_exo -52.01 123.6 12.86 Favored 'Trans proline' 0 C--N 1.36 1.167 0 C-N-CA 123.059 2.506 . . . . 1.01 112.234 177.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1598 ' ' CYS . . . . . 0.621 ' HA ' ' CE1' ' A' 1606 ' ' TYR . 43.7 t -77.94 117.84 68.42 Favored Pre-proline 0 C--N 1.299 -1.627 0 CA-C-N 114.959 -1.018 . . . . 0.75 109.659 -178.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -63.93 -30.31 67.23 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.914 2.409 . . . . 1.7 111.855 178.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1600 ' ' SER . . . . . 0.64 ' HA ' ' HB2' ' B' ' 53' ' ' LEU . 14.4 m -61.65 -49.27 77.23 Favored 'General case' 0 C--O 1.25 1.083 0 CA-C-N 116.009 -0.542 . . . . 2.26 110.852 178.264 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1601 ' ' LYS . . . . . 0.686 ' HG2' HD22 ' A' 1604 ' ' LEU . 0.6 OUTLIER -120.81 98.49 6.03 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 107.114 -1.439 . . . . 3.01 107.114 -178.958 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 19.3 m -57.96 119.32 6.55 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 113.822 1.045 . . . . 2.07 113.822 -171.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 98.96 -8.45 61.19 Favored Glycine 0 CA--C 1.499 -0.964 0 N-CA-C 111.595 -0.602 . . . . 1.08 111.595 177.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1604 ' ' LEU . . . . . 0.686 HD22 ' HG2' ' A' 1601 ' ' LYS . 8.8 tp -90.97 170.98 9.6 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.735 -1.209 . . . . 1.84 107.735 -179.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 32.5 t -130.48 150.93 51.47 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 108.644 -0.873 . . . . 1.41 108.644 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1606 ' ' TYR . . . . . 0.621 ' CE1' ' HA ' ' A' 1598 ' ' CYS . 57.8 m-85 -71.48 157.76 37.46 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.744 -0.662 . . . . 0.6 110.856 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1607 ' ' LYS . . . . . 0.506 ' HA ' ' O ' ' A' 1592 ' ' TYR . 75.7 tttt -157.39 125.44 5.47 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 109.21 -0.663 . . . . 1.45 109.21 -173.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1608 ' ' SER . . . . . . . . . . . . . 28.5 m -112.48 132.05 55.26 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-N 116.278 -0.419 . . . . 1.15 109.933 -178.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1609 ' ' VAL . . . . . 0.515 HG22 HG23 ' A' 1591 ' ' VAL . 39.8 t -109.35 108.59 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.507 0 N-CA-C 108.448 -0.945 . . . . 0.25 108.448 177.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1610 ' ' ILE . . . . . 0.449 ' HB ' ' HB2' ' A' 1590 ' ' LEU . 68.7 mt -95.24 126.66 47.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 N-CA-C 108.06 -1.089 . . . . 0.45 108.06 179.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 23.4 m -127.26 118.47 24.3 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 116.138 -0.483 . . . . 1.26 110.911 -178.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1612 ' ' PHE . . . . . 0.811 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 70.0 m-85 -95.55 128.02 42.07 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.912 -0.585 . . . . 0.26 109.596 177.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1613 ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' 1641 ' ' HIS . 66.2 t -122.7 138.84 51.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 CA-C-N 115.402 -0.817 . . . . 0.5 109.443 -177.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1614 ' ' CYS . . . . . 0.71 ' HB2' ' HA ' ' A' 1646 ' ' CYS . 4.0 t -52.07 119.82 4.75 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 124.352 1.061 . . . . 0.77 113.169 176.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1615 ' ' ARG . . . . . 0.824 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 22.2 tpt180 -135.29 89.66 22.63 Favored Pre-proline 0 N--CA 1.439 -0.993 0 N-CA-C 107.739 -1.208 . . . . 2.53 107.739 170.09 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1616 ' ' PRO . . . . . 0.572 ' HD3' ' SG ' ' A' 1614 ' ' CYS . 51.3 Cg_endo -68.94 -23.06 35.06 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.195 1.93 . . . . 1.1 113.425 -172.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -94.86 -3.56 48.61 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.527 -0.306 . . . . 3.05 111.051 -179.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . 59.51 -165.85 0.19 Allowed 'General case' 0 CA--C 1.554 1.108 0 N-CA-C 109.455 -0.572 . . . . 1.55 109.455 -173.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . 135.3 -163.54 24.88 Favored Glycine 0 N--CA 1.415 -2.739 0 C-N-CA 120.961 -0.637 . . . . 0.93 112.403 174.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -61.3 -8.24 10.02 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 124.243 3.295 . . . . 0.88 115.069 -177.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1621 ' ' THR . . . . . . . . . . . . . 19.0 p -96.43 -0.65 48.9 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-O 121.199 0.523 . . . . 0.97 111.369 -177.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 41.4 t30 -87.25 63.43 7.79 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 122.243 1.02 . . . . 0.72 109.059 178.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 -172.76 140.07 0.95 Allowed Pre-proline 0 C--N 1.304 -1.387 0 N-CA-C 107.443 -1.318 . . . . 3.26 107.443 -177.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1624 ' ' PRO . . . . . 0.69 ' HG2' ' HB2' ' A' 1540 ' ' ALA . 35.1 Cg_endo -64.08 99.72 0.29 Allowed 'Trans proline' 0 C--O 1.246 0.917 0 C-N-CA 122.859 2.372 . . . . 0.59 112.355 -176.243 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 70.7 mtm -98.07 133.49 42.45 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.99 -0.55 . . . . 1.37 110.703 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 1.4 tm? -74.58 116.62 15.48 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 108.15 -1.056 . . . . 0.89 108.15 -178.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1627 ' ' ILE . . . . . 0.505 HD11 ' HB2' ' A' 1639 ' ' SER . 43.1 mm -79.56 -55.63 8.83 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 N-CA-C 108.378 -0.971 . . . . 0.58 108.378 177.41 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 77.9 p -164.72 150.27 10.03 Favored 'General case' 0 N--CA 1.419 -1.982 0 CA-C-N 114.833 -1.076 . . . . 1.39 109.537 -179.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1629 ' ' LEU . . . . . 0.865 HD13 ' HG ' ' A' 1636 ' ' LEU . 27.8 tp -119.14 112.31 19.36 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 106.885 -1.524 . . . . 1.25 106.885 172.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 33.1 t70 -78.4 128.86 34.24 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 117.549 -1.661 . . . . 1.09 111.628 177.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1631 ' ' LYS . . . . . 0.513 ' HD3' ' H ' ' A' 1631 ' ' LYS . 0.1 OUTLIER -66.05 -28.96 69.24 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 112.726 -2.034 . . . . 3.6 113.108 -175.564 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 11.1 mm100 -103.0 -35.44 8.55 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 119.918 -0.713 . . . . 2.6 112.134 -174.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 73.9 p -91.99 -6.59 50.92 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-O 120.8 0.333 . . . . 0.75 111.605 -178.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 64.1 m 54.06 33.51 17.83 Favored 'General case' 0 C--N 1.362 1.147 0 C-N-CA 124.669 1.187 . . . . 0.53 111.898 176.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1635 ' ' THR . . . . . . . . . . . . . 29.2 m -100.53 132.1 46.09 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 115.624 -0.716 . . . . 0.46 109.37 -178.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1636 ' ' LEU . . . . . 0.865 ' HG ' HD13 ' A' 1629 ' ' LEU . 0.6 OUTLIER -111.08 124.11 51.54 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 107.919 -1.141 . . . . 0.86 107.919 -177.604 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -106.5 129.38 54.47 Favored 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 120.997 -0.281 . . . . 0.45 110.494 -179.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -125.36 134.9 52.01 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.197 -0.456 . . . . 0.5 110.269 -178.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1639 ' ' SER . . . . . 0.505 ' HB2' HD11 ' A' 1627 ' ' ILE . 31.0 t -110.29 148.81 31.18 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 107.663 -1.236 . . . . 1.04 107.663 176.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 2.6 t90 -152.69 114.27 4.29 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 105.951 -1.87 . . . . 0.68 105.951 -178.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1641 ' ' HIS . . . . . 0.824 ' HB3' ' HB2' ' A' 1615 ' ' ARG . 8.9 m-70 -105.04 115.56 30.48 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 108.889 -0.782 . . . . 0.9 108.889 -178.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1642 ' ' THR . . . . . . . . . . . . . 3.0 t -137.24 150.59 69.51 Favored Pre-proline 0 C--N 1.3 -1.547 0 C-N-CA 123.065 0.546 . . . . 0.48 110.445 -172.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1643 ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.49 -18.38 17.74 Favored 'Trans proline' 0 C--N 1.367 1.524 0 C-N-CA 122.622 2.215 . . . . 0.66 113.328 178.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1644 ' ' LEU . . . . . 0.482 HD21 ' HG ' ' A' 1532 ' ' LEU . 3.8 pp -84.45 -1.47 55.72 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 119.806 -0.757 . . . . 0.97 111.729 -178.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -120.06 28.66 7.95 Favored 'General case' 0 CA--C 1.498 -1.048 0 CA-C-O 122.103 0.954 . . . . 0.84 109.531 -178.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1646 ' ' CYS . . . . . 0.71 ' HA ' ' HB2' ' A' 1614 ' ' CYS . 45.9 t -105.7 140.87 38.1 Favored 'General case' 0 N--CA 1.41 -2.471 0 CA-C-N 114.842 -1.072 . . . . 1.19 109.835 -177.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -100.83 123.3 46.03 Favored Pre-proline 0 N--CA 1.419 -2.018 0 N-CA-C 104.928 -2.249 . . . . 3.14 104.928 175.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1648 ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -27.69 103.61 0.02 OUTLIER 'Trans proline' 0 C--N 1.367 1.51 1 C-N-CA 125.943 4.429 . . . . 2.58 116.304 -171.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 . . . . . 0 C--O 1.251 1.175 0 CA-C-N 114.981 -1.009 . . . . 4.72 109.215 178.073 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.683 0 N-CA-C 108.573 -0.899 . . . . 9.97 108.573 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 2' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -126.82 131.95 51.12 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.714 -0.847 . . . . 7.68 108.714 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -114.15 144.54 31.83 Favored Pre-proline 0 C--N 1.294 -1.812 0 N-CA-C 108.606 -0.887 . . . . 6.11 108.606 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -76.58 55.72 4.88 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 123.095 2.53 . . . . 4.84 112.734 178.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 13.4 m 60.15 9.58 1.93 Allowed 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 127.108 2.163 . . . . 4.6 115.519 171.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 64.2 24.96 13.52 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.859 1.263 . . . . 4.23 110.586 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 3.7 p -130.65 116.15 17.69 Favored 'General case' 0 C--N 1.283 -2.287 0 CA-C-N 113.433 -1.712 . . . . 3.14 108.404 177.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.58 ' HB2' ' H ' ' B' ' 12' ' ' GLU . 78.9 mt -64.59 113.99 4.09 Favored 'General case' 0 C--O 1.247 0.965 0 N-CA-C 108.761 -0.829 . . . . 3.96 108.761 177.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 20.1 m -50.47 -21.57 1.54 Allowed 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.986 1.314 . . . . 2.84 114.24 -174.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . 0.439 ' O ' HG12 ' B' ' 14' ' ' VAL . . . -117.62 -65.7 0.34 Allowed Glycine 0 N--CA 1.425 -2.071 0 C-N-CA 120.518 -0.849 . . . . 2.09 111.433 179.142 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -55.72 -55.07 30.72 Favored Glycine 0 C--O 1.24 0.502 0 N-CA-C 114.388 0.515 . . . . 1.84 114.388 -174.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . 0.58 ' H ' ' HB2' ' B' ' 8' ' ' LEU . 55.8 mt-10 -74.25 -32.49 62.98 Favored 'General case' 0 CA--C 1.505 -0.775 0 C-N-CA 120.69 -0.404 . . . . 2.55 111.282 -177.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . 0.411 HD13 ' HA ' ' B' ' 13' ' ' LEU . 1.1 mm? -58.1 -59.0 5.96 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.175 0.512 . . . . 2.35 111.411 178.006 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . 0.439 HG12 ' O ' ' B' ' 10' ' ' GLY . 13.0 p -68.89 -35.33 68.84 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 CA-C-N 115.857 -0.61 . . . . 2.11 111.882 -176.131 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -78.34 -26.69 46.85 Favored 'General case' 0 C--O 1.213 -0.866 0 N-CA-C 114.105 1.15 . . . . 2.04 114.105 -179.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 19.6 p -67.09 -36.6 82.33 Favored 'General case' 0 C--O 1.256 1.437 0 CA-C-N 119.692 1.133 . . . . 1.84 108.819 174.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.72 ' HB3' ' HB3' ' B' ' 26' ' ' PHE . 10.4 mp -60.77 -47.85 84.43 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-N 114.978 -1.01 . . . . 1.74 111.335 171.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -63.09 -33.3 75.15 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.036 0.446 . . . . 2.39 110.07 179.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -55.52 -59.25 5.09 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 112.905 0.706 . . . . 0.96 112.905 -179.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 9.8 p -98.51 -20.21 5.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 C-N-CA 117.314 -1.755 . . . . 1.37 112.068 -179.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 21' ' ' CYS . . . . . 0.461 ' HB2' ' O ' ' B' ' 17' ' ' LEU . 69.4 m -99.66 1.25 43.33 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 113.473 0.916 . . . . 1.66 113.473 -175.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -49.29 -36.59 22.94 Favored Glycine 0 N--CA 1.483 1.806 0 N-CA-C 114.789 0.676 . . . . 1.53 114.789 -178.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -52.05 -46.91 65.28 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.873 0.869 . . . . 2.72 111.891 176.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . 0.408 ' HD3' ' O ' ' B' ' 62' ' ' THR . 42.8 ttm180 -97.56 -43.47 7.22 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.277 0.56 . . . . 4.33 111.348 178.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 128.19 165.54 11.84 Favored Glycine 0 N--CA 1.425 -2.082 0 N-CA-C 110.19 -1.164 . . . . 1.53 110.19 -179.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . 0.72 ' HB3' ' HB3' ' B' ' 17' ' ' LEU . 3.4 p90 -98.25 128.01 44.48 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 117.163 0.481 . . . . 1.65 109.83 175.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 27' ' ' TYR . . . . . 0.629 ' HB2' ' HA ' ' B' ' 61' ' ' ALA . 53.6 m-85 -132.78 72.92 1.5 Allowed 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 121.577 0.703 . . . . 3.42 110.482 -176.354 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 28' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -104.43 -3.83 23.55 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.123 -0.944 . . . . 2.26 109.282 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 29' ' ' SER . . . . . 0.593 ' HA ' ' HG2' ' B' ' 40' ' ' ARG . 14.9 m -101.9 51.49 0.83 Allowed 'General case' 0 N--CA 1.441 -0.904 0 CA-C-O 121.922 0.868 . . . . 3.68 109.082 -176.059 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . 0.401 ' HA ' ' HD3' ' B' ' 31' ' ' PRO . 73.8 mtp180 -102.33 113.84 65.69 Favored Pre-proline 0 C--N 1.299 -1.601 0 CA-C-N 115.312 -0.858 . . . . 3.81 108.884 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . 0.451 ' HA ' ' O ' ' B' ' 38' ' ' ARG . 20.0 Cg_exo -62.46 -25.34 75.92 Favored 'Trans proline' 0 C--O 1.249 1.031 0 C-N-CA 123.305 2.67 . . . . 4.02 113.357 -177.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . 61.08 16.47 7.13 Favored 'General case' 0 C--N 1.36 1.061 0 C-N-CA 125.71 1.604 . . . . 4.92 112.837 174.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . 0.402 ' O ' ' HB2' ' B' ' 31' ' ' PRO . 29.4 t 175.14 157.43 0.18 Allowed 'General case' 0 N--CA 1.389 -3.522 0 N-CA-C 104.464 -2.421 . . . . 6.72 104.464 -177.185 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 34' ' ' ARG . . . . . . . . . . . . . 46.7 ttt180 -87.6 -1.66 58.09 Favored 'General case' 0 C--N 1.271 -2.84 0 N-CA-C 108.52 -0.918 . . . . 11.63 108.52 -177.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 51.4 t -87.09 -5.46 10.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 114.649 -1.159 . . . . 9.61 109.403 178.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 20.4 t 64.61 29.21 13.13 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.1 -0.954 . . . . 6.71 109.294 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 55.6 ttp180 -57.08 -49.79 74.77 Favored 'General case' 0 N--CA 1.436 -1.175 0 CA-C-N 114.641 -1.163 . . . . 10.0 111.149 -177.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . 0.451 ' O ' ' HA ' ' B' ' 31' ' ' PRO . 11.8 tpp85 -85.42 102.97 13.89 Favored 'General case' 0 N--CA 1.423 -1.824 0 N-CA-C 107.228 -1.397 . . . . 7.94 107.228 174.114 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 17.8 m -97.19 72.79 2.46 Favored 'General case' 0 C--O 1.258 1.526 0 N-CA-C 108.985 -0.746 . . . . 5.76 108.985 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . 0.593 ' HG2' ' HA ' ' B' ' 29' ' ' SER . 91.8 mtt180 62.71 130.26 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 126.18 1.792 . . . . 6.03 112.652 -174.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . -96.48 170.9 27.35 Favored Glycine 0 N--CA 1.438 -1.2 0 N-CA-C 110.139 -1.184 . . . . 2.37 110.139 178.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . 0.27 18.4 pt 60.84 -30.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 C-N-CA 127.185 2.194 . . . . 2.07 116.314 178.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . . . . . . . . . 2.7 p -48.97 -46.23 16.61 Favored 'Isoleucine or valine' 0 C--O 1.245 0.837 0 N-CA-C 114.047 1.128 . . . . 2.24 114.047 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -96.69 -30.61 13.13 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 108.579 -0.897 . . . . 3.36 108.579 -172.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -64.72 -42.4 95.26 Favored 'General case' 0 C--O 1.214 -0.798 0 CA-C-N 114.869 -1.059 . . . . 3.08 111.179 177.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 46' ' ' CYS . . . . . 0.421 ' HA ' ' O ' ' B' ' 49' ' ' ARG . 35.7 t -89.33 -3.12 58.6 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.447 0.642 . . . . 2.23 110.703 -179.468 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 41.9 t -83.41 -50.42 8.33 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.638 0.732 . . . . 2.37 109.491 175.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -88.67 -20.04 25.4 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.866 0.691 . . . . 2.82 112.866 -177.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . 0.421 ' O ' ' HA ' ' B' ' 46' ' ' CYS . 36.1 mmt180 -130.68 150.31 51.93 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 106.68 -1.6 . . . . 4.09 106.68 177.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 22.1 t -79.96 127.5 32.34 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 106.827 -1.545 . . . . 2.67 106.827 178.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 24.3 p -90.52 139.21 30.91 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 109.36 -0.607 . . . . 2.11 109.36 -173.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -85.87 165.0 17.16 Favored 'General case' 0 C--O 1.249 1.07 0 C-N-CA 120.566 -0.454 . . . . 2.67 110.305 177.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . 0.64 ' HB2' ' HA ' ' A' 1600 ' ' SER . 63.5 tp -53.2 -45.02 68.43 Favored 'General case' 0 C--N 1.321 -0.663 0 O-C-N 123.479 0.487 . . . . 1.9 111.649 178.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.89 -32.41 63.69 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.368 -0.833 . . . . 1.52 113.184 -171.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 65.9 tp -70.42 -57.65 4.58 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 121.012 0.434 . . . . 1.97 110.295 179.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 2.9 pp -71.97 -25.25 61.79 Favored 'General case' 0 C--O 1.213 -0.867 0 CA-C-N 116.043 -0.526 . . . . 1.53 111.195 -174.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -64.82 -55.6 18.62 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 122.638 0.375 . . . . 2.27 110.162 178.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 13.2 t -78.89 -27.42 43.91 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 119.331 -0.947 . . . . 2.33 112.06 -177.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 59' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -71.66 -57.19 4.6 Favored 'General case' 0 C--O 1.219 -0.527 0 N-CA-C 107.02 -1.474 . . . . 2.86 107.02 178.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 9.9 t 22.44 -82.59 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 117.121 2.267 . . . . 2.3 117.121 174.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 61' ' ' ALA . . . . . 0.629 ' HA ' ' HB2' ' B' ' 27' ' ' TYR . . . -144.18 -168.77 2.96 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-O 121.854 0.835 . . . . 3.19 110.719 -170.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 62' ' ' THR . . . . . 0.408 ' O ' ' HD3' ' B' ' 24' ' ' ARG . 4.4 t -145.34 148.72 38.63 Favored Pre-proline 0 N--CA 1.406 -2.648 0 N-CA-C 104.547 -2.39 . . . . 3.68 104.547 176.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -51.28 -31.18 36.18 Favored 'Trans proline' 0 N--CA 1.477 0.545 0 C-N-CA 123.666 2.911 . . . . 5.08 116.518 -165.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 58.22 33.4 23.12 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 126.443 1.897 . . . . 5.1 112.429 173.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 47.7 tttm 62.5 132.78 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.449 1.499 . . . . 8.51 112.221 -175.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 22.4 m -89.35 151.64 21.96 Favored 'General case' 0 N--CA 1.427 -1.603 0 N-CA-C 108.083 -1.081 . . . . 8.12 108.083 176.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 . . . . . 0 C--N 1.305 -1.327 0 N-CA-C 108.138 -1.06 . . . . 10.21 108.138 -178.21 . . . . . . . . 0 0 . 1 stop_ save_